Citrus Sinensis ID: 044997

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560---
Protein Sequence
MPLVTTMATLYLFPCLLFFSSLASAFGSGIPIKPSVMDSFPCNEHINTCNALLYHINQGLPVERIASFYSANPSQIKPIFRGNQKDYLITVPCSCKDVNSTRAMIYSGQAWKVGGEENYFIAGVAVPIHLLCGCVETGTQVVVTYTVQQQDTLSIIATLLSAEISGIESMNKMVAQNPGYIDVCWVLFVPMELNGLPTAEKSGKTHKWVTVIALLSAVALFSVITLIIILLRRKRPEEKITEDAKHVSKAMSITTRAFSSQGQCKENTEDVTVLESERTIIFSLEEIEEATNNFDESRIIGRGGFGNVYFGLLGDREAAIKKMRSNKSKEFFAELKVLCKIHHINVFISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITSTEWEASLGGDSQVFSGLFNGR
Secondary Structure (PSIPRED)
cccccHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccccccEEEEccccccHHHHHHHHcccccccccccccccccEEEEccccccccccccEEEEEcccccccccccccccccEEEEEEEccccccccccEEEEEccccccHHHHHHHHcccccccccccccccccccccccccEEEcccccccccccccccccccEEEEHHHHHHHHHHHHHHHHHHHHHcccccccccccHHcccccccccccccccccccccccccccccccccEEEEEHHHHHHHHcccccccccccccccEEEEEEEcccEEEEEEccccHHHHHHHHHHHHHcccccccEEEEcccccHHHHcccccccccccccHHHHHHHHHHHHHHHHHHHcccccccEEcccccccccccccccEEcccccccccccccccccEEEEEEcccccccccccccccccccccccccccccccccccccHHHHHHHHHHHcccccccccccccccHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHHHccccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
ccHHHHHHHHHHHHHHHHcccccccccccccccHcccccccccccEEEcccccEEEcccccccccccccccccccccHHHHHccccccccccHHHccccccccEEcccccccccccccccccccccccEcccccccccccccccHHHHHHHcccccccEEEccccccccccccccccccccccccccEEcccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccccccccccccccccccccccEEcHHHHHHHHccccHHccccccccccEEEEEccccEEEEEEcccccHHHHHHHHHHHHHHHHHHcEEEccccccHHHHHccccccccccccHHHHHHHHHHHHHHHHHHHHccHccEEcccccHHHEEEcccccEEEccccccEEccccccccEcEEEEEEccccccHHHcccccEEEccccccccccEccccHHHHHHHHHHHHHccccccccccccccccHHHHHHHHHHHHHHHcccccccccHHHHHHHHcccccccccccccccccccccccccccc
Coil and Loop (DISEMBL)
MPLVTTMATLYLFPCLLFFSSLAsafgsgipikpsvmdsfpcnehiNTCNALLYHinqglpveriasfysanpsqikpifrgnqkdylitvpcsckdvnstramiysgqawkvggeenyfIAGVAVPIHLLCGCVETGTQVVVTYTVQQQDTLSIIATLLSAEISGIESMNKMvaqnpgyidVCWVLFvpmelnglptaeksgkthKWVTVIALLSAVALFSVITLIIILLRrkrpeekiTEDAKHVSKAMSITtrafssqgqckentedvtvleSERTIIFSLEEIEEatnnfdesriigrggfgnvyfgLLGDREAAIKKMRSNKSKEFFAELKVLCKIHHINVFIStfgngslsdhlhdpllkghqpltWTARTQIALDAAKGIEYIHDHtkaryvhrdiktsnillddglrakVADFGLVKLEERTNEKEMLATRlvgtpgylppeyiFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITgkralirddseptkMKSLITIMAAVAEWClnedavdrpeMRDIVAILSQIMITSTeweaslggdsqvfsglfngr
Flexible Loop (DISEMBL)
MPLVTTMATLYLFPCLLFFSSLASAFGSGIPIKPSVMDSFPCNEHINTCNALLYHINQGLPVERIASFYSANPSQIKPIFRGNQKDYLITVPCSCKDVNSTRAMIYSGQAWKVGGEENYFIAGVAVPIHLLCGCVETGTQVVVTYTVQQQDTLSIIATLLSAEISGIESMNKMVAQNPGYIDVCWVLFVPMELNGLPTAEKSGKTHKWVTVIALLSAVALFSVITLIIILlrrkrpeekitedakhvskamsittrafssqgqckentedvtvlesERTIIFSLEeieeatnnfdesriigrgGFGNVYFGLLGDREAAIKKMRSNKSKEFFAELKVLCKIHHINVFISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHtkaryvhrdiktsnillddglraKVADFGlvkleertnekemlatrlvgtpgylpPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAElitgkralirddseptKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITSTeweaslggdsqvfsglfngr
Low Complexity Region (SEG)
MPLVTTMATLYLFPCllffsslasafgsgIPIKPSVMDSFPCNEHINTCNALLYHINQGLPVERIASFYSANPSQIKPIFRGNQKDYLITVPCSCKDVNSTRAMIYSGQAWKVGGEENYFIAGVAVPIHLLCGCvetgtqvvvtytvqqqdtLSIIATLLSAEISGIESMNKMVAQNPGYIDVCWVLFVPMELNGLPTAEKSGKTHKWVTVIALLSAVALFSVITliiillrrkrPEEKITEDAKHVSKAMSITTRAFSSQGQCKENTEDVTVLESERTIIFSLEEIEEATNNFDESRIIGRGGFGNVYFGLLGDREAAIKKMRSNKSKEFFAELKVLCKIHHINVFISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITSTEWEASLGGDSQVFSGLFNGR
Disordered region (IsUnstruct)
***VTTMATLYLFPCLLFFSSLASAFGSGIPIKPSVMDSFPCNEHINTCNALLYHINQGLPVERIASFYSANPSQIKPIFRGNQKDYLITVPCSCKDVNSTRAMIYSGQAWKVGGEENYFIAGVAVPIHLLCGCVETGTQVVVTYTVQQQDTLSIIATLLSAEISGIESMNKMVAQNPGYIDVCWVLFVPMELNGLPTAEKSGKTHKWVTVIALLSAVALFSVITLIIILLRR*************************************VTVLESERTIIFSLEEIEEATNNFDESRIIGRGGFGNVYFGLLGDREAAIKKMR**KSKEFFAELKVLCKIHHINVFISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDD***TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITSTEWEASLGGD**VF*******
Disordered Region (DISOPRED)
****TTMATLYLFPCLLFFSSLASAFGSGIPIKPSVMDSFPCNEHINTCNALLYHINQGLPVERIASFYSANPSQIKPIFRGNQKDYLITVPCSCKDVNSTRAMIYSGQAWKVGGEENYFIAGVAVPIHLLCGCVETGTQVVVTYTVQQQDTLSIIATLLSAEIS**************YIDVCWV************************VIALLSAVALFSVITLIIILLRR**********************************************IIFSLEEIEEATNNFDESRIIGRGGFGNVYFGLLGDREAAIKKMRSNK*KEFFAELKVLCKIHHINVFISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK***************LITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIM************************
Disordered Region (DISEMBL)
MPLVTTMATLYLFPCLLFFSSLASAFGSGIPIKPSVMDSFPCNEHINTCNALLYHINQGLPVERIASFYSANPSQIKPIFRGNQKDYLITVPCSCKDVNSTRAMIYSGQAWKVGGEENYFIAGVAVPIHLLCGCVETGTQVVVTYTVQQQDTLSIIATLLSAEISGIESMNKMVAQNPGYIDVCWVLFVPMELNGLPTAEKSGKTHKWVTVIALLSAVALFSVITLIIILLRRKRPEEKITEDAKHVSKAMSITT***************VTVLESERTIIFSLEEIEEATNNFDESRIIGRGGFGNVYFGLLGDREAAIKKMRSNKSKEFFAELKVLCKIHHINVFISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITSTEWEASLGGDSQVFSGLFNGR
Disordered Region (DISPRO)
MPLVTTMATLYLFPCLLFFSSLASAFGSGIPIKPSVMDSFPCNEHINTCNALLYHINQGLPVERIASFYSANPSQIKPIFRGNQKDYLITVPCSCKDVNSTRAMIYSGQAWKVGGEENYFIAGVAVPIHLLCGCVETGTQVVVTYTVQQQDTLSIIATLLSAEISGIESMNKMVAQNPGYIDVCWVLFVPMELNGLPT****GKTHKWVTVIALLSAVALFSVITLIIILLRRKRPE***************************************ERTIIFSLEEIEEATNNFDESRIIGRGGFGNVYFGLLGDREAAIKKMRSNKSKEFFAELKVLCKIHHINVFISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSS**ELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQ**************************
Transmembrane Helix (TMHMM)
oooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
iiiiiiHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
SSSSSSSSSSSSSSSSSSSSSSSSSooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
SSSSSSSSSSSSSSSSSSSSSSSSSSooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MPLVTTMATLYLFPCLLFFSSLASAFGSGIPIKPSVMDSFPCNEHINTCNALLYHINQGLPVERIASFYSANPSQIKPIFRGNQKDYLITVPCSCKDVNSTRAMIYSGQAWKVGGEENYFIAGVAVPIHLLCGCVETGTQVVVTYTVQQQDTLSIIATLLSAEISGIESMNKMVAQNPGYIDVCWVLFVPMELNGLPTAEKSGKTHKWVTVIALLSAVALFSVITLIIILLRRKRPEEKITEDAKHVSKAMSITTRAFSSQGQCKENTEDVTVLESERTIIFSLEEIEEATNNFDESRIIGRGGFGNVYFGLLGDREAAIKKMRSNKSKEFFAELKVLCKIHHINVFISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITSTEWEASLGGDSQVFSGLFNGR
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	563	2.2.26 [Sep-21-2011]
F4IB81	651	LysM domain receptor-like	yes	no	0.493	0.427	0.440	6e-77
A8R7E6	617	Chitin elicitor receptor	no	no	0.682	0.622	0.331	6e-57
D7UPN3	605	Chitin elicitor receptor	no	no	0.795	0.740	0.312	2e-53
Q8RWW0	744	Receptor-like serine/thre	no	no	0.582	0.440	0.295	7e-41
Q9CAL8	710	Proline-rich receptor-lik	no	no	0.529	0.419	0.316	9e-40
Q9LV48	652	Proline-rich receptor-lik	no	no	0.456	0.394	0.342	1e-39
Q9FFW5	681	Proline-rich receptor-lik	no	no	0.477	0.395	0.309	2e-39
Q9SFT7	414	Serine/threonine-protein	no	no	0.454	0.618	0.356	8e-39
C0LGI2	929	Probable LRR receptor-lik	no	no	0.419	0.254	0.363	1e-38
P43298	942	Probable receptor protein	no	no	0.452	0.270	0.338	1e-38

>sp|F4IB81|LYK3_ARATH LysM domain receptor-like kinase 3 OS=Arabidopsis thaliana GN=LYK3 PE=2 SV=1

 Score =  288 bits (738), Expect = 6e-77,   Method: Compositional matrix adjust.
 Identities = 152/345 (44%), Positives = 209/345 (60%), Gaps = 67/345 (19%)

Query: 273 VLESERTIIFSLEEIEEATNNFDESRIIGRGGFGNVYFGLLGDREAAIKKMRSNKSKEFF 332
           + E E+ ++F+ EEI  AT+ F +S ++G G +G+VYFGLL ++E A+K+M + K+KEF 
Sbjct: 320 MFEIEKPMVFTYEEIRAATDEFSDSNLLGHGNYGSVYFGLLREQEVAVKRMTATKTKEFA 379

Query: 333 AELKVLCKIHHIN---------------VFISTFGNGSLSDHLHDPLLKGHQPLTWTART 377
           AE+KVLCK+HH N               V       G L  HLHDP  KG+ PL+W  R 
Sbjct: 380 AEMKVLCKVHHSNLVELIGYAATVDELFVVYEYVRKGMLKSHLHDPQSKGNTPLSWIMRN 439

Query: 378 QIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLA 437
           QIALDAA+G+EYIH+HTK  YVHRDIKTSNILLD+  RAK++DFGL KL E+T E E+  
Sbjct: 440 QIALDAARGLEYIHEHTKTHYVHRDIKTSNILLDEAFRAKISDFGLAKLVEKTGEGEISV 499

Query: 438 TRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDD 497
           T++VGT GYL PEY+              +   T+K+D++AFGVVL E+I+G+ A+IR +
Sbjct: 500 TKVVGTYGYLAPEYL-------------SDGLATSKSDIYAFGVVLFEIISGREAVIRTE 546

Query: 498 SEPTK---MKSLITIMAAV------------------------------------AEWCL 518
           +  TK    + L +IM AV                                    A+ C+
Sbjct: 547 AIGTKNPERRPLASIMLAVLKNSPDSMNMSSLKEFVDPNMMDLYPHDCLFKIATLAKQCV 606

Query: 519 NEDAVDRPEMRDIVAILSQIMITSTEWEASLGGDSQVFSGLFNGR 563
           ++D + RP M+ +V  LSQI+++S EWEA+L G+SQVFSGL  GR
Sbjct: 607 DDDPILRPNMKQVVISLSQILLSSIEWEATLAGNSQVFSGLVQGR 651

Putative Lysin motif (LysM) receptor kinase that may recognize microbe-derived N-acetylglucosamine (NAG)-containing ligands.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: -

>sp|A8R7E6|CERK1_ARATH Chitin elicitor receptor kinase 1 OS=Arabidopsis thaliana GN=CERK1 PE=1 SV=1

 Score =  222 bits (566), Expect = 6e-57,   Method: Compositional matrix adjust.
 Identities = 159/480 (33%), Positives = 240/480 (50%), Gaps = 96/480 (20%)

Query: 132 CGC----VETGTQVVVTYTVQQQDTLSIIA--TLLSAEISGIESMNKMVAQNPGYIDVCW 185
           C C    V     + VTY ++ +D+LS IA  + +SA+I  ++  N  V  N G      
Sbjct: 153 CSCGDESVSKDFGLFVTYPLRPEDSLSSIARSSGVSADI--LQRYNPGVNFNSG----NG 206

Query: 186 VLFVP-MELNG-LPTAEKSGKTHKWVTVIALLSAVALFSVITLIIILLRRKRPEEKITED 243
           +++VP  + NG  P  + S +      VIA    + +  ++ L++IL        K    
Sbjct: 207 IVYVPGRDPNGAFPPFKSSKQDGVGAGVIA---GIVIGVIVALLLILFIVYYAYRKNKSK 263

Query: 244 AKHVSKAMSITTRAFSSQGQCKEN--------TEDVTVLESERTIIFSLEEIEEATNNFD 295
               S ++ ++T+A  +     ++        +  +  +  ++++ FSLEE+ +AT+NF+
Sbjct: 264 GDSFSSSIPLSTKADHASSTSLQSGGLGGAGVSPGIAAISVDKSVEFSLEELAKATDNFN 323

Query: 296 ESRIIGRGGFGNVYFGLLGDREAAIKKMRSNKSKEFFAELKVLCKIHHINVFISTFG--- 352
            S  IG+GGFG VY+  L   +AAIKKM    SK+F AELKVL ++HH+N+ +   G   
Sbjct: 324 LSFKIGQGGFGAVYYAELRGEKAAIKKMDMEASKQFLAELKVLTRVHHVNL-VRLIGYCV 382

Query: 353 ------------NGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVH 400
                       NG+L  HLH     G +PL WT R QIALD+A+G+EYIH+HT   YVH
Sbjct: 383 EGSLFLVYEYVENGNLGQHLHG---SGREPLPWTKRVQIALDSARGLEYIHEHTVPVYVH 439

Query: 401 RDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATR-LVGTPGYLPPEYIFVKRFRF 459
           RDIK++NIL+D   RAKVADFGL KL E        ATR  +GT GY+ PE ++      
Sbjct: 440 RDIKSANILIDQKFRAKVADFGLTKLTEVGGS----ATRGAMGTFGYMAPETVYG----- 490

Query: 460 DMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKMKSLITI---------- 509
                    +V+ K DV+AFGVVL ELI+ K A+++      + + L+ +          
Sbjct: 491 ---------EVSAKVDVYAFGVVLYELISAKGAVVKMTEAVGEFRGLVGVFEESFKETDK 541

Query: 510 -----------------------MAAVAEWCLNEDAVDRPEMRDIVAILSQIMITSTEWE 546
                                  MA + + C  E+A  RP MR IV  LS +  ++  W+
Sbjct: 542 EEALRKIIDPRLGDSYPFDSVYKMAELGKACTQENAQLRPSMRYIVVALSTLFSSTGNWD 601

Lysin motif (LysM) receptor kinase that functions as a cell surface receptor in chitin elicitor (chitooligosaccharides) signaling leading to innate immunity toward both biotic and abiotic stresses (e.g. tolerance to salinity, heavy-metal stresses, and Botrytis cinerea infection). Recognizes microbe-derived N-acetylglucosamine (NAG)-containing ligands. Involved in the resistance to pathogenic fungi Alternaria brassicicola and Erysiphe cichoracearum, probably by sensing microbe-associated molecular patterns (MAMP) and pathogen-associated molecular patterns (PAMP). Plays an essential role in detecting peptidoglycans (e.g. PGNs) and restricting bacterial growth. Target of the bacterial type III effector E3-ligase protein hopAB2/avrPtoB of Pseudomonas syringae pv. tomato DC3000 that mediates ubiquitination and subsequent proteolysis, thus blocking all defense responses by suppressing PAMP-triggered immunity (PTI).

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|D7UPN3|CERK1_ORYSJ Chitin elicitor receptor kinase 1 OS=Oryza sativa subsp. japonica GN=CERK1 PE=1 SV=1

 Score =  211 bits (536), Expect = 2e-53,   Method: Compositional matrix adjust.
 Identities = 175/560 (31%), Positives = 262/560 (46%), Gaps = 112/560 (20%)

Query: 36  VMDSFPCNEHINTCNALLYHINQGLPVERIASFYSANPSQIKPIFRGNQKDYLITVPCSC 95
           V+  FPC     +C         GLP    ++F +       P+ RG    Y   V  + 
Sbjct: 81  VLVPFPC-----SC--------LGLPAAPASTFLAGAIPYPLPLPRGGGDTY-DAVAANY 126

Query: 96  KDVNSTRAMIYSGQAWKVGGEENYFIAG----VAVPIHLLCGC--VETGTQVVVTYTVQQ 149
            D+ +T A + +  A+  G      I G    V V I+  CG   V     + +TY +  
Sbjct: 127 ADL-TTAAWLEATNAYPPG-----RIPGGDGRVNVTINCSCGDERVSPRYGLFLTYPLWD 180

Query: 150 QDTLSIIATLLSAEISGIESMNKMVAQNPGYIDVCW--VLFVPM-ELNGLPTAEKSGKTH 206
            +TL  +A       S    M  +   NPG   V    ++F+P+ + NG     KSG   
Sbjct: 181 GETLESVAAQYG--FSSPAEMELIRRYNPGMGGVSGKGIVFIPVKDPNGSYHPLKSGGMG 238

Query: 207 KWVTVIAL----LSAVALFSVITLIIILLRRKRPEEKITEDAKHVSKAMSITTRAFSSQG 262
             ++  A+    ++ +A+F V   +II+  R +             K    T+R    + 
Sbjct: 239 NSLSGGAIAGIVIACIAIFIVAIWLIIMFYRWQ-------------KFRKATSRPSPEET 285

Query: 263 QCKENTEDVTVLESERTIIFSLEEIEEATNNFDESRIIGRGGFGNVYFGLLGDREAAIKK 322
              ++      ++ ER+I FS EEI  AT  F     IG+GGFG+VY+  L   + AIKK
Sbjct: 286 SHLDDASQAEGIKVERSIEFSYEEIFNATQGFSMEHKIGQGGFGSVYYAELRGEKTAIKK 345

Query: 323 MRSNKSKEFFAELKVLCKIHHINV-------------FISTF-GNGSLSDHLHDPLLKGH 368
           M    ++EF AELKVL  +HH+N+              +  F  NG+LS HL      G+
Sbjct: 346 MGMQATQEFLAELKVLTHVHHLNLVRLIGYCVENCLFLVYEFIDNGNLSQHLQR---TGY 402

Query: 369 QPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEE 428
            PL+W  R QIALD+A+G+EY+H+H    YVHRDIK++NILLD   RAK+ADFGL KL E
Sbjct: 403 APLSWATRVQIALDSARGLEYLHEHVVPVYVHRDIKSANILLDKDFRAKIADFGLAKLTE 462

Query: 429 RTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
             +  + L+TR+ GT GY+PPE     R+           +V+ K DV+AFGVVL EL++
Sbjct: 463 VGSMSQSLSTRVAGTFGYMPPE----ARYG----------EVSPKVDVYAFGVVLYELLS 508

Query: 489 GKRALIRDDSEPTKMKSLITI---------------------------------MAAVAE 515
            K+A++R     ++ K L+ +                                 +A++A+
Sbjct: 509 AKQAIVRSSESVSESKGLVFLFEEALSAPNPTEALDELIDPSLQGDYPVDSALKIASLAK 568

Query: 516 WCLNEDAVDRPEMRDIVAIL 535
            C +E+   RP MR +V  L
Sbjct: 569 SCTHEEPGMRPTMRSVVVAL 588

Plays an essential role in detecting peptidoglycans (e.g. PGNs) and restricting bacterial growth. Recognizes microbe-derived N-acetylglucosamine (NAG)-containing ligands (By similarity). Lysin motif (LysM) receptor kinase required as a cell surface receptor for chitin elicitor (chitooligosaccharides) signaling leading to innate immunity in response to both biotic and abiotic stresses. Involved in the resistance to pathogenic fungi, probably by sensing microbe-associated molecular patterns (MAMP) and pathogen-associated molecular patterns (PAMP).

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8RWW0|ALE2_ARATH Receptor-like serine/threonine-protein kinase ALE2 OS=Arabidopsis thaliana GN=ALE2 PE=1 SV=1

 Score =  169 bits (427), Expect = 7e-41,   Method: Compositional matrix adjust.
 Identities = 123/416 (29%), Positives = 205/416 (49%), Gaps = 88/416 (21%)

Query: 189 VPMELNGLPTAEKS-GKTHKWVTVIALLSAVALFSVITLIIILLRRKRPEEKITEDAKHV 247
           +P+ +N    A KS G   + + +IAL   V +  ++  I I+++ K    KI + +  V
Sbjct: 238 LPIPINATTFANKSQGIGFRTIAIIALSGFVLILVLVGAISIIVKWK----KIGKSSNAV 293

Query: 248 SKAMSITTRAFSSQGQCKENTEDVTVLESERTII---------FSLEEIEEATNNFDESR 298
             A++ +       G    ++   +  +S  + +         F+L E+E+AT+ F   R
Sbjct: 294 GPALAPSINKRPGAGSMFSSSARSSGSDSLMSSMATCALSVKTFTLSELEKATDRFSAKR 353

Query: 299 IIGRGGFGNVYFGLLGD-REAAIK---KMRSNKSKEFFAELKVLCKIHHINVFISTFG-- 352
           ++G GGFG VY G + D  E A+K   +   N+ +EF AE+++L ++HH N+ +   G  
Sbjct: 354 VLGEGGFGRVYQGSMEDGTEVAVKLLTRDNQNRDREFIAEVEMLSRLHHRNL-VKLIGIC 412

Query: 353 --------------NGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARY 398
                         NGS+  HLH+  L       W AR +IAL AA+G+ Y+H+ +  R 
Sbjct: 413 IEGRTRCLIYELVHNGSVESHLHEGTLD------WDARLKIALGAARGLAYLHEDSNPRV 466

Query: 399 VHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFR 458
           +HRD K SN+LL+D    KV+DFGL +  E T   + ++TR++GT GY+ PEY       
Sbjct: 467 IHRDFKASNVLLEDDFTPKVSDFGLAR--EATEGSQHISTRVMGTFGYVAPEY------- 517

Query: 459 FDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKMKSLITI--------- 509
                  M   +  K+DV+++GVVL EL+TG+R +  D S+P+  ++L+T          
Sbjct: 518 ------AMTGHLLVKSDVYSYGVVLLELLTGRRPV--DMSQPSGEENLVTWARPLLANRE 569

Query: 510 ---------------------MAAVAEWCLNEDAVDRPEMRDIVAILSQIMITSTE 544
                                +AA+A  C++++   RP M ++V  L  I   + E
Sbjct: 570 GLEQLVDPALAGTYNFDDMAKVAAIASMCVHQEVSHRPFMGEVVQALKLIYNDADE 625

Required during the differentiation of the protoderm into shoots epidermis and cuticle.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9CAL8|PEK13_ARATH Proline-rich receptor-like protein kinase PERK13 OS=Arabidopsis thaliana GN=PERK13 PE=2 SV=1

 Score =  165 bits (417), Expect = 9e-40,   Method: Compositional matrix adjust.
 Identities = 122/386 (31%), Positives = 191/386 (49%), Gaps = 88/386 (22%)

Query: 189 VPMELNGLPTAEKSGKTHKWVTVIALLSAVALFSVITL--IIILLRRKR----------- 235
           VP   N +P    SG  ++  T+     A+A F+VI L  ++ L+RRK+           
Sbjct: 214 VPSSGNSVPPPANSGGGYQGKTMAGF--AIAGFAVIALMAVVFLVRRKKKRNIDAYSDSQ 271

Query: 236 -------------------PEEKITEDAKHVSKAMSITTRAFSSQ----GQCKENT-EDV 271
                              P +  +    + S+  S +  +F SQ    G  +  +  D 
Sbjct: 272 YLPPSNFSIKSDGFLYGQNPTKGYSGPGGYNSQQQSNSGNSFGSQRGGGGYTRSGSAPDS 331

Query: 272 TVLESERTIIFSLEEIEEATNNFDESRIIGRGGFGNVYFGLLGDRE-AAIKKMR---SNK 327
            V+ S +T  F+ EE+ + T  F +  I+G GGFG VY G L D +  A+K+++      
Sbjct: 332 AVMGSGQTH-FTYEELTDITEGFSKHNILGEGGFGCVYKGKLNDGKLVAVKQLKVGSGQG 390

Query: 328 SKEFFAELKVLCKIHHINVFISTFG----------------NGSLSDHLHDPLLKGHQPL 371
            +EF AE++++ ++HH ++ +S  G                N +L  HLH    KG   L
Sbjct: 391 DREFKAEVEIISRVHHRHL-VSLVGYCIADSERLLIYEYVPNQTLEHHLHG---KGRPVL 446

Query: 372 TWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTN 431
            W  R +IA+ +AKG+ Y+H+    + +HRDIK++NILLDD   A+VADFGL KL + T 
Sbjct: 447 EWARRVRIAIGSAKGLAYLHEDCHPKIIHRDIKSANILLDDEFEAQVADFGLAKLNDST- 505

Query: 432 EKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKR 491
            +  ++TR++GT GYL PEY                 ++T ++DVF+FGVVL ELITG++
Sbjct: 506 -QTHVSTRVMGTFGYLAPEY-------------AQSGKLTDRSDVFSFGVVLLELITGRK 551

Query: 492 ALIRDDSEPTKMKSLITIMAAVAEWC 517
            +  D  +P   +SL+       EW 
Sbjct: 552 PV--DQYQPLGEESLV-------EWA 568

Regulates negatively root hairs elongation.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LV48|PERK1_ARATH Proline-rich receptor-like protein kinase PERK1 OS=Arabidopsis thaliana GN=PERK1 PE=1 SV=1

 Score =  164 bits (416), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 112/327 (34%), Positives = 163/327 (49%), Gaps = 70/327 (21%)

Query: 282 FSLEEIEEATNNFDESRIIGRGGFGNVYFGLL-GDREAAIKKMRSNKS---KEFFAELKV 337
           F+ EE+  ATN F E+ ++G+GGFG V+ G+L   +E A+K++++      +EF AE+++
Sbjct: 268 FTYEELSRATNGFSEANLLGQGGFGYVHKGILPSGKEVAVKQLKAGSGQGEREFQAEVEI 327

Query: 338 LCKIHHINVFISTFG----------------NGSLSDHLHDPLLKGHQPLTWTARTQIAL 381
           + ++HH ++ +S  G                N +L  HLH    KG   + W+ R +IAL
Sbjct: 328 ISRVHHRHL-VSLIGYCMAGVQRLLVYEFVPNNNLEFHLHG---KGRPTMEWSTRLKIAL 383

Query: 382 DAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLV 441
            +AKG+ Y+H+    + +HRDIK SNIL+D    AKVADFGL K+   TN    ++TR++
Sbjct: 384 GSAKGLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIASDTNTH--VSTRVM 441

Query: 442 GTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK----------- 490
           GT GYL PEY                 ++T K+DVF+FGVVL ELITG+           
Sbjct: 442 GTFGYLAPEY-------------AASGKLTEKSDVFSFGVVLLELITGRRPVDANNVYVD 488

Query: 491 -------RALIRDDSEPTKMKSL-------------ITIMAAVAEWCLNEDAVDRPEMRD 530
                  R L+   SE    + L             +  M A A  C+   A  RP M  
Sbjct: 489 DSLVDWARPLLNRASEEGDFEGLADSKMGNEYDREEMARMVACAAACVRHSARRRPRMSQ 548

Query: 531 IVAILSQIMITSTEWEASLGGDSQVFS 557
           IV  L   +  S   E    G S V+S
Sbjct: 549 IVRALEGNVSLSDLNEGMRPGHSNVYS 575

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FFW5|PERK8_ARATH Proline-rich receptor-like protein kinase PERK8 OS=Arabidopsis thaliana GN=PERK8 PE=1 SV=1

 Score =  164 bits (414), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 106/342 (30%), Positives = 170/342 (49%), Gaps = 73/342 (21%)

Query: 268 TEDVTVLESERTIIFSLEEIEEATNNFDESRIIGRGGFGNVYFGLLGD-REAAIKKMR-- 324
           + D  ++ ++R+  FS +E+ + T+ F E  ++G GGFG VY G+L D RE A+K+++  
Sbjct: 314 SSDSGMVSNQRSW-FSYDELSQVTSGFSEKNLLGEGGFGCVYKGVLSDGREVAVKQLKIG 372

Query: 325 -SNKSKEFFAELKVLCKIHHINVFISTFG----------------NGSLSDHLHDPLLKG 367
            S   +EF AE++++ ++HH ++ ++  G                N +L  HLH P   G
Sbjct: 373 GSQGEREFKAEVEIISRVHHRHL-VTLVGYCISEQHRLLVYDYVPNNTLHYHLHAP---G 428

Query: 368 HQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLE 427
              +TW  R ++A  AA+GI Y+H+    R +HRDIK+SNILLD+   A VADFGL K+ 
Sbjct: 429 RPVMTWETRVRVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDNSFEALVADFGLAKIA 488

Query: 428 ERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELI 487
           +  +    ++TR++GT GY+ PEY                 +++ K DV+++GV+L ELI
Sbjct: 489 QELDLNTHVSTRVMGTFGYMAPEY-------------ATSGKLSEKADVYSYGVILLELI 535

Query: 488 TGKRALIRDDSEPTKMKSLITI---------------------------------MAAVA 514
           TG++ +  D S+P   +SL+                                   M   A
Sbjct: 536 TGRKPV--DTSQPLGDESLVEWARPLLGQAIENEEFDELVDPRLGKNFIPGEMFRMVEAA 593

Query: 515 EWCLNEDAVDRPEMRDIVAILSQIMITSTEWEASLGGDSQVF 556
             C+   A  RP+M  +V  L  +   +        G SQVF
Sbjct: 594 AACVRHSAAKRPKMSQVVRALDTLEEATDITNGMRPGQSQVF 635

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SFT7|Y3707_ARATH Serine/threonine-protein kinase At3g07070 OS=Arabidopsis thaliana GN=At3g07070 PE=2 SV=1

 Score =  162 bits (409), Expect = 8e-39,   Method: Compositional matrix adjust.
 Identities = 115/323 (35%), Positives = 156/323 (48%), Gaps = 67/323 (20%)

Query: 263 QCKENTEDVTVLESERTIIFSLEEIEEATNNFDESRIIGRGGFGNVYFGLLGDRE--AAI 320
           Q K N ED  V  +     FS  E+  AT NF +  +IG GGFG VY G L       A+
Sbjct: 48  QNKNNDEDKEVTNNIAAQTFSFRELATATKNFRQECLIGEGGFGRVYKGKLEKTGMIVAV 107

Query: 321 KKMRSNK---SKEFFAELKVLCKIHH---INVF------------ISTFGNGSLSDHLHD 362
           K++  N    +KEF  E+ +L  +HH   +N+                   GSL DHL D
Sbjct: 108 KQLDRNGLQGNKEFIVEVLMLSLLHHKHLVNLIGYCADGDQRLLVYEYMSRGSLEDHLLD 167

Query: 363 PLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFG 422
            L     PL W  R +IAL AA G+EY+HD      ++RD+K +NILLD    AK++DFG
Sbjct: 168 -LTPDQIPLDWDTRIRIALGAAMGLEYLHDKANPPVIYRDLKAANILLDGEFNAKLSDFG 226

Query: 423 LVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVV 482
           L KL     +K+ +++R++GT GY  PEY                 Q+TTK+DV++FGVV
Sbjct: 227 LAKLGP-VGDKQHVSSRVMGTYGYCAPEYQRTG-------------QLTTKSDVYSFGVV 272

Query: 483 LAELITGKRALIRDDSEPTKMKSLIT------------------------------IMAA 512
           L ELITG+R +  D + P   ++L+T                                 A
Sbjct: 273 LLELITGRRVI--DTTRPKDEQNLVTWAQPVFKEPSRFPELADPSLEGVFPEKALNQAVA 330

Query: 513 VAEWCLNEDAVDRPEMRDIVAIL 535
           VA  CL E+A  RP M D+V  L
Sbjct: 331 VAAMCLQEEATVRPLMSDVVTAL 353

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGI2|Y1677_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g67720 OS=Arabidopsis thaliana GN=At1g67720 PE=2 SV=1

 Score =  161 bits (408), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 112/308 (36%), Positives = 160/308 (51%), Gaps = 72/308 (23%)

Query: 283 SLEEIEEATNNFDESRIIGRGGFGNVYFGLLGD-REAAIK---KMRSNKSKEFFAELKVL 338
           SL  +EEAT+NF  S+ +GRG FG+VY+G + D +E A+K      S+ +++F  E+ +L
Sbjct: 597 SLPVLEEATDNF--SKKVGRGSFGSVYYGRMKDGKEVAVKITADPSSHLNRQFVTEVALL 654

Query: 339 CKIHHINVF---------------ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDA 383
            +IHH N+                     NGSL DHLH      ++PL W  R QIA DA
Sbjct: 655 SRIHHRNLVPLIGYCEEADRRILVYEYMHNGSLGDHLHGS--SDYKPLDWLTRLQIAQDA 712

Query: 384 AKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLV-- 441
           AKG+EY+H       +HRD+K+SNILLD  +RAKV+DFGL     R  E+++     V  
Sbjct: 713 AKGLEYLHTGCNPSIIHRDVKSSNILLDINMRAKVSDFGL----SRQTEEDLTHVSSVAK 768

Query: 442 GTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP- 500
           GT GYL PEY   +             Q+T K+DV++FGVVL EL++GK+ +  +D  P 
Sbjct: 769 GTVGYLDPEYYASQ-------------QLTEKSDVYSFGVVLFELLSGKKPVSAEDFGPE 815

Query: 501 ---------------------------TKMKSLITIMAAVAEWCLNEDAVDRPEMRD-IV 532
                                       K++S+  + A VA  C+ +   +RP M++ IV
Sbjct: 816 LNIVHWARSLIRKGDVCGIIDPCIASNVKIESVWRV-AEVANQCVEQRGHNRPRMQEVIV 874

Query: 533 AILSQIMI 540
           AI   I I
Sbjct: 875 AIQDAIRI 882

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P43298|TMK1_ARATH Probable receptor protein kinase TMK1 OS=Arabidopsis thaliana GN=TMK1 PE=2 SV=1

 Score =  161 bits (408), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 111/328 (33%), Positives = 165/328 (50%), Gaps = 73/328 (22%)

Query: 266 ENTEDVTVLESERTIIFSLEEIEEATNNFDESRIIGRGGFGNVYFGLLGD-REAAIKKMR 324
           E  +++ ++E+   +I S++ +   TNNF    I+G GGFG VY G L D  + A+K+M 
Sbjct: 561 EVGDNIQMVEAGNMLI-SIQVLRSVTNNFSSDNILGSGGFGVVYKGELHDGTKIAVKRME 619

Query: 325 SN-----KSKEFFAELKVLCKIHHINVFISTFG----------------NGSLSDHLHDP 363
           +         EF +E+ VL K+ H ++ ++  G                 G+LS HL + 
Sbjct: 620 NGVIAGKGFAEFKSEIAVLTKVRHRHL-VTLLGYCLDGNEKLLVYEYMPQGTLSRHLFEW 678

Query: 364 LLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGL 423
             +G +PL W  R  +ALD A+G+EY+H      ++HRD+K SNILL D +RAKVADFGL
Sbjct: 679 SEEGLKPLLWKQRLTLALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 738

Query: 424 VKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVL 483
           V+L      K  + TR+ GT GYL PEY    R             VTTK DV++FGV+L
Sbjct: 739 VRLAPEG--KGSIETRIAGTFGYLAPEYAVTGR-------------VTTKVDVYSFGVIL 783

Query: 484 AELITGKRALIRDDSEPTKMKSLIT--------------------------------IMA 511
            ELITG+++L  D+S+P +   L++                                 +A
Sbjct: 784 MELITGRKSL--DESQPEESIHLVSWFKRMYINKEASFKKAIDTTIDLDEETLASVHTVA 841

Query: 512 AVAEWCLNEDAVDRPEMRDIVAILSQIM 539
            +A  C   +   RP+M   V ILS ++
Sbjct: 842 ELAGHCCAREPYQRPDMGHAVNILSSLV 869

Probable receptor.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	563
359495908	605	PREDICTED: serine/threonine-protein kina	0.902	0.839	0.567	0.0
255573989	623	serine-threonine protein kinase, plant-t	0.909	0.821	0.562	0.0
357485755	622	Wall-associated receptor kinase-like pro	0.939	0.850	0.523	1e-174
356524022	615	PREDICTED: proline-rich receptor-like pr	0.943	0.863	0.523	1e-170
290490594	620	LysM type receptor kinase [Lotus japonic	0.960	0.872	0.513	1e-169
290490564	620	LysM type receptor kinase [Lotus japonic	0.960	0.872	0.511	1e-169
356497738	639	PREDICTED: probable LRR receptor-like se	0.928	0.818	0.531	1e-167
224135885	562	predicted protein [Populus trichocarpa]	0.875	0.877	0.511	1e-166
224100163	559	predicted protein [Populus trichocarpa]	0.905	0.912	0.495	1e-145
242053241	618	hypothetical protein SORBIDRAFT_03g02454	0.875	0.797	0.459	1e-131

>gi|359495908|ref|XP_002272814.2| PREDICTED: serine/threonine-protein kinase At3g07070-like [Vitis vinifera]

 Score =  662 bits (1708), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 354/624 (56%), Positives = 422/624 (67%), Gaps = 116/624 (18%)

Query: 37  MDSFPCNEHINTCNALLYHINQGLPVERIASFYSANPSQIKPIFRGNQKDYLITVPCSCK 96
           M  FPC+E I  CN+ LYHIN GL  E+IA FYS N S+I  +     +DYL+TVPCSC+
Sbjct: 1   MYPFPCSESIKICNSSLYHINNGLQAEQIAFFYSVNRSEITYV---KNQDYLVTVPCSCQ 57

Query: 97  DVN--------------------STRAMIYSGQAWKVGGEENYFIAGVAVPIHLLCGCVE 136
            +N                    +    IYSGQAW  GGEE+ FI G  V I+L CGCVE
Sbjct: 58  KINDIAGYFYHTTYPVKKDDTFVNVSGQIYSGQAWSFGGEESKFIEGHEVDIYLPCGCVE 117

Query: 137 TGTQVVVTYTVQQQDTLSIIATLLSAEISGIESMNKMVAQNPGYIDVCWVLFVPMELNGL 196
             +Q+VVTYTVQ  DTLS IATLLSA+ISGIESMN ++ QN  YIDV WVLF+P E NGL
Sbjct: 118 RKSQIVVTYTVQLHDTLSDIATLLSAKISGIESMNSILIQNSEYIDVGWVLFIPREKNGL 177

Query: 197 PTAEK---------------------------SGKTHKWVTVIALLSAVALFSVITLIII 229
              ++                           SG  HKW  +I++L+AV + S+ TLIII
Sbjct: 178 SKDKEGESNILEISLKSLYIFLKQLTCFFHSLSGTKHKWAIIISILAAVTVLSISTLIII 237

Query: 230 LLRRKRPEEKITEDAKHVSKAMSITTRAFSSQGQ-CKENTEDVTVLESERTIIFSLEEIE 288
           +LRR R ++   ED K VSK++S + R FS + Q  +EN EDV   ESER +IFSLEEIE
Sbjct: 238 VLRRNRSQKNSEEDPK-VSKSLS-SNRTFSFRNQHLQENIEDVPGFESERPVIFSLEEIE 295

Query: 289 EATNNFDESRIIGRGGFGNVYFGLLGDREAAIKKMRSNKSKEFFAELKVLCKIHHINVFI 348
           +ATNNFDE+R IG GG+G+VYFG+LG++E AIKKMRSNKSKEFFAELKVLCKIHHINV +
Sbjct: 296 DATNNFDETRKIGEGGYGSVYFGVLGEQEVAIKKMRSNKSKEFFAELKVLCKIHHINV-V 354

Query: 349 STFG----------------NGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHD 392
              G                NGSL+DHLHDPLLKG+QPL+WTARTQIALDAA+GIEYIHD
Sbjct: 355 ELLGYASGDDHLYLVYEYVQNGSLNDHLHDPLLKGNQPLSWTARTQIALDAARGIEYIHD 414

Query: 393 HTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYI 452
           HTKARYVHRDIKTSNILLD+ LRAKVADFGL KL  RTNE++ +ATRLVGTPGYLPPE  
Sbjct: 415 HTKARYVHRDIKTSNILLDETLRAKVADFGLAKLVGRTNEEDFIATRLVGTPGYLPPE-- 472

Query: 453 FVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKMKSLITI--- 509
                      SV ELQVT+KTDVFA+GVVLAELITG+RAL+RD+ EP KM+SLIT+   
Sbjct: 473 -----------SVKELQVTSKTDVFAYGVVLAELITGQRALVRDNREPNKMRSLITVVNE 521

Query: 510 ------------------------------MAAVAEWCLNEDAVDRPEMRDIVAILSQIM 539
                                         MA +AE CL+E+AVDRP+MR+IV IL+QIM
Sbjct: 522 IFHNEDPEIALEDAIDRTLRGSYPLEDAYKMAEIAERCLSEEAVDRPKMREIVVILTQIM 581

Query: 540 ITSTEWEASLGGDSQVFSGLFNGR 563
            ++ EWEASLGG+SQVFSGLF+GR
Sbjct: 582 TSALEWEASLGGNSQVFSGLFSGR 605

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255573989|ref|XP_002527912.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223532687|gb|EEF34469.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis]

 Score =  658 bits (1698), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 343/610 (56%), Positives = 418/610 (68%), Gaps = 98/610 (16%)

Query: 37  MDSFPCNE---HINTCNALLYHINQGLPVERIASFYSANPSQIKPIFRGNQKDYLITVPC 93
           M  F C+E   H+  CNA LYHIN+GL +++IA FY+ + +QI PI  G++KDY+I VPC
Sbjct: 29  MHPFTCSEESNHVRMCNASLYHINKGLQIDQIAYFYNVSITQITPILNGDRKDYIIMVPC 88

Query: 94  SCKDVNSTRA--------------------MIYSGQAWKVGGEENYFIAGVAVPIHLLCG 133
           SC++VN T+A                     +YSGQAW+VG E + FI G  VP+HLLCG
Sbjct: 89  SCENVNGTKAYFYDAIYQVKENDTFLNVSDQMYSGQAWEVGNESSTFITGYQVPMHLLCG 148

Query: 134 CVETGTQVVVTYTVQQQDTLSIIATLLSAEISGIESMNKMVAQNPGYIDVCWVLFVPMEL 193
           CVE+ +Q+VVTYT++QQDTLS IA+ LS+  SGI  MN  V ++P ++   WVLFVP E+
Sbjct: 149 CVESESQIVVTYTIEQQDTLSDIASRLSSTTSGILDMNSFVIKDPNFLRPDWVLFVPKEI 208

Query: 194 NGLPTA-----------EKSGKTHKWVTVIALLSAVALFSVITLIIILLRRKRPEEKITE 242
           NG+PT             +SGK  KW  +I++LS V L  +IT+III+LR K  +    E
Sbjct: 209 NGIPTPNTGGSEFSPKIHESGKRQKWAIIISILSVVTLLLMITVIIIVLRMKISQPNNKE 268

Query: 243 DAKHVSKAMSITTRAFSSQGQCKENTEDVTVLESERTIIFSLEEIEEATNNFDESRIIGR 302
           D K +SK+MS T R  S Q    +  ED T  ESE+ +I+S EEIEEATNNFDESR IG 
Sbjct: 269 DPKALSKSMS-TIRGHSLQILNMDIIEDGTAFESEKPVIYSPEEIEEATNNFDESRKIGA 327

Query: 303 GGFGNVYFGLLGDREAAIKKMRSNKSKEFFAELKVLCKIHHINVFISTFG---------- 352
           GG+G+VYFG L  +E AIKKM+SNKSKEFFAELKVLC+IHHINV +   G          
Sbjct: 328 GGYGSVYFGELAGQEVAIKKMKSNKSKEFFAELKVLCRIHHINV-VELLGYASGDDHLYL 386

Query: 353 ------NGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTS 406
                 NGSLSDHLHDPLLKG+Q L+WTARTQIA+DAAKGIEYIHDHTK RYVHRDIK+S
Sbjct: 387 VYEYIQNGSLSDHLHDPLLKGYQALSWTARTQIAVDAAKGIEYIHDHTKTRYVHRDIKSS 446

Query: 407 NILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVM 466
           NILLD+GLRAKVADFGL KL ERTN+++++ATRLVGTPGYLPPE             SV 
Sbjct: 447 NILLDEGLRAKVADFGLAKLVERTNDEDLIATRLVGTPGYLPPE-------------SVK 493

Query: 467 ELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKMKSLITI----------------- 509
           ELQVTTKTDVFAFGVVLAELITG+RAL+RD+ EPTK +SLIT+                 
Sbjct: 494 ELQVTTKTDVFAFGVVLAELITGQRALVRDNWEPTKTRSLITVVYKIFEDDDPETALENS 553

Query: 510 ----------------MAAVAEWCLNEDAVDRPEMRDIVAILSQIMITSTEWEASLGGDS 553
                           MA +AEWCLNED ++RPEMRDIV  LS+IM +S EWEASLGG+S
Sbjct: 554 VDRNLQGSFPVEDVYKMAEIAEWCLNEDPINRPEMRDIVPNLSKIMTSSVEWEASLGGNS 613

Query: 554 QVFSGLFNGR 563
            VFSG++NGR
Sbjct: 614 TVFSGIYNGR 623

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357485755|ref|XP_003613165.1| Wall-associated receptor kinase-like protein [Medicago truncatula] gi|355514500|gb|AES96123.1| Wall-associated receptor kinase-like protein [Medicago truncatula]

 Score =  618 bits (1594), Expect = e-174,   Method: Compositional matrix adjust.
 Identities = 328/627 (52%), Positives = 406/627 (64%), Gaps = 98/627 (15%)

Query: 17  LFFSSLASAFGSGIPIKPSVMDSFPCNEHINTCNALLYHINQGLPVERIASFYSANPSQI 76
           L  SSL + F   + +K + M+ + C+  + TCNA LYHIN    +E+IA+FYS +PSQI
Sbjct: 14  LLASSLPTIFSIEVSMKKAYMEPYKCSTKMRTCNASLYHINYNHNIEQIANFYSIDPSQI 73

Query: 77  KPIFRGNQKDYLITVPCSCKDV----------------NSTRA----MIYSGQAWKVGGE 116
           KPI R  ++DYL+ VPCSCK++                N T      +IYSGQAW+V  +
Sbjct: 74  KPIIRSTKQDYLVKVPCSCKNIKDLSGYFYETTYKVSPNETSVDIMNLIYSGQAWQVNED 133

Query: 117 ENYFIAGVAVPIHLLCGCVETGTQVVVTYTVQQQDTLSIIATLLSAEISGIESMNKMVAQ 176
               +A   V IH+ CGC E  +Q+VVTYTVQQ DT + I+ LL+A I G+  +N+++  
Sbjct: 134 ---LVANENVTIHIPCGCSEFESQIVVTYTVQQSDTPTSISLLLNATIDGMVRINQILGP 190

Query: 177 NPGYIDVCWVLFVPMELNGLPTAEKSGKTHKWVTVIALLSAVALFSVITLIIILLRRKRP 236
           NP +ID+ WVL+VP EL G P      K HKWV +I +L +V L SVITLII +LRR + 
Sbjct: 191 NPTFIDIGWVLYVPKELKGSPLYHGKEKKHKWVIIIGILVSVTLLSVITLIIFILRRNKA 250

Query: 237 EEKITEDAKHVSKAMSITTRAFSSQGQ--CKENTE---------DVTVLESERTIIFSLE 285
            E    D K VSK  S   R  S +     KE  E         D T  +SER +I+  E
Sbjct: 251 YETSKYDPKTVSKR-SFGNRTISLRNHEFHKEYMEGLFMVNIGTDATQFDSERPVIYDFE 309

Query: 286 EIEEATNNFDESRIIGRGGFGNVYFGLLGDREAAIKKMRSNKSKEFFAELKVLCKIHHIN 345
           EIE ATNNFDE+R IG GG+G VYFG+L ++E A+KKM+SNKSKEF+AELK LCKIHHIN
Sbjct: 310 EIEHATNNFDETRRIGVGGYGTVYFGMLEEKEVAVKKMKSNKSKEFYAELKALCKIHHIN 369

Query: 346 VFISTFG----------------NGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEY 389
           + +   G                NGSLS+HLHDPLLKGHQPL+W ARTQIALD+AKGIEY
Sbjct: 370 I-VELLGYASGDDHLYLVYEYVPNGSLSEHLHDPLLKGHQPLSWCARTQIALDSAKGIEY 428

Query: 390 IHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPP 449
           IHD+TKARYVHRDIKTSNILLD+ LRAKVADFGL KL ERTN++E LATRLVGTPGYLPP
Sbjct: 429 IHDYTKARYVHRDIKTSNILLDEKLRAKVADFGLAKLVERTNDEEFLATRLVGTPGYLPP 488

Query: 450 EYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKMKSLITI 509
           E             SV ELQVT KTDVFAFGVV++ELITGKRAL RD+ E   MKSLI +
Sbjct: 489 E-------------SVKELQVTIKTDVFAFGVVISELITGKRALFRDNKEANNMKSLIAV 535

Query: 510 ---------------------------------MAAVAEWCLNEDAVDRPEMRDIVAILS 536
                                            MA ++ WCL+E+ VDRPEM++IV  +S
Sbjct: 536 VNKIFQDEDPVAALEAVVDGNLLRNYPIEGVYKMAELSHWCLSEEPVDRPEMKEIVVAVS 595

Query: 537 QIMITSTEWEASLGGDSQVFSGLFNGR 563
           +I+++S EWEASLGGDSQVFSG+F+GR
Sbjct: 596 KIVMSSIEWEASLGGDSQVFSGVFDGR 622

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356524022|ref|XP_003530632.1| PREDICTED: proline-rich receptor-like protein kinase PERK8-like [Glycine max]

 Score =  606 bits (1562), Expect = e-170,   Method: Compositional matrix adjust.
 Identities = 328/626 (52%), Positives = 414/626 (66%), Gaps = 95/626 (15%)

Query: 12  LFPCLLFFSSLASAFGSGIPIKPSVMDSFPCNEHINTCNALLYHINQGLPVERIASFYSA 71
           LFP  LF +S    F S + IK + +    C+  I TCNA LYHI+Q L +E+IASFYS 
Sbjct: 11  LFP--LFTTSFVRVFASEVSIKTTNLSPLNCSSKIRTCNASLYHISQNLTIEQIASFYSV 68

Query: 72  NPSQIKPIFRGNQKDYLITVPCSCKDV----------------NSTRA----MIYSGQAW 111
             SQI PI  G ++DYLI VPCSCK+                 N T A    +I+SGQAW
Sbjct: 69  ISSQITPIMHGIKQDYLIRVPCSCKNTSGLSGYFYDTTYKVRPNDTFANISNLIFSGQAW 128

Query: 112 KVGGEENYFIAGVAVPIHLLCGCVETGTQVVVTYTVQQQDTLSIIATLLSAEISGIESMN 171
            V    +       + IH+ CGC E+ +QVVVTYTVQ  DT  +IA LL++ ++ +++MN
Sbjct: 129 PVN---HTLQPNETLAIHIPCGCSESKSQVVVTYTVQPNDTPMMIANLLNSTLADMQNMN 185

Query: 172 KMVAQNPGYIDVCWVLFVPMELNGL---PTAEKSGKTHKWVTVI-ALLSAVALFSVITLI 227
           K++A N  +IDV WVLFVP E  GL   P+A K  K +KW T+I  +L  + L S++T I
Sbjct: 186 KVLAPNIEFIDVGWVLFVPKESKGLLLLPSATKK-KHNKWTTIIIGILGGMTLLSIVTTI 244

Query: 228 IILLRRKRPEEKITEDAKHVSKAMSITTRAFSSQGQC-KENTEDVTVLESERTIIFSLEE 286
           I++LRR + ++   ED++ +S   SI  +  SS+    KE  ED+   ESER +I++LE+
Sbjct: 245 ILILRRNKVDKISIEDSRLIS-GRSIANKTISSKYSLHKEFVEDLISFESERPLIYNLED 303

Query: 287 IEEATNNFDESRIIGRGGFGNVYFGLLGDREAAIKKMRSNKSKEFFAELKVLCKIHHINV 346
           IEEATNNFDESR IG GG+G+VYFG+LG++E A+KKMRSNKSKEF+AELKVLCKIHHIN+
Sbjct: 304 IEEATNNFDESRKIGSGGYGSVYFGILGNKEVAVKKMRSNKSKEFYAELKVLCKIHHINI 363

Query: 347 FISTFG----------------NGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYI 390
            +   G                NGSLSDHLH+PLLKG+QPL+W+AR QIALDAAKG+EYI
Sbjct: 364 -VELLGYANGEDYLYLVYEYVPNGSLSDHLHNPLLKGNQPLSWSARVQIALDAAKGLEYI 422

Query: 391 HDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPE 450
           HD+TKARYVHRDIKTSNILLD+  RAKV DFGL KL +RT+++  +ATRLVGTPGYLPPE
Sbjct: 423 HDYTKARYVHRDIKTSNILLDNKFRAKVGDFGLAKLVDRTDDENFIATRLVGTPGYLPPE 482

Query: 451 YIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKMKSLITI- 509
                        S+ ELQVT KTDVFAFGVVL+EL+TGKRAL R+  E  KMKSLIT+ 
Sbjct: 483 -------------SLKELQVTPKTDVFAFGVVLSELLTGKRALFRESHEDIKMKSLITVV 529

Query: 510 --------------------------------MAAVAEWCLNEDAVDRPEMRDIVAILSQ 537
                                           M  +AEWCL ED ++RPEMRDI+  LSQ
Sbjct: 530 NEIFQDDDPETALEDAIDKNLEASYPMEDVYKMTEIAEWCLQEDPMERPEMRDIIGALSQ 589

Query: 538 IMITSTEWEASLGGDSQVFSGLFNGR 563
           I+++STEWEASL G+SQVFSGLF+GR
Sbjct: 590 IVMSSTEWEASLCGNSQVFSGLFSGR 615

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|290490594|dbj|BAI79284.1| LysM type receptor kinase [Lotus japonicus]

 Score =  600 bits (1547), Expect = e-169,   Method: Compositional matrix adjust.
 Identities = 325/633 (51%), Positives = 416/633 (65%), Gaps = 92/633 (14%)

Query: 5   TTMATLYLFPCLLF----FSSLASAFGSGIPIKPSVMDSFPCNEHINTCNALLYHINQGL 60
           TTMA+L    C+L      +S AS F   +  K + M+ F C+  I TCN+LLYHI+ GL
Sbjct: 6   TTMASLTHPLCVLLTLMAAASFASVFSLEVSSKTTYMEPFNCSTKIRTCNSLLYHISIGL 65

Query: 61  PVERIASFYSANPSQIKPIFRGNQKDYLITVPCSCKDVN--------------------S 100
            VE IA FYS N S+IKPI RG ++DYL++VPC+C++ N                     
Sbjct: 66  KVEEIARFYSVNLSRIKPITRGTKQDYLVSVPCTCRNTNGLNGYFYHTSYKVKVNDSFVD 125

Query: 101 TRAMIYSGQAWKVGGEENYFIAGVAVPIHLLCGCVETGTQVVVTYTVQQQDTLSIIATLL 160
            + + YSGQAW V   E+  +    + IH+ CGC E+G+Q+VVTYTVQ+ DT   IA LL
Sbjct: 126 IQNLFYSGQAWPVN--EDLVVPNETMTIHIPCGCSESGSQIVVTYTVQRNDTPLSIALLL 183

Query: 161 SAEISGIESMNKMVAQNPGYIDVCWVLFVPMELNGLPTAEKSGKTHKWVTVIALLSAVAL 220
           +A + G+ S+N ++A NP +IDV WVL+VP ELN  P +      HK   +I +L+ V L
Sbjct: 184 NATVEGMVSVNSVMAPNPTFIDVGWVLYVPKELN--PISHGKENKHKLEKIIGILAGVIL 241

Query: 221 FSVITLIIILLRRKRPEEKITEDAKHVSK-AMSITTRAFSSQGQCKENTEDVTVLESERT 279
            S+ITLII+++RR R  E   +D + +SK ++   T +  ++   KE  ED T  +SER 
Sbjct: 242 LSIITLIILIVRRNRSYETCKDDPRAISKRSIGKRTSSLMNRDFHKEYMEDATSFDSERP 301

Query: 280 IIFSLEEIEEATNNFDESRIIGRGGFGNVYFGLLGDREAAIKKMRSNKSKEFFAELKVLC 339
           +I++LEEIE+ATN+FDE+R IG GG+G VYFG+LG++E AIKKM+SNKSKEF+AELK LC
Sbjct: 302 VIYTLEEIEQATNDFDETRRIGVGGYGTVYFGVLGEKEVAIKKMKSNKSKEFYAELKALC 361

Query: 340 KIHHINVFISTFG----------------NGSLSDHLHDPLLKGHQPLTWTARTQIALDA 383
           KIHHIN+ +   G                NGSLS+HLHDPLLKGHQPL+W AR QIALD+
Sbjct: 362 KIHHINI-VELLGYASGDDHLYLVYEYVPNGSLSEHLHDPLLKGHQPLSWCARIQIALDS 420

Query: 384 AKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGT 443
           AKGIEYIHD+TKA+YVHRDIKTSNILLD+ LRAKVADFGL KL ERTN++E +ATRLVGT
Sbjct: 421 AKGIEYIHDYTKAQYVHRDIKTSNILLDEKLRAKVADFGLAKLVERTNDEEFIATRLVGT 480

Query: 444 PGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKM 503
           PGYLPPE             S+ ELQVT KTDVFAFGVV+ ELITGKRAL RD+ E   M
Sbjct: 481 PGYLPPE-------------SLKELQVTVKTDVFAFGVVMLELITGKRALFRDNQEANNM 527

Query: 504 KSLITI---------------------------------MAAVAEWCLNEDAVDRPEMRD 530
           +SL+ +                                 MA ++ WCL E+ VDRPEM +
Sbjct: 528 RSLVAVVNQIFQEDNPETALEVTVDGNLQRSYPMEDVYNMAELSHWCLRENPVDRPEMSE 587

Query: 531 IVAILSQIMITSTEWEASLGGDSQVFSGLFNGR 563
           IV  LS+I+++S EWEASLGGDSQVFSG+F+GR
Sbjct: 588 IVVKLSKIIMSSIEWEASLGGDSQVFSGVFDGR 620

Source: Lotus japonicus

Species: Lotus japonicus

Genus: Lotus

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|290490564|dbj|BAI79269.1| LysM type receptor kinase [Lotus japonicus]

 Score =  600 bits (1546), Expect = e-169,   Method: Compositional matrix adjust.
 Identities = 324/633 (51%), Positives = 416/633 (65%), Gaps = 92/633 (14%)

Query: 5   TTMATLYLFPCLLF----FSSLASAFGSGIPIKPSVMDSFPCNEHINTCNALLYHINQGL 60
           TTMA+L    C+L      +S AS F   +  K + M+ F C+  I TCN+LLYHI+ GL
Sbjct: 6   TTMASLTHPLCVLLTLMAAASFASVFSLEVSSKTTYMEPFNCSTKIRTCNSLLYHISIGL 65

Query: 61  PVERIASFYSANPSQIKPIFRGNQKDYLITVPCSCKDVN--------------------S 100
            VE IA FYS N S+IKPI RG ++DYL++VPC+C++ N                     
Sbjct: 66  KVEEIARFYSVNLSRIKPITRGTKQDYLVSVPCTCRNTNGLNGYFYHTSYKVKVNDSFVD 125

Query: 101 TRAMIYSGQAWKVGGEENYFIAGVAVPIHLLCGCVETGTQVVVTYTVQQQDTLSIIATLL 160
            + + YSGQAW V   E+  +    + IH+ CGC E+G+Q+VVTYTVQ+ DT   IA LL
Sbjct: 126 IQNLFYSGQAWPVN--EDLVVPNETMTIHIPCGCSESGSQIVVTYTVQRNDTPLSIALLL 183

Query: 161 SAEISGIESMNKMVAQNPGYIDVCWVLFVPMELNGLPTAEKSGKTHKWVTVIALLSAVAL 220
           +A + G+ S+N ++A NP +IDV WVL+VP ELN  P +      HK   +I +L+ V L
Sbjct: 184 NATVEGMVSVNSVMAPNPTFIDVGWVLYVPKELN--PISHGKENKHKLEKIIGILAGVIL 241

Query: 221 FSVITLIIILLRRKRPEEKITEDAKHVSK-AMSITTRAFSSQGQCKENTEDVTVLESERT 279
            S+ITLII+++RR R  E   +D + +SK ++   T +  ++   KE  ED T  +SER 
Sbjct: 242 LSIITLIILIVRRNRSYETCKDDPRAISKRSIGKRTSSLMNRDFHKEYMEDATSFDSERP 301

Query: 280 IIFSLEEIEEATNNFDESRIIGRGGFGNVYFGLLGDREAAIKKMRSNKSKEFFAELKVLC 339
           +I++LEEIE+ATN+FDE+R IG GG+G VYFG+LG++E AIKKM+SNKSKEF+AELK LC
Sbjct: 302 VIYTLEEIEQATNDFDETRRIGVGGYGTVYFGVLGEKEVAIKKMKSNKSKEFYAELKALC 361

Query: 340 KIHHINVFISTFG----------------NGSLSDHLHDPLLKGHQPLTWTARTQIALDA 383
           KIHHIN+ +   G                NGSLS+HLHDPLLKGHQPL+W AR Q+ALD+
Sbjct: 362 KIHHINI-VELLGYASGDDHLYLVYEYVPNGSLSEHLHDPLLKGHQPLSWCARIQVALDS 420

Query: 384 AKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGT 443
           AKGIEYIHD+TKA+YVHRDIKTSNILLD+ LRAKVADFGL KL ERTN++E +ATRLVGT
Sbjct: 421 AKGIEYIHDYTKAQYVHRDIKTSNILLDEKLRAKVADFGLAKLVERTNDEEFIATRLVGT 480

Query: 444 PGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKM 503
           PGYLPPE             S+ ELQVT KTDVFAFGVV+ ELITGKRAL RD+ E   M
Sbjct: 481 PGYLPPE-------------SLKELQVTVKTDVFAFGVVMLELITGKRALFRDNQEANNM 527

Query: 504 KSLITI---------------------------------MAAVAEWCLNEDAVDRPEMRD 530
           +SL+ +                                 MA ++ WCL E+ VDRPEM +
Sbjct: 528 RSLVAVVNQIFQEDNPETALEVTVDGNLQRSYPMEDVYNMAELSHWCLRENPVDRPEMSE 587

Query: 531 IVAILSQIMITSTEWEASLGGDSQVFSGLFNGR 563
           IV  LS+I+++S EWEASLGGDSQVFSG+F+GR
Sbjct: 588 IVVKLSKIIMSSIEWEASLGGDSQVFSGVFDGR 620

Source: Lotus japonicus

Species: Lotus japonicus

Genus: Lotus

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356497738|ref|XP_003517716.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g51880-like [Glycine max]

 Score =  596 bits (1536), Expect = e-167,   Method: Compositional matrix adjust.
 Identities = 327/615 (53%), Positives = 403/615 (65%), Gaps = 92/615 (14%)

Query: 23  ASAFGSGIPIKPSVMDSFPCNEHINTCNALLYHINQGLPVERIASFYSANPSQIKPIFRG 82
           A+ F   + IK + ++ F C+  I TCNA LYHI+ G  ++ IA+FYS + SQIKPI R 
Sbjct: 43  ATVFSLQVSIKTTYLEPFKCSPKITTCNASLYHISYGNNIDDIATFYSVSTSQIKPIMRT 102

Query: 83  NQKDYLITVPCSCKDVN--------------------STRAMIYSGQAWKVGGEENYFIA 122
            ++DYLITVPCSC D N                    +    +YSGQAW + GE +    
Sbjct: 103 TEQDYLITVPCSCNDTNGLGGYFYDTTYKVKSNDTFVNINNFVYSGQAWPINGELD---Q 159

Query: 123 GVAVPIHLLCGCVE-TGTQVVVTYTVQQQDTLSIIATLLSAEISGIESMNKMVAQNPGYI 181
              + IHL CGC E + +Q+VVTYTVQ+ DT   IA LL+A +  + SMN+++AQNP +I
Sbjct: 160 NEELTIHLPCGCSEKSDSQIVVTYTVQRNDTPVSIAALLNATLDDMVSMNEVLAQNPSFI 219

Query: 182 DVCWVLFVPMELNGLPTAEKSGKTHKWVTVIALLSAVALFSVITLII--ILLRRKRPEEK 239
           DV WVL+VP ELNGLP ++   K  K   +I +L+ V L S+ITLII  ++LRR R  + 
Sbjct: 220 DVTWVLYVPRELNGLPLSKGKDKKQKLEIIIGILAGVTLLSIITLIILSVVLRRSRANKT 279

Query: 240 ITEDAKHVSKAMSITTRAFSSQGQ--CKENTEDVTVLESERTIIFSLEEIEEATNNFDES 297
              D   VSK  SIT R  S + +    E  ED T  ESER +I++LEEIE+ATNNFDE+
Sbjct: 280 AKNDPSVVSK-RSITNRTISIKNRDFHTEYIEDATTFESERPVIYALEEIEDATNNFDET 338

Query: 298 RIIGRGGFGNVYFGLLGDREAAIKKMRSNKSKEFFAELKVLCKIHHINVFISTFG----- 352
           R IG GG+G VYFG+L ++E A+KKMRSNKSKEF+AELK LC+IHHIN+ +   G     
Sbjct: 339 RRIGVGGYGTVYFGMLEEKEVAVKKMRSNKSKEFYAELKALCRIHHINI-VELLGYASGD 397

Query: 353 -----------NGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHR 401
                      NGSL +HLHDPLLKGHQPL+W AR QIALDAAKG+EYIHD+TKARYVHR
Sbjct: 398 DHLYLVYEFVPNGSLCEHLHDPLLKGHQPLSWCARIQIALDAAKGLEYIHDYTKARYVHR 457

Query: 402 DIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDM 461
           DIKTSNILLD+ LRAKVADFGL KL ERTN++E++ATRLVGTPGYLPPE           
Sbjct: 458 DIKTSNILLDEKLRAKVADFGLAKLVERTNDEELIATRLVGTPGYLPPE----------- 506

Query: 462 HSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKMKSLITI------------ 509
             SV ELQVT KTDVFAFGVVLAELITGKRAL RD+ E + MKSL ++            
Sbjct: 507 --SVKELQVTIKTDVFAFGVVLAELITGKRALFRDNQEASNMKSLTSVVGQIFKDDDPET 564

Query: 510 ---------------------MAAVAEWCLNEDAVDRPEMRDIVAILSQIMITSTEWEAS 548
                                MA +A WCL ED   RPEMR+IV  LSQI+++STEWEAS
Sbjct: 565 VLADAIDGNLQRSYPMEDVYKMAELAHWCLCEDPNVRPEMREIVVALSQIVMSSTEWEAS 624

Query: 549 LGGDSQVFSGLFNGR 563
           LGGD +VFSG+ +GR
Sbjct: 625 LGGDREVFSGVLDGR 639

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224135885|ref|XP_002322185.1| predicted protein [Populus trichocarpa] gi|222869181|gb|EEF06312.1| predicted protein [Populus trichocarpa]

 Score =  591 bits (1524), Expect = e-166,   Method: Compositional matrix adjust.
 Identities = 305/596 (51%), Positives = 391/596 (65%), Gaps = 103/596 (17%)

Query: 37  MDSFPCNEHINTCNALLYHINQGLPVERIASFYSANPSQIKPIFRGNQKDYLITVPCSCK 96
           M  F C++ +  C++ LYHI++GL +E+IASFYS   S ++PI  G ++DYL++VPC+CK
Sbjct: 1   MYPFSCSDQVQNCDSYLYHISEGLSIEQIASFYSVKSSNVEPITHGLKQDYLVSVPCTCK 60

Query: 97  DVNSTRA--------------------MIYSGQAWKVGGEENYFIAGVAVPIHLLCGCVE 136
           DVN T+                     ++YSGQAW+V G E  FIAG  + +HL+CGC+E
Sbjct: 61  DVNGTQGYFYDTFYSVQSGDIFTNVTWVLYSGQAWEVPGVERLFIAGDMISVHLVCGCLE 120

Query: 137 TGTQVVVTYTVQQQDTLSIIATLLSAEISGIESMNKMVAQNPGYIDVCWVLFVPMELNGL 196
              + +VTYTVQ+ DTL+ IA LLSAE++GIE++N+   +NP  IDV WVLFVP E NG+
Sbjct: 121 VEAKEIVTYTVQENDTLTGIAELLSAELTGIENLNERFTRNPNLIDVGWVLFVPREKNGI 180

Query: 197 PTAEKSGKTHKWVTVIALLSAVALFSVITLIIILLRRKRPEEKITEDAKHVSKAMSITTR 256
             A K GK H    ++  LSAV LFSV +L++ L RR R  +   ED + V+KA + T  
Sbjct: 181 -QAPKQGKQHNLAIILGTLSAVTLFSVCSLLLFLHRRNRNHKNRKEDPEVVNKAQNAT-- 237

Query: 257 AFSSQGQCKENTEDVTVLESERTIIFSLEEIEEATNNFDESRIIGRGGFGNVYFGLLGDR 316
                             ESER I++SL+EI+EAT+ FDESR IG GG+G VY G L +R
Sbjct: 238 -----------------FESERPIVYSLKEIDEATSQFDESRKIGAGGYGIVYIGTLKER 280

Query: 317 EAAIKKMRSNKSKEFFAELKVLCKIHHINVFISTFG----------------NGSLSDHL 360
           E AIKKM+S++SKEF++ELKVLCKIHHINV +   G                NGSL+DHL
Sbjct: 281 EVAIKKMKSSRSKEFYSELKVLCKIHHINV-VELLGYATGDNHLYLVYEYIQNGSLNDHL 339

Query: 361 HDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVAD 420
           HDPLLKGH PL+W AR QIALDAA+GIEYIHDHTKARY+HRDIKTSNILLD GL AKVAD
Sbjct: 340 HDPLLKGHSPLSWLARAQIALDAARGIEYIHDHTKARYIHRDIKTSNILLDKGLGAKVAD 399

Query: 421 FGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFG 480
           FGL +L ER+NE++ +ATRLVGTPGY+ PE             SV ELQ+T+KTDVF+FG
Sbjct: 400 FGLARLVERSNEEDAVATRLVGTPGYIAPE-------------SVRELQMTSKTDVFSFG 446

Query: 481 VVLAELITGKRALIRDDSEPTKMKSLITIMAAV--------------------------- 513
           VVLAELITG+RAL RD+ +P KMK L+ +M A+                           
Sbjct: 447 VVLAELITGQRALARDNGQPNKMKVLVAVMTAIFRDQDPETALEANIDENMKGSYPMDEV 506

Query: 514 ------AEWCLNEDAVDRPEMRDIVAILSQIMITSTEWEASLGGDSQVFSGLFNGR 563
                 +  C+NED  +RPEMR+IV  L +I+++S EWEASLGG SQVF+ LF+GR
Sbjct: 507 YKMAELSTHCMNEDPTNRPEMREIVQKLCKILMSSIEWEASLGGSSQVFTRLFDGR 562

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224100163|ref|XP_002311768.1| predicted protein [Populus trichocarpa] gi|222851588|gb|EEE89135.1| predicted protein [Populus trichocarpa]

 Score =  521 bits (1341), Expect = e-145,   Method: Compositional matrix adjust.
 Identities = 297/600 (49%), Positives = 382/600 (63%), Gaps = 90/600 (15%)

Query: 3   LVTTMATLYLFPCLLFFSSLASAFGSGIPIKPSVMDSFPCN--EHINTCNALLYHIN-QG 59
           L+T MATL           +A  F S        M  F C+  E I  CNA LYH N   
Sbjct: 11  LITLMATL-----------VALGFASDDSTNSPNMYPFTCSDSEDIKICNASLYHTNYDS 59

Query: 60  LPVERIASFYSANPSQIKPIFRGNQKDYLITVPCSCKDVNST------------------ 101
           L  E++AS Y  +P+QI  I   +++DYL+TVPCSCK++N T                  
Sbjct: 60  LQKEQLASIYGVSPAQIISISYASRQDYLVTVPCSCKNINGTVGYFYDAIHNVSQGELFS 119

Query: 102 --RAMIYSGQAWKVGGEENYFIAGVAVPIHLLCGCVETGTQVVVTYTVQQQDTLSIIATL 159
              A I++GQAW V  E   F       +HLLCGC ++ +Q+VVTYTVQQ DTLS I+T 
Sbjct: 120 NVSAQIFNGQAWWVEDEAWLFNPRNNFSMHLLCGCTKSKSQIVVTYTVQQHDTLSDISTR 179

Query: 160 LSAEISGIESMNKMVAQNPGYIDVCWVLFVPMELNGLPTAEKSGKTHKWVTVIALLSAVA 219
           LS+ + GI+SMN  + +NP  I+V WVLFVPM+ +   + + SG+ HKW+ ++ +LS++ 
Sbjct: 180 LSSTVGGIQSMNINLIKNPSSINVDWVLFVPMD-SKPASGKGSGRGHKWIIIVGILSSLT 238

Query: 220 LFSVITLIIILLRRKRPEEKITEDAKHVSKAMSITTRAFSSQGQCKENTEDVTVLESERT 279
             S+ITL+I+LL RK   +   ED K V K+MS T RAFS Q   K + ED T  ESE+ 
Sbjct: 239 ALSIITLVILLLWRKGCRQNSEEDLKPVPKSMS-TNRAFSLQSLYKGSNEDGTAFESEKP 297

Query: 280 IIFSLEEIEEATNNFDESRIIGRGGFGNVYFGLLGDREAAIKKMRSNKSKEFFAELKVLC 339
           ++FSLEEIEEAT +FD+++ IG GG+G VY GLL  +E A+KKMRSNKS EFFAELKVLC
Sbjct: 298 VVFSLEEIEEATKSFDKTKKIGEGGYGCVYHGLLRGQEVAVKKMRSNKSHEFFAELKVLC 357

Query: 340 KIHHINVFISTFG----------------NGSLSDHLHDPLLKGHQPLTWTARTQIALDA 383
           KIHHINV +   G                NGSLSDHLHDPLLKGHQPL+WTAR QIALDA
Sbjct: 358 KIHHINV-VELLGYAGGDDHFYLIYEYVRNGSLSDHLHDPLLKGHQPLSWTARAQIALDA 416

Query: 384 AKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGT 443
           AKGIEYIHDHTKARYVHRDIKTSNILLD+GLRAKVADFGL KL ERT++++++ATRLV  
Sbjct: 417 AKGIEYIHDHTKARYVHRDIKTSNILLDEGLRAKVADFGLAKLVERTSDEDLIATRLVYK 476

Query: 444 PGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKM 503
                   IF  +   D  ++                  LA++I      +R +S P + 
Sbjct: 477 --------IFEDK---DPETA------------------LADVIDKN---LR-NSYPMED 503

Query: 504 KSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITSTEWEASLGGDSQVFSGLFNGR 563
              +  MA +A+WCL+E+A++RPEMR++V  LS I+++S EWEASLGG S +FSG+FNGR
Sbjct: 504 ---VYKMAEIADWCLSEEAINRPEMREVVQKLSMIVVSSVEWEASLGG-SSIFSGVFNGR 559

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|242053241|ref|XP_002455766.1| hypothetical protein SORBIDRAFT_03g024540 [Sorghum bicolor] gi|241927741|gb|EES00886.1| hypothetical protein SORBIDRAFT_03g024540 [Sorghum bicolor]

 Score =  475 bits (1223), Expect = e-131,   Method: Compositional matrix adjust.
 Identities = 272/592 (45%), Positives = 358/592 (60%), Gaps = 99/592 (16%)

Query: 48  TCNALLYHINQGLPVERIASFYSANPSQIKPIFR-GNQKDYLITVPCSCKDVNSTRAMIY 106
           +C + LY   QG  +  I S ++ N S I+ I R    +D L+ V C C+ +++T    +
Sbjct: 50  SCGSFLYVTPQGRSLSEIVSVFNGNASLIQTINRLSGSQDLLMGVACKCQAISNTTTAFF 109

Query: 107 SGQAWKVG--------------------GEENYFIAGVAVPIHLLCGCVETGTQVVVTYT 146
               +KV                     G+ +    G  + +HL CGC  T ++ +++Y+
Sbjct: 110 HDTQYKVEPDDTPGEVKSNTFSGLAMNVGDGSELTPGNTITVHLPCGCSSTASEGILSYS 169

Query: 147 VQQQDTLSIIATLLSAEISGIESMNKMVAQNPGYIDVCWVLFVPMELNGLPTAEKSGKTH 206
           VQ++DTL  IA L  +    I ++N  V  NP +I   W+LF+PM + G   ++KS  + 
Sbjct: 170 VQEEDTLLTIANLFHSSPQDILNLNPSVT-NPDFIKPGWILFIPMGVAG--PSKKSVGSM 226

Query: 207 KWVTVIALLSAVALFSVITLIIILLRR------KRPEEKITEDAKHVSKAMSITTRAFSS 260
             +   ++ +A+  F V T+I+ L RR      + PE K+     + S A ++ +R F S
Sbjct: 227 TIIISASISAAILFFCVFTVILRLRRRSSQHTVEAPEIKMERAPSNTSIA-ALESRYFPS 285

Query: 261 QGQCKENTEDVTVLESERTIIFSLEEIEEATNNFDESRIIGRGGFGNVYFGLLGDREAAI 320
                    D+   ++ER +IFSL+ I +AT NFDE R IG GG+G+VY G +G  E AI
Sbjct: 286 M-----RINDIDPFQTERPVIFSLKVIGDATANFDEKRKIGEGGYGSVYLGFIGAHEIAI 340

Query: 321 KKMRSNKSKEFFAELKVLCKIHHINVFISTFG----------------NGSLSDHLHDPL 364
           KKM+++KSKEFFAELK LCK+HHINV +   G                NGSLS+HLHDPL
Sbjct: 341 KKMKASKSKEFFAELKALCKVHHINV-VELIGYAAGDDHLYLVYEYVQNGSLSEHLHDPL 399

Query: 365 LKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLV 424
           LKGHQPL+WTARTQIALDAA+GIEYIHDHTKA YVHRDIKTSNILLD+GLRAKVADFGLV
Sbjct: 400 LKGHQPLSWTARTQIALDAARGIEYIHDHTKACYVHRDIKTSNILLDNGLRAKVADFGLV 459

Query: 425 KLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLA 484
           KL ER++E+E +ATRLVGTPGYLPPE             SV+EL +TTK+DV+AFGVVLA
Sbjct: 460 KLVERSDEEECMATRLVGTPGYLPPE-------------SVLELHMTTKSDVYAFGVVLA 506

Query: 485 ELITGKRALIRDDSEPTKMKSLITI---------------------------------MA 511
           ELITG RALIRD+ E  KMKS+I+I                                 MA
Sbjct: 507 ELITGLRALIRDNKEVNKMKSIISIMRKVFKSENLESSLETIIDPNLKDCYPIEEVCKMA 566

Query: 512 AVAEWCLNEDAVDRPEMRDIVAILSQIMITSTEWEASLGGDSQVFSGLFNGR 563
            V+ WCL+ED ++RPEMRDI+  L QI +TS EWEASLGGD +VFSG+  GR
Sbjct: 567 NVSIWCLSEDPLNRPEMRDIMPTLCQIHLTSIEWEASLGGDGEVFSGVSYGR 618

Source: Sorghum bicolor

Species: Sorghum bicolor

Genus: Sorghum

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	563
TAIR|locus:2195814	651	LYK3 "LysM-containing receptor	0.435	0.376	0.460	9.1e-78
UNIPROTKB|D7UPN3	605	CERK1 "Chitin elicitor recepto	0.429	0.4	0.413	2e-52
TAIR|locus:2089860	617	CERK1 "chitin elicitor recepto	0.506	0.461	0.385	5.7e-43
TAIR|locus:2151191	378	CDL1 "CDG1-like 1" [Arabidopsi	0.287	0.428	0.408	1e-40
TAIR|locus:2159873	681	PERK8 "proline-rich extensin-l	0.392	0.324	0.359	1.2e-38
TAIR|locus:504954886	1113	AT5G56890 [Arabidopsis thalian	0.305	0.154	0.351	1.3e-36
TAIR|locus:2085720	386	AT3G20530 [Arabidopsis thalian	0.355	0.518	0.334	3.1e-36
TAIR|locus:2095188	928	AT3G23750 [Arabidopsis thalian	0.271	0.164	0.451	2.1e-35
TAIR|locus:2098580	414	AT3G07070 [Arabidopsis thalian	0.291	0.396	0.392	3.2e-35
TAIR|locus:2087263	363	AT3G24790 [Arabidopsis thalian	0.245	0.380	0.445	3.9e-35

TAIR|locus:2195814 LYK3 "LysM-containing receptor-like kinase 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 602 (217.0 bits), Expect = 9.1e-78, Sum P(3) = 9.1e-78
 Identities = 128/278 (46%), Positives = 184/278 (66%)

Query:   273 VLESERTIIFSLEEIEEATNNFDESRIIGRGGFGNVYFGLLGDREAAIKKMRSNKSKEFF 332
             + E E+ ++F+ EEI  AT+ F +S ++G G +G+VYFGLL ++E A+K+M + K+KEF 
Sbjct:   320 MFEIEKPMVFTYEEIRAATDEFSDSNLLGHGNYGSVYFGLLREQEVAVKRMTATKTKEFA 379

Query:   333 AELKVLCKIHHINV-----FISTFGN----------GSLSDHLHDPLLKGHQPLTWTART 377
             AE+KVLCK+HH N+     + +T             G L  HLHDP  KG+ PL+W  R 
Sbjct:   380 AEMKVLCKVHHSNLVELIGYAATVDELFVVYEYVRKGMLKSHLHDPQSKGNTPLSWIMRN 439

Query:   378 QIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLA 437
             QIALDAA+G+EYIH+HTK  YVHRDIKTSNILLD+  RAK++DFGL KL E+T E E+  
Sbjct:   440 QIALDAARGLEYIHEHTKTHYVHRDIKTSNILLDEAFRAKISDFGLAKLVEKTGEGEISV 499

Query:   438 TRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDD 497
             T++VGT GYL PEY+          S  +    T+K+D++AFGVVL E+I+G+ A+IR +
Sbjct:   500 TKVVGTYGYLAPEYL----------SDGL---ATSKSDIYAFGVVLFEIISGREAVIRTE 546

Query:   498 SEPTK---MKSLITIMAAVAEWCLNEDAVDRPEMRDIV 532
             +  TK    + L +IM AV +   + D+++   +++ V
Sbjct:   547 AIGTKNPERRPLASIMLAVLK--NSPDSMNMSSLKEFV 582

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0016998 "cell wall macromolecule catabolic process" evidence=IEA

GO:0007020 "microtubule nucleation" evidence=RCA

UNIPROTKB|D7UPN3 CERK1 "Chitin elicitor receptor kinase 1" [Oryza sativa Japonica Group (taxid:39947)]

 Score = 484 (175.4 bits), Expect = 2.0e-52, Sum P(3) = 2.0e-52
 Identities = 113/273 (41%), Positives = 158/273 (57%)

Query:   249 KAMSITTRAFSSQGQCKENTEDVTVLESERTIIFSLEEIEEATNNFDESRIIGRGGFGNV 308
             K    T+R    +    ++      ++ ER+I FS EEI  AT  F     IG+GGFG+V
Sbjct:   272 KFRKATSRPSPEETSHLDDASQAEGIKVERSIEFSYEEIFNATQGFSMEHKIGQGGFGSV 331

Query:   309 YFGLLGDREAAIKKMRSNKSKEFFAELKVLCKIHHINV------------FI--STFGNG 354
             Y+  L   + AIKKM    ++EF AELKVL  +HH+N+            F+      NG
Sbjct:   332 YYAELRGEKTAIKKMGMQATQEFLAELKVLTHVHHLNLVRLIGYCVENCLFLVYEFIDNG 391

Query:   355 SLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGL 414
             +LS HL      G+ PL+W  R QIALD+A+G+EY+H+H    YVHRDIK++NILLD   
Sbjct:   392 NLSQHLQRT---GYAPLSWATRVQIALDSARGLEYLHEHVVPVYVHRDIKSANILLDKDF 448

Query:   415 RAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKT 474
             RAK+ADFGL KL E  +  + L+TR+ GT GY+PPE       R+         +V+ K 
Sbjct:   449 RAKIADFGLAKLTEVGSMSQSLSTRVAGTFGYMPPEA------RYG--------EVSPKV 494

Query:   475 DVFAFGVVLAELITGKRALIRDDSEPTKMKSLI 507
             DV+AFGVVL EL++ K+A++R     ++ K L+
Sbjct:   495 DVYAFGVVLYELLSAKQAIVRSSESVSESKGLV 527

GO:0005515 "protein binding" evidence=IPI

GO:0008061 "chitin binding" evidence=IDA

GO:0010200 "response to chitin" evidence=IDA

GO:0043621 "protein self-association" evidence=IDA

TAIR|locus:2089860 CERK1 "chitin elicitor receptor kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 454 (164.9 bits), Expect = 5.7e-43, P = 5.7e-43
 Identities = 126/327 (38%), Positives = 180/327 (55%)

Query:   271 VTVLESERTIIFSLEEIEEATNNFDESRIIGRGGFGNVYFGLLGDREAAIKKMRSNKSKE 330
             +  +  ++++ FSLEE+ +AT+NF+ S  IG+GGFG VY+  L   +AAIKKM    SK+
Sbjct:   299 IAAISVDKSVEFSLEELAKATDNFNLSFKIGQGGFGAVYYAELRGEKAAIKKMDMEASKQ 358

Query:   331 FFAELKVLCKIHHINV--FI------STF------GNGSLSDHLHDPLLKGHQPLTWTAR 376
             F AELKVL ++HH+N+   I      S F       NG+L  HLH     G +PL WT R
Sbjct:   359 FLAELKVLTRVHHVNLVRLIGYCVEGSLFLVYEYVENGNLGQHLHG---SGREPLPWTKR 415

Query:   377 TQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEML 436
              QIALD+A+G+EYIH+HT   YVHRDIK++NIL+D   RAKVADFGL KL E        
Sbjct:   416 VQIALDSARGLEYIHEHTVPVYVHRDIKSANILIDQKFRAKVADFGLTKLTEVGGS---- 471

Query:   437 ATR-LVGTPGYLPPEYIFVK-RFRFDMHSSVMELQ--VTTKTDVFAFGVVLAE---LI-- 487
             ATR  +GT GY+ PE ++ +   + D+++  + L   ++ K  V      + E   L+  
Sbjct:   472 ATRGAMGTFGYMAPETVYGEVSAKVDVYAFGVVLYELISAKGAVVKMTEAVGEFRGLVGV 531

Query:   488 -------TGKRALIRDDSEPTKMKSL----ITIMAAVAEWCLNEDAVDRPEMRDIVAILS 536
                    T K   +R   +P    S     +  MA + + C  E+A  RP MR IV  LS
Sbjct:   532 FEESFKETDKEEALRKIIDPRLGDSYPFDSVYKMAELGKACTQENAQLRPSMRYIVVALS 591

Query:   537 QIMITSTEWEASLGGDSQVFSGLFNGR 563
              +  ++  W+     +  + S L +GR
Sbjct:   592 TLFSSTGNWDVGNFQNEDLVS-LMSGR 617

GO:0005576 "extracellular region" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0005886 "plasma membrane" evidence=IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IDA

GO:0019199 "transmembrane receptor protein kinase activity" evidence=IMP;IDA

GO:0032491 "detection of molecule of fungal origin" evidence=IEP;IMP

GO:0035556 "intracellular signal transduction" evidence=RCA;IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0009817 "defense response to fungus, incompatible interaction" evidence=IMP

GO:0010200 "response to chitin" evidence=RCA;IMP

GO:0005515 "protein binding" evidence=IPI

GO:0002752 "cell surface pattern recognition receptor signaling pathway" evidence=IDA

GO:0042742 "defense response to bacterium" evidence=IDA

GO:0008061 "chitin binding" evidence=IDA

GO:2001080 "chitosan binding" evidence=IDA

GO:0032499 "detection of peptidoglycan" evidence=IMP

GO:0045087 "innate immune response" evidence=IMP

GO:0002679 "respiratory burst involved in defense response" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006944 "cellular membrane fusion" evidence=RCA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0042803 "protein homodimerization activity" evidence=IDA

GO:0071219 "cellular response to molecule of bacterial origin" evidence=IEP

GO:0071323 "cellular response to chitin" evidence=IEP

TAIR|locus:2151191 CDL1 "CDG1-like 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 320 (117.7 bits), Expect = 1.0e-40, Sum P(2) = 1.0e-40
 Identities = 80/196 (40%), Positives = 113/196 (57%)

Query:   328 SKEFFAELKVLCKIHHINVFISTFGN----------------GSLSDHLHDPLLKGHQPL 371
             ++EF  E+ +L  +HH N+ ++  G                 GSL DHLHD +  G QPL
Sbjct:   112 NREFLVEVLMLSLLHHPNL-VNLIGYCADGDQRLLVYEYMPLGSLEDHLHD-ISPGKQPL 169

Query:   372 TWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTN 431
              W  R +IA  AAKG+EY+HD T    ++RD+K SNILLDD    K++DFGL KL     
Sbjct:   170 DWNTRMKIAAGAAKGLEYLHDKTMPPVIYRDLKCSNILLDDDYFPKLSDFGLAKLGP-VG 228

Query:   432 EKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKR 491
             +K  ++TR++GT GY  PEY              M  Q+T K+DV++FGVVL E+ITG++
Sbjct:   229 DKSHVSTRVMGTYGYCAPEY-------------AMTGQLTLKSDVYSFGVVLLEIITGRK 275

Query:   492 ALIRDDSEPTKMKSLI 507
             A+  D S  T  ++L+
Sbjct:   276 AI--DSSRSTGEQNLV 289

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:1900459 "positive regulation of brassinosteroid mediated signaling pathway" evidence=IMP

GO:0045892 "negative regulation of transcription, DNA-dependent" evidence=RCA

TAIR|locus:2159873 PERK8 "proline-rich extensin-like receptor kinase 8" [Arabidopsis thaliana (taxid:3702)]

 Score = 388 (141.6 bits), Expect = 1.2e-38, Sum P(2) = 1.2e-38
 Identities = 93/259 (35%), Positives = 149/259 (57%)

Query:   268 TEDVTVLESERTIIFSLEEIEEATNNFDESRIIGRGGFGNVYFGLLGD-REAAIKKMR-- 324
             + D  ++ ++R+  FS +E+ + T+ F E  ++G GGFG VY G+L D RE A+K+++  
Sbjct:   314 SSDSGMVSNQRSW-FSYDELSQVTSGFSEKNLLGEGGFGCVYKGVLSDGREVAVKQLKIG 372

Query:   325 -SNKSKEFFAELKVLCKIHH------INVFIST---------FGNGSLSDHLHDPLLKGH 368
              S   +EF AE++++ ++HH      +   IS            N +L  HLH P   G 
Sbjct:   373 GSQGEREFKAEVEIISRVHHRHLVTLVGYCISEQHRLLVYDYVPNNTLHYHLHAP---GR 429

Query:   369 QPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEE 428
               +TW  R ++A  AA+GI Y+H+    R +HRDIK+SNILLD+   A VADFGL K+ +
Sbjct:   430 PVMTWETRVRVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDNSFEALVADFGLAKIAQ 489

Query:   429 RTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
               +    ++TR++GT GY+ PEY                 +++ K DV+++GV+L ELIT
Sbjct:   490 ELDLNTHVSTRVMGTFGYMAPEY-------------ATSGKLSEKADVYSYGVILLELIT 536

Query:   489 GKRALIRDDSEPTKMKSLI 507
             G++ +  D S+P   +SL+
Sbjct:   537 GRKPV--DTSQPLGDESLV 553

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005199 "structural constituent of cell wall" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0051510 "regulation of unidimensional cell growth" evidence=RCA

TAIR|locus:504954886 AT5G56890 [Arabidopsis thaliana (taxid:3702)]

 Score = 300 (110.7 bits), Expect = 1.3e-36, Sum P(2) = 1.3e-36
 Identities = 72/205 (35%), Positives = 117/205 (57%)

Query:   320 IKKMRSNKSKEFFAELKVLCKIHHINVFISTFG----------------NGSLSDHLHDP 363
             +K+     S+EF AE+++L ++HH N+ ++  G                NGS+  HLH  
Sbjct:   753 LKRDDQQGSREFLAEVEMLSRLHHRNL-VNLIGICIEDRNRSLVYELIPNGSVESHLHG- 810

Query:   364 LLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGL 423
             + K   PL W AR +IAL AA+G+ Y+H+ +  R +HRD K+SNILL++    KV+DFGL
Sbjct:   811 IDKASSPLDWDARLKIALGAARGLAYLHEDSSPRVIHRDFKSSNILLENDFTPKVSDFGL 870

Query:   424 VKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVL 483
              +      +   ++TR++GT GY+ PEY              M   +  K+DV+++GVVL
Sbjct:   871 ARNALDDEDNRHISTRVMGTFGYVAPEY-------------AMTGHLLVKSDVYSYGVVL 917

Query:   484 AELITGKRALIRDDSEPTKMKSLIT 508
              EL+TG++ +  D S+P   ++L++
Sbjct:   918 LELLTGRKPV--DMSQPPGQENLVS 940

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2085720 AT3G20530 [Arabidopsis thaliana (taxid:3702)]

 Score = 305 (112.4 bits), Expect = 3.1e-36, Sum P(2) = 3.1e-36
 Identities = 88/263 (33%), Positives = 132/263 (50%)

Query:   328 SKEFFAELKVLCKIHHINVFISTFG----------------NGSLSDHLHDPLLKGHQPL 371
             ++EF  E+ +L  +HH N+ ++  G                NGSL DHL +      +PL
Sbjct:   121 NREFLVEVMMLSLLHHQNL-VNLVGYCADGDQRILVYEYMQNGSLEDHLLELARNKKKPL 179

Query:   372 TWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTN 431
              W  R ++A  AA+G+EY+H+      ++RD K SNILLD+    K++DFGL K+     
Sbjct:   180 DWDTRMKVAAGAARGLEYLHETADPPVIYRDFKASNILLDEEFNPKLSDFGLAKVGPTGG 239

Query:   432 EKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKR 491
             E  + +TR++GT GY  PEY                 Q+T K+DV++FGVV  E+ITG+R
Sbjct:   240 ETHV-STRVMGTYGYCAPEYALTG-------------QLTVKSDVYSFGVVFLEMITGRR 285

Query:   492 ALIRDDSEPTKMKSLIT-------------IMA-----------------AVAEWCLNED 521
              +  D ++PT+ ++L+T             +MA                 AVA  CL E+
Sbjct:   286 VI--DTTKPTEEQNLVTWASPLFKDRRKFTLMADPLLEGKYPIKGLYQALAVAAMCLQEE 343

Query:   522 AVDRPEMRDIVAILSQIMITSTE 544
             A  RP M D+V  L  + +T TE
Sbjct:   344 AATRPMMSDVVTALEYLAVTKTE 366

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2095188 AT3G23750 [Arabidopsis thaliana (taxid:3702)]

 Score = 321 (118.1 bits), Expect = 2.1e-35, Sum P(2) = 2.1e-35
 Identities = 83/184 (45%), Positives = 106/184 (57%)

Query:   326 NKS-KEFFAELKVLCKIHHIN-VFISTF---GN-----------GSLSDHLHDPLLKGHQ 369
             NK   EF AE+ VL K+ H + V +  +   GN           G+L  HL +    G+ 
Sbjct:   615 NKGMSEFQAEIAVLTKVRHRHLVALLGYCVNGNERLLVYEYMPQGNLGQHLFEWSELGYS 674

Query:   370 PLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEER 429
             PLTW  R  IALD A+G+EY+H   +  ++HRD+K SNILL D +RAKVADFGLVK    
Sbjct:   675 PLTWKQRVSIALDVARGVEYLHSLAQQSFIHRDLKPSNILLGDDMRAKVADFGLVK--NA 732

Query:   430 TNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
              + K  + TRL GT GYL PEY    R             VTTK DV+AFGVVL E++TG
Sbjct:   733 PDGKYSVETRLAGTFGYLAPEYAATGR-------------VTTKVDVYAFGVVLMEILTG 779

Query:   490 KRAL 493
             ++AL
Sbjct:   780 RKAL 783

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0005829 "cytosol" evidence=RCA

GO:0009506 "plasmodesma" evidence=IDA

GO:0005794 "Golgi apparatus" evidence=IDA

TAIR|locus:2098580 AT3G07070 [Arabidopsis thaliana (taxid:3702)]

 Score = 298 (110.0 bits), Expect = 3.2e-35, Sum P(2) = 3.2e-35
 Identities = 77/196 (39%), Positives = 110/196 (56%)

Query:   328 SKEFFAELKVLCKIHH---INVF------------ISTFGNGSLSDHLHDPLLKGHQPLT 372
             +KEF  E+ +L  +HH   +N+                   GSL DHL D L     PL 
Sbjct:   118 NKEFIVEVLMLSLLHHKHLVNLIGYCADGDQRLLVYEYMSRGSLEDHLLD-LTPDQIPLD 176

Query:   373 WTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNE 432
             W  R +IAL AA G+EY+HD      ++RD+K +NILLD    AK++DFGL KL     +
Sbjct:   177 WDTRIRIALGAAMGLEYLHDKANPPVIYRDLKAANILLDGEFNAKLSDFGLAKLGP-VGD 235

Query:   433 KEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRA 492
             K+ +++R++GT GY  PEY   +R            Q+TTK+DV++FGVVL ELITG+R 
Sbjct:   236 KQHVSSRVMGTYGYCAPEY---QRTG----------QLTTKSDVYSFGVVLLELITGRRV 282

Query:   493 LIRDDSEPTKMKSLIT 508
             +  D + P   ++L+T
Sbjct:   283 I--DTTRPKDEQNLVT 296

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2087263 AT3G24790 [Arabidopsis thaliana (taxid:3702)]

 Score = 290 (107.1 bits), Expect = 3.9e-35, Sum P(2) = 3.9e-35
 Identities = 69/155 (44%), Positives = 97/155 (62%)

Query:   354 GSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDG 413
             GSL DHL D L  G +PL W  R +IAL AAKGIEY+HD      ++RD+K+SNILLD  
Sbjct:   127 GSLEDHLLD-LEPGQKPLDWNTRIKIALGAAKGIEYLHDEADPPVIYRDLKSSNILLDPE 185

Query:   414 LRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTK 473
               AK++DFGL KL     +   +++R++GT GY  PEY   +R  +          +T K
Sbjct:   186 YVAKLSDFGLAKLGP-VGDTLHVSSRVMGTYGYCAPEY---QRTGY----------LTNK 231

Query:   474 TDVFAFGVVLAELITGKRALIRDDSEPTKMKSLIT 508
             +DV++FGVVL ELI+G+R +  D   P+  ++L+T
Sbjct:   232 SDVYSFGVVLLELISGRRVI--DTMRPSHEQNLVT 264

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.691

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: gw1.XV.1680.1 hypothetical protein (550 aa) (Populus trichocarpa)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	563
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	3e-44
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	1e-43
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	5e-39
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	7e-38
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	2e-36
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	9e-36
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	2e-33
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	1e-29
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	1e-29
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	7e-28
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	3e-24
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	8e-24
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	5e-20
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	6e-19
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	2e-18
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	6e-18
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	7e-18
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	1e-17
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	2e-17
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	3e-17
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	3e-17
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	4e-17
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	7e-17
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	1e-16
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	2e-16
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	2e-16
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	2e-16
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	2e-16
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	3e-16
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	5e-16
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	7e-16
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	7e-16
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	8e-16
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	8e-16
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	9e-16
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	9e-16
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	1e-15
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	1e-15
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	1e-15
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	1e-15
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	2e-15
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	2e-15
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	3e-15
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	4e-15
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	6e-15
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	7e-15
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	8e-15
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	9e-15
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	1e-14
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	1e-14
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	1e-14
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	2e-14
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	2e-14
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	4e-14
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	4e-14
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	4e-14
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	5e-14
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	7e-14
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	9e-14
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	1e-13
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	1e-13
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	2e-13
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	2e-13
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	2e-13
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	3e-13
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	3e-13
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	3e-13
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	4e-13
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	4e-13
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	5e-13
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	6e-13
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	6e-13
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	7e-13
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	8e-13
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	2e-12
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	3e-12
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	4e-12
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	4e-12
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	4e-12
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	5e-12
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	5e-12
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	5e-12
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	7e-12
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	8e-12
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	1e-11
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	1e-11
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	1e-11
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	2e-11
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	3e-11
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	3e-11
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	3e-11
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	4e-11
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	4e-11
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	6e-11
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	8e-11
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	9e-11
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	9e-11
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	1e-10
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	1e-10
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	1e-10
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	2e-10
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	2e-10
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	2e-10
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	2e-10
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	2e-10
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	2e-10
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	2e-10
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	4e-10
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	5e-10
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	5e-10
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	6e-10
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	7e-10
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	7e-10
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	7e-10
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	8e-10
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	1e-09
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	1e-09
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	1e-09
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	3e-09
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	3e-09
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	4e-09
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	4e-09
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	4e-09
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	5e-09
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	6e-09
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	7e-09
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	9e-09
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	9e-09
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	9e-09
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	9e-09
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	1e-08
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	1e-08
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	1e-08
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	1e-08
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	2e-08
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	2e-08
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	2e-08
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	2e-08
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	2e-08
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	2e-08
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	2e-08
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	3e-08
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	3e-08
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	3e-08
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	3e-08
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	3e-08
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	3e-08
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	3e-08
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	3e-08
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	3e-08
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	3e-08
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	3e-08
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	4e-08
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	4e-08
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	4e-08
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	4e-08
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	4e-08
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	5e-08
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	6e-08
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	6e-08
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	6e-08
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	6e-08
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	7e-08
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	7e-08
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	8e-08
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	9e-08
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	9e-08
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	1e-07
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	1e-07
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	1e-07
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	1e-07
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	1e-07
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	1e-07
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	1e-07
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	2e-07
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	2e-07
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	3e-07
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	3e-07
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	3e-07
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	3e-07
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	4e-07
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	4e-07
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	4e-07
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	4e-07
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	5e-07
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	5e-07
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	6e-07
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	7e-07
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	7e-07
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	8e-07
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	9e-07
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	1e-06
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	1e-06
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	1e-06
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	1e-06
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	1e-06
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	1e-06
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	1e-06
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	1e-06
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	1e-06
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	2e-06
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	2e-06
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	2e-06
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	2e-06
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	2e-06
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	2e-06
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	2e-06
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	3e-06
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	4e-06
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	4e-06
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	4e-06
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	4e-06
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	4e-06
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	5e-06
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	5e-06
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	5e-06
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	5e-06
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	5e-06
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	5e-06
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	5e-06
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	5e-06
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	6e-06
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	6e-06
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	7e-06
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	7e-06
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	8e-06
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	8e-06
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	8e-06
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	9e-06
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	1e-05
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	1e-05
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	1e-05
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	1e-05
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	2e-05
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	2e-05
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	2e-05
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	2e-05
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	2e-05
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	2e-05
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	2e-05
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	2e-05
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	2e-05
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	3e-05
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	3e-05
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	3e-05
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	3e-05
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	3e-05
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	4e-05
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	5e-05
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	5e-05
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	6e-05
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	6e-05
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	7e-05
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	8e-05
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	9e-05
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	1e-04
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	1e-04
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	1e-04
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	1e-04
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	1e-04
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	1e-04
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	2e-04
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	2e-04
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	2e-04
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	2e-04
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	2e-04
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	2e-04
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	2e-04
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	3e-04
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	3e-04
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	3e-04
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	3e-04
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	4e-04
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	5e-04
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	5e-04
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	6e-04
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	6e-04
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	6e-04
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	0.001
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	0.001
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	0.001
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	0.001
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	0.001
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	0.001
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	0.002
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	0.002
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	0.002
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	0.003
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	0.003
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	0.003
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	0.004

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  157 bits (399), Expect = 3e-44
 Identities = 67/277 (24%), Positives = 118/277 (42%), Gaps = 62/277 (22%)

Query: 298 RIIGRGGFGNVYFGLL------GDREAAIKKMRSNKS----KEFFAELKVLCKIHHINVF 347
           + +G G FG VY G L       + E A+K ++ + S    +EF  E +++ K+ H N+ 
Sbjct: 5   KKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI- 63

Query: 348 ISTFG----------------NGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIH 391
           +   G                 G L D+L        + L+ +     AL  A+G+EY+ 
Sbjct: 64  VKLLGVCTEEEPLMIVMEYMPGGDLLDYLRK---NRPKELSLSDLLSFALQIARGMEYLE 120

Query: 392 DHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP-GYLPPE 450
                 ++HRD+   N L+ + L  K++DFGL +     +  ++   +L   P  ++ PE
Sbjct: 121 SK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKL---PIRWMAPE 174

Query: 451 YIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GK-----------RALIRDDS 498
            +   +F             T+K+DV++FGV+L E+ T G+              ++   
Sbjct: 175 SLKEGKF-------------TSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGY 221

Query: 499 EPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAIL 535
              K  +    +  +   C  ED  DRP   ++V IL
Sbjct: 222 RLPKPPNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  155 bits (394), Expect = 1e-43
 Identities = 66/278 (23%), Positives = 114/278 (41%), Gaps = 63/278 (22%)

Query: 297 SRIIGRGGFGNVYFGLL------GDREAAIKKMRSNKS----KEFFAELKVLCKIHHINV 346
            + +G G FG VY G L         E A+K ++ + S    +EF  E +++ K+ H NV
Sbjct: 4   GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63

Query: 347 FISTFG----------------NGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYI 390
            +   G                 G L  +L          L+ +     AL  A+G+EY+
Sbjct: 64  -VKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKN----RPKLSLSDLLSFALQIARGMEYL 118

Query: 391 HDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP-GYLPP 449
                  ++HRD+   N L+ + L  K++DFGL +     +       +L   P  ++ P
Sbjct: 119 ESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKL---PIRWMAP 172

Query: 450 EYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GK-----------RALIRDD 497
           E +   +F             T+K+DV++FGV+L E+ T G+              +++ 
Sbjct: 173 ESLKEGKF-------------TSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNG 219

Query: 498 SEPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAIL 535
               +  +    +  +   C  ED  DRP   ++V IL
Sbjct: 220 YRLPQPPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  143 bits (363), Expect = 5e-39
 Identities = 70/284 (24%), Positives = 108/284 (38%), Gaps = 69/284 (24%)

Query: 298 RIIGRGGFGNVYFGLL-----GDREAAIKKMRSNKS----KEFFAELKVLCKIHHINVFI 348
           + +G G FG VY G L        E A+K ++ + S    K+F  E +V+ K+ H NV +
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNV-V 59

Query: 349 STFG----------------NGSLSDHL----HDPLLKGHQPLTWTARTQIALDAAKGIE 388
              G                 G L D+L              L+       A+  AKG+E
Sbjct: 60  RLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119

Query: 389 YIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGL-----VKLEERTNEKEMLATRLVGT 443
           Y+      ++VHRD+   N L+ + L  K++DFGL          R      L  R    
Sbjct: 120 YLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR---- 172

Query: 444 PGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GK-----------R 491
             ++ PE +    F             T+K+DV++FGV+L E+ T G             
Sbjct: 173 --WMAPESLKDGIF-------------TSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVL 217

Query: 492 ALIRDDSEPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAIL 535
             +R      K +     +  +   C   D  DRP   ++V  L
Sbjct: 218 EYLRKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERL 261

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  138 bits (350), Expect = 7e-38
 Identities = 72/258 (27%), Positives = 110/258 (42%), Gaps = 65/258 (25%)

Query: 300 IGRGGFGNVYFGLLGD--REAAIKKMRSNKSK----EFFAELKVLCKIHHINV--FISTF 351
           +G GGFG VY        ++ AIK ++   S     E   E+++L K++H N+      F
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 352 -------------GNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARY 398
                          GSL D L     +    L+     +I L   +G+EY+H +     
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLK----ENEGKLSEDEILRILLQILEGLEYLHSN---GI 113

Query: 399 VHRDIKTSNILLDDG-LRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRF 457
           +HRD+K  NILLD    + K+ADFGL KL       + L   +VGTP Y+ PE +  K  
Sbjct: 114 IHRDLKPENILLDSDNGKVKLADFGLSKLL---TSDKSLLKTIVGTPAYMAPEVLLGKG- 169

Query: 458 RFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKMKSLITIMAAVAEWC 517
                        + K+D+++ GV+L EL               ++K LI          
Sbjct: 170 -----------YYSEKSDIWSLGVILYEL--------------PELKDLI-------RKM 197

Query: 518 LNEDAVDRPEMRDIVAIL 535
           L +D   RP  ++I+  L
Sbjct: 198 LQKDPEKRPSAKEILEHL 215

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  135 bits (343), Expect = 2e-36
 Identities = 70/287 (24%), Positives = 113/287 (39%), Gaps = 82/287 (28%)

Query: 298 RIIGRGGFGNVYFGLL------GDREAAIKKMR----SNKSKEFFAELKVLCKIHHINV- 346
           + +G G FG VY G L       + + A+K ++      + +EF  E  ++ K+ H N+ 
Sbjct: 5   KKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIV 64

Query: 347 ----FISTFG----------NGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHD 392
                 +              G L D L        + LT     Q+AL  AKG+EY+  
Sbjct: 65  RLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHG----EKLTLKDLLQMALQIAKGMEYLES 120

Query: 393 HTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLP---- 448
                +VHRD+   N L+ + L  K++DFGL +     +             G LP    
Sbjct: 121 K---NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDD------YYRKRGGGKLPIKWM 171

Query: 449 -PEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GK-----------RALIR 495
            PE +   +F             T+K+DV++FGV+L E+ T G+             L+ 
Sbjct: 172 APESLKDGKF-------------TSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLE 218

Query: 496 D-------DSEPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAIL 535
           D       ++ P ++  L+         C   D  DRP   ++V  L
Sbjct: 219 DGYRLPRPENCPDELYELML-------QCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  134 bits (339), Expect = 9e-36
 Identities = 77/274 (28%), Positives = 115/274 (41%), Gaps = 62/274 (22%)

Query: 298 RIIGRGGFGNVYFG-LLGDREA-AIKKMR-----SNKSKEFFAELKVLCKIHHINV--FI 348
           R +G G FG VY     G  +  A+K ++     S K +    E+++L ++ H N+   I
Sbjct: 5   RKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLI 64

Query: 349 STF-------------GNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTK 395
             F               G L D+L         PL+     +IAL   +G+EY+H +  
Sbjct: 65  DAFEDKDHLYLVMEYCEGGDLFDYLSR-----GGPLSEDEAKKIALQILRGLEYLHSN-- 117

Query: 396 ARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVK 455
              +HRD+K  NILLD+    K+ADFGL K   +++      T  VGTP Y+ PE +   
Sbjct: 118 -GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSS---LTTFVGTPWYMAPEVLLGG 173

Query: 456 RFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK----------------RALIRDDSE 499
                            K DV++ GV+L EL+TGK                R L      
Sbjct: 174 NG------------YGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEF 221

Query: 500 PTKMKSLITIMAA-VAEWCLNEDAVDRPEMRDIV 532
                S  +  A  + + CLN+D   RP   +I+
Sbjct: 222 DEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEIL 255

Length = 260

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  127 bits (321), Expect = 2e-33
 Identities = 60/231 (25%), Positives = 89/231 (38%), Gaps = 47/231 (20%)

Query: 298 RIIGRGGFGNVYFG--LLGDREAAIKKMRSNKSKE----FFAELKVLCKIHHINV--FIS 349
             +G G FG VY        +  AIK ++  K K+       E+K+L K+ H N+     
Sbjct: 5   EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64

Query: 350 TF-------------GNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKA 396
            F               G L D L     +G                   +EY+H     
Sbjct: 65  VFEDEDKLYLVMEYCEGGDLFDLLKK---RGRLSEDEARF--YLRQILSALEYLHSK--- 116

Query: 397 RYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKR 456
             VHRD+K  NILLD+    K+ADFGL +  +         T  VGTP Y+ PE      
Sbjct: 117 GIVHRDLKPENILLDEDGHVKLADFGLARQLDPG----EKLTTFVGTPEYMAPE------ 166

Query: 457 FRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKMKSLI 507
                   ++        D+++ GV+L EL+TG +     D +  ++   I
Sbjct: 167 -------VLLGKGYGKAVDIWSLGVILYELLTG-KPPFPGDDQLLELFKKI 209

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  117 bits (295), Expect = 1e-29
 Identities = 74/295 (25%), Positives = 120/295 (40%), Gaps = 84/295 (28%)

Query: 293 NFDESRIIGRGGFGNVYFGLLGDREA----AIKKMR----SNKSKEF-FAELKVLCKIHH 343
            ++  + IG+G FG VY  L+  +       +K++     S K +E    E+K+L K++H
Sbjct: 1   KYEIIKQIGKGSFGKVY--LVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNH 58

Query: 344 INV--FISTF-------------GNGSLSDHLHDPLLKG-----HQPLTWTARTQIALDA 383
            N+  +  +F               G LS  +     +G      Q L W    Q+ L  
Sbjct: 59  PNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWF--VQLCL-- 114

Query: 384 AKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGT 443
              ++Y+H     + +HRDIK  NI L      K+ DFG+ K+   T +   LA  +VGT
Sbjct: 115 --ALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVD---LAKTVVGT 166

Query: 444 PGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRA----------- 492
           P YL PE    K +               K+D+++ G VL EL T K             
Sbjct: 167 PYYLSPELCQNKPY-------------NYKSDIWSLGCVLYELCTLKHPFEGENLLELAL 213

Query: 493 -LIRDDSEP------TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMI 540
            +++    P      +++++L+          L +D  +RP    I  IL    I
Sbjct: 214 KILKGQYPPIPSQYSSELRNLV-------SSLLQKDPEERP---SIAQILQSPFI 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  117 bits (295), Expect = 1e-29
 Identities = 58/224 (25%), Positives = 94/224 (41%), Gaps = 58/224 (25%)

Query: 298 RIIGRGGFGNVYFGLLGD--REAAIKKMRSNKSKEFFA-----ELKVLCKIHH------- 343
            ++GRG FG+VY  L  D     A+K +  +   E        E+++L  + H       
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 344 ----------INVFISTFGNGSLSDH------LHDPLLKGHQPLTWTARTQIALDAAKGI 387
                     +N+F+     GSLS        L +P+++      +T   QI     +G+
Sbjct: 66  GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIR-----KYT--RQIL----EGL 114

Query: 388 EYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYL 447
            Y+H +     VHRDIK +NIL+D     K+ADFG  K        E   + + GTP ++
Sbjct: 115 AYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGS-VRGTPYWM 170

Query: 448 PPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKR 491
            PE I  +             +     D+++ G  + E+ TGK 
Sbjct: 171 APEVIRGE-------------EYGRAADIWSLGCTVIEMATGKP 201

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  111 bits (281), Expect = 7e-28
 Identities = 72/236 (30%), Positives = 102/236 (43%), Gaps = 58/236 (24%)

Query: 300 IGRGGFGNVYFG--LLGDREAAIKKMRSNKSKEF---FAELKVLCKIHHINV--FISTF- 351
           IG+GGFG VY        +E AIK ++    ++      E+++L K  H N+  +  ++ 
Sbjct: 8   IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL 67

Query: 352 ------------GNGSLSDHLHDPLLKGH-QPLTWTARTQIA---LDAAKGIEYIHDHTK 395
                         GSL D     LLK   Q LT    +QIA    +  KG+EY+H +  
Sbjct: 68  KKDELWIVMEFCSGGSLKD-----LLKSTNQTLT---ESQIAYVCKELLKGLEYLHSN-- 117

Query: 396 ARYVHRDIKTSNILL-DDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFV 454
              +HRDIK +NILL  DG   K+ DFGL                +VGTP ++ PE I  
Sbjct: 118 -GIIHRDIKAANILLTSDG-EVKLIDFGLSA----QLSDTKARNTMVGTPYWMAPEVING 171

Query: 455 KRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKMKSLITIM 510
           K +               K D+++ G+   EL  GK       SE   MK+L  I 
Sbjct: 172 KPY-------------DYKADIWSLGITAIELAEGKPPY----SELPPMKALFKIA 210

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  104 bits (259), Expect = 3e-24
 Identities = 67/268 (25%), Positives = 107/268 (39%), Gaps = 42/268 (15%)

Query: 293 NFDESRIIGRGGFGNVYFGLLGDREAAIKKMRSNKSKE------FFAELKVLCKIHHINV 346
           ++   R +G G FG VY      +  A+K +      +      F  E+++L  ++H   
Sbjct: 1   SYRILRKLGEGSFGEVYLARD-RKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPN 59

Query: 347 FISTFG----------------NGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYI 390
            +  +                  GSL D L     KG  PL+ +    I       +EY+
Sbjct: 60  IVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKG--PLSESEALFILAQILSALEYL 117

Query: 391 HDHTKARYVHRDIKTSNILLD-DGLRAKVADFGLVKL---EERTNEKEMLATRLVGTPGY 446
           H       +HRDIK  NILLD DG   K+ DFGL KL      T+    L +  VGTPGY
Sbjct: 118 HSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGY 174

Query: 447 LPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKMKSL 506
           + PE +                  ++ +D+++ G+ L EL+TG      + +     ++L
Sbjct: 175 MAPEVLLGLSLA----------YASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTL 224

Query: 507 ITIMAAVAEWCLNEDAVDRPEMRDIVAI 534
             I+        +  +   PE+    A 
Sbjct: 225 KIILELPTPSLASPLSPSNPELISKAAS 252

Length = 384

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  100 bits (251), Expect = 8e-24
 Identities = 62/215 (28%), Positives = 101/215 (46%), Gaps = 52/215 (24%)

Query: 300 IGRGGFGNVYFGLLGDREAAIKKMR--SNKSKEFFAELKVLCKIHHIN------------ 345
           IG+G FG+V  G    ++ A+K ++  S  ++ F AE  V+  + H N            
Sbjct: 14  IGKGEFGDVMLGDYRGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGN 73

Query: 346 -VFIST--FGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRD 402
            ++I T     GSL D+L     +G   +T   +   ALD  +G+EY+ +     +VHRD
Sbjct: 74  PLYIVTEYMAKGSLVDYLRS---RGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRD 127

Query: 403 IKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLP-----PEYIFVKRF 457
           +   N+L+ + L AKV+DFGL K   +  +            G LP     PE +  K+F
Sbjct: 128 LAARNVLVSEDLVAKVSDFGLAKEASQGQDS-----------GKLPVKWTAPEALREKKF 176

Query: 458 RFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRA 492
                        +TK+DV++FG++L E+ +  R 
Sbjct: 177 -------------STKSDVWSFGILLWEIYSFGRV 198

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 90.3 bits (225), Expect = 5e-20
 Identities = 63/236 (26%), Positives = 104/236 (44%), Gaps = 45/236 (19%)

Query: 298 RIIGRGGFGNVYFGLLGDREA--AIKKMRSNKSKEFFA-----ELKVLCKIHHINV---- 346
             IG G +G VY           A+KK+R    KE F      E+K+L K+ H N+    
Sbjct: 5   AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLK 64

Query: 347 -FISTFGNGSLS------DH-----LHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHT 394
             +++ G GS+       DH     L  P +K     T +          +G++Y+H + 
Sbjct: 65  EIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVK----FTESQIKCYMKQLLEGLQYLHSN- 119

Query: 395 KARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFV 454
               +HRDIK SNIL+++    K+ADFGL +   + N  +   T  V T  Y PPE +  
Sbjct: 120 --GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADY--TNRVITLWYRPPELLL- 174

Query: 455 KRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKMKSLITIM 510
                         +   + D+++ G +LAEL  GK  + +  +E  +++ +  + 
Sbjct: 175 -----------GATRYGPEVDMWSVGCILAELFLGK-PIFQGSTELEQLEKIFELC 218

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 86.6 bits (215), Expect = 6e-19
 Identities = 59/210 (28%), Positives = 94/210 (44%), Gaps = 41/210 (19%)

Query: 298 RIIGRGGFGNVYFGL-LGDREAAIKKMR--SNKSKEFFAELKVLCKIHHIN--------- 345
           R +G G FG V+ G   G  + A+K ++  +   + F  E +++ K+ H           
Sbjct: 12  RKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCS 71

Query: 346 ----VFIST--FGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYV 399
               ++I T     GSL D L     +G + L       +A   A+G+ Y+       Y+
Sbjct: 72  EEEPIYIVTEYMSKGSLLDFLKSG--EGKK-LRLPQLVDMAAQIAEGMAYLE---SRNYI 125

Query: 400 HRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP-GYLPPEYIFVKRFR 458
           HRD+   NIL+ + L  K+ADFGL +L E   + E  A      P  +  PE     RF 
Sbjct: 126 HRDLAARNILVGENLVCKIADFGLARLIE---DDEYTAREGAKFPIKWTAPEAANYGRF- 181

Query: 459 FDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
                       T K+DV++FG++L E++T
Sbjct: 182 ------------TIKSDVWSFGILLTEIVT 199

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 85.8 bits (212), Expect = 2e-18
 Identities = 69/226 (30%), Positives = 111/226 (49%), Gaps = 57/226 (25%)

Query: 299 IIGRGGFGNVYFGLL---GDR-EAAIKKMRS----NKSKEFFAELKVLCKI-HHINVFIS 349
           +IG G FG V   ++   G +  AAIK ++     N  ++F  EL+VLCK+ HH N+ I+
Sbjct: 9   VIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNI-IN 67

Query: 350 TFGN----------------GSLSDHLH-------DPLL-KGH---QPLTWTARTQIALD 382
             G                 G+L D L        DP   K H     LT     Q A D
Sbjct: 68  LLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASD 127

Query: 383 AAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVG 442
            A G++Y+ +    +++HRD+   N+L+ + L +K+ADFGL + EE   +K M       
Sbjct: 128 VATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTM------- 177

Query: 443 TPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
             G LP  ++ ++   + ++        TTK+DV++FGV+L E+++
Sbjct: 178 --GRLPVRWMAIESLNYSVY--------TTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 83.3 bits (206), Expect = 6e-18
 Identities = 70/266 (26%), Positives = 107/266 (40%), Gaps = 65/266 (24%)

Query: 300 IGRGGFGNVYFGLLGD-------REAAIKKMRSNKSKEFFAELKVLCKIHH--------- 343
           IG+G FG V+  +          ++  + KM   + +E   E +VL K+           
Sbjct: 8   IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYES 67

Query: 344 ------INVFISTFGNGSLSDHLHDPLLKGHQPLT----WTARTQIALDAAKGIEYIHDH 393
                 +N+ +    NG L   L    ++  +PL     W    QI L    G+ ++H  
Sbjct: 68  FLDKGKLNIVMEYAENGDLHKLLK---MQRGRPLPEDQVWRFFIQILL----GLAHLH-- 118

Query: 394 TKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIF 453
              + +HRDIK+ N+ LD     K+ D G+ KL    ++    A  +VGTP YL PE   
Sbjct: 119 -SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKL---LSDNTNFANTIVGTPYYLSPELCE 174

Query: 454 VKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK------------RALIRDDSEPT 501
            K +               K+DV+A GVVL E  TGK              +IR    P 
Sbjct: 175 DKPY-------------NEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPV 221

Query: 502 KMKSLITIMAAVAEWCLNEDAVDRPE 527
                  + A + + CL +D   RP+
Sbjct: 222 SQMYSQQL-AQLIDQCLTKDYRQRPD 246

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 83.4 bits (207), Expect = 7e-18
 Identities = 69/259 (26%), Positives = 105/259 (40%), Gaps = 55/259 (21%)

Query: 300 IGRGGFGNVYFGLLGD--REAAIKK----MRSNKSKEFFAELKVLCKIHHINVFISTFG- 352
           +G+G  G VY        +  A+KK          K+   ELK L       V +  +G 
Sbjct: 9   LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYV-VKCYGA 67

Query: 353 ---------------NGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKAR 397
                           GSL+D     LLK    +       IA    KG++Y+H  TK  
Sbjct: 68  FYKEGEISIVLEYMDGGSLAD-----LLKKVGKIPEPVLAYIARQILKGLDYLH--TKRH 120

Query: 398 YVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRF 457
            +HRDIK SN+L++     K+ADFG+ K+ E T ++       VGT  Y+ PE     R 
Sbjct: 121 IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTF---VGTVTYMSPE-----RI 172

Query: 458 RFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKMKSLITIMAAVAEWC 517
           + + +S           D+++ G+ L E   GK   +     P    S   +M A+ +  
Sbjct: 173 QGESYS--------YAADIWSLGLTLLECALGKFPFL-----PPGQPSFFELMQAICDGP 219

Query: 518 ---LNEDAVDRPEMRDIVA 533
              L  +    PE RD ++
Sbjct: 220 PPSLPAEEFS-PEFRDFIS 237

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 82.7 bits (205), Expect = 1e-17
 Identities = 67/223 (30%), Positives = 101/223 (45%), Gaps = 64/223 (28%)

Query: 299 IIGRGGFGNVYFGLLGDRE----AAIKKMRSNKSKE-----FFAELKVLCKIHHINV--- 346
           +IGRG FG VY GL  + E     AIK++   K KE        E+ +L  + H N+   
Sbjct: 7   LIGRGAFGVVYKGL--NLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKY 64

Query: 347 --FISTFG----------NGSLSDHLHDPLLKGHQPL--TWTAR--TQIALDAAKGIEYI 390
              I T            NGSL       ++K   P   +  A    Q+     +G+ Y+
Sbjct: 65  IGSIETSDSLYIILEYAENGSLRQ-----IIKKFGPFPESLVAVYVYQVL----QGLAYL 115

Query: 391 HDHTKARYVHRDIKTSNILL-DDGLRAKVADFGL-VKLEERTNEKEMLATRLVGTPGYLP 448
           H+      +HRDIK +NIL   DG+  K+ADFG+  KL    N+       +VGTP ++ 
Sbjct: 116 HEQG---VIHRDIKAANILTTKDGV-VKLADFGVATKL----NDVSKDDASVVGTPYWMA 167

Query: 449 PEYIFVKRFRFDMHSSVMELQ-VTTKTDVFAFGVVLAELITGK 490
           PE              V+E+   +T +D+++ G  + EL+TG 
Sbjct: 168 PE--------------VIEMSGASTASDIWSLGCTVIELLTGN 196

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 82.1 bits (203), Expect = 2e-17
 Identities = 55/210 (26%), Positives = 90/210 (42%), Gaps = 41/210 (19%)

Query: 298 RIIGRGGFGNVYFGLL-GDREAAIKKMR--SNKSKEFFAELKVLCKIHHIN--------- 345
           R +G G FG V+ GL       A+K ++  +   K+F AE +++ K+ H           
Sbjct: 12  RKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCT 71

Query: 346 ----VFIST--FGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYV 399
               ++I T     GSL ++L        + L       +A   A G+ Y+       Y+
Sbjct: 72  LEEPIYIVTELMKYGSLLEYLQG---GAGRALKLPQLIDMAAQVASGMAYLEAQN---YI 125

Query: 400 HRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP-GYLPPEYIFVKRFR 458
           HRD+   N+L+ +    KVADFGL ++     E    A      P  +  PE     RF 
Sbjct: 126 HRDLAARNVLVGENNICKVADFGLARV---IKEDIYEAREGAKFPIKWTAPEAALYNRF- 181

Query: 459 FDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
                       + K+DV++FG++L E++T
Sbjct: 182 ------------SIKSDVWSFGILLTEIVT 199

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 81.6 bits (202), Expect = 3e-17
 Identities = 65/225 (28%), Positives = 92/225 (40%), Gaps = 45/225 (20%)

Query: 300 IGRGGFGNVYFG-------LLGDREAAIKKMRSNKSKEFFAELKVLCKIHHINVFISTFG 352
           IG G FG VY         L+  +E  I+       KE   E+KVL  + H N+ +  +G
Sbjct: 8   IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNL-VKYYG 66

Query: 353 ----------------NGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKA 396
                            G+L + L                  + L   +G+ Y+H H   
Sbjct: 67  VEVHREKVYIFMEYCSGGTLEELLE---HGRILDEHVIRVYTLQL--LEGLAYLHSH--- 118

Query: 397 RYVHRDIKTSNILLDDGLRAKVADFGL-VKLEER-TNEKEMLATRLVGTPGYLPPEYIFV 454
             VHRDIK +NI LD     K+ DFG  VKL+   T   E + + L GTP Y+ PE I  
Sbjct: 119 GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQS-LAGTPAYMAPEVI-- 175

Query: 455 KRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE 499
              +   H            D+++ G V+ E+ TGKR     D+E
Sbjct: 176 TGGKGKGHGRAA--------DIWSLGCVVLEMATGKRPWSELDNE 212

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 81.7 bits (201), Expect = 3e-17
 Identities = 62/226 (27%), Positives = 110/226 (48%), Gaps = 57/226 (25%)

Query: 299 IIGRGGFGNVYFGLLGD----REAAIKKMRS----NKSKEFFAELKVLCKI-HHINVFIS 349
           +IG G FG V    +       +AAIK+M+     +  ++F  EL+VLCK+ HH N+ I+
Sbjct: 2   VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI-IN 60

Query: 350 TFGN----------------GSLSDHLH-------DPLL-KGHQPLTWTARTQI---ALD 382
             G                 G+L D L        DP     +   +  +  Q+   A D
Sbjct: 61  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120

Query: 383 AAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVG 442
            A+G++Y+   ++ +++HRD+   NIL+ +   AK+ADFGL + +E   +K M       
Sbjct: 121 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM------- 170

Query: 443 TPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
             G LP  ++ ++   + ++        TT +DV+++GV+L E+++
Sbjct: 171 --GRLPVRWMAIESLNYSVY--------TTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 81.5 bits (202), Expect = 4e-17
 Identities = 73/273 (26%), Positives = 111/273 (40%), Gaps = 65/273 (23%)

Query: 291 TNNFDESRIIGRGGFGNVYFGL-LGD-REAAIKKMR-SNKSKE-FFAELKVLCKIHHINV 346
              +     IG G  G VY        +E AIKKMR   ++KE    E+ ++    H N+
Sbjct: 18  RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNI 77

Query: 347 --FISTF-------------GNGSLSDHLHDPLLKGHQPLTWTARTQIA---LDAAKGIE 388
             +  ++               GSL+D     ++  +  +      QIA    +  +G+E
Sbjct: 78  VDYYDSYLVGDELWVVMEYMDGGSLTD-----IITQN-FVRMN-EPQIAYVCREVLQGLE 130

Query: 389 YIHDHTKARYVHRDIKTSNILLD-DGLRAKVADFGL-VKLEERTNEKEMLATRLVGTPGY 446
           Y+H       +HRDIK+ NILL  DG   K+ADFG   +L   T EK    + +VGTP +
Sbjct: 131 YLH---SQNVIHRDIKSDNILLSKDG-SVKLADFGFAAQL---TKEKSKRNS-VVGTPYW 182

Query: 447 LPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK---------RAL--IR 495
           + PE I  KR  +             K D+++ G++  E+  G+         RAL  I 
Sbjct: 183 MAPEVI--KRKDYG-----------PKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLIT 229

Query: 496 DDSEP--TKMKSLITIMAAVAEWCLNEDAVDRP 526
               P     +            CL +D   RP
Sbjct: 230 TKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRP 262

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 80.7 bits (200), Expect = 7e-17
 Identities = 56/240 (23%), Positives = 90/240 (37%), Gaps = 62/240 (25%)

Query: 292 NNFDESRIIGRGGFGNVYFGLL--GDREAAIK---K---MRSNKSKEFFAELKVLCKI-H 342
           ++F   +IIG G F  V        ++E AIK   K   ++  K K    E +VL ++  
Sbjct: 1   DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60

Query: 343 HINVF--ISTF-------------GNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGI 387
           H  +     TF              NG L  ++      G      T     A +    +
Sbjct: 61  HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRK---YGSLDEKCT--RFYAAEILLAL 115

Query: 388 EYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKL---------------EERTNE 432
           EY+H       +HRD+K  NILLD  +  K+ DFG  K+                  +  
Sbjct: 116 EYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQI 172

Query: 433 KEMLATR--LVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
           ++        VGT  Y+ PE +              E      +D++A G ++ +++TGK
Sbjct: 173 EKNRRRFASFVGTAEYVSPELL-------------NEKPAGKSSDLWALGCIIYQMLTGK 219

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 80.2 bits (198), Expect = 1e-16
 Identities = 68/228 (29%), Positives = 100/228 (43%), Gaps = 49/228 (21%)

Query: 281 IFSLEEIEEATNNFDESRIIGRGGFGNVYFG--LLGDREAAIKKMRSN------KSKEFF 332
           +FS ++ E+    F + R IG G FG VYF   +  +   AIKKM  +      K ++  
Sbjct: 7   LFSKDDPEKL---FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDII 63

Query: 333 AELKVLCKIHHINV--------------FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQ 378
            E++ L ++ H N                +  +  GS SD L +   K  Q +   A   
Sbjct: 64  KEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCLGSASDIL-EVHKKPLQEVEIAA--- 119

Query: 379 IALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLAT 438
           I   A +G+ Y+H H +   +HRDIK  NILL +    K+ADFG   L    N       
Sbjct: 120 ICHGALQGLAYLHSHER---IHRDIKAGNILLTEPGTVKLADFGSASLVSPANS------ 170

Query: 439 RLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAEL 486
             VGTP ++ PE I           ++ E Q   K DV++ G+   EL
Sbjct: 171 -FVGTPYWMAPEVIL----------AMDEGQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 79.3 bits (196), Expect = 2e-16
 Identities = 76/289 (26%), Positives = 121/289 (41%), Gaps = 78/289 (26%)

Query: 298 RIIGRGGFGNVYFGLL---GDRE--AAIKKMRSNKSK----EFFAELKVLCKIHHINV-- 346
           ++IG G FG V  G L   G +E   AIK +++  S     +F  E  ++ +  H N+  
Sbjct: 10  KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69

Query: 347 -----------FIST--FGNGSLSDHLHDPLLKGH-QPLTWTARTQIALDAAKGIEYIHD 392
                       I T    NGSL     D  L+ +    T      +    A G++Y+ +
Sbjct: 70  LEGVVTKSRPVMIITEYMENGSL-----DKFLRENDGKFTVGQLVGMLRGIASGMKYLSE 124

Query: 393 HTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLP---- 448
                YVHRD+   NIL++  L  KV+DFGL +  E +       T+     G +P    
Sbjct: 125 MN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEAT--YTTK----GGKIPIRWT 175

Query: 449 -PEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKR------------ALI 494
            PE I  ++F             T+ +DV++FG+V+ E+++ G+R            A+ 
Sbjct: 176 APEAIAYRKF-------------TSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVE 222

Query: 495 RDDSEPTKM---KSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMI 540
                P  M    +L  +M      C  +D  +RP    IV+ L + MI
Sbjct: 223 DGYRLPPPMDCPSALYQLM----LDCWQKDRNERPTFSQIVSTLDK-MI 266

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 78.7 bits (195), Expect = 2e-16
 Identities = 52/218 (23%), Positives = 80/218 (36%), Gaps = 55/218 (25%)

Query: 300 IGRGGFGNVY--FGLLGDREAAIKKMRSNKSKEF--------FAELKVLCKIHHINV--- 346
           +G+G FG V         +  A+K ++  K K            E  +L +I+H  +   
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLK--KKKIIKRKEVEHTLTERNILSRINHPFIVKL 58

Query: 347 -----------FISTFGN-GSLSDHLHDPLLKGHQPLTWTAR--TQIALDAAKGIEYIHD 392
                       +  +   G L  HL     +G            +I L     +EY+H 
Sbjct: 59  HYAFQTEEKLYLVLEYAPGGELFSHLSK---EGRFSEERARFYAAEIVL----ALEYLHS 111

Query: 393 HTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYI 452
                 ++RD+K  NILLD     K+ DFGL K       +        GTP YL PE +
Sbjct: 112 L---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSR---TNTFCGTPEYLAPEVL 165

Query: 453 FVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
                        +        D ++ GV+L E++TGK
Sbjct: 166 -------------LGKGYGKAVDWWSLGVLLYEMLTGK 190

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 79.5 bits (196), Expect = 2e-16
 Identities = 75/311 (24%), Positives = 125/311 (40%), Gaps = 96/311 (30%)

Query: 292 NNFDESRIIGRGGFGNVY----FGLLGDRE---AAIKKMRSNKS----KEFFAELKVLCK 340
           NN +  R IG+G FG V+     GLL        A+K ++   S     +F  E  ++ +
Sbjct: 5   NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 64

Query: 341 IHHINV---------------FISTFGNGSLSDHL------------HDPL-----LKGH 368
             H N+                      G L++ L            H            
Sbjct: 65  FDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNP 124

Query: 369 QPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGL---VK 425
            PL+ T +  IA   A G+ Y+ +    ++VHRD+ T N L+ + +  K+ADFGL   + 
Sbjct: 125 LPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIY 181

Query: 426 LEE--RTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVL 483
             +  + +E + +  R      ++PPE IF  R+             TT++DV+A+GVVL
Sbjct: 182 SADYYKASENDAIPIR------WMPPESIFYNRY-------------TTESDVWAYGVVL 222

Query: 484 AELIT-GKR-----------ALIRD-------DSEPTKMKSLITIMAAVAEWCLNEDAVD 524
            E+ + G +             +RD       D+ P ++ +L+ +       C ++   D
Sbjct: 223 WEIFSYGMQPYYGMAHEEVIYYVRDGNVLSCPDNCPLELYNLMRL-------CWSKLPSD 275

Query: 525 RPEMRDIVAIL 535
           RP    I  IL
Sbjct: 276 RPSFASINRIL 286

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 79.4 bits (196), Expect = 2e-16
 Identities = 71/293 (24%), Positives = 114/293 (38%), Gaps = 90/293 (30%)

Query: 300 IGRGGFGNVYFG---LLGDREA----AIKKMRSNKS----KEFFAELKVLCKIHHIN--- 345
           +G G FG VY G      +R +    AIK ++ N      +EF  E +++  + H N   
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72

Query: 346 ------------VFISTFGNGSLSDHL--HDPL---------LKGHQPLTWTARTQIALD 382
                       +      +G L + L  + P                L  +    IA+ 
Sbjct: 73  LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132

Query: 383 AAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKL-----EERTNEKEMLA 437
            A G+EY+  H    +VHRD+   N L+ +GL  K++DFGL +        R   K +L 
Sbjct: 133 IAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189

Query: 438 TRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVL-------------- 483
            R      ++PPE I   +F             TT++D+++FGVVL              
Sbjct: 190 VR------WMPPEAILYGKF-------------TTESDIWSFGVVLWEIFSYGLQPYYGF 230

Query: 484 -----AELITGKRALIRDDSEPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDI 531
                 E+I  ++ L   +  P ++ +L+         C NE    RP  +DI
Sbjct: 231 SNQEVIEMIRSRQLLPCPEDCPARVYALMI-------ECWNEIPARRPRFKDI 276

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 79.0 bits (195), Expect = 3e-16
 Identities = 66/240 (27%), Positives = 103/240 (42%), Gaps = 73/240 (30%)

Query: 298 RIIGRGGFGNVYFG----LLGDREAAI------KKMRSNKSKE-FFAELKVLCKIHHINV 346
           R +G G FG V+ G    L  + +  +      K+  SN +++ F  E ++L    H N+
Sbjct: 11  RELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENI 70

Query: 347 FISTFG----------------NGSLSDHL--HDP---LLKG----HQPLTWTARTQIAL 381
            +  +G                +G L+  L  H P    LK        LT +   QIA+
Sbjct: 71  -VKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAV 129

Query: 382 DAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGL---------VKLEERTNE 432
             A G+ Y+       +VHRD+ T N L+   L  K+ DFG+          ++   T  
Sbjct: 130 QIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHT-- 184

Query: 433 KEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKR 491
             ML  R      ++PPE I  ++F             TT++DV++FGVVL E+ T GK+
Sbjct: 185 --MLPIR------WMPPESIMYRKF-------------TTESDVWSFGVVLWEIFTYGKQ 223

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 79.3 bits (196), Expect = 5e-16
 Identities = 62/226 (27%), Positives = 98/226 (43%), Gaps = 44/226 (19%)

Query: 287 IEEATNNFDESRIIGRGGFGNVYFGLL--GDREAAIKKM-RSNKSKEF----FAELKVLC 339
           + E  + +     +G G +G V         R+ AIKK+ R  +S       + EL++L 
Sbjct: 10  VWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLK 69

Query: 340 KIHH------INVF-----ISTFGNGSLSDHLHDPLLKG---HQPLTWTARTQIALDAAK 385
            + H      ++VF     +  F +  L  HL    L      Q L+      +     +
Sbjct: 70  HMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQILR 129

Query: 386 GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPG 445
           G++YIH    A  +HRD+K SNI +++    K+ DFGL     R  + EM  T  V T  
Sbjct: 130 GLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLA----RHTDDEM--TGYVATRW 180

Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKT-DVFAFGVVLAELITGK 490
           Y  PE +        MH          +T D+++ G ++AEL+TGK
Sbjct: 181 YRAPEIMLNW-----MH--------YNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 77.4 bits (190), Expect = 7e-16
 Identities = 62/210 (29%), Positives = 97/210 (46%), Gaps = 40/210 (19%)

Query: 300 IGRGGFGNVYFGLL-GDREAAIKKMR--SNKSKEFFAELKVLCKIHH------------- 343
           +G G FG V+ G   G+ + A+K ++  +   + F  E +++ K+ H             
Sbjct: 14  LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSEE 73

Query: 344 -INVFISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRD 402
            I +       GSL D L D      + L       +A   A G+ YI    +  Y+HRD
Sbjct: 74  PIYIVTEYMSKGSLLDFLKD---GEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRD 127

Query: 403 IKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP-GYLPPEYIFVKRFRFDM 461
           ++++NIL+ DGL  K+ADFGL +L E   + E  A +    P  +  PE     RF    
Sbjct: 128 LRSANILVGDGLVCKIADFGLARLIE---DNEYTARQGAKFPIKWTAPEAALYGRF---- 180

Query: 462 HSSVMELQVTTKTDVFAFGVVLAELITGKR 491
                    T K+DV++FG++L EL+T  R
Sbjct: 181 ---------TIKSDVWSFGILLTELVTKGR 201

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 77.5 bits (191), Expect = 7e-16
 Identities = 59/224 (26%), Positives = 94/224 (41%), Gaps = 46/224 (20%)

Query: 292 NNFDESRIIGRGGFGNVYFGLLGD--REAAIKKMRSNK-SKEFFAELKVL-CKIH----- 342
            N+   +++G+G FG VY     D  RE A+K++  +  S E   E+  L C+I      
Sbjct: 2   TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL 61

Query: 343 ----------------HINVFISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKG 386
                            +++F+     GS+ D L     K +  LT T   +      +G
Sbjct: 62  QHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQL-----KAYGALTETVTRKYTRQILEG 116

Query: 387 IEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGY 446
           +EY+H +     VHRDIK +NIL D     K+ DFG  K  +           + GTP +
Sbjct: 117 VEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYW 173

Query: 447 LPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
           + PE I  + +               K DV++ G  + E++T K
Sbjct: 174 MSPEVISGEGY-------------GRKADVWSVGCTVVEMLTEK 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 77.8 bits (192), Expect = 8e-16
 Identities = 56/237 (23%), Positives = 91/237 (38%), Gaps = 63/237 (26%)

Query: 297 SRIIGRGGFGNVYFG---LLGDR---EAAIKKMR----SNKSKEFFAELKVLCKIHHINV 346
            + +G G FG V       LGD    + A+K +          +F  E+++L  + H N+
Sbjct: 9   IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENI 68

Query: 347 F----IST-------------FGNGSLSDHLHDPLLKGHQPLTWTAR-TQIALDAAKGIE 388
                +                 +GSL D+L     + H+      R    +    KG++
Sbjct: 69  VKYKGVCEKPGGRSLRLIMEYLPSGSLRDYL-----QRHRDQINLKRLLLFSSQICKGMD 123

Query: 389 YIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLP 448
           Y+      RY+HRD+   NIL++     K++DFGL K+     +        V  PG  P
Sbjct: 124 YLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYY-----VKEPGESP 175

Query: 449 -----PEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP 500
                PE +   +F             ++ +DV++FGV L EL T           P
Sbjct: 176 IFWYAPECLRTSKF-------------SSASDVWSFGVTLYELFT----YGDPSQSP 215

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 78.2 bits (192), Expect = 8e-16
 Identities = 69/223 (30%), Positives = 96/223 (43%), Gaps = 48/223 (21%)

Query: 294 FDESRIIGRGGFGNVYFG--LLGDREAAIKKMR------SNKSKEFFAELKVLCKIHHIN 345
           F + R IG G FG VYF   +  +   AIKKM       + K ++   E+K L +I H N
Sbjct: 27  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86

Query: 346 V--------------FISTFGNGSLSDHLHDPLLKGHQ-PLTWTARTQIALDAAKGIEYI 390
                           +  +  GS SD     LL+ H+ PL       I   A +G+ Y+
Sbjct: 87  SIEYKGCYLREHTAWLVMEYCLGSASD-----LLEVHKKPLQEVEIAAITHGALQGLAYL 141

Query: 391 HDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPE 450
           H H     +HRDIK  NILL +  + K+ADFG   +    N         VGTP ++ PE
Sbjct: 142 HSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPANS-------FVGTPYWMAPE 191

Query: 451 YIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRAL 493
            I           ++ E Q   K DV++ G+   EL   K  L
Sbjct: 192 VIL----------AMDEGQYDGKVDVWSLGITCIELAERKPPL 224

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 76.9 bits (189), Expect = 9e-16
 Identities = 67/270 (24%), Positives = 119/270 (44%), Gaps = 54/270 (20%)

Query: 298 RIIGRGGFGNVYFGLLGDREAAIKKMRSNKSKE-FFAELKVLCKIHHINV---------- 346
           + IG+G FG+V  G     + A+K ++++ + + F AE  V+ ++ H N+          
Sbjct: 12  QTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEE 71

Query: 347 ----FIST--FGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVH 400
               +I T     GSL D+L     +G   L      + +LD  + +EY+  +    +VH
Sbjct: 72  KGGLYIVTEYMAKGSLVDYLRS---RGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVH 125

Query: 401 RDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFD 460
           RD+   N+L+ +   AKV+DFGL K    T +   L  +      +  PE +  K+F   
Sbjct: 126 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK------WTAPEALREKKF--- 176

Query: 461 MHSSVMELQVTTKTDVFAFGVVLAELITGKRA---------LIRDDSEPTKMKS---LIT 508
                     +TK+DV++FG++L E+ +  R          ++    +  KM +      
Sbjct: 177 ----------STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPP 226

Query: 509 IMAAVAEWCLNEDAVDRPEMRDIVAILSQI 538
           ++  V + C + DA  RP    +   L  I
Sbjct: 227 VVYDVMKQCWHLDAATRPSFLQLREQLEHI 256

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 76.9 bits (190), Expect = 9e-16
 Identities = 61/225 (27%), Positives = 98/225 (43%), Gaps = 61/225 (27%)

Query: 294 FDESRIIGRGGFGNVYFGL--LGDREAAIKKMRSN-KSKEFFAELKVL--CKIHHINVFI 348
           FD    +G G +G+VY  +     +  AIK +      +E   E+ +L  C   +I   +
Sbjct: 5   FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYI---V 61

Query: 349 STFGN----------------GSLSDHLHDPLLKGHQPLTWTART----QIAL---DAAK 385
             +G+                GS+SD     ++K       T +T    +IA       K
Sbjct: 62  KYYGSYFKNTDLWIVMEYCGAGSVSD-----IMKI------TNKTLTEEEIAAILYQTLK 110

Query: 386 GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPG 445
           G+EY+H + K   +HRDIK  NILL++  +AK+ADFG+      T  K      ++GTP 
Sbjct: 111 GLEYLHSNKK---IHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAK---RNTVIGTPF 164

Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
           ++ PE I              E+    K D+++ G+   E+  GK
Sbjct: 165 WMAPEVI-------------QEIGYNNKADIWSLGITAIEMAEGK 196

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 77.6 bits (192), Expect = 1e-15
 Identities = 57/219 (26%), Positives = 88/219 (40%), Gaps = 54/219 (24%)

Query: 300 IGRGGFGNVYFGL--LGDREAAIKKMRSNKSKE------FFA--ELKVLCKIHHINV--F 347
           +G G +  VY        R  AIKK++  + KE      F A  E+K+L ++ H N+   
Sbjct: 8   LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGL 67

Query: 348 ISTFGNGS------------LSDHLHDP---LLKGHQPLTWTARTQIALDAAKGIEYIHD 392
           +  FG+ S            L   + D    L                L   +G+EY+H 
Sbjct: 68  LDVFGHKSNINLVFEFMETDLEKVIKDKSIVLTPADI-------KSYMLMTLRGLEYLHS 120

Query: 393 HTKARYV-HRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEY 451
           +    ++ HRD+K +N+L+      K+ADFGL +     N K M  T  V T  Y  PE 
Sbjct: 121 N----WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRK-M--THQVVTRWYRAPEL 173

Query: 452 IFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
           +F  R                  D+++ G + AEL+   
Sbjct: 174 LFGAR------------HYGVGVDMWSVGCIFAELLLRV 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 77.1 bits (190), Expect = 1e-15
 Identities = 61/221 (27%), Positives = 96/221 (43%), Gaps = 50/221 (22%)

Query: 298 RIIGRGGFGNVYFGL---LGDR---EAAIKKMRSNKS----KEFFAELKVLCKIHHINV- 346
           +++G G FG VY G+    G++     AIK +R   S    KE   E  V+  + H +V 
Sbjct: 13  KVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVV 72

Query: 347 ------------FISTFGN-GSLSDHLHDPL--LKGHQPLTWTARTQIALDAAKGIEYIH 391
                        I+     G L D++ +    +     L W    QIA    KG+ Y+ 
Sbjct: 73  RLLGICLSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWC--VQIA----KGMSYLE 126

Query: 392 DHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEY 451
           +    R VHRD+   N+L+      K+ DFGL KL +  +EKE  A        ++  E 
Sbjct: 127 EK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV-DEKEYHAEGGKVPIKWMALES 182

Query: 452 IFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKR 491
           I  + +             T K+DV+++GV + EL+T G +
Sbjct: 183 ILHRIY-------------THKSDVWSYGVTVWELMTFGAK 210

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 76.8 bits (189), Expect = 1e-15
 Identities = 63/210 (30%), Positives = 97/210 (46%), Gaps = 40/210 (19%)

Query: 300 IGRGGFGNVYFGLL-GDREAAIKKMR--SNKSKEFFAELKVLCKIHH------------- 343
           +G G FG V+ G   G  + AIK ++  S   + F AE  ++ ++ H             
Sbjct: 14  LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQE 73

Query: 344 -INVFISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRD 402
            I +      NGSL D L  P  +G + LT      +A   A+G+ +I    +  Y+HRD
Sbjct: 74  PIYIITEYMENGSLVDFLKTP--EGIK-LTINKLIDMAAQIAEGMAFIE---RKNYIHRD 127

Query: 403 IKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP-GYLPPEYIFVKRFRFDM 461
           ++ +NIL+ + L  K+ADFGL +L E     E  A      P  +  PE I    F    
Sbjct: 128 LRAANILVSETLCCKIADFGLARLIEDN---EYTAREGAKFPIKWTAPEAINYGTF---- 180

Query: 462 HSSVMELQVTTKTDVFAFGVVLAELITGKR 491
                    T K+DV++FG++L E++T  R
Sbjct: 181 ---------TIKSDVWSFGILLTEIVTYGR 201

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 77.3 bits (190), Expect = 1e-15
 Identities = 66/225 (29%), Positives = 109/225 (48%), Gaps = 55/225 (24%)

Query: 299 IIGRGGFGNVYFGLL---GDR-EAAIKKMRSNKSKE----FFAELKVLCKI-HHINVF-- 347
           +IG G FG V    +   G R +AAIK+M+   SK+    F  EL+VLCK+ HH N+   
Sbjct: 14  VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 73

Query: 348 -------------ISTFGNGSLSDHLH-------DPLLKGHQPLTWTARTQ----IALDA 383
                        I    +G+L D L        DP          T  +Q     A D 
Sbjct: 74  LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 133

Query: 384 AKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGT 443
           A+G++Y+   ++ +++HRD+   NIL+ +   AK+ADFGL + +E   +K M        
Sbjct: 134 ARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM-------- 182

Query: 444 PGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
            G LP  ++ ++   + ++        TT +DV+++GV+L E+++
Sbjct: 183 -GRLPVRWMAIESLNYSVY--------TTNSDVWSYGVLLWEIVS 218

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 76.5 bits (189), Expect = 2e-15
 Identities = 69/268 (25%), Positives = 104/268 (38%), Gaps = 63/268 (23%)

Query: 300 IGRGGFGNVYFG---LLGDREA--AIKK---MRSNKSKEFFAELKVLCKIHHINV--FIS 349
           I +G +G V+       GD  A   IKK   +R N+  +   E  +L +     V     
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60

Query: 350 TFG-------------NGSLSDHLHDPLLKGHQPLTWTAR---TQIALDAAKGIEYIHDH 393
           +F               G L+  L +    G       AR    +I L     +EY+H +
Sbjct: 61  SFQGKKNLYLVMEYLPGGDLASLLEN---VGSLDEDV-ARIYIAEIVL----ALEYLHSN 112

Query: 394 TKARYVHRDIKTSNILLDDGLRAKVADFGL-----VKLEERTNEKEMLATRLVGTPGYLP 448
                +HRD+K  NIL+D     K+ DFGL     V+ +   N+ E    R+VGTP Y+ 
Sbjct: 113 ---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIA 169

Query: 449 PEYIFVKRFRFDMHSSVMELQVTTKT-DVFAFGVVLAELITGKRALIRDDSEPTKMKSLI 507
           PE              V+  Q  +KT D ++ G +L E + G      +  E        
Sbjct: 170 PE--------------VILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQN--- 212

Query: 508 TIMAAVAEWCLNEDAVDRPEMRDIVAIL 535
            I+    EW   ED     E  D+++ L
Sbjct: 213 -ILNGKIEW--PEDVEVSDEAIDLISKL 237

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 75.8 bits (186), Expect = 2e-15
 Identities = 56/209 (26%), Positives = 98/209 (46%), Gaps = 40/209 (19%)

Query: 299 IIGRGGFGNVYFGLLGDREAAIKKMRSN-KSKEFFAELKVLCKIHHIN------------ 345
           IIG G FG V  G    ++ A+K ++ +  ++ F  E  V+ K+HH N            
Sbjct: 13  IIGEGEFGAVLQGEYTGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILHNG 72

Query: 346 --VFISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDI 403
             + +     G+L + L     +G   ++     Q +LD A+G+EY+      + VHRD+
Sbjct: 73  LYIVMELMSKGNLVNFLRT---RGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDL 126

Query: 404 KTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHS 463
              NIL+ +   AKV+DFGL ++     +   L  +      +  PE +  K+F      
Sbjct: 127 AARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK------WTAPEALKHKKF------ 174

Query: 464 SVMELQVTTKTDVFAFGVVLAELITGKRA 492
                  ++K+DV+++GV+L E+ +  RA
Sbjct: 175 -------SSKSDVWSYGVLLWEVFSYGRA 196

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 75.5 bits (186), Expect = 3e-15
 Identities = 63/225 (28%), Positives = 95/225 (42%), Gaps = 63/225 (28%)

Query: 294 FDESRIIGRGGFGNVYFGL-LGDREAAIKKMRSN---KSKEFFAELKVLCKIHHIN---- 345
           F   R +G G FG V+ GL       AIK ++S+   K ++F  E++ L ++ H +    
Sbjct: 8   FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67

Query: 346 ---------VFIST--FGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHT 394
                    V+I T     GSL   L  P  +G Q L   +   +A   A+G+ Y+ +  
Sbjct: 68  FAVCSVGEPVYIITELMEKGSLLAFLRSP--EG-QVLPVASLIDMACQVAEGMAYLEEQ- 123

Query: 395 KARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLP------ 448
               +HRD+   NIL+ + L  KVADFGL               RL+    YL       
Sbjct: 124 --NSIHRDLAARNILVGEDLVCKVADFGL--------------ARLIKEDVYLSSDKKIP 167

Query: 449 -----PEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
                PE      F             +TK+DV++FG++L E+ T
Sbjct: 168 YKWTAPEAASHGTF-------------STKSDVWSFGILLYEMFT 199

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 75.6 bits (187), Expect = 4e-15
 Identities = 58/230 (25%), Positives = 91/230 (39%), Gaps = 60/230 (26%)

Query: 299 IIGRGGFGNVY--FGLLGDREAAIKKMRSNKSKEFFA-----ELKVLCKIHHINV--FIS 349
            +G G +G VY           A+KK+R +  +E        E+ +L ++ H N+   + 
Sbjct: 6   KLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLD 65

Query: 350 TF-GNGSLS---DHL-HDPLLKGHQPLTWTARTQIALDAA----------KGIEYIHDHT 394
                  L    ++   D  LK +       +    L             +G+ Y H H 
Sbjct: 66  VIHTERKLYLVFEYCDMD--LKKYL-----DKRPGPLSPNLIKSIMYQLLRGLAYCHSH- 117

Query: 395 KARYVHRDIKTSNILLDDGLRAKVADFGL-----VKLEERTNEKEMLATRLVGTPGYLPP 449
             R +HRD+K  NIL++     K+ADFGL     + L   T+E        V T  Y  P
Sbjct: 118 --RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHE--------VVTLWYRAP 167

Query: 450 EYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE 499
           E +   +              +T  D+++ G + AE+ITGK  L   DSE
Sbjct: 168 EILLGSKH------------YSTAVDIWSVGCIFAEMITGK-PLFPGDSE 204

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 75.4 bits (185), Expect = 6e-15
 Identities = 71/268 (26%), Positives = 107/268 (39%), Gaps = 60/268 (22%)

Query: 300 IGRGGFGNVYFGLLG--DREAAIKKMR------SNKSKEFFAELKVLCKIHHINV----- 346
           IG G FG VYF      +   A+KKM       + K ++   E+K L ++ H N      
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88

Query: 347 ---------FISTFGNGSLSDHLHDPLLKGHQ-PLTWTARTQIALDAAKGIEYIHDHTKA 396
                     +  +  GS SD     LL+ H+ PL       I   A +G+ Y+H H   
Sbjct: 89  CYLKEHTAWLVMEYCLGSASD-----LLEVHKKPLQEVEIAAITHGALQGLAYLHSHNM- 142

Query: 397 RYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKR 456
             +HRDIK  NILL +  + K+ADFG        N         VGTP ++ PE I    
Sbjct: 143 --IHRDIKAGNILLTEPGQVKLADFGSASKSSPANS-------FVGTPYWMAPEVIL--- 190

Query: 457 FRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALI------------RDDSEPTKMK 504
                  ++ E Q   K DV++ G+   EL   K  L             ++DS   +  
Sbjct: 191 -------AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSN 243

Query: 505 SLITIMAAVAEWCLNEDAVDRPEMRDIV 532
                     ++CL +   +RP   +++
Sbjct: 244 EWTDSFRGFVDYCLQKIPQERPASAELL 271

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 74.4 bits (183), Expect = 7e-15
 Identities = 69/267 (25%), Positives = 105/267 (39%), Gaps = 63/267 (23%)

Query: 298 RIIGRGGFGNVYFGLLGDREA--AIKKM----RSNKSKEFFAEL----KVLCKIHH---- 343
            ++G G FG+VY GL  D     A+K++         +E   +L     +L K+ H    
Sbjct: 6   ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65

Query: 344 -----------INVFISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIAL---DAAKGIEY 389
                      + +F+     GSL+      LLK +          I L       G+EY
Sbjct: 66  QYLGTEREEDNLYIFLELVPGGSLAK-----LLKKYGSFP---EPVIRLYTRQILLGLEY 117

Query: 390 IHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK-LEERTNEKEMLATRLVGTPGYLP 448
           +HD      VHRDIK +NIL+D     K+ADFG+ K + E +  K        G+P ++ 
Sbjct: 118 LHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSF-----KGSPYWMA 169

Query: 449 PEYIFVKR---FRFDMHS---SVMELQVTTK---TDVFAFGVVLAELITGKRALIRDDSE 499
           PE I  +       D+ S   +V+E+  T K   + +     V     + +   I D   
Sbjct: 170 PEVIAQQGGYGLAADIWSLGCTVLEM-ATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLS 228

Query: 500 PTKMKSLITIMAAVAEWCLNEDAVDRP 526
             + K  I         CL  D   RP
Sbjct: 229 D-EAKDFILK-------CLQRDPSLRP 247

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 75.1 bits (184), Expect = 8e-15
 Identities = 65/216 (30%), Positives = 93/216 (43%), Gaps = 48/216 (22%)

Query: 294 FDESRIIGRGGFGNVYFG--LLGDREAAIKKM-----RSN-KSKEFFAELKVLCKIHHIN 345
           F + R IG G FG VYF   +      AIKKM     +SN K ++   E++ L K+ H N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 346 V--------------FISTFGNGSLSDHLHDPLLKGHQ-PLTWTARTQIALDAAKGIEYI 390
                           +  +  GS SD     LL+ H+ PL       +   A +G+ Y+
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASD-----LLEVHKKPLQEVEIAAVTHGALQGLAYL 131

Query: 391 HDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPE 450
           H H     +HRD+K  NILL +    K+ DFG   +    N         VGTP ++ PE
Sbjct: 132 HSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX-------FVGTPYWMAPE 181

Query: 451 YIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAEL 486
            I           ++ E Q   K DV++ G+   EL
Sbjct: 182 VIL----------AMDEGQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 75.0 bits (185), Expect = 9e-15
 Identities = 68/241 (28%), Positives = 99/241 (41%), Gaps = 62/241 (25%)

Query: 290 ATNNFDESRIIGRGGFGNVYFG--LLGDREAAIKKMRSNKSKEFFA-----ELKVLCKIH 342
              +++    +G G FG VY    +   R  A+KK+  +  K+ F      E+K+L K+ 
Sbjct: 6   KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLK 65

Query: 343 HINVF-----------ISTFGNGS-----------LSDHLHDPLLKGHQPLTWTARTQIA 380
           H NV             S    GS           LS  L +P +K  +        QI 
Sbjct: 66  HPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTES-------QIK 118

Query: 381 ---LDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKL--EERTNEKEM 435
              L   +GI Y+H+      +HRDIK +NIL+D+    K+ADFGL +       N K  
Sbjct: 119 CYMLQLLEGINYLHE---NHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGG 175

Query: 436 LA------TRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
                   T LV T  Y PPE +  +R            + TT  D++  G V AE+ T 
Sbjct: 176 GGGGTRKYTNLVVTRWYRPPELLLGER------------RYTTAVDIWGIGCVFAEMFTR 223

Query: 490 K 490
           +
Sbjct: 224 R 224

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 73.8 bits (181), Expect = 1e-14
 Identities = 66/224 (29%), Positives = 98/224 (43%), Gaps = 51/224 (22%)

Query: 293 NFDESRIIGRGGFGNVYF--GLLGDREAAIK-----KMRSNKSKEFFAELKVLCKIHHIN 345
            ++  + IG G FG +Y            IK     KM   + +    E+ +L K+ H N
Sbjct: 1   RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60

Query: 346 V--FISTFG-NGSLS---------------DHLHDPLLKGHQPLTWTARTQIALDAAKGI 387
           +  F ++F  NG L                +     L    Q L+W    QI+L    G+
Sbjct: 61  IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWF--VQISL----GL 114

Query: 388 EYIHDHTKARYVHRDIKTSNILLD-DGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGY 446
           ++IHD    + +HRDIK+ NI L  +G+ AK+ DFG+ +    + E   LA   VGTP Y
Sbjct: 115 KHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME---LAYTCVGTPYY 168

Query: 447 LPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
           L PE    + +               KTD+++ G VL EL T K
Sbjct: 169 LSPEICQNRPY-------------NNKTDIWSLGCVLYELCTLK 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 73.9 bits (182), Expect = 1e-14
 Identities = 55/227 (24%), Positives = 88/227 (38%), Gaps = 58/227 (25%)

Query: 293 NFDESRIIGRGGFGNV----------YFGLLGDREAAIKKMRSNKSKEFFAELKVLCKIH 342
           +F+  R+IG+G FG V           F +    +    +  S ++     E ++L +++
Sbjct: 1   HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRN--VLNERRILQELN 58

Query: 343 H---INVFISTF-------------GNGSLSDHL-HDPLLKGHQPLTWTARTQIALDAAK 385
           H   +N++  +F               G L  HL         Q   W    +I L    
Sbjct: 59  HPFLVNLW-YSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWIC--EIVL---- 111

Query: 386 GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGL-VKLEERTNEKEMLATRLVGTP 444
            +EY+H       +HRDIK  NILLD+     + DF +  K+   T       T   GTP
Sbjct: 112 ALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL-----TTSTSGTP 163

Query: 445 GYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKR 491
           GY+ PE +  + +                 D ++ GV   E + GKR
Sbjct: 164 GYMAPEVLCRQGYSV-------------AVDWWSLGVTAYECLRGKR 197

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 75.6 bits (186), Expect = 1e-14
 Identities = 70/241 (29%), Positives = 100/241 (41%), Gaps = 58/241 (24%)

Query: 298 RIIGRGGFGNVYFGLLGD----REAAIKKMRS-----NKSKEFFAELKVLCKIHHINVFI 348
           R IG G FG V+   + D    +  A+KKM +        K  F ELK+LC   H NV  
Sbjct: 6   RPIGYGAFGVVW--SVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVL- 62

Query: 349 STFGNGSLSDHLHDPLLK---------------------GHQPLTWTARTQIALDAAKGI 387
                 S  D L  P +                        QPL+            +G+
Sbjct: 63  ------SALDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGL 116

Query: 388 EYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYL 447
           +Y+H    A  +HRDIK  N+L++     K+ DFGL ++EE    K M  T+ V T  Y 
Sbjct: 117 KYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHM--TQEVVTQYYR 171

Query: 448 PPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKMKSLI 507
            PE +   R              T+  D+++ G + AEL+ G+R L +  S P +   LI
Sbjct: 172 APEILMGSR------------HYTSAVDIWSVGCIFAELL-GRRILFQAQS-PIQQLDLI 217

Query: 508 T 508
           T
Sbjct: 218 T 218

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 73.6 bits (180), Expect = 2e-14
 Identities = 62/210 (29%), Positives = 96/210 (45%), Gaps = 40/210 (19%)

Query: 300 IGRGGFGNVYFGLL-GDREAAIKKMR--SNKSKEFFAELKVLCKIHH------------- 343
           +G+G FG V+ G   G  + AIK ++  +   + F  E +++ K+ H             
Sbjct: 14  LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSEE 73

Query: 344 -INVFISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRD 402
            I +     G GSL D L +      + L       +A   A G+ YI    +  Y+HRD
Sbjct: 74  PIYIVTEFMGKGSLLDFLKE---GDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRD 127

Query: 403 IKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP-GYLPPEYIFVKRFRFDM 461
           ++ +NIL+ D L  K+ADFGL +L E   + E  A +    P  +  PE     RF    
Sbjct: 128 LRAANILVGDNLVCKIADFGLARLIE---DNEYTARQGAKFPIKWTAPEAALYGRF---- 180

Query: 462 HSSVMELQVTTKTDVFAFGVVLAELITGKR 491
                    T K+DV++FG++L EL+T  R
Sbjct: 181 ---------TIKSDVWSFGILLTELVTKGR 201

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 73.9 bits (182), Expect = 2e-14
 Identities = 57/217 (26%), Positives = 89/217 (41%), Gaps = 37/217 (17%)

Query: 293 NFDESRIIGRGGFGNVYFG--LLGDREAAIKKMRSNKSKE-----FFAELKVLCKIHHIN 345
            F++   IG G +G VY           A+KK+R +  ++        E+ +L  + H N
Sbjct: 8   EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPN 67

Query: 346 V-----------FISTFGNGSLSDHLHDPLLKGHQ-PLTWTARTQIALDAAKGIEYIHDH 393
           +             S F      +     LL     P + +    + L   +G++Y+H++
Sbjct: 68  IVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHEN 127

Query: 394 TKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIF 453
                +HRD+K SN+LL D    K+ADFGL +       K M  T  V T  Y  PE + 
Sbjct: 128 F---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG-LPAKPM--TPKVVTLWYRAPELLL 181

Query: 454 VKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
                            TT  D++A G +LAEL+  K
Sbjct: 182 GCT------------TYTTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 72.9 bits (179), Expect = 4e-14
 Identities = 65/222 (29%), Positives = 99/222 (44%), Gaps = 60/222 (27%)

Query: 300 IGRGGFGNV---YFGLLGDREA---AIKKMRSNKSKE---FFAELKVLCKIHHINV---- 346
           +G+G FG+V    +  L D      A+KK++ + ++    F  E+++L  + H N+    
Sbjct: 12  LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71

Query: 347 -------------FISTFGNGSLSDHL--HDPLLKGHQPLTWTARTQIALDAAKGIEYIH 391
                         +     GSL D+L  H   L   + L +   +QI     KG+EY+ 
Sbjct: 72  GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYA--SQIC----KGMEYL- 124

Query: 392 DHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLP--- 448
                RYVHRD+ T NIL++   R K+ DFGL K+  +  E        V  PG  P   
Sbjct: 125 --GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYK-----VREPGESPIFW 177

Query: 449 --PEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
             PE             S+ E + +  +DV++FGVVL EL T
Sbjct: 178 YAPE-------------SLTESKFSVASDVWSFGVVLYELFT 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 72.5 bits (178), Expect = 4e-14
 Identities = 64/219 (29%), Positives = 100/219 (45%), Gaps = 50/219 (22%)

Query: 298 RIIGRGGFGNVYFGLLGD-----REAAIKKMRS----NKSKEFFAELKVLCKIHHINVFI 348
           R+IG+G FG VY G L D        A+K +       + ++F  E  ++    H NV +
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNV-L 59

Query: 349 STFG-----------------NGSLSDHLHDPLLKGHQPLTWTARTQIA--LDAAKGIEY 389
           S  G                 +G L + +       H P   T +  I   L  AKG+EY
Sbjct: 60  SLLGICLPSEGSPLVVLPYMKHGDLRNFIRSE---THNP---TVKDLIGFGLQVAKGMEY 113

Query: 390 IHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPP 449
           +      ++VHRD+   N +LD+    KVADFGL +      +KE  +     T   LP 
Sbjct: 114 L---ASKKFVHRDLAARNCMLDESFTVKVADFGLAR---DIYDKEYYSVH-NHTGAKLPV 166

Query: 450 EYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
           +++ ++        S+   + TTK+DV++FGV+L EL+T
Sbjct: 167 KWMALE--------SLQTQKFTTKSDVWSFGVLLWELMT 197

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 72.5 bits (178), Expect = 4e-14
 Identities = 62/225 (27%), Positives = 95/225 (42%), Gaps = 58/225 (25%)

Query: 298 RIIGRGGFGNVYFGLLGDREA-------AIKKMRSNKSKE----FFAELKVLCKIHHINV 346
           R +G G FG VY GL   R+        A+K +  + S++    F  E  ++ K +H N+
Sbjct: 12  RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71

Query: 347 -------------FI--STFGNGSLSDHLHD--PLLKGHQPLTWTARTQIALDAAKGIEY 389
                        FI       G L   L +  P  +    LT       A D AKG +Y
Sbjct: 72  VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131

Query: 390 IHDHTKARYVHRDIKTSNILLDD---GLRAKVADFGLVKLEERT-----NEKEMLATRLV 441
           + +     ++HRDI   N LL     G  AK+ADFG+ +   R        + ML  +  
Sbjct: 132 LEE---NHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIK-- 186

Query: 442 GTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAEL 486
               ++PPE             + ++   T+KTDV++FGV+L E+
Sbjct: 187 ----WMPPE-------------AFLDGIFTSKTDVWSFGVLLWEI 214

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 72.0 bits (176), Expect = 5e-14
 Identities = 64/212 (30%), Positives = 94/212 (44%), Gaps = 44/212 (20%)

Query: 300 IGRGGFGNVYFGLL-GDREAAIKKMR--SNKSKEFFAELKVLCKIHH------------- 343
           +G+G FG V+ G   G    AIK ++  +   + F  E +V+ K+ H             
Sbjct: 14  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 73

Query: 344 -INVFISTFGNGSLSDHLHDPLLKGH--QPLTWTARTQIALDAAKGIEYIHDHTKARYVH 400
            I +       GSL D      LKG   + L       +A   A G+ Y+    +  YVH
Sbjct: 74  PIYIVTEYMSKGSLLD-----FLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 125

Query: 401 RDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP-GYLPPEYIFVKRFRF 459
           RD++ +NIL+ + L  KVADFGL +L E   + E  A +    P  +  PE     RF  
Sbjct: 126 RDLRAANILVGENLVCKVADFGLARLIE---DNEYTARQGAKFPIKWTAPEAALYGRF-- 180

Query: 460 DMHSSVMELQVTTKTDVFAFGVVLAELITGKR 491
                      T K+DV++FG++L EL T  R
Sbjct: 181 -----------TIKSDVWSFGILLTELTTKGR 201

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 71.9 bits (177), Expect = 7e-14
 Identities = 74/294 (25%), Positives = 118/294 (40%), Gaps = 74/294 (25%)

Query: 289 EATNNFDESRIIGRGGFGNVYFGLL--GDREAAIKKM--RSNKSKEFFAELKVLCKI-HH 343
           + T  F+   +IG G +G VY        +  AIK M    ++ +E   E  +L K  +H
Sbjct: 3   DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNH 62

Query: 344 INVFISTF-----------------------GNGSLSDHLHDPLLKGHQPLT--WTARTQ 378
            N  I+TF                       G GS++D L   L K  + L   W A   
Sbjct: 63  PN--IATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTD-LVKGLRKKGKRLKEEWIA--Y 117

Query: 379 IALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLAT 438
           I  +  +G+ Y+H++   + +HRDIK  NILL      K+ DFG+    + T  +     
Sbjct: 118 ILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRR---N 171

Query: 439 RLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK-------- 490
             +GTP ++ PE I              +     ++DV++ G+   EL  GK        
Sbjct: 172 TFIGTPYWMAPEVI--------ACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHP 223

Query: 491 -RAL---IRDDSEPTKMKS-------LITIMAAVAEWCLNEDAVDRPEMRDIVA 533
            RAL    R  + P  +KS           ++     CL ++   RP M +++ 
Sbjct: 224 MRALFKIPR--NPPPTLKSPENWSKKFNDFIS----ECLIKNYEQRPFMEELLE 271

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 71.1 bits (174), Expect = 9e-14
 Identities = 71/273 (26%), Positives = 120/273 (43%), Gaps = 70/273 (25%)

Query: 300 IGRGGFGNVYFG-LLGDREAAIKKMR--SNKSKEFFAELKVLCKIHHIN----------- 345
           +G G FG V +G   G  + AIK ++  S    EF  E KV+ K+ H             
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQ 71

Query: 346 --VFIST--FGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHR 401
             ++I T    NG L ++L +   K  QP   +   ++  D  +G+ Y+      +++HR
Sbjct: 72  RPIYIVTEYMSNGCLLNYLRE-HGKRFQP---SQLLEMCKDVCEGMAYLESK---QFIHR 124

Query: 402 DIKTSNILLDDGLRAKVADFGLVK--LEERTNEKEMLATRLVGTP---GYLPPEYIFVKR 456
           D+   N L+DD    KV+DFGL +  L++         T  VG+     + PPE +   +
Sbjct: 125 DLAARNCLVDDQGCVKVSDFGLSRYVLDDEY-------TSSVGSKFPVRWSPPEVLLYSK 177

Query: 457 FRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIRDDSEPTKMK----------- 504
           F             ++K+DV+AFGV++ E+ + GK    R ++  T  K           
Sbjct: 178 F-------------SSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPH 224

Query: 505 ----SLITIMAAVAEWCLNEDAVDRPEMRDIVA 533
                +  IM +    C +E A +RP  + +++
Sbjct: 225 LASEKVYAIMYS----CWHEKAEERPTFQQLLS 253

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 70.6 bits (173), Expect = 1e-13
 Identities = 57/215 (26%), Positives = 93/215 (43%), Gaps = 54/215 (25%)

Query: 300 IGRGGFGNVYFGL-LGDREAAIKKMR--SNKSKEFFAELKVLCKIHHIN----------- 345
           +G G FG V+ G   G  + AIK +R  +    +F  E KV+ K+ H N           
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQ 71

Query: 346 --VFIST--FGNGSLSDHL--HDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYV 399
             +FI T    NG L ++L      L     L       +  D  + +EY+  +    ++
Sbjct: 72  RPIFIVTEYMANGCLLNYLRERKGKLGTEWLL------DMCSDVCEAMEYLESNG---FI 122

Query: 400 HRDIKTSNILLDDGLRAKVADFGLVK--LEERTNEKEMLATRLVGTP---GYLPPEYIFV 454
           HRD+   N L+ +    KV+DFGL +  L+++        T   GT     + PPE    
Sbjct: 123 HRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY-------TSSQGTKFPVKWAPPEVFDY 175

Query: 455 KRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
            RF             ++K+DV++FGV++ E+ + 
Sbjct: 176 SRF-------------SSKSDVWSFGVLMWEVFSE 197

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 70.6 bits (173), Expect = 1e-13
 Identities = 63/272 (23%), Positives = 112/272 (41%), Gaps = 65/272 (23%)

Query: 293 NFDESRIIGRGGFGNVYF-------GLLGDREAAIKKMRSNKSKEFFAELKVLCKIHHIN 345
           ++   R++G+G FG            L+  +E  + ++   + ++   E+ +L  + H N
Sbjct: 1   HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPN 60

Query: 346 VFISTFG----NGSL--------SDHLHDPLLKGHQPLTWTARTQIAL--DAAKGIEYIH 391
           + I+ +     + +L           L+D +++    L +     +         + YIH
Sbjct: 61  I-IAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQL-FEEEMVLWYLFQIVSAVSYIH 118

Query: 392 DHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEY 451
              KA  +HRDIKT NI L      K+ DFG+ K+      +  +A  +VGTP Y+ PE 
Sbjct: 119 ---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKI---LGSEYSMAETVVGTPYYMSPEL 172

Query: 452 IFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKM-------- 503
               ++ F             K+D++A G VL EL+T KR    D + P  +        
Sbjct: 173 CQGVKYNF-------------KSDIWALGCVLYELLTLKRTF--DATNPLNLVVKIVQGN 217

Query: 504 ---------KSLITIMAAVAEWCLNEDAVDRP 526
                      LI+++ +     L +D   RP
Sbjct: 218 YTPVVSVYSSELISLVHS----LLQQDPEKRP 245

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 70.8 bits (174), Expect = 2e-13
 Identities = 57/210 (27%), Positives = 86/210 (40%), Gaps = 40/210 (19%)

Query: 300 IGRGGFGNVYFGLLGDREA----AIKKMRSNKSKEFFA-----ELKVLCKIHHINV--FI 348
           IG G  G V+     DRE     A+KK+   + +         E+K L    H  V   +
Sbjct: 8   IGEGAHGIVF--KAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLL 65

Query: 349 STFGNGS---------LSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYV 399
             F +GS          SD L + L    +PL             KG+ Y+H       +
Sbjct: 66  DVFPHGSGFVLVMEYMPSD-LSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH---ANGIM 121

Query: 400 HRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRF 459
           HRD+K +N+L+      K+ADFGL +L   + E+  L +  V T  Y  PE ++  R   
Sbjct: 122 HRDLKPANLLISADGVLKIADFGLARL--FSEEEPRLYSHQVATRWYRAPELLYGAR--- 176

Query: 460 DMHSSVMELQVTTKTDVFAFGVVLAELITG 489
                    +     D++A G + AEL+ G
Sbjct: 177 ---------KYDPGVDLWAVGCIFAELLNG 197

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 70.2 bits (172), Expect = 2e-13
 Identities = 67/235 (28%), Positives = 98/235 (41%), Gaps = 59/235 (25%)

Query: 300 IGRGGFGNVYFGLLGDR---------EAAIKKMRSNKSKEFFAELKVLCKIHHINV--FI 348
           IG G FG     L+  +         E  I KM   + +E   E+ VL  + H N+  + 
Sbjct: 8   IGEGSFGKAI--LVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQ 65

Query: 349 STF---GN----------GSLSDHLHDP---LLKGHQPLTWTARTQIALDAAKGIEYIHD 392
            +F   GN          G L   ++     L    Q L W    QI L     ++++HD
Sbjct: 66  ESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWF--VQICL----ALKHVHD 119

Query: 393 HTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYI 452
               + +HRDIK+ NI L      K+ DFG+ ++   T E   LA   +GTP YL PE  
Sbjct: 120 R---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE---LARTCIGTPYYLSPEIC 173

Query: 453 FVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKMKSLI 507
             + +               K+D++A G VL E+ T K A      E   MK+L+
Sbjct: 174 ENRPY-------------NNKSDIWALGCVLYEMCTLKHAF-----EAGNMKNLV 210

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 69.9 bits (171), Expect = 2e-13
 Identities = 61/226 (26%), Positives = 99/226 (43%), Gaps = 52/226 (23%)

Query: 293 NFDESRIIGRGGFGNVYFGLLGD-------REAAIKKMRSNKSKEFFAELKVLCKIHHIN 345
            +++ R++GRG FG V+             ++  +++M  ++      E +VL  + H N
Sbjct: 1   KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60

Query: 346 V--FISTF-------------GNGSLSDHLHD---PLLKGHQPLTWTARTQIALDAAKGI 387
           +  +   F               G+L++++      LL     L +  +  +AL      
Sbjct: 61  IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALH----- 115

Query: 388 EYIHDHTKARYVHRDIKTSNILLDD-GLRAKVADFGLVKLEERTNEKEMLATRLVGTPGY 446
              H HTK   +HRD+KT NILLD   +  K+ DFG+ K    +  K   A  +VGTP Y
Sbjct: 116 ---HVHTK-LILHRDLKTQNILLDKHKMVVKIGDFGISK-ILSSKSK---AYTVVGTPCY 167

Query: 447 LPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRA 492
           + PE    K +               K+D++A G VL EL + KRA
Sbjct: 168 ISPELCEGKPY-------------NQKSDIWALGCVLYELASLKRA 200

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 70.1 bits (172), Expect = 3e-13
 Identities = 60/217 (27%), Positives = 92/217 (42%), Gaps = 47/217 (21%)

Query: 300 IGRGGFGNVY--FGLLGDREAAIKKMRSNKSKEFFAEL----KVLCKIHHINVFISTFGN 353
           IG G    VY    L  + + AIK++   K +    EL    + + + +H NV +  + +
Sbjct: 9   IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNV-VKYYTS 67

Query: 354 ----------------GSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKAR 397
                           GSL D +     +G       A   +  +  KG+EY+H +    
Sbjct: 68  FVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIA--TVLKEVLKGLEYLHSN---G 122

Query: 398 YVHRDIKTSNILLDDGLRAKVADFGL-VKLEERTNEKEMLATRLVGTPGYLPPEYIFVKR 456
            +HRDIK  NILL +    K+ADFG+   L +  +    +    VGTP ++ PE      
Sbjct: 123 QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPE------ 176

Query: 457 FRFDMHSSVMELQV---TTKTDVFAFGVVLAELITGK 490
                   VME QV     K D+++FG+   EL TG 
Sbjct: 177 --------VME-QVHGYDFKADIWSFGITAIELATGA 204

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 70.0 bits (171), Expect = 3e-13
 Identities = 77/291 (26%), Positives = 130/291 (44%), Gaps = 70/291 (24%)

Query: 292 NNFDESRIIGRGGFGNVYFGLL---GDREA--AIKKMRS----NKSKEFFAELKVLCKIH 342
           ++  + ++IG G FG V+ G+L   G +E   AIK ++      + ++F +E  ++ +  
Sbjct: 5   SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFS 64

Query: 343 HINVF-----ISTFG----------NGSLSDHL--HDPLLKGHQPLTWTARTQIALDAAK 385
           H N+      ++ F           NG+L  +L  HD     +Q L    R       A 
Sbjct: 65  HHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQ-LVGMLR-----GIAA 118

Query: 386 GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPG 445
           G++Y+ D     YVHRD+   NIL++  L  KV+DFGL ++ E   E          + G
Sbjct: 119 GMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTT-----SGG 170

Query: 446 YLP-----PEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP 500
            +P     PE I  ++F             T+ +DV++FG+V+ E+++       D S  
Sbjct: 171 KIPIRWTAPEAIAYRKF-------------TSASDVWSFGIVMWEVMSFGERPYWDMSNH 217

Query: 501 TKMKS------LITIM---AAVAEW---CLNEDAVDRPEMRDIVAILSQIM 539
             MK+      L   M   +AV +    C  +D   RP   DIV +L +++
Sbjct: 218 EVMKAINDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKLL 268

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 69.5 bits (170), Expect = 3e-13
 Identities = 74/284 (26%), Positives = 129/284 (45%), Gaps = 68/284 (23%)

Query: 298 RIIGRGGFGNVYFGLL---GDRE--AAIKKMRS----NKSKEFFAELKVLCKIHHINVF- 347
           ++IG G FG V  G L   G RE   AIK +++     + ++F +E  ++ +  H N+  
Sbjct: 10  KVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIH 69

Query: 348 --------------ISTFGNGSLSDHLHDPLLKGHQ-PLTWTARTQIALDAAKGIEYIHD 392
                              NGSL     D  L+ H    T      +    A G++Y+ D
Sbjct: 70  LEGVVTKSKPVMIVTEYMENGSL-----DAFLRKHDGQFTVIQLVGMLRGIASGMKYLSD 124

Query: 393 HTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLP---- 448
                YVHRD+   NIL++  L  KV+DFGL ++ E  ++ E   T      G +P    
Sbjct: 125 MG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE--DDPEAAYTT---RGGKIPIRWT 176

Query: 449 -PEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRA--------LIRDDS 498
            PE I  ++F             T+ +DV+++G+V+ E+++ G+R         +I+   
Sbjct: 177 APEAIAYRKF-------------TSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIE 223

Query: 499 EPTKMKSLITIMAAVAEW---CLNEDAVDRPEMRDIVAILSQIM 539
           E  ++ + +   AA+ +    C  +D  +RP+   IV+IL +++
Sbjct: 224 EGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKLI 267

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 69.9 bits (172), Expect = 4e-13
 Identities = 59/228 (25%), Positives = 95/228 (41%), Gaps = 75/228 (32%)

Query: 300 IGRGGFGNVYFGLLGDREA----AIKKMRSNKSKEFFA--------ELKVLCKI-HHINV 346
           +G G FG+VY     ++E     AIKKM+    K+F++        E+K L K+  H N+
Sbjct: 7   LGDGTFGSVYLAR--NKETGELVAIKKMK----KKFYSWEECMNLREVKSLRKLNEHPNI 60

Query: 347 --------------FISTFGNGSLSDHLHDPLLKGHQPLTWTART------QIALDAAKG 386
                         F+  +  G+L       L+K  +   ++         QI      G
Sbjct: 61  VKLKEVFRENDELYFVFEYMEGNLYQ-----LMKDRKGKPFSESVIRSIIYQILQ----G 111

Query: 387 IEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLA----TRLVG 442
           + +IH H    + HRD+K  N+L+      K+ADFGL +        E+ +    T  V 
Sbjct: 112 LAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAR--------EIRSRPPYTDYVS 160

Query: 443 TPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
           T  Y  PE +        + S+     V    D++A G ++AEL T +
Sbjct: 161 TRWYRAPEIL--------LRSTSYSSPV----DIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 69.2 bits (170), Expect = 4e-13
 Identities = 70/265 (26%), Positives = 108/265 (40%), Gaps = 68/265 (25%)

Query: 300 IGRGGFGNVYFG--LLGDREAAIKKMRSNKSKEFFA----ELKVL--CKIHHINVFISTF 351
           IG+G FG VY       ++  AIK +   ++++       E++ L  C+  +I  +  +F
Sbjct: 9   IGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSF 68

Query: 352 -------------GNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARY 398
                        G GS  D     LLK    L  T    I  +   G+EY+H+  K   
Sbjct: 69  LKGSKLWIIMEYCGGGSCLD-----LLK-PGKLDETYIAFILREVLLGLEYLHEEGK--- 119

Query: 399 VHRDIKTSNILLDDGLRAKVADFGLV-KLEERTNEKEMLATRLVGTPGYLPPEYIFVKRF 457
           +HRDIK +NILL +    K+ADFG+  +L    +++       VGTP ++ PE I     
Sbjct: 120 IHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT----FVGTPFWMAPEVI----- 170

Query: 458 RFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKMKSLITIMAAVA--- 514
                    +     K D+++ G+   EL  G+  L   D  P  M+ L  I        
Sbjct: 171 --------KQSGYDEKADIWSLGITAIELAKGEPPL--SDLHP--MRVLFLIPKNNPPSL 218

Query: 515 -------------EWCLNEDAVDRP 526
                          CLN+D  +RP
Sbjct: 219 EGNKFSKPFKDFVSLCLNKDPKERP 243

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 69.8 bits (171), Expect = 5e-13
 Identities = 68/242 (28%), Positives = 101/242 (41%), Gaps = 51/242 (21%)

Query: 288 EEATNNFDESRIIGRGGFGNVYFGL--LGDREAAIKKMRSNKSKEFFA-----ELKVLCK 340
           +   + FD    IG G +G VY           A+KK+R +  KE F      E+K+L +
Sbjct: 3   KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQ 62

Query: 341 IHHINV---------------FISTFGNGSLSDHLHDPLLKG--HQPLTWTARTQIA--- 380
           ++H N+               F    G   L     D  L G     L   +   I    
Sbjct: 63  LNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFM 122

Query: 381 ---LDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLA 437
              L+   G+ Y H   K  ++HRDIK SNILL++  + K+ADFGL +L     E+    
Sbjct: 123 KQLLE---GLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNS--EESRPY 174

Query: 438 TRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDD 497
           T  V T  Y PPE +            + E +     DV++ G +L EL T K+ + + +
Sbjct: 175 TNKVITLWYRPPELL------------LGEERYGPAIDVWSCGCILGELFT-KKPIFQAN 221

Query: 498 SE 499
            E
Sbjct: 222 QE 223

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 69.2 bits (170), Expect = 6e-13
 Identities = 62/212 (29%), Positives = 95/212 (44%), Gaps = 41/212 (19%)

Query: 300 IGRGGFGNVYFGL--LGDREAAIKKMRSNKSKEFFA-----ELKVLCKIHHIN-VFISTF 351
           I  G +G VY           A+KK++  K KE F      E+ +L K+ H N V +   
Sbjct: 13  IEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEV 72

Query: 352 GNGSLSDHL--------HDPLLKG-----HQPLTWTARTQIALDAAKGIEYIHDHTKARY 398
             GS  D +        HD  LK       QP   +    + L    G+ ++HD+     
Sbjct: 73  VVGSNLDKIYMVMEYVEHD--LKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW---I 127

Query: 399 VHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFR 458
           +HRD+KTSN+LL++    K+ DFGL + E  +  K    T+LV T  Y  PE +   +  
Sbjct: 128 LHRDLKTSNLLLNNRGILKICDFGLAR-EYGSPLKPY--TQLVVTLWYRAPELLLGAK-- 182

Query: 459 FDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
                     + +T  D+++ G + AEL+T K
Sbjct: 183 ----------EYSTAIDMWSVGCIFAELLTKK 204

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 69.0 bits (169), Expect = 6e-13
 Identities = 72/298 (24%), Positives = 109/298 (36%), Gaps = 81/298 (27%)

Query: 293 NFDESRIIGRGGFGNVYFG-----LLGDREA--AIKKMRSNKSK----EFFAELKVLCKI 341
           N  E   +GRG FG V+            E    +K ++  K +    EF  EL +  K+
Sbjct: 6   NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL 65

Query: 342 HHINVFISTFGN----------------GSLSDHL-----HDPLLKGHQPLTWTARTQIA 380
            H NV +   G                 G L   L      D  LK   PL+   +  + 
Sbjct: 66  SHKNV-VRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKP-PPLSTKQKVALC 123

Query: 381 LDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRL 440
              A G++++   + AR+VHRD+   N L+      KV+   L K        E    R 
Sbjct: 124 TQIALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSK---DVYNSEYYKLRN 177

Query: 441 VGTP-GYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT----------- 488
              P  +L PE             +V E   +TK+DV++FGV++ E+ T           
Sbjct: 178 ALIPLRWLAPE-------------AVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD 224

Query: 489 ---------GKRALIRDDSEPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQ 537
                    GK  L   +  P     L  +M     W +N    DRP   ++V+ L +
Sbjct: 225 EEVLNRLQAGKLELPVPEGCP---SRLYKLMTRC--WAVN--PKDRPSFSELVSALGE 275

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 68.9 bits (169), Expect = 7e-13
 Identities = 61/227 (26%), Positives = 93/227 (40%), Gaps = 58/227 (25%)

Query: 298 RIIGRGGFGNVYFGLL-------GDREAAIKKMRSNKS----KEFFAELKVLCKI--HHI 344
           R +G+G FG VY GL         +   AIK +  N S     EF  E  V+ +   HH+
Sbjct: 12  RELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHV 71

Query: 345 N-------------VFISTFGNGSLSDHLH-----DPLLKGHQPLTWTARTQIALDAAKG 386
                         V +     G L  +L           G  P T     Q+A + A G
Sbjct: 72  VRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADG 131

Query: 387 IEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTN-----EKEMLATRLV 441
           + Y+      ++VHRD+   N ++ + L  K+ DFG+ +    T+      K +L  R  
Sbjct: 132 MAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVR-- 186

Query: 442 GTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
               ++ PE             S+ +   TTK+DV++FGVVL E+ T
Sbjct: 187 ----WMAPE-------------SLKDGVFTTKSDVWSFGVVLWEMAT 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 68.5 bits (167), Expect = 8e-13
 Identities = 71/265 (26%), Positives = 112/265 (42%), Gaps = 57/265 (21%)

Query: 300 IGRGGFGNVYFGLLGDRE--AAIK----KMRSNKSKEFFAELKVL--CKIHHINVFISTF 351
           IG+G FG VY G+    +   AIK    +   ++ ++   E+ VL  C   +I  +  ++
Sbjct: 12  IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71

Query: 352 -------------GNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARY 398
                        G GS  D     LLK   PL  T    I  +  KG++Y+H     R 
Sbjct: 72  LKGTKLWIIMEYLGGGSALD-----LLKP-GPLEETYIATILREILKGLDYLHSE---RK 122

Query: 399 VHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFR 458
           +HRDIK +N+LL +    K+ADFG+     +  + ++     VGTP ++ PE I    + 
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAG---QLTDTQIKRNTFVGTPFWMAPEVIKQSAYD 179

Query: 459 FDMHSSVMELQVTTKTDVFAFGVVLAELITGKRA-----------LIRDDSEPTKMKSLI 507
           F             K D+++ G+   EL  G+             LI  +S PT      
Sbjct: 180 F-------------KADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYS 226

Query: 508 TIMAAVAEWCLNEDAVDRPEMRDIV 532
                  E CLN+D   RP  ++++
Sbjct: 227 KPFKEFVEACLNKDPRFRPTAKELL 251

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 67.3 bits (164), Expect = 2e-12
 Identities = 62/234 (26%), Positives = 103/234 (44%), Gaps = 65/234 (27%)

Query: 300 IGRGGFGNVYFG----LLGDRE------AAIKKMRSNKSKEFFAELKVLCKIHHINVFIS 349
           +G G FG V+      LL +++       A+K+   +  ++F  E ++L  + H ++ + 
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHI-VR 71

Query: 350 TFG----------------NGSLSDHL--HDP---LLKGHQ-----PLTWTARTQIALDA 383
            +G                +G L+  L  H P   +L G +      LT      IA   
Sbjct: 72  FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131

Query: 384 AKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK-----LEERTNEKEMLAT 438
           A G+ Y+       +VHRD+ T N L+  GL  K+ DFG+ +        R   + ML  
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 188

Query: 439 RLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKR 491
           R      ++PPE I  ++F             TT++D+++FGVVL E+ T GK+
Sbjct: 189 R------WMPPESILYRKF-------------TTESDIWSFGVVLWEIFTYGKQ 223

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 66.9 bits (164), Expect = 3e-12
 Identities = 64/247 (25%), Positives = 103/247 (41%), Gaps = 60/247 (24%)

Query: 294 FDESRIIGRGGFGNVYFG--LLGDREAAIKKMRSNKSKEF---FAELKVLCKIHHINV-- 346
           ++  + IG G +G+VY    +      AIK ++     +F     E+ +L +  H N+  
Sbjct: 5   YELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVA 64

Query: 347 FISTF-------------GNGSLSDHLHDPLLKGHQPLTWTARTQIAL---DAAKGIEYI 390
           +  ++             G GSL D           PL+     QIA    +  KG+ Y+
Sbjct: 65  YFGSYLRRDKLWIVMEYCGGGSLQDIYQ----VTRGPLS---ELQIAYVCRETLKGLAYL 117

Query: 391 HDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPE 450
           H+  K   +HRDIK +NILL +    K+ADFG+      T  K       +GTP ++ PE
Sbjct: 118 HETGK---IHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKR---KSFIGTPYWMAPE 171

Query: 451 YIFV-KRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK---------RALI---RDD 497
              V ++  +D            K D++A G+   EL   +         RAL    + +
Sbjct: 172 VAAVERKGGYDG-----------KCDIWALGITAIELAELQPPMFDLHPMRALFLISKSN 220

Query: 498 SEPTKMK 504
             P K+K
Sbjct: 221 FPPPKLK 227

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 66.6 bits (162), Expect = 4e-12
 Identities = 68/271 (25%), Positives = 119/271 (43%), Gaps = 57/271 (21%)

Query: 294 FDESRIIGRGGFGNVYFGL--LGDREAAIK----KMRSNKSKEFFAELKVL--CKIHHIN 345
           F +   IG+G FG V+ G+     +  AIK    +   ++ ++   E+ VL  C   ++ 
Sbjct: 6   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 346 VFISTF-------------GNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHD 392
            +  ++             G GS  D L +P      PL  T    I  +  KG++Y+H 
Sbjct: 66  KYYGSYLKDTKLWIIMEYLGGGSALDLL-EP-----GPLDETQIATILREILKGLDYLHS 119

Query: 393 HTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYI 452
             K   +HRDIK +N+LL +    K+ADFG+     +  + ++     VGTP ++ PE I
Sbjct: 120 EKK---IHRDIKAANVLLSEHGEVKLADFGVAG---QLTDTQIKRNTFVGTPFWMAPEVI 173

Query: 453 FVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRA-----------LIRDDSEPT 501
             K+  +D           +K D+++ G+   EL  G+             LI  ++ PT
Sbjct: 174 --KQSAYD-----------SKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPT 220

Query: 502 KMKSLITIMAAVAEWCLNEDAVDRPEMRDIV 532
              +    +    E CLN++   RP  ++++
Sbjct: 221 LEGNYSKPLKEFVEACLNKEPSFRPTAKELL 251

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 67.2 bits (164), Expect = 4e-12
 Identities = 65/220 (29%), Positives = 99/220 (45%), Gaps = 41/220 (18%)

Query: 289 EATNNFDESRIIGRGGFGNV--YFGLLGDREAAIKKMRSNKS-----KEFFAELKVLCKI 341
           E TN + + + +G G FG V      L  +  AIKK+    S     K  + ELK+L  +
Sbjct: 7   EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHL 66

Query: 342 HHIN------VFIST-----FGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYI 390
            H N      +FIS      F    L   LH  LL   +PL             +G++Y+
Sbjct: 67  RHENIISLSDIFISPLEDIYFVTELLGTDLHR-LLTS-RPLEKQFIQYFLYQILRGLKYV 124

Query: 391 HDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPE 450
           H    A  VHRD+K SNIL+++    K+ DFGL     R  + +M  T  V T  Y  PE
Sbjct: 125 H---SAGVVHRDLKPSNILINENCDLKICDFGLA----RIQDPQM--TGYVSTRYYRAPE 175

Query: 451 YIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
            +   + ++D+           + D+++ G + AE++ GK
Sbjct: 176 IMLTWQ-KYDV-----------EVDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 66.1 bits (162), Expect = 4e-12
 Identities = 60/231 (25%), Positives = 96/231 (41%), Gaps = 48/231 (20%)

Query: 300 IGRGGFGNVY--FGLLGDREAAIKKMRS------NKSKEFFAELKVLCKIHH--INVFIS 349
           +G GGFG V        +R  A+K ++        + +  F+E ++L + +H  I     
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60

Query: 350 TFGN-------------GSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKA 396
           TF +             G L   L D   +G     +TAR  IA       EY+H+    
Sbjct: 61  TFKDKKYIYMLMEYCLGGELWTILRD---RGLFD-EYTARFYIAC-VVLAFEYLHNRG-- 113

Query: 397 RYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKR 456
             ++RD+K  N+LLD     K+ DFG  K  +   +         GTP Y+ PE I  K 
Sbjct: 114 -IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQK----TWTFCGTPEYVAPEIILNKG 168

Query: 457 FRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKMKSLI 507
           +                 D ++ G++L EL+TG+     DD +P ++ + I
Sbjct: 169 Y-------------DFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDI 206

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 66.9 bits (163), Expect = 5e-12
 Identities = 74/285 (25%), Positives = 124/285 (43%), Gaps = 65/285 (22%)

Query: 294 FDESRIIGRGGFGNVYFGL-LGDRE-----AAIKKMRSNKS----KEFFAELKVLCKIHH 343
           F + +++G G FG VY GL + + E      AIK++R   S    KE   E  V+  + +
Sbjct: 9   FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68

Query: 344 --------------INVFISTFGNGSLSDHL--HDPLLKGHQPLTWTARTQIALDAAKGI 387
                         + +       G L D++  H   +     L W    QIA    KG+
Sbjct: 69  PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC--VQIA----KGM 122

Query: 388 EYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYL 447
            Y+ +    R VHRD+   N+L+      K+ DFGL KL    +EKE  A       G +
Sbjct: 123 NYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG-ADEKEYHA-----EGGKV 173

Query: 448 PPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKR----------ALIRD 496
           P +++ ++        S++    T ++DV+++GV + EL+T G +          + I +
Sbjct: 174 PIKWMALE--------SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 225

Query: 497 DSEPTKMKSLITI---MAAVAEWCLNEDAVDRPEMRDIVAILSQI 538
             E      + TI   M  V  W +  DA  RP+ R+++   S++
Sbjct: 226 KGERLPQPPICTIDVYMIMVKCWMI--DADSRPKFRELIIEFSKM 268

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 66.1 bits (162), Expect = 5e-12
 Identities = 48/228 (21%), Positives = 81/228 (35%), Gaps = 63/228 (27%)

Query: 299 IIGRGGFGNVYF-------GLLGDREAAIKKMRSNKSKEFFAELKVLCKIHHINVFISTF 351
            IG+G FG V          +L  +E     M   + ++  +E+ +L ++ H N+     
Sbjct: 7   TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIV---- 62

Query: 352 GNGSLSDHLHDP-----------------------LLKGHQPLT----WTARTQIALDAA 384
                 D + D                          K  + +     W   TQ+ L   
Sbjct: 63  ---RYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLL--- 116

Query: 385 KGIEYIHDHTKARYV--HRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVG 442
             +   H+ +       HRD+K +NI LD     K+ DFGL K+    +     A   VG
Sbjct: 117 -ALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDS---SFAKTYVG 172

Query: 443 TPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
           TP Y+ PE +               +    K+D+++ G ++ EL    
Sbjct: 173 TPYYMSPEQL-------------NHMSYDEKSDIWSLGCLIYELCALS 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 66.0 bits (161), Expect = 5e-12
 Identities = 74/284 (26%), Positives = 125/284 (44%), Gaps = 68/284 (23%)

Query: 299 IIGRGGFGNVYFGLL---GDRE--AAIKKMRS----NKSKEFFAELKVLCKIHHINVF-- 347
           +IG G FG V  G L   G RE   AIK ++S     + ++F +E  ++ +  H N+   
Sbjct: 11  VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70

Query: 348 ------------ISTF-GNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHT 394
                       I+ F  NG+L   L        Q  T      +    A G++Y+ +  
Sbjct: 71  EGVVTKSRPVMIITEFMENGALDSFLR---QNDGQ-FTVIQLVGMLRGIAAGMKYLSEMN 126

Query: 395 KARYVHRDIKTSNILLDDGLRAKVADFGLVK-LEERTNEKEMLATRLVGTPGYLP----- 448
              YVHRD+   NIL++  L  KV+DFGL + LE+ T++     T      G +P     
Sbjct: 127 ---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD----PTYTSSLGGKIPIRWTA 179

Query: 449 PEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKR------------ALIR 495
           PE I  ++F             T+ +DV+++G+V+ E+++ G+R            A+ +
Sbjct: 180 PEAIAYRKF-------------TSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQ 226

Query: 496 DDSEPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIM 539
           D   P  M     +   + + C  +D   RP+   IV+ L +++
Sbjct: 227 DYRLPPPMDCPTALHQLMLD-CWQKDRNARPKFGQIVSTLDKMI 269

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 65.5 bits (160), Expect = 7e-12
 Identities = 57/277 (20%), Positives = 111/277 (40%), Gaps = 61/277 (22%)

Query: 293 NFDESRIIGRGGFGNVYFGLLGDREA-----AIKK-----MRSNKSKEFFAELKVLCKIH 342
           +F   + +G+G +G+VY      R +     A+K+     M   + ++   E+++L  ++
Sbjct: 1   DFKVLKKLGKGSYGSVY---KVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVN 57

Query: 343 HINV--FISTF--GN-----------GSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGI 387
           H N+  +   F  GN           G LS  +     K  + +      +I +   +G+
Sbjct: 58  HPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKR-KLIPEQEIWRIFIQLLRGL 116

Query: 388 EYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYL 447
           + +H+    + +HRD+K++NILL      K+ D G+ K+      K+ +A   +GTP Y+
Sbjct: 117 QALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKV-----LKKNMAKTQIGTPHYM 168

Query: 448 PPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKMKSLI 507
            PE ++  R              + K+D+++ G +L E+ T          +  + K   
Sbjct: 169 APE-VWKGR------------PYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQR 215

Query: 508 TI-----------MAAVAEWCLNEDAVDRPEMRDIVA 533
                        +       L      RP    I+A
Sbjct: 216 GKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 65.6 bits (160), Expect = 8e-12
 Identities = 62/238 (26%), Positives = 96/238 (40%), Gaps = 63/238 (26%)

Query: 300 IGRGGFGNVYFGLLGDREAAIKKM---------RSNKSKEF---FAELKVLCKIH----- 342
           +G+GGFG V       +  A  KM         R  K K       E K+L K+      
Sbjct: 1   LGKGGFGEVC----ACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIV 56

Query: 343 ----------HINVFISTFGNGSLSDHLHD---PLLKGHQPLTWTARTQIALDAAKGIEY 389
                      + + ++    G L  H+++   P     + + + A  QI      G+E+
Sbjct: 57  SLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAA--QIIC----GLEH 110

Query: 390 IHDHTKARYVHRDIKTSNILLDDGLRAKVADFGL-VKLEERTNEKEMLATRLVGTPGYLP 448
           +H     R V+RD+K  N+LLDD    +++D GL V+L+     K        GTPGY+ 
Sbjct: 111 LHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGR-----AGTPGYMA 162

Query: 449 PEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKMKSL 506
           PE +  + + F               D FA G  L E+I G R+  R   E  + + L
Sbjct: 163 PEVLQGEVYDF-------------SVDWFALGCTLYEMIAG-RSPFRQRKEKVEKEEL 206

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 65.1 bits (159), Expect = 1e-11
 Identities = 57/216 (26%), Positives = 88/216 (40%), Gaps = 50/216 (23%)

Query: 300 IGRGGFGNVYFG----LLGDR-EAAIKKMRSNK----SKEFFAELKVLCKIHHINVFIST 350
           +G G FG V  G      G     A+K ++S+K      +F  E  ++  + H N+ I  
Sbjct: 3   LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENL-IRL 61

Query: 351 FG---------------NGSLSDHLHDPLLKGHQPLT--WTARTQIALDAAKGIEYIHDH 393
           +G                GSL D L    L GH  ++       QIA     G+ Y+   
Sbjct: 62  YGVVLTHPLMMVTELAPLGSLLDRLRKDAL-GHFLISTLCDYAVQIA----NGMRYLE-- 114

Query: 394 TKARYVHRDIKTSNILLDDGLRAKVADFGLVK-LEERTNEKEMLATRLVGTPGYLPPEYI 452
              R++HRD+   NILL    + K+ DFGL++ L +  +   M     V    +  PE +
Sbjct: 115 -SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFA-WCAPESL 172

Query: 453 FVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
             + F             +  +DV+ FGV L E+ T
Sbjct: 173 RTRTF-------------SHASDVWMFGVTLWEMFT 195

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 64.8 bits (158), Expect = 1e-11
 Identities = 58/223 (26%), Positives = 94/223 (42%), Gaps = 51/223 (22%)

Query: 291 TNNFDESRIIGRGGFGNVYFG--LLGDREAAIKK-----MRSNKSKE-FFAELKVLCKIH 342
             NF   + IG+G F  VY    LL  R  A+KK     M   K+++    E+ +L ++ 
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60

Query: 343 HINV--FISTF-------------GNGSLSDHLHDPLLKGHQPL----TWTARTQIALDA 383
           H NV  ++++F               G LS  +     K  + +     W    Q+    
Sbjct: 61  HPNVIKYLASFIENNELNIVLELADAGDLS-RMIKHFKKQKRLIPERTIWKYFVQLC--- 116

Query: 384 AKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGT 443
              +E++H     R +HRDIK +N+ +      K+ D GL +     + K   A  LVGT
Sbjct: 117 -SALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRF---FSSKTTAAHSLVGT 169

Query: 444 PGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAEL 486
           P Y+ PE I    + F             K+D+++ G +L E+
Sbjct: 170 PYYMSPERIHENGYNF-------------KSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 64.9 bits (158), Expect = 1e-11
 Identities = 57/220 (25%), Positives = 97/220 (44%), Gaps = 55/220 (25%)

Query: 300 IGRGGFGNVY---FGLLGDREAAIK--KMRSNKSKEF---FAELKVLCKIHH-------- 343
           +G+GGFG V        G   A  K  K R  K K +     E ++L K+H         
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60

Query: 344 -------INVFISTFGNGSLSDHLHD-----PLLKGHQPLTWTARTQIALDAAKGIEYIH 391
                  + + ++    G L  H+++     P     +   +TA  QI      G+E++H
Sbjct: 61  AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTA--QIIS----GLEHLH 114

Query: 392 DHTKARYVHRDIKTSNILLDDGLRAKVADFGL-VKLEERTNEKEMLATRLVGTPGYLPPE 450
                R ++RD+K  N+LLD+    +++D GL V+L++  ++ +  A    GTPG++ PE
Sbjct: 115 QR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA----GTPGFMAPE 167

Query: 451 YIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
            +  + + F +             D FA GV L E+I  +
Sbjct: 168 LLQGEEYDFSV-------------DYFALGVTLYEMIAAR 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 64.7 bits (158), Expect = 2e-11
 Identities = 54/217 (24%), Positives = 86/217 (39%), Gaps = 36/217 (16%)

Query: 300 IGRGGFGNVYFG--LLGDREAAIKKMRSNKSKEFFA-----ELKVLCKIHHINV--FIST 350
           IG G +G VY     L     AIKK++     E        E+K+L +++H N+   +  
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66

Query: 351 FGNGS-------LSDHLHDPLLKGHQ-PLTWTARTQIALDAAKGIEYIHDHTKARYVHRD 402
           F +           D     L+K  Q  L  +          +G+ + H H     +HRD
Sbjct: 67  FRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH---GILHRD 123

Query: 403 IKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMH 462
           +K  N+L++     K+ADFGL +            T  V T  Y  PE +   +      
Sbjct: 124 LKPENLLINTEGVLKLADFGLARS---FGSPVRPYTHYVVTRWYRAPELLLGDK------ 174

Query: 463 SSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE 499
                   +T  D+++ G + AEL++  R L    SE
Sbjct: 175 ------GYSTPVDIWSVGCIFAELLSR-RPLFPGKSE 204

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 64.9 bits (159), Expect = 3e-11
 Identities = 38/108 (35%), Positives = 53/108 (49%), Gaps = 17/108 (15%)

Query: 385 KGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK-LEERTNEKEMLA-TRLVG 442
           K ++YIH       +HRD+K SNILL+   R K+ADFGL + L E     E    T  V 
Sbjct: 118 KALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVA 174

Query: 443 TPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
           T  Y  PE I +   R+           T   D+++ G +L E++ GK
Sbjct: 175 TRWYRAPE-ILLGSTRY-----------TKGVDMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 64.5 bits (158), Expect = 3e-11
 Identities = 59/218 (27%), Positives = 97/218 (44%), Gaps = 44/218 (20%)

Query: 298 RIIGRGGFGNVYFGL--LGDREAAIKKMRSNKSKEFFA-----ELKVLCKIHH------I 344
           + IG G +G V   +     R+ AIKK+ +       A     E+K+L  + H      +
Sbjct: 6   KPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLL 65

Query: 345 NVFI----STFGNGSL------SDHLHDPLLKGHQPLTWTARTQ-IALDAAKGIEYIHDH 393
           ++        F +  +      +D LH  ++K  QPLT     Q       +G++Y+H  
Sbjct: 66  DILRPPSPEDFNDVYIVTELMETD-LHK-VIKSPQPLT-DDHIQYFLYQILRGLKYLH-- 120

Query: 394 TKARYVHRDIKTSNILLDDGLRAKVADFGLVK-LEERTNEKEMLATRLVGTPGYLPPEYI 452
             A  +HRD+K SNIL++     K+ DFGL + ++   +EK  L T  V T  Y  PE +
Sbjct: 121 -SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFL-TEYVVTRWYRAPELL 178

Query: 453 FVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
                       +   + T   D+++ G + AEL+T K
Sbjct: 179 ------------LSSSRYTKAIDIWSVGCIFAELLTRK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 63.7 bits (155), Expect = 3e-11
 Identities = 67/274 (24%), Positives = 108/274 (39%), Gaps = 74/274 (27%)

Query: 300 IGRGGFGNVYFGLLG--DREAAIKKMRSN--KSKEFFAELKVLCKIHHINV--------- 346
           +G G +G VY G+        A+K ++ +  + +EF  E  V+ +I H N+         
Sbjct: 14  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 73

Query: 347 ----FIST--FGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVH 400
               +I T     G+L D+L +      Q +       +A   +  +EY+    K  ++H
Sbjct: 74  EPPFYIITEFMTYGNLLDYLRE---CNRQEVNAVVLLYMATQISSAMEYLE---KKNFIH 127

Query: 401 RDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP---GYLPPEYIFVKRF 457
           RD+   N L+ +    KVADFGL +L           T   G      +  PE +   +F
Sbjct: 128 RDLAARNCLVGENHLVKVADFGLSRL-----MTGDTYTAHAGAKFPIKWTAPESLAYNKF 182

Query: 458 RFDMHSSVMELQVTTKTDVFAFGVVLAELIT--------------------GKRALIRDD 497
                        + K+DV+AFGV+L E+ T                    G R + R +
Sbjct: 183 -------------SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYR-MERPE 228

Query: 498 SEPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDI 531
             P K+  L   M A  +W    +  DRP   +I
Sbjct: 229 GCPPKVYEL---MRACWQW----NPSDRPSFAEI 255

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 63.4 bits (154), Expect = 4e-11
 Identities = 62/259 (23%), Positives = 108/259 (41%), Gaps = 56/259 (21%)

Query: 300 IGRGGFGNVYFGL-LGDREAAIKKMRSN--KSKEFFAELKVLCKIHHINVFISTFG---- 352
           IG G FG V+ G  L  R+ AIK +R      ++F  E +V+ K+ H    +  +G    
Sbjct: 12  IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSH-PKLVQLYGVCTE 70

Query: 353 ------------NGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVH 400
                       +G LSD+L     +G    +      + LD  +G+ Y+     +  +H
Sbjct: 71  RSPICLVFEFMEHGCLSDYLRAQ--RGK--FSQETLLGMCLDVCEGMAYLE---SSNVIH 123

Query: 401 RDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGY-LPPEYIFVKRFRF 459
           RD+   N L+ +    KV+DFG+ +         +L  +   + G   P ++   + F F
Sbjct: 124 RDLAARNCLVGENQVVKVSDFGMTRF--------VLDDQYTSSTGTKFPVKWSSPEVFSF 175

Query: 460 DMHSSVMELQVTTKTDVFAFGVVLAELITGKRALI--RDDSEPT----------KMKSLI 507
             +SS        K+DV++FGV++ E+ +  +     R +SE            K +   
Sbjct: 176 SKYSS--------KSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLAS 227

Query: 508 TIMAAVAEWCLNEDAVDRP 526
             +  + + C  E   DRP
Sbjct: 228 QSVYELMQHCWKERPEDRP 246

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 63.7 bits (155), Expect = 4e-11
 Identities = 51/177 (28%), Positives = 81/177 (45%), Gaps = 40/177 (22%)

Query: 329 KEFFAELKVL--CKIHHINVFISTFGN-------------GSLSDHLHDPLLKGHQPLTW 373
           K+   EL+++  C+  +I  F   F N             GSL     D + K   P+  
Sbjct: 48  KQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSL-----DRIYKKGGPIPV 102

Query: 374 TARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEK 433
               +IA+   +G+ Y+++    R +HRDIK SNIL++   + K+ DFG+    E  N  
Sbjct: 103 EILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSG--ELINS- 157

Query: 434 EMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
             +A   VGT  Y+ PE     R +          + T K+DV++ G+ + EL  GK
Sbjct: 158 --IADTFVGTSTYMSPE-----RIQGG--------KYTVKSDVWSLGISIIELALGK 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 62.7 bits (152), Expect = 6e-11
 Identities = 65/249 (26%), Positives = 103/249 (41%), Gaps = 63/249 (25%)

Query: 293 NFDESRIIGRGGFGNVYFGLLGD--REAAIKKM-----RSNKSKEFFA---ELKVLCKIH 342
           N+   +++GRG FG VY     D  RE A+K++         SKE  A   E+++L  + 
Sbjct: 3   NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62

Query: 343 H-----------------INVFISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAK 385
           H                 +++F+     GS+ D L     K +  LT     +      +
Sbjct: 63  HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQL-----KAYGALTENVTRRYTRQILQ 117

Query: 386 GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLAT---RLVG 442
           G+ Y+H +     VHRDIK +NIL D     K+ DFG  K   R     M  T    + G
Sbjct: 118 GVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASK---RIQTICMSGTGIKSVTG 171

Query: 443 TPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK---------RAL 493
           TP ++ PE I  + +               K DV++    + E++T K          A+
Sbjct: 172 TPYWMSPEVISGEGY-------------GRKADVWSVACTVVEMLTEKPPWAEYEAMAAI 218

Query: 494 IRDDSEPTK 502
            +  ++PTK
Sbjct: 219 FKIATQPTK 227

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 62.7 bits (152), Expect = 8e-11
 Identities = 70/281 (24%), Positives = 120/281 (42%), Gaps = 65/281 (23%)

Query: 298 RIIGRGGFGNVYFGL-LGDRE-----AAIKKMRSNKS----KEFFAELKVL--------- 338
           +++G G FG VY G+ + D E      AIK +R N S    KE   E  V+         
Sbjct: 13  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVC 72

Query: 339 -----CKIHHINVFISTFGNGSLSDHL--HDPLLKGHQPLTWTARTQIALDAAKGIEYIH 391
                C    + +       G L D++  +   +     L W    QIA    KG+ Y+ 
Sbjct: 73  RLLGICLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWC--VQIA----KGMSYLE 126

Query: 392 DHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEY 451
           +    R VHRD+   N+L+      K+ DFGL +L +  +E E  A       G +P ++
Sbjct: 127 E---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLD-IDETEYHA-----DGGKVPIKW 177

Query: 452 IFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRAL----------IRDDSEP 500
           + ++        S++  + T ++DV+++GV + EL+T G +            + +  E 
Sbjct: 178 MALE--------SILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGER 229

Query: 501 TKMKSLITI---MAAVAEWCLNEDAVDRPEMRDIVAILSQI 538
                + TI   M  V  W ++ +   RP  R++V   S++
Sbjct: 230 LPQPPICTIDVYMIMVKCWMIDSEC--RPRFRELVDEFSRM 268

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 62.5 bits (152), Expect = 9e-11
 Identities = 63/271 (23%), Positives = 109/271 (40%), Gaps = 63/271 (23%)

Query: 300 IGRGGFGNVYFGLLGDRE----AAIKKMRSNKSKE---FFAELKVLCKIHHINV--FIST 350
           +G G FG VY      +E    AA K ++    +E   F  E+ +L +  H N+      
Sbjct: 13  LGDGAFGKVY--KAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEA 70

Query: 351 F-------------GNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKAR 397
           +               G+L D +   L +    LT      +     + + ++H H   +
Sbjct: 71  YFYENKLWILIEFCDGGAL-DSIMLELER---GLTEPQIRYVCRQMLEALNFLHSH---K 123

Query: 398 YVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRF 457
            +HRD+K  NILL      K+ADFG+    + T +K       +GTP ++ PE +  + F
Sbjct: 124 VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKR---DTFIGTPYWMAPEVVACETF 180

Query: 458 RFDMHSSVMELQVTTKTDVFAFGVVLAELITGK---------RALIR-DDSEPTKM---- 503
           + + +          K D+++ G+ L EL   +         R L++   SEP  +    
Sbjct: 181 KDNPYDY--------KADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPS 232

Query: 504 ---KSLITIMAAVAEWCLNEDAVDRPEMRDI 531
               S    + +    CL +D  DRP   ++
Sbjct: 233 KWSSSFNDFLKS----CLVKDPDDRPTAAEL 259

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 62.0 bits (151), Expect = 9e-11
 Identities = 64/279 (22%), Positives = 107/279 (38%), Gaps = 66/279 (23%)

Query: 300 IGRGGFGNVYFGLLGDR-----EAAIKKMRSNKS----KEFFAELKVLCKIHHINVFIST 350
           +G G FG+V  G+   +     E A+K ++        KEF  E  V+ ++ H  + +  
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCI-VRL 61

Query: 351 FG---------------NGSLSDHLHD-PLLKGHQPLTWTARTQIALDAAKGIEYIHDHT 394
            G                G L  +L     +            Q+A+    G+ Y+    
Sbjct: 62  IGVCKGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELA--HQVAM----GMAYLES-- 113

Query: 395 KARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLP-----P 449
              +VHRD+   N+LL +  +AK++DFG+ +           AT    T G  P     P
Sbjct: 114 -KHFVHRDLAARNVLLVNRHQAKISDFGMSR-ALGAGSDYYRAT----TAGRWPLKWYAP 167

Query: 450 EYIFVKRFRFDMHSSVMELQVTTKTDVFAFG----------VVLAELITGKRALIRDDSE 499
           E I     +F   S V    VT   + F++G           V+A L +G+R L R +  
Sbjct: 168 ECINY--GKFSSKSDVWSYGVTL-WEAFSYGAKPYGEMKGAEVIAMLESGER-LPRPEEC 223

Query: 500 PTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQI 538
           P   + + +IM +    C      DRP   ++ +   + 
Sbjct: 224 P---QEIYSIMLS----CWKYRPEDRPTFSELESTFRRD 255

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 62.2 bits (151), Expect = 1e-10
 Identities = 54/225 (24%), Positives = 91/225 (40%), Gaps = 51/225 (22%)

Query: 298 RIIGRGGFGNVYFGLL--------GDREAAIKKMRS----NKSKEFFAELKVLCKIHHIN 345
             +G G FG VY G          G    A+K +R      + KEF  E  ++   +H N
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60

Query: 346 V---------------FISTFGNGSLSDHLHDPLLKGHQP--LTWTARTQIALDAAKGIE 388
           +                +     G L  +L D  ++   P  LT      I LD AKG  
Sbjct: 61  IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120

Query: 389 YIHDHTKARYVHRDIKTSNILLD--DGLR---AKVADFGLVKLEERTNEKEMLATRLVGT 443
           Y+       ++HRD+   N L+           K+ DFGL +   +++        L+  
Sbjct: 121 YLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV 177

Query: 444 PGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
             ++ PE             S+++ + TT++DV++FGV++ E++T
Sbjct: 178 R-WMAPE-------------SLLDGKFTTQSDVWSFGVLMWEILT 208

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 62.7 bits (153), Expect = 1e-10
 Identities = 68/240 (28%), Positives = 94/240 (39%), Gaps = 63/240 (26%)

Query: 294 FDESRIIGRGGFGNVYFG--LLGDREAAIKKMRSNKSKEFF--------AELKVLCKIHH 343
           ++E   IG G +G VY    L   R  A+KK+R   S+E          A LK L    H
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60

Query: 344 INVFISTFGNGSLSDHLHDPLLKG-----------HQPLT-------------WTARTQI 379
            N+         L D  H P                Q L               T +  +
Sbjct: 61  PNIV-------RLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIK-DL 112

Query: 380 ALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATR 439
                +G++++H H   R VHRD+K  NIL+    + K+ADFGL     R    EM  T 
Sbjct: 113 MRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLA----RIYSFEMALTS 165

Query: 440 LVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE 499
           +V T  Y  PE +        + SS       T  D+++ G + AEL   +R L R  SE
Sbjct: 166 VVVTLWYRAPEVL--------LQSSYA-----TPVDMWSVGCIFAELFR-RRPLFRGTSE 211

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 62.4 bits (151), Expect = 1e-10
 Identities = 64/233 (27%), Positives = 105/233 (45%), Gaps = 61/233 (26%)

Query: 298 RIIGRGGFGNVY----FGLLGDRE---AAIKKMRS---NKSKEFFAELKVLCKIHHINV- 346
           R +G G FG V+    + L  +++    A+K ++    N  K+F  E ++L  + H ++ 
Sbjct: 11  RELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIV 70

Query: 347 -----------FISTF---GNGSLSDHL--HDP----LLKGHQP--LTWTARTQIALDAA 384
                       I  F    +G L+  L  H P    + +G++P  LT +    IA   A
Sbjct: 71  KFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIA 130

Query: 385 KGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK-----LEERTNEKEMLATR 439
            G+ Y+       +VHRD+ T N L+ + L  K+ DFG+ +        R     ML  R
Sbjct: 131 AGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR 187

Query: 440 LVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKR 491
                 ++PPE I  ++F             TT++DV++ GVVL E+ T GK+
Sbjct: 188 ------WMPPESIMYRKF-------------TTESDVWSLGVVLWEIFTYGKQ 221

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 63.3 bits (154), Expect = 2e-10
 Identities = 48/148 (32%), Positives = 74/148 (50%), Gaps = 24/148 (16%)

Query: 391 HDHTKARYVHRDIKTSNILL-DDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPP 449
           H H+K   +HRDIK++NILL  +GL  K+ DFG  K+   T   ++  T   GTP Y+ P
Sbjct: 158 HVHSK-HMIHRDIKSANILLCSNGL-VKLGDFGFSKMYAATVSDDVGRT-FCGTPYYVAP 214

Query: 450 EYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKMKSLITI 509
           E I+ ++              + K D+F+ GV+L EL+T KR    ++ E    K+L   
Sbjct: 215 E-IWRRK------------PYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGR 261

Query: 510 MAAVAEWCLNEDAVDRPEMRDIVAILSQ 537
              +        ++  PEM++IV  L  
Sbjct: 262 YDPLP------PSIS-PEMQEIVTALLS 282

Length = 496

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 61.6 bits (149), Expect = 2e-10
 Identities = 69/271 (25%), Positives = 115/271 (42%), Gaps = 57/271 (21%)

Query: 298 RIIGRGGFGNVYFGLLGDR-EAAIKKMR--SNKSKEFFAELKVLCKIHH----------- 343
           + +G G FG V+ G   +  + A+K ++  +   + F  E  ++  + H           
Sbjct: 12  KKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 71

Query: 344 ----INVFISTFGNGSLSDHLH-DPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARY 398
               I +       GSL D L  D   K   P       QIA    +G+ YI    +  Y
Sbjct: 72  KEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIA----EGMAYIE---RKNY 124

Query: 399 VHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP-GYLPPEYIFVKRF 457
           +HRD++ +N+L+ + L  K+ADFGL ++ E   + E  A      P  +  PE I    F
Sbjct: 125 IHRDLRAANVLVSESLMCKIADFGLARVIE---DNEYTAREGAKFPIKWTAPEAINFGSF 181

Query: 458 RFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GK------------RALIRDDSEPTKMK 504
                        T K+DV++FG++L E++T GK             AL R    P +M+
Sbjct: 182 -------------TIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMP-RME 227

Query: 505 SLITIMAAVAEWCLNEDAVDRPEMRDIVAIL 535
           +    +  + + C  E A +RP    + ++L
Sbjct: 228 NCPDELYDIMKTCWKEKAEERPTFDYLQSVL 258

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 62.3 bits (152), Expect = 2e-10
 Identities = 65/252 (25%), Positives = 111/252 (44%), Gaps = 43/252 (17%)

Query: 298 RIIGRGGFGNVYFGL--LGDREAAIKKMRS-----NKSKEFFAELKVLCKIHHINV---- 346
             IG G +G V   +     ++ AIKK+         +K    ELK+L    H N+    
Sbjct: 11  ENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIR 70

Query: 347 ---------FISTFGNGSL--SDHLHDPLLKGHQPLTWTARTQIAL-DAAKGIEYIHDHT 394
                    F   +    L  SD LH  ++   QPLT     +  L    +G++YIH   
Sbjct: 71  DILRPPGADFKDVYVVMDLMESD-LHH-IIHSDQPLT-EEHIRYFLYQLLRGLKYIH--- 124

Query: 395 KARYVHRDIKTSNILLDDGLRAKVADFGLVK-LEERTNEKEMLATRLVGTPGYLPPEYIF 453
            A  +HRD+K SN+L+++    ++ DFG+ + L     E +   T  V T  Y  PE + 
Sbjct: 125 SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLL 184

Query: 454 VKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKMKSLITIMAAV 513
                  +       + TT  D+++ G + AE++ G+R L    +   ++K +++++ + 
Sbjct: 185 S------LP------EYTTAIDMWSVGCIFAEML-GRRQLFPGKNYVHQLKLILSVLGSP 231

Query: 514 AEWCLNEDAVDR 525
           +E  LN    DR
Sbjct: 232 SEEVLNRIGSDR 243

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 62.3 bits (151), Expect = 2e-10
 Identities = 64/223 (28%), Positives = 95/223 (42%), Gaps = 42/223 (18%)

Query: 289 EATNNFDESRIIGRGGFGNVYFGLLGDREA--AIKKMRSNKSKEFFA-----ELKVLCKI 341
           E  + + + + +G G +G V   L     A  AIKK+      E FA     EL++L  +
Sbjct: 12  EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM 71

Query: 342 HHINV--FISTFGNGSLSDHLHD-----PL-------LKGHQPLTWTARTQIALDAAKGI 387
            H NV   +  F      D  HD     P        L  H+ L+      +     KG+
Sbjct: 72  KHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKGL 131

Query: 388 EYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYL 447
           +YIH    A  +HRD+K  N+ +++    K+ DFGL     R  + EM  T  V T  Y 
Sbjct: 132 KYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLA----RQTDSEM--TGYVVTRWYR 182

Query: 448 PPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
            PE I        MH        T   D+++ G ++AE++TGK
Sbjct: 183 APEVILNW-----MH-------YTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 61.1 bits (148), Expect = 2e-10
 Identities = 60/218 (27%), Positives = 93/218 (42%), Gaps = 51/218 (23%)

Query: 298 RIIGRGGFGNVYF--GLLGDREAAIKKMRSNKS----KEFFAELKVLCKIHHINV--FIS 349
           R++G G FG       +  D++ A+K++R  KS    ++   E  +L K+ H N+  F  
Sbjct: 6   RVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKE 65

Query: 350 TF-------------GNGSLSDHLHDP---LLKGHQPLTWTARTQIALDAAKGIEYIHDH 393
           +F               G L   +      L      L W    Q+ L    G+++IH+ 
Sbjct: 66  SFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWF--VQMCL----GVQHIHEK 119

Query: 394 TKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIF 453
              R +HRDIK+ NI L    + K+ DFG  +L          A   VGTP Y+PPE   
Sbjct: 120 ---RVLHRDIKSKNIFLTQNGKVKLGDFGSARL---LTSPGAYACTYVGTPYYVPPE--- 170

Query: 454 VKRFRFDMHSSVME-LQVTTKTDVFAFGVVLAELITGK 490
                      + E +    K+D+++ G +L EL T K
Sbjct: 171 -----------IWENMPYNNKSDIWSLGCILYELCTLK 197

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 61.7 bits (150), Expect = 2e-10
 Identities = 54/231 (23%), Positives = 94/231 (40%), Gaps = 56/231 (24%)

Query: 300 IGRGGFGNVY--FGLLGDREAAIKKMRSNKSKEFFA-----------------ELKVLCK 340
           +G G +G V   +  L  +  AIKK++  +                       ELK++ +
Sbjct: 17  LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76

Query: 341 IHHINVF--ISTFGNGS----LSDHLHDPLLK---GHQPLTWTARTQIALDAAKGIEYIH 391
           I H N+   +  +  G     + D +   L K       LT +    I L    G+  +H
Sbjct: 77  IKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKIRLTESQVKCILLQILNGLNVLH 136

Query: 392 DHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK-----------LEERTNEKEMLATRL 440
              K  ++HRD+  +NI ++     K+ADFGL +            ++ T ++    T  
Sbjct: 137 ---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSK 193

Query: 441 VGTPGYLPPEYIF-VKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
           V T  Y  PE +   +++    H +V         D+++ G + AEL+TGK
Sbjct: 194 VVTLWYRAPELLMGAEKY----HFAV---------DMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 61.2 bits (148), Expect = 2e-10
 Identities = 62/261 (23%), Positives = 115/261 (44%), Gaps = 49/261 (18%)

Query: 300 IGRGGFGNVYFGLLGDREA--AIKKM----RSNKSKEFFAELKVL--CKIHHINVFISTF 351
           IG+G FG V+ G+    +   AIK +      ++ ++   E+ VL  C   ++  +  ++
Sbjct: 12  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71

Query: 352 GNGS----LSDHLH-----DPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRD 402
             G+    + ++L      D L  G  P        +  +  KG++Y+H   K   +HRD
Sbjct: 72  LKGTKLWIIMEYLGGGSALDLLRAG--PFDEFQIATMLKEILKGLDYLHSEKK---IHRD 126

Query: 403 IKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMH 462
           IK +N+LL +    K+ADFG+     +  + ++     VGTP ++ PE I  ++  +D  
Sbjct: 127 IKAANVLLSEQGDVKLADFGVAG---QLTDTQIKRNTFVGTPFWMAPEVI--QQSAYD-- 179

Query: 463 SSVMELQVTTKTDVFAFGVVLAELITGKRA-----------LIRDDSEPTKMKSLITIMA 511
                    +K D+++ G+   EL  G+             LI  ++ PT          
Sbjct: 180 ---------SKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFK 230

Query: 512 AVAEWCLNEDAVDRPEMRDIV 532
              + CLN+D   RP  ++++
Sbjct: 231 EFIDACLNKDPSFRPTAKELL 251

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 60.5 bits (146), Expect = 4e-10
 Identities = 58/225 (25%), Positives = 94/225 (41%), Gaps = 48/225 (21%)

Query: 293 NFDESRIIGRGGFGNVYFGLLGD--REAAIKKMR-----SNKSKEFFA---ELKVLCKIH 342
           N+   +++G+G FG VY     D  RE A K+++        SKE  A   E+++L  + 
Sbjct: 3   NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62

Query: 343 H-----------------INVFISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAK 385
           H                 + +F+     GS+ D L     K +  LT +   +      +
Sbjct: 63  HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQL-----KAYGALTESVTRKYTRQILE 117

Query: 386 GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPG 445
           G+ Y+H +     VHRDIK +NIL D     K+ DFG  K  +           + GTP 
Sbjct: 118 GMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPY 174

Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
           ++ PE I  + +               K DV++ G  + E++T K
Sbjct: 175 WMSPEVISGEGY-------------GRKADVWSLGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 60.3 bits (147), Expect = 5e-10
 Identities = 60/225 (26%), Positives = 90/225 (40%), Gaps = 58/225 (25%)

Query: 292 NNFDESRIIGRGGFGNVYFGLLGDREA--AIKKMRSNK---SKE---FFAELKVLCKIHH 343
           ++F+  + +G G FG V            A+K +   K    K+      E ++L  I H
Sbjct: 1   DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60

Query: 344 ---INVFISTFGN------------GSLSDHLHDPLLKGHQPLTWTAR---TQIALDAAK 385
              +N++ S   +            G L  HL      G  P    AR    Q+ L    
Sbjct: 61  PFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRK---SGRFPEPV-ARFYAAQVVL---- 112

Query: 386 GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK-LEERTNEKEMLATRLVGTP 444
            +EY+H       V+RD+K  N+LLD     K+ DFG  K ++ RT         L GTP
Sbjct: 113 ALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRT-------YTLCGTP 162

Query: 445 GYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
            YL PE I  K        +V         D +A G+++ E++ G
Sbjct: 163 EYLAPEIILSK----GYGKAV---------DWWALGILIYEMLAG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 59.8 bits (145), Expect = 5e-10
 Identities = 41/166 (24%), Positives = 65/166 (39%), Gaps = 29/166 (17%)

Query: 367 GHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKL 426
           G  P  W A+  IA +   G+E +H       +HRDIK  N+L+D     K+ DFGL   
Sbjct: 92  GGLPEDW-AKQYIA-EVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGL--- 143

Query: 427 EERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAEL 486
               +   +   + VGTP YL PE             +++ +     +D ++ G V+ E 
Sbjct: 144 ----SRNGLENKKFVGTPDYLAPE-------------TILGVGDDKMSDWWSLGCVIFEF 186

Query: 487 ITGKRALIRDDSEPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIV 532
           + G           T       I++    W         PE  D++
Sbjct: 187 LFGYPPF----HAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLI 228

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 59.6 bits (144), Expect = 6e-10
 Identities = 63/238 (26%), Positives = 104/238 (43%), Gaps = 60/238 (25%)

Query: 298 RIIGRGGFGNVYFGLLGDR----EAAIKKM--RSNKSKEFFA---ELKVLCKIHHINV-- 346
           R++G+G +G V   L+  R    +  IKK+  R+   +E  A   E ++L ++ H N+  
Sbjct: 6   RVVGKGSYGEV--SLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVA 63

Query: 347 -------------FISTF-GNGSLSDHLHD---PLLKGHQPLTWTARTQIALDAAKGIEY 389
                         +  F   G L   L +    LL  +Q + W  +  +AL      +Y
Sbjct: 64  YRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMAL------QY 117

Query: 390 IHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPP 449
           +H+      +HRD+KT N+ L      KV D G+ ++ E   +   +A+ L+GTP Y+ P
Sbjct: 118 LHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD---MASTLIGTPYYMSP 171

Query: 450 EYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKMKSLI 507
           E    K + +             K+DV+A G  + E+ T K A    D     M SL+
Sbjct: 172 ELFSNKPYNY-------------KSDVWALGCCVYEMATLKHAFNAKD-----MNSLV 211

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 59.7 bits (144), Expect = 7e-10
 Identities = 57/225 (25%), Positives = 96/225 (42%), Gaps = 48/225 (21%)

Query: 293 NFDESRIIGRGGFGNVYFGLLGD--REAAIKKMRSN-----KSKEFFA---ELKVLCKIH 342
           N+   +++G+G FG VY     D  RE A+K+++ +      SKE  A   E+++L  + 
Sbjct: 3   NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62

Query: 343 H-----------------INVFISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAK 385
           H                 +++F+     GS+ D L     K +  LT     +      +
Sbjct: 63  HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQL-----KSYGALTENVTRKYTRQILE 117

Query: 386 GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPG 445
           G+ Y+H +     VHRDIK +NIL D     K+ DFG  K  +           + GTP 
Sbjct: 118 GVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPY 174

Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
           ++ PE I  + +               K D+++ G  + E++T K
Sbjct: 175 WMSPEVISGEGY-------------GRKADIWSVGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 60.3 bits (146), Expect = 7e-10
 Identities = 63/234 (26%), Positives = 94/234 (40%), Gaps = 47/234 (20%)

Query: 282 FSLEEIE----EATNNFDESRIIGRGGFGNV--YFGLLGDREAAIKKMRSNKSKEFFA-- 333
           F  EE+     E    +   + +G G +G+V          + AIKK+      E FA  
Sbjct: 1   FYREEVNKTVWELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKR 60

Query: 334 ---ELKVLCKIHHINV--FISTFGNGSLSDHLHDPLL------------KGHQPLTWTAR 376
              EL +L  + H NV   +  F +    D   D  L             GH PL+    
Sbjct: 61  AYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGH-PLSEDKV 119

Query: 377 TQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEML 436
             +      G++YIH    A  +HRD+K  N+ +++    K+ DFGL     R  + EM 
Sbjct: 120 QYLVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLA----RHADAEM- 171

Query: 437 ATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
            T  V T  Y  PE I        MH            D+++ G ++AE++TGK
Sbjct: 172 -TGYVVTRWYRAPEVILNW-----MH-------YNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 59.4 bits (144), Expect = 7e-10
 Identities = 56/213 (26%), Positives = 92/213 (43%), Gaps = 43/213 (20%)

Query: 298 RIIGRGGFGNVYFGLLGDR-EAAIKKMRSNKSKE----FFAELKVLCKIHHINVF----I 348
             IG+G FG+VY G+L    E A+K  RS    +    F  E ++L +  H N+     +
Sbjct: 1   EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60

Query: 349 ST-----------FGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKAR 397
                           GSL   L     K    LT     Q++LDAA G+EY+       
Sbjct: 61  CVQKQPIYIVMELVPGGSLLTFLR----KKKNRLTVKKLLQMSLDAAAGMEYLESKN--- 113

Query: 398 YVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP-GYLPPEYIFVKR 456
            +HRD+   N L+ +    K++DFG+ + EE       ++  L   P  +  PE +   R
Sbjct: 114 CIHRDLAARNCLVGENNVLKISDFGMSR-EEEGGIYT-VSDGLKQIPIKWTAPEALNYGR 171

Query: 457 FRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
           +             T+++DV+++G++L E  + 
Sbjct: 172 Y-------------TSESDVWSYGILLWETFSL 191

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 59.5 bits (144), Expect = 8e-10
 Identities = 40/154 (25%), Positives = 68/154 (44%), Gaps = 23/154 (14%)

Query: 339 CKIHHINVFISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARY 398
           C+  H N+F+     GS+S  L       +                +G+ Y+H++   + 
Sbjct: 73  CEDSHFNLFVEWMAGGSVSHLLSK-----YGAFKEAVIINYTEQLLRGLSYLHEN---QI 124

Query: 399 VHRDIKTSNILLDD-GLRAKVADFG-LVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKR 456
           +HRD+K +N+L+D  G R ++ADFG   +L  +         +L+GT  ++ PE   V R
Sbjct: 125 IHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPE---VLR 181

Query: 457 FRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
                       Q     DV++ G V+ E+ T K
Sbjct: 182 GE----------QYGRSCDVWSVGCVIIEMATAK 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 59.3 bits (143), Expect = 1e-09
 Identities = 65/240 (27%), Positives = 101/240 (42%), Gaps = 44/240 (18%)

Query: 286 EIEEATNNFDESRIIGRGGFGNVYFGLLGDR-EAAIKKMR--SNKSKEFFAELKVLCKIH 342
           EI   +   +  + +G G FG V+        + A+K M+  S   + F AE  V+  + 
Sbjct: 2   EIPRESLKLE--KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQ 59

Query: 343 H--------------INVFISTFGNGSLSDHLH-DPLLKGHQPLTWTARTQIALDAAKGI 387
           H              I +       GSL D L  D   K   P       QIA    +G+
Sbjct: 60  HDKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIA----EGM 115

Query: 388 EYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP-GY 446
            +I    +  Y+HRD++ +NIL+   L  K+ADFGL ++ E   + E  A      P  +
Sbjct: 116 AFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIE---DNEYTAREGAKFPIKW 169

Query: 447 LPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKMKSL 506
             PE I    F             T K+DV++FG++L E++T  R      S P  +++L
Sbjct: 170 TAPEAINFGSF-------------TIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL 216

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 59.2 bits (143), Expect = 1e-09
 Identities = 71/295 (24%), Positives = 111/295 (37%), Gaps = 94/295 (31%)

Query: 300 IGRGGFGNVYFGLL---GDREA---AIKKMRSNKSK----EFFAELKVLCKIHHINV--- 346
           +G   FG +Y G L   G   A   AIK ++   +     EF  E  ++ ++HH N+   
Sbjct: 13  LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72

Query: 347 ------------FISTFGNGSLSDHL--------------HDPLLKGHQPLTWTARTQIA 380
                              G L + L               D  +K    L       IA
Sbjct: 73  LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVK--SSLDHGDFLHIA 130

Query: 381 LDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKL-----EERTNEKEM 435
           +  A G+EY+  H    +VH+D+   NIL+ + L  K++D GL +        R   K +
Sbjct: 131 IQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSL 187

Query: 436 LATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT------- 488
           L  R      ++PPE I   +F             ++ +D+++FGVVL E+ +       
Sbjct: 188 LPIR------WMPPEAIMYGKF-------------SSDSDIWSFGVVLWEIFSFGLQPYY 228

Query: 489 -----------GKRALIRDDSE-PTKMKSLITIMAAVAEWCLNEDAVDRPEMRDI 531
                       KR L+    + P +M SL+T        C  E    RP  +DI
Sbjct: 229 GFSNQEVIEMVRKRQLLPCSEDCPPRMYSLMT-------ECWQEGPSRRPRFKDI 276

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 58.7 bits (142), Expect = 1e-09
 Identities = 65/286 (22%), Positives = 106/286 (37%), Gaps = 73/286 (25%)

Query: 300 IGRGGFGNVYF--------GLLGDREAAI--------KKMRSNKSKEFFAELKVLCK-IH 342
           +G G FG VY          LL  +E  +        K+ R     +  +E+ ++ + + 
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67

Query: 343 HINV--FISTFGNG-------------SLSDHLHDPLLKGH---QPLTWTARTQIALDAA 384
           H N+  +  TF                 L +H +    K     +   W    Q+ L   
Sbjct: 68  HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVL--- 124

Query: 385 KGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP 444
             + Y+H   + R VHRD+  +NI+L +  +  + DFGL K   +   +  L T +VGT 
Sbjct: 125 -ALRYLH--KEKRIVHRDLTPNNIMLGEDDKVTITDFGLAK---QKQPESKL-TSVVGTI 177

Query: 445 GYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAE------------LITGKRA 492
            Y  PE              V       K DV+AFG +L +            +++    
Sbjct: 178 LYSCPEI-------------VKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATK 224

Query: 493 LIRDDSEPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQI 538
           ++    EP         +  V   CL  DA  RP   DI+ + + I
Sbjct: 225 IVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARP---DIIQVSAMI 267

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 58.1 bits (140), Expect = 3e-09
 Identities = 67/255 (26%), Positives = 111/255 (43%), Gaps = 52/255 (20%)

Query: 278 RTIIFSLEEIEEATNNFDESRIIGRGGFGNVYFGLLGDRE---AAIKKMR--SNKSKEFF 332
            + +  LE + + T+ ++    IG+G +G VY  +   ++   AA+K +   S+  +E  
Sbjct: 8   NSSMLGLESLGDPTDTWEIIETIGKGTYGKVY-KVTNKKDGSLAAVKILDPISDVDEEIE 66

Query: 333 AELKVLCKI-HHINV--FISTF-----------------GNGSLSDHLHDPLLKGHQPLT 372
           AE  +L  + +H NV  F   F                  NG     L   LL   Q L 
Sbjct: 67  AEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLD 126

Query: 373 WTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNE 432
               + I   A  G++++H++   R +HRD+K +NILL      K+ DFG+         
Sbjct: 127 EAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGV--------S 175

Query: 433 KEMLATRL-----VGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELI 487
            ++ +TRL     VGTP ++ PE I  ++ ++D            + DV++ G+   EL 
Sbjct: 176 AQLTSTRLRRNTSVGTPFWMAPEVIACEQ-QYDY-------SYDARCDVWSLGITAIELG 227

Query: 488 TGKRALIRDDSEPTK 502
            G   L   D  P K
Sbjct: 228 DGDPPLF--DMHPVK 240

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 57.8 bits (139), Expect = 3e-09
 Identities = 68/278 (24%), Positives = 116/278 (41%), Gaps = 57/278 (20%)

Query: 294 FDESRIIGRGGFGNVYFG--LLGDREAAIKKM--RSNKSKEFFAELKVLCKI-HHINV-- 346
           F+   ++G G +G VY G  +   + AAIK M    ++ +E   E+ +L K  HH N+  
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 67

Query: 347 FISTF-------------------GNGSLSDHLHDPLLKGHQ-PLTWTARTQIALDAAKG 386
           +   F                   G GS++D + +   KG+     W A   I  +  +G
Sbjct: 68  YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNT--KGNTLKEEWIA--YICREILRG 123

Query: 387 IEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGY 446
           + ++H H   + +HRDIK  N+LL +    K+ DFG+    +RT  +       +GTP +
Sbjct: 124 LSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRR---NTFIGTPYW 177

Query: 447 LPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK---------RALI--- 494
           + PE I              +     K+D+++ G+   E+  G          RAL    
Sbjct: 178 MAPEVIAC--------DENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP 229

Query: 495 RDDSEPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIV 532
           R+ +   K K       +  E CL ++   RP    ++
Sbjct: 230 RNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLM 267

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 57.4 bits (138), Expect = 4e-09
 Identities = 53/184 (28%), Positives = 87/184 (47%), Gaps = 31/184 (16%)

Query: 293 NFDESRIIGRGGFGNVYFG--LLGDREAAIKKMRSNKSKEFFA---ELKVL--CKIHHIN 345
           +F+  + IG G +G+VY    +     AAIK ++    ++F     E+ ++  CK  +I 
Sbjct: 10  DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIV 69

Query: 346 VFISTF-------------GNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHD 392
            +  ++             G GSL D  H   + G  PL+ +    ++ +  +G+ Y+H 
Sbjct: 70  AYFGSYLRRDKLWICMEFCGGGSLQDIYH---VTG--PLSESQIAYVSRETLQGLYYLHS 124

Query: 393 HTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYI 452
             K   +HRDIK +NILL D    K+ADFG+      T  K       +GTP ++ PE  
Sbjct: 125 KGK---MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKR---KSFIGTPYWMAPEVA 178

Query: 453 FVKR 456
            V+R
Sbjct: 179 AVER 182

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 57.7 bits (139), Expect = 4e-09
 Identities = 54/214 (25%), Positives = 96/214 (44%), Gaps = 43/214 (20%)

Query: 316 REAAIKKM--RSNKSKEF-FAELKVLCKIHHINVFISTFGNGSLSDHLHDPL--LKG--- 367
           ++ A+KKM  R  + +E  F E+ ++   HH NV +  + +  + D L   +  L+G   
Sbjct: 48  KQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENV-VDMYNSYLVGDELWVVMEFLEGGAL 106

Query: 368 -----HQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFG 422
                H  +       + L   + + Y+H+      +HRDIK+ +ILL    R K++DFG
Sbjct: 107 TDIVTHTRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFG 163

Query: 423 LVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVV 482
                 +   K      LVGTP ++ PE I               L   T+ D+++ G++
Sbjct: 164 FCAQVSKEVPKR---KSLVGTPYWMAPEVI-------------SRLPYGTEVDIWSLGIM 207

Query: 483 LAELITGK---------RALIR-DDSEPTKMKSL 506
           + E+I G+         +A+ R  D+ P ++K  
Sbjct: 208 VIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDS 241

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 57.8 bits (140), Expect = 4e-09
 Identities = 65/249 (26%), Positives = 106/249 (42%), Gaps = 55/249 (22%)

Query: 292 NNFDESRIIGRGGFGNVYFG--LLGDREAAIKKMRSNKSKEFFA-----ELKVLCKIHHI 344
           + +++   IG+G FG V+        +  A+KK+     KE F      E+K+L  + H 
Sbjct: 12  SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHE 71

Query: 345 NVF--------ISTFGNGSLSD-HL------HDPLLKGHQPLTWTARTQIALDAAK---- 385
           NV          +T  N      +L      HD  L G   L      +  L   K    
Sbjct: 72  NVVNLIEICRTKATPYNRYKGSFYLVFEFCEHD--LAG---LLSNKNVKFTLSEIKKVMK 126

Query: 386 ----GIEYIHDHTKARYVHRDIKTSNILLD-DGLRAKVADFGLVK-LEERTNEKEMLATR 439
               G+ YIH   + + +HRD+K +NIL+  DG+  K+ADFGL +      N K    T 
Sbjct: 127 MLLNGLYYIH---RNKILHRDMKAANILITKDGI-LKLADFGLARAFSLSKNSKPNRYTN 182

Query: 440 LVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE 499
            V T  Y PPE +  +R                  D++  G ++AE+ T +  +++ ++E
Sbjct: 183 RVVTLWYRPPELLLGER------------DYGPPIDMWGAGCIMAEMWT-RSPIMQGNTE 229

Query: 500 PTKMKSLIT 508
             ++  LI+
Sbjct: 230 QHQLT-LIS 237

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 57.3 bits (138), Expect = 5e-09
 Identities = 62/243 (25%), Positives = 98/243 (40%), Gaps = 78/243 (32%)

Query: 298 RIIGRGGFGNVY----FGLLGDRE---AAIKKMRS---NKSKEFFAELKVLCKIHHINV- 346
           R +G G FG V+    + L   ++    A+K ++       K+F  E ++L  + H ++ 
Sbjct: 11  RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 70

Query: 347 -FISTFGNGSLSDHLHDPL---------------LKGHQP----------------LTWT 374
            F    G+G       DPL               L+ H P                L  +
Sbjct: 71  KFYGVCGDG-------DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLS 123

Query: 375 ARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK-----LEER 429
               IA   A G+ Y+       +VHRD+ T N L+   L  K+ DFG+ +        R
Sbjct: 124 QMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYR 180

Query: 430 TNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT- 488
                ML  R      ++PPE I  ++F             TT++DV++FGV+L E+ T 
Sbjct: 181 VGGHTMLPIR------WMPPESIMYRKF-------------TTESDVWSFGVILWEIFTY 221

Query: 489 GKR 491
           GK+
Sbjct: 222 GKQ 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 56.9 bits (137), Expect = 6e-09
 Identities = 59/227 (25%), Positives = 101/227 (44%), Gaps = 49/227 (21%)

Query: 294 FDESRIIGRGGFGNVYFGLLGD-----REAAIKKMR-----SNKSKEFFAELKVLCKIHH 343
           F   R++G+G FG+V    L       ++ A+K ++     S+  +EF  E   + +  H
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60

Query: 344 ------INVFISTFGNGSLS---------DH--LHDPLLK---GHQPLTWTART--QIAL 381
                 I V + +   G L           H  LH  LL    G +P T   +T  +  +
Sbjct: 61  PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120

Query: 382 DAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLV 441
           D A G+EY+   +   ++HRD+   N +L++ +   VADFGL K     +          
Sbjct: 121 DIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQ------ 171

Query: 442 GTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
           G    LP +++ ++        S+ +   TT +DV+AFGV + E++T
Sbjct: 172 GCASKLPVKWLALE--------SLADNVYTTHSDVWAFGVTMWEIMT 210

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 56.8 bits (137), Expect = 7e-09
 Identities = 57/220 (25%), Positives = 97/220 (44%), Gaps = 45/220 (20%)

Query: 299 IIGRGGFGNVYFGL--LGDREAAIKKM-----------RSNKSKEFFA-ELKVLCKIHHI 344
           +IG G FG+VY G+        A+K++           R     +  A E+ +L ++ H 
Sbjct: 7   LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66

Query: 345 NVFISTFGNGSLSDHLH-----------DPLLKGHQPLTWTARTQIALDAAKGIEYIHDH 393
           N+ +   G+   +DHL+             LL  +     T          KG+ Y+H+ 
Sbjct: 67  NI-VQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNR 125

Query: 394 TKARYVHRDIKTSNILLDDGLRAKVADFGLV-KLEERTNEKEMLATR--LVGTPGYLPPE 450
                +HRDIK +NIL+D+    K++DFG+  KLE  +   +    R  L G+  ++ PE
Sbjct: 126 ---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPE 182

Query: 451 YIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
                         V +   T K D+++ G ++ E++TGK
Sbjct: 183 V-------------VKQTSYTRKADIWSLGCLVVEMLTGK 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 56.6 bits (136), Expect = 9e-09
 Identities = 53/196 (27%), Positives = 89/196 (45%), Gaps = 37/196 (18%)

Query: 284 LEEIEEATNNFDESRIIGRGGFGNVYFG--LLGDREAAIKKM--RSNKSKEFFAELKVLC 339
           L  + +    F+   ++G G +G VY G  +   + AAIK M    ++ +E   E+ +L 
Sbjct: 8   LSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLK 67

Query: 340 KI-HHINV--FISTF-------------------GNGSLSDHLHDPLLKGHQ-PLTWTAR 376
           K  HH N+  +   F                   G GS++D + +   KG+     W A 
Sbjct: 68  KYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNT--KGNALKEDWIA- 124

Query: 377 TQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEML 436
             I  +  +G+ ++H H   + +HRDIK  N+LL +    K+ DFG+    +RT  +   
Sbjct: 125 -YICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRR-- 178

Query: 437 ATRLVGTPGYLPPEYI 452
               +GTP ++ PE I
Sbjct: 179 -NTFIGTPYWMAPEVI 193

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 56.6 bits (137), Expect = 9e-09
 Identities = 61/216 (28%), Positives = 88/216 (40%), Gaps = 48/216 (22%)

Query: 300 IGRGGFGNVY---FGLLGDREAAIKKMRSNKSKE----FFAELKVLCKIH---HI----- 344
           IG G  G VY   F   G    A+K+MR   +KE       +L V+ K H   +I     
Sbjct: 23  IGSGTCGQVYKMRFKKTG-HVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYG 81

Query: 345 ------NVFISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARY 398
                 +VFI      +  D L   L +   P+      ++ +   K + Y+ +  K   
Sbjct: 82  YFITDSDVFICMELMSTCLDKL---LKRIQGPIPEDILGKMTVAIVKALHYLKE--KHGV 136

Query: 399 VHRDIKTSNILLDDGLRAKVADFG----LVKLEERTNEKEMLATRLVGTPGYLPPEYIFV 454
           +HRD+K SNILLD     K+ DFG    LV             TR  G   Y+ PE    
Sbjct: 137 IHRDVKPSNILLDASGNVKLCDFGISGRLV--------DSKAKTRSAGCAAYMAPE---- 184

Query: 455 KRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
              R D      +  +  + DV++ G+ L EL TG+
Sbjct: 185 ---RIDPPDPNPKYDI--RADVWSLGISLVELATGQ 215

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 56.2 bits (135), Expect = 9e-09
 Identities = 67/290 (23%), Positives = 112/290 (38%), Gaps = 67/290 (23%)

Query: 293 NFDESRIIGRGGFGNVYFG--LLGDREAAIKK------MRSNKSKEFFAELKVLCKIHHI 344
           NF   + IGRG F  VY    LL  +  A+KK      M +   ++   E+ +L +++H 
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62

Query: 345 NV--FISTF-------------GNGSLSDHLHDPLLKGHQPL-----TWTARTQIALDAA 384
           NV  ++ +F               G LS  +     K  + L      W    Q+     
Sbjct: 63  NVIKYLDSFIEDNELNIVLELADAGDLSQMIK--YFKKQKRLIPERTVWKYFVQLC---- 116

Query: 385 KGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP 444
             +E++H     R +HRDIK +N+ +      K+ D GL +     + K   A  LVGTP
Sbjct: 117 SAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRF---FSSKTTAAHSLVGTP 170

Query: 445 GYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRD-------- 496
            Y+ PE I    + F             K+D+++ G +L E+   +     D        
Sbjct: 171 YYMSPERIHENGYNF-------------KSDIWSLGCLLYEMAALQSPFYGDKMNLFSLC 217

Query: 497 ------DSEPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMI 540
                 D  P   +     +  +   C+  D   RP++  +  I  Q+ +
Sbjct: 218 QKIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMHV 267

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 56.7 bits (137), Expect = 9e-09
 Identities = 54/245 (22%), Positives = 104/245 (42%), Gaps = 58/245 (23%)

Query: 315 DREAAIKKM--RSNKSKEF-FAELKVLCKIHHINVFISTFGN----------------GS 355
            R+ A+KKM  R  + +E  F E+ ++    H N+ +  + +                G+
Sbjct: 44  GRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNI-VEMYSSYLVGDELWVVMEFLEGGA 102

Query: 356 LSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLR 415
           L+D      +  H  +       + L   K + ++H       +HRDIK+ +ILL    R
Sbjct: 103 LTD------IVTHTRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGR 153

Query: 416 AKVADFGLV-KLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKT 474
            K++DFG   ++ +    ++     LVGTP ++ PE I   R  +            T+ 
Sbjct: 154 VKLSDFGFCAQVSKEVPRRK----SLVGTPYWMAPEVI--SRLPYG-----------TEV 196

Query: 475 DVFAFGVVLAELITGKRALIRD----------DSEPTKMKSLITIMAAVAEWCLNEDAVD 524
           D+++ G+++ E++ G+     +          D+ P K+K+L  +   +  + L+   V 
Sbjct: 197 DIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSF-LDRMLVR 255

Query: 525 RPEMR 529
            P  R
Sbjct: 256 DPAQR 260

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 56.9 bits (138), Expect = 1e-08
 Identities = 72/295 (24%), Positives = 114/295 (38%), Gaps = 84/295 (28%)

Query: 292 NNFDESRIIGRGGFGNVYFGLLGDREA----AIKKMR------SNKSKEFFAELKVLCKI 341
           ++F+  ++IGRG FG V+  L+ D++     A+K +R       N+     AE  +L   
Sbjct: 1   DDFEVIKVIGRGAFGEVW--LVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADA 58

Query: 342 HH--INVFISTFGNGSLSDHLHDPLLKGHQP----LTW----------TARTQIA-LDAA 384
               I     +F +    +HL+  L+  + P    +            TAR  IA L  A
Sbjct: 59  DSPWIVKLYYSFQD---EEHLY--LVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLA 113

Query: 385 KGIEYIHDHTKARYVHRDIKTSNILLD-DGLRAKVADFGL-----------VKLEERTNE 432
             ++ +H   K  ++HRDIK  NIL+D DG   K+ADFGL             L +  N 
Sbjct: 114 --LDSVH---KLGFIHRDIKPDNILIDADG-HIKLADFGLCKKMNKAKDREYYLNDSHNL 167

Query: 433 KEMLATRL---------------VGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVF 477
                  +               VGTP Y+ PE +    +               + D +
Sbjct: 168 LFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPY-------------GLECDWW 214

Query: 478 AFGVVLAELITGKRALIRDDSEPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIV 532
           + GV+L E++ G      D  + T  K    I+          D    PE  D++
Sbjct: 215 SLGVILYEMLYGFPPFYSDTLQETYNK----IINWKESLRFPPDPPVSPEAIDLI 265

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 57.9 bits (140), Expect = 1e-08
 Identities = 60/245 (24%), Positives = 98/245 (40%), Gaps = 72/245 (29%)

Query: 294 FDESRIIGRGGFGNVYFG--LLGDREAAIKKMRSNKS------KEFFAELKVLCKIHHIN 345
           +D  R+IG+GG G VY     +  R  A+KK+R + S      K F  E K+   + H  
Sbjct: 4   YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPG 63

Query: 346 V------------------FISTFGNGSL------SDHLHDPLLKGHQPLTWTARTQIAL 381
           +                  +I  +   SL       + L   L    +  +  A   I  
Sbjct: 64  IVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKEL---AEKTSVGAFLSIFH 120

Query: 382 DAAKGIEYIHDHTKARYV-HRDIKTSNILLDDGLRAKVA--DFGLVKLEERTNEKEM--- 435
                IEY+H    ++ V HRD+K  NILL  GL  +V   D+G    ++   E  +   
Sbjct: 121 KICATIEYVH----SKGVLHRDLKPDNILL--GLFGEVVILDWGAAIFKKLEEEDLLDID 174

Query: 436 ------------LATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVL 483
                       +  ++VGTP Y+ PE              ++ +  +  TD++A GV+L
Sbjct: 175 VDERNICYSSMTIPGKIVGTPDYMAPE-------------RLLGVPASESTDIYALGVIL 221

Query: 484 AELIT 488
            +++T
Sbjct: 222 YQMLT 226

Length = 932

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 56.0 bits (135), Expect = 1e-08
 Identities = 64/237 (27%), Positives = 99/237 (41%), Gaps = 61/237 (25%)

Query: 293 NFDESRIIGRGGFGNVYFG--LLGDREAAIKKMRSNKSKE-----FFAELKVLCKIHHIN 345
           NF +   IG G +G VY     L     A+KK+R +   E        E+ +L +++H N
Sbjct: 1   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60

Query: 346 VFISTFGNGSLSDHLHD--------PLLKGHQPLT----WTARTQIALDAAK-------- 385
           +         L D +H           L  HQ L      +  + I L   K        
Sbjct: 61  IV-------KLLDVIHTENKLYLVFEFL--HQDLKKFMDASPLSGIPLPLIKSYLFQLLQ 111

Query: 386 GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK---LEERTNEKEMLATRLVG 442
           G+ + H H   R +HRD+K  N+L++     K+ADFGL +   +  RT   E      V 
Sbjct: 112 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHE------VV 162

Query: 443 TPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE 499
           T  Y  PE +   ++             +T  D+++ G + AE++T +RAL   DSE
Sbjct: 163 TLWYRAPEILLGCKY------------YSTAVDIWSLGCIFAEMVT-RRALFPGDSE 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 55.8 bits (134), Expect = 1e-08
 Identities = 55/222 (24%), Positives = 96/222 (43%), Gaps = 48/222 (21%)

Query: 298 RIIGRGGFGNVYFGLLGDREA----AIKKMR-----SNKSKEFFAELKVLCKIHHINV-- 346
           + +G G FG+V  G L   ++    A+K M+      ++ ++F +E   + +  H NV  
Sbjct: 5   KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMR 64

Query: 347 FISTFGNGSLSD---------------HLHDPLLK---GHQPLTWTARTQIAL--DAAKG 386
            I        S+                LH  LL    G  P     +  +    D A G
Sbjct: 65  LIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASG 124

Query: 387 IEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGY 446
           +EY+   +   ++HRD+   N +L++ +   VADFGL K  +  N       R+      
Sbjct: 125 MEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSK--KIYNGDYYRQGRI----AK 175

Query: 447 LPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
           +P ++I ++        S+ +   TTK+DV++FGV + E+ T
Sbjct: 176 MPVKWIAIE--------SLADRVYTTKSDVWSFGVTMWEIAT 209

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 55.7 bits (134), Expect = 2e-08
 Identities = 51/242 (21%), Positives = 102/242 (42%), Gaps = 74/242 (30%)

Query: 298 RIIGRGGFGNVY-------FGLLGDREAAIKKMRSNKS----KEFFAELKVLCKIHHINV 346
           + +G G FG V         G  G    A+K ++ N S    ++  +E  +L +++H +V
Sbjct: 6   KTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHV 65

Query: 347 --------------------------------------FISTFGNGSLSDHLHDPLLKGH 368
                                                 ++ + GN + S   +       
Sbjct: 66  IKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNP----DE 121

Query: 369 QPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK--L 426
           + LT       A   ++G++Y+    + + VHRD+   N+L+ +G + K++DFGL +   
Sbjct: 122 RALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVY 178

Query: 427 EERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAEL 486
           EE +  K         + G +P +++ ++        S+ +   TT++DV++FGV+L E+
Sbjct: 179 EEDSYVKR--------SKGRIPVKWMAIE--------SLFDHIYTTQSDVWSFGVLLWEI 222

Query: 487 IT 488
           +T
Sbjct: 223 VT 224

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 55.5 bits (134), Expect = 2e-08
 Identities = 47/224 (20%), Positives = 87/224 (38%), Gaps = 64/224 (28%)

Query: 303 GGFGNVYFGLLGD------REAAIKKMRSNKSKE----FFAELKVLCKIHHINVF----I 348
           G FG +++G+L D       E  +K ++ + S+        E  +L  + H N+     +
Sbjct: 17  GTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHV 76

Query: 349 STFGN------------GSLSDHLHDPLL---KGHQPLTWTARTQIALDAAKGIEYIHDH 393
                            G+L   L    L      Q L+      +A+  A G+ Y+H  
Sbjct: 77  CIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR 136

Query: 394 TKARYVHRDIKTSNILLDDGLRAKVADFGLVK---------LEERTNEKEMLATRLVGTP 444
                +H+DI   N ++D+ L+ K+ D  L +         L +  NE   +        
Sbjct: 137 ---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGD--NENRPVK------- 184

Query: 445 GYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
            ++  E +  K +             ++ +DV++FGV+L EL+T
Sbjct: 185 -WMALESLVNKEY-------------SSASDVWSFGVLLWELMT 214

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 56.0 bits (135), Expect = 2e-08
 Identities = 50/179 (27%), Positives = 80/179 (44%), Gaps = 26/179 (14%)

Query: 292 NNFDESRIIGRGGFGNVYFGLLGDREA----AIKKMR-----SNKSKEFFAELKVLCKIH 342
            +FD   ++GRG FG V   ++ ++      A+K M+     + ++  FF E + +  I 
Sbjct: 1   KDFDVKSLVGRGHFGEVQ--VVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSIS 58

Query: 343 HINVFISTFGNGSLSDHLHDPLLKGHQP----LTWTARTQIALDA-------AKGIEYIH 391
           +              D+L+  L+  +QP    L+   R +   D        A+ +  IH
Sbjct: 59  NSPWIPQLQYAFQDKDNLY--LVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIH 116

Query: 392 DHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPE 450
              +  YVHRDIK  N+L+D     K+ADFG       T  K + +   VGTP Y+ PE
Sbjct: 117 SVHQMGYVHRDIKPENVLIDRTGHIKLADFG--SAARLTANKMVNSKLPVGTPDYIAPE 173

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 56.0 bits (135), Expect = 2e-08
 Identities = 62/273 (22%), Positives = 109/273 (39%), Gaps = 42/273 (15%)

Query: 233 RKRPEEKITEDAKHVSKAMSITTRAFSSQGQCKENTEDVTVLESERTIIFSLEEIEEATN 292
           R+RP+  +    +  S A+ +     SS      ++       S    +  LE +     
Sbjct: 25  RRRPDLTLPLPQRDPSLAVPLPLPPPSSSSSSSSSSSASGSAPSAAKSLSELERV----- 79

Query: 293 NFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNKS----KEFFAELKVLCKIHHINV 346
                  IG G  G VY  +     R  A+K +  N      ++   E+++L  ++H NV
Sbjct: 80  -----NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNV 134

Query: 347 FISTFG----NGSLS---DHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYV 399
            +        NG +    + +    L+G           +A     GI Y+H   +   V
Sbjct: 135 -VKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVARQILSGIAYLH---RRHIV 190

Query: 400 HRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIF--VKRF 457
           HRDIK SN+L++     K+ADFG+ ++  +T +        VGT  Y+ PE I   +   
Sbjct: 191 HRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP---CNSSVGTIAYMSPERINTDLNHG 247

Query: 458 RFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
            +D ++           D+++ GV + E   G+
Sbjct: 248 AYDGYAG----------DIWSLGVSILEFYLGR 270

Length = 353

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 55.2 bits (133), Expect = 2e-08
 Identities = 53/215 (24%), Positives = 89/215 (41%), Gaps = 52/215 (24%)

Query: 298 RIIGRGGFGNVYFGLLGDR-EAAIKKMRSNKSKE--FFAELKVLCKIHH----------- 343
           + +G G FG V+ G    + + AIK +      E  F  E KV+ K+ H           
Sbjct: 10  KELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCT 69

Query: 344 ----INVFISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYV 399
               + +      NG L ++L     +G   L+      +  D  +G+EY+    +  ++
Sbjct: 70  QQKPLYIVTEFMENGCLLNYLRQR--QGK--LSKDMLLSMCQDVCEGMEYLE---RNSFI 122

Query: 400 HRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPG------YLPPEYIF 453
           HRD+   N L+      KV+DFG+ +         +L      + G      + PPE   
Sbjct: 123 HRDLAARNCLVSSTGVVKVSDFGMTRY--------VLDDEYTSSSGAKFPVKWSPPEV-- 172

Query: 454 VKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
              F F  +SS        K+DV++FGV++ E+ T
Sbjct: 173 ---FNFSKYSS--------KSDVWSFGVLMWEVFT 196

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 55.7 bits (134), Expect = 2e-08
 Identities = 57/226 (25%), Positives = 92/226 (40%), Gaps = 48/226 (21%)

Query: 298 RIIGRGGFGNVYFG-LLGDRE----AAIKK------------MRSNKSKEFFAELKVLCK 340
           +++G+G FG V    L G  E     A+KK            M   +      E   L  
Sbjct: 1   KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60

Query: 341 IH-------HINVFISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDH 393
           ++       H+   +     G L  H+ D   KG   L     T  A +   G++++H  
Sbjct: 61  LYCTFQTKEHLFFVMEFLNGGDLMFHIQD---KGRFDLYRA--TFYAAEIVCGLQFLHSK 115

Query: 394 TKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIF 453
                ++RD+K  N++LD     K+ADFG+ K E    +    A+   GTP Y+ PE + 
Sbjct: 116 G---IIYRDLKLDNVMLDRDGHIKIADFGMCK-ENVFGDNR--ASTFCGTPDYIAPEIL- 168

Query: 454 VKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE 499
                         L+ T   D ++FGV+L E++ G+     DD +
Sbjct: 169 ------------QGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED 202

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 55.6 bits (134), Expect = 2e-08
 Identities = 61/233 (26%), Positives = 96/233 (41%), Gaps = 56/233 (24%)

Query: 292 NNFDESRIIGRGGFGNVYFGLLGDREA----AIKKMRS------NKSKEFFAELKVLCKI 341
            +F+  ++I  G +G VY  L+  +E     A+KK+        N+ ++ F E  +L   
Sbjct: 1   EDFETIKLISNGAYGAVY--LVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFA 58

Query: 342 HHINVFI-STFGNGSLSDHLH-----------DPLLKGHQPL-TWTARTQIALDAAKGIE 388
              N F+ S F +     HL              LLK    L    AR   A +    +E
Sbjct: 59  E--NPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFA-ETVLALE 115

Query: 389 YIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK---LEERTN---------EKEML 436
           Y+H++     VHRD+K  N+L+      K+ DFGL K   +   TN          +E L
Sbjct: 116 YLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFL 172

Query: 437 ATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
             ++ GTP Y+ PE I  + +                 D +A G++L E + G
Sbjct: 173 DKQVCGTPEYIAPEVILRQGY-------------GKPVDWWAMGIILYEFLVG 212

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 55.4 bits (134), Expect = 3e-08
 Identities = 32/106 (30%), Positives = 54/106 (50%), Gaps = 15/106 (14%)

Query: 385 KGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP 444
           +G++YIH    A  +HRD+K SN+LL+     K+ DFGL ++ +  ++     T  V T 
Sbjct: 117 RGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATR 173

Query: 445 GYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
            Y  PE          M +S      T   D+++ G +LAE+++ +
Sbjct: 174 WYRAPEI---------MLNSK---GYTKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 55.5 bits (134), Expect = 3e-08
 Identities = 36/114 (31%), Positives = 56/114 (49%), Gaps = 19/114 (16%)

Query: 386 GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPG 445
           G++Y+H++   + V+RD+K  N+LLD     K+ADFGL K  E     +  +T   GTP 
Sbjct: 113 GLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCK--EGMGFGDRTST-FCGTPE 166

Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE 499
           +L PE              + E   T   D +  GV++ E++ G+     DD E
Sbjct: 167 FLAPEV-------------LTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE 207

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 55.1 bits (133), Expect = 3e-08
 Identities = 57/214 (26%), Positives = 88/214 (41%), Gaps = 41/214 (19%)

Query: 300 IGRGGFGNVYFGLL--GDREAAIKKMRSN----KSKEFFAELKVLCK----IHHINVFIS 349
           IGRG FG V   L        A+K++RS     + K    +L V+ +     + +  + +
Sbjct: 12  IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71

Query: 350 TFGNG------SLSDHLHDPLLK---GHQPLTWTART--QIALDAAKGIEYIHDHTKARY 398
            F  G       L D   D   K                +IA+   K + Y+    + + 
Sbjct: 72  LFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLK--EELKI 129

Query: 399 VHRDIKTSNILLDDGLRAKVADFGLV-KLEERTNEKEMLATRLVGTPGYLPPEYIFVKRF 457
           +HRD+K SNILLD     K+ DFG+  +L +      +  TR  G   Y+ PE I     
Sbjct: 130 IHRDVKPSNILLDRNGNIKLCDFGISGQLVD-----SIAKTRDAGCRPYMAPERIDPSAR 184

Query: 458 R-FDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
             +D+ S           DV++ G+ L E+ TGK
Sbjct: 185 DGYDVRS-----------DVWSLGITLYEVATGK 207

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 54.6 bits (132), Expect = 3e-08
 Identities = 55/224 (24%), Positives = 85/224 (37%), Gaps = 69/224 (30%)

Query: 300 IGRGGFGNVYFGLLGDREAAIKKMRSNKSKEFFA------------------ELKVLCKI 341
           +G G  G V             K+    + +  A                  EL +L K 
Sbjct: 9   LGAGNSGVVS------------KVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKC 56

Query: 342 HHINV--FISTF-------------GNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKG 386
           +   +  F   F               GSL   L    ++G  P     +  IA+   KG
Sbjct: 57  NSPYIVGFYGAFYNNGDISICMEYMDGGSLDKIL--KEVQGRIPERILGK--IAVAVLKG 112

Query: 387 IEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGY 446
           + Y+H+  K   +HRD+K SNIL++   + K+ DFG+    +  N    LA   VGT  Y
Sbjct: 113 LTYLHEKHKI--IHRDVKPSNILVNSRGQIKLCDFGVSG--QLVNS---LAKTFVGTSSY 165

Query: 447 LPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
           + PE I                  + K+D+++ G+ L EL TG+
Sbjct: 166 MAPERI-------------QGNDYSVKSDIWSLGLSLIELATGR 196

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 55.0 bits (132), Expect = 3e-08
 Identities = 59/244 (24%), Positives = 101/244 (41%), Gaps = 50/244 (20%)

Query: 300 IGRGGFGNVYFGL---LGDREAAIKKMRSNKSKEFF--------AELKVLCKIHHINVFI 348
           IG G +G V+       G R  A+K++R    +E          A L+ L    H NV +
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV-V 67

Query: 349 STFGNGSLS------------DHLHDPLL----KGHQPLTWTARTQ-IALDAAKGIEYIH 391
             F   ++S            +H+   L     K  +P   T   + +     +G++++H
Sbjct: 68  RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 127

Query: 392 DHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEY 451
            H   R VHRD+K  NIL+    + K+ADFGL     R    +M  T +V T  Y  PE 
Sbjct: 128 SH---RVVHRDLKPQNILVTSSGQIKLADFGLA----RIYSFQMALTSVVVTLWYRAPEV 180

Query: 452 IFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKMKSLITIMA 511
           +    +              T  D+++ G + AE+   ++ L R  S+  ++  ++ ++ 
Sbjct: 181 LLQSSY-------------ATPVDLWSVGCIFAEMFR-RKPLFRGSSDVDQLGKILDVIG 226

Query: 512 AVAE 515
              E
Sbjct: 227 LPGE 230

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 55.2 bits (133), Expect = 3e-08
 Identities = 33/114 (28%), Positives = 59/114 (51%), Gaps = 19/114 (16%)

Query: 386 GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPG 445
           G++++H   K   ++RD+K  N+LLD     K+ADFG+ K E    E +  A+   GTP 
Sbjct: 108 GLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCK-ENMNGEGK--ASTFCGTPD 161

Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE 499
           Y+ PE +  +++   +             D ++FGV+L E++ G+     +D +
Sbjct: 162 YIAPEILKGQKYNESV-------------DWWSFGVLLYEMLIGQSPFHGEDED 202

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 54.7 bits (132), Expect = 3e-08
 Identities = 67/296 (22%), Positives = 109/296 (36%), Gaps = 89/296 (30%)

Query: 297 SRIIGRGGFGNVYFGLLGDRE-----AAIKKMRSN----KSKEFFAELKVLCKIHHINVF 347
            R IG G FG+VY G+    E      A+K  ++       ++F  E  ++ +  H ++ 
Sbjct: 11  GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70

Query: 348 ----------------ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIH 391
                           ++  G       L   L      L   +    +   +  + Y+ 
Sbjct: 71  KLIGVITENPVWIVMELAPLG------ELRSYLQVNKYSLDLASLILYSYQLSTALAYLE 124

Query: 392 DHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK-LEERTNEKEMLATRLVGTPGYLP-- 448
                R+VHRDI   N+L+      K+ DFGL + LE+ +  K   A++     G LP  
Sbjct: 125 ---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYK---ASK-----GKLPIK 173

Query: 449 ---PEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT----------------- 488
              PE I  +RF             T+ +DV+ FGV + E++                  
Sbjct: 174 WMAPESINFRRF-------------TSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGR 220

Query: 489 ---GKRALIRDDSEPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMIT 541
              G+R L    + P  + SL+T   A        D   RP   ++ A LS I+  
Sbjct: 221 IENGER-LPMPPNCPPTLYSLMTKCWAY-------DPSKRPRFTELKAQLSDILQE 268

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 55.4 bits (133), Expect = 3e-08
 Identities = 58/212 (27%), Positives = 92/212 (43%), Gaps = 42/212 (19%)

Query: 300 IGRGGFGNV--YFGLLGDREAAIKKM-RSNKS----KEFFAELKVLCKIHHINV--FIST 350
           +G G +G+V   F        A+KK+ R  +S    K  + EL++L  + H NV   +  
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84

Query: 351 FGNGSLSDHLHDPLLKGH------------QPLTWTARTQIALDAAKGIEYIHDHTKARY 398
           F      +  +D  L  H            Q LT      +     +G++YIH    A  
Sbjct: 85  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADI 141

Query: 399 VHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFR 458
           +HRD+K SN+ +++    K+ DFGL     R  + EM  T  V T  Y  PE +      
Sbjct: 142 IHRDLKPSNLAVNEDCELKILDFGLA----RHTDDEM--TGYVATRWYRAPEIML----- 190

Query: 459 FDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
                + M    T   D+++ G ++AEL+TG+
Sbjct: 191 -----NWMHYNQT--VDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 55.1 bits (132), Expect = 3e-08
 Identities = 57/241 (23%), Positives = 105/241 (43%), Gaps = 49/241 (20%)

Query: 270 DVTVLESERTIIFSLEEIEEATNNFDESRIIGRGGFGNVYFGL--LGDREAAIKKM---- 323
           D  +LE  R+I+ S+ + ++    F++   IG+G  G VY  +     +E AIK+M    
Sbjct: 1   DEEILEKLRSIV-SVGDPKKKYTRFEK---IGQGASGTVYTAIDIATGQEVAIKQMNLQQ 56

Query: 324 --------------RSNKSKEFFAELKVLCKIHHINVFISTFGNGSLSDHLHDPLLKGHQ 369
                         R NK+      L        + V +     GSL+D + +  +   Q
Sbjct: 57  QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQ 116

Query: 370 PLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEER 429
                    +  +  + ++++H +   + +HRDIK+ NILL      K+ DFG     + 
Sbjct: 117 I------AAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCA--QI 165

Query: 430 TNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
           T E+   +T +VGTP ++ PE +  K +               K D+++ G++  E++ G
Sbjct: 166 TPEQSKRST-MVGTPYWMAPEVVTRKAY-------------GPKVDIWSLGIMAIEMVEG 211

Query: 490 K 490
           +
Sbjct: 212 E 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 54.7 bits (131), Expect = 3e-08
 Identities = 57/243 (23%), Positives = 102/243 (41%), Gaps = 53/243 (21%)

Query: 270 DVTVLESERTIIFSLEEIEEATNNFDESRIIGRGGFGNVYFGL--LGDREAAIKKM---- 323
           D  +LE  R+I+ S+ + ++    F++   IG+G  G VY  +     +E AI++M    
Sbjct: 2   DEEILEKLRSIV-SVGDPKKKYTRFEK---IGQGASGTVYTAMDVATGQEVAIRQMNLQQ 57

Query: 324 --------------RSNKSKEFFAELKVLCKIHHINVFISTFGNGSLSDHLHDPLLKGHQ 369
                         R NK+      L        + V +     GSL+D + +  +   Q
Sbjct: 58  QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQ 117

Query: 370 PLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK--LE 427
                    +  +  + +E++H +   + +HRDIK+ NILL      K+ DFG       
Sbjct: 118 I------AAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168

Query: 428 ERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELI 487
           E++    M     VGTP ++ PE +  K +               K D+++ G++  E+I
Sbjct: 169 EQSKRSTM-----VGTPYWMAPEVVTRKAY-------------GPKVDIWSLGIMAIEMI 210

Query: 488 TGK 490
            G+
Sbjct: 211 EGE 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 54.6 bits (132), Expect = 3e-08
 Identities = 65/230 (28%), Positives = 93/230 (40%), Gaps = 61/230 (26%)

Query: 300 IGRGGFGNVYFG--LLGDREAAIKKMRSNKSKE-----FFAELKVLCKIHHINVFISTFG 352
           IG G +G VY     L     A+KK+R     E        E+ +L +++H N+      
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIV----- 61

Query: 353 NGSLSDHLH------------DPLLKGHQ---PLTWTARTQIA---LDAAKGIEYIHDHT 394
              L D +H            D  LK +    PLT      I        +GI Y H H 
Sbjct: 62  --RLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH- 118

Query: 395 KARYVHRDIKTSNILLDDGLRAKVADFGL-----VKLEERTNEKEMLATRLVGTPGYLPP 449
             R +HRD+K  N+L+D     K+ADFGL     V +   T+E        V T  Y  P
Sbjct: 119 --RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHE--------VVTLWYRAP 168

Query: 450 EYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE 499
           E +   R            Q +T  D+++ G + AE++  +R L   DSE
Sbjct: 169 EILLGSR------------QYSTPVDIWSIGCIFAEMVN-RRPLFPGDSE 205

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 54.5 bits (131), Expect = 4e-08
 Identities = 60/230 (26%), Positives = 94/230 (40%), Gaps = 48/230 (20%)

Query: 286 EIEEATNNFDESRIIGRGGFGNVYFG--LLGDREAAIKKMRSNKSKE---FFAELKVLCK 340
           E E   +   E  ++G+G +G VY    L      AIK++    S+       E+ +   
Sbjct: 2   EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSY 61

Query: 341 IHHINV---------------FISTFGNGSLSDHLHD---PLLKGHQPLTWTARTQIALD 382
           + H N+               F+     GSLS  L     PL    Q + +  + QI   
Sbjct: 62  LKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTK-QIL-- 118

Query: 383 AAKGIEYIHDHTKARYVHRDIKTSNILLD--DGLRAKVADFGLVKLEERTNEKEMLATRL 440
             +G++Y+HD+   + VHRDIK  N+L++   G+  K++DFG  K     N         
Sbjct: 119 --EGLKYLHDN---QIVHRDIKGDNVLVNTYSGV-VKISDFGTSKRLAGINP---CTETF 169

Query: 441 VGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
            GT  Y+ PE I  K  R                D+++ G  + E+ TGK
Sbjct: 170 TGTLQYMAPEVI-DKGPR----------GYGAPADIWSLGCTIVEMATGK 208

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 54.6 bits (132), Expect = 4e-08
 Identities = 39/136 (28%), Positives = 53/136 (38%), Gaps = 41/136 (30%)

Query: 385 KGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK-LEERTNEK--EMLATR-- 439
           + I Y H H     +HRDIK  NIL+ +    K+ DFG  + L  R      + +ATR  
Sbjct: 111 QAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWY 167

Query: 440 -----LVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALI 494
                LVG   Y  P                         DV+A G ++AEL+ G   L 
Sbjct: 168 RAPELLVGDTNYGKP------------------------VDVWAIGCIMAELLDG-EPLF 202

Query: 495 RDDSEPTKMKSLITIM 510
             DS+   +  L  I 
Sbjct: 203 PGDSD---IDQLYLIQ 215

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 54.4 bits (131), Expect = 4e-08
 Identities = 44/178 (24%), Positives = 68/178 (38%), Gaps = 43/178 (24%)

Query: 378 QIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLA 437
           +IA    KG+ Y+H     + +HRDIK SNILL    + K+ DFG+    E  N    LA
Sbjct: 109 KIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSG--ELVNS---LA 160

Query: 438 TRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDD 497
               GT  Y+ PE I  K +             +  +DV++ G+ L E+   +     + 
Sbjct: 161 GTFTGTSFYMAPERIQGKPY-------------SITSDVWSLGLTLLEVAQNRFPFPPEG 207

Query: 498 SEPTKMKSLITI----------------------MAAVAEWCLNEDAVDRPEMRDIVA 533
             P     L++                            + CL +D   RP   D++ 
Sbjct: 208 EPPLGPIELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 54.4 bits (131), Expect = 4e-08
 Identities = 56/223 (25%), Positives = 96/223 (43%), Gaps = 49/223 (21%)

Query: 298 RIIGRGGFGNVYFGLLGDREA-----AIKKMR-----SNKSKEFFAELKVLCKIHHINV- 346
           +I+G G FG+V  G L   +      A+K M+      ++ +EF +E   +    H NV 
Sbjct: 5   KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVM 64

Query: 347 ------FISTFGNGSLS----------DHLHDPLLK---GHQPLTWTART--QIALDAAK 385
                 F ++                   LH  LL    G  P     +T  +  +D A 
Sbjct: 65  KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIAL 124

Query: 386 GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPG 445
           G+EY+   +   ++HRD+   N +L + +   VADFGL K  +  +       R+     
Sbjct: 125 GMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSK--KIYSGDYYRQGRI----A 175

Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
            +P ++I ++        S+ +   T+K+DV+AFGV + E+ T
Sbjct: 176 KMPVKWIAIE--------SLADRVYTSKSDVWAFGVTMWEIAT 210

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 54.3 bits (130), Expect = 4e-08
 Identities = 51/182 (28%), Positives = 80/182 (43%), Gaps = 41/182 (22%)

Query: 300 IGRGGFGNVYFG--LLGDREAAIKKMRSNKSKEF-FAELKVL----CKIHHINVFISTF- 351
           +G G +G+VY    L     AA+K ++     +F   + ++     CK  +I  +  ++ 
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76

Query: 352 ------------GNGSLSD--HLHDPLLKGHQPLTWTARTQIAL---DAAKGIEYIHDHT 394
                       G GSL D  H+  PL          +  QIA    +  +G+ Y+H   
Sbjct: 77  SREKLWICMEYCGGGSLQDIYHVTGPL----------SELQIAYVCRETLQGLAYLHSKG 126

Query: 395 KARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFV 454
           K   +HRDIK +NILL D    K+ADFG+      T  K       +GTP ++ PE   V
Sbjct: 127 K---MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKR---KSFIGTPYWMAPEVAAV 180

Query: 455 KR 456
           ++
Sbjct: 181 EK 182

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 54.1 bits (130), Expect = 5e-08
 Identities = 63/244 (25%), Positives = 109/244 (44%), Gaps = 55/244 (22%)

Query: 270 DVTVLESERTIIFSLEEIEEATNNFDESRIIGRGGFGNVYFGL--LGDREAAIKKM---R 324
           D  +LE  RTI+ S+ + ++    F++   IG+G  G VY  +     +E AIK+M   +
Sbjct: 1   DEEILEKLRTIV-SVGDPKKKYTRFEK---IGQGASGTVYTAIDVATGQEVAIKQMNLQQ 56

Query: 325 SNKSKEFFAELKVLCKIHHIN---------------VFISTFGNGSLSDHLHDPLLKGHQ 369
             K +    E+ V+ +  H N               V +     GSL+D + +       
Sbjct: 57  QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE------- 109

Query: 370 PLTWTARTQIAL---DAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKL 426
             T     QIA    +  + +E++H +   + +HRDIK+ NILL      K+ DFG    
Sbjct: 110 --TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCA- 163

Query: 427 EERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAEL 486
            + T E+   +T +VGTP ++ PE +  K                 K D+++ G++  E+
Sbjct: 164 -QITPEQSKRST-MVGTPYWMAPEVVTRK-------------AYGPKVDIWSLGIMAIEM 208

Query: 487 ITGK 490
           + G+
Sbjct: 209 VEGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 53.9 bits (129), Expect = 6e-08
 Identities = 59/232 (25%), Positives = 96/232 (41%), Gaps = 48/232 (20%)

Query: 288 EEATNNFDESRIIGRGGFGNVYFGLLG-------DREAAIKKMRSNKSK----EFFAELK 336
           E A      SR +G+G FG VY G+         +   AIK +    S     EF  E  
Sbjct: 2   EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 61

Query: 337 VLCKI--HHIN-------------VFISTFGNGSLSDHLHD--PLLKGH---QPLTWTAR 376
           V+ +   HH+              V +     G L  +L    P ++ +    P +    
Sbjct: 62  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKM 121

Query: 377 TQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEML 436
            Q+A + A G+ Y++ +   ++VHRD+   N ++ +    K+ DFG+ +    T+     
Sbjct: 122 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK- 177

Query: 437 ATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
                G  G LP         R+    S+ +   TT +DV++FGVVL E+ T
Sbjct: 178 -----GGKGLLP--------VRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 54.0 bits (130), Expect = 6e-08
 Identities = 55/241 (22%), Positives = 94/241 (39%), Gaps = 81/241 (33%)

Query: 299 IIGRGGFGNV----YFGLLGDREA---AIKKMRSNKS----KEFFAELKVLCKI-HHINV 346
            +G G FG V      GL    E    A+K ++ + +     +  +E++++  I  H N+
Sbjct: 19  PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78

Query: 347 FISTFG----------------NGSLSDHLH-----------DPLLKGHQPLTWTARTQI 379
            I+  G                +G+L D L            D      + LT       
Sbjct: 79  -INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSF 137

Query: 380 ALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK-------LEERTNE 432
           A   A+G+E++      + +HRD+   N+L+ +    K+ADFGL +         + TN 
Sbjct: 138 AYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTN- 193

Query: 433 KEMLATRLVGTPGYLP-----PEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELI 487
                       G LP     PE +F + +             T ++DV++FGV+L E+ 
Sbjct: 194 ------------GRLPVKWMAPEALFDRVY-------------THQSDVWSFGVLLWEIF 228

Query: 488 T 488
           T
Sbjct: 229 T 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 54.0 bits (130), Expect = 6e-08
 Identities = 47/157 (29%), Positives = 74/157 (47%), Gaps = 42/157 (26%)

Query: 387 IEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGY 446
           ++YIH   K   +HRDIK +NIL+ +    K+ DFG+  L  + + K    +  VGTP +
Sbjct: 114 LKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKR---STFVGTPYW 167

Query: 447 LPPEYIFVKRFRFDMHSSVMELQV-TTKTDVFAFGVVLAELITGK---------RA--LI 494
           + PE I              E +   TK D+++ G+ + E+ TG          RA  LI
Sbjct: 168 MAPEVI-------------TEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLI 214

Query: 495 RDDSEPTKM------KSLITIMAAVAEWCLNEDAVDR 525
              S+P ++      K L   +AA    CL+E+  +R
Sbjct: 215 -PKSKPPRLEDNGYSKLLREFVAA----CLDEEPKER 246

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 54.0 bits (130), Expect = 6e-08
 Identities = 56/227 (24%), Positives = 93/227 (40%), Gaps = 53/227 (23%)

Query: 292 NNFDESRIIGRGGFGNVY----FGLLGDREAAIK---KM-----RSNKSKEFFAELKVLC 339
           NN    + +G G FG V     +GL    +A +K   KM      S++ +   +ELK++ 
Sbjct: 35  NNLSFGKTLGAGAFGKVVEATAYGL-SKSDAVMKVAVKMLKPTAHSSEREALMSELKIMS 93

Query: 340 KI-HHINVF----ISTFGN-----------GSLSDHLHDPLLKGHQPLTWTARTQIALDA 383
            + +H N+       T G            G L + L     K    LT       +   
Sbjct: 94  HLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRR---KRESFLTLEDLLSFSYQV 150

Query: 384 AKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK-LEERTNEKEMLATRLVG 442
           AKG+ ++        +HRD+   N+LL  G   K+ DFGL + +   +N       RL  
Sbjct: 151 AKGMAFL---ASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARL-- 205

Query: 443 TP-GYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
            P  ++ PE IF                 T ++DV+++G++L E+ +
Sbjct: 206 -PVKWMAPESIF-------------NCVYTFESDVWSYGILLWEIFS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 55.2 bits (133), Expect = 7e-08
 Identities = 31/102 (30%), Positives = 49/102 (48%), Gaps = 20/102 (19%)

Query: 399 VHRDIKTSNILL---DDGLRAKVADFGLVKL----EERTNEKEMLATRLVGTPGYLPPEY 451
           VHRD+K  NI++        AKV DFG+  L     +         T ++GTP Y  PE 
Sbjct: 101 VHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPE- 159

Query: 452 IFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRAL 493
               + R +         VT  +D++A+G++  E +TG+R +
Sbjct: 160 ----QLRGE--------PVTPNSDLYAWGLIFLECLTGQRVV 189

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 53.7 bits (129), Expect = 7e-08
 Identities = 62/222 (27%), Positives = 97/222 (43%), Gaps = 50/222 (22%)

Query: 294 FDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNKSK----EFFA--ELKVLCKIHHIN 345
           F   R++G+GGFG V    +    +  A KK+   + K    E  A  E ++L K++   
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61

Query: 346 V--------------FISTFGNG-SLSDHLHDPLLKGHQPLTWTARTQI-ALDAAKGIEY 389
           V               + T  NG  L  H+++    G        R    A +   G+E 
Sbjct: 62  VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFD----EERAVFYAAEITCGLED 117

Query: 390 IHDHTKARYVHRDIKTSNILLDDGLRAKVADFGL-VKLEERTNEKEMLATRLVGTPGYLP 448
           +H   + R V+RD+K  NILLDD    +++D GL V++     E E +  R VGT GY+ 
Sbjct: 118 LH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIP----EGETIRGR-VGTVGYMA 169

Query: 449 PEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
           PE +  +R+ F               D +  G ++ E+I GK
Sbjct: 170 PEVVKNERYTF-------------SPDWWGLGCLIYEMIEGK 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 53.5 bits (128), Expect = 8e-08
 Identities = 64/278 (23%), Positives = 103/278 (37%), Gaps = 67/278 (24%)

Query: 293 NFDESRIIGRGGFGNVYFG--LLGDREAAIKK------MRSNKSKEFFAELKVLCKIHH- 343
           NF   + IGRG F  VY    LL     A+KK      M +    +   E+ +L +++H 
Sbjct: 3   NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62

Query: 344 --------------INVFISTFGNGSLSDHLHDPLLKGHQPL-----TWTARTQIALDAA 384
                         +N+ +     G LS  +     K  + L      W    Q+     
Sbjct: 63  NVIKYYASFIEDNELNIVLELADAGDLSRMIKH--FKKQKRLIPEKTVWKYFVQLC---- 116

Query: 385 KGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP 444
             +E++H     R +HRDIK +N+ +      K+ D GL +     + K   A  LVGTP
Sbjct: 117 SALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRF---FSSKTTAAHSLVGTP 170

Query: 445 GYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRD-------- 496
            Y+ PE I    + F             K+D+++ G +L E+   +     D        
Sbjct: 171 YYMSPERIHENGYNF-------------KSDIWSLGCLLYEMAALQSPFYGDKMNLYSLC 217

Query: 497 ------DSEPTKMKSLITIMAAVAEWCLNEDAVDRPEM 528
                 D  P         +  +   C+N D   RP++
Sbjct: 218 KKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDI 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 53.9 bits (130), Expect = 9e-08
 Identities = 60/212 (28%), Positives = 94/212 (44%), Gaps = 39/212 (18%)

Query: 300 IGRGGFGNVYFGL--LGDREAAIKKMRS---NK--SKEFFAELKVLCKIHHINVFI---- 348
           IGRG +G V        + + AIKK+ +   N+  +K    E+K+L  + H NV      
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDI 72

Query: 349 ------STFGNGSLSDHLHDP----LLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARY 398
                   F +  +   L D     +++  Q L+            +G++YIH    A  
Sbjct: 73  MPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIH---SANV 129

Query: 399 VHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFR 458
           +HRD+K SN+LL+     K+ DFGL +    T+EK    T  V T  Y  PE +      
Sbjct: 130 LHRDLKPSNLLLNANCDLKICDFGLART---TSEKGDFMTEYVVTRWYRAPELL------ 180

Query: 459 FDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
             ++ S    + TT  DV++ G + AEL+  K
Sbjct: 181 --LNCS----EYTTAIDVWSVGCIFAELLGRK 206

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 53.5 bits (128), Expect = 9e-08
 Identities = 38/121 (31%), Positives = 59/121 (48%), Gaps = 27/121 (22%)

Query: 386 GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPG 445
           G+E +H   + R V+RD+K  NILLDD    +++D GL        E + +  R VGT G
Sbjct: 114 GLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAV---HVPEGQTIKGR-VGTVG 166

Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG-------KRALIRDDS 498
           Y+ PE +  +R+ F               D +A G +L E+I G       K+ + R++ 
Sbjct: 167 YMAPEVVKNERYTF-------------SPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV 213

Query: 499 E 499
           E
Sbjct: 214 E 214

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 54.0 bits (130), Expect = 1e-07
 Identities = 62/234 (26%), Positives = 91/234 (38%), Gaps = 71/234 (30%)

Query: 293 NFDESRIIGRGGFGNVYFGLLGDREAAIKKMRSNKSKEFFAELKVLCKIHHI----NVF- 347
           +FD  ++IGRG FG V            + +R   SK+ +A +K+L K   I    + F 
Sbjct: 44  DFDVIKVIGRGAFGEV------------QLVRHKSSKQVYA-MKLLSKFEMIKRSDSAFF 90

Query: 348 -----ISTFGNGSLSDHLH----DP-----------------LLKGHQ-PLTW----TAR 376
                I    N      LH    D                  L+  +  P  W    TA 
Sbjct: 91  WEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAE 150

Query: 377 TQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEML 436
             +ALDA      IH      ++HRD+K  N+LLD     K+ADFG      + +   M+
Sbjct: 151 VVLALDA------IH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCM---KMDANGMV 198

Query: 437 -ATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
                VGTP Y+ PE          + S   +     + D ++ GV L E++ G
Sbjct: 199 RCDTAVGTPDYISPEV---------LKSQGGDGYYGRECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 53.1 bits (128), Expect = 1e-07
 Identities = 49/204 (24%), Positives = 84/204 (41%), Gaps = 60/204 (29%)

Query: 319 AIKKMR----SNKSKEFFAELKVLCKIHHINV-------------FIST--FGNGSLSDH 359
           A+K +R     N  ++F  E+K+L ++   N+              +      NG L+  
Sbjct: 50  AVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQF 109

Query: 360 L--HDPLLKGH----QPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDG 413
           L  H     G     + L+++    +A   A G+ Y+       +VHRD+ T N L+   
Sbjct: 110 LQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRNCLVGKN 166

Query: 414 LRAKVADFGL---------VKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSS 464
              K+ADFG+          +++ R      L  R      ++  E + + +F       
Sbjct: 167 YTIKIADFGMSRNLYSSDYYRVQGRA----PLPIR------WMAWESVLLGKF------- 209

Query: 465 VMELQVTTKTDVFAFGVVLAELIT 488
                 TTK+DV+AFGV L E++T
Sbjct: 210 ------TTKSDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 53.0 bits (127), Expect = 1e-07
 Identities = 54/214 (25%), Positives = 92/214 (42%), Gaps = 39/214 (18%)

Query: 298 RIIGRGGFGNV---YFGLLGDR---EAAIKKM----RSNKSKEFFAELKVLCKIHHINVF 347
           R +G G FG V    +   GD    + A+K +      N   +   E+++L  ++H N+ 
Sbjct: 10  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 69

Query: 348 ----ISTFGNGS----LSDHLHDPLLKGHQP-----LTWTARTQIALDAAKGIEYIHDHT 394
               I T   G+    + + L    LK + P     +    + + A+   KG++Y+    
Sbjct: 70  KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSR- 128

Query: 395 KARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFV 454
             +YVHRD+   N+L++   + K+ DFGL K  E   E   +   L     +  PE +  
Sbjct: 129 --QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQ 186

Query: 455 KRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
            +F                +DV++FGV L EL+T
Sbjct: 187 SKFYI-------------ASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 53.1 bits (127), Expect = 1e-07
 Identities = 50/208 (24%), Positives = 88/208 (42%), Gaps = 40/208 (19%)

Query: 300 IGRGGFGNVYFGLLGDREAAI---KKMRSNKSKE----FFAELKVLCKIHHINV------ 346
           +G G FG VY     ++E  +    K+   KS+E    +  E+ +L    H N+      
Sbjct: 13  LGDGAFGKVYKA--QNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 70

Query: 347 --------FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARY 398
                    +  F  G   D +   +L+  +PLT      +     + + Y+H++   + 
Sbjct: 71  FYYENNLWILIEFCAGGAVDAV---MLELERPLTEPQIRVVCKQTLEALNYLHEN---KI 124

Query: 399 VHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFR 458
           +HRD+K  NIL       K+ADFG+     RT ++       +GTP ++ PE +      
Sbjct: 125 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR---DSFIGTPYWMAPEVV------ 175

Query: 459 FDMHSSVMELQVTTKTDVFAFGVVLAEL 486
             M  +  +     K DV++ G+ L E+
Sbjct: 176 --MCETSKDRPYDYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 52.6 bits (126), Expect = 1e-07
 Identities = 66/278 (23%), Positives = 116/278 (41%), Gaps = 71/278 (25%)

Query: 300 IGRGGFGNVYFGLLGDREA------------AIKKMRSNKSKEFFAELKVLCKIHH--IN 345
           +G+G FG VY  L+ D++A             + ++  N++ +   E ++L K+ H  I 
Sbjct: 8   LGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIV 65

Query: 346 VFISTF-------------GNGSLSDHLHD-----PLLKGHQPLTWTARTQIALDAAKGI 387
            F ++F                 L   L +       L  +Q   W    Q+ L    G+
Sbjct: 66  KFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWF--IQLLL----GV 119

Query: 388 EYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYL 447
            Y+H     R +HRD+K  NI L + L  K+ DFG+ +L   + +   LAT   GTP Y+
Sbjct: 120 HYMHQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCD---LATTFTGTPYYM 172

Query: 448 PPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRAL-----------IRD 496
            PE +  K   +D           +K+D+++ G +L E+     A            I +
Sbjct: 173 SPEAL--KHQGYD-----------SKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVE 219

Query: 497 DSEPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI 534
              P+  ++    + ++ +  LN+D   RP   +I+  
Sbjct: 220 GPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 52.8 bits (127), Expect = 1e-07
 Identities = 38/188 (20%), Positives = 75/188 (39%), Gaps = 37/188 (19%)

Query: 365 LKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLV 424
           L   + L++  +  +A+D  KG+  ++ +T   Y +  + + + L+ +  + K+   GL 
Sbjct: 113 LDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKN--LTSVSFLVTENYKLKIICHGLE 170

Query: 425 KLEERTNEKEMLATRLVGTPGYLPPEY---IFVKRFRFDMHSSVMELQVTTKTDVFAFGV 481
           K+      K       V    Y   +    IF +               T K D+++ GV
Sbjct: 171 KILSSPPFKN------VNFMVYFSYKMLNDIFSEY--------------TIKDDIYSLGV 210

Query: 482 VLAELITGK------------RALIRDDSEPTKMKSLITIMAAVAEWCLNEDAVDRPEMR 529
           VL E+ TGK              +I  ++           +  + E C + D++ RP ++
Sbjct: 211 VLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIK 270

Query: 530 DIVAILSQ 537
           +I+  LS 
Sbjct: 271 EILYNLSL 278

Length = 283

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 53.1 bits (127), Expect = 1e-07
 Identities = 68/281 (24%), Positives = 121/281 (43%), Gaps = 65/281 (23%)

Query: 298 RIIGRGGFGNVYFGLL---GDR---EAAIKKMRSNKSK----EFFAELKVLCKIHH---- 343
           +++G G FG VY G+    G+      AIK +          EF  E  ++  + H    
Sbjct: 13  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 72

Query: 344 ----------INVFISTFGNGSLSDHLHDPL--LKGHQPLTWTARTQIALDAAKGIEYIH 391
                     I +      +G L D++H+    +     L W  +       AKG+ Y+ 
Sbjct: 73  RLLGVCLSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQI------AKGMMYLE 126

Query: 392 DHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEY 451
           +    R VHRD+   N+L+      K+ DFGL +L E  +EKE  A       G +P ++
Sbjct: 127 ER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLE-GDEKEYNA-----DGGKMPIKW 177

Query: 452 IFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT--GK-------RAL--IRDDSEP 500
           + ++   +         + T ++DV+++GV + EL+T  GK       R +  + +  E 
Sbjct: 178 MALECIHYR--------KFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGER 229

Query: 501 TKMKSLITI---MAAVAEWCLNEDAVDRPEMRDIVAILSQI 538
                + TI   M  V  W ++ D+  RP+ +++ A  S++
Sbjct: 230 LPQPPICTIDVYMVMVKCWMIDADS--RPKFKELAAEFSRM 268

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 52.2 bits (125), Expect = 2e-07
 Identities = 53/221 (23%), Positives = 91/221 (41%), Gaps = 51/221 (23%)

Query: 299 IIGRGGFGNVYFGLLGDRE-AAIKKMRSNKSKEFFAE---------LKVLCKIHHINV-- 346
           ++G+G +G VY GL    +  A+K++  + S    AE         + +L  + H+N+  
Sbjct: 7   VLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66

Query: 347 -------------FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDH 393
                        F+     GS+S      +L    PL      +       G+ Y+H++
Sbjct: 67  YLGTCLDDNTISIFMEFVPGGSISS-----ILNRFGPLPEPVFCKYTKQILDGVAYLHNN 121

Query: 394 TKARYVHRDIKTSNILLDDGLRAKVADFGLVK----LEERTNEKEMLATRLVGTPGYLPP 449
                VHRDIK +N++L      K+ DFG  +    +        ML + + GTP ++ P
Sbjct: 122 C---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKS-MHGTPYWMAP 177

Query: 450 EYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
           E I              E     K+D+++ G  + E+ TGK
Sbjct: 178 EVI-------------NESGYGRKSDIWSIGCTVFEMATGK 205

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 52.3 bits (125), Expect = 2e-07
 Identities = 34/118 (28%), Positives = 55/118 (46%), Gaps = 27/118 (22%)

Query: 386 GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKL----EERTNEKEMLATRLV 441
           G++++H       V+RD+K  NILLD     K+ADFG+ K     + +T           
Sbjct: 108 GLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCT-------FC 157

Query: 442 GTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE 499
           GTP Y+ PE +  +++              T  D ++FGV+L E++ G+      D E
Sbjct: 158 GTPDYIAPEILLGQKY-------------NTSVDWWSFGVLLYEMLIGQSPFHGHDEE 202

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 52.1 bits (125), Expect = 3e-07
 Identities = 36/103 (34%), Positives = 47/103 (45%), Gaps = 24/103 (23%)

Query: 388 EYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK-LEERTNEKEMLATRLVGTPGY 446
           EY+H       ++RD+K  N+LLD+    KV DFG  K + +RT         L GTP Y
Sbjct: 132 EYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT-------FTLCGTPEY 181

Query: 447 LPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
           L PE I  K      H   +        D +  GV+L E I G
Sbjct: 182 LAPEVIQSKG-----HGKAV--------DWWTMGVLLYEFIAG 211

Length = 329

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 51.9 bits (124), Expect = 3e-07
 Identities = 57/233 (24%), Positives = 100/233 (42%), Gaps = 47/233 (20%)

Query: 300 IGRGGFGNVYFGLL--GDREAAIKKM--RSNKSKEF-FAELKVLCKIHHINVFISTFGNG 354
           IG G  G V    +    +  A+KKM  R  + +E  F E+ ++    H NV +  + + 
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV-VEMYNSY 86

Query: 355 SLSDHLHDPL--LKG--------HQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIK 404
            + D L   +  L+G        H  +       + L   K +  +H       +HRDIK
Sbjct: 87  LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIK 143

Query: 405 TSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSS 464
           + +ILL    R K++DFG      + +++      LVGTP ++ PE I            
Sbjct: 144 SDSILLTHDGRVKLSDFGFCA---QVSKEVPRRKSLVGTPYWMAPELI------------ 188

Query: 465 VMELQVTTKTDVFAFGVVLAELITGK-----------RALIRDDSEPTKMKSL 506
              L    + D+++ G+++ E++ G+             +IRD+  P K+K+L
Sbjct: 189 -SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL-PPKLKNL 239

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 52.0 bits (124), Expect = 3e-07
 Identities = 56/242 (23%), Positives = 109/242 (45%), Gaps = 51/242 (21%)

Query: 270 DVTVLESERTIIFSLEEIEEATNNFDESRIIGRGGFGNVYFGL---LGDREAAIKKM--- 323
           D  ++E  RTI+     I +    +     IG+G  G V+  +    G +E AIK++   
Sbjct: 1   DEEIMEKLRTIV----SIGDPKKKYTRYEKIGQGASGTVFTAIDVATG-QEVAIKQINLQ 55

Query: 324 RSNKSKEFFAELKVLCKIHHINV--FISTF-------------GNGSLSDHLHDPLLKGH 368
           +  K +    E+ V+ ++ + N+  F+ +F               GSL+D + +  +   
Sbjct: 56  KQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEA 115

Query: 369 QPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEE 428
           Q         +  +  + +E++H +   + +HRDIK+ N+LL      K+ DFG     +
Sbjct: 116 QI------AAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCA--Q 164

Query: 429 RTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
            T E+   +T +VGTP ++ PE +  K +               K D+++ G++  E++ 
Sbjct: 165 ITPEQSKRST-MVGTPYWMAPEVVTRKAY-------------GPKVDIWSLGIMAIEMVE 210

Query: 489 GK 490
           G+
Sbjct: 211 GE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 51.7 bits (124), Expect = 3e-07
 Identities = 36/131 (27%), Positives = 61/131 (46%), Gaps = 29/131 (22%)

Query: 385 KGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGL-----VKLEERTNEKEMLATR 439
           KGI + H++   R +HRD+K  N+L++     K+ADFGL     + +   +NE       
Sbjct: 111 KGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNE------- 160

Query: 440 LVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE 499
            V T  Y  P+ +   R              +T  D+++ G ++AE+ITG R L    + 
Sbjct: 161 -VVTLWYRAPDVLLGSR------------TYSTSIDIWSVGCIMAEMITG-RPLFPGTNN 206

Query: 500 PTKMKSLITIM 510
             ++  +  IM
Sbjct: 207 EDQLLKIFRIM 217

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 51.8 bits (124), Expect = 4e-07
 Identities = 54/219 (24%), Positives = 87/219 (39%), Gaps = 64/219 (29%)

Query: 355 SLSDH--LHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDD 412
           SLSD     +      +PLT       +   A+G+E++      + +HRD+   NILL +
Sbjct: 152 SLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFL---ASRKCIHRDLAARNILLSE 208

Query: 413 GLRAKVADFGLVKLEERTNEKEMLATRLVGTPGY-------LP-----PEYIFVKRFRFD 460
               K+ DFG             LA  +   P Y       LP     PE IF K +   
Sbjct: 209 NNVVKICDFG-------------LARDIYKDPDYVRKGDARLPLKWMAPESIFDKVY--- 252

Query: 461 MHSSVMELQVTTKTDVFAFGVVLAELIT----------GKRALIRDDSEPTKMKS----- 505
                     TT++DV++FGV+L E+ +                R   E T+M++     
Sbjct: 253 ----------TTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYAT 302

Query: 506 --LITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITS 542
             + +IM      C + +  DRP   ++V IL  ++  +
Sbjct: 303 PEIYSIMLD----CWHNNPEDRPTFSELVEILGDLLQEN 337

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 51.8 bits (124), Expect = 4e-07
 Identities = 34/111 (30%), Positives = 53/111 (47%), Gaps = 19/111 (17%)

Query: 380 ALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATR 439
           A +    + ++H H     ++RD+K  NILLD     K+ADFG+ K E   N   +  T 
Sbjct: 102 AAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCK-EGILN--GVTTTT 155

Query: 440 LVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
             GTP Y+ PE +              EL+     D +A GV++ E++ G+
Sbjct: 156 FCGTPDYIAPEIL-------------QELEYGPSVDWWALGVLMYEMMAGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 51.3 bits (123), Expect = 4e-07
 Identities = 34/117 (29%), Positives = 57/117 (48%), Gaps = 23/117 (19%)

Query: 378 QIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFG----LVKLEERTNEK 433
           +IA+   K +EY+H  +K   +HRD+K SN+L++   + K+ DFG    LV         
Sbjct: 107 KIAVSIVKALEYLH--SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLV--------D 156

Query: 434 EMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
            +  T   G   Y+ PE     R   +++          K+DV++ G+ + EL TG+
Sbjct: 157 SVAKTIDAGCKPYMAPE-----RINPELNQK----GYDVKSDVWSLGITMIELATGR 204

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 51.3 bits (123), Expect = 4e-07
 Identities = 36/105 (34%), Positives = 49/105 (46%), Gaps = 24/105 (22%)

Query: 387 IEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK-LEERTNEKEMLATRLVGTPG 445
           +EY+H       V+RD+K  NILLD     K+ DFG  K L +RT         L GTP 
Sbjct: 114 LEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT-------WTLCGTPE 163

Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
           YL PE I  K      H+           D +A G+++ E++ G 
Sbjct: 164 YLAPEVIQSKG-----HN--------KAVDWWALGILIYEMLVGY 195

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 51.1 bits (122), Expect = 5e-07
 Identities = 59/224 (26%), Positives = 99/224 (44%), Gaps = 54/224 (24%)

Query: 294 FDESRIIGRGGFGNV---YFGLLGDREAA--IKKMRSNKSK-EFFA--ELKVLCKIHH-- 343
           F + R++G+GGFG V        G   A   ++K R  K K E  A  E ++L K++   
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61

Query: 344 -------------INVFISTFGNGSLSDHLHD---PLLKGHQPLTWTARTQIALDAAKGI 387
                        + + ++    G L  H+++   P  +  + L + A      +   G+
Sbjct: 62  VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAA------EILCGL 115

Query: 388 EYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGL-VKLEERTNEKEMLATRLVGTPGY 446
           E +H   +   V+RD+K  NILLDD    +++D GL VK+     E E +  R VGT GY
Sbjct: 116 EDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIP----EGESIRGR-VGTVGY 167

Query: 447 LPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
           + PE +  +R+                 D +  G ++ E+I G+
Sbjct: 168 MAPEVLNNQRYTL-------------SPDYWGLGCLIYEMIEGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 52.4 bits (125), Expect = 5e-07
 Identities = 58/248 (23%), Positives = 94/248 (37%), Gaps = 61/248 (24%)

Query: 288 EEATNNFDESRIIGRGGFGNVYF-------GLLGDREAAIKKMRSNKSKEFFAELKVLCK 340
           E   N ++  + IG G FG V+             +  + + ++  +  +   E+ V+ +
Sbjct: 9   ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRE 68

Query: 341 IHHINV--FISTFGN---------------GSLSDHLHDPLLKGHQPLTWTARTQIALDA 383
           + H N+  +I  F N               G LS ++     K    +   A   I    
Sbjct: 69  LKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQK-CYKMFGKIEEHAIVDITRQL 127

Query: 384 AKGIEYIHDHTKA----RYVHRDIKTSNILLDDGLR-----------------AKVADFG 422
              + Y H+        R +HRD+K  NI L  G+R                 AK+ DFG
Sbjct: 128 LHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFG 187

Query: 423 LVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVV 482
           L K        E +A   VGTP Y  PE +  +   +D            K+D++A G +
Sbjct: 188 LSK----NIGIESMAHSCVGTPYYWSPELLLHETKSYD-----------DKSDMWALGCI 232

Query: 483 LAELITGK 490
           + EL +GK
Sbjct: 233 IYELCSGK 240

Length = 1021

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 50.8 bits (122), Expect = 6e-07
 Identities = 32/112 (28%), Positives = 47/112 (41%), Gaps = 18/112 (16%)

Query: 378 QIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLA 437
           +I     + + + H H     +HRD+K  NIL+    + K+ DFG  ++           
Sbjct: 104 KIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARI---LTGPGDDY 157

Query: 438 TRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
           T  V T  Y  PE +            V + Q     DV+A G V AEL+TG
Sbjct: 158 TDYVATRWYRAPELL------------VGDTQYGPPVDVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 50.7 bits (121), Expect = 7e-07
 Identities = 54/217 (24%), Positives = 92/217 (42%), Gaps = 49/217 (22%)

Query: 298 RIIGRGGFGNVYFGLL---GDR---EAAIKKMRSNKSKEFFAE----------------- 334
           +++G G FG V+ G+    GD      AIK ++    ++ F E                 
Sbjct: 13  KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIV 72

Query: 335 -LKVLCKIHHINVFISTFGNGSLSDHL--HDPLLKGHQPLTWTARTQIALDAAKGIEYIH 391
            L  +C    + +       GSL DH+  H   L   + L W    QIA    KG+ Y+ 
Sbjct: 73  RLLGICPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWC--VQIA----KGMYYLE 126

Query: 392 DHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEY 451
           +H   R VHR++   NILL      ++ADFG+  L    ++K+   +       ++  E 
Sbjct: 127 EH---RMVHRNLAARNILLKSDSIVQIADFGVADLLY-PDDKKYFYSEHKTPIKWMALES 182

Query: 452 IFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
           I   R+             T ++DV+++GV + E+++
Sbjct: 183 ILFGRY-------------THQSDVWSYGVTVWEMMS 206

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 50.8 bits (122), Expect = 7e-07
 Identities = 33/120 (27%), Positives = 54/120 (45%), Gaps = 19/120 (15%)

Query: 380 ALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATR 439
           A +   G++++H+      ++RD+K  N+LLD     K+ADFG+ K  E        +T 
Sbjct: 102 AAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCK--EGILGGVTTST- 155

Query: 440 LVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE 499
             GTP Y+ PE +                      D +A GV+L E++ G+     DD +
Sbjct: 156 FCGTPDYIAPEIL-------------SYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED 202

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 50.9 bits (122), Expect = 8e-07
 Identities = 60/216 (27%), Positives = 89/216 (41%), Gaps = 41/216 (18%)

Query: 300 IGRGGFGNV----YFGLLGDREAAIKKMRSNKSKEFFA-----ELKVL----------CK 340
           +G+G +G V          +   AIKK+ +  SK+  A     ELK+L          C 
Sbjct: 8   LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCL 67

Query: 341 IHHINVFISTFGNGSLSDHLHD----PLLKGHQPLTWTARTQIAL-DAAKGIEYIHDHTK 395
                VF   F    L + L +     +++  QPLT  A  Q  +     G++YIH    
Sbjct: 68  YDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLT-DAHFQSFIYQILCGLKYIH---S 123

Query: 396 ARYVHRDIKTSNILLDDGLRAKVADFGLVK-LEERTNEKEMLATRLVGTPGYLPPEYIFV 454
           A  +HRD+K  N+L++     K+ DFGL +   E   E     T  V T  Y  PE +  
Sbjct: 124 ANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLS 183

Query: 455 KRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
            +              T   DV++ G +LAEL+  K
Sbjct: 184 FQ------------SYTKAIDVWSVGCILAELLGRK 207

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 50.6 bits (121), Expect = 9e-07
 Identities = 64/244 (26%), Positives = 100/244 (40%), Gaps = 56/244 (22%)

Query: 300 IGRGGFGNVYFGLLGDREA----AIKKMRSNKSKE-----FFAELKVLCKIHHINV---- 346
           IG G +G VY     DR      A+KK+R  +  E        E+ +L ++ H N+    
Sbjct: 10  IGEGTYGVVYKA--RDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQ 67

Query: 347 ----------FISTFGNGSLSDHLHD-PLLKGHQPLTWTARTQIALDAAKGIEYIHDHTK 395
                      +  + +  L  H+   P    +  L  T   QI     +GI Y H H  
Sbjct: 68  DVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQIL----RGIAYCHSH-- 121

Query: 396 ARYVHRDIKTSNILLDDGLRA-KVADFGLVK---LEERTNEKEMLATRLVGTPGYLPPEY 451
            R +HRD+K  N+L+D    A K+ADFGL +   +  RT   E      V T  Y  PE 
Sbjct: 122 -RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHE------VVTLWYRAPEI 174

Query: 452 IFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKMKSLITIMA 511
           +   R              +T  D+++ G + AE++  ++ L   DSE  ++  +  I+ 
Sbjct: 175 LLGSR------------HYSTPVDIWSVGCIFAEMVN-QKPLFPGDSEIDELFKIFRILG 221

Query: 512 AVAE 515
              E
Sbjct: 222 TPNE 225

Length = 294

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 51.0 bits (122), Expect = 1e-06
 Identities = 45/170 (26%), Positives = 64/170 (37%), Gaps = 57/170 (33%)

Query: 375 ARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK--------- 425
           AR  IA +    IE +H   K  ++HRDIK  NIL+D     K+ DFGL           
Sbjct: 103 ARFYIA-ELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158

Query: 426 -----------------------------LEERTNEKEM--LATRLVGTPGYLPPEYIFV 454
                                        LE R   +    LA  LVGTP Y+ PE +  
Sbjct: 159 YYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR 218

Query: 455 KRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKMK 504
             +             T   D ++ GV+L E++ G+   + D    T++K
Sbjct: 219 TGY-------------TQLCDWWSVGVILYEMLVGQPPFLADTPAETQLK 255

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 50.5 bits (121), Expect = 1e-06
 Identities = 55/233 (23%), Positives = 98/233 (42%), Gaps = 44/233 (18%)

Query: 315 DREAAIKK--MRSNKS-KEFFAELKVLCKIHHIN---VFISTFGNGS-LSDHLHDPL--- 364
           D+  A+KK  +   +S K    E+K++ ++ H N   V+     +GS L++ +       
Sbjct: 30  DKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELN 89

Query: 365 ---------------LKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNIL 409
                          +    PL+            +G++YIH    A  +HRD+K +N+ 
Sbjct: 90  SVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANVF 146

Query: 410 LD-DGLRAKVADFGLVK-LEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVME 467
           ++ + L  K+ DFGL + ++   + K  L+  LV T  Y  P  +               
Sbjct: 147 INTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLV-TKWYRSPRLLLSPN----------- 194

Query: 468 LQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKMKSLITIMAAVAEWCLNE 520
              T   D++A G + AE++TGK  L     E  +M+ ++  +  V E   NE
Sbjct: 195 -NYTKAIDMWAAGCIFAEMLTGK-PLFAGAHELEQMQLILESVPVVREEDRNE 245

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 49.8 bits (119), Expect = 1e-06
 Identities = 50/225 (22%), Positives = 96/225 (42%), Gaps = 54/225 (24%)

Query: 299 IIGRGGFGNVYFGL---LGDREAAIKKMRSNKS-------------KEFFAELKVLCKIH 342
           +IG+G +G VY  L    G+   A+K++    +             K   +E++ L  + 
Sbjct: 8   LIGKGTYGRVYLALNVTTGEM-MAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD 66

Query: 343 HINV-----------FISTF----GNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGI 387
           H+N+           ++S F      GS+   L     +  + L      Q+     +G+
Sbjct: 67  HLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYG-RFEEQLVRFFTEQVL----EGL 121

Query: 388 EYIHDHTKARYVHRDIKTSNILLD-DGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGY 446
            Y+H       +HRD+K  N+L+D DG+  K++DFG+ K  +   + +     + G+  +
Sbjct: 122 AYLH---SKGILHRDLKADNLLVDADGI-CKISDFGISKKSDDIYDNDQ-NMSMQGSVFW 176

Query: 447 LPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKR 491
           + PE I      +           + K D+++ G V+ E+  G+R
Sbjct: 177 MAPEVIHSYSQGY-----------SAKVDIWSLGCVVLEMFAGRR 210

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 49.9 bits (119), Expect = 1e-06
 Identities = 61/222 (27%), Positives = 97/222 (43%), Gaps = 61/222 (27%)

Query: 299 IIGRGGFGNVYFGLLGDREAAIKKMRSNK-----------------SKEFFAELK----- 336
           IIGRGGFG VY    G R+A   KM + K                 ++     L      
Sbjct: 1   IIGRGGFGEVY----GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDC 56

Query: 337 --VLCKIHHINV-----FISTFGNG-SLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIE 388
             ++C  +  +      FI    NG  L  HL    +     + + A  +I L    G+E
Sbjct: 57  PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYA-AEIIL----GLE 111

Query: 389 YIHDHTKARYV-HRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYL 447
           ++H+    R+V +RD+K +NILLD+    +++D GL       ++K+  A+  VGT GY+
Sbjct: 112 HMHN----RFVVYRDLKPANILLDEHGHVRISDLGLAC---DFSKKKPHAS--VGTHGYM 162

Query: 448 PPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
            PE +  K   +D           +  D F+ G +L +L+ G
Sbjct: 163 APE-VLQKGVAYD-----------SSADWFSLGCMLFKLLRG 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 50.0 bits (119), Expect = 1e-06
 Identities = 52/218 (23%), Positives = 87/218 (39%), Gaps = 53/218 (24%)

Query: 316 REAAIKKM--RSNKSKEF-FAELKVLCKIHHINV---------------FISTFGNGSLS 357
           R+ A+K M  R  + +E  F E+ ++    H NV                +     G+L+
Sbjct: 47  RQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALT 106

Query: 358 DHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAK 417
           D +    L   Q  T      +     + + Y+H       +HRDIK+ +ILL    R K
Sbjct: 107 DIVSQTRLNEEQIAT------VCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVK 157

Query: 418 VADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVF 477
           ++DFG      +   K      LVGTP ++ PE I                   T+ D++
Sbjct: 158 LSDFGFCAQISKDVPKR---KSLVGTPYWMAPEVI-------------SRTPYGTEVDIW 201

Query: 478 AFGVVLAELITGKRALIRD----------DSEPTKMKS 505
           + G+++ E++ G+     D          DS P K+K+
Sbjct: 202 SLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKN 239

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 50.2 bits (120), Expect = 1e-06
 Identities = 26/65 (40%), Positives = 37/65 (56%), Gaps = 7/65 (10%)

Query: 387 IEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFG-LVKLEERTNEKEMLATRLVGTPG 445
           I+ +H   +  YVHRDIK  N+LLD     ++ADFG  ++L      +  +A   VGTP 
Sbjct: 115 IDSVH---QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVA---VGTPD 168

Query: 446 YLPPE 450
           Y+ PE
Sbjct: 169 YISPE 173

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 49.7 bits (119), Expect = 1e-06
 Identities = 62/233 (26%), Positives = 96/233 (41%), Gaps = 66/233 (28%)

Query: 300 IGRGGFGNVYFG--LLGDREAAIKKMRSNKSKE-----FFAELKVLCKIHHINV------ 346
           IG G +G VY G      +  A+KK+R    +E        E+ +L ++ H N+      
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67

Query: 347 --------FISTFGNGSLSDHLHDPLLKGHQPLTWTART---QIALDAAKGIEYIHDHTK 395
                    I  F +  L  +L D L KG        ++   QI     +GI + H    
Sbjct: 68  LMQESRLYLIFEFLSMDLKKYL-DSLPKGQYMDAELVKSYLYQIL----QGILFCHSR-- 120

Query: 396 ARYVHRDIKTSNILLDDGLRAKVADFGL-----VKLEERTNEKEMLATR----LVGTPGY 446
            R +HRD+K  N+L+D+    K+ADFGL     + +   T+E   L  R    L+G+P Y
Sbjct: 121 -RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRY 179

Query: 447 LPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE 499
                                   +T  D+++ G + AE+ T K+ L   DSE
Sbjct: 180 ------------------------STPVDIWSIGTIFAEMAT-KKPLFHGDSE 207

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 50.8 bits (121), Expect = 1e-06
 Identities = 39/147 (26%), Positives = 71/147 (48%), Gaps = 30/147 (20%)

Query: 393 HTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEM-LATRLVGTPGYLPPEY 451
           H++ + +HRD+K++NI L      K+ DFG  K  + ++   + +A+   GTP YL PE 
Sbjct: 186 HSR-KMMHRDLKSANIFLMPTGIIKLGDFGFSK--QYSDSVSLDVASSFCGTPYYLAPEL 242

Query: 452 IFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKMKSLI---- 507
              KR+             + K D+++ GV+L EL+T  R   +  S+   M+ ++    
Sbjct: 243 WERKRY-------------SKKADMWSLGVILYELLTLHRPF-KGPSQREIMQQVLYGKY 288

Query: 508 --------TIMAAVAEWCLNEDAVDRP 526
                   + M A+ +  L+++   RP
Sbjct: 289 DPFPCPVSSGMKALLDPLLSKNPALRP 315

Length = 478

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 49.9 bits (119), Expect = 1e-06
 Identities = 47/170 (27%), Positives = 68/170 (40%), Gaps = 53/170 (31%)

Query: 354 GSLSDHLHDPLLKGHQPLTWTARTQIALDAAK---GIEYIHDHTKARYVHRDIKTSNILL 410
           GSL D+L         P       Q+ L A +   G+ Y+H      Y+HRD+   N+LL
Sbjct: 93  GSLRDYL---------PKHKLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLL 140

Query: 411 DDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVM---- 466
           D+    K+ DFGL K                     +P  + +  R R D  S V     
Sbjct: 141 DNDRLVKIGDFGLAK--------------------AVPEGHEYY-RVREDGDSPVFWYAV 179

Query: 467 ----ELQVTTKTDVFAFGVVLAELITGKRALIRDD---SEPTKMKSLITI 509
               E + +  +DV++FGV L EL+T        D   S P K + +I  
Sbjct: 180 ECLKENKFSYASDVWSFGVTLYELLT------HCDSKQSPPKKFEEMIGP 223

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 50.0 bits (119), Expect = 2e-06
 Identities = 36/114 (31%), Positives = 51/114 (44%), Gaps = 21/114 (18%)

Query: 387 IEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGY 446
           +EY+H       V+RDIK  N++LD     K+ DFGL K E  ++   M      GTP Y
Sbjct: 108 LEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATM--KTFCGTPEY 161

Query: 447 LPPEYIFVKRFRFDMHSSVMELQVTTKT-DVFAFGVVLAELITGKRALIRDDSE 499
           L PE              V+E     +  D +  GVV+ E++ G+      D E
Sbjct: 162 LAPE--------------VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE 201

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 49.5 bits (118), Expect = 2e-06
 Identities = 49/203 (24%), Positives = 88/203 (43%), Gaps = 52/203 (25%)

Query: 319 AIKKMRSNKSK----EFFAELKVLCKIHHINVFISTFG----------------NGSLSD 358
           A+K +R + +K    +F  E+K+L ++   N+ I   G                NG L+ 
Sbjct: 50  AVKILRPDANKNARNDFLKEVKILSRLKDPNI-IRLLGVCVDEDPLCMITEYMENGDLNQ 108

Query: 359 HL-HDPLLKGHQP-------------LTWTARTQIALDAAKGIEYIHDHTKARYVHRDIK 404
            L    L    +              +++++   +AL  A G++Y+   +   +VHRD+ 
Sbjct: 109 FLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLA 165

Query: 405 TSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSS 464
           T N L+ + L  K+ADFG+ +      +   +  R V    ++  E I + +F       
Sbjct: 166 TRNCLVGENLTIKIADFGMSR-NLYAGDYYRIQGRAVLPIRWMAWECILMGKF------- 217

Query: 465 VMELQVTTKTDVFAFGVVLAELI 487
                 TT +DV+AFGV L E++
Sbjct: 218 ------TTASDVWAFGVTLWEIL 234

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 49.2 bits (117), Expect = 2e-06
 Identities = 37/133 (27%), Positives = 63/133 (47%), Gaps = 25/133 (18%)

Query: 385 KGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP 444
           +G++++H +     VHRD+K  NIL+  G + K+ADFGL     R    +M  T +V T 
Sbjct: 119 RGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLA----RIYSCQMALTPVVVTL 171

Query: 445 GYLPPEYIFVKRFRFDMHSSVMELQVT--TKTDVFAFGVVLAELITGKRALIRDDSEPTK 502
            Y  PE +               LQ T  T  D+++ G + AE+   ++ L   +SE  +
Sbjct: 172 WYRAPEVL---------------LQSTYATPVDMWSVGCIFAEMFR-RKPLFCGNSEADQ 215

Query: 503 MKSLITIMAAVAE 515
           +  +  ++    E
Sbjct: 216 LGKIFDLIGLPPE 228

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 49.6 bits (118), Expect = 2e-06
 Identities = 50/177 (28%), Positives = 79/177 (44%), Gaps = 22/177 (12%)

Query: 292 NNFDESRIIGRGGFGNVYFGLLGDREAAIKKMRSNKSKEFFAELKVLCKIHHINVFIS-- 349
           ++F+  ++IGRG FG V    +   E  I  M+     E     +  C     NV ++  
Sbjct: 1   DDFEIIKVIGRGAFGEVAVVKMKHTER-IYAMKILNKWEMLKRAETACFREERNVLVNGD 59

Query: 350 ----TFGNGSLSDHLHDPLLK----GHQPLTWTARTQIAL--DAAK-----GIEYIHDHT 394
               T  + +  D  +  L+     G   LT  ++ +  L  D A+      +  IH   
Sbjct: 60  CQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIH 119

Query: 395 KARYVHRDIKTSNILLDDGLRAKVADFG-LVKLEERTNEKEMLATRLVGTPGYLPPE 450
           +  YVHRDIK  N+LLD     ++ADFG  +K+ +    +  +A   VGTP Y+ PE
Sbjct: 120 QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVA---VGTPDYISPE 173

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 49.5 bits (118), Expect = 2e-06
 Identities = 46/163 (28%), Positives = 69/163 (42%), Gaps = 33/163 (20%)

Query: 399 VHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFR 458
           ++RD+K  N+LLD     K+ADFG+ K E   N K    +   GTP Y+ PE +      
Sbjct: 118 IYRDLKLDNVLLDHEGHCKLADFGMCK-EGIFNGK--TTSTFCGTPDYIAPEIL------ 168

Query: 459 FDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKMKSLITIMAAVAEWCL 518
                   E+      D +A GV+L E++ G  A    ++E    ++++        W L
Sbjct: 169 -------QEMLYGPSVDWWAMGVLLYEMLCG-HAPFEAENEDDLFEAILNDEVVYPTW-L 219

Query: 519 NEDAVD--------RPEMR-------DIVAILSQIMITSTEWE 546
           ++DAVD         P MR          AIL        +WE
Sbjct: 220 SQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDWE 262

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 49.7 bits (119), Expect = 2e-06
 Identities = 58/224 (25%), Positives = 88/224 (39%), Gaps = 71/224 (31%)

Query: 292 NNFDESRIIGRGGFGNVYFGLLGDREA----AIKKMRSNKSKEFF--------AELKVLC 339
           ++F+  ++IGRG FG V   L+  ++     A+KK+R  KS+           AE  +L 
Sbjct: 1   DDFESIKVIGRGAFGEVR--LVQKKDTGHIYAMKKLR--KSEMLEKEQVAHVRAERDILA 56

Query: 340 KIHH---INVFISTFGNGSLSDHLHDPLLKGHQPLTW----------TARTQIALDAAKG 386
           +  +   + ++ S      L  +L    L G   +T             R  IA +    
Sbjct: 57  EADNPWVVKLYYSFQDENYL--YLIMEYLPGGDMMTLLMKKDTFTEEETRFYIA-ETILA 113

Query: 387 IEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLV---------------------- 424
           I+ IH   K  Y+HRDIK  N+LLD     K++DFGL                       
Sbjct: 114 IDSIH---KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSN 170

Query: 425 -------------KLEERTNEKEMLATRLVGTPGYLPPEYIFVK 455
                        K E     +  LA   VGTP Y+ PE +F++
Sbjct: 171 FLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPE-VFLQ 213

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 49.2 bits (117), Expect = 2e-06
 Identities = 55/224 (24%), Positives = 89/224 (39%), Gaps = 52/224 (23%)

Query: 298 RIIGRGGFGNVYFGLLGD-------REAAIKKMRSNKSK----EFFAELKVL--CKIHHI 344
           R +G+G FG VY G   D          A+K +  + S     EF  E  V+     HH+
Sbjct: 12  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 71

Query: 345 N-------------VFISTFGNGSLSDHL-------HDPLLKGHQPLTWTARTQIALDAA 384
                         V +    +G L  +L        +    G  P T     Q+A + A
Sbjct: 72  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENN--PGRPPPTLQEMIQMAAEIA 129

Query: 385 KGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP 444
            G+ Y++     ++VHRD+   N ++      K+ DFG+ +    T+          G  
Sbjct: 130 DGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRK------GGK 180

Query: 445 GYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
           G LP         R+    S+ +   TT +D+++FGVVL E+ +
Sbjct: 181 GLLP--------VRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 48.5 bits (115), Expect = 3e-06
 Identities = 47/205 (22%), Positives = 96/205 (46%), Gaps = 38/205 (18%)

Query: 299 IIGRGGFGNVYFGLLGDR-EAAIKKMRSNKSKE----FFAELKVLCKIHHINVFISTFGN 353
           ++G+G FG V+ G L D+   A+K  + +  +E    F +E ++L +  H N+ +   G 
Sbjct: 2   LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNI-VKLIGV 60

Query: 354 GSLSDHLH--DPLLKGHQPLTWTAR----------TQIALDAAKGIEYIHDHTKARYVHR 401
            +    ++    L+ G   L++  +           + ALDAA G+ Y+        +HR
Sbjct: 61  CTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHR 117

Query: 402 DIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP-GYLPPEYIFVKRFRFD 460
           D+   N L+ +    K++DFG+ + E+   +    ++ L   P  +  PE +   R+   
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRQED---DGIYSSSGLKQIPIKWTAPEALNYGRY--- 171

Query: 461 MHSSVMELQVTTKTDVFAFGVVLAE 485
                     ++++DV+++G++L E
Sbjct: 172 ----------SSESDVWSYGILLWE 186

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 48.6 bits (116), Expect = 4e-06
 Identities = 31/108 (28%), Positives = 49/108 (45%), Gaps = 18/108 (16%)

Query: 385 KGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP 444
           + ++YIH    A   HRD+K  NIL +   + K+ DFGL ++        +  T  V T 
Sbjct: 114 RALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170

Query: 445 GYLPPEYI--FVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
            Y  PE    F  ++             T   D+++ G + AE++TGK
Sbjct: 171 WYRAPELCGSFFSKY-------------TPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 48.6 bits (116), Expect = 4e-06
 Identities = 35/111 (31%), Positives = 55/111 (49%), Gaps = 19/111 (17%)

Query: 380 ALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATR 439
           A + A G+ ++H       ++RD+K  N++LD     K+ADFG+ K  E     +   T 
Sbjct: 107 AAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCK--ENIFGGKTTRT- 160

Query: 440 LVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
             GTP Y+ PE I  + +      SV         D +AFGV+L E++ G+
Sbjct: 161 FCGTPDYIAPEIIAYQPY----GKSV---------DWWAFGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 48.5 bits (115), Expect = 4e-06
 Identities = 31/112 (27%), Positives = 56/112 (50%), Gaps = 21/112 (18%)

Query: 380 ALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATR 439
           A + + G+ ++H   +   ++RD+K  N++LD     K+ADFG+ K     +  + + TR
Sbjct: 107 AAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCK----EHMVDGVTTR 159

Query: 440 -LVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
              GTP Y+ PE I  + +                 D +A+GV+L E++ G+
Sbjct: 160 TFCGTPDYIAPEIIAYQPY-------------GKSVDWWAYGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 48.5 bits (115), Expect = 4e-06
 Identities = 55/226 (24%), Positives = 89/226 (39%), Gaps = 48/226 (21%)

Query: 298 RIIGRGGFGNV----------YFGL-LGDREAAIKK-----------MRSNKSKEFFAEL 335
           +++G+G FG V          Y+ + +  +E  + K           +  N    F   L
Sbjct: 1   KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60

Query: 336 KVLCKIHHINVFISTFGNG-SLSDHL-HDPLLKGHQPLTWTARTQIALDAAKGIEYIHDH 393
           K   + H    F+  + NG  L  HL  + +    +   + A    ALD      Y+H  
Sbjct: 61  KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALD------YLH-- 112

Query: 394 TKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIF 453
           ++   V+RD+K  N++LD     K+ DFGL K  E   +   + T   GTP YL PE + 
Sbjct: 113 SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKT-FCGTPEYLAPEVLE 169

Query: 454 VKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE 499
              +                 D +  GVV+ E++ G+      D E
Sbjct: 170 DNDY-------------GRAVDWWGLGVVMYEMMCGRLPFYNQDHE 202

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 48.5 bits (115), Expect = 4e-06
 Identities = 62/262 (23%), Positives = 113/262 (43%), Gaps = 56/262 (21%)

Query: 278 RTIIFSLEEIEEATNNFDESRIIGRGGFGNVY--FGLLGDREAAIKKMRS--NKSKEFFA 333
           +TIIF  +   + ++ ++    IG+G +G V+         +AA+K +    +  +E  A
Sbjct: 6   KTIIF--DSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEA 63

Query: 334 ELKVLCKIH-HINV--FISTF------------------GNGSLSDHLHDPLLKGHQPLT 372
           E  +L  +  H NV  F   +                    GS++D L    LK  + + 
Sbjct: 64  EYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTD-LVKGFLKRGERME 122

Query: 373 WTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNE 432
                 I  +A  G++++H +   + +HRD+K +NILL      K+ DFG+         
Sbjct: 123 EPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGV--------S 171

Query: 433 KEMLATRL-----VGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELI 487
            ++ +TRL     VGTP ++ PE I  ++         ++     + DV++ G+   EL 
Sbjct: 172 AQLTSTRLRRNTSVGTPFWMAPEVIACEQ--------QLDSTYDARCDVWSLGITAIELG 223

Query: 488 TGKRALIRDDSEPTKMKSLITI 509
            G   L    ++   M++L  I
Sbjct: 224 DGDPPL----ADLHPMRALFKI 241

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 49.5 bits (118), Expect = 5e-06
 Identities = 65/319 (20%), Positives = 125/319 (39%), Gaps = 79/319 (24%)

Query: 194 NGLPTAEKSGKTHKWVTVIA-LLSAVALFSVITLIIILLRRKRPEEKITEDAKHVSKAMS 252
           +GLP  ++  KT  W   I   L A  + +++    + +R +   E      K V     
Sbjct: 614 SGLPPCKRVRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLE-----LKRVEN--- 665

Query: 253 ITTRAFSSQGQCKENTEDVTVLESERTIIFSLEEIEEATNNFDESRIIGRGGFGNVYFG- 311
                       ++ T ++   +S+ +   ++ +I  +     E  +I RG  G  Y G 
Sbjct: 666 ------------EDGTWELQFFDSKVSKSITINDILSSLK---EENVISRGKKGASYKGK 710

Query: 312 -LLGDREAAIKKMRSNKS--KEFFAELKVLCKIHHINV--------------FISTFGNG 354
            +    +  +K++    S      A++    K+ H N+               I  +  G
Sbjct: 711 SIKNGMQFVVKEINDVNSIPSSEIADMG---KLQHPNIVKLIGLCRSEKGAYLIHEYIEG 767

Query: 355 -SLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLD-- 411
            +LS+ L +        L+W  R +IA+  AK + ++H       V  ++    I++D  
Sbjct: 768 KNLSEVLRN--------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGK 819

Query: 412 DGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVT 471
           D    +++  GL+  +          T+   +  Y+ PE     R   D+         T
Sbjct: 820 DEPHLRLSLPGLLCTD----------TKCFISSAYVAPE----TRETKDI---------T 856

Query: 472 TKTDVFAFGVVLAELITGK 490
            K+D++ FG++L EL+TGK
Sbjct: 857 EKSDIYGFGLILIELLTGK 875

Length = 968

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 48.1 bits (114), Expect = 5e-06
 Identities = 32/101 (31%), Positives = 50/101 (49%), Gaps = 17/101 (16%)

Query: 390 IHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPP 449
           + D  + R V+RD+K  NILLDD    +++D GL     +  E E +  R VGT GY+ P
Sbjct: 115 LEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAV---QIPEGETVRGR-VGTVGYMAP 170

Query: 450 EYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
           E I  +++ F               D +  G ++ E+I G+
Sbjct: 171 EVINNEKYTF-------------SPDWWGLGCLIYEMIQGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 48.1 bits (114), Expect = 5e-06
 Identities = 62/222 (27%), Positives = 99/222 (44%), Gaps = 61/222 (27%)

Query: 299 IIGRGGFGNVYFGLLGDREAAIKKMRSNK-----------------SKEFFAELK----- 336
           IIGRGGFG VY    G R+A   KM + K                 ++     L      
Sbjct: 1   IIGRGGFGEVY----GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDC 56

Query: 337 --VLCKIHHINV-----FISTFGNG-SLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIE 388
             ++C  +  +      FI    NG  L  HL    +   + + + A T+I L    G+E
Sbjct: 57  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYA-TEIIL----GLE 111

Query: 389 YIHDHTKARYV-HRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYL 447
           ++H+    R+V +RD+K +NILLD+    +++D GL       ++K+  A+  VGT GY+
Sbjct: 112 HMHN----RFVVYRDLKPANILLDEHGHVRISDLGLAC---DFSKKKPHAS--VGTHGYM 162

Query: 448 PPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
            PE +  K   +D           +  D F+ G +L +L+ G
Sbjct: 163 APE-VLQKGTAYD-----------SSADWFSLGCMLFKLLRG 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 48.0 bits (114), Expect = 5e-06
 Identities = 55/232 (23%), Positives = 97/232 (41%), Gaps = 61/232 (26%)

Query: 300 IGRGGFGNVYF----GLL-----GDRE-------AAIKKMRSNKSK----EFFAELKVLC 339
           +G G FG V+     GL      G  E        A+K +R++ +K    +F  E+K++ 
Sbjct: 13  LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72

Query: 340 KIHHINVFISTFG----------------NGSLSDHLHDPLLKGH-------QPLTWTAR 376
           ++ + N+ I   G                NG L+  L    ++           ++    
Sbjct: 73  RLKNPNI-IRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANL 131

Query: 377 TQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEML 436
             +A+  A G++Y+       +VHRD+ T N L+ +    K+ADFG+             
Sbjct: 132 LYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGM------------- 175

Query: 437 ATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
            +R + +  Y   +   V   R+    S++  + TT +DV+AFGV L E+ T
Sbjct: 176 -SRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 48.0 bits (114), Expect = 5e-06
 Identities = 56/217 (25%), Positives = 98/217 (45%), Gaps = 43/217 (19%)

Query: 298 RIIGRGGFGNVYFGLL---GDRE--AAIKKMRSNKSKE----FFAELKVLCKIHHINVF- 347
           RI+G G FG +  G L     RE   AI  +R+  S +    F AE   L +  H N+  
Sbjct: 11  RILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVR 70

Query: 348 ---ISTFGNG------SLSDHLHDPLLKGHQ-PLTWTARTQIALDAAKGIEYIHDHTKAR 397
              + T GN        +S+   D  L+ H+  L       +    A G++Y+   ++  
Sbjct: 71  LEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYL---SEMG 127

Query: 398 YVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYL--PPEYIFVK 455
           YVH+ +    +L++  L  K++ F   +L+E  ++ E + T + G    L   PE I   
Sbjct: 128 YVHKGLAAHKVLVNSDLVCKISGFR--RLQE--DKSEAIYTTMSGKSPVLWAAPEAIQYH 183

Query: 456 RFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKR 491
            F             ++ +DV++FG+V+ E+++ G+R
Sbjct: 184 HF-------------SSASDVWSFGIVMWEVMSYGER 207

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 48.2 bits (115), Expect = 5e-06
 Identities = 34/103 (33%), Positives = 49/103 (47%), Gaps = 16/103 (15%)

Query: 387 IEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGY 446
           ++++H   +   ++RDIK  NILLD      + DFGL K  E   E+E  A    GT  Y
Sbjct: 118 LDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSK--EFLAEEEERAYSFCGTIEY 172

Query: 447 LPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
           + PE I   R     H   +        D ++ GV+  EL+TG
Sbjct: 173 MAPEVI---RGGSGGHDKAV--------DWWSLGVLTFELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 48.4 bits (115), Expect = 5e-06
 Identities = 30/91 (32%), Positives = 43/91 (47%), Gaps = 16/91 (17%)

Query: 399 VHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFR 458
           ++RD+K  NILLD      + DFGL KL  + ++K        GTP YL PE +      
Sbjct: 115 IYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDK---TNTFCGTPEYLAPELL------ 165

Query: 459 FDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
                  +    T   D +  GV+L E++TG
Sbjct: 166 -------LGHGYTKAVDWWTLGVLLYEMLTG 189

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 48.2 bits (115), Expect = 5e-06
 Identities = 48/173 (27%), Positives = 80/173 (46%), Gaps = 42/173 (24%)

Query: 334 ELKVL--CKIHHINVFISTF-GNGSLS---DHLH----DPLLK--GHQPLTWTARTQIAL 381
           ELKVL  C   +I  F   F  +G +S   +H+     D +LK  G  P     +  IA+
Sbjct: 49  ELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAV 108

Query: 382 DAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFG----LVKLEERTNEKEMLA 437
              +G+ Y+ +  K + +HRD+K SNIL++     K+ DFG    L+         + +A
Sbjct: 109 --LRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---------DSMA 155

Query: 438 TRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
              VGT  Y+ PE +    +             T ++D+++ G+ L E+  G+
Sbjct: 156 NSFVGTRSYMSPERLQGTHY-------------TVQSDIWSLGLSLVEMAIGR 195

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 48.2 bits (115), Expect = 6e-06
 Identities = 55/221 (24%), Positives = 89/221 (40%), Gaps = 56/221 (25%)

Query: 298 RIIGRGGFGNV--YFGLLGDREAAIKKMR-----SNKSKEFFAELKVLCKIHH------I 344
           + IG G  G V   +  +  +  AIKK+         +K  + EL ++  ++H      +
Sbjct: 22  KPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLL 81

Query: 345 NVF-----ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAK----------GIEY 389
           NVF     +  F +  L   L D  L   Q +      Q+ LD  +          GI++
Sbjct: 82  NVFTPQKSLEEFQDVYLVMELMDANL--CQVI------QMDLDHERMSYLLYQMLCGIKH 133

Query: 390 IHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPP 449
           +H    A  +HRD+K SNI++      K+ DFGL     RT     + T  V T  Y  P
Sbjct: 134 LHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA----RTAGTSFMMTPYVVTRYYRAP 186

Query: 450 EYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
           E I             + +      D+++ G ++ E+I G 
Sbjct: 187 EVI-------------LGMGYKENVDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 48.1 bits (114), Expect = 6e-06
 Identities = 59/221 (26%), Positives = 102/221 (46%), Gaps = 40/221 (18%)

Query: 288 EEATNNFDESRIIGRGGFGNVY------FGLLGDREAAIKKMRSNKSKEFFAELKVL--C 339
           E   ++F++   +G G  G V+       GL+  R+    +++     +   EL+VL  C
Sbjct: 1   ELKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC 60

Query: 340 KIHHINVFISTF-GNGSLS---DHLH----DPLLK--GHQPLTWTARTQIALDAAKGIEY 389
              +I  F   F  +G +S   +H+     D +LK  G  P     +  IA+   KG+ Y
Sbjct: 61  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV--IKGLTY 118

Query: 390 IHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPP 449
           + +  K + +HRD+K SNIL++     K+ DFG+          + +A   VGT  Y+ P
Sbjct: 119 LRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGV-----SGQLIDSMANSFVGTRSYMSP 171

Query: 450 EYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
           E     R +   H SV       ++D+++ G+ L E+  G+
Sbjct: 172 E-----RLQ-GTHYSV-------QSDIWSMGLSLVEMAIGR 199

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 47.7 bits (114), Expect = 7e-06
 Identities = 60/239 (25%), Positives = 95/239 (39%), Gaps = 73/239 (30%)

Query: 294 FDESRIIGRGGFGNVYFGLLGD----REAAIKKMRSNK------SKEFFAELKVLCKIHH 343
           ++    IGRG +G VY     +    +E AIKK + +K      S+    E+ +L ++ H
Sbjct: 2   YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61

Query: 344 IN------VFIS---------------------TFGNGSLSDHLHDPLLKGHQPLTWTAR 376
            N      VF+                       F   +    +   ++K    L W   
Sbjct: 62  ENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKS---LLW--- 115

Query: 377 TQIALDAAKGIEYIHDHTKARYV-HRDIKTSNILL----DDGLRAKVADFGLVKLEERTN 431
            QI L+   G+ Y+H    + +V HRD+K +NIL+     +    K+ D GL +L     
Sbjct: 116 -QI-LN---GVHYLH----SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFN--A 164

Query: 432 EKEMLAT--RLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
             + LA    +V T  Y  PE +   R     H        T   D++A G + AEL+T
Sbjct: 165 PLKPLADLDPVVVTIWYRAPELLLGAR-----H-------YTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 47.7 bits (113), Expect = 7e-06
 Identities = 34/113 (30%), Positives = 55/113 (48%), Gaps = 21/113 (18%)

Query: 385 KGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP 444
           +G++YIH    A  +HRD+K SN+ +++    ++ DFGL     R  + EM  T  V T 
Sbjct: 129 RGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLA----RQADDEM--TGYVATR 179

Query: 445 GYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDD 497
            Y  PE +        MH +          D+++ G ++AEL+ GK     +D
Sbjct: 180 WYRAPEIMLNW-----MHYN-------QTVDIWSVGCIMAELLKGKALFPGND 220

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 47.7 bits (113), Expect = 8e-06
 Identities = 46/167 (27%), Positives = 81/167 (48%), Gaps = 30/167 (17%)

Query: 334 ELKVL--CKIHHINVFISTF-GNGSLS---DHLH----DPLLKGHQPLTWTARTQIALDA 383
           EL+VL  C   +I  F   F  +G +S   +H+     D +LK  + +      ++++  
Sbjct: 53  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAV 112

Query: 384 AKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGT 443
            +G+ Y+ +  K + +HRD+K SNIL++     K+ DFG+          + +A   VGT
Sbjct: 113 LRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGV-----SGQLIDSMANSFVGT 165

Query: 444 PGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
             Y+ PE     R +   H SV       ++D+++ G+ L EL  G+
Sbjct: 166 RSYMSPE-----RLQ-GTHYSV-------QSDIWSMGLSLVELAIGR 199

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 47.5 bits (113), Expect = 8e-06
 Identities = 37/122 (30%), Positives = 52/122 (42%), Gaps = 14/122 (11%)

Query: 331 FFAELKVLCKIHHINVFISTFGNG-SLSDHL-HDPLLKGHQPLTWTARTQIALDAAKGIE 388
           F   LK   + H    F+  + NG  L  HL  + +    +   + A    AL       
Sbjct: 56  FLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALG------ 109

Query: 389 YIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLP 448
           Y+H       V+RD+K  N++LD     K+ DFGL K E  ++   M      GTP YL 
Sbjct: 110 YLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCK-EGISDGATM--KTFCGTPEYLA 163

Query: 449 PE 450
           PE
Sbjct: 164 PE 165

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 47.8 bits (113), Expect = 8e-06
 Identities = 54/182 (29%), Positives = 85/182 (46%), Gaps = 30/182 (16%)

Query: 293 NFDESRIIGRGGFGNVYFGLL--GDREAAIK------KMRSNKSKEFFAELKVLCKIHHI 344
           +F+  ++IGRG FG V    L   D+  A+K       ++  ++  F  E  VL  ++  
Sbjct: 2   DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVL--VNGD 59

Query: 345 NVFISTFGNGSLSD---HLHDPLLKGHQPLTWTARTQIAL--DAAK--------GIEYIH 391
           N +I+T       +   +L      G   LT  ++ +  L  D A+         I+ +H
Sbjct: 60  NQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVH 119

Query: 392 DHTKARYVHRDIKTSNILLDDGLRAKVADFG-LVKLEERTNEKEMLATRLVGTPGYLPPE 450
              +  YVHRDIK  NIL+D     ++ADFG  +KL E    +  +A   VGTP Y+ PE
Sbjct: 120 ---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVA---VGTPDYISPE 173

Query: 451 YI 452
            +
Sbjct: 174 IL 175

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 47.7 bits (113), Expect = 9e-06
 Identities = 64/286 (22%), Positives = 107/286 (37%), Gaps = 57/286 (19%)

Query: 265 KENTEDVTVLESERTIIFSLEEIEEATNNFDESRIIGRGGFGNVYFGLLGDREAAIKKMR 324
           ++N      L     I+  + +++    ++D  ++IGRG FG V       R  + +K+ 
Sbjct: 16  RKNKNIDNFLNRYEKIVRKIRKLQMKAEDYDVVKVIGRGAFGEVQLV----RHKSSQKVY 71

Query: 325 SNK-----------SKEFFAE-------------LKVLCKIH---HINVFISTFGNGSLS 357
           + K              FF E             +++ C      ++ + +     G L 
Sbjct: 72  AMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLV 131

Query: 358 DHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAK 417
           + + +  +       +TA   +ALDA      IH       +HRD+K  N+LLD     K
Sbjct: 132 NLMSNYDVPEKWAKFYTAEVVLALDA------IHSMG---LIHRDVKPDNMLLDKHGHLK 182

Query: 418 VADFGLVKLEERTNEKEML-ATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDV 476
           +ADFG      + +E  M+     VGTP Y+ PE          + S   +     + D 
Sbjct: 183 LADFGTCM---KMDETGMVRCDTAVGTPDYISPEV---------LKSQGGDGYYGRECDW 230

Query: 477 FAFGVVLAELITGKRALIRDDSEPTKMKSLITIMAAVAEWCLNEDA 522
           ++ GV L E++ G      D    T  K    IM         ED 
Sbjct: 231 WSVGVFLFEMLVGDTPFYADSLVGTYSK----IMDHKNSLNFPEDV 272

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 46.8 bits (111), Expect = 1e-05
 Identities = 33/113 (29%), Positives = 56/113 (49%), Gaps = 21/113 (18%)

Query: 378 QIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLA 437
           +IA+   KG+ Y+      + +HRD+K SN+L++   + K+ DFG+      T     +A
Sbjct: 99  RIAVAVVKGLTYLW---SLKILHRDVKPSNMLVNTRGQVKLCDFGV-----STQLVNSIA 150

Query: 438 TRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
              VGT  Y+ PE I  +  ++ +HS           DV++ G+   EL  G+
Sbjct: 151 KTYVGTNAYMAPERISGE--QYGIHS-----------DVWSLGISFMELALGR 190

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 46.9 bits (111), Expect = 1e-05
 Identities = 41/173 (23%), Positives = 71/173 (41%), Gaps = 43/173 (24%)

Query: 378 QIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLA 437
            I    A G+E++  H     VH+D+ T N+L+ D L  K++D GL +     +  +++ 
Sbjct: 128 HIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMG 184

Query: 438 TRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVL-------------- 483
             L+    ++ PE I   +F  D             +D++++GVVL              
Sbjct: 185 NSLLPIR-WMSPEAIMYGKFSID-------------SDIWSYGVVLWEVFSYGLQPYCGY 230

Query: 484 -----AELITGKRALIRDDSEPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDI 531
                 E+I  ++ L   D  P  + +L+         C NE    RP  +DI
Sbjct: 231 SNQDVIEMIRNRQVLPCPDDCPAWVYTLML-------ECWNEFPSRRPRFKDI 276

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 46.9 bits (111), Expect = 1e-05
 Identities = 34/121 (28%), Positives = 58/121 (47%), Gaps = 21/121 (17%)

Query: 380 ALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATR 439
           A + A G+ ++H       ++RD+K  N++LD     K+ADFG+ K     N  + + T+
Sbjct: 107 AAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK----ENMWDGVTTK 159

Query: 440 -LVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDS 498
              GTP Y+ PE I  + +                 D +AFGV+L E++ G+     +D 
Sbjct: 160 TFCGTPDYIAPEIIAYQPY-------------GKSVDWWAFGVLLYEMLAGQAPFEGEDE 206

Query: 499 E 499
           +
Sbjct: 207 D 207

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 46.5 bits (110), Expect = 1e-05
 Identities = 59/227 (25%), Positives = 97/227 (42%), Gaps = 55/227 (24%)

Query: 300 IGRGGFGNV------YFGLLGDREAAIKKMRSNKSKEFFA--ELKVLCKIH--------- 342
           +G+GGFG V        G +   +   KK    KS E  A  E ++L K++         
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60

Query: 343 ------HINVFISTFGNGSLSDHLHDPLLKG---HQPLTWTARTQIALDAAKGIEYIHDH 393
                 H+ + +S    G L  H+++   +G    + + ++A  QI      GI ++H  
Sbjct: 61  AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSA--QITC----GILHLHS- 113

Query: 394 TKARYVHRDIKTSNILLDDGLRAKVADFGL-VKLEERTNEKEMLATRLVGTPGYLPPEYI 452
                V+RD+K  N+LLDD    +++D GL V+L++         T+  GT GY+ PE +
Sbjct: 114 --MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT-----ITQRAGTNGYMAPEIL 166

Query: 453 FVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE 499
                         E   +   D FA G  + E++ G R   +D  E
Sbjct: 167 -------------KEEPYSYPVDWFAMGCSIYEMVAG-RTPFKDHKE 199

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 46.6 bits (110), Expect = 2e-05
 Identities = 49/205 (23%), Positives = 90/205 (43%), Gaps = 34/205 (16%)

Query: 300 IGRGGFGNVYFGLLGDREA---AIKKMRSNKSKE----FFAELKVL--CKIHHINVFIST 350
           +G G FG VY     ++E    A  K+   KS+E    +  E+++L  C   +I   +  
Sbjct: 20  LGDGAFGKVYKA--KNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGA 77

Query: 351 F-GNGSLSDHLH--------DPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHR 401
           F  +G L   +           +L+  + LT      I     + ++Y+H     + +HR
Sbjct: 78  FYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLH---SMKIIHR 134

Query: 402 DIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDM 461
           D+K  N+LL      K+ADFG+     +T ++       +GTP ++ PE +        M
Sbjct: 135 DLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRR---DSFIGTPYWMAPEVV--------M 183

Query: 462 HSSVMELQVTTKTDVFAFGVVLAEL 486
             ++ +     K D+++ G+ L E+
Sbjct: 184 CETMKDTPYDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 46.4 bits (111), Expect = 2e-05
 Identities = 35/129 (27%), Positives = 51/129 (39%), Gaps = 38/129 (29%)

Query: 387 IEYIHDHTKARYVHRDIKTSNILLDDGL-RAKVADFGLVKLEERTNEKEMLATRLVGTPG 445
           +E ++D  K   +H DIK  N+L D    R  + D+GL K              ++GTP 
Sbjct: 119 VEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCK--------------IIGTPS 164

Query: 446 -------YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDS 498
                  Y  PE I  K   +D+             D +A GV+  EL+TGK     D+ 
Sbjct: 165 CYDGTLDYFSPEKI--KGHNYDVS-----------FDWWAVGVLTYELLTGKHPFKEDED 211

Query: 499 E---PTKMK 504
           E      + 
Sbjct: 212 EELDLESLL 220

Length = 267

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 46.7 bits (111), Expect = 2e-05
 Identities = 50/179 (27%), Positives = 77/179 (43%), Gaps = 32/179 (17%)

Query: 380 ALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATR 439
           A + A  + Y+H       ++RD+K  NILLD      + DFGL K  E     +  +T 
Sbjct: 102 AAEIASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCK--EGIEHSKTTST- 155

Query: 440 LVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKT-DVFAFGVVLAELITGKRALI-RDD 497
             GTP YL PE              V+  Q   +T D +  G VL E++ G      RD 
Sbjct: 156 FCGTPEYLAPE--------------VLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT 201

Query: 498 SE--------PTKMKSLITIMAA-VAEWCLNEDAVDRPEMR-DIVAILSQIMITSTEWE 546
           +E        P ++K  I++ A  + E  L +D   R   + D + I + +  +S  W+
Sbjct: 202 AEMYDNILNKPLRLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINWD 260

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 46.5 bits (110), Expect = 2e-05
 Identities = 45/174 (25%), Positives = 66/174 (37%), Gaps = 61/174 (35%)

Query: 375 ARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLV---------- 424
           AR  IA +    IE +H   K  ++HRDIK  NIL+D     K+ DFGL           
Sbjct: 103 ARFYIA-ELTLAIESVH---KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSK 158

Query: 425 --------------------------------KLEERTNEKEM--LATRLVGTPGYLPPE 450
                                            LE+R  ++    LA  LVGTP Y+ PE
Sbjct: 159 YYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPE 218

Query: 451 YIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKMK 504
            +  K +             T   D ++ GV+L E++ G+   +      T++K
Sbjct: 219 VLLRKGY-------------TQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLK 259

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 46.8 bits (111), Expect = 2e-05
 Identities = 30/117 (25%), Positives = 52/117 (44%), Gaps = 21/117 (17%)

Query: 385 KGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP 444
           +G+ Y+H     R +HRD+KT NI ++D  +  + D G  +          L   L GT 
Sbjct: 168 EGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFP--VVAPAFLG--LAGTV 220

Query: 445 GYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRD-DSEP 500
               PE +   R +++           +K D+++ G+VL E++     +  D  S P
Sbjct: 221 ETNAPEVL--ARDKYN-----------SKADIWSAGIVLFEMLAYPSTIFEDPPSTP 264

Length = 357

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 46.3 bits (110), Expect = 2e-05
 Identities = 34/91 (37%), Positives = 49/91 (53%), Gaps = 16/91 (17%)

Query: 399 VHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFR 458
           ++RD+K  NILLD+    K+ DFGL K E   +EK+  A    GT  Y+ PE   V R R
Sbjct: 120 IYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKK--AYSFCGTVEYMAPE--VVNR-R 173

Query: 459 FDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
               S+          D ++FGV++ E++TG
Sbjct: 174 GHTQSA----------DWWSFGVLMFEMLTG 194

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 46.5 bits (110), Expect = 2e-05
 Identities = 36/111 (32%), Positives = 50/111 (45%), Gaps = 21/111 (18%)

Query: 380 ALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATR 439
           A + A  I Y+H       ++RD+K  NILLD      + DFGL K  E    +E  +T 
Sbjct: 102 AAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTST- 155

Query: 440 LVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKT-DVFAFGVVLAELITG 489
             GTP YL PE              V+  +   +T D +  G VL E++ G
Sbjct: 156 FCGTPEYLAPE--------------VLRKEPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 46.2 bits (109), Expect = 2e-05
 Identities = 32/114 (28%), Positives = 50/114 (43%), Gaps = 19/114 (16%)

Query: 386 GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPG 445
            ++Y+H     + V+RD+K  N++LD     K+ DFGL K  E   +   + T   GTP 
Sbjct: 107 ALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCK--EGITDAATMKT-FCGTPE 160

Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE 499
           YL PE +    +                 D +  GVV+ E++ G+      D E
Sbjct: 161 YLAPEVLEDNDY-------------GRAVDWWGLGVVMYEMMCGRLPFYNQDHE 201

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 46.1 bits (109), Expect = 2e-05
 Identities = 49/184 (26%), Positives = 82/184 (44%), Gaps = 36/184 (19%)

Query: 293 NFDESRIIGRGGFGNVYFGLLGDRE---AAIKK------MRSNKSKEFFAELKVLCKIHH 343
           +F+  R +G G FG V      + +    AIK+      ++  +    F+E K+L  I+H
Sbjct: 31  DFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINH 90

Query: 344 ---INVFISTFGNGSLSD----HLHDPLLKGHQPLTWTARTQ-----IALDAAKGIEYIH 391
              +N++      GS  D    +L    + G +  T+  R +     +    A  I  I 
Sbjct: 91  PFCVNLY------GSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIF 144

Query: 392 DHTKA-RYVHRDIKTSNILLDDGLRAKVADFGLVKL-EERTNEKEMLATRLVGTPGYLPP 449
           ++ ++   V+RD+K  N+LLD     K+ DFG  K+ + RT         L GTP Y+ P
Sbjct: 145 EYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRT-------YTLCGTPEYIAP 197

Query: 450 EYIF 453
           E + 
Sbjct: 198 EILL 201

Length = 340

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 45.9 bits (109), Expect = 3e-05
 Identities = 31/105 (29%), Positives = 47/105 (44%), Gaps = 18/105 (17%)

Query: 385 KGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP 444
           +GIE+ H H     +HRDIK  NIL+      K+ DFG  +      E   + T  V T 
Sbjct: 111 RGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE---VYTDYVATR 164

Query: 445 GYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
            Y  PE +            V + +     D++A G ++ E++TG
Sbjct: 165 WYRAPELL------------VGDTKYGRAVDIWAVGCLVTEMLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 46.0 bits (109), Expect = 3e-05
 Identities = 48/195 (24%), Positives = 88/195 (45%), Gaps = 42/195 (21%)

Query: 319 AIKKMRSNKSK----EFFAELKVLCK------IHHINVFIST---------FGNGSLSDH 359
           A+K +R + +K    +F  E+K++ +      I  + V I++           NG L+  
Sbjct: 50  AVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQF 109

Query: 360 L--HDPLLKGHQP----LTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDG 413
           L  H+P     +     ++++    +A   A G++Y+   +   +VHRD+ T N L+   
Sbjct: 110 LSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKN 166

Query: 414 LRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTK 473
              K+ADFG+ +      +   +  R V    ++  E I + +F             TT 
Sbjct: 167 YTIKIADFGMSRNLYS-GDYYRIQGRAVLPIRWMSWESILLGKF-------------TTA 212

Query: 474 TDVFAFGVVLAELIT 488
           +DV+AFGV L E++T
Sbjct: 213 SDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 46.1 bits (109), Expect = 3e-05
 Identities = 47/192 (24%), Positives = 80/192 (41%), Gaps = 48/192 (25%)

Query: 370 PLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK-LEE 428
           PLT       +   A+G+E++      + +HRD+   NILL +    K+ DFGL + + +
Sbjct: 170 PLTMEDLICYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYK 226

Query: 429 RTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
             +     + RL     ++ PE IF K +             TT++DV++FGV+L E+ +
Sbjct: 227 DPDYVRKGSARL--PLKWMAPESIFDKVY-------------TTQSDVWSFGVLLWEIFS 271

Query: 489 ---------------------GKRALIRDDSEPTKMKSLITIMAAVAEWCLNEDAVDRPE 527
                                G R    +++ P     +  IM A    C   D  +RP 
Sbjct: 272 LGASPYPGVQINEEFCQRLKDGTRMRAPENATP----EIYRIMLA----CWQGDPKERPT 323

Query: 528 MRDIVAILSQIM 539
              +V IL  ++
Sbjct: 324 FSALVEILGDLL 335

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 45.9 bits (109), Expect = 3e-05
 Identities = 28/92 (30%), Positives = 42/92 (45%), Gaps = 19/92 (20%)

Query: 398 YVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRF 457
           Y+HRD+K  N L+D     K+ DFGL K           A  +VG+P Y+ PE +  K +
Sbjct: 122 YIHRDLKPENFLIDASGHIKLTDFGLSK------GIVTYANSVVGSPDYMAPEVLRGKGY 175

Query: 458 RFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
            F +             D ++ G +L E + G
Sbjct: 176 DFTV-------------DYWSLGCMLYEFLCG 194

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 45.8 bits (108), Expect = 3e-05
 Identities = 38/125 (30%), Positives = 57/125 (45%), Gaps = 22/125 (17%)

Query: 373 WTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNE 432
           +TA   +ALDA      IH      ++HRD+K  N+LLD     K+ADFG      + N+
Sbjct: 147 YTAEVVLALDA------IHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCM---KMNK 194

Query: 433 KEML-ATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKR 491
           + M+     VGTP Y+ PE          + S   +     + D ++ GV L E++ G  
Sbjct: 195 EGMVRCDTAVGTPDYISPEV---------LKSQGGDGYYGRECDWWSVGVFLYEMLVGDT 245

Query: 492 ALIRD 496
               D
Sbjct: 246 PFYAD 250

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 45.8 bits (108), Expect = 4e-05
 Identities = 43/191 (22%), Positives = 84/191 (43%), Gaps = 32/191 (16%)

Query: 368 HQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK-L 426
            + LT+      A   A+G+EY+      + +HRD+   N+L+ +    K+ADFGL + +
Sbjct: 128 EEQLTFKDLVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDV 184

Query: 427 EERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAEL 486
                 K+    RL     ++ PE +F + +             T ++DV++FGV+L E+
Sbjct: 185 HNIDYYKKTTNGRL--PVKWMAPEALFDRVY-------------THQSDVWSFGVLLWEI 229

Query: 487 ITGKRA------------LIRDDSEPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI 534
            T   +            L+++     K  +    +  +   C +     RP  + +V  
Sbjct: 230 FTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289

Query: 535 LSQIM-ITSTE 544
           L +++ +TST+
Sbjct: 290 LDRVLTVTSTD 300

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 45.4 bits (107), Expect = 5e-05
 Identities = 57/239 (23%), Positives = 97/239 (40%), Gaps = 44/239 (18%)

Query: 276 SERTIIFSLEEIEEAT----NNFDESRIIGRGGFGNV--YFGLLGDREAAIKKM-----R 324
           S+R   F   EI ++T      +   + IG G  G V   +  + +R  AIKK+      
Sbjct: 4   SKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQN 63

Query: 325 SNKSKEFFAELKVLCKIHHINV--FISTFG-NGSLSDHLHDPLLKGHQPLTWTARTQIAL 381
              +K  + EL ++  ++H N+   ++ F    SL +     ++            Q+ L
Sbjct: 64  QTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMEL 123

Query: 382 DAAK----------GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTN 431
           D  +          GI+++H    A  +HRD+K SNI++      K+ DFGL     RT 
Sbjct: 124 DHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA----RTA 176

Query: 432 EKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
               + T  V T  Y  PE I    ++                D+++ G ++ E+I G 
Sbjct: 177 GTSFMMTPYVVTRYYRAPEVILGMGYK-------------ENVDIWSVGCIMGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 45.0 bits (106), Expect = 5e-05
 Identities = 31/121 (25%), Positives = 60/121 (49%), Gaps = 19/121 (15%)

Query: 369 QPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK-LE 427
           + L++      A   A+G+EY+      R +HRD+   N+L+ +    K+ADFGL + + 
Sbjct: 129 EQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIADFGLARGVH 185

Query: 428 ERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELI 487
           +    K+    RL     ++ PE +F + +             T ++DV++FG+++ E+ 
Sbjct: 186 DIDYYKKTSNGRL--PVKWMAPEALFDRVY-------------THQSDVWSFGILMWEIF 230

Query: 488 T 488
           T
Sbjct: 231 T 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 45.3 bits (107), Expect = 6e-05
 Identities = 42/172 (24%), Positives = 72/172 (41%), Gaps = 40/172 (23%)

Query: 384 AKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGT 443
           AKG+ ++        +HRD+   NILL  G   K+ DFGL +  +  N+   +       
Sbjct: 224 AKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLAR--DIRNDSNYVVKGNARL 278

Query: 444 P-GYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRAL--IRDDSE 499
           P  ++ PE IF                 T ++DV+++G++L E+ + G      +  DS+
Sbjct: 279 PVKWMAPESIF-------------NCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSK 325

Query: 500 PTKM--------------KSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQ 537
             KM                +  IM +    C + D + RP  + IV ++ Q
Sbjct: 326 FYKMIKEGYRMLSPECAPSEMYDIMKS----CWDADPLKRPTFKQIVQLIEQ 373

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 45.0 bits (106), Expect = 6e-05
 Identities = 71/290 (24%), Positives = 108/290 (37%), Gaps = 71/290 (24%)

Query: 298 RIIGRGGFGNVYFGLLGDREAAIKKMRSNKSKEFFAELKVLCKIHHINV----FISTFGN 353
           ++IG+G FG V                 +K++E F  +KVL K   +       I +  N
Sbjct: 1   KVIGKGSFGKVLLA-------------RHKAEEKFYAVKVLQKKAILKKKEEKHIMSERN 47

Query: 354 GSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHD--------HTKARY------- 398
             L +  H  L+  H       +    LD   G E  +           +AR+       
Sbjct: 48  VLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIAS 107

Query: 399 ----------VHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLP 448
                     V+RD+K  NILLD      + DFGL K      E     +   GTP YL 
Sbjct: 108 ALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCK---ENIEHNGTTSTFCGTPEYLA 164

Query: 449 PEYIFVKRFRFDMHSSVMELQVTTKT-DVFAFGVVLAELITG-------KRALIRDD--S 498
           PE              V+  Q   +T D +  G VL E++ G         A + D+  +
Sbjct: 165 PE--------------VLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN 210

Query: 499 EPTKMKSLITIMAA-VAEWCLNEDAVDRPEMR-DIVAILSQIMITSTEWE 546
           +P ++K  IT  A  + E  L +D   R   + D + I + I  +   W+
Sbjct: 211 KPLQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPINWD 260

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 44.7 bits (105), Expect = 7e-05
 Identities = 30/118 (25%), Positives = 56/118 (47%), Gaps = 25/118 (21%)

Query: 373 WTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNE 432
           ++A   +AL+      Y+H+      ++RD+K  N+LLD     K+ D+G+ K   R  +
Sbjct: 101 YSAEISLALN------YLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD 151

Query: 433 KEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
                +   GTP Y+ PE +  + + F +             D +A GV++ E++ G+
Sbjct: 152 T---TSTFCGTPNYIAPEILRGEDYGFSV-------------DWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 45.0 bits (106), Expect = 8e-05
 Identities = 40/163 (24%), Positives = 58/163 (35%), Gaps = 60/163 (36%)

Query: 386 GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK-------------------- 425
            +E +H   K  ++HRDIK  NIL+D     K+ DFGL                      
Sbjct: 113 AVESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQD 169

Query: 426 ----------------------LEERT--NEKEMLATRLVGTPGYLPPEYIFVKRFRFDM 461
                                 LE R     +  LA  LVGTP Y+ PE +    +    
Sbjct: 170 SMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGY---- 225

Query: 462 HSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKMK 504
                    T   D ++ GV+L E++ G+   +      T+MK
Sbjct: 226 ---------TQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMK 259

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 44.6 bits (105), Expect = 9e-05
 Identities = 30/104 (28%), Positives = 47/104 (45%), Gaps = 20/104 (19%)

Query: 386 GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPG 445
           GI+++H    A  +HRD+K SNI++      K+ DFGL     RT     + T  V T  
Sbjct: 135 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA----RTACTNFMMTPYVVTRY 187

Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
           Y  PE I    ++                D+++ G ++ EL+ G
Sbjct: 188 YRAPEVILGMGYK-------------ENVDIWSVGCIMGELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 44.0 bits (104), Expect = 1e-04
 Identities = 34/140 (24%), Positives = 55/140 (39%), Gaps = 30/140 (21%)

Query: 366 KGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLD-DGLRAKVADFGL- 423
              +PL             KG+ + H H     +HRD+K  N+L+D      K+AD GL 
Sbjct: 102 GPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLG 158

Query: 424 ----VKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAF 479
               + ++  T+E        + T  Y  PE +                  +T  D+++ 
Sbjct: 159 RAFSIPVKSYTHE--------IVTLWYRAPEVLLGST------------HYSTPVDIWSV 198

Query: 480 GVVLAELITGKRALIRDDSE 499
           G + AE+   K+ L   DSE
Sbjct: 199 GCIFAEMSR-KQPLFPGDSE 217

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 44.2 bits (104), Expect = 1e-04
 Identities = 36/103 (34%), Positives = 51/103 (49%), Gaps = 17/103 (16%)

Query: 387 IEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGY 446
           +E++H   K   V+RDIK  NILLD      + DFGL K E  + EKE   +   GT  Y
Sbjct: 118 LEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSK-EFLSEEKERTYS-FCGTIEY 172

Query: 447 LPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
           + PE I  K      H   +        D ++ G+++ EL+TG
Sbjct: 173 MAPEIIRGK----GGHGKAV--------DWWSLGILIFELLTG 203

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 43.9 bits (103), Expect = 1e-04
 Identities = 30/121 (24%), Positives = 58/121 (47%), Gaps = 19/121 (15%)

Query: 369 QPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK-LE 427
           + +T+          A+G+EY+      + +HRD+   N+L+ +    K+ADFGL + + 
Sbjct: 132 EQMTFKDLVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVN 188

Query: 428 ERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELI 487
                K+    RL     ++ PE +F + +             T ++DV++FGV++ E+ 
Sbjct: 189 NIDYYKKTTNGRL--PVKWMAPEALFDRVY-------------THQSDVWSFGVLMWEIF 233

Query: 488 T 488
           T
Sbjct: 234 T 234

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 43.8 bits (103), Expect = 1e-04
 Identities = 61/218 (27%), Positives = 87/218 (39%), Gaps = 52/218 (23%)

Query: 298 RIIGRGGFGNVYFGLLGDREA-----AIKKMRSN------KSKEFFAELKVLCK-IHHIN 345
           ++IG+G FG V   LL  R+      A+K ++        + K   AE  VL K + H  
Sbjct: 1   KVIGKGSFGKV---LLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPF 57

Query: 346 V--------------FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIH 391
           +              F+  F NG     L   L +        AR   A + A  + Y+H
Sbjct: 58  LVGLHYSFQTTEKLYFVLDFVNGG---ELFFHLQRERSFPEPRARFYAA-EIASALGYLH 113

Query: 392 DHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEY 451
                  V+RD+K  NILLD      + DFGL K  E   + +   T   GTP YL PE 
Sbjct: 114 ---SINIVYRDLKPENILLDSQGHVVLTDFGLCK--EGIAQSDT-TTTFCGTPEYLAPEV 167

Query: 452 IFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
           I  ++  +D              D +  G VL E++ G
Sbjct: 168 I--RKQPYD-----------NTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 43.6 bits (103), Expect = 1e-04
 Identities = 32/112 (28%), Positives = 50/112 (44%), Gaps = 24/112 (21%)

Query: 385 KGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK---LEERTNEKEMLATRLV 441
           KG+ + H H     +HRD+K  N+L++     K+ADFGL +   +  R    E      V
Sbjct: 110 KGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAE------V 160

Query: 442 GTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRAL 493
            T  Y PP+ +F  +              +T  D+++ G + AEL    R L
Sbjct: 161 VTLWYRPPDVLFGAKL------------YSTSIDMWSAGCIFAELANAGRPL 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 43.4 bits (102), Expect = 1e-04
 Identities = 46/210 (21%), Positives = 93/210 (44%), Gaps = 33/210 (15%)

Query: 300 IGRGGFGNVYFGL----LGDREAAIKKMRSNKS----KEFFAELKVLCKIHHINVFISTF 351
           IG G FG V  G         +  +K++R + S     +F  E +    + H N+     
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62

Query: 352 GNGSLSDHL----HDPL--LKGH-------QPLTWTART--QIALDAAKGIEYIHDHTKA 396
               ++ +L      PL  LKG+       + +T    T  ++A + A G+ ++H +   
Sbjct: 63  QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN-- 120

Query: 397 RYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKR 456
            ++H D+   N LL   L  K+ D+GL   + +  +  +   +L     ++ PE +    
Sbjct: 121 -FIHSDLALRNCLLTADLTVKIGDYGLSHNKYK-EDYYVTPDQLWVPLRWIAPELV---- 174

Query: 457 FRFDMHSSVMELQVTTKTDVFAFGVVLAEL 486
              ++H +++ +  T +++V++ GV + EL
Sbjct: 175 --DEVHGNLLVVDQTKESNVWSLGVTIWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 43.9 bits (103), Expect = 2e-04
 Identities = 53/212 (25%), Positives = 86/212 (40%), Gaps = 42/212 (19%)

Query: 300 IGRGGFGNV---YFGLLGDREAAIKKM-----RSNKSKEFFAELKVLCKIHHINV--FIS 349
           IG G  G V   Y  +L DR  AIKK+         +K  + EL ++  ++H N+   ++
Sbjct: 25  IGSGAQGIVCAAYDAVL-DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83

Query: 350 TFGNGSLSDHLHDP-LLKGHQPLTWTARTQIALDAAK----------GIEYIHDHTKARY 398
            F      +   D  L+            Q+ LD  +          GI+++H    A  
Sbjct: 84  VFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH---SAGI 140

Query: 399 VHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFR 458
           +HRD+K SNI++      K+ DFGL     RT     + T  V T  Y  PE I    ++
Sbjct: 141 IHRDLKPSNIVVKSDCTLKILDFGLA----RTAGTSFMMTPYVVTRYYRAPEVILGMGYK 196

Query: 459 FDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
                           D+++ G ++ E++  K
Sbjct: 197 -------------ENVDIWSVGCIMGEMVRHK 215

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 43.3 bits (102), Expect = 2e-04
 Identities = 45/219 (20%), Positives = 88/219 (40%), Gaps = 47/219 (21%)

Query: 300 IGRGGFGNVYFG----LLGDREAAIKKMRSNKSKE----FFAELKVLCKIHHINVF---- 347
           IG G FG V  G     +      +K++R++ + +    F  E++   +++H NV     
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62

Query: 348 ----------ISTFGN-GSLSDHLHDPLLKGHQPLTWTARTQ--IALDAAKGIEYIHDHT 394
                     +  F   G L ++L     +G             +A + A G+ ++H   
Sbjct: 63  QCIESIPYLLVLEFCPLGDLKNYLRSN--RGMVAQMAQKDVLQRMACEVASGLLWLH--- 117

Query: 395 KARYVHRDIKTSNILLDDGLRAKVADFGLVKLEER-----TNEKEMLATRLVGTPGYLPP 449
           +A ++H D+   N  L   L  K+ D+GL   +       T +   +  R      +L P
Sbjct: 118 QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLR------WLAP 171

Query: 450 EYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
           E + ++         ++    T K+++++ GV + EL T
Sbjct: 172 ELVEIR------GQDLLPKDQTKKSNIWSLGVTMWELFT 204

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 43.5 bits (102), Expect = 2e-04
 Identities = 31/121 (25%), Positives = 57/121 (47%), Gaps = 19/121 (15%)

Query: 369 QPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEE 428
           + LT       +   AKG+E++      + +HRD+   NILL +    K+ DFGL +  +
Sbjct: 174 KVLTLEDLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLAR--D 228

Query: 429 RTNEKEMLATRLVGTP-GYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELI 487
              + + +       P  ++ PE IF + +             T ++DV++FGV+L E+ 
Sbjct: 229 IYKDPDYVRKGDARLPLKWMAPETIFDRVY-------------TIQSDVWSFGVLLWEIF 275

Query: 488 T 488
           +
Sbjct: 276 S 276

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 43.5 bits (102), Expect = 2e-04
 Identities = 33/132 (25%), Positives = 64/132 (48%), Gaps = 19/132 (14%)

Query: 358 DHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAK 417
           ++ ++P     + L++      A   A+G+EY+      + +HRD+   N+L+ +    K
Sbjct: 124 EYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMK 180

Query: 418 VADFGLVK-LEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDV 476
           +ADFGL + +      K+    RL     ++ PE +F + +             T ++DV
Sbjct: 181 IADFGLARDIHHIDYYKKTTNGRL--PVKWMAPEALFDRIY-------------THQSDV 225

Query: 477 FAFGVVLAELIT 488
           ++FGV+L E+ T
Sbjct: 226 WSFGVLLWEIFT 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 43.1 bits (101), Expect = 2e-04
 Identities = 29/109 (26%), Positives = 54/109 (49%), Gaps = 24/109 (22%)

Query: 385 KGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEE---RTNEKEMLATRLV 441
           +G+ Y H   K + +HRD+K  N+L+++    K+ADFGL + +    +T   E++     
Sbjct: 114 RGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV----- 165

Query: 442 GTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
            T  Y PP+ +            +   + +T  D++  G +L E+ TG+
Sbjct: 166 -TLWYRPPDVL------------LGSTEYSTPIDMWGVGCILYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 43.5 bits (102), Expect = 2e-04
 Identities = 37/168 (22%), Positives = 72/168 (42%), Gaps = 36/168 (21%)

Query: 399 VHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFR 458
           ++RD+K  N+LLD     K+ D+G+ K      +     +   GTP Y+ PE +  + + 
Sbjct: 118 IYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDT---TSTFCGTPNYIAPEILRGEEYG 174

Query: 459 FDMHSSVMELQVTTKTDVFAFGVVLAELITGKRA--LIRDDSE--------------PTK 502
           F +             D +A GV++ E++ G+    +I D+ +              P +
Sbjct: 175 FSV-------------DWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIR 221

Query: 503 MKSLITIMAA-VAEWCLNEDAVDRPEMR---DIVAILSQIMITSTEWE 546
           +   +++ A+ V +  LN+D  +R   +       I S     S +W+
Sbjct: 222 IPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWD 269

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 43.1 bits (101), Expect = 2e-04
 Identities = 31/110 (28%), Positives = 51/110 (46%), Gaps = 20/110 (18%)

Query: 385 KGIEYIHDHTKARYV-HRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGT 443
           +G+ YIH     RY+ HRD+K  N+L+ D    K+ADFGL + +   +      +  V T
Sbjct: 114 RGLSYIHQ----RYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHT---YSNEVVT 166

Query: 444 PGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRAL 493
             Y PP+ +            +   + +T  D++  G +  E+I G  A 
Sbjct: 167 LWYRPPDVL------------LGSTEYSTCLDMWGVGCIFVEMIQGVAAF 204

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 42.6 bits (100), Expect = 3e-04
 Identities = 48/214 (22%), Positives = 89/214 (41%), Gaps = 54/214 (25%)

Query: 300 IGRGGFGNVYFGLL----GDREAAIKKMRSNKSK-----EFFAELKVL------------ 338
           +G G FG V  G+      ++  A+K ++++ +      E   E  V+            
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62

Query: 339 --CKIHHINVFISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKA 396
             C+     + +     G L     +  L+ ++ +T    T++    + G++Y+ +    
Sbjct: 63  GICEAESWMLVMELAELGPL-----NKFLQKNKHVTEKNITELVHQVSMGMKYLEETN-- 115

Query: 397 RYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLP-----PEY 451
            +VHRD+   N+LL     AK++DFGL K     +E    A     T G  P     PE 
Sbjct: 116 -FVHRDLAARNVLLVTQHYAKISDFGLSK-ALGADENYYKAK----THGKWPVKWYAPEC 169

Query: 452 IFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAE 485
           +   +F             ++K+DV++FGV++ E
Sbjct: 170 MNYYKF-------------SSKSDVWSFGVLMWE 190

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 42.3 bits (99), Expect = 3e-04
 Identities = 50/205 (24%), Positives = 90/205 (43%), Gaps = 38/205 (18%)

Query: 300 IGRGGFGNVYFGLL--GDREAAIKKMRSN-----KSKEFFAELKVLCKIHHINVFISTFG 352
           IGRG FG V+ G L   +   A+K  R       K+K F  E ++L +  H N+ +   G
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAK-FLQEARILKQYSHPNI-VRLIG 60

Query: 353 NGSLSDHLH--DPLLKGHQPLTWTART----------QIALDAAKGIEYIHDHTKARYVH 400
             +    ++    L++G   LT+              Q+  +AA G+EY+        +H
Sbjct: 61  VCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLE---SKHCIH 117

Query: 401 RDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFD 460
           RD+   N L+ +    K++DFG+ + EE          + +    +  PE +   R+   
Sbjct: 118 RDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVK-WTAPEALNYGRY--- 173

Query: 461 MHSSVMELQVTTKTDVFAFGVVLAE 485
                     ++++DV++FG++L E
Sbjct: 174 ----------SSESDVWSFGILLWE 188

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 42.7 bits (100), Expect = 3e-04
 Identities = 27/109 (24%), Positives = 53/109 (48%), Gaps = 24/109 (22%)

Query: 385 KGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK---LEERTNEKEMLATRLV 441
           +G+ Y H   + + +HRD+K  N+L+++    K+ADFGL +   +  +T   E++     
Sbjct: 115 RGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV----- 166

Query: 442 GTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
            T  Y PP+ +            +     +T+ D++  G +  E+ TG+
Sbjct: 167 -TLWYRPPDIL------------LGSTDYSTQIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 42.6 bits (100), Expect = 3e-04
 Identities = 30/103 (29%), Positives = 45/103 (43%), Gaps = 18/103 (17%)

Query: 387 IEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGY 446
           +E++H +     V+RD+K  NILLD      + DFGL K     N+         GT  Y
Sbjct: 109 LEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDNK---TTNTFCGTTEY 162

Query: 447 LPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
           L PE +            + E   T   D ++ GV++ E+  G
Sbjct: 163 LAPEVL------------LDEKGYTKHVDFWSLGVLVFEMCCG 193

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 42.3 bits (99), Expect = 4e-04
 Identities = 39/149 (26%), Positives = 58/149 (38%), Gaps = 54/149 (36%)

Query: 373 WTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLV-------- 424
           + A T +A+DA      IH   +  ++HRDIK  N+LLD     K++DFGL         
Sbjct: 106 YIAETVLAIDA------IH---QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHR 156

Query: 425 ------------------------KLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFD 460
                                   K E     +  LA   VGTP Y+ PE +F       
Sbjct: 157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPE-VF------- 208

Query: 461 MHSSVMELQVTTKTDVFAFGVVLAELITG 489
                M+       D ++ GV++ E++ G
Sbjct: 209 -----MQTGYNKLCDWWSLGVIMYEMLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 42.5 bits (100), Expect = 5e-04
 Identities = 19/37 (51%), Positives = 25/37 (67%), Gaps = 3/37 (8%)

Query: 387 IEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGL 423
           IE +H   K  ++HRDIK  NIL+D G   K++DFGL
Sbjct: 114 IEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGL 147

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 41.9 bits (98), Expect = 5e-04
 Identities = 40/150 (26%), Positives = 65/150 (43%), Gaps = 21/150 (14%)

Query: 386 GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPG 445
            +E++H   K   ++RDIK  NILLD      + DFGL K E   +E E  A    GT  
Sbjct: 117 ALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSK-EFHEDEVER-AYSFCGTIE 171

Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKMKS 505
           Y+ P+ +       D              D ++ GV++ EL+TG      D  + ++ + 
Sbjct: 172 YMAPDIVRGGDGGHD-----------KAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEI 220

Query: 506 LITIMAAVAEW-----CLNEDAVDRPEMRD 530
              I+ +   +      L +D + R  M+D
Sbjct: 221 SRRILKSEPPYPQEMSALAKDIIQRLLMKD 250

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 41.9 bits (98), Expect = 6e-04
 Identities = 43/174 (24%), Positives = 73/174 (41%), Gaps = 40/174 (22%)

Query: 384 AKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK-LEERTNEKEMLATRLVG 442
           A+G+E++        VHRD+   N+LL  G   K+ DFGL + +   +N     +T L  
Sbjct: 247 ARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFL-- 301

Query: 443 TPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELI----TGKRALIRDDS 498
              ++ PE IF   +             TT +DV+++G++L E+     T    +I D +
Sbjct: 302 PVKWMAPESIFDNLY-------------TTLSDVWSYGILLWEIFSLGGTPYPGMIVDST 348

Query: 499 EPTKMKS-------------LITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIM 539
              K+KS             +  IM      C N +   RP    +  I+  ++
Sbjct: 349 FYNKIKSGYRMAKPDHATQEVYDIMVK----CWNSEPEKRPSFLHLSDIVESLL 398

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 42.1 bits (99), Expect = 6e-04
 Identities = 33/125 (26%), Positives = 55/125 (44%), Gaps = 21/125 (16%)

Query: 389 YIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLV-KLEERTNEKEMLATRLVGTPGYL 447
           Y+H       +HRD+KT NI LD+   A + DFG   KL+   +  +       GT    
Sbjct: 200 YLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYG--WSGTLETN 254

Query: 448 PPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRAL--IRDDSEPTKMKS 505
            PE + +  +               KTD+++ G+VL E+      L   +  S  ++++S
Sbjct: 255 SPELLALDPY-------------CAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRS 301

Query: 506 LITIM 510
           +I  M
Sbjct: 302 IIRCM 306

Length = 392

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 41.9 bits (98), Expect = 6e-04
 Identities = 32/119 (26%), Positives = 56/119 (47%), Gaps = 19/119 (15%)

Query: 371 LTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK-LEER 429
           L++      +   A G+E++        VHRD+   N+L+ +G   K+ DFGL + +   
Sbjct: 236 LSYMDLVGFSYQVANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRD 292

Query: 430 TNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
           +N     +T L     ++ PE IF   +             TT +DV++FG++L E+ T
Sbjct: 293 SNYISKGSTFL--PLKWMAPESIFNNLY-------------TTLSDVWSFGILLWEIFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 41.6 bits (97), Expect = 0.001
 Identities = 37/149 (24%), Positives = 56/149 (37%), Gaps = 54/149 (36%)

Query: 373 WTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLV-------- 424
           + A T +A+D+      IH   +  ++HRDIK  N+LLD     K++DFGL         
Sbjct: 106 YIAETVLAIDS------IH---QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHR 156

Query: 425 ------------------------KLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFD 460
                                   K E     +  LA   VGTP Y+ PE          
Sbjct: 157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVF-------- 208

Query: 461 MHSSVMELQVTTKTDVFAFGVVLAELITG 489
                M+       D ++ GV++ E++ G
Sbjct: 209 -----MQTGYNKLCDWWSLGVIMYEMLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 40.8 bits (96), Expect = 0.001
 Identities = 30/108 (27%), Positives = 52/108 (48%), Gaps = 24/108 (22%)

Query: 385 KGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK---LEERTNEKEMLATRLV 441
           +G+ Y H   + R +HRD+K  N+L+ +    K+ADFGL +   +  +T   E      V
Sbjct: 114 RGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNE------V 164

Query: 442 GTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
            T  Y PP+ +        + S+    + +T  D++  G +  E+ TG
Sbjct: 165 VTLWYRPPDVL--------LGST----EYSTSLDMWGVGCIFYEMATG 200

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 41.0 bits (96), Expect = 0.001
 Identities = 25/92 (27%), Positives = 45/92 (48%), Gaps = 16/92 (17%)

Query: 399 VHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFR 458
           ++RD+K  N+LLD     K+ D+G+ K   R  +     +   GTP Y+ PE +  + + 
Sbjct: 118 IYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD---TTSTFCGTPNYIAPEILRGEDYG 174

Query: 459 FDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
           F +             D +A GV++ E++ G+
Sbjct: 175 FSV-------------DWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 41.0 bits (96), Expect = 0.001
 Identities = 47/210 (22%), Positives = 87/210 (41%), Gaps = 46/210 (21%)

Query: 349 STFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNI 408
           S+  + S  +   +       PL      + +   A+G++++        +HRD+   N+
Sbjct: 191 SSQSSDSKDEEDTEDS----WPLDLDDLLRFSSQVAQGMDFL---ASKNCIHRDVAARNV 243

Query: 409 LLDDGLRAKVADFGLVK-LEERTNEKEMLATRLVGTP-GYLPPEYIFVKRFRFDMHSSVM 466
           LL DG  AK+ DFGL + +   +N       RL   P  ++ PE IF             
Sbjct: 244 LLTDGRVAKICDFGLARDIMNDSNYVVKGNARL---PVKWMAPESIF------------- 287

Query: 467 ELQVTTKTDVFAFGVVLAELIT-GKRAL--IRDDSEPTKM--------------KSLITI 509
           +   T ++DV+++G++L E+ + GK     I  +S+  KM                + +I
Sbjct: 288 DCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSI 347

Query: 510 MAAVAEWCLNEDAVDRPEMRDIVAILSQIM 539
           M      C N +  +RP    I  ++ + +
Sbjct: 348 MKM----CWNLEPTERPTFSQISQLIQRQL 373

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 40.2 bits (94), Expect = 0.001
 Identities = 29/114 (25%), Positives = 54/114 (47%), Gaps = 20/114 (17%)

Query: 378 QIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGL--VKLEE---RTNE 432
           ++A + A G+ ++H H    ++H D+   N  L   L  KV D+G+   + +E    T +
Sbjct: 103 RMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETED 159

Query: 433 KEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAEL 486
            + +  R      +L PE +       + H  ++  + T  ++V+A GV L EL
Sbjct: 160 DKCVPLR------WLAPELV------GEFHGGLITAEQTKPSNVWALGVTLWEL 201

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 40.8 bits (95), Expect = 0.001
 Identities = 33/120 (27%), Positives = 52/120 (43%), Gaps = 19/120 (15%)

Query: 369 QPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEE 428
           +PL    R  I       +EYIHD    + +HRDIK  NI L+   +  + DFG     E
Sbjct: 263 RPLLKQTR-AIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKIVLGDFGTAMPFE 318

Query: 429 RTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
              E+E      VGT     PE +              E+     TD+++ G++L ++++
Sbjct: 319 --KEREAFDYGWVGTVATNSPEIL--------AGDGYCEI-----TDIWSCGLILLDMLS 363

Length = 501

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 40.4 bits (94), Expect = 0.002
 Identities = 28/109 (25%), Positives = 56/109 (51%), Gaps = 24/109 (22%)

Query: 385 KGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEE---RTNEKEMLATRLV 441
           +G+ Y H   + + +HRD+K  N+L+++    K+ADFGL + +    +T   E++     
Sbjct: 115 RGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV----- 166

Query: 442 GTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
            T  Y PP+ +        + SS    + +T+ D++  G +  E+ +G+
Sbjct: 167 -TLWYRPPDVL--------LGSS----EYSTQIDMWGVGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 40.4 bits (94), Expect = 0.002
 Identities = 60/248 (24%), Positives = 99/248 (39%), Gaps = 64/248 (25%)

Query: 275 ESERTIIFSLEEIEEATN-NFDESRIIGRGGFGNVYFGLLGD--REAAIKKMRSNKSKEF 331
           + E+ I     +I  + N ++    IIG G FG VY  +  D   + AIKK+  +   + 
Sbjct: 51  DEEKMID---NDINRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKN 107

Query: 332 FAELKVLCKIHHINVFISTFGNGSLSDHLHDPLLKG------------------HQPLTW 373
             EL ++  ++HIN+         L D+ +    K                   H+ +  
Sbjct: 108 -RELLIMKNLNHINIIF-------LKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKH 159

Query: 374 TARTQIAL----------DAAKGIEYIHDHTKARYV-HRDIKTSNILLDDGLRA-KVADF 421
            AR   AL             + + YIH    ++++ HRD+K  N+L+D      K+ DF
Sbjct: 160 YARNNHALPLFLVKLYSYQLCRALAYIH----SKFICHRDLKPQNLLIDPNTHTLKLCDF 215

Query: 422 GLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGV 481
           G        + K +LA       G     YI   RF       +     TT  D+++ G 
Sbjct: 216 G--------SAKNLLA-------GQRSVSYI-CSRFYRAPELMLGATNYTTHIDLWSLGC 259

Query: 482 VLAELITG 489
           ++AE+I G
Sbjct: 260 IIAEMILG 267

Length = 440

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 39.9 bits (94), Expect = 0.002
 Identities = 28/105 (26%), Positives = 48/105 (45%), Gaps = 22/105 (20%)

Query: 385 KGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK-LEERTNEKEMLATRLVGT 443
           K ++++H +      HRDIK  NIL+ D +  K+ADFG  + +  +    E ++TR    
Sbjct: 111 KSLDHMHRNG---IFHRDIKPENILIKDDI-LKLADFGSCRGIYSKPPYTEYISTRW--- 163

Query: 444 PGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
             Y  PE +    +               K D++A G V  E+++
Sbjct: 164 --YRAPECLLTDGY------------YGPKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 39.7 bits (92), Expect = 0.003
 Identities = 57/221 (25%), Positives = 90/221 (40%), Gaps = 46/221 (20%)

Query: 300 IGRGGFGNVYFGLLGD----REAAIKKMR-SNKSKEFFAELKVLCKIHHINVFISTFGNG 354
           +GRG +G+VY     D    +E A+K++  +  S     E+ +L ++ H NV        
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFL 68

Query: 355 SLSDHL---------HD--PLLKGHQP---------LTWTARTQIALDAAKGIEYIHDHT 394
           S SD           HD   ++K H+          L  +    +      GI Y+H   
Sbjct: 69  SHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH--- 125

Query: 395 KARYV-HRDIKTSNILL----DDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPP 449
            A +V HRD+K +NIL+     +  R K+AD G  +L     +       +V T  Y  P
Sbjct: 126 -ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184

Query: 450 EYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
           E +   R              T   D++A G + AEL+T +
Sbjct: 185 ELLLGAR------------HYTKAIDIWAIGCIFAELLTSE 213

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 39.9 bits (93), Expect = 0.003
 Identities = 23/76 (30%), Positives = 39/76 (51%), Gaps = 7/76 (9%)

Query: 374 TARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEK 433
            A   I+ + A  ++Y+H H     +HRD+K  N+L+ +    K+ DFGL K+   T  +
Sbjct: 105 MAVKYIS-EVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKV---TLNR 157

Query: 434 EMLATRLVGTPGYLPP 449
           E+    ++ TP    P
Sbjct: 158 ELNMMDILTTPSMAKP 173

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 39.4 bits (92), Expect = 0.003
 Identities = 24/60 (40%), Positives = 32/60 (53%), Gaps = 4/60 (6%)

Query: 391 HDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPE 450
           H H +   ++RD+K  NILLD     K+ DFGL K  E  +E  +  T   GT  Y+ PE
Sbjct: 115 HLHQQG-IIYRDLKPENILLDAQGHVKLTDFGLCK--ESIHEGTVTHT-FCGTIEYMAPE 170

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 39.3 bits (92), Expect = 0.004
 Identities = 36/141 (25%), Positives = 56/141 (39%), Gaps = 36/141 (25%)

Query: 298 RIIGRGGFGNVYFGLLG-----DREAAIKKMR-SNKSKEFFAELKVLCKI-----H-HIN 345
            +IG+  F ++    L      +   A+KK+   + SKE    L+          H +I 
Sbjct: 4   TLIGKC-FEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNIL 62

Query: 346 VFISTF-------------GNGSLSDHLHDPLLKGHQP--LTWTARTQIALDAAKGIEYI 390
            ++++F               GS  D     LLK H P  L   A   I  D    ++YI
Sbjct: 63  PYVTSFIVDSELYVVSPLMAYGSCED-----LLKTHFPEGLPELAIAFILKDVLNALDYI 117

Query: 391 HDHTKARYVHRDIKTSNILLD 411
           H      ++HR +K S+ILL 
Sbjct: 118 H---SKGFIHRSVKASHILLS 135

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	563
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	99.98
PLN00009	294	cyclin-dependent kinase A; Provisional	99.98
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	99.98
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.98
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	99.98
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	99.98
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.98
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.98
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.98
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	99.98
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.98
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	99.98
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	99.98
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	99.98
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.98
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.98
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.98
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.98
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	99.98
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.98
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	99.98
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.98
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.98
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.97
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.97
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.97
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.97
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.97
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.97
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.97
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.97
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.97
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.97
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.97
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.97
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.97
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.97
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.97
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.97
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.97
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.97
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.97
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.97
KOG0586	596	consensus Serine/threonine protein kinase [General	99.97
KOG0596	677	consensus Dual specificity; serine/threonine and t	99.97
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.97
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.97
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.97
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.97
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	99.97
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.97
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.97
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.97
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.96
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.96
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.96
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.96
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.96
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.96
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.96
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.96
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.96
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.96
KOG0607	463	consensus MAP kinase-interacting kinase and relate	99.96
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.96
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.95
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.95
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.95
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.95
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.95
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.95
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.94
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.94
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.93
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.93
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.92
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.92
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.92
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.92
KOG1152	772	consensus Signal transduction serine/threonine kin	99.91
PLN00181	793	protein SPA1-RELATED; Provisional	99.91
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.9
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.9
PRK09188	365	serine/threonine protein kinase; Provisional	99.88
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.88
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.87
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.82
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.81
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.8
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.78
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.77
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.77
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.77
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.74
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.74
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.73
PRK12274	218	serine/threonine protein kinase; Provisional	99.73
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.72
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.72
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.72
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.71
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.67
smart00090	237	RIO RIO-like kinase.	99.67
PRK14879	211	serine/threonine protein kinase; Provisional	99.65
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.65
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.64
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.64
PRK10345	210	hypothetical protein; Provisional	99.63
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.61
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.54
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.51
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.47
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.36
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.33
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.23
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.21
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.03
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	98.97
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	98.94
COG4248	637	Uncharacterized protein with protein kinase and he	98.81
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	98.8
KOG3087	229	consensus Serine/threonine protein kinase [General	98.76
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.76
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	98.75
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.69
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.68
KOG1243	690	consensus Protein kinase [General function predict	98.65
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.57
PRK09902	216	hypothetical protein; Provisional	98.54
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.49
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.46
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.15
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.05
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.02
PRK10783	456	mltD membrane-bound lytic murein transglycosylase	97.98
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	97.81
PF01636	239	APH: Phosphotransferase enzyme family This family	97.67
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.67
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	97.66
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	97.64
KOG0576	829	consensus Mitogen-activated protein kinase kinase	97.56
PRK06347	592	autolysin; Reviewed	97.49
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	97.34
KOG1235	538	consensus Predicted unusual protein kinase [Genera	97.34
PRK06347	592	autolysin; Reviewed	97.25
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.23
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.2
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.16
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.06
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.03
PF01476	44	LysM: LysM domain; InterPro: IPR018392 This domain	97.0
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	96.92
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	96.9
PRK05231	319	homoserine kinase; Provisional	96.87
PRK10593	297	hypothetical protein; Provisional	96.85
PLN02876	822	acyl-CoA dehydrogenase	96.82
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	96.66
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	96.61
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	96.56
PLN02236	344	choline kinase	96.25
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	95.9
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	95.79
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	95.44
TIGR02899	44	spore_safA spore coat assembly protein SafA. in wh	95.4
PRK09550	401	mtnK methylthioribose kinase; Reviewed	95.36
cd00118	46	LysM Lysin domain, found in a variety of enzymes i	94.92
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	94.28
PF08693	40	SKG6: Transmembrane alpha-helix domain; InterPro:	94.27
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	94.11
COG2334	331	Putative homoserine kinase type II (protein kinase	94.09
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	93.81
KOG2270	520	consensus Serine/threonine protein kinase involved	93.67
KOG1236	565	consensus Predicted unusual protein kinase [Genera	93.43
PTZ00384	383	choline kinase; Provisional	93.38
PRK14125	103	cell division suppressor protein YneA; Provisional	93.25
PLN02756	418	S-methyl-5-thioribose kinase	93.08
PF03109	119	ABC1: ABC1 family; InterPro: IPR004147 This entry	92.78
KOG2268	465	consensus Serine/threonine protein kinase [Signal	92.51
PTZ00296	442	choline kinase; Provisional	92.12

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-48  Score=401.53  Aligned_cols=245  Identities=43%  Similarity=0.734  Sum_probs=205.4

Q ss_pred             cccccCHHHHHHHhcCCCccceecccCcEEEEEEEECC-ceEEEEEeccCC---hHHHHHHHHHHHhccccce-------
Q 044997          278 RTIIFSLEEIEEATNNFDESRIIGRGGFGNVYFGLLGD-REAAIKKMRSNK---SKEFFAELKVLCKIHHINV-------  346 (563)
Q Consensus       278 ~~~~~~~~el~~~~~~f~~~~~LG~G~fG~Vy~g~~~~-~~vavK~~~~~~---~~~f~~Ei~~l~~l~H~ni-------  346 (563)
                      ....|+++|+..+|++|...++||+||||.||+|.+.+ ..||||++....   .++|.+|+++|.+++|||+       
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            34679999999999999999999999999999999976 899999998654   5679999999999999997       


Q ss_pred             ---------EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEE
Q 044997          347 ---------FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAK  417 (563)
Q Consensus       347 ---------V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~k  417 (563)
                               |+|||+||+|.++|+...  .. +++|..|++||.++|+||+|||+...|+||||||||+|||||+++++|
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~--~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aK  217 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKK--GE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAK  217 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCC--CC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEE
Confidence                     689999999999999732  11 899999999999999999999999888999999999999999999999


Q ss_pred             EeecCCCcccccccccccccccc-cCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCC
Q 044997          418 VADFGLVKLEERTNEKEMLATRL-VGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRD  496 (563)
Q Consensus       418 l~DFGla~~~~~~~~~~~~~~~~-~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~  496 (563)
                      |+|||+|+..... ..  ..... .||.+|+|||++.             .+.++.|+|||||||+|+||+||+++....
T Consensus       218 lsDFGLa~~~~~~-~~--~~~~~~~gt~gY~~PEy~~-------------~g~lt~KsDVySFGVvllElitgr~~~d~~  281 (361)
T KOG1187|consen  218 LSDFGLAKLGPEG-DT--SVSTTVMGTFGYLAPEYAS-------------TGKLTEKSDVYSFGVVLLELITGRKAVDQS  281 (361)
T ss_pred             ccCccCcccCCcc-cc--ceeeecCCCCccCChhhhc-------------cCCcCcccccccchHHHHHHHhCCcccCCC
Confidence            9999999754321 11  11112 7999999999874             456799999999999999999999887532


Q ss_pred             C--CCc-------------------------hhhH--HHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 044997          497 D--SEP-------------------------TKMK--SLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMIT  541 (563)
Q Consensus       497 ~--~~~-------------------------~~~~--~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~  541 (563)
                      .  ...                         ....  .....+..++.+|++.+|.+||+|.||++.|+.+...
T Consensus       282 ~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~  355 (361)
T KOG1187|consen  282 RPRGELSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL  355 (361)
T ss_pred             CCcccccHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence            2  000                         0001  2344488999999999999999999999999766543

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-45  Score=380.73  Aligned_cols=229  Identities=33%  Similarity=0.501  Sum_probs=194.3

Q ss_pred             CccceecccCcEEEEEEEECCce-EEEEEeccCC-----hHHHHHHHHHHHhccccce----------------EEEeec
Q 044997          295 DESRIIGRGGFGNVYFGLLGDRE-AAIKKMRSNK-----SKEFFAELKVLCKIHHINV----------------FISTFG  352 (563)
Q Consensus       295 ~~~~~LG~G~fG~Vy~g~~~~~~-vavK~~~~~~-----~~~f~~Ei~~l~~l~H~ni----------------V~e~~~  352 (563)
                      ...+.||+|+||+||+|.++++. ||||++....     .++|.+|+.+|.+++||||                |+||++
T Consensus        44 ~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~  123 (362)
T KOG0192|consen   44 PIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMP  123 (362)
T ss_pred             hhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCC
Confidence            33456999999999999999988 9999998654     4589999999999999997                689999


Q ss_pred             CCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCC-cEEEeecCCCccccccc
Q 044997          353 NGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGL-RAKVADFGLVKLEERTN  431 (563)
Q Consensus       353 ~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~-~~kl~DFGla~~~~~~~  431 (563)
                      +|+|.++|+..   ....++|..+++++.|||+||+|||+++.  ||||||||+|||++.++ ++||+|||+++......
T Consensus       124 ~GsL~~~l~~~---~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~  198 (362)
T KOG0192|consen  124 GGSLSVLLHKK---RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK  198 (362)
T ss_pred             CCcHHHHHhhc---ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc
Confidence            99999999863   35789999999999999999999999863  99999999999999997 99999999998654322


Q ss_pred             ccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCC------------C
Q 044997          432 EKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDS------------E  499 (563)
Q Consensus       432 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~------------~  499 (563)
                         ...+...||..|||||++.+.           ...++.|+|||||||+||||+||+.||.....            .
T Consensus       199 ---~~~~~~~GT~~wMAPEv~~~~-----------~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~R  264 (362)
T KOG0192|consen  199 ---TSMTSVAGTYRWMAPEVLRGE-----------KSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLR  264 (362)
T ss_pred             ---ccccCCCCCccccChhhhcCC-----------CCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCC
Confidence               223446899999999999732           12359999999999999999999999976542            2


Q ss_pred             chhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcC
Q 044997          500 PTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITS  542 (563)
Q Consensus       500 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~  542 (563)
                      +.........+..|+.+||+.||.+||++.+|+..|+.+....
T Consensus       265 p~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~  307 (362)
T KOG0192|consen  265 PPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHI  307 (362)
T ss_pred             CCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhh
Confidence            2223346677999999999999999999999999999887633

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-43  Score=364.36  Aligned_cols=228  Identities=26%  Similarity=0.455  Sum_probs=191.5

Q ss_pred             CCccceecccCcEEEEEEEECCc-eEEEEEeccC--ChHHHHHHHHHHHhccccce---------------EEEeecCCC
Q 044997          294 FDESRIIGRGGFGNVYFGLLGDR-EAAIKKMRSN--KSKEFFAELKVLCKIHHINV---------------FISTFGNGS  355 (563)
Q Consensus       294 f~~~~~LG~G~fG~Vy~g~~~~~-~vavK~~~~~--~~~~f~~Ei~~l~~l~H~ni---------------V~e~~~~gs  355 (563)
                      +...+.||+|-||+||.|.+++. +||+|.++..  ..++|.+|+++|++|+|+||               |+|||++|+
T Consensus       208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~Gs  287 (468)
T KOG0197|consen  208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGS  287 (468)
T ss_pred             HHHHHHhcCCccceEEEEEEcCCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCc
Confidence            44568999999999999999876 9999999874  34789999999999999997               579999999


Q ss_pred             cccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccccccccccc
Q 044997          356 LSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEM  435 (563)
Q Consensus       356 L~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~  435 (563)
                      |.+||..   .++..+...+.+.++.|||+||+||+++.   +|||||.++|||++++..+||+||||||....+...  
T Consensus       288 Ll~yLr~---~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~--  359 (468)
T KOG0197|consen  288 LLDYLRT---REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYT--  359 (468)
T ss_pred             HHHHhhh---cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCcee--
Confidence            9999986   34677999999999999999999999997   999999999999999999999999999954433221  


Q ss_pred             ccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCCCcCCC-----------CCchhh
Q 044997          436 LATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIRDD-----------SEPTKM  503 (563)
Q Consensus       436 ~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p~~~~~-----------~~~~~~  503 (563)
                      ......-+..|.|||.+...+|             +.|||||||||+||||+| |+.|+.+..           .+...+
T Consensus       360 ~~~~~kfPIkWtAPEa~~~~~F-------------S~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P  426 (468)
T KOG0197|consen  360 ASEGGKFPIKWTAPEALNYGKF-------------SSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRP  426 (468)
T ss_pred             ecCCCCCCceecCHHHHhhCCc-------------ccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCC
Confidence            1222334678999999876655             899999999999999999 555643322           123345


Q ss_pred             HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcC
Q 044997          504 KSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITS  542 (563)
Q Consensus       504 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~  542 (563)
                      ..+++.+.+||..||+.+|++|||++.+...|+++....
T Consensus       427 ~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~  465 (468)
T KOG0197|consen  427 EGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTST  465 (468)
T ss_pred             CCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhcc
Confidence            567888999999999999999999999999999887643

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-43  Score=371.52  Aligned_cols=231  Identities=26%  Similarity=0.458  Sum_probs=191.7

Q ss_pred             CccceecccCcEEEEEEEEC-----CceEEEEEeccC----ChHHHHHHHHHHHhccccce---------------EEEe
Q 044997          295 DESRIIGRGGFGNVYFGLLG-----DREAAIKKMRSN----KSKEFFAELKVLCKIHHINV---------------FIST  350 (563)
Q Consensus       295 ~~~~~LG~G~fG~Vy~g~~~-----~~~vavK~~~~~----~~~~f~~Ei~~l~~l~H~ni---------------V~e~  350 (563)
                      .+.++||.|.||+||+|+++     ...||||.++..    .+.+|+.|..||.+++||||               |.||
T Consensus       632 ~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEy  711 (996)
T KOG0196|consen  632 KIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEY  711 (996)
T ss_pred             EEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhh
Confidence            45689999999999999884     356999999864    35689999999999999998               3599


Q ss_pred             ecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccccc
Q 044997          351 FGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERT  430 (563)
Q Consensus       351 ~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~  430 (563)
                      |+||+|+.||+..    ...++|.+...++++||.||+||-+++   +|||||.++|||++++..+|++|||++|.++++
T Consensus       712 MENGsLDsFLR~~----DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvledd  784 (996)
T KOG0196|consen  712 MENGSLDSFLRQN----DGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  784 (996)
T ss_pred             hhCCcHHHHHhhc----CCceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecccC
Confidence            9999999999873    345999999999999999999999998   999999999999999999999999999988765


Q ss_pred             cccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCCCcCCCC-----------
Q 044997          431 NEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIRDDS-----------  498 (563)
Q Consensus       431 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p~~~~~~-----------  498 (563)
                      .+.........-..+|.|||.+..++|             |.+||||||||||||.++ |.+|+-.-..           
T Consensus       785 ~~~~ytt~GGKIPiRWTAPEAIa~RKF-------------TsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gy  851 (996)
T KOG0196|consen  785 PEAAYTTLGGKIPIRWTAPEAIAYRKF-------------TSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGY  851 (996)
T ss_pred             CCccccccCCccceeecChhHhhhccc-------------CchhhccccceEEEEecccCCCcccccchHHHHHHHHhcc
Confidence            432222221223569999999987776             999999999999999987 7777632211           


Q ss_pred             CchhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcChhh
Q 044997          499 EPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITSTEW  545 (563)
Q Consensus       499 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~w  545 (563)
                      +...+..++..+.+|+..||++|-.+||.+.+|+..|.+++.....-
T Consensus       852 RLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~SL  898 (996)
T KOG0196|consen  852 RLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNSL  898 (996)
T ss_pred             CCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchhh
Confidence            11222345666999999999999999999999999999998876544

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1.1e-42  Score=374.20  Aligned_cols=236  Identities=27%  Similarity=0.449  Sum_probs=194.5

Q ss_pred             HhcCCCccceecccCcEEEEEEEECC-------ceEEEEEeccCC----hHHHHHHHHHHHhccccce------------
Q 044997          290 ATNNFDESRIIGRGGFGNVYFGLLGD-------REAAIKKMRSNK----SKEFFAELKVLCKIHHINV------------  346 (563)
Q Consensus       290 ~~~~f~~~~~LG~G~fG~Vy~g~~~~-------~~vavK~~~~~~----~~~f~~Ei~~l~~l~H~ni------------  346 (563)
                      .+.+....+.||+|+||+||+|+..+       .-||||.++...    .++|.+|+++|..++||||            
T Consensus       484 ~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P  563 (774)
T KOG1026|consen  484 PRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDP  563 (774)
T ss_pred             chhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCe
Confidence            34556667899999999999997632       469999998654    4689999999999999999            


Q ss_pred             ---EEEeecCCCcccccccccc-----cCCC----CCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCC
Q 044997          347 ---FISTFGNGSLSDHLHDPLL-----KGHQ----PLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGL  414 (563)
Q Consensus       347 ---V~e~~~~gsL~~~L~~~~~-----~~~~----~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~  414 (563)
                         |.|||..|||.+||....-     .+..    +|+..+.+.||.|||.||+||-++.   +|||||..+|+||.++.
T Consensus       564 ~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l  640 (774)
T KOG1026|consen  564 LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENL  640 (774)
T ss_pred             eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccce
Confidence               4699999999999974321     1223    3999999999999999999999986   99999999999999999


Q ss_pred             cEEEeecCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCCC
Q 044997          415 RAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRAL  493 (563)
Q Consensus       415 ~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p~  493 (563)
                      .+||+|||++|.....+... ......-.++|||||.+..++|             |++||||||||||||+++ |+.|+
T Consensus       641 ~VKIsDfGLsRdiYssDYYk-~~~~t~lPIRWMppEsIly~kF-------------TteSDVWs~GVvLWEIFsyG~QPy  706 (774)
T KOG1026|consen  641 VVKISDFGLSRDIYSSDYYK-VRGNTLLPIRWMPPESILYGKF-------------TTESDVWSFGVVLWEIFSYGKQPY  706 (774)
T ss_pred             EEEecccccchhhhhhhhhc-ccCCceeeeecCCHHHhhcCcc-------------cchhhhhhhhhhhhhhhccccCcc
Confidence            99999999999766544332 1223345689999998866655             999999999999999998 88888


Q ss_pred             cCCCCC-----------chhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcC
Q 044997          494 IRDDSE-----------PTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITS  542 (563)
Q Consensus       494 ~~~~~~-----------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~  542 (563)
                      ++-..+           ...++.++..+.+||..||+.+|++||+++||-..|+.....+
T Consensus       707 ~glSn~EVIe~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s  766 (774)
T KOG1026|consen  707 YGLSNQEVIECIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQAS  766 (774)
T ss_pred             cccchHHHHHHHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcC
Confidence            764432           2334566778999999999999999999999999999876654

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-42  Score=340.15  Aligned_cols=213  Identities=26%  Similarity=0.451  Sum_probs=183.0

Q ss_pred             ccceecccCcEEEEEEEEC--CceEEEEEeccC----ChHHHHHHHHHHHhccccceE----------------EEeecC
Q 044997          296 ESRIIGRGGFGNVYFGLLG--DREAAIKKMRSN----KSKEFFAELKVLCKIHHINVF----------------ISTFGN  353 (563)
Q Consensus       296 ~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~----~~~~f~~Ei~~l~~l~H~niV----------------~e~~~~  353 (563)
                      ..+.||+|..|+||+++++  ++.+|+|.+..+    ..+++.+|++++++.+||+||                ||||.+
T Consensus        83 ~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDg  162 (364)
T KOG0581|consen   83 RLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDG  162 (364)
T ss_pred             hhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCC
Confidence            3688999999999999885  678899999433    357789999999999999983                799999


Q ss_pred             CCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccccccc
Q 044997          354 GSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHD-HTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNE  432 (563)
Q Consensus       354 gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~  432 (563)
                      |+|++.+..     .+.+++...-+|+.+|++||.|||+ ++   ||||||||+|||+++.|++||||||.++.+...  
T Consensus       163 GSLd~~~k~-----~g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS--  232 (364)
T KOG0581|consen  163 GSLDDILKR-----VGRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS--  232 (364)
T ss_pred             CCHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhhh--
Confidence            999999875     3669999999999999999999996 54   999999999999999999999999999876543  


Q ss_pred             cccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCC--------------
Q 044997          433 KEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDS--------------  498 (563)
Q Consensus       433 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~--------------  498 (563)
                         .....+||..|||||.+.+..|             +.++||||||+.++|+.+|+.|+.....              
T Consensus       233 ---~a~tfvGT~~YMsPERi~g~~Y-------------s~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~  296 (364)
T KOG0581|consen  233 ---IANTFVGTSAYMSPERISGESY-------------SVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVD  296 (364)
T ss_pred             ---hcccccccccccChhhhcCCcC-------------CcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhc
Confidence               4566899999999999877665             7899999999999999999999876411              


Q ss_pred             --CchhhH-HHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          499 --EPTKMK-SLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       499 --~~~~~~-~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                        .+..+. .+.++++.++..||++||.+||+++|+++.
T Consensus       297 ~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H  335 (364)
T KOG0581|consen  297 EPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH  335 (364)
T ss_pred             CCCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence              122233 367789999999999999999999999874

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.9e-42  Score=338.54  Aligned_cols=223  Identities=26%  Similarity=0.445  Sum_probs=187.6

Q ss_pred             HhcCCCccceecccCcEEEEEEEE--CCceEEEEEeccCCh----------HHHHHHHHHHHhccccce-----------
Q 044997          290 ATNNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNKS----------KEFFAELKVLCKIHHINV-----------  346 (563)
Q Consensus       290 ~~~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~~----------~~f~~Ei~~l~~l~H~ni-----------  346 (563)
                      ..+.|...+.||+|+||.|-+|.-  +++.||||.++++..          .+..+|+++|++++||||           
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d  249 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD  249 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence            456678889999999999999976  579999999875421          234699999999999998           


Q ss_pred             ----EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCC---CcEEEe
Q 044997          347 ----FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDG---LRAKVA  419 (563)
Q Consensus       347 ----V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~---~~~kl~  419 (563)
                          |+||+++|+|.+.+..     ++.+.+..-..+++|++.|+.|||++|   |+||||||+|||+..+   ..+||+
T Consensus       250 s~YmVlE~v~GGeLfd~vv~-----nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKIt  321 (475)
T KOG0615|consen  250 SSYMVLEYVEGGELFDKVVA-----NKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKIT  321 (475)
T ss_pred             ceEEEEEEecCccHHHHHHh-----ccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEec
Confidence                5799999999999875     355777777889999999999999998   9999999999999766   789999


Q ss_pred             ecCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCC
Q 044997          420 DFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE  499 (563)
Q Consensus       420 DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~  499 (563)
                      |||+||.....    ..+...+||+.|.|||++..+.+.          .+..|+|+||+||+||-+++|..||......
T Consensus       322 DFGlAK~~g~~----sfm~TlCGTpsYvAPEVl~~kg~~----------~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~  387 (475)
T KOG0615|consen  322 DFGLAKVSGEG----SFMKTLCGTPSYVAPEVLASKGVE----------YYPSKVDIWSLGCVLFVCLSGYPPFSEEYTD  387 (475)
T ss_pred             ccchhhccccc----eehhhhcCCccccChhheecCCee----------cccchheeeeccceEEEEeccCCCcccccCC
Confidence            99999975422    245668999999999999876542          2235999999999999999999999765443


Q ss_pred             c---------------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          500 P---------------TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       500 ~---------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                      +               ..+.++.+...+||.+||..||++|||+.|+++.
T Consensus       388 ~sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h  437 (475)
T KOG0615|consen  388 PSLKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNH  437 (475)
T ss_pred             ccHHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence            3               3456777889999999999999999999999873

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-41  Score=334.68  Aligned_cols=218  Identities=28%  Similarity=0.479  Sum_probs=180.4

Q ss_pred             hcCCCccceecccCcEEEEEEEEC--CceEEEEEeccCC-----hHHHHHHHHHHHhccccce---------------EE
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNK-----SKEFFAELKVLCKIHHINV---------------FI  348 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~-----~~~f~~Ei~~l~~l~H~ni---------------V~  348 (563)
                      ..+|...+.||+|+||.||+|+++  +..||||.+....     .+....|+++|+.++||||               ||
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM   88 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM   88 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence            356778888999999999999884  6899999987653     3557889999999999998               68


Q ss_pred             EeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCC------CcEEEeecC
Q 044997          349 STFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDG------LRAKVADFG  422 (563)
Q Consensus       349 e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~------~~~kl~DFG  422 (563)
                      |||.+|+|.+|++.     ...+++.....++.|+|.||++||+.+   ||||||||+||||+..      -.+||+|||
T Consensus        89 EyC~gGDLs~yi~~-----~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFG  160 (429)
T KOG0595|consen   89 EYCNGGDLSDYIRR-----RGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFG  160 (429)
T ss_pred             EeCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccc
Confidence            99999999999986     357999999999999999999999998   9999999999999865      468999999


Q ss_pred             CCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCC-----
Q 044997          423 LVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDD-----  497 (563)
Q Consensus       423 la~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~-----  497 (563)
                      +||.+....    .....+|++-|||||++...+|             +.|+|+||.|+++||+++|+.||....     
T Consensus       161 fAR~L~~~~----~a~tlcGSplYMAPEV~~~~~Y-------------dAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~  223 (429)
T KOG0595|consen  161 FARFLQPGS----MAETLCGSPLYMAPEVIMSQQY-------------DAKADLWSIGTILYQCLTGKPPFDAETPKELL  223 (429)
T ss_pred             hhhhCCchh----HHHHhhCCccccCHHHHHhccc-------------cchhhHHHHHHHHHHHHhCCCCccccCHHHHH
Confidence            999876432    3455789999999999865554             899999999999999999999997332     


Q ss_pred             --------CCchhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          498 --------SEPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       498 --------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                              ..+...........+|+...++.+|.+|-++.+...
T Consensus       224 ~~~~k~~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~  267 (429)
T KOG0595|consen  224 LYIKKGNEIVPVLPAELSNPLRELLISLLQRNPKDRISFEDFFD  267 (429)
T ss_pred             HHHhccccccCchhhhccCchhhhhhHHHhcCccccCchHHhhh
Confidence                    222223344445667888888888888877766554

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.2e-41  Score=348.40  Aligned_cols=219  Identities=23%  Similarity=0.463  Sum_probs=191.0

Q ss_pred             cCCCccceecccCcEEEEEEEE--CCceEEEEEecc------CChHHHHHHHHHHHhccccceE---------------E
Q 044997          292 NNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRS------NKSKEFFAELKVLCKIHHINVF---------------I  348 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~------~~~~~f~~Ei~~l~~l~H~niV---------------~  348 (563)
                      ..|...+.||+|||..+|+++.  .|+.+|+|++.+      ..++...+|+++.++|+|||||               .
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            5688999999999999999987  589999999864      3457789999999999999983               5


Q ss_pred             EeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccc
Q 044997          349 STFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEE  428 (563)
Q Consensus       349 e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~  428 (563)
                      |++.+|+|.++++.     ++++++.++..+.+||+.||.|||+++   |+|||||..|+||++++++||+|||||..++
T Consensus        98 ELC~~~sL~el~Kr-----rk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le  169 (592)
T KOG0575|consen   98 ELCHRGSLMELLKR-----RKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLE  169 (592)
T ss_pred             EecCCccHHHHHHh-----cCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeec
Confidence            89999999998863     578999999999999999999999998   9999999999999999999999999999887


Q ss_pred             cccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc--------
Q 044997          429 RTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP--------  500 (563)
Q Consensus       429 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~--------  500 (563)
                      ..++.   ....+||+.|.|||++....+             +..+||||+||+||-|+.|++||....-..        
T Consensus       170 ~~~Er---k~TlCGTPNYIAPEVl~k~gH-------------sfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~  233 (592)
T KOG0575|consen  170 YDGER---KKTLCGTPNYIAPEVLNKSGH-------------SFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLN  233 (592)
T ss_pred             Ccccc---cceecCCCcccChhHhccCCC-------------CCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhc
Confidence            65433   345799999999999976555             789999999999999999999997654221        


Q ss_pred             --hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          501 --TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       501 --~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                        ..+..+..+..+||.++|+.||.+|||+++|+..
T Consensus       234 ~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h  269 (592)
T KOG0575|consen  234 EYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH  269 (592)
T ss_pred             CcccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence              2234566778999999999999999999999875

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.4e-41  Score=320.64  Aligned_cols=226  Identities=25%  Similarity=0.411  Sum_probs=188.5

Q ss_pred             cCCCccceecccCcEEEEEEEE--CCceEEEEEeccC-----ChHHHHHHHHHHHhccccce-----------------E
Q 044997          292 NNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSN-----KSKEFFAELKVLCKIHHINV-----------------F  347 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~-----~~~~f~~Ei~~l~~l~H~ni-----------------V  347 (563)
                      .+|.+.++||+|.||+||++..  ++..+|.|.++-+     ..++...|+.+|++|+||||                 |
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv   98 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV   98 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence            3467789999999999999965  6889999988632     34678899999999999998                 5


Q ss_pred             EEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCc--eEeCCCCCCCeEecCCCcEEEeecCCCc
Q 044997          348 ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKAR--YVHRDIKTSNILLDDGLRAKVADFGLVK  425 (563)
Q Consensus       348 ~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivHrDLk~~NILl~~~~~~kl~DFGla~  425 (563)
                      ||++..|+|.+.+..- .+..+.+++..+++++.|++.||.++|+.. ++  ++||||||.||+|+.+|.+||+|||+++
T Consensus        99 mE~c~~GDLsqmIk~~-K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r  176 (375)
T KOG0591|consen   99 MELCDAGDLSQMIKHF-KKQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGLGR  176 (375)
T ss_pred             HHhhcccCHHHHHHHH-HhccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchhHh
Confidence            7999999999988653 245678999999999999999999999842 34  9999999999999999999999999999


Q ss_pred             ccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCC------
Q 044997          426 LEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE------  499 (563)
Q Consensus       426 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~------  499 (563)
                      .+....   ......+|||.||+||.+....|             +.||||||+||++|||..-+.||.+++-.      
T Consensus       177 ~l~s~~---tfA~S~VGTPyYMSPE~i~~~~Y-------------~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI  240 (375)
T KOG0591|consen  177 FLSSKT---TFAHSLVGTPYYMSPERIHESGY-------------NFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKI  240 (375)
T ss_pred             Hhcchh---HHHHhhcCCCcccCHHHHhcCCC-------------CcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHH
Confidence            876432   34556899999999999977766             89999999999999999999999876421      


Q ss_pred             -----chhh-HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 044997          500 -----PTKM-KSLITIMAAVAEWCLNEDAVDRPEMRDIVAIL  535 (563)
Q Consensus       500 -----~~~~-~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  535 (563)
                           +..+ ...++.+.+|+..|+..||+.||+.-.++..+
T Consensus       241 ~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di  282 (375)
T KOG0591|consen  241 EQGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDI  282 (375)
T ss_pred             HcCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHH
Confidence                 1122 45677799999999999999999854444433

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-40  Score=344.94  Aligned_cols=245  Identities=27%  Similarity=0.442  Sum_probs=200.5

Q ss_pred             CHHHHHHHhcCCCccceecccCcEEEEEEEECCceEEEEEeccCC-----hHHHHHHHHHHHhccccce-----------
Q 044997          283 SLEEIEEATNNFDESRIIGRGGFGNVYFGLLGDREAAIKKMRSNK-----SKEFFAELKVLCKIHHINV-----------  346 (563)
Q Consensus       283 ~~~el~~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~vavK~~~~~~-----~~~f~~Ei~~l~~l~H~ni-----------  346 (563)
                      +.++|+...+.+.....||+|.||+||+|+|.| .||||.++.+.     .+.|.+|+.++++-+|.||           
T Consensus       383 s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~  461 (678)
T KOG0193|consen  383 SLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP  461 (678)
T ss_pred             cccccccCHHHhhccceeccccccceeeccccc-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc
Confidence            446777777888889999999999999999975 69999997553     4779999999999999998           


Q ss_pred             ---EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCC
Q 044997          347 ---FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGL  423 (563)
Q Consensus       347 ---V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGl  423 (563)
                         |..++++.+|..|||..    +..++..+.+.||+|||+||.|||.++   |||||||+.||++.+++++||+|||+
T Consensus       462 ~AIiTqwCeGsSLY~hlHv~----etkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGL  534 (678)
T KOG0193|consen  462 LAIITQWCEGSSLYTHLHVQ----ETKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGL  534 (678)
T ss_pred             eeeeehhccCchhhhhccch----hhhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccc
Confidence               34677888999999973    366899999999999999999999997   99999999999999999999999999


Q ss_pred             CcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc---
Q 044997          424 VKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP---  500 (563)
Q Consensus       424 a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~---  500 (563)
                      +..-...... .......|..-|||||++..+.          ...+++.+||||||+|+|||++|..|+.....+.   
T Consensus       535 atvk~~w~g~-~q~~qp~gsilwmAPEvIRmqd----------~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIif  603 (678)
T KOG0193|consen  535 ATVKTRWSGE-QQLEQPHGSLLWMAPEVIRMQD----------DNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIF  603 (678)
T ss_pred             eeeeeeeccc-cccCCCccchhhhcHHHHhhcc----------cCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEE
Confidence            8653332211 1223345788999999997442          4578999999999999999999999987322111   


Q ss_pred             ------------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcChhhh
Q 044997          501 ------------TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITSTEWE  546 (563)
Q Consensus       501 ------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~w~  546 (563)
                                  .........|.+|+..||..++++||.+.+|+..|+.++.+-+.-.
T Consensus       604 mVGrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~pki~  661 (678)
T KOG0193|consen  604 MVGRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSLPKIN  661 (678)
T ss_pred             EecccccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcccccc
Confidence                        1122445679999999999999999999999999998887544333

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-39  Score=325.58  Aligned_cols=238  Identities=26%  Similarity=0.404  Sum_probs=192.4

Q ss_pred             CCCccceecccCcEEEEEEEECCceEEEEEeccCChHHHHHHHHHHHh--ccccce-------------------EEEee
Q 044997          293 NFDESRIIGRGGFGNVYFGLLGDREAAIKKMRSNKSKEFFAELKVLCK--IHHINV-------------------FISTF  351 (563)
Q Consensus       293 ~f~~~~~LG~G~fG~Vy~g~~~~~~vavK~~~~~~~~~f~~Ei~~l~~--l~H~ni-------------------V~e~~  351 (563)
                      .....++||+|+||.||+|.++++.||||++..+..+.|.+|-++.+-  ++|+||                   |++|.
T Consensus       211 pl~l~eli~~Grfg~V~KaqL~~~~VAVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh  290 (534)
T KOG3653|consen  211 PLQLLELIGRGRFGCVWKAQLDNRLVAVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFH  290 (534)
T ss_pred             chhhHHHhhcCccceeehhhccCceeEEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeec
Confidence            344567899999999999999999999999999999999999888664  589997                   67999


Q ss_pred             cCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh------cCCCceEeCCCCCCCeEecCCCcEEEeecCCCc
Q 044997          352 GNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHD------HTKARYVHRDIKTSNILLDDGLRAKVADFGLVK  425 (563)
Q Consensus       352 ~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~------~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~  425 (563)
                      ++|+|.+||..      ..++|....+|+.-+++||+|||+      +.+|+|+|||||++|||+.+|+++.|+|||+|.
T Consensus       291 ~kGsL~dyL~~------ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl  364 (534)
T KOG3653|consen  291 PKGSLCDYLKA------NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLAL  364 (534)
T ss_pred             cCCcHHHHHHh------ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeE
Confidence            99999999975      679999999999999999999996      446789999999999999999999999999999


Q ss_pred             ccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCC------
Q 044997          426 LEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE------  499 (563)
Q Consensus       426 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~------  499 (563)
                      .+..+...... ...+||.+|||||++.+...       ......-.+.||||+|.|||||+++...+..+...      
T Consensus       365 ~~~p~~~~~d~-~~qVGT~RYMAPEvLEgain-------l~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpf  436 (534)
T KOG3653|consen  365 RLEPGKPQGDT-HGQVGTRRYMAPEVLEGAIN-------LQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPF  436 (534)
T ss_pred             EecCCCCCcch-hhhhhhhhhcCHHHHhhhcc-------cccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCch
Confidence            88765443332 33789999999999976542       11122235799999999999999987655321100      


Q ss_pred             ---------chhhHH-------------------HHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcChh
Q 044997          500 ---------PTKMKS-------------------LITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITSTE  544 (563)
Q Consensus       500 ---------~~~~~~-------------------~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~  544 (563)
                               .+.++.                   -...+.+.+..||..||+.|-|+.=+.+.+.++.....+
T Consensus       437 e~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~~  509 (534)
T KOG3653|consen  437 EAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWED  509 (534)
T ss_pred             hHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCCc
Confidence                     011111                   123388999999999999999999999999888765544

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-39  Score=324.04  Aligned_cols=240  Identities=24%  Similarity=0.368  Sum_probs=194.9

Q ss_pred             HHhcCCCccceecccCcEEEEEEEECCceEEEEEeccCChHHHHHHHHHHHh--ccccce-------------------E
Q 044997          289 EATNNFDESRIIGRGGFGNVYFGLLGDREAAIKKMRSNKSKEFFAELKVLCK--IHHINV-------------------F  347 (563)
Q Consensus       289 ~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~vavK~~~~~~~~~f~~Ei~~l~~--l~H~ni-------------------V  347 (563)
                      ...+.....+.||+|.||+||+|.|+|+.||||.+...+.+.+.+|.++.+.  ++|+||                   |
T Consensus       208 TiarqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLv  287 (513)
T KOG2052|consen  208 TIARQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSRDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLV  287 (513)
T ss_pred             hhhheeEEEEEecCccccceeeccccCCceEEEEecccchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEe
Confidence            3456778889999999999999999999999999999999999999998875  599998                   6


Q ss_pred             EEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh-----cCCCceEeCCCCCCCeEecCCCcEEEeecC
Q 044997          348 ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHD-----HTKARYVHRDIKTSNILLDDGLRAKVADFG  422 (563)
Q Consensus       348 ~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-----~~~~~ivHrDLk~~NILl~~~~~~kl~DFG  422 (563)
                      .+|.++|||.|||..      ..++....++++..+|.||+|||.     +++|.|.|||||+.|||+.+++.+.|+|+|
T Consensus       288 TdYHe~GSL~DyL~r------~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLG  361 (513)
T KOG2052|consen  288 TDYHEHGSLYDYLNR------NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG  361 (513)
T ss_pred             eecccCCcHHHHHhh------ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeece
Confidence            799999999999974      679999999999999999999995     688999999999999999999999999999


Q ss_pred             CCcccccc-cccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCC----------C
Q 044997          423 LVKLEERT-NEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK----------R  491 (563)
Q Consensus       423 la~~~~~~-~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~----------~  491 (563)
                      ||-..... +.-.......+||.+|||||++....-       ...-+.-..+||||||.|+||+..+.          .
T Consensus       362 LAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin-------~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~  434 (513)
T KOG2052|consen  362 LAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETIN-------MKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQL  434 (513)
T ss_pred             eeEEecccCCcccCCCCCccceeeccChHHhhhhcC-------hhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcC
Confidence            99765443 233334456799999999999854321       11122235699999999999998642          4


Q ss_pred             CCcCCCC---Cchh-------------------hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 044997          492 ALIRDDS---EPTK-------------------MKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMIT  541 (563)
Q Consensus       492 p~~~~~~---~~~~-------------------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~  541 (563)
                      ||++--.   ..+.                   .......+.+|++.||..+|..|-|+-.|-+.|.++.++
T Consensus       435 Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~  506 (513)
T KOG2052|consen  435 PYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNS  506 (513)
T ss_pred             CcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcC
Confidence            5533111   1111                   123445689999999999999999999999999998753

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-40  Score=338.53  Aligned_cols=220  Identities=30%  Similarity=0.465  Sum_probs=188.8

Q ss_pred             ccCHHHHHHHhcCCCccceecccCcEEEEEEEECCceEEEEEeccCChHHHHHHHHHHHhccccce--------------
Q 044997          281 IFSLEEIEEATNNFDESRIIGRGGFGNVYFGLLGDREAAIKKMRSNKSKEFFAELKVLCKIHHINV--------------  346 (563)
Q Consensus       281 ~~~~~el~~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~vavK~~~~~~~~~f~~Ei~~l~~l~H~ni--------------  346 (563)
                      ...++++.+       .+-||.|+.|.||+|++.++.||||+++..+.    .+|+-|++|+|+||              
T Consensus       120 eiPFe~IsE-------LeWlGSGaQGAVF~Grl~netVAVKKV~elkE----TdIKHLRkLkH~NII~FkGVCtqsPcyC  188 (904)
T KOG4721|consen  120 EIPFEEISE-------LEWLGSGAQGAVFLGRLHNETVAVKKVRELKE----TDIKHLRKLKHPNIITFKGVCTQSPCYC  188 (904)
T ss_pred             cCCHHHhhh-------hhhhccCcccceeeeeccCceehhHHHhhhhh----hhHHHHHhccCcceeeEeeeecCCceeE
Confidence            455666644       57899999999999999999999999876544    47999999999998              


Q ss_pred             -EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCc
Q 044997          347 -FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK  425 (563)
Q Consensus       347 -V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~  425 (563)
                       ||||+..|-|...|+.     +++++......+..+||.||.|||.+.   |||||||+-||||..+..+||+|||-++
T Consensus       189 IiMEfCa~GqL~~VLka-----~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~  260 (904)
T KOG4721|consen  189 IIMEFCAQGQLYEVLKA-----GRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSK  260 (904)
T ss_pred             EeeeccccccHHHHHhc-----cCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchH
Confidence             6899999999999975     577888999999999999999999996   9999999999999999999999999998


Q ss_pred             ccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCC------
Q 044997          426 LEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE------  499 (563)
Q Consensus       426 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~------  499 (563)
                      .....    .....++||..|||||++...++             ++|+||||||||||||+||..|+..-+..      
T Consensus       261 e~~~~----STkMSFaGTVaWMAPEvIrnePc-------------sEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGV  323 (904)
T KOG4721|consen  261 ELSDK----STKMSFAGTVAWMAPEVIRNEPC-------------SEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGV  323 (904)
T ss_pred             hhhhh----hhhhhhhhhHhhhCHHHhhcCCc-------------ccccceehhHHHHHHHHhcCCCccccchheeEEec
Confidence            54432    12345789999999999976665             89999999999999999999998654321      


Q ss_pred             ------chhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 044997          500 ------PTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILS  536 (563)
Q Consensus       500 ------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  536 (563)
                            ...+..+++-+.-|+++||+..|..||+|++|+..|+
T Consensus       324 GsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~Hld  366 (904)
T KOG4721|consen  324 GSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLD  366 (904)
T ss_pred             cCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHh
Confidence                  1234566777899999999999999999999999986

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-39  Score=325.60  Aligned_cols=226  Identities=29%  Similarity=0.466  Sum_probs=186.9

Q ss_pred             cCCCccceecccCcEEEEEEEEC--CceEEEEEeccCC---hHHHHHHHHHHHhccccceE-----------------EE
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNK---SKEFFAELKVLCKIHHINVF-----------------IS  349 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~---~~~f~~Ei~~l~~l~H~niV-----------------~e  349 (563)
                      .++...+.||+|.||.||++...  +...|||.+....   .+.+.+|+.+|.+++|||||                 +|
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE   96 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME   96 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence            45677899999999999999885  5899999987665   45588999999999999984                 68


Q ss_pred             eecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecC-CCcEEEeecCCCcccc
Q 044997          350 TFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDD-GLRAKVADFGLVKLEE  428 (563)
Q Consensus       350 ~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~-~~~~kl~DFGla~~~~  428 (563)
                      |+++|+|.+++...   +. .+++..+.++..|+++||+|||+++   ||||||||+|||++. ++.+||+|||+++...
T Consensus        97 y~~~GsL~~~~~~~---g~-~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~  169 (313)
T KOG0198|consen   97 YAPGGSLSDLIKRY---GG-KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLE  169 (313)
T ss_pred             ccCCCcHHHHHHHc---CC-CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccc
Confidence            99999999999762   23 7999999999999999999999998   999999999999999 7999999999998765


Q ss_pred             cccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCC------------
Q 044997          429 RTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRD------------  496 (563)
Q Consensus       429 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~------------  496 (563)
                      .............||+.|||||++..+.            ...+++|||||||++.||+||+.||...            
T Consensus       170 ~~~~~~~~~~~~~Gtp~~maPEvi~~g~------------~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~  237 (313)
T KOG0198|consen  170 SKGTKSDSELSVQGTPNYMAPEVIRNGE------------VARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGR  237 (313)
T ss_pred             cccccccccccccCCccccCchhhcCCC------------cCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhc
Confidence            3111112233478999999999986421            1236999999999999999999998752            


Q ss_pred             -CCCchhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 044997          497 -DSEPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILS  536 (563)
Q Consensus       497 -~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  536 (563)
                       ...+..+..+++...+++.+|++.||++|||+.++++..-
T Consensus       238 ~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf  278 (313)
T KOG0198|consen  238 EDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPF  278 (313)
T ss_pred             cCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChh
Confidence             1123344566778999999999999999999999998653

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-39  Score=321.86  Aligned_cols=231  Identities=25%  Similarity=0.432  Sum_probs=187.9

Q ss_pred             hcCCCccceecccCcEEEEEEEEC--CceEEEEEeccCC------hHHHHHHHHHHHhccccce---------------E
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNK------SKEFFAELKVLCKIHHINV---------------F  347 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~------~~~f~~Ei~~l~~l~H~ni---------------V  347 (563)
                      .++|+..++||+|+||+||.++.+  ++.+|+|.|++..      .+...+|..+|.+++||.|               |
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV  103 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV  103 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence            357889999999999999999774  6779999997643      3557889999999999998               5


Q ss_pred             EEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccc
Q 044997          348 ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLE  427 (563)
Q Consensus       348 ~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~  427 (563)
                      .+|+.+|.|..+|..     ...+++..+.-++.+|+.||.|||+++   ||||||||+|||||.+|+++|+|||+++..
T Consensus       104 ld~~~GGeLf~hL~~-----eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~  175 (357)
T KOG0598|consen  104 LDYLNGGELFYHLQR-----EGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKED  175 (357)
T ss_pred             EeccCCccHHHHHHh-----cCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhc
Confidence            799999999999975     456888888899999999999999998   999999999999999999999999999954


Q ss_pred             ccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc-------
Q 044997          428 ERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP-------  500 (563)
Q Consensus       428 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~-------  500 (563)
                      ...+.   ....++||+.|||||++.+..|             +..+|+||+|+++|||++|.+||...+...       
T Consensus       176 ~~~~~---~t~tfcGT~eYmAPEil~~~gy-------------~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~  239 (357)
T KOG0598|consen  176 LKDGD---ATRTFCGTPEYMAPEILLGKGY-------------DKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILK  239 (357)
T ss_pred             ccCCC---ccccccCCccccChHHHhcCCC-------------CcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhc
Confidence            33222   2344799999999999977665             899999999999999999999998765321       


Q ss_pred             ----hhhHHHHHHHHHHHHHhhccCCCCCC----CHHHHHHHHHHhhhcChhhhcc
Q 044997          501 ----TKMKSLITIMAAVAEWCLNEDAVDRP----EMRDIVAILSQIMITSTEWEAS  548 (563)
Q Consensus       501 ----~~~~~~~~~l~~li~~cl~~dP~~RP----s~~evl~~L~~i~~~~~~w~~~  548 (563)
                          ....-+....+++++..+..||++|-    .+.+|-   ..-+-...+|+.-
T Consensus       240 ~k~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik---~HpfF~~inW~~l  292 (357)
T KOG0598|consen  240 GKLPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIK---RHPFFKGINWEKL  292 (357)
T ss_pred             CcCCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhh---cCcccccCCHHHH
Confidence                11223566799999999999999995    333322   1223345567653

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=6.9e-39  Score=332.16  Aligned_cols=235  Identities=26%  Similarity=0.407  Sum_probs=186.4

Q ss_pred             HhcCCCccceecccCcEEEEEEEEC-------CceEEEEEeccCC----hHHHHHHHHHHHhc-cccce-----------
Q 044997          290 ATNNFDESRIIGRGGFGNVYFGLLG-------DREAAIKKMRSNK----SKEFFAELKVLCKI-HHINV-----------  346 (563)
Q Consensus       290 ~~~~f~~~~~LG~G~fG~Vy~g~~~-------~~~vavK~~~~~~----~~~f~~Ei~~l~~l-~H~ni-----------  346 (563)
                      ..++|+..+.||+|+||.||+|...       ++.||+|+++...    .+.+.+|+++|.++ +||||           
T Consensus         5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~   84 (338)
T cd05102           5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN   84 (338)
T ss_pred             chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence            3467888999999999999999741       3579999987532    35688999999999 89997           


Q ss_pred             -----EEEeecCCCccccccccccc-------------------------------------------------------
Q 044997          347 -----FISTFGNGSLSDHLHDPLLK-------------------------------------------------------  366 (563)
Q Consensus       347 -----V~e~~~~gsL~~~L~~~~~~-------------------------------------------------------  366 (563)
                           |+||+++|+|.+++......                                                       
T Consensus        85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (338)
T cd05102          85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD  164 (338)
T ss_pred             CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence                 47999999999888642100                                                       


Q ss_pred             --CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccccccccccccccccCCC
Q 044997          367 --GHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP  444 (563)
Q Consensus       367 --~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~  444 (563)
                        ...++++.++..++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||+++........ .......++.
T Consensus       165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~~~~~  240 (338)
T cd05102         165 DLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY-VRKGSARLPL  240 (338)
T ss_pred             ccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcch-hcccCCCCCc
Confidence              0245889999999999999999999987   999999999999999999999999999864322111 1122234678


Q ss_pred             cccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCCCcCCCCCchh------------hHHHHHHHH
Q 044997          445 GYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIRDDSEPTK------------MKSLITIMA  511 (563)
Q Consensus       445 ~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p~~~~~~~~~~------------~~~~~~~l~  511 (563)
                      .|+|||++.+..             ++.++|||||||++|||++ |+.||.........            .......+.
T Consensus       241 ~y~aPE~~~~~~-------------~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  307 (338)
T cd05102         241 KWMAPESIFDKV-------------YTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIY  307 (338)
T ss_pred             cccCcHHhhcCC-------------CCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHH
Confidence            899999885443             4889999999999999997 99998654322111            122345689


Q ss_pred             HHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 044997          512 AVAEWCLNEDAVDRPEMRDIVAILSQIMIT  541 (563)
Q Consensus       512 ~li~~cl~~dP~~RPs~~evl~~L~~i~~~  541 (563)
                      +++.+||+.||.+||++.|+++.|++++..
T Consensus       308 ~li~~cl~~dp~~RPs~~el~~~l~~~~~~  337 (338)
T cd05102         308 RIMLACWQGDPKERPTFSALVEILGDLLQE  337 (338)
T ss_pred             HHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-39  Score=357.90  Aligned_cols=236  Identities=27%  Similarity=0.421  Sum_probs=190.6

Q ss_pred             hcCCCccceecccCcEEEEEEEECC-------ceEEEEEeccC----ChHHHHHHHHHHHhccccce-------------
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLLGD-------REAAIKKMRSN----KSKEFFAELKVLCKIHHINV-------------  346 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~~~-------~~vavK~~~~~----~~~~f~~Ei~~l~~l~H~ni-------------  346 (563)
                      .++.+..+.||+|+||.||+|...+       ..||||.+++.    +..+|++|..+|++++||||             
T Consensus       691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~  770 (1025)
T KOG1095|consen  691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP  770 (1025)
T ss_pred             hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence            3455668899999999999998742       24899998765    34679999999999999998             


Q ss_pred             --EEEeecCCCccccccccccc--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecC
Q 044997          347 --FISTFGNGSLSDHLHDPLLK--GHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFG  422 (563)
Q Consensus       347 --V~e~~~~gsL~~~L~~~~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFG  422 (563)
                        ++|||++|+|..||++..-.  ....|+..+.+.++.|||+|++||+++.   +|||||..+|+||+....+||+|||
T Consensus       771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFG  847 (1025)
T KOG1095|consen  771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFG  847 (1025)
T ss_pred             EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccc
Confidence              46999999999999875322  1356899999999999999999999987   9999999999999999999999999


Q ss_pred             CCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCCCcCCC----
Q 044997          423 LVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIRDD----  497 (563)
Q Consensus       423 la~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p~~~~~----  497 (563)
                      +|+.+...+... ...+..-...|||||.+..             +.++.|+|||||||+|||++| |..|+....    
T Consensus       848 lArDiy~~~yyr-~~~~a~lPvkWm~PEsl~d-------------~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v  913 (1025)
T KOG1095|consen  848 LARDIYDKDYYR-KHGEAMLPVKWMPPESLKD-------------GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEV  913 (1025)
T ss_pred             hhHhhhhchhee-ccCccccceecCCHHHHhh-------------cccccccchhhhHHHHHHHHhCCCCCCCCcchHHH
Confidence            999554433221 1111233568999998854             556999999999999999999 455553322    


Q ss_pred             -------CCchhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcCh
Q 044997          498 -------SEPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITST  543 (563)
Q Consensus       498 -------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~  543 (563)
                             .+...+..+++.+.+||.+||+.+|++||++..|++.+..+.....
T Consensus       914 ~~~~~~ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~  966 (1025)
T KOG1095|consen  914 LLDVLEGGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAAL  966 (1025)
T ss_pred             HHHHHhCCccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhc
Confidence                   1233445677789999999999999999999999999998877544

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-38  Score=327.41  Aligned_cols=219  Identities=25%  Similarity=0.474  Sum_probs=188.8

Q ss_pred             hcCCCccceecccCcEEEEEEEE--CCceEEEEEeccCC---hHHHHHHHHHHHhccccce---------------EEEe
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNK---SKEFFAELKVLCKIHHINV---------------FIST  350 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~---~~~f~~Ei~~l~~l~H~ni---------------V~e~  350 (563)
                      ...|....+||+|+.|.||.++.  .++.||||+|....   ++-.++|+.+|+..+|+||               ||||
T Consensus       272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy  351 (550)
T KOG0578|consen  272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY  351 (550)
T ss_pred             hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence            45677788999999999999976  57889999997543   3557899999999999997               6999


Q ss_pred             ecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccccc
Q 044997          351 FGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERT  430 (563)
Q Consensus       351 ~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~  430 (563)
                      |++|+|.+.+..      ..+++.++..|++++++||+|||.++   |+|||||++|||++.++.+||+|||++..+...
T Consensus       352 m~ggsLTDvVt~------~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~  422 (550)
T KOG0578|consen  352 MEGGSLTDVVTK------TRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEE  422 (550)
T ss_pred             cCCCchhhhhhc------ccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccc
Confidence            999999888864      45899999999999999999999998   999999999999999999999999999866543


Q ss_pred             cccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCC-----------
Q 044997          431 NEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE-----------  499 (563)
Q Consensus       431 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~-----------  499 (563)
                      ..   .....+||+.|||||++....|             ++|.||||||++++||+.|.+||..++..           
T Consensus       423 ~~---KR~TmVGTPYWMAPEVvtrk~Y-------------G~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~  486 (550)
T KOG0578|consen  423 QS---KRSTMVGTPYWMAPEVVTRKPY-------------GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGT  486 (550)
T ss_pred             cC---ccccccCCCCccchhhhhhccc-------------CccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCC
Confidence            32   3456899999999999876665             89999999999999999999999764421           


Q ss_pred             --chhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          500 --PTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       500 --~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                        ......+...+++++.+||+.|+.+||++.|+|+.
T Consensus       487 P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H  523 (550)
T KOG0578|consen  487 PKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH  523 (550)
T ss_pred             CCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence              12345667789999999999999999999999974

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-38  Score=313.71  Aligned_cols=227  Identities=24%  Similarity=0.422  Sum_probs=188.4

Q ss_pred             hcCCCccceecccCcEEEEEEEE--CCceEEEEEeccCC----hHHHHHHHHHHHhccccce---------------EEE
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNK----SKEFFAELKVLCKIHHINV---------------FIS  349 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~----~~~f~~Ei~~l~~l~H~ni---------------V~e  349 (563)
                      .+.|+..++||.|..+.||+|+.  .+..||||+++-++    .+.+.+|+..|+.++||||               ||.
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp  104 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP  104 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence            35688899999999999999987  47899999997443    3678899999999999998               578


Q ss_pred             eecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccccc
Q 044997          350 TFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEER  429 (563)
Q Consensus       350 ~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~  429 (563)
                      ||..|++.+.+....-   ..+++..+..|.+++++||.|||.+|   .||||||+.||||+++|.+||+|||.+..+..
T Consensus       105 fMa~GS~ldIik~~~~---~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~  178 (516)
T KOG0582|consen  105 FMAGGSLLDIIKTYYP---DGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFD  178 (516)
T ss_pred             hhcCCcHHHHHHHHcc---ccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecc
Confidence            9999999999876432   34899999999999999999999998   99999999999999999999999999776554


Q ss_pred             cccccccc-ccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCC----------
Q 044997          430 TNEKEMLA-TRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDS----------  498 (563)
Q Consensus       430 ~~~~~~~~-~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~----------  498 (563)
                      .+...... ...+||+.|||||++...           ...|+.|+||||||++..||.+|..||..-..          
T Consensus       179 ~G~R~~~rf~tfvgtp~wmAPEvl~q~-----------~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn  247 (516)
T KOG0582|consen  179 SGDRQVTRFNTFVGTPCWMAPEVLMQQ-----------LHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQN  247 (516)
T ss_pred             cCceeeEeeccccCcccccChHHhhhc-----------ccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcC
Confidence            44322222 557999999999997443           33568999999999999999999999854321          


Q ss_pred             ----------CchhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          499 ----------EPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       499 ----------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                                ..+..+.....+++++..||++||.+|||++++++.
T Consensus       248 ~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh  293 (516)
T KOG0582|consen  248 DPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH  293 (516)
T ss_pred             CCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence                      112233445569999999999999999999999874

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.1e-38  Score=320.75  Aligned_cols=220  Identities=28%  Similarity=0.379  Sum_probs=180.6

Q ss_pred             cCCCccceecccCcEEEEEEEE--CCceEEEEEeccCCh-----HHHHHHHHHHHhccccce-----------------E
Q 044997          292 NNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNKS-----KEFFAELKVLCKIHHINV-----------------F  347 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~~-----~~f~~Ei~~l~~l~H~ni-----------------V  347 (563)
                      +.|+..++||+|.||.||+|+.  +++.||+|+++.+..     .-..+||.+|++|+||||                 |
T Consensus       117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV  196 (560)
T KOG0600|consen  117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV  196 (560)
T ss_pred             HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence            4567778999999999999987  578899999976542     346799999999999998                 4


Q ss_pred             EEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccc
Q 044997          348 ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLE  427 (563)
Q Consensus       348 ~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~  427 (563)
                      .|||++ +|.-++..    ..-.++..++..++.|++.||+|+|+++   ++|||||.+|||||.+|.+||+|||||+.+
T Consensus       197 FeYMdh-DL~GLl~~----p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y  268 (560)
T KOG0600|consen  197 FEYMDH-DLSGLLSS----PGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFY  268 (560)
T ss_pred             Eecccc-hhhhhhcC----CCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeec
Confidence            578877 77777664    2456999999999999999999999998   999999999999999999999999999976


Q ss_pred             ccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCch------
Q 044997          428 ERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPT------  501 (563)
Q Consensus       428 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~------  501 (563)
                      ......  ..+..+-|.+|.|||++.+..            .|+.+.|+||.||||.||+.|++.+.+..+..+      
T Consensus       269 ~~~~~~--~~T~rVvTLWYRpPELLLG~t------------~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfk  334 (560)
T KOG0600|consen  269 TPSGSA--PYTSRVVTLWYRPPELLLGAT------------SYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFK  334 (560)
T ss_pred             cCCCCc--ccccceEEeeccChHHhcCCc------------ccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHH
Confidence            654332  245567899999999997653            569999999999999999999988755432110      


Q ss_pred             ---------------------------------hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          502 ---------------------------------KMKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       502 ---------------------------------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                                                       ....+.....+|+..+|..||.+|.|+.+.++
T Consensus       335 lcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  335 LCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             HhCCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence                                             01122334788999999999999999999876

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-38  Score=321.83  Aligned_cols=220  Identities=26%  Similarity=0.357  Sum_probs=181.7

Q ss_pred             hcCCCccceecccCcEEEEEEEE--CCceEEEEEeccCC--hHH--HHHHHHHHHhcc-ccce----------------E
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNK--SKE--FFAELKVLCKIH-HINV----------------F  347 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~--~~~--f~~Ei~~l~~l~-H~ni----------------V  347 (563)
                      .++|...++||.|.||.||+|+-  .+..||||+|+..-  .++  -++|++.|++++ ||||                |
T Consensus         9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV   88 (538)
T KOG0661|consen    9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV   88 (538)
T ss_pred             HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence            45688889999999999999976  47889999998652  333  468999999999 9998                3


Q ss_pred             EEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccc
Q 044997          348 ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLE  427 (563)
Q Consensus       348 ~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~  427 (563)
                      +|||+. +|.+.+++    +++++++..+..|+.||++||+|+|.+|   +.|||+||+|||+..+..+||+|||+||..
T Consensus        89 fE~Md~-NLYqLmK~----R~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev  160 (538)
T KOG0661|consen   89 FEFMDC-NLYQLMKD----RNRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREV  160 (538)
T ss_pred             HHhhhh-hHHHHHhh----cCCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEeccccccccc
Confidence            466654 78787776    3688999999999999999999999998   999999999999999999999999999965


Q ss_pred             ccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCchhh----
Q 044997          428 ERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKM----  503 (563)
Q Consensus       428 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~~~----  503 (563)
                      ....    ..+..+.|.+|+|||++..            .+.|+.+.|+||+|||++|+.+-++.|.+..+.++..    
T Consensus       161 ~Skp----PYTeYVSTRWYRAPEvLLr------------s~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~  224 (538)
T KOG0661|consen  161 RSKP----PYTEYVSTRWYRAPEVLLR------------SGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICE  224 (538)
T ss_pred             ccCC----CcchhhhcccccchHHhhh------------ccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHH
Confidence            4332    3466789999999999854            4567999999999999999999988776554321111    


Q ss_pred             ------------------------------------HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          504 ------------------------------------KSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       504 ------------------------------------~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                                                          ..+.....+|+.+|++.||.+|||+.|.++.
T Consensus       225 VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  225 VLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             HhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence                                                1123448899999999999999999999875

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=1.6e-37  Score=314.17  Aligned_cols=220  Identities=20%  Similarity=0.315  Sum_probs=182.3

Q ss_pred             ccceecccCcEEEEEEEECCceEEEEEeccCC------hHHHHHHHHHHHhccccce-------------------EEEe
Q 044997          296 ESRIIGRGGFGNVYFGLLGDREAAIKKMRSNK------SKEFFAELKVLCKIHHINV-------------------FIST  350 (563)
Q Consensus       296 ~~~~LG~G~fG~Vy~g~~~~~~vavK~~~~~~------~~~f~~Ei~~l~~l~H~ni-------------------V~e~  350 (563)
                      ....||+|++|.||+|.++++.||||+++...      .+.|.+|+++|.+++||||                   |+||
T Consensus        24 ~~~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey  103 (283)
T PHA02988         24 TSVLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY  103 (283)
T ss_pred             CCeEEeeCCceEEEEEEECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence            34789999999999999999999999987532      2567899999999999997                   4688


Q ss_pred             ecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCceEeCCCCCCCeEecCCCcEEEeecCCCccccc
Q 044997          351 FGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDH-TKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEER  429 (563)
Q Consensus       351 ~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~  429 (563)
                      +.+|+|.+++..     ...++|.....++.|++.||.|||+. +   ++||||||+|||+++++.+||+|||+++....
T Consensus       104 ~~~g~L~~~l~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~  175 (283)
T PHA02988        104 CTRGYLREVLDK-----EKDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSS  175 (283)
T ss_pred             CCCCcHHHHHhh-----CCCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhcc
Confidence            899999999875     35689999999999999999999984 4   77999999999999999999999999885432


Q ss_pred             ccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc---------
Q 044997          430 TNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP---------  500 (563)
Q Consensus       430 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~---------  500 (563)
                      ..      ....|+..|+|||++.+.           ...++.++|||||||++|||++|+.||.......         
T Consensus       176 ~~------~~~~~~~~y~aPE~~~~~-----------~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~  238 (283)
T PHA02988        176 PP------FKNVNFMVYFSYKMLNDI-----------FSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKN  238 (283)
T ss_pred             cc------ccccCcccccCHHHhhhc-----------cccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcC
Confidence            21      224578899999987531           1345899999999999999999999997543211         


Q ss_pred             ---hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhh
Q 044997          501 ---TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMI  540 (563)
Q Consensus       501 ---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~  540 (563)
                         ......++.+.+++.+||+.||.+|||+.|+++.|+++..
T Consensus       239 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~  281 (283)
T PHA02988        239 NSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF  281 (283)
T ss_pred             CCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence               1111345679999999999999999999999999998753

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=9.2e-38  Score=299.04  Aligned_cols=219  Identities=23%  Similarity=0.344  Sum_probs=178.5

Q ss_pred             cCCCccceecccCcEEEEEEEEC--CceEEEEEeccCCh-----HHHHHHHHHHHhccccce---------------EEE
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNKS-----KEFFAELKVLCKIHHINV---------------FIS  349 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~-----~~f~~Ei~~l~~l~H~ni---------------V~e  349 (563)
                      +.|+...++|+|+||.||+++.+  |+.||||++.....     +-.++|+++|++++|+|+               |.|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            34667788999999999999874  78999999865432     457899999999999997               678


Q ss_pred             eecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccccc
Q 044997          350 TFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEER  429 (563)
Q Consensus       350 ~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~  429 (563)
                      |++..-|.+.=+     ....++.....+++.|+++|+.|+|+++   ++||||||+||||+.++.+||||||+|+.+..
T Consensus        82 ~~dhTvL~eLe~-----~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~  153 (396)
T KOG0593|consen   82 YCDHTVLHELER-----YPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSA  153 (396)
T ss_pred             ecchHHHHHHHh-----ccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcC
Confidence            888755544322     2355888999999999999999999998   99999999999999999999999999998764


Q ss_pred             ccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc---------
Q 044997          430 TNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP---------  500 (563)
Q Consensus       430 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~---------  500 (563)
                      .++   ..+..+.|.+|.|||.+.+            ..+|++.+||||.||++.||++|.+-|.+....+         
T Consensus       154 pgd---~YTDYVATRWYRaPELLvG------------DtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktL  218 (396)
T KOG0593|consen  154 PGD---NYTDYVATRWYRAPELLVG------------DTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTL  218 (396)
T ss_pred             Ccc---hhhhhhhhhhccChhhhcc------------cCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHH
Confidence            322   3456788999999999865            3456899999999999999999997775443211         


Q ss_pred             --------------------------------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          501 --------------------------------TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       501 --------------------------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                                                      .....+...+.++++.|++.||.+|++-+|++.
T Consensus       219 G~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  219 GNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             cccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence                                            112233445899999999999999999999875

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=8.5e-38  Score=320.93  Aligned_cols=230  Identities=24%  Similarity=0.385  Sum_probs=186.9

Q ss_pred             HhcCCCccceecccCcEEEEEEEECC-ceEEEEEeccCC----hHHHHHHHHHHHhccccceE---------------EE
Q 044997          290 ATNNFDESRIIGRGGFGNVYFGLLGD-REAAIKKMRSNK----SKEFFAELKVLCKIHHINVF---------------IS  349 (563)
Q Consensus       290 ~~~~f~~~~~LG~G~fG~Vy~g~~~~-~~vavK~~~~~~----~~~f~~Ei~~l~~l~H~niV---------------~e  349 (563)
                      +++.....++||+|.||+|.++...+ ..||||.++.+.    +++|.+|+++|.+++|||||               +|
T Consensus       536 PRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~E  615 (807)
T KOG1094|consen  536 PRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITE  615 (807)
T ss_pred             chhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHH
Confidence            44556678999999999999999876 899999998764    47899999999999999983               69


Q ss_pred             eecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccccc
Q 044997          350 TFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEER  429 (563)
Q Consensus       350 ~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~  429 (563)
                      ||++|+|.+||.....   ..+.-..-++|+.|||.||+||.+..   +|||||.++|||+|.++++||+|||+++-+..
T Consensus       616 YmEnGDLnqFl~ahea---pt~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lys  689 (807)
T KOG1094|consen  616 YMENGDLNQFLSAHEL---PTAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYS  689 (807)
T ss_pred             HHhcCcHHHHHHhccC---cccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCccccccccc
Confidence            9999999999976321   12455667789999999999999986   99999999999999999999999999996654


Q ss_pred             ccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc--CCCCCcCCCCC--------
Q 044997          430 TNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT--GKRALIRDDSE--------  499 (563)
Q Consensus       430 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt--g~~p~~~~~~~--------  499 (563)
                      ++. .....+.+-.++|||||.+..++             +|.+||||+|||++||+++  ...|+..-..+        
T Consensus       690 g~y-y~vqgr~vlpiRwmawEsillgk-------------FttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~  755 (807)
T KOG1094|consen  690 GDY-YRVQGRAVLPIRWMAWESILLGK-------------FTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGE  755 (807)
T ss_pred             CCc-eeeecceeeeeeehhHHHHHhcc-------------ccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhh
Confidence            433 22345567789999999876554             5999999999999999875  56676432211        


Q ss_pred             ----------chhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhh
Q 044997          500 ----------PTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIM  539 (563)
Q Consensus       500 ----------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~  539 (563)
                                ...+.-++..+.+++.+||..|-++||+++++...|++..
T Consensus       756 ~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~  805 (807)
T KOG1094|consen  756 FFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA  805 (807)
T ss_pred             hcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence                      1122344566889999999999999999999999887643

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-38  Score=320.55  Aligned_cols=234  Identities=24%  Similarity=0.384  Sum_probs=191.6

Q ss_pred             HhcCCCccceecccCcEEEEEEEE--CCceEEEEEeccC------ChHHHHHHHHHHHhc-cccce--------------
Q 044997          290 ATNNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSN------KSKEFFAELKVLCKI-HHINV--------------  346 (563)
Q Consensus       290 ~~~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~------~~~~f~~Ei~~l~~l-~H~ni--------------  346 (563)
                      ..++|..++.||+|+|++|++|+.  .++.+|||++.++      +.+-...|-++|.+| +||.|              
T Consensus        71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY  150 (604)
T KOG0592|consen   71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY  150 (604)
T ss_pred             ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence            346788899999999999999977  4789999998643      334566788999999 89987              


Q ss_pred             -EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCc
Q 044997          347 -FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK  425 (563)
Q Consensus       347 -V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~  425 (563)
                       |+||.+||+|.++|+.     ...+++.....++.+|+.||+|||++|   ||||||||+|||||+|+++||+|||-|+
T Consensus       151 FvLe~A~nGdll~~i~K-----~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK  222 (604)
T KOG0592|consen  151 FVLEYAPNGDLLDLIKK-----YGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAK  222 (604)
T ss_pred             EEEEecCCCcHHHHHHH-----hCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccc
Confidence             5799999999999975     367999999999999999999999998   9999999999999999999999999999


Q ss_pred             cccccccc------c--cc--cccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcC
Q 044997          426 LEERTNEK------E--ML--ATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIR  495 (563)
Q Consensus       426 ~~~~~~~~------~--~~--~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~  495 (563)
                      .+......      .  ..  ...++||..|.+||++..+             ..++.+|+|+|||+||.|+.|++||..
T Consensus       223 ~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~-------------~~~~~sDiWAlGCilyQmlaG~PPFra  289 (604)
T KOG0592|consen  223 ILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDS-------------PAGPSSDLWALGCILYQMLAGQPPFRA  289 (604)
T ss_pred             cCChhhccccCccCcccccCcccceeeeecccCHHHhcCC-------------CCCcccchHHHHHHHHHHhcCCCCCcc
Confidence            87643221      0  11  1348999999999998544             458999999999999999999999987


Q ss_pred             CCCCc----------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcChhhhc
Q 044997          496 DDSEP----------TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITSTEWEA  547 (563)
Q Consensus       496 ~~~~~----------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~w~~  547 (563)
                      .++-.          .....+++.+.+|+++.|..||.+|++.++|.+..   +-...+|+.
T Consensus       290 ~NeyliFqkI~~l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp---FF~~Vdw~n  348 (604)
T KOG0592|consen  290 ANEYLIFQKIQALDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHP---FFEGVDWEN  348 (604)
T ss_pred             ccHHHHHHHHHHhcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCc---ccccCChhh
Confidence            65421          12234456689999999999999999998877642   344556654

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-37  Score=321.14  Aligned_cols=222  Identities=24%  Similarity=0.380  Sum_probs=188.3

Q ss_pred             HHhcCCCccceecccCcEEEEEEEE--CCceEEEEEeccC--------ChHHHHHHHHHHHhcc-ccce-----------
Q 044997          289 EATNNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSN--------KSKEFFAELKVLCKIH-HINV-----------  346 (563)
Q Consensus       289 ~~~~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~--------~~~~f~~Ei~~l~~l~-H~ni-----------  346 (563)
                      ...++|...+.||+|+||.|++|..  .++.||+|.++..        ..+...+|+.++++++ ||||           
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~   93 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT   93 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence            3456889999999999999999977  5799999977653        1344667999999999 9998           


Q ss_pred             ----EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCC-CcEEEeec
Q 044997          347 ----FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDG-LRAKVADF  421 (563)
Q Consensus       347 ----V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~-~~~kl~DF  421 (563)
                          |+||+.+|+|.+++.+     ..++.+.....++.|++.|++|+|+++   |+||||||+|||+|.+ +++||+||
T Consensus        94 ~~~ivmEy~~gGdL~~~i~~-----~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DF  165 (370)
T KOG0583|consen   94 KIYIVMEYCSGGDLFDYIVN-----KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDF  165 (370)
T ss_pred             eEEEEEEecCCccHHHHHHH-----cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEecc
Confidence                6899999999999975     467888999999999999999999998   9999999999999999 99999999


Q ss_pred             CCCcccccccccccccccccCCCcccCcccccccc-cccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCC-
Q 044997          422 GLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKR-FRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE-  499 (563)
Q Consensus       422 Gla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~-~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~-  499 (563)
                      |++....   .........+||+.|+|||++.+.. |+            +.++||||+||+||.|++|+.||...+.. 
T Consensus       166 G~s~~~~---~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~------------g~~aDvWS~GViLy~ml~G~~PF~d~~~~~  230 (370)
T KOG0583|consen  166 GLSAISP---GEDGLLKTFCGSPAYAAPEVLSGKGTYS------------GKAADVWSLGVILYVLLCGRLPFDDSNVPN  230 (370)
T ss_pred             ccccccC---CCCCcccCCCCCcccCCHHHhCCCCCcC------------CchhhhhhhHHHHHHHHhCCCCCCCccHHH
Confidence            9998763   1222445678999999999998876 63            68999999999999999999999874421 


Q ss_pred             ---------chhhHHH-HHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          500 ---------PTKMKSL-ITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       500 ---------~~~~~~~-~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                               ...+..+ ...+..|+.+|+..||.+|+++.+|++
T Consensus       231 l~~ki~~~~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~  274 (370)
T KOG0583|consen  231 LYRKIRKGEFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILE  274 (370)
T ss_pred             HHHHHhcCCccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence                     1122334 677899999999999999999999993

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=2e-36  Score=355.60  Aligned_cols=235  Identities=24%  Similarity=0.381  Sum_probs=185.0

Q ss_pred             cCHHHHHHHhcCCCccceecccCcEEEEEEEE--CCceEEEEEeccCChHHHHHHHHHHHhccccce-------------
Q 044997          282 FSLEEIEEATNNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNKSKEFFAELKVLCKIHHINV-------------  346 (563)
Q Consensus       282 ~~~~el~~~~~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~~~~f~~Ei~~l~~l~H~ni-------------  346 (563)
                      ++++++   ...|...+.||+|+||.||+|+.  ++..||||+++.... ...+|++.+++++||||             
T Consensus       683 ~~~~~~---~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~  758 (968)
T PLN00113        683 ITINDI---LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-IPSSEIADMGKLQHPNIVKLIGLCRSEKGA  758 (968)
T ss_pred             hhHHHH---HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-ccHHHHHHHhhCCCCCcceEEEEEEcCCCC
Confidence            344444   34577889999999999999986  578999999865432 22357899999999998             


Q ss_pred             --EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCC
Q 044997          347 --FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLV  424 (563)
Q Consensus       347 --V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla  424 (563)
                        |+||+++|+|.++++.        ++|.++.+|+.|+|+||+|||++..++++||||||+||+++.++.+++. ||..
T Consensus       759 ~lv~Ey~~~g~L~~~l~~--------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~  829 (968)
T PLN00113        759 YLIHEYIEGKNLSEVLRN--------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLP  829 (968)
T ss_pred             EEEEeCCCCCcHHHHHhc--------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccc
Confidence              5799999999999853        8999999999999999999997766679999999999999999988876 6665


Q ss_pred             cccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc----
Q 044997          425 KLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP----  500 (563)
Q Consensus       425 ~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~----  500 (563)
                      .....       .....||..|+|||++.+..             ++.++|||||||++|||++|+.|+.......    
T Consensus       830 ~~~~~-------~~~~~~t~~y~aPE~~~~~~-------------~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~  889 (968)
T PLN00113        830 GLLCT-------DTKCFISSAYVAPETRETKD-------------ITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIV  889 (968)
T ss_pred             ccccc-------CCCccccccccCcccccCCC-------------CCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHH
Confidence            43211       11236789999999875443             4899999999999999999999974321100    


Q ss_pred             ------------------------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcChhhhccc
Q 044997          501 ------------------------TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITSTEWEASL  549 (563)
Q Consensus       501 ------------------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~w~~~~  549 (563)
                                              .........+.+++.+||+.||++||+|+||++.|+++...+.+....+
T Consensus       890 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~~~~~~~~  962 (968)
T PLN00113        890 EWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSSSSCVTGL  962 (968)
T ss_pred             HHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhccccccccCc
Confidence                                    0011223357789999999999999999999999999988766555444

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=5.9e-37  Score=289.07  Aligned_cols=220  Identities=25%  Similarity=0.352  Sum_probs=179.8

Q ss_pred             cCCCccceecccCcEEEEEEEE--CCceEEEEEeccCCh-----HHHHHHHHHHHhccccce---------------EEE
Q 044997          292 NNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNKS-----KEFFAELKVLCKIHHINV---------------FIS  349 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~~-----~~f~~Ei~~l~~l~H~ni---------------V~e  349 (563)
                      ++|...++||+|.||.||+|+.  +++.||||+++....     ...++|++.|+.++|+||               |.|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            4577789999999999999987  478999999975543     357899999999999997               567


Q ss_pred             eecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccccc
Q 044997          350 TFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEER  429 (563)
Q Consensus       350 ~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~  429 (563)
                      ||+. +|...+++    ....++..++..++.++++||+|||++.   |+||||||.|+|++++|.+||+|||+|+.+..
T Consensus        82 fm~t-dLe~vIkd----~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~  153 (318)
T KOG0659|consen   82 FMPT-DLEVVIKD----KNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGS  153 (318)
T ss_pred             eccc-cHHHHhcc----cccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCC
Confidence            7765 78777776    3567999999999999999999999998   99999999999999999999999999998765


Q ss_pred             ccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCch--------
Q 044997          430 TNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPT--------  501 (563)
Q Consensus       430 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~--------  501 (563)
                      .+..   .+..+-|..|.|||.+.+.+            .|+...|+||.||++.||+-|.+-|.++...++        
T Consensus       154 p~~~---~~~~V~TRWYRAPELLfGsr------------~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~L  218 (318)
T KOG0659|consen  154 PNRI---QTHQVVTRWYRAPELLFGSR------------QYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRAL  218 (318)
T ss_pred             CCcc---cccceeeeeccChHHhccch------------hcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHc
Confidence            4332   23336789999999998764            468999999999999999998765544332110        


Q ss_pred             ------h------------------------hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          502 ------K------------------------MKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       502 ------~------------------------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                            .                        .....+...+|+..++..||.+|++++|.+++
T Consensus       219 GTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  219 GTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             CCCCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence                  0                        01112337899999999999999999999875

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=5.8e-37  Score=314.82  Aligned_cols=235  Identities=24%  Similarity=0.390  Sum_probs=187.6

Q ss_pred             cCCCccceecccCcEEEEEEEEC--Cc----eEEEEEeccCC----hHHHHHHHHHHHhccccce--------------E
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG--DR----EAAIKKMRSNK----SKEFFAELKVLCKIHHINV--------------F  347 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~--~~----~vavK~~~~~~----~~~f~~Ei~~l~~l~H~ni--------------V  347 (563)
                      .+|+..+.||+|+||.||+|++.  +.    .||+|.++...    .++|.+|+.+++.++||||              +
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~~~~~v   86 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLI   86 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCCCceee
Confidence            45888999999999999999862  33    38999986432    3578899999999999998              4


Q ss_pred             EEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccc
Q 044997          348 ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLE  427 (563)
Q Consensus       348 ~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~  427 (563)
                      ++|+.+|+|.+++...    ...+++..++.++.|++.||+|||+++   ++||||||+|||+++++.+||+|||+++..
T Consensus        87 ~e~~~~g~l~~~l~~~----~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~  159 (316)
T cd05108          87 TQLMPFGCLLDYVREH----KDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL  159 (316)
T ss_pred             eecCCCCCHHHHHHhc----cccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccccccc
Confidence            6888999999988752    345899999999999999999999987   999999999999999999999999999865


Q ss_pred             ccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCCCcCCCCCc------
Q 044997          428 ERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIRDDSEP------  500 (563)
Q Consensus       428 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p~~~~~~~~------  500 (563)
                      ...... .......++..|+|||++....             ++.++|||||||++|||++ |+.|+.......      
T Consensus       160 ~~~~~~-~~~~~~~~~~~y~apE~~~~~~-------------~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~  225 (316)
T cd05108         160 GADEKE-YHAEGGKVPIKWMALESILHRI-------------YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE  225 (316)
T ss_pred             cCCCcc-eeccCCccceeecChHHhccCC-------------CCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Confidence            433221 1111223467899999875443             4889999999999999998 888886432211      


Q ss_pred             -----hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcChhhhc
Q 044997          501 -----TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITSTEWEA  547 (563)
Q Consensus       501 -----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~w~~  547 (563)
                           .........+.+++.+||+.||.+||++.+++..|.++......|..
T Consensus       226 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~~~~~~  277 (316)
T cd05108         226 KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLV  277 (316)
T ss_pred             CCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCCchheE
Confidence                 00112234588999999999999999999999999999887766544

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=1.1e-36  Score=308.17  Aligned_cols=218  Identities=23%  Similarity=0.369  Sum_probs=177.9

Q ss_pred             CCCccceecccCcEEEEEEEE--CCceEEEEEeccCC------hHHHHHHHHHHHhccccce---------------EEE
Q 044997          293 NFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNK------SKEFFAELKVLCKIHHINV---------------FIS  349 (563)
Q Consensus       293 ~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~------~~~f~~Ei~~l~~l~H~ni---------------V~e  349 (563)
                      .|+..+.||+|+||.||++..  +++.+|+|.+....      ...+.+|++++.+++|+|+               |+|
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            367789999999999999986  47899999886432      2357889999999999997               578


Q ss_pred             eecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccccc
Q 044997          350 TFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEER  429 (563)
Q Consensus       350 ~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~  429 (563)
                      |+++|+|.+++...   ....+++..+..++.|++.||+|||+.+   ++||||||+|||+++++.+||+|||+++....
T Consensus        81 ~~~~g~L~~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~  154 (285)
T cd05631          81 IMNGGDLKFHIYNM---GNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPE  154 (285)
T ss_pred             ecCCCcHHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC
Confidence            99999998887642   2346899999999999999999999987   99999999999999999999999999976432


Q ss_pred             ccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCch--------
Q 044997          430 TNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPT--------  501 (563)
Q Consensus       430 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~--------  501 (563)
                      ..    ......||..|+|||++.+..             ++.++|||||||++|||++|+.||........        
T Consensus       155 ~~----~~~~~~g~~~y~aPE~~~~~~-------------~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~  217 (285)
T cd05631         155 GE----TVRGRVGTVGYMAPEVINNEK-------------YTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRV  217 (285)
T ss_pred             CC----eecCCCCCCCccCHhhhcCCC-------------CCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHh
Confidence            21    123356899999999986544             48899999999999999999999976433210        


Q ss_pred             ------hhHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 044997          502 ------KMKSLITIMAAVAEWCLNEDAVDRPE-----MRDIVA  533 (563)
Q Consensus       502 ------~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~  533 (563)
                            ........+.+|+.+||+.||.+||+     +.++++
T Consensus       218 ~~~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         218 KEDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             hcccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence                  11124456899999999999999997     677765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=6.1e-37  Score=308.92  Aligned_cols=229  Identities=28%  Similarity=0.468  Sum_probs=183.5

Q ss_pred             cCCCccceecccCcEEEEEEEECC-------ceEEEEEeccCC----hHHHHHHHHHHHhccccce--------------
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLGD-------REAAIKKMRSNK----SKEFFAELKVLCKIHHINV--------------  346 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~~-------~~vavK~~~~~~----~~~f~~Ei~~l~~l~H~ni--------------  346 (563)
                      ++|+..+.||+|+||.||+|...+       ..+|+|.++...    .++|.+|++++.+++||||              
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            357788999999999999998643       468999987543    3568899999999999997              


Q ss_pred             -EEEeecCCCcccccccccccC-----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCC
Q 044997          347 -FISTFGNGSLSDHLHDPLLKG-----------HQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGL  414 (563)
Q Consensus       347 -V~e~~~~gsL~~~L~~~~~~~-----------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~  414 (563)
                       ++||+++|+|.+++.......           ...+++..++.++.|++.||.|||+.+   ++||||||+||++++++
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL  161 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence             568999999999986532111           156899999999999999999999987   99999999999999999


Q ss_pred             cEEEeecCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCCC
Q 044997          415 RAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRAL  493 (563)
Q Consensus       415 ~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p~  493 (563)
                      .+||+|||+++........ .......+++.|+|||.+...             .++.++|||||||++|||++ |..||
T Consensus       162 ~~~L~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~-------------~~~~~sDv~slG~il~el~~~g~~p~  227 (283)
T cd05048         162 TVKISDFGLSRDIYSADYY-RVQSKSLLPVRWMPPEAILYG-------------KFTTESDIWSFGVVLWEIFSYGLQPY  227 (283)
T ss_pred             cEEECCCcceeeccccccc-cccCCCcccccccCHHHhccC-------------cCchhhhHHHHHHHHHHHHcCCCCCC
Confidence            9999999998764332211 122334567889999987543             34889999999999999998 99998


Q ss_pred             cCCCCCc-----------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 044997          494 IRDDSEP-----------TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQ  537 (563)
Q Consensus       494 ~~~~~~~-----------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  537 (563)
                      .......           .....++..+.+|+.+||+.||.+||++.||++.|++
T Consensus       228 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         228 YGFSNQEVIEMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             CCCCHHHHHHHHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence            6533211           1122345679999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=7e-37  Score=321.90  Aligned_cols=232  Identities=24%  Similarity=0.405  Sum_probs=182.4

Q ss_pred             HhcCCCccceecccCcEEEEEEEE-------CCceEEEEEeccCC----hHHHHHHHHHHHhc-cccce-----------
Q 044997          290 ATNNFDESRIIGRGGFGNVYFGLL-------GDREAAIKKMRSNK----SKEFFAELKVLCKI-HHINV-----------  346 (563)
Q Consensus       290 ~~~~f~~~~~LG~G~fG~Vy~g~~-------~~~~vavK~~~~~~----~~~f~~Ei~~l~~l-~H~ni-----------  346 (563)
                      ..++|+..+.||+|+||.||+|.+       .+..||||+++...    .+.+.+|+++|..+ +||||           
T Consensus        33 ~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~  112 (375)
T cd05104          33 PRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGG  112 (375)
T ss_pred             chHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC
Confidence            355788899999999999999964       23579999987532    35688999999999 89998           


Q ss_pred             ----EEEeecCCCcccccccccc---------------------------------------------------------
Q 044997          347 ----FISTFGNGSLSDHLHDPLL---------------------------------------------------------  365 (563)
Q Consensus       347 ----V~e~~~~gsL~~~L~~~~~---------------------------------------------------------  365 (563)
                          |+||+++|+|.+++.....                                                         
T Consensus       113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (375)
T cd05104         113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG  192 (375)
T ss_pred             cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence                4799999999988864210                                                         


Q ss_pred             -------------cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccccccc
Q 044997          366 -------------KGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNE  432 (563)
Q Consensus       366 -------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~  432 (563)
                                   .....++|..+..++.|++.||+|||+++   ++||||||+|||+++++.+||+|||+++.......
T Consensus       193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  269 (375)
T cd05104         193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSN  269 (375)
T ss_pred             eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCccc
Confidence                         01235899999999999999999999987   99999999999999999999999999986543221


Q ss_pred             cccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCCCcCCCCCch----------
Q 044997          433 KEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIRDDSEPT----------  501 (563)
Q Consensus       433 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p~~~~~~~~~----------  501 (563)
                      . .......++..|+|||.+.+..             ++.++|||||||++|||++ |..||........          
T Consensus       270 ~-~~~~~~~~~~~y~aPE~~~~~~-------------~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~  335 (375)
T cd05104         270 Y-VVKGNARLPVKWMAPESIFNCV-------------YTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYR  335 (375)
T ss_pred             c-cccCCCCCCcceeChhHhcCCC-------------CCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCcc
Confidence            1 1112234567899999875443             4889999999999999998 7778754322111          


Q ss_pred             --hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 044997          502 --KMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQI  538 (563)
Q Consensus       502 --~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  538 (563)
                        .....+..+.+++.+||+.||++||++.||++.|++.
T Consensus       336 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         336 MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence              1112345689999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6e-38  Score=327.81  Aligned_cols=234  Identities=28%  Similarity=0.419  Sum_probs=188.1

Q ss_pred             HHHHhcCCCccceecccCcEEEEEEEEC---C--ce-EEEEEeccC------ChHHHHHHHHHHHhccccce--------
Q 044997          287 IEEATNNFDESRIIGRGGFGNVYFGLLG---D--RE-AAIKKMRSN------KSKEFFAELKVLCKIHHINV--------  346 (563)
Q Consensus       287 l~~~~~~f~~~~~LG~G~fG~Vy~g~~~---~--~~-vavK~~~~~------~~~~f~~Ei~~l~~l~H~ni--------  346 (563)
                      |+...++....++||+|+||.||+|++.   +  .. ||||.++..      ..++|.+|.++|++++||||        
T Consensus       152 Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~  231 (474)
T KOG0194|consen  152 WELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAV  231 (474)
T ss_pred             cEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence            4444555666799999999999999873   1  23 899998852      34789999999999999998        


Q ss_pred             -------EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEe
Q 044997          347 -------FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVA  419 (563)
Q Consensus       347 -------V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~  419 (563)
                             |+|++.+|+|.+||...    ...++..+++.++.+.|.||+|||+++   ++||||.++|+|++.++.+||+
T Consensus       232 ~~~Pl~ivmEl~~gGsL~~~L~k~----~~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKIS  304 (474)
T KOG0194|consen  232 LEEPLMLVMELCNGGSLDDYLKKN----KKSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKIS  304 (474)
T ss_pred             CCCccEEEEEecCCCcHHHHHHhC----CCCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeC
Confidence                   57999999999999862    336999999999999999999999997   9999999999999999999999


Q ss_pred             ecCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCCCcCCCC
Q 044997          420 DFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIRDDS  498 (563)
Q Consensus       420 DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p~~~~~~  498 (563)
                      |||+++....   .........-...|+|||.+...             .+++++|||||||++||+++ |..|+.+...
T Consensus       305 DFGLs~~~~~---~~~~~~~~klPirWLAPEtl~~~-------------~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~  368 (474)
T KOG0194|consen  305 DFGLSRAGSQ---YVMKKFLKKLPIRWLAPETLNTG-------------IFSFKTDVWSFGVLLWEIFENGAEPYPGMKN  368 (474)
T ss_pred             ccccccCCcc---eeeccccccCcceecChhhhccC-------------ccccccchhheeeeEEeeeccCCCCCCCCCH
Confidence            9999875321   11111112346789999987544             55999999999999999999 7888765432


Q ss_pred             C------------chhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcCh
Q 044997          499 E------------PTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITST  543 (563)
Q Consensus       499 ~------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~  543 (563)
                      .            .......+..+..++.+||..||++||+|.++.+.|+.+.....
T Consensus       369 ~~v~~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~  425 (474)
T KOG0194|consen  369 YEVKAKIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE  425 (474)
T ss_pred             HHHHHHHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence            1            11122445668899999999999999999999999998876544

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=1.4e-36  Score=310.13  Aligned_cols=228  Identities=26%  Similarity=0.414  Sum_probs=178.4

Q ss_pred             cCCCccceecccCcEEEEEEEEC------------------CceEEEEEeccCC----hHHHHHHHHHHHhccccce---
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG------------------DREAAIKKMRSNK----SKEFFAELKVLCKIHHINV---  346 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~------------------~~~vavK~~~~~~----~~~f~~Ei~~l~~l~H~ni---  346 (563)
                      ++|...++||+|+||.||++.++                  +..||+|.++...    ..+|.+|+++|.+++||||   
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            56888899999999999999753                  2359999987643    3568999999999999997   


Q ss_pred             ------------EEEeecCCCccccccccccc--------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEe
Q 044997          347 ------------FISTFGNGSLSDHLHDPLLK--------------GHQPLTWTARTQIALDAAKGIEYIHDHTKARYVH  400 (563)
Q Consensus       347 ------------V~e~~~~gsL~~~L~~~~~~--------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH  400 (563)
                                  |+||+++|+|.+++......              ....++|..+..++.|++.||.|||+++   ++|
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH  161 (304)
T cd05096          85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVH  161 (304)
T ss_pred             EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence                        57899999999988542211              1235789999999999999999999997   999


Q ss_pred             CCCCCCCeEecCCCcEEEeecCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHH
Q 044997          401 RDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFG  480 (563)
Q Consensus       401 rDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfG  480 (563)
                      |||||+|||+++++.+||+|||+++....... ........++..|+|||++....             ++.++||||||
T Consensus       162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~-------------~~~~~Dv~slG  227 (304)
T cd05096         162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDY-YRIQGRAVLPIRWMAWECILMGK-------------FTTASDVWAFG  227 (304)
T ss_pred             cCcchhheEEcCCccEEECCCccceecccCce-eEecCcCCCCccccCHHHHhcCC-------------CCchhhhHHHH
Confidence            99999999999999999999999986533221 11223345678999999875443             48899999999


Q ss_pred             HHHHHHHc--CCCCCcCCCCCch------------------hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 044997          481 VVLAELIT--GKRALIRDDSEPT------------------KMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILS  536 (563)
Q Consensus       481 vvl~Ellt--g~~p~~~~~~~~~------------------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  536 (563)
                      +++|||++  +..|+........                  .....+..+.+++.+||+.||++|||+.+|.+.|+
T Consensus       228 ~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~  303 (304)
T cd05096         228 VTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT  303 (304)
T ss_pred             HHHHHHHHccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence            99999987  4556643321110                  00122356889999999999999999999998875

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=8.5e-37  Score=305.60  Aligned_cols=225  Identities=22%  Similarity=0.400  Sum_probs=181.8

Q ss_pred             cCCCccceecccCcEEEEEEEEC-----CceEEEEEeccCC----hHHHHHHHHHHHhccccce---------------E
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG-----DREAAIKKMRSNK----SKEFFAELKVLCKIHHINV---------------F  347 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~-----~~~vavK~~~~~~----~~~f~~Ei~~l~~l~H~ni---------------V  347 (563)
                      ++|+..+.||+|+||.||+|.+.     +..||+|.++...    .+.|.+|+.++.+++||||               |
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   84 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV   84 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence            46788899999999999999763     4679999987653    2468899999999999997               6


Q ss_pred             EEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccc
Q 044997          348 ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLE  427 (563)
Q Consensus       348 ~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~  427 (563)
                      +||+++|+|.+++...    ...++|.+++.++.|++.||+|||+++   ++||||||+|||++.++.+|++|||.+...
T Consensus        85 ~e~~~~~~L~~~l~~~----~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~  157 (266)
T cd05064          85 TEYMSNGALDSFLRKH----EGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQED  157 (266)
T ss_pred             EEeCCCCcHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccc
Confidence            8999999999998642    346899999999999999999999987   999999999999999999999999987643


Q ss_pred             ccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCCCcCCCCC-------
Q 044997          428 ERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIRDDSE-------  499 (563)
Q Consensus       428 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p~~~~~~~-------  499 (563)
                      .....  .......++..|+|||.+.+..             ++.++|||||||++||+++ |+.||......       
T Consensus       158 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~-------------~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~  222 (266)
T cd05064         158 KSEAI--YTTMSGKSPVLWAAPEAIQYHH-------------FSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVE  222 (266)
T ss_pred             cccch--hcccCCCCceeecCHHHHhhCC-------------ccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHH
Confidence            21111  1111233567899999875443             4889999999999999875 99998643221       


Q ss_pred             ----chhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 044997          500 ----PTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQI  538 (563)
Q Consensus       500 ----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  538 (563)
                          ......++..+.+++.+||+.+|.+||++.+|.+.|.++
T Consensus       223 ~~~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         223 DGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             CCCCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence                111233456689999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=2.1e-36  Score=304.95  Aligned_cols=233  Identities=21%  Similarity=0.351  Sum_probs=185.5

Q ss_pred             cCCCccceecccCcEEEEEEEE--CCc----eEEEEEeccCC----hHHHHHHHHHHHhccccce--------------E
Q 044997          292 NNFDESRIIGRGGFGNVYFGLL--GDR----EAAIKKMRSNK----SKEFFAELKVLCKIHHINV--------------F  347 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~--~~~----~vavK~~~~~~----~~~f~~Ei~~l~~l~H~ni--------------V  347 (563)
                      ++|+..+.||+|+||.||+|.+  .++    .+++|.+....    ..++..|+..+++++||||              +
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~~~~~~i   86 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPGASLQLV   86 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECCCccEEE
Confidence            3567789999999999999987  343    47888875432    2467778889999999997              4


Q ss_pred             EEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccc
Q 044997          348 ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLE  427 (563)
Q Consensus       348 ~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~  427 (563)
                      +||+++|+|.+++..    ....++|..+..++.|++.||+|||+.+   ++||||||+|||+++++.+||+|||+++..
T Consensus        87 ~e~~~~gsL~~~l~~----~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~  159 (279)
T cd05111          87 TQLSPLGSLLDHVRQ----HRDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLL  159 (279)
T ss_pred             EEeCCCCcHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceec
Confidence            688999999999874    2356899999999999999999999987   999999999999999999999999999865


Q ss_pred             ccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCCCcCCCCCc------
Q 044997          428 ERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIRDDSEP------  500 (563)
Q Consensus       428 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p~~~~~~~~------  500 (563)
                      ..... ........++..|+|||.+.+.             .++.++||||||+++||+++ |+.|+.......      
T Consensus       160 ~~~~~-~~~~~~~~~~~~y~~pE~~~~~-------------~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~  225 (279)
T cd05111         160 YPDDK-KYFYSEHKTPIKWMALESILFG-------------RYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLE  225 (279)
T ss_pred             cCCCc-ccccCCCCCcccccCHHHhccC-------------CcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence            43221 1122334577889999987544             34899999999999999998 998886543211      


Q ss_pred             -----hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcChhh
Q 044997          501 -----TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITSTEW  545 (563)
Q Consensus       501 -----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~w  545 (563)
                           .........+.+++.+||..||.+||++.|+++.|..+...+..|
T Consensus       226 ~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~~~~  275 (279)
T cd05111         226 KGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDPPRY  275 (279)
T ss_pred             CCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCCcce
Confidence                 001112345788999999999999999999999999988877665

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=2e-37  Score=317.33  Aligned_cols=218  Identities=25%  Similarity=0.398  Sum_probs=184.7

Q ss_pred             cCCCccceecccCcEEEEEEEEC--CceEEEEEeccCCh-----HHHHHHHHHHHhccccce---------------EEE
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNKS-----KEFFAELKVLCKIHHINV---------------FIS  349 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~-----~~f~~Ei~~l~~l~H~ni---------------V~e  349 (563)
                      ++|.+.+.||+|.||.||+|+.+  .+.||+|.+.+..+     +...+|++++++++||||               |.|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            46778899999999999999775  57899999876544     348899999999999998               456


Q ss_pred             eecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccccc
Q 044997          350 TFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEER  429 (563)
Q Consensus       350 ~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~  429 (563)
                      |+.+ +|..+|.+     ...+++..+..|+.|+..||.|||+..   |.|||+||+|||++.++.+|++|||+||.+..
T Consensus        82 ~a~g-~L~~il~~-----d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~  152 (808)
T KOG0597|consen   82 YAVG-DLFTILEQ-----DGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMST  152 (808)
T ss_pred             hhhh-hHHHHHHh-----ccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhccc
Confidence            6655 99999975     467999999999999999999999987   99999999999999999999999999996543


Q ss_pred             ccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCC----------C
Q 044997          430 TNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDS----------E  499 (563)
Q Consensus       430 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~----------~  499 (563)
                         .....+.+.||+-|||||.+.++.|             +..+|.||+||++||+.+|++||+....          .
T Consensus       153 ---~t~vltsikGtPlYmAPElv~e~py-------------d~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~  216 (808)
T KOG0597|consen  153 ---NTSVLTSIKGTPLYMAPELVEEQPY-------------DHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDP  216 (808)
T ss_pred             ---CceeeeeccCcccccCHHHHcCCCc-------------cchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCC
Confidence               3345677899999999999876665             7889999999999999999999965321          1


Q ss_pred             chhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          500 PTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       500 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                      ...+......+..+++..+.+||.+|.+..+++..
T Consensus       217 v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H  251 (808)
T KOG0597|consen  217 VKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH  251 (808)
T ss_pred             CCCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence            12223556668999999999999999999998764

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1.7e-36  Score=318.86  Aligned_cols=234  Identities=22%  Similarity=0.383  Sum_probs=183.8

Q ss_pred             HHhcCCCccceecccCcEEEEEEEEC-------CceEEEEEeccCC----hHHHHHHHHHHHhc-cccce----------
Q 044997          289 EATNNFDESRIIGRGGFGNVYFGLLG-------DREAAIKKMRSNK----SKEFFAELKVLCKI-HHINV----------  346 (563)
Q Consensus       289 ~~~~~f~~~~~LG~G~fG~Vy~g~~~-------~~~vavK~~~~~~----~~~f~~Ei~~l~~l-~H~ni----------  346 (563)
                      -..++|+..+.||+|+||.||+|+..       +..||+|+++...    .+.+.+|+++++++ +|+||          
T Consensus        35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~  114 (374)
T cd05106          35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHG  114 (374)
T ss_pred             ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence            34457888999999999999998752       2469999997543    34588999999999 89997          


Q ss_pred             -----EEEeecCCCcccccccccc--------------------------------------------------------
Q 044997          347 -----FISTFGNGSLSDHLHDPLL--------------------------------------------------------  365 (563)
Q Consensus       347 -----V~e~~~~gsL~~~L~~~~~--------------------------------------------------------  365 (563)
                           |+||+.+|+|.+++.....                                                        
T Consensus       115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (374)
T cd05106         115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS  194 (374)
T ss_pred             CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence                 4689999999988753210                                                        


Q ss_pred             ---------cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccccccccccc
Q 044997          366 ---------KGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEML  436 (563)
Q Consensus       366 ---------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~  436 (563)
                               ....++++.++++++.|++.||+|||+++   ++||||||+|||+++++.+||+|||+++........ ..
T Consensus       195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~-~~  270 (374)
T cd05106         195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY-VV  270 (374)
T ss_pred             ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcce-ee
Confidence                     01235889999999999999999999987   999999999999999999999999999754332211 11


Q ss_pred             cccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCCCcCCCCCchh------------h
Q 044997          437 ATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIRDDSEPTK------------M  503 (563)
Q Consensus       437 ~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p~~~~~~~~~~------------~  503 (563)
                      .....++..|+|||++...             .++.++|||||||++|||++ |+.||.........            .
T Consensus       271 ~~~~~~~~~y~aPE~~~~~-------------~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~  337 (374)
T cd05106         271 KGNARLPVKWMAPESIFDC-------------VYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRP  337 (374)
T ss_pred             ccCCCCccceeCHHHhcCC-------------CCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCC
Confidence            1223456789999987543             34899999999999999997 99998654322111            1


Q ss_pred             HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhh
Q 044997          504 KSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIM  539 (563)
Q Consensus       504 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~  539 (563)
                      ...+..+.+++.+||+.||.+||++.+|++.|++++
T Consensus       338 ~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         338 DFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence            122466899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=4.6e-37  Score=306.61  Aligned_cols=220  Identities=29%  Similarity=0.496  Sum_probs=173.0

Q ss_pred             ccceecccCcEEEEEEEEC------CceEEEEEeccCC----hHHHHHHHHHHHhccccce---------------EEEe
Q 044997          296 ESRIIGRGGFGNVYFGLLG------DREAAIKKMRSNK----SKEFFAELKVLCKIHHINV---------------FIST  350 (563)
Q Consensus       296 ~~~~LG~G~fG~Vy~g~~~------~~~vavK~~~~~~----~~~f~~Ei~~l~~l~H~ni---------------V~e~  350 (563)
                      ..+.||.|.||.||+|.+.      +..|+||.++...    .++|.+|++.+++++||||               |+||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~   82 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence            4678999999999999987      5789999996532    4679999999999999997               5799


Q ss_pred             ecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccccc
Q 044997          351 FGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERT  430 (563)
Q Consensus       351 ~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~  430 (563)
                      +++|+|.++|...   ....+++.++..|+.|+++||.|||+++   ++|+||+++||++++++.+||+|||+++.....
T Consensus        83 ~~~g~L~~~L~~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~  156 (259)
T PF07714_consen   83 CPGGSLDDYLKSK---NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEK  156 (259)
T ss_dssp             -TTEBHHHHHHHT---CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTS
T ss_pred             ccccccccccccc---cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc
Confidence            9999999999863   2467999999999999999999999987   999999999999999999999999998865222


Q ss_pred             cccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCCCcCCCCCc---------
Q 044997          431 NEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIRDDSEP---------  500 (563)
Q Consensus       431 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p~~~~~~~~---------  500 (563)
                      ... .......+...|+|||.+....+             +.++||||||+++||+++ |+.|+.......         
T Consensus       157 ~~~-~~~~~~~~~~~~~aPE~~~~~~~-------------~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~  222 (259)
T PF07714_consen  157 SKY-KNDSSQQLPLRYLAPEVLKDGEY-------------TKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQ  222 (259)
T ss_dssp             SSE-EESTTSESGGGGS-HHHHHHSEE-------------SHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTE
T ss_pred             ccc-ccccccccccccccccccccccc-------------cccccccccccccccccccccccccccccccccccccccc
Confidence            111 11222346778999998865543             899999999999999999 667765432111         


Q ss_pred             --hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 044997          501 --TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAIL  535 (563)
Q Consensus       501 --~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  535 (563)
                        .....++..+.+++.+||+.||.+||+++++++.|
T Consensus       223 ~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  223 RLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             ETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             cceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence              11223455689999999999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.1e-37  Score=309.73  Aligned_cols=216  Identities=25%  Similarity=0.348  Sum_probs=178.9

Q ss_pred             cCCCccceecccCcEEEEEEEEC--CceEEEEEeccC------ChHHHHHHHHHHHhccccce---------------EE
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSN------KSKEFFAELKVLCKIHHINV---------------FI  348 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~------~~~~f~~Ei~~l~~l~H~ni---------------V~  348 (563)
                      ++|+..+.||+|+||.||+|...  ++.+|+|.++..      ..+.+.+|++++++++||||               |+
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            46888999999999999999875  788999998643      23568889999999999997               68


Q ss_pred             EeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccc
Q 044997          349 STFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEE  428 (563)
Q Consensus       349 e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~  428 (563)
                      ||+++|+|.+++..     ...+++.....++.|++.||+|||+++   ++||||||+|||+++++.+||+|||+++...
T Consensus        81 e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~  152 (291)
T cd05612          81 EYVPGGELFSYLRN-----SGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLR  152 (291)
T ss_pred             eCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhcc
Confidence            99999999999864     356899999999999999999999997   9999999999999999999999999988543


Q ss_pred             cccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc--------
Q 044997          429 RTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP--------  500 (563)
Q Consensus       429 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~--------  500 (563)
                      ..      .....|++.|+|||++.+..             ++.++|||||||++|||++|+.||.......        
T Consensus       153 ~~------~~~~~gt~~y~aPE~~~~~~-------------~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~  213 (291)
T cd05612         153 DR------TWTLCGTPEYLAPEVIQSKG-------------HNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAG  213 (291)
T ss_pred             CC------cccccCChhhcCHHHHcCCC-------------CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Confidence            21      12346899999999885543             3789999999999999999999997543211        


Q ss_pred             --hhhHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 044997          501 --TKMKSLITIMAAVAEWCLNEDAVDRPE-----MRDIVAI  534 (563)
Q Consensus       501 --~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~  534 (563)
                        .........+.+++++||+.||.+||+     +.|+++.
T Consensus       214 ~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  254 (291)
T cd05612         214 KLEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH  254 (291)
T ss_pred             CcCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence              111223456899999999999999995     7776653

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.2e-36  Score=314.76  Aligned_cols=222  Identities=23%  Similarity=0.366  Sum_probs=174.6

Q ss_pred             CCCccceecccCcEEEEEEEE--CCceEEEEEeccC-----ChHHHHHHHHHHHhccccceE------------------
Q 044997          293 NFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSN-----KSKEFFAELKVLCKIHHINVF------------------  347 (563)
Q Consensus       293 ~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~-----~~~~f~~Ei~~l~~l~H~niV------------------  347 (563)
                      +|+..+.||+|+||.||+|+.  +++.||||+++..     ...++.+|++++++++||||+                  
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            477889999999999999987  4688999998642     234688999999999999973                  


Q ss_pred             --EEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCc
Q 044997          348 --ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK  425 (563)
Q Consensus       348 --~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~  425 (563)
                        +||++ ++|.+++..     ...+++..+..++.|+++||.|||+++   |+||||||+|||+++++.+||+|||+++
T Consensus        81 lv~e~~~-~~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~  151 (338)
T cd07859          81 VVFELME-SDLHQVIKA-----NDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLAR  151 (338)
T ss_pred             EEEecCC-CCHHHHHHh-----cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccc
Confidence              45553 577776653     346899999999999999999999997   9999999999999999999999999998


Q ss_pred             ccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCch----
Q 044997          426 LEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPT----  501 (563)
Q Consensus       426 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~----  501 (563)
                      ................||..|+|||++.+.           ...++.++|||||||++|||++|+.||........    
T Consensus       152 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-----------~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~  220 (338)
T cd07859         152 VAFNDTPTAIFWTDYVATRWYRAPELCGSF-----------FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLI  220 (338)
T ss_pred             ccccccCccccccCCCCCCCcCCHHHHhcc-----------ccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHH
Confidence            543322222222345799999999987431           13458899999999999999999999865432100    


Q ss_pred             ----------h---------------------------hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          502 ----------K---------------------------MKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       502 ----------~---------------------------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                                .                           .......+.+++.+||+.||++||+++|+++.
T Consensus       221 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h  290 (338)
T cd07859         221 TDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD  290 (338)
T ss_pred             HHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence                      0                           00112346899999999999999999999874

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-37  Score=309.66  Aligned_cols=218  Identities=28%  Similarity=0.461  Sum_probs=183.9

Q ss_pred             CCCccceecccCcEEEEEEEEC--CceEEEEEeccC----ChHHHHHHHHHHHhccccce---------------EEEee
Q 044997          293 NFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSN----KSKEFFAELKVLCKIHHINV---------------FISTF  351 (563)
Q Consensus       293 ~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~----~~~~f~~Ei~~l~~l~H~ni---------------V~e~~  351 (563)
                      .|...+.||+|.||.||+|...  ++.||+|.+.-+    ..++..+|+.+|.+++++||               +|||+
T Consensus        14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~   93 (467)
T KOG0201|consen   14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC   93 (467)
T ss_pred             ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence            3566789999999999999874  688999999744    34678999999999999997               58999


Q ss_pred             cCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccccccc
Q 044997          352 GNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTN  431 (563)
Q Consensus       352 ~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~  431 (563)
                      .+|++.+.|..     ...+++....-|++++..||.|||.++   .+|||||+.|||+..+|.+||+|||.+-....+.
T Consensus        94 ~gGsv~~lL~~-----~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~  165 (467)
T KOG0201|consen   94 GGGSVLDLLKS-----GNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTV  165 (467)
T ss_pred             cCcchhhhhcc-----CCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechh
Confidence            99999998875     344577777889999999999999997   9999999999999999999999999987654432


Q ss_pred             ccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCC-----------Cc
Q 044997          432 EKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDS-----------EP  500 (563)
Q Consensus       432 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~-----------~~  500 (563)
                      .   ....++||+.|||||++....|             +.|+||||+|++.+||++|.+|+.....           .+
T Consensus       166 ~---rr~tfvGTPfwMAPEVI~~~~Y-------------~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP  229 (467)
T KOG0201|consen  166 K---RRKTFVGTPFWMAPEVIKQSGY-------------DTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPP  229 (467)
T ss_pred             h---ccccccccccccchhhhccccc-------------cchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCC
Confidence            2   2255899999999999975554             8999999999999999999999865432           22


Q ss_pred             hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          501 TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       501 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                      .....+...+++++..||++||+.||++.++++.
T Consensus       230 ~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh  263 (467)
T KOG0201|consen  230 RLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKH  263 (467)
T ss_pred             ccccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence            2233666779999999999999999999999874

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1e-36  Score=307.33  Aligned_cols=230  Identities=25%  Similarity=0.338  Sum_probs=184.9

Q ss_pred             HHHhcCCCccceecccCcEEEEEEEE--CCceEEEEEeccCC-----------------hHHHHHHHHHHHhccccce--
Q 044997          288 EEATNNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNK-----------------SKEFFAELKVLCKIHHINV--  346 (563)
Q Consensus       288 ~~~~~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~-----------------~~~f~~Ei~~l~~l~H~ni--  346 (563)
                      .+..++|+..+.||+|.||.|-+|+.  +++.+|||.+.+..                 .+...+|+.+|++++||||  
T Consensus        93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~  172 (576)
T KOG0585|consen   93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK  172 (576)
T ss_pred             ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence            44567899999999999999999987  57889999986432                 1467899999999999998  


Q ss_pred             ---------------EEEeecCCCcccccccccccCCCC-CCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEe
Q 044997          347 ---------------FISTFGNGSLSDHLHDPLLKGHQP-LTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILL  410 (563)
Q Consensus       347 ---------------V~e~~~~gsL~~~L~~~~~~~~~~-l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl  410 (563)
                                     |.||+..|.+...=.      ..+ ++..+.+++++|+..||+|||.++   ||||||||+|+||
T Consensus       173 LiEvLDDP~s~~~YlVley~s~G~v~w~p~------d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl  243 (576)
T KOG0585|consen  173 LIEVLDDPESDKLYLVLEYCSKGEVKWCPP------DKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLL  243 (576)
T ss_pred             EEEeecCcccCceEEEEEeccCCccccCCC------CcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEE
Confidence                           458888777644322      234 999999999999999999999998   9999999999999


Q ss_pred             cCCCcEEEeecCCCccccccc--ccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc
Q 044997          411 DDGLRAKVADFGLVKLEERTN--EKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT  488 (563)
Q Consensus       411 ~~~~~~kl~DFGla~~~~~~~--~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt  488 (563)
                      +++|++||+|||.+.....+.  +......+.+||+.|+|||.+.++.-         ....+.+.||||+||+||.|+-
T Consensus       244 ~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~---------~~~~g~a~DiWalGVTLYCllf  314 (576)
T KOG0585|consen  244 SSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNS---------FSYSGFALDIWALGVTLYCLLF  314 (576)
T ss_pred             cCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCC---------ccccchhhhhhhhhhhHHHhhh
Confidence            999999999999987653321  12223345789999999999876321         2234789999999999999999


Q ss_pred             CCCCCcCCCCCc------------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 044997          489 GKRALIRDDSEP------------TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAIL  535 (563)
Q Consensus       489 g~~p~~~~~~~~------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  535 (563)
                      |+.||.++....            ....++.+.+.+|++++|++||++|.+..+|....
T Consensus       315 G~~PF~~~~~~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp  373 (576)
T KOG0585|consen  315 GQLPFFDDFELELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP  373 (576)
T ss_pred             ccCCcccchHHHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence            999998754321            11124566799999999999999999999998754

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=2.4e-36  Score=313.22  Aligned_cols=234  Identities=27%  Similarity=0.428  Sum_probs=184.6

Q ss_pred             hcCCCccceecccCcEEEEEEEEC-------CceEEEEEeccCC----hHHHHHHHHHHHhc-cccce------------
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLLG-------DREAAIKKMRSNK----SKEFFAELKVLCKI-HHINV------------  346 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~~-------~~~vavK~~~~~~----~~~f~~Ei~~l~~l-~H~ni------------  346 (563)
                      .++|+..+.||+|+||.||+|...       ++.||+|+++...    .+.+.+|++++.++ +|+||            
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~   85 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG   85 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence            456888999999999999999652       3579999987432    24577899999999 89986            


Q ss_pred             ----EEEeecCCCccccccccccc--------------------------------------------------------
Q 044997          347 ----FISTFGNGSLSDHLHDPLLK--------------------------------------------------------  366 (563)
Q Consensus       347 ----V~e~~~~gsL~~~L~~~~~~--------------------------------------------------------  366 (563)
                          ++||+++|+|.+++......                                                        
T Consensus        86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (337)
T cd05054          86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL  165 (337)
T ss_pred             CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence                47899999998887532100                                                        


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccccccccccccccccCCCcc
Q 044997          367 GHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGY  446 (563)
Q Consensus       367 ~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y  446 (563)
                      ...+++|..+..++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+++........ .......++..|
T Consensus       166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~-~~~~~~~~~~~y  241 (337)
T cd05054         166 YKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY-VRKGDARLPLKW  241 (337)
T ss_pred             hhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcch-hhccCCCCCccc
Confidence            0136899999999999999999999987   999999999999999999999999999865332211 112234567789


Q ss_pred             cCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCCCcCCCCCchh------------hHHHHHHHHHH
Q 044997          447 LPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIRDDSEPTK------------MKSLITIMAAV  513 (563)
Q Consensus       447 ~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p~~~~~~~~~~------------~~~~~~~l~~l  513 (563)
                      +|||++.+..             ++.++|||||||++|||++ |+.||......+..            .......+.++
T Consensus       242 ~aPE~~~~~~-------------~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  308 (337)
T cd05054         242 MAPESIFDKV-------------YTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSI  308 (337)
T ss_pred             cCcHHhcCCC-------------CCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHH
Confidence            9999885544             4899999999999999998 98888643221111            11234568999


Q ss_pred             HHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 044997          514 AEWCLNEDAVDRPEMRDIVAILSQIMIT  541 (563)
Q Consensus       514 i~~cl~~dP~~RPs~~evl~~L~~i~~~  541 (563)
                      +.+||+.+|++||++.|+++.|+++++.
T Consensus       309 ~~~cl~~~p~~RPs~~ell~~l~~~~~~  336 (337)
T cd05054         309 MLDCWHNNPEDRPTFSELVEILGDLLQE  336 (337)
T ss_pred             HHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            9999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-37  Score=316.72  Aligned_cols=239  Identities=24%  Similarity=0.376  Sum_probs=199.7

Q ss_pred             HHHHHHHhcCCCccceecccCcEEEEEEEECC--ceEEEEEeccCC--hHHHHHHHHHHHhccccce-------------
Q 044997          284 LEEIEEATNNFDESRIIGRGGFGNVYFGLLGD--REAAIKKMRSNK--SKEFFAELKVLCKIHHINV-------------  346 (563)
Q Consensus       284 ~~el~~~~~~f~~~~~LG~G~fG~Vy~g~~~~--~~vavK~~~~~~--~~~f~~Ei~~l~~l~H~ni-------------  346 (563)
                      +++|+-.+.+....++||-|.||.||.|+|+.  -.||||.++.+.  .++|++|..+|+.++|||+             
T Consensus       259 ~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF  338 (1157)
T KOG4278|consen  259 ADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF  338 (1157)
T ss_pred             cchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence            46677667778888999999999999999974  579999998775  5899999999999999996             


Q ss_pred             --EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCC
Q 044997          347 --FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLV  424 (563)
Q Consensus       347 --V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla  424 (563)
                        |.|||++|+|.+||++.   .+..++-...+.++.||+.||+||..++   +|||||..+|+|+.++..+||+|||++
T Consensus       339 YIiTEfM~yGNLLdYLRec---nr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLs  412 (1157)
T KOG4278|consen  339 YIITEFMCYGNLLDYLREC---NRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLS  412 (1157)
T ss_pred             EEEEecccCccHHHHHHHh---chhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchh
Confidence              57999999999999874   4566788888999999999999999886   999999999999999999999999999


Q ss_pred             cccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCCCcCCCC-----
Q 044997          425 KLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIRDDS-----  498 (563)
Q Consensus       425 ~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p~~~~~~-----  498 (563)
                      +++..+...  ......-.+.|.|||-+....|             +.|+|||+|||+|||+.| |..|+.+.+.     
T Consensus       413 RlMtgDTYT--AHAGAKFPIKWTAPEsLAyNtF-------------SiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~  477 (1157)
T KOG4278|consen  413 RLMTGDTYT--AHAGAKFPIKWTAPESLAYNTF-------------SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYG  477 (1157)
T ss_pred             hhhcCCcee--cccCccCcccccCccccccccc-------------ccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHH
Confidence            987543211  1111223578999998876665             899999999999999998 6777654331     


Q ss_pred             ------CchhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcCh
Q 044997          499 ------EPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITST  543 (563)
Q Consensus       499 ------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~  543 (563)
                            +...++.+++.+.+|+++||+.+|.+||++.|+-+.++.+++++.
T Consensus       478 LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~sS  528 (1157)
T KOG4278|consen  478 LLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSSS  528 (1157)
T ss_pred             HHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcccc
Confidence                  223345667779999999999999999999999999999987664

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=6.9e-37  Score=296.63  Aligned_cols=221  Identities=27%  Similarity=0.325  Sum_probs=176.9

Q ss_pred             cCCCccceecccCcEEEEEEEEC--CceEEEEEeccCChH-----HHHHHHHHHHhccccceE--EEeecCC--------
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNKSK-----EFFAELKVLCKIHHINVF--ISTFGNG--------  354 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~-----~f~~Ei~~l~~l~H~niV--~e~~~~g--------  354 (563)
                      ++|+..++|++|.||.||+|+.+  ++.||+|+++.+..+     .-++|+.+|.+++|||||  .|.+.+.        
T Consensus        76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V  155 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV  155 (419)
T ss_pred             HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence            34667899999999999999874  688999999876643     367999999999999993  2333333        


Q ss_pred             ------CcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccc
Q 044997          355 ------SLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEE  428 (563)
Q Consensus       355 ------sL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~  428 (563)
                            +|...++.    -.+++...+...+..|+++|++|||++.   |+|||||++|+|++..|.+||+|||+||.+.
T Consensus       156 Me~~EhDLksl~d~----m~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg  228 (419)
T KOG0663|consen  156 MEYVEHDLKSLMET----MKQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYG  228 (419)
T ss_pred             HHHHHhhHHHHHHh----ccCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhc
Confidence                  44444443    2368999999999999999999999998   9999999999999999999999999999765


Q ss_pred             cccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCchh------
Q 044997          429 RTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTK------  502 (563)
Q Consensus       429 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~~------  502 (563)
                      ..   ....+..+-|..|.|||.+.+.+            .|++..|+||+|||+.|++++++-|.+.....+.      
T Consensus       229 sp---~k~~T~lVVTLWYRaPELLLG~~------------tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~l  293 (419)
T KOG0663|consen  229 SP---LKPYTPLVVTLWYRAPELLLGAK------------TYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKL  293 (419)
T ss_pred             CC---cccCcceEEEeeecCHHHhcCCc------------ccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHH
Confidence            43   22346677899999999997654            4699999999999999999999777554321100      


Q ss_pred             ----------------------------------h--HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          503 ----------------------------------M--KSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       503 ----------------------------------~--~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                                                        .  ..+.+.-.+|+...+..||.+|-|+.|.++.
T Consensus       294 lGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h  361 (419)
T KOG0663|consen  294 LGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH  361 (419)
T ss_pred             hCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence                                              0  0123457889999999999999999998864

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=1.4e-36  Score=313.08  Aligned_cols=212  Identities=24%  Similarity=0.371  Sum_probs=174.6

Q ss_pred             ceecccCcEEEEEEEE--CCceEEEEEeccC------ChHHHHHHHHHHHhccccce---------------EEEeecCC
Q 044997          298 RIIGRGGFGNVYFGLL--GDREAAIKKMRSN------KSKEFFAELKVLCKIHHINV---------------FISTFGNG  354 (563)
Q Consensus       298 ~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~------~~~~f~~Ei~~l~~l~H~ni---------------V~e~~~~g  354 (563)
                      +.||+|+||.||+++.  +++.+|+|.++..      ....+.+|++++++++||||               |+||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            4699999999999987  4788999998743      22467889999999999997               57999999


Q ss_pred             CcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccccccccc
Q 044997          355 SLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKE  434 (563)
Q Consensus       355 sL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~  434 (563)
                      +|.+++..     ...+++.++..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++......   
T Consensus        81 ~L~~~l~~-----~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~---  149 (323)
T cd05571          81 ELFFHLSR-----ERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG---  149 (323)
T ss_pred             cHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC---
Confidence            99888864     356899999999999999999999997   9999999999999999999999999987432211   


Q ss_pred             cccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc----------hhhH
Q 044997          435 MLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP----------TKMK  504 (563)
Q Consensus       435 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~----------~~~~  504 (563)
                      .......||+.|+|||++.+..             ++.++|||||||++|||++|+.||...+...          ....
T Consensus       150 ~~~~~~~gt~~y~aPE~~~~~~-------------~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~  216 (323)
T cd05571         150 ATMKTFCGTPEYLAPEVLEDND-------------YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR  216 (323)
T ss_pred             CcccceecCccccChhhhcCCC-------------CCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence            1123356999999999886544             4789999999999999999999996543211          1122


Q ss_pred             HHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 044997          505 SLITIMAAVAEWCLNEDAVDRP-----EMRDIVA  533 (563)
Q Consensus       505 ~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  533 (563)
                      .+...+.+++.+||+.||++||     ++.++++
T Consensus       217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         217 TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             CCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence            3456689999999999999999     7888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.2e-37  Score=318.65  Aligned_cols=219  Identities=26%  Similarity=0.376  Sum_probs=190.8

Q ss_pred             cCCCccceecccCcEEEEEEEE--CCceEEEEEeccCC------hHHHHHHHHHHHhccccce---------------EE
Q 044997          292 NNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNK------SKEFFAELKVLCKIHHINV---------------FI  348 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~------~~~f~~Ei~~l~~l~H~ni---------------V~  348 (563)
                      .-|+.++.||.|+-|.|-.|++  .|+.+|||.+.+..      .....+|+-+|+-+.|||+               |.
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl   91 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL   91 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence            3477899999999999999987  58999999987652      2457789999999999997               57


Q ss_pred             EeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccc
Q 044997          349 STFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEE  428 (563)
Q Consensus       349 e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~  428 (563)
                      ||+++|.|.++|..     ..++++.+..+++.||+.|+.|+|..+   |+||||||+|+|||.++++||+|||+|.+..
T Consensus        92 Eyv~gGELFdylv~-----kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~  163 (786)
T KOG0588|consen   92 EYVPGGELFDYLVR-----KGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEV  163 (786)
T ss_pred             EecCCchhHHHHHh-----hCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeeccc
Confidence            99999999999975     467999999999999999999999997   9999999999999999999999999998643


Q ss_pred             cccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc--------
Q 044997          429 RTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP--------  500 (563)
Q Consensus       429 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~--------  500 (563)
                      .+    ......+|++.|.|||++.+.+|+            +.++||||.|||||.|+||+.||.+++...        
T Consensus       164 ~g----klLeTSCGSPHYA~PEIV~G~pYd------------G~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G  227 (786)
T KOG0588|consen  164 PG----KLLETSCGSPHYAAPEIVSGRPYD------------GRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRG  227 (786)
T ss_pred             CC----ccccccCCCcccCCchhhcCCCCC------------CCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcC
Confidence            32    244557899999999999999996            789999999999999999999998655321        


Q ss_pred             --hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          501 --TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       501 --~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                        +.+..++.+.++|+.+|+..||+.|.|++||++.
T Consensus       228 ~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH  263 (786)
T KOG0588|consen  228 VFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKH  263 (786)
T ss_pred             cccCCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence              2234566779999999999999999999999986

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=5.2e-36  Score=298.47  Aligned_cols=226  Identities=24%  Similarity=0.458  Sum_probs=183.7

Q ss_pred             cCCCccceecccCcEEEEEEEEC-CceEEEEEeccCC--hHHHHHHHHHHHhccccce---------------EEEeecC
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG-DREAAIKKMRSNK--SKEFFAELKVLCKIHHINV---------------FISTFGN  353 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~vavK~~~~~~--~~~f~~Ei~~l~~l~H~ni---------------V~e~~~~  353 (563)
                      ++|+..++||+|+||.||+|... +..+|+|.+....  .+.+.+|+.++++++|+||               ++||+++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   85 (261)
T cd05072           6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAK   85 (261)
T ss_pred             HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCC
Confidence            56888999999999999999874 5779999887543  4678999999999999997               5789999


Q ss_pred             CCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccccccccc
Q 044997          354 GSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEK  433 (563)
Q Consensus       354 gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~  433 (563)
                      |+|.+++...   ....+++..+..++.|++.||+|||+.+   ++||||||+||++++++.+||+|||+++....... 
T Consensus        86 ~~L~~~l~~~---~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-  158 (261)
T cd05072          86 GSLLDFLKSD---EGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY-  158 (261)
T ss_pred             CcHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCce-
Confidence            9999998652   2356899999999999999999999987   99999999999999999999999999986543211 


Q ss_pred             ccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCCCcCCCCCc-----------h
Q 044997          434 EMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIRDDSEP-----------T  501 (563)
Q Consensus       434 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p~~~~~~~~-----------~  501 (563)
                       .......++..|+|||++...             .++.++|||||||++|||++ |+.||.......           .
T Consensus       159 -~~~~~~~~~~~y~aPE~~~~~-------------~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~  224 (261)
T cd05072         159 -TAREGAKFPIKWTAPEAINFG-------------SFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMP  224 (261)
T ss_pred             -eccCCCccceecCCHHHhccC-------------CCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCC
Confidence             111223456789999987543             34789999999999999998 888885432211           1


Q ss_pred             hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 044997          502 KMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQI  538 (563)
Q Consensus       502 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  538 (563)
                      .....+..+.+++.+||+.+|++||+++++.+.|+++
T Consensus       225 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  261 (261)
T cd05072         225 RMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF  261 (261)
T ss_pred             CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence            1123446689999999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=6.2e-36  Score=298.60  Aligned_cols=227  Identities=24%  Similarity=0.391  Sum_probs=183.7

Q ss_pred             cCCCccceecccCcEEEEEEEEC--CceEEEEEeccCC--hHHHHHHHHHHHhccccce---------------EEEeec
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNK--SKEFFAELKVLCKIHHINV---------------FISTFG  352 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~--~~~f~~Ei~~l~~l~H~ni---------------V~e~~~  352 (563)
                      .+|...+.||+|+||.||+|...  ++.+|+|.++...  .+++.+|++++++++|+||               ++||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   85 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT   85 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCC
Confidence            35777899999999999999874  6789999987554  3578999999999999986               579999


Q ss_pred             CCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccccccc
Q 044997          353 NGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNE  432 (563)
Q Consensus       353 ~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~  432 (563)
                      +|+|.+++...   ....+++..++.++.|++.||+|||+.+   ++||||||+||++++++.+||+|||+++.......
T Consensus        86 ~~~L~~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~  159 (263)
T cd05052          86 YGNLLDYLREC---NRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY  159 (263)
T ss_pred             CCcHHHHHHhC---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence            99999998652   2356899999999999999999999987   99999999999999999999999999876543211


Q ss_pred             cccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCCCcCCCCC-----------c
Q 044997          433 KEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIRDDSE-----------P  500 (563)
Q Consensus       433 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p~~~~~~~-----------~  500 (563)
                      .  ......++..|+|||.+.+..             ++.++||||||+++|||++ |..|+......           .
T Consensus       160 ~--~~~~~~~~~~y~aPE~~~~~~-------------~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~  224 (263)
T cd05052         160 T--AHAGAKFPIKWTAPESLAYNK-------------FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRM  224 (263)
T ss_pred             e--ccCCCCCccccCCHHHhccCC-------------CCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCC
Confidence            1  111123466899999875443             4789999999999999998 88887543221           1


Q ss_pred             hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhh
Q 044997          501 TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIM  539 (563)
Q Consensus       501 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~  539 (563)
                      ......+..+.+++.+||+.||++||++.++++.|+.++
T Consensus       225 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  263 (263)
T cd05052         225 ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETMF  263 (263)
T ss_pred             CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhhC
Confidence            112234466899999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=5.5e-36  Score=302.71  Aligned_cols=219  Identities=21%  Similarity=0.286  Sum_probs=176.6

Q ss_pred             cCCCccceecccCcEEEEEEEEC--CceEEEEEeccC-----ChHHHHHHHHHHHhccccce---------------EEE
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSN-----KSKEFFAELKVLCKIHHINV---------------FIS  349 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~-----~~~~f~~Ei~~l~~l~H~ni---------------V~e  349 (563)
                      ++|+..+.||+|+||.||+++.+  ++.+|+|+++..     ..+.+.+|++++++++|+||               |+|
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            46888999999999999999884  678999998643     23568899999999999997               579


Q ss_pred             eecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccccc
Q 044997          350 TFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEER  429 (563)
Q Consensus       350 ~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~  429 (563)
                      |++++.+..+...     ...+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++....
T Consensus        81 ~~~~~~l~~~~~~-----~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  152 (287)
T cd07848          81 YVEKNMLELLEEM-----PNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSE  152 (287)
T ss_pred             cCCCCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccc
Confidence            9988776554322     346899999999999999999999987   99999999999999999999999999986543


Q ss_pred             ccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCchh-------
Q 044997          430 TNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTK-------  502 (563)
Q Consensus       430 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~~-------  502 (563)
                      ....  ......|++.|+|||++.+..             ++.++|||||||++|||++|+.||.........       
T Consensus       153 ~~~~--~~~~~~~~~~y~aPE~~~~~~-------------~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~  217 (287)
T cd07848         153 GSNA--NYTEYVATRWYRSPELLLGAP-------------YGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVL  217 (287)
T ss_pred             cccc--cccccccccccCCcHHHcCCC-------------CCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhh
Confidence            2211  123356899999999885443             478999999999999999999998653211000       


Q ss_pred             -----------------------------------hHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          503 -----------------------------------MKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       503 -----------------------------------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                                                         ...++..+.+++++||+.||++|||++|+++
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         218 GPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             CCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence                                               0013445899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=6.8e-36  Score=309.07  Aligned_cols=219  Identities=21%  Similarity=0.370  Sum_probs=179.7

Q ss_pred             hcCCCccceecccCcEEEEEEEEC--CceEEEEEeccCC----hHHHHHHHHHHHhccccce---------------EEE
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNK----SKEFFAELKVLCKIHHINV---------------FIS  349 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~----~~~f~~Ei~~l~~l~H~ni---------------V~e  349 (563)
                      .++|+..+.||+|+||.||+++..  +..+|+|.++...    .+++.+|+++|++++||||               |+|
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence            367889999999999999999885  6789999887542    3568999999999999997               579


Q ss_pred             eecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccccc
Q 044997          350 TFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEER  429 (563)
Q Consensus       350 ~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~  429 (563)
                      |+++|+|.+++..     ...+++..+..++.|++.||.|||+.+  .++||||||+|||+++++.+||+|||+++....
T Consensus        84 ~~~~~~L~~~l~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  156 (331)
T cd06649          84 HMDGGSLDQVLKE-----AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  156 (331)
T ss_pred             cCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccc
Confidence            9999999999864     346899999999999999999999853  399999999999999999999999999875432


Q ss_pred             ccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCch--------
Q 044997          430 TNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPT--------  501 (563)
Q Consensus       430 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~--------  501 (563)
                      .     ......|+..|+|||++.+..             ++.++|||||||++|||++|+.||...+....        
T Consensus       157 ~-----~~~~~~g~~~y~aPE~~~~~~-------------~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~  218 (331)
T cd06649         157 S-----MANSFVGTRSYMSPERLQGTH-------------YSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPV  218 (331)
T ss_pred             c-----ccccCCCCcCcCCHhHhcCCC-------------CCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccc
Confidence            1     123356899999999885443             48899999999999999999999853211000        


Q ss_pred             --------------------------------------------------hhHHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 044997          502 --------------------------------------------------KMKSLITIMAAVAEWCLNEDAVDRPEMRDI  531 (563)
Q Consensus       502 --------------------------------------------------~~~~~~~~l~~li~~cl~~dP~~RPs~~ev  531 (563)
                                                                        ........+.+++.+||+.||++||++.|+
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~el  298 (331)
T cd06649         219 VDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKML  298 (331)
T ss_pred             cccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHH
Confidence                                                              000134568999999999999999999999


Q ss_pred             HHH
Q 044997          532 VAI  534 (563)
Q Consensus       532 l~~  534 (563)
                      ++.
T Consensus       299 l~h  301 (331)
T cd06649         299 MNH  301 (331)
T ss_pred             hcC
Confidence            875

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=6.1e-36  Score=302.95  Aligned_cols=238  Identities=24%  Similarity=0.402  Sum_probs=189.3

Q ss_pred             cCCCccceecccCcEEEEEEEEC-------CceEEEEEeccCC---hHHHHHHHHHHHhccccce---------------
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG-------DREAAIKKMRSNK---SKEFFAELKVLCKIHHINV---------------  346 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~-------~~~vavK~~~~~~---~~~f~~Ei~~l~~l~H~ni---------------  346 (563)
                      ++|...+.||+|+||.||++...       +..+|+|.++...   .+.+.+|++++++++|+||               
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   84 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence            56888899999999999999741       3458999886543   3568999999999999997               


Q ss_pred             EEEeecCCCcccccccccc--------cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEE
Q 044997          347 FISTFGNGSLSDHLHDPLL--------KGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKV  418 (563)
Q Consensus       347 V~e~~~~gsL~~~L~~~~~--------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl  418 (563)
                      |+||+++|+|.+++.....        .....++|.++..++.|++.||+|||+++   ++||||||+|||+++++.+||
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl  161 (288)
T cd05093          85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI  161 (288)
T ss_pred             EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEe
Confidence            5789999999998864211        11235999999999999999999999987   999999999999999999999


Q ss_pred             eecCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCCCcCCC
Q 044997          419 ADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIRDD  497 (563)
Q Consensus       419 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p~~~~~  497 (563)
                      +|||+++....... ........++..|+|||++.+..             ++.++|||||||++|||++ |+.||....
T Consensus       162 ~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~-------------~~~~sDiwslG~il~~l~t~g~~p~~~~~  227 (288)
T cd05093         162 GDFGMSRDVYSTDY-YRVGGHTMLPIRWMPPESIMYRK-------------FTTESDVWSLGVVLWEIFTYGKQPWYQLS  227 (288)
T ss_pred             ccCCccccccCCce-eecCCCCCccccccCHHHhccCC-------------CCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence            99999985533221 11122344677899999875443             4889999999999999998 888875433


Q ss_pred             CCc-----------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcChhhh
Q 044997          498 SEP-----------TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITSTEWE  546 (563)
Q Consensus       498 ~~~-----------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~w~  546 (563)
                      ...           .........+.+++.+||+.||.+||++.++++.|+++.+.+..|.
T Consensus       228 ~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~~~~~~  287 (288)
T cd05093         228 NNEVIECITQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKASPVYL  287 (288)
T ss_pred             HHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHhccccc
Confidence            211           1112334568999999999999999999999999999998776653

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=6.6e-36  Score=299.44  Aligned_cols=229  Identities=24%  Similarity=0.372  Sum_probs=178.4

Q ss_pred             CCccceecccCcEEEEEEEECC----ceEEEEEeccC-----ChHHHHHHHHHHHhccccce------------------
Q 044997          294 FDESRIIGRGGFGNVYFGLLGD----REAAIKKMRSN-----KSKEFFAELKVLCKIHHINV------------------  346 (563)
Q Consensus       294 f~~~~~LG~G~fG~Vy~g~~~~----~~vavK~~~~~-----~~~~f~~Ei~~l~~l~H~ni------------------  346 (563)
                      |...+.||+|+||.||+|.+.+    ..+|+|.++..     ..+.|.+|++++++++|+||                  
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            3457889999999999998753    25899987643     23568899999999999986                  


Q ss_pred             ---EEEeecCCCcccccccccc-cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecC
Q 044997          347 ---FISTFGNGSLSDHLHDPLL-KGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFG  422 (563)
Q Consensus       347 ---V~e~~~~gsL~~~L~~~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFG  422 (563)
                         ++||+++|+|.+++..... .....++|.....++.|++.||+|||+++   |+||||||+|||+++++.+||+|||
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg  157 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG  157 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence               4578888999888743222 12345899999999999999999999987   9999999999999999999999999


Q ss_pred             CCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCCCcCCCCCc-
Q 044997          423 LVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIRDDSEP-  500 (563)
Q Consensus       423 la~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p~~~~~~~~-  500 (563)
                      +++........ .......+++.|+|||.+.+.             .++.++||||||+++|||++ |+.||....... 
T Consensus       158 ~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~-------------~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~  223 (272)
T cd05075         158 LSKKIYNGDYY-RQGRIAKMPVKWIAIESLADR-------------VYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEI  223 (272)
T ss_pred             cccccCcccce-ecCCcccCCcccCCHHHccCC-------------CcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence            99865432211 111223456789999987543             34889999999999999999 777875432110 


Q ss_pred             ----------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhh
Q 044997          501 ----------TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIM  539 (563)
Q Consensus       501 ----------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~  539 (563)
                                .......+.+.+++.+||+.||++||++.++++.|++++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~~  272 (272)
T cd05075         224 YDYLRQGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKAL  272 (272)
T ss_pred             HHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence                      111234456899999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-36  Score=316.10  Aligned_cols=233  Identities=25%  Similarity=0.437  Sum_probs=187.5

Q ss_pred             HhcCCCccceecccCcEEEEEEEEC--CceEEEEEeccCC------hHHHHHHHHHHHhcc-ccce--------------
Q 044997          290 ATNNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNK------SKEFFAELKVLCKIH-HINV--------------  346 (563)
Q Consensus       290 ~~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~------~~~f~~Ei~~l~~l~-H~ni--------------  346 (563)
                      ..++|...++||+|.||+|+++..+  ++.+|||.++++.      .+....|-.++.-.+ ||-+              
T Consensus       366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~  445 (694)
T KOG0694|consen  366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF  445 (694)
T ss_pred             cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence            3468999999999999999999885  5789999998753      356777888877765 8876              


Q ss_pred             -EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCc
Q 044997          347 -FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK  425 (563)
Q Consensus       347 -V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~  425 (563)
                       ||||..+|++..+.+.      ..+++..+..++..|+.||+|||+++   ||+||||.+|||||.+|++||+|||++|
T Consensus       446 fvmey~~Ggdm~~~~~~------~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcK  516 (694)
T KOG0694|consen  446 FVMEYVAGGDLMHHIHT------DVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCK  516 (694)
T ss_pred             EEEEecCCCcEEEEEec------ccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEeccccccc
Confidence             7999999997666653      56899999999999999999999998   9999999999999999999999999998


Q ss_pred             ccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCch----
Q 044997          426 LEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPT----  501 (563)
Q Consensus       426 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~----  501 (563)
                      ..-.   ....++.++||+.|||||++.+..|             +.++|+|||||+||||+.|..||.++++++.    
T Consensus       517 e~m~---~g~~TsTfCGTpey~aPEil~e~~Y-------------t~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI  580 (694)
T KOG0694|consen  517 EGMG---QGDRTSTFCGTPEFLAPEVLTEQSY-------------TRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSI  580 (694)
T ss_pred             ccCC---CCCccccccCChhhcChhhhccCcc-------------cchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Confidence            4321   2224567899999999999976665             8999999999999999999999987765421    


Q ss_pred             ------hhHHHHHHHHHHHHHhhccCCCCCCCH--HHHHHHHHHhhhcChhhhc
Q 044997          502 ------KMKSLITIMAAVAEWCLNEDAVDRPEM--RDIVAILSQIMITSTEWEA  547 (563)
Q Consensus       502 ------~~~~~~~~l~~li~~cl~~dP~~RPs~--~evl~~L~~i~~~~~~w~~  547 (563)
                            -+..++.+..+++++++.++|++|--+  .+--+....-+-.+.+|+.
T Consensus       581 ~~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~  634 (694)
T KOG0694|consen  581 VNDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDD  634 (694)
T ss_pred             hcCCCCCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHH
Confidence                  233455668999999999999999765  1122222233444556665

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=8.3e-36  Score=296.62  Aligned_cols=219  Identities=22%  Similarity=0.365  Sum_probs=176.7

Q ss_pred             eecccCcEEEEEEEE----CCceEEEEEeccCC-----hHHHHHHHHHHHhccccce--------------EEEeecCCC
Q 044997          299 IIGRGGFGNVYFGLL----GDREAAIKKMRSNK-----SKEFFAELKVLCKIHHINV--------------FISTFGNGS  355 (563)
Q Consensus       299 ~LG~G~fG~Vy~g~~----~~~~vavK~~~~~~-----~~~f~~Ei~~l~~l~H~ni--------------V~e~~~~gs  355 (563)
                      .||+|+||.||+|.+    ++..+|+|.++...     .+++.+|++++++++|+||              |+||+++|+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~   81 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEAESWMLVMELAELGP   81 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCcEEEEecCCCCc
Confidence            589999999999976    35789999986442     3578899999999999996              578899999


Q ss_pred             cccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccccccccccc
Q 044997          356 LSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEM  435 (563)
Q Consensus       356 L~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~  435 (563)
                      |.+++..     ...+++..+..++.|++.||+|||+++   ++||||||+||++++++.+||+|||+++..........
T Consensus        82 L~~~l~~-----~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~  153 (257)
T cd05116          82 LNKFLQK-----NKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK  153 (257)
T ss_pred             HHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence            9998864     346899999999999999999999987   99999999999999999999999999986543322111


Q ss_pred             ccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCCCcCCCCC-----------chhh
Q 044997          436 LATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIRDDSE-----------PTKM  503 (563)
Q Consensus       436 ~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p~~~~~~~-----------~~~~  503 (563)
                      ......++..|+|||.+...             .++.++||||||+++|||++ |+.||......           ....
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~-------------~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~  220 (257)
T cd05116         154 AKTHGKWPVKWYAPECMNYY-------------KFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECP  220 (257)
T ss_pred             ecCCCCCCccccCHhHhccC-------------CcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCC
Confidence            11223346789999987543             34789999999999999998 89898643221           1112


Q ss_pred             HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 044997          504 KSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQI  538 (563)
Q Consensus       504 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  538 (563)
                      ...+..+.+++.+||+.||++||++.+|.+.|++.
T Consensus       221 ~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         221 QRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             CCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence            23456789999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=9e-36  Score=297.80  Aligned_cols=227  Identities=26%  Similarity=0.455  Sum_probs=183.0

Q ss_pred             cCCCccceecccCcEEEEEEEEC-----CceEEEEEeccCC----hHHHHHHHHHHHhccccce---------------E
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG-----DREAAIKKMRSNK----SKEFFAELKVLCKIHHINV---------------F  347 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~-----~~~vavK~~~~~~----~~~f~~Ei~~l~~l~H~ni---------------V  347 (563)
                      ++|+..+.||+|+||.||+|.+.     ...+|||.++...    ..+|.+|+.++++++|+||               +
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   83 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII   83 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence            56888999999999999999874     2478999986542    3568899999999999997               5


Q ss_pred             EEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccc
Q 044997          348 ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLE  427 (563)
Q Consensus       348 ~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~  427 (563)
                      +||+++|+|.+++...    ...++|..+..++.|++.||+|||+++   ++||||||+|||+++++.+||+|||+++..
T Consensus        84 ~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~  156 (266)
T cd05033          84 TEYMENGSLDKFLREN----DGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRL  156 (266)
T ss_pred             EEcCCCCCHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhcc
Confidence            7999999999998652    246899999999999999999999987   999999999999999999999999999876


Q ss_pred             ccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCCCcCCCCCc------
Q 044997          428 ERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIRDDSEP------  500 (563)
Q Consensus       428 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p~~~~~~~~------  500 (563)
                      ...... .......++..|+|||.+.+..             ++.++||||||+++||+++ |..|+.......      
T Consensus       157 ~~~~~~-~~~~~~~~~~~y~~Pe~~~~~~-------------~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~  222 (266)
T cd05033         157 EDSEAT-YTTKGGKIPIRWTAPEAIAYRK-------------FTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVE  222 (266)
T ss_pred             cccccc-eeccCCCCCccccChhhhccCC-------------CccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Confidence            421111 1111234567899999875443             4889999999999999998 888875432110      


Q ss_pred             -----hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhh
Q 044997          501 -----TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIM  539 (563)
Q Consensus       501 -----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~  539 (563)
                           ......+..+.+++.+||+.+|++||++.||++.|++++
T Consensus       223 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~~  266 (266)
T cd05033         223 DGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKMI  266 (266)
T ss_pred             cCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence                 111223456899999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-36  Score=311.68  Aligned_cols=216  Identities=22%  Similarity=0.343  Sum_probs=181.0

Q ss_pred             cCCCccceecccCcEEEEEEEEC--CceEEEEEeccC------ChHHHHHHHHHHHhccccce---------------EE
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSN------KSKEFFAELKVLCKIHHINV---------------FI  348 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~------~~~~f~~Ei~~l~~l~H~ni---------------V~  348 (563)
                      ++|+..+.||+|+||.||+|+..  ++.||+|.++..      ..+.+.+|++++.+++||||               |+
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            46888999999999999999884  688999998743      23568899999999999997               57


Q ss_pred             EeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccc
Q 044997          349 STFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEE  428 (563)
Q Consensus       349 e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~  428 (563)
                      ||+++|+|.+++..     ...+++..+..++.|++.||.|||+++   ++||||||+|||+++++.+||+|||+++...
T Consensus        81 e~~~g~~L~~~l~~-----~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~  152 (333)
T cd05600          81 EYVPGGDFRTLLNN-----LGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIV  152 (333)
T ss_pred             eCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCcccc
Confidence            99999999999864     356899999999999999999999997   9999999999999999999999999987543


Q ss_pred             cccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCchh------
Q 044997          429 RTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTK------  502 (563)
Q Consensus       429 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~~------  502 (563)
                      .      ......||+.|+|||++.+..             ++.++|||||||++|||++|+.||.........      
T Consensus       153 ~------~~~~~~gt~~y~aPE~~~~~~-------------~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~  213 (333)
T cd05600         153 T------YANSVVGSPDYMAPEVLRGKG-------------YDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYW  213 (333)
T ss_pred             c------ccCCcccCccccChhHhcCCC-------------CCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhc
Confidence            2      223457899999999886544             488999999999999999999998654321100      


Q ss_pred             ------------hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          503 ------------MKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       503 ------------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                                  ...+.+.+.+++.+||..+|.+||++.++++.
T Consensus       214 ~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         214 KETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             cccccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence                        01335678999999999999999999999865

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=9.4e-36  Score=299.91  Aligned_cols=234  Identities=24%  Similarity=0.386  Sum_probs=185.7

Q ss_pred             cCCCccceecccCcEEEEEEEE--CCc----eEEEEEeccCC----hHHHHHHHHHHHhccccce--------------E
Q 044997          292 NNFDESRIIGRGGFGNVYFGLL--GDR----EAAIKKMRSNK----SKEFFAELKVLCKIHHINV--------------F  347 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~--~~~----~vavK~~~~~~----~~~f~~Ei~~l~~l~H~ni--------------V  347 (563)
                      ++|+..+.||+|+||.||+|++  +++    .||+|.++...    .+++.+|+.++..++|+||              +
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~l~   86 (279)
T cd05109           7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTSTVQLV   86 (279)
T ss_pred             hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCCCcEEE
Confidence            4677889999999999999986  333    48999986543    3568899999999999997              4


Q ss_pred             EEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccc
Q 044997          348 ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLE  427 (563)
Q Consensus       348 ~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~  427 (563)
                      ++|+++|+|.++++..    ...+++..++.++.|++.||+|||+.+   ++||||||+|||+++++.+||+|||+++..
T Consensus        87 ~~~~~~g~l~~~l~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~  159 (279)
T cd05109          87 TQLMPYGCLLDYVREN----KDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLL  159 (279)
T ss_pred             EEcCCCCCHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeec
Confidence            6889999999988752    346899999999999999999999987   999999999999999999999999999865


Q ss_pred             ccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCCCcCCCCC-------
Q 044997          428 ERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIRDDSE-------  499 (563)
Q Consensus       428 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p~~~~~~~-------  499 (563)
                      ...... .......++..|+|||.+.+..             ++.++||||||+++|||++ |..||......       
T Consensus       160 ~~~~~~-~~~~~~~~~~~y~~PE~~~~~~-------------~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~  225 (279)
T cd05109         160 DIDETE-YHADGGKVPIKWMALESILHRR-------------FTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLE  225 (279)
T ss_pred             ccccce-eecCCCccchhhCCHHHhccCC-------------CCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence            432211 1111223567899999875443             4889999999999999998 88887543211       


Q ss_pred             ----chhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcChhhh
Q 044997          500 ----PTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITSTEWE  546 (563)
Q Consensus       500 ----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~w~  546 (563)
                          ..........+.+++.+||+.||++||++.++++.|.++......|+
T Consensus       226 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~~~~~  276 (279)
T cd05109         226 KGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDPSRFV  276 (279)
T ss_pred             CCCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCCcCeE
Confidence                11112234568899999999999999999999999998877665554

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=7e-36  Score=296.85  Aligned_cols=223  Identities=24%  Similarity=0.408  Sum_probs=179.6

Q ss_pred             cCCCccceecccCcEEEEEEEECC-ceEEEEEeccCC--hHHHHHHHHHHHhccccce---------------EEEeecC
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLGD-REAAIKKMRSNK--SKEFFAELKVLCKIHHINV---------------FISTFGN  353 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~~-~~vavK~~~~~~--~~~f~~Ei~~l~~l~H~ni---------------V~e~~~~  353 (563)
                      ++|+..+.||+|+||.||++.+++ ..+|+|.++...  .++|.+|++++++++||||               |+||+++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~   83 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMEN   83 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCC
Confidence            357778999999999999998854 589999887543  4679999999999999997               5799999


Q ss_pred             CCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccccccccc
Q 044997          354 GSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEK  433 (563)
Q Consensus       354 gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~  433 (563)
                      |+|.++++..    ...++|..+..++.|++.||+|||+++   ++||||||+||++++++.+||+|||+++........
T Consensus        84 ~~L~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~  156 (256)
T cd05114          84 GCLLNYLRQR----QGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT  156 (256)
T ss_pred             CcHHHHHHhC----ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCcee
Confidence            9999988742    235899999999999999999999987   999999999999999999999999998754322111


Q ss_pred             ccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCCCcCCCCCch-----------
Q 044997          434 EMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIRDDSEPT-----------  501 (563)
Q Consensus       434 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p~~~~~~~~~-----------  501 (563)
                        ......++..|+|||.+.+..             ++.++||||||+++|||++ |+.||........           
T Consensus       157 --~~~~~~~~~~y~aPE~~~~~~-------------~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~  221 (256)
T cd05114         157 --SSSGAKFPVKWSPPEVFNFSK-------------YSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLY  221 (256)
T ss_pred             --ccCCCCCchhhCChhhcccCc-------------cchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCC
Confidence              111233566899999875443             4789999999999999999 8888865432110           


Q ss_pred             hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 044997          502 KMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILS  536 (563)
Q Consensus       502 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  536 (563)
                      ........+.+++.+||+.||.+||++.++++.|.
T Consensus       222 ~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~  256 (256)
T cd05114         222 RPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT  256 (256)
T ss_pred             CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence            11123345899999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-36  Score=309.94  Aligned_cols=212  Identities=25%  Similarity=0.364  Sum_probs=171.3

Q ss_pred             ecccCcEEEEEEEEC--CceEEEEEeccC------ChHHHHHHHHHHHhccccce---------------EEEeecCCCc
Q 044997          300 IGRGGFGNVYFGLLG--DREAAIKKMRSN------KSKEFFAELKVLCKIHHINV---------------FISTFGNGSL  356 (563)
Q Consensus       300 LG~G~fG~Vy~g~~~--~~~vavK~~~~~------~~~~f~~Ei~~l~~l~H~ni---------------V~e~~~~gsL  356 (563)
                      ||+|+||.||+++..  ++.+|+|.++..      ..+.+.+|++++.+++||||               |+||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            699999999999874  678999998642      23567889999999999997               5789999999


Q ss_pred             ccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccccccccccc
Q 044997          357 SDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEML  436 (563)
Q Consensus       357 ~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~  436 (563)
                      .+++..     ...+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.......   .
T Consensus        81 ~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~---~  149 (312)
T cd05585          81 FHHLQR-----EGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD---K  149 (312)
T ss_pred             HHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCCC---c
Confidence            998864     346899999999999999999999987   99999999999999999999999999885332211   2


Q ss_pred             cccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc----------hhhHHH
Q 044997          437 ATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP----------TKMKSL  506 (563)
Q Consensus       437 ~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~----------~~~~~~  506 (563)
                      .....||+.|+|||++.+..             ++.++|||||||++|||++|+.||.......          .....+
T Consensus       150 ~~~~~gt~~y~aPE~~~~~~-------------~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~  216 (312)
T cd05585         150 TNTFCGTPEYLAPELLLGHG-------------YTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGF  216 (312)
T ss_pred             cccccCCcccCCHHHHcCCC-------------CCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCCCcC
Confidence            23457999999999886543             4889999999999999999999997543211          111234


Q ss_pred             HHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 044997          507 ITIMAAVAEWCLNEDAVDRPEMRDIVAIL  535 (563)
Q Consensus       507 ~~~l~~li~~cl~~dP~~RPs~~evl~~L  535 (563)
                      ...+.+++.+||+.||.+||++.++.+.|
T Consensus       217 ~~~~~~li~~~L~~dp~~R~~~~~~~e~l  245 (312)
T cd05585         217 DRDAKDLLIGLLSRDPTRRLGYNGAQEIK  245 (312)
T ss_pred             CHHHHHHHHHHcCCCHHHcCCCCCHHHHH
Confidence            45689999999999999998654433333

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=4.4e-36  Score=326.19  Aligned_cols=229  Identities=24%  Similarity=0.356  Sum_probs=185.9

Q ss_pred             HHHhcCCCccceecccCcEEEEEEEE--CCceEEEEEeccCC-----hHHHHHHHHHHHhccccce--------------
Q 044997          288 EEATNNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNK-----SKEFFAELKVLCKIHHINV--------------  346 (563)
Q Consensus       288 ~~~~~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~-----~~~f~~Ei~~l~~l~H~ni--------------  346 (563)
                      ....++|...+.||+|+||.||+++.  +++.||||.++...     ...+.+|+..+..++|+|+              
T Consensus        28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~  107 (496)
T PTZ00283         28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN  107 (496)
T ss_pred             cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence            34457899999999999999999976  57899999986432     3467889999999998875              


Q ss_pred             ---------EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEE
Q 044997          347 ---------FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAK  417 (563)
Q Consensus       347 ---------V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~k  417 (563)
                               |+||+.+|+|.+++.... .....+++..+..++.|++.||+|||+++   |+||||||+|||+++++.+|
T Consensus       108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~-~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vk  183 (496)
T PTZ00283        108 PENVLMIALVLDYANAGDLRQEIKSRA-KTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVK  183 (496)
T ss_pred             cccceEEEEEEeCCCCCcHHHHHHHhh-ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEE
Confidence                     468889999999987532 23457899999999999999999999987   99999999999999999999


Q ss_pred             EeecCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCC
Q 044997          418 VADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDD  497 (563)
Q Consensus       418 l~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~  497 (563)
                      |+|||+++........ .......||+.|+|||++.+..             ++.++|||||||++|||++|+.||....
T Consensus       184 L~DFGls~~~~~~~~~-~~~~~~~Gt~~Y~aPE~~~~~~-------------~s~k~DVwSlGvilyeLltG~~Pf~~~~  249 (496)
T PTZ00283        184 LGDFGFSKMYAATVSD-DVGRTFCGTPYYVAPEIWRRKP-------------YSKKADMFSLGVLLYELLTLKRPFDGEN  249 (496)
T ss_pred             EEecccCeeccccccc-cccccccCCcceeCHHHhCCCC-------------CCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence            9999999865432111 1223457999999999886544             4889999999999999999999996543


Q ss_pred             CCc-----------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          498 SEP-----------TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       498 ~~~-----------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                      ...           .....+.+.+.+++.+||+.||.+||++.+++..
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        250 MEEVMHKTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             HHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence            211           1122345679999999999999999999999864

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.1e-35  Score=300.12  Aligned_cols=224  Identities=25%  Similarity=0.384  Sum_probs=178.6

Q ss_pred             CCccceecccCcEEEEEEEE------CCceEEEEEeccCC----hHHHHHHHHHHHhccccce-----------------
Q 044997          294 FDESRIIGRGGFGNVYFGLL------GDREAAIKKMRSNK----SKEFFAELKVLCKIHHINV-----------------  346 (563)
Q Consensus       294 f~~~~~LG~G~fG~Vy~g~~------~~~~vavK~~~~~~----~~~f~~Ei~~l~~l~H~ni-----------------  346 (563)
                      |+..+.||+|+||.||++..      .++.+|+|.++...    .+.|.+|++++++++||||                 
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL   85 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence            37789999999999988753      35679999987542    3578899999999999997                 


Q ss_pred             EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcc
Q 044997          347 FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKL  426 (563)
Q Consensus       347 V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~  426 (563)
                      ++||+.+|+|.+++..      ..++|.++..++.|++.||+|||+++   ++||||||+|||+++++.+||+|||+++.
T Consensus        86 v~e~~~~~~l~~~~~~------~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~  156 (283)
T cd05080          86 IMEYVPLGSLRDYLPK------HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKA  156 (283)
T ss_pred             EecCCCCCCHHHHHHH------cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccc
Confidence            4678888999888864      35899999999999999999999987   99999999999999999999999999986


Q ss_pred             cccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc------
Q 044997          427 EERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP------  500 (563)
Q Consensus       427 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~------  500 (563)
                      ...............++..|+|||.+...             .++.++||||||+++|||++|+.|+.......      
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-------------~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~  223 (283)
T cd05080         157 VPEGHEYYRVREDGDSPVFWYAVECLKEN-------------KFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGP  223 (283)
T ss_pred             cCCcchhhccCCCCCCCceeeCHhHhccc-------------CCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcc
Confidence            54322211111223456679999987543             34889999999999999999998875322100      


Q ss_pred             -------hh-------------hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhh
Q 044997          501 -------TK-------------MKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIM  539 (563)
Q Consensus       501 -------~~-------------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~  539 (563)
                             ..             ....+..+.+++.+||+.||++||+++++++.|+++.
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         224 KQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             cccccchhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence                   00             1122457899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.1e-36  Score=297.27  Aligned_cols=227  Identities=25%  Similarity=0.425  Sum_probs=183.3

Q ss_pred             hcCCCccceecccCcEEEEEEEEC-CceEEEEEeccCC--hHHHHHHHHHHHhccccce---------------EEEeec
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLLG-DREAAIKKMRSNK--SKEFFAELKVLCKIHHINV---------------FISTFG  352 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~~-~~~vavK~~~~~~--~~~f~~Ei~~l~~l~H~ni---------------V~e~~~  352 (563)
                      .++|+..+.||+|+||.||+|..+ ++.+|+|.++...  .++|.+|++++++++|+|+               ++||++
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   84 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMK   84 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeeccc
Confidence            456888999999999999999874 5679999987543  4679999999999999997               468888


Q ss_pred             CCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccccccc
Q 044997          353 NGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNE  432 (563)
Q Consensus       353 ~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~  432 (563)
                      +++|.+++...   ....++|..+..++.|++.||.|||+.+   ++||||||+||++++++.+||+|||+++.......
T Consensus        85 ~~~L~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~  158 (261)
T cd05068          85 YGSLLEYLQGG---AGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIY  158 (261)
T ss_pred             CCcHHHHHhcc---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence            99999998752   2356899999999999999999999987   99999999999999999999999999986542211


Q ss_pred             cccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCCCcCCCCCc-----------
Q 044997          433 KEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIRDDSEP-----------  500 (563)
Q Consensus       433 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p~~~~~~~~-----------  500 (563)
                      .  .......+..|+|||++.+..             ++.++||||||+++|||++ |+.||.......           
T Consensus       159 ~--~~~~~~~~~~y~aPE~~~~~~-------------~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~  223 (261)
T cd05068         159 E--AREGAKFPIKWTAPEAALYNR-------------FSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRM  223 (261)
T ss_pred             c--ccCCCcCceeccCccccccCC-------------CCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC
Confidence            1  111122345799999875443             4889999999999999999 888885433211           


Q ss_pred             hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 044997          501 TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQI  538 (563)
Q Consensus       501 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  538 (563)
                      .........+.+++.+||+.+|.+||++.++++.|+++
T Consensus       224 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~  261 (261)
T cd05068         224 PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF  261 (261)
T ss_pred             CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence            01123356689999999999999999999999999853

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=9.2e-36  Score=295.98  Aligned_cols=222  Identities=28%  Similarity=0.465  Sum_probs=182.9

Q ss_pred             cCCCccceecccCcEEEEEEEECCceEEEEEeccCC-hHHHHHHHHHHHhccccce----------------EEEeecCC
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLGDREAAIKKMRSNK-SKEFFAELKVLCKIHHINV----------------FISTFGNG  354 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~~~~vavK~~~~~~-~~~f~~Ei~~l~~l~H~ni----------------V~e~~~~g  354 (563)
                      ++|+..+.||+|+||.||++..++..+|+|.++... .+.|.+|+.++++++|+|+                ++||+++|
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~   85 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKG   85 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCCchHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCC
Confidence            467888999999999999999999999999987654 4579999999999999987                56888999


Q ss_pred             CcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccccccccc
Q 044997          355 SLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKE  434 (563)
Q Consensus       355 sL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~  434 (563)
                      +|.+++...   ....++|..++.++.|++.||+|||+++   ++||||||+||++++++.+||+|||+++......   
T Consensus        86 ~L~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~---  156 (256)
T cd05082          86 SLVDYLRSR---GRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---  156 (256)
T ss_pred             cHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC---
Confidence            999988752   2345899999999999999999999987   9999999999999999999999999987543211   


Q ss_pred             cccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCCCcCCCCCc-----------hh
Q 044997          435 MLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIRDDSEP-----------TK  502 (563)
Q Consensus       435 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p~~~~~~~~-----------~~  502 (563)
                         ....++..|+|||++.+.             .++.++||||||+++|||++ |+.|+.......           ..
T Consensus       157 ---~~~~~~~~y~aPE~~~~~-------------~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~  220 (256)
T cd05082         157 ---DTGKLPVKWTAPEALREK-------------KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDA  220 (256)
T ss_pred             ---CCCccceeecCHHHHccC-------------CCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCC
Confidence               122345689999987543             34789999999999999998 888875432211           11


Q ss_pred             hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 044997          503 MKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQI  538 (563)
Q Consensus       503 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  538 (563)
                      ....+..+.+++.+||+.||++||++.++++.|+++
T Consensus       221 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         221 PDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence            123346689999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=9e-36  Score=301.92  Aligned_cols=232  Identities=24%  Similarity=0.400  Sum_probs=183.2

Q ss_pred             CCCccceecccCcEEEEEEEECC-------ceEEEEEeccCC----hHHHHHHHHHHHhccccce---------------
Q 044997          293 NFDESRIIGRGGFGNVYFGLLGD-------REAAIKKMRSNK----SKEFFAELKVLCKIHHINV---------------  346 (563)
Q Consensus       293 ~f~~~~~LG~G~fG~Vy~g~~~~-------~~vavK~~~~~~----~~~f~~Ei~~l~~l~H~ni---------------  346 (563)
                      +|...+.||+|+||.||+|+...       ..+++|.+....    .+++.+|++++++++||||               
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            46778999999999999997632       468888886543    2468899999999999997               


Q ss_pred             EEEeecCCCccccccccc-------------------ccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCC
Q 044997          347 FISTFGNGSLSDHLHDPL-------------------LKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSN  407 (563)
Q Consensus       347 V~e~~~~gsL~~~L~~~~-------------------~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~N  407 (563)
                      ++||+.+|+|.+++....                   ......++|..++.++.|++.||+|||+++   ++||||||+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence            478999999999875421                   012246899999999999999999999987   9999999999


Q ss_pred             eEecCCCcEEEeecCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHH
Q 044997          408 ILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELI  487 (563)
Q Consensus       408 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ell  487 (563)
                      ||+++++.+||+|||+++........ .......++..|+|||.+.+.             .++.++||||||+++|||+
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~apE~~~~~-------------~~~~~~Di~slG~~l~el~  223 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDSY-VKRSKGRIPVKWMAIESLFDH-------------IYTTQSDVWSFGVLLWEIV  223 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccch-hcccCCCCCccccCHHHHccC-------------CcchHhHHHHHHHHHHHHH
Confidence            99999999999999999754332211 111223456789999987443             3488999999999999999


Q ss_pred             c-CCCCCcCCCCCc-----------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 044997          488 T-GKRALIRDDSEP-----------TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMIT  541 (563)
Q Consensus       488 t-g~~p~~~~~~~~-----------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~  541 (563)
                      + |+.||.......           .........+.+++.+||+.||.+||++.|+++.|++++..
T Consensus       224 t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~  289 (290)
T cd05045         224 TLGGNPYPGIAPERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK  289 (290)
T ss_pred             hcCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence            8 888885432211           11122345689999999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=2.6e-36  Score=311.96  Aligned_cols=216  Identities=25%  Similarity=0.353  Sum_probs=177.9

Q ss_pred             cCCCccceecccCcEEEEEEEEC--CceEEEEEeccC------ChHHHHHHHHHHHhccccce---------------EE
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSN------KSKEFFAELKVLCKIHHINV---------------FI  348 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~------~~~~f~~Ei~~l~~l~H~ni---------------V~  348 (563)
                      ++|+..+.||+|+||.||+|+..  ++.+|+|.++..      ..+.+.+|++++++++||||               |+
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   97 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL   97 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence            56888999999999999999884  688999998643      23568899999999999997               57


Q ss_pred             EeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccc
Q 044997          349 STFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEE  428 (563)
Q Consensus       349 e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~  428 (563)
                      ||+.+|+|.+++..     ...+++.....++.|++.||+|||+++   |+||||||+|||+++++.+||+|||+++...
T Consensus        98 e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~  169 (329)
T PTZ00263         98 EFVVGGELFTHLRK-----AGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVP  169 (329)
T ss_pred             cCCCCChHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcC
Confidence            89999999998864     346889999999999999999999997   9999999999999999999999999998543


Q ss_pred             cccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc--------
Q 044997          429 RTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP--------  500 (563)
Q Consensus       429 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~--------  500 (563)
                      ..      .....||+.|+|||++.+..             ++.++|||||||++|||++|+.||.......        
T Consensus       170 ~~------~~~~~gt~~y~aPE~~~~~~-------------~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~  230 (329)
T PTZ00263        170 DR------TFTLCGTPEYLAPEVIQSKG-------------HGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAG  230 (329)
T ss_pred             CC------cceecCChhhcCHHHHcCCC-------------CCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcC
Confidence            21      12346899999999886544             3789999999999999999999997543211        


Q ss_pred             --hhhHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 044997          501 --TKMKSLITIMAAVAEWCLNEDAVDRPE-----MRDIVAI  534 (563)
Q Consensus       501 --~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~  534 (563)
                        .........+.+++.+||+.||.+||+     +++++..
T Consensus       231 ~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  271 (329)
T PTZ00263        231 RLKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH  271 (329)
T ss_pred             CcCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence              011123456889999999999999997     5666643

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=9.2e-36  Score=302.10  Aligned_cols=236  Identities=24%  Similarity=0.396  Sum_probs=187.8

Q ss_pred             cCCCccceecccCcEEEEEEEEC-------CceEEEEEeccCC---hHHHHHHHHHHHhccccce---------------
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG-------DREAAIKKMRSNK---SKEFFAELKVLCKIHHINV---------------  346 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~-------~~~vavK~~~~~~---~~~f~~Ei~~l~~l~H~ni---------------  346 (563)
                      .+|...+.||+|+||.||+|+..       +..+++|.++...   .+.+.+|++++++++|+||               
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM   84 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence            35777899999999999999752       3458899987554   3568999999999999997               


Q ss_pred             EEEeecCCCcccccccccc-----------cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCc
Q 044997          347 FISTFGNGSLSDHLHDPLL-----------KGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLR  415 (563)
Q Consensus       347 V~e~~~~gsL~~~L~~~~~-----------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~  415 (563)
                      |+||+++|+|.+++.....           .....++|..++.++.|++.||+|||+++   ++||||||+|||+++++.
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~  161 (291)
T cd05094          85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL  161 (291)
T ss_pred             EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence            5799999999999864211           11235899999999999999999999997   999999999999999999


Q ss_pred             EEEeecCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCCCc
Q 044997          416 AKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALI  494 (563)
Q Consensus       416 ~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p~~  494 (563)
                      +||+|||+++....... ........++..|+|||++.+..             ++.++||||||+++|||++ |+.||.
T Consensus       162 ~~l~dfg~a~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~-------------~~~~~Di~slG~il~el~t~g~~p~~  227 (291)
T cd05094         162 VKIGDFGMSRDVYSTDY-YRVGGHTMLPIRWMPPESIMYRK-------------FTTESDVWSFGVILWEIFTYGKQPWF  227 (291)
T ss_pred             EEECCCCcccccCCCce-eecCCCCCcceeecChHHhccCC-------------CCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            99999999975433221 11123345678899999875443             4789999999999999999 999975


Q ss_pred             CCCCC-----------chhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcChh
Q 044997          495 RDDSE-----------PTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITSTE  544 (563)
Q Consensus       495 ~~~~~-----------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~  544 (563)
                      .....           .......+..+.+++.+||+.||.+||++++|++.|+++....+.
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~~~~  288 (291)
T cd05094         228 QLSNTEVIECITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKATPI  288 (291)
T ss_pred             CCCHHHHHHHHhCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhhcCc
Confidence            43321           111123345689999999999999999999999999999876543

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=1e-35  Score=314.89  Aligned_cols=236  Identities=24%  Similarity=0.391  Sum_probs=186.6

Q ss_pred             HHHhcCCCccceecccCcEEEEEEEECC-------ceEEEEEeccCC----hHHHHHHHHHHHhcc-ccce---------
Q 044997          288 EEATNNFDESRIIGRGGFGNVYFGLLGD-------REAAIKKMRSNK----SKEFFAELKVLCKIH-HINV---------  346 (563)
Q Consensus       288 ~~~~~~f~~~~~LG~G~fG~Vy~g~~~~-------~~vavK~~~~~~----~~~f~~Ei~~l~~l~-H~ni---------  346 (563)
                      ....++|...++||+|+||.||+|...+       ..||||+++...    .+.|.+|+++|++++ ||||         
T Consensus        33 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~  112 (400)
T cd05105          33 EFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTK  112 (400)
T ss_pred             eccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc
Confidence            3346788899999999999999998632       369999997543    356889999999996 9998         


Q ss_pred             ------EEEeecCCCcccccccccc-------------------------------------------------------
Q 044997          347 ------FISTFGNGSLSDHLHDPLL-------------------------------------------------------  365 (563)
Q Consensus       347 ------V~e~~~~gsL~~~L~~~~~-------------------------------------------------------  365 (563)
                            |+||+++|+|.++|+....                                                       
T Consensus       113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (400)
T cd05105         113 SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPML  192 (400)
T ss_pred             CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhh
Confidence                  5799999999988864210                                                       


Q ss_pred             ------------------------------------cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeE
Q 044997          366 ------------------------------------KGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNIL  409 (563)
Q Consensus       366 ------------------------------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NIL  409 (563)
                                                          .....+++..+..++.|++.||+|||+.+   ++||||||+|||
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nil  269 (400)
T cd05105         193 EIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVL  269 (400)
T ss_pred             hhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEE
Confidence                                                01235889999999999999999999987   999999999999


Q ss_pred             ecCCCcEEEeecCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-
Q 044997          410 LDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-  488 (563)
Q Consensus       410 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-  488 (563)
                      +++++.+||+|||+++........ .......++..|+|||.+.+..             ++.++|||||||++|||++ 
T Consensus       270 l~~~~~~kL~DfGla~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~-------------~~~~~DiwSlGvil~ellt~  335 (400)
T cd05105         270 LAQGKIVKICDFGLARDIMHDSNY-VSKGSTFLPVKWMAPESIFDNL-------------YTTLSDVWSYGILLWEIFSL  335 (400)
T ss_pred             EeCCCEEEEEeCCcceeccccccc-cccCCcCCCcceEChhhhcCCC-------------CCchhhHHHHHHHHHHHHHC
Confidence            999999999999999864332211 1122345678899999875443             4889999999999999997 


Q ss_pred             CCCCCcCCCCCc------------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhh
Q 044997          489 GKRALIRDDSEP------------TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMI  540 (563)
Q Consensus       489 g~~p~~~~~~~~------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~  540 (563)
                      |..||.......            .....++..+.+++.+||+.||++||++.+|.+.|++++.
T Consensus       336 g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~  399 (400)
T cd05105         336 GGTPYPGMIVDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP  399 (400)
T ss_pred             CCCCCcccchhHHHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence            888875432211            1122345668999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.5e-35  Score=302.39  Aligned_cols=220  Identities=21%  Similarity=0.336  Sum_probs=174.5

Q ss_pred             hcCCCccceecccCcEEEEEEEE--CCceEEEEEeccCC----hHHHHHHHHHHHhccccce---------------EEE
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNK----SKEFFAELKVLCKIHHINV---------------FIS  349 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~----~~~f~~Ei~~l~~l~H~ni---------------V~e  349 (563)
                      .++|+..+.||+|+||.||+|+.  +++.+|||.++...    ...+.+|++++++++||||               |+|
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            46789999999999999999987  47889999986432    3467889999999999997               467


Q ss_pred             eecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccccc
Q 044997          350 TFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEER  429 (563)
Q Consensus       350 ~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~  429 (563)
                      |+. ++|.+++..    ....+++..+..++.|++.||+|||+++   |+||||||+|||+++++.+||+|||+++....
T Consensus        84 ~~~-~~l~~~~~~----~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  155 (303)
T cd07869          84 YVH-TDLCQYMDK----HPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSV  155 (303)
T ss_pred             CCC-cCHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccC
Confidence            774 677776653    2356889999999999999999999997   99999999999999999999999999875332


Q ss_pred             ccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCchhh------
Q 044997          430 TNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKM------  503 (563)
Q Consensus       430 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~~~------  503 (563)
                      ..   .......|++.|+|||++.+.            ..++.++|||||||++|||++|+.||..........      
T Consensus       156 ~~---~~~~~~~~~~~y~aPE~~~~~------------~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  220 (303)
T cd07869         156 PS---HTYSNEVVTLWYRPPDVLLGS------------TEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLV  220 (303)
T ss_pred             CC---ccCCCCcccCCCCChHHHcCC------------CCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHH
Confidence            11   112334688999999987532            234789999999999999999999996532110000      


Q ss_pred             -------------------------------H------HHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          504 -------------------------------K------SLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       504 -------------------------------~------~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                                                     .      .....+.+++.+|++.||++|||+.|+++
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         221 LGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             hCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence                                           0      01234779999999999999999999986

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=8.5e-36  Score=301.79  Aligned_cols=218  Identities=23%  Similarity=0.378  Sum_probs=169.5

Q ss_pred             cCCCccceecccCcEEEEEEEE---CCceEEEEEeccCC-----hHHHHHHHHHHHhc---cccceE-------------
Q 044997          292 NNFDESRIIGRGGFGNVYFGLL---GDREAAIKKMRSNK-----SKEFFAELKVLCKI---HHINVF-------------  347 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~---~~~~vavK~~~~~~-----~~~f~~Ei~~l~~l---~H~niV-------------  347 (563)
                      ++|+..+.||+|+||.||+|+.   .++.||+|.++...     ...+.+|+++++++   +||||+             
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            3688899999999999999986   25779999886432     24567788777766   699984             


Q ss_pred             -------EEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEee
Q 044997          348 -------ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVAD  420 (563)
Q Consensus       348 -------~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~D  420 (563)
                             +||+. |+|.+++..   .....+++..+..++.|++.||.|||+++   ++||||||+|||+++++.+||+|
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~D  153 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDK---VPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD  153 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHh---CCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEcc
Confidence                   23333 566666653   12345899999999999999999999987   99999999999999999999999


Q ss_pred             cCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc
Q 044997          421 FGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP  500 (563)
Q Consensus       421 FGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~  500 (563)
                      ||+++.....    .......||+.|+|||.+.+..             ++.++|||||||++|||++|+.||.......
T Consensus       154 fg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~-------------~~~~~DiwslG~il~el~~g~~~f~~~~~~~  216 (290)
T cd07862         154 FGLARIYSFQ----MALTSVVVTLWYRAPEVLLQSS-------------YATPVDLWSVGCIFAEMFRRKPLFRGSSDVD  216 (290)
T ss_pred             ccceEeccCC----cccccccccccccChHHHhCCC-------------CCCccchHHHHHHHHHHHcCCCCcCCCCHHH
Confidence            9999754322    1223456899999999875443             4789999999999999999999986543210


Q ss_pred             h--------------h-----------------------hHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          501 T--------------K-----------------------MKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       501 ~--------------~-----------------------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                      .              .                       ...+...+.+++.+||+.||++||++.|+++
T Consensus       217 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         217 QLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             HHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence            0              0                       0112345789999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.4e-35  Score=299.29  Aligned_cols=227  Identities=27%  Similarity=0.413  Sum_probs=179.5

Q ss_pred             cCCCccceecccCcEEEEEEEE------CCceEEEEEeccCC---hHHHHHHHHHHHhccccce----------------
Q 044997          292 NNFDESRIIGRGGFGNVYFGLL------GDREAAIKKMRSNK---SKEFFAELKVLCKIHHINV----------------  346 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~------~~~~vavK~~~~~~---~~~f~~Ei~~l~~l~H~ni----------------  346 (563)
                      ++|+..+.||+|+||.||++..      .+..+|+|+++...   .+.|.+|++++++++||||                
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   83 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR   83 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence            4677889999999999999975      35789999987554   3578899999999999996                


Q ss_pred             -EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCc
Q 044997          347 -FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK  425 (563)
Q Consensus       347 -V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~  425 (563)
                       |+||+++|+|.+++...    ...++|..+..++.|++.||+|||+++   ++||||||+||++++++.+||+|||+++
T Consensus        84 lv~e~~~~~~L~~~l~~~----~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~  156 (284)
T cd05081          84 LVMEYLPYGSLRDYLQKH----RERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTK  156 (284)
T ss_pred             EEEEecCCCCHHHHHHhc----CcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccc
Confidence             56888999999998642    346899999999999999999999987   9999999999999999999999999998


Q ss_pred             ccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCC------
Q 044997          426 LEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE------  499 (563)
Q Consensus       426 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~------  499 (563)
                      ................++..|+|||++.+..             ++.++|||||||++|||++|..++......      
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-------------~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~  223 (284)
T cd05081         157 VLPQDKEYYKVREPGESPIFWYAPESLTESK-------------FSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMG  223 (284)
T ss_pred             cccCCCcceeecCCCCCceEeeCHHHhccCC-------------cChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcc
Confidence            6543222111111123445699999875443             478999999999999999987664322110      


Q ss_pred             -----ch----------------hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 044997          500 -----PT----------------KMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQI  538 (563)
Q Consensus       500 -----~~----------------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  538 (563)
                           ..                ....+...+.+++.+||+.+|++|||+.||++.|+.+
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         224 NDKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             cccccccchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence                 00                0012335689999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=5.4e-36  Score=301.35  Aligned_cols=230  Identities=24%  Similarity=0.393  Sum_probs=181.2

Q ss_pred             HhcCCCccceecccCcEEEEEEEEC-------CceEEEEEeccCC----hHHHHHHHHHHHhccccce------------
Q 044997          290 ATNNFDESRIIGRGGFGNVYFGLLG-------DREAAIKKMRSNK----SKEFFAELKVLCKIHHINV------------  346 (563)
Q Consensus       290 ~~~~f~~~~~LG~G~fG~Vy~g~~~-------~~~vavK~~~~~~----~~~f~~Ei~~l~~l~H~ni------------  346 (563)
                      .+++|+..+.||+|+||.||+|...       +..+|+|.++...    ..+|.+|+.++++++|+||            
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   83 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   83 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            4577999999999999999999764       3569999986432    3468899999999999997            


Q ss_pred             ---EEEeecCCCccccccccccc-----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEE
Q 044997          347 ---FISTFGNGSLSDHLHDPLLK-----GHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKV  418 (563)
Q Consensus       347 ---V~e~~~~gsL~~~L~~~~~~-----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl  418 (563)
                         |+||+++|+|.+++......     ....++|..+..++.|++.||+|||+.+   ++||||||+||++++++.+||
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l  160 (277)
T cd05062          84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI  160 (277)
T ss_pred             eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence               57999999999998642110     1235789999999999999999999987   999999999999999999999


Q ss_pred             eecCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCCCcCCC
Q 044997          419 ADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIRDD  497 (563)
Q Consensus       419 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p~~~~~  497 (563)
                      +|||+++......... ......++..|+|||++.+..             ++.++|||||||++|||++ |..||....
T Consensus       161 ~dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~-------------~~~~~Di~slG~~l~el~~~~~~p~~~~~  226 (277)
T cd05062         161 GDFGMTRDIYETDYYR-KGGKGLLPVRWMSPESLKDGV-------------FTTYSDVWSFGVVLWEIATLAEQPYQGMS  226 (277)
T ss_pred             CCCCCccccCCcceee-cCCCCccCHhhcChhHhhcCC-------------cCchhHHHHHHHHHHHHHcCCCCCCCCCC
Confidence            9999987543322111 111234577899999875433             4889999999999999999 677775432


Q ss_pred             CCc-----------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 044997          498 SEP-----------TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILS  536 (563)
Q Consensus       498 ~~~-----------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  536 (563)
                      ...           .......+.+.+++.+||+.||++||++.|+++.|+
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  276 (277)
T cd05062         227 NEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK  276 (277)
T ss_pred             HHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence            211           111234456899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-36  Score=279.89  Aligned_cols=237  Identities=23%  Similarity=0.323  Sum_probs=191.7

Q ss_pred             hcCCCccceecccCcEEEEEEEE--CCceEEEEEeccC---ChHHHHHHHHHHHhccccce-------------------
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSN---KSKEFFAELKVLCKIHHINV-------------------  346 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~---~~~~f~~Ei~~l~~l~H~ni-------------------  346 (563)
                      .++|...+.||+|||.-||.++.  +++.+|+|++.-.   +.+..++|++..++++|||+                   
T Consensus        20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y   99 (302)
T KOG2345|consen   20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY   99 (302)
T ss_pred             CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence            35788899999999999999874  6788999998643   45678899999999999997                   


Q ss_pred             -EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCc
Q 044997          347 -FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK  425 (563)
Q Consensus       347 -V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~  425 (563)
                       +..|+..|+|.+++..... ++..+++.+.++|+.++++||++||+.. |++.||||||.|||+.+.+.++|.|||.+.
T Consensus       100 ll~Pyy~~Gsl~d~i~~~k~-kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~  177 (302)
T KOG2345|consen  100 LLLPYYKRGSLLDEIERLKI-KGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSAT  177 (302)
T ss_pred             EEeehhccccHHHHHHHHhh-cCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCcc
Confidence             4688999999999976543 3457999999999999999999999985 579999999999999999999999999987


Q ss_pred             ccccccccc------cccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCC
Q 044997          426 LEERTNEKE------MLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE  499 (563)
Q Consensus       426 ~~~~~~~~~------~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~  499 (563)
                      .....-...      ........|..|.|||.+.-+.          ...+++++|||||||+||+|+.|..||......
T Consensus       178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~----------~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~  247 (302)
T KOG2345|consen  178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKS----------HCTITERTDIWSLGCTLYAMMFGESPFERIYQQ  247 (302)
T ss_pred             ccceEeechHHHHHHHHHHHHhCCCcccCchheeccc----------CcccccccchhhhhHHHHHHHHcCCcchHHhhc
Confidence            432211100      0112235789999999986543          456799999999999999999999998543211


Q ss_pred             --------------chhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhh
Q 044997          500 --------------PTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIM  539 (563)
Q Consensus       500 --------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~  539 (563)
                                    .......++.+.+++++|++.||.+||+..+++..++.+.
T Consensus       248 GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li  301 (302)
T KOG2345|consen  248 GGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI  301 (302)
T ss_pred             CCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence                          0111236677999999999999999999999999998764

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.5e-35  Score=313.16  Aligned_cols=216  Identities=20%  Similarity=0.259  Sum_probs=171.7

Q ss_pred             hcCCCccceecccCcEEEEEEEE--CCceEEEEEeccCChHHHHHHHHHHHhccccceE---------------EEeecC
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNKSKEFFAELKVLCKIHHINVF---------------ISTFGN  353 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~~~~f~~Ei~~l~~l~H~niV---------------~e~~~~  353 (563)
                      .++|+..+.||+|+||.||++..  .++.||+|...   .+.+.+|+++|++++|||||               +|++ .
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~-~  166 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ---RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY-K  166 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh---hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC-C
Confidence            35799999999999999999987  46889999754   34567899999999999983               3444 3


Q ss_pred             CCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccccccccc
Q 044997          354 GSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEK  433 (563)
Q Consensus       354 gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~  433 (563)
                      ++|..++..     ...+++.+++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++....... 
T Consensus       167 ~~L~~~l~~-----~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~-  237 (391)
T PHA03212        167 TDLYCYLAA-----KRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA-  237 (391)
T ss_pred             CCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccccccccc-
Confidence            567666643     346899999999999999999999997   99999999999999999999999999975322111 


Q ss_pred             ccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc-------------
Q 044997          434 EMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP-------------  500 (563)
Q Consensus       434 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~-------------  500 (563)
                       .......||+.|+|||++.+..             ++.++|||||||++|||++|+.|+.......             
T Consensus       238 -~~~~~~~gt~~y~aPE~~~~~~-------------~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~  303 (391)
T PHA03212        238 -NKYYGWAGTIATNAPELLARDP-------------YGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLII  303 (391)
T ss_pred             -cccccccCccCCCChhhhcCCC-------------CCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHH
Confidence             1123357999999999885544             4889999999999999999998875422100             


Q ss_pred             ---------------h------------------------hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          501 ---------------T------------------------KMKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       501 ---------------~------------------------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                                     .                        ....+...+.+|+.+||+.||.+|||++|+++
T Consensus       304 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~  375 (391)
T PHA03212        304 RRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD  375 (391)
T ss_pred             HHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence                           0                        00122345889999999999999999999986

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=1.1e-35  Score=310.16  Aligned_cols=219  Identities=24%  Similarity=0.362  Sum_probs=172.4

Q ss_pred             CCCccceecccCcEEEEEEEEC--CceEEEEEeccCC----hHHHHHHHHHHHhccccce---------------EEEee
Q 044997          293 NFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNK----SKEFFAELKVLCKIHHINV---------------FISTF  351 (563)
Q Consensus       293 ~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~----~~~f~~Ei~~l~~l~H~ni---------------V~e~~  351 (563)
                      +|+..+.||+|+||.||+|+..  ++.||||.+....    .+.+.+|++++++++|+||               |+||+
T Consensus        75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  154 (353)
T PLN00034         75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM  154 (353)
T ss_pred             HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence            3455688999999999999874  7899999986543    3568899999999999997               46788


Q ss_pred             cCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccccccc
Q 044997          352 GNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTN  431 (563)
Q Consensus       352 ~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~  431 (563)
                      .+|+|.+.         ....+..+..++.|++.||+|||+++   ++||||||+|||+++++.+||+|||+++......
T Consensus       155 ~~~~L~~~---------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~  222 (353)
T PLN00034        155 DGGSLEGT---------HIADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM  222 (353)
T ss_pred             CCCccccc---------ccCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceeccccc
Confidence            88877543         23567778899999999999999997   9999999999999999999999999998654321


Q ss_pred             ccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc-----------
Q 044997          432 EKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP-----------  500 (563)
Q Consensus       432 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~-----------  500 (563)
                      .   ......||..|+|||++.....        .....+.++|||||||++|||++|+.||.......           
T Consensus       223 ~---~~~~~~gt~~y~aPE~~~~~~~--------~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~  291 (353)
T PLN00034        223 D---PCNSSVGTIAYMSPERINTDLN--------HGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMS  291 (353)
T ss_pred             c---cccccccCccccCccccccccc--------cCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhcc
Confidence            1   1233578999999998743221        11223568999999999999999999996432211           


Q ss_pred             ---hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          501 ---TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       501 ---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                         .........+.+++.+||+.||++||++.|+++.
T Consensus       292 ~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        292 QPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence               1112334568999999999999999999999874

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=1.8e-35  Score=294.50  Aligned_cols=221  Identities=20%  Similarity=0.359  Sum_probs=176.4

Q ss_pred             eecccCcEEEEEEEEC----CceEEEEEeccCC----hHHHHHHHHHHHhccccce--------------EEEeecCCCc
Q 044997          299 IIGRGGFGNVYFGLLG----DREAAIKKMRSNK----SKEFFAELKVLCKIHHINV--------------FISTFGNGSL  356 (563)
Q Consensus       299 ~LG~G~fG~Vy~g~~~----~~~vavK~~~~~~----~~~f~~Ei~~l~~l~H~ni--------------V~e~~~~gsL  356 (563)
                      .||+|+||.||+|.+.    +..||+|.++...    .++|.+|++++++++|+||              |+||+++|+|
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~lv~e~~~~~~L   81 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEAEALMLVMEMASGGPL   81 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcCCCeEEEEEeCCCCCH
Confidence            3899999999999763    3468999886543    3568899999999999997              5799999999


Q ss_pred             ccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccccccccccc
Q 044997          357 SDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEML  436 (563)
Q Consensus       357 ~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~  436 (563)
                      .+++..    ....+++.++++++.|++.||+|||+++   ++||||||+|||++.++.+||+|||+++...........
T Consensus        82 ~~~l~~----~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  154 (257)
T cd05115          82 NKFLSG----KKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA  154 (257)
T ss_pred             HHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence            998864    2356899999999999999999999987   999999999999999999999999999855433221111


Q ss_pred             cccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCCCcCCCCCc-----------hhhH
Q 044997          437 ATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIRDDSEP-----------TKMK  504 (563)
Q Consensus       437 ~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p~~~~~~~~-----------~~~~  504 (563)
                      .....++..|+|||.+....             ++.++||||||+++||+++ |+.||.......           ....
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~-------------~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  221 (257)
T cd05115         155 RSAGKWPLKWYAPECINFRK-------------FSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPA  221 (257)
T ss_pred             cCCCCCCcccCCHHHHccCC-------------CCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCC
Confidence            12223457899999875433             4789999999999999996 999986433211           1112


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhh
Q 044997          505 SLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIM  539 (563)
Q Consensus       505 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~  539 (563)
                      ...+.+.+++.+||..||++||++.+|.+.|+++.
T Consensus       222 ~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~~  256 (257)
T cd05115         222 ECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTYY  256 (257)
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhhc
Confidence            23566889999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=1.8e-35  Score=295.72  Aligned_cols=228  Identities=27%  Similarity=0.488  Sum_probs=182.1

Q ss_pred             cCCCccceecccCcEEEEEEEEC--C---ceEEEEEeccCC----hHHHHHHHHHHHhccccce---------------E
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG--D---REAAIKKMRSNK----SKEFFAELKVLCKIHHINV---------------F  347 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~--~---~~vavK~~~~~~----~~~f~~Ei~~l~~l~H~ni---------------V  347 (563)
                      ++|+..+.||+|+||.||+|+..  +   ..+|+|.++...    .+++.+|++++++++|+|+               |
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (268)
T cd05063           5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII   84 (268)
T ss_pred             HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence            46788899999999999999873  2   368999986542    3568899999999999996               5


Q ss_pred             EEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccc
Q 044997          348 ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLE  427 (563)
Q Consensus       348 ~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~  427 (563)
                      +||+++|+|.+++..    ....++|.++..++.|++.||+|||+.+   ++||||||+||++++++.+||+|||++...
T Consensus        85 ~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~  157 (268)
T cd05063          85 TEYMENGALDKYLRD----HDGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVL  157 (268)
T ss_pred             EEcCCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceec
Confidence            799999999999864    2356899999999999999999999987   999999999999999999999999998765


Q ss_pred             ccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCCCcCCCCCc------
Q 044997          428 ERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIRDDSEP------  500 (563)
Q Consensus       428 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p~~~~~~~~------  500 (563)
                      ...............+..|+|||++....             ++.++|||||||++||+++ |+.||.......      
T Consensus       158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-------------~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~  224 (268)
T cd05063         158 EDDPEGTYTTSGGKIPIRWTAPEAIAYRK-------------FTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAIN  224 (268)
T ss_pred             ccccccceeccCCCcCceecCHHHhhcCC-------------cChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHh
Confidence            43222111111122356799999875433             4789999999999999997 999985433211      


Q ss_pred             -----hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhh
Q 044997          501 -----TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIM  539 (563)
Q Consensus       501 -----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~  539 (563)
                           .........+.+++.+||+.+|.+||++.+|++.|.+++
T Consensus       225 ~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~~  268 (268)
T cd05063         225 DGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKLL  268 (268)
T ss_pred             cCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence                 111123456889999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=8.1e-36  Score=307.49  Aligned_cols=213  Identities=25%  Similarity=0.380  Sum_probs=174.3

Q ss_pred             ceecccCcEEEEEEEE--CCceEEEEEeccC------ChHHHHHHHHHHHhccccce---------------EEEeecCC
Q 044997          298 RIIGRGGFGNVYFGLL--GDREAAIKKMRSN------KSKEFFAELKVLCKIHHINV---------------FISTFGNG  354 (563)
Q Consensus       298 ~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~------~~~~f~~Ei~~l~~l~H~ni---------------V~e~~~~g  354 (563)
                      +.||+|+||.||+++.  +++.||+|.++..      ....+.+|++++++++||||               |+||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            4699999999999986  4788999998643      23457789999999999997               57999999


Q ss_pred             CcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccccccccc
Q 044997          355 SLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKE  434 (563)
Q Consensus       355 sL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~  434 (563)
                      +|.+++..     ...+++..+..++.|++.||+|||+++   ++||||||+|||+++++.+||+|||+++......   
T Consensus        81 ~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~---  149 (323)
T cd05595          81 ELFFHLSR-----ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG---  149 (323)
T ss_pred             cHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCC---
Confidence            99888764     356899999999999999999999997   9999999999999999999999999987432211   


Q ss_pred             cccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc----------hhhH
Q 044997          435 MLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP----------TKMK  504 (563)
Q Consensus       435 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~----------~~~~  504 (563)
                      .......||+.|+|||++.+..             ++.++|||||||++|||++|+.||...+...          ....
T Consensus       150 ~~~~~~~gt~~y~aPE~~~~~~-------------~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~  216 (323)
T cd05595         150 ATMKTFCGTPEYLAPEVLEDND-------------YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR  216 (323)
T ss_pred             CccccccCCcCcCCcccccCCC-------------CCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCC
Confidence            1122356899999999885544             4789999999999999999999996543221          1122


Q ss_pred             HHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 044997          505 SLITIMAAVAEWCLNEDAVDRP-----EMRDIVAI  534 (563)
Q Consensus       505 ~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  534 (563)
                      .+.+.+.+++.+||+.||.+||     ++.++++.
T Consensus       217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h  251 (323)
T cd05595         217 TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  251 (323)
T ss_pred             CCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence            3456789999999999999998     78888753

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-36  Score=287.01  Aligned_cols=207  Identities=25%  Similarity=0.364  Sum_probs=177.6

Q ss_pred             cCCCccceecccCcEEEEEEEEC--CceEEEEEeccCCh------HHHHHHHHHHHhccccce---------------EE
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNKS------KEFFAELKVLCKIHHINV---------------FI  348 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~------~~f~~Ei~~l~~l~H~ni---------------V~  348 (563)
                      ++|+..+.||.|+||.|.+++.+  +..+|+|.+++++.      +...+|..+|+.+.||.+               ||
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm  123 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM  123 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence            45777899999999999999874  67899999987642      446789999999999997               68


Q ss_pred             EeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccc
Q 044997          349 STFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEE  428 (563)
Q Consensus       349 e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~  428 (563)
                      ||.++|.|..+|+.     .+.++......+|.+|+.||+|||+.+   |++|||||+|||||.+|.+||+|||+|+...
T Consensus       124 eyv~GGElFS~Lrk-----~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~  195 (355)
T KOG0616|consen  124 EYVPGGELFSYLRK-----SGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVS  195 (355)
T ss_pred             eccCCccHHHHHHh-----cCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEec
Confidence            99999999999985     467999999999999999999999998   9999999999999999999999999999653


Q ss_pred             cccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc--------
Q 044997          429 RTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP--------  500 (563)
Q Consensus       429 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~--------  500 (563)
                      .      ..-..+||+.|+|||.+..+.|             ..++|.|||||++|||+.|..||.......        
T Consensus       196 ~------rT~TlCGTPeYLAPEii~sk~y-------------nkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~  256 (355)
T KOG0616|consen  196 G------RTWTLCGTPEYLAPEIIQSKGY-------------NKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEG  256 (355)
T ss_pred             C------cEEEecCCccccChHHhhcCCC-------------CcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhC
Confidence            2      1334789999999999987776             789999999999999999999998765421        


Q ss_pred             --hhhHHHHHHHHHHHHHhhccCCCCC
Q 044997          501 --TKMKSLITIMAAVAEWCLNEDAVDR  525 (563)
Q Consensus       501 --~~~~~~~~~l~~li~~cl~~dP~~R  525 (563)
                        ..+..+...+++|++..++.|-.+|
T Consensus       257 ~v~fP~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  257 KVKFPSYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             cccCCcccCHHHHHHHHHHHhhhhHhh
Confidence              1223344568999999999999999

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=2e-35  Score=295.16  Aligned_cols=227  Identities=24%  Similarity=0.387  Sum_probs=184.6

Q ss_pred             cCCCccceecccCcEEEEEEEE--CCceEEEEEeccC------ChHHHHHHHHHHHhccccce---------------EE
Q 044997          292 NNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSN------KSKEFFAELKVLCKIHHINV---------------FI  348 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~------~~~~f~~Ei~~l~~l~H~ni---------------V~  348 (563)
                      ++|+..+.||+|+||.||+|+.  +++.+|||.++..      ....+.+|++++++++|||+               ++
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            5788899999999999999987  5789999987532      12468899999999999997               57


Q ss_pred             EeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccc
Q 044997          349 STFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEE  428 (563)
Q Consensus       349 e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~  428 (563)
                      ||+++|+|.+++.... .....+++..+..++.|++.||.|||+++   ++|+||||+||+++.++.++|+|||++....
T Consensus        82 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~  157 (267)
T cd08228          82 ELADAGDLSQMIKYFK-KQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS  157 (267)
T ss_pred             EecCCCcHHHHHHHhh-hccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceecc
Confidence            8999999988875321 22356889999999999999999999987   9999999999999999999999999987654


Q ss_pred             cccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc--------
Q 044997          429 RTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP--------  500 (563)
Q Consensus       429 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~--------  500 (563)
                      ....   ......|+..|+|||.+.+..             ++.++||||||+++|||++|+.|+.......        
T Consensus       158 ~~~~---~~~~~~~~~~~~aPE~~~~~~-------------~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~  221 (267)
T cd08228         158 SKTT---AAHSLVGTPYYMSPERIHENG-------------YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIE  221 (267)
T ss_pred             chhH---HHhcCCCCccccChhhhccCC-------------CCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHh
Confidence            3211   122346888999999875433             4789999999999999999999986543221        


Q ss_pred             ------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 044997          501 ------TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQI  538 (563)
Q Consensus       501 ------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  538 (563)
                            .........+.+++.+||+.+|++||++.+|++.|+++
T Consensus       222 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~  265 (267)
T cd08228         222 QCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM  265 (267)
T ss_pred             cCCCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence                  11123446689999999999999999999999999876

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.8e-35  Score=294.02  Aligned_cols=221  Identities=23%  Similarity=0.379  Sum_probs=177.4

Q ss_pred             ceecccCcEEEEEEEEC--C---ceEEEEEeccCC----hHHHHHHHHHHHhccccce--------------EEEeecCC
Q 044997          298 RIIGRGGFGNVYFGLLG--D---REAAIKKMRSNK----SKEFFAELKVLCKIHHINV--------------FISTFGNG  354 (563)
Q Consensus       298 ~~LG~G~fG~Vy~g~~~--~---~~vavK~~~~~~----~~~f~~Ei~~l~~l~H~ni--------------V~e~~~~g  354 (563)
                      ++||+|+||.||+|.+.  +   ..+|+|.++...    .+++.+|++++++++|+|+              |+||+++|
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~~~~~   80 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKGEPLMLVMELAPLG   80 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcCCceEEEEEeCCCC
Confidence            46999999999999763  2   579999987543    3568899999999999997              46888899


Q ss_pred             CcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccccccccc
Q 044997          355 SLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKE  434 (563)
Q Consensus       355 sL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~  434 (563)
                      +|.+++..     ...+++..+..++.|++.||+|||+.+   ++||||||+|||++.++.+||+|||+++.........
T Consensus        81 ~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~  152 (257)
T cd05060          81 PLLKYLKK-----RREIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY  152 (257)
T ss_pred             cHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence            99999875     236899999999999999999999987   9999999999999999999999999998654332211


Q ss_pred             cccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCCCcCCCCCc-----------hh
Q 044997          435 MLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIRDDSEP-----------TK  502 (563)
Q Consensus       435 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p~~~~~~~~-----------~~  502 (563)
                      .......++..|+|||.+.+.             .++.++||||||+++||+++ |+.||.......           ..
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~-------------~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~  219 (257)
T cd05060         153 RATTAGRWPLKWYAPECINYG-------------KFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPR  219 (257)
T ss_pred             ccccCccccccccCHHHhcCC-------------CCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCC
Confidence            111122345679999987543             34889999999999999998 888885433211           11


Q ss_pred             hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhh
Q 044997          503 MKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIM  539 (563)
Q Consensus       503 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~  539 (563)
                      .......+.+++.+||+.+|.+||++.++++.|+++.
T Consensus       220 ~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  256 (257)
T cd05060         220 PEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP  256 (257)
T ss_pred             CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence            2233456899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=7.6e-36  Score=308.35  Aligned_cols=213  Identities=23%  Similarity=0.369  Sum_probs=174.7

Q ss_pred             ceecccCcEEEEEEEE--CCceEEEEEeccC------ChHHHHHHHHHHHhccccce---------------EEEeecCC
Q 044997          298 RIIGRGGFGNVYFGLL--GDREAAIKKMRSN------KSKEFFAELKVLCKIHHINV---------------FISTFGNG  354 (563)
Q Consensus       298 ~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~------~~~~f~~Ei~~l~~l~H~ni---------------V~e~~~~g  354 (563)
                      +.||+|+||.||+++.  .++.+|+|.++..      ....+.+|++++++++||||               |+||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            4699999999999987  4788999998643      23568889999999999997               57999999


Q ss_pred             CcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccccccccc
Q 044997          355 SLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKE  434 (563)
Q Consensus       355 sL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~  434 (563)
                      +|.+++..     ...+++.++..++.|++.||+|||+++   |+||||||+|||+++++.+||+|||+++......   
T Consensus        81 ~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~---  149 (328)
T cd05593          81 ELFFHLSR-----ERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA---  149 (328)
T ss_pred             CHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCcc---
Confidence            99888864     356899999999999999999999997   9999999999999999999999999987532211   


Q ss_pred             cccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc----------hhhH
Q 044997          435 MLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP----------TKMK  504 (563)
Q Consensus       435 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~----------~~~~  504 (563)
                      .......||+.|+|||++.+..             ++.++|||||||++|||++|+.||...+...          ....
T Consensus       150 ~~~~~~~gt~~y~aPE~~~~~~-------------~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p~  216 (328)
T cd05593         150 ATMKTFCGTPEYLAPEVLEDND-------------YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPR  216 (328)
T ss_pred             cccccccCCcCccChhhhcCCC-------------CCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCCC
Confidence            1123357999999999885544             4789999999999999999999996543211          1112


Q ss_pred             HHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 044997          505 SLITIMAAVAEWCLNEDAVDRP-----EMRDIVAI  534 (563)
Q Consensus       505 ~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  534 (563)
                      .+...+.+++.+||+.||.+||     ++.|+++.
T Consensus       217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         217 TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence            3446689999999999999997     88888764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=2.8e-35  Score=293.91  Aligned_cols=227  Identities=26%  Similarity=0.430  Sum_probs=183.9

Q ss_pred             cCCCccceecccCcEEEEEEEECC-ceEEEEEeccCC--hHHHHHHHHHHHhccccce--------------EEEeecCC
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLGD-REAAIKKMRSNK--SKEFFAELKVLCKIHHINV--------------FISTFGNG  354 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~~-~~vavK~~~~~~--~~~f~~Ei~~l~~l~H~ni--------------V~e~~~~g  354 (563)
                      ++|...++||+|+||.||+|...+ ..||+|.++...  .++|.+|++++++++|+||              |+||+++|
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~lv~e~~~~~   85 (262)
T cd05071           6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKG   85 (262)
T ss_pred             HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEECCCCcEEEEEcCCCC
Confidence            468889999999999999998753 579999987533  4679999999999999996              57899999


Q ss_pred             CcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccccccccc
Q 044997          355 SLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKE  434 (563)
Q Consensus       355 sL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~  434 (563)
                      +|.+++...   ....++|..+..++.|++.||+|||+.+   ++||||||+||++++++.+||+|||.++........ 
T Consensus        86 ~L~~~~~~~---~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~-  158 (262)
T cd05071          86 SLLDFLKGE---MGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-  158 (262)
T ss_pred             cHHHHHhhc---cccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccccccc-
Confidence            999999752   2345899999999999999999999987   999999999999999999999999999765432211 


Q ss_pred             cccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCCCcCCCCCc-----------hh
Q 044997          435 MLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIRDDSEP-----------TK  502 (563)
Q Consensus       435 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p~~~~~~~~-----------~~  502 (563)
                       ......++..|+|||+..+.             .++.++||||||+++|||++ |+.||.......           ..
T Consensus       159 -~~~~~~~~~~y~~PE~~~~~-------------~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~  224 (262)
T cd05071         159 -ARQGAKFPIKWTAPEAALYG-------------RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC  224 (262)
T ss_pred             -cccCCcccceecCHhHhccC-------------CCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCC
Confidence             11223466789999977443             34889999999999999999 777775432211           11


Q ss_pred             hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhh
Q 044997          503 MKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIM  539 (563)
Q Consensus       503 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~  539 (563)
                      ....+..+.+++.+||+.||++||++.++++.|+..+
T Consensus       225 ~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~  261 (262)
T cd05071         225 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  261 (262)
T ss_pred             ccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence            1234566899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-36  Score=309.40  Aligned_cols=231  Identities=26%  Similarity=0.434  Sum_probs=195.4

Q ss_pred             HHHhcCCCccceecccCcEEEEEEEECC------ceEEEEEeccC----ChHHHHHHHHHHHhccccce-----------
Q 044997          288 EEATNNFDESRIIGRGGFGNVYFGLLGD------REAAIKKMRSN----KSKEFFAELKVLCKIHHINV-----------  346 (563)
Q Consensus       288 ~~~~~~f~~~~~LG~G~fG~Vy~g~~~~------~~vavK~~~~~----~~~~f~~Ei~~l~~l~H~ni-----------  346 (563)
                      +..++.....+.||.|-||.||+|.+..      --||||..+.+    ..+.|+.|.-+|++++||||           
T Consensus       385 el~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~P  464 (974)
T KOG4257|consen  385 ELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQP  464 (974)
T ss_pred             eeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeeccc
Confidence            3344556677899999999999998742      24899988764    35789999999999999997           


Q ss_pred             ---EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCC
Q 044997          347 ---FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGL  423 (563)
Q Consensus       347 ---V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGl  423 (563)
                         |||.++-|.|+.||...    ...|+......++.|+..+|.|||+..   +|||||..+|||+.+...+||+|||+
T Consensus       465 ~WivmEL~~~GELr~yLq~n----k~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGL  537 (974)
T KOG4257|consen  465 MWIVMELAPLGELREYLQQN----KDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGL  537 (974)
T ss_pred             eeEEEecccchhHHHHHHhc----cccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccch
Confidence               68999999999999863    456888999999999999999999986   99999999999999999999999999


Q ss_pred             CcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCCCcCCC-----
Q 044997          424 VKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIRDD-----  497 (563)
Q Consensus       424 a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p~~~~~-----  497 (563)
                      ++.++.....  ..++..-.+.|||||.+..++|             +.+||||-|||+|||+++ |.+||.+-.     
T Consensus       538 SR~~ed~~yY--kaS~~kLPIKWmaPESINfRrF-------------TtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI  602 (974)
T KOG4257|consen  538 SRYLEDDAYY--KASRGKLPIKWMAPESINFRRF-------------TTASDVWMFGVCMWEILSLGVKPFQGVKNSDVI  602 (974)
T ss_pred             hhhccccchh--hccccccceeecCccccchhcc-------------cchhhHHHHHHHHHHHHHhcCCccccccccceE
Confidence            9987755433  2334455778999998866655             999999999999999986 889997533     


Q ss_pred             ------CCchhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhh
Q 044997          498 ------SEPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMI  540 (563)
Q Consensus       498 ------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~  540 (563)
                            ++...+..+++.+..|+.+||+.||.+||.+.++...|+++++
T Consensus       603 ~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q  651 (974)
T KOG4257|consen  603 GHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ  651 (974)
T ss_pred             EEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence                  2344566788889999999999999999999999999998876

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=1.4e-35  Score=298.23  Aligned_cols=228  Identities=28%  Similarity=0.433  Sum_probs=182.7

Q ss_pred             cCCCccceecccCcEEEEEEEEC-------CceEEEEEeccCC----hHHHHHHHHHHHhccccce--------------
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG-------DREAAIKKMRSNK----SKEFFAELKVLCKIHHINV--------------  346 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~-------~~~vavK~~~~~~----~~~f~~Ei~~l~~l~H~ni--------------  346 (563)
                      ++|...+.||+|+||.||+|...       ++.+|+|.++...    .+.|.+|+++|++++|+|+              
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   84 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI   84 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence            45777899999999999999763       3679999987543    3578999999999999996              


Q ss_pred             -EEEeecCCCccccccccc---------ccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcE
Q 044997          347 -FISTFGNGSLSDHLHDPL---------LKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRA  416 (563)
Q Consensus       347 -V~e~~~~gsL~~~L~~~~---------~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~  416 (563)
                       |+||+++|+|.+++....         ......+++.++..++.|++.||.|||+++   ++||||||+||+++.++.+
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~  161 (280)
T cd05049          85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVV  161 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeE
Confidence             579999999999986531         112345899999999999999999999987   9999999999999999999


Q ss_pred             EEeecCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCCCcC
Q 044997          417 KVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIR  495 (563)
Q Consensus       417 kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p~~~  495 (563)
                      ||+|||+++........ .......+++.|+|||++.+..             +++++||||||+++|||++ |+.||..
T Consensus       162 kl~d~g~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~-------------~~~~~Di~slG~il~e~~~~g~~p~~~  227 (280)
T cd05049         162 KIGDFGMSRDVYTTDYY-RVGGHTMLPIRWMPPESIMYRK-------------FTTESDVWSFGVVLWEIFTYGKQPWYG  227 (280)
T ss_pred             EECCcccceecccCcce-ecCCCCcccceecChhhhccCC-------------cchhhhHHHHHHHHHHHHhcCCCCCCC
Confidence            99999998754322111 1122334678899999885443             4889999999999999998 9999865


Q ss_pred             CCCCc-----------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 044997          496 DDSEP-----------TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILS  536 (563)
Q Consensus       496 ~~~~~-----------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  536 (563)
                      .....           .........+.+++.+||+.||.+||++.||++.|+
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         228 LSNEEVIECITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             CCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence            43211           111234466899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=2.1e-35  Score=299.18  Aligned_cols=219  Identities=20%  Similarity=0.317  Sum_probs=174.2

Q ss_pred             cCCCccceecccCcEEEEEEEEC--CceEEEEEeccC----ChHHHHHHHHHHHhccccce---------------EEEe
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSN----KSKEFFAELKVLCKIHHINV---------------FIST  350 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~----~~~~f~~Ei~~l~~l~H~ni---------------V~e~  350 (563)
                      ++|...+.||+|+||.||+|+..  ++.||+|.++..    ....+.+|++++++++||||               |+||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY   84 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence            46888999999999999999874  688999998643    23567899999999999997               4577


Q ss_pred             ecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccccc
Q 044997          351 FGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERT  430 (563)
Q Consensus       351 ~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~  430 (563)
                      +. |+|.+++..    ....+++..+..++.|++.||+|||+++   |+||||||+|||+++++.+||+|||+++.....
T Consensus        85 ~~-~~l~~~l~~----~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~  156 (288)
T cd07871          85 LD-SDLKQYLDN----CGNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVP  156 (288)
T ss_pred             CC-cCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCC
Confidence            66 488877754    2345889999999999999999999987   999999999999999999999999998754322


Q ss_pred             cccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCchh--------
Q 044997          431 NEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTK--------  502 (563)
Q Consensus       431 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~~--------  502 (563)
                      ..   ......|++.|+|||.+.+.            ..++.++||||+||++|||++|+.||.........        
T Consensus       157 ~~---~~~~~~~~~~y~aPE~~~~~------------~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~  221 (288)
T cd07871         157 TK---TYSNEVVTLWYRPPDVLLGS------------TEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLG  221 (288)
T ss_pred             Cc---cccCceecccccChHHhcCC------------cccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence            11   12234678999999987532            23478999999999999999999998653311000        


Q ss_pred             --------------------------------hHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          503 --------------------------------MKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       503 --------------------------------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                                                      ...+.....+++.+|++.||.+|||++|+++
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         222 TPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             CCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence                                            0012345789999999999999999999975

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=4.6e-35  Score=304.41  Aligned_cols=234  Identities=25%  Similarity=0.394  Sum_probs=182.9

Q ss_pred             hcCCCccceecccCcEEEEEEEE-------CCceEEEEEeccCC----hHHHHHHHHHHHhc-cccce------------
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLL-------GDREAAIKKMRSNK----SKEFFAELKVLCKI-HHINV------------  346 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~-------~~~~vavK~~~~~~----~~~f~~Ei~~l~~l-~H~ni------------  346 (563)
                      .++|+..+.||+|+||.||+|..       .++.||||+++...    ...+.+|++++.++ +|+||            
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   85 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence            45788899999999999999974       34689999997533    24578899999999 67886            


Q ss_pred             ----EEEeecCCCccccccccccc--------------------------------------------------------
Q 044997          347 ----FISTFGNGSLSDHLHDPLLK--------------------------------------------------------  366 (563)
Q Consensus       347 ----V~e~~~~gsL~~~L~~~~~~--------------------------------------------------------  366 (563)
                          ++||+++|+|.+++......                                                        
T Consensus        86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (343)
T cd05103          86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE  165 (343)
T ss_pred             ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence                57999999999888642100                                                        


Q ss_pred             ------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccccccccccccccc
Q 044997          367 ------GHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRL  440 (563)
Q Consensus       367 ------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~  440 (563)
                            ....++|.++..++.|++.||+|||+++   ++||||||+|||+++++.+||+|||+++........ ......
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~  241 (343)
T cd05103         166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY-VRKGDA  241 (343)
T ss_pred             hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcch-hhcCCC
Confidence                  0134789999999999999999999987   999999999999999999999999998764322111 111223


Q ss_pred             cCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCCCcCCCCCchh------------hHHHH
Q 044997          441 VGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIRDDSEPTK------------MKSLI  507 (563)
Q Consensus       441 ~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p~~~~~~~~~~------------~~~~~  507 (563)
                      .++..|+|||.+.+..             ++.++||||||+++|||++ |..|+.........            .....
T Consensus       242 ~~~~~y~aPE~~~~~~-------------~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (343)
T cd05103         242 RLPLKWMAPETIFDRV-------------YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTT  308 (343)
T ss_pred             CCCcceECcHHhcCCC-------------CCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCC
Confidence            4567899999875443             4889999999999999997 88887543321111            11123


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 044997          508 TIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMIT  541 (563)
Q Consensus       508 ~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~  541 (563)
                      ..+.+++.+||+.||++||++.||++.|+.+++.
T Consensus       309 ~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~  342 (343)
T cd05103         309 PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  342 (343)
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            4588999999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.9e-35  Score=293.64  Aligned_cols=229  Identities=25%  Similarity=0.404  Sum_probs=179.9

Q ss_pred             CCccceecccCcEEEEEEEEC-----CceEEEEEeccCC-----hHHHHHHHHHHHhccccce-----------------
Q 044997          294 FDESRIIGRGGFGNVYFGLLG-----DREAAIKKMRSNK-----SKEFFAELKVLCKIHHINV-----------------  346 (563)
Q Consensus       294 f~~~~~LG~G~fG~Vy~g~~~-----~~~vavK~~~~~~-----~~~f~~Ei~~l~~l~H~ni-----------------  346 (563)
                      |...+.||+|+||.||+|...     +..+|+|+++...     .+.+.+|++.+++++|+|+                 
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            466789999999999999873     2569999987542     2468899999999999997                 


Q ss_pred             ----EEEeecCCCccccccccccc-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeec
Q 044997          347 ----FISTFGNGSLSDHLHDPLLK-GHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADF  421 (563)
Q Consensus       347 ----V~e~~~~gsL~~~L~~~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DF  421 (563)
                          ++||+++|+|..++...... ....+++.....++.|++.||.|||+.+   ++||||||+||++++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence                34788889998888543221 2346899999999999999999999987   999999999999999999999999


Q ss_pred             CCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCCCcCCCCCc
Q 044997          422 GLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIRDDSEP  500 (563)
Q Consensus       422 Gla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p~~~~~~~~  500 (563)
                      |+++......... ......++..|+|||.+....             ++.++||||||+++|||++ |..||.......
T Consensus       158 g~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~-------------~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~  223 (273)
T cd05035         158 GLSKKIYSGDYYR-QGRIAKMPVKWIAIESLADRV-------------YTSKSDVWAFGVTMWEIATRGQTPYPGVENHE  223 (273)
T ss_pred             cceeecccccccc-ccccccCCccccCHhhcccCC-------------CCcccchHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            9998654322111 111233567899999875433             4789999999999999999 778775433211


Q ss_pred             -----------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhh
Q 044997          501 -----------TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIM  539 (563)
Q Consensus       501 -----------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~  539 (563)
                                 .........+.+++.+||+.||.+||++.|+++.|++++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~~  273 (273)
T cd05035         224 IYDYLRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENIL  273 (273)
T ss_pred             HHHHHHcCCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhhC
Confidence                       111233456899999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=3.1e-35  Score=292.92  Aligned_cols=225  Identities=27%  Similarity=0.487  Sum_probs=182.1

Q ss_pred             cCCCccceecccCcEEEEEEEEC-CceEEEEEeccC--ChHHHHHHHHHHHhccccce--------------EEEeecCC
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG-DREAAIKKMRSN--KSKEFFAELKVLCKIHHINV--------------FISTFGNG  354 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~vavK~~~~~--~~~~f~~Ei~~l~~l~H~ni--------------V~e~~~~g  354 (563)
                      ++|+..+.||+|+||.||+|... +..+|+|.++..  ..++|.+|++++++++|+|+              ++||+++|
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~lv~e~~~~~   85 (260)
T cd05070           6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSEEPIYIVTEYMSKG   85 (260)
T ss_pred             HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEECCCCcEEEEEecCCC
Confidence            46788899999999999999874 567999998754  34679999999999999996              57899999


Q ss_pred             CcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccccccccc
Q 044997          355 SLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKE  434 (563)
Q Consensus       355 sL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~  434 (563)
                      +|.+++...   ....+++.++..++.|++.||+|||+++   ++||||||+||++++++.+||+|||+++........ 
T Consensus        86 ~L~~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~-  158 (260)
T cd05070          86 SLLDFLKDG---EGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT-  158 (260)
T ss_pred             cHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCcccc-
Confidence            999998752   2356899999999999999999999987   999999999999999999999999999765432211 


Q ss_pred             cccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCCCcCCCCCc-----------hh
Q 044997          435 MLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIRDDSEP-----------TK  502 (563)
Q Consensus       435 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p~~~~~~~~-----------~~  502 (563)
                       ......++..|+|||.+.+.             .++.++||||||+++|||++ |+.||.......           ..
T Consensus       159 -~~~~~~~~~~y~aPE~~~~~-------------~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~  224 (260)
T cd05070         159 -ARQGAKFPIKWTAPEAALYG-------------RFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPC  224 (260)
T ss_pred             -cccCCCCCccccChHHHhcC-------------CCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence             11122356689999987443             34889999999999999999 788885533211           11


Q ss_pred             hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 044997          503 MKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQ  537 (563)
Q Consensus       503 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  537 (563)
                      .......+.+++.+||+.||.+|||+.++.+.|++
T Consensus       225 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         225 PQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             CCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            12234568999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2e-35  Score=298.52  Aligned_cols=227  Identities=22%  Similarity=0.382  Sum_probs=180.6

Q ss_pred             CCCccceecccCcEEEEEEEE------CCceEEEEEeccCC----hHHHHHHHHHHHhccccce----------------
Q 044997          293 NFDESRIIGRGGFGNVYFGLL------GDREAAIKKMRSNK----SKEFFAELKVLCKIHHINV----------------  346 (563)
Q Consensus       293 ~f~~~~~LG~G~fG~Vy~g~~------~~~~vavK~~~~~~----~~~f~~Ei~~l~~l~H~ni----------------  346 (563)
                      .|+..+.||+|+||.||++.+      .+..+|+|.++...    .+.+.+|++++++++|+|+                
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK   84 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence            467789999999999999974      35779999987442    3568899999999999986                


Q ss_pred             -EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCc
Q 044997          347 -FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK  425 (563)
Q Consensus       347 -V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~  425 (563)
                       |+||+++|+|.+++..    ....++|..+..++.|++.||+|||+.+   ++||||||+||++++++.+||+|||+++
T Consensus        85 lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~  157 (284)
T cd05079          85 LIMEFLPSGSLKEYLPR----NKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTK  157 (284)
T ss_pred             EEEEccCCCCHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCcccc
Confidence             5688999999998864    2346899999999999999999999987   9999999999999999999999999998


Q ss_pred             ccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCC-------
Q 044997          426 LEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDS-------  498 (563)
Q Consensus       426 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~-------  498 (563)
                      ................++..|+|||++.+.             .++.++||||||+++|||++++.|......       
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-------------~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~  224 (284)
T cd05079         158 AIETDKEYYTVKDDLDSPVFWYAPECLIQS-------------KFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIG  224 (284)
T ss_pred             ccccCccceeecCCCCCCccccCHHHhccC-------------CCCccccchhhhhhhhhhhcCCCCCccccchhhhhcc
Confidence            654332211112234567789999987543             347899999999999999998765422100       


Q ss_pred             ----C---------------chhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhh
Q 044997          499 ----E---------------PTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIM  539 (563)
Q Consensus       499 ----~---------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~  539 (563)
                          .               .......+..+.+++.+||+.||.+||++.++++.|++++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~~  284 (284)
T cd05079         225 PTHGQMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAIL  284 (284)
T ss_pred             cccccccHHHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhhC
Confidence                0               0011123456899999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=2.1e-35  Score=294.06  Aligned_cols=226  Identities=27%  Similarity=0.487  Sum_probs=184.1

Q ss_pred             hcCCCccceecccCcEEEEEEEE-CCceEEEEEeccCC--hHHHHHHHHHHHhccccce--------------EEEeecC
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLL-GDREAAIKKMRSNK--SKEFFAELKVLCKIHHINV--------------FISTFGN  353 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~-~~~~vavK~~~~~~--~~~f~~Ei~~l~~l~H~ni--------------V~e~~~~  353 (563)
                      .++|+..++||+|+||.||+|.. +++.+|+|.+....  .++|.+|++++++++|+|+              ++||+.+
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~~~   84 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQEPIYIITEYMEN   84 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEccCCcEEEEEcCCC
Confidence            45788899999999999999987 46889999987543  4679999999999999997              5788899


Q ss_pred             CCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccccccccc
Q 044997          354 GSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEK  433 (563)
Q Consensus       354 gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~  433 (563)
                      |+|.+++...   ....+++.++..++.|++.||+|||+.+   ++||||||+||++++++.++|+|||+++........
T Consensus        85 ~~L~~~~~~~---~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~  158 (260)
T cd05067          85 GSLVDFLKTP---EGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT  158 (260)
T ss_pred             CCHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCcc
Confidence            9999988652   3456899999999999999999999987   999999999999999999999999998765422111


Q ss_pred             ccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCCCcCCCCCc-----------h
Q 044997          434 EMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIRDDSEP-----------T  501 (563)
Q Consensus       434 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p~~~~~~~~-----------~  501 (563)
                        ......++..|+|||++...             .++.++||||||+++||+++ |+.||.......           .
T Consensus       159 --~~~~~~~~~~y~~pe~~~~~-------------~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~  223 (260)
T cd05067         159 --AREGAKFPIKWTAPEAINYG-------------TFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMP  223 (260)
T ss_pred             --cccCCcccccccCHHHhccC-------------CcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCC
Confidence              11223456789999987543             34789999999999999999 898886443211           1


Q ss_pred             hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 044997          502 KMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQ  537 (563)
Q Consensus       502 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  537 (563)
                      ........+.+++.+||+.+|++||+++++++.|+.
T Consensus       224 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         224 RPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence            112234569999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=3.4e-35  Score=295.87  Aligned_cols=233  Identities=23%  Similarity=0.381  Sum_probs=185.5

Q ss_pred             hcCCCccceecccCcEEEEEEEEC------CceEEEEEeccCC----hHHHHHHHHHHHhccccce--------------
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLLG------DREAAIKKMRSNK----SKEFFAELKVLCKIHHINV--------------  346 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~~------~~~vavK~~~~~~----~~~f~~Ei~~l~~l~H~ni--------------  346 (563)
                      .++|...+.||+|+||.||+|...      +..|++|+++...    .+.+.+|+.++++++|+|+              
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~   84 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP   84 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence            467888999999999999999874      3778999887542    3568899999999999997              


Q ss_pred             --EEEeecCCCccccccccccc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeec
Q 044997          347 --FISTFGNGSLSDHLHDPLLK---GHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADF  421 (563)
Q Consensus       347 --V~e~~~~gsL~~~L~~~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DF  421 (563)
                        +++|+++|+|.+++......   ....+++.++..++.|++.||+|||+++   ++||||||+||++++++.+||+||
T Consensus        85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d~  161 (280)
T cd05043          85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDN  161 (280)
T ss_pred             EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECCC
Confidence              35677889999988653211   1256999999999999999999999987   999999999999999999999999


Q ss_pred             CCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCCCcCCCCCc
Q 044997          422 GLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIRDDSEP  500 (563)
Q Consensus       422 Gla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p~~~~~~~~  500 (563)
                      |+++.+...... .......++..|+|||++.+..             ++.++||||||+++||+++ |+.||.......
T Consensus       162 g~~~~~~~~~~~-~~~~~~~~~~~y~apE~~~~~~-------------~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~  227 (280)
T cd05043         162 ALSRDLFPMDYH-CLGDNENRPVKWMALESLVNKE-------------YSSASDVWSFGVLLWELMTLGQTPYVEIDPFE  227 (280)
T ss_pred             CCcccccCCceE-EeCCCCCcchhccCHHHHhcCC-------------CCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH
Confidence            999865432211 1112234577899999875443             4889999999999999999 999986432211


Q ss_pred             -----------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhh
Q 044997          501 -----------TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMI  540 (563)
Q Consensus       501 -----------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~  540 (563)
                                 ......++.+.+++.+||..||++||++.++++.|+.+.+
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~  278 (280)
T cd05043         228 MAAYLKDGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA  278 (280)
T ss_pred             HHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence                       1112234668999999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-35  Score=320.67  Aligned_cols=238  Identities=21%  Similarity=0.334  Sum_probs=193.6

Q ss_pred             hcCCCccceecccCcEEEEEEEEC--CceEEEEEeccCC---hHHHHHHHHHHHhcc-ccceE-----------------
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNK---SKEFFAELKVLCKIH-HINVF-----------------  347 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~---~~~f~~Ei~~l~~l~-H~niV-----------------  347 (563)
                      ..++.+.+.|.+|||+.||.+...  +.++|+|++-..+   .+...+|+++|++|. |+|||                 
T Consensus        36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~  115 (738)
T KOG1989|consen   36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW  115 (738)
T ss_pred             CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence            345677899999999999999884  3899999986543   356889999999997 99984                 


Q ss_pred             -----EEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecC
Q 044997          348 -----ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFG  422 (563)
Q Consensus       348 -----~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFG  422 (563)
                           ||||++|.|-+++..+.   ...|++.++++|+.|+++|+.+||.. +|+|||||||-+||||+.++..||||||
T Consensus       116 EvllLmEyC~gg~Lvd~mn~Rl---q~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFG  191 (738)
T KOG1989|consen  116 EVLLLMEYCKGGSLVDFMNTRL---QTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFG  191 (738)
T ss_pred             EEEeehhhccCCcHHHHHHHHH---hccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCccc
Confidence                 69999999999998643   23499999999999999999999998 5779999999999999999999999999


Q ss_pred             CCccccccc--cccc--c--cccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCC
Q 044997          423 LVKLEERTN--EKEM--L--ATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRD  496 (563)
Q Consensus       423 la~~~~~~~--~~~~--~--~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~  496 (563)
                      -|.-.-...  ..+.  .  .....-|+.|+|||++.-.          ..-.+++|+||||+||+||.|+....||...
T Consensus       192 Satt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDly----------sg~pI~eKsDIWALGclLYkLCy~t~PFe~s  261 (738)
T KOG1989|consen  192 SATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLY----------SGLPIGEKSDIWALGCLLYKLCYFTTPFEES  261 (738)
T ss_pred             ccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhh----------cCCCCcchhHHHHHHHHHHHHHHhCCCcCcC
Confidence            986322111  0000  0  0113468999999998543          2456799999999999999999999999766


Q ss_pred             CCC--------chhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcC
Q 044997          497 DSE--------PTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITS  542 (563)
Q Consensus       497 ~~~--------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~  542 (563)
                      ...        -.......+.+.+||..||+.||.+||++-+|+..+.++....
T Consensus       262 g~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~  315 (738)
T KOG1989|consen  262 GKLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP  315 (738)
T ss_pred             cceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence            321        1223567888999999999999999999999999999887643

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=3.8e-35  Score=310.47  Aligned_cols=236  Identities=25%  Similarity=0.414  Sum_probs=185.5

Q ss_pred             HHHHhcCCCccceecccCcEEEEEEEECC-------ceEEEEEeccCC----hHHHHHHHHHHHhcc-ccce--------
Q 044997          287 IEEATNNFDESRIIGRGGFGNVYFGLLGD-------REAAIKKMRSNK----SKEFFAELKVLCKIH-HINV--------  346 (563)
Q Consensus       287 l~~~~~~f~~~~~LG~G~fG~Vy~g~~~~-------~~vavK~~~~~~----~~~f~~Ei~~l~~l~-H~ni--------  346 (563)
                      ++...++|...+.||+|+||.||+|++.+       ..||+|+++...    .+.+.+|+++|.++. ||||        
T Consensus        32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~  111 (401)
T cd05107          32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT  111 (401)
T ss_pred             ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence            34445667888999999999999998643       579999997542    246889999999997 9997        


Q ss_pred             -------EEEeecCCCcccccccccc------------------------------------------------------
Q 044997          347 -------FISTFGNGSLSDHLHDPLL------------------------------------------------------  365 (563)
Q Consensus       347 -------V~e~~~~gsL~~~L~~~~~------------------------------------------------------  365 (563)
                             |+||+.+|+|.++++....                                                      
T Consensus       112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (401)
T cd05107         112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP  191 (401)
T ss_pred             cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence                   5799999999998864210                                                      


Q ss_pred             ---------------------------------------cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCC
Q 044997          366 ---------------------------------------KGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTS  406 (563)
Q Consensus       366 ---------------------------------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~  406 (563)
                                                             .....++|..++.++.|++.||+|||+.+   ++||||||+
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~  268 (401)
T cd05107         192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAAR  268 (401)
T ss_pred             hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcc
Confidence                                                   01135788899999999999999999886   999999999


Q ss_pred             CeEecCCCcEEEeecCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHH
Q 044997          407 NILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAEL  486 (563)
Q Consensus       407 NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~El  486 (563)
                      |||+++++.+||+|||+++........ .......++..|+|||.+...             .++.++|||||||++|||
T Consensus       269 NiLl~~~~~~kL~DfGla~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~-------------~~~~~~DvwslGvil~e~  334 (401)
T cd05107         269 NVLICEGKLVKICDFGLARDIMRDSNY-ISKGSTFLPLKWMAPESIFNN-------------LYTTLSDVWSFGILLWEI  334 (401)
T ss_pred             eEEEeCCCEEEEEecCcceeccccccc-ccCCCcCCCCceeChHHhcCC-------------CCCcHhHHHHHHHHHHHH
Confidence            999999999999999999854322111 111224567889999987543             348899999999999999


Q ss_pred             Hc-CCCCCcCCCCCch------------hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhh
Q 044997          487 IT-GKRALIRDDSEPT------------KMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIM  539 (563)
Q Consensus       487 lt-g~~p~~~~~~~~~------------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~  539 (563)
                      ++ |+.|+........            .+......+.+++.+||+.+|.+||+++||++.|++++
T Consensus       335 l~~g~~P~~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         335 FTLGGTPYPELPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             HHcCCCCCCCCCchHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence            98 8888754332111            11123466899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=2.5e-35  Score=293.42  Aligned_cols=227  Identities=27%  Similarity=0.437  Sum_probs=185.3

Q ss_pred             HhcCCCccceecccCcEEEEEEEEC-CceEEEEEeccCC---hHHHHHHHHHHHhccccce---------------EEEe
Q 044997          290 ATNNFDESRIIGRGGFGNVYFGLLG-DREAAIKKMRSNK---SKEFFAELKVLCKIHHINV---------------FIST  350 (563)
Q Consensus       290 ~~~~f~~~~~LG~G~fG~Vy~g~~~-~~~vavK~~~~~~---~~~f~~Ei~~l~~l~H~ni---------------V~e~  350 (563)
                      ...+|+..+.||.|+||.||+|... +..+|+|.++...   ..++.+|++++++++|+||               |+||
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   83 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL   83 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence            4456888999999999999999875 5789999987554   3678899999999999996               6799


Q ss_pred             ecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccccc
Q 044997          351 FGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERT  430 (563)
Q Consensus       351 ~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~  430 (563)
                      +++|+|.+++...   ....+++.++..++.|++.||+|||+.+   ++||||||+||++++++.+||+|||++......
T Consensus        84 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~  157 (261)
T cd05148          84 MEKGSLLAFLRSP---EGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKED  157 (261)
T ss_pred             cccCCHHHHHhcC---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCc
Confidence            9999999999762   3456899999999999999999999987   999999999999999999999999998765322


Q ss_pred             cccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCCCcCCCCCc---------
Q 044997          431 NEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIRDDSEP---------  500 (563)
Q Consensus       431 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p~~~~~~~~---------  500 (563)
                      ..   ......++..|+|||.+....             ++.++||||||+++|||++ |+.||.......         
T Consensus       158 ~~---~~~~~~~~~~~~~PE~~~~~~-------------~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~  221 (261)
T cd05148         158 VY---LSSDKKIPYKWTAPEAASHGT-------------FSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGY  221 (261)
T ss_pred             cc---cccCCCCceEecCHHHHccCC-------------CCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCC
Confidence            11   111234567899999875443             4789999999999999998 788885543211         


Q ss_pred             --hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 044997          501 --TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQI  538 (563)
Q Consensus       501 --~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  538 (563)
                        ......++.+.+++.+||+.||.+||++.++++.|+.+
T Consensus       222 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         222 RMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence              11123345689999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-35  Score=309.12  Aligned_cols=221  Identities=25%  Similarity=0.379  Sum_probs=181.8

Q ss_pred             cCCCccceecccCcEEEEEEEEC--CceEEEEEeccC------ChHHHHHHHHHHHhccccce---------------EE
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSN------KSKEFFAELKVLCKIHHINV---------------FI  348 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~------~~~~f~~Ei~~l~~l~H~ni---------------V~  348 (563)
                      ++|...+.||+|+||.||+|+..  ++.+|||+++..      ..+.+.+|++++..++|+||               |+
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            46888999999999999999885  789999998643      33568899999999999997               67


Q ss_pred             EeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccc
Q 044997          349 STFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEE  428 (563)
Q Consensus       349 e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~  428 (563)
                      ||+++|+|.+++..     ...+++..+..++.|++.||+|||+++   ++||||||+|||++.++.+||+|||+++...
T Consensus        81 e~~~~~~L~~~l~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~  152 (350)
T cd05573          81 EYMPGGDLMNLLIR-----KDVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMN  152 (350)
T ss_pred             cCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCc
Confidence            99999999999875     256899999999999999999999987   9999999999999999999999999998654


Q ss_pred             cccc--------------------------cccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHH
Q 044997          429 RTNE--------------------------KEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVV  482 (563)
Q Consensus       429 ~~~~--------------------------~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvv  482 (563)
                      ....                          .........||+.|+|||++.+..             ++.++|||||||+
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------------~~~~~DiwSlG~i  219 (350)
T cd05573         153 KAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTP-------------YGLECDWWSLGVI  219 (350)
T ss_pred             ccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCC-------------CCCceeeEecchh
Confidence            3220                          001123356999999999886543             4899999999999


Q ss_pred             HHHHHcCCCCCcCCCCCch--------------hhHHHHHHHHHHHHHhhccCCCCCCC-HHHHHHH
Q 044997          483 LAELITGKRALIRDDSEPT--------------KMKSLITIMAAVAEWCLNEDAVDRPE-MRDIVAI  534 (563)
Q Consensus       483 l~Elltg~~p~~~~~~~~~--------------~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~~  534 (563)
                      +|||++|+.||........              ....+...+.+++.+|+. ||.+||+ +.++++.
T Consensus       220 l~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         220 LYEMLYGFPPFYSDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             hhhhccCCCCCCCCCHHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence            9999999999975442110              011235668999999997 9999999 9999874

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-35  Score=298.22  Aligned_cols=219  Identities=25%  Similarity=0.368  Sum_probs=178.1

Q ss_pred             CCCccceecccCcEEEEEEEE--CCceEEEEEeccCC------hHHHHHHHHHHHhccccce---------------EEE
Q 044997          293 NFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNK------SKEFFAELKVLCKIHHINV---------------FIS  349 (563)
Q Consensus       293 ~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~------~~~f~~Ei~~l~~l~H~ni---------------V~e  349 (563)
                      +|+..+.||+|+||.||++..  +++.||+|.+....      ...+.+|++++++++|+||               |+|
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            477889999999999999987  47889999986432      2457789999999999997               579


Q ss_pred             eecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccccc
Q 044997          350 TFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEER  429 (563)
Q Consensus       350 ~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~  429 (563)
                      |+++|+|.+++..   .....+++..+..++.|++.||+|||+.+   ++||||||+||++++++.++|+|||+++....
T Consensus        81 ~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~  154 (285)
T cd05605          81 LMNGGDLKFHIYN---MGNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPE  154 (285)
T ss_pred             ccCCCcHHHHHHh---cCcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCC
Confidence            9999999988864   22356899999999999999999999987   99999999999999999999999999876432


Q ss_pred             ccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCch--------
Q 044997          430 TNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPT--------  501 (563)
Q Consensus       430 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~--------  501 (563)
                      ..    ......|+..|+|||++.+..             ++.++|||||||++||+++|+.||........        
T Consensus       155 ~~----~~~~~~~~~~y~aPE~~~~~~-------------~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~  217 (285)
T cd05605         155 GE----TIRGRVGTVGYMAPEVVKNER-------------YTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRV  217 (285)
T ss_pred             CC----ccccccCCCCccCcHHhcCCC-------------CCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHh
Confidence            21    112346899999999885443             47899999999999999999999975433211        


Q ss_pred             ------hhHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 044997          502 ------KMKSLITIMAAVAEWCLNEDAVDRP-----EMRDIVAI  534 (563)
Q Consensus       502 ------~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  534 (563)
                            ........+.+++.+||+.||.+||     ++.+++..
T Consensus       218 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05605         218 KEDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH  261 (285)
T ss_pred             hhcccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence                  0123445689999999999999999     77777553

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=2.8e-35  Score=304.50  Aligned_cols=220  Identities=22%  Similarity=0.286  Sum_probs=175.9

Q ss_pred             CCCccceecccCcEEEEEEEE-----CCceEEEEEeccC-------ChHHHHHHHHHHHhc-cccce-------------
Q 044997          293 NFDESRIIGRGGFGNVYFGLL-----GDREAAIKKMRSN-------KSKEFFAELKVLCKI-HHINV-------------  346 (563)
Q Consensus       293 ~f~~~~~LG~G~fG~Vy~g~~-----~~~~vavK~~~~~-------~~~~f~~Ei~~l~~l-~H~ni-------------  346 (563)
                      +|+..+.||+|+||.||+++.     .++.+|+|.++..       ..+.+.+|++++.++ +|+||             
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            477889999999999999875     3678999998642       124578899999999 47876             


Q ss_pred             --EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCC
Q 044997          347 --FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLV  424 (563)
Q Consensus       347 --V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla  424 (563)
                        |+||+.+|+|.+++..     ...+++.++..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++
T Consensus        81 ~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~  152 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQ-----RDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLS  152 (332)
T ss_pred             EEEEeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCC
Confidence              5799999999998864     356899999999999999999999997   999999999999999999999999998


Q ss_pred             cccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCch---
Q 044997          425 KLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPT---  501 (563)
Q Consensus       425 ~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~---  501 (563)
                      +........  ......||..|+|||++.+..            .++.++|||||||++|||++|+.||........   
T Consensus       153 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~------------~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~  218 (332)
T cd05614         153 KEFLSEEKE--RTYSFCGTIEYMAPEIIRGKG------------GHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSE  218 (332)
T ss_pred             ccccccCCC--ccccccCCccccCHHHhcCCC------------CCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHH
Confidence            754322211  122357999999999885432            247899999999999999999999964332111   


Q ss_pred             -----------hhHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 044997          502 -----------KMKSLITIMAAVAEWCLNEDAVDRP-----EMRDIVAI  534 (563)
Q Consensus       502 -----------~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  534 (563)
                                 ....+...+.+++.+||+.||++||     +++++++.
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  267 (332)
T cd05614         219 VSRRILKCDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH  267 (332)
T ss_pred             HHHHHhcCCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence                       0112345689999999999999999     66677653

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=5.2e-35  Score=292.12  Aligned_cols=228  Identities=24%  Similarity=0.383  Sum_probs=185.6

Q ss_pred             cCCCccceecccCcEEEEEEEE--CCceEEEEEeccC------ChHHHHHHHHHHHhccccce---------------EE
Q 044997          292 NNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSN------KSKEFFAELKVLCKIHHINV---------------FI  348 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~------~~~~f~~Ei~~l~~l~H~ni---------------V~  348 (563)
                      ++|+..+.||+|+||.||++..  +++.+|||.+...      ..+++.+|++++++++|+||               ++
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            4677889999999999999986  5789999987532      23578899999999999997               57


Q ss_pred             EeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccc
Q 044997          349 STFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEE  428 (563)
Q Consensus       349 e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~  428 (563)
                      ||+++++|.+++.... .....++|..+..++.|+++||.|||+++   ++|+||||+||+++.++.+||+|||++....
T Consensus        82 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~  157 (267)
T cd08229          82 ELADAGDLSRMIKHFK-KQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS  157 (267)
T ss_pred             EecCCCCHHHHHHHhh-ccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhccc
Confidence            8999999999886421 22456899999999999999999999987   9999999999999999999999999987543


Q ss_pred             cccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc--------
Q 044997          429 RTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP--------  500 (563)
Q Consensus       429 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~--------  500 (563)
                      ....   ......|+..|+|||.+.+..             ++.++||||||+++|||++|..||.......        
T Consensus       158 ~~~~---~~~~~~~~~~~~ape~~~~~~-------------~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~  221 (267)
T cd08229         158 SKTT---AAHSLVGTPYYMSPERIHENG-------------YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIE  221 (267)
T ss_pred             cCCc---ccccccCCcCccCHHHhcCCC-------------ccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhh
Confidence            2211   112346888999999875443             4789999999999999999999986543211        


Q ss_pred             ------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhh
Q 044997          501 ------TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIM  539 (563)
Q Consensus       501 ------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~  539 (563)
                            .........+.+++.+||+.||.+||||.+|++.++++.
T Consensus       222 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~  266 (267)
T cd08229         222 QCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH  266 (267)
T ss_pred             cCCCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence                  111234567999999999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.4e-35  Score=289.76  Aligned_cols=222  Identities=28%  Similarity=0.486  Sum_probs=183.9

Q ss_pred             cCCCccceecccCcEEEEEEEECCceEEEEEeccCC--hHHHHHHHHHHHhccccce---------------EEEeecCC
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLGDREAAIKKMRSNK--SKEFFAELKVLCKIHHINV---------------FISTFGNG  354 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~~~~vavK~~~~~~--~~~f~~Ei~~l~~l~H~ni---------------V~e~~~~g  354 (563)
                      ++|+..+.||+|+||.||+|...++.+|+|.++...  .+++.+|+.++++++|+|+               |+||++++
T Consensus         6 ~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~   85 (256)
T cd05039           6 KELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKG   85 (256)
T ss_pred             hhccceeeeecCCCceEEEEEecCcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCC
Confidence            467888999999999999999999999999997654  4679999999999999997               57899999


Q ss_pred             CcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccccccccc
Q 044997          355 SLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKE  434 (563)
Q Consensus       355 sL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~  434 (563)
                      +|.+++...   ....++|..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+|||.++......   
T Consensus        86 ~L~~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~---  156 (256)
T cd05039          86 SLVDYLRSR---GRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ---  156 (256)
T ss_pred             cHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEccccccccccccc---
Confidence            999998752   2346899999999999999999999997   9999999999999999999999999998653211   


Q ss_pred             cccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCCCcCCCCCc-----------hh
Q 044997          435 MLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIRDDSEP-----------TK  502 (563)
Q Consensus       435 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p~~~~~~~~-----------~~  502 (563)
                         ....++..|+|||++...             .++.++||||||+++||+++ |+.||.......           ..
T Consensus       157 ---~~~~~~~~~~ape~~~~~-------------~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~  220 (256)
T cd05039         157 ---DSGKLPVKWTAPEALREK-------------KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEA  220 (256)
T ss_pred             ---ccCCCcccccCchhhcCC-------------cCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCC
Confidence               122346689999987543             34789999999999999997 888875442211           11


Q ss_pred             hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 044997          503 MKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQI  538 (563)
Q Consensus       503 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  538 (563)
                      ....++.+.+++.+||..+|++||++.|+++.|+++
T Consensus       221 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  256 (256)
T cd05039         221 PEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI  256 (256)
T ss_pred             ccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence            123356789999999999999999999999999754

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1.2e-35  Score=308.46  Aligned_cols=216  Identities=23%  Similarity=0.343  Sum_probs=178.0

Q ss_pred             cCCCccceecccCcEEEEEEEECC---ceEEEEEeccC------ChHHHHHHHHHHHhccccce---------------E
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLGD---REAAIKKMRSN------KSKEFFAELKVLCKIHHINV---------------F  347 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~~---~~vavK~~~~~------~~~~f~~Ei~~l~~l~H~ni---------------V  347 (563)
                      ++|+..+.||+|+||.||+|...+   ..+|+|.+...      ..+.+.+|++++++++||||               |
T Consensus        30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv  109 (340)
T PTZ00426         30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV  109 (340)
T ss_pred             hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence            468889999999999999998642   57999988532      23568899999999999997               5


Q ss_pred             EEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccc
Q 044997          348 ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLE  427 (563)
Q Consensus       348 ~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~  427 (563)
                      +||+++|+|.+++..     ...+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||+++..
T Consensus       110 ~Ey~~~g~L~~~i~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~  181 (340)
T PTZ00426        110 LEFVIGGEFFTFLRR-----NKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVV  181 (340)
T ss_pred             EeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence            799999999998864     356899999999999999999999997   999999999999999999999999999864


Q ss_pred             ccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc-------
Q 044997          428 ERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP-------  500 (563)
Q Consensus       428 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~-------  500 (563)
                      ...      .....||+.|+|||++.+..             ++.++|||||||++|||++|+.||.......       
T Consensus       182 ~~~------~~~~~gt~~y~aPE~~~~~~-------------~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~  242 (340)
T PTZ00426        182 DTR------TYTLCGTPEYIAPEILLNVG-------------HGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILE  242 (340)
T ss_pred             CCC------cceecCChhhcCHHHHhCCC-------------CCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhc
Confidence            321      12356899999999885543             3789999999999999999999997644211       


Q ss_pred             ---hhhHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 044997          501 ---TKMKSLITIMAAVAEWCLNEDAVDRP-----EMRDIVAI  534 (563)
Q Consensus       501 ---~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  534 (563)
                         ..+..+...+.+++++|++.||++|+     +++++++.
T Consensus       243 ~~~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        243 GIIYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             CCCCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence               01122345688999999999999995     78887654

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=7.8e-35  Score=290.01  Aligned_cols=223  Identities=28%  Similarity=0.411  Sum_probs=173.4

Q ss_pred             ceecccCcEEEEEEEEC-----CceEEEEEeccCC----hHHHHHHHHHHHhccccce----------------EEEeec
Q 044997          298 RIIGRGGFGNVYFGLLG-----DREAAIKKMRSNK----SKEFFAELKVLCKIHHINV----------------FISTFG  352 (563)
Q Consensus       298 ~~LG~G~fG~Vy~g~~~-----~~~vavK~~~~~~----~~~f~~Ei~~l~~l~H~ni----------------V~e~~~  352 (563)
                      +.||+|+||.||+|...     ...+|+|++....    .+.+.+|+.++++++|||+                +++|+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            46899999999999863     2468999985432    3578899999999999997                467888


Q ss_pred             CCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccccccc
Q 044997          353 NGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNE  432 (563)
Q Consensus       353 ~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~  432 (563)
                      +|+|.+++...    ...+++..+..++.|+++||.|||+.+   ++||||||+|||+++++.+||+|||+++.......
T Consensus        81 ~~~L~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~  153 (262)
T cd05058          81 HGDLRNFIRSE----THNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEY  153 (262)
T ss_pred             CCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCcc
Confidence            89999988642    234688888999999999999999987   99999999999999999999999999875432211


Q ss_pred             cc-cccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCC-CcCCCC-----------C
Q 044997          433 KE-MLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRA-LIRDDS-----------E  499 (563)
Q Consensus       433 ~~-~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p-~~~~~~-----------~  499 (563)
                      .. .......++..|+|||.+....             ++.++||||||+++|||++|+.| +.....           .
T Consensus       154 ~~~~~~~~~~~~~~y~aPE~~~~~~-------------~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~  220 (262)
T cd05058         154 YSVHNHTGAKLPVKWMALESLQTQK-------------FTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRR  220 (262)
T ss_pred             eeecccccCcCCccccChhHhccCc-------------cchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC
Confidence            11 1112234577899999875433             47899999999999999996554 432211           0


Q ss_pred             chhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhh
Q 044997          500 PTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMI  540 (563)
Q Consensus       500 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~  540 (563)
                      .......++.+.+++.+||+.+|++||++.||++.|+++..
T Consensus       221 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~  261 (262)
T cd05058         221 LLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS  261 (262)
T ss_pred             CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence            01112234668999999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.2e-35  Score=304.27  Aligned_cols=212  Identities=20%  Similarity=0.343  Sum_probs=172.2

Q ss_pred             ceecccCcEEEEEEEE-----CCceEEEEEeccC-------ChHHHHHHHHHHHhccccce---------------EEEe
Q 044997          298 RIIGRGGFGNVYFGLL-----GDREAAIKKMRSN-------KSKEFFAELKVLCKIHHINV---------------FIST  350 (563)
Q Consensus       298 ~~LG~G~fG~Vy~g~~-----~~~~vavK~~~~~-------~~~~f~~Ei~~l~~l~H~ni---------------V~e~  350 (563)
                      +.||+|+||.||+++.     .++.+|+|.++..       ....+.+|+++|++++||||               |+||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            6799999999999975     3678999998642       12457789999999999997               5789


Q ss_pred             ecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccccc
Q 044997          351 FGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERT  430 (563)
Q Consensus       351 ~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~  430 (563)
                      +.+|+|.+++..     ...+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus        82 ~~~~~L~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  153 (323)
T cd05584          82 LSGGELFMHLER-----EGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHE  153 (323)
T ss_pred             CCCchHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccC
Confidence            999999988864     356788889999999999999999997   999999999999999999999999998743221


Q ss_pred             cccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc----------
Q 044997          431 NEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP----------  500 (563)
Q Consensus       431 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~----------  500 (563)
                      .   .......||+.|+|||++.+..             ++.++|||||||++|||++|+.||...+...          
T Consensus       154 ~---~~~~~~~gt~~y~aPE~~~~~~-------------~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~  217 (323)
T cd05584         154 G---TVTHTFCGTIEYMAPEILMRSG-------------HGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKL  217 (323)
T ss_pred             C---CcccccCCCccccChhhccCCC-------------CCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC
Confidence            1   1123356899999999885443             3789999999999999999999997544211          


Q ss_pred             hhhHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 044997          501 TKMKSLITIMAAVAEWCLNEDAVDRP-----EMRDIVA  533 (563)
Q Consensus       501 ~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  533 (563)
                      .....+.+.+.+++.+||+.||++||     ++.++++
T Consensus       218 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         218 NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence            11123345689999999999999999     7888766

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=1.9e-35  Score=299.63  Aligned_cols=233  Identities=23%  Similarity=0.390  Sum_probs=184.0

Q ss_pred             HhcCCCccceecccCcEEEEEEEECC-------ceEEEEEeccCCh----HHHHHHHHHHHhc-cccce-----------
Q 044997          290 ATNNFDESRIIGRGGFGNVYFGLLGD-------REAAIKKMRSNKS----KEFFAELKVLCKI-HHINV-----------  346 (563)
Q Consensus       290 ~~~~f~~~~~LG~G~fG~Vy~g~~~~-------~~vavK~~~~~~~----~~f~~Ei~~l~~l-~H~ni-----------  346 (563)
                      ..++|+..+.||+|+||.||++...+       ..+|+|.++....    .++.+|++++.++ +|+||           
T Consensus        10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~   89 (293)
T cd05053          10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG   89 (293)
T ss_pred             CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence            34568888999999999999998642       5689999875432    4588999999999 79997           


Q ss_pred             ----EEEeecCCCccccccccc-----------ccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEec
Q 044997          347 ----FISTFGNGSLSDHLHDPL-----------LKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLD  411 (563)
Q Consensus       347 ----V~e~~~~gsL~~~L~~~~-----------~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~  411 (563)
                          ++||+++|+|.+++....           ......++|..++.++.|++.||+|||+.+   ++||||||+|||++
T Consensus        90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~  166 (293)
T cd05053          90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVT  166 (293)
T ss_pred             CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEc
Confidence                578999999999986421           022456999999999999999999999987   99999999999999


Q ss_pred             CCCcEEEeecCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CC
Q 044997          412 DGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GK  490 (563)
Q Consensus       412 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~  490 (563)
                      +++.+||+|||+++......... ......++..|+|||.+.+..             ++.++|||||||++||+++ |.
T Consensus       167 ~~~~~kL~Dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~-------------~~~~~Di~slG~il~el~~~g~  232 (293)
T cd05053         167 EDHVMKIADFGLARDIHHIDYYR-KTTNGRLPVKWMAPEALFDRV-------------YTHQSDVWSFGVLLWEIFTLGG  232 (293)
T ss_pred             CCCeEEeCcccccccccccccee-ccCCCCCCccccCHHHhccCC-------------cCcccceeehhhHHHHHhcCCC
Confidence            99999999999998654322111 112233567899999875443             4889999999999999998 88


Q ss_pred             CCCcCCCCCc-----------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhh
Q 044997          491 RALIRDDSEP-----------TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIM  539 (563)
Q Consensus       491 ~p~~~~~~~~-----------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~  539 (563)
                      .|+.......           .........+.+++.+||+.||.+|||+.|+++.|++++
T Consensus       233 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         233 SPYPGIPVEELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             CCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence            8875432211           111223456889999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=6.4e-35  Score=291.95  Aligned_cols=227  Identities=27%  Similarity=0.465  Sum_probs=181.8

Q ss_pred             cCCCccceecccCcEEEEEEEEC-----CceEEEEEeccCC----hHHHHHHHHHHHhccccce---------------E
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG-----DREAAIKKMRSNK----SKEFFAELKVLCKIHHINV---------------F  347 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~-----~~~vavK~~~~~~----~~~f~~Ei~~l~~l~H~ni---------------V  347 (563)
                      ++|+..+.||+|+||.||+|...     +..+|+|.++...    .+.|.+|++++++++||||               |
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            46778899999999999999762     2368999886532    3568899999999999997               5


Q ss_pred             EEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccc
Q 044997          348 ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLE  427 (563)
Q Consensus       348 ~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~  427 (563)
                      +||+++|+|.+++...    ...+++.++..++.|++.||+|||+.+   ++||||||+|||+++++.+||+|||+++..
T Consensus        84 ~e~~~~~~L~~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~  156 (267)
T cd05066          84 TEYMENGSLDAFLRKH----DGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVL  156 (267)
T ss_pred             EEcCCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccc
Confidence            7999999999998642    346899999999999999999999987   999999999999999999999999999865


Q ss_pred             ccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCCCcCCCCCc------
Q 044997          428 ERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIRDDSEP------  500 (563)
Q Consensus       428 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p~~~~~~~~------  500 (563)
                      ..............++..|+|||++.+..             ++.++||||||+++||+++ |+.||.......      
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~-------------~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~  223 (267)
T cd05066         157 EDDPEAAYTTRGGKIPIRWTAPEAIAYRK-------------FTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIE  223 (267)
T ss_pred             ccccceeeecCCCccceeecCHhHhccCc-------------cCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHh
Confidence            43222111112223456899999885443             4889999999999999887 999986443211      


Q ss_pred             -----hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 044997          501 -----TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQI  538 (563)
Q Consensus       501 -----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  538 (563)
                           ......+..+.+++.+||+.+|.+||+|.++++.|+++
T Consensus       224 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         224 EGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             CCCcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence                 11112345689999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=6.4e-35  Score=290.75  Aligned_cols=225  Identities=27%  Similarity=0.473  Sum_probs=182.1

Q ss_pred             cCCCccceecccCcEEEEEEEECC-ceEEEEEeccCC--hHHHHHHHHHHHhccccce--------------EEEeecCC
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLGD-REAAIKKMRSNK--SKEFFAELKVLCKIHHINV--------------FISTFGNG  354 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~~-~~vavK~~~~~~--~~~f~~Ei~~l~~l~H~ni--------------V~e~~~~g  354 (563)
                      ++|...+.||+|+||.||+|...+ ..+|+|.+....  .+.|.+|++++++++|+|+              ++||+++|
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~~~~   85 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSEEPIYIVTEFMGKG   85 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCcEEEEEcCCCC
Confidence            457788999999999999998754 579999887543  3678999999999999996              57899999


Q ss_pred             CcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccccccccc
Q 044997          355 SLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKE  434 (563)
Q Consensus       355 sL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~  434 (563)
                      +|.++++..   ....++|..+..++.|++.||.|||+.+   ++||||||+||++++++.+||+|||+++........ 
T Consensus        86 ~L~~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~-  158 (260)
T cd05069          86 SLLDFLKEG---DGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT-  158 (260)
T ss_pred             CHHHHHhhC---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCccc-
Confidence            999999752   2345899999999999999999999987   999999999999999999999999999765332211 


Q ss_pred             cccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCCCcCCCCCc-----------hh
Q 044997          435 MLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIRDDSEP-----------TK  502 (563)
Q Consensus       435 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p~~~~~~~~-----------~~  502 (563)
                       ......++..|+|||...+.             .++.++||||||+++|||++ |+.||.......           ..
T Consensus       159 -~~~~~~~~~~y~~Pe~~~~~-------------~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~  224 (260)
T cd05069         159 -ARQGAKFPIKWTAPEAALYG-------------RFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPC  224 (260)
T ss_pred             -ccCCCccchhhCCHHHhccC-------------CcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence             11123456789999977443             34889999999999999999 888876532211           11


Q ss_pred             hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 044997          503 MKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQ  537 (563)
Q Consensus       503 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  537 (563)
                      ....+..+.+++.+||+.||.+||++++|++.|++
T Consensus       225 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         225 PQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             CcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            22345668999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=4.4e-35  Score=328.39  Aligned_cols=242  Identities=25%  Similarity=0.413  Sum_probs=193.5

Q ss_pred             cCCCccceecccCcEEEEEEEEC--CceEEEEEeccCC------hHHHHHHHHHHHhccccce---------------EE
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNK------SKEFFAELKVLCKIHHINV---------------FI  348 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~------~~~f~~Ei~~l~~l~H~ni---------------V~  348 (563)
                      ++|+..++||+|+||.||+|+..  ++.||+|+++...      .++|.+|++++++++||||               ++
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            57889999999999999999874  7899999986431      3568999999999999997               57


Q ss_pred             EeecCCCcccccccccc------cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecC
Q 044997          349 STFGNGSLSDHLHDPLL------KGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFG  422 (563)
Q Consensus       349 e~~~~gsL~~~L~~~~~------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFG  422 (563)
                      ||+++|+|.+++.....      .....+++..++.++.|+++||+|||+++   |+||||||+|||++.++.+||+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence            89999999998864211      11245678889999999999999999987   9999999999999999999999999


Q ss_pred             CCccccccccc---------------ccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHH
Q 044997          423 LVKLEERTNEK---------------EMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELI  487 (563)
Q Consensus       423 la~~~~~~~~~---------------~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ell  487 (563)
                      +++........               ........||+.|+|||++.+..             ++.++|||||||++|||+
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~-------------~S~kSDIWSLGVILyELL  225 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVP-------------ASESTDIYALGVILYQML  225 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCC-------------CCcHhHHHHHHHHHHHHH
Confidence            99865211100               01112357999999999875443             488999999999999999


Q ss_pred             cCCCCCcCCCCCch-------------hhHHHHHHHHHHHHHhhccCCCCCC-CHHHHHHHHHHhhhcChhhhccc
Q 044997          488 TGKRALIRDDSEPT-------------KMKSLITIMAAVAEWCLNEDAVDRP-EMRDIVAILSQIMITSTEWEASL  549 (563)
Q Consensus       488 tg~~p~~~~~~~~~-------------~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~i~~~~~~w~~~~  549 (563)
                      +|+.||........             ....++..+.+++.+|++.||++|| +++++.+.|+..++...+|....
T Consensus       226 TG~~PF~~~~~~ki~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~~p~w~~~~  301 (932)
T PRK13184        226 TLSFPYRRKKGRKISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQGSPEWTVKA  301 (932)
T ss_pred             HCCCCCCCcchhhhhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcCccccccc
Confidence            99999965432111             0123455689999999999999995 68889999999999888887653

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=6.1e-35  Score=302.23  Aligned_cols=219  Identities=21%  Similarity=0.385  Sum_probs=177.4

Q ss_pred             hcCCCccceecccCcEEEEEEEEC--CceEEEEEeccCC----hHHHHHHHHHHHhccccce---------------EEE
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNK----SKEFFAELKVLCKIHHINV---------------FIS  349 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~----~~~f~~Ei~~l~~l~H~ni---------------V~e  349 (563)
                      .++|+..+.||+|+||.||++...  +..+|+|.++...    .+.+.+|++++++++|+||               |+|
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence            367889999999999999999884  6788999876542    2568899999999999997               579


Q ss_pred             eecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccccc
Q 044997          350 TFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEER  429 (563)
Q Consensus       350 ~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~  429 (563)
                      |+++|+|.+++..     ...+++.....++.|++.||.|||+..  +++||||||+|||+++++.+||+|||+++....
T Consensus        84 ~~~~~~L~~~l~~-----~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~  156 (333)
T cd06650          84 HMDGGSLDQVLKK-----AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  156 (333)
T ss_pred             cCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhh
Confidence            9999999999864     346889999999999999999999742  399999999999999999999999999875432


Q ss_pred             ccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCch--------
Q 044997          430 TNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPT--------  501 (563)
Q Consensus       430 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~--------  501 (563)
                      .     ......|+..|+|||++.+..             ++.++|||||||++|||++|+.||........        
T Consensus       157 ~-----~~~~~~~~~~y~aPE~~~~~~-------------~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~  218 (333)
T cd06650         157 S-----MANSFVGTRSYMSPERLQGTH-------------YSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPV  218 (333)
T ss_pred             h-----ccccCCCCccccCHHHhcCCC-------------CCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcc
Confidence            1     122346899999999885443             47899999999999999999999853221000        


Q ss_pred             -------------------------------hh-----------------HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          502 -------------------------------KM-----------------KSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       502 -------------------------------~~-----------------~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                                                     ..                 ......+.+++.+||+.||++||++.|+++
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~  298 (333)
T cd06650         219 EGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMV  298 (333)
T ss_pred             cCCccccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhh
Confidence                                           00                 012345789999999999999999999976


Q ss_pred             H
Q 044997          534 I  534 (563)
Q Consensus       534 ~  534 (563)
                      .
T Consensus       299 h  299 (333)
T cd06650         299 H  299 (333)
T ss_pred             C
Confidence            3

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=4.9e-35  Score=295.33  Aligned_cols=229  Identities=25%  Similarity=0.418  Sum_probs=180.4

Q ss_pred             cCCCccceecccCcEEEEEEEE------CCceEEEEEeccCC----hHHHHHHHHHHHhccccce---------------
Q 044997          292 NNFDESRIIGRGGFGNVYFGLL------GDREAAIKKMRSNK----SKEFFAELKVLCKIHHINV---------------  346 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~------~~~~vavK~~~~~~----~~~f~~Ei~~l~~l~H~ni---------------  346 (563)
                      ++|+..+.||+|+||.||+|..      .+..+|+|.++...    .++|.+|++++++++|+||               
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            4577789999999999999975      24679999987533    2568899999999999997               


Q ss_pred             EEEeecCCCcccccccccc------------cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCC
Q 044997          347 FISTFGNGSLSDHLHDPLL------------KGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGL  414 (563)
Q Consensus       347 V~e~~~~gsL~~~L~~~~~------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~  414 (563)
                      ++||+++|+|.+++.....            .....+++.+.+.++.|++.||+|||+++   ++||||||+|||+++++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence            5799999999998853210            01235889999999999999999999987   99999999999999999


Q ss_pred             cEEEeecCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCCC
Q 044997          415 RAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRAL  493 (563)
Q Consensus       415 ~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p~  493 (563)
                      .+||+|||+++........ .......++..|+|||++.+.             .++.++||||||+++|||++ |..||
T Consensus       162 ~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~-------------~~~~~~Dv~slG~il~el~~~g~~p~  227 (283)
T cd05090         162 HVKISDLGLSREIYSADYY-RVQPKSLLPIRWMPPEAIMYG-------------KFSSDSDIWSFGVVLWEIFSFGLQPY  227 (283)
T ss_pred             cEEeccccccccccCCcce-ecccCCCccceecChHHhccC-------------CCCchhhhHHHHHHHHHHHcCCCCCC
Confidence            9999999999765332211 112233457789999987543             34889999999999999998 88888


Q ss_pred             cCCCCCc-----------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 044997          494 IRDDSEP-----------TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQ  537 (563)
Q Consensus       494 ~~~~~~~-----------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  537 (563)
                      .......           .....+...+.+++.+||+.||++||++.+|.+.|..
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         228 YGFSNQEVIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             CCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence            6432210           1112345668999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=4.7e-35  Score=298.90  Aligned_cols=238  Identities=27%  Similarity=0.440  Sum_probs=186.2

Q ss_pred             cCCCccceecccCcEEEEEEEEC--Cc--eEEEEEeccCC----hHHHHHHHHHHHhc-cccce---------------E
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG--DR--EAAIKKMRSNK----SKEFFAELKVLCKI-HHINV---------------F  347 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~--~~--~vavK~~~~~~----~~~f~~Ei~~l~~l-~H~ni---------------V  347 (563)
                      ++|+..+.||+|+||.||+|...  +.  .+|+|.++...    .++|.+|++++.++ +|+||               |
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv   86 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   86 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence            46788899999999999999874  33  46888876432    34688899999999 89997               5


Q ss_pred             EEeecCCCcccccccccc-----------cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcE
Q 044997          348 ISTFGNGSLSDHLHDPLL-----------KGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRA  416 (563)
Q Consensus       348 ~e~~~~gsL~~~L~~~~~-----------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~  416 (563)
                      +||+++|+|.++++....           .....+++.+++.++.|++.||+|||+++   ++||||||+|||+++++.+
T Consensus        87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~  163 (303)
T cd05088          87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA  163 (303)
T ss_pred             EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcE
Confidence            799999999999864321           11236899999999999999999999987   9999999999999999999


Q ss_pred             EEeecCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCCCcC
Q 044997          417 KVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIR  495 (563)
Q Consensus       417 kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p~~~  495 (563)
                      ||+|||+++......    ......++..|+|||++.+.             .++.++|||||||++|||+| |..||..
T Consensus       164 kl~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~-------------~~~~~~Di~slG~il~ellt~g~~p~~~  226 (303)
T cd05088         164 KIADFGLSRGQEVYV----KKTMGRLPVRWMAIESLNYS-------------VYTTNSDVWSYGVLLWEIVSLGGTPYCG  226 (303)
T ss_pred             EeCccccCcccchhh----hcccCCCcccccCHHHHhcc-------------CCcccccchhhhhHHHHHHhcCCCCccc
Confidence            999999986422111    11112346679999987443             34789999999999999998 9999864


Q ss_pred             CCCCc-----------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcChhhhccc
Q 044997          496 DDSEP-----------TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITSTEWEASL  549 (563)
Q Consensus       496 ~~~~~-----------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~w~~~~  549 (563)
                      .....           .........+.+++.+||+.+|++||++.++++.|.+++.....|....
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~~~~~~~  291 (303)
T cd05088         227 MTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTT  291 (303)
T ss_pred             CChHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhhhhhhhh
Confidence            33211           1111234568999999999999999999999999999987766665543

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=3.7e-35  Score=292.05  Aligned_cols=223  Identities=25%  Similarity=0.432  Sum_probs=179.1

Q ss_pred             cCCCccceecccCcEEEEEEEECC-ceEEEEEeccCC--hHHHHHHHHHHHhccccce---------------EEEeecC
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLGD-REAAIKKMRSNK--SKEFFAELKVLCKIHHINV---------------FISTFGN  353 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~~-~~vavK~~~~~~--~~~f~~Ei~~l~~l~H~ni---------------V~e~~~~  353 (563)
                      ++|...+.||+|+||.||+|.+.+ ..+|+|.++...  .++|.+|+.++++++||||               |+||+.+
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   83 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSN   83 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCC
Confidence            356778999999999999998865 469999887543  4679999999999999997               5788889


Q ss_pred             CCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccccccccc
Q 044997          354 GSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEK  433 (563)
Q Consensus       354 gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~  433 (563)
                      |+|.+++...    ...++|.+++.++.|++.||+|||+.+   ++|+||||+||++++++.+||+|||+++........
T Consensus        84 ~~l~~~i~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~  156 (256)
T cd05113          84 GCLLNYLREH----GKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT  156 (256)
T ss_pred             CcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCcee
Confidence            9999988642    236899999999999999999999987   999999999999999999999999998755332211


Q ss_pred             ccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCCCcCCCCCc-----------h
Q 044997          434 EMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIRDDSEP-----------T  501 (563)
Q Consensus       434 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p~~~~~~~~-----------~  501 (563)
                        ......++..|+|||.+.+..             ++.++||||||+++|||++ |+.||.......           .
T Consensus       157 --~~~~~~~~~~y~~pe~~~~~~-------------~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~  221 (256)
T cd05113         157 --SSVGSKFPVRWSPPEVLLYSK-------------FSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLY  221 (256)
T ss_pred             --ecCCCccChhhCCHHHHhcCc-------------ccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCC
Confidence              111234567899999875433             4789999999999999999 888885433211           0


Q ss_pred             hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 044997          502 KMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILS  536 (563)
Q Consensus       502 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  536 (563)
                      ........+.+++.+||+.||.+||++.++++.|+
T Consensus       222 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         222 RPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence            11123456899999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=1.2e-34  Score=289.09  Aligned_cols=228  Identities=24%  Similarity=0.391  Sum_probs=186.4

Q ss_pred             cCCCccceecccCcEEEEEEEEC--CceEEEEEeccC------ChHHHHHHHHHHHhccccce---------------EE
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSN------KSKEFFAELKVLCKIHHINV---------------FI  348 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~------~~~~f~~Ei~~l~~l~H~ni---------------V~  348 (563)
                      ++|+..+.||+|+||.||+|...  ++.+|+|.++..      ..+.+.+|++++++++|+|+               |+
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            57889999999999999999884  788999987532      24678899999999999997               57


Q ss_pred             EeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccc
Q 044997          349 STFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEE  428 (563)
Q Consensus       349 e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~  428 (563)
                      ||+++|+|.+++.... .....+++.++..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++...
T Consensus        82 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~  157 (267)
T cd08224          82 ELADAGDLSRMIKHFK-KQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFS  157 (267)
T ss_pred             ecCCCCCHHHHHHHhc-ccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeecc
Confidence            9999999998886421 23456899999999999999999999987   9999999999999999999999999987543


Q ss_pred             cccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc--------
Q 044997          429 RTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP--------  500 (563)
Q Consensus       429 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~--------  500 (563)
                      ....   ......++..|+|||.+.+..             ++.++|||||||++|||++|+.||.......        
T Consensus       158 ~~~~---~~~~~~~~~~y~apE~~~~~~-------------~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~  221 (267)
T cd08224         158 SKTT---AAHSLVGTPYYMSPERIHENG-------------YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIE  221 (267)
T ss_pred             CCCc---ccceecCCccccCHHHhccCC-------------CCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhh
Confidence            2211   112245788999999875443             4789999999999999999999986543211        


Q ss_pred             ------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhh
Q 044997          501 ------TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIM  539 (563)
Q Consensus       501 ------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~  539 (563)
                            .........+.+++.+||+.+|++||++.+|++.|+++.
T Consensus       222 ~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         222 KCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             cCCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence                  111144557899999999999999999999999998763

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.4e-35  Score=289.64  Aligned_cols=221  Identities=26%  Similarity=0.417  Sum_probs=177.4

Q ss_pred             CCCccceecccCcEEEEEEEEC-CceEEEEEeccC--ChHHHHHHHHHHHhccccce---------------EEEeecCC
Q 044997          293 NFDESRIIGRGGFGNVYFGLLG-DREAAIKKMRSN--KSKEFFAELKVLCKIHHINV---------------FISTFGNG  354 (563)
Q Consensus       293 ~f~~~~~LG~G~fG~Vy~g~~~-~~~vavK~~~~~--~~~~f~~Ei~~l~~l~H~ni---------------V~e~~~~g  354 (563)
                      +|+..+.||+|+||.||+|.+. +..+|+|.++..  ..++|.+|++++++++|+||               |+||++++
T Consensus         5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~   84 (256)
T cd05059           5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANG   84 (256)
T ss_pred             HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCC
Confidence            4677899999999999999875 457999998754  34678999999999999997               46888999


Q ss_pred             CcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccccccccc
Q 044997          355 SLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKE  434 (563)
Q Consensus       355 sL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~  434 (563)
                      +|.+++...    ...++|..+..++.|++.||+|||+.+   ++||||||+||++++++.+||+|||+++........ 
T Consensus        85 ~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~-  156 (256)
T cd05059          85 CLLNYLRER----KGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT-  156 (256)
T ss_pred             CHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceeccccccc-
Confidence            999988642    236899999999999999999999987   999999999999999999999999998754322111 


Q ss_pred             cccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCCCcCCCCCc-----------hh
Q 044997          435 MLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIRDDSEP-----------TK  502 (563)
Q Consensus       435 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p~~~~~~~~-----------~~  502 (563)
                       ......++..|+|||.+.+..             ++.++||||||+++||+++ |+.||.......           ..
T Consensus       157 -~~~~~~~~~~y~~Pe~~~~~~-------------~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~  222 (256)
T cd05059         157 -SSQGTKFPVKWAPPEVFDYSR-------------FSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYR  222 (256)
T ss_pred             -ccCCCCCCccccCHHHhccCC-------------CCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCC
Confidence             111123456799999875443             4789999999999999999 788875432211           11


Q ss_pred             hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 044997          503 MKSLITIMAAVAEWCLNEDAVDRPEMRDIVAIL  535 (563)
Q Consensus       503 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  535 (563)
                      ....+..+.+++.+||+.+|++||++.|+++.|
T Consensus       223 ~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         223 PKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence            122356699999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=4.3e-35  Score=317.76  Aligned_cols=222  Identities=23%  Similarity=0.339  Sum_probs=180.2

Q ss_pred             CCccceecccCcEEEEEEEEC---CceEEEEEeccCC---hHHHHHHHHHHHhccccce---------------EEEeec
Q 044997          294 FDESRIIGRGGFGNVYFGLLG---DREAAIKKMRSNK---SKEFFAELKVLCKIHHINV---------------FISTFG  352 (563)
Q Consensus       294 f~~~~~LG~G~fG~Vy~g~~~---~~~vavK~~~~~~---~~~f~~Ei~~l~~l~H~ni---------------V~e~~~  352 (563)
                      |...+.||+|+||.||++...   ++.||+|.+....   ...+.+|+++|++++||||               |+||++
T Consensus        69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~  148 (478)
T PTZ00267         69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS  148 (478)
T ss_pred             EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence            788899999999999999763   5678888765443   2457789999999999998               579999


Q ss_pred             CCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccccccc
Q 044997          353 NGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNE  432 (563)
Q Consensus       353 ~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~  432 (563)
                      +|+|.++|.... ....++++.++..++.|++.||+|||+++   |+||||||+|||+++++.+||+|||+++.......
T Consensus       149 gg~L~~~l~~~~-~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~  224 (478)
T PTZ00267        149 GGDLNKQIKQRL-KEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS  224 (478)
T ss_pred             CCCHHHHHHHHH-hccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence            999999886532 23457899999999999999999999987   99999999999999999999999999986543221


Q ss_pred             cccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc-----------h
Q 044997          433 KEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP-----------T  501 (563)
Q Consensus       433 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~-----------~  501 (563)
                       ........||++|+|||++.+..             ++.++|||||||++|||++|+.||.......           .
T Consensus       225 -~~~~~~~~gt~~y~aPE~~~~~~-------------~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~  290 (478)
T PTZ00267        225 -LDVASSFCGTPYYLAPELWERKR-------------YSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDP  290 (478)
T ss_pred             -cccccccCCCccccCHhHhCCCC-------------CCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC
Confidence             11233457999999999885443             4889999999999999999999986543211           0


Q ss_pred             hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          502 KMKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       502 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                      ....+...+.+++.+||+.||++||++.+++.
T Consensus       291 ~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        291 FPCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             CCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence            11234466899999999999999999999875

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=7.1e-35  Score=296.57  Aligned_cols=231  Identities=29%  Similarity=0.448  Sum_probs=181.3

Q ss_pred             cCCCccceecccCcEEEEEEEECC----ceEEEEEeccCC----hHHHHHHHHHHHhc-cccce---------------E
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLGD----REAAIKKMRSNK----SKEFFAELKVLCKI-HHINV---------------F  347 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~~----~~vavK~~~~~~----~~~f~~Ei~~l~~l-~H~ni---------------V  347 (563)
                      ++|+..+.||+|+||.||+|...+    ..+++|.++...    .++|.+|++++.++ +||||               +
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            468888999999999999998743    246888887432    25688999999999 79986               5


Q ss_pred             EEeecCCCccccccccccc-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcE
Q 044997          348 ISTFGNGSLSDHLHDPLLK-----------GHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRA  416 (563)
Q Consensus       348 ~e~~~~gsL~~~L~~~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~  416 (563)
                      +||+++|+|.+++......           ....+++..+..++.|++.||+|||+++   ++||||||+|||+++++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence            7899999999998642110           1235899999999999999999999987   9999999999999999999


Q ss_pred             EEeecCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCCCcC
Q 044997          417 KVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIR  495 (563)
Q Consensus       417 kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p~~~  495 (563)
                      ||+|||++.......    .......+..|+|||++....             ++.++|||||||++|||++ |+.||..
T Consensus       159 kl~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~-------------~~~~~DvwSlG~il~el~t~g~~pf~~  221 (297)
T cd05089         159 KIADFGLSRGEEVYV----KKTMGRLPVRWMAIESLNYSV-------------YTTKSDVWSFGVLLWEIVSLGGTPYCG  221 (297)
T ss_pred             EECCcCCCcccccee----ccCCCCcCccccCchhhccCC-------------CCchhhHHHHHHHHHHHHcCCCCCCCC
Confidence            999999986422110    111122355799999875443             4789999999999999998 9999865


Q ss_pred             CCCCc-----------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcC
Q 044997          496 DDSEP-----------TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITS  542 (563)
Q Consensus       496 ~~~~~-----------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~  542 (563)
                      .....           .....+...+.+++.+||+.||.+||++.++++.|..+....
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~  279 (297)
T cd05089         222 MTCAELYEKLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR  279 (297)
T ss_pred             CCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence            43211           111234466899999999999999999999999999887643

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-35  Score=291.33  Aligned_cols=223  Identities=26%  Similarity=0.378  Sum_probs=178.3

Q ss_pred             HhcCCCccceecccCcEEEEEEEE--CCceEEEEEecc--C---ChHHHHHHHHHHHhccccceEE--------------
Q 044997          290 ATNNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRS--N---KSKEFFAELKVLCKIHHINVFI--------------  348 (563)
Q Consensus       290 ~~~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~--~---~~~~f~~Ei~~l~~l~H~niV~--------------  348 (563)
                      ....|...+.||+|+||.|..+..  +++.||||++..  +   ..++-.+|+++|+.++|+|||.              
T Consensus        20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~   99 (359)
T KOG0660|consen   20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN   99 (359)
T ss_pred             ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence            344566678999999999999977  478999999862  2   2467889999999999999842              


Q ss_pred             ------EeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecC
Q 044997          349 ------STFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFG  422 (563)
Q Consensus       349 ------e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFG  422 (563)
                            |+| ..+|.+.++     .++.|+......+.+|+++||+|+|+.+   ++||||||+|+|++.+...||+|||
T Consensus       100 DvYiV~elM-etDL~~iik-----~~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFG  170 (359)
T KOG0660|consen  100 DVYLVFELM-ETDLHQIIK-----SQQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFG  170 (359)
T ss_pred             eeEEehhHH-hhHHHHHHH-----cCccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEecccc
Confidence                  222 224444443     3456999999999999999999999998   9999999999999999999999999


Q ss_pred             CCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCch-
Q 044997          423 LVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPT-  501 (563)
Q Consensus       423 la~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~-  501 (563)
                      +|+..... ......+..+.|..|.|||++..            ...|+.+.||||.||++.||++|+.-|.+.+...+ 
T Consensus       171 LAR~~~~~-~~~~~mTeYVaTRWYRAPElll~------------~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql  237 (359)
T KOG0660|consen  171 LARYLDKF-FEDGFMTEYVATRWYRAPELLLN------------SSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQL  237 (359)
T ss_pred             ceeecccc-CcccchhcceeeeeecCHHHHhc------------cccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHH
Confidence            99977644 33445677889999999999843            34679999999999999999999998876553110 


Q ss_pred             -------------hh---------------------------HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          502 -------------KM---------------------------KSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       502 -------------~~---------------------------~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                                   ..                           ....+...+|+.+||..||.+|+|++|.++.
T Consensus       238 ~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h  310 (359)
T KOG0660|consen  238 QLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH  310 (359)
T ss_pred             HHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence                         00                           0112337899999999999999999999875

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=9.1e-35  Score=295.00  Aligned_cols=229  Identities=24%  Similarity=0.404  Sum_probs=180.2

Q ss_pred             hcCCCccceecccCcEEEEEEEECC------------------ceEEEEEeccCC----hHHHHHHHHHHHhccccce--
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLLGD------------------REAAIKKMRSNK----SKEFFAELKVLCKIHHINV--  346 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~~~------------------~~vavK~~~~~~----~~~f~~Ei~~l~~l~H~ni--  346 (563)
                      .++|+..+.||+|+||.||++...+                  ..+|+|.+....    .++|.+|++++++++|+|+  
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            3578889999999999999987642                  458999987653    3578899999999999997  


Q ss_pred             -------------EEEeecCCCcccccccccc------cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCC
Q 044997          347 -------------FISTFGNGSLSDHLHDPLL------KGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSN  407 (563)
Q Consensus       347 -------------V~e~~~~gsL~~~L~~~~~------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~N  407 (563)
                                   ++||+++++|.+++.....      .....+++..++.++.|++.||+|||+++   ++||||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N  160 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence                         4688889999999865321      11236899999999999999999999987   9999999999


Q ss_pred             eEecCCCcEEEeecCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHH
Q 044997          408 ILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELI  487 (563)
Q Consensus       408 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ell  487 (563)
                      |++++++.+||+|||+++........ .......++..|+|||++...             .++.++||||||+++|||+
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~-------------~~~~~~Dv~slG~~l~el~  226 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYSSDYY-RVQGRAPLPIRWMAWESVLLG-------------KFTTKSDVWAFGVTLWEIL  226 (296)
T ss_pred             eeecCCCceEEccccceeecccCcce-eecCcCCCCceecCHHHhhcC-------------CCCccchhhhhHHHHHHHH
Confidence            99999999999999998754332211 122334567889999987543             3489999999999999999


Q ss_pred             c--CCCCCcCCCCCch------------------hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 044997          488 T--GKRALIRDDSEPT------------------KMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILS  536 (563)
Q Consensus       488 t--g~~p~~~~~~~~~------------------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  536 (563)
                      +  |..|+........                  .....+..+.+++.+||+.||.+||++.||++.|+
T Consensus       227 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         227 TLCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             hcCCCCCCCCcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence            8  5666643221110                  01112356899999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=4.1e-35  Score=309.22  Aligned_cols=221  Identities=27%  Similarity=0.382  Sum_probs=175.8

Q ss_pred             CCCccceecccCcEEEEEEEE--CCceEEEEEeccCC------hHHHHHHHHHHHhccccce---------------EEE
Q 044997          293 NFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNK------SKEFFAELKVLCKIHHINV---------------FIS  349 (563)
Q Consensus       293 ~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~------~~~f~~Ei~~l~~l~H~ni---------------V~e  349 (563)
                      .|+..+.||+|+||.||+|+.  .++.+|+|.++...      .+.+.+|++++++++|+||               |+|
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            578889999999999999987  46789999986432      3468899999999999997               579


Q ss_pred             eecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccccc
Q 044997          350 TFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEER  429 (563)
Q Consensus       350 ~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~  429 (563)
                      |+++|+|.+++..     ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++++||+|||+++....
T Consensus        82 ~~~gg~L~~~l~~-----~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~  153 (381)
T cd05626          82 YIPGGDMMSLLIR-----MEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRW  153 (381)
T ss_pred             cCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccccc
Confidence            9999999999864     346889999999999999999999987   99999999999999999999999999764311


Q ss_pred             cccc--------------------------------------------ccccccccCCCcccCccccccccccccccccc
Q 044997          430 TNEK--------------------------------------------EMLATRLVGTPGYLPPEYIFVKRFRFDMHSSV  465 (563)
Q Consensus       430 ~~~~--------------------------------------------~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~  465 (563)
                      ....                                            .......+||+.|+|||++.+..         
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~---------  224 (381)
T cd05626         154 THNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKG---------  224 (381)
T ss_pred             ccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCC---------
Confidence            0000                                            00112357999999999886544         


Q ss_pred             ccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCchhh--------------HHHHHHHHHHHHH--hhccCCCCCCCHH
Q 044997          466 MELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKM--------------KSLITIMAAVAEW--CLNEDAVDRPEMR  529 (563)
Q Consensus       466 ~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~~~--------------~~~~~~l~~li~~--cl~~dP~~RPs~~  529 (563)
                          ++.++|||||||++|||++|+.||..........              ..+...+.+++.+  |+..+|..||++.
T Consensus       225 ----~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~  300 (381)
T cd05626         225 ----YTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGAD  300 (381)
T ss_pred             ----CCCccceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHH
Confidence                4789999999999999999999997644321110              1234567888887  5566777799999


Q ss_pred             HHHHH
Q 044997          530 DIVAI  534 (563)
Q Consensus       530 evl~~  534 (563)
                      |++..
T Consensus       301 ~~l~h  305 (381)
T cd05626         301 DIKAH  305 (381)
T ss_pred             HHhcC
Confidence            99874

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=8.9e-36  Score=293.63  Aligned_cols=220  Identities=27%  Similarity=0.406  Sum_probs=172.8

Q ss_pred             CCCccceecccCcEEEEEEEEC--CceEEEEEeccCChHHHHHHHHHHHhccccceE--------------------EEe
Q 044997          293 NFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNKSKEFFAELKVLCKIHHINVF--------------------IST  350 (563)
Q Consensus       293 ~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~f~~Ei~~l~~l~H~niV--------------------~e~  350 (563)
                      .|...+++|.|+||.||+|...  ++.||||+.-.+.+ .--+|+++|+++.|||||                    +||
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r-~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVley  103 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR-YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEY  103 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC-cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHh
Confidence            3566799999999999999884  68899999865543 112599999999999995                    244


Q ss_pred             ecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCC-CcEEEeecCCCccccc
Q 044997          351 FGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDG-LRAKVADFGLVKLEER  429 (563)
Q Consensus       351 ~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~-~~~kl~DFGla~~~~~  429 (563)
                      |+. +|.+.++. ....++.++...+.-+..|+.+||.|||+++   |+||||||.|+|+|.+ |.+||||||.|+.+..
T Consensus       104 mP~-tL~~~~r~-~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~  178 (364)
T KOG0658|consen  104 MPE-TLYRVIRH-YTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVK  178 (364)
T ss_pred             chH-HHHHHHHH-HhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceeecc
Confidence            443 45444443 1223466888888889999999999999987   9999999999999976 9999999999998876


Q ss_pred             ccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCchh-------
Q 044997          430 TNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTK-------  502 (563)
Q Consensus       430 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~~-------  502 (563)
                      +...    .....|..|.|||.+.+..            .|+.+.||||.|||+.||+-|+.-|.++....+.       
T Consensus       179 ~epn----iSYicSRyYRaPELifga~------------~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~l  242 (364)
T KOG0658|consen  179 GEPN----ISYICSRYYRAPELIFGAT------------EYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVL  242 (364)
T ss_pred             CCCc----eeEEEeccccCHHHHcCcc------------ccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHh
Confidence            5432    2345678899999997754            4699999999999999999999888765432110       


Q ss_pred             --------------------------------hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          503 --------------------------------MKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       503 --------------------------------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                                                      .........+++.++++.+|.+|.++.|++..
T Consensus       243 G~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h  306 (364)
T KOG0658|consen  243 GTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH  306 (364)
T ss_pred             CCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence                                            01123348899999999999999999998864

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=3.7e-35  Score=296.04  Aligned_cols=227  Identities=24%  Similarity=0.351  Sum_probs=178.3

Q ss_pred             CCccceecccCcEEEEEEEEC-------CceEEEEEeccCC----hHHHHHHHHHHHhccccce---------------E
Q 044997          294 FDESRIIGRGGFGNVYFGLLG-------DREAAIKKMRSNK----SKEFFAELKVLCKIHHINV---------------F  347 (563)
Q Consensus       294 f~~~~~LG~G~fG~Vy~g~~~-------~~~vavK~~~~~~----~~~f~~Ei~~l~~l~H~ni---------------V  347 (563)
                      |...+.||+|+||.||+|...       +..||+|+++...    .+.|.+|+.++.+++||||               +
T Consensus         7 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~   86 (283)
T cd05091           7 VRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMI   86 (283)
T ss_pred             HHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEE
Confidence            556788999999999999863       3679999997543    2568889999999999998               3


Q ss_pred             EEeecCCCcccccccccc-----------cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcE
Q 044997          348 ISTFGNGSLSDHLHDPLL-----------KGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRA  416 (563)
Q Consensus       348 ~e~~~~gsL~~~L~~~~~-----------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~  416 (563)
                      ++|+.+++|.+++.....           .....+++..+..++.|++.||+|||+++   ++||||||+||++++++.+
T Consensus        87 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~  163 (283)
T cd05091          87 FSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLNV  163 (283)
T ss_pred             EEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCce
Confidence            578888999888753210           11245899999999999999999999997   9999999999999999999


Q ss_pred             EEeecCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCCCcC
Q 044997          417 KVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIR  495 (563)
Q Consensus       417 kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p~~~  495 (563)
                      ||+|||+++........ .......+++.|+|||.+.+.             .++.++||||||+++|||++ |..|+..
T Consensus       164 kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~-------------~~~~~~Dv~slG~~l~el~~~g~~p~~~  229 (283)
T cd05091         164 KISDLGLFREVYAADYY-KLMGNSLLPIRWMSPEAIMYG-------------KFSIDSDIWSYGVVLWEVFSYGLQPYCG  229 (283)
T ss_pred             Eecccccccccccchhe-eeccCccCCccccCHHHHhcC-------------CCCcchhHHHHHHHHHHHHcCCCCCCCC
Confidence            99999998865433211 112233467889999987543             34889999999999999998 7777754


Q ss_pred             CCCCc-----------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 044997          496 DDSEP-----------TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQ  537 (563)
Q Consensus       496 ~~~~~-----------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  537 (563)
                      .....           ......++.+.+++.+||+.+|.+||++.+|+..|+.
T Consensus       230 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         230 YSNQDVIEMIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             CCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence            32210           1112345568999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-34  Score=289.19  Aligned_cols=222  Identities=26%  Similarity=0.412  Sum_probs=179.9

Q ss_pred             cCCCccceecccCcEEEEEEEE--CCceEEEEEeccCC--------hHHHHHHHHHHHhccccce---------------
Q 044997          292 NNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNK--------SKEFFAELKVLCKIHHINV---------------  346 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~--------~~~f~~Ei~~l~~l~H~ni---------------  346 (563)
                      ++|+..+.||+|++|.||++..  .++++|+|.+....        .+.+.+|++++++++||||               
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            5788999999999999999976  46899999876431        2468889999999999997               


Q ss_pred             EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcc
Q 044997          347 FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKL  426 (563)
Q Consensus       347 V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~  426 (563)
                      |+||+++++|.+++..     ...+++.....++.|++.||.|||+.+   ++||||||+||++++++++||+|||+++.
T Consensus        82 v~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~  153 (263)
T cd06625          82 FMEYMPGGSVKDQLKA-----YGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR  153 (263)
T ss_pred             EEEECCCCcHHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeccccee
Confidence            4688999999888864     346889999999999999999999987   99999999999999999999999999875


Q ss_pred             cccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc------
Q 044997          427 EERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP------  500 (563)
Q Consensus       427 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~------  500 (563)
                      ...............|+..|+|||.+.+..             ++.++||||||+++|||++|+.||...+...      
T Consensus       154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-------------~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~  220 (263)
T cd06625         154 LQTICSSGTGMKSVTGTPYWMSPEVISGEG-------------YGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIA  220 (263)
T ss_pred             ccccccccccccCCCcCccccCcceeccCC-------------CCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHh
Confidence            433211111112345788999999885443             4789999999999999999999986543211      


Q ss_pred             ------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          501 ------TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       501 ------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                            .........+.+++.+||..+|.+||++.|+++.
T Consensus       221 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         221 TQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             ccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence                  1122345668999999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=1.2e-34  Score=290.30  Aligned_cols=228  Identities=21%  Similarity=0.340  Sum_probs=174.2

Q ss_pred             ceecccCcEEEEEEEECC----ceEEEEEeccCC----hHHHHHHHHHHHhccccce---------------EEEeecCC
Q 044997          298 RIIGRGGFGNVYFGLLGD----REAAIKKMRSNK----SKEFFAELKVLCKIHHINV---------------FISTFGNG  354 (563)
Q Consensus       298 ~~LG~G~fG~Vy~g~~~~----~~vavK~~~~~~----~~~f~~Ei~~l~~l~H~ni---------------V~e~~~~g  354 (563)
                      +.||+|+||.||+|...+    ..+|+|+++...    ...|.+|+.++++++||||               |+||+++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            368999999999998642    468999887543    2468889999999999997               57999999


Q ss_pred             CcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccccccccc
Q 044997          355 SLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKE  434 (563)
Q Consensus       355 sL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~  434 (563)
                      +|.+++...........++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||+++....... .
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~-~  156 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDY-Y  156 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcce-e
Confidence            9999997532222345778888899999999999999987   99999999999999999999999999875432211 1


Q ss_pred             cccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCCCcCCCCCchh-----------
Q 044997          435 MLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIRDDSEPTK-----------  502 (563)
Q Consensus       435 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p~~~~~~~~~~-----------  502 (563)
                      .......++..|+|||++.....      ......++.++||||||+++|||++ |+.||.........           
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~------~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~  230 (269)
T cd05087         157 VTPDQLWVPLRWIAPELVDEVHG------NLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKL  230 (269)
T ss_pred             ecCCCcCCcccccCHhHhccccc------cccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCC
Confidence            11223457888999998853221      0112245889999999999999996 99898543221110           


Q ss_pred             -----hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 044997          503 -----MKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILS  536 (563)
Q Consensus       503 -----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  536 (563)
                           .....+.+.+++.+|| .+|++||+++||+..|+
T Consensus       231 ~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         231 PKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             CCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence                 0122345788999999 68999999999998875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=3.5e-35  Score=302.82  Aligned_cols=212  Identities=25%  Similarity=0.380  Sum_probs=171.9

Q ss_pred             CCCccceecccCcEEEEEEEEC--CceEEEEEeccC------ChHHHHHHHHHHHhccccc-e---------------EE
Q 044997          293 NFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSN------KSKEFFAELKVLCKIHHIN-V---------------FI  348 (563)
Q Consensus       293 ~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~------~~~~f~~Ei~~l~~l~H~n-i---------------V~  348 (563)
                      +|+..+.||+|+||.||+|+..  ++.+|+|.++..      ..+.+..|.+++..++|++ |               |+
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            4778899999999999999875  568999998642      2356788999999998765 3               57


Q ss_pred             EeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccc
Q 044997          349 STFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEE  428 (563)
Q Consensus       349 e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~  428 (563)
                      ||+++|+|.+++..     ...+++..+..++.|++.||+|||+++   |+||||||+|||+++++.+||+|||+++...
T Consensus        81 E~~~~g~L~~~~~~-----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~  152 (324)
T cd05587          81 EYVNGGDLMYHIQQ-----VGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENI  152 (324)
T ss_pred             cCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecC
Confidence            88999999888864     346899999999999999999999987   9999999999999999999999999987432


Q ss_pred             cccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc--------
Q 044997          429 RTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP--------  500 (563)
Q Consensus       429 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~--------  500 (563)
                      ...   .......||+.|+|||++.+..             ++.++|||||||++|||++|+.||.......        
T Consensus       153 ~~~---~~~~~~~gt~~y~aPE~~~~~~-------------~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~  216 (324)
T cd05587         153 FGG---KTTRTFCGTPDYIAPEIIAYQP-------------YGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEH  216 (324)
T ss_pred             CCC---CceeeecCCccccChhhhcCCC-------------CCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcC
Confidence            111   1123356899999999986544             3789999999999999999999996543211        


Q ss_pred             --hhhHHHHHHHHHHHHHhhccCCCCCCCH
Q 044997          501 --TKMKSLITIMAAVAEWCLNEDAVDRPEM  528 (563)
Q Consensus       501 --~~~~~~~~~l~~li~~cl~~dP~~RPs~  528 (563)
                        .....+...+.+++.+||+.||.+||+.
T Consensus       217 ~~~~~~~~~~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         217 NVSYPKSLSKEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             CCCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence              1112345568899999999999999976

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=7.6e-35  Score=293.91  Aligned_cols=214  Identities=22%  Similarity=0.360  Sum_probs=172.0

Q ss_pred             ecccCcEEEEEEEE--CCceEEEEEeccCC------hHHHHHHHHHHHhccccce---------------EEEeecCCCc
Q 044997          300 IGRGGFGNVYFGLL--GDREAAIKKMRSNK------SKEFFAELKVLCKIHHINV---------------FISTFGNGSL  356 (563)
Q Consensus       300 LG~G~fG~Vy~g~~--~~~~vavK~~~~~~------~~~f~~Ei~~l~~l~H~ni---------------V~e~~~~gsL  356 (563)
                      ||+|+||.||++..  +++.+|+|.+....      .+.+..|++++++++|+||               |+||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            69999999999977  46889999986432      2457789999999999997               5799999999


Q ss_pred             ccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccccccccccc
Q 044997          357 SDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEML  436 (563)
Q Consensus       357 ~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~  436 (563)
                      .+++.... .....+++..+..++.|++.||+|||+++   ++||||||+||++++++.+||+|||+++.......   .
T Consensus        81 ~~~~~~~~-~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~---~  153 (280)
T cd05608          81 RYHIYNVD-EENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS---K  153 (280)
T ss_pred             HHHHHhcc-ccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc---c
Confidence            88875421 23456899999999999999999999987   99999999999999999999999999875433221   1


Q ss_pred             cccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCch--------------h
Q 044997          437 ATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPT--------------K  502 (563)
Q Consensus       437 ~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~--------------~  502 (563)
                      .....||+.|+|||.+.+..             ++.++|||||||++|||++|+.||........              .
T Consensus       154 ~~~~~g~~~y~aPE~~~~~~-------------~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  220 (280)
T cd05608         154 TKGYAGTPGFMAPELLQGEE-------------YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTY  220 (280)
T ss_pred             ccccCCCcCccCHHHhcCCC-------------CCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCC
Confidence            22356899999999886544             47899999999999999999999975432111              0


Q ss_pred             hHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 044997          503 MKSLITIMAAVAEWCLNEDAVDRP-----EMRDIVA  533 (563)
Q Consensus       503 ~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  533 (563)
                      ...+...+.+++.+||+.||++||     +++++++
T Consensus       221 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~  256 (280)
T cd05608         221 PDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT  256 (280)
T ss_pred             cccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence            122455689999999999999999     5566665

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=6.8e-35  Score=297.61  Aligned_cols=236  Identities=22%  Similarity=0.375  Sum_probs=184.9

Q ss_pred             hcCCCccceecccCcEEEEEEEEC---------CceEEEEEeccCC----hHHHHHHHHHHHhc-cccce----------
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLLG---------DREAAIKKMRSNK----SKEFFAELKVLCKI-HHINV----------  346 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~~---------~~~vavK~~~~~~----~~~f~~Ei~~l~~l-~H~ni----------  346 (563)
                      .++|...+.||+|+||.||+++..         +..+|+|.++...    .+++.+|+++++++ +|+||          
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   93 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   93 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence            456778899999999999999741         2468999886532    35688999999999 89997          


Q ss_pred             -----EEEeecCCCccccccccccc-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEe
Q 044997          347 -----FISTFGNGSLSDHLHDPLLK-----------GHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILL  410 (563)
Q Consensus       347 -----V~e~~~~gsL~~~L~~~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl  410 (563)
                           |+||+++|+|.+++......           ....++|.++..++.|++.||.|||+++   ++||||||+||++
T Consensus        94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nili  170 (304)
T cd05101          94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLV  170 (304)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEEE
Confidence                 57999999999998753110           1245899999999999999999999997   9999999999999


Q ss_pred             cCCCcEEEeecCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-C
Q 044997          411 DDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-G  489 (563)
Q Consensus       411 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g  489 (563)
                      ++++.+||+|||+++......... ......++..|+|||++.+..             ++.++||||||+++||+++ |
T Consensus       171 ~~~~~~kl~D~g~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~-------------~~~~~Di~slG~~l~el~~~g  236 (304)
T cd05101         171 TENNVMKIADFGLARDVNNIDYYK-KTTNGRLPVKWMAPEALFDRV-------------YTHQSDVWSFGVLMWEIFTLG  236 (304)
T ss_pred             cCCCcEEECCCccceecccccccc-cccCCCCCceeeCchhhccCC-------------CCchhhHHHHHHHHHHHHcCC
Confidence            999999999999998654322111 112234567899999875443             4789999999999999998 6


Q ss_pred             CCCCcCCCCCc-----------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcCh
Q 044997          490 KRALIRDDSEP-----------TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITST  543 (563)
Q Consensus       490 ~~p~~~~~~~~-----------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~  543 (563)
                      ..|+.......           .........+.+++.+||+.+|.+||++.|+++.|.+++....
T Consensus       237 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~~  301 (304)
T cd05101         237 GSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLTT  301 (304)
T ss_pred             CCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhhh
Confidence            77764332111           1112234568999999999999999999999999999887544

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=3.4e-35  Score=301.25  Aligned_cols=237  Identities=24%  Similarity=0.385  Sum_probs=188.3

Q ss_pred             HhcCCCccceecccCcEEEEEEEE--CCceEEEEEeccC------ChHHHHHHHHHHHhccccce---------------
Q 044997          290 ATNNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSN------KSKEFFAELKVLCKIHHINV---------------  346 (563)
Q Consensus       290 ~~~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~------~~~~f~~Ei~~l~~l~H~ni---------------  346 (563)
                      ..++|+..+.||+|+||+||+++.  .|..+|+|++++.      +.+..+.|-++|...++++|               
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL  218 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL  218 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence            457899999999999999999976  4788999999764      33567889999999988887               


Q ss_pred             EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcc
Q 044997          347 FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKL  426 (563)
Q Consensus       347 V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~  426 (563)
                      ||||+++|++...|..     ...|+......++.+++.|++-||.+|   ||||||||+|+|||..|++||+||||++.
T Consensus       219 iMEylPGGD~mTLL~~-----~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~g  290 (550)
T KOG0605|consen  219 IMEYLPGGDMMTLLMR-----KDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTG  290 (550)
T ss_pred             EEEecCCccHHHHHHh-----cCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccch
Confidence            6899999999999875     467999999999999999999999998   99999999999999999999999999863


Q ss_pred             ccccc---------------------ccc-----------------------cccccccCCCcccCcccccccccccccc
Q 044997          427 EERTN---------------------EKE-----------------------MLATRLVGTPGYLPPEYIFVKRFRFDMH  462 (563)
Q Consensus       427 ~~~~~---------------------~~~-----------------------~~~~~~~gt~~y~APE~l~~~~~~~~~~  462 (563)
                      +....                     +..                       ...-..+|||.|||||++.+..|     
T Consensus       291 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY-----  365 (550)
T KOG0605|consen  291 LDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGY-----  365 (550)
T ss_pred             hhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCC-----
Confidence            32100                     000                       00112489999999999987766     


Q ss_pred             cccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCchhh--------------HHHHHHHHHHHHHhhccCCCCCCCH
Q 044997          463 SSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKM--------------KSLITIMAAVAEWCLNEDAVDRPEM  528 (563)
Q Consensus       463 ~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~~~--------------~~~~~~l~~li~~cl~~dP~~RPs~  528 (563)
                              +..+|+||+||||||||.|-+||..+.......              ..+.++..+||.+|+. ||++|--.
T Consensus       366 --------~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~  436 (550)
T KOG0605|consen  366 --------GKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGS  436 (550)
T ss_pred             --------CccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCc
Confidence                    789999999999999999999998776532211              1234668999999999 99999763


Q ss_pred             HHHHHHHHHhhhcChhhhcc
Q 044997          529 RDIVAILSQIMITSTEWEAS  548 (563)
Q Consensus       529 ~evl~~L~~i~~~~~~w~~~  548 (563)
                      .-+-+.-..-.-...+|+--
T Consensus       437 ~G~~EIK~HPfF~~v~W~~l  456 (550)
T KOG0605|consen  437 KGAEEIKKHPFFKGVDWDHL  456 (550)
T ss_pred             ccHHHHhcCCccccCCcchh
Confidence            33333333334455677654

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=3.9e-35  Score=293.82  Aligned_cols=228  Identities=27%  Similarity=0.444  Sum_probs=182.1

Q ss_pred             HHhcCCCccceecccCcEEEEEEEE--CCceEEEEEeccC--ChHHHHHHHHHHHhc-cccce-----------------
Q 044997          289 EATNNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSN--KSKEFFAELKVLCKI-HHINV-----------------  346 (563)
Q Consensus       289 ~~~~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~--~~~~f~~Ei~~l~~l-~H~ni-----------------  346 (563)
                      .+++.|+..+.||+|+||.||+|..  .++.+|+|.+...  ...++.+|+.++.++ +|+|+                 
T Consensus         3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (272)
T cd06637           3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD   82 (272)
T ss_pred             ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence            4567788889999999999999987  4678999998644  345788999999998 69886                 


Q ss_pred             ----EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecC
Q 044997          347 ----FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFG  422 (563)
Q Consensus       347 ----V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFG  422 (563)
                          ++||+++|+|.+++...   ....++|..+..++.|++.||+|||+++   ++||||||+||++++++.+||+|||
T Consensus        83 ~~~iv~e~~~~~~L~~~l~~~---~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg  156 (272)
T cd06637          83 QLWLVMEFCGAGSVTDLIKNT---KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFG  156 (272)
T ss_pred             EEEEEEEcCCCCcHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCC
Confidence                46788889999988752   2456899999999999999999999987   9999999999999999999999999


Q ss_pred             CCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc--
Q 044997          423 LVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP--  500 (563)
Q Consensus       423 la~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~--  500 (563)
                      +++.......   ......|+..|+|||++.....        ....++.++|||||||++|||++|+.||.......  
T Consensus       157 ~~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~--------~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~  225 (272)
T cd06637         157 VSAQLDRTVG---RRNTFIGTPYWMAPEVIACDEN--------PDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL  225 (272)
T ss_pred             Cceecccccc---cCCcccccccccCHhHhccccC--------cCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHH
Confidence            9875432211   1233568899999998854321        13346889999999999999999999985432111  


Q ss_pred             ----------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          501 ----------TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       501 ----------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                                .........+.+++.+||..||.+||++.++++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         226 FLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             HHHhcCCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence                      011223456899999999999999999999975

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=1.2e-34  Score=295.86  Aligned_cols=228  Identities=22%  Similarity=0.394  Sum_probs=182.7

Q ss_pred             hcCCCccceecccCcEEEEEEEEC-------CceEEEEEeccCC----hHHHHHHHHHHHhc-cccce------------
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLLG-------DREAAIKKMRSNK----SKEFFAELKVLCKI-HHINV------------  346 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~~-------~~~vavK~~~~~~----~~~f~~Ei~~l~~l-~H~ni------------  346 (563)
                      .++|...+.||+|+||.||++...       +..+|+|.++...    .+.+.+|+++++++ +|+||            
T Consensus        34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  113 (302)
T cd05055          34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP  113 (302)
T ss_pred             HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence            356888999999999999999741       3478999887543    35688999999999 79997            


Q ss_pred             ---EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCC
Q 044997          347 ---FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGL  423 (563)
Q Consensus       347 ---V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGl  423 (563)
                         ++||+.+|+|.+++...   ....+++.++..++.|++.||+|||+++   ++|+||||+|||++.++.+|++|||+
T Consensus       114 ~~lv~e~~~~~~L~~~i~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~  187 (302)
T cd05055         114 ILVITEYCCYGDLLNFLRRK---RESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGL  187 (302)
T ss_pred             eEEEEEcCCCCcHHHHHHhC---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcc
Confidence               57899999999998652   2234899999999999999999999987   99999999999999999999999999


Q ss_pred             CcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCCCcCCCCCchh
Q 044997          424 VKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIRDDSEPTK  502 (563)
Q Consensus       424 a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p~~~~~~~~~~  502 (563)
                      ++........ .......++..|+|||.+.+..             ++.++|||||||++|||++ |+.||.........
T Consensus       188 ~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~-------------~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~  253 (302)
T cd05055         188 ARDIMNDSNY-VVKGNARLPVKWMAPESIFNCV-------------YTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKF  253 (302)
T ss_pred             cccccCCCce-eecCCCCcccccCCHhhhccCC-------------CCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHH
Confidence            9855332211 1112234577899999875443             4889999999999999998 88887654322111


Q ss_pred             ------------hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 044997          503 ------------MKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQI  538 (563)
Q Consensus       503 ------------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  538 (563)
                                  .......+.+++.+||+.+|++||++.|+++.|+++
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         254 YKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             HHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence                        112345689999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=1.7e-35  Score=305.34  Aligned_cols=213  Identities=24%  Similarity=0.379  Sum_probs=173.6

Q ss_pred             ceecccCcEEEEEEEE--CCceEEEEEeccC------ChHHHHHHHHHHHhccccce---------------EEEeecCC
Q 044997          298 RIIGRGGFGNVYFGLL--GDREAAIKKMRSN------KSKEFFAELKVLCKIHHINV---------------FISTFGNG  354 (563)
Q Consensus       298 ~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~------~~~~f~~Ei~~l~~l~H~ni---------------V~e~~~~g  354 (563)
                      +.||+|+||.||++..  .++.+|+|.++..      ...++.+|++++.+++||||               |+||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            4699999999999986  4788999998643      23567789999999999997               68999999


Q ss_pred             CcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCceEeCCCCCCCeEecCCCcEEEeecCCCccccccccc
Q 044997          355 SLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHD-HTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEK  433 (563)
Q Consensus       355 sL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~  433 (563)
                      +|.+++..     ...+++..+..++.|++.||+|||+ .+   |+||||||+|||+++++.+||+|||+++....... 
T Consensus        81 ~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-  151 (325)
T cd05594          81 ELFFHLSR-----ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-  151 (325)
T ss_pred             cHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc-
Confidence            99888764     3568999999999999999999997 55   99999999999999999999999999874322111 


Q ss_pred             ccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCch----------hh
Q 044997          434 EMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPT----------KM  503 (563)
Q Consensus       434 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~----------~~  503 (563)
                        ......||+.|+|||++.+..             ++.++|||||||++|||++|+.||........          ..
T Consensus       152 --~~~~~~gt~~y~aPE~~~~~~-------------~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p  216 (325)
T cd05594         152 --TMKTFCGTPEYLAPEVLEDND-------------YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP  216 (325)
T ss_pred             --ccccccCCcccCCHHHHccCC-------------CCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCC
Confidence              122356999999999885544             47899999999999999999999965433111          11


Q ss_pred             HHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 044997          504 KSLITIMAAVAEWCLNEDAVDRP-----EMRDIVAI  534 (563)
Q Consensus       504 ~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  534 (563)
                      ..+...+.+++.+||+.||++|+     ++.++++.
T Consensus       217 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         217 RTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             CCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence            23456689999999999999996     89988754

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=7.4e-35  Score=293.21  Aligned_cols=229  Identities=27%  Similarity=0.421  Sum_probs=179.4

Q ss_pred             hcCCCccceecccCcEEEEEEEECC-------ceEEEEEeccCC----hHHHHHHHHHHHhccccce-------------
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLLGD-------REAAIKKMRSNK----SKEFFAELKVLCKIHHINV-------------  346 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~~~-------~~vavK~~~~~~----~~~f~~Ei~~l~~l~H~ni-------------  346 (563)
                      +++|...+.||+|+||.||+|.+.+       ..||+|.++...    ...|.+|+.++++++|+||             
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   84 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR   84 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence            4668889999999999999998843       568999886433    3468999999999999997             


Q ss_pred             --EEEeecCCCccccccccccc--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCC---cEEEe
Q 044997          347 --FISTFGNGSLSDHLHDPLLK--GHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGL---RAKVA  419 (563)
Q Consensus       347 --V~e~~~~gsL~~~L~~~~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~---~~kl~  419 (563)
                        |+||+++|+|.+++......  ....++|.++++++.|++.||+|||+.+   ++||||||+||+++.++   .+||+
T Consensus        85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~  161 (277)
T cd05036          85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIA  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEec
Confidence              57899999999998653211  1235899999999999999999999987   99999999999998654   69999


Q ss_pred             ecCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCCCcCCCC
Q 044997          420 DFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIRDDS  498 (563)
Q Consensus       420 DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p~~~~~~  498 (563)
                      |||+++........ ........+..|+|||++.+..             ++.++|||||||++|||++ |+.||.....
T Consensus       162 dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~-------------~~~~~DiwslG~il~el~~~g~~pf~~~~~  227 (277)
T cd05036         162 DFGMARDIYRASYY-RKGGRAMLPIKWMPPEAFLDGI-------------FTSKTDVWSFGVLLWEIFSLGYMPYPGRTN  227 (277)
T ss_pred             cCccccccCCccce-ecCCCCCccHhhCCHHHHhcCC-------------cCchhHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence            99999865322111 1111223456899999875443             4899999999999999997 8888864332


Q ss_pred             Cc-----------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 044997          499 EP-----------TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILS  536 (563)
Q Consensus       499 ~~-----------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  536 (563)
                      ..           .....++..+.+++.+||+.+|++||++.+|++.|.
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         228 QEVMEFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence            11           111223456889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=6.1e-35  Score=305.86  Aligned_cols=222  Identities=24%  Similarity=0.383  Sum_probs=174.3

Q ss_pred             cCCCccceecccCcEEEEEEEEC--CceEEEEEeccCC------hHHHHHHHHHHHhccccce---------------EE
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNK------SKEFFAELKVLCKIHHINV---------------FI  348 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~------~~~f~~Ei~~l~~l~H~ni---------------V~  348 (563)
                      ++|+..+.||+|+||.||+++..  ++.+|+|.++...      ...+.+|++++.+++|+||               |+
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            46888999999999999999874  6889999986532      2457889999999999987               57


Q ss_pred             EeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccc
Q 044997          349 STFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEE  428 (563)
Q Consensus       349 e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~  428 (563)
                      ||+++|+|.+++..     ...+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus        81 E~~~gg~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~  152 (363)
T cd05628          81 EFLPGGDMMTLLMK-----KDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLK  152 (363)
T ss_pred             cCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccc
Confidence            99999999999864     356899999999999999999999997   9999999999999999999999999987543


Q ss_pred             ccccc--------------------------------ccccccccCCCcccCcccccccccccccccccccCCCCCcchH
Q 044997          429 RTNEK--------------------------------EMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDV  476 (563)
Q Consensus       429 ~~~~~--------------------------------~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDV  476 (563)
                      .....                                .......+||+.|+|||++.+..             ++.++||
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-------------~~~~~Dv  219 (363)
T cd05628         153 KAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTG-------------YNKLCDW  219 (363)
T ss_pred             ccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCC-------------CCCchhh
Confidence            21100                                00112357999999999986544             4789999


Q ss_pred             HHHHHHHHHHHcCCCCCcCCCCCchhh--------------HHHHHHHHHHHHHhhc--cCCCCCCCHHHHHHH
Q 044997          477 FAFGVVLAELITGKRALIRDDSEPTKM--------------KSLITIMAAVAEWCLN--EDAVDRPEMRDIVAI  534 (563)
Q Consensus       477 wSfGvvl~Elltg~~p~~~~~~~~~~~--------------~~~~~~l~~li~~cl~--~dP~~RPs~~evl~~  534 (563)
                      |||||++|||++|+.||..........              ..+.+.+.+++.+++.  .++..||+++||++.
T Consensus       220 wSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h  293 (363)
T cd05628         220 WSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN  293 (363)
T ss_pred             hhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence            999999999999999997543211100              1123457777777443  344457899999875

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=1.2e-34  Score=287.19  Aligned_cols=220  Identities=29%  Similarity=0.438  Sum_probs=181.1

Q ss_pred             CCCccceecccCcEEEEEEEE--CCceEEEEEeccC-----ChHHHHHHHHHHHhccccce---------------EEEe
Q 044997          293 NFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSN-----KSKEFFAELKVLCKIHHINV---------------FIST  350 (563)
Q Consensus       293 ~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~-----~~~~f~~Ei~~l~~l~H~ni---------------V~e~  350 (563)
                      +|+..+.||+|++|.||+|..  +++.+++|.+...     ..+++.+|++++++++|||+               |+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            477789999999999999987  4688999987632     24678899999999999997               5799


Q ss_pred             ecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccccc
Q 044997          351 FGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERT  430 (563)
Q Consensus       351 ~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~  430 (563)
                      +++++|.+++...   ....+++..+..++.|++.||.|||+.+   ++|+||||+||++++++.+||+|||+++.....
T Consensus        81 ~~~~~L~~~l~~~---~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~  154 (256)
T cd08529          81 AENGDLHKLLKMQ---RGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN  154 (256)
T ss_pred             CCCCcHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCc
Confidence            9999999998752   2457899999999999999999999987   999999999999999999999999998865432


Q ss_pred             cccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc----------
Q 044997          431 NEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP----------  500 (563)
Q Consensus       431 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~----------  500 (563)
                      ..   ......|+..|+|||++.+..             ++.++||||||+++|||++|+.||.......          
T Consensus       155 ~~---~~~~~~~~~~y~aPE~~~~~~-------------~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~  218 (256)
T cd08529         155 TN---FANTIVGTPYYLSPELCEDKP-------------YNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVF  218 (256)
T ss_pred             cc---hhhccccCccccCHHHhcCCC-------------CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC
Confidence            21   122346888999999875443             4789999999999999999999986544211          


Q ss_pred             -hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          501 -TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       501 -~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                       .....+...+.+++.+||+.+|++||++.++++.
T Consensus       219 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         219 PPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             CCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence             1112344568999999999999999999999863

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-35  Score=308.79  Aligned_cols=220  Identities=26%  Similarity=0.412  Sum_probs=176.6

Q ss_pred             cCCCccceecccCcEEEEEEEE--CCceEEEEEeccC------ChHHHHHHHHHHHhccccce---------------EE
Q 044997          292 NNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSN------KSKEFFAELKVLCKIHHINV---------------FI  348 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~------~~~~f~~Ei~~l~~l~H~ni---------------V~  348 (563)
                      ++|+..+.||+|+||.||+++.  .++.||||.++..      ..+.+.+|+++|..++|+||               |+
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            4788899999999999999987  4688999998643      23457889999999999997               57


Q ss_pred             EeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccc
Q 044997          349 STFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEE  428 (563)
Q Consensus       349 e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~  428 (563)
                      ||+++|+|.+++..     ...+++..+..++.|++.||+|||+++   ++||||||+|||++.++.+||+|||+++...
T Consensus        81 E~~~~g~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  152 (364)
T cd05599          81 EYLPGGDMMTLLMK-----KDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLK  152 (364)
T ss_pred             CCCCCcHHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecc
Confidence            99999999999864     346899999999999999999999997   9999999999999999999999999987543


Q ss_pred             cccccc-----------------------------------cccccccCCCcccCcccccccccccccccccccCCCCCc
Q 044997          429 RTNEKE-----------------------------------MLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTK  473 (563)
Q Consensus       429 ~~~~~~-----------------------------------~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~k  473 (563)
                      ......                                   ......+||+.|+|||++....             ++.+
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------------~~~~  219 (364)
T cd05599         153 KSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTG-------------YNKE  219 (364)
T ss_pred             ccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCC-------------CCCe
Confidence            211000                                   0011246999999999885443             4889


Q ss_pred             chHHHHHHHHHHHHcCCCCCcCCCCCch--------------hhHHHHHHHHHHHHHhhccCCCCCCC---HHHHHH
Q 044997          474 TDVFAFGVVLAELITGKRALIRDDSEPT--------------KMKSLITIMAAVAEWCLNEDAVDRPE---MRDIVA  533 (563)
Q Consensus       474 sDVwSfGvvl~Elltg~~p~~~~~~~~~--------------~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl~  533 (563)
                      +|||||||++|||++|+.||........              ....+.+.+.+++.+|+. +|.+|++   +.|+++
T Consensus       220 ~DiwSlG~il~el~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~  295 (364)
T cd05599         220 CDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS  295 (364)
T ss_pred             eeeecchhHHHHhhcCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence            9999999999999999999965432110              001234568899999996 9999998   777765

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=5.3e-35  Score=290.20  Aligned_cols=221  Identities=26%  Similarity=0.455  Sum_probs=181.8

Q ss_pred             cCCCccceecccCcEEEEEEEECCceEEEEEeccCC-hHHHHHHHHHHHhccccce--------------EEEeecCCCc
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLGDREAAIKKMRSNK-SKEFFAELKVLCKIHHINV--------------FISTFGNGSL  356 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~~~~vavK~~~~~~-~~~f~~Ei~~l~~l~H~ni--------------V~e~~~~gsL  356 (563)
                      ++|...+.||+|+||.||+|...++.+|+|.++... .+.+.+|+.++++++|+|+              ++||+++|+|
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~v~e~~~~~~L   85 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILHNGLYIVMELMSKGNL   85 (254)
T ss_pred             HHceeeeeeccCCCCceEecccCCCceEEEeecCcchHHHHHHHHHHHHhCCCCCcCeEEEEEcCCCcEEEEECCCCCCH
Confidence            457888999999999999999999999999987653 4678999999999999996              5799999999


Q ss_pred             ccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccccccccccc
Q 044997          357 SDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEML  436 (563)
Q Consensus       357 ~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~  436 (563)
                      .+++...   ....+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++......     
T Consensus        86 ~~~l~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~-----  154 (254)
T cd05083          86 VNFLRTR---GRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV-----  154 (254)
T ss_pred             HHHHHhc---CcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccccC-----
Confidence            9998752   3346899999999999999999999987   9999999999999999999999999987533211     


Q ss_pred             cccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCCCcCCCCCc-----------hhhH
Q 044997          437 ATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIRDDSEP-----------TKMK  504 (563)
Q Consensus       437 ~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p~~~~~~~~-----------~~~~  504 (563)
                       .....+..|+|||.+.+.             .++.++||||||+++|||++ |+.||.......           ....
T Consensus       155 -~~~~~~~~y~~pe~~~~~-------------~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  220 (254)
T cd05083         155 -DNSKLPVKWTAPEALKHK-------------KFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPE  220 (254)
T ss_pred             -CCCCCCceecCHHHhccC-------------CcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCCCC
Confidence             122345679999987543             34789999999999999998 888875443211           1112


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 044997          505 SLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQ  537 (563)
Q Consensus       505 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  537 (563)
                      ..+..+.+++.+||+.+|.+||++.++++.|++
T Consensus       221 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         221 GCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence            334568899999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=8.8e-35  Score=291.12  Aligned_cols=226  Identities=27%  Similarity=0.453  Sum_probs=180.0

Q ss_pred             CCCccceecccCcEEEEEEEEC--C---ceEEEEEeccCC----hHHHHHHHHHHHhccccce---------------EE
Q 044997          293 NFDESRIIGRGGFGNVYFGLLG--D---REAAIKKMRSNK----SKEFFAELKVLCKIHHINV---------------FI  348 (563)
Q Consensus       293 ~f~~~~~LG~G~fG~Vy~g~~~--~---~~vavK~~~~~~----~~~f~~Ei~~l~~l~H~ni---------------V~  348 (563)
                      +|+..+.||+|+||.||+|...  +   ..+|||.++...    .++|..|++++++++||||               |+
T Consensus         5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   84 (269)
T cd05065           5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT   84 (269)
T ss_pred             HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence            4677899999999999999874  2   359999987542    3579999999999999997               57


Q ss_pred             EeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccc
Q 044997          349 STFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEE  428 (563)
Q Consensus       349 e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~  428 (563)
                      ||+++|+|.+++...    ...+++.+++.++.|++.||+|||+++   ++||||||+||+++.++.+||+|||+++...
T Consensus        85 e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~  157 (269)
T cd05065          85 EFMENGALDSFLRQN----DGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLE  157 (269)
T ss_pred             ecCCCCcHHHHHhhC----CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccc
Confidence            999999999988652    346899999999999999999999987   9999999999999999999999999987654


Q ss_pred             ccccccccccccc--CCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCCCcCCCCCc-----
Q 044997          429 RTNEKEMLATRLV--GTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIRDDSEP-----  500 (563)
Q Consensus       429 ~~~~~~~~~~~~~--gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p~~~~~~~~-----  500 (563)
                      .............  .+..|+|||++.+..             ++.++||||||+++||+++ |+.||.......     
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-------------~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i  224 (269)
T cd05065         158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRK-------------FTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAI  224 (269)
T ss_pred             cCccccccccccCCCcceeecCHhHhccCc-------------ccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHH
Confidence            3222111111111  245799999875443             4789999999999999986 999986433211     


Q ss_pred             ------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 044997          501 ------TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQI  538 (563)
Q Consensus       501 ------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  538 (563)
                            ......+..+.+++.+||+.+|.+||++.+|+..|+++
T Consensus       225 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         225 EQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             HcCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                  11123345689999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=6.8e-35  Score=312.82  Aligned_cols=223  Identities=22%  Similarity=0.329  Sum_probs=172.3

Q ss_pred             HhcCCCccceecccCcEEEEEEEE--CCceEEEEEeccCChHHHHHHHHHHHhccccceE--------------------
Q 044997          290 ATNNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNKSKEFFAELKVLCKIHHINVF--------------------  347 (563)
Q Consensus       290 ~~~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~~~~f~~Ei~~l~~l~H~niV--------------------  347 (563)
                      ..++|...+.||+|+||.||+|..  .++.||||++.... ....+|+.+|++++|+|||                    
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l  142 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFL  142 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEE
Confidence            346799999999999999999987  46889999886543 3345799999999999974                    


Q ss_pred             ---EEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCC-cEEEeecCC
Q 044997          348 ---ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGL-RAKVADFGL  423 (563)
Q Consensus       348 ---~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~-~~kl~DFGl  423 (563)
                         +||++ |+|.+++... ......+++..+..++.|++.||+|||+++   |+||||||+|||++.++ .+||+|||+
T Consensus       143 ~lvmE~~~-~~l~~~~~~~-~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DFGl  217 (440)
T PTZ00036        143 NVVMEFIP-QTVHKYMKHY-ARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGS  217 (440)
T ss_pred             EEEEecCC-ccHHHHHHHH-hhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeecccc
Confidence               34444 3455544321 123467899999999999999999999997   99999999999999664 799999999


Q ss_pred             CcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCchh-
Q 044997          424 VKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTK-  502 (563)
Q Consensus       424 a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~~-  502 (563)
                      ++......    ......||+.|+|||++.+.            ..++.++|||||||++|||++|+.||.+....... 
T Consensus       218 a~~~~~~~----~~~~~~~t~~y~aPE~~~~~------------~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~  281 (440)
T PTZ00036        218 AKNLLAGQ----RSVSYICSRFYRAPELMLGA------------TNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLV  281 (440)
T ss_pred             chhccCCC----CcccCCCCcCccCHHHhcCC------------CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence            98654322    12235689999999987542            23588999999999999999999998654321000 


Q ss_pred             ---------------------------------h-----HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          503 ---------------------------------M-----KSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       503 ---------------------------------~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                                                       .     ...++.+.+|+.+||+.||.+|||+.|+++.
T Consensus       282 ~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h  351 (440)
T PTZ00036        282 RIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD  351 (440)
T ss_pred             HHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence                                             0     0123458899999999999999999999854

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=8.5e-36  Score=306.51  Aligned_cols=209  Identities=22%  Similarity=0.338  Sum_probs=170.7

Q ss_pred             ceecccCcEEEEEEEE-----CCceEEEEEeccC-----ChHHHHHHHHHHHhccccce---------------EEEeec
Q 044997          298 RIIGRGGFGNVYFGLL-----GDREAAIKKMRSN-----KSKEFFAELKVLCKIHHINV---------------FISTFG  352 (563)
Q Consensus       298 ~~LG~G~fG~Vy~g~~-----~~~~vavK~~~~~-----~~~~f~~Ei~~l~~l~H~ni---------------V~e~~~  352 (563)
                      +.||+|+||.||+++.     .++.+|+|.++..     ....+.+|+++|++++||||               |+||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            5799999999999864     4688999998743     23457789999999999997               578999


Q ss_pred             CCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccccccc
Q 044997          353 NGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNE  432 (563)
Q Consensus       353 ~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~  432 (563)
                      +|+|.+++..     ...+++..+..++.|++.||+|||+++   ++||||||+|||+++++.+||+|||+++.......
T Consensus        82 ~~~L~~~l~~-----~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~  153 (318)
T cd05582          82 GGDLFTRLSK-----EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK  153 (318)
T ss_pred             CCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC
Confidence            9999988854     356899999999999999999999997   99999999999999999999999999875432211


Q ss_pred             cccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc----------hh
Q 044997          433 KEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP----------TK  502 (563)
Q Consensus       433 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~----------~~  502 (563)
                         ......|++.|+|||.+.+..             ++.++|||||||++|||++|+.||.......          ..
T Consensus       154 ---~~~~~~g~~~y~aPE~~~~~~-------------~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~  217 (318)
T cd05582         154 ---KAYSFCGTVEYMAPEVVNRRG-------------HTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGM  217 (318)
T ss_pred             ---ceecccCChhhcCHHHHcCCC-------------CCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCC
Confidence               123357899999999885443             3789999999999999999999996543211          11


Q ss_pred             hHHHHHHHHHHHHHhhccCCCCCCCHHH
Q 044997          503 MKSLITIMAAVAEWCLNEDAVDRPEMRD  530 (563)
Q Consensus       503 ~~~~~~~l~~li~~cl~~dP~~RPs~~e  530 (563)
                      ...+...+.+++.+||+.||++||++.+
T Consensus       218 p~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         218 PQFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             CCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence            1234566899999999999999999655

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=1.1e-34  Score=290.27  Aligned_cols=228  Identities=21%  Similarity=0.324  Sum_probs=172.0

Q ss_pred             ceecccCcEEEEEEEEC----CceEEEEEeccCC----hHHHHHHHHHHHhccccce---------------EEEeecCC
Q 044997          298 RIIGRGGFGNVYFGLLG----DREAAIKKMRSNK----SKEFFAELKVLCKIHHINV---------------FISTFGNG  354 (563)
Q Consensus       298 ~~LG~G~fG~Vy~g~~~----~~~vavK~~~~~~----~~~f~~Ei~~l~~l~H~ni---------------V~e~~~~g  354 (563)
                      +.||+|+||.||+|...    ...+++|.+....    ...|.+|+++++.++|+||               |+||+++|
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG   80 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence            35899999999999753    2468888876432    2468899999999999997               57999999


Q ss_pred             CcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccccccccc
Q 044997          355 SLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKE  434 (563)
Q Consensus       355 sL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~  434 (563)
                      +|.+++...........++.....++.|++.||+|||+++   ++||||||+|||+++++.+||+|||+++........ 
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~-  156 (269)
T cd05042          81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYY-  156 (269)
T ss_pred             cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhe-
Confidence            9999997643222344678888999999999999999987   999999999999999999999999998753322111 


Q ss_pred             cccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCCCcCCCCCc-------------
Q 044997          435 MLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIRDDSEP-------------  500 (563)
Q Consensus       435 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p~~~~~~~~-------------  500 (563)
                      .......++..|+|||++......      .....++.++|||||||++|||++ |..||.......             
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~------~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~  230 (269)
T cd05042         157 ITKDCHAVPLRWLAPELVEIRGQD------LLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKL  230 (269)
T ss_pred             eccCCCCCcccccCHHHHhhcccc------ccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccC
Confidence            111223467789999987543221      123456889999999999999999 667765432110             


Q ss_pred             ---hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 044997          501 ---TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILS  536 (563)
Q Consensus       501 ---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  536 (563)
                         .....+...+.+++..|| .||++||++++|++.|.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         231 PKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             CCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence               011133455778899999 59999999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=5.6e-35  Score=300.28  Aligned_cols=211  Identities=24%  Similarity=0.404  Sum_probs=168.3

Q ss_pred             ceecccCcEEEEEEEEC--CceEEEEEeccC------ChHHHHHHHHHHHh-ccccce---------------EEEeecC
Q 044997          298 RIIGRGGFGNVYFGLLG--DREAAIKKMRSN------KSKEFFAELKVLCK-IHHINV---------------FISTFGN  353 (563)
Q Consensus       298 ~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~------~~~~f~~Ei~~l~~-l~H~ni---------------V~e~~~~  353 (563)
                      +.||+|+||.||+|+..  ++.||+|.++..      ..+.+..|.+++.. .+||||               |+||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999874  567999998643      22445667777765 489987               5799999


Q ss_pred             CCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccccccccc
Q 044997          354 GSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEK  433 (563)
Q Consensus       354 gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~  433 (563)
                      |+|.+++..     ...+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++......  
T Consensus        81 g~L~~~~~~-----~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--  150 (316)
T cd05592          81 GDLMFHIQS-----SGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--  150 (316)
T ss_pred             CcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--
Confidence            999988864     346899999999999999999999987   9999999999999999999999999997533221  


Q ss_pred             ccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc----------hhh
Q 044997          434 EMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP----------TKM  503 (563)
Q Consensus       434 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~----------~~~  503 (563)
                       .......||+.|+|||++.+..             ++.++|||||||++|||++|+.||...+...          ...
T Consensus       151 -~~~~~~~gt~~y~aPE~~~~~~-------------~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~  216 (316)
T cd05592         151 -GKASTFCGTPDYIAPEILKGQK-------------YNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFP  216 (316)
T ss_pred             -CccccccCCccccCHHHHcCCC-------------CCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence             1223457899999999886544             4789999999999999999999997543211          111


Q ss_pred             HHHHHHHHHHHHHhhccCCCCCCCHH-HHH
Q 044997          504 KSLITIMAAVAEWCLNEDAVDRPEMR-DIV  532 (563)
Q Consensus       504 ~~~~~~l~~li~~cl~~dP~~RPs~~-evl  532 (563)
                      ..+...+.+++.+||+.||.+||++. +++
T Consensus       217 ~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05592         217 RWISKEAKDCLSKLFERDPTKRLGVDGDIR  246 (316)
T ss_pred             CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence            22345688999999999999999875 443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=6.5e-35  Score=300.79  Aligned_cols=215  Identities=25%  Similarity=0.389  Sum_probs=171.3

Q ss_pred             CCccceecccCcEEEEEEEEC--CceEEEEEeccC------ChHHHHHHHHHH---Hhccccce---------------E
Q 044997          294 FDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSN------KSKEFFAELKVL---CKIHHINV---------------F  347 (563)
Q Consensus       294 f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~------~~~~f~~Ei~~l---~~l~H~ni---------------V  347 (563)
                      |+..+.||+|+||.||+|...  ++.||||.++..      ..+.+.+|++++   ++++||||               |
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            566789999999999999874  688999998643      224566666554   56789997               6


Q ss_pred             EEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccc
Q 044997          348 ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLE  427 (563)
Q Consensus       348 ~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~  427 (563)
                      +||+++|+|..++..      ..+++..+..++.|++.||+|||+++   ++||||||+|||+++++.+||+|||+++..
T Consensus        81 ~E~~~~~~L~~~~~~------~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~  151 (324)
T cd05589          81 MEYAAGGDLMMHIHT------DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEG  151 (324)
T ss_pred             EcCCCCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccC
Confidence            799999999887753      45899999999999999999999987   999999999999999999999999998743


Q ss_pred             ccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc-------
Q 044997          428 ERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP-------  500 (563)
Q Consensus       428 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~-------  500 (563)
                      ....   .......|++.|+|||.+.+..             ++.++|||||||++|||++|+.||.......       
T Consensus       152 ~~~~---~~~~~~~g~~~y~aPE~~~~~~-------------~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~  215 (324)
T cd05589         152 MGFG---DRTSTFCGTPEFLAPEVLTETS-------------YTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVN  215 (324)
T ss_pred             CCCC---CcccccccCccccCHhHhcCCC-------------CCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence            2211   1223457899999999885443             4789999999999999999999997543211       


Q ss_pred             ---hhhHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 044997          501 ---TKMKSLITIMAAVAEWCLNEDAVDRP-----EMRDIVA  533 (563)
Q Consensus       501 ---~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  533 (563)
                         .....+...+.+++.+||+.||.+||     ++.++++
T Consensus       216 ~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~  256 (324)
T cd05589         216 DEVRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK  256 (324)
T ss_pred             CCCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence               11123456688999999999999999     4666655

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=2.9e-35  Score=309.01  Aligned_cols=225  Identities=22%  Similarity=0.333  Sum_probs=181.8

Q ss_pred             HhcCCCccceecccCcEEEEEEEEC--CceEEEEEeccC------ChHHHHHHHHHHHhccccce---------------
Q 044997          290 ATNNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSN------KSKEFFAELKVLCKIHHINV---------------  346 (563)
Q Consensus       290 ~~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~------~~~~f~~Ei~~l~~l~H~ni---------------  346 (563)
                      ..++|+..+.||+|+||.||+++..  ++.+|+|.++..      ..+.+.+|+++++.++||||               
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l  120 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM  120 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence            4567899999999999999999874  678999998642      23457789999999999997               


Q ss_pred             EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcc
Q 044997          347 FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKL  426 (563)
Q Consensus       347 V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~  426 (563)
                      |+||+++|+|.+++..      ..++...+..++.|++.||+|||+++   |+||||||+|||+++++.+||+|||+++.
T Consensus       121 v~Ey~~gg~L~~~l~~------~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~  191 (370)
T cd05596         121 VMEYMPGGDLVNLMSN------YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMK  191 (370)
T ss_pred             EEcCCCCCcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceee
Confidence            5799999999998864      34788888899999999999999987   99999999999999999999999999976


Q ss_pred             cccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCch-----
Q 044997          427 EERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPT-----  501 (563)
Q Consensus       427 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~-----  501 (563)
                      ......  .......||+.|+|||++....         ....++.++|||||||++|||++|+.||........     
T Consensus       192 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~---------~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~  260 (370)
T cd05596         192 MDANGM--VRCDTAVGTPDYISPEVLKSQG---------GDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM  260 (370)
T ss_pred             ccCCCc--ccCCCCCCCcCeECHHHhccCC---------CCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHH
Confidence            533211  1123357999999999885432         123468999999999999999999999976543110     


Q ss_pred             ---------hhHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 044997          502 ---------KMKSLITIMAAVAEWCLNEDAVD--RPEMRDIVAI  534 (563)
Q Consensus       502 ---------~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~  534 (563)
                               ....+...+.+++.+|++.+|.+  ||++.|+++.
T Consensus       261 ~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         261 DHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             cCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence                     00123566899999999999988  9999999764

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=1.5e-34  Score=291.30  Aligned_cols=214  Identities=24%  Similarity=0.362  Sum_probs=172.7

Q ss_pred             ecccCcEEEEEEEEC--CceEEEEEeccCC------hHHHHHHHHHHHhccccce---------------EEEeecCCCc
Q 044997          300 IGRGGFGNVYFGLLG--DREAAIKKMRSNK------SKEFFAELKVLCKIHHINV---------------FISTFGNGSL  356 (563)
Q Consensus       300 LG~G~fG~Vy~g~~~--~~~vavK~~~~~~------~~~f~~Ei~~l~~l~H~ni---------------V~e~~~~gsL  356 (563)
                      ||+|+||.||++...  ++.+|+|.+....      .+.+..|++++++++||||               |+||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            699999999999874  7899999986421      2345679999999999997               5799999999


Q ss_pred             ccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccccccccccc
Q 044997          357 SDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEML  436 (563)
Q Consensus       357 ~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~  436 (563)
                      .+++..   .....+++..+..++.|++.||+|||+.+   ++||||||+||++++++.+||+|||++.......    .
T Consensus        81 ~~~~~~---~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~----~  150 (277)
T cd05607          81 KYHIYN---VGERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK----T  150 (277)
T ss_pred             HHHHHh---ccccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc----e
Confidence            888864   23456899999999999999999999987   9999999999999999999999999987543221    1


Q ss_pred             cccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCchh--------------
Q 044997          437 ATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTK--------------  502 (563)
Q Consensus       437 ~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~~--------------  502 (563)
                      .....|+..|+|||++.+..             ++.++|||||||++|||++|+.||.........              
T Consensus       151 ~~~~~~~~~y~aPE~~~~~~-------------~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  217 (277)
T cd05607         151 ITQRAGTNGYMAPEILKEEP-------------YSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKF  217 (277)
T ss_pred             eeccCCCCCccCHHHHccCC-------------CCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcccccc
Confidence            22346899999999875443             488999999999999999999998653321110              


Q ss_pred             -hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 044997          503 -MKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILS  536 (563)
Q Consensus       503 -~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  536 (563)
                       ...+...+.+++.+||+.||++||+++|+++.+.
T Consensus       218 ~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~  252 (277)
T cd05607         218 EHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPR  252 (277)
T ss_pred             ccccCCHHHHHHHHHHhccCHhhCCCCccchhhhh
Confidence             0123456899999999999999999988765443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=1.4e-34  Score=293.05  Aligned_cols=235  Identities=23%  Similarity=0.367  Sum_probs=183.8

Q ss_pred             HhcCCCccceecccCcEEEEEEEEC-------CceEEEEEeccCC----hHHHHHHHHHHHhccccce------------
Q 044997          290 ATNNFDESRIIGRGGFGNVYFGLLG-------DREAAIKKMRSNK----SKEFFAELKVLCKIHHINV------------  346 (563)
Q Consensus       290 ~~~~f~~~~~LG~G~fG~Vy~g~~~-------~~~vavK~~~~~~----~~~f~~Ei~~l~~l~H~ni------------  346 (563)
                      .+++|+..+.||+|+||.||+|..+       +..||+|.++...    ..++.+|+.++++++|+||            
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP   83 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            4577899999999999999999753       3478999886443    2458889999999999997            


Q ss_pred             ---EEEeecCCCcccccccccc-----cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEE
Q 044997          347 ---FISTFGNGSLSDHLHDPLL-----KGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKV  418 (563)
Q Consensus       347 ---V~e~~~~gsL~~~L~~~~~-----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl  418 (563)
                         |+||+++|+|.+++.....     .+....++..+..++.|++.||.|||+++   ++||||||+|||+++++.+||
T Consensus        84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L  160 (288)
T cd05061          84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI  160 (288)
T ss_pred             cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence               5799999999999964211     11245678889999999999999999987   999999999999999999999


Q ss_pred             eecCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCCCcCCC
Q 044997          419 ADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIRDD  497 (563)
Q Consensus       419 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p~~~~~  497 (563)
                      +|||+++........ .......++..|+|||.+.+.             .++.++|||||||++|||++ |..||....
T Consensus       161 ~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~~pE~~~~~-------------~~~~~~DvwslG~~l~el~~~~~~p~~~~~  226 (288)
T cd05061         161 GDFGMTRDIYETDYY-RKGGKGLLPVRWMAPESLKDG-------------VFTTSSDMWSFGVVLWEITSLAEQPYQGLS  226 (288)
T ss_pred             CcCCccccccccccc-cccCCCcccccccCHHHhccC-------------CCChHhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence            999998854332211 111223456789999987543             34889999999999999998 677775432


Q ss_pred             CCc-----------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 044997          498 SEP-----------TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMIT  541 (563)
Q Consensus       498 ~~~-----------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~  541 (563)
                      ...           .........+.+++.+||+.||++||++.++++.|.+.+..
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~  281 (288)
T cd05061         227 NEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHP  281 (288)
T ss_pred             HHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCC
Confidence            211           11112346699999999999999999999999999887643

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.1e-35  Score=292.33  Aligned_cols=229  Identities=27%  Similarity=0.394  Sum_probs=182.2

Q ss_pred             hcCCCccceecccCcEEEEEEEECC-------ceEEEEEeccCC----hHHHHHHHHHHHhccccce-------------
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLLGD-------REAAIKKMRSNK----SKEFFAELKVLCKIHHINV-------------  346 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~~~-------~~vavK~~~~~~----~~~f~~Ei~~l~~l~H~ni-------------  346 (563)
                      .++|...+.||+|+||.||+|...+       ..+|+|.+....    ...+.+|+.++++++|+||             
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   84 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT   84 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence            4578889999999999999998743       569999986543    2468899999999999997             


Q ss_pred             --EEEeecCCCccccccccccc-----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEe
Q 044997          347 --FISTFGNGSLSDHLHDPLLK-----GHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVA  419 (563)
Q Consensus       347 --V~e~~~~gsL~~~L~~~~~~-----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~  419 (563)
                        |+||+++|+|.+++......     ....++|..+..++.|++.||.|||+.+   ++||||||+||++++++.+||+
T Consensus        85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~  161 (277)
T cd05032          85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence              56899999999998643211     1235889999999999999999999987   9999999999999999999999


Q ss_pred             ecCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCCCcCCCC
Q 044997          420 DFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIRDDS  498 (563)
Q Consensus       420 DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p~~~~~~  498 (563)
                      |||+++........ .......++..|+|||.+...             .++.++|||||||++||+++ |+.|+.....
T Consensus       162 dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~-------------~~~~~~Di~slG~il~el~t~g~~p~~~~~~  227 (277)
T cd05032         162 DFGMTRDIYETDYY-RKGGKGLLPVRWMAPESLKDG-------------VFTTKSDVWSFGVVLWEMATLAEQPYQGLSN  227 (277)
T ss_pred             CcccchhhccCccc-ccCCCCCccccccCHHHHhcC-------------CCCcccchHHHHHHHHHhhccCCCCCccCCH
Confidence            99998865433211 112234567899999987433             35889999999999999998 8888754321


Q ss_pred             C-----------chhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 044997          499 E-----------PTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILS  536 (563)
Q Consensus       499 ~-----------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  536 (563)
                      .           ..........+.+++.+||+.+|++|||+.++++.|+
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         228 EEVLKFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence            1           1112234566899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1.2e-34  Score=287.04  Aligned_cols=218  Identities=24%  Similarity=0.380  Sum_probs=173.0

Q ss_pred             ceecccCcEEEEEEEE--CCceEEEEEeccCC----hHHHHHHHHHHHhccccce---------------EEEeecCCCc
Q 044997          298 RIIGRGGFGNVYFGLL--GDREAAIKKMRSNK----SKEFFAELKVLCKIHHINV---------------FISTFGNGSL  356 (563)
Q Consensus       298 ~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~----~~~f~~Ei~~l~~l~H~ni---------------V~e~~~~gsL  356 (563)
                      +.||+|+||.||+|..  +++.+|+|.+....    ...|.+|++++++++|+||               |+||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            4689999999999987  57889999876432    3568999999999999997               5799999999


Q ss_pred             ccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccccccccccc
Q 044997          357 SDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEML  436 (563)
Q Consensus       357 ~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~  436 (563)
                      .+++..    ....++|..++.++.|++.||.|||+++   ++||||||+||+++.++.+||+|||+++........ ..
T Consensus        81 ~~~~~~----~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~-~~  152 (252)
T cd05084          81 LTFLRT----EGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYA-ST  152 (252)
T ss_pred             HHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCccccccccc-cc
Confidence            999864    2346899999999999999999999987   999999999999999999999999998754321110 00


Q ss_pred             cccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCCCcCCCCCc-----------hhhH
Q 044997          437 ATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIRDDSEP-----------TKMK  504 (563)
Q Consensus       437 ~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p~~~~~~~~-----------~~~~  504 (563)
                      .....++..|+|||.+.+..             ++.++||||||+++||+++ |..|+.......           ....
T Consensus       153 ~~~~~~~~~y~aPE~~~~~~-------------~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~  219 (252)
T cd05084         153 GGMKQIPVKWTAPEALNYGR-------------YSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPE  219 (252)
T ss_pred             CCCCCCceeecCchhhcCCC-------------CChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCcc
Confidence            11112345799999875443             4889999999999999998 777774332111           1112


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 044997          505 SLITIMAAVAEWCLNEDAVDRPEMRDIVAILS  536 (563)
Q Consensus       505 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  536 (563)
                      ..+..+.+++.+||+.||++||++.++++.|.
T Consensus       220 ~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         220 LCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            23456899999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=8.3e-35  Score=297.50  Aligned_cols=235  Identities=23%  Similarity=0.381  Sum_probs=184.1

Q ss_pred             hcCCCccceecccCcEEEEEEEECC---------ceEEEEEeccCC----hHHHHHHHHHHHhc-cccce----------
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLLGD---------REAAIKKMRSNK----SKEFFAELKVLCKI-HHINV----------  346 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~~~---------~~vavK~~~~~~----~~~f~~Ei~~l~~l-~H~ni----------  346 (563)
                      .++|...+.||+|+||.||++...+         ..+|+|.++...    .+++.+|+++++++ +|+||          
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   96 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   96 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            3568889999999999999997532         469999997542    24688899999999 79997          


Q ss_pred             -----EEEeecCCCcccccccccc-----------cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEe
Q 044997          347 -----FISTFGNGSLSDHLHDPLL-----------KGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILL  410 (563)
Q Consensus       347 -----V~e~~~~gsL~~~L~~~~~-----------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl  410 (563)
                           |+||+++|+|.+++.....           .....++|.+++.++.|++.||+|||+++   ++||||||+||++
T Consensus        97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill  173 (307)
T cd05098          97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV  173 (307)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence                 5799999999999975311           01245899999999999999999999987   9999999999999


Q ss_pred             cCCCcEEEeecCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-C
Q 044997          411 DDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-G  489 (563)
Q Consensus       411 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g  489 (563)
                      +.++.+||+|||+++......... ......++..|+|||.+.+..             ++.++|||||||++|||++ |
T Consensus       174 ~~~~~~kL~dfg~a~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~-------------~~~~~DvwslG~~l~el~~~g  239 (307)
T cd05098         174 TEDNVMKIADFGLARDIHHIDYYK-KTTNGRLPVKWMAPEALFDRI-------------YTHQSDVWSFGVLLWEIFTLG  239 (307)
T ss_pred             cCCCcEEECCCcccccccccchhh-ccccCCCccceeChHHhccCC-------------CCcHHHHHHHHHHHHHHHcCC
Confidence            999999999999987543221111 111123456899999875443             4889999999999999998 7


Q ss_pred             CCCCcCCCCCc-----------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcC
Q 044997          490 KRALIRDDSEP-----------TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITS  542 (563)
Q Consensus       490 ~~p~~~~~~~~-----------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~  542 (563)
                      +.||.......           .........+.+++.+||+.+|.+||++.++++.|.+++...
T Consensus       240 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~  303 (307)
T cd05098         240 GSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT  303 (307)
T ss_pred             CCCCCcCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHh
Confidence            77775432210           111233456889999999999999999999999999988653

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=1.7e-35  Score=305.75  Aligned_cols=226  Identities=23%  Similarity=0.269  Sum_probs=181.8

Q ss_pred             cCCCccceecccCcEEEEEEEE--CCceEEEEEeccC------ChHHHHHHHHHHHhccccce---------------EE
Q 044997          292 NNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSN------KSKEFFAELKVLCKIHHINV---------------FI  348 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~------~~~~f~~Ei~~l~~l~H~ni---------------V~  348 (563)
                      ++|+..+.||+|+||.||+++.  .++.+|+|.++..      ..+.+.+|+++++.++|+||               |+
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            4688899999999999999987  4788999998753      23557889999999999996               57


Q ss_pred             EeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccc
Q 044997          349 STFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEE  428 (563)
Q Consensus       349 e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~  428 (563)
                      ||+++|+|.+++...    ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus        81 e~~~~~~L~~~l~~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~  153 (330)
T cd05601          81 EYQPGGDLLSLLNRY----EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLT  153 (330)
T ss_pred             CCCCCCCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECC
Confidence            999999999988642    356899999999999999999999997   9999999999999999999999999998654


Q ss_pred             cccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCch-------
Q 044997          429 RTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPT-------  501 (563)
Q Consensus       429 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~-------  501 (563)
                      .....  ......||+.|+|||++.....       .....++.++|||||||++|||++|+.||........       
T Consensus       154 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~-------~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~  224 (330)
T cd05601         154 ANKMV--NSKLPVGTPDYIAPEVLTTMNG-------DGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNF  224 (330)
T ss_pred             CCCce--eeecccCCccccCHHHhccccc-------cccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcC
Confidence            32211  2223468999999998854321       1134568999999999999999999999965432110       


Q ss_pred             -------hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          502 -------KMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       502 -------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                             ....+...+.+|+..|++ +|.+||++.+++..
T Consensus       225 ~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h  263 (330)
T cd05601         225 QRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH  263 (330)
T ss_pred             CCccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence                   011245568899999998 99999999998753

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-34  Score=289.85  Aligned_cols=222  Identities=29%  Similarity=0.467  Sum_probs=174.1

Q ss_pred             ceecccCcEEEEEEEECC----ceEEEEEeccCC----hHHHHHHHHHHHhc-cccce---------------EEEeecC
Q 044997          298 RIIGRGGFGNVYFGLLGD----REAAIKKMRSNK----SKEFFAELKVLCKI-HHINV---------------FISTFGN  353 (563)
Q Consensus       298 ~~LG~G~fG~Vy~g~~~~----~~vavK~~~~~~----~~~f~~Ei~~l~~l-~H~ni---------------V~e~~~~  353 (563)
                      +.||+|+||.||+|...+    ..+++|.++...    .+.+.+|++++.++ +||||               ++||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            368999999999998743    246888887432    35688999999999 89986               5799999


Q ss_pred             CCcccccccccc-----------cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecC
Q 044997          354 GSLSDHLHDPLL-----------KGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFG  422 (563)
Q Consensus       354 gsL~~~L~~~~~-----------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFG  422 (563)
                      |+|.+++.....           .....+++.++..++.|++.||+|||+.+   ++||||||+|||+++++.+||+|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence            999999865321           11235889999999999999999999987   9999999999999999999999999


Q ss_pred             CCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCCCcCCCCCc-
Q 044997          423 LVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIRDDSEP-  500 (563)
Q Consensus       423 la~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p~~~~~~~~-  500 (563)
                      +++......    .......+..|+|||++....             ++.++||||||+++|||++ |..||....... 
T Consensus       158 l~~~~~~~~----~~~~~~~~~~y~apE~~~~~~-------------~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~  220 (270)
T cd05047         158 LSRGQEVYV----KKTMGRLPVRWMAIESLNYSV-------------YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL  220 (270)
T ss_pred             Cccccchhh----hccCCCCccccCChHHHccCC-------------CCchhhHHHHHHHHHHHHcCCCCCccccCHHHH
Confidence            986322110    111122356799999875433             4789999999999999997 999985432111 


Q ss_pred             ----------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhh
Q 044997          501 ----------TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIM  539 (563)
Q Consensus       501 ----------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~  539 (563)
                                .........+.+++.+||+.||.+||++.+++..|.+++
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         221 YEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             HHHHhCCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence                      111223456899999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=5.6e-35  Score=300.88  Aligned_cols=213  Identities=23%  Similarity=0.361  Sum_probs=171.4

Q ss_pred             ceecccCcEEEEEEEEC--CceEEEEEeccC------ChHHHHHHHHHHHhc-cccce---------------EEEeecC
Q 044997          298 RIIGRGGFGNVYFGLLG--DREAAIKKMRSN------KSKEFFAELKVLCKI-HHINV---------------FISTFGN  353 (563)
Q Consensus       298 ~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~------~~~~f~~Ei~~l~~l-~H~ni---------------V~e~~~~  353 (563)
                      +.||+|+||.||+|+..  ++.+|+|.++..      ..+.+..|.+++..+ +||||               |+||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            46999999999999885  578999998643      224577889998866 79886               6799999


Q ss_pred             CCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccccccccc
Q 044997          354 GSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEK  433 (563)
Q Consensus       354 gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~  433 (563)
                      |+|..++..     ...+++..+..++.|++.||.|||+++   |+||||||+|||+++++.+||+|||+++......  
T Consensus        81 ~~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~--  150 (321)
T cd05591          81 GDLMFQIQR-----SRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--  150 (321)
T ss_pred             CcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCC--
Confidence            999888864     356899999999999999999999997   9999999999999999999999999987532211  


Q ss_pred             ccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCchh----------h
Q 044997          434 EMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTK----------M  503 (563)
Q Consensus       434 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~~----------~  503 (563)
                       .......||+.|+|||++.+..             ++.++|||||||++|||++|+.||.........          +
T Consensus       151 -~~~~~~~gt~~y~aPE~~~~~~-------------~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p  216 (321)
T cd05591         151 -VTTTTFCGTPDYIAPEILQELE-------------YGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYP  216 (321)
T ss_pred             -ccccccccCccccCHHHHcCCC-------------CCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence             1223456899999999885444             478999999999999999999999755422111          1


Q ss_pred             HHHHHHHHHHHHHhhccCCCCCC-------CHHHHHHH
Q 044997          504 KSLITIMAAVAEWCLNEDAVDRP-------EMRDIVAI  534 (563)
Q Consensus       504 ~~~~~~l~~li~~cl~~dP~~RP-------s~~evl~~  534 (563)
                      ..+...+.+++.+||+.||++||       ++.++++.
T Consensus       217 ~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h  254 (321)
T cd05591         217 VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH  254 (321)
T ss_pred             CCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence            12345688999999999999999       67777654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2e-34  Score=292.87  Aligned_cols=228  Identities=24%  Similarity=0.384  Sum_probs=177.7

Q ss_pred             cCCCccceecccCcEEEEEEEECC----------------ceEEEEEeccCC----hHHHHHHHHHHHhccccce-----
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLGD----------------REAAIKKMRSNK----SKEFFAELKVLCKIHHINV-----  346 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~~----------------~~vavK~~~~~~----~~~f~~Ei~~l~~l~H~ni-----  346 (563)
                      ++|+..+.||+|+||.||+++..+                ..||+|.++...    .+.|.+|++++++++|+|+     
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            568889999999999999987532                248999987542    3468899999999999996     


Q ss_pred             ----------EEEeecCCCccccccccccc-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeE
Q 044997          347 ----------FISTFGNGSLSDHLHDPLLK-------GHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNIL  409 (563)
Q Consensus       347 ----------V~e~~~~gsL~~~L~~~~~~-------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NIL  409 (563)
                                |+||+++++|.+++......       ....++|.+++.++.|++.||+|||+++   ++||||||+||+
T Consensus        85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil  161 (295)
T cd05097          85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCL  161 (295)
T ss_pred             EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEE
Confidence                      67999999999988643211       1124789999999999999999999987   999999999999


Q ss_pred             ecCCCcEEEeecCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-
Q 044997          410 LDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-  488 (563)
Q Consensus       410 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-  488 (563)
                      +++++.+||+|||+++....... ........++..|+|||.+...             .++.++|||||||++|||++ 
T Consensus       162 l~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~-------------~~~~~~DvwSlG~~l~el~~~  227 (295)
T cd05097         162 VGNHYTIKIADFGMSRNLYSGDY-YRIQGRAVLPIRWMAWESILLG-------------KFTTASDVWAFGVTLWEMFTL  227 (295)
T ss_pred             EcCCCcEEecccccccccccCcc-eeccCcCcCceeecChhhhccC-------------CcCchhhHHHHHHHHHHHHHc
Confidence            99999999999999875433221 1112233457789999987543             34899999999999999998 


Q ss_pred             -CCCCCcCCCCCch------------------hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 044997          489 -GKRALIRDDSEPT------------------KMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILS  536 (563)
Q Consensus       489 -g~~p~~~~~~~~~------------------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  536 (563)
                       |..||........                  .....+..+.+++.+||+.||++||++.+|++.|.
T Consensus       228 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         228 CKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             CCCCCCcccChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence             4556643221100                  01112356899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=7.2e-35  Score=300.02  Aligned_cols=207  Identities=23%  Similarity=0.371  Sum_probs=168.5

Q ss_pred             ceecccCcEEEEEEEEC--CceEEEEEeccC------ChHHHHHHHHHHHhc-cccce---------------EEEeecC
Q 044997          298 RIIGRGGFGNVYFGLLG--DREAAIKKMRSN------KSKEFFAELKVLCKI-HHINV---------------FISTFGN  353 (563)
Q Consensus       298 ~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~------~~~~f~~Ei~~l~~l-~H~ni---------------V~e~~~~  353 (563)
                      +.||+|+||.||+|+.+  ++.||+|.++..      ..+.+..|.+++..+ +||||               |+||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999874  678999998643      235577888888876 69986               6799999


Q ss_pred             CCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccccccccc
Q 044997          354 GSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEK  433 (563)
Q Consensus       354 gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~  433 (563)
                      |+|.+++..     ...+++..+..++.|++.||+|||+++   ++||||||+|||+++++.+||+|||+++......  
T Consensus        81 g~L~~~i~~-----~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--  150 (320)
T cd05590          81 GDLMFHIQK-----SRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--  150 (320)
T ss_pred             chHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--
Confidence            999988864     356899999999999999999999987   9999999999999999999999999987532211  


Q ss_pred             ccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc----------hhh
Q 044997          434 EMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP----------TKM  503 (563)
Q Consensus       434 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~----------~~~  503 (563)
                       .......||+.|+|||++.+..             ++.++|||||||++|||++|+.||.......          ...
T Consensus       151 -~~~~~~~gt~~y~aPE~~~~~~-------------~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~  216 (320)
T cd05590         151 -KTTSTFCGTPDYIAPEILQEML-------------YGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYP  216 (320)
T ss_pred             -CcccccccCccccCHHHHcCCC-------------CCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCC
Confidence             1223457999999999885443             4789999999999999999999997544211          111


Q ss_pred             HHHHHHHHHHHHHhhccCCCCCCCH
Q 044997          504 KSLITIMAAVAEWCLNEDAVDRPEM  528 (563)
Q Consensus       504 ~~~~~~l~~li~~cl~~dP~~RPs~  528 (563)
                      ..+...+.+++.+||+.||.+||++
T Consensus       217 ~~~~~~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         217 TWLSQDAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             CCCCHHHHHHHHHHcccCHHHCCCC
Confidence            2245568999999999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=1.2e-34  Score=289.55  Aligned_cols=223  Identities=24%  Similarity=0.373  Sum_probs=179.9

Q ss_pred             cCCCccceecccCcEEEEEEEE--CCceEEEEEeccCC---hHHHHHHHHHHHhccccce---------------EEEee
Q 044997          292 NNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNK---SKEFFAELKVLCKIHHINV---------------FISTF  351 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~---~~~f~~Ei~~l~~l~H~ni---------------V~e~~  351 (563)
                      ++|+..+.||+|+||.||+|+.  +++.+|+|+++...   .+.+.+|+.++.+++||||               |+||+
T Consensus         9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~   88 (267)
T cd06646           9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC   88 (267)
T ss_pred             hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence            5688899999999999999987  46789999986542   3457789999999999997               56899


Q ss_pred             cCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccccccc
Q 044997          352 GNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTN  431 (563)
Q Consensus       352 ~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~  431 (563)
                      ++|+|.++++.     ..++++.++..++.|++.||+|||+.+   ++||||||+||++++++.+||+|||+++......
T Consensus        89 ~~~~L~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd06646          89 GGGSLQDIYHV-----TGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATI  160 (267)
T ss_pred             CCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeecccc
Confidence            99999998864     346899999999999999999999987   9999999999999999999999999988553221


Q ss_pred             ccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc-----------
Q 044997          432 EKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP-----------  500 (563)
Q Consensus       432 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~-----------  500 (563)
                      .   ......|+..|+|||.+....          ...++.++|||||||++|||++|+.|+.......           
T Consensus       161 ~---~~~~~~~~~~y~~PE~~~~~~----------~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~  227 (267)
T cd06646         161 A---KRKSFIGTPYWMAPEVAAVEK----------NGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQ  227 (267)
T ss_pred             c---ccCccccCccccCHhHccccc----------CCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCC
Confidence            1   112346888999999874321          2335789999999999999999999985432110           


Q ss_pred             -h---hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 044997          501 -T---KMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAIL  535 (563)
Q Consensus       501 -~---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  535 (563)
                       .   ....+...+.+++.+||+.||++||+++++++.|
T Consensus       228 ~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         228 PPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             CCCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence             0   0123456789999999999999999999998753

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=2.1e-34  Score=295.61  Aligned_cols=221  Identities=24%  Similarity=0.317  Sum_probs=166.8

Q ss_pred             cceecccCcEEEEEEEEC----CceEEEEEeccCC-hHHHHHHHHHHHhccccceE-----------------EEeecCC
Q 044997          297 SRIIGRGGFGNVYFGLLG----DREAAIKKMRSNK-SKEFFAELKVLCKIHHINVF-----------------ISTFGNG  354 (563)
Q Consensus       297 ~~~LG~G~fG~Vy~g~~~----~~~vavK~~~~~~-~~~f~~Ei~~l~~l~H~niV-----------------~e~~~~g  354 (563)
                      .++||+|+||.||+|+..    ++.+|+|.++... ...+.+|+++|++++||||+                 +||+ ++
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~-~~   84 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA-EH   84 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc-CC
Confidence            568999999999999863    4679999987543 45688999999999999983                 3443 34


Q ss_pred             Ccccccccccc----cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEe----cCCCcEEEeecCCCcc
Q 044997          355 SLSDHLHDPLL----KGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILL----DDGLRAKVADFGLVKL  426 (563)
Q Consensus       355 sL~~~L~~~~~----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl----~~~~~~kl~DFGla~~  426 (563)
                      +|.+++.....    .....+++..+..++.|++.||+|||+++   |+||||||+|||+    +.++.+||+|||+++.
T Consensus        85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~  161 (317)
T cd07868          85 DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARL  161 (317)
T ss_pred             CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCceec
Confidence            66665542111    12235899999999999999999999997   9999999999999    4567999999999986


Q ss_pred             cccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCch-----
Q 044997          427 EERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPT-----  501 (563)
Q Consensus       427 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~-----  501 (563)
                      ...............||+.|+|||++.+..            .++.++||||+||++|||++|+.||........     
T Consensus       162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~------------~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~  229 (317)
T cd07868         162 FNSPLKPLADLDPVVVTFWYRAPELLLGAR------------HYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPY  229 (317)
T ss_pred             cCCCCccccccCCccccccccCCHHHcCCC------------CcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccc
Confidence            543222111223457899999999885432            247899999999999999999999854321100     


Q ss_pred             ------------------hhHH----------------------------------HHHHHHHHHHHhhccCCCCCCCHH
Q 044997          502 ------------------KMKS----------------------------------LITIMAAVAEWCLNEDAVDRPEMR  529 (563)
Q Consensus       502 ------------------~~~~----------------------------------~~~~l~~li~~cl~~dP~~RPs~~  529 (563)
                                        ....                                  ....+.+++.+||+.||.+|||++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~  309 (317)
T cd07868         230 HHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSE  309 (317)
T ss_pred             cHHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHH
Confidence                              0000                                  012366899999999999999999


Q ss_pred             HHHH
Q 044997          530 DIVA  533 (563)
Q Consensus       530 evl~  533 (563)
                      |+++
T Consensus       310 e~l~  313 (317)
T cd07868         310 QAMQ  313 (317)
T ss_pred             HHhc
Confidence            9985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.4e-34  Score=291.30  Aligned_cols=226  Identities=23%  Similarity=0.405  Sum_probs=180.7

Q ss_pred             CCCccceecccCcEEEEEEEEC------CceEEEEEeccCC----hHHHHHHHHHHHhccccce----------------
Q 044997          293 NFDESRIIGRGGFGNVYFGLLG------DREAAIKKMRSNK----SKEFFAELKVLCKIHHINV----------------  346 (563)
Q Consensus       293 ~f~~~~~LG~G~fG~Vy~g~~~------~~~vavK~~~~~~----~~~f~~Ei~~l~~l~H~ni----------------  346 (563)
                      .|...+.||+|+||.||++.++      +..+|||.++...    .++|.+|++++++++|+||                
T Consensus         5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~   84 (284)
T cd05038           5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLR   84 (284)
T ss_pred             hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceE
Confidence            4666789999999999999864      4689999987553    3579999999999999987                


Q ss_pred             -EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCc
Q 044997          347 -FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK  425 (563)
Q Consensus       347 -V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~  425 (563)
                       ++||+++|+|.+++...    ...++|..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||++.
T Consensus        85 lv~e~~~~~~l~~~l~~~----~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~  157 (284)
T cd05038          85 LIMEYLPSGSLRDYLQRH----RDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAK  157 (284)
T ss_pred             EEEecCCCCCHHHHHHhC----ccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEccccccc
Confidence             46788889999988652    235999999999999999999999987   9999999999999999999999999998


Q ss_pred             ccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCch----
Q 044997          426 LEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPT----  501 (563)
Q Consensus       426 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~----  501 (563)
                      ................++..|+|||.+...             .++.++||||||+++|||++|+.|+........    
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-------------~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~  224 (284)
T cd05038         158 VLPEDKDYYYVKEPGESPIFWYAPECLRTS-------------KFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIG  224 (284)
T ss_pred             ccccCCcceeccCCCCCcccccCcHHHccC-------------CCCcccchHHHhhhhheeeccCCCcccccchhccccc
Confidence            654222111111123455679999987443             347899999999999999999998754321110    


Q ss_pred             ----------------------hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 044997          502 ----------------------KMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQI  538 (563)
Q Consensus       502 ----------------------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  538 (563)
                                            ........+.+++.+||+.+|.+||++.||++.|+++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         225 IAQGQMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             cccccccHHHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence                                  0112235688999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=4.8e-35  Score=301.64  Aligned_cols=208  Identities=25%  Similarity=0.389  Sum_probs=167.1

Q ss_pred             ceecccCcEEEEEEEE--CCceEEEEEeccCC------hHHHHHHHH-HHHhccccce---------------EEEeecC
Q 044997          298 RIIGRGGFGNVYFGLL--GDREAAIKKMRSNK------SKEFFAELK-VLCKIHHINV---------------FISTFGN  353 (563)
Q Consensus       298 ~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~------~~~f~~Ei~-~l~~l~H~ni---------------V~e~~~~  353 (563)
                      +.||+|+||.||+|+.  +++.||+|.+....      .+++.+|.. +++.++||||               |+||+.+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            4699999999999988  47889999986431      234555555 5678999997               5799999


Q ss_pred             CCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccccccccc
Q 044997          354 GSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEK  433 (563)
Q Consensus       354 gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~  433 (563)
                      |+|.+++..     ...+++..+..++.|++.||+|||+++   |+||||||+|||+++++.+||+|||+++......  
T Consensus        81 g~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~--  150 (323)
T cd05575          81 GELFFHLQR-----ERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS--  150 (323)
T ss_pred             CCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccCC--
Confidence            999988864     356899999999999999999999997   9999999999999999999999999987432211  


Q ss_pred             ccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc----------hhh
Q 044997          434 EMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP----------TKM  503 (563)
Q Consensus       434 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~----------~~~  503 (563)
                       .......||+.|+|||++.+..             ++.++|||||||++|||++|+.||...+...          ...
T Consensus       151 -~~~~~~~gt~~y~aPE~~~~~~-------------~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  216 (323)
T cd05575         151 -KTTSTFCGTPEYLAPEVLRKQP-------------YDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLK  216 (323)
T ss_pred             -CccccccCChhhcChhhhcCCC-------------CCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence             1223456899999999885543             4789999999999999999999997543211          111


Q ss_pred             HHHHHHHHHHHHHhhccCCCCCCCHH
Q 044997          504 KSLITIMAAVAEWCLNEDAVDRPEMR  529 (563)
Q Consensus       504 ~~~~~~l~~li~~cl~~dP~~RPs~~  529 (563)
                      ..+...+.+++.+||+.||.+||+++
T Consensus       217 ~~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         217 PNISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             CCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence            23456689999999999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=8.3e-35  Score=299.03  Aligned_cols=211  Identities=25%  Similarity=0.409  Sum_probs=169.1

Q ss_pred             ceecccCcEEEEEEEEC--CceEEEEEeccC------ChHHHHHHHHHHHhc-cccce---------------EEEeecC
Q 044997          298 RIIGRGGFGNVYFGLLG--DREAAIKKMRSN------KSKEFFAELKVLCKI-HHINV---------------FISTFGN  353 (563)
Q Consensus       298 ~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~------~~~~f~~Ei~~l~~l-~H~ni---------------V~e~~~~  353 (563)
                      +.||+|+||.||+|+..  ++.+|+|.++..      ..+.+..|..++... +||||               |+||+.+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46999999999999884  678999998743      234567788888754 88886               6799999


Q ss_pred             CCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccccccccc
Q 044997          354 GSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEK  433 (563)
Q Consensus       354 gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~  433 (563)
                      |+|.+++..     ...+++.++..++.|++.||+|||+++   |+||||||+|||+++++.+||+|||+++......  
T Consensus        81 g~L~~~i~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--  150 (316)
T cd05620          81 GDLMFHIQD-----KGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--  150 (316)
T ss_pred             CcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCC--
Confidence            999988864     346899999999999999999999997   9999999999999999999999999987432111  


Q ss_pred             ccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc----------hhh
Q 044997          434 EMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP----------TKM  503 (563)
Q Consensus       434 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~----------~~~  503 (563)
                       .......||+.|+|||++.+..             ++.++|||||||++|||++|+.||...+...          ...
T Consensus       151 -~~~~~~~gt~~y~aPE~~~~~~-------------~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~  216 (316)
T cd05620         151 -NRASTFCGTPDYIAPEILQGLK-------------YTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYP  216 (316)
T ss_pred             -CceeccCCCcCccCHHHHcCCC-------------CCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC
Confidence             1223457899999999886544             4789999999999999999999997543211          011


Q ss_pred             HHHHHHHHHHHHHhhccCCCCCCCHH-HHH
Q 044997          504 KSLITIMAAVAEWCLNEDAVDRPEMR-DIV  532 (563)
Q Consensus       504 ~~~~~~l~~li~~cl~~dP~~RPs~~-evl  532 (563)
                      ..+...+.+++.+||+.||.+||++. ++.
T Consensus       217 ~~~~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         217 RWITKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence            12345688999999999999999984 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=9.4e-35  Score=299.47  Aligned_cols=212  Identities=24%  Similarity=0.366  Sum_probs=170.6

Q ss_pred             CCCccceecccCcEEEEEEEEC--CceEEEEEeccCC------hHHHHHHHHHHHhcc-ccce---------------EE
Q 044997          293 NFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNK------SKEFFAELKVLCKIH-HINV---------------FI  348 (563)
Q Consensus       293 ~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~------~~~f~~Ei~~l~~l~-H~ni---------------V~  348 (563)
                      +|+..+.||+|+||.||+|+..  ++.+|+|.++...      .+.+..|..++..+. |++|               |+
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            4778899999999999999875  5689999987432      234667888888774 5654               67


Q ss_pred             EeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccc
Q 044997          349 STFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEE  428 (563)
Q Consensus       349 e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~  428 (563)
                      ||+++|+|.+++..     ...+++.++..++.|++.||+|||+++   |+||||||+|||+++++.+||+|||+++...
T Consensus        81 E~~~~g~L~~~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~  152 (323)
T cd05616          81 EYVNGGDLMYQIQQ-----VGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENM  152 (323)
T ss_pred             cCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecC
Confidence            99999999888864     346899999999999999999999987   9999999999999999999999999987432


Q ss_pred             cccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCch-------
Q 044997          429 RTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPT-------  501 (563)
Q Consensus       429 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~-------  501 (563)
                      ...   .......||+.|+|||++.+..             ++.++|||||||++|||++|+.||........       
T Consensus       153 ~~~---~~~~~~~gt~~y~aPE~~~~~~-------------~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~  216 (323)
T cd05616         153 WDG---VTTKTFCGTPDYIAPEIIAYQP-------------YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH  216 (323)
T ss_pred             CCC---CccccCCCChhhcCHHHhcCCC-------------CCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Confidence            111   1223457899999999886544             48899999999999999999999975432110       


Q ss_pred             ---hhHHHHHHHHHHHHHhhccCCCCCCCH
Q 044997          502 ---KMKSLITIMAAVAEWCLNEDAVDRPEM  528 (563)
Q Consensus       502 ---~~~~~~~~l~~li~~cl~~dP~~RPs~  528 (563)
                         .+..+...+.+++.+|++.||.+|++.
T Consensus       217 ~~~~p~~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         217 NVAYPKSMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             CCCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence               112345668999999999999999984

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=2.1e-34  Score=288.58  Aligned_cols=228  Identities=23%  Similarity=0.384  Sum_probs=183.7

Q ss_pred             cCCCccceecccCcEEEEEEEECC-----ceEEEEEeccCC----hHHHHHHHHHHHhccccce--------------EE
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLGD-----REAAIKKMRSNK----SKEFFAELKVLCKIHHINV--------------FI  348 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~~-----~~vavK~~~~~~----~~~f~~Ei~~l~~l~H~ni--------------V~  348 (563)
                      ++|...+.||+|+||.||+|...+     ..+|||......    .+.|.+|+.++++++|+|+              |+
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~lv~   85 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITENPVWIVM   85 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcCCCcEEEE
Confidence            457788999999999999998632     368999886543    3578999999999999997              57


Q ss_pred             EeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccc
Q 044997          349 STFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEE  428 (563)
Q Consensus       349 e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~  428 (563)
                      ||+++|+|.+++...    ...+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||+++...
T Consensus        86 e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~  158 (270)
T cd05056          86 ELAPLGELRSYLQVN----KYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLE  158 (270)
T ss_pred             EcCCCCcHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeecc
Confidence            899999999998642    345899999999999999999999987   9999999999999999999999999987654


Q ss_pred             cccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCCCcCCCCCc-------
Q 044997          429 RTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIRDDSEP-------  500 (563)
Q Consensus       429 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p~~~~~~~~-------  500 (563)
                      .....  ..+...++..|+|||.+....             ++.++||||||+++||+++ |+.||.......       
T Consensus       159 ~~~~~--~~~~~~~~~~y~aPE~~~~~~-------------~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~  223 (270)
T cd05056         159 DESYY--KASKGKLPIKWMAPESINFRR-------------FTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIEN  223 (270)
T ss_pred             cccce--ecCCCCccccccChhhhccCC-------------CCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc
Confidence            32111  112233456899999875433             4789999999999999996 999986543211       


Q ss_pred             ----hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 044997          501 ----TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMIT  541 (563)
Q Consensus       501 ----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~  541 (563)
                          .....++..+.+++.+|+..+|.+||++.++++.|+++..+
T Consensus       224 ~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~  268 (270)
T cd05056         224 GERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE  268 (270)
T ss_pred             CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence                11223456799999999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1.3e-34  Score=304.36  Aligned_cols=219  Identities=27%  Similarity=0.394  Sum_probs=172.0

Q ss_pred             CCCccceecccCcEEEEEEEE--CCceEEEEEeccC-----ChHHHHHHHHHHHhccccceE------------------
Q 044997          293 NFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSN-----KSKEFFAELKVLCKIHHINVF------------------  347 (563)
Q Consensus       293 ~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~-----~~~~f~~Ei~~l~~l~H~niV------------------  347 (563)
                      +|+..+.||+|+||.||++..  +++.||||++...     ..+++.+|+++++.++|+||+                  
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            477889999999999999986  5789999998643     235688999999999999973                  


Q ss_pred             --EEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCc
Q 044997          348 --ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK  425 (563)
Q Consensus       348 --~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~  425 (563)
                        +||+. ++|.+++..     ...+++..+..++.|++.||+|||+++   ++||||||+|||+++++.+||+|||+++
T Consensus        81 lv~e~~~-~~l~~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~  151 (372)
T cd07853          81 VVTELMQ-SDLHKIIVS-----PQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLAR  151 (372)
T ss_pred             EEeeccc-cCHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEecccccee
Confidence              34443 455555432     356899999999999999999999997   9999999999999999999999999998


Q ss_pred             ccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCch----
Q 044997          426 LEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPT----  501 (563)
Q Consensus       426 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~----  501 (563)
                      .......  .......++..|+|||.+.+..            .++.++|||||||++|||++|+.||........    
T Consensus       152 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~------------~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i  217 (372)
T cd07853         152 VEEPDES--KHMTQEVVTQYYRAPEILMGSR------------HYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLI  217 (372)
T ss_pred             ecccCcc--ccCCCCCcCCCcCCHHHHcCCC------------CCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHH
Confidence            6433221  1223346789999999875432            347899999999999999999999865432100    


Q ss_pred             ----------h----------------------------hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          502 ----------K----------------------------MKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       502 ----------~----------------------------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                                .                            .....+.+.+++.+||+.||.+|||+.|+++.
T Consensus       218 ~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  288 (372)
T cd07853         218 TDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH  288 (372)
T ss_pred             HHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence                      0                            00113457899999999999999999999874

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=2.4e-34  Score=285.71  Aligned_cols=220  Identities=24%  Similarity=0.411  Sum_probs=177.0

Q ss_pred             ceecccCcEEEEEEEECC-----ceEEEEEeccCCh----HHHHHHHHHHHhccccce--------------EEEeecCC
Q 044997          298 RIIGRGGFGNVYFGLLGD-----REAAIKKMRSNKS----KEFFAELKVLCKIHHINV--------------FISTFGNG  354 (563)
Q Consensus       298 ~~LG~G~fG~Vy~g~~~~-----~~vavK~~~~~~~----~~f~~Ei~~l~~l~H~ni--------------V~e~~~~g  354 (563)
                      +.||+|++|.||+|.+..     ..+|||.++....    ++|.+|++++++++|+||              |+||+++|
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~~~~~   80 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLTHPLMMVTELAPLG   80 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcCCeEEEEEEecCCC
Confidence            468999999999998732     3589999876543    578899999999999997              46888899


Q ss_pred             CcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccccccccc
Q 044997          355 SLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKE  434 (563)
Q Consensus       355 sL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~  434 (563)
                      +|.+++....   ...++|.....++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||+++.........
T Consensus        81 ~L~~~l~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~  154 (257)
T cd05040          81 SLLDRLRKDA---LGHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY  154 (257)
T ss_pred             cHHHHHHhcc---cccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccccccce
Confidence            9999987631   156899999999999999999999987   9999999999999999999999999998764432211


Q ss_pred             cccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCCCcCCCCCc------------h
Q 044997          435 MLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIRDDSEP------------T  501 (563)
Q Consensus       435 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p~~~~~~~~------------~  501 (563)
                      .......++..|+|||++....             ++.++||||||+++|||++ |+.|+.......            .
T Consensus       155 ~~~~~~~~~~~y~~pE~~~~~~-------------~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~  221 (257)
T cd05040         155 VMEEHLKVPFAWCAPESLRTRT-------------FSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLE  221 (257)
T ss_pred             ecccCCCCCceecCHHHhcccC-------------cCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCC
Confidence            1122345778999999875443             4889999999999999999 999985432111            1


Q ss_pred             hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 044997          502 KMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILS  536 (563)
Q Consensus       502 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  536 (563)
                      .....+..+.+++.+||+.+|++||++.++++.|.
T Consensus       222 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         222 RPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence            11233466899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-34  Score=287.67  Aligned_cols=227  Identities=25%  Similarity=0.449  Sum_probs=183.7

Q ss_pred             HhcCCCccceecccCcEEEEEEEEC-CceEEEEEeccCC--hHHHHHHHHHHHhccccce---------------EEEee
Q 044997          290 ATNNFDESRIIGRGGFGNVYFGLLG-DREAAIKKMRSNK--SKEFFAELKVLCKIHHINV---------------FISTF  351 (563)
Q Consensus       290 ~~~~f~~~~~LG~G~fG~Vy~g~~~-~~~vavK~~~~~~--~~~f~~Ei~~l~~l~H~ni---------------V~e~~  351 (563)
                      ..++|...+.||+|+||.||+|..+ ++.+|||.+....  .+++.+|++++++++|+|+               |+||+
T Consensus         4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   83 (261)
T cd05034           4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM   83 (261)
T ss_pred             chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence            3467888999999999999999875 4679999987543  4679999999999999997               57889


Q ss_pred             cCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccccccc
Q 044997          352 GNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTN  431 (563)
Q Consensus       352 ~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~  431 (563)
                      ++++|.+++...   ....+++.++..++.|++.||.|||+.+   ++|+||||+||++++++.+||+|||+++......
T Consensus        84 ~~~~L~~~i~~~---~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~  157 (261)
T cd05034          84 SKGSLLDFLKSG---EGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDE  157 (261)
T ss_pred             CCCCHHHHHhcc---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchh
Confidence            999999999752   2356899999999999999999999987   9999999999999999999999999987654221


Q ss_pred             ccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCCCcCCCCCc----------
Q 044997          432 EKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIRDDSEP----------  500 (563)
Q Consensus       432 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p~~~~~~~~----------  500 (563)
                      ..  ......++..|+|||.+.+.             .++.++||||||+++||+++ |+.||.......          
T Consensus       158 ~~--~~~~~~~~~~y~~PE~~~~~-------------~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~  222 (261)
T cd05034         158 YT--AREGAKFPIKWTAPEAANYG-------------RFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYR  222 (261)
T ss_pred             hh--hhhccCCCccccCHHHhccC-------------CcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Confidence            11  11122345689999987543             34789999999999999998 888885433211          


Q ss_pred             -hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 044997          501 -TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQ  537 (563)
Q Consensus       501 -~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  537 (563)
                       ......+..+.+++.+||+.+|++||+++++.+.|+.
T Consensus       223 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         223 MPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence             1111234568999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=2.2e-34  Score=286.93  Aligned_cols=226  Identities=24%  Similarity=0.432  Sum_probs=183.0

Q ss_pred             hcCCCccceecccCcEEEEEEEEC-CceEEEEEeccCC--hHHHHHHHHHHHhccccce--------------EEEeecC
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLLG-DREAAIKKMRSNK--SKEFFAELKVLCKIHHINV--------------FISTFGN  353 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~~-~~~vavK~~~~~~--~~~f~~Ei~~l~~l~H~ni--------------V~e~~~~  353 (563)
                      .++|+..+.||+|+||.||++... +..+|+|.++...  .+.|.+|++++++++|+|+              ++||+++
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~v~e~~~~   84 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITEFMAK   84 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEecCCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcCCCeEEEEEeCCC
Confidence            467888999999999999999874 5679999887543  3678999999999999987              5789999


Q ss_pred             CCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccccccccc
Q 044997          354 GSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEK  433 (563)
Q Consensus       354 gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~  433 (563)
                      |+|.+++...   ....++|..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++....... 
T Consensus        85 ~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-  157 (260)
T cd05073          85 GSLLDFLKSD---EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY-  157 (260)
T ss_pred             CcHHHHHHhC---CccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCc-
Confidence            9999998652   2356899999999999999999999987   99999999999999999999999999875533211 


Q ss_pred             ccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCCCcCCCCCc-----------h
Q 044997          434 EMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIRDDSEP-----------T  501 (563)
Q Consensus       434 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p~~~~~~~~-----------~  501 (563)
                       .......++..|+|||++...             .++.++|||||||++||+++ |+.||.......           .
T Consensus       158 -~~~~~~~~~~~y~~PE~~~~~-------------~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~  223 (260)
T cd05073         158 -TAREGAKFPIKWTAPEAINFG-------------SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMP  223 (260)
T ss_pred             -ccccCCcccccccCHhHhccC-------------CcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCC
Confidence             111223456789999987543             34889999999999999999 888886433211           1


Q ss_pred             hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 044997          502 KMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQ  537 (563)
Q Consensus       502 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  537 (563)
                      ........+.+++.+||+.+|++||++.++.+.|+.
T Consensus       224 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         224 RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            112334568999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1.7e-34  Score=293.51  Aligned_cols=230  Identities=24%  Similarity=0.386  Sum_probs=179.2

Q ss_pred             hcCCCccceecccCcEEEEEEEEC------------------CceEEEEEeccCC----hHHHHHHHHHHHhccccce--
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLLG------------------DREAAIKKMRSNK----SKEFFAELKVLCKIHHINV--  346 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~~------------------~~~vavK~~~~~~----~~~f~~Ei~~l~~l~H~ni--  346 (563)
                      .++|+..+.||+|+||.||++...                  ...+|+|.++...    .++|.+|++++++++|+||  
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~   83 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR   83 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence            356888999999999999998542                  2358999987542    3568899999999999996  


Q ss_pred             -------------EEEeecCCCccccccccccc------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCC
Q 044997          347 -------------FISTFGNGSLSDHLHDPLLK------GHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSN  407 (563)
Q Consensus       347 -------------V~e~~~~gsL~~~L~~~~~~------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~N  407 (563)
                                   |+||+++|+|.+++......      ....+++.++..++.|++.||+|||+++   ++||||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~N  160 (296)
T cd05095          84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhe
Confidence                         57899999999998753211      1235889999999999999999999997   9999999999


Q ss_pred             eEecCCCcEEEeecCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHH
Q 044997          408 ILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELI  487 (563)
Q Consensus       408 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ell  487 (563)
                      ||+++++.+||+|||+++........ .......++..|+|||....+             .++.++|||||||++|||+
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~-------------~~~~~~DiwSlG~~l~el~  226 (296)
T cd05095         161 CLVGKNYTIKIADFGMSRNLYSGDYY-RIQGRAVLPIRWMSWESILLG-------------KFTTASDVWAFGVTLWEIL  226 (296)
T ss_pred             EEEcCCCCEEeccCcccccccCCcce-eccCcCcCccccCCHHHHhcC-------------CccchhhhhHHHHHHHHHH
Confidence            99999999999999998865332211 112223456789999976443             3588999999999999999


Q ss_pred             c--CCCCCcCCCCCc------------------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 044997          488 T--GKRALIRDDSEP------------------TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQ  537 (563)
Q Consensus       488 t--g~~p~~~~~~~~------------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  537 (563)
                      +  |..|+.......                  .........+.+++.+||+.||.+||++.+|.+.|++
T Consensus       227 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  296 (296)
T cd05095         227 TLCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE  296 (296)
T ss_pred             HhCCCCCccccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            8  667775332111                  0011234668999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1.9e-34  Score=298.56  Aligned_cols=234  Identities=23%  Similarity=0.377  Sum_probs=182.9

Q ss_pred             cCCCccceecccCcEEEEEEEEC---------CceEEEEEeccCC----hHHHHHHHHHHHhc-cccce-----------
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG---------DREAAIKKMRSNK----SKEFFAELKVLCKI-HHINV-----------  346 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~---------~~~vavK~~~~~~----~~~f~~Ei~~l~~l-~H~ni-----------  346 (563)
                      .+|...+.||+|+||.||+++..         ...+|+|.++...    .+++.+|++++.++ +|+||           
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG   91 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence            46888999999999999999752         1368999887532    35688999999999 89997           


Q ss_pred             ----EEEeecCCCcccccccccc-----------cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEec
Q 044997          347 ----FISTFGNGSLSDHLHDPLL-----------KGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLD  411 (563)
Q Consensus       347 ----V~e~~~~gsL~~~L~~~~~-----------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~  411 (563)
                          ++||+++|+|.+++.....           .....++|.+++.++.|++.||.|||+++   ++||||||+|||++
T Consensus        92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~  168 (334)
T cd05100          92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVT  168 (334)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEc
Confidence                4689999999999864210           12345899999999999999999999987   99999999999999


Q ss_pred             CCCcEEEeecCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CC
Q 044997          412 DGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GK  490 (563)
Q Consensus       412 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~  490 (563)
                      +++.+||+|||+++........ .......++..|+|||.+.+..             ++.++||||||+++|||++ |.
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~-------------~~~~~Di~slG~il~el~~~g~  234 (334)
T cd05100         169 EDNVMKIADFGLARDVHNIDYY-KKTTNGRLPVKWMAPEALFDRV-------------YTHQSDVWSFGVLLWEIFTLGG  234 (334)
T ss_pred             CCCcEEECCcccceeccccccc-ccccCCCcCceEcCHHHhccCC-------------cCchhhhHHHHHHHHHHHhcCC
Confidence            9999999999999855332111 1112223456799999875443             4789999999999999998 77


Q ss_pred             CCCcCCCCCc-----------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcC
Q 044997          491 RALIRDDSEP-----------TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITS  542 (563)
Q Consensus       491 ~p~~~~~~~~-----------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~  542 (563)
                      .||.......           .........+.+++.+||+.+|.+||++.|+++.|.++...+
T Consensus       235 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~  297 (334)
T cd05100         235 SPYPGIPVEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT  297 (334)
T ss_pred             CCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence            7775432111           111223456889999999999999999999999999988544

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=2.2e-34  Score=290.96  Aligned_cols=217  Identities=22%  Similarity=0.314  Sum_probs=168.4

Q ss_pred             CCCccceecccCcEEEEEEEEC--CceEEEEEeccCC-----hHHHHHHHHHHHhc---cccceE---------------
Q 044997          293 NFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNK-----SKEFFAELKVLCKI---HHINVF---------------  347 (563)
Q Consensus       293 ~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~-----~~~f~~Ei~~l~~l---~H~niV---------------  347 (563)
                      +|+..+.||+|+||.||+|+..  ++.+|+|.++...     ...+.+|+++++++   +||||+               
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            4778899999999999999874  6789999886432     23566788777665   699973               


Q ss_pred             -----EEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecC
Q 044997          348 -----ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFG  422 (563)
Q Consensus       348 -----~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFG  422 (563)
                           +||+. ++|.+++...   ....+++..+..++.|++.||+|||+++   ++||||||+|||+++++.+||+|||
T Consensus        81 ~~~lv~e~~~-~~l~~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg  153 (288)
T cd07863          81 KVTLVFEHVD-QDLRTYLDKV---PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFG  153 (288)
T ss_pred             eEEEEEcccc-cCHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccC
Confidence                 24443 4666666531   2345899999999999999999999997   9999999999999999999999999


Q ss_pred             CCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCch-
Q 044997          423 LVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPT-  501 (563)
Q Consensus       423 la~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~-  501 (563)
                      +++......    ......||..|+|||++.+..             ++.++|||||||++|||++|+.||........ 
T Consensus       154 ~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~-------------~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~  216 (288)
T cd07863         154 LARIYSCQM----ALTPVVVTLWYRAPEVLLQST-------------YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQL  216 (288)
T ss_pred             ccccccCcc----cCCCccccccccCchHhhCCC-------------CCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHH
Confidence            998653221    123356889999999885443             48899999999999999999998854322100 


Q ss_pred             ------------------------------------hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          502 ------------------------------------KMKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       502 ------------------------------------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                                                          ....+.+.+.+++.+|++.||++||++.|++.
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         217 GKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             HHHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence                                                00123445789999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=1.3e-34  Score=297.62  Aligned_cols=211  Identities=26%  Similarity=0.432  Sum_probs=169.6

Q ss_pred             ceecccCcEEEEEEEEC--CceEEEEEeccC------ChHHHHHHHHHHHh-ccccce---------------EEEeecC
Q 044997          298 RIIGRGGFGNVYFGLLG--DREAAIKKMRSN------KSKEFFAELKVLCK-IHHINV---------------FISTFGN  353 (563)
Q Consensus       298 ~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~------~~~~f~~Ei~~l~~-l~H~ni---------------V~e~~~~  353 (563)
                      +.||+|+||.||+|+..  ++.+|||.++..      ..+.+..|..++.. ++||||               |+||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999874  578999998753      23456778888876 489996               6799999


Q ss_pred             CCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccccccccc
Q 044997          354 GSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEK  433 (563)
Q Consensus       354 gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~  433 (563)
                      |+|.+++..     ...+++.++..++.|++.||+|||+++   ++||||||+|||+++++.+||+|||+++....... 
T Consensus        81 g~L~~~l~~-----~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-  151 (316)
T cd05619          81 GDLMFHIQS-----CHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-  151 (316)
T ss_pred             CcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-
Confidence            999998864     346899999999999999999999987   99999999999999999999999999874322111 


Q ss_pred             ccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc----------hhh
Q 044997          434 EMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP----------TKM  503 (563)
Q Consensus       434 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~----------~~~  503 (563)
                        ......||..|+|||++.+..             ++.++|||||||++|||++|+.||...+...          ...
T Consensus       152 --~~~~~~gt~~y~aPE~~~~~~-------------~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~  216 (316)
T cd05619         152 --KTCTFCGTPDYIAPEILLGQK-------------YNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYP  216 (316)
T ss_pred             --ceeeecCCccccCHHHHcCCC-------------CCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC
Confidence              123356899999999885544             4789999999999999999999996543211          011


Q ss_pred             HHHHHHHHHHHHHhhccCCCCCCCHH-HHH
Q 044997          504 KSLITIMAAVAEWCLNEDAVDRPEMR-DIV  532 (563)
Q Consensus       504 ~~~~~~l~~li~~cl~~dP~~RPs~~-evl  532 (563)
                      ..+...+.+++.+||+.||.+||++. ++.
T Consensus       217 ~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05619         217 RWLTREAKDILVKLFVREPERRLGVKGDIR  246 (316)
T ss_pred             ccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence            12345588999999999999999997 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=1.6e-34  Score=291.41  Aligned_cols=228  Identities=25%  Similarity=0.415  Sum_probs=179.9

Q ss_pred             cCCCccceecccCcEEEEEEEE-------CCceEEEEEeccCC---hHHHHHHHHHHHhccccce---------------
Q 044997          292 NNFDESRIIGRGGFGNVYFGLL-------GDREAAIKKMRSNK---SKEFFAELKVLCKIHHINV---------------  346 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~-------~~~~vavK~~~~~~---~~~f~~Ei~~l~~l~H~ni---------------  346 (563)
                      ++|...++||+|+||.||++..       ++..+|+|.++...   .+.|.+|++++++++|+||               
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM   84 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence            4577789999999999999964       24578899876543   3579999999999999997               


Q ss_pred             EEEeecCCCcccccccccc----------cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcE
Q 044997          347 FISTFGNGSLSDHLHDPLL----------KGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRA  416 (563)
Q Consensus       347 V~e~~~~gsL~~~L~~~~~----------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~  416 (563)
                      ++||+++|+|.+++.....          .....+++..+..++.|++.||+|||+++   ++||||||+|||+++++.+
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~  161 (280)
T cd05092          85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV  161 (280)
T ss_pred             EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence            4689999999998864210          01135899999999999999999999987   9999999999999999999


Q ss_pred             EEeecCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCCCcC
Q 044997          417 KVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIR  495 (563)
Q Consensus       417 kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p~~~  495 (563)
                      ||+|||+++........ .......+++.|+|||.+.+..             ++.++|||||||++|||++ |+.||..
T Consensus       162 kL~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~-------------~~~~~Di~slG~il~el~~~g~~p~~~  227 (280)
T cd05092         162 KIGDFGMSRDIYSTDYY-RVGGRTMLPIRWMPPESILYRK-------------FTTESDIWSFGVVLWEIFTYGKQPWYQ  227 (280)
T ss_pred             EECCCCceeEcCCCcee-ecCCCccccccccCHHHhccCC-------------cCchhhHHHHHHHHHHHHcCCCCCCcc
Confidence            99999998754322111 1122234577899999875443             4889999999999999998 8888854


Q ss_pred             CCCC-----------chhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 044997          496 DDSE-----------PTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILS  536 (563)
Q Consensus       496 ~~~~-----------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  536 (563)
                      ....           .......+..+.+++.+||+.||.+||++.||++.|+
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         228 LSNTEAIECITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             CCHHHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence            3221           1112234566899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=2.3e-34  Score=300.91  Aligned_cols=217  Identities=23%  Similarity=0.317  Sum_probs=170.2

Q ss_pred             HhcCCCccceecccCcEEEEEEEE--CCceEEEEEeccC-----ChHHHHHHHHHHHhccccceEE--------------
Q 044997          290 ATNNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSN-----KSKEFFAELKVLCKIHHINVFI--------------  348 (563)
Q Consensus       290 ~~~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~-----~~~~f~~Ei~~l~~l~H~niV~--------------  348 (563)
                      ..++|...+.||+|+||.||++..  .+..+|+|.+...     ..+++.+|+.++++++||||+.              
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            457899999999999999999977  4788999998643     2356889999999999999842              


Q ss_pred             -------EeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeec
Q 044997          349 -------STFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADF  421 (563)
Q Consensus       349 -------e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DF  421 (563)
                             ||++ ++|.+.++       ..+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+||
T Consensus        99 ~~~~lv~e~~~-~~l~~~~~-------~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Df  167 (359)
T cd07876          99 QDVYLVMELMD-ANLCQVIH-------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDF  167 (359)
T ss_pred             ceeEEEEeCCC-cCHHHHHh-------ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecC
Confidence                   2222 22322221       34788899999999999999999997   999999999999999999999999


Q ss_pred             CCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCch
Q 044997          422 GLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPT  501 (563)
Q Consensus       422 Gla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~  501 (563)
                      |+++.....    .......||..|+|||.+.+..             ++.++|||||||++|||++|+.||...+....
T Consensus       168 g~a~~~~~~----~~~~~~~~t~~y~aPE~~~~~~-------------~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~  230 (359)
T cd07876         168 GLARTACTN----FMMTPYVVTRYYRAPEVILGMG-------------YKENVDIWSVGCIMGELVKGSVIFQGTDHIDQ  230 (359)
T ss_pred             CCccccccC----ccCCCCcccCCCCCchhccCCC-------------CCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            999753321    1223356899999999886544             47899999999999999999999965432100


Q ss_pred             --------------h-------h-------------------------------HHHHHHHHHHHHHhhccCCCCCCCHH
Q 044997          502 --------------K-------M-------------------------------KSLITIMAAVAEWCLNEDAVDRPEMR  529 (563)
Q Consensus       502 --------------~-------~-------------------------------~~~~~~l~~li~~cl~~dP~~RPs~~  529 (563)
                                    .       .                               ....+.+.+++.+||+.||++|||+.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~  310 (359)
T cd07876         231 WNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVD  310 (359)
T ss_pred             HHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHH
Confidence                          0       0                               00123478999999999999999999


Q ss_pred             HHHHH
Q 044997          530 DIVAI  534 (563)
Q Consensus       530 evl~~  534 (563)
                      |+++.
T Consensus       311 e~l~h  315 (359)
T cd07876         311 EALRH  315 (359)
T ss_pred             HHhcC
Confidence            99874

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=9.2e-35  Score=300.39  Aligned_cols=212  Identities=25%  Similarity=0.370  Sum_probs=170.0

Q ss_pred             ceecccCcEEEEEEEEC--CceEEEEEeccCC------hHHHHHHHHHHHhc-cccce---------------EEEeecC
Q 044997          298 RIIGRGGFGNVYFGLLG--DREAAIKKMRSNK------SKEFFAELKVLCKI-HHINV---------------FISTFGN  353 (563)
Q Consensus       298 ~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~------~~~f~~Ei~~l~~l-~H~ni---------------V~e~~~~  353 (563)
                      +.||+|+||.||+++..  ++.+|+|.++...      .+.+.+|..++.++ +||||               |+||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            46999999999999874  6789999987532      24577899999998 79997               5799999


Q ss_pred             CCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccccccccc
Q 044997          354 GSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEK  433 (563)
Q Consensus       354 gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~  433 (563)
                      |+|.+++..     ...+++..+..++.|++.||+|||+++   ++||||||+|||+++++.+||+|||+++......  
T Consensus        81 g~L~~~~~~-----~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~--  150 (329)
T cd05588          81 GDLMFHMQR-----QRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG--  150 (329)
T ss_pred             CCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccCC--
Confidence            999888754     356999999999999999999999997   9999999999999999999999999987422111  


Q ss_pred             ccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc-------------
Q 044997          434 EMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP-------------  500 (563)
Q Consensus       434 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~-------------  500 (563)
                       .......||+.|+|||++.+..             ++.++|||||||++|||++|+.||.......             
T Consensus       151 -~~~~~~~gt~~y~aPE~~~~~~-------------~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~  216 (329)
T cd05588         151 -DTTSTFCGTPNYIAPEILRGED-------------YGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQV  216 (329)
T ss_pred             -CccccccCCccccCHHHHcCCC-------------CCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHH
Confidence             1223457899999999886544             4789999999999999999999995321100             


Q ss_pred             ------hhhHHHHHHHHHHHHHhhccCCCCCCC------HHHHHH
Q 044997          501 ------TKMKSLITIMAAVAEWCLNEDAVDRPE------MRDIVA  533 (563)
Q Consensus       501 ------~~~~~~~~~l~~li~~cl~~dP~~RPs------~~evl~  533 (563)
                            ..+..+...+.+++.+||+.||.+||+      +.++++
T Consensus       217 ~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~  261 (329)
T cd05588         217 ILEKQIRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS  261 (329)
T ss_pred             HHcCCCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence                  001123455889999999999999998      566654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.7e-35  Score=290.93  Aligned_cols=219  Identities=24%  Similarity=0.450  Sum_probs=188.6

Q ss_pred             hcCCCccceecccCcEEEEEEEE--CCceEEEEEeccCCh------HHHHHHHHHHHhccccce---------------E
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNKS------KEFFAELKVLCKIHHINV---------------F  347 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~~------~~f~~Ei~~l~~l~H~ni---------------V  347 (563)
                      ..+|+..+.||+|.||.|-+++.  .|+.||||.++++..      -.+.+|+++|..|+||||               |
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv  131 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV  131 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence            35677889999999999999965  589999999987643      237899999999999997               6


Q ss_pred             EEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccc
Q 044997          348 ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLE  427 (563)
Q Consensus       348 ~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~  427 (563)
                      |||..+|.|.+|+.+     .+.|++.+..++++||..|+.|+|.+.   ++|||||.+|||+|.++++||+|||++.++
T Consensus       132 MEYaS~GeLYDYiSe-----r~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly  203 (668)
T KOG0611|consen  132 MEYASGGELYDYISE-----RGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLY  203 (668)
T ss_pred             EEecCCccHHHHHHH-----hccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhh
Confidence            899999999999976     467999999999999999999999987   999999999999999999999999999876


Q ss_pred             ccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCchhhH---
Q 044997          428 ERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKMK---  504 (563)
Q Consensus       428 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~~~~---  504 (563)
                      ....    ..+.++|++-|.+||++.+.+|.            ++..|-||+||+||-|+.|.-||.+.+... ..+   
T Consensus       204 ~~~k----fLqTFCGSPLYASPEIvNG~PY~------------GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~-lvrQIs  266 (668)
T KOG0611|consen  204 ADKK----FLQTFCGSPLYASPEIVNGTPYK------------GPEVDSWSLGVLLYTLVYGTMPFDGRDHKR-LVRQIS  266 (668)
T ss_pred             cccc----HHHHhcCCcccCCccccCCCCCC------------CCccchhhHHHHHHHHhhcccccCCchHHH-HHHHhh
Confidence            5432    45678999999999999998885            789999999999999999999998765321 111   


Q ss_pred             -------HHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          505 -------SLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       505 -------~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                             .-+.....||++||..+|++|-|+.+|...
T Consensus       267 ~GaYrEP~~PSdA~gLIRwmLmVNP~RRATieDiAsH  303 (668)
T KOG0611|consen  267 RGAYREPETPSDASGLIRWMLMVNPERRATIEDIASH  303 (668)
T ss_pred             cccccCCCCCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence                   112337789999999999999999999875

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=7.1e-35  Score=306.00  Aligned_cols=229  Identities=22%  Similarity=0.319  Sum_probs=181.4

Q ss_pred             HHHHHhcCCCccceecccCcEEEEEEEEC--CceEEEEEeccC------ChHHHHHHHHHHHhccccce-----------
Q 044997          286 EIEEATNNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSN------KSKEFFAELKVLCKIHHINV-----------  346 (563)
Q Consensus       286 el~~~~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~------~~~~f~~Ei~~l~~l~H~ni-----------  346 (563)
                      ++....++|+..+.||+|+||.||+++..  ++.+|+|.++..      ..+.+.+|+++++.++||||           
T Consensus        37 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~  116 (370)
T cd05621          37 KLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDK  116 (370)
T ss_pred             hcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence            33444578999999999999999999884  678999998642      23457889999999999997           


Q ss_pred             ----EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecC
Q 044997          347 ----FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFG  422 (563)
Q Consensus       347 ----V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFG  422 (563)
                          |+||+++|+|.+++..      ..+++..+..++.|++.||+|||+++   |+||||||+|||+++++.+||+|||
T Consensus       117 ~~~lv~Ey~~gg~L~~~l~~------~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG  187 (370)
T cd05621         117 YLYMVMEYMPGGDLVNLMSN------YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFG  187 (370)
T ss_pred             EEEEEEcCCCCCcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecc
Confidence                5799999999998864      34788899999999999999999987   9999999999999999999999999


Q ss_pred             CCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCch-
Q 044997          423 LVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPT-  501 (563)
Q Consensus       423 la~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~-  501 (563)
                      +++.......  .......||+.|+|||++.....         .+.++.++||||+||++|||++|+.||........ 
T Consensus       188 ~a~~~~~~~~--~~~~~~~gt~~Y~aPE~~~~~~~---------~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~  256 (370)
T cd05621         188 TCMKMDETGM--VRCDTAVGTPDYISPEVLKSQGG---------DGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTY  256 (370)
T ss_pred             cceecccCCc--eecccCCCCcccCCHHHHhccCC---------CCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHH
Confidence            9986532221  11234579999999999854321         23357899999999999999999999975432110 


Q ss_pred             -------------hhHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 044997          502 -------------KMKSLITIMAAVAEWCLNEDAVD--RPEMRDIVAI  534 (563)
Q Consensus       502 -------------~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~  534 (563)
                                   ....+...+.+++.+|+..++.+  ||++.|+++.
T Consensus       257 ~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         257 SKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             HHHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence                         01123556889999999855543  8899998875

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=2.1e-34  Score=291.49  Aligned_cols=230  Identities=28%  Similarity=0.442  Sum_probs=181.0

Q ss_pred             hcCCCccceecccCcEEEEEEEEC-------CceEEEEEeccCC----hHHHHHHHHHHHhccccce-------------
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLLG-------DREAAIKKMRSNK----SKEFFAELKVLCKIHHINV-------------  346 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~~-------~~~vavK~~~~~~----~~~f~~Ei~~l~~l~H~ni-------------  346 (563)
                      .++|+..+.||+|+||.||++...       +..+|+|.+....    .++|.+|++++++++|||+             
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~   83 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM   83 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence            457888999999999999999863       4679999987543    3568899999999999997             


Q ss_pred             --EEEeecCCCcccccccccc-----------------cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCC
Q 044997          347 --FISTFGNGSLSDHLHDPLL-----------------KGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSN  407 (563)
Q Consensus       347 --V~e~~~~gsL~~~L~~~~~-----------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~N  407 (563)
                        ++||+++|+|.+++.....                 .....+++.+++.++.|++.||.|||+.+   ++||||||+|
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n  160 (288)
T cd05050          84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN  160 (288)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence              5688999999999864210                 11235889999999999999999999987   9999999999


Q ss_pred             eEecCCCcEEEeecCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHH
Q 044997          408 ILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELI  487 (563)
Q Consensus       408 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ell  487 (563)
                      |++++++.+||+|||+++......... .......+..|+|||.+.+..             ++.++|||||||++|||+
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~-------------~~~~~Dv~slG~il~el~  226 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADYYK-ASENDAIPIRWMPPESIFYNR-------------YTTESDVWAYGVVLWEIF  226 (288)
T ss_pred             eEecCCCceEECccccceecccCcccc-ccCCCccChhhcCHHHHhcCC-------------CCchhHHHHHHHHHHHHH
Confidence            999999999999999987543221111 111223466799999875443             488999999999999999


Q ss_pred             c-CCCCCcCCCCCc-----------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 044997          488 T-GKRALIRDDSEP-----------TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQ  537 (563)
Q Consensus       488 t-g~~p~~~~~~~~-----------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  537 (563)
                      + |..||.......           ......+..+.+++.+||+.||.+||++.|+++.|++
T Consensus       227 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         227 SYGMQPYYGMAHEEVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             hCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence            8 777875432111           0112344678999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=2.9e-34  Score=294.34  Aligned_cols=221  Identities=24%  Similarity=0.309  Sum_probs=166.6

Q ss_pred             cceecccCcEEEEEEEEC----CceEEEEEeccCC-hHHHHHHHHHHHhccccceE-----------------EEeecCC
Q 044997          297 SRIIGRGGFGNVYFGLLG----DREAAIKKMRSNK-SKEFFAELKVLCKIHHINVF-----------------ISTFGNG  354 (563)
Q Consensus       297 ~~~LG~G~fG~Vy~g~~~----~~~vavK~~~~~~-~~~f~~Ei~~l~~l~H~niV-----------------~e~~~~g  354 (563)
                      ..+||+|+||.||+|+..    +..+|+|.++... ...+.+|++++++++||||+                 +||++ +
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~   84 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE-H   84 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC-C
Confidence            468999999999999864    3679999987654 45688999999999999983                 35544 4


Q ss_pred             Cccccccccc----ccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEe----cCCCcEEEeecCCCcc
Q 044997          355 SLSDHLHDPL----LKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILL----DDGLRAKVADFGLVKL  426 (563)
Q Consensus       355 sL~~~L~~~~----~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl----~~~~~~kl~DFGla~~  426 (563)
                      +|.+++....    ......+++..+..++.|++.||.|||+++   ++||||||+|||+    ++++++||+|||+++.
T Consensus        85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~  161 (317)
T cd07867          85 DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARL  161 (317)
T ss_pred             cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccceec
Confidence            5655553211    112245899999999999999999999987   9999999999999    5668999999999986


Q ss_pred             cccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCch-----
Q 044997          427 EERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPT-----  501 (563)
Q Consensus       427 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~-----  501 (563)
                      ...............||..|+|||++.+..            .++.++|||||||++|||++|+.||........     
T Consensus       162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~------------~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~  229 (317)
T cd07867         162 FNSPLKPLADLDPVVVTFWYRAPELLLGAR------------HYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPF  229 (317)
T ss_pred             cCCCcccccccCcceecccccCcHHhcCCC------------ccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccc
Confidence            543322211223456899999999875422            348899999999999999999999854321100     


Q ss_pred             ------------------hhH----------------------------------HHHHHHHHHHHHhhccCCCCCCCHH
Q 044997          502 ------------------KMK----------------------------------SLITIMAAVAEWCLNEDAVDRPEMR  529 (563)
Q Consensus       502 ------------------~~~----------------------------------~~~~~l~~li~~cl~~dP~~RPs~~  529 (563)
                                        ...                                  .....+.+|+.+|++.||.+|||+.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~  309 (317)
T cd07867         230 HHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSE  309 (317)
T ss_pred             cHHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHH
Confidence                              000                                  0012366799999999999999999


Q ss_pred             HHHH
Q 044997          530 DIVA  533 (563)
Q Consensus       530 evl~  533 (563)
                      |+++
T Consensus       310 e~l~  313 (317)
T cd07867         310 QALQ  313 (317)
T ss_pred             HHhc
Confidence            9985

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1.1e-34  Score=298.43  Aligned_cols=212  Identities=25%  Similarity=0.410  Sum_probs=171.8

Q ss_pred             ceecccCcEEEEEEEEC--CceEEEEEeccC------ChHHHHHHHHHHHhc-cccce---------------EEEeecC
Q 044997          298 RIIGRGGFGNVYFGLLG--DREAAIKKMRSN------KSKEFFAELKVLCKI-HHINV---------------FISTFGN  353 (563)
Q Consensus       298 ~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~------~~~~f~~Ei~~l~~l-~H~ni---------------V~e~~~~  353 (563)
                      +.||+|+||.||+++..  ++.+|||.++..      ..+.+.+|.+++..+ +||||               |+||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999884  578999998743      234577899999888 69997               5799999


Q ss_pred             CCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccccccccc
Q 044997          354 GSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEK  433 (563)
Q Consensus       354 gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~  433 (563)
                      |+|.+++..     ...+++.++..++.|++.||.|||+.+   ++||||||+|||+++++.+||+|||+++......  
T Consensus        81 ~~L~~~~~~-----~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--  150 (318)
T cd05570          81 GDLMFHIQR-----SGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--  150 (318)
T ss_pred             CCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCC--
Confidence            999888764     346999999999999999999999987   9999999999999999999999999987422111  


Q ss_pred             ccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc----------hhh
Q 044997          434 EMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP----------TKM  503 (563)
Q Consensus       434 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~----------~~~  503 (563)
                       .......|+..|+|||++.+..             ++.++|||||||++|||++|+.||.......          ...
T Consensus       151 -~~~~~~~g~~~y~aPE~~~~~~-------------~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~  216 (318)
T cd05570         151 -VTTSTFCGTPDYIAPEILSYQP-------------YGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYP  216 (318)
T ss_pred             -CcccceecCccccCHHHhcCCC-------------CCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence             1122346899999999986544             4789999999999999999999996543211          111


Q ss_pred             HHHHHHHHHHHHHhhccCCCCCCCH-----HHHHH
Q 044997          504 KSLITIMAAVAEWCLNEDAVDRPEM-----RDIVA  533 (563)
Q Consensus       504 ~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~  533 (563)
                      ..+...+.+++.+||+.||.+||++     .++++
T Consensus       217 ~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~  251 (318)
T cd05570         217 RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG  251 (318)
T ss_pred             CcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence            2345668999999999999999999     66654

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-34  Score=307.69  Aligned_cols=228  Identities=25%  Similarity=0.382  Sum_probs=186.9

Q ss_pred             ccceecccCcEEEEEEEE--CC----ceEEEEEeccC----ChHHHHHHHHHHHhccccce--------------EEEee
Q 044997          296 ESRIIGRGGFGNVYFGLL--GD----REAAIKKMRSN----KSKEFFAELKVLCKIHHINV--------------FISTF  351 (563)
Q Consensus       296 ~~~~LG~G~fG~Vy~g~~--~~----~~vavK~~~~~----~~~~f~~Ei~~l~~l~H~ni--------------V~e~~  351 (563)
                      ..++||+|+||.||+|.|  ++    .+||||.+...    ..++++.|+-+|.+++|||+              |.+||
T Consensus       700 k~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~~qlvtq~m  779 (1177)
T KOG1025|consen  700 KDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLSTLQLVTQLM  779 (1177)
T ss_pred             hhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccchHHHHHHhc
Confidence            468999999999999987  22    46899988643    35789999999999999997              46999


Q ss_pred             cCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccccccc
Q 044997          352 GNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTN  431 (563)
Q Consensus       352 ~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~  431 (563)
                      +.|+|.+|++..    +..+--...+.+..|||+||.|||++.   +|||||..+|||+.+-..+||.|||+++....+.
T Consensus       780 P~G~LlDyvr~h----r~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~  852 (1177)
T KOG1025|consen  780 PLGCLLDYVREH----RDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE  852 (1177)
T ss_pred             ccchHHHHHHHh----hccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence            999999999873    456888899999999999999999886   9999999999999999999999999999877654


Q ss_pred             ccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCCCcCCCCC-----------
Q 044997          432 EKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIRDDSE-----------  499 (563)
Q Consensus       432 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p~~~~~~~-----------  499 (563)
                      .. .......-.+.|||-|.+...+|             +.++|||||||++||++| |.+|+.+...+           
T Consensus       853 ~e-y~~~~gK~pikwmale~i~~~~~-------------thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geR  918 (1177)
T KOG1025|consen  853 KE-YSAPGGKVPIKWMALESIRIRKY-------------THQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGER  918 (1177)
T ss_pred             cc-ccccccccCcHHHHHHHhhccCC-------------CchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcccc
Confidence            32 22333344678999998866655             899999999999999998 77887654321           


Q ss_pred             chhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcChh
Q 044997          500 PTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITSTE  544 (563)
Q Consensus       500 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~  544 (563)
                      ..++....-.+..++.+||..|+..||+++++...+.++....+.
T Consensus       919 LsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardpqr  963 (1177)
T KOG1025|consen  919 LSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDPQR  963 (1177)
T ss_pred             CCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCcce
Confidence            122223334488899999999999999999999999988776543

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=3.4e-34  Score=292.47  Aligned_cols=230  Identities=24%  Similarity=0.405  Sum_probs=181.5

Q ss_pred             cCCCccceecccCcEEEEEEEE--CCc----eEEEEEeccCCh----HHHHHHHHHHHhccccce--------------E
Q 044997          292 NNFDESRIIGRGGFGNVYFGLL--GDR----EAAIKKMRSNKS----KEFFAELKVLCKIHHINV--------------F  347 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~--~~~----~vavK~~~~~~~----~~f~~Ei~~l~~l~H~ni--------------V  347 (563)
                      ++|+..+.||+|+||.||+|.+  .+.    .+|+|.+.....    .++.+|+.++++++|+||              +
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~v   86 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQLV   86 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCCCceee
Confidence            4567789999999999999987  333    478998875432    368899999999999997              4


Q ss_pred             EEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccc
Q 044997          348 ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLE  427 (563)
Q Consensus       348 ~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~  427 (563)
                      ++|+++|+|.+++...    ...+++..+..++.|++.||+|||+++   ++||||||+||++++++.+||+|||+++..
T Consensus        87 ~e~~~~g~l~~~~~~~----~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~  159 (303)
T cd05110          87 TQLMPHGCLLDYVHEH----KDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLL  159 (303)
T ss_pred             ehhcCCCCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccc
Confidence            6788899999888642    346899999999999999999999987   999999999999999999999999999865


Q ss_pred             ccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCCCcCCCCCc------
Q 044997          428 ERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIRDDSEP------  500 (563)
Q Consensus       428 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p~~~~~~~~------  500 (563)
                      ...... .......++..|+|||++.+..             ++.++||||||+++||+++ |+.||.......      
T Consensus       160 ~~~~~~-~~~~~~~~~~~y~~PE~~~~~~-------------~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~  225 (303)
T cd05110         160 EGDEKE-YNADGGKMPIKWMALECIHYRK-------------FTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLE  225 (303)
T ss_pred             cCcccc-cccCCCccccccCCHHHhccCC-------------CChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            432211 1122234567899999875443             4889999999999999997 888885432110      


Q ss_pred             -----hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcC
Q 044997          501 -----TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITS  542 (563)
Q Consensus       501 -----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~  542 (563)
                           .........+.+++.+||..+|++||++.++++.|.++....
T Consensus       226 ~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~  272 (303)
T cd05110         226 KGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP  272 (303)
T ss_pred             CCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence                 001122345789999999999999999999999999887653

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=2.4e-34  Score=291.02  Aligned_cols=217  Identities=24%  Similarity=0.372  Sum_probs=175.5

Q ss_pred             CCccceecccCcEEEEEEEEC--CceEEEEEeccCC------hHHHHHHHHHHHhccccce---------------EEEe
Q 044997          294 FDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNK------SKEFFAELKVLCKIHHINV---------------FIST  350 (563)
Q Consensus       294 f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~------~~~f~~Ei~~l~~l~H~ni---------------V~e~  350 (563)
                      |+..+.||+|+||.||+|...  ++.+|+|.+....      .+.+.+|+++|++++|+|+               ++||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            666789999999999999884  6889999986432      2347789999999999997               5789


Q ss_pred             ecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccccc
Q 044997          351 FGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERT  430 (563)
Q Consensus       351 ~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~  430 (563)
                      +++|+|.+++..   .+...+++..+..++.|++.||.|||+++   |+||||||+||++++++.+||+|||++......
T Consensus        82 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~  155 (285)
T cd05632          82 MNGGDLKFHIYN---MGNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEG  155 (285)
T ss_pred             ccCccHHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCC
Confidence            999999988864   22346999999999999999999999987   999999999999999999999999998754322


Q ss_pred             cccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc----------
Q 044997          431 NEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP----------  500 (563)
Q Consensus       431 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~----------  500 (563)
                      .    ......|+..|+|||++.+..             ++.++||||||+++|||++|+.||.......          
T Consensus       156 ~----~~~~~~g~~~~~aPE~~~~~~-------------~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~  218 (285)
T cd05632         156 E----SIRGRVGTVGYMAPEVLNNQR-------------YTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVL  218 (285)
T ss_pred             C----cccCCCCCcCccChHHhcCCC-------------CCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhh
Confidence            1    112346899999999885443             4789999999999999999999996543211          


Q ss_pred             ----hhhHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 044997          501 ----TKMKSLITIMAAVAEWCLNEDAVDRPE-----MRDIVA  533 (563)
Q Consensus       501 ----~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~  533 (563)
                          .....+...+.+++.+||+.||++||+     +.+++.
T Consensus       219 ~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05632         219 ETEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR  260 (285)
T ss_pred             ccccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence                011234456899999999999999999     555554

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=9.7e-35  Score=300.25  Aligned_cols=207  Identities=26%  Similarity=0.386  Sum_probs=165.9

Q ss_pred             ceecccCcEEEEEEEEC--CceEEEEEeccCC------hHHHHHHHHHHHhc-cccce---------------EEEeecC
Q 044997          298 RIIGRGGFGNVYFGLLG--DREAAIKKMRSNK------SKEFFAELKVLCKI-HHINV---------------FISTFGN  353 (563)
Q Consensus       298 ~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~------~~~f~~Ei~~l~~l-~H~ni---------------V~e~~~~  353 (563)
                      +.||+|+||.||+++..  ++.+|+|.++...      .+.+.+|+.++.++ +||||               |+||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            46999999999999874  6789999987531      24577888888776 79997               5799999


Q ss_pred             CCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccccccccc
Q 044997          354 GSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEK  433 (563)
Q Consensus       354 gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~  433 (563)
                      |+|..++..     ...+++..+..++.|++.||+|||+++   ++||||||+|||++.++.+||+|||+++....... 
T Consensus        81 ~~L~~~~~~-----~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~-  151 (329)
T cd05618          81 GDLMFHMQR-----QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-  151 (329)
T ss_pred             CCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC-
Confidence            999888754     356899999999999999999999997   99999999999999999999999999874322111 


Q ss_pred             ccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCC----c---------
Q 044997          434 EMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE----P---------  500 (563)
Q Consensus       434 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~----~---------  500 (563)
                        ......||..|+|||++.+..             ++.++|||||||++|||++|+.||......    .         
T Consensus       152 --~~~~~~gt~~y~aPE~~~~~~-------------~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~  216 (329)
T cd05618         152 --TTSTFCGTPNYIAPEILRGED-------------YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV  216 (329)
T ss_pred             --ccccccCCccccCHHHHcCCC-------------CCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHH
Confidence              123357899999999886544             478999999999999999999998521110    0         


Q ss_pred             ------hhhHHHHHHHHHHHHHhhccCCCCCCCH
Q 044997          501 ------TKMKSLITIMAAVAEWCLNEDAVDRPEM  528 (563)
Q Consensus       501 ------~~~~~~~~~l~~li~~cl~~dP~~RPs~  528 (563)
                            ..+......+.+++.+||+.||.+||++
T Consensus       217 i~~~~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~  250 (329)
T cd05618         217 ILEKQIRIPRSLSVKAASVLKSFLNKDPKERLGC  250 (329)
T ss_pred             HhcCCCCCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence                  0112234557899999999999999983

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=7.3e-35  Score=306.67  Aligned_cols=221  Identities=27%  Similarity=0.352  Sum_probs=175.7

Q ss_pred             cCCCccceecccCcEEEEEEEEC--CceEEEEEeccC------ChHHHHHHHHHHHhccccce---------------EE
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSN------KSKEFFAELKVLCKIHHINV---------------FI  348 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~------~~~~f~~Ei~~l~~l~H~ni---------------V~  348 (563)
                      ++|+..+.||+|+||.||+++..  ++.+|||.+...      ..+.+.+|+++|++++|+||               |+
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            36888999999999999999874  688999998642      23568899999999999997               57


Q ss_pred             EeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccc
Q 044997          349 STFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEE  428 (563)
Q Consensus       349 e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~  428 (563)
                      ||+++|+|.+++..     ...+++.....++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus        81 E~~~~g~L~~~i~~-----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~  152 (376)
T cd05598          81 DYIPGGDMMSLLIR-----LGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFR  152 (376)
T ss_pred             eCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCcccc
Confidence            99999999999864     346888899999999999999999997   9999999999999999999999999975321


Q ss_pred             cccc----------------------------------------cccccccccCCCcccCcccccccccccccccccccC
Q 044997          429 RTNE----------------------------------------KEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMEL  468 (563)
Q Consensus       429 ~~~~----------------------------------------~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~  468 (563)
                      ....                                        .........||+.|+|||++.+..            
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------------  220 (376)
T cd05598         153 WTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTG------------  220 (376)
T ss_pred             ccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCC------------
Confidence            0000                                        000112357999999999986544            


Q ss_pred             CCCCcchHHHHHHHHHHHHcCCCCCcCCCCCchh--------------hHHHHHHHHHHHHHhhccCCCCCC---CHHHH
Q 044997          469 QVTTKTDVFAFGVVLAELITGKRALIRDDSEPTK--------------MKSLITIMAAVAEWCLNEDAVDRP---EMRDI  531 (563)
Q Consensus       469 ~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~~--------------~~~~~~~l~~li~~cl~~dP~~RP---s~~ev  531 (563)
                       ++.++|||||||++|||++|+.||.........              ...+...+.+++.+|+ .+|.+|+   ++.|+
T Consensus       221 -~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~el  298 (376)
T cd05598         221 -YTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEI  298 (376)
T ss_pred             -CCcceeeeeccceeeehhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHH
Confidence             378999999999999999999999765432110              1123456788888876 5999999   88888


Q ss_pred             HHH
Q 044997          532 VAI  534 (563)
Q Consensus       532 l~~  534 (563)
                      ++.
T Consensus       299 l~h  301 (376)
T cd05598         299 KAH  301 (376)
T ss_pred             hCC
Confidence            765

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-34  Score=305.30  Aligned_cols=221  Identities=24%  Similarity=0.368  Sum_probs=174.5

Q ss_pred             cCCCccceecccCcEEEEEEEE--CCceEEEEEeccC------ChHHHHHHHHHHHhccccce---------------EE
Q 044997          292 NNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSN------KSKEFFAELKVLCKIHHINV---------------FI  348 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~------~~~~f~~Ei~~l~~l~H~ni---------------V~  348 (563)
                      ++|...+.||+|+||.||++..  +++.+|||.+...      ..+.+.+|++++++++||||               |+
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            4688899999999999999977  4788999998643      23567889999999999997               57


Q ss_pred             EeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccc
Q 044997          349 STFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEE  428 (563)
Q Consensus       349 e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~  428 (563)
                      ||+++|+|.+++..     ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus        81 E~~~gg~L~~~l~~-----~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~  152 (377)
T cd05629          81 EFLPGGDLMTMLIK-----YDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFH  152 (377)
T ss_pred             eCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccc
Confidence            99999999998864     356889999999999999999999998   9999999999999999999999999986322


Q ss_pred             ccccc--------------------------------------------ccccccccCCCcccCcccccccccccccccc
Q 044997          429 RTNEK--------------------------------------------EMLATRLVGTPGYLPPEYIFVKRFRFDMHSS  464 (563)
Q Consensus       429 ~~~~~--------------------------------------------~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~  464 (563)
                      .....                                            .......+||+.|+|||++.+..        
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--------  224 (377)
T cd05629         153 KQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQG--------  224 (377)
T ss_pred             cccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCC--------
Confidence            11000                                            00001246999999999885544        


Q ss_pred             cccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCchh--------------hHHHHHHHHHHHHHhhccCCCCC---CC
Q 044997          465 VMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTK--------------MKSLITIMAAVAEWCLNEDAVDR---PE  527 (563)
Q Consensus       465 ~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~~--------------~~~~~~~l~~li~~cl~~dP~~R---Ps  527 (563)
                           ++.++|||||||++|||++|+.||.........              ...+...+.+++.+|+. +|.+|   ++
T Consensus       225 -----~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~  298 (377)
T cd05629         225 -----YGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGG  298 (377)
T ss_pred             -----CCCceeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCC
Confidence                 488999999999999999999999654321110              01234568899999997 67665   58


Q ss_pred             HHHHHHH
Q 044997          528 MRDIVAI  534 (563)
Q Consensus       528 ~~evl~~  534 (563)
                      +.|++..
T Consensus       299 ~~~~l~h  305 (377)
T cd05629         299 AHEIKSH  305 (377)
T ss_pred             HHHHhcC
Confidence            8888764

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=3.8e-34  Score=286.16  Aligned_cols=220  Identities=25%  Similarity=0.413  Sum_probs=173.6

Q ss_pred             cCCCccceecccCcEEEEEEEE--CCceEEEEEeccCC--------hHHHHHHHHHHHhccccce---------------
Q 044997          292 NNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNK--------SKEFFAELKVLCKIHHINV---------------  346 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~--------~~~f~~Ei~~l~~l~H~ni---------------  346 (563)
                      .+|+..+.||+|+||.||+|..  .++.+|+|+++...        .+.+.+|++++++++|+||               
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            4688899999999999999986  46889999875321        2458889999999999997               


Q ss_pred             --EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCC
Q 044997          347 --FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLV  424 (563)
Q Consensus       347 --V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla  424 (563)
                        ++||+++++|.+++..     ...+++.....++.|++.||+|||+.+   ++||||||+||++++++.+||+|||++
T Consensus        82 ~l~~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~  153 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKA-----YGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGAS  153 (266)
T ss_pred             EEEEeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCc
Confidence              3577778888888754     245899999999999999999999987   999999999999999999999999998


Q ss_pred             cccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc----
Q 044997          425 KLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP----  500 (563)
Q Consensus       425 ~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~----  500 (563)
                      +................++..|+|||++.+..             ++.++|||||||++|||++|+.||.......    
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-------------~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~  220 (266)
T cd06651         154 KRLQTICMSGTGIRSVTGTPYWMSPEVISGEG-------------YGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFK  220 (266)
T ss_pred             cccccccccCCccccCCccccccCHHHhCCCC-------------CCchhhhHHHHHHHHHHHHCCCCccccchHHHHHH
Confidence            75432111111122345888999999885443             4789999999999999999999986443211    


Q ss_pred             --------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          501 --------TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       501 --------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                              .......+.+.+++ +||..+|++||+++||++
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         221 IATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             HhcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence                    11123344567777 688899999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=7.6e-35  Score=299.85  Aligned_cols=215  Identities=25%  Similarity=0.361  Sum_probs=168.0

Q ss_pred             ceecccCcEEEEEEEE--CCceEEEEEeccCC------hHHHHHHHH-HHHhccccce---------------EEEeecC
Q 044997          298 RIIGRGGFGNVYFGLL--GDREAAIKKMRSNK------SKEFFAELK-VLCKIHHINV---------------FISTFGN  353 (563)
Q Consensus       298 ~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~------~~~f~~Ei~-~l~~l~H~ni---------------V~e~~~~  353 (563)
                      +.||+|+||.||+|+.  +++.+|+|.+....      ..++.+|.. +++.++||||               |+||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            4699999999999987  46789999986432      234555654 6788999997               5799999


Q ss_pred             CCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccccccccc
Q 044997          354 GSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEK  433 (563)
Q Consensus       354 gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~  433 (563)
                      |+|..++..     ...+++.++..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++......  
T Consensus        81 ~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--  150 (321)
T cd05603          81 GELFFHLQR-----ERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE--  150 (321)
T ss_pred             CCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCC--
Confidence            999887754     356888899999999999999999987   9999999999999999999999999987432111  


Q ss_pred             ccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc----------hhh
Q 044997          434 EMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP----------TKM  503 (563)
Q Consensus       434 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~----------~~~  503 (563)
                       .......||+.|+|||.+.+..             ++.++|||||||++|||++|+.||...+...          ...
T Consensus       151 -~~~~~~~gt~~y~aPE~~~~~~-------------~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~  216 (321)
T cd05603         151 -ETTSTFCGTPEYLAPEVLRKEP-------------YDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLP  216 (321)
T ss_pred             -CccccccCCcccCCHHHhcCCC-------------CCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCC
Confidence             1223457899999999885443             4789999999999999999999997654211          011


Q ss_pred             HHHHHHHHHHHHHhhccCCCCCCCHH-HHHHHHH
Q 044997          504 KSLITIMAAVAEWCLNEDAVDRPEMR-DIVAILS  536 (563)
Q Consensus       504 ~~~~~~l~~li~~cl~~dP~~RPs~~-evl~~L~  536 (563)
                      ......+.+++.+||+.||.+||+.. ++.+.++
T Consensus       217 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~  250 (321)
T cd05603         217 GGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKN  250 (321)
T ss_pred             CCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhC
Confidence            12334588999999999999999764 3334333

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=2.9e-34  Score=284.92  Aligned_cols=220  Identities=24%  Similarity=0.380  Sum_probs=179.6

Q ss_pred             CCCccceecccCcEEEEEEEE--CCceEEEEEeccC----ChHHHHHHHHHHHhccccce---------------EEEee
Q 044997          293 NFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSN----KSKEFFAELKVLCKIHHINV---------------FISTF  351 (563)
Q Consensus       293 ~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~----~~~~f~~Ei~~l~~l~H~ni---------------V~e~~  351 (563)
                      +|+..+.||+|+||.||++..  .++.+|+|.++..    ..+.+.+|+.++++++|+|+               ++||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            477789999999999999987  4788999988543    23568889999999999997               57899


Q ss_pred             cCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccccccc
Q 044997          352 GNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTN  431 (563)
Q Consensus       352 ~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~  431 (563)
                      ++|+|.+++...   ....+++.....++.|++.||.|||+++   ++|+||||+||++++++.++++|||+++......
T Consensus        81 ~~~~l~~~~~~~---~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~  154 (255)
T cd08219          81 DGGDLMQKIKLQ---RGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG  154 (255)
T ss_pred             CCCcHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeecccc
Confidence            999999888642   2356889999999999999999999987   9999999999999999999999999987553321


Q ss_pred             ccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc-----------
Q 044997          432 EKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP-----------  500 (563)
Q Consensus       432 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~-----------  500 (563)
                      .   ......|+..|+|||++.+..             ++.++||||||+++|+|++|+.||...+...           
T Consensus       155 ~---~~~~~~~~~~~~aPE~~~~~~-------------~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~  218 (255)
T cd08219         155 A---YACTYVGTPYYVPPEIWENMP-------------YNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYK  218 (255)
T ss_pred             c---ccccccCCccccCHHHHccCC-------------cCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCC
Confidence            1   122356888999999875433             4889999999999999999999987543211           


Q ss_pred             hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          501 TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       501 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                      .....+...+.+++.+||+.||++||++.+++..
T Consensus       219 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         219 PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            1112344568999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=3.1e-34  Score=291.88  Aligned_cols=218  Identities=23%  Similarity=0.438  Sum_probs=180.1

Q ss_pred             cCCCccceecccCcEEEEEEEE--CCceEEEEEeccCC---hHHHHHHHHHHHhccccce---------------EEEee
Q 044997          292 NNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNK---SKEFFAELKVLCKIHHINV---------------FISTF  351 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~---~~~f~~Ei~~l~~l~H~ni---------------V~e~~  351 (563)
                      .+|+..+.||+|+||.||+|+.  .++.+|+|.+....   .+.+.+|++++++++|+|+               |+||+
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~   99 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence            5788889999999999999986  46889999886543   3568899999999999997               57899


Q ss_pred             cCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccccccc
Q 044997          352 GNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTN  431 (563)
Q Consensus       352 ~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~  431 (563)
                      ++|+|.+++..      ..+++.++..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||+++......
T Consensus       100 ~~~~L~~~~~~------~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~  170 (296)
T cd06654         100 AGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  170 (296)
T ss_pred             CCCCHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccccc
Confidence            99999998854      35889999999999999999999987   9999999999999999999999999987543221


Q ss_pred             ccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc-----------
Q 044997          432 EKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP-----------  500 (563)
Q Consensus       432 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~-----------  500 (563)
                      .   ......|++.|+|||.+.+..             ++.++|||||||++|||++|+.||.......           
T Consensus       171 ~---~~~~~~~~~~y~aPE~~~~~~-------------~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~  234 (296)
T cd06654         171 S---KRSTMVGTPYWMAPEVVTRKA-------------YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP  234 (296)
T ss_pred             c---ccCcccCCccccCHHHHcCCC-------------CCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCC
Confidence            1   122346889999999875433             4789999999999999999999986543211           


Q ss_pred             --hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          501 --TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       501 --~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                        .....+...+.+++.+||..||++||++.|+++.
T Consensus       235 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~  270 (296)
T cd06654         235 ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (296)
T ss_pred             CCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence              1123345668999999999999999999999973

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=2.9e-34  Score=294.55  Aligned_cols=234  Identities=21%  Similarity=0.375  Sum_probs=182.5

Q ss_pred             hcCCCccceecccCcEEEEEEEEC---------CceEEEEEeccCC----hHHHHHHHHHHHhc-cccce----------
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLLG---------DREAAIKKMRSNK----SKEFFAELKVLCKI-HHINV----------  346 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~~---------~~~vavK~~~~~~----~~~f~~Ei~~l~~l-~H~ni----------  346 (563)
                      .++|...+.||+|+||.||+++..         ...+|+|.++...    ..++.+|+++++++ +||||          
T Consensus        11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (314)
T cd05099          11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE   90 (314)
T ss_pred             HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence            356788999999999999999752         3468999887543    24688999999999 69997          


Q ss_pred             -----EEEeecCCCcccccccccc-----------cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEe
Q 044997          347 -----FISTFGNGSLSDHLHDPLL-----------KGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILL  410 (563)
Q Consensus       347 -----V~e~~~~gsL~~~L~~~~~-----------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl  410 (563)
                           ++||+++|+|.+++.....           .....++|.++..++.|++.||.|||+++   ++||||||+|||+
T Consensus        91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill  167 (314)
T cd05099          91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLV  167 (314)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEE
Confidence                 4689999999999865211           11246899999999999999999999987   9999999999999


Q ss_pred             cCCCcEEEeecCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-C
Q 044997          411 DDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-G  489 (563)
Q Consensus       411 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g  489 (563)
                      ++++++||+|||+++......... ......++..|+|||.+.+.             .++.++||||||+++|||++ |
T Consensus       168 ~~~~~~kL~Dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-------------~~~~~~DiwslG~~l~el~~~g  233 (314)
T cd05099         168 TEDNVMKIADFGLARGVHDIDYYK-KTSNGRLPVKWMAPEALFDR-------------VYTHQSDVWSFGILMWEIFTLG  233 (314)
T ss_pred             cCCCcEEEcccccccccccccccc-ccccCCCCccccCHHHHccC-------------CcCccchhhHHHHHHHHHHhCC
Confidence            999999999999998654221111 11122345679999987543             34889999999999999999 7


Q ss_pred             CCCCcCCCCCc-----------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 044997          490 KRALIRDDSEP-----------TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMIT  541 (563)
Q Consensus       490 ~~p~~~~~~~~-----------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~  541 (563)
                      +.||.......           .........+.+++.+||+.||++||++.|+++.|.++...
T Consensus       234 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~  296 (314)
T cd05099         234 GSPYPGIPVEELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAA  296 (314)
T ss_pred             CCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHH
Confidence            88875432110           11122345688999999999999999999999999988753

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.7e-35  Score=301.45  Aligned_cols=221  Identities=24%  Similarity=0.415  Sum_probs=188.8

Q ss_pred             cCCCccceecccCcEEEEEEEE--CCceEEEEEeccCC-----hHHHHHHHHHHHhccccce----------------EE
Q 044997          292 NNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNK-----SKEFFAELKVLCKIHHINV----------------FI  348 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~-----~~~f~~Ei~~l~~l~H~ni----------------V~  348 (563)
                      ++|...+++|+|+||.++..+.  ++..+++|.+.-..     ++...+|+.++++++||||                ||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            5678889999999999987765  46789999986432     3467889999999999997                58


Q ss_pred             EeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccc
Q 044997          349 STFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEE  428 (563)
Q Consensus       349 e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~  428 (563)
                      +|+++|++.+.+...   ....+++..+..++.|++.|+.|||+..   |+|||||+.||+++.+..+||.|||+||.+.
T Consensus        84 ~Y~eGg~l~~~i~~~---k~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~  157 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQ---KGVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILN  157 (426)
T ss_pred             eecCCCCHHHHHHHH---hhccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcC
Confidence            999999999999863   2467899999999999999999999775   9999999999999999999999999999876


Q ss_pred             cccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCch-------
Q 044997          429 RTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPT-------  501 (563)
Q Consensus       429 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~-------  501 (563)
                      ...   ......+||+.||.||.+.+.+|             ..|+||||+||++|||++-+++|...+....       
T Consensus       158 ~~~---~~a~tvvGTp~YmcPEil~d~pY-------------n~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~  221 (426)
T KOG0589|consen  158 PED---SLASTVVGTPYYMCPEILSDIPY-------------NEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRG  221 (426)
T ss_pred             Cch---hhhheecCCCcccCHHHhCCCCC-------------CccCcchhhcchHHHHHhcccccCccchHHHHHHHhhc
Confidence            443   24456789999999999987776             8999999999999999999999987665322       


Q ss_pred             ----hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          502 ----KMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       502 ----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                          ........++.+++.|+..+|..||++.+++..
T Consensus       222 ~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  222 LYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             cCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence                223445669999999999999999999999986

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=1.8e-34  Score=312.27  Aligned_cols=221  Identities=24%  Similarity=0.382  Sum_probs=170.0

Q ss_pred             HHHHHHhcCCCccceecccCcEEEEEEEE--CCceEEEEEeccC--ChHHHHHHHHHHHhccccc------e--------
Q 044997          285 EEIEEATNNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSN--KSKEFFAELKVLCKIHHIN------V--------  346 (563)
Q Consensus       285 ~el~~~~~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~--~~~~f~~Ei~~l~~l~H~n------i--------  346 (563)
                      +++...+++|+..++||+|+||.||+|..  .++.||||+++..  ..+++..|++++.+++|.+      +        
T Consensus       122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~  201 (467)
T PTZ00284        122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ  201 (467)
T ss_pred             CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence            44555678899999999999999999987  4678999999643  2345677888888887654      2        


Q ss_pred             --------EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCceEeCCCCCCCeEecCCC---
Q 044997          347 --------FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDH-TKARYVHRDIKTSNILLDDGL---  414 (563)
Q Consensus       347 --------V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivHrDLk~~NILl~~~~---  414 (563)
                              |++++ +++|.+++..     ...+++..+..|+.|++.||+|||++ +   ||||||||+|||++.++   
T Consensus       202 ~~~~~~~iv~~~~-g~~l~~~l~~-----~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~  272 (467)
T PTZ00284        202 NETGHMCIVMPKY-GPCLLDWIMK-----HGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVV  272 (467)
T ss_pred             cCCceEEEEEecc-CCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCccc
Confidence                    22222 4566666643     35699999999999999999999974 6   99999999999998765   


Q ss_pred             -------------cEEEeecCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHH
Q 044997          415 -------------RAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGV  481 (563)
Q Consensus       415 -------------~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGv  481 (563)
                                   .+||+|||.+.....      ..+...||+.|+|||++.+..|             +.++|||||||
T Consensus       273 ~~~~~~~~~~~~~~vkl~DfG~~~~~~~------~~~~~~gt~~Y~APE~~~~~~~-------------~~~~DiwSlGv  333 (467)
T PTZ00284        273 DPVTNRALPPDPCRVRICDLGGCCDERH------SRTAIVSTRHYRSPEVVLGLGW-------------MYSTDMWSMGC  333 (467)
T ss_pred             ccccccccCCCCceEEECCCCccccCcc------ccccccCCccccCcHHhhcCCC-------------CcHHHHHHHHH
Confidence                         499999998763211      1234679999999999865544             88999999999


Q ss_pred             HHHHHHcCCCCCcCCCCCch-------------hh-------------------------HH--------------HHHH
Q 044997          482 VLAELITGKRALIRDDSEPT-------------KM-------------------------KS--------------LITI  509 (563)
Q Consensus       482 vl~Elltg~~p~~~~~~~~~-------------~~-------------------------~~--------------~~~~  509 (563)
                      ++|||++|+.||...+....             ..                         ..              ..+.
T Consensus       334 il~elltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  413 (467)
T PTZ00284        334 IIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDL  413 (467)
T ss_pred             HHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHH
Confidence            99999999999964332100             00                         00              0123


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHHH
Q 044997          510 MAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       510 l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                      +.+|+.+||+.||.+|||++|+++
T Consensus       414 ~~dli~~mL~~dP~~R~ta~e~L~  437 (467)
T PTZ00284        414 LCDLIYGLLHYDRQKRLNARQMTT  437 (467)
T ss_pred             HHHHHHHhCCcChhhCCCHHHHhc
Confidence            668999999999999999999987

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1.7e-34  Score=291.51  Aligned_cols=238  Identities=24%  Similarity=0.373  Sum_probs=188.3

Q ss_pred             cCHHHHHHHhcCCCccceecccCcEEEEEEEE--CCceEEEEEeccCC--hHHHHHHHHHHHhc-cccce----------
Q 044997          282 FSLEEIEEATNNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNK--SKEFFAELKVLCKI-HHINV----------  346 (563)
Q Consensus       282 ~~~~el~~~~~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~--~~~f~~Ei~~l~~l-~H~ni----------  346 (563)
                      +.++++..+.++|+..+.||+|+||.||++..  .++.+|+|..+...  .+++.+|+.+++++ +|+|+          
T Consensus         8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   87 (286)
T cd06638           8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKK   87 (286)
T ss_pred             EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence            34466777889999999999999999999987  46789999886533  36688999999999 69987          


Q ss_pred             ----------EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcE
Q 044997          347 ----------FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRA  416 (563)
Q Consensus       347 ----------V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~  416 (563)
                                |+||+++|+|.+++.... .....+++..+..++.|+++||.|||+++   ++||||||+||++++++.+
T Consensus        88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~  163 (286)
T cd06638          88 DVKNGDQLWLVLELCNGGSVTDLVKGFL-KRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGV  163 (286)
T ss_pred             ccCCCCeEEEEEeecCCCCHHHHHHHhh-ccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCE
Confidence                      468888999988875421 22356899999999999999999999987   9999999999999999999


Q ss_pred             EEeecCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCC
Q 044997          417 KVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRD  496 (563)
Q Consensus       417 kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~  496 (563)
                      ||+|||+++.......   ......|+..|+|||++.....        ....++.++|||||||++|||++|+.|+...
T Consensus       164 kl~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~--------~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~  232 (286)
T cd06638         164 KLVDFGVSAQLTSTRL---RRNTSVGTPFWMAPEVIACEQQ--------LDSTYDARCDVWSLGITAIELGDGDPPLADL  232 (286)
T ss_pred             EEccCCceeecccCCC---ccccccCCCcccChhhhchhhh--------ccccccchhhhhhHHHHHHHHhcCCCCCCCC
Confidence            9999999876532211   1223468999999998754321        1344688999999999999999999998644


Q ss_pred             CCCch-------------hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          497 DSEPT-------------KMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       497 ~~~~~-------------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                      .....             ........+.+++.+||+.||++||++.|+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         233 HPMRALFKIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             chhHHHhhccccCCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence            32110             011123468999999999999999999999875

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.4e-34  Score=287.77  Aligned_cols=233  Identities=24%  Similarity=0.386  Sum_probs=184.9

Q ss_pred             cCCCccceecccCcEEEEEEEEC--C----ceEEEEEeccCC----hHHHHHHHHHHHhccccce--------------E
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG--D----REAAIKKMRSNK----SKEFFAELKVLCKIHHINV--------------F  347 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~--~----~~vavK~~~~~~----~~~f~~Ei~~l~~l~H~ni--------------V  347 (563)
                      .+|+..+.||+|+||.||+|...  +    ..+|+|.++...    .+++.+|+.++++++|+|+              |
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~v   86 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLSSQVQLI   86 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCceEEE
Confidence            45777899999999999999863  2    258999887553    3568899999999999996              5


Q ss_pred             EEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccc
Q 044997          348 ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLE  427 (563)
Q Consensus       348 ~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~  427 (563)
                      +||+++|+|.+++...    ...+++..+..++.|++.||+|||+++   ++||||||+||++++++.+||+|||+++..
T Consensus        87 ~e~~~~g~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~  159 (279)
T cd05057          87 TQLMPLGCLLDYVRNH----KDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL  159 (279)
T ss_pred             EecCCCCcHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcccccc
Confidence            6889999999998752    345899999999999999999999987   999999999999999999999999999865


Q ss_pred             ccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCCCcCCCCCc------
Q 044997          428 ERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIRDDSEP------  500 (563)
Q Consensus       428 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p~~~~~~~~------  500 (563)
                      ....... ......++..|+|||.+...             .++.++||||||+++||+++ |+.||.......      
T Consensus       160 ~~~~~~~-~~~~~~~~~~y~~PE~~~~~-------------~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~  225 (279)
T cd05057         160 DVDEKEY-HAEGGKVPIKWMALESILHR-------------IYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLE  225 (279)
T ss_pred             cCcccce-ecCCCcccccccCHHHhhcC-------------CcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Confidence            4322111 11112245689999987433             34789999999999999999 999986543211      


Q ss_pred             -----hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcChhh
Q 044997          501 -----TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITSTEW  545 (563)
Q Consensus       501 -----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~w  545 (563)
                           .........+.+++.+||..||.+||++.++++.|.++.....+.
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~~~~  275 (279)
T cd05057         226 KGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARDPQRY  275 (279)
T ss_pred             CCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhCCcce
Confidence                 001112345789999999999999999999999999998765543

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=8.4e-35  Score=300.10  Aligned_cols=226  Identities=25%  Similarity=0.406  Sum_probs=173.8

Q ss_pred             ceecccCcEEEEEEEEC--CceEEEEEeccCC------hHHHHHHHH-HHHhccccce---------------EEEeecC
Q 044997          298 RIIGRGGFGNVYFGLLG--DREAAIKKMRSNK------SKEFFAELK-VLCKIHHINV---------------FISTFGN  353 (563)
Q Consensus       298 ~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~------~~~f~~Ei~-~l~~l~H~ni---------------V~e~~~~  353 (563)
                      +.||+|+||.||+++..  ++.+|+|.+....      ..++..|.. +++.++|+||               |+||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            46999999999999874  5779999986432      233444544 5678999997               5799999


Q ss_pred             CCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccccccccc
Q 044997          354 GSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEK  433 (563)
Q Consensus       354 gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~  433 (563)
                      |+|.+++..     ...+++.....++.|++.||+|||+++   |+||||||+|||+++++.+||+|||+++......  
T Consensus        81 ~~L~~~~~~-----~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~--  150 (325)
T cd05602          81 GELFYHLQR-----ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN--  150 (325)
T ss_pred             CcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCC--
Confidence            999988864     345788888899999999999999997   9999999999999999999999999987432211  


Q ss_pred             ccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc----------hhh
Q 044997          434 EMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP----------TKM  503 (563)
Q Consensus       434 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~----------~~~  503 (563)
                       .......||+.|+|||++.+..             ++.++|||||||++|||++|+.||.......          ...
T Consensus       151 -~~~~~~~gt~~y~aPE~~~~~~-------------~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~  216 (325)
T cd05602         151 -GTTSTFCGTPEYLAPEVLHKQP-------------YDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK  216 (325)
T ss_pred             -CCcccccCCccccCHHHHcCCC-------------CCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCC
Confidence             1223457999999999886544             4789999999999999999999997543211          111


Q ss_pred             HHHHHHHHHHHHHhhccCCCCCCCHHHHH-HHHHHhhhcChhhhc
Q 044997          504 KSLITIMAAVAEWCLNEDAVDRPEMRDIV-AILSQIMITSTEWEA  547 (563)
Q Consensus       504 ~~~~~~l~~li~~cl~~dP~~RPs~~evl-~~L~~i~~~~~~w~~  547 (563)
                      ..+...+.+++.+|++.||.+||++.+.+ +.++...-...+|+.
T Consensus       217 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~~~~~  261 (325)
T cd05602         217 PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPINWDD  261 (325)
T ss_pred             CCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCCCHHH
Confidence            23455689999999999999999987544 333334344455654

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1.5e-34  Score=305.02  Aligned_cols=219  Identities=25%  Similarity=0.349  Sum_probs=173.1

Q ss_pred             CCCccceecccCcEEEEEEEE--CCceEEEEEeccCC------hHHHHHHHHHHHhccccce---------------EEE
Q 044997          293 NFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNK------SKEFFAELKVLCKIHHINV---------------FIS  349 (563)
Q Consensus       293 ~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~------~~~f~~Ei~~l~~l~H~ni---------------V~e  349 (563)
                      .|+..+.||+|+||.||+|+.  .++.+|+|.+....      .+.+.+|++++++++|+||               |+|
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            578899999999999999987  46789999986532      3468889999999999997               679


Q ss_pred             eecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccccc
Q 044997          350 TFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEER  429 (563)
Q Consensus       350 ~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~  429 (563)
                      |+++|+|.+++..     ...+++.....++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus        82 ~~~gg~L~~~l~~-----~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~  153 (382)
T cd05625          82 YIPGGDMMSLLIR-----MGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW  153 (382)
T ss_pred             CCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccc
Confidence            9999999998864     246888899999999999999999997   99999999999999999999999999753211


Q ss_pred             ccc--------------------------------------------cccccccccCCCcccCccccccccccccccccc
Q 044997          430 TNE--------------------------------------------KEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSV  465 (563)
Q Consensus       430 ~~~--------------------------------------------~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~  465 (563)
                      ...                                            ........+||+.|+|||++.+..         
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~---------  224 (382)
T cd05625         154 THDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTG---------  224 (382)
T ss_pred             cccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCC---------
Confidence            000                                            000112346999999999886544         


Q ss_pred             ccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCchh--------------hHHHHHHHHHHHHHhhccCCCCCCC---H
Q 044997          466 MELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTK--------------MKSLITIMAAVAEWCLNEDAVDRPE---M  528 (563)
Q Consensus       466 ~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~~--------------~~~~~~~l~~li~~cl~~dP~~RPs---~  528 (563)
                          ++.++|||||||++|||++|+.||.........              ...+.+.+.+++.+++ .+|.+|++   +
T Consensus       225 ----~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~  299 (382)
T cd05625         225 ----YTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGA  299 (382)
T ss_pred             ----CCCeeeEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCH
Confidence                478999999999999999999999754321111              1123456778887765 59999987   7


Q ss_pred             HHHHH
Q 044997          529 RDIVA  533 (563)
Q Consensus       529 ~evl~  533 (563)
                      .++++
T Consensus       300 ~ei~~  304 (382)
T cd05625         300 DEIKA  304 (382)
T ss_pred             HHHhc
Confidence            77765

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=2.5e-34  Score=291.01  Aligned_cols=218  Identities=26%  Similarity=0.392  Sum_probs=176.7

Q ss_pred             CCccceecccCcEEEEEEEEC--CceEEEEEeccCC------hHHHHHHHHHHHhccccce---------------EEEe
Q 044997          294 FDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNK------SKEFFAELKVLCKIHHINV---------------FIST  350 (563)
Q Consensus       294 f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~------~~~f~~Ei~~l~~l~H~ni---------------V~e~  350 (563)
                      |+..+.||+|+||.||++...  ++.+|+|.+....      .+.+.+|+.++++++|+|+               |+||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            667789999999999999874  6789999886432      2457789999999999987               5789


Q ss_pred             ecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccccc
Q 044997          351 FGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERT  430 (563)
Q Consensus       351 ~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~  430 (563)
                      +++|+|.+++..   .....+++.++..++.|++.||.|||+.+   ++||||||+||++++++.++|+|||++......
T Consensus        82 ~~g~~L~~~l~~---~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~  155 (285)
T cd05630          82 MNGGDLKFHIYH---MGEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEG  155 (285)
T ss_pred             cCCCcHHHHHHH---hcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCC
Confidence            999999998864   22346899999999999999999999987   999999999999999999999999998754322


Q ss_pred             cccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc--hh------
Q 044997          431 NEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP--TK------  502 (563)
Q Consensus       431 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~--~~------  502 (563)
                      .    ......|+..|+|||++.+..             ++.++|||||||++|||++|+.||.......  ..      
T Consensus       156 ~----~~~~~~g~~~y~aPE~~~~~~-------------~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~  218 (285)
T cd05630         156 Q----TIKGRVGTVGYMAPEVVKNER-------------YTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVK  218 (285)
T ss_pred             c----cccCCCCCccccChHHHcCCC-------------CCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhh
Confidence            1    112346899999999885544             4789999999999999999999997543211  00      


Q ss_pred             ------hHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 044997          503 ------MKSLITIMAAVAEWCLNEDAVDRPE-----MRDIVAI  534 (563)
Q Consensus       503 ------~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~  534 (563)
                            .......+.+++.+||+.||++||+     +.|+++.
T Consensus       219 ~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h  261 (285)
T cd05630         219 EVQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH  261 (285)
T ss_pred             hhhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence                  1123445899999999999999999     7788763

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-35  Score=306.20  Aligned_cols=221  Identities=24%  Similarity=0.392  Sum_probs=184.7

Q ss_pred             ccceecccCcEEEEEEEEC---C--ceEEEEEeccCC----hHHHHHHHHHHHhccccceE--------------EEeec
Q 044997          296 ESRIIGRGGFGNVYFGLLG---D--REAAIKKMRSNK----SKEFFAELKVLCKIHHINVF--------------ISTFG  352 (563)
Q Consensus       296 ~~~~LG~G~fG~Vy~g~~~---~--~~vavK~~~~~~----~~~f~~Ei~~l~~l~H~niV--------------~e~~~  352 (563)
                      ..++||+|.||.|++|.|+   |  -.||||.++.+.    ..+|++|+.+|.+|+|+|+|              +|.++
T Consensus       114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~qp~mMV~ELap  193 (1039)
T KOG0199|consen  114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLDQPAMMVFELAP  193 (1039)
T ss_pred             HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeeccchhhHHhhhcc
Confidence            4588999999999999995   2  458999998654    47899999999999999983              58889


Q ss_pred             CCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccccccc
Q 044997          353 NGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNE  432 (563)
Q Consensus       353 ~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~  432 (563)
                      .|+|.+.|++   .....+.....-.++.|||.||.||.++.   +|||||..+|+||-....+||+||||.+.+...++
T Consensus       194 lGSLldrLrk---a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ned  267 (1039)
T KOG0199|consen  194 LGSLLDRLRK---AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGENED  267 (1039)
T ss_pred             cchHHHHHhh---ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCCCc
Confidence            9999999986   23456777888899999999999999886   99999999999999999999999999998776554


Q ss_pred             cccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCCCcCCC-----------CCc
Q 044997          433 KEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIRDD-----------SEP  500 (563)
Q Consensus       433 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p~~~~~-----------~~~  500 (563)
                      ...+.....-...|+|||.+...+|             +.+||||+|||++|||+| |..||.+..           +..
T Consensus       268 ~Yvm~p~rkvPfAWCaPEsLrh~kF-------------ShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erL  334 (1039)
T KOG0199|consen  268 MYVMAPQRKVPFAWCAPESLRHRKF-------------SHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERL  334 (1039)
T ss_pred             ceEecCCCcCcccccCHhHhccccc-------------cccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccC
Confidence            4333334455678999999876665             899999999999999998 667886533           233


Q ss_pred             hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 044997          501 TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAIL  535 (563)
Q Consensus       501 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  535 (563)
                      ...+.+++.+.+++++||..+|++||+|..|.+.+
T Consensus       335 pRPk~csedIY~imk~cWah~paDRptFsair~~~  369 (1039)
T KOG0199|consen  335 PRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL  369 (1039)
T ss_pred             CCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence            44566788899999999999999999999998544

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=5.7e-34  Score=284.70  Aligned_cols=212  Identities=23%  Similarity=0.331  Sum_probs=166.7

Q ss_pred             ceecccCcEEEEEEEECC--------------ceEEEEEeccCC---hHHHHHHHHHHHhccccce--------------
Q 044997          298 RIIGRGGFGNVYFGLLGD--------------REAAIKKMRSNK---SKEFFAELKVLCKIHHINV--------------  346 (563)
Q Consensus       298 ~~LG~G~fG~Vy~g~~~~--------------~~vavK~~~~~~---~~~f~~Ei~~l~~l~H~ni--------------  346 (563)
                      +.||+|+||.||+|++..              ..|++|.+....   ...|.+|+.++++++||||              
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            468999999999998532              248889876543   3468889999999999998              


Q ss_pred             -EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCc-------EEE
Q 044997          347 -FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLR-------AKV  418 (563)
Q Consensus       347 -V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~-------~kl  418 (563)
                       |+||+++|+|..++..    ....+++..+.+++.|+++||+|||+.+   ++||||||+|||++.++.       +|+
T Consensus        81 lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l  153 (262)
T cd05077          81 MVEEFVEFGPLDLFMHR----KSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKL  153 (262)
T ss_pred             EEEecccCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEe
Confidence             4688999999888764    2356899999999999999999999987   999999999999987654       899


Q ss_pred             eecCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHH-cCCCCCcCCC
Q 044997          419 ADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELI-TGKRALIRDD  497 (563)
Q Consensus       419 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ell-tg~~p~~~~~  497 (563)
                      +|||++......       ....++..|+|||.+...            ..++.++|||||||++|||+ +|+.|+....
T Consensus       154 ~d~g~~~~~~~~-------~~~~~~~~y~aPE~~~~~------------~~~~~~~DiwslG~~l~el~~~~~~p~~~~~  214 (262)
T cd05077         154 SDPGIPITVLSR-------QECVERIPWIAPECVEDS------------KNLSIAADKWSFGTTLWEICYNGEIPLKDKT  214 (262)
T ss_pred             CCCCCCccccCc-------ccccccccccChhhhcCC------------CCCCchhHHHHHHHHHHHHHhCCCCCCCCcc
Confidence            999998654321       123578889999987422            23478999999999999998 5777765432


Q ss_pred             CCch---------hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 044997          498 SEPT---------KMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAIL  535 (563)
Q Consensus       498 ~~~~---------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  535 (563)
                      ....         ......+.+.+|+.+||+.||.+||++.+|++.+
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         215 LAEKERFYEGQCMLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             hhHHHHHHhcCccCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence            2110         0011235688999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=4.1e-34  Score=299.63  Aligned_cols=217  Identities=24%  Similarity=0.330  Sum_probs=171.1

Q ss_pred             HhcCCCccceecccCcEEEEEEEE--CCceEEEEEeccC-----ChHHHHHHHHHHHhccccceE---------------
Q 044997          290 ATNNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSN-----KSKEFFAELKVLCKIHHINVF---------------  347 (563)
Q Consensus       290 ~~~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~-----~~~~f~~Ei~~l~~l~H~niV---------------  347 (563)
                      ..++|...+.||+|+||.||+++.  .++.+|||++...     ..+++.+|+.+++.++||||+               
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            357899999999999999999987  4688999998643     235688999999999999973               


Q ss_pred             ------EEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeec
Q 044997          348 ------ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADF  421 (563)
Q Consensus       348 ------~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DF  421 (563)
                            +||++ ++|.+++.       ..+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+||
T Consensus       102 ~~~~lv~e~~~-~~l~~~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Df  170 (364)
T cd07875         102 QDVYIVMELMD-ANLCQVIQ-------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDF  170 (364)
T ss_pred             CeEEEEEeCCC-CCHHHHHH-------hcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeC
Confidence                  34443 34444442       24788999999999999999999987   999999999999999999999999


Q ss_pred             CCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc-
Q 044997          422 GLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP-  500 (563)
Q Consensus       422 Gla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~-  500 (563)
                      |+++......    ......||..|+|||++.+..             ++.++|||||||++|||++|+.||...+... 
T Consensus       171 G~a~~~~~~~----~~~~~~~t~~y~aPE~~~~~~-------------~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~  233 (364)
T cd07875         171 GLARTAGTSF----MMTPYVVTRYYRAPEVILGMG-------------YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ  233 (364)
T ss_pred             CCccccCCCC----cccCCcccCCcCCHHHHhCCC-------------CCchhhHHhHHHHHHHHHhCCCCCCCCCHHHH
Confidence            9998543221    223356899999999886544             4789999999999999999999986433110 


Q ss_pred             -------------hhhH--------------------------------------HHHHHHHHHHHHhhccCCCCCCCHH
Q 044997          501 -------------TKMK--------------------------------------SLITIMAAVAEWCLNEDAVDRPEMR  529 (563)
Q Consensus       501 -------------~~~~--------------------------------------~~~~~l~~li~~cl~~dP~~RPs~~  529 (563)
                                   ....                                      ...+.+.+++.+|++.||.+|||+.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~  313 (364)
T cd07875         234 WNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVD  313 (364)
T ss_pred             HHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHH
Confidence                         0000                                      0113478999999999999999999


Q ss_pred             HHHHH
Q 044997          530 DIVAI  534 (563)
Q Consensus       530 evl~~  534 (563)
                      |+++.
T Consensus       314 e~L~h  318 (364)
T cd07875         314 EALQH  318 (364)
T ss_pred             HHhcC
Confidence            99874

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=3.3e-34  Score=299.27  Aligned_cols=218  Identities=22%  Similarity=0.303  Sum_probs=170.6

Q ss_pred             HHhcCCCccceecccCcEEEEEEEE--CCceEEEEEeccC-----ChHHHHHHHHHHHhccccceEE-------------
Q 044997          289 EATNNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSN-----KSKEFFAELKVLCKIHHINVFI-------------  348 (563)
Q Consensus       289 ~~~~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~-----~~~~f~~Ei~~l~~l~H~niV~-------------  348 (563)
                      ...++|...+.||+|+||.||++..  .++.+|||++...     ..+.+.+|+.+++.++|+||+.             
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   93 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE   93 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence            3457899999999999999999976  4788999998643     2356788999999999999842             


Q ss_pred             --------EeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEee
Q 044997          349 --------STFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVAD  420 (563)
Q Consensus       349 --------e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~D  420 (563)
                              ||++ ++|.+++.       ..+++..+..++.|++.||.|||+++   |+||||||+|||+++++.+||+|
T Consensus        94 ~~~~~lv~e~~~-~~l~~~~~-------~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~D  162 (355)
T cd07874          94 FQDVYLVMELMD-ANLCQVIQ-------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILD  162 (355)
T ss_pred             cceeEEEhhhhc-ccHHHHHh-------hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEee
Confidence                    2222 23333322       34788999999999999999999997   99999999999999999999999


Q ss_pred             cCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc
Q 044997          421 FGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP  500 (563)
Q Consensus       421 FGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~  500 (563)
                      ||+++......    ......||..|+|||++.+..             ++.++|||||||++|||++|+.||...+...
T Consensus       163 fg~~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~-------------~~~~~DiwslG~il~el~~g~~pf~~~~~~~  225 (355)
T cd07874         163 FGLARTAGTSF----MMTPYVVTRYYRAPEVILGMG-------------YKENVDIWSVGCIMGEMVRHKILFPGRDYID  225 (355)
T ss_pred             CcccccCCCcc----ccCCccccCCccCHHHHcCCC-------------CCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            99998543221    223356899999999886544             4789999999999999999999986543100


Q ss_pred             h--------------h--------------------------------------hHHHHHHHHHHHHHhhccCCCCCCCH
Q 044997          501 T--------------K--------------------------------------MKSLITIMAAVAEWCLNEDAVDRPEM  528 (563)
Q Consensus       501 ~--------------~--------------------------------------~~~~~~~l~~li~~cl~~dP~~RPs~  528 (563)
                      .              .                                      .......+.+++.+||+.||++|||+
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~  305 (355)
T cd07874         226 QWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV  305 (355)
T ss_pred             HHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCH
Confidence            0              0                                      00012346899999999999999999


Q ss_pred             HHHHHH
Q 044997          529 RDIVAI  534 (563)
Q Consensus       529 ~evl~~  534 (563)
                      .|+++.
T Consensus       306 ~ell~h  311 (355)
T cd07874         306 DEALQH  311 (355)
T ss_pred             HHHhcC
Confidence            999985

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=9.1e-35  Score=274.58  Aligned_cols=229  Identities=25%  Similarity=0.381  Sum_probs=191.3

Q ss_pred             HHHHhcCCCccceecccCcEEEEEEEE--CCceEEEEEeccCC-----------hHHHHHHHHHHHhc-cccce------
Q 044997          287 IEEATNNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNK-----------SKEFFAELKVLCKI-HHINV------  346 (563)
Q Consensus       287 l~~~~~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~-----------~~~f~~Ei~~l~~l-~H~ni------  346 (563)
                      -...-+.|...+.||+|..+.|-++..  .+++.|+|++....           .+.-.+|+.+|+++ .||+|      
T Consensus        12 a~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~   91 (411)
T KOG0599|consen   12 AKGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDV   91 (411)
T ss_pred             HhhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeee
Confidence            344556788899999999999998866  47889999885221           24456799999998 69998      


Q ss_pred             ---------EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEE
Q 044997          347 ---------FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAK  417 (563)
Q Consensus       347 ---------V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~k  417 (563)
                               |.+.|+.|.|.++|..     .-.++++...+|++|+.+|++|||...   ||||||||+|||+|++.++|
T Consensus        92 yes~sF~FlVFdl~prGELFDyLts-----~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~  163 (411)
T KOG0599|consen   92 YESDAFVFLVFDLMPRGELFDYLTS-----KVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIK  163 (411)
T ss_pred             ccCcchhhhhhhhcccchHHHHhhh-----heeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceE
Confidence                     3588899999999975     356999999999999999999999987   99999999999999999999


Q ss_pred             EeecCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCC
Q 044997          418 VADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDD  497 (563)
Q Consensus       418 l~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~  497 (563)
                      |+|||+++.++.+.    .....+||++|+|||.+...-|+       ....|+...|.||.||+||-|+.|.+||....
T Consensus       164 isDFGFa~~l~~Ge----kLrelCGTPgYLAPEtikC~m~e-------~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk  232 (411)
T KOG0599|consen  164 ISDFGFACQLEPGE----KLRELCGTPGYLAPETIKCSMYE-------NHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK  232 (411)
T ss_pred             EeccceeeccCCch----hHHHhcCCCcccChhheeeeccc-------CCCCccchhhHHHHHHHHHHHHcCCCchhHHH
Confidence            99999999877654    34557899999999999776552       45678999999999999999999999984321


Q ss_pred             --------------CCchhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          498 --------------SEPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       498 --------------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                                    -...++.++.+...+|+.+||+.||.+|.|++|.+..
T Consensus       233 QmlMLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH  283 (411)
T KOG0599|consen  233 QMLMLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAH  283 (411)
T ss_pred             HHHHHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence                          1234455667779999999999999999999999874

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=5.4e-34  Score=281.95  Aligned_cols=217  Identities=22%  Similarity=0.392  Sum_probs=173.9

Q ss_pred             ceecccCcEEEEEEEEC-CceEEEEEeccCC----hHHHHHHHHHHHhccccce---------------EEEeecCCCcc
Q 044997          298 RIIGRGGFGNVYFGLLG-DREAAIKKMRSNK----SKEFFAELKVLCKIHHINV---------------FISTFGNGSLS  357 (563)
Q Consensus       298 ~~LG~G~fG~Vy~g~~~-~~~vavK~~~~~~----~~~f~~Ei~~l~~l~H~ni---------------V~e~~~~gsL~  357 (563)
                      ++||+|+||.||+|... ++.+|+|.++...    ...|.+|++++++++||||               |+||+++|+|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            36899999999999874 5789999987543    2468899999999999997               57999999999


Q ss_pred             cccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccccccccccccc
Q 044997          358 DHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLA  437 (563)
Q Consensus       358 ~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~  437 (563)
                      +++...    ...++|..+..++.|++.||.|||+++   ++||||||+||++++++.+||+|||++.........  ..
T Consensus        81 ~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~--~~  151 (250)
T cd05085          81 SFLRKK----KDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS--SS  151 (250)
T ss_pred             HHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccc--cC
Confidence            988642    345899999999999999999999987   999999999999999999999999998753322111  11


Q ss_pred             ccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCCCcCCCCCc-----------hhhHH
Q 044997          438 TRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIRDDSEP-----------TKMKS  505 (563)
Q Consensus       438 ~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p~~~~~~~~-----------~~~~~  505 (563)
                      ....++..|+|||++...             .++.++||||||+++||+++ |..||.......           .....
T Consensus       152 ~~~~~~~~y~aPE~~~~~-------------~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  218 (250)
T cd05085         152 GLKQIPIKWTAPEALNYG-------------RYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQK  218 (250)
T ss_pred             CCCCCcccccCHHHhccC-------------CCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Confidence            112346789999987543             34889999999999999998 888885432211           11123


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 044997          506 LITIMAAVAEWCLNEDAVDRPEMRDIVAILS  536 (563)
Q Consensus       506 ~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  536 (563)
                      +...+.+++.+||+.+|++||++.|+++.|.
T Consensus       219 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         219 CPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            4466899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=2.1e-34  Score=302.66  Aligned_cols=232  Identities=21%  Similarity=0.328  Sum_probs=182.6

Q ss_pred             HHHHHHHhcCCCccceecccCcEEEEEEEEC--CceEEEEEeccC------ChHHHHHHHHHHHhccccce---------
Q 044997          284 LEEIEEATNNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSN------KSKEFFAELKVLCKIHHINV---------  346 (563)
Q Consensus       284 ~~el~~~~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~------~~~~f~~Ei~~l~~l~H~ni---------  346 (563)
                      +.++....++|+..+.||+|+||.||+++..  ++.+|+|.+...      ..+.+.+|+++++.++||||         
T Consensus        35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~  114 (371)
T cd05622          35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD  114 (371)
T ss_pred             HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence            4455556689999999999999999999884  678999998642      23457889999999999997         


Q ss_pred             ------EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEee
Q 044997          347 ------FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVAD  420 (563)
Q Consensus       347 ------V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~D  420 (563)
                            |+||+++|+|.+++..      ..++...+..++.|++.||+|||+++   |+||||||+|||+++++.+||+|
T Consensus       115 ~~~~~lv~Ey~~gg~L~~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~D  185 (371)
T cd05622         115 DRYLYMVMEYMPGGDLVNLMSN------YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLAD  185 (371)
T ss_pred             CCEEEEEEcCCCCCcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEe
Confidence                  5799999999998864      34788888999999999999999997   99999999999999999999999


Q ss_pred             cCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc
Q 044997          421 FGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP  500 (563)
Q Consensus       421 FGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~  500 (563)
                      ||+++.......  .......||+.|+|||++....         ..+.++.++|||||||++|||++|+.||.......
T Consensus       186 fG~a~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~---------~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~  254 (371)
T cd05622         186 FGTCMKMNKEGM--VRCDTAVGTPDYISPEVLKSQG---------GDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG  254 (371)
T ss_pred             CCceeEcCcCCc--ccccCcccCccccCHHHHhccC---------CCccCCCccceeehhHHHHHHHhCCCCCCCCCHHH
Confidence            999986532211  1123457999999999986432         12346899999999999999999999997543210


Q ss_pred             --------------hhhHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHHH
Q 044997          501 --------------TKMKSLITIMAAVAEWCLNEDAVD--RPEMRDIVAIL  535 (563)
Q Consensus       501 --------------~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~L  535 (563)
                                    .....+...+.+++.+|+..++.+  ||++.|+++..
T Consensus       255 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~  305 (371)
T cd05622         255 TYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL  305 (371)
T ss_pred             HHHHHHcCCCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence                          011134566889999999844433  67888887754

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=2.8e-34  Score=296.00  Aligned_cols=212  Identities=24%  Similarity=0.382  Sum_probs=170.9

Q ss_pred             CCCccceecccCcEEEEEEEEC--CceEEEEEeccC------ChHHHHHHHHHHHhcccc-ce---------------EE
Q 044997          293 NFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSN------KSKEFFAELKVLCKIHHI-NV---------------FI  348 (563)
Q Consensus       293 ~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~------~~~~f~~Ei~~l~~l~H~-ni---------------V~  348 (563)
                      +|+..+.||+|+||.||+++..  ++.||+|.++..      ..+.+..|.+++..+.|+ +|               |+
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            4677899999999999999874  678999998643      224577899999888664 33               67


Q ss_pred             EeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccc
Q 044997          349 STFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEE  428 (563)
Q Consensus       349 e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~  428 (563)
                      ||+++|+|.+++..     ...+++.++..++.|++.||+|||+++   ++||||||+|||+++++.+||+|||+++...
T Consensus        81 Ey~~~g~L~~~i~~-----~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~  152 (323)
T cd05615          81 EYVNGGDLMYHIQQ-----VGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHM  152 (323)
T ss_pred             cCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccC
Confidence            99999999988864     356999999999999999999999987   9999999999999999999999999987432


Q ss_pred             cccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc--------
Q 044997          429 RTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP--------  500 (563)
Q Consensus       429 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~--------  500 (563)
                      ...   .......||+.|+|||++.+..             ++.++|||||||++|||++|+.||.......        
T Consensus       153 ~~~---~~~~~~~gt~~y~aPE~~~~~~-------------~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~  216 (323)
T cd05615         153 VDG---VTTRTFCGTPDYIAPEIIAYQP-------------YGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEH  216 (323)
T ss_pred             CCC---ccccCccCCccccCHHHHcCCC-------------CCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Confidence            211   1122356899999999885443             4789999999999999999999997543211        


Q ss_pred             --hhhHHHHHHHHHHHHHhhccCCCCCCCH
Q 044997          501 --TKMKSLITIMAAVAEWCLNEDAVDRPEM  528 (563)
Q Consensus       501 --~~~~~~~~~l~~li~~cl~~dP~~RPs~  528 (563)
                        ..+..+...+.+++.+||+.||.+|++.
T Consensus       217 ~~~~p~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         217 NVSYPKSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             CCCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence              0112344568899999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=5.4e-34  Score=291.78  Aligned_cols=219  Identities=20%  Similarity=0.331  Sum_probs=173.8

Q ss_pred             cCCCccceecccCcEEEEEEEE--CCceEEEEEeccCC----hHHHHHHHHHHHhccccce---------------EEEe
Q 044997          292 NNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNK----SKEFFAELKVLCKIHHINV---------------FIST  350 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~----~~~f~~Ei~~l~~l~H~ni---------------V~e~  350 (563)
                      ++|...+.||+|+||.||+|+.  .++.+|+|.++...    ...+.+|++++++++|+||               |+||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            4688899999999999999987  46789999986432    3467889999999999997               4677


Q ss_pred             ecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccccc
Q 044997          351 FGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERT  430 (563)
Q Consensus       351 ~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~  430 (563)
                      +++ +|.+++..    ....+++..+..++.|++.||+|||+++   |+||||||+|||+++++.+||+|||+++.....
T Consensus        86 ~~~-~l~~~~~~----~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  157 (309)
T cd07872          86 LDK-DLKQYMDD----CGNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVP  157 (309)
T ss_pred             CCC-CHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCC
Confidence            764 77777654    2345889999999999999999999987   999999999999999999999999998754322


Q ss_pred             cccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCch---------
Q 044997          431 NEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPT---------  501 (563)
Q Consensus       431 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~---------  501 (563)
                      ..   ......++..|+|||.+.+.            ..++.++|||||||++|||++|+.||........         
T Consensus       158 ~~---~~~~~~~~~~y~aPE~~~~~------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~  222 (309)
T cd07872         158 TK---TYSNEVVTLWYRPPDVLLGS------------SEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLG  222 (309)
T ss_pred             cc---ccccccccccccCCHHHhCC------------CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence            11   12234678999999987432            2347899999999999999999999865432100         


Q ss_pred             -----h--------------------------hHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          502 -----K--------------------------MKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       502 -----~--------------------------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                           .                          ...+...+.+++.+|++.||.+|||+.|+++
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         223 TPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             CCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence                 0                          0012345789999999999999999999987

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=4.9e-34  Score=283.24  Aligned_cols=222  Identities=25%  Similarity=0.430  Sum_probs=178.7

Q ss_pred             cCCCccceecccCcEEEEEEEEC-CceEEEEEeccCC--hHHHHHHHHHHHhccccce---------------EEEeecC
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG-DREAAIKKMRSNK--SKEFFAELKVLCKIHHINV---------------FISTFGN  353 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~vavK~~~~~~--~~~f~~Ei~~l~~l~H~ni---------------V~e~~~~  353 (563)
                      .+|+..+.||+|+||.||++.+. ++.+|+|.++...  .++|.+|++++++++|||+               |+||+.+
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~   83 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEH   83 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCC
Confidence            35777899999999999999875 7789999987543  4679999999999999997               5688999


Q ss_pred             CCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccccccccc
Q 044997          354 GSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEK  433 (563)
Q Consensus       354 gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~  433 (563)
                      |+|.+++...    ...++|..+..++.+++.||+|||+.+   ++||||||+||+++.++.+||+|||+++........
T Consensus        84 ~~L~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~  156 (256)
T cd05112          84 GCLSDYLRAQ----RGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT  156 (256)
T ss_pred             CcHHHHHHhC----ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCccc
Confidence            9999988642    245899999999999999999999987   999999999999999999999999998754321110


Q ss_pred             ccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCCCcCCCCCc-----------h
Q 044997          434 EMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIRDDSEP-----------T  501 (563)
Q Consensus       434 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p~~~~~~~~-----------~  501 (563)
                        ......++.+|+|||.+.+..             ++.++||||||+++|||++ |+.||.......           .
T Consensus       157 --~~~~~~~~~~~~aPe~~~~~~-------------~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~  221 (256)
T cd05112         157 --SSTGTKFPVKWSSPEVFSFSK-------------YSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLY  221 (256)
T ss_pred             --ccCCCccchhhcCHhHhccCC-------------cChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCC
Confidence              111223567899999875443             4789999999999999998 888885433110           0


Q ss_pred             hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 044997          502 KMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAIL  535 (563)
Q Consensus       502 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  535 (563)
                      ......+.+.+++.+||+.+|++||++.|+++.|
T Consensus       222 ~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         222 KPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL  255 (256)
T ss_pred             CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence            1112345689999999999999999999999887

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-35  Score=302.05  Aligned_cols=216  Identities=32%  Similarity=0.500  Sum_probs=182.1

Q ss_pred             CCccceecccCcEEEEEEEE--CCceEEEEEeccC------ChHHHHHHHHHHHhccccce---------------EEEe
Q 044997          294 FDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSN------KSKEFFAELKVLCKIHHINV---------------FIST  350 (563)
Q Consensus       294 f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~------~~~~f~~Ei~~l~~l~H~ni---------------V~e~  350 (563)
                      |...+.||.|+||.||.++.  +.+.||||+|.-.      +..++++|+..|.+++|||.               ||||
T Consensus        28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY  107 (948)
T KOG0577|consen   28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY  107 (948)
T ss_pred             HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence            66678899999999999976  4688999999632      24679999999999999997               4565


Q ss_pred             ecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccccc
Q 044997          351 FGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERT  430 (563)
Q Consensus       351 ~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~  430 (563)
                      |- |+-.+.|.-    ..+++...++..|+.+.+.||.|||+++   .||||||..|||+++.|.+||+|||.|....+ 
T Consensus       108 Cl-GSAsDlleV----hkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P-  178 (948)
T KOG0577|consen  108 CL-GSASDLLEV----HKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAP-  178 (948)
T ss_pred             Hh-ccHHHHHHH----HhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCc-
Confidence            54 566666643    2467999999999999999999999998   99999999999999999999999999876543 


Q ss_pred             cccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCC------------C
Q 044997          431 NEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDD------------S  498 (563)
Q Consensus       431 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~------------~  498 (563)
                            ...++|||.|||||++.          +...|+|+-|+||||+|++..||..+++|++.-+            .
T Consensus       179 ------AnsFvGTPywMAPEVIL----------AMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNes  242 (948)
T KOG0577|consen  179 ------ANSFVGTPYWMAPEVIL----------AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES  242 (948)
T ss_pred             ------hhcccCCccccchhHhe----------eccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCC
Confidence                  34578999999999986          3457889999999999999999999999976432            2


Q ss_pred             CchhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          499 EPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       499 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                      +.-...++.+.++.++..||++-|.+|||..+++..
T Consensus       243 PtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H  278 (948)
T KOG0577|consen  243 PTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLKH  278 (948)
T ss_pred             CCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence            223345788889999999999999999999998764

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=6.8e-34  Score=281.87  Aligned_cols=219  Identities=27%  Similarity=0.430  Sum_probs=181.4

Q ss_pred             cCCCccceecccCcEEEEEEEEC--CceEEEEEeccCC-hHHHHHHHHHHHhccccce---------------EEEeecC
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNK-SKEFFAELKVLCKIHHINV---------------FISTFGN  353 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~-~~~f~~Ei~~l~~l~H~ni---------------V~e~~~~  353 (563)
                      ++|+..+.||+|+||.||+|...  ++.+++|.++... .+++.+|++++++++|+|+               ++||+++
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~   82 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGA   82 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCC
Confidence            57888999999999999999885  5889999987654 5789999999999999997               4688899


Q ss_pred             CCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccccccccc
Q 044997          354 GSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEK  433 (563)
Q Consensus       354 gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~  433 (563)
                      ++|.+++..    ....++|..+..++.|++.||.|||+.+   ++||||+|+||++++++.+||+|||++........ 
T Consensus        83 ~~L~~~l~~----~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-  154 (256)
T cd06612          83 GSVSDIMKI----TNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-  154 (256)
T ss_pred             CcHHHHHHh----CccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc-
Confidence            999998864    2357899999999999999999999987   99999999999999999999999999886543221 


Q ss_pred             ccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc-------------
Q 044997          434 EMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP-------------  500 (563)
Q Consensus       434 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~-------------  500 (563)
                        ......|+..|+|||++.+..             ++.++||||||+++|||++|+.|+.......             
T Consensus       155 --~~~~~~~~~~y~~PE~~~~~~-------------~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~  219 (256)
T cd06612         155 --KRNTVIGTPFWMAPEVIQEIG-------------YNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTL  219 (256)
T ss_pred             --ccccccCCccccCHHHHhcCC-------------CCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCC
Confidence              122345788999999875443             4789999999999999999999986432211             


Q ss_pred             hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          501 TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       501 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                      .....+...+.+++.+||+.||.+||++.|+++
T Consensus       220 ~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         220 SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence            111233456899999999999999999999986

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=5e-34  Score=289.15  Aligned_cols=239  Identities=26%  Similarity=0.379  Sum_probs=189.8

Q ss_pred             ccCHHHHHHHhcCCCccceecccCcEEEEEEEE--CCceEEEEEeccCC--hHHHHHHHHHHHhc-cccce---------
Q 044997          281 IFSLEEIEEATNNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNK--SKEFFAELKVLCKI-HHINV---------  346 (563)
Q Consensus       281 ~~~~~el~~~~~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~--~~~f~~Ei~~l~~l-~H~ni---------  346 (563)
                      .++++++..++++|...+.||+|+||.||++..  +++.+|+|.+....  .+++.+|+.++.++ +|+|+         
T Consensus        11 ~~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   90 (291)
T cd06639          11 MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYK   90 (291)
T ss_pred             hhhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence            456677778899999999999999999999987  46789999986542  46678899999999 79886         


Q ss_pred             -----------EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCc
Q 044997          347 -----------FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLR  415 (563)
Q Consensus       347 -----------V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~  415 (563)
                                 |+||+++|+|.++++... .....++|..+..++.|++.||+|||+++   ++||||||+||++++++.
T Consensus        91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~-~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~  166 (291)
T cd06639          91 ADKLVGGQLWLVLELCNGGSVTELVKGLL-ICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGG  166 (291)
T ss_pred             ccccCCCeeEEEEEECCCCcHHHHHHHhh-hcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCC
Confidence                       467888999998876421 22456899999999999999999999987   999999999999999999


Q ss_pred             EEEeecCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcC
Q 044997          416 AKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIR  495 (563)
Q Consensus       416 ~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~  495 (563)
                      +||+|||+++.......   ......|+..|+|||.+.....        ....++.++|||||||++|||++|+.|+..
T Consensus       167 ~kl~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~--------~~~~~~~~~Di~slGvi~~el~~g~~p~~~  235 (291)
T cd06639         167 VKLVDFGVSAQLTSTRL---RRNTSVGTPFWMAPEVIACEQQ--------YDYSYDARCDVWSLGITAIELGDGDPPLFD  235 (291)
T ss_pred             EEEeecccchhcccccc---cccCccCCccccChhhhcCCCC--------cccccCCccchHHHHHHHHHHhhCCCCCCC
Confidence            99999999876443221   1123468889999998754321        123458999999999999999999999865


Q ss_pred             CCCCch-------------hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          496 DDSEPT-------------KMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       496 ~~~~~~-------------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                      ......             ........+.+++.+||+.||++||++.|+++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  287 (291)
T cd06639         236 MHPVKTLFKIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH  287 (291)
T ss_pred             CcHHHHHHHHhcCCCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence            432110             112234568899999999999999999999863

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=3.3e-34  Score=284.55  Aligned_cols=217  Identities=29%  Similarity=0.495  Sum_probs=176.3

Q ss_pred             CCccceecccCcEEEEEEEEC--CceEEEEEeccCChH-----HHHHHHHHHHhccccce---------------EEEee
Q 044997          294 FDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNKSK-----EFFAELKVLCKIHHINV---------------FISTF  351 (563)
Q Consensus       294 f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~-----~f~~Ei~~l~~l~H~ni---------------V~e~~  351 (563)
                      |+..+.||+|+||.||+++..  ++.+|+|.+......     ...+|+.++++++|+||               |++++
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            456789999999999999985  457999999876532     23459999999999997               57999


Q ss_pred             cCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccccccc
Q 044997          352 GNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTN  431 (563)
Q Consensus       352 ~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~  431 (563)
                      .+++|.+++..     ...+++..+..++.|+++||.|||+++   ++|+||||+||++++++.++|+|||.+.....  
T Consensus        81 ~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~--  150 (260)
T PF00069_consen   81 PGGSLQDYLQK-----NKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLSE--  150 (260)
T ss_dssp             TTEBHHHHHHH-----HSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEESTS--
T ss_pred             ccccccccccc-----ccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc--
Confidence            99999999972     356899999999999999999999997   99999999999999999999999999875311  


Q ss_pred             ccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCch--hh-H----
Q 044997          432 EKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPT--KM-K----  504 (563)
Q Consensus       432 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~--~~-~----  504 (563)
                       .........++..|+|||.+..            ....+.++||||+|+++|+|++|+.|+........  .. .    
T Consensus       151 -~~~~~~~~~~~~~y~aPE~~~~------------~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~  217 (260)
T PF00069_consen  151 -NNENFNPFVGTPEYMAPEVLQQ------------GKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKR  217 (260)
T ss_dssp             -TTSEBSSSSSSGGGSCHHHHTT------------TSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHT
T ss_pred             -cccccccccccccccccccccc------------cccccccccccccccccccccccccccccccchhhhhhhhhcccc
Confidence             1112334578999999998751            23348999999999999999999999976521100  00 0    


Q ss_pred             ----------HHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          505 ----------SLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       505 ----------~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                                .....+.+++.+||+.||++||++.++++
T Consensus       218 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  218 PLPSSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             HHHHHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             cccccccccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                      01256999999999999999999999975

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=1.3e-34  Score=303.01  Aligned_cols=234  Identities=24%  Similarity=0.378  Sum_probs=178.9

Q ss_pred             cCCCccceecccCcEEEEEEEEC--CceEEEEEeccC------ChHHHHHHHHHHHhccccce---------------EE
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSN------KSKEFFAELKVLCKIHHINV---------------FI  348 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~------~~~~f~~Ei~~l~~l~H~ni---------------V~  348 (563)
                      ++|+..+.||+|+||.||+++..  ++.+|+|.++..      ..+.+.+|++++.+++|+||               |+
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46888999999999999999874  688999998642      23567889999999999987               57


Q ss_pred             EeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccc
Q 044997          349 STFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEE  428 (563)
Q Consensus       349 e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~  428 (563)
                      ||+++|+|.+++..     ...+++.....++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus        81 E~~~gg~L~~~l~~-----~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~  152 (360)
T cd05627          81 EFLPGGDMMTLLMK-----KDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLK  152 (360)
T ss_pred             eCCCCccHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccc
Confidence            99999999999864     356899999999999999999999997   9999999999999999999999999987543


Q ss_pred             ccccc--------------------------------ccccccccCCCcccCcccccccccccccccccccCCCCCcchH
Q 044997          429 RTNEK--------------------------------EMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDV  476 (563)
Q Consensus       429 ~~~~~--------------------------------~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDV  476 (563)
                      .....                                .......+||+.|+|||++.+..             ++.++||
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~-------------~~~~~Di  219 (360)
T cd05627         153 KAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTG-------------YNKLCDW  219 (360)
T ss_pred             cccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCC-------------CCCccee
Confidence            21100                                00112357999999999986544             4789999


Q ss_pred             HHHHHHHHHHHcCCCCCcCCCCCchh--------------hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcC
Q 044997          477 FAFGVVLAELITGKRALIRDDSEPTK--------------MKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITS  542 (563)
Q Consensus       477 wSfGvvl~Elltg~~p~~~~~~~~~~--------------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~  542 (563)
                      |||||++|||++|+.||.........              ...+.+.+.+++.+++ .||.+|++...+-+.++.-.-..
T Consensus       220 wSlGvilyel~tG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~  298 (360)
T cd05627         220 WSLGVIMYEMLIGYPPFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSHPFFEG  298 (360)
T ss_pred             ccccceeeecccCCCCCCCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcCCCCCC
Confidence            99999999999999999754432110              0113456788888876 49999986433333333333333


Q ss_pred             hhhhc
Q 044997          543 TEWEA  547 (563)
Q Consensus       543 ~~w~~  547 (563)
                      .+|+.
T Consensus       299 ~~~~~  303 (360)
T cd05627         299 VDWGH  303 (360)
T ss_pred             CCHHH
Confidence            44543

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=8e-34  Score=286.31  Aligned_cols=223  Identities=22%  Similarity=0.366  Sum_probs=178.7

Q ss_pred             CCccceecccCcEEEEEEEEC--CceEEEEEeccCC---hHHHHHHHHHHHhccccce---------------EEEeecC
Q 044997          294 FDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNK---SKEFFAELKVLCKIHHINV---------------FISTFGN  353 (563)
Q Consensus       294 f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~---~~~f~~Ei~~l~~l~H~ni---------------V~e~~~~  353 (563)
                      |+..+.||+|+||.||+|...  +..+++|.+....   .+.+.+|++++++++|+|+               |+||+++
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~   86 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG   86 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence            456788999999999999885  5678899886543   3568899999999999997               5789999


Q ss_pred             CCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccccccccc
Q 044997          354 GSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEK  433 (563)
Q Consensus       354 gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~  433 (563)
                      |+|..++..    ...+++|..+..++.|+++||.|||+.+   ++||||||+||+++.++++||+|||+++....... 
T Consensus        87 ~~l~~~~~~----~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~-  158 (282)
T cd06643          87 GAVDAVMLE----LERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-  158 (282)
T ss_pred             CcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccccccccc-
Confidence            999887764    2357999999999999999999999987   99999999999999999999999999875432211 


Q ss_pred             ccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc-------------
Q 044997          434 EMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP-------------  500 (563)
Q Consensus       434 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~-------------  500 (563)
                        ......++..|+|||++.....        ....++.++|||||||++|||++|+.||.......             
T Consensus       159 --~~~~~~~~~~y~aPE~~~~~~~--------~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  228 (282)
T cd06643         159 --RRDSFIGTPYWMAPEVVMCETS--------KDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTL  228 (282)
T ss_pred             --ccccccccccccCHhhccccCC--------CCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCC
Confidence              1223468899999998753321        23345789999999999999999999986433211             


Q ss_pred             hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          501 TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       501 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                      .....+...+.+++.+||+.||.+||++.++++.
T Consensus       229 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  262 (282)
T cd06643         229 AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH  262 (282)
T ss_pred             CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            1122345679999999999999999999998764

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=9e-34  Score=281.06  Aligned_cols=222  Identities=29%  Similarity=0.437  Sum_probs=179.6

Q ss_pred             ceecccCcEEEEEEEEC-----CceEEEEEeccCC----hHHHHHHHHHHHhccccce---------------EEEeecC
Q 044997          298 RIIGRGGFGNVYFGLLG-----DREAAIKKMRSNK----SKEFFAELKVLCKIHHINV---------------FISTFGN  353 (563)
Q Consensus       298 ~~LG~G~fG~Vy~g~~~-----~~~vavK~~~~~~----~~~f~~Ei~~l~~l~H~ni---------------V~e~~~~  353 (563)
                      +.||+|+||.||+|...     +..+++|.++...    .+.+.+|++.+.+++|+|+               |+||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            46899999999999885     6789999987543    4678899999999999997               5799999


Q ss_pred             CCccccccccccc----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccccc
Q 044997          354 GSLSDHLHDPLLK----GHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEER  429 (563)
Q Consensus       354 gsL~~~L~~~~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~  429 (563)
                      |+|.+++......    ....+++.++..++.|++.||+|||+++   ++||||||+||++++++.+||+|||.++....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence            9999998763100    1367999999999999999999999987   99999999999999999999999999986654


Q ss_pred             ccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCCCcCCCCC---------
Q 044997          430 TNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIRDDSE---------  499 (563)
Q Consensus       430 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p~~~~~~~---------  499 (563)
                      ... ........++..|+|||.+...             .++.++||||+|+++|||++ |+.||......         
T Consensus       158 ~~~-~~~~~~~~~~~~y~aPE~~~~~-------------~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~  223 (262)
T cd00192         158 DDY-YRKKTGGKLPIRWMAPESLKDG-------------IFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKG  223 (262)
T ss_pred             ccc-cccccCCCcCccccCHHHhccC-------------CcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence            321 1122334578899999987543             34889999999999999999 58887654221         


Q ss_pred             --chhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 044997          500 --PTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILS  536 (563)
Q Consensus       500 --~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  536 (563)
                        ......++..+.+++.+||+.||.+||++.|+++.|+
T Consensus       224 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         224 YRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             CCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence              1112233467899999999999999999999998873

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.2e-33  Score=293.59  Aligned_cols=219  Identities=23%  Similarity=0.380  Sum_probs=172.2

Q ss_pred             HHhcCCCccceecccCcEEEEEEEE--CCceEEEEEeccCC-----hHHHHHHHHHHHhccccceEE-------------
Q 044997          289 EATNNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNK-----SKEFFAELKVLCKIHHINVFI-------------  348 (563)
Q Consensus       289 ~~~~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~-----~~~f~~Ei~~l~~l~H~niV~-------------  348 (563)
                      +..++|...+.||+|+||.||+|..  .++.||||+++...     .+.+.+|+++|++++|+||+.             
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07878          12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN   91 (343)
T ss_pred             hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence            3457899999999999999999986  46789999986532     356778999999999999841             


Q ss_pred             -------EeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeec
Q 044997          349 -------STFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADF  421 (563)
Q Consensus       349 -------e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DF  421 (563)
                             ..+.+++|.+++.      ...+++..+..++.|++.||.|||+++   |+||||||+|||+++++.+||+||
T Consensus        92 ~~~~~~~~~~~~~~l~~~~~------~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Df  162 (343)
T cd07878          92 FNEVYLVTNLMGADLNNIVK------CQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDF  162 (343)
T ss_pred             cCcEEEEeecCCCCHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCC
Confidence                   1112456655553      246899999999999999999999997   999999999999999999999999


Q ss_pred             CCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc-
Q 044997          422 GLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP-  500 (563)
Q Consensus       422 Gla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~-  500 (563)
                      |+++.....      .....||..|+|||++.+.            ..++.++|||||||++|||++|+.||...+... 
T Consensus       163 g~~~~~~~~------~~~~~~t~~y~aPE~~~~~------------~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~  224 (343)
T cd07878         163 GLARQADDE------MTGYVATRWYRAPEIMLNW------------MHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQ  224 (343)
T ss_pred             ccceecCCC------cCCccccccccCchHhcCC------------ccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH
Confidence            999854321      2234689999999987542            234789999999999999999999986432110 


Q ss_pred             -------------hhh---------------------------HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          501 -------------TKM---------------------------KSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       501 -------------~~~---------------------------~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                                   ...                           ....+.+.+++.+|++.||.+|||+.|+++.
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h  298 (343)
T cd07878         225 LKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH  298 (343)
T ss_pred             HHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                         000                           0011236789999999999999999999964

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1.1e-33  Score=285.03  Aligned_cols=213  Identities=23%  Similarity=0.397  Sum_probs=172.8

Q ss_pred             cCCCccceecccCcEEEEEEEE--CCceEEEEEeccCC----hHHHHHHHHHHHhccccce---------------EEEe
Q 044997          292 NNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNK----SKEFFAELKVLCKIHHINV---------------FIST  350 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~----~~~f~~Ei~~l~~l~H~ni---------------V~e~  350 (563)
                      ++|+..+.||+|+||.||+|+.  .++.+|+|.+....    .+++.+|++++++++|||+               |+||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   80 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF   80 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence            3577789999999999999986  46889999986442    3568899999999999997               4688


Q ss_pred             ecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccccc
Q 044997          351 FGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERT  430 (563)
Q Consensus       351 ~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~  430 (563)
                      +++|+|..+         ..+++..+..++.|++.||.|||+.+   ++|+||||+|||++.++.+||+|||++......
T Consensus        81 ~~~~~l~~~---------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~  148 (279)
T cd06619          81 MDGGSLDVY---------RKIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS  148 (279)
T ss_pred             CCCCChHHh---------hcCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc
Confidence            888887543         23678888999999999999999997   999999999999999999999999998754322


Q ss_pred             cccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc-----hh---
Q 044997          431 NEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP-----TK---  502 (563)
Q Consensus       431 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~-----~~---  502 (563)
                           ......|+..|+|||++.+..             ++.++||||||+++|||++|+.||.......     ..   
T Consensus       149 -----~~~~~~~~~~y~aPE~~~~~~-------------~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~  210 (279)
T cd06619         149 -----IAKTYVGTNAYMAPERISGEQ-------------YGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQ  210 (279)
T ss_pred             -----cccCCCCChhhcCceeecCCC-------------CCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHH
Confidence                 122356899999999885443             4889999999999999999999985422110     00   


Q ss_pred             -----------hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          503 -----------MKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       503 -----------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                                 .......+.+++.+||+.||++||+++|+++.
T Consensus       211 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         211 CIVDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             HHhccCCCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence                       11233468899999999999999999999874

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=8.3e-34  Score=281.58  Aligned_cols=220  Identities=25%  Similarity=0.414  Sum_probs=178.8

Q ss_pred             CCCccceecccCcEEEEEEEE--CCceEEEEEeccC-----ChHHHHHHHHHHHhccccce----------------EEE
Q 044997          293 NFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSN-----KSKEFFAELKVLCKIHHINV----------------FIS  349 (563)
Q Consensus       293 ~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~-----~~~~f~~Ei~~l~~l~H~ni----------------V~e  349 (563)
                      +|+..+.||+|++|.||++..  +++.+|+|++...     ..+.+.+|++++++++|+|+                ++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            477889999999999999987  4678999998643     23568889999999999997                457


Q ss_pred             eecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccccc
Q 044997          350 TFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEER  429 (563)
Q Consensus       350 ~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~  429 (563)
                      |+++++|.+++...   ....+++.++..++.|++.||+|||+.+   ++||||||+||++++++.+||+|||+++....
T Consensus        81 ~~~~~~l~~~l~~~---~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~  154 (257)
T cd08223          81 FCEGGDLYHKLKEQ---KGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN  154 (257)
T ss_pred             ccCCCcHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecc
Confidence            78888998888652   2356899999999999999999999987   99999999999999999999999999876533


Q ss_pred             ccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc---------
Q 044997          430 TNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP---------  500 (563)
Q Consensus       430 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~---------  500 (563)
                      ...   ......+++.|+|||++.+..             ++.++||||||+++|||++|+.||...+...         
T Consensus       155 ~~~---~~~~~~~~~~y~aPE~~~~~~-------------~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~  218 (257)
T cd08223         155 QCD---MASTLIGTPYYMSPELFSNKP-------------YNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGK  218 (257)
T ss_pred             cCC---ccccccCCcCccChhHhcCCC-------------CCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcC
Confidence            211   223356889999999875443             4789999999999999999999986543211         


Q ss_pred             --hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          501 --TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       501 --~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                        .........+.+++.+||+.||++||++.++++.
T Consensus       219 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         219 LPPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             CCCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence              1112344668999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=9.6e-34  Score=282.95  Aligned_cols=220  Identities=25%  Similarity=0.401  Sum_probs=175.5

Q ss_pred             cCCCccceecccCcEEEEEEEEC--CceEEEEEeccCC--------hHHHHHHHHHHHhccccce---------------
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNK--------SKEFFAELKVLCKIHHINV---------------  346 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~--------~~~f~~Ei~~l~~l~H~ni---------------  346 (563)
                      .+|+..+.||+|+||.||+|...  ++.||+|.+....        .+.+.+|++++++++|+||               
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            47888999999999999999873  6889999875321        2467889999999999997               


Q ss_pred             --EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCC
Q 044997          347 --FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLV  424 (563)
Q Consensus       347 --V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla  424 (563)
                        ++||+++|+|.+++..     ...+++....+++.|++.||+|||+++   ++|+||||+||+++.++.+||+|||++
T Consensus        82 ~~v~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~  153 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKS-----YGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGAS  153 (265)
T ss_pred             EEEEEecCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccc
Confidence              4688889999888864     245788999999999999999999987   999999999999999999999999998


Q ss_pred             cccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCC-----
Q 044997          425 KLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE-----  499 (563)
Q Consensus       425 ~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~-----  499 (563)
                      +................|+..|+|||.+.+.             .++.++|||||||++|||++|+.||......     
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-------------~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~  220 (265)
T cd06652         154 KRLQTICLSGTGMKSVTGTPYWMSPEVISGE-------------GYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFK  220 (265)
T ss_pred             cccccccccccccccCCCCccccChhhhcCC-------------CCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHH
Confidence            7543221111112234588899999987543             3478999999999999999999998643211     


Q ss_pred             -------chhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          500 -------PTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       500 -------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                             +.........+.+++.+|+. +|.+||+++||++
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         221 IATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR  260 (265)
T ss_pred             HhcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence                   11223445568889999995 9999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=2.1e-34  Score=297.54  Aligned_cols=207  Identities=24%  Similarity=0.358  Sum_probs=166.7

Q ss_pred             ceecccCcEEEEEEEEC--CceEEEEEeccCC------hHHHHHHHHHHHhc-cccce---------------EEEeecC
Q 044997          298 RIIGRGGFGNVYFGLLG--DREAAIKKMRSNK------SKEFFAELKVLCKI-HHINV---------------FISTFGN  353 (563)
Q Consensus       298 ~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~------~~~f~~Ei~~l~~l-~H~ni---------------V~e~~~~  353 (563)
                      +.||+|+||.||+++..  ++.+|+|.++...      .+.+.+|+.++.++ +|+||               |+||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999874  6789999997532      24577899999888 68886               5799999


Q ss_pred             CCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccccccccc
Q 044997          354 GSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEK  433 (563)
Q Consensus       354 gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~  433 (563)
                      |+|.+++..     ...+++..+..++.|++.||+|||+++   ++||||||+|||+++++.+||+|||+++....... 
T Consensus        81 ~~L~~~~~~-----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-  151 (327)
T cd05617          81 GDLMFHMQR-----QRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD-  151 (327)
T ss_pred             CcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCCC-
Confidence            999888754     356999999999999999999999997   99999999999999999999999999874321111 


Q ss_pred             ccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc-------------
Q 044997          434 EMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP-------------  500 (563)
Q Consensus       434 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~-------------  500 (563)
                        ......||+.|+|||++.+..             ++.++|||||||++|||++|+.||.......             
T Consensus       152 --~~~~~~gt~~y~aPE~~~~~~-------------~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  216 (327)
T cd05617         152 --TTSTFCGTPNYIAPEILRGEE-------------YGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVIL  216 (327)
T ss_pred             --ceecccCCcccCCHHHHCCCC-------------CCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHH
Confidence              123457999999999886544             4789999999999999999999995422111             


Q ss_pred             ----hhhHHHHHHHHHHHHHhhccCCCCCCCH
Q 044997          501 ----TKMKSLITIMAAVAEWCLNEDAVDRPEM  528 (563)
Q Consensus       501 ----~~~~~~~~~l~~li~~cl~~dP~~RPs~  528 (563)
                          ..+..+...+.+++.+||+.||.+||++
T Consensus       217 ~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~  248 (327)
T cd05617         217 EKPIRIPRFLSVKASHVLKGFLNKDPKERLGC  248 (327)
T ss_pred             hCCCCCCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence                0111233458899999999999999985

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5.8e-34  Score=305.54  Aligned_cols=218  Identities=21%  Similarity=0.289  Sum_probs=170.7

Q ss_pred             cCCCccceecccCcEEEEEEEEC--CceEEEEEeccCChHHHHHHHHHHHhccccceE---------------EEeecCC
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNKSKEFFAELKVLCKIHHINVF---------------ISTFGNG  354 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~f~~Ei~~l~~l~H~niV---------------~e~~~~g  354 (563)
                      .+|...+.||+|+||.||+++..  ++.||||....   ..+.+|+++|++++|+|||               ++++ .|
T Consensus       169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~-~~  244 (461)
T PHA03211        169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY-RS  244 (461)
T ss_pred             CCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc-CC
Confidence            46888999999999999999885  57899996432   3467899999999999983               4555 46


Q ss_pred             CcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccccccccc
Q 044997          355 SLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKE  434 (563)
Q Consensus       355 sL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~  434 (563)
                      +|.+++..    ....++|.+++.|+.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++....... .
T Consensus       245 ~L~~~l~~----~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~-~  316 (461)
T PHA03211        245 DLYTYLGA----RLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS-T  316 (461)
T ss_pred             CHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccc-c
Confidence            77777653    2346999999999999999999999997   99999999999999999999999999986532211 1


Q ss_pred             cccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc------hhh-----
Q 044997          435 MLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP------TKM-----  503 (563)
Q Consensus       435 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~------~~~-----  503 (563)
                      .......||..|+|||++.+..             ++.++|||||||+||||++|..++.......      ...     
T Consensus       317 ~~~~~~~GT~~Y~APE~~~~~~-------------~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~  383 (461)
T PHA03211        317 PFHYGIAGTVDTNAPEVLAGDP-------------YTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIR  383 (461)
T ss_pred             ccccccCCCcCCcCHHHHcCCC-------------CCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHH
Confidence            1122357999999999886544             4889999999999999999887654321100      000     


Q ss_pred             -----------------------------------------HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          504 -----------------------------------------KSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       504 -----------------------------------------~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                                                               ......+.+|+.+||+.||.+|||+.|+++.
T Consensus       384 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        384 QAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             hhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence                                                     0111247789999999999999999999874

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=3.8e-34  Score=286.22  Aligned_cols=222  Identities=27%  Similarity=0.470  Sum_probs=175.3

Q ss_pred             ceecccCcEEEEEEEECC--------ceEEEEEeccC----ChHHHHHHHHHHHhccccce---------------EEEe
Q 044997          298 RIIGRGGFGNVYFGLLGD--------REAAIKKMRSN----KSKEFFAELKVLCKIHHINV---------------FIST  350 (563)
Q Consensus       298 ~~LG~G~fG~Vy~g~~~~--------~~vavK~~~~~----~~~~f~~Ei~~l~~l~H~ni---------------V~e~  350 (563)
                      +.||+|+||.||+|+..+        ..+|+|.+...    ...+|.+|++++++++||||               |+||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            468999999999998743        56899987643    24678999999999999998               4689


Q ss_pred             ecCCCccccccccccc--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCC-----cEEEeecCC
Q 044997          351 FGNGSLSDHLHDPLLK--GHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGL-----RAKVADFGL  423 (563)
Q Consensus       351 ~~~gsL~~~L~~~~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~-----~~kl~DFGl  423 (563)
                      +++|+|.+++......  ....++|.+++.++.|++.||+|||+.+   ++|+||||+||+++.+.     .+||+|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence            9999999999753211  2245899999999999999999999987   99999999999999877     899999999


Q ss_pred             CcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCCCcCCCCC---
Q 044997          424 VKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIRDDSE---  499 (563)
Q Consensus       424 a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p~~~~~~~---  499 (563)
                      ++........ .......++..|+|||++.+.             .++.++|||||||++|||++ |+.||......   
T Consensus       158 ~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~-------------~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~  223 (269)
T cd05044         158 ARDIYKSDYY-RKEGEGLLPVRWMAPESLLDG-------------KFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVL  223 (269)
T ss_pred             cccccccccc-ccCcccCCCccccCHHHHccC-------------CcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHH
Confidence            8754322111 111223456789999987543             35899999999999999998 88888543211   


Q ss_pred             --------chhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 044997          500 --------PTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILS  536 (563)
Q Consensus       500 --------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  536 (563)
                              .......+..+.+++.+||+.+|.+||++.+|++.|+
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  268 (269)
T cd05044         224 QHVTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ  268 (269)
T ss_pred             HHHhcCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence                    1112234566899999999999999999999999886

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=9.4e-34  Score=283.95  Aligned_cols=228  Identities=24%  Similarity=0.373  Sum_probs=176.6

Q ss_pred             CCccceecccCcEEEEEEEEC-----CceEEEEEeccCC-----hHHHHHHHHHHHhccccceE----------------
Q 044997          294 FDESRIIGRGGFGNVYFGLLG-----DREAAIKKMRSNK-----SKEFFAELKVLCKIHHINVF----------------  347 (563)
Q Consensus       294 f~~~~~LG~G~fG~Vy~g~~~-----~~~vavK~~~~~~-----~~~f~~Ei~~l~~l~H~niV----------------  347 (563)
                      |...+.||+|+||.||+|.+.     ++.+|||.++.+.     .+++.+|++++++++|||++                
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            456789999999999999763     4789999887542     35688999999999999962                


Q ss_pred             -----EEeecCCCccccccccccc-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeec
Q 044997          348 -----ISTFGNGSLSDHLHDPLLK-GHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADF  421 (563)
Q Consensus       348 -----~e~~~~gsL~~~L~~~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DF  421 (563)
                           ++|+.+|+|.+++...... ....+++.....++.|++.||+|||+.+   ++||||||+||++++++.+||+||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence                 3566778888776532211 2235899999999999999999999987   999999999999999999999999


Q ss_pred             CCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCCCcCCCCCc
Q 044997          422 GLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIRDDSEP  500 (563)
Q Consensus       422 Gla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p~~~~~~~~  500 (563)
                      |+++........ .......++..|++||.+....             ++.++||||||+++|||++ |+.|+...+...
T Consensus       158 g~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~-------------~~~~sDi~slG~il~el~~~g~~p~~~~~~~~  223 (273)
T cd05074         158 GLSKKIYSGDYY-RQGCASKLPVKWLALESLADNV-------------YTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE  223 (273)
T ss_pred             cccccccCCcce-ecCCCccCchhhcCHhHHhcCc-------------cchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH
Confidence            998865332211 1112234567899999875443             4789999999999999999 778875443211


Q ss_pred             h-----------hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 044997          501 T-----------KMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQI  538 (563)
Q Consensus       501 ~-----------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  538 (563)
                      .           ........+.+++.+||+.+|++||++.++++.|+++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         224 IYNYLIKGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             HHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            0           0112345689999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5.7e-34  Score=297.84  Aligned_cols=217  Identities=21%  Similarity=0.326  Sum_probs=169.1

Q ss_pred             HhcCCCccceecccCcEEEEEEEEC--CceEEEEEeccCChHHHHHHHHHHHhccccce---------------EEEeec
Q 044997          290 ATNNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNKSKEFFAELKVLCKIHHINV---------------FISTFG  352 (563)
Q Consensus       290 ~~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~f~~Ei~~l~~l~H~ni---------------V~e~~~  352 (563)
                      ...+|...+.||+|+||.||+|+..  ++.||+|.....   ....|+.++++++|+||               |++++ 
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~---~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~-  139 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG---TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY-  139 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc---ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEcc-
Confidence            3457999999999999999999885  468999975443   23569999999999998               34655 


Q ss_pred             CCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccccccc
Q 044997          353 NGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNE  432 (563)
Q Consensus       353 ~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~  432 (563)
                      .|+|.+++..    ....++|..+..|+.|++.||.|||+++   |+||||||+|||+++++.+||+|||+++...... 
T Consensus       140 ~~~l~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-  211 (357)
T PHA03209        140 SSDLYTYLTK----RSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP-  211 (357)
T ss_pred             CCcHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccCc-
Confidence            4678777754    2457999999999999999999999997   9999999999999999999999999987432211 


Q ss_pred             cccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc-h----------
Q 044997          433 KEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP-T----------  501 (563)
Q Consensus       433 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~-~----------  501 (563)
                         ......||..|+|||++.+..             ++.++|||||||++|||+++..++....... .          
T Consensus       212 ---~~~~~~gt~~y~aPE~~~~~~-------------~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l  275 (357)
T PHA03209        212 ---AFLGLAGTVETNAPEVLARDK-------------YNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHL  275 (357)
T ss_pred             ---ccccccccccccCCeecCCCC-------------CCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHH
Confidence               122356899999999886544             4889999999999999999766653321110 0          


Q ss_pred             ---------------------hhH----------------------HHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          502 ---------------------KMK----------------------SLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       502 ---------------------~~~----------------------~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                                           ...                      .+...+.+++.+||+.||.+|||+.|+++.
T Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h  351 (357)
T PHA03209        276 LKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY  351 (357)
T ss_pred             HHHHHHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence                                 000                      011224569999999999999999999863

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5.1e-34  Score=301.99  Aligned_cols=219  Identities=21%  Similarity=0.309  Sum_probs=173.3

Q ss_pred             hcCCCccceecccCcEEEEEEEEC----CceEEEEEeccCChHHHHHHHHHHHhccccceE---------------EEee
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLLG----DREAAIKKMRSNKSKEFFAELKVLCKIHHINVF---------------ISTF  351 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~~----~~~vavK~~~~~~~~~f~~Ei~~l~~l~H~niV---------------~e~~  351 (563)
                      ..+|...+.||+|+||.||++...    +..||+|.+...  +.+.+|+++|++++|||||               ++++
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~  168 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKY  168 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc--ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhc
Confidence            457999999999999999999763    367899988654  3456899999999999984               3444


Q ss_pred             cCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccccccc
Q 044997          352 GNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTN  431 (563)
Q Consensus       352 ~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~  431 (563)
                       .++|.+++..     ...++|.+++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++......
T Consensus       169 -~~~l~~~l~~-----~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~  239 (392)
T PHA03207        169 -KCDLFTYVDR-----SGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP  239 (392)
T ss_pred             -CCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence             3577777632     357999999999999999999999997   9999999999999999999999999997654322


Q ss_pred             ccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc--hhh------
Q 044997          432 EKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP--TKM------  503 (563)
Q Consensus       432 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~--~~~------  503 (563)
                      .. .......||+.|+|||++.+..             ++.++|||||||++|||++|+.||.......  ...      
T Consensus       240 ~~-~~~~~~~gt~~y~aPE~~~~~~-------------~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~  305 (392)
T PHA03207        240 DT-PQCYGWSGTLETNSPELLALDP-------------YCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRC  305 (392)
T ss_pred             cc-ccccccccccCccCHhHhcCCC-------------CCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHH
Confidence            11 1122457999999999886544             4789999999999999999999986543210  000      


Q ss_pred             ---------------------------------------HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          504 ---------------------------------------KSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       504 ---------------------------------------~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                                                             ......+.+++.+||..||.+||++.|++..
T Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        306 MQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             hccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence                                                   0112346789999999999999999999875

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.4e-34  Score=298.57  Aligned_cols=211  Identities=26%  Similarity=0.367  Sum_probs=167.7

Q ss_pred             ceecccCcEEEEEEEE--CCceEEEEEeccC------ChHHHHHHHH-HHHhccccce---------------EEEeecC
Q 044997          298 RIIGRGGFGNVYFGLL--GDREAAIKKMRSN------KSKEFFAELK-VLCKIHHINV---------------FISTFGN  353 (563)
Q Consensus       298 ~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~------~~~~f~~Ei~-~l~~l~H~ni---------------V~e~~~~  353 (563)
                      +.||+|+||.||+++.  +++.+|+|.+...      ..+++..|.. +++.++||||               |+||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            4699999999999987  4788999998643      2244556655 4677999997               5799999


Q ss_pred             CCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccccccccc
Q 044997          354 GSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEK  433 (563)
Q Consensus       354 gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~  433 (563)
                      |+|..++..     ...+++..+..++.|++.||+|||+++   ++||||||+|||+++++.+||+|||+++......  
T Consensus        81 ~~L~~~l~~-----~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~--  150 (325)
T cd05604          81 GELFFHLQR-----ERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS--  150 (325)
T ss_pred             CCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCCC--
Confidence            999888754     356899999999999999999999997   9999999999999999999999999987432111  


Q ss_pred             ccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCchh----------h
Q 044997          434 EMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTK----------M  503 (563)
Q Consensus       434 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~~----------~  503 (563)
                       .......||+.|+|||++.+..             ++.++|||||||++|||++|+.||...+.....          .
T Consensus       151 -~~~~~~~gt~~y~aPE~~~~~~-------------~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~  216 (325)
T cd05604         151 -DTTTTFCGTPEYLAPEVIRKQP-------------YDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLR  216 (325)
T ss_pred             -CCcccccCChhhCCHHHHcCCC-------------CCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCC
Confidence             1223457999999999886544             378999999999999999999999754321110          1


Q ss_pred             HHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 044997          504 KSLITIMAAVAEWCLNEDAVDRPEMRDIV  532 (563)
Q Consensus       504 ~~~~~~l~~li~~cl~~dP~~RPs~~evl  532 (563)
                      ......+.+++.+|++.||.+||++++.+
T Consensus       217 ~~~~~~~~~ll~~ll~~~p~~R~~~~~~~  245 (325)
T cd05604         217 PGASLTAWSILEELLEKDRQRRLGAKEDF  245 (325)
T ss_pred             CCCCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence            12344578999999999999999886443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=8.7e-34  Score=289.67  Aligned_cols=238  Identities=23%  Similarity=0.388  Sum_probs=189.1

Q ss_pred             cCCCccceecccCcEEEEEEEEC--CceEEEEEeccCC------hHHHHHHHHHHHhccccce---------------EE
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNK------SKEFFAELKVLCKIHHINV---------------FI  348 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~------~~~f~~Ei~~l~~l~H~ni---------------V~  348 (563)
                      ++|+..+.||+|+||.||++...  ++.|++|.++...      .+.+.+|++++++++||||               |+
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            46888999999999999999874  5789999986542      3467899999999999987               57


Q ss_pred             EeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccc
Q 044997          349 STFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEE  428 (563)
Q Consensus       349 e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~  428 (563)
                      ||+++|+|.+++..     ...+++..+..++.|++.||+|||+++   ++||||||+||++++++.+||+|||+++...
T Consensus        81 e~~~g~~L~~~l~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~  152 (305)
T cd05609          81 EYVEGGDCATLLKN-----IGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGL  152 (305)
T ss_pred             ecCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccC
Confidence            89999999999864     346899999999999999999999987   9999999999999999999999999987421


Q ss_pred             cccc------------cccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCC
Q 044997          429 RTNE------------KEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRD  496 (563)
Q Consensus       429 ~~~~------------~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~  496 (563)
                      ....            .........|+..|+|||.+...             .++.++||||||+++||+++|+.||.+.
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-------------~~~~~~Di~slG~vl~el~~g~~pf~~~  219 (305)
T cd05609         153 MSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQ-------------GYGKPVDWWAMGIILYEFLVGCVPFFGD  219 (305)
T ss_pred             cCccccccccccccchhhccccCCccCccccCchhccCC-------------CCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            1100            00111224578899999987543             3488999999999999999999998754


Q ss_pred             CCCchh-------------hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcChhhhcccC
Q 044997          497 DSEPTK-------------MKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITSTEWEASLG  550 (563)
Q Consensus       497 ~~~~~~-------------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~w~~~~~  550 (563)
                      ......             ....+..+.+++.+||+.||++||++.++.+.|+.-.-...+|.....
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~~~~~~  286 (305)
T cd05609         220 TPEELFGQVISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDWNGLLR  286 (305)
T ss_pred             CHHHHHHHHHhcccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCHHHHhh
Confidence            321100             012345689999999999999999988888888876556677776543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1.1e-33  Score=285.31  Aligned_cols=218  Identities=22%  Similarity=0.346  Sum_probs=173.3

Q ss_pred             CCCccceecccCcEEEEEEEE--CCceEEEEEeccCC-----hHHHHHHHHHHHhccccce---------------EEEe
Q 044997          293 NFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNK-----SKEFFAELKVLCKIHHINV---------------FIST  350 (563)
Q Consensus       293 ~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~-----~~~f~~Ei~~l~~l~H~ni---------------V~e~  350 (563)
                      +|+..+.||+|+||.||+|+.  .++.+|+|+++...     .+.+.+|++++++++|+|+               |+||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            477789999999999999988  47889999986432     2567889999999999997               4677


Q ss_pred             ecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccccc
Q 044997          351 FGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERT  430 (563)
Q Consensus       351 ~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~  430 (563)
                      ++ ++|.+++..    ....+++..+..++.|+++||.|||+++   ++||||||+||+++.++.+||+|||+++.....
T Consensus        81 ~~-~~l~~~~~~----~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  152 (284)
T cd07839          81 CD-QDLKKYFDS----CNGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIP  152 (284)
T ss_pred             CC-CCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCC
Confidence            76 577777653    2356899999999999999999999987   999999999999999999999999998754322


Q ss_pred             cccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCchh--------
Q 044997          431 NEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTK--------  502 (563)
Q Consensus       431 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~~--------  502 (563)
                      ..   ......++..|+|||.+.+..            .++.++|||||||++|||++|+.|+.........        
T Consensus       153 ~~---~~~~~~~~~~y~aPE~~~~~~------------~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~  217 (284)
T cd07839         153 VR---CYSAEVVTLWYRPPDVLFGAK------------LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLL  217 (284)
T ss_pred             CC---CcCCCccccCCcChHHHhCCc------------ccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHh
Confidence            11   122345788999999875432            2478999999999999999999986543321110        


Q ss_pred             --------------------------------hHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          503 --------------------------------MKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       503 --------------------------------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                                                      ...+...+.+++.+||+.||.+|||+.++++
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         218 GTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             CCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence                                            0123355789999999999999999999876

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=1.5e-33  Score=288.58  Aligned_cols=218  Identities=22%  Similarity=0.398  Sum_probs=176.3

Q ss_pred             cCCCccceecccCcEEEEEEEEC--CceEEEEEeccCC----hHHHHHHHHHHHhccccce---------------EEEe
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNK----SKEFFAELKVLCKIHHINV---------------FIST  350 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~----~~~f~~Ei~~l~~l~H~ni---------------V~e~  350 (563)
                      ++|+..+.||+|+||.||++...  +..+|+|.++...    .+++.+|++++.+++||||               |+||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            46888999999999999999874  5778999886542    2458899999999999997               5799


Q ss_pred             ecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccccc
Q 044997          351 FGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERT  430 (563)
Q Consensus       351 ~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~  430 (563)
                      +++|+|.+++..     ...+++..+..++.|+++||.|||+..  +++||||||+|||+++++.+||+|||++......
T Consensus        81 ~~~~~L~~~l~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  153 (308)
T cd06615          81 MDGGSLDQVLKK-----AGRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  153 (308)
T ss_pred             cCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCccccccc
Confidence            999999999864     256899999999999999999999732  3999999999999999999999999998754221


Q ss_pred             cccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCchh--------
Q 044997          431 NEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTK--------  502 (563)
Q Consensus       431 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~~--------  502 (563)
                           ......|+..|+|||.+.+..             ++.++||||||+++|||++|+.||...+.....        
T Consensus       154 -----~~~~~~~~~~~~aPE~~~~~~-------------~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~  215 (308)
T cd06615         154 -----MANSFVGTRSYMSPERLQGTH-------------YTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVS  215 (308)
T ss_pred             -----ccccCCCCcCccChhHhcCCC-------------CCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccc
Confidence                 122356889999999875433             478999999999999999999997432210000        


Q ss_pred             ----------------------------------------hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          503 ----------------------------------------MKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       503 ----------------------------------------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                                                              .......+.+++.+||+.||++||++.|+++.
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  287 (308)
T cd06615         216 EGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH  287 (308)
T ss_pred             cccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                                                    00123458899999999999999999999886

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=9.9e-34  Score=288.24  Aligned_cols=217  Identities=23%  Similarity=0.445  Sum_probs=179.5

Q ss_pred             cCCCccceecccCcEEEEEEEE--CCceEEEEEeccC---ChHHHHHHHHHHHhccccce---------------EEEee
Q 044997          292 NNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSN---KSKEFFAELKVLCKIHHINV---------------FISTF  351 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~---~~~~f~~Ei~~l~~l~H~ni---------------V~e~~  351 (563)
                      .+|+..+.||.|+||.||+|..  +++.+++|.+...   ..+.+.+|++++++++|+|+               |+||+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   98 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL   98 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence            4688899999999999999985  5789999988643   24678899999999999997               56889


Q ss_pred             cCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccccccc
Q 044997          352 GNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTN  431 (563)
Q Consensus       352 ~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~  431 (563)
                      .+|+|.+++..      ..+++.++..++.|++.||+|||+++   ++||||||+||+++.++.+||+|||+++......
T Consensus        99 ~~~~L~~~~~~------~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~  169 (296)
T cd06655          99 AGGSLTDVVTE------TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ  169 (296)
T ss_pred             CCCcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhccccc
Confidence            99999988753      35899999999999999999999997   9999999999999999999999999987543322


Q ss_pred             ccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc-----------
Q 044997          432 EKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP-----------  500 (563)
Q Consensus       432 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~-----------  500 (563)
                      .   ......|+..|+|||.+.+..             ++.++|||||||++|||++|+.||...+...           
T Consensus       170 ~---~~~~~~~~~~y~aPE~~~~~~-------------~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~  233 (296)
T cd06655         170 S---KRSTMVGTPYWMAPEVVTRKA-------------YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTP  233 (296)
T ss_pred             c---cCCCcCCCccccCcchhcCCC-------------CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCc
Confidence            1   122346888999999875443             4789999999999999999999986543211           


Q ss_pred             --hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          501 --TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       501 --~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                        .....+...+.+++.+||..||.+||++.+++.
T Consensus       234 ~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~  268 (296)
T cd06655         234 ELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ  268 (296)
T ss_pred             ccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence              112234456889999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=4.6e-34  Score=284.42  Aligned_cols=213  Identities=21%  Similarity=0.335  Sum_probs=167.6

Q ss_pred             ceecccCcEEEEEEEEC---------CceEEEEEeccCC---hHHHHHHHHHHHhccccce---------------EEEe
Q 044997          298 RIIGRGGFGNVYFGLLG---------DREAAIKKMRSNK---SKEFFAELKVLCKIHHINV---------------FIST  350 (563)
Q Consensus       298 ~~LG~G~fG~Vy~g~~~---------~~~vavK~~~~~~---~~~f~~Ei~~l~~l~H~ni---------------V~e~  350 (563)
                      +.||+|+||.||+|...         ..++|+|.+....   .++|.+|+.++++++|||+               |+||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            46899999999999763         2348888876543   3578899999999999997               5799


Q ss_pred             ecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCc--------EEEeecC
Q 044997          351 FGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLR--------AKVADFG  422 (563)
Q Consensus       351 ~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~--------~kl~DFG  422 (563)
                      +.+|+|.+++...    ...++|..++.++.|++.||+|||+.+   ++||||||+||+++.++.        +|++|||
T Consensus        81 ~~~g~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g  153 (258)
T cd05078          81 VKFGSLDTYLKKN----KNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG  153 (258)
T ss_pred             CCCCcHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccc
Confidence            9999999998752    346899999999999999999999987   999999999999987765        6999999


Q ss_pred             CCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCchh
Q 044997          423 LVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTK  502 (563)
Q Consensus       423 la~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~~  502 (563)
                      ++......       ....++..|+|||++.+.            ..++.++||||||+++|||++|..++.........
T Consensus       154 ~~~~~~~~-------~~~~~~~~y~aPE~~~~~------------~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~  214 (258)
T cd05078         154 ISITVLPK-------EILLERIPWVPPECIENP------------QNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK  214 (258)
T ss_pred             cccccCCc-------hhccccCCccCchhccCC------------CCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH
Confidence            88643221       224578899999987542            23478999999999999999996443322211110


Q ss_pred             ----------hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 044997          503 ----------MKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILS  536 (563)
Q Consensus       503 ----------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  536 (563)
                                .......+.+++.+||+.||++||+++++++.|+
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         215 LQFYEDRHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             HHHHHccccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence                      1122345889999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=6.6e-34  Score=284.27  Aligned_cols=221  Identities=25%  Similarity=0.379  Sum_probs=178.0

Q ss_pred             cCCCccceecccCcEEEEEEEE--CCceEEEEEeccCC---hHHHHHHHHHHHhccccce---------------EEEee
Q 044997          292 NNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNK---SKEFFAELKVLCKIHHINV---------------FISTF  351 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~---~~~f~~Ei~~l~~l~H~ni---------------V~e~~  351 (563)
                      ++|...+.||+|+||.||+|+.  +++.+|+|.++...   ...+.+|+.+++.++||||               |+||+
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~   88 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC   88 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence            4677788999999999999987  46889999987543   2457889999999999997               57889


Q ss_pred             cCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccccccc
Q 044997          352 GNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTN  431 (563)
Q Consensus       352 ~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~  431 (563)
                      ++|+|.+++..     ...+++.++..++.|++.||.|||+++   ++|+||||+||+++.++.+||+|||++.......
T Consensus        89 ~~~~L~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd06645          89 GGGSLQDIYHV-----TGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATI  160 (267)
T ss_pred             CCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCcc
Confidence            99999998864     346899999999999999999999997   9999999999999999999999999987543221


Q ss_pred             ccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCch----------
Q 044997          432 EKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPT----------  501 (563)
Q Consensus       432 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~----------  501 (563)
                         .......|+..|+|||++....          ...++.++|||||||++|||++|+.|+........          
T Consensus       161 ---~~~~~~~~~~~y~aPE~~~~~~----------~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~  227 (267)
T cd06645         161 ---AKRKSFIGTPYWMAPEVAAVER----------KGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQ  227 (267)
T ss_pred             ---cccccccCcccccChhhhcccc----------CCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCC
Confidence               1122346899999999874211          23457899999999999999999999864332110          


Q ss_pred             -----hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          502 -----KMKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       502 -----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                           ....+...+.+++.+||+.||++||++++|++
T Consensus       228 ~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         228 PPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             CCcccccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence                 01123456889999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.2e-33  Score=280.70  Aligned_cols=214  Identities=23%  Similarity=0.341  Sum_probs=170.2

Q ss_pred             ceecccCcEEEEEEEECCc------------eEEEEEeccCC--hHHHHHHHHHHHhccccce--------------EEE
Q 044997          298 RIIGRGGFGNVYFGLLGDR------------EAAIKKMRSNK--SKEFFAELKVLCKIHHINV--------------FIS  349 (563)
Q Consensus       298 ~~LG~G~fG~Vy~g~~~~~------------~vavK~~~~~~--~~~f~~Ei~~l~~l~H~ni--------------V~e  349 (563)
                      +.||+|+||.||+|...+.            .+++|.+....  ...|.+|++++++++|+||              |+|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e   80 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVRDENIMVEE   80 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEecCCcEEEEE
Confidence            4689999999999988533            37888876543  4679999999999999997              568


Q ss_pred             eecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCC-------cEEEeecC
Q 044997          350 TFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGL-------RAKVADFG  422 (563)
Q Consensus       350 ~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~-------~~kl~DFG  422 (563)
                      |+++|+|.+++...    ...+++..+..++.|++.||+|||+++   ++||||||+|||++.++       .+||+|||
T Consensus        81 ~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg  153 (259)
T cd05037          81 YVKFGPLDVFLHRE----KNNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG  153 (259)
T ss_pred             cCCCCcHHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCC
Confidence            89999999998752    236899999999999999999999987   99999999999999887       79999999


Q ss_pred             CCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcC-CCCCcCCCCCch
Q 044997          423 LVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG-KRALIRDDSEPT  501 (563)
Q Consensus       423 la~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg-~~p~~~~~~~~~  501 (563)
                      +++....       .....++..|+|||++...           ...++.++||||||+++|||++| ..|+........
T Consensus       154 ~a~~~~~-------~~~~~~~~~y~aPE~~~~~-----------~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~  215 (259)
T cd05037         154 IPITVLS-------REERVERIPWIAPECIRNG-----------QASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEK  215 (259)
T ss_pred             ccccccc-------ccccccCCCccChhhhcCC-----------CCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhH
Confidence            9875432       1123467789999987543           12458899999999999999995 666644321110


Q ss_pred             h---------hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 044997          502 K---------MKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILS  536 (563)
Q Consensus       502 ~---------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  536 (563)
                      .         .......+.+++.+||..+|.+||++.++++.|+
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         216 ERFYQDQHRLPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             HHHHhcCCCCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            0         0011256889999999999999999999998773

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=5.3e-34  Score=286.91  Aligned_cols=212  Identities=22%  Similarity=0.334  Sum_probs=166.4

Q ss_pred             eecccCcEEEEEEEEC--------------------------CceEEEEEeccCC---hHHHHHHHHHHHhccccce---
Q 044997          299 IIGRGGFGNVYFGLLG--------------------------DREAAIKKMRSNK---SKEFFAELKVLCKIHHINV---  346 (563)
Q Consensus       299 ~LG~G~fG~Vy~g~~~--------------------------~~~vavK~~~~~~---~~~f~~Ei~~l~~l~H~ni---  346 (563)
                      .||+|+||.||+|.+.                          +..|++|.++...   ..+|.+|++++++++||||   
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            6899999999999752                          1247889886543   3568889999999999997   


Q ss_pred             ------------EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCC
Q 044997          347 ------------FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGL  414 (563)
Q Consensus       347 ------------V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~  414 (563)
                                  |+||+++|+|..++..    ....+++..+..++.|+++||+|||+.+   ++||||||+|||+++.+
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~----~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~  154 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRK----EKGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLG  154 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccC
Confidence                        5799999999988864    2356899999999999999999999987   99999999999997643


Q ss_pred             -------cEEEeecCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHH
Q 044997          415 -------RAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELI  487 (563)
Q Consensus       415 -------~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ell  487 (563)
                             .+|++|||++......       ....++..|+|||.+.+.            ..++.++||||||+++||++
T Consensus       155 ~~~~~~~~~kl~d~g~~~~~~~~-------~~~~~~~~~~aPe~~~~~------------~~~~~~~Dv~slG~~l~el~  215 (274)
T cd05076         155 LAEGTSPFIKLSDPGVSFTALSR-------EERVERIPWIAPECVPGG------------NSLSTAADKWSFGTTLLEIC  215 (274)
T ss_pred             cccCccceeeecCCccccccccc-------cccccCCcccCchhhcCC------------CCCCcHHHHHHHHHHHHHHH
Confidence                   4899999987643211       123467889999987432            23589999999999999995


Q ss_pred             -cCCCCCcCCCCCch---------hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 044997          488 -TGKRALIRDDSEPT---------KMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILS  536 (563)
Q Consensus       488 -tg~~p~~~~~~~~~---------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  536 (563)
                       +|+.|+........         ........+.+++.+||+.+|++||++.+|++.|+
T Consensus       216 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         216 FDGEVPLKERTPSEKERFYEKKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             hCCCCCccccChHHHHHHHHhccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence             78888864332110         01112245889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=1.5e-33  Score=282.08  Aligned_cols=227  Identities=26%  Similarity=0.377  Sum_probs=180.3

Q ss_pred             HHHHhcCCCccceecccCcEEEEEEEEC--CceEEEEEeccCC---hHHHHHHHHHHHhccccce---------------
Q 044997          287 IEEATNNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNK---SKEFFAELKVLCKIHHINV---------------  346 (563)
Q Consensus       287 l~~~~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~---~~~f~~Ei~~l~~l~H~ni---------------  346 (563)
                      ++.+++++.....||+|+||.||+|...  +..+|+|.+....   .+.+.+|++++++++|+||               
T Consensus         3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   82 (268)
T cd06624           3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI   82 (268)
T ss_pred             cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence            4556777878889999999999999864  5679999887543   3578899999999999997               


Q ss_pred             EEEeecCCCcccccccccccCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecC-CCcEEEeecCC
Q 044997          347 FISTFGNGSLSDHLHDPLLKGHQPL--TWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDD-GLRAKVADFGL  423 (563)
Q Consensus       347 V~e~~~~gsL~~~L~~~~~~~~~~l--~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~-~~~~kl~DFGl  423 (563)
                      |+||+++++|.+++...    ...+  ++..+..++.|++.||+|||+.+   ++||||||+||+++. ++.+||+|||+
T Consensus        83 v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~  155 (268)
T cd06624          83 FMEQVPGGSLSALLRSK----WGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGT  155 (268)
T ss_pred             EEecCCCCCHHHHHHHh----cccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchh
Confidence            46889999999998752    1334  78888999999999999999987   999999999999986 67999999999


Q ss_pred             CcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc---
Q 044997          424 VKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP---  500 (563)
Q Consensus       424 a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~---  500 (563)
                      +........   ......|+..|+|||++....           ..++.++||||||+++|||++|+.|+.......   
T Consensus       156 ~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~-----------~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~  221 (268)
T cd06624         156 SKRLAGINP---CTETFTGTLQYMAPEVIDKGP-----------RGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAM  221 (268)
T ss_pred             heecccCCC---ccccCCCCccccChhhhcccc-----------ccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhH
Confidence            875432211   122345789999999875432           224789999999999999999999986432211   


Q ss_pred             ----------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          501 ----------TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       501 ----------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                                .......+.+.+++.+||+.+|.+||++.|+++.
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  265 (268)
T cd06624         222 FKVGMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD  265 (268)
T ss_pred             hhhhhhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence                      1112344568999999999999999999999863

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=1.9e-33  Score=285.23  Aligned_cols=224  Identities=20%  Similarity=0.344  Sum_probs=179.9

Q ss_pred             cCCCccceecccCcEEEEEEEEC--CceEEEEEeccCC---hHHHHHHHHHHHhccccce---------------EEEee
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNK---SKEFFAELKVLCKIHHINV---------------FISTF  351 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~---~~~f~~Ei~~l~~l~H~ni---------------V~e~~  351 (563)
                      +.|+..+.||+|+||.||+|+..  +..+++|.+....   .+.+.+|++++++++|+|+               |+||+
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   91 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC   91 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence            56778899999999999999874  6789999987554   3568889999999999997               57899


Q ss_pred             cCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccccccc
Q 044997          352 GNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTN  431 (563)
Q Consensus       352 ~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~  431 (563)
                      ++|+|..++..    ....+++..+..++.|++.||+|||+++   ++||||||+||+++.++.+||+|||++.......
T Consensus        92 ~~~~l~~~~~~----~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~  164 (292)
T cd06644          92 PGGAVDAIMLE----LDRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL  164 (292)
T ss_pred             CCCcHHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceeccccc
Confidence            99999887754    2346899999999999999999999987   9999999999999999999999999987532211


Q ss_pred             ccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc-----------
Q 044997          432 EKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP-----------  500 (563)
Q Consensus       432 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~-----------  500 (563)
                      .   ......++..|+|||++.+...        ....++.++|||||||++|||++|+.|+.......           
T Consensus       165 ~---~~~~~~~~~~y~aPE~~~~~~~--------~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~  233 (292)
T cd06644         165 Q---RRDSFIGTPYWMAPEVVMCETM--------KDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPP  233 (292)
T ss_pred             c---ccceecCCccccCceeeccccc--------cCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCc
Confidence            1   1123457889999998854332        13345789999999999999999999986533110           


Q ss_pred             --hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          501 --TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       501 --~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                        .....+...+.+++.+||+.||++||++.++++
T Consensus       234 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         234 TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence              111233456889999999999999999999976

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.7e-33  Score=281.15  Aligned_cols=220  Identities=25%  Similarity=0.424  Sum_probs=177.3

Q ss_pred             CCCccceecccCcEEEEEEEE--CCceEEEEEeccCC------------hHHHHHHHHHHHhccccce------------
Q 044997          293 NFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNK------------SKEFFAELKVLCKIHHINV------------  346 (563)
Q Consensus       293 ~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~------------~~~f~~Ei~~l~~l~H~ni------------  346 (563)
                      +|...+.||+|+||.||+|..  .++.+|+|.+....            .+.+.+|++++++++||||            
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            366788999999999999986  46889999875321            1457889999999999997            


Q ss_pred             ---EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCC
Q 044997          347 ---FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGL  423 (563)
Q Consensus       347 ---V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGl  423 (563)
                         ++||+++++|.+++..     ...+++..+..++.|++.||+|||+.+   ++||||||+||++++++.+||+|||+
T Consensus        81 ~~lv~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~  152 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNN-----YGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGI  152 (267)
T ss_pred             cEEEEEecCCCCHHHHHHh-----ccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCC
Confidence               5788999999998864     356889999999999999999999987   99999999999999999999999999


Q ss_pred             Cccccccccc---ccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCC-
Q 044997          424 VKLEERTNEK---EMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE-  499 (563)
Q Consensus       424 a~~~~~~~~~---~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~-  499 (563)
                      ++........   ........|+..|+|||.+.+..             ++.++||||||+++|||++|+.||...... 
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~-------------~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~  219 (267)
T cd06628         153 SKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTS-------------YTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ  219 (267)
T ss_pred             CcccccccccCCccccccccCCCcCccChhHhccCC-------------CCchhhhHHHHHHHHHHhhCCCCCCCccHHH
Confidence            8865421111   01112245888999999875443             478999999999999999999998653321 


Q ss_pred             ----------chhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          500 ----------PTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       500 ----------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                                +.........+.+++.+||+.||.+||++.|+++
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         220 AIFKIGENASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             HHHHHhccCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence                      1112234566899999999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=1.4e-33  Score=284.50  Aligned_cols=220  Identities=25%  Similarity=0.308  Sum_probs=174.0

Q ss_pred             CCCccceecccCcEEEEEEEE--CCceEEEEEeccC-----ChHHHHHHHHHHHhccccce---------------EEEe
Q 044997          293 NFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSN-----KSKEFFAELKVLCKIHHINV---------------FIST  350 (563)
Q Consensus       293 ~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~-----~~~~f~~Ei~~l~~l~H~ni---------------V~e~  350 (563)
                      +|+..+.||+|++|.||+|+.  ++..+|+|+++..     ..+.+.+|+.++++++|||+               |+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            477789999999999999987  4788999998643     23568899999999999997               4677


Q ss_pred             ecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccccc
Q 044997          351 FGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERT  430 (563)
Q Consensus       351 ~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~  430 (563)
                      ++ |+|.+++...  .....+++.++..++.|++.||+|||+++   ++||||||+||++++++.+||+|||+++.....
T Consensus        81 ~~-~~l~~~~~~~--~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  154 (285)
T cd07861          81 LS-MDLKKYLDSL--PKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP  154 (285)
T ss_pred             CC-CCHHHHHhcC--CCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCC
Confidence            76 6787777542  22356899999999999999999999987   999999999999999999999999998754322


Q ss_pred             cccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCchh--------
Q 044997          431 NEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTK--------  502 (563)
Q Consensus       431 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~~--------  502 (563)
                      .   .......+++.|+|||.+.+.            ..++.++||||||+++|||++|+.||.........        
T Consensus       155 ~---~~~~~~~~~~~y~aPE~~~~~------------~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~  219 (285)
T cd07861         155 V---RVYTHEVVTLWYRAPEVLLGS------------PRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILG  219 (285)
T ss_pred             c---ccccCCcccccccChHHhcCC------------CCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhC
Confidence            1   112234578899999987432            23478999999999999999999998654321000        


Q ss_pred             -------------------------------hHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          503 -------------------------------MKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       503 -------------------------------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                                                     ...+...+.+++.+||+.||.+|||+.++++
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         220 TPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             CCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence                                           0112345779999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=1.3e-33  Score=284.60  Aligned_cols=234  Identities=26%  Similarity=0.441  Sum_probs=185.3

Q ss_pred             CHHHHHHHhcCCCccceecccCcEEEEEEEE--CCceEEEEEeccCC--hHHHHHHHHHHHhc-cccce-----------
Q 044997          283 SLEEIEEATNNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNK--SKEFFAELKVLCKI-HHINV-----------  346 (563)
Q Consensus       283 ~~~el~~~~~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~--~~~f~~Ei~~l~~l-~H~ni-----------  346 (563)
                      ++.++..+.+.|+..+.||+|+||.||+|..  .++.+|+|.+....  ..++..|+.++.++ +|+|+           
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~   86 (282)
T cd06636           7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKS   86 (282)
T ss_pred             hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhccc
Confidence            4556666778899999999999999999988  46789999886543  35688899999998 68886           


Q ss_pred             ----------EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcE
Q 044997          347 ----------FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRA  416 (563)
Q Consensus       347 ----------V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~  416 (563)
                                ++||+++|+|.+++...   ....+++..+..++.|++.||.|||+++   ++||||||+||++++++.+
T Consensus        87 ~~~~~~~~~iv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~  160 (282)
T cd06636          87 PPGHDDQLWLVMEFCGAGSVTDLVKNT---KGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEV  160 (282)
T ss_pred             ccCCCCEEEEEEEeCCCCcHHHHHHHc---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCE
Confidence                      56888899999888642   2356889999999999999999999987   9999999999999999999


Q ss_pred             EEeecCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCC
Q 044997          417 KVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRD  496 (563)
Q Consensus       417 kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~  496 (563)
                      ||+|||+++.......   ......|+..|+|||.+....        .....++.++|||||||++|||++|+.||...
T Consensus       161 ~l~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~l~~~~--------~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~  229 (282)
T cd06636         161 KLVDFGVSAQLDRTVG---RRNTFIGTPYWMAPEVIACDE--------NPDATYDYRSDIWSLGITAIEMAEGAPPLCDM  229 (282)
T ss_pred             EEeeCcchhhhhcccc---CCCcccccccccCHhhcCccc--------CcCcCCCcccchhHHHHHHHHHHhCCCCcccc
Confidence            9999999875432111   122356889999999875321        11345678999999999999999999998643


Q ss_pred             CCCc------------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          497 DSEP------------TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       497 ~~~~------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                      ....            .....+...+.+++.+||+.||.+||++.|+++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         230 HPMRALFLIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             CHHhhhhhHhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence            2111            011234567899999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.1e-34  Score=268.16  Aligned_cols=220  Identities=23%  Similarity=0.354  Sum_probs=184.3

Q ss_pred             hcCCCccceecccCcEEEEEEEEC--CceEEEEEeccCC------hHHHHHHHHHHHhccccce---------------E
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNK------SKEFFAELKVLCKIHHINV---------------F  347 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~------~~~f~~Ei~~l~~l~H~ni---------------V  347 (563)
                      .++|+.++.||+|.||.||.|+.+  +-.||+|++.+.+      ..++.+|+++-+.|+||||               +
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi  100 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI  100 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence            356888999999999999999885  4679999986543      3678899999999999998               5


Q ss_pred             EEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccc
Q 044997          348 ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLE  427 (563)
Q Consensus       348 ~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~  427 (563)
                      .||..+|.+...|.+.   ....++......++.|+|.||.|+|...   ++||||||+|+|++.++..||+|||-+-..
T Consensus       101 lEya~~gel~k~L~~~---~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~  174 (281)
T KOG0580|consen  101 LEYAPRGELYKDLQEG---RMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHA  174 (281)
T ss_pred             EEecCCchHHHHHHhc---ccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeec
Confidence            7999999999999852   3456788888899999999999999886   999999999999999999999999997642


Q ss_pred             ccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCch------
Q 044997          428 ERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPT------  501 (563)
Q Consensus       428 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~------  501 (563)
                      .     .......+||..|.+||+..+..+             +.++|+|++||+.||++.|.+||........      
T Consensus       175 p-----~~kR~tlcgt~dyl~pEmv~~~~h-------------d~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k  236 (281)
T KOG0580|consen  175 P-----SNKRKTLCGTLDYLPPEMVEGRGH-------------DKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRK  236 (281)
T ss_pred             C-----CCCceeeecccccCCHhhcCCCCc-------------cchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHH
Confidence            2     112345789999999999877665             7899999999999999999999976553211      


Q ss_pred             ----hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          502 ----KMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       502 ----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                          .+..+....+++|.+|+..+|.+|....|+++.
T Consensus       237 ~~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h  273 (281)
T KOG0580|consen  237 VDLKFPSTISGGAADLISRLLVKNPIERLALTEVMDH  273 (281)
T ss_pred             ccccCCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence                123345568999999999999999999999864

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=1.7e-33  Score=283.90  Aligned_cols=219  Identities=23%  Similarity=0.372  Sum_probs=176.0

Q ss_pred             cCCCccceecccCcEEEEEEEEC--CceEEEEEeccC-----ChHHHHHHHHHHHhccccce---------------EEE
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSN-----KSKEFFAELKVLCKIHHINV---------------FIS  349 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~-----~~~~f~~Ei~~l~~l~H~ni---------------V~e  349 (563)
                      ++|+..+.||+|+||.||+|+..  ++.+|+|++...     ..+.+.+|++++++++|+|+               |+|
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            46888899999999999999884  688999988532     23567899999999999997               568


Q ss_pred             eecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccccc
Q 044997          350 TFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEER  429 (563)
Q Consensus       350 ~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~  429 (563)
                      |++++.|..++..     ...++|..+..++.|++.||+|||+.+   ++||||||+||++++++.+||+|||++.....
T Consensus        81 ~~~~~~l~~~~~~-----~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  152 (286)
T cd07847          81 YCDHTVLNELEKN-----PRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTG  152 (286)
T ss_pred             ccCccHHHHHHhC-----CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCC
Confidence            8888888776643     345899999999999999999999987   99999999999999999999999999986543


Q ss_pred             ccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCch--------
Q 044997          430 TNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPT--------  501 (563)
Q Consensus       430 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~--------  501 (563)
                      ...   ......++..|+|||.+.+.            ..++.++||||||+++|||++|+.||........        
T Consensus       153 ~~~---~~~~~~~~~~~~aPE~~~~~------------~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~  217 (286)
T cd07847         153 PGD---DYTDYVATRWYRAPELLVGD------------TQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTL  217 (286)
T ss_pred             Ccc---cccCcccccccCCHHHHhCC------------CCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Confidence            221   11224578889999987532            2347899999999999999999999864332100        


Q ss_pred             ---------------------------------hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          502 ---------------------------------KMKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       502 ---------------------------------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                                                       ....+...+.+++.+||+.||++||++.|++.
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         218 GDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             CCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence                                             01122455889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.1e-34  Score=285.84  Aligned_cols=226  Identities=23%  Similarity=0.387  Sum_probs=183.0

Q ss_pred             hcCCCccceecccCcEEEEEEEEC--CceEEEEEeccCC---hHHHHHHHHHHHhccccce---------------EEEe
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNK---SKEFFAELKVLCKIHHINV---------------FIST  350 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~---~~~f~~Ei~~l~~l~H~ni---------------V~e~  350 (563)
                      .++|+..+.||+|+||.||+|...  +..+|+|.++...   .+.|.+|++++++++|+|+               |+||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF   83 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence            456888899999999999999874  6889999987543   3568899999999999997               5789


Q ss_pred             ecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccccc
Q 044997          351 FGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERT  430 (563)
Q Consensus       351 ~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~  430 (563)
                      +++|+|.+++..    ....+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++......
T Consensus        84 ~~~~~L~~~~~~----~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~  156 (280)
T cd06611          84 CDGGALDSIMLE----LERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKST  156 (280)
T ss_pred             cCCCcHHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhccc
Confidence            999999998864    2356999999999999999999999997   999999999999999999999999998654322


Q ss_pred             cccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc----------
Q 044997          431 NEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP----------  500 (563)
Q Consensus       431 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~----------  500 (563)
                      ..   ......|+..|+|||.+..+.+        ....++.++||||||+++|||++|+.||.......          
T Consensus       157 ~~---~~~~~~~~~~y~~PE~~~~~~~--------~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~  225 (280)
T cd06611         157 LQ---KRDTFIGTPYWMAPEVVACETF--------KDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEP  225 (280)
T ss_pred             cc---ccceeecchhhcCHHHHhhccc--------CCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCC
Confidence            11   1123468899999998854432        13345789999999999999999999986543211          


Q ss_pred             ---hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          501 ---TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       501 ---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                         .....+...+.+++.+||+.||.+||++.++++.
T Consensus       226 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         226 PTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             CCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence               0112344568999999999999999999999774

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.1e-33  Score=277.84  Aligned_cols=218  Identities=27%  Similarity=0.424  Sum_probs=174.2

Q ss_pred             ceecccCcEEEEEEEEC-CceEEEEEeccCC----hHHHHHHHHHHHhccccce---------------EEEeecCCCcc
Q 044997          298 RIIGRGGFGNVYFGLLG-DREAAIKKMRSNK----SKEFFAELKVLCKIHHINV---------------FISTFGNGSLS  357 (563)
Q Consensus       298 ~~LG~G~fG~Vy~g~~~-~~~vavK~~~~~~----~~~f~~Ei~~l~~l~H~ni---------------V~e~~~~gsL~  357 (563)
                      ++||+|+||.||++... ++.+|+|.++...    .+.|.+|++++++++|+||               |+||+.+++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            46899999999999875 7899999887543    3578999999999999997               56888999999


Q ss_pred             cccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccccccccccccc
Q 044997          358 DHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLA  437 (563)
Q Consensus       358 ~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~  437 (563)
                      +++...    ...+++..+..++.+++.||+|||+++   ++||||||+||+++.++.+||+|||+++....... ....
T Consensus        81 ~~l~~~----~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~  152 (251)
T cd05041          81 TFLRKK----KNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIY-TVSD  152 (251)
T ss_pred             HHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcc-eecc
Confidence            998642    346889999999999999999999987   99999999999999999999999999875432111 0011


Q ss_pred             ccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCCCcCCCCCc-----------hhhHH
Q 044997          438 TRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIRDDSEP-----------TKMKS  505 (563)
Q Consensus       438 ~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p~~~~~~~~-----------~~~~~  505 (563)
                      ....++..|+|||.+.+.             .++.++|||||||++|||++ |..||.......           .....
T Consensus       153 ~~~~~~~~y~~PE~~~~~-------------~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~~~~  219 (251)
T cd05041         153 GLKQIPIKWTAPEALNYG-------------RYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQL  219 (251)
T ss_pred             ccCcceeccCChHhhccC-------------CCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCCCcc
Confidence            112345679999987543             34889999999999999999 777775433111           11123


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 044997          506 LITIMAAVAEWCLNEDAVDRPEMRDIVAILS  536 (563)
Q Consensus       506 ~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  536 (563)
                      .+..+.+++.+||+.+|.+||++.|+++.|.
T Consensus       220 ~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         220 CPEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             CCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            3467899999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=5.3e-33  Score=278.46  Aligned_cols=227  Identities=20%  Similarity=0.295  Sum_probs=168.8

Q ss_pred             ceecccCcEEEEEEEEC-C---ceEEEEEeccCC----hHHHHHHHHHHHhccccce---------------EEEeecCC
Q 044997          298 RIIGRGGFGNVYFGLLG-D---REAAIKKMRSNK----SKEFFAELKVLCKIHHINV---------------FISTFGNG  354 (563)
Q Consensus       298 ~~LG~G~fG~Vy~g~~~-~---~~vavK~~~~~~----~~~f~~Ei~~l~~l~H~ni---------------V~e~~~~g  354 (563)
                      +.||+|+||.||+|... +   ..+++|.++...    .+.|.+|+++++.++||||               |+||+++|
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   80 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG   80 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence            35899999999999753 2   245677765432    3579999999999999997               57999999


Q ss_pred             CcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccccccccc
Q 044997          355 SLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKE  434 (563)
Q Consensus       355 sL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~  434 (563)
                      +|.+++..... .....++.....++.|++.||+|||+.+   ++||||||+|||++.++.+||+|||++....... ..
T Consensus        81 ~L~~~l~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~-~~  155 (268)
T cd05086          81 DLKSYLSQEQW-HRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKED-YI  155 (268)
T ss_pred             cHHHHHHhhhc-ccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcch-hh
Confidence            99999975321 1245677788899999999999999987   9999999999999999999999999986422111 11


Q ss_pred             cccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcC-CCCCcCCCCCc-------------
Q 044997          435 MLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG-KRALIRDDSEP-------------  500 (563)
Q Consensus       435 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg-~~p~~~~~~~~-------------  500 (563)
                      .......++..|+|||++.....      ......++.++|||||||++|||+++ ..|+.......             
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~------~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~  229 (268)
T cd05086         156 ETEDDKCVPLRWLAPELVGEFHG------GLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKL  229 (268)
T ss_pred             hcccCCcCcccccCchhcccccC------ccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhccccc
Confidence            11223467889999998753321      11223457899999999999999975 55664322110             


Q ss_pred             ---hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 044997          501 ---TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILS  536 (563)
Q Consensus       501 ---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  536 (563)
                         .......+.+.+++..|| .+|.+||++++|++.|.
T Consensus       230 ~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         230 FKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             CCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence               001123455788999999 67999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-34  Score=279.81  Aligned_cols=240  Identities=24%  Similarity=0.325  Sum_probs=193.6

Q ss_pred             HHHHHHHhcCCCccceecccCcEEEEEEEECC-------ceEEEEEeccCCh----HHHHHHHHHHHhccccce------
Q 044997          284 LEEIEEATNNFDESRIIGRGGFGNVYFGLLGD-------REAAIKKMRSNKS----KEFFAELKVLCKIHHINV------  346 (563)
Q Consensus       284 ~~el~~~~~~f~~~~~LG~G~fG~Vy~g~~~~-------~~vavK~~~~~~~----~~f~~Ei~~l~~l~H~ni------  346 (563)
                      ..|+.....++....++.+|.||.||+|.|.+       +.|-+|.++....    ..|+.|--.+..+.|||+      
T Consensus       276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V  355 (563)
T KOG1024|consen  276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV  355 (563)
T ss_pred             HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence            45666667788889999999999999997743       4567787776543    568899999999999997      


Q ss_pred             ----------EEEeecCCCccccccccc---ccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCC
Q 044997          347 ----------FISTFGNGSLSDHLHDPL---LKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDG  413 (563)
Q Consensus       347 ----------V~e~~~~gsL~~~L~~~~---~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~  413 (563)
                                ++.++.-|+|..+|...+   -+..+.++..+...++.|++.|++|||.++   +||.||..+|++||+.
T Consensus       356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~  432 (563)
T KOG1024|consen  356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQ  432 (563)
T ss_pred             EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhh
Confidence                      356777899999998322   123467888999999999999999999998   9999999999999999


Q ss_pred             CcEEEeecCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCC
Q 044997          414 LRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRA  492 (563)
Q Consensus       414 ~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p  492 (563)
                      .++||+|=.++|.+-+.+.. ......-.+..||+||.+....|             +.++|||||||+||||+| |+.|
T Consensus       433 LqVkltDsaLSRDLFP~DYh-cLGDnEnRPvkWMslEal~n~~y-------------ssasDvWsfGVllWELmtlg~~P  498 (563)
T KOG1024|consen  433 LQVKLTDSALSRDLFPGDYH-CLGDNENRPVKWMSLEALQNSHY-------------SSASDVWSFGVLLWELMTLGKLP  498 (563)
T ss_pred             eeEEeccchhccccCccccc-ccCCCCCCcccccCHHHHhhhhh-------------cchhhhHHHHHHHHHHHhcCCCC
Confidence            99999999999876554322 22222334678999998866554             899999999999999998 7778


Q ss_pred             CcCCC-----------CCchhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhh
Q 044997          493 LIRDD-----------SEPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMI  540 (563)
Q Consensus       493 ~~~~~-----------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~  540 (563)
                      +...+           .+..++-++++++..++.-||..+|++||+++|++..|.+...
T Consensus       499 yaeIDPfEm~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~  557 (563)
T KOG1024|consen  499 YAEIDPFEMEHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHT  557 (563)
T ss_pred             ccccCHHHHHHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHH
Confidence            65433           2334455778899999999999999999999999999987643

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1.6e-33  Score=286.82  Aligned_cols=218  Identities=22%  Similarity=0.433  Sum_probs=180.1

Q ss_pred             hcCCCccceecccCcEEEEEEEE--CCceEEEEEeccCC---hHHHHHHHHHHHhccccce---------------EEEe
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNK---SKEFFAELKVLCKIHHINV---------------FIST  350 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~---~~~f~~Ei~~l~~l~H~ni---------------V~e~  350 (563)
                      .++|...+.||+|+||.||+|..  .++.+|+|.+....   .+.+.+|+.++++++|+|+               |+||
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   97 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   97 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence            36788899999999999999986  47899999986432   3568889999999999997               5688


Q ss_pred             ecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccccc
Q 044997          351 FGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERT  430 (563)
Q Consensus       351 ~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~  430 (563)
                      +++++|.+++..      ..+++.++..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++......
T Consensus        98 ~~~~~L~~~~~~------~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~  168 (297)
T cd06656          98 LAGGSLTDVVTE------TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  168 (297)
T ss_pred             cCCCCHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCC
Confidence            999999998853      45889999999999999999999987   999999999999999999999999998754322


Q ss_pred             cccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc----------
Q 044997          431 NEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP----------  500 (563)
Q Consensus       431 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~----------  500 (563)
                      ..   ......+++.|+|||.+.+..             ++.++|||||||++|++++|+.||...+...          
T Consensus       169 ~~---~~~~~~~~~~y~aPE~~~~~~-------------~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~  232 (297)
T cd06656         169 QS---KRSTMVGTPYWMAPEVVTRKA-------------YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGT  232 (297)
T ss_pred             cc---CcCcccCCccccCHHHHcCCC-------------CCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCC
Confidence            11   122346888999999875433             4789999999999999999999986543211          


Q ss_pred             ---hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          501 ---TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       501 ---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                         .....+...+.+++.+||+.||.+||++.++++
T Consensus       233 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         233 PELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence               112344566899999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-33  Score=292.42  Aligned_cols=226  Identities=22%  Similarity=0.303  Sum_probs=176.6

Q ss_pred             cCCCccceecccCcEEEEEEEEC--CceEEEEEeccC------ChHHHHHHHHHHHhccccce---------------EE
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSN------KSKEFFAELKVLCKIHHINV---------------FI  348 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~------~~~~f~~Ei~~l~~l~H~ni---------------V~  348 (563)
                      ++|+..+.||+|+||.||+++..  ++.+|+|.++..      ..+.|.+|+.++.+++|+||               |+
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            46888999999999999999874  688999998642      23458889999999999986               67


Q ss_pred             EeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccc
Q 044997          349 STFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEE  428 (563)
Q Consensus       349 e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~  428 (563)
                      ||+++|+|.+++..    ....+++..+..++.|++.||+|||+++   ++||||||+|||++.++.+||+|||+++...
T Consensus        81 e~~~g~~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~  153 (331)
T cd05597          81 DYYVGGDLLTLLSK----FEDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLL  153 (331)
T ss_pred             ecCCCCcHHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecC
Confidence            99999999999864    1346899999999999999999999997   9999999999999999999999999987543


Q ss_pred             cccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc--------
Q 044997          429 RTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP--------  500 (563)
Q Consensus       429 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~--------  500 (563)
                      .....  ......||+.|+|||++.....        ....++.++|||||||++|||++|+.||.......        
T Consensus       154 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~--------~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~  223 (331)
T cd05597         154 ADGTV--QSNVAVGTPDYISPEILQAMED--------GKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH  223 (331)
T ss_pred             CCCCc--cccceeccccccCHHHHhhccc--------cccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcC
Confidence            32211  1122468999999999853210        12345789999999999999999999996543211        


Q ss_pred             -------hhhHHHHHHHHHHHHHhhccCC--CCCCCHHHHHHH
Q 044997          501 -------TKMKSLITIMAAVAEWCLNEDA--VDRPEMRDIVAI  534 (563)
Q Consensus       501 -------~~~~~~~~~l~~li~~cl~~dP--~~RPs~~evl~~  534 (563)
                             .....+.+.+.+++.+|+..++  ..||+++++++.
T Consensus       224 ~~~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         224 KEHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             CCcccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence                   0111245668889988775533  347888888875

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=1.3e-33  Score=284.14  Aligned_cols=216  Identities=30%  Similarity=0.453  Sum_probs=176.7

Q ss_pred             CCccceecccCcEEEEEEEE--CCceEEEEEeccCC----hHHHHHHHHHHHhccccce---------------EEEeec
Q 044997          294 FDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNK----SKEFFAELKVLCKIHHINV---------------FISTFG  352 (563)
Q Consensus       294 f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~----~~~f~~Ei~~l~~l~H~ni---------------V~e~~~  352 (563)
                      |+..+.||+|+||.||+|..  .++.||+|.++...    .+.+.+|++++++++|+||               |+||++
T Consensus         6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   85 (277)
T cd06642           6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG   85 (277)
T ss_pred             HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence            55667899999999999987  36789999887433    2568899999999999997               689999


Q ss_pred             CCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccccccc
Q 044997          353 NGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNE  432 (563)
Q Consensus       353 ~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~  432 (563)
                      +|+|.+++..      ..+++..+..++.|+++||.|||+++   ++|+||+|+||++++++.+||+|||+++.......
T Consensus        86 ~~~L~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06642          86 GGSALDLLKP------GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             CCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence            9999988853      46899999999999999999999987   99999999999999999999999999876543221


Q ss_pred             cccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCC-----------ch
Q 044997          433 KEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE-----------PT  501 (563)
Q Consensus       433 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~-----------~~  501 (563)
                         ......|+..|+|||++.+..             ++.++||||||+++|||++|+.|+......           +.
T Consensus       157 ---~~~~~~~~~~y~aPE~~~~~~-------------~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~  220 (277)
T cd06642         157 ---KRNTFVGTPFWMAPEVIKQSA-------------YDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPT  220 (277)
T ss_pred             ---hhhcccCcccccCHHHhCcCC-------------CchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCC
Confidence               112245788999999875443             478999999999999999999998543211           11


Q ss_pred             hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          502 KMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       502 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                      ........+.+++.+||+.+|.+||++.++++.
T Consensus       221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06642         221 LEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH  253 (277)
T ss_pred             CCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence            112344568999999999999999999999984

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=1.7e-33  Score=284.15  Aligned_cols=219  Identities=25%  Similarity=0.410  Sum_probs=176.5

Q ss_pred             cCCCccceecccCcEEEEEEEEC--CceEEEEEeccCC-----hHHHHHHHHHHHhccccce---------------EEE
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNK-----SKEFFAELKVLCKIHHINV---------------FIS  349 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~-----~~~f~~Ei~~l~~l~H~ni---------------V~e  349 (563)
                      ++|+..+.||+|+||.||+|...  ++.+|+|++....     .+.+.+|++++++++|+||               |+|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            46788899999999999999884  6889999875432     3568899999999999997               679


Q ss_pred             eecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccccc
Q 044997          350 TFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEER  429 (563)
Q Consensus       350 ~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~  429 (563)
                      |+++++|.++...     ...++|.++..++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||+++....
T Consensus        81 ~~~~~~l~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~  152 (286)
T cd07846          81 FVDHTVLDDLEKY-----PNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAA  152 (286)
T ss_pred             cCCccHHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccC
Confidence            9999888876643     245899999999999999999999987   99999999999999999999999999876533


Q ss_pred             ccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCch--------
Q 044997          430 TNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPT--------  501 (563)
Q Consensus       430 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~--------  501 (563)
                      ...   ......++..|+|||++.+.            ..++.++||||||+++|||++|+.||........        
T Consensus       153 ~~~---~~~~~~~~~~y~aPE~~~~~------------~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~  217 (286)
T cd07846         153 PGE---VYTDYVATRWYRAPELLVGD------------TKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCL  217 (286)
T ss_pred             Ccc---ccCcccceeeccCcHHhccc------------cccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHh
Confidence            221   12334578899999987432            2347899999999999999999988754331100        


Q ss_pred             ---------------------------------hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          502 ---------------------------------KMKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       502 ---------------------------------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                                                       ....+...+.+++.+||+.||++||++.++++
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         218 GNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             CCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence                                             00123455889999999999999999999876

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=2.3e-33  Score=280.04  Aligned_cols=220  Identities=25%  Similarity=0.451  Sum_probs=177.3

Q ss_pred             CCCccceecccCcEEEEEEEE-CCceEEEEEeccCC---------hHHHHHHHHHHHhccccce---------------E
Q 044997          293 NFDESRIIGRGGFGNVYFGLL-GDREAAIKKMRSNK---------SKEFFAELKVLCKIHHINV---------------F  347 (563)
Q Consensus       293 ~f~~~~~LG~G~fG~Vy~g~~-~~~~vavK~~~~~~---------~~~f~~Ei~~l~~l~H~ni---------------V  347 (563)
                      +|...+.||+|+||.||+|.. +++.+|+|.++...         .+.+.+|++++++++|+||               +
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            477789999999999999987 56789999886431         2458889999999999997               5


Q ss_pred             EEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccc
Q 044997          348 ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLE  427 (563)
Q Consensus       348 ~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~  427 (563)
                      +||+++|+|.+++..     ...+++..+..++.|++.||+|||+.+   ++|+||||+||++++++.+||+|||+++..
T Consensus        81 ~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  152 (265)
T cd06631          81 MEFVPGGSISSILNR-----FGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRL  152 (265)
T ss_pred             EecCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhh
Confidence            789999999999864     246889999999999999999999987   999999999999999999999999998754


Q ss_pred             cccc---ccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc----
Q 044997          428 ERTN---EKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP----  500 (563)
Q Consensus       428 ~~~~---~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~----  500 (563)
                      ....   ..........|+..|+|||++.+..             ++.++||||||+++|||++|+.||...+...    
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-------------~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~  219 (265)
T cd06631         153 AWVGLHGTHSNMLKSMHGTPYWMAPEVINESG-------------YGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFY  219 (265)
T ss_pred             hhccccccccccccccCCCccccChhhhcCCC-------------CcchhhHHHHHHHHHHHHhCCCccccCChHHHHHH
Confidence            3211   1111122356889999999875443             4789999999999999999999986533211    


Q ss_pred             ---------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          501 ---------TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       501 ---------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                               .........+.+++.+||+.+|.+||++.|+++
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         220 IGAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             hhhccCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                     112233456899999999999999999999875

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=2.9e-33  Score=278.91  Aligned_cols=225  Identities=26%  Similarity=0.451  Sum_probs=182.1

Q ss_pred             cCCCccceecccCcEEEEEEEE--CCceEEEEEeccCC----hHHHHHHHHHHHhccccce---------------EEEe
Q 044997          292 NNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNK----SKEFFAELKVLCKIHHINV---------------FIST  350 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~----~~~f~~Ei~~l~~l~H~ni---------------V~e~  350 (563)
                      ++|+..+.||.|+||.||+|..  ++..+++|++....    .+.+.+|+++++.++|+|+               |+|+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            4688899999999999999987  46789999986432    3678899999999999997               4688


Q ss_pred             ecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccccc
Q 044997          351 FGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERT  430 (563)
Q Consensus       351 ~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~  430 (563)
                      +++++|.+++....  ....+++.....++.|++.||.|||+.+   ++||||||+||++++++.+||+|||++......
T Consensus        81 ~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~  155 (267)
T cd06610          81 LSGGSLLDIMKSSY--PRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADG  155 (267)
T ss_pred             cCCCcHHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccC
Confidence            89999999986521  1246899999999999999999999987   999999999999999999999999998765543


Q ss_pred             cccc-cccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCch--------
Q 044997          431 NEKE-MLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPT--------  501 (563)
Q Consensus       431 ~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~--------  501 (563)
                      .... .......|+..|+|||++...            ...+.++|||||||++|||++|+.||........        
T Consensus       156 ~~~~~~~~~~~~~~~~y~~Pe~~~~~------------~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~  223 (267)
T cd06610         156 GDRTRKVRKTFVGTPCWMAPEVMEQV------------HGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQND  223 (267)
T ss_pred             ccccccccccccCChhhcChHHHccc------------cCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCC
Confidence            2221 122335688999999987543            1348899999999999999999999865432110        


Q ss_pred             --------hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          502 --------KMKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       502 --------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                              ....+...+.+++.+||+.||++||++.++++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         224 PPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             CCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence                    01244567899999999999999999999986

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-33  Score=281.66  Aligned_cols=217  Identities=28%  Similarity=0.429  Sum_probs=179.4

Q ss_pred             cCCCccceecccCcEEEEEEEE--CCceEEEEEeccCC----hHHHHHHHHHHHhccccce---------------EEEe
Q 044997          292 NNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNK----SKEFFAELKVLCKIHHINV---------------FIST  350 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~----~~~f~~Ei~~l~~l~H~ni---------------V~e~  350 (563)
                      ++|+..+.||.|+||.||+|..  +++.+|+|.+....    ...+.+|++++++++|+|+               |+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            3677889999999999999987  46889999986543    3568899999999999997               4689


Q ss_pred             ecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccccc
Q 044997          351 FGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERT  430 (563)
Q Consensus       351 ~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~  430 (563)
                      +++++|.+++..      .++++..+..++.|++.||.|||+++   ++||||+|+||++++++.++|+|||+++.....
T Consensus        81 ~~~~~L~~~~~~------~~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~  151 (274)
T cd06609          81 CGGGSCLDLLKP------GKLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTST  151 (274)
T ss_pred             eCCCcHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeeccc
Confidence            999999998864      27899999999999999999999987   999999999999999999999999999865433


Q ss_pred             cccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc----------
Q 044997          431 NEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP----------  500 (563)
Q Consensus       431 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~----------  500 (563)
                      ..   ......++..|+|||++.+..             ++.++||||||+++|||++|+.||...+...          
T Consensus       152 ~~---~~~~~~~~~~y~~PE~~~~~~-------------~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~  215 (274)
T cd06609         152 MS---KRNTFVGTPFWMAPEVIKQSG-------------YDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNP  215 (274)
T ss_pred             cc---ccccccCCccccChhhhccCC-------------CCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCC
Confidence            21   122346788999999885443             4899999999999999999999986433111          


Q ss_pred             -hhhHH-HHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          501 -TKMKS-LITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       501 -~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                       ..... ....+.+++.+||..||++||+++++++
T Consensus       216 ~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         216 PSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLK  250 (274)
T ss_pred             CCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence             11111 4556899999999999999999999977

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.2e-33  Score=292.31  Aligned_cols=226  Identities=22%  Similarity=0.307  Sum_probs=177.4

Q ss_pred             cCCCccceecccCcEEEEEEEEC--CceEEEEEeccC------ChHHHHHHHHHHHhccccce---------------EE
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSN------KSKEFFAELKVLCKIHHINV---------------FI  348 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~------~~~~f~~Ei~~l~~l~H~ni---------------V~  348 (563)
                      ++|+..+.||+|+||.||+++.+  ++.+|+|.+...      ..+.|.+|+.++..++|+||               |+
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            46888999999999999999885  577999998642      22457889999999999986               68


Q ss_pred             EeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccc
Q 044997          349 STFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEE  428 (563)
Q Consensus       349 e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~  428 (563)
                      ||+++|+|.+++..    ....+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus        81 ey~~~g~L~~~l~~----~~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~  153 (332)
T cd05623          81 DYYVGGDLLTLLSK----FEDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLM  153 (332)
T ss_pred             eccCCCcHHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecc
Confidence            99999999999964    2346899999999999999999999987   9999999999999999999999999987543


Q ss_pred             cccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc--------
Q 044997          429 RTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP--------  500 (563)
Q Consensus       429 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~--------  500 (563)
                      ....  .......||+.|+|||++.....        ....++.++|||||||++|||++|+.||.......        
T Consensus       154 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~--------~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~  223 (332)
T cd05623         154 EDGT--VQSSVAVGTPDYISPEILQAMED--------GKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH  223 (332)
T ss_pred             cCCc--ceecccccCccccCHHHHhcccc--------CCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCC
Confidence            2211  11223579999999998853211        12346889999999999999999999997543211        


Q ss_pred             -------hhhHHHHHHHHHHHHHhhccCCC--CCCCHHHHHHH
Q 044997          501 -------TKMKSLITIMAAVAEWCLNEDAV--DRPEMRDIVAI  534 (563)
Q Consensus       501 -------~~~~~~~~~l~~li~~cl~~dP~--~RPs~~evl~~  534 (563)
                             .....+...+.+++.+|+..++.  .||++.|+++.
T Consensus       224 ~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         224 KERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             CccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence                   11123456688999998865444  36889888776

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=2.9e-33  Score=282.28  Aligned_cols=219  Identities=23%  Similarity=0.328  Sum_probs=174.3

Q ss_pred             CCCccceecccCcEEEEEEEE--CCceEEEEEeccCC-----hHHHHHHHHHHHhccccce---------------EEEe
Q 044997          293 NFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNK-----SKEFFAELKVLCKIHHINV---------------FIST  350 (563)
Q Consensus       293 ~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~-----~~~f~~Ei~~l~~l~H~ni---------------V~e~  350 (563)
                      +|+..+.||.|++|.||+|+.  .++.+|||+++...     .+.+.+|++++++++||||               |+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            478889999999999999987  47889999886432     2568899999999999997               5688


Q ss_pred             ecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccccc
Q 044997          351 FGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERT  430 (563)
Q Consensus       351 ~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~  430 (563)
                      +. ++|..++..   .....+++..+..++.|++.||+|||+++   ++||||+|+||++++++.+||+|||+++.....
T Consensus        81 ~~-~~l~~~~~~---~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~  153 (284)
T cd07860          81 LH-QDLKKFMDA---SPLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP  153 (284)
T ss_pred             cc-cCHHHHHHh---CCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccC
Confidence            75 678887764   23456899999999999999999999987   999999999999999999999999998754322


Q ss_pred             cccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCchh--------
Q 044997          431 NEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTK--------  502 (563)
Q Consensus       431 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~~--------  502 (563)
                      ..   ......++..|+|||.+.+..            .++.++||||||+++|||++|+.||.........        
T Consensus       154 ~~---~~~~~~~~~~y~aPE~~~~~~------------~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~  218 (284)
T cd07860         154 VR---TYTHEVVTLWYRAPEILLGCK------------YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG  218 (284)
T ss_pred             cc---ccccccccccccCCeEEecCC------------CCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhC
Confidence            11   112235688999999875432            2478899999999999999999998654321100        


Q ss_pred             -------------------------------hHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          503 -------------------------------MKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       503 -------------------------------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                                                     ...+...+.+++.+||+.||++||+++++++
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         219 TPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             CCChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence                                           0012344778999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=1.6e-33  Score=287.18  Aligned_cols=219  Identities=21%  Similarity=0.343  Sum_probs=174.3

Q ss_pred             cCCCccceecccCcEEEEEEEEC--CceEEEEEeccCC----hHHHHHHHHHHHhccccce---------------EEEe
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNK----SKEFFAELKVLCKIHHINV---------------FIST  350 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~----~~~f~~Ei~~l~~l~H~ni---------------V~e~  350 (563)
                      ++|...+.||+|+||.||+|+..  ++.||+|.++...    ...+.+|+.++++++|+||               |+||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~   85 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   85 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence            46888899999999999999874  6889999986432    3467889999999999997               4677


Q ss_pred             ecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccccc
Q 044997          351 FGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERT  430 (563)
Q Consensus       351 ~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~  430 (563)
                      ++ ++|.+++..    ....+++..+..++.|+++||+|||+.+   ++||||||+||++++++.+||+|||+++.....
T Consensus        86 ~~-~~l~~~l~~----~~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  157 (301)
T cd07873          86 LD-KDLKQYLDD----CGNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIP  157 (301)
T ss_pred             cc-cCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCC
Confidence            76 588877764    2346889999999999999999999987   999999999999999999999999998754322


Q ss_pred             cccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCch---------
Q 044997          431 NEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPT---------  501 (563)
Q Consensus       431 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~---------  501 (563)
                      ..   ......+++.|+|||.+.+.            ..++.++|||||||++|||++|+.||...+....         
T Consensus       158 ~~---~~~~~~~~~~y~~PE~~~~~------------~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~  222 (301)
T cd07873         158 TK---TYSNEVVTLWYRPPDILLGS------------TDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILG  222 (301)
T ss_pred             CC---cccccceeecccCcHHHhCC------------CCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcC
Confidence            11   11224568899999987432            2347899999999999999999999864331100         


Q ss_pred             -------------------------------hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          502 -------------------------------KMKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       502 -------------------------------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                                                     ....+.+.+.+|+.+|++.||.+|||+.|+++
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         223 TPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             CCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence                                           00123445789999999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=4.9e-33  Score=279.96  Aligned_cols=217  Identities=28%  Similarity=0.452  Sum_probs=178.6

Q ss_pred             CCCccceecccCcEEEEEEEE--CCceEEEEEeccCC----hHHHHHHHHHHHhccccce---------------EEEee
Q 044997          293 NFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNK----SKEFFAELKVLCKIHHINV---------------FISTF  351 (563)
Q Consensus       293 ~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~----~~~f~~Ei~~l~~l~H~ni---------------V~e~~  351 (563)
                      .|+..+.||+|+||.||+|..  .+..+|+|.++...    .+.+.+|++++++++|+||               |+||+
T Consensus         5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06640           5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence            466778899999999999987  46889999887443    3568899999999999997               57999


Q ss_pred             cCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccccccc
Q 044997          352 GNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTN  431 (563)
Q Consensus       352 ~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~  431 (563)
                      ++|+|.+++..      .++++.+...++.|++.||+|||+.+   ++|+||+|+||+++++++++|+|||++.......
T Consensus        85 ~~~~L~~~i~~------~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06640          85 GGGSALDLLRA------GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ  155 (277)
T ss_pred             CCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCc
Confidence            99999998863      35889999999999999999999987   9999999999999999999999999987654322


Q ss_pred             ccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCC-----------Cc
Q 044997          432 EKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDS-----------EP  500 (563)
Q Consensus       432 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~-----------~~  500 (563)
                      .   ......++..|+|||++.+.             .++.++|||||||++|||++|+.|+.....           .+
T Consensus       156 ~---~~~~~~~~~~y~apE~~~~~-------------~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~  219 (277)
T cd06640         156 I---KRNTFVGTPFWMAPEVIQQS-------------AYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPP  219 (277)
T ss_pred             c---ccccccCcccccCHhHhccC-------------CCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCC
Confidence            1   12234578899999987543             348899999999999999999999864321           11


Q ss_pred             hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          501 TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       501 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                      .........+.+++.+||+.+|++||++.+++..
T Consensus       220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         220 TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             CCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence            2223456678999999999999999999999775

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=2.6e-33  Score=281.27  Aligned_cols=227  Identities=25%  Similarity=0.392  Sum_probs=179.2

Q ss_pred             cCCCccceecccCcEEEEEEEEC-------CceEEEEEeccCC----hHHHHHHHHHHHhccccce--------------
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG-------DREAAIKKMRSNK----SKEFFAELKVLCKIHHINV--------------  346 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~-------~~~vavK~~~~~~----~~~f~~Ei~~l~~l~H~ni--------------  346 (563)
                      ++|+..+.||+|+||.||+|+..       .+.+++|.+....    .+++.+|++++++++|+||              
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            56888899999999999999863       3568999886543    3579999999999999997              


Q ss_pred             -EEEeecCCCccccccccccc----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeec
Q 044997          347 -FISTFGNGSLSDHLHDPLLK----GHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADF  421 (563)
Q Consensus       347 -V~e~~~~gsL~~~L~~~~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DF  421 (563)
                       |+||+++|+|.+++......    ....+++..+..++.|++.||+|||+.+   ++||||||+||++++++.+|++||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence             57999999999998753211    0126899999999999999999999987   999999999999999999999999


Q ss_pred             CCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCCCcCCCCCc
Q 044997          422 GLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIRDDSEP  500 (563)
Q Consensus       422 Gla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p~~~~~~~~  500 (563)
                      |+++.......  .......++..|+|||.+.+.             ..+.++||||||+++||+++ |..||.......
T Consensus       162 ~~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~-------------~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~  226 (275)
T cd05046         162 SLSKDVYNSEY--YKLRNALIPLRWLAPEAVQED-------------DFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE  226 (275)
T ss_pred             ccccccCcccc--cccCCceeEEeecChhhhccC-------------CCCchhhHHHHHHHHHHHHhCCCCCccccchHH
Confidence            99874332211  112223567789999987543             34789999999999999999 677775322111


Q ss_pred             ------------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 044997          501 ------------TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILS  536 (563)
Q Consensus       501 ------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  536 (563)
                                  ......+..+.+++.+||+.||.+||++.|++..|.
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         227 VLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             HHHHHHcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence                        011233456899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=4.7e-33  Score=276.18  Aligned_cols=220  Identities=25%  Similarity=0.381  Sum_probs=179.3

Q ss_pred             CCCccceecccCcEEEEEEEE--CCceEEEEEeccC-----ChHHHHHHHHHHHhccccce---------------EEEe
Q 044997          293 NFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSN-----KSKEFFAELKVLCKIHHINV---------------FIST  350 (563)
Q Consensus       293 ~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~-----~~~~f~~Ei~~l~~l~H~ni---------------V~e~  350 (563)
                      +|+..+.||+|+||.||.++.  +++.+++|.+...     ..+++.+|++++++++|+||               ++||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            478889999999999888766  5788999987533     23568899999999999998               4799


Q ss_pred             ecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccccc
Q 044997          351 FGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERT  430 (563)
Q Consensus       351 ~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~  430 (563)
                      +++|+|.+++...   ....+++.++..++.|++.||.|||+.+   ++|+||||+||++++++.+||+|||+++.....
T Consensus        81 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~  154 (256)
T cd08221          81 ANGGTLYDKIVRQ---KGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSE  154 (256)
T ss_pred             cCCCcHHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccc
Confidence            9999999998752   2356899999999999999999999987   999999999999999999999999998765332


Q ss_pred             cccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCch---------
Q 044997          431 NEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPT---------  501 (563)
Q Consensus       431 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~---------  501 (563)
                      ..   ......|++.|+|||.+.+..             .+.++||||||+++|||++|+.||........         
T Consensus       155 ~~---~~~~~~~~~~y~ape~~~~~~-------------~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~  218 (256)
T cd08221         155 YS---MAETVVGTPYYMSPELCQGVK-------------YNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNY  218 (256)
T ss_pred             cc---cccccCCCccccCHhhcCCCC-------------CCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCC
Confidence            21   223356899999999875433             47899999999999999999999865332111         


Q ss_pred             --hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          502 --KMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       502 --~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                        ........+.+++.+||+.+|.+||++.++++.
T Consensus       219 ~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~  253 (256)
T cd08221         219 TPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ  253 (256)
T ss_pred             CCCccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence              112234568999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.9e-33  Score=276.10  Aligned_cols=223  Identities=26%  Similarity=0.403  Sum_probs=180.8

Q ss_pred             hcCCCccceecccCcEEEEEEEEC--CceEEEEEeccC---ChHHHHHHHHHHHhccccce---------------EEEe
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSN---KSKEFFAELKVLCKIHHINV---------------FIST  350 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~---~~~~f~~Ei~~l~~l~H~ni---------------V~e~  350 (563)
                      .++|+..+.||+|+||.||+|...  ++.+++|.+...   ..+.+.+|++++++++|||+               ++||
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~   81 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY   81 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence            357888999999999999999873  578999988754   34678899999999999997               5788


Q ss_pred             ecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccccc
Q 044997          351 FGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERT  430 (563)
Q Consensus       351 ~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~  430 (563)
                      +++++|.+++...    ...+++.++..++.|++.||.|||+++   ++|+||||+||++++++.+||+|||++......
T Consensus        82 ~~~~~l~~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~  154 (262)
T cd06613          82 CGGGSLQDIYQVT----RGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTAT  154 (262)
T ss_pred             CCCCcHHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhh
Confidence            8999999888642    256899999999999999999999987   999999999999999999999999998754432


Q ss_pred             cccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc----------
Q 044997          431 NEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP----------  500 (563)
Q Consensus       431 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~----------  500 (563)
                      ..   ......++..|+|||.+....          ...++.++||||||+++|||++|+.|+.......          
T Consensus       155 ~~---~~~~~~~~~~y~~Pe~~~~~~----------~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~  221 (262)
T cd06613         155 IA---KRKSFIGTPYWMAPEVAAVER----------KGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNF  221 (262)
T ss_pred             hh---ccccccCCccccCchhhcccc----------cCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC
Confidence            11   112346788999999875431          1245789999999999999999999986533111          


Q ss_pred             -----hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          501 -----TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       501 -----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                           .........+.+++.+||+.||.+||++.+|+.
T Consensus       222 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         222 PPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             CCccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                 112234566899999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=2.3e-33  Score=276.93  Aligned_cols=224  Identities=22%  Similarity=0.294  Sum_probs=170.5

Q ss_pred             cCCCccceecccCcEEEEEEEE--CCceEEEEEeccCC-----hHHHHHHHHHHHhccccc-eEE--Eeec---------
Q 044997          292 NNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNK-----SKEFFAELKVLCKIHHIN-VFI--STFG---------  352 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~-----~~~f~~Ei~~l~~l~H~n-iV~--e~~~---------  352 (563)
                      ..|...++||+|+||.||+|+.  +|+.||+|+++-+.     .....+|+.+|++++|+| ||.  +.+.         
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~   90 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG   90 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence            3455567899999999999976  57899999987543     245689999999999999 642  2211         


Q ss_pred             ---------CCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCC
Q 044997          353 ---------NGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGL  423 (563)
Q Consensus       353 ---------~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGl  423 (563)
                               .-+|..++.... ...+.++...+..++.|++.||+|||+++   |+||||||+||||+++|.+||+|||+
T Consensus        91 ~l~lvfe~~d~DL~~ymd~~~-~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGl  166 (323)
T KOG0594|consen   91 KLYLVFEFLDRDLKKYMDSLP-KKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGL  166 (323)
T ss_pred             eEEEEEEeecccHHHHHHhcc-ccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccch
Confidence                     124555554321 01135777889999999999999999998   99999999999999999999999999


Q ss_pred             CcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCchh-
Q 044997          424 VKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTK-  502 (563)
Q Consensus       424 a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~~-  502 (563)
                      |+...-..   ...+..++|..|.|||++.+..+            |++..||||+||++.||++++.-|.++....+. 
T Consensus       167 Ara~~ip~---~~yt~evvTlWYRaPEvLlGs~~------------Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~  231 (323)
T KOG0594|consen  167 ARAFSIPM---RTYTPEVVTLWYRAPEVLLGSTS------------YSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLF  231 (323)
T ss_pred             HHHhcCCc---ccccccEEEeeccCHHHhcCCCc------------CCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHH
Confidence            99544221   12455678999999999977642            589999999999999999988776543321000 


Q ss_pred             --------------------------------hHHH-------HHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          503 --------------------------------MKSL-------ITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       503 --------------------------------~~~~-------~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                                                      .+.+       .....+++.+|++.+|.+|.|++..+..
T Consensus       232 ~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  232 RIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             HHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence                                            0111       1247899999999999999999999875

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.4e-33  Score=317.59  Aligned_cols=229  Identities=25%  Similarity=0.389  Sum_probs=181.2

Q ss_pred             HHhcCCCccceecccCcEEEEEEEEC--CceEEEEEeccC-----ChHHHHHHHHHHHhccccce---------------
Q 044997          289 EATNNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSN-----KSKEFFAELKVLCKIHHINV---------------  346 (563)
Q Consensus       289 ~~~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~-----~~~~f~~Ei~~l~~l~H~ni---------------  346 (563)
                      ...++|.+.+.||+|+||.||++...  +..+|+|.+...     ....|..|+.+|.+++||||               
T Consensus        10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l   89 (1021)
T PTZ00266         10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL   89 (1021)
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence            34568999999999999999999874  567899988643     23568899999999999997               


Q ss_pred             --EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCC----CceEeCCCCCCCeEecC--------
Q 044997          347 --FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTK----ARYVHRDIKTSNILLDD--------  412 (563)
Q Consensus       347 --V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~----~~ivHrDLk~~NILl~~--------  412 (563)
                        |+||+++|+|.++|.... .....+++..++.|+.||+.||.|||+.+.    .+||||||||+||||+.        
T Consensus        90 yIVMEY~~gGSL~~lL~k~~-~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i  168 (1021)
T PTZ00266         90 YILMEFCDAGDLSRNIQKCY-KMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI  168 (1021)
T ss_pred             EEEEeCCCCCcHHHHHHHHh-hccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence              578999999999886522 223569999999999999999999998542    34999999999999964        


Q ss_pred             ---------CCcEEEeecCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHH
Q 044997          413 ---------GLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVL  483 (563)
Q Consensus       413 ---------~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl  483 (563)
                               ...+||+|||+++......    ......||+.|+|||++.+.           ...++.++|||||||+|
T Consensus       169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s----~~~s~vGTp~YmAPEvL~ge-----------~~~~s~KSDVWSLG~IL  233 (1021)
T PTZ00266        169 TAQANNLNGRPIAKIGDFGLSKNIGIES----MAHSCVGTPYYWSPELLLHE-----------TKSYDDKSDMWALGCII  233 (1021)
T ss_pred             cccccccCCCCceEEccCCccccccccc----cccccCCCccccCHHHHhcc-----------CCCCCchhHHHHHHHHH
Confidence                     2358999999998643221    12335789999999987532           22358899999999999


Q ss_pred             HHHHcCCCCCcCCCCCchhh-----------HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          484 AELITGKRALIRDDSEPTKM-----------KSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       484 ~Elltg~~p~~~~~~~~~~~-----------~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                      |||++|+.||..........           ......+.+|+..||+.+|.+||++.|++.
T Consensus       234 YELLTGk~PF~~~~~~~qli~~lk~~p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        234 YELCSGKTPFHKANNFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             HHHHHCCCCCCcCCcHHHHHHHHhcCCCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence            99999999996544321111           122456899999999999999999999984

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=5.1e-33  Score=275.60  Aligned_cols=219  Identities=27%  Similarity=0.399  Sum_probs=178.0

Q ss_pred             CCCccceecccCcEEEEEEEE--CCceEEEEEeccC-----ChHHHHHHHHHHHhccccce---------------EEEe
Q 044997          293 NFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSN-----KSKEFFAELKVLCKIHHINV---------------FIST  350 (563)
Q Consensus       293 ~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~-----~~~~f~~Ei~~l~~l~H~ni---------------V~e~  350 (563)
                      +|+..+.||+|+||.||++..  .++.+|+|.+...     ..+.+.+|++++++++|+|+               |+||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            477889999999999999877  4688999988643     23568899999999999996               5789


Q ss_pred             ecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCC-CcEEEeecCCCccccc
Q 044997          351 FGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDG-LRAKVADFGLVKLEER  429 (563)
Q Consensus       351 ~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~-~~~kl~DFGla~~~~~  429 (563)
                      +++++|.+++...   ....+++..+.+++.+++.||+|||+++   ++|+||||+||+++++ +.+||+|||+++....
T Consensus        81 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~  154 (256)
T cd08220          81 APGGTLAEYIQKR---CNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSS  154 (256)
T ss_pred             CCCCCHHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCC
Confidence            9999999999752   2456899999999999999999999987   9999999999999855 5689999999886533


Q ss_pred             ccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc---------
Q 044997          430 TNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP---------  500 (563)
Q Consensus       430 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~---------  500 (563)
                      ..    ......|+..|+|||.+.+.             ..+.++||||||+++|||++|+.||...+...         
T Consensus       155 ~~----~~~~~~~~~~y~aPE~~~~~-------------~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~  217 (256)
T cd08220         155 KS----KAYTVVGTPCYISPELCEGK-------------PYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGT  217 (256)
T ss_pred             Cc----cccccccCCcccCchhccCC-------------CCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcC
Confidence            21    11234688899999987543             34789999999999999999999986543211         


Q ss_pred             --hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          501 --TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       501 --~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                        .........+.+++.+||+.||.+||++.|+++.
T Consensus       218 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~  253 (256)
T cd08220         218 FAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ  253 (256)
T ss_pred             CCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence              1112345568999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=5.7e-33  Score=280.54  Aligned_cols=227  Identities=21%  Similarity=0.340  Sum_probs=181.3

Q ss_pred             cCCCccceecccCcEEEEEEEEC--CceEEEEEeccCC----hHHHHHHHHHHHhccccce---------------EEEe
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNK----SKEFFAELKVLCKIHHINV---------------FIST  350 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~----~~~f~~Ei~~l~~l~H~ni---------------V~e~  350 (563)
                      ++|+..+.||+|+||.||++...  +..+|+|.++...    .+.+.+|++++++++|+||               |+||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            35778899999999999999885  7889999886432    3568899999999999997               6899


Q ss_pred             ecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccccc
Q 044997          351 FGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERT  430 (563)
Q Consensus       351 ~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~  430 (563)
                      +++++|..++...  .....+++..+..++.|++.||.|||+..  +++||||||+||++++++.+||+|||+++.....
T Consensus        81 ~~~~~l~~~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  156 (286)
T cd06622          81 MDAGSLDKLYAGG--VATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS  156 (286)
T ss_pred             cCCCCHHHHHHhc--cccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCC
Confidence            9999998888652  11346899999999999999999999741  3999999999999999999999999998754321


Q ss_pred             cccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc----------
Q 044997          431 NEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP----------  500 (563)
Q Consensus       431 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~----------  500 (563)
                           ......++..|+|||.+.+...       .....++.++|||||||++|||++|+.||.......          
T Consensus       157 -----~~~~~~~~~~y~aPE~~~~~~~-------~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  224 (286)
T cd06622         157 -----LAKTNIGCQSYMAPERIKSGGP-------NQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVD  224 (286)
T ss_pred             -----ccccCCCccCccCcchhcCCCC-------CccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhh
Confidence                 1122457889999998855432       123345889999999999999999999986433211          


Q ss_pred             ----hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          501 ----TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       501 ----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                          .....+...+.+++.+||+.+|.+||++.+++..
T Consensus       225 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~  262 (286)
T cd06622         225 GDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH  262 (286)
T ss_pred             cCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence                1112345668999999999999999999999873

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.5e-33  Score=283.14  Aligned_cols=217  Identities=25%  Similarity=0.382  Sum_probs=177.7

Q ss_pred             cCCCccceecccCcEEEEEEEEC--CceEEEEEeccCC----hHHHHHHHHHHHhccccce---------------EEEe
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNK----SKEFFAELKVLCKIHHINV---------------FIST  350 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~----~~~f~~Ei~~l~~l~H~ni---------------V~e~  350 (563)
                      ++|+..+.||+|+||.||++...  ++.+|+|.+....    .+++.+|++++++++||||               |+||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF   84 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence            45777899999999999999875  7889999876432    3678899999999999997               6799


Q ss_pred             ecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCceEeCCCCCCCeEecCCCcEEEeecCCCccccc
Q 044997          351 FGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHD-HTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEER  429 (563)
Q Consensus       351 ~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~  429 (563)
                      +++|+|.+++..     ...+++.....++.+++.||.|||+ ++   ++||||||+||++++++.++|+|||++.....
T Consensus        85 ~~~~~L~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~  156 (284)
T cd06620          85 MDCGSLDRIYKK-----GGPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELIN  156 (284)
T ss_pred             CCCCCHHHHHHh-----ccCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhh
Confidence            999999988764     3468999999999999999999997 44   99999999999999999999999999864322


Q ss_pred             ccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc---------
Q 044997          430 TNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP---------  500 (563)
Q Consensus       430 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~---------  500 (563)
                      .     ......|+..|+|||++.+.             .++.++|||||||++||+++|+.||.......         
T Consensus       157 ~-----~~~~~~~~~~~~aPE~~~~~-------------~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~  218 (284)
T cd06620         157 S-----IADTFVGTSTYMSPERIQGG-------------KYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGI  218 (284)
T ss_pred             h-----ccCccccCcccCCHHHHccC-------------CCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHH
Confidence            1     11235689999999987543             44789999999999999999999987543210         


Q ss_pred             -hh-------------hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          501 -TK-------------MKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       501 -~~-------------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                       ..             .......+.+++.+||+.||++||++.|+++.
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~  266 (284)
T cd06620         219 LDLLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAM  266 (284)
T ss_pred             HHHHHHHhhccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence             00             01134568899999999999999999999986

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=3.8e-33  Score=276.89  Aligned_cols=220  Identities=25%  Similarity=0.376  Sum_probs=179.1

Q ss_pred             CCCccceecccCcEEEEEEEE--CCceEEEEEeccC-----ChHHHHHHHHHHHhccccce---------------EEEe
Q 044997          293 NFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSN-----KSKEFFAELKVLCKIHHINV---------------FIST  350 (563)
Q Consensus       293 ~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~-----~~~~f~~Ei~~l~~l~H~ni---------------V~e~  350 (563)
                      +|+..+.||+|+||.||++..  +++.+|+|.+...     ..+++.+|++++++++|+||               |+||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            477889999999999999977  4688999988532     23578899999999999997               5789


Q ss_pred             ecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccccc
Q 044997          351 FGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERT  430 (563)
Q Consensus       351 ~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~  430 (563)
                      +.+++|.+++...   ....+++.++..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++......
T Consensus        81 ~~~~~l~~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~  154 (256)
T cd08218          81 CEGGDLYKKINAQ---RGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNST  154 (256)
T ss_pred             CCCCcHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcc
Confidence            9999999888642   2346899999999999999999999987   999999999999999999999999998754332


Q ss_pred             cccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc----------
Q 044997          431 NEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP----------  500 (563)
Q Consensus       431 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~----------  500 (563)
                      ..   ......|+..|+|||++.+..             .+.++|||||||++|||++|+.|+...+...          
T Consensus       155 ~~---~~~~~~~~~~~~~pe~~~~~~-------------~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~  218 (256)
T cd08218         155 VE---LARTCIGTPYYLSPEICENRP-------------YNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSY  218 (256)
T ss_pred             hh---hhhhccCCccccCHHHhCCCC-------------CCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCC
Confidence            11   112345788999999875443             4789999999999999999999986443211          


Q ss_pred             -hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          501 -TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       501 -~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                       .........+.+++.+||+.+|.+||++.+|++.
T Consensus       219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~  253 (256)
T cd08218         219 PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK  253 (256)
T ss_pred             CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence             1122334568999999999999999999999873

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=5.3e-33  Score=276.75  Aligned_cols=223  Identities=30%  Similarity=0.442  Sum_probs=179.2

Q ss_pred             CCCccceecccCcEEEEEEEE--CCceEEEEEeccCC-----hHHHHHHHHHHHhccccce---------------EEEe
Q 044997          293 NFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNK-----SKEFFAELKVLCKIHHINV---------------FIST  350 (563)
Q Consensus       293 ~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~-----~~~f~~Ei~~l~~l~H~ni---------------V~e~  350 (563)
                      +|+..+.||+|+||.||+|..  +++.+++|.++...     .+.+.+|++++++++|+||               |+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            477889999999999999987  46889999986542     3578899999999999996               5789


Q ss_pred             ecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccccc
Q 044997          351 FGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERT  430 (563)
Q Consensus       351 ~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~  430 (563)
                      +++++|.+++..     ...+++..+..++.+++.||.|||+.+   ++|+||||+||++++++.+||+|||++......
T Consensus        81 ~~~~~L~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~  152 (264)
T cd06626          81 CSGGTLEELLEH-----GRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNN  152 (264)
T ss_pred             CCCCcHHHHHhh-----cCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCC
Confidence            999999998864     345889999999999999999999987   999999999999999999999999998865433


Q ss_pred             cccccc-cccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCch--------
Q 044997          431 NEKEML-ATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPT--------  501 (563)
Q Consensus       431 ~~~~~~-~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~--------  501 (563)
                      ...... .....++..|+|||++....          ....+.++||||||+++||+++|+.||...+....        
T Consensus       153 ~~~~~~~~~~~~~~~~~~~PE~~~~~~----------~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~  222 (264)
T cd06626         153 TTTMGEEVQSLAGTPAYMAPEVITGGK----------GKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAG  222 (264)
T ss_pred             CCcccccccCCcCCcCccChhhccCCC----------CCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcC
Confidence            221111 11245788999999885432          12358899999999999999999999864422110        


Q ss_pred             ----h--hHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          502 ----K--MKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       502 ----~--~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                          .  .......+.+++.+||+.||.+||++.|++.
T Consensus       223 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         223 HKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             CCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence                0  1122456789999999999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=2.6e-33  Score=284.64  Aligned_cols=216  Identities=24%  Similarity=0.437  Sum_probs=174.9

Q ss_pred             CCccceecccCcEEEEEEEE--CCceEEEEEeccCC---hHHHHHHHHHHHhccccce---------------EEEeecC
Q 044997          294 FDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNK---SKEFFAELKVLCKIHHINV---------------FISTFGN  353 (563)
Q Consensus       294 f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~---~~~f~~Ei~~l~~l~H~ni---------------V~e~~~~  353 (563)
                      |.....||+|+||.||++..  ++..+|||.+....   .+.+.+|+.++++++|+|+               |+||+++
T Consensus        24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~  103 (292)
T cd06658          24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG  103 (292)
T ss_pred             HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence            33456799999999999987  46889999986533   3568899999999999996               6899999


Q ss_pred             CCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccccccccc
Q 044997          354 GSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEK  433 (563)
Q Consensus       354 gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~  433 (563)
                      ++|.+++..      ..+++.++..++.|++.||+|||+++   ++||||||+||++++++.+||+|||++........ 
T Consensus       104 ~~L~~~~~~------~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-  173 (292)
T cd06658         104 GALTDIVTH------TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-  173 (292)
T ss_pred             CcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-
Confidence            999998753      35889999999999999999999987   99999999999999999999999999875432211 


Q ss_pred             ccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCch------------
Q 044997          434 EMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPT------------  501 (563)
Q Consensus       434 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~------------  501 (563)
                        ......|+..|+|||.+.+.             .++.++||||||+++|||++|+.||........            
T Consensus       174 --~~~~~~~~~~y~aPE~~~~~-------------~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  238 (292)
T cd06658         174 --KRKSLVGTPYWMAPEVISRL-------------PYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRV  238 (292)
T ss_pred             --cCceeecCccccCHHHHccC-------------CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCcc
Confidence              12234688999999987543             347899999999999999999999865432110            


Q ss_pred             -hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          502 -KMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       502 -~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                       ........+.+++.+||..||.+||++.|+++.
T Consensus       239 ~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         239 KDSHKVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             ccccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence             011234558899999999999999999999974

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=6.8e-33  Score=280.82  Aligned_cols=221  Identities=21%  Similarity=0.299  Sum_probs=172.1

Q ss_pred             HhcCCCccceecccCcEEEEEEEE--CCceEEEEEeccCC----hHHHHHHHHHHHhccccce---------------EE
Q 044997          290 ATNNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNK----SKEFFAELKVLCKIHHINV---------------FI  348 (563)
Q Consensus       290 ~~~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~----~~~f~~Ei~~l~~l~H~ni---------------V~  348 (563)
                      ++++|...+.||+|+||.||+|..  +++.+|+|.++...    ...+.+|++++++++|+||               |+
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   82 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF   82 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence            357889999999999999999976  47899999986432    2467889999999999997               45


Q ss_pred             EeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccc
Q 044997          349 STFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEE  428 (563)
Q Consensus       349 e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~  428 (563)
                      ||+. ++|.+++..    ....+++..+..++.|++.||.|||+++   ++||||||+|||++.++++||+|||+++...
T Consensus        83 e~~~-~~l~~~~~~----~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~  154 (291)
T cd07870          83 EYMH-TDLAQYMIQ----HPGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKS  154 (291)
T ss_pred             eccc-CCHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccC
Confidence            6774 566665543    2345788899999999999999999987   9999999999999999999999999987543


Q ss_pred             cccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCchhh-----
Q 044997          429 RTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKM-----  503 (563)
Q Consensus       429 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~~~-----  503 (563)
                      ....   ......++..|+|||.+.+.            ..++.++|||||||++|||++|+.||..........     
T Consensus       155 ~~~~---~~~~~~~~~~y~aPE~~~~~------------~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~  219 (291)
T cd07870         155 IPSQ---TYSSEVVTLWYRPPDVLLGA------------TDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWT  219 (291)
T ss_pred             CCCC---CCCCccccccccCCceeecC------------CCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHH
Confidence            2211   11223578899999987532            124778999999999999999999986432210000     


Q ss_pred             --------------------------------H------HHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          504 --------------------------------K------SLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       504 --------------------------------~------~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                                                      .      .....+.+++.+|++.||.+|||+.|++.
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         220 VLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             HcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence                                            0      01234789999999999999999999875

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=4.7e-33  Score=287.29  Aligned_cols=221  Identities=19%  Similarity=0.262  Sum_probs=171.0

Q ss_pred             ccceeccc--CcEEEEEEEE--CCceEEEEEeccCC-----hHHHHHHHHHHHhccccce---------------EEEee
Q 044997          296 ESRIIGRG--GFGNVYFGLL--GDREAAIKKMRSNK-----SKEFFAELKVLCKIHHINV---------------FISTF  351 (563)
Q Consensus       296 ~~~~LG~G--~fG~Vy~g~~--~~~~vavK~~~~~~-----~~~f~~Ei~~l~~l~H~ni---------------V~e~~  351 (563)
                      ..++||+|  +||.||++..  +++.||+|+++...     .+.+.+|+++++.++||||               |+||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            35789999  7899999987  46889999987542     2456779999999999998               57899


Q ss_pred             cCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccccccc
Q 044997          352 GNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTN  431 (563)
Q Consensus       352 ~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~  431 (563)
                      ++|+|.+++...   ....+++..+..++.|++.||+|||+++   ++||||||+|||++.++.++++||+.........
T Consensus        82 ~~~~l~~~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~  155 (327)
T cd08227          82 AYGSAKDLICTH---FMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHG  155 (327)
T ss_pred             CCCcHHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccc
Confidence            999999988642   2345899999999999999999999987   9999999999999999999999998654322111


Q ss_pred             ccc----cccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc-------
Q 044997          432 EKE----MLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP-------  500 (563)
Q Consensus       432 ~~~----~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~-------  500 (563)
                      ...    .......++..|+|||++.+..           ..++.++|||||||++|||++|+.||.......       
T Consensus       156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-----------~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~  224 (327)
T cd08227         156 QRLRVVHDFPKYSVKVLPWLSPEVLQQNL-----------QGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLN  224 (327)
T ss_pred             ccccccccccccccceecccChHHhhccc-----------CCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhc
Confidence            100    0112235677899999885421           235889999999999999999999985321100       


Q ss_pred             -------------------------------------------------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 044997          501 -------------------------------------------------TKMKSLITIMAAVAEWCLNEDAVDRPEMRDI  531 (563)
Q Consensus       501 -------------------------------------------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev  531 (563)
                                                                       .......+.+.+++.+||+.||++|||++|+
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~el  304 (327)
T cd08227         225 GTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTL  304 (327)
T ss_pred             CCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHH
Confidence                                                             0011234568899999999999999999999


Q ss_pred             HH
Q 044997          532 VA  533 (563)
Q Consensus       532 l~  533 (563)
                      ++
T Consensus       305 l~  306 (327)
T cd08227         305 LN  306 (327)
T ss_pred             hc
Confidence            87

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=6.5e-33  Score=276.94  Aligned_cols=220  Identities=22%  Similarity=0.399  Sum_probs=178.0

Q ss_pred             CCCccceecccCcEEEEEEEE--CCceEEEEEeccCC---------hHHHHHHHHHHHhccccce---------------
Q 044997          293 NFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNK---------SKEFFAELKVLCKIHHINV---------------  346 (563)
Q Consensus       293 ~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~---------~~~f~~Ei~~l~~l~H~ni---------------  346 (563)
                      +|+..+.||+|+||.||+|..  +++.+|+|.++...         .+.+.+|++++++++|+||               
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            477889999999999999976  57889999986432         3568899999999999997               


Q ss_pred             EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCC-cEEEeecCCCc
Q 044997          347 FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGL-RAKVADFGLVK  425 (563)
Q Consensus       347 V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~-~~kl~DFGla~  425 (563)
                      |+||+++++|.+++..     ..++++..+..++.|++.||.|||+++   ++|+||||+||+++.++ .+||+|||++.
T Consensus        81 v~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~  152 (268)
T cd06630          81 FVEWMAGGSVSHLLSK-----YGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAA  152 (268)
T ss_pred             EEeccCCCcHHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccc
Confidence            5799999999998864     346899999999999999999999997   99999999999998775 69999999987


Q ss_pred             cccccccc-ccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc----
Q 044997          426 LEERTNEK-EMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP----  500 (563)
Q Consensus       426 ~~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~----  500 (563)
                      ........ ........|+..|+|||.+.+..             ++.++||||+|+++|||++|+.||.......    
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-------------~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~  219 (268)
T cd06630         153 RLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQ-------------YGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLAL  219 (268)
T ss_pred             ccccccccCCccccccccccceeCHhHhccCC-------------CCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHH
Confidence            65432111 11122346889999999875443             3789999999999999999999986443211    


Q ss_pred             -----------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          501 -----------TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       501 -----------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                                 .....+...+.+++.+||..+|++||++.|+++
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         220 IFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             HHHHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence                       111234566889999999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-34  Score=296.19  Aligned_cols=216  Identities=27%  Similarity=0.455  Sum_probs=181.2

Q ss_pred             ceecccCcEEEEEEEECC--ceEEEEEeccCCh---HHHHHHHHHHHhccccce---------------EEEeecCCCcc
Q 044997          298 RIIGRGGFGNVYFGLLGD--REAAIKKMRSNKS---KEFFAELKVLCKIHHINV---------------FISTFGNGSLS  357 (563)
Q Consensus       298 ~~LG~G~fG~Vy~g~~~~--~~vavK~~~~~~~---~~f~~Ei~~l~~l~H~ni---------------V~e~~~~gsL~  357 (563)
                      -+||+|.||.||-|+...  ..+|||-+.....   +-+..|+.+.++++|.||               +||.+++|+|+
T Consensus       581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS  660 (1226)
T KOG4279|consen  581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS  660 (1226)
T ss_pred             EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence            479999999999998754  4579999876543   347789999999999998               47889999999


Q ss_pred             cccccccccCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEec-CCCcEEEeecCCCcccccccccc
Q 044997          358 DHLHDPLLKGHQPL--TWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLD-DGLRAKVADFGLVKLEERTNEKE  434 (563)
Q Consensus       358 ~~L~~~~~~~~~~l--~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~-~~~~~kl~DFGla~~~~~~~~~~  434 (563)
                      +.|+...    .++  .+..+-.+.+||++||.|||+..   |||||||-+|||++ -.|.+||+|||-+|.+..-+.  
T Consensus       661 sLLrskW----GPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP--  731 (1226)
T KOG4279|consen  661 SLLRSKW----GPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINP--  731 (1226)
T ss_pred             HHHHhcc----CCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccCCc--
Confidence            9998642    445  77788889999999999999987   99999999999996 578999999999997654332  


Q ss_pred             cccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCC-------------ch
Q 044997          435 MLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE-------------PT  501 (563)
Q Consensus       435 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~-------------~~  501 (563)
                       ....+.||..|||||++..+.           ..|++++|||||||++.||.||++||..-...             +.
T Consensus       732 -~TETFTGTLQYMAPEvIDqG~-----------RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~  799 (1226)
T KOG4279|consen  732 -CTETFTGTLQYMAPEVIDQGP-----------RGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPP  799 (1226)
T ss_pred             -cccccccchhhhChHhhccCC-----------cCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCC
Confidence             344577999999999996554           34689999999999999999999999654432             34


Q ss_pred             hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          502 KMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       502 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                      .+.++....+.++.+|+.+||.+||++.++++-
T Consensus       800 iPeelsaeak~FilrcFepd~~~R~sA~~LL~D  832 (1226)
T KOG4279|consen  800 IPEELSAEAKNFILRCFEPDPCDRPSAKDLLQD  832 (1226)
T ss_pred             CcHHHHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence            456788889999999999999999999999863

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-33  Score=288.73  Aligned_cols=227  Identities=23%  Similarity=0.350  Sum_probs=175.3

Q ss_pred             hcCCCccceecccCcEEEEEEEE--CCceEEEEEeccC----ChHHHHHHHHHHHhccccceE-----------------
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSN----KSKEFFAELKVLCKIHHINVF-----------------  347 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~----~~~~f~~Ei~~l~~l~H~niV-----------------  347 (563)
                      .++|+..+.||+|+||.||+|..  +++.||+|.++..    ...++.+|+.++++++|+||+                 
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            46899999999999999999987  4788999998642    235678899999999999973                 


Q ss_pred             ---EEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCC
Q 044997          348 ---ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLV  424 (563)
Q Consensus       348 ---~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla  424 (563)
                         +||++ ++|.+++.      ...+++..+..++.|++.||+|||+++   ++||||||+||++++++.+||+|||++
T Consensus        84 ~lv~e~~~-~~l~~~~~------~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~  153 (336)
T cd07849          84 YIVQELME-TDLYKLIK------TQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLA  153 (336)
T ss_pred             EEEehhcc-cCHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccce
Confidence               23333 34444443      246899999999999999999999997   999999999999999999999999998


Q ss_pred             cccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc----
Q 044997          425 KLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP----  500 (563)
Q Consensus       425 ~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~----  500 (563)
                      +................|+..|+|||.+.+.            ..++.++|||||||++|||++|+.||...+...    
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~------------~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~  221 (336)
T cd07849         154 RIADPEHDHTGFLTEYVATRWYRAPEIMLNS------------KGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNL  221 (336)
T ss_pred             eeccccccccCCcCCcCcCCCccChHHhhCC------------CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            8654332222222335688999999976432            234789999999999999999999985432100    


Q ss_pred             ----------hh---------------------------hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHHhh
Q 044997          501 ----------TK---------------------------MKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI--LSQIM  539 (563)
Q Consensus       501 ----------~~---------------------------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~i~  539 (563)
                                ..                           .......+.+++.+||+.||++||++.|+++.  +....
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~  299 (336)
T cd07849         222 ILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH  299 (336)
T ss_pred             HHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence                      00                           01123457899999999999999999999986  55443

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=4.9e-33  Score=275.61  Aligned_cols=221  Identities=29%  Similarity=0.475  Sum_probs=176.3

Q ss_pred             CCccceecccCcEEEEEEEECC------ceEEEEEeccCC----hHHHHHHHHHHHhccccce---------------EE
Q 044997          294 FDESRIIGRGGFGNVYFGLLGD------REAAIKKMRSNK----SKEFFAELKVLCKIHHINV---------------FI  348 (563)
Q Consensus       294 f~~~~~LG~G~fG~Vy~g~~~~------~~vavK~~~~~~----~~~f~~Ei~~l~~l~H~ni---------------V~  348 (563)
                      |+..+.||+|+||.||++...+      ..+|+|.++...    .+.+..|++++.+++|+|+               ++
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            3457889999999999998864      779999997553    4578899999999999997               56


Q ss_pred             EeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccc
Q 044997          349 STFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEE  428 (563)
Q Consensus       349 e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~  428 (563)
                      ||+++++|.+++...   ....+++.++..++.|++.||+|||+.+   ++||||||+||++++++.+||+|||+++...
T Consensus        81 e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~  154 (258)
T smart00219       81 EYMEGGDLLDYLRKN---RPKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLY  154 (258)
T ss_pred             eccCCCCHHHHHHhh---hhccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecc
Confidence            888899999998752   1122899999999999999999999987   9999999999999999999999999998654


Q ss_pred             cccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCCCcCCCCC--------
Q 044997          429 RTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIRDDSE--------  499 (563)
Q Consensus       429 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p~~~~~~~--------  499 (563)
                      .....  ......++..|+|||.+...             .++.++||||+|+++|||++ |+.|+......        
T Consensus       155 ~~~~~--~~~~~~~~~~y~~Pe~~~~~-------------~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~  219 (258)
T smart00219      155 DDDYY--KKKGGKLPIRWMAPESLKDG-------------KFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKK  219 (258)
T ss_pred             ccccc--ccccCCCcccccChHHhccC-------------CCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc
Confidence            33111  11122367899999987433             34889999999999999998 67776532211        


Q ss_pred             ---chhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 044997          500 ---PTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAIL  535 (563)
Q Consensus       500 ---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  535 (563)
                         ..........+.+++.+|+..||++|||+.|+++.|
T Consensus       220 ~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      220 GYRLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             CCCCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence               111122456689999999999999999999998764

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=4.1e-33  Score=277.90  Aligned_cols=218  Identities=26%  Similarity=0.439  Sum_probs=178.7

Q ss_pred             cCCCccceecccCcEEEEEEEEC--CceEEEEEeccCC----hHHHHHHHHHHHhccccce---------------EEEe
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNK----SKEFFAELKVLCKIHHINV---------------FIST  350 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~----~~~f~~Ei~~l~~l~H~ni---------------V~e~  350 (563)
                      ++|+..+.||+|+||.||++...  ++.+|+|.+....    .+++.+|++++++++||||               ++||
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY   80 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence            35777889999999999999885  7889999886542    3568899999999999997               5789


Q ss_pred             ecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCceEeCCCCCCCeEecCCCcEEEeecCCCccccc
Q 044997          351 FGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHD-HTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEER  429 (563)
Q Consensus       351 ~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~  429 (563)
                      +++++|.+++...    ...+++....+++.|++.||+|||+ .+   ++|+||||+||++++++.+||+|||.+.....
T Consensus        81 ~~~~~L~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~  153 (265)
T cd06605          81 MDGGSLDKILKEV----QGRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVN  153 (265)
T ss_pred             cCCCcHHHHHHHc----cCCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHH
Confidence            9999999988752    2678999999999999999999999 76   99999999999999999999999999875432


Q ss_pred             ccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCch--------
Q 044997          430 TNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPT--------  501 (563)
Q Consensus       430 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~--------  501 (563)
                      ...     ....++..|+|||.+.+.             .++.++||||||+++|||++|+.|+........        
T Consensus       154 ~~~-----~~~~~~~~y~~PE~~~~~-------------~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~  215 (265)
T cd06605         154 SLA-----KTFVGTSSYMAPERIQGN-------------DYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQY  215 (265)
T ss_pred             HHh-----hcccCChhccCHHHHcCC-------------CCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHH
Confidence            211     115688899999987544             348899999999999999999999865421110        


Q ss_pred             --------hhHH-HHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          502 --------KMKS-LITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       502 --------~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                              .... +...+.+++.+||..||++||++.+++..
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  257 (265)
T cd06605         216 IVNEPPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH  257 (265)
T ss_pred             HhcCCCCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence                    1111 45568999999999999999999999753

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=5.5e-33  Score=276.13  Aligned_cols=225  Identities=22%  Similarity=0.347  Sum_probs=179.3

Q ss_pred             CCCccceecccCcEEEEEEEE--CCceEEEEEeccCC-----hHHHHHHHHHHHhccccce-----------------EE
Q 044997          293 NFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNK-----SKEFFAELKVLCKIHHINV-----------------FI  348 (563)
Q Consensus       293 ~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~-----~~~f~~Ei~~l~~l~H~ni-----------------V~  348 (563)
                      +|+..+.||.|+||.||++..  +++.+|+|.++...     .+++..|++++++++|+|+                 ++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            477789999999999999976  46789999886432     3568889999999999997                 45


Q ss_pred             EeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCceEeCCCCCCCeEecCCCcEEEeecCCCcc
Q 044997          349 STFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHT--KARYVHRDIKTSNILLDDGLRAKVADFGLVKL  426 (563)
Q Consensus       349 e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~  426 (563)
                      ||+++++|.+++.... ....++++..++.++.|++.||.|||..+  ..+++|+||||+||++++++.+||+|||+++.
T Consensus        81 e~~~~~~L~~~l~~~~-~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~  159 (265)
T cd08217          81 EYCEGGDLAQLIQKCK-KERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI  159 (265)
T ss_pred             hhccCCCHHHHHHHHh-hcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence            7788899988886421 23467999999999999999999999332  22499999999999999999999999999986


Q ss_pred             cccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc------
Q 044997          427 EERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP------  500 (563)
Q Consensus       427 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~------  500 (563)
                      ......   ......++..|+|||.+....             ++.++||||||+++|+|++|+.|+.......      
T Consensus       160 ~~~~~~---~~~~~~~~~~~~~pE~~~~~~-------------~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~  223 (265)
T cd08217         160 LGHDSS---FAKTYVGTPYYMSPEQLNHMS-------------YDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIK  223 (265)
T ss_pred             ccCCcc---cccccccCCCccChhhhcCCC-------------CCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHh
Confidence            543321   122346889999999875433             4789999999999999999999986543111      


Q ss_pred             -----hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          501 -----TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       501 -----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                           .........+.+++.+|++.+|.+||++.+|++.
T Consensus       224 ~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         224 EGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             cCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence                 1122344668999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=7.6e-33  Score=281.31  Aligned_cols=218  Identities=24%  Similarity=0.334  Sum_probs=174.6

Q ss_pred             CCCccceecccCcEEEEEEEE--CCceEEEEEeccCC--------hHHHHHHHHHHHhccccce---------------E
Q 044997          293 NFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNK--------SKEFFAELKVLCKIHHINV---------------F  347 (563)
Q Consensus       293 ~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~--------~~~f~~Ei~~l~~l~H~ni---------------V  347 (563)
                      +|+..+.||+|+||.||+|..  .++.+|||.++...        ...+..|++++++++|+||               |
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            477788999999999999987  46899999987542        2356789999999999996               6


Q ss_pred             EEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccc
Q 044997          348 ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLE  427 (563)
Q Consensus       348 ~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~  427 (563)
                      +||+ +|+|.+++...    ...+++..+..++.|+++||.|||+++   ++|+||||+||+++.++.+||+|||+++..
T Consensus        81 ~e~~-~~~L~~~i~~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~  152 (298)
T cd07841          81 FEFM-ETDLEKVIKDK----SIVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSF  152 (298)
T ss_pred             Eccc-CCCHHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeec
Confidence            7899 89999998652    236999999999999999999999997   999999999999999999999999999865


Q ss_pred             ccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCch------
Q 044997          428 ERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPT------  501 (563)
Q Consensus       428 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~------  501 (563)
                      .....   ......++..|+|||.+.+.            ..++.++|||||||++|||++|..+|........      
T Consensus       153 ~~~~~---~~~~~~~~~~y~aPE~~~~~------------~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~  217 (298)
T cd07841         153 GSPNR---KMTHQVVTRWYRAPELLFGA------------RHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFE  217 (298)
T ss_pred             cCCCc---cccccccceeeeCHHHHhCC------------CCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHH
Confidence            43221   12223567889999987432            2347899999999999999999776643322100      


Q ss_pred             --------------------------------hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          502 --------------------------------KMKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       502 --------------------------------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                                                      ........+.+++.+||+.||.+||++.|+++
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~  281 (298)
T cd07841         218 ALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE  281 (298)
T ss_pred             HcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence                                            00122355889999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1.5e-33  Score=291.57  Aligned_cols=226  Identities=22%  Similarity=0.311  Sum_probs=176.7

Q ss_pred             cCCCccceecccCcEEEEEEEEC--CceEEEEEeccC------ChHHHHHHHHHHHhccccce---------------EE
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSN------KSKEFFAELKVLCKIHHINV---------------FI  348 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~------~~~~f~~Ei~~l~~l~H~ni---------------V~  348 (563)
                      ++|...+.||+|+||.||+++..  ++.+|+|.++..      ..+.+.+|..++.+++|+||               |+
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46888999999999999999874  578999998642      22457889999999999986               67


Q ss_pred             EeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccc
Q 044997          349 STFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEE  428 (563)
Q Consensus       349 e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~  428 (563)
                      ||+++|+|.+++...    ...+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus        81 Ey~~gg~L~~~l~~~----~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~  153 (331)
T cd05624          81 DYYVGGDLLTLLSKF----EDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMN  153 (331)
T ss_pred             eCCCCCcHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeecc
Confidence            999999999999641    346899999999999999999999987   9999999999999999999999999987654


Q ss_pred             cccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc--------
Q 044997          429 RTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP--------  500 (563)
Q Consensus       429 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~--------  500 (563)
                      ....  .......||+.|+|||++.+...        ..+.++.++|||||||++|||++|+.||.......        
T Consensus       154 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~--------~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~  223 (331)
T cd05624         154 QDGT--VQSSVAVGTPDYISPEILQAMED--------GMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH  223 (331)
T ss_pred             CCCc--eeeccccCCcccCCHHHHhcccc--------CCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcC
Confidence            3221  11223569999999998854211        11345789999999999999999999996543211        


Q ss_pred             -------hhhHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 044997          501 -------TKMKSLITIMAAVAEWCLNEDAVD--RPEMRDIVAI  534 (563)
Q Consensus       501 -------~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~  534 (563)
                             .....+.+.+.+++.+|+..++.+  |++++++++.
T Consensus       224 ~~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h  266 (331)
T cd05624         224 EERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH  266 (331)
T ss_pred             CCcccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence                   111223567889999999865544  4677777654

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-33  Score=279.22  Aligned_cols=230  Identities=27%  Similarity=0.413  Sum_probs=183.5

Q ss_pred             HHhcCCCccceecccCcEEEEEEEEC--CceEEEEEeccCC--hHHHHHHHHHHHhc-cccce-----------------
Q 044997          289 EATNNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNK--SKEFFAELKVLCKI-HHINV-----------------  346 (563)
Q Consensus       289 ~~~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~--~~~f~~Ei~~l~~l-~H~ni-----------------  346 (563)
                      .++++|+..+.||+|+||.||+|...  ++.+++|.+....  .+++.+|+++++++ +|+||                 
T Consensus         3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (275)
T cd06608           3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD   82 (275)
T ss_pred             CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence            35688999999999999999999884  5789999987543  46789999999999 69875                 


Q ss_pred             ----EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecC
Q 044997          347 ----FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFG  422 (563)
Q Consensus       347 ----V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFG  422 (563)
                          |+||+++++|.+++.... .....+++..+..++.|++.||.|||+++   ++|+||+|+||++++++.+||+|||
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~  158 (275)
T cd06608          83 QLWLVMELCGGGSVTDLVKGLR-KKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFG  158 (275)
T ss_pred             EEEEEEEcCCCCcHHHHHHHHh-hcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCc
Confidence                568888889888876421 12357899999999999999999999987   9999999999999999999999999


Q ss_pred             CCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc--
Q 044997          423 LVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP--  500 (563)
Q Consensus       423 la~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~--  500 (563)
                      ++........   ......|+..|+|||.+.....        ....++.++||||||+++|||++|+.||.......  
T Consensus       159 ~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~--------~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~  227 (275)
T cd06608         159 VSAQLDSTLG---RRNTFIGTPYWMAPEVIACDEQ--------PDASYDARSDVWSLGITAIELADGKPPLCDMHPMRAL  227 (275)
T ss_pred             cceecccchh---hhcCccccccccCHhHhccccc--------ccCCccccccHHHhHHHHHHHHhCCCCccccchHHHH
Confidence            9875432211   1223458889999998754332        23456789999999999999999999986432211  


Q ss_pred             -----------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          501 -----------TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       501 -----------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                                 .....+...+.+++.+||..||.+|||+.|+++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         228 FKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             HHhhccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence                       011224457899999999999999999999986

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.2e-34  Score=293.29  Aligned_cols=211  Identities=24%  Similarity=0.325  Sum_probs=165.9

Q ss_pred             ecccCcEEEEEEEEC--CceEEEEEeccCC------hHHHHHHHHHHHhc---cccce---------------EEEeecC
Q 044997          300 IGRGGFGNVYFGLLG--DREAAIKKMRSNK------SKEFFAELKVLCKI---HHINV---------------FISTFGN  353 (563)
Q Consensus       300 LG~G~fG~Vy~g~~~--~~~vavK~~~~~~------~~~f~~Ei~~l~~l---~H~ni---------------V~e~~~~  353 (563)
                      ||+|+||.||+|+..  ++.+|||.+....      ...+..|.+++.+.   +||||               |+||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            699999999999874  7889999986431      23455677777665   68886               5799999


Q ss_pred             CCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccccccccc
Q 044997          354 GSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEK  433 (563)
Q Consensus       354 gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~  433 (563)
                      |+|.+++..     ...+++..+..++.|++.||+|||+++   |+||||||+|||+++++.+||+|||+++......  
T Consensus        81 g~L~~~l~~-----~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--  150 (330)
T cd05586          81 GELFWHLQK-----EGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDN--  150 (330)
T ss_pred             ChHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--
Confidence            999888864     356899999999999999999999997   9999999999999999999999999987532221  


Q ss_pred             ccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCchh-----------
Q 044997          434 EMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTK-----------  502 (563)
Q Consensus       434 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~~-----------  502 (563)
                       .......||..|+|||++.+..            .++.++|||||||++|||++|+.||.........           
T Consensus       151 -~~~~~~~gt~~y~aPE~~~~~~------------~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~  217 (330)
T cd05586         151 -KTTNTFCGTTEYLAPEVLLDEK------------GYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFP  217 (330)
T ss_pred             -CCccCccCCccccCHHHHcCCC------------CCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence             1123456999999999875432            2478999999999999999999999764422110           


Q ss_pred             hHHHHHHHHHHHHHhhccCCCCCCC----HHHHHH
Q 044997          503 MKSLITIMAAVAEWCLNEDAVDRPE----MRDIVA  533 (563)
Q Consensus       503 ~~~~~~~l~~li~~cl~~dP~~RPs----~~evl~  533 (563)
                      ...+.+.+.+++.+||+.||.+||+    +.++++
T Consensus       218 ~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         218 KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence            0123566889999999999999985    555544

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=3.9e-33  Score=277.31  Aligned_cols=215  Identities=25%  Similarity=0.386  Sum_probs=178.7

Q ss_pred             CCCccceecccCcEEEEEEEEC--CceEEEEEeccC------ChHHHHHHHHHHHhccccce---------------EEE
Q 044997          293 NFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSN------KSKEFFAELKVLCKIHHINV---------------FIS  349 (563)
Q Consensus       293 ~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~------~~~~f~~Ei~~l~~l~H~ni---------------V~e  349 (563)
                      +|+..+.||+|+||.||++...  +..+|+|.+...      ..+.+.+|++++++++||||               |+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            4788899999999999999885  788999998643      24678999999999999997               579


Q ss_pred             eecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccccc
Q 044997          350 TFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEER  429 (563)
Q Consensus       350 ~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~  429 (563)
                      |+.+++|.+++..     ..++++..+..++.|+++||.|||+++   ++|+||||+||++++++.++|+|||++.....
T Consensus        81 ~~~~~~L~~~l~~-----~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~  152 (258)
T cd05578          81 LLLGGDLRYHLSQ-----KVKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTP  152 (258)
T ss_pred             CCCCCCHHHHHHh-----cCCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCC
Confidence            9999999998864     247899999999999999999999987   99999999999999999999999999876433


Q ss_pred             ccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCC----------
Q 044997          430 TNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE----------  499 (563)
Q Consensus       430 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~----------  499 (563)
                      ..    ......|+..|+|||.+....             .+.++|+||||+++|+|++|+.|+......          
T Consensus       153 ~~----~~~~~~~~~~y~~PE~~~~~~-------------~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~  215 (258)
T cd05578         153 DT----LTTSTSGTPGYMAPEVLCRQG-------------YSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQE  215 (258)
T ss_pred             Cc----cccccCCChhhcCHHHHcccC-------------CCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhc
Confidence            21    122345788999999875433             488999999999999999999998765431          


Q ss_pred             ---chhhHHHHHHHHHHHHHhhccCCCCCCCH--HHHH
Q 044997          500 ---PTKMKSLITIMAAVAEWCLNEDAVDRPEM--RDIV  532 (563)
Q Consensus       500 ---~~~~~~~~~~l~~li~~cl~~dP~~RPs~--~evl  532 (563)
                         ......++..+.+++.+||+.||.+||++  +|++
T Consensus       216 ~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         216 TADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             cccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence               11122345679999999999999999999  5554

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=1.1e-32  Score=277.94  Aligned_cols=220  Identities=24%  Similarity=0.342  Sum_probs=177.3

Q ss_pred             CCCccceecccCcEEEEEEEE--CCceEEEEEeccCC-----hHHHHHHHHHHHhccccce---------------EEEe
Q 044997          293 NFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNK-----SKEFFAELKVLCKIHHINV---------------FIST  350 (563)
Q Consensus       293 ~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~-----~~~f~~Ei~~l~~l~H~ni---------------V~e~  350 (563)
                      +|+..+.||+|+||.||+|..  .++.+|+|++....     .+.+.+|++++++++|+|+               |+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            477889999999999999987  47889999987443     3578999999999999997               5788


Q ss_pred             ecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccccc
Q 044997          351 FGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERT  430 (563)
Q Consensus       351 ~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~  430 (563)
                      + +++|.+++...    ..++++.++..++.|+++||+|||+++   ++|+||||+||++++++.++|+|||+++.....
T Consensus        81 ~-~~~L~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~  152 (286)
T cd07832          81 M-PSDLSEVLRDE----ERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEE  152 (286)
T ss_pred             c-CCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCC
Confidence            8 89999888642    366999999999999999999999987   999999999999999999999999998865433


Q ss_pred             cccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc----------
Q 044997          431 NEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP----------  500 (563)
Q Consensus       431 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~----------  500 (563)
                      ..  .......|+..|+|||.+.+..            .++.++||||+|+++|||++|+.+|.......          
T Consensus       153 ~~--~~~~~~~~~~~y~aPE~~~~~~------------~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~  218 (286)
T cd07832         153 EP--RLYSHQVATRWYRAPELLYGAR------------KYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLG  218 (286)
T ss_pred             CC--CccccccCcccccCceeeeccc------------cCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcC
Confidence            21  1122346889999999874322            34789999999999999999977664332100          


Q ss_pred             ------------------------------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          501 ------------------------------TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       501 ------------------------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                                                    .........+.+++.+|++.||.+||++++++..
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h  282 (286)
T cd07832         219 TPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH  282 (286)
T ss_pred             CCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence                                          0001234668899999999999999999999863

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.1e-32  Score=273.39  Aligned_cols=217  Identities=28%  Similarity=0.429  Sum_probs=177.2

Q ss_pred             CCCccceecccCcEEEEEEEEC--CceEEEEEeccC--------ChHHHHHHHHHHHhccccce---------------E
Q 044997          293 NFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSN--------KSKEFFAELKVLCKIHHINV---------------F  347 (563)
Q Consensus       293 ~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~--------~~~~f~~Ei~~l~~l~H~ni---------------V  347 (563)
                      +|+..+.||+|+||.||+|...  ++.+++|.+...        ..+.+.+|++++++++|+|+               +
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            4677899999999999999874  788999987542        23568899999999999996               5


Q ss_pred             EEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccc
Q 044997          348 ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLE  427 (563)
Q Consensus       348 ~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~  427 (563)
                      +||+++++|.+++..     ...+++..+..++.|++.||+|||+.+   ++|+||+|+||+++.++.+||+|||++...
T Consensus        81 ~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~  152 (258)
T cd06632          81 LELVPGGSLAKLLKK-----YGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQV  152 (258)
T ss_pred             EEecCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceec
Confidence            789999999998864     245899999999999999999999987   999999999999999999999999998764


Q ss_pred             ccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc-------
Q 044997          428 ERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP-------  500 (563)
Q Consensus       428 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~-------  500 (563)
                      ....    ......|+..|+|||.+....            .++.++|+||||+++|||++|+.||.......       
T Consensus       153 ~~~~----~~~~~~~~~~y~~pe~~~~~~------------~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~  216 (258)
T cd06632         153 VEFS----FAKSFKGSPYWMAPEVIAQQG------------GYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGR  216 (258)
T ss_pred             cccc----cccccCCCcceeCHHHhcCCC------------CCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHh
Confidence            3322    123356888999999874322            25889999999999999999999985543211       


Q ss_pred             -----hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          501 -----TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       501 -----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                           .....+...+.+++.+||+.+|.+||++.+++.
T Consensus       217 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         217 SKELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             cccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence                 111223456889999999999999999999985

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.4e-33  Score=283.29  Aligned_cols=223  Identities=22%  Similarity=0.331  Sum_probs=178.4

Q ss_pred             cCCCccceecccCcEEEEEEEEC--CceEEEEEeccCC------hHHHHHHHHHHHhccccce---------------EE
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNK------SKEFFAELKVLCKIHHINV---------------FI  348 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~------~~~f~~Ei~~l~~l~H~ni---------------V~  348 (563)
                      ++|+..+.||+|+||.||++...  ++.+|+|.+....      .+.+.+|++++.+++|+||               |+
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            46888999999999999999874  6889999987542      2468899999999999997               57


Q ss_pred             EeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccc
Q 044997          349 STFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEE  428 (563)
Q Consensus       349 e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~  428 (563)
                      ||+.+++|.+++...   ....+++..+..++.|++.||+|||+.+   ++|+||||+||+++.++.++|+|||++....
T Consensus        81 e~~~~~~L~~~~~~~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~  154 (316)
T cd05574          81 DYCPGGELFRLLQRQ---PGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSD  154 (316)
T ss_pred             EecCCCCHHHHHHhC---CCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccc
Confidence            899999999988642   2356899999999999999999999987   9999999999999999999999999987543


Q ss_pred             ccccc--------------------------ccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHH
Q 044997          429 RTNEK--------------------------EMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVV  482 (563)
Q Consensus       429 ~~~~~--------------------------~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvv  482 (563)
                      .....                          ........|+..|+|||++.+..             ++.++||||||++
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-------------~~~~~Di~slG~l  221 (316)
T cd05574         155 VEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDG-------------HGSAVDWWTLGIL  221 (316)
T ss_pred             ccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCC-------------CCchHHHHHHHHH
Confidence            21110                          00112346889999999875433             4889999999999


Q ss_pred             HHHHHcCCCCCcCCCCCchh------------hHHHHHHHHHHHHHhhccCCCCCCC----HHHHHH
Q 044997          483 LAELITGKRALIRDDSEPTK------------MKSLITIMAAVAEWCLNEDAVDRPE----MRDIVA  533 (563)
Q Consensus       483 l~Elltg~~p~~~~~~~~~~------------~~~~~~~l~~li~~cl~~dP~~RPs----~~evl~  533 (563)
                      +|||++|+.||...+.....            .......+.+++.+||+.||++||+    +.|++.
T Consensus       222 l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         222 LYEMLYGTTPFKGSNRDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             HHHHhhCCCCCCCCchHHHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence            99999999998654322111            1124567999999999999999999    555554

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=1e-32  Score=280.58  Aligned_cols=223  Identities=19%  Similarity=0.205  Sum_probs=160.8

Q ss_pred             cCCCccceecccCcEEEEEEEECC-----ceEEEEEeccCCh--------------HHHHHHHHHHHhccccceEEEeec
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLGD-----REAAIKKMRSNKS--------------KEFFAELKVLCKIHHINVFISTFG  352 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~~-----~~vavK~~~~~~~--------------~~f~~Ei~~l~~l~H~niV~e~~~  352 (563)
                      ++|...++||+|+||.||+|...+     ..+|+|.......              .....+...+..++|+|++..+-.
T Consensus        12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~   91 (294)
T PHA02882         12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC   91 (294)
T ss_pred             CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence            578899999999999999998753     3556665332211              112233345566789887543321


Q ss_pred             C------------------CCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCC
Q 044997          353 N------------------GSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGL  414 (563)
Q Consensus       353 ~------------------gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~  414 (563)
                      +                  .++.+.+.     .....++..+..|+.|++.||+|||+.+   ++||||||+|||++.++
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~  163 (294)
T PHA02882         92 GSFKRCRMYYRFILLEKLVENTKEIFK-----RIKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNN  163 (294)
T ss_pred             eeEecCCceEEEEEEehhccCHHHHHH-----hhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCC
Confidence            1                  11111111     1234578888999999999999999987   99999999999999999


Q ss_pred             cEEEeecCCCccccccccc----ccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCC
Q 044997          415 RAKVADFGLVKLEERTNEK----EMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK  490 (563)
Q Consensus       415 ~~kl~DFGla~~~~~~~~~----~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~  490 (563)
                      .+||+|||+++........    ........||+.|+|||++.+..             ++.++|||||||++|||++|+
T Consensus       164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~-------------~~~~~DiwSlG~~l~el~~g~  230 (294)
T PHA02882        164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGAC-------------VTRRGDLESLGYCMLKWAGIK  230 (294)
T ss_pred             cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCC-------------CCcHHHHHHHHHHHHHHHhCC
Confidence            9999999999865322111    01112246999999999875444             489999999999999999999


Q ss_pred             CCCcCCCCCchh------------------hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 044997          491 RALIRDDSEPTK------------------MKSLITIMAAVAEWCLNEDAVDRPEMRDIVAIL  535 (563)
Q Consensus       491 ~p~~~~~~~~~~------------------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  535 (563)
                      .||.........                  .......+.+++..||+.+|++||++.++.+.|
T Consensus       231 ~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~  293 (294)
T PHA02882        231 LPWKGFGHNGNLIHAAKCDFIKRLHEGKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF  293 (294)
T ss_pred             CCCCccccchHHHHHhHHHHHHHhhhhhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence            999765322110                  112245588999999999999999999999876

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=4.6e-33  Score=283.44  Aligned_cols=214  Identities=23%  Similarity=0.413  Sum_probs=174.4

Q ss_pred             ccceecccCcEEEEEEEE--CCceEEEEEeccC---ChHHHHHHHHHHHhccccce---------------EEEeecCCC
Q 044997          296 ESRIIGRGGFGNVYFGLL--GDREAAIKKMRSN---KSKEFFAELKVLCKIHHINV---------------FISTFGNGS  355 (563)
Q Consensus       296 ~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~---~~~~f~~Ei~~l~~l~H~ni---------------V~e~~~~gs  355 (563)
                      ....||+|+||.||++..  +++.+|+|.++..   ..+.+.+|+.++.+++|||+               |+||+++++
T Consensus        25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~  104 (297)
T cd06659          25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA  104 (297)
T ss_pred             hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCC
Confidence            345799999999999976  4789999998643   24568899999999999997               579999999


Q ss_pred             cccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccccccccccc
Q 044997          356 LSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEM  435 (563)
Q Consensus       356 L~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~  435 (563)
                      |..++..      ..+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||+++.......   
T Consensus       105 L~~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~---  172 (297)
T cd06659         105 LTDIVSQ------TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP---  172 (297)
T ss_pred             HHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcccccc---
Confidence            9887643      45899999999999999999999987   99999999999999999999999999875432211   


Q ss_pred             ccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc-------------hh
Q 044997          436 LATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP-------------TK  502 (563)
Q Consensus       436 ~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~-------------~~  502 (563)
                      ......|+..|+|||++.+..             ++.++||||||+++|||++|+.||.......             ..
T Consensus       173 ~~~~~~~~~~y~aPE~~~~~~-------------~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  239 (297)
T cd06659         173 KRKSLVGTPYWMAPEVISRTP-------------YGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKN  239 (297)
T ss_pred             cccceecCccccCHHHHccCC-------------CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccc
Confidence            122356889999999885443             4789999999999999999999986443211             01


Q ss_pred             hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          503 MKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       503 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                      .......+.+++.+||+.+|.+||++.++++.
T Consensus       240 ~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         240 AHKISPVLRDFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             cCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            11234568899999999999999999999984

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.1e-32  Score=276.31  Aligned_cols=222  Identities=22%  Similarity=0.430  Sum_probs=177.2

Q ss_pred             CCCccceecccCcEEEEEEEE--CCceEEEEEeccCC-------------hHHHHHHHHHHHhccccce-----------
Q 044997          293 NFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNK-------------SKEFFAELKVLCKIHHINV-----------  346 (563)
Q Consensus       293 ~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~-------------~~~f~~Ei~~l~~l~H~ni-----------  346 (563)
                      +|...+.||+|+||.||+|..  +++.+|+|.++...             .+.+.+|++++++++|+|+           
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            467788999999999999976  47889999875311             1357789999999999996           


Q ss_pred             ----EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecC
Q 044997          347 ----FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFG  422 (563)
Q Consensus       347 ----V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFG  422 (563)
                          |+||+.+|+|.+++..     ...+++..+..++.|++.||.|||+++   ++||||||+||++++++.+||+|||
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~  153 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRT-----YGRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFG  153 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhh-----ccCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecc
Confidence                5789999999998865     256899999999999999999999987   9999999999999999999999999


Q ss_pred             CCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc--
Q 044997          423 LVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP--  500 (563)
Q Consensus       423 la~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~--  500 (563)
                      +++........ .......|+..|+|||.+....           ..++.++||||||+++||+++|+.|+...+...  
T Consensus       154 ~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~-----------~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~  221 (272)
T cd06629         154 ISKKSDDIYDN-DQNMSMQGSVFWMAPEVIHSYS-----------QGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAM  221 (272)
T ss_pred             ccccccccccc-cccccccCCccccCHHHhcccc-----------CCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHH
Confidence            98754322111 1123346889999999875332           135889999999999999999999985432210  


Q ss_pred             --------------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          501 --------------TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       501 --------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                                    .....+...+.+++.+||+.||.+||++.+|++.
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (272)
T cd06629         222 FKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH  269 (272)
T ss_pred             HHhhccccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence                          0011235678999999999999999999999863

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.9e-33  Score=277.09  Aligned_cols=222  Identities=23%  Similarity=0.292  Sum_probs=182.3

Q ss_pred             CCCccceecccCcEEEEEEEECC--ceEEEEEeccCC------hHHHHHHHHHHHhccccce---------------EEE
Q 044997          293 NFDESRIIGRGGFGNVYFGLLGD--REAAIKKMRSNK------SKEFFAELKVLCKIHHINV---------------FIS  349 (563)
Q Consensus       293 ~f~~~~~LG~G~fG~Vy~g~~~~--~~vavK~~~~~~------~~~f~~Ei~~l~~l~H~ni---------------V~e  349 (563)
                      .|+..+.||+|.-|+||++++++  ...|+|+|.+..      ..+...|-+||+.++||-+               +||
T Consensus        78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~me  157 (459)
T KOG0610|consen   78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVME  157 (459)
T ss_pred             HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEe
Confidence            45667899999999999999976  678999997643      3456779999999999986               799


Q ss_pred             eecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccccc
Q 044997          350 TFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEER  429 (563)
Q Consensus       350 ~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~  429 (563)
                      ||++|+|...++.   ...+.++...+..++.+|+-||+|||-.|   ||.|||||+||||.++|++.|+||.|+.....
T Consensus       158 yCpGGdL~~Lrqk---Qp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~  231 (459)
T KOG0610|consen  158 YCPGGDLHSLRQK---QPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPV  231 (459)
T ss_pred             cCCCccHHHHHhh---CCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence            9999999888875   34577999999999999999999999998   99999999999999999999999998743210


Q ss_pred             ---------------------------------cccc--------------------ccccccccCCCcccCcccccccc
Q 044997          430 ---------------------------------TNEK--------------------EMLATRLVGTPGYLPPEYIFVKR  456 (563)
Q Consensus       430 ---------------------------------~~~~--------------------~~~~~~~~gt~~y~APE~l~~~~  456 (563)
                                                       ....                    .......+||-.|+|||++.+..
T Consensus       232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G  311 (459)
T KOG0610|consen  232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG  311 (459)
T ss_pred             CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence                                             0000                    01112368999999999998877


Q ss_pred             cccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCchhh------------HHHHHHHHHHHHHhhccCCCC
Q 044997          457 FRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKM------------KSLITIMAAVAEWCLNEDAVD  524 (563)
Q Consensus       457 ~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~~~------------~~~~~~l~~li~~cl~~dP~~  524 (563)
                      +             +.++|+|+|||++|||+.|+.||.+.+.+.+..            ......+++||++.|.+||.+
T Consensus       312 H-------------gsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~k  378 (459)
T KOG0610|consen  312 H-------------GSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSK  378 (459)
T ss_pred             C-------------CchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhh
Confidence            6             789999999999999999999998876543321            144566899999999999999


Q ss_pred             CCC----HHHHHH
Q 044997          525 RPE----MRDIVA  533 (563)
Q Consensus       525 RPs----~~evl~  533 (563)
                      |-.    +.||-+
T Consensus       379 Rlg~~rGA~eIK~  391 (459)
T KOG0610|consen  379 RLGSKRGAAEIKR  391 (459)
T ss_pred             hhccccchHHhhc
Confidence            987    666554

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-35  Score=272.20  Aligned_cols=218  Identities=23%  Similarity=0.369  Sum_probs=180.1

Q ss_pred             hcCCCccceecccCcEEEEEEEE--CCceEEEEEe-----ccCChHHHHHHHHHHHhccccce---------------EE
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLL--GDREAAIKKM-----RSNKSKEFFAELKVLCKIHHINV---------------FI  348 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~-----~~~~~~~f~~Ei~~l~~l~H~ni---------------V~  348 (563)
                      .++|+..+.||+|.|+.||+...  .|++.|+|.+     .....+++.+|+.+-+.++||||               |.
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF   89 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   89 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence            45677788999999999999866  4677776654     44566888999999999999998               46


Q ss_pred             EeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecC---CCcEEEeecCCCc
Q 044997          349 STFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDD---GLRAKVADFGLVK  425 (563)
Q Consensus       349 e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~---~~~~kl~DFGla~  425 (563)
                      |+|.+|+|..-+-.+     ...++...-..++||+++|.|+|.++   |||||+||+|+|+.+   .--+||+|||+|.
T Consensus        90 e~m~G~dl~~eIV~R-----~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi  161 (355)
T KOG0033|consen   90 DLVTGGELFEDIVAR-----EFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAI  161 (355)
T ss_pred             ecccchHHHHHHHHH-----HHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEE
Confidence            889999987666542     34677788899999999999999998   999999999999954   3468999999998


Q ss_pred             ccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCC-------
Q 044997          426 LEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDS-------  498 (563)
Q Consensus       426 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~-------  498 (563)
                      ....    .......+||++|||||++...+|             +..+|||+-||+||-|+.|..||.+++.       
T Consensus       162 ~l~~----g~~~~G~~GtP~fmaPEvvrkdpy-------------~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I  224 (355)
T KOG0033|consen  162 EVND----GEAWHGFAGTPGYLSPEVLKKDPY-------------SKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQI  224 (355)
T ss_pred             EeCC----ccccccccCCCcccCHHHhhcCCC-------------CCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHH
Confidence            7652    123455789999999999977665             8899999999999999999999987432       


Q ss_pred             -------CchhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          499 -------EPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       499 -------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                             ....+..+.+..++|+++||..||.+|.|+.|.+.
T Consensus       225 ~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~  266 (355)
T KOG0033|consen  225 KAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK  266 (355)
T ss_pred             hccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence                   22345566778999999999999999999998775

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=9.2e-33  Score=280.15  Aligned_cols=223  Identities=21%  Similarity=0.286  Sum_probs=172.9

Q ss_pred             cCCCccceecccCcEEEEEEEE--CCceEEEEEeccCC-----hHHHHHHHHHHHhcc-ccce-----------------
Q 044997          292 NNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNK-----SKEFFAELKVLCKIH-HINV-----------------  346 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~-----~~~f~~Ei~~l~~l~-H~ni-----------------  346 (563)
                      ++|+..+.||+|+||.||+|..  +++.||+|.++...     .+.+.+|++++++++ |+||                 
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            4688899999999999999987  46889999876432     356888999999995 5776                 


Q ss_pred             ---EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecC-CCcEEEeecC
Q 044997          347 ---FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDD-GLRAKVADFG  422 (563)
Q Consensus       347 ---V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~-~~~~kl~DFG  422 (563)
                         |+||++ |+|.+++..........+++..+..++.|+++||.|||+++   ++||||||+||+++. ++.+||+|||
T Consensus        81 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLD-SDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccC-cCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence               346665 47777775432122356899999999999999999999987   999999999999998 8999999999


Q ss_pred             CCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCch-
Q 044997          423 LVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPT-  501 (563)
Q Consensus       423 la~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~-  501 (563)
                      +++.......   ......+++.|+|||++.+.            ..++.++||||||+++|||++|+.||........ 
T Consensus       157 ~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~------------~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~  221 (295)
T cd07837         157 LGRAFSIPVK---SYTHEIVTLWYRAPEVLLGS------------THYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQL  221 (295)
T ss_pred             cceecCCCcc---ccCCcccccCCCChHHhhCC------------CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHH
Confidence            9875432211   11223567889999987432            2347899999999999999999998864321100 


Q ss_pred             ---------------------------------h----hHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          502 ---------------------------------K----MKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       502 ---------------------------------~----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                                                       .    ...+...+.+++.+||+.||.+||++.|++.
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         222 LHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             HHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence                                             0    0123456889999999999999999999875

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=6.5e-33  Score=288.30  Aligned_cols=218  Identities=25%  Similarity=0.383  Sum_probs=186.3

Q ss_pred             HhcCCCccceecccCcEEEEEEEEC--CceEEEEEeccCCh------HHHHHHHHHHHhcc-ccce--------------
Q 044997          290 ATNNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNKS------KEFFAELKVLCKIH-HINV--------------  346 (563)
Q Consensus       290 ~~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~------~~f~~Ei~~l~~l~-H~ni--------------  346 (563)
                      ....|+..+.||+|.||.||+++.+  ++.+|+|.+++...      +...+|+.+|+++. ||||              
T Consensus        33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~  112 (382)
T KOG0032|consen   33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY  112 (382)
T ss_pred             ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence            3456888899999999999999874  78899999875432      57899999999999 9997              


Q ss_pred             -EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCC----CcEEEeec
Q 044997          347 -FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDG----LRAKVADF  421 (563)
Q Consensus       347 -V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~----~~~kl~DF  421 (563)
                       |+|++.+|.|.+.+...      .+++.....++.|++.+++|||+.+   ++||||||+|+|+...    +.+|++||
T Consensus       113 lvmEL~~GGeLfd~i~~~------~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DF  183 (382)
T KOG0032|consen  113 LVMELCEGGELFDRIVKK------HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDF  183 (382)
T ss_pred             EEEEecCCchHHHHHHHc------cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeC
Confidence             57999999999998763      2899999999999999999999988   9999999999999643    58999999


Q ss_pred             CCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCC--
Q 044997          422 GLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE--  499 (563)
Q Consensus       422 Gla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~--  499 (563)
                      |+++....    .......+||+.|+|||++....|             +..+||||+||++|.|++|..||......  
T Consensus       184 Gla~~~~~----~~~~~~~~Gtp~y~APEvl~~~~y-------------~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~  246 (382)
T KOG0032|consen  184 GLAKFIKP----GERLHTIVGTPEYVAPEVLGGRPY-------------GDEVDVWSIGVILYILLSGVPPFWGETEFEI  246 (382)
T ss_pred             CCceEccC----CceEeeecCCccccCchhhcCCCC-------------CcccchhHHHHHHHHHhhCCCCCcCCChhHH
Confidence            99997654    123455789999999999865544             89999999999999999999999876532  


Q ss_pred             ------------chhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          500 ------------PTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       500 ------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                                  ...+..+.+.+.+++..++..||.+|+++.++++
T Consensus       247 ~~~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~  292 (382)
T KOG0032|consen  247 FLAILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ  292 (382)
T ss_pred             HHHHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence                        2234456677999999999999999999999998

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=1.6e-32  Score=280.68  Aligned_cols=218  Identities=32%  Similarity=0.477  Sum_probs=173.5

Q ss_pred             cCCCccceecccCcEEEEEEEE--CCceEEEEEeccCC------hHHHHHHHHHHHhccccceE---------------E
Q 044997          292 NNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNK------SKEFFAELKVLCKIHHINVF---------------I  348 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~------~~~f~~Ei~~l~~l~H~niV---------------~  348 (563)
                      +.|+..+.||+|+||.||+|..  .++.||+|.+....      .+++.+|++++++++|||++               +
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            4577889999999999999987  47889999885321      24688999999999999973               3


Q ss_pred             EeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccc
Q 044997          349 STFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEE  428 (563)
Q Consensus       349 e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~  428 (563)
                      ||+. |++.+++..    ....+++..+..++.|++.||.|||+.+   ++||||+|+||++++++.+||+|||+++...
T Consensus        95 e~~~-g~l~~~~~~----~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~  166 (307)
T cd06607          95 EYCL-GSASDILEV----HKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVS  166 (307)
T ss_pred             HhhC-CCHHHHHHH----cccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecC
Confidence            5554 566555542    2346899999999999999999999987   9999999999999999999999999987543


Q ss_pred             cccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCC---------
Q 044997          429 RTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE---------  499 (563)
Q Consensus       429 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~---------  499 (563)
                      ..       ....++..|+|||++...          ....++.++||||||+++|||++|+.|+...+..         
T Consensus       167 ~~-------~~~~~~~~y~aPE~~~~~----------~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~  229 (307)
T cd06607         167 PA-------NSFVGTPYWMAPEVILAM----------DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN  229 (307)
T ss_pred             CC-------CCccCCccccCceeeecc----------CCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcC
Confidence            21       224578899999987421          1234688999999999999999999998643311         


Q ss_pred             ---chhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          500 ---PTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       500 ---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                         ......+...+.+++.+||+.||++||++.+|+..
T Consensus       230 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  267 (307)
T cd06607         230 DSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH  267 (307)
T ss_pred             CCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence               11122355678999999999999999999999874

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-32  Score=278.37  Aligned_cols=220  Identities=25%  Similarity=0.332  Sum_probs=176.0

Q ss_pred             cCCCccceecccCcEEEEEEEEC--CceEEEEEeccC-----ChHHHHHHHHHHHhccccce---------------EEE
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSN-----KSKEFFAELKVLCKIHHINV---------------FIS  349 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~-----~~~~f~~Ei~~l~~l~H~ni---------------V~e  349 (563)
                      ++|+..+.||+|+||.||+|...  ++.+|+|.++..     ..+.+.+|++++++++|+||               ++|
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            36888999999999999999884  678999988643     23678899999999999997               568


Q ss_pred             eecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccccc
Q 044997          350 TFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEER  429 (563)
Q Consensus       350 ~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~  429 (563)
                      |++++.+..+...     ...+++.++..++.|++.||.|||+.+   ++||||+|+||++++++.+||+|||+++....
T Consensus        81 ~~~~~~l~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~  152 (288)
T cd07833          81 YVERTLLELLEAS-----PGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRA  152 (288)
T ss_pred             cCCCCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCC
Confidence            8887766655432     345899999999999999999999987   99999999999999999999999999886544


Q ss_pred             ccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCch--------
Q 044997          430 TNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPT--------  501 (563)
Q Consensus       430 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~--------  501 (563)
                      ...  .......++..|+|||++....            .++.++||||||+++|||++|+.||........        
T Consensus       153 ~~~--~~~~~~~~~~~~~~PE~~~~~~------------~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~  218 (288)
T cd07833         153 RPA--SPLTDYVATRWYRAPELLVGDT------------NYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCL  218 (288)
T ss_pred             Ccc--ccccCcccccCCcCCchhcCCC------------CcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence            322  1223356788999999885441            347899999999999999999988754321000        


Q ss_pred             ----------------------------------hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          502 ----------------------------------KMKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       502 ----------------------------------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                                                        ....+...+.+++++||+.+|++||+++++++
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         219 GPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             CCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence                                              00112466899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-32  Score=281.59  Aligned_cols=225  Identities=23%  Similarity=0.311  Sum_probs=173.0

Q ss_pred             CCCccceecccCcEEEEEEEE----CCceEEEEEeccCC------hHHHHHHHHHHHhccccce----------------
Q 044997          293 NFDESRIIGRGGFGNVYFGLL----GDREAAIKKMRSNK------SKEFFAELKVLCKIHHINV----------------  346 (563)
Q Consensus       293 ~f~~~~~LG~G~fG~Vy~g~~----~~~~vavK~~~~~~------~~~f~~Ei~~l~~l~H~ni----------------  346 (563)
                      +|+..+.||+|+||.||+|..    .++.+|+|.+....      .+.+.+|++++++++||||                
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            477788999999999999987    45889999987632      3667889999999999997                


Q ss_pred             -EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecC----CCcEEEeec
Q 044997          347 -FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDD----GLRAKVADF  421 (563)
Q Consensus       347 -V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~----~~~~kl~DF  421 (563)
                       |+||+++ +|.+++..........+++..+..++.|++.||.|||+.+   ++||||||+||+++.    ++.+||+||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence             3566553 5555554322222347899999999999999999999987   999999999999999    999999999


Q ss_pred             CCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc-
Q 044997          422 GLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP-  500 (563)
Q Consensus       422 Gla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~-  500 (563)
                      |+++................++..|+|||.+.+..            .++.++||||||+++|||++|+.||....... 
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~------------~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~  224 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGAR------------HYTKAIDIWAIGCIFAELLTLEPIFKGREAKIK  224 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCHHHHhCCC------------CCCcHHHHHHHHHHHHHHHhcCCCCcCCccccc
Confidence            99986543322111223356788999999874422            34789999999999999999999986443221 


Q ss_pred             ------------------------------------------------hhhH-------HHHHHHHHHHHHhhccCCCCC
Q 044997          501 ------------------------------------------------TKMK-------SLITIMAAVAEWCLNEDAVDR  525 (563)
Q Consensus       501 ------------------------------------------------~~~~-------~~~~~l~~li~~cl~~dP~~R  525 (563)
                                                                      ....       .....+.+++.+||+.||++|
T Consensus       225 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R  304 (316)
T cd07842         225 KSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKR  304 (316)
T ss_pred             ccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccC
Confidence                                                            0000       112347789999999999999


Q ss_pred             CCHHHHHH
Q 044997          526 PEMRDIVA  533 (563)
Q Consensus       526 Ps~~evl~  533 (563)
                      ||+.|+++
T Consensus       305 ps~~eil~  312 (316)
T cd07842         305 ITAEEALE  312 (316)
T ss_pred             cCHHHHhc
Confidence            99999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=6.9e-33  Score=277.24  Aligned_cols=223  Identities=24%  Similarity=0.386  Sum_probs=177.2

Q ss_pred             CCCccceecccCcEEEEEEEEC---CceEEEEEeccC-------------ChHHHHHHHHHHHh-ccccce---------
Q 044997          293 NFDESRIIGRGGFGNVYFGLLG---DREAAIKKMRSN-------------KSKEFFAELKVLCK-IHHINV---------  346 (563)
Q Consensus       293 ~f~~~~~LG~G~fG~Vy~g~~~---~~~vavK~~~~~-------------~~~~f~~Ei~~l~~-l~H~ni---------  346 (563)
                      +|+..+.||+|+||.||+|...   ++.+|+|.+...             ...++.+|+.++.+ ++|+||         
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            4777889999999999999884   477999987522             12457788888865 799997         


Q ss_pred             ------EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCceEeCCCCCCCeEecCCCcEEEe
Q 044997          347 ------FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHD-HTKARYVHRDIKTSNILLDDGLRAKVA  419 (563)
Q Consensus       347 ------V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDLk~~NILl~~~~~~kl~  419 (563)
                            ++||+++++|.+++.... .....+++..++.++.|++.||.|||+ .+   ++|+||||+||++++++.+||+
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~  156 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLK-EKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTIT  156 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHH-hccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEe
Confidence                  578999999988875321 224568999999999999999999996 44   9999999999999999999999


Q ss_pred             ecCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCC
Q 044997          420 DFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE  499 (563)
Q Consensus       420 DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~  499 (563)
                      |||++.......    ......|+..|+|||.+.+..             ++.++||||||+++|||++|+.||......
T Consensus       157 dfg~~~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~-------------~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~  219 (269)
T cd08528         157 DFGLAKQKQPES----KLTSVVGTILYSCPEIVKNEP-------------YGEKADVWAFGCILYQMCTLQPPFYSTNML  219 (269)
T ss_pred             cccceeeccccc----ccccccCcccCcChhhhcCCC-------------CchHHHHHHHHHHHHHHHhCCCcccccCHH
Confidence            999997644322    223456889999999875433             488999999999999999999998643321


Q ss_pred             c------------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 044997          500 P------------TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILS  536 (563)
Q Consensus       500 ~------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  536 (563)
                      .            .........+.+++.+||+.||++||++.|+.+.++
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         220 SLATKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             HHHHHHhhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence            0            011123456899999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-33  Score=308.46  Aligned_cols=240  Identities=25%  Similarity=0.396  Sum_probs=187.3

Q ss_pred             HHHHHhcCCCccceecccCcEEEEEEEEC---------CceEEEEEeccCC----hHHHHHHHHHHHhc-cccce-----
Q 044997          286 EIEEATNNFDESRIIGRGGFGNVYFGLLG---------DREAAIKKMRSNK----SKEFFAELKVLCKI-HHINV-----  346 (563)
Q Consensus       286 el~~~~~~f~~~~~LG~G~fG~Vy~g~~~---------~~~vavK~~~~~~----~~~f~~Ei~~l~~l-~H~ni-----  346 (563)
                      .++...++....+.||+|.||.|++|...         ...||||.++...    .+.+..|+++|+.+ +|+|+     
T Consensus       290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG  369 (609)
T KOG0200|consen  290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG  369 (609)
T ss_pred             ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence            34445555666779999999999999753         2468999987543    46799999999999 49997     


Q ss_pred             ----------EEEeecCCCccccccccc---------ccCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCC
Q 044997          347 ----------FISTFGNGSLSDHLHDPL---------LKGH--QPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKT  405 (563)
Q Consensus       347 ----------V~e~~~~gsL~~~L~~~~---------~~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~  405 (563)
                                |+||++.|+|.++|+...         ....  ..++..+.+.++.|||.||+||++..   +|||||..
T Consensus       370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAa  446 (609)
T KOG0200|consen  370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAA  446 (609)
T ss_pred             eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhh
Confidence                      579999999999998754         1111  24999999999999999999999986   99999999


Q ss_pred             CCeEecCCCcEEEeecCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHH
Q 044997          406 SNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAE  485 (563)
Q Consensus       406 ~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~E  485 (563)
                      +|||+.++..+||+|||+|+............+...-...|||||.+....             ++.|||||||||+|||
T Consensus       447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~-------------ft~kSDVWSfGI~L~E  513 (609)
T KOG0200|consen  447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRV-------------FTSKSDVWSFGILLWE  513 (609)
T ss_pred             hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCc-------------ccccchhhHHHHHHHH
Confidence            999999999999999999996544332221111101245699999886544             4999999999999999


Q ss_pred             HHc-CCCCCcCCC------------CCchhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 044997          486 LIT-GKRALIRDD------------SEPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMIT  541 (563)
Q Consensus       486 llt-g~~p~~~~~------------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~  541 (563)
                      ++| |..|+.+-.            .+..++..+.+.+.++++.||+.+|++||++.++.+.++..+..
T Consensus       514 ifsLG~~PYp~~~~~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~~  582 (609)
T KOG0200|consen  514 IFTLGGTPYPGIPPTEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQD  582 (609)
T ss_pred             HhhCCCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHHH
Confidence            999 555654311            12233445567799999999999999999999999999997653

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=1.3e-32  Score=277.07  Aligned_cols=224  Identities=21%  Similarity=0.348  Sum_probs=173.3

Q ss_pred             cCCCccceecccCcEEEEEEEEC--CceEEEEEeccCC----hHHHHHHHHH-HHhccccceE---------------EE
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNK----SKEFFAELKV-LCKIHHINVF---------------IS  349 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~----~~~f~~Ei~~-l~~l~H~niV---------------~e  349 (563)
                      ++|+..+.||+|+||.||+++..  ++.||+|+++...    ..++..|+++ ++.++|||++               +|
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            46888899999999999999874  7899999987542    2456667665 6667899983               45


Q ss_pred             eecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCceEeCCCCCCCeEecCCCcEEEeecCCCcccc
Q 044997          350 TFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDH-TKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEE  428 (563)
Q Consensus       350 ~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~  428 (563)
                      |++ |+|.+++.... .....+++..+..++.|++.||+|||++ +   ++||||||+||++++++.+||+|||+++...
T Consensus        81 ~~~-~~l~~~l~~~~-~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~  155 (283)
T cd06617          81 VMD-TSLDKFYKKVY-DKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLV  155 (283)
T ss_pred             hhc-ccHHHHHHHhc-cCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecccccccc
Confidence            654 67777765422 2235789999999999999999999986 5   9999999999999999999999999987543


Q ss_pred             cccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCchh------
Q 044997          429 RTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTK------  502 (563)
Q Consensus       429 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~~------  502 (563)
                      ...    ..+...|+..|+|||.+.+..         ....++.++|+||||+++|||++|+.||.........      
T Consensus       156 ~~~----~~~~~~~~~~y~aPE~~~~~~---------~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~  222 (283)
T cd06617         156 DSV----AKTIDAGCKPYMAPERINPEL---------NQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVE  222 (283)
T ss_pred             ccc----ccccccCCccccChhhcCCcc---------cccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHh
Confidence            211    122346888999999875422         1234578999999999999999999998643221110      


Q ss_pred             -------hHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          503 -------MKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       503 -------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                             ...++..+.+++.+||..+|.+||++.++++
T Consensus       223 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         223 EPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             cCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                   1234566899999999999999999999987

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-32  Score=278.23  Aligned_cols=219  Identities=21%  Similarity=0.332  Sum_probs=172.8

Q ss_pred             cCCCccceecccCcEEEEEEEE--CCceEEEEEeccCC----hHHHHHHHHHHHhccccce---------------EEEe
Q 044997          292 NNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNK----SKEFFAELKVLCKIHHINV---------------FIST  350 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~----~~~f~~Ei~~l~~l~H~ni---------------V~e~  350 (563)
                      ++|+..+.||+|++|.||+|..  +++.+|+|.+....    ...+.+|++++++++|+||               |+||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY   84 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence            5688899999999999999987  46889999986432    3457789999999999997               5688


Q ss_pred             ecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccccc
Q 044997          351 FGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERT  430 (563)
Q Consensus       351 ~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~  430 (563)
                      ++ ++|.+++...    ...+++.....++.|+++||.|||+.+   ++||||||+||++++++.+||+|||+++.....
T Consensus        85 ~~-~~L~~~~~~~----~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~  156 (291)
T cd07844          85 LD-TDLKQYMDDC----GGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVP  156 (291)
T ss_pred             CC-CCHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCC
Confidence            87 4888887642    346899999999999999999999987   999999999999999999999999998753221


Q ss_pred             cccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCchhh-------
Q 044997          431 NEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKM-------  503 (563)
Q Consensus       431 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~~~-------  503 (563)
                      ..   ......++..|+|||++.+.            ..++.++||||||+++|||++|+.||..........       
T Consensus       157 ~~---~~~~~~~~~~~~aPE~~~~~------------~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~  221 (291)
T cd07844         157 SK---TYSNEVVTLWYRPPDVLLGS------------TEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVL  221 (291)
T ss_pred             Cc---cccccccccccCCcHHhhcC------------cccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhc
Confidence            11   11223467889999987432            234789999999999999999999985443110000       


Q ss_pred             ----------------------------------HHHH--HHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          504 ----------------------------------KSLI--TIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       504 ----------------------------------~~~~--~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                                                        ..+.  ..+.+++.+|++.||.+||++.|+++
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         222 GTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             CCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence                                              0111  45679999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=9.1e-33  Score=279.98  Aligned_cols=215  Identities=25%  Similarity=0.377  Sum_probs=177.2

Q ss_pred             cCCCccceecccCcEEEEEEEE--CCceEEEEEeccC------ChHHHHHHHHHHHhccccce---------------EE
Q 044997          292 NNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSN------KSKEFFAELKVLCKIHHINV---------------FI  348 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~------~~~~f~~Ei~~l~~l~H~ni---------------V~  348 (563)
                      ++|...+.||+|+||.||++..  .++.+|+|.++..      ..+.+.+|++++++++||||               |+
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            4688899999999999999987  4688999998642      23568899999999999997               57


Q ss_pred             EeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccc
Q 044997          349 STFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEE  428 (563)
Q Consensus       349 e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~  428 (563)
                      ||+++|+|.+++..     ...+++..+..++.|++.||.|||+.+   ++||||+|+||++++++.+||+|||+++...
T Consensus        81 e~~~~~~L~~~~~~-----~~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~  152 (290)
T cd05580          81 EYVPGGELFSHLRK-----SGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVK  152 (290)
T ss_pred             ecCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccC
Confidence            99999999998864     356899999999999999999999987   9999999999999999999999999988653


Q ss_pred             cccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc--------
Q 044997          429 RTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP--------  500 (563)
Q Consensus       429 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~--------  500 (563)
                      ..      .....|++.|+|||.+.+.             ..+.++||||||+++|||++|+.||.......        
T Consensus       153 ~~------~~~~~~~~~y~aPE~~~~~-------------~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~  213 (290)
T cd05580         153 GR------TYTLCGTPEYLAPEIILSK-------------GYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEG  213 (290)
T ss_pred             CC------CCCCCCCccccChhhhcCC-------------CCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC
Confidence            22      2234688999999987543             34789999999999999999999986544211        


Q ss_pred             --hhhHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 044997          501 --TKMKSLITIMAAVAEWCLNEDAVDRP-----EMRDIVA  533 (563)
Q Consensus       501 --~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  533 (563)
                        .........+.+++.+||+.||.+||     +++|+++
T Consensus       214 ~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~  253 (290)
T cd05580         214 KVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN  253 (290)
T ss_pred             CccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence              01122345689999999999999998     6666654

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6.9e-34  Score=296.42  Aligned_cols=212  Identities=24%  Similarity=0.457  Sum_probs=172.2

Q ss_pred             cceecccCcEEEEEEEEC--CceEE---EEE--e-c-cCChHHHHHHHHHHHhccccceE-----------------EEe
Q 044997          297 SRIIGRGGFGNVYFGLLG--DREAA---IKK--M-R-SNKSKEFFAELKVLCKIHHINVF-----------------IST  350 (563)
Q Consensus       297 ~~~LG~G~fG~Vy~g~~~--~~~va---vK~--~-~-~~~~~~f~~Ei~~l~~l~H~niV-----------------~e~  350 (563)
                      ..+||+|+|-+||+|...  |.+||   ||.  + + ....++|..|+.+|+.|+|+|||                 .|.
T Consensus        45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL  124 (632)
T KOG0584|consen   45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL  124 (632)
T ss_pred             hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence            467999999999999874  44554   222  1 1 22347899999999999999983                 588


Q ss_pred             ecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCC-CcEEEeecCCCccccc
Q 044997          351 FGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDG-LRAKVADFGLVKLEER  429 (563)
Q Consensus       351 ~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~-~~~kl~DFGla~~~~~  429 (563)
                      |..|+|..|+..     .+.++......+++||++||.|||++. |||+|||||.+||+|+.+ |.+||+|+|||+....
T Consensus       125 ~TSGtLr~Y~kk-----~~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~  198 (632)
T KOG0584|consen  125 FTSGTLREYRKK-----HRRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK  198 (632)
T ss_pred             ccCCcHHHHHHH-----hccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence            999999999975     466888999999999999999999985 679999999999999865 8999999999987654


Q ss_pred             ccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCchhhHHH---
Q 044997          430 TNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKMKSL---  506 (563)
Q Consensus       430 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~~~~~~---  506 (563)
                      ..     .....|||.|||||++.              ..|.+.+||||||++|+||+|+..|+..-...-+..+.+   
T Consensus       199 s~-----aksvIGTPEFMAPEmYE--------------E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SG  259 (632)
T KOG0584|consen  199 SH-----AKSVIGTPEFMAPEMYE--------------ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSG  259 (632)
T ss_pred             cc-----cceeccCccccChHHHh--------------hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcC
Confidence            32     34478999999999874              345899999999999999999999986544322221111   


Q ss_pred             ----------HHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          507 ----------ITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       507 ----------~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                                ...++++|.+|+.. .++|||+.|++..
T Consensus       260 iKP~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d  296 (632)
T KOG0584|consen  260 IKPAALSKVKDPEVREFIEKCLAT-KSERLSAKELLKD  296 (632)
T ss_pred             CCHHHhhccCCHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence                      24589999999999 9999999999873

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=1.5e-32  Score=273.24  Aligned_cols=219  Identities=27%  Similarity=0.451  Sum_probs=182.0

Q ss_pred             cCCCccceecccCcEEEEEEEEC--CceEEEEEeccCC----hHHHHHHHHHHHhccccce---------------EEEe
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNK----SKEFFAELKVLCKIHHINV---------------FIST  350 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~----~~~f~~Ei~~l~~l~H~ni---------------V~e~  350 (563)
                      ++|+..+.||+|++|.||++...  ++.+++|++....    .+++.+|++.+.+++|+|+               |+||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            36788899999999999999874  7889999987653    4679999999999999997               5789


Q ss_pred             ecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCceEeCCCCCCCeEecCCCcEEEeecCCCccccc
Q 044997          351 FGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHD-HTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEER  429 (563)
Q Consensus       351 ~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~  429 (563)
                      +++++|.+++..     ...+++..+..++.|+++||+|||+ .+   ++||||+|+||+++.++.++|+|||++.....
T Consensus        81 ~~~~~L~~~l~~-----~~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~  152 (264)
T cd06623          81 MDGGSLADLLKK-----VGKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLEN  152 (264)
T ss_pred             cCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence            999999999865     2568999999999999999999999 87   99999999999999999999999999886543


Q ss_pred             ccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCC-----------
Q 044997          430 TNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDS-----------  498 (563)
Q Consensus       430 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~-----------  498 (563)
                      ....   .....++..|+|||.+...             .++.++||||||+++|||++|+.|+.....           
T Consensus       153 ~~~~---~~~~~~~~~y~~pE~~~~~-------------~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~  216 (264)
T cd06623         153 TLDQ---CNTFVGTVTYMSPERIQGE-------------SYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC  216 (264)
T ss_pred             CCCc---ccceeecccccCHhhhCCC-------------CCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh
Confidence            2211   1234578899999987543             348899999999999999999999866531           


Q ss_pred             ---CchhhHH-HHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          499 ---EPTKMKS-LITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       499 ---~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                         ....... .+..+.+++.+||+.+|++||++.++++.
T Consensus       217 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         217 DGPPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             cCCCCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence               0111112 45679999999999999999999999874

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=1.5e-32  Score=279.03  Aligned_cols=218  Identities=24%  Similarity=0.446  Sum_probs=179.1

Q ss_pred             cCCCccceecccCcEEEEEEEE--CCceEEEEEeccC---ChHHHHHHHHHHHhccccce---------------EEEee
Q 044997          292 NNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSN---KSKEFFAELKVLCKIHHINV---------------FISTF  351 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~---~~~~f~~Ei~~l~~l~H~ni---------------V~e~~  351 (563)
                      ++|...+.||+|+||.||++..  +++.+|+|.+...   ..+.+.+|+.++++++|||+               |+||+
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~   98 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL   98 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence            5788899999999999999976  4678999998643   23568899999999999997               57899


Q ss_pred             cCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccccccc
Q 044997          352 GNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTN  431 (563)
Q Consensus       352 ~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~  431 (563)
                      ++|+|.+++..      ..+++.++..++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++.......
T Consensus        99 ~~~~L~~~~~~------~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~  169 (293)
T cd06647          99 AGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  169 (293)
T ss_pred             CCCcHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceecccccc
Confidence            99999998864      35789999999999999999999997   9999999999999999999999999987543322


Q ss_pred             ccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc-----------
Q 044997          432 EKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP-----------  500 (563)
Q Consensus       432 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~-----------  500 (563)
                      .   ......|++.|+|||.+...             .++.++||||||+++||+++|+.||.......           
T Consensus       170 ~---~~~~~~~~~~y~~PE~~~~~-------------~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~  233 (293)
T cd06647         170 S---KRSTMVGTPYWMAPEVVTRK-------------AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTP  233 (293)
T ss_pred             c---ccccccCChhhcCchhhccC-------------CCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCC
Confidence            1   12234688899999987543             34789999999999999999999986443211           


Q ss_pred             --hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          501 --TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       501 --~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                        .....+...+.+++.+||+.+|.+||++.+++..
T Consensus       234 ~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         234 ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence              0112344568999999999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=1.6e-32  Score=272.20  Aligned_cols=220  Identities=26%  Similarity=0.400  Sum_probs=177.6

Q ss_pred             CCCccceecccCcEEEEEEEEC--CceEEEEEeccC-----ChHHHHHHHHHHHhccccce---------------EEEe
Q 044997          293 NFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSN-----KSKEFFAELKVLCKIHHINV---------------FIST  350 (563)
Q Consensus       293 ~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~-----~~~~f~~Ei~~l~~l~H~ni---------------V~e~  350 (563)
                      +|+..+.||+|+||.||+|..+  +..+|+|.+...     ..+.+.+|++++++++|+|+               |+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            4778899999999999999884  688999998643     34568899999999999997               5799


Q ss_pred             ecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCC-cEEEeecCCCccccc
Q 044997          351 FGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGL-RAKVADFGLVKLEER  429 (563)
Q Consensus       351 ~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~-~~kl~DFGla~~~~~  429 (563)
                      +++++|.+++...   ....++|..+..++.|++.||.|||+.+   ++|+||||+||++++++ .+||+|||.+.....
T Consensus        81 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~  154 (257)
T cd08225          81 CDGGDLMKRINRQ---RGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND  154 (257)
T ss_pred             CCCCcHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccC
Confidence            9999999988652   2346899999999999999999999987   99999999999999885 569999999876543


Q ss_pred             ccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCchh-------
Q 044997          430 TNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTK-------  502 (563)
Q Consensus       430 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~~-------  502 (563)
                      ...   ......|++.|+|||++...             .++.++||||||+++||+++|+.|+.........       
T Consensus       155 ~~~---~~~~~~~~~~~~ape~~~~~-------------~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~  218 (257)
T cd08225         155 SME---LAYTCVGTPYYLSPEICQNR-------------PYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGY  218 (257)
T ss_pred             Ccc---cccccCCCccccCHHHHcCC-------------CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccc
Confidence            221   11224588899999987433             3478999999999999999999998644321111       


Q ss_pred             ----hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          503 ----MKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       503 ----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                          .......+.+++.+||+.+|++||++.|+++.
T Consensus       219 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~  254 (257)
T cd08225         219 FAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKR  254 (257)
T ss_pred             CCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence                11234568999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-32  Score=273.59  Aligned_cols=220  Identities=25%  Similarity=0.394  Sum_probs=176.1

Q ss_pred             cCCCccceecccCcEEEEEEEE--CCceEEEEEeccC--------ChHHHHHHHHHHHhccccce---------------
Q 044997          292 NNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSN--------KSKEFFAELKVLCKIHHINV---------------  346 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~--------~~~~f~~Ei~~l~~l~H~ni---------------  346 (563)
                      .+|+..+.||+|+||.||+|..  ++..+|+|.+...        ..+.+.+|++++++++|+||               
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            4688899999999999999986  4688999987422        12468889999999999987               


Q ss_pred             --EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCC
Q 044997          347 --FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLV  424 (563)
Q Consensus       347 --V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla  424 (563)
                        ++||+++++|.+++..     ...+++.....++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++
T Consensus        82 ~~v~e~~~~~~L~~~~~~-----~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~  153 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKA-----YGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGAS  153 (264)
T ss_pred             EEEEEeCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccc
Confidence              4578888888888754     245889999999999999999999987   999999999999999999999999999


Q ss_pred             cccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCC-----
Q 044997          425 KLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE-----  499 (563)
Q Consensus       425 ~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~-----  499 (563)
                      +................|+..|+|||++.+..             .+.++|||||||++|||++|+.||......     
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-------------~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~  220 (264)
T cd06653         154 KRIQTICMSGTGIKSVTGTPYWMSPEVISGEG-------------YGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFK  220 (264)
T ss_pred             cccccccccCccccccCCcccccCHhhhcCCC-------------CCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHH
Confidence            85432111111122356889999999875433             478999999999999999999998654211     


Q ss_pred             -------chhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          500 -------PTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       500 -------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                             +.......+.+.+++.+||. +|.+||+..+++.
T Consensus       221 ~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         221 IATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             HHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence                   11233455679999999999 5799999998875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.1e-32  Score=275.62  Aligned_cols=220  Identities=25%  Similarity=0.328  Sum_probs=178.2

Q ss_pred             cCCCccceecccCcEEEEEEEE--CCceEEEEEeccCC----hHHHHHHHHHHHhccccce-----------------EE
Q 044997          292 NNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNK----SKEFFAELKVLCKIHHINV-----------------FI  348 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~----~~~f~~Ei~~l~~l~H~ni-----------------V~  348 (563)
                      ++|+..+.||.|++|.||++..  .++.+|+|.+....    .+++.+|++++++++|+||                 |+
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            4678889999999999999988  46889999987532    3568999999999999997                 46


Q ss_pred             EeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccc
Q 044997          349 STFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEE  428 (563)
Q Consensus       349 e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~  428 (563)
                      ||+++|+|.+++.... .....+++.....++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||++....
T Consensus        81 e~~~~~~L~~~l~~~~-~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~  156 (287)
T cd06621          81 EYCEGGSLDSIYKKVK-KRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELV  156 (287)
T ss_pred             EecCCCCHHHHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeecccccccc
Confidence            8888999988775321 23456899999999999999999999987   9999999999999999999999999987543


Q ss_pred             cccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCC----ch---
Q 044997          429 RTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE----PT---  501 (563)
Q Consensus       429 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~----~~---  501 (563)
                      ...     .....++..|+|||.+.+..             ++.++||||||+++|||++|+.|+......    ..   
T Consensus       157 ~~~-----~~~~~~~~~y~~pE~~~~~~-------------~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~  218 (287)
T cd06621         157 NSL-----AGTFTGTSFYMAPERIQGKP-------------YSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLS  218 (287)
T ss_pred             ccc-----cccccCCccccCHHHhcCCC-------------CCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHH
Confidence            221     12345788999999875443             478999999999999999999998755210    00   


Q ss_pred             --------hh-------HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          502 --------KM-------KSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       502 --------~~-------~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                              ..       ..+.+.+.+++.+||+.||.+|||+.|+++
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~  265 (287)
T cd06621         219 YIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE  265 (287)
T ss_pred             HHhcCCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence                    00       123456889999999999999999999987

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=1.6e-32  Score=277.49  Aligned_cols=222  Identities=26%  Similarity=0.452  Sum_probs=182.6

Q ss_pred             HHhcCCCccceecccCcEEEEEEEEC--CceEEEEEeccCC--hHHHHHHHHHHHhccccce---------------EEE
Q 044997          289 EATNNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNK--SKEFFAELKVLCKIHHINV---------------FIS  349 (563)
Q Consensus       289 ~~~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~--~~~f~~Ei~~l~~l~H~ni---------------V~e  349 (563)
                      ..++.|+..+.||+|+||.||+|...  ++.+++|.++...  .+.+.+|++++++++|+|+               ++|
T Consensus        16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   95 (286)
T cd06614          16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME   95 (286)
T ss_pred             CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence            35667888899999999999999885  7889999997654  5678899999999999997               468


Q ss_pred             eecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccccc
Q 044997          350 TFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEER  429 (563)
Q Consensus       350 ~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~  429 (563)
                      |+++++|.+++...    ...+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++.....
T Consensus        96 ~~~~~~L~~~l~~~----~~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~  168 (286)
T cd06614          96 YMDGGSLTDIITQN----FVRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTK  168 (286)
T ss_pred             ccCCCcHHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhcc
Confidence            88999999999752    147999999999999999999999987   99999999999999999999999999765432


Q ss_pred             ccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc---------
Q 044997          430 TNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP---------  500 (563)
Q Consensus       430 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~---------  500 (563)
                      ...   ......++..|+|||.+.+..             ++.++|||||||++|||++|+.|+.......         
T Consensus       169 ~~~---~~~~~~~~~~y~~PE~~~~~~-------------~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~  232 (286)
T cd06614         169 EKS---KRNSVVGTPYWMAPEVIKRKD-------------YGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKG  232 (286)
T ss_pred             chh---hhccccCCcccCCHhHhcCCC-------------CCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC
Confidence            211   112345788999999875433             4789999999999999999999986433211         


Q ss_pred             ----hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          501 ----TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       501 ----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                          .....+...+.+++.+||+.+|.+||++.++++
T Consensus       233 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  269 (286)
T cd06614         233 IPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ  269 (286)
T ss_pred             CCCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence                011124566899999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=2.7e-32  Score=268.52  Aligned_cols=217  Identities=30%  Similarity=0.474  Sum_probs=179.1

Q ss_pred             CCCccceecccCcEEEEEEEEC--CceEEEEEeccCC---hHHHHHHHHHHHhccccce---------------EEEeec
Q 044997          293 NFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNK---SKEFFAELKVLCKIHHINV---------------FISTFG  352 (563)
Q Consensus       293 ~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~---~~~f~~Ei~~l~~l~H~ni---------------V~e~~~  352 (563)
                      +|+..+.||+|++|.||++...  +..+++|++....   .+.+.+|++++++++|+|+               ++||++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            3677899999999999999885  7889999987653   4678999999999999997               468889


Q ss_pred             CCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccccccc
Q 044997          353 NGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNE  432 (563)
Q Consensus       353 ~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~  432 (563)
                      +++|.+++...    ...+++..+..++.+++.||.|||+.+   ++||||+|+||++++++.+||+|||.+........
T Consensus        81 ~~~L~~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  153 (253)
T cd05122          81 GGSLKDLLKST----NQTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA  153 (253)
T ss_pred             CCcHHHHHhhc----CCCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc
Confidence            99999888652    257899999999999999999999987   99999999999999999999999999876543221


Q ss_pred             cccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCch-----------
Q 044997          433 KEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPT-----------  501 (563)
Q Consensus       433 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~-----------  501 (563)
                          .....++..|+|||.+....             .+.++||||||+++|+|++|+.|+...+....           
T Consensus       154 ----~~~~~~~~~~~~PE~~~~~~-------------~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~  216 (253)
T cd05122         154 ----RNTMVGTPYWMAPEVINGKP-------------YDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPG  216 (253)
T ss_pred             ----ccceecCCcccCHHHHcCCC-------------CCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCC
Confidence                23356888999999875432             48899999999999999999999865422110           


Q ss_pred             h--hHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          502 K--MKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       502 ~--~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                      .  ...+...+.+++.+||+.||++||++.|+++
T Consensus       217 ~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         217 LRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             cCcccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            0  1112466899999999999999999999986

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-32  Score=274.24  Aligned_cols=218  Identities=23%  Similarity=0.304  Sum_probs=172.5

Q ss_pred             CCccceecccCcEEEEEEEE--CCceEEEEEeccCC-----hHHHHHHHHHHHhccccce---------------EEEee
Q 044997          294 FDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNK-----SKEFFAELKVLCKIHHINV---------------FISTF  351 (563)
Q Consensus       294 f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~-----~~~f~~Ei~~l~~l~H~ni---------------V~e~~  351 (563)
                      |+..+.||.|++|.||+|..  ++..+|+|++....     .+.+.+|++++++++|+|+               ++||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            56678999999999999987  47899999986432     3568899999999999997               46777


Q ss_pred             cCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccccccc
Q 044997          352 GNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTN  431 (563)
Q Consensus       352 ~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~  431 (563)
                      + ++|.+++...   ....+++..+..++.|+++||+|||+++   ++||||+|+||++++++.+||+|||+++......
T Consensus        81 ~-~~l~~~~~~~---~~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~  153 (283)
T cd07835          81 D-LDLKKYMDSS---PLTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPV  153 (283)
T ss_pred             C-cCHHHHHhhC---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCc
Confidence            4 6888887642   2246899999999999999999999987   9999999999999999999999999987543221


Q ss_pred             ccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCch----------
Q 044997          432 EKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPT----------  501 (563)
Q Consensus       432 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~----------  501 (563)
                      .   ......++..|+|||++.+.            ..++.++||||||+++|||++|+.||........          
T Consensus       154 ~---~~~~~~~~~~~~aPE~~~~~------------~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~  218 (283)
T cd07835         154 R---TYTHEVVTLWYRAPEILLGS------------RQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGT  218 (283)
T ss_pred             c---ccCccccccCCCCCceeecC------------cccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence            1   11223568899999987432            2347899999999999999999999864321100          


Q ss_pred             -----------------------------hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          502 -----------------------------KMKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       502 -----------------------------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                                                   ....+...+.+++.+||+.||.+||+++|+++
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         219 PDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             CChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence                                         00112245789999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-32  Score=275.36  Aligned_cols=217  Identities=24%  Similarity=0.430  Sum_probs=176.8

Q ss_pred             CCCccceecccCcEEEEEEEE--CCceEEEEEeccC----ChHHHHHHHHHHHhcc---ccce---------------EE
Q 044997          293 NFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSN----KSKEFFAELKVLCKIH---HINV---------------FI  348 (563)
Q Consensus       293 ~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~----~~~~f~~Ei~~l~~l~---H~ni---------------V~  348 (563)
                      .|+..+.||+|+||.||+|..  +++.+|+|.++..    ..+++.+|++++++++   |+|+               |+
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            467788999999999999987  4688999988643    2356889999999997   9987               47


Q ss_pred             EeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccc
Q 044997          349 STFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEE  428 (563)
Q Consensus       349 e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~  428 (563)
                      ||+++++|.+++..      ..+++.....++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++....
T Consensus        82 e~~~~~~L~~~~~~------~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~  152 (277)
T cd06917          82 EYAEGGSVRTLMKA------GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLN  152 (277)
T ss_pred             ecCCCCcHHHHHHc------cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecC
Confidence            88999999888753      36899999999999999999999987   9999999999999999999999999987654


Q ss_pred             cccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc--------
Q 044997          429 RTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP--------  500 (563)
Q Consensus       429 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~--------  500 (563)
                      ....   ......|+..|+|||.+...            ..++.++|||||||++|||++|+.||.......        
T Consensus       153 ~~~~---~~~~~~~~~~y~aPE~~~~~------------~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~  217 (277)
T cd06917         153 QNSS---KRSTFVGTPYWMAPEVITEG------------KYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS  217 (277)
T ss_pred             CCcc---ccccccCCcceeCHHHhccC------------CccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccC
Confidence            3321   12234688999999987432            234789999999999999999999986443211        


Q ss_pred             ---hh-hHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          501 ---TK-MKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       501 ---~~-~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                         .. .......+.+++.+||+.||++||++.|++.
T Consensus       218 ~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         218 KPPRLEDNGYSKLLREFVAACLDEEPKERLSAEELLK  254 (277)
T ss_pred             CCCCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence               00 1124556899999999999999999999986

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=2.8e-32  Score=275.93  Aligned_cols=235  Identities=23%  Similarity=0.320  Sum_probs=187.6

Q ss_pred             CCCccceecccCcEEEEEEEE-----CCceEEEEEeccC-------ChHHHHHHHHHHHhc-cccce-------------
Q 044997          293 NFDESRIIGRGGFGNVYFGLL-----GDREAAIKKMRSN-------KSKEFFAELKVLCKI-HHINV-------------  346 (563)
Q Consensus       293 ~f~~~~~LG~G~fG~Vy~g~~-----~~~~vavK~~~~~-------~~~~f~~Ei~~l~~l-~H~ni-------------  346 (563)
                      +|+..+.||+|+||.||+++.     +++.+|||.++..       ..+.+.+|++++.++ +|+||             
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            467789999999999999875     3567999988642       235688999999999 58876             


Q ss_pred             --EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCC
Q 044997          347 --FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLV  424 (563)
Q Consensus       347 --V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla  424 (563)
                        |+||+.+|+|.+++..     ...+++.....++.|+++||.|||+.+   ++||||||+||+++.++.+||+|||++
T Consensus        81 ~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~  152 (288)
T cd05583          81 HLILDYVNGGELFTHLYQ-----REHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLS  152 (288)
T ss_pred             EEEEecCCCCcHHHHHhh-----cCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccc
Confidence              6899999999998864     346899999999999999999999987   999999999999999999999999998


Q ss_pred             cccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCch--h
Q 044997          425 KLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPT--K  502 (563)
Q Consensus       425 ~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~--~  502 (563)
                      +........  ......|+..|+|||.+.+..           ...+.++||||||+++|||++|+.||........  .
T Consensus       153 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~-----------~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~  219 (288)
T cd05583         153 KEFLAEEEE--RAYSFCGTIEYMAPEVIRGGS-----------GGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSE  219 (288)
T ss_pred             ccccccccc--ccccccCCccccCHHHhcCCC-----------CCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHH
Confidence            764432211  112345889999999875432           1247899999999999999999999854322111  0


Q ss_pred             ------------hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcChhhhcc
Q 044997          503 ------------MKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITSTEWEAS  548 (563)
Q Consensus       503 ------------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~w~~~  548 (563)
                                  ...+...+.+++.+||+.||++|||+.++.+.|....-...+|+.-
T Consensus       220 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~~~~  277 (288)
T cd05583         220 ISRRILKSKPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDWDDL  277 (288)
T ss_pred             HHHHHHccCCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCHHHH
Confidence                        1123456899999999999999999999999999888788888643

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=3.4e-32  Score=268.91  Aligned_cols=219  Identities=27%  Similarity=0.437  Sum_probs=180.5

Q ss_pred             CCCccceecccCcEEEEEEEEC--CceEEEEEeccCC-----hHHHHHHHHHHHhccccce-----------------EE
Q 044997          293 NFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNK-----SKEFFAELKVLCKIHHINV-----------------FI  348 (563)
Q Consensus       293 ~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~-----~~~f~~Ei~~l~~l~H~ni-----------------V~  348 (563)
                      +|+..+.||+|++|.||+|...  ++.+++|.++...     .+.+.+|++++++++|+||                 ++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            4677899999999999999885  7889999987654     5678999999999999997                 45


Q ss_pred             EeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccc
Q 044997          349 STFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEE  428 (563)
Q Consensus       349 e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~  428 (563)
                      ||+.+++|.+++..     ...++|..+..++.+++.||+|||+.+   ++|+||+|+||+++.++.+||+|||.+....
T Consensus        81 e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~  152 (260)
T cd06606          81 EYVSGGSLSSLLKK-----FGKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLG  152 (260)
T ss_pred             EecCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecc
Confidence            77788899888864     237999999999999999999999987   9999999999999999999999999987654


Q ss_pred             cccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCC---------
Q 044997          429 RTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE---------  499 (563)
Q Consensus       429 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~---------  499 (563)
                      ..... .......++..|+|||.+....             .+.++||||||+++|||++|+.||......         
T Consensus       153 ~~~~~-~~~~~~~~~~~y~~pE~~~~~~-------------~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~  218 (260)
T cd06606         153 DIETG-EGTGSVRGTPYWMAPEVIRGEE-------------YGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGS  218 (260)
T ss_pred             ccccc-ccccCCCCCccccCHhhhcCCC-------------CCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccc
Confidence            33211 0122346888999999875433             488999999999999999999998665411         


Q ss_pred             ----chhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          500 ----PTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       500 ----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                          ..........+.+++.+|++.||.+||++.|++.
T Consensus       219 ~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         219 SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence                1112234567999999999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=1.8e-32  Score=272.49  Aligned_cols=225  Identities=24%  Similarity=0.390  Sum_probs=178.0

Q ss_pred             ecccCcEEEEEEEEC--CceEEEEEeccCC------hHHHHHHHHHHHhccccce---------------EEEeecCCCc
Q 044997          300 IGRGGFGNVYFGLLG--DREAAIKKMRSNK------SKEFFAELKVLCKIHHINV---------------FISTFGNGSL  356 (563)
Q Consensus       300 LG~G~fG~Vy~g~~~--~~~vavK~~~~~~------~~~f~~Ei~~l~~l~H~ni---------------V~e~~~~gsL  356 (563)
                      ||+|+||.||+++..  ++.+++|.+....      .+.+.+|++++++++|+|+               ++||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            689999999999985  7899999986542      3568889999999999996               6799999999


Q ss_pred             ccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccccccccc---
Q 044997          357 SDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEK---  433 (563)
Q Consensus       357 ~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~---  433 (563)
                      .+++..     ...+++..+..++.|++.||+|||+.+   ++|+||+|+||++++++.+||+|||++.........   
T Consensus        81 ~~~l~~-----~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~  152 (265)
T cd05579          81 ASLLEN-----VGSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLN  152 (265)
T ss_pred             HHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccc
Confidence            998864     236899999999999999999999987   999999999999999999999999998754322110   


Q ss_pred             --ccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc----------h
Q 044997          434 --EMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP----------T  501 (563)
Q Consensus       434 --~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~----------~  501 (563)
                        ........++..|+|||.+....             .+.++||||||+++||+++|+.||.......          .
T Consensus       153 ~~~~~~~~~~~~~~~~~Pe~~~~~~-------------~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~  219 (265)
T cd05579         153 DDEKEDKRIVGTPDYIAPEVILGQG-------------HSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIE  219 (265)
T ss_pred             cccccccCcccCccccCHHHhcCCC-------------CCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcC
Confidence              01122346788999999875433             4789999999999999999999986443211          0


Q ss_pred             hhHH--HHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcChhh
Q 044997          502 KMKS--LITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITSTEW  545 (563)
Q Consensus       502 ~~~~--~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~w  545 (563)
                      ....  ....+.+++.+||+.+|.+||++.++.+.|+.-.-...+|
T Consensus       220 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~~~  265 (265)
T cd05579         220 WPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGIDW  265 (265)
T ss_pred             CCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCCCC
Confidence            0111  2567899999999999999999977777776443334444

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-34  Score=274.59  Aligned_cols=218  Identities=27%  Similarity=0.418  Sum_probs=186.2

Q ss_pred             CCccceecccCcEEEEEEEE--CCceEEEEEeccC-ChHHHHHHHHHHHhccccce---------------EEEeecCCC
Q 044997          294 FDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSN-KSKEFFAELKVLCKIHHINV---------------FISTFGNGS  355 (563)
Q Consensus       294 f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~-~~~~f~~Ei~~l~~l~H~ni---------------V~e~~~~gs  355 (563)
                      |++..+||+|+||.||++.+  .|+.+|||++..+ +.+++.+|+.+|.+...+.+               ||||++.|+
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGS  114 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGS  114 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCc
Confidence            56678999999999999976  4889999999765 46889999999999987764               789999999


Q ss_pred             cccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccccccccccc
Q 044997          356 LSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEM  435 (563)
Q Consensus       356 L~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~  435 (563)
                      .++.++.    ++++|++.++..++++.++||+|||...   -+|||||..|||++.+|.+||+|||.|-.+..+-.   
T Consensus       115 iSDI~R~----R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA---  184 (502)
T KOG0574|consen  115 ISDIMRA----RRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA---  184 (502)
T ss_pred             HHHHHHH----hcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhhHH---
Confidence            9999875    4688999999999999999999999985   79999999999999999999999999875543221   


Q ss_pred             ccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCC-----------C--chh
Q 044997          436 LATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDS-----------E--PTK  502 (563)
Q Consensus       436 ~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~-----------~--~~~  502 (563)
                      ....+.||+.|||||++..-.|             ..++||||+|++..||..|++|+.+...           .  -..
T Consensus       185 KRNTVIGTPFWMAPEVI~EIGY-------------~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~K  251 (502)
T KOG0574|consen  185 KRNTVIGTPFWMAPEVIEEIGY-------------DTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKK  251 (502)
T ss_pred             hhCccccCcccccHHHHHHhcc-------------chhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCC
Confidence            2244789999999999865554             7899999999999999999999754321           1  134


Q ss_pred             hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          503 MKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       503 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                      ++.+.+.+.++++.||-++|++|-++.++++.
T Consensus       252 PE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H  283 (502)
T KOG0574|consen  252 PEEWSSEFNDFIRSCLIKKPEERKTALRLCEH  283 (502)
T ss_pred             hHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence            56888999999999999999999999998775

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=3.7e-32  Score=273.53  Aligned_cols=216  Identities=29%  Similarity=0.468  Sum_probs=176.3

Q ss_pred             CCccceecccCcEEEEEEEE--CCceEEEEEeccCC----hHHHHHHHHHHHhccccce---------------EEEeec
Q 044997          294 FDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNK----SKEFFAELKVLCKIHHINV---------------FISTFG  352 (563)
Q Consensus       294 f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~----~~~f~~Ei~~l~~l~H~ni---------------V~e~~~  352 (563)
                      |+..+.||+|+||.||+|..  ++..+|+|......    .+.+.+|++++++++|+||               |+||++
T Consensus         6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   85 (277)
T cd06641           6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG   85 (277)
T ss_pred             hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence            66788999999999999976  46789999876432    2568899999999999997               578999


Q ss_pred             CCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccccccc
Q 044997          353 NGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNE  432 (563)
Q Consensus       353 ~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~  432 (563)
                      +|+|.+++..      ..+++..+..++.|++.||.|||+.+   ++|+||||+||++++++.++|+|||+++.......
T Consensus        86 ~~~l~~~i~~------~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06641          86 GGSALDLLEP------GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             CCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchh
Confidence            9999988853      35899999999999999999999987   99999999999999999999999999875433211


Q ss_pred             cccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCC-----------ch
Q 044997          433 KEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE-----------PT  501 (563)
Q Consensus       433 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~-----------~~  501 (563)
                         ......++..|+|||.+...             ..+.++|||||||++|||++|+.|+......           +.
T Consensus       157 ---~~~~~~~~~~y~~PE~~~~~-------------~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~  220 (277)
T cd06641         157 ---KRNTFVGTPFWMAPEVIKQS-------------AYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPT  220 (277)
T ss_pred             ---hhccccCCccccChhhhccC-------------CCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCC
Confidence               12234578899999987543             3478999999999999999999998643211           11


Q ss_pred             hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          502 KMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       502 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                      ........+.+++.+||+.+|.+||++.++++.
T Consensus       221 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         221 LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             CCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            112234568999999999999999999999984

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-33  Score=268.49  Aligned_cols=234  Identities=26%  Similarity=0.391  Sum_probs=193.7

Q ss_pred             hcCCCccceecccCcEEEEEEEE--CCceEEEEEeccCC------hHHHHHHHHHHHhccccce---------------E
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNK------SKEFFAELKVLCKIHHINV---------------F  347 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~------~~~f~~Ei~~l~~l~H~ni---------------V  347 (563)
                      .++|+..++||+|.||.|-+++-  .++.+|+|.++++.      ...-+.|-++|+..+||.+               |
T Consensus       167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV  246 (516)
T KOG0690|consen  167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV  246 (516)
T ss_pred             cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence            46788899999999999998876  47889999998653      2334668899999999886               8


Q ss_pred             EEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccc
Q 044997          348 ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLE  427 (563)
Q Consensus       348 ~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~  427 (563)
                      |||..+|.|.-||..     .+.+++.....+...|..||.|||+++   ||.||||.+|.|+|.+|++||+|||+++..
T Consensus       247 MeyanGGeLf~HLsr-----er~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~  318 (516)
T KOG0690|consen  247 MEYANGGELFFHLSR-----ERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEE  318 (516)
T ss_pred             EEEccCceEeeehhh-----hhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhc
Confidence            999999999999865     456888888888999999999999987   999999999999999999999999999842


Q ss_pred             ccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc-------
Q 044997          428 ERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP-------  500 (563)
Q Consensus       428 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~-------  500 (563)
                      -.   ........+||+.|+|||++....|             +.+.|.|.+|||||||++|+.||+..+...       
T Consensus       319 I~---~g~t~kTFCGTPEYLAPEVleDnDY-------------graVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~  382 (516)
T KOG0690|consen  319 IK---YGDTTKTFCGTPEYLAPEVLEDNDY-------------GRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILM  382 (516)
T ss_pred             cc---ccceeccccCChhhcCchhhccccc-------------cceeehhhhhHHHHHHHhccCcccccchhHHHHHHHh
Confidence            21   2223456899999999999865544             889999999999999999999998766532       


Q ss_pred             ---hhhHHHHHHHHHHHHHhhccCCCCCC--CHHHHHHHHHHhhhcChhhhcc
Q 044997          501 ---TKMKSLITIMAAVAEWCLNEDAVDRP--EMRDIVAILSQIMITSTEWEAS  548 (563)
Q Consensus       501 ---~~~~~~~~~l~~li~~cl~~dP~~RP--s~~evl~~L~~i~~~~~~w~~~  548 (563)
                         ..++.+.++...|+...|.+||.+|-  .-++..+....-+-.+.+|++.
T Consensus       383 ed~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~  435 (516)
T KOG0690|consen  383 EDLKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEAT  435 (516)
T ss_pred             hhccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHH
Confidence               22345567789999999999999995  4566666666667778899874

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=2.2e-32  Score=283.11  Aligned_cols=223  Identities=23%  Similarity=0.375  Sum_probs=177.0

Q ss_pred             hcCCCccceecccCcEEEEEEEE--CCceEEEEEeccC-----ChHHHHHHHHHHHhccccce-----------------
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSN-----KSKEFFAELKVLCKIHHINV-----------------  346 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~-----~~~~f~~Ei~~l~~l~H~ni-----------------  346 (563)
                      .++|+..+.||+|+||.||+|..  +++.+|+|++...     ..+.+.+|+.+|++++|+||                 
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            36788899999999999999986  4789999998653     23567789999999999997                 


Q ss_pred             --EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCC
Q 044997          347 --FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLV  424 (563)
Q Consensus       347 --V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla  424 (563)
                        |+||+. |+|.+++..     ...+++..+..++.|++.||.|||+++   ++||||||+||++++++.+||+|||++
T Consensus        84 ~lv~e~~~-~~l~~~~~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~  154 (334)
T cd07855          84 YVVMDLME-SDLHHIIHS-----DQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMA  154 (334)
T ss_pred             EEEEehhh-hhHHHHhcc-----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccc
Confidence              456664 577777753     345899999999999999999999987   999999999999999999999999999


Q ss_pred             ccccccccc-ccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc---
Q 044997          425 KLEERTNEK-EMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP---  500 (563)
Q Consensus       425 ~~~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~---  500 (563)
                      +........ ........|+..|+|||.+...            ..++.++|||||||++|||++|+.||...+...   
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~------------~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~  222 (334)
T cd07855         155 RGLSSSPTEHKYFMTEYVATRWYRAPELLLSL------------PEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLK  222 (334)
T ss_pred             eeecccCcCCCcccccccccccccChHHhcCC------------cccccccchHHHHHHHHHHHcCCCccCCCChHHHHH
Confidence            765433221 1112335688999999987432            235889999999999999999999985432100   


Q ss_pred             --------------------------------------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          501 --------------------------------------TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       501 --------------------------------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                                                            .........+.+++++||+.||.+||++.+++..
T Consensus       223 ~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  294 (334)
T cd07855         223 LILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH  294 (334)
T ss_pred             HHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence                                                  0001234568899999999999999999998874

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=4.4e-32  Score=277.97  Aligned_cols=222  Identities=18%  Similarity=0.246  Sum_probs=173.8

Q ss_pred             ccceecccCcEEEEEEEECCceEEEEEeccC-----ChHHHHHHHHHHHhccccce---------------EEEeecCCC
Q 044997          296 ESRIIGRGGFGNVYFGLLGDREAAIKKMRSN-----KSKEFFAELKVLCKIHHINV---------------FISTFGNGS  355 (563)
Q Consensus       296 ~~~~LG~G~fG~Vy~g~~~~~~vavK~~~~~-----~~~~f~~Ei~~l~~l~H~ni---------------V~e~~~~gs  355 (563)
                      ..+.+|.|+++.||++..+++.+|+|+++..     ..+.+.+|++++++++|+||               ++||+++|+
T Consensus         6 i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~   85 (314)
T cd08216           6 IGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS   85 (314)
T ss_pred             hhHhhcCCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence            3455677778888888888999999998654     23578899999999999997               579999999


Q ss_pred             cccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccccccccc--
Q 044997          356 LSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEK--  433 (563)
Q Consensus       356 L~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~--  433 (563)
                      |.+++...   ....+++.....++.|+++||+|||+++   |+||||||+||+++.++.+||+|||.+.........  
T Consensus        86 l~~~l~~~---~~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~  159 (314)
T cd08216          86 CEDLLKTH---FPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR  159 (314)
T ss_pred             HHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeecccccccc
Confidence            99998753   2345889999999999999999999997   999999999999999999999999988754322111  


Q ss_pred             --ccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCch----------
Q 044997          434 --EMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPT----------  501 (563)
Q Consensus       434 --~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~----------  501 (563)
                        ........++..|+|||++....           ..++.++|||||||++|||++|+.||........          
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~-----------~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  228 (314)
T cd08216         160 VVHDFPKSSVKNLPWLSPEVLQQNL-----------QGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVP  228 (314)
T ss_pred             ccccccccccccccccCHHHhcCCC-----------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCc
Confidence              11122345778899999885421           2357899999999999999999999864321100          


Q ss_pred             ----------------------------------hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          502 ----------------------------------KMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       502 ----------------------------------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                                                        ....+...+.+++.+||+.||++||++.++++.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  295 (314)
T cd08216         229 CLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH  295 (314)
T ss_pred             cccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence                                              011223457889999999999999999999874

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=8.6e-33  Score=291.54  Aligned_cols=226  Identities=27%  Similarity=0.394  Sum_probs=181.4

Q ss_pred             CCccceecccCcEEEEEEEE--CCceEEEEEeccC----ChHHHHHHHHHHHhccccce---------------------
Q 044997          294 FDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSN----KSKEFFAELKVLCKIHHINV---------------------  346 (563)
Q Consensus       294 f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~----~~~~f~~Ei~~l~~l~H~ni---------------------  346 (563)
                      |...+.||+||||.||+|+.  .|+.||||.++..    ..+...+|+++|++++|+||                     
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl   94 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL   94 (732)
T ss_pred             eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence            44467899999999999986  4899999998763    35778899999999999998                     


Q ss_pred             EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEec--CCC--cEEEeecC
Q 044997          347 FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLD--DGL--RAKVADFG  422 (563)
Q Consensus       347 V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~--~~~--~~kl~DFG  422 (563)
                      ||||+.+|||+..|..+.  ....|++.+.+.+..+++.||.|||+++   |+||||||.||++-  .+|  --||+|||
T Consensus        95 vmEyC~gGsL~~~L~~PE--N~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG  169 (732)
T KOG4250|consen   95 VMEYCSGGSLRKVLNSPE--NAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFG  169 (732)
T ss_pred             EEeecCCCcHHHHhcCcc--cccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeeccc
Confidence            589999999999998753  3466999999999999999999999998   99999999999983  333  47999999


Q ss_pred             CCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCch-
Q 044997          423 LVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPT-  501 (563)
Q Consensus       423 la~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~-  501 (563)
                      .||.++.+.    ..+..+||..|.+||++...            ..++..+|.|||||++||++||..||........ 
T Consensus       170 ~Arel~d~s----~~~S~vGT~~YLhPel~E~q------------~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~  233 (732)
T KOG4250|consen  170 AARELDDNS----LFTSLVGTEEYLHPELYERQ------------KKYTATVDLWSFGVTLYECATGELPFIPFGGPKNN  233 (732)
T ss_pred             ccccCCCCC----eeeeecCchhhcChHHHhhc------------cCcCceeehhhhhhHHHHHhccCCCCCcCCCcccc
Confidence            999766443    45678999999999998632            3358899999999999999999999854332210 


Q ss_pred             --------------------------------------hhHHHHHHHHHHHHHhhccCCCCCC--CHHHHHHHHHHhhh
Q 044997          502 --------------------------------------KMKSLITIMAAVAEWCLNEDAVDRP--EMRDIVAILSQIMI  540 (563)
Q Consensus       502 --------------------------------------~~~~~~~~l~~li~~cl~~dP~~RP--s~~evl~~L~~i~~  540 (563)
                                                            ....+...+...+..++..+|.+|-  .+.+....+..|+.
T Consensus       234 ~~~~~~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~  312 (732)
T KOG4250|consen  234 KEIMWHIITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILN  312 (732)
T ss_pred             chhhhhhhccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHh
Confidence                                                  0112223355666778888888888  77777777777664

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=3e-32  Score=276.34  Aligned_cols=219  Identities=25%  Similarity=0.351  Sum_probs=171.2

Q ss_pred             cCCCccceecccCcEEEEEEEEC--CceEEEEEeccCC-----hHHHHHHHHHHHhccccceE-----------------
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNK-----SKEFFAELKVLCKIHHINVF-----------------  347 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~-----~~~f~~Ei~~l~~l~H~niV-----------------  347 (563)
                      ++|+..+.||+|+||.||+|...  ++.+|+|.++...     ...+.+|++++++++||||+                 
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            46788899999999999999884  6789999986432     23567899999999999983                 


Q ss_pred             EEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccc
Q 044997          348 ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLE  427 (563)
Q Consensus       348 ~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~  427 (563)
                      +||+. ++|.+++..    ....+++..+..++.|++.||+|||+.+   ++|+||||+||++++++.+||+|||+++..
T Consensus        85 ~e~~~-~~L~~~~~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~  156 (293)
T cd07843          85 MEYVE-HDLKSLMET----MKQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREY  156 (293)
T ss_pred             ehhcC-cCHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeec
Confidence            34444 466666543    1236899999999999999999999997   999999999999999999999999998865


Q ss_pred             ccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCchh-----
Q 044997          428 ERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTK-----  502 (563)
Q Consensus       428 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~~-----  502 (563)
                      .....   ......++..|+|||.+.+..            ..+.++|+||||+++|||++|+.||.........     
T Consensus       157 ~~~~~---~~~~~~~~~~~~aPE~~~~~~------------~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~  221 (293)
T cd07843         157 GSPLK---PYTQLVVTLWYRAPELLLGAK------------EYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFK  221 (293)
T ss_pred             cCCcc---ccccccccccccCchhhcCCc------------cccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence            43211   122345788999999875332            2478999999999999999999988543211000     


Q ss_pred             -----------------------------------hHH--HHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          503 -----------------------------------MKS--LITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       503 -----------------------------------~~~--~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                                                         ...  +.+.+.+++.+||+.||++||++.|++.
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         222 LLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             HhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence                                               000  2455789999999999999999999986

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=1.5e-32  Score=277.68  Aligned_cols=224  Identities=25%  Similarity=0.361  Sum_probs=168.9

Q ss_pred             CCCccceecccCcEEEEEEEEC--CceEEEEEeccCC----hHHHHHHHHHHHhcc-ccceE---------------EEe
Q 044997          293 NFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNK----SKEFFAELKVLCKIH-HINVF---------------IST  350 (563)
Q Consensus       293 ~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~----~~~f~~Ei~~l~~l~-H~niV---------------~e~  350 (563)
                      +|...+.||+|+||.||++...  ++.+|+|.+....    ...+.+|+.++.++. |+||+               +||
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~   84 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL   84 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence            4455678999999999999874  6889999986432    356889999999996 99984               233


Q ss_pred             ecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCceEeCCCCCCCeEecCCCcEEEeecCCCccccc
Q 044997          351 FGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDH-TKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEER  429 (563)
Q Consensus       351 ~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~  429 (563)
                      +. +++.++...........+++.....++.+++.||+|||+. +   ++||||||+||++++++.+||+|||+++....
T Consensus        85 ~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  160 (288)
T cd06616          85 MD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLVD  160 (288)
T ss_pred             cc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence            32 2333322110111235689999999999999999999974 5   99999999999999999999999999875432


Q ss_pred             ccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc---------
Q 044997          430 TNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP---------  500 (563)
Q Consensus       430 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~---------  500 (563)
                      ..    ......|+..|+|||.+....          ...++.++|||||||++|||++|+.||.......         
T Consensus       161 ~~----~~~~~~~~~~y~aPE~~~~~~----------~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~  226 (288)
T cd06616         161 SI----AKTRDAGCRPYMAPERIDPSA----------RDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKG  226 (288)
T ss_pred             CC----ccccccCccCccCHHHhcccc----------ccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCC
Confidence            21    112345888999999885431          1245889999999999999999999985432100         


Q ss_pred             -------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          501 -------TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       501 -------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                             .........+.+++.+||+.||++||++.+|++.
T Consensus       227 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         227 DPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             CCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                   0011245668999999999999999999999874

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=5.1e-32  Score=273.02  Aligned_cols=220  Identities=21%  Similarity=0.313  Sum_probs=174.5

Q ss_pred             CCCccceecccCcEEEEEEEE--CCceEEEEEeccCC----hHHHHHHHHHHHhccccce---------------EEEee
Q 044997          293 NFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNK----SKEFFAELKVLCKIHHINV---------------FISTF  351 (563)
Q Consensus       293 ~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~----~~~f~~Ei~~l~~l~H~ni---------------V~e~~  351 (563)
                      +|+..+.||+|++|.||+|+.  ++..+|||.++...    .+.+.+|++++++++|+|+               |+||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            578889999999999999988  47889999986532    3567889999999999997               56777


Q ss_pred             cCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccccccc
Q 044997          352 GNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTN  431 (563)
Q Consensus       352 ~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~  431 (563)
                      + |+|.+++....  ....+++..+..++.|++.||+|||+.+   ++||||||+||++++++.+||+|||+++......
T Consensus        81 ~-~~l~~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~  154 (284)
T cd07836          81 D-KDLKKYMDTHG--VRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPV  154 (284)
T ss_pred             C-ccHHHHHHhcC--CCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc
Confidence            7 47888775421  2346899999999999999999999987   9999999999999999999999999987543221


Q ss_pred             ccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCchh---------
Q 044997          432 EKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTK---------  502 (563)
Q Consensus       432 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~~---------  502 (563)
                      .   ......++..|++||.+.+.            ..++.++|||||||++|||++|+.||.........         
T Consensus       155 ~---~~~~~~~~~~y~~PE~~~~~------------~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~  219 (284)
T cd07836         155 N---TFSNEVVTLWYRAPDVLLGS------------RTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGT  219 (284)
T ss_pred             c---ccccccccccccChHHhcCC------------CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Confidence            1   11224578899999987432            23478999999999999999999998654321100         


Q ss_pred             ------------------------------hHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          503 ------------------------------MKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       503 ------------------------------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                                                    .......+.+++.+|++.||.+||++.|+++
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         220 PTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             CChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                                          0122345789999999999999999999875

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=4.5e-32  Score=274.39  Aligned_cols=215  Identities=24%  Similarity=0.424  Sum_probs=174.5

Q ss_pred             CCccceecccCcEEEEEEEE--CCceEEEEEeccCC---hHHHHHHHHHHHhccccce---------------EEEeecC
Q 044997          294 FDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNK---SKEFFAELKVLCKIHHINV---------------FISTFGN  353 (563)
Q Consensus       294 f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~---~~~f~~Ei~~l~~l~H~ni---------------V~e~~~~  353 (563)
                      |...+.||+|++|.||++..  .++.+++|+++...   .+.+.+|+.++++++|+|+               ++||+.+
T Consensus        21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~  100 (285)
T cd06648          21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG  100 (285)
T ss_pred             hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence            45568999999999999986  46889999886432   3568899999999999996               5688889


Q ss_pred             CCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccccccccc
Q 044997          354 GSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEK  433 (563)
Q Consensus       354 gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~  433 (563)
                      ++|.+++..      ..+++..+..++.|++.||+|||+++   ++||||||+||+++.++.+||+|||++........ 
T Consensus       101 ~~L~~~~~~------~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-  170 (285)
T cd06648         101 GALTDIVTH------TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-  170 (285)
T ss_pred             CCHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCc-
Confidence            999988864      45899999999999999999999997   99999999999999999999999998875432211 


Q ss_pred             ccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc-------------
Q 044997          434 EMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP-------------  500 (563)
Q Consensus       434 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~-------------  500 (563)
                        ......|+..|+|||.+.+..             ++.++|||||||++|||++|+.||...+...             
T Consensus       171 --~~~~~~~~~~y~aPE~~~~~~-------------~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~  235 (285)
T cd06648         171 --RRKSLVGTPYWMAPEVISRLP-------------YGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKL  235 (285)
T ss_pred             --ccccccCCccccCHHHhcCCC-------------CCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCC
Confidence              112245889999999875433             4789999999999999999999986543210             


Q ss_pred             hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          501 TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       501 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                      .........+.+++.+||+.+|.+||++.++++
T Consensus       236 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         236 KNLHKVSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             cccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence            001123456899999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2e-32  Score=298.19  Aligned_cols=228  Identities=22%  Similarity=0.308  Sum_probs=161.3

Q ss_pred             HHhcCCCccceecccCcEEEEEEEECC---ceEEE------------------EEeccC--ChHHHHHHHHHHHhccccc
Q 044997          289 EATNNFDESRIIGRGGFGNVYFGLLGD---REAAI------------------KKMRSN--KSKEFFAELKVLCKIHHIN  345 (563)
Q Consensus       289 ~~~~~f~~~~~LG~G~fG~Vy~g~~~~---~~vav------------------K~~~~~--~~~~f~~Ei~~l~~l~H~n  345 (563)
                      ...++|+..+.||+|+||.||++..+.   ...+.                  |+++..  ....+.+|+++|++++|+|
T Consensus       145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn  224 (501)
T PHA03210        145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN  224 (501)
T ss_pred             hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence            345789999999999999999986532   11121                  111111  1345889999999999999


Q ss_pred             eE--EEeec------------CCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEec
Q 044997          346 VF--ISTFG------------NGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLD  411 (563)
Q Consensus       346 iV--~e~~~------------~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~  411 (563)
                      ||  ++++.            .++|.+++..............+...|+.|++.||+|||+++   |+||||||+|||++
T Consensus       225 Iv~l~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl~  301 (501)
T PHA03210        225 ILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFLN  301 (501)
T ss_pred             cCcEeEEEEECCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEC
Confidence            84  22221            345555554322222223345667789999999999999987   99999999999999


Q ss_pred             CCCcEEEeecCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCC
Q 044997          412 DGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKR  491 (563)
Q Consensus       412 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~  491 (563)
                      .++.+||+|||+++.......  .......||..|+|||++.+..             ++.++|||||||++|||++|+.
T Consensus       302 ~~~~vkL~DFGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~-------------~~~~~DiwSlGvil~ell~~~~  366 (501)
T PHA03210        302 CDGKIVLGDFGTAMPFEKERE--AFDYGWVGTVATNSPEILAGDG-------------YCEITDIWSCGLILLDMLSHDF  366 (501)
T ss_pred             CCCCEEEEeCCCceecCcccc--cccccccCCcCCCCchhhcCCC-------------CCcHHHHHHHHHHHHHHHHCCC
Confidence            999999999999986543221  1222357999999999986544             4789999999999999999886


Q ss_pred             CCcCCCC-Cc-hhh------------------H-------------------------HHHHHHHHHHHHhhccCCCCCC
Q 044997          492 ALIRDDS-EP-TKM------------------K-------------------------SLITIMAAVAEWCLNEDAVDRP  526 (563)
Q Consensus       492 p~~~~~~-~~-~~~------------------~-------------------------~~~~~l~~li~~cl~~dP~~RP  526 (563)
                      ++..... .. ...                  .                         .+...+.+++.+||+.||.+||
T Consensus       367 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rp  446 (501)
T PHA03210        367 CPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRP  446 (501)
T ss_pred             CCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCc
Confidence            5432211 00 000                  0                         0112256678899999999999


Q ss_pred             CHHHHHHH
Q 044997          527 EMRDIVAI  534 (563)
Q Consensus       527 s~~evl~~  534 (563)
                      ++.|++..
T Consensus       447 sa~elL~h  454 (501)
T PHA03210        447 GAAELLAL  454 (501)
T ss_pred             CHHHHhhC
Confidence            99999863

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=2.6e-32  Score=282.80  Aligned_cols=223  Identities=23%  Similarity=0.342  Sum_probs=174.1

Q ss_pred             HhcCCCccceecccCcEEEEEEEE--CCceEEEEEeccC-----ChHHHHHHHHHHHhc-cccce---------------
Q 044997          290 ATNNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSN-----KSKEFFAELKVLCKI-HHINV---------------  346 (563)
Q Consensus       290 ~~~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~-----~~~~f~~Ei~~l~~l-~H~ni---------------  346 (563)
                      ..++|+..+.||+|+||.||+|..  .++.+|+|++...     ....+.+|+.+++++ +|+||               
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~   84 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI   84 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence            356788889999999999999987  4688999988532     235577899999999 99997               


Q ss_pred             --EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCC
Q 044997          347 --FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLV  424 (563)
Q Consensus       347 --V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla  424 (563)
                        |+||++ ++|.+++..      ..++|..+..++.|++.||+|||+.+   ++||||||+||++++++.+||+|||++
T Consensus        85 ~lv~e~~~-~~L~~~~~~------~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~  154 (337)
T cd07852          85 YLVFEYME-TDLHAVIRA------NILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLA  154 (337)
T ss_pred             EEEecccc-cCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccch
Confidence              345554 466666543      26889999999999999999999987   999999999999999999999999999


Q ss_pred             ccccccccc--ccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCch-
Q 044997          425 KLEERTNEK--EMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPT-  501 (563)
Q Consensus       425 ~~~~~~~~~--~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~-  501 (563)
                      +........  ........|+..|+|||.+.+.            ...+.++||||||+++|||++|+.||........ 
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~------------~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~  222 (337)
T cd07852         155 RSLSELEENPENPVLTDYVATRWYRAPEILLGS------------TRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQL  222 (337)
T ss_pred             hccccccccccCcchhcccccccccCceeeecc------------ccccccchHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence            865433211  1122345689999999987432            2347899999999999999999999854321100 


Q ss_pred             ----------------------------------------hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          502 ----------------------------------------KMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       502 ----------------------------------------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                                                              ........+.+++.+||+.||.+||++.++++.
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         223 EKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             HHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence                                                    001123457899999999999999999999975

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-33  Score=313.25  Aligned_cols=228  Identities=28%  Similarity=0.375  Sum_probs=183.4

Q ss_pred             HHHhcCCCccceecccCcEEEEEEEE--CCceEEEEEeccCC-----hHHHHHHHHHHHhccccceE-------------
Q 044997          288 EEATNNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNK-----SKEFFAELKVLCKIHHINVF-------------  347 (563)
Q Consensus       288 ~~~~~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~-----~~~f~~Ei~~l~~l~H~niV-------------  347 (563)
                      ...+-++.....||.|.||.||-|..  +|...|+|-++-+.     .+...+|+.+|..++|||+|             
T Consensus      1231 snV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~ 1310 (1509)
T KOG4645|consen 1231 SNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVY 1310 (1509)
T ss_pred             ccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHH
Confidence            34456778889999999999999976  46778999876432     25577899999999999984             


Q ss_pred             --EEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCc
Q 044997          348 --ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK  425 (563)
Q Consensus       348 --~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~  425 (563)
                        |||+++|+|.+.+..     ....++.-...+-.|++.|+.|||++|   ||||||||.||+|+.+|.+|++|||.|.
T Consensus      1311 IFMEyC~~GsLa~ll~~-----gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ 1382 (1509)
T KOG4645|consen 1311 IFMEYCEGGSLASLLEH-----GRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAV 1382 (1509)
T ss_pred             HHHHHhccCcHHHHHHh-----cchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeeccccee
Confidence              699999999998864     234555555667789999999999998   9999999999999999999999999998


Q ss_pred             cccccc-ccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCC------
Q 044997          426 LEERTN-EKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDS------  498 (563)
Q Consensus       426 ~~~~~~-~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~------  498 (563)
                      .+.... ..........||+.|||||++.+.+-         .| -..+.||||+|||.+||+||++||..-+.      
T Consensus      1383 ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~---------kG-~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy 1452 (1509)
T KOG4645|consen 1383 KIKNNAQTMPGELQSMMGTPMYMAPEVITGTKG---------KG-HGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMY 1452 (1509)
T ss_pred             EecCchhcCCHHHHhhcCCchhcCchhhccccc---------CC-CCcchhhhcccceEEEeecCCCchhhccchhHHHh
Confidence            765432 11222345789999999999976542         11 25689999999999999999999864332      


Q ss_pred             ------CchhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          499 ------EPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       499 ------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                            .+..+..+..+-++++.+|++.||++|.++.|+++
T Consensus      1453 ~V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1453 HVAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred             HHhccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence                  34445568888999999999999999988776665

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-32  Score=278.82  Aligned_cols=219  Identities=21%  Similarity=0.350  Sum_probs=186.2

Q ss_pred             cCCCccceecccCcEEEEEEEE--CCceEEEEEeccCCh-----HHHHHHHHHHHhccccceE---------------EE
Q 044997          292 NNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNKS-----KEFFAELKVLCKIHHINVF---------------IS  349 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~~-----~~f~~Ei~~l~~l~H~niV---------------~e  349 (563)
                      .-|+..+.||+|.|..|-++++  .|.+||||++.+.+.     ..+.+|+.-|+-++|||||               .|
T Consensus        18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE   97 (864)
T KOG4717|consen   18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE   97 (864)
T ss_pred             eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence            3467778999999999998854  899999999987653     4578899999999999995               35


Q ss_pred             eecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEe-cCCCcEEEeecCCCcccc
Q 044997          350 TFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILL-DDGLRAKVADFGLVKLEE  428 (563)
Q Consensus       350 ~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl-~~~~~~kl~DFGla~~~~  428 (563)
                      .-.+|+|.+|+..    ....+.+....+++.||+.|+.|+|...   +|||||||+||.+ ..-|-+||.|||++..+.
T Consensus        98 LGD~GDl~DyImK----He~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~  170 (864)
T KOG4717|consen   98 LGDGGDLFDYIMK----HEEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ  170 (864)
T ss_pred             ecCCchHHHHHHh----hhccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCC
Confidence            5568899999975    2456899999999999999999999986   9999999999976 456899999999998766


Q ss_pred             cccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc--------
Q 044997          429 RTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP--------  500 (563)
Q Consensus       429 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~--------  500 (563)
                      ++.    ..+..+|+..|.|||++.+..|+            .++.||||+||+||-|++|+.||...+..+        
T Consensus       171 PG~----kL~TsCGSLAYSAPEILLGDsYD------------APAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDC  234 (864)
T KOG4717|consen  171 PGK----KLTTSCGSLAYSAPEILLGDSYD------------APAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDC  234 (864)
T ss_pred             Ccc----hhhcccchhhccCchhhhcCccC------------CcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcc
Confidence            543    34557899999999999999886            789999999999999999999998665432        


Q ss_pred             --hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          501 --TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       501 --~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                        ..+..+..+.++||..||..||.+|.+.+||+.
T Consensus       235 KYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s  269 (864)
T KOG4717|consen  235 KYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS  269 (864)
T ss_pred             cccCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence              234567788999999999999999999999875

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=99.98  E-value=4.6e-32  Score=270.20  Aligned_cols=209  Identities=26%  Similarity=0.410  Sum_probs=171.2

Q ss_pred             ecccCcEEEEEEEEC--CceEEEEEeccC------ChHHHHHHHHHHHhccccce---------------EEEeecCCCc
Q 044997          300 IGRGGFGNVYFGLLG--DREAAIKKMRSN------KSKEFFAELKVLCKIHHINV---------------FISTFGNGSL  356 (563)
Q Consensus       300 LG~G~fG~Vy~g~~~--~~~vavK~~~~~------~~~~f~~Ei~~l~~l~H~ni---------------V~e~~~~gsL  356 (563)
                      ||.|+||.||+++..  ++.+|+|.+...      ..+.+.+|++++++++|+||               ++||+++|+|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            699999999999986  789999998643      23568899999999999997               5789999999


Q ss_pred             ccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccccccccccc
Q 044997          357 SDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEML  436 (563)
Q Consensus       357 ~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~  436 (563)
                      .+++..     ...+++..+..++.|++.||+|||+.+   ++|+||||+||++++++.+||+|||+++......    .
T Consensus        81 ~~~l~~-----~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~----~  148 (262)
T cd05572          81 WTILRD-----RGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ----K  148 (262)
T ss_pred             HHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc----c
Confidence            999865     245899999999999999999999987   9999999999999999999999999988654321    1


Q ss_pred             cccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCchh--------------
Q 044997          437 ATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTK--------------  502 (563)
Q Consensus       437 ~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~~--------------  502 (563)
                      .....|+..|+|||.+....             ++.++|+||||+++|||++|+.|+.........              
T Consensus       149 ~~~~~~~~~~~~PE~~~~~~-------------~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  215 (262)
T cd05572         149 TWTFCGTPEYVAPEIILNKG-------------YDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEF  215 (262)
T ss_pred             cccccCCcCccChhHhcCCC-------------CCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCC
Confidence            12346788999999875433             478999999999999999999999765421111              


Q ss_pred             hHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 044997          503 MKSLITIMAAVAEWCLNEDAVDRPE-----MRDIVA  533 (563)
Q Consensus       503 ~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~  533 (563)
                      +....+.+.+++.+||+.||++||+     +.|+++
T Consensus       216 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         216 PNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             CcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence            1122456899999999999999999     565554

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.98  E-value=6.1e-32  Score=274.27  Aligned_cols=220  Identities=24%  Similarity=0.328  Sum_probs=171.2

Q ss_pred             cCCCccceecccCcEEEEEEEEC--CceEEEEEeccC-----ChHHHHHHHHHHHhccccce---------------EEE
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSN-----KSKEFFAELKVLCKIHHINV---------------FIS  349 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~-----~~~~f~~Ei~~l~~l~H~ni---------------V~e  349 (563)
                      ++|+..+.||+|++|.||+|...  ++.+|+|.++..     ..+.+.+|++++++++|+|+               |+|
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            56888999999999999999874  678999988643     23568899999999999998               467


Q ss_pred             eecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecC-CCcEEEeecCCCcccc
Q 044997          350 TFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDD-GLRAKVADFGLVKLEE  428 (563)
Q Consensus       350 ~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~-~~~~kl~DFGla~~~~  428 (563)
                      |++ ++|.+++..   .....+++.....++.|++.||+|||+++   ++||||||+||++++ ++.+||+|||+++...
T Consensus        82 ~~~-~~l~~~~~~---~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~  154 (294)
T PLN00009         82 YLD-LDLKKHMDS---SPDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFG  154 (294)
T ss_pred             ccc-ccHHHHHHh---CCCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccC
Confidence            775 577776643   12334678888899999999999999987   999999999999985 5679999999997543


Q ss_pred             cccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCchh------
Q 044997          429 RTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTK------  502 (563)
Q Consensus       429 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~~------  502 (563)
                      ....   ..+...++..|+|||++.+.            ..++.++||||||+++|||++|+.||.........      
T Consensus       155 ~~~~---~~~~~~~~~~y~~PE~~~~~------------~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~  219 (294)
T PLN00009        155 IPVR---TFTHEVVTLWYRAPEILLGS------------RHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRI  219 (294)
T ss_pred             CCcc---ccccCceeecccCHHHHhCC------------CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence            2211   11234578899999987432            23478999999999999999999998643221000      


Q ss_pred             ---------------------------------hHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          503 ---------------------------------MKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       503 ---------------------------------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                                                       .......+.+++.+|++.||++||++.++++
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        220 LGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             hCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence                                             0112345789999999999999999999986

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=99.98  E-value=6.1e-32  Score=272.65  Aligned_cols=211  Identities=25%  Similarity=0.361  Sum_probs=164.8

Q ss_pred             eecccCcEEEEEEEE--CCceEEEEEeccCC------hHHHHHHHHHHHh---ccccce---------------EEEeec
Q 044997          299 IIGRGGFGNVYFGLL--GDREAAIKKMRSNK------SKEFFAELKVLCK---IHHINV---------------FISTFG  352 (563)
Q Consensus       299 ~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~------~~~f~~Ei~~l~~---l~H~ni---------------V~e~~~  352 (563)
                      .||+|+||.||++..  +++.+|+|.+....      ...+.+|..++..   .+|+|+               |+||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            489999999999987  46889999886432      1234455444333   468886               579999


Q ss_pred             CCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccccccc
Q 044997          353 NGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNE  432 (563)
Q Consensus       353 ~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~  432 (563)
                      +|+|.+++..     ...++|..+..++.|++.||+|||+.+   ++||||||+|||+++++.+||+|||++....... 
T Consensus        81 ~~~L~~~i~~-----~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~-  151 (279)
T cd05633          81 GGDLHYHLSQ-----HGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-  151 (279)
T ss_pred             CCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC-
Confidence            9999988864     356999999999999999999999997   9999999999999999999999999987543211 


Q ss_pred             cccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCch-----------
Q 044997          433 KEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPT-----------  501 (563)
Q Consensus       433 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~-----------  501 (563)
                          .....|+..|+|||.+..+            ..++.++|||||||++|||++|+.||........           
T Consensus       152 ----~~~~~~~~~y~aPE~~~~~------------~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  215 (279)
T cd05633         152 ----PHASVGTHGYMAPEVLQKG------------TAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVN  215 (279)
T ss_pred             ----ccCcCCCcCccCHHHhcCC------------CCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCC
Confidence                1224689999999987422            2347899999999999999999999965432111           


Q ss_pred             --hhHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 044997          502 --KMKSLITIMAAVAEWCLNEDAVDRP-----EMRDIVAI  534 (563)
Q Consensus       502 --~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  534 (563)
                        ....+...+.+++.+||+.||++||     +++|+++.
T Consensus       216 ~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         216 VELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             cCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence              1123445689999999999999999     58888664

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.98  E-value=8.9e-32  Score=279.58  Aligned_cols=228  Identities=23%  Similarity=0.358  Sum_probs=169.8

Q ss_pred             hcCCCccceecccCcEEEEEEEE--CCceEEEEEeccCC-----hHHHHHHHHHHHhccccceEE--EeecCC----Ccc
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNK-----SKEFFAELKVLCKIHHINVFI--STFGNG----SLS  357 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~-----~~~f~~Ei~~l~~l~H~niV~--e~~~~g----sL~  357 (563)
                      .++|...+.||+|+||.||+|+.  +++.+|+|+++...     ...+.+|++++++++|+||+.  +++...    +..
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            37899999999999999999986  47899999986431     245789999999999999842  221110    000


Q ss_pred             ------cccccccc-cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccccc
Q 044997          358 ------DHLHDPLL-KGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERT  430 (563)
Q Consensus       358 ------~~L~~~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~  430 (563)
                            +++..... .....+++..+..++.|++.||+|||+++   ++||||||+||++++++.+||+|||+++.....
T Consensus        94 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~  170 (342)
T cd07879          94 DFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHADAE  170 (342)
T ss_pred             eEEEEecccccCHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCCcCCCCC
Confidence                  11110000 01235899999999999999999999987   999999999999999999999999998754221


Q ss_pred             cccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCchh--------
Q 044997          431 NEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTK--------  502 (563)
Q Consensus       431 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~~--------  502 (563)
                            .....++..|+|||.+.+.            ..++.++|||||||++|||++|+.||...+.....        
T Consensus       171 ------~~~~~~~~~y~aPE~~~~~------------~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~  232 (342)
T cd07879         171 ------MTGYVVTRWYRAPEVILNW------------MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTG  232 (342)
T ss_pred             ------CCCceeeecccChhhhcCc------------cccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence                  1234578889999987432            23478999999999999999999999754311000        


Q ss_pred             ---------------------------------hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHHhh
Q 044997          503 ---------------------------------MKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI--LSQIM  539 (563)
Q Consensus       503 ---------------------------------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~i~  539 (563)
                                                       .......+.+++.+||+.||.+||++.+++..  ++.+.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~  304 (342)
T cd07879         233 VPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR  304 (342)
T ss_pred             CCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence                                             00112347899999999999999999999864  55543

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=4.7e-33  Score=287.46  Aligned_cols=223  Identities=21%  Similarity=0.398  Sum_probs=182.5

Q ss_pred             CCccceecccCcEEEEEEEECCce--EEEEEeccC---ChHHHHHHHHHHHhccccce---------------EEEeecC
Q 044997          294 FDESRIIGRGGFGNVYFGLLGDRE--AAIKKMRSN---KSKEFFAELKVLCKIHHINV---------------FISTFGN  353 (563)
Q Consensus       294 f~~~~~LG~G~fG~Vy~g~~~~~~--vavK~~~~~---~~~~f~~Ei~~l~~l~H~ni---------------V~e~~~~  353 (563)
                      |.+...||.|+||.||++..+...  .|.|.+...   ..++|+-|++||...+||+|               ++|||++
T Consensus        34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~G  113 (1187)
T KOG0579|consen   34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGG  113 (1187)
T ss_pred             HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCC
Confidence            555678999999999999876543  467777543   35789999999999999997               4699999


Q ss_pred             CCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccccccccc
Q 044997          354 GSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEK  433 (563)
Q Consensus       354 gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~  433 (563)
                      |-.+..+.+    -..+|+..++..++++++.||.|||++.   |||||||+.|||++-+|.++|+|||.+.......  
T Consensus       114 GAVDaimlE----L~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~--  184 (1187)
T KOG0579|consen  114 GAVDAIMLE----LGRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTR--  184 (1187)
T ss_pred             chHhHHHHH----hccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchhHH--
Confidence            998877754    2467999999999999999999999997   9999999999999999999999999976433221  


Q ss_pred             ccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCC-----------C--c
Q 044997          434 EMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDS-----------E--P  500 (563)
Q Consensus       434 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~-----------~--~  500 (563)
                       .....+.||+.|||||+.....+        ....|+.++||||||++|.||..+.+|...-..           .  .
T Consensus       185 -qkRDsFIGTPYWMAPEVvmCET~--------KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTL  255 (1187)
T KOG0579|consen  185 -QKRDSFIGTPYWMAPEVVMCETF--------KDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTL  255 (1187)
T ss_pred             -hhhccccCCcccccchheeeccc--------cCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcc
Confidence             12234789999999999877654        456778999999999999999999988643221           1  1


Q ss_pred             hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          501 TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       501 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                      ..+..+...+.+++++||.+||..||++.++++.
T Consensus       256 lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H  289 (1187)
T KOG0579|consen  256 LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH  289 (1187)
T ss_pred             cCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence            2345677779999999999999999999999864

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=99.98  E-value=1.2e-31  Score=275.43  Aligned_cols=218  Identities=32%  Similarity=0.491  Sum_probs=174.5

Q ss_pred             CCccceecccCcEEEEEEEE--CCceEEEEEeccCC------hHHHHHHHHHHHhccccce---------------EEEe
Q 044997          294 FDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNK------SKEFFAELKVLCKIHHINV---------------FIST  350 (563)
Q Consensus       294 f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~------~~~f~~Ei~~l~~l~H~ni---------------V~e~  350 (563)
                      |+..+.||+|+||.||+|+.  ++..+|+|.+....      .+++.+|++++++++|+|+               |+||
T Consensus        27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  106 (317)
T cd06635          27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY  106 (317)
T ss_pred             hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence            66788999999999999987  46889999986431      2468889999999999997               4566


Q ss_pred             ecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccccc
Q 044997          351 FGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERT  430 (563)
Q Consensus       351 ~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~  430 (563)
                      +. |+|.+.+..    ...+++|.++..++.|++.||.|||+++   ++||||+|+||+++.++.+||+|||++......
T Consensus       107 ~~-g~l~~~~~~----~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~  178 (317)
T cd06635         107 CL-GSASDLLEV----HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPA  178 (317)
T ss_pred             CC-CCHHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCCc
Confidence            65 577666643    2356899999999999999999999987   999999999999999999999999998753321


Q ss_pred             cccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc----------
Q 044997          431 NEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP----------  500 (563)
Q Consensus       431 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~----------  500 (563)
                             ....|+..|+|||++...          ..+.++.++|||||||++|||++|+.||.......          
T Consensus       179 -------~~~~~~~~y~aPE~~~~~----------~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~  241 (317)
T cd06635         179 -------NSFVGTPYWMAPEVILAM----------DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES  241 (317)
T ss_pred             -------ccccCCccccChhhhhcC----------CCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccC
Confidence                   224578899999987421          12345889999999999999999999986543211          


Q ss_pred             --hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 044997          501 --TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILS  536 (563)
Q Consensus       501 --~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  536 (563)
                        .........+.+++.+||+.+|.+||++.++++.+-
T Consensus       242 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~  279 (317)
T cd06635         242 PTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMF  279 (317)
T ss_pred             CCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChh
Confidence              111234556899999999999999999999998654

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.98  E-value=1.9e-31  Score=268.65  Aligned_cols=217  Identities=25%  Similarity=0.378  Sum_probs=172.5

Q ss_pred             CCccceecccCcEEEEEEEEC--CceEEEEEeccCC----hHHHHHHHHHHHhcc-ccce---------------EEEee
Q 044997          294 FDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNK----SKEFFAELKVLCKIH-HINV---------------FISTF  351 (563)
Q Consensus       294 f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~----~~~f~~Ei~~l~~l~-H~ni---------------V~e~~  351 (563)
                      |+..+.||+|+||.||+|...  ++.++||++....    .....+|+..+++++ |+|+               |+||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            566789999999999999984  6789999986532    234567999999999 9987               67888


Q ss_pred             cCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccccccc
Q 044997          352 GNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTN  431 (563)
Q Consensus       352 ~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~  431 (563)
                       +|+|.+++...   ....++|.++..++.|++.+|.|||+++   ++|+||+|+||++++++.+||+|||+++......
T Consensus        81 -~~~l~~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~  153 (283)
T cd07830          81 -EGNLYQLMKDR---KGKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP  153 (283)
T ss_pred             -CCCHHHHHHhc---ccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCC
Confidence             88998888652   2356899999999999999999999987   9999999999999999999999999987543221


Q ss_pred             ccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCchh---------
Q 044997          432 EKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTK---------  502 (563)
Q Consensus       432 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~~---------  502 (563)
                      .    .....++..|+|||.+...            ..++.++||||||+++|||++|+.||.........         
T Consensus       154 ~----~~~~~~~~~~~aPE~~~~~------------~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~  217 (283)
T cd07830         154 P----YTDYVSTRWYRAPEILLRS------------TSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGT  217 (283)
T ss_pred             C----cCCCCCcccccCceeeecC------------cCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCC
Confidence            1    1234578899999987432            23578999999999999999999888543211000         


Q ss_pred             ---------------------------hH----HHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          503 ---------------------------MK----SLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       503 ---------------------------~~----~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                                                 ..    .....+.+++.+||+.||++||+++|++.
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  279 (283)
T cd07830         218 PTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ  279 (283)
T ss_pred             CChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence                                       00    11245889999999999999999999875

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.98  E-value=7.3e-32  Score=275.90  Aligned_cols=220  Identities=27%  Similarity=0.374  Sum_probs=171.5

Q ss_pred             hcCCCccceecccCcEEEEEEEE--CCceEEEEEeccCC-----hHHHHHHHHHHHhccccce-----------------
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNK-----SKEFFAELKVLCKIHHINV-----------------  346 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~-----~~~f~~Ei~~l~~l~H~ni-----------------  346 (563)
                      .++|+..+.||+|+||.||+|..  .++.||+|.++...     ...+.+|++++++++|+|+                 
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            35788899999999999999987  47899999986432     2346789999999999997                 


Q ss_pred             EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcc
Q 044997          347 FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKL  426 (563)
Q Consensus       347 V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~  426 (563)
                      |+||+. ++|.+++..    ....+++.++..++.|+++||+|||+.+   ++||||||+||++++++.+||+|||+++.
T Consensus        86 v~e~~~-~~l~~~l~~----~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~  157 (309)
T cd07845          86 VMEYCE-QDLASLLDN----MPTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLART  157 (309)
T ss_pred             EEecCC-CCHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeee
Confidence            345544 356666543    1356899999999999999999999998   99999999999999999999999999886


Q ss_pred             cccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCch-----
Q 044997          427 EERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPT-----  501 (563)
Q Consensus       427 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~-----  501 (563)
                      ......   ......++..|+|||.+.+..            .++.++||||||+++|||++|+.||........     
T Consensus       158 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~------------~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~  222 (309)
T cd07845         158 YGLPAK---PMTPKVVTLWYRAPELLLGCT------------TYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLII  222 (309)
T ss_pred             cCCccC---CCCcccccccccChhhhcCCC------------CcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            543211   112234578899999875322            347899999999999999999998853321100     


Q ss_pred             -----------------------------------hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          502 -----------------------------------KMKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       502 -----------------------------------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                                                         ........+.+++.+|++.||++||++.|++.
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~  289 (309)
T cd07845         223 QLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE  289 (309)
T ss_pred             HhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence                                               00112455788999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.98  E-value=9.5e-32  Score=274.36  Aligned_cols=223  Identities=23%  Similarity=0.319  Sum_probs=169.6

Q ss_pred             hcCCCccceecccCcEEEEEEEE--CCceEEEEEeccCC-----hHHHHHHHHHHHhccccceE----------------
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNK-----SKEFFAELKVLCKIHHINVF----------------  347 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~-----~~~f~~Ei~~l~~l~H~niV----------------  347 (563)
                      .++|+..+.||+|+||.||+|..  +++.+|||.+....     ...+.+|++++++++||||+                
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   90 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY   90 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence            35688899999999999999987  47889999885432     23567899999999999873                


Q ss_pred             -------EEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEee
Q 044997          348 -------ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVAD  420 (563)
Q Consensus       348 -------~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~D  420 (563)
                             +||+. ++|.+++..    ....+++.++..++.|++.||+|||+++   ++|+||||+||++++++.+||+|
T Consensus        91 ~~~~~lv~e~~~-~~l~~~l~~----~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~d  162 (310)
T cd07865          91 KGSFYLVFEFCE-HDLAGLLSN----KNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLAD  162 (310)
T ss_pred             CceEEEEEcCCC-cCHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECc
Confidence                   23333 355555543    2346899999999999999999999997   99999999999999999999999


Q ss_pred             cCCCccccccccc-ccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCC
Q 044997          421 FGLVKLEERTNEK-EMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE  499 (563)
Q Consensus       421 FGla~~~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~  499 (563)
                      ||++......... ........++..|+|||.+.+..            .++.++||||||+++|||++|+.||......
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~------------~~~~~~Di~slG~~l~el~t~~~~~~~~~~~  230 (310)
T cd07865         163 FGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGER------------DYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQ  230 (310)
T ss_pred             CCCcccccCCcccCCCCccCcccCccccCcHHhcCCc------------ccCchhhhHHHHHHHHHHHhCCCCCCCCCHH
Confidence            9999765432211 11122345788999999874432            2478999999999999999999888543311


Q ss_pred             ch---------------------------------hhHH---------HHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          500 PT---------------------------------KMKS---------LITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       500 ~~---------------------------------~~~~---------~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                      ..                                 ....         ....+.+++.+||..||.+||++.|+++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         231 HQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             HHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence            00                                 0000         0133678999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=99.98  E-value=8.6e-33  Score=277.25  Aligned_cols=215  Identities=26%  Similarity=0.390  Sum_probs=177.3

Q ss_pred             cCCCccceecccCcEEEEEEEE--CCceEEEEEeccCC------hHHHHHHHHHHHhccccce---------------EE
Q 044997          292 NNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNK------SKEFFAELKVLCKIHHINV---------------FI  348 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~------~~~f~~Ei~~l~~l~H~ni---------------V~  348 (563)
                      +.|..-++||+||||.||-++.  .|+-+|.|++.+..      ....++|-.+|.+++.+-|               |+
T Consensus       185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL  264 (591)
T KOG0986|consen  185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL  264 (591)
T ss_pred             cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence            5688889999999999998765  57788988775432      2346789999999988776               56


Q ss_pred             EeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccc
Q 044997          349 STFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEE  428 (563)
Q Consensus       349 e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~  428 (563)
                      ..|.+|+|..||.+   .+...+++..++.++.+|+.||++||...   ||.|||||+|||||++|+++|+|.|+|..+.
T Consensus       265 tlMNGGDLkfHiyn---~g~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~  338 (591)
T KOG0986|consen  265 TLMNGGDLKFHIYN---HGNPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIP  338 (591)
T ss_pred             EeecCCceeEEeec---cCCCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecC
Confidence            88999999999987   34567999999999999999999999987   9999999999999999999999999998665


Q ss_pred             cccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc--------
Q 044997          429 RTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP--------  500 (563)
Q Consensus       429 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~--------  500 (563)
                      ....    ....+||.||||||++.+++|             +...|.||+||++|||+.|+.||.......        
T Consensus       339 ~g~~----~~~rvGT~GYMAPEvl~ne~Y-------------~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr  401 (591)
T KOG0986|consen  339 EGKP----IRGRVGTVGYMAPEVLQNEVY-------------DFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRR  401 (591)
T ss_pred             CCCc----cccccCcccccCHHHHcCCcc-------------cCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHH
Confidence            4332    233489999999999976665             789999999999999999999996543211        


Q ss_pred             ------hhhHHHHHHHHHHHHHhhccCCCCCCCHH
Q 044997          501 ------TKMKSLITIMAAVAEWCLNEDAVDRPEMR  529 (563)
Q Consensus       501 ------~~~~~~~~~l~~li~~cl~~dP~~RPs~~  529 (563)
                            ...+.+++...+|.+..|++||++|--.+
T Consensus       402 ~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr  436 (591)
T KOG0986|consen  402 TLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR  436 (591)
T ss_pred             HhcchhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence                  11234566789999999999999996544

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.98  E-value=1.2e-32  Score=303.75  Aligned_cols=145  Identities=26%  Similarity=0.434  Sum_probs=110.7

Q ss_pred             HHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccc----c-----------cccccccc
Q 044997          373 WTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEE----R-----------TNEKEMLA  437 (563)
Q Consensus       373 ~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~----~-----------~~~~~~~~  437 (563)
                      -...++++++|+.||.|+|+++   +|||||||.||++|++..+||+|||+|+...    .           ........
T Consensus       696 ~d~~wrLFreIlEGLaYIH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~  772 (1351)
T KOG1035|consen  696 RDEAWRLFREILEGLAYIHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDL  772 (1351)
T ss_pred             hHHHHHHHHHHHHHHHHHHhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCccc
Confidence            3456789999999999999998   9999999999999999999999999998621    0           01112234


Q ss_pred             ccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCC------------Cchh---
Q 044997          438 TRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDS------------EPTK---  502 (563)
Q Consensus       438 ~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~------------~~~~---  502 (563)
                      +..+||.-|+|||++.+..          ...|+.|+|+||+|||++||+.-   |....+            .+..   
T Consensus       773 Ts~VGTalYvAPEll~~~~----------~~~Yn~KiDmYSLGIVlFEM~yP---F~TsMERa~iL~~LR~g~iP~~~~f  839 (1351)
T KOG1035|consen  773 TSQVGTALYVAPELLSDTS----------SNKYNSKIDMYSLGIVLFEMLYP---FGTSMERASILTNLRKGSIPEPADF  839 (1351)
T ss_pred             ccccceeeeecHHHhcccc----------cccccchhhhHHHHHHHHHHhcc---CCchHHHHHHHHhcccCCCCCCccc
Confidence            5678999999999985432          24679999999999999999863   322111            1111   


Q ss_pred             hHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          503 MKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       503 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                      ...-...-+.+|.++++.||.+|||+.|++.
T Consensus       840 ~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  840 FDPEHPEEASLIRWLLSHDPSKRPTATELLN  870 (1351)
T ss_pred             ccccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence            1222334578999999999999999999986

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=99.98  E-value=5.8e-32  Score=272.14  Aligned_cols=208  Identities=25%  Similarity=0.375  Sum_probs=167.6

Q ss_pred             ecccCcEEEEEEEE--CCceEEEEEeccCC------hHHHHHHHHHHHhccccce---------------EEEeecCCCc
Q 044997          300 IGRGGFGNVYFGLL--GDREAAIKKMRSNK------SKEFFAELKVLCKIHHINV---------------FISTFGNGSL  356 (563)
Q Consensus       300 LG~G~fG~Vy~g~~--~~~~vavK~~~~~~------~~~f~~Ei~~l~~l~H~ni---------------V~e~~~~gsL  356 (563)
                      ||+|+||.||++..  +++.+|+|.+....      .+.+.+|++++++++|||+               |+||+++|+|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            69999999999976  47889999886422      3457789999999999997               5789999999


Q ss_pred             ccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccccccccccc
Q 044997          357 SDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEML  436 (563)
Q Consensus       357 ~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~  436 (563)
                      .+++...   ....+++..+..++.|++.||.|||+.+   ++||||+|+||++++++.+||+|||++.......    .
T Consensus        81 ~~~l~~~---~~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~----~  150 (277)
T cd05577          81 KYHIYNV---GEPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK----K  150 (277)
T ss_pred             HHHHHHc---CcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCC----c
Confidence            9988752   2346899999999999999999999987   9999999999999999999999999987543211    1


Q ss_pred             cccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc--------------hh
Q 044997          437 ATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP--------------TK  502 (563)
Q Consensus       437 ~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~--------------~~  502 (563)
                      .....++..|+|||.+.+..             ++.++||||||+++|||++|+.||.......              ..
T Consensus       151 ~~~~~~~~~y~~PE~~~~~~-------------~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  217 (277)
T cd05577         151 IKGRAGTPGYMAPEVLQGEV-------------YDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEY  217 (277)
T ss_pred             cccccCCCCcCCHHHhcCCC-------------CCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccC
Confidence            12345788999999875433             4789999999999999999999986543311              01


Q ss_pred             hHHHHHHHHHHHHHhhccCCCCCCCHHH
Q 044997          503 MKSLITIMAAVAEWCLNEDAVDRPEMRD  530 (563)
Q Consensus       503 ~~~~~~~l~~li~~cl~~dP~~RPs~~e  530 (563)
                      .....+.+.+++.+||+.||.+||++++
T Consensus       218 ~~~~~~~~~~li~~~l~~~p~~R~~~~~  245 (277)
T cd05577         218 PDKFSPEAKDLCEALLQKDPEKRLGCRG  245 (277)
T ss_pred             CccCCHHHHHHHHHHccCChhHccCCCc
Confidence            1223456899999999999999995444

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=99.98  E-value=3.6e-32  Score=286.04  Aligned_cols=177  Identities=26%  Similarity=0.424  Sum_probs=143.8

Q ss_pred             CCCccceecccCcEEEEEEEE--CCceEEEEEeccCCh--HHHHHHHHHHHhcc-cc-----ce---------------E
Q 044997          293 NFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNKS--KEFFAELKVLCKIH-HI-----NV---------------F  347 (563)
Q Consensus       293 ~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~~--~~f~~Ei~~l~~l~-H~-----ni---------------V  347 (563)
                      +|.+.+.||+|.||.|.++..  .++.||||.++.+..  .+-..|+.+|..++ |.     |+               |
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciV  266 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIV  266 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeee
Confidence            788999999999999999987  478999999987653  45567999999997 32     23               3


Q ss_pred             EEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCC--CcEEEeecCCCc
Q 044997          348 ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDG--LRAKVADFGLVK  425 (563)
Q Consensus       348 ~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~--~~~kl~DFGla~  425 (563)
                      .|.+. -+|.++|+..   ....++...+..|+.||+.||.+||+.+   |||+||||+||||.+.  .++||+|||.|.
T Consensus       267 fELL~-~NLYellK~n---~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc  339 (586)
T KOG0667|consen  267 FELLS-TNLYELLKNN---KFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSC  339 (586)
T ss_pred             ehhhh-hhHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEeccccc
Confidence            33333 4788888874   4466999999999999999999999987   9999999999999653  479999999998


Q ss_pred             ccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcC
Q 044997          426 LEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIR  495 (563)
Q Consensus       426 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~  495 (563)
                      .....-     . ...-+..|.|||++.+.+|             +.+.||||||||+.||++|.+.|.+
T Consensus       340 ~~~q~v-----y-tYiQSRfYRAPEVILGlpY-------------~~~IDmWSLGCIlAEL~tG~PLfpG  390 (586)
T KOG0667|consen  340 FESQRV-----Y-TYIQSRFYRAPEVILGLPY-------------DTAIDMWSLGCILAELFTGEPLFPG  390 (586)
T ss_pred             ccCCcc-----e-eeeeccccccchhhccCCC-------------CCccceeehhhhHHhHhcCccccCC
Confidence            644321     1 3456778999999988776             8999999999999999999655533

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=99.98  E-value=1.4e-31  Score=269.36  Aligned_cols=215  Identities=21%  Similarity=0.256  Sum_probs=168.4

Q ss_pred             CCccceecccCcEEEEEEEE--CCceEEEEEeccCC----hHHHHHHHHHHHhcc-ccce-----------------EEE
Q 044997          294 FDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNK----SKEFFAELKVLCKIH-HINV-----------------FIS  349 (563)
Q Consensus       294 f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~----~~~f~~Ei~~l~~l~-H~ni-----------------V~e  349 (563)
                      |+..+.||+|+||.||+|..  +++.+|+|.++...    .....+|+.++.++. |+|+                 |+|
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            55678899999999999987  46889999986531    234567999999985 9987                 456


Q ss_pred             eecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccccc
Q 044997          350 TFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEER  429 (563)
Q Consensus       350 ~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~  429 (563)
                      |++ |+|.+++..    ....++|.++..++.|++.||+|||+.+   ++||||||+||++++ +.+||+|||+++....
T Consensus        81 ~~~-~~l~~~l~~----~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~  151 (282)
T cd07831          81 LMD-MNLYELIKG----RKRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYS  151 (282)
T ss_pred             cCC-ccHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEeccccccccc
Confidence            665 566666654    2356899999999999999999999987   999999999999999 9999999999986543


Q ss_pred             ccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc---------
Q 044997          430 TNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP---------  500 (563)
Q Consensus       430 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~---------  500 (563)
                      ...    .....++..|+|||.+...            ..++.++|||||||++|||++|+.||...+...         
T Consensus       152 ~~~----~~~~~~~~~y~aPE~~~~~------------~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~  215 (282)
T cd07831         152 KPP----YTEYISTRWYRAPECLLTD------------GYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVL  215 (282)
T ss_pred             CCC----cCCCCCCcccCChhHhhcC------------CCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHc
Confidence            221    1234578899999976432            234789999999999999999999986432110         


Q ss_pred             ----h--------------------------hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          501 ----T--------------------------KMKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       501 ----~--------------------------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                          .                          .....+..+.+++.+||+.||++||++.++++
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         216 GTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             CCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence                0                          00123466899999999999999999999986

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.98  E-value=7.8e-32  Score=266.86  Aligned_cols=220  Identities=23%  Similarity=0.373  Sum_probs=179.9

Q ss_pred             CCCccceecccCcEEEEEEEE--CCceEEEEEeccC-----ChHHHHHHHHHHHhccccce---------------EEEe
Q 044997          293 NFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSN-----KSKEFFAELKVLCKIHHINV---------------FIST  350 (563)
Q Consensus       293 ~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~-----~~~~f~~Ei~~l~~l~H~ni---------------V~e~  350 (563)
                      +|+..+.||+|+||.||++..  +++.+++|.+...     ...++.+|++++++++|+||               |+||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            477889999999999999977  4678999998643     23567889999999999997               5788


Q ss_pred             ecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccccc
Q 044997          351 FGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERT  430 (563)
Q Consensus       351 ~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~  430 (563)
                      +++++|.+++.... .....+++..+..++.|++.||+|||+.+   ++|+||+|+||++++++.+||+|||+++.....
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~  156 (256)
T cd08530          81 APFGDLSKAISKRK-KKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN  156 (256)
T ss_pred             cCCCCHHHHHHHHH-hhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC
Confidence            99999999886532 22356899999999999999999999987   999999999999999999999999999865432


Q ss_pred             cccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCC-----------
Q 044997          431 NEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE-----------  499 (563)
Q Consensus       431 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~-----------  499 (563)
                           ......++..|+|||.+.+..             ++.++|+||||+++|||++|+.||...+..           
T Consensus       157 -----~~~~~~~~~~~~~Pe~~~~~~-------------~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~  218 (256)
T cd08530         157 -----MAKTQIGTPHYMAPEVWKGRP-------------YSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKY  218 (256)
T ss_pred             -----CcccccCCccccCHHHHCCCC-------------CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC
Confidence                 112245788999999875443             478999999999999999999998654321           


Q ss_pred             chhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          500 PTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       500 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                      +.........+.+++.+|++.+|.+||++.++++.
T Consensus       219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  253 (256)
T cd08530         219 PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS  253 (256)
T ss_pred             CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            11122345668999999999999999999999863

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.98  E-value=7.6e-32  Score=279.50  Aligned_cols=225  Identities=26%  Similarity=0.369  Sum_probs=176.7

Q ss_pred             hcCCCccceecccCcEEEEEEEE--CCceEEEEEeccC-----ChHHHHHHHHHHHhccccceE----------------
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSN-----KSKEFFAELKVLCKIHHINVF----------------  347 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~-----~~~~f~~Ei~~l~~l~H~niV----------------  347 (563)
                      .++|...+.||+|+||.||+|+.  +++.||||.++..     ..+++.+|+.++++++|+||+                
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            45788899999999999999987  4788999988642     235677899999999999983                


Q ss_pred             ----EEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCC
Q 044997          348 ----ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGL  423 (563)
Q Consensus       348 ----~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGl  423 (563)
                          +||+. ++|.+++..     ...+++.....++.|++.||.|||+++   ++||||||+||+++.++.+||+|||+
T Consensus        84 ~~lv~e~~~-~~L~~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~  154 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRS-----SQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGL  154 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcc
Confidence                34553 567666643     356899999999999999999999987   99999999999999999999999999


Q ss_pred             CcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc---
Q 044997          424 VKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP---  500 (563)
Q Consensus       424 a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~---  500 (563)
                      ++......   .......++..|+|||.+...            ..++.++|||||||++|||++|+.||...+...   
T Consensus       155 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~------------~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~  219 (337)
T cd07858         155 ARTTSEKG---DFMTEYVVTRWYRAPELLLNC------------SEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLK  219 (337)
T ss_pred             ccccCCCc---ccccccccccCccChHHHhcC------------CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHH
Confidence            98654321   112234578899999987432            235789999999999999999999985432100   


Q ss_pred             --------------------------------------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHHhh
Q 044997          501 --------------------------------------TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI--LSQIM  539 (563)
Q Consensus       501 --------------------------------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~i~  539 (563)
                                                            .....+...+.+++.+||+.||++||+++|+++.  +..+.
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~  298 (337)
T cd07858         220 LITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLH  298 (337)
T ss_pred             HHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhc
Confidence                                                  0001234557899999999999999999999986  65543

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.98  E-value=1e-31  Score=279.48  Aligned_cols=226  Identities=24%  Similarity=0.352  Sum_probs=176.5

Q ss_pred             cCHHHHHHHhcCCCccceecccCcEEEEEEEE--CCceEEEEEeccCC-----hHHHHHHHHHHHhccccceEE--E---
Q 044997          282 FSLEEIEEATNNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNK-----SKEFFAELKVLCKIHHINVFI--S---  349 (563)
Q Consensus       282 ~~~~el~~~~~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~-----~~~f~~Ei~~l~~l~H~niV~--e---  349 (563)
                      ....++...+++|...+.||+|+||.||+|..  +++.||+|+++...     .+.+.+|++++++++|+||+.  +   
T Consensus         7 ~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~   86 (345)
T cd07877           7 ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT   86 (345)
T ss_pred             hHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeee
Confidence            34566777889999999999999999999976  47889999986432     356788999999999999842  1   


Q ss_pred             ---------------eecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCC
Q 044997          350 ---------------TFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGL  414 (563)
Q Consensus       350 ---------------~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~  414 (563)
                                     ++.+++|.+++..      ..+++..+..++.|+++||+|||+++   ++||||||+||++++++
T Consensus        87 ~~~~~~~~~~~~lv~~~~~~~L~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~  157 (345)
T cd07877          87 PARSLEEFNDVYLVTHLMGADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDC  157 (345)
T ss_pred             ecccccccccEEEEehhcccCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCC
Confidence                           1223455444432      35899999999999999999999987   99999999999999999


Q ss_pred             cEEEeecCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCc
Q 044997          415 RAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALI  494 (563)
Q Consensus       415 ~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~  494 (563)
                      .+||+|||+++.....      .....++..|+|||.+.+.            ..++.++|||||||++|||++|+.||.
T Consensus       158 ~~kl~dfg~~~~~~~~------~~~~~~~~~y~aPE~~~~~------------~~~~~~~DvwslG~il~el~~g~~pf~  219 (345)
T cd07877         158 ELKILDFGLARHTDDE------MTGYVATRWYRAPEIMLNW------------MHYNQTVDIWSVGCIMAELLTGRTLFP  219 (345)
T ss_pred             CEEEeccccccccccc------ccccccCCCccCHHHHhCc------------cCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence            9999999998754321      1234678899999987432            234789999999999999999999985


Q ss_pred             CCCCCch--------------h--------hH-------------------HHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          495 RDDSEPT--------------K--------MK-------------------SLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       495 ~~~~~~~--------------~--------~~-------------------~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                      ..+....              .        ..                   .....+.+++.+|++.||.+||++.+++.
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  299 (345)
T cd07877         220 GTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  299 (345)
T ss_pred             CCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc
Confidence            4332100              0        00                   01234789999999999999999999987


Q ss_pred             H
Q 044997          534 I  534 (563)
Q Consensus       534 ~  534 (563)
                      .
T Consensus       300 h  300 (345)
T cd07877         300 H  300 (345)
T ss_pred             C
Confidence            5

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.98  E-value=1.1e-31  Score=273.31  Aligned_cols=223  Identities=26%  Similarity=0.378  Sum_probs=172.0

Q ss_pred             HHhcCCCccceecccCcEEEEEEEEC--CceEEEEEeccCC-----hHHHHHHHHHHHhccccceEE-------------
Q 044997          289 EATNNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNK-----SKEFFAELKVLCKIHHINVFI-------------  348 (563)
Q Consensus       289 ~~~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~-----~~~f~~Ei~~l~~l~H~niV~-------------  348 (563)
                      ...++|+..+.||+|+||.||+|...  ++.||+|.++...     ...+.+|++++++++|||++.             
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            34578899999999999999999884  6889999986432     246778999999999999842             


Q ss_pred             ------------EeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcE
Q 044997          349 ------------STFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRA  416 (563)
Q Consensus       349 ------------e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~  416 (563)
                                  ||++ +++...+..    ....+++.++..++.|++.||+|||+.+   ++||||||+||++++++.+
T Consensus        84 ~~~~~~~~~lv~e~~~-~~l~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~  155 (302)
T cd07864          84 FKKDKGAFYLVFEYMD-HDLMGLLES----GLVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQI  155 (302)
T ss_pred             ccccCCcEEEEEcccC-ccHHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcE
Confidence                        3333 244444432    1346899999999999999999999987   9999999999999999999


Q ss_pred             EEeecCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCC
Q 044997          417 KVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRD  496 (563)
Q Consensus       417 kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~  496 (563)
                      ||+|||+++........  ......++..|+|||.+.+.            ...+.++|||||||++|||++|+.||...
T Consensus       156 kl~dfg~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~------------~~~~~~~Di~slG~~~~el~~g~~~~~~~  221 (302)
T cd07864         156 KLADFGLARLYNSEESR--PYTNKVITLWYRPPELLLGE------------ERYGPAIDVWSCGCILGELFTKKPIFQAN  221 (302)
T ss_pred             EeCcccccccccCCccc--ccccceeccCccChHHhcCC------------CCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence            99999999865433211  11223467789999987432            23478999999999999999999888643


Q ss_pred             CCCc----------------------------------------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          497 DSEP----------------------------------------TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       497 ~~~~----------------------------------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                      +...                                        .....++..+.+++.+||+.||.+||++.+++.
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         222 QELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             ChHHHHHHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            2100                                        001123466899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=99.98  E-value=1.2e-31  Score=279.90  Aligned_cols=217  Identities=23%  Similarity=0.321  Sum_probs=170.5

Q ss_pred             HhcCCCccceecccCcEEEEEEEE--CCceEEEEEeccC-----ChHHHHHHHHHHHhccccceE---------------
Q 044997          290 ATNNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSN-----KSKEFFAELKVLCKIHHINVF---------------  347 (563)
Q Consensus       290 ~~~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~-----~~~~f~~Ei~~l~~l~H~niV---------------  347 (563)
                      ..++|+..+.||+|+||.||++..  .++.+|+|.+...     ..+++.+|++++++++|+||+               
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            457899999999999999999987  4789999998642     235677899999999999973               


Q ss_pred             ------EEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeec
Q 044997          348 ------ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADF  421 (563)
Q Consensus       348 ------~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DF  421 (563)
                            +||+. |+|.+.+..       .+++..+..++.|++.||+|||+++   ++||||||+||++++++.+||+||
T Consensus        94 ~~~~lv~e~~~-~~l~~~~~~-------~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Df  162 (353)
T cd07850          94 QDVYLVMELMD-ANLCQVIQM-------DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDF  162 (353)
T ss_pred             CcEEEEEeccC-CCHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccC
Confidence                  33332 345444432       2888899999999999999999987   999999999999999999999999


Q ss_pred             CCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc-
Q 044997          422 GLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP-  500 (563)
Q Consensus       422 Gla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~-  500 (563)
                      |+++......    ......++..|+|||.+.+..             ++.++|||||||++|+|++|+.||...+... 
T Consensus       163 g~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~-------------~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~  225 (353)
T cd07850         163 GLARTAGTSF----MMTPYVVTRYYRAPEVILGMG-------------YKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQ  225 (353)
T ss_pred             ccceeCCCCC----CCCCCcccccccCHHHHhCCC-------------CCCchhhHhHHHHHHHHHHCCCCCCCCCHHHH
Confidence            9998643221    122345788999999875443             4889999999999999999999986433100 


Q ss_pred             ------------hh----------------------------------------hHHHHHHHHHHHHHhhccCCCCCCCH
Q 044997          501 ------------TK----------------------------------------MKSLITIMAAVAEWCLNEDAVDRPEM  528 (563)
Q Consensus       501 ------------~~----------------------------------------~~~~~~~l~~li~~cl~~dP~~RPs~  528 (563)
                                  ..                                        .....+.+.+++.+||+.||++||++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~  305 (353)
T cd07850         226 WNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISV  305 (353)
T ss_pred             HHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCH
Confidence                        00                                        00123447899999999999999999


Q ss_pred             HHHHHH
Q 044997          529 RDIVAI  534 (563)
Q Consensus       529 ~evl~~  534 (563)
                      .|+++.
T Consensus       306 ~eiL~~  311 (353)
T cd07850         306 DDALQH  311 (353)
T ss_pred             HHHhcC
Confidence            999864

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.98  E-value=1.4e-31  Score=268.23  Aligned_cols=220  Identities=24%  Similarity=0.301  Sum_probs=171.1

Q ss_pred             HHHHHHHhcCCCcccee--cccCcEEEEEEEE--CCceEEEEEeccCChHHHHHHHHHHHh-ccccce------------
Q 044997          284 LEEIEEATNNFDESRII--GRGGFGNVYFGLL--GDREAAIKKMRSNKSKEFFAELKVLCK-IHHINV------------  346 (563)
Q Consensus       284 ~~el~~~~~~f~~~~~L--G~G~fG~Vy~g~~--~~~~vavK~~~~~~~~~f~~Ei~~l~~-l~H~ni------------  346 (563)
                      ..+.....++|+..+.+  |+|+||.||++..  .+..+|+|..........  |+..... .+|+|+            
T Consensus         6 ~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--e~~~~~~~~~h~~iv~~~~~~~~~~~   83 (267)
T PHA03390          6 LSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI--EPMVHQLMKDNPNFIKLYYSVTTLKG   83 (267)
T ss_pred             HHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh--hHHHHHHhhcCCCEEEEEEEEecCCe
Confidence            34455556677777766  9999999999986  467889998875433222  2222222 268887            


Q ss_pred             ---EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCC-cEEEeecC
Q 044997          347 ---FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGL-RAKVADFG  422 (563)
Q Consensus       347 ---V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~-~~kl~DFG  422 (563)
                         |+||+++|+|.+++..     ...++|.++..++.|+++||.|||+.+   ++||||||+||+++.++ .++|+|||
T Consensus        84 ~~iv~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg  155 (267)
T PHA03390         84 HVLIMDYIKDGDLFDLLKK-----EGKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYG  155 (267)
T ss_pred             eEEEEEcCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCc
Confidence               5799999999999865     237999999999999999999999997   99999999999999998 99999999


Q ss_pred             CCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCch-
Q 044997          423 LVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPT-  501 (563)
Q Consensus       423 la~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~-  501 (563)
                      +++.....       ....|+..|+|||++.+..             ++.++||||||+++|||++|+.||........ 
T Consensus       156 ~~~~~~~~-------~~~~~~~~y~aPE~~~~~~-------------~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~  215 (267)
T PHA03390        156 LCKIIGTP-------SCYDGTLDYFSPEKIKGHN-------------YDVSFDWWAVGVLTYELLTGKHPFKEDEDEELD  215 (267)
T ss_pred             cceecCCC-------ccCCCCCcccChhhhcCCC-------------CCchhhHHHHHHHHHHHHHCCCCCCCCCcchhh
Confidence            98754321       1235788999999885443             47899999999999999999999974432211 


Q ss_pred             -------------hhHHHHHHHHHHHHHhhccCCCCCCC-HHHHHH
Q 044997          502 -------------KMKSLITIMAAVAEWCLNEDAVDRPE-MRDIVA  533 (563)
Q Consensus       502 -------------~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~  533 (563)
                                   ..+.....+.+++.+||+.||.+||+ ++|+++
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        216 LESLLKRQQKKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             HHHHHHhhcccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence                         11134566899999999999999995 688874

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=99.98  E-value=1.7e-31  Score=269.10  Aligned_cols=218  Identities=26%  Similarity=0.356  Sum_probs=171.1

Q ss_pred             CCccceecccCcEEEEEEEEC--CceEEEEEeccCC-----hHHHHHHHHHHHhccccce-----------------EEE
Q 044997          294 FDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNK-----SKEFFAELKVLCKIHHINV-----------------FIS  349 (563)
Q Consensus       294 f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~-----~~~f~~Ei~~l~~l~H~ni-----------------V~e  349 (563)
                      |+..+.||+|+||.||+|...  ++.+|+|+++...     .+.+.+|++++++++|+|+                 |+|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            566789999999999999885  5889999997542     3568899999999999997                 345


Q ss_pred             eecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccccc
Q 044997          350 TFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEER  429 (563)
Q Consensus       350 ~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~  429 (563)
                      |++ ++|.+++..    ....+++.++..++.|++.||+|||+.+   ++|+||||+||++++++.+||+|||++.....
T Consensus        81 ~~~-~~l~~~~~~----~~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~  152 (287)
T cd07840          81 YMD-HDLTGLLDS----PEVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTK  152 (287)
T ss_pred             ccc-ccHHHHHhc----cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccC
Confidence            554 366666653    1246899999999999999999999987   99999999999999999999999999886543


Q ss_pred             ccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCch--------
Q 044997          430 TNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPT--------  501 (563)
Q Consensus       430 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~--------  501 (563)
                      ....  ..+...++..|+|||.+.+.            ..++.++||||||+++|||++|+.||........        
T Consensus       153 ~~~~--~~~~~~~~~~y~~PE~~~~~------------~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~  218 (287)
T cd07840         153 RNSA--DYTNRVITLWYRPPELLLGA------------TRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELC  218 (287)
T ss_pred             CCcc--cccccccccccCCceeeEcc------------ccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Confidence            3211  12234567889999976432            2347899999999999999999999854332100        


Q ss_pred             --------------------------------hhHH-HHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          502 --------------------------------KMKS-LITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       502 --------------------------------~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                                                      .... ....+.+++.+||+.||.+||++.++++
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         219 GSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             CCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence                                            0001 1445789999999999999999999876

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.98  E-value=7.1e-32  Score=268.53  Aligned_cols=221  Identities=24%  Similarity=0.346  Sum_probs=172.5

Q ss_pred             ceecccCcEEEEEEEE--CCceEEEEEeccCCh------HHHHHHHHH-HHhccccce---------------EEEeecC
Q 044997          298 RIIGRGGFGNVYFGLL--GDREAAIKKMRSNKS------KEFFAELKV-LCKIHHINV---------------FISTFGN  353 (563)
Q Consensus       298 ~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~~------~~f~~Ei~~-l~~l~H~ni---------------V~e~~~~  353 (563)
                      +.||+|+||.||+|..  .++.+|+|.++....      ..+..|..+ ....+|+|+               |+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            5689999999999987  468999999865321      234445444 345588886               5799999


Q ss_pred             CCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccccccccc
Q 044997          354 GSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEK  433 (563)
Q Consensus       354 gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~  433 (563)
                      |+|.+++..     ...+++..+..++.|++.||.|||+.+   ++||||+|+||++++++.+||+|||+++....    
T Consensus        82 ~~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----  149 (260)
T cd05611          82 GDCASLIKT-----LGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----  149 (260)
T ss_pred             CCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc----
Confidence            999998864     346899999999999999999999987   99999999999999999999999999875322    


Q ss_pred             ccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc-------------
Q 044997          434 EMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP-------------  500 (563)
Q Consensus       434 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~-------------  500 (563)
                         .....|+..|+|||.+.+..             ++.++||||||+++|||++|..||.......             
T Consensus       150 ---~~~~~~~~~y~~pe~~~~~~-------------~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~  213 (260)
T cd05611         150 ---NKKFVGTPDYLAPETILGVG-------------DDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWP  213 (260)
T ss_pred             ---cccCCCCcCccChhhhcCCC-------------CcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCC
Confidence               12345788999999875433             4889999999999999999999986443211             


Q ss_pred             -hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcChhhh
Q 044997          501 -TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITSTEWE  546 (563)
Q Consensus       501 -~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~w~  546 (563)
                       .....+...+.+++.+||+.||++||++.++.+.|..-.-....||
T Consensus       214 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~~~~  260 (260)
T cd05611         214 EEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSINWD  260 (260)
T ss_pred             CcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcCCCC
Confidence             0111245668999999999999999988877776665444445554

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.98  E-value=1.1e-31  Score=265.39  Aligned_cols=221  Identities=27%  Similarity=0.422  Sum_probs=181.1

Q ss_pred             CCCccceecccCcEEEEEEEEC--CceEEEEEeccC-----ChHHHHHHHHHHHhccccce---------------EEEe
Q 044997          293 NFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSN-----KSKEFFAELKVLCKIHHINV---------------FIST  350 (563)
Q Consensus       293 ~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~-----~~~~f~~Ei~~l~~l~H~ni---------------V~e~  350 (563)
                      +|+..+.||+|+||.||++...  ++.+++|++...     ..+++.+|++++++++|+|+               |+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            4778899999999999999885  789999998753     34568899999999999996               5788


Q ss_pred             ecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccccc
Q 044997          351 FGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERT  430 (563)
Q Consensus       351 ~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~  430 (563)
                      +++++|.+++..... ....+++..+..++.+++.||.|||+.+   ++|+||+|+||++++++.+||+|||++......
T Consensus        81 ~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~  156 (258)
T cd08215          81 ADGGDLSQKIKKQKK-EGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST  156 (258)
T ss_pred             cCCCcHHHHHHHhhc-cCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccC
Confidence            999999998875321 2367999999999999999999999987   999999999999999999999999998765433


Q ss_pred             cccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc----------
Q 044997          431 NEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP----------  500 (563)
Q Consensus       431 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~----------  500 (563)
                      .   .......|++.|+|||.+....             ++.++||||+|+++|+|++|+.|+...+...          
T Consensus       157 ~---~~~~~~~~~~~y~~pe~~~~~~-------------~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~  220 (258)
T cd08215         157 V---DLAKTVVGTPYYLSPELCQNKP-------------YNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQY  220 (258)
T ss_pred             c---ceecceeeeecccChhHhccCC-------------CCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCC
Confidence            2   1222346888999999875433             4789999999999999999999986543211          


Q ss_pred             -hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          501 -TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       501 -~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                       .........+.+++.+||..+|++||++.|+++
T Consensus       221 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         221 PPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence             011134466899999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.97  E-value=1.5e-31  Score=272.94  Aligned_cols=223  Identities=29%  Similarity=0.373  Sum_probs=170.1

Q ss_pred             hcCCCccceecccCcEEEEEEEEC--CceEEEEEeccCC-----hHHHHHHHHHHHhccccceEE---------------
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNK-----SKEFFAELKVLCKIHHINVFI---------------  348 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~-----~~~f~~Ei~~l~~l~H~niV~---------------  348 (563)
                      .++|+..+.||+|+||.||+|...  ++.+|+|++....     ...+.+|++++++++|+||+.               
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            468999999999999999999874  6889999875322     245788999999999999842               


Q ss_pred             --------EeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEee
Q 044997          349 --------STFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVAD  420 (563)
Q Consensus       349 --------e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~D  420 (563)
                              +|+. ++|...+..    ....+++.++..++.|+++||+|||+++   ++||||||+||++++++.+||+|
T Consensus        87 ~~~~~lv~~~~~-~~l~~~~~~----~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~d  158 (311)
T cd07866          87 RGSVYMVTPYMD-HDLSGLLEN----PSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIAD  158 (311)
T ss_pred             CceEEEEEecCC-cCHHHHHhc----cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECc
Confidence                    2222 234444432    2346999999999999999999999997   99999999999999999999999


Q ss_pred             cCCCcccccccccc--------cccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCC
Q 044997          421 FGLVKLEERTNEKE--------MLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRA  492 (563)
Q Consensus       421 FGla~~~~~~~~~~--------~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p  492 (563)
                      ||+++.........        ...+...+++.|+|||.+.+.            ..++.++||||||+++|||++|+.|
T Consensus       159 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~------------~~~~~~~Dv~slG~il~el~~g~~~  226 (311)
T cd07866         159 FGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGE------------RRYTTAVDIWGIGCVFAEMFTRRPI  226 (311)
T ss_pred             CccchhccCCCcccccCCcccccccccceeccCcCChHHhhCC------------CccCchhHhHHHHHHHHHHHhCCCC
Confidence            99997544322110        111234578889999987432            2347899999999999999999988


Q ss_pred             CcCCCCCch----------------------------------------hhHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 044997          493 LIRDDSEPT----------------------------------------KMKSLITIMAAVAEWCLNEDAVDRPEMRDIV  532 (563)
Q Consensus       493 ~~~~~~~~~----------------------------------------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl  532 (563)
                      |........                                        ........+.+++.+|++.||++|||+.|++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell  306 (311)
T cd07866         227 LQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDAL  306 (311)
T ss_pred             CCCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHh
Confidence            854321100                                        0011224578999999999999999999987


Q ss_pred             H
Q 044997          533 A  533 (563)
Q Consensus       533 ~  533 (563)
                      .
T Consensus       307 ~  307 (311)
T cd07866         307 E  307 (311)
T ss_pred             c
Confidence            5

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.97  E-value=2.2e-31  Score=269.66  Aligned_cols=220  Identities=22%  Similarity=0.332  Sum_probs=173.5

Q ss_pred             CCCccceecccCcEEEEEEEE-----CCceEEEEEeccC-------ChHHHHHHHHHHHhc-cccce-------------
Q 044997          293 NFDESRIIGRGGFGNVYFGLL-----GDREAAIKKMRSN-------KSKEFFAELKVLCKI-HHINV-------------  346 (563)
Q Consensus       293 ~f~~~~~LG~G~fG~Vy~g~~-----~~~~vavK~~~~~-------~~~~f~~Ei~~l~~l-~H~ni-------------  346 (563)
                      +|+..+.||+|+||.||++..     ++..+|+|.++..       ..+.+.+|++++.++ +|+||             
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            477789999999999999976     4688999998642       135678899999999 57876             


Q ss_pred             --EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCC
Q 044997          347 --FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLV  424 (563)
Q Consensus       347 --V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla  424 (563)
                        |+||+++|+|.+++..     ...+++..+..++.|++.||.|||+.+   ++||||||+|||+++++++||+|||++
T Consensus        81 ~lv~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~  152 (290)
T cd05613          81 HLILDYINGGELFTHLSQ-----RERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLS  152 (290)
T ss_pred             EEEEecCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCccc
Confidence              5789999999998864     346889999999999999999999987   999999999999999999999999998


Q ss_pred             cccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCch---
Q 044997          425 KLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPT---  501 (563)
Q Consensus       425 ~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~---  501 (563)
                      +........  ......|+..|+|||.+....           ...+.++||||||+++|||++|+.|+........   
T Consensus       153 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~-----------~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~  219 (290)
T cd05613         153 KEFHEDEVE--RAYSFCGTIEYMAPDIVRGGD-----------GGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAE  219 (290)
T ss_pred             eeccccccc--ccccccCCcccCChhhccCCC-----------CCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHH
Confidence            764332211  122346889999999874321           2347899999999999999999999864322111   


Q ss_pred             -----------hhHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 044997          502 -----------KMKSLITIMAAVAEWCLNEDAVDRP-----EMRDIVA  533 (563)
Q Consensus       502 -----------~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  533 (563)
                                 ........+.+++.+||+.||++||     ++.+++.
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         220 ISRRILKSEPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             HHHHhhccCCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence                       0112345588999999999999997     5666654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.97  E-value=2.3e-32  Score=262.66  Aligned_cols=229  Identities=25%  Similarity=0.332  Sum_probs=176.7

Q ss_pred             hcCCCccceecccCcEEEEEEEEC------CceEEEEEeccCC-----hHHHHHHHHHHHhccccceE------------
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLLG------DREAAIKKMRSNK-----SKEFFAELKVLCKIHHINVF------------  347 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~~------~~~vavK~~~~~~-----~~~f~~Ei~~l~~l~H~niV------------  347 (563)
                      ...|+....||+|.||.||+++..      ...+|||+++.++     .....+|+.+++.++|+|+|            
T Consensus        23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~  102 (438)
T KOG0666|consen   23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK  102 (438)
T ss_pred             HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence            356888899999999999999652      2368999998663     35678999999999999983            


Q ss_pred             ----EEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCC----CcEEEe
Q 044997          348 ----ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDG----LRAKVA  419 (563)
Q Consensus       348 ----~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~----~~~kl~  419 (563)
                          +||.+. +|.+.++.......+.++......|+.||+.|+.|||+..   |+||||||.|||+..+    |++||+
T Consensus       103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIa  178 (438)
T KOG0666|consen  103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIA  178 (438)
T ss_pred             EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEee
Confidence                355554 6766665443334467899999999999999999999998   9999999999999877    999999


Q ss_pred             ecCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCC
Q 044997          420 DFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE  499 (563)
Q Consensus       420 DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~  499 (563)
                      |||+++.+...-..-.....++-|..|.|||.+.+.+            .||++.||||.||++.||++-++-|.+.+..
T Consensus       179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~------------hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k  246 (438)
T KOG0666|consen  179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGAR------------HYTKAIDVWAIGCIFAELLTLEPLFKGREEK  246 (438)
T ss_pred             cccHHHHhhccccccccCCceEEEEEecChHHhcccc------------cccchhhhHHHHHHHHHHHccCccccchhhh
Confidence            9999998754322222234467899999999998766            3699999999999999999987666443211


Q ss_pred             c--------hhhHHH------------------------------------------------HHHHHHHHHHhhccCCC
Q 044997          500 P--------TKMKSL------------------------------------------------ITIMAAVAEWCLNEDAV  523 (563)
Q Consensus       500 ~--------~~~~~~------------------------------------------------~~~l~~li~~cl~~dP~  523 (563)
                      .        .+...+                                                .+...+|+..+|..||.
T Consensus       247 ~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~  326 (438)
T KOG0666|consen  247 IKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPI  326 (438)
T ss_pred             cccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCch
Confidence            0        000000                                                01167889999999999


Q ss_pred             CCCCHHHHHHHH
Q 044997          524 DRPEMRDIVAIL  535 (563)
Q Consensus       524 ~RPs~~evl~~L  535 (563)
                      +|.|+++.++..
T Consensus       327 kRIta~qAleh~  338 (438)
T KOG0666|consen  327 KRITAEQALEHP  338 (438)
T ss_pred             hhccHHHHhccc
Confidence            999999887753

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=2.3e-31  Score=262.93  Aligned_cols=217  Identities=27%  Similarity=0.470  Sum_probs=177.8

Q ss_pred             CCCccceecccCcEEEEEEEEC--CceEEEEEeccCC-----hHHHHHHHHHHHhccccce---------------EEEe
Q 044997          293 NFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNK-----SKEFFAELKVLCKIHHINV---------------FIST  350 (563)
Q Consensus       293 ~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~-----~~~f~~Ei~~l~~l~H~ni---------------V~e~  350 (563)
                      +|+..+.||+|++|.||++...  ++.+++|.+....     .+.+.+|++++++++|+|+               +++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            4777899999999999999874  6789999986543     3568899999999999996               4688


Q ss_pred             ecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccccc
Q 044997          351 FGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERT  430 (563)
Q Consensus       351 ~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~  430 (563)
                      +++++|.+++..     ...+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++......
T Consensus        81 ~~~~~L~~~~~~-----~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  152 (254)
T cd06627          81 AENGSLRQIIKK-----FGPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDV  152 (254)
T ss_pred             CCCCcHHHHHHh-----ccCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCC
Confidence            888999888864     256899999999999999999999987   999999999999999999999999999865433


Q ss_pred             cccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCch---------
Q 044997          431 NEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPT---------  501 (563)
Q Consensus       431 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~---------  501 (563)
                      ...   .....++..|+|||.+.+.             .++.++||||+|+++|||++|+.|+........         
T Consensus       153 ~~~---~~~~~~~~~y~~pe~~~~~-------------~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~  216 (254)
T cd06627         153 SKD---DASVVGTPYWMAPEVIEMS-------------GASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDH  216 (254)
T ss_pred             ccc---ccccccchhhcCHhhhcCC-------------CCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCC
Confidence            221   2234678899999987433             247899999999999999999999864332111         


Q ss_pred             --hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          502 --KMKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       502 --~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                        ......+.+.+++.+||..+|++||++.+++.
T Consensus       217 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         217 PPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             CCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence              11233466899999999999999999999874

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.97  E-value=2.2e-31  Score=267.88  Aligned_cols=217  Identities=23%  Similarity=0.316  Sum_probs=173.9

Q ss_pred             CCccceecccCcEEEEEEEE--CCceEEEEEeccCC-----hHHHHHHHHHHHhccccce---------------EEEee
Q 044997          294 FDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNK-----SKEFFAELKVLCKIHHINV---------------FISTF  351 (563)
Q Consensus       294 f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~-----~~~f~~Ei~~l~~l~H~ni---------------V~e~~  351 (563)
                      |+..+.||+|++|.||++..  +++.+++|.++...     .+.+.+|++++++++|+||               |+||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            45678899999999999987  47889999986543     3568889999999999997               56777


Q ss_pred             cCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccccccc
Q 044997          352 GNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTN  431 (563)
Q Consensus       352 ~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~  431 (563)
                      ++ +|.+++..    ....+++..+..++.|++.||.|||+++   ++|+||||+||++++++.+||+|||.+.......
T Consensus        81 ~~-~l~~~l~~----~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~  152 (283)
T cd05118          81 DT-DLYKLIKD----RQRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV  152 (283)
T ss_pred             CC-CHHHHHHh----hcccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc
Confidence            64 78777764    2357999999999999999999999987   9999999999999999999999999987654332


Q ss_pred             ccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc-----------
Q 044997          432 EKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP-----------  500 (563)
Q Consensus       432 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~-----------  500 (563)
                         .......++..|+|||.+.+.            ...+.++||||||+++|+|++|+.||...+...           
T Consensus       153 ---~~~~~~~~~~~~~~PE~~~~~------------~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~  217 (283)
T cd05118         153 ---RPYTHYVVTRWYRAPELLLGD------------KGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGT  217 (283)
T ss_pred             ---ccccCccCcccccCcHHHhcC------------CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCC
Confidence               112234578889999987543            135889999999999999999998885433100           


Q ss_pred             -----------------------------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          501 -----------------------------TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       501 -----------------------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                                                   .....+...+.+++.+||+.||.+||++.+++.
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         218 PDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             CchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence                                         011124456899999999999999999999985

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.97  E-value=2.2e-31  Score=270.67  Aligned_cols=222  Identities=26%  Similarity=0.421  Sum_probs=171.2

Q ss_pred             cCCCccceecccCcEEEEEEEEC--CceEEEEEeccCC----hHHHHHHHHHHHhcc-ccce---------------EEE
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNK----SKEFFAELKVLCKIH-HINV---------------FIS  349 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~----~~~f~~Ei~~l~~l~-H~ni---------------V~e  349 (563)
                      ++|+..+.||+|+||.||+|...  ++.+|||.++...    ..++.+|++++.+.+ |+||               ++|
T Consensus        15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e   94 (296)
T cd06618          15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME   94 (296)
T ss_pred             chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence            55778899999999999999986  7899999987532    345677888777775 9997               356


Q ss_pred             eecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccc
Q 044997          350 TFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHD-HTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEE  428 (563)
Q Consensus       350 ~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~  428 (563)
                      |++ +++.+++..    ....+++..+..++.|++.||+|||+ .+   ++||||+|+||++++++.+||+|||++....
T Consensus        95 ~~~-~~l~~l~~~----~~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~  166 (296)
T cd06618          95 LMS-TCLDKLLKR----IQGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLV  166 (296)
T ss_pred             ccC-cCHHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence            553 355554432    13479999999999999999999997 45   9999999999999999999999999987543


Q ss_pred             cccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCch-------
Q 044997          429 RTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPT-------  501 (563)
Q Consensus       429 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~-------  501 (563)
                      ....    .....++..|+|||.+.....         .+.++.++||||||+++|||++|+.||........       
T Consensus       167 ~~~~----~~~~~~~~~y~aPE~~~~~~~---------~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~  233 (296)
T cd06618         167 DSKA----KTRSAGCAAYMAPERIDPPDP---------NPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQ  233 (296)
T ss_pred             CCCc----ccCCCCCccccCHhhcCCCCC---------ccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhc
Confidence            2221    122357889999998854431         23468899999999999999999999864221100       


Q ss_pred             -------hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          502 -------KMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       502 -------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                             ........+.+++.+||+.||.+||++.++++.
T Consensus       234 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         234 EEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             CCCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                   001234568999999999999999999999865

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.97  E-value=3.6e-31  Score=266.82  Aligned_cols=216  Identities=23%  Similarity=0.331  Sum_probs=166.8

Q ss_pred             CCccceecccCcEEEEEEEEC--CceEEEEEeccCC-----hHHHHHHHHHHHhc---cccceE----------------
Q 044997          294 FDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNK-----SKEFFAELKVLCKI---HHINVF----------------  347 (563)
Q Consensus       294 f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~-----~~~f~~Ei~~l~~l---~H~niV----------------  347 (563)
                      |+..+.||+|+||.||+|+..  ++.+|+|+++...     ...+.+|++++.++   +|+|++                
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            567889999999999999984  6899999986421     24566788877666   599973                


Q ss_pred             ----EEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCC
Q 044997          348 ----ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGL  423 (563)
Q Consensus       348 ----~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGl  423 (563)
                          +||+. ++|.+++...   ....++|.++..++.|+++||.|||+.+   ++|+||||+||++++++++||+|||+
T Consensus        81 ~~l~~e~~~-~~l~~~l~~~---~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~  153 (287)
T cd07838          81 LTLVFEHVD-QDLATYLSKC---PKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGL  153 (287)
T ss_pred             eEEEehhcc-cCHHHHHHHc---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCc
Confidence                23333 4666666431   2235899999999999999999999987   99999999999999999999999999


Q ss_pred             CcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc---
Q 044997          424 VKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP---  500 (563)
Q Consensus       424 a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~---  500 (563)
                      +.......    ......++..|+|||.+.+..             ++.++||||||+++|||++|+.||.......   
T Consensus       154 ~~~~~~~~----~~~~~~~~~~~~~PE~~~~~~-------------~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~  216 (287)
T cd07838         154 ARIYSFEM----ALTSVVVTLWYRAPEVLLQSS-------------YATPVDMWSVGCIFAELFRRRPLFRGTSEADQLD  216 (287)
T ss_pred             ceeccCCc----ccccccccccccChHHhccCC-------------CCCcchhhhHHHHHHHHHhCCCcccCCChHHHHH
Confidence            87653321    112235788999999885443             4789999999999999999988875432110   


Q ss_pred             ----------------------------------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          501 ----------------------------------TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       501 ----------------------------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                                                        .........+.+++.+||+.||.+||++.|++.
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         217 KIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             HHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence                                              001133456789999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.97  E-value=2.8e-31  Score=274.05  Aligned_cols=221  Identities=26%  Similarity=0.379  Sum_probs=175.0

Q ss_pred             CCCccceecccCcEEEEEEEEC--CceEEEEEeccC-----ChHHHHHHHHHHHhccccce-------------------
Q 044997          293 NFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSN-----KSKEFFAELKVLCKIHHINV-------------------  346 (563)
Q Consensus       293 ~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~-----~~~~f~~Ei~~l~~l~H~ni-------------------  346 (563)
                      +|+..+.||+|+||.||+|+..  ++.+|||++...     ..+.+.+|++++++++|+||                   
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            4778899999999999999874  688999988653     23678899999999999986                   


Q ss_pred             -EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCc
Q 044997          347 -FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK  425 (563)
Q Consensus       347 -V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~  425 (563)
                       +++|++ ++|.+++..     ...+++..+..++.|++.||+|||+++   ++||||||+|||++.++.+||+|||++.
T Consensus        81 lv~e~~~-~~l~~~l~~-----~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~  151 (330)
T cd07834          81 IVTELME-TDLHKVIKS-----PQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLAR  151 (330)
T ss_pred             EEecchh-hhHHHHHhC-----CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceE
Confidence             345555 467666653     347999999999999999999999997   9999999999999999999999999998


Q ss_pred             ccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc-----
Q 044997          426 LEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP-----  500 (563)
Q Consensus       426 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~-----  500 (563)
                      ................++..|+|||.+.+..            .++.++||||||+++|+|++|+.||.......     
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~------------~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i  219 (330)
T cd07834         152 GVDPDEDEKGFLTEYVVTRWYRAPELLLSSS------------RYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLI  219 (330)
T ss_pred             eecccccccccccccccccCcCCceeeeccc------------CCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHH
Confidence            6544321111223356788999999885431            35889999999999999999999985433110     


Q ss_pred             ---------h---------------------------hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          501 ---------T---------------------------KMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       501 ---------~---------------------------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                               .                           ........+.+++.+||+.||.+||++.+++..
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  289 (330)
T cd07834         220 VEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH  289 (330)
T ss_pred             HHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence                     0                           001123457899999999999999999999874

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.97  E-value=1.5e-31  Score=268.35  Aligned_cols=221  Identities=26%  Similarity=0.397  Sum_probs=179.2

Q ss_pred             cCCCccceecccCcEEEEEEEE--CCceEEEEEeccC------ChHHHHHHHHHHHhcc-ccce---------------E
Q 044997          292 NNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSN------KSKEFFAELKVLCKIH-HINV---------------F  347 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~------~~~~f~~Ei~~l~~l~-H~ni---------------V  347 (563)
                      ++|...+.||+|+||.||+|..  +++.+|+|.+...      ..+.+.+|++++.+++ |+||               |
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            4688889999999999999987  4788999988642      2356888999999999 9997               6


Q ss_pred             EEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccc
Q 044997          348 ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLE  427 (563)
Q Consensus       348 ~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~  427 (563)
                      +|++++++|.+++..     ...+++..+..++.|++.||.|||+++   ++|+||||+||+++++++++|+|||++...
T Consensus        81 ~e~~~~~~L~~~l~~-----~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~  152 (280)
T cd05581          81 LEYAPNGELLQYIRK-----YGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVL  152 (280)
T ss_pred             EcCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCcccccc
Confidence            799999999998865     347999999999999999999999987   999999999999999999999999998755


Q ss_pred             cccccc-----------------ccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCC
Q 044997          428 ERTNEK-----------------EMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK  490 (563)
Q Consensus       428 ~~~~~~-----------------~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~  490 (563)
                      ......                 ........++..|+|||.+...             .++.++||||||++++|+++|+
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-------------~~~~~~Di~slG~~l~~l~~g~  219 (280)
T cd05581         153 DPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEK-------------PAGKSSDLWALGCIIYQMLTGK  219 (280)
T ss_pred             CCccccccCCCCCccccccccccccccccccCCccccCHHHhCCC-------------CCChhhhHHHHHHHHHHHHhCC
Confidence            432210                 0112234678899999987433             3588999999999999999999


Q ss_pred             CCCcCCCCCc----------hhhHHHHHHHHHHHHHhhccCCCCCCCH----HHHHH
Q 044997          491 RALIRDDSEP----------TKMKSLITIMAAVAEWCLNEDAVDRPEM----RDIVA  533 (563)
Q Consensus       491 ~p~~~~~~~~----------~~~~~~~~~l~~li~~cl~~dP~~RPs~----~evl~  533 (563)
                      .|+.......          .....+...+.+++.+||+.||.+||++    +++++
T Consensus       220 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         220 PPFRGSNEYLTFQKILKLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             CCCCCccHHHHHHHHHhcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence            9987543211          1112334568999999999999999999    66654

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.97  E-value=2.6e-31  Score=276.10  Aligned_cols=220  Identities=22%  Similarity=0.372  Sum_probs=169.3

Q ss_pred             cCCCccceecccCcEEEEEEEEC--CceEEEEEeccCC---hHHHHHHHHHHHhccccceE-------------------
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNK---SKEFFAELKVLCKIHHINVF-------------------  347 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~---~~~f~~Ei~~l~~l~H~niV-------------------  347 (563)
                      .+|...+.||+|+||.||+|...  ++.||+|.+....   .+.+.+|++++++++||||+                   
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS   84 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence            67888999999999999999874  6789999886533   35688999999999999863                   


Q ss_pred             ----------EEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEec-CCCcE
Q 044997          348 ----------ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLD-DGLRA  416 (563)
Q Consensus       348 ----------~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~-~~~~~  416 (563)
                                +||++ ++|.+++..      ..+++.....++.|++.||.|||+++   ++||||||+||+++ +++.+
T Consensus        85 ~~~~~~~~lv~e~~~-~~L~~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~  154 (342)
T cd07854          85 LTELNSVYIVQEYME-TDLANVLEQ------GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVL  154 (342)
T ss_pred             ccccceEEEEeeccc-ccHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceE
Confidence                      34443 455555532      45889999999999999999999997   99999999999997 45678


Q ss_pred             EEeecCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCC
Q 044997          417 KVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRD  496 (563)
Q Consensus       417 kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~  496 (563)
                      ||+|||+++................++..|+|||.+...            ..++.++|||||||++|||++|+.||...
T Consensus       155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~------------~~~~~~~DiwSlGvil~el~~g~~pf~~~  222 (342)
T cd07854         155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSP------------NNYTKAIDMWAAGCIFAEMLTGKPLFAGA  222 (342)
T ss_pred             EECCcccceecCCccccccccccccccccccCHHHHhCc------------cccCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            999999987653322111112234578899999976432            23478999999999999999999999643


Q ss_pred             CCCch----------------------------------------hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          497 DSEPT----------------------------------------KMKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       497 ~~~~~----------------------------------------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                      .....                                        ....+...+.+++.+||+.||.+||++.|++.
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  299 (342)
T cd07854         223 HELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM  299 (342)
T ss_pred             CHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence            21000                                        00112345788999999999999999999985

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.97  E-value=2.5e-31  Score=270.14  Aligned_cols=212  Identities=23%  Similarity=0.406  Sum_probs=172.3

Q ss_pred             cceecccCcEEEEEEEE--CCceEEEEEeccCC---hHHHHHHHHHHHhccccce---------------EEEeecCCCc
Q 044997          297 SRIIGRGGFGNVYFGLL--GDREAAIKKMRSNK---SKEFFAELKVLCKIHHINV---------------FISTFGNGSL  356 (563)
Q Consensus       297 ~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~---~~~f~~Ei~~l~~l~H~ni---------------V~e~~~~gsL  356 (563)
                      ...||+|+||.||++..  +++.+|||++....   .+.+.+|+.++++++|+|+               |+||+++++|
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  104 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL  104 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence            46799999999999987  46889999885432   3568899999999999996               6799999999


Q ss_pred             ccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccccccccccc
Q 044997          357 SDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEML  436 (563)
Q Consensus       357 ~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~  436 (563)
                      .+++..      ..+++.....++.|++.||+|||+.+   ++|+||||+||++++++.++|+|||++........   .
T Consensus       105 ~~~~~~------~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~---~  172 (292)
T cd06657         105 TDIVTH------TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP---R  172 (292)
T ss_pred             HHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccccc---c
Confidence            887743      35899999999999999999999987   99999999999999999999999999875432211   1


Q ss_pred             cccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc-------------hhh
Q 044997          437 ATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP-------------TKM  503 (563)
Q Consensus       437 ~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~-------------~~~  503 (563)
                      .....|+..|+|||.+....             ++.++||||||+++|||++|+.||.......             ...
T Consensus       173 ~~~~~~~~~y~~pE~~~~~~-------------~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  239 (292)
T cd06657         173 RKSLVGTPYWMAPELISRLP-------------YGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNL  239 (292)
T ss_pred             ccccccCccccCHHHhcCCC-------------CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCc
Confidence            22346889999999875433             4789999999999999999999986543211             011


Q ss_pred             HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          504 KSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       504 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                      ..+...+.+++.+||+.||.+||++.++++
T Consensus       240 ~~~~~~l~~li~~~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         240 HKVSPSLKGFLDRLLVRDPAQRATAAELLK  269 (292)
T ss_pred             ccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence            123456889999999999999999999887

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.97  E-value=4.5e-31  Score=272.61  Aligned_cols=220  Identities=20%  Similarity=0.316  Sum_probs=168.9

Q ss_pred             ceeccc--CcEEEEEEEE--CCceEEEEEeccCC-----hHHHHHHHHHHHhccccce---------------EEEeecC
Q 044997          298 RIIGRG--GFGNVYFGLL--GDREAAIKKMRSNK-----SKEFFAELKVLCKIHHINV---------------FISTFGN  353 (563)
Q Consensus       298 ~~LG~G--~fG~Vy~g~~--~~~~vavK~~~~~~-----~~~f~~Ei~~l~~l~H~ni---------------V~e~~~~  353 (563)
                      ..||+|  +||.||+++.  .++.||+|.++...     .+.+.+|+.+++.++||||               |+||+.+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            356666  9999999987  57999999986432     2568889999999999998               4688899


Q ss_pred             CCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccccccccc
Q 044997          354 GSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEK  433 (563)
Q Consensus       354 gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~  433 (563)
                      |+|.+++...   ....+++..+..++.|++.||+|||+.+   ++||||||+|||+++++.+|++||+.+.........
T Consensus        84 ~~l~~~l~~~---~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~  157 (328)
T cd08226          84 GSANSLLKTY---FPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQK  157 (328)
T ss_pred             CCHHHHHHhh---cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcc
Confidence            9999888652   2345899999999999999999999987   999999999999999999999999865432211110


Q ss_pred             c----cccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc---------
Q 044997          434 E----MLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP---------  500 (563)
Q Consensus       434 ~----~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~---------  500 (563)
                      .    .......++..|+|||++.+..           ..++.++|||||||++|||++|+.||.......         
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-----------~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~  226 (328)
T cd08226         158 AKVVYDFPQFSTSVLPWLSPELLRQDL-----------YGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGP  226 (328)
T ss_pred             ccccccccccccCccCccChhhhcCCC-----------CCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCC
Confidence            0    0011123566799999985432           235789999999999999999999985432100         


Q ss_pred             ------------------------------------------------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 044997          501 ------------------------------------------------TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIV  532 (563)
Q Consensus       501 ------------------------------------------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl  532 (563)
                                                                      .........+.+|+.+||+.||++|||+.|++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l  306 (328)
T cd08226         227 PYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLL  306 (328)
T ss_pred             CCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHh
Confidence                                                            01122445689999999999999999999998


Q ss_pred             HH
Q 044997          533 AI  534 (563)
Q Consensus       533 ~~  534 (563)
                      +.
T Consensus       307 ~~  308 (328)
T cd08226         307 SH  308 (328)
T ss_pred             hC
Confidence            63

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.97  E-value=6.1e-31  Score=269.88  Aligned_cols=216  Identities=31%  Similarity=0.482  Sum_probs=171.8

Q ss_pred             CCccceecccCcEEEEEEEE--CCceEEEEEeccCC------hHHHHHHHHHHHhccccce---------------EEEe
Q 044997          294 FDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNK------SKEFFAELKVLCKIHHINV---------------FIST  350 (563)
Q Consensus       294 f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~------~~~f~~Ei~~l~~l~H~ni---------------V~e~  350 (563)
                      |...+.||+|+||.||+|+.  .++.+++|.+....      .+++.+|++++++++|+|+               |+||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            55577899999999999987  47889999986421      2467889999999999997               4576


Q ss_pred             ecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccccc
Q 044997          351 FGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERT  430 (563)
Q Consensus       351 ~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~  430 (563)
                      +. |++.+++..    ...+++|.++..++.|++.||.|||+.+   ++||||||+||++++++.+||+|||++..... 
T Consensus       103 ~~-~~l~~~l~~----~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-  173 (313)
T cd06633         103 CL-GSASDLLEV----HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP-  173 (313)
T ss_pred             CC-CCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC-
Confidence            64 566666643    2356899999999999999999999987   99999999999999999999999999863221 


Q ss_pred             cccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc----------
Q 044997          431 NEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP----------  500 (563)
Q Consensus       431 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~----------  500 (563)
                            .....|+..|+|||++...          ..+.++.++|||||||++|||++|+.|+...+...          
T Consensus       174 ------~~~~~~~~~y~aPE~~~~~----------~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~  237 (313)
T cd06633         174 ------ANSFVGTPYWMAPEVILAM----------DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDS  237 (313)
T ss_pred             ------CCCccccccccChhhcccc----------CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC
Confidence                  1234688899999987421          12345789999999999999999999986543211          


Q ss_pred             --hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          501 --TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       501 --~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                        .....+...+.+++.+||+.+|.+||++.+++..
T Consensus       238 ~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         238 PTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence              1112334568999999999999999999999864

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.97  E-value=4.9e-31  Score=272.77  Aligned_cols=222  Identities=25%  Similarity=0.348  Sum_probs=169.9

Q ss_pred             CCCccceecccCcEEEEEEEEC----CceEEEEEeccC-----ChHHHHHHHHHHHhc-cccceEE--------------
Q 044997          293 NFDESRIIGRGGFGNVYFGLLG----DREAAIKKMRSN-----KSKEFFAELKVLCKI-HHINVFI--------------  348 (563)
Q Consensus       293 ~f~~~~~LG~G~fG~Vy~g~~~----~~~vavK~~~~~-----~~~~f~~Ei~~l~~l-~H~niV~--------------  348 (563)
                      +|+..+.||+|+||.||++...    +..+|+|++...     ..+.+.+|+++++++ +|+||+.              
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            4777899999999999999875    458999988642     135678899999999 5998742              


Q ss_pred             ----EeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCC
Q 044997          349 ----STFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLV  424 (563)
Q Consensus       349 ----e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla  424 (563)
                          +++.+++|.+++..     ...+++..+..++.|++.||+|||+++   ++||||||+||++++++.+||+|||++
T Consensus        81 ~~~~~e~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a  152 (332)
T cd07857          81 LYLYEELMEADLHQIIRS-----GQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLA  152 (332)
T ss_pred             EEEEEecccCCHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence                11123566666543     456899999999999999999999997   999999999999999999999999999


Q ss_pred             ccccccccc-ccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc---
Q 044997          425 KLEERTNEK-EMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP---  500 (563)
Q Consensus       425 ~~~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~---  500 (563)
                      +........ ........|+..|+|||.+.+.            ..++.++|||||||++||+++|+.||...+...   
T Consensus       153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~------------~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~  220 (332)
T cd07857         153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSF------------QSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLN  220 (332)
T ss_pred             eecccccccccccccCcccCccccCcHHHhCC------------CCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHH
Confidence            865432211 1112335789999999986432            234789999999999999999999886533100   


Q ss_pred             -----------hh-----------------------h----HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          501 -----------TK-----------------------M----KSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       501 -----------~~-----------------------~----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                                 ..                       .    ......+.+++.+|++.||.+||++.|++..
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~  292 (332)
T cd07857         221 QILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH  292 (332)
T ss_pred             HHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence                       00                       0    0112458899999999999999999998753

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.97  E-value=2.7e-31  Score=271.84  Aligned_cols=219  Identities=31%  Similarity=0.460  Sum_probs=173.5

Q ss_pred             CCCccceecccCcEEEEEEEE--CCceEEEEEeccC------ChHHHHHHHHHHHhccccce---------------EEE
Q 044997          293 NFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSN------KSKEFFAELKVLCKIHHINV---------------FIS  349 (563)
Q Consensus       293 ~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~------~~~~f~~Ei~~l~~l~H~ni---------------V~e  349 (563)
                      .|+..+.||+|+||.||+|+.  ++..+|+|.+...      ..+++.+|++++++++|+|+               |+|
T Consensus        16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   95 (308)
T cd06634          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (308)
T ss_pred             HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence            366678899999999999987  4678999988632      12467889999999999996               467


Q ss_pred             eecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccccc
Q 044997          350 TFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEER  429 (563)
Q Consensus       350 ~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~  429 (563)
                      |+. |++.+++..    ...++++.++..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++.....
T Consensus        96 ~~~-~~l~~~~~~----~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~  167 (308)
T cd06634          96 YCL-GSASDLLEV----HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  167 (308)
T ss_pred             ccC-CCHHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence            775 677766643    2346899999999999999999999987   99999999999999999999999999875432


Q ss_pred             ccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCch--------
Q 044997          430 TNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPT--------  501 (563)
Q Consensus       430 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~--------  501 (563)
                      .       ....|+..|+|||.+...          ....++.++|||||||++|||++|+.|+........        
T Consensus       168 ~-------~~~~~~~~y~aPE~~~~~----------~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~  230 (308)
T cd06634         168 A-------NXFVGTPYWMAPEVILAM----------DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE  230 (308)
T ss_pred             c-------ccccCCccccCHHHHhhc----------ccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcC
Confidence            1       234578899999987421          123457899999999999999999999865332110        


Q ss_pred             ----hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 044997          502 ----KMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILS  536 (563)
Q Consensus       502 ----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  536 (563)
                          ........+.+++.+||+.+|.+||++.+++...-
T Consensus       231 ~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~  269 (308)
T cd06634         231 SPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF  269 (308)
T ss_pred             CCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence                11234456899999999999999999999997643

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.97  E-value=3e-31  Score=275.77  Aligned_cols=218  Identities=27%  Similarity=0.413  Sum_probs=171.1

Q ss_pred             HHHhcCCCccceecccCcEEEEEEEE--CCceEEEEEeccCC-----hHHHHHHHHHHHhccccceE-------------
Q 044997          288 EEATNNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNK-----SKEFFAELKVLCKIHHINVF-------------  347 (563)
Q Consensus       288 ~~~~~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~-----~~~f~~Ei~~l~~l~H~niV-------------  347 (563)
                      ....++|+..+.||+|+||.||++..  ++..||||++....     .+.+.+|+++|++++|+||+             
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   90 (343)
T cd07880          11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD   90 (343)
T ss_pred             hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence            33567899999999999999999986  47889999985421     24678999999999999974             


Q ss_pred             --------EEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEe
Q 044997          348 --------ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVA  419 (563)
Q Consensus       348 --------~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~  419 (563)
                              ++|+ +++|.+++.      ...+++..+..++.|++.||+|||+++   ++||||||+||++++++.+||+
T Consensus        91 ~~~~~~lv~e~~-~~~l~~~~~------~~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~  160 (343)
T cd07880          91 RFHDFYLVMPFM-GTDLGKLMK------HEKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKIL  160 (343)
T ss_pred             ccceEEEEEecC-CCCHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEe
Confidence                    2232 345554443      246899999999999999999999987   9999999999999999999999


Q ss_pred             ecCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCC
Q 044997          420 DFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE  499 (563)
Q Consensus       420 DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~  499 (563)
                      |||+++.....      .....++..|+|||.+.+.            ..++.++||||||+++|++++|+.||......
T Consensus       161 dfg~~~~~~~~------~~~~~~~~~y~aPE~~~~~------------~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~  222 (343)
T cd07880         161 DFGLARQTDSE------MTGYVVTRWYRAPEVILNW------------MHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHL  222 (343)
T ss_pred             ecccccccccC------ccccccCCcccCHHHHhCC------------CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            99998754321      1224578899999987432            23578999999999999999999998644321


Q ss_pred             chh-----------------------------------------hHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          500 PTK-----------------------------------------MKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       500 ~~~-----------------------------------------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                      ...                                         .......+.+++.+|++.||.+||++.+++.
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~  297 (343)
T cd07880         223 DQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA  297 (343)
T ss_pred             HHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            000                                         0012234789999999999999999999985

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.97  E-value=7.5e-31  Score=264.49  Aligned_cols=210  Identities=25%  Similarity=0.368  Sum_probs=164.5

Q ss_pred             eecccCcEEEEEEEE--CCceEEEEEeccCC------hHHHHHHHH---HHHhccccce---------------EEEeec
Q 044997          299 IIGRGGFGNVYFGLL--GDREAAIKKMRSNK------SKEFFAELK---VLCKIHHINV---------------FISTFG  352 (563)
Q Consensus       299 ~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~------~~~f~~Ei~---~l~~l~H~ni---------------V~e~~~  352 (563)
                      .||+|+||.||++..  .++.||+|.+....      ...+..|..   .+...+|+|+               |+||+.
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            489999999999976  46889999886432      122444443   3444578887               578999


Q ss_pred             CCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccccccc
Q 044997          353 NGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNE  432 (563)
Q Consensus       353 ~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~  432 (563)
                      +|+|.+++..     ...++|..+..++.|++.||+|||+.+   ++||||||+||++++++.+||+|||+++...... 
T Consensus        81 g~~L~~~l~~-----~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~-  151 (278)
T cd05606          81 GGDLHYHLSQ-----HGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-  151 (278)
T ss_pred             CCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC-
Confidence            9999888754     356999999999999999999999987   9999999999999999999999999987543221 


Q ss_pred             cccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCch-----------
Q 044997          433 KEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPT-----------  501 (563)
Q Consensus       433 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~-----------  501 (563)
                          .....|+..|+|||.+..+            ..++.++|||||||++|||++|+.||........           
T Consensus       152 ----~~~~~~~~~y~aPE~~~~~------------~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~  215 (278)
T cd05606         152 ----PHASVGTHGYMAPEVLQKG------------VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA  215 (278)
T ss_pred             ----CcCcCCCcCCcCcHHhcCC------------CCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccC
Confidence                1224689999999987532            1347899999999999999999999965422110           


Q ss_pred             --hhHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 044997          502 --KMKSLITIMAAVAEWCLNEDAVDRP-----EMRDIVA  533 (563)
Q Consensus       502 --~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  533 (563)
                        ........+.+++.+|+..+|.+||     ++.++++
T Consensus       216 ~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         216 VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             CCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence              1112346689999999999999999     8888875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.97  E-value=6.1e-31  Score=261.77  Aligned_cols=220  Identities=24%  Similarity=0.396  Sum_probs=172.4

Q ss_pred             CCCccceecccCcEEEEEEEEC--CceEEEEEecc--------CChHHHHHHHHHHHhccccce---------------E
Q 044997          293 NFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRS--------NKSKEFFAELKVLCKIHHINV---------------F  347 (563)
Q Consensus       293 ~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~--------~~~~~f~~Ei~~l~~l~H~ni---------------V  347 (563)
                      +|...+.||+|+||.||++...  +..+++|.++.        ....++..|++++++++|||+               |
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            4777899999999999999874  34455555442        123457789999999999996               6


Q ss_pred             EEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccc
Q 044997          348 ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLE  427 (563)
Q Consensus       348 ~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~  427 (563)
                      +||+++++|.+++.... .....+++.+++.++.|++.||.|||+.+   ++|+||||+||++++ +.+||+|||+++..
T Consensus        81 ~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~  155 (260)
T cd08222          81 TEYCEGRDLDCKLEELK-HTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLL  155 (260)
T ss_pred             EEeCCCCCHHHHHHHHh-hcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeec
Confidence            89999999998886421 22457999999999999999999999987   999999999999986 46999999998765


Q ss_pred             ccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCC--------
Q 044997          428 ERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE--------  499 (563)
Q Consensus       428 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~--------  499 (563)
                      .....   ......|+..|+|||.+.+..             ++.++|+||||+++|+|++|..|+......        
T Consensus       156 ~~~~~---~~~~~~~~~~~~~pe~~~~~~-------------~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~  219 (260)
T cd08222         156 MGSCD---LATTFTGTPYYMSPEALKHQG-------------YDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVE  219 (260)
T ss_pred             CCCcc---cccCCCCCcCccCHHHHccCC-------------CCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHc
Confidence            33221   122345788999999875433             377899999999999999999998543211        


Q ss_pred             ---chhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          500 ---PTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       500 ---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                         +.........+.+++.+||+.||++||++.|+++
T Consensus       220 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         220 GPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             CCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence               1112244567899999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.97  E-value=6.1e-31  Score=272.27  Aligned_cols=221  Identities=22%  Similarity=0.322  Sum_probs=170.3

Q ss_pred             cCCC-ccceecccCcEEEEEEEE--CCceEEEEEeccCCh-----------------HHHHHHHHHHHhccccce-----
Q 044997          292 NNFD-ESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNKS-----------------KEFFAELKVLCKIHHINV-----  346 (563)
Q Consensus       292 ~~f~-~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~~-----------------~~f~~Ei~~l~~l~H~ni-----  346 (563)
                      ++|. ..+.||+|+||.||+|..  .++.+|||.++....                 ..+.+|++++++++|+||     
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            3454 357799999999999986  478899998864321                 247789999999999997     


Q ss_pred             ----------EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcE
Q 044997          347 ----------FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRA  416 (563)
Q Consensus       347 ----------V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~  416 (563)
                                |+||+. |+|.+++..     ...+++.....++.|++.||+|||+.+   ++||||||+||+++.++.+
T Consensus        88 ~~~~~~~~~lv~e~~~-~~l~~~l~~-----~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~  158 (335)
T PTZ00024         88 VYVEGDFINLVMDIMA-SDLKKVVDR-----KIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGIC  158 (335)
T ss_pred             EEecCCcEEEEEeccc-cCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCE
Confidence                      456665 688777753     345899999999999999999999987   9999999999999999999


Q ss_pred             EEeecCCCccccccc-----------ccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHH
Q 044997          417 KVADFGLVKLEERTN-----------EKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAE  485 (563)
Q Consensus       417 kl~DFGla~~~~~~~-----------~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~E  485 (563)
                      ||+|||+++......           ..........++..|+|||.+.+..            .++.++||||||+++||
T Consensus       159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~------------~~~~~~Dv~slG~~l~e  226 (335)
T PTZ00024        159 KIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAE------------KYHFAVDMWSVGCIFAE  226 (335)
T ss_pred             EECCccceeecccccccccccccccccccccccccccccCCCCChhcccCC------------CCCcHHHHHHHHHHHHH
Confidence            999999987544110           0001112234678899999875322            24789999999999999


Q ss_pred             HHcCCCCCcCCCCCchh--------------------------------------hHHHHHHHHHHHHHhhccCCCCCCC
Q 044997          486 LITGKRALIRDDSEPTK--------------------------------------MKSLITIMAAVAEWCLNEDAVDRPE  527 (563)
Q Consensus       486 lltg~~p~~~~~~~~~~--------------------------------------~~~~~~~l~~li~~cl~~dP~~RPs  527 (563)
                      |++|+.||...+.....                                      .....+.+.+++.+||+.||++||+
T Consensus       227 l~tg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s  306 (335)
T PTZ00024        227 LLTGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERIS  306 (335)
T ss_pred             HHhCCCCCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccC
Confidence            99999988644321000                                      0112345789999999999999999


Q ss_pred             HHHHHH
Q 044997          528 MRDIVA  533 (563)
Q Consensus       528 ~~evl~  533 (563)
                      +.|++.
T Consensus       307 ~~~~l~  312 (335)
T PTZ00024        307 AKEALK  312 (335)
T ss_pred             HHHHhc
Confidence            999986

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.97  E-value=4.7e-31  Score=272.65  Aligned_cols=221  Identities=27%  Similarity=0.400  Sum_probs=173.7

Q ss_pred             HHHHHhcCCCccceecccCcEEEEEEEE--CCceEEEEEeccC-----ChHHHHHHHHHHHhccccceE-----------
Q 044997          286 EIEEATNNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSN-----KSKEFFAELKVLCKIHHINVF-----------  347 (563)
Q Consensus       286 el~~~~~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~-----~~~~f~~Ei~~l~~l~H~niV-----------  347 (563)
                      ++...+++|+..+.||+|+||.||++..  +++.+|+|++...     ..+.+.+|++++++++|||++           
T Consensus         4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~   83 (328)
T cd07856           4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLE   83 (328)
T ss_pred             ceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence            3445678899999999999999999976  4688999987532     246788999999999999984           


Q ss_pred             -----EEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecC
Q 044997          348 -----ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFG  422 (563)
Q Consensus       348 -----~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFG  422 (563)
                           +||+ +++|.+++..      .++++.....++.|+++||+|||+.+   ++||||||+||++++++.+||+|||
T Consensus        84 ~~~lv~e~~-~~~L~~~~~~------~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg  153 (328)
T cd07856          84 DIYFVTELL-GTDLHRLLTS------RPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFG  153 (328)
T ss_pred             cEEEEeehh-ccCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccc
Confidence                 3444 4466655542      45788888899999999999999987   9999999999999999999999999


Q ss_pred             CCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc--
Q 044997          423 LVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP--  500 (563)
Q Consensus       423 la~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~--  500 (563)
                      +++.....      .....++..|+|||.+.+.            ..++.++||||||+++|||++|+.||.......  
T Consensus       154 ~~~~~~~~------~~~~~~~~~y~aPE~~~~~------------~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~  215 (328)
T cd07856         154 LARIQDPQ------MTGYVSTRYYRAPEIMLTW------------QKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQF  215 (328)
T ss_pred             cccccCCC------cCCCcccccccCceeeecc------------CCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            98743221      1224578889999987432            234889999999999999999999985432100  


Q ss_pred             -----------h----------------------------hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          501 -----------T----------------------------KMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       501 -----------~----------------------------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                                 .                            ......+.+.+++.+||+.+|++||++.+++..
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         216 SIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             HHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                       0                            001123568999999999999999999999875

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.97  E-value=1.7e-31  Score=278.30  Aligned_cols=221  Identities=23%  Similarity=0.361  Sum_probs=187.2

Q ss_pred             HhcCCCccceecccCcEEEEEEEE--CCceEEEEEeccCC-----hHHHHHHHHHHHhccccce---------------E
Q 044997          290 ATNNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNK-----SKEFFAELKVLCKIHHINV---------------F  347 (563)
Q Consensus       290 ~~~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~-----~~~f~~Ei~~l~~l~H~ni---------------V  347 (563)
                      -...|...+.||+|.|+.|..|+.  .+..||||.+++..     ...+.+|+++|+.++||||               |
T Consensus        54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV  133 (596)
T KOG0586|consen   54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV  133 (596)
T ss_pred             cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence            346788899999999999999987  58999999987653     2458899999999999998               5


Q ss_pred             EEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccc
Q 044997          348 ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLE  427 (563)
Q Consensus       348 ~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~  427 (563)
                      +||..+|.+.+||..     ...+.......++.|+.++++|+|+++   |||||||++||||+.+..+||+|||++..+
T Consensus       134 ~eya~~ge~~~yl~~-----~gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~  205 (596)
T KOG0586|consen  134 MEYASGGELFDYLVK-----HGRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFF  205 (596)
T ss_pred             EEeccCchhHHHHHh-----cccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceee
Confidence            799999999999976     234555888889999999999999998   999999999999999999999999999876


Q ss_pred             ccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCchhh----
Q 044997          428 ERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKM----  503 (563)
Q Consensus       428 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~~~----  503 (563)
                      ....    .....+|++.|.|||++.+.+|+            ++++|+||+||++|-|++|..||.+..-..-..    
T Consensus       206 ~~~~----~lqt~cgsppyAaPEl~~g~~y~------------gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~  269 (596)
T KOG0586|consen  206 DYGL----MLQTFCGSPPYAAPELFNGKKYD------------GPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLR  269 (596)
T ss_pred             cccc----cccccCCCCCccChHhhcCcccC------------CcceehhhhhhhheeeeecccccCCcccccccchhee
Confidence            5332    34557899999999999888874            899999999999999999999998665432211    


Q ss_pred             ------HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          504 ------KSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       504 ------~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                            .-+.....+++++++-.+|.+|+++++|.+.
T Consensus       270 gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~  306 (596)
T KOG0586|consen  270 GKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD  306 (596)
T ss_pred             eeecccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence                  1223447899999999999999999999764

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=9e-32  Score=275.81  Aligned_cols=232  Identities=22%  Similarity=0.330  Sum_probs=173.2

Q ss_pred             cCCCccceecccCcEEEEEEEEC-CceEEEEEeccCC-----hHHHHHHHHHHHhcc-ccceEE--E----------e--
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG-DREAAIKKMRSNK-----SKEFFAELKVLCKIH-HINVFI--S----------T--  350 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~vavK~~~~~~-----~~~f~~Ei~~l~~l~-H~niV~--e----------~--  350 (563)
                      ..|+..+.||+||.+.||++... .+.+|+|++....     ...|.+|++.|.+|+ |.+||-  +          .  
T Consensus       361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE  440 (677)
T KOG0596|consen  361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVME  440 (677)
T ss_pred             chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEee
Confidence            45777899999999999999885 4667888765322     356999999999995 666631  1          1  


Q ss_pred             ecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccccc
Q 044997          351 FGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERT  430 (563)
Q Consensus       351 ~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~  430 (563)
                      +++-+|..+|...   ......| .+..+..|++.++.++|.++   |||.||||.|.|+-+ |++||+|||+|+.+..+
T Consensus       441 ~Gd~DL~kiL~k~---~~~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~D  512 (677)
T KOG0596|consen  441 CGDIDLNKILKKK---KSIDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVK-GRLKLIDFGIANAIQPD  512 (677)
T ss_pred             cccccHHHHHHhc---cCCCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEe-eeEEeeeechhcccCcc
Confidence            2345788888762   3344456 67788999999999999998   999999999999875 58999999999976544


Q ss_pred             cccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCchh--------
Q 044997          431 NEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTK--------  502 (563)
Q Consensus       431 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~~--------  502 (563)
                      . ........+||+.||+||.+....++.  ......-.++++|||||+||+||+|+.|+.||..-.....+        
T Consensus       513 T-TsI~kdsQvGT~NYMsPEAl~~~~s~~--~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~  589 (677)
T KOG0596|consen  513 T-TSIVKDSQVGTVNYMSPEALTDMSSSR--ENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPN  589 (677)
T ss_pred             c-cceeeccccCcccccCHHHHhhccccc--cCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCC
Confidence            3 223334568999999999997655431  11122345789999999999999999999998532211000        


Q ss_pred             ----hHH--HHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          503 ----MKS--LITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       503 ----~~~--~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                          ...  -..++.++++.||+.||.+||+..|+++.
T Consensus       590 ~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh  627 (677)
T KOG0596|consen  590 HEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH  627 (677)
T ss_pred             ccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence                000  01238899999999999999999999874

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.97  E-value=4.8e-31  Score=274.21  Aligned_cols=217  Identities=25%  Similarity=0.403  Sum_probs=173.0

Q ss_pred             HhcCCCccceecccCcEEEEEEEEC--CceEEEEEeccC-----ChHHHHHHHHHHHhccccceE---------------
Q 044997          290 ATNNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSN-----KSKEFFAELKVLCKIHHINVF---------------  347 (563)
Q Consensus       290 ~~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~-----~~~~f~~Ei~~l~~l~H~niV---------------  347 (563)
                      ..++|+..+.||+|+||.||+|+..  ++.+|+|++...     ..+.+.+|+.++++++|+|++               
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF   92 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence            4678999999999999999999884  678999998642     235577899999999999872               


Q ss_pred             ------EEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeec
Q 044997          348 ------ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADF  421 (563)
Q Consensus       348 ------~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DF  421 (563)
                            ++|+ +++|.+++..      ..+++..+..++.|+++||+|||+.+   ++||||||+||++++++.+||+||
T Consensus        93 ~~~~lv~e~~-~~~L~~~~~~------~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~df  162 (343)
T cd07851          93 QDVYLVTHLM-GADLNNIVKC------QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDF  162 (343)
T ss_pred             ccEEEEEecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccc
Confidence                  3443 5577776653      46899999999999999999999987   999999999999999999999999


Q ss_pred             CCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCch
Q 044997          422 GLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPT  501 (563)
Q Consensus       422 Gla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~  501 (563)
                      |++......      .....++..|+|||.+.+.            ..++.++|||||||++||+++|+.||........
T Consensus       163 g~~~~~~~~------~~~~~~~~~y~aPE~~~~~------------~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~  224 (343)
T cd07851         163 GLARHTDDE------MTGYVATRWYRAPEIMLNW------------MHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQ  224 (343)
T ss_pred             ccccccccc------ccCCcccccccCHHHHhCC------------CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence            998754321      2234578899999987432            1347899999999999999999999864332100


Q ss_pred             -----------------------------------------hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          502 -----------------------------------------KMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       502 -----------------------------------------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                                                               ........+.+++.+||+.||.+|||+.||++.
T Consensus       225 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h  298 (343)
T cd07851         225 LKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH  298 (343)
T ss_pred             HHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence                                                     000124568899999999999999999999863

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.97  E-value=1.7e-30  Score=261.22  Aligned_cols=217  Identities=25%  Similarity=0.350  Sum_probs=173.0

Q ss_pred             CCccceecccCcEEEEEEEEC--CceEEEEEeccCC-----hHHHHHHHHHHHhccccce---------------EEEee
Q 044997          294 FDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNK-----SKEFFAELKVLCKIHHINV---------------FISTF  351 (563)
Q Consensus       294 f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~-----~~~f~~Ei~~l~~l~H~ni---------------V~e~~  351 (563)
                      |+..+.||+|+||.||+|+..  ++.+|+|.+....     .+.+..|++++++++|+|+               |+||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            456688999999999999884  6889999987532     3567889999999999997               56777


Q ss_pred             cCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccccccc
Q 044997          352 GNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTN  431 (563)
Q Consensus       352 ~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~  431 (563)
                      + ++|.+++...    ...+++..+..++.|++.||+|||+++   ++||||+|+||++++++.+||+|||+++......
T Consensus        81 ~-~~l~~~i~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~  152 (282)
T cd07829          81 D-MDLKKYLDKR----PGPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPL  152 (282)
T ss_pred             C-cCHHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCc
Confidence            7 5898888752    246999999999999999999999997   9999999999999999999999999987643321


Q ss_pred             ccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCch----------
Q 044997          432 EKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPT----------  501 (563)
Q Consensus       432 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~----------  501 (563)
                      .   ......++..|+|||.+...            ..++.++||||||+++||+++|+.||........          
T Consensus       153 ~---~~~~~~~~~~~~aPE~~~~~------------~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~  217 (282)
T cd07829         153 R---TYTHEVVTLWYRAPEILLGS------------KHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGT  217 (282)
T ss_pred             c---ccCccccCcCcCChHHhcCC------------cCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCC
Confidence            1   11223457789999987543            1347899999999999999999988854331100          


Q ss_pred             -----------------------------hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          502 -----------------------------KMKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       502 -----------------------------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                                                   ........+.+++.+||+.||++||++.+++.
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         218 PTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             CcHHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence                                         00112346899999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.97  E-value=2.8e-30  Score=255.03  Aligned_cols=207  Identities=27%  Similarity=0.394  Sum_probs=169.8

Q ss_pred             ecccCcEEEEEEEEC--CceEEEEEeccCC------hHHHHHHHHHHHhccccce---------------EEEeecCCCc
Q 044997          300 IGRGGFGNVYFGLLG--DREAAIKKMRSNK------SKEFFAELKVLCKIHHINV---------------FISTFGNGSL  356 (563)
Q Consensus       300 LG~G~fG~Vy~g~~~--~~~vavK~~~~~~------~~~f~~Ei~~l~~l~H~ni---------------V~e~~~~gsL  356 (563)
                      ||+|+||.||++...  ++.+|+|.++...      .+.+..|++++++++|+|+               ++||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            699999999999884  6889999986543      3478899999999999986               6799999999


Q ss_pred             ccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccccccccccc
Q 044997          357 SDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEML  436 (563)
Q Consensus       357 ~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~  436 (563)
                      .+++..     ...+++.....++.|++.||.|||+.+   ++|+||||+||++++++.++|+|||++........   .
T Consensus        81 ~~~l~~-----~~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~---~  149 (250)
T cd05123          81 FSHLSK-----EGRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS---R  149 (250)
T ss_pred             HHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCCC---c
Confidence            999864     246899999999999999999999987   99999999999999999999999999876543211   1


Q ss_pred             cccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc----------hhhHHH
Q 044997          437 ATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP----------TKMKSL  506 (563)
Q Consensus       437 ~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~----------~~~~~~  506 (563)
                      .....++..|+|||...+..             .+.++|+||||+++||+++|+.||...+...          ......
T Consensus       150 ~~~~~~~~~~~~Pe~~~~~~-------------~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  216 (250)
T cd05123         150 TNTFCGTPEYLAPEVLLGKG-------------YGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFL  216 (250)
T ss_pred             ccCCcCCccccChHHhCCCC-------------CCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Confidence            23356788999999875433             4789999999999999999999996544211          111223


Q ss_pred             HHHHHHHHHHhhccCCCCCCCHHH
Q 044997          507 ITIMAAVAEWCLNEDAVDRPEMRD  530 (563)
Q Consensus       507 ~~~l~~li~~cl~~dP~~RPs~~e  530 (563)
                      ...+.+++++||..||++||++.+
T Consensus       217 ~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         217 SPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             CHHHHHHHHHHhcCCHhhCCCccc
Confidence            456899999999999999999954

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.97  E-value=4.1e-30  Score=282.27  Aligned_cols=240  Identities=16%  Similarity=0.193  Sum_probs=160.0

Q ss_pred             HhcCCCccceecccCcEEEEEEEEC------CceEEEEEeccCChHH-HHHHHH----------HHHhc---------cc
Q 044997          290 ATNNFDESRIIGRGGFGNVYFGLLG------DREAAIKKMRSNKSKE-FFAELK----------VLCKI---------HH  343 (563)
Q Consensus       290 ~~~~f~~~~~LG~G~fG~Vy~g~~~------~~~vavK~~~~~~~~~-f~~Ei~----------~l~~l---------~H  343 (563)
                      ..++|+..+.||+|+||.||+|++.      +..+|+|+++.....+ +..|..          .+..+         .+
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~~~~e~l~~~~~~~~~~~~~~~~~~~~~~~~~~  209 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNERVRRACPNSCADFVYGFLEPVSSKKEDE  209 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHHHHHHHHHhhchhhHHHHHHhhhcccccccCCc
Confidence            4578999999999999999999874      5689999987543322 111110          00010         12


Q ss_pred             cceEEEeecCCCccccccccccc---------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCe
Q 044997          344 INVFISTFGNGSLSDHLHDPLLK---------------GHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNI  408 (563)
Q Consensus       344 ~niV~e~~~~gsL~~~L~~~~~~---------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NI  408 (563)
                      ..+|+||+++|+|.+++......               ......+..+..++.|++.||+|||+++   |+||||||+||
T Consensus       210 ~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLKP~NI  286 (566)
T PLN03225        210 YWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVKPQNI  286 (566)
T ss_pred             eEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCCHHHE
Confidence            34689999999999888642100               0011223445679999999999999987   99999999999


Q ss_pred             EecC-CCcEEEeecCCCcccccccccccccccccCCCcccCccccccccccccccc---------ccccCCCCCcchHHH
Q 044997          409 LLDD-GLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHS---------SVMELQVTTKTDVFA  478 (563)
Q Consensus       409 Ll~~-~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~---------~~~~~~~s~ksDVwS  478 (563)
                      |+++ ++.+||+|||+++.......  .......+++.|+|||.+...........         ......++.++||||
T Consensus       287 Ll~~~~~~~KL~DFGlA~~l~~~~~--~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwS  364 (566)
T PLN03225        287 IFSEGSGSFKIIDLGAAADLRVGIN--YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS  364 (566)
T ss_pred             EEeCCCCcEEEEeCCCccccccccc--cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHH
Confidence            9986 58999999999986533221  22344678999999997644322100000         000123456789999


Q ss_pred             HHHHHHHHHcCCCCCcCCC-----------CCchhhH---------HH----------HHHHHHHHHHhhccCCCCCCCH
Q 044997          479 FGVVLAELITGKRALIRDD-----------SEPTKMK---------SL----------ITIMAAVAEWCLNEDAVDRPEM  528 (563)
Q Consensus       479 fGvvl~Elltg~~p~~~~~-----------~~~~~~~---------~~----------~~~l~~li~~cl~~dP~~RPs~  528 (563)
                      |||+||||+++..+.....           .......         ..          .....+|+.+|++.||.+|||+
T Consensus       365 lGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta  444 (566)
T PLN03225        365 AGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISA  444 (566)
T ss_pred             HHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCCH
Confidence            9999999998765532110           0000000         00          0113489999999999999999


Q ss_pred             HHHHHH
Q 044997          529 RDIVAI  534 (563)
Q Consensus       529 ~evl~~  534 (563)
                      .|+++.
T Consensus       445 ~e~L~H  450 (566)
T PLN03225        445 KAALAH  450 (566)
T ss_pred             HHHhCC
Confidence            999874

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=99.97  E-value=8.6e-30  Score=241.14  Aligned_cols=233  Identities=23%  Similarity=0.355  Sum_probs=175.1

Q ss_pred             cceecccCcEEEEEEEEC--CceEEEEEeccCC----hHHHHHHHHHHHhcc-ccceEEE---eecCCCc----------
Q 044997          297 SRIIGRGGFGNVYFGLLG--DREAAIKKMRSNK----SKEFFAELKVLCKIH-HINVFIS---TFGNGSL----------  356 (563)
Q Consensus       297 ~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~----~~~f~~Ei~~l~~l~-H~niV~e---~~~~gsL----------  356 (563)
                      ...||.|..|.|++.++.  +...|||.|....    .++++..++++.+-+ -|.||.-   |+-+-+.          
T Consensus        97 l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs~C  176 (391)
T KOG0983|consen   97 LGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMSTC  176 (391)
T ss_pred             HHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHHHH
Confidence            467999999999999885  5889999997654    355777778777665 5888742   3334332          


Q ss_pred             -ccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccccccccccc
Q 044997          357 -SDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEM  435 (563)
Q Consensus       357 -~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~  435 (563)
                       +..|.    .-.+++++...-++..-+.+||.||.++.  .|+|||+||+|||+|+.|++|++|||++-.+....    
T Consensus       177 ~ekLlk----rik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk----  246 (391)
T KOG0983|consen  177 AEKLLK----RIKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK----  246 (391)
T ss_pred             HHHHHH----HhcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccc----
Confidence             22222    12467888888889999999999998765  59999999999999999999999999987654332    


Q ss_pred             ccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCchh-------------
Q 044997          436 LATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTK-------------  502 (563)
Q Consensus       436 ~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~~-------------  502 (563)
                      ..++.+|-+.|||||.+...          ....|+-++||||||+.++||.||+.|+...+.+-+.             
T Consensus       247 AhtrsAGC~~YMaPERidp~----------~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~  316 (391)
T KOG0983|consen  247 AHTRSAGCAAYMAPERIDPP----------DKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLP  316 (391)
T ss_pred             ccccccCCccccCccccCCC----------CCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCC
Confidence            23556789999999988543          2456788999999999999999999999764432111             


Q ss_pred             -hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH-----HHHhhhcChhhhccc
Q 044997          503 -MKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI-----LSQIMITSTEWEASL  549 (563)
Q Consensus       503 -~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~-----L~~i~~~~~~w~~~~  549 (563)
                       ...+...+.+++..||.+|+.+||...++++.     -+.+-..-.+|=.+.
T Consensus       317 ~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye~a~~dVa~WF~dV  369 (391)
T KOG0983|consen  317 GHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYETAEVDVASWFKDV  369 (391)
T ss_pred             cccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeecchhhccHHHHHHHH
Confidence             11255668999999999999999999999875     223333334675543

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.97  E-value=7.4e-30  Score=286.67  Aligned_cols=126  Identities=26%  Similarity=0.410  Sum_probs=112.6

Q ss_pred             cCCCccceecccCcEEEEEEEEC--CceEEEEEeccCC------hHHHHHHHHHHHhccccce---------------EE
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNK------SKEFFAELKVLCKIHHINV---------------FI  348 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~------~~~f~~Ei~~l~~l~H~ni---------------V~  348 (563)
                      ++|...+.||+|+||.||+|...  ++.||||+++...      .+.+.+|++++..++|+||               |+
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm   83 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM   83 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence            57888999999999999999986  7899999987532      2568889999999999997               57


Q ss_pred             EeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCc
Q 044997          349 STFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK  425 (563)
Q Consensus       349 e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~  425 (563)
                      ||+.+|+|.+++..     ...+++..++.|+.||+.||+|||.++   |+||||||+|||++.++.+||+|||+++
T Consensus        84 Ey~~g~~L~~li~~-----~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          84 EYLIGGDVKSLLHI-----YGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             eCCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            99999999998864     245889999999999999999999987   9999999999999999999999999986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.97  E-value=8.1e-31  Score=280.25  Aligned_cols=225  Identities=26%  Similarity=0.322  Sum_probs=171.9

Q ss_pred             CCCccceecccCcEE-EEEEEECCceEEEEEeccCChHHHHHHHHHHHhc-cccceEEEeec--------------CCCc
Q 044997          293 NFDESRIIGRGGFGN-VYFGLLGDREAAIKKMRSNKSKEFFAELKVLCKI-HHINVFISTFG--------------NGSL  356 (563)
Q Consensus       293 ~f~~~~~LG~G~fG~-Vy~g~~~~~~vavK~~~~~~~~~f~~Ei~~l~~l-~H~niV~e~~~--------------~gsL  356 (563)
                      -|...+.+|.|..|. ||+|.+.++.||||++-.+..+-..+|+..|+.- +|||||.-|+.              ..+|
T Consensus       510 ~~~~~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~sL  589 (903)
T KOG1027|consen  510 FFSPKEILGYGSNGTVVFRGVYEGREVAVKRLLEEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCACSL  589 (903)
T ss_pred             eeccHHHcccCCCCcEEEEEeeCCceehHHHHhhHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhhhH
Confidence            355567789998876 8999999999999999887777778999998876 69999865543              4567


Q ss_pred             ccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecC-----CCcEEEeecCCCccccccc
Q 044997          357 SDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDD-----GLRAKVADFGLVKLEERTN  431 (563)
Q Consensus       357 ~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~-----~~~~kl~DFGla~~~~~~~  431 (563)
                      .+++... ........-...+.+..|+++||++||+.+   ||||||||.||||+.     ..+++|+|||+++....+.
T Consensus       590 ~dlie~~-~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~  665 (903)
T KOG1027|consen  590 QDLIESS-GLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGK  665 (903)
T ss_pred             HHHHhcc-ccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccCCCc
Confidence            8887653 111111111445678899999999999987   999999999999975     2589999999999877654


Q ss_pred             ccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcC-CCCCcCCCCCchh--------
Q 044997          432 EKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG-KRALIRDDSEPTK--------  502 (563)
Q Consensus       432 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg-~~p~~~~~~~~~~--------  502 (563)
                      ..-.......||-||+|||++...+-             +.++||||+|||+|..++| ++||...-.++..        
T Consensus       666 sS~~r~s~~sGt~GW~APE~L~~~~~-------------~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~~~~L  732 (903)
T KOG1027|consen  666 SSFSRLSGGSGTSGWQAPEQLREDRK-------------TQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTGNYTL  732 (903)
T ss_pred             chhhcccCCCCcccccCHHHHhcccc-------------CcccchhhcCceEEEEecCCccCCCchHHhhhhhhcCccce
Confidence            43333455789999999999976543             6699999999999999987 7888654322110        


Q ss_pred             --hHH-HHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          503 --MKS-LITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       503 --~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                        ... ...+..+||.+|+++||..||++.+|+..
T Consensus       733 ~~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~H  767 (903)
T KOG1027|consen  733 VHLEPLPDCEAKDLISRMLNPDPQLRPSATDVLNH  767 (903)
T ss_pred             eeeccCchHHHHHHHHHhcCCCcccCCCHHHHhCC
Confidence              000 01168899999999999999999999853

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.97  E-value=1.7e-30  Score=248.83  Aligned_cols=220  Identities=19%  Similarity=0.338  Sum_probs=180.2

Q ss_pred             HhcCCCcc-ceecccCcEEEEEEEE--CCceEEEEEeccCChHHHHHHHHHHHhc-cccce-------------------
Q 044997          290 ATNNFDES-RIIGRGGFGNVYFGLL--GDREAAIKKMRSNKSKEFFAELKVLCKI-HHINV-------------------  346 (563)
Q Consensus       290 ~~~~f~~~-~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~~~~f~~Ei~~l~~l-~H~ni-------------------  346 (563)
                      .+++|... ++||-|-.|.|..+..  .+++.|+|.+.....  ..+|+++.-+. .|+||                   
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~K--ARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLi  136 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSPK--ARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLI  136 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCHH--HHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEe
Confidence            34556553 6899999999998876  478899999865433  34677764433 68887                   


Q ss_pred             EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecC---CCcEEEeecCC
Q 044997          347 FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDD---GLRAKVADFGL  423 (563)
Q Consensus       347 V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~---~~~~kl~DFGl  423 (563)
                      |||.|++|.|...+.+   ++.+.+++.++-+|+.||+.|+.|||+.+   |.||||||+|+|...   |-.+||+|||+
T Consensus       137 VmE~meGGeLfsriq~---~g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfGF  210 (400)
T KOG0604|consen  137 VMECMEGGELFSRIQD---RGDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFGF  210 (400)
T ss_pred             eeecccchHHHHHHHH---cccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEeccccc
Confidence            5899999999998887   46788999999999999999999999997   999999999999964   55799999999


Q ss_pred             CcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCC-----
Q 044997          424 VKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDS-----  498 (563)
Q Consensus       424 a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~-----  498 (563)
                      ||......    .....+-|+.|.|||++-.++|             +..+|+||+||+||-|++|.+||+....     
T Consensus       211 AK~t~~~~----~L~TPc~TPyYvaPevlg~eKy-------------dkscdmwSlgVimYIlLCGyPPFYS~hg~aisp  273 (400)
T KOG0604|consen  211 AKETQEPG----DLMTPCFTPYYVAPEVLGPEKY-------------DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP  273 (400)
T ss_pred             ccccCCCc----cccCCcccccccCHHHhCchhc-------------CCCCCccchhHHHHHhhcCCCcccccCCccCCh
Confidence            99654322    2344577999999999876665             7899999999999999999999976543     


Q ss_pred             -------------CchhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          499 -------------EPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       499 -------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                                   ...++..+++...++|+.+|..+|.+|-|+.+++..
T Consensus       274 gMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h  322 (400)
T KOG0604|consen  274 GMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH  322 (400)
T ss_pred             hHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence                         224556777889999999999999999999999864

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1e-30  Score=261.08  Aligned_cols=227  Identities=24%  Similarity=0.415  Sum_probs=182.3

Q ss_pred             cCCCccceecccCcEEEEEEEE--CCceEEEEEeccCC------h----HHHHHHHHHHHhccccce-------------
Q 044997          292 NNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNK------S----KEFFAELKVLCKIHHINV-------------  346 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~------~----~~f~~Ei~~l~~l~H~ni-------------  346 (563)
                      ++|-..++||+|||++||++..  ..+.||||.-.-++      .    +...+|.++.+.|+||.|             
T Consensus       463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds  542 (775)
T KOG1151|consen  463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS  542 (775)
T ss_pred             HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence            3556678999999999999965  46789999743211      1    335679999999999998             


Q ss_pred             ---EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecC---CCcEEEee
Q 044997          347 ---FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDD---GLRAKVAD  420 (563)
Q Consensus       347 ---V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~---~~~~kl~D  420 (563)
                         |.||+++.+|+-||+.     .+.+++.+...|+.||+.||.||.+. ++||||-||||.||||.+   .|.+||.|
T Consensus       543 FCTVLEYceGNDLDFYLKQ-----hklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITD  616 (775)
T KOG1151|consen  543 FCTVLEYCEGNDLDFYLKQ-----HKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITD  616 (775)
T ss_pred             ceeeeeecCCCchhHHHHh-----hhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeee
Confidence               4699999999999976     46789999999999999999999987 577999999999999954   58899999


Q ss_pred             cCCCcccccccccc----cccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCC
Q 044997          421 FGLVKLEERTNEKE----MLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRD  496 (563)
Q Consensus       421 FGla~~~~~~~~~~----~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~  496 (563)
                      ||++++++.+....    .......||.+|++||.+.-++         ....++.|+||||.||++|..+.|++||..+
T Consensus       617 FGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgk---------ePPKIsnKVDVWSvGVIFyQClYGrKPFGhn  687 (775)
T KOG1151|consen  617 FGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGK---------EPPKISNKVDVWSVGVIFYQCLYGRKPFGHN  687 (775)
T ss_pred             cchhhhccCCccCcccceeeecccCceeeecCcceeecCC---------CCCccccceeeEeeehhhhhhhccCCCCCCc
Confidence            99999887654321    2234578999999999986553         3567899999999999999999999999765


Q ss_pred             CCCchhh----------------HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          497 DSEPTKM----------------KSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       497 ~~~~~~~----------------~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                      .......                ..+..+..++|++||+.--++|....++..
T Consensus       688 qsQQdILqeNTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~  740 (775)
T KOG1151|consen  688 QSQQDILQENTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC  740 (775)
T ss_pred             hhHHHHHhhhchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence            4322111                123455889999999999999988777654

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.96  E-value=1e-29  Score=250.06  Aligned_cols=198  Identities=19%  Similarity=0.199  Sum_probs=157.1

Q ss_pred             cCcEEEEEEEE--CCceEEEEEeccCChHHHHHHHHHHHhccccce---------------EEEeecCCCcccccccccc
Q 044997          303 GGFGNVYFGLL--GDREAAIKKMRSNKSKEFFAELKVLCKIHHINV---------------FISTFGNGSLSDHLHDPLL  365 (563)
Q Consensus       303 G~fG~Vy~g~~--~~~~vavK~~~~~~~~~f~~Ei~~l~~l~H~ni---------------V~e~~~~gsL~~~L~~~~~  365 (563)
                      |.+|.||+++.  +++.+|+|+++...  .+.+|...+....|||+               |+||+++|+|.+++..   
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS--EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK---   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh--hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH---
Confidence            88999999987  47889999987643  34456666666678886               5799999999998864   


Q ss_pred             cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccccccccccccccccCCCc
Q 044997          366 KGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPG  445 (563)
Q Consensus       366 ~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~  445 (563)
                        ...+++..+..++.|++.||+|||+.+   ++||||||+||++++++.++++|||.+......      .....++..
T Consensus        79 --~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~------~~~~~~~~~  147 (237)
T cd05576          79 --FLNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS------CDGEAVENM  147 (237)
T ss_pred             --hcCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc------cccCCcCcc
Confidence              245899999999999999999999987   999999999999999999999999987654322      112345678


Q ss_pred             ccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCC------chhhHHHHHHHHHHHHHhhc
Q 044997          446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE------PTKMKSLITIMAAVAEWCLN  519 (563)
Q Consensus       446 y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~------~~~~~~~~~~l~~li~~cl~  519 (563)
                      |+|||.+.+.             .++.++||||+|+++|||++|+.|+......      ......+...+.+++.+|++
T Consensus       148 y~aPE~~~~~-------------~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  214 (237)
T cd05576         148 YCAPEVGGIS-------------EETEACDWWSLGAILFELLTGKTLVECHPSGINTHTTLNIPEWVSEEARSLLQQLLQ  214 (237)
T ss_pred             ccCCcccCCC-------------CCCchhhHHHHHHHHHHHHHCcchhhcCchhcccccccCCcccCCHHHHHHHHHHcc
Confidence            9999987433             3478999999999999999999876432211      11123345668999999999


Q ss_pred             cCCCCCCCHH
Q 044997          520 EDAVDRPEMR  529 (563)
Q Consensus       520 ~dP~~RPs~~  529 (563)
                      .||++||++.
T Consensus       215 ~dp~~R~~~~  224 (237)
T cd05576         215 FNPTERLGAG  224 (237)
T ss_pred             CCHHHhcCCC
Confidence            9999999973

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.6e-30  Score=285.07  Aligned_cols=244  Identities=23%  Similarity=0.327  Sum_probs=189.8

Q ss_pred             cCHHHHHHHhcCCCccceecccCcEEEEEEEEC--CceEEEEEeccC------ChHHHHHHHHHHHhcc-----------
Q 044997          282 FSLEEIEEATNNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSN------KSKEFFAELKVLCKIH-----------  342 (563)
Q Consensus       282 ~~~~el~~~~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~------~~~~f~~Ei~~l~~l~-----------  342 (563)
                      -...+++--.++|.+.++||+|+||.|..++.+  ++.+|+|++++.      ...-|..|-++|..-+           
T Consensus        65 ~~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAF  144 (1317)
T KOG0612|consen   65 KKVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAF  144 (1317)
T ss_pred             HHHHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHh
Confidence            345566667789999999999999999999885  677899998752      3456888888876543           


Q ss_pred             ----ccceEEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEE
Q 044997          343 ----HINVFISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKV  418 (563)
Q Consensus       343 ----H~niV~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl  418 (563)
                          |-.+||+||++|+|-..|..     ..+++...+..++..|..||.-||+.|   +|||||||+|||||..|++||
T Consensus       145 QD~~~LYlVMdY~pGGDlltLlSk-----~~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikL  216 (1317)
T KOG0612|consen  145 QDERYLYLVMDYMPGGDLLTLLSK-----FDRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKL  216 (1317)
T ss_pred             cCccceEEEEecccCchHHHHHhh-----cCCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEee
Confidence                33358999999999998865     237899999999999999999999998   999999999999999999999


Q ss_pred             eecCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCC
Q 044997          419 ADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDS  498 (563)
Q Consensus       419 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~  498 (563)
                      +|||-+-.+..++..  .....+|||.|.+||++....-        ..+.|++.+|+||+||++|||+.|..||+.+.-
T Consensus       217 ADFGsClkm~~dG~V--~s~~aVGTPDYISPEvLqs~~~--------~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadsl  286 (1317)
T KOG0612|consen  217 ADFGSCLKMDADGTV--RSSVAVGTPDYISPEVLQSQGD--------GKGEYGRECDWWSLGVFMYEMLYGETPFYADSL  286 (1317)
T ss_pred             ccchhHHhcCCCCcE--EeccccCCCCccCHHHHHhhcC--------CccccCCccchhhhHHHHHHHHcCCCcchHHHH
Confidence            999998766544332  3345789999999999975432        247889999999999999999999999976532


Q ss_pred             Cch--------------hhHHHHHHHHHHHHHhhccCCCCCCC---HHHHHHHHHHhhhcChhhhc
Q 044997          499 EPT--------------KMKSLITIMAAVAEWCLNEDAVDRPE---MRDIVAILSQIMITSTEWEA  547 (563)
Q Consensus       499 ~~~--------------~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl~~L~~i~~~~~~w~~  547 (563)
                      -.+              ....++....+||.+.+. +|+.|-.   ++++-.   ..+-...+|+.
T Consensus       287 veTY~KIm~hk~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~---HpFF~g~~W~~  348 (1317)
T KOG0612|consen  287 VETYGKIMNHKESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKN---HPFFEGIDWDN  348 (1317)
T ss_pred             HHHHHHHhchhhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHh---CccccCCChhh
Confidence            110              112355668888887665 6778877   666544   34555567744

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=4.3e-30  Score=254.75  Aligned_cols=212  Identities=25%  Similarity=0.392  Sum_probs=168.4

Q ss_pred             hcCCCccceecccCcEEEEEEEECC--ceEEEEEeccCCh------HHHHHHHHHHHhcc----------------ccce
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLLGD--REAAIKKMRSNKS------KEFFAELKVLCKIH----------------HINV  346 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~~~--~~vavK~~~~~~~------~~f~~Ei~~l~~l~----------------H~ni  346 (563)
                      ..+|....+||+|+||.|.++..+|  +.+|||+++++..      +--..|-++|.--.                .-..
T Consensus       348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF  427 (683)
T KOG0696|consen  348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF  427 (683)
T ss_pred             ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence            3468889999999999999998865  5689999876521      11223333333222                2334


Q ss_pred             EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcc
Q 044997          347 FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKL  426 (563)
Q Consensus       347 V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~  426 (563)
                      ||||+.+|+|..++.+     -..+.+..+..+|.+||-||-|||+++   |+.||||..|||||.+|++||+|||+++.
T Consensus       428 VMEyvnGGDLMyhiQQ-----~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKE  499 (683)
T KOG0696|consen  428 VMEYVNGGDLMYHIQQ-----VGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE  499 (683)
T ss_pred             EEEEecCchhhhHHHH-----hcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccccc
Confidence            8999999999999875     245677788889999999999999998   99999999999999999999999999984


Q ss_pred             cccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc------
Q 044997          427 EERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP------  500 (563)
Q Consensus       427 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~------  500 (563)
                      --..   .......+||+.|+|||++..++|             +..+|+|||||+||||+.|+.||.++++..      
T Consensus       500 ni~~---~~TTkTFCGTPdYiAPEIi~YqPY-------------gksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~  563 (683)
T KOG0696|consen  500 NIFD---GVTTKTFCGTPDYIAPEIIAYQPY-------------GKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIM  563 (683)
T ss_pred             cccC---CcceeeecCCCcccccceEEeccc-------------ccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Confidence            2211   123345899999999999987776             789999999999999999999998876532      


Q ss_pred             ----hhhHHHHHHHHHHHHHhhccCCCCCC
Q 044997          501 ----TKMKSLITIMAAVAEWCLNEDAVDRP  526 (563)
Q Consensus       501 ----~~~~~~~~~l~~li~~cl~~dP~~RP  526 (563)
                          ..+++++.+..++.+..+.+.|.+|-
T Consensus       564 ehnvsyPKslSkEAv~ickg~ltK~P~kRL  593 (683)
T KOG0696|consen  564 EHNVSYPKSLSKEAVAICKGLLTKHPGKRL  593 (683)
T ss_pred             HccCcCcccccHHHHHHHHHHhhcCCcccc
Confidence                12345666788999999999999994

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=1.4e-30  Score=243.80  Aligned_cols=221  Identities=23%  Similarity=0.339  Sum_probs=168.1

Q ss_pred             CCccceecccCcEEEEEEEEC--CceEEEEEeccCC-----hHHHHHHHHHHHhccccceE-------------------
Q 044997          294 FDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNK-----SKEFFAELKVLCKIHHINVF-------------------  347 (563)
Q Consensus       294 f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~-----~~~f~~Ei~~l~~l~H~niV-------------------  347 (563)
                      |....+||+|.||+||+++.+  ++.||+|+.-.+.     ...-++|+++|..+.|+|++                   
T Consensus        19 yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t   98 (376)
T KOG0669|consen   19 YEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRAT   98 (376)
T ss_pred             HHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccce
Confidence            445678999999999999764  6778988754322     24578999999999999972                   


Q ss_pred             ----EEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCC
Q 044997          348 ----ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGL  423 (563)
Q Consensus       348 ----~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGl  423 (563)
                          +.+++ -+|...|.+    ....++..++.+++.++..||.|+|...   |+|||+|++|+||+.++.+||+|||+
T Consensus        99 ~ylVf~~ce-hDLaGlLsn----~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGl  170 (376)
T KOG0669|consen   99 FYLVFDFCE-HDLAGLLSN----RKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGL  170 (376)
T ss_pred             eeeeHHHhh-hhHHHHhcC----ccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeecccc
Confidence                22222 245555543    2356889999999999999999999986   99999999999999999999999999


Q ss_pred             Ccccccccc-cccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCch-
Q 044997          424 VKLEERTNE-KEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPT-  501 (563)
Q Consensus       424 a~~~~~~~~-~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~-  501 (563)
                      ++.+..... .....+..+-|..|.+||.+.+.+            .++++.|||+.||+|.||++|.+-+.++..... 
T Consensus       171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r------------~yg~~iDiWgAgCimaeMwtrspimqgnteqqql  238 (376)
T KOG0669|consen  171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDR------------EYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQL  238 (376)
T ss_pred             ccceecccccCCCCcccceeeeecCCHHHhhccc------------ccCCcchhHhHHHHHHHHHccCccccCChHHHHH
Confidence            986654332 222234456799999999998765            469999999999999999999877654432110 


Q ss_pred             ----------------------h-------------hHHHH---------HHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          502 ----------------------K-------------MKSLI---------TIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       502 ----------------------~-------------~~~~~---------~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                                            .             .+.+.         +...+|+..++..||.+|+.+++++..
T Consensus       239 ~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh  315 (376)
T KOG0669|consen  239 HLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH  315 (376)
T ss_pred             HHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence                                  0             00111         236789999999999999999887753

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.96  E-value=7.1e-29  Score=266.51  Aligned_cols=240  Identities=17%  Similarity=0.177  Sum_probs=167.3

Q ss_pred             HhcCCCccceecccCcEEEEEEEE------------------CCceEEEEEeccCC---hHH--------------HHHH
Q 044997          290 ATNNFDESRIIGRGGFGNVYFGLL------------------GDREAAIKKMRSNK---SKE--------------FFAE  334 (563)
Q Consensus       290 ~~~~f~~~~~LG~G~fG~Vy~g~~------------------~~~~vavK~~~~~~---~~~--------------f~~E  334 (563)
                      ..++|+..++||+|+||.||+|.+                  +++.||||+++...   .++              +..|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            367899999999999999999964                  23579999986432   123              3346


Q ss_pred             HHHHHhccccc----------------------------eEEEeecCCCcccccccccc-------------------cC
Q 044997          335 LKVLCKIHHIN----------------------------VFISTFGNGSLSDHLHDPLL-------------------KG  367 (563)
Q Consensus       335 i~~l~~l~H~n----------------------------iV~e~~~~gsL~~~L~~~~~-------------------~~  367 (563)
                      +.++.+++|.+                            +|+||+++|+|.++|+....                   ..
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            67777776643                            47899999999999874210                   01


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccccccccccccccccCCCccc
Q 044997          368 HQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYL  447 (563)
Q Consensus       368 ~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~  447 (563)
                      ...++|..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||+++........  ......+++.|+
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~--~~~~g~~tp~Y~  377 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF--NPLYGMLDPRYS  377 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCcc--CccccCCCccee
Confidence            134678889999999999999999987   999999999999999999999999999754322111  111233578999


Q ss_pred             Ccccccccccccccccc---------cccCCCCCcchHHHHHHHHHHHHcCCC-CCcCCCCC------------------
Q 044997          448 PPEYIFVKRFRFDMHSS---------VMELQVTTKTDVFAFGVVLAELITGKR-ALIRDDSE------------------  499 (563)
Q Consensus       448 APE~l~~~~~~~~~~~~---------~~~~~~s~ksDVwSfGvvl~Elltg~~-p~~~~~~~------------------  499 (563)
                      |||.+............         ........+.||||+||+++||++|.. |+......                  
T Consensus       378 aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~  457 (507)
T PLN03224        378 PPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYK  457 (507)
T ss_pred             ChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhc
Confidence            99988643211000000         000112345799999999999999875 54321100                  


Q ss_pred             -----chhhHHHHHHHHHHHHHhhccCC---CCCCCHHHHHHH
Q 044997          500 -----PTKMKSLITIMAAVAEWCLNEDA---VDRPEMRDIVAI  534 (563)
Q Consensus       500 -----~~~~~~~~~~l~~li~~cl~~dP---~~RPs~~evl~~  534 (563)
                           ........+...+|+.+++..+|   .+|+|+.|++++
T Consensus       458 ~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H  500 (507)
T PLN03224        458 GQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH  500 (507)
T ss_pred             ccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence                 00011234558899999999866   689999999863

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.3e-29  Score=265.69  Aligned_cols=216  Identities=23%  Similarity=0.349  Sum_probs=169.4

Q ss_pred             HhcCCCccceecccCcEEEEEEEE--CCceEEEEEeccCChHHHHHHHHHHHhc-cccce---------------EEEee
Q 044997          290 ATNNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNKSKEFFAELKVLCKI-HHINV---------------FISTF  351 (563)
Q Consensus       290 ~~~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~~~~f~~Ei~~l~~l-~H~ni---------------V~e~~  351 (563)
                      .++.|.....+|.|+|+.|-++..  +++..++|++.+. ..+-.+|+.++.+. +|+|+               |+|.+
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~-~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l  398 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR-ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELL  398 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheecccc-ccccccccchhhhhcCCCcceeecceecCCceeeeeehhc
Confidence            467788888899999999999977  4678899999766 22333577555544 78997               45666


Q ss_pred             cCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEe-cCCCcEEEeecCCCcccccc
Q 044997          352 GNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILL-DDGLRAKVADFGLVKLEERT  430 (563)
Q Consensus       352 ~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl-~~~~~~kl~DFGla~~~~~~  430 (563)
                      .+|-+.+.+..      .+....++.+|+.+++.++.|||+++   +|||||||+|||+ ++.++++|+|||.++.....
T Consensus       399 ~g~ell~ri~~------~~~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~  469 (612)
T KOG0603|consen  399 DGGELLRRIRS------KPEFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS  469 (612)
T ss_pred             cccHHHHHHHh------cchhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence            66665555442      22333777889999999999999998   9999999999999 58899999999999865443


Q ss_pred             cccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCch---------
Q 044997          431 NEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPT---------  501 (563)
Q Consensus       431 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~---------  501 (563)
                            ....+-|..|.|||++....             +++++|+||||++||||++|+.||.......+         
T Consensus       470 ------~~tp~~t~~y~APEvl~~~~-------------yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~  530 (612)
T KOG0603|consen  470 ------CDTPALTLQYVAPEVLAIQE-------------YTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPK  530 (612)
T ss_pred             ------hcccchhhcccChhhhccCC-------------CCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCc
Confidence                  11234578899999986544             49999999999999999999999976544311         


Q ss_pred             hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          502 KMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       502 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                      ....+++..++|+.+||+.||.+||+|.++...
T Consensus       531 ~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h  563 (612)
T KOG0603|consen  531 FSECVSDEAKDLLQQLLQVDPALRLGADEIGAH  563 (612)
T ss_pred             cccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence            124567789999999999999999999999763

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.96  E-value=6.9e-29  Score=266.66  Aligned_cols=235  Identities=26%  Similarity=0.418  Sum_probs=194.5

Q ss_pred             CHHHHHHHhcCCCccceecccCcEEEEEEEE--CCceEEEEEeccC--ChHHHHHHHHHHHhc-cccce-----------
Q 044997          283 SLEEIEEATNNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSN--KSKEFFAELKVLCKI-HHINV-----------  346 (563)
Q Consensus       283 ~~~el~~~~~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~--~~~~f~~Ei~~l~~l-~H~ni-----------  346 (563)
                      .++.+...++-|++.++||.|.+|.||+++.  +++.+|+|++...  ..++...|.++|+.. +|||+           
T Consensus        10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~   89 (953)
T KOG0587|consen   10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKD   89 (953)
T ss_pred             chhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence            3444555677788999999999999998865  5788888888654  456778888888877 68886           


Q ss_pred             ---------EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEE
Q 044997          347 ---------FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAK  417 (563)
Q Consensus       347 ---------V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~k  417 (563)
                               |||||.+|+.-+.++...   ...+.|..+..|++.++.||.+||...   ++|||||=.|||++.++.+|
T Consensus        90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~---g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VK  163 (953)
T KOG0587|consen   90 PGNGDQLWLVMEFCGGGSVTDLVKNTK---GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVK  163 (953)
T ss_pred             CCCCCeEEEEeeccCCccHHHHHhhhc---ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEE
Confidence                     789999999999988743   577999999999999999999999986   99999999999999999999


Q ss_pred             EeecCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCC
Q 044997          418 VADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDD  497 (563)
Q Consensus       418 l~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~  497 (563)
                      ++|||++..+..+-.   .....+||+.|||||++....        .....|+..+|+||+|++..||.-|.+|+.+..
T Consensus       164 LvDFGvSaQldsT~g---rRnT~iGtP~WMAPEViac~e--------~~d~tyd~R~D~WsLGITaIEladG~PPl~DmH  232 (953)
T KOG0587|consen  164 LVDFGVSAQLDSTVG---RRNTFIGTPYWMAPEVIACDE--------SPDATYDYRSDLWSLGITAIEMAEGAPPLCDMH  232 (953)
T ss_pred             Eeeeeeeeeeecccc---cccCcCCCcccccceeeeccc--------CCCCCcccccchhhccceeehhcCCCCCccCcc
Confidence            999999886654432   233468999999999997653        245677899999999999999999999975432


Q ss_pred             C-----------C--chhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          498 S-----------E--PTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       498 ~-----------~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                      .           .  ...+..+...+.++|..|+.+|-++||++.++++.
T Consensus       233 PmraLF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h  282 (953)
T KOG0587|consen  233 PMRALFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH  282 (953)
T ss_pred             hhhhhccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence            1           1  12356788889999999999999999999998763

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.96  E-value=3.8e-28  Score=237.08  Aligned_cols=205  Identities=30%  Similarity=0.465  Sum_probs=168.9

Q ss_pred             CcEEEEEEEEC--CceEEEEEeccCC----hHHHHHHHHHHHhccccce---------------EEEeecCCCccccccc
Q 044997          304 GFGNVYFGLLG--DREAAIKKMRSNK----SKEFFAELKVLCKIHHINV---------------FISTFGNGSLSDHLHD  362 (563)
Q Consensus       304 ~fG~Vy~g~~~--~~~vavK~~~~~~----~~~f~~Ei~~l~~l~H~ni---------------V~e~~~~gsL~~~L~~  362 (563)
                      +||.||+|...  ++.+|+|++....    .+.+.+|++.+++++|+|+               ++||+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            58999999985  5889999987543    4789999999999999997               5789999999998865


Q ss_pred             ccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccccccccccccccccC
Q 044997          363 PLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVG  442 (563)
Q Consensus       363 ~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~g  442 (563)
                      .     ..+++..+..++.+++.++.|||+.+   ++|+||+|+||++++++.++|+|||.+.......    ......+
T Consensus        81 ~-----~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~----~~~~~~~  148 (244)
T smart00220       81 R-----GRLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG----LLTTFVG  148 (244)
T ss_pred             c-----cCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc----ccccccC
Confidence            2     23899999999999999999999987   9999999999999999999999999988654332    2233567


Q ss_pred             CCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCchhh-----------HH---HHH
Q 044997          443 TPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKM-----------KS---LIT  508 (563)
Q Consensus       443 t~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~~~-----------~~---~~~  508 (563)
                      +..|++||.+...             .++.++||||||+++||+++|+.|+..........           ..   +..
T Consensus       149 ~~~~~~pE~~~~~-------------~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  215 (244)
T smart00220      149 TPEYMAPEVLLGK-------------GYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISP  215 (244)
T ss_pred             CcCCCCHHHHccC-------------CCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCH
Confidence            8899999987533             34789999999999999999999986522211100           00   456


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          509 IMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       509 ~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                      .+.+++.+||..+|++||++.++++
T Consensus       216 ~~~~~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      216 EAKDLIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             HHHHHHHHHccCCchhccCHHHHhh
Confidence            7899999999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.96  E-value=1.1e-29  Score=258.20  Aligned_cols=213  Identities=22%  Similarity=0.408  Sum_probs=173.1

Q ss_pred             cceecccCcEEEEEEEE--CCceEEEEEeccC-----ChHHHHHHHHHHHhccccceE---------------EEeecCC
Q 044997          297 SRIIGRGGFGNVYFGLL--GDREAAIKKMRSN-----KSKEFFAELKVLCKIHHINVF---------------ISTFGNG  354 (563)
Q Consensus       297 ~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~-----~~~~f~~Ei~~l~~l~H~niV---------------~e~~~~g  354 (563)
                      .++||.|.||.||-|+.  .|+.||||.+.+.     ..+.+.+|+.||.+++||.||               ||-+ +|
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~G  647 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HG  647 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cc
Confidence            47899999999999977  5899999998643     346788999999999999985               2222 45


Q ss_pred             CcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCC---CcEEEeecCCCccccccc
Q 044997          355 SLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDG---LRAKVADFGLVKLEERTN  431 (563)
Q Consensus       355 sL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~---~~~kl~DFGla~~~~~~~  431 (563)
                      +..+.+..   .....|+...-..++.||+.||.|||.++   |||+||||+|||+.+.   -++||+|||+|+.+....
T Consensus       648 DMLEMILS---sEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks  721 (888)
T KOG4236|consen  648 DMLEMILS---SEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS  721 (888)
T ss_pred             hHHHHHHH---hhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhh
Confidence            54444433   23456888888888999999999999998   9999999999999754   379999999999875432


Q ss_pred             ccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCC------------
Q 044997          432 EKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE------------  499 (563)
Q Consensus       432 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~------------  499 (563)
                          ....++||+.|+|||++..+.|             ...-|+||.||++|--++|..||..++..            
T Consensus       722 ----FRrsVVGTPAYLaPEVLrnkGy-------------NrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaFMyP  784 (888)
T KOG4236|consen  722 ----FRRSVVGTPAYLAPEVLRNKGY-------------NRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFMYP  784 (888)
T ss_pred             ----hhhhhcCCccccCHHHHhhccc-------------cccccceeeeEEEEEEecccccCCCccchhHHhhccccccC
Confidence                3345789999999999987766             67899999999999999999999766542            


Q ss_pred             chhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          500 PTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       500 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                      +..+.++.....+||...|+..-.+|-+..+-+.
T Consensus       785 p~PW~eis~~AidlIn~LLqVkm~kRysvdk~ls  818 (888)
T KOG4236|consen  785 PNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLS  818 (888)
T ss_pred             CCchhhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence            3345677778999999999999999988877654

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.96  E-value=2e-28  Score=236.24  Aligned_cols=230  Identities=20%  Similarity=0.327  Sum_probs=182.6

Q ss_pred             CHHHHHHHhcCCCccceecccCcEEEEEEEE--CCceEEEEEeccC---ChHHHHHHHHHHHhc-cccce----------
Q 044997          283 SLEEIEEATNNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSN---KSKEFFAELKVLCKI-HHINV----------  346 (563)
Q Consensus       283 ~~~el~~~~~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~---~~~~f~~Ei~~l~~l-~H~ni----------  346 (563)
                      .++|+-+.|     .+.||+|+|+.|--++.  .+.++|||++.+.   .+.+..+|++++.+. .|+||          
T Consensus        74 ~F~d~YkLt-----~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd  148 (463)
T KOG0607|consen   74 KFEDMYKLT-----SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD  148 (463)
T ss_pred             hHHHHHHhH-----HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence            456776666     46799999999987754  7899999999765   357788999999988 48997          


Q ss_pred             -----EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCC---cEEE
Q 044997          347 -----FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGL---RAKV  418 (563)
Q Consensus       347 -----V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~---~~kl  418 (563)
                           |+|-|.+|.|..+++.     +..+++.+..++..+||.||.|||.++   |.||||||+|||-.+..   -+||
T Consensus       149 ~~FYLVfEKm~GGplLshI~~-----~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKi  220 (463)
T KOG0607|consen  149 TRFYLVFEKMRGGPLLSHIQK-----RKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKI  220 (463)
T ss_pred             ceEEEEEecccCchHHHHHHH-----hhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceee
Confidence                 6788999999999976     456899999999999999999999998   99999999999987554   5899


Q ss_pred             eecCCCccccccccc----ccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCc
Q 044997          419 ADFGLVKLEERTNEK----EMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALI  494 (563)
Q Consensus       419 ~DFGla~~~~~~~~~----~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~  494 (563)
                      +||.+..-+...++-    .......+|+..|||||+..-..        .....|+.++|.||+|||||-|++|..||.
T Consensus       221 CDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv--------~qA~~YDKrCDlwSLGvIlYImLsGYpPFv  292 (463)
T KOG0607|consen  221 CDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFV--------DQATFYDKRCDLWSLGVILYIMLSGYPPFV  292 (463)
T ss_pred             eccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhc--------cccccccccccHHHHHHHHHHHHhCCCCcc
Confidence            999987643322221    11223467999999999874321        234567899999999999999999999996


Q ss_pred             CCCC-----------------------------CchhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          495 RDDS-----------------------------EPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       495 ~~~~-----------------------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                      +.-.                             ....+..++.+..+++...+..|+.+|-++.+++.
T Consensus       293 G~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  293 GHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             CccCCcCCccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence            5311                             11223455677899999999999999999999887

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.96  E-value=1.1e-28  Score=220.48  Aligned_cols=218  Identities=22%  Similarity=0.353  Sum_probs=167.8

Q ss_pred             CCCccceecccCcEEEEEEEEC--CceEEEEEeccCC-----hHHHHHHHHHHHhccccceEE---------------Ee
Q 044997          293 NFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNK-----SKEFFAELKVLCKIHHINVFI---------------ST  350 (563)
Q Consensus       293 ~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~-----~~~f~~Ei~~l~~l~H~niV~---------------e~  350 (563)
                      +|+..++||+|.||+||+|+..  ++.||+|+++-++     ....++|+.+|+.+.|.|||.               ||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            4666789999999999999764  5789999987543     356889999999999999963               33


Q ss_pred             ecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccccc
Q 044997          351 FGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERT  430 (563)
Q Consensus       351 ~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~  430 (563)
                      + ..+|..|...    -+..++......++.|+++||.|.|+++   +.||||||.|.||+.+|+.|++|||+++.+...
T Consensus        83 c-dqdlkkyfds----lng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgip  154 (292)
T KOG0662|consen   83 C-DQDLKKYFDS----LNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIP  154 (292)
T ss_pred             h-hHHHHHHHHh----cCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCc
Confidence            2 2355555432    2456888889999999999999999997   999999999999999999999999999865432


Q ss_pred             cccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCchhhH------
Q 044997          431 NEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKMK------  504 (563)
Q Consensus       431 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~~~~------  504 (563)
                      -.   ..+..+-|..|.+|.++.+.+.            |++..|+||.||++.|+.....|.........+..      
T Consensus       155 vr---cysaevvtlwyrppdvlfgakl------------y~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~l  219 (292)
T KOG0662|consen  155 VR---CYSAEVVTLWYRPPDVLFGAKL------------YSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLL  219 (292)
T ss_pred             eE---eeeceeeeeeccCcceeeeeeh------------hccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHh
Confidence            21   1233467899999999987653            58999999999999999986666543322111111      


Q ss_pred             ----------------------------------HHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          505 ----------------------------------SLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       505 ----------------------------------~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                                                        .+...-+++++..+.-+|.+|.++++.++
T Consensus       220 g~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq  282 (292)
T KOG0662|consen  220 GTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ  282 (292)
T ss_pred             CCCccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence                                              11112578888999999999999988765

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.95  E-value=5.2e-30  Score=241.84  Aligned_cols=233  Identities=26%  Similarity=0.369  Sum_probs=167.9

Q ss_pred             cccccCHHHHHHHhcCCCccceecccCcEEEEEEEEC--CceEEEEEeccCC----hHHHHHHHHHHHhc-cccceEEEe
Q 044997          278 RTIIFSLEEIEEATNNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNK----SKEFFAELKVLCKI-HHINVFIST  350 (563)
Q Consensus       278 ~~~~~~~~el~~~~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~----~~~f~~Ei~~l~~l-~H~niV~e~  350 (563)
                      ....|+-++++.       ...||.|+||.|++-.++  |+..|||+++...    .++++.|.+...+- +-||||.-|
T Consensus        57 ~~~~F~~~~Lqd-------lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfy  129 (361)
T KOG1006|consen   57 HLHTFTSDNLQD-------LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFY  129 (361)
T ss_pred             cccccccchHHH-------HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHh
Confidence            334566555544       467999999999998774  7889999997543    35688888865544 568885322


Q ss_pred             ---ecCC-----------CcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcE
Q 044997          351 ---FGNG-----------SLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRA  416 (563)
Q Consensus       351 ---~~~g-----------sL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~  416 (563)
                         +..|           +|+.+...-.......+++.-.-.|..-..+||.||-+.-  .|+|||+||+|||+|..|.+
T Consensus       130 Ga~F~EGdcWiCMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~v  207 (361)
T KOG1006|consen  130 GALFSEGDCWICMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDV  207 (361)
T ss_pred             hhhhcCCceeeeHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCE
Confidence               1222           2322221111112345777777788888899999998754  69999999999999999999


Q ss_pred             EEeecCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCC
Q 044997          417 KVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRD  496 (563)
Q Consensus       417 kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~  496 (563)
                      ||||||++-.+...    ...+.-+|-..|||||.+....           ..++-+|||||+|++|+|+.||+.|+.+-
T Consensus       208 KLCDFGIcGqLv~S----iAkT~daGCrpYmAPERi~p~~-----------~gyDiRSDvWSLGITL~EvAtG~fPyr~w  272 (361)
T KOG1006|consen  208 KLCDFGICGQLVDS----IAKTVDAGCRPYMAPERIDPSD-----------KGYDIRSDVWSLGITLYEVATGNFPYRKW  272 (361)
T ss_pred             eeecccchHhHHHH----HHhhhccCCccccChhccCCcc-----------CCcchhhhhhhhcceEeeeecCCCCcchH
Confidence            99999998755432    2234567889999999885332           24688999999999999999999997532


Q ss_pred             CCCc-----------------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          497 DSEP-----------------TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       497 ~~~~-----------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                      +..-                 ....+....+..++..|+.+|-.+||...++.+.
T Consensus       273 ~svfeql~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  273 DSVFEQLCQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             HHHHHHHHHHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence            2110                 0111244558999999999999999999998764

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.95  E-value=1.3e-28  Score=243.44  Aligned_cols=225  Identities=23%  Similarity=0.379  Sum_probs=172.6

Q ss_pred             ccCHHHHHHHhcCCCccceecccCcEEEEEEEEC--CceEEEEEeccCC--hHHHHHHHHHHHhccc--cc---------
Q 044997          281 IFSLEEIEEATNNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNK--SKEFFAELKVLCKIHH--IN---------  345 (563)
Q Consensus       281 ~~~~~el~~~~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~--~~~f~~Ei~~l~~l~H--~n---------  345 (563)
                      +|...++.  +++|.....+|+|.||.|-.+...  +..||||+++.-.  .+.-+-|+++|.++.+  |+         
T Consensus        80 v~~~gD~l--~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~  157 (415)
T KOG0671|consen   80 VYQVGDIL--TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMR  157 (415)
T ss_pred             EEEecccc--ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeee
Confidence            44444443  778999999999999999998764  5789999998643  3556679999999943  22         


Q ss_pred             ----------eEEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEec----
Q 044997          346 ----------VFISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLD----  411 (563)
Q Consensus       346 ----------iV~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~----  411 (563)
                                ||.|.+ +-|+.++|..   .+..+++..++..|+.|++++++|||+..   ++|-||||+|||+.    
T Consensus       158 ~wFdyrghiCivfell-G~S~~dFlk~---N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~  230 (415)
T KOG0671|consen  158 DWFDYRGHICIVFELL-GLSTFDFLKE---NNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEY  230 (415)
T ss_pred             hhhhccCceEEEEecc-ChhHHHHhcc---CCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccce
Confidence                      233333 2378888876   34577899999999999999999999987   99999999999983    


Q ss_pred             ----------------CCCcEEEeecCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcch
Q 044997          412 ----------------DGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTD  475 (563)
Q Consensus       412 ----------------~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksD  475 (563)
                                      .+..+||+|||-|+.....      .+..+.|..|.|||++.+-.+             +.++|
T Consensus       231 ~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~------hs~iVsTRHYRAPEViLgLGw-------------S~pCD  291 (415)
T KOG0671|consen  231 FKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEH------HSTIVSTRHYRAPEVILGLGW-------------SQPCD  291 (415)
T ss_pred             EEEeccCCccceeccCCCcceEEEecCCcceeccC------cceeeeccccCCchheeccCc-------------CCccC
Confidence                            1346899999999753322      245678999999999987665             88999


Q ss_pred             HHHHHHHHHHHHcCCCCCcCCCCCch-------------h----h-----------------------------------
Q 044997          476 VFAFGVVLAELITGKRALIRDDSEPT-------------K----M-----------------------------------  503 (563)
Q Consensus       476 VwSfGvvl~Elltg~~p~~~~~~~~~-------------~----~-----------------------------------  503 (563)
                      |||+||||.|+.+|...|...+..+.             .    .                                   
T Consensus       292 vWSiGCIL~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~  371 (415)
T KOG0671|consen  292 VWSIGCILVELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKY  371 (415)
T ss_pred             ceeeeeEEEEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHH
Confidence            99999999999999987755432110             0    0                                   


Q ss_pred             ----HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          504 ----KSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       504 ----~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                          ......+.+|++++|..||.+|+|++|++.
T Consensus       372 ~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~  405 (415)
T KOG0671|consen  372 MLQDDLEHVQLFDLLRRMLEFDPARRITLREALS  405 (415)
T ss_pred             hccCcHHHhHHHHHHHHHHccCccccccHHHHhc
Confidence                000122899999999999999999999875

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.1e-28  Score=250.38  Aligned_cols=231  Identities=22%  Similarity=0.353  Sum_probs=184.8

Q ss_pred             cCCCccceecccCcEEEEEEEECCce--EEEEEeccC------ChHHHHHHHHHHHhccccceE---------------E
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLGDRE--AAIKKMRSN------KSKEFFAELKVLCKIHHINVF---------------I  348 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~~~~--vavK~~~~~------~~~~f~~Ei~~l~~l~H~niV---------------~  348 (563)
                      .+++....||-||||.|-+...+++.  .|+|.+++.      ..+....|-.+|...+.+.||               |
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm  499 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM  499 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence            34555678999999999999887766  688877653      235577899999999888873               5


Q ss_pred             EeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccc
Q 044997          349 STFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEE  428 (563)
Q Consensus       349 e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~  428 (563)
                      |-|-+|.|...|++     +..++......++..+.+|++|||.++   ||.|||||+|+++|.+|-+||.|||+|+.+.
T Consensus       500 EaClGGElWTiLrd-----Rg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~  571 (732)
T KOG0614|consen  500 EACLGGELWTILRD-----RGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIG  571 (732)
T ss_pred             HhhcCchhhhhhhh-----cCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhc
Confidence            77789999998876     456788888889999999999999998   9999999999999999999999999999775


Q ss_pred             cccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCch-------
Q 044997          429 RTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPT-------  501 (563)
Q Consensus       429 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~-------  501 (563)
                      .+.    ....++||+.|.|||++..+.+             +.++|.||+|+++|||++|++||.+.+....       
T Consensus       572 ~g~----KTwTFcGTpEYVAPEIILnKGH-------------D~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkG  634 (732)
T KOG0614|consen  572 SGR----KTWTFCGTPEYVAPEIILNKGH-------------DRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKG  634 (732)
T ss_pred             cCC----ceeeecCCcccccchhhhccCc-------------chhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhh
Confidence            443    2345899999999999987766             6799999999999999999999987664321       


Q ss_pred             -----hhHHHHHHHHHHHHHhhccCCCCCCC--HHHHHHHHHHhhhcChhhhc
Q 044997          502 -----KMKSLITIMAAVAEWCLNEDAVDRPE--MRDIVAILSQIMITSTEWEA  547 (563)
Q Consensus       502 -----~~~~~~~~l~~li~~cl~~dP~~RPs--~~evl~~L~~i~~~~~~w~~  547 (563)
                           .++.+.....+|+++....+|.+|-.  ...|-+.=...--...+|+.
T Consensus       635 id~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweg  687 (732)
T KOG0614|consen  635 IDKIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEG  687 (732)
T ss_pred             hhhhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhh
Confidence                 22344455789999999999999976  34444433334445667775

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.95  E-value=6.7e-28  Score=223.03  Aligned_cols=217  Identities=20%  Similarity=0.348  Sum_probs=174.3

Q ss_pred             hcCCCccceecccCcEEEEEEE--ECCceEEEEEeccCChHHHHHHHHHHHhcc-ccceE-----------------EEe
Q 044997          291 TNNFDESRIIGRGGFGNVYFGL--LGDREAAIKKMRSNKSKEFFAELKVLCKIH-HINVF-----------------IST  350 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~--~~~~~vavK~~~~~~~~~f~~Ei~~l~~l~-H~niV-----------------~e~  350 (563)
                      .++|+..+++|+|.|++||.|.  .++++++||.+++-+.+.+.+|+++|..+. |||||                 .||
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~  116 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEY  116 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhh
Confidence            4678888999999999999997  468899999999999999999999999998 99985                 355


Q ss_pred             ecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCC-CcEEEeecCCCccccc
Q 044997          351 FGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDG-LRAKVADFGLVKLEER  429 (563)
Q Consensus       351 ~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~-~~~kl~DFGla~~~~~  429 (563)
                      +.|.+.....        ..|+-.++.....++++||.|+|++|   |.|||+||.|++||.. ...+|+|+|+|.....
T Consensus       117 v~n~Dfk~ly--------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp  185 (338)
T KOG0668|consen  117 VNNTDFKQLY--------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  185 (338)
T ss_pred             hccccHHHHh--------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcCC
Confidence            5555443322        34777788899999999999999998   9999999999999964 5799999999987655


Q ss_pred             ccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCchhhHH----
Q 044997          430 TNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKMKS----  505 (563)
Q Consensus       430 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~~~~~----  505 (563)
                      ..+.    ...+.+..|--||.+...+            .++..-|+|||||++.+|+-.+.||..+.....+.-.    
T Consensus       186 ~~eY----nVRVASRyfKGPELLVdy~------------~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakV  249 (338)
T KOG0668|consen  186 GKEY----NVRVASRYFKGPELLVDYQ------------MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKV  249 (338)
T ss_pred             Ccee----eeeeehhhcCCchheeech------------hccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHH
Confidence            4332    2245677789999986433            3577899999999999999999999766543221100    


Q ss_pred             -------------------------------------------H-HHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          506 -------------------------------------------L-ITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       506 -------------------------------------------~-~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                                                                 + .++..+++...|..|..+|||++|.+..
T Consensus       250 LGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H  322 (338)
T KOG0668|consen  250 LGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH  322 (338)
T ss_pred             hChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence                                                       0 1337899999999999999999998753

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.4e-28  Score=232.58  Aligned_cols=218  Identities=26%  Similarity=0.364  Sum_probs=167.0

Q ss_pred             CccceecccCcEEEEEEEE--CCceEEEEEeccC-----ChHHHHHHHHHHHhccccceEE----------Eeec-----
Q 044997          295 DESRIIGRGGFGNVYFGLL--GDREAAIKKMRSN-----KSKEFFAELKVLCKIHHINVFI----------STFG-----  352 (563)
Q Consensus       295 ~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~-----~~~~f~~Ei~~l~~l~H~niV~----------e~~~-----  352 (563)
                      +..+.||-|+||.||....  +++.||.|++..-     ..+++.+|+++|..++|.|++-          +|++     
T Consensus        56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~  135 (449)
T KOG0664|consen   56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL  135 (449)
T ss_pred             CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence            3457899999999998876  5789999998642     3578999999999999999731          1111     


Q ss_pred             ----CCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccc
Q 044997          353 ----NGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEE  428 (563)
Q Consensus       353 ----~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~  428 (563)
                          ..+|...+.     ..++|+-..+.-+.+||++||+|||+.+   |.||||||.|.|++++...||+|||+++..+
T Consensus       136 TELmQSDLHKIIV-----SPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee  207 (449)
T KOG0664|consen  136 TELMQSDLHKIIV-----SPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWD  207 (449)
T ss_pred             HHHHHhhhhheec-----cCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccc
Confidence                224444433     3578898999999999999999999987   9999999999999999999999999999755


Q ss_pred             cccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCchhhHH---
Q 044997          429 RTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKMKS---  505 (563)
Q Consensus       429 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~~~~~---  505 (563)
                      ..+..  .++..+-|..|.|||++.+.+            .|+.+.||||.||++.||+.++-.|...... +..+-   
T Consensus       208 ~d~~~--hMTqEVVTQYYRAPEiLMGaR------------hYs~AvDiWSVGCIFaELLgRrILFQAq~Pi-qQL~lItd  272 (449)
T KOG0664|consen  208 QRDRL--NMTHEVVTQYYRAPELLMGAR------------RYTGAVDIWSVGCIFAELLQRKILFQAAGPI-EQLQMIID  272 (449)
T ss_pred             hhhhh--hhHHHHHHHHhccHHHhhcch------------hhcCccceehhhHHHHHHHhhhhhhhccChH-HHHHHHHH
Confidence            44332  345566788999999998765            3589999999999999999888666433221 11000   


Q ss_pred             ------------------------------------------HHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 044997          506 ------------------------------------------LITIMAAVAEWCLNEDAVDRPEMRDIVAIL  535 (563)
Q Consensus       506 ------------------------------------------~~~~l~~li~~cl~~dP~~RPs~~evl~~L  535 (563)
                                                                -..+...+...++..||.+|.+..+.+..+
T Consensus       273 LLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~  344 (449)
T KOG0664|consen  273 LLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR  344 (449)
T ss_pred             HhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence                                                      011245677788899999999888877654

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.7e-27  Score=230.85  Aligned_cols=230  Identities=24%  Similarity=0.385  Sum_probs=175.7

Q ss_pred             hcCCCccceecccCcEEEEEEEEC--CceEEEEEeccCCh------HHHHHHHHHHHhc-cccce---------------
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNKS------KEFFAELKVLCKI-HHINV---------------  346 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~------~~f~~Ei~~l~~l-~H~ni---------------  346 (563)
                      .++|+..++||+|+|..|..+++.  ++.+|+|.++++..      +=.+.|-.+..+. +||.+               
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff  328 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF  328 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence            468999999999999999999874  57789998875421      1133455555444 56665               


Q ss_pred             EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcc
Q 044997          347 FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKL  426 (563)
Q Consensus       347 V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~  426 (563)
                      |+||+.+|+|.-++..     .+.|++..+..+-..|..||.|||++|   |+.||||..|+|+|..|++||.|+|+++.
T Consensus       329 vieyv~ggdlmfhmqr-----qrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke  400 (593)
T KOG0695|consen  329 VIEYVNGGDLMFHMQR-----QRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKE  400 (593)
T ss_pred             EEEEecCcceeeehhh-----hhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhc
Confidence            6899999999988864     467999999999999999999999998   99999999999999999999999999985


Q ss_pred             cccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCC--chh--
Q 044997          427 EERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE--PTK--  502 (563)
Q Consensus       427 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~--~~~--  502 (563)
                      --...   ...+.++||+.|.|||++.+..|             +...|+|++||+|+||+.|+.||.--...  ...  
T Consensus       401 ~l~~g---d~tstfcgtpnyiapeilrgeey-------------gfsvdwwalgvlmfemmagrspfdivgm~n~d~nte  464 (593)
T KOG0695|consen  401 GLGPG---DTTSTFCGTPNYIAPEILRGEEY-------------GFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTE  464 (593)
T ss_pred             CCCCC---cccccccCCCcccchhhhccccc-------------CceehHHHHHHHHHHHHcCCCCcceecCCCcccchh
Confidence            33222   23456899999999999988776             78999999999999999999998532211  100  


Q ss_pred             --------------hHHHHHHHHHHHHHhhccCCCCCCC------HHHHHHHHHHhhhcChhhhc
Q 044997          503 --------------MKSLITIMAAVAEWCLNEDAVDRPE------MRDIVAILSQIMITSTEWEA  547 (563)
Q Consensus       503 --------------~~~~~~~l~~li~~cl~~dP~~RPs------~~evl~~L~~i~~~~~~w~~  547 (563)
                                    +++++-....+++.-+++||.+|-.      ++++.   +.-+-.+.+|+.
T Consensus       465 dylfqvilekqiriprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik---~h~ffr~idwd~  526 (593)
T KOG0695|consen  465 DYLFQVILEKQIRIPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIK---SHAFFRSIDWDL  526 (593)
T ss_pred             HHHHHHHhhhcccccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhh---cchhhhhCCHHH
Confidence                          1122223677889999999999842      23332   222334667876

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.94  E-value=5e-26  Score=216.31  Aligned_cols=192  Identities=35%  Similarity=0.609  Sum_probs=163.0

Q ss_pred             ecccCcEEEEEEEEC--CceEEEEEeccCCh----HHHHHHHHHHHhccccce---------------EEEeecCCCccc
Q 044997          300 IGRGGFGNVYFGLLG--DREAAIKKMRSNKS----KEFFAELKVLCKIHHINV---------------FISTFGNGSLSD  358 (563)
Q Consensus       300 LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~----~~f~~Ei~~l~~l~H~ni---------------V~e~~~~gsL~~  358 (563)
                      ||+|++|.||++...  ++.+++|.+.....    +.+.+|++.++++.|+++               ++|++.+++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            689999999999987  78999999987654    679999999999999886               568888899999


Q ss_pred             ccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecC-CCcEEEeecCCCccccccccccccc
Q 044997          359 HLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDD-GLRAKVADFGLVKLEERTNEKEMLA  437 (563)
Q Consensus       359 ~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~-~~~~kl~DFGla~~~~~~~~~~~~~  437 (563)
                      ++...    ...+++..+..++.+++++|+|||+.+   ++|+||+|.||+++. +++++|+|||.+........   ..
T Consensus        81 ~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~---~~  150 (215)
T cd00180          81 LLKEN----EGKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS---LL  150 (215)
T ss_pred             HHHhc----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc---hh
Confidence            88642    146899999999999999999999997   999999999999999 89999999999875543221   12


Q ss_pred             ccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCchhhHHHHHHHHHHHHHh
Q 044997          438 TRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKMKSLITIMAAVAEWC  517 (563)
Q Consensus       438 ~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~~~~~~~~~l~~li~~c  517 (563)
                      ....+...|++||.+...            ...+.+.|+|++|++++++                     ..+.+++..|
T Consensus       151 ~~~~~~~~~~~pe~~~~~------------~~~~~~~D~~~lg~~~~~l---------------------~~~~~~l~~~  197 (215)
T cd00180         151 KTIVGTPAYMAPEVLLGK------------GYYSEKSDIWSLGVILYEL---------------------PELKDLIRKM  197 (215)
T ss_pred             hcccCCCCccChhHhccc------------CCCCchhhhHHHHHHHHHH---------------------HHHHHHHHHH
Confidence            234577889999987432            1447899999999999999                     5688999999


Q ss_pred             hccCCCCCCCHHHHHHH
Q 044997          518 LNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       518 l~~dP~~RPs~~evl~~  534 (563)
                      ++.||.+||++.++++.
T Consensus       198 l~~~p~~R~~~~~l~~~  214 (215)
T cd00180         198 LQKDPEKRPSAKEILEH  214 (215)
T ss_pred             hhCCcccCcCHHHHhhC
Confidence            99999999999999864

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.94  E-value=4.2e-27  Score=214.80  Aligned_cols=193  Identities=23%  Similarity=0.342  Sum_probs=143.3

Q ss_pred             HHHhcCCCccceecccCcEEEEEEE--ECCceEEEEEeccC----ChHHHHHHHHHHHhc-cccceEEEe---ecCC---
Q 044997          288 EEATNNFDESRIIGRGGFGNVYFGL--LGDREAAIKKMRSN----KSKEFFAELKVLCKI-HHINVFIST---FGNG---  354 (563)
Q Consensus       288 ~~~~~~f~~~~~LG~G~fG~Vy~g~--~~~~~vavK~~~~~----~~~~f~~Ei~~l~~l-~H~niV~e~---~~~g---  354 (563)
                      +...+.......||+|++|.|-+-+  .+|...|+|+++..    ..++.+.|+++..+- .-|.+|.-|   +..|   
T Consensus        42 eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvw  121 (282)
T KOG0984|consen   42 EVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVW  121 (282)
T ss_pred             ccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEE
Confidence            3344455567889999999875554  47899999998753    345677788876554 345554321   1222   


Q ss_pred             --------CcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcc
Q 044997          355 --------SLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKL  426 (563)
Q Consensus       355 --------sL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~  426 (563)
                              +|+.+-.+ .++.+..+++...-+|+..+.+||.|||++-  .++|||+||+||||+.+|++|+||||++-.
T Consensus       122 IcME~M~tSldkfy~~-v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~  198 (282)
T KOG0984|consen  122 ICMELMDTSLDKFYRK-VLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGY  198 (282)
T ss_pred             EeHHHhhhhHHHHHHH-HHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEccccccee
Confidence                    34333332 2345677899999999999999999999875  699999999999999999999999999876


Q ss_pred             cccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCC
Q 044997          427 EERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRD  496 (563)
Q Consensus       427 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~  496 (563)
                      +...-    ..+...|-..|||||.+..+.         ....|+-||||||+|+.+.||.+++.|+..-
T Consensus       199 L~dSi----Akt~daGCkpYmaPEri~~e~---------n~~gY~vksDvWSLGItmiElA~lr~PY~~w  255 (282)
T KOG0984|consen  199 LVDSI----AKTMDAGCKPYMAPERINPEL---------NQKGYSVKSDVWSLGITMIEMAILRFPYESW  255 (282)
T ss_pred             ehhhh----HHHHhcCCCccCChhhcCccc---------Ccccceeehhhhhhhhhhhhhhhcccccccc
Confidence            55432    122246788999999886543         2347899999999999999999999998643

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.93  E-value=6.2e-26  Score=212.39  Aligned_cols=152  Identities=20%  Similarity=0.268  Sum_probs=122.8

Q ss_pred             CCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccccccccc
Q 044997          354 GSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEK  433 (563)
Q Consensus       354 gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~  433 (563)
                      |+|.+++..    ....++|.+++.|+.|+++||+|||+++         ||+|||++.++.+|+  ||+++.....   
T Consensus         1 GsL~~~l~~----~~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~---   62 (176)
T smart00750        1 VSLADILEV----RGRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPE---   62 (176)
T ss_pred             CcHHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeeccc---
Confidence            688888864    2356999999999999999999999874         999999999999999  9998754322   


Q ss_pred             ccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCch------------
Q 044997          434 EMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPT------------  501 (563)
Q Consensus       434 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~------------  501 (563)
                           ...||+.|||||++.+..+             +.++|||||||++|||++|+.||........            
T Consensus        63 -----~~~g~~~y~aPE~~~~~~~-------------~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  124 (176)
T smart00750       63 -----QSRVDPYFMAPEVIQGQSY-------------TEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPAD  124 (176)
T ss_pred             -----cCCCcccccChHHhcCCCC-------------cchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccC
Confidence                 1258899999999865544             7899999999999999999999864432111            


Q ss_pred             ------hhHHHHH--HHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 044997          502 ------KMKSLIT--IMAAVAEWCLNEDAVDRPEMRDIVAILSQIMIT  541 (563)
Q Consensus       502 ------~~~~~~~--~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~  541 (563)
                            ......+  .+.+++.+||+.||.+||++.|+++.+..+...
T Consensus       125 ~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~  172 (176)
T smart00750      125 DPRDRSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFAE  172 (176)
T ss_pred             CccccccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHH
Confidence                  1122333  589999999999999999999999998776543

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.93  E-value=7e-26  Score=234.94  Aligned_cols=186  Identities=27%  Similarity=0.405  Sum_probs=147.0

Q ss_pred             cCCCccceecccCcEEEEEEEEC--CceEEEEEeccCC------hHHHHHHHHHHHhccccce---------------EE
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNK------SKEFFAELKVLCKIHHINV---------------FI  348 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~------~~~f~~Ei~~l~~l~H~ni---------------V~  348 (563)
                      .-|...+.||-|+||+|.+++..  ...+|+|.+++.+      ......|-+||...+.+-|               ||
T Consensus       629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM  708 (1034)
T KOG0608|consen  629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM  708 (1034)
T ss_pred             cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence            34777899999999999999764  3567888876532      2345678888888776554               68


Q ss_pred             EeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccc
Q 044997          349 STFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEE  428 (563)
Q Consensus       349 e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~  428 (563)
                      +|+++|++..+|..     ...+.+.....++.++..|+++.|..|   +|||||||+|||||.+|++||.||||+.-+-
T Consensus       709 dYIPGGDmMSLLIr-----mgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfR  780 (1034)
T KOG0608|consen  709 DYIPGGDMMSLLIR-----MGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFR  780 (1034)
T ss_pred             eccCCccHHHHHHH-----hccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccce
Confidence            99999999988864     245777777788889999999999998   9999999999999999999999999985221


Q ss_pred             c---------cc------------------------------ccccccccccCCCcccCcccccccccccccccccccCC
Q 044997          429 R---------TN------------------------------EKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQ  469 (563)
Q Consensus       429 ~---------~~------------------------------~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~  469 (563)
                      -         ++                              .........+||+.|+|||++....|            
T Consensus       781 WTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~------------  848 (1034)
T KOG0608|consen  781 WTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGY------------  848 (1034)
T ss_pred             eccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCc------------
Confidence            0         00                              00011123589999999999965544            


Q ss_pred             CCCcchHHHHHHHHHHHHcCCCCCcCCCC
Q 044997          470 VTTKTDVFAFGVVLAELITGKRALIRDDS  498 (563)
Q Consensus       470 ~s~ksDVwSfGvvl~Elltg~~p~~~~~~  498 (563)
                       +..+|+||.|||||||+.|+.||..+..
T Consensus       849 -~q~cdwws~gvil~em~~g~~pf~~~tp  876 (1034)
T KOG0608|consen  849 -TQLCDWWSVGVILYEMLVGQPPFLADTP  876 (1034)
T ss_pred             -cccchhhHhhHHHHHHhhCCCCccCCCC
Confidence             8899999999999999999999976654

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.92  E-value=4.4e-26  Score=238.40  Aligned_cols=223  Identities=25%  Similarity=0.381  Sum_probs=183.3

Q ss_pred             HhcCCCccceecccCcEEEEEEEE--CCceEEEEEeccCC---hHHHHHHHHHHHhccccce---------------EEE
Q 044997          290 ATNNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNK---SKEFFAELKVLCKIHHINV---------------FIS  349 (563)
Q Consensus       290 ~~~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~---~~~f~~Ei~~l~~l~H~ni---------------V~e  349 (563)
                      ..++|+...++|.|.||.||+++.  .++.+|+|.++-+.   .+-..+|+-+++..+|+||               .||
T Consensus        13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME   92 (829)
T KOG0576|consen   13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME   92 (829)
T ss_pred             CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence            456788899999999999999987  47888999887543   3445679999999999998               489


Q ss_pred             eecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccccc
Q 044997          350 TFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEER  429 (563)
Q Consensus       350 ~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~  429 (563)
                      |+.+|+|.+.-+.     -.++++.++..+++..++||+|||+.+   -+|||||-.|||+++.+.+|++|||.+..+..
T Consensus        93 ycgggslQdiy~~-----TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqita  164 (829)
T KOG0576|consen   93 YCGGGSLQDIYHV-----TGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITA  164 (829)
T ss_pred             ecCCCcccceeee-----cccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhh
Confidence            9999999887764     468999999999999999999999998   68999999999999999999999999865443


Q ss_pred             ccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCC-----------
Q 044997          430 TNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDS-----------  498 (563)
Q Consensus       430 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~-----------  498 (563)
                      .-.   ....+.||+.|||||+..-++          .+.|..++|||+.|+...|+-.-+.|..+-..           
T Consensus       165 ti~---KrksfiGtpywmapEvaaver----------kggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~  231 (829)
T KOG0576|consen  165 TIA---KRKSFIGTPYWMAPEVAAVER----------KGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSG  231 (829)
T ss_pred             hhh---hhhcccCCccccchhHHHHHh----------cccccccccccccccchhhhhhcCCcccccchHHHHHHhhccC
Confidence            321   223478999999999876543          56789999999999999999887777543221           


Q ss_pred             ----CchhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          499 ----EPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       499 ----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                          .......+.+.+.++++.|+-++|++||+++.++.
T Consensus       232 ~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  232 FQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             CCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence                11222356777999999999999999999988765

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.92  E-value=2.6e-25  Score=215.41  Aligned_cols=213  Identities=25%  Similarity=0.346  Sum_probs=162.6

Q ss_pred             CCCccceecccCcEEEEEEEE--CCceEEEEEeccC-----ChHHHHHHHHHHHhccccceEE-----------------
Q 044997          293 NFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSN-----KSKEFFAELKVLCKIHHINVFI-----------------  348 (563)
Q Consensus       293 ~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~-----~~~~f~~Ei~~l~~l~H~niV~-----------------  348 (563)
                      +|.-.+.+|.|.- .|..+..  .+++||+|++...     ..++..+|...+..++|+|+|.                 
T Consensus        18 Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~   96 (369)
T KOG0665|consen   18 RYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEV   96 (369)
T ss_pred             eeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhH
Confidence            4555677888876 5555533  5899999987532     3467789999999999999852                 


Q ss_pred             ----EeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCC
Q 044997          349 ----STFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLV  424 (563)
Q Consensus       349 ----e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla  424 (563)
                          |+|. ++|.+.++       ..++-.....|..|++.|++|||+.+   |+||||||+||++..+..+||.|||+|
T Consensus        97 y~v~e~m~-~nl~~vi~-------~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~a  165 (369)
T KOG0665|consen   97 YLVMELMD-ANLCQVIL-------MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLA  165 (369)
T ss_pred             HHHHHhhh-hHHHHHHH-------HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhh
Confidence                3322 24444433       23677788899999999999999998   999999999999999999999999999


Q ss_pred             cccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCch---
Q 044997          425 KLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPT---  501 (563)
Q Consensus       425 ~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~---  501 (563)
                      +....    ....+..+.|..|.|||++.+-.             +.+.+||||.||++.||++|+--|.+.+....   
T Consensus       166 r~e~~----~~~mtpyVvtRyyrapevil~~~-------------~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~k  228 (369)
T KOG0665|consen  166 RTEDT----DFMMTPYVVTRYYRAPEVILGMG-------------YKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNK  228 (369)
T ss_pred             cccCc----ccccCchhheeeccCchheeccC-------------CcccchhhhhhhHHHHHhhceEEecCchHHHHHHH
Confidence            85322    23556678899999999986543             58999999999999999999877654332110   


Q ss_pred             -----------hhHH--------------------------------------HHHHHHHHHHHhhccCCCCCCCHHHHH
Q 044997          502 -----------KMKS--------------------------------------LITIMAAVAEWCLNEDAVDRPEMRDIV  532 (563)
Q Consensus       502 -----------~~~~--------------------------------------~~~~l~~li~~cl~~dP~~RPs~~evl  532 (563)
                                 ....                                      -...+++++.+||-.||++|-++++++
T Consensus       229 i~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL  308 (369)
T KOG0665|consen  229 IIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDAL  308 (369)
T ss_pred             HHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHh
Confidence                       0000                                      012278999999999999999999998


Q ss_pred             HH
Q 044997          533 AI  534 (563)
Q Consensus       533 ~~  534 (563)
                      ..
T Consensus       309 ~H  310 (369)
T KOG0665|consen  309 RH  310 (369)
T ss_pred             cC
Confidence            74

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.92  E-value=3.7e-24  Score=207.00  Aligned_cols=180  Identities=30%  Similarity=0.491  Sum_probs=149.4

Q ss_pred             CCccceecccCcEEEEEEEEC--CceEEEEEeccC----ChHHHHHHHHHHHhccccce---------------EEEeec
Q 044997          294 FDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSN----KSKEFFAELKVLCKIHHINV---------------FISTFG  352 (563)
Q Consensus       294 f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~----~~~~f~~Ei~~l~~l~H~ni---------------V~e~~~  352 (563)
                      |+..+.||+|++|.||++...  ++.+++|.+...    ..+.+.+|++.+.+++|+|+               ++|+++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            456789999999999999885  588999999765    35678899999999999986               568888


Q ss_pred             CCCcccccccccccCCCC-CCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccccccc
Q 044997          353 NGSLSDHLHDPLLKGHQP-LTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTN  431 (563)
Q Consensus       353 ~gsL~~~L~~~~~~~~~~-l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~  431 (563)
                      +++|.+++...     .. +++.....++.+++.++.|||+++   ++|+||+++||+++.++.++|+|||.+.......
T Consensus        81 ~~~L~~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~  152 (225)
T smart00221       81 GGDLFDYLRKK-----GGKLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDL  152 (225)
T ss_pred             CCCHHHHHHhc-----ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc
Confidence            88999988652     23 899999999999999999999987   9999999999999999999999999988654332


Q ss_pred             ccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcC
Q 044997          432 EKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIR  495 (563)
Q Consensus       432 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~  495 (563)
                      ..  ......++..|++||.+.            ....++.++|||+||++++||++|+.||..
T Consensus       153 ~~--~~~~~~~~~~~~~pe~~~------------~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      153 AA--LLKTVKGTPFYLAPEVLL------------GGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             cc--cccceeccCCcCCHhHhc------------CCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            00  122345778899999873            122346799999999999999999999954

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.92  E-value=6.6e-25  Score=207.94  Aligned_cols=220  Identities=21%  Similarity=0.311  Sum_probs=166.2

Q ss_pred             hcCCCccceecccCcEEEEEEEEC--CceEEEEEeccCC--hHHHHHHHHHHHhc-cccce----------------EEE
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNK--SKEFFAELKVLCKI-HHINV----------------FIS  349 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~--~~~f~~Ei~~l~~l-~H~ni----------------V~e  349 (563)
                      .+.|.+.+.||+|.||.+-+++++  .+.+++|.+....  .++|.+|..---.| .|.||                ++|
T Consensus        23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE  102 (378)
T KOG1345|consen   23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE  102 (378)
T ss_pred             hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence            356888999999999999999986  4678999987654  47899997643333 46676                479


Q ss_pred             eecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEe-cC-CCcEEEeecCCCccc
Q 044997          350 TFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILL-DD-GLRAKVADFGLVKLE  427 (563)
Q Consensus       350 ~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl-~~-~~~~kl~DFGla~~~  427 (563)
                      |++.|+|..-+..      ..+-+..-.+++.|+++|+.|||+..   +||||||.+|||| +. ..++||+|||+.+..
T Consensus       103 ~aP~gdL~snv~~------~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~  173 (378)
T KOG1345|consen  103 FAPRGDLRSNVEA------AGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKV  173 (378)
T ss_pred             cCccchhhhhcCc------ccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeeccccccc
Confidence            9999999887754      34777788899999999999999997   9999999999999 33 358999999998754


Q ss_pred             ccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc-------
Q 044997          428 ERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP-------  500 (563)
Q Consensus       428 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~-------  500 (563)
                      ...      .....-+..|.|||.......        ......+.+|||.||+++|.++||+.||.......       
T Consensus       174 g~t------V~~~~~~~~y~~pe~~~~~~n--------e~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~  239 (378)
T KOG1345|consen  174 GTT------VKYLEYVNNYHAPELCDTVVN--------EKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWE  239 (378)
T ss_pred             Cce------ehhhhhhcccCCcHHHhhccc--------cceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHH
Confidence            322      122334567999998754421        23456789999999999999999999997543221       


Q ss_pred             -----------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          501 -----------TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       501 -----------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                                 .....+.+.+..+.++-+.++|++|=-..++.+
T Consensus       240 ~w~~rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk  283 (378)
T KOG1345|consen  240 QWLKRKNPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKK  283 (378)
T ss_pred             HHhcccCccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHH
Confidence                       122333455778888899999999944444443

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.91  E-value=6.1e-25  Score=226.47  Aligned_cols=179  Identities=23%  Similarity=0.411  Sum_probs=146.7

Q ss_pred             cCCCccceecccCcEEEEEEEEC--CceEEEEEeccCCh--H---------HHHHHHHHHHhcc---ccceE--EEeecC
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNKS--K---------EFFAELKVLCKIH---HINVF--ISTFGN  353 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~--~---------~f~~Ei~~l~~l~---H~niV--~e~~~~  353 (563)
                      .+|...+.+|.|+||.|+.+.++  ...|+||.+.+++.  +         ..-.|+.||..++   |+||+  .+++++
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd  640 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED  640 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence            35788899999999999999885  46789998876532  1         1335999999998   99994  333332


Q ss_pred             --------------CCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEe
Q 044997          354 --------------GSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVA  419 (563)
Q Consensus       354 --------------gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~  419 (563)
                                    -+|.+++.-     ...+++.+...|+.||+.|+++||+++   |||||||-+|+.+|.+|-+||+
T Consensus       641 dd~yyl~te~hg~gIDLFd~IE~-----kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~kli  712 (772)
T KOG1152|consen  641 DDYYYLETEVHGEGIDLFDFIEF-----KPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLI  712 (772)
T ss_pred             CCeeEEEecCCCCCcchhhhhhc-----cCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEe
Confidence                          356666643     356899999999999999999999998   9999999999999999999999


Q ss_pred             ecCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcC
Q 044997          420 DFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIR  495 (563)
Q Consensus       420 DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~  495 (563)
                      |||.+.....+     ....++||.+|.|||++.+.+|.            +..-|||++|++||-++....|++.
T Consensus       713 dfgsaa~~ksg-----pfd~f~gtv~~aapevl~g~~y~------------gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  713 DFGSAAYTKSG-----PFDVFVGTVDYAAPEVLGGEKYL------------GKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             eccchhhhcCC-----CcceeeeeccccchhhhCCCccC------------CCcchhhhhhheeeEEEeccCCCcC
Confidence            99998765432     23457899999999999998884            6778999999999999998888763

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.91  E-value=1.9e-24  Score=248.31  Aligned_cols=172  Identities=16%  Similarity=0.181  Sum_probs=122.8

Q ss_pred             cccce--EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecC-------
Q 044997          342 HHINV--FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDD-------  412 (563)
Q Consensus       342 ~H~ni--V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~-------  412 (563)
                      +|.++  ++|++ .++|.++|..    ....+++.+++.++.||++||.|||+++   |+||||||+||||+.       
T Consensus        51 ~~~~~~~~~e~~-~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~al~~lH~~g---IvHrDlKP~NiLl~~~~~~k~~  122 (793)
T PLN00181         51 DDDSIVRALECE-DVSLRQWLDN----PDRSVDAFECFHVFRQIVEIVNAAHSQG---IVVHNVRPSCFVMSSFNHVSFI  122 (793)
T ss_pred             ccchhhhhhccC-CccHHHHHhc----ccccccHHHHHHHHHHHHHHHHHHHhCC---eeeccCCchhEEEcccCcEEEe
Confidence            44554  34554 6699999974    2356999999999999999999999987   999999999999965       


Q ss_pred             ------------CCcEEEeecCCCcccccccc-------------cccccccccCCCcccCccccccccccccccccccc
Q 044997          413 ------------GLRAKVADFGLVKLEERTNE-------------KEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVME  467 (563)
Q Consensus       413 ------------~~~~kl~DFGla~~~~~~~~-------------~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~  467 (563)
                                  ++.+|++|||+++.......             .........||+.|||||++.+..           
T Consensus       123 d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~-----------  191 (793)
T PLN00181        123 ESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSS-----------  191 (793)
T ss_pred             eccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCC-----------
Confidence                        44556666666653211000             000011245889999999886554           


Q ss_pred             CCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc---------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          468 LQVTTKTDVFAFGVVLAELITGKRALIRDDSEP---------TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       468 ~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~---------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                        ++.++|||||||+||||++|..|+.......         ............++.+||+.||.+||+|.|+++.
T Consensus       192 --~~~~sDVwSlGviL~ELl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h  265 (793)
T PLN00181        192 --SNCASDVYRLGVLLFELFCPVSSREEKSRTMSSLRHRVLPPQILLNWPKEASFCLWLLHPEPSCRPSMSELLQS  265 (793)
T ss_pred             --CCchhhhhhHHHHHHHHhhCCCchhhHHHHHHHHHHhhcChhhhhcCHHHHHHHHHhCCCChhhCcChHHHhhc
Confidence              4889999999999999999988864321100         0000112235678889999999999999999863

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.90  E-value=3.8e-24  Score=214.56  Aligned_cols=225  Identities=23%  Similarity=0.379  Sum_probs=171.3

Q ss_pred             HHHHhcCCCccceecccCcEEEEEEEE-----CCceEEEEEeccCC-hHHHHHHHHHHHhccc-cc--------------
Q 044997          287 IEEATNNFDESRIIGRGGFGNVYFGLL-----GDREAAIKKMRSNK-SKEFFAELKVLCKIHH-IN--------------  345 (563)
Q Consensus       287 l~~~~~~f~~~~~LG~G~fG~Vy~g~~-----~~~~vavK~~~~~~-~~~f~~Ei~~l~~l~H-~n--------------  345 (563)
                      +....+.|...++||+|.|++||++..     +++.||+|.+.... ..+..+|+++|..+.. .|              
T Consensus        31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v  110 (418)
T KOG1167|consen   31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQV  110 (418)
T ss_pred             hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhhccCCee
Confidence            344556788999999999999999965     35789999987654 5778899999998842 33              


Q ss_pred             -eEEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecC-CCcEEEeecCC
Q 044997          346 -VFISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDD-GLRAKVADFGL  423 (563)
Q Consensus       346 -iV~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~-~~~~kl~DFGl  423 (563)
                       ||++|+++-...+++.+        ++..++..+++.+..||.++|..|   ||||||||+|+|.+. .++-.|.|||+
T Consensus       111 ~ivlp~~~H~~f~~l~~~--------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgL  179 (418)
T KOG1167|consen  111 AIVLPYFEHDRFRDLYRS--------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGL  179 (418)
T ss_pred             EEEecccCccCHHHHHhc--------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechh
Confidence             37899988888777754        678888999999999999999998   999999999999985 46889999999


Q ss_pred             Cccccccc---------------------------------cc--------ccccccccCCCcccCcccccccccccccc
Q 044997          424 VKLEERTN---------------------------------EK--------EMLATRLVGTPGYLPPEYIFVKRFRFDMH  462 (563)
Q Consensus       424 a~~~~~~~---------------------------------~~--------~~~~~~~~gt~~y~APE~l~~~~~~~~~~  462 (563)
                      |...+...                                 ..        ....-..+||+||.|||++..-       
T Consensus       180 A~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~-------  252 (418)
T KOG1167|consen  180 AQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRC-------  252 (418)
T ss_pred             HHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhc-------
Confidence            86211000                                 00        0000124799999999998543       


Q ss_pred             cccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCchh----------------------------------------
Q 044997          463 SSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTK----------------------------------------  502 (563)
Q Consensus       463 ~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~~----------------------------------------  502 (563)
                           +..++++||||-||+++-+++++.||.........                                        
T Consensus       253 -----~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~  327 (418)
T KOG1167|consen  253 -----PRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVN  327 (418)
T ss_pred             -----cCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhc
Confidence                 34489999999999999999999998543211000                                        


Q ss_pred             h-----H-----------------HHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          503 M-----K-----------------SLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       503 ~-----~-----------------~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                      .     .                 ..+..+.+++.+|++.||.+|.+++|.++.
T Consensus       328 f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH  381 (418)
T KOG1167|consen  328 FETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH  381 (418)
T ss_pred             hhccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence            0     0                 001137899999999999999999998764

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.90  E-value=3.5e-24  Score=218.38  Aligned_cols=188  Identities=24%  Similarity=0.329  Sum_probs=144.9

Q ss_pred             ccCHHHHHHHhcCCCccceecccCcEEEEEEEE--CCceEEEEEeccCCh--HHHHHHHHHHHhcc--------------
Q 044997          281 IFSLEEIEEATNNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNKS--KEFFAELKVLCKIH--------------  342 (563)
Q Consensus       281 ~~~~~el~~~~~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~~--~~f~~Ei~~l~~l~--------------  342 (563)
                      .+.+.|+  .-.+|.+....|+|-|+.|.+|..  .+..||||+++.+..  +.=++|+++|++|+              
T Consensus       423 rv~igE~--LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~  500 (752)
T KOG0670|consen  423 RVRIGEL--LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLF  500 (752)
T ss_pred             EEehhhh--hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHH
Confidence            3444444  346788888999999999999977  478999999987653  55678999998883              


Q ss_pred             -------ccceEEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCC-C
Q 044997          343 -------HINVFISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDG-L  414 (563)
Q Consensus       343 -------H~niV~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~-~  414 (563)
                             |-.+|+|-+.- +|.+.|...  ...-.|....+..++.|+..||..|-..+   |+|.||||.|||+++. .
T Consensus       501 r~F~hknHLClVFE~Lsl-NLRevLKKy--G~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~  574 (752)
T KOG0670|consen  501 RHFKHKNHLCLVFEPLSL-NLREVLKKY--GRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKN  574 (752)
T ss_pred             HHhhhcceeEEEehhhhc-hHHHHHHHh--CcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcc
Confidence                   33345554333 677777642  23345888899999999999999999987   9999999999999865 5


Q ss_pred             cEEEeecCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCc
Q 044997          415 RAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALI  494 (563)
Q Consensus       415 ~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~  494 (563)
                      .+||||||-|.......-     +...-+..|.|||++.+-+|             +...|+||.||+||||.||+-.|.
T Consensus       575 iLKLCDfGSA~~~~enei-----tPYLVSRFYRaPEIiLG~~y-------------d~~iD~WSvgctLYElYtGkIlFp  636 (752)
T KOG0670|consen  575 ILKLCDFGSASFASENEI-----TPYLVSRFYRAPEIILGLPY-------------DYPIDTWSVGCTLYELYTGKILFP  636 (752)
T ss_pred             eeeeccCccccccccccc-----cHHHHHHhccCcceeecCcc-------------cCCccceeeceeeEEeeccceecC
Confidence            789999999875443322     22233557999999988877             568999999999999999986653

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.88  E-value=2.9e-22  Score=206.93  Aligned_cols=153  Identities=19%  Similarity=0.217  Sum_probs=119.3

Q ss_pred             HHhcCCCccceecccCcEEEEEEEE---CCceEEEEEeccC--------ChHHHHHHHHHHHhccccce-----------
Q 044997          289 EATNNFDESRIIGRGGFGNVYFGLL---GDREAAIKKMRSN--------KSKEFFAELKVLCKIHHINV-----------  346 (563)
Q Consensus       289 ~~~~~f~~~~~LG~G~fG~Vy~g~~---~~~~vavK~~~~~--------~~~~f~~Ei~~l~~l~H~ni-----------  346 (563)
                      ...++|...+.||+|+||.||+|+.   +++.+|||++...        ..+.|.+|+++|++++|+|+           
T Consensus        15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~~~~~   94 (365)
T PRK09188         15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLATGKDG   94 (365)
T ss_pred             cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEcCCcE
Confidence            3456799999999999999999976   3567899986532        13468999999999999996           


Q ss_pred             -EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCC-CCCCeEecCCCcEEEeecCCC
Q 044997          347 -FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDI-KTSNILLDDGLRAKVADFGLV  424 (563)
Q Consensus       347 -V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDL-k~~NILl~~~~~~kl~DFGla  424 (563)
                       ||||+++++|... ..     ..      ...++.++++||.|||+++   |+|||| ||+|||++.++++||+|||+|
T Consensus        95 LVmE~~~G~~L~~~-~~-----~~------~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFGlA  159 (365)
T PRK09188         95 LVRGWTEGVPLHLA-RP-----HG------DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQLA  159 (365)
T ss_pred             EEEEccCCCCHHHh-Cc-----cc------hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECccc
Confidence             4688888887521 10     01      1467889999999999997   999999 999999999999999999999


Q ss_pred             cccccccccccc-----cccccCCCcccCcccccccc
Q 044997          425 KLEERTNEKEML-----ATRLVGTPGYLPPEYIFVKR  456 (563)
Q Consensus       425 ~~~~~~~~~~~~-----~~~~~gt~~y~APE~l~~~~  456 (563)
                      +...........     .+...+++.|+|||++...+
T Consensus       160 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~  196 (365)
T PRK09188        160 SVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRE  196 (365)
T ss_pred             eecccCcchhhhhhhhhhhhhhccCccCCcccCChhh
Confidence            976543322111     13567889999999987654

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.88  E-value=6.5e-22  Score=201.00  Aligned_cols=113  Identities=23%  Similarity=0.455  Sum_probs=91.1

Q ss_pred             cCCCccceecccCcEEEEEEEE--CCceEEEEEeccCC--hHHHHHHHHHHHhcc-----ccc---e-------------
Q 044997          292 NNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNK--SKEFFAELKVLCKIH-----HIN---V-------------  346 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~--~~~f~~Ei~~l~~l~-----H~n---i-------------  346 (563)
                      .+|.+.++||=|.|++||++..  ..+.||+|+.+..+  .+..+.||++|++++     |++   |             
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpN  157 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPN  157 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCC
Confidence            6788999999999999999977  46889999998654  466788999999983     222   1             


Q ss_pred             ------EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEe
Q 044997          347 ------FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILL  410 (563)
Q Consensus       347 ------V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl  410 (563)
                            |.|+++. +|..++...   ..+.++...+.+|++||+.||.|||...  .|||-||||+|||+
T Consensus       158 G~HVCMVfEvLGd-nLLklI~~s---~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl  221 (590)
T KOG1290|consen  158 GQHVCMVFEVLGD-NLLKLIKYS---NYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL  221 (590)
T ss_pred             CcEEEEEehhhhh-HHHHHHHHh---CCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence                  3444433 566666542   3466899999999999999999999987  69999999999998

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.87  E-value=3.5e-23  Score=196.14  Aligned_cols=221  Identities=20%  Similarity=0.308  Sum_probs=172.6

Q ss_pred             cceecccCcEEEEEEEECCceEEEEEeccC-----ChHHHHHHHHHHHhccccce---------------EEEeecCCCc
Q 044997          297 SRIIGRGGFGNVYFGLLGDREAAIKKMRSN-----KSKEFFAELKVLCKIHHINV---------------FISTFGNGSL  356 (563)
Q Consensus       297 ~~~LG~G~fG~Vy~g~~~~~~vavK~~~~~-----~~~~f~~Ei~~l~~l~H~ni---------------V~e~~~~gsL  356 (563)
                      ..+|.+...|+.|+|+|.+..+++|.++.+     ..++|..|.-.|+-+.||||               +..||+.|+|
T Consensus       195 ~tkl~e~hsgelwrgrwqgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gsl  274 (448)
T KOG0195|consen  195 ITKLAESHSGELWRGRWQGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSL  274 (448)
T ss_pred             hhhhccCCCcccccccccCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHH
Confidence            456778888999999999999988887643     35789999999999999997               4699999999


Q ss_pred             ccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccccccccccc
Q 044997          357 SDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEML  436 (563)
Q Consensus       357 ~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~  436 (563)
                      ...|++.   ..-..+..+..+++.|+|+|++|||+.. |-|.---|.+..+++|++.+++|+= +-++..-       .
T Consensus       275 ynvlhe~---t~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarism-ad~kfsf-------q  342 (448)
T KOG0195|consen  275 YNVLHEQ---TSVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISM-ADTKFSF-------Q  342 (448)
T ss_pred             HHHHhcC---ccEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheec-ccceeee-------e
Confidence            9999973   3456788899999999999999999975 3355557999999999999888751 1111100       0


Q ss_pred             cccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCC------------chhhH
Q 044997          437 ATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE------------PTKMK  504 (563)
Q Consensus       437 ~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~------------~~~~~  504 (563)
                      .....-.+.||+||.+..++.+          .--.++|+|||.+++|||.|+..||..-...            ...+.
T Consensus       343 e~gr~y~pawmspealqrkped----------~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ipp  412 (448)
T KOG0195|consen  343 EVGRAYSPAWMSPEALQRKPED----------LNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPP  412 (448)
T ss_pred             ccccccCcccCCHHHHhcCchh----------cchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCC
Confidence            1112346789999999766542          2246899999999999999999999653321            12233


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhh
Q 044997          505 SLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIM  539 (563)
Q Consensus       505 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~  539 (563)
                      .+...+..|+.-|+..||.+||.+..|+-.|+++.
T Consensus       413 gis~hm~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  413 GISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             CccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence            45566999999999999999999999999999864

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.82  E-value=1.4e-20  Score=206.72  Aligned_cols=218  Identities=21%  Similarity=0.306  Sum_probs=167.9

Q ss_pred             CccceecccCcEEEEEEEEC--CceEEEEEec----cCC-hH----HHHHHHHHHHhccccce---------------EE
Q 044997          295 DESRIIGRGGFGNVYFGLLG--DREAAIKKMR----SNK-SK----EFFAELKVLCKIHHINV---------------FI  348 (563)
Q Consensus       295 ~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~----~~~-~~----~f~~Ei~~l~~l~H~ni---------------V~  348 (563)
                      ...+++|.|++|.|+.....  ....+.|..+    ... ..    .+..|..+-..++|+|+               +|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            45688999999977766442  2223333221    221 11    24557777888899996               36


Q ss_pred             EeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccc
Q 044997          349 STFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEE  428 (563)
Q Consensus       349 e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~  428 (563)
                      ||++. +|...+..     ...++..++-.++.|+..|++|||++|   +.|||+|++|++++.++.+||+|||.+....
T Consensus       401 E~~~~-Dlf~~~~~-----~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~  471 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMS-----NGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFR  471 (601)
T ss_pred             hcccH-HHHHHHhc-----ccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeec
Confidence            88888 88887764     246888889999999999999999998   9999999999999999999999999987654


Q ss_pred             ccccc-ccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc-------
Q 044997          429 RTNEK-EMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP-------  500 (563)
Q Consensus       429 ~~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~-------  500 (563)
                      ...+. .......+|+-+|+|||.+.+.+|+            ....||||.|+++..|++|+.||.......       
T Consensus       472 ~~~e~~~~~~~g~~gS~pY~apE~~~~~~yd------------pr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~  539 (601)
T KOG0590|consen  472 YPWEKNIHESSGIVGSDPYLAPEVLTGKEYD------------PRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNN  539 (601)
T ss_pred             cCcchhhhhhcCcccCCcCcCcccccccccC------------cchhhhhhccceEEEEecCCCccccccccccchhhhc
Confidence            43322 1344557899999999999988885            578999999999999999999985332211       


Q ss_pred             ------------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          501 ------------TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       501 ------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                                  .....++...+.++.++++.||.+|-++.+|++
T Consensus       540 ~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  540 YSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             cccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence                        112345566889999999999999999999986

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.81  E-value=6.6e-19  Score=177.83  Aligned_cols=225  Identities=28%  Similarity=0.452  Sum_probs=172.7

Q ss_pred             CCccceecccCcEEEEEEEECCceEEEEEeccCC------hHHHHHHHHHHHhcccc-ce---------------EEEee
Q 044997          294 FDESRIIGRGGFGNVYFGLLGDREAAIKKMRSNK------SKEFFAELKVLCKIHHI-NV---------------FISTF  351 (563)
Q Consensus       294 f~~~~~LG~G~fG~Vy~g~~~~~~vavK~~~~~~------~~~f~~Ei~~l~~l~H~-ni---------------V~e~~  351 (563)
                      |...+.||.|+||.||++... ..+++|.+....      ...|.+|+.++..+.|+ ++               +++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~-~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~   80 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR-KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYV   80 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec-cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecC
Confidence            566788999999999999887 788999886432      45689999999999988 45               46777


Q ss_pred             cCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCC-cEEEeecCCCcccccc
Q 044997          352 GNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGL-RAKVADFGLVKLEERT  430 (563)
Q Consensus       352 ~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~-~~kl~DFGla~~~~~~  430 (563)
                      .++++.+++......  ..++......+..+++.++.|+|+.+   ++|||+||+||+++... .++++|||.++.....
T Consensus        81 ~~~~l~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~  155 (384)
T COG0515          81 DGGSLEDLLKKIGRK--GPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP  155 (384)
T ss_pred             CCCcHHHHHHhcccc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence            888888555432100  36888999999999999999999998   99999999999999988 7999999999854433


Q ss_pred             cccc---cccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCC---CchhhH
Q 044997          431 NEKE---MLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDS---EPTKMK  504 (563)
Q Consensus       431 ~~~~---~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~---~~~~~~  504 (563)
                      ....   .......|+..|+|||.+.+..          ....+...|+||+|++++++++|..|+.....   ......
T Consensus       156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~----------~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~  225 (384)
T COG0515         156 GSTSSIPALPSTSVGTPGYMAPEVLLGLS----------LAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLK  225 (384)
T ss_pred             CccccccccccccccccccCCHHHhcCCC----------CCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHH
Confidence            2211   1234568999999999875420          02458899999999999999999999655442   010000


Q ss_pred             ---------------HH-----HHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          505 ---------------SL-----ITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       505 ---------------~~-----~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                                     ..     ...+.+++..++..+|..|.+..+....
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         226 IILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             HHHhcCCcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence                           00     1357889999999999999998887765

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.80  E-value=1.3e-18  Score=179.28  Aligned_cols=230  Identities=21%  Similarity=0.287  Sum_probs=168.4

Q ss_pred             CCCccceecccCcEEEEEEEECC---ceEEEEEeccCC---hHHHHHHHHHHHhcc------ccceEE------------
Q 044997          293 NFDESRIIGRGGFGNVYFGLLGD---REAAIKKMRSNK---SKEFFAELKVLCKIH------HINVFI------------  348 (563)
Q Consensus       293 ~f~~~~~LG~G~fG~Vy~g~~~~---~~vavK~~~~~~---~~~f~~Ei~~l~~l~------H~niV~------------  348 (563)
                      +|...+.||+|+||.||.+....   ..+|+|......   ...+..|..++..+.      |..-+.            
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            78999999999999999998754   358888776432   126778999998887      211111            


Q ss_pred             -EeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCC-----CcEEEeecC
Q 044997          349 -STFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDG-----LRAKVADFG  422 (563)
Q Consensus       349 -e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~-----~~~kl~DFG  422 (563)
                       --+.+.+|.+.....   ..+.++..+.++|+.|++.+|++||+.|   ++||||||+|+++...     ..+.|.|||
T Consensus        99 VM~l~G~sL~dl~~~~---~~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfG  172 (322)
T KOG1164|consen   99 VMSLLGPSLEDLRKRN---PPGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFG  172 (322)
T ss_pred             EEeccCccHHHHHHhC---CCCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecC
Confidence             122344666654331   2467999999999999999999999998   9999999999999764     469999999


Q ss_pred             CCc--cccccccc---cc-c-cccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcC
Q 044997          423 LVK--LEERTNEK---EM-L-ATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIR  495 (563)
Q Consensus       423 la~--~~~~~~~~---~~-~-~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~  495 (563)
                      +++  ........   .. . .....||..|++++.-.             ....+.+.|+||++.++.|+..|..||..
T Consensus       173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~-------------~~e~~r~DDles~~Y~l~el~~g~LPW~~  239 (322)
T KOG1164|consen  173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHL-------------GIEQGRRDDLESLFYMLLELLKGSLPWEA  239 (322)
T ss_pred             CCccccccCCCCcccccCCCCccCCCCccccccHHHhC-------------CCccCCchhhhhHHHHHHHHhcCCCCCcc
Confidence            998  32222211   11 1 12356999999999654             34458999999999999999999999865


Q ss_pred             CCCCchh--h-------------HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 044997          496 DDSEPTK--M-------------KSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMIT  541 (563)
Q Consensus       496 ~~~~~~~--~-------------~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~  541 (563)
                      .......  .             ...+..+..+...+-..+..++|....+...|.+....
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~  300 (322)
T KOG1164|consen  240 LEMTDLKSKFEKDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDS  300 (322)
T ss_pred             ccccchHHHHHHHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence            4422110  0             01234567777777778999999999999999887664

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.78  E-value=7.9e-19  Score=166.64  Aligned_cols=122  Identities=19%  Similarity=0.254  Sum_probs=98.4

Q ss_pred             cceecccCcEEEEEEEE-CCceEEEEEeccCCh------------HHH-----------------HHHHHHHHhccccc-
Q 044997          297 SRIIGRGGFGNVYFGLL-GDREAAIKKMRSNKS------------KEF-----------------FAELKVLCKIHHIN-  345 (563)
Q Consensus       297 ~~~LG~G~fG~Vy~g~~-~~~~vavK~~~~~~~------------~~f-----------------~~Ei~~l~~l~H~n-  345 (563)
                      ...||+|+||.||+|.. +|+.||||.++....            ..|                 .+|++.|.++.|++ 
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            46799999999999987 588999999865421            122                 24899999986543 


Q ss_pred             ------------eEEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCceEeCCCCCCCeEecC
Q 044997          346 ------------VFISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYI-HDHTKARYVHRDIKTSNILLDD  412 (563)
Q Consensus       346 ------------iV~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~ivHrDLk~~NILl~~  412 (563)
                                  |||||++++++......     ...+++.....++.|++.+|.|+ |+.+   |+||||||+|||++ 
T Consensus        82 ~~p~~~~~~~~~iVmE~i~g~~l~~~~~~-----~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~-  152 (190)
T cd05147          82 PCPEPILLKSHVLVMEFIGDDGWAAPRLK-----DAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH-  152 (190)
T ss_pred             CCCcEEEecCCEEEEEEeCCCCCcchhhh-----cCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-
Confidence                        48999998877654322     24688999999999999999999 6777   99999999999998 


Q ss_pred             CCcEEEeecCCCccc
Q 044997          413 GLRAKVADFGLVKLE  427 (563)
Q Consensus       413 ~~~~kl~DFGla~~~  427 (563)
                      +++++|+|||+|...
T Consensus       153 ~~~v~LiDFG~a~~~  167 (190)
T cd05147         153 DGKLYIIDVSQSVEH  167 (190)
T ss_pred             CCcEEEEEccccccC
Confidence            478999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.77  E-value=3.3e-18  Score=162.65  Aligned_cols=123  Identities=17%  Similarity=0.198  Sum_probs=100.1

Q ss_pred             cceecccCcEEEEEEEEC-CceEEEEEeccCCh-----------------------------HHHHHHHHHHHhccccc-
Q 044997          297 SRIIGRGGFGNVYFGLLG-DREAAIKKMRSNKS-----------------------------KEFFAELKVLCKIHHIN-  345 (563)
Q Consensus       297 ~~~LG~G~fG~Vy~g~~~-~~~vavK~~~~~~~-----------------------------~~f~~Ei~~l~~l~H~n-  345 (563)
                      ...||+|+||.||+|... |+.||||.++....                             ..+.+|.+.+.++.|++ 
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            468999999999999874 89999999875421                             11357889999998775 


Q ss_pred             ------------eEEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCceEeCCCCCCCeEecC
Q 044997          346 ------------VFISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHD-HTKARYVHRDIKTSNILLDD  412 (563)
Q Consensus       346 ------------iV~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDLk~~NILl~~  412 (563)
                                  +||||++++++......     ...++..+...++.+++.++.+||+ .+   ++||||||+|||++ 
T Consensus        82 ~~p~~~~~~~~~lVmE~~~g~~~~~~~l~-----~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~-  152 (190)
T cd05145          82 PVPEPILLKKNVLVMEFIGDDGSPAPRLK-----DVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH-  152 (190)
T ss_pred             CCceEEEecCCEEEEEEecCCCchhhhhh-----hccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-
Confidence                        47999998865433211     2357788899999999999999999 87   99999999999999 


Q ss_pred             CCcEEEeecCCCcccc
Q 044997          413 GLRAKVADFGLVKLEE  428 (563)
Q Consensus       413 ~~~~kl~DFGla~~~~  428 (563)
                      +++++|+|||+++...
T Consensus       153 ~~~~~liDFG~a~~~~  168 (190)
T cd05145         153 DGKPYIIDVSQAVELD  168 (190)
T ss_pred             CCCEEEEEcccceecC
Confidence            8899999999998654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.77  E-value=9.7e-19  Score=184.15  Aligned_cols=182  Identities=24%  Similarity=0.321  Sum_probs=140.5

Q ss_pred             EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcc
Q 044997          347 FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKL  426 (563)
Q Consensus       347 V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~  426 (563)
                      |.+|+..|+|.+.+..    ....++|.....+.+|++.||+|||+..  -..|+.++++|+++|..+.+||+|||+...
T Consensus        25 i~~~c~rGsl~D~i~~----~~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~s~nClvd~~w~lklt~~Gl~~~   98 (484)
T KOG1023|consen   25 IWEYCSRGSLLDILSN----EDIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALKSSNCLVDSRWVLKLTDFGLNSL   98 (484)
T ss_pred             EEeeecCccHHhHHhc----cccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeeccccceeeeeEEEEechhhhccc
Confidence            6799999999999976    3567999999999999999999999864  239999999999999999999999999876


Q ss_pred             cccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCchh----
Q 044997          427 EERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTK----  502 (563)
Q Consensus       427 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~~----  502 (563)
                      ........ ......-..-|.|||.+......      ......+.+.||||||++++|+++.+.||.........    
T Consensus        99 ~~~~~~~~-~~~~~~~~~lw~aPellr~~~~~------~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~~~~~~~~~eii  171 (484)
T KOG1023|consen   99 LEETAEPE-AHHPIRKALLWTAPELLRGALSQ------SLESALTQKGDIYSFGIIMYEILFRSGPFDLRNLVEDPDEII  171 (484)
T ss_pred             cccccccc-ccchhHHHHhccCHHHhcccccc------cccccccccCCeehHHHHHHHHHhccCccccccccCChHHHH
Confidence            64311110 11112234569999999776431      12233588999999999999999999998653221110    


Q ss_pred             -----------------hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 044997          503 -----------------MKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMIT  541 (563)
Q Consensus       503 -----------------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~  541 (563)
                                       ..+..+.+..++.+||..+|.+||++++|-..++.+...
T Consensus       172 ~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~  227 (484)
T KOG1023|consen  172 LRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG  227 (484)
T ss_pred             HHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence                             013344588999999999999999999999998877654

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.77  E-value=1e-18  Score=192.29  Aligned_cols=230  Identities=18%  Similarity=0.196  Sum_probs=161.0

Q ss_pred             CCCccceecccCcEEEEEEEECCceEEEEEeccCC----hHHHH---HHHHHHHhccccceE---------------EEe
Q 044997          293 NFDESRIIGRGGFGNVYFGLLGDREAAIKKMRSNK----SKEFF---AELKVLCKIHHINVF---------------IST  350 (563)
Q Consensus       293 ~f~~~~~LG~G~fG~Vy~g~~~~~~vavK~~~~~~----~~~f~---~Ei~~l~~l~H~niV---------------~e~  350 (563)
                      ++...+.||++.|=+|.+|+.++..|+||++-++.    .+.|.   +|++ ..-.+|||.+               .+|
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRqy  102 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQY  102 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence            56667899999999999999988889999985543    23444   3444 5556899972               234


Q ss_pred             ecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccccc
Q 044997          351 FGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERT  430 (563)
Q Consensus       351 ~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~  430 (563)
                      ..+ +|.|.|..     +.-|...+..-|+.|++.||.-+|..+   |+|+|||.+||||++-.-+.|+||.--|...-.
T Consensus       103 vkh-nLyDRlST-----RPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLP  173 (1431)
T KOG1240|consen  103 VKH-NLYDRLST-----RPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLP  173 (1431)
T ss_pred             Hhh-hhhhhhcc-----chHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCC
Confidence            333 55555543     345777788889999999999999998   999999999999999999999999877654322


Q ss_pred             cccc----cccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcC-CCCCc-------CCCC
Q 044997          431 NEKE----MLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG-KRALI-------RDDS  498 (563)
Q Consensus       431 ~~~~----~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg-~~p~~-------~~~~  498 (563)
                      ++..    ........-..|.|||.+.....  .....+.....+++.||||+||++.||++- +++|.       +...
T Consensus       174 eDNPadf~fFFDTSrRRtCYiAPERFv~~~~--~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~  251 (1431)
T KOG1240|consen  174 EDNPADFTFFFDTSRRRTCYIAPERFVSALG--KTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGN  251 (1431)
T ss_pred             CCCcccceEEEecCCceeeecChHhhhcccc--ccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccC
Confidence            2211    11111112236999998865320  001112233478999999999999999985 55552       1111


Q ss_pred             CchhhHHHHH-----HHHHHHHHhhccCCCCCCCHHHHHHHH
Q 044997          499 EPTKMKSLIT-----IMAAVAEWCLNEDAVDRPEMRDIVAIL  535 (563)
Q Consensus       499 ~~~~~~~~~~-----~l~~li~~cl~~dP~~RPs~~evl~~L  535 (563)
                       ....+.+.+     .+++|+..|++.||++|-++++.++.-
T Consensus       252 -~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~y  292 (1431)
T KOG1240|consen  252 -ADDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQKY  292 (1431)
T ss_pred             -ccCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHhh
Confidence             111222221     389999999999999999999999983

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.74  E-value=1.5e-17  Score=155.80  Aligned_cols=227  Identities=23%  Similarity=0.334  Sum_probs=166.9

Q ss_pred             hcCCCccceecccCcEEEEEEEE--CCceEEEEEeccCCh-HHHHHHHHHHHhccc----cc-----------e-EEEee
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNKS-KEFFAELKVLCKIHH----IN-----------V-FISTF  351 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~~-~~f~~Ei~~l~~l~H----~n-----------i-V~e~~  351 (563)
                      ..+|...++||.|+||.+|.|..  .|.+||||.-+.... ..+..|.++...++|    |.           + ||+..
T Consensus        14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL   93 (341)
T KOG1163|consen   14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL   93 (341)
T ss_pred             ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc
Confidence            35789999999999999999976  689999998776543 456678888777754    22           2 45544


Q ss_pred             cCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecC---CCcEEEeecCCCcccc
Q 044997          352 GNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDD---GLRAKVADFGLVKLEE  428 (563)
Q Consensus       352 ~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~---~~~~kl~DFGla~~~~  428 (563)
                       +.+|.+.+.-    ..+.++..+.+-++-|++.-++|+|.++   ++||||||+|.|..-   ..++.++|||+|+...
T Consensus        94 -GPsLEdLfnf----C~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~  165 (341)
T KOG1163|consen   94 -GPSLEDLFNF----CSRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR  165 (341)
T ss_pred             -CccHHHHHHH----HhhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhc
Confidence             4577776653    2356888999999999999999999998   999999999999863   3578999999999765


Q ss_pred             ccccccc----ccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc--hh
Q 044997          429 RTNEKEM----LATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP--TK  502 (563)
Q Consensus       429 ~~~~~~~----~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~--~~  502 (563)
                      +......    ......||.+|.+-....+             ...+...|+-|+|.+|....-|..||.+-....  ++
T Consensus       166 d~~t~~HIpyre~r~ltGTaRYASinAh~g-------------~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QK  232 (341)
T KOG1163|consen  166 DIRTRQHIPYREDRNLTGTARYASINAHLG-------------IEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQK  232 (341)
T ss_pred             cccccccCccccCCccceeeeehhhhhhhh-------------hhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHH
Confidence            4332211    1233679999988775432             334788999999999999999999997654321  11


Q ss_pred             h----------------HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 044997          503 M----------------KSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQI  538 (563)
Q Consensus       503 ~----------------~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  538 (563)
                      .                ...+.++...+.-|-..--++-|...-+-+...-+
T Consensus       233 yEkI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriL  284 (341)
T KOG1163|consen  233 YEKISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRIL  284 (341)
T ss_pred             HHHHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHH
Confidence            1                12344567777888888888888876655544433

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.74  E-value=5.7e-17  Score=158.31  Aligned_cols=227  Identities=19%  Similarity=0.303  Sum_probs=164.1

Q ss_pred             CCCccceecccCcEEEEEEEE--CCceEEEEEeccC-ChHHHHHHHHHHHhccc----cce------------EEEeecC
Q 044997          293 NFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSN-KSKEFFAELKVLCKIHH----INV------------FISTFGN  353 (563)
Q Consensus       293 ~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~-~~~~f~~Ei~~l~~l~H----~ni------------V~e~~~~  353 (563)
                      +|.++++||+|.||.++.|+.  +++.||||.-... +..++..|....+.|.+    |++            |+|.+ +
T Consensus        29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-G  107 (449)
T KOG1165|consen   29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-G  107 (449)
T ss_pred             cceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-C
Confidence            588999999999999999964  8999999976433 33456667776666644    222            22222 3


Q ss_pred             CCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCC-----CcEEEeecCCCcccc
Q 044997          354 GSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDG-----LRAKVADFGLVKLEE  428 (563)
Q Consensus       354 gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~-----~~~kl~DFGla~~~~  428 (563)
                      .+|++.+.-    ..+.++.+....||.|++.-++|+|++.   +|.|||||+|.||...     ..+.|+|||+|+..-
T Consensus       108 PSLEDLFD~----CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr  180 (449)
T KOG1165|consen  108 PSLEDLFDL----CGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR  180 (449)
T ss_pred             cCHHHHHHH----hcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence            456655432    2467899999999999999999999997   9999999999999643     358999999999654


Q ss_pred             cccccccc----cccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc----
Q 044997          429 RTNEKEML----ATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP----  500 (563)
Q Consensus       429 ~~~~~~~~----~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~----  500 (563)
                      +.......    .....||.+||+-..-.++             +.+.+.|.-|+|-++...+-|..||.+-....    
T Consensus       181 Dp~TkqHIPYrE~KSLsGTARYMSINTHlGr-------------EQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~k  247 (449)
T KOG1165|consen  181 DPKTKQHIPYREHKSLSGTARYMSINTHLGR-------------EQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEK  247 (449)
T ss_pred             CccccccCccccccccccceeeeEeeccccc-------------hhhhhhhHHHhhhhhhhhccCCCccccccCcchHHH
Confidence            43322211    2346799999998865444             34889999999999999999999997643211    


Q ss_pred             --------------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhh
Q 044997          501 --------------TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMI  540 (563)
Q Consensus       501 --------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~  540 (563)
                                    .....++.++..-+.-.-..+-.+-|..+-+...+..++.
T Consensus       248 YeKIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvld  301 (449)
T KOG1165|consen  248 YEKIGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLD  301 (449)
T ss_pred             HHHhccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHH
Confidence                          1123345556666666667777788887766666665554

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.73  E-value=6.4e-18  Score=163.02  Aligned_cols=153  Identities=12%  Similarity=0.116  Sum_probs=115.2

Q ss_pred             HhcCCCccceecccCcEEEEEEEECCceEEEEEeccCC--hH----H------HHHHHHHHHhccccce-----------
Q 044997          290 ATNNFDESRIIGRGGFGNVYFGLLGDREAAIKKMRSNK--SK----E------FFAELKVLCKIHHINV-----------  346 (563)
Q Consensus       290 ~~~~f~~~~~LG~G~fG~Vy~g~~~~~~vavK~~~~~~--~~----~------f~~Ei~~l~~l~H~ni-----------  346 (563)
                      ..++|...++||.|+||.||+...++..+|||.+++..  .+    .      |.+|++.+.+++|++|           
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~  108 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE  108 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence            46889999999999999999987777899999997532  11    2      5789999999999885           


Q ss_pred             ------------EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCC
Q 044997          347 ------------FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGL  414 (563)
Q Consensus       347 ------------V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~  414 (563)
                                  +|||+++.+|.++..         ++.    ....+++.+|..+|+++   ++|||+||+||++++++
T Consensus       109 ~~~~~~~~~~~lvmEyi~G~tL~~~~~---------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g  172 (232)
T PRK10359        109 RKTLRYAHTYIMLIEYIEGVELNDMPE---------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG  172 (232)
T ss_pred             cccccccCCeEEEEEEECCccHHHhhh---------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC
Confidence                        467777777766521         221    34569999999999998   99999999999999988


Q ss_pred             cEEEeecCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHH
Q 044997          415 RAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELI  487 (563)
Q Consensus       415 ~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ell  487 (563)
                       ++|+|||..+........+               .++..             ..+..++|+|+||+.+.-..
T Consensus       173 -i~liDfg~~~~~~e~~a~d---------------~~vle-------------r~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        173 -LRIIDLSGKRCTAQRKAKD---------------RIDLE-------------RHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             -EEEEECCCcccccchhhHH---------------HHHHH-------------hHhcccccccceeEeehHHH
Confidence             9999999876542211110               02211             12346899999999887654

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.73  E-value=2.9e-17  Score=155.36  Aligned_cols=177  Identities=16%  Similarity=0.141  Sum_probs=127.9

Q ss_pred             CccceecccCcEEEEEEEECCceEEEEEeccCCh-------HHHHHHHHHHHhccc-cce-----------EEEeecCCC
Q 044997          295 DESRIIGRGGFGNVYFGLLGDREAAIKKMRSNKS-------KEFFAELKVLCKIHH-INV-----------FISTFGNGS  355 (563)
Q Consensus       295 ~~~~~LG~G~fG~Vy~g~~~~~~vavK~~~~~~~-------~~f~~Ei~~l~~l~H-~ni-----------V~e~~~~gs  355 (563)
                      .+...|++|+||+||.+...+.+++.+.+.....       ..|.+|+++|++++| +++           +++|+.+.+
T Consensus         5 ~~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~~~~lvmeyI~G~~   84 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWDGRHLDRSYLAGAA   84 (218)
T ss_pred             ccceeecCCCcceEEEeecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEcCEEEEEeeecCcc
Confidence            4567899999999998887889999888765432       257899999999954 332           567777777


Q ss_pred             cccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCC-CCCCeEecCCCcEEEeecCCCccccccccc-
Q 044997          356 LSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDI-KTSNILLDDGLRAKVADFGLVKLEERTNEK-  433 (563)
Q Consensus       356 L~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDL-k~~NILl~~~~~~kl~DFGla~~~~~~~~~-  433 (563)
                      |.+.+..            ....++.+++.+|+++|+++   |+|||| ||+|||++.++.++|+|||++......... 
T Consensus        85 L~~~~~~------------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~  149 (218)
T PRK12274         85 MYQRPPR------------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWM  149 (218)
T ss_pred             HHhhhhh------------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHH
Confidence            7543211            11357789999999999998   999999 799999999999999999999854432210 


Q ss_pred             -----c----cccccccCCCcccCcccccccccccccccccccCCCC-CcchHHHHHHHHHHHHcCCCCCcCCCC
Q 044997          434 -----E----MLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVT-TKTDVFAFGVVLAELITGKRALIRDDS  498 (563)
Q Consensus       434 -----~----~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s-~ksDVwSfGvvl~Elltg~~p~~~~~~  498 (563)
                           .    ........++.|+.|+.-..            ....+ ...+.++-|.-+|.++|++.+...+.+
T Consensus       150 r~L~~rDl~~llk~~~~y~~~~l~~~~~~~------------l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~  212 (218)
T PRK12274        150 RLLAREDLRHLLKHKRMYCPAALTPVERRV------------LKRTSWIRELWFATGKPVYRFVTRRVLHWEDNE  212 (218)
T ss_pred             HHHHHHHHHHHHHHHHhcCCCCCCHHHHhh------------hccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence                 0    00011235677788874321            11112 557889999999999999988765543

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.72  E-value=1.4e-17  Score=165.48  Aligned_cols=217  Identities=22%  Similarity=0.290  Sum_probs=136.7

Q ss_pred             CCccceecccCcEEEEEEEEC--CceEEEEEeccC------ChHHHHHHHHHHHhccc----------cce-----E---
Q 044997          294 FDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSN------KSKEFFAELKVLCKIHH----------INV-----F---  347 (563)
Q Consensus       294 f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~------~~~~f~~Ei~~l~~l~H----------~ni-----V---  347 (563)
                      +...+.||.|+++.||+++..  +++.|+|.....      ..+++.+|.-....+.+          -.+     +   
T Consensus        14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i   93 (288)
T PF14531_consen   14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI   93 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred             EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence            445789999999999999985  589999986422      23556666544444322          001     0   


Q ss_pred             ---------------------EEeec--CCCccccccccccc--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCC
Q 044997          348 ---------------------ISTFG--NGSLSDHLHDPLLK--GHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRD  402 (563)
Q Consensus       348 ---------------------~e~~~--~gsL~~~L~~~~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrD  402 (563)
                                           ...++  .++|.+.+..-...  ....+....++.+..|+++.+++||+++   +||+|
T Consensus        94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHgd  170 (288)
T PF14531_consen   94 PGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVHGD  170 (288)
T ss_dssp             TTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEEST
T ss_pred             cCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEecc
Confidence                                 01111  34555543210001  1123455667788899999999999998   99999


Q ss_pred             CCCCCeEecCCCcEEEeecCCCcccccccccccccccccCCCcccCcccccccc-cccccccccccCCCCCcchHHHHHH
Q 044997          403 IKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKR-FRFDMHSSVMELQVTTKTDVFAFGV  481 (563)
Q Consensus       403 Lk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~-~~~~~~~~~~~~~~s~ksDVwSfGv  481 (563)
                      |||+|++++.+|.++|+||+.........   . .  ...+..|.+||...... |      ......++.+.|.|++|+
T Consensus       171 i~~~nfll~~~G~v~Lg~F~~~~r~g~~~---~-~--~~~~~~~~PPe~~~~~~~~------~~~~~~~t~~~DaW~LG~  238 (288)
T PF14531_consen  171 IKPENFLLDQDGGVFLGDFSSLVRAGTRY---R-C--SEFPVAFTPPELESCAGQF------GQNNAPYTFATDAWQLGI  238 (288)
T ss_dssp             -SGGGEEE-TTS-EEE--GGGEEETTEEE---E-G--GGS-TTTS-HHHHHHHTSC------HHSEEEE-HHHHHHHHHH
T ss_pred             cceeeEEEcCCCCEEEcChHHHeecCcee---e-c--cCCCcccCChhhhhhhccc------CcccceeeeccCHHHHHH
Confidence            99999999999999999998766432211   1 0  23457799999764321 1      012345689999999999


Q ss_pred             HHHHHHcCCCCCcCCCCCc------hhhHHHHHHHHHHHHHhhccCCCCC
Q 044997          482 VLAELITGKRALIRDDSEP------TKMKSLITIMAAVAEWCLNEDAVDR  525 (563)
Q Consensus       482 vl~Elltg~~p~~~~~~~~------~~~~~~~~~l~~li~~cl~~dP~~R  525 (563)
                      ++|.|++++.||.......      ....+.++.++.||..+|+.||.+|
T Consensus       239 ~ly~lWC~~lPf~~~~~~~~~~~~f~~C~~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  239 TLYSLWCGRLPFGLSSPEADPEWDFSRCRDMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HHHHHHHSS-STCCCGGGSTSGGGGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred             HHHHHHHccCCCCCCCccccccccchhcCCcCHHHHHHHHHHccCCcccC
Confidence            9999999999986432211      1123778889999999999999988

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.72  E-value=9.5e-18  Score=167.04  Aligned_cols=166  Identities=20%  Similarity=0.219  Sum_probs=116.9

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEe--cCCC--cEEEeecCCCcccccccc---cccccccccC
Q 044997          370 PLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILL--DDGL--RAKVADFGLVKLEERTNE---KEMLATRLVG  442 (563)
Q Consensus       370 ~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl--~~~~--~~kl~DFGla~~~~~~~~---~~~~~~~~~g  442 (563)
                      ..+.....-|+.|+++|+.|||.|+   +.|||+|++|||+  |+|.  ...|+|||++-..+..+-   .....-...|
T Consensus       337 ~~s~r~~~~~laQlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GG  413 (598)
T KOG4158|consen  337 HRSYRTGRVILAQLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGG  413 (598)
T ss_pred             CCchHHHHHHHHHHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCC
Confidence            3455566678899999999999998   9999999999998  3443  578999998753222110   0111122457


Q ss_pred             CCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCC------------CchhhHHHHHHH
Q 044997          443 TPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDS------------EPTKMKSLITIM  510 (563)
Q Consensus       443 t~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~------------~~~~~~~~~~~l  510 (563)
                      .-.-||||+....+-       .....--.|+|.|+.|.+.||++....||+....            .+..+..++..+
T Consensus       414 Na~lmAPEi~ta~PG-------p~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~~vpp~~  486 (598)
T KOG4158|consen  414 NAKLMAPEIATAVPG-------PNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPSRVPPVA  486 (598)
T ss_pred             cceecchhhhhcCCC-------CceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCcccCChHH
Confidence            778999998754321       1112224689999999999999999999987432            122334556679


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHHHHHHhhhcChhh
Q 044997          511 AAVAEWCLNEDAVDRPEMRDIVAILSQIMITSTEW  545 (563)
Q Consensus       511 ~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~w  545 (563)
                      ++++...++.||++||+..-....|.--+....+|
T Consensus       487 rqlV~~lL~r~pskRvsp~iAANvl~LsLw~~~~~  521 (598)
T KOG4158|consen  487 RQLVFDLLKRDPSKRVSPNIAANVLNLSLWRMGED  521 (598)
T ss_pred             HHHHHHHhcCCccccCCccHHHhHHHHHHhcCchH
Confidence            99999999999999999876666665444433343

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.72  E-value=8.3e-18  Score=185.18  Aligned_cols=215  Identities=24%  Similarity=0.431  Sum_probs=152.8

Q ss_pred             cCCCccceecccCcEEEEEEEEC--CceEEEEEeccCChHHHHHHHHHHHhccccceEEEeecCCCcccccccccccCCC
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNKSKEFFAELKVLCKIHHINVFISTFGNGSLSDHLHDPLLKGHQ  369 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~f~~Ei~~l~~l~H~niV~e~~~~gsL~~~L~~~~~~~~~  369 (563)
                      .+|+..+.|..|+||.||..+++  .+..|+ +++++..  ..+-  ++.....|.+|      |+-...++.     -.
T Consensus        83 ~df~~IklisngAygavylvrh~~trqrfa~-kiNkq~l--ilRn--ilt~a~npfvv------gDc~tllk~-----~g  146 (1205)
T KOG0606|consen   83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAM-KINKQNL--ILRN--ILTFAGNPFVV------GDCATLLKN-----IG  146 (1205)
T ss_pred             cccceeEeeccCCCCceeeeeccccccchhh-cccccch--hhhc--cccccCCccee------chhhhhccc-----CC
Confidence            57888999999999999999876  677888 4443321  1111  55555666665      565555543     22


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccccc------------ccccccc
Q 044997          370 PLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERT------------NEKEMLA  437 (563)
Q Consensus       370 ~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~------------~~~~~~~  437 (563)
                      +++        .|++.+++|||+.+   |+|||+||+|.+|+.-|++|+.|||+++..-..            ...+...
T Consensus       147 ~lP--------vdmvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~d  215 (1205)
T KOG0606|consen  147 PLP--------VDMVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQD  215 (1205)
T ss_pred             CCc--------chhhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhh
Confidence            333        12378999999998   999999999999999999999999998753211            1122233


Q ss_pred             ccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc-------------hhhH
Q 044997          438 TRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP-------------TKMK  504 (563)
Q Consensus       438 ~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~-------------~~~~  504 (563)
                      ..++||+.|.|||++..+.|             +..+|+|++|+++||.+-|+.||+++..+.             +...
T Consensus       216 KqvcgTPeyiaPeVilrqgy-------------gkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~de  282 (1205)
T KOG0606|consen  216 KQVCGTPEYIAPEVILRQGY-------------GKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEEDE  282 (1205)
T ss_pred             ccccCCccccChhhhhhhcc-------------CCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccccCc
Confidence            45789999999999976665             889999999999999999999998874322             1123


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcChhhh
Q 044997          505 SLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITSTEWE  546 (563)
Q Consensus       505 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~w~  546 (563)
                      .+..+.++++.+.|+.+|..|--...-++.-++=+-...||.
T Consensus       283 a~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~  324 (1205)
T KOG0606|consen  283 ALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWK  324 (1205)
T ss_pred             CCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccc
Confidence            345568999999999999999433333333222222335665

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.71  E-value=2.5e-18  Score=181.16  Aligned_cols=219  Identities=21%  Similarity=0.272  Sum_probs=165.5

Q ss_pred             eecccCcEEEEEEEE-----CCceEEEEEeccCC-----hHHHHHHHHHHHhcc-ccceE---------------EEeec
Q 044997          299 IIGRGGFGNVYFGLL-----GDREAAIKKMRSNK-----SKEFFAELKVLCKIH-HINVF---------------ISTFG  352 (563)
Q Consensus       299 ~LG~G~fG~Vy~g~~-----~~~~vavK~~~~~~-----~~~f~~Ei~~l~~l~-H~niV---------------~e~~~  352 (563)
                      ++|+|.||.|+..+.     .+.-.|+|.+++..     ......|..++..++ ||.+|               +++..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            379999999987532     34556777664321     123445777888887 77764               35556


Q ss_pred             CCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccccccc
Q 044997          353 NGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNE  432 (563)
Q Consensus       353 ~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~  432 (563)
                      +|.|...+..     ....+..........++-+++++|+.+   ++|||+|++||+++.+|++|+.|||+++..-....
T Consensus        81 gg~lft~l~~-----~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~  152 (612)
T KOG0603|consen   81 GGDLFTRLSK-----EVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI  152 (612)
T ss_pred             cchhhhcccc-----CCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhh
Confidence            6666666653     344566666677788999999999998   99999999999999999999999999985433221


Q ss_pred             cccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCC------CchhhHHH
Q 044997          433 KEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDS------EPTKMKSL  506 (563)
Q Consensus       433 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~------~~~~~~~~  506 (563)
                             .+||..|||||++.+               ....+|.||||++++||+||..||..+..      +...++.+
T Consensus       153 -------~cgt~eymApEI~~g---------------h~~a~D~ws~gvl~felltg~~pf~~~~~~~Il~~~~~~p~~l  210 (612)
T KOG0603|consen  153 -------ACGTYEYRAPEIING---------------HLSAADWWSFGVLAFELLTGTLPFGGDTMKRILKAELEMPREL  210 (612)
T ss_pred             -------cccchhhhhhHhhhc---------------cCCcccchhhhhhHHHHhhCCCCCchHHHHHHhhhccCCchhh
Confidence                   278999999999852               26789999999999999999999976211      22334566


Q ss_pred             HHHHHHHHHHhhccCCCCCCCH--HHHHHHHHHhhhcChhhhc
Q 044997          507 ITIMAAVAEWCLNEDAVDRPEM--RDIVAILSQIMITSTEWEA  547 (563)
Q Consensus       507 ~~~l~~li~~cl~~dP~~RPs~--~evl~~L~~i~~~~~~w~~  547 (563)
                      ......++..++..+|.+|--.  ..+.+.++.-.-...+|..
T Consensus       211 ~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~~  253 (612)
T KOG0603|consen  211 SAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWNE  253 (612)
T ss_pred             hHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeHhh
Confidence            7778999999999999999655  6777888877888888883

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.67  E-value=2.9e-16  Score=176.34  Aligned_cols=234  Identities=20%  Similarity=0.251  Sum_probs=171.3

Q ss_pred             HHHHhcCCCccceecccCcEEEEEEEE-CCceEEEEEeccCChHHHHHHHHHHHhcc--------c----------cceE
Q 044997          287 IEEATNNFDESRIIGRGGFGNVYFGLL-GDREAAIKKMRSNKSKEFFAELKVLCKIH--------H----------INVF  347 (563)
Q Consensus       287 l~~~~~~f~~~~~LG~G~fG~Vy~g~~-~~~~vavK~~~~~~~~~f~~Ei~~l~~l~--------H----------~niV  347 (563)
                      .+.....|.+.+.||+|+||+||+|.. +++.||+|.-++...=+|.--.+++.||+        |          ..+|
T Consensus       693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv  772 (974)
T KOG1166|consen  693 FEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYICLQVMERLKPQMLPSIMHISSAHVFQNASVLV  772 (974)
T ss_pred             eeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeeehHHHHHhhchhhhcchHHHHHHHccCCcceee
Confidence            333446678889999999999999977 57889999877654433332333333333        1          2357


Q ss_pred             EEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEec-------CCCcEEEee
Q 044997          348 ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLD-------DGLRAKVAD  420 (563)
Q Consensus       348 ~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~-------~~~~~kl~D  420 (563)
                      .+|.+.|+|.+++..     .+.++|.-...+..|+++-+++||.++   |||+||||+|.||.       ....++|+|
T Consensus       773 ~ey~~~Gtlld~~N~-----~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lID  844 (974)
T KOG1166|consen  773 SEYSPYGTLLDLINT-----NKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLID  844 (974)
T ss_pred             eeccccccHHHhhcc-----CCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEe
Confidence            899999999999873     567999999999999999999999998   99999999999994       235699999


Q ss_pred             cCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCC-
Q 044997          421 FGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE-  499 (563)
Q Consensus       421 FGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~-  499 (563)
                      ||.+-.+.--.+. ......++|-.+-.+|+..++.+             +.+.|-|.+..+++-|+-|+.--..++.. 
T Consensus       845 fG~siDm~lfp~~-~~F~~~~~td~f~C~EM~~grpW-------------tYq~DyfGlAa~~h~mLFG~y~q~~~g~~~  910 (974)
T KOG1166|consen  845 FGRSIDMKLFPDG-TKFKAVWHTDLFDCIEMREGRPW-------------TYQIDYFGLAATVHVMLFGKYMEVKNGSSW  910 (974)
T ss_pred             cccceeeeEcCCC-cEEeeeeccccchhHHHhcCCCC-------------chhhhhHHHHHHHHHHHHHHHHHhcCCcce
Confidence            9998654332222 23345678999999999988776             78999999999999999997442222211 


Q ss_pred             --chhhHHH--HHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcC
Q 044997          500 --PTKMKSL--ITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITS  542 (563)
Q Consensus       500 --~~~~~~~--~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~  542 (563)
                        ...++.+  -+...++...+|+.|-..=|...++...+++++...
T Consensus       911 ~~~~~~~Ry~~~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~~  957 (974)
T KOG1166|consen  911 MVKTNFPRYWKRDMWNKFFDLLLNPDCDTLPNLQELRTELEEVLAEH  957 (974)
T ss_pred             eccccchhhhhHHHHHHHHHHHhCcCcccchhHHHHHHHHHHHHHHH
Confidence              1111111  233556777777766666688888888888876543

>smart00090 RIO RIO-like kinase

Probab=99.67  E-value=4.6e-16  Score=152.80  Aligned_cols=127  Identities=17%  Similarity=0.137  Sum_probs=102.3

Q ss_pred             CCCccceecccCcEEEEEEE---ECCceEEEEEeccCCh---------------------------HHHHHHHHHHHhcc
Q 044997          293 NFDESRIIGRGGFGNVYFGL---LGDREAAIKKMRSNKS---------------------------KEFFAELKVLCKIH  342 (563)
Q Consensus       293 ~f~~~~~LG~G~fG~Vy~g~---~~~~~vavK~~~~~~~---------------------------~~f~~Ei~~l~~l~  342 (563)
                      .|...+.||+|+||.||+|.   .+++.||+|.++....                           ..+.+|++.+.++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            47788999999999999998   3689999998864320                           12567999999887


Q ss_pred             ccc-------------eEEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeE
Q 044997          343 HIN-------------VFISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNIL  409 (563)
Q Consensus       343 H~n-------------iV~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NIL  409 (563)
                      |..             +|+||+++++|..+...     ...+...+...++.|++.+|.|||+++  .++||||||+||+
T Consensus       109 ~~~i~~p~~~~~~~~~lV~E~~~g~~L~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp~NIl  181 (237)
T smart00090      109 EAGVPVPKPIAWRRNVLVMEFIGGDGLPAPRLK-----DVEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSEYNIL  181 (237)
T ss_pred             hcCCCCCeeeEecCceEEEEEecCCcccccccc-----cCCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCChhhEE
Confidence            522             57899999888776532     233555667889999999999999985  4999999999999


Q ss_pred             ecCCCcEEEeecCCCccc
Q 044997          410 LDDGLRAKVADFGLVKLE  427 (563)
Q Consensus       410 l~~~~~~kl~DFGla~~~  427 (563)
                      ++ +++++|+|||.+...
T Consensus       182 i~-~~~i~LiDFg~a~~~  198 (237)
T smart00090      182 VH-DGKVVIIDVSQSVEL  198 (237)
T ss_pred             EE-CCCEEEEEChhhhcc
Confidence            99 889999999998743

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.65  E-value=5.3e-16  Score=149.66  Aligned_cols=116  Identities=21%  Similarity=0.370  Sum_probs=99.0

Q ss_pred             ceecccCcEEEEEEEECCceEEEEEeccCC-----------hHHHHHHHHHHHhccccce---------------EEEee
Q 044997          298 RIIGRGGFGNVYFGLLGDREAAIKKMRSNK-----------SKEFFAELKVLCKIHHINV---------------FISTF  351 (563)
Q Consensus       298 ~~LG~G~fG~Vy~g~~~~~~vavK~~~~~~-----------~~~f~~Ei~~l~~l~H~ni---------------V~e~~  351 (563)
                      +.||+|++|.||+|.+.+..+++|+.....           ...+.+|++++.+++|+++               ++||+
T Consensus         2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   81 (211)
T PRK14879          2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYI   81 (211)
T ss_pred             cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEe
Confidence            578999999999999999999999865321           1357789999999988764               67999


Q ss_pred             cCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcc
Q 044997          352 GNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKL  426 (563)
Q Consensus       352 ~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~  426 (563)
                      ++++|.+++..        ..+ .+..++.+++.+|.+||+.+   ++|+|++|+|||++ ++.++|+|||.++.
T Consensus        82 ~G~~L~~~~~~--------~~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         82 EGEPLKDLINS--------NGM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             CCcCHHHHHHh--------ccH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            99999888753        112 78899999999999999997   99999999999999 78999999999875

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.65  E-value=1.4e-15  Score=145.52  Aligned_cols=129  Identities=18%  Similarity=0.151  Sum_probs=101.8

Q ss_pred             HHHHHhcCCCccceecccCcEEEEEEEE-CCceEEEEEeccCC-------------------------hHHHHHHHHHHH
Q 044997          286 EIEEATNNFDESRIIGRGGFGNVYFGLL-GDREAAIKKMRSNK-------------------------SKEFFAELKVLC  339 (563)
Q Consensus       286 el~~~~~~f~~~~~LG~G~fG~Vy~g~~-~~~~vavK~~~~~~-------------------------~~~f~~Ei~~l~  339 (563)
                      ++...-..|...+.||+|+||.||++.. +++.+|||+++...                         ...+..|..++.
T Consensus         9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   88 (198)
T cd05144           9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK   88 (198)
T ss_pred             HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence            3444333477789999999999999988 58899999865321                         113567888898


Q ss_pred             hccccc-------------eEEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCC
Q 044997          340 KIHHIN-------------VFISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTS  406 (563)
Q Consensus       340 ~l~H~n-------------iV~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~  406 (563)
                      +++|++             +|+||+++++|.+....           .....++.+++.++.++|+++   ++||||||+
T Consensus        89 ~l~~~~i~v~~~~~~~~~~lv~e~~~g~~L~~~~~~-----------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~  154 (198)
T cd05144          89 ALYEEGFPVPKPIDWNRHAVVMEYIDGVELYRVRVL-----------EDPEEVLDEILEEIVKAYKHG---IIHGDLSEF  154 (198)
T ss_pred             HHHHcCCCCCceeecCCceEEEEEeCCcchhhcccc-----------ccHHHHHHHHHHHHHHHHHCC---CCcCCCCcc
Confidence            887763             37899999888765321           234578899999999999987   999999999


Q ss_pred             CeEecCCCcEEEeecCCCcccc
Q 044997          407 NILLDDGLRAKVADFGLVKLEE  428 (563)
Q Consensus       407 NILl~~~~~~kl~DFGla~~~~  428 (563)
                      ||+++++++++|+|||++....
T Consensus       155 Nill~~~~~~~liDfg~~~~~~  176 (198)
T cd05144         155 NILVDDDEKIYIIDWPQMVSTD  176 (198)
T ss_pred             cEEEcCCCcEEEEECCccccCC
Confidence            9999999999999999986543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.64  E-value=7.8e-17  Score=166.90  Aligned_cols=166  Identities=25%  Similarity=0.367  Sum_probs=123.9

Q ss_pred             ccceEEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecC
Q 044997          343 HINVFISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFG  422 (563)
Q Consensus       343 H~niV~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFG  422 (563)
                      |++|.|+++..++|.+||..+.  .....+|...+.++.|++.|++|   ++   .+|||+||.||+...+..+||.|||
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~--~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFg  401 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRR--TGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFG  401 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCC--cccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhh
Confidence            5667788899999999997542  33557889999999999999999   55   8999999999999999999999999


Q ss_pred             CCccccccc---ccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCCCcCC--
Q 044997          423 LVKLEERTN---EKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIRD--  496 (563)
Q Consensus       423 la~~~~~~~---~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p~~~~--  496 (563)
                      +........   ......+.-+||..||+||.+.+..|             +.|+||||+|++|+|++. -..++...  
T Consensus       402 l~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y-------------~~kvdIyaLGlil~EL~~~f~T~~er~~t  468 (516)
T KOG1033|consen  402 LVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQY-------------SEKVDIYALGLILAELLIQFSTQFERIAT  468 (516)
T ss_pred             heeecccCCcccchhhhhhhcccccccCCHHHHhhhhh-------------hhhcchhhHHHHHHHHHHHhccHHHHHHh
Confidence            976544332   01123355689999999999876655             899999999999999998 33333211  


Q ss_pred             ------CCCchhhHHHHHHHHHHHHHhhccCCCCCCCHH
Q 044997          497 ------DSEPTKMKSLITIMAAVAEWCLNEDAVDRPEMR  529 (563)
Q Consensus       497 ------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~  529 (563)
                            ...+.....-.+.-..++.+++.+.|.+||++.
T Consensus       469 ~~d~r~g~ip~~~~~d~p~e~~ll~~lls~~p~~RP~~~  507 (516)
T KOG1033|consen  469 LTDIRDGIIPPEFLQDYPEEYTLLQQLLSPSPEERPSAI  507 (516)
T ss_pred             hhhhhcCCCChHHhhcCcHHHHHHHHhcCCCcccCchHH
Confidence                  111111111112246789999999999999443

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.64  E-value=6.7e-16  Score=147.58  Aligned_cols=113  Identities=22%  Similarity=0.346  Sum_probs=94.6

Q ss_pred             eecccCcEEEEEEEECCceEEEEEeccCC-----------hHHHHHHHHHHHhccccce---------------EEEeec
Q 044997          299 IIGRGGFGNVYFGLLGDREAAIKKMRSNK-----------SKEFFAELKVLCKIHHINV---------------FISTFG  352 (563)
Q Consensus       299 ~LG~G~fG~Vy~g~~~~~~vavK~~~~~~-----------~~~f~~Ei~~l~~l~H~ni---------------V~e~~~  352 (563)
                      .||+|+||.||+|.+.+..+++|......           .+++.+|++++.+++|+++               |+||++
T Consensus         1 ~ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~   80 (199)
T TIGR03724         1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIE   80 (199)
T ss_pred             CCCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEEC
Confidence            48999999999999999999999864321           1457789999999987653               689999


Q ss_pred             CCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccc
Q 044997          353 NGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLE  427 (563)
Q Consensus       353 ~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~  427 (563)
                      +++|.+++...     ..       .++.+++.+|.+||+.+   ++|+|++|+||+++ +++++++|||+++..
T Consensus        81 g~~l~~~~~~~-----~~-------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~~  139 (199)
T TIGR03724        81 GKPLKDVIEEG-----ND-------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKYS  139 (199)
T ss_pred             CccHHHHHhhc-----HH-------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence            99998876531     10       78999999999999987   99999999999999 889999999998753

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK10345 hypothetical protein; Provisional

Probab=99.63  E-value=1.2e-15  Score=146.48  Aligned_cols=119  Identities=19%  Similarity=0.171  Sum_probs=88.1

Q ss_pred             CCccceecccCcEEEEEEEECCceEEEEEeccC---ChHHHHHHHHHHHhc-----cccceE------------------
Q 044997          294 FDESRIIGRGGFGNVYFGLLGDREAAIKKMRSN---KSKEFFAELKVLCKI-----HHINVF------------------  347 (563)
Q Consensus       294 f~~~~~LG~G~fG~Vy~g~~~~~~vavK~~~~~---~~~~f~~Ei~~l~~l-----~H~niV------------------  347 (563)
                      ....+.||+|+||.||.-. .....+||++...   ..+++.+|+++++++     +||||+                  
T Consensus         4 L~~~~~LG~G~~~~Vy~hp-~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~   82 (210)
T PRK10345          4 LSEQSPLGTGRHRKCYAHP-EDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV   82 (210)
T ss_pred             cCCcceecCCCceEEEECC-CCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence            3456889999999999622 2233479988654   456799999999999     579972                  


Q ss_pred             -EEe--ecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHH-HHHHhcCCCceEeCCCCCCCeEecC----CCcEEEe
Q 044997          348 -IST--FGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGI-EYIHDHTKARYVHRDIKTSNILLDD----GLRAKVA  419 (563)
Q Consensus       348 -~e~--~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL-~yLH~~~~~~ivHrDLk~~NILl~~----~~~~kl~  419 (563)
                       +||  ...|+|.+++.+      ..+++.  ..++.+++.++ +|||+++   |+||||||+|||++.    +++++|+
T Consensus        83 I~e~~G~~~~tL~~~l~~------~~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~Li  151 (210)
T PRK10345         83 IADFDGKPSITLTEFAEQ------CRYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVC  151 (210)
T ss_pred             EecCCCCcchhHHHHHHc------ccccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEE
Confidence             455  235778777753      124444  35677888888 9999998   999999999999974    3489999


Q ss_pred             ecCCC
Q 044997          420 DFGLV  424 (563)
Q Consensus       420 DFGla  424 (563)
                      ||+-+
T Consensus       152 Dg~G~  156 (210)
T PRK10345        152 DNIGE  156 (210)
T ss_pred             ECCCC
Confidence            95443

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.61  E-value=1.6e-15  Score=166.88  Aligned_cols=121  Identities=25%  Similarity=0.360  Sum_probs=98.3

Q ss_pred             HHhcCCCccceecccCcEEEEEEEECCceEEEEEeccC-----------ChHHHHHHHHHHHhccccce-----------
Q 044997          289 EATNNFDESRIIGRGGFGNVYFGLLGDREAAIKKMRSN-----------KSKEFFAELKVLCKIHHINV-----------  346 (563)
Q Consensus       289 ~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~vavK~~~~~-----------~~~~f~~Ei~~l~~l~H~ni-----------  346 (563)
                      .....|...+.||+|+||.||+|.+.+..+++|+....           ..+++.+|++++.+++|+++           
T Consensus       330 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~  409 (535)
T PRK09605        330 EVKRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE  409 (535)
T ss_pred             ccccccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC
Confidence            33445567899999999999999998777766653211           12458899999999999875           


Q ss_pred             ----EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecC
Q 044997          347 ----FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFG  422 (563)
Q Consensus       347 ----V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFG  422 (563)
                          |+||+++++|.+++.             ....++.+++++|.|||+.+   ++||||||+|||+ +++.++|+|||
T Consensus       410 ~~~lv~E~~~g~~L~~~l~-------------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFG  472 (535)
T PRK09605        410 EKTIVMEYIGGKDLKDVLE-------------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFG  472 (535)
T ss_pred             CCEEEEEecCCCcHHHHHH-------------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCc
Confidence                578888888877664             34678999999999999997   9999999999999 67799999999


Q ss_pred             CCcc
Q 044997          423 LVKL  426 (563)
Q Consensus       423 la~~  426 (563)
                      +++.
T Consensus       473 la~~  476 (535)
T PRK09605        473 LGKY  476 (535)
T ss_pred             cccc
Confidence            9874

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.54  E-value=4.1e-14  Score=133.74  Aligned_cols=121  Identities=19%  Similarity=0.252  Sum_probs=90.4

Q ss_pred             cceecccCcEEEEEEEEC-CceEEEEEeccCCh-----HHH----------------------HHHHHHHHhcccc----
Q 044997          297 SRIIGRGGFGNVYFGLLG-DREAAIKKMRSNKS-----KEF----------------------FAELKVLCKIHHI----  344 (563)
Q Consensus       297 ~~~LG~G~fG~Vy~g~~~-~~~vavK~~~~~~~-----~~f----------------------~~Ei~~l~~l~H~----  344 (563)
                      .+.||+|+||.||+|... ++.||||.++....     ..+                      ..|.+.+.++++.    
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            467999999999999886 88999998765321     111                      2466666665443    


Q ss_pred             ---------ceEEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCceEeCCCCCCCeEecCCC
Q 044997          345 ---------NVFISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHD-HTKARYVHRDIKTSNILLDDGL  414 (563)
Q Consensus       345 ---------niV~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDLk~~NILl~~~~  414 (563)
                               .+|+||+++|.+........     ... .+...++.+++.++.++|. ++   ++||||||+||+++ ++
T Consensus        82 ~~~~~~~~~~lv~e~~~g~~~~~~~l~~~-----~~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~-~~  151 (187)
T cd05119          82 PKPIDLNRHVLVMEFIGGDGIPAPRLKDV-----RLL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD-DG  151 (187)
T ss_pred             CceEecCCCEEEEEEeCCCCccChhhhhh-----hhc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-CC
Confidence                     35899999976543221110     011 5677899999999999998 76   99999999999999 89


Q ss_pred             cEEEeecCCCccc
Q 044997          415 RAKVADFGLVKLE  427 (563)
Q Consensus       415 ~~kl~DFGla~~~  427 (563)
                      .++|+|||.+...
T Consensus       152 ~~~liDfg~a~~~  164 (187)
T cd05119         152 KVYIIDVPQAVEI  164 (187)
T ss_pred             cEEEEECcccccc
Confidence            9999999998643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.51  E-value=9.4e-14  Score=136.65  Aligned_cols=117  Identities=24%  Similarity=0.363  Sum_probs=93.4

Q ss_pred             cceec-ccCcEEEEEEEECCceEEEEEeccC----------------ChHHHHHHHHHHHhccccc--------------
Q 044997          297 SRIIG-RGGFGNVYFGLLGDREAAIKKMRSN----------------KSKEFFAELKVLCKIHHIN--------------  345 (563)
Q Consensus       297 ~~~LG-~G~fG~Vy~g~~~~~~vavK~~~~~----------------~~~~f~~Ei~~l~~l~H~n--------------  345 (563)
                      ...|| .||.|+||+....+..++||++...                ....+.+|++++.+++|++              
T Consensus        36 ~~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~  115 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH  115 (239)
T ss_pred             CceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence            46788 8999999999999999999987531                1245788999999998866              


Q ss_pred             -------eEEEeecC-CCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEE
Q 044997          346 -------VFISTFGN-GSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAK  417 (563)
Q Consensus       346 -------iV~e~~~~-gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~k  417 (563)
                             +|+|++++ .+|.+++..      .+++..    .+.+++.+|.+||+.+   |+||||||+|||++.++.++
T Consensus       116 ~~~~~~~lV~e~l~G~~~L~~~l~~------~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~  182 (239)
T PRK01723        116 GLFYRADILIERIEGARDLVALLQE------APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFW  182 (239)
T ss_pred             CcceeeeEEEEecCCCCCHHHHHhc------CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEE
Confidence                   35677775 577776643      234433    3568999999999998   99999999999999999999


Q ss_pred             EeecCCCcc
Q 044997          418 VADFGLVKL  426 (563)
Q Consensus       418 l~DFGla~~  426 (563)
                      |+|||.++.
T Consensus       183 LIDfg~~~~  191 (239)
T PRK01723        183 LIDFDRGEL  191 (239)
T ss_pred             EEECCCccc
Confidence            999998864

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.47  E-value=5.2e-13  Score=120.29  Aligned_cols=128  Identities=18%  Similarity=0.215  Sum_probs=95.4

Q ss_pred             ccceecccCcEEEEEEEECCceEEEEEeccCC-hHHHHHHHHHHHhcccc--ce--EEEeecCCC----ccccccccccc
Q 044997          296 ESRIIGRGGFGNVYFGLLGDREAAIKKMRSNK-SKEFFAELKVLCKIHHI--NV--FISTFGNGS----LSDHLHDPLLK  366 (563)
Q Consensus       296 ~~~~LG~G~fG~Vy~g~~~~~~vavK~~~~~~-~~~f~~Ei~~l~~l~H~--ni--V~e~~~~gs----L~~~L~~~~~~  366 (563)
                      +.+.||+|.++.||++...+..+++|..+... ..++.+|+..+.+++|.  ++  +..+...++    +.+++....  
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~--   79 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKDEDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGET--   79 (155)
T ss_pred             cceecccccccceEEEEecCCeEEEEecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCee--
Confidence            35789999999999999988899999987654 36788999999999764  32  122222111    122221110  


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcc
Q 044997          367 GHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKL  426 (563)
Q Consensus       367 ~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~  426 (563)
                       ...+++.....++.+++++|++||.....+++|+|++|+||++++++.+++.|||.++.
T Consensus        80 -~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          80 -LDEVSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             -cccCCHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence             01125677788999999999999986555699999999999999989999999999874

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.36  E-value=6.2e-14  Score=154.42  Aligned_cols=224  Identities=25%  Similarity=0.357  Sum_probs=163.3

Q ss_pred             cCCCccceecccCcEEEEEEEEC---CceEEEEEeccCC-----hHHHHHHHHHHHhcc-ccceE---------------
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG---DREAAIKKMRSNK-----SKEFFAELKVLCKIH-HINVF---------------  347 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~---~~~vavK~~~~~~-----~~~f~~Ei~~l~~l~-H~niV---------------  347 (563)
                      ..|...+.||+|+|+.|-.....   ...+|+|.+....     .+....|..+-.++. |.|++               
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~   99 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS   99 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence            34566677999999999877552   3456666664332     122334666666666 98874               


Q ss_pred             EEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCceEeCCCCCCCeEecCCC-cEEEeecCCCc
Q 044997          348 ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIH-DHTKARYVHRDIKTSNILLDDGL-RAKVADFGLVK  425 (563)
Q Consensus       348 ~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~~ivHrDLk~~NILl~~~~-~~kl~DFGla~  425 (563)
                      .+|..+|++.+.+..   ......+....-.+..|+..++.|+| +.+   +.|||+||+|.+++..+ ..|++|||+|.
T Consensus       100 ~~~s~g~~~f~~i~~---~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At  173 (601)
T KOG0590|consen  100 LSYSDGGSLFSKISH---PDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLAT  173 (601)
T ss_pred             cCccccccccccccc---CCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhc
Confidence            466677777777621   11113555566778999999999999 776   99999999999999999 99999999998


Q ss_pred             ccccccccccccccccC-CCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc----
Q 044997          426 LEERTNEKEMLATRLVG-TPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP----  500 (563)
Q Consensus       426 ~~~~~~~~~~~~~~~~g-t~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~----  500 (563)
                      .....+..........| ++.|+|||...+..|            ..+..|+||.|+++.-+++|..|+.......    
T Consensus       174 ~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~------------~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~  241 (601)
T KOG0590|consen  174 AYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAY------------RGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYS  241 (601)
T ss_pred             cccccCCcceeeecccCCCCCCCCcccccchhh------------cCCCcccccccccccccccCCCCccccccccccce
Confidence            76552333334445678 999999998876544            2788999999999999999999975433221    


Q ss_pred             -----------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          501 -----------TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       501 -----------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                                 .....+.....++..+++..+|..|.+.+++..
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~  285 (601)
T KOG0590|consen  242 SWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL  285 (601)
T ss_pred             eecccccccccCccccCChhhhhcccccccCCchhccccccccc
Confidence                       122344455788888899999999999888754

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.33  E-value=9.1e-12  Score=133.08  Aligned_cols=126  Identities=19%  Similarity=0.236  Sum_probs=92.8

Q ss_pred             cCCCccceecccCcEEEEEEEE-CCceEEEEEeccCChHH----------------------------------------
Q 044997          292 NNFDESRIIGRGGFGNVYFGLL-GDREAAIKKMRSNKSKE----------------------------------------  330 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~-~~~~vavK~~~~~~~~~----------------------------------------  330 (563)
                      ..|+ .+.||.|++|.||+|++ +|+.||||+.++...+.                                        
T Consensus       118 ~~fd-~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~  196 (437)
T TIGR01982       118 AEFE-EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRR  196 (437)
T ss_pred             hhCC-CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHH
Confidence            3444 36899999999999998 58999999987653322                                        


Q ss_pred             ---HHHHHHHHHhcc-----ccc---------------eEEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHH-H
Q 044997          331 ---FFAELKVLCKIH-----HIN---------------VFISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAK-G  386 (563)
Q Consensus       331 ---f~~Ei~~l~~l~-----H~n---------------iV~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~-g  386 (563)
                         |.+|.+.+.++.     +++               +||||+++++|.+.....    ....   .+.+++..++. .
T Consensus       197 Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~----~~~~---~~~~ia~~~~~~~  269 (437)
T TIGR01982       197 ELDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALD----EAGL---DRKALAENLARSF  269 (437)
T ss_pred             HHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHH----hcCC---CHHHHHHHHHHHH
Confidence               334444444442     222               478999999998876431    1112   24456777666 4


Q ss_pred             HHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccc
Q 044997          387 IEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEE  428 (563)
Q Consensus       387 L~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~  428 (563)
                      +..+|..+   ++|+|++|.||+++++++++++|||++..+.
T Consensus       270 l~ql~~~g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       270 LNQVLRDG---FFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             HHHHHhCC---ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            78899887   9999999999999999999999999987654

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.23  E-value=1.4e-11  Score=120.81  Aligned_cols=173  Identities=17%  Similarity=0.266  Sum_probs=118.8

Q ss_pred             EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcc
Q 044997          347 FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKL  426 (563)
Q Consensus       347 V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~  426 (563)
                      +.|||..|++.++|+... +....+......+++-||..||.|||+. .|+|+|+++..+-|++..++-+|+.--.-...
T Consensus       150 iteymssgs~~~fLkrt~-~~~~a~~~~~wkkw~tqIlsal~yLhs~-~PpiihgnlTc~tifiq~ngLIkig~~ap~s~  227 (458)
T KOG1266|consen  150 ITEYMSSGSLKQFLKRTK-KNQKALFQKAWKKWCTQILSALSYLHSC-DPPIIHGNLTCDTIFIQHNGLIKIGSVAPDST  227 (458)
T ss_pred             EEecccchhHHHHHHHHH-HhhhhhhHHHHHHHHHHHHhhhhhhhcc-CCccccCCcchhheeecCCceEEecccCcccc
Confidence            469999999999998643 2345688888889999999999999997 57799999999999999998888753111000


Q ss_pred             ccccc-ccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCchhhHH
Q 044997          427 EERTN-EKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKMKS  505 (563)
Q Consensus       427 ~~~~~-~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~~~~~  505 (563)
                      -.... ........-.+-++|.+||+             ......+.++|||+||...+||.-+.--.............
T Consensus       228 h~s~~~~~~~Ek~~~~~~~g~~a~~s-------------g~~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~  294 (458)
T KOG1266|consen  228 HPSVNSTREAEKSVNTSLPGFSAPES-------------GTTTNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEEN  294 (458)
T ss_pred             chhhhhhhHhhhhccccCCccccCCc-------------CcccccccchhhhhhhHHHHHHHHheeccCCCcceeehhhh
Confidence            00000 00111122346789999994             34455678999999999999998776432211111111111


Q ss_pred             H--------HHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          506 L--------ITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       506 ~--------~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                      .        ...=++++..|++.+|..||+|++++..
T Consensus       295 ia~~i~~len~lqr~~i~kcl~~eP~~rp~ar~llfH  331 (458)
T KOG1266|consen  295 IANVIIGLENGLQRGSITKCLEGEPNGRPDARLLLFH  331 (458)
T ss_pred             hhhheeeccCccccCcCcccccCCCCCCcchhhhhcC
Confidence            1        0113567889999999999999998764

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.21  E-value=6.8e-11  Score=109.64  Aligned_cols=116  Identities=13%  Similarity=0.060  Sum_probs=87.1

Q ss_pred             cceecccCcEEEEEEEECCceEEEEEeccCC--hHHHHHHHHHHHhccccce--------------EEEeecCCCccccc
Q 044997          297 SRIIGRGGFGNVYFGLLGDREAAIKKMRSNK--SKEFFAELKVLCKIHHINV--------------FISTFGNGSLSDHL  360 (563)
Q Consensus       297 ~~~LG~G~fG~Vy~g~~~~~~vavK~~~~~~--~~~f~~Ei~~l~~l~H~ni--------------V~e~~~~gsL~~~L  360 (563)
                      .+.|+.|.++.||++...++.+++|......  ...+.+|+++++.+.+.++              |+|++++.++.+. 
T Consensus         3 ~~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~~~~~~lv~e~i~G~~l~~~-   81 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVANKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFDPETGVLITEFIEGSELLTE-   81 (170)
T ss_pred             eeecCCcccCceEEEEECCeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEeCCCCeEEEEecCCCccccc-
Confidence            4578899999999999999999999976553  3456789999988865443              4455555444321 


Q ss_pred             ccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCceEeCCCCCCCeEecCCCcEEEeecCCCcc
Q 044997          361 HDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHT--KARYVHRDIKTSNILLDDGLRAKVADFGLVKL  426 (563)
Q Consensus       361 ~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~  426 (563)
                                  ......++.+++++|+.||..+  ...++|+|++|.||+++ +++++++|||.+..
T Consensus        82 ------------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          82 ------------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             ------------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence                        0112345679999999999876  23469999999999999 66899999998763

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.03  E-value=2.1e-10  Score=121.60  Aligned_cols=220  Identities=25%  Similarity=0.239  Sum_probs=153.1

Q ss_pred             CCCccceecc--cCcEEEEEEEE----CCceEEEEEecc-----CChHHHHHHHHHHHhc-cccceEE------------
Q 044997          293 NFDESRIIGR--GGFGNVYFGLL----GDREAAIKKMRS-----NKSKEFFAELKVLCKI-HHINVFI------------  348 (563)
Q Consensus       293 ~f~~~~~LG~--G~fG~Vy~g~~----~~~~vavK~~~~-----~~~~~f~~Ei~~l~~l-~H~niV~------------  348 (563)
                      .|...+.+|.  |.+|.||.+..    .+..+|+|+-+.     .....=.+|+....++ .|+|.|.            
T Consensus       115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf  194 (524)
T KOG0601|consen  115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF  194 (524)
T ss_pred             hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence            4666788999  99999999876    356788887321     1223334566655555 3666643            


Q ss_pred             --EeecCCCcccccccccccCCCCCCHHHHHHHHHHHHH----HHHHHHhcCCCceEeCCCCCCCeEecCC-CcEEEeec
Q 044997          349 --STFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAK----GIEYIHDHTKARYVHRDIKTSNILLDDG-LRAKVADF  421 (563)
Q Consensus       349 --e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~----gL~yLH~~~~~~ivHrDLk~~NILl~~~-~~~kl~DF  421 (563)
                        ...++.+|.++.+..    ...++....+.+..+...    ||.++|+..   ++|-|+||.||++.++ ...++.||
T Consensus       195 iqtE~~~~sl~~~~~~~----~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df  267 (524)
T KOG0601|consen  195 IQTELCGESLQSYCHTP----CNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDF  267 (524)
T ss_pred             eeeccccchhHHhhhcc----cccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCc
Confidence              233445666666542    233555666667777777    999999987   9999999999999999 88999999


Q ss_pred             CCCcccccccccc--cccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCC--C
Q 044997          422 GLVKLEERTNEKE--MLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRD--D  497 (563)
Q Consensus       422 Gla~~~~~~~~~~--~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~--~  497 (563)
                      |+...+...+-..  ....+..|...|++||..              .+.++.+.|+|++|.+..|..++...+...  .
T Consensus       268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~--------------~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~  333 (524)
T KOG0601|consen  268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL--------------NGLATFASDIFSLGEVILEAILGSHLPSVGKNS  333 (524)
T ss_pred             ceeEEccCCccccceeeeecCCCCceEeChhhh--------------ccccchHhhhcchhhhhHhhHhhcccccCCCCC
Confidence            9988766543211  111233577789999976              455689999999999999999987665332  1


Q ss_pred             -C--------CchhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          498 -S--------EPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       498 -~--------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                       .        ..+........+...+..+++.+|..|++.+.+..
T Consensus       334 ~W~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  334 SWSQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             CccccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence             1        11111222334666889999999999999887764

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=98.97  E-value=5.8e-09  Score=98.72  Aligned_cols=120  Identities=18%  Similarity=0.207  Sum_probs=87.2

Q ss_pred             ceecccCcEEEEEEEEC--------CceEEEEEeccC-------------C------------hHHHH----HHHHHHHh
Q 044997          298 RIIGRGGFGNVYFGLLG--------DREAAIKKMRSN-------------K------------SKEFF----AELKVLCK  340 (563)
Q Consensus       298 ~~LG~G~fG~Vy~g~~~--------~~~vavK~~~~~-------------~------------~~~f~----~Ei~~l~~  340 (563)
                      ..||.|.-+.||.|.-.        +..+|||..+..             .            .+.+.    +|.+.|++
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            46899999999999754        368999975411             0            11222    78899988


Q ss_pred             ccccc-------------eEEEeecCCCccc-ccccccccCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCceEeCCCCC
Q 044997          341 IHHIN-------------VFISTFGNGSLSD-HLHDPLLKGHQPLTWTARTQIALDAAKGIEYI-HDHTKARYVHRDIKT  405 (563)
Q Consensus       341 l~H~n-------------iV~e~~~~gsL~~-~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~ivHrDLk~  405 (563)
                      +....             |||||++++.+.. .|.+      ..++..+...+..+++.+|.+| |..+   +||+||++
T Consensus        83 l~~~Gv~vP~pi~~~~~~lvME~Ig~~~~~~~~Lkd------~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDLs~  153 (197)
T cd05146          83 MQKAGIPCPEVVVLKKHVLVMSFIGDDQVPAPKLKD------AKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADLSE  153 (197)
T ss_pred             HHHcCCCCCeEEEecCCEEEEEEcCCCCccchhhhc------cccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCCCH
Confidence            85422             4789998765432 2222      2344556677889999999999 7776   99999999


Q ss_pred             CCeEecCCCcEEEeecCCCccc
Q 044997          406 SNILLDDGLRAKVADFGLVKLE  427 (563)
Q Consensus       406 ~NILl~~~~~~kl~DFGla~~~  427 (563)
                      .|||++ ++.+.|+|||.+-..
T Consensus       154 ~NIL~~-~~~v~iIDF~qav~~  174 (197)
T cd05146         154 YNMLWH-DGKVWFIDVSQSVEP  174 (197)
T ss_pred             HHEEEE-CCcEEEEECCCceeC
Confidence            999997 468999999988644

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=98.94  E-value=2.5e-09  Score=116.02  Aligned_cols=129  Identities=17%  Similarity=0.244  Sum_probs=84.5

Q ss_pred             HhcCCCccceecccCcEEEEEEEEC--CceEEEEEeccCChH--------------------------------------
Q 044997          290 ATNNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNKSK--------------------------------------  329 (563)
Q Consensus       290 ~~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~--------------------------------------  329 (563)
                      .-.+|+. +.||+|++|.||+|++.  |+.||||+.+++..+                                      
T Consensus       118 ~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~  196 (537)
T PRK04750        118 WFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKT  196 (537)
T ss_pred             HHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHH
Confidence            3456776 78999999999999984  799999998754211                                      


Q ss_pred             -----HHHHHHHHHHhcc----ccc----------------eEEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHH
Q 044997          330 -----EFFAELKVLCKIH----HIN----------------VFISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAA  384 (563)
Q Consensus       330 -----~f~~Ei~~l~~l~----H~n----------------iV~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia  384 (563)
                           +|.+|+..+.+++    +.+                +||||+.++.+.+.-.-   . ....+   +..++...+
T Consensus       197 l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l---~-~~g~d---~~~la~~~v  269 (537)
T PRK04750        197 LHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAAL---R-AAGTD---MKLLAERGV  269 (537)
T ss_pred             HHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHH---H-hcCCC---HHHHHHHHH
Confidence                 1344554444442    211                47899999999764211   0 01111   112222222


Q ss_pred             H-HHHHHHhcCCCceEeCCCCCCCeEecCCC----cEEEeecCCCccccc
Q 044997          385 K-GIEYIHDHTKARYVHRDIKTSNILLDDGL----RAKVADFGLVKLEER  429 (563)
Q Consensus       385 ~-gL~yLH~~~~~~ivHrDLk~~NILl~~~~----~~kl~DFGla~~~~~  429 (563)
                      . -+.-++..+   ++|+|+||.||+++.++    ++++.|||++..+..
T Consensus       270 ~~~~~Qif~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        270 EVFFTQVFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             HHHHHHHHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            1 123334556   99999999999999888    999999999876543

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.81  E-value=1.6e-07  Score=95.82  Aligned_cols=160  Identities=20%  Similarity=0.298  Sum_probs=117.5

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccccccccccccccccCCCcccC
Q 044997          369 QPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLP  448 (563)
Q Consensus       369 ~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~A  448 (563)
                      ....|...++.++.+|.+.+-||++|   .+-+|++++|+|+.+++.+.|.|=.--...    ......-..+|...|.+
T Consensus       112 P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfqi~----~ng~~~~cpVg~~eftP  184 (637)
T COG4248         112 PHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQIN----ANGTLHLCPVGVSEFTP  184 (637)
T ss_pred             CccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccceeec----cCCceEecccCccccCC
Confidence            35789999999999999999999998   889999999999999999999984322111    11122234578999999


Q ss_pred             cccccccccccccccccccCCCCCcchHHHHHHHHHHHHcC-CCCCcCCCCC----------------------------
Q 044997          449 PEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG-KRALIRDDSE----------------------------  499 (563)
Q Consensus       449 PE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg-~~p~~~~~~~----------------------------  499 (563)
                      ||.-.-..+        ....-+...|-|.+||++++++.| ++|+.+....                            
T Consensus       185 PElQ~~~sf--------~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~ya~~~~~g~~p  256 (637)
T COG4248         185 PELQTLPSF--------VGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFAYASDQRRGLKP  256 (637)
T ss_pred             HHHhccccc--------cccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceeeechhccCCCCC
Confidence            997542322        233447889999999999999887 8887542210                            


Q ss_pred             ---chhhHHHHHHHHHHHHHhhcc--CCCCCCCHHHHHHHHHHhhhcCh
Q 044997          500 ---PTKMKSLITIMAAVAEWCLNE--DAVDRPEMRDIVAILSQIMITST  543 (563)
Q Consensus       500 ---~~~~~~~~~~l~~li~~cl~~--dP~~RPs~~evl~~L~~i~~~~~  543 (563)
                         ......+...+..|..+|+..  ++.-|||++.-+..|..+.++-.
T Consensus       257 ~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~  305 (637)
T COG4248         257 PPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLK  305 (637)
T ss_pred             CCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhh
Confidence               011233455588899999986  35689999999998887765443

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=98.80  E-value=7.3e-08  Score=93.09  Aligned_cols=124  Identities=20%  Similarity=0.278  Sum_probs=92.7

Q ss_pred             cceecccCcEEEEEEEECC-ceEEEEEeccCC----hHHHHHHHHHHHhccccc--------------------eEEEee
Q 044997          297 SRIIGRGGFGNVYFGLLGD-REAAIKKMRSNK----SKEFFAELKVLCKIHHIN--------------------VFISTF  351 (563)
Q Consensus       297 ~~~LG~G~fG~Vy~g~~~~-~~vavK~~~~~~----~~~f~~Ei~~l~~l~H~n--------------------iV~e~~  351 (563)
                      .+.|+.|..+.||++...+ +.+++|......    ..++.+|.+++..+++..                    +|+||+
T Consensus         3 ~~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i   82 (223)
T cd05154           3 VRQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV   82 (223)
T ss_pred             ceecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence            3578999999999998876 899999876543    457889999999886522                    245555


Q ss_pred             cCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcC-------------------------------------
Q 044997          352 GNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHT-------------------------------------  394 (563)
Q Consensus       352 ~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-------------------------------------  394 (563)
                      +++++.+.+..      ..++..++..++.++++.|.+||+..                                     
T Consensus        83 ~G~~l~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (223)
T cd05154          83 DGRVLRDRLLR------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPA  156 (223)
T ss_pred             CCEecCCCCCC------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHH
Confidence            55555443321      24677788888889999998888521                                     


Q ss_pred             ----------------CCceEeCCCCCCCeEecC--CCcEEEeecCCCcc
Q 044997          395 ----------------KARYVHRDIKTSNILLDD--GLRAKVADFGLVKL  426 (563)
Q Consensus       395 ----------------~~~ivHrDLk~~NILl~~--~~~~kl~DFGla~~  426 (563)
                                      ...++|+|+++.||+++.  ++.+.|+||+.+..
T Consensus       157 ~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         157 MERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                            245799999999999998  66789999998764

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=98.76  E-value=5.4e-08  Score=89.10  Aligned_cols=124  Identities=23%  Similarity=0.301  Sum_probs=91.3

Q ss_pred             ccceecccCcEEEEEEEECCceEEEEEeccC-----------ChHHHHHHHHHHHhccc-----cc----------eEEE
Q 044997          296 ESRIIGRGGFGNVYFGLLGDREAAIKKMRSN-----------KSKEFFAELKVLCKIHH-----IN----------VFIS  349 (563)
Q Consensus       296 ~~~~LG~G~fG~Vy~g~~~~~~vavK~~~~~-----------~~~~f~~Ei~~l~~l~H-----~n----------iV~e  349 (563)
                      ....|-||+-+.|+++.+.|+...||.-...           ..++..+|++.|.+++-     |-          |+||
T Consensus        11 ~l~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME   90 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYME   90 (229)
T ss_pred             cceeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEE
Confidence            4678999999999999999999888853221           12567789999998753     22          3678


Q ss_pred             eecC-CCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCC---cEEEeecCCCc
Q 044997          350 TFGN-GSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGL---RAKVADFGLVK  425 (563)
Q Consensus       350 ~~~~-gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~---~~kl~DFGla~  425 (563)
                      |+++ .++.+++.....   ....-.....++.++-+.+.-||..+   |+|+||..+||++.+++   .+.++|||++.
T Consensus        91 ~~~g~~~vk~~i~~~~~---~~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~  164 (229)
T KOG3087|consen   91 FIDGASTVKDFILSTME---DESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSS  164 (229)
T ss_pred             eccchhHHHHHHHHHcc---CcccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchh
Confidence            8866 366777654221   11222223678888899999999987   99999999999996554   45899999975

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.76  E-value=2.8e-09  Score=118.82  Aligned_cols=236  Identities=18%  Similarity=0.282  Sum_probs=152.6

Q ss_pred             hcCCCccceecccCcEEEEEEEEC--CceEEEEEe------ccCChHHHHHHHHHHHhccccc---------------eE
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLLG--DREAAIKKM------RSNKSKEFFAELKVLCKIHHIN---------------VF  347 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~------~~~~~~~f~~Ei~~l~~l~H~n---------------iV  347 (563)
                      .+.|...+-+.+|.++.++.+.-.  +...++|..      ...+.+....+-.++-..+||-               ++
T Consensus       803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~  882 (1205)
T KOG0606|consen  803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLV  882 (1205)
T ss_pred             CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchh
Confidence            345666677888999998876442  222222221      1222222223333333223333               35


Q ss_pred             EEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccc
Q 044997          348 ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLE  427 (563)
Q Consensus       348 ~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~  427 (563)
                      ++|+.+|+|...|+..     ...+..-.......+..+++|||...   +.|||++|.|+|+..+++.+++|||.....
T Consensus       883 ~~~~~~~~~~Skl~~~-----~~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v  954 (1205)
T KOG0606|consen  883 GHYLNGGDLPSKLHNS-----GCLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKV  954 (1205)
T ss_pred             hHHhccCCchhhhhcC-----CCcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCcccccccc
Confidence            6788888888888752     23443334445567788999999875   899999999999999999999999843211


Q ss_pred             cc---------------------ccc-----c--ccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHH
Q 044997          428 ER---------------------TNE-----K--EMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAF  479 (563)
Q Consensus       428 ~~---------------------~~~-----~--~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSf  479 (563)
                      ..                     ...     .  ........||+.|.+||...+...             ...+|+|++
T Consensus       955 g~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~h-------------gs~ad~~~~ 1021 (1205)
T KOG0606|consen  955 GLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRH-------------GSAADWWSS 1021 (1205)
T ss_pred             ccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccC-------------CCcchhhhh
Confidence            10                     000     0  011233679999999999877654             788999999


Q ss_pred             HHHHHHHHcCCCCCcCCCCCc-------------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcChhhh
Q 044997          480 GVVLAELITGKRALIRDDSEP-------------TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITSTEWE  546 (563)
Q Consensus       480 Gvvl~Elltg~~p~~~~~~~~-------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~w~  546 (563)
                      |++++|.++|..||.......             .........+.+++...+..+|.+|-.+.--.+.=..-+....+|+
T Consensus      1022 g~~l~e~l~g~pp~na~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~~ 1101 (1205)
T KOG0606|consen 1022 GVCLFEVLTGIPPFNAETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDWE 1101 (1205)
T ss_pred             hhhhhhhhcCCCCCCCcchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCcc
Confidence            999999999999986543321             1122334558889999999999999777644443333444555665


Q ss_pred             c
Q 044997          547 A  547 (563)
Q Consensus       547 ~  547 (563)
                      .
T Consensus      1102 ~ 1102 (1205)
T KOG0606|consen 1102 N 1102 (1205)
T ss_pred             c
Confidence            5

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=98.75  E-value=6e-08  Score=89.18  Aligned_cols=113  Identities=24%  Similarity=0.360  Sum_probs=88.2

Q ss_pred             ceecccCcEEEEEEEECCceEEEEEeccC-----------ChHHHHHHHHHHHhccc-------------cc--eEEEee
Q 044997          298 RIIGRGGFGNVYFGLLGDREAAIKKMRSN-----------KSKEFFAELKVLCKIHH-------------IN--VFISTF  351 (563)
Q Consensus       298 ~~LG~G~fG~Vy~g~~~~~~vavK~~~~~-----------~~~~f~~Ei~~l~~l~H-------------~n--iV~e~~  351 (563)
                      ..+++|+-..+|.+.+.|.++++|.=.+.           ..++-.+|..++.+++-             .|  |+|||+
T Consensus         2 ~~i~~GAEa~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I   81 (204)
T COG3642           2 DLIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI   81 (204)
T ss_pred             chhhCCcceeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence            35789999999999988878777743211           12446679999988743             23  589999


Q ss_pred             cCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcc
Q 044997          352 GNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKL  426 (563)
Q Consensus       352 ~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~  426 (563)
                      ++..|.+.+...            +..++..+-.-+.-||..+   |+|+||.++||++.++. +.++|||++..
T Consensus        82 ~G~~lkd~l~~~------------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          82 EGELLKDALEEA------------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             CChhHHHHHHhc------------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence            999988888651            2456777777888899998   99999999999998775 99999999873

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.69  E-value=9.8e-09  Score=109.07  Aligned_cols=225  Identities=20%  Similarity=0.228  Sum_probs=148.9

Q ss_pred             HHHHhcCCCccceecccCcEEEEEEEEC---CceEEEEEeccCCh---------HHHHHHHHHHHhccccc--eE-----
Q 044997          287 IEEATNNFDESRIIGRGGFGNVYFGLLG---DREAAIKKMRSNKS---------KEFFAELKVLCKIHHIN--VF-----  347 (563)
Q Consensus       287 l~~~~~~f~~~~~LG~G~fG~Vy~g~~~---~~~vavK~~~~~~~---------~~f~~Ei~~l~~l~H~n--iV-----  347 (563)
                      ....+.+|.+...||.|.|+.|+....+   +..+++|.+.....         .+...|+.+...+++.+  ..     
T Consensus       260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r  339 (524)
T KOG0601|consen  260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR  339 (524)
T ss_pred             ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccc
Confidence            4445678999999999999999987653   56778887654321         12222333333333333  11     


Q ss_pred             -----EEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCC-CcEEEeec
Q 044997          348 -----ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDG-LRAKVADF  421 (563)
Q Consensus       348 -----~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~-~~~kl~DF  421 (563)
                           -||+.++++.....-     ...++...++++..+++.++.++|+..   ++|+|+||+||++..+ +..++.||
T Consensus       340 ~~~ip~e~~~~~s~~l~~~~-----~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~  411 (524)
T KOG0601|consen  340 QGYIPLEFCEGGSSSLRSVT-----SQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDF  411 (524)
T ss_pred             cccCchhhhcCcchhhhhHH-----HHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhcccc
Confidence                 256666665544421     244677778889999999999999876   9999999999999886 88899999


Q ss_pred             CCCcccccccccccccccccCCCccc-CcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCC---
Q 044997          422 GLVKLEERTNEKEMLATRLVGTPGYL-PPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDD---  497 (563)
Q Consensus       422 Gla~~~~~~~~~~~~~~~~~gt~~y~-APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~---  497 (563)
                      |++..+.-..      ....+.-++. .+|.+.            +...+..+.|++|||.-+.|.+++..--....   
T Consensus       412 ~~~t~~~~~~------~~~~~~~r~~p~~~~~~------------e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~  473 (524)
T KOG0601|consen  412 GCWTRLAFSS------GVFHHIDRLYPIAEILL------------EDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSL  473 (524)
T ss_pred             ccccccceec------ccccccccccccchhhc------------cccccccccccccccccccccccCcccCcccccce
Confidence            9986422111      1112223344 244332            23344789999999999999999874322111   


Q ss_pred             ----CCchhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 044997          498 ----SEPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQ  537 (563)
Q Consensus       498 ----~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  537 (563)
                          ..........+.+..+.+.+..+++..||.+.++....+.
T Consensus       474 ~i~~~~~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~  517 (524)
T KOG0601|consen  474 TIRSGDTPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEF  517 (524)
T ss_pred             eeecccccCCCchHHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence                1111222333667888999999999999999888765543

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.68  E-value=2e-07  Score=93.09  Aligned_cols=122  Identities=16%  Similarity=0.126  Sum_probs=88.1

Q ss_pred             ceecccCcEEEEEEEECCceEEEEEeccCCh--------------HHHHHHHHHHHhccccc------------------
Q 044997          298 RIIGRGGFGNVYFGLLGDREAAIKKMRSNKS--------------KEFFAELKVLCKIHHIN------------------  345 (563)
Q Consensus       298 ~~LG~G~fG~Vy~g~~~~~~vavK~~~~~~~--------------~~f~~Ei~~l~~l~H~n------------------  345 (563)
                      +.+-.-....|++..+.|+.+.||+......              ..+.+|...+.++...+                  
T Consensus        28 e~v~~~~~rrvvr~~~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~  107 (268)
T PRK15123         28 EVFRELEGRRTLRFELAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT  107 (268)
T ss_pred             cEEecCCCceEEEEEECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence            3444333355778888999999998754331              13778988888874322                  


Q ss_pred             ----eEEEeecCC-CcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecC-------C
Q 044997          346 ----VFISTFGNG-SLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDD-------G  413 (563)
Q Consensus       346 ----iV~e~~~~g-sL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~-------~  413 (563)
                          +|+|++++- +|.+++.+.   ...+.+...+..++.+++..+.-||+.+   ++|+|++++|||++.       +
T Consensus       108 ~~s~LVte~l~~~~sL~~~~~~~---~~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~  181 (268)
T PRK15123        108 RTSFIITEDLAPTISLEDYCADW---ATNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREED  181 (268)
T ss_pred             ceeEEEEeeCCCCccHHHHHHhh---cccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCC
Confidence                355666654 566665321   0123455677789999999999999998   999999999999975       4


Q ss_pred             CcEEEeecCCCc
Q 044997          414 LRAKVADFGLVK  425 (563)
Q Consensus       414 ~~~kl~DFGla~  425 (563)
                      ..+.++||+.++
T Consensus       182 ~~~~LIDl~r~~  193 (268)
T PRK15123        182 LKLSVIDLHRAQ  193 (268)
T ss_pred             ceEEEEECCccc
Confidence            789999999875

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=98.65  E-value=3e-07  Score=98.92  Aligned_cols=202  Identities=17%  Similarity=0.183  Sum_probs=119.9

Q ss_pred             CCceEEEEEeccCCh---HHHHHHHHHHHhccccceEEEeecCCCccc--ccccccccCCCCCC-------HHHHHHHHH
Q 044997          314 GDREAAIKKMRSNKS---KEFFAELKVLCKIHHINVFISTFGNGSLSD--HLHDPLLKGHQPLT-------WTARTQIAL  381 (563)
Q Consensus       314 ~~~~vavK~~~~~~~---~~f~~Ei~~l~~l~H~niV~e~~~~gsL~~--~L~~~~~~~~~~l~-------~~~~~~i~~  381 (563)
                      ++.+|.|...+....   +...+-++.|+.++||||+ .|+..-..+.  ||...   .-.|+.       -....-.+.
T Consensus        36 ~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il-~yL~t~e~~~~~ylvTE---rV~Pl~~~lk~l~~~~v~~Gl~  111 (690)
T KOG1243|consen   36 DGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNIL-SYLDTTEEEGTLYLVTE---RVRPLETVLKELGKEEVCLGLF  111 (690)
T ss_pred             cCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhh-hhhhhhcccCceEEEee---ccccHHHHHHHhHHHHHHHHHH
Confidence            466777776654433   4466778999999999994 3333222222  34332   123333       223344678


Q ss_pred             HHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccccccccccccccccCCCcccCccccccccccccc
Q 044997          382 DAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDM  461 (563)
Q Consensus       382 ~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~  461 (563)
                      ||+.||.|||+.+  .++|++|.-+.|+++..|+.||++|.++......+.   ......--..|..|+.+...      
T Consensus       112 qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~---~~~~~~~~~s~~~P~~~~~s------  180 (690)
T KOG1243|consen  112 QILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA---PAKSLYLIESFDDPEEIDPS------  180 (690)
T ss_pred             HHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc---ccccchhhhcccChhhcCcc------
Confidence            9999999999766  599999999999999999999999988764332221   01111122346667643111      


Q ss_pred             ccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCchhhH-HHH--------------HHHHHHHHHhhccCCCCCC
Q 044997          462 HSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKMK-SLI--------------TIMAAVAEWCLNEDAVDRP  526 (563)
Q Consensus       462 ~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~~~~-~~~--------------~~l~~li~~cl~~dP~~RP  526 (563)
                               +-..|.|-||+++||++.|..+-..+........ ...              .....++..|...-+--|=
T Consensus       181 ---------~~s~D~~~Lg~li~el~ng~~~~~~~~~~~~~ipk~~~~~~~k~~~~~~~~r~n~~~~~~~~~~~~gff~n  251 (690)
T KOG1243|consen  181 ---------EWSIDSWGLGCLIEELFNGSLLTKTDLSNTGKIPKALIELYCKKLGATELKRPNKLRFILECRLLGGFFRN  251 (690)
T ss_pred             ---------ccchhhhhHHHHHHHHhCcccCcchhhhccCccchhHHHHHHHHhccccccccchhhHHHHHHhccccccc
Confidence                     1246999999999999999332211111111000 000              0134555556665555565


Q ss_pred             CHHHHHHHHHHhh
Q 044997          527 EMRDIVAILSQIM  539 (563)
Q Consensus       527 s~~evl~~L~~i~  539 (563)
                      .+-+++..|+++.
T Consensus       252 ~fvd~~~fLeel~  264 (690)
T KOG1243|consen  252 DFVDTLLFLEELR  264 (690)
T ss_pred             hHHHHHHHHHhcc
Confidence            6666666666554

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.57  E-value=1.6e-08  Score=108.87  Aligned_cols=140  Identities=23%  Similarity=0.369  Sum_probs=100.2

Q ss_pred             HHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccccccc-----ccc-ccccccCCCcccCccccc
Q 044997          380 ALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNE-----KEM-LATRLVGTPGYLPPEYIF  453 (563)
Q Consensus       380 ~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~-----~~~-~~~~~~gt~~y~APE~l~  453 (563)
                      +.++++||.|+|.+.  .+||++|.|++|.++.++.+||+.|+.+........     .+. ...-......|.|||++.
T Consensus       105 l~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~  182 (700)
T KOG2137|consen  105 LGNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL  182 (700)
T ss_pred             hhcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence            345669999999865  699999999999999999999999998754332111     110 111123456799999885


Q ss_pred             ccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCC-C--------------chhhHHHHHHHHHHHHHhh
Q 044997          454 VKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDS-E--------------PTKMKSLITIMAAVAEWCL  518 (563)
Q Consensus       454 ~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~-~--------------~~~~~~~~~~l~~li~~cl  518 (563)
                      +             ...++++|+||+||++|.+..|..+...... .              .....+++.++++=+.+.+
T Consensus       183 ~-------------~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l  249 (700)
T KOG2137|consen  183 G-------------TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLL  249 (700)
T ss_pred             c-------------ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHh
Confidence            4             2348999999999999999955555322211 0              0112356677888899999


Q ss_pred             ccCCCCCCCHHHHHHH
Q 044997          519 NEDAVDRPEMRDIVAI  534 (563)
Q Consensus       519 ~~dP~~RPs~~evl~~  534 (563)
                      ..++.-||++.++...
T Consensus       250 ~~~~~~rp~~~~l~~~  265 (700)
T KOG2137|consen  250 NGDSAVRPTLDLLLSI  265 (700)
T ss_pred             cCCcccCcchhhhhcc
Confidence            9999999988777543

>PRK09902 hypothetical protein; Provisional

Probab=98.54  E-value=7.7e-07  Score=84.62  Aligned_cols=121  Identities=15%  Similarity=0.147  Sum_probs=93.7

Q ss_pred             ecccCcEEEEEEEECCceEEEEEec---------cCChHHHHHHHHHHHhccccce---------------------EEE
Q 044997          300 IGRGGFGNVYFGLLGDREAAIKKMR---------SNKSKEFFAELKVLCKIHHINV---------------------FIS  349 (563)
Q Consensus       300 LG~G~fG~Vy~g~~~~~~vavK~~~---------~~~~~~f~~Ei~~l~~l~H~ni---------------------V~e  349 (563)
                      -|+||.+.|++-.+.|..+=+|+-.         +.....|.+|...|.++...++                     |+|
T Consensus        26 ~~rgG~SgV~r~~~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVTe  105 (216)
T PRK09902         26 YRRNGMSGVQCVERNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVTE  105 (216)
T ss_pred             cCCCCcceEEEEEeCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEEE
Confidence            4778999999999888888888764         3345789999999999976443                     334


Q ss_pred             eec-CCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCc--EEEeecCCCcc
Q 044997          350 TFG-NGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLR--AKVADFGLVKL  426 (563)
Q Consensus       350 ~~~-~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~--~kl~DFGla~~  426 (563)
                      -++ .-+|.+++.+.   ...+.+...+..+..+++..+.-||+.+   +.|+|+.+.|||++.++.  ++++||.-++.
T Consensus       106 ~L~g~~~L~~~l~~~---~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        106 DMAGFISIADWYAQH---AVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             eCCCCccHHHHHhcC---CcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            333 24666676441   1234577778899999999999999998   999999999999986666  99999987653

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.49  E-value=8.1e-07  Score=83.78  Aligned_cols=110  Identities=25%  Similarity=0.365  Sum_probs=72.3

Q ss_pred             EEEEEEE-CCceEEEEEeccCC-----------------------------hHHHHHHHHHHHhccccc-----------
Q 044997          307 NVYFGLL-GDREAAIKKMRSNK-----------------------------SKEFFAELKVLCKIHHIN-----------  345 (563)
Q Consensus       307 ~Vy~g~~-~~~~vavK~~~~~~-----------------------------~~~f~~Ei~~l~~l~H~n-----------  345 (563)
                      .||.|.. ++..+|+|..+...                             .....+|.+.|.++..-.           
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~~   80 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYNR   80 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEET
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEeC
Confidence            3899987 57899999764210                             023567999999997543           


Q ss_pred             --eEEEeec-CCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCceEeCCCCCCCeEecCCCcEEEeec
Q 044997          346 --VFISTFG-NGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYI-HDHTKARYVHRDIKTSNILLDDGLRAKVADF  421 (563)
Q Consensus       346 --iV~e~~~-~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~ivHrDLk~~NILl~~~~~~kl~DF  421 (563)
                        |||||++ +|.....|.+.      .++......++.+++..+..+ |..+   ++|+||.+.|||++++ .+.|+||
T Consensus        81 ~~ivME~I~~~G~~~~~l~~~------~~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~iIDf  150 (188)
T PF01163_consen   81 NVIVMEYIGEDGVPLPRLKDV------DLSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYIIDF  150 (188)
T ss_dssp             TEEEEE--EETTEEGGCHHHC------GGGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE--G
T ss_pred             CEEEEEecCCCccchhhHHhc------cccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEEEec
Confidence              3799998 33333334331      112344566778888866664 6776   9999999999999988 9999999


Q ss_pred             CCCcc
Q 044997          422 GLVKL  426 (563)
Q Consensus       422 Gla~~  426 (563)
                      |.+..
T Consensus       151 ~qav~  155 (188)
T PF01163_consen  151 GQAVD  155 (188)
T ss_dssp             TTEEE
T ss_pred             Cccee
Confidence            98764

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.46  E-value=4.3e-06  Score=87.60  Aligned_cols=193  Identities=15%  Similarity=0.200  Sum_probs=132.8

Q ss_pred             EEEEEEEE--CCceEEEEEeccCC---hHHHHHHHHHHHhccccce-------------------EEEeecC-CCccccc
Q 044997          306 GNVYFGLL--GDREAAIKKMRSNK---SKEFFAELKVLCKIHHINV-------------------FISTFGN-GSLSDHL  360 (563)
Q Consensus       306 G~Vy~g~~--~~~~vavK~~~~~~---~~~f~~Ei~~l~~l~H~ni-------------------V~e~~~~-gsL~~~L  360 (563)
                      ...|++..  +|..+++||+...+   ...-..-+++++++.|.|+                   |++|+++ ++|.++-
T Consensus       290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~  369 (655)
T KOG3741|consen  290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY  369 (655)
T ss_pred             ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence            46788865  68889999994432   2222345889999999998                   4577764 4555443


Q ss_pred             cccc----------ccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccccc
Q 044997          361 HDPL----------LKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERT  430 (563)
Q Consensus       361 ~~~~----------~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~  430 (563)
                      ....          ...+...++...+.++.|+..||.++|+.|   +.-+-|.+.+||++.+.+++|+.-|+...+..+
T Consensus       370 F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d  446 (655)
T KOG3741|consen  370 FANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQED  446 (655)
T ss_pred             ccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence            3211          112345788999999999999999999998   777999999999999999999988876544322


Q ss_pred             cccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCC-----chhhHH
Q 044997          431 NEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE-----PTKMKS  505 (563)
Q Consensus       431 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~-----~~~~~~  505 (563)
                      ..                 |-+..                -.+-|.=.||.+++.|.||..--...+..     ......
T Consensus       447 ~~-----------------~~le~----------------~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I~~~  493 (655)
T KOG3741|consen  447 PT-----------------EPLES----------------QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRITTT  493 (655)
T ss_pred             CC-----------------cchhH----------------HhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHhhhh
Confidence            10                 11111                24679999999999999996542222111     112234


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 044997          506 LITIMAAVAEWCLNEDAVDRPEMRDIVAIL  535 (563)
Q Consensus       506 ~~~~l~~li~~cl~~dP~~RPs~~evl~~L  535 (563)
                      ....+++++.-....++.+ -+..+++...
T Consensus       494 yS~D~rn~v~yl~s~~~~~-ksI~~llp~~  522 (655)
T KOG3741|consen  494 YSTDLRNVVEYLESLNFRE-KSIQDLLPMI  522 (655)
T ss_pred             hhHHHHHHHHHHHhcCccc-ccHHHHHHHH
Confidence            4566888888888888876 5677776653

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.15  E-value=5.7e-06  Score=79.58  Aligned_cols=90  Identities=22%  Similarity=0.294  Sum_probs=68.5

Q ss_pred             HHHHHHHHHHHhccccce---------------------EEEeecCC-CcccccccccccCCCCCCHHHHHHHHHHHHHH
Q 044997          329 KEFFAELKVLCKIHHINV---------------------FISTFGNG-SLSDHLHDPLLKGHQPLTWTARTQIALDAAKG  386 (563)
Q Consensus       329 ~~f~~Ei~~l~~l~H~ni---------------------V~e~~~~g-sL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~g  386 (563)
                      ....+|...+.++....|                     |+|++++. +|.+++...     ...+......++.+++..
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~-----~~~~~~~~~~ll~~l~~~  130 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQW-----EQLDPSQRRELLRALARL  130 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhh-----cccchhhHHHHHHHHHHH
Confidence            457788888887754333                     44555542 566665431     125566778899999999


Q ss_pred             HHHHHhcCCCceEeCCCCCCCeEecCCC---cEEEeecCCCcc
Q 044997          387 IEYIHDHTKARYVHRDIKTSNILLDDGL---RAKVADFGLVKL  426 (563)
Q Consensus       387 L~yLH~~~~~~ivHrDLk~~NILl~~~~---~~kl~DFGla~~  426 (563)
                      +.-||+.+   ++|+|+++.|||++.+.   .+.++||+.++.
T Consensus       131 i~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  131 IAKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HHHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            99999998   99999999999999887   899999998764

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.05  E-value=4.4e-05  Score=74.67  Aligned_cols=119  Identities=19%  Similarity=0.151  Sum_probs=83.4

Q ss_pred             CCccceecccCcEEEEEEEEC-CceEEEEEeccCC-------------------------hHHHHHHHHHHHhcccc---
Q 044997          294 FDESRIIGRGGFGNVYFGLLG-DREAAIKKMRSNK-------------------------SKEFFAELKVLCKIHHI---  344 (563)
Q Consensus       294 f~~~~~LG~G~fG~Vy~g~~~-~~~vavK~~~~~~-------------------------~~~f~~Ei~~l~~l~H~---  344 (563)
                      ...++.||-|.-+.||.|... |.++|||.=+-..                         +....+|.++|.++...   
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            345689999999999999885 8999999532110                         12356799999998543   


Q ss_pred             ---------c-eEEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCC
Q 044997          345 ---------N-VFISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGL  414 (563)
Q Consensus       345 ---------n-iV~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~  414 (563)
                               | ||||++++--|...-          ++-...-.|+..|+.-+.-+-..|   |||+|+..=||+++++|
T Consensus       173 VP~P~~~nRHaVvMe~ieG~eL~~~r----------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~dg  239 (304)
T COG0478         173 VPKPIAWNRHAVVMEYIEGVELYRLR----------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTEDG  239 (304)
T ss_pred             CCCccccccceeeeehcccceeeccc----------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEecCC
Confidence                     1 478988885553311          122333345555555554444555   99999999999999999


Q ss_pred             cEEEeecCCCc
Q 044997          415 RAKVADFGLVK  425 (563)
Q Consensus       415 ~~kl~DFGla~  425 (563)
                      .+.++||--+.
T Consensus       240 ~~~vIDwPQ~v  250 (304)
T COG0478         240 DIVVIDWPQAV  250 (304)
T ss_pred             CEEEEeCcccc
Confidence            99999997654

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.02  E-value=3e-05  Score=84.03  Aligned_cols=128  Identities=20%  Similarity=0.226  Sum_probs=84.1

Q ss_pred             HhcCCCccceecccCcEEEEEEEEC-CceEEEEEeccCChHHHHH-----------------------------------
Q 044997          290 ATNNFDESRIIGRGGFGNVYFGLLG-DREAAIKKMRSNKSKEFFA-----------------------------------  333 (563)
Q Consensus       290 ~~~~f~~~~~LG~G~fG~Vy~g~~~-~~~vavK~~~~~~~~~f~~-----------------------------------  333 (563)
                      .-..|+ .+.|+.++-|.||+|++. |+.||||+.+++-.+.+..                                   
T Consensus       124 ~F~eF~-~~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l  202 (517)
T COG0661         124 LFSEFE-PEPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRL  202 (517)
T ss_pred             HHHHcC-CCchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHH
Confidence            334554 378999999999999996 8999999987654433333                                   


Q ss_pred             --------HHHHHHhcc-----ccce---------------EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHH
Q 044997          334 --------ELKVLCKIH-----HINV---------------FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAK  385 (563)
Q Consensus       334 --------Ei~~l~~l~-----H~ni---------------V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~  385 (563)
                              |..-+.+++     .+++               +|||+.+-.+.+...-.    ....+   +..++..+++
T Consensus       203 ~~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~----~~g~d---~k~ia~~~~~  275 (517)
T COG0661         203 REELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALK----SAGID---RKELAELLVR  275 (517)
T ss_pred             HHHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHH----hcCCC---HHHHHHHHHH
Confidence                    333333331     1221               57888887777664221    12344   3334444443


Q ss_pred             H-HHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccc
Q 044997          386 G-IEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEE  428 (563)
Q Consensus       386 g-L~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~  428 (563)
                      + +.-+=.++   ++|.|..|.||+++.++++-+.|||+...+.
T Consensus       276 ~f~~q~~~dg---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~  316 (517)
T COG0661         276 AFLRQLLRDG---FFHADPHPGNILVRSDGRIVLLDFGIVGRLD  316 (517)
T ss_pred             HHHHHHHhcC---ccccCCCccceEEecCCcEEEEcCcceecCC
Confidence            3 22333345   9999999999999999999999999987554

>PRK10783 mltD membrane-bound lytic murein transglycosylase D; Provisional

Probab=97.98  E-value=1.4e-05  Score=85.55  Aligned_cols=132  Identities=15%  Similarity=0.147  Sum_probs=93.4

Q ss_pred             cCCCCHHHHHHhhCCCcccccccccC-------C--CccEEEEeeccc------c-------------------CCCC--
Q 044997           57 NQGLPVERIASFYSANPSQIKPIFRG-------N--QKDYLITVPCSC------K-------------------DVNS--  100 (563)
Q Consensus        57 ~~~~~~~~i~~l~~~~~~~i~~~n~~-------~--~~~~~vp~~C~C------~-------------------~~~~--  100 (563)
                      ....+|..||.++|++..+|..+|+.       +  .+.++||..-.=      .                   ...+  
T Consensus       269 ~~~i~L~~iA~~~gvs~~eL~~LNP~~kr~~t~p~g~~~llvP~~~~~~f~~~l~~~~~~~~~p~~~~~~~~~~~~~y~V  348 (456)
T PRK10783        269 GQQIELAQAAEMAGMSLTKLKTFNAGYKRSTTAPSGPHYIMVPKKHADQLRESLASGEIAAVQSTLVADNTPLNSRSYKV  348 (456)
T ss_pred             CCCcCHHHHHHHcCCCHHHHHHhCccccCCCcCCCCCeEEEecCchhhHHHHhhhhhhhhhcccccccccCcCCceEEEE
Confidence            45679999999999999999999973       1  144557764210      0                   0000  


Q ss_pred             ccccccccc------------cccCCCCCcceecCcEEEEeeeeecCC-CCceeEEEEEccCCCcHHHHHHHhcCCccch
Q 044997          101 TRAMIYSGQ------------AWKVGGEENYFIAGVAVPIHLLCGCVE-TGTQVVVTYTVQQQDTLSIIATLLSAEISGI  167 (563)
Q Consensus       101 ~~~~ty~~~------------a~~~~~~~~l~~~g~~l~vpl~C~C~~-~~~~~llTY~~~~gd~ls~ia~~f~~s~~~i  167 (563)
                      ..|+|+..+            .||......+ .+|++|.||..|.|.. ......++|.|+.||++.+||.+||++.+.|
T Consensus       349 k~GDTL~sIA~r~gvs~~~L~~~N~l~~~~L-~~Gq~L~Ip~~~~~~~~~~~~~~~~Y~Vr~GDTL~sIA~kygVtv~~L  427 (456)
T PRK10783        349 RSGDTLSGIASRLNVSTKDLQQWNNLRGSKL-KVGQTLTIGAGSSAQRLANNSDSITYRVRKGDSLSSIAKRHGVNIKDV  427 (456)
T ss_pred             CCCCcHHHHHHHHCcCHHHHHHHcCCCcccC-CCCCEEEecCCcccccccccccceeEEeCCCCCHHHHHHHhCCCHHHH
Confidence            123444443            2565444444 8999999998887742 2344568999999999999999999999999


Q ss_pred             hhcccccccCCcccccceeeeecCc
Q 044997          168 ESMNKMVAQNPGYIDVCWVLFVPME  192 (563)
Q Consensus       168 ~~~N~~~~~~~~~~~~~~~~~vp~~  192 (563)
                      ...|+.. .+  .+.+|..+-|+.+
T Consensus       428 ~~~N~l~-~~--~L~pGq~L~l~v~  449 (456)
T PRK10783        428 MRWNSDT-AK--NLQPGDKLTLFVK  449 (456)
T ss_pred             HHhcCCC-CC--cCCCCCEEEEecC
Confidence            9999964 22  5778887777664

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=97.81  E-value=0.00023  Score=68.13  Aligned_cols=119  Identities=16%  Similarity=0.213  Sum_probs=84.9

Q ss_pred             HhcCCCccceecccCcEEEEEEEECCceEEEEEeccCCh------------HHHHHHHHHHHhccc--------------
Q 044997          290 ATNNFDESRIIGRGGFGNVYFGLLGDREAAIKKMRSNKS------------KEFFAELKVLCKIHH--------------  343 (563)
Q Consensus       290 ~~~~f~~~~~LG~G~fG~Vy~g~~~~~~vavK~~~~~~~------------~~f~~Ei~~l~~l~H--------------  343 (563)
                      ..++|...+++-......|.+-..++....+|..+....            ....+++..+.+++.              
T Consensus        29 ~~~~~~~~kv~k~~~r~~ValIei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e  108 (229)
T PF06176_consen   29 LDNNYKIIKVFKNTKRNYVALIEIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE  108 (229)
T ss_pred             HhCCceEEEeecCCCccEEEEEEECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence            346788888888888888888888999999998765432            112233443333321              


Q ss_pred             --------cc-eEEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCC
Q 044997          344 --------IN-VFISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGL  414 (563)
Q Consensus       344 --------~n-iV~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~  414 (563)
                              .. +++||+++-.|.+...         ++.    .++..+++++.-||..|   +.|+|..|.|+++++++
T Consensus       109 kk~~~~~~~~~ll~EYIeG~~l~d~~~---------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~~  172 (229)
T PF06176_consen  109 KKIFRYTSSYVLLMEYIEGVELNDIED---------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNNG  172 (229)
T ss_pred             eeeccceeEEEEEEEEecCeecccchh---------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECCc
Confidence                    11 2678888877765432         221    35567788899999998   99999999999998654


Q ss_pred             cEEEeecCCCc
Q 044997          415 RAKVADFGLVK  425 (563)
Q Consensus       415 ~~kl~DFGla~  425 (563)
                       +++.||+..+
T Consensus       173 -i~iID~~~k~  182 (229)
T PF06176_consen  173 -IRIIDTQGKR  182 (229)
T ss_pred             -EEEEECcccc
Confidence             9999998765

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=97.67  E-value=0.00028  Score=68.30  Aligned_cols=128  Identities=20%  Similarity=0.203  Sum_probs=74.3

Q ss_pred             cceecccCcEEEEEEEECCceEEEEEeccC-ChHHHHHHHHHHHhccccc-----e---------------EEEeecCCC
Q 044997          297 SRIIGRGGFGNVYFGLLGDREAAIKKMRSN-KSKEFFAELKVLCKIHHIN-----V---------------FISTFGNGS  355 (563)
Q Consensus       297 ~~~LG~G~fG~Vy~g~~~~~~vavK~~~~~-~~~~f~~Ei~~l~~l~H~n-----i---------------V~e~~~~gs  355 (563)
                      .+.|+.|..+.||+...+++.+++|..... ......+|..++..+....     +               +++++++..
T Consensus         2 i~~l~~G~~n~~~~v~~~~~~~vlK~~~~~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~~   81 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDDGRYVLKFYRPPDAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGRP   81 (239)
T ss_dssp             EEEEEESSSSEEEEEEETTSEEEEEEESSHHHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSEE
T ss_pred             CccCCCCCeeeEEEEEECCcEEEEEEeCCCCCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecccc
Confidence            367899999999999998889999998766 4566778888888775322     1               456666655


Q ss_pred             ccc----------------c---cccccccCCCCCCHHHH---------HHH------------HHHHHH-HHHHHHhc-
Q 044997          356 LSD----------------H---LHDPLLKGHQPLTWTAR---------TQI------------ALDAAK-GIEYIHDH-  393 (563)
Q Consensus       356 L~~----------------~---L~~~~~~~~~~l~~~~~---------~~i------------~~~ia~-gL~yLH~~-  393 (563)
                      +..                .   |+... ....+..+...         ...            ...+.. .++.+++. 
T Consensus        82 ~~~~~~~~~~~~~~~~~~~~l~~lh~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (239)
T PF01636_consen   82 LDDELSPEQRPELLRQLGRALAQLHQVP-PPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEALL  160 (239)
T ss_dssp             HHHTSTHHHHHHHHHHHHHHHHHHHHSH-TTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccchhhhhhccccc-ccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhhh
Confidence            544                0   11100 01111111110         000            112222 33344431 


Q ss_pred             ---CCCceEeCCCCCCCeEec-CCCcEEEeecCCCc
Q 044997          394 ---TKARYVHRDIKTSNILLD-DGLRAKVADFGLVK  425 (563)
Q Consensus       394 ---~~~~ivHrDLk~~NILl~-~~~~~kl~DFGla~  425 (563)
                         ....++|+|+.+.|||++ +++++.|+||+.+.
T Consensus       161 ~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  161 PKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             HCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             ccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence               345699999999999999 66777899998765

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.67  E-value=0.00037  Score=64.09  Aligned_cols=124  Identities=14%  Similarity=0.093  Sum_probs=78.1

Q ss_pred             CccceecccCcEEEEEEEECCceEEEEEeccCC-hHHHHHHHHHHHhccccce---EEEeecCCCcccccccccccCCCC
Q 044997          295 DESRIIGRGGFGNVYFGLLGDREAAIKKMRSNK-SKEFFAELKVLCKIHHINV---FISTFGNGSLSDHLHDPLLKGHQP  370 (563)
Q Consensus       295 ~~~~~LG~G~fG~Vy~g~~~~~~vavK~~~~~~-~~~f~~Ei~~l~~l~H~ni---V~e~~~~gsL~~~L~~~~~~~~~~  370 (563)
                      ...+.|++|.+|.||+|.+.+..+|+|.-+.+. ...+..|.++|..+.-.++   |+.|-..--..+++..     ...
T Consensus        25 ~v~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~ds~r~~l~kEakiLeil~g~~~~p~vy~yg~~~i~me~i~G-----~~L   99 (201)
T COG2112          25 RVEKELAKGTTSVVYLGEWRGGEVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEVYFYGEDFIRMEYIDG-----RPL   99 (201)
T ss_pred             hhhhhhhcccccEEEEeeccCceEEEEEecCCcchhhHHHHHHHHHHhhhcCCCceEEEechhhhhhhhhcC-----cch
Confidence            345789999999999999999999999887665 4678999999999987655   2222222222333322     111


Q ss_pred             CCHHHH--HHHHHHHHHHHHHHHhcCCCceEeCCCC-CCCeEecCCCcEEEeecCCCcc
Q 044997          371 LTWTAR--TQIALDAAKGIEYIHDHTKARYVHRDIK-TSNILLDDGLRAKVADFGLVKL  426 (563)
Q Consensus       371 l~~~~~--~~i~~~ia~gL~yLH~~~~~~ivHrDLk-~~NILl~~~~~~kl~DFGla~~  426 (563)
                      ..|...  .+-...+++.---|-..|   |-|+.|. |...+|..+..+.|+||.-|+.
T Consensus       100 ~~~~~~~~rk~l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112         100 GKLEIGGDRKHLLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             hhhhhcccHHHHHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence            222220  223344555533344444   7788775 4444444445999999998873

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=97.66  E-value=0.00053  Score=66.92  Aligned_cols=44  Identities=18%  Similarity=0.211  Sum_probs=33.2

Q ss_pred             ceecccCcEEEEEEEECCceEEEEEeccCC-hHHHHHHHHHHHhccc
Q 044997          298 RIIGRGGFGNVYFGLLGDREAAIKKMRSNK-SKEFFAELKVLCKIHH  343 (563)
Q Consensus       298 ~~LG~G~fG~Vy~g~~~~~~vavK~~~~~~-~~~f~~Ei~~l~~l~H  343 (563)
                      ..||+|..+.||+.  .+...++|...... ..+..+|.+++..+..
T Consensus         7 ~~i~~G~t~~~y~~--~~~~~VlR~~~~~~~~~~i~~E~~~l~~l~~   51 (226)
T TIGR02172         7 TQTGEGGNGESYTH--KTGKWMLKLYNPGFDKETIKREFDASRKVFS   51 (226)
T ss_pred             eeecCCCCcceeEe--cCCCEEEEeCCCCCCHHHHHHHHHHHHHHHH
Confidence            57899999999984  35567888876543 3557889999888753

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=97.64  E-value=0.00083  Score=65.21  Aligned_cols=138  Identities=20%  Similarity=0.260  Sum_probs=91.6

Q ss_pred             cCHHHHHHHhcCCCccceec---ccCcEEEEEEEE-CCceEEEEEeccCCh----------------------HH-----
Q 044997          282 FSLEEIEEATNNFDESRIIG---RGGFGNVYFGLL-GDREAAIKKMRSNKS----------------------KE-----  330 (563)
Q Consensus       282 ~~~~el~~~~~~f~~~~~LG---~G~fG~Vy~g~~-~~~~vavK~~~~~~~----------------------~~-----  330 (563)
                      .+.+.+....++.......|   .|.-..||+|.- ++..+|||+.+....                      ++     
T Consensus        35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W  114 (268)
T COG1718          35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW  114 (268)
T ss_pred             HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence            35556666666666555554   566667999976 578999998753210                      01     


Q ss_pred             HHHHHHHHHhccc------------cc-eEEEeecCCC-cccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 044997          331 FFAELKVLCKIHH------------IN-VFISTFGNGS-LSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKA  396 (563)
Q Consensus       331 f~~Ei~~l~~l~H------------~n-iV~e~~~~gs-L~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~  396 (563)
                      -.+|..-|.++..            .| +||||++... -.-.|.+      .++...+...+..++++.+.-|-...  
T Consensus       115 ~~kEf~NL~R~~eAGVrvP~Pi~~~~nVLvMEfIg~~g~pAP~LkD------v~~e~~e~~~~~~~~v~~~~~l~~~a--  186 (268)
T COG1718         115 ARKEFRNLKRAYEAGVRVPEPIAFRNNVLVMEFIGDDGLPAPRLKD------VPLELEEAEGLYEDVVEYMRRLYKEA--  186 (268)
T ss_pred             HHHHHHHHHHHHHcCCCCCCceeecCCeEEEEeccCCCCCCCCccc------CCcCchhHHHHHHHHHHHHHHHHHhc--
Confidence            2357777777632            23 3789987652 2222222      22333356677788888888887632  


Q ss_pred             ceEeCCCCCCCeEecCCCcEEEeecCCCcccc
Q 044997          397 RYVHRDIKTSNILLDDGLRAKVADFGLVKLEE  428 (563)
Q Consensus       397 ~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~  428 (563)
                      .+||+||..=|||+. ++.+.|+|||-|....
T Consensus       187 ~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~  217 (268)
T COG1718         187 GLVHGDLSEYNILVH-DGEPYIIDVSQAVTID  217 (268)
T ss_pred             CcccccchhhheEEE-CCeEEEEECccccccC
Confidence            499999999999999 8899999999886443

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=97.56  E-value=1.8e-05  Score=84.92  Aligned_cols=173  Identities=18%  Similarity=0.116  Sum_probs=116.2

Q ss_pred             CCccceecccCcEEEEEEEECC-ceEEEEEeccCChHHHHHHHHHHHhccccceEEEeecCCCcccccccc--cccCC--
Q 044997          294 FDESRIIGRGGFGNVYFGLLGD-REAAIKKMRSNKSKEFFAELKVLCKIHHINVFISTFGNGSLSDHLHDP--LLKGH--  368 (563)
Q Consensus       294 f~~~~~LG~G~fG~Vy~g~~~~-~~vavK~~~~~~~~~f~~Ei~~l~~l~H~niV~e~~~~gsL~~~L~~~--~~~~~--  368 (563)
                      +...+-+++|+++++++.+-.. +....+.+...  ....-++++|.+++|||-++.|....+.++++.-.  .....  
T Consensus       244 s~~fh~fvK~altknpKkRptaeklL~h~fvs~~--l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs  321 (829)
T KOG0576|consen  244 SEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT--LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRS  321 (829)
T ss_pred             hHHHHHHHHHHhcCCCccCCChhhheeceeeccc--hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCcc
Confidence            3344567899999999876542 23334444433  33445899999999999767777766666655321  10111  


Q ss_pred             ---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccccccccccccccc
Q 044997          369 ---------QPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATR  439 (563)
Q Consensus       369 ---------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~  439 (563)
                               ..+...+...+.+.-.++|+|||+..   -+|||    ||+..+ ...|..||+....+.+..    ....
T Consensus       322 ~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~----~~~t  389 (829)
T KOG0576|consen  322 SALEMTVSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM----KPRT  389 (829)
T ss_pred             ccccCChhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCccc----cccc
Confidence                     11223334455666778999999863   48999    777766 578999999887655432    2344


Q ss_pred             ccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCC
Q 044997          440 LVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRAL  493 (563)
Q Consensus       440 ~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~  493 (563)
                      ..+++.|+|||+.....+             ..+.|+|+.|+--.++.-|-.|-
T Consensus       390 ~~~~~~~~~pev~~~~~~-------------~~~p~~~~~~~~~~~~ap~~pPr  430 (829)
T KOG0576|consen  390 AIGTPEPLAPEVIQENTI-------------DGCPDSGSLAVSAIQMAPGLPPR  430 (829)
T ss_pred             CCCCCCCCCchhhccccc-------------ccCCCccCCCcchhhcCCCCCCC
Confidence            679999999998765544             67899999998777777766553

>PRK06347 autolysin; Reviewed

Probab=97.49  E-value=0.00021  Score=78.40  Aligned_cols=132  Identities=17%  Similarity=0.188  Sum_probs=92.7

Q ss_pred             eeeccCCCCHHHHHHhhCCCcccccccccC------CCccEEEEeecc-----------------------ccCCCC--c
Q 044997           53 LYHINQGLPVERIASFYSANPSQIKPIFRG------NQKDYLITVPCS-----------------------CKDVNS--T  101 (563)
Q Consensus        53 ~~~~~~~~~~~~i~~l~~~~~~~i~~~n~~------~~~~~~vp~~C~-----------------------C~~~~~--~  101 (563)
                      .|....+.++..|+.-|+++..+|..+|+.      .+|.+.||..=.                       |.. .+  .
T Consensus       407 ~ytVk~GDTL~sIA~kygVSv~~L~~~N~l~s~~L~~Gq~L~IP~~~~~~~~t~~~s~~~~~~k~~s~~~~~~~-~YtVk  485 (592)
T PRK06347        407 VYTVVKGDSLWRIANNNKVTIANLKSWNNLKSDFIYPGQKLKVSAGSTSNTNTSKPSTNTNTSKPSTNTNTNAK-VYTVA  485 (592)
T ss_pred             eEEecCCCCHHHHHHHhCCCHHHHHHHhCCCcceeccCcEEEEecCCcccccccccccccccccccccccccce-eeeec
Confidence            466678999999999999999999999973      577777885310                       000 01  1


Q ss_pred             cccccccc------------cccCCCCCcceecCcEEEEeeeeecCC-------C---CceeEEEEEccCCCcHHHHHHH
Q 044997          102 RAMIYSGQ------------AWKVGGEENYFIAGVAVPIHLLCGCVE-------T---GTQVVVTYTVQQQDTLSIIATL  159 (563)
Q Consensus       102 ~~~ty~~~------------a~~~~~~~~l~~~g~~l~vpl~C~C~~-------~---~~~~llTY~~~~gd~ls~ia~~  159 (563)
                      .|+|+.++            +||......| .+|++|.||....=..       .   ...-..+|.|+.||++..||.+
T Consensus       486 ~GDTL~sIAkkygVSv~~L~~~N~l~s~~L-~~GQ~L~Ip~~~~~s~~~t~~~s~~~~~~~~~~~Y~Vk~GDTL~sIA~K  564 (592)
T PRK06347        486 KGDSLWRIANNNKVTIANLKSWNNLKSDFI-YPGQKLKVSAGSTTNNTNTAKPSTNKPSNSTVKTYTVKKGDSLWAISRQ  564 (592)
T ss_pred             CCCCHHHHHHHHCCCHHHHHHhcCCCcccc-cCCcEEEEecCcccccccccCCccCCccCccceeeecCCCCcHHHHHHH
Confidence            24555543            3676544455 9999999998653110       0   0123578999999999999999


Q ss_pred             hcCCccchhhcccccccCCcccccceeeee
Q 044997          160 LSAEISGIESMNKMVAQNPGYIDVCWVLFV  189 (563)
Q Consensus       160 f~~s~~~i~~~N~~~~~~~~~~~~~~~~~v  189 (563)
                      ||++.+.|...|++. .  ..+.++..+.|
T Consensus       565 ygvSv~~L~~~N~L~-~--~~L~~GQ~L~I  591 (592)
T PRK06347        565 YKTTVDNIKAWNKLT-S--NMIHVGQKLTI  591 (592)
T ss_pred             hCCCHHHHHHhcCCC-c--ccCCCCCEEec
Confidence            999999999999874 2  34666655544

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=97.34  E-value=0.0013  Score=64.72  Aligned_cols=126  Identities=17%  Similarity=0.086  Sum_probs=72.3

Q ss_pred             eecccCc-EEEEEEEECCceEEEEEeccCChHHHHHHHHHHHhccc----------------cceEEEeecCCCccccc-
Q 044997          299 IIGRGGF-GNVYFGLLGDREAAIKKMRSNKSKEFFAELKVLCKIHH----------------INVFISTFGNGSLSDHL-  360 (563)
Q Consensus       299 ~LG~G~f-G~Vy~g~~~~~~vavK~~~~~~~~~f~~Ei~~l~~l~H----------------~niV~e~~~~gsL~~~L-  360 (563)
                      .|-.|.. ..||+...++.++.+|........+..+|++++..+..                +-+|++++++.++.... 
T Consensus         5 ~~~~g~~~~~v~~~~~~~~~~~vk~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~   84 (244)
T cd05150           5 RVTEGQSGATVYRLDGKNPGLYLKIAPSGPTYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAALWE   84 (244)
T ss_pred             ecCCCCCcCeEEEEcCCCCcEEEEecCCCcccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHhhc
Confidence            3445555 67899887777888888876544556778888877632                22467777776655331 


Q ss_pred             ------------------ccccccCCCCCC--HHHHHHHHH--------------------HHHHHHHHHHh----cCCC
Q 044997          361 ------------------HDPLLKGHQPLT--WTARTQIAL--------------------DAAKGIEYIHD----HTKA  396 (563)
Q Consensus       361 ------------------~~~~~~~~~~l~--~~~~~~i~~--------------------~ia~gL~yLH~----~~~~  396 (563)
                                        |... ....+..  +.....-..                    .+...+..|-.    ...+
T Consensus        85 ~~~~~~~~~~l~~~l~~lH~i~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  163 (244)
T cd05150          85 ELEPERLVDALAEALRRLHALP-VADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEEDL  163 (244)
T ss_pred             ccCHHHHHHHHHHHHHHHhcCC-cccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcCce
Confidence                              1100 0000111  001110000                    01111222211    1235


Q ss_pred             ceEeCCCCCCCeEecCCCcEEEeecCCCc
Q 044997          397 RYVHRDIKTSNILLDDGLRAKVADFGLVK  425 (563)
Q Consensus       397 ~ivHrDLk~~NILl~~~~~~kl~DFGla~  425 (563)
                      .++|+|+.|.|||++++....|+||+.+.
T Consensus       164 ~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         164 VVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             EEECCCCCCccEEEeCCcEEEEEEccccc
Confidence            69999999999999998778999999775

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=97.34  E-value=0.0016  Score=70.56  Aligned_cols=127  Identities=17%  Similarity=0.180  Sum_probs=80.3

Q ss_pred             cCCCccceecccCcEEEEEEEEC-CceEEEEEeccCChH----------------------------------------H
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG-DREAAIKKMRSNKSK----------------------------------------E  330 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~vavK~~~~~~~~----------------------------------------~  330 (563)
                      ..|+ .+.||.-+.|.||+|+++ |+.||||+-++.-.+                                        +
T Consensus       162 ~~f~-~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELD  240 (538)
T KOG1235|consen  162 SEFD-EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELD  240 (538)
T ss_pred             HhcC-cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcc
Confidence            3444 468999999999999985 788999976543211                                        2


Q ss_pred             HHHHHHHHHhc----cccc-------------------eEEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHH
Q 044997          331 FFAELKVLCKI----HHIN-------------------VFISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGI  387 (563)
Q Consensus       331 f~~Ei~~l~~l----~H~n-------------------iV~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL  387 (563)
                      |.+|.+-..++    .|-+                   ++|||+++..+.+.-.-    ....++-..+..-+.+...-+
T Consensus       241 F~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i----~~~gi~~~~i~~~l~~~~~~q  316 (538)
T KOG1235|consen  241 FTKEAKNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAI----DKRGISPHDILNKLVEAYLEQ  316 (538)
T ss_pred             hHHHHHhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHH----HHcCCCHHHHHHHHHHHHHHH
Confidence            44454433332    2322                   16899999887765321    123344443333333322222


Q ss_pred             HHHHhcCCCceEeCCCCCCCeEecC----CCcEEEeecCCCcccc
Q 044997          388 EYIHDHTKARYVHRDIKTSNILLDD----GLRAKVADFGLVKLEE  428 (563)
Q Consensus       388 ~yLH~~~~~~ivHrDLk~~NILl~~----~~~~kl~DFGla~~~~  428 (563)
                      -+  .+|   ++|+|-.|.||+++.    ++++.+-|||+.+.+.
T Consensus       317 If--~~G---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is  356 (538)
T KOG1235|consen  317 IF--KTG---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS  356 (538)
T ss_pred             HH--hcC---CccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence            22  234   999999999999983    6789999999987544

>PRK06347 autolysin; Reviewed

Probab=97.25  E-value=0.00069  Score=74.39  Aligned_cols=135  Identities=16%  Similarity=0.111  Sum_probs=94.5

Q ss_pred             eeccCCCCHHHHHHhhCCCcccccccccC------CCccEEEEeec------------------------cccCCCC--c
Q 044997           54 YHINQGLPVERIASFYSANPSQIKPIFRG------NQKDYLITVPC------------------------SCKDVNS--T  101 (563)
Q Consensus        54 ~~~~~~~~~~~i~~l~~~~~~~i~~~n~~------~~~~~~vp~~C------------------------~C~~~~~--~  101 (563)
                      |....+.+|..||.-|+++..+|..+|+.      .+|.+.||..=                        .|.. .+  .
T Consensus       333 Y~V~sGDTL~~IA~rygvSv~eL~~~N~l~~d~L~~Gq~L~VP~~~~~~~~~t~~~~~~~~~~~~~~~~~~~~~-~ytVk  411 (592)
T PRK06347        333 YTVVKGDSLWRIANNHKVTVANLKAWNNLKSDFIYPGQKLKVSAGSTTSDTNTSKPSTGTSTSKPSTGTSTNAK-VYTVV  411 (592)
T ss_pred             EEeCCCCCHHHHHHHhCCCHHHHHHHhCCCccccccCcEEEEeccccccccccccccccccccccccccccCce-eEEec
Confidence            56678999999999999999999999973      67888898630                        1100 01  1


Q ss_pred             cccccccc------------cccCCCCCcceecCcEEEEeeeee------cCCC----------CceeEEEEEccCCCcH
Q 044997          102 RAMIYSGQ------------AWKVGGEENYFIAGVAVPIHLLCG------CVET----------GTQVVVTYTVQQQDTL  153 (563)
Q Consensus       102 ~~~ty~~~------------a~~~~~~~~l~~~g~~l~vpl~C~------C~~~----------~~~~llTY~~~~gd~l  153 (563)
                      .|+|..++            .||...... +.+|+.|.||..=.      .|..          ...-..+|.|+.||++
T Consensus       412 ~GDTL~sIA~kygVSv~~L~~~N~l~s~~-L~~Gq~L~IP~~~~~~~~t~~~s~~~~~~k~~s~~~~~~~~YtVk~GDTL  490 (592)
T PRK06347        412 KGDSLWRIANNNKVTIANLKSWNNLKSDF-IYPGQKLKVSAGSTSNTNTSKPSTNTNTSKPSTNTNTNAKVYTVAKGDSL  490 (592)
T ss_pred             CCCCHHHHHHHhCCCHHHHHHHhCCCcce-eccCcEEEEecCCcccccccccccccccccccccccccceeeeecCCCCH
Confidence            23444443            256433334 48999999986411      1100          0112468999999999


Q ss_pred             HHHHHHhcCCccchhhcccccccCCcccccceeeeecCcC
Q 044997          154 SIIATLLSAEISGIESMNKMVAQNPGYIDVCWVLFVPMEL  193 (563)
Q Consensus       154 s~ia~~f~~s~~~i~~~N~~~~~~~~~~~~~~~~~vp~~~  193 (563)
                      ..||.+||++.+.|.+.|++. .  +.+.++..+.||...
T Consensus       491 ~sIAkkygVSv~~L~~~N~l~-s--~~L~~GQ~L~Ip~~~  527 (592)
T PRK06347        491 WRIANNNKVTIANLKSWNNLK-S--DFIYPGQKLKVSAGS  527 (592)
T ss_pred             HHHHHHHCCCHHHHHHhcCCC-c--ccccCCcEEEEecCc
Confidence            999999999999999999864 2  346788888888743

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.23  E-value=0.0022  Score=65.02  Aligned_cols=129  Identities=16%  Similarity=0.151  Sum_probs=79.0

Q ss_pred             cceecccCcEEEEEEEECCceEEEEEeccCChHHHHHHHHHHHhccccc-----------------------eEEEeecC
Q 044997          297 SRIIGRGGFGNVYFGLLGDREAAIKKMRSNKSKEFFAELKVLCKIHHIN-----------------------VFISTFGN  353 (563)
Q Consensus       297 ~~~LG~G~fG~Vy~g~~~~~~vavK~~~~~~~~~f~~Ei~~l~~l~H~n-----------------------iV~e~~~~  353 (563)
                      .+.|..|....+|+...++..+++|.......++...|++++..+++..                       +|++++++
T Consensus        19 i~~i~~G~~n~~y~v~~~~~~~vLr~~~~~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i~G   98 (296)
T cd05153          19 FEGISAGIENTNYFVTTDSGRYVLTLFEKVSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFLAG   98 (296)
T ss_pred             eecccCccccceEEEEeCCCcEEEEEcCCCChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeCCC
Confidence            4567777778899988877889999887655566777888888875422                       24577766


Q ss_pred             CCcccc--------------ccccc--cc----CCCCCCHHHHHH----------HHHHHHHHHHHHHhc----CCCceE
Q 044997          354 GSLSDH--------------LHDPL--LK----GHQPLTWTARTQ----------IALDAAKGIEYIHDH----TKARYV  399 (563)
Q Consensus       354 gsL~~~--------------L~~~~--~~----~~~~l~~~~~~~----------i~~~ia~gL~yLH~~----~~~~iv  399 (563)
                      ..+...              ||...  ..    ......|.....          ....+...+.++...    -...++
T Consensus        99 ~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~l~  178 (296)
T cd05153          99 EHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPRGVI  178 (296)
T ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCCcCC
Confidence            554320              11000  00    001123332211          111233445555431    123599


Q ss_pred             eCCCCCCCeEecCCCcEEEeecCCCc
Q 044997          400 HRDIKTSNILLDDGLRAKVADFGLVK  425 (563)
Q Consensus       400 HrDLk~~NILl~~~~~~kl~DFGla~  425 (563)
                      |+|+.|.|||++++....|.||+.+.
T Consensus       179 HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         179 HADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             ccCcCcccEEEeCCceEEEeehhhhc
Confidence            99999999999998778999998765

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.20  E-value=0.0015  Score=61.74  Aligned_cols=93  Identities=23%  Similarity=0.263  Sum_probs=68.4

Q ss_pred             HHHHHHHhcccc-ce-----------EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEe
Q 044997          333 AELKVLCKIHHI-NV-----------FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVH  400 (563)
Q Consensus       333 ~Ei~~l~~l~H~-ni-----------V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH  400 (563)
                      .|.-+|+.+++. ++           +.||.+.+++...-..  ......-+|..|.+||.++++.+++|++.....+.-
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~CG~~~v~E~~~~~~~~~~~~~--l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~~l   85 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSCGRFYVVEYVGAGSLYGIYRP--LSQFLQSPWEQRAKIALQLLELLEELDHGPLGFFYL   85 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeECCCEEEEEeecCccccccccc--cccccccCHHHHHHHHHHHHHHHHHHhcCCCCcEEE
Confidence            477788888773 22           5677776655321000  001123689999999999999999999855445888


Q ss_pred             CCCCCCCeEecCCCcEEEeecCCCccc
Q 044997          401 RDIKTSNILLDDGLRAKVADFGLVKLE  427 (563)
Q Consensus       401 rDLk~~NILl~~~~~~kl~DFGla~~~  427 (563)
                      .|++++|+-+++++++|+.|...+-..
T Consensus        86 cDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   86 CDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             eecchHHeEEeCCCcEEEEechhcchh
Confidence            999999999999999999999876543

Proteins in this uncharacterised family are described as transmembrane proteins.

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.16  E-value=0.0053  Score=59.93  Aligned_cols=30  Identities=20%  Similarity=0.420  Sum_probs=26.7

Q ss_pred             CceEeCCCCCCCeEecC-CCcEEEeecCCCc
Q 044997          396 ARYVHRDIKTSNILLDD-GLRAKVADFGLVK  425 (563)
Q Consensus       396 ~~ivHrDLk~~NILl~~-~~~~kl~DFGla~  425 (563)
                      ..++|+|+.+.|||+++ +..+.++||..|.
T Consensus       170 ~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~  200 (235)
T cd05157         170 IVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG  200 (235)
T ss_pred             EEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence            46999999999999998 5789999998775

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.06  E-value=0.0061  Score=57.81  Aligned_cols=120  Identities=18%  Similarity=0.296  Sum_probs=77.4

Q ss_pred             cCCCccceecccCc-EEEEEEEECCceEEEEEecc---C------------C---------hHHHHHHHHHHHhcccc--
Q 044997          292 NNFDESRIIGRGGF-GNVYFGLLGDREAAIKKMRS---N------------K---------SKEFFAELKVLCKIHHI--  344 (563)
Q Consensus       292 ~~f~~~~~LG~G~f-G~Vy~g~~~~~~vavK~~~~---~------------~---------~~~f~~Ei~~l~~l~H~--  344 (563)
                      .+++..+.||.|.- |.||+.+.+|+.+|+|..+.   .            .         ...|..|.+...+|++.  
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~  116 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGR  116 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccc
Confidence            78888999999999 99999999999999999321   0            0         12477888887777543  


Q ss_pred             -ce--E--EEeecCC---Cc---------------ccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeC
Q 044997          345 -NV--F--ISTFGNG---SL---------------SDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHR  401 (563)
Q Consensus       345 -ni--V--~e~~~~g---sL---------------~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHr  401 (563)
                       ++  |  ..|+---   -+               ....++ .......+.    ..-+.+|.+-|..+|..+   |+-+
T Consensus       117 e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD-~v~~~~~~~----~~~~~~~~~dl~~~~k~g---I~~~  188 (207)
T PF13095_consen  117 EGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKD-FVPDDPPLQ----IRDIPQMLRDLKILHKLG---IVPR  188 (207)
T ss_pred             cCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEe-ecCCccccc----hhHHHHHHHHHHHHHHCC---eeec
Confidence             33  1  1222100   00               000000 001111122    334566777888899988   9999


Q ss_pred             CCCCCCeEecCCCcEEEeecCCC
Q 044997          402 DIKTSNILLDDGLRAKVADFGLV  424 (563)
Q Consensus       402 DLk~~NILl~~~~~~kl~DFGla  424 (563)
                      |+|+.|..     .-||+|||.+
T Consensus       189 Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  189 DVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             cCcccccc-----CCEEEecccC
Confidence            99999976     4599999864

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.03  E-value=0.0048  Score=61.25  Aligned_cols=125  Identities=12%  Similarity=0.050  Sum_probs=71.9

Q ss_pred             ecccCcEEEEEEEECCceEEEEEeccCCh---HHHHHHHHHHHhccc----cce--------EEEeecCCCcccc-----
Q 044997          300 IGRGGFGNVYFGLLGDREAAIKKMRSNKS---KEFFAELKVLCKIHH----INV--------FISTFGNGSLSDH-----  359 (563)
Q Consensus       300 LG~G~fG~Vy~g~~~~~~vavK~~~~~~~---~~f~~Ei~~l~~l~H----~ni--------V~e~~~~gsL~~~-----  359 (563)
                      +..|-...+|+...+++.+++|.......   -+..+|.++++.+..    |.+        |++|+++..+...     
T Consensus         4 ~~~G~tn~~y~~~~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~~~~v~e~i~G~~~~~~~~~~~   83 (256)
T TIGR02721         4 LSGGLTNRSWRIEHPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNEHWLLVEWLEGEVITLDQFVAL   83 (256)
T ss_pred             CCCcCcCCeEEEEeCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeCCEEEEEeccCcccccccccCc
Confidence            45677788999887788889987654321   135678888888754    332        5788776555321     


Q ss_pred             ------------cccccccCCCCCCHHHHH-HHHH---------HHHHHHHHHHhc-----CCCceEeCCCCCCCeEecC
Q 044997          360 ------------LHDPLLKGHQPLTWTART-QIAL---------DAAKGIEYIHDH-----TKARYVHRDIKTSNILLDD  412 (563)
Q Consensus       360 ------------L~~~~~~~~~~l~~~~~~-~i~~---------~ia~gL~yLH~~-----~~~~ivHrDLk~~NILl~~  412 (563)
                                  ||.... ...+++...+. ....         .+..-++.+-..     ..+.++|+|+.|.||++++
T Consensus        84 ~~~~~la~~l~~lH~~~~-~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Nil~~~  162 (256)
T TIGR02721        84 DLLLELAALLHQLHSQPR-FGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNLVVTP  162 (256)
T ss_pred             hhHHHHHHHHHHHhCCCC-CCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcEEEeC
Confidence                        111100 11122222111 1110         111112222211     1235899999999999998


Q ss_pred             CCcEEEeecCCCcc
Q 044997          413 GLRAKVADFGLVKL  426 (563)
Q Consensus       413 ~~~~kl~DFGla~~  426 (563)
                      ++ ++|+||..+..
T Consensus       163 ~~-~~lIDwE~a~~  175 (256)
T TIGR02721       163 QG-LKLIDWEYASD  175 (256)
T ss_pred             CC-CEEEeccccCc
Confidence            76 78999998764

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PF01476 LysM: LysM domain; InterPro: IPR018392 This domain is about 40 residues long and is found in a variety of enzymes involved in bacterial cell wall degradation []

Probab=97.00  E-value=0.00059  Score=47.92  Aligned_cols=44  Identities=27%  Similarity=0.348  Sum_probs=32.3

Q ss_pred             EEccCCCcHHHHHHHhcCCccchhhcccccccCCcccccceeeeec
Q 044997          145 YTVQQQDTLSIIATLLSAEISGIESMNKMVAQNPGYIDVCWVLFVP  190 (563)
Q Consensus       145 Y~~~~gd~ls~ia~~f~~s~~~i~~~N~~~~~~~~~~~~~~~~~vp  190 (563)
                      |.+++|||+..||.+|+++.+.+.++|+... .+. +.++..+.||
T Consensus         1 y~V~~gDtl~~IA~~~~~~~~~l~~~N~~~~-~~~-l~~G~~l~iP   44 (44)
T PF01476_consen    1 YTVQPGDTLWSIAKRYGISVDELMELNPNID-SDN-LQPGQKLCIP   44 (44)
T ss_dssp             EEE-TT--HHHHHHHTTS-HHHHHHHCCTTH-GGC-GGTTEEEEEC
T ss_pred             CEECcCCcHHHHHhhhhhhHhHHHHhcCCCC-ccc-CCCCCEEEeC
Confidence            8999999999999999999999999994432 222 6777777776

This domain may have a general peptidoglycan binding function.; GO: 0016998 cell wall macromolecule catabolic process; PDB: 2DJP_A 3ZQD_A 1Y7M_B 4A52_A 2L9Y_A 1E0G_A.

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=96.92  E-value=0.0089  Score=58.54  Aligned_cols=31  Identities=32%  Similarity=0.623  Sum_probs=26.2

Q ss_pred             CceEeCCCCCCCeEecCCCcEEEeecCCCcc
Q 044997          396 ARYVHRDIKTSNILLDDGLRAKVADFGLVKL  426 (563)
Q Consensus       396 ~~ivHrDLk~~NILl~~~~~~kl~DFGla~~  426 (563)
                      +.++|+|+.+.|||++++....|.||+.+..
T Consensus       164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~  194 (235)
T cd05155         164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV  194 (235)
T ss_pred             ceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence            4489999999999999776667999998753

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=96.90  E-value=0.0017  Score=74.67  Aligned_cols=182  Identities=17%  Similarity=0.165  Sum_probs=118.2

Q ss_pred             HHHHHHHHhccccceEE-------------------EeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 044997          332 FAELKVLCKIHHINVFI-------------------STFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHD  392 (563)
Q Consensus       332 ~~Ei~~l~~l~H~niV~-------------------e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~  392 (563)
                      ..|.+.+.++.|+|++-                   +++..-++...+..     -..++....+.+..+...||.|+|+
T Consensus       230 E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~-----v~~i~~~~~r~~~~~~~~GL~~~h~  304 (1351)
T KOG1035|consen  230 EIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQS-----VGSIPLETLRILHQKLLEGLAYLHS  304 (1351)
T ss_pred             HHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhh-----ccccCHHHHHHHHHHHhhhHHHHHH
Confidence            45778899999999842                   12222223222222     3457778888889999999999999


Q ss_pred             cCCCceEeCCCCCC---CeEecCCCcEEEe--ecCCCcccccccccccccccccCCCcccCccccccccccccccccccc
Q 044997          393 HTKARYVHRDIKTS---NILLDDGLRAKVA--DFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVME  467 (563)
Q Consensus       393 ~~~~~ivHrDLk~~---NILl~~~~~~kl~--DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~  467 (563)
                      ..   ..|.-+..+   +-..+..+...++  ||+..+.........    ...-+..|.+||......+          
T Consensus       305 ~~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~----~~~~~~~~~~~e~~~~~~~----------  367 (1351)
T KOG1035|consen  305 LS---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF----SDLLAEIRNADEDLKENTA----------  367 (1351)
T ss_pred             hc---cceeEEecccccccccCccceeecchhhhcccccCCCcccch----hhcCccccccccccccccc----------
Confidence            84   556555555   4455666777777  898877554322111    1123445778887644332          


Q ss_pred             CCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCchhhHHHH-HHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 044997          468 LQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKMKSLI-TIMAAVAEWCLNEDAVDRPEMRDIVAILS  536 (563)
Q Consensus       468 ~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~~~~~~~-~~l~~li~~cl~~dP~~RPs~~evl~~L~  536 (563)
                       ......|+|.+|.....+..|..+............... ..+......|+..++++|++..+++....
T Consensus       368 -~~~r~~dL~~lgll~~~~~~~~~i~~~~~~~~~~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f  436 (1351)
T KOG1035|consen  368 -KKSRLTDLWCLGLLLLQLSQGEDISEKSAVPVSLLDVLSTSELLDALPKCLDEDSEERLSALELLTHPF  436 (1351)
T ss_pred             -hhhhhhHHHHHHHHHhhhhhcCcccccccchhhhhccccchhhhhhhhhhcchhhhhccchhhhhhchh
Confidence             234557999999999999998765433322222222111 15677888999999999999999988653

>PRK05231 homoserine kinase; Provisional

Probab=96.87  E-value=0.019  Score=58.85  Aligned_cols=61  Identities=13%  Similarity=0.099  Sum_probs=38.3

Q ss_pred             cCHHHHHHHhcCCCc-----cceecccCcEEEEEEEECCceEEEEEeccCChHHHHHHHHHHHhcc
Q 044997          282 FSLEEIEEATNNFDE-----SRIIGRGGFGNVYFGLLGDREAAIKKMRSNKSKEFFAELKVLCKIH  342 (563)
Q Consensus       282 ~~~~el~~~~~~f~~-----~~~LG~G~fG~Vy~g~~~~~~vavK~~~~~~~~~f~~Ei~~l~~l~  342 (563)
                      .+.+++......|..     .+.|+.|....+|+...++..+++|+......+....|++++..+.
T Consensus         7 ls~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~~g~~vLK~~~~~~~~~l~~~~~~l~~L~   72 (319)
T PRK05231          7 VSDDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTTQGEYVLTLFERLTAEDLPFFLGLMQHLA   72 (319)
T ss_pred             CCHHHHHHHHHhcCCchhhccchhccccccceEEEEeCCCcEEEEEeccCChHHhHHHHHHHHHHH
Confidence            344555555455544     3456667767899988777789999886333444455666666653

>PRK10593 hypothetical protein; Provisional

Probab=96.85  E-value=0.022  Score=57.92  Aligned_cols=48  Identities=10%  Similarity=-0.039  Sum_probs=36.7

Q ss_pred             CccceecccCcEEEEEEEECCceEEEEEeccC-ChHHHHHHHHHHHhcc
Q 044997          295 DESRIIGRGGFGNVYFGLLGDREAAIKKMRSN-KSKEFFAELKVLCKIH  342 (563)
Q Consensus       295 ~~~~~LG~G~fG~Vy~g~~~~~~vavK~~~~~-~~~~f~~Ei~~l~~l~  342 (563)
                      ...+.||.|..+.||+....+..+.+|..+.. ....|.+|.+.|+.+.
T Consensus        17 ~~~~~i~~G~~~~vy~~~~~~~~~~~k~~~~~~~~~~~~~Ea~~L~~L~   65 (297)
T PRK10593         17 SRVECISEQPYAALWALYDSQGNPMPLMARSFSTPGVAQQEAWKLSMLA   65 (297)
T ss_pred             heeeecCCccceeEEEEEcCCCCEEEEEecccccchHHHHHHHHHHHHc
Confidence            34578999999999998776667777876553 3457889999888763

>PLN02876 acyl-CoA dehydrogenase

Probab=96.82  E-value=0.015  Score=67.79  Aligned_cols=49  Identities=16%  Similarity=0.290  Sum_probs=36.0

Q ss_pred             cceecccCcEEEEEEEECC----ceEEEEEeccC----ChHHHHHHHHHHHhcc-ccc
Q 044997          297 SRIIGRGGFGNVYFGLLGD----REAAIKKMRSN----KSKEFFAELKVLCKIH-HIN  345 (563)
Q Consensus       297 ~~~LG~G~fG~Vy~g~~~~----~~vavK~~~~~----~~~~f~~Ei~~l~~l~-H~n  345 (563)
                      .+.++.|.+..+|+....+    ..+++|+....    ....+.+|.++|+.+. |.+
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~  100 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTD  100 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCC
Confidence            5678899999999987754    46778876542    2356889999998885 544

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=96.66  E-value=0.02  Score=58.19  Aligned_cols=32  Identities=25%  Similarity=0.422  Sum_probs=27.8

Q ss_pred             CCceEeCCCCCCCeEecCC----CcEEEeecCCCcc
Q 044997          395 KARYVHRDIKTSNILLDDG----LRAKVADFGLVKL  426 (563)
Q Consensus       395 ~~~ivHrDLk~~NILl~~~----~~~kl~DFGla~~  426 (563)
                      ...++|+|+.+.|||++++    +.++++||..|..
T Consensus       178 ~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~  213 (302)
T cd05156         178 PVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY  213 (302)
T ss_pred             CceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence            4568999999999999985    8899999998763

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=96.61  E-value=0.044  Score=55.94  Aligned_cols=143  Identities=15%  Similarity=0.189  Sum_probs=82.0

Q ss_pred             CHHHHHHHhcCCCc-----cceecccCcEEEEEEEECCceEEEEEeccCC-hHHHHHHHHHHHhccccc-----------
Q 044997          283 SLEEIEEATNNFDE-----SRIIGRGGFGNVYFGLLGDREAAIKKMRSNK-SKEFFAELKVLCKIHHIN-----------  345 (563)
Q Consensus       283 ~~~el~~~~~~f~~-----~~~LG~G~fG~Vy~g~~~~~~vavK~~~~~~-~~~f~~Ei~~l~~l~H~n-----------  345 (563)
                      +.+++....+.|..     .+.++.|-...+|+...++...++|..+... .++...|.+++..|.+..           
T Consensus         8 ~~~~l~~~l~~y~~~~~~~i~~~~~G~~n~~y~v~t~~~~~vLK~~~~~~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~   87 (307)
T TIGR00938         8 SDEEMSSFLDGYDLGELLSLKGIAEGVENSNYLLTTDVGRYILTLYEKRVKAEELPFFLALTTHLAARGLPVPKPVKSRD   87 (307)
T ss_pred             CHHHHHHHHHhcCCCCceeccccCCccccceEEEEeCCCcEEEEEecCCCCHHHHHHHHHHHHHHHHCCCCCCccccCCC
Confidence            34555555555544     3456666667899987777778889876542 345566777777764211           


Q ss_pred             ------------eEEEeecCCCcccc--------------ccccc--ccCC-----CCCCHHHHHH------------HH
Q 044997          346 ------------VFISTFGNGSLSDH--------------LHDPL--LKGH-----QPLTWTARTQ------------IA  380 (563)
Q Consensus       346 ------------iV~e~~~~gsL~~~--------------L~~~~--~~~~-----~~l~~~~~~~------------i~  380 (563)
                                  ++++|+++..+...              +|...  ....     ..-.|.....            ..
T Consensus        88 g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~  167 (307)
T TIGR00938        88 GRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMG  167 (307)
T ss_pred             CCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHH
Confidence                        25677776543211              11100  0000     0112221110            11


Q ss_pred             HHHHHHHHHHHh----cCCCceEeCCCCCCCeEecCCCcEEEeecCCCc
Q 044997          381 LDAAKGIEYIHD----HTKARYVHRDIKTSNILLDDGLRAKVADFGLVK  425 (563)
Q Consensus       381 ~~ia~gL~yLH~----~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~  425 (563)
                      ..+.+.++++..    .-...++|+|+.+.||++++++...|.||+.+.
T Consensus       168 ~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       168 AELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             HHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            223345555543    223469999999999999998777899999875

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=96.56  E-value=0.025  Score=53.91  Aligned_cols=115  Identities=28%  Similarity=0.369  Sum_probs=72.0

Q ss_pred             CccceecccCcEEEEEEEECCceEEEEEeccCC-------------------hHHHHHHHHHHHhcc-ccce--------
Q 044997          295 DESRIIGRGGFGNVYFGLLGDREAAIKKMRSNK-------------------SKEFFAELKVLCKIH-HINV--------  346 (563)
Q Consensus       295 ~~~~~LG~G~fG~Vy~g~~~~~~vavK~~~~~~-------------------~~~f~~Ei~~l~~l~-H~ni--------  346 (563)
                      +....||+|+.-.||.-- .+....||+++...                   .+++.+|+.-...+. +.++        
T Consensus         4 ~~~~~i~~G~~R~cy~HP-~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~   82 (199)
T PF10707_consen    4 SESDLIAQGGERDCYQHP-DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF   82 (199)
T ss_pred             CCCcccccCCCceEEECC-CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence            345789999999998522 24556788877665                   577888888777776 4443        


Q ss_pred             ------------EEEeec--CCC----cccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCe
Q 044997          347 ------------FISTFG--NGS----LSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNI  408 (563)
Q Consensus       347 ------------V~e~~~--~gs----L~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NI  408 (563)
                                  |+|.+.  +|+    |.+++.+      ..++. ...+.+.   +-.+||-++.   |+.+|++|.||
T Consensus        83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~------~~~~~-~~~~~L~---~f~~~l~~~~---Iv~~dl~~~NI  149 (199)
T PF10707_consen   83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKE------GGLTE-ELRQALD---EFKRYLLDHH---IVIRDLNPHNI  149 (199)
T ss_pred             eEEEecCCceEEEEEEEECCCCCcCccHHHHHHc------CCccH-HHHHHHH---HHHHHHHHcC---CeecCCCcccE
Confidence                        334433  233    4444432      23444 3333333   3345666665   99999999999


Q ss_pred             EecCC---C-cEEEee-cCC
Q 044997          409 LLDDG---L-RAKVAD-FGL  423 (563)
Q Consensus       409 Ll~~~---~-~~kl~D-FGl  423 (563)
                      ++...   . ++.|+| ||-
T Consensus       150 v~~~~~~~~~~lvlIDG~G~  169 (199)
T PF10707_consen  150 VVQRRDSGEFRLVLIDGLGE  169 (199)
T ss_pred             EEEecCCCceEEEEEeCCCC
Confidence            99532   2 577887 554

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PLN02236 choline kinase

Probab=96.25  E-value=0.04  Score=57.30  Aligned_cols=31  Identities=19%  Similarity=0.483  Sum_probs=26.7

Q ss_pred             CceEeCCCCCCCeEecC-CCcEEEeecCCCcc
Q 044997          396 ARYVHRDIKTSNILLDD-GLRAKVADFGLVKL  426 (563)
Q Consensus       396 ~~ivHrDLk~~NILl~~-~~~~kl~DFGla~~  426 (563)
                      ..++|+|+++.|||+++ ++.+.++||..+..
T Consensus       200 ~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        200 IGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             ceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence            35899999999999986 47899999998764

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=95.90  E-value=0.087  Score=53.02  Aligned_cols=32  Identities=28%  Similarity=0.499  Sum_probs=26.5

Q ss_pred             CceEeCCCCCCCeEecCCCc-EEEeecCCCccc
Q 044997          396 ARYVHRDIKTSNILLDDGLR-AKVADFGLVKLE  427 (563)
Q Consensus       396 ~~ivHrDLk~~NILl~~~~~-~kl~DFGla~~~  427 (563)
                      +.++|+|+.+.|||++++++ .-|.||+.+..-
T Consensus       185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG  217 (276)
T cd05152         185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKVG  217 (276)
T ss_pred             CeeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence            45899999999999997555 569999988753

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=95.79  E-value=0.075  Score=54.97  Aligned_cols=30  Identities=20%  Similarity=0.405  Sum_probs=26.0

Q ss_pred             ceEeCCCCCCCeEecC-CCcEEEeecCCCcc
Q 044997          397 RYVHRDIKTSNILLDD-GLRAKVADFGLVKL  426 (563)
Q Consensus       397 ~ivHrDLk~~NILl~~-~~~~kl~DFGla~~  426 (563)
                      ..+|.|+.+.|||+++ ++.++++||..|..
T Consensus       183 v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        183 VFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             EEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            4789999999999974 57899999998764

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=95.44  E-value=0.016  Score=55.67  Aligned_cols=30  Identities=27%  Similarity=0.510  Sum_probs=21.5

Q ss_pred             ceEeCCCCCCCeEe-cCCCcEEEeecCCCcc
Q 044997          397 RYVHRDIKTSNILL-DDGLRAKVADFGLVKL  426 (563)
Q Consensus       397 ~ivHrDLk~~NILl-~~~~~~kl~DFGla~~  426 (563)
                      .+.|.|+.+.|||+ +.++.++++||..|..
T Consensus       144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred             eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence            48899999999999 8889999999998864

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>TIGR02899 spore_safA spore coat assembly protein SafA

Probab=95.40  E-value=0.015  Score=40.26  Aligned_cols=43  Identities=28%  Similarity=0.321  Sum_probs=33.0

Q ss_pred             ccCCCcHHHHHHHhcCCccchhhcccccccCCcccccceeeeec
Q 044997          147 VQQQDTLSIIATLLSAEISGIESMNKMVAQNPGYIDVCWVLFVP  190 (563)
Q Consensus       147 ~~~gd~ls~ia~~f~~s~~~i~~~N~~~~~~~~~~~~~~~~~vp  190 (563)
                      +++||++.+||.+|+++.+.+...|+.. .++..+.++..+.+|
T Consensus         1 v~~gdtl~~IA~~~~~~~~~l~~~N~~~-~~~~~~~~g~~l~ip   43 (44)
T TIGR02899         1 VQKGDTLWKIAKKYGVDFDELIQANPQL-SNPNLIYPGMKIKIP   43 (44)
T ss_pred             CCCCCCHHHHHHHHCcCHHHHHHHhhcC-CCCCCcCCCCEEecC
Confidence            4789999999999999999999999743 233345566666665

in which one of which is found in most examples of endospore-forming bacteria. Lysin motifs are repeated in many proteins.

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=95.36  E-value=0.22  Score=52.64  Aligned_cols=45  Identities=18%  Similarity=0.115  Sum_probs=33.6

Q ss_pred             cceecccCcEEEEEEEECC--ceEEEEEecc----------CChHHHHHHHHHHHhc
Q 044997          297 SRIIGRGGFGNVYFGLLGD--REAAIKKMRS----------NKSKEFFAELKVLCKI  341 (563)
Q Consensus       297 ~~~LG~G~fG~Vy~g~~~~--~~vavK~~~~----------~~~~~f~~Ei~~l~~l  341 (563)
                      .+.||.|.+..||+....+  +.+.||.-.+          -..+++..|.+.|..+
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l   87 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQ   87 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHH
Confidence            3578999999999998865  3899998431          1235677788888875

>cd00118 LysM Lysin domain, found in a variety of enzymes involved in bacterial cell wall degradation

Probab=94.92  E-value=0.034  Score=38.08  Aligned_cols=30  Identities=37%  Similarity=0.498  Sum_probs=28.2

Q ss_pred             EEEccCCCcHHHHHHHhcCCccchhhcccc
Q 044997          144 TYTVQQQDTLSIIATLLSAEISGIESMNKM  173 (563)
Q Consensus       144 TY~~~~gd~ls~ia~~f~~s~~~i~~~N~~  173 (563)
                      +|.++.||++..||.+|+++...+...|+.
T Consensus         2 ~~~v~~gdt~~~ia~~~~~~~~~~~~~N~~   31 (46)
T cd00118           2 TYTVKKGDTLSSIAQRYGISVEELLKLNGL   31 (46)
T ss_pred             EEEECCCCCHHHHHHHHCcCHHHHHHHcCC
Confidence            688999999999999999999999999986

This domain may have a general peptidoglycan binding function.

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=94.28  E-value=0.68  Score=47.37  Aligned_cols=35  Identities=29%  Similarity=0.490  Sum_probs=30.3

Q ss_pred             CCceEeCCCCCCCeEecCCCcEEEeecCCCccccc
Q 044997          395 KARYVHRDIKTSNILLDDGLRAKVADFGLVKLEER  429 (563)
Q Consensus       395 ~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~  429 (563)
                      .+.++|+|+.+.|++++.+.-.-|.||+++..-++
T Consensus       197 ~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP  231 (321)
T COG3173         197 PPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDP  231 (321)
T ss_pred             CceeeeCCcccCCEEEeCCCeeEEEeccccccCCc
Confidence            35799999999999999988899999999876443

>PF08693 SKG6: Transmembrane alpha-helix domain; InterPro: IPR014805 SKG6 and AXL2 are membrane proteins that show polarised intracellular localisation [, ]

Probab=94.27  E-value=0.039  Score=37.45  Aligned_cols=26  Identities=4%  Similarity=0.216  Sum_probs=12.7

Q ss_pred             ccceEEEehhhHHHHHHHHHHHhhhh
Q 044997          205 THKWVTVIALLSAVALFSVITLIIIL  230 (563)
Q Consensus       205 ~~~~~i~i~~~~~v~~~~~~~~~~~~  230 (563)
                      +....+.+++++.+++++++++++++
T Consensus         8 ~~~vaIa~~VvVPV~vI~~vl~~~l~   33 (40)
T PF08693_consen    8 SNTVAIAVGVVVPVGVIIIVLGAFLF   33 (40)
T ss_pred             CceEEEEEEEEechHHHHHHHHHHhh
Confidence            33444556665555544444444343

This entry represents the highly conserved transmembrane alpha-helical domain found in these proteins [, ]. The full-length AXL2 protein has a negative regulatory function in cytokinesis [].

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=94.11  E-value=0.011  Score=70.12  Aligned_cols=146  Identities=14%  Similarity=0.075  Sum_probs=95.8

Q ss_pred             HHHHHHHHHhccccceEE-----------------EeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhc
Q 044997          331 FFAELKVLCKIHHINVFI-----------------STFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDH  393 (563)
Q Consensus       331 f~~Ei~~l~~l~H~niV~-----------------e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~  393 (563)
                      ...|.+.++...|+++..                 +|+..|.+...+-... +...+++..-......+...+..-+|+.
T Consensus      1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~-ee~~~ld~~~v~~~~kvsvl~~~~~ls~ 1354 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGL-EESPDLDRSPVHLRHKVSVLNRNVILSL 1354 (2724)
T ss_pred             hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhcc-ccCCcchhchHHHHHHHHHhccchhhhc
Confidence            344555666778988743                 4445566555554321 2233444333333333335555665553


Q ss_pred             C--CCceEeCCCCCCCeEecCCCcEEEeecCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCC
Q 044997          394 T--KARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVT  471 (563)
Q Consensus       394 ~--~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s  471 (563)
                      .  ...-+|+++|+-|.+|..+.++|+.++|+.|.....   ....+..++++-|+.|+....-+             ++
T Consensus      1355 tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~---~sf~Gl~l~sp~~v~qli~N~ik-------------~t 1418 (2724)
T KOG1826|consen 1355 TNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPV---LSFFGLELCSPIYVLQLIKNEIK-------------FT 1418 (2724)
T ss_pred             ccCCccchhhhhhhhccceecCCcccccccccccccCch---HhhhhhhhCCHHHHHHHHHHHHh-------------hh
Confidence            3  224789999999999999999999999999843221   12234456788899999764443             37


Q ss_pred             CcchHHHHHHHHHHHHcCCCCC
Q 044997          472 TKTDVFAFGVVLAELITGKRAL  493 (563)
Q Consensus       472 ~ksDVwSfGvvl~Elltg~~p~  493 (563)
                      .++|+|..|+-+|+.--|..+|
T Consensus      1419 ~rsdilr~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1419 KRSDILRRSLSLYLRSDGNAYF 1440 (2724)
T ss_pred             hHHHHHHHHHHHHHHhcccHHH
Confidence            7799999999999998887665

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=94.09  E-value=0.69  Score=47.72  Aligned_cols=121  Identities=16%  Similarity=0.199  Sum_probs=73.7

Q ss_pred             cEEEEEEEECCceEEEEEeccC-ChHHHHHHHHHHHhccccc-------------------------eEEEeecCCCccc
Q 044997          305 FGNVYFGLLGDREAAIKKMRSN-KSKEFFAELKVLCKIHHIN-------------------------VFISTFGNGSLSD  358 (563)
Q Consensus       305 fG~Vy~g~~~~~~vavK~~~~~-~~~~f~~Ei~~l~~l~H~n-------------------------iV~e~~~~gsL~~  358 (563)
                      -..+|+....++..++|..+.. ...+...|++.|..+.-..                         .+.+|+++..+..
T Consensus        38 eN~~f~~~~~~g~~iLki~~~~~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~G~~~~~  117 (331)
T COG2334          38 ENSNFRVQTEDGRYILKIYRPGWTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLPGRPLER  117 (331)
T ss_pred             cCceEEEEecCCCeEEEEecCCCCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecCCcCcCC
Confidence            3568988887777799998876 5566677777777663211                         2568888777662


Q ss_pred             -cc--------------cc--cccc--C---CCCCCHHH-------------HHHHHHHHHHHHHHHHhcC----C---C
Q 044997          359 -HL--------------HD--PLLK--G---HQPLTWTA-------------RTQIALDAAKGIEYIHDHT----K---A  396 (563)
Q Consensus       359 -~L--------------~~--~~~~--~---~~~l~~~~-------------~~~i~~~ia~gL~yLH~~~----~---~  396 (563)
                       ..              |.  ....  .   .....|..             ......++...+..+.+.-    .   .
T Consensus       118 ~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~lp~~~~  197 (331)
T COG2334         118 DDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHLPALGD  197 (331)
T ss_pred             CCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhhCCcccc
Confidence             11              00  0000  0   11234431             0112334444455554421    1   1


Q ss_pred             ceEeCCCCCCCeEecCCCc-EEEeecCCCc
Q 044997          397 RYVHRDIKTSNILLDDGLR-AKVADFGLVK  425 (563)
Q Consensus       397 ~ivHrDLk~~NILl~~~~~-~kl~DFGla~  425 (563)
                      .+||+|+.|.||+++.+.. ..+.||+-+.
T Consensus       198 ~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         198 QIIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             eeeecCCCccceeEcCCCCeeeEEEccccc
Confidence            2899999999999999875 8999999875

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=93.81  E-value=0.25  Score=49.93  Aligned_cols=48  Identities=13%  Similarity=0.036  Sum_probs=36.8

Q ss_pred             CccceecccCcEEEEEEEECCceEEEEEeccCChHHHHHHHHHHHhcc
Q 044997          295 DESRIIGRGGFGNVYFGLLGDREAAIKKMRSNKSKEFFAELKVLCKIH  342 (563)
Q Consensus       295 ~~~~~LG~G~fG~Vy~g~~~~~~vavK~~~~~~~~~f~~Ei~~l~~l~  342 (563)
                      +..+.++.|....+|+...+++.+.||.-.......|..|.+-|+.|.
T Consensus        20 ~~~~~v~GG~i~~a~~~~~~~~~~FvK~~~~~~~~~f~~Ea~gL~~L~   67 (288)
T PF03881_consen   20 TSIEPVSGGDINEAYRLDTDGGSYFVKVNSESGRDMFEGEAEGLKALA   67 (288)
T ss_dssp             -EEEEE--SSSSEEEEEETTS-EEEEEEEEGGGCCHHHHHHHHHHHHC
T ss_pred             eeeEecCCCChhheEEEECCCccEEEEecChhhHHHHHHHHHHHHHHH
Confidence            345778889999999988788999999988666778999999888883

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=93.67  E-value=0.73  Score=47.69  Aligned_cols=121  Identities=19%  Similarity=0.255  Sum_probs=85.6

Q ss_pred             cceecccCcEEEEEEEE-CCceEEEEEeccC-------C------------------hHH----HHHHHHHHHhccccc-
Q 044997          297 SRIIGRGGFGNVYFGLL-GDREAAIKKMRSN-------K------------------SKE----FFAELKVLCKIHHIN-  345 (563)
Q Consensus       297 ~~~LG~G~fG~Vy~g~~-~~~~vavK~~~~~-------~------------------~~~----f~~Ei~~l~~l~H~n-  345 (563)
                      ...|..|.-..||.+.- +|..+|||+++..       .                  ++.    ..+|+.-|.+++... 
T Consensus       149 nGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGI  228 (520)
T KOG2270|consen  149 NGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGI  228 (520)
T ss_pred             ccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCC
Confidence            34677888889999976 5788999986421       0                  011    235788888886422 


Q ss_pred             ------------eEEEeecCCC-cccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecC
Q 044997          346 ------------VFISTFGNGS-LSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDD  412 (563)
Q Consensus       346 ------------iV~e~~~~gs-L~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~  412 (563)
                                  +||+|++... -.-.|.      ...++...+..+-.+++.-|.-|-..+  ++||.||.-=|+|+-+
T Consensus       229 P~PePIlLk~hVLVM~FlGrdgw~aPkLK------d~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyhd  300 (520)
T KOG2270|consen  229 PCPEPILLKNHVLVMEFLGRDGWAAPKLK------DASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYHD  300 (520)
T ss_pred             CCCCceeeecceEeeeeccCCCCcCcccc------cccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEEC
Confidence                        2788887322 222333      245777777888888888888887766  6999999999998864


Q ss_pred             CCcEEEeecCCCcc
Q 044997          413 GLRAKVADFGLVKL  426 (563)
Q Consensus       413 ~~~~kl~DFGla~~  426 (563)
                       |.+.|+|-+-+-.
T Consensus       301 -G~lyiIDVSQSVE  313 (520)
T KOG2270|consen  301 -GKLYIIDVSQSVE  313 (520)
T ss_pred             -CEEEEEEcccccc
Confidence             5899999987653

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=93.43  E-value=0.19  Score=52.41  Aligned_cols=53  Identities=32%  Similarity=0.465  Sum_probs=34.5

Q ss_pred             HHHHHhcCCCccceecccCcEEEEEEEEC-----------------CceEEEEEeccCChHHHHHHHHHHH
Q 044997          286 EIEEATNNFDESRIIGRGGFGNVYFGLLG-----------------DREAAIKKMRSNKSKEFFAELKVLC  339 (563)
Q Consensus       286 el~~~~~~f~~~~~LG~G~fG~Vy~g~~~-----------------~~~vavK~~~~~~~~~f~~Ei~~l~  339 (563)
                      .++++-.+|+ ...||.|.-..||+|..+                 .+.+|||...++..+.+...+.+|.
T Consensus       184 ~~~eiF~efn-~~PIGsG~IAQVY~atl~~a~lekd~~~~~~~~~~tq~~AiKv~Hp~V~~~ir~Dl~Il~  253 (565)
T KOG1236|consen  184 KIEEIFSEFN-REPIGSGCIAQVYRATLKTAYLEKDSGKEYVQKLGTQSCAIKVLHPNVEKQIRLDLGILG  253 (565)
T ss_pred             cHHHHHHhcC-CcccccchhhhhhhhhhhHHHhhcccchhhhcCCccceeeeeccCccHHHHHHHHHHHHh
Confidence            3444444454 357999999999998531                 2468999988776655554444443

>PTZ00384 choline kinase; Provisional

Probab=93.38  E-value=0.52  Score=49.71  Aligned_cols=29  Identities=24%  Similarity=0.316  Sum_probs=24.2

Q ss_pred             ceEeCCCCCCCeEecCCCcEEEeecCCCcc
Q 044997          397 RYVHRDIKTSNILLDDGLRAKVADFGLVKL  426 (563)
Q Consensus       397 ~ivHrDLk~~NILl~~~~~~kl~DFGla~~  426 (563)
                      ..+|.|+-+.|||.+++ .++++||..|..
T Consensus       228 VfCHNDL~~gNIL~~~~-~l~lID~EYA~~  256 (383)
T PTZ00384        228 LFCHNDLFFTNILDFNQ-GIYFIDFDFAGF  256 (383)
T ss_pred             eeeeccCCcccEEecCC-CEEEEEeccccC
Confidence            57999999999997654 699999987753

>PRK14125 cell division suppressor protein YneA; Provisional

Probab=93.25  E-value=0.13  Score=43.45  Aligned_cols=50  Identities=26%  Similarity=0.238  Sum_probs=38.3

Q ss_pred             eEEEEEccCCCcHHHHHHHhcCCc--------cchhhcccccccCCcccccceeeeecCcC
Q 044997          141 VVVTYTVQQQDTLSIIATLLSAEI--------SGIESMNKMVAQNPGYIDVCWVLFVPMEL  193 (563)
Q Consensus       141 ~llTY~~~~gd~ls~ia~~f~~s~--------~~i~~~N~~~~~~~~~~~~~~~~~vp~~~  193 (563)
                      ...+|.|++|||+.+||.+++.+.        +.+.+.|+..  ++ .+.+|..+.||...
T Consensus        35 ~~~~~tV~~GDTLW~IA~~y~~~~~l~~~~~v~~I~~~N~l~--~~-~I~~Gq~L~IP~~~   92 (103)
T PRK14125         35 QYVEITVQEGDTLWALADQYAGKHHMAKNEFIEWVEDVNNLP--SG-HIKAGDKLVIPVLK   92 (103)
T ss_pred             CcEEEEECCCCCHHHHHHHhCCCcCCCHHHHHHHHHHhcCCC--CC-cCCCCCEEEEecCC
Confidence            457899999999999999998752        3456678753  32 47889999999754

>PLN02756 S-methyl-5-thioribose kinase

Probab=93.08  E-value=4.2  Score=43.17  Aligned_cols=30  Identities=20%  Similarity=0.344  Sum_probs=24.4

Q ss_pred             CCCceEeCCCCCCCeEecCCCcEEEeecCCC
Q 044997          394 TKARYVHRDIKTSNILLDDGLRAKVADFGLV  424 (563)
Q Consensus       394 ~~~~ivHrDLk~~NILl~~~~~~kl~DFGla  424 (563)
                      ..+..+|+|+.+.||+++.++ .++.|..++
T Consensus       228 ~~~~L~HGDl~~g~i~~~~~~-~~~id~ef~  257 (418)
T PLN02756        228 RAQALVHGDLHTGSVMVTPDS-TQVIDPEFA  257 (418)
T ss_pred             cccceeecCCCCCcEEEcCCC-ceEecchhh
Confidence            345799999999999999875 888886544

>PF03109 ABC1: ABC1 family; InterPro: IPR004147 This entry includes ABC1 from yeast [] and AarF from Escherichia coli []

Probab=92.78  E-value=0.063  Score=46.68  Aligned_cols=48  Identities=23%  Similarity=0.364  Sum_probs=41.1

Q ss_pred             CCCccceecccCcEEEEEEEEC-CceEEEEEeccCChHHHHHHHHHHHhc
Q 044997          293 NFDESRIIGRGGFGNVYFGLLG-DREAAIKKMRSNKSKEFFAELKVLCKI  341 (563)
Q Consensus       293 ~f~~~~~LG~G~fG~Vy~g~~~-~~~vavK~~~~~~~~~f~~Ei~~l~~l  341 (563)
                      .|+ .+.||.|+.|.||+|++. |++||||..+++..+.+..++.+|+.+
T Consensus        13 ~fd-~~PlasASiaQVh~a~l~~g~~VaVKV~rP~i~~~i~~Dl~~l~~~   61 (119)
T PF03109_consen   13 EFD-PEPLASASIAQVHRARLKDGEEVAVKVQRPGIEEQIEADLRILRRL   61 (119)
T ss_pred             HCC-cchhhheehhhheeeeecccchhhhhhcchHHHHHHHHHHHHHHHH
Confidence            344 478999999999999984 899999999999888888888888765

These proteins have a nuclear or mitochondrial subcellular location in eukaryotes. The exact molecular functions of these proteins is not clear, however yeast ABC1 suppresses a cytochrome b mRNA translation defect and is essential for the electron transfer in the bc 1 complex [] and E. coli AarF is required for ubiquinone production []. It has been suggested that members of the ABC1 family are novel chaperonins []. These proteins are unrelated to the ABC transporter proteins.

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=92.51  E-value=0.17  Score=51.31  Aligned_cols=117  Identities=19%  Similarity=0.150  Sum_probs=77.4

Q ss_pred             CCccceecccCcEEEEEEEEC-CceEEEEEecc----------C-------C--------hHHHHHHHHHHHhccc----
Q 044997          294 FDESRIIGRGGFGNVYFGLLG-DREAAIKKMRS----------N-------K--------SKEFFAELKVLCKIHH----  343 (563)
Q Consensus       294 f~~~~~LG~G~fG~Vy~g~~~-~~~vavK~~~~----------~-------~--------~~~f~~Ei~~l~~l~H----  343 (563)
                      +..++.||-|.-+.||.+-.. |++.++|.-+-          .       .        +-...+|..-|+.+..    
T Consensus        94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp  173 (465)
T KOG2268|consen   94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP  173 (465)
T ss_pred             hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence            566899999999999999775 78888774210          0       0        0123467777777632    


Q ss_pred             --------cc-eEEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCC
Q 044997          344 --------IN-VFISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGL  414 (563)
Q Consensus       344 --------~n-iV~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~  414 (563)
                              .+ +|||++.+-.|.+.-+-        .+.   -.+..++..-+--|..+|   +||+|..-=||+++++.
T Consensus       174 VPkpiD~~RH~Vvmelv~g~Pl~~v~~v--------~d~---~~ly~~lm~~Iv~la~~G---lIHgDFNEFNimv~dd~  239 (465)
T KOG2268|consen  174 VPKPIDHNRHCVVMELVDGYPLRQVRHV--------EDP---PTLYDDLMGLIVRLANHG---LIHGDFNEFNIMVKDDD  239 (465)
T ss_pred             CCCcccccceeeHHHhhcccceeeeeec--------CCh---HHHHHHHHHHHHHHHHcC---ceecccchheeEEecCC
Confidence                    12 35666666555443221        111   234444444556677777   99999999999999999


Q ss_pred             cEEEeecCCC
Q 044997          415 RAKVADFGLV  424 (563)
Q Consensus       415 ~~kl~DFGla  424 (563)
                      .++++||--.
T Consensus       240 ~i~vIDFPQm  249 (465)
T KOG2268|consen  240 KIVVIDFPQM  249 (465)
T ss_pred             CEEEeechHh
Confidence            9999999654

>PTZ00296 choline kinase; Provisional

Probab=92.12  E-value=1.3  Score=47.70  Aligned_cols=30  Identities=20%  Similarity=0.403  Sum_probs=24.8

Q ss_pred             CceEeCCCCCCCeEecCCCcEEEeecCCCcc
Q 044997          396 ARYVHRDIKTSNILLDDGLRAKVADFGLVKL  426 (563)
Q Consensus       396 ~~ivHrDLk~~NILl~~~~~~kl~DFGla~~  426 (563)
                      ..++|.|+-+.|||.+++ .++++||..|..
T Consensus       284 ~VfCHNDl~~~NiL~~~~-~l~LIDfEYAg~  313 (442)
T PTZ00296        284 IVFCHNDLQENNIINTNK-CLRLIDFEYSGY  313 (442)
T ss_pred             eeEEeCCCCccceeecCC-CEEEEeeccccc
Confidence            358999999999988655 499999987753

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	563
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		2e-33
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		3e-33
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		4e-33
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		4e-33
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		8e-33
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		4e-31
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		1e-24
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		2e-24
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		8e-17
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		9e-17
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		6e-15
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		7e-15
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		7e-15
2pl0_A	289	Lck Bound To Imatinib Length = 289		7e-15
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		7e-15
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		7e-15
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		7e-15
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		1e-14
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		1e-14
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		1e-14
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		1e-14
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		1e-14
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		1e-14
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		1e-14
1fvr_A	327	Tie2 Kinase Domain Length = 327		2e-14
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		2e-14
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		2e-14
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		2e-14
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		2e-14
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		3e-14
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		5e-14
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		5e-14
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		5e-14
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		6e-14
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		8e-14
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		9e-14
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		1e-13
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		1e-13
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		1e-13
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		2e-13
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		2e-13
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		2e-13
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		3e-13
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		3e-13
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		3e-13
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		4e-13
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		4e-13
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		5e-13
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		5e-13
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		6e-13
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		7e-13
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		8e-13
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		8e-13
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		9e-13
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		1e-12
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		1e-12
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		1e-12
4h58_A	275	Braf In Complex With Compound 3 Length = 275		1e-12
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		1e-12
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		1e-12
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		1e-12
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		1e-12
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		1e-12
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		2e-12
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		2e-12
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		2e-12
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		2e-12
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		4e-12
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		4e-12
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		5e-12
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		5e-12
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		5e-12
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		8e-12
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		1e-11
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		1e-11
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		1e-11
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-11
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		1e-11
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		2e-11
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		2e-11
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		2e-11
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		2e-11
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		2e-11
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		2e-11
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		2e-11
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-11
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		3e-11
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		3e-11
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		3e-11
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		3e-11
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		3e-11
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		3e-11
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		3e-11
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		3e-11
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		3e-11
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		3e-11
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		3e-11
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		3e-11
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		3e-11
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		3e-11
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		4e-11
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		4e-11
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		4e-11
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		4e-11
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		4e-11
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		4e-11
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		4e-11
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		4e-11
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		4e-11
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		5e-11
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		5e-11
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		6e-11
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-11
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		6e-11
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		7e-11
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		8e-11
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		9e-11
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-10
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-10
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		1e-10
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		1e-10
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		1e-10
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		1e-10
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		1e-10
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-10
3a7f_A	303	Human Mst3 Kinase Length = 303		2e-10
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		2e-10
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-10
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-10
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		2e-10
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-10
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-10
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		2e-10
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-10
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		2e-10
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-10
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		2e-10
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-10
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		2e-10
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		2e-10
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		2e-10
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-10
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		3e-10
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		3e-10
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		4e-10
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		4e-10
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		4e-10
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		4e-10
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		4e-10
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		4e-10
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		4e-10
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		5e-10
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		5e-10
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		5e-10
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		5e-10
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		5e-10
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		5e-10
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		5e-10
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		5e-10
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		6e-10
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		6e-10
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		6e-10
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		6e-10
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		6e-10
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		7e-10
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		7e-10
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		7e-10
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		7e-10
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		7e-10
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		9e-10
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		1e-09
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		1e-09
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		1e-09
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		1e-09
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		1e-09
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		1e-09
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		2e-09
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		2e-09
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		2e-09
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		2e-09
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		2e-09
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		2e-09
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		3e-09
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		3e-09
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		4e-09
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		4e-09
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		4e-09
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		4e-09
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		4e-09
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		4e-09
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		5e-09
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		6e-09
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		6e-09
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		6e-09
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		6e-09
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		6e-09
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		6e-09
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		7e-09
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		7e-09
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		7e-09
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		8e-09
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		8e-09
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		8e-09
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		8e-09
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		8e-09
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		9e-09
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		9e-09
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		9e-09
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		9e-09
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		1e-08
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		1e-08
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		1e-08
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		1e-08
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		1e-08
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		1e-08
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		1e-08
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		1e-08
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-08
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		1e-08
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-08
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-08
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-08
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-08
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-08
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		2e-08
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-08
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		2e-08
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		2e-08
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-08
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-08
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		2e-08
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		2e-08
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		2e-08
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		2e-08
3a4o_X	286	Lyn Kinase Domain Length = 286		2e-08
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		2e-08
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		2e-08
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		2e-08
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-08
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		2e-08
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		3e-08
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		3e-08
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-08
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-08
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		3e-08
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		3e-08
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		3e-08
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		3e-08
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		3e-08
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-08
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		3e-08
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		3e-08
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		3e-08
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		3e-08
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-08
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		3e-08
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		3e-08
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		3e-08
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		3e-08
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		3e-08
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		3e-08
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		3e-08
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		4e-08
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		4e-08
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		4e-08
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		4e-08
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		4e-08
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		4e-08
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		4e-08
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		4e-08
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		4e-08
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		4e-08
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		4e-08
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		4e-08
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		5e-08
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		5e-08
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		5e-08
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		5e-08
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		5e-08
2oza_B	366	Structure Of P38alpha Complex Length = 366		5e-08
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		5e-08
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		5e-08
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		5e-08
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		5e-08
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		5e-08
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		5e-08
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		6e-08
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		6e-08
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		6e-08
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		6e-08
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		6e-08
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		6e-08
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		6e-08
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		6e-08
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		6e-08
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		6e-08
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		6e-08
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		6e-08
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		6e-08
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		6e-08
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		6e-08
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		6e-08
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		6e-08
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		6e-08
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		7e-08
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		7e-08
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		7e-08
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		7e-08
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		7e-08
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		7e-08
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		7e-08
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		7e-08
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		7e-08
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		7e-08
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		7e-08
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		7e-08
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		7e-08
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		7e-08
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		7e-08
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		7e-08
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		7e-08
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		7e-08
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		8e-08
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		8e-08
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		8e-08
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		8e-08
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		8e-08
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		8e-08
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		8e-08
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		8e-08
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		8e-08
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		8e-08
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		8e-08
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		8e-08
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		8e-08
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		9e-08
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		9e-08
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		9e-08
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		9e-08
3hec_A	348	P38 In Complex With Imatinib Length = 348		9e-08
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		9e-08
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		9e-08
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		9e-08
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		9e-08
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		9e-08
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		9e-08
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		9e-08
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		9e-08
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		9e-08
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		9e-08
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		9e-08
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		9e-08
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		9e-08
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		9e-08
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		9e-08
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		1e-07
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		1e-07
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		1e-07
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		1e-07
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		1e-07
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		1e-07
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		1e-07
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		1e-07
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		1e-07
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		1e-07
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		1e-07
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		1e-07
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		1e-07
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		1e-07
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		1e-07
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		1e-07
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		1e-07
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		1e-07
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-07
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		1e-07
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		1e-07
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		1e-07
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		1e-07
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		1e-07
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-07
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-07
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-07
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		1e-07
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		1e-07
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		1e-07
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		1e-07
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		1e-07
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-07
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		1e-07
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		1e-07
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		1e-07
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		1e-07
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		2e-07
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		2e-07
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		2e-07
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		2e-07
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		2e-07
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		2e-07
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		2e-07
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		2e-07
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		2e-07
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		2e-07
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		2e-07
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		2e-07
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		2e-07
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		2e-07
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		2e-07
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		2e-07
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		2e-07
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		2e-07
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		2e-07
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-07
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		2e-07
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		3e-07
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		3e-07
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		3e-07
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		3e-07
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		3e-07
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		3e-07
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		3e-07
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		3e-07
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		3e-07
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		3e-07
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		3e-07
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		3e-07
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-07
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		3e-07
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		3e-07
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-07
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		3e-07
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		3e-07
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		3e-07
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-07
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		3e-07
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		3e-07
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		3e-07
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		3e-07
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		3e-07
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		3e-07
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		3e-07
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		3e-07
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		3e-07
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		3e-07
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		3e-07
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		3e-07
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		3e-07
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		3e-07
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		3e-07
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		3e-07
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		3e-07
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		3e-07
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-07
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		4e-07
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		4e-07
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		4e-07
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		4e-07
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		4e-07
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		4e-07
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		4e-07
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		4e-07
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		4e-07
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		4e-07
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		4e-07
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		4e-07
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		4e-07
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		4e-07
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		4e-07
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		5e-07
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		5e-07
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		5e-07
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		5e-07
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		5e-07
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		5e-07
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		5e-07
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		5e-07
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		5e-07
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		5e-07
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		5e-07
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		5e-07
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		5e-07
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		5e-07
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		5e-07
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		5e-07
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		5e-07
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		5e-07
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		5e-07
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		5e-07
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		5e-07
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		5e-07
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		5e-07
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		6e-07
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		6e-07
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		6e-07
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		6e-07
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		6e-07
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		6e-07
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		6e-07
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		6e-07
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		6e-07
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		6e-07
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		6e-07
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		6e-07
4exu_A	371	Mapk13, Inactive Form Length = 371		6e-07
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		6e-07
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		6e-07
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		6e-07
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		6e-07
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		7e-07
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		7e-07
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		7e-07
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		7e-07
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		7e-07
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		7e-07
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		7e-07
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		7e-07
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		7e-07
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		8e-07
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		8e-07
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		8e-07
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		8e-07
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		8e-07
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		8e-07
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		8e-07
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		8e-07
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		8e-07
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		8e-07
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		8e-07
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		9e-07
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		9e-07
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		9e-07
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		9e-07
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		9e-07
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		9e-07
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		9e-07
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		9e-07
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		9e-07
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		9e-07
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		9e-07
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		9e-07
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		9e-07
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		9e-07
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		1e-06
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-06
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		1e-06
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		1e-06
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		1e-06
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		1e-06
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-06
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		1e-06
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		1e-06
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		1e-06
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-06
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-06
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		1e-06
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		1e-06
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-06
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-06
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		2e-06
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		2e-06
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		2e-06
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		2e-06
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		2e-06
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		2e-06
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		2e-06
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		2e-06
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		2e-06
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		2e-06
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		2e-06
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		2e-06
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		2e-06
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		2e-06
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-06
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		2e-06
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		2e-06
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		2e-06
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		3e-06
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		3e-06
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		3e-06
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		3e-06
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		3e-06
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		3e-06
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		3e-06
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		3e-06
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-06
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-06
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		3e-06
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		3e-06
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		3e-06
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		3e-06
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		3e-06
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		3e-06
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		3e-06
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		3e-06
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		3e-06
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		3e-06
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		3e-06
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		3e-06
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		4e-06
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		4e-06
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-06
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-06
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		4e-06
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		4e-06
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		5e-06
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		5e-06
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		5e-06
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		5e-06
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		5e-06
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		5e-06
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		6e-06
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		6e-06
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		6e-06
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		6e-06
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		6e-06
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		6e-06
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		7e-06
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-06
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		7e-06
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		8e-06
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		8e-06
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		8e-06
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		9e-06
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		9e-06
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		1e-05
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-05
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		1e-05
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-05
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		1e-05
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-05
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		1e-05
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		1e-05
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		1e-05
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		2e-05
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		2e-05
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		2e-05
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		2e-05
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		2e-05
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		2e-05
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		2e-05
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		2e-05
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		2e-05
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		2e-05
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		2e-05
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-05
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		2e-05
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		2e-05
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		2e-05
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		2e-05
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-05
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-05
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		2e-05
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		2e-05
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-05
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		3e-05
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		3e-05
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		3e-05
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		3e-05
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		3e-05
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		3e-05
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		3e-05
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		3e-05
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		3e-05
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		3e-05
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		3e-05
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		3e-05
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-05
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		3e-05
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		3e-05
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		3e-05
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		3e-05
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		3e-05
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		4e-05
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-05
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		4e-05
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		4e-05
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		4e-05
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		4e-05
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		4e-05
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-05
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		4e-05
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		4e-05
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		4e-05
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		4e-05
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-05
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		4e-05
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-05
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		4e-05
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		5e-05
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		5e-05
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		5e-05
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		5e-05
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		5e-05
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		5e-05
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		5e-05
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		5e-05
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		5e-05
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		5e-05
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		5e-05
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		5e-05
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		5e-05
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		6e-05
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-05
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		6e-05
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		6e-05
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		6e-05
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		6e-05
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		6e-05
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-05
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		6e-05
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		6e-05
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		6e-05
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		6e-05
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		6e-05
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		6e-05
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		6e-05
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		7e-05
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		7e-05
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		7e-05
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		7e-05
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		7e-05
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		7e-05
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		7e-05
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		7e-05
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		7e-05
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		7e-05
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		7e-05
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		8e-05
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		8e-05
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		8e-05
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		8e-05
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		8e-05
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		8e-05
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		9e-05
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		9e-05
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		9e-05
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		9e-05
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		1e-04
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-04
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		1e-04
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		1e-04
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		1e-04
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		1e-04
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		1e-04
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		1e-04
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		1e-04
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		1e-04
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		1e-04
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		1e-04
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		1e-04
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		1e-04
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		1e-04
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		1e-04
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		1e-04
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		1e-04
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		1e-04
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		1e-04
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		1e-04
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		1e-04
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		1e-04
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		1e-04
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		1e-04
3g51_A	325	Structural Diversity Of The Active Conformation Of		1e-04
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-04
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-04
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-04
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		1e-04
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-04
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		1e-04
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		2e-04
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		2e-04
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		2e-04
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		2e-04
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		2e-04
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		2e-04
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		2e-04
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		2e-04
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-04
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		2e-04
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		2e-04
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		2e-04
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		2e-04
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		2e-04
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		2e-04
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		2e-04
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		2e-04
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		2e-04
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		2e-04
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-04
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		2e-04
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		2e-04
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		2e-04
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		2e-04
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		2e-04
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		2e-04
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		2e-04
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		2e-04
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-04
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-04
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		2e-04
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		2e-04
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		2e-04
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		2e-04
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		3e-04
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		3e-04
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		3e-04
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		3e-04
4fie_A	423	Full-Length Human Pak4 Length = 423		3e-04
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		3e-04
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-04
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		3e-04
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		3e-04
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-04
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		3e-04
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		3e-04
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		3e-04
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		3e-04
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		4e-04
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		4e-04
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		4e-04
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		4e-04
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		4e-04
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		4e-04
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		4e-04
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		4e-04
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		4e-04
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		4e-04
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		4e-04
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		4e-04
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		4e-04
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		4e-04
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		4e-04
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		4e-04
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		4e-04
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		4e-04
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		4e-04
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		4e-04
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		5e-04
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-04
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		5e-04
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		5e-04
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		5e-04
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		5e-04
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		5e-04
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		5e-04
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		5e-04
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		5e-04
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		5e-04
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		5e-04
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		5e-04
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		5e-04
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		5e-04
4ae6_A	343	Structure And Function Of The Human Sperm-specific		5e-04
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		5e-04
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		5e-04
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		5e-04
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		5e-04
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		5e-04
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		6e-04
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		6e-04
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		6e-04
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		6e-04
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		6e-04
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		6e-04
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		6e-04
4ae9_A	343	Structure And Function Of The Human Sperm-specific		6e-04
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		6e-04
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		6e-04
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		6e-04
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		6e-04
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		6e-04
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		6e-04
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		7e-04
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		7e-04
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		7e-04
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		7e-04
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		7e-04
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		7e-04
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		8e-04
3soa_A	444	Full-Length Human Camkii Length = 444		8e-04
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		8e-04
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		8e-04
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		8e-04
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		8e-04
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		8e-04
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		8e-04
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		9e-04

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  140 bits (353), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 99/311 (31%), Positives = 155/311 (49%), Gaps = 75/311 (24%)
Query: 282 FSLEEIEEATNNFDESRI------IGRGGFGNVYFGLLGDREAAIKKMRS-------NKS 328
           FS  E++  TNNFDE  I      +G GGFG VY G + +   A+KK+ +          
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELK 74
Query: 329 KEFFAELKVLCKIHHINVF----ISTFG-----------NGSLSDHLHDPLLKGHQPLTW 373
           ++F  E+KV+ K  H N+      S+ G           NGSL D L    L G  PL+W
Sbjct: 75  QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRL--SCLDGTPPLSW 132
Query: 374 TARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEK 433
             R +IA  AA GI ++H++    ++HRDIK++NILLD+   AK++DFGL +  E+  + 
Sbjct: 133 HMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQT 189
Query: 434 EMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRAL 493
            ++ +R+VGT  Y+ PE               +  ++T K+D+++FGVVL E+ITG  A 
Sbjct: 190 -VMXSRIVGTTAYMAPE--------------ALRGEITPKSDIYSFGVVLLEIITGLPA- 233
Query: 494 IRDDSEPT----------------------KMK----SLITIMAAVAEWCLNEDAVDRPE 527
           + +  EP                       KM     + +  M +VA  CL+E    RP+
Sbjct: 234 VDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPD 293
Query: 528 MRDIVAILSQI 538
           ++ +  +L ++
Sbjct: 294 IKKVQQLLQEM 304

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  139 bits (351), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 99/311 (31%), Positives = 154/311 (49%), Gaps = 75/311 (24%)
Query: 282 FSLEEIEEATNNFDESRI------IGRGGFGNVYFGLLGDREAAIKKMRS-------NKS 328
           FS  E++  TNNFDE  I      +G GGFG VY G + +   A+KK+ +          
Sbjct: 9   FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELK 68
Query: 329 KEFFAELKVLCKIHHINVF----ISTFG-----------NGSLSDHLHDPLLKGHQPLTW 373
           ++F  E+KV+ K  H N+      S+ G           NGSL D L    L G  PL+W
Sbjct: 69  QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRL--SCLDGTPPLSW 126
Query: 374 TARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEK 433
             R +IA  AA GI ++H++    ++HRDIK++NILLD+   AK++DFGL +  E+   +
Sbjct: 127 HMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARASEKF-AQ 182
Query: 434 EMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRAL 493
            ++  R+VGT  Y+ PE               +  ++T K+D+++FGVVL E+ITG  A 
Sbjct: 183 XVMXXRIVGTTAYMAPE--------------ALRGEITPKSDIYSFGVVLLEIITGLPA- 227
Query: 494 IRDDSEPT----------------------KMK----SLITIMAAVAEWCLNEDAVDRPE 527
           + +  EP                       KM     + +  M +VA  CL+E    RP+
Sbjct: 228 VDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPD 287
Query: 528 MRDIVAILSQI 538
           ++ +  +L ++
Sbjct: 288 IKKVQQLLQEM 298

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  139 bits (351), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 99/311 (31%), Positives = 154/311 (49%), Gaps = 75/311 (24%)
Query: 282 FSLEEIEEATNNFDESRI------IGRGGFGNVYFGLLGDREAAIKKMRS-------NKS 328
           FS  E++  TNNFDE  I      +G GGFG VY G + +   A+KK+ +          
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELK 74
Query: 329 KEFFAELKVLCKIHHINVF----ISTFG-----------NGSLSDHLHDPLLKGHQPLTW 373
           ++F  E+KV+ K  H N+      S+ G           NGSL D L    L G  PL+W
Sbjct: 75  QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRL--SCLDGTPPLSW 132
Query: 374 TARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEK 433
             R +IA  AA GI ++H++    ++HRDIK++NILLD+   AK++DFGL +  E+  + 
Sbjct: 133 HMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQT 189
Query: 434 EMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRAL 493
            ++  R+VGT  Y+ PE               +  ++T K+D+++FGVVL E+ITG  A 
Sbjct: 190 -VMXXRIVGTTAYMAPE--------------ALRGEITPKSDIYSFGVVLLEIITGLPA- 233
Query: 494 IRDDSEPT----------------------KMK----SLITIMAAVAEWCLNEDAVDRPE 527
           + +  EP                       KM     + +  M +VA  CL+E    RP+
Sbjct: 234 VDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPD 293
Query: 528 MRDIVAILSQI 538
           ++ +  +L ++
Sbjct: 294 IKKVQQLLQEM 304

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  139 bits (350), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 95/304 (31%), Positives = 149/304 (49%), Gaps = 65/304 (21%)
Query: 282 FSLEEIEEATNNFDESRIIGRGGFGNVYFGLLGDRE-AAIKKMRSNKSK----EFFAELK 336
           FSL E++ A++NF    I+GRGGFG VY G L D    A+K+++  + +    +F  E++
Sbjct: 28  FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQTEVE 87
Query: 337 VLCKIHHINVF---------------ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIAL 381
           ++    H N+                     NGS++  L +   +   PL W  R +IAL
Sbjct: 88  MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRE-RPESQPPLDWPKRQRIAL 146
Query: 382 DAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLV 441
            +A+G+ Y+HDH   + +HRD+K +NILLD+   A V DFGL KL +  +     A R  
Sbjct: 147 GSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVR-- 204
Query: 442 GTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRA-----LIRD 496
           GT G++ PEY+   +              + KTDVF +GV+L ELITG+RA     L  D
Sbjct: 205 GTIGHIAPEYLSTGK-------------SSEKTDVFGYGVMLLELITGQRAFDLARLAND 251
Query: 497 DS-----------EPTKMKSLITI-------------MAAVAEWCLNEDAVDRPEMRDIV 532
           D            +  K+++L+ +             +  VA  C     ++RP+M ++V
Sbjct: 252 DDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVV 311
Query: 533 AILS 536
            +L 
Sbjct: 312 RMLE 315

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  138 bits (347), Expect = 8e-33,   Method: Compositional matrix adjust.
 Identities = 97/305 (31%), Positives = 152/305 (49%), Gaps = 67/305 (21%)
Query: 282 FSLEEIEEATNNFDESRIIGRGGFGNVYFGLLGDRE-AAIKKMRSNKSK----EFFAELK 336
           FSL E++ A++NF    I+GRGGFG VY G L D    A+K+++  +++    +F  E++
Sbjct: 20  FSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQTEVE 79
Query: 337 VLCKIHHINV-----FIST----------FGNGSLSDHLHD-PLLKGHQPLTWTARTQIA 380
           ++    H N+     F  T            NGS++  L + P  +   PL W  R +IA
Sbjct: 80  MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERP--ESQPPLDWPKRQRIA 137
Query: 381 LDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRL 440
           L +A+G+ Y+HDH   + +HRD+K +NILLD+   A V DFGL KL +  +     A R 
Sbjct: 138 LGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVR- 196
Query: 441 VGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRA-----LIR 495
            G  G++ PEY+   +              + KTDVF +GV+L ELITG+RA     L  
Sbjct: 197 -GXIGHIAPEYLSTGK-------------SSEKTDVFGYGVMLLELITGQRAFDLARLAN 242
Query: 496 DDS-----------EPTKMKSLITI-------------MAAVAEWCLNEDAVDRPEMRDI 531
           DD            +  K+++L+ +             +  VA  C     ++RP+M ++
Sbjct: 243 DDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEV 302
Query: 532 VAILS 536
           V +L 
Sbjct: 303 VRMLE 307

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  132 bits (333), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 96/310 (30%), Positives = 148/310 (47%), Gaps = 75/310 (24%)
Query: 282 FSLEEIEEATNNFDESRI------IGRGGFGNVYFGLLGDREAAIKKMRS-------NKS 328
           FS  E++  TNNFDE  I       G GGFG VY G + +   A+KK+ +          
Sbjct: 6   FSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELK 65
Query: 329 KEFFAELKVLCKIHHINVF----ISTFG-----------NGSLSDHLHDPLLKGHQPLTW 373
           ++F  E+KV  K  H N+      S+ G           NGSL D L    L G  PL+W
Sbjct: 66  QQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRL--SCLDGTPPLSW 123
Query: 374 TARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEK 433
             R +IA  AA GI ++H++    ++HRDIK++NILLD+   AK++DFGL +  E+   +
Sbjct: 124 HXRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARASEKF-AQ 179
Query: 434 EMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRAL 493
            +  +R+VGT  Y  PE               +  ++T K+D+++FGVVL E+ITG  A 
Sbjct: 180 XVXXSRIVGTTAYXAPE--------------ALRGEITPKSDIYSFGVVLLEIITGLPA- 224
Query: 494 IRDDSEPTKM--------------------------KSLITIMAAVAEWCLNEDAVDRPE 527
           + +  EP  +                           + +    +VA  CL+E    RP+
Sbjct: 225 VDEHREPQLLLDIKEEIEDEEKTIEDYIDKKXNDADSTSVEAXYSVASQCLHEKKNKRPD 284
Query: 528 MRDIVAILSQ 537
           ++ +  +L +
Sbjct: 285 IKKVQQLLQE 294

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  111 bits (278), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 81/254 (31%), Positives = 126/254 (49%), Gaps = 46/254 (18%)
Query: 284 LEEIEEATNNFDESRIIGRGGFGNVYFGLLGDREAAIKKMRSNKSKE------------- 330
           L ++EEATNNFD   +IG G FG VY G+L D      K R+ +S +             
Sbjct: 31  LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLS 90
Query: 331 -----FFAELKVLCKIHHINVFISTF-GNGSLSDHLHDPLLKGHQPLTWTARTQIALDAA 384
                    L   C   +  + I  +  NG+L  HL+   L     ++W  R +I + AA
Sbjct: 91  FCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPT-MSMSWEQRLEICIGAA 149
Query: 385 KGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP 444
           +G+ Y+  HT+A  +HRD+K+ NILLD+    K+ DFG+ K     ++  +    + GT 
Sbjct: 150 RGLHYL--HTRA-IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXV-VKGTL 205
Query: 445 GYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKMK 504
           GY+ PEY F+K             ++T K+DV++FGVVL E++  + A++         +
Sbjct: 206 GYIDPEY-FIKG------------RLTEKSDVYSFGVVLFEVLCARSAIV---------Q 243
Query: 505 SLITIMAAVAEWCL 518
           SL   M  +AEW +
Sbjct: 244 SLPREMVNLAEWAV 257

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  110 bits (276), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 81/254 (31%), Positives = 125/254 (49%), Gaps = 46/254 (18%)
Query: 284 LEEIEEATNNFDESRIIGRGGFGNVYFGLLGDREAAIKKMRSNKSKE------------- 330
           L ++EEATNNFD   +IG G FG VY G+L D      K R+ +S +             
Sbjct: 31  LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLS 90
Query: 331 -----FFAELKVLCKIHHINVFISTF-GNGSLSDHLHDPLLKGHQPLTWTARTQIALDAA 384
                    L   C   +  + I  +  NG+L  HL+   L     ++W  R +I + AA
Sbjct: 91  FCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPT-MSMSWEQRLEICIGAA 149
Query: 385 KGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP 444
           +G+ Y+  HT+A  +HRD+K+ NILLD+    K+ DFG+ K      +  +    + GT 
Sbjct: 150 RGLHYL--HTRA-IIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXV-VKGTL 205
Query: 445 GYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKMK 504
           GY+ PEY F+K             ++T K+DV++FGVVL E++  + A++         +
Sbjct: 206 GYIDPEY-FIKG------------RLTEKSDVYSFGVVLFEVLCARSAIV---------Q 243
Query: 505 SLITIMAAVAEWCL 518
           SL   M  +AEW +
Sbjct: 244 SLPREMVNLAEWAV 257

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 67/273 (24%), Positives = 121/273 (44%), Gaps = 57/273 (20%)
Query: 299 IIGRGGFGNVYFGLLGDREAAIKKMRS-NKSKEFFAELKVLCKIHHINVFISTFG----- 352
           ++GRG FG V       ++ AIK++ S ++ K F  EL+ L +++H N+ +  +G     
Sbjct: 16  VVGRGAFGVVCKAKWRAKDVAIKQIESESERKAFIVELRQLSRVNHPNI-VKLYGACLNP 74
Query: 353 ---------NGSLSDHLHDPLLKGHQPLTWTARTQI---ALDAAKGIEYIHDHTKARYVH 400
                     GSL + LH     G +PL +          L  ++G+ Y+H       +H
Sbjct: 75  VCLVMEYAEGGSLYNVLH-----GAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIH 129
Query: 401 RDIKTSNILL-DDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRF 459
           RD+K  N+LL   G   K+ DFG         + +   T   G+  ++ PE      +  
Sbjct: 130 RDLKPPNLLLVAGGTVLKICDFGT------ACDIQTHMTNNKGSAAWMAPEVFEGSNY-- 181
Query: 460 DMHSSVMELQVTTKTDVFAFGVVLAELITGKRAL-------------IRDDSEPTKMKSL 506
                      + K DVF++G++L E+IT ++               + + + P  +K+L
Sbjct: 182 -----------SEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNL 230
Query: 507 ITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIM 539
              + ++   C ++D   RP M +IV I++ +M
Sbjct: 231 PKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLM 263

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 85.1 bits (209), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 67/273 (24%), Positives = 121/273 (44%), Gaps = 57/273 (20%)
Query: 299 IIGRGGFGNVYFGLLGDREAAIKKMRS-NKSKEFFAELKVLCKIHHINVFISTFG----- 352
           ++GRG FG V       ++ AIK++ S ++ K F  EL+ L +++H N+ +  +G     
Sbjct: 15  VVGRGAFGVVCKAKWRAKDVAIKQIESESERKAFIVELRQLSRVNHPNI-VKLYGACLNP 73
Query: 353 ---------NGSLSDHLHDPLLKGHQPLTWTARTQI---ALDAAKGIEYIHDHTKARYVH 400
                     GSL + LH     G +PL +          L  ++G+ Y+H       +H
Sbjct: 74  VCLVMEYAEGGSLYNVLH-----GAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIH 128
Query: 401 RDIKTSNILL-DDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRF 459
           RD+K  N+LL   G   K+ DFG         + +   T   G+  ++ PE      +  
Sbjct: 129 RDLKPPNLLLVAGGTVLKICDFGT------ACDIQTHMTNNKGSAAWMAPEVFEGSNY-- 180
Query: 460 DMHSSVMELQVTTKTDVFAFGVVLAELITGKRAL-------------IRDDSEPTKMKSL 506
                      + K DVF++G++L E+IT ++               + + + P  +K+L
Sbjct: 181 -----------SEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNL 229
Query: 507 ITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIM 539
              + ++   C ++D   RP M +IV I++ +M
Sbjct: 230 PKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLM 262

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 76/298 (25%), Positives = 125/298 (41%), Gaps = 76/298 (25%)
Query: 290 ATNNFDESRIIGRGGFGNVYFG--------------LLGDREAAIKKMRSNKSKEFFAEL 335
           A N  +  + IG+GGFG V+ G              +LGD E   + +   K +EF  E+
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIE--KFQEFQREV 74
Query: 336 KVLCKIHHINVFISTFGNGSLSDHLHDP----------------LLKGHQPLTWTARTQI 379
            ++  ++H N+         L   +H+P                LL    P+ W+ + ++
Sbjct: 75  FIMSNLNHPNIV-------KLYGLMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRL 127
Query: 380 ALDAAKGIEYIHDHTKARYVHRDIKTSNILL-----DDGLRAKVADFGLVKLEERTNEKE 434
            LD A GIEY+ +      VHRD+++ NI L     +  + AKVADFGL      + +  
Sbjct: 128 MLDIALGIEYMQNQNPP-IVHRDLRSPNIFLQSLDENAPVCAKVADFGL------SQQSV 180
Query: 435 MLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRA-- 492
              + L+G   ++ PE I              E   T K D ++F ++L  ++TG+    
Sbjct: 181 HSVSGLLGNFQWMAPETI-----------GAEEESYTEKADTYSFAMILYTILTGEGPFD 229
Query: 493 -----------LIRDDS-EPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQI 538
                      +IR++   PT  +     +  V E C + D   RP    IV  LS++
Sbjct: 230 EYSYGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 75/282 (26%), Positives = 118/282 (41%), Gaps = 67/282 (23%)
Query: 300 IGRGGFGNVYFGLL-GDREAAIKKMR--SNKSKEFFAELKVLCKIHH------------- 343
           +G G FG V+ G   G  + A+K ++  S     F AE  ++ ++ H             
Sbjct: 30  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE 89
Query: 344 -INVFISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRD 402
            I +      NGSL D L  P       LT      +A   A+G+ +I +     Y+HRD
Sbjct: 90  PIYIITEYMENGSLVDFLKTP---SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRD 143
Query: 403 IKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP-GYLPPEYIFVKRFRFDM 461
           ++ +NIL+ D L  K+ADFGL +L E   + E  A      P  +  PE I    F    
Sbjct: 144 LRAANILVSDTLSCKIADFGLARLIE---DNEXTAREGAKFPIKWTAPEAINYGTF---- 196
Query: 462 HSSVMELQVTTKTDVFAFGVVLAELITGKR-------------------ALIRDDSEPTK 502
                    T K+DV++FG++L E++T  R                    ++R D+ P +
Sbjct: 197 ---------TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEE 247
Query: 503 MKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITSTE 544
           +  L+ +       C  E   DRP    + ++L     T+TE
Sbjct: 248 LYQLMRL-------CWKERPEDRPTFDYLRSVLEDF-FTATE 281

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 75/282 (26%), Positives = 118/282 (41%), Gaps = 67/282 (23%)
Query: 300 IGRGGFGNVYFGLL-GDREAAIKKMR--SNKSKEFFAELKVLCKIHH------------- 343
           +G G FG V+ G   G  + A+K ++  S     F AE  ++ ++ H             
Sbjct: 29  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE 88
Query: 344 -INVFISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRD 402
            I +      NGSL D L  P       LT      +A   A+G+ +I +     Y+HRD
Sbjct: 89  PIYIITEYMENGSLVDFLKTP---SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRD 142
Query: 403 IKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP-GYLPPEYIFVKRFRFDM 461
           ++ +NIL+ D L  K+ADFGL +L E   + E  A      P  +  PE I    F    
Sbjct: 143 LRAANILVSDTLSCKIADFGLARLIE---DNEXTAREGAKFPIKWTAPEAINYGTF---- 195
Query: 462 HSSVMELQVTTKTDVFAFGVVLAELITGKR-------------------ALIRDDSEPTK 502
                    T K+DV++FG++L E++T  R                    ++R D+ P +
Sbjct: 196 ---------TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEE 246
Query: 503 MKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITSTE 544
           +  L+ +       C  E   DRP    + ++L     T+TE
Sbjct: 247 LYQLMRL-------CWKERPEDRPTFDYLRSVLEDF-FTATE 280

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 75/282 (26%), Positives = 118/282 (41%), Gaps = 67/282 (23%)
Query: 300 IGRGGFGNVYFGLL-GDREAAIKKMR--SNKSKEFFAELKVLCKIHH------------- 343
           +G G FG V+ G   G  + A+K ++  S     F AE  ++ ++ H             
Sbjct: 31  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE 90
Query: 344 -INVFISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRD 402
            I +      NGSL D L  P       LT      +A   A+G+ +I +     Y+HRD
Sbjct: 91  PIYIITEYMENGSLVDFLKTP---SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRD 144
Query: 403 IKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP-GYLPPEYIFVKRFRFDM 461
           ++ +NIL+ D L  K+ADFGL +L E   + E  A      P  +  PE I    F    
Sbjct: 145 LRAANILVSDTLSCKIADFGLARLIE---DNEYTAREGAKFPIKWTAPEAINYGTF---- 197
Query: 462 HSSVMELQVTTKTDVFAFGVVLAELITGKR-------------------ALIRDDSEPTK 502
                    T K+DV++FG++L E++T  R                    ++R D+ P +
Sbjct: 198 ---------TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEE 248
Query: 503 MKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITSTE 544
           +  L+ +       C  E   DRP    + ++L     T+TE
Sbjct: 249 LYQLMRL-------CWKERPEDRPTFDYLRSVLEDF-FTATE 282

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 75/282 (26%), Positives = 118/282 (41%), Gaps = 67/282 (23%)
Query: 300 IGRGGFGNVYFGLL-GDREAAIKKMR--SNKSKEFFAELKVLCKIHH------------- 343
           +G G FG V+ G   G  + A+K ++  S     F AE  ++ ++ H             
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE 80
Query: 344 -INVFISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRD 402
            I +      NGSL D L  P       LT      +A   A+G+ +I +     Y+HRD
Sbjct: 81  PIYIITEYMENGSLVDFLKTP---SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRD 134
Query: 403 IKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP-GYLPPEYIFVKRFRFDM 461
           ++ +NIL+ D L  K+ADFGL +L E   + E  A      P  +  PE I    F    
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLIE---DNEXTAREGAKFPIKWTAPEAINYGTF---- 187
Query: 462 HSSVMELQVTTKTDVFAFGVVLAELITGKR-------------------ALIRDDSEPTK 502
                    T K+DV++FG++L E++T  R                    ++R D+ P +
Sbjct: 188 ---------TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEE 238
Query: 503 MKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITSTE 544
           +  L+ +       C  E   DRP    + ++L     T+TE
Sbjct: 239 LYQLMRL-------CWKERPEDRPTFDYLRSVLEDF-FTATE 272

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 75/282 (26%), Positives = 118/282 (41%), Gaps = 67/282 (23%)
Query: 300 IGRGGFGNVYFGLL-GDREAAIKKMR--SNKSKEFFAELKVLCKIHH------------- 343
           +G G FG V+ G   G  + A+K ++  S     F AE  ++ ++ H             
Sbjct: 26  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE 85
Query: 344 -INVFISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRD 402
            I +      NGSL D L  P       LT      +A   A+G+ +I +     Y+HRD
Sbjct: 86  PIYIITEYMENGSLVDFLKTP---SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRD 139
Query: 403 IKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP-GYLPPEYIFVKRFRFDM 461
           ++ +NIL+ D L  K+ADFGL +L E   + E  A      P  +  PE I    F    
Sbjct: 140 LRAANILVSDTLSCKIADFGLARLIE---DNEYTAREGAKFPIKWTAPEAINYGTF---- 192
Query: 462 HSSVMELQVTTKTDVFAFGVVLAELITGKR-------------------ALIRDDSEPTK 502
                    T K+DV++FG++L E++T  R                    ++R D+ P +
Sbjct: 193 ---------TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEE 243
Query: 503 MKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITSTE 544
           +  L+ +       C  E   DRP    + ++L     T+TE
Sbjct: 244 LYQLMRL-------CWKERPEDRPTFDYLRSVLEDF-FTATE 277

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 75/282 (26%), Positives = 118/282 (41%), Gaps = 67/282 (23%)
Query: 300 IGRGGFGNVYFGLL-GDREAAIKKMR--SNKSKEFFAELKVLCKIHH------------- 343
           +G G FG V+ G   G  + A+K ++  S     F AE  ++ ++ H             
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE 86
Query: 344 -INVFISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRD 402
            I +      NGSL D L  P       LT      +A   A+G+ +I +     Y+HRD
Sbjct: 87  PIYIITEYMENGSLVDFLKTP---SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRD 140
Query: 403 IKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP-GYLPPEYIFVKRFRFDM 461
           ++ +NIL+ D L  K+ADFGL +L E   + E  A      P  +  PE I    F    
Sbjct: 141 LRAANILVSDTLSCKIADFGLARLIE---DNEXTAREGAKFPIKWTAPEAINYGTF---- 193
Query: 462 HSSVMELQVTTKTDVFAFGVVLAELITGKR-------------------ALIRDDSEPTK 502
                    T K+DV++FG++L E++T  R                    ++R D+ P +
Sbjct: 194 ---------TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEE 244
Query: 503 MKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITSTE 544
           +  L+ +       C  E   DRP    + ++L     T+TE
Sbjct: 245 LYQLMRL-------CWKERPEDRPTFDYLRSVLEDF-FTATE 278

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 68/278 (24%), Positives = 119/278 (42%), Gaps = 57/278 (20%)
Query: 300 IGRGGFGNVYFGLLGDREAAIK-----KMRSNKSKEFFAELKVLCKIHHINVFI------ 348
           IG G FG V+       + A+K        + +  EF  E+ ++ ++ H N+ +      
Sbjct: 45  IGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVT 104
Query: 349 ---------STFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYV 399
                         GSL   LH       + L    R  +A D AKG+ Y+H+      V
Sbjct: 105 QPPNLSIVTEYLSRGSLYRLLHKS--GAREQLDERRRLSMAYDVAKGMNYLHNRNPP-IV 161
Query: 400 HRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATR-LVGTPGYLPPEYIFVKRFR 458
           HR++K+ N+L+D     KV DFGL +L+  T     L+++   GTP ++ PE +      
Sbjct: 162 HRNLKSPNLLVDKKYTVKVCDFGLSRLKAST----FLSSKSAAGTPEWMAPEVL------ 211
Query: 459 FDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKM--------------K 504
                   +     K+DV++FGV+L EL T ++     +  P ++              +
Sbjct: 212 -------RDEPSNEKSDVYSFGVILWELATLQQPW--GNLNPAQVVAAVGFKCKRLEIPR 262
Query: 505 SLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITS 542
           +L   +AA+ E C   +   RP    I+ +L  ++ ++
Sbjct: 263 NLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 96/210 (45%), Gaps = 40/210 (19%)
Query: 300 IGRGGFGNVYFGLL-GDREAAIKKMRSN--KSKEFFAELKVLCKIHH------------- 343
           +G G FG V+ G   G+ + AIK ++      + F  E +++ K+ H             
Sbjct: 17  LGNGQFGEVWMGTWNGNTKVAIKTLKPGTMSPESFLEEAQIMKKLKHDKLVQLYAVVSEE 76
Query: 344 -INVFISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRD 402
            I +       GSL D L D      + L       +A   A G+ YI    +  Y+HRD
Sbjct: 77  PIYIVTEYMNKGSLLDFLKD---GEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRD 130
Query: 403 IKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP-GYLPPEYIFVKRFRFDM 461
           ++++NIL+ +GL  K+ADFGL +L E   + E  A +    P  +  PE     RF    
Sbjct: 131 LRSANILVGNGLICKIADFGLARLIE---DNEXTARQGAKFPIKWTAPEAALYGRF---- 183
Query: 462 HSSVMELQVTTKTDVFAFGVVLAELITGKR 491
                    T K+DV++FG++L EL+T  R
Sbjct: 184 ---------TIKSDVWSFGILLTELVTKGR 204

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/277 (24%), Positives = 116/277 (41%), Gaps = 55/277 (19%)
Query: 300 IGRGGFGNVYFGLLGDREAAIK-----KMRSNKSKEFFAELKVLCKIHHINVFI------ 348
           IG G FG V+       + A+K        + +  EF  E+ ++ ++ H N+ +      
Sbjct: 45  IGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVT 104
Query: 349 ---------STFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYV 399
                         GSL   LH       + L    R  +A D AKG+ Y+H+      V
Sbjct: 105 QPPNLSIVTEYLSRGSLYRLLHKS--GAREQLDERRRLSMAYDVAKGMNYLHNRNPP-IV 161
Query: 400 HRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRF 459
           HRD+K+ N+L+D     KV DFGL +L+       + +    GTP ++ PE +       
Sbjct: 162 HRDLKSPNLLVDKKYTVKVCDFGLSRLKA---SXFLXSKXAAGTPEWMAPEVL------- 211
Query: 460 DMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKM--------------KS 505
                  +     K+DV++FGV+L EL T ++     +  P ++              ++
Sbjct: 212 ------RDEPSNEKSDVYSFGVILWELATLQQPW--GNLNPAQVVAAVGFKCKRLEIPRN 263
Query: 506 LITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITS 542
           L   +AA+ E C   +   RP    I+ +L  ++ ++
Sbjct: 264 LNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 111/232 (47%), Gaps = 55/232 (23%)
Query: 292 NNFDESRIIGRGGFGNVYFGLL---GDR-EAAIKKMRSNKSKE----FFAELKVLCKI-H 342
           N+     +IG G FG V    +   G R +AAIK+M+   SK+    F  EL+VLCK+ H
Sbjct: 15  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 74
Query: 343 HINVF---------------ISTFGNGSLSDHLH-------DPLLKGHQPLTWTARTQ-- 378
           H N+                I    +G+L D L        DP          T  +Q  
Sbjct: 75  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 134
Query: 379 --IALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEML 436
              A D A+G++Y+   ++ +++HRD+   NIL+ +   AK+ADFGL + +E   +K M 
Sbjct: 135 LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM- 190
Query: 437 ATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
                   G LP  ++ ++   + ++        TT +DV+++GV+L E+++
Sbjct: 191 --------GRLPVRWMAIESLNYSVY--------TTNSDVWSYGVLLWEIVS 226

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 72/280 (25%), Positives = 115/280 (41%), Gaps = 66/280 (23%)
Query: 300 IGRGGFGNVYFGLL-GDREAAIKKMR--SNKSKEFFAELKVLCKIHH------------- 343
           +G G FG V+ G   G  + A+K ++  S     F AE  ++ ++ H             
Sbjct: 22  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE 81
Query: 344 -INVFISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRD 402
            I +      NGSL D L  P       LT      +A   A+G+ +I +     Y+HRD
Sbjct: 82  PIYIITEYMENGSLVDFLKTP---SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRD 135
Query: 403 IKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP-GYLPPEYIFVKRFRFDM 461
           ++ +NIL+ D L  K+ADFGL +L E   + E  A      P  +  PE I    F    
Sbjct: 136 LRAANILVSDTLSCKIADFGLARLIE---DNEXTAREGAKFPIKWTAPEAINYGTF---- 188
Query: 462 HSSVMELQVTTKTDVFAFGVVLAELITGKR-------------------ALIRDDSEPTK 502
                    T K+DV++FG++L E++T  R                    ++R D+ P +
Sbjct: 189 ---------TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEE 239
Query: 503 MKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITS 542
           +  L+ +       C  E   DRP    + ++L      +
Sbjct: 240 LYQLMRL-------CWKERPEDRPTFDYLRSVLEDFFTAT 272

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 72/280 (25%), Positives = 115/280 (41%), Gaps = 66/280 (23%)
Query: 300 IGRGGFGNVYFGLL-GDREAAIKKMR--SNKSKEFFAELKVLCKIHH------------- 343
           +G G FG V+ G   G  + A+K ++  S     F AE  ++ ++ H             
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE 86
Query: 344 -INVFISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRD 402
            I +      NGSL D L  P       LT      +A   A+G+ +I +     Y+HRD
Sbjct: 87  PIYIITEYMENGSLVDFLKTP---SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRD 140
Query: 403 IKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP-GYLPPEYIFVKRFRFDM 461
           ++ +NIL+ D L  K+ADFGL +L E   + E  A      P  +  PE I    F    
Sbjct: 141 LRAANILVSDTLSCKIADFGLARLIE---DNEYTAREGAKFPIKWTAPEAINYGTF---- 193
Query: 462 HSSVMELQVTTKTDVFAFGVVLAELITGKR-------------------ALIRDDSEPTK 502
                    T K+DV++FG++L E++T  R                    ++R D+ P +
Sbjct: 194 ---------TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEE 244
Query: 503 MKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITS 542
           +  L+ +       C  E   DRP    + ++L      +
Sbjct: 245 LYQLMRL-------CWKERPEDRPTFDYLRSVLEDFFTAT 277

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 72/280 (25%), Positives = 115/280 (41%), Gaps = 66/280 (23%)
Query: 300 IGRGGFGNVYFGLL-GDREAAIKKMR--SNKSKEFFAELKVLCKIHH------------- 343
           +G G FG V+ G   G  + A+K ++  S     F AE  ++ ++ H             
Sbjct: 23  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE 82
Query: 344 -INVFISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRD 402
            I +      NGSL D L  P       LT      +A   A+G+ +I +     Y+HRD
Sbjct: 83  PIYIITEYMENGSLVDFLKTP---SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRD 136
Query: 403 IKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP-GYLPPEYIFVKRFRFDM 461
           ++ +NIL+ D L  K+ADFGL +L E   + E  A      P  +  PE I    F    
Sbjct: 137 LRAANILVSDTLSCKIADFGLARLIE---DNEXTAREGAKFPIKWTAPEAINYGTF---- 189
Query: 462 HSSVMELQVTTKTDVFAFGVVLAELITGKR-------------------ALIRDDSEPTK 502
                    T K+DV++FG++L E++T  R                    ++R D+ P +
Sbjct: 190 ---------TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEE 240
Query: 503 MKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITS 542
           +  L+ +       C  E   DRP    + ++L      +
Sbjct: 241 LYQLMRL-------CWKERPEDRPTFDYLRSVLEDFFTAT 273

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 111/232 (47%), Gaps = 55/232 (23%)
Query: 292 NNFDESRIIGRGGFGNVYFGLL---GDR-EAAIKKMRSNKSKE----FFAELKVLCKI-H 342
           N+     +IG G FG V    +   G R +AAIK+M+   SK+    F  EL+VLCK+ H
Sbjct: 25  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 84
Query: 343 HINVF---------------ISTFGNGSLSDHLH-------DPLLKGHQPLTWTARTQ-- 378
           H N+                I    +G+L D L        DP          T  +Q  
Sbjct: 85  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 379 --IALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEML 436
              A D A+G++Y+   ++ +++HRD+   NIL+ +   AK+ADFGL + +E   +K M 
Sbjct: 145 LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM- 200
Query: 437 ATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
                   G LP  ++ ++   + ++        TT +DV+++GV+L E+++
Sbjct: 201 --------GRLPVRWMAIESLNYSVY--------TTNSDVWSYGVLLWEIVS 236

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 72/280 (25%), Positives = 115/280 (41%), Gaps = 66/280 (23%)
Query: 300 IGRGGFGNVYFGLL-GDREAAIKKMR--SNKSKEFFAELKVLCKIHH------------- 343
           +G G FG V+ G   G  + A+K ++  S     F AE  ++ ++ H             
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE 80
Query: 344 -INVFISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRD 402
            I +      NGSL D L  P       LT      +A   A+G+ +I +     Y+HRD
Sbjct: 81  PIYIITEYMENGSLVDFLKTP---SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRD 134
Query: 403 IKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP-GYLPPEYIFVKRFRFDM 461
           ++ +NIL+ D L  K+ADFGL +L E   + E  A      P  +  PE I    F    
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLIE---DNEYTAREGAKFPIKWTAPEAINYGTF---- 187
Query: 462 HSSVMELQVTTKTDVFAFGVVLAELITGKR-------------------ALIRDDSEPTK 502
                    T K+DV++FG++L E++T  R                    ++R D+ P +
Sbjct: 188 ---------TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEE 238
Query: 503 MKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITS 542
           +  L+ +       C  E   DRP    + ++L      +
Sbjct: 239 LYQLMRL-------CWKERPEDRPTFDYLRSVLEDFFTAT 271

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 72/280 (25%), Positives = 115/280 (41%), Gaps = 66/280 (23%)
Query: 300 IGRGGFGNVYFGLL-GDREAAIKKMR--SNKSKEFFAELKVLCKIHH------------- 343
           +G G FG V+ G   G  + A+K ++  S     F AE  ++ ++ H             
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE 80
Query: 344 -INVFISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRD 402
            I +      NGSL D L  P       LT      +A   A+G+ +I +     Y+HRD
Sbjct: 81  PIYIITEYMENGSLVDFLKTP---SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRD 134
Query: 403 IKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP-GYLPPEYIFVKRFRFDM 461
           ++ +NIL+ D L  K+ADFGL +L E   + E  A      P  +  PE I    F    
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLIE---DNEXTAREGAKFPIKWTAPEAINYGTF---- 187
Query: 462 HSSVMELQVTTKTDVFAFGVVLAELITGKR-------------------ALIRDDSEPTK 502
                    T K+DV++FG++L E++T  R                    ++R D+ P +
Sbjct: 188 ---------TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEE 238
Query: 503 MKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITS 542
           +  L+ +       C  E   DRP    + ++L      +
Sbjct: 239 LYQLMRL-------CWKERPEDRPTFDYLRSVLEDFFTAT 271

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 72/273 (26%), Positives = 114/273 (41%), Gaps = 66/273 (24%)
Query: 300 IGRGGFGNVYFGLL-GDREAAIKKMR--SNKSKEFFAELKVLCKIHH------------- 343
           +G G FG V+ G   G  + A+K ++  S     F AE  ++ ++ H             
Sbjct: 16  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE 75
Query: 344 -INVFISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRD 402
            I +      NGSL D L  P       LT      +A   A+G+ +I +     Y+HRD
Sbjct: 76  PIYIITEYMENGSLVDFLKTP---SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRD 129
Query: 403 IKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP-GYLPPEYIFVKRFRFDM 461
           ++ +NIL+ D L  K+ADFGL +L E   + E  A      P  +  PE I    F    
Sbjct: 130 LRAANILVSDTLSCKIADFGLARLIE---DNEYTAREGAKFPIKWTAPEAINYGTF---- 182
Query: 462 HSSVMELQVTTKTDVFAFGVVLAELITGKR-------------------ALIRDDSEPTK 502
                    T K+DV++FG++L E++T  R                    ++R D+ P +
Sbjct: 183 ---------TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEE 233
Query: 503 MKSLITIMAAVAEWCLNEDAVDRPEMRDIVAIL 535
           +  L+ +       C  E   DRP    + ++L
Sbjct: 234 LYQLMRL-------CWKERPEDRPTFDYLRSVL 259

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 75/298 (25%), Positives = 124/298 (41%), Gaps = 76/298 (25%)
Query: 290 ATNNFDESRIIGRGGFGNVYFG--------------LLGDREAAIKKMRSNKSKEFFAEL 335
           A N  +  + IG+GGFG V+ G              +LGD E   + +   K +EF  E+
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIE--KFQEFQREV 74
Query: 336 KVLCKIHHINVFISTFGNGSLSDHLHDP----------------LLKGHQPLTWTARTQI 379
            ++  ++H N+         L   +H+P                LL    P+ W+ + ++
Sbjct: 75  FIMSNLNHPNIV-------KLYGLMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRL 127
Query: 380 ALDAAKGIEYIHDHTKARYVHRDIKTSNILL-----DDGLRAKVADFGLVKLEERTNEKE 434
            LD A GIEY+ +      VHRD+++ NI L     +  + AKVADFG       + +  
Sbjct: 128 MLDIALGIEYMQNQNPP-IVHRDLRSPNIFLQSLDENAPVCAKVADFGT------SQQSV 180
Query: 435 MLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRA-- 492
              + L+G   ++ PE I              E   T K D ++F ++L  ++TG+    
Sbjct: 181 HSVSGLLGNFQWMAPETI-----------GAEEESYTEKADTYSFAMILYTILTGEGPFD 229
Query: 493 -----------LIRDDS-EPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQI 538
                      +IR++   PT  +     +  V E C + D   RP    IV  LS++
Sbjct: 230 EYSYGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 75/298 (25%), Positives = 124/298 (41%), Gaps = 76/298 (25%)
Query: 290 ATNNFDESRIIGRGGFGNVYFG--------------LLGDREAAIKKMRSNKSKEFFAEL 335
           A N  +  + IG+GGFG V+ G              +LGD E   + +   K +EF  E+
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIE--KFQEFQREV 74
Query: 336 KVLCKIHHINVFISTFGNGSLSDHLHDP----------------LLKGHQPLTWTARTQI 379
            ++  ++H N+         L   +H+P                LL    P+ W+ + ++
Sbjct: 75  FIMSNLNHPNIV-------KLYGLMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRL 127
Query: 380 ALDAAKGIEYIHDHTKARYVHRDIKTSNILL-----DDGLRAKVADFGLVKLEERTNEKE 434
            LD A GIEY+ +      VHRD+++ NI L     +  + AKVADF L      + +  
Sbjct: 128 MLDIALGIEYMQNQNPP-IVHRDLRSPNIFLQSLDENAPVCAKVADFSL------SQQSV 180
Query: 435 MLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRA-- 492
              + L+G   ++ PE I              E   T K D ++F ++L  ++TG+    
Sbjct: 181 HSVSGLLGNFQWMAPETI-----------GAEEESYTEKADTYSFAMILYTILTGEGPFD 229
Query: 493 -----------LIRDDS-EPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQI 538
                      +IR++   PT  +     +  V E C + D   RP    IV  LS++
Sbjct: 230 EYSYGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 79/279 (28%), Positives = 113/279 (40%), Gaps = 61/279 (21%)
Query: 300 IGRGGFGNVYFGLL-GDREAAIKKMRSN--KSKEFFAELKVLCKIHH------------- 343
           +G+G FG V+ G   G    AIK ++      + F  E +V+ K+ H             
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 85
Query: 344 -INVFISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRD 402
            I + I     GSL D L   + K    L       +A   A G+ Y+    +  YVHRD
Sbjct: 86  PIYIVIEYMSKGSLLDFLKGEMGKY---LRLPQLVDMAAQIASGMAYVE---RMNYVHRD 139
Query: 403 IKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP-GYLPPEYIFVKRFRFDM 461
           ++ +NIL+ + L  KVADFGL +L E   + E  A +    P  +  PE     RF    
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIE---DNEXTARQGAKFPIKWTAPEAALYGRF---- 192
Query: 462 HSSVMELQVTTKTDVFAFGVVLAELITGKRAL----------------IRDDSEPTKMKS 505
                    T K+DV++FG++L EL T  R                   R    P   +S
Sbjct: 193 ---------TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPES 243
Query: 506 LITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITSTE 544
           L  +M      C  +D  +RP    + A L     TSTE
Sbjct: 244 LHDLMCQ----CWRKDPEERPTFEYLQAFLEDY-FTSTE 277

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 79/279 (28%), Positives = 113/279 (40%), Gaps = 61/279 (21%)
Query: 300 IGRGGFGNVYFGLL-GDREAAIKKMRSN--KSKEFFAELKVLCKIHH------------- 343
           +G+G FG V+ G   G    AIK ++      + F  E +V+ K+ H             
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 85
Query: 344 -INVFISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRD 402
            I + I     GSL D L   + K    L       +A   A G+ Y+    +  YVHRD
Sbjct: 86  PIYIVIEYMSKGSLLDFLKGEMGKY---LRLPQLVDMAAQIASGMAYVE---RMNYVHRD 139
Query: 403 IKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP-GYLPPEYIFVKRFRFDM 461
           ++ +NIL+ + L  KVADFGL +L E   + E  A +    P  +  PE     RF    
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIE---DNEYTARQGAKFPIKWTAPEAALYGRF---- 192
Query: 462 HSSVMELQVTTKTDVFAFGVVLAELITGKRAL----------------IRDDSEPTKMKS 505
                    T K+DV++FG++L EL T  R                   R    P   +S
Sbjct: 193 ---------TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPES 243
Query: 506 LITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITSTE 544
           L  +M      C  +D  +RP    + A L     TSTE
Sbjct: 244 LHDLMCQ----CWRKDPEERPTFEYLQAFLEDY-FTSTE 277

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 66/232 (28%), Positives = 111/232 (47%), Gaps = 55/232 (23%)
Query: 292 NNFDESRIIGRGGFGNVYFGLL---GDR-EAAIKKMRSNKSKE----FFAELKVLCKI-H 342
           N+     +IG G FG V    +   G R +AAIK+M+   SK+    F  EL+VLCK+ H
Sbjct: 22  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 81
Query: 343 HINVF---------------ISTFGNGSLSDHLH-------DPLLKGHQPLTWTARTQ-- 378
           H N+                I    +G+L D L        DP          T  +Q  
Sbjct: 82  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 141
Query: 379 --IALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEML 436
              A D A+G++Y+   ++ +++HR++   NIL+ +   AK+ADFGL + +E   +K M 
Sbjct: 142 LHFAADVARGMDYL---SQKQFIHRNLAARNILVGENYVAKIADFGLSRGQEVYVKKTM- 197
Query: 437 ATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
                   G LP  ++ ++   + ++        TT +DV+++GV+L E+++
Sbjct: 198 --------GRLPVRWMAIESLNYSVY--------TTNSDVWSYGVLLWEIVS 233

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 71/280 (25%), Positives = 115/280 (41%), Gaps = 66/280 (23%)
Query: 300 IGRGGFGNVYFGLL-GDREAAIKKMR--SNKSKEFFAELKVLCKIHH------------- 343
           +G G FG V+ G   G  + A+K ++  S     F AE  ++ ++ H             
Sbjct: 17  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE 76
Query: 344 -INVFISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRD 402
            I +      NGSL D L  P       LT      +A   A+G+ +I +     Y+HR+
Sbjct: 77  PIYIITEYMENGSLVDFLKTP---SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRN 130
Query: 403 IKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP-GYLPPEYIFVKRFRFDM 461
           ++ +NIL+ D L  K+ADFGL +L E   + E  A      P  +  PE I    F    
Sbjct: 131 LRAANILVSDTLSCKIADFGLARLIE---DNEYTAREGAKFPIKWTAPEAINYGTF---- 183
Query: 462 HSSVMELQVTTKTDVFAFGVVLAELITGKR-------------------ALIRDDSEPTK 502
                    T K+DV++FG++L E++T  R                    ++R D+ P +
Sbjct: 184 ---------TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEE 234
Query: 503 MKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITS 542
           +  L+ +       C  E   DRP    + ++L      +
Sbjct: 235 LYQLMRL-------CWKERPEDRPTFDYLRSVLEDFFTAT 267

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 74/282 (26%), Positives = 117/282 (41%), Gaps = 67/282 (23%)
Query: 300 IGRGGFGNVYFGLL-GDREAAIKKMR--SNKSKEFFAELKVLCKIHH------------- 343
           +G G  G V+ G   G  + A+K ++  S     F AE  ++ ++ H             
Sbjct: 21  LGAGQAGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE 80
Query: 344 -INVFISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRD 402
            I +      NGSL D L  P       LT      +A   A+G+ +I +     Y+HRD
Sbjct: 81  PIYIITEYMENGSLVDFLKTP---SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRD 134
Query: 403 IKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP-GYLPPEYIFVKRFRFDM 461
           ++ +NIL+ D L  K+ADFGL +L E   + E  A      P  +  PE I    F    
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLIE---DAEXTAREGAKFPIKWTAPEAINYGTF---- 187
Query: 462 HSSVMELQVTTKTDVFAFGVVLAELITGKR-------------------ALIRDDSEPTK 502
                    T K+DV++FG++L E++T  R                    ++R D+ P +
Sbjct: 188 ---------TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEE 238
Query: 503 MKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITSTE 544
           +  L+ +       C  E   DRP    + ++L     T+TE
Sbjct: 239 LYQLMRL-------CWKERPEDRPTFDYLRSVLEDF-FTATE 272

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 79/279 (28%), Positives = 112/279 (40%), Gaps = 61/279 (21%)
Query: 300 IGRGGFGNVYFGLL-GDREAAIKKMRSN--KSKEFFAELKVLCKIHH------------- 343
           +G+G FG V+ G   G    AIK ++      + F  E +V+ KI H             
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKIRHEKLVQLYAVVSEE 85
Query: 344 -INVFISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRD 402
            I +       GSL D L   + K    L       +A   A G+ Y+    +  YVHRD
Sbjct: 86  PIYIVTEYMSKGSLLDFLKGEMGKY---LRLPQLVDMAAQIASGMAYVE---RMNYVHRD 139
Query: 403 IKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP-GYLPPEYIFVKRFRFDM 461
           ++ +NIL+ + L  KVADFGL +L E   + E  A +    P  +  PE     RF    
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIE---DNEYTARQGAKFPIKWTAPEAALYGRF---- 192
Query: 462 HSSVMELQVTTKTDVFAFGVVLAELITGKRAL----------------IRDDSEPTKMKS 505
                    T K+DV++FG++L EL T  R                   R    P   +S
Sbjct: 193 ---------TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPES 243
Query: 506 LITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITSTE 544
           L  +M      C  +D  +RP    + A L     TSTE
Sbjct: 244 LHDLMCQ----CWRKDPEERPTFEYLQAFLEDY-FTSTE 277

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 78/279 (27%), Positives = 112/279 (40%), Gaps = 61/279 (21%)
Query: 300 IGRGGFGNVYFGLL-GDREAAIKKMRSN--KSKEFFAELKVLCKIHH------------- 343
           +G+G FG V+ G   G    AIK ++      + F  E +V+ K+ H             
Sbjct: 15  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 74
Query: 344 -INVFISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRD 402
            I +       GSL D L   + K    L       +A   A G+ Y+    +  YVHRD
Sbjct: 75  PIYIVTEYMSKGSLLDFLKGEMGKY---LRLPQLVDMAAQIASGMAYVE---RMNYVHRD 128
Query: 403 IKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP-GYLPPEYIFVKRFRFDM 461
           ++ +NIL+ + L  KVADFGL +L E   + E  A +    P  +  PE     RF    
Sbjct: 129 LRAANILVGENLVCKVADFGLARLIE---DNEYTARQGAKFPIKWTAPEAALYGRF---- 181
Query: 462 HSSVMELQVTTKTDVFAFGVVLAELITGKRAL----------------IRDDSEPTKMKS 505
                    T K+DV++FG++L EL T  R                   R    P   +S
Sbjct: 182 ---------TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPES 232
Query: 506 LITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITSTE 544
           L  +M      C  +D  +RP    + A L     TSTE
Sbjct: 233 LHDLMCQ----CWRKDPEERPTFEYLQAFLEDY-FTSTE 266

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 78/279 (27%), Positives = 112/279 (40%), Gaps = 61/279 (21%)
Query: 300 IGRGGFGNVYFGLL-GDREAAIKKMRSN--KSKEFFAELKVLCKIHH------------- 343
           +G+G FG V+ G   G    AIK ++      + F  E +V+ K+ H             
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 85
Query: 344 -INVFISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRD 402
            I +       GSL D L   + K    L       +A   A G+ Y+    +  YVHRD
Sbjct: 86  PIYIVCEYMSKGSLLDFLKGEMGKY---LRLPQLVDMAAQIASGMAYVE---RMNYVHRD 139
Query: 403 IKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP-GYLPPEYIFVKRFRFDM 461
           ++ +NIL+ + L  KVADFGL +L E   + E  A +    P  +  PE     RF    
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIE---DNEYTARQGAKFPIKWTAPEAALYGRF---- 192
Query: 462 HSSVMELQVTTKTDVFAFGVVLAELITGKRAL----------------IRDDSEPTKMKS 505
                    T K+DV++FG++L EL T  R                   R    P   +S
Sbjct: 193 ---------TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPES 243
Query: 506 LITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITSTE 544
           L  +M      C  +D  +RP    + A L     TSTE
Sbjct: 244 LHDLMCQ----CWRKDPEERPTFEYLQAFLEDY-FTSTE 277

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 101/212 (47%), Gaps = 42/212 (19%)
Query: 300 IGRGGFGNVYFGLL-GDREAAIKKMRSNKSKEFFA---ELKVLCKIHHINVF-------- 347
           IG G FG VY G   GD    I K+     ++F A   E+ VL K  H+N+         
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK 103
Query: 348 -----ISTFGNGS-LSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHR 401
                ++ +  GS L  HLH    K            IA   A+G++Y+H       +HR
Sbjct: 104 DNLAIVTQWCEGSSLYKHLHVQETK----FQMFQLIDIARQTAQGMDYLH---AKNIIHR 156
Query: 402 DIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKR---FR 458
           D+K++NI L +GL  K+ DFGL  ++ R +  + +  +  G+  ++ PE I ++    F 
Sbjct: 157 DMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVE-QPTGSVLWMAPEVIRMQDNNPFS 215
Query: 459 FDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
           F             ++DV+++G+VL EL+TG+
Sbjct: 216 F-------------QSDVYSYGIVLYELMTGE 234

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 78/279 (27%), Positives = 112/279 (40%), Gaps = 61/279 (21%)
Query: 300 IGRGGFGNVYFGLL-GDREAAIKKMRSN--KSKEFFAELKVLCKIHH------------- 343
           +G+G FG V+ G   G    AIK ++      + F  E +V+ K+ H             
Sbjct: 17  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 76
Query: 344 -INVFISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRD 402
            I +       GSL D L   + K    L       +A   A G+ Y+    +  YVHRD
Sbjct: 77  PIYIVTEYMSKGSLLDFLKGEMGKY---LRLPQLVDMAAQIASGMAYVE---RMNYVHRD 130
Query: 403 IKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP-GYLPPEYIFVKRFRFDM 461
           ++ +NIL+ + L  KVADFGL +L E   + E  A +    P  +  PE     RF    
Sbjct: 131 LRAANILVGENLVCKVADFGLARLIE---DNEYTARQGAKFPIKWTAPEAALYGRF---- 183
Query: 462 HSSVMELQVTTKTDVFAFGVVLAELITGKRAL----------------IRDDSEPTKMKS 505
                    T K+DV++FG++L EL T  R                   R    P   +S
Sbjct: 184 ---------TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPES 234
Query: 506 LITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITSTE 544
           L  +M      C  +D  +RP    + A L     TSTE
Sbjct: 235 LHDLMCQ----CWRKDPEERPTFEYLQAFLEDY-FTSTE 268

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 83/285 (29%), Positives = 118/285 (41%), Gaps = 61/285 (21%)
Query: 300 IGRGGFGNVYFGLL-GDREAAIKKMR-SNKSKE-FFAELKVLCKIHH------------- 343
           +G+G FG V+ G   G    AIK ++  N S E F  E +V+ K+ H             
Sbjct: 193 LGQGCFGEVWMGTWNGTTRVAIKTLKPGNMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 252
Query: 344 -INVFISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRD 402
            I +       GSL D L   + K    L       +A   A G+ Y+    +  YVHRD
Sbjct: 253 PIYIVTEYMSKGSLLDFLKGEMGKY---LRLPQLVDMAAQIASGMAYVE---RMNYVHRD 306
Query: 403 IKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP-GYLPPEYIFVKRFRFDM 461
           ++ +NIL+ + L  KVADFGL +L E   + E  A +    P  +  PE     RF    
Sbjct: 307 LRAANILVGENLVCKVADFGLGRLIE---DNEYTARQGAKFPIKWTAPEAALYGRF---- 359
Query: 462 HSSVMELQVTTKTDVFAFGVVLAELITGKRAL--------IRDDSE--------PTKMKS 505
                    T K+DV++FG++L EL T  R          + D  E        P   +S
Sbjct: 360 ---------TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPES 410
Query: 506 LITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITSTEWEASLG 550
           L  +M      C  +D  +RP    + A L     TSTE +   G
Sbjct: 411 LHDLMCQ----CWRKDPEERPTFEYLQAFLEDY-FTSTEPQXQPG 450

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 78/279 (27%), Positives = 112/279 (40%), Gaps = 61/279 (21%)
Query: 300 IGRGGFGNVYFGLL-GDREAAIKKMRSN--KSKEFFAELKVLCKIHH------------- 343
           +G+G FG V+ G   G    AIK ++      + F  E +V+ K+ H             
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 85
Query: 344 -INVFISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRD 402
            I +       GSL D L   + K    L       +A   A G+ Y+    +  YVHRD
Sbjct: 86  PIYIVTEYMSKGSLLDFLKGEMGKY---LRLPQLVDMAAQIASGMAYVE---RMNYVHRD 139
Query: 403 IKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP-GYLPPEYIFVKRFRFDM 461
           ++ +NIL+ + L  KVADFGL +L E   + E  A +    P  +  PE     RF    
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIE---DNEYTARQGAKFPIKWTAPEAALYGRF---- 192
Query: 462 HSSVMELQVTTKTDVFAFGVVLAELITGKRAL----------------IRDDSEPTKMKS 505
                    T K+DV++FG++L EL T  R                   R    P   +S
Sbjct: 193 ---------TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPES 243
Query: 506 LITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITSTE 544
           L  +M      C  +D  +RP    + A L     TSTE
Sbjct: 244 LHDLMCQ----CWRKDPEERPTFEYLQAFLEDY-FTSTE 277

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 100/211 (47%), Gaps = 42/211 (19%)
Query: 298 RIIGRGGFGNVYFGLLGDREAAIKKMRSNKSKE-FFAELKVLCKIHHINV---------- 346
           + IG+G FG+V  G     + A+K ++++ + + F AE  V+ ++ H N+          
Sbjct: 12  QTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEE 71
Query: 347 ----FIST--FGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVH 400
               +I T     GSL D+L     +G   L      + +LD  + +EY+  +    +VH
Sbjct: 72  KGGLYIVTEYMAKGSLVDYLRS---RGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVH 125
Query: 401 RDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFD 460
           RD+   N+L+ +   AKV+DFGL K    T +   L  +      +  PE +  K+F   
Sbjct: 126 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK------WTAPEALREKKF--- 176
Query: 461 MHSSVMELQVTTKTDVFAFGVVLAELITGKR 491
                     +TK+DV++FG++L E+ +  R
Sbjct: 177 ----------STKSDVWSFGILLWEIYSFGR 197

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 77/279 (27%), Positives = 112/279 (40%), Gaps = 61/279 (21%)
Query: 300 IGRGGFGNVYFGLL-GDREAAIKKMRSN--KSKEFFAELKVLCKIHH------------- 343
           +G+G FG V+ G   G    AIK ++      + F  E +V+ K+ H             
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 85
Query: 344 -INVFISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRD 402
            I + +     G L D L   + K    L       +A   A G+ Y+    +  YVHRD
Sbjct: 86  PIYIVMEYMSKGCLLDFLKGEMGKY---LRLPQLVDMAAQIASGMAYVE---RMNYVHRD 139
Query: 403 IKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP-GYLPPEYIFVKRFRFDM 461
           ++ +NIL+ + L  KVADFGL +L E   + E  A +    P  +  PE     RF    
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIE---DNEYTARQGAKFPIKWTAPEAALYGRF---- 192
Query: 462 HSSVMELQVTTKTDVFAFGVVLAELITGKRAL----------------IRDDSEPTKMKS 505
                    T K+DV++FG++L EL T  R                   R    P   +S
Sbjct: 193 ---------TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPES 243
Query: 506 LITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITSTE 544
           L  +M      C  +D  +RP    + A L     TSTE
Sbjct: 244 LHDLMCQ----CWRKDPEERPTFEYLQAFLEDY-FTSTE 277

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 100/211 (47%), Gaps = 42/211 (19%)
Query: 298 RIIGRGGFGNVYFGLLGDREAAIKKMRSNKSKE-FFAELKVLCKIHHINV---------- 346
           + IG+G FG+V  G     + A+K ++++ + + F AE  V+ ++ H N+          
Sbjct: 27  QTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEE 86
Query: 347 ----FIST--FGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVH 400
               +I T     GSL D+L     +G   L      + +LD  + +EY+  +    +VH
Sbjct: 87  KGGLYIVTEYMAKGSLVDYLRS---RGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVH 140
Query: 401 RDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFD 460
           RD+   N+L+ +   AKV+DFGL K    T +   L  +      +  PE +  K+F   
Sbjct: 141 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK------WTAPEALREKKF--- 191
Query: 461 MHSSVMELQVTTKTDVFAFGVVLAELITGKR 491
                     +TK+DV++FG++L E+ +  R
Sbjct: 192 ----------STKSDVWSFGILLWEIYSFGR 212

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 100/211 (47%), Gaps = 42/211 (19%)
Query: 298 RIIGRGGFGNVYFGLLGDREAAIKKMRSNKSKE-FFAELKVLCKIHHINV---------- 346
           + IG+G FG+V  G     + A+K ++++ + + F AE  V+ ++ H N+          
Sbjct: 199 QTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEE 258
Query: 347 ----FIST--FGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVH 400
               +I T     GSL D+L     +G   L      + +LD  + +EY+  +    +VH
Sbjct: 259 KGGLYIVTEYMAKGSLVDYLRS---RGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVH 312
Query: 401 RDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFD 460
           RD+   N+L+ +   AKV+DFGL K    T +   L  +      +  PE +  K+F   
Sbjct: 313 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK------WTAPEALREKKF--- 363
Query: 461 MHSSVMELQVTTKTDVFAFGVVLAELITGKR 491
                     +TK+DV++FG++L E+ +  R
Sbjct: 364 ----------STKSDVWSFGILLWEIYSFGR 384

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 78/279 (27%), Positives = 111/279 (39%), Gaps = 61/279 (21%)
Query: 300 IGRGGFGNVYFGLL-GDREAAIKKMRSN--KSKEFFAELKVLCKIHH------------- 343
           +G+G FG V+ G   G    AIK ++      + F  E +V+ K+ H             
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 85
Query: 344 -INVFISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRD 402
            I +       GSL D L   + K    L       +A   A G+ Y+    +  YVHRD
Sbjct: 86  PIYIVTEYMSKGSLLDFLKGEMGKY---LRLPQLVDMAAQIASGMAYVE---RMNYVHRD 139
Query: 403 IKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP-GYLPPEYIFVKRFRFDM 461
           +  +NIL+ + L  KVADFGL +L E   + E  A +    P  +  PE     RF    
Sbjct: 140 LAAANILVGENLVCKVADFGLARLIE---DNEYTARQGAKFPIKWTAPEAALYGRF---- 192
Query: 462 HSSVMELQVTTKTDVFAFGVVLAELITGKRAL----------------IRDDSEPTKMKS 505
                    T K+DV++FG++L EL T  R                   R    P   +S
Sbjct: 193 ---------TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPES 243
Query: 506 LITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITSTE 544
           L  +M      C  +D  +RP    + A L     TSTE
Sbjct: 244 LHDLMCQ----CWRKDPEERPTFEYLQAFLEDY-FTSTE 277

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 93/212 (43%), Gaps = 44/212 (20%)
Query: 300 IGRGGFGNVYFGLL-GDREAAIKKMRSN--KSKEFFAELKVLCKIHH------------- 343
           +G+G FG V+ G   G    AIK ++      + F  E +V+ K+ H             
Sbjct: 16  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 75
Query: 344 -INVFISTFGNGSLSDHLHDPLLKGH--QPLTWTARTQIALDAAKGIEYIHDHTKARYVH 400
            I +       GSL D      LKG   + L       +A   A G+ Y+    +  YVH
Sbjct: 76  PIXIVTEYMSKGSLLD-----FLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 127
Query: 401 RDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP-GYLPPEYIFVKRFRF 459
           RD++ +NIL+ + L  KVADFGL +L E   + E  A +    P  +  PE     RF  
Sbjct: 128 RDLRAANILVGENLVCKVADFGLARLIE---DNEXTARQGAKFPIKWTAPEAALYGRF-- 182
Query: 460 DMHSSVMELQVTTKTDVFAFGVVLAELITGKR 491
                      T K+DV++FG++L EL T  R
Sbjct: 183 -----------TIKSDVWSFGILLTELTTKGR 203

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 77/279 (27%), Positives = 111/279 (39%), Gaps = 61/279 (21%)
Query: 300 IGRGGFGNVYFGLL-GDREAAIKKMRSN--KSKEFFAELKVLCKIHH------------- 343
           +G+G FG V+ G   G    AIK ++      + F  E +V+ K+ H             
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 85
Query: 344 -INVFISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRD 402
            I +       G L D L   + K    L       +A   A G+ Y+    +  YVHRD
Sbjct: 86  PIYIVTEYMSKGCLLDFLKGEMGKY---LRLPQLVDMAAQIASGMAYVE---RMNYVHRD 139
Query: 403 IKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP-GYLPPEYIFVKRFRFDM 461
           ++ +NIL+ + L  KVADFGL +L E   + E  A +    P  +  PE     RF    
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIE---DNEYTARQGAKFPIKWTAPEAALYGRF---- 192
Query: 462 HSSVMELQVTTKTDVFAFGVVLAELITGKRAL----------------IRDDSEPTKMKS 505
                    T K+DV++FG++L EL T  R                   R    P   +S
Sbjct: 193 ---------TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPES 243
Query: 506 LITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITSTE 544
           L  +M      C  +D  +RP    + A L     TSTE
Sbjct: 244 LHDLMCQ----CWRKDPEERPTFEYLQAFLEDY-FTSTE 277

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 93/212 (43%), Gaps = 44/212 (20%)
Query: 300 IGRGGFGNVYFGLL-GDREAAIKKMRSN--KSKEFFAELKVLCKIHH------------- 343
           +G+G FG V+ G   G    AIK ++      + F  E +V+ K+ H             
Sbjct: 19  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 78
Query: 344 -INVFISTFGNGSLSDHLHDPLLKGH--QPLTWTARTQIALDAAKGIEYIHDHTKARYVH 400
            I +       GSL D      LKG   + L       +A   A G+ Y+    +  YVH
Sbjct: 79  PIYIVTEYMSKGSLLD-----FLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 130
Query: 401 RDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP-GYLPPEYIFVKRFRF 459
           RD++ +NIL+ + L  KVADFGL +L E   + E  A +    P  +  PE     RF  
Sbjct: 131 RDLRAANILVGENLVCKVADFGLARLIE---DNEYTARQGAKFPIKWTAPEAALYGRF-- 185
Query: 460 DMHSSVMELQVTTKTDVFAFGVVLAELITGKR 491
                      T K+DV++FG++L EL T  R
Sbjct: 186 -----------TIKSDVWSFGILLTELTTKGR 206

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 95/224 (42%), Gaps = 48/224 (21%)
Query: 294 FDESRIIGRGGFGNVYFG--LLGDREAAIKKM-----RSN-KSKEFFAELKVLCKIHHIN 345
           F + R IG G FG VYF   +      AIKKM     +SN K ++   E++ L K+ H N
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 346 V--------------FISTFGNGSLSDHLHDPLLKGHQ-PLTWTARTQIALDAAKGIEYI 390
                           +  +  GS SD     LL+ H+ PL       +   A +G+ Y+
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCLGSASD-----LLEVHKKPLQEVEIAAVTHGALQGLAYL 170
Query: 391 HDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPE 450
           H H     +HRD+K  NILL +    K+ DFG   +    N         VGTP ++ PE
Sbjct: 171 HSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX-------FVGTPYWMAPE 220
Query: 451 YIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALI 494
            I           ++ E Q   K DV++ G+   EL   K  L 
Sbjct: 221 VIL----------AMDEGQYDGKVDVWSLGITCIELAERKPPLF 254

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 93/212 (43%), Gaps = 44/212 (20%)
Query: 300 IGRGGFGNVYFGLL-GDREAAIKKMRSN--KSKEFFAELKVLCKIHH------------- 343
           +G+G FG V+ G   G    AIK ++      + F  E +V+ K+ H             
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 251
Query: 344 -INVFISTFGNGSLSDHLHDPLLKGH--QPLTWTARTQIALDAAKGIEYIHDHTKARYVH 400
            I +       GSL D      LKG   + L       +A   A G+ Y+    +  YVH
Sbjct: 252 PIYIVTEYMSKGSLLD-----FLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 303
Query: 401 RDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP-GYLPPEYIFVKRFRF 459
           RD++ +NIL+ + L  KVADFGL +L E   + E  A +    P  +  PE     RF  
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLIE---DNEYTARQGAKFPIKWTAPEAALYGRF-- 358
Query: 460 DMHSSVMELQVTTKTDVFAFGVVLAELITGKR 491
                      T K+DV++FG++L EL T  R
Sbjct: 359 -----------TIKSDVWSFGILLTELTTKGR 379

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 93/212 (43%), Gaps = 44/212 (20%)
Query: 300 IGRGGFGNVYFGLL-GDREAAIKKMRSN--KSKEFFAELKVLCKIHH------------- 343
           +G+G FG V+ G   G    AIK ++      + F  E +V+ K+ H             
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 251
Query: 344 -INVFISTFGNGSLSDHLHDPLLKGH--QPLTWTARTQIALDAAKGIEYIHDHTKARYVH 400
            I +       GSL D      LKG   + L       +A   A G+ Y+    +  YVH
Sbjct: 252 PIYIVTEYMSKGSLLD-----FLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 303
Query: 401 RDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP-GYLPPEYIFVKRFRF 459
           RD++ +NIL+ + L  KVADFGL +L E   + E  A +    P  +  PE     RF  
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLIE---DNEYTARQGAKFPIKWTAPEAALYGRF-- 358
Query: 460 DMHSSVMELQVTTKTDVFAFGVVLAELITGKR 491
                      T K+DV++FG++L EL T  R
Sbjct: 359 -----------TIKSDVWSFGILLTELTTKGR 379

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 95/224 (42%), Gaps = 48/224 (21%)
Query: 294 FDESRIIGRGGFGNVYFG--LLGDREAAIKKM-----RSN-KSKEFFAELKVLCKIHHIN 345
           F + R IG G FG VYF   +      AIKKM     +SN K ++   E++ L K+ H N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 346 V--------------FISTFGNGSLSDHLHDPLLKGHQ-PLTWTARTQIALDAAKGIEYI 390
                           +  +  GS SD     LL+ H+ PL       +   A +G+ Y+
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASD-----LLEVHKKPLQEVEIAAVTHGALQGLAYL 131
Query: 391 HDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPE 450
           H H     +HRD+K  NILL +    K+ DFG   +    N         VGTP ++ PE
Sbjct: 132 HSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX-------FVGTPYWMAPE 181
Query: 451 YIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALI 494
            I           ++ E Q   K DV++ G+   EL   K  L 
Sbjct: 182 VIL----------AMDEGQYDGKVDVWSLGITCIELAERKPPLF 215

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 99/211 (46%), Gaps = 42/211 (19%)
Query: 298 RIIGRGGFGNVYFGLLGDREAAIKKMRSNKSKE-FFAELKVLCKIHHINV---------- 346
           + IG+G FG+V  G     + A+K ++++ + + F AE  V+ ++ H N+          
Sbjct: 18  QTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEE 77
Query: 347 ----FIST--FGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVH 400
               +I T     GSL D+L     +G   L      + +LD  + +EY+  +    +VH
Sbjct: 78  KGGLYIVTEYMAKGSLVDYLRS---RGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVH 131
Query: 401 RDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFD 460
           RD+   N+L+ +   AKV+DFGL K    T +            G LP ++   +  R  
Sbjct: 132 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT-----------GKLPVKWTAPEALR-- 178
Query: 461 MHSSVMELQVTTKTDVFAFGVVLAELITGKR 491
                 E   +TK+DV++FG++L E+ +  R
Sbjct: 179 ------EAAFSTKSDVWSFGILLWEIYSFGR 203

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 100/211 (47%), Gaps = 40/211 (18%)
Query: 300 IGRGGFGNVYFGLL-GDREAAIKKMR-----SNKSKEFFAELKVLCKIHHINVF------ 347
           IG G FG VY G   GD   A+K +        + + F  E+ VL K  H+N+       
Sbjct: 21  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 78
Query: 348 -------ISTFGNGS-LSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYV 399
                  ++ +  GS L  HLH    K            IA   A+G++Y+H  +    +
Sbjct: 79  TKPQLAIVTQWCEGSSLYHHLHIIETK----FEMIKLIDIARQTAQGMDYLHAKS---II 131
Query: 400 HRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRF 459
           HRD+K++NI L + L  K+ DFGL  ++ R +       +L G+  ++ PE I ++    
Sbjct: 132 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFE-QLSGSILWMAPEVIRMQD--- 187
Query: 460 DMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
                  +   + ++DV+AFG+VL EL+TG+
Sbjct: 188 -------KNPYSFQSDVYAFGIVLYELMTGQ 211

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 100/211 (47%), Gaps = 40/211 (18%)
Query: 300 IGRGGFGNVYFGLL-GDREAAIKKMR-----SNKSKEFFAELKVLCKIHHINVF------ 347
           IG G FG VY G   GD   A+K +        + + F  E+ VL K  H+N+       
Sbjct: 16  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 348 -------ISTFGNGS-LSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYV 399
                  ++ +  GS L  HLH    K            IA   A+G++Y+H  +    +
Sbjct: 74  TAPQLAIVTQWCEGSSLYHHLHIIETK----FEMIKLIDIARQTAQGMDYLHAKS---II 126
Query: 400 HRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRF 459
           HRD+K++NI L + L  K+ DFGL  ++ R +       +L G+  ++ PE I ++    
Sbjct: 127 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFE-QLSGSILWMAPEVIRMQD--- 182
Query: 460 DMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
                  +   + ++DV+AFG+VL EL+TG+
Sbjct: 183 -------KNPYSFQSDVYAFGIVLYELMTGQ 206

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 100/211 (47%), Gaps = 40/211 (18%)
Query: 300 IGRGGFGNVYFGLL-GDREAAIKKMR-----SNKSKEFFAELKVLCKIHHINVF------ 347
           IG G FG VY G   GD   A+K +        + + F  E+ VL K  H+N+       
Sbjct: 16  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 348 -------ISTFGNGS-LSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYV 399
                  ++ +  GS L  HLH    K            IA   A+G++Y+H  +    +
Sbjct: 74  TKPQLAIVTQWCEGSSLYHHLHIIETK----FEMIKLIDIARQTAQGMDYLHAKS---II 126
Query: 400 HRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRF 459
           HRD+K++NI L + L  K+ DFGL  ++ R +       +L G+  ++ PE I ++    
Sbjct: 127 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFE-QLSGSILWMAPEVIRMQD--- 182
Query: 460 DMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
                  +   + ++DV+AFG+VL EL+TG+
Sbjct: 183 -------KNPYSFQSDVYAFGIVLYELMTGQ 206

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 93/212 (43%), Gaps = 44/212 (20%)
Query: 300 IGRGGFGNVYFGLL-GDREAAIKKMRSN--KSKEFFAELKVLCKIHH------------- 343
           +G+G FG V+ G   G    AIK ++      + F  E +V+ K+ H             
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 82
Query: 344 -INVFISTFGNGSLSDHLHDPLLKGH--QPLTWTARTQIALDAAKGIEYIHDHTKARYVH 400
            I +       GSL D      LKG   + L       ++   A G+ Y+    +  YVH
Sbjct: 83  PIYIVTEYMNKGSLLD-----FLKGETGKYLRLPQLVDMSAQIASGMAYVE---RMNYVH 134
Query: 401 RDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP-GYLPPEYIFVKRFRF 459
           RD++ +NIL+ + L  KVADFGL +L E   + E  A +    P  +  PE     RF  
Sbjct: 135 RDLRAANILVGENLVCKVADFGLARLIE---DNEWTARQGAKFPIKWTAPEAALYGRF-- 189
Query: 460 DMHSSVMELQVTTKTDVFAFGVVLAELITGKR 491
                      T K+DV++FG++L EL T  R
Sbjct: 190 -----------TIKSDVWSFGILLTELTTKGR 210

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 100/211 (47%), Gaps = 40/211 (18%)
Query: 300 IGRGGFGNVYFGLL-GDREAAIKKMR-----SNKSKEFFAELKVLCKIHHINVF------ 347
           IG G FG VY G   GD   A+K +        + + F  E+ VL K  H+N+       
Sbjct: 21  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 78
Query: 348 -------ISTFGNGS-LSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYV 399
                  ++ +  GS L  HLH    K            IA   A+G++Y+H  +    +
Sbjct: 79  TKPQLAIVTQWCEGSSLYHHLHIIETK----FEMIKLIDIARQTAQGMDYLHAKS---II 131
Query: 400 HRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRF 459
           HRD+K++NI L + L  K+ DFGL  ++ R +       +L G+  ++ PE I ++    
Sbjct: 132 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFE-QLSGSILWMAPEVIRMQD--- 187
Query: 460 DMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
                  +   + ++DV+AFG+VL EL+TG+
Sbjct: 188 -------KNPYSFQSDVYAFGIVLYELMTGQ 211

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 100/211 (47%), Gaps = 40/211 (18%)
Query: 300 IGRGGFGNVYFGLL-GDREAAIKKMR-----SNKSKEFFAELKVLCKIHHINVF------ 347
           IG G FG VY G   GD   A+K +        + + F  E+ VL K  H+N+       
Sbjct: 18  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 75
Query: 348 -------ISTFGNGS-LSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYV 399
                  ++ +  GS L  HLH    K            IA   A+G++Y+H  +    +
Sbjct: 76  TKPQLAIVTQWCEGSSLYHHLHIIETK----FEMIKLIDIARQTAQGMDYLHAKS---II 128
Query: 400 HRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRF 459
           HRD+K++NI L + L  K+ DFGL  ++ R +       +L G+  ++ PE I ++    
Sbjct: 129 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFE-QLSGSILWMAPEVIRMQD--- 184
Query: 460 DMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
                  +   + ++DV+AFG+VL EL+TG+
Sbjct: 185 -------KNPYSFQSDVYAFGIVLYELMTGQ 208

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 93/212 (43%), Gaps = 44/212 (20%)
Query: 300 IGRGGFGNVYFGLL-GDREAAIKKMRSN--KSKEFFAELKVLCKIHH------------- 343
           +G+G FG V+ G   G    AIK ++      + F  E +V+ K+ H             
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 82
Query: 344 -INVFISTFGNGSLSDHLHDPLLKGH--QPLTWTARTQIALDAAKGIEYIHDHTKARYVH 400
            I +       GSL D      LKG   + L       ++   A G+ Y+    +  YVH
Sbjct: 83  PIYIVTEYMNKGSLLD-----FLKGETGKYLRLPQLVDMSAQIASGMAYVE---RMNYVH 134
Query: 401 RDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP-GYLPPEYIFVKRFRF 459
           RD++ +NIL+ + L  KVADFGL +L E   + E  A +    P  +  PE     RF  
Sbjct: 135 RDLRAANILVGENLVCKVADFGLARLIE---DNEYTARQGAKFPIKWTAPEAALYGRF-- 189
Query: 460 DMHSSVMELQVTTKTDVFAFGVVLAELITGKR 491
                      T K+DV++FG++L EL T  R
Sbjct: 190 -----------TIKSDVWSFGILLTELTTKGR 210

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 93/212 (43%), Gaps = 44/212 (20%)
Query: 300 IGRGGFGNVYFGLL-GDREAAIKKMRSN--KSKEFFAELKVLCKIHH------------- 343
           +G+G FG V+ G   G    AIK ++      + F  E +V+ K+ H             
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 334
Query: 344 -INVFISTFGNGSLSDHLHDPLLKGH--QPLTWTARTQIALDAAKGIEYIHDHTKARYVH 400
            I +       GSL D      LKG   + L       +A   A G+ Y+    +  YVH
Sbjct: 335 PIYIVTEYMSKGSLLD-----FLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 386
Query: 401 RDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP-GYLPPEYIFVKRFRF 459
           RD++ +NIL+ + L  KVADFGL +L E   + E  A +    P  +  PE     RF  
Sbjct: 387 RDLRAANILVGENLVCKVADFGLARLIE---DNEYTARQGAKFPIKWTAPEAALYGRF-- 441
Query: 460 DMHSSVMELQVTTKTDVFAFGVVLAELITGKR 491
                      T K+DV++FG++L EL T  R
Sbjct: 442 -----------TIKSDVWSFGILLTELTTKGR 462

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 99/211 (46%), Gaps = 40/211 (18%)
Query: 300 IGRGGFGNVYFGLL-GDREAAIKKMR-----SNKSKEFFAELKVLCKIHHINVF------ 347
           IG G FG VY G   GD   A+K +        + + F  E+ VL K  H+N+       
Sbjct: 20  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 77
Query: 348 -------ISTFGNGS-LSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYV 399
                  ++ +  GS L  HLH    K            IA   A+G++Y+H  +    +
Sbjct: 78  TKPQLAIVTQWCEGSSLYHHLHASETK----FEMKKLIDIARQTARGMDYLHAKS---II 130
Query: 400 HRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRF 459
           HRD+K++NI L +    K+ DFGL  ++ R +       +L G+  ++ PE I ++    
Sbjct: 131 HRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFE-QLSGSILWMAPEVIRMQ---- 185
Query: 460 DMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
              S+    Q    +DV+AFG+VL EL+TG+
Sbjct: 186 --DSNPYSFQ----SDVYAFGIVLYELMTGQ 210

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 93/212 (43%), Gaps = 44/212 (20%)
Query: 300 IGRGGFGNVYFGLL-GDREAAIKKMRSN--KSKEFFAELKVLCKIHH------------- 343
           +G+G FG V+ G   G    AIK ++      + F  E +V+ K+ H             
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 251
Query: 344 -INVFISTFGNGSLSDHLHDPLLKGH--QPLTWTARTQIALDAAKGIEYIHDHTKARYVH 400
            I +       GSL D      LKG   + L       +A   A G+ Y+    +  YVH
Sbjct: 252 PIYIVGEYMSKGSLLD-----FLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 303
Query: 401 RDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP-GYLPPEYIFVKRFRF 459
           RD++ +NIL+ + L  KVADFGL +L E   + E  A +    P  +  PE     RF  
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLIE---DNEYTARQGAKFPIKWTAPEAALYGRF-- 358
Query: 460 DMHSSVMELQVTTKTDVFAFGVVLAELITGKR 491
                      T K+DV++FG++L EL T  R
Sbjct: 359 -----------TIKSDVWSFGILLTELTTKGR 379

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 100/211 (47%), Gaps = 40/211 (18%)
Query: 300 IGRGGFGNVYFGLL-GDREAAIKKMR-----SNKSKEFFAELKVLCKIHHINVF------ 347
           IG G FG VY G   GD   A+K +        + + F  E+ VL K  H+N+       
Sbjct: 43  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 100
Query: 348 -------ISTFGNGS-LSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYV 399
                  ++ +  GS L  HLH    K            IA   A+G++Y+H  +    +
Sbjct: 101 TKPQLAIVTQWCEGSSLYHHLHIIETK----FEMIKLIDIARQTAQGMDYLHAKS---II 153
Query: 400 HRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRF 459
           HRD+K++NI L + L  K+ DFGL  ++ R +       +L G+  ++ PE I ++    
Sbjct: 154 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFE-QLSGSILWMAPEVIRMQD--- 209
Query: 460 DMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
                  +   + ++DV+AFG+VL EL+TG+
Sbjct: 210 -------KNPYSFQSDVYAFGIVLYELMTGQ 233

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 100/211 (47%), Gaps = 40/211 (18%)
Query: 300 IGRGGFGNVYFGLL-GDREAAIKKMR-----SNKSKEFFAELKVLCKIHHINVF------ 347
           IG G FG VY G   GD   A+K +        + + F  E+ VL K  H+N+       
Sbjct: 44  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 101
Query: 348 -------ISTFGNGS-LSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYV 399
                  ++ +  GS L  HLH    K            IA   A+G++Y+H  +    +
Sbjct: 102 TKPQLAIVTQWCEGSSLYHHLHIIETK----FEMIKLIDIARQTAQGMDYLHAKS---II 154
Query: 400 HRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRF 459
           HRD+K++NI L + L  K+ DFGL  ++ R +       +L G+  ++ PE I ++    
Sbjct: 155 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFE-QLSGSILWMAPEVIRMQD--- 210
Query: 460 DMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
                  +   + ++DV+AFG+VL EL+TG+
Sbjct: 211 -------KNPYSFQSDVYAFGIVLYELMTGQ 234

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 99/211 (46%), Gaps = 40/211 (18%)
Query: 300 IGRGGFGNVYFGLL-GDREAAIKKMR-----SNKSKEFFAELKVLCKIHHINVF------ 347
           IG G FG VY G   GD   A+K +        + + F  E+ VL K  H+N+       
Sbjct: 16  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 348 -------ISTFGNGS-LSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYV 399
                  ++ +  GS L  HLH    K            IA   A+G++Y+H  +    +
Sbjct: 74  TKPQLAIVTQWCEGSSLYHHLHIIETK----FEMIKLIDIARQTAQGMDYLHAKS---II 126
Query: 400 HRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRF 459
           HRD+K++NI L + L  K+ DFGL   + R +       +L G+  ++ PE I ++    
Sbjct: 127 HRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFE-QLSGSILWMAPEVIRMQD--- 182
Query: 460 DMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
                  +   + ++DV+AFG+VL EL+TG+
Sbjct: 183 -------KNPYSFQSDVYAFGIVLYELMTGQ 206

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 98/211 (46%), Gaps = 40/211 (18%)
Query: 300 IGRGGFGNVYFGLL-GDREAAIKKMR-----SNKSKEFFAELKVLCKIHHINVF------ 347
           IG G FG VY G   GD   A+K +        + + F  E+ VL K  H+N+       
Sbjct: 32  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 348 -------ISTFGNGS-LSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYV 399
                  ++ +  GS L  HLH    K            IA   A+G++Y+H  +    +
Sbjct: 90  TAPQLAIVTQWCEGSSLYHHLHASETK----FEMKKLIDIARQTARGMDYLHAKS---II 142
Query: 400 HRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRF 459
           HRD+K++NI L +    K+ DFGL   + R +       +L G+  ++ PE I ++    
Sbjct: 143 HRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQF-EQLSGSILWMAPEVIRMQ---- 197
Query: 460 DMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
              S+    Q    +DV+AFG+VL EL+TG+
Sbjct: 198 --DSNPYSFQ----SDVYAFGIVLYELMTGQ 222

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 98/211 (46%), Gaps = 40/211 (18%)
Query: 300 IGRGGFGNVYFGLL-GDREAAIKKMR-----SNKSKEFFAELKVLCKIHHINVF------ 347
           IG G FG VY G   GD   A+K +        + + F  E+ VL K  H+N+       
Sbjct: 32  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 348 -------ISTFGNGS-LSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYV 399
                  ++ +  GS L  HLH    K            IA   A+G++Y+H  +    +
Sbjct: 90  TKPQLAIVTQWCEGSSLYHHLHASETK----FEMKKLIDIARQTARGMDYLHAKS---II 142
Query: 400 HRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRF 459
           HRD+K++NI L +    K+ DFGL   + R +       +L G+  ++ PE I ++    
Sbjct: 143 HRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFE-QLSGSILWMAPEVIRMQ---- 197
Query: 460 DMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
              S+    Q    +DV+AFG+VL EL+TG+
Sbjct: 198 --DSNPYSFQ----SDVYAFGIVLYELMTGQ 222

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 99/211 (46%), Gaps = 40/211 (18%)
Query: 300 IGRGGFGNVYFGLL-GDREAAIKKMR-----SNKSKEFFAELKVLCKIHHINVF------ 347
           IG G FG VY G   GD   A+K +        + + F  E+ VL K  H+N+       
Sbjct: 44  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 101
Query: 348 -------ISTFGNGS-LSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYV 399
                  ++ +  GS L  HLH    K            IA   A+G++Y+H  +    +
Sbjct: 102 TKPQLAIVTQWCEGSSLYHHLHIIETK----FEMIKLIDIARQTAQGMDYLHAKS---II 154
Query: 400 HRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRF 459
           HRD+K++NI L + L  K+ DFGL   + R +       +L G+  ++ PE I ++    
Sbjct: 155 HRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFE-QLSGSILWMAPEVIRMQD--- 210
Query: 460 DMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
                  +   + ++DV+AFG+VL EL+TG+
Sbjct: 211 -------KNPYSFQSDVYAFGIVLYELMTGQ 234

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 99/211 (46%), Gaps = 40/211 (18%)
Query: 300 IGRGGFGNVYFGLL-GDREAAIKKMR-----SNKSKEFFAELKVLCKIHHINVF------ 347
           IG G FG VY G   GD   A+K +        + + F  E+ VL K  H+N+       
Sbjct: 36  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 93
Query: 348 -------ISTFGNGS-LSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYV 399
                  ++ +  GS L  HLH    K            IA   A+G++Y+H  +    +
Sbjct: 94  TKPQLAIVTQWCEGSSLYHHLHIIETK----FEMIKLIDIARQTAQGMDYLHAKS---II 146
Query: 400 HRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRF 459
           HRD+K++NI L + L  K+ DFGL   + R +       +L G+  ++ PE I ++    
Sbjct: 147 HRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFE-QLSGSILWMAPEVIRMQD--- 202
Query: 460 DMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
                  +   + ++DV+AFG+VL EL+TG+
Sbjct: 203 -------KNPYSFQSDVYAFGIVLYELMTGQ 226

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 72/280 (25%), Positives = 123/280 (43%), Gaps = 59/280 (21%)
Query: 298 RIIGRGGFGNVYFGLL----GDREA--AIKKMRSNKSK----EFFAELKVLCKIHHINVF 347
           ++IG G FG VY G+L    G +E   AIK +++  ++    +F  E  ++ +  H N+ 
Sbjct: 50  KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNII 109
Query: 348 -----ISTFG----------NGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHD 392
                IS +           NG+L   L +         +      +    A G++Y+ +
Sbjct: 110 RLEGVISKYKPMMIITEYMENGALDKFLREK----DGEFSVLQLVGMLRGIAAGMKYLAN 165
Query: 393 HTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYI 452
                YVHRD+   NIL++  L  KV+DFGL ++ E   E     +       +  PE I
Sbjct: 166 MN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAI 222
Query: 453 FVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRAL-----------IRDDSE- 499
             ++F             T+ +DV++FG+V+ E++T G+R             I D    
Sbjct: 223 SYRKF-------------TSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRL 269
Query: 500 PTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIM 539
           PT M     I   + + C  ++   RP+  DIV+IL +++
Sbjct: 270 PTPMDCPSAIYQLMMQ-CWQQERARRPKFADIVSILDKLI 308

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 72/285 (25%), Positives = 123/285 (43%), Gaps = 60/285 (21%)
Query: 293 NFDESRIIGRGGFGNVYFGLLG-----DREAAIKKMR----SNKSKEFFAELKVLCKIHH 343
           N    +++G G FG V  G L      +   AIK ++      + ++F  E  ++ +  H
Sbjct: 17  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 76
Query: 344 INVF---------------ISTFGNGSLSDHLHDPLLKGHQP-LTWTARTQIALDAAKGI 387
            N+                     NGSL     D  L+ H    T      +    A G+
Sbjct: 77  PNIIRLEGVVTKSKPVMIVTEXMENGSL-----DSFLRKHDAQFTVIQLVGMLRGIASGM 131
Query: 388 EYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP-GY 446
           +Y+ D     YVHRD+   NIL++  L  KV+DFGL ++ E   E     TR    P  +
Sbjct: 132 KYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEA-AYTTRGGKIPIRW 187
Query: 447 LPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRA--------LIRDD 497
             PE I  ++F             T+ +DV+++G+VL E+++ G+R         +I+  
Sbjct: 188 TSPEAIAYRKF-------------TSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 234
Query: 498 SEPTKMKSLITIMAAVAEW---CLNEDAVDRPEMRDIVAILSQIM 539
            E  ++   +   AA+ +    C  +D  +RP+   IV+IL +++
Sbjct: 235 DEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 279

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 75/285 (26%), Positives = 125/285 (43%), Gaps = 60/285 (21%)
Query: 293 NFDESRIIGRGGFGNVYFGLLG-----DREAAIKKMR----SNKSKEFFAELKVLCKIHH 343
           N    +++G G FG V  G L      +   AIK ++      + ++F  E  ++ +  H
Sbjct: 34  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 93
Query: 344 IN-------------VFIST--FGNGSLSDHLHDPLLKGHQP-LTWTARTQIALDAAKGI 387
            N             V I T    NGSL     D  L+ H    T      +    A G+
Sbjct: 94  PNIIRLEGVVTKSKPVMIVTEYMENGSL-----DSFLRKHDAQFTVIQLVGMLRGIASGM 148
Query: 388 EYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP-GY 446
           +Y+ D     YVHRD+   NIL++  L  KV+DFGL ++ E   E     TR    P  +
Sbjct: 149 KYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEA-AYTTRGGKIPIRW 204
Query: 447 LPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRA--------LIRDD 497
             PE I  ++F             T+ +DV+++G+VL E+++ G+R         +I+  
Sbjct: 205 TSPEAIAYRKF-------------TSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 251
Query: 498 SEPTKMKSLITIMAAVAEW---CLNEDAVDRPEMRDIVAILSQIM 539
            E  ++   +   AA+ +    C  +D  +RP+   IV+IL +++
Sbjct: 252 DEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 296

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 75/285 (26%), Positives = 125/285 (43%), Gaps = 60/285 (21%)
Query: 293 NFDESRIIGRGGFGNVYFGLLG-----DREAAIKKMR----SNKSKEFFAELKVLCKIHH 343
           N    +++G G FG V  G L      +   AIK ++      + ++F  E  ++ +  H
Sbjct: 17  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 76
Query: 344 IN-------------VFIST--FGNGSLSDHLHDPLLKGHQP-LTWTARTQIALDAAKGI 387
            N             V I T    NGSL     D  L+ H    T      +    A G+
Sbjct: 77  PNIIRLEGVVTKSKPVMIVTEYMENGSL-----DSFLRKHDAQFTVIQLVGMLRGIASGM 131
Query: 388 EYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP-GY 446
           +Y+ D     YVHRD+   NIL++  L  KV+DFGL ++ E   E     TR    P  +
Sbjct: 132 KYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEA-AYTTRGGKIPIRW 187
Query: 447 LPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRA--------LIRDD 497
             PE I  ++F             T+ +DV+++G+VL E+++ G+R         +I+  
Sbjct: 188 TSPEAIAYRKF-------------TSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 234
Query: 498 SEPTKMKSLITIMAAVAEW---CLNEDAVDRPEMRDIVAILSQIM 539
            E  ++   +   AA+ +    C  +D  +RP+   IV+IL +++
Sbjct: 235 DEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 279

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 75/285 (26%), Positives = 125/285 (43%), Gaps = 60/285 (21%)
Query: 293 NFDESRIIGRGGFGNVYFGLLG-----DREAAIKKMR----SNKSKEFFAELKVLCKIHH 343
           N    +++G G FG V  G L      +   AIK ++      + ++F  E  ++ +  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 344 IN-------------VFIST--FGNGSLSDHLHDPLLKGHQP-LTWTARTQIALDAAKGI 387
            N             V I T    NGSL     D  L+ H    T      +    A G+
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSL-----DSFLRKHDAQFTVIQLVGMLRGIASGM 160
Query: 388 EYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP-GY 446
           +Y+ D     YVHRD+   NIL++  L  KV+DFGL ++ E   E     TR    P  +
Sbjct: 161 KYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEA-AYTTRGGKIPIRW 216
Query: 447 LPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRA--------LIRDD 497
             PE I  ++F             T+ +DV+++G+VL E+++ G+R         +I+  
Sbjct: 217 TSPEAIAYRKF-------------TSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 263
Query: 498 SEPTKMKSLITIMAAVAEW---CLNEDAVDRPEMRDIVAILSQIM 539
            E  ++   +   AA+ +    C  +D  +RP+   IV+IL +++
Sbjct: 264 DEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 72/285 (25%), Positives = 123/285 (43%), Gaps = 60/285 (21%)
Query: 293 NFDESRIIGRGGFGNVYFGLLG-----DREAAIKKMR----SNKSKEFFAELKVLCKIHH 343
           N    +++G G FG V  G L      +   AIK ++      + ++F  E  ++ +  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 344 INVF---------------ISTFGNGSLSDHLHDPLLKGHQP-LTWTARTQIALDAAKGI 387
            N+                     NGSL     D  L+ H    T      +    A G+
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEXMENGSL-----DSFLRKHDAQFTVIQLVGMLRGIASGM 160
Query: 388 EYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP-GY 446
           +Y+ D     YVHRD+   NIL++  L  KV+DFGL ++ E   E     TR    P  +
Sbjct: 161 KYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEA-AYTTRGGKIPIRW 216
Query: 447 LPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRA--------LIRDD 497
             PE I  ++F             T+ +DV+++G+VL E+++ G+R         +I+  
Sbjct: 217 TSPEAIAYRKF-------------TSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 263
Query: 498 SEPTKMKSLITIMAAVAEW---CLNEDAVDRPEMRDIVAILSQIM 539
            E  ++   +   AA+ +    C  +D  +RP+   IV+IL +++
Sbjct: 264 DEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 71/279 (25%), Positives = 126/279 (45%), Gaps = 58/279 (20%)
Query: 298 RIIGRGGFGNVYFGLL---GDREAA--IKKMR----SNKSKEFFAELKVLCKIHHINVF- 347
           R+IG G FG V  G L   G R+ A  IK ++      + ++F  E  ++ +  H NV  
Sbjct: 49  RVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVH 108
Query: 348 --------------ISTFGNGSLSDHLHDPLLKGHQ-PLTWTARTQIALDAAKGIEYIHD 392
                         I    NG+L     D  L+ H    T      +    A G+ Y+ D
Sbjct: 109 LEGVVTRGKPVMIVIEFMENGAL-----DAFLRKHDGQFTVIQLVGMLRGIAAGMRYLAD 163
Query: 393 HTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYI 452
                YVHRD+   NIL++  L  KV+DFGL ++ E  ++ E + T    T G +P    
Sbjct: 164 MG---YVHRDLAARNILVNSNLVCKVSDFGLSRVIE--DDPEAVYTT---TGGKIP---- 211
Query: 453 FVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRA--------LIRDDSEPTKM 503
                R+    ++   + T+ +DV+++G+V+ E+++ G+R         +I+   E  ++
Sbjct: 212 ----VRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGYRL 267
Query: 504 KSLITIMAAVAEW---CLNEDAVDRPEMRDIVAILSQIM 539
            + +   A + +    C  ++  +RP+   IV IL +++
Sbjct: 268 PAPMDCPAGLHQLMLDCWQKERAERPKFEQIVGILDKMI 306

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 72/285 (25%), Positives = 123/285 (43%), Gaps = 60/285 (21%)
Query: 293 NFDESRIIGRGGFGNVYFGLLG-----DREAAIKKMR----SNKSKEFFAELKVLCKIHH 343
           N    +++G G FG V  G L      +   AIK ++      + ++F  E  ++ +  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 344 INVF---------------ISTFGNGSLSDHLHDPLLKGHQP-LTWTARTQIALDAAKGI 387
            N+                     NGSL     D  L+ H    T      +    A G+
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSL-----DSFLRKHDAQFTVIQLVGMLRGIASGM 160
Query: 388 EYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP-GY 446
           +Y+ D     YVHRD+   NIL++  L  KV+DFGL ++ E   E     TR    P  +
Sbjct: 161 KYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEA-AYTTRGGKIPIRW 216
Query: 447 LPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRA--------LIRDD 497
             PE I  ++F             T+ +DV+++G+VL E+++ G+R         +I+  
Sbjct: 217 TSPEAIAYRKF-------------TSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 263
Query: 498 SEPTKMKSLITIMAAVAEW---CLNEDAVDRPEMRDIVAILSQIM 539
            E  ++   +   AA+ +    C  +D  +RP+   IV+IL +++
Sbjct: 264 DEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 72/285 (25%), Positives = 123/285 (43%), Gaps = 60/285 (21%)
Query: 293 NFDESRIIGRGGFGNVYFGLLG-----DREAAIKKMR----SNKSKEFFAELKVLCKIHH 343
           N    +++G G FG V  G L      +   AIK ++      + ++F  E  ++ +  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 344 INVF---------------ISTFGNGSLSDHLHDPLLKGHQP-LTWTARTQIALDAAKGI 387
            N+                     NGSL     D  L+ H    T      +    A G+
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSL-----DSFLRKHDAQFTVIQLVGMLRGIASGM 160
Query: 388 EYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP-GY 446
           +Y+ D     YVHRD+   NIL++  L  KV+DFGL ++ E   E     TR    P  +
Sbjct: 161 KYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEA-AYTTRGGKIPIRW 216
Query: 447 LPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRA--------LIRDD 497
             PE I  ++F             T+ +DV+++G+VL E+++ G+R         +I+  
Sbjct: 217 TSPEAIAYRKF-------------TSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 263
Query: 498 SEPTKMKSLITIMAAVAEW---CLNEDAVDRPEMRDIVAILSQIM 539
            E  ++   +   AA+ +    C  +D  +RP+   IV+IL +++
Sbjct: 264 DEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 78/306 (25%), Positives = 128/306 (41%), Gaps = 69/306 (22%)
Query: 282 FSLEEIEEATNNFDES---------RIIGRGGFGNVYFG---LLGDRE--AAIKKMRS-- 325
           F+ E+  EA   F +          ++IG G FG V  G   L G RE   AIK ++S  
Sbjct: 14  FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 73
Query: 326 --NKSKEFFAELKVLCKIHHINVF--------------ISTF-GNGSLSDHLHDPLLKGH 368
              + ++F +E  ++ +  H NV               I+ F  NGSL   L     +  
Sbjct: 74  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLR----QND 129
Query: 369 QPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEE 428
              T      +    A G++Y+ D     YVHRD+   NIL++  L  KV+DFGL +  E
Sbjct: 130 GQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 186
Query: 429 RTNEKEMLATRLVGTPG--YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAEL 486
                    + L G     +  PE I  ++F             T+ +DV+++G+V+ E+
Sbjct: 187 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKF-------------TSASDVWSYGIVMWEV 233
Query: 487 IT-GKR------------ALIRDDSEPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVA 533
           ++ G+R            A+ +D   P  M     +   + + C  +D   RP+   IV 
Sbjct: 234 MSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLD-CWQKDRNHRPKFGQIVN 292
Query: 534 ILSQIM 539
            L +++
Sbjct: 293 TLDKMI 298

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 75/285 (26%), Positives = 125/285 (43%), Gaps = 60/285 (21%)
Query: 293 NFDESRIIGRGGFGNVYFGLLG-----DREAAIKKMR----SNKSKEFFAELKVLCKIHH 343
           N    +++G G FG V  G L      +   AIK ++      + ++F  E  ++ +  H
Sbjct: 44  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 103
Query: 344 IN-------------VFIST--FGNGSLSDHLHDPLLKGHQP-LTWTARTQIALDAAKGI 387
            N             V I T    NGSL     D  L+ H    T      +    A G+
Sbjct: 104 PNIIRLEGVVTKSKPVMIVTEYMENGSL-----DSFLRKHDAQFTVIQLVGMLRGIASGM 158
Query: 388 EYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP-GY 446
           +Y+ D     YVHRD+   NIL++  L  KV+DFGL ++ E   E     TR    P  +
Sbjct: 159 KYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEA-AYTTRGGKIPIRW 214
Query: 447 LPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRA--------LIRDD 497
             PE I  ++F             T+ +DV+++G+VL E+++ G+R         +I+  
Sbjct: 215 TSPEAIAYRKF-------------TSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 261
Query: 498 SEPTKMKSLITIMAAVAEW---CLNEDAVDRPEMRDIVAILSQIM 539
            E  ++   +   AA+ +    C  +D  +RP+   IV+IL +++
Sbjct: 262 DEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 306

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 72/279 (25%), Positives = 122/279 (43%), Gaps = 58/279 (20%)
Query: 298 RIIGRGGFGNVYFGLL---GDRE--AAIKKMR----SNKSKEFFAELKVLCKIHHINVF- 347
           R+IG G FG V  G L   G RE   AIK ++      + ++F  E  ++ +  H N+  
Sbjct: 28  RVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIH 87
Query: 348 --------------ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDH 393
                              NGSL   L     K     T      +    + G++Y+ D 
Sbjct: 88  LEGVVTKSKPVMIVTEYMENGSLDTFLK----KNDGQFTVIQLVGMLRGISAGMKYLSDM 143
Query: 394 TKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP-GYLPPEYI 452
               YVHRD+   NIL++  L  KV+DFGL ++ E   E     TR    P  +  PE I
Sbjct: 144 G---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEA-AYTTRGGKIPIRWTAPEAI 199
Query: 453 FVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRA--------LIRDDSEPTKM 503
             ++F             T+ +DV+++G+V+ E+++ G+R         +I+   E  ++
Sbjct: 200 AFRKF-------------TSASDVWSYGIVMWEVVSYGERPYWEMTNQDVIKAVEEGYRL 246
Query: 504 KSLITIMAAVAEW---CLNEDAVDRPEMRDIVAILSQIM 539
            S +   AA+ +    C  ++   RP+  +IV +L +++
Sbjct: 247 PSPMDCPAALYQLMLDCWQKERNSRPKFDEIVNMLDKLI 285

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 72/285 (25%), Positives = 123/285 (43%), Gaps = 60/285 (21%)
Query: 293 NFDESRIIGRGGFGNVYFGLLG-----DREAAIKKMR----SNKSKEFFAELKVLCKIHH 343
           N    +++G G FG V  G L      +   AIK ++      + ++F  E  ++ +  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 344 INVF---------------ISTFGNGSLSDHLHDPLLKGHQP-LTWTARTQIALDAAKGI 387
            N+                     NGSL     D  L+ H    T      +    A G+
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSL-----DSFLRKHDAQFTVIQLVGMLRGIASGM 160
Query: 388 EYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP-GY 446
           +Y+ D     YVHRD+   NIL++  L  KV+DFGL ++ E   E     TR    P  +
Sbjct: 161 KYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEA-AYTTRGGKIPIRW 216
Query: 447 LPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRA--------LIRDD 497
             PE I  ++F             T+ +DV+++G+VL E+++ G+R         +I+  
Sbjct: 217 TSPEAIAYRKF-------------TSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 263
Query: 498 SEPTKMKSLITIMAAVAEW---CLNEDAVDRPEMRDIVAILSQIM 539
            E  ++   +   AA+ +    C  +D  +RP+   IV+IL +++
Sbjct: 264 DEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 75/285 (26%), Positives = 125/285 (43%), Gaps = 60/285 (21%)
Query: 293 NFDESRIIGRGGFGNVYFGLLG-----DREAAIKKMR----SNKSKEFFAELKVLCKIHH 343
           N    +++G G FG V  G L      +   AIK ++      + ++F  E  ++ +  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 344 IN-------------VFIST--FGNGSLSDHLHDPLLKGHQP-LTWTARTQIALDAAKGI 387
            N             V I T    NGSL     D  L+ H    T      +    A G+
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSL-----DSFLRKHDAQFTVIQLVGMLRGIASGM 160
Query: 388 EYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP-GY 446
           +Y+ D     YVHRD+   NIL++  L  KV+DFGL ++ E   E     TR    P  +
Sbjct: 161 KYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEA-AYTTRGGKIPIRW 216
Query: 447 LPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRA--------LIRDD 497
             PE I  ++F             T+ +DV+++G+VL E+++ G+R         +I+  
Sbjct: 217 TSPEAIAYRKF-------------TSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 263
Query: 498 SEPTKMKSLITIMAAVAEW---CLNEDAVDRPEMRDIVAILSQIM 539
            E  ++   +   AA+ +    C  +D  +RP+   IV+IL +++
Sbjct: 264 DEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 101/221 (45%), Gaps = 46/221 (20%)
Query: 293 NFDESRIIGRGGFGNVYFGLLGDREA-----AIKKMRS----NKSKEFFAELKVLCKIHH 343
           +F+E  +IGRG FG VY G L D +      A+K +       +  +F  E  ++    H
Sbjct: 52  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 109
Query: 344 INVF----------------ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGI 387
            NV                 +    +G L + + +   + H P T        L  AKG+
Sbjct: 110 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN---ETHNP-TVKDLIGFGLQVAKGM 165
Query: 388 EYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYL 447
           +Y+      ++VHRD+   N +LD+    KVADFGL +      +KE  +     T   L
Sbjct: 166 KYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR---DMYDKEYYSVH-NKTGAKL 218
Query: 448 PPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
           P +++ ++        S+   + TTK+DV++FGV+L EL+T
Sbjct: 219 PVKWMALE--------SLQTQKFTTKSDVWSFGVLLWELMT 251

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 101/221 (45%), Gaps = 46/221 (20%)
Query: 293 NFDESRIIGRGGFGNVYFGLLGDREA-----AIKKMRS----NKSKEFFAELKVLCKIHH 343
           +F+E  +IGRG FG VY G L D +      A+K +       +  +F  E  ++    H
Sbjct: 33  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 90
Query: 344 INVF----------------ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGI 387
            NV                 +    +G L + + +   + H P T        L  AKG+
Sbjct: 91  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN---ETHNP-TVKDLIGFGLQVAKGM 146
Query: 388 EYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYL 447
           +Y+      ++VHRD+   N +LD+    KVADFGL +      +KE  +     T   L
Sbjct: 147 KYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR---DMYDKEYYSVH-NKTGAKL 199
Query: 448 PPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
           P +++ ++        S+   + TTK+DV++FGV+L EL+T
Sbjct: 200 PVKWMALE--------SLQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 75/285 (26%), Positives = 125/285 (43%), Gaps = 60/285 (21%)
Query: 293 NFDESRIIGRGGFGNVYFGLLG-----DREAAIKKMR----SNKSKEFFAELKVLCKIHH 343
           N    +++G G FG V  G L      +   AIK ++      + ++F  E  ++ +  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 344 IN-------------VFIST--FGNGSLSDHLHDPLLKGHQP-LTWTARTQIALDAAKGI 387
            N             V I T    NGSL     D  L+ H    T      +    A G+
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSL-----DSFLRKHDAQFTVIQLVGMLRGIASGM 160
Query: 388 EYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP-GY 446
           +Y+ D     YVHRD+   NIL++  L  KV+DFGL ++ E   E     TR    P  +
Sbjct: 161 KYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEA-AYTTRGGKIPIRW 216
Query: 447 LPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRA--------LIRDD 497
             PE I  ++F             T+ +DV+++G+VL E+++ G+R         +I+  
Sbjct: 217 TSPEAIAYRKF-------------TSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 263
Query: 498 SEPTKMKSLITIMAAVAEW---CLNEDAVDRPEMRDIVAILSQIM 539
            E  ++   +   AA+ +    C  +D  +RP+   IV+IL +++
Sbjct: 264 DEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 101/221 (45%), Gaps = 46/221 (20%)
Query: 293 NFDESRIIGRGGFGNVYFGLLGDREA-----AIKKMRS----NKSKEFFAELKVLCKIHH 343
           +F+E  +IGRG FG VY G L D +      A+K +       +  +F  E  ++    H
Sbjct: 32  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 89
Query: 344 INVF----------------ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGI 387
            NV                 +    +G L + + +   + H P T        L  AKG+
Sbjct: 90  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN---ETHNP-TVKDLIGFGLQVAKGM 145
Query: 388 EYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYL 447
           +Y+      ++VHRD+   N +LD+    KVADFGL +      +KE  +     T   L
Sbjct: 146 KYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR---DMYDKEXXSVH-NKTGAKL 198
Query: 448 PPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
           P +++ ++        S+   + TTK+DV++FGV+L EL+T
Sbjct: 199 PVKWMALE--------SLQTQKFTTKSDVWSFGVLLWELMT 231

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 101/221 (45%), Gaps = 46/221 (20%)
Query: 293 NFDESRIIGRGGFGNVYFGLLGDREA-----AIKKMRS----NKSKEFFAELKVLCKIHH 343
           +F+E  +IGRG FG VY G L D +      A+K +       +  +F  E  ++    H
Sbjct: 25  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 82
Query: 344 INVF----------------ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGI 387
            NV                 +    +G L + + +   + H P T        L  AKG+
Sbjct: 83  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN---ETHNP-TVKDLIGFGLQVAKGM 138
Query: 388 EYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYL 447
           +Y+      ++VHRD+   N +LD+    KVADFGL +      +KE  +     T   L
Sbjct: 139 KYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR---DMYDKEYYSVH-NKTGAKL 191
Query: 448 PPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
           P +++ ++        S+   + TTK+DV++FGV+L EL+T
Sbjct: 192 PVKWMALE--------SLQTQKFTTKSDVWSFGVLLWELMT 224

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 101/221 (45%), Gaps = 46/221 (20%)
Query: 293 NFDESRIIGRGGFGNVYFGLLGDREA-----AIKKMRS----NKSKEFFAELKVLCKIHH 343
           +F+E  +IGRG FG VY G L D +      A+K +       +  +F  E  ++    H
Sbjct: 51  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 108
Query: 344 INVF----------------ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGI 387
            NV                 +    +G L + + +   + H P T        L  AKG+
Sbjct: 109 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN---ETHNP-TVKDLIGFGLQVAKGM 164
Query: 388 EYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYL 447
           +Y+      ++VHRD+   N +LD+    KVADFGL +      +KE  +     T   L
Sbjct: 165 KYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR---DMYDKEYYSVH-NKTGAKL 217
Query: 448 PPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
           P +++ ++        S+   + TTK+DV++FGV+L EL+T
Sbjct: 218 PVKWMALE--------SLQTQKFTTKSDVWSFGVLLWELMT 250

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 101/221 (45%), Gaps = 46/221 (20%)
Query: 293 NFDESRIIGRGGFGNVYFGLLGDREA-----AIKKMRS----NKSKEFFAELKVLCKIHH 343
           +F+E  +IGRG FG VY G L D +      A+K +       +  +F  E  ++    H
Sbjct: 28  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 85
Query: 344 INVF----------------ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGI 387
            NV                 +    +G L + + +   + H P T        L  AKG+
Sbjct: 86  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN---ETHNP-TVKDLIGFGLQVAKGM 141
Query: 388 EYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYL 447
           +Y+      ++VHRD+   N +LD+    KVADFGL +      +KE  +     T   L
Sbjct: 142 KYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR---DMYDKEYYSVH-NKTGAKL 194
Query: 448 PPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
           P +++ ++        S+   + TTK+DV++FGV+L EL+T
Sbjct: 195 PVKWMALE--------SLQTQKFTTKSDVWSFGVLLWELMT 227

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 101/221 (45%), Gaps = 46/221 (20%)
Query: 293 NFDESRIIGRGGFGNVYFGLLGDREA-----AIKKMRS----NKSKEFFAELKVLCKIHH 343
           +F+E  +IGRG FG VY G L D +      A+K +       +  +F  E  ++    H
Sbjct: 30  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87
Query: 344 INVF----------------ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGI 387
            NV                 +    +G L + + +   + H P T        L  AKG+
Sbjct: 88  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN---ETHNP-TVKDLIGFGLQVAKGM 143
Query: 388 EYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYL 447
           +Y+      ++VHRD+   N +LD+    KVADFGL +      +KE  +     T   L
Sbjct: 144 KYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR---DMYDKEYYSVH-NKTGAKL 196
Query: 448 PPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
           P +++ ++        S+   + TTK+DV++FGV+L EL+T
Sbjct: 197 PVKWMALE--------SLQTQKFTTKSDVWSFGVLLWELMT 229

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 97/215 (45%), Gaps = 46/215 (21%)
Query: 300 IGRGGFGNV---YFGLLGDREA---AIKKMRSNKS---KEFFAELKVLCKIHHINV---- 346
           +G+G FG+V    +  L D      A+KK++ +     ++F  E+++L  + H N+    
Sbjct: 17  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 76
Query: 347 -------------FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDH 393
                         +     GSL D+L     K  + +      Q      KG+EY+   
Sbjct: 77  GVCYSAGRRNLKLIMEYLPYGSLRDYLQ----KHKERIDHIKLLQYTSQICKGMEYL--- 129
Query: 394 TKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIF 453
              RY+HRD+ T NIL+++  R K+ DFGL K+  +  E        V  PG  P   IF
Sbjct: 130 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXK-----VKEPGESP---IF 181
Query: 454 VKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
                +    S+ E + +  +DV++FGVVL EL T
Sbjct: 182 -----WYAPESLTESKFSVASDVWSFGVVLYELFT 211

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 101/221 (45%), Gaps = 46/221 (20%)
Query: 293 NFDESRIIGRGGFGNVYFGLLGDREA-----AIKKMRS----NKSKEFFAELKVLCKIHH 343
           +F+E  +IGRG FG VY G L D +      A+K +       +  +F  E  ++    H
Sbjct: 31  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 88
Query: 344 INVF----------------ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGI 387
            NV                 +    +G L + + +   + H P T        L  AKG+
Sbjct: 89  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN---ETHNP-TVKDLIGFGLQVAKGM 144
Query: 388 EYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYL 447
           +Y+      ++VHRD+   N +LD+    KVADFGL +      +KE  +     T   L
Sbjct: 145 KYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR---DMYDKEYYSVH-NKTGAKL 197
Query: 448 PPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
           P +++ ++        S+   + TTK+DV++FGV+L EL+T
Sbjct: 198 PVKWMALE--------SLQTQKFTTKSDVWSFGVLLWELMT 230

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 101/221 (45%), Gaps = 46/221 (20%)
Query: 293 NFDESRIIGRGGFGNVYFGLLGDREA-----AIKKMRS----NKSKEFFAELKVLCKIHH 343
           +F+E  +IGRG FG VY G L D +      A+K +       +  +F  E  ++    H
Sbjct: 33  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 90
Query: 344 INVF----------------ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGI 387
            NV                 +    +G L + + +   + H P T        L  AKG+
Sbjct: 91  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN---ETHNP-TVKDLIGFGLQVAKGM 146
Query: 388 EYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYL 447
           +Y+      ++VHRD+   N +LD+    KVADFGL +      +KE  +     T   L
Sbjct: 147 KYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR---DMYDKEYYSVH-NKTGAKL 199
Query: 448 PPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
           P +++ ++        S+   + TTK+DV++FGV+L EL+T
Sbjct: 200 PVKWMALE--------SLQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 97/214 (45%), Gaps = 40/214 (18%)
Query: 300 IGRGGFGNVYFGLLGDREAAIKKMRSNKSKEFFAELKVLCKI--HHINV--FIST----- 350
           +G+G +G V+ GL      A+K   S   + +F E ++   +   H N+  FI++     
Sbjct: 16  VGKGRYGEVWRGLWHGESVAVKIFSSRDEQSWFRETEIYNTVLLRHDNILGFIASDMTSR 75
Query: 351 ------------FGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIH-----DH 393
                         +GSL D L    L+ H  L      ++A+ AA G+ ++H       
Sbjct: 76  NSSTQLWLITHYHEHGSLYDFLQRQTLEPHLAL------RLAVSAACGLAHLHVEIFGTQ 129
Query: 394 TKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEK-EMLATRLVGTPGYLPPEYI 452
            K    HRD K+ N+L+   L+  +AD GL  +  + ++  ++     VGT  Y+ PE +
Sbjct: 130 GKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYMAPE-V 188
Query: 453 FVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAEL 486
             ++ R D   S         TD++AFG+VL E+
Sbjct: 189 LDEQIRTDCFESY------KWTDIWAFGLVLWEI 216

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 97/215 (45%), Gaps = 46/215 (21%)
Query: 300 IGRGGFGNV---YFGLLGDREA---AIKKMRSNKS---KEFFAELKVLCKIHHINV---- 346
           +G+G FG+V    +  L D      A+KK++ +     ++F  E+++L  + H N+    
Sbjct: 16  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 75
Query: 347 -------------FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDH 393
                         +     GSL D+L     K  + +      Q      KG+EY+   
Sbjct: 76  GVCYSAGRRNLKLIMEYLPYGSLRDYLQ----KHKERIDHIKLLQYTSQICKGMEYL--- 128
Query: 394 TKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIF 453
              RY+HRD+ T NIL+++  R K+ DFGL K+  +  E        V  PG  P   IF
Sbjct: 129 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXK-----VKEPGESP---IF 180
Query: 454 VKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
                +    S+ E + +  +DV++FGVVL EL T
Sbjct: 181 -----WYAPESLTESKFSVASDVWSFGVVLYELFT 210

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 97/215 (45%), Gaps = 46/215 (21%)
Query: 300 IGRGGFGNV---YFGLLGDREA---AIKKMRSNKS---KEFFAELKVLCKIHHINV---- 346
           +G+G FG+V    +  L D      A+KK++ +     ++F  E+++L  + H N+    
Sbjct: 22  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 81
Query: 347 -------------FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDH 393
                         +     GSL D+L     K  + +      Q      KG+EY+   
Sbjct: 82  GVCYSAGRRNLKLIMEYLPYGSLRDYLQ----KHKERIDHIKLLQYTSQICKGMEYL--- 134
Query: 394 TKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIF 453
              RY+HRD+ T NIL+++  R K+ DFGL K+  +  E        V  PG  P   IF
Sbjct: 135 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXK-----VKEPGESP---IF 186
Query: 454 VKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
                +    S+ E + +  +DV++FGVVL EL T
Sbjct: 187 -----WYAPESLTESKFSVASDVWSFGVVLYELFT 216

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 101/221 (45%), Gaps = 46/221 (20%)
Query: 293 NFDESRIIGRGGFGNVYFGLLGDREA-----AIKKMRS----NKSKEFFAELKVLCKIHH 343
           +F+E  +IGRG FG VY G L D +      A+K +       +  +F  E  ++    H
Sbjct: 32  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 89
Query: 344 INVF----------------ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGI 387
            NV                 +    +G L + + +   + H P T        L  AKG+
Sbjct: 90  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN---ETHNP-TVKDLIGFGLQVAKGM 145
Query: 388 EYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYL 447
           +Y+      ++VHRD+   N +LD+    KVADFGL +      +KE  +     T   L
Sbjct: 146 KYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR---DMYDKEYYSVH-NKTGAKL 198
Query: 448 PPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
           P +++ ++        S+   + TTK+DV++FGV+L EL+T
Sbjct: 199 PVKWMALE--------SLQTQKFTTKSDVWSFGVLLWELMT 231

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 98/215 (45%), Gaps = 46/215 (21%)
Query: 300 IGRGGFGNV---YFGLLGDREA---AIKKMRSNKS---KEFFAELKVLCKIHHINV---- 346
           +G+G FG+V    +  L D      A+KK++ +     ++F  E+++L  + H N+    
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 347 -------------FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDH 393
                         +     GSL D+L     K  + +      Q      KG+EY+   
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYLQ----KHKERIDHIKLLQYTSQICKGMEYL--- 130
Query: 394 TKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIF 453
              RY+HRD+ T NIL+++  R K+ DFGL K+     +KE      V  PG  P   IF
Sbjct: 131 GTKRYIHRDLATRNILVENENRVKIGDFGLTKV--LPQDKEFFK---VKEPGESP---IF 182
Query: 454 VKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
                +    S+ E + +  +DV++FGVVL EL T
Sbjct: 183 -----WYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 97/215 (45%), Gaps = 46/215 (21%)
Query: 300 IGRGGFGNV---YFGLLGDREA---AIKKMRSNKS---KEFFAELKVLCKIHHINV---- 346
           +G+G FG+V    +  L D      A+KK++ +     ++F  E+++L  + H N+    
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 347 -------------FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDH 393
                         +     GSL D+L     K  + +      Q      KG+EY+   
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYLQ----KHKERIDHIKLLQYTSQICKGMEYL--- 130
Query: 394 TKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIF 453
              RY+HRD+ T NIL+++  R K+ DFGL K+  +  E        V  PG  P   IF
Sbjct: 131 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXK-----VKEPGESP---IF 182
Query: 454 VKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
                +    S+ E + +  +DV++FGVVL EL T
Sbjct: 183 -----WYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 97/215 (45%), Gaps = 46/215 (21%)
Query: 300 IGRGGFGNV---YFGLLGDREA---AIKKMRSNKS---KEFFAELKVLCKIHHINV---- 346
           +G+G FG+V    +  L D      A+KK++ +     ++F  E+++L  + H N+    
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 347 -------------FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDH 393
                         +     GSL D+L     K  + +      Q      KG+EY+   
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYLQ----KHKERIDHIKLLQYTSQICKGMEYL--- 130
Query: 394 TKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIF 453
              RY+HRD+ T NIL+++  R K+ DFGL K+  +  E        V  PG  P   IF
Sbjct: 131 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXK-----VKEPGESP---IF 182
Query: 454 VKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
                +    S+ E + +  +DV++FGVVL EL T
Sbjct: 183 -----WYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 97/215 (45%), Gaps = 46/215 (21%)
Query: 300 IGRGGFGNV---YFGLLGDREA---AIKKMRSNKS---KEFFAELKVLCKIHHINV---- 346
           +G+G FG+V    +  L D      A+KK++ +     ++F  E+++L  + H N+    
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 347 -------------FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDH 393
                         +     GSL D+L     K  + +      Q      KG+EY+   
Sbjct: 109 GVCYSAGRRNLKLIMEYLPYGSLRDYLQ----KHKERIDHIKLLQYTSQICKGMEYL--- 161
Query: 394 TKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIF 453
              RY+HRD+ T NIL+++  R K+ DFGL K+  +  E        V  PG  P   IF
Sbjct: 162 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXK-----VKEPGESP---IF 213
Query: 454 VKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
                +    S+ E + +  +DV++FGVVL EL T
Sbjct: 214 -----WYAPESLTESKFSVASDVWSFGVVLYELFT 243

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 97/215 (45%), Gaps = 46/215 (21%)
Query: 300 IGRGGFGNV---YFGLLGDREA---AIKKMRSNKS---KEFFAELKVLCKIHHINV---- 346
           +G+G FG+V    +  L D      A+KK++ +     ++F  E+++L  + H N+    
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 347 -------------FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDH 393
                         +     GSL D+L     K  + +      Q      KG+EY+   
Sbjct: 81  GVCYSAGRRNLKLIMEYLPYGSLRDYLQ----KHKERIDHIKLLQYTSQICKGMEYL--- 133
Query: 394 TKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIF 453
              RY+HRD+ T NIL+++  R K+ DFGL K+  +  E        V  PG  P   IF
Sbjct: 134 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXK-----VKEPGESP---IF 185
Query: 454 VKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
                +    S+ E + +  +DV++FGVVL EL T
Sbjct: 186 -----WYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 97/215 (45%), Gaps = 46/215 (21%)
Query: 300 IGRGGFGNV---YFGLLGDREA---AIKKMRSNKS---KEFFAELKVLCKIHHINV---- 346
           +G+G FG+V    +  L D      A+KK++ +     ++F  E+++L  + H N+    
Sbjct: 24  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 83
Query: 347 -------------FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDH 393
                         +     GSL D+L     K  + +      Q      KG+EY+   
Sbjct: 84  GVCYSAGRRNLKLIMEYLPYGSLRDYLQ----KHKERIDHIKLLQYTSQICKGMEYL--- 136
Query: 394 TKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIF 453
              RY+HRD+ T NIL+++  R K+ DFGL K+  +  E        V  PG  P   IF
Sbjct: 137 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXK-----VKEPGESP---IF 188
Query: 454 VKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
                +    S+ E + +  +DV++FGVVL EL T
Sbjct: 189 -----WYAPESLTESKFSVASDVWSFGVVLYELFT 218

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 97/215 (45%), Gaps = 46/215 (21%)
Query: 300 IGRGGFGNV---YFGLLGDREA---AIKKMRSNKS---KEFFAELKVLCKIHHINV---- 346
           +G+G FG+V    +  L D      A+KK++ +     ++F  E+++L  + H N+    
Sbjct: 23  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 82
Query: 347 -------------FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDH 393
                         +     GSL D+L     K  + +      Q      KG+EY+   
Sbjct: 83  GVCYSAGRRNLKLIMEYLPYGSLRDYLQ----KHKERIDHIKLLQYTSQICKGMEYL--- 135
Query: 394 TKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIF 453
              RY+HRD+ T NIL+++  R K+ DFGL K+  +  E        V  PG  P   IF
Sbjct: 136 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXK-----VKEPGESP---IF 187
Query: 454 VKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
                +    S+ E + +  +DV++FGVVL EL T
Sbjct: 188 -----WYAPESLTESKFSVASDVWSFGVVLYELFT 217

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 97/215 (45%), Gaps = 46/215 (21%)
Query: 300 IGRGGFGNV---YFGLLGDREA---AIKKMRSNKS---KEFFAELKVLCKIHHINV---- 346
           +G+G FG+V    +  L D      A+KK++ +     ++F  E+++L  + H N+    
Sbjct: 25  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 84
Query: 347 -------------FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDH 393
                         +     GSL D+L     K  + +      Q      KG+EY+   
Sbjct: 85  GVCYSAGRRNLKLIMEYLPYGSLRDYLQ----KHKERIDHIKLLQYTSQICKGMEYL--- 137
Query: 394 TKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIF 453
              RY+HRD+ T NIL+++  R K+ DFGL K+  +  E        V  PG  P   IF
Sbjct: 138 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXK-----VKEPGESP---IF 189
Query: 454 VKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
                +    S+ E + +  +DV++FGVVL EL T
Sbjct: 190 -----WYAPESLTESKFSVASDVWSFGVVLYELFT 219

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 97/215 (45%), Gaps = 46/215 (21%)
Query: 300 IGRGGFGNV---YFGLLGDREA---AIKKMRSNKS---KEFFAELKVLCKIHHINV---- 346
           +G+G FG+V    +  L D      A+KK++ +     ++F  E+++L  + H N+    
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 347 -------------FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDH 393
                         +     GSL D+L     K  + +      Q      KG+EY+   
Sbjct: 96  GVCYSAGRRNLKLIMEYLPYGSLRDYLQ----KHKERIDHIKLLQYTSQICKGMEYL--- 148
Query: 394 TKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIF 453
              RY+HRD+ T NIL+++  R K+ DFGL K+  +  E        V  PG  P   IF
Sbjct: 149 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXK-----VKEPGESP---IF 200
Query: 454 VKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
                +    S+ E + +  +DV++FGVVL EL T
Sbjct: 201 -----WYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 92/214 (42%), Gaps = 40/214 (18%)
Query: 300 IGRGGFGNVYFGLLGDREAAIKKMRSNKSKEFFAELK----VLCKIHHINVFIST----- 350
           IG+G +G V+ G     + A+K   + +   +F E +    VL +  +I  FI+      
Sbjct: 45  IGKGRYGEVWMGKWRGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGT 104
Query: 351 ------------FGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHD-----H 393
                         NGSL D+L    L     L      ++A  +  G+ ++H       
Sbjct: 105 GSWTQLYLITDYHENGSLYDYLKSTTLDAKSML------KLAYSSVSGLCHLHTEIFSTQ 158
Query: 394 TKARYVHRDIKTSNILLDDGLRAKVADFGL-VKLEERTNEKEMLATRLVGTPGYLPPEYI 452
            K    HRD+K+ NIL+       +AD GL VK    TNE ++     VGT  Y+PPE +
Sbjct: 159 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVL 218
Query: 453 FVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAEL 486
                R    S +M        D+++FG++L E+
Sbjct: 219 DESLNRNHFQSYIM-------ADMYSFGLILWEV 245

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 97/215 (45%), Gaps = 46/215 (21%)
Query: 300 IGRGGFGNV---YFGLLGDREA---AIKKMRSNKS---KEFFAELKVLCKIHHINV---- 346
           +G+G FG+V    +  L D      A+KK++ +     ++F  E+++L  + H N+    
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 347 -------------FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDH 393
                         +     GSL D+L     K  + +      Q      KG+EY+   
Sbjct: 96  GVCYSAGRRNLKLIMEYLPYGSLRDYLQ----KHKERIDHIKLLQYTSQICKGMEYL--- 148
Query: 394 TKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIF 453
              RY+HRD+ T NIL+++  R K+ DFGL K+  +  E        V  PG  P   IF
Sbjct: 149 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXK-----VKEPGESP---IF 200
Query: 454 VKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
                +    S+ E + +  +DV++FGVVL EL T
Sbjct: 201 -----WYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 125/285 (43%), Gaps = 60/285 (21%)
Query: 293 NFDESRIIGRGGFGNVYFGLLG-----DREAAIKKMR----SNKSKEFFAELKVLCKIHH 343
           N    +++G G FG V  G L      +   AIK ++      + ++F  E  ++ +  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 344 IN-------------VFIST--FGNGSLSDHLHDPLLKGHQP-LTWTARTQIALDAAKGI 387
            N             V I T    NGSL     D  L+ H    T      +    A G+
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSL-----DSFLRKHDAQFTVIQLVGMLRGIASGM 160
Query: 388 EYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP-GY 446
           +Y+ D     +VHRD+   NIL++  L  KV+DFGL ++ E   E     TR    P  +
Sbjct: 161 KYLSDMG---FVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEA-AYTTRGGKIPIRW 216
Query: 447 LPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRA--------LIRDD 497
             PE I  ++F             T+ +DV+++G+VL E+++ G+R         +I+  
Sbjct: 217 TSPEAIAYRKF-------------TSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 263
Query: 498 SEPTKMKSLITIMAAVAEW---CLNEDAVDRPEMRDIVAILSQIM 539
            E  ++   +   AA+ +    C  +D  +RP+   IV+IL +++
Sbjct: 264 DEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 75/297 (25%), Positives = 116/297 (39%), Gaps = 68/297 (22%)
Query: 284 LEEIEEATNNFDESRIIGRGGFGNVYFGLLGDREAAIKKMRSNKSKEFFA-------ELK 336
           L EI+ A    +E  IIG GGFG VY       E A+K  R +  ++          E K
Sbjct: 1   LLEIDFAELTLEE--IIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAK 58
Query: 337 VLCKIHHINV--------------FISTFGNGS-LSDHLHDPLLKGHQPLTWTARTQIAL 381
           +   + H N+               +  F  G  L+  L    +     + W      A+
Sbjct: 59  LFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNW------AV 112
Query: 382 DAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLR--------AKVADFGLVKLEERTNEK 433
             A+G+ Y+HD      +HRD+K+SNIL+   +          K+ DFGL +   RT + 
Sbjct: 113 QIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKM 172
Query: 434 EMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRAL 493
                   G   ++ PE I    F             +  +DV+++GV+L EL+TG+   
Sbjct: 173 SA-----AGAYAWMAPEVIRASMF-------------SKGSDVWSYGVLLWELLTGEVPF 214
Query: 494 IRDD----SEPTKMKSLITIM--------AAVAEWCLNEDAVDRPEMRDIVAILSQI 538
              D    +    M  L   +        A + E C N D   RP   +I+  L+ I
Sbjct: 215 RGIDGLAVAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 98/217 (45%), Gaps = 46/217 (21%)
Query: 298 RIIGRGGFGNV---YFGLLGDREA---AIKKMRSNKS---KEFFAELKVLCKIHHINV-- 346
           R +G+G FG+V    +  L D      A+KK++ +     ++F  E+++L  + H N+  
Sbjct: 19  RQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 78
Query: 347 ---------------FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIH 391
                           +     GSL ++L     K  + +      Q      KG+EY+ 
Sbjct: 79  YKGVCYSAGRRNLKLIMEFLPYGSLREYLQ----KHKERIDHIKLLQYTSQICKGMEYL- 133
Query: 392 DHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEY 451
                RY+HRD+ T NIL+++  R K+ DFGL K+  +  E        V  PG  P   
Sbjct: 134 --GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXK-----VKEPGESP--- 183
Query: 452 IFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
           IF     +    S+ E + +  +DV++FGVVL EL T
Sbjct: 184 IF-----WYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 101/217 (46%), Gaps = 50/217 (23%)
Query: 300 IGRGGFGNV---YFGLLGDREA---AIKKMRSNKS---KEFFAELKVLCKIHHINV---- 346
           +G+G FG+V    +  L D      A+KK++ +     ++F  E+++L  + H N+    
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 347 -------------FISTFGNGSLSDHL--HDPLLKGHQPLTWTARTQIALDAAKGIEYIH 391
                         +     GSL D+L  H   +   + L +T++        KG+EY+ 
Sbjct: 81  GVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQI------CKGMEYL- 133
Query: 392 DHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEY 451
                RY+HRD+ T NIL+++  R K+ DFGL K+  +  E        V  PG  P   
Sbjct: 134 --GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXK-----VKEPGESP--- 183
Query: 452 IFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
           IF     +    S+ E + +  +DV++FGVVL EL T
Sbjct: 184 IF-----WYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 72/277 (25%), Positives = 108/277 (38%), Gaps = 81/277 (29%)
Query: 300 IGRGGFGNVYFGLLGDREAAIKKMRSNKSKEFFA------------------ELKVL--C 339
           IG+G FG VY G+             N +KE  A                  E+ VL  C
Sbjct: 27  IGKGSFGEVYKGI------------DNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQC 74
Query: 340 KIHHINVFISTF-------------GNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKG 386
              +I  +  ++             G GS  D     LLK   PL  T    I  +  KG
Sbjct: 75  DSPYITRYFGSYLKSTKLWIIMEYLGGGSALD-----LLKP-GPLEETYIATILREILKG 128
Query: 387 IEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGY 446
           ++Y+H     R +HRDIK +N+LL +    K+ADFG+     +  + ++     VGTP +
Sbjct: 129 LDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAG---QLTDTQIKRNXFVGTPFW 182
Query: 447 LPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRA-----------LIR 495
           + PE I    + F             K D+++ G+   EL  G+             LI 
Sbjct: 183 MAPEVIKQSAYDF-------------KADIWSLGITAIELAKGEPPNSDLHPMRVLFLIP 229
Query: 496 DDSEPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIV 532
            +S PT             E CLN+D   RP  ++++
Sbjct: 230 KNSPPTLEGQHSKPFKEFVEACLNKDPRFRPTAKELL 266

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 71/285 (24%), Positives = 122/285 (42%), Gaps = 60/285 (21%)
Query: 293 NFDESRIIGRGGFGNVYFGLLG-----DREAAIKKMR----SNKSKEFFAELKVLCKIHH 343
           N    +++G G FG V  G L      +   AIK ++      + ++F  E  ++ +  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 344 INVF---------------ISTFGNGSLSDHLHDPLLKGHQP-LTWTARTQIALDAAKGI 387
            N+                     NGSL     D  L+ H    T      +    A G+
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEXMENGSL-----DSFLRKHDAQFTVIQLVGMLRGIASGM 160
Query: 388 EYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP-GY 446
           +Y+ D      VHRD+   NIL++  L  KV+DFGL ++ E   E     TR    P  +
Sbjct: 161 KYLSDMGA---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEA-AYTTRGGKIPIRW 216
Query: 447 LPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRA--------LIRDD 497
             PE I  ++F             T+ +DV+++G+VL E+++ G+R         +I+  
Sbjct: 217 TSPEAIAYRKF-------------TSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 263
Query: 498 SEPTKMKSLITIMAAVAEW---CLNEDAVDRPEMRDIVAILSQIM 539
            E  ++   +   AA+ +    C  +D  +RP+   IV+IL +++
Sbjct: 264 DEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 102/221 (46%), Gaps = 46/221 (20%)
Query: 293 NFDESRIIGRGGFGNVYFGLLGDREA-----AIKKMRS----NKSKEFFAELKVLCKIHH 343
           +F+E  +IGRG FG VY G L D +      A+K +       +  +F  E  ++    H
Sbjct: 92  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 149
Query: 344 INVF----------------ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGI 387
            NV                 +    +G L + + +   + H P T        L  AKG+
Sbjct: 150 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN---ETHNP-TVKDLIGFGLQVAKGM 205
Query: 388 EYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYL 447
           +++      ++VHRD+   N +LD+    KVADFGL + +    E + +  +   T   L
Sbjct: 206 KFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR-DMYDKEFDSVHNK---TGAKL 258
Query: 448 PPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
           P +++ ++        S+   + TTK+DV++FGV+L EL+T
Sbjct: 259 PVKWMALE--------SLQTQKFTTKSDVWSFGVLLWELMT 291

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 102/221 (46%), Gaps = 46/221 (20%)
Query: 293 NFDESRIIGRGGFGNVYFGLLGDREA-----AIKKMRS----NKSKEFFAELKVLCKIHH 343
           +F+E  +IGRG FG VY G L D +      A+K +       +  +F  E  ++    H
Sbjct: 38  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 95
Query: 344 INVF----------------ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGI 387
            NV                 +    +G L + + +   + H P T        L  AKG+
Sbjct: 96  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN---ETHNP-TVKDLIGFGLQVAKGM 151
Query: 388 EYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYL 447
           +++      ++VHRD+   N +LD+    KVADFGL + +    E + +  +   T   L
Sbjct: 152 KFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR-DMYDKEFDSVHNK---TGAKL 204
Query: 448 PPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
           P +++ ++        S+   + TTK+DV++FGV+L EL+T
Sbjct: 205 PVKWMALE--------SLQTQKFTTKSDVWSFGVLLWELMT 237

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 88/198 (44%), Gaps = 36/198 (18%)
Query: 346 VFISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKT 405
           + +   G GS  D L         PL  T    I  +  KG++Y+H   K   +HRDIK 
Sbjct: 102 IIMEYLGGGSALDLLEP------GPLDETQIATILREILKGLDYLHSEKK---IHRDIKA 152
Query: 406 SNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSV 465
           +N+LL +    K+ADFG+     +  + ++     VGTP ++ PE I  K+  +D     
Sbjct: 153 ANVLLSEHGEVKLADFGVAG---QLTDTQIKRNTFVGTPFWMAPEVI--KQSAYD----- 202
Query: 466 MELQVTTKTDVFAFGVVLAELITGKRA-----------LIRDDSEPTKMKSLITIMAAVA 514
                 +K D+++ G+   EL  G+             LI  ++ PT   +    +    
Sbjct: 203 ------SKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFV 256
Query: 515 EWCLNEDAVDRPEMRDIV 532
           E CLN++   RP  ++++
Sbjct: 257 EACLNKEPSFRPTAKELL 274

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 70/288 (24%), Positives = 113/288 (39%), Gaps = 72/288 (25%)
Query: 297 SRIIGRGGFGNVYFGLLGDR-----EAAIKKMRS----NKSKEFFAELKVLCKIHHINVF 347
            R+IG+G FG VY G   D+     + AIK +       + + F  E  ++  ++H NV 
Sbjct: 26  DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL 85
Query: 348 ----------------ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIH 391
                           +    +G L   +  P     +  T        L  A+G+EY+ 
Sbjct: 86  ALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSP----QRNPTVKDLISFGLQVARGMEYL- 140
Query: 392 DHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEY 451
              + ++VHRD+   N +LD+    KVADFGL +                     L  EY
Sbjct: 141 --AEQKFVHRDLAARNCMLDESFTVKVADFGLAR-------------------DILDREY 179
Query: 452 IFVKRFR-------FDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKMK 504
             V++ R       +    S+   + TTK+DV++FGV+L EL+T      R   +P  + 
Sbjct: 180 YSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYR-HIDPFDLT 238
Query: 505 SLIT-------------IMAAVAEWCLNEDAVDRPEMRDIVAILSQIM 539
             +               +  V + C   D   RP  R +V  + QI+
Sbjct: 239 HFLAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIV 286

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 71/280 (25%), Positives = 122/280 (43%), Gaps = 60/280 (21%)
Query: 298 RIIGRGGFGNVYFGLL---GDRE--AAIKKMRS----NKSKEFFAELKVLCKIHHINVF- 347
           ++IG G FG V  G L   G RE   AIK +++     + ++F +E  ++ +  H N+  
Sbjct: 14  KVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIH 73
Query: 348 --------------ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDH 393
                              NGSL   L     K     T      +      G++Y+ D 
Sbjct: 74  LEGVVTKCKPVMIITEYMENGSLDAFLR----KNDGRFTVIQLVGMLRGIGSGMKYLSDM 129
Query: 394 TKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP-GYLPPEYI 452
           +   YVHRD+   NIL++  L  KV+DFG+ ++ E   E     TR    P  +  PE I
Sbjct: 130 S---YVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAA-YTTRGGKIPIRWTAPEAI 185
Query: 453 FVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRA--------LIRDDSE---- 499
             ++F             T+ +DV+++G+V+ E+++ G+R         +I+   E    
Sbjct: 186 AYRKF-------------TSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGYRL 232
Query: 500 PTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIM 539
           P  M   I +   + + C  ++  DRP+   IV +L +++
Sbjct: 233 PPPMDCPIALHQLMLD-CWQKERSDRPKFGQIVNMLDKLI 271

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 102/221 (46%), Gaps = 46/221 (20%)
Query: 293 NFDESRIIGRGGFGNVYFGLLGDREA-----AIKKMRS----NKSKEFFAELKVLCKIHH 343
           +F+E  +IGRG FG VY G L D +      A+K +       +  +F  E  ++    H
Sbjct: 34  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 91
Query: 344 INVF----------------ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGI 387
            NV                 +    +G L + + +   + H P T        L  AKG+
Sbjct: 92  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN---ETHNP-TVKDLIGFGLQVAKGM 147
Query: 388 EYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYL 447
           +++      ++VHRD+   N +LD+    KVADFGL + +    E + +  +   T   L
Sbjct: 148 KFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR-DMYDKEFDSVHNK---TGAKL 200
Query: 448 PPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
           P +++ ++        S+   + TTK+DV++FGV+L EL+T
Sbjct: 201 PVKWMALE--------SLQTQKFTTKSDVWSFGVLLWELMT 233

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 88/198 (44%), Gaps = 36/198 (18%)
Query: 346 VFISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKT 405
           + +   G GS  D L         PL  T    I  +  KG++Y+H   K   +HRDIK 
Sbjct: 82  IIMEYLGGGSALDLLEP------GPLDETQIATILREILKGLDYLHSEKK---IHRDIKA 132
Query: 406 SNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSV 465
           +N+LL +    K+ADFG+     +  + ++     VGTP ++ PE I  K+  +D     
Sbjct: 133 ANVLLSEHGEVKLADFGVAG---QLTDTQIKRNXFVGTPFWMAPEVI--KQSAYD----- 182
Query: 466 MELQVTTKTDVFAFGVVLAELITGKRA-----------LIRDDSEPTKMKSLITIMAAVA 514
                 +K D+++ G+   EL  G+             LI  ++ PT   +    +    
Sbjct: 183 ------SKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFV 236
Query: 515 EWCLNEDAVDRPEMRDIV 532
           E CLN++   RP  ++++
Sbjct: 237 EACLNKEPSFRPTAKELL 254

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 88/198 (44%), Gaps = 36/198 (18%)
Query: 346 VFISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKT 405
           + +   G GS  D L         PL  T    I  +  KG++Y+H   K   +HRDIK 
Sbjct: 97  IIMEYLGGGSALDLLEP------GPLDETQIATILREILKGLDYLHSEKK---IHRDIKA 147
Query: 406 SNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSV 465
           +N+LL +    K+ADFG+     +  + ++     VGTP ++ PE I  K+  +D     
Sbjct: 148 ANVLLSEHGEVKLADFGVAG---QLTDTQIKRNXFVGTPFWMAPEVI--KQSAYD----- 197
Query: 466 MELQVTTKTDVFAFGVVLAELITGKRA-----------LIRDDSEPTKMKSLITIMAAVA 514
                 +K D+++ G+   EL  G+             LI  ++ PT   +    +    
Sbjct: 198 ------SKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFV 251
Query: 515 EWCLNEDAVDRPEMRDIV 532
           E CLN++   RP  ++++
Sbjct: 252 EACLNKEPSFRPTAKELL 269

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 71/280 (25%), Positives = 122/280 (43%), Gaps = 60/280 (21%)
Query: 298 RIIGRGGFGNVYFGLL---GDRE--AAIKKMRS----NKSKEFFAELKVLCKIHHINVF- 347
           ++IG G FG V  G L   G RE   AIK +++     + ++F +E  ++ +  H N+  
Sbjct: 20  KVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIH 79
Query: 348 --------------ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDH 393
                              NGSL   L     K     T      +      G++Y+ D 
Sbjct: 80  LEGVVTKCKPVMIITEYMENGSLDAFLR----KNDGRFTVIQLVGMLRGIGSGMKYLSDM 135
Query: 394 TKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP-GYLPPEYI 452
           +   YVHRD+   NIL++  L  KV+DFG+ ++ E   E     TR    P  +  PE I
Sbjct: 136 S---YVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEA-AYTTRGGKIPIRWTAPEAI 191
Query: 453 FVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRA--------LIRDDSE---- 499
             ++F             T+ +DV+++G+V+ E+++ G+R         +I+   E    
Sbjct: 192 AYRKF-------------TSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGYRL 238
Query: 500 PTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIM 539
           P  M   I +   + + C  ++  DRP+   IV +L +++
Sbjct: 239 PPPMDCPIALHQLMLD-CWQKERSDRPKFGQIVNMLDKLI 277

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 102/221 (46%), Gaps = 46/221 (20%)
Query: 293 NFDESRIIGRGGFGNVYFGLLGDREA-----AIKKMRS----NKSKEFFAELKVLCKIHH 343
           +F+E  +IGRG FG VY G L D +      A+K +       +  +F  E  ++    H
Sbjct: 31  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 88
Query: 344 INVF----------------ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGI 387
            NV                 +    +G L + + +   + H P T        L  AKG+
Sbjct: 89  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN---ETHNP-TVKDLIGFGLQVAKGM 144
Query: 388 EYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYL 447
           +++      ++VHRD+   N +LD+    KVADFGL + +    E + +  +   T   L
Sbjct: 145 KFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR-DMYDKEFDSVHNK---TGAKL 197
Query: 448 PPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
           P +++ ++        S+   + TTK+DV++FGV+L EL+T
Sbjct: 198 PVKWMALE--------SLQTQKFTTKSDVWSFGVLLWELMT 230

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 102/221 (46%), Gaps = 46/221 (20%)
Query: 293 NFDESRIIGRGGFGNVYFGLLGDREA-----AIKKMRS----NKSKEFFAELKVLCKIHH 343
           +F+E  +IGRG FG VY G L D +      A+K +       +  +F  E  ++    H
Sbjct: 33  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 90
Query: 344 INVF----------------ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGI 387
            NV                 +    +G L + + +   + H P T        L  AKG+
Sbjct: 91  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN---ETHNP-TVKDLIGFGLQVAKGM 146
Query: 388 EYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYL 447
           +++      ++VHRD+   N +LD+    KVADFGL + +    E + +  +   T   L
Sbjct: 147 KFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR-DMYDKEFDSVHNK---TGAKL 199
Query: 448 PPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
           P +++ ++        S+   + TTK+DV++FGV+L EL+T
Sbjct: 200 PVKWMALE--------SLQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 102/221 (46%), Gaps = 46/221 (20%)
Query: 293 NFDESRIIGRGGFGNVYFGLLGDREA-----AIKKMRS----NKSKEFFAELKVLCKIHH 343
           +F+E  +IGRG FG VY G L D +      A+K +       +  +F  E  ++    H
Sbjct: 33  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 90
Query: 344 INVF----------------ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGI 387
            NV                 +    +G L + + +   + H P T        L  AKG+
Sbjct: 91  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN---ETHNP-TVKDLIGFGLQVAKGM 146
Query: 388 EYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYL 447
           +++      ++VHRD+   N +LD+    KVADFGL + +    E + +  +   T   L
Sbjct: 147 KFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR-DMYDKEFDSVHNK---TGAKL 199
Query: 448 PPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
           P +++ ++        S+   + TTK+DV++FGV+L EL+T
Sbjct: 200 PVKWMALE--------SLQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 69/279 (24%), Positives = 118/279 (42%), Gaps = 58/279 (20%)
Query: 298 RIIGRGGFGNVYFGLL---GDREA--AIKKMRSN----KSKEFFAELKVLCKIHHINVF- 347
           +IIG G  G V +G L   G R+   AIK +++     + ++F +E  ++ +  H N+  
Sbjct: 55  KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114
Query: 348 ---ISTFG-----------NGSLSDHLHDPLLKGHQ-PLTWTARTQIALDAAKGIEYIHD 392
              + T G           NGSL     D  L+ H    T      +      G+ Y+ D
Sbjct: 115 LEGVVTRGRLAMIVTEYMENGSL-----DTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSD 169
Query: 393 HTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYI 452
                YVHRD+   N+L+D  L  KV+DFGL ++ E   +     T       +  PE I
Sbjct: 170 LG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRWTAPEAI 226
Query: 453 FVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT---------GKRALIRDDSEPTKM 503
             + F             ++ +DV++FGVV+ E++            R +I    E  ++
Sbjct: 227 AFRTF-------------SSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRL 273
Query: 504 KSLITIMAAVAEW---CLNEDAVDRPEMRDIVAILSQIM 539
            + +    A+ +    C ++D   RP    IV++L  ++
Sbjct: 274 PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALI 312

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 88/198 (44%), Gaps = 36/198 (18%)
Query: 346 VFISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKT 405
           + +   G GS  D L         PL  T    I  +  KG++Y+H   K   +HRDIK 
Sbjct: 82  IIMEYLGGGSALDLLEP------GPLDETQIATILREILKGLDYLHSEKK---IHRDIKA 132
Query: 406 SNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSV 465
           +N+LL +    K+ADFG+     +  + ++     VGTP ++ PE I  K+  +D     
Sbjct: 133 ANVLLSEHGEVKLADFGVAG---QLTDTQIKRNTFVGTPFWMAPEVI--KQSAYD----- 182
Query: 466 MELQVTTKTDVFAFGVVLAELITGKRA-----------LIRDDSEPTKMKSLITIMAAVA 514
                 +K D+++ G+   EL  G+             LI  ++ PT   +    +    
Sbjct: 183 ------SKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFV 236
Query: 515 EWCLNEDAVDRPEMRDIV 532
           E CLN++   RP  ++++
Sbjct: 237 EACLNKEPSFRPTAKELL 254

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/248 (24%), Positives = 103/248 (41%), Gaps = 49/248 (19%)
Query: 299 IIGRGGFGNVYFGLLGDREAA-------IKKMRSNKSKEFFAELKVLCKIHHINV--FIS 349
           ++G+G FG      +  RE         + +      + F  E+KV+  + H NV  FI 
Sbjct: 17  VLGKGCFGQAI--KVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIG 74
Query: 350 TFGNGS----LSDHLHDPLLKG-----HQPLTWTARTQIALDAAKGIEYIHDHTKARYVH 400
                     +++++    L+G          W+ R   A D A G+ Y+H       +H
Sbjct: 75  VLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHS---MNIIH 131
Query: 401 RDIKTSNILLDDGLRAKVADFGLVKL--EERTNEKEMLATR---------LVGTPGYLPP 449
           RD+ + N L+ +     VADFGL +L  +E+T  + + + +         +VG P ++ P
Sbjct: 132 RDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAP 191
Query: 450 EYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKMKSLITI 509
           E I  + +               K DVF+FG+VL E+I   R     D  P  M   + +
Sbjct: 192 EMINGRSY-------------DEKVDVFSFGIVLCEIIG--RVNADPDYLPRTMDFGLNV 236
Query: 510 MAAVAEWC 517
              +  +C
Sbjct: 237 RGFLDRYC 244

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 69/279 (24%), Positives = 118/279 (42%), Gaps = 58/279 (20%)
Query: 298 RIIGRGGFGNVYFGLL---GDREA--AIKKMRSN----KSKEFFAELKVLCKIHHINVF- 347
           +IIG G  G V +G L   G R+   AIK +++     + ++F +E  ++ +  H N+  
Sbjct: 55  KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114
Query: 348 ---ISTFG-----------NGSLSDHLHDPLLKGHQ-PLTWTARTQIALDAAKGIEYIHD 392
              + T G           NGSL     D  L+ H    T      +      G+ Y+ D
Sbjct: 115 LEGVVTRGRLAMIVTEYMENGSL-----DTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSD 169
Query: 393 HTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYI 452
                YVHRD+   N+L+D  L  KV+DFGL ++ E   +     T       +  PE I
Sbjct: 170 LG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAI 226
Query: 453 FVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT---------GKRALIRDDSEPTKM 503
             + F             ++ +DV++FGVV+ E++            R +I    E  ++
Sbjct: 227 AFRTF-------------SSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRL 273
Query: 504 KSLITIMAAVAEW---CLNEDAVDRPEMRDIVAILSQIM 539
            + +    A+ +    C ++D   RP    IV++L  ++
Sbjct: 274 PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALI 312

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 102/221 (46%), Gaps = 46/221 (20%)
Query: 293 NFDESRIIGRGGFGNVYFGLLGDREA-----AIKKMRS----NKSKEFFAELKVLCKIHH 343
           +F+E  +IGRG FG VY G L D +      A+K +       +  +F  E  ++    H
Sbjct: 34  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 91
Query: 344 INVF----------------ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGI 387
            NV                 +    +G L + + +   + H P T        L  AKG+
Sbjct: 92  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN---ETHNP-TVKDLIGFGLQVAKGM 147
Query: 388 EYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYL 447
           +++      ++VHRD+   N +LD+    KVADFGL + +    E + +  +   T   L
Sbjct: 148 KFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR-DMLDKEFDSVHNK---TGAKL 200
Query: 448 PPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
           P +++ ++        S+   + TTK+DV++FGV+L EL+T
Sbjct: 201 PVKWMALE--------SLQTQKFTTKSDVWSFGVLLWELMT 233

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 73/287 (25%), Positives = 122/287 (42%), Gaps = 65/287 (22%)
Query: 292 NNFDESRIIGRGGFGNVYFGLL---GDR---EAAIKKMRSNKS----KEFFAELKVL--- 338
             F + +++G G FG VY GL    G++     AIK++R   S    KE   E  V+   
Sbjct: 16  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 75
Query: 339 -----------CKIHHINVFISTFGNGSLSDHL--HDPLLKGHQPLTWTARTQIALDAAK 385
                      C    + + +     G L D++  H   +     L W  +       AK
Sbjct: 76  DNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AK 129
Query: 386 GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPG 445
           G+ Y+ D    R VHRD+   N+L+      K+ DFGL KL     EKE  A       G
Sbjct: 130 GMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG-AEEKEYHAEG-----G 180
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRAL----------I 494
            +P +++ ++        S++    T ++DV+++GV + EL+T G +            I
Sbjct: 181 KVPIKWMALE--------SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 232
Query: 495 RDDSEPTKMKSLITI---MAAVAEWCLNEDAVDRPEMRDIVAILSQI 538
            +  E      + TI   M  V  W ++ D+  RP+ R+++   S++
Sbjct: 233 LEKGERLPQPPICTIDVYMIMVKCWMIDADS--RPKFRELIIEFSKM 277

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 98/215 (45%), Gaps = 46/215 (21%)
Query: 300 IGRGGFGNV---YFGLLGDREA---AIKKMRSNKS---KEFFAELKVLCKIHHINV---- 346
           +G+G FG+V    +  L D      A+KK++ +     ++F  E+++L  + H N+    
Sbjct: 19  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 78
Query: 347 -------------FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDH 393
                         +     GSL D+L     K  + +      Q      KG+EY+   
Sbjct: 79  GVCYSAGRRNLKLIMEYLPYGSLRDYLQ----KHKERIDHIKLLQYTSQICKGMEYL--- 131
Query: 394 TKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIF 453
              RY+HR++ T NIL+++  R K+ DFGL K+     +KE      V  PG  P   IF
Sbjct: 132 GTKRYIHRNLATRNILVENENRVKIGDFGLTKV--LPQDKEYYK---VKEPGESP---IF 183
Query: 454 VKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
                +    S+ E + +  +DV++FGVVL EL T
Sbjct: 184 -----WYAPESLTESKFSVASDVWSFGVVLYELFT 213

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 73/287 (25%), Positives = 122/287 (42%), Gaps = 65/287 (22%)
Query: 292 NNFDESRIIGRGGFGNVYFGLL---GDR---EAAIKKMRSNKS----KEFFAELKVL--- 338
             F + +++G G FG VY GL    G++     AIK++R   S    KE   E  V+   
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 339 -----------CKIHHINVFISTFGNGSLSDHL--HDPLLKGHQPLTWTARTQIALDAAK 385
                      C    + + +     G L D++  H   +     L W  +       AK
Sbjct: 75  DNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AK 128
Query: 386 GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPG 445
           G+ Y+ D    R VHRD+   N+L+      K+ DFGL KL     EKE  A       G
Sbjct: 129 GMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG-AEEKEYHAEG-----G 179
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRAL----------I 494
            +P +++ ++        S++    T ++DV+++GV + EL+T G +            I
Sbjct: 180 KVPIKWMALE--------SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 231
Query: 495 RDDSEPTKMKSLITI---MAAVAEWCLNEDAVDRPEMRDIVAILSQI 538
            +  E      + TI   M  V  W ++ D+  RP+ R+++   S++
Sbjct: 232 LEKGERLPQPPICTIDVYMIMVKCWMIDADS--RPKFRELIIEFSKM 276

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 73/287 (25%), Positives = 122/287 (42%), Gaps = 65/287 (22%)
Query: 292 NNFDESRIIGRGGFGNVYFGLL---GDR---EAAIKKMRSNKS----KEFFAELKVL--- 338
             F + +++G G FG VY GL    G++     AIK++R   S    KE   E  V+   
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 339 -----------CKIHHINVFISTFGNGSLSDHL--HDPLLKGHQPLTWTARTQIALDAAK 385
                      C    + + +     G L D++  H   +     L W  +       AK
Sbjct: 78  DNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AK 131
Query: 386 GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPG 445
           G+ Y+ D    R VHRD+   N+L+      K+ DFGL KL     EKE  A       G
Sbjct: 132 GMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG-AEEKEYHAEG-----G 182
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRAL----------I 494
            +P +++ ++        S++    T ++DV+++GV + EL+T G +            I
Sbjct: 183 KVPIKWMALE--------SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 234
Query: 495 RDDSEPTKMKSLITI---MAAVAEWCLNEDAVDRPEMRDIVAILSQI 538
            +  E      + TI   M  V  W ++ D+  RP+ R+++   S++
Sbjct: 235 LEKGERLPQPPICTIDVYMIMVKCWMIDADS--RPKFRELIIEFSKM 279

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 73/287 (25%), Positives = 122/287 (42%), Gaps = 65/287 (22%)
Query: 292 NNFDESRIIGRGGFGNVYFGLL---GDR---EAAIKKMRSNKS----KEFFAELKVL--- 338
             F + +++G G FG VY GL    G++     AIK++R   S    KE   E  V+   
Sbjct: 19  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 78
Query: 339 -----------CKIHHINVFISTFGNGSLSDHL--HDPLLKGHQPLTWTARTQIALDAAK 385
                      C    + + +     G L D++  H   +     L W  +       AK
Sbjct: 79  DNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AK 132
Query: 386 GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPG 445
           G+ Y+ D    R VHRD+   N+L+      K+ DFGL KL     EKE  A       G
Sbjct: 133 GMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG-AEEKEYHAEG-----G 183
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRAL----------I 494
            +P +++ ++        S++    T ++DV+++GV + EL+T G +            I
Sbjct: 184 KVPIKWMALE--------SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 235
Query: 495 RDDSEPTKMKSLITI---MAAVAEWCLNEDAVDRPEMRDIVAILSQI 538
            +  E      + TI   M  V  W ++ D+  RP+ R+++   S++
Sbjct: 236 LEKGERLPQPPICTIDVYMIMVKCWMIDADS--RPKFRELIIEFSKM 280

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 73/287 (25%), Positives = 122/287 (42%), Gaps = 65/287 (22%)
Query: 292 NNFDESRIIGRGGFGNVYFGLL---GDR---EAAIKKMRSNKS----KEFFAELKVL--- 338
             F + +++G G FG VY GL    G++     AIK++R   S    KE   E  V+   
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 339 -----------CKIHHINVFISTFGNGSLSDHL--HDPLLKGHQPLTWTARTQIALDAAK 385
                      C    + + +     G L D++  H   +     L W  +       AK
Sbjct: 77  DNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AK 130
Query: 386 GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPG 445
           G+ Y+ D    R VHRD+   N+L+      K+ DFGL KL     EKE  A       G
Sbjct: 131 GMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG-AEEKEYHAEG-----G 181
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRAL----------I 494
            +P +++ ++        S++    T ++DV+++GV + EL+T G +            I
Sbjct: 182 KVPIKWMALE--------SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 233
Query: 495 RDDSEPTKMKSLITI---MAAVAEWCLNEDAVDRPEMRDIVAILSQI 538
            +  E      + TI   M  V  W ++ D+  RP+ R+++   S++
Sbjct: 234 LEKGERLPQPPICTIDVYMIMVKCWMIDADS--RPKFRELIIEFSKM 278

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 73/287 (25%), Positives = 122/287 (42%), Gaps = 65/287 (22%)
Query: 292 NNFDESRIIGRGGFGNVYFGLL---GDR---EAAIKKMRSNKS----KEFFAELKVL--- 338
             F + +++G G FG VY GL    G++     AIK++R   S    KE   E  V+   
Sbjct: 16  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 75
Query: 339 -----------CKIHHINVFISTFGNGSLSDHL--HDPLLKGHQPLTWTARTQIALDAAK 385
                      C    + + +     G L D++  H   +     L W  +       AK
Sbjct: 76  DNPHVCRLLGICLTSTVQLIMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQI------AK 129
Query: 386 GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPG 445
           G+ Y+ D    R VHRD+   N+L+      K+ DFGL KL     EKE  A       G
Sbjct: 130 GMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG-AEEKEYHAEG-----G 180
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRAL----------I 494
            +P +++ ++        S++    T ++DV+++GV + EL+T G +            I
Sbjct: 181 KVPIKWMALE--------SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 232
Query: 495 RDDSEPTKMKSLITI---MAAVAEWCLNEDAVDRPEMRDIVAILSQI 538
            +  E      + TI   M  V  W ++ D+  RP+ R+++   S++
Sbjct: 233 LEKGERLPQPPICTIDVYMIMVKCWMIDADS--RPKFRELIIEFSKM 277

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 66/233 (28%), Positives = 98/233 (42%), Gaps = 55/233 (23%)
Query: 300 IGRGGFGNVYFGLLGD-------REAAIKKMRSNKSKEFFAELKVLCKIHHINV--FIST 350
           IG G FG        +       +E  I +M S + +E   E+ VL  + H N+  +  +
Sbjct: 32  IGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRES 91
Query: 351 FG-NGSLS---------------DHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHT 394
           F  NGSL                +     L +  Q L W  +  +AL      +++HD  
Sbjct: 92  FEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLAL------KHVHDR- 144
Query: 395 KARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFV 454
             + +HRDIK+ NI L      ++ DFG+ ++   T E   LA   +GTP YL PE    
Sbjct: 145 --KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE---LARACIGTPYYLSPEICEN 199
Query: 455 KRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKMKSLI 507
           K +               K+D++A G VL EL T K A      E   MK+L+
Sbjct: 200 KPY-------------NNKSDIWALGCVLYELCTLKHAF-----EAGSMKNLV 234

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 72/292 (24%), Positives = 121/292 (41%), Gaps = 76/292 (26%)
Query: 300 IGRGGFGNVYFG----LLGDREA------AIKKMRSNKSKEFFAELKVLCKIHHINVFIS 349
           +G G FG V+      LL +++       A+K+   +  ++F  E ++L  + H ++ + 
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHI-VR 107
Query: 350 TFG----------------NGSLSDHL--HDP---LLKGHQ-----PLTWTARTQIALDA 383
            FG                +G L+  L  H P   LL G +     PL       +A   
Sbjct: 108 FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 167
Query: 384 AKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK-----LEERTNEKEMLAT 438
           A G+ Y+       +VHRD+ T N L+  GL  K+ DFG+ +        R   + ML  
Sbjct: 168 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 224
Query: 439 RLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRAL---- 493
           R      ++PPE I  ++F             TT++DV++FGVVL E+ T GK+      
Sbjct: 225 R------WMPPESILYRKF-------------TTESDVWSFGVVLWEIFTYGKQPWYQLS 265
Query: 494 -------IRDDSEPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQI 538
                  I    E  + ++    + A+   C   +   R  ++D+ A L  +
Sbjct: 266 NTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQAL 317

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 73/287 (25%), Positives = 121/287 (42%), Gaps = 65/287 (22%)
Query: 292 NNFDESRIIGRGGFGNVYFGLL---GDR---EAAIKKMRSNKS----KEFFAELKVL--- 338
             F + +++G G FG VY GL    G++     AIK++R   S    KE   E  V+   
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 339 -----------CKIHHINVFISTFGNGSLSDHL--HDPLLKGHQPLTWTARTQIALDAAK 385
                      C    + +       G L D++  H   +     L W  +       AK
Sbjct: 75  DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AK 128
Query: 386 GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPG 445
           G+ Y+ D    R VHRD+   N+L+      K+ DFGL KL     EKE  A       G
Sbjct: 129 GMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG-AEEKEYHAEG-----G 179
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRAL----------I 494
            +P +++ ++        S++    T ++DV+++GV + EL+T G +            I
Sbjct: 180 KVPIKWMALE--------SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 231
Query: 495 RDDSEPTKMKSLITI---MAAVAEWCLNEDAVDRPEMRDIVAILSQI 538
            +  E      + TI   M  V  W ++ D+  RP+ R+++   S++
Sbjct: 232 LEKGERLPQPPICTIDVYMIMVKCWMIDADS--RPKFRELIIEFSKM 276

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 73/287 (25%), Positives = 121/287 (42%), Gaps = 65/287 (22%)
Query: 292 NNFDESRIIGRGGFGNVYFGLL---GDR---EAAIKKMRSNKS----KEFFAELKVL--- 338
             F + +++G G FG VY GL    G++     AIK++R   S    KE   E  V+   
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 339 -----------CKIHHINVFISTFGNGSLSDHL--HDPLLKGHQPLTWTARTQIALDAAK 385
                      C    + +       G L D++  H   +     L W  +       AK
Sbjct: 78  DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AK 131
Query: 386 GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPG 445
           G+ Y+ D    R VHRD+   N+L+      K+ DFGL KL     EKE  A       G
Sbjct: 132 GMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG-AEEKEYHAEG-----G 182
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRAL----------I 494
            +P +++ ++        S++    T ++DV+++GV + EL+T G +            I
Sbjct: 183 KVPIKWMALE--------SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 234
Query: 495 RDDSEPTKMKSLITI---MAAVAEWCLNEDAVDRPEMRDIVAILSQI 538
            +  E      + TI   M  V  W ++ D+  RP+ R+++   S++
Sbjct: 235 LEKGERLPQPPICTIDVYMIMVKCWMIDADS--RPKFRELIIEFSKM 279

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 73/287 (25%), Positives = 121/287 (42%), Gaps = 65/287 (22%)
Query: 292 NNFDESRIIGRGGFGNVYFGLL---GDR---EAAIKKMRSNKS----KEFFAELKVL--- 338
             F + +++G G FG VY GL    G++     AIK++R   S    KE   E  V+   
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 339 -----------CKIHHINVFISTFGNGSLSDHL--HDPLLKGHQPLTWTARTQIALDAAK 385
                      C    + +       G L D++  H   +     L W  +       AK
Sbjct: 77  DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AK 130
Query: 386 GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPG 445
           G+ Y+ D    R VHRD+   N+L+      K+ DFGL KL     EKE  A       G
Sbjct: 131 GMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG-AEEKEYHAEG-----G 181
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRAL----------I 494
            +P +++ ++        S++    T ++DV+++GV + EL+T G +            I
Sbjct: 182 KVPIKWMALE--------SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 233
Query: 495 RDDSEPTKMKSLITI---MAAVAEWCLNEDAVDRPEMRDIVAILSQI 538
            +  E      + TI   M  V  W ++ D+  RP+ R+++   S++
Sbjct: 234 LEKGERLPQPPICTIDVYMIMVKCWMIDADS--RPKFRELIIEFSKM 278

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 73/287 (25%), Positives = 121/287 (42%), Gaps = 65/287 (22%)
Query: 292 NNFDESRIIGRGGFGNVYFGLL---GDR---EAAIKKMRSNKS----KEFFAELKVL--- 338
             F + +++G G FG VY GL    G++     AIK++R   S    KE   E  V+   
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 339 -----------CKIHHINVFISTFGNGSLSDHL--HDPLLKGHQPLTWTARTQIALDAAK 385
                      C    + +       G L D++  H   +     L W  +       AK
Sbjct: 78  DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AK 131
Query: 386 GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPG 445
           G+ Y+ D    R VHRD+   N+L+      K+ DFGL KL     EKE  A       G
Sbjct: 132 GMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG-AEEKEYHAEG-----G 182
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRAL----------I 494
            +P +++ ++        S++    T ++DV+++GV + EL+T G +            I
Sbjct: 183 KVPIKWMALE--------SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 234
Query: 495 RDDSEPTKMKSLITI---MAAVAEWCLNEDAVDRPEMRDIVAILSQI 538
            +  E      + TI   M  V  W ++ D+  RP+ R+++   S++
Sbjct: 235 LEKGERLPQPPICTIDVYMIMVKCWMIDADS--RPKFRELIIEFSKM 279

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 73/287 (25%), Positives = 121/287 (42%), Gaps = 65/287 (22%)
Query: 292 NNFDESRIIGRGGFGNVYFGLL---GDR---EAAIKKMRSNKS----KEFFAELKVL--- 338
             F + +++G G FG VY GL    G++     AIK++R   S    KE   E  V+   
Sbjct: 22  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 339 -----------CKIHHINVFISTFGNGSLSDHL--HDPLLKGHQPLTWTARTQIALDAAK 385
                      C    + +       G L D++  H   +     L W  +       AK
Sbjct: 82  DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AK 135
Query: 386 GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPG 445
           G+ Y+ D    R VHRD+   N+L+      K+ DFGL KL     EKE  A       G
Sbjct: 136 GMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG-AEEKEYHAEG-----G 186
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRAL----------I 494
            +P +++ ++        S++    T ++DV+++GV + EL+T G +            I
Sbjct: 187 KVPIKWMALE--------SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 238
Query: 495 RDDSEPTKMKSLITI---MAAVAEWCLNEDAVDRPEMRDIVAILSQI 538
            +  E      + TI   M  V  W ++ D+  RP+ R+++   S++
Sbjct: 239 LEKGERLPQPPICTIDVYMIMVKCWMIDADS--RPKFRELIIEFSKM 283

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 72/292 (24%), Positives = 121/292 (41%), Gaps = 76/292 (26%)
Query: 300 IGRGGFGNVYFG----LLGDREA------AIKKMRSNKSKEFFAELKVLCKIHHINVFIS 349
           +G G FG V+      LL +++       A+K+   +  ++F  E ++L  + H ++ + 
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHI-VR 78
Query: 350 TFG----------------NGSLSDHL--HDP---LLKGHQ-----PLTWTARTQIALDA 383
            FG                +G L+  L  H P   LL G +     PL       +A   
Sbjct: 79  FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 138
Query: 384 AKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK-----LEERTNEKEMLAT 438
           A G+ Y+       +VHRD+ T N L+  GL  K+ DFG+ +        R   + ML  
Sbjct: 139 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 195
Query: 439 RLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRAL---- 493
           R      ++PPE I  ++F             TT++DV++FGVVL E+ T GK+      
Sbjct: 196 R------WMPPESILYRKF-------------TTESDVWSFGVVLWEIFTYGKQPWYQLS 236
Query: 494 -------IRDDSEPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQI 538
                  I    E  + ++    + A+   C   +   R  ++D+ A L  +
Sbjct: 237 NTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQAL 288

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 73/287 (25%), Positives = 121/287 (42%), Gaps = 65/287 (22%)
Query: 292 NNFDESRIIGRGGFGNVYFGLL---GDR---EAAIKKMRSNKS----KEFFAELKVL--- 338
             F + +++G G FG VY GL    G++     AIK++R   S    KE   E  V+   
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 339 -----------CKIHHINVFISTFGNGSLSDHL--HDPLLKGHQPLTWTARTQIALDAAK 385
                      C    + +       G L D++  H   +     L W  +       AK
Sbjct: 75  DNPHVCRLLGICLTSTVQLITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQI------AK 128
Query: 386 GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPG 445
           G+ Y+ D    R VHRD+   N+L+      K+ DFGL KL     EKE  A       G
Sbjct: 129 GMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG-AEEKEYHAEG-----G 179
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRAL----------I 494
            +P +++ ++        S++    T ++DV+++GV + EL+T G +            I
Sbjct: 180 KVPIKWMALE--------SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 231
Query: 495 RDDSEPTKMKSLITI---MAAVAEWCLNEDAVDRPEMRDIVAILSQI 538
            +  E      + TI   M  V  W ++ D+  RP+ R+++   S++
Sbjct: 232 LEKGERLPQPPICTIDVYMIMVKCWMIDADS--RPKFRELIIEFSKM 276

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 73/281 (25%), Positives = 120/281 (42%), Gaps = 60/281 (21%)
Query: 298 RIIGRGGFGNVYFG---LLGDRE--AAIKKMRS----NKSKEFFAELKVLCKIHHINVF- 347
           ++IG G FG V  G   L G RE   AIK ++S     + ++F +E  ++ +  H NV  
Sbjct: 13  QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIH 72
Query: 348 -------------ISTF-GNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDH 393
                        I+ F  NGSL   L     +     T      +    A G++Y+ D 
Sbjct: 73  LEGVVTKSTPVMIITEFMENGSLDSFLR----QNDGQFTVIQLVGMLRGIAAGMKYLAD- 127
Query: 394 TKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGT-P-GYLPPEY 451
               YVHR +   NIL++  L  KV+DFGL +  E         + L G  P  +  PE 
Sbjct: 128 --MNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEA 185
Query: 452 IFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKR------------ALIRDDS 498
           I  ++F             T+ +DV+++G+V+ E+++ G+R            A+ +D  
Sbjct: 186 IQYRKF-------------TSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYR 232
Query: 499 EPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIM 539
            P  M     +   + + C  +D   RP+   IV  L +++
Sbjct: 233 LPPPMDCPSALHQLMLD-CWQKDRNHRPKFGQIVNTLDKMI 272

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 73/287 (25%), Positives = 121/287 (42%), Gaps = 65/287 (22%)
Query: 292 NNFDESRIIGRGGFGNVYFGLL---GDR---EAAIKKMRSNKS----KEFFAELKVL--- 338
             F + +++G G FG VY GL    G++     AIK++R   S    KE   E  V+   
Sbjct: 21  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 80
Query: 339 -----------CKIHHINVFISTFGNGSLSDHL--HDPLLKGHQPLTWTARTQIALDAAK 385
                      C    + +       G L D++  H   +     L W  +       AK
Sbjct: 81  DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AK 134
Query: 386 GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPG 445
           G+ Y+ D    R VHRD+   N+L+      K+ DFGL KL     EKE  A       G
Sbjct: 135 GMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG-AEEKEYHAEG-----G 185
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRAL----------I 494
            +P +++ ++        S++    T ++DV+++GV + EL+T G +            I
Sbjct: 186 KVPIKWMALE--------SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 237
Query: 495 RDDSEPTKMKSLITI---MAAVAEWCLNEDAVDRPEMRDIVAILSQI 538
            +  E      + TI   M  V  W ++ D+  RP+ R+++   S++
Sbjct: 238 LEKGERLPQPPICTIDVYMIMVKCWMIDADS--RPKFRELIIEFSKM 282

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 72/285 (25%), Positives = 119/285 (41%), Gaps = 61/285 (21%)
Query: 292 NNFDESRIIGRGGFGNVYFGLL---GDR---EAAIKKMRSNKS----KEFFAELKVL--- 338
             F + +++G G FG VY GL    G++     AIK++R   S    KE   E  V+   
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 339 -----------CKIHHINVFISTFGNGSLSDHL--HDPLLKGHQPLTWTARTQIALDAAK 385
                      C    + +       G L D++  H   +     L W  +       AK
Sbjct: 75  DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AK 128
Query: 386 GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPG 445
           G+ Y+ D    R VHRD+   N+L+      K+ DFGL KL     EKE  A       G
Sbjct: 129 GMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG-AEEKEYHAEG-----G 179
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRAL----------I 494
            +P +++ ++        S++    T ++DV+++GV + EL+T G +            I
Sbjct: 180 KVPIKWMALE--------SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 231
Query: 495 RDDSEPTKMKSLITI-MAAVAEWCLNEDAVDRPEMRDIVAILSQI 538
            +  E      + TI +  +   C   DA  RP+ R+++   S++
Sbjct: 232 LEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKM 276

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 72/292 (24%), Positives = 121/292 (41%), Gaps = 76/292 (26%)
Query: 300 IGRGGFGNVYFG----LLGDREA------AIKKMRSNKSKEFFAELKVLCKIHHINVFIS 349
           +G G FG V+      LL +++       A+K+   +  ++F  E ++L  + H ++ + 
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHI-VR 84
Query: 350 TFG----------------NGSLSDHL--HDP---LLKGHQ-----PLTWTARTQIALDA 383
            FG                +G L+  L  H P   LL G +     PL       +A   
Sbjct: 85  FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 144
Query: 384 AKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK-----LEERTNEKEMLAT 438
           A G+ Y+       +VHRD+ T N L+  GL  K+ DFG+ +        R   + ML  
Sbjct: 145 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 201
Query: 439 RLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRAL---- 493
           R      ++PPE I  ++F             TT++DV++FGVVL E+ T GK+      
Sbjct: 202 R------WMPPESILYRKF-------------TTESDVWSFGVVLWEIFTYGKQPWYQLS 242
Query: 494 -------IRDDSEPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQI 538
                  I    E  + ++    + A+   C   +   R  ++D+ A L  +
Sbjct: 243 NTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQAL 294

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 73/287 (25%), Positives = 121/287 (42%), Gaps = 65/287 (22%)
Query: 292 NNFDESRIIGRGGFGNVYFGLL---GDR---EAAIKKMRSNKS----KEFFAELKVL--- 338
             F + +++G G FG VY GL    G++     AIK++R   S    KE   E  V+   
Sbjct: 9   TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68
Query: 339 -----------CKIHHINVFISTFGNGSLSDHL--HDPLLKGHQPLTWTARTQIALDAAK 385
                      C    + +       G L D++  H   +     L W  +       AK
Sbjct: 69  DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AK 122
Query: 386 GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPG 445
           G+ Y+ D    R VHRD+   N+L+      K+ DFGL KL     EKE  A       G
Sbjct: 123 GMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG-AEEKEYHAEG-----G 173
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRAL----------I 494
            +P +++ ++        S++    T ++DV+++GV + EL+T G +            I
Sbjct: 174 KVPIKWMALE--------SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 225
Query: 495 RDDSEPTKMKSLITI---MAAVAEWCLNEDAVDRPEMRDIVAILSQI 538
            +  E      + TI   M  V  W ++ D+  RP+ R+++   S++
Sbjct: 226 LEKGERLPQPPICTIDVYMIMVKCWMIDADS--RPKFRELIIEFSKM 270

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 73/285 (25%), Positives = 121/285 (42%), Gaps = 65/285 (22%)
Query: 294 FDESRIIGRGGFGNVYFGLL---GDR---EAAIKKMRSNKS----KEFFAELKVL----- 338
           F + +++G G FG VY GL    G++     AIK++R   S    KE   E  V+     
Sbjct: 42  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 101
Query: 339 ---------CKIHHINVFISTFGNGSLSDHL--HDPLLKGHQPLTWTARTQIALDAAKGI 387
                    C    + +       G L D++  H   +     L W  +       AKG+
Sbjct: 102 PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGM 155
Query: 388 EYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYL 447
            Y+ D    R VHRD+   N+L+      K+ DFGL KL     EKE  A       G +
Sbjct: 156 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL-LGAEEKEYHAEG-----GKV 206
Query: 448 PPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRAL----------IRD 496
           P +++ ++        S++    T ++DV+++GV + EL+T G +            I +
Sbjct: 207 PIKWMALE--------SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 258
Query: 497 DSEPTKMKSLITI---MAAVAEWCLNEDAVDRPEMRDIVAILSQI 538
             E      + TI   M  V  W ++ D+  RP+ R+++   S++
Sbjct: 259 KGERLPQPPICTIDVYMIMVKCWMIDADS--RPKFRELIIEFSKM 301

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 98/238 (41%), Gaps = 64/238 (26%)
Query: 293 NFDESRIIGRGGFGNVYFG--LLGDREAAIKKMRSNKSKEFFAELKVLCKIHHINV---- 346
           +F E  +IG GGFG V+     +  +   I++++ N  K    E+K L K+ H+N+    
Sbjct: 13  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAE-REVKALAKLDHVNIVHYN 71
Query: 347 -------FISTFGNGSLSDHLHDPLLKGHQPLTWTA--------------------RTQI 379
                  +     + SL    +DP    +   + T                     R   
Sbjct: 72  GCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE 131
Query: 380 ALDA----------AKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEER 429
            LD            KG++YIH     + +HRD+K SNI L D  + K+ DFGLV   + 
Sbjct: 132 KLDKVLALELFEQITKGVDYIH---SKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKN 188
Query: 430 TNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELI 487
             ++    TR  GT  Y+ PE I  + +               + D++A G++LAEL+
Sbjct: 189 DGKR----TRSKGTLRYMSPEQISSQDY-------------GKEVDLYALGLILAELL 229

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 96/217 (44%), Gaps = 49/217 (22%)
Query: 298 RIIGRGGFGNVYFGL-LGDRE-----AAIKKMRSNKS----KEFFAELKVL--------- 338
           +++G G FG VY G+ + D E      AIK +R N S    KE   E  V+         
Sbjct: 23  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVS 82
Query: 339 -----CKIHHINVFISTFGNGSLSDHLHD--PLLKGHQPLTWTARTQIALDAAKGIEYIH 391
                C    + +       G L DH+ +    L     L W       +  AKG+ Y+ 
Sbjct: 83  RLLGICLTSTVQLVTQLMPYGCLLDHVRENRGRLGSQDLLNW------CMQIAKGMSYLE 136
Query: 392 DHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEY 451
           D    R VHRD+   N+L+      K+ DFGL +L +  +E E  A       G +P ++
Sbjct: 137 D---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLD-IDETEYHADG-----GKVPIKW 187
Query: 452 IFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
           + ++        S++  + T ++DV+++GV + EL+T
Sbjct: 188 MALE--------SILRRRFTHQSDVWSYGVTVWELMT 216

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 92/208 (44%), Gaps = 28/208 (13%)
Query: 300 IGRGGFGNVYFGLLGDREAAIKKMRSNKSKEFF--AELKVLCKIHHINV--FISTFG--N 353
           IG+G FG V+ G     E A+K   S + + +F  AE+     + H N+  FI+     N
Sbjct: 11  IGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDN 70
Query: 354 GSLSD-------HLHDPLLK--GHQPLTWTARTQIALDAAKGIEYIH-----DHTKARYV 399
           G+ +        H H  L        +T     ++AL  A G+ ++H        K    
Sbjct: 71  GTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIA 130
Query: 400 HRDIKTSNILLDDGLRAKVADFGL-VKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFR 458
           HRD+K+ NIL+       +AD GL V+ +  T+  ++     VGT  Y+ PE +      
Sbjct: 131 HRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL------ 184
Query: 459 FDMHSSVMELQVTTKTDVFAFGVVLAEL 486
            D   ++   +   + D++A G+V  E+
Sbjct: 185 -DDSINMKHFESFKRADIYAMGLVFWEI 211

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 92/208 (44%), Gaps = 28/208 (13%)
Query: 300 IGRGGFGNVYFGLLGDREAAIKKMRSNKSKEFF--AELKVLCKIHHINV--FISTFG--N 353
           IG+G FG V+ G     E A+K   S + + +F  AE+     + H N+  FI+     N
Sbjct: 50  IGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDN 109
Query: 354 GSLSD-------HLHDPLLK--GHQPLTWTARTQIALDAAKGIEYIH-----DHTKARYV 399
           G+ +        H H  L        +T     ++AL  A G+ ++H        K    
Sbjct: 110 GTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIA 169
Query: 400 HRDIKTSNILLDDGLRAKVADFGL-VKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFR 458
           HRD+K+ NIL+       +AD GL V+ +  T+  ++     VGT  Y+ PE +      
Sbjct: 170 HRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL------ 223
Query: 459 FDMHSSVMELQVTTKTDVFAFGVVLAEL 486
            D   ++   +   + D++A G+V  E+
Sbjct: 224 -DDSINMKHFESFKRADIYAMGLVFWEI 250

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 92/208 (44%), Gaps = 28/208 (13%)
Query: 300 IGRGGFGNVYFGLLGDREAAIKKMRSNKSKEFF--AELKVLCKIHHINV--FISTFG--N 353
           IG+G FG V+ G     E A+K   S + + +F  AE+     + H N+  FI+     N
Sbjct: 12  IGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDN 71
Query: 354 GSLSD-------HLHDPLLK--GHQPLTWTARTQIALDAAKGIEYIH-----DHTKARYV 399
           G+ +        H H  L        +T     ++AL  A G+ ++H        K    
Sbjct: 72  GTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIA 131
Query: 400 HRDIKTSNILLDDGLRAKVADFGL-VKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFR 458
           HRD+K+ NIL+       +AD GL V+ +  T+  ++     VGT  Y+ PE +      
Sbjct: 132 HRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL------ 185
Query: 459 FDMHSSVMELQVTTKTDVFAFGVVLAEL 486
            D   ++   +   + D++A G+V  E+
Sbjct: 186 -DDSINMKHFESFKRADIYAMGLVFWEI 212

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 92/208 (44%), Gaps = 28/208 (13%)
Query: 300 IGRGGFGNVYFGLLGDREAAIKKMRSNKSKEFF--AELKVLCKIHHINV--FISTFG--N 353
           IG+G FG V+ G     E A+K   S + + +F  AE+     + H N+  FI+     N
Sbjct: 17  IGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDN 76
Query: 354 GSLSD-------HLHDPLLK--GHQPLTWTARTQIALDAAKGIEYIH-----DHTKARYV 399
           G+ +        H H  L        +T     ++AL  A G+ ++H        K    
Sbjct: 77  GTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIA 136
Query: 400 HRDIKTSNILLDDGLRAKVADFGL-VKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFR 458
           HRD+K+ NIL+       +AD GL V+ +  T+  ++     VGT  Y+ PE +      
Sbjct: 137 HRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL------ 190
Query: 459 FDMHSSVMELQVTTKTDVFAFGVVLAEL 486
            D   ++   +   + D++A G+V  E+
Sbjct: 191 -DDSINMKHFESFKRADIYAMGLVFWEI 217

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 72/285 (25%), Positives = 119/285 (41%), Gaps = 61/285 (21%)
Query: 292 NNFDESRIIGRGGFGNVYFGLL---GDR---EAAIKKMRSNKS----KEFFAELKVL--- 338
             F + +++G G FG VY GL    G++     AIK++R   S    KE   E  V+   
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 339 -----------CKIHHINVFISTFGNGSLSDHL--HDPLLKGHQPLTWTARTQIALDAAK 385
                      C    + +       G L D++  H   +     L W  +       AK
Sbjct: 78  DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AK 131
Query: 386 GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPG 445
           G+ Y+ D    R VHRD+   N+L+      K+ DFGL KL     EKE  A       G
Sbjct: 132 GMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG-AEEKEYHAEG-----G 182
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRAL----------I 494
            +P +++ ++        S++    T ++DV+++GV + EL+T G +            I
Sbjct: 183 KVPIKWMALE--------SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 234
Query: 495 RDDSEPTKMKSLITI-MAAVAEWCLNEDAVDRPEMRDIVAILSQI 538
            +  E      + TI +  +   C   DA  RP+ R+++   S++
Sbjct: 235 LEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKM 279

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 92/208 (44%), Gaps = 28/208 (13%)
Query: 300 IGRGGFGNVYFGLLGDREAAIKKMRSNKSKEFF--AELKVLCKIHHINV--FISTFG--N 353
           IG+G FG V+ G     E A+K   S + + +F  AE+     + H N+  FI+     N
Sbjct: 37  IGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDN 96
Query: 354 GSLSD-------HLHDPLLK--GHQPLTWTARTQIALDAAKGIEYIH-----DHTKARYV 399
           G+ +        H H  L        +T     ++AL  A G+ ++H        K    
Sbjct: 97  GTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIA 156
Query: 400 HRDIKTSNILLDDGLRAKVADFGL-VKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFR 458
           HRD+K+ NIL+       +AD GL V+ +  T+  ++     VGT  Y+ PE +      
Sbjct: 157 HRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL------ 210
Query: 459 FDMHSSVMELQVTTKTDVFAFGVVLAEL 486
            D   ++   +   + D++A G+V  E+
Sbjct: 211 -DDSINMKHFESFKRADIYAMGLVFWEI 237

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 92/208 (44%), Gaps = 28/208 (13%)
Query: 300 IGRGGFGNVYFGLLGDREAAIKKMRSNKSKEFF--AELKVLCKIHHINV--FISTFG--N 353
           IG+G FG V+ G     E A+K   S + + +F  AE+     + H N+  FI+     N
Sbjct: 14  IGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDN 73
Query: 354 GSLSD-------HLHDPLLK--GHQPLTWTARTQIALDAAKGIEYIH-----DHTKARYV 399
           G+ +        H H  L        +T     ++AL  A G+ ++H        K    
Sbjct: 74  GTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIA 133
Query: 400 HRDIKTSNILLDDGLRAKVADFGL-VKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFR 458
           HRD+K+ NIL+       +AD GL V+ +  T+  ++     VGT  Y+ PE +      
Sbjct: 134 HRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL------ 187
Query: 459 FDMHSSVMELQVTTKTDVFAFGVVLAEL 486
            D   ++   +   + D++A G+V  E+
Sbjct: 188 -DDSINMKHFESFKRADIYAMGLVFWEI 214

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 76/311 (24%), Positives = 132/311 (42%), Gaps = 71/311 (22%)
Query: 278 RTII--FSLEEIEEATNNFDES---------RIIGRGGFGNVYFGLL---GDRE--AAIK 321
           RT +  F+ E+  +A   F +          ++IG G FG V  G L   G RE   AIK
Sbjct: 4   RTFVDPFTFEDPNQAVREFAKEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIK 63
Query: 322 KMRS----NKSKEFFAELKVLCKIHHINVF---------------ISTFGNGSLSDHLHD 362
            +++     + ++F +E  ++ +  H N+                     NGSL   L  
Sbjct: 64  TLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLR- 122
Query: 363 PLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFG 422
              K     T      +      G++Y+ D +    VHRD+   NIL++  L  KV+DFG
Sbjct: 123 ---KNDGRFTVIQLVGMLRGIGSGMKYLSDMSA---VHRDLAARNILVNSNLVCKVSDFG 176
Query: 423 LVKLEERTNEKEMLATRLVGTP-GYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGV 481
           + ++ E   E     TR    P  +  PE I  ++F             T+ +DV+++G+
Sbjct: 177 MSRVLEDDPEA-AYTTRGGKIPIRWTAPEAIAYRKF-------------TSASDVWSYGI 222
Query: 482 VLAELIT-GKRA--------LIRDDSE----PTKMKSLITIMAAVAEWCLNEDAVDRPEM 528
           V+ E+++ G+R         +I+   E    P  M   I +   + + C  ++  DRP+ 
Sbjct: 223 VMWEVMSYGERPYWDMSNQDVIKAIEEGYRLPPPMDCPIALHQLMLD-CWQKERSDRPKF 281
Query: 529 RDIVAILSQIM 539
             IV +L +++
Sbjct: 282 GQIVNMLDKLI 292

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 72/285 (25%), Positives = 119/285 (41%), Gaps = 61/285 (21%)
Query: 292 NNFDESRIIGRGGFGNVYFGLL---GDR---EAAIKKMRSNKS----KEFFAELKVL--- 338
             F + +++G G FG VY GL    G++     AIK++R   S    KE   E  V+   
Sbjct: 25  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 84
Query: 339 -----------CKIHHINVFISTFGNGSLSDHL--HDPLLKGHQPLTWTARTQIALDAAK 385
                      C    + +       G L D++  H   +     L W  +       AK
Sbjct: 85  DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AK 138
Query: 386 GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPG 445
           G+ Y+ D    R VHRD+   N+L+      K+ DFGL KL     EKE  A       G
Sbjct: 139 GMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG-AEEKEYHAEG-----G 189
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRAL----------I 494
            +P +++ ++        S++    T ++DV+++GV + EL+T G +            I
Sbjct: 190 KVPIKWMALE--------SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 241
Query: 495 RDDSEPTKMKSLITI-MAAVAEWCLNEDAVDRPEMRDIVAILSQI 538
            +  E      + TI +  +   C   DA  RP+ R+++   S++
Sbjct: 242 LEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKM 286

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 94/225 (41%), Gaps = 40/225 (17%)
Query: 300 IGRGGFGNVYFGLLGDR-EAAIKKMR--SNKSKEFFAELKVLCKIHH------------- 343
           +G G FG V+        + A+K M+  S   + F AE  V+  + H             
Sbjct: 23  LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKE 82
Query: 344 -INVFISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRD 402
            I +       GSL D L        QPL        +   A+G+ +I       Y+HRD
Sbjct: 83  PIYIITEFMAKGSLLDFLKSDE-GSKQPLP--KLIDFSAQIAEGMAFIEQRN---YIHRD 136
Query: 403 IKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP-GYLPPEYIFVKRFRFDM 461
           ++ +NIL+   L  K+ADFGL ++ E   + E  A      P  +  PE I    F    
Sbjct: 137 LRAANILVSASLVCKIADFGLARVIE---DNEYTAREGAKFPIKWTAPEAINFGSF---- 189
Query: 462 HSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKMKSL 506
                    T K+DV++FG++L E++T  R      S P  +++L
Sbjct: 190 ---------TIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL 225

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 64/240 (26%), Positives = 107/240 (44%), Gaps = 63/240 (26%)
Query: 292 NNFDESRIIGRGGFGNVY----FGLLGDRE---AAIKKMRS---NKSKEFFAELKVLCKI 341
           +N    R +G G FG V+    + L  +++    A+K ++    N  K+F  E ++L  +
Sbjct: 13  HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL 72
Query: 342 HHINVFISTFG----------------NGSLSDHL--HDP----LLKGHQP--LTWTART 377
            H ++ +  +G                +G L+  L  H P    + +G+ P  LT +   
Sbjct: 73  QHEHI-VKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQML 131
Query: 378 QIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK-----LEERTNE 432
            IA   A G+ Y+       +VHRD+ T N L+ + L  K+ DFG+ +        R   
Sbjct: 132 HIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGG 188
Query: 433 KEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKR 491
             ML  R      ++PPE I  ++F             TT++DV++ GVVL E+ T GK+
Sbjct: 189 HTMLPIR------WMPPESIMYRKF-------------TTESDVWSLGVVLWEIFTYGKQ 229

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 72/287 (25%), Positives = 121/287 (42%), Gaps = 65/287 (22%)
Query: 292 NNFDESRIIGRGGFGNVYFGLL---GDR---EAAIKKMRSNKS----KEFFAELKVL--- 338
             F + +++G G FG VY GL    G++     AIK++R   S    KE   E  V+   
Sbjct: 19  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 78
Query: 339 -----------CKIHHINVFISTFGNGSLSDHL--HDPLLKGHQPLTWTARTQIALDAAK 385
                      C    + + +     G L D++  H   +     L W  +       AK
Sbjct: 79  DNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AK 132
Query: 386 GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPG 445
           G+ Y+ D    R VHRD+   N+L+      K+ DFG  KL     EKE  A       G
Sbjct: 133 GMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLG-AEEKEYHAEG-----G 183
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRAL----------I 494
            +P +++ ++        S++    T ++DV+++GV + EL+T G +            I
Sbjct: 184 KVPIKWMALE--------SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 235
Query: 495 RDDSEPTKMKSLITI---MAAVAEWCLNEDAVDRPEMRDIVAILSQI 538
            +  E      + TI   M  V  W ++ D+  RP+ R+++   S++
Sbjct: 236 LEKGERLPQPPICTIDVYMIMVKCWMIDADS--RPKFRELIIEFSKM 280

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 72/287 (25%), Positives = 121/287 (42%), Gaps = 65/287 (22%)
Query: 292 NNFDESRIIGRGGFGNVYFGLL---GDR---EAAIKKMRSNKS----KEFFAELKVL--- 338
             F + +++G G FG VY GL    G++     AIK++R   S    KE   E  V+   
Sbjct: 12  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 71
Query: 339 -----------CKIHHINVFISTFGNGSLSDHL--HDPLLKGHQPLTWTARTQIALDAAK 385
                      C    + +       G L D++  H   +     L W  +       A+
Sbjct: 72  DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AE 125
Query: 386 GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPG 445
           G+ Y+ D    R VHRD+   N+L+      K+ DFGL KL     EKE  A       G
Sbjct: 126 GMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG-AEEKEYHAEG-----G 176
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRAL----------I 494
            +P +++ ++        S++    T ++DV+++GV + EL+T G +            I
Sbjct: 177 KVPIKWMALE--------SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 228
Query: 495 RDDSEPTKMKSLITI---MAAVAEWCLNEDAVDRPEMRDIVAILSQI 538
            +  E      + TI   M  V  W ++ D+  RP+ R+++   S++
Sbjct: 229 LEKGERLPQPPICTIDVYMIMVKCWMIDADS--RPKFRELIIEFSKM 273

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 72/287 (25%), Positives = 121/287 (42%), Gaps = 65/287 (22%)
Query: 292 NNFDESRIIGRGGFGNVYFGLL---GDR---EAAIKKMRSNKS----KEFFAELKVL--- 338
             F + +++G G FG VY GL    G++     AIK++R   S    KE   E  V+   
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 339 -----------CKIHHINVFISTFGNGSLSDHL--HDPLLKGHQPLTWTARTQIALDAAK 385
                      C    + + +     G L D++  H   +     L W  +       AK
Sbjct: 77  DNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AK 130
Query: 386 GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPG 445
           G+ Y+ D    R VHRD+   N+L+      K+ DFG  KL     EKE  A       G
Sbjct: 131 GMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLG-AEEKEYHAEG-----G 181
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRAL----------I 494
            +P +++ ++        S++    T ++DV+++GV + EL+T G +            I
Sbjct: 182 KVPIKWMALE--------SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 233
Query: 495 RDDSEPTKMKSLITI---MAAVAEWCLNEDAVDRPEMRDIVAILSQI 538
            +  E      + TI   M  V  W ++ D+  RP+ R+++   S++
Sbjct: 234 LEKGERLPQPPICTIDVYMIMVKCWMIDADS--RPKFRELIIEFSKM 278

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/251 (24%), Positives = 102/251 (40%), Gaps = 72/251 (28%)
Query: 288 EEATNNFDESRIIGRGGFGNVYF----GLLGDRE---AAIKKMRSNKSKEFFAEL----- 335
           E   NN +  R IG G FG V+     GLL        A+K ++   S +  A+      
Sbjct: 43  EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 102
Query: 336 --------------------KVLCKIHH------INVFISTFGNGSLSDHLHDPLL---- 365
                               K +C +        +N F+ +    ++    H  L     
Sbjct: 103 LMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRAR 162
Query: 366 ---KGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFG 422
               G  PL+   +  IA   A G+ Y+   ++ ++VHRD+ T N L+ + +  K+ADFG
Sbjct: 163 VSSPGPPPLSCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFG 219
Query: 423 LVKL-----EERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVF 477
           L +        + +  + +  R      ++PPE IF  R+             TT++DV+
Sbjct: 220 LSRNIYSADYYKADGNDAIPIR------WMPPESIFYNRY-------------TTESDVW 260
Query: 478 AFGVVLAELIT 488
           A+GVVL E+ +
Sbjct: 261 AYGVVLWEIFS 271

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 72/287 (25%), Positives = 121/287 (42%), Gaps = 65/287 (22%)
Query: 292 NNFDESRIIGRGGFGNVYFGLL---GDR---EAAIKKMRSNKS----KEFFAELKVL--- 338
             F + +++  G FG VY GL    G++     AIK++R   S    KE   E  V+   
Sbjct: 22  TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 339 -----------CKIHHINVFISTFGNGSLSDHL--HDPLLKGHQPLTWTARTQIALDAAK 385
                      C    + + +     G L D++  H   +     L W  +       AK
Sbjct: 82  DNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AK 135
Query: 386 GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPG 445
           G+ Y+ D    R VHRD+   N+L+      K+ DFGL KL     EKE  A       G
Sbjct: 136 GMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG-AEEKEYHAEG-----G 186
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRAL----------I 494
            +P +++ ++        S++    T ++DV+++GV + EL+T G +            I
Sbjct: 187 KVPIKWMALE--------SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 238
Query: 495 RDDSEPTKMKSLITI---MAAVAEWCLNEDAVDRPEMRDIVAILSQI 538
            +  E      + TI   M  V  W ++ D+  RP+ R+++   S++
Sbjct: 239 LEKGERLPQPPICTIDVYMIMVKCWMIDADS--RPKFRELIIEFSKM 283

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 79/315 (25%), Positives = 129/315 (40%), Gaps = 75/315 (23%)
Query: 274 LESERTIIFSLEEIEEATNN----------FDESRIIGRGGFGNVYFGLL---GDR---E 317
           L  ER ++  L    EA N           F + +++G G FG VY GL    G++    
Sbjct: 21  LLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIP 80
Query: 318 AAIKKMRSNKS----KEFFAELKVL--------------CKIHHINVFISTFGNGSLSDH 359
            AI ++R   S    KE   E  V+              C    + +       G L D+
Sbjct: 81  VAIMELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDY 140
Query: 360 L--HDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAK 417
           +  H   +     L W  +       AKG+ Y+ D    R VHRD+   N+L+      K
Sbjct: 141 VREHKDNIGSQYLLNWCVQI------AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVK 191
Query: 418 VADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVF 477
           + DFGL KL     EKE  A       G +P +++ ++        S++    T ++DV+
Sbjct: 192 ITDFGLAKLLG-AEEKEYHAEG-----GKVPIKWMALE--------SILHRIYTHQSDVW 237
Query: 478 AFGVVLAELIT-GKRAL----------IRDDSEPTKMKSLITI---MAAVAEWCLNEDAV 523
           ++GV + EL+T G +            I +  E      + TI   M  V  W ++ D+ 
Sbjct: 238 SYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADS- 296
Query: 524 DRPEMRDIVAILSQI 538
            RP+ R+++   S++
Sbjct: 297 -RPKFRELIIEFSKM 310

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 78/302 (25%), Positives = 119/302 (39%), Gaps = 84/302 (27%)
Query: 293 NFDESRIIGRGGFGNVYFG--LLGDREAAIKKMRSNKSKEFFAELKVLCKIHHINVFIST 350
           +F E  +IG GGFG V+     +  +   IK+++ N  K    E+K L K+ H+N+    
Sbjct: 12  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAE-REVKALAKLDHVNI---V 67
Query: 351 FGNGSLSDHLHDPLL---------------------KGHQPLTWTARTQIALDA------ 383
             NG      +DP                       KG        R    LD       
Sbjct: 68  HYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALEL 127
Query: 384 ----AKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATR 439
                KG++YIH     + ++RD+K SNI L D  + K+ DFGLV   +   ++     R
Sbjct: 128 FEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR----XR 180
Query: 440 LVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELI------------ 487
             GT  Y+ PE I  + +               + D++A G++LAEL+            
Sbjct: 181 SKGTLRYMSPEQISSQDY-------------GKEVDLYALGLILAELLHVCDTAFETSKF 227
Query: 488 -TGKRALIRDDSEPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITSTEWE 546
            T  R  I  D    K K+L+  +       L++   DRP         S+I+ T T W+
Sbjct: 228 FTDLRDGIISDIFDKKEKTLLQKL-------LSKKPEDRPNT-------SEILRTLTVWK 273
Query: 547 AS 548
            S
Sbjct: 274 KS 275

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 75/159 (47%), Gaps = 30/159 (18%)
Query: 385 KGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP 444
           KG++Y+H   K   +HRDIK +N+LL +    K+ADFG+     +  + ++     VGTP
Sbjct: 131 KGLDYLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAG---QLTDTQIKRNTFVGTP 184
Query: 445 GYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRA-----------L 493
            ++ PE I  ++  +D           +K D+++ G+   EL  G+             L
Sbjct: 185 FWMAPEVI--QQSAYD-----------SKADIWSLGITAIELAKGEPPNSDMHPMRVLFL 231
Query: 494 IRDDSEPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIV 532
           I  ++ PT +           + CLN+D   RP  ++++
Sbjct: 232 IPKNNPPTLVGDFTKSFKEFIDACLNKDPSFRPTAKELL 270

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 94/225 (41%), Gaps = 40/225 (17%)
Query: 300 IGRGGFGNVYFGLLGDR-EAAIKKMR--SNKSKEFFAELKVLCKIHH------------- 343
           +G G FG V+        + A+K M+  S   + F AE  V+  + H             
Sbjct: 196 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKE 255
Query: 344 -INVFISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRD 402
            I +       GSL D L        QPL        +   A+G+ +I       Y+HRD
Sbjct: 256 PIYIITEFMAKGSLLDFLKSDE-GSKQPLP--KLIDFSAQIAEGMAFIEQRN---YIHRD 309
Query: 403 IKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP-GYLPPEYIFVKRFRFDM 461
           ++ +NIL+   L  K+ADFGL ++ E   + E  A      P  +  PE I    F    
Sbjct: 310 LRAANILVSASLVCKIADFGLARVIE---DNEYTAREGAKFPIKWTAPEAINFGSF---- 362
Query: 462 HSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKMKSL 506
                    T K+DV++FG++L E++T  R      S P  +++L
Sbjct: 363 ---------TIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL 398

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 71/285 (24%), Positives = 119/285 (41%), Gaps = 61/285 (21%)
Query: 292 NNFDESRIIGRGGFGNVYFGLL---GDR---EAAIKKMRSNKS----KEFFAELKVL--- 338
             F + +++G G FG VY GL    G++     AIK++R   S    KE   E  V+   
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 339 -----------CKIHHINVFISTFGNGSLSDHL--HDPLLKGHQPLTWTARTQIALDAAK 385
                      C    + + +     G L D++  H   +     L W  +       AK
Sbjct: 77  DNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AK 130
Query: 386 GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPG 445
           G+ Y+ D    R VHRD+   N+L+      K+ DFG  KL     EKE  A       G
Sbjct: 131 GMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLG-AEEKEYHAEG-----G 181
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRAL----------I 494
            +P +++ ++        S++    T ++DV+++GV + EL+T G +            I
Sbjct: 182 KVPIKWMALE--------SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 233
Query: 495 RDDSEPTKMKSLITI-MAAVAEWCLNEDAVDRPEMRDIVAILSQI 538
            +  E      + TI +  +   C   DA  RP+ R+++   S++
Sbjct: 234 LEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKM 278

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 72/287 (25%), Positives = 120/287 (41%), Gaps = 65/287 (22%)
Query: 292 NNFDESRIIGRGGFGNVYFGLL---GDR---EAAIKKMRSNKS----KEFFAELKVL--- 338
             F + +++  G FG VY GL    G++     AIK++R   S    KE   E  V+   
Sbjct: 15  TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 339 -----------CKIHHINVFISTFGNGSLSDHL--HDPLLKGHQPLTWTARTQIALDAAK 385
                      C    + +       G L D++  H   +     L W  +       AK
Sbjct: 75  DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AK 128
Query: 386 GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPG 445
           G+ Y+ D    R VHRD+   N+L+      K+ DFGL KL     EKE  A       G
Sbjct: 129 GMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG-AEEKEYHAEG-----G 179
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRAL----------I 494
            +P +++ ++        S++    T ++DV+++GV + EL+T G +            I
Sbjct: 180 KVPIKWMALE--------SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 231
Query: 495 RDDSEPTKMKSLITI---MAAVAEWCLNEDAVDRPEMRDIVAILSQI 538
            +  E      + TI   M  V  W ++ D+  RP+ R+++   S++
Sbjct: 232 LEKGERLPQPPICTIDVYMIMVKCWMIDADS--RPKFRELIIEFSKM 276

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 72/287 (25%), Positives = 120/287 (41%), Gaps = 65/287 (22%)
Query: 292 NNFDESRIIGRGGFGNVYFGLL---GDR---EAAIKKMRSNKS----KEFFAELKVL--- 338
             F + +++G G FG VY GL    G++     AIK++R   S    KE   E  V+   
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 339 -----------CKIHHINVFISTFGNGSLSDHL--HDPLLKGHQPLTWTARTQIALDAAK 385
                      C    + +       G L D++  H   +     L W  +       AK
Sbjct: 75  DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AK 128
Query: 386 GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPG 445
           G+ Y+ D    R VHRD+   N+L+      K+ DFG  KL     EKE  A       G
Sbjct: 129 GMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLG-AEEKEYHAEG-----G 179
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRAL----------I 494
            +P +++ ++        S++    T ++DV+++GV + EL+T G +            I
Sbjct: 180 KVPIKWMALE--------SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 231
Query: 495 RDDSEPTKMKSLITI---MAAVAEWCLNEDAVDRPEMRDIVAILSQI 538
            +  E      + TI   M  V  W ++ D+  RP+ R+++   S++
Sbjct: 232 LEKGERLPQPPICTIDVYMIMVKCWMIDADS--RPKFRELIIEFSKM 276

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 72/287 (25%), Positives = 120/287 (41%), Gaps = 65/287 (22%)
Query: 292 NNFDESRIIGRGGFGNVYFGLL---GDR---EAAIKKMRSNKS----KEFFAELKVL--- 338
             F + +++  G FG VY GL    G++     AIK++R   S    KE   E  V+   
Sbjct: 22  TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 339 -----------CKIHHINVFISTFGNGSLSDHL--HDPLLKGHQPLTWTARTQIALDAAK 385
                      C    + +       G L D++  H   +     L W  +       AK
Sbjct: 82  DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AK 135
Query: 386 GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPG 445
           G+ Y+ D    R VHRD+   N+L+      K+ DFGL KL     EKE  A       G
Sbjct: 136 GMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG-AEEKEYHAEG-----G 186
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRAL----------I 494
            +P +++ ++        S++    T ++DV+++GV + EL+T G +            I
Sbjct: 187 KVPIKWMALE--------SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 238
Query: 495 RDDSEPTKMKSLITI---MAAVAEWCLNEDAVDRPEMRDIVAILSQI 538
            +  E      + TI   M  V  W ++ D+  RP+ R+++   S++
Sbjct: 239 LEKGERLPQPPICTIDVYMIMVKCWMIDADS--RPKFRELIIEFSKM 283

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 72/287 (25%), Positives = 120/287 (41%), Gaps = 65/287 (22%)
Query: 292 NNFDESRIIGRGGFGNVYFGLL---GDR---EAAIKKMRSNKS----KEFFAELKVL--- 338
             F + +++G G FG VY GL    G++     AIK++R   S    KE   E  V+   
Sbjct: 22  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 339 -----------CKIHHINVFISTFGNGSLSDHL--HDPLLKGHQPLTWTARTQIALDAAK 385
                      C    + +       G L D++  H   +     L W  +       AK
Sbjct: 82  DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AK 135
Query: 386 GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPG 445
           G+ Y+ D    R VHRD+   N+L+      K+ DFG  KL     EKE  A       G
Sbjct: 136 GMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLG-AEEKEYHAEG-----G 186
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRAL----------I 494
            +P +++ ++        S++    T ++DV+++GV + EL+T G +            I
Sbjct: 187 KVPIKWMALE--------SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 238
Query: 495 RDDSEPTKMKSLITI---MAAVAEWCLNEDAVDRPEMRDIVAILSQI 538
            +  E      + TI   M  V  W ++ D+  RP+ R+++   S++
Sbjct: 239 LEKGERLPQPPICTIDVYMIMVKCWMIDADS--RPKFRELIIEFSKM 283

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 71/285 (24%), Positives = 118/285 (41%), Gaps = 61/285 (21%)
Query: 292 NNFDESRIIGRGGFGNVYFGLL---GDR---EAAIKKMRSNKS----KEFFAELKVL--- 338
             F + +++G G FG VY GL    G++     AIK++R   S    KE   E  V+   
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 339 -----------CKIHHINVFISTFGNGSLSDHL--HDPLLKGHQPLTWTARTQIALDAAK 385
                      C    + +       G L D++  H   +     L W  +       AK
Sbjct: 77  DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AK 130
Query: 386 GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPG 445
           G+ Y+ D    R VHRD+   N+L+      K+ DFG  KL     EKE  A       G
Sbjct: 131 GMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLG-AEEKEYHAEG-----G 181
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRAL----------I 494
            +P +++ ++        S++    T ++DV+++GV + EL+T G +            I
Sbjct: 182 KVPIKWMALE--------SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 233
Query: 495 RDDSEPTKMKSLITI-MAAVAEWCLNEDAVDRPEMRDIVAILSQI 538
            +  E      + TI +  +   C   DA  RP+ R+++   S++
Sbjct: 234 LEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKM 278

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 93/224 (41%), Gaps = 49/224 (21%)
Query: 290 ATNNFDESRIIGRGGFGNVYFGLLGDRE--AAIKKM------RSNKSKEFFAELKVLCKI 341
           A  +F+  R +G+G FGNVY      R+   A+K +      ++    +   E+++   +
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 62
Query: 342 HHINVFISTFGNGSLSDHLHDP----LLKGHQPLTWTARTQIAL---DAAKGIEYIHD-- 392
            H N+         L  + HD     L+  + PL    R    L   D  +   YI +  
Sbjct: 63  RHPNIL-------RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 115
Query: 393 ------HTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGY 446
                 H+K R +HRDIK  N+LL      K+ADFG        +      T L GT  Y
Sbjct: 116 NALSYCHSK-RVIHRDIKPENLLLGSAGELKIADFGWS-----VHAPSSRRTTLCGTLDY 169
Query: 447 LPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
           LPPE I  +     MH          K D+++ GV+  E + GK
Sbjct: 170 LPPEMIEGR-----MHDE--------KVDLWSLGVLCYEFLVGK 200

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 67/276 (24%), Positives = 121/276 (43%), Gaps = 52/276 (18%)
Query: 299 IIGRGGFGNVYFGLL---GDREA--AIKKMRSN----KSKEFFAELKVLCKIHHIN---- 345
           +IG G FG V  G L   G +E+  AIK ++      + +EF +E  ++ +  H N    
Sbjct: 21  VIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRL 80
Query: 346 --VFISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIAL-----DAAKGIEYIHDHTKARY 398
             V  ++     L++ + +  L     L     T I L       A G+ Y+ + +   Y
Sbjct: 81  EGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLAEMS---Y 137
Query: 399 VHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGT-P-GYLPPEYIFVKR 456
           VHRD+   NIL++  L  KV+DFGL +  E  +      + L G  P  +  PE I  ++
Sbjct: 138 VHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAIAFRK 197
Query: 457 FRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKR------------ALIRDDSEPTKM 503
           F             T+ +D +++G+V+ E+++ G+R            A+ +D   P   
Sbjct: 198 F-------------TSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIEQDYRLPPPP 244
Query: 504 KSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIM 539
               ++   + + C  +D   RP    +V+ L +++
Sbjct: 245 DCPTSLHQLMLD-CWQKDRNARPRFPQVVSALDKMI 279

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 53/225 (23%), Positives = 99/225 (44%), Gaps = 43/225 (19%)
Query: 292 NNFDESRIIGRGGFGNVYFGLLGDRE--AAIKKMRSNKSK----EFFAELKVLCKIHHIN 345
           ++++   +IG G    V       ++   AIK++   K +    E   E++ + + HH N
Sbjct: 10  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 69
Query: 346 V--FISTF-------------GNGSLSDHLHDPLLKGHQP---LTWTARTQIALDAAKGI 387
           +  + ++F               GS+ D +   + KG      L  +    I  +  +G+
Sbjct: 70  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 129
Query: 388 EYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNE--KEMLATRLVGTPG 445
           EY+H + +   +HRD+K  NILL +    ++ADFG+        +  +  +    VGTP 
Sbjct: 130 EYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 186
Query: 446 YLPPEYI-FVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
           ++ PE +  V+ + F             K D+++FG+   EL TG
Sbjct: 187 WMAPEVMEQVRGYDF-------------KADIWSFGITAIELATG 218

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 94/222 (42%), Gaps = 45/222 (20%)
Query: 299 IIGRGGFGNVYFGLLGDREAAIKKMRSNKSKEFFAELKV----LCKIHHINVFI------ 348
           +IGRG +G VY G L +R  A+K       + F  E  +    L +  +I  FI      
Sbjct: 20  LIGRGRYGAVYKGSLDERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERV 79
Query: 349 ------------STFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIH----- 391
                         + NGSL  +L            W +  ++A    +G+ Y+H     
Sbjct: 80  TADGRMEYLLVMEYYPNGSLXKYL------SLHTSDWVSSCRLAHSVTRGLAYLHTELPR 133
Query: 392 -DHTKARYVHRDIKTSNILLDDGLRAKVADFGL-VKLEE----RTNEKEMLATRLVGTPG 445
            DH K    HRD+ + N+L+ +     ++DFGL ++L      R  E++  A   VGT  
Sbjct: 134 GDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIR 193
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELI 487
           Y+ PE +       D  S++ ++      D++A G++  E+ 
Sbjct: 194 YMAPEVLEGAVNLRDXESALKQV------DMYALGLIYWEIF 229

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 53/225 (23%), Positives = 99/225 (44%), Gaps = 43/225 (19%)
Query: 292 NNFDESRIIGRGGFGNVYFGLLGDRE--AAIKKMRSNKSK----EFFAELKVLCKIHHIN 345
           ++++   +IG G    V       ++   AIK++   K +    E   E++ + + HH N
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 346 V--FISTF-------------GNGSLSDHLHDPLLKGHQP---LTWTARTQIALDAAKGI 387
           +  + ++F               GS+ D +   + KG      L  +    I  +  +G+
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 388 EYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNE--KEMLATRLVGTPG 445
           EY+H + +   +HRD+K  NILL +    ++ADFG+        +  +  +    VGTP 
Sbjct: 135 EYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191
Query: 446 YLPPEYI-FVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
           ++ PE +  V+ + F             K D+++FG+   EL TG
Sbjct: 192 WMAPEVMEQVRGYDF-------------KADIWSFGITAIELATG 223

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 33/106 (31%), Positives = 56/106 (52%), Gaps = 19/106 (17%)
Query: 385 KGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP 444
           +G++Y+H++   R +HRD+K  N+ L+D +  K+ DFGL    E   E++     L GTP
Sbjct: 153 QGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERK---KXLCGTP 206
Query: 445 GYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
            Y+ PE +  K   F++             D+++ G +L  L+ GK
Sbjct: 207 NYIAPEVLCKKGHSFEV-------------DIWSLGCILYTLLVGK 239

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 61/243 (25%), Positives = 103/243 (42%), Gaps = 45/243 (18%)
Query: 272 TVLESERTIIFSLE---EIEEATNNFDESRIIGRGGFGNV--YFGLLGDREAAIKKMRSN 326
           T+   ER   +  E    I E    +     +G G +G+V   + +    + A+KK+   
Sbjct: 28  TMSHKERPTFYRQELNKTIWEVPERYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSRP 87
Query: 327 -----KSKEFFAELKVLCKIHHINV--FISTFGNGSLSDHLHDPLLKGH----------- 368
                 +K  + EL++L  + H NV   +  F   +  +  +D  L  H           
Sbjct: 88  FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPATSLEEFNDVYLVTHLMGADLNNIVK 147
Query: 369 -QPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLE 427
            Q LT      +     +G++YIH    A  +HRD+K SN+ +++    K+ DFGL    
Sbjct: 148 CQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA--- 201
Query: 428 ERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELI 487
            R  + EM  T  V T  Y  PE I +    ++M             D+++ G ++AEL+
Sbjct: 202 -RHTDDEM--TGYVATRWYRAPE-IMLNWMHYNM-----------TVDIWSVGCIMAELL 246
Query: 488 TGK 490
           TG+
Sbjct: 247 TGR 249

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 66/275 (24%), Positives = 118/275 (42%), Gaps = 62/275 (22%)
Query: 300 IGRGGFGNVYFG-LLGDREAAIKKMR--SNKSKEFFAELKVLCKIHH------------- 343
           +G G FG V +G   G  + AIK ++  S    EF  E KV+  + H             
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 76
Query: 344 --INVFISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHR 401
             I +      NG L ++L +     H+  T     ++  D  + +EY+      +++HR
Sbjct: 77  RPIFIITEYMANGCLLNYLRE---MRHRFQT-QQLLEMCKDVCEAMEYLES---KQFLHR 129
Query: 402 DIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP-GYLPPEYIFVKRFRFD 460
           D+   N L++D    KV+DFGL +      + E  ++R    P  + PPE +   +F   
Sbjct: 130 DLAARNCLVNDQGVVKVSDFGLSRY---VLDDEYTSSRGSKFPVRWSPPEVLMYSKF--- 183
Query: 461 MHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIRDDSEPT---------------KMK 504
                     ++K+D++AFGV++ E+ + GK    R  +  T                 +
Sbjct: 184 ----------SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASE 233
Query: 505 SLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIM 539
            + TIM +    C +E A +RP  + +++ +  +M
Sbjct: 234 KVYTIMYS----CWHEKADERPTFKILLSNILDVM 264

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 33/106 (31%), Positives = 56/106 (52%), Gaps = 19/106 (17%)
Query: 385 KGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP 444
           +G++Y+H++   R +HRD+K  N+ L+D +  K+ DFGL    E   E++     L GTP
Sbjct: 153 QGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERK---KTLCGTP 206
Query: 445 GYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
            Y+ PE +  K   F++             D+++ G +L  L+ GK
Sbjct: 207 NYIAPEVLCKKGHSFEV-------------DIWSLGCILYTLLVGK 239

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 97/211 (45%), Gaps = 38/211 (18%)
Query: 300 IGRGGFGNV---YFGLLGDREAAIKKMRS------NKSKEFFAELKVLCKIHH---INVF 347
           +G+G FG+V    +  LGD   A+  ++       ++ ++F  E+++L  +H    +   
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 348 ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAA----------KGIEYIHDHTKAR 397
             ++G G  S  L    L       +  R +  LDA+          KG+EY+      R
Sbjct: 91  GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYL---GSRR 147
Query: 398 YVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRF 457
            VHRD+   NIL++     K+ADFGL KL     +K+    R    PG  P   IF    
Sbjct: 148 CVHRDLAARNILVESEAHVKIADFGLAKL--LPLDKDYYVVR---EPGQSP---IF---- 195
Query: 458 RFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
            +    S+ +   + ++DV++FGVVL EL T
Sbjct: 196 -WYAPESLSDNIFSRQSDVWSFGVVLYELFT 225

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 97/217 (44%), Gaps = 45/217 (20%)
Query: 294 FDESRIIGRGGFGNVYFGLLGD--REAAIKKMRSNKS-KEFFAELKVL--CKIHHINVFI 348
           FD    +G G +G+VY  +  +  +  AIK++      +E   E+ ++  C   H+  + 
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYY 90
Query: 349 STF-------------GNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTK 395
            ++             G GS+SD +    L+ ++ LT      I     KG+EY+H    
Sbjct: 91  GSYFKNTDLWIVMEYCGAGSVSDIIR---LR-NKTLTEDEIATILQSTLKGLEYLH---F 143
Query: 396 ARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATR--LVGTPGYLPPEYIF 453
            R +HRDIK  NILL+    AK+ADFG+          + +A R  ++GTP ++ PE I 
Sbjct: 144 MRKIHRDIKAGNILLNTEGHAKLADFGVA-----GQLTDXMAKRNXVIGTPFWMAPEVI- 197
Query: 454 VKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
                        E+      D+++ G+   E+  GK
Sbjct: 198 ------------QEIGYNCVADIWSLGITAIEMAEGK 222

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 97/211 (45%), Gaps = 38/211 (18%)
Query: 300 IGRGGFGNV---YFGLLGDREAAIKKMRS------NKSKEFFAELKVLCKIHH---INVF 347
           +G+G FG+V    +  LGD   A+  ++       ++ ++F  E+++L  +H    +   
Sbjct: 18  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 77
Query: 348 ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAA----------KGIEYIHDHTKAR 397
             ++G G  S  L    L       +  R +  LDA+          KG+EY+      R
Sbjct: 78  GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYL---GSRR 134
Query: 398 YVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRF 457
            VHRD+   NIL++     K+ADFGL KL     +K+    R    PG  P   IF    
Sbjct: 135 CVHRDLAARNILVESEAHVKIADFGLAKL--LPLDKDYYVVR---EPGQSP---IF---- 182
Query: 458 RFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
            +    S+ +   + ++DV++FGVVL EL T
Sbjct: 183 -WYAPESLSDNIFSRQSDVWSFGVVLYELFT 212

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 33/106 (31%), Positives = 56/106 (52%), Gaps = 19/106 (17%)
Query: 385 KGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP 444
           +G++Y+H++   R +HRD+K  N+ L+D +  K+ DFGL    E   E++     L GTP
Sbjct: 153 QGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERK---KDLCGTP 206
Query: 445 GYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
            Y+ PE +  K   F++             D+++ G +L  L+ GK
Sbjct: 207 NYIAPEVLCKKGHSFEV-------------DIWSLGCILYTLLVGK 239

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 97/211 (45%), Gaps = 38/211 (18%)
Query: 300 IGRGGFGNV---YFGLLGDREAAIKKMRS------NKSKEFFAELKVLCKIHH---INVF 347
           +G+G FG+V    +  LGD   A+  ++       ++ ++F  E+++L  +H    +   
Sbjct: 19  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 78
Query: 348 ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAA----------KGIEYIHDHTKAR 397
             ++G G  S  L    L       +  R +  LDA+          KG+EY+      R
Sbjct: 79  GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYL---GSRR 135
Query: 398 YVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRF 457
            VHRD+   NIL++     K+ADFGL KL     +K+    R    PG  P   IF    
Sbjct: 136 CVHRDLAARNILVESEAHVKIADFGLAKL--LPLDKDYYVVR---EPGQSP---IF---- 183
Query: 458 RFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
            +    S+ +   + ++DV++FGVVL EL T
Sbjct: 184 -WYAPESLSDNIFSRQSDVWSFGVVLYELFT 213

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 92/214 (42%), Gaps = 40/214 (18%)
Query: 300 IGRGGFGNVYFGLLGDREAAIKKMRSNKSKEFFAELK----VLCKIHHINVFIST----- 350
           +G+G +G V+ G       A+K   S   K +F E +    V+ +  +I  FI++     
Sbjct: 45  VGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSR 104
Query: 351 ------------FGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIH-----DH 393
                          GSL D+L    L     L      +I L  A G+ ++H       
Sbjct: 105 HSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCL------RIVLSIASGLAHLHIEIFGTQ 158
Query: 394 TKARYVHRDIKTSNILLDDGLRAKVADFGL-VKLEERTNEKEMLATRLVGTPGYLPPEYI 452
            K    HRD+K+ NIL+    +  +AD GL V   + TN+ ++     VGT  Y+ PE +
Sbjct: 159 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPE-V 217
Query: 453 FVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAEL 486
             +  + D   S        + D++AFG+VL E+
Sbjct: 218 LDETIQVDCFDSY------KRVDIWAFGLVLWEV 245

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 97/217 (44%), Gaps = 50/217 (23%)
Query: 300 IGRGGFGNV---YFGLLGDREAAIKKMRS------NKSKEFFAELKVLCKIH-------- 342
           +G+G FG+V    +  LGD   A+  ++       ++ ++F  E+++L  +H        
Sbjct: 15  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 74
Query: 343 ---------HINVFISTFGNGSLSDHL--HDPLLKGHQPLTWTARTQIALDAAKGIEYIH 391
                     + + +    +G L D L  H   L   + L ++++        KG+EY+ 
Sbjct: 75  GVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQI------CKGMEYLG 128
Query: 392 DHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEY 451
                R VHRD+   NIL++     K+ADFGL KL     +       +V  PG  P   
Sbjct: 129 SR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKD-----XXVVREPGQSP--- 177
Query: 452 IFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
           IF     +    S+ +   + ++DV++FGVVL EL T
Sbjct: 178 IF-----WYAPESLSDNIFSRQSDVWSFGVVLYELFT 209

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 92/214 (42%), Gaps = 40/214 (18%)
Query: 300 IGRGGFGNVYFGLLGDREAAIKKMRSNKSKEFFAELK----VLCKIHHINVFIST----- 350
           +G+G +G V+ G       A+K   S   K +F E +    V+ +  +I  FI++     
Sbjct: 16  VGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSR 75
Query: 351 ------------FGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIH-----DH 393
                          GSL D+L    L     L      +I L  A G+ ++H       
Sbjct: 76  HSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCL------RIVLSIASGLAHLHIEIFGTQ 129
Query: 394 TKARYVHRDIKTSNILLDDGLRAKVADFGL-VKLEERTNEKEMLATRLVGTPGYLPPEYI 452
            K    HRD+K+ NIL+    +  +AD GL V   + TN+ ++     VGT  Y+ PE +
Sbjct: 130 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPE-V 188
Query: 453 FVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAEL 486
             +  + D   S        + D++AFG+VL E+
Sbjct: 189 LDETIQVDCFDSY------KRVDIWAFGLVLWEV 216

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 92/214 (42%), Gaps = 40/214 (18%)
Query: 300 IGRGGFGNVYFGLLGDREAAIKKMRSNKSKEFFAELKVL--CKIHHINV--FIST----- 350
           +G+G +G V+ G       A+K   S   K +F E ++     + H N+  FI++     
Sbjct: 16  VGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSR 75
Query: 351 ------------FGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIH-----DH 393
                          GSL D+L    L     L      +I L  A G+ ++H       
Sbjct: 76  HSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCL------RIVLSIASGLAHLHIEIFGTQ 129
Query: 394 TKARYVHRDIKTSNILLDDGLRAKVADFGL-VKLEERTNEKEMLATRLVGTPGYLPPEYI 452
            K    HRD+K+ NIL+    +  +AD GL V   + TN+ ++     VGT  Y+ PE +
Sbjct: 130 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPE-V 188
Query: 453 FVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAEL 486
             +  + D   S        + D++AFG+VL E+
Sbjct: 189 LDETIQVDCFDSY------KRVDIWAFGLVLWEV 216

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 64/274 (23%), Positives = 116/274 (42%), Gaps = 60/274 (21%)
Query: 300 IGRGGFGNVYFG-LLGDREAAIKKMR--SNKSKEFFAELKVLCKIHH------------- 343
           +G G FG V +G   G  + AIK ++  S    EF  E KV+  + H             
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 91
Query: 344 --INVFISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHR 401
             I +      NG L ++L +     H+  T     ++  D  + +EY+      +++HR
Sbjct: 92  RPIFIITEYMANGCLLNYLRE---MRHRFQT-QQLLEMCKDVCEAMEYLES---KQFLHR 144
Query: 402 DIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDM 461
           D+   N L++D    KV+DFGL +      E   + ++      + PPE +   +F    
Sbjct: 145 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKF--PVRWSPPEVLMYSKF---- 198
Query: 462 HSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIRDDSEPT---------------KMKS 505
                    ++K+D++AFGV++ E+ + GK    R  +  T                 + 
Sbjct: 199 ---------SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEK 249
Query: 506 LITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIM 539
           + TIM +    C +E A +RP  + +++ +  +M
Sbjct: 250 VYTIMYS----CWHEKADERPTFKILLSNILDVM 279

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 95/208 (45%), Gaps = 42/208 (20%)
Query: 300 IGRGGFGNVYFGLL-GDREAAIKKMR--SNKSKEFFAELKVLCKIHH------------- 343
           +G G FG V  G   G  + A+K ++  S    EFF E + + K+ H             
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKE 75
Query: 344 --INVFISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHR 401
             I +      NG L ++L     KG +P   +   ++  D  +G+ ++  H   +++HR
Sbjct: 76  YPIYIVTEYISNGCLLNYLRSHG-KGLEP---SQLLEMCYDVCEGMAFLESH---QFIHR 128
Query: 402 DIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPG-YLPPEYIFVKRFRFD 460
           D+   N L+D  L  KV+DFG+ +         +L  + V + G   P ++   + F + 
Sbjct: 129 DLAARNCLVDRDLCVKVSDFGMTRY--------VLDDQYVSSVGTKFPVKWSAPEVFHYF 180
Query: 461 MHSSVMELQVTTKTDVFAFGVVLAELIT 488
            +SS        K+DV+AFG+++ E+ +
Sbjct: 181 KYSS--------KSDVWAFGILMWEVFS 200

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 100/220 (45%), Gaps = 47/220 (21%)
Query: 299 IIGRGGFGNVYFGLL---GDREA--AIKKMRSN----KSKEFFAELKVLCKIHHINVF-- 347
           +IG G FG V  G L   G +E+  AIK ++      + +EF +E  ++ +  H N+   
Sbjct: 23  VIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRL 82
Query: 348 ------------ISTF-GNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHT 394
                       ++ F  NG+L   L   L  G    T      +    A G+ Y+ + +
Sbjct: 83  EGVVTNSMPVMILTEFMENGALDSFLR--LNDGQ--FTVIQLVGMLRGIASGMRYLAEMS 138
Query: 395 KARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGT-P-GYLPPEYI 452
              YVHRD+   NIL++  L  KV+DFGL +  E  +      + L G  P  +  PE I
Sbjct: 139 ---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAI 195
Query: 453 FVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKR 491
             ++F             T+ +D +++G+V+ E+++ G+R
Sbjct: 196 AFRKF-------------TSASDAWSYGIVMWEVMSFGER 222

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 92/222 (41%), Gaps = 48/222 (21%)
Query: 298 RIIGRGGFGNVYFGLLGDR-------EAAIKKMRSNKSKE----FFAELKVLCKIHHINV 346
           R +G G FG VY G +          + A+K +    S++    F  E  ++ K++H N+
Sbjct: 37  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNI 96
Query: 347 ---------------FISTFGNGSLSDHLHDPLLKGHQP--LTWTARTQIALDAAKGIEY 389
                           +     G L   L +   +  QP  L       +A D A G +Y
Sbjct: 97  VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 156
Query: 390 IHDHTKARYVHRDIKTSNILL---DDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGY 446
           + ++    ++HRDI   N LL     G  AK+ DFG+ +   R +        ++    +
Sbjct: 157 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV-KW 212
Query: 447 LPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
           +PPE             + ME   T+KTD ++FGV+L E+ +
Sbjct: 213 MPPE-------------AFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 33/106 (31%), Positives = 56/106 (52%), Gaps = 19/106 (17%)
Query: 385 KGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP 444
           +G++Y+H++   R +HRD+K  N+ L+D +  K+ DFGL    E   E++     L GTP
Sbjct: 137 QGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERK---KDLCGTP 190
Query: 445 GYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
            Y+ PE +  K   F++             D+++ G +L  L+ GK
Sbjct: 191 NYIAPEVLCKKGHSFEV-------------DIWSLGCILYTLLVGK 223

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 92/222 (41%), Gaps = 48/222 (21%)
Query: 298 RIIGRGGFGNVYFGLLGDR-------EAAIKKMRSNKSKE----FFAELKVLCKIHHINV 346
           R +G G FG VY G +          + A+K +    S++    F  E  ++ K++H N+
Sbjct: 51  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNI 110
Query: 347 ---------------FISTFGNGSLSDHLHDPLLKGHQP--LTWTARTQIALDAAKGIEY 389
                           +     G L   L +   +  QP  L       +A D A G +Y
Sbjct: 111 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 170
Query: 390 IHDHTKARYVHRDIKTSNILL---DDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGY 446
           + ++    ++HRDI   N LL     G  AK+ DFG+ +   R +        ++    +
Sbjct: 171 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV-KW 226
Query: 447 LPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
           +PPE             + ME   T+KTD ++FGV+L E+ +
Sbjct: 227 MPPE-------------AFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 91/222 (40%), Gaps = 48/222 (21%)
Query: 298 RIIGRGGFGNVYFGLLGDR-------EAAIKKMRSNKSKE----FFAELKVLCKIHHINV 346
           R +G G FG VY G +          + A+K +    S++    F  E  ++ K +H N+
Sbjct: 51  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNI 110
Query: 347 ---------------FISTFGNGSLSDHLHDPLLKGHQP--LTWTARTQIALDAAKGIEY 389
                           +     G L   L +   +  QP  L       +A D A G +Y
Sbjct: 111 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 170
Query: 390 IHDHTKARYVHRDIKTSNILL---DDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGY 446
           + ++    ++HRDI   N LL     G  AK+ DFG+ +   R +        ++    +
Sbjct: 171 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV-KW 226
Query: 447 LPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
           +PPE             + ME   T+KTD ++FGV+L E+ +
Sbjct: 227 MPPE-------------AFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 91/222 (40%), Gaps = 48/222 (21%)
Query: 298 RIIGRGGFGNVYFGLLGDR-------EAAIKKMRSNKSKE----FFAELKVLCKIHHINV 346
           R +G G FG VY G +          + A+K +    S++    F  E  ++ K +H N+
Sbjct: 36  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95
Query: 347 ---------------FISTFGNGSLSDHLHDPLLKGHQP--LTWTARTQIALDAAKGIEY 389
                           +     G L   L +   +  QP  L       +A D A G +Y
Sbjct: 96  VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155
Query: 390 IHDHTKARYVHRDIKTSNILL---DDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGY 446
           + ++    ++HRDI   N LL     G  AK+ DFG+ +   R +        ++    +
Sbjct: 156 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV-KW 211
Query: 447 LPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
           +PPE             + ME   T+KTD ++FGV+L E+ +
Sbjct: 212 MPPE-------------AFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 91/222 (40%), Gaps = 48/222 (21%)
Query: 298 RIIGRGGFGNVYFGLLGDR-------EAAIKKMRSNKSKE----FFAELKVLCKIHHINV 346
           R +G G FG VY G +          + A+K +    S++    F  E  ++ K +H N+
Sbjct: 53  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 112
Query: 347 ---------------FISTFGNGSLSDHLHDPLLKGHQP--LTWTARTQIALDAAKGIEY 389
                           +     G L   L +   +  QP  L       +A D A G +Y
Sbjct: 113 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 172
Query: 390 IHDHTKARYVHRDIKTSNILL---DDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGY 446
           + ++    ++HRDI   N LL     G  AK+ DFG+ +   R +        ++    +
Sbjct: 173 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV-KW 228
Query: 447 LPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
           +PPE             + ME   T+KTD ++FGV+L E+ +
Sbjct: 229 MPPE-------------AFMEGIFTSKTDTWSFGVLLWEIFS 257

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/238 (24%), Positives = 98/238 (41%), Gaps = 49/238 (20%)
Query: 283 SLEEIEEAT-NNFDESRIIGRGGFGNVYFGLLGDR-------EAAIKKMRSNKSKE---- 330
           S+ +++E    N    R +G G FG VY G +          + A+K +    S++    
Sbjct: 12  SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD 71
Query: 331 FFAELKVLCKIHHINV---------------FISTFGNGSLSDHLHDPLLKGHQP--LTW 373
           F  E  ++ K +H N+                +     G L   L +   +  QP  L  
Sbjct: 72  FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAM 131
Query: 374 TARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILL---DDGLRAKVADFGLVKLEERT 430
                +A D A G +Y+ ++    ++HRDI   N LL     G  AK+ DFG+ +   R 
Sbjct: 132 LDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 188
Query: 431 NEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
           +        ++    ++PPE             + ME   T+KTD ++FGV+L E+ +
Sbjct: 189 SYYRKGGCAMLPV-KWMPPE-------------AFMEGIFTSKTDTWSFGVLLWEIFS 232

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 73/157 (46%), Gaps = 29/157 (18%)
Query: 386 GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPG 445
           G +Y+H   + R +HRD+K  N+ L++ L  K+ DFGL    E   E++ +   L GTP 
Sbjct: 153 GCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV---LCGTPN 206
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRA----------LIR 495
           Y+ PE +  K   F++             DV++ G ++  L+ GK            L  
Sbjct: 207 YIAPEVLSKKGHSFEV-------------DVWSIGCIMYTLLVGKPPFETSCLKETYLRI 253
Query: 496 DDSEPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIV 532
             +E +  K +  + A++ +  L  D   RP + +++
Sbjct: 254 KKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELL 290

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 73/157 (46%), Gaps = 29/157 (18%)
Query: 386 GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPG 445
           G +Y+H   + R +HRD+K  N+ L++ L  K+ DFGL    E   E++ +   L GTP 
Sbjct: 151 GCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV---LCGTPN 204
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRA----------LIR 495
           Y+ PE +  K   F++             DV++ G ++  L+ GK            L  
Sbjct: 205 YIAPEVLSKKGHSFEV-------------DVWSIGCIMYTLLVGKPPFETSCLKETYLRI 251
Query: 496 DDSEPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIV 532
             +E +  K +  + A++ +  L  D   RP + +++
Sbjct: 252 KKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELL 288

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 96/226 (42%), Gaps = 53/226 (23%)
Query: 290 ATNNFDESRIIGRGGFGNVYFGLLGDREA----AIKKM------RSNKSKEFFAELKVLC 339
           A  +F+  R +G+G FGNVY  L  ++++    A+K +      ++    +   E+++  
Sbjct: 6   ALEDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 340 KIHHINVFISTFGNGSLSDHLHDP----LLKGHQPLTWTARTQIAL---DAAKGIEYIHD 392
            + H N+         L  + HD     L+  + PL    R    L   D  +   YI +
Sbjct: 64  HLRHPNIL-------RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 116
Query: 393 --------HTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP 444
                   H+K R +HRDIK  N+LL      K+ADFG        +      T L GT 
Sbjct: 117 LANALSYCHSK-RVIHRDIKPENLLLGSAGELKIADFGWS-----VHAPSSRRTELCGTL 170
Query: 445 GYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
            YLPPE I  +     MH          K D+++ GV+  E + GK
Sbjct: 171 DYLPPEMIEGR-----MHDE--------KVDLWSLGVLCYEFLVGK 203

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 91/222 (40%), Gaps = 48/222 (21%)
Query: 298 RIIGRGGFGNVYFGLLGDR-------EAAIKKMRSNKSKE----FFAELKVLCKIHHINV 346
           R +G G FG VY G +          + A+K +    S++    F  E  ++ K +H N+
Sbjct: 36  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95
Query: 347 ---------------FISTFGNGSLSDHLHDPLLKGHQP--LTWTARTQIALDAAKGIEY 389
                           +     G L   L +   +  QP  L       +A D A G +Y
Sbjct: 96  VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155
Query: 390 IHDHTKARYVHRDIKTSNILL---DDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGY 446
           + ++    ++HRDI   N LL     G  AK+ DFG+ +   R +        ++    +
Sbjct: 156 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV-KW 211
Query: 447 LPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
           +PPE             + ME   T+KTD ++FGV+L E+ +
Sbjct: 212 MPPE-------------AFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 91/222 (40%), Gaps = 48/222 (21%)
Query: 298 RIIGRGGFGNVYFGLLGDR-------EAAIKKMRSNKSKE----FFAELKVLCKIHHINV 346
           R +G G FG VY G +          + A+K +    S++    F  E  ++ K +H N+
Sbjct: 37  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 96
Query: 347 ---------------FISTFGNGSLSDHLHDPLLKGHQP--LTWTARTQIALDAAKGIEY 389
                           +     G L   L +   +  QP  L       +A D A G +Y
Sbjct: 97  VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 156
Query: 390 IHDHTKARYVHRDIKTSNILL---DDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGY 446
           + ++    ++HRDI   N LL     G  AK+ DFG+ +   R +        ++    +
Sbjct: 157 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV-KW 212
Query: 447 LPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
           +PPE             + ME   T+KTD ++FGV+L E+ +
Sbjct: 213 MPPE-------------AFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 73/157 (46%), Gaps = 29/157 (18%)
Query: 386 GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPG 445
           G +Y+H   + R +HRD+K  N+ L++ L  K+ DFGL    E   E++ +   L GTP 
Sbjct: 127 GCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV---LCGTPN 180
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRA----------LIR 495
           Y+ PE +  K   F++             DV++ G ++  L+ GK            L  
Sbjct: 181 YIAPEVLSKKGHSFEV-------------DVWSIGCIMYTLLVGKPPFETSCLKETYLRI 227
Query: 496 DDSEPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIV 532
             +E +  K +  + A++ +  L  D   RP + +++
Sbjct: 228 KKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELL 264

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 91/222 (40%), Gaps = 48/222 (21%)
Query: 298 RIIGRGGFGNVYFGLLGDR-------EAAIKKMRSNKSKE----FFAELKVLCKIHHINV 346
           R +G G FG VY G +          + A+K +    S++    F  E  ++ K +H N+
Sbjct: 43  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 102
Query: 347 ---------------FISTFGNGSLSDHLHDPLLKGHQP--LTWTARTQIALDAAKGIEY 389
                           +     G L   L +   +  QP  L       +A D A G +Y
Sbjct: 103 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 162
Query: 390 IHDHTKARYVHRDIKTSNILL---DDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGY 446
           + ++    ++HRDI   N LL     G  AK+ DFG+ +   R +        ++    +
Sbjct: 163 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV-KW 218
Query: 447 LPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
           +PPE             + ME   T+KTD ++FGV+L E+ +
Sbjct: 219 MPPE-------------AFMEGIFTSKTDTWSFGVLLWEIFS 247

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 91/222 (40%), Gaps = 48/222 (21%)
Query: 298 RIIGRGGFGNVYFGLLGDR-------EAAIKKMRSNKSKE----FFAELKVLCKIHHINV 346
           R +G G FG VY G +          + A+K +    S++    F  E  ++ K +H N+
Sbjct: 51  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 110
Query: 347 ---------------FISTFGNGSLSDHLHDPLLKGHQP--LTWTARTQIALDAAKGIEY 389
                           +     G L   L +   +  QP  L       +A D A G +Y
Sbjct: 111 VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 170
Query: 390 IHDHTKARYVHRDIKTSNILL---DDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGY 446
           + ++    ++HRDI   N LL     G  AK+ DFG+ +   R +        ++    +
Sbjct: 171 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV-KW 226
Query: 447 LPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
           +PPE             + ME   T+KTD ++FGV+L E+ +
Sbjct: 227 MPPE-------------AFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 90/222 (40%), Gaps = 48/222 (21%)
Query: 298 RIIGRGGFGNVYFGLLGDR-------EAAIKKMRSNKSKE----FFAELKVLCKIHHINV 346
           R +G G FG VY G +          + A+K +    S++    F  E  ++ K +H N+
Sbjct: 77  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 136
Query: 347 ---------------FISTFGNGSLSDHLHDPLLKGHQP--LTWTARTQIALDAAKGIEY 389
                           +     G L   L +   +  QP  L       +A D A G +Y
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196
Query: 390 IHDHTKARYVHRDIKTSNILL---DDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGY 446
           + ++    ++HRDI   N LL     G  AK+ DFG+ +   R          ++    +
Sbjct: 197 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPV-KW 252
Query: 447 LPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
           +PPE             + ME   T+KTD ++FGV+L E+ +
Sbjct: 253 MPPE-------------AFMEGIFTSKTDTWSFGVLLWEIFS 281

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 92/224 (41%), Gaps = 49/224 (21%)
Query: 290 ATNNFDESRIIGRGGFGNVYFGLLGDRE--AAIKKM------RSNKSKEFFAELKVLCKI 341
           A  +F+  R +G+G FGNVY       +   A+K +      ++    +   E+++   +
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 342 HHINVFISTFGNGSLSDHLHDP----LLKGHQPLTWTARTQIAL---DAAKGIEYIHD-- 392
            H N+         L  + HD     L+  + PL    R    L   D  +   YI +  
Sbjct: 92  RHPNIL-------RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 144
Query: 393 ------HTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGY 446
                 H+K R +HRDIK  N+LL      K+ADFG        +      T L GT  Y
Sbjct: 145 NALSYCHSK-RVIHRDIKPENLLLGSAGELKIADFGWS-----VHAPSSRRTTLCGTLDY 198
Query: 447 LPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
           LPPE I  +     MH          K D+++ GV+  E + GK
Sbjct: 199 LPPEMIEGR-----MHDE--------KVDLWSLGVLCYEFLVGK 229

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 90/222 (40%), Gaps = 48/222 (21%)
Query: 298 RIIGRGGFGNVYFGLLGDR-------EAAIKKMRSNKSKE----FFAELKVLCKIHHINV 346
           R +G G FG VY G +          + A+K +    S++    F  E  ++ K +H N+
Sbjct: 54  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 113
Query: 347 ---------------FISTFGNGSLSDHLHDPLLKGHQP--LTWTARTQIALDAAKGIEY 389
                           +     G L   L +   +  QP  L       +A D A G +Y
Sbjct: 114 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 173
Query: 390 IHDHTKARYVHRDIKTSNILL---DDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGY 446
           + ++    ++HRDI   N LL     G  AK+ DFG+ +   R          ++    +
Sbjct: 174 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPV-KW 229
Query: 447 LPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
           +PPE             + ME   T+KTD ++FGV+L E+ +
Sbjct: 230 MPPE-------------AFMEGIFTSKTDTWSFGVLLWEIFS 258

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 106/237 (44%), Gaps = 44/237 (18%)
Query: 316 REAAIKKM--RSNKSKEF-FAELKVLCKIHHINVFISTFGNGSLSDHLHDPL--LKG--- 367
           ++ A+KKM  R  + +E  F E+ ++   HH NV +  + +  + D L   +  L+G   
Sbjct: 71  KQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNV-VDMYSSYLVGDELWVVMEFLEGGAL 129
Query: 368 -----HQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFG 422
                H  +       + L   + + Y+H+      +HRDIK+ +ILL    R K++DFG
Sbjct: 130 TDIVTHTRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFG 186
Query: 423 LVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVV 482
                 +   K      LVGTP ++ PE I               L   T+ D+++ G++
Sbjct: 187 FCAQVSKEVPKR---KXLVGTPYWMAPEVI-------------SRLPYGTEVDIWSLGIM 230
Query: 483 LAELITGK---------RALIR-DDSEPTKMKSLITIMAAVAEWCLNEDAVDRPEMR 529
           + E+I G+         +A+ R  DS P ++K L  + ++V    L+   V  P  R
Sbjct: 231 VIEMIDGEPPYFNEPPLQAMRRIRDSLPPRVKDLHKV-SSVLRGFLDLMLVREPSQR 286

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 72/157 (45%), Gaps = 29/157 (18%)
Query: 386 GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPG 445
           G +Y+H   + R +HRD+K  N+ L++ L  K+ DFGL    E   E++     L GTP 
Sbjct: 129 GCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK---KTLCGTPN 182
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRA----------LIR 495
           Y+ PE +  K   F++             DV++ G ++  L+ GK            L  
Sbjct: 183 YIAPEVLSKKGHSFEV-------------DVWSIGCIMYTLLVGKPPFETSCLKETYLRI 229
Query: 496 DDSEPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIV 532
             +E +  K +  + A++ +  L  D   RP + +++
Sbjct: 230 KKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELL 266

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 72/157 (45%), Gaps = 29/157 (18%)
Query: 386 GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPG 445
           G +Y+H   + R +HRD+K  N+ L++ L  K+ DFGL    E   E++     L GTP 
Sbjct: 133 GCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK---KTLCGTPN 186
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRA----------LIR 495
           Y+ PE +  K   F++             DV++ G ++  L+ GK            L  
Sbjct: 187 YIAPEVLSKKGHSFEV-------------DVWSIGCIMYTLLVGKPPFETSCLKETYLRI 233
Query: 496 DDSEPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIV 532
             +E +  K +  + A++ +  L  D   RP + +++
Sbjct: 234 KKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELL 270

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 91/222 (40%), Gaps = 48/222 (21%)
Query: 298 RIIGRGGFGNVYFGLLGDR-------EAAIKKMRSNKSKE----FFAELKVLCKIHHINV 346
           R +G G FG VY G +          + A+K +    S++    F  E  ++ K +H N+
Sbjct: 37  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 96
Query: 347 ---------------FISTFGNGSLSDHLHDPLLKGHQP--LTWTARTQIALDAAKGIEY 389
                           +     G L   L +   +  QP  L       +A D A G +Y
Sbjct: 97  VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 156
Query: 390 IHDHTKARYVHRDIKTSNILL---DDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGY 446
           + ++    ++HRDI   N LL     G  AK+ DFG+ +   R +        ++    +
Sbjct: 157 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAMLPV-KW 212
Query: 447 LPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
           +PPE             + ME   T+KTD ++FGV+L E+ +
Sbjct: 213 MPPE-------------AFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 72/157 (45%), Gaps = 29/157 (18%)
Query: 386 GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPG 445
           G +Y+H   + R +HRD+K  N+ L++ L  K+ DFGL    E   E++     L GTP 
Sbjct: 129 GCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK---KTLCGTPN 182
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRA----------LIR 495
           Y+ PE +  K   F++             DV++ G ++  L+ GK            L  
Sbjct: 183 YIAPEVLSKKGHSFEV-------------DVWSIGCIMYTLLVGKPPFETSCLKETYLRI 229
Query: 496 DDSEPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIV 532
             +E +  K +  + A++ +  L  D   RP + +++
Sbjct: 230 KKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELL 266

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 91/222 (40%), Gaps = 48/222 (21%)
Query: 298 RIIGRGGFGNVYFGLLGDR-------EAAIKKMRSNKSKE----FFAELKVLCKIHHINV 346
           R +G G FG VY G +          + A+K +    S++    F  E  ++ K +H N+
Sbjct: 63  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 122
Query: 347 ---------------FISTFGNGSLSDHLHDPLLKGHQP--LTWTARTQIALDAAKGIEY 389
                           +     G L   L +   +  QP  L       +A D A G +Y
Sbjct: 123 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 182
Query: 390 IHDHTKARYVHRDIKTSNILL---DDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGY 446
           + ++    ++HRDI   N LL     G  AK+ DFG+ +   R +        ++    +
Sbjct: 183 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV-KW 238
Query: 447 LPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
           +PPE             + ME   T+KTD ++FGV+L E+ +
Sbjct: 239 MPPE-------------AFMEGIFTSKTDTWSFGVLLWEIFS 267

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 92/224 (41%), Gaps = 49/224 (21%)
Query: 290 ATNNFDESRIIGRGGFGNVYFGLLGDRE--AAIKKM------RSNKSKEFFAELKVLCKI 341
           A  +F+  R +G+G FGNVY       +   A+K +      ++    +   E+++   +
Sbjct: 23  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 82
Query: 342 HHINVFISTFGNGSLSDHLHDP----LLKGHQPLTWTARTQIAL---DAAKGIEYIHD-- 392
            H N+         L  + HD     L+  + PL    R    L   D  +   YI +  
Sbjct: 83  RHPNIL-------RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 135
Query: 393 ------HTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGY 446
                 H+K R +HRDIK  N+LL      K+ADFG        +      T L GT  Y
Sbjct: 136 NALSYCHSK-RVIHRDIKPENLLLGSAGELKIADFGWS-----VHAPSSRRTTLCGTLDY 189
Query: 447 LPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
           LPPE I  +     MH          K D+++ GV+  E + GK
Sbjct: 190 LPPEMIEGR-----MHDE--------KVDLWSLGVLCYEFLVGK 220

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 92/224 (41%), Gaps = 49/224 (21%)
Query: 290 ATNNFDESRIIGRGGFGNVYFGLLGDRE--AAIKKM------RSNKSKEFFAELKVLCKI 341
           A  +F+  R +G+G FGNVY       +   A+K +      ++    +   E+++   +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 342 HHINVFISTFGNGSLSDHLHDP----LLKGHQPLTWTARTQIAL---DAAKGIEYIHD-- 392
            H N+         L  + HD     L+  + PL    R    L   D  +   YI +  
Sbjct: 69  RHPNIL-------RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 121
Query: 393 ------HTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGY 446
                 H+K R +HRDIK  N+LL      K+ADFG        +      T L GT  Y
Sbjct: 122 NALSYCHSK-RVIHRDIKPENLLLGSAGELKIADFGWS-----VHAPSSRRTTLCGTLDY 175
Query: 447 LPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
           LPPE I  +     MH          K D+++ GV+  E + GK
Sbjct: 176 LPPEMIEGR-----MHDE--------KVDLWSLGVLCYEFLVGK 206

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 96/226 (42%), Gaps = 53/226 (23%)
Query: 290 ATNNFDESRIIGRGGFGNVYFGLLGDREA----AIKKM------RSNKSKEFFAELKVLC 339
           A  +F+  R +G+G FGNVY  L  ++++    A+K +      ++    +   E+++  
Sbjct: 6   ALEDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 340 KIHHINVFISTFGNGSLSDHLHDP----LLKGHQPLTWTARTQIAL---DAAKGIEYIHD 392
            + H N+         L  + HD     L+  + PL    R    L   D  +   YI +
Sbjct: 64  HLRHPNIL-------RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 116
Query: 393 --------HTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP 444
                   H+K R +HRDIK  N+LL      K+ADFG        +      T L GT 
Sbjct: 117 LANALSYCHSK-RVIHRDIKPENLLLGSAGELKIADFGWS-----VHAPSSRRTTLCGTL 170
Query: 445 GYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
            YLPPE I  +     MH          K D+++ GV+  E + GK
Sbjct: 171 DYLPPEMIEGR-----MHDE--------KVDLWSLGVLCYEFLVGK 203

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 96/226 (42%), Gaps = 53/226 (23%)
Query: 290 ATNNFDESRIIGRGGFGNVYFGLLGDREA----AIKKM------RSNKSKEFFAELKVLC 339
           A  +F+  R +G+G FGNVY  L  ++++    A+K +      ++    +   E+++  
Sbjct: 11  ALEDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 68
Query: 340 KIHHINVFISTFGNGSLSDHLHDP----LLKGHQPLTWTARTQIAL---DAAKGIEYIHD 392
            + H N+         L  + HD     L+  + PL    R    L   D  +   YI +
Sbjct: 69  HLRHPNIL-------RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 121
Query: 393 --------HTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP 444
                   H+K R +HRDIK  N+LL      K+ADFG        +      T L GT 
Sbjct: 122 LANALSYCHSK-RVIHRDIKPENLLLGSAGELKIADFGWS-----VHAPSSRRTTLCGTL 175
Query: 445 GYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
            YLPPE I  +     MH          K D+++ GV+  E + GK
Sbjct: 176 DYLPPEMIEGR-----MHDE--------KVDLWSLGVLCYEFLVGK 208

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 90/209 (43%), Gaps = 43/209 (20%)
Query: 300 IGRGGFGNVYFGLLGDR-EAAIKKMRSN--KSKEFFAELKVLCKIHH------------- 343
           +G G FG V+ G   +  + A+K ++      + F  E  ++  + H             
Sbjct: 21  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTRE 80
Query: 344 --INVFISTFGNGSLSDHLH-DPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVH 400
             I +       GSL D L  D   K   P       QIA    +G+ YI    +  Y+H
Sbjct: 81  EPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIA----EGMAYIE---RKNYIH 133
Query: 401 RDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP-GYLPPEYIFVKRFRF 459
           RD++ +N+L+ + L  K+ADFGL ++ E   + E  A      P  +  PE I    F  
Sbjct: 134 RDLRAANVLVSESLMCKIADFGLARVIE---DNEYTAREGAKFPIKWTAPEAINFGCF-- 188
Query: 460 DMHSSVMELQVTTKTDVFAFGVVLAELIT 488
                      T K+DV++FG++L E++T
Sbjct: 189 -----------TIKSDVWSFGILLYEIVT 206

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 91/224 (40%), Gaps = 48/224 (21%)
Query: 300 IGRGGFGNVYFGLLGDR-EAAIKKMR--SNKSKEFFAELKVLCKIHH------------- 343
           +G G FG V+        + A+K M+  S   + F AE  V+  + H             
Sbjct: 190 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKE 249
Query: 344 -INVFISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRD 402
            I +       GSL D L        QPL        +   A+G+ +I       Y+HRD
Sbjct: 250 PIYIITEFMAKGSLLDFLKSDE-GSKQPLP--KLIDFSAQIAEGMAFIEQRN---YIHRD 303
Query: 403 IKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMH 462
           ++ +NIL+   L  K+ADFGL ++  +   K            +  PE I    F     
Sbjct: 304 LRAANILVSASLVCKIADFGLARVGAKFPIK------------WTAPEAINFGSF----- 346
Query: 463 SSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKMKSL 506
                   T K+DV++FG++L E++T  R      S P  +++L
Sbjct: 347 --------TIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL 382

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/252 (24%), Positives = 105/252 (41%), Gaps = 56/252 (22%)
Query: 284 LEEIEEATNNFDESRIIGRGGFGNVY---FGLLGDREAAIKKMRSNKS-----KEFFAEL 335
           LE      + F + R++GRGGFG V+       G   A  K  +         +    E 
Sbjct: 177 LEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEK 236
Query: 336 KVLCKIH---------------HINVFISTFGNGSLSDHLHD-----PLLKGHQPLTWTA 375
           K+L K+H                + + ++    G +  H+++     P  +  + + +TA
Sbjct: 237 KILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTA 296
Query: 376 RTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGL-VKLEERTNEKE 434
           +         G+E++H       ++RD+K  N+LLDD    +++D GL V+L+    + +
Sbjct: 297 QI------VSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTK 347
Query: 435 MLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALI 494
             A    GTPG++ PE +  + + F +             D FA GV L E+I   R   
Sbjct: 348 GYA----GTPGFMAPELLLGEEYDFSV-------------DYFALGVTLYEMIAA-RGPF 389
Query: 495 RDDSEPTKMKSL 506
           R   E  + K L
Sbjct: 390 RARGEKVENKEL 401

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 92/224 (41%), Gaps = 49/224 (21%)
Query: 290 ATNNFDESRIIGRGGFGNVYFGLLGDRE--AAIKKM------RSNKSKEFFAELKVLCKI 341
           A  +F+  R +G+G FGNVY       +   A+K +      ++    +   E+++   +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 342 HHINVFISTFGNGSLSDHLHDP----LLKGHQPLTWTARTQIAL---DAAKGIEYIHD-- 392
            H N+         L  + HD     L+  + PL    R    L   D  +   YI +  
Sbjct: 66  RHPNIL-------RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 118
Query: 393 ------HTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGY 446
                 H+K R +HRDIK  N+LL      K+ADFG        +      T L GT  Y
Sbjct: 119 NALSYCHSK-RVIHRDIKPENLLLGSAGELKIADFGWS-----VHAPSSRRTDLCGTLDY 172
Query: 447 LPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
           LPPE I  +     MH          K D+++ GV+  E + GK
Sbjct: 173 LPPEMIEGR-----MHDE--------KVDLWSLGVLCYEFLVGK 203

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 89/208 (42%), Gaps = 40/208 (19%)
Query: 300 IGRGGFGNVYFGLLGDREAAI---KKMRSNKSKE----FFAELKVLCKIHHINV------ 346
           +G G FG VY     ++E ++    K+   KS+E    +  E+ +L    H N+      
Sbjct: 45  LGDGAFGKVYKA--QNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 102
Query: 347 --------FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARY 398
                    +  F  G   D +   +L+  +PLT +    +       + Y+HD+   + 
Sbjct: 103 FYYENNLWILIEFCAGGAVDAV---MLELERPLTESQIQVVCKQTLDALNYLHDN---KI 156
Query: 399 VHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFR 458
           +HRD+K  NIL       K+ADFG+     RT ++       +GTP ++ PE +      
Sbjct: 157 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR---DSFIGTPYWMAPEVV------ 207
Query: 459 FDMHSSVMELQVTTKTDVFAFGVVLAEL 486
             M  +  +     K DV++ G+ L E+
Sbjct: 208 --MCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 95/219 (43%), Gaps = 45/219 (20%)
Query: 299 IIGRGGFGNVYFGLLGDREAAIK--KMRSNKSKEFFAELKVLCKIHHINVF--------- 347
           +  RG FG V+   L +   A+K   ++  +S +   E+  L  + H N+          
Sbjct: 31  VKARGRFGCVWKAQLLNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRG 90
Query: 348 ---------ISTFG-NGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIH------ 391
                    I+ F   GSLSD L   ++      +W     IA   A+G+ Y+H      
Sbjct: 91  TSVDVDLWLITAFHEKGSLSDFLKANVV------SWNELCHIAETMARGLAYLHEDIPGL 144
Query: 392 -DHTKARYVHRDIKTSNILLDDGLRAKVADFGL-VKLEERTNEKEMLATRLVGTPGYLPP 449
            D  K    HRDIK+ N+LL + L A +ADFGL +K E   +  +      VGT  Y+ P
Sbjct: 145 KDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQ--VGTRRYMAP 202
Query: 450 EYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
           E +      F   + +       + D++A G+VL EL +
Sbjct: 203 E-VLEGAINFQRDAFL-------RIDMYAMGLVLWELAS 233

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 92/224 (41%), Gaps = 49/224 (21%)
Query: 290 ATNNFDESRIIGRGGFGNVYFGLLGDRE--AAIKKM------RSNKSKEFFAELKVLCKI 341
           A  +F+  R +G+G FGNVY       +   A+K +      ++    +   E+++   +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 342 HHINVFISTFGNGSLSDHLHDP----LLKGHQPLTWTARTQIAL---DAAKGIEYIHD-- 392
            H N+         L  + HD     L+  + PL    R    L   D  +   YI +  
Sbjct: 67  RHPNIL-------RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 119
Query: 393 ------HTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGY 446
                 H+K R +HRDIK  N+LL      K+ADFG        +      T L GT  Y
Sbjct: 120 NALSYCHSK-RVIHRDIKPENLLLGSAGELKIADFGWS-----VHAPSSRRTDLCGTLDY 173
Query: 447 LPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
           LPPE I  +     MH          K D+++ GV+  E + GK
Sbjct: 174 LPPEMIEGR-----MHDE--------KVDLWSLGVLCYEFLVGK 204

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 88/214 (41%), Gaps = 39/214 (18%)
Query: 298 RIIGRGGFGNV---YFGLLGD---REAAIKKMRSNKSKEFFAELK----VLCKIHHINVF 347
           R +G G FG V    +   GD    + A+K ++        A+LK    +L  ++H N+ 
Sbjct: 27  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 348 ------ISTFGNGSL-------SDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHT 394
                     GNG         S  L + L K    +    + + A+   KG++Y+    
Sbjct: 87  KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSR- 145
Query: 395 KARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFV 454
             +YVHRD+   N+L++   + K+ DFGL K  E   E   +         +  PE +  
Sbjct: 146 --QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQ 203
Query: 455 KRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
            +F                +DV++FGV L EL+T
Sbjct: 204 SKFYI-------------ASDVWSFGVTLHELLT 224

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/252 (24%), Positives = 105/252 (41%), Gaps = 56/252 (22%)
Query: 284 LEEIEEATNNFDESRIIGRGGFGNVY---FGLLGDREAAIKKMRSNKS-----KEFFAEL 335
           LE      + F + R++GRGGFG V+       G   A  K  +         +    E 
Sbjct: 177 LEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEK 236
Query: 336 KVLCKIH---------------HINVFISTFGNGSLSDHLHD-----PLLKGHQPLTWTA 375
           K+L K+H                + + ++    G +  H+++     P  +  + + +TA
Sbjct: 237 KILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTA 296
Query: 376 RTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGL-VKLEERTNEKE 434
           +         G+E++H       ++RD+K  N+LLDD    +++D GL V+L+    + +
Sbjct: 297 QI------VSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTK 347
Query: 435 MLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALI 494
             A    GTPG++ PE +  + + F +             D FA GV L E+I   R   
Sbjct: 348 GYA----GTPGFMAPELLLGEEYDFSV-------------DYFALGVTLYEMIAA-RGPF 389
Query: 495 RDDSEPTKMKSL 506
           R   E  + K L
Sbjct: 390 RARGEKVENKEL 401

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/252 (24%), Positives = 105/252 (41%), Gaps = 56/252 (22%)
Query: 284 LEEIEEATNNFDESRIIGRGGFGNVY---FGLLGDREAAIKKMRSNKS-----KEFFAEL 335
           LE      + F + R++GRGGFG V+       G   A  K  +         +    E 
Sbjct: 177 LEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEK 236
Query: 336 KVLCKIH---------------HINVFISTFGNGSLSDHLHD-----PLLKGHQPLTWTA 375
           K+L K+H                + + ++    G +  H+++     P  +  + + +TA
Sbjct: 237 KILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTA 296
Query: 376 RTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGL-VKLEERTNEKE 434
           +         G+E++H       ++RD+K  N+LLDD    +++D GL V+L+    + +
Sbjct: 297 QI------VSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTK 347
Query: 435 MLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALI 494
             A    GTPG++ PE +  + + F +             D FA GV L E+I   R   
Sbjct: 348 GYA----GTPGFMAPELLLGEEYDFSV-------------DYFALGVTLYEMIAA-RGPF 389
Query: 495 RDDSEPTKMKSL 506
           R   E  + K L
Sbjct: 390 RARGEKVENKEL 401

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 96/226 (42%), Gaps = 53/226 (23%)
Query: 290 ATNNFDESRIIGRGGFGNVYFGLLGDREA----AIKKM------RSNKSKEFFAELKVLC 339
           A  +F+  R +G+G FGNVY  L  ++++    A+K +      ++    +   E+++  
Sbjct: 6   ALEDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 340 KIHHINVFISTFGNGSLSDHLHDP----LLKGHQPLTWTARTQIAL---DAAKGIEYIHD 392
            + H N+         L  + HD     L+  + PL    R    L   D  +   YI +
Sbjct: 64  HLRHPNIL-------RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 116
Query: 393 --------HTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP 444
                   H+K R +HRDIK  N+LL      K+ADFG        +      T L GT 
Sbjct: 117 LANALSYCHSK-RVIHRDIKPENLLLGSAGELKIADFGWS-----VHAPSSRRTXLCGTL 170
Query: 445 GYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
            YLPPE I  +     MH          K D+++ GV+  E + GK
Sbjct: 171 DYLPPEMIEGR-----MHDE--------KVDLWSLGVLCYEFLVGK 203

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 96/226 (42%), Gaps = 53/226 (23%)
Query: 290 ATNNFDESRIIGRGGFGNVYFGLLGDREA----AIKKM------RSNKSKEFFAELKVLC 339
           A  +F+  R +G+G FGNVY  L  ++++    A+K +      ++    +   E+++  
Sbjct: 10  ALEDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 67
Query: 340 KIHHINVFISTFGNGSLSDHLHDP----LLKGHQPLTWTARTQIAL---DAAKGIEYIHD 392
            + H N+         L  + HD     L+  + PL    R    L   D  +   YI +
Sbjct: 68  HLRHPNIL-------RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 120
Query: 393 --------HTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP 444
                   H+K R +HRDIK  N+LL      K+ADFG        +      T L GT 
Sbjct: 121 LANALSYCHSK-RVIHRDIKPENLLLGSAGELKIADFGWS-----VHAPSSRRTTLCGTL 174
Query: 445 GYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
            YLPPE I  +     MH          K D+++ GV+  E + GK
Sbjct: 175 DYLPPEMIEGR-----MHDE--------KVDLWSLGVLCYEFLVGK 207

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 39/105 (37%), Positives = 52/105 (49%), Gaps = 19/105 (18%)
Query: 386 GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPG 445
            IEY H H   + VHRD+K  N+LLDD L  K+ADFGL  +    N    L T   G+P 
Sbjct: 120 AIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN---FLKTS-CGSPN 172
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
           Y  PE I  K            L    + DV++ G+VL  ++ G+
Sbjct: 173 YAAPEVINGK------------LYAGPEVDVWSCGIVLYVMLVGR 205

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 70/278 (25%), Positives = 117/278 (42%), Gaps = 58/278 (20%)
Query: 300 IGRGGFGNVYFGLLGDR-EAAIKKMRSN--KSKEFFAELKVLCKIHH------------- 343
           +G G FG V+ G   +  + A+K ++      + F  E  ++  + H             
Sbjct: 20  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKE 79
Query: 344 --INVFISTFGNGSLSDHLH-DPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVH 400
             I +       GSL D L  D   K   P       QIA    +G+ YI    +  Y+H
Sbjct: 80  EPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIA----EGMAYIE---RKNYIH 132
Query: 401 RDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP-GYLPPEYIFVKRFRF 459
           RD++ +N+L+ + L  K+ADFGL ++ E   + E  A      P  +  PE I    F  
Sbjct: 133 RDLRAANVLVSESLMCKIADFGLARVIE---DNEYTAREGAKFPIKWTAPEAINFGCF-- 187
Query: 460 DMHSSVMELQVTTKTDVFAFGVVLAELIT-GK------------RALIRDDSEPTKMKSL 506
                      T K++V++FG++L E++T GK             AL +    P +M++ 
Sbjct: 188 -----------TIKSNVWSFGILLYEIVTYGKIPYPGRTNADVMSALSQGYRMP-RMENC 235
Query: 507 ITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITSTE 544
              +  + + C  E A +RP    + ++L     T+TE
Sbjct: 236 PDELYDIMKMCWKEKAEERPTFDYLQSVLDDF-YTATE 272

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 96/226 (42%), Gaps = 53/226 (23%)
Query: 290 ATNNFDESRIIGRGGFGNVYFGLLGDREA----AIKKM------RSNKSKEFFAELKVLC 339
           A  +F+  R +G+G FGNVY  L  ++++    A+K +      ++    +   E+++  
Sbjct: 9   ALEDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 340 KIHHINVFISTFGNGSLSDHLHDP----LLKGHQPLTWTARTQIAL---DAAKGIEYIHD 392
            + H N+         L  + HD     L+  + PL    R    L   D  +   YI +
Sbjct: 67  HLRHPNIL-------RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 119
Query: 393 --------HTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP 444
                   H+K R +HRDIK  N+LL      K+ADFG        +      T L GT 
Sbjct: 120 LANALSYCHSK-RVIHRDIKPENLLLGSAGELKIADFGWS-----VHAPSSRRTTLCGTL 173
Query: 445 GYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
            YLPPE I  +     MH          K D+++ GV+  E + GK
Sbjct: 174 DYLPPEMIEGR-----MHDE--------KVDLWSLGVLCYEFLVGK 206

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 92/224 (41%), Gaps = 49/224 (21%)
Query: 290 ATNNFDESRIIGRGGFGNVYFGLLGDRE--AAIKKM------RSNKSKEFFAELKVLCKI 341
           A  +F+  R +G+G FGNVY       +   A+K +      ++    +   E+++   +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 342 HHINVFISTFGNGSLSDHLHDP----LLKGHQPLTWTARTQIAL---DAAKGIEYIHD-- 392
            H N+         L  + HD     L+  + PL    R    L   D  +   YI +  
Sbjct: 71  RHPNIL-------RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 123
Query: 393 ------HTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGY 446
                 H+K R +HRDIK  N+LL      K+ADFG        +      T L GT  Y
Sbjct: 124 NALSYCHSK-RVIHRDIKPENLLLGSAGELKIADFGWS-----VHAPSSRRTDLCGTLDY 177
Query: 447 LPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
           LPPE I  +     MH          K D+++ GV+  E + GK
Sbjct: 178 LPPEMIEGR-----MHDE--------KVDLWSLGVLCYEFLVGK 208

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 96/226 (42%), Gaps = 53/226 (23%)
Query: 290 ATNNFDESRIIGRGGFGNVYFGLLGDREA----AIKKM------RSNKSKEFFAELKVLC 339
           A  +F+  R +G+G FGNVY  L  ++++    A+K +      ++    +   E+++  
Sbjct: 5   ALEDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 62
Query: 340 KIHHINVFISTFGNGSLSDHLHDP----LLKGHQPLTWTARTQIAL---DAAKGIEYIHD 392
            + H N+         L  + HD     L+  + PL    R    L   D  +   YI +
Sbjct: 63  HLRHPNIL-------RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 115
Query: 393 --------HTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP 444
                   H+K R +HRDIK  N+LL      K+ADFG        +      T L GT 
Sbjct: 116 LANALSYCHSK-RVIHRDIKPENLLLGSAGELKIADFGWS-----VHAPSSRRTTLCGTL 169
Query: 445 GYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
            YLPPE I  +     MH          K D+++ GV+  E + GK
Sbjct: 170 DYLPPEMIEGR-----MHDE--------KVDLWSLGVLCYEFLVGK 202

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 68/272 (25%), Positives = 113/272 (41%), Gaps = 58/272 (21%)
Query: 300 IGRGGFGNVYFGL-LGDREAAIKKMRSNKSKE--FFAELKVLCKIHH------------- 343
           IG G FG V+ G  L   + AIK +R     E  F  E +V+ K+ H             
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 74
Query: 344 --INVFISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIA--LDAAKGIEYIHDHTKARYV 399
             I +      +G LSD+L        Q   + A T +   LD  +G+ Y+ +   A  +
Sbjct: 75  APICLVFEFMEHGCLSDYLRT------QRGLFAAETLLGMCLDVCEGMAYLEE---ACVI 125
Query: 400 HRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPG-YLPPEYIFVKRFR 458
           HRD+   N L+ +    KV+DFG+ +         +L  +   + G   P ++   + F 
Sbjct: 126 HRDLAARNCLVGENQVIKVSDFGMTRF--------VLDDQYTSSTGTKFPVKWASPEVFS 177
Query: 459 FDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALI--RDDSEPT----------KMKSL 506
           F  +SS        K+DV++FGV++ E+ +  +     R +SE            K +  
Sbjct: 178 FSRYSS--------KSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLA 229
Query: 507 ITIMAAVAEWCLNEDAVDRPEMRDIVAILSQI 538
            T +  +   C  E   DRP    ++  L++I
Sbjct: 230 STHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 261

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/252 (24%), Positives = 105/252 (41%), Gaps = 56/252 (22%)
Query: 284 LEEIEEATNNFDESRIIGRGGFGNVY---FGLLGDREAAIKKMRSNKS-----KEFFAEL 335
           LE      + F + R++GRGGFG V+       G   A  K  +         +    E 
Sbjct: 177 LEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEK 236
Query: 336 KVLCKIH---------------HINVFISTFGNGSLSDHLHD-----PLLKGHQPLTWTA 375
           K+L K+H                + + ++    G +  H+++     P  +  + + +TA
Sbjct: 237 KILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTA 296
Query: 376 RTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGL-VKLEERTNEKE 434
           +         G+E++H       ++RD+K  N+LLDD    +++D GL V+L+    + +
Sbjct: 297 QI------VSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTK 347
Query: 435 MLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALI 494
             A    GTPG++ PE +  + + F +             D FA GV L E+I   R   
Sbjct: 348 GYA----GTPGFMAPELLLGEEYDFSV-------------DYFALGVTLYEMIAA-RGPF 389
Query: 495 RDDSEPTKMKSL 506
           R   E  + K L
Sbjct: 390 RARGEKVENKEL 401

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/248 (23%), Positives = 108/248 (43%), Gaps = 49/248 (19%)
Query: 270 DVTVLESERTIIFSLEEIEEATNNFDESRIIGRGGFGNVYFGL--LGDREAAIKKM---- 323
           D  +LE  R+I+ S+ + ++    F++   IG+G  G VY  +     +E AI++M    
Sbjct: 2   DEEILEKLRSIV-SVGDPKKKYTRFEK---IGQGASGTVYTAMDVATGQEVAIRQMNLQQ 57
Query: 324 --------------RSNKSKEFFAELKVLCKIHHINVFISTFGNGSLSDHLHDPLLKGHQ 369
                         R NK+      L        + V +     GSL+D + +  +   Q
Sbjct: 58  QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQ 117
Query: 370 PLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEER 429
                    +  +  + +E++H +   + +HRDIK+ NILL      K+ DFG     + 
Sbjct: 118 ------IAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCA--QI 166
Query: 430 TNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
           T E+   +T +VGTP ++ PE +  K +               K D+++ G++  E+I G
Sbjct: 167 TPEQSKRST-MVGTPYWMAPEVVTRKAY-------------GPKVDIWSLGIMAIEMIEG 212
Query: 490 KRALIRDD 497
           +   + ++
Sbjct: 213 EPPYLNEN 220

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 92/224 (41%), Gaps = 49/224 (21%)
Query: 290 ATNNFDESRIIGRGGFGNVYFGLLGDRE--AAIKKM------RSNKSKEFFAELKVLCKI 341
           A  +F+  R +G+G FGNVY       +   A+K +      ++    +   E+++   +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 342 HHINVFISTFGNGSLSDHLHDP----LLKGHQPLTWTARTQIAL---DAAKGIEYIHD-- 392
            H N+         L  + HD     L+  + PL    R    L   D  +   YI +  
Sbjct: 66  RHPNIL-------RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 118
Query: 393 ------HTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGY 446
                 H+K R +HRDIK  N+LL      K+ADFG        +      T L GT  Y
Sbjct: 119 NALSYCHSK-RVIHRDIKPENLLLGSAGELKIADFGWS-----VHAPSSRRTDLCGTLDY 172
Query: 447 LPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
           LPPE I  +     MH          K D+++ GV+  E + GK
Sbjct: 173 LPPEMIEGR-----MHDE--------KVDLWSLGVLCYEFLVGK 203

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 89/214 (41%), Gaps = 39/214 (18%)
Query: 298 RIIGRGGFGNV---YFGLLGD---REAAIKKMRSNKSKEFFAELK----VLCKIHHINVF 347
           R +G G FG V    +   GD    + A+K ++        A+LK    +L  ++H N+ 
Sbjct: 15  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 74
Query: 348 ------ISTFGNGSL-------SDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHT 394
                     GNG         S  L + L K    +    + + A+   KG++Y+    
Sbjct: 75  KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYL---G 131
Query: 395 KARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFV 454
             +YVHRD+   N+L++   + K+ DFGL K  E   E   +         +  PE    
Sbjct: 132 SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPE---- 187
Query: 455 KRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
                     +M+ +    +DV++FGV L EL+T
Sbjct: 188 ---------CLMQSKFYIASDVWSFGVTLHELLT 212

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 73/291 (25%), Positives = 121/291 (41%), Gaps = 68/291 (23%)
Query: 283 SLEEIE-----EATNNFDESRIIGRGGFGNVYFG--LLGDREAAIKKMR--SNKSKEFFA 333
           SL+EI+     +    F+   ++G G +G VY G  +   + AAIK M    ++ +E   
Sbjct: 10  SLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQ 69
Query: 334 ELKVLCKI-HHINV--FISTF-------------------GNGSLSDHLHDPLLKGHQPL 371
           E+ +L K  HH N+  +   F                   G GS++D     L+K  +  
Sbjct: 70  EINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD-----LIKNTKGN 124
Query: 372 T----WTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLE 427
           T    W A   I  +  +G+ ++H H   + +HRDIK  N+LL +    K+ DFG+    
Sbjct: 125 TLKEEWIA--YICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 179
Query: 428 ERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELI 487
           +RT  +       +GTP ++ PE I              +     K+D+++ G+   E+ 
Sbjct: 180 DRTVGRR---NTFIGTPYWMAPEVIAC--------DENPDATYDFKSDLWSLGITAIEMA 228
Query: 488 TGK---------RALI---RDDSEPTKMKSLITIMAAVAEWCLNEDAVDRP 526
            G          RAL    R+ +   K K       +  E CL ++   RP
Sbjct: 229 EGAPPLCDMHPMRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRP 279

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 68/272 (25%), Positives = 113/272 (41%), Gaps = 58/272 (21%)
Query: 300 IGRGGFGNVYFGL-LGDREAAIKKMRSNKSKE--FFAELKVLCKIHH------------- 343
           IG G FG V+ G  L   + AIK +R     E  F  E +V+ K+ H             
Sbjct: 13  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 72
Query: 344 --INVFISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIA--LDAAKGIEYIHDHTKARYV 399
             I +      +G LSD+L        Q   + A T +   LD  +G+ Y+ +   A  +
Sbjct: 73  APICLVFEFMEHGCLSDYLRT------QRGLFAAETLLGMCLDVCEGMAYLEE---ACVI 123
Query: 400 HRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPG-YLPPEYIFVKRFR 458
           HRD+   N L+ +    KV+DFG+ +         +L  +   + G   P ++   + F 
Sbjct: 124 HRDLAARNCLVGENQVIKVSDFGMTRF--------VLDDQYTSSTGTKFPVKWASPEVFS 175
Query: 459 FDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALI--RDDSEPT----------KMKSL 506
           F  +SS        K+DV++FGV++ E+ +  +     R +SE            K +  
Sbjct: 176 FSRYSS--------KSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLA 227
Query: 507 ITIMAAVAEWCLNEDAVDRPEMRDIVAILSQI 538
            T +  +   C  E   DRP    ++  L++I
Sbjct: 228 STHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/241 (25%), Positives = 97/241 (40%), Gaps = 45/241 (18%)
Query: 274 LESERTIIFSLE---EIEEATNNFDESRIIGRGGFGNVYFGL---LGDREAAIKKMRSNK 327
           +  ER   +  E    I E    +     +G G +G+V        G R A  K  R  +
Sbjct: 1   MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQ 60
Query: 328 S----KEFFAELKVLCKIHHINV--FISTFGNGSLSDHLHDPLLKGH------------Q 369
           S    K  + EL++L  + H NV   +  F      +  +D  L  H            Q
Sbjct: 61  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 370 PLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEER 429
            LT      +     +G++YIH    A  +HRD+K SN+ +++    K+ DFGL     R
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA----R 173
Query: 430 TNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
             + EM  T  V T  Y  PE +            +  +      D+++ G ++AEL+TG
Sbjct: 174 HTDDEM--TGYVATRWYRAPEIM------------LNWMHYNQTVDIWSVGCIMAELLTG 219
Query: 490 K 490
           +
Sbjct: 220 R 220

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/242 (25%), Positives = 102/242 (42%), Gaps = 54/242 (22%)
Query: 281 IFSLEEIEEATNNFDESRIIGRGGFGNVYFGLLG-------DREAAIKKMRSNKSK---- 329
           ++  +E E A      SR +G+G FG VY G+         +   AIK +    S     
Sbjct: 8   VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI 67
Query: 330 EFFAELKVLCKI--HHIN-------------VFISTFGNGSLSDHL--------HDPLLK 366
           EF  E  V+ +   HH+              V +     G L  +L        ++P+L 
Sbjct: 68  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 127
Query: 367 GHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKL 426
              P + +   Q+A + A G+ Y++ +   ++VHRD+   N ++ +    K+ DFG+ + 
Sbjct: 128 ---PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRD 181
Query: 427 EERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAEL 486
              T+          G  G LP         R+    S+ +   TT +DV++FGVVL E+
Sbjct: 182 IXETDXXRK------GGKGLLP--------VRWMSPESLKDGVFTTYSDVWSFGVVLWEI 227
Query: 487 IT 488
            T
Sbjct: 228 AT 229

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 94/222 (42%), Gaps = 53/222 (23%)
Query: 293 NFDESRIIGRGGFGNVYFGLLGDREA----AIKKM------RSNKSKEFFAELKVLCKIH 342
           +FD  R +G+G FGNVY  L  +R++    A+K +      ++    +   E+++   + 
Sbjct: 13  DFDIGRPLGKGKFGNVY--LARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLR 70
Query: 343 HINVFISTFGNGSLSDHLHDP----LLKGHQPLTWTARTQIAL---DAAKGIEYIHD--- 392
           H N+         L  + HD     L+  + PL    R    L   D  +   YI +   
Sbjct: 71  HPNIL-------RLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELAN 123
Query: 393 -----HTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYL 447
                H+K R +HRDIK  N+LL      K+ADFG        +      T L GT  YL
Sbjct: 124 ALSYCHSK-RVIHRDIKPENLLLGSNGELKIADFGWS-----VHAPSSRRTTLCGTLDYL 177
Query: 448 PPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
           PPE I  +     MH          K D+++ GV+  E + G
Sbjct: 178 PPEMIEGR-----MHDE--------KVDLWSLGVLCYEFLVG 206

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 62/242 (25%), Positives = 102/242 (42%), Gaps = 54/242 (22%)
Query: 281 IFSLEEIEEATNNFDESRIIGRGGFGNVYFGLLG-------DREAAIKKMRSNKSK---- 329
           +F  +E E A      SR +G+G FG VY G+         +   AIK +    S     
Sbjct: 5   VFVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI 64
Query: 330 EFFAELKVLCKI--HHIN-------------VFISTFGNGSLSDHL--------HDPLLK 366
           EF  E  V+ +   HH+              V +     G L  +L        ++P+L 
Sbjct: 65  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 124
Query: 367 GHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKL 426
              P + +   Q+A + A G+ Y++ +   ++VHRD+   N ++ +    K+ DFG+ + 
Sbjct: 125 ---PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRD 178
Query: 427 EERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAEL 486
              T+          G  G LP         R+    S+ +   TT +DV++FGVVL E+
Sbjct: 179 IYETDYYRK------GGKGLLP--------VRWMSPESLKDGVFTTYSDVWSFGVVLWEI 224
Query: 487 IT 488
            T
Sbjct: 225 AT 226

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/234 (22%), Positives = 99/234 (42%), Gaps = 50/234 (21%)
Query: 291 TNNFDESRIIGRGGFGNVYFG--LLGDREAAIKKMRSNKSKE------FFAELKVLCKIH 342
           ++ ++   I+G GG   V+    L   R+ A+K +R++ +++      F  E +    ++
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 343 HINVFISTFGNG--------------------SLSDHLHDPLLKGHQPLTWTARTQIALD 382
           H  + ++ +  G                    +L D +H        P+T     ++  D
Sbjct: 71  HPAI-VAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT-----EGPMTPKRAIEVIAD 124
Query: 383 AAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVG 442
           A + + + H +     +HRD+K +NIL+      KV DFG+ +    +         ++G
Sbjct: 125 ACQALNFSHQNG---IIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIG 181
Query: 443 TPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRD 496
           T  YL PE     + R D         V  ++DV++ G VL E++TG+     D
Sbjct: 182 TAQYLSPE-----QARGD--------SVDARSDVYSLGCVLYEVLTGEPPFTGD 222

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 88/212 (41%), Gaps = 42/212 (19%)
Query: 300 IGRGGFGNVYFGLLGDREA--AIKKMRSNKSKEFFA-----ELKVLCKIHHINV--FIST 350
           +G G +G V   + G   A  AIKK+      E FA     EL++L  + H NV   +  
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDV 92
Query: 351 FGNGSLSDHLHD-----PL-------LKGHQPLTWTARTQIALDAAKGIEYIHDHTKARY 398
           F      D   D     P        L  H+ L       +     KG+ YIH    A  
Sbjct: 93  FTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIH---AAGI 149
Query: 399 VHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFR 458
           +HRD+K  N+ +++    K+ DFGL     R  + EM     V T  Y  PE I      
Sbjct: 150 IHRDLKPGNLAVNEDCELKILDFGLA----RQADSEMXGX--VVTRWYRAPEVI------ 197
Query: 459 FDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
                 +  ++ T   D+++ G ++AE+ITGK
Sbjct: 198 ------LNWMRYTQTVDIWSVGCIMAEMITGK 223

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 67/280 (23%), Positives = 119/280 (42%), Gaps = 72/280 (25%)
Query: 300 IGRGGFGNVYFG-LLGDREAAIKKMR--SNKSKEFFAELKVLCKIHH------------- 343
           +G G FG V +G   G  + AIK ++  S    EF  E KV+  + H             
Sbjct: 16  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 75
Query: 344 --INVFISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHR 401
             I +      NG L ++L +     H+  T     ++  D  + +EY+      +++HR
Sbjct: 76  RPIFIITEYMANGCLLNYLRE---MRHRFQT-QQLLEMCKDVCEAMEYLES---KQFLHR 128
Query: 402 DIKTSNILLDDGLRAKVADFGLVKL---EERTNEKEMLATRLVGTP---GYLPPEYIFVK 455
           D+   N L++D    KV+DFGL +    +E T+         VG+     + PPE +   
Sbjct: 129 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS--------VGSKFPVRWSPPEVLMYS 180
Query: 456 RFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIRDDSEPT------------- 501
           +F             ++K+D++AFGV++ E+ + GK    R  +  T             
Sbjct: 181 KF-------------SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRP 227
Query: 502 --KMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIM 539
               + + TIM +    C +E A +RP  + +++ +  +M
Sbjct: 228 HLASEKVYTIMYS----CWHEKADERPTFKILLSNILDVM 263

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 68/272 (25%), Positives = 113/272 (41%), Gaps = 58/272 (21%)
Query: 300 IGRGGFGNVYFGL-LGDREAAIKKMRSNKSKE--FFAELKVLCKIHH------------- 343
           IG G FG V+ G  L   + AIK +R     E  F  E +V+ K+ H             
Sbjct: 18  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 77
Query: 344 --INVFISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIA--LDAAKGIEYIHDHTKARYV 399
             I +      +G LSD+L        Q   + A T +   LD  +G+ Y+ +   A  +
Sbjct: 78  APICLVFEFMEHGCLSDYLRT------QRGLFAAETLLGMCLDVCEGMAYLEE---ACVI 128
Query: 400 HRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPG-YLPPEYIFVKRFR 458
           HRD+   N L+ +    KV+DFG+ +         +L  +   + G   P ++   + F 
Sbjct: 129 HRDLAARNCLVGENQVIKVSDFGMTRF--------VLDDQYTSSTGTKFPVKWASPEVFS 180
Query: 459 FDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALI--RDDSEPT----------KMKSL 506
           F  +SS        K+DV++FGV++ E+ +  +     R +SE            K +  
Sbjct: 181 FSRYSS--------KSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLA 232
Query: 507 ITIMAAVAEWCLNEDAVDRPEMRDIVAILSQI 538
            T +  +   C  E   DRP    ++  L++I
Sbjct: 233 STHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 264

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 96/226 (42%), Gaps = 53/226 (23%)
Query: 290 ATNNFDESRIIGRGGFGNVYFGLLGDREA----AIKKM------RSNKSKEFFAELKVLC 339
           A  +F+  R +G+G FGNVY  L  ++++    A+K +      ++    +   E+++  
Sbjct: 7   ALEDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 64
Query: 340 KIHHINVFISTFGNGSLSDHLHDP----LLKGHQPLTWTARTQIAL---DAAKGIEYIHD 392
            + H N+         L  + HD     L+  + PL    R    L   D  +   YI +
Sbjct: 65  HLRHPNIL-------RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 117
Query: 393 --------HTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP 444
                   H+K R +HRDIK  N+LL      K+ADFG        +      T L GT 
Sbjct: 118 LANALSYCHSK-RVIHRDIKPENLLLGSAGELKIADFGWS-----CHAPSSRRTTLSGTL 171
Query: 445 GYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
            YLPPE I  +     MH          K D+++ GV+  E + GK
Sbjct: 172 DYLPPEMIEGR-----MHDE--------KVDLWSLGVLCYEFLVGK 204

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 61/241 (25%), Positives = 97/241 (40%), Gaps = 45/241 (18%)
Query: 274 LESERTIIFSLE---EIEEATNNFDESRIIGRGGFGNVYFGL---LGDREAAIKKMRSNK 327
           +  ER   +  E    I E    +     +G G +G+V        G R A  K  R  +
Sbjct: 20  MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQ 79
Query: 328 S----KEFFAELKVLCKIHHINV--FISTFGNGSLSDHLHDPLLKGH------------Q 369
           S    K  + EL++L  + H NV   +  F      +  +D  L  H            Q
Sbjct: 80  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 139
Query: 370 PLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEER 429
            LT      +     +G++YIH    A  +HRD+K SN+ +++    K+ DFGL     R
Sbjct: 140 KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA----R 192
Query: 430 TNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
             + EM  T  V T  Y  PE +            +  +      D+++ G ++AEL+TG
Sbjct: 193 HTDDEM--TGYVATRWYRAPEIM------------LNWMHYNQTVDIWSVGCIMAELLTG 238
Query: 490 K 490
           +
Sbjct: 239 R 239

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 61/241 (25%), Positives = 98/241 (40%), Gaps = 45/241 (18%)
Query: 274 LESERTIIFSLE---EIEEATNNFDESRIIGRGGFGNV---YFGLLGDREAAIKKMRSNK 327
           +  ER   +  E    I E    +     +G G +G+V   +    G R A  K  R  +
Sbjct: 21  MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQ 80
Query: 328 S----KEFFAELKVLCKIHHINV--FISTFGNGSLSDHLHDPLLKGH------------Q 369
           S    K  + EL++L  + H NV   +  F      +  +D  L  H            Q
Sbjct: 81  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 140
Query: 370 PLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEER 429
            LT      +     +G++YIH    A  +HRD+K SN+ +++    K+ DFGL     R
Sbjct: 141 KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA----R 193
Query: 430 TNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
             + EM  T  V T  Y  PE +            +  +      D+++ G ++AEL+TG
Sbjct: 194 HTDDEM--TGYVATRWYRAPEIM------------LNWMHYNQTVDIWSVGCIMAELLTG 239
Query: 490 K 490
           +
Sbjct: 240 R 240

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 68/273 (24%), Positives = 115/273 (42%), Gaps = 60/273 (21%)
Query: 300 IGRGGFGNVYFGL-LGDREAAIKKMRSNKSKE--FFAELKVLCKIHHINVFISTFG---- 352
           IG G FG V+ G  L   + AIK +R     E  F  E +V+ K+ H  + +  +G    
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKL-VQLYGVCLE 74
Query: 353 ------------NGSLSDHLHDPLLKGHQPLTWTARTQIA--LDAAKGIEYIHDHTKARY 398
                       +G LSD+L        Q   + A T +   LD  +G+ Y+ +   A  
Sbjct: 75  QAPICLVTEFMEHGCLSDYLRT------QRGLFAAETLLGMCLDVCEGMAYLEE---ACV 125
Query: 399 VHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPG-YLPPEYIFVKRF 457
           +HRD+   N L+ +    KV+DFG+ +         +L  +   + G   P ++   + F
Sbjct: 126 IHRDLAARNCLVGENQVIKVSDFGMTRF--------VLDDQYTSSTGTKFPVKWASPEVF 177
Query: 458 RFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALI--RDDSEPT----------KMKS 505
            F  +SS        K+DV++FGV++ E+ +  +     R +SE            K + 
Sbjct: 178 SFSRYSS--------KSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRL 229
Query: 506 LITIMAAVAEWCLNEDAVDRPEMRDIVAILSQI 538
             T +  +   C  E   DRP    ++  L++I
Sbjct: 230 ASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 262

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 100/238 (42%), Gaps = 54/238 (22%)
Query: 285 EEIEEATNNFDESRIIGRGGFGNVYFGLLG-------DREAAIKKMRSNKSK----EFFA 333
           +E E A      SR +G+G FG VY G+         +   AIK +    S     EF  
Sbjct: 3   DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 62
Query: 334 ELKVLCKI--HHIN-------------VFISTFGNGSLSDHL--------HDPLLKGHQP 370
           E  V+ +   HH+              V +     G L  +L        ++P+L    P
Sbjct: 63  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA---P 119
Query: 371 LTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERT 430
            + +   Q+A + A G+ Y++ +   ++VHRD+   N ++ +    K+ DFG+ +    T
Sbjct: 120 PSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXET 176
Query: 431 NEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
           +          G  G LP         R+    S+ +   TT +DV++FGVVL E+ T
Sbjct: 177 DXXRK------GGKGLLP--------VRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 220

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 63/274 (22%), Positives = 115/274 (41%), Gaps = 60/274 (21%)
Query: 300 IGRGGFGNVYFG-LLGDREAAIKKMR--SNKSKEFFAELKVLCKIHH------------- 343
           +G G FG V +G   G  + AIK ++  S    EF  E KV+  + H             
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 91
Query: 344 --INVFISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHR 401
             I +      NG L ++L +     H+  T     ++  D  + +EY+      +++HR
Sbjct: 92  RPIFIITEYMANGCLLNYLRE---MRHRFQT-QQLLEMCKDVCEAMEYLES---KQFLHR 144
Query: 402 DIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDM 461
           D+   N L++D    KV+DFGL +          + ++      + PPE +   +F    
Sbjct: 145 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKF--PVRWSPPEVLMYSKF---- 198
Query: 462 HSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIRDDSEPT---------------KMKS 505
                    ++K+D++AFGV++ E+ + GK    R  +  T                 + 
Sbjct: 199 ---------SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEK 249
Query: 506 LITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIM 539
           + TIM +    C +E A +RP  + +++ +  +M
Sbjct: 250 VYTIMYS----CWHEKADERPTFKILLSNILDVM 279

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 68/272 (25%), Positives = 112/272 (41%), Gaps = 58/272 (21%)
Query: 300 IGRGGFGNVYFGL-LGDREAAIKKMRSNKSKE--FFAELKVLCKIHH------------- 343
           IG G FG V+ G  L   + AIK +R     E  F  E +V+ K+ H             
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 74
Query: 344 --INVFISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIA--LDAAKGIEYIHDHTKARYV 399
             I +      +G LSD+L        Q   + A T +   LD  +G+ Y+ +   A  +
Sbjct: 75  APICLVFEFMEHGCLSDYLRT------QRGLFAAETLLGMCLDVCEGMAYLEE---ASVI 125
Query: 400 HRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPG-YLPPEYIFVKRFR 458
           HRD+   N L+ +    KV+DFG+ +         +L  +   + G   P ++   + F 
Sbjct: 126 HRDLAARNCLVGENQVIKVSDFGMTRF--------VLDDQYTSSTGTKFPVKWASPEVFS 177
Query: 459 FDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALI--RDDSEPT----------KMKSL 506
           F  +SS        K+DV++FGV++ E+ +  +     R +SE            K +  
Sbjct: 178 FSRYSS--------KSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLA 229
Query: 507 ITIMAAVAEWCLNEDAVDRPEMRDIVAILSQI 538
            T +  +   C  E   DRP    ++  L+ I
Sbjct: 230 STHVYQIMNHCWKERPEDRPAFSRLLRQLAAI 261

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 67/280 (23%), Positives = 119/280 (42%), Gaps = 72/280 (25%)
Query: 300 IGRGGFGNVYFG-LLGDREAAIKKMR--SNKSKEFFAELKVLCKIHH------------- 343
           +G G FG V +G   G  + AIK ++  S    EF  E KV+  + H             
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 76
Query: 344 --INVFISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHR 401
             I +      NG L ++L +     H+  T     ++  D  + +EY+      +++HR
Sbjct: 77  RPIFIITEYMANGCLLNYLRE---MRHRFQT-QQLLEMCKDVCEAMEYLES---KQFLHR 129
Query: 402 DIKTSNILLDDGLRAKVADFGLVKL---EERTNEKEMLATRLVGTP---GYLPPEYIFVK 455
           D+   N L++D    KV+DFGL +    +E T+         VG+     + PPE +   
Sbjct: 130 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS--------VGSKFPVRWSPPEVLMYS 181
Query: 456 RFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIRDDSEPT------------- 501
           +F             ++K+D++AFGV++ E+ + GK    R  +  T             
Sbjct: 182 KF-------------SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRP 228
Query: 502 --KMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIM 539
               + + TIM +    C +E A +RP  + +++ +  +M
Sbjct: 229 HLASEKVYTIMYS----CWHEKADERPTFKILLSNILDVM 264

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/250 (23%), Positives = 106/250 (42%), Gaps = 53/250 (21%)
Query: 270 DVTVLESERTIIFSLEEIEEATNNFDESRIIGRGGFGNVYFGL--LGDREAAIKKM---- 323
           D  +LE  R+I+ S+ + ++    F++   IG+G  G VY  +     +E AI++M    
Sbjct: 2   DEEILEKLRSIV-SVGDPKKKYTRFEK---IGQGASGTVYTAMDVATGQEVAIRQMNLQQ 57
Query: 324 --------------RSNKSKEFFAELKVLCKIHHINVFISTFGNGSLSDHLHDPLLKGHQ 369
                         R NK+      L        + V +     GSL+D + +  +   Q
Sbjct: 58  QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQ 117
Query: 370 PLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK--LE 427
                    +  +  + +E++H +   + +HRDIK+ NILL      K+ DFG       
Sbjct: 118 ------IAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168
Query: 428 ERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELI 487
           E++   EM     VGTP ++ PE +  K +               K D+++ G++  E+I
Sbjct: 169 EQSKRSEM-----VGTPYWMAPEVVTRKAY-------------GPKVDIWSLGIMAIEMI 210
Query: 488 TGKRALIRDD 497
            G+   + ++
Sbjct: 211 EGEPPYLNEN 220

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 92/225 (40%), Gaps = 42/225 (18%)
Query: 287 IEEATNNFDESRIIGRGGFGNVYFGL---LGDREAAIKKMRSNKS----KEFFAELKVLC 339
           I E    +     +G G +G+V        G R A  K  R  +S    K  + EL++L 
Sbjct: 13  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLK 72
Query: 340 KIHHINV--FISTFGNGSLSDHLHDPLLKGH------------QPLTWTARTQIALDAAK 385
            + H NV   +  F      +  +D  L  H            Q LT      +     +
Sbjct: 73  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 132
Query: 386 GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPG 445
           G++YIH    A  +HRD+K SN+ +++    K+ DFGL     R  + EM  T  V T  
Sbjct: 133 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA----RHTDDEM--TGYVATRW 183
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
           Y  PE +            +  +      D+++ G ++AEL+TG+
Sbjct: 184 YRAPEIM------------LNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 55/248 (22%), Positives = 106/248 (42%), Gaps = 49/248 (19%)
Query: 270 DVTVLESERTIIFSLEEIEEATNNFDESRIIGRGGFGNVYFGL--LGDREAAIKKM---- 323
           D  +LE  R+I+ S+ + ++    F++   IG+G  G VY  +     +E AI++M    
Sbjct: 3   DEEILEKLRSIV-SVGDPKKKYTRFEK---IGQGASGTVYTAMDVATGQEVAIRQMNLQQ 58
Query: 324 --------------RSNKSKEFFAELKVLCKIHHINVFISTFGNGSLSDHLHDPLLKGHQ 369
                         R NK+      L        + V +     GSL+D + +  +   Q
Sbjct: 59  QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQ 118
Query: 370 PLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEER 429
                    +  +  + +E++H +   + +HRDIK+ NILL      K+ DFG      +
Sbjct: 119 ------IAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCA---Q 166
Query: 430 TNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
              ++   + +VGTP ++ PE +  K +               K D+++ G++  E+I G
Sbjct: 167 ITPEQSKRSXMVGTPYWMAPEVVTRKAY-------------GPKVDIWSLGIMAIEMIEG 213
Query: 490 KRALIRDD 497
           +   + ++
Sbjct: 214 EPPYLNEN 221

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 92/225 (40%), Gaps = 42/225 (18%)
Query: 287 IEEATNNFDESRIIGRGGFGNV--YFGLLGDREAAIKKMRSN-----KSKEFFAELKVLC 339
           I E    +     IG G +G+V   F        A+KK+         +K  + EL++L 
Sbjct: 22  IWEVPERYQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 81
Query: 340 KIHHINV--FISTFGNGSLSDHLHDPLLKGH------------QPLTWTARTQIALDAAK 385
            + H NV   +  F      +  +D  L  H            Q LT      +     +
Sbjct: 82  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 141
Query: 386 GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPG 445
           G++YIH    A  +HRD+K SN+ +++    K+ DFGL     R  + EM  T  V T  
Sbjct: 142 GLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLA----RHTDDEM--TGYVATRW 192
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
           Y  PE +            +  +      D+++ G ++AEL+TG+
Sbjct: 193 YRAPEIM------------LNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 59/241 (24%), Positives = 97/241 (40%), Gaps = 45/241 (18%)
Query: 274 LESERTIIFSLE---EIEEATNNFDESRIIGRGGFGNV--YFGLLGDREAAIKKMRSN-- 326
           +  ER   +  E    I E    +     +G G +G+V   F        A+KK+     
Sbjct: 1   MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 60
Query: 327 ---KSKEFFAELKVLCKIHHINV--FISTFGNGSLSDHLHDPLLKGH------------Q 369
               +K  + EL++L  + H NV   +  F      +  +D  L  H            Q
Sbjct: 61  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 370 PLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEER 429
            LT      +     +G++YIH    A  +HRD+K SN+ +++    K+ DFGL     R
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA----R 173
Query: 430 TNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
             + EM  T  V T  Y  PE +            +  +      D+++ G ++AEL+TG
Sbjct: 174 HTDDEM--TGYVATRWYRAPEIM------------LNAMHYNQTVDIWSVGCIMAELLTG 219
Query: 490 K 490
           +
Sbjct: 220 R 220

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 92/225 (40%), Gaps = 42/225 (18%)
Query: 287 IEEATNNFDESRIIGRGGFGNV--YFGLLGDREAAIKKMRSN-----KSKEFFAELKVLC 339
           I E    +     +G G +G+V   F        A+KK+         +K  + EL++L 
Sbjct: 23  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLK 82
Query: 340 KIHHINV--FISTFGNGSLSDHLHDPLLKGH------------QPLTWTARTQIALDAAK 385
            + H NV   +  F      +  +D  L  H            Q LT      +     +
Sbjct: 83  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 142
Query: 386 GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPG 445
           G++YIH    A  +HRD+K SN+ +++    K+ DFGL     R  + EM  T  V T  
Sbjct: 143 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA----RHTDDEM--TGYVATRW 193
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
           Y  PE +            +  +      D+++ G ++AEL+TG+
Sbjct: 194 YRAPEIM------------LNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 67/280 (23%), Positives = 119/280 (42%), Gaps = 72/280 (25%)
Query: 300 IGRGGFGNVYFG-LLGDREAAIKKMR--SNKSKEFFAELKVLCKIHH------------- 343
           +G G FG V +G   G  + AIK ++  S    EF  E KV+  + H             
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 71
Query: 344 --INVFISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHR 401
             I +      NG L ++L +     H+  T     ++  D  + +EY+      +++HR
Sbjct: 72  RPIFIITEYMANGCLLNYLRE---MRHRFQT-QQLLEMCKDVCEAMEYLES---KQFLHR 124
Query: 402 DIKTSNILLDDGLRAKVADFGLVKL---EERTNEKEMLATRLVGTP---GYLPPEYIFVK 455
           D+   N L++D    KV+DFGL +    +E T+         VG+     + PPE +   
Sbjct: 125 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS--------VGSKFPVRWSPPEVLMYS 176
Query: 456 RFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIRDDSEPT------------- 501
           +F             ++K+D++AFGV++ E+ + GK    R  +  T             
Sbjct: 177 KF-------------SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRP 223
Query: 502 --KMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIM 539
               + + TIM +    C +E A +RP  + +++ +  +M
Sbjct: 224 HLASEKVYTIMYS----CWHEKADERPTFKILLSNILDVM 259

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 61/242 (25%), Positives = 102/242 (42%), Gaps = 54/242 (22%)
Query: 281 IFSLEEIEEATNNFDESRIIGRGGFGNVYFGLLG-------DREAAIKKMRSNKSK---- 329
           ++  +E E A      SR +G+G FG VY G+         +   AIK +    S     
Sbjct: 14  VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI 73
Query: 330 EFFAELKVLCKI--HHIN-------------VFISTFGNGSLSDHL--------HDPLLK 366
           EF  E  V+ +   HH+              V +     G L  +L        ++P+L 
Sbjct: 74  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLA 133
Query: 367 GHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKL 426
              P + +   Q+A + A G+ Y++ +   ++VHRD+   N ++ +    K+ DFG+ + 
Sbjct: 134 ---PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRD 187
Query: 427 EERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAEL 486
              T+          G  G LP         R+    S+ +   TT +DV++FGVVL E+
Sbjct: 188 IYETDYYRK------GGKGLLP--------VRWMSPESLKDGVFTTYSDVWSFGVVLWEI 233
Query: 487 IT 488
            T
Sbjct: 234 AT 235

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 89/212 (41%), Gaps = 42/212 (19%)
Query: 300 IGRGGFGNVYFGL---LGDREAAIKKMRSNKS----KEFFAELKVLCKIHHINV--FIST 350
           +G G +G+V        G R A  K  R  +S    K  + EL++L  + H NV   +  
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 99
Query: 351 FGNGSLSDHLHDPLLKGH------------QPLTWTARTQIALDAAKGIEYIHDHTKARY 398
           F      +  +D  L  H            Q LT      +     +G++YIH    A  
Sbjct: 100 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADI 156
Query: 399 VHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFR 458
           +HRD+K SN+ +++    K+ DFGL     R  + EM  T  V T  Y  PE +      
Sbjct: 157 IHRDLKPSNLAVNEDCELKILDFGLA----RHTDDEM--TGYVATRWYRAPEIM------ 204
Query: 459 FDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
                 +  +      D+++ G ++AEL+TG+
Sbjct: 205 ------LNWMHYNQTVDIWSVGCIMAELLTGR 230

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 61/242 (25%), Positives = 102/242 (42%), Gaps = 54/242 (22%)
Query: 281 IFSLEEIEEATNNFDESRIIGRGGFGNVYFGLLG-------DREAAIKKMRSNKSK---- 329
           ++  +E E A      SR +G+G FG VY G+         +   AIK +    S     
Sbjct: 7   VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI 66
Query: 330 EFFAELKVLCKI--HHIN-------------VFISTFGNGSLSDHL--------HDPLLK 366
           EF  E  V+ +   HH+              V +     G L  +L        ++P+L 
Sbjct: 67  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 126
Query: 367 GHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKL 426
              P + +   Q+A + A G+ Y++ +   ++VHRD+   N ++ +    K+ DFG+ + 
Sbjct: 127 ---PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRD 180
Query: 427 EERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAEL 486
              T+          G  G LP         R+    S+ +   TT +DV++FGVVL E+
Sbjct: 181 IYETDYYRK------GGKGLLP--------VRWMSPESLKDGVFTTYSDVWSFGVVLWEI 226
Query: 487 IT 488
            T
Sbjct: 227 AT 228

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 55/248 (22%), Positives = 106/248 (42%), Gaps = 49/248 (19%)
Query: 270 DVTVLESERTIIFSLEEIEEATNNFDESRIIGRGGFGNVYFGL--LGDREAAIKKM---- 323
           D  +LE  R+I+ S+ + ++    F++   IG+G  G VY  +     +E AI++M    
Sbjct: 2   DEEILEKLRSIV-SVGDPKKKYTRFEK---IGQGASGTVYTAMDVATGQEVAIRQMNLQQ 57
Query: 324 --------------RSNKSKEFFAELKVLCKIHHINVFISTFGNGSLSDHLHDPLLKGHQ 369
                         R NK+      L        + V +     GSL+D + +  +   Q
Sbjct: 58  QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQ 117
Query: 370 PLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEER 429
                    +  +  + +E++H +   + +HRDIK+ NILL      K+ DFG      +
Sbjct: 118 ------IAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCA---Q 165
Query: 430 TNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
              ++   + +VGTP ++ PE +  K +               K D+++ G++  E+I G
Sbjct: 166 ITPEQSKRSXMVGTPYWMAPEVVTRKAY-------------GPKVDIWSLGIMAIEMIEG 212
Query: 490 KRALIRDD 497
           +   + ++
Sbjct: 213 EPPYLNEN 220

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 63/274 (22%), Positives = 115/274 (41%), Gaps = 60/274 (21%)
Query: 300 IGRGGFGNVYFG-LLGDREAAIKKMR--SNKSKEFFAELKVLCKIHH------------- 343
           +G G FG V +G   G  + AIK ++  S    EF  E KV+  + H             
Sbjct: 23  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 82
Query: 344 --INVFISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHR 401
             I +      NG L ++L +     H+  T     ++  D  + +EY+      +++HR
Sbjct: 83  RPIFIITEYMANGCLLNYLRE---MRHRFQT-QQLLEMCKDVCEAMEYLES---KQFLHR 135
Query: 402 DIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDM 461
           D+   N L++D    KV+DFGL +          + ++      + PPE +   +F    
Sbjct: 136 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKF--PVRWSPPEVLMYSKF---- 189
Query: 462 HSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIRDDSEPT---------------KMKS 505
                    ++K+D++AFGV++ E+ + GK    R  +  T                 + 
Sbjct: 190 ---------SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEK 240
Query: 506 LITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIM 539
           + TIM +    C +E A +RP  + +++ +  +M
Sbjct: 241 VYTIMYS----CWHEKADERPTFKILLSNILDVM 270

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 88/210 (41%), Gaps = 34/210 (16%)
Query: 300 IGRGGFGNV--YFGLLGDREAAIKKMRSNKSKEF----FAELKVLCKIHHINVF-ISTFG 352
           IG G +G V   +  +     AIKK+   + + +      E+K+L +  H N+  I+   
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 110
Query: 353 NGSLSDHLHDPLLKGH------------QPLTWTARTQIALDAAKGIEYIHDHTKARYVH 400
                + + D  L  H            Q L+            +G++YIH    A  +H
Sbjct: 111 RAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLH 167
Query: 401 RDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFD 460
           RD+K SN+LL+     K+ DFGL ++ +  ++     T  V T  Y  PE +   +    
Sbjct: 168 RDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK---- 223
Query: 461 MHSSVMELQVTTKTDVFAFGVVLAELITGK 490
                     T   D+++ G +LAE+++ +
Sbjct: 224 --------GYTKSIDIWSVGCILAEMLSNR 245

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 82/176 (46%), Gaps = 33/176 (18%)
Query: 329 KEFFAELKVLCKIHHINVF-ISTFGNGSLSDHLH--------DPLLK--GHQPLTWTART 377
           ++ + E+ +L K+ H NV  +    +    DHL+         P+++    +PL+     
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQAR 140
Query: 378 QIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNE---KE 434
               D  KGIEY+H     + +HRDIK SN+L+ +    K+ADFG+      +NE    +
Sbjct: 141 FYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGV------SNEFKGSD 191
Query: 435 MLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
            L +  VGTP ++ PE +   R  F   +           DV+A GV L   + G+
Sbjct: 192 ALLSNTVGTPAFMAPESLSETRKIFSGKA----------LDVWAMGVTLYCFVFGQ 237

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 90/215 (41%), Gaps = 38/215 (17%)
Query: 300 IGRGGFGNVYFGL--LGDREAAIKKMRS-----NKSKEFFAELKVLCKIHHINV------ 346
           IG G +G V      L  ++ AIKK+ +       +K    ELK+L    H N+      
Sbjct: 63  IGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDI 122
Query: 347 ---------FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKAR 397
                    F S +    L +     ++   QPLT            +G++Y+H    A+
Sbjct: 123 LRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMH---SAQ 179
Query: 398 YVHRDIKTSNILLDDGLRAKVADFGLVK-LEERTNEKEMLATRLVGTPGYLPPEYIFVKR 456
            +HRD+K SN+L+++    K+ DFG+ + L     E +   T  V T  Y  PE +    
Sbjct: 180 VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELM---- 235
Query: 457 FRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKR 491
               +H      + T   D+++ G +  E++  ++
Sbjct: 236 --LSLH------EYTQAIDLWSVGCIFGEMLARRQ 262

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 61/242 (25%), Positives = 102/242 (42%), Gaps = 54/242 (22%)
Query: 281 IFSLEEIEEATNNFDESRIIGRGGFGNVYFGLLG-------DREAAIKKMRSNKSK---- 329
           ++  +E E A      SR +G+G FG VY G+         +   AIK +    S     
Sbjct: 4   VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI 63
Query: 330 EFFAELKVLCKI--HHIN-------------VFISTFGNGSLSDHL--------HDPLLK 366
           EF  E  V+ +   HH+              V +     G L  +L        ++P+L 
Sbjct: 64  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLA 123
Query: 367 GHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKL 426
              P + +   Q+A + A G+ Y++ +   ++VHRD+   N ++ +    K+ DFG+ + 
Sbjct: 124 ---PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRD 177
Query: 427 EERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAEL 486
              T+          G  G LP         R+    S+ +   TT +DV++FGVVL E+
Sbjct: 178 IYETDYYRK------GGKGLLP--------VRWMSPESLKDGVFTTYSDVWSFGVVLWEI 223
Query: 487 IT 488
            T
Sbjct: 224 AT 225

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 59/241 (24%), Positives = 97/241 (40%), Gaps = 45/241 (18%)
Query: 274 LESERTIIFSLE---EIEEATNNFDESRIIGRGGFGNV--YFGLLGDREAAIKKMRSN-- 326
           +  ER   +  E    I E    +     +G G +G+V   F        A+KK+     
Sbjct: 1   MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 60
Query: 327 ---KSKEFFAELKVLCKIHHINV--FISTFGNGSLSDHLHDPLLKGH------------Q 369
               +K  + EL++L  + H NV   +  F      +  +D  L  H            Q
Sbjct: 61  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 370 PLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEER 429
            LT      +     +G++YIH    A  +HRD+K SN+ +++    K+ DFGL     R
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA----R 173
Query: 430 TNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
             + EM  T  V T  Y  PE +            +  +      D+++ G ++AEL+TG
Sbjct: 174 HTDDEM--TGYVATRWYRAPEIM------------LNWMHYNQTVDIWSVGCIMAELLTG 219
Query: 490 K 490
           +
Sbjct: 220 R 220

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 59/241 (24%), Positives = 97/241 (40%), Gaps = 45/241 (18%)
Query: 274 LESERTIIFSLE---EIEEATNNFDESRIIGRGGFGNV--YFGLLGDREAAIKKMRSN-- 326
           +  ER   +  E    I E    +     +G G +G+V   F        A+KK+     
Sbjct: 13  MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQ 72
Query: 327 ---KSKEFFAELKVLCKIHHINV--FISTFGNGSLSDHLHDPLLKGH------------Q 369
               +K  + EL++L  + H NV   +  F      +  +D  L  H            Q
Sbjct: 73  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 132
Query: 370 PLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEER 429
            LT      +     +G++YIH    A  +HRD+K SN+ +++    K+ DFGL     R
Sbjct: 133 KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA----R 185
Query: 430 TNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
             + EM  T  V T  Y  PE +            +  +      D+++ G ++AEL+TG
Sbjct: 186 HTDDEM--TGYVATRWYRAPEIM------------LNWMHYNQTVDIWSVGCIMAELLTG 231
Query: 490 K 490
           +
Sbjct: 232 R 232

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 60/241 (24%), Positives = 96/241 (39%), Gaps = 45/241 (18%)
Query: 274 LESERTIIFSLE---EIEEATNNFDESRIIGRGGFGNVYFGL---LGDREAAIKKMRSNK 327
           +  ER   +  E    I E    +     +G G +G+V        G R A  K  R  +
Sbjct: 1   MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQ 60
Query: 328 S----KEFFAELKVLCKIHHINV--FISTFGNGSLSDHLHDPLLKGH------------Q 369
           S    K  + EL++L  + H NV   +  F      +  +D  L  H            Q
Sbjct: 61  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 370 PLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEER 429
            LT      +     +G++YIH    A  +HRD+K SN+ +++    K+ DFGL     R
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA----R 173
Query: 430 TNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
             + EM     V T  Y  PE +            +  +      D+++ G ++AEL+TG
Sbjct: 174 HTDDEMAG--FVATRWYRAPEIM------------LNWMHYNQTVDIWSVGCIMAELLTG 219
Query: 490 K 490
           +
Sbjct: 220 R 220

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 59/241 (24%), Positives = 97/241 (40%), Gaps = 45/241 (18%)
Query: 274 LESERTIIFSLE---EIEEATNNFDESRIIGRGGFGNV--YFGLLGDREAAIKKMRSN-- 326
           +  ER   +  E    I E    +     +G G +G+V   F        A+KK+     
Sbjct: 3   MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 62
Query: 327 ---KSKEFFAELKVLCKIHHINV--FISTFGNGSLSDHLHDPLLKGH------------Q 369
               +K  + EL++L  + H NV   +  F      +  +D  L  H            Q
Sbjct: 63  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 122
Query: 370 PLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEER 429
            LT      +     +G++YIH    A  +HRD+K SN+ +++    K+ DFGL     R
Sbjct: 123 KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA----R 175
Query: 430 TNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
             + EM  T  V T  Y  PE +            +  +      D+++ G ++AEL+TG
Sbjct: 176 HTDDEM--TGYVATRWYRAPEIM------------LNWMHYNQTVDIWSVGCIMAELLTG 221
Query: 490 K 490
           +
Sbjct: 222 R 222

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 59/241 (24%), Positives = 97/241 (40%), Gaps = 45/241 (18%)
Query: 274 LESERTIIFSLE---EIEEATNNFDESRIIGRGGFGNV--YFGLLGDREAAIKKMRSN-- 326
           +  ER   +  E    I E    +     +G G +G+V   F        A+KK+     
Sbjct: 1   MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 60
Query: 327 ---KSKEFFAELKVLCKIHHINV--FISTFGNGSLSDHLHDPLLKGH------------Q 369
               +K  + EL++L  + H NV   +  F      +  +D  L  H            Q
Sbjct: 61  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 370 PLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEER 429
            LT      +     +G++YIH    A  +HRD+K SN+ +++    K+ DFGL     R
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA----R 173
Query: 430 TNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
             + EM  T  V T  Y  PE +            +  +      D+++ G ++AEL+TG
Sbjct: 174 HTDDEM--TGYVATRWYRAPEIM------------LNWMHYNQTVDIWSVGCIMAELLTG 219
Query: 490 K 490
           +
Sbjct: 220 R 220

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 60/241 (24%), Positives = 96/241 (39%), Gaps = 45/241 (18%)
Query: 274 LESERTIIFSLE---EIEEATNNFDESRIIGRGGFGNVYFGL---LGDREAAIKKMRSNK 327
           +  ER   +  E    I E    +     +G G +G+V        G R A  K  R  +
Sbjct: 1   MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQ 60
Query: 328 S----KEFFAELKVLCKIHHINV--FISTFGNGSLSDHLHDPLLKGH------------Q 369
           S    K  + EL++L  + H NV   +  F      +  +D  L  H            Q
Sbjct: 61  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 370 PLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEER 429
            LT      +     +G++YIH    A  +HRD+K SN+ +++    K+ DFGL     R
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA----R 173
Query: 430 TNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
             + EM     V T  Y  PE +            +  +      D+++ G ++AEL+TG
Sbjct: 174 HTDDEMAG--FVATRWYRAPEIM------------LNWMHYNQTVDIWSVGCIMAELLTG 219
Query: 490 K 490
           +
Sbjct: 220 R 220

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 59/241 (24%), Positives = 97/241 (40%), Gaps = 45/241 (18%)
Query: 274 LESERTIIFSLE---EIEEATNNFDESRIIGRGGFGNV--YFGLLGDREAAIKKMRSN-- 326
           +  ER   +  E    I E    +     +G G +G+V   F        A+KK+     
Sbjct: 1   MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 60
Query: 327 ---KSKEFFAELKVLCKIHHINV--FISTFGNGSLSDHLHDPLLKGH------------Q 369
               +K  + EL++L  + H NV   +  F      +  +D  L  H            Q
Sbjct: 61  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 370 PLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEER 429
            LT      +     +G++YIH    A  +HRD+K SN+ +++    K+ DFGL     R
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA----R 173
Query: 430 TNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
             + EM  T  V T  Y  PE +            +  +      D+++ G ++AEL+TG
Sbjct: 174 HTDDEM--TGXVATRWYRAPEIM------------LNWMHYNQTVDIWSVGCIMAELLTG 219
Query: 490 K 490
           +
Sbjct: 220 R 220

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 61/242 (25%), Positives = 102/242 (42%), Gaps = 54/242 (22%)
Query: 281 IFSLEEIEEATNNFDESRIIGRGGFGNVYFGLLG-------DREAAIKKMRSNKSK---- 329
           ++  +E E A      SR +G+G FG VY G+         +   AIK +    S     
Sbjct: 14  VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI 73
Query: 330 EFFAELKVLCKI--HHIN-------------VFISTFGNGSLSDHL--------HDPLLK 366
           EF  E  V+ +   HH+              V +     G L  +L        ++P+L 
Sbjct: 74  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 133
Query: 367 GHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKL 426
              P + +   Q+A + A G+ Y++ +   ++VHRD+   N ++ +    K+ DFG+ + 
Sbjct: 134 ---PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRD 187
Query: 427 EERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAEL 486
              T+          G  G LP         R+    S+ +   TT +DV++FGVVL E+
Sbjct: 188 IYETDYYRK------GGKGLLP--------VRWMSPESLKDGVFTTYSDVWSFGVVLWEI 233
Query: 487 IT 488
            T
Sbjct: 234 AT 235

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 59/241 (24%), Positives = 97/241 (40%), Gaps = 45/241 (18%)
Query: 274 LESERTIIFSLE---EIEEATNNFDESRIIGRGGFGNV--YFGLLGDREAAIKKMRSN-- 326
           +  ER   +  E    I E    +     +G G +G+V   F        A+KK+     
Sbjct: 7   MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 66
Query: 327 ---KSKEFFAELKVLCKIHHINV--FISTFGNGSLSDHLHDPLLKGH------------Q 369
               +K  + EL++L  + H NV   +  F      +  +D  L  H            Q
Sbjct: 67  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 126
Query: 370 PLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEER 429
            LT      +     +G++YIH    A  +HRD+K SN+ +++    K+ DFGL     R
Sbjct: 127 KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA----R 179
Query: 430 TNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
             + EM  T  V T  Y  PE +            +  +      D+++ G ++AEL+TG
Sbjct: 180 HTDDEM--TGYVATRWYRAPEIM------------LNWMHYNQTVDIWSVGCIMAELLTG 225
Query: 490 K 490
           +
Sbjct: 226 R 226

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 59/241 (24%), Positives = 97/241 (40%), Gaps = 45/241 (18%)
Query: 274 LESERTIIFSLE---EIEEATNNFDESRIIGRGGFGNV--YFGLLGDREAAIKKMRSN-- 326
           +  ER   +  E    I E    +     +G G +G+V   F        A+KK+     
Sbjct: 6   MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 65
Query: 327 ---KSKEFFAELKVLCKIHHINV--FISTFGNGSLSDHLHDPLLKGH------------Q 369
               +K  + EL++L  + H NV   +  F      +  +D  L  H            Q
Sbjct: 66  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 125
Query: 370 PLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEER 429
            LT      +     +G++YIH    A  +HRD+K SN+ +++    K+ DFGL     R
Sbjct: 126 KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA----R 178
Query: 430 TNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
             + EM  T  V T  Y  PE +            +  +      D+++ G ++AEL+TG
Sbjct: 179 HTDDEM--TGYVATRWYRAPEIM------------LNWMHYNQTVDIWSVGCIMAELLTG 224
Query: 490 K 490
           +
Sbjct: 225 R 225

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 59/241 (24%), Positives = 97/241 (40%), Gaps = 45/241 (18%)
Query: 274 LESERTIIFSLE---EIEEATNNFDESRIIGRGGFGNV--YFGLLGDREAAIKKMRSN-- 326
           +  ER   +  E    I E    +     +G G +G+V   F        A+KK+     
Sbjct: 1   MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 60
Query: 327 ---KSKEFFAELKVLCKIHHINV--FISTFGNGSLSDHLHDPLLKGH------------Q 369
               +K  + EL++L  + H NV   +  F      +  +D  L  H            Q
Sbjct: 61  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 370 PLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEER 429
            LT      +     +G++YIH    A  +HRD+K SN+ +++    K+ DFGL     R
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA----R 173
Query: 430 TNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
             + EM  T  V T  Y  PE +            +  +      D+++ G ++AEL+TG
Sbjct: 174 HTDDEM--TGYVATRWYRAPEIM------------LNWMHYNQTVDIWSVGCIMAELLTG 219
Query: 490 K 490
           +
Sbjct: 220 R 220

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 59/241 (24%), Positives = 97/241 (40%), Gaps = 45/241 (18%)
Query: 274 LESERTIIFSLE---EIEEATNNFDESRIIGRGGFGNV--YFGLLGDREAAIKKMRSN-- 326
           +  ER   +  E    I E    +     +G G +G+V   F        A+KK+     
Sbjct: 3   MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 62
Query: 327 ---KSKEFFAELKVLCKIHHINV--FISTFGNGSLSDHLHDPLLKGH------------Q 369
               +K  + EL++L  + H NV   +  F      +  +D  L  H            Q
Sbjct: 63  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 122
Query: 370 PLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEER 429
            LT      +     +G++YIH    A  +HRD+K SN+ +++    K+ DFGL     R
Sbjct: 123 KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA----R 175
Query: 430 TNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
             + EM  T  V T  Y  PE +            +  +      D+++ G ++AEL+TG
Sbjct: 176 HTDDEM--TGYVATRWYRAPEIM------------LNWMHYNQTVDIWSVGCIMAELLTG 221
Query: 490 K 490
           +
Sbjct: 222 R 222

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 59/241 (24%), Positives = 97/241 (40%), Gaps = 45/241 (18%)
Query: 274 LESERTIIFSLE---EIEEATNNFDESRIIGRGGFGNV--YFGLLGDREAAIKKMRSN-- 326
           +  ER   +  E    I E    +     +G G +G+V   F        A+KK+     
Sbjct: 1   MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 60
Query: 327 ---KSKEFFAELKVLCKIHHINV--FISTFGNGSLSDHLHDPLLKGH------------Q 369
               +K  + EL++L  + H NV   +  F      +  +D  L  H            Q
Sbjct: 61  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 370 PLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEER 429
            LT      +     +G++YIH    A  +HRD+K SN+ +++    K+ DFGL     R
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA----R 173
Query: 430 TNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
             + EM  T  V T  Y  PE +            +  +      D+++ G ++AEL+TG
Sbjct: 174 HTDDEM--TGYVATRWYRAPEIM------------LNWMHYNQTVDIWSVGCIMAELLTG 219
Query: 490 K 490
           +
Sbjct: 220 R 220

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 61/242 (25%), Positives = 102/242 (42%), Gaps = 54/242 (22%)
Query: 281 IFSLEEIEEATNNFDESRIIGRGGFGNVYFGLLG-------DREAAIKKMRSNKSK---- 329
           ++  +E E A      SR +G+G FG VY G+         +   AIK +    S     
Sbjct: 7   VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI 66
Query: 330 EFFAELKVLCKI--HHIN-------------VFISTFGNGSLSDHL--------HDPLLK 366
           EF  E  V+ +   HH+              V +     G L  +L        ++P+L 
Sbjct: 67  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 126
Query: 367 GHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKL 426
              P + +   Q+A + A G+ Y++ +   ++VHRD+   N ++ +    K+ DFG+ + 
Sbjct: 127 ---PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRD 180
Query: 427 EERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAEL 486
              T+          G  G LP         R+    S+ +   TT +DV++FGVVL E+
Sbjct: 181 IYETDYYRK------GGKGLLP--------VRWMSPESLKDGVFTTYSDVWSFGVVLWEI 226
Query: 487 IT 488
            T
Sbjct: 227 AT 228

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 59/241 (24%), Positives = 97/241 (40%), Gaps = 45/241 (18%)
Query: 274 LESERTIIFSLE---EIEEATNNFDESRIIGRGGFGNV--YFGLLGDREAAIKKMRSN-- 326
           +  ER   +  E    I E    +     +G G +G+V   F        A+KK+     
Sbjct: 13  MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 72
Query: 327 ---KSKEFFAELKVLCKIHHINV--FISTFGNGSLSDHLHDPLLKGH------------Q 369
               +K  + EL++L  + H NV   +  F      +  +D  L  H            Q
Sbjct: 73  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 132
Query: 370 PLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEER 429
            LT      +     +G++YIH    A  +HRD+K SN+ +++    K+ DFGL     R
Sbjct: 133 KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA----R 185
Query: 430 TNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
             + EM  T  V T  Y  PE +            +  +      D+++ G ++AEL+TG
Sbjct: 186 HTDDEM--TGYVATRWYRAPEIM------------LNWMHYNQTVDIWSVGCIMAELLTG 231
Query: 490 K 490
           +
Sbjct: 232 R 232

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 59/241 (24%), Positives = 97/241 (40%), Gaps = 45/241 (18%)
Query: 274 LESERTIIFSLE---EIEEATNNFDESRIIGRGGFGNV--YFGLLGDREAAIKKMRSN-- 326
           +  ER   +  E    I E    +     +G G +G+V   F        A+KK+     
Sbjct: 13  MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 72
Query: 327 ---KSKEFFAELKVLCKIHHINV--FISTFGNGSLSDHLHDPLLKGH------------Q 369
               +K  + EL++L  + H NV   +  F      +  +D  L  H            Q
Sbjct: 73  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 132
Query: 370 PLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEER 429
            LT      +     +G++YIH    A  +HRD+K SN+ +++    K+ DFGL     R
Sbjct: 133 KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA----R 185
Query: 430 TNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
             + EM  T  V T  Y  PE +            +  +      D+++ G ++AEL+TG
Sbjct: 186 HTDDEM--TGYVATRWYRAPEIM------------LNWMHYNQTVDIWSVGCIMAELLTG 231
Query: 490 K 490
           +
Sbjct: 232 R 232

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 95/226 (42%), Gaps = 53/226 (23%)
Query: 290 ATNNFDESRIIGRGGFGNVYFGLLGDREA----AIKKM------RSNKSKEFFAELKVLC 339
           A  +F+  R +G+G FGNVY  L  ++++    A+K +      ++    +   E+++  
Sbjct: 9   ALEDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 340 KIHHINVFISTFGNGSLSDHLHDP----LLKGHQPLTWTARTQIAL---DAAKGIEYIHD 392
            + H N+         L  + HD     L+  + PL    R    L   D  +   YI +
Sbjct: 67  HLRHPNIL-------RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 119
Query: 393 --------HTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP 444
                   H+K R +HRDIK  N+LL      K+ADFG        +        L GT 
Sbjct: 120 LANALSYCHSK-RVIHRDIKPENLLLGSAGELKIADFGWS-----VHAPSSRRAALCGTL 173
Query: 445 GYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
            YLPPE I  +     MH          K D+++ GV+  E + GK
Sbjct: 174 DYLPPEMIEGR-----MHDE--------KVDLWSLGVLCYEFLVGK 206

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 59/241 (24%), Positives = 97/241 (40%), Gaps = 45/241 (18%)
Query: 274 LESERTIIFSLE---EIEEATNNFDESRIIGRGGFGNV--YFGLLGDREAAIKKMRSN-- 326
           +  ER   +  E    I E    +     +G G +G+V   F        A+KK+     
Sbjct: 1   MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 60
Query: 327 ---KSKEFFAELKVLCKIHHINV--FISTFGNGSLSDHLHDPLLKGH------------Q 369
               +K  + EL++L  + H NV   +  F      +  +D  L  H            Q
Sbjct: 61  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 370 PLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEER 429
            LT      +     +G++YIH    A  +HRD+K SN+ +++    K+ DFGL     R
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA----R 173
Query: 430 TNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
             + EM  T  V T  Y  PE +            +  +      D+++ G ++AEL+TG
Sbjct: 174 HTDDEM--TGYVATRWYRAPEIM------------LNWMHYNQTVDIWSVGCIMAELLTG 219
Query: 490 K 490
           +
Sbjct: 220 R 220

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 59/241 (24%), Positives = 97/241 (40%), Gaps = 45/241 (18%)
Query: 274 LESERTIIFSLE---EIEEATNNFDESRIIGRGGFGNV--YFGLLGDREAAIKKMRSN-- 326
           +  ER   +  E    I E    +     +G G +G+V   F        A+KK+     
Sbjct: 1   MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 60
Query: 327 ---KSKEFFAELKVLCKIHHINV--FISTFGNGSLSDHLHDPLLKGH------------Q 369
               +K  + EL++L  + H NV   +  F      +  +D  L  H            Q
Sbjct: 61  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 370 PLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEER 429
            LT      +     +G++YIH    A  +HRD+K SN+ +++    K+ DFGL     R
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA----R 173
Query: 430 TNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
             + EM  T  V T  Y  PE +            +  +      D+++ G ++AEL+TG
Sbjct: 174 HTDDEM--TGYVATRWYRAPEIM------------LNWMHYNQTVDIWSVGCIMAELLTG 219
Query: 490 K 490
           +
Sbjct: 220 R 220

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 61/242 (25%), Positives = 102/242 (42%), Gaps = 54/242 (22%)
Query: 281 IFSLEEIEEATNNFDESRIIGRGGFGNVYFGLLG-------DREAAIKKMRSNKSK---- 329
           ++  +E E A      SR +G+G FG VY G+         +   AIK +    S     
Sbjct: 8   VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI 67
Query: 330 EFFAELKVLCKI--HHIN-------------VFISTFGNGSLSDHL--------HDPLLK 366
           EF  E  V+ +   HH+              V +     G L  +L        ++P+L 
Sbjct: 68  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 127
Query: 367 GHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKL 426
              P + +   Q+A + A G+ Y++ +   ++VHRD+   N ++ +    K+ DFG+ + 
Sbjct: 128 ---PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRD 181
Query: 427 EERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAEL 486
              T+          G  G LP         R+    S+ +   TT +DV++FGVVL E+
Sbjct: 182 IYETDYYRK------GGKGLLP--------VRWMSPESLKDGVFTTYSDVWSFGVVLWEI 227
Query: 487 IT 488
            T
Sbjct: 228 AT 229

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 51/234 (21%), Positives = 99/234 (42%), Gaps = 50/234 (21%)
Query: 291 TNNFDESRIIGRGGFGNVYFG--LLGDREAAIKKMRSNKSKE------FFAELKVLCKIH 342
           ++ ++   I+G GG   V+    L   R+ A+K +R++ +++      F  E +    ++
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 343 HINVFISTFGNG--------------------SLSDHLHDPLLKGHQPLTWTARTQIALD 382
           H  + ++ +  G                    +L D +H        P+T     ++  D
Sbjct: 71  HPAI-VAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT-----EGPMTPKRAIEVIAD 124
Query: 383 AAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVG 442
           A + + + H +     +HRD+K +NI++      KV DFG+ +    +         ++G
Sbjct: 125 ACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIG 181
Query: 443 TPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRD 496
           T  YL PE     + R D         V  ++DV++ G VL E++TG+     D
Sbjct: 182 TAQYLSPE-----QARGD--------SVDARSDVYSLGCVLYEVLTGEPPFTGD 222

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 59/241 (24%), Positives = 97/241 (40%), Gaps = 45/241 (18%)
Query: 274 LESERTIIFSLE---EIEEATNNFDESRIIGRGGFGNV--YFGLLGDREAAIKKMRSN-- 326
           +  ER   +  E    I E    +     +G G +G+V   F        A+KK+     
Sbjct: 12  MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 71
Query: 327 ---KSKEFFAELKVLCKIHHINV--FISTFGNGSLSDHLHDPLLKGH------------Q 369
               +K  + EL++L  + H NV   +  F      +  +D  L  H            Q
Sbjct: 72  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 131
Query: 370 PLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEER 429
            LT      +     +G++YIH    A  +HRD+K SN+ +++    K+ DFGL     R
Sbjct: 132 KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLA----R 184
Query: 430 TNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
             + EM  T  V T  Y  PE +            +  +      D+++ G ++AEL+TG
Sbjct: 185 HTDDEM--TGYVATRWYRAPEIM------------LNWMHYNQTVDIWSVGCIMAELLTG 230
Query: 490 K 490
           +
Sbjct: 231 R 231

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 59/241 (24%), Positives = 97/241 (40%), Gaps = 45/241 (18%)
Query: 274 LESERTIIFSLE---EIEEATNNFDESRIIGRGGFGNV--YFGLLGDREAAIKKMRSN-- 326
           +  ER   +  E    I E    +     +G G +G+V   F        A+KK+     
Sbjct: 24  MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 83
Query: 327 ---KSKEFFAELKVLCKIHHINV--FISTFGNGSLSDHLHDPLLKGH------------Q 369
               +K  + EL++L  + H NV   +  F      +  +D  L  H            Q
Sbjct: 84  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 143
Query: 370 PLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEER 429
            LT      +     +G++YIH    A  +HRD+K SN+ +++    K+ DFGL     R
Sbjct: 144 KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA----R 196
Query: 430 TNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
             + EM  T  V T  Y  PE +            +  +      D+++ G ++AEL+TG
Sbjct: 197 HTDDEM--TGYVATRWYRAPEIM------------LNWMHYNQTVDIWSVGCIMAELLTG 242
Query: 490 K 490
           +
Sbjct: 243 R 243

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 94/218 (43%), Gaps = 44/218 (20%)
Query: 293 NFDESRIIGRGGFGNVYFG--LLGDREAAIK-----KMRSNKSKEFFAELKVLCKIHHIN 345
           N+   + IG+G F  V     +L  RE AIK     ++     ++ F E++++  ++H N
Sbjct: 16  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75
Query: 346 V--------------FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIH 391
           +               I  + +G     + D L+   +     AR++        ++Y H
Sbjct: 76  IVKLFEVIETEKTLYLIMEYASGG---EVFDYLVAHGRMKEKEARSKFR-QIVSAVQYCH 131
Query: 392 DHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEY 451
              + R VHRD+K  N+LLD  +  K+ADFG     E T   ++ A    G P Y  PE 
Sbjct: 132 ---QKRIVHRDLKAENLLLDADMNIKIADFGFSN--EFTVGGKLDA--FCGAPPYAAPEL 184
Query: 452 IFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
              K++               + DV++ GV+L  L++G
Sbjct: 185 FQGKKYD------------GPEVDVWSLGVILYTLVSG 210

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 92/224 (41%), Gaps = 49/224 (21%)
Query: 290 ATNNFDESRIIGRGGFGNVYFGLLGDRE--AAIKKM------RSNKSKEFFAELKVLCKI 341
           A  +F+  R +G+G FGNVY       +   A+K +      ++    +   E+++   +
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 342 HHINVFISTFGNGSLSDHLHDP----LLKGHQPLTWTARTQIAL---DAAKGIEYIHD-- 392
            H N+         L  + HD     L+  + PL    R    L   D  +   YI +  
Sbjct: 68  RHPNIL-------RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 120
Query: 393 ------HTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGY 446
                 H+K R +HRDIK  N+LL      K+A+FG        +      T L GT  Y
Sbjct: 121 NALSYCHSK-RVIHRDIKPENLLLGSAGELKIANFGWS-----VHAPSSRRTTLCGTLDY 174
Query: 447 LPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
           LPPE I  +     MH          K D+++ GV+  E + GK
Sbjct: 175 LPPEMIEGR-----MHDE--------KVDLWSLGVLCYEFLVGK 205

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 59/241 (24%), Positives = 97/241 (40%), Gaps = 45/241 (18%)
Query: 274 LESERTIIFSLE---EIEEATNNFDESRIIGRGGFGNV--YFGLLGDREAAIKKMRSN-- 326
           +  ER   +  E    I E    +     +G G +G+V   F        A+KK+     
Sbjct: 12  MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 71
Query: 327 ---KSKEFFAELKVLCKIHHINV--FISTFGNGSLSDHLHDPLLKGH------------Q 369
               +K  + EL++L  + H NV   +  F      +  +D  L  H            Q
Sbjct: 72  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 131
Query: 370 PLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEER 429
            LT      +     +G++YIH    A  +HRD+K SN+ +++    K+ DFGL     R
Sbjct: 132 KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA----R 184
Query: 430 TNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
             + EM  T  V T  Y  PE +            +  +      D+++ G ++AEL+TG
Sbjct: 185 HTDDEM--TGYVATRWYRAPEIM------------LNWMHYNQTVDIWSVGCIMAELLTG 230
Query: 490 K 490
           +
Sbjct: 231 R 231

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 61/241 (25%), Positives = 99/241 (41%), Gaps = 45/241 (18%)
Query: 274 LESERTIIFSLE---EIEEATNNFDESRIIGRGGFGNV--YFGLLGDREAAIKKM-RSNK 327
           +  ER   +  E    I E    +     +G G +G+V   F        A+KK+ R  +
Sbjct: 1   MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 60
Query: 328 S----KEFFAELKVLCKIHHINV--FISTFGNGSLSDHLHDPLLKGH------------Q 369
           S    K  + EL++L  + H NV   +  F      +  +D  L  H            Q
Sbjct: 61  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQ 120
Query: 370 PLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEER 429
            LT      +     +G++YIH    A  +HRD+K SN+ +++    K+ DFGL     R
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLA----R 173
Query: 430 TNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
             + EM  T  V T  Y  PE +            +  +      D+++ G ++AEL+TG
Sbjct: 174 HTDDEM--TGYVATRWYRAPEIM------------LNWMHYNQTVDIWSVGCIMAELLTG 219
Query: 490 K 490
           +
Sbjct: 220 R 220

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 94/225 (41%), Gaps = 40/225 (17%)
Query: 283 SLEEIEEATNNFDESRIIGRGGFGNVYFGLLGDRE--AAIKKMRSN--KSKEFFAELKVL 338
           SL++ E    +      +G G +G VY G+        A+K ++ +  + +EF  E  V+
Sbjct: 2   SLDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVM 61
Query: 339 CKIHHIN---------------VFISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDA 383
            +I H N               + I     G+L D+L +      Q ++      +A   
Sbjct: 62  KEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLREC---NRQEVSAVVLLYMATQI 118
Query: 384 AKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGT 443
           +  +EY+    K  ++HRD+   N L+ +    KVADFGL +L        M        
Sbjct: 119 SSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRL--------MTGDTXTAH 167
Query: 444 PGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
            G   P        ++    S+   + + K+DV+AFGV+L E+ T
Sbjct: 168 AGAKFP-------IKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 205

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 92/224 (41%), Gaps = 49/224 (21%)
Query: 290 ATNNFDESRIIGRGGFGNVYFGLLGDRE--AAIKKM------RSNKSKEFFAELKVLCKI 341
           A  +F+  R +G+G FGNVY       +   A+K +      ++    +   E+++   +
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 342 HHINVFISTFGNGSLSDHLHDP----LLKGHQPLTWTARTQIAL---DAAKGIEYIHD-- 392
            H N+         L  + HD     L+  + PL    R    L   D  +   YI +  
Sbjct: 92  RHPNIL-------RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 144
Query: 393 ------HTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGY 446
                 H+K R +HRDIK  N+LL      K+ADFG       +   +     L GT  Y
Sbjct: 145 NALSYCHSK-RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDD-----LCGTLDY 198
Query: 447 LPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
           LPPE I  +     MH          K D+++ GV+  E + GK
Sbjct: 199 LPPEMIEGR-----MHDE--------KVDLWSLGVLCYEFLVGK 229

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 59/241 (24%), Positives = 97/241 (40%), Gaps = 45/241 (18%)
Query: 274 LESERTIIFSLE---EIEEATNNFDESRIIGRGGFGNV--YFGLLGDREAAIKKMRSN-- 326
           +  ER   +  E    I E    +     +G G +G+V   F        A+KK+     
Sbjct: 1   MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 60
Query: 327 ---KSKEFFAELKVLCKIHHINV--FISTFGNGSLSDHLHDPLLKGH------------Q 369
               +K  + EL++L  + H NV   +  F      +  +D  L  H            Q
Sbjct: 61  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQ 120
Query: 370 PLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEER 429
            LT      +     +G++YIH    A  +HRD+K SN+ +++    K+ DFGL     R
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA----R 173
Query: 430 TNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
             + EM  T  V T  Y  PE +            +  +      D+++ G ++AEL+TG
Sbjct: 174 HTDDEM--TGYVATRWYRAPEIM------------LNWMHYNQTVDIWSVGCIMAELLTG 219
Query: 490 K 490
           +
Sbjct: 220 R 220

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 92/225 (40%), Gaps = 42/225 (18%)
Query: 287 IEEATNNFDESRIIGRGGFGNV--YFGLLGDREAAIKKMRSN-----KSKEFFAELKVLC 339
           I E    +     +G G +G+V   F        A+KK+         +K  + EL++L 
Sbjct: 24  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 83
Query: 340 KIHHINV--FISTFGNGSLSDHLHDPLLKGH------------QPLTWTARTQIALDAAK 385
            + H NV   +  F      +  +D  L  H            Q LT      +     +
Sbjct: 84  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 143
Query: 386 GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPG 445
           G++YIH    A  +HRD+K SN+ +++    K+ DFGL     R  + EM  T  V T  
Sbjct: 144 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA----RHTDDEM--TGYVATRW 194
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
           Y  PE +            +  +      D+++ G ++AEL+TG+
Sbjct: 195 YRAPEIM------------LNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 90/215 (41%), Gaps = 38/215 (17%)
Query: 300 IGRGGFGNVYFGL--LGDREAAIKKMRS-----NKSKEFFAELKVLCKIHHINV------ 346
           IG G +G V      L  ++ AIKK+ +       +K    ELK+L    H N+      
Sbjct: 62  IGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDI 121
Query: 347 ---------FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKAR 397
                    F S +    L +     ++   QPLT            +G++Y+H    A+
Sbjct: 122 LRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMH---SAQ 178
Query: 398 YVHRDIKTSNILLDDGLRAKVADFGLVK-LEERTNEKEMLATRLVGTPGYLPPEYIFVKR 456
            +HRD+K SN+L+++    K+ DFG+ + L     E +   T  V T  Y  PE +    
Sbjct: 179 VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELM---- 234
Query: 457 FRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKR 491
               +H      + T   D+++ G +  E++  ++
Sbjct: 235 --LSLH------EYTQAIDLWSVGCIFGEMLARRQ 261

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 60/241 (24%), Positives = 96/241 (39%), Gaps = 45/241 (18%)
Query: 274 LESERTIIFSLE---EIEEATNNFDESRIIGRGGFGNVYFGL---LGDREAAIKKMRSNK 327
           +  ER   +  E    I E    +     +G G +G+V        G R A  K  R  +
Sbjct: 21  MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQ 80
Query: 328 S----KEFFAELKVLCKIHHINV--FISTFGNGSLSDHLHDPLLKGH------------Q 369
           S    K  + EL++L  + H NV   +  F      +  +D  L  H            Q
Sbjct: 81  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 140
Query: 370 PLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEER 429
            LT      +     +G++YIH    A  +HRD+K SN+ +++    K+ DFGL     R
Sbjct: 141 KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA----R 193
Query: 430 TNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
             + EM     V T  Y  PE +            +  +      D+++ G ++AEL+TG
Sbjct: 194 HTDDEMXGX--VATRWYRAPEIM------------LNWMHYNQTVDIWSVGCIMAELLTG 239
Query: 490 K 490
           +
Sbjct: 240 R 240

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 59/241 (24%), Positives = 97/241 (40%), Gaps = 45/241 (18%)
Query: 274 LESERTIIFSLE---EIEEATNNFDESRIIGRGGFGNV--YFGLLGDREAAIKKMRSN-- 326
           +  ER   +  E    I E    +     +G G +G+V   F        A+KK+     
Sbjct: 20  MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 79
Query: 327 ---KSKEFFAELKVLCKIHHINV--FISTFGNGSLSDHLHDPLLKGH------------Q 369
               +K  + EL++L  + H NV   +  F      +  +D  L  H            Q
Sbjct: 80  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 139
Query: 370 PLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEER 429
            LT      +     +G++YIH    A  +HRD+K SN+ +++    K+ DFGL     R
Sbjct: 140 KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA----R 192
Query: 430 TNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
             + EM  T  V T  Y  PE +            +  +      D+++ G ++AEL+TG
Sbjct: 193 HTDDEM--TGYVATRWYRAPEIM------------LNWMHYNQTVDIWSVGCIMAELLTG 238
Query: 490 K 490
           +
Sbjct: 239 R 239

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 92/225 (40%), Gaps = 42/225 (18%)
Query: 287 IEEATNNFDESRIIGRGGFGNV--YFGLLGDREAAIKKMRSN-----KSKEFFAELKVLC 339
           I E    +     +G G +G+V   F        A+KK+         +K  + EL++L 
Sbjct: 22  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 81
Query: 340 KIHHINV--FISTFGNGSLSDHLHDPLLKGH------------QPLTWTARTQIALDAAK 385
            + H NV   +  F      +  +D  L  H            Q LT      +     +
Sbjct: 82  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 141
Query: 386 GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPG 445
           G++YIH    A  +HRD+K SN+ +++    K+ DFGL     R  + EM  T  V T  
Sbjct: 142 GLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLA----RHTDDEM--TGYVATRW 192
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
           Y  PE +            +  +      D+++ G ++AEL+TG+
Sbjct: 193 YRAPEIM------------LNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 40/121 (33%), Positives = 58/121 (47%), Gaps = 20/121 (16%)
Query: 386 GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPG 445
           G++Y H H     VHRD+K  N+LLD  + AK+ADFGL  +    ++ E L     G+P 
Sbjct: 128 GVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNM---MSDGEFLRXS-CGSPN 180
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKMKS 505
           Y  PE I  +            L    + D+++ GV+L  L+ G      DD  PT  K 
Sbjct: 181 YAAPEVISGR------------LYAGPEVDIWSSGVILYALLCGTLPF-DDDHVPTLFKK 227
Query: 506 L 506
           +
Sbjct: 228 I 228

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 59/241 (24%), Positives = 97/241 (40%), Gaps = 45/241 (18%)
Query: 274 LESERTIIFSLE---EIEEATNNFDESRIIGRGGFGNV--YFGLLGDREAAIKKMRSN-- 326
           +  ER   +  E    I E    +     +G G +G+V   F        A+KK+     
Sbjct: 21  MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 80
Query: 327 ---KSKEFFAELKVLCKIHHINV--FISTFGNGSLSDHLHDPLLKGH------------Q 369
               +K  + EL++L  + H NV   +  F      +  +D  L  H            Q
Sbjct: 81  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 140
Query: 370 PLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEER 429
            LT      +     +G++YIH    A  +HRD+K SN+ +++    K+ DFGL     R
Sbjct: 141 KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA----R 193
Query: 430 TNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
             + EM  T  V T  Y  PE +            +  +      D+++ G ++AEL+TG
Sbjct: 194 HTDDEM--TGYVATRWYRAPEIM------------LNWMHYNQTVDIWSVGCIMAELLTG 239
Query: 490 K 490
           +
Sbjct: 240 R 240

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 94/220 (42%), Gaps = 48/220 (21%)
Query: 293 NFDESRIIGRGGFGNVYFG--LLGDREAAIK-----KMRSNKSKEFFAELKVLCKIHHIN 345
           N+   + IG+G F  V     +L  RE AIK     ++     ++ F E++++  ++H N
Sbjct: 13  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 72
Query: 346 V--------------FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIH 391
           +               I  + +G     + D L+   +     AR++        ++Y H
Sbjct: 73  IVKLFEVIETEKTLYLIMEYASGG---EVFDYLVAHGRMKEKEARSKFR-QIVSAVQYCH 128
Query: 392 DHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLAT--RLVGTPGYLPP 449
              + R VHRD+K  N+LLD  +  K+ADFG       +NE  +        G+P Y  P
Sbjct: 129 ---QKRIVHRDLKAENLLLDADMNIKIADFGF------SNEFTVGGKLDTFCGSPPYAAP 179
Query: 450 EYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
           E    K++               + DV++ GV+L  L++G
Sbjct: 180 ELFQGKKYD------------GPEVDVWSLGVILYTLVSG 207

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 91/224 (40%), Gaps = 49/224 (21%)
Query: 290 ATNNFDESRIIGRGGFGNVYFGLLGDRE--AAIKKM------RSNKSKEFFAELKVLCKI 341
           A  +F+  R +G+G FGNVY       +   A+K +      ++    +   E+++   +
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 342 HHINVFISTFGNGSLSDHLHDP----LLKGHQPLTWTARTQIAL---DAAKGIEYIHD-- 392
            H N+         L  + HD     L+  + PL    R    L   D  +   YI +  
Sbjct: 68  RHPNIL-------RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 120
Query: 393 ------HTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGY 446
                 H+K R +HRDIK  N+LL      K+ADFG        +        L GT  Y
Sbjct: 121 NALSYCHSK-RVIHRDIKPENLLLGSAGELKIADFGWS-----VHAPSSRRXXLCGTLDY 174
Query: 447 LPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
           LPPE I  +     MH          K D+++ GV+  E + GK
Sbjct: 175 LPPEMIEGR-----MHDE--------KVDLWSLGVLCYEFLVGK 205

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 92/225 (40%), Gaps = 42/225 (18%)
Query: 287 IEEATNNFDESRIIGRGGFGNV--YFGLLGDREAAIKKMRSN-----KSKEFFAELKVLC 339
           I E    +     +G G +G+V   F        A+KK+         +K  + EL++L 
Sbjct: 14  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 73
Query: 340 KIHHINV--FISTFGNGSLSDHLHDPLLKGH------------QPLTWTARTQIALDAAK 385
            + H NV   +  F      +  +D  L  H            Q LT      +     +
Sbjct: 74  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 133
Query: 386 GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPG 445
           G++YIH    A  +HRD+K SN+ +++    K+ DFGL     R  + EM  T  V T  
Sbjct: 134 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA----RHTDDEM--TGYVATRW 184
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
           Y  PE +            +  +      D+++ G ++AEL+TG+
Sbjct: 185 YRAPEIM------------LNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 51/237 (21%), Positives = 100/237 (42%), Gaps = 50/237 (21%)
Query: 291 TNNFDESRIIGRGGFGNVYFG--LLGDREAAIKKMRSNKSKE------FFAELKVLCKIH 342
           ++ ++   I+G GG   V+    L   R+ A+K +R++ +++      F  E +    ++
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 343 HINVFISTFGNG--------------------SLSDHLHDPLLKGHQPLTWTARTQIALD 382
           H  + ++ +  G                    +L D +H        P+T     ++  D
Sbjct: 71  HPAI-VAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT-----EGPMTPKRAIEVIAD 124
Query: 383 AAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVG 442
           A + + + H +     +HRD+K +NI++      KV DFG+ +    +         ++G
Sbjct: 125 ACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIG 181
Query: 443 TPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE 499
           T  YL PE     + R D         V  ++DV++ G VL E++TG+     D  +
Sbjct: 182 TAQYLSPE-----QARGD--------SVDARSDVYSLGCVLYEVLTGEPPFTGDSPD 225

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 101/230 (43%), Gaps = 62/230 (26%)
Query: 300 IGRGGFGNVYFGLLGD--REAAIKKMR---SNKSKEFFA-ELKVLCKIHHINVF------ 347
           +G GGFG V   +  D   + AIK+ R   S K++E +  E++++ K++H NV       
Sbjct: 23  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 82
Query: 348 ---------------ISTFGNGSLSDHLHD-----PLLKGHQPLTWTARTQIALDAAKGI 387
                          +     G L  +L+       L +G  P+    RT ++ D +  +
Sbjct: 83  DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEG--PI----RTLLS-DISSAL 135
Query: 388 EYIHDHTKARYVHRDIKTSNILLDDG---LRAKVADFGLVKLEERTNEKEMLATRLVGTP 444
            Y+H++   R +HRD+K  NI+L  G   L  K+ D G  K  ++      L T  VGT 
Sbjct: 136 RYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE----LCTEFVGTL 188
Query: 445 GYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALI 494
            YL PE +  K++             T   D ++FG +  E ITG R  +
Sbjct: 189 QYLAPELLEQKKY-------------TVTVDYWSFGTLAFECITGFRPFL 225

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 92/225 (40%), Gaps = 42/225 (18%)
Query: 287 IEEATNNFDESRIIGRGGFGNV--YFGLLGDREAAIKKMRSN-----KSKEFFAELKVLC 339
           I E    +     +G G +G+V   F        A+KK+         +K  + EL++L 
Sbjct: 22  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 81
Query: 340 KIHHINV--FISTFGNGSLSDHLHDPLLKGH------------QPLTWTARTQIALDAAK 385
            + H NV   +  F      +  +D  L  H            Q LT      +     +
Sbjct: 82  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 141
Query: 386 GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPG 445
           G++YIH    A  +HRD+K SN+ +++    K+ DFGL     R  + EM  T  V T  
Sbjct: 142 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA----RHTDDEM--TGYVATRW 192
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
           Y  PE +            +  +      D+++ G ++AEL+TG+
Sbjct: 193 YRAPEIM------------LNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 92/225 (40%), Gaps = 42/225 (18%)
Query: 287 IEEATNNFDESRIIGRGGFGNV--YFGLLGDREAAIKKMRSN-----KSKEFFAELKVLC 339
           I E    +     +G G +G+V   F        A+KK+         +K  + EL++L 
Sbjct: 16  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 75
Query: 340 KIHHINV--FISTFGNGSLSDHLHDPLLKGH------------QPLTWTARTQIALDAAK 385
            + H NV   +  F      +  +D  L  H            Q LT      +     +
Sbjct: 76  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 135
Query: 386 GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPG 445
           G++YIH    A  +HRD+K SN+ +++    K+ DFGL     R  + EM  T  V T  
Sbjct: 136 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA----RHTDDEM--TGYVATRW 186
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
           Y  PE +            +  +      D+++ G ++AEL+TG+
Sbjct: 187 YRAPEIM------------LNWMHYNQTVDIWSVGCIMAELLTGR 219

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 62/279 (22%), Positives = 110/279 (39%), Gaps = 56/279 (20%)
Query: 287 IEEATNNFDESRIIGRGGFGNVYFG--LLGDREAAIKKM------RSNKSKEFFAELKVL 338
           I E   +F    ++G+G F  VY    +    E AIK +      ++   +    E+K+ 
Sbjct: 6   IGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIH 65
Query: 339 CKIHH---------------INVFISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDA 383
           C++ H               + + +    NG ++ +L + +    +P +           
Sbjct: 66  CQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRV----KPFSENEARHFMHQI 121
Query: 384 AKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGT 443
             G+ Y+H H     +HRD+  SN+LL   +  K+ADFGL    +  +EK      L GT
Sbjct: 122 ITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHY---TLCGT 175
Query: 444 PGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPT-- 501
           P Y+ PE     R    + S           DV++ G +   L+ G+     D  + T  
Sbjct: 176 PNYISPE--IATRSAHGLES-----------DVWSLGCMFYTLLIGRPPFDTDTVKNTLN 222
Query: 502 -------KMKSLITIMAA-VAEWCLNEDAVDRPEMRDIV 532
                  +M S ++I A  +    L  +  DR  +  ++
Sbjct: 223 KVVLADYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVL 261

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 96/226 (42%), Gaps = 53/226 (23%)
Query: 290 ATNNFDESRIIGRGGFGNVYFGLLGDREA----AIKKM------RSNKSKEFFAELKVLC 339
           A  +F+  R +G+G FGNVY  L  ++++    A+K +      ++    +   E+++  
Sbjct: 9   ALEDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 340 KIHHINVFISTFGNGSLSDHLHDP----LLKGHQPLTWTARTQIAL---DAAKGIEYIHD 392
            + H N+         L  + HD     L+  + PL    R    L   D  +   YI +
Sbjct: 67  HLRHPNIL-------RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 119
Query: 393 --------HTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP 444
                   H+K R +HRDIK  N+LL      K+A+FG        +      T L GT 
Sbjct: 120 LANALSYCHSK-RVIHRDIKPENLLLGSAGELKIANFGWS-----VHAPSSRRTTLCGTL 173
Query: 445 GYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
            YLPPE I  +     MH          K D+++ GV+  E + GK
Sbjct: 174 DYLPPEMIEGR-----MHDE--------KVDLWSLGVLCYEFLVGK 206

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 59/241 (24%), Positives = 97/241 (40%), Gaps = 45/241 (18%)
Query: 274 LESERTIIFSLE---EIEEATNNFDESRIIGRGGFGNV--YFGLLGDREAAIKKMRSN-- 326
           +  ER   +  E    I E    +     +G G +G+V   F        A+KK+     
Sbjct: 3   MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 62
Query: 327 ---KSKEFFAELKVLCKIHHINV--FISTFGNGSLSDHLHDPLLKGH------------Q 369
               +K  + EL++L  + H NV   +  F      +  +D  L  H            Q
Sbjct: 63  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 122
Query: 370 PLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEER 429
            LT      +     +G++YIH    A  +HRD+K SN+ +++    K+ DFGL     R
Sbjct: 123 KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDSELKILDFGLA----R 175
Query: 430 TNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
             + EM  T  V T  Y  PE +            +  +      D+++ G ++AEL+TG
Sbjct: 176 HTDDEM--TGYVATRWYRAPEIM------------LNWMHYNQTVDIWSVGCIMAELLTG 221
Query: 490 K 490
           +
Sbjct: 222 R 222

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 96/227 (42%), Gaps = 55/227 (24%)
Query: 290 ATNNFDESRIIGRGGFGNVYFGLLGDREA----AIKKM------RSNKSKEFFAELKVLC 339
           A  +F+  R +G+G FGNVY  L  ++++    A+K +      ++    +   E+++  
Sbjct: 11  ALEDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 68
Query: 340 KIHHINVFISTFGNGSLSDHLHDPLLKGHQPLTWTARTQI--------ALDAAKGIEYIH 391
            + H N+         L  + HD   + +  L +  R ++          D  +   YI 
Sbjct: 69  HLRHPNIL-------RLYGYFHDAT-RVYLILEYAPRGEVYKELQKLSKFDEQRTATYIT 120
Query: 392 D--------HTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGT 443
           +        H+K R +HRDIK  N+LL      K+ADFG        +      T L GT
Sbjct: 121 ELANALSYCHSK-RVIHRDIKPENLLLGSAGELKIADFGWS-----VHAPSSRRTTLCGT 174
Query: 444 PGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
             YLPPE I  +     MH          K D+++ GV+  E + GK
Sbjct: 175 LDYLPPEMIEGR-----MHDE--------KVDLWSLGVLCYEFLVGK 208

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 92/225 (40%), Gaps = 42/225 (18%)
Query: 287 IEEATNNFDESRIIGRGGFGNV--YFGLLGDREAAIKKMRSN-----KSKEFFAELKVLC 339
           I E    +     +G G +G+V   F        A+KK+         +K  + EL++L 
Sbjct: 19  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 78
Query: 340 KIHHINV--FISTFGNGSLSDHLHDPLLKGH------------QPLTWTARTQIALDAAK 385
            + H NV   +  F      +  +D  L  H            Q LT      +     +
Sbjct: 79  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 138
Query: 386 GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPG 445
           G++YIH    A  +HRD+K SN+ +++    K+ DFGL     R  + EM  T  V T  
Sbjct: 139 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA----RHTDDEM--TGYVATRW 189
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
           Y  PE +            +  +      D+++ G ++AEL+TG+
Sbjct: 190 YRAPEIM------------LNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 92/225 (40%), Gaps = 42/225 (18%)
Query: 287 IEEATNNFDESRIIGRGGFGNV--YFGLLGDREAAIKKMRSN-----KSKEFFAELKVLC 339
           I E    +     +G G +G+V   F        A+KK+         +K  + EL++L 
Sbjct: 13  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 72
Query: 340 KIHHINV--FISTFGNGSLSDHLHDPLLKGH------------QPLTWTARTQIALDAAK 385
            + H NV   +  F      +  +D  L  H            Q LT      +     +
Sbjct: 73  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 132
Query: 386 GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPG 445
           G++YIH    A  +HRD+K SN+ +++    K+ DFGL     R  + EM  T  V T  
Sbjct: 133 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA----RHTDDEM--TGYVATRW 183
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
           Y  PE +            +  +      D+++ G ++AEL+TG+
Sbjct: 184 YRAPEIM------------LNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 101/230 (43%), Gaps = 62/230 (26%)
Query: 300 IGRGGFGNVYFGLLGD--REAAIKKMR---SNKSKEFFA-ELKVLCKIHHINVF------ 347
           +G GGFG V   +  D   + AIK+ R   S K++E +  E++++ K++H NV       
Sbjct: 22  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 81
Query: 348 ---------------ISTFGNGSLSDHLHD-----PLLKGHQPLTWTARTQIALDAAKGI 387
                          +     G L  +L+       L +G  P+    RT ++ D +  +
Sbjct: 82  DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEG--PI----RTLLS-DISSAL 134
Query: 388 EYIHDHTKARYVHRDIKTSNILLDDG---LRAKVADFGLVKLEERTNEKEMLATRLVGTP 444
            Y+H++   R +HRD+K  NI+L  G   L  K+ D G  K  ++      L T  VGT 
Sbjct: 135 RYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE----LCTEFVGTL 187
Query: 445 GYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALI 494
            YL PE +  K++             T   D ++FG +  E ITG R  +
Sbjct: 188 QYLAPELLEQKKY-------------TVTVDYWSFGTLAFECITGFRPFL 224

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 92/225 (40%), Gaps = 42/225 (18%)
Query: 287 IEEATNNFDESRIIGRGGFGNV--YFGLLGDREAAIKKMRSN-----KSKEFFAELKVLC 339
           I E    +     +G G +G+V   F        A+KK+         +K  + EL++L 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 340 KIHHINV--FISTFGNGSLSDHLHDPLLKGH------------QPLTWTARTQIALDAAK 385
            + H NV   +  F      +  +D  L  H            Q LT      +     +
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 136
Query: 386 GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPG 445
           G++YIH    A  +HRD+K SN+ +++    K+ DFGL     R  + EM  T  V T  
Sbjct: 137 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA----RHTDDEM--TGYVATRW 187
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
           Y  PE +            +  +      D+++ G ++AEL+TG+
Sbjct: 188 YRAPEIM------------LNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 96/225 (42%), Gaps = 40/225 (17%)
Query: 283 SLEEIEEATNNFDESRIIGRGGFGNVYFGLLGDRE--AAIKKMRSN--KSKEFFAELKVL 338
           SL++ E    +      +G G FG VY G+        A+K ++ +  + +EF  E  V+
Sbjct: 2   SLDKWEMERTDITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVM 61
Query: 339 CKIHHINV--------------FISTFGN-GSLSDHLHDPLLKGHQPLTWTARTQIALDA 383
            +I H N+               I+ F   G+L D+L +      Q ++      +A   
Sbjct: 62  KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC---NRQEVSAVVLLYMATQI 118
Query: 384 AKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGT 443
           +  +EY+    K  ++HRD+   N L+ +    KVADFGL +L        M        
Sbjct: 119 SSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRL--------MTGDTXTAH 167
Query: 444 PGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
            G   P        ++    S+   + + K+DV+AFGV+L E+ T
Sbjct: 168 AGAKFP-------IKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 205

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 91/225 (40%), Gaps = 42/225 (18%)
Query: 287 IEEATNNFDESRIIGRGGFGNVYFGL---LGDREAAIKKMRSNKS----KEFFAELKVLC 339
           I E    +     +G G +G+V        G R A  K  R  +S    K  + EL++L 
Sbjct: 13  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLK 72
Query: 340 KIHHINV--FISTFGNGSLSDHLHDPLLKGH------------QPLTWTARTQIALDAAK 385
            + H NV   +  F      +  +D  L  H            Q LT      +     +
Sbjct: 73  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 132
Query: 386 GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPG 445
           G++YIH    A  +HRD+K SN+ +++    K+ DFGL     R  + EM     V T  
Sbjct: 133 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA----RHTDDEMAG--FVATRW 183
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
           Y  PE +            +  +      D+++ G ++AEL+TG+
Sbjct: 184 YRAPEIM------------LNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 91/228 (39%), Gaps = 57/228 (25%)
Query: 290 ATNNFDESRIIGRGGFGNVYFGLLGDREAAIKKM------------RSNKSKEFFAELKV 337
           A  +F+  R +G+G FGNVY      RE   K +            ++    +   E+++
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLA----REKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 64
Query: 338 LCKIHHINVFISTFGNGSLSDHLHDP----LLKGHQPLTWTARTQIAL---DAAKGIEYI 390
              + H N+         L  + HD     L+  + PL    R    L   D  +   YI
Sbjct: 65  QSHLRHPNIL-------RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 117
Query: 391 HD--------HTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVG 442
            +        H+K R +HRDIK  N+LL      K+ADFG       +   +     L G
Sbjct: 118 TELANALSYCHSK-RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDD-----LCG 171
Query: 443 TPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
           T  YLPPE I  +     MH          K D+++ GV+  E + GK
Sbjct: 172 TLDYLPPEMIEGR-----MHDE--------KVDLWSLGVLCYEFLVGK 206

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 57/231 (24%), Positives = 88/231 (38%), Gaps = 47/231 (20%)
Query: 292 NNFDESRIIGRGGFGNV----------YFGLLGDREAAI------------KKMRSNKSK 329
           N+FD  +++G+G FG V          Y+ +   R+  I             ++  N   
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 330 EFFAELKVLCKIHHINVFISTFGNGS-LSDHLHDPLLKGHQPLTWTARTQIALDAAKGIE 388
            F   LK   + H    F+  + NG  L  HL        +  T         +    +E
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHL-----SRERVFTEERARFYGAEIVSALE 119
Query: 389 YIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLP 448
           Y+H       V+RDIK  N++LD     K+ DFGL K  E  ++   + T   GTP YL 
Sbjct: 120 YLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKT-FCGTPEYLA 173
Query: 449 PEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE 499
           PE +              +       D +  GVV+ E++ G+      D E
Sbjct: 174 PEVL-------------EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE 211

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 88/208 (42%), Gaps = 40/208 (19%)
Query: 300 IGRGGFGNVYFGLLGDREAAI---KKMRSNKSKE----FFAELKVLCKIHHINV------ 346
           +G G FG VY     ++E ++    K+   KS+E    +  E+ +L    H N+      
Sbjct: 45  LGDGAFGKVYKA--QNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 102
Query: 347 --------FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARY 398
                    +  F  G   D +   +L+  +PLT +    +       + Y+HD+   + 
Sbjct: 103 FYYENNLWILIEFCAGGAVDAV---MLELERPLTESQIQVVCKQTLDALNYLHDN---KI 156
Query: 399 VHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFR 458
           +HRD+K  NIL       K+ADFG+     R  ++       +GTP ++ PE +      
Sbjct: 157 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRR---DSFIGTPYWMAPEVV------ 207
Query: 459 FDMHSSVMELQVTTKTDVFAFGVVLAEL 486
             M  +  +     K DV++ G+ L E+
Sbjct: 208 --MCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 92/225 (40%), Gaps = 42/225 (18%)
Query: 287 IEEATNNFDESRIIGRGGFGNV--YFGLLGDREAAIKKMRSN-----KSKEFFAELKVLC 339
           I E    +     +G G +G+V   F        A+KK+         +K  + EL++L 
Sbjct: 14  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 73
Query: 340 KIHHINV--FISTFGNGSLSDHLHDPLLKGH------------QPLTWTARTQIALDAAK 385
            + H NV   +  F      +  +D  L  H            Q LT      +     +
Sbjct: 74  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 133
Query: 386 GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPG 445
           G++YIH    A  +HRD+K SN+ +++    K+ DFGL     R  + EM  T  V T  
Sbjct: 134 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA----RHTDDEM--TGYVATRW 184
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
           Y  PE +            +  +      D+++ G ++AEL+TG+
Sbjct: 185 YRAPEIM------------LNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 67/272 (24%), Positives = 113/272 (41%), Gaps = 58/272 (21%)
Query: 300 IGRGGFGNVYFGL-LGDREAAIKKMRSNKSKE--FFAELKVLCKIHH------------- 343
           IG G FG V+ G  L   + AIK ++     E  F  E +V+ K+ H             
Sbjct: 35  IGSGQFGLVHLGYWLNKDKVAIKTIKEGSMSEDDFIEEAEVMMKLSHPKLVQLYGVCLEQ 94
Query: 344 --INVFISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIA--LDAAKGIEYIHDHTKARYV 399
             I +      +G LSD+L        Q   + A T +   LD  +G+ Y+ +   A  +
Sbjct: 95  APICLVFEFMEHGCLSDYLRT------QRGLFAAETLLGMCLDVCEGMAYLEE---ACVI 145
Query: 400 HRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPG-YLPPEYIFVKRFR 458
           HRD+   N L+ +    KV+DFG+ +         +L  +   + G   P ++   + F 
Sbjct: 146 HRDLAARNCLVGENQVIKVSDFGMTRF--------VLDDQYTSSTGTKFPVKWASPEVFS 197
Query: 459 FDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALI--RDDSEPT----------KMKSL 506
           F  +SS        K+DV++FGV++ E+ +  +     R +SE            K +  
Sbjct: 198 FSRYSS--------KSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLA 249
Query: 507 ITIMAAVAEWCLNEDAVDRPEMRDIVAILSQI 538
            T +  +   C  E   DRP    ++  L++I
Sbjct: 250 STHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 281

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 61/242 (25%), Positives = 102/242 (42%), Gaps = 54/242 (22%)
Query: 281 IFSLEEIEEATNNFDESRIIGRGGFGNVYFGLLG-------DREAAIKKMRSNKSK---- 329
           ++  +E E A      SR +G+G FG VY G+         +   AIK +    S     
Sbjct: 36  VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI 95
Query: 330 EFFAELKVLCKI--HHIN-------------VFISTFGNGSLSDHL--------HDPLLK 366
           EF  E  V+ +   HH+              V +     G L  +L        ++P+L 
Sbjct: 96  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 155
Query: 367 GHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKL 426
              P + +   Q+A + A G+ Y++ +   ++VHRD+   N ++ +    K+ DFG+ + 
Sbjct: 156 ---PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRD 209
Query: 427 EERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAEL 486
              T+          G  G LP         R+    S+ +   TT +DV++FGVVL E+
Sbjct: 210 IYETDYYRK------GGKGLLP--------VRWMSPESLKDGVFTTYSDVWSFGVVLWEI 255
Query: 487 IT 488
            T
Sbjct: 256 AT 257

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 92/225 (40%), Gaps = 42/225 (18%)
Query: 287 IEEATNNFDESRIIGRGGFGNV--YFGLLGDREAAIKKMRSN-----KSKEFFAELKVLC 339
           I E    +     +G G +G+V   F        A+KK+         +K  + EL++L 
Sbjct: 15  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 74
Query: 340 KIHHINV--FISTFGNGSLSDHLHDPLLKGH------------QPLTWTARTQIALDAAK 385
            + H NV   +  F      +  +D  L  H            Q LT      +     +
Sbjct: 75  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 134
Query: 386 GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPG 445
           G++YIH    A  +HRD+K SN+ +++    K+ DFGL     R  + EM  T  V T  
Sbjct: 135 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA----RHTDDEM--TGYVATRW 185
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
           Y  PE +            +  +      D+++ G ++AEL+TG+
Sbjct: 186 YRAPEIM------------LNWMHYNQTVDIWSVGCIMAELLTGR 218

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 51/234 (21%), Positives = 99/234 (42%), Gaps = 50/234 (21%)
Query: 291 TNNFDESRIIGRGGFGNVYFG--LLGDREAAIKKMRSNKSKE------FFAELKVLCKIH 342
           ++ ++   I+G GG   V+    L   R+ A+K +R++ +++      F  E +    ++
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 343 HINVFISTFGNG--------------------SLSDHLHDPLLKGHQPLTWTARTQIALD 382
           H  + ++ +  G                    +L D +H        P+T     ++  D
Sbjct: 71  HPAI-VAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHT-----EGPMTPKRAIEVIAD 124
Query: 383 AAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVG 442
           A + + + H +     +HRD+K +NI++      KV DFG+ +    +         ++G
Sbjct: 125 ACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIG 181
Query: 443 TPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRD 496
           T  YL PE     + R D         V  ++DV++ G VL E++TG+     D
Sbjct: 182 TAQYLSPE-----QARGD--------SVDARSDVYSLGCVLYEVLTGEPPFTGD 222

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 59/241 (24%), Positives = 97/241 (40%), Gaps = 45/241 (18%)
Query: 274 LESERTIIFSLE---EIEEATNNFDESRIIGRGGFGNV--YFGLLGDREAAIKKMRSN-- 326
           +  ER   +  E    I E    +     +G G +G+V   F        A+KK+     
Sbjct: 7   MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 66
Query: 327 ---KSKEFFAELKVLCKIHHINV--FISTFGNGSLSDHLHDPLLKGH------------Q 369
               +K  + EL++L  + H NV   +  F      +  +D  L  H            Q
Sbjct: 67  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 126
Query: 370 PLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEER 429
            LT      +     +G++YIH    A  +HRD+K SN+ +++    K+ DFGL     R
Sbjct: 127 KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDSELKILDFGLA----R 179
Query: 430 TNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
             + EM  T  V T  Y  PE +            +  +      D+++ G ++AEL+TG
Sbjct: 180 HTDDEM--TGYVATRWYRAPEIM------------LNWMHYNQTVDIWSVGCIMAELLTG 225
Query: 490 K 490
           +
Sbjct: 226 R 226

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 92/225 (40%), Gaps = 42/225 (18%)
Query: 287 IEEATNNFDESRIIGRGGFGNV--YFGLLGDREAAIKKMRSN-----KSKEFFAELKVLC 339
           I E    +     +G G +G+V   F        A+KK+         +K  + EL++L 
Sbjct: 23  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 82
Query: 340 KIHHINV--FISTFGNGSLSDHLHDPLLKGH------------QPLTWTARTQIALDAAK 385
            + H NV   +  F      +  +D  L  H            Q LT      +     +
Sbjct: 83  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 142
Query: 386 GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPG 445
           G++YIH    A  +HRD+K SN+ +++    K+ DFGL     R  + EM  T  V T  
Sbjct: 143 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA----RHTDDEM--TGYVATRW 193
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
           Y  PE +            +  +      D+++ G ++AEL+TG+
Sbjct: 194 YRAPEIM------------LNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 95/226 (42%), Gaps = 53/226 (23%)
Query: 290 ATNNFDESRIIGRGGFGNVYFGLLGDREA----AIKKM------RSNKSKEFFAELKVLC 339
           A  +F+  R +G+G FGNVY  L  ++++    A+K +      ++    +   E+++  
Sbjct: 9   ALEDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 340 KIHHINVFISTFGNGSLSDHLHDP----LLKGHQPLTWTARTQIAL---DAAKGIEYIHD 392
            + H N+         L  + HD     L+  + PL    R    L   D  +   YI +
Sbjct: 67  HLRHPNIL-------RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 119
Query: 393 --------HTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP 444
                   H+K R +HRDIK  N+LL      K+ADFG        +        L GT 
Sbjct: 120 LANALSYCHSK-RVIHRDIKPENLLLGSAGELKIADFGWS-----VHAPSSRRXXLCGTL 173
Query: 445 GYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
            YLPPE I  +     MH          K D+++ GV+  E + GK
Sbjct: 174 DYLPPEMIEGR-----MHDE--------KVDLWSLGVLCYEFLVGK 206

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 95/224 (42%), Gaps = 49/224 (21%)
Query: 290 ATNNFDESRIIGRGGFGNVYFGLLGDRE--AAIKKM------RSNKSKEFFAELKVLCKI 341
           A  +F+  R +G+G FGNVY       +   A+K +      ++    +   E+++   +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 342 HHINVFISTFGNGSLSDHLHDP----LLKGHQPLTWTARTQIAL---DAAKGIEYIHD-- 392
            H N+         L  + HD     L+  + PL    R    L   D  +   YI +  
Sbjct: 67  RHPNIL-------RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 119
Query: 393 ------HTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGY 446
                 H+K R +HRDIK  N+LL      K+ADFG   +   ++ ++ L     GT  Y
Sbjct: 120 NALSYCHSK-RVIHRDIKPENLLLGSAGELKIADFGW-SVHAPSSRRDTLC----GTLDY 173
Query: 447 LPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
           LPPE I  +     MH          K D+++ GV+  E + GK
Sbjct: 174 LPPEMIEGR-----MHDE--------KVDLWSLGVLCYEFLVGK 204

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 95/226 (42%), Gaps = 53/226 (23%)
Query: 290 ATNNFDESRIIGRGGFGNVYFGLLGDREA----AIKKM------RSNKSKEFFAELKVLC 339
           A  +F+  R +G+G FGNVY  L  ++++    A+K +      ++    +   E+++  
Sbjct: 6   ALEDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 340 KIHHINVFISTFGNGSLSDHLHDP----LLKGHQPLTWTARTQIAL---DAAKGIEYIHD 392
            + H N+         L  + HD     L+  + PL    R    L   D  +   YI +
Sbjct: 64  HLRHPNIL-------RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 116
Query: 393 --------HTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP 444
                   H+K R +HRDIK  N+LL      K+ADFG        +        L GT 
Sbjct: 117 LANALSYCHSK-RVIHRDIKPENLLLGSAGELKIADFGWS-----VHAPSSRRXXLCGTL 170
Query: 445 GYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
            YLPPE I  +     MH          K D+++ GV+  E + GK
Sbjct: 171 DYLPPEMIEGR-----MHDE--------KVDLWSLGVLCYEFLVGK 203

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 95/226 (42%), Gaps = 53/226 (23%)
Query: 290 ATNNFDESRIIGRGGFGNVYFGLLGDREA----AIKKM------RSNKSKEFFAELKVLC 339
           A  +F+  R +G+G FGNVY  L  ++++    A+K +      ++    +   E+++  
Sbjct: 6   ALEDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 340 KIHHINVFISTFGNGSLSDHLHDP----LLKGHQPLTWTARTQIAL---DAAKGIEYIHD 392
            + H N+         L  + HD     L+  + PL    R    L   D  +   YI +
Sbjct: 64  HLRHPNIL-------RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 116
Query: 393 --------HTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP 444
                   H+K R +HRDIK  N+LL      K+ADFG        +        L GT 
Sbjct: 117 LANALSYCHSK-RVIHRDIKPENLLLGSAGELKIADFGWS-----VHAPSSRRAALCGTL 170
Query: 445 GYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
            YLPPE I  +     MH          K D+++ GV+  E + GK
Sbjct: 171 DYLPPEMIEGR-----MHDE--------KVDLWSLGVLCYEFLVGK 203

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 89/211 (42%), Gaps = 36/211 (17%)
Query: 300 IGRGGFGNV--YFGLLGDREAAIKKMRSNKSKEF----FAELKVLCKIHHINVF-ISTFG 352
           IG G +G V   +  L     AIKK+   + + +      E+K+L +  H N+  I+   
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 95
Query: 353 NGSLSDHLHD-------------PLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYV 399
                + + D              LLK  Q L+            +G++YIH    A  +
Sbjct: 96  RAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIH---SANVL 151
Query: 400 HRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRF 459
           HRD+K SN+LL+     K+ DFGL ++ +  ++     T  V T  Y  PE +   +   
Sbjct: 152 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK--- 208
Query: 460 DMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
                      T   D+++ G +LAE+++ +
Sbjct: 209 ---------GYTKSIDIWSVGCILAEMLSNR 230

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 89/211 (42%), Gaps = 36/211 (17%)
Query: 300 IGRGGFGNV--YFGLLGDREAAIKKMRSNKSKEF----FAELKVLCKIHHINVF-ISTFG 352
           IG G +G V   +  L     AIKK+   + + +      E+K+L +  H N+  I+   
Sbjct: 37  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 96
Query: 353 NGSLSDHLHD-------------PLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYV 399
                + + D              LLK  Q L+            +G++YIH    A  +
Sbjct: 97  RAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIH---SANVL 152
Query: 400 HRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRF 459
           HRD+K SN+LL+     K+ DFGL ++ +  ++     T  V T  Y  PE +   +   
Sbjct: 153 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK--- 209
Query: 460 DMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
                      T   D+++ G +LAE+++ +
Sbjct: 210 ---------GYTKSIDIWSVGCILAEMLSNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 89/211 (42%), Gaps = 36/211 (17%)
Query: 300 IGRGGFGNV--YFGLLGDREAAIKKMRSNKSKEF----FAELKVLCKIHHINVF-ISTFG 352
           IG G +G V   +  L     AIKK+   + + +      E+K+L +  H N+  I+   
Sbjct: 28  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 87
Query: 353 NGSLSDHLHD-------------PLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYV 399
                + + D              LLK  Q L+            +G++YIH    A  +
Sbjct: 88  RAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIH---SANVL 143
Query: 400 HRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRF 459
           HRD+K SN+LL+     K+ DFGL ++ +  ++     T  V T  Y  PE +   +   
Sbjct: 144 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK--- 200
Query: 460 DMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
                      T   D+++ G +LAE+++ +
Sbjct: 201 ---------GYTKSIDIWSVGCILAEMLSNR 222

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 89/211 (42%), Gaps = 36/211 (17%)
Query: 300 IGRGGFGNV--YFGLLGDREAAIKKMRSNKSKEF----FAELKVLCKIHHINVF-ISTFG 352
           IG G +G V   +  L     AIKK+   + + +      E+K+L +  H N+  I+   
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 353 NGSLSDHLHD-------------PLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYV 399
                + + D              LLK  Q L+            +G++YIH    A  +
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIH---SANVL 150
Query: 400 HRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRF 459
           HRD+K SN+LL+     K+ DFGL ++ +  ++     T  V T  Y  PE +   +   
Sbjct: 151 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK--- 207
Query: 460 DMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
                      T   D+++ G +LAE+++ +
Sbjct: 208 ---------GYTKSIDIWSVGCILAEMLSNR 229

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 89/211 (42%), Gaps = 36/211 (17%)
Query: 300 IGRGGFGNV--YFGLLGDREAAIKKMRSNKSKEF----FAELKVLCKIHHINVF-ISTFG 352
           IG G +G V   +  L     AIKK+   + + +      E+K+L +  H N+  I+   
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 88
Query: 353 NGSLSDHLHD-------------PLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYV 399
                + + D              LLK  Q L+            +G++YIH    A  +
Sbjct: 89  RAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIH---SANVL 144
Query: 400 HRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRF 459
           HRD+K SN+LL+     K+ DFGL ++ +  ++     T  V T  Y  PE +   +   
Sbjct: 145 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK--- 201
Query: 460 DMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
                      T   D+++ G +LAE+++ +
Sbjct: 202 ---------GYTKSIDIWSVGCILAEMLSNR 223

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 64/278 (23%), Positives = 110/278 (39%), Gaps = 59/278 (21%)
Query: 297 SRIIGRGGFGNVYFGLLGDREA-----AIKKMRSN----KSKEFFAELKVLCKIHHINV- 346
           +RI+G G FG VY G+  + +      A+K  + +      ++F +E  ++  + H ++ 
Sbjct: 29  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 88
Query: 347 -------------FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDH 393
                         +  +  G L  +L     +    L        +L   K + Y+   
Sbjct: 89  KLIGIIEEEPTWIIMELYPYGELGHYLE----RNKNSLKVLTLVLYSLQICKAMAYLE-- 142
Query: 394 TKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIF 453
                VHRDI   NIL+      K+ DFGL +  E  +  +   TRL     ++ PE I 
Sbjct: 143 -SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL--PIKWMSPESIN 199
Query: 454 VKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKR------------ALIRDDSEP 500
            +RF             TT +DV+ F V + E+++ GK+             L + D  P
Sbjct: 200 FRRF-------------TTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLP 246
Query: 501 TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQI 538
            K      ++  +   C + D  DRP   ++V  LS +
Sbjct: 247 -KPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV 283

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/237 (25%), Positives = 99/237 (41%), Gaps = 60/237 (25%)
Query: 293 NFDESRIIGRGGFGNVYFGL--LGDREAAIKKMR-SNKS---KEFFAELKVLCKIHHINV 346
           +F+  + +GRGGFG V+     + D   AIK++R  N+    ++   E+K L K+ H   
Sbjct: 6   DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG- 64
Query: 347 FISTFGNGSLSDHLHDPL------------------------LKGHQPLTWTART---QI 379
            I  + N  L  +  + L                        + G   +    R+    I
Sbjct: 65  -IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHI 123
Query: 380 ALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATR 439
            L  A+ +E++H       +HRD+K SNI        KV DFGLV   ++  E++ + T 
Sbjct: 124 FLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 180
Query: 440 L---------VGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELI 487
           +         VGT  Y+ PE I    +             + K D+F+ G++L EL+
Sbjct: 181 MPAYARHTGQVGTKLYMSPEQIHGNSY-------------SHKVDIFSLGLILFELL 224

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 88/208 (42%), Gaps = 40/208 (19%)
Query: 300 IGRGGFGNVYFGLLGDREAAI---KKMRSNKSKE----FFAELKVLCKIHHINV------ 346
           +G G FG VY     ++E ++    K+   KS+E    +  E+ +L    H N+      
Sbjct: 45  LGDGAFGKVYKA--QNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 102
Query: 347 --------FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARY 398
                    +  F  G   D +   +L+  +PLT +    +       + Y+HD+   + 
Sbjct: 103 FYYENNLWILIEFCAGGAVDAV---MLELERPLTESQIQVVCKQTLDALNYLHDN---KI 156
Query: 399 VHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFR 458
           +HRD+K  NIL       K+ADFG+     R  ++       +GTP ++ PE +      
Sbjct: 157 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRR---DXFIGTPYWMAPEVV------ 207
Query: 459 FDMHSSVMELQVTTKTDVFAFGVVLAEL 486
             M  +  +     K DV++ G+ L E+
Sbjct: 208 --MCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 89/211 (42%), Gaps = 36/211 (17%)
Query: 300 IGRGGFGNV--YFGLLGDREAAIKKMRSNKSKEF----FAELKVLCKIHHINVF-ISTFG 352
           IG G +G V   +  L     AIKK+   + + +      E+K+L +  H N+  I+   
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 88
Query: 353 NGSLSDHLHD-------------PLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYV 399
                + + D              LLK  Q L+            +G++YIH    A  +
Sbjct: 89  RAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIH---SANVL 144
Query: 400 HRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRF 459
           HRD+K SN+LL+     K+ DFGL ++ +  ++     T  V T  Y  PE +   +   
Sbjct: 145 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK--- 201
Query: 460 DMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
                      T   D+++ G +LAE+++ +
Sbjct: 202 ---------GYTKSIDIWSVGCILAEMLSNR 223

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 67/279 (24%), Positives = 110/279 (39%), Gaps = 61/279 (21%)
Query: 297 SRIIGRGGFGNVYFGLLGDREA-----AIKKMR-----SNKSKEFFAELKVLCKIHHINV 346
           +RI+G G FG VY G+  + +      A+K  +      NK K F +E  ++  + H ++
Sbjct: 13  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEK-FMSEAVIMKNLDHPHI 71
Query: 347 --------------FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHD 392
                          +  +  G L  +L     +    L        +L   K + Y+  
Sbjct: 72  VKLIGIIEEEPTWIIMELYPYGELGHYLE----RNKNSLKVLTLVLYSLQICKAMAYLE- 126
Query: 393 HTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYI 452
                 VHRDI   NIL+      K+ DFGL +  E  +  +   TRL     ++ PE I
Sbjct: 127 --SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL--PIKWMSPESI 182
Query: 453 FVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKR------------ALIRDDSE 499
             +RF             TT +DV+ F V + E+++ GK+             L + D  
Sbjct: 183 NFRRF-------------TTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRL 229
Query: 500 PTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQI 538
           P K      ++  +   C + D  DRP   ++V  LS +
Sbjct: 230 P-KPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV 267

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/248 (23%), Positives = 107/248 (43%), Gaps = 49/248 (19%)
Query: 270 DVTVLESERTIIFSLEEIEEATNNFDESRIIGRGGFGNVYFGL--LGDREAAIKKM---- 323
           D  +LE  R II S+ + ++    F++   IG+G  G VY  +     +E AI++M    
Sbjct: 3   DEEILEKLR-IIVSVGDPKKKYTRFEK---IGQGASGTVYTAMDVATGQEVAIRQMNLQQ 58
Query: 324 --------------RSNKSKEFFAELKVLCKIHHINVFISTFGNGSLSDHLHDPLLKGHQ 369
                         R NK+      L        + V +     GSL+D + +  +   Q
Sbjct: 59  QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQ 118
Query: 370 PLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEER 429
                    +  +  + +E++H +   + +HR+IK+ NILL      K+ DFG     + 
Sbjct: 119 ------IAAVCRECLQALEFLHSN---QVIHRNIKSDNILLGMDGSVKLTDFGFCA--QI 167
Query: 430 TNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
           T E+   +T +VGTP ++ PE +  K +               K D+++ G++  E+I G
Sbjct: 168 TPEQSKRST-MVGTPYWMAPEVVTRKAY-------------GPKVDIWSLGIMAIEMIEG 213
Query: 490 KRALIRDD 497
           +   + ++
Sbjct: 214 EPPYLNEN 221

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 64/278 (23%), Positives = 110/278 (39%), Gaps = 59/278 (21%)
Query: 297 SRIIGRGGFGNVYFGLLGDREA-----AIKKMRSN----KSKEFFAELKVLCKIHHINV- 346
           +RI+G G FG VY G+  + +      A+K  + +      ++F +E  ++  + H ++ 
Sbjct: 17  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76
Query: 347 -------------FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDH 393
                         +  +  G L  +L     +    L        +L   K + Y+   
Sbjct: 77  KLIGIIEEEPTWIIMELYPYGELGHYLE----RNKNSLKVLTLVLYSLQICKAMAYLE-- 130
Query: 394 TKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIF 453
                VHRDI   NIL+      K+ DFGL +  E  +  +   TRL     ++ PE I 
Sbjct: 131 -SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL--PIKWMSPESIN 187
Query: 454 VKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKR------------ALIRDDSEP 500
            +RF             TT +DV+ F V + E+++ GK+             L + D  P
Sbjct: 188 FRRF-------------TTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLP 234
Query: 501 TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQI 538
            K      ++  +   C + D  DRP   ++V  LS +
Sbjct: 235 -KPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV 271

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 89/211 (42%), Gaps = 36/211 (17%)
Query: 300 IGRGGFGNV--YFGLLGDREAAIKKMRSNKSKEF----FAELKVLCKIHHINVF-ISTFG 352
           IG G +G V   +  L     AIKK+   + + +      E+K+L +  H N+  I+   
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 353 NGSLSDHLHD-------------PLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYV 399
                + + D              LLK  Q L+            +G++YIH    A  +
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKC-QHLSNDHICYFLYQILRGLKYIH---SANVL 150
Query: 400 HRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRF 459
           HRD+K SN+LL+     K+ DFGL ++ +  ++     T  V T  Y  PE +   +   
Sbjct: 151 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK--- 207
Query: 460 DMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
                      T   D+++ G +LAE+++ +
Sbjct: 208 ---------GYTKSIDIWSVGCILAEMLSNR 229

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/231 (24%), Positives = 88/231 (38%), Gaps = 47/231 (20%)
Query: 292 NNFDESRIIGRGGFGNV----------YFGLLGDREAAI------------KKMRSNKSK 329
           N+FD  +++G+G FG V          Y+ +   R+  I             ++  N   
Sbjct: 8   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 67
Query: 330 EFFAELKVLCKIHHINVFISTFGNG-SLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIE 388
            F   LK   + H    F+  + NG  L  HL        +  T         +    +E
Sbjct: 68  PFLTALKYAFQTHDRLCFVMEYANGGELFFHL-----SRERVFTEERARFYGAEIVSALE 122
Query: 389 YIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLP 448
           Y+H       V+RDIK  N++LD     K+ DFGL K  E  ++   + T   GTP YL 
Sbjct: 123 YLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKT-FCGTPEYLA 176
Query: 449 PEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE 499
           PE +              +       D +  GVV+ E++ G+      D E
Sbjct: 177 PEVL-------------EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE 214

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/235 (25%), Positives = 102/235 (43%), Gaps = 51/235 (21%)
Query: 290 ATNNFDESRIIGRGGFGNVYFGL--LGDREAAIKKMRSNKSKE-----FFAELKVLCKIH 342
           +  NF +   IG G +G VY     L     A+KK+R +   E        E+ +L +++
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 343 HINV--------------FISTFGNGSLSDHLHDPLLKG-HQPLTWTARTQIALDAAKGI 387
           H N+               +  F +  L D +    L G   PL  +   Q+     +G+
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKDFMDASALTGIPLPLIKSYLFQLL----QGL 116
Query: 388 EYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK---LEERTNEKEMLATRLVGTP 444
            + H H   R +HRD+K  N+L++     K+ADFGL +   +  RT   E++      T 
Sbjct: 117 AFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV------TL 167
Query: 445 GYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE 499
            Y  PE +   ++             +T  D+++ G + AE++T +RAL   DSE
Sbjct: 168 WYRAPEILLGCKY------------YSTAVDIWSLGCIFAEMVT-RRALFPGDSE 209

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/235 (25%), Positives = 102/235 (43%), Gaps = 51/235 (21%)
Query: 290 ATNNFDESRIIGRGGFGNVYFGL--LGDREAAIKKMRSNKSKE-----FFAELKVLCKIH 342
           +  NF +   IG G +G VY     L     A+KK+R +   E        E+ +L +++
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 343 HINV--------------FISTFGNGSLSDHLHDPLLKG-HQPLTWTARTQIALDAAKGI 387
           H N+               +  F +  L D +    L G   PL  +   Q+     +G+
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLL----QGL 119
Query: 388 EYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK---LEERTNEKEMLATRLVGTP 444
            + H H   R +HRD+K  N+L++     K+ADFGL +   +  RT   E++      T 
Sbjct: 120 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV------TL 170
Query: 445 GYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE 499
            Y  PE +   ++             +T  D+++ G + AE++T +RAL   DSE
Sbjct: 171 WYRAPEILLGCKY------------YSTAVDIWSLGCIFAEMVT-RRALFPGDSE 212

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/231 (24%), Positives = 88/231 (38%), Gaps = 47/231 (20%)
Query: 292 NNFDESRIIGRGGFGNV----------YFGLLGDREAAI------------KKMRSNKSK 329
           N+FD  +++G+G FG V          Y+ +   R+  I             ++  N   
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 330 EFFAELKVLCKIHHINVFISTFGNGS-LSDHLHDPLLKGHQPLTWTARTQIALDAAKGIE 388
            F   LK   + H    F+  + NG  L  HL        +  T         +    +E
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHL-----SRERVFTEERARFYGAEIVSALE 119
Query: 389 YIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLP 448
           Y+H       V+RDIK  N++LD     K+ DFGL K  E  ++   + T   GTP YL 
Sbjct: 120 YLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKT-FCGTPEYLA 173
Query: 449 PEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE 499
           PE +              +       D +  GVV+ E++ G+      D E
Sbjct: 174 PEVL-------------EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE 211

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 97/222 (43%), Gaps = 53/222 (23%)
Query: 293 NFDESRIIGRGGFGNVYFGLLGDREA----AIKKM------RSNKSKEFFAELKVLCKIH 342
           +FD  R +G+G FGNVY  L  +R++    A+K +      ++    +   E+++   + 
Sbjct: 13  DFDIGRPLGKGKFGNVY--LARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLR 70
Query: 343 HINVFISTFGNGSLSDHLHDP----LLKGHQPLTWTARTQIAL---DAAKGIEYIHD--- 392
           H N+         L  + HD     L+  + PL    R    L   D  +   YI +   
Sbjct: 71  HPNIL-------RLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELAN 123
Query: 393 -----HTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYL 447
                H+K R +HRDIK  N+LL      K+ADFG   +   ++ ++ L     GT  YL
Sbjct: 124 ALSYCHSK-RVIHRDIKPENLLLGSNGELKIADFGW-SVHAPSSRRDTLC----GTLDYL 177
Query: 448 PPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
           PPE I  +     MH          K D+++ GV+  E + G
Sbjct: 178 PPEMIEGR-----MHDE--------KVDLWSLGVLCYEFLVG 206

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 66/235 (28%), Positives = 103/235 (43%), Gaps = 49/235 (20%)
Query: 289 EATNNFDESRIIGRGGFGNVYFGL--LGDREAAIKKMRSNKSKE-----FFAELKVLCKI 341
           E   NF +   IG G +G VY     L     A+KK+R +   E        E+ +L ++
Sbjct: 7   EFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 66
Query: 342 HHINVF-----ISTFGNGSLS-DHLHDPLLKGHQPLTWTARTQIALDAAK--------GI 387
           +H N+      I T     L  + LH  L K    +  +A T I L   K        G+
Sbjct: 67  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKF---MDASALTGIPLPLIKSYLFQLLQGL 123
Query: 388 EYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK---LEERTNEKEMLATRLVGTP 444
            + H H   R +HRD+K  N+L++     K+ADFGL +   +  RT   E++      T 
Sbjct: 124 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV------TL 174
Query: 445 GYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE 499
            Y  PE +   ++             +T  D+++ G + AE++T +RAL   DSE
Sbjct: 175 WYRAPEILLGXKY------------YSTAVDIWSLGCIFAEMVT-RRALFPGDSE 216

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 100/238 (42%), Gaps = 54/238 (22%)
Query: 285 EEIEEATNNFDESRIIGRGGFGNVYFGLLG-------DREAAIKKMRSNKSK----EFFA 333
           +E E A      SR +G+G FG VY G+         +   AIK +    S     EF  
Sbjct: 5   DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 64
Query: 334 ELKVLCKI--HHIN-------------VFISTFGNGSLSDHL--------HDPLLKGHQP 370
           E  V+ +   HH+              V +     G L  +L        ++P+L    P
Sbjct: 65  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA---P 121
Query: 371 LTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERT 430
            + +   Q+A + A G+ Y++ +   ++VHRD+   N ++ +    K+ DFG+ +    T
Sbjct: 122 PSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET 178
Query: 431 NEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
           +          G  G LP         R+    S+ +   TT +DV++FGVVL E+ T
Sbjct: 179 DYYRK------GGKGLLP--------VRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/217 (23%), Positives = 92/217 (42%), Gaps = 36/217 (16%)
Query: 294 FDESRIIGRGGFGNVY--FGLLGDREAAIKKMRSNKSKEF----FAELKVLCKIHHINVF 347
           + + + IG G +G V   +  +     AIKK+   + + +      E+++L +  H NV 
Sbjct: 45  YTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVI 104
Query: 348 -ISTFGNGSLSDHLHD-------------PLLKGHQPLTWTARTQIALDAAKGIEYIHDH 393
            I      S  + + D              LLK  Q L+            +G++YIH  
Sbjct: 105 GIRDILRASTLEAMRDVYIVQDLMETDLYKLLKSQQ-LSNDHICYFLYQILRGLKYIH-- 161
Query: 394 TKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIF 453
             A  +HRD+K SN+L++     K+ DFGL ++ +  ++     T  V T  Y  PE + 
Sbjct: 162 -SANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEIML 220
Query: 454 VKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
             +              T   D+++ G +LAE+++ +
Sbjct: 221 NSK------------GYTKSIDIWSVGCILAEMLSNR 245

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/235 (25%), Positives = 102/235 (43%), Gaps = 51/235 (21%)
Query: 290 ATNNFDESRIIGRGGFGNVYFGL--LGDREAAIKKMRSNKSKE-----FFAELKVLCKIH 342
           +  NF +   IG G +G VY     L     A+KK+R +   E        E+ +L +++
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 343 HINV--------------FISTFGNGSLSDHLHDPLLKG-HQPLTWTARTQIALDAAKGI 387
           H N+               +  F +  L D +    L G   PL  +   Q+     +G+
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLL----QGL 118
Query: 388 EYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK---LEERTNEKEMLATRLVGTP 444
            + H H   R +HRD+K  N+L++     K+ADFGL +   +  RT   E++      T 
Sbjct: 119 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV------TL 169
Query: 445 GYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE 499
            Y  PE +   ++             +T  D+++ G + AE++T +RAL   DSE
Sbjct: 170 WYRAPEILLGCKY------------YSTAVDIWSLGCIFAEMVT-RRALFPGDSE 211

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 96/225 (42%), Gaps = 40/225 (17%)
Query: 283 SLEEIEEATNNFDESRIIGRGGFGNVYFGLLGDRE--AAIKKMRSN--KSKEFFAELKVL 338
           SL++ E    +      +G G +G VY G+        A+K ++ +  + +EF  E  V+
Sbjct: 2   SLDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVM 61
Query: 339 CKIHHINV--------------FISTFGN-GSLSDHLHDPLLKGHQPLTWTARTQIALDA 383
            +I H N+               I+ F   G+L D+L +      Q ++      +A   
Sbjct: 62  KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC---NRQEVSAVVLLYMATQI 118
Query: 384 AKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGT 443
           +  +EY+    K  ++HRD+   N L+ +    KVADFGL +L        M        
Sbjct: 119 SSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRL--------MTGDTFTAH 167
Query: 444 PGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
            G   P        ++    S+   + + K+DV+AFGV+L E+ T
Sbjct: 168 AGAKFP-------IKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 205

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 89/211 (42%), Gaps = 36/211 (17%)
Query: 300 IGRGGFGNV--YFGLLGDREAAIKKMRSNKSKEF----FAELKVLCKIHHINVF-ISTFG 352
           IG G +G V   +  L     AIKK+   + + +      E+K+L +  H N+  I+   
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 353 NGSLSDHLHD-------------PLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYV 399
                + + D              LLK  Q L+            +G++YIH    A  +
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIH---SANVL 150
Query: 400 HRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRF 459
           HRD+K SN+LL+     K+ DFGL ++ +  ++     T  V T  Y  PE +   +   
Sbjct: 151 HRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK--- 207
Query: 460 DMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
                      T   D+++ G +LAE+++ +
Sbjct: 208 ---------GYTKSIDIWSVGCILAEMLSNR 229

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 88/208 (42%), Gaps = 40/208 (19%)
Query: 300 IGRGGFGNVYFGLLGDRE--AAIKKMRSN--KSKEFFAELKVLCKIHHIN---------- 345
           +G G +G VY G+        A+K ++ +  + +EF  E  V+ +I H N          
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80
Query: 346 -----VFISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVH 400
                + I     G+L D+L +      Q ++      +A   +  +EY+    K  ++H
Sbjct: 81  EPPFYIIIEFMTYGNLLDYLREC---NRQEVSAVVLLYMATQISSAMEYLE---KKNFIH 134
Query: 401 RDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFD 460
           RD+   N L+ +    KVADFGL +L        M         G   P        ++ 
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRL--------MTGDTYTAHAGAKFP-------IKWT 179
Query: 461 MHSSVMELQVTTKTDVFAFGVVLAELIT 488
              S+   + + K+DV+AFGV+L E+ T
Sbjct: 180 APESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 95/220 (43%), Gaps = 38/220 (17%)
Query: 299 IIGRGGFGNVYFGLLGDREAAIKKMRSNKSKEFFAELKVLCK--IHHINV--FISTFGNG 354
           I  RG FG V+   L +   A+K       + + +E ++     + H N+  FI+    G
Sbjct: 22  IKARGRFGCVWKAQLMNDFVAVKIFPLQDKQSWQSEREIFSTPGMKHENLLQFIAAEKRG 81
Query: 355 S-------LSDHLHDP-----LLKGHQPLTWTARTQIALDAAKGIEYIHDHT-------- 394
           S       L    HD       LKG+  +TW     +A   ++G+ Y+H+          
Sbjct: 82  SNLEVELWLITAFHDKGSLTDYLKGN-IITWNELCHVAETMSRGLSYLHEDVPWCRGEGH 140
Query: 395 KARYVHRDIKTSNILLDDGLRAKVADFGL-VKLEERTNEKEMLATRLVGTPGYLPPEYI- 452
           K    HRD K+ N+LL   L A +ADFGL V+ E      +      VGT  Y+ PE + 
Sbjct: 141 KPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQ--VGTRRYMAPEVLE 198
Query: 453 FVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRA 492
               F+ D            + D++A G+VL EL++  +A
Sbjct: 199 GAINFQRD---------AFLRIDMYAMGLVLWELVSRCKA 229

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 89/211 (42%), Gaps = 36/211 (17%)
Query: 300 IGRGGFGNV--YFGLLGDREAAIKKMRSNKSKEF----FAELKVLCKIHHINVF-ISTFG 352
           IG G +G V   +  L     AIKK+   + + +      E+K+L +  H N+  I+   
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENIIGINDII 94
Query: 353 NGSLSDHLHD-------------PLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYV 399
                + + D              LLK  Q L+            +G++YIH    A  +
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIH---SANVL 150
Query: 400 HRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRF 459
           HRD+K SN+LL+     K+ DFGL ++ +  ++     T  V T  Y  PE +   +   
Sbjct: 151 HRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK--- 207
Query: 460 DMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
                      T   D+++ G +LAE+++ +
Sbjct: 208 ---------GYTKSIDIWSVGCILAEMLSNR 229

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/121 (33%), Positives = 59/121 (48%), Gaps = 20/121 (16%)
Query: 386 GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPG 445
            +EY H H   + VHRD+K  N+LLD+ L  K+ADFGL  +    N    L T   G+P 
Sbjct: 125 AVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN---FLKTS-CGSPN 177
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKMKS 505
           Y  PE I  K            L    + DV++ GV+L  ++  +R    D+S P   K+
Sbjct: 178 YAAPEVISGK------------LYAGPEVDVWSCGVILYVMLC-RRLPFDDESIPVLFKN 224
Query: 506 L 506
           +
Sbjct: 225 I 225

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/241 (24%), Positives = 97/241 (40%), Gaps = 45/241 (18%)
Query: 274 LESERTIIFSLE---EIEEATNNFDESRIIGRGGFGNV--YFGLLGDREAAIKKMRSN-- 326
           +  ER   +  E    I E    +     +G G +G+V   F        A+KK+     
Sbjct: 1   MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 60
Query: 327 ---KSKEFFAELKVLCKIHHINV--FISTFGNGSLSDHLHDPLLKGH------------Q 369
               +K  + EL++L  + H NV   +  F      +  +D  L  H            Q
Sbjct: 61  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 370 PLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEER 429
            LT      +     +G++YIH    A  +HRD+K SN+ +++    K+ D+GL     R
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDYGLA----R 173
Query: 430 TNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
             + EM  T  V T  Y  PE +            +  +      D+++ G ++AEL+TG
Sbjct: 174 HTDDEM--TGYVATRWYRAPEIM------------LNWMHYNQTVDIWSVGCIMAELLTG 219
Query: 490 K 490
           +
Sbjct: 220 R 220

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/234 (21%), Positives = 99/234 (42%), Gaps = 50/234 (21%)
Query: 291 TNNFDESRIIGRGGFGNVYFG--LLGDREAAIKKMRSNKSKE------FFAELKVLCKIH 342
           ++ ++   I+G GG   V+    L   R+ A+K +R++ +++      F  E +    ++
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 343 HINVFISTFGNG--------------------SLSDHLHDPLLKGHQPLTWTARTQIALD 382
           H  + ++ +  G                    +L D +H        P+T     ++  D
Sbjct: 71  HPAI-VAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT-----EGPMTPKRAIEVIAD 124
Query: 383 AAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVG 442
           A + + + H +     +HRD+K +NI++      KV DFG+ +    +         ++G
Sbjct: 125 ACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIG 181
Query: 443 TPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRD 496
           T  YL PE     + R D         V  ++DV++ G VL E++TG+     D
Sbjct: 182 TAQYLSPE-----QARGD--------SVDARSDVYSLGCVLYEVLTGEPPFTGD 222

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 65/276 (23%), Positives = 103/276 (37%), Gaps = 63/276 (22%)
Query: 293 NFDESRIIGRGGFGNVYFG--LLGDREAAIKK------MRSNKSKEFFAELKVLCKIHHI 344
           NF   + IGRG F  VY    LL     A+KK      M +    +   E+ +L +++H 
Sbjct: 33  NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 92
Query: 345 NV--FISTF-------------GNGSLS---DHLHDPLLKGHQPLTWTARTQIALDAAKG 386
           NV  + ++F               G LS    H         +   W    Q+       
Sbjct: 93  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLC----SA 148
Query: 387 IEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGY 446
           +E++H     R +HRDIK +N+ +      K+ D GL +     + K   A  LVGTP Y
Sbjct: 149 LEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRF---FSSKTTAAHSLVGTPYY 202
Query: 447 LPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRD---------- 496
           + PE I    + F             K+D+++ G +L E+   +     D          
Sbjct: 203 MSPERIHENGYNF-------------KSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKK 249
Query: 497 ----DSEPTKMKSLITIMAAVAEWCLNEDAVDRPEM 528
               D  P         +  +   C+N D   RP++
Sbjct: 250 IEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDV 285

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 88/208 (42%), Gaps = 40/208 (19%)
Query: 300 IGRGGFGNVYFGLLGDRE--AAIKKMRSN--KSKEFFAELKVLCKIHHIN---------- 345
           +G G +G VY G+        A+K ++ +  + +EF  E  V+ +I H N          
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80
Query: 346 -----VFISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVH 400
                + I     G+L D+L +      Q ++      +A   +  +EY+    K  ++H
Sbjct: 81  EPPFYIIIEFMTYGNLLDYLREC---NRQEVSAVVLLYMATQISSAMEYLE---KKNFIH 134
Query: 401 RDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFD 460
           RD+   N L+ +    KVADFGL +L        M         G   P        ++ 
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRL--------MTGDTYTAHAGAKFP-------IKWT 179
Query: 461 MHSSVMELQVTTKTDVFAFGVVLAELIT 488
              S+   + + K+DV+AFGV+L E+ T
Sbjct: 180 APESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/121 (33%), Positives = 59/121 (48%), Gaps = 20/121 (16%)
Query: 386 GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPG 445
            +EY H H   + VHRD+K  N+LLD+ L  K+ADFGL  +    N    L T   G+P 
Sbjct: 124 AVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN---FLKTS-CGSPN 176
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKMKS 505
           Y  PE I  K            L    + DV++ GV+L  ++  +R    D+S P   K+
Sbjct: 177 YAAPEVISGK------------LYAGPEVDVWSCGVILYVMLC-RRLPFDDESIPVLFKN 223
Query: 506 L 506
           +
Sbjct: 224 I 224

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 91/225 (40%), Gaps = 42/225 (18%)
Query: 287 IEEATNNFDESRIIGRGGFGNV--YFGLLGDREAAIKKMRSN-----KSKEFFAELKVLC 339
           I E    +     +G G +G+V   F        A+KK+         +K  + EL++L 
Sbjct: 24  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 83
Query: 340 KIHHINV--FISTFGNGSLSDHLHDPLLKGH------------QPLTWTARTQIALDAAK 385
            + H NV   +  F      +  +D  L  H            Q LT      +     +
Sbjct: 84  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 143
Query: 386 GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPG 445
           G++YIH    A  +HRD+K SN+ +++    K+ DFGL     R    EM  T  V T  
Sbjct: 144 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA----RHTADEM--TGYVATRW 194
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
           Y  PE +            +  +      D+++ G ++AEL+TG+
Sbjct: 195 YRAPEIM------------LNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/242 (25%), Positives = 101/242 (41%), Gaps = 54/242 (22%)
Query: 281 IFSLEEIEEATNNFDESRIIGRGGFGNVYFGLLG-------DREAAIKKMRSNKSK---- 329
           ++  +E E A      SR +G+G FG VY G+         +   AIK +    S     
Sbjct: 1   VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI 60
Query: 330 EFFAELKVLCKI--HHIN-------------VFISTFGNGSLSDHL--------HDPLLK 366
           EF  E  V+ +   HH+              V +     G L  +L        ++P+L 
Sbjct: 61  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 120
Query: 367 GHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKL 426
              P + +   Q+A + A G+ Y++ +   ++VHRD+   N  + +    K+ DFG+ + 
Sbjct: 121 ---PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMTRD 174
Query: 427 EERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAEL 486
              T+          G  G LP         R+    S+ +   TT +DV++FGVVL E+
Sbjct: 175 IYETDYYRK------GGKGLLP--------VRWMSPESLKDGVFTTYSDVWSFGVVLWEI 220
Query: 487 IT 488
            T
Sbjct: 221 AT 222

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/121 (33%), Positives = 59/121 (48%), Gaps = 20/121 (16%)
Query: 386 GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPG 445
            +EY H H   + VHRD+K  N+LLD+ L  K+ADFGL  +    N    L T   G+P 
Sbjct: 119 AVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN---FLKTS-CGSPN 171
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKMKS 505
           Y  PE I  K            L    + DV++ GV+L  ++  +R    D+S P   K+
Sbjct: 172 YAAPEVISGK------------LYAGPEVDVWSCGVILYVMLC-RRLPFDDESIPVLFKN 218
Query: 506 L 506
           +
Sbjct: 219 I 219

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 91/225 (40%), Gaps = 42/225 (18%)
Query: 287 IEEATNNFDESRIIGRGGFGNV--YFGLLGDREAAIKKMRSN-----KSKEFFAELKVLC 339
           I E    +     +G G +G+V   F        A+KK+         +K  + EL++L 
Sbjct: 24  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 83
Query: 340 KIHHINV--FISTFGNGSLSDHLHDPLLKGH------------QPLTWTARTQIALDAAK 385
            + H NV   +  F      +  +D  L  H            Q LT      +     +
Sbjct: 84  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 143
Query: 386 GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPG 445
           G++YIH    A  +HRD+K SN+ +++    K+ DFGL     R    EM  T  V T  
Sbjct: 144 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA----RHTADEM--TGYVATRW 194
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
           Y  PE +            +  +      D+++ G ++AEL+TG+
Sbjct: 195 YRAPEIM------------LNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 94/226 (41%), Gaps = 53/226 (23%)
Query: 290 ATNNFDESRIIGRGGFGNVYFGLLGDREA----AIKKM------RSNKSKEFFAELKVLC 339
           A  +F+  R +G+G FGNVY  L  ++++    A+K +      ++    +   E+++  
Sbjct: 11  ALEDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 68
Query: 340 KIHHINVFISTFGNGSLSDHLHDP----LLKGHQPLTWTARTQIAL---DAAKGIEYIHD 392
            + H N+         L  + HD     L+  + PL    R    L   D  +   YI +
Sbjct: 69  HLRHPNIL-------RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 121
Query: 393 --------HTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP 444
                   H+K R +HRDIK  N+LL      K+ADFG        +      T L GT 
Sbjct: 122 LANALSYCHSK-RVIHRDIKPENLLLGSAGELKIADFGWS-----VHAPSSRRTTLCGTL 175
Query: 445 GYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
            YLPPE I  +                 K D+++ GV+  E + GK
Sbjct: 176 DYLPPEXIEGRXH-------------DEKVDLWSLGVLCYEFLVGK 208

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 91/225 (40%), Gaps = 42/225 (18%)
Query: 287 IEEATNNFDESRIIGRGGFGNV--YFGLLGDREAAIKKMRSN-----KSKEFFAELKVLC 339
           I E    +     +G G +G+V   F        A+KK+         +K  + EL++L 
Sbjct: 24  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 83
Query: 340 KIHHINV--FISTFGNGSLSDHLHDPLLKGH------------QPLTWTARTQIALDAAK 385
            + H NV   +  F      +  +D  L  H            Q LT      +     +
Sbjct: 84  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 143
Query: 386 GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPG 445
           G++YIH    A  +HRD+K SN+ +++    K+ DFGL     R    EM  T  V T  
Sbjct: 144 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA----RHTADEM--TGYVATRW 194
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
           Y  PE +            +  +      D+++ G ++AEL+TG+
Sbjct: 195 YRAPEIM------------LNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 92/225 (40%), Gaps = 42/225 (18%)
Query: 287 IEEATNNFDESRIIGRGGFGNV--YFGLLGDREAAIKKMRSN-----KSKEFFAELKVLC 339
           I E    +     +G G +G+V   F        A+KK+         +K  + EL++L 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 340 KIHHINV--FISTFGNGSLSDHLHDPLLKGH------------QPLTWTARTQIALDAAK 385
            + H NV   +  F      +  +D  L  H            Q LT      +     +
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKSQKLTDDHVQFLIYQILR 136
Query: 386 GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPG 445
           G++YIH    A  +HRD+K SN+ +++    K+ DFGL     R  + EM  T  V T  
Sbjct: 137 GLKYIH---SADIIHRDLKPSNLAVNEDSELKILDFGLC----RHTDDEM--TGYVATRW 187
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
           Y  PE +            +  +      D+++ G ++AEL+TG+
Sbjct: 188 YRAPEIM------------LNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/240 (24%), Positives = 95/240 (39%), Gaps = 77/240 (32%)
Query: 297 SRIIGRGGFGNVY----FGLLGDREAAIKKMRSNKS------KEFFAELKVLCKIHHINV 346
            R +G G FG V+    + L   ++  +  +++ K       K+F  E ++L  + H ++
Sbjct: 20  KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 79
Query: 347 --FISTFGNGSLSDHLHDPL---------------LKGHQP----------------LTW 373
             F    G+G       DPL               L+ H P                L  
Sbjct: 80  VKFYGVCGDG-------DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGL 132
Query: 374 TARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK-----LEE 428
           +    IA   A G+ Y+       +VHRD+ T N L+   L  K+ DFG+ +        
Sbjct: 133 SQMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYY 189
Query: 429 RTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
           R     ML  R      ++PPE I  ++F             TT++DV++FGV+L E+ T
Sbjct: 190 RVGGHTMLPIR------WMPPESIMYRKF-------------TTESDVWSFGVILWEIFT 230

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/121 (33%), Positives = 59/121 (48%), Gaps = 20/121 (16%)
Query: 386 GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPG 445
            +EY H H   + VHRD+K  N+LLD+ L  K+ADFGL  +    N    L T   G+P 
Sbjct: 115 AVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN---FLKTS-CGSPN 167
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKMKS 505
           Y  PE I  K            L    + DV++ GV+L  ++  +R    D+S P   K+
Sbjct: 168 YAAPEVISGK------------LYAGPEVDVWSCGVILYVMLC-RRLPFDDESIPVLFKN 214
Query: 506 L 506
           +
Sbjct: 215 I 215

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/228 (21%), Positives = 98/228 (42%), Gaps = 50/228 (21%)
Query: 291 TNNFDESRIIGRGGFGNVYFG--LLGDREAAIKKMRSNKSKE------FFAELKVLCKIH 342
           ++ ++   I+G GG   V+    L   R+ A+K +R++ +++      F  E +    ++
Sbjct: 28  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 87
Query: 343 HINVFISTFGNG--------------------SLSDHLHDPLLKGHQPLTWTARTQIALD 382
           H  + ++ +  G                    +L D +H        P+T     ++  D
Sbjct: 88  HPAI-VAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT-----EGPMTPKRAIEVIAD 141
Query: 383 AAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVG 442
           A + + + H +     +HRD+K +NI++      KV DFG+ +    +         ++G
Sbjct: 142 ACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIG 198
Query: 443 TPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
           T  YL PE     + R D         V  ++DV++ G VL E++TG+
Sbjct: 199 TAQYLSPE-----QARGD--------SVDARSDVYSLGCVLYEVLTGE 233

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 91/219 (41%), Gaps = 37/219 (16%)
Query: 292 NNFDESRIIGRGGFGNVYFGLLGDREA--AIKKMRS------NKSKEFFAELKVLCKIHH 343
           ++F+  R IG+G FG V      D +   A+K M        N+ +  F EL+++  + H
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 344 ---INVFISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAK--------GIEYIHD 392
              +N++ S F +      + D LL G              +  K         ++Y+ +
Sbjct: 75  PFLVNLWYS-FQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQN 133
Query: 393 HTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYI 452
               R +HRD+K  NILLD+     + DF +  +  R    E   T + GT  Y+ PE  
Sbjct: 134 Q---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR----ETQITTMAGTKPYMAPE-- 184
Query: 453 FVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKR 491
                   M SS      +   D ++ GV   EL+ G+R
Sbjct: 185 --------MFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 91/225 (40%), Gaps = 42/225 (18%)
Query: 287 IEEATNNFDESRIIGRGGFGNV--YFGLLGDREAAIKKMRSN-----KSKEFFAELKVLC 339
           I E    +     +G G +G+V   F        A+KK+         +K  + EL++L 
Sbjct: 40  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 99
Query: 340 KIHHINV--FISTFGNGSLSDHLHDPLLKGH------------QPLTWTARTQIALDAAK 385
            + H NV   +  F      +  +D  L  H            Q LT      +     +
Sbjct: 100 HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 159
Query: 386 GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPG 445
           G++YIH    A  +HRD+K SN+ +++    K+ DFGL     R  + EM     V T  
Sbjct: 160 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA----RHTDDEMXG--YVATRW 210
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
           Y  PE +            +  +      D+++ G ++AEL+TG+
Sbjct: 211 YRAPEIM------------LNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 89/211 (42%), Gaps = 36/211 (17%)
Query: 300 IGRGGFGNV--YFGLLGDREAAIKKMRSNKSKEF----FAELKVLCKIHHINVF-ISTFG 352
           IG G +G V   +  L     AI+K+   + + +      E+K+L +  H N+  I+   
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 353 NGSLSDHLHD-------------PLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYV 399
                + + D              LLK  Q L+            +G++YIH    A  +
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIH---SANVL 150
Query: 400 HRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRF 459
           HRD+K SN+LL+     K+ DFGL ++ +  ++     T  V T  Y  PE +   +   
Sbjct: 151 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK--- 207
Query: 460 DMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
                      T   D+++ G +LAE+++ +
Sbjct: 208 ---------GYTKSIDIWSVGCILAEMLSNR 229

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 66/235 (28%), Positives = 103/235 (43%), Gaps = 49/235 (20%)
Query: 289 EATNNFDESRIIGRGGFGNVYFGL--LGDREAAIKKMRSNKSKE-----FFAELKVLCKI 341
           E   NF +   IG G +G VY     L     A+KK+R +   E        E+ +L ++
Sbjct: 7   EFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 66
Query: 342 HHINVF-----ISTFGNGSLS-DHLHDPLLKGHQPLTWTARTQIALDAAK--------GI 387
           +H N+      I T     L  + LH  L K    +  +A T I L   K        G+
Sbjct: 67  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKF---MDASALTGIPLPLIKSYLFQLLQGL 123
Query: 388 EYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK---LEERTNEKEMLATRLVGTP 444
            + H H   R +HRD+K  N+L++     K+ADFGL +   +  RT   E++      T 
Sbjct: 124 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV------TL 174
Query: 445 GYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE 499
            Y  PE +   ++             +T  D+++ G + AE++T +RAL   DSE
Sbjct: 175 WYRAPEILLGCKY------------YSTAVDIWSLGCIFAEMVT-RRALFPGDSE 216

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 87/208 (41%), Gaps = 40/208 (19%)
Query: 300 IGRGGFGNVYFGLLGDRE--AAIKKMRSN--KSKEFFAELKVLCKIHHIN---------- 345
           +G G +G VY G+        A+K ++ +  + +EF  E  V+ +I H N          
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 85
Query: 346 -----VFISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVH 400
                + I     G+L D+L +      Q +       +A   +  +EY+    K  ++H
Sbjct: 86  EPPFYIIIEFMTYGNLLDYLREC---NRQEVNAVVLLYMATQISSAMEYLE---KKNFIH 139
Query: 401 RDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFD 460
           RD+   N L+ +    KVADFGL +L        M         G   P        ++ 
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRL--------MTGDTYTAHAGAKFP-------IKWT 184
Query: 461 MHSSVMELQVTTKTDVFAFGVVLAELIT 488
              S+   + + K+DV+AFGV+L E+ T
Sbjct: 185 APESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 70/156 (44%), Gaps = 31/156 (19%)
Query: 387 IEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGY 446
           ++Y H H     VHRD+K  N+LLD  + AK+ADFGL  +    ++ E L T   G+P Y
Sbjct: 124 VDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNM---MSDGEFLRTS-CGSPNY 176
Query: 447 LPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKMKSL 506
             PE I  +            L    + D+++ GV+L  L+ G      D+  PT  K +
Sbjct: 177 AAPEVISGR------------LYAGPEVDIWSCGVILYALLCGTLPF-DDEHVPTLFKKI 223
Query: 507 ITIMAAVAEWC-----------LNEDAVDRPEMRDI 531
              +  + E+            L  D + R  ++DI
Sbjct: 224 RGGVFYIPEYLNRSVATLLMHMLQVDPLKRATIKDI 259

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 102/231 (44%), Gaps = 49/231 (21%)
Query: 293 NFDESRIIGRGGFGNVYFGL--LGDREAAIKKMRSNKSKE-----FFAELKVLCKIHHIN 345
           NF +   IG G +G VY     L     A+KK+R +   E        E+ +L +++H N
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 346 VF-----ISTFGNGSLS-DHLHDPLLKGHQPLTWTARTQIALDAAK--------GIEYIH 391
           +      I T     L  + LH  L K    +  +A T I L   K        G+ + H
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLHQDLKKF---MDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 392 DHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK---LEERTNEKEMLATRLVGTPGYLP 448
            H   R +HRD+K  N+L++     K+ADFGL +   +  RT   E++      T  Y  
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV------TLWYRA 171
Query: 449 PEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE 499
           PE +   ++             +T  D+++ G + AE++T +RAL   DSE
Sbjct: 172 PEILLGXKY------------YSTAVDIWSLGCIFAEMVT-RRALFPGDSE 209

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 92/224 (41%), Gaps = 49/224 (21%)
Query: 290 ATNNFDESRIIGRGGFGNVYFGLLGDRE--AAIKKM------RSNKSKEFFAELKVLCKI 341
           A  +F+  R +G+G FGNVY     + +   A+K +      ++    +   E+++   +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 342 HHINVFISTFGNGSLSDHLHDP----LLKGHQPLTWTARTQIAL---DAAKGIEYIHD-- 392
            H N+         L  + HD     L+  + PL    R    L   D  +   YI +  
Sbjct: 66  RHPNIL-------RLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 118
Query: 393 ------HTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGY 446
                 H+K + +HRDIK  N+LL      K+ADFG        +        L GT  Y
Sbjct: 119 NALSYCHSK-KVIHRDIKPENLLLGSAGELKIADFGWS-----VHAPSSRRAALCGTLDY 172
Query: 447 LPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
           LPPE I  +     MH          K D+++ GV+  E + GK
Sbjct: 173 LPPEMIEGR-----MHDE--------KVDLWSLGVLCYEFLVGK 203

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 87/208 (41%), Gaps = 40/208 (19%)
Query: 300 IGRGGFGNVYFGLLGDRE--AAIKKMRSN--KSKEFFAELKVLCKIHHIN---------- 345
           +G G +G VY G+        A+K ++ +  + +EF  E  V+ +I H N          
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 81
Query: 346 -----VFISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVH 400
                + I     G+L D+L +      Q +       +A   +  +EY+    K  ++H
Sbjct: 82  EPPFYIIIEFMTYGNLLDYLREC---NRQEVNAVVLLYMATQISSAMEYLE---KKNFIH 135
Query: 401 RDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFD 460
           RD+   N L+ +    KVADFGL +L        M         G   P        ++ 
Sbjct: 136 RDLAARNCLVGENHLVKVADFGLSRL--------MTGDTXTAHAGAKFP-------IKWT 180
Query: 461 MHSSVMELQVTTKTDVFAFGVVLAELIT 488
              S+   + + K+DV+AFGV+L E+ T
Sbjct: 181 APESLAYNKFSIKSDVWAFGVLLWEIAT 208

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 89/211 (42%), Gaps = 36/211 (17%)
Query: 300 IGRGGFGNV--YFGLLGDREAAIKKMRSNKSKEF----FAELKVLCKIHHINVF-ISTFG 352
           IG G +G V   +  +     AIKK+   + + +      E+K+L +  H N+  I+   
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 92
Query: 353 NGSLSDHLHD-------------PLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYV 399
                + + D              LLK  Q L+            +G++YIH    A  +
Sbjct: 93  RAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIH---SANVL 148
Query: 400 HRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRF 459
           HRD+K SN+LL+     K+ DFGL ++ +  ++     T  V T  Y  PE +   +   
Sbjct: 149 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK--- 205
Query: 460 DMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
                      T   D+++ G +LAE+++ +
Sbjct: 206 ---------GYTKSIDIWSVGCILAEMLSNR 227

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 89/211 (42%), Gaps = 36/211 (17%)
Query: 300 IGRGGFGNV--YFGLLGDREAAIKKMRSNKSKEF----FAELKVLCKIHHINVF-ISTFG 352
           IG G +G V   +  +     AIKK+   + + +      E+K+L +  H N+  I+   
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 353 NGSLSDHLHD-------------PLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYV 399
                + + D              LLK  Q L+            +G++YIH    A  +
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIH---SANVL 146
Query: 400 HRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRF 459
           HRD+K SN+LL+     K+ DFGL ++ +  ++     T  V T  Y  PE +   +   
Sbjct: 147 HRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK--- 203
Query: 460 DMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
                      T   D+++ G +LAE+++ +
Sbjct: 204 ---------GYTKSIDIWSVGCILAEMLSNR 225

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 89/211 (42%), Gaps = 36/211 (17%)
Query: 300 IGRGGFGNV--YFGLLGDREAAIKKMRSNKSKEF----FAELKVLCKIHHINVF-ISTFG 352
           IG G +G V   +  +     AIKK+   + + +      E+K+L +  H N+  I+   
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 353 NGSLSDHLHD-------------PLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYV 399
                + + D              LLK  Q L+            +G++YIH    A  +
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIH---SANVL 146
Query: 400 HRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRF 459
           HRD+K SN+LL+     K+ DFGL ++ +  ++     T  V T  Y  PE +   +   
Sbjct: 147 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK--- 203
Query: 460 DMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
                      T   D+++ G +LAE+++ +
Sbjct: 204 ---------GYTKSIDIWSVGCILAEMLSNR 225

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 68/272 (25%), Positives = 104/272 (38%), Gaps = 64/272 (23%)
Query: 260 SQGQCKENTEDVTVLESE-----------RTIIFS-------LEEIEEATNNFDESRIIG 301
            QG CK+  +++T L  E            +I F+       LE      N F + R++G
Sbjct: 134 EQGPCKDLFQELTRLTHEYLSVAPFADYLDSIYFNRFLQWKWLERQPVTKNTFRQYRVLG 193
Query: 302 RGGFGNV---------------------YFGLLGDREAAIKKMRSNK-SKEFFAELKVLC 339
           +GGFG V                          G+  A  +K    K +  F   L    
Sbjct: 194 KGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAY 253
Query: 340 KIHHINVFISTFGNGS-LSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARY 398
           +       + T  NG  L  H++     G            A +   G+E +H   + R 
Sbjct: 254 ETKDALCLVLTLMNGGDLKFHIYH---MGQAGFPEARAVFYAAEICCGLEDLH---RERI 307
Query: 399 VHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFR 458
           V+RD+K  NILLDD    +++D GL        E + +  R VGT GY+ PE +  +R+ 
Sbjct: 308 VYRDLKPENILLDDHGHIRISDLGLAV---HVPEGQTIKGR-VGTVGYMAPEVVKNERYT 363
Query: 459 FDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
           F               D +A G +L E+I G+
Sbjct: 364 FS-------------PDWWALGCLLYEMIAGQ 382

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 89/211 (42%), Gaps = 36/211 (17%)
Query: 300 IGRGGFGNV--YFGLLGDREAAIKKMRSNKSKEF----FAELKVLCKIHHINVF-ISTFG 352
           IG G +G V   +  +     AIKK+   + + +      E+K+L +  H N+  I+   
Sbjct: 39  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 98
Query: 353 NGSLSDHLHD-------------PLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYV 399
                + + D              LLK  Q L+            +G++YIH    A  +
Sbjct: 99  RAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIH---SANVL 154
Query: 400 HRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRF 459
           HRD+K SN+LL+     K+ DFGL ++ +  ++     T  V T  Y  PE +   +   
Sbjct: 155 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK--- 211
Query: 460 DMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
                      T   D+++ G +LAE+++ +
Sbjct: 212 ---------GYTKSIDIWSVGCILAEMLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 89/211 (42%), Gaps = 36/211 (17%)
Query: 300 IGRGGFGNV--YFGLLGDREAAIKKMRSNKSKEF----FAELKVLCKIHHINVF-ISTFG 352
           IG G +G V   +  +     AIKK+   + + +      E+K+L +  H N+  I+   
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 353 NGSLSDHLHD-------------PLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYV 399
                + + D              LLK  Q L+            +G++YIH    A  +
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIH---SANVL 146
Query: 400 HRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRF 459
           HRD+K SN+LL+     K+ DFGL ++ +  ++     T  V T  Y  PE +   +   
Sbjct: 147 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK--- 203
Query: 460 DMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
                      T   D+++ G +LAE+++ +
Sbjct: 204 ---------GYTKSIDIWSVGCILAEMLSNR 225

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 59/242 (24%), Positives = 98/242 (40%), Gaps = 54/242 (22%)
Query: 281 IFSLEEIEEATNNFDESRIIGRGGFGNVYFG-----LLGDREAAIKKMRSNKSK------ 329
           +F  +E E +       R +G+G FG VY G     + G+ E  +     N+S       
Sbjct: 6   VFVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI 65
Query: 330 EFFAELKVLCKI--HHIN-------------VFISTFGNGSLSDHL--------HDPLLK 366
           EF  E  V+     HH+              V +    +G L  +L        ++P   
Sbjct: 66  EFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNP--- 122
Query: 367 GHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKL 426
           G  P T     Q+A + A G+ Y++     ++VHRD+   N ++      K+ DFG+ + 
Sbjct: 123 GRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRD 179
Query: 427 EERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAEL 486
              T+          G  G LP         R+    S+ +   TT +D+++FGVVL E+
Sbjct: 180 IXETDXXRK------GGKGLLP--------VRWMAPESLKDGVFTTSSDMWSFGVVLWEI 225
Query: 487 IT 488
            +
Sbjct: 226 TS 227

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/234 (24%), Positives = 98/234 (41%), Gaps = 40/234 (17%)
Query: 274 LESERTIIFSLEEIEEATNNFDESRIIGRGGFGNVYFGLLGDRE--AAIKKMRSN--KSK 329
           L +E     S+++ E    +      +G G +G VY G+        A+K ++ +  + +
Sbjct: 14  LGTENLYFQSMDKWEMERTDITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEVE 73
Query: 330 EFFAELKVLCKIHHINV-------------FIST--FGNGSLSDHLHDPLLKGHQPLTWT 374
           EF  E  V+ +I H N+             +I T     G+L D+L +      + +T  
Sbjct: 74  EFLKEAAVMKEIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYLREC---NREEVTAV 130
Query: 375 ARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKE 434
               +A   +  +EY+    K  ++HRD+   N L+ +    KVADFGL +L        
Sbjct: 131 VLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHVVKVADFGLSRL-------- 179
Query: 435 MLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
           M         G   P        ++    S+     + K+DV+AFGV+L E+ T
Sbjct: 180 MTGDTYTAHAGAKFP-------IKWTAPESLAYNTFSIKSDVWAFGVLLWEIAT 226

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 91/225 (40%), Gaps = 42/225 (18%)
Query: 287 IEEATNNFDESRIIGRGGFGNVYFGL---LGDREAAIKKMRSNKS----KEFFAELKVLC 339
           I E    +     +G G +G+V        G R A  K  R  +S    K  + EL++L 
Sbjct: 13  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLK 72
Query: 340 KIHHINV--FISTFGNGSLSDHLHDPLLKGH------------QPLTWTARTQIALDAAK 385
            + H NV   +  F      +  +D  L  H              LT      +     +
Sbjct: 73  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCAKLTDDHVQFLIYQILR 132
Query: 386 GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPG 445
           G++YIH    A  +HRD+K SN+ +++    K+ DFGL     R  + EM  T  V T  
Sbjct: 133 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA----RHTDDEM--TGYVATRW 183
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
           Y  PE +            +  +      D+++ G ++AEL+TG+
Sbjct: 184 YRAPEIM------------LNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 89/211 (42%), Gaps = 36/211 (17%)
Query: 300 IGRGGFGNV--YFGLLGDREAAIKKMRSNKSKEF----FAELKVLCKIHHINVF-ISTFG 352
           IG G +G V   +  +     AIKK+   + + +      E+K+L +  H N+  I+   
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 353 NGSLSDHLHD-------------PLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYV 399
                + + D              LLK  Q L+            +G++YIH    A  +
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIH---SANVL 146
Query: 400 HRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRF 459
           HRD+K SN+LL+     K+ DFGL ++ +  ++     T  V T  Y  PE +   +   
Sbjct: 147 HRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK--- 203
Query: 460 DMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
                      T   D+++ G +LAE+++ +
Sbjct: 204 ---------GYTKSIDIWSVGCILAEMLSNR 225

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 90/208 (43%), Gaps = 40/208 (19%)
Query: 300 IGRGGFGNVYFGLLGDRE--AAIKKMRSN--KSKEFFAELKVLCKIHHINV--------- 346
           +G G +G VY G+        A+K ++ +  + +EF  E  V+ +I H N+         
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80
Query: 347 -----FISTFGN-GSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVH 400
                 I+ F   G+L D+L +      Q ++      +A   +  +EY+    K  ++H
Sbjct: 81  EPPFYIITEFMTYGNLLDYLREC---NRQEVSAVVLLYMATQISSAMEYLE---KKNFIH 134
Query: 401 RDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFD 460
           RD+   N L+ +    KVADFGL +L        M         G   P        ++ 
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRL--------MTGDTYTAHAGAKFP-------IKWT 179
Query: 461 MHSSVMELQVTTKTDVFAFGVVLAELIT 488
              S+   + + K+DV+AFGV+L E+ T
Sbjct: 180 APESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 103/234 (44%), Gaps = 49/234 (20%)
Query: 290 ATNNFDESRIIGRGGFGNVYFGL--LGDREAAIKKMRSNKSKE-----FFAELKVLCKIH 342
           +  NF +   IG G +G VY     L     A+KK+R +   E        E+ +L +++
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 343 HINVF-----ISTFGNGSLS-DHLHDPLLKGHQPLTWTARTQIALDAAK--------GIE 388
           H N+      I T     L  + LH  L K    +  +A T I L   K        G+ 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKF---MDASALTGIPLPLIKSYLFQLLQGLA 117
Query: 389 YIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK---LEERTNEKEMLATRLVGTPG 445
           + H H   R +HRD+K  N+L++     K+ADFGL +   +  RT   E++      T  
Sbjct: 118 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV------TLW 168
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE 499
           Y  PE +   ++             +T  D+++ G + AE++T +RAL   DSE
Sbjct: 169 YRAPEILLGCKY------------YSTAVDIWSLGCIFAEMVT-RRALFPGDSE 209

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 89/208 (42%), Gaps = 40/208 (19%)
Query: 300 IGRGGFGNVYFGLLGDRE--AAIKKMRSN--KSKEFFAELKVLCKIHHINV--------- 346
           +G G +G VY G+        A+K ++ +  + +EF  E  V+ +I H N+         
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 81
Query: 347 -----FISTFGN-GSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVH 400
                 I+ F   G+L D+L +      Q +       +A   +  +EY+    K  ++H
Sbjct: 82  EPPFYIITEFMTYGNLLDYLREC---NRQEVNAVVLLYMATQISSAMEYLE---KKNFIH 135
Query: 401 RDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFD 460
           RD+   N L+ +    KVADFGL +L        M         G   P        ++ 
Sbjct: 136 RDLAARNCLVGENHLVKVADFGLSRL--------MTGDTYTAPAGAKFP-------IKWT 180
Query: 461 MHSSVMELQVTTKTDVFAFGVVLAELIT 488
              S+   + + K+DV+AFGV+L E+ T
Sbjct: 181 APESLAYNKFSIKSDVWAFGVLLWEIAT 208

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 59/242 (24%), Positives = 98/242 (40%), Gaps = 54/242 (22%)
Query: 281 IFSLEEIEEATNNFDESRIIGRGGFGNVYFG-----LLGDREAAIKKMRSNKSK------ 329
           +F  +E E +       R +G+G FG VY G     + G+ E  +     N+S       
Sbjct: 3   VFVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI 62
Query: 330 EFFAELKVLCKI--HHIN-------------VFISTFGNGSLSDHL--------HDPLLK 366
           EF  E  V+     HH+              V +    +G L  +L        ++P   
Sbjct: 63  EFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNP--- 119
Query: 367 GHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKL 426
           G  P T     Q+A + A G+ Y++     ++VHRD+   N ++      K+ DFG+ + 
Sbjct: 120 GRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRD 176
Query: 427 EERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAEL 486
              T+          G  G LP         R+    S+ +   TT +D+++FGVVL E+
Sbjct: 177 IXETDXXRK------GGKGLLP--------VRWMAPESLKDGVFTTSSDMWSFGVVLWEI 222
Query: 487 IT 488
            +
Sbjct: 223 TS 224

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 102/231 (44%), Gaps = 49/231 (21%)
Query: 293 NFDESRIIGRGGFGNVYFGL--LGDREAAIKKMRSNKSKE-----FFAELKVLCKIHHIN 345
           NF +   IG G +G VY     L     A+KK+R +   E        E+ +L +++H N
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 346 VF-----ISTFGNGSLS-DHLHDPLLKGHQPLTWTARTQIALDAAK--------GIEYIH 391
           +      I T     L  + LH  L K    +  +A T I L   K        G+ + H
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLHQDLKKF---MDASALTGIPLPLIKSYLFQLLQGLSFCH 120
Query: 392 DHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK---LEERTNEKEMLATRLVGTPGYLP 448
            H   R +HRD+K  N+L++     K+ADFGL +   +  RT   E++      T  Y  
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV------TLWYRA 171
Query: 449 PEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE 499
           PE +   ++             +T  D+++ G + AE++T +RAL   DSE
Sbjct: 172 PEILLGCKY------------YSTAVDIWSLGCIFAEMVT-RRALFPGDSE 209

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 103/234 (44%), Gaps = 49/234 (20%)
Query: 290 ATNNFDESRIIGRGGFGNVYFGL--LGDREAAIKKMRSNKSKE-----FFAELKVLCKIH 342
           +  NF +   IG G +G VY     L     A+KK+R +   E        E+ +L +++
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 343 HINVF-----ISTFGNGSLS-DHLHDPLLKGHQPLTWTARTQIALDAAK--------GIE 388
           H N+      I T     L  + LH  L K    +  +A T I L   K        G+ 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKF---MDASALTGIPLPLIKSYLFQLLQGLA 117
Query: 389 YIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK---LEERTNEKEMLATRLVGTPG 445
           + H H   R +HRD+K  N+L++     K+ADFGL +   +  RT   E++      T  
Sbjct: 118 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV------TLW 168
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE 499
           Y  PE +   ++             +T  D+++ G + AE++T +RAL   DSE
Sbjct: 169 YRAPEILLGCKY------------YSTAVDIWSLGCIFAEMVT-RRALFPGDSE 209

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 89/211 (42%), Gaps = 36/211 (17%)
Query: 300 IGRGGFGNV--YFGLLGDREAAIKKMRSNKSKEF----FAELKVLCKIHHINVF-ISTFG 352
           IG G +G V   +  +     AIKK+   + + +      E+K+L +  H N+  I+   
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 110
Query: 353 NGSLSDHLHD-------------PLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYV 399
                + + D              LLK  Q L+            +G++YIH    A  +
Sbjct: 111 RAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIH---SANVL 166
Query: 400 HRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRF 459
           HRD+K SN+LL+     K+ DFGL ++ +  ++     T  V T  Y  PE +   +   
Sbjct: 167 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK--- 223
Query: 460 DMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
                      T   D+++ G +LAE+++ +
Sbjct: 224 ---------GYTKSIDIWSVGCILAEMLSNR 245

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 103/234 (44%), Gaps = 49/234 (20%)
Query: 290 ATNNFDESRIIGRGGFGNVYFGL--LGDREAAIKKMRSNKSKE-----FFAELKVLCKIH 342
           +  NF +   IG G +G VY     L     A+KK+R +   E        E+ +L +++
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 343 HINVF-----ISTFGNGSLS-DHLHDPLLKGHQPLTWTARTQIALDAAK--------GIE 388
           H N+      I T     L  + LH  L K    +  +A T I L   K        G+ 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKF---MDASALTGIPLPLIKSYLFQLLQGLA 120
Query: 389 YIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK---LEERTNEKEMLATRLVGTPG 445
           + H H   R +HRD+K  N+L++     K+ADFGL +   +  RT   E++      T  
Sbjct: 121 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV------TLW 171
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE 499
           Y  PE +   ++             +T  D+++ G + AE++T +RAL   DSE
Sbjct: 172 YRAPEILLGCKY------------YSTAVDIWSLGCIFAEMVT-RRALFPGDSE 212

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 103/234 (44%), Gaps = 49/234 (20%)
Query: 290 ATNNFDESRIIGRGGFGNVYFGL--LGDREAAIKKMRSNKSKE-----FFAELKVLCKIH 342
           +  NF +   IG G +G VY     L     A+KK+R +   E        E+ +L +++
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 343 HINVF-----ISTFGNGSLS-DHLHDPLLKGHQPLTWTARTQIALDAAK--------GIE 388
           H N+      I T     L  + LH  L K    +  +A T I L   K        G+ 
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKF---MDASALTGIPLPLIKSYLFQLLQGLA 119
Query: 389 YIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK---LEERTNEKEMLATRLVGTPG 445
           + H H   R +HRD+K  N+L++     K+ADFGL +   +  RT   E++      T  
Sbjct: 120 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV------TLW 170
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE 499
           Y  PE +   ++             +T  D+++ G + AE++T +RAL   DSE
Sbjct: 171 YRAPEILLGCKY------------YSTAVDIWSLGCIFAEMVT-RRALFPGDSE 211

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 103/234 (44%), Gaps = 49/234 (20%)
Query: 290 ATNNFDESRIIGRGGFGNVYFGL--LGDREAAIKKMRSNKSKE-----FFAELKVLCKIH 342
           +  NF +   IG G +G VY     L     A+KK+R +   E        E+ +L +++
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 343 HINVF-----ISTFGNGSLS-DHLHDPLLKGHQPLTWTARTQIALDAAK--------GIE 388
           H N+      I T     L  + LH  L K    +  +A T I L   K        G+ 
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKF---MDASALTGIPLPLIKSYLFQLLQGLA 118
Query: 389 YIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK---LEERTNEKEMLATRLVGTPG 445
           + H H   R +HRD+K  N+L++     K+ADFGL +   +  RT   E++      T  
Sbjct: 119 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV------TLW 169
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE 499
           Y  PE +   ++             +T  D+++ G + AE++T +RAL   DSE
Sbjct: 170 YRAPEILLGCKY------------YSTAVDIWSLGCIFAEMVT-RRALFPGDSE 210

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 90/208 (43%), Gaps = 40/208 (19%)
Query: 300 IGRGGFGNVYFGLLGDRE--AAIKKMRSN--KSKEFFAELKVLCKIHHINV--------- 346
           +G G +G VY G+        A+K ++ +  + +EF  E  V+ +I H N+         
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 85
Query: 347 -----FISTFGN-GSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVH 400
                 I+ F   G+L D+L +      Q ++      +A   +  +EY+    K  ++H
Sbjct: 86  EPPFYIITEFMTYGNLLDYLREC---NRQEVSAVVLLYMATQISSAMEYLE---KKNFIH 139
Query: 401 RDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFD 460
           RD+   N L+ +    KVADFGL +L        M         G   P        ++ 
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRL--------MTGDTYTAHAGAKFP-------IKWT 184
Query: 461 MHSSVMELQVTTKTDVFAFGVVLAELIT 488
              S+   + + K+DV+AFGV+L E+ T
Sbjct: 185 APESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 103/234 (44%), Gaps = 49/234 (20%)
Query: 290 ATNNFDESRIIGRGGFGNVYFGL--LGDREAAIKKMRSNKSKE-----FFAELKVLCKIH 342
           +  NF +   IG G +G VY     L     A+KK+R +   E        E+ +L +++
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 343 HINVF-----ISTFGNGSLS-DHLHDPLLKGHQPLTWTARTQIALDAAK--------GIE 388
           H N+      I T     L  + LH  L K    +  +A T I L   K        G+ 
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKF---MDASALTGIPLPLIKSYLFQLLQGLA 119
Query: 389 YIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK---LEERTNEKEMLATRLVGTPG 445
           + H H   R +HRD+K  N+L++     K+ADFGL +   +  RT   E++      T  
Sbjct: 120 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV------TLW 170
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE 499
           Y  PE +   ++             +T  D+++ G + AE++T +RAL   DSE
Sbjct: 171 YRAPEILLGCKY------------YSTAVDIWSLGCIFAEMVT-RRALFPGDSE 211

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 103/234 (44%), Gaps = 49/234 (20%)
Query: 290 ATNNFDESRIIGRGGFGNVYFGL--LGDREAAIKKMRSNKSKE-----FFAELKVLCKIH 342
           +  NF +   IG G +G VY     L     A+KK+R +   E        E+ +L +++
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 343 HINVF-----ISTFGNGSLS-DHLHDPLLKGHQPLTWTARTQIALDAAK--------GIE 388
           H N+      I T     L  + LH  L K    +  +A T I L   K        G+ 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKF---MDASALTGIPLPLIKSYLFQLLQGLA 117
Query: 389 YIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK---LEERTNEKEMLATRLVGTPG 445
           + H H   R +HRD+K  N+L++     K+ADFGL +   +  RT   E++      T  
Sbjct: 118 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV------TLW 168
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE 499
           Y  PE +   ++             +T  D+++ G + AE++T +RAL   DSE
Sbjct: 169 YRAPEILLGCKY------------YSTAVDIWSLGCIFAEMVT-RRALFPGDSE 209

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/241 (24%), Positives = 97/241 (40%), Gaps = 45/241 (18%)
Query: 274 LESERTIIFSLE---EIEEATNNFDESRIIGRGGFGNV---YFGLLGDREAAIKKMRSNK 327
           +  ER   +  E    I E    +     +G G +G+V   +    G R A  K  R  +
Sbjct: 1   MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQ 60
Query: 328 S----KEFFAELKVLCKIHHINV--FISTFGNGSLSDHLHDPLLKGH------------Q 369
           S    K  + EL++L  + H NV   +  F      +  +D  L  H            Q
Sbjct: 61  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 370 PLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEER 429
            LT      +     +G++YIH    A  +HRD+K SN+ +++    K+ DF L     R
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFYLA----R 173
Query: 430 TNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
             + EM  T  V T  Y  PE +            +  +      D+++ G ++AEL+TG
Sbjct: 174 HTDDEM--TGYVATRWYRAPEIM------------LNWMHYNQTVDIWSVGCIMAELLTG 219
Query: 490 K 490
           +
Sbjct: 220 R 220

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 102/231 (44%), Gaps = 49/231 (21%)
Query: 293 NFDESRIIGRGGFGNVYFGL--LGDREAAIKKMRSNKSKE-----FFAELKVLCKIHHIN 345
           NF +   IG G +G VY     L     A+KK+R +   E        E+ +L +++H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 346 VF-----ISTFGNGSLS-DHLHDPLLKGHQPLTWTARTQIALDAAK--------GIEYIH 391
           +      I T     L  + LH  L K    +  +A T I L   K        G+ + H
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQDLKKF---MDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 392 DHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK---LEERTNEKEMLATRLVGTPGYLP 448
            H   R +HRD+K  N+L++     K+ADFGL +   +  RT   E++      T  Y  
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV------TLWYRA 170
Query: 449 PEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE 499
           PE +   ++             +T  D+++ G + AE++T +RAL   DSE
Sbjct: 171 PEILLGCKY------------YSTAVDIWSLGCIFAEMVT-RRALFPGDSE 208

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 103/234 (44%), Gaps = 49/234 (20%)
Query: 290 ATNNFDESRIIGRGGFGNVYFGL--LGDREAAIKKMRSNKSKE-----FFAELKVLCKIH 342
           +  NF +   IG G +G VY     L     A+KK+R +   E        E+ +L +++
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 343 HINVF-----ISTFGNGSLS-DHLHDPLLKGHQPLTWTARTQIALDAAK--------GIE 388
           H N+      I T     L  + LH  L K    +  +A T I L   K        G+ 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKF---MDASALTGIPLPLIKSYLFQLLQGLA 120
Query: 389 YIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK---LEERTNEKEMLATRLVGTPG 445
           + H H   R +HRD+K  N+L++     K+ADFGL +   +  RT   E++      T  
Sbjct: 121 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV------TLW 171
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE 499
           Y  PE +   ++             +T  D+++ G + AE++T +RAL   DSE
Sbjct: 172 YRAPEILLGCKY------------YSTAVDIWSLGCIFAEMVT-RRALFPGDSE 212

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 68/271 (25%), Positives = 104/271 (38%), Gaps = 64/271 (23%)
Query: 261 QGQCKENTEDVTVLESE-----------RTIIFS-------LEEIEEATNNFDESRIIGR 302
           QG CK+  +++T L  E            +I F+       LE      N F + R++G+
Sbjct: 135 QGPCKDLFQELTRLTHEYLSVAPFADYLDSIYFNRFLQWKWLERQPVTKNTFRQYRVLGK 194
Query: 303 GGFGNV---------------------YFGLLGDREAAIKKMRSNK-SKEFFAELKVLCK 340
           GGFG V                          G+  A  +K    K +  F   L    +
Sbjct: 195 GGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYE 254
Query: 341 IHHINVFISTFGNGS-LSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYV 399
                  + T  NG  L  H++     G            A +   G+E +H   + R V
Sbjct: 255 TKDALCLVLTLMNGGDLKFHIYH---MGQAGFPEARAVFYAAEICCGLEDLH---RERIV 308
Query: 400 HRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRF 459
           +RD+K  NILLDD    +++D GL        E + +  R VGT GY+ PE +  +R+ F
Sbjct: 309 YRDLKPENILLDDHGHIRISDLGLAV---HVPEGQTIKGR-VGTVGYMAPEVVKNERYTF 364
Query: 460 DMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
                          D +A G +L E+I G+
Sbjct: 365 S-------------PDWWALGCLLYEMIAGQ 382

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 59/242 (24%), Positives = 100/242 (41%), Gaps = 65/242 (26%)
Query: 290 ATNNFDESRIIGRGGFGNVYFGL--LGDREAAIKKMRSNKSKE-----FFAELKVLCKIH 342
           +  NF +   IG G +G VY     L     A+KK+R +   E        E+ +L +++
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 343 HINVF----------------------ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIA 380
           H N+                       + TF + S    +  PL+K +            
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLHQDLKTFMDASALTGIPLPLIKSY-----------L 112
Query: 381 LDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK---LEERTNEKEMLA 437
               +G+ + H H   R +HRD+K  N+L++     K+ADFGL +   +  RT   E++ 
Sbjct: 113 FQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV- 168
Query: 438 TRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDD 497
                T  Y  PE +   ++             +T  D+++ G + AE++T +RAL   D
Sbjct: 169 -----TLWYRAPEILLGCKY------------YSTAVDIWSLGCIFAEMVT-RRALFPGD 210
Query: 498 SE 499
           SE
Sbjct: 211 SE 212

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 102/231 (44%), Gaps = 49/231 (21%)
Query: 293 NFDESRIIGRGGFGNVYFGL--LGDREAAIKKMRSNKSKE-----FFAELKVLCKIHHIN 345
           NF +   IG G +G VY     L     A+KK+R +   E        E+ +L +++H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 346 VF-----ISTFGNGSLS-DHLHDPLLKGHQPLTWTARTQIALDAAK--------GIEYIH 391
           +      I T     L  +H+H  L      +  +A T I L   K        G+ + H
Sbjct: 63  IVKLLDVIHTENKLYLVFEHVHQDLKTF---MDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 392 DHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK---LEERTNEKEMLATRLVGTPGYLP 448
            H   R +HRD+K  N+L++     K+ADFGL +   +  RT   E++      T  Y  
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV------TLWYRA 170
Query: 449 PEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE 499
           PE +   ++             +T  D+++ G + AE++T +RAL   DSE
Sbjct: 171 PEILLGCKY------------YSTAVDIWSLGCIFAEMVT-RRALFPGDSE 208

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 37/127 (29%), Positives = 59/127 (46%), Gaps = 20/127 (15%)
Query: 365 LKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLV 424
           ++ H PL+             GI++ HD    R VHRDIK  NIL+D     K+ DFG+ 
Sbjct: 102 IESHGPLSVDTAINFTNQILDGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIA 158
Query: 425 KLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTK-TDVFAFGVVL 483
           K    T+  +     ++GT  Y  PE                + + T + TD+++ G+VL
Sbjct: 159 KALSETSLTQ--TNHVLGTVQYFSPEQ--------------AKGEATDECTDIYSIGIVL 202
Query: 484 AELITGK 490
            E++ G+
Sbjct: 203 YEMLVGE 209

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 37/118 (31%), Positives = 58/118 (49%), Gaps = 27/118 (22%)
Query: 386 GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKL----EERTNEKEMLATRLV 441
           G++++H       V+RD+K  NILLD     K+ADFG+ K     + +TNE         
Sbjct: 131 GLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNE-------FC 180
Query: 442 GTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE 499
           GTP Y+ PE +  +++    HS           D ++FGV+L E++ G+      D E
Sbjct: 181 GTPDYIAPEILLGQKYN---HS----------VDWWSFGVLLYEMLIGQSPFHGQDEE 225

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 102/231 (44%), Gaps = 49/231 (21%)
Query: 293 NFDESRIIGRGGFGNVYFGL--LGDREAAIKKMRSNKSKE-----FFAELKVLCKIHHIN 345
           NF +   IG G +G VY     L     A+KK+R +   E        E+ +L +++H N
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 346 VF-----ISTFGNGSLS-DHLHDPLLKGHQPLTWTARTQIALDAAK--------GIEYIH 391
           +      I T     L  + LH  L K    +  +A T I L   K        G+ + H
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLHQDLKKF---MDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 392 DHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK---LEERTNEKEMLATRLVGTPGYLP 448
            H   R +HRD+K  N+L++     K+ADFGL +   +  RT   E++      T  Y  
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV------TLWYRA 171
Query: 449 PEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE 499
           PE +   ++             +T  D+++ G + AE++T +RAL   DSE
Sbjct: 172 PEILLGCKY------------YSTAVDIWSLGCIFAEMVT-RRALFPGDSE 209

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 103/234 (44%), Gaps = 49/234 (20%)
Query: 290 ATNNFDESRIIGRGGFGNVYFGL--LGDREAAIKKMRSNKSKE-----FFAELKVLCKIH 342
           +  NF +   IG G +G VY     L     A+KK+R +   E        E+ +L +++
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 343 HINVF-----ISTFGNGSLS-DHLHDPLLKGHQPLTWTARTQIALDAAK--------GIE 388
           H N+      I T     L  + LH  L K    +  +A T I L   K        G+ 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKF---MDASALTGIPLPLIKSYLFQLLQGLA 117
Query: 389 YIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK---LEERTNEKEMLATRLVGTPG 445
           + H H   R +HRD+K  N+L++     K+ADFGL +   +  RT   E++      T  
Sbjct: 118 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV------TLW 168
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE 499
           Y  PE +   ++             +T  D+++ G + AE++T +RAL   DSE
Sbjct: 169 YRAPEILLGCKY------------YSTAVDIWSLGCIFAEMVT-RRALFPGDSE 209

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 102/231 (44%), Gaps = 49/231 (21%)
Query: 293 NFDESRIIGRGGFGNVYFGL--LGDREAAIKKMRSNKSKE-----FFAELKVLCKIHHIN 345
           NF +   IG G +G VY     L     A+KK+R +   E        E+ +L +++H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 346 VF-----ISTFGNGSLS-DHLHDPLLKGHQPLTWTARTQIALDAAK--------GIEYIH 391
           +      I T     L  + LH  L K    +  +A T I L   K        G+ + H
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQDLKKF---MDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 392 DHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK---LEERTNEKEMLATRLVGTPGYLP 448
            H   R +HRD+K  N+L++     K+ADFGL +   +  RT   E++      T  Y  
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV------TLWYRA 170
Query: 449 PEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE 499
           PE +   ++             +T  D+++ G + AE++T +RAL   DSE
Sbjct: 171 PEILLGCKY------------YSTAVDIWSLGCIFAEMVT-RRALFPGDSE 208

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 95/227 (41%), Gaps = 55/227 (24%)
Query: 290 ATNNFDESRIIGRGGFGNVYFGLLGDREA----AIKKM------RSNKSKEFFAELKVLC 339
           A  +F+  R +G+G FGNVY  L  ++++    A+K +      ++    +   E+++  
Sbjct: 11  ALEDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 68
Query: 340 KIHHINVFISTFGNGSLSDHLHDPLLKGHQPLTWTARTQI--------ALDAAKGIEYIH 391
            + H N+         L  + HD   + +  L +  R ++          D  +   YI 
Sbjct: 69  HLRHPNIL-------RLYGYFHDAT-RVYLILEYAPRGEVYKELQKLSKFDEQRTATYIT 120
Query: 392 D--------HTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGT 443
           +        H+K R +HRDIK  N+LL      K+ADFG        +        L GT
Sbjct: 121 ELANALSYCHSK-RVIHRDIKPENLLLGSAGELKIADFGWS-----VHAPSSRRXXLXGT 174
Query: 444 PGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
             YLPPE I  +     MH          K D+++ GV+  E + GK
Sbjct: 175 LDYLPPEMIEGR-----MHDE--------KVDLWSLGVLCYEFLVGK 208

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 101/236 (42%), Gaps = 48/236 (20%)
Query: 284 LEEIEEATNNFDESRIIGRGGFGNVYFGLLGDREA-----AIKKMRSNKS-----KEFFA 333
           LE++    N     +I+G G FG+V  G L   +      A+K M+ + S     +EF +
Sbjct: 26  LEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLS 85
Query: 334 ELKVLCKIHHINVF--------ISTFG------------NGSLSDHL-HDPLLKGHQPLT 372
           E   +    H NV         +S+ G             G L  +L +  L  G + + 
Sbjct: 86  EAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIP 145
Query: 373 WTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNE 432
                +  +D A G+EY+ +     ++HRD+   N +L D +   VADFGL K     + 
Sbjct: 146 LQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDY 202
Query: 433 KEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
                    G    +P ++I ++        S+ +   T+K+DV+AFGV + E+ T
Sbjct: 203 YRQ------GRIAKMPVKWIAIE--------SLADRVYTSKSDVWAFGVTMWEIAT 244

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 103/234 (44%), Gaps = 49/234 (20%)
Query: 290 ATNNFDESRIIGRGGFGNVYFGL--LGDREAAIKKMRSNKSKE-----FFAELKVLCKIH 342
           +  NF +   IG G +G VY     L     A+KK+R +   E        E+ +L +++
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 343 HINVF-----ISTFGNGSLS-DHLHDPLLKGHQPLTWTARTQIALDAAK--------GIE 388
           H N+      I T     L  + LH  L K    +  +A T I L   K        G+ 
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKF---MDASALTGIPLPLIKSYLFQLLQGLA 119
Query: 389 YIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK---LEERTNEKEMLATRLVGTPG 445
           + H H   R +HRD+K  N+L++     K+ADFGL +   +  RT   E++      T  
Sbjct: 120 FCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV------TLW 170
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE 499
           Y  PE +   ++             +T  D+++ G + AE++T +RAL   DSE
Sbjct: 171 YRAPEILLGCKY------------YSTAVDIWSLGCIFAEMVT-RRALFPGDSE 211

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 103/234 (44%), Gaps = 49/234 (20%)
Query: 290 ATNNFDESRIIGRGGFGNVYFGL--LGDREAAIKKMRSNKSKE-----FFAELKVLCKIH 342
           +  NF +   IG G +G VY     L     A+KK+R +   E        E+ +L +++
Sbjct: 5   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 64
Query: 343 HINVF-----ISTFGNGSLS-DHLHDPLLKGHQPLTWTARTQIALDAAK--------GIE 388
           H N+      I T     L  + LH  L K    +  +A T I L   K        G+ 
Sbjct: 65  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKF---MDASALTGIPLPLIKSYLFQLLQGLA 121
Query: 389 YIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK---LEERTNEKEMLATRLVGTPG 445
           + H H   R +HRD+K  N+L++     K+ADFGL +   +  RT   E++      T  
Sbjct: 122 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV------TLW 172
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE 499
           Y  PE +   ++             +T  D+++ G + AE++T +RAL   DSE
Sbjct: 173 YRAPEILLGCKY------------YSTAVDIWSLGCIFAEMVT-RRALFPGDSE 213

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 103/234 (44%), Gaps = 49/234 (20%)
Query: 290 ATNNFDESRIIGRGGFGNVYFGL--LGDREAAIKKMRSNKSKE-----FFAELKVLCKIH 342
           +  NF +   IG G +G VY     L     A+KK+R +   E        E+ +L +++
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 343 HINVF-----ISTFGNGSLS-DHLHDPLLKGHQPLTWTARTQIALDAAK--------GIE 388
           H N+      I T     L  + LH  L K    +  +A T I L   K        G+ 
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKF---MDASALTGIPLPLIKSYLFQLLQGLA 118
Query: 389 YIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK---LEERTNEKEMLATRLVGTPG 445
           + H H   R +HRD+K  N+L++     K+ADFGL +   +  RT   E++      T  
Sbjct: 119 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV------TLW 169
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE 499
           Y  PE +   ++             +T  D+++ G + AE++T +RAL   DSE
Sbjct: 170 YRAPEILLGCKY------------YSTAVDIWSLGCIFAEMVT-RRALFPGDSE 210

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 90/208 (43%), Gaps = 40/208 (19%)
Query: 300 IGRGGFGNVYFGLLGDRE--AAIKKMRSN--KSKEFFAELKVLCKIHHINV--------- 346
           +G G +G VY G+        A+K ++ +  + +EF  E  V+ +I H N+         
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80
Query: 347 -----FISTFGN-GSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVH 400
                 I+ F   G+L D+L +      Q ++      +A   +  +EY+    K  ++H
Sbjct: 81  EPPFYIITEFMTYGNLLDYLREC---NRQEVSAVVLLYMATQISSAMEYLE---KKNFIH 134
Query: 401 RDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFD 460
           RD+   N L+ +    KVADFGL +L        M         G   P        ++ 
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRL--------MTGDTYTAHAGAKFP-------IKWT 179
Query: 461 MHSSVMELQVTTKTDVFAFGVVLAELIT 488
              S+   + + K+DV+AFGV+L E+ T
Sbjct: 180 APESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 89/208 (42%), Gaps = 40/208 (19%)
Query: 300 IGRGGFGNVYFGLLGDRE--AAIKKMRSN--KSKEFFAELKVLCKIHHINV--------- 346
           +G G +G VY G+        A+K ++ +  + +EF  E  V+ +I H N+         
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 82
Query: 347 -----FISTFGN-GSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVH 400
                 I+ F   G+L D+L +      Q +       +A   +  +EY+    K  ++H
Sbjct: 83  EPPFYIITEFMTYGNLLDYLREC---NRQEVNAVVLLYMATQISSAMEYLE---KKNFIH 136
Query: 401 RDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFD 460
           RD+   N L+ +    KVADFGL +L        M         G   P        ++ 
Sbjct: 137 RDLAARNCLVGENHLVKVADFGLSRL--------MTGDTYTAPAGAKFP-------IKWT 181
Query: 461 MHSSVMELQVTTKTDVFAFGVVLAELIT 488
              S+   + + K+DV+AFGV+L E+ T
Sbjct: 182 APESLAYNKFSIKSDVWAFGVLLWEIAT 209

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 102/231 (44%), Gaps = 49/231 (21%)
Query: 293 NFDESRIIGRGGFGNVYFGL--LGDREAAIKKMRSNKSKE-----FFAELKVLCKIHHIN 345
           NF +   IG G +G VY     L     A+KK+R +   E        E+ +L +++H N
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 346 VF-----ISTFGNGSLS-DHLHDPLLKGHQPLTWTARTQIALDAAK--------GIEYIH 391
           +      I T     L  + LH  L K    +  +A T I L   K        G+ + H
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLHQDLKKF---MDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 392 DHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK---LEERTNEKEMLATRLVGTPGYLP 448
            H   R +HRD+K  N+L++     K+ADFGL +   +  RT   E++      T  Y  
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV------TLWYRA 171
Query: 449 PEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE 499
           PE +   ++             +T  D+++ G + AE++T +RAL   DSE
Sbjct: 172 PEILLGCKY------------YSTAVDIWSLGCIFAEMVT-RRALFPGDSE 209

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 103/234 (44%), Gaps = 49/234 (20%)
Query: 290 ATNNFDESRIIGRGGFGNVYFGL--LGDREAAIKKMRSNKSKE-----FFAELKVLCKIH 342
           +  NF +   IG G +G VY     L     A+KK+R +   E        E+ +L +++
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 343 HINVF-----ISTFGNGSLS-DHLHDPLLKGHQPLTWTARTQIALDAAK--------GIE 388
           H N+      I T     L  + LH  L K    +  +A T I L   K        G+ 
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKF---MDASALTGIPLPLIKSYLFQLLQGLA 118
Query: 389 YIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK---LEERTNEKEMLATRLVGTPG 445
           + H H   R +HRD+K  N+L++     K+ADFGL +   +  RT   E++      T  
Sbjct: 119 FCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV------TLW 169
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE 499
           Y  PE +   ++             +T  D+++ G + AE++T +RAL   DSE
Sbjct: 170 YRAPEILLGCKY------------YSTAVDIWSLGCIFAEMVT-RRALFPGDSE 210

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 67/281 (23%), Positives = 121/281 (43%), Gaps = 65/281 (23%)
Query: 298 RIIGRGGFGNVYFGLL---GDR---EAAIKKMRSNKSK----EFFAELKVLCKIHH---- 343
           +++G G FG VY G+    G+      AIK +          EF  E  ++  + H    
Sbjct: 44  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 103
Query: 344 ----------INVFISTFGNGSLSDHLHDPL--LKGHQPLTWTARTQIALDAAKGIEYIH 391
                     I +      +G L +++H+    +     L W  +       AKG+ Y+ 
Sbjct: 104 RLLGVCLSPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQI------AKGMMYLE 157
Query: 392 DHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEY 451
           +    R VHRD+   N+L+      K+ DFGL +L E  +EKE  A       G +P ++
Sbjct: 158 ER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLE-GDEKEYNADG-----GKMPIKW 208
Query: 452 IFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT--GK-------RAL--IRDDSEP 500
           + ++   +         + T ++DV+++GV + EL+T  GK       R +  + +  E 
Sbjct: 209 MALECIHYR--------KFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGER 260
Query: 501 TKMKSLITI---MAAVAEWCLNEDAVDRPEMRDIVAILSQI 538
                + TI   M  V  W ++ D+  RP+ +++ A  S++
Sbjct: 261 LPQPPICTIDVYMVMVKCWMIDADS--RPKFKELAAEFSRM 299

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 102/231 (44%), Gaps = 49/231 (21%)
Query: 293 NFDESRIIGRGGFGNVYFGL--LGDREAAIKKMRSNKSKE-----FFAELKVLCKIHHIN 345
           NF +   IG G +G VY     L     A+KK+R +   E        E+ +L +++H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 346 VF-----ISTFGNGSLS-DHLHDPLLKGHQPLTWTARTQIALDAAK--------GIEYIH 391
           +      I T     L  + LH  L K    +  +A T I L   K        G+ + H
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQDLKKF---MDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 392 DHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK---LEERTNEKEMLATRLVGTPGYLP 448
            H   R +HRD+K  N+L++     K+ADFGL +   +  RT   E++      T  Y  
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV------TLWYRA 170
Query: 449 PEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE 499
           PE +   ++             +T  D+++ G + AE++T +RAL   DSE
Sbjct: 171 PEILLGCKY------------YSTAVDIWSLGCIFAEMVT-RRALFPGDSE 208

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 102/231 (44%), Gaps = 49/231 (21%)
Query: 293 NFDESRIIGRGGFGNVYFGL--LGDREAAIKKMRSNKSKE-----FFAELKVLCKIHHIN 345
           NF +   IG G +G VY     L     A+KK+R +   E        E+ +L +++H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 346 VF-----ISTFGNGSLS-DHLHDPLLKGHQPLTWTARTQIALDAAK--------GIEYIH 391
           +      I T     L  + LH  L K    +  +A T I L   K        G+ + H
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQDLKKF---MDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 392 DHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK---LEERTNEKEMLATRLVGTPGYLP 448
            H   R +HRD+K  N+L++     K+ADFGL +   +  RT   E++      T  Y  
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV------TLWYRA 170
Query: 449 PEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE 499
           PE +   ++             +T  D+++ G + AE++T +RAL   DSE
Sbjct: 171 PEILLGCKY------------YSTAVDIWSLGCIFAEMVT-RRALFPGDSE 208

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 102/231 (44%), Gaps = 49/231 (21%)
Query: 293 NFDESRIIGRGGFGNVYFGL--LGDREAAIKKMRSNKSKE-----FFAELKVLCKIHHIN 345
           NF +   IG G +G VY     L     A+KK+R +   E        E+ +L +++H N
Sbjct: 5   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 64
Query: 346 VF-----ISTFGNGSLS-DHLHDPLLKGHQPLTWTARTQIALDAAK--------GIEYIH 391
           +      I T     L  + LH  L K    +  +A T I L   K        G+ + H
Sbjct: 65  IVKLLDVIHTENKLYLVFEFLHQDLKKF---MDASALTGIPLPLIKSYLFQLLQGLAFCH 121
Query: 392 DHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK---LEERTNEKEMLATRLVGTPGYLP 448
            H   R +HRD+K  N+L++     K+ADFGL +   +  RT   E++      T  Y  
Sbjct: 122 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV------TLWYRA 172
Query: 449 PEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE 499
           PE +   ++             +T  D+++ G + AE++T +RAL   DSE
Sbjct: 173 PEILLGCKY------------YSTAVDIWSLGCIFAEMVT-RRALFPGDSE 210

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 89/211 (42%), Gaps = 36/211 (17%)
Query: 300 IGRGGFGNV--YFGLLGDREAAIKKMRSNKSKEF----FAELKVLCKIHHINVF-ISTFG 352
           IG G +G V   +  +     AIKK+   + + +      E+K+L +  H N+  I+   
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 353 NGSLSDHLHD-------------PLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYV 399
                + + D              LLK  Q L+            +G++YIH    A  +
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIH---SANVL 146
Query: 400 HRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRF 459
           HRD+K SN+LL+     K+ DFGL ++ +  ++     T  V T  Y  PE +   +   
Sbjct: 147 HRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK--- 203
Query: 460 DMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
                      T   D+++ G +LAE+++ +
Sbjct: 204 ---------GYTKSIDIWSVGCILAEMLSNR 225

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/231 (24%), Positives = 87/231 (37%), Gaps = 47/231 (20%)
Query: 292 NNFDESRIIGRGGFGNV----------YFGLLGDREAAI------------KKMRSNKSK 329
           N+FD  +++G+G FG V          Y+ +   R+  I             ++  N   
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 330 EFFAELKVLCKIHHINVFISTFGNG-SLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIE 388
            F   LK   + H    F+  + NG  L  HL        +  T         +    +E
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHL-----SRERVFTEERARFYGAEIVSALE 119
Query: 389 YIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLP 448
           Y+H       V+RDIK  N++LD     K+ DFGL K  E  ++   +     GTP YL 
Sbjct: 120 YLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKX-FCGTPEYLA 173
Query: 449 PEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE 499
           PE +              +       D +  GVV+ E++ G+      D E
Sbjct: 174 PEVL-------------EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE 211

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 89/208 (42%), Gaps = 40/208 (19%)
Query: 300 IGRGGFGNVYFGLLGDRE--AAIKKMRSN--KSKEFFAELKVLCKIHHINV--------- 346
           +G G +G VY G+        A+K ++ +  + +EF  E  V+ +I H N+         
Sbjct: 34  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 93
Query: 347 -----FISTFGN-GSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVH 400
                 I+ F   G+L D+L +      Q +       +A   +  +EY+    K  ++H
Sbjct: 94  EPPFYIITEFMTYGNLLDYLREC---NRQEVNAVVLLYMATQISSAMEYLE---KKNFIH 147
Query: 401 RDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFD 460
           RD+   N L+ +    KVADFGL +L        M         G   P        ++ 
Sbjct: 148 RDLAARNCLVGENHLVKVADFGLSRL--------MTGDTYTAHAGAKFP-------IKWT 192
Query: 461 MHSSVMELQVTTKTDVFAFGVVLAELIT 488
              S+   + + K+DV+AFGV+L E+ T
Sbjct: 193 APESLAYNKFSIKSDVWAFGVLLWEIAT 220

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 89/208 (42%), Gaps = 40/208 (19%)
Query: 300 IGRGGFGNVYFGLLGDRE--AAIKKMRSN--KSKEFFAELKVLCKIHHINV--------- 346
           +G G +G VY G+        A+K ++ +  + +EF  E  V+ +I H N+         
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 82
Query: 347 -----FISTFGN-GSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVH 400
                 I+ F   G+L D+L +      Q +       +A   +  +EY+    K  ++H
Sbjct: 83  EPPFYIITEFMTYGNLLDYLREC---NRQEVNAVVLLYMATQISSAMEYLE---KKNFIH 136
Query: 401 RDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFD 460
           RD+   N L+ +    KVADFGL +L        M         G   P        ++ 
Sbjct: 137 RDLAARNCLVGENHLVKVADFGLSRL--------MTGDTYTAHAGAKFP-------IKWT 181
Query: 461 MHSSVMELQVTTKTDVFAFGVVLAELIT 488
              S+   + + K+DV+AFGV+L E+ T
Sbjct: 182 APESLAYNKFSIKSDVWAFGVLLWEIAT 209

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/231 (24%), Positives = 87/231 (37%), Gaps = 47/231 (20%)
Query: 292 NNFDESRIIGRGGFGNV----------YFGLLGDREAAI------------KKMRSNKSK 329
           N+FD  +++G+G FG V          Y+ +   R+  I             ++  N   
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 330 EFFAELKVLCKIHHINVFISTFGNG-SLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIE 388
            F   LK   + H    F+  + NG  L  HL        +  T         +    +E
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHL-----SRERVFTEERARFYGAEIVSALE 119
Query: 389 YIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLP 448
           Y+H       V+RDIK  N++LD     K+ DFGL K  E  ++   +     GTP YL 
Sbjct: 120 YLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKX-FCGTPEYLA 173
Query: 449 PEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE 499
           PE +              +       D +  GVV+ E++ G+      D E
Sbjct: 174 PEVL-------------EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE 211

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 89/208 (42%), Gaps = 40/208 (19%)
Query: 300 IGRGGFGNVYFGLLGDRE--AAIKKMRSN--KSKEFFAELKVLCKIHHINV--------- 346
           +G G +G VY G+        A+K ++ +  + +EF  E  V+ +I H N+         
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 82
Query: 347 -----FISTFGN-GSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVH 400
                 I+ F   G+L D+L +      Q +       +A   +  +EY+    K  ++H
Sbjct: 83  EPPFYIITEFMTYGNLLDYLREC---NRQEVNAVVLLYMATQISSAMEYLE---KKNFIH 136
Query: 401 RDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFD 460
           RD+   N L+ +    KVADFGL +L        M         G   P        ++ 
Sbjct: 137 RDLAARNCLVGENHLVKVADFGLSRL--------MTGDTYTAHAGAKFP-------IKWT 181
Query: 461 MHSSVMELQVTTKTDVFAFGVVLAELIT 488
              S+   + + K+DV+AFGV+L E+ T
Sbjct: 182 APESLAYNKFSIKSDVWAFGVLLWEIAT 209

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 91/222 (40%), Gaps = 38/222 (17%)
Query: 286 EIEEATNNFDESRIIGRGGFGNVYFGLLGDRE--AAIKKMRSNKSKEF--------FAEL 335
           +++     +++   +G G F  VY     +     AIKK++     E           E+
Sbjct: 4   DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63
Query: 336 KVLCKIHHINV--FISTFGNGS--------LSDHLHDPLLKGHQPLTWTARTQIALDAAK 385
           K+L ++ H N+   +  FG+ S        +   L   +      LT +      L   +
Sbjct: 64  KLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQ 123
Query: 386 GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPG 445
           G+EY+H H     +HRD+K +N+LLD+    K+ADFGL K     N         V T  
Sbjct: 124 GLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA---YXHQVVTRW 177
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELI 487
           Y  PE +F  R                  D++A G +LAEL+
Sbjct: 178 YRAPELLFGARM------------YGVGVDMWAVGCILAELL 207

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/231 (24%), Positives = 87/231 (37%), Gaps = 47/231 (20%)
Query: 292 NNFDESRIIGRGGFGNV----------YFGLLGDREAAI------------KKMRSNKSK 329
           N+FD  +++G+G FG V          Y+ +   R+  I             ++  N   
Sbjct: 10  NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 69
Query: 330 EFFAELKVLCKIHHINVFISTFGNG-SLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIE 388
            F   LK   + H    F+  + NG  L  HL        +  T         +    +E
Sbjct: 70  PFLTALKYAFQTHDRLCFVMEYANGGELFFHL-----SRERVFTEERARFYGAEIVSALE 124
Query: 389 YIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLP 448
           Y+H       V+RDIK  N++LD     K+ DFGL K  E  ++   +     GTP YL 
Sbjct: 125 YLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKX-FCGTPEYLA 178
Query: 449 PEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE 499
           PE +              +       D +  GVV+ E++ G+      D E
Sbjct: 179 PEVL-------------EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE 216

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 89/208 (42%), Gaps = 40/208 (19%)
Query: 300 IGRGGFGNVYFGLLGDRE--AAIKKMRSN--KSKEFFAELKVLCKIHHINV--------- 346
           +G G +G VY G+        A+K ++ +  + +EF  E  V+ +I H N+         
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80
Query: 347 -----FISTFGN-GSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVH 400
                 I+ F   G+L D+L +      Q +       +A   +  +EY+    K  ++H
Sbjct: 81  EPPFYIITEFMTYGNLLDYLREC---NRQEVNAVVLLYMATQISSAMEYLE---KKNFIH 134
Query: 401 RDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFD 460
           RD+   N L+ +    KVADFGL +L        M         G   P        ++ 
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRL--------MTGDTYTAHAGAKFP-------IKWT 179
Query: 461 MHSSVMELQVTTKTDVFAFGVVLAELIT 488
              S+   + + K+DV+AFGV+L E+ T
Sbjct: 180 APESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 56/231 (24%), Positives = 87/231 (37%), Gaps = 47/231 (20%)
Query: 292 NNFDESRIIGRGGFGNV----------YFGLLGDREAAI------------KKMRSNKSK 329
           N+FD  +++G+G FG V          Y+ +   R+  I             ++  N   
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 330 EFFAELKVLCKIHHINVFISTFGNG-SLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIE 388
            F   LK   + H    F+  + NG  L  HL        +  T         +    +E
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHL-----SRERVFTEERARFYGAEIVSALE 119
Query: 389 YIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLP 448
           Y+H       V+RDIK  N++LD     K+ DFGL K  E  ++   +     GTP YL 
Sbjct: 120 YLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKX-FCGTPEYLA 173
Query: 449 PEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE 499
           PE +              +       D +  GVV+ E++ G+      D E
Sbjct: 174 PEVL-------------EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE 211

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 30/106 (28%), Positives = 53/106 (50%), Gaps = 15/106 (14%)
Query: 385 KGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP 444
           +G++YIH    A  +HRD+K SN+LL+     K+ DFGL ++ +  ++     T  V T 
Sbjct: 137 RGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 193
Query: 445 GYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
            Y  PE +   +              T   D+++ G +LAE+++ +
Sbjct: 194 WYRAPEIMLNSK------------GYTKSIDIWSVGCILAEMLSNR 227

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 89/208 (42%), Gaps = 40/208 (19%)
Query: 300 IGRGGFGNVYFGLLGDRE--AAIKKMRSN--KSKEFFAELKVLCKIHHINV--------- 346
           +G G +G VY G+        A+K ++ +  + +EF  E  V+ +I H N+         
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 85
Query: 347 -----FISTFGN-GSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVH 400
                 I+ F   G+L D+L +      Q +       +A   +  +EY+    K  ++H
Sbjct: 86  EPPFYIITEFMTYGNLLDYLREC---NRQEVNAVVLLYMATQISSAMEYLE---KKNFIH 139
Query: 401 RDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFD 460
           RD+   N L+ +    KVADFGL +L        M         G   P        ++ 
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRL--------MTGDTYTAHAGAKFP-------IKWT 184
Query: 461 MHSSVMELQVTTKTDVFAFGVVLAELIT 488
              S+   + + K+DV+AFGV+L E+ T
Sbjct: 185 APESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 89/208 (42%), Gaps = 40/208 (19%)
Query: 300 IGRGGFGNVYFGLLGDRE--AAIKKMRSN--KSKEFFAELKVLCKIHHINV--------- 346
           +G G +G VY G+        A+K ++ +  + +EF  E  V+ +I H N+         
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80
Query: 347 -----FISTFGN-GSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVH 400
                 I+ F   G+L D+L +      Q +       +A   +  +EY+    K  ++H
Sbjct: 81  EPPFYIITEFMTYGNLLDYLREC---NRQEVNAVVLLYMATQISSAMEYLE---KKNFIH 134
Query: 401 RDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFD 460
           RD+   N L+ +    KVADFGL +L        M         G   P        ++ 
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRL--------MTGDTYTAHAGAKFP-------IKWT 179
Query: 461 MHSSVMELQVTTKTDVFAFGVVLAELIT 488
              S+   + + K+DV+AFGV+L E+ T
Sbjct: 180 APESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 103/223 (46%), Gaps = 49/223 (21%)
Query: 292 NNFDESRIIGRGGFGNVYFGLLGDREAAIKKMRS----NKSKEFFAELKVLCKIHHINVF 347
           N+F   RIIGRGGFG VY    G R+A   KM +    +K +    + + L     I + 
Sbjct: 189 NDFSVHRIIGRGGFGEVY----GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLS 244
Query: 348 ISTFGNGS----LSDHLHDP--------LLKG---HQPLTWT---ARTQIALDAAK---G 386
           + + G+      +S   H P        L+ G   H  L+     +   +   AA+   G
Sbjct: 245 LVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILG 304
Query: 387 IEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGY 446
           +E++H+      V+RD+K +NILLD+    +++D GL       ++K+  A+  VGT GY
Sbjct: 305 LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLAC---DFSKKKPHAS--VGTHGY 356
Query: 447 LPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
           + PE +  K   +D           +  D F+ G +L +L+ G
Sbjct: 357 MAPE-VLQKGVAYD-----------SSADWFSLGCMLFKLLRG 387

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 60/242 (24%), Positives = 98/242 (40%), Gaps = 54/242 (22%)
Query: 281 IFSLEEIEEATNNFDESRIIGRGGFGNVYFG-----LLGDREAAIKKMRSNKSK------ 329
           +F  +E E +       R +G+G FG VY G     + G+ E  +     N+S       
Sbjct: 6   VFVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI 65
Query: 330 EFFAELKVLCKI--HHIN-------------VFISTFGNGSLSDHL--------HDPLLK 366
           EF  E  V+     HH+              V +    +G L  +L        ++P   
Sbjct: 66  EFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNP--- 122
Query: 367 GHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKL 426
           G  P T     Q+A + A G+ Y++     ++VHRD+   N ++      K+ DFG+   
Sbjct: 123 GRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGM--- 176
Query: 427 EERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAEL 486
              T +    A    G  G LP         R+    S+ +   TT +D+++FGVVL E+
Sbjct: 177 ---TRDIYETAYYRKGGKGLLP--------VRWMAPESLKDGVFTTSSDMWSFGVVLWEI 225
Query: 487 IT 488
            +
Sbjct: 226 TS 227

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 103/223 (46%), Gaps = 49/223 (21%)
Query: 292 NNFDESRIIGRGGFGNVYFGLLGDREAAIKKMRS----NKSKEFFAELKVLCKIHHINVF 347
           N+F   RIIGRGGFG VY    G R+A   KM +    +K +    + + L     I + 
Sbjct: 189 NDFSVHRIIGRGGFGEVY----GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLS 244
Query: 348 ISTFGNGS----LSDHLHDP--------LLKG---HQPLTWT---ARTQIALDAAK---G 386
           + + G+      +S   H P        L+ G   H  L+     +   +   AA+   G
Sbjct: 245 LVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILG 304
Query: 387 IEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGY 446
           +E++H+      V+RD+K +NILLD+    +++D GL       ++K+  A+  VGT GY
Sbjct: 305 LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLAC---DFSKKKPHAS--VGTHGY 356
Query: 447 LPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
           + PE +  K   +D           +  D F+ G +L +L+ G
Sbjct: 357 MAPE-VLQKGVAYD-----------SSADWFSLGCMLFKLLRG 387

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 35/114 (30%), Positives = 55/114 (48%), Gaps = 19/114 (16%)
Query: 386 GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPG 445
           G++++H       V+RD+K  NILLD     K+ADFG+ K     + K        GTP 
Sbjct: 130 GLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK---TNXFCGTPD 183
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE 499
           Y+ PE +  +++    HS           D ++FGV+L E++ G+      D E
Sbjct: 184 YIAPEILLGQKYN---HS----------VDWWSFGVLLYEMLIGQSPFHGQDEE 224

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 33/105 (31%), Positives = 52/105 (49%), Gaps = 16/105 (15%)
Query: 386 GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPG 445
           G+ Y+H        HRDIK  N+LLD+    K++DFGL  +  R N +E L  ++ GT  
Sbjct: 117 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATV-FRYNNRERLLNKMCGTLP 172
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
           Y+ PE +  + F                 DV++ G+VL  ++ G+
Sbjct: 173 YVAPELLKRREFH------------AEPVDVWSCGIVLTAMLAGE 205

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 102/231 (44%), Gaps = 49/231 (21%)
Query: 293 NFDESRIIGRGGFGNVYFGL--LGDREAAIKKMRSNKSKE-----FFAELKVLCKIHHIN 345
           NF +   IG G +G VY     L     A+KK+R +   E        E+ +L +++H N
Sbjct: 8   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 67
Query: 346 VF-----ISTFGNGSLS-DHLHDPLLKGHQPLTWTARTQIALDAAK--------GIEYIH 391
           +      I T     L  + LH  L K    +  +A T I L   K        G+ + H
Sbjct: 68  IVKLLDVIHTENKLYLVFEFLHQDLKKF---MDASALTGIPLPLIKSYLFQLLQGLAFCH 124
Query: 392 DHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK---LEERTNEKEMLATRLVGTPGYLP 448
            H   R +HRD+K  N+L++     K+ADFGL +   +  RT   E++      T  Y  
Sbjct: 125 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV------TLWYRA 175
Query: 449 PEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE 499
           PE +   ++             +T  D+++ G + AE++T +RAL   DSE
Sbjct: 176 PEILLGCKY------------YSTAVDIWSLGCIFAEMVT-RRALFPGDSE 213

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 88/211 (41%), Gaps = 36/211 (17%)
Query: 300 IGRGGFGNV--YFGLLGDREAAIKKMRSNKSKEF----FAELKVLCKIHHINVF-ISTFG 352
           IG G +G V   +  L     AIKK+   + + +      E+K+L +  H N+  I+   
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 353 NGSLSDHLHD-------------PLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYV 399
                + + D              LLK  Q L+            +G++YIH    A  +
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIH---SANVL 150
Query: 400 HRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRF 459
           HRD+K SN+LL+     K+ DFGL ++ +  ++        V T  Y  PE +   +   
Sbjct: 151 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSK--- 207
Query: 460 DMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
                      T   D+++ G +LAE+++ +
Sbjct: 208 ---------GYTKSIDIWSVGCILAEMLSNR 229

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 89/208 (42%), Gaps = 40/208 (19%)
Query: 300 IGRGGFGNVYFGLLGDRE--AAIKKMRSN--KSKEFFAELKVLCKIHHINV--------- 346
           +G G +G VY G+        A+K ++ +  + +EF  E  V+ +I H N+         
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 85
Query: 347 -----FISTFGN-GSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVH 400
                 I+ F   G+L D+L +      Q +       +A   +  +EY+    K  ++H
Sbjct: 86  EPPFYIITEFMTYGNLLDYLREC---NRQEVNAVVLLYMATQISSAMEYLE---KKNFIH 139
Query: 401 RDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFD 460
           RD+   N L+ +    KVADFGL +L        M         G   P        ++ 
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRL--------MTGDTYTAHAGAKFP-------IKWT 184
Query: 461 MHSSVMELQVTTKTDVFAFGVVLAELIT 488
              S+   + + K+DV+AFGV+L E+ T
Sbjct: 185 APESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 89/208 (42%), Gaps = 40/208 (19%)
Query: 300 IGRGGFGNVYFGLLGDRE--AAIKKMRSN--KSKEFFAELKVLCKIHHINV--------- 346
           +G G +G VY G+        A+K ++ +  + +EF  E  V+ +I H N+         
Sbjct: 25  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 84
Query: 347 -----FISTFGN-GSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVH 400
                 I+ F   G+L D+L +      Q +       +A   +  +EY+    K  ++H
Sbjct: 85  EPPFYIITEFMTYGNLLDYLREC---NRQEVNAVVLLYMATQISSAMEYLE---KKNFIH 138
Query: 401 RDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFD 460
           RD+   N L+ +    KVADFGL +L        M         G   P        ++ 
Sbjct: 139 RDLAARNCLVGENHLVKVADFGLSRL--------MTGDTYTAHAGAKFP-------IKWT 183
Query: 461 MHSSVMELQVTTKTDVFAFGVVLAELIT 488
              S+   + + K+DV+AFGV+L E+ T
Sbjct: 184 APESLAYNKFSIKSDVWAFGVLLWEIAT 211

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 88/211 (41%), Gaps = 36/211 (17%)
Query: 300 IGRGGFGNV--YFGLLGDREAAIKKMRSNKSKEF----FAELKVLCKIHHINVF-ISTFG 352
           IG G +G V   +  L     AIKK+   + + +      E+K+L +  H N+  I+   
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 95
Query: 353 NGSLSDHLHD-------------PLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYV 399
                + + D              LLK  Q L+            +G++YIH    A  +
Sbjct: 96  RAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIH---SANVL 151
Query: 400 HRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRF 459
           HRD+K SN+LL+     K+ DFGL ++ +  ++        V T  Y  PE +   +   
Sbjct: 152 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSK--- 208
Query: 460 DMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
                      T   D+++ G +LAE+++ +
Sbjct: 209 ---------GYTKSIDIWSVGCILAEMLSNR 230

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 46/171 (26%), Positives = 71/171 (41%), Gaps = 39/171 (22%)
Query: 292 NNFDESRIIGRGGFGNVY--FGLLGDREAAIKKMRSNKSK--EFFAELKVLCKIHHINV- 346
           ++F+E  ++G+G FG V      L  R  AIKK+R  + K     +E+ +L  ++H  V 
Sbjct: 6   SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVV 65
Query: 347 -----------FISTFG----------------NGSLSDHLHDPLLKGHQPLTWTARTQI 379
                      F+                    NG+L D +H   L   +   W    QI
Sbjct: 66  RYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQI 125
Query: 380 ALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERT 430
                + + YIH       +HRD+K  NI +D+    K+ DFGL K   R+
Sbjct: 126 L----EALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRS 169

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 33/105 (31%), Positives = 52/105 (49%), Gaps = 16/105 (15%)
Query: 386 GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPG 445
           G+ Y+H        HRDIK  N+LLD+    K++DFGL  +  R N +E L  ++ GT  
Sbjct: 116 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATV-FRYNNRERLLNKMCGTLP 171
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
           Y+ PE +  + F                 DV++ G+VL  ++ G+
Sbjct: 172 YVAPELLKRREFH------------AEPVDVWSCGIVLTAMLAGE 204

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 64/242 (26%), Positives = 103/242 (42%), Gaps = 45/242 (18%)
Query: 293 NFDESRIIGRGGFGNVYFGLLGDRE--AAIKKMRSNKSKEFFAELKVLCKIHHINVF--- 347
           ++ ++++IG G FG VY   L D     AIKK+   K+ +   EL+++ K+ H N+    
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFK-NRELQIMRKLDHCNIVRLR 79
Query: 348 ISTFGNGSLSDHLHDPLLKGHQPLT------WTARTQIALDAA----------KGIEYIH 391
              + +G   D ++  L+  + P T        +R +  L             + + YIH
Sbjct: 80  YFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 139
Query: 392 DHTKARYVHRDIKTSNILLD-DGLRAKVADFGLVKLEERTNEK-EMLATRLVGTPGYLPP 449
                   HRDIK  N+LLD D    K+ DFG  K   R       + +R      Y  P
Sbjct: 140 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-----YRAP 191
Query: 450 EYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKMKSLITI 509
           E IF                 T+  DV++ G VLAEL+ G+  +   DS   ++  +I +
Sbjct: 192 ELIF------------GATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKV 238
Query: 510 MA 511
           + 
Sbjct: 239 LG 240

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 58/247 (23%), Positives = 105/247 (42%), Gaps = 64/247 (25%)
Query: 288 EEATNNFDESRIIGRGGFGNV-------YFGLLGDREAAIKKMRSNKS----KEFFAELK 336
           E    N    + +G G FG V         G  G    A+K ++ N S    ++  +E  
Sbjct: 19  EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFN 78
Query: 337 VLCKIHHINVFISTFGN----------------GSLSDHLHDPLLKG------------- 367
           VL +++H +V I  +G                 GSL   L +    G             
Sbjct: 79  VLKQVNHPHV-IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSS 137
Query: 368 ------HQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADF 421
                  + LT       A   ++G++Y+    + + VHRD+   NIL+ +G + K++DF
Sbjct: 138 SLDHPDERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDF 194
Query: 422 GLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGV 481
           GL +      E++    R   + G +P +++ ++        S+ +   TT++DV++FGV
Sbjct: 195 GLSR---DVYEEDSYVKR---SQGRIPVKWMAIE--------SLFDHIYTTQSDVWSFGV 240
Query: 482 VLAELIT 488
           +L E++T
Sbjct: 241 LLWEIVT 247

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 92/225 (40%), Gaps = 54/225 (24%)
Query: 298 RIIGRGGFGNVYFG-----LLGDREAAIKKMRSNKSK------EFFAELKVLCKI--HHI 344
           R +G+G FG VY G     + G+ E  +     N+S       EF  E  V+     HH+
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 82
Query: 345 N-------------VFISTFGNGSLSDHL--------HDPLLKGHQPLTWTARTQIALDA 383
                         V +    +G L  +L        ++P   G  P T     Q+A + 
Sbjct: 83  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNP---GRPPPTLQEMIQMAAEI 139
Query: 384 AKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGT 443
           A G+ Y++     ++VHRD+   N ++      K+ DFG+ +    T+          G 
Sbjct: 140 ADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRK------GG 190
Query: 444 PGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
            G LP         R+    S+ +   TT +D+++FGVVL E+ +
Sbjct: 191 KGLLP--------VRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 58/247 (23%), Positives = 105/247 (42%), Gaps = 64/247 (25%)
Query: 288 EEATNNFDESRIIGRGGFGNV-------YFGLLGDREAAIKKMRSNKS----KEFFAELK 336
           E    N    + +G G FG V         G  G    A+K ++ N S    ++  +E  
Sbjct: 19  EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFN 78
Query: 337 VLCKIHHINVFISTFGN----------------GSLSDHLHDPLLKG------------- 367
           VL +++H +V I  +G                 GSL   L +    G             
Sbjct: 79  VLKQVNHPHV-IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSS 137
Query: 368 ------HQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADF 421
                  + LT       A   ++G++Y+    + + VHRD+   NIL+ +G + K++DF
Sbjct: 138 SLDHPDERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDF 194
Query: 422 GLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGV 481
           GL +      E++    R   + G +P +++ ++        S+ +   TT++DV++FGV
Sbjct: 195 GLSR---DVYEEDSXVKR---SQGRIPVKWMAIE--------SLFDHIYTTQSDVWSFGV 240
Query: 482 VLAELIT 488
           +L E++T
Sbjct: 241 LLWEIVT 247

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 36/105 (34%), Positives = 55/105 (52%), Gaps = 16/105 (15%)
Query: 386 GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPG 445
           G+ Y+H        HRDIK  N+LLD+    K++DFGL  +  R N +E L  ++ GT  
Sbjct: 117 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATV-FRYNNRERLLNKMCGTLP 172
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
           Y+ PE   +KR  F  H+           DV++ G+VL  ++ G+
Sbjct: 173 YVAPE--LLKRREF--HAE--------PVDVWSCGIVLTAMLAGE 205

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 89/208 (42%), Gaps = 40/208 (19%)
Query: 300 IGRGGFGNVYFGLLGDRE--AAIKKMRSN--KSKEFFAELKVLCKIHHINV--------- 346
           +G G +G VY G+        A+K ++ +  + +EF  E  V+ +I H N+         
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 85
Query: 347 -----FISTFGN-GSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVH 400
                 I+ F   G+L D+L +      Q +       +A   +  +EY+    K  ++H
Sbjct: 86  EPPFYIITEFMTYGNLLDYLREC---NRQEVNAVVLLYMATQISSAMEYLE---KKNFIH 139
Query: 401 RDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFD 460
           RD+   N L+ +    KVADFGL +L        M         G   P        ++ 
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRL--------MTGDTXTAHAGAKFP-------IKWT 184
Query: 461 MHSSVMELQVTTKTDVFAFGVVLAELIT 488
              S+   + + K+DV+AFGV+L E+ T
Sbjct: 185 APESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 36/105 (34%), Positives = 55/105 (52%), Gaps = 16/105 (15%)
Query: 386 GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPG 445
           G+ Y+H        HRDIK  N+LLD+    K++DFGL  +  R N +E L  ++ GT  
Sbjct: 117 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATV-FRYNNRERLLNKMCGTLP 172
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
           Y+ PE   +KR  F  H+           DV++ G+VL  ++ G+
Sbjct: 173 YVAPE--LLKRREF--HAE--------PVDVWSCGIVLTAMLAGE 205

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 36/105 (34%), Positives = 55/105 (52%), Gaps = 16/105 (15%)
Query: 386 GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPG 445
           G+ Y+H        HRDIK  N+LLD+    K++DFGL  +  R N +E L  ++ GT  
Sbjct: 116 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATV-FRYNNRERLLNKMCGTLP 171
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
           Y+ PE   +KR  F  H+           DV++ G+VL  ++ G+
Sbjct: 172 YVAPE--LLKRREF--HAE--------PVDVWSCGIVLTAMLAGE 204

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 36/105 (34%), Positives = 55/105 (52%), Gaps = 16/105 (15%)
Query: 386 GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPG 445
           G+ Y+H        HRDIK  N+LLD+    K++DFGL  +  R N +E L  ++ GT  
Sbjct: 117 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATV-FRYNNRERLLNKMCGTLP 172
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
           Y+ PE   +KR  F  H+           DV++ G+VL  ++ G+
Sbjct: 173 YVAPE--LLKRREF--HAE--------PVDVWSCGIVLTAMLAGE 205

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 36/105 (34%), Positives = 55/105 (52%), Gaps = 16/105 (15%)
Query: 386 GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPG 445
           G+ Y+H        HRDIK  N+LLD+    K++DFGL  +  R N +E L  ++ GT  
Sbjct: 117 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATV-FRYNNRERLLNKMCGTLP 172
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
           Y+ PE   +KR  F  H+           DV++ G+VL  ++ G+
Sbjct: 173 YVAPE--LLKRREF--HAE--------PVDVWSCGIVLTAMLAGE 205

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 36/105 (34%), Positives = 55/105 (52%), Gaps = 16/105 (15%)
Query: 386 GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPG 445
           G+ Y+H        HRDIK  N+LLD+    K++DFGL  +  R N +E L  ++ GT  
Sbjct: 116 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATV-FRYNNRERLLNKMCGTLP 171
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
           Y+ PE   +KR  F  H+           DV++ G+VL  ++ G+
Sbjct: 172 YVAPE--LLKRREF--HAE--------PVDVWSCGIVLTAMLAGE 204

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 36/105 (34%), Positives = 55/105 (52%), Gaps = 16/105 (15%)
Query: 386 GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPG 445
           G+ Y+H        HRDIK  N+LLD+    K++DFGL  +  R N +E L  ++ GT  
Sbjct: 117 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATV-FRYNNRERLLNKMCGTLP 172
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
           Y+ PE   +KR  F  H+           DV++ G+VL  ++ G+
Sbjct: 173 YVAPE--LLKRREF--HAE--------PVDVWSCGIVLTAMLAGE 205

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 36/105 (34%), Positives = 55/105 (52%), Gaps = 16/105 (15%)
Query: 386 GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPG 445
           G+ Y+H        HRDIK  N+LLD+    K++DFGL  +  R N +E L  ++ GT  
Sbjct: 116 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATV-FRYNNRERLLNKMCGTLP 171
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
           Y+ PE   +KR  F  H+           DV++ G+VL  ++ G+
Sbjct: 172 YVAPE--LLKRREF--HAE--------PVDVWSCGIVLTAMLAGE 204

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 58/241 (24%), Positives = 96/241 (39%), Gaps = 45/241 (18%)
Query: 274 LESERTIIFSLE---EIEEATNNFDESRIIGRGGFGNV--YFGLLGDREAAIKKMRSN-- 326
           +  ER   +  E    I E    +     +G G +G+V   F        A+KK+     
Sbjct: 1   MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 60
Query: 327 ---KSKEFFAELKVLCKIHHINV--FISTFGNGSLSDHLHDPLLKGH------------Q 369
               +K  + EL++L  + H NV   +  F      +  +D  L  H            Q
Sbjct: 61  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 370 PLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEER 429
            LT      +     +G++YIH    A  +HRD+K SN+ +++    K+  FGL     R
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILGFGLA----R 173
Query: 430 TNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
             + EM  T  V T  Y  PE +            +  +      D+++ G ++AEL+TG
Sbjct: 174 HTDDEM--TGYVATRWYRAPEIM------------LNWMHYNQTVDIWSVGCIMAELLTG 219
Query: 490 K 490
           +
Sbjct: 220 R 220

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 36/105 (34%), Positives = 55/105 (52%), Gaps = 16/105 (15%)
Query: 386 GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPG 445
           G+ Y+H        HRDIK  N+LLD+    K++DFGL  +  R N +E L  ++ GT  
Sbjct: 116 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATV-FRYNNRERLLNKMCGTLP 171
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
           Y+ PE   +KR  F  H+           DV++ G+VL  ++ G+
Sbjct: 172 YVAPE--LLKRREF--HAE--------PVDVWSCGIVLTAMLAGE 204

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 36/105 (34%), Positives = 55/105 (52%), Gaps = 16/105 (15%)
Query: 386 GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPG 445
           G+ Y+H        HRDIK  N+LLD+    K++DFGL  +  R N +E L  ++ GT  
Sbjct: 116 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATV-FRYNNRERLLNKMCGTLP 171
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
           Y+ PE   +KR  F  H+           DV++ G+VL  ++ G+
Sbjct: 172 YVAPE--LLKRREF--HAE--------PVDVWSCGIVLTAMLAGE 204

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 36/105 (34%), Positives = 55/105 (52%), Gaps = 16/105 (15%)
Query: 386 GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPG 445
           G+ Y+H        HRDIK  N+LLD+    K++DFGL  +  R N +E L  ++ GT  
Sbjct: 116 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATV-FRYNNRERLLNKMCGTLP 171
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
           Y+ PE   +KR  F  H+           DV++ G+VL  ++ G+
Sbjct: 172 YVAPE--LLKRREF--HAE--------PVDVWSCGIVLTAMLAGE 204

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 103/223 (46%), Gaps = 49/223 (21%)
Query: 292 NNFDESRIIGRGGFGNVYFGLLGDREAAIKKMRS----NKSKEFFAELKVLCKIHHINVF 347
           N+F   RIIGRGGFG VY    G R+A   KM +    +K +    + + L     I + 
Sbjct: 189 NDFSVHRIIGRGGFGEVY----GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLS 244
Query: 348 ISTFGNGS----LSDHLHDP--------LLKG---HQPLTWT---ARTQIALDAAK---G 386
           + + G+      +S   H P        L+ G   H  L+     +   +   AA+   G
Sbjct: 245 LVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILG 304
Query: 387 IEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGY 446
           +E++H+      V+RD+K +NILLD+    +++D GL       ++K+  A+  VGT GY
Sbjct: 305 LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLAC---DFSKKKPHAS--VGTHGY 356
Query: 447 LPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
           + PE +  K   +D           +  D F+ G +L +L+ G
Sbjct: 357 MAPE-VLQKGVAYD-----------SSADWFSLGCMLFKLLRG 387

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 103/223 (46%), Gaps = 49/223 (21%)
Query: 292 NNFDESRIIGRGGFGNVYFGLLGDREAAIKKMRS----NKSKEFFAELKVLCKIHHINVF 347
           N+F   RIIGRGGFG VY    G R+A   KM +    +K +    + + L     I + 
Sbjct: 188 NDFSVHRIIGRGGFGEVY----GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLS 243
Query: 348 ISTFGNGS----LSDHLHDP--------LLKG---HQPLTWT---ARTQIALDAAK---G 386
           + + G+      +S   H P        L+ G   H  L+     +   +   AA+   G
Sbjct: 244 LVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILG 303
Query: 387 IEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGY 446
           +E++H+      V+RD+K +NILLD+    +++D GL       ++K+  A+  VGT GY
Sbjct: 304 LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLAC---DFSKKKPHAS--VGTHGY 355
Query: 447 LPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
           + PE +  K   +D           +  D F+ G +L +L+ G
Sbjct: 356 MAPE-VLQKGVAYD-----------SSADWFSLGCMLFKLLRG 386

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 89/213 (41%), Gaps = 45/213 (21%)
Query: 300 IGRGGFGNVYFGL--LGDREAAIKKMRSNKSKEFFA-----ELKVLCKIHHINV--FIST 350
           +G G +G+V   +      + AIKK+      E FA     EL +L  + H NV   +  
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 109
Query: 351 FGNGSLSDHLHDPLLKGHQPLTWTARTQI-------------ALDAAKGIEYIHDHTKAR 397
           F   S   + +D  L    P   T   +I                  KG++YIH    A 
Sbjct: 110 FTPASSLRNFYDFYLV--MPFMQTDLQKIMGMEFSEEKIQYLVYQMLKGLKYIHS---AG 164
Query: 398 YVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRF 457
            VHRD+K  N+ +++    K+ DFGL     R  + EM  T  V T  Y  PE I     
Sbjct: 165 VVHRDLKPGNLAVNEDCELKILDFGLA----RHADAEM--TGYVVTRWYRAPEVIL---- 214
Query: 458 RFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
                 S M    T   D+++ G ++AE++TGK
Sbjct: 215 ------SWMHYNQT--VDIWSVGCIMAEMLTGK 239

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 89/213 (41%), Gaps = 45/213 (21%)
Query: 300 IGRGGFGNVYFGL--LGDREAAIKKMRSNKSKEFFA-----ELKVLCKIHHINV--FIST 350
           +G G +G+V   +      + AIKK+      E FA     EL +L  + H NV   +  
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 91
Query: 351 FGNGSLSDHLHDPLLKGHQPLTWTARTQI-------------ALDAAKGIEYIHDHTKAR 397
           F   S   + +D  L    P   T   +I                  KG++YIH    A 
Sbjct: 92  FTPASSLRNFYDFYLV--MPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGLKYIHS---AG 146
Query: 398 YVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRF 457
            VHRD+K  N+ +++    K+ DFGL     R  + EM  T  V T  Y  PE I     
Sbjct: 147 VVHRDLKPGNLAVNEDCELKILDFGLA----RHADAEM--TGYVVTRWYRAPEVIL---- 196
Query: 458 RFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
                 S M    T   D+++ G ++AE++TGK
Sbjct: 197 ------SWMHYNQT--VDIWSVGCIMAEMLTGK 221

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 36/105 (34%), Positives = 55/105 (52%), Gaps = 16/105 (15%)
Query: 386 GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPG 445
           G+ Y+H        HRDIK  N+LLD+    K++DFGL  +  R N +E L  ++ GT  
Sbjct: 117 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATV-FRYNNRERLLNKMCGTLP 172
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
           Y+ PE   +KR  F  H+           DV++ G+VL  ++ G+
Sbjct: 173 YVAPE--LLKRREF--HAE--------PVDVWSCGIVLTAMLAGE 205

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 36/105 (34%), Positives = 55/105 (52%), Gaps = 16/105 (15%)
Query: 386 GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPG 445
           G+ Y+H        HRDIK  N+LLD+    K++DFGL  +  R N +E L  ++ GT  
Sbjct: 115 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATV-FRYNNRERLLNKMCGTLP 170
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
           Y+ PE   +KR  F  H+           DV++ G+VL  ++ G+
Sbjct: 171 YVAPE--LLKRREF--HAE--------PVDVWSCGIVLTAMLAGE 203

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 36/105 (34%), Positives = 55/105 (52%), Gaps = 16/105 (15%)
Query: 386 GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPG 445
           G+ Y+H        HRDIK  N+LLD+    K++DFGL  +  R N +E L  ++ GT  
Sbjct: 116 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATV-FRYNNRERLLNKMCGTLP 171
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
           Y+ PE   +KR  F  H+           DV++ G+VL  ++ G+
Sbjct: 172 YVAPE--LLKRREF--HAE--------PVDVWSCGIVLTAMLAGE 204

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 36/105 (34%), Positives = 55/105 (52%), Gaps = 16/105 (15%)
Query: 386 GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPG 445
           G+ Y+H        HRDIK  N+LLD+    K++DFGL  +  R N +E L  ++ GT  
Sbjct: 116 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATV-FRYNNRERLLNKMXGTLP 171
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
           Y+ PE   +KR  F  H+           DV++ G+VL  ++ G+
Sbjct: 172 YVAPE--LLKRREF--HAE--------PVDVWSCGIVLTAMLAGE 204

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 50/218 (22%), Positives = 91/218 (41%), Gaps = 44/218 (20%)
Query: 293 NFDESRIIGRGGFGNVYFG--LLGDREAAIK-----KMRSNKSKEFFAELKVLCKIHHIN 345
           N+   + IG+G F  V     +L  RE A+K     ++     ++ F E++++  ++H N
Sbjct: 16  NYRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75
Query: 346 V--------------FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIH 391
           +               +  + +G     + D L+   +     AR +        ++Y H
Sbjct: 76  IVKLFEVIETEKTLYLVMEYASGG---EVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCH 131
Query: 392 DHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEY 451
              +   VHRD+K  N+LLD  +  K+ADFG        N+ +       G+P Y  PE 
Sbjct: 132 ---QKYIVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDTFC----GSPPYAAPEL 184
Query: 452 IFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
              K++               + DV++ GV+L  L++G
Sbjct: 185 FQGKKYD------------GPEVDVWSLGVILYTLVSG 210

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 36/105 (34%), Positives = 55/105 (52%), Gaps = 16/105 (15%)
Query: 386 GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPG 445
           G+ Y+H        HRDIK  N+LLD+    K++DFGL  +  R N +E L  ++ GT  
Sbjct: 116 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATV-FRYNNRERLLNKMXGTLP 171
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
           Y+ PE   +KR  F  H+           DV++ G+VL  ++ G+
Sbjct: 172 YVAPE--LLKRREF--HAE--------PVDVWSCGIVLTAMLAGE 204

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 58/241 (24%), Positives = 96/241 (39%), Gaps = 45/241 (18%)
Query: 274 LESERTIIFSLE---EIEEATNNFDESRIIGRGGFGNV--YFGLLGDREAAIKKMRSN-- 326
           +  ER   +  E    I E    +     +G G +G+V   F        A+KK+     
Sbjct: 1   MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 60
Query: 327 ---KSKEFFAELKVLCKIHHINV--FISTFGNGSLSDHLHDPLLKGH------------Q 369
               +K  + EL++L  + H NV   +  F      +  +D  L  H            Q
Sbjct: 61  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 370 PLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEER 429
            LT      +     +G++YIH    A  +HRD+K SN+ +++    K+ D GL     R
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDAGLA----R 173
Query: 430 TNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
             + EM  T  V T  Y  PE +            +  +      D+++ G ++AEL+TG
Sbjct: 174 HTDDEM--TGYVATRWYRAPEIM------------LNWMHYNQTVDIWSVGCIMAELLTG 219
Query: 490 K 490
           +
Sbjct: 220 R 220

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 30/106 (28%), Positives = 53/106 (50%), Gaps = 15/106 (14%)
Query: 385 KGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP 444
           +G++YIH    A  +HRD+K SN+LL+     K+ DFGL ++ +  ++     T  V T 
Sbjct: 137 RGLKYIH---SANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATR 193
Query: 445 GYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
            Y  PE +   +              T   D+++ G +LAE+++ +
Sbjct: 194 WYRAPEIMLNSK------------GYTKSIDIWSVGCILAEMLSNR 227

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 58/241 (24%), Positives = 96/241 (39%), Gaps = 45/241 (18%)
Query: 274 LESERTIIFSLE---EIEEATNNFDESRIIGRGGFGNV--YFGLLGDREAAIKKMRSN-- 326
           +  ER   +  E    I E    +     +G G +G+V   F        A+KK+     
Sbjct: 1   MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 60
Query: 327 ---KSKEFFAELKVLCKIHHINV--FISTFGNGSLSDHLHDPLLKGH------------Q 369
               +K  + EL++L  + H NV   +  F      +  +D  L  H            Q
Sbjct: 61  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 370 PLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEER 429
            LT      +     +G++YIH    A  +HRD+K SN+ +++    K+ D GL     R
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDRGLA----R 173
Query: 430 TNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
             + EM  T  V T  Y  PE +            +  +      D+++ G ++AEL+TG
Sbjct: 174 HTDDEM--TGYVATRWYRAPEIM------------LNWMHYNQTVDIWSVGCIMAELLTG 219
Query: 490 K 490
           +
Sbjct: 220 R 220

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 59/242 (24%), Positives = 98/242 (40%), Gaps = 54/242 (22%)
Query: 281 IFSLEEIEEATNNFDESRIIGRGGFGNVYFG-----LLGDREAAIKKMRSNKSK------ 329
           +F  +E E +       R +G+G FG VY G     + G+ E  +     N+S       
Sbjct: 6   VFVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI 65
Query: 330 EFFAELKVLCKI--HHIN-------------VFISTFGNGSLSDHL--------HDPLLK 366
           EF  E  V+     HH+              V +    +G L  +L        ++P   
Sbjct: 66  EFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNP--- 122
Query: 367 GHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKL 426
           G  P T     Q+A + A G+ Y++     ++VHRD+   N ++      K+ DFG+ + 
Sbjct: 123 GRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRD 179
Query: 427 EERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAEL 486
              T+          G  G LP         R+    S+ +   TT +D+++FGVVL E+
Sbjct: 180 IYETDYYRK------GGKGLLP--------VRWMAPESLKDGVFTTSSDMWSFGVVLWEI 225
Query: 487 IT 488
            +
Sbjct: 226 TS 227

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 66/281 (23%), Positives = 119/281 (42%), Gaps = 65/281 (23%)
Query: 298 RIIGRGGFGNVYFGLLGDR------EAAIKKMRSNKSK----EFFAELKVLCKIHH---- 343
           +++G G FG VY G+            AIK +          EF  E  ++  + H    
Sbjct: 21  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 80
Query: 344 ----------INVFISTFGNGSLSDHLHDPL--LKGHQPLTWTARTQIALDAAKGIEYIH 391
                     I +      +G L +++H+    +     L W  +       AKG+ Y+ 
Sbjct: 81  RLLGVCLSPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQI------AKGMMYLE 134
Query: 392 DHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEY 451
           +    R VHRD+   N+L+      K+ DFGL +L E  +EKE  A       G +P ++
Sbjct: 135 ER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLE-GDEKEYNADG-----GKMPIKW 185
Query: 452 IFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT--GK-------RAL--IRDDSEP 500
           + ++   +         + T ++DV+++GV + EL+T  GK       R +  + +  E 
Sbjct: 186 MALECIHYR--------KFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGER 237
Query: 501 TKMKSLITI---MAAVAEWCLNEDAVDRPEMRDIVAILSQI 538
                + TI   M  V  W ++ D+  RP+ +++ A  S++
Sbjct: 238 LPQPPICTIDVYMVMVKCWMIDADS--RPKFKELAAEFSRM 276

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 64/242 (26%), Positives = 103/242 (42%), Gaps = 45/242 (18%)
Query: 293 NFDESRIIGRGGFGNVYFGLLGDRE--AAIKKMRSNKSKEFFAELKVLCKIHHINVF--- 347
           ++ ++++IG G FG VY   L D     AIKK+   K+ +   EL+++ K+ H N+    
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFK-NRELQIMRKLDHCNIVRLR 79
Query: 348 ISTFGNGSLSDHLHDPLLKGHQPLT------WTARTQIALDAA----------KGIEYIH 391
              + +G   D ++  L+  + P T        +R +  L             + + YIH
Sbjct: 80  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 139
Query: 392 DHTKARYVHRDIKTSNILLD-DGLRAKVADFGLVKLEERTNEK-EMLATRLVGTPGYLPP 449
                   HRDIK  N+LLD D    K+ DFG  K   R       + +R      Y  P
Sbjct: 140 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAP 191
Query: 450 EYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKMKSLITI 509
           E IF                 T+  DV++ G VLAEL+ G+  +   DS   ++  +I +
Sbjct: 192 ELIF------------GATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKV 238
Query: 510 MA 511
           + 
Sbjct: 239 LG 240

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 36/105 (34%), Positives = 55/105 (52%), Gaps = 16/105 (15%)
Query: 386 GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPG 445
           G+ Y+H        HRDIK  N+LLD+    K++DFGL  +  R N +E L  ++ GT  
Sbjct: 116 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATV-FRYNNRERLLNKMXGTLP 171
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
           Y+ PE   +KR  F  H+           DV++ G+VL  ++ G+
Sbjct: 172 YVAPE--LLKRREF--HAE--------PVDVWSCGIVLTAMLAGE 204

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 36/105 (34%), Positives = 55/105 (52%), Gaps = 16/105 (15%)
Query: 386 GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPG 445
           G+ Y+H        HRDIK  N+LLD+    K++DFGL  +  R N +E L  ++ GT  
Sbjct: 116 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATV-FRYNNRERLLNKMXGTLP 171
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
           Y+ PE   +KR  F  H+           DV++ G+VL  ++ G+
Sbjct: 172 YVAPE--LLKRREF--HAE--------PVDVWSCGIVLTAMLAGE 204

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 64/234 (27%), Positives = 103/234 (44%), Gaps = 49/234 (20%)
Query: 290 ATNNFDESRIIGRGGFGNVYFGL--LGDREAAIKKMRSNKSKE-----FFAELKVLCKIH 342
           +  NF +   IG G +G VY     L     A+KK+R +   E        E+ +L +++
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 343 HINVF-----ISTFGNGSLS-DHLHDPLLKGHQPLTWTARTQIALDAAK--------GIE 388
           H N+      I T     L  +H+   L K    +  +A T I L   K        G+ 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEHVDQDLKKF---MDASALTGIPLPLIKSYLFQLLQGLA 120
Query: 389 YIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK---LEERTNEKEMLATRLVGTPG 445
           + H H   R +HRD+K  N+L++     K+ADFGL +   +  RT   E++      T  
Sbjct: 121 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV------TLW 171
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE 499
           Y  PE +   ++             +T  D+++ G + AE++T +RAL   DSE
Sbjct: 172 YRAPEILLGCKY------------YSTAVDIWSLGCIFAEMVT-RRALFPGDSE 212

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 94/221 (42%), Gaps = 44/221 (19%)
Query: 293 NFDESRIIGRGGFGNVYFGLLGDRE--AAIKKMRSNKSKEFFAELKVLCKIHHINVF--- 347
           ++ ++++IG G FG VY   L D     AIKK+  +K  +   EL+++ K+ H N+    
Sbjct: 49  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK-NRELQIMRKLDHCNIVRLR 107
Query: 348 ISTFGNGSLSDHLHDPLLKGHQPLT------WTARTQIALDAA----------KGIEYIH 391
              + +G   D ++  L+  + P T        +R +  L             + + YIH
Sbjct: 108 YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 167
Query: 392 DHTKARYVHRDIKTSNILLD-DGLRAKVADFGLVKLEERTNEK-EMLATRLVGTPGYLPP 449
                   HRDIK  N+LLD D    K+ DFG  K   R       + +R      Y  P
Sbjct: 168 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAP 219
Query: 450 EYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
           E IF                 T+  DV++ G VLAEL+ G+
Sbjct: 220 ELIF------------GATDYTSSIDVWSAGCVLAELLLGQ 248

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 60/235 (25%), Positives = 101/235 (42%), Gaps = 51/235 (21%)
Query: 290 ATNNFDESRIIGRGGFGNVYFGL--LGDREAAIKKMRSNKSKE-----FFAELKVLCKIH 342
           +  NF +   IG G +G VY     L     A+KK+R +   E        E+ +L +++
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 343 HINV--------------FISTFGNGSLSDHLHDPLLKG-HQPLTWTARTQIALDAAKGI 387
           H N+               +  F +  L   +    L G   PL  +   Q+     +G+
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQLL----QGL 117
Query: 388 EYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK---LEERTNEKEMLATRLVGTP 444
            + H H   R +HRD+K  N+L++     K+ADFGL +   +  RT   E++      T 
Sbjct: 118 AFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV------TL 168
Query: 445 GYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE 499
            Y  PE +   ++             +T  D+++ G + AE++T +RAL   DSE
Sbjct: 169 WYRAPEILLGCKY------------YSTAVDIWSLGCIFAEMVT-RRALFPGDSE 210

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 36/105 (34%), Positives = 55/105 (52%), Gaps = 16/105 (15%)
Query: 386 GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPG 445
           G+ Y+H        HRDIK  N+LLD+    K++DFGL  +  R N +E L  ++ GT  
Sbjct: 117 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATV-FRYNNRERLLNKMXGTLP 172
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
           Y+ PE   +KR  F  H+           DV++ G+VL  ++ G+
Sbjct: 173 YVAPE--LLKRREF--HAE--------PVDVWSCGIVLTAMLAGE 205

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 60/235 (25%), Positives = 101/235 (42%), Gaps = 51/235 (21%)
Query: 290 ATNNFDESRIIGRGGFGNVYFGL--LGDREAAIKKMRSNKSKE-----FFAELKVLCKIH 342
           +  NF +   IG G +G VY     L     A+KK+R +   E        E+ +L +++
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 343 HINV--------------FISTFGNGSLSDHLHDPLLKG-HQPLTWTARTQIALDAAKGI 387
           H N+               +  F +  L   +    L G   PL  +   Q+     +G+
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQLL----QGL 119
Query: 388 EYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK---LEERTNEKEMLATRLVGTP 444
            + H H   R +HRD+K  N+L++     K+ADFGL +   +  RT   E++      T 
Sbjct: 120 AFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV------TL 170
Query: 445 GYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE 499
            Y  PE +   ++             +T  D+++ G + AE++T +RAL   DSE
Sbjct: 171 WYRAPEILLGCKY------------YSTAVDIWSLGCIFAEMVT-RRALFPGDSE 212

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 54/234 (23%), Positives = 106/234 (45%), Gaps = 40/234 (17%)
Query: 287 IEEATNNFDESRIIGRGGFGNVY------FGLLGDREAAIKKMRSNKSKEFFAELKVL-- 338
           +E   ++F++   +G G  G V+       GL+  R+    +++     +   EL+VL  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 339 CKIHHINVFISTF-GNGSLS---DHLH----DPLLKGHQPLTWTARTQIALDAAKGIEYI 390
           C   +I  F   F  +G +S   +H+     D +LK    +      ++++   KG+ Y+
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYL 120
Query: 391 HDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPE 450
            +  K + +HRD+K SNIL++     K+ DFG+          + +A   VGT  Y+ PE
Sbjct: 121 RE--KHKIMHRDVKPSNILVNSRGEIKLCDFGV-----SGQLIDSMANSFVGTRSYMSPE 173
Query: 451 YIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRAL----IRDDSEP 500
            +    +             + ++D+++ G+ L E+  G+  +     ++DS P
Sbjct: 174 RLQGTHY-------------SVQSDIWSMGLSLVEMAVGRYPIPPPDAKEDSRP 214

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 64/242 (26%), Positives = 103/242 (42%), Gaps = 45/242 (18%)
Query: 293 NFDESRIIGRGGFGNVYFGLLGDRE--AAIKKMRSNKSKEFFAELKVLCKIHHINVF--- 347
           ++ ++++IG G FG VY   L D     AIKK+  +K  +   EL+++ K+ H N+    
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK-NRELQIMRKLDHCNIVRLR 79
Query: 348 ISTFGNGSLSDHLHDPLLKGHQPLT------WTARTQIALDAA----------KGIEYIH 391
              + +G   D ++  L+  + P T        +R +  L             + + YIH
Sbjct: 80  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 139
Query: 392 DHTKARYVHRDIKTSNILLD-DGLRAKVADFGLVKLEERTNEK-EMLATRLVGTPGYLPP 449
                   HRDIK  N+LLD D    K+ DFG  K   R       + +R      Y  P
Sbjct: 140 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAP 191
Query: 450 EYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKMKSLITI 509
           E IF                 T+  DV++ G VLAEL+ G+  +   DS   ++  +I +
Sbjct: 192 ELIF------------GATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKV 238
Query: 510 MA 511
           + 
Sbjct: 239 LG 240

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 64/242 (26%), Positives = 103/242 (42%), Gaps = 45/242 (18%)
Query: 293 NFDESRIIGRGGFGNVYFGLLGDRE--AAIKKMRSNKSKEFFAELKVLCKIHHINVF--- 347
           ++ ++++IG G FG VY   L D     AIKK+  +K  +   EL+++ K+ H N+    
Sbjct: 26  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK-NRELQIMRKLDHCNIVRLR 84
Query: 348 ISTFGNGSLSDHLHDPLLKGHQPLT------WTARTQIALDAA----------KGIEYIH 391
              + +G   D ++  L+  + P T        +R +  L             + + YIH
Sbjct: 85  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 144
Query: 392 DHTKARYVHRDIKTSNILLD-DGLRAKVADFGLVKLEERTNEK-EMLATRLVGTPGYLPP 449
                   HRDIK  N+LLD D    K+ DFG  K   R       + +R      Y  P
Sbjct: 145 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAP 196
Query: 450 EYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKMKSLITI 509
           E IF                 T+  DV++ G VLAEL+ G+  +   DS   ++  +I +
Sbjct: 197 ELIF------------GATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKV 243
Query: 510 MA 511
           + 
Sbjct: 244 LG 245

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 64/242 (26%), Positives = 103/242 (42%), Gaps = 45/242 (18%)
Query: 293 NFDESRIIGRGGFGNVYFGLLGDRE--AAIKKMRSNKSKEFFAELKVLCKIHHINVF--- 347
           ++ ++++IG G FG VY   L D     AIKK+  +K  +   EL+++ K+ H N+    
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK-NRELQIMRKLDHCNIVRLR 79
Query: 348 ISTFGNGSLSDHLHDPLLKGHQPLT------WTARTQIALDAA----------KGIEYIH 391
              + +G   D ++  L+  + P T        +R +  L             + + YIH
Sbjct: 80  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 139
Query: 392 DHTKARYVHRDIKTSNILLD-DGLRAKVADFGLVKLEERTNEK-EMLATRLVGTPGYLPP 449
                   HRDIK  N+LLD D    K+ DFG  K   R       + +R      Y  P
Sbjct: 140 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-----YRAP 191
Query: 450 EYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKMKSLITI 509
           E IF                 T+  DV++ G VLAEL+ G+  +   DS   ++  +I +
Sbjct: 192 ELIF------------GATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKV 238
Query: 510 MA 511
           + 
Sbjct: 239 LG 240

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 64/242 (26%), Positives = 103/242 (42%), Gaps = 45/242 (18%)
Query: 293 NFDESRIIGRGGFGNVYFGLLGDRE--AAIKKMRSNKSKEFFAELKVLCKIHHINVF--- 347
           ++ ++++IG G FG VY   L D     AIKK+   K+ +   EL+++ K+ H N+    
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFK-NRELQIMRKLDHCNIVRLR 79
Query: 348 ISTFGNGSLSDHLHDPLLKGHQPLT------WTARTQIALDAA----------KGIEYIH 391
              + +G   D ++  L+  + P T        +R +  L             + + YIH
Sbjct: 80  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 139
Query: 392 DHTKARYVHRDIKTSNILLD-DGLRAKVADFGLVKLEERTNEK-EMLATRLVGTPGYLPP 449
                   HRDIK  N+LLD D    K+ DFG  K   R       + +R      Y  P
Sbjct: 140 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAP 191
Query: 450 EYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKMKSLITI 509
           E IF                 T+  DV++ G VLAEL+ G+  +   DS   ++  +I +
Sbjct: 192 ELIF------------GATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKV 238
Query: 510 MA 511
           + 
Sbjct: 239 LG 240

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 94/221 (42%), Gaps = 44/221 (19%)
Query: 293 NFDESRIIGRGGFGNVYFGLLGDRE--AAIKKMRSNKSKEFFAELKVLCKIHHINVF--- 347
           ++ ++++IG G FG VY   L D     AIKK+  +K  +   EL+++ K+ H N+    
Sbjct: 57  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK-NRELQIMRKLDHCNIVRLR 115
Query: 348 ISTFGNGSLSDHLHDPLLKGHQPLT------WTARTQIALDAA----------KGIEYIH 391
              + +G   D ++  L+  + P T        +R +  L             + + YIH
Sbjct: 116 YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 175
Query: 392 DHTKARYVHRDIKTSNILLD-DGLRAKVADFGLVKLEERTNEK-EMLATRLVGTPGYLPP 449
                   HRDIK  N+LLD D    K+ DFG  K   R       + +R      Y  P
Sbjct: 176 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAP 227
Query: 450 EYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
           E IF                 T+  DV++ G VLAEL+ G+
Sbjct: 228 ELIF------------GATDYTSSIDVWSAGCVLAELLLGQ 256

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 94/221 (42%), Gaps = 44/221 (19%)
Query: 293 NFDESRIIGRGGFGNVYFGLLGDRE--AAIKKMRSNKSKEFFAELKVLCKIHHINVF--- 347
           ++ ++++IG G FG VY   L D     AIKK+  +K  +   EL+++ K+ H N+    
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK-NRELQIMRKLDHCNIVRLR 113
Query: 348 ISTFGNGSLSDHLHDPLLKGHQPLT------WTARTQIALDAA----------KGIEYIH 391
              + +G   D ++  L+  + P T        +R +  L             + + YIH
Sbjct: 114 YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 173
Query: 392 DHTKARYVHRDIKTSNILLD-DGLRAKVADFGLVKLEERTNEK-EMLATRLVGTPGYLPP 449
                   HRDIK  N+LLD D    K+ DFG  K   R       + +R      Y  P
Sbjct: 174 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAP 225
Query: 450 EYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
           E IF                 T+  DV++ G VLAEL+ G+
Sbjct: 226 ELIF------------GATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 94/221 (42%), Gaps = 44/221 (19%)
Query: 293 NFDESRIIGRGGFGNVYFGLLGDRE--AAIKKMRSNKSKEFFAELKVLCKIHHINVF--- 347
           ++ ++++IG G FG VY   L D     AIKK+  +K  +   EL+++ K+ H N+    
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK-NRELQIMRKLDHCNIVRLR 113
Query: 348 ISTFGNGSLSDHLHDPLLKGHQPLT------WTARTQIALDAA----------KGIEYIH 391
              + +G   D ++  L+  + P T        +R +  L             + + YIH
Sbjct: 114 YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 173
Query: 392 DHTKARYVHRDIKTSNILLD-DGLRAKVADFGLVKLEERTNEK-EMLATRLVGTPGYLPP 449
                   HRDIK  N+LLD D    K+ DFG  K   R       + +R      Y  P
Sbjct: 174 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-----YRAP 225
Query: 450 EYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
           E IF                 T+  DV++ G VLAEL+ G+
Sbjct: 226 ELIF------------GATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 94/221 (42%), Gaps = 44/221 (19%)
Query: 293 NFDESRIIGRGGFGNVYFGLLGDRE--AAIKKMRSNKSKEFFAELKVLCKIHHINVF--- 347
           ++ ++++IG G FG VY   L D     AIKK+  +K  +   EL+++ K+ H N+    
Sbjct: 40  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK-NRELQIMRKLDHCNIVRLR 98
Query: 348 ISTFGNGSLSDHLHDPLLKGHQPLT------WTARTQIALDAA----------KGIEYIH 391
              + +G   D ++  L+  + P T        +R +  L             + + YIH
Sbjct: 99  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 158
Query: 392 DHTKARYVHRDIKTSNILLD-DGLRAKVADFGLVKLEERTNEK-EMLATRLVGTPGYLPP 449
                   HRDIK  N+LLD D    K+ DFG  K   R       + +R      Y  P
Sbjct: 159 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-----YRAP 210
Query: 450 EYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
           E IF                 T+  DV++ G VLAEL+ G+
Sbjct: 211 ELIF------------GATDYTSSIDVWSAGCVLAELLLGQ 239

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 64/242 (26%), Positives = 103/242 (42%), Gaps = 45/242 (18%)
Query: 293 NFDESRIIGRGGFGNVYFGLLGDRE--AAIKKMRSNKSKEFFAELKVLCKIHHINVF--- 347
           ++ ++++IG G FG VY   L D     AIKK+  +K  +   EL+++ K+ H N+    
Sbjct: 59  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK-NRELQIMRKLDHCNIVRLR 117
Query: 348 ISTFGNGSLSDHLHDPLLKGHQPLT------WTARTQIALDAA----------KGIEYIH 391
              + +G   D ++  L+  + P T        +R +  L             + + YIH
Sbjct: 118 YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 177
Query: 392 DHTKARYVHRDIKTSNILLD-DGLRAKVADFGLVKLEERTNEK-EMLATRLVGTPGYLPP 449
                   HRDIK  N+LLD D    K+ DFG  K   R       + +R      Y  P
Sbjct: 178 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAP 229
Query: 450 EYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKMKSLITI 509
           E IF                 T+  DV++ G VLAEL+ G+  +   DS   ++  +I +
Sbjct: 230 ELIF------------GATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKV 276
Query: 510 MA 511
           + 
Sbjct: 277 LG 278

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 64/242 (26%), Positives = 103/242 (42%), Gaps = 45/242 (18%)
Query: 293 NFDESRIIGRGGFGNVYFGLLGDRE--AAIKKMRSNKSKEFFAELKVLCKIHHINVF--- 347
           ++ ++++IG G FG VY   L D     AIKK+  +K  +   EL+++ K+ H N+    
Sbjct: 34  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK-NRELQIMRKLDHCNIVRLR 92
Query: 348 ISTFGNGSLSDHLHDPLLKGHQPLT------WTARTQIALDAA----------KGIEYIH 391
              + +G   D ++  L+  + P T        +R +  L             + + YIH
Sbjct: 93  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 152
Query: 392 DHTKARYVHRDIKTSNILLD-DGLRAKVADFGLVKLEERTNEK-EMLATRLVGTPGYLPP 449
                   HRDIK  N+LLD D    K+ DFG  K   R       + +R      Y  P
Sbjct: 153 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAP 204
Query: 450 EYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKMKSLITI 509
           E IF                 T+  DV++ G VLAEL+ G+  +   DS   ++  +I +
Sbjct: 205 ELIF------------GATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKV 251
Query: 510 MA 511
           + 
Sbjct: 252 LG 253

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 43/88 (48%), Gaps = 16/88 (18%)
Query: 399 VHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFR 458
           +HRD+K +N+ LD     K+ DFGL ++    N  E  A   VGTP Y+ PE        
Sbjct: 138 LHRDLKPANVFLDGKQNVKLGDFGLARI---LNHDEDFAKEFVGTPYYMSPE-------- 186
Query: 459 FDMHSSVMELQVTTKTDVFAFGVVLAEL 486
                 +  +    K+D+++ G +L EL
Sbjct: 187 -----QMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 64/242 (26%), Positives = 103/242 (42%), Gaps = 45/242 (18%)
Query: 293 NFDESRIIGRGGFGNVYFGLLGDRE--AAIKKMRSNKSKEFFAELKVLCKIHHINVF--- 347
           ++ ++++IG G FG VY   L D     AIKK+  +K  +   EL+++ K+ H N+    
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK-NRELQIMRKLDHCNIVRLR 79
Query: 348 ISTFGNGSLSDHLHDPLLKGHQPLT------WTARTQIALDAA----------KGIEYIH 391
              + +G   D ++  L+  + P T        +R +  L             + + YIH
Sbjct: 80  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 139
Query: 392 DHTKARYVHRDIKTSNILLD-DGLRAKVADFGLVKLEERTNEK-EMLATRLVGTPGYLPP 449
                   HRDIK  N+LLD D    K+ DFG  K   R       + +R      Y  P
Sbjct: 140 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-----YRAP 191
Query: 450 EYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKMKSLITI 509
           E IF                 T+  DV++ G VLAEL+ G+  +   DS   ++  +I +
Sbjct: 192 ELIF------------GATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKV 238
Query: 510 MA 511
           + 
Sbjct: 239 LG 240

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 69/156 (44%), Gaps = 31/156 (19%)
Query: 387 IEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGY 446
           ++Y H H     VHRD+K  N+LLD  + AK+ADFGL  +    ++ E L     G+P Y
Sbjct: 124 VDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNM---MSDGEFLRDS-CGSPNY 176
Query: 447 LPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKMKSL 506
             PE I  +            L    + D+++ GV+L  L+ G      D+  PT  K +
Sbjct: 177 AAPEVISGR------------LYAGPEVDIWSCGVILYALLCGTLPF-DDEHVPTLFKKI 223
Query: 507 ITIMAAVAEWC-----------LNEDAVDRPEMRDI 531
              +  + E+            L  D + R  ++DI
Sbjct: 224 RGGVFYIPEYLNRSVATLLMHMLQVDPLKRATIKDI 259

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 61/255 (23%), Positives = 105/255 (41%), Gaps = 40/255 (15%)
Query: 274 LESERTIIFSLEEIEEATNNFDESRIIGRGGF-----------GNVYFGLLGDREAAIKK 322
           L+    I+  L+E+    ++F+  ++IGRG F           G VY   + ++   +K+
Sbjct: 43  LQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKR 102
Query: 323 -----MRSNKSKEFFAELKVLCKIH-------HINVFISTFGNGSLSDHLHDPLLKGHQP 370
                 R  +      + + + ++H       ++ + +  +  G L   L      G + 
Sbjct: 103 GEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSK---FGERI 159
Query: 371 LTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFG-LVKLEER 429
               AR  +A +    I+ +H   +  YVHRDIK  NILLD     ++ADFG  +KL   
Sbjct: 160 PAEMARFYLA-EIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRAD 215
Query: 430 TNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
              + ++A   VGTP YL PE +        +           + D +A GV   E+  G
Sbjct: 216 GTVRSLVA---VGTPDYLSPEILQA------VGGGPGTGSYGPECDWWALGVFAYEMFYG 266
Query: 490 KRALIRDDSEPTKMK 504
           +     D +  T  K
Sbjct: 267 QTPFYADSTAETYGK 281

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 64/242 (26%), Positives = 103/242 (42%), Gaps = 45/242 (18%)
Query: 293 NFDESRIIGRGGFGNVYFGLLGDRE--AAIKKMRSNKSKEFFAELKVLCKIHHINVF--- 347
           ++ ++++IG G FG VY   L D     AIKK+  +K  +   EL+++ K+ H N+    
Sbjct: 25  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK-NRELQIMRKLDHCNIVRLR 83
Query: 348 ISTFGNGSLSDHLHDPLLKGHQPLT------WTARTQIALDAA----------KGIEYIH 391
              + +G   D ++  L+  + P T        +R +  L             + + YIH
Sbjct: 84  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 143
Query: 392 DHTKARYVHRDIKTSNILLD-DGLRAKVADFGLVKLEERTNEK-EMLATRLVGTPGYLPP 449
                   HRDIK  N+LLD D    K+ DFG  K   R       + +R      Y  P
Sbjct: 144 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-----YRAP 195
Query: 450 EYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKMKSLITI 509
           E IF                 T+  DV++ G VLAEL+ G+  +   DS   ++  +I +
Sbjct: 196 ELIF------------GATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKV 242
Query: 510 MA 511
           + 
Sbjct: 243 LG 244

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 58/247 (23%), Positives = 105/247 (42%), Gaps = 64/247 (25%)
Query: 288 EEATNNFDESRIIGRGGFGNV-------YFGLLGDREAAIKKMRSNKS----KEFFAELK 336
           E    N    + +G G FG V         G  G    A+K ++ N S    ++  +E  
Sbjct: 19  EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFN 78
Query: 337 VLCKIHHINVFISTFGN----------------GSLSDHLHDPLLKG------------- 367
           VL +++H +V I  +G                 GSL   L +    G             
Sbjct: 79  VLKQVNHPHV-IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSS 137
Query: 368 ------HQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADF 421
                  + LT       A   ++G++Y+ + +    VHRD+   NIL+ +G + K++DF
Sbjct: 138 SLDHPDERALTMGDLISFAWQISQGMQYLAEMS---LVHRDLAARNILVAEGRKMKISDF 194
Query: 422 GLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGV 481
           GL +      E++    R   + G +P +++ ++        S+ +   TT++DV++FGV
Sbjct: 195 GLSR---DVYEEDSXVKR---SQGRIPVKWMAIE--------SLFDHIYTTQSDVWSFGV 240
Query: 482 VLAELIT 488
           +L E++T
Sbjct: 241 LLWEIVT 247

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 64/242 (26%), Positives = 103/242 (42%), Gaps = 45/242 (18%)
Query: 293 NFDESRIIGRGGFGNVYFGLLGDRE--AAIKKMRSNKSKEFFAELKVLCKIHHINVF--- 347
           ++ ++++IG G FG VY   L D     AIKK+  +K  +   EL+++ K+ H N+    
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK-NRELQIMRKLDHCNIVRLR 91
Query: 348 ISTFGNGSLSDHLHDPLLKGHQPLT------WTARTQIALDAA----------KGIEYIH 391
              + +G   D ++  L+  + P T        +R +  L             + + YIH
Sbjct: 92  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 151
Query: 392 DHTKARYVHRDIKTSNILLD-DGLRAKVADFGLVKLEERTNEK-EMLATRLVGTPGYLPP 449
                   HRDIK  N+LLD D    K+ DFG  K   R       + +R      Y  P
Sbjct: 152 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-----YRAP 203
Query: 450 EYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKMKSLITI 509
           E IF                 T+  DV++ G VLAEL+ G+  +   DS   ++  +I +
Sbjct: 204 ELIF------------GATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKV 250
Query: 510 MA 511
           + 
Sbjct: 251 LG 252

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 94/221 (42%), Gaps = 44/221 (19%)
Query: 293 NFDESRIIGRGGFGNVYFGLLGDRE--AAIKKMRSNKSKEFFAELKVLCKIHHINVF--- 347
           ++ ++++IG G FG VY   L D     AIKK+  +K  +   EL+++ K+ H N+    
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK-NRELQIMRKLDHCNIVRLR 91
Query: 348 ISTFGNGSLSDHLHDPLLKGHQPLT------WTARTQIALDAA----------KGIEYIH 391
              + +G   D ++  L+  + P T        +R +  L             + + YIH
Sbjct: 92  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 151
Query: 392 DHTKARYVHRDIKTSNILLD-DGLRAKVADFGLVKLEERTNEK-EMLATRLVGTPGYLPP 449
                   HRDIK  N+LLD D    K+ DFG  K   R       + +R      Y  P
Sbjct: 152 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-----YRAP 203
Query: 450 EYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
           E IF                 T+  DV++ G VLAEL+ G+
Sbjct: 204 ELIF------------GATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/241 (24%), Positives = 96/241 (39%), Gaps = 45/241 (18%)
Query: 274 LESERTIIFSLE---EIEEATNNFDESRIIGRGGFGNV--YFGLLGDREAAIKKMRSN-- 326
           +  ER   +  E    I E    +     +G G +G+V   F        A+KK+     
Sbjct: 1   MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 60
Query: 327 ---KSKEFFAELKVLCKIHHINV--FISTFGNGSLSDHLHDPLLKGH------------Q 369
               +K  + EL++L  + H NV   +  F      +  +D  L  H            Q
Sbjct: 61  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 370 PLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEER 429
            LT      +     +G++YIH    A  +HRD+K SN+ +++    K+ D GL     R
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDGGLA----R 173
Query: 430 TNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
             + EM  T  V T  Y  PE +            +  +      D+++ G ++AEL+TG
Sbjct: 174 HTDDEM--TGYVATRWYRAPEIM------------LNWMHYNQTVDIWSVGCIMAELLTG 219
Query: 490 K 490
           +
Sbjct: 220 R 220

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 64/242 (26%), Positives = 103/242 (42%), Gaps = 45/242 (18%)
Query: 293 NFDESRIIGRGGFGNVYFGLLGDRE--AAIKKMRSNKSKEFFAELKVLCKIHHINVF--- 347
           ++ ++++IG G FG VY   L D     AIKK+  +K  +   EL+++ K+ H N+    
Sbjct: 22  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK-NRELQIMRKLDHCNIVRLR 80
Query: 348 ISTFGNGSLSDHLHDPLLKGHQPLT------WTARTQIALDAA----------KGIEYIH 391
              + +G   D ++  L+  + P T        +R +  L             + + YIH
Sbjct: 81  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 140
Query: 392 DHTKARYVHRDIKTSNILLD-DGLRAKVADFGLVKLEERTNEK-EMLATRLVGTPGYLPP 449
                   HRDIK  N+LLD D    K+ DFG  K   R       + +R      Y  P
Sbjct: 141 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-----YRAP 192
Query: 450 EYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKMKSLITI 509
           E IF                 T+  DV++ G VLAEL+ G+  +   DS   ++  +I +
Sbjct: 193 ELIF------------GATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKV 239
Query: 510 MA 511
           + 
Sbjct: 240 LG 241

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 64/242 (26%), Positives = 103/242 (42%), Gaps = 45/242 (18%)
Query: 293 NFDESRIIGRGGFGNVYFGLLGDRE--AAIKKMRSNKSKEFFAELKVLCKIHHINVF--- 347
           ++ ++++IG G FG VY   L D     AIKK+  +K  +   EL+++ K+ H N+    
Sbjct: 100 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK-NRELQIMRKLDHCNIVRLR 158
Query: 348 ISTFGNGSLSDHLHDPLLKGHQPLT------WTARTQIALDAA----------KGIEYIH 391
              + +G   D ++  L+  + P T        +R +  L             + + YIH
Sbjct: 159 YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 218
Query: 392 DHTKARYVHRDIKTSNILLD-DGLRAKVADFGLVKLEERTNEK-EMLATRLVGTPGYLPP 449
                   HRDIK  N+LLD D    K+ DFG  K   R       + +R      Y  P
Sbjct: 219 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAP 270
Query: 450 EYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKMKSLITI 509
           E IF                 T+  DV++ G VLAEL+ G+  +   DS   ++  +I +
Sbjct: 271 ELIF------------GATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKV 317
Query: 510 MA 511
           + 
Sbjct: 318 LG 319

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 94/221 (42%), Gaps = 44/221 (19%)
Query: 293 NFDESRIIGRGGFGNVYFGLLGDRE--AAIKKMRSNKSKEFFAELKVLCKIHHINVF--- 347
           ++ ++++IG G FG VY   L D     AIKK+  +K  +   EL+++ K+ H N+    
Sbjct: 29  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK-NRELQIMRKLDHCNIVRLR 87
Query: 348 ISTFGNGSLSDHLHDPLLKGHQPLT------WTARTQIALDAA----------KGIEYIH 391
              + +G   D ++  L+  + P T        +R +  L             + + YIH
Sbjct: 88  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 147
Query: 392 DHTKARYVHRDIKTSNILLD-DGLRAKVADFGLVKLEERTNEK-EMLATRLVGTPGYLPP 449
                   HRDIK  N+LLD D    K+ DFG  K   R       + +R      Y  P
Sbjct: 148 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-----YRAP 199
Query: 450 EYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
           E IF                 T+  DV++ G VLAEL+ G+
Sbjct: 200 ELIF------------GATDYTSSIDVWSAGCVLAELLLGQ 228

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/218 (22%), Positives = 93/218 (42%), Gaps = 44/218 (20%)
Query: 293 NFDESRIIGRGGFGNVYFG--LLGDREAAIK-----KMRSNKSKEFFAELKVLCKIHHIN 345
           N+   + IG+G F  V     +L  +E A+K     ++ S+  ++ F E++++  ++H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 346 V--------------FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIH 391
           +               +  + +G     + D L+   +     AR +        ++Y H
Sbjct: 75  IVKLFEVIETEKTLYLVMEYASGG---EVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCH 130
Query: 392 DHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEY 451
              +   VHRD+K  N+LLD  +  K+ADFG        N+ +       G+P Y  PE 
Sbjct: 131 ---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFC----GSPPYAAPEL 183
Query: 452 IFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
              K++               + DV++ GV+L  L++G
Sbjct: 184 FQGKKYD------------GPEVDVWSLGVILYTLVSG 209

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/218 (22%), Positives = 93/218 (42%), Gaps = 44/218 (20%)
Query: 293 NFDESRIIGRGGFGNVYFG--LLGDREAAIK-----KMRSNKSKEFFAELKVLCKIHHIN 345
           N+   + IG+G F  V     +L  +E A+K     ++ S+  ++ F E++++  ++H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 346 V--------------FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIH 391
           +               +  + +G     + D L+   +     AR +        ++Y H
Sbjct: 75  IVKLFEVIETEKTLYLVMEYASGG---EVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCH 130
Query: 392 DHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEY 451
              +   VHRD+K  N+LLD  +  K+ADFG        N+ +       G+P Y  PE 
Sbjct: 131 ---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFC----GSPPYAAPEL 183
Query: 452 IFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
              K++               + DV++ GV+L  L++G
Sbjct: 184 FQGKKYD------------GPEVDVWSLGVILYTLVSG 209

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 35/131 (26%), Positives = 62/131 (47%), Gaps = 21/131 (16%)
Query: 385 KGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP 444
           +G++++H H   R VHRD+K  NIL+    + K+ADFGL     R    +M  T +V T 
Sbjct: 131 RGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLA----RIYSFQMALTSVVVTL 183
Query: 445 GYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKMK 504
            Y  PE +    +              T  D+++ G + AE+   ++ L R  S+  ++ 
Sbjct: 184 WYRAPEVLLQSSY-------------ATPVDLWSVGCIFAEMFR-RKPLFRGSSDVDQLG 229
Query: 505 SLITIMAAVAE 515
            ++ ++    E
Sbjct: 230 KILDVIGLPGE 240

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/236 (24%), Positives = 93/236 (39%), Gaps = 55/236 (23%)
Query: 300 IGRGGFGNVYFGL--LGDREAAIKKM--RSNKSKEF-FAELKVLCKIHHINV-------- 346
           IG G  G V         R+ A+K M  R  + +E  F E+ ++    H NV        
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112
Query: 347 -------FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYV 399
                   +     G+L+D +    L   Q  T      +     + + Y+H       +
Sbjct: 113 VGEELWVLMEFLQGGALTDIVSQVRLNEEQIAT------VCEAVLQALAYLHAQG---VI 163
Query: 400 HRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRF 459
           HRDIK+ +ILL    R K++DFG      +   K      LVGTP ++ PE I    +  
Sbjct: 164 HRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR---KXLVGTPYWMAPEVISRSLY-- 218
Query: 460 DMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRD----------DSEPTKMKS 505
                       T+ D+++ G+++ E++ G+     D          DS P K+K+
Sbjct: 219 -----------ATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKN 263

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 35/131 (26%), Positives = 63/131 (48%), Gaps = 21/131 (16%)
Query: 385 KGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP 444
           +G++++H H   R VHRD+K  NIL+    + K+ADFGL     R    +M  T +V T 
Sbjct: 131 RGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLA----RIYSFQMALTSVVVTL 183
Query: 445 GYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKMK 504
            Y  PE +             ++    T  D+++ G + AE+   ++ L R  S+  ++ 
Sbjct: 184 WYRAPEVL-------------LQSSYATPVDLWSVGCIFAEMFR-RKPLFRGSSDVDQLG 229
Query: 505 SLITIMAAVAE 515
            ++ ++    E
Sbjct: 230 KILDVIGLPGE 240

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/229 (22%), Positives = 104/229 (45%), Gaps = 36/229 (15%)
Query: 287 IEEATNNFDESRIIGRGGFGNVY------FGLLGDREAAIKKMRSNKSKEFFAELKVL-- 338
           +E   ++F++   +G G  G V+       GL+  R+    +++     +   EL+VL  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 339 CKIHHINVFISTF-GNGSLS---DHLH----DPLLKGHQPLTWTARTQIALDAAKGIEYI 390
           C   +I  F   F  +G +S   +H+     D +LK    +      ++++   KG+ Y+
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYL 120
Query: 391 HDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPE 450
            +  K + +HRD+K SNIL++     K+ DFG+          + +A   VGT  Y+ PE
Sbjct: 121 RE--KHKIMHRDVKPSNILVNSRGEIKLCDFGV-----SGQLIDSMANSFVGTRSYMSPE 173
Query: 451 YIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE 499
            +    +             + ++D+++ G+ L E+  G+  +   D++
Sbjct: 174 RLQGTHY-------------SVQSDIWSMGLSLVEMAVGRYPIPPPDAK 209

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 94/218 (43%), Gaps = 44/218 (20%)
Query: 293 NFDESRIIGRGGFGNVYFG--LLGDREAAIK-----KMRSNKSKEFFAELKVLCKIHHIN 345
           N+   + IG+G F  V     +L  +E A+K     ++ S+  ++ F E++++  ++H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 346 V--------------FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIH 391
           +               +  + +G     + D L+   +     AR +        ++Y H
Sbjct: 75  IVKLFEVIETEKTLYLVMEYASGG---EVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCH 130
Query: 392 DHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEY 451
              +   VHRD+K  N+LLD  +  K+ADFG     E T   ++ A    G P Y  PE 
Sbjct: 131 ---QKFIVHRDLKAENLLLDADMNIKIADFGFS--NEFTFGNKLDA--FCGAPPYAAPEL 183
Query: 452 IFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
              K++               + DV++ GV+L  L++G
Sbjct: 184 FQGKKYD------------GPEVDVWSLGVILYTLVSG 209

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/232 (24%), Positives = 92/232 (39%), Gaps = 48/232 (20%)
Query: 292 NNFDESRIIGRGGFGNV----------YFGL-LGDREAAIKK-----------MRSNKSK 329
           N F+  +++G+G FG V          Y+ + +  +E  + K           +  N   
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207
Query: 330 EFFAELKVLCKIHHINVFISTFGNG-SLSDHL-HDPLLKGHQPLTWTARTQIALDAAKGI 387
            F   LK   + H    F+  + NG  L  HL  + +    +   + A    ALD     
Sbjct: 208 PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALD----- 262
Query: 388 EYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYL 447
            Y+H  ++   V+RD+K  N++LD     K+ DFGL K  E   +   + T   GTP YL
Sbjct: 263 -YLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKT-FCGTPEYL 316
Query: 448 PPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE 499
            PE +              +       D +  GVV+ E++ G+      D E
Sbjct: 317 APEVL-------------EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE 355

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 35/131 (26%), Positives = 63/131 (48%), Gaps = 21/131 (16%)
Query: 385 KGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP 444
           +G++++H H   R VHRD+K  NIL+    + K+ADFGL     R    +M  T +V T 
Sbjct: 131 RGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLA----RIYSFQMALTSVVVTL 183
Query: 445 GYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKMK 504
            Y  PE +             ++    T  D+++ G + AE+   ++ L R  S+  ++ 
Sbjct: 184 WYRAPEVL-------------LQSSYATPVDLWSVGCIFAEMFR-RKPLFRGSSDVDQLG 229
Query: 505 SLITIMAAVAE 515
            ++ ++    E
Sbjct: 230 KILDVIGLPGE 240

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/229 (22%), Positives = 104/229 (45%), Gaps = 36/229 (15%)
Query: 287 IEEATNNFDESRIIGRGGFGNVY------FGLLGDREAAIKKMRSNKSKEFFAELKVL-- 338
           +E   ++F++   +G G  G V+       GL+  R+    +++     +   EL+VL  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 339 CKIHHINVFISTF-GNGSLS---DHLH----DPLLKGHQPLTWTARTQIALDAAKGIEYI 390
           C   +I  F   F  +G +S   +H+     D +LK    +      ++++   KG+ Y+
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYL 120
Query: 391 HDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPE 450
            +  K + +HRD+K SNIL++     K+ DFG+          + +A   VGT  Y+ PE
Sbjct: 121 RE--KHKIMHRDVKPSNILVNSRGEIKLCDFGV-----SGQLIDSMANSFVGTRSYMSPE 173
Query: 451 YIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE 499
            +    +             + ++D+++ G+ L E+  G+  +   D++
Sbjct: 174 RLQGTHY-------------SVQSDIWSMGLSLVEMAVGRYPIPPPDAK 209

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 101/231 (43%), Gaps = 49/231 (21%)
Query: 293 NFDESRIIGRGGFGNVYFGL--LGDREAAIKKMRSNKSKE-----FFAELKVLCKIHHIN 345
           NF +   IG G +G VY     L     A+ K+R +   E        E+ +L +++H N
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 346 VF-----ISTFGNGSLS-DHLHDPLLKGHQPLTWTARTQIALDAAK--------GIEYIH 391
           +      I T     L  + LH  L K    +  +A T I L   K        G+ + H
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLHQDLKKF---MDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 392 DHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK---LEERTNEKEMLATRLVGTPGYLP 448
            H   R +HRD+K  N+L++     K+ADFGL +   +  RT   E++      T  Y  
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV------TLWYRA 171
Query: 449 PEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE 499
           PE +   ++             +T  D+++ G + AE++T +RAL   DSE
Sbjct: 172 PEILLGCKY------------YSTAVDIWSLGCIFAEMVT-RRALFPGDSE 209

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 101/231 (43%), Gaps = 49/231 (21%)
Query: 293 NFDESRIIGRGGFGNVYFGL--LGDREAAIKKMRSNKSKE-----FFAELKVLCKIHHIN 345
           NF +   IG G +G VY     L     A+ K+R +   E        E+ +L +++H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 346 VF-----ISTFGNGSLS-DHLHDPLLKGHQPLTWTARTQIALDAAK--------GIEYIH 391
           +      I T     L  + LH  L K    +  +A T I L   K        G+ + H
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQDLKKF---MDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 392 DHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK---LEERTNEKEMLATRLVGTPGYLP 448
            H   R +HRD+K  N+L++     K+ADFGL +   +  RT   E++      T  Y  
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV------TLWYRA 170
Query: 449 PEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE 499
           PE +   ++             +T  D+++ G + AE++T +RAL   DSE
Sbjct: 171 PEILLGCKY------------YSTAVDIWSLGCIFAEMVT-RRALFPGDSE 208

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/229 (22%), Positives = 104/229 (45%), Gaps = 36/229 (15%)
Query: 287 IEEATNNFDESRIIGRGGFGNVY------FGLLGDREAAIKKMRSNKSKEFFAELKVL-- 338
           +E   ++F++   +G G  G V+       GL+  R+    +++     +   EL+VL  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 339 CKIHHINVFISTF-GNGSLS---DHLH----DPLLKGHQPLTWTARTQIALDAAKGIEYI 390
           C   +I  F   F  +G +S   +H+     D +LK    +      ++++   KG+ Y+
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYL 120
Query: 391 HDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPE 450
            +  K + +HRD+K SNIL++     K+ DFG+          + +A   VGT  Y+ PE
Sbjct: 121 RE--KHKIMHRDVKPSNILVNSRGEIKLCDFGV-----SGQLIDSMANSFVGTRSYMSPE 173
Query: 451 YIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE 499
            +    +             + ++D+++ G+ L E+  G+  +   D++
Sbjct: 174 RLQGTHY-------------SVQSDIWSMGLSLVEMAVGRYPIPPPDAK 209

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/229 (22%), Positives = 104/229 (45%), Gaps = 36/229 (15%)
Query: 287 IEEATNNFDESRIIGRGGFGNVY------FGLLGDREAAIKKMRSNKSKEFFAELKVL-- 338
           +E   ++F++   +G G  G V+       GL+  R+    +++     +   EL+VL  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 339 CKIHHINVFISTF-GNGSLS---DHLH----DPLLKGHQPLTWTARTQIALDAAKGIEYI 390
           C   +I  F   F  +G +S   +H+     D +LK    +      ++++   KG+ Y+
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYL 120
Query: 391 HDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPE 450
            +  K + +HRD+K SNIL++     K+ DFG+          + +A   VGT  Y+ PE
Sbjct: 121 RE--KHKIMHRDVKPSNILVNSRGEIKLCDFGV-----SGQLIDSMANSFVGTRSYMSPE 173
Query: 451 YIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE 499
            +    +             + ++D+++ G+ L E+  G+  +   D++
Sbjct: 174 RLQGTHY-------------SVQSDIWSMGLSLVEMAVGRYPIPPPDAK 209

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/190 (26%), Positives = 82/190 (43%), Gaps = 35/190 (18%)
Query: 319 AIKKMRSNKSKE----FFAELKVLCKIHHINVFISTFGN--------------GSLSDHL 360
           A+K+MR + +KE       +L V+ K H     +  FG               G+ ++ L
Sbjct: 54  AVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKL 113
Query: 361 HDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVAD 420
               ++G  P     +  +A+   K + Y+ +  K   +HRD+K SNILLD+  + K+ D
Sbjct: 114 KK-RMQGPIPERILGKMTVAI--VKALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCD 168
Query: 421 FGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFG 480
           FG+         K+    R  G   Y+ PE       R D      +     + DV++ G
Sbjct: 169 FGISGRLVDDKAKD----RSAGCAAYMAPE-------RIDPPDPT-KPDYDIRADVWSLG 216
Query: 481 VVLAELITGK 490
           + L EL TG+
Sbjct: 217 ISLVELATGQ 226

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/232 (24%), Positives = 91/232 (39%), Gaps = 48/232 (20%)
Query: 292 NNFDESRIIGRGGFGNV----------YFGLLGDREAAI------------KKMRSNKSK 329
           N F+  +++G+G FG V          Y+ +   ++  I             ++  N   
Sbjct: 151 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 210
Query: 330 EFFAELKVLCKIHHINVFISTFGNG-SLSDHL-HDPLLKGHQPLTWTARTQIALDAAKGI 387
            F   LK   + H    F+  + NG  L  HL  + +    +   + A    ALD     
Sbjct: 211 PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALD----- 265
Query: 388 EYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYL 447
            Y+H  ++   V+RD+K  N++LD     K+ DFGL K  E   +   + T   GTP YL
Sbjct: 266 -YLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKT-FCGTPEYL 319
Query: 448 PPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE 499
            PE +              +       D +  GVV+ E++ G+      D E
Sbjct: 320 APEVL-------------EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE 358

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 49/92 (53%), Gaps = 13/92 (14%)
Query: 399 VHRDIKTSNILLDDGLRAKVADFGL-VKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRF 457
           VHRD+K  NILLDD ++ +++DFG    LE     +E     L GTPGYL PE   +K  
Sbjct: 222 VHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRE-----LCGTPGYLAPE--ILKCS 274
Query: 458 RFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
             + H          + D++A GV+L  L+ G
Sbjct: 275 MDETHPG-----YGKEVDLWACGVILFTLLAG 301

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/160 (25%), Positives = 71/160 (44%), Gaps = 29/160 (18%)
Query: 384 AKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGT 443
           A G+EY+  H     VH+D+ T N+L+ D L  K++D GL +     +  ++L   L+  
Sbjct: 155 AAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPI 211
Query: 444 PGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALI----RDDS 498
             ++ PE I   +F  D             +D++++GVVL E+ + G +       +D  
Sbjct: 212 -RWMAPEAIMYGKFSID-------------SDIWSYGVVLWEVFSYGLQPYCGYSNQDVV 257
Query: 499 EPTKMKSLITIMAAVAEW-------CLNEDAVDRPEMRDI 531
           E  + + ++        W       C NE    RP  +DI
Sbjct: 258 EMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDI 297

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 92/225 (40%), Gaps = 54/225 (24%)
Query: 298 RIIGRGGFGNVYFG-----LLGDREAAIKKMRSNKSK------EFFAELKVLCKI--HHI 344
           R +G+G FG VY G     + G+ E  +     N+S       EF  E  V+     HH+
Sbjct: 22  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 81
Query: 345 N-------------VFISTFGNGSLSDHL--------HDPLLKGHQPLTWTARTQIALDA 383
                         V +    +G L  +L        ++P   G  P T     Q+A + 
Sbjct: 82  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNP---GRPPPTLQEMIQMAAEI 138
Query: 384 AKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGT 443
           A G+ Y++     ++VHRD+   N ++      K+ DFG+ +    T+          G 
Sbjct: 139 ADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRK------GG 189
Query: 444 PGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
            G LP         R+    S+ +   TT +D+++FGVVL E+ +
Sbjct: 190 KGLLP--------VRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 226

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 64/242 (26%), Positives = 103/242 (42%), Gaps = 45/242 (18%)
Query: 293 NFDESRIIGRGGFGNVYFGLLGDRE--AAIKKMRSNKSKEFFAELKVLCKIHHINVF--- 347
           ++ ++++IG G FG VY   L D     AIKK+  +K  +   EL+++ K+ H N+    
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK-NRELQIMRKLDHCNIVRLR 79
Query: 348 ISTFGNGSLSDHLHDPLLKGHQPLT------WTARTQIALDAA----------KGIEYIH 391
              + +G   D ++  L+  + P T        +R +  L             + + YIH
Sbjct: 80  YFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 139
Query: 392 DHTKARYVHRDIKTSNILLD-DGLRAKVADFGLVKLEERTNEK-EMLATRLVGTPGYLPP 449
                   HRDIK  N+LLD D    K+ DFG  K   R       + +R      Y  P
Sbjct: 140 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-----YRAP 191
Query: 450 EYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKMKSLITI 509
           E IF                 T+  DV++ G VLAEL+ G+  +   DS   ++  +I +
Sbjct: 192 ELIF------------GATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKV 238
Query: 510 MA 511
           + 
Sbjct: 239 LG 240

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/160 (25%), Positives = 71/160 (44%), Gaps = 29/160 (18%)
Query: 384 AKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGT 443
           A G+EY+  H     VH+D+ T N+L+ D L  K++D GL +     +  ++L   L+  
Sbjct: 138 AAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPI 194
Query: 444 PGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALI----RDDS 498
             ++ PE I   +F  D             +D++++GVVL E+ + G +       +D  
Sbjct: 195 -RWMAPEAIMYGKFSID-------------SDIWSYGVVLWEVFSYGLQPYCGYSNQDVV 240
Query: 499 EPTKMKSLITIMAAVAEW-------CLNEDAVDRPEMRDI 531
           E  + + ++        W       C NE    RP  +DI
Sbjct: 241 EMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDI 280

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 91/217 (41%), Gaps = 37/217 (17%)
Query: 292 NNFDESRIIGRGGFGNVYFG--LLGDREAAIKKM------RSNKSKEFFAELKVLCKIHH 343
            +F   +I+G G F  V     L   RE AIK +      + NK      E  V+ ++ H
Sbjct: 10  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 69
Query: 344 ---INVFISTFGNGS-----LSDHLHDPLLKGHQPLTWTARTQIALDAAK---GIEYIHD 392
              + ++  TF +       LS   +  LLK  + +     T      A+    +EY+H 
Sbjct: 70  PFFVKLYF-TFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 128
Query: 393 HTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYI 452
                 +HRD+K  NILL++ +  ++ DFG  K+      K+  A   VGT  Y+ PE +
Sbjct: 129 KG---IIHRDLKPENILLNEDMHIQITDFGTAKVLS-PESKQARANXFVGTAQYVSPELL 184
Query: 453 FVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
                         E      +D++A G ++ +L+ G
Sbjct: 185 -------------TEKSACKSSDLWALGCIIYQLVAG 208

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 101/221 (45%), Gaps = 40/221 (18%)
Query: 288 EEATNNFDESRIIGRGGFGNVY------FGLLGDREAAIKKMRSNKSKEFFAELKVL--C 339
           E   ++F++   +G G  G V+       GL+  R+    +++     +   EL+VL  C
Sbjct: 5   ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC 64
Query: 340 KIHHINVFISTF-GNGSLS---DHLH----DPLLKGHQPLTWTARTQIALDAAKGIEYIH 391
              +I  F   F  +G +S   +H+     D +LK    +      ++++   KG+ Y+ 
Sbjct: 65  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR 124
Query: 392 DHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK--LEERTNEKEMLATRLVGTPGYLPP 449
           +  K + +HRD+K SNIL++     K+ DFG+    ++E  NE        VGT  Y+ P
Sbjct: 125 E--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEMANE-------FVGTRSYMSP 175
Query: 450 EYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
           E +    +             + ++D+++ G+ L E+  G+
Sbjct: 176 ERLQGTHY-------------SVQSDIWSMGLSLVEMAVGR 203

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 92/217 (42%), Gaps = 37/217 (17%)
Query: 292 NNFDESRIIGRGGFGNVYFG--LLGDREAAIKKM------RSNKSKEFFAELKVLCKIHH 343
            +F   +I+G G F  V     L   RE AIK +      + NK      E  V+ ++ H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 344 ---INVFISTFGNG-----SLSDHLHDPLLKGHQPLTWTARTQIALDAAK---GIEYIHD 392
              + ++  TF +       LS   +  LLK  + +     T      A+    +EY+H 
Sbjct: 92  PFFVKLYF-TFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 150
Query: 393 HTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYI 452
                 +HRD+K  NILL++ +  ++ DFG  K+      K+  A   VGT  Y+ PE +
Sbjct: 151 KG---IIHRDLKPENILLNEDMHIQITDFGTAKVLS-PESKQARANSFVGTAQYVSPELL 206
Query: 453 FVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
                         E   +  +D++A G ++ +L+ G
Sbjct: 207 -------------TEKSASKSSDLWALGCIIYQLVAG 230

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/218 (22%), Positives = 93/218 (42%), Gaps = 44/218 (20%)
Query: 293 NFDESRIIGRGGFGNVYFG--LLGDREAAIK-----KMRSNKSKEFFAELKVLCKIHHIN 345
           N+   + IG+G F  V     +L  +E A++     ++ S+  ++ F E++++  ++H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 346 V--------------FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIH 391
           +               +  + +G     + D L+   +     AR +        ++Y H
Sbjct: 75  IVKLFEVIETEKTLYLVMEYASGG---EVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCH 130
Query: 392 DHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEY 451
              +   VHRD+K  N+LLD  +  K+ADFG        N+ +       G+P Y  PE 
Sbjct: 131 ---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLD----EFCGSPPYAAPEL 183
Query: 452 IFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
              K++               + DV++ GV+L  L++G
Sbjct: 184 FQGKKYD------------GPEVDVWSLGVILYTLVSG 209

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/218 (22%), Positives = 93/218 (42%), Gaps = 44/218 (20%)
Query: 293 NFDESRIIGRGGFGNVYFG--LLGDREAAIK-----KMRSNKSKEFFAELKVLCKIHHIN 345
           N+   + IG+G F  V     +L  +E A++     ++ S+  ++ F E++++  ++H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 346 V--------------FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIH 391
           +               +  + +G     + D L+   +     AR +        ++Y H
Sbjct: 75  IVKLFEVIETEKTLYLVMEYASGG---EVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCH 130
Query: 392 DHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEY 451
              +   VHRD+K  N+LLD  +  K+ADFG        N+ +       G+P Y  PE 
Sbjct: 131 ---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFC----GSPPYAAPEL 183
Query: 452 IFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
              K++               + DV++ GV+L  L++G
Sbjct: 184 FQGKKYD------------GPEVDVWSLGVILYTLVSG 209

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/218 (22%), Positives = 92/218 (42%), Gaps = 44/218 (20%)
Query: 293 NFDESRIIGRGGFGNVYFG--LLGDREAAIK-----KMRSNKSKEFFAELKVLCKIHHIN 345
           N+   + IG+G F  V     +L  +E A+K     ++ S+  ++ F E++++  ++H N
Sbjct: 8   NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 67
Query: 346 V--------------FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIH 391
           +               +  + +G     + D L+         AR +        ++Y H
Sbjct: 68  IVKLFEVIETEKTLYLVMEYASGG---EVFDYLVAHGWMKEKEARAKFR-QIVSAVQYCH 123
Query: 392 DHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEY 451
              +   VHRD+K  N+LLD  +  K+ADFG        N+ +       G+P Y  PE 
Sbjct: 124 ---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFC----GSPPYAAPEL 176
Query: 452 IFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
              K++               + DV++ GV+L  L++G
Sbjct: 177 FQGKKYD------------GPEVDVWSLGVILYTLVSG 202

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 91/217 (41%), Gaps = 37/217 (17%)
Query: 292 NNFDESRIIGRGGFGNVYFG--LLGDREAAIKKM------RSNKSKEFFAELKVLCKIHH 343
            +F   +I+G G F  V     L   RE AIK +      + NK      E  V+ ++ H
Sbjct: 7   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 66
Query: 344 ---INVFISTFGNGS-----LSDHLHDPLLKGHQPLTWTARTQIALDAAK---GIEYIHD 392
              + ++  TF +       LS   +  LLK  + +     T      A+    +EY+H 
Sbjct: 67  PFFVKLYF-TFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 125
Query: 393 HTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYI 452
                 +HRD+K  NILL++ +  ++ DFG  K+      K+  A   VGT  Y+ PE +
Sbjct: 126 KG---IIHRDLKPENILLNEDMHIQITDFGTAKVLS-PESKQARANXFVGTAQYVSPELL 181
Query: 453 FVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
                         E      +D++A G ++ +L+ G
Sbjct: 182 -------------TEKSACKSSDLWALGCIIYQLVAG 205

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 91/217 (41%), Gaps = 37/217 (17%)
Query: 292 NNFDESRIIGRGGFGNVYFG--LLGDREAAIKKM------RSNKSKEFFAELKVLCKIHH 343
            +F   +I+G G F  V     L   RE AIK +      + NK      E  V+ ++ H
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 344 ---INVFISTFGNGS-----LSDHLHDPLLKGHQPLTWTARTQIALDAAK---GIEYIHD 392
              + ++  TF +       LS   +  LLK  + +     T      A+    +EY+H 
Sbjct: 68  PFFVKLYF-TFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 126
Query: 393 HTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYI 452
                 +HRD+K  NILL++ +  ++ DFG  K+      K+  A   VGT  Y+ PE +
Sbjct: 127 KG---IIHRDLKPENILLNEDMHIQITDFGTAKVLS-PESKQARANXFVGTAQYVSPELL 182
Query: 453 FVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
                         E      +D++A G ++ +L+ G
Sbjct: 183 -------------TEKSACKSSDLWALGCIIYQLVAG 206

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 46/173 (26%), Positives = 73/173 (42%), Gaps = 34/173 (19%)
Query: 378 QIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLA 437
            I +  A+ +E++H       +HRD+K SNI        KV DFGLV   ++  E++ + 
Sbjct: 168 HIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 224
Query: 438 TRL---------VGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
           T +         VGT  Y+ PE I    +             + K D+F+ G++L EL+ 
Sbjct: 225 TPMPAYATHXGQVGTKLYMSPEQIHGNNY-------------SHKVDIFSLGLILFELLY 271
Query: 489 G-----KRALIRDDSEPTKMKSLITIMAA----VAEWCLNEDAVDRPEMRDIV 532
                 +R  I  D    K   L T        + +  L+    +RPE  DI+
Sbjct: 272 SFSTQMERVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDII 324

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 91/217 (41%), Gaps = 37/217 (17%)
Query: 292 NNFDESRIIGRGGFGNVYFG--LLGDREAAIKKM------RSNKSKEFFAELKVLCKIHH 343
            +F   +I+G G F  V     L   RE AIK +      + NK      E  V+ ++ H
Sbjct: 14  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 73
Query: 344 ---INVFISTFGNGS-----LSDHLHDPLLKGHQPLTWTARTQIALDAAK---GIEYIHD 392
              + ++  TF +       LS   +  LLK  + +     T      A+    +EY+H 
Sbjct: 74  PFFVKLYF-TFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 132
Query: 393 HTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYI 452
                 +HRD+K  NILL++ +  ++ DFG  K+      K+  A   VGT  Y+ PE +
Sbjct: 133 KG---IIHRDLKPENILLNEDMHIQITDFGTAKVLS-PESKQARANXFVGTAQYVSPELL 188
Query: 453 FVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
                         E      +D++A G ++ +L+ G
Sbjct: 189 -------------TEKSACKSSDLWALGCIIYQLVAG 212

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/228 (22%), Positives = 103/228 (45%), Gaps = 36/228 (15%)
Query: 288 EEATNNFDESRIIGRGGFGNVY------FGLLGDREAAIKKMRSNKSKEFFAELKVL--C 339
           E   ++F++   +G G  G V+       GL+  R+    +++     +   EL+VL  C
Sbjct: 64  ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC 123
Query: 340 KIHHINVFISTF-GNGSLS---DHLH----DPLLKGHQPLTWTARTQIALDAAKGIEYIH 391
              +I  F   F  +G +S   +H+     D +LK    +      ++++   KG+ Y+ 
Sbjct: 124 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR 183
Query: 392 DHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEY 451
           +  K + +HRD+K SNIL++     K+ DFG+          + +A   VGT  Y+ PE 
Sbjct: 184 E--KHKIMHRDVKPSNILVNSRGEIKLCDFGV-----SGQLIDSMANSFVGTRSYMSPER 236
Query: 452 IFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE 499
           +    +             + ++D+++ G+ L E+  G+  +   D++
Sbjct: 237 LQGTHY-------------SVQSDIWSMGLSLVEMAVGRYPIPPPDAK 271

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 89/210 (42%), Gaps = 44/210 (20%)
Query: 300 IGRGGFGNVYFGLLGDRE--AAIKKMRSN--KSKEFFAELKVLCKIHHINVF-------- 347
           +G G +G VY G+        A+K ++ +  + +EF  E  V+ +I H N+         
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 287
Query: 348 ---------ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARY 398
                      T+GN  L D+L +      Q ++      +A   +  +EY+    K  +
Sbjct: 288 EPPFYIITEFMTYGN--LLDYLRE---CNRQEVSAVVLLYMATQISSAMEYLE---KKNF 339
Query: 399 VHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFR 458
           +HR++   N L+ +    KVADFGL +L        M         G   P        +
Sbjct: 340 IHRNLAARNCLVGENHLVKVADFGLSRL--------MTGDTYTAHAGAKFP-------IK 384
Query: 459 FDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
           +    S+   + + K+DV+AFGV+L E+ T
Sbjct: 385 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 414

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 67/159 (42%), Gaps = 31/159 (19%)
Query: 354 GSLSDHLHDPLLKGHQPLTWTARTQIALDAAK---GIEYIHDHTKARYVHRDIKTSNILL 410
           GSL D+L         P       Q+ L A +   G+ Y+H      Y+HRD+   N+LL
Sbjct: 120 GSLRDYL---------PRHSIGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLL 167
Query: 411 DDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQV 470
           D+    K+ DFGL K     +E   +         +  PE +   +F +           
Sbjct: 168 DNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPECLKEYKFYY----------- 216
Query: 471 TTKTDVFAFGVVLAELITGKRALIRDDSEPTKMKSLITI 509
              +DV++FGV L EL+T   +     S PTK   LI I
Sbjct: 217 --ASDVWSFGVTLYELLTHCDS---SQSPPTKFLELIGI 250

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 91/217 (41%), Gaps = 37/217 (17%)
Query: 292 NNFDESRIIGRGGFGNVYFG--LLGDREAAIKKM------RSNKSKEFFAELKVLCKIHH 343
            +F   +I+G G F  V     L   RE AIK +      + NK      E  V+ ++ H
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 344 ---INVFISTFGNG-----SLSDHLHDPLLKGHQPLTWTARTQIALDAAK---GIEYIHD 392
              + ++  TF +       LS   +  LLK  + +     T      A+    +EY+H 
Sbjct: 93  PFFVKLYF-TFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 151
Query: 393 HTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYI 452
                 +HRD+K  NILL++ +  ++ DFG  K+      K+  A   VGT  Y+ PE +
Sbjct: 152 KG---IIHRDLKPENILLNEDMHIQITDFGTAKVLS-PESKQARANSFVGTAQYVSPELL 207
Query: 453 FVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
                         E      +D++A G ++ +L+ G
Sbjct: 208 -------------TEKSACKSSDLWALGCIIYQLVAG 231

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 91/217 (41%), Gaps = 37/217 (17%)
Query: 292 NNFDESRIIGRGGFGNVYFG--LLGDREAAIKKM------RSNKSKEFFAELKVLCKIHH 343
            +F   +I+G G F  V     L   RE AIK +      + NK      E  V+ ++ H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 344 ---INVFISTFGNGS-----LSDHLHDPLLKGHQPLTWTARTQIALDAAK---GIEYIHD 392
              + ++  TF +       LS   +  LLK  + +     T      A+    +EY+H 
Sbjct: 92  PFFVKLYF-TFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 150
Query: 393 HTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYI 452
                 +HRD+K  NILL++ +  ++ DFG  K+      K+  A   VGT  Y+ PE +
Sbjct: 151 KG---IIHRDLKPENILLNEDMHIQITDFGTAKVLS-PESKQARANXFVGTAQYVSPELL 206
Query: 453 FVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
                         E      +D++A G ++ +L+ G
Sbjct: 207 -------------TEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 91/217 (41%), Gaps = 37/217 (17%)
Query: 292 NNFDESRIIGRGGFGNVYFG--LLGDREAAIKKM------RSNKSKEFFAELKVLCKIHH 343
            +F   +I+G G F  V     L   RE AIK +      + NK      E  V+ ++ H
Sbjct: 35  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 94
Query: 344 ---INVFISTFGNG-----SLSDHLHDPLLKGHQPLTWTARTQIALDAAK---GIEYIHD 392
              + ++  TF +       LS   +  LLK  + +     T      A+    +EY+H 
Sbjct: 95  PFFVKLYF-TFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 153
Query: 393 HTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYI 452
                 +HRD+K  NILL++ +  ++ DFG  K+      K+  A   VGT  Y+ PE +
Sbjct: 154 KG---IIHRDLKPENILLNEDMHIQITDFGTAKVLS-PESKQARANXFVGTAQYVSPELL 209
Query: 453 FVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
                         E      +D++A G ++ +L+ G
Sbjct: 210 -------------TEKSACKSSDLWALGCIIYQLVAG 233

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 91/217 (41%), Gaps = 37/217 (17%)
Query: 292 NNFDESRIIGRGGFGNVYFG--LLGDREAAIKKM------RSNKSKEFFAELKVLCKIHH 343
            +F   +I+G G F  V     L   RE AIK +      + NK      E  V+ ++ H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 344 ---INVFISTFGNGS-----LSDHLHDPLLKGHQPLTWTARTQIALDAAK---GIEYIHD 392
              + ++  TF +       LS   +  LLK  + +     T      A+    +EY+H 
Sbjct: 90  PFFVKLYF-TFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 148
Query: 393 HTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYI 452
                 +HRD+K  NILL++ +  ++ DFG  K+      K+  A   VGT  Y+ PE +
Sbjct: 149 KG---IIHRDLKPENILLNEDMHIQITDFGTAKVLS-PESKQARANXFVGTAQYVSPELL 204
Query: 453 FVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
                         E      +D++A G ++ +L+ G
Sbjct: 205 -------------TEKSACKSSDLWALGCIIYQLVAG 228

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 91/217 (41%), Gaps = 37/217 (17%)
Query: 292 NNFDESRIIGRGGFGNVYFG--LLGDREAAIKKM------RSNKSKEFFAELKVLCKIHH 343
            +F   +I+G G F  V     L   RE AIK +      + NK      E  V+ ++ H
Sbjct: 9   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 68
Query: 344 ---INVFISTFGNGS-----LSDHLHDPLLKGHQPLTWTARTQIALDAAK---GIEYIHD 392
              + ++  TF +       LS   +  LLK  + +     T      A+    +EY+H 
Sbjct: 69  PFFVKLYF-TFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 127
Query: 393 HTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYI 452
                 +HRD+K  NILL++ +  ++ DFG  K+      K+  A   VGT  Y+ PE +
Sbjct: 128 KG---IIHRDLKPENILLNEDMHIQITDFGTAKVLS-PESKQARANXFVGTAQYVSPELL 183
Query: 453 FVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
                         E      +D++A G ++ +L+ G
Sbjct: 184 -------------TEKSACKSSDLWALGCIIYQLVAG 207

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 91/217 (41%), Gaps = 37/217 (17%)
Query: 292 NNFDESRIIGRGGFGNVYFG--LLGDREAAIKKM------RSNKSKEFFAELKVLCKIHH 343
            +F   +I+G G F  V     L   RE AIK +      + NK      E  V+ ++ H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 344 ---INVFISTFGNG-----SLSDHLHDPLLKGHQPLTWTARTQIALDAAK---GIEYIHD 392
              + ++  TF +       LS   +  LLK  + +     T      A+    +EY+H 
Sbjct: 92  PFFVKLYF-TFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 150
Query: 393 HTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYI 452
                 +HRD+K  NILL++ +  ++ DFG  K+      K+  A   VGT  Y+ PE +
Sbjct: 151 KG---IIHRDLKPENILLNEDMHIQITDFGTAKVLS-PESKQARANXFVGTAQYVSPELL 206
Query: 453 FVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
                         E      +D++A G ++ +L+ G
Sbjct: 207 -------------TEKSACKSSDLWALGCIIYQLVAG 230

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 91/217 (41%), Gaps = 37/217 (17%)
Query: 292 NNFDESRIIGRGGFGNVYFG--LLGDREAAIKKM------RSNKSKEFFAELKVLCKIHH 343
            +F   +I+G G F  V     L   RE AIK +      + NK      E  V+ ++ H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 344 ---INVFISTFGNG-----SLSDHLHDPLLKGHQPLTWTARTQIALDAAK---GIEYIHD 392
              + ++  TF +       LS   +  LLK  + +     T      A+    +EY+H 
Sbjct: 90  PFFVKLYF-TFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 148
Query: 393 HTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYI 452
                 +HRD+K  NILL++ +  ++ DFG  K+      K+  A   VGT  Y+ PE +
Sbjct: 149 KG---IIHRDLKPENILLNEDMHIQITDFGTAKVLS-PESKQARANXFVGTAQYVSPELL 204
Query: 453 FVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
                         E      +D++A G ++ +L+ G
Sbjct: 205 -------------TEKSACKSSDLWALGCIIYQLVAG 228

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 91/217 (41%), Gaps = 37/217 (17%)
Query: 292 NNFDESRIIGRGGFGNVYFG--LLGDREAAIKKM------RSNKSKEFFAELKVLCKIHH 343
            +F   +I+G G F  V     L   RE AIK +      + NK      E  V+ ++ H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 344 ---INVFISTFGNG-----SLSDHLHDPLLKGHQPLTWTARTQIALDAAK---GIEYIHD 392
              + ++  TF +       LS   +  LLK  + +     T      A+    +EY+H 
Sbjct: 90  PFFVKLYF-TFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 148
Query: 393 HTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYI 452
                 +HRD+K  NILL++ +  ++ DFG  K+      K+  A   VGT  Y+ PE +
Sbjct: 149 KG---IIHRDLKPENILLNEDMHIQITDFGTAKVLS-PESKQARANAFVGTAQYVSPELL 204
Query: 453 FVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
                         E      +D++A G ++ +L+ G
Sbjct: 205 -------------TEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/113 (33%), Positives = 56/113 (49%), Gaps = 15/113 (13%)
Query: 378 QIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLA 437
           +I L   K + ++ ++ K   +HRDIK SNILLD     K+ DFG+      +  K    
Sbjct: 129 KITLATVKALNHLKENLKI--IHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAK---- 182
Query: 438 TRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
           TR  G   Y+ PE       R D  +S     V  ++DV++ G+ L EL TG+
Sbjct: 183 TRDAGCRPYMAPE-------RIDPSASRQGYDV--RSDVWSLGITLYELATGR 226

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 91/217 (41%), Gaps = 37/217 (17%)
Query: 292 NNFDESRIIGRGGFGNVYFG--LLGDREAAIKKM------RSNKSKEFFAELKVLCKIHH 343
            +F   +I+G G F  V     L   RE AIK +      + NK      E  V+ ++ H
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 344 ---INVFISTFGNG-----SLSDHLHDPLLKGHQPLTWTARTQIALDAAK---GIEYIHD 392
              + ++  TF +       LS   +  LLK  + +     T      A+    +EY+H 
Sbjct: 93  PFFVKLYF-TFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 151
Query: 393 HTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYI 452
                 +HRD+K  NILL++ +  ++ DFG  K+      K+  A   VGT  Y+ PE +
Sbjct: 152 KG---IIHRDLKPENILLNEDMHIQITDFGTAKVLS-PESKQARANXFVGTAQYVSPELL 207
Query: 453 FVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
                         E      +D++A G ++ +L+ G
Sbjct: 208 -------------TEKSACKSSDLWALGCIIYQLVAG 231

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 91/217 (41%), Gaps = 37/217 (17%)
Query: 292 NNFDESRIIGRGGFGNVYFG--LLGDREAAIKKM------RSNKSKEFFAELKVLCKIHH 343
            +F   +I+G G F  V     L   RE AIK +      + NK      E  V+ ++ H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 344 ---INVFISTFGNG-----SLSDHLHDPLLKGHQPLTWTARTQIALDAAK---GIEYIHD 392
              + ++  TF +       LS   +  LLK  + +     T      A+    +EY+H 
Sbjct: 92  PFFVKLYF-TFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 150
Query: 393 HTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYI 452
                 +HRD+K  NILL++ +  ++ DFG  K+      K+  A   VGT  Y+ PE +
Sbjct: 151 KG---IIHRDLKPENILLNEDMHIQITDFGTAKVLS-PESKQARANXFVGTAQYVSPELL 206
Query: 453 FVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
                         E      +D++A G ++ +L+ G
Sbjct: 207 -------------TEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 91/217 (41%), Gaps = 37/217 (17%)
Query: 292 NNFDESRIIGRGGFGNVYFG--LLGDREAAIKKM------RSNKSKEFFAELKVLCKIHH 343
            +F   +I+G G F  V     L   RE AIK +      + NK      E  V+ ++ H
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 344 ---INVFISTFGNGS-----LSDHLHDPLLKGHQPLTWTARTQIALDAAK---GIEYIHD 392
              + ++  TF +       LS   +  LLK  + +     T      A+    +EY+H 
Sbjct: 89  PFFVKLYF-TFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 147
Query: 393 HTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYI 452
                 +HRD+K  NILL++ +  ++ DFG  K+      K+  A   VGT  Y+ PE +
Sbjct: 148 KG---IIHRDLKPENILLNEDMHIQITDFGTAKVLS-PESKQARANSFVGTAQYVSPELL 203
Query: 453 FVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
                         E      +D++A G ++ +L+ G
Sbjct: 204 -------------TEKSACKSSDLWALGCIIYQLVAG 227

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/238 (23%), Positives = 103/238 (43%), Gaps = 51/238 (21%)
Query: 284 LEEIEEATNNFDESRIIGRGGFGNVYFGLLGDREA-----AIKKMR-----SNKSKEFFA 333
           LE++      F   R++G+G FG+V    L   +      A+K ++     S+  +EF  
Sbjct: 15  LEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLR 74
Query: 334 ELKVLCKIHH------INVFISTFGNGSLS-----------DHLHDPLLK---GHQPLTW 373
           E   + +  H      + V + +   G L              LH  LL    G  P   
Sbjct: 75  EAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNL 134
Query: 374 TART--QIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLV-KLEERT 430
             +T  +  +D A G+EY+   +   ++HRD+   N +L + +   VADFGL  K+    
Sbjct: 135 PLQTLVRFMVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGD 191
Query: 431 NEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
             ++  A++       LP +++ ++    +++        T  +DV+AFGV + E++T
Sbjct: 192 YYRQGCASK-------LPVKWLALESLADNLY--------TVHSDVWAFGVTMWEIMT 234

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 91/217 (41%), Gaps = 37/217 (17%)
Query: 292 NNFDESRIIGRGGFGNVYFG--LLGDREAAIKKM------RSNKSKEFFAELKVLCKIHH 343
            +F   +I+G G F  V     L   RE AIK +      + NK      E  V+ ++ H
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 344 ---INVFISTFGNGS-----LSDHLHDPLLKGHQPLTWTARTQIALDAAK---GIEYIHD 392
              + ++  TF +       LS   +  LLK  + +     T      A+    +EY+H 
Sbjct: 89  PFFVKLYF-TFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 147
Query: 393 HTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYI 452
                 +HRD+K  NILL++ +  ++ DFG  K+      K+  A   VGT  Y+ PE +
Sbjct: 148 KG---IIHRDLKPENILLNEDMHIQITDFGTAKVLS-PESKQARANXFVGTAQYVSPELL 203
Query: 453 FVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
                         E      +D++A G ++ +L+ G
Sbjct: 204 -------------TEKSACKSSDLWALGCIIYQLVAG 227

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 91/217 (41%), Gaps = 37/217 (17%)
Query: 292 NNFDESRIIGRGGFGNVYFG--LLGDREAAIKKM------RSNKSKEFFAELKVLCKIHH 343
            +F   +I+G G F  V     L   RE AIK +      + NK      E  V+ ++ H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 344 ---INVFISTFGNG-----SLSDHLHDPLLKGHQPLTWTARTQIALDAAK---GIEYIHD 392
              + ++  TF +       LS   +  LLK  + +     T      A+    +EY+H 
Sbjct: 92  PFFVKLYF-TFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 150
Query: 393 HTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYI 452
                 +HRD+K  NILL++ +  ++ DFG  K+      K+  A   VGT  Y+ PE +
Sbjct: 151 KG---IIHRDLKPENILLNEDMHIQITDFGTAKVLS-PESKQARANXFVGTAQYVSPELL 206
Query: 453 FVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
                         E      +D++A G ++ +L+ G
Sbjct: 207 -------------TEKSAXKSSDLWALGCIIYQLVAG 230

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 91/217 (41%), Gaps = 37/217 (17%)
Query: 292 NNFDESRIIGRGGFGNVYFG--LLGDREAAIKKM------RSNKSKEFFAELKVLCKIHH 343
            +F   +I+G G F  V     L   RE AIK +      + NK      E  V+ ++ H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 344 ---INVFISTFGNG-----SLSDHLHDPLLKGHQPLTWTARTQIALDAAK---GIEYIHD 392
              + ++  TF +       LS   +  LLK  + +     T      A+    +EY+H 
Sbjct: 92  PFFVKLYF-TFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 150
Query: 393 HTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYI 452
                 +HRD+K  NILL++ +  ++ DFG  K+      K+  A   VGT  Y+ PE +
Sbjct: 151 KG---IIHRDLKPENILLNEDMHIQITDFGTAKVLS-PESKQARANXFVGTAQYVSPELL 206
Query: 453 FVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
                         E      +D++A G ++ +L+ G
Sbjct: 207 -------------TEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 95/218 (43%), Gaps = 50/218 (22%)
Query: 298 RIIGRGGFGNVYFGLLGDR----EAAIKKMRSNKSK----EFFAELKVLCKIHHINVF-- 347
           R +G G FG+V+  L+ +R    E  IK +  ++S+    +  AE++VL  + H N+   
Sbjct: 28  RKLGSGAFGDVH--LVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKI 85
Query: 348 -------------ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHT 394
                        + T   G L + +     +G + L+     ++       + Y H   
Sbjct: 86  FEVFEDYHNMYIVMETCEGGELLERIVSAQARG-KALSEGYVAELMKQMMNALAYFHSQ- 143
Query: 395 KARYVHRDIKTSNILLDDGLRA---KVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEY 451
               VH+D+K  NIL  D       K+ DFGL +L  +++E    +T   GT  Y+ PE 
Sbjct: 144 --HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF-KSDEH---STNAAGTALYMAPE- 196
Query: 452 IFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
                        V +  VT K D+++ GVV+  L+TG
Sbjct: 197 -------------VFKRDVTFKCDIWSAGVVMYFLLTG 221

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 89/214 (41%), Gaps = 42/214 (19%)
Query: 298 RIIGRGGFGNV---YFGLLGDREAAIKKMRSNKS----KEFFAELKVLCKIHHINVF--- 347
           R +G G +G+V   Y   L  + A  K  R  +S    +  + EL++L  + H NV    
Sbjct: 26  RPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 85
Query: 348 --------ISTFGNGSLSDHLHDPLLKG---HQPLTWTARTQIALDAAKGIEYIHDHTKA 396
                   I  F    L   L    L      Q L+      +     +G++YIH    A
Sbjct: 86  DVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIH---SA 142
Query: 397 RYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKR 456
             +HRD+K SN+ +++    ++ DFGL     R  ++EM  T  V T  Y  PE +    
Sbjct: 143 GIIHRDLKPSNVAVNEDCELRILDFGLA----RQADEEM--TGYVATRWYRAPEIM---- 192
Query: 457 FRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
                   +  +      D+++ G ++AEL+ GK
Sbjct: 193 --------LNWMHYNQTVDIWSVGCIMAELLQGK 218

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 90/214 (42%), Gaps = 42/214 (19%)
Query: 298 RIIGRGGFGNV---YFGLLGDREAAIKKMRSNKS----KEFFAELKVLCKIHHINVF--- 347
           R +G G +G+V   Y   L  + A  K  R  +S    +  + EL++L  + H NV    
Sbjct: 34  RPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 348 --------ISTFGNGSLSDHLHDPLLKG---HQPLTWTARTQIALDAAKGIEYIHDHTKA 396
                   I  F    L   L    L      Q L+      +     +G++YIH    A
Sbjct: 94  DVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQFLVYQLLRGLKYIH---SA 150
Query: 397 RYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKR 456
             +HRD+K SN+ +++    ++ DFGL     R  ++EM  T  V T  Y  PE I +  
Sbjct: 151 GIIHRDLKPSNVAVNEDSELRILDFGLA----RQADEEM--TGYVATRWYRAPE-IMLNW 203
Query: 457 FRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
             ++              D+++ G ++AEL+ GK
Sbjct: 204 MHYNQ-----------TVDIWSVGCIMAELLQGK 226

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/228 (24%), Positives = 104/228 (45%), Gaps = 36/228 (15%)
Query: 288 EEATNNFDESRIIGRGGFGNVY------FGLLGDREAAIKKMRSNKSKEFFAELKVL--C 339
           E   ++F++   +G G  G V+       GL+  R+    +++     +   EL+VL  C
Sbjct: 29  ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC 88
Query: 340 KIHHINVFISTF-GNGSLS---DHLH----DPLLKGHQPLTWTARTQIALDAAKGIEYIH 391
              +I  F   F  +G +S   +H+     D +LK    +      ++++   KG+ Y+ 
Sbjct: 89  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR 148
Query: 392 DHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEY 451
           +  K + +HRD+K SNIL++     K+ DFG+          + +A   VGT  Y+ PE 
Sbjct: 149 E--KHKIMHRDVKPSNILVNSRGEIKLCDFGV-----SGQLIDSMANSFVGTRSYMSPER 201
Query: 452 IFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE 499
           +         H SV       ++D+++ G+ L E+  G+  +   D++
Sbjct: 202 L------QGTHYSV-------QSDIWSMGLSLVEMAVGRYPIPPPDAK 236

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 45/171 (26%), Positives = 70/171 (40%), Gaps = 39/171 (22%)
Query: 292 NNFDESRIIGRGGFGNVY--FGLLGDREAAIKKMRSNKSK--EFFAELKVLCKIHHINV- 346
           ++F+E  ++G+G FG V      L  R  AIKK+R  + K     +E+ +L  ++H  V 
Sbjct: 6   SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVV 65
Query: 347 -----------FISTFG----------------NGSLSDHLHDPLLKGHQPLTWTARTQI 379
                      F+                    N +L D +H   L   +   W    QI
Sbjct: 66  RYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRLFRQI 125
Query: 380 ALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERT 430
                + + YIH       +HRD+K  NI +D+    K+ DFGL K   R+
Sbjct: 126 L----EALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRS 169

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 100/219 (45%), Gaps = 36/219 (16%)
Query: 288 EEATNNFDESRIIGRGGFGNVY------FGLLGDREAAIKKMRSNKSKEFFAELKVL--C 339
           E   ++F++   +G G  G V+       GL+  R+    +++     +   EL+VL  C
Sbjct: 21  ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC 80
Query: 340 KIHHINVFISTF-GNGSLS---DHLH----DPLLKGHQPLTWTARTQIALDAAKGIEYIH 391
              +I  F   F  +G +S   +H+     D +LK    +      ++++   KG+ Y+ 
Sbjct: 81  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR 140
Query: 392 DHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEY 451
           +  K + +HRD+K SNIL++     K+ DFG+          + +A   VGT  Y+ PE 
Sbjct: 141 E--KHKIMHRDVKPSNILVNSRGEIKLCDFGV-----SGQLIDSMANSFVGTRSYMSPER 193
Query: 452 IFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
           +         H SV       ++D+++ G+ L E+  G+
Sbjct: 194 L------QGTHYSV-------QSDIWSMGLSLVEMAVGR 219

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 92/225 (40%), Gaps = 54/225 (24%)
Query: 298 RIIGRGGFGNVYFG-----LLGDREAAIKKMRSNKSK------EFFAELKVLCKI--HHI 344
           R +G+G FG VY G     + G+ E  +     N+S       EF  E  V+     HH+
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 82
Query: 345 N-------------VFISTFGNGSLSDHL--------HDPLLKGHQPLTWTARTQIALDA 383
                         V +    +G L  +L        ++P   G  P T     Q+A + 
Sbjct: 83  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNP---GRPPPTLQEMIQMAAEI 139
Query: 384 AKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGT 443
           A G+ Y++     ++VHR++   N ++      K+ DFG+ +    T+          G 
Sbjct: 140 ADGMAYLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRK------GG 190
Query: 444 PGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
            G LP         R+    S+ +   TT +D+++FGVVL E+ +
Sbjct: 191 KGLLP--------VRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 66/293 (22%), Positives = 113/293 (38%), Gaps = 59/293 (20%)
Query: 300 IGRGGFGNVYFGLLGDRE--AAIKKMRSN--KSKEFFAELKVLCKIHHINVF-------- 347
           +G G +G VY G+        A+K ++ +  + +EF  E  V+ +I H N+         
Sbjct: 267 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 326
Query: 348 ---------ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARY 398
                      T+GN  L D+L +      Q +       +A   +  +EY+    K  +
Sbjct: 327 EPPFYIITEFMTYGN--LLDYLRE---CNRQEVNAVVLLYMATQISSAMEYLE---KKNF 378
Query: 399 VHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFR 458
           +HR++   N L+ +    KVADFGL +L        M         G   P        +
Sbjct: 379 IHRNLAARNCLVGENHLVKVADFGLSRL--------MTGDTYTAHAGAKFP-------IK 423
Query: 459 FDMHSSVMELQVTTKTDVFAFGVVLAELITGKRA------------LIRDDSEPTKMKSL 506
           +    S+   + + K+DV+AFGV+L E+ T   +            L+  D    + +  
Sbjct: 424 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGC 483
Query: 507 ITIMAAVAEWCLNEDAVDRP---EMRDIVAILSQIMITSTEWEASLGGDSQVF 556
              +  +   C   +  DRP   E+      + Q    S E E  LG ++  F
Sbjct: 484 PEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKENLYF 536

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 92/225 (40%), Gaps = 54/225 (24%)
Query: 298 RIIGRGGFGNVYFG-----LLGDREAAIKKMRSNKSK------EFFAELKVLCKI--HHI 344
           R +G+G FG VY G     + G+ E  +     N+S       EF  E  V+     HH+
Sbjct: 24  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 83
Query: 345 N-------------VFISTFGNGSLSDHL--------HDPLLKGHQPLTWTARTQIALDA 383
                         V +    +G L  +L        ++P   G  P T     Q+A + 
Sbjct: 84  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNP---GRPPPTLQEMIQMAAEI 140
Query: 384 AKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGT 443
           A G+ Y++     ++VHR++   N ++      K+ DFG+ +    T+          G 
Sbjct: 141 ADGMAYLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRK------GG 191
Query: 444 PGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
            G LP         R+    S+ +   TT +D+++FGVVL E+ +
Sbjct: 192 KGLLP--------VRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 228

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 27/88 (30%), Positives = 42/88 (47%), Gaps = 16/88 (18%)
Query: 399 VHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFR 458
           +HRD+K +N+ LD     K+ DFGL ++    N     A   VGTP Y+ PE        
Sbjct: 138 LHRDLKPANVFLDGKQNVKLGDFGLARI---LNHDTSFAKTFVGTPYYMSPE-------- 186
Query: 459 FDMHSSVMELQVTTKTDVFAFGVVLAEL 486
                 +  +    K+D+++ G +L EL
Sbjct: 187 -----QMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 56/232 (24%), Positives = 91/232 (39%), Gaps = 48/232 (20%)
Query: 292 NNFDESRIIGRGGFGNV----------YFGL-LGDREAAIKK-----------MRSNKSK 329
           N F+  +++G+G FG V          Y+ + +  +E  + K           +  N   
Sbjct: 9   NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 68
Query: 330 EFFAELKVLCKIHHINVFISTFGNGS-LSDHL-HDPLLKGHQPLTWTARTQIALDAAKGI 387
            F   LK   + H    F+  + NG  L  HL  + +    +   + A    ALD     
Sbjct: 69  PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALD----- 123
Query: 388 EYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYL 447
            Y+H  ++   V+RD+K  N++LD     K+ DFGL K  E   +   +     GTP YL
Sbjct: 124 -YLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKX-FCGTPEYL 177
Query: 448 PPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE 499
            PE +              +       D +  GVV+ E++ G+      D E
Sbjct: 178 APEVL-------------EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE 216

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 27/88 (30%), Positives = 42/88 (47%), Gaps = 16/88 (18%)
Query: 399 VHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFR 458
           +HRD+K +N+ LD     K+ DFGL ++    N     A   VGTP Y+ PE        
Sbjct: 138 LHRDLKPANVFLDGKQNVKLGDFGLARI---LNHDTSFAKAFVGTPYYMSPE-------- 186
Query: 459 FDMHSSVMELQVTTKTDVFAFGVVLAEL 486
                 +  +    K+D+++ G +L EL
Sbjct: 187 -----QMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 67/304 (22%), Positives = 122/304 (40%), Gaps = 74/304 (24%)
Query: 285 EEIEEATNNFDESRIIGRGGFGNVY----FGLLGDREA----AIKKMRS----NKSKEFF 332
           E+ E   NN    + +G G FG V     FGL G  +A    A+K ++S    ++ +   
Sbjct: 31  EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGL-GKEDAVLKVAVKMLKSTAHADEKEALM 89
Query: 333 AELKVLCKIHHINVFISTFGN----------------GSLSDHLH-----DPLLKGHQPL 371
           +ELK++  +      ++  G                 G L + L      D   +  +PL
Sbjct: 90  SELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPL 149
Query: 372 TWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTN 431
                   +   A+G+ ++        +HRD+   N+LL +G  AK+ DFGL +  +  N
Sbjct: 150 ELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR--DIMN 204
Query: 432 EKEMLATRLVGTP-GYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAE----- 485
           +   +       P  ++ PE IF             +   T ++DV+++G++L E     
Sbjct: 205 DSNYIVKGNARLPVKWMAPESIF-------------DCVYTVQSDVWSYGILLWEIFSLG 251
Query: 486 -------LITGK-RALIRDDSEPTK----MKSLITIMAAVAEWCLNEDAVDRPEMRDIVA 533
                  L+  K   L++D  +  +     K++ +IM A    C   +   RP  + I +
Sbjct: 252 LNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQA----CWALEPTHRPTFQQICS 307
Query: 534 ILSQ 537
            L +
Sbjct: 308 FLQE 311

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 66/286 (23%), Positives = 107/286 (37%), Gaps = 57/286 (19%)
Query: 265 KENTEDVTVLESERTIIFSLEEIEEATNNFDESRIIGRGGFGNVYFGLLGDREAAIKKMR 324
           ++N      L     I+  +  ++    ++D  ++IGRG FG V       R  A +K+ 
Sbjct: 48  RKNKNIDNFLNRYEKIVKKIRGLQMKAEDYDVVKVIGRGAFGEVQLV----RHKASQKVY 103
Query: 325 SNK-----------SKEFFAE-------------LKVLCKIH---HINVFISTFGNGSLS 357
           + K              FF E             +++ C      ++ + +     G L 
Sbjct: 104 AMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLV 163
Query: 358 DHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAK 417
           + + +  +       +TA   +ALDA   +  IH         RD+K  N+LLD     K
Sbjct: 164 NLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIH---------RDVKPDNMLLDKHGHLK 214
Query: 418 VADFGLVKLEERTNEKEML-ATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDV 476
           +ADFG      + +E  M+     VGTP Y+ PE          + S   +     + D 
Sbjct: 215 LADFGTCM---KMDETGMVHCDTAVGTPDYISPEV---------LKSQGGDGYYGRECDW 262
Query: 477 FAFGVVLAELITGKRALIRDDSEPTKMKSLITIMAAVAEWCLNEDA 522
           ++ GV L E++ G      D    T  K    IM      C  EDA
Sbjct: 263 WSVGVFLFEMLVGDTPFYADSLVGTYSK----IMDHKNSLCFPEDA 304

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 58/252 (23%), Positives = 102/252 (40%), Gaps = 66/252 (26%)
Query: 285 EEIEEATNNFDESR--------IIGRGGFGNVYFGLLGDREA-----AIKKMRSN----- 326
           E+ ++ +NN D  +        ++G+G FG V   +L DR+      AIK ++ +     
Sbjct: 4   EDRKQPSNNLDRVKLTDFNFLMVLGKGSFGKV---MLADRKGTEELYAIKILKKDVVIQD 60
Query: 327 ----------------KSKEFFAELKVLCKIHHINVFISTFGNG-SLSDHLHD-PLLKGH 368
                               F  +L    +      F+  + NG  L  H+      K  
Sbjct: 61  DDVECTMVEKRVLALLDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEP 120
Query: 369 QPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEE 428
           Q + + A   I      G+ ++H   K   ++RD+K  N++LD     K+ADFG+ K   
Sbjct: 121 QAVFYAAEISI------GLFFLH---KRGIIYRDLKLDNVMLDSEGHIKIADFGMCK--- 168
Query: 429 RTNEKEMLATR-LVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELI 487
             +  + + TR   GTP Y+ PE I  + +                 D +A+GV+L E++
Sbjct: 169 -EHMMDGVTTREFCGTPDYIAPEIIAYQPY-------------GKSVDWWAYGVLLYEML 214
Query: 488 TGKRALIRDDSE 499
            G+     +D +
Sbjct: 215 AGQPPFDGEDED 226

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 90/219 (41%), Gaps = 41/219 (18%)
Query: 292 NNFDESRIIGRGGFGNVYFG--LLGDREAAIKKM------RSNKSKEFFAELKVLCKIHH 343
            +F   +I+G G F  V     L   RE AIK +      + NK      E  V+ ++ H
Sbjct: 37  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 96
Query: 344 ---INVFIS-------TFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAK---GIEYI 390
              + ++          FG   LS   +  LLK  + +     T      A+    +EY+
Sbjct: 97  PFFVKLYFCFQDDEKLYFG---LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYL 153
Query: 391 HDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPE 450
           H       +HRD+K  NILL++ +  ++ DFG  K+      K+  A   VGT  Y+ PE
Sbjct: 154 HGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLS-PESKQARANXFVGTAQYVSPE 209
Query: 451 YIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
            +              E      +D++A G ++ +L+ G
Sbjct: 210 LL-------------TEKSACKSSDLWALGCIIYQLVAG 235

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 56/232 (24%), Positives = 91/232 (39%), Gaps = 48/232 (20%)
Query: 292 NNFDESRIIGRGGFGNV----------YFGL-LGDREAAIKK-----------MRSNKSK 329
           N F+  +++G+G FG V          Y+ + +  +E  + K           +  N   
Sbjct: 10  NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 69
Query: 330 EFFAELKVLCKIHHINVFISTFGNGS-LSDHL-HDPLLKGHQPLTWTARTQIALDAAKGI 387
            F   LK   + H    F+  + NG  L  HL  + +    +   + A    ALD     
Sbjct: 70  PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALD----- 124
Query: 388 EYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYL 447
            Y+H  ++   V+RD+K  N++LD     K+ DFGL K  E   +   +     GTP YL
Sbjct: 125 -YLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKX-FCGTPEYL 178
Query: 448 PPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE 499
            PE +              +       D +  GVV+ E++ G+      D E
Sbjct: 179 APEVL-------------EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE 217

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 56/232 (24%), Positives = 91/232 (39%), Gaps = 48/232 (20%)
Query: 292 NNFDESRIIGRGGFGNV----------YFGL-LGDREAAIKK-----------MRSNKSK 329
           N F+  +++G+G FG V          Y+ + +  +E  + K           +  N   
Sbjct: 8   NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 67
Query: 330 EFFAELKVLCKIHHINVFISTFGNGS-LSDHL-HDPLLKGHQPLTWTARTQIALDAAKGI 387
            F   LK   + H    F+  + NG  L  HL  + +    +   + A    ALD     
Sbjct: 68  PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALD----- 122
Query: 388 EYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYL 447
            Y+H  ++   V+RD+K  N++LD     K+ DFGL K  E   +   +     GTP YL
Sbjct: 123 -YLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKX-FCGTPEYL 176
Query: 448 PPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE 499
            PE +              +       D +  GVV+ E++ G+      D E
Sbjct: 177 APEVL-------------EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE 215

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 90/214 (42%), Gaps = 42/214 (19%)
Query: 298 RIIGRGGFGNV---YFGLLGDREAAIKKMRSNKS----KEFFAELKVLCKIHHINVF--- 347
           R +G G +G+V   Y   L  + A  K  R  +S    +  + EL++L  + H NV    
Sbjct: 34  RPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 348 --------ISTFGNGSLSDHLHDPLLKG---HQPLTWTARTQIALDAAKGIEYIHDHTKA 396
                   I  F    L   L    L      Q L+      +     +G++YIH    A
Sbjct: 94  DVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIH---SA 150
Query: 397 RYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKR 456
             +HRD+K SN+ +++    ++ DFGL     R  ++EM  T  V T  Y  PE I +  
Sbjct: 151 GIIHRDLKPSNVAVNEDSELRILDFGLA----RQADEEM--TGYVATRWYRAPE-IMLNW 203
Query: 457 FRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
             ++              D+++ G ++AEL+ GK
Sbjct: 204 MHYNQ-----------TVDIWSVGCIMAELLQGK 226

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 92/218 (42%), Gaps = 44/218 (20%)
Query: 293 NFDESRIIGRGGFGNVYFG--LLGDREAAIK-----KMRSNKSKEFFAELKVLCKIHHIN 345
           N+   + IG+G F  V     +L  +E A+K     ++ S+  ++ F E+++   ++H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPN 74
Query: 346 V--------------FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIH 391
           +               +  + +G     + D L+   +     AR +        ++Y H
Sbjct: 75  IVKLFEVIETEKTLYLVXEYASGG---EVFDYLVAHGRXKEKEARAKFR-QIVSAVQYCH 130
Query: 392 DHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEY 451
              +   VHRD+K  N+LLD     K+ADFG     E T   ++ A    G P Y  PE 
Sbjct: 131 ---QKFIVHRDLKAENLLLDADXNIKIADFGFSN--EFTFGNKLDA--FCGAPPYAAPEL 183
Query: 452 IFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
              K++               + DV++ GV+L  L++G
Sbjct: 184 FQGKKYD------------GPEVDVWSLGVILYTLVSG 209

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 37/131 (28%), Positives = 57/131 (43%), Gaps = 19/131 (14%)
Query: 379 IALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLAT 438
            A    +G+ Y+H      Y+HR++   N+LLD+    K+ DFGL K     +E   +  
Sbjct: 122 FAQQICEGMAYLHSQ---HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVRE 178
Query: 439 RLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDS 498
                  +  PE +   +F +              +DV++FGV L EL+T   +     S
Sbjct: 179 DGDSPVFWYAPECLKEYKFYY-------------ASDVWSFGVTLYELLTHCDS---SQS 222
Query: 499 EPTKMKSLITI 509
            PTK   LI I
Sbjct: 223 PPTKFLELIGI 233

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 56/227 (24%), Positives = 94/227 (41%), Gaps = 56/227 (24%)
Query: 300 IGRGGFGNVY----FGL---LGDREAAIKKMRS----NKSKEFFAELKVLCKI-HHINVF 347
           +GRG FG V     FG+      R  A+K ++     ++ +   +ELK+L  I HH+NV 
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 348 ------------------ISTFGNGSLSDHLHDPLLKGHQP-------LTWTARTQIALD 382
                                FGN S            ++P       LT       +  
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYSFQ 156
Query: 383 AAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVG 442
            AKG+E++      + +HRD+   NILL +    K+ DFGL +  +   + + +      
Sbjct: 157 VAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLAR--DIXKDPDXVRKGDAR 211
Query: 443 TP-GYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
            P  ++ PE IF + +             T ++DV++FGV+L E+ +
Sbjct: 212 LPLKWMAPETIFDRVY-------------TIQSDVWSFGVLLWEIFS 245

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 56/236 (23%), Positives = 103/236 (43%), Gaps = 56/236 (23%)
Query: 300 IGRGGFGNVYFGLLGD-REAAIKKMRSNKSKE-----FFAELKVLCKIHHINVFISTFGN 353
           +G G +G VY       R  A+K++R +   E        E+ +L ++HH N+       
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIV------ 82
Query: 354 GSLSDHLHD----------------PLLKGHQPLTWTARTQIAL-DAAKGIEYIHDHTKA 396
            SL D +H                  +L  ++     ++ +I L    +G+ + H H   
Sbjct: 83  -SLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQH--- 138
Query: 397 RYVHRDIKTSNILLDDGLRAKVADFGLVK---LEERTNEKEMLATRLVGTPGYLPPEYIF 453
           R +HRD+K  N+L++     K+ADFGL +   +  R+   E++      T  Y  P+ + 
Sbjct: 139 RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV------TLWYRAPDVLM 192
Query: 454 VKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRAL--IRDDSEPTKMKSLI 507
             +            + +T  D+++ G + AE+ITGK     + DD +  K+ S++
Sbjct: 193 GSK------------KYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSIL 236

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 90/217 (41%), Gaps = 37/217 (17%)
Query: 292 NNFDESRIIGRGGFGNVYFG--LLGDREAAIKKM------RSNKSKEFFAELKVLCKIHH 343
            +F   +I+G G F        L   RE AIK +      + NK      E  V+ ++ H
Sbjct: 30  EDFKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 344 ---INVFISTFGNGS-----LSDHLHDPLLKGHQPLTWTARTQIALDAAK---GIEYIHD 392
              + ++  TF +       LS   +  LLK  + +     T      A+    +EY+H 
Sbjct: 90  PFFVKLYF-TFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 148
Query: 393 HTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYI 452
                 +HRD+K  NILL++ +  ++ DFG  K+      K+  A   VGT  Y+ PE +
Sbjct: 149 KG---IIHRDLKPENILLNEDMHIQITDFGTAKVLS-PESKQARANXFVGTAQYVSPELL 204
Query: 453 FVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
                         E      +D++A G ++ +L+ G
Sbjct: 205 -------------TEKSACKSSDLWALGCIIYQLVAG 228

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 93/199 (46%), Gaps = 30/199 (15%)
Query: 311 GLLGDREAAIKKMRSNKSKEFFAELKVL--CKIHHINVFISTF-GNGSLS---DHLH--- 361
           GL+  R+    +++     +   EL+VL  C   +I  F   F  +G +S   +H+    
Sbjct: 41  GLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGS 100
Query: 362 -DPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVAD 420
            D +LK  + +      ++++   +G+ Y+ +  K + +HRD+K SNIL++     K+ D
Sbjct: 101 LDQVLKEAKRIPEEILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCD 158
Query: 421 FGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFG 480
           FG+          + +A   VGT  Y+ PE +         H SV       ++D+++ G
Sbjct: 159 FGV-----SGQLIDSMANSFVGTRSYMAPERL------QGTHYSV-------QSDIWSMG 200
Query: 481 VVLAELITGKRALIRDDSE 499
           + L EL  G+  +   D++
Sbjct: 201 LSLVELAVGRYPIPPPDAK 219

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 67/159 (42%), Gaps = 31/159 (19%)
Query: 354 GSLSDHLHDPLLKGHQPLTWTARTQIALDAAK---GIEYIHDHTKARYVHRDIKTSNILL 410
           GSL D+L         P       Q+ L A +   G+ Y+H      Y+HR++   N+LL
Sbjct: 103 GSLRDYL---------PRHSIGLAQLLLFAQQICEGMAYLH---AQHYIHRNLAARNVLL 150
Query: 411 DDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQV 470
           D+    K+ DFGL K     +E   +         +  PE +   +F +           
Sbjct: 151 DNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYY----------- 199
Query: 471 TTKTDVFAFGVVLAELITGKRALIRDDSEPTKMKSLITI 509
              +DV++FGV L EL+T   +     S PTK   LI I
Sbjct: 200 --ASDVWSFGVTLYELLTHCDS---SQSPPTKFLELIGI 233

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 67/304 (22%), Positives = 122/304 (40%), Gaps = 74/304 (24%)
Query: 285 EEIEEATNNFDESRIIGRGGFGNVY----FGLLGDREA----AIKKMRS----NKSKEFF 332
           E+ E   NN    + +G G FG V     FGL G  +A    A+K ++S    ++ +   
Sbjct: 39  EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGL-GKEDAVLKVAVKMLKSTAHADEKEALM 97
Query: 333 AELKVLCKIHHINVFISTFGN----------------GSLSDHLH-----DPLLKGHQPL 371
           +ELK++  +      ++  G                 G L + L      D   +  +PL
Sbjct: 98  SELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPL 157
Query: 372 TWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTN 431
                   +   A+G+ ++        +HRD+   N+LL +G  AK+ DFGL +  +  N
Sbjct: 158 ELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR--DIMN 212
Query: 432 EKEMLATRLVGTP-GYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAE----- 485
           +   +       P  ++ PE IF             +   T ++DV+++G++L E     
Sbjct: 213 DSNYIVKGNARLPVKWMAPESIF-------------DCVYTVQSDVWSYGILLWEIFSLG 259
Query: 486 -------LITGK-RALIRDDSEPTK----MKSLITIMAAVAEWCLNEDAVDRPEMRDIVA 533
                  L+  K   L++D  +  +     K++ +IM A    C   +   RP  + I +
Sbjct: 260 LNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQA----CWALEPTHRPTFQQICS 315
Query: 534 ILSQ 537
            L +
Sbjct: 316 FLQE 319

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 61/262 (23%), Positives = 110/262 (41%), Gaps = 62/262 (23%)
Query: 267 NTEDVTVLESERTIIFSLEEIEEATNNFDESRIIGRGGFGNVY----FGL---LGDREAA 319
           + +++ + E    + +   + E   +  +  + +GRG FG V     FG+      R  A
Sbjct: 2   DPDELPLDEHCERLPYDASKWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVA 61
Query: 320 IKKMRS----NKSKEFFAELKVLCKI-HHINVF------------------ISTFGNGSL 356
           +K ++     ++ +   +ELK+L  I HH+NV                      FGN  L
Sbjct: 62  VKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGN--L 119
Query: 357 SDHL---------HDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSN 407
           S +L         +  L K    LT       +   AKG+E++      + +HRD+   N
Sbjct: 120 STYLRSKRNEFVPYKDLYKDF--LTLEHLICYSFQVAKGMEFL---ASRKXIHRDLAARN 174
Query: 408 ILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP-GYLPPEYIFVKRFRFDMHSSVM 466
           ILL +    K+ DFGL +  +   + + +       P  ++ PE IF + +         
Sbjct: 175 ILLSEKNVVKICDFGLAR--DIYKDPDYVRKGDARLPLKWMAPETIFDRVY--------- 223
Query: 467 ELQVTTKTDVFAFGVVLAELIT 488
               T ++DV++FGV+L E+ +
Sbjct: 224 ----TIQSDVWSFGVLLWEIFS 241

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/231 (24%), Positives = 96/231 (41%), Gaps = 53/231 (22%)
Query: 285 EEIEEATNNFDESRIIGRGGFGNVYFGLLGDREAAI------KKMRSNKSKEFFAELKVL 338
           ++ E+  + +D   ++G G F  V        +  +      KK    K      E+ VL
Sbjct: 11  KQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVL 70
Query: 339 CKIHHINV---------------FISTFGNGSLSDHLHDPLLKGHQPLTWTAR--TQIAL 381
            KI H N+                +     G L D +   + KG     +T R  +++  
Sbjct: 71  HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRI---VEKGF----YTERDASRLIF 123
Query: 382 DAAKGIEYIHDHTKARYVHRDIKTSNIL---LDDGLRAKVADFGLVKLEERTNEKEMLAT 438
                ++Y+HD      VHRD+K  N+L   LD+  +  ++DFGL K+E+  +   +L+T
Sbjct: 124 QVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---VLST 177
Query: 439 RLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
              GTPGY+ PE +  K +             +   D ++ GV+   L+ G
Sbjct: 178 -ACGTPGYVAPEVLAQKPY-------------SKAVDCWSIGVIAYILLCG 214

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 61/262 (23%), Positives = 110/262 (41%), Gaps = 62/262 (23%)
Query: 267 NTEDVTVLESERTIIFSLEEIEEATNNFDESRIIGRGGFGNVY----FGL---LGDREAA 319
           + +++ + E    + +   + E   +  +  + +GRG FG V     FG+      R  A
Sbjct: 2   DPDELPLDEHCERLPYDASKWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVA 61
Query: 320 IKKMRS----NKSKEFFAELKVLCKI-HHINVF------------------ISTFGNGSL 356
           +K ++     ++ +   +ELK+L  I HH+NV                      FGN  L
Sbjct: 62  VKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGN--L 119
Query: 357 SDHL---------HDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSN 407
           S +L         +  L K    LT       +   AKG+E++      + +HRD+   N
Sbjct: 120 STYLRSKRNEFVPYKDLYKDF--LTLEHLIXYSFQVAKGMEFL---ASRKXIHRDLAARN 174
Query: 408 ILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP-GYLPPEYIFVKRFRFDMHSSVM 466
           ILL +    K+ DFGL +  +   + + +       P  ++ PE IF + +         
Sbjct: 175 ILLSEKNVVKIXDFGLAR--DIYKDPDYVRKGDARLPLKWMAPETIFDRVY--------- 223
Query: 467 ELQVTTKTDVFAFGVVLAELIT 488
               T ++DV++FGV+L E+ +
Sbjct: 224 ----TIQSDVWSFGVLLWEIFS 241

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 74/289 (25%), Positives = 118/289 (40%), Gaps = 66/289 (22%)
Query: 290 ATNNF---DESRIIGRGGFGNVY------FGLLGDREAAIKKMRSNKSKEFFA-ELKVLC 339
           A N+F    ++ I+G G FG V+       GL     A I K R  K KE    E+ V+ 
Sbjct: 84  AVNSFYTVSKTEILGGGRFGQVHKCEETATGL--KLAAKIIKTRGMKDKEEVKNEISVMN 141
Query: 340 KIHHIN--------------VFISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAK 385
           ++ H N              V +  + +G     L D ++     LT            +
Sbjct: 142 QLDHANLIQLYDAFESKNDIVLVMEYVDGG---ELFDRIIDESYNLTELDTILFMKQICE 198
Query: 386 GIEYIHDHTKARYVHRDIKTSNILL--DDGLRAKVADFGLVKLEERTNEKEMLATRLVGT 443
           GI ++H   +   +H D+K  NIL    D  + K+ DFGL +   R   +E L     GT
Sbjct: 199 GIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLAR---RYKPREKLKVNF-GT 251
Query: 444 PGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKM 503
           P +L PE +      +D         V+  TD+++ GV+   L++G    + D+   T  
Sbjct: 252 PEFLAPEVV-----NYDF--------VSFPTDMWSVGVIAYMLLSGLSPFLGDNDAET-- 296
Query: 504 KSLITIMAAVAEWCLNEDAVDRPEMRDIV----AILSQIMITSTEWEAS 548
             L  I+A    W L ++     E +DI       +S+++I    W  S
Sbjct: 297 --LNNILA--CRWDLEDE-----EFQDISEEAKEFISKLLIKEKSWRIS 336

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/236 (23%), Positives = 103/236 (43%), Gaps = 56/236 (23%)
Query: 300 IGRGGFGNVYFGLLGD-REAAIKKMRSNKSKE-----FFAELKVLCKIHHINVFISTFGN 353
           +G G +G VY       R  A+K++R +   E        E+ +L ++HH N+       
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIV------ 82
Query: 354 GSLSDHLHD----------------PLLKGHQPLTWTARTQIAL-DAAKGIEYIHDHTKA 396
            SL D +H                  +L  ++     ++ +I L    +G+ + H H   
Sbjct: 83  -SLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQH--- 138
Query: 397 RYVHRDIKTSNILLDDGLRAKVADFGLVK---LEERTNEKEMLATRLVGTPGYLPPEYIF 453
           R +HRD+K  N+L++     K+ADFGL +   +  R+   E++      T  Y  P+ + 
Sbjct: 139 RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV------TLWYRAPDVLM 192
Query: 454 VKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRAL--IRDDSEPTKMKSLI 507
             +            + +T  D+++ G + AE+ITGK     + DD +  K+ S++
Sbjct: 193 GSK------------KYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSIL 236

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 96/213 (45%), Gaps = 45/213 (21%)
Query: 299 IIGRGGFGNVYF--GLLGDREAAIKKMR--SNKSKE---FFAELKVLCKIHHINVF---- 347
           ++G+G FG V      +  +E A+K +   S K+K+      E+++L K+ H N+     
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 348 ----ISTF---GNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVH 400
                S+F   G       L D ++K  +  +     +I      GI Y+H H     VH
Sbjct: 89  ILEDSSSFYIVGELYTGGELFDEIIK-RKRFSEHDAARIIKQVFSGITYMHKHN---IVH 144
Query: 401 RDIKTSNILLDDGLRA---KVADFGLVK-LEERTNEKEMLATRLVGTPGYLPPEYIFVKR 456
           RD+K  NILL+   +    K+ DFGL    ++ T  K+      +GT  Y+ PE   V R
Sbjct: 145 RDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR-----IGTAYYIAPE---VLR 196
Query: 457 FRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
             +D            K DV++ GV+L  L++G
Sbjct: 197 GTYD-----------EKCDVWSAGVILYILLSG 218

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/268 (22%), Positives = 104/268 (38%), Gaps = 65/268 (24%)
Query: 298 RIIGRGGFGNVYFG--LLGDREAAIKKMRSNKSKEFFAELKVLCKIH----HINV----- 346
           R++  GGF  VY    +   RE A+K++ SN+ ++  A ++ +C +     H N+     
Sbjct: 34  RVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCS 93
Query: 347 -----------------FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEY 389
                             ++    G L + L    ++   PL+     +I     + +++
Sbjct: 94  AASIGKEESDTGQAEFLLLTELCKGQLVEFLKK--MESRGPLSCDTVLKIFYQTCRAVQH 151
Query: 390 IHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLV-------- 441
           +H   K   +HRD+K  N+LL +    K+ DFG         +    A R          
Sbjct: 152 MH-RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITR 210
Query: 442 -GTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVL---------------AE 485
             TP Y  PE I       D++S+     +  K D++A G +L                 
Sbjct: 211 NTTPMYRTPEII-------DLYSN---FPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR 260
Query: 486 LITGKRALIRDDSEPTKMKSLITIMAAV 513
           ++ GK ++   D++ T   SLI  M  V
Sbjct: 261 IVNGKYSIPPHDTQYTVFHSLIRAMLQV 288

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 101/231 (43%), Gaps = 42/231 (18%)
Query: 284 LEEIEEATNNFDESRIIGRGGFGNVYFGLLGDREAAIKKMRSNKSKEFFAELKVLCKIHH 343
           ++E++    +F+  ++IGRG FG V    + + E  I  M+     E     +  C    
Sbjct: 66  VKEMQLHREDFEIIKVIGRGAFGEVAVVKMKNTER-IYAMKILNKWEMLKRAETACFREE 124
Query: 344 INVFIS------TFGNGSLSDHLHDPLLK----GHQPLTWTARTQIAL--DAAK------ 385
            +V ++      T  + +  D  H  L+     G   LT  ++ +  L  D A+      
Sbjct: 125 RDVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEM 184
Query: 386 --GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFG-LVKLEERTNEKEMLATRLVG 442
              I+ IH   +  YVHRDIK  N+LLD     ++ADFG  +K+ +    +  +A   VG
Sbjct: 185 VLAIDSIH---QLHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVA---VG 238
Query: 443 TPGYLPPEYIFVKRFRFDMHSSVMEL---QVTTKTDVFAFGVVLAELITGK 490
           TP Y+ PE +             ME    +   + D ++ GV + E++ G+
Sbjct: 239 TPDYISPEIL-----------QAMEDGMGKYGPECDWWSLGVCMYEMLYGE 278

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 70/296 (23%), Positives = 118/296 (39%), Gaps = 65/296 (21%)
Query: 283 SLEEIEEATNNFDESRIIGRGGFGNVYFGLLGDRE-----AAIKKMRSNKS----KEFFA 333
           S  + E      +  R IG G FG+V+ G+    E      AIK  ++  S    ++F  
Sbjct: 1   STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQ 60
Query: 334 ELKVLCKIHHINV--FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIH 391
           E   + +  H ++   I       +   +   L    +  ++    + +LD A  I Y +
Sbjct: 61  EALTMRQFDHPHIVKLIGVITENPVWIIME--LCTLGELRSFLQVRKFSLDLASLILYAY 118
Query: 392 DHTKA-------RYVHRDIKTSNILLDDGLRAKVADFGLVK-LEERTNEKEMLATRLVGT 443
             + A       R+VHRDI   N+L+      K+ DFGL + +E+ T  K   A++    
Sbjct: 119 QLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXK---ASKGKLP 175
Query: 444 PGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELI---------------- 487
             ++ PE I  +RF             T+ +DV+ FGV + E++                
Sbjct: 176 IKWMAPESINFRRF-------------TSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI 222
Query: 488 ----TGKRALIRDDSEPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIM 539
                G+R  +  +  PT + SL+T        C   D   RP   ++ A LS I+
Sbjct: 223 GRIENGERLPMPPNCPPT-LYSLMTK-------CWAYDPSRRPRFTELKAQLSTIL 270

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 56/108 (51%), Gaps = 26/108 (24%)
Query: 386 GIEYIHDHTKARYVHRDIKTSNILLD----DGLRAKVADFGLVKLEERTNEKEMLATRLV 441
           G+ Y+H H     VHRD+K  N+LL+    D L  K+ DFGL  + E  N+K+M     +
Sbjct: 148 GVTYLHKHN---IVHRDLKPENLLLESKEKDAL-IKIVDFGLSAVFE--NQKKM--KERL 199
Query: 442 GTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
           GT  Y+ PE   V R ++D            K DV++ GV+L  L+ G
Sbjct: 200 GTAYYIAPE---VLRKKYD-----------EKCDVWSIGVILFILLAG 233

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 96/213 (45%), Gaps = 45/213 (21%)
Query: 299 IIGRGGFGNVYF--GLLGDREAAIKKMR--SNKSKE---FFAELKVLCKIHHINVFI--- 348
           ++G+G FG V      +  +E A+K +   S K+K+      E+++L K+ H N+     
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 349 -----STF---GNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVH 400
                S+F   G       L D ++K  +  +     +I      GI Y+H H     VH
Sbjct: 89  ILEDSSSFYIVGELYTGGELFDEIIK-RKRFSEHDAARIIKQVFSGITYMHKHN---IVH 144
Query: 401 RDIKTSNILLDDGLR---AKVADFGLVK-LEERTNEKEMLATRLVGTPGYLPPEYIFVKR 456
           RD+K  NILL+   +    K+ DFGL    ++ T  K+      +GT  Y+ PE   V R
Sbjct: 145 RDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR-----IGTAYYIAPE---VLR 196
Query: 457 FRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
             +D            K DV++ GV+L  L++G
Sbjct: 197 GTYD-----------EKCDVWSAGVILYILLSG 218

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 94/217 (43%), Gaps = 49/217 (22%)
Query: 298 RIIGRGGFGNVYFGLLGDREAAIK-----KMRSNKS--KEFFA----------------- 333
           +++G G FG V+ G+      +IK     K+  +KS  + F A                 
Sbjct: 37  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 96
Query: 334 ELKVLCKIHHINVFISTFGNGSLSDHL--HDPLLKGHQPLTWTARTQIALDAAKGIEYIH 391
            L  LC    + +       GSL DH+  H   L     L W       +  AKG+ Y+ 
Sbjct: 97  RLLGLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNW------GVQIAKGMYYLE 150
Query: 392 DHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEY 451
           +H     VHR++   N+LL    + +VADFG+  L    ++K++L +         P ++
Sbjct: 151 EHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLP-PDDKQLLYSE-----AKTPIKW 201
Query: 452 IFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
           + ++   F  +        T ++DV+++GV + EL+T
Sbjct: 202 MALESIHFGKY--------THQSDVWSYGVTVWELMT 230

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 38/147 (25%), Positives = 61/147 (41%), Gaps = 28/147 (19%)
Query: 380 ALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATR 439
           A +    +EY+H       ++RD+K  NILLD     K+ DFG  K          +   
Sbjct: 112 AAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD------VTYX 162
Query: 440 LVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE 499
           L GTP Y+ PE +  K +                 D ++FG+++ E++ G       ++ 
Sbjct: 163 LCGTPDYIAPEVVSTKPY-------------NKSIDWWSFGILIYEMLAGYTPFYDSNT- 208
Query: 500 PTKMKSLITIMAAVAEW--CLNEDAVD 524
              MK+   I+ A   +    NED  D
Sbjct: 209 ---MKTYEKILNAELRFPPFFNEDVKD 232

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 96/213 (45%), Gaps = 45/213 (21%)
Query: 299 IIGRGGFGNVYF--GLLGDREAAIKKMR--SNKSKE---FFAELKVLCKIHHINVF---- 347
           ++G+G FG V      +  +E A+K +   S K+K+      E+++L K+ H N+     
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 348 ----ISTF---GNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVH 400
                S+F   G       L D ++K  +  +     +I      GI Y+H H     VH
Sbjct: 89  ILEDSSSFYIVGELYTGGELFDEIIK-RKRFSEHDAARIIKQVFSGITYMHKHN---IVH 144
Query: 401 RDIKTSNILLDDGLR---AKVADFGLVK-LEERTNEKEMLATRLVGTPGYLPPEYIFVKR 456
           RD+K  NILL+   +    K+ DFGL    ++ T  K+      +GT  Y+ PE   V R
Sbjct: 145 RDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR-----IGTAYYIAPE---VLR 196
Query: 457 FRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
             +D            K DV++ GV+L  L++G
Sbjct: 197 GTYD-----------EKCDVWSAGVILYILLSG 218

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 96/221 (43%), Gaps = 44/221 (19%)
Query: 291 TNNFDESRIIGRGGFGNVYF--GLLGDREAAIKKMRSNKSKE------FFAELKVLCKIH 342
           ++ +   R++G+G FG V      +  +E A+K +   + K+         E+++L ++ 
Sbjct: 31  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 90
Query: 343 HINV-----------FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIH 391
           H N+           +    G       L D ++   +  +     +I      GI Y+H
Sbjct: 91  HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEII-SRKRFSEVDAARIIRQVLSGITYMH 149
Query: 392 DHTKARYVHRDIKTSNILLDDGLR---AKVADFGLVKLEERTNEKEMLATRLVGTPGYLP 448
              K + VHRD+K  N+LL+   +    ++ DFGL    E +  K+M     +GT  Y+ 
Sbjct: 150 ---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS--KKMKDK--IGTAYYIA 202
Query: 449 PEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
           PE          +H +  E     K DV++ GV+L  L++G
Sbjct: 203 PEV---------LHGTYDE-----KCDVWSTGVILYILLSG 229

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 70/286 (24%), Positives = 112/286 (39%), Gaps = 51/286 (17%)
Query: 292 NNFDESRIIGRGGFGNVYFGLLGDREA--AIKKM------RSNKSKEFFAELKVLCKIHH 343
           ++F   ++IG+G FG V        E   A+K +      +  + K   +E  VL K   
Sbjct: 38  SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK 97
Query: 344 INVFISTFGNGSLSDHLHDPL--LKGHQPLTWTARTQIALDA---------AKGIEYIHD 392
               +    +   +D L+  L  + G +      R +  L+          A  + Y+H 
Sbjct: 98  HPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHS 157
Query: 393 HTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYI 452
                 V+RD+K  NILLD      + DFGL K      E     +   GTP YL PE  
Sbjct: 158 ---LNIVYRDLKPENILLDSQGHIVLTDFGLCK---ENIEHNSTTSTFCGTPEYLAPE-- 209
Query: 453 FVKRFRFDMHSSVMELQVTTKT-DVFAFGVVLAELITG-------KRALIRDD--SEPTK 502
                       V+  Q   +T D +  G VL E++ G         A + D+  ++P +
Sbjct: 210 ------------VLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQ 257
Query: 503 MKSLITIMAA-VAEWCLNEDAVDRPEMR-DIVAILSQIMITSTEWE 546
           +K  IT  A  + E  L +D   R   + D + I S +  +   W+
Sbjct: 258 LKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWD 303

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/153 (26%), Positives = 71/153 (46%), Gaps = 25/153 (16%)
Query: 338 LCKIHHINVFISTFGNGSLSDHL--HDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTK 395
           LC    + +       GSL DH+  H   L     L W       +  AKG+ Y+ +H  
Sbjct: 83  LCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNW------GVQIAKGMYYLEEHG- 135
Query: 396 ARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVK 455
              VHR++   N+LL    + +VADFG+  L    ++K++L +         P +++ ++
Sbjct: 136 --MVHRNLAARNVLLKSPSQVQVADFGVADLLP-PDDKQLLYSE-----AKTPIKWMALE 187
Query: 456 RFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
              F  +        T ++DV+++GV + EL+T
Sbjct: 188 SIHFGKY--------THQSDVWSYGVTVWELMT 212

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 67/310 (21%), Positives = 124/310 (40%), Gaps = 80/310 (25%)
Query: 285 EEIEEATNNFDESRIIGRGGFGNVY----FGLLGDREA----AIKKMRS----NKSKEFF 332
           E+ E   NN    + +G G FG V     FGL G  +A    A+K ++S    ++ +   
Sbjct: 39  EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGL-GKEDAVLKVAVKMLKSTAHADEKEALM 97
Query: 333 AELKVLCKIHHINVFISTFGN----------------GSLSDHL-----------HDPLL 365
           +ELK++  +      ++  G                 G L + L           ++P  
Sbjct: 98  SELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSH 157
Query: 366 KGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK 425
              + L+       +   A+G+ ++        +HRD+   N+LL +G  AK+ DFGL +
Sbjct: 158 NPEEQLSSRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR 214
Query: 426 LEERTNEKEMLATRLVGTP-GYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLA 484
             +  N+   +       P  ++ PE IF             +   T ++DV+++G++L 
Sbjct: 215 --DIMNDSNYIVKGNARLPVKWMAPESIF-------------DCVYTVQSDVWSYGILLW 259
Query: 485 E------------LITGK-RALIRDDSEPTK----MKSLITIMAAVAEWCLNEDAVDRPE 527
           E            L+  K   L++D  +  +     K++ +IM A   W L  +   RP 
Sbjct: 260 EIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQAC--WAL--EPTHRPT 315
Query: 528 MRDIVAILSQ 537
            + I + L +
Sbjct: 316 FQQICSFLQE 325

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 101/231 (43%), Gaps = 42/231 (18%)
Query: 284 LEEIEEATNNFDESRIIGRGGFGNVYFGLLGDREAAIKKMRSNKSKEFFAELKVLCKIHH 343
           ++E++    +F+  ++IGRG FG V    + + E  I  M+     E     +  C    
Sbjct: 82  VKEMQLHREDFEIIKVIGRGAFGEVAVVKMKNTER-IYAMKILNKWEMLKRAETACFREE 140
Query: 344 INVFIS------TFGNGSLSDHLHDPLLK----GHQPLTWTARTQIAL--DAAK------ 385
            +V ++      T  + +  D  H  L+     G   LT  ++ +  L  D A+      
Sbjct: 141 RDVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEM 200
Query: 386 --GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFG-LVKLEERTNEKEMLATRLVG 442
              I+ IH   +  YVHRDIK  N+LLD     ++ADFG  +K+ +    +  +A   VG
Sbjct: 201 VLAIDSIH---QLHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVA---VG 254
Query: 443 TPGYLPPEYIFVKRFRFDMHSSVMEL---QVTTKTDVFAFGVVLAELITGK 490
           TP Y+ PE +             ME    +   + D ++ GV + E++ G+
Sbjct: 255 TPDYISPEIL-----------QAMEDGMGKYGPECDWWSLGVCMYEMLYGE 294

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/171 (26%), Positives = 72/171 (42%), Gaps = 39/171 (22%)
Query: 292 NNFDESRIIGRGGFGNVY--FGLLGDREAAIKKMRSNKSK--EFFAELKVLCKIHHINV- 346
           ++F+E  ++G+G FG V      L  R  AIKK+R  + K     +E+ +L  ++H  V 
Sbjct: 6   SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVXLLASLNHQYVV 65
Query: 347 -----------FI---------STF-------GNGSLSDHLHDPLLKGHQPLTWTARTQI 379
                      F+         ST         N +L D +H   L   +   W    QI
Sbjct: 66  RYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRLFRQI 125
Query: 380 ALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERT 430
                + + YIH       +HR++K  NI +D+    K+ DFGL K   R+
Sbjct: 126 L----EALSYIHSQG---IIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRS 169

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/102 (29%), Positives = 50/102 (49%), Gaps = 18/102 (17%)
Query: 399 VHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATR-LVGTPGYLPPEYIFVKRF 457
           ++RD+K  N++LD     K+ADFG+ K     N  + + T+   GTP Y+ PE I  + +
Sbjct: 464 IYRDLKLDNVMLDSEGHIKIADFGMCK----ENIWDGVTTKXFCGTPDYIAPEIIAYQPY 519
Query: 458 RFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE 499
                            D +AFGV+L E++ G+     +D +
Sbjct: 520 -------------GKSVDWWAFGVLLYEMLAGQAPFEGEDED 548

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 60/263 (22%), Positives = 110/263 (41%), Gaps = 61/263 (23%)
Query: 267 NTEDVTVLESERTIIFSLEEIEEATNNFDESRIIGRGGFGNVY----FGLLGD---REAA 319
           + +++ + E    + +   + E   +  +  + +GRG FG V     FG+      R  A
Sbjct: 3   DPDELPLDEHCERLPYDASKWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATCRTVA 62
Query: 320 IKKMRS----NKSKEFFAELKVLCKI-HHINVF------------------ISTFGNGSL 356
           +K ++     ++ +   +ELK+L  I HH+NV                      FGN  L
Sbjct: 63  VKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGN--L 120
Query: 357 SDHLH---DPLLKGHQP-------LTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTS 406
           S +L    +  +    P       LT       +   AKG+E++      + +HRD+   
Sbjct: 121 STYLRSKRNEFVPYKTPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAAR 177
Query: 407 NILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP-GYLPPEYIFVKRFRFDMHSSV 465
           NILL +    K+ DFGL +  +   + + +       P  ++ PE IF + +        
Sbjct: 178 NILLSEKNVVKICDFGLAR--DIXKDPDXVRKGDARLPLKWMAPETIFDRVY-------- 227
Query: 466 MELQVTTKTDVFAFGVVLAELIT 488
                T ++DV++FGV+L E+ +
Sbjct: 228 -----TIQSDVWSFGVLLWEIFS 245

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 60/231 (25%), Positives = 99/231 (42%), Gaps = 30/231 (12%)
Query: 275 ESERTIIFSLEEIEEATNNFDESRIIGRGGFGNVYFGL----LGDREAAIKKMRSNKSKE 330
           ++ +T IF L+E +      +   +IG+G FG VY G     +  R   I++   ++ K 
Sbjct: 17  KASQTSIF-LQEWDIPFEQLEIGELIGKGRFGQVYHGRWHGEVAIRLIDIERDNEDQLKA 75
Query: 331 FFAELKVLCKIHHINVFISTFGNGSLS-DHLH--DPLLKGHQPLTWTARTQIALDA---- 383
           F  E+    +  H NV +  F    +S  HL     L KG    +     +I LD     
Sbjct: 76  FKREVMAYRQTRHENVVL--FMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTR 133
Query: 384 ------AKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEE--RTNEKEM 435
                  KG+ Y+H       +H+D+K+ N+  D+G +  + DFGL  +    +   +E 
Sbjct: 134 QIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRRED 189
Query: 436 LATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAEL 486
                 G   +L PE I  ++   D      +L  +  +DVFA G +  EL
Sbjct: 190 KLRIQNGWLCHLAPEII--RQLSPDTEED--KLPFSKHSDVFALGTIWYEL 236

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 62/275 (22%), Positives = 111/275 (40%), Gaps = 45/275 (16%)
Query: 284 LEEIEEATNNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNKSKEFFAELKVLCKI 341
           ++E E   + +    ++G GGFG+VY G+    +   AIK +  ++  ++  EL    ++
Sbjct: 1   MKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDW-GELPNGTRV 59
Query: 342 HHINVFISTFGNG-----SLSDHLHDP-----LLKGHQPLT-----WTARTQIALDAAKG 386
               V +    +G      L D    P     +L+  +P+       T R  +  + A+ 
Sbjct: 60  PMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS 119
Query: 387 -----IEYIHDHTKARYVHRDIKTSNILLD-DGLRAKVADFGLVKLEERTNEKEMLATRL 440
                +E +        +HRDIK  NIL+D +    K+ DFG   L      K+ + T  
Sbjct: 120 FFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL-----LKDTVYTDF 174
Query: 441 VGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDD--- 497
            GT  Y PPE+I   R+                  V++ G++L +++ G      D+   
Sbjct: 175 DGTRVYSPPEWIRYHRYH------------GRSAAVWSLGILLYDMVCGDIPFEHDEEII 222
Query: 498 -SEPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDI 531
             +    + + +    +  WCL     DRP   +I
Sbjct: 223 RGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEI 257

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 96/221 (43%), Gaps = 44/221 (19%)
Query: 291 TNNFDESRIIGRGGFGNVYF--GLLGDREAAIKKMRSNKSKE------FFAELKVLCKIH 342
           ++ +   R++G+G FG V      +  +E A+K +   + K+         E+++L ++ 
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 343 HINV-----------FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIH 391
           H N+           +    G       L D ++   +  +     +I      GI Y+H
Sbjct: 85  HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEII-SRKRFSEVDAARIIRQVLSGITYMH 143
Query: 392 DHTKARYVHRDIKTSNILLDDGLRA---KVADFGLVKLEERTNEKEMLATRLVGTPGYLP 448
              K + VHRD+K  N+LL+   +    ++ DFGL    E +  K+M     +GT  Y+ 
Sbjct: 144 ---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS--KKMKDK--IGTAYYIA 196
Query: 449 PEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
           PE          +H +  E     K DV++ GV+L  L++G
Sbjct: 197 PEV---------LHGTYDE-----KCDVWSTGVILYILLSG 223

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 76/316 (24%), Positives = 120/316 (37%), Gaps = 80/316 (25%)
Query: 267 NTEDVTVLESERTIIFSLEEIEEATNNFDESRIIGRGGFGNVYFGLLGDRE-----AAIK 321
           + ED   + S R      E IE         R IG G FG+V+ G+    E      AIK
Sbjct: 372 DEEDTYTMPSTRDYEIQRERIELG-------RCIGEGQFGDVHQGIYMSPENPAMAVAIK 424
Query: 322 KMRSNKS----KEFFAELKVLCKIHHINV--FISTFGNGSLSDHLHDPLLKGHQPLTWTA 375
             ++  S    ++F  E   + +  H ++   I       +   +   L    +  ++  
Sbjct: 425 TCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWIIME--LCTLGELRSFLQ 482
Query: 376 RTQIALDAAKGIEYIHDHTKA-------RYVHRDIKTSNILLDDGLRAKVADFGLVKLEE 428
             + +LD A  I Y +  + A       R+VHRDI   N+L+      K+ DFGL +  E
Sbjct: 483 VRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 542
Query: 429 RTNEKEMLATRLVGTPGYLP-----PEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVL 483
            +       T    + G LP     PE I  +RF             T+ +DV+ FGV +
Sbjct: 543 DS-------TYYKASKGKLPIKWMAPESINFRRF-------------TSASDVWMFGVCM 582
Query: 484 AELI--------------------TGKRALIRDDSEPTKMKSLITIMAAVAEWCLNEDAV 523
            E++                     G+R  +  +  PT + SL+T        C   D  
Sbjct: 583 WEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPT-LYSLMTK-------CWAYDPS 634
Query: 524 DRPEMRDIVAILSQIM 539
            RP   ++ A LS I+
Sbjct: 635 RRPRFTELKAQLSTIL 650

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 63/258 (24%), Positives = 104/258 (40%), Gaps = 52/258 (20%)
Query: 290 ATNNFDESRIIGRGGFGNVYFGLL---GDREAAIKKMRSN-------------------- 326
             +NF+  R++G+G FG V    +   GD   A+K ++ +                    
Sbjct: 21  GIDNFEFIRVLGKGSFGKVMLARVKETGDL-YAVKVLKKDVILQDDDVECTMTEKRILSL 79
Query: 327 -KSKEFFAELKVLCKIHHINVFISTFGNG-SLSDHLHDPLLKGHQPLTWTARTQIALDAA 384
            ++  F  +L    +      F+  F NG  L  H+     K  +     AR   A +  
Sbjct: 80  ARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQ----KSRRFDEARARF-YAAEII 134
Query: 385 KGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP 444
             + ++HD      ++RD+K  N+LLD     K+ADFG+ K  E        AT   GTP
Sbjct: 135 SALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCK--EGICNGVTTAT-FCGTP 188
Query: 445 GYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKMK 504
            Y+ PE +              E+      D +A GV+L E++ G  A    ++E    +
Sbjct: 189 DYIAPEIL-------------QEMLYGPAVDWWAMGVLLYEMLCG-HAPFEAENEDDLFE 234
Query: 505 SLITIMAAVAEWCLNEDA 522
           +++        W L+EDA
Sbjct: 235 AILNDEVVYPTW-LHEDA 251

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 71/300 (23%), Positives = 115/300 (38%), Gaps = 73/300 (24%)
Query: 283 SLEEIEEATNNFDESRIIGRGGFGNVYFGLLGDRE-----AAIKKMRSNKS----KEFFA 333
           S  + E      +  R IG G FG+V+ G+    E      AIK  ++  S    ++F  
Sbjct: 29  STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQ 88
Query: 334 ELKVLCKIHHINV--FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIH 391
           E   + +  H ++   I       +   +   L    +  ++    + +LD A  I Y +
Sbjct: 89  EALTMRQFDHPHIVKLIGVITENPVWIIME--LCTLGELRSFLQVRKYSLDLASLILYAY 146
Query: 392 DHTKA-------RYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP 444
             + A       R+VHRDI   N+L+      K+ DFGL +  E +       T    + 
Sbjct: 147 QLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS-------TYYKASK 199
Query: 445 GYLP-----PEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELI------------ 487
           G LP     PE I  +RF             T+ +DV+ FGV + E++            
Sbjct: 200 GKLPIKWMAPESINFRRF-------------TSASDVWMFGVCMWEILMHGVKPFQGVKN 246
Query: 488 --------TGKRALIRDDSEPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIM 539
                    G+R  +  +  PT + SL+T        C   D   RP   ++ A LS I+
Sbjct: 247 NDVIGRIENGERLPMPPNCPPT-LYSLMTK-------CWAYDPSRRPRFTELKAQLSTIL 298

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 71/300 (23%), Positives = 115/300 (38%), Gaps = 73/300 (24%)
Query: 283 SLEEIEEATNNFDESRIIGRGGFGNVYFGLLGDRE-----AAIKKMRSNKS----KEFFA 333
           S  + E      +  R IG G FG+V+ G+    E      AIK  ++  S    ++F  
Sbjct: 1   STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQ 60
Query: 334 ELKVLCKIHHINV--FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIH 391
           E   + +  H ++   I       +   +   L    +  ++    + +LD A  I Y +
Sbjct: 61  EALTMRQFDHPHIVKLIGVITENPVWIIME--LCTLGELRSFLQVRKYSLDLASLILYAY 118
Query: 392 DHTKA-------RYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP 444
             + A       R+VHRDI   N+L+      K+ DFGL +  E +       T    + 
Sbjct: 119 QLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS-------TYYKASK 171
Query: 445 GYLP-----PEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELI------------ 487
           G LP     PE I  +RF             T+ +DV+ FGV + E++            
Sbjct: 172 GKLPIKWMAPESINFRRF-------------TSASDVWMFGVCMWEILMHGVKPFQGVKN 218
Query: 488 --------TGKRALIRDDSEPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIM 539
                    G+R  +  +  PT + SL+T        C   D   RP   ++ A LS I+
Sbjct: 219 NDVIGRIENGERLPMPPNCPPT-LYSLMTK-------CWAYDPSRRPRFTELKAQLSTIL 270

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 71/300 (23%), Positives = 115/300 (38%), Gaps = 73/300 (24%)
Query: 283 SLEEIEEATNNFDESRIIGRGGFGNVYFGLLGDRE-----AAIKKMRSNKS----KEFFA 333
           S  + E      +  R IG G FG+V+ G+    E      AIK  ++  S    ++F  
Sbjct: 6   STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQ 65
Query: 334 ELKVLCKIHHINV--FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIH 391
           E   + +  H ++   I       +   +   L    +  ++    + +LD A  I Y +
Sbjct: 66  EALTMRQFDHPHIVKLIGVITENPVWIIME--LCTLGELRSFLQVRKYSLDLASLILYAY 123
Query: 392 DHTKA-------RYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP 444
             + A       R+VHRDI   N+L+      K+ DFGL +  E +       T    + 
Sbjct: 124 QLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS-------TYYKASK 176
Query: 445 GYLP-----PEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELI------------ 487
           G LP     PE I  +RF             T+ +DV+ FGV + E++            
Sbjct: 177 GKLPIKWMAPESINFRRF-------------TSASDVWMFGVCMWEILMHGVKPFQGVKN 223
Query: 488 --------TGKRALIRDDSEPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIM 539
                    G+R  +  +  PT + SL+T        C   D   RP   ++ A LS I+
Sbjct: 224 NDVIGRIENGERLPMPPNCPPT-LYSLMTK-------CWAYDPSRRPRFTELKAQLSTIL 275

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 71/300 (23%), Positives = 115/300 (38%), Gaps = 73/300 (24%)
Query: 283 SLEEIEEATNNFDESRIIGRGGFGNVYFGLLGDRE-----AAIKKMRSNKS----KEFFA 333
           S  + E      +  R IG G FG+V+ G+    E      AIK  ++  S    ++F  
Sbjct: 1   STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQ 60
Query: 334 ELKVLCKIHHINV--FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIH 391
           E   + +  H ++   I       +   +   L    +  ++    + +LD A  I Y +
Sbjct: 61  EALTMRQFDHPHIVKLIGVITENPVWIIME--LCTLGELRSFLQVRKYSLDLASLILYAY 118
Query: 392 DHTKA-------RYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP 444
             + A       R+VHRDI   N+L+      K+ DFGL +  E +       T    + 
Sbjct: 119 QLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS-------TYYKASK 171
Query: 445 GYLP-----PEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELI------------ 487
           G LP     PE I  +RF             T+ +DV+ FGV + E++            
Sbjct: 172 GKLPIKWMAPESINFRRF-------------TSASDVWMFGVCMWEILMHGVKPFQGVKN 218
Query: 488 --------TGKRALIRDDSEPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIM 539
                    G+R  +  +  PT + SL+T        C   D   RP   ++ A LS I+
Sbjct: 219 NDVIGRIENGERLPMPPNCPPT-LYSLMTK-------CWAYDPSRRPRFTELKAQLSTIL 270

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 55/231 (23%), Positives = 96/231 (41%), Gaps = 53/231 (22%)
Query: 285 EEIEEATNNFDESRIIGRGGFGNVYFGLLGDREAAI------KKMRSNKSKEFFAELKVL 338
           ++ E+  + +D   ++G G F  V        +  +      K+    K      E+ VL
Sbjct: 11  KQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVL 70
Query: 339 CKIHHINV---------------FISTFGNGSLSDHLHDPLLKGHQPLTWTAR--TQIAL 381
            KI H N+                +     G L D +   + KG     +T R  +++  
Sbjct: 71  HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRI---VEKGF----YTERDASRLIF 123
Query: 382 DAAKGIEYIHDHTKARYVHRDIKTSNIL---LDDGLRAKVADFGLVKLEERTNEKEMLAT 438
                ++Y+HD      VHRD+K  N+L   LD+  +  ++DFGL K+E+  +   +L+T
Sbjct: 124 QVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---VLST 177
Query: 439 RLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
              GTPGY+ PE +  K +             +   D ++ GV+   L+ G
Sbjct: 178 A-CGTPGYVAPEVLAQKPY-------------SKAVDCWSIGVIAYILLCG 214

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 67/308 (21%), Positives = 122/308 (39%), Gaps = 78/308 (25%)
Query: 285 EEIEEATNNFDESRIIGRGGFGNVY----FGLLGDREA----AIKKMRS----NKSKEFF 332
           E+ E   NN    + +G G FG V     FGL G  +A    A+K ++S    ++ +   
Sbjct: 39  EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGL-GKEDAVLKVAVKMLKSTAHADEKEALM 97
Query: 333 AELKVLCKIHHINVFISTFGN----------------GSLSDHLH--------DPLLK-G 367
           +ELK++  +      ++  G                 G L + L         DP     
Sbjct: 98  SELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIA 157
Query: 368 HQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLE 427
           +  L+       +   A+G+ ++        +HRD+   N+LL +G  AK+ DFGL +  
Sbjct: 158 NSTLSTRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR-- 212
Query: 428 ERTNEKEMLATRLVGTP-GYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAE- 485
           +  N+   +       P  ++ PE IF             +   T ++DV+++G++L E 
Sbjct: 213 DIMNDSNYIVKGNARLPVKWMAPESIF-------------DCVYTVQSDVWSYGILLWEI 259
Query: 486 -----------LITGK-RALIRDDSEPTK----MKSLITIMAAVAEWCLNEDAVDRPEMR 529
                      L+  K   L++D  +  +     K++ +IM A    C   +   RP  +
Sbjct: 260 FSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQA----CWALEPTHRPTFQ 315
Query: 530 DIVAILSQ 537
            I + L +
Sbjct: 316 QICSFLQE 323

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 69/285 (24%), Positives = 111/285 (38%), Gaps = 73/285 (25%)
Query: 298 RIIGRGGFGNVYFGLLGDRE-----AAIKKMRSNKS----KEFFAELKVLCKIHHINV-- 346
           R IG G FG+V+ G+    E      AIK  ++  S    ++F  E   + +  H ++  
Sbjct: 13  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 72
Query: 347 FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKA-------RYV 399
            I       +   +   L    +  ++    + +LD A  I Y +  + A       R+V
Sbjct: 73  LIGVITENPVWIIME--LCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFV 130
Query: 400 HRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLP-----PEYIFV 454
           HRDI   N+L+      K+ DFGL +  E +       T    + G LP     PE I  
Sbjct: 131 HRDIAARNVLVSSNDCVKLGDFGLSRYMEDS-------TYYKASKGKLPIKWMAPESINF 183
Query: 455 KRFRFDMHSSVMELQVTTKTDVFAFGVVLAELI--------------------TGKRALI 494
           +RF             T+ +DV+ FGV + E++                     G+R  +
Sbjct: 184 RRF-------------TSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPM 230
Query: 495 RDDSEPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIM 539
             +  PT + SL+T        C   D   RP   ++ A LS I+
Sbjct: 231 PPNCPPT-LYSLMTK-------CWAYDPSRRPRFTELKAQLSTIL 267

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 30/102 (29%), Positives = 50/102 (49%), Gaps = 18/102 (17%)
Query: 399 VHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATR-LVGTPGYLPPEYIFVKRF 457
           ++RD+K  N++LD     K+ADFG+ K     N  + + T+   GTP Y+ PE I  + +
Sbjct: 143 IYRDLKLDNVMLDSEGHIKIADFGMCK----ENIWDGVTTKXFCGTPDYIAPEIIAYQPY 198
Query: 458 RFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE 499
                            D +AFGV+L E++ G+     +D +
Sbjct: 199 -------------GKSVDWWAFGVLLYEMLAGQAPFEGEDED 227

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 55/231 (23%), Positives = 96/231 (41%), Gaps = 53/231 (22%)
Query: 285 EEIEEATNNFDESRIIGRGGFGNVYFGLLGDREAAI------KKMRSNKSKEFFAELKVL 338
           ++ E+  + +D   ++G G F  V        +  +      K+    K      E+ VL
Sbjct: 11  KQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVL 70
Query: 339 CKIHHINV---------------FISTFGNGSLSDHLHDPLLKGHQPLTWTAR--TQIAL 381
            KI H N+                +     G L D +   + KG     +T R  +++  
Sbjct: 71  HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRI---VEKGF----YTERDASRLIF 123
Query: 382 DAAKGIEYIHDHTKARYVHRDIKTSNIL---LDDGLRAKVADFGLVKLEERTNEKEMLAT 438
                ++Y+HD      VHRD+K  N+L   LD+  +  ++DFGL K+E+  +   +L+T
Sbjct: 124 QVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---VLST 177
Query: 439 RLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
              GTPGY+ PE +  K +             +   D ++ GV+   L+ G
Sbjct: 178 -ACGTPGYVAPEVLAQKPY-------------SKAVDCWSIGVIAYILLCG 214

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 33/121 (27%), Positives = 61/121 (50%), Gaps = 19/121 (15%)
Query: 369 QPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK-LE 427
           +P+T       +   A+G+E++   +  + +HRD+   NILL +    K+ DFGL + + 
Sbjct: 194 EPITMEDLISYSFQVARGMEFL---SSRKCIHRDLAARNILLSENNVVKICDFGLARDIY 250
Query: 428 ERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELI 487
           +  +      TRL     ++ PE IF K +             +TK+DV+++GV+L E+ 
Sbjct: 251 KNPDYVRKGDTRL--PLKWMAPESIFDKIY-------------STKSDVWSYGVLLWEIF 295
Query: 488 T 488
           +
Sbjct: 296 S 296

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 71/300 (23%), Positives = 115/300 (38%), Gaps = 73/300 (24%)
Query: 283 SLEEIEEATNNFDESRIIGRGGFGNVYFGLLGDRE-----AAIKKMRSNKS----KEFFA 333
           S  + E      +  R IG G FG+V+ G+    E      AIK  ++  S    ++F  
Sbjct: 3   STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQ 62
Query: 334 ELKVLCKIHHINV--FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIH 391
           E   + +  H ++   I       +   +   L    +  ++    + +LD A  I Y +
Sbjct: 63  EALTMRQFDHPHIVKLIGVITENPVWIIME--LCTLGELRSFLQVRKYSLDLASLILYAY 120
Query: 392 DHTKA-------RYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP 444
             + A       R+VHRDI   N+L+      K+ DFGL +  E +       T    + 
Sbjct: 121 QLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS-------TYYKASK 173
Query: 445 GYLP-----PEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELI------------ 487
           G LP     PE I  +RF             T+ +DV+ FGV + E++            
Sbjct: 174 GKLPIKWMAPESINFRRF-------------TSASDVWMFGVCMWEILMHGVKPFQGVKN 220
Query: 488 --------TGKRALIRDDSEPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIM 539
                    G+R  +  +  PT + SL+T        C   D   RP   ++ A LS I+
Sbjct: 221 NDVIGRIENGERLPMPPNCPPT-LYSLMTK-------CWAYDPSRRPRFTELKAQLSTIL 272

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 55/231 (23%), Positives = 96/231 (41%), Gaps = 53/231 (22%)
Query: 285 EEIEEATNNFDESRIIGRGGFGNVYFGLLGDREAAI------KKMRSNKSKEFFAELKVL 338
           ++ E+  + +D   ++G G F  V        +  +      K+    K      E+ VL
Sbjct: 11  KQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVL 70
Query: 339 CKIHHINV---------------FISTFGNGSLSDHLHDPLLKGHQPLTWTAR--TQIAL 381
            KI H N+                +     G L D +   + KG     +T R  +++  
Sbjct: 71  HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRI---VEKGF----YTERDASRLIF 123
Query: 382 DAAKGIEYIHDHTKARYVHRDIKTSNIL---LDDGLRAKVADFGLVKLEERTNEKEMLAT 438
                ++Y+HD      VHRD+K  N+L   LD+  +  ++DFGL K+E+  +   +L+T
Sbjct: 124 QVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---VLST 177
Query: 439 RLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
              GTPGY+ PE +  K +             +   D ++ GV+   L+ G
Sbjct: 178 -ACGTPGYVAPEVLAQKPY-------------SKAVDCWSIGVIAYILLCG 214

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 62/275 (22%), Positives = 111/275 (40%), Gaps = 45/275 (16%)
Query: 284 LEEIEEATNNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNKSKEFFAELKVLCKI 341
           ++E E   + +    ++G GGFG+VY G+    +   AIK +  ++  ++  EL    ++
Sbjct: 1   MKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDW-GELPNGTRV 59
Query: 342 HHINVFISTFGNG-----SLSDHLHDP-----LLKGHQPLT-----WTARTQIALDAAKG 386
               V +    +G      L D    P     +L+  +P+       T R  +  + A+ 
Sbjct: 60  PMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS 119
Query: 387 -----IEYIHDHTKARYVHRDIKTSNILLD-DGLRAKVADFGLVKLEERTNEKEMLATRL 440
                +E +        +HRDIK  NIL+D +    K+ DFG   L      K+ + T  
Sbjct: 120 FFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL-----LKDTVYTDF 174
Query: 441 VGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDD--- 497
            GT  Y PPE+I   R+                  V++ G++L +++ G      D+   
Sbjct: 175 DGTRVYSPPEWIRYHRYH------------GRSAAVWSLGILLYDMVCGDIPFEHDEEII 222
Query: 498 -SEPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDI 531
             +    + + +    +  WCL     DRP   +I
Sbjct: 223 RGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEI 257

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 96/221 (43%), Gaps = 44/221 (19%)
Query: 291 TNNFDESRIIGRGGFGNVYF--GLLGDREAAIKKMRSNKSKE------FFAELKVLCKIH 342
           ++ +   R++G+G FG V      +  +E A+K +   + K+         E+++L ++ 
Sbjct: 48  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 107
Query: 343 HINV-----------FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIH 391
           H N+           +    G       L D ++   +  +     +I      GI Y+H
Sbjct: 108 HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEII-SRKRFSEVDAARIIRQVLSGITYMH 166
Query: 392 DHTKARYVHRDIKTSNILLDDGLRA---KVADFGLVKLEERTNEKEMLATRLVGTPGYLP 448
              K + VHRD+K  N+LL+   +    ++ DFGL    E +  K+M     +GT  Y+ 
Sbjct: 167 ---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS--KKMKDK--IGTAYYIA 219
Query: 449 PEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
           PE          +H +  E     K DV++ GV+L  L++G
Sbjct: 220 PEV---------LHGTYDE-----KCDVWSTGVILYILLSG 246

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 71/300 (23%), Positives = 115/300 (38%), Gaps = 73/300 (24%)
Query: 283 SLEEIEEATNNFDESRIIGRGGFGNVYFGLLGDRE-----AAIKKMRSNKS----KEFFA 333
           S  + E      +  R IG G FG+V+ G+    E      AIK  ++  S    ++F  
Sbjct: 4   STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQ 63
Query: 334 ELKVLCKIHHINV--FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIH 391
           E   + +  H ++   I       +   +   L    +  ++    + +LD A  I Y +
Sbjct: 64  EALTMRQFDHPHIVKLIGVITENPVWIIME--LCTLGELRSFLQVRKYSLDLASLILYAY 121
Query: 392 DHTKA-------RYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP 444
             + A       R+VHRDI   N+L+      K+ DFGL +  E +       T    + 
Sbjct: 122 QLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS-------TYYKASK 174
Query: 445 GYLP-----PEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELI------------ 487
           G LP     PE I  +RF             T+ +DV+ FGV + E++            
Sbjct: 175 GKLPIKWMAPESINFRRF-------------TSASDVWMFGVCMWEILMHGVKPFQGVKN 221
Query: 488 --------TGKRALIRDDSEPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIM 539
                    G+R  +  +  PT + SL+T        C   D   RP   ++ A LS I+
Sbjct: 222 NDVIGRIENGERLPMPPNCPPT-LYSLMTK-------CWAYDPSRRPRFTELKAQLSTIL 273

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 36/108 (33%), Positives = 52/108 (48%), Gaps = 22/108 (20%)
Query: 385 KGIEYIHDHTKARYVHRDIKTSNILLDD---GLRAKVADFGLVKLEERTNEKEMLATRLV 441
           + + +IH H     VHRD+K  N+LL     G   K+ADFGL  +E +  ++        
Sbjct: 141 ESVNHIHQHD---IVHRDLKPENLLLASKCKGAAVKLADFGLA-IEVQGEQQAWFG--FA 194
Query: 442 GTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
           GTPGYL PE +     R D +            D++A GV+L  L+ G
Sbjct: 195 GTPGYLSPEVL-----RKDPYGK--------PVDIWACGVILYILLVG 229

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 37/107 (34%), Positives = 52/107 (48%), Gaps = 24/107 (22%)
Query: 386 GIEYIHDHTKARYVHRDIKTSNILLDDG---LRAKVADFGLVKLEERTNEKEMLATRLVG 442
           GI Y+H H     VHRDIK  NILL++    L  K+ DFGL     +  +   L  RL G
Sbjct: 158 GICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK---LRDRL-G 210
Query: 443 TPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
           T  Y+ PE              V++ +   K DV++ GV++  L+ G
Sbjct: 211 TAYYIAPE--------------VLKKKYNEKCDVWSCGVIMYILLCG 243

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 62/275 (22%), Positives = 111/275 (40%), Gaps = 45/275 (16%)
Query: 284 LEEIEEATNNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNKSKEFFAELKVLCKI 341
           ++E E   + +    ++G GGFG+VY G+    +   AIK +  ++  ++  EL    ++
Sbjct: 1   MKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDW-GELPNGTRV 59
Query: 342 HHINVFISTFGNG-----SLSDHLHDP-----LLKGHQPLT-----WTARTQIALDAAKG 386
               V +    +G      L D    P     +L+  +P+       T R  +  + A+ 
Sbjct: 60  PMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS 119
Query: 387 -----IEYIHDHTKARYVHRDIKTSNILLD-DGLRAKVADFGLVKLEERTNEKEMLATRL 440
                +E +        +HRDIK  NIL+D +    K+ DFG   L      K+ + T  
Sbjct: 120 FFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL-----LKDTVYTDF 174
Query: 441 VGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDD--- 497
            GT  Y PPE+I   R+                  V++ G++L +++ G      D+   
Sbjct: 175 DGTRVYSPPEWIRYHRYH------------GRSAAVWSLGILLYDMVCGDIPFEHDEEII 222
Query: 498 -SEPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDI 531
             +    + + +    +  WCL     DRP   +I
Sbjct: 223 RGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEI 257

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 96/221 (43%), Gaps = 44/221 (19%)
Query: 291 TNNFDESRIIGRGGFGNVYF--GLLGDREAAIKKMRSNKSKE------FFAELKVLCKIH 342
           ++ +   R++G+G FG V      +  +E A+K +   + K+         E+++L ++ 
Sbjct: 49  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 108
Query: 343 HINV-----------FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIH 391
           H N+           +    G       L D ++   +  +     +I      GI Y+H
Sbjct: 109 HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEII-SRKRFSEVDAARIIRQVLSGITYMH 167
Query: 392 DHTKARYVHRDIKTSNILLDDGLRA---KVADFGLVKLEERTNEKEMLATRLVGTPGYLP 448
              K + VHRD+K  N+LL+   +    ++ DFGL    E +  K+M     +GT  Y+ 
Sbjct: 168 ---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS--KKMKDK--IGTAYYIA 220
Query: 449 PEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
           PE          +H +  E     K DV++ GV+L  L++G
Sbjct: 221 PEV---------LHGTYDE-----KCDVWSTGVILYILLSG 247

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 93/214 (43%), Gaps = 41/214 (19%)
Query: 266 ENTEDVTVLESERTIIFSL-EEIEEATNNFDESRIIGRGGFGNVYFGLLGDRE----AAI 320
           E+ E V + E  + + +   EE+  AT+       +GRG FG V+   + D++     A+
Sbjct: 51  EDNEGVLLTEKLKPVDYEYREEVHWATHQLR----LGRGSFGEVH--RMEDKQTGFQCAV 104
Query: 321 KKMRSNKSKEFFAELKVLC----------------KIHHINVFISTFGNGSLSDHLHDPL 364
           KK+R    + F AE  + C                +   +N+F+     GSL       L
Sbjct: 105 KKVRL---EVFRAEELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQ-----L 156
Query: 365 LKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILL-DDGLRAKVADFG- 422
           +K    L           A +G+EY+H     R +H D+K  N+LL  DG  A + DFG 
Sbjct: 157 VKEQGCLPEDRALYYLGQALEGLEYLHSR---RILHGDVKADNVLLSSDGSHAALCDFGH 213
Query: 423 LVKLEERTNEKEMLATRLV-GTPGYLPPEYIFVK 455
            V L+     K++L    + GT  ++ PE +  +
Sbjct: 214 AVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLGR 247

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 62/274 (22%), Positives = 110/274 (40%), Gaps = 45/274 (16%)
Query: 285 EEIEEATNNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNKSKEFFAELKVLCKIH 342
           +E E   + +    ++G GGFG+VY G+    +   AIK +  ++  ++  EL    ++ 
Sbjct: 30  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDW-GELPNGTRVP 88
Query: 343 HINVFISTFGNG-----SLSDHLHDP-----LLKGHQPLT-----WTARTQIALDAAKG- 386
              V +    +G      L D    P     +L+  +P+       T R  +  + A+  
Sbjct: 89  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 148
Query: 387 ----IEYIHDHTKARYVHRDIKTSNILLD-DGLRAKVADFGLVKLEERTNEKEMLATRLV 441
               +E +        +HRDIK  NIL+D +    K+ DFG   L      K+ + T   
Sbjct: 149 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL-----LKDTVYTDFD 203
Query: 442 GTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDD---- 497
           GT  Y PPE+I   R+                  V++ G++L +++ G      D+    
Sbjct: 204 GTRVYSPPEWIRYHRYH------------GRSAAVWSLGILLYDMVCGDIPFEHDEEIIG 251
Query: 498 SEPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDI 531
            +    + + +    +  WCL     DRP   +I
Sbjct: 252 GQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEI 285

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 99/231 (42%), Gaps = 62/231 (26%)
Query: 300 IGRGGFGNVY----FGLLGD---REAAIKKMRS----NKSKEFFAELKVLCKI-HHINVF 347
           +GRG FG V     FG+      R  A+K ++     ++ +   +ELK+L  I HH+NV 
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 348 ---------------ISTFGN-GSLSDHLH-------------DPLLKGHQPLTWTARTQ 378
                          I+ F   G+LS +L              + L K    LT      
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF--LTLEHLIC 143
Query: 379 IALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLAT 438
            +   AKG+E++      + +HRD+   NILL +    K+ DFGL +  +   + + +  
Sbjct: 144 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR--DIXKDPDXVRK 198
Query: 439 RLVGTP-GYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
                P  ++ PE IF + +             T ++DV++FGV+L E+ +
Sbjct: 199 GDARLPLKWMAPETIFDRVY-------------TIQSDVWSFGVLLWEIFS 236

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 62/274 (22%), Positives = 110/274 (40%), Gaps = 45/274 (16%)
Query: 285 EEIEEATNNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNKSKEFFAELKVLCKIH 342
           +E E   + +    ++G GGFG+VY G+    +   AIK +  ++  ++  EL    ++ 
Sbjct: 30  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDW-GELPNGTRVP 88
Query: 343 HINVFISTFGNG-----SLSDHLHDP-----LLKGHQPLT-----WTARTQIALDAAKG- 386
              V +    +G      L D    P     +L+  +P+       T R  +  + A+  
Sbjct: 89  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 148
Query: 387 ----IEYIHDHTKARYVHRDIKTSNILLD-DGLRAKVADFGLVKLEERTNEKEMLATRLV 441
               +E +        +HRDIK  NIL+D +    K+ DFG   L      K+ + T   
Sbjct: 149 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL-----LKDTVYTDFD 203
Query: 442 GTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDD---- 497
           GT  Y PPE+I   R+                  V++ G++L +++ G      D+    
Sbjct: 204 GTRVYSPPEWIRYHRYH------------GRSAAVWSLGILLYDMVCGDIPFEHDEEIIG 251
Query: 498 SEPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDI 531
            +    + + +    +  WCL     DRP   +I
Sbjct: 252 GQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEI 285

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 62/274 (22%), Positives = 110/274 (40%), Gaps = 45/274 (16%)
Query: 285 EEIEEATNNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNKSKEFFAELKVLCKIH 342
           +E E   + +    ++G GGFG+VY G+    +   AIK +  ++  ++  EL    ++ 
Sbjct: 36  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDW-GELPNGTRVP 94
Query: 343 HINVFISTFGNG-----SLSDHLHDP-----LLKGHQPLT-----WTARTQIALDAAKG- 386
              V +    +G      L D    P     +L+  +P+       T R  +  + A+  
Sbjct: 95  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 154
Query: 387 ----IEYIHDHTKARYVHRDIKTSNILLD-DGLRAKVADFGLVKLEERTNEKEMLATRLV 441
               +E +        +HRDIK  NIL+D +    K+ DFG   L      K+ + T   
Sbjct: 155 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL-----LKDTVYTDFD 209
Query: 442 GTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDD---- 497
           GT  Y PPE+I   R+                  V++ G++L +++ G      D+    
Sbjct: 210 GTRVYSPPEWIRYHRYH------------GRSAAVWSLGILLYDMVCGDIPFEHDEEIIR 257
Query: 498 SEPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDI 531
            +    + + +    +  WCL     DRP   +I
Sbjct: 258 GQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEI 291

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 62/274 (22%), Positives = 110/274 (40%), Gaps = 45/274 (16%)
Query: 285 EEIEEATNNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNKSKEFFAELKVLCKIH 342
           +E E   + +    ++G GGFG+VY G+    +   AIK +  ++  ++  EL    ++ 
Sbjct: 44  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDW-GELPNGTRVP 102
Query: 343 HINVFISTFGNG-----SLSDHLHDP-----LLKGHQPLT-----WTARTQIALDAAKG- 386
              V +    +G      L D    P     +L+  +P+       T R  +  + A+  
Sbjct: 103 MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 162
Query: 387 ----IEYIHDHTKARYVHRDIKTSNILLD-DGLRAKVADFGLVKLEERTNEKEMLATRLV 441
               +E +        +HRDIK  NIL+D +    K+ DFG   L      K+ + T   
Sbjct: 163 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL-----LKDTVYTDFD 217
Query: 442 GTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDD---- 497
           GT  Y PPE+I   R+                  V++ G++L +++ G      D+    
Sbjct: 218 GTRVYSPPEWIRYHRYH------------GRSAAVWSLGILLYDMVCGDIPFEHDEEIIR 265
Query: 498 SEPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDI 531
            +    + + +    +  WCL     DRP   +I
Sbjct: 266 GQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEI 299

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 62/274 (22%), Positives = 110/274 (40%), Gaps = 45/274 (16%)
Query: 285 EEIEEATNNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNKSKEFFAELKVLCKIH 342
           +E E   + +    ++G GGFG+VY G+    +   AIK +  ++  ++  EL    ++ 
Sbjct: 17  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDW-GELPNGTRVP 75
Query: 343 HINVFISTFGNG-----SLSDHLHDP-----LLKGHQPLT-----WTARTQIALDAAKG- 386
              V +    +G      L D    P     +L+  +P+       T R  +  + A+  
Sbjct: 76  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 135
Query: 387 ----IEYIHDHTKARYVHRDIKTSNILLD-DGLRAKVADFGLVKLEERTNEKEMLATRLV 441
               +E +        +HRDIK  NIL+D +    K+ DFG   L      K+ + T   
Sbjct: 136 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL-----LKDTVYTDFD 190
Query: 442 GTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDD---- 497
           GT  Y PPE+I   R+                  V++ G++L +++ G      D+    
Sbjct: 191 GTRVYSPPEWIRYHRYH------------GRSAAVWSLGILLYDMVCGDIPFEHDEEIIR 238
Query: 498 SEPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDI 531
            +    + + +    +  WCL     DRP   +I
Sbjct: 239 GQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEI 272

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 62/274 (22%), Positives = 110/274 (40%), Gaps = 45/274 (16%)
Query: 285 EEIEEATNNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNKSKEFFAELKVLCKIH 342
           +E E   + +    ++G GGFG+VY G+    +   AIK +  ++  ++  EL    ++ 
Sbjct: 29  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDW-GELPNGTRVP 87
Query: 343 HINVFISTFGNG-----SLSDHLHDP-----LLKGHQPLT-----WTARTQIALDAAKG- 386
              V +    +G      L D    P     +L+  +P+       T R  +  + A+  
Sbjct: 88  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 147
Query: 387 ----IEYIHDHTKARYVHRDIKTSNILLD-DGLRAKVADFGLVKLEERTNEKEMLATRLV 441
               +E +        +HRDIK  NIL+D +    K+ DFG   L      K+ + T   
Sbjct: 148 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL-----LKDTVYTDFD 202
Query: 442 GTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDD---- 497
           GT  Y PPE+I   R+                  V++ G++L +++ G      D+    
Sbjct: 203 GTRVYSPPEWIRYHRYH------------GRSAAVWSLGILLYDMVCGDIPFEHDEEIIG 250
Query: 498 SEPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDI 531
            +    + + +    +  WCL     DRP   +I
Sbjct: 251 GQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEI 284

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 99/231 (42%), Gaps = 62/231 (26%)
Query: 300 IGRGGFGNVY----FGLLGD---REAAIKKMRS----NKSKEFFAELKVLCKI-HHINVF 347
           +GRG FG V     FG+      R  A+K ++     ++ +   +ELK+L  I HH+NV 
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 348 ---------------ISTFGN-GSLSDHLH-------------DPLLKGHQPLTWTARTQ 378
                          I+ F   G+LS +L              + L K    LT      
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF--LTLEHLIC 143
Query: 379 IALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLAT 438
            +   AKG+E++      + +HRD+   NILL +    K+ DFGL +  +   + + +  
Sbjct: 144 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR--DIYKDPDYVRK 198
Query: 439 RLVGTP-GYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
                P  ++ PE IF + +             T ++DV++FGV+L E+ +
Sbjct: 199 GDARLPLKWMAPETIFDRVY-------------TIQSDVWSFGVLLWEIFS 236

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 52/222 (23%), Positives = 93/222 (41%), Gaps = 46/222 (20%)
Query: 291 TNNFDESRIIGRGGFGNVYF--GLLGDREAAIKKMRSNKSKE------FFAELKVLCKIH 342
           ++ +   R++G+G FG V      +  +E A+K +   + K+         E+++L ++ 
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 343 HINV-----------FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIH 391
           H N+           +    G       L D ++   +  +     +I      GI Y H
Sbjct: 85  HPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEII-SRKRFSEVDAARIIRQVLSGITYXH 143
Query: 392 DHTKARYVHRDIKTSNILLDDGLRA---KVADFGL-VKLEERTNEKEMLATRLVGTPGYL 447
              K + VHRD+K  N+LL+   +    ++ DFGL    E     K+      +GT  Y+
Sbjct: 144 ---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDK-----IGTAYYI 195
Query: 448 PPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
            PE          +H +  E     K DV++ GV+L  L++G
Sbjct: 196 APEV---------LHGTYDE-----KCDVWSTGVILYILLSG 223

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 62/274 (22%), Positives = 110/274 (40%), Gaps = 45/274 (16%)
Query: 285 EEIEEATNNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNKSKEFFAELKVLCKIH 342
           +E E   + +    ++G GGFG+VY G+    +   AIK +  ++  ++  EL    ++ 
Sbjct: 16  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDW-GELPNGTRVP 74
Query: 343 HINVFISTFGNG-----SLSDHLHDP-----LLKGHQPLT-----WTARTQIALDAAKG- 386
              V +    +G      L D    P     +L+  +P+       T R  +  + A+  
Sbjct: 75  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 134
Query: 387 ----IEYIHDHTKARYVHRDIKTSNILLD-DGLRAKVADFGLVKLEERTNEKEMLATRLV 441
               +E +        +HRDIK  NIL+D +    K+ DFG   L      K+ + T   
Sbjct: 135 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL-----LKDTVYTDFD 189
Query: 442 GTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDD---- 497
           GT  Y PPE+I   R+                  V++ G++L +++ G      D+    
Sbjct: 190 GTRVYSPPEWIRYHRYH------------GRSAAVWSLGILLYDMVCGDIPFEHDEEIIR 237
Query: 498 SEPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDI 531
            +    + + +    +  WCL     DRP   +I
Sbjct: 238 GQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEI 271

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 37/125 (29%), Positives = 56/125 (44%), Gaps = 22/125 (17%)
Query: 373 WTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNE 432
           +TA   +ALDA   + +IH         RD+K  N+LLD     K+ADFG      + N+
Sbjct: 178 YTAEVVLALDAIHSMGFIH---------RDVKPDNMLLDKSGHLKLADFGTCM---KMNK 225
Query: 433 KEML-ATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKR 491
           + M+     VGTP Y+ PE          + S   +     + D ++ GV L E++ G  
Sbjct: 226 EGMVRCDTAVGTPDYISPEV---------LKSQGGDGYYGRECDWWSVGVFLYEMLVGDT 276
Query: 492 ALIRD 496
               D
Sbjct: 277 PFYAD 281

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 91/207 (43%), Gaps = 36/207 (17%)
Query: 300 IGRGGFGNVYFGLL--GDREAAIKKMRS----NKSKEFFAELKVLCKIHHINVFISTFGN 353
           IGRG FG V+ G L   +   A+K  R     +   +F  E ++L +  H N+ +   G 
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNI-VRLIGV 180
Query: 354 GSLSDHLH--DPLLKGHQPLTWT----ART------QIALDAAKGIEYIHDHTKARYVHR 401
            +    ++    L++G   LT+     AR       Q+  DAA G+EY+        +HR
Sbjct: 181 CTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC---CIHR 237
Query: 402 DIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDM 461
           D+   N L+ +    K++DFG+ + E           R V    +  PE +   R+    
Sbjct: 238 DLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPV-KWTAPEALNYGRY---- 292
Query: 462 HSSVMELQVTTKTDVFAFGVVLAELIT 488
                    ++++DV++FG++L E  +
Sbjct: 293 ---------SSESDVWSFGILLWETFS 310

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 99/231 (42%), Gaps = 62/231 (26%)
Query: 300 IGRGGFGNVY----FGLLGD---REAAIKKMRS----NKSKEFFAELKVLCKI-HHINVF 347
           +GRG FG V     FG+      R  A+K ++     ++ +   +ELK+L  I HH+NV 
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 348 ---------------ISTFGN-GSLSDHLH-------------DPLLKGHQPLTWTARTQ 378
                          I+ F   G+LS +L              + L K    LT      
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF--LTLEHLIC 143
Query: 379 IALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLAT 438
            +   AKG+E++      + +HRD+   NILL +    K+ DFGL +  +   + + +  
Sbjct: 144 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR--DIYKDPDYVRK 198
Query: 439 RLVGTP-GYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
                P  ++ PE IF + +             T ++DV++FGV+L E+ +
Sbjct: 199 GDARLPLKWMAPETIFDRVY-------------TIQSDVWSFGVLLWEIFS 236

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 37/125 (29%), Positives = 56/125 (44%), Gaps = 22/125 (17%)
Query: 373 WTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNE 432
           +TA   +ALDA   + +IH         RD+K  N+LLD     K+ADFG      + N+
Sbjct: 178 YTAEVVLALDAIHSMGFIH---------RDVKPDNMLLDKSGHLKLADFGTCM---KMNK 225
Query: 433 KEML-ATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKR 491
           + M+     VGTP Y+ PE          + S   +     + D ++ GV L E++ G  
Sbjct: 226 EGMVRCDTAVGTPDYISPEV---------LKSQGGDGYYGRECDWWSVGVFLYEMLVGDT 276
Query: 492 ALIRD 496
               D
Sbjct: 277 PFYAD 281

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 71/300 (23%), Positives = 115/300 (38%), Gaps = 73/300 (24%)
Query: 283 SLEEIEEATNNFDESRIIGRGGFGNVYFGLLGDRE-----AAIKKMRSNKS----KEFFA 333
           S  + E      +  R IG G FG+V+ G+    E      AIK  ++  S    ++F  
Sbjct: 1   STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQ 60
Query: 334 ELKVLCKIHHINV--FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIH 391
           E   + +  H ++   I       +   +   L    +  ++    + +LD A  I Y +
Sbjct: 61  EALTMRQFDHPHIVKLIGVITENPVWIIME--LCTLGELRSFLQVRKFSLDLASLILYAY 118
Query: 392 DHTKA-------RYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP 444
             + A       R+VHRDI   N+L+      K+ DFGL +  E +       T    + 
Sbjct: 119 QLSTALAYLESKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDS-------TYYKASK 171
Query: 445 GYLP-----PEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELI------------ 487
           G LP     PE I  +RF             T+ +DV+ FGV + E++            
Sbjct: 172 GKLPIKWMAPESINFRRF-------------TSASDVWMFGVCMWEILMHGVKPFQGVKN 218
Query: 488 --------TGKRALIRDDSEPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIM 539
                    G+R  +  +  PT + SL+T        C   D   RP   ++ A LS I+
Sbjct: 219 NDVIGRIENGERLPMPPNCPPT-LYSLMTK-------CWAYDPSRRPRFTELKAQLSTIL 270

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 37/125 (29%), Positives = 56/125 (44%), Gaps = 22/125 (17%)
Query: 373 WTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNE 432
           +TA   +ALDA   + +IH         RD+K  N+LLD     K+ADFG      + N+
Sbjct: 173 YTAEVVLALDAIHSMGFIH---------RDVKPDNMLLDKSGHLKLADFGTCM---KMNK 220
Query: 433 KEML-ATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKR 491
           + M+     VGTP Y+ PE          + S   +     + D ++ GV L E++ G  
Sbjct: 221 EGMVRCDTAVGTPDYISPEV---------LKSQGGDGYYGRECDWWSVGVFLYEMLVGDT 271
Query: 492 ALIRD 496
               D
Sbjct: 272 PFYAD 276

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 62/274 (22%), Positives = 110/274 (40%), Gaps = 45/274 (16%)
Query: 285 EEIEEATNNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNKSKEFFAELKVLCKIH 342
           +E E   + +    ++G GGFG+VY G+    +   AIK +  ++  ++  EL    ++ 
Sbjct: 29  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDW-GELPNGTRVP 87
Query: 343 HINVFISTFGNG-----SLSDHLHDP-----LLKGHQPLT-----WTARTQIALDAAKG- 386
              V +    +G      L D    P     +L+  +P+       T R  +  + A+  
Sbjct: 88  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 147
Query: 387 ----IEYIHDHTKARYVHRDIKTSNILLD-DGLRAKVADFGLVKLEERTNEKEMLATRLV 441
               +E +        +HRDIK  NIL+D +    K+ DFG   L      K+ + T   
Sbjct: 148 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL-----LKDTVYTDFD 202
Query: 442 GTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDD---- 497
           GT  Y PPE+I   R+                  V++ G++L +++ G      D+    
Sbjct: 203 GTRVYSPPEWIRYHRYH------------GRSAAVWSLGILLYDMVCGDIPFEHDEEIIG 250
Query: 498 SEPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDI 531
            +    + + +    +  WCL     DRP   +I
Sbjct: 251 GQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEI 284

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 58/231 (25%), Positives = 97/231 (41%), Gaps = 62/231 (26%)
Query: 300 IGRGGFGNVY----FGLLGD---REAAIKKMRS----NKSKEFFAELKVLCKI-HHINVF 347
           +GRG FG V     FG+      R  A+K ++     ++ +   +ELK+L  I HH+NV 
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 348 ------------------ISTFGNGSLSDHLHD------PLLKGHQPL-----TWTARTQ 378
                                FGN  LS +L        P  +  + L     T      
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGN--LSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLIC 154
Query: 379 IALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLAT 438
            +   AKG+E++      + +HRD+   NILL +    K+ DFGL +  +   + + +  
Sbjct: 155 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR--DIYKDPDYVRK 209
Query: 439 RLVGTP-GYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
                P  ++ PE IF + +             T ++DV++FGV+L E+ +
Sbjct: 210 GDARLPLKWMAPETIFDRVY-------------TIQSDVWSFGVLLWEIFS 247

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 63/278 (22%), Positives = 111/278 (39%), Gaps = 51/278 (18%)
Query: 284 LEEIEEATNNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNKSKEFFAELKVLCKI 341
           ++E E   + +    ++G GGFG+VY G+    +   AIK +  ++  ++  EL    ++
Sbjct: 23  MKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDW-GELPNGTRV 81
Query: 342 HHINVFISTFGNG-----SLSDHLHDP-----LLKGHQPLT-----WTARTQIALDAAKG 386
               V +    +G      L D    P     +L+  +P+       T R  +  + A+ 
Sbjct: 82  PMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS 141
Query: 387 -----IEYIHDHTKARYVHRDIKTSNILLD-DGLRAKVADFGLVKLEERTNEKEMLATRL 440
                +E +        +HRDIK  NIL+D +    K+ DFG   L      K+ + T  
Sbjct: 142 FFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL-----LKDTVYTDF 196
Query: 441 VGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP 500
            GT  Y PPE+I   R+                  V++ G++L +++ G      D+   
Sbjct: 197 DGTRVYSPPEWIRYHRYH------------GRSAAVWSLGILLYDMVCGDIPFEHDEE-- 242
Query: 501 TKMKSLITIMAAVA-------EWCLNEDAVDRPEMRDI 531
             ++  +     V+        WCL     DRP   +I
Sbjct: 243 -IIRGQVFFRQRVSXECQHLIRWCLALRPSDRPTFEEI 279

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 62/274 (22%), Positives = 110/274 (40%), Gaps = 45/274 (16%)
Query: 285 EEIEEATNNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNKSKEFFAELKVLCKIH 342
           +E E   + +    ++G GGFG+VY G+    +   AIK +  ++  ++  EL    ++ 
Sbjct: 29  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDW-GELPNGTRVP 87
Query: 343 HINVFISTFGNG-----SLSDHLHDP-----LLKGHQPLT-----WTARTQIALDAAKG- 386
              V +    +G      L D    P     +L+  +P+       T R  +  + A+  
Sbjct: 88  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 147
Query: 387 ----IEYIHDHTKARYVHRDIKTSNILLD-DGLRAKVADFGLVKLEERTNEKEMLATRLV 441
               +E +        +HRDIK  NIL+D +    K+ DFG   L      K+ + T   
Sbjct: 148 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL-----LKDTVYTDFD 202
Query: 442 GTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDD---- 497
           GT  Y PPE+I   R+                  V++ G++L +++ G      D+    
Sbjct: 203 GTRVYSPPEWIRYHRYH------------GRSAAVWSLGILLYDMVCGDIPFEHDEEIIR 250
Query: 498 SEPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDI 531
            +    + + +    +  WCL     DRP   +I
Sbjct: 251 GQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEI 284

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 47/96 (48%), Gaps = 13/96 (13%)
Query: 395 KARYVHRDIKTSNILLDDGLRAKVADFGL-VKLEERTNEKEMLATRLVGTPGYLPPEYIF 453
           K   VHRD+K  NILLDD +  K+ DFG   +L+     +E     + GTP YL PE I 
Sbjct: 129 KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRE-----VCGTPSYLAPEIIE 183
Query: 454 VKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
                 D H          + D+++ GV++  L+ G
Sbjct: 184 CS--MNDNHPG-----YGKEVDMWSTGVIMYTLLAG 212

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 52/223 (23%), Positives = 84/223 (37%), Gaps = 53/223 (23%)
Query: 292 NNFDESRIIGRGGFGNVYFGLLGDRE--AAIKKM-RSNKSKE-----FFAELKVLCKIHH 343
           ++FD  R +G+G FGNVY       +   A+K + +S   KE        E+++   + H
Sbjct: 15  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 74
Query: 344 INVFISTFGNGSLSDHLHD-----------------PLLKGHQPLTWTARTQIALDAAKG 386
            N+         + ++ HD                   L+ H             + A  
Sbjct: 75  PNIL-------RMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADA 127
Query: 387 IEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGY 446
           + Y H+    + +HRDIK  N+L+      K+ADFG        +   +    + GT  Y
Sbjct: 128 LHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWS-----VHAPSLRRRXMCGTLDY 179
Query: 447 LPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
           LPPE I  K                 K D++  GV+  E + G
Sbjct: 180 LPPEMIEGKTH-------------DEKVDLWCAGVLCYEFLVG 209

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 58/238 (24%), Positives = 99/238 (41%), Gaps = 44/238 (18%)
Query: 276 SERTIIFSLEEIEEAT----NNFDESRIIGRGGFGNVY--FGLLGDREAAIKKM-----R 324
           S+R   F   EI ++T      +   + IG G  G V   +  + +R  AIKK+      
Sbjct: 4   SKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVVAAYDAILERNVAIKKLSRPFQN 63
Query: 325 SNKSKEFFAELKVLCKIHHINV--FISTFG-NGSLSDHLHDPLLKGHQPLTWTARTQIAL 381
              +K  + EL ++  ++H N+   ++ F    SL +     ++        +   Q+ L
Sbjct: 64  QTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMEL 123
Query: 382 DAAK----------GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTN 431
           D  +          GI+++H    A  +HRD+K SNI++      K+ DFGL     RT 
Sbjct: 124 DHERMSYLLYQMLVGIKHLHS---AGIIHRDLKPSNIVVKSDATLKILDFGLA----RTA 176
Query: 432 EKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
               + T  V T  Y  PE I    ++                D+++ GV++ E+I G
Sbjct: 177 GTSFMMTPYVVTRYYRAPEVILGMGYK-------------ENVDIWSVGVIMGEMIKG 221

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 97/233 (41%), Gaps = 66/233 (28%)
Query: 300 IGRGGFGNVY----FGLLGD---REAAIKKMRS----NKSKEFFAELKVLCKI-HHINVF 347
           +GRG FG V     FG+      R  A+K ++     ++ +   +ELK+L  I HH+NV 
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 348 ------------------ISTFGNGSLSDHLH-------------DPLLKGHQPLTWTAR 376
                                FGN  LS +L              + L K    LT    
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGN--LSTYLRSKRNEFVPYKVAPEDLYKDF--LTLEHL 150
Query: 377 TQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEML 436
              +   AKG+E++      + +HRD+   NILL +    K+ DFGL +  +   + + +
Sbjct: 151 ICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR--DIXKDPDXV 205
Query: 437 ATRLVGTP-GYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
                  P  ++ PE IF + +             T ++DV++FGV+L E+ +
Sbjct: 206 RKGDARLPLKWMAPETIFDRVY-------------TIQSDVWSFGVLLWEIFS 245

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 76/316 (24%), Positives = 120/316 (37%), Gaps = 80/316 (25%)
Query: 267 NTEDVTVLESERTIIFSLEEIEEATNNFDESRIIGRGGFGNVYFGLLGDRE-----AAIK 321
           + ED   + S R      E IE         R IG G FG+V+ G+    E      AIK
Sbjct: 372 DEEDTYTMPSTRDYEIQRERIELG-------RCIGEGQFGDVHQGIYMSPENPAMAVAIK 424
Query: 322 KMRSNKS----KEFFAELKVLCKIHHINV--FISTFGNGSLSDHLHDPLLKGHQPLTWTA 375
             ++  S    ++F  E   + +  H ++   I       +   +   L    +  ++  
Sbjct: 425 TCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWIIME--LCTLGELRSFLQ 482
Query: 376 RTQIALDAAKGIEYIHDHTKA-------RYVHRDIKTSNILLDDGLRAKVADFGLVKLEE 428
             + +LD A  I Y +  + A       R+VHRDI   N+L+      K+ DFGL +  E
Sbjct: 483 VRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSATDCVKLGDFGLSRYME 542
Query: 429 RTNEKEMLATRLVGTPGYLP-----PEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVL 483
            +       T    + G LP     PE I  +RF             T+ +DV+ FGV +
Sbjct: 543 DS-------TYYKASKGKLPIKWMAPESINFRRF-------------TSASDVWMFGVCM 582
Query: 484 AELI--------------------TGKRALIRDDSEPTKMKSLITIMAAVAEWCLNEDAV 523
            E++                     G+R  +  +  PT + SL+T        C   D  
Sbjct: 583 WEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPT-LYSLMTK-------CWAYDPS 634
Query: 524 DRPEMRDIVAILSQIM 539
            RP   ++ A LS I+
Sbjct: 635 RRPRFTELKAQLSTIL 650

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 47/96 (48%), Gaps = 13/96 (13%)
Query: 395 KARYVHRDIKTSNILLDDGLRAKVADFGL-VKLEERTNEKEMLATRLVGTPGYLPPEYIF 453
           K   VHRD+K  NILLDD +  K+ DFG   +L+     +E     + GTP YL PE I 
Sbjct: 142 KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRE-----VCGTPSYLAPEIIE 196
Query: 454 VKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
                 D H          + D+++ GV++  L+ G
Sbjct: 197 CS--MNDNHPG-----YGKEVDMWSTGVIMYTLLAG 225

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 62/274 (22%), Positives = 110/274 (40%), Gaps = 45/274 (16%)
Query: 285 EEIEEATNNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNKSKEFFAELKVLCKIH 342
           +E E   + +    ++G GGFG+VY G+    +   AIK +  ++  ++  EL    ++ 
Sbjct: 1   KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDW-GELPNGTRVP 59
Query: 343 HINVFISTFGNG-----SLSDHLHDP-----LLKGHQPLT-----WTARTQIALDAAKG- 386
              V +    +G      L D    P     +L+  +P+       T R  +  + A+  
Sbjct: 60  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERMEPVQDLFDFITERGALQEELARSF 119
Query: 387 ----IEYIHDHTKARYVHRDIKTSNILLD-DGLRAKVADFGLVKLEERTNEKEMLATRLV 441
               +E +        +HRDIK  NIL+D +    K+ DFG   L      K+ + T   
Sbjct: 120 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL-----LKDTVYTDFD 174
Query: 442 GTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDD---- 497
           GT  Y PPE+I   R+                  V++ G++L +++ G      D+    
Sbjct: 175 GTRVYSPPEWIRYHRYH------------GRSAAVWSLGILLYDMVCGDIPFEHDEEIIR 222
Query: 498 SEPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDI 531
            +    + + +    +  WCL     DRP   +I
Sbjct: 223 GQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEI 256

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 62/274 (22%), Positives = 110/274 (40%), Gaps = 45/274 (16%)
Query: 285 EEIEEATNNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNKSKEFFAELKVLCKIH 342
           +E E   + +    ++G GGFG+VY G+    +   AIK +  ++  ++  EL    ++ 
Sbjct: 1   KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDW-GELPNGTRVP 59
Query: 343 HINVFISTFGNG-----SLSDHLHDP-----LLKGHQPLT-----WTARTQIALDAAKG- 386
              V +    +G      L D    P     +L+  +P+       T R  +  + A+  
Sbjct: 60  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 119
Query: 387 ----IEYIHDHTKARYVHRDIKTSNILLD-DGLRAKVADFGLVKLEERTNEKEMLATRLV 441
               +E +        +HRDIK  NIL+D +    K+ DFG   L      K+ + T   
Sbjct: 120 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL-----LKDTVYTDFD 174
Query: 442 GTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDD---- 497
           GT  Y PPE+I   R+                  V++ G++L +++ G      D+    
Sbjct: 175 GTRVYSPPEWIRYHRYH------------GRSAAVWSLGILLYDMVCGDIPFEHDEEIIR 222
Query: 498 SEPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDI 531
            +    + + +    +  WCL     DRP   +I
Sbjct: 223 GQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEI 256

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 97/233 (41%), Gaps = 66/233 (28%)
Query: 300 IGRGGFGNVY----FGLLGD---REAAIKKMRS----NKSKEFFAELKVLCKI-HHINVF 347
           +GRG FG V     FG+      R  A+K ++     ++ +   +ELK+L  I HH+NV 
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 348 ------------------ISTFGNGSLSDHLH-------------DPLLKGHQPLTWTAR 376
                                FGN  LS +L              + L K    LT    
Sbjct: 86  NLLGACTKPGGPLMVIVEFCKFGN--LSTYLRSKRNEFVPYKVAPEDLYKDF--LTLEHL 141
Query: 377 TQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEML 436
              +   AKG+E++      + +HRD+   NILL +    K+ DFGL +  +   + + +
Sbjct: 142 ICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR--DIXKDPDXV 196
Query: 437 ATRLVGTP-GYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
                  P  ++ PE IF + +             T ++DV++FGV+L E+ +
Sbjct: 197 RKGDARLPLKWMAPETIFDRVY-------------TIQSDVWSFGVLLWEIFS 236

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 97/233 (41%), Gaps = 66/233 (28%)
Query: 300 IGRGGFGNVY----FGLLGD---REAAIKKMRS----NKSKEFFAELKVLCKI-HHINVF 347
           +GRG FG V     FG+      R  A+K ++     ++ +   +ELK+L  I HH+NV 
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 348 ------------------ISTFGNGSLSDHLH-------------DPLLKGHQPLTWTAR 376
                                FGN  LS +L              + L K    LT    
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGN--LSTYLRSKRNEFVPYKVAPEDLYKDF--LTLEHL 150
Query: 377 TQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEML 436
              +   AKG+E++      + +HRD+   NILL +    K+ DFGL +  +   + + +
Sbjct: 151 ICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR--DIYKDPDXV 205
Query: 437 ATRLVGTP-GYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
                  P  ++ PE IF + +             T ++DV++FGV+L E+ +
Sbjct: 206 RKGDARLPLKWMAPETIFDRVY-------------TIQSDVWSFGVLLWEIFS 245

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 60/239 (25%), Positives = 100/239 (41%), Gaps = 46/239 (19%)
Query: 276 SERTIIFSLEEIEEAT----NNFDESRIIGRGGFGNV---YFGLLGDREAAIKKM----- 323
           S+R   F   EI ++T      +   + IG G  G V   Y  +L +R  AIKK+     
Sbjct: 4   SKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAIL-ERNVAIKKLSRPFQ 62
Query: 324 RSNKSKEFFAELKVLCKIHHINV--FISTFG-NGSLSDHLHDPLLKGHQPLTWTARTQIA 380
               +K  + EL ++  ++H N+   ++ F    SL +     ++        +   Q+ 
Sbjct: 63  NQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQME 122
Query: 381 LDAAK----------GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERT 430
           LD  +          GI+++H    A  +HRD+K SNI++      K+ DFGL     RT
Sbjct: 123 LDHERMSYLLYQMLVGIKHLHS---AGIIHRDLKPSNIVVKSDATLKILDFGLA----RT 175
Query: 431 NEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
                + T  V T  Y  PE I    ++                D+++ GV++ E+I G
Sbjct: 176 AGTSFMMTPYVVTRYYRAPEVILGMGYK-------------ENVDIWSVGVIMGEMIKG 221

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 63/277 (22%), Positives = 110/277 (39%), Gaps = 51/277 (18%)
Query: 285 EEIEEATNNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNKSKEFFAELKVLCKIH 342
           +E E   + +    ++G GGFG+VY G+    +   AIK +  ++  ++  EL    ++ 
Sbjct: 17  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDW-GELPNGTRVP 75
Query: 343 HINVFISTFGNG-----SLSDHLHDP-----LLKGHQPLT-----WTARTQIALDAAKG- 386
              V +    +G      L D    P     +L+  +P+       T R  +  + A+  
Sbjct: 76  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 135
Query: 387 ----IEYIHDHTKARYVHRDIKTSNILLD-DGLRAKVADFGLVKLEERTNEKEMLATRLV 441
               +E +        +HRDIK  NIL+D +    K+ DFG   L      K+ + T   
Sbjct: 136 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL-----LKDTVYTDFD 190
Query: 442 GTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPT 501
           GT  Y PPE+I   R+                  V++ G++L +++ G      D+    
Sbjct: 191 GTRVYSPPEWIRYHRYH------------GRSAAVWSLGILLYDMVCGDIPFEHDEE--- 235
Query: 502 KMKSLITIMAAVA-------EWCLNEDAVDRPEMRDI 531
            ++  +     V+        WCL     DRP   +I
Sbjct: 236 IIRGQVFFRQRVSXECQHLIRWCLALRPXDRPTFEEI 272

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 59/232 (25%), Positives = 95/232 (40%), Gaps = 39/232 (16%)
Query: 247 VSKAMSITTRAFSSQGQCKENTEDVTVLESERTIIFSLEEIEEATNNFDESRIIGRGGFG 306
           ++K  S  +      G   E+ E V + E  + + +   E  E  +       +GRG FG
Sbjct: 32  LAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDY---EYREEVHWMTHQPRVGRGSFG 88
Query: 307 NVYFGLLGDRE----AAIKKMRSNKSKEFFAELKVLC----------------KIHHINV 346
            V+   + D++     A+KK+R    + F  E  V C                +   +N+
Sbjct: 89  EVHR--MKDKQTGFQCAVKKVRL---EVFRVEELVACAGLSSPRIVPLYGAVREGPWVNI 143
Query: 347 FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTS 406
           F+     GSL       L+K    L           A +G+EY+H     R +H D+K  
Sbjct: 144 FMELLEGGSLGQ-----LIKQMGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKAD 195
Query: 407 NILL-DDGLRAKVADFG-LVKLEERTNEKEMLATRLV-GTPGYLPPEYIFVK 455
           N+LL  DG RA + DFG  + L+     K +L    + GT  ++ PE +  K
Sbjct: 196 NVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK 247

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 45/203 (22%), Positives = 88/203 (43%), Gaps = 30/203 (14%)
Query: 300 IGRGGFGNVYFGLLGDREA-AIKKMRSNKSKE----FFAELKVLCKIHH---INVFISTF 351
           +G G FG VY     +  A A  K+   KS+E    +  E+++L    H   + +  + +
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 78
Query: 352 GNGSL--------SDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDI 403
            +G L           +   +L+  + LT      +     + + ++H     R +HRD+
Sbjct: 79  HDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH---SKRIIHRDL 135
Query: 404 KTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHS 463
           K  N+L+      ++ADFG+     +T +K       +GTP ++ PE +        M  
Sbjct: 136 KAGNVLMTLEGDIRLADFGVSAKNLKTLQKR---DSFIGTPYWMAPEVV--------MCE 184
Query: 464 SVMELQVTTKTDVFAFGVVLAEL 486
           ++ +     K D+++ G+ L E+
Sbjct: 185 TMKDTPYDYKADIWSLGITLIEM 207

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 97/233 (41%), Gaps = 66/233 (28%)
Query: 300 IGRGGFGNVY----FGLLGD---REAAIKKMRS----NKSKEFFAELKVLCKI-HHINVF 347
           +GRG FG V     FG+      R  A+K ++     ++ +   +ELK+L  I HH+NV 
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 348 ------------------ISTFGNGSLSDHLH-------------DPLLKGHQPLTWTAR 376
                                FGN  LS +L              + L K    LT    
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGN--LSTYLRSKRNEFVPYKVAPEDLYKDF--LTLEHL 150
Query: 377 TQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEML 436
              +   AKG+E++      + +HRD+   NILL +    K+ DFGL +  +   + + +
Sbjct: 151 ICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR--DIYKDPDYV 205
Query: 437 ATRLVGTP-GYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
                  P  ++ PE IF + +             T ++DV++FGV+L E+ +
Sbjct: 206 RKGDARLPLKWMAPETIFDRVY-------------TIQSDVWSFGVLLWEIFS 245

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 48/223 (21%), Positives = 94/223 (42%), Gaps = 36/223 (16%)
Query: 286 EIEEATNNFDESRI------IGRGGFGNVYFGLLGDREA-AIKKMRSNKSKE----FFAE 334
           E E    + D + +      +G G FG VY     +  A A  K+   KS+E    +  E
Sbjct: 7   EYEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVE 66
Query: 335 LKVLCKIHH---INVFISTFGNGSL--------SDHLHDPLLKGHQPLTWTARTQIALDA 383
           +++L    H   + +  + + +G L           +   +L+  + LT      +    
Sbjct: 67  IEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQM 126
Query: 384 AKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGT 443
            + + ++H     R +HRD+K  N+L+      ++ADFG+     +T +K       +GT
Sbjct: 127 LEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKR---DSFIGT 180
Query: 444 PGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAEL 486
           P ++ PE +        M  ++ +     K D+++ G+ L E+
Sbjct: 181 PYWMAPEVV--------MCETMKDTPYDYKADIWSLGITLIEM 215

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 59/232 (25%), Positives = 95/232 (40%), Gaps = 39/232 (16%)
Query: 247 VSKAMSITTRAFSSQGQCKENTEDVTVLESERTIIFSLEEIEEATNNFDESRIIGRGGFG 306
           ++K  S  +      G   E+ E V + E  + + +   E  E  +       +GRG FG
Sbjct: 16  LAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDY---EYREEVHWMTHQPRVGRGSFG 72
Query: 307 NVYFGLLGDRE----AAIKKMRSNKSKEFFAELKVLC----------------KIHHINV 346
            V+   + D++     A+KK+R    + F  E  V C                +   +N+
Sbjct: 73  EVHR--MKDKQTGFQCAVKKVRL---EVFRVEELVACAGLSSPRIVPLYGAVREGPWVNI 127
Query: 347 FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTS 406
           F+     GSL       L+K    L           A +G+EY+H     R +H D+K  
Sbjct: 128 FMELLEGGSLGQ-----LIKQMGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKAD 179
Query: 407 NILL-DDGLRAKVADFG-LVKLEERTNEKEMLATRLV-GTPGYLPPEYIFVK 455
           N+LL  DG RA + DFG  + L+     K +L    + GT  ++ PE +  K
Sbjct: 180 NVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK 231

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 63/277 (22%), Positives = 110/277 (39%), Gaps = 51/277 (18%)
Query: 285 EEIEEATNNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNKSKEFFAELKVLCKIH 342
           +E E   + +    ++G GGFG+VY G+    +   AIK +  ++  ++  EL    ++ 
Sbjct: 17  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDW-GELPNGTRVP 75
Query: 343 HINVFISTFGNG-----SLSDHLHDP-----LLKGHQPLT-----WTARTQIALDAAKG- 386
              V +    +G      L D    P     +L+  +P+       T R  +  + A+  
Sbjct: 76  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 135
Query: 387 ----IEYIHDHTKARYVHRDIKTSNILLD-DGLRAKVADFGLVKLEERTNEKEMLATRLV 441
               +E +        +HRDIK  NIL+D +    K+ DFG   L      K+ + T   
Sbjct: 136 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL-----LKDTVYTDFD 190
Query: 442 GTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPT 501
           GT  Y PPE+I   R+                  V++ G++L +++ G      D+    
Sbjct: 191 GTRVYSPPEWIRYHRYH------------GRSAAVWSLGILLYDMVCGDIPFEHDEE--- 235
Query: 502 KMKSLITIMAAVA-------EWCLNEDAVDRPEMRDI 531
            ++  +     V+        WCL     DRP   +I
Sbjct: 236 IIRGQVFFRQRVSXECQHLIRWCLALRPSDRPTFEEI 272

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 35/111 (31%), Positives = 48/111 (43%), Gaps = 24/111 (21%)
Query: 387 IEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK-LEERTNEKEMLATRLVGTPG 445
            EY+H       ++RD+K  N+L+D     KVADFG  K ++ RT         L GTP 
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRT-------WXLCGTPE 203
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRD 496
           YL PE I  K +                 D +A GV++ E+  G      D
Sbjct: 204 YLAPEIILSKGY-------------NKAVDWWALGVLIYEMAAGYPPFFAD 241

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 91/207 (43%), Gaps = 36/207 (17%)
Query: 300 IGRGGFGNVYFGLL--GDREAAIKKMRS----NKSKEFFAELKVLCKIHHINVFISTFGN 353
           IGRG FG V+ G L   +   A+K  R     +   +F  E ++L +  H N+ +   G 
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNI-VRLIGV 180
Query: 354 GSLSDHLH--DPLLKGHQPLTWT----ART------QIALDAAKGIEYIHDHTKARYVHR 401
            +    ++    L++G   LT+     AR       Q+  DAA G+EY+        +HR
Sbjct: 181 CTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC---CIHR 237
Query: 402 DIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDM 461
           D+   N L+ +    K++DFG+ + E           R V    +  PE +   R+    
Sbjct: 238 DLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPV-KWTAPEALNYGRY---- 292
Query: 462 HSSVMELQVTTKTDVFAFGVVLAELIT 488
                    ++++DV++FG++L E  +
Sbjct: 293 ---------SSESDVWSFGILLWETFS 310

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 92/214 (42%), Gaps = 41/214 (19%)
Query: 266 ENTEDVTVLESERTIIFSL-EEIEEATNNFDESRIIGRGGFGNVYFGLLGDRE----AAI 320
           E+ E V + E  + + +   EE+  AT+       +GRG FG V+   + D++     A+
Sbjct: 70  EDNEGVLLTEKLKPVDYEYREEVHWATHQLR----LGRGSFGEVH--RMEDKQTGFQCAV 123
Query: 321 KKMRSNKSKEFFAELKVLC----------------KIHHINVFISTFGNGSLSDHLHDPL 364
           KK+R    + F AE  + C                +   +N+F+     GSL       L
Sbjct: 124 KKVRL---EVFRAEELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQ-----L 175
Query: 365 LKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILL-DDGLRAKVADFG- 422
           +K    L           A +G+EY+H     R +H D+K  N+LL  DG  A + DFG 
Sbjct: 176 VKEQGCLPEDRALYYLGQALEGLEYLHSR---RILHGDVKADNVLLSSDGSHAALCDFGH 232
Query: 423 LVKLEERTNEKEMLATRLV-GTPGYLPPEYIFVK 455
            V L+     K +L    + GT  ++ PE +  +
Sbjct: 233 AVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGR 266

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 63/277 (22%), Positives = 110/277 (39%), Gaps = 51/277 (18%)
Query: 285 EEIEEATNNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNKSKEFFAELKVLCKIH 342
           +E E   + +    ++G GGFG+VY G+    +   AIK +  ++  ++  EL    ++ 
Sbjct: 44  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDW-GELPNGTRVP 102
Query: 343 HINVFISTFGNG-----SLSDHLHDP-----LLKGHQPLT-----WTARTQIALDAAKG- 386
              V +    +G      L D    P     +L+  +P+       T R  +  + A+  
Sbjct: 103 MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 162
Query: 387 ----IEYIHDHTKARYVHRDIKTSNILLD-DGLRAKVADFGLVKLEERTNEKEMLATRLV 441
               +E +        +HRDIK  NIL+D +    K+ DFG   L      K+ + T   
Sbjct: 163 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL-----LKDTVYTDFD 217
Query: 442 GTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPT 501
           GT  Y PPE+I   R+                  V++ G++L +++ G      D+    
Sbjct: 218 GTRVYSPPEWIRYHRYH------------GRSAAVWSLGILLYDMVCGDIPFEHDEE--- 262
Query: 502 KMKSLITIMAAVA-------EWCLNEDAVDRPEMRDI 531
            ++  +     V+        WCL     DRP   +I
Sbjct: 263 IIRGQVFFRQRVSXECQHLIRWCLALRPSDRPTFEEI 299

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 91/226 (40%), Gaps = 54/226 (23%)
Query: 291 TNNFDESRIIGRGGFGNVYF--GLLGDREAAIKKMR------SNKSKEFFAELKVLCKIH 342
           ++ +   + +G G +G V      L   E AIK ++      ++ S     E+ VL ++ 
Sbjct: 20  SDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLD 79
Query: 343 HINVF---------------ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGI 387
           H N+                +  +  G L D +   +L+  Q  +      I      G 
Sbjct: 80  HPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEI---ILR--QKFSEVDAAVIMKQVLSGT 134
Query: 388 EYIHDHTKARYVHRDIKTSNILLDDGLR---AKVADFGL-VKLEERTNEKEMLATRLVGT 443
            Y+H H     VHRD+K  N+LL+   R    K+ DFGL    E     KE L     GT
Sbjct: 135 TYLHKHN---IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERL-----GT 186
Query: 444 PGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
             Y+ PE   V R ++D            K DV++ GV+L  L+ G
Sbjct: 187 AYYIAPE---VLRKKYD-----------EKCDVWSCGVILYILLCG 218

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 35/111 (31%), Positives = 48/111 (43%), Gaps = 24/111 (21%)
Query: 387 IEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK-LEERTNEKEMLATRLVGTPG 445
            EY+H       ++RD+K  N+L+D     KVADFG  K ++ RT         L GTP 
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRT-------WXLCGTPE 203
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRD 496
           YL PE I  K +                 D +A GV++ E+  G      D
Sbjct: 204 YLAPEIILSKGY-------------NKAVDWWALGVLIYEMAAGYPPFFAD 241

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 35/111 (31%), Positives = 48/111 (43%), Gaps = 24/111 (21%)
Query: 387 IEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK-LEERTNEKEMLATRLVGTPG 445
            EY+H       ++RD+K  N+L+D     KVADFG  K ++ RT         L GTP 
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRT-------WXLCGTPE 203
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRD 496
           YL PE I  K +                 D +A GV++ E+  G      D
Sbjct: 204 YLAPEIILSKGY-------------NKAVDWWALGVLIYEMAAGYPPFFAD 241

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 63/277 (22%), Positives = 110/277 (39%), Gaps = 51/277 (18%)
Query: 285 EEIEEATNNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNKSKEFFAELKVLCKIH 342
           +E E   + +    ++G GGFG+VY G+    +   AIK +  ++  ++  EL    ++ 
Sbjct: 16  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDW-GELPNGTRVP 74
Query: 343 HINVFISTFGNG-----SLSDHLHDP-----LLKGHQPLT-----WTARTQIALDAAKG- 386
              V +    +G      L D    P     +L+  +P+       T R  +  + A+  
Sbjct: 75  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 134
Query: 387 ----IEYIHDHTKARYVHRDIKTSNILLD-DGLRAKVADFGLVKLEERTNEKEMLATRLV 441
               +E +        +HRDIK  NIL+D +    K+ DFG   L      K+ + T   
Sbjct: 135 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL-----LKDTVYTDFD 189
Query: 442 GTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPT 501
           GT  Y PPE+I   R+                  V++ G++L +++ G      D+    
Sbjct: 190 GTRVYSPPEWIRYHRYH------------GRSAAVWSLGILLYDMVCGDIPFEHDEE--- 234
Query: 502 KMKSLITIMAAVA-------EWCLNEDAVDRPEMRDI 531
            ++  +     V+        WCL     DRP   +I
Sbjct: 235 IIRGQVFFRQRVSXECQHLIRWCLALRPSDRPTFEEI 271

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 35/111 (31%), Positives = 48/111 (43%), Gaps = 24/111 (21%)
Query: 387 IEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK-LEERTNEKEMLATRLVGTPG 445
            EY+H       ++RD+K  N+L+D     KVADFG  K ++ RT         L GTP 
Sbjct: 155 FEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRT-------WXLCGTPE 204
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRD 496
           YL PE I  K +                 D +A GV++ E+  G      D
Sbjct: 205 YLAPEIILSKGY-------------NKAVDWWALGVLIYEMAAGYPPFFAD 242

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 62/274 (22%), Positives = 109/274 (39%), Gaps = 45/274 (16%)
Query: 285 EEIEEATNNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNKSKEFFAELKVLCKIH 342
           +E E   + +    ++G GGFG+VY G+    +   AIK +  ++  ++  EL    ++ 
Sbjct: 30  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDW-GELPNGTRVP 88
Query: 343 HINVFISTFGNG-----SLSDHLHDP-----LLKGHQPLT-----WTARTQIALDAAKG- 386
              V +    +G      L D    P     +L+  +P+       T R  +  + A+  
Sbjct: 89  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 148
Query: 387 ----IEYIHDHTKARYVHRDIKTSNILLD-DGLRAKVADFGLVKLEERTNEKEMLATRLV 441
               +E +        +HRDIK  NIL+D +    K+ DFG   L      K+ + T   
Sbjct: 149 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL-----LKDTVYTDFD 203
Query: 442 GTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDD---- 497
           GT  Y PPE+I   R+                  V++ G++L +++ G      D+    
Sbjct: 204 GTRVYSPPEWIRYHRYH------------GRSAAVWSLGILLYDMVCGDIPFEHDEEIIG 251
Query: 498 SEPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDI 531
            +    + +      +  WCL     DRP   +I
Sbjct: 252 GQVFFRQRVSXECQHLIRWCLALRPSDRPTFEEI 285

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 35/109 (32%), Positives = 54/109 (49%), Gaps = 21/109 (19%)
Query: 386 GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFG-LVKLEERTNEKEMLATRLVGTP 444
            I+ +H   +  YVHRDIK  NIL+D     ++ADFG  +KL E    +  +A   VGTP
Sbjct: 187 AIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVA---VGTP 240
Query: 445 GYLPPEYIFVKRFRFDMHSSVME---LQVTTKTDVFAFGVVLAELITGK 490
            Y+ PE +             ME    +   + D ++ GV + E++ G+
Sbjct: 241 DYISPEIL-----------QAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 97/233 (41%), Gaps = 66/233 (28%)
Query: 300 IGRGGFGNVY----FGLLGD---REAAIKKMRS----NKSKEFFAELKVLCKI-HHINVF 347
           +GRG FG V     FG+      R  A+K ++     ++ +   +ELK+L  I HH+NV 
Sbjct: 72  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 131
Query: 348 ------------------ISTFGNGSLSDHLH-------------DPLLKGHQPLTWTAR 376
                                FGN  LS +L              + L K    LT    
Sbjct: 132 NLLGACTKPGGPLMVIVEFCKFGN--LSTYLRSKRNEFVPYKVAPEDLYKDF--LTLEHL 187
Query: 377 TQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEML 436
              +   AKG+E++      + +HRD+   NILL +    K+ DFGL +  +   + + +
Sbjct: 188 ICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR--DIYKDPDYV 242
Query: 437 ATRLVGTP-GYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
                  P  ++ PE IF + +             T ++DV++FGV+L E+ +
Sbjct: 243 RKGDARLPLKWMAPETIFDRVY-------------TIQSDVWSFGVLLWEIFS 282

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 62/273 (22%), Positives = 109/273 (39%), Gaps = 45/273 (16%)
Query: 286 EIEEATNNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNKSKEFFAELKVLCKIHH 343
           E E   + +    ++G GGFG+VY G+    +   AIK +  ++  ++  EL    ++  
Sbjct: 1   EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDW-GELPNGTRVPM 59
Query: 344 INVFISTFGNG-----SLSDHLHDP-----LLKGHQPLT-----WTARTQIALDAAKG-- 386
             V +    +G      L D    P     +L+  +P+       T R  +  + A+   
Sbjct: 60  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF 119
Query: 387 ---IEYIHDHTKARYVHRDIKTSNILLD-DGLRAKVADFGLVKLEERTNEKEMLATRLVG 442
              +E +        +HRDIK  NIL+D +    K+ DFG   L      K+ + T   G
Sbjct: 120 WQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL-----LKDTVYTDFDG 174
Query: 443 TPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDD----S 498
           T  Y PPE+I   R+                  V++ G++L +++ G      D+     
Sbjct: 175 TRVYSPPEWIRYHRYH------------GRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG 222
Query: 499 EPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDI 531
           +    + + +    +  WCL     DRP   +I
Sbjct: 223 QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEI 255

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 85/211 (40%), Gaps = 40/211 (18%)
Query: 300 IGRGGFGNV--YFGLLGDREAAIKKM-----RSNKSKEFFAELKVLCKIHH------INV 346
           IG G  G V   +  + DR  AIKK+         +K  + EL ++  ++H      +NV
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNV 91
Query: 347 F-----ISTFGNGSLSDHLHDPLLKG--HQPLTWTARTQIALDAAKGIEYIHDHTKARYV 399
           F     +  F +  L   L D  L       L     + +      GI+++H    A  +
Sbjct: 92  FTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGIKHLHS---AGII 148
Query: 400 HRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRF 459
           HRD+K SNI++      K+ DFGL     RT     + T  V T  Y  PE I    ++ 
Sbjct: 149 HRDLKPSNIVVKSDXTLKILDFGLA----RTAGTSFMMTPYVVTRYYRAPEVILGMGYK- 203
Query: 460 DMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
                          D+++ G ++ E++  K
Sbjct: 204 ------------ENVDIWSVGCIMGEMVRHK 222

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 62/274 (22%), Positives = 109/274 (39%), Gaps = 45/274 (16%)
Query: 285 EEIEEATNNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNKSKEFFAELKVLCKIH 342
           +E E   + +    ++G GGFG+VY G+    +   AIK +  ++  ++  EL    ++ 
Sbjct: 30  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDW-GELPNGTRVP 88
Query: 343 HINVFISTFGNG-----SLSDHLHDP-----LLKGHQPLT-----WTARTQIALDAAKG- 386
              V +    +G      L D    P     +L+  +P+       T R  +  + A+  
Sbjct: 89  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 148
Query: 387 ----IEYIHDHTKARYVHRDIKTSNILLD-DGLRAKVADFGLVKLEERTNEKEMLATRLV 441
               +E +        +HRDIK  NIL+D +    K+ DFG   L      K+ + T   
Sbjct: 149 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL-----LKDTVYTDFD 203
Query: 442 GTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDD---- 497
           GT  Y PPE+I   R+                  V++ G++L +++ G      D+    
Sbjct: 204 GTRVYSPPEWIRYHRYH------------GRSAAVWSLGILLYDMVCGDIPFEHDEEIIG 251
Query: 498 SEPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDI 531
            +    + +      +  WCL     DRP   +I
Sbjct: 252 GQVFFRQRVSXECQHLIRWCLALRPSDRPTFEEI 285

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 63/277 (22%), Positives = 110/277 (39%), Gaps = 51/277 (18%)
Query: 285 EEIEEATNNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNKSKEFFAELKVLCKIH 342
           +E E   + +    ++G GGFG+VY G+    +   AIK +  ++  ++  EL    ++ 
Sbjct: 49  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDW-GELPNGTRVP 107
Query: 343 HINVFISTFGNG-----SLSDHLHDP-----LLKGHQPLT-----WTARTQIALDAAKG- 386
              V +    +G      L D    P     +L+  +P+       T R  +  + A+  
Sbjct: 108 MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 167
Query: 387 ----IEYIHDHTKARYVHRDIKTSNILLD-DGLRAKVADFGLVKLEERTNEKEMLATRLV 441
               +E +        +HRDIK  NIL+D +    K+ DFG   L      K+ + T   
Sbjct: 168 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL-----LKDTVYTDFD 222
Query: 442 GTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPT 501
           GT  Y PPE+I   R+                  V++ G++L +++ G      D+    
Sbjct: 223 GTRVYSPPEWIRYHRYH------------GRSAAVWSLGILLYDMVCGDIPFEHDEE--- 267
Query: 502 KMKSLITIMAAVA-------EWCLNEDAVDRPEMRDI 531
            ++  +     V+        WCL     DRP   +I
Sbjct: 268 IIRGQVFFRQRVSXECQHLIRWCLALRPSDRPTFEEI 304

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 52/230 (22%), Positives = 98/230 (42%), Gaps = 59/230 (25%)
Query: 300 IGRGGFGNVYF----GLLGDR-----EAAIKKMRSNKSKEFFAEL-------KVLCKIHH 343
           +G G FG V      GL  D+     + A+K ++S+ +++  ++L       K++ K  +
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 344 I-------------NVFISTFGNGSLSDHLH-----------DPLLKGHQPLTWTARTQI 379
           I              V +     G+L ++L            +P     + L+       
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSC 155
Query: 380 ALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK-LEERTNEKEMLAT 438
           A   A+G+EY+      + +HRD+   N+L+ +    K+ADFGL + +      K+    
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTNG 212
Query: 439 RLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
           RL     ++ PE +F + +             T ++DV++FGV+L E+ T
Sbjct: 213 RL--PVKWMAPEALFDRIY-------------THQSDVWSFGVLLWEIFT 247

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 62/274 (22%), Positives = 109/274 (39%), Gaps = 45/274 (16%)
Query: 285 EEIEEATNNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNKSKEFFAELKVLCKIH 342
           +E E   + +    ++G GGFG+VY G+    +   AIK +  ++  ++  EL    ++ 
Sbjct: 29  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDW-GELPNGTRVP 87
Query: 343 HINVFISTFGNG-----SLSDHLHDP-----LLKGHQPLT-----WTARTQIALDAAKG- 386
              V +    +G      L D    P     +L+  +P+       T R  +  + A+  
Sbjct: 88  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 147
Query: 387 ----IEYIHDHTKARYVHRDIKTSNILLD-DGLRAKVADFGLVKLEERTNEKEMLATRLV 441
               +E +        +HRDIK  NIL+D +    K+ DFG   L      K+ + T   
Sbjct: 148 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL-----LKDTVYTDFD 202
Query: 442 GTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDD---- 497
           GT  Y PPE+I   R+                  V++ G++L +++ G      D+    
Sbjct: 203 GTRVYSPPEWIRYHRYH------------GRSAAVWSLGILLYDMVCGDIPFEHDEEIIG 250
Query: 498 SEPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDI 531
            +    + +      +  WCL     DRP   +I
Sbjct: 251 GQVFFRQRVSXECQHLIRWCLALRPSDRPTFEEI 284

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 52/223 (23%), Positives = 84/223 (37%), Gaps = 53/223 (23%)
Query: 292 NNFDESRIIGRGGFGNVYFGLLGDRE--AAIKKM-RSNKSKE-----FFAELKVLCKIHH 343
           ++FD  R +G+G FGNVY       +   A+K + +S   KE        E+++   + H
Sbjct: 14  DDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 344 INVFISTFGNGSLSDHLHD-----------------PLLKGHQPLTWTARTQIALDAAKG 386
            N+         + ++ HD                   L+ H             + A  
Sbjct: 74  PNIL-------RMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADA 126
Query: 387 IEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGY 446
           + Y H+    + +HRDIK  N+L+      K+ADFG        +   +    + GT  Y
Sbjct: 127 LHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWS-----VHAPSLRRRXMCGTLDY 178
Query: 447 LPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
           LPPE I  K                 K D++  GV+  E + G
Sbjct: 179 LPPEMIEGKTH-------------DEKVDLWCAGVLCYEFLVG 208

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 59/232 (25%), Positives = 95/232 (40%), Gaps = 39/232 (16%)
Query: 247 VSKAMSITTRAFSSQGQCKENTEDVTVLESERTIIFSLEEIEEATNNFDESRIIGRGGFG 306
           ++K  S  +      G   E+ E V + E  + + +   E  E  +       +GRG FG
Sbjct: 30  LAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDY---EYREEVHWMTHQPRLGRGSFG 86
Query: 307 NVYFGLLGDRE----AAIKKMRSNKSKEFFAELKVLC----------------KIHHINV 346
            V+   + D++     A+KK+R    + F  E  V C                +   +N+
Sbjct: 87  EVH--RMKDKQTGFQCAVKKVRL---EVFRVEELVACAGLSSPRIVPLYGAVREGPWVNI 141
Query: 347 FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTS 406
           F+     GSL       L+K    L           A +G+EY+H     R +H D+K  
Sbjct: 142 FMELLEGGSLGQ-----LIKQMGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKAD 193
Query: 407 NILL-DDGLRAKVADFG-LVKLEERTNEKEMLATRLV-GTPGYLPPEYIFVK 455
           N+LL  DG RA + DFG  + L+     K +L    + GT  ++ PE +  K
Sbjct: 194 NVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK 245

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 33/95 (34%), Positives = 47/95 (49%), Gaps = 11/95 (11%)
Query: 395 KARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFV 454
           K   VHRD+K  NILLDD +  K+ DFG      + +  E L + + GTP YL PE I  
Sbjct: 142 KLNIVHRDLKPENILLDDDMNIKLTDFG---FSCQLDPGEKLRS-VCGTPSYLAPEIIEC 197
Query: 455 KRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
                D H          + D+++ GV++  L+ G
Sbjct: 198 S--MNDNHPG-----YGKEVDMWSTGVIMYTLLAG 225

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 70/311 (22%), Positives = 123/311 (39%), Gaps = 84/311 (27%)
Query: 285 EEIEEATNNFDESRIIGRGGFGNVY----FGLLGDREA----AIKKMRS----NKSKEFF 332
           E+ E   NN    + +G G FG V     FGL G  +A    A+K ++S    ++ +   
Sbjct: 39  EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGL-GKEDAVLKVAVKMLKSTAHADEKEALM 97
Query: 333 AELKVLCKIHHINVFISTFGN----------------GSLSDHLH--------DPLLKGH 368
           +ELK++  +      ++  G                 G L + L         DP     
Sbjct: 98  SELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIA 157
Query: 369 QPLTWTARTQIAL----DAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLV 424
                TA T+  L      A+G+ ++        +HRD+   N+LL +G  AK+ DFGL 
Sbjct: 158 NS---TASTRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLA 211
Query: 425 KLEERTNEKEMLATRLVGTP-GYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVL 483
           +  +  N+   +       P  ++ PE IF             +   T ++DV+++G++L
Sbjct: 212 R--DIMNDSNYIVKGNARLPVKWMAPESIF-------------DCVYTVQSDVWSYGILL 256
Query: 484 AE------------LITGK-RALIRDDSEPTK----MKSLITIMAAVAEWCLNEDAVDRP 526
            E            L+  K   L++D  +  +     K++ +IM A    C   +   RP
Sbjct: 257 WEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQA----CWALEPTHRP 312
Query: 527 EMRDIVAILSQ 537
             + I + L +
Sbjct: 313 TFQQICSFLQE 323

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 52/230 (22%), Positives = 99/230 (43%), Gaps = 59/230 (25%)
Query: 300 IGRGGFGNVYF----GLLGDR-----EAAIKKMRSNKSKEFFAEL-------KVLCKIHH 343
           +G G FG V      GL  D+     + A+K ++S+ +++  ++L       K++ K  +
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 344 I-------------NVFISTFGNGSLSDHL-----------HDPLLKGHQPLTWTARTQI 379
           I              V +     G+L ++L           ++P     + L+       
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 155
Query: 380 ALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK-LEERTNEKEMLAT 438
           A   A+G+EY+      + +HRD+   N+L+ +    K+ADFGL + +      K+    
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 439 RLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
           RL     ++ PE +F + +             T ++DV++FGV+L E+ T
Sbjct: 213 RL--PVKWMAPEALFDRIY-------------THQSDVWSFGVLLWEIFT 247

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 55/264 (20%), Positives = 107/264 (40%), Gaps = 40/264 (15%)
Query: 244 AKHVSKAMSITTRAFSSQGQCKENTEDVTVLESERTIIFSLEEIEEATNNFDESRIIGRG 303
            K  +  + I   AF           D   L+S+  I    +  E   ++ +    +GRG
Sbjct: 6   GKKRNPGLKIPKEAFEQPQTSSTPPRD---LDSKACISIGNQNFEVKADDLEPIMELGRG 62
Query: 304 GFGNV--YFGLLGDREAAIKKMR----SNKSKEFFAELKVLCKIHHINVFISTFG----- 352
            +G V     +   +  A+K++R    S + K    +L +  +       ++ +G     
Sbjct: 63  AYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFRE 122
Query: 353 ----------NGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRD 402
                     + SL D  +  ++   Q +      +IA+   K +E  H H+K   +HRD
Sbjct: 123 GDVWICMELMDTSL-DKFYKQVIDKGQTIPEDILGKIAVSIVKALE--HLHSKLSVIHRD 179
Query: 403 IKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMH 462
           +K SN+L++   + K+ DFG+      +  K + A    G   Y+ PE I         +
Sbjct: 180 VKPSNVLINALGQVKMCDFGISGYLVDSVAKTIDA----GCKPYMAPERI---------N 226
Query: 463 SSVMELQVTTKTDVFAFGVVLAEL 486
             + +   + K+D+++ G+ + EL
Sbjct: 227 PELNQKGYSVKSDIWSLGITMIEL 250

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 85/211 (40%), Gaps = 40/211 (18%)
Query: 300 IGRGGFGNV--YFGLLGDREAAIKKM-----RSNKSKEFFAELKVLCKIHHINV--FIST 350
           IG G  G V   +  + DR  AIKK+         +K  + EL ++  ++H N+   ++ 
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNV 91
Query: 351 FGNGSLSDHLHDP-LLKGHQPLTWTARTQIALDAAK----------GIEYIHDHTKARYV 399
           F      +   D  L+            Q+ LD  +          GI+++H    A  +
Sbjct: 92  FTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLCGIKHLHS---AGII 148
Query: 400 HRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRF 459
           HRD+K SNI++      K+ DFGL     RT     + T  V T  Y  PE I    ++ 
Sbjct: 149 HRDLKPSNIVVKSDXTLKILDFGLA----RTAGTSFMMTPYVVTRYYRAPEVILGMGYK- 203
Query: 460 DMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
                          D+++ G ++ E++  K
Sbjct: 204 ------------ENVDIWSVGCIMGEMVRHK 222

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 69/317 (21%), Positives = 122/317 (38%), Gaps = 87/317 (27%)
Query: 285 EEIEEATNNFDESRIIGRGGFGNVY----FGLLGDREA----AIKKMRS----NKSKEFF 332
           E+ E   NN    + +G G FG V     FGL G  +A    A+K ++S    ++ +   
Sbjct: 24  EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGL-GKEDAVLKVAVKMLKSTAHADEKEALM 82
Query: 333 AELKVLCKIHHINVFISTFGN----------------GSLSDHLH-------DPLLKGHQ 369
           +ELK++  +      ++  G                 G L + L         P L   Q
Sbjct: 83  SELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQ 142
Query: 370 -----------PLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKV 418
                      PL        +   A+G+ ++        +HRD+   N+LL +G  AK+
Sbjct: 143 DPEGLDKEDGRPLELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKI 199
Query: 419 ADFGLVKLEERTNEKEMLATRLVGTP-GYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVF 477
            DFGL +  +  N+   +       P  ++ PE IF             +   T ++DV+
Sbjct: 200 GDFGLAR--DIMNDSNYIVKGNARLPVKWMAPESIF-------------DCVYTVQSDVW 244
Query: 478 AFGVVLAE------------LITGK-RALIRDDSEPTK----MKSLITIMAAVAEWCLNE 520
           ++G++L E            L+  K   L++D  +  +     K++ +IM A    C   
Sbjct: 245 SYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQA----CWAL 300
Query: 521 DAVDRPEMRDIVAILSQ 537
           +   RP  + I + L +
Sbjct: 301 EPTHRPTFQQICSFLQE 317

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/230 (22%), Positives = 99/230 (43%), Gaps = 59/230 (25%)
Query: 300 IGRGGFGNVYF----GLLGDR-----EAAIKKMRSNKSKEFFAEL-------KVLCKIHH 343
           +G G FG V      GL  D+     + A+K ++S+ +++  ++L       K++ K  +
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 344 I-------------NVFISTFGNGSLSDHL-----------HDPLLKGHQPLTWTARTQI 379
           I              V +     G+L ++L           ++P     + L+       
Sbjct: 89  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 148
Query: 380 ALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK-LEERTNEKEMLAT 438
           A   A+G+EY+      + +HRD+   N+L+ +    K+ADFGL + +      K+    
Sbjct: 149 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 205
Query: 439 RLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
           RL     ++ PE +F + +             T ++DV++FGV+L E+ T
Sbjct: 206 RL--PVKWMAPEALFDRIY-------------THQSDVWSFGVLLWEIFT 240

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 46/91 (50%), Gaps = 16/91 (17%)
Query: 393 HTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYI 452
           H +    HRD+K SNIL+D   R K++DFG     E   +K++  +R  GT  ++PPE+ 
Sbjct: 168 HNEKNICHRDVKPSNILMDKNGRVKLSDFG---ESEYMVDKKIKGSR--GTYEFMPPEF- 221
Query: 453 FVKRFRFDMHSSVMELQVTTKTDVFAFGVVL 483
                 F   SS        K D+++ G+ L
Sbjct: 222 ------FSNESSYN----GAKVDIWSLGICL 242

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 87/216 (40%), Gaps = 40/216 (18%)
Query: 294 FDESRIIGRGGFGNV--YFGLLGDREAAIKKM-----RSNKSKEFFAELKVLCKIHH--- 343
           + + + IG G  G V   F  +     A+KK+         +K  + EL +L  ++H   
Sbjct: 24  YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNI 83
Query: 344 ---INVF-----ISTFGNGSLSDHLHDPLLKG--HQPLTWTARTQIALDAAKGIEYIHDH 393
              +NVF     +  F +  L   L D  L    H  L     + +      GI+++H  
Sbjct: 84  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLH-- 141
Query: 394 TKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIF 453
             A  +HRD+K SNI++      K+ DFGL     RT     + T  V T  Y  PE I 
Sbjct: 142 -SAGIIHRDLKPSNIVVKSDCTLKILDFGLA----RTASTNFMMTPYVVTRYYRAPEVIL 196
Query: 454 VKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
              ++                D+++ G ++ EL+ G
Sbjct: 197 GMGYK-------------ENVDIWSVGCIMGELVKG 219

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/230 (22%), Positives = 99/230 (43%), Gaps = 59/230 (25%)
Query: 300 IGRGGFGNVYF----GLLGDR-----EAAIKKMRSNKSKEFFAEL-------KVLCKIHH 343
           +G G FG V      GL  D+     + A+K ++S+ +++  ++L       K++ K  +
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 344 I-------------NVFISTFGNGSLSDHL-----------HDPLLKGHQPLTWTARTQI 379
           I              V +     G+L ++L           ++P     + L+       
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 380 ALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK-LEERTNEKEMLAT 438
           A   A+G+EY+      + +HRD+   N+L+ +    K+ADFGL + +      K+    
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 439 RLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
           RL     ++ PE +F + +             T ++DV++FGV+L E+ T
Sbjct: 213 RL--PVKWMAPEALFDRIY-------------THQSDVWSFGVLLWEIFT 247

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 85/211 (40%), Gaps = 40/211 (18%)
Query: 300 IGRGGFGNV--YFGLLGDREAAIKKM-----RSNKSKEFFAELKVLCKIHHINV--FIST 350
           IG G  G V   +  + DR  AIKK+         +K  + EL ++  ++H N+   ++ 
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNV 91
Query: 351 FGNGSLSDHLHDP-LLKGHQPLTWTARTQIALDAAK----------GIEYIHDHTKARYV 399
           F      +   D  L+            Q+ LD  +          GI+++H    A  +
Sbjct: 92  FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS---AGII 148
Query: 400 HRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRF 459
           HRD+K SNI++      K+ DFGL     RT     + T  V T  Y  PE I    ++ 
Sbjct: 149 HRDLKPSNIVVKSDXTLKILDFGLA----RTAGTSFMMTPYVVTRYYRAPEVILGMGYK- 203
Query: 460 DMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
                          D+++ G ++ E++  K
Sbjct: 204 ------------ENVDIWSVGCIMGEMVRHK 222

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/230 (22%), Positives = 99/230 (43%), Gaps = 59/230 (25%)
Query: 300 IGRGGFGNVYF----GLLGDR-----EAAIKKMRSNKSKEFFAEL-------KVLCKIHH 343
           +G G FG V      GL  D+     + A+K ++S+ +++  ++L       K++ K  +
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 344 I-------------NVFISTFGNGSLSDHL-----------HDPLLKGHQPLTWTARTQI 379
           I              V +     G+L ++L           ++P     + L+       
Sbjct: 81  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 140
Query: 380 ALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK-LEERTNEKEMLAT 438
           A   A+G+EY+      + +HRD+   N+L+ +    K+ADFGL + +      K+    
Sbjct: 141 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 197
Query: 439 RLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
           RL     ++ PE +F + +             T ++DV++FGV+L E+ T
Sbjct: 198 RL--PVKWMAPEALFDRIY-------------THQSDVWSFGVLLWEIFT 232

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 83/226 (36%), Gaps = 59/226 (26%)
Query: 292 NNFDESRIIGRGGFGNVYFGLLGDREAAIKKMRSNKSKEFFAELKVLCK--IHHINVFIS 349
           ++F+  R +G+G FGNVY                 K   F   LKVL K  I    V   
Sbjct: 23  DDFEIGRPLGKGKFGNVYLA-------------REKKSHFIVALKVLFKSQIEKEGVEHQ 69
Query: 350 TFGNGSLSDHLHDP-LLKGHQPLTWTARTQIALDAAKGIEYIHDHTKA------------ 396
                 +  HLH P +L+ +       R  + L+ A   E   +  K+            
Sbjct: 70  LRREIEIQAHLHHPNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCTFDEQRTATIM 129
Query: 397 -------------RYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGT 443
                        + +HRDIK  N+LL      K+ADFG          K M      GT
Sbjct: 130 EELADALMYCHGKKVIHRDIKPENLLLGLKGELKIADFGWSVHAPSLRRKTM-----CGT 184
Query: 444 PGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
             YLPPE I  +     MH+         K D++  GV+  EL+ G
Sbjct: 185 LDYLPPEMIEGR-----MHNE--------KVDLWCIGVLCYELLVG 217

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/230 (22%), Positives = 99/230 (43%), Gaps = 59/230 (25%)
Query: 300 IGRGGFGNVYF----GLLGDR-----EAAIKKMRSNKSKEFFAEL-------KVLCKIHH 343
           +G G FG V      GL  D+     + A+K ++S+ +++  ++L       K++ K  +
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 344 I-------------NVFISTFGNGSLSDHL-----------HDPLLKGHQPLTWTARTQI 379
           I              V +     G+L ++L           ++P     + L+       
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 380 ALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK-LEERTNEKEMLAT 438
           A   A+G+EY+      + +HRD+   N+L+ +    K+ADFGL + +      K+    
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 439 RLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
           RL     ++ PE +F + +             T ++DV++FGV+L E+ T
Sbjct: 213 RL--PVKWMAPEALFDRIY-------------THQSDVWSFGVLLWEIFT 247

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 51/217 (23%), Positives = 87/217 (40%), Gaps = 40/217 (18%)
Query: 294 FDESRIIGRGGFGNV--YFGLLGDREAAIKKM-----RSNKSKEFFAELKVLCKIHHINV 346
           +   + IG G  G V   +  + DR  AIKK+         +K  + EL ++  ++H N+
Sbjct: 64  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 123
Query: 347 --FISTFGNGSLSDHLHDP-LLKGHQPLTWTARTQIALDAAK----------GIEYIHDH 393
              ++ F      +   D  L+            Q+ LD  +          GI+++H  
Sbjct: 124 ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH-- 181
Query: 394 TKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIF 453
             A  +HRD+K SNI++      K+ DFGL     RT     + T  V T  Y  PE I 
Sbjct: 182 -SAGIIHRDLKPSNIVVKSDCTLKILDFGLA----RTAGTSFMMTPYVVTRYYRAPEVIL 236
Query: 454 VKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
              ++                D+++ G ++ E++  K
Sbjct: 237 GMGYK-------------ENVDIWSVGCIMGEMVRHK 260

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/224 (23%), Positives = 99/224 (44%), Gaps = 51/224 (22%)
Query: 292 NNFDESRIIGRGGFGNVY-------------FGLLGDREAAIK---KMRSNKSKEFFAEL 335
           + F+  +++G+G FG V+             + +   ++A +K   ++R+   ++   E+
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV 83
Query: 336 K--VLCKIHH-------INVFISTFGNGSLSDHLHDPLLKGHQPLT-WTARTQIALDAAK 385
               + K+H+       + + +     G L   L   ++   + +  + A   +ALD   
Sbjct: 84  NHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALD--- 140
Query: 386 GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPG 445
                H H+    ++RD+K  NILLD+    K+ DFGL K E   +EK+  A    GT  
Sbjct: 141 -----HLHSLG-IIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKK--AYSFCGTVE 191
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
           Y+ PE +  +               T   D ++FGV++ E++TG
Sbjct: 192 YMAPEVVNRRGH-------------TQSADWWSFGVLMFEMLTG 222

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/224 (23%), Positives = 99/224 (44%), Gaps = 51/224 (22%)
Query: 292 NNFDESRIIGRGGFGNVY-------------FGLLGDREAAIK---KMRSNKSKEFFAEL 335
           + F+  +++G+G FG V+             + +   ++A +K   ++R+   ++   E+
Sbjct: 25  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV 84
Query: 336 K--VLCKIHH-------INVFISTFGNGSLSDHLHDPLLKGHQPLT-WTARTQIALDAAK 385
               + K+H+       + + +     G L   L   ++   + +  + A   +ALD   
Sbjct: 85  NHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALD--- 141
Query: 386 GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPG 445
                H H+    ++RD+K  NILLD+    K+ DFGL K E   +EK+  A    GT  
Sbjct: 142 -----HLHSLG-IIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKK--AYSFCGTVE 192
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
           Y+ PE +  +               T   D ++FGV++ E++TG
Sbjct: 193 YMAPEVVNRRGH-------------TQSADWWSFGVLMFEMLTG 223

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/230 (22%), Positives = 99/230 (43%), Gaps = 59/230 (25%)
Query: 300 IGRGGFGNVYF----GLLGDR-----EAAIKKMRSNKSKEFFAEL-------KVLCKIHH 343
           +G G FG V      GL  D+     + A+K ++S+ +++  ++L       K++ K  +
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 344 I-------------NVFISTFGNGSLSDHL-----------HDPLLKGHQPLTWTARTQI 379
           I              V +     G+L ++L           ++P     + L+       
Sbjct: 85  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 144
Query: 380 ALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK-LEERTNEKEMLAT 438
           A   A+G+EY+      + +HRD+   N+L+ +    K+ADFGL + +      K+    
Sbjct: 145 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 201
Query: 439 RLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
           RL     ++ PE +F + +             T ++DV++FGV+L E+ T
Sbjct: 202 RL--PVKWMAPEALFDRIY-------------THQSDVWSFGVLLWEIFT 236

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/230 (22%), Positives = 99/230 (43%), Gaps = 59/230 (25%)
Query: 300 IGRGGFGNVYF----GLLGDR-----EAAIKKMRSNKSKEFFAEL-------KVLCKIHH 343
           +G G FG V      GL  D+     + A+K ++S+ +++  ++L       K++ K  +
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 344 I-------------NVFISTFGNGSLSDHL-----------HDPLLKGHQPLTWTARTQI 379
           I              V +     G+L ++L           ++P     + L+       
Sbjct: 88  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 147
Query: 380 ALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK-LEERTNEKEMLAT 438
           A   A+G+EY+      + +HRD+   N+L+ +    K+ADFGL + +      K+    
Sbjct: 148 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 204
Query: 439 RLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
           RL     ++ PE +F + +             T ++DV++FGV+L E+ T
Sbjct: 205 RL--PVKWMAPEALFDRIY-------------THQSDVWSFGVLLWEIFT 239

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 55/233 (23%), Positives = 100/233 (42%), Gaps = 47/233 (20%)
Query: 300 IGRGGFGNVYFGLL--GDREAAIKKM--RSNKSKEF-FAELKVLCKIHHINVFISTFGNG 354
           IG G  G V    +    +  A+KKM  R  + +E  F E+ ++    H NV +  + + 
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV-VEMYNSY 86
Query: 355 SLSDHLHDPL--LKG--------HQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIK 404
            + D L   +  L+G        H  +       + L   + +  +H       +HRDIK
Sbjct: 87  LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIK 143
Query: 405 TSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSS 464
           + +ILL    R K++DFG      + +++      LVGTP ++ PE I            
Sbjct: 144 SDSILLTHDGRVKLSDFGFCA---QVSKEVPRRKXLVGTPYWMAPELI------------ 188
Query: 465 VMELQVTTKTDVFAFGVVLAELITGK-----------RALIRDDSEPTKMKSL 506
              L    + D+++ G+++ E++ G+             +IRD+  P ++K+L
Sbjct: 189 -SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL-PPRLKNL 239

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 60/260 (23%), Positives = 105/260 (40%), Gaps = 45/260 (17%)
Query: 299 IIGRGGFGNVYFGLL--GDREAAIKKMRSNKSKEFFAELKVLCKIHHINVFISTFGNG-- 354
           ++G GGFG+VY G+    +   AIK +  ++  ++  EL    ++    V +    +G  
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDW-GELPNGTRVPMEVVLLKKVSSGFS 69
Query: 355 ---SLSDHLHDP-----LLKGHQPLT-----WTARTQIALDAAKG-----IEYIHDHTKA 396
               L D    P     +L+  +P+       T R  +  + A+      +E +      
Sbjct: 70  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 129
Query: 397 RYVHRDIKTSNILLD-DGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVK 455
             +HRDIK  NIL+D +    K+ DFG   L      K+ + T   GT  Y PPE+I   
Sbjct: 130 GVLHRDIKDENILIDLNRGELKLIDFGSGAL-----LKDTVYTDFDGTRVYSPPEWIRYH 184
Query: 456 RFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDD----SEPTKMKSLITIMA 511
           R+                  V++ G++L +++ G      D+     +    + + +   
Sbjct: 185 RYH------------GRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSSECQ 232
Query: 512 AVAEWCLNEDAVDRPEMRDI 531
            +  WCL     DRP   +I
Sbjct: 233 HLIRWCLALRPSDRPTFEEI 252

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 55/233 (23%), Positives = 100/233 (42%), Gaps = 47/233 (20%)
Query: 300 IGRGGFGNVYFGLL--GDREAAIKKM--RSNKSKEF-FAELKVLCKIHHINVFISTFGNG 354
           IG G  G V    +    +  A+KKM  R  + +E  F E+ ++    H NV +  + + 
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV-VEMYNSY 95
Query: 355 SLSDHLHDPL--LKG--------HQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIK 404
            + D L   +  L+G        H  +       + L   + +  +H       +HRDIK
Sbjct: 96  LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIK 152
Query: 405 TSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSS 464
           + +ILL    R K++DFG      + +++      LVGTP ++ PE I            
Sbjct: 153 SDSILLTHDGRVKLSDFGFCA---QVSKEVPRRKXLVGTPYWMAPELI------------ 197
Query: 465 VMELQVTTKTDVFAFGVVLAELITGK-----------RALIRDDSEPTKMKSL 506
              L    + D+++ G+++ E++ G+             +IRD+  P ++K+L
Sbjct: 198 -SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL-PPRLKNL 248

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 34/131 (25%), Positives = 60/131 (45%), Gaps = 21/131 (16%)
Query: 385 KGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP 444
           +G++++H +     VHRD+K  NIL+  G   K+ADFGL     R    +M  T +V T 
Sbjct: 131 RGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLA----RIYSYQMALTPVVVTL 183
Query: 445 GYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKMK 504
            Y  PE +    +              T  D+++ G + AE+   ++ L   +SE  ++ 
Sbjct: 184 WYRAPEVLLQSTY-------------ATPVDMWSVGCIFAEMFR-RKPLFCGNSEADQLG 229
Query: 505 SLITIMAAVAE 515
            +  ++    E
Sbjct: 230 KIFDLIGLPPE 240

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 91/226 (40%), Gaps = 54/226 (23%)
Query: 291 TNNFDESRIIGRGGFGNVYF--GLLGDREAAIKKMR------SNKSKEFFAELKVLCKIH 342
           ++ +   + +G G +G V      L   E AIK ++      ++ S     E+ VL ++ 
Sbjct: 3   SDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLD 62
Query: 343 HINVF---------------ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGI 387
           H N+                +  +  G L D +   +L+  Q  +      I      G 
Sbjct: 63  HPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEI---ILR--QKFSEVDAAVIMKQVLSGT 117
Query: 388 EYIHDHTKARYVHRDIKTSNILLDDGLRA---KVADFGL-VKLEERTNEKEMLATRLVGT 443
            Y+H H     VHRD+K  N+LL+   R    K+ DFGL    E     KE L     GT
Sbjct: 118 TYLHKHN---IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERL-----GT 169
Query: 444 PGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
             Y+ PE   V R ++D            K DV++ GV+L  L+ G
Sbjct: 170 AYYIAPE---VLRKKYD-----------EKCDVWSCGVILYILLCG 201

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 60/260 (23%), Positives = 105/260 (40%), Gaps = 45/260 (17%)
Query: 299 IIGRGGFGNVYFGLL--GDREAAIKKMRSNKSKEFFAELKVLCKIHHINVFISTFGNG-- 354
           ++G GGFG+VY G+    +   AIK +  ++  ++  EL    ++    V +    +G  
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDW-GELPNGTRVPMEVVLLKKVSSGFS 69
Query: 355 ---SLSDHLHDP-----LLKGHQPLT-----WTARTQIALDAAKG-----IEYIHDHTKA 396
               L D    P     +L+  +P+       T R  +  + A+      +E +      
Sbjct: 70  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 129
Query: 397 RYVHRDIKTSNILLD-DGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVK 455
             +HRDIK  NIL+D +    K+ DFG   L      K+ + T   GT  Y PPE+I   
Sbjct: 130 GVLHRDIKDENILIDLNRGELKLIDFGSGAL-----LKDTVYTDFDGTRVYSPPEWIRYH 184
Query: 456 RFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDD----SEPTKMKSLITIMA 511
           R+                  V++ G++L +++ G      D+     +    + + +   
Sbjct: 185 RYH------------GRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQ 232
Query: 512 AVAEWCLNEDAVDRPEMRDI 531
            +  WCL     DRP   +I
Sbjct: 233 HLIRWCLALRPSDRPTFEEI 252

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/233 (22%), Positives = 100/233 (42%), Gaps = 59/233 (25%)
Query: 297 SRIIGRGGFGNVYF----GLLGDR-----EAAIKKMRSNKSKEFFAEL-------KVLCK 340
            + +G G FG V      GL  D+     + A+K ++S+ +++  ++L       K++ K
Sbjct: 74  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133
Query: 341 IHHI-------------NVFISTFGNGSLSDHL-----------HDPLLKGHQPLTWTAR 376
             +I              V +     G+L ++L           ++P     + L+    
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193
Query: 377 TQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK-LEERTNEKEM 435
              A   A+G+EY+      + +HRD+   N+L+ +    K+ADFGL + +      K+ 
Sbjct: 194 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 250
Query: 436 LATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
              RL     ++ PE +F + +             T ++DV++FGV+L E+ T
Sbjct: 251 TNGRL--PVKWMAPEALFDRIY-------------THQSDVWSFGVLLWEIFT 288

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 55/233 (23%), Positives = 100/233 (42%), Gaps = 47/233 (20%)
Query: 300 IGRGGFGNVYFGLL--GDREAAIKKM--RSNKSKEF-FAELKVLCKIHHINVFISTFGNG 354
           IG G  G V    +    +  A+KKM  R  + +E  F E+ ++    H NV +  + + 
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV-VEMYNSY 97
Query: 355 SLSDHLHDPL--LKG--------HQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIK 404
            + D L   +  L+G        H  +       + L   + +  +H       +HRDIK
Sbjct: 98  LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIK 154
Query: 405 TSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSS 464
           + +ILL    R K++DFG      + +++      LVGTP ++ PE I            
Sbjct: 155 SDSILLTHDGRVKLSDFGFCA---QVSKEVPRRKXLVGTPYWMAPELI------------ 199
Query: 465 VMELQVTTKTDVFAFGVVLAELITGK-----------RALIRDDSEPTKMKSL 506
              L    + D+++ G+++ E++ G+             +IRD+  P ++K+L
Sbjct: 200 -SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL-PPRLKNL 250

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 46/94 (48%), Gaps = 19/94 (20%)
Query: 399 VHRDIKTSNILLDD---GLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVK 455
           VHRD+K  N+LL     G   K+ADFGL  +E + +++        GTPGYL PE +  +
Sbjct: 125 VHRDLKPENLLLASKCKGAAVKLADFGLA-IEVQGDQQAWFG--FAGTPGYLSPEVLRKE 181
Query: 456 RFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
            +                 D++A GV+L  L+ G
Sbjct: 182 AY-------------GKPVDIWACGVILYILLVG 202

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 51/217 (23%), Positives = 87/217 (40%), Gaps = 40/217 (18%)
Query: 294 FDESRIIGRGGFGNV--YFGLLGDREAAIKKM-----RSNKSKEFFAELKVLCKIHHINV 346
           +   + IG G  G V   +  + DR  AIKK+         +K  + EL ++  ++H N+
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 86
Query: 347 --FISTFGNGSLSDHLHDP-LLKGHQPLTWTARTQIALDAAK----------GIEYIHDH 393
              ++ F      +   D  L+            Q+ LD  +          GI+++H  
Sbjct: 87  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS- 145
Query: 394 TKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIF 453
             A  +HRD+K SNI++      K+ DFGL     RT     + T  V T  Y  PE I 
Sbjct: 146 --AGIIHRDLKPSNIVVKSDCTLKILDFGLA----RTAGTSFMMTPYVVTRYYRAPEVIL 199
Query: 454 VKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
              ++                D+++ G ++ E++  K
Sbjct: 200 GMGYK-------------ENVDIWSVGCIMGEMVRHK 223

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 51/217 (23%), Positives = 87/217 (40%), Gaps = 40/217 (18%)
Query: 294 FDESRIIGRGGFGNV--YFGLLGDREAAIKKM-----RSNKSKEFFAELKVLCKIHHINV 346
           +   + IG G  G V   +  + DR  AIKK+         +K  + EL ++  ++H N+
Sbjct: 64  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 123
Query: 347 --FISTFGNGSLSDHLHDP-LLKGHQPLTWTARTQIALDAAK----------GIEYIHDH 393
              ++ F      +   D  L+            Q+ LD  +          GI+++H  
Sbjct: 124 ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS- 182
Query: 394 TKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIF 453
             A  +HRD+K SNI++      K+ DFGL     RT     + T  V T  Y  PE I 
Sbjct: 183 --AGIIHRDLKPSNIVVKSDCTLKILDFGLA----RTAGTSFMMTPYVVTRYYRAPEVIL 236
Query: 454 VKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
              ++                D+++ G ++ E++  K
Sbjct: 237 GMGYK-------------ENVDIWSVGCIMGEMVRHK 260

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/224 (23%), Positives = 99/224 (44%), Gaps = 51/224 (22%)
Query: 292 NNFDESRIIGRGGFGNVY-------------FGLLGDREAAIK---KMRSNKSKEFFAEL 335
           + F+  +++G+G FG V+             + +   ++A +K   ++R+   ++   E+
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV 83
Query: 336 K--VLCKIHH-------INVFISTFGNGSLSDHLHDPLLKGHQPLT-WTARTQIALDAAK 385
               + K+H+       + + +     G L   L   ++   + +  + A   +ALD   
Sbjct: 84  NHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALD--- 140
Query: 386 GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPG 445
                H H+    ++RD+K  NILLD+    K+ DFGL K E   +EK+  A    GT  
Sbjct: 141 -----HLHSLG-IIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKK--AYSFCGTVE 191
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
           Y+ PE +  +               T   D ++FGV++ E++TG
Sbjct: 192 YMAPEVVNRRGH-------------TQSADWWSFGVLMFEMLTG 222

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 38/138 (27%), Positives = 57/138 (41%), Gaps = 28/138 (20%)
Query: 354 GSLSDHLHDPLLKGHQPLTWTARTQIALDAAK---GIEYIHDHTKARYVHRDIKTSNILL 410
           GSL D+L         P       Q+ L A +   G+ Y+H      Y+HR +   N+LL
Sbjct: 97  GSLRDYL---------PRHCVGLAQLLLFAQQICEGMAYLH---AQHYIHRALAARNVLL 144
Query: 411 DDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQV 470
           D+    K+ DFGL K     +E   +         +  PE              + E + 
Sbjct: 145 DNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPE-------------CLKECKF 191
Query: 471 TTKTDVFAFGVVLAELIT 488
              +DV++FGV L EL+T
Sbjct: 192 YYASDVWSFGVTLYELLT 209

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 38/138 (27%), Positives = 57/138 (41%), Gaps = 28/138 (20%)
Query: 354 GSLSDHLHDPLLKGHQPLTWTARTQIALDAAK---GIEYIHDHTKARYVHRDIKTSNILL 410
           GSL D+L         P       Q+ L A +   G+ Y+H      Y+HR +   N+LL
Sbjct: 98  GSLRDYL---------PRHCVGLAQLLLFAQQICEGMAYLH---AQHYIHRALAARNVLL 145
Query: 411 DDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQV 470
           D+    K+ DFGL K     +E   +         +  PE              + E + 
Sbjct: 146 DNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPE-------------CLKECKF 192
Query: 471 TTKTDVFAFGVVLAELIT 488
              +DV++FGV L EL+T
Sbjct: 193 YYASDVWSFGVTLYELLT 210

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 57/238 (23%), Positives = 98/238 (41%), Gaps = 44/238 (18%)
Query: 276 SERTIIFSLEEIEEAT----NNFDESRIIGRGGFGNV--YFGLLGDREAAIKKM-----R 324
           S+R   F   EI ++T      +   + IG G  G V   +  + +R  AIKK+      
Sbjct: 4   SKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQN 63
Query: 325 SNKSKEFFAELKVLCKIHHINV--FISTFG-NGSLSDHLHDPLLKGHQPLTWTARTQIAL 381
              +K  + EL ++  ++H N+   ++ F    SL +     ++        +   Q+ L
Sbjct: 64  QTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMEL 123
Query: 382 DAAK----------GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTN 431
           D  +          GI+++H    A  +HRD+K SNI++      K+ DFGL     RT 
Sbjct: 124 DHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA----RTA 176
Query: 432 EKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
               + T  V T  Y  PE I    ++                D+++ G ++ E+I G
Sbjct: 177 GTSFMMTPYVVTRYYRAPEVILGMGYK-------------ENVDIWSVGCIMGEMIKG 221

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 85/211 (40%), Gaps = 40/211 (18%)
Query: 300 IGRGGFGNV--YFGLLGDREAAIKKM-----RSNKSKEFFAELKVLCKIHHINV--FIST 350
           IG G  G V   +  + DR  AIKK+         +K  + EL ++  ++H N+   ++ 
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 91
Query: 351 FGNGSLSDHLHDP-LLKGHQPLTWTARTQIALDAAK----------GIEYIHDHTKARYV 399
           F      +   D  L+            Q+ LD  +          GI+++H    A  +
Sbjct: 92  FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS---AGII 148
Query: 400 HRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRF 459
           HRD+K SNI++      K+ DFGL     RT     + T  V T  Y  PE I    ++ 
Sbjct: 149 HRDLKPSNIVVKSDCTLKILDFGLA----RTAGTSFMMTPYVVTRYYRAPEVILGMGYK- 203
Query: 460 DMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
                          D+++ G ++ E++  K
Sbjct: 204 ------------ENVDIWSVGCIMGEMVRHK 222

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 34/111 (30%), Positives = 48/111 (43%), Gaps = 24/111 (21%)
Query: 387 IEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK-LEERTNEKEMLATRLVGTPG 445
            EY+H       ++RD+K  N+++D     KV DFGL K ++ RT         L GTP 
Sbjct: 154 FEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVKGRT-------WXLCGTPE 203
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRD 496
           YL PE I  K +                 D +A GV++ E+  G      D
Sbjct: 204 YLAPEIILSKGY-------------NKAVDWWALGVLIYEMAAGYPPFFAD 241

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 33/94 (35%), Positives = 48/94 (51%), Gaps = 19/94 (20%)
Query: 399 VHRDIKTSNILL---DDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVK 455
           VHRD+K  N+LL     G   K+ADFGL  +E + +++        GTPGYL PE +   
Sbjct: 125 VHRDLKPENLLLASKSKGAAVKLADFGLA-IEVQGDQQAWFG--FAGTPGYLSPEVL--- 178
Query: 456 RFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
             R D +   +        D++A GV+L  L+ G
Sbjct: 179 --RKDPYGKPV--------DMWACGVILYILLVG 202

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 85/211 (40%), Gaps = 40/211 (18%)
Query: 300 IGRGGFGNV--YFGLLGDREAAIKKM-----RSNKSKEFFAELKVLCKIHHINV--FIST 350
           IG G  G V   +  + DR  AIKK+         +K  + EL ++  ++H N+   ++ 
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 91
Query: 351 FGNGSLSDHLHDP-LLKGHQPLTWTARTQIALDAAK----------GIEYIHDHTKARYV 399
           F      +   D  L+            Q+ LD  +          GI+++H    A  +
Sbjct: 92  FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS---AGII 148
Query: 400 HRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRF 459
           HRD+K SNI++      K+ DFGL     RT     + T  V T  Y  PE I    ++ 
Sbjct: 149 HRDLKPSNIVVKSDCTLKILDFGLA----RTAGTSFMMTPYVVTRYYRAPEVILGMGYK- 203
Query: 460 DMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
                          D+++ G ++ E++  K
Sbjct: 204 ------------ENVDIWSVGCIMGEMVRHK 222

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 55/233 (23%), Positives = 100/233 (42%), Gaps = 47/233 (20%)
Query: 300 IGRGGFGNVYFGLL--GDREAAIKKM--RSNKSKEF-FAELKVLCKIHHINVFISTFGNG 354
           IG G  G V    +    +  A+KKM  R  + +E  F E+ ++    H NV +  + + 
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV-VEMYNSY 90
Query: 355 SLSDHLHDPL--LKG--------HQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIK 404
            + D L   +  L+G        H  +       + L   + +  +H       +HRDIK
Sbjct: 91  LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIK 147
Query: 405 TSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSS 464
           + +ILL    R K++DFG      + +++      LVGTP ++ PE I            
Sbjct: 148 SDSILLTHDGRVKLSDFGFCA---QVSKEVPRRKXLVGTPYWMAPELI------------ 192
Query: 465 VMELQVTTKTDVFAFGVVLAELITGK-----------RALIRDDSEPTKMKSL 506
              L    + D+++ G+++ E++ G+             +IRD+  P ++K+L
Sbjct: 193 -SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL-PPRLKNL 243

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 85/211 (40%), Gaps = 40/211 (18%)
Query: 300 IGRGGFGNV--YFGLLGDREAAIKKM-----RSNKSKEFFAELKVLCKIHH------INV 346
           IG G  G V   +  + DR  AIKK+         +K  + EL ++  ++H      +NV
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 91
Query: 347 F-----ISTFGNGSLSDHLHDPLLKG--HQPLTWTARTQIALDAAKGIEYIHDHTKARYV 399
           F     +  F +  L   L D  L       L     + +      GI+++H    A  +
Sbjct: 92  FTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGIKHLHS---AGII 148
Query: 400 HRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRF 459
           HRD+K SNI++      K+ DFGL     RT     + T  V T  Y  PE I    ++ 
Sbjct: 149 HRDLKPSNIVVKSDXTLKILDFGLA----RTAGTSFMMTPYVVTRYYRAPEVILGMGYK- 203
Query: 460 DMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
                          D+++ G ++ E++  K
Sbjct: 204 ------------ENVDIWSVGCIMGEMVRHK 222

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 85/211 (40%), Gaps = 40/211 (18%)
Query: 300 IGRGGFGNV--YFGLLGDREAAIKKM-----RSNKSKEFFAELKVLCKIHH------INV 346
           IG G  G V   +  + DR  AIKK+         +K  + EL ++  ++H      +NV
Sbjct: 25  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 84
Query: 347 F-----ISTFGNGSLSDHLHDPLLKG--HQPLTWTARTQIALDAAKGIEYIHDHTKARYV 399
           F     +  F +  L   L D  L       L     + +      GI+++H    A  +
Sbjct: 85  FTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGIKHLHS---AGII 141
Query: 400 HRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRF 459
           HRD+K SNI++      K+ DFGL     RT     + T  V T  Y  PE I    ++ 
Sbjct: 142 HRDLKPSNIVVKSDXTLKILDFGLA----RTAGTSFMMTPYVVTRYYRAPEVILGMGYK- 196
Query: 460 DMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
                          D+++ G ++ E++  K
Sbjct: 197 ------------ENVDIWSVGCIMGEMVRHK 215

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 51/217 (23%), Positives = 87/217 (40%), Gaps = 40/217 (18%)
Query: 294 FDESRIIGRGGFGNV--YFGLLGDREAAIKKM-----RSNKSKEFFAELKVLCKIHHINV 346
           +   + IG G  G V   +  + DR  AIKK+         +K  + EL ++  ++H N+
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 86
Query: 347 --FISTFGNGSLSDHLHDP-LLKGHQPLTWTARTQIALDAAK----------GIEYIHDH 393
              ++ F      +   D  L+            Q+ LD  +          GI+++H  
Sbjct: 87  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS- 145
Query: 394 TKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIF 453
             A  +HRD+K SNI++      K+ DFGL     RT     + T  V T  Y  PE I 
Sbjct: 146 --AGIIHRDLKPSNIVVKSDCTLKILDFGLA----RTAGTSFMMTPYVVTRYYRAPEVIL 199
Query: 454 VKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
              ++                D+++ G ++ E++  K
Sbjct: 200 GMGYK-------------ENVDIWSVGCIMGEMVRHK 223

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 87/216 (40%), Gaps = 40/216 (18%)
Query: 294 FDESRIIGRGGFGNV--YFGLLGDREAAIKKM-----RSNKSKEFFAELKVLCKIHH--- 343
           + + + IG G  G V   F  +     A+KK+         +K  + EL +L  ++H   
Sbjct: 26  YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNI 85
Query: 344 ---INVF-----ISTFGNGSLSDHLHDPLLKG--HQPLTWTARTQIALDAAKGIEYIHDH 393
              +NVF     +  F +  L   L D  L    H  L     + +      GI+++H  
Sbjct: 86  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLH-- 143
Query: 394 TKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIF 453
             A  +HRD+K SNI++      K+ DFGL     RT     + T  V T  Y  PE I 
Sbjct: 144 -SAGIIHRDLKPSNIVVKSDCTLKILDFGLA----RTACTNFMMTPYVVTRYYRAPEVI- 197
Query: 454 VKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
                       + +      D+++ G ++ EL+ G
Sbjct: 198 ------------LGMGYAANVDIWSVGCIMGELVKG 221

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 64/266 (24%), Positives = 112/266 (42%), Gaps = 57/266 (21%)
Query: 300 IGRGGFGNVYFGLLGD--REAAIKKM---RSNKSKEFFAELKVLCKIHHINV-----FIS 349
           +G GG G V+  +  D  +  AIKK+        K    E+K++ ++ H N+      + 
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILG 78
Query: 350 TFGN------GSLSD-------------HLHDPLLKGHQPLTWTARTQIALDAAKGIEYI 390
             G+      GSL++              L + L +G  PL             +G++YI
Sbjct: 79  PSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQG--PLLEEHARLFMYQLLRGLKYI 136
Query: 391 HDHTKARYVHRDIKTSNILLD-DGLRAKVADFGLVK-LEERTNEKEMLATRLVGTPGYLP 448
           H    A  +HRD+K +N+ ++ + L  K+ DFGL + ++   + K  L+  LV T  Y  
Sbjct: 137 H---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLV-TKWYRS 192
Query: 449 PEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKMKSLIT 508
           P  +                  T   D++A G + AE++TGK  L     E  +M+ ++ 
Sbjct: 193 PRLLLSPN------------NYTKAIDMWAAGCIFAEMLTGK-TLFAGAHELEQMQLILE 239
Query: 509 IMAAVAEWCLNEDAVDRPEMRDIVAI 534
            +  V E        DR E+  ++ +
Sbjct: 240 SIPVVHEE-------DRQELLSVIPV 258

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/94 (35%), Positives = 47/94 (50%), Gaps = 19/94 (20%)
Query: 399 VHRDIKTSNILL---DDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVK 455
           VHRD+K  N+LL     G   K+ADFGL  +E + +++        GTPGYL PE +   
Sbjct: 125 VHRDLKPENLLLASKSKGAAVKLADFGLA-IEVQGDQQAWFG--FAGTPGYLSPEVL--- 178
Query: 456 RFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
             R D +            D++A GV+L  L+ G
Sbjct: 179 --RKDPYGK--------PVDMWACGVILYILLVG 202

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 57/238 (23%), Positives = 98/238 (41%), Gaps = 44/238 (18%)
Query: 276 SERTIIFSLEEIEEAT----NNFDESRIIGRGGFGNV--YFGLLGDREAAIKKM-----R 324
           S+R   F   EI ++T      +   + IG G  G V   +  + +R  AIKK+      
Sbjct: 4   SKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQN 63
Query: 325 SNKSKEFFAELKVLCKIHHINV--FISTFG-NGSLSDHLHDPLLKGHQPLTWTARTQIAL 381
              +K  + EL ++  ++H N+   ++ F    SL +     ++        +   Q+ L
Sbjct: 64  QTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMEL 123
Query: 382 DAAK----------GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTN 431
           D  +          GI+++H    A  +HRD+K SNI++      K+ DFGL     RT 
Sbjct: 124 DHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDATLKILDFGLA----RTA 176
Query: 432 EKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
               + T  V T  Y  PE I    ++                D+++ G ++ E+I G
Sbjct: 177 GTSFMMTPYVVTRYYRAPEVILGMGYK-------------ENVDIWSVGCIMGEMIKG 221

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 51/217 (23%), Positives = 87/217 (40%), Gaps = 40/217 (18%)
Query: 294 FDESRIIGRGGFGNV--YFGLLGDREAAIKKM-----RSNKSKEFFAELKVLCKIHHINV 346
           +   + IG G  G V   +  + DR  AIKK+         +K  + EL ++  ++H N+
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78
Query: 347 --FISTFGNGSLSDHLHDP-LLKGHQPLTWTARTQIALDAAK----------GIEYIHDH 393
              ++ F      +   D  L+            Q+ LD  +          GI+++H  
Sbjct: 79  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS- 137
Query: 394 TKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIF 453
             A  +HRD+K SNI++      K+ DFGL     RT     + T  V T  Y  PE I 
Sbjct: 138 --AGIIHRDLKPSNIVVKSDCTLKILDFGLA----RTAGTSFMMTPYVVTRYYRAPEVIL 191
Query: 454 VKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
              ++                D+++ G ++ E++  K
Sbjct: 192 GMGYK-------------ENVDIWSVGCIMGEMVRHK 215

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 85/211 (40%), Gaps = 40/211 (18%)
Query: 300 IGRGGFGNV--YFGLLGDREAAIKKM-----RSNKSKEFFAELKVLCKIHHINV--FIST 350
           IG G  G V   +  + DR  AIKK+         +K  + EL ++  ++H N+   ++ 
Sbjct: 31  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 90
Query: 351 FGNGSLSDHLHDP-LLKGHQPLTWTARTQIALDAAK----------GIEYIHDHTKARYV 399
           F      +   D  L+            Q+ LD  +          GI+++H    A  +
Sbjct: 91  FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS---AGII 147
Query: 400 HRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRF 459
           HRD+K SNI++      K+ DFGL     RT     + T  V T  Y  PE I    ++ 
Sbjct: 148 HRDLKPSNIVVKSDCTLKILDFGLA----RTAGTSFMMTPYVVTRYYRAPEVILGMGYK- 202
Query: 460 DMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
                          D+++ G ++ E++  K
Sbjct: 203 ------------ENVDIWSVGCIMGEMVRHK 221

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 64/150 (42%), Gaps = 23/150 (15%)
Query: 386 GIEYIHDHTKARYVHRDIKTSNILLD--DGLRAKVADFGLVKLEERTNEKEMLATRLVGT 443
           G+ Y H     +  HRD+K  N LLD     R K+ADFG  K     ++ +      VGT
Sbjct: 127 GVSYAH---AMQVAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPK----SAVGT 179
Query: 444 PGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKM 503
           P Y+ PE +  K +   +             DV++ GV L  ++ G      D  EP   
Sbjct: 180 PAYIAPEVLLKKEYDGKV------------ADVWSCGVTLYVMLVGAYPF-EDPEEPKNF 226
Query: 504 KSLITIMAAVAEWCLNEDAVDRPEMRDIVA 533
           +  I  +  V ++ + +     PE R +++
Sbjct: 227 RKTIHRILNV-QYAIPDYVHISPECRHLIS 255

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 51/217 (23%), Positives = 87/217 (40%), Gaps = 40/217 (18%)
Query: 294 FDESRIIGRGGFGNV--YFGLLGDREAAIKKM-----RSNKSKEFFAELKVLCKIHHINV 346
           +   + IG G  G V   +  + DR  AIKK+         +K  + EL ++  ++H N+
Sbjct: 20  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 79
Query: 347 --FISTFGNGSLSDHLHDP-LLKGHQPLTWTARTQIALDAAK----------GIEYIHDH 393
              ++ F      +   D  L+            Q+ LD  +          GI+++H  
Sbjct: 80  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH-- 137
Query: 394 TKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIF 453
             A  +HRD+K SNI++      K+ DFGL     RT     + T  V T  Y  PE I 
Sbjct: 138 -SAGIIHRDLKPSNIVVKSDCTLKILDFGLA----RTAGTSFMMTPYVVTRYYRAPEVIL 192
Query: 454 VKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
              ++                D+++ G ++ E++  K
Sbjct: 193 GMGYK-------------ENVDIWSVGCIMGEMVRHK 216

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 51/217 (23%), Positives = 87/217 (40%), Gaps = 40/217 (18%)
Query: 294 FDESRIIGRGGFGNV--YFGLLGDREAAIKKM-----RSNKSKEFFAELKVLCKIHHINV 346
           +   + IG G  G V   +  + DR  AIKK+         +K  + EL ++  ++H N+
Sbjct: 20  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 79
Query: 347 --FISTFGNGSLSDHLHDP-LLKGHQPLTWTARTQIALDAAK----------GIEYIHDH 393
              ++ F      +   D  L+            Q+ LD  +          GI+++H  
Sbjct: 80  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS- 138
Query: 394 TKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIF 453
             A  +HRD+K SNI++      K+ DFGL     RT     + T  V T  Y  PE I 
Sbjct: 139 --AGIIHRDLKPSNIVVKSDCTLKILDFGLA----RTAGTSFMMTPYVVTRYYRAPEVIL 192
Query: 454 VKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
              ++                D+++ G ++ E++  K
Sbjct: 193 GMGYK-------------ENVDIWSVGCIMGEMVRHK 216

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 32/121 (26%), Positives = 64/121 (52%), Gaps = 4/121 (3%)
Query: 387 IEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGY 446
           +E +H   +   VH D+K +N L+ DG+  K+ DFG+   + + +   ++    VGT  Y
Sbjct: 121 LEAVHTIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIAN-QMQPDTTSVVKDSQVGTVNY 178
Query: 447 LPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKMKSL 506
           +PPE I  K       +   + +++ K+DV++ G +L  +  GK    +  ++ +K+ ++
Sbjct: 179 MPPEAI--KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI 236
Query: 507 I 507
           I
Sbjct: 237 I 237

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/179 (22%), Positives = 73/179 (40%), Gaps = 32/179 (17%)
Query: 379 IALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLAT 438
            +   AKG+ ++        +HRD+   NILL  G   K+ DFGL +  +  N+   +  
Sbjct: 168 FSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLAR--DIKNDSNYVVK 222
Query: 439 RLVGTP-GYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDD 497
                P  ++ PE IF   + F+             +DV+++G+ L EL +   +     
Sbjct: 223 GNARLPVKWMAPESIFNCVYTFE-------------SDVWSYGIFLWELFSLGSSPYPGM 269
Query: 498 SEPTKMKSLI-------------TIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITST 543
              +K   +I               M  + + C + D + RP  + IV ++ + +  ST
Sbjct: 270 PVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISEST 328

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/179 (22%), Positives = 73/179 (40%), Gaps = 32/179 (17%)
Query: 379 IALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLAT 438
            +   AKG+ ++        +HRD+   NILL  G   K+ DFGL +  +  N+   +  
Sbjct: 166 FSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLAR--DIKNDSNYVVK 220
Query: 439 RLVGTP-GYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDD 497
                P  ++ PE IF   + F+             +DV+++G+ L EL +   +     
Sbjct: 221 GNARLPVKWMAPESIFNCVYTFE-------------SDVWSYGIFLWELFSLGSSPYPGM 267
Query: 498 SEPTKMKSLI-------------TIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITST 543
              +K   +I               M  + + C + D + RP  + IV ++ + +  ST
Sbjct: 268 PVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISEST 326

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/180 (22%), Positives = 73/180 (40%), Gaps = 32/180 (17%)
Query: 378 QIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLA 437
             +   AKG+ ++        +HRD+   NILL  G   K+ DFGL +  +  N+   + 
Sbjct: 149 SFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLAR--DIKNDSNYVV 203
Query: 438 TRLVGTP-GYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRD 496
                 P  ++ PE IF   + F+             +DV+++G+ L EL +   +    
Sbjct: 204 KGNARLPVKWMAPESIFNCVYTFE-------------SDVWSYGIFLWELFSLGSSPYPG 250
Query: 497 DSEPTKMKSLI-------------TIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITST 543
               +K   +I               M  + + C + D + RP  + IV ++ + +  ST
Sbjct: 251 MPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISEST 310

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 57/238 (23%), Positives = 98/238 (41%), Gaps = 44/238 (18%)
Query: 276 SERTIIFSLEEIEEAT----NNFDESRIIGRGGFGNV--YFGLLGDREAAIKKM-----R 324
           S+R   F   EI ++T      +   + IG G  G V   +  + +R  AIKK+      
Sbjct: 4   SKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQN 63
Query: 325 SNKSKEFFAELKVLCKIHHINV--FISTFG-NGSLSDHLHDPLLKGHQPLTWTARTQIAL 381
              +K  + EL ++  ++H N+   ++ F    SL +     ++        +   Q+ L
Sbjct: 64  QTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMEL 123
Query: 382 DAAK----------GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTN 431
           D  +          GI+++H    A  +HRD+K SNI++      K+ DFGL     RT 
Sbjct: 124 DHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDATLKILDFGLA----RTA 176
Query: 432 EKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
               + T  V T  Y  PE I    ++                D+++ G ++ E+I G
Sbjct: 177 GTSFMMTPYVVTRYYRAPEVILGMGYK-------------ENVDIWSVGCIMGEMIKG 221

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 32/121 (26%), Positives = 64/121 (52%), Gaps = 4/121 (3%)
Query: 387 IEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGY 446
           +E +H   +   VH D+K +N L+ DG+  K+ DFG+   + + +   ++    VGT  Y
Sbjct: 117 LEAVHTIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIAN-QMQPDTTSVVKDSQVGTVNY 174
Query: 447 LPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKMKSL 506
           +PPE I  K       +   + +++ K+DV++ G +L  +  GK    +  ++ +K+ ++
Sbjct: 175 MPPEAI--KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI 232
Query: 507 I 507
           I
Sbjct: 233 I 233

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/179 (22%), Positives = 73/179 (40%), Gaps = 32/179 (17%)
Query: 379 IALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLAT 438
            +   AKG+ ++        +HRD+   NILL  G   K+ DFGL +  +  N+   +  
Sbjct: 173 FSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLAR--DIKNDSNYVVK 227
Query: 439 RLVGTP-GYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDD 497
                P  ++ PE IF   + F+             +DV+++G+ L EL +   +     
Sbjct: 228 GNARLPVKWMAPESIFNCVYTFE-------------SDVWSYGIFLWELFSLGSSPYPGM 274
Query: 498 SEPTKMKSLI-------------TIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITST 543
              +K   +I               M  + + C + D + RP  + IV ++ + +  ST
Sbjct: 275 PVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISEST 333

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 57/238 (23%), Positives = 97/238 (40%), Gaps = 44/238 (18%)
Query: 276 SERTIIFSLEEIEEAT----NNFDESRIIGRGGFGNV--YFGLLGDREAAIKKM-----R 324
           S+R   F   EI ++T      +   + IG G  G V   +  + +R  AIKK+      
Sbjct: 4   SKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQN 63
Query: 325 SNKSKEFFAELKVLCKIHHINV--FISTFG-NGSLSDHLHDPLLKGHQPLTWTARTQIAL 381
              +K  + EL ++  ++H N+   ++ F    SL +     ++            Q+ L
Sbjct: 64  QTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMEL 123
Query: 382 DAAK----------GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTN 431
           D  +          GI+++H    A  +HRD+K SNI++      K+ DFGL     RT 
Sbjct: 124 DHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA----RTA 176
Query: 432 EKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
               + T  V T  Y  PE I    ++                D+++ G ++ E+I G
Sbjct: 177 GTSFMMTPYVVTRYYRAPEVILGMGYK-------------ENVDIWSVGCIMGEMIKG 221

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 52/224 (23%), Positives = 87/224 (38%), Gaps = 50/224 (22%)
Query: 292 NNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRS------------NKSKEFFAELK- 336
            +FD  R+IGRG +  V    L   DR  A+K ++                K  F +   
Sbjct: 20  QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 79
Query: 337 --VLCKIH-------HINVFISTFGNGSLSDHLHDPL-LKGHQPLTWTARTQIALDAAKG 386
              L  +H        +   I     G L  H+     L       ++A   +AL+    
Sbjct: 80  HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALN---- 135
Query: 387 IEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGY 446
             Y+H+      ++RD+K  N+LLD     K+ D+G+ K   R  +     +   GTP Y
Sbjct: 136 --YLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT---TSXFCGTPNY 187
Query: 447 LPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
           + PE +  + + F               D +A GV++ E++ G+
Sbjct: 188 IAPEILRGEDYGF-------------SVDWWALGVLMFEMMAGR 218

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 57/238 (23%), Positives = 98/238 (41%), Gaps = 44/238 (18%)
Query: 276 SERTIIFSLEEIEEAT----NNFDESRIIGRGGFGNV--YFGLLGDREAAIKKM-----R 324
           S+R   F   EI ++T      +   + IG G  G V   +  + +R  AIKK+      
Sbjct: 4   SKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQN 63
Query: 325 SNKSKEFFAELKVLCKIHHINV--FISTFG-NGSLSDHLHDPLLKGHQPLTWTARTQIAL 381
              +K  + EL ++  ++H N+   ++ F    SL +     ++        +   Q+ L
Sbjct: 64  QTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMEL 123
Query: 382 DAAK----------GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTN 431
           D  +          GI+++H    A  +HRD+K SNI++      K+ DFGL     RT 
Sbjct: 124 DHERMSYLLYQMLVGIKHLHS---AGIIHRDLKPSNIVVKSDATLKILDFGLA----RTA 176
Query: 432 EKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
               + T  V T  Y  PE I    ++                D+++ G ++ E+I G
Sbjct: 177 GTSFMMTPYVVTRYYRAPEVILGMGYK-------------ENVDIWSVGCIMGEMIKG 221

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 57/238 (23%), Positives = 97/238 (40%), Gaps = 44/238 (18%)
Query: 276 SERTIIFSLEEIEEAT----NNFDESRIIGRGGFGNV--YFGLLGDREAAIKKM-----R 324
           S+R   F   EI ++T      +   + IG G  G V   +  + +R  AIKK+      
Sbjct: 5   SKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQN 64
Query: 325 SNKSKEFFAELKVLCKIHHINV--FISTFG-NGSLSDHLHDPLLKGHQPLTWTARTQIAL 381
              +K  + EL ++  ++H N+   ++ F    SL +     ++            Q+ L
Sbjct: 65  QTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMEL 124
Query: 382 DAAK----------GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTN 431
           D  +          GI+++H    A  +HRD+K SNI++      K+ DFGL     RT 
Sbjct: 125 DHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA----RTA 177
Query: 432 EKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
               + T  V T  Y  PE I    ++                D+++ G ++ E+I G
Sbjct: 178 GTSFMMTPYVVTRYYRAPEVILGMGYK-------------ENVDIWSVGCIMGEMIKG 222

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 83/206 (40%), Gaps = 34/206 (16%)
Query: 300 IGRGGFGNVYFGLLGDREA-AIKKMRSNKSKE-----FFAELKVLCKIHHINVF-----I 348
           IG G +G VY       E  A+KK+R  K  E        E+ +L ++ H N+      I
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 349 STFGNGSLS-DHLHDPLLK----GHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDI 403
            T     L  +HL   L K        L         L    GI Y HD    R +HRD+
Sbjct: 70  HTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDL 126
Query: 404 KTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHS 463
           K  N+L++     K+ADFGL +       K    T  V T  Y  P+ +   +       
Sbjct: 127 KPQNLLINREGELKIADFGLARAFGIPVRK---YTHEVVTLWYRAPDVLMGSK------- 176
Query: 464 SVMELQVTTKTDVFAFGVVLAELITG 489
                + +T  D+++ G + AE++ G
Sbjct: 177 -----KYSTTIDIWSVGCIFAEMVNG 197

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 83/206 (40%), Gaps = 34/206 (16%)
Query: 300 IGRGGFGNVYFGLLGDREA-AIKKMRSNKSKE-----FFAELKVLCKIHHINVF-----I 348
           IG G +G VY       E  A+KK+R  K  E        E+ +L ++ H N+      I
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 349 STFGNGSLS-DHLHDPLLK----GHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDI 403
            T     L  +HL   L K        L         L    GI Y HD    R +HRD+
Sbjct: 70  HTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDL 126
Query: 404 KTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHS 463
           K  N+L++     K+ADFGL +       K    T  V T  Y  P+ +   +       
Sbjct: 127 KPQNLLINREGELKIADFGLARAFGIPVRK---YTHEVVTLWYRAPDVLMGSK------- 176
Query: 464 SVMELQVTTKTDVFAFGVVLAELITG 489
                + +T  D+++ G + AE++ G
Sbjct: 177 -----KYSTTIDIWSVGCIFAEMVNG 197

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 54/238 (22%), Positives = 97/238 (40%), Gaps = 57/238 (23%)
Query: 300 IGRGGFGNVYFGLL--GDREAAIKKM--RSNKSKEF-FAELKVLCKIHHINVF------- 347
           IG G  G V    +    +  A+KKM  R  + +E  F E+ ++    H NV        
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 141
Query: 348 --------ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYV 399
                   +     G+L+D      +  H  +       + L   + +  +H       +
Sbjct: 142 VGDELWVVMEFLEGGALTD------IVTHTRMNEEQIAAVCLAVLQALSVLHAQG---VI 192
Query: 400 HRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRF 459
           HRDIK+ +ILL    R K++DFG      + +++      LVGTP ++ PE I       
Sbjct: 193 HRDIKSDSILLTHDGRVKLSDFGFCA---QVSKEVPRRKXLVGTPYWMAPELI------- 242
Query: 460 DMHSSVMELQVTTKTDVFAFGVVLAELITGKRA-----------LIRDDSEPTKMKSL 506
                   L    + D+++ G+++ E++ G+             +IRD+  P ++K+L
Sbjct: 243 ------SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL-PPRLKNL 293

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 32/121 (26%), Positives = 64/121 (52%), Gaps = 4/121 (3%)
Query: 387 IEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGY 446
           +E +H   +   VH D+K +N L+ DG+  K+ DFG+   + + +   ++    VGT  Y
Sbjct: 137 LEAVHTIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIAN-QMQPDXXXVVKDSQVGTVNY 194
Query: 447 LPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKMKSL 506
           +PPE I  K       +   + +++ K+DV++ G +L  +  GK    +  ++ +K+ ++
Sbjct: 195 MPPEAI--KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI 252
Query: 507 I 507
           I
Sbjct: 253 I 253

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 32/121 (26%), Positives = 64/121 (52%), Gaps = 4/121 (3%)
Query: 387 IEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGY 446
           +E +H   +   VH D+K +N L+ DG+  K+ DFG+   + + +   ++    VGT  Y
Sbjct: 137 LEAVHTIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIAN-QMQPDTTSVVKDSQVGTVNY 194
Query: 447 LPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKMKSL 506
           +PPE I  K       +   + +++ K+DV++ G +L  +  GK    +  ++ +K+ ++
Sbjct: 195 MPPEAI--KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI 252
Query: 507 I 507
           I
Sbjct: 253 I 253

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 38/160 (23%), Positives = 76/160 (47%), Gaps = 17/160 (10%)
Query: 387 IEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGY 446
           +E +H   +   VH D+K +N L+ DG+  K+ DFG+   + + +   ++    VGT  Y
Sbjct: 118 LEAVHTIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIAN-QMQPDTTSVVKDSQVGTVNY 175
Query: 447 LPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKMKSL 506
           +PPE I  K       +   + +++ K+DV++ G +L  +  GK    +  ++ +K+ ++
Sbjct: 176 MPPEAI--KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI 233
Query: 507 I-------------TIMAAVAEWCLNEDAVDRPEMRDIVA 533
           I               +  V + CL  D   R  + +++A
Sbjct: 234 IDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 273

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 60/262 (22%), Positives = 103/262 (39%), Gaps = 58/262 (22%)
Query: 284 LEEIEEATNNFDESRIIGRGGFGNVYFGLLGDREA---AIKKMRSNKS------------ 328
           + E+    + +   R I  G +G V  G+  D E    AIK++ +  S            
Sbjct: 14  IAELHAMQSPYTVQRFISSGSYGAVCAGV--DSEGIPVAIKRVFNTVSDGRTVNILSDSF 71
Query: 329 --KEFFAELKVLCKIHHINVFISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIA------ 380
             K    E+++L   HH N+     G   +  H  +P +     +T   RT +A      
Sbjct: 72  LCKRVLREIRLLNHFHHPNIL----GLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQ 127
Query: 381 --LDAAKGIEYIHDHT--------KARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERT 430
             + + + I+Y   H         +A  VHRD+   NILL D     + DF L     R 
Sbjct: 128 RIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLA----RE 183
Query: 431 NEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTK-TDVFAFGVVLAELITG 489
           +  +   T  V    Y  PE              VM+ +  TK  D+++ G V+AE+   
Sbjct: 184 DTADANKTHYVTHRWYRAPEL-------------VMQFKGFTKLVDMWSAGCVMAEMF-N 229
Query: 490 KRALIRDDSEPTKMKSLITIMA 511
           ++AL R  +   ++  ++ ++ 
Sbjct: 230 RKALFRGSTFYNQLNKIVEVVG 251

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/179 (22%), Positives = 72/179 (40%), Gaps = 32/179 (17%)
Query: 379 IALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLAT 438
            +   AKG+ ++        +HRD+   NILL  G   K+ DFGL +     N+   +  
Sbjct: 173 FSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLAR--HIKNDSNYVVK 227
Query: 439 RLVGTP-GYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDD 497
                P  ++ PE IF   + F+             +DV+++G+ L EL +   +     
Sbjct: 228 GNARLPVKWMAPESIFNCVYTFE-------------SDVWSYGIFLWELFSLGSSPYPGM 274
Query: 498 SEPTKMKSLI-------------TIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITST 543
              +K   +I               M  + + C + D + RP  + IV ++ + +  ST
Sbjct: 275 PVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISEST 333

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 91/217 (41%), Gaps = 48/217 (22%)
Query: 299 IIGRGGFGNVYFG--LLGDREAAIKKM---RSNKSKEFFAELKVLCKIHH---------- 343
           ++G+G +G VY G  L      AIK++    S  S+    E+ +   + H          
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 344 -----INVFISTFGNGSLSDHLHD---PLLKGHQPLTWTARTQIALDAAKGIEYIHDHTK 395
                I +F+     GSLS  L     PL    Q + +  +  +     +G++Y+HD+  
Sbjct: 89  SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQIL-----EGLKYLHDN-- 141
Query: 396 ARYVHRDIKTSNILLD--DGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIF 453
            + VHRDIK  N+L++   G+  K++DFG  K     N          GT  Y+ PE I 
Sbjct: 142 -QIVHRDIKGDNVLINTYSGV-LKISDFGTSKRLAGINP---CTETFTGTLQYMAPE-II 195
Query: 454 VKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
            K  R                D+++ G  + E+ TGK
Sbjct: 196 DKGPR----------GYGKAADIWSLGCTIIEMATGK 222

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 57/238 (23%), Positives = 97/238 (40%), Gaps = 44/238 (18%)
Query: 276 SERTIIFSLEEIEEAT----NNFDESRIIGRGGFGNV--YFGLLGDREAAIKKM-----R 324
           S+R   F   EI ++T      +   + IG G  G V   +  + +R  AIKK+      
Sbjct: 4   SKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQN 63
Query: 325 SNKSKEFFAELKVLCKIHHINV--FISTFG-NGSLSDHLHDPLLKGHQPLTWTARTQIAL 381
              +K  + EL ++  ++H N+   ++ F    SL +     ++            Q+ L
Sbjct: 64  QTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMEL 123
Query: 382 DAAK----------GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTN 431
           D  +          GI+++H    A  +HRD+K SNI++      K+ DFGL     RT 
Sbjct: 124 DHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA----RTA 176
Query: 432 EKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
               + T  V T  Y  PE I    ++                D+++ G ++ E+I G
Sbjct: 177 GTSFMMTPYVVTRYYRAPEVILGMGYK-------------ENVDIWSVGCIMGEMIKG 221

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 33/94 (35%), Positives = 46/94 (48%), Gaps = 19/94 (20%)
Query: 399 VHRDIKTSNILLDDGLRA---KVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVK 455
           VHRD+K  N+LL   L+    K+ADFGL  +E    ++        GTPGYL PE +   
Sbjct: 143 VHRDLKPENLLLASKLKGAAVKLADFGLA-IEVEGEQQAWFG--FAGTPGYLSPEVL--- 196
Query: 456 RFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
             R D +            D++A GV+L  L+ G
Sbjct: 197 --RKDPYGK--------PVDLWACGVILYILLVG 220

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 30/109 (27%), Positives = 55/109 (50%), Gaps = 15/109 (13%)
Query: 378 QIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLA 437
           +IA+   K +E  H H+K   +HRD+K SN+L++   + K+ DFG+         K++ A
Sbjct: 113 KIAVSIVKALE--HLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDA 170
Query: 438 TRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAEL 486
               G   Y+ PE I         +  + +   + K+D+++ G+ + EL
Sbjct: 171 ----GCKPYMAPERI---------NPELNQKGYSVKSDIWSLGITMIEL 206

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 60/262 (22%), Positives = 103/262 (39%), Gaps = 58/262 (22%)
Query: 284 LEEIEEATNNFDESRIIGRGGFGNVYFGLLGDREA---AIKKMRSNKS------------ 328
           + E+    + +   R I  G +G V  G+  D E    AIK++ +  S            
Sbjct: 14  IAELHAMQSPYTVQRFISSGSYGAVCAGV--DSEGIPVAIKRVFNTVSDGRTVNILSDSF 71
Query: 329 --KEFFAELKVLCKIHHINVFISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIA------ 380
             K    E+++L   HH N+     G   +  H  +P +     +T   RT +A      
Sbjct: 72  LCKRVLREIRLLNHFHHPNIL----GLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQ 127
Query: 381 --LDAAKGIEYIHDHT--------KARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERT 430
             + + + I+Y   H         +A  VHRD+   NILL D     + DF L     R 
Sbjct: 128 RIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLA----RE 183
Query: 431 NEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTK-TDVFAFGVVLAELITG 489
           +  +   T  V    Y  PE              VM+ +  TK  D+++ G V+AE+   
Sbjct: 184 DTADANKTHYVTHRWYRAPEL-------------VMQFKGFTKLVDMWSAGCVMAEMF-N 229
Query: 490 KRALIRDDSEPTKMKSLITIMA 511
           ++AL R  +   ++  ++ ++ 
Sbjct: 230 RKALFRGSTFYNQLNKIVEVVG 251

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 54/238 (22%), Positives = 97/238 (40%), Gaps = 57/238 (23%)
Query: 300 IGRGGFGNVYFGLL--GDREAAIKKM--RSNKSKEF-FAELKVLCKIHHINVF------- 347
           IG G  G V    +    +  A+KKM  R  + +E  F E+ ++    H NV        
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 218
Query: 348 --------ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYV 399
                   +     G+L+D      +  H  +       + L   + +  +H       +
Sbjct: 219 VGDELWVVMEFLEGGALTD------IVTHTRMNEEQIAAVCLAVLQALSVLHAQG---VI 269
Query: 400 HRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRF 459
           HRDIK+ +ILL    R K++DFG      + +++      LVGTP ++ PE I       
Sbjct: 270 HRDIKSDSILLTHDGRVKLSDFGFCA---QVSKEVPRRKXLVGTPYWMAPELI------- 319
Query: 460 DMHSSVMELQVTTKTDVFAFGVVLAELITGKRA-----------LIRDDSEPTKMKSL 506
                   L    + D+++ G+++ E++ G+             +IRD+  P ++K+L
Sbjct: 320 ------SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL-PPRLKNL 370

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 52/224 (23%), Positives = 87/224 (38%), Gaps = 50/224 (22%)
Query: 292 NNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRS------------NKSKEFFAELK- 336
            +FD  R+IGRG +  V    L   DR  A+K ++                K  F +   
Sbjct: 5   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 64
Query: 337 --VLCKIH-------HINVFISTFGNGSLSDHLHDPL-LKGHQPLTWTARTQIALDAAKG 386
              L  +H        +   I     G L  H+     L       ++A   +AL+    
Sbjct: 65  HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALN---- 120
Query: 387 IEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGY 446
             Y+H+      ++RD+K  N+LLD     K+ D+G+ K   R  +     +   GTP Y
Sbjct: 121 --YLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT---TSXFCGTPNY 172
Query: 447 LPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
           + PE +  + + F               D +A GV++ E++ G+
Sbjct: 173 IAPEILRGEDYGF-------------SVDWWALGVLMFEMMAGR 203

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 86/215 (40%), Gaps = 49/215 (22%)
Query: 298 RIIGRGGFGNVYF---GLLGDREA--AIKKMRSNKSKEFFAELKVLCKIHHINVF----- 347
            ++G G F  V+     L G   A   IKK  + +      E+ VL KI H N+      
Sbjct: 15  EVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDI 74
Query: 348 ----------ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKAR 397
                     +     G L D +   L +G    T    + +       ++Y+H++    
Sbjct: 75  YESTTHYYLVMQLVSGGELFDRI---LERG--VYTEKDASLVIQQVLSAVKYLHENG--- 126
Query: 398 YVHRDIKTSNILL---DDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFV 454
            VHRD+K  N+L    ++  +  + DFGL K+E+       + +   GTPGY+ PE +  
Sbjct: 127 IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-----IMSTACGTPGYVAPEVLAQ 181
Query: 455 KRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
           K +             +   D ++ GV+   L+ G
Sbjct: 182 KPY-------------SKAVDCWSIGVITYILLCG 203

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 83/206 (40%), Gaps = 34/206 (16%)
Query: 300 IGRGGFGNVYFGLLGDREA-AIKKMRSNKSKE-----FFAELKVLCKIHHINVF-----I 348
           IG G +G VY       E  A+KK+R  K  E        E+ +L ++ H N+      I
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 349 STFGNGSLS-DHLHDPLLK----GHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDI 403
            T     L  +HL   L K        L         L    GI Y HD    R +HRD+
Sbjct: 70  HTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDL 126
Query: 404 KTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHS 463
           K  N+L++     K+ADFGL +       K    T  + T  Y  P+ +   +       
Sbjct: 127 KPQNLLINREGELKIADFGLARAFGIPVRK---YTHEIVTLWYRAPDVLMGSK------- 176
Query: 464 SVMELQVTTKTDVFAFGVVLAELITG 489
                + +T  D+++ G + AE++ G
Sbjct: 177 -----KYSTTIDIWSVGCIFAEMVNG 197

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 61/263 (23%), Positives = 105/263 (39%), Gaps = 51/263 (19%)
Query: 299 IIGRGGFGNVYFGLL--GDREAAIKKMRSNKSKEFFAELKVLCKIHHINVFISTFGNG-- 354
           ++G GGFG+VY G+    +   AIK +  ++  ++  EL    ++    V +    +G  
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDW-GELPNGTRVPMEVVLLKKVSSGFS 69
Query: 355 ---SLSDHLHDP-----LLKGHQPLT-----WTARTQIALDAAKG-----IEYIHDHTKA 396
               L D    P     +L+  +P+       T R  +  + A+      +E +      
Sbjct: 70  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNX 129
Query: 397 RYVHRDIKTSNILLD-DGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVK 455
             +HRDIK  NIL+D +    K+ DFG   L      K+ + T   GT  Y PPE+I   
Sbjct: 130 GVLHRDIKDENILIDLNRGELKLIDFGSGAL-----LKDTVYTDFDGTRVYSPPEWIRYH 184
Query: 456 RFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKMKSLITIMAAVA- 514
           R+                  V++ G++L +++ G      D+     ++  +     V+ 
Sbjct: 185 RYH------------GRSAAVWSLGILLYDMVCGDIPFEHDEE---IIRGQVFFRQRVSX 229
Query: 515 ------EWCLNEDAVDRPEMRDI 531
                  WCL     DRP   +I
Sbjct: 230 ECQHLIRWCLALRPSDRPTFEEI 252

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 54/229 (23%), Positives = 89/229 (38%), Gaps = 49/229 (21%)
Query: 285 EEIEEATNNFDESRIIGRGGFGNVYF------GLLGDREAAIKKMRSNKSKEFFAELKVL 338
           ++ E+    F+    +G G F  V        G L   +   KK    K      E+ VL
Sbjct: 15  KQAEDIKKIFEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVL 74
Query: 339 CKIHHINVF---------------ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDA 383
            KI H N+                +     G L D + +      +  +   R    LDA
Sbjct: 75  RKIKHENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQ--VLDA 132
Query: 384 AKGIEYIHDHTKARYVHRDIKTSNILL---DDGLRAKVADFGLVKLEERTNEKEMLATRL 440
              + Y+H   +   VHRD+K  N+L    D+  +  ++DFGL K+E + +    + +  
Sbjct: 133 ---VYYLH---RMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGD----VMSTA 182
Query: 441 VGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
            GTPGY+ PE +  K +             +   D ++ GV+   L+ G
Sbjct: 183 CGTPGYVAPEVLAQKPY-------------SKAVDCWSIGVIAYILLCG 218

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 32/121 (26%), Positives = 64/121 (52%), Gaps = 4/121 (3%)
Query: 387 IEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGY 446
           +E +H   +   VH D+K +N L+ DG+  K+ DFG+   + + +   ++    VGT  Y
Sbjct: 165 LEAVHTIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIAN-QMQPDTTSVVKDSQVGTVNY 222
Query: 447 LPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKMKSL 506
           +PPE I  K       +   + +++ K+DV++ G +L  +  GK    +  ++ +K+ ++
Sbjct: 223 MPPEAI--KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI 280
Query: 507 I 507
           I
Sbjct: 281 I 281

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 30/118 (25%), Positives = 55/118 (46%), Gaps = 25/118 (21%)
Query: 373 WTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNE 432
           ++A   +AL+      Y+H+      ++RD+K  N+LLD     K+ D+G+ K   R  +
Sbjct: 158 YSAEISLALN------YLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD 208
Query: 433 KEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
                +   GTP Y+ PE +  + + F               D +A GV++ E++ G+
Sbjct: 209 T---TSTFCGTPNYIAPEILRGEDYGF-------------SVDWWALGVLMFEMMAGR 250

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 47/111 (42%), Gaps = 24/111 (21%)
Query: 387 IEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK-LEERTNEKEMLATRLVGTPG 445
            EY+H       ++RD+K  N+++D     KV DFG  K ++ RT         L GTP 
Sbjct: 155 FEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRT-------WXLCGTPE 204
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRD 496
           YL PE I  K +                 D +A GV++ E+  G      D
Sbjct: 205 YLAPEIILSKGY-------------NKAVDWWALGVLIYEMAAGYPPFFAD 242

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 90/220 (40%), Gaps = 51/220 (23%)
Query: 300 IGRGGFGNVYFGLLGD--REAAIKKMRSNKSKEFFA-----ELKVLCKIHHINV------ 346
           IG+G FG V+        ++ A+KK+     KE F      E+K+L  + H NV      
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 347 ----------------FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYI 390
                            +  F    L+  L + L+K     T +   ++      G+ YI
Sbjct: 86  CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK----FTLSEIKRVMQMLLNGLYYI 141
Query: 391 HDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEE--RTNEKEMLATRLVGTPGYLP 448
           H   + + +HRD+K +N+L+      K+ADFGL +     + ++      R+V T  Y P
Sbjct: 142 H---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV-TLWYRP 197
Query: 449 PEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
           PE +  +R                  D++  G ++AE+ T
Sbjct: 198 PELLLGER------------DYGPPIDLWGAGCIMAEMWT 225

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 47/111 (42%), Gaps = 24/111 (21%)
Query: 387 IEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK-LEERTNEKEMLATRLVGTPG 445
            EY+H       ++RD+K  N+++D     KV DFG  K ++ RT         L GTP 
Sbjct: 155 FEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRT-------WXLCGTPE 204
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRD 496
           YL PE I  K +                 D +A GV++ E+  G      D
Sbjct: 205 YLAPEIILSKGY-------------NKAVDWWALGVLIYEMAAGYPPFFAD 242

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 47/111 (42%), Gaps = 24/111 (21%)
Query: 387 IEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK-LEERTNEKEMLATRLVGTPG 445
            EY+H       ++RD+K  N+++D     KV DFG  K ++ RT         L GTP 
Sbjct: 154 FEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRT-------WXLCGTPE 203
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRD 496
           YL PE I  K +                 D +A GV++ E+  G      D
Sbjct: 204 YLAPEIILSKGY-------------NKAVDWWALGVLIYEMAAGYPPFFAD 241

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 32/121 (26%), Positives = 64/121 (52%), Gaps = 4/121 (3%)
Query: 387 IEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGY 446
           +E +H   +   VH D+K +N L+ DG+  K+ DFG+   + + +   ++    VGT  Y
Sbjct: 165 LEAVHTIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIAN-QMQPDTTSVVKDSQVGTVNY 222
Query: 447 LPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKMKSL 506
           +PPE I  K       +   + +++ K+DV++ G +L  +  GK    +  ++ +K+ ++
Sbjct: 223 MPPEAI--KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI 280
Query: 507 I 507
           I
Sbjct: 281 I 281

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 47/111 (42%), Gaps = 24/111 (21%)
Query: 387 IEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK-LEERTNEKEMLATRLVGTPG 445
            EY+H       ++RD+K  N+++D     KV DFG  K ++ RT         L GTP 
Sbjct: 155 FEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRT-------WXLCGTPE 204
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRD 496
           YL PE I  K +                 D +A GV++ E+  G      D
Sbjct: 205 YLAPEIILSKGY-------------NKAVDWWALGVLIYEMAAGYPPFFAD 242

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 47/111 (42%), Gaps = 24/111 (21%)
Query: 387 IEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK-LEERTNEKEMLATRLVGTPG 445
            EY+H       ++RD+K  N+++D     KV DFG  K ++ RT         L GTP 
Sbjct: 155 FEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRT-------WXLCGTPE 204
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRD 496
           YL PE I  K +                 D +A GV++ E+  G      D
Sbjct: 205 YLAPEIILSKGY-------------NKAVDWWALGVLIYEMAAGYPPFFAD 242

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 48/111 (43%), Gaps = 24/111 (21%)
Query: 387 IEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK-LEERTNEKEMLATRLVGTPG 445
            EY+H       ++RD+K  N+++D     +V DFGL K ++ RT         L GTP 
Sbjct: 154 FEYLHS---LDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVKGRT-------WXLCGTPE 203
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRD 496
           YL PE I  K +                 D +A GV++ E+  G      D
Sbjct: 204 YLAPEIILSKGY-------------NKAVDWWALGVLIYEMAAGYPPFFAD 241

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 47/111 (42%), Gaps = 24/111 (21%)
Query: 387 IEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK-LEERTNEKEMLATRLVGTPG 445
            EY+H       ++RD+K  N+++D     KV DFG  K ++ RT         L GTP 
Sbjct: 154 FEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRT-------WXLCGTPE 203
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRD 496
           YL PE I  K +                 D +A GV++ E+  G      D
Sbjct: 204 YLAPEIILSKGY-------------NKAVDWWALGVLIYEMAAGYPPFFAD 241

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 53/231 (22%), Positives = 95/231 (41%), Gaps = 51/231 (22%)
Query: 289 EATNNFDESRIIGRGGFGNVYFGLLGD--REAAIKKMRSNKSKEFFA-----ELKVLCKI 341
           +  + +++   IG+G FG V+        ++ A+KK+     KE F      E+K+L  +
Sbjct: 15  DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL 74
Query: 342 HHINV----------------------FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQI 379
            H NV                       +  F    L+  L + L+K     T +   ++
Sbjct: 75  KHENVVNLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVK----FTLSEIKRV 130
Query: 380 ALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEE--RTNEKEMLA 437
                 G+ YIH   + + +HRD+K +N+L+      K+ADFGL +     + ++     
Sbjct: 131 MQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYX 187
Query: 438 TRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
            R+V T  Y PPE +  +R                  D++  G ++AE+ T
Sbjct: 188 NRVV-TLWYRPPELLLGER------------DYGPPIDLWGAGCIMAEMWT 225

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 96/230 (41%), Gaps = 51/230 (22%)
Query: 289 EATNNFDESR---IIGRGGFGNVYFG--LLGDREAAIKKM---RSNKSKEFFAELKVLCK 340
           E    +DE+    ++G+G +G VY G  L      AIK++    S  S+    E+ +   
Sbjct: 2   EYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKH 61
Query: 341 IHH---------------INVFISTFGNGSLSDHLHD---PLLKGHQPLTWTARTQIALD 382
           + H               I +F+     GSLS  L     PL    Q + +  +  +   
Sbjct: 62  LKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQIL--- 118
Query: 383 AAKGIEYIHDHTKARYVHRDIKTSNILLD--DGLRAKVADFGLVKLEERTNEKEMLATRL 440
             +G++Y+HD+   + VHRDIK  N+L++   G+  K++DFG  K     N         
Sbjct: 119 --EGLKYLHDN---QIVHRDIKGDNVLINTYSGV-LKISDFGTSKRLAGINP---CTETF 169
Query: 441 VGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
            GT  Y+ PE I  K  R                D+++ G  + E+ TGK
Sbjct: 170 TGTLQYMAPE-IIDKGPR----------GYGKAADIWSLGCTIIEMATGK 208

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 90/227 (39%), Gaps = 59/227 (25%)
Query: 294 FDESRIIGRGGFGNVYFG-LLGDREAAIKKMRSNKSKEFFAELKVLCKIHHINVF---IS 349
           +   ++IG G FG V+   L+   E AIKK+  +K  +   EL+++  + H NV      
Sbjct: 42  YTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKN-RELQIMRIVKHPNVVDLKAF 100
Query: 350 TFGNGSLSDHLHDPLLKGHQPLT-WTARTQIA---------------LDAAKGIEYIHDH 393
            + NG   D +   L+  + P T + A    A                   + + YIH  
Sbjct: 101 FYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS- 159
Query: 394 TKARYVHRDIKTSNILLD--DGLRAKVADFGLVKLEERTNEKEMLATRLVGTPG------ 445
                 HRDIK  N+LLD   G+  K+ DFG  K+             + G P       
Sbjct: 160 --IGICHRDIKPQNLLLDPPSGV-LKLIDFGSAKI------------LIAGEPNVSXICS 204
Query: 446 --YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
             Y  PE IF                 TT  D+++ G V+AEL+ G+
Sbjct: 205 RYYRAPELIF------------GATNYTTNIDIWSTGCVMAELMQGQ 239

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 44/211 (20%), Positives = 89/211 (42%), Gaps = 42/211 (19%)
Query: 300 IGRGGFGNVYFGLLGDR----EAAIKKMRSNKSK----EFFAELKVL------------- 338
           +G G FG+V  G+   R    + AIK ++    K    E   E +++             
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 339 -CKIHHINVFISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKAR 397
            C+   + + +   G G L    H  L+   + +  +   ++    + G++Y+ +     
Sbjct: 78  VCQAEALMLVMEMAGGGPL----HKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--- 130
Query: 398 YVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRF 457
           +VHRD+   N+LL +   AK++DFGL K     +      +       +  PE I  ++F
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 190
Query: 458 RFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
                        ++++DV+++GV + E ++
Sbjct: 191 -------------SSRSDVWSYGVTMWEALS 208

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 57/238 (23%), Positives = 97/238 (40%), Gaps = 44/238 (18%)
Query: 276 SERTIIFSLEEIEEAT----NNFDESRIIGRGGFGNV--YFGLLGDREAAIKKM-----R 324
           S+R   F   EI ++T      +   + IG G  G V   +  + +R  AIKK+      
Sbjct: 4   SKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQN 63
Query: 325 SNKSKEFFAELKVLCKIHHINV--FISTFG-NGSLSDHLHDPLLKGHQPLTWTARTQIAL 381
              +K  + EL ++  ++H N+   ++ F    SL +     ++            Q+ L
Sbjct: 64  QTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMEL 123
Query: 382 DAAK----------GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTN 431
           D  +          GI+++H    A  +HRD+K SNI++      K+ DFGL     RT 
Sbjct: 124 DHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA----RTA 176
Query: 432 EKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
               + T  V T  Y  PE I    ++                D+++ G ++ E+I G
Sbjct: 177 GTSFMMTPEVVTRYYRAPEVILGMGYK-------------ENVDIWSVGCIMGEMIKG 221

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 53/231 (22%), Positives = 95/231 (41%), Gaps = 51/231 (22%)
Query: 289 EATNNFDESRIIGRGGFGNVYFGLLGD--REAAIKKMRSNKSKEFFA-----ELKVLCKI 341
           +  + +++   IG+G FG V+        ++ A+KK+     KE F      E+K+L  +
Sbjct: 14  DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL 73
Query: 342 HHINV----------------------FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQI 379
            H NV                       +  F    L+  L + L+K     T +   ++
Sbjct: 74  KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK----FTLSEIKRV 129
Query: 380 ALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEE--RTNEKEMLA 437
                 G+ YIH   + + +HRD+K +N+L+      K+ADFGL +     + ++     
Sbjct: 130 MQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYX 186
Query: 438 TRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
            R+V T  Y PPE +  +R                  D++  G ++AE+ T
Sbjct: 187 NRVV-TLWYRPPELLLGER------------DYGPPIDLWGAGCIMAEMWT 224

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 53/231 (22%), Positives = 95/231 (41%), Gaps = 51/231 (22%)
Query: 289 EATNNFDESRIIGRGGFGNVYFGLLGD--REAAIKKMRSNKSKEFFA-----ELKVLCKI 341
           +  + +++   IG+G FG V+        ++ A+KK+     KE F      E+K+L  +
Sbjct: 15  DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL 74
Query: 342 HHINV----------------------FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQI 379
            H NV                       +  F    L+  L + L+K     T +   ++
Sbjct: 75  KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK----FTLSEIKRV 130
Query: 380 ALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEE--RTNEKEMLA 437
                 G+ YIH   + + +HRD+K +N+L+      K+ADFGL +     + ++     
Sbjct: 131 MQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYX 187
Query: 438 TRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
            R+V T  Y PPE +  +R                  D++  G ++AE+ T
Sbjct: 188 NRVV-TLWYRPPELLLGER------------DYGPPIDLWGAGCIMAEMWT 225

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 33/112 (29%), Positives = 48/112 (42%), Gaps = 24/112 (21%)
Query: 387 IEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK-LEERTNEKEMLATRLVGTPG 445
            EY+H       ++RD+K  N+L+D     +V DFG  K ++ RT         L GTP 
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-------WXLCGTPE 203
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDD 497
           YL PE I  K +                 D +A GV++ E+  G      D+
Sbjct: 204 YLAPEIILSKGY-------------NKAVDWWALGVLIYEMAAGYPPFFADE 242

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 32/134 (23%), Positives = 58/134 (43%), Gaps = 24/134 (17%)
Query: 385 KGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK---LEERTNEKEMLATRLV 441
           KG+ + H       +HRD+K  N+L++     K+ADFGL +   +  R    E++     
Sbjct: 112 KGLGFCHSRN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVV----- 163
Query: 442 GTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPT 501
            T  Y PP+ +F  +              +T  D+++ G + AEL    R L   +    
Sbjct: 164 -TLWYRPPDVLFGAKL------------YSTSIDMWSAGCIFAELANAARPLFPGNDVDD 210
Query: 502 KMKSLITIMAAVAE 515
           ++K +  ++    E
Sbjct: 211 QLKRIFRLLGTPTE 224

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 48/111 (43%), Gaps = 24/111 (21%)
Query: 387 IEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK-LEERTNEKEMLATRLVGTPG 445
            EY+H       ++RD+K  N+L+D+    +V DFG  K ++ RT         L GTP 
Sbjct: 141 FEYLHS---LDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVKGRT-------WXLCGTPE 190
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRD 496
           YL PE I  K +                 D +A GV++ E+  G      D
Sbjct: 191 YLAPEIILSKGY-------------NKAVDWWALGVLIYEMAAGYPPFFAD 228

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 52/224 (23%), Positives = 87/224 (38%), Gaps = 50/224 (22%)
Query: 292 NNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRS------------NKSKEFFAELK- 336
            +FD  R+IGRG +  V    L   DR  A+K ++                K  F +   
Sbjct: 9   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 68
Query: 337 --VLCKIH-------HINVFISTFGNGSLSDHLHDPL-LKGHQPLTWTARTQIALDAAKG 386
              L  +H        +   I     G L  H+     L       ++A   +AL+    
Sbjct: 69  HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALN---- 124
Query: 387 IEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGY 446
             Y+H+      ++RD+K  N+LLD     K+ D+G+ K   R  +     +   GTP Y
Sbjct: 125 --YLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT---TSXFCGTPNY 176
Query: 447 LPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
           + PE +  + + F               D +A GV++ E++ G+
Sbjct: 177 IAPEILRGEDYGF-------------SVDWWALGVLMFEMMAGR 207

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 39/150 (26%), Positives = 63/150 (42%), Gaps = 23/150 (15%)
Query: 386 GIEYIHDHTKARYVHRDIKTSNILLDD--GLRAKVADFGLVKLEERTNEKEMLATRLVGT 443
           G+ Y H     +  HRD+K  N LLD     R K+ DFG  K     ++ +      VGT
Sbjct: 126 GVSYCH---AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK----STVGT 178
Query: 444 PGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKM 503
           P Y+ PE +  K +   +             DV++ GV L  ++ G      D  EP   
Sbjct: 179 PAYIAPEVLLKKEYDGKV------------ADVWSCGVTLYVMLVGAYPF-EDPEEPKNF 225
Query: 504 KSLITIMAAVAEWCLNEDAVDRPEMRDIVA 533
           +  I  +  V ++ + +     PE R +++
Sbjct: 226 RKTIHRILNV-QYAIPDYVHISPECRHLIS 254

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 39/150 (26%), Positives = 63/150 (42%), Gaps = 23/150 (15%)
Query: 386 GIEYIHDHTKARYVHRDIKTSNILLD--DGLRAKVADFGLVKLEERTNEKEMLATRLVGT 443
           G+ Y H     +  HRD+K  N LLD     R K+ DFG  K     ++ +      VGT
Sbjct: 127 GVSYCH---AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK----STVGT 179
Query: 444 PGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKM 503
           P Y+ PE +  K +   +             DV++ GV L  ++ G      D  EP   
Sbjct: 180 PAYIAPEVLLKKEYDGKV------------ADVWSCGVTLYVMLVGAYPF-EDPEEPKNF 226
Query: 504 KSLITIMAAVAEWCLNEDAVDRPEMRDIVA 533
           +  I  +  V ++ + +     PE R +++
Sbjct: 227 RKTIHRILNV-QYAIPDYVHISPECRHLIS 255

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 47/111 (42%), Gaps = 24/111 (21%)
Query: 387 IEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK-LEERTNEKEMLATRLVGTPG 445
            EY+H       ++RD+K  N+L+D     +V DFG  K ++ RT         L GTP 
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-------WXLAGTPE 203
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRD 496
           YL PE I  K +                 D +A GV++ E+  G      D
Sbjct: 204 YLAPEIILSKGY-------------NKAVDWWALGVLIYEMAAGYPPFFAD 241

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 33/131 (25%), Positives = 59/131 (45%), Gaps = 21/131 (16%)
Query: 385 KGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP 444
           +G++++H +     VHRD+K  NIL+  G   K+ADFGL     R    +M    +V T 
Sbjct: 123 RGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLA----RIYSYQMALAPVVVTL 175
Query: 445 GYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKMK 504
            Y  PE +    +              T  D+++ G + AE+   ++ L   +SE  ++ 
Sbjct: 176 WYRAPEVLLQSTY-------------ATPVDMWSVGCIFAEMFR-RKPLFCGNSEADQLG 221
Query: 505 SLITIMAAVAE 515
            +  ++    E
Sbjct: 222 KIFDLIGLPPE 232

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 47/111 (42%), Gaps = 24/111 (21%)
Query: 387 IEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK-LEERTNEKEMLATRLVGTPG 445
            EY+H       ++RD+K  N+L+D     +V DFG  K ++ RT         L GTP 
Sbjct: 175 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-------WXLCGTPE 224
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRD 496
           YL PE I  K +                 D +A GV++ E+  G      D
Sbjct: 225 YLAPEIILSKGY-------------NKAVDWWALGVLIYEMAAGYPPFFAD 262

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 47/111 (42%), Gaps = 24/111 (21%)
Query: 387 IEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK-LEERTNEKEMLATRLVGTPG 445
            EY+H       ++RD+K  N+L+D     +V DFG  K ++ RT         L GTP 
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-------WXLCGTPE 203
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRD 496
           YL PE I  K +                 D +A GV++ E+  G      D
Sbjct: 204 YLAPEIILSKGY-------------NKAVDWWALGVLIYEMAAGYPPFFAD 241

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 47/111 (42%), Gaps = 24/111 (21%)
Query: 387 IEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK-LEERTNEKEMLATRLVGTPG 445
            EY+H       ++RD+K  N+L+D     +V DFG  K ++ RT         L GTP 
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-------WXLCGTPE 203
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRD 496
           YL PE I  K +                 D +A GV++ E+  G      D
Sbjct: 204 YLAPEIILSKGY-------------NKAVDWWALGVLIYEMAAGYPPFFAD 241

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 47/111 (42%), Gaps = 24/111 (21%)
Query: 387 IEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK-LEERTNEKEMLATRLVGTPG 445
            EY+H       ++RD+K  N+L+D     +V DFG  K ++ RT         L GTP 
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-------WXLCGTPE 203
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRD 496
           YL PE I  K +                 D +A GV++ E+  G      D
Sbjct: 204 YLAPEIILSKGY-------------NKAVDWWALGVLIYEMAAGYPPFFAD 241

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 47/111 (42%), Gaps = 24/111 (21%)
Query: 387 IEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK-LEERTNEKEMLATRLVGTPG 445
            EY+H       ++RD+K  N+L+D     +V DFG  K ++ RT         L GTP 
Sbjct: 155 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-------WXLCGTPE 204
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRD 496
           YL PE I  K +                 D +A GV++ E+  G      D
Sbjct: 205 YLAPEIILSKGY-------------NKAVDWWALGVLIYEMAAGYPPFFAD 242

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 47/111 (42%), Gaps = 24/111 (21%)
Query: 387 IEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK-LEERTNEKEMLATRLVGTPG 445
            EY+H       ++RD+K  N+L+D     +V DFG  K ++ RT         L GTP 
Sbjct: 175 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-------WXLCGTPE 224
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRD 496
           YL PE I  K +                 D +A GV++ E+  G      D
Sbjct: 225 YLAPEIILSKGY-------------NKAVDWWALGVLIYEMAAGYPPFFAD 262

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 47/111 (42%), Gaps = 24/111 (21%)
Query: 387 IEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK-LEERTNEKEMLATRLVGTPG 445
            EY+H       ++RD+K  N+L+D     +V DFG  K ++ RT         L GTP 
Sbjct: 155 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-------WXLCGTPE 204
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRD 496
           YL PE I  K +                 D +A GV++ E+  G      D
Sbjct: 205 YLAPEIILSKGY-------------NKAVDWWALGVLIYEMAAGYPPFFAD 242

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 47/111 (42%), Gaps = 24/111 (21%)
Query: 387 IEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK-LEERTNEKEMLATRLVGTPG 445
            EY+H       ++RD+K  N+L+D     +V DFG  K ++ RT         L GTP 
Sbjct: 155 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-------WXLCGTPE 204
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRD 496
           YL PE I  K +                 D +A GV++ E+  G      D
Sbjct: 205 YLAPEIILSKGY-------------NKAVDWWALGVLIYEMAAGYPPFFAD 242

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 47/111 (42%), Gaps = 24/111 (21%)
Query: 387 IEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK-LEERTNEKEMLATRLVGTPG 445
            EY+H       ++RD+K  N+L+D     +V DFG  K ++ RT         L GTP 
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-------WXLCGTPE 203
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRD 496
           YL PE I  K +                 D +A GV++ E+  G      D
Sbjct: 204 YLAPEIILSKGY-------------NKAVDWWALGVLIYEMAAGYPPFFAD 241

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 47/111 (42%), Gaps = 24/111 (21%)
Query: 387 IEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK-LEERTNEKEMLATRLVGTPG 445
            EY+H       ++RD+K  N+L+D     +V DFG  K ++ RT         L GTP 
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-------WXLCGTPE 203
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRD 496
           YL PE I  K +                 D +A GV++ E+  G      D
Sbjct: 204 YLAPEIILSKGY-------------NKAVDWWALGVLIYEMAAGYPPFFAD 241

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 47/111 (42%), Gaps = 24/111 (21%)
Query: 387 IEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK-LEERTNEKEMLATRLVGTPG 445
            EY+H       ++RD+K  N+L+D     +V DFG  K ++ RT         L GTP 
Sbjct: 155 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-------WXLCGTPE 204
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRD 496
           YL PE I  K +                 D +A GV++ E+  G      D
Sbjct: 205 YLAPEIILSKGY-------------NKAVDWWALGVLIYEMAAGYPPFFAD 242

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 47/111 (42%), Gaps = 24/111 (21%)
Query: 387 IEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK-LEERTNEKEMLATRLVGTPG 445
            EY+H       ++RD+K  N+L+D     +V DFG  K ++ RT         L GTP 
Sbjct: 155 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-------WXLCGTPE 204
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRD 496
           YL PE I  K +                 D +A GV++ E+  G      D
Sbjct: 205 YLAPEIILSKGY-------------NKAVDWWALGVLIYEMAAGYPPFFAD 242

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 47/111 (42%), Gaps = 24/111 (21%)
Query: 387 IEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK-LEERTNEKEMLATRLVGTPG 445
            EY+H       ++RD+K  N+L+D     +V DFG  K ++ RT         L GTP 
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-------WXLCGTPE 203
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRD 496
           YL PE I  K +                 D +A GV++ E+  G      D
Sbjct: 204 YLAPEIILSKGY-------------NKAVDWWALGVLIYEMAAGYPPFFAD 241

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 47/111 (42%), Gaps = 24/111 (21%)
Query: 387 IEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK-LEERTNEKEMLATRLVGTPG 445
            EY+H       ++RD+K  N+L+D     +V DFG  K ++ RT         L GTP 
Sbjct: 147 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-------WXLCGTPE 196
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRD 496
           YL PE I  K +                 D +A GV++ E+  G      D
Sbjct: 197 YLAPEIILSKGY-------------NKAVDWWALGVLIYEMAAGYPPFFAD 234

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 47/111 (42%), Gaps = 24/111 (21%)
Query: 387 IEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK-LEERTNEKEMLATRLVGTPG 445
            EY+H       ++RD+K  N+L+D     +V DFG  K ++ RT         L GTP 
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-------WXLCGTPE 203
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRD 496
           YL PE I  K +                 D +A GV++ E+  G      D
Sbjct: 204 YLAPEIILSKGY-------------NKAVDWWALGVLIYEMAAGYPPFFAD 241

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 47/111 (42%), Gaps = 24/111 (21%)
Query: 387 IEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK-LEERTNEKEMLATRLVGTPG 445
            EY+H       ++RD+K  N+L+D     +V DFG  K ++ RT         L GTP 
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-------WXLCGTPE 203
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRD 496
           YL PE I  K +                 D +A GV++ E+  G      D
Sbjct: 204 YLAPEIILSKGY-------------NKAVDWWALGVLIYEMAAGYPPFFAD 241

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 47/111 (42%), Gaps = 24/111 (21%)
Query: 387 IEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK-LEERTNEKEMLATRLVGTPG 445
            EY+H       ++RD+K  N+L+D     +V DFG  K ++ RT         L GTP 
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-------WXLCGTPE 203
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRD 496
           YL PE I  K +                 D +A GV++ E+  G      D
Sbjct: 204 YLAPEIILSKGY-------------NKAVDWWALGVLIYEMAAGYPPFFAD 241

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 47/111 (42%), Gaps = 24/111 (21%)
Query: 387 IEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK-LEERTNEKEMLATRLVGTPG 445
            EY+H       ++RD+K  N+L+D     +V DFG  K ++ RT         L GTP 
Sbjct: 155 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-------WXLCGTPE 204
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRD 496
           YL PE I  K +                 D +A GV++ E+  G      D
Sbjct: 205 YLAPEIILSKGY-------------NKAVDWWALGVLIYEMAAGYPPFFAD 242

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 47/111 (42%), Gaps = 24/111 (21%)
Query: 387 IEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK-LEERTNEKEMLATRLVGTPG 445
            EY+H       ++RD+K  N+L+D     +V DFG  K ++ RT         L GTP 
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-------WXLCGTPE 203
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRD 496
           YL PE I  K +                 D +A GV++ E+  G      D
Sbjct: 204 YLAPEIILSKGY-------------NKAVDWWALGVLIYEMAAGYPPFFAD 241

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 47/111 (42%), Gaps = 24/111 (21%)
Query: 387 IEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK-LEERTNEKEMLATRLVGTPG 445
            EY+H       ++RD+K  N+L+D     +V DFG  K ++ RT         L GTP 
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-------WXLCGTPE 203
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRD 496
           YL PE I  K +                 D +A GV++ E+  G      D
Sbjct: 204 YLAPEIILSKGY-------------NKAVDWWALGVLIYEMAAGYPPFFAD 241

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 56/238 (23%), Positives = 96/238 (40%), Gaps = 44/238 (18%)
Query: 276 SERTIIFSLEEIEEAT----NNFDESRIIGRGGFGNV--YFGLLGDREAAIKKM-----R 324
           S+R   F   EI ++T      +   + IG G  G V   +  + +R  AIKK+      
Sbjct: 6   SKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQN 65
Query: 325 SNKSKEFFAELKVLCKIHHINV--FISTFG-NGSLSDHLHDPLLKGHQPLTWTARTQIAL 381
              +K  + EL ++  ++H N+   ++ F    SL +     ++            Q+ L
Sbjct: 66  QTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMEL 125
Query: 382 DAAK----------GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTN 431
           D  +          GI+++H    A  +HRD+K SNI++      K+ DFGL     RT 
Sbjct: 126 DHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA----RTA 178
Query: 432 EKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
               +    V T  Y  PE I    ++                D+++ G ++ E+I G
Sbjct: 179 GTSFMMVPFVVTRYYRAPEVILGMGYK-------------ENVDIWSVGCIMGEMIKG 223

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 47/111 (42%), Gaps = 24/111 (21%)
Query: 387 IEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK-LEERTNEKEMLATRLVGTPG 445
            EY+H       ++RD+K  N+L+D     +V DFG  K ++ RT         L GTP 
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-------WXLCGTPE 203
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRD 496
           YL PE I  K +                 D +A GV++ E+  G      D
Sbjct: 204 YLAPEIILSKGY-------------NKAVDWWALGVLIYEMAAGYPPFFAD 241

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 47/111 (42%), Gaps = 24/111 (21%)
Query: 387 IEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK-LEERTNEKEMLATRLVGTPG 445
            EY+H       ++RD+K  N+L+D     +V DFG  K ++ RT         L GTP 
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-------WXLCGTPE 203
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRD 496
           YL PE I  K +                 D +A GV++ E+  G      D
Sbjct: 204 YLAPEIILSKGY-------------NKAVDWWALGVLIYEMAAGYPPFFAD 241

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 47/111 (42%), Gaps = 24/111 (21%)
Query: 387 IEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK-LEERTNEKEMLATRLVGTPG 445
            EY+H       ++RD+K  N+L+D     +V DFG  K ++ RT         L GTP 
Sbjct: 155 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-------WTLCGTPE 204
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRD 496
           YL PE I  K +                 D +A GV++ E+  G      D
Sbjct: 205 YLAPEIILSKGY-------------NKAVDWWALGVLIYEMAAGYPPFFAD 242

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 47/111 (42%), Gaps = 24/111 (21%)
Query: 387 IEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK-LEERTNEKEMLATRLVGTPG 445
            EY+H       ++RD+K  N+L+D     +V DFG  K ++ RT         L GTP 
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-------WXLXGTPE 203
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRD 496
           YL PE I  K +                 D +A GV++ E+  G      D
Sbjct: 204 YLAPEIILSKGY-------------NKAVDWWALGVLIYEMAAGYPPFFAD 241

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 47/111 (42%), Gaps = 24/111 (21%)
Query: 387 IEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK-LEERTNEKEMLATRLVGTPG 445
            EY+H       ++RD+K  N+L+D     +V DFG  K ++ RT         L GTP 
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-------WXLCGTPE 203
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRD 496
           YL PE I  K +                 D +A GV++ E+  G      D
Sbjct: 204 YLAPEIILSKGY-------------NKAVDWWALGVLIYEMAAGYPPFFAD 241

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 47/111 (42%), Gaps = 24/111 (21%)
Query: 387 IEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK-LEERTNEKEMLATRLVGTPG 445
            EY+H       ++RD+K  N+L+D     +V DFG  K ++ RT         L GTP 
Sbjct: 147 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-------WXLCGTPE 196
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRD 496
           YL PE I  K +                 D +A GV++ E+  G      D
Sbjct: 197 YLAPEIILSKGY-------------NKAVDWWALGVLIYEMAAGYPPFFAD 234

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 47/111 (42%), Gaps = 24/111 (21%)
Query: 387 IEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK-LEERTNEKEMLATRLVGTPG 445
            EY+H       ++RD+K  N+L+D     +V DFG  K ++ RT         L GTP 
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-------WXLCGTPE 203
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRD 496
           YL PE I  K +                 D +A GV++ E+  G      D
Sbjct: 204 YLAPEIILSKGY-------------NKAVDWWALGVLIYEMAAGYPPFFAD 241

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 47/111 (42%), Gaps = 24/111 (21%)
Query: 387 IEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK-LEERTNEKEMLATRLVGTPG 445
            EY+H       ++RD+K  N+L+D     +V DFG  K ++ RT         L GTP 
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-------WXLCGTPE 203
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRD 496
           YL PE I  K +                 D +A GV++ E+  G      D
Sbjct: 204 YLAPEIILSKGY-------------NKAVDWWALGVLIYEMAAGYPPFFAD 241

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 47/111 (42%), Gaps = 24/111 (21%)
Query: 387 IEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK-LEERTNEKEMLATRLVGTPG 445
            EY+H       ++RD+K  N+L+D     +V DFG  K ++ RT         L GTP 
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-------WXLCGTPE 203
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRD 496
           YL PE I  K +                 D +A GV++ E+  G      D
Sbjct: 204 YLAPEIILSKGY-------------NKAVDWWALGVLIYEMAAGYPPFFAD 241

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 38/144 (26%), Positives = 61/144 (42%), Gaps = 23/144 (15%)
Query: 386 GIEYIHDHTKARYVHRDIKTSNILLD--DGLRAKVADFGLVKLEERTNEKEMLATRLVGT 443
           G+ Y H     +  HRD+K  N LLD     R K+ DFG  K     ++ +      VGT
Sbjct: 128 GVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK----STVGT 180
Query: 444 PGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKM 503
           P Y+ PE +  + +   +             DV++ GV L  ++ G      D  EP   
Sbjct: 181 PAYIAPEVLLRQEYDGKI------------ADVWSCGVTLYVMLVGAYPF-EDPEEPRDY 227
Query: 504 KSLITIMAAVAEWCLNEDAVDRPE 527
           +  I  + +V ++ + +D    PE
Sbjct: 228 RKTIQRILSV-KYSIPDDIRISPE 250

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 33/131 (25%), Positives = 59/131 (45%), Gaps = 21/131 (16%)
Query: 385 KGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP 444
           +G++++H +     VHRD+K  NIL+  G   K+ADFGL     R    +M    +V T 
Sbjct: 123 RGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLA----RIYSYQMALDPVVVTL 175
Query: 445 GYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKMK 504
            Y  PE +    +              T  D+++ G + AE+   ++ L   +SE  ++ 
Sbjct: 176 WYRAPEVLLQSTY-------------ATPVDMWSVGCIFAEMFR-RKPLFCGNSEADQLG 221
Query: 505 SLITIMAAVAE 515
            +  ++    E
Sbjct: 222 KIFDLIGLPPE 232

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 59/246 (23%), Positives = 96/246 (39%), Gaps = 57/246 (23%)
Query: 292 NNFDESRIIGRGGFGNVYFGLLGDREAAIKKMRSNKSKEFFAELK-VLCKIHHINVFIST 350
           +N+    +IGRG +G VY     + E  +   + N+  E   + K +L +I  +N   S 
Sbjct: 26  DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSD 85
Query: 351 FGNGSLSDHLHDPLLKGHQ------------------PLTWTAR--TQIALDAAKGIEYI 390
           +        + D LLK  +                  P+  T      I  +   G  +I
Sbjct: 86  YIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFI 145
Query: 391 HDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK-------------LEE-------RT 430
           H+   +  +HRD+K +N LL+     KV DFGL +             LEE         
Sbjct: 146 HE---SGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNK 202
Query: 431 NEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
           N K+ L + +V T  Y  PE I ++               T   D+++ G + AEL+   
Sbjct: 203 NLKKQLTSHVV-TRWYRAPELILLQE------------NYTKSIDIWSTGCIFAELLNML 249
Query: 491 RALIRD 496
           ++ I D
Sbjct: 250 QSHIND 255

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 47/111 (42%), Gaps = 24/111 (21%)
Query: 387 IEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK-LEERTNEKEMLATRLVGTPG 445
            EY+H       ++RD+K  N+L+D     +V DFG  K ++ RT         L GTP 
Sbjct: 149 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-------WXLCGTPE 198
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRD 496
           YL PE I  K +                 D +A GV++ E+  G      D
Sbjct: 199 YLAPEIILSKGY-------------NKAVDWWALGVLIYEMAAGYPPFFAD 236

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 36/124 (29%), Positives = 54/124 (43%), Gaps = 33/124 (26%)
Query: 385 KGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGL----VKLEERTN--------- 431
           K I+Y+H       +HRD+K SNILL+     KVADFGL    V +   TN         
Sbjct: 120 KVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINEN 176
Query: 432 -----EKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAEL 486
                + + + T  V T  Y  PE +            +   + T   D+++ G +L E+
Sbjct: 177 TENFDDDQPILTDYVATRWYRAPEIL------------LGSTKYTKGIDMWSLGCILGEI 224
Query: 487 ITGK 490
           + GK
Sbjct: 225 LCGK 228

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 68/161 (42%), Gaps = 29/161 (18%)
Query: 391 HDHTKARYVHRDIKTSNILLDDGLR---AKVADFGLVKLEERTNEKEMLATRLVGTPGYL 447
           H H++   VHRDIK  NIL+D  LR   AK+ DFG   L       +   TR+     Y 
Sbjct: 154 HCHSRG-VVHRDIKDENILID--LRRGCAKLIDFGSGALLHDEPYTDFDGTRV-----YS 205
Query: 448 PPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRD----DSEPTKM 503
           PPE+I     R   H+            V++ G++L +++ G     RD    ++E    
Sbjct: 206 PPEWI----SRHQYHA--------LPATVWSLGILLYDMVCGDIPFERDQEILEAELHFP 253
Query: 504 KSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITSTE 544
             +     A+   CL      RP + +I  +L   M T  E
Sbjct: 254 AHVSPDCCALIRRCLAPKPSSRPSLEEI--LLDPWMQTPAE 292

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 33/122 (27%), Positives = 56/122 (45%), Gaps = 23/122 (18%)
Query: 385 KGIEYIHDHTKARYVHRDIKTSNILLDDGL---RAKVADFGLVKLEERTNEKEMLATRLV 441
           +G+ Y+H +     VH D+K  NILL         K+ DFG+ +      E       ++
Sbjct: 142 EGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE----LREIM 194
Query: 442 GTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPT 501
           GTP YL PE +      +D         +TT TD++  G++   L+T     + +D++ T
Sbjct: 195 GTPEYLAPEIL-----NYD--------PITTATDMWNIGIIAYMLLTHTSPFVGEDNQET 241
Query: 502 KM 503
            +
Sbjct: 242 YL 243

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 47/111 (42%), Gaps = 24/111 (21%)
Query: 387 IEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK-LEERTNEKEMLATRLVGTPG 445
            EY+H       ++RD+K  N+L+D     +V DFG  K ++ RT         L GTP 
Sbjct: 140 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-------WTLCGTPE 189
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRD 496
           YL PE I  K +                 D +A GV++ E+  G      D
Sbjct: 190 YLAPEIILSKGY-------------NKAVDWWALGVLIYEMAAGYPPFFAD 227

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 31/104 (29%), Positives = 52/104 (50%), Gaps = 18/104 (17%)
Query: 386 GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP- 444
           G++Y+ +   + +VHRD+   N+LL     AK++DFGL K   R +E    A      P 
Sbjct: 123 GMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSK-ALRADENXYKAQTHGKWPV 178
Query: 445 GYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
            +  PE I   +F             ++K+DV++FGV++ E  +
Sbjct: 179 KWYAPECINYYKF-------------SSKSDVWSFGVLMWEAFS 209

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 41/164 (25%), Positives = 74/164 (45%), Gaps = 35/164 (21%)
Query: 385 KGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK---LEERTNEKEMLATRLV 441
           +G+ + H++   + +HRD+K  N+L++   + K+ DFGL +   +   T   E++     
Sbjct: 119 QGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV----- 170
Query: 442 GTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPT 501
            T  Y  P+ +   R              +T  D+++ G +LAE+ITGK  L    ++  
Sbjct: 171 -TLWYRAPDVLMGSR------------TYSTSIDIWSCGCILAEMITGK-PLFPGTNDEE 216
Query: 502 KMKSLITIMAAVAE--WC-------LNEDAVDRPEMRDIVAILS 536
           ++K +  IM    E  W         N +   RP  RD+  +L 
Sbjct: 217 QLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPP-RDLRQVLQ 259

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 39/137 (28%), Positives = 61/137 (44%), Gaps = 23/137 (16%)
Query: 399 VHRDIKTSNILLDDGLRA---KVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVK 455
           VHR++K  N+LL   L+    K+ADFGL  +E    ++        GTPGYL PE +   
Sbjct: 132 VHRNLKPENLLLASKLKGAAVKLADFGLA-IEVEGEQQAWFG--FAGTPGYLSPEVL--- 185
Query: 456 RFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKMKSLITIMAAVAE 515
             R D +            D++A GV+L  L+ G      +D    + +    I A   +
Sbjct: 186 --RKDPYGK--------PVDLWACGVILYILLVGYPPFWDED----QHRLYQQIKAGAYD 231
Query: 516 WCLNEDAVDRPEMRDIV 532
           +   E     PE +D++
Sbjct: 232 FPSPEWDTVTPEAKDLI 248

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 33/131 (25%), Positives = 59/131 (45%), Gaps = 21/131 (16%)
Query: 385 KGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP 444
           +G++++H +     VHRD+K  NIL+  G   K+ADFGL     R    +M    +V T 
Sbjct: 123 RGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLA----RIYSYQMALFPVVVTL 175
Query: 445 GYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKMK 504
            Y  PE +    +              T  D+++ G + AE+   ++ L   +SE  ++ 
Sbjct: 176 WYRAPEVLLQSTY-------------ATPVDMWSVGCIFAEMFR-RKPLFCGNSEADQLG 221
Query: 505 SLITIMAAVAE 515
            +  ++    E
Sbjct: 222 KIFDLIGLPPE 232

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 37/135 (27%), Positives = 61/135 (45%), Gaps = 20/135 (14%)
Query: 354 GSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDG 413
           GSL D L     +GH  L   +R   A+  A+G+ Y+      R++HRD+   N+LL   
Sbjct: 95  GSLLDRLRKH--QGHFLLGTLSR--YAVQVAEGMGYLE---SKRFIHRDLAARNLLLATR 147
Query: 414 LRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTK 473
              K+ DFGL++   + ++  ++         +  PE +  + F    H+S         
Sbjct: 148 DLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKTRTFS---HAS--------- 195
Query: 474 TDVFAFGVVLAELIT 488
            D + FGV L E+ T
Sbjct: 196 -DTWMFGVTLWEMFT 209

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 29/106 (27%), Positives = 54/106 (50%), Gaps = 19/106 (17%)
Query: 384 AKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK-LEERTNEKEMLATRLVG 442
           A+G+EY+      + +HRD+   N+L+ +    K+ADFGL + +      K+    RL  
Sbjct: 167 ARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNGRL-- 221
Query: 443 TPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
              ++ PE +F + +             T ++DV++FGV++ E+ T
Sbjct: 222 PVKWMAPEALFDRVY-------------THQSDVWSFGVLMWEIFT 254

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 37/135 (27%), Positives = 61/135 (45%), Gaps = 20/135 (14%)
Query: 354 GSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDG 413
           GSL D L     +GH  L   +R   A+  A+G+ Y+      R++HRD+   N+LL   
Sbjct: 99  GSLLDRLRKH--QGHFLLGTLSR--YAVQVAEGMGYLE---SKRFIHRDLAARNLLLATR 151
Query: 414 LRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTK 473
              K+ DFGL++   + ++  ++         +  PE +  + F    H+S         
Sbjct: 152 DLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFS---HAS--------- 199
Query: 474 TDVFAFGVVLAELIT 488
            D + FGV L E+ T
Sbjct: 200 -DTWMFGVTLWEMFT 213

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 29/106 (27%), Positives = 54/106 (50%), Gaps = 19/106 (17%)
Query: 384 AKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK-LEERTNEKEMLATRLVG 442
           A+G+EY+      + +HRD+   N+L+ +    K+ADFGL + +      K+    RL  
Sbjct: 167 ARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNGRL-- 221
Query: 443 TPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
              ++ PE +F + +             T ++DV++FGV++ E+ T
Sbjct: 222 PVKWMAPEALFDRVY-------------THQSDVWSFGVLMWEIFT 254

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 37/135 (27%), Positives = 61/135 (45%), Gaps = 20/135 (14%)
Query: 354 GSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDG 413
           GSL D L     +GH  L   +R   A+  A+G+ Y+      R++HRD+   N+LL   
Sbjct: 105 GSLLDRLRKH--QGHFLLGTLSR--YAVQVAEGMGYLE---SKRFIHRDLAARNLLLATR 157
Query: 414 LRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTK 473
              K+ DFGL++   + ++  ++         +  PE +  + F    H+S         
Sbjct: 158 DLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKTRTFS---HAS--------- 205
Query: 474 TDVFAFGVVLAELIT 488
            D + FGV L E+ T
Sbjct: 206 -DTWMFGVTLWEMFT 219

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 42.0 bits (97), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 32/111 (28%), Positives = 47/111 (42%), Gaps = 24/111 (21%)
Query: 387 IEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK-LEERTNEKEMLATRLVGTPG 445
            EY+H       ++RD+K  N+++D     +V DFG  K ++ RT         L GTP 
Sbjct: 154 FEYLHS---LDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVKGRT-------WXLCGTPE 203
Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRD 496
           YL PE I  K +                 D +A GV++ E+  G      D
Sbjct: 204 YLAPEIILSKGY-------------NKAVDWWALGVLIYEMAAGYPPFFAD 241

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	563
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	9e-82
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	3e-81
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	2e-80
3soc_A	322	Activin receptor type-2A; structural genomics cons	1e-62
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	8e-56
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	4e-52
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	5e-52
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	8e-50
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	5e-48
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	1e-47
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	4e-46
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	5e-46
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	1e-45
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	2e-45
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	2e-45
3q4u_A	301	Activin receptor type-1; structural genomics conso	3e-45
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	7e-45
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	3e-44
2a19_B	284	Interferon-induced, double-stranded RNA-activated	2e-32
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-30
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	2e-30
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	2e-30
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	5e-30
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	9e-30
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	2e-29
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	6e-29
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	7e-29
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	8e-29
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	2e-28
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	4e-28
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	4e-28
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	8e-28
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	8e-28
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	3e-27
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	4e-27
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	4e-27
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	4e-27
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	4e-27
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	5e-27
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	5e-27
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	8e-27
3pls_A	298	Macrophage-stimulating protein receptor; protein k	1e-26
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	1e-26
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	1e-26
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	2e-26
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	2e-26
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	2e-26
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	3e-26
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	5e-26
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	6e-26
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	7e-26
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	8e-26
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	9e-26
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	9e-26
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	1e-25
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	1e-25
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	1e-25
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	1e-25
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	1e-25
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	2e-25
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	2e-25
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	2e-25
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	2e-25
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	4e-25
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	4e-25
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	4e-25
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	5e-25
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	6e-25
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	7e-25
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	7e-25
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	9e-25
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	1e-24
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	1e-24
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	1e-24
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	2e-24
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	2e-24
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	2e-24
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	2e-24
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	2e-24
4aoj_A	329	High affinity nerve growth factor receptor; transf	2e-24
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	2e-24
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	3e-24
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	3e-24
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	3e-24
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	5e-24
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	5e-24
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	7e-24
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	1e-23
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	2e-23
3ork_A	311	Serine/threonine protein kinase; structural genomi	2e-23
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	3e-23
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	5e-23
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	7e-23
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	1e-22
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-22
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	1e-04
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	2e-22
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	3e-22
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	3e-22
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	4e-22
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	5e-22
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	1e-21
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	2e-21
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	2e-21
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	2e-21
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	2e-21
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	5e-21
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	2e-20
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	2e-20
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	3e-20
3an0_A	340	Dual specificity mitogen-activated protein kinase;	3e-20
3aln_A	327	Dual specificity mitogen-activated protein kinase;	6e-20
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	6e-20
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	1e-19
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	1e-19
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	2e-19
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	2e-19
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	5e-19
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	7e-19
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	4e-18
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	5e-18
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	7e-18
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	1e-17
3fme_A	290	Dual specificity mitogen-activated protein kinase;	1e-17
2dyl_A	318	Dual specificity mitogen-activated protein kinase	3e-17
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	4e-17
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	5e-17
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	1e-16
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	1e-16
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	2e-16
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	3e-16
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	4e-16
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	5e-16
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	8e-16
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-15
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	1e-15
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-15
3o0g_A	292	Cell division protein kinase 5; kinase activator c	2e-15
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	2e-15
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	2e-15
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	2e-15
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	2e-15
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	4e-15
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	6e-15
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	7e-15
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	9e-15
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	1e-14
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	1e-14
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	2e-14
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	2e-14
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-14
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	2e-14
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	2e-14
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	2e-14
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	2e-14
3niz_A	311	Rhodanese family protein; structural genomics, str	3e-14
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	3e-14
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	4e-14
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	5e-14
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	6e-14
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	8e-14
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	9e-14
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	1e-13
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	1e-13
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-13
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	1e-13
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	1e-13
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	1e-13
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	2e-13
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	2e-13
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	2e-13
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	2e-13
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	3e-13
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	4e-13
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	4e-13
3uqc_A	286	Probable conserved transmembrane protein; structur	5e-13
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	8e-13
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	8e-13
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	1e-12
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	1e-12
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	2e-12
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	2e-12
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	2e-12
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	4e-12
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	4e-12
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	4e-12
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	5e-12
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	6e-12
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	6e-12
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	7e-12
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	9e-12
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	1e-11
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	1e-11
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-11
3bhy_A	283	Death-associated protein kinase 3; death associate	2e-11
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	2e-11
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	2e-11
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	3e-11
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	4e-11
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	6e-11
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	6e-11
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	6e-11
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	1e-10
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	1e-10
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	1e-10
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	2e-10
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	3e-10
3rp9_A	458	Mitogen-activated protein kinase; structural genom	3e-10
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	4e-10
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	4e-10
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	8e-10
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	9e-10
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	1e-09
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	2e-09
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	2e-09
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	2e-09
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	3e-09
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	3e-09
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	3e-09
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	5e-09
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	6e-09
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	7e-09
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	9e-09
4eby_A	212	Chitin elicitor receptor kinase 1; pathogen-associ	1e-08
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	2e-08
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	2e-08
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-08
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	5e-08
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	6e-08
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	7e-08
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	9e-08
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	1e-07
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	1e-07
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	5e-07
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	2e-06
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	9e-05
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	2e-04
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	2e-04
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	8e-04

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  257 bits (660), Expect = 9e-82
 Identities = 90/310 (29%), Positives = 141/310 (45%), Gaps = 76/310 (24%)

Query: 282 FSLEEIEEATNNFDESRIIGRGGFGNVYFGLLGD-REAAIKKMRSNKS---KEFFAELKV 337
             L ++EEATNNFD   +IG G FG VY G+L D  + A+K+     S   +EF  E++ 
Sbjct: 29  VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIET 88

Query: 338 LCKIHHINVFISTFG----------------NGSLSDHLHDPLLKGHQPLTWTARTQIAL 381
           L    H ++ +S  G                NG+L  HL+         ++W  R +I +
Sbjct: 89  LSFCRHPHL-VSLIGFCDERNEMILIYKYMENGNLKRHLYGS-DLPTMSMSWEQRLEICI 146

Query: 382 DAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKL---EERTNEKEMLAT 438
            AA+G+ Y+H       +HRD+K+ NILLD+    K+ DFG+ K     ++T+    L+T
Sbjct: 147 GAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTH----LST 199

Query: 439 RLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDS 498
            + GT GY+ PEY              ++ ++T K+DV++FGVVL E++  + A+    S
Sbjct: 200 VVKGTLGYIDPEY-------------FIKGRLTEKSDVYSFGVVLFEVLCARSAI--VQS 244

Query: 499 EPTKMKSLIT-----------------------------IMAAVAEWCLNEDAVDRPEMR 529
            P +M +L                                    A  CL   + DRP M 
Sbjct: 245 LPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMG 304

Query: 530 DIVAILSQIM 539
           D++  L   +
Sbjct: 305 DVLWKLEYAL 314

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  255 bits (654), Expect = 3e-81
 Identities = 94/326 (28%), Positives = 153/326 (46%), Gaps = 83/326 (25%)

Query: 274 LESERTIIFSLEEIEEATNNFDE------SRIIGRGGFGNVYFGLLGDREAAIKKMRSNK 327
           +   R   FS  E++  TNNFDE         +G GGFG VY G + +   A+KK+ +  
Sbjct: 7   VSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMV 66

Query: 328 S-------KEFFAELKVLCKIHHINV------------------FISTFGNGSLSDHLHD 362
                   ++F  E+KV+ K  H N+                  ++    NGSL D L  
Sbjct: 67  DITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMP---NGSLLDRLSC 123

Query: 363 PLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFG 422
               G  PL+W  R +IA  AA GI ++H++     +HRDIK++NILLD+   AK++DFG
Sbjct: 124 L--DGTPPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFG 178

Query: 423 LVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVV 482
           L +  E    + ++ +R+VGT  Y+ PE               +  ++T K+D+++FGVV
Sbjct: 179 LARASE-KFAQTVMTSRIVGTTAYMAPEA--------------LRGEITPKSDIYSFGVV 223

Query: 483 LAELITGKRALIRDDSEPTKM------------KSLITI---------------MAAVAE 515
           L E+ITG  A+  D+    ++            K++                  M +VA 
Sbjct: 224 LLEIITGLPAV--DEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVAS 281

Query: 516 WCLNEDAVDRPEMRDIVAILSQIMIT 541
            CL+E    RP+++ +  +L ++  +
Sbjct: 282 QCLHEKKNKRPDIKKVQQLLQEMTAS 307

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  254 bits (652), Expect = 2e-80
 Identities = 95/309 (30%), Positives = 148/309 (47%), Gaps = 75/309 (24%)

Query: 281 IFSLEEIEEATNNFDESRIIGRGGFGNVYFGLLGD-REAAIKKMRSNKS----KEFFAEL 335
            FSL E++ A++NF    I+GRGGFG VY G L D    A+K+++  ++     +F  E+
Sbjct: 19  RFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEV 78

Query: 336 KVLCKIHHINVFISTFG----------------NGSLSDHLHDPLLKGHQPLTWTARTQI 379
           +++    H N+ +   G                NGS++  L +   +   PL W  R +I
Sbjct: 79  EMISMAVHRNL-LRLRGFCMTPTERLLVYPYMANGSVASCLRERP-ESQPPLDWPKRQRI 136

Query: 380 ALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKL--EERTNEKEMLA 437
           AL +A+G+ Y+HDH   + +HRD+K +NILLD+   A V DFGL KL   + T+    + 
Sbjct: 137 ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH----VT 192

Query: 438 TRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDD 497
           T + GT G++ PEY             +   + + KTDVF +GV+L ELITG+RA   D 
Sbjct: 193 TAVRGTIGHIAPEY-------------LSTGKSSEKTDVFGYGVMLLELITGQRAF--DL 237

Query: 498 SEPT---------------KMKSLITI----------------MAAVAEWCLNEDAVDRP 526
           +                  K K L  +                +  VA  C     ++RP
Sbjct: 238 ARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERP 297

Query: 527 EMRDIVAIL 535
           +M ++V +L
Sbjct: 298 KMSEVVRML 306

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  208 bits (530), Expect = 1e-62
 Identities = 70/320 (21%), Positives = 113/320 (35%), Gaps = 78/320 (24%)

Query: 282 FSLEEIEEATNNFDESRIIGRGGFGNVYFGLLGDREAAIKKMRSNKSKEFFAELKV--LC 339
              E +   +       +  RG FG V+   L +   A+K       + +  E +V  L 
Sbjct: 14  LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQSWQNEYEVYSLP 73

Query: 340 KIHHINV--FI--STFG---------------NGSLSDHLHDPLLKGHQPLTWTARTQIA 380
            + H N+  FI     G                GSLSD L          ++W     IA
Sbjct: 74  GMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK------ANVVSWNELCHIA 127

Query: 381 LDAAKGIEYIHDHT-------KARYVHRDIKTSNILLDDGLRAKVADFGL-VKLEERTNE 432
              A+G+ Y+H+         K    HRDIK+ N+LL + L A +ADFGL +K E   + 
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187

Query: 433 KEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRA 492
            +      VGT  Y+ PE +          +   +     + D++A G+VL EL +   A
Sbjct: 188 GDT--HGQVGTRRYMAPEVL--------EGAINFQRDAFLRIDMYAMGLVLWELASRCTA 237

Query: 493 --------------LIRDDSEPTKMKSL-------------------ITIMAAVAEWCLN 519
                          I        M+ +                   + ++    E C +
Sbjct: 238 ADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWD 297

Query: 520 EDAVDRPEMRDIVAILSQIM 539
            DA  R     +   ++Q+ 
Sbjct: 298 HDAEARLSAGCVGERITQMQ 317

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  189 bits (481), Expect = 8e-56
 Identities = 68/288 (23%), Positives = 123/288 (42%), Gaps = 53/288 (18%)

Query: 283 SLEEIEEATNNFDESRIIGRGGFGNVYFGLLGDREAAIKKMRS-NKSKEFFAELKVLCKI 341
           SL  I+      +   ++GRG FG V       ++ AIK++ S ++ K F  EL+ L ++
Sbjct: 1   SLHMIDY--KEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESESERKAFIVELRQLSRV 58

Query: 342 HHINVFISTFG--------------NGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGI 387
           +H N+ +  +G               GSL + LH    +     T        L  ++G+
Sbjct: 59  NHPNI-VKLYGACLNPVCLVMEYAEGGSLYNVLHGA--EPLPYYTAAHAMSWCLQCSQGV 115

Query: 388 EYIHDHTKARYVHRDIKTSNILLD-DGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGY 446
            Y+H       +HRD+K  N+LL   G   K+ DFG         + +   T   G+  +
Sbjct: 116 AYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC------DIQTHMTNNKGSAAW 169

Query: 447 LPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKR-------------AL 493
           + PE      +             + K DVF++G++L E+IT ++               
Sbjct: 170 MAPEVFEGSNY-------------SEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWA 216

Query: 494 IRDDSEPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMIT 541
           + + + P  +K+L   + ++   C ++D   RP M +IV I++ +M  
Sbjct: 217 VHNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRY 264

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  179 bits (456), Expect = 4e-52
 Identities = 67/286 (23%), Positives = 114/286 (39%), Gaps = 67/286 (23%)

Query: 298 RIIGRGGFGNVYFGLLGDREAAIKKMR-----SNKSKEFFAELKVLCKIHHINV--FI-- 348
             IG G FG V+       + A+K +      + +  EF  E+ ++ ++ H N+  F+  
Sbjct: 43  EKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA 102

Query: 349 ----STF-------GNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKAR 397
                           GSL   LH       + L    R  +A D AKG+ Y+H+     
Sbjct: 103 VTQPPNLSIVTEYLSRGSLYRLLHKS--GAREQLDERRRLSMAYDVAKGMNYLHNR-NPP 159

Query: 398 YVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRF 457
            VHR++K+ N+L+D     KV DFGL +L+  T      +    GTP ++ PE +  +  
Sbjct: 160 IVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS---SKSAAGTPEWMAPEVLRDEPS 216

Query: 458 RFDMHSSVMELQVTTKTDVFAFGVVLAELITGK--------------------RALIRDD 497
                          K+DV++FGV+L EL T +                    R  I  +
Sbjct: 217 -------------NEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRN 263

Query: 498 SEPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITST 543
               ++ ++I       E C   +   RP    I+ +L  ++ ++ 
Sbjct: 264 L-NPQVAAII-------EGCWTNEPWKRPSFATIMDLLRPLIKSAV 301

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  180 bits (457), Expect = 5e-52
 Identities = 65/332 (19%), Positives = 113/332 (34%), Gaps = 81/332 (24%)

Query: 282 FSLEEIEEATNNFDESRIIGRGGFGNVYFGLLGDREAAIKKMRSNKSKEFFAELKV--LC 339
            +  E     +N     +IGRG +G VY G L +R  A+K       + F  E  +  + 
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANRQNFINEKNIYRVP 62

Query: 340 KIHHINV--FI--STFG----------------NGSLSDHLHDPLLKGHQPLTWTARTQI 379
            + H N+  FI                      NGSL  +L            W +  ++
Sbjct: 63  LMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL------HTSDWVSSCRL 116

Query: 380 ALDAAKGIEYIH------DHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERT--- 430
           A    +G+ Y+H      DH K    HRD+ + N+L+ +     ++DFGL          
Sbjct: 117 AHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLV 176

Query: 431 --NEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
              E++  A   VGT  Y+ PE +          +         + D++A G++  E+  
Sbjct: 177 RPGEEDNAAISEVGTIRYMAPEVL------EGAVNLRDXESALKQVDMYALGLIYWEIFM 230

Query: 489 GKRALIRDDSEPT----------------KMKSLI--------------------TIMAA 512
               L   +S P                  M+ L+                      +  
Sbjct: 231 RCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKE 290

Query: 513 VAEWCLNEDAVDRPEMRDIVAILSQIMITSTE 544
             E C ++DA  R   +     ++++M+    
Sbjct: 291 TIEDCWDQDAEARLTAQXAEERMAELMMIWER 322

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  172 bits (438), Expect = 8e-50
 Identities = 72/292 (24%), Positives = 121/292 (41%), Gaps = 68/292 (23%)

Query: 292 NNFDESRIIGRGGFGNVYFGLLGDREA--AIKKMRSNKS----------KEFFAELKVLC 339
           N  +  + IG+GGFG V+ G L   ++  AIK +    S          +EF  E+ ++ 
Sbjct: 19  NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78

Query: 340 KIHHINVFISTFG--------------NGSLSDHLHDPLLKGHQPLTWTARTQIALDAAK 385
            ++H N+ +  +G               G L   L D       P+ W+ + ++ LD A 
Sbjct: 79  NLNHPNI-VKLYGLMHNPPRMVMEFVPCGDLYHRLLDK----AHPIKWSVKLRLMLDIAL 133

Query: 386 GIEYIHDHTKARYVHRDIKTSNILLDDG-----LRAKVADFGLVKLEERTNEKEMLATRL 440
           GIEY+ +      VHRD+++ NI L        + AKVADFGL +    +       + L
Sbjct: 134 GIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS------VSGL 186

Query: 441 VGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKR--------- 491
           +G   ++ PE I  +   +           T K D ++F ++L  ++TG+          
Sbjct: 187 LGNFQWMAPETIGAEEESY-----------TEKADTYSFAMILYTILTGEGPFDEYSYGK 235

Query: 492 -----ALIRDDSEPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQI 538
                 +  +   PT  +     +  V E C + D   RP    IV  LS++
Sbjct: 236 IKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  168 bits (428), Expect = 5e-48
 Identities = 57/286 (19%), Positives = 102/286 (35%), Gaps = 67/286 (23%)

Query: 298 RIIGRGGFGNVYFGLLGDREAAIKKMR-----SNKSKEFFAELKVLCKIHHINV--FIST 350
            +IG+G FG VY G     E AI+ +       ++ K F  E+    +  H NV  F+  
Sbjct: 39  ELIGKGRFGQVYHGRWHG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFM-- 95

Query: 351 FG----------------NGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHT 394
            G                  +L   + D        L      QIA +  KG+ Y+H   
Sbjct: 96  -GACMSPPHLAIITSLCKGRTLYSVVRDA----KIVLDVNKTRQIAQEIVKGMGYLHAK- 149

Query: 395 KARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERT--NEKEMLATRLVGTPGYLPPEYI 452
               +H+D+K+ N+  D+G +  + DFGL  +        +E       G   +L PE I
Sbjct: 150 --GILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEII 206

Query: 453 FVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK-------------------RAL 493
                  +      +L  +  +DVFA G +  EL   +                   +  
Sbjct: 207 RQLSPDTEED----KLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPN 262

Query: 494 IRDDSEPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIM 539
           +       ++  ++        +C   +  +RP    ++ +L ++ 
Sbjct: 263 LSQIGMGKEISDIL-------LFCWAFEQEERPTFTKLMDMLEKLP 301

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  166 bits (422), Expect = 1e-47
 Identities = 67/284 (23%), Positives = 105/284 (36%), Gaps = 68/284 (23%)

Query: 298 RIIGRGGFGNVYFGLLGDREAAIKKMRSNKS-------KEFFAELKVLCKIHHINVFIST 350
            IIG GGFG VY       E A+K  R +         +    E K+   + H N+ I+ 
Sbjct: 13  EIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNI-IAL 71

Query: 351 FG----------------NGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHT 394
            G                 G L+  L        + +        A+  A+G+ Y+HD  
Sbjct: 72  RGVCLKEPNLCLVMEFARGGPLNRVLSG------KRIPPDILVNWAVQIARGMNYLHDEA 125

Query: 395 KARYVHRDIKTSNILLDDGLR--------AKVADFGLVKLEERTNEKEMLATRLVGTPGY 446
               +HRD+K+SNIL+   +          K+ DFGL +   RT           G   +
Sbjct: 126 IVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT-----KMSAAGAYAW 180

Query: 447 LPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKR------------ALI 494
           + PE I    F             +  +DV+++GV+L EL+TG+              + 
Sbjct: 181 MAPEVIRASMF-------------SKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVA 227

Query: 495 RDDSEPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQI 538
            +        +     A + E C N D   RP   +I+  L+ I
Sbjct: 228 MNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  164 bits (416), Expect = 4e-46
 Identities = 64/301 (21%), Positives = 111/301 (36%), Gaps = 72/301 (23%)

Query: 298 RIIGRGGFGNVYFGLLGDREAAIKKMRSNKSKEFFAELKV--LCKIHHINV--FI--STF 351
           + IG+G +G V+ G     + A+K   + +   +F E ++     + H N+  FI     
Sbjct: 43  KQIGKGRYGEVWMGKWRGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIK 102

Query: 352 G---------------NGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIH----- 391
           G               NGSL D+L          L   +  ++A  +  G+ ++H     
Sbjct: 103 GTGSWTQLYLITDYHENGSLYDYLK------STTLDAKSMLKLAYSSVSGLCHLHTEIFS 156

Query: 392 DHTKARYVHRDIKTSNILLDDGLRAKVADFGL-VKLEERTNEKEMLATRLVGTPGYLPPE 450
              K    HRD+K+ NIL+       +AD GL VK    TNE ++     VGT  Y+PPE
Sbjct: 157 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPE 216

Query: 451 YIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRA-------------LIRDD 497
            +       D   +    Q     D+++FG++L E+     +             L+  D
Sbjct: 217 VL-------DESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSD 269

Query: 498 SEPTKMKSLITI-------------------MAAVAEWCLNEDAVDRPEMRDIVAILSQI 538
                M+ ++ I                   M  +   C   +   R     +   L+++
Sbjct: 270 PSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKM 329

Query: 539 M 539
            
Sbjct: 330 S 330

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  162 bits (412), Expect = 5e-46
 Identities = 68/284 (23%), Positives = 112/284 (39%), Gaps = 68/284 (23%)

Query: 298 RIIGRGGFGNVYFGLLGDREAAIKKMR-----SNKSKEFFAELKVLCKIHHINV--FIST 350
           + IG G FG VY G     + A+K +        + + F  E+ VL K  H+N+  F+  
Sbjct: 30  QRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM-- 86

Query: 351 FG---------------NGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTK 395
            G                 SL  HLH                 IA   A+G++Y+H  + 
Sbjct: 87  -GYSTAPQLAIVTQWCEGSSLYHHLHAS----ETKFEMKKLIDIARQTARGMDYLHAKS- 140

Query: 396 ARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVK 455
              +HRD+K++NI L +    K+ DFGL   + R +          G+  ++ PE I ++
Sbjct: 141 --IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQL-SGSILWMAPEVIRMQ 197

Query: 456 RFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK-------------RALIRDDSEPTK 502
                          + ++DV+AFG+VL EL+TG+               + R    P  
Sbjct: 198 D----------SNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDL 247

Query: 503 M-------KSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIM 539
                   K +  +M      CL +   +RP    I+A + ++ 
Sbjct: 248 SKVRSNCPKRMKRLM----AECLKKKRDERPSFPRILAEIEELA 287

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  160 bits (408), Expect = 1e-45
 Identities = 48/278 (17%), Positives = 103/278 (37%), Gaps = 62/278 (22%)

Query: 298 RIIGRGGFGNVYFGLLGDREAAIKKMR-----SNKSKEFFAELKVLCKIHHINV--FIST 350
             +     G ++ G     +  +K ++     + KS++F  E   L    H NV   +  
Sbjct: 16  TKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVL-- 73

Query: 351 FG------------------NGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHD 392
            G                   GSL + LH+     +  +  +   + ALD A+G+ ++H 
Sbjct: 74  -GACQSPPAPHPTLITHWMPYGSLYNVLHE---GTNFVVDQSQAVKFALDMARGMAFLHT 129

Query: 393 HTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYI 452
                     + + ++++D+ + A+++   +    +            +  P ++ PE +
Sbjct: 130 LEPL-IPRHALNSRSVMIDEDMTARISMADVKFSFQSPGR--------MYAPAWVAPEAL 180

Query: 453 FVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKR------------ALIRDDSEP 500
             K                   D+++F V+L EL+T +              +  +   P
Sbjct: 181 QKKPED----------TNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRP 230

Query: 501 TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQI 538
           T    +   ++ + + C+NED   RP+   IV IL ++
Sbjct: 231 TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKM 268

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  160 bits (407), Expect = 3e-45
 Identities = 66/302 (21%), Positives = 107/302 (35%), Gaps = 76/302 (25%)

Query: 298 RIIGRGGFGNVYFGLLGDREAAIKKMRSNKSKEFFAELKV--LCKIHHINV--FI--STF 351
             +G+G +G V+ G       A+K   S   K +F E ++     + H N+  FI     
Sbjct: 14  ECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMT 73

Query: 352 G---------------NGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIH----- 391
                            GSL D+L          L   +  +I L  A G+ ++H     
Sbjct: 74  SRHSSTQLWLITHYHEMGSLYDYLQ------LTTLDTVSCLRIVLSIASGLAHLHIEIFG 127

Query: 392 DHTKARYVHRDIKTSNILLDDGLRAKVADFGL-VKLEERTNEKEMLATRLVGTPGYLPPE 450
              K    HRD+K+ NIL+    +  +AD GL V   + TN+ ++     VGT  Y+ PE
Sbjct: 128 TQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPE 187

Query: 451 YIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKM------- 503
            +  +  + D   S        + D++AFG+VL E+    R +     E  K        
Sbjct: 188 -VLDETIQVDCFDS------YKRVDIWAFGLVLWEVAR--RMVSNGIVEDYKPPFYDVVP 238

Query: 504 --KSLITIMAAVA-------------------------EWCLNEDAVDRPEMRDIVAILS 536
              S   +   V                          + C  ++   R     I   L+
Sbjct: 239 NDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLT 298

Query: 537 QI 538
           +I
Sbjct: 299 KI 300

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  160 bits (406), Expect = 7e-45
 Identities = 58/288 (20%), Positives = 95/288 (32%), Gaps = 70/288 (24%)

Query: 298 RIIGRGGFGNVYFGLLG--DREAAIKKMRSNKS---KEFFAELKVLCKIHHINV------ 346
            ++G+G FG               +K++        + F  E+KV+  + H NV      
Sbjct: 16  EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75

Query: 347 ------------FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHT 394
                       +I     G+L   +            W+ R   A D A G+ Y+H   
Sbjct: 76  LYKDKRLNFITEYIK---GGTLRGIIKSM----DSQYPWSQRVSFAKDIASGMAYLHSM- 127

Query: 395 KARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNE-----------KEMLATRLVGT 443
               +HRD+ + N L+ +     VADFGL +L                        +VG 
Sbjct: 128 --NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGN 185

Query: 444 PGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRA----------- 492
           P ++ PE I  + +               K DVF+FG+VL E+I    A           
Sbjct: 186 PYWMAPEMINGRSY-------------DEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF 232

Query: 493 --LIRDDSEPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQI 538
              +R   +     +       +   C + D   RP    +   L  +
Sbjct: 233 GLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETL 280

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  159 bits (404), Expect = 3e-44
 Identities = 65/300 (21%), Positives = 113/300 (37%), Gaps = 72/300 (24%)

Query: 299 IIGRGGFGNVYFGLLGDREAAIKKMRSNKSKEFFAELKV--LCKIHHINV--FIST---- 350
            IG+G FG V+ G     E A+K   S + + +F E ++     + H N+  FI+     
Sbjct: 49  SIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKD 108

Query: 351 -------------FGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHT--- 394
                          +GSL D+L+         +T     ++AL  A G+ ++H      
Sbjct: 109 NGTWTQLWLVSDYHEHGSLFDYLN------RYTVTVEGMIKLALSTASGLAHLHMEIVGT 162

Query: 395 --KARYVHRDIKTSNILLDDGLRAKVADFGL-VKLEERTNEKEMLATRLVGTPGYLPPEY 451
             K    HRD+K+ NIL+       +AD GL V+ +  T+  ++     VGT  Y+ PE 
Sbjct: 163 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 222

Query: 452 IFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRA-------------LIRDDS 498
           +       D   ++   +   + D++A G+V  E+                   L+  D 
Sbjct: 223 L-------DDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 275

Query: 499 EPTKMKSLI-------------------TIMAAVAEWCLNEDAVDRPEMRDIVAILSQIM 539
              +M+ ++                    +MA +   C   +   R     I   LSQ+ 
Sbjct: 276 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 335

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  125 bits (315), Expect = 2e-32
 Identities = 67/290 (23%), Positives = 111/290 (38%), Gaps = 85/290 (29%)

Query: 292 NNFDESRIIGRGGFGNVYFG--LLGDREAAIKKMRSNKSKEFFAELKVLCKIHHINV--F 347
            +F E  +IG GGFG V+     +  +   IK+++ N  K    E+K L K+ H+N+  +
Sbjct: 11  MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAE-REVKALAKLDHVNIVHY 69

Query: 348 ISTF-----------------------------GNGSLSDHLHDPLLKGHQPLT----WT 374
              +                               G+L   +     +  + L       
Sbjct: 70  NGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEK---RRGEKLDKVLALE 126

Query: 375 ARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKE 434
              QI      G++YIH     + ++RD+K SNI L D  + K+ DFGLV   +   +  
Sbjct: 127 LFEQITK----GVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK-- 177

Query: 435 MLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKR--- 491
              TR  GT  Y+ PE I  + +               + D++A G++LAEL+       
Sbjct: 178 --RTRSKGTLRYMSPEQISSQDY-------------GKEVDLYALGLILAELLHVCDTAF 222

Query: 492 ------ALIRDDSEPT----KMKSLITIMAAVAEWCLNEDAVDRPEMRDI 531
                   +RD         K K+L+       +  L++   DRP   +I
Sbjct: 223 ETSKFFTDLRDGIISDIFDKKEKTLL-------QKLLSKKPEDRPNTSEI 265

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  120 bits (303), Expect = 2e-30
 Identities = 57/297 (19%), Positives = 103/297 (34%), Gaps = 73/297 (24%)

Query: 293 NFDESRIIGRGGFGNVYF--GLLGDREAAIKKMRSNKSKE---FFAELKVLCKIHHINV- 346
           ++   + +G GGF  V    GL      A+K++  ++ ++      E  +    +H N+ 
Sbjct: 30  HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNIL 89

Query: 347 -FISTF-----------------GNGSLSDHLHDPLLKGHQPLT-WTARTQIALDAAKGI 387
             ++                     G+L + + + L      LT       + L   +G+
Sbjct: 90  RLVAYCLRERGAKHEAWLLLPFFKRGTLWNEI-ERLKDKGNFLTEDQIL-WLLLGICRGL 147

Query: 388 EYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRL------V 441
           E IH      Y HRD+K +NILL D  +  + D G +       E    A  L       
Sbjct: 148 EAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQR 204

Query: 442 GTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK----------- 490
            T  Y  PE   V+              +  +TDV++ G VL  ++ G+           
Sbjct: 205 CTISYRAPELFSVQSHCV----------IDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD 254

Query: 491 ---RALIRDDSEP------TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQI 538
               A+    S P      + +  L+          +  D   RP +  +++ L  +
Sbjct: 255 SVALAVQNQLSIPQSPRHSSALWQLLN-------SMMTVDPHQRPHIPLLLSQLEAL 304

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  121 bits (305), Expect = 2e-30
 Identities = 60/285 (21%), Positives = 97/285 (34%), Gaps = 74/285 (25%)

Query: 298 RIIGRGGFGNVYFGLL--GDREAAIKKMRSNKSK----EFFAELKVLCKIHHINVFISTF 351
             IGRG FG V+ G L   +   A+K  R         +F  E ++L +  H N+ +   
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNI-VRLI 178

Query: 352 G----------------NGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTK 395
           G                 G     L          L      Q+  DAA G+EY+     
Sbjct: 179 GVCTQKQPIYIVMELVQGGDFLTFLR----TEGARLRVKTLLQMVGDAAAGMEYLESK-- 232

Query: 396 ARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLP-----PE 450
              +HRD+   N L+ +    K++DFG+ + E              G    +P     PE
Sbjct: 233 -CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAAS------GGLRQVPVKWTAPE 285

Query: 451 YIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GK-----------RALIRDD- 497
            +   R+             ++++DV++FG++L E  + G            R  +    
Sbjct: 286 ALNYGRY-------------SSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGG 332

Query: 498 --SEPTKM-KSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIM 539
               P     ++  +M    E C   +   RP    I   L  I 
Sbjct: 333 RLPCPELCPDAVFRLM----EQCWAYEPGQRPSFSTIYQELQSIR 373

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  120 bits (304), Expect = 2e-30
 Identities = 66/284 (23%), Positives = 103/284 (36%), Gaps = 77/284 (27%)

Query: 292 NNFDESRIIGRGGFGNVYFGL--LGDREAAIKKMR----SNKSKEF-FAELKVLCKIHHI 344
             +   + IG G FG           R+  IK++     S+K +E    E+ VL  + H 
Sbjct: 24  EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83

Query: 345 NV--FISTF-------------GNGSLSDHLHDPLLKGHQPLT----WTARTQIALDAAK 385
           N+  +  +F               G L   ++    +               QI L    
Sbjct: 84  NIVQYRESFEENGSLYIVMDYCEGGDLFKRINA---QKGVLFQEDQILDWFVQICL---- 136

Query: 386 GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPG 445
            ++++HD    + +HRDIK+ NI L      ++ DFG+ ++   T E   LA   +GTP 
Sbjct: 137 ALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE---LARACIGTPY 190

Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRA-----------LI 494
           YL PE                      K+D++A G VL EL T K A            I
Sbjct: 191 YLSPEIC-------------ENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKI 237

Query: 495 RDDSEP-------TKMKSLITIMAAVAEWCLNEDAVDRPEMRDI 531
              S P         ++SL++            +  DRP +  I
Sbjct: 238 ISGSFPPVSLHYSYDLRSLVS-------QLFKRNPRDRPSVNSI 274

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  118 bits (298), Expect = 5e-30
 Identities = 62/300 (20%), Positives = 108/300 (36%), Gaps = 87/300 (29%)

Query: 292 NNFDESRIIGRGGFGNVYFG--LLGDREAAIKKMRSNKS----KEFFAELKVLCKIHHIN 345
            +F+  + +GRGGFG V+     + D   AIK++R        ++   E+K L K+ H  
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64

Query: 346 V--FISTF-------------------------GNGSLSDHLHDPLLKGHQP--LTWTAR 376
           +  + + +                            +L D ++       +   +     
Sbjct: 65  IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124

Query: 377 TQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEM- 435
            QIA      +E++H       +HRD+K SNI        KV DFGLV   ++  E++  
Sbjct: 125 LQIAE----AVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 177

Query: 436 --------LATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELI 487
                     T  VGT  Y+ PE I         +S         K D+F+ G++L EL+
Sbjct: 178 LTPMPAYARHTGQVGTKLYMSPEQIHGNS-----YSH--------KVDIFSLGLILFELL 224

Query: 488 T------GKRALIRD----------DSEPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDI 531
                   +   + D            +      ++          L+   ++RPE  +I
Sbjct: 225 YPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQ-------DMLSPSPMERPEAINI 277

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  118 bits (297), Expect = 9e-30
 Identities = 64/303 (21%), Positives = 112/303 (36%), Gaps = 74/303 (24%)

Query: 292 NNFDESRIIGRGGFGNVYFGL-LGDREA-AIKKMR-----SNKSKEF-FAELKVLCKIHH 343
            NF   + IGRG F  VY    L D    A+KK++       K++     E+ +L +++H
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91

Query: 344 INV--FISTF-------------GNGSLSDHL-----HDPLLKGHQPLTWTARTQIALDA 383
            NV  + ++F               G LS  +        L+       +    Q+    
Sbjct: 92  PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYF--VQLCS-- 147

Query: 384 AKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGT 443
              +E++H     R +HRDIK +N+ +      K+ D GL +           A  LVGT
Sbjct: 148 --ALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT---AAHSLVGT 199

Query: 444 PGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKM 503
           P Y+ PE I              E     K+D+++ G +L E+   +        +   +
Sbjct: 200 PYYMSPERI-------------HENGYNFKSDIWSLGCLLYEMAALQSPF---YGDKMNL 243

Query: 504 KSLITI-----------------MAAVAEWCLNEDAVDRPEMRDIVAILSQIM-ITSTEW 545
            SL                    +  +   C+N D   RP++  +  +  ++   T++  
Sbjct: 244 YSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSL 303

Query: 546 EAS 548
           E  
Sbjct: 304 EHH 306

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  120 bits (302), Expect = 2e-29
 Identities = 55/209 (26%), Positives = 97/209 (46%), Gaps = 44/209 (21%)

Query: 298 RIIGRGGFGNVYFGLLGDREAAIKKMRSNKS-KEFFAELKVLCKIHHINVFISTFG---- 352
           + IG+G FG+V  G     + A+K ++++ + + F AE  V+ ++ H N+ +   G    
Sbjct: 199 QTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNL-VQLLGVIVE 257

Query: 353 -------------NGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYV 399
                         GSL D+L      G   L      + +LD  + +EY+  +    +V
Sbjct: 258 EKGGLYIVTEYMAKGSLVDYLRSR---GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFV 311

Query: 400 HRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRF 459
           HRD+   N+L+ +   AKV+DFGL K    T +   L  +      +  PE +  K+F  
Sbjct: 312 HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK------WTAPEALREKKF-- 363

Query: 460 DMHSSVMELQVTTKTDVFAFGVVLAELIT 488
                      +TK+DV++FG++L E+ +
Sbjct: 364 -----------STKSDVWSFGILLWEIYS 381

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  115 bits (290), Expect = 6e-29
 Identities = 63/303 (20%), Positives = 109/303 (35%), Gaps = 88/303 (29%)

Query: 291 TNNFDESRIIGRGGFGNVYFG--LLGDREAAIKKMRSNKSKE--FFAELKVLCKIHHINV 346
            ++F+E  ++G+G FG V      L  R  AIKK+R  + K     +E+ +L  ++H  V
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYV 64

Query: 347 --FISTF--------------------------GNGSLSDHLHDPLLKGHQPLTWTARTQ 378
             + + +                           NG+L D +H   L   +   W    Q
Sbjct: 65  VRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQ 124

Query: 379 IALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEM--- 435
           I       + YIH       +HRD+K  NI +D+    K+ DFGL K   R+ +      
Sbjct: 125 ILE----ALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177

Query: 436 --------LATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELI 487
                     T  +GT  Y+  E +                    K D+++ G++  E+I
Sbjct: 178 QNLPGSSDNLTSAIGTAMYVATEVLDGTG------------HYNEKIDMYSLGIIFFEMI 225

Query: 488 TG------KRALIR-------------DDSEPTKMKSLITIMAAVAEWCLNEDAVDRPEM 528
                   +  +++             DD++    K +I          ++ D   RP  
Sbjct: 226 YPFSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKII-------RLLIDHDPNKRPGA 278

Query: 529 RDI 531
           R +
Sbjct: 279 RTL 281

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  114 bits (289), Expect = 7e-29
 Identities = 55/209 (26%), Positives = 98/209 (46%), Gaps = 44/209 (21%)

Query: 298 RIIGRGGFGNVYFGLLGDREAAIKKMRSNKS-KEFFAELKVLCKIHHINVFISTFG---- 352
           + IG+G FG+V  G     + A+K ++++ + + F AE  V+ ++ H N+ +   G    
Sbjct: 27  QTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNL-VQLLGVIVE 85

Query: 353 -------------NGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYV 399
                         GSL D+L     +G   L      + +LD  + +EY+  +    +V
Sbjct: 86  EKGGLYIVTEYMAKGSLVDYLRS---RGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFV 139

Query: 400 HRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRF 459
           HRD+   N+L+ +   AKV+DFGL K    T +   L  +      +  PE +  K+F  
Sbjct: 140 HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK------WTAPEALREKKF-- 191

Query: 460 DMHSSVMELQVTTKTDVFAFGVVLAELIT 488
                      +TK+DV++FG++L E+ +
Sbjct: 192 -----------STKSDVWSFGILLWEIYS 209

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  120 bits (302), Expect = 8e-29
 Identities = 53/278 (19%), Positives = 87/278 (31%), Gaps = 68/278 (24%)

Query: 298 RIIGRGGFGNVYFGL---LGDREAAIKKMRSNKSKE----FFAELKVLCKIHHIN-VFIS 349
             I  GG G +Y  L   +  R   +K +  +   E      AE + L ++ H + V I 
Sbjct: 86  GCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIF 145

Query: 350 TFGN-------------------GSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYI 390
            F                      SL       L     P+         L+    + Y+
Sbjct: 146 NFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKL-----PVAEAIA--YLLEILPALSYL 198

Query: 391 HDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPE 450
           H       V+ D+K  NI+L +  + K+ D G V               L GTPG+  PE
Sbjct: 199 HSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFGY-------LYGTPGFQAPE 247

Query: 451 YIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKR----ALIRDDSEPTKMKSL 506
                         ++    T  TD++  G  LA L           +    E   +   
Sbjct: 248 --------------IVRTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDDPVLKT 293

Query: 507 ITIMAAVAEWCLNEDAVDRP----EMR-DIVAILSQIM 539
                 +    ++ D   R     EM   +  +L +++
Sbjct: 294 YDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLREVV 331

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  114 bits (287), Expect = 2e-28
 Identities = 58/280 (20%), Positives = 105/280 (37%), Gaps = 69/280 (24%)

Query: 298 RIIGRGGFGNVYFGLLGDREA-AIKKMRSNKSKE-----FFAELKVLCKIHHIN------ 345
           + IG GG   V+  L   ++  AIK +   ++       +  E+  L K+   +      
Sbjct: 34  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93

Query: 346 --VFIST--------FGNGSLSDHLHDPLLKGHQPLT-WTART---QIALDAAKGIEYIH 391
               I+          GN  L+       LK  + +  W  ++    +     + +  IH
Sbjct: 94  YDYEITDQYIYMVMECGNIDLNS-----WLKKKKSIDPWERKSYWKNML----EAVHTIH 144

Query: 392 DHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEY 451
            H     VH D+K +N L+ DG   K+ DFG+    +      +  +  VGT  Y+PPE 
Sbjct: 145 QH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDS-QVGTVNYMPPEA 199

Query: 452 IFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK-------------RALIRDDS 498
           I  K       +   + +++ K+DV++ G +L  +  GK              A+I  + 
Sbjct: 200 I--KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH 257

Query: 499 E---PTKM----KSLITIMAAVAEWCLNEDAVDRPEMRDI 531
           E   P       + ++         CL  D   R  + ++
Sbjct: 258 EIEFPDIPEKDLQDVLK-------CCLKRDPKQRISIPEL 290

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  112 bits (283), Expect = 4e-28
 Identities = 54/288 (18%), Positives = 98/288 (34%), Gaps = 76/288 (26%)

Query: 292 NNFDESRIIGRGGFGNVYFG--LLGDREAAIKKMR----SNKSKEF-FAELKVLCKIHHI 344
            +++    IG G +G           +    K++     +   K+   +E+ +L ++ H 
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65

Query: 345 NV--FISTF---------------GNGSLSDHLHDPLLKGHQPLT----WTARTQIALDA 383
           N+  +                     G L+  +     K  Q L         TQ+ L  
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITK-GTKERQYLDEEFVLRVMTQLTL-- 122

Query: 384 AKGIEYIHDHTKARY--VHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLV 441
              ++  H  +   +  +HRD+K +N+ LD     K+ DFGL ++          A   V
Sbjct: 123 --ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS---FAKTFV 177

Query: 442 GTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRA--------- 492
           GTP Y+ PE +    +               K+D+++ G +L EL               
Sbjct: 178 GTPYYMSPEQMNRMSY-------------NEKSDIWSLGCLLYELCALMPPFTAFSQKEL 224

Query: 493 --LIRDDSEP-------TKMKSLITIMAAVAEWCLNEDAVDRPEMRDI 531
              IR+            ++  +IT         LN     RP + +I
Sbjct: 225 AGKIREGKFRRIPYRYSDELNEIIT-------RMLNLKDYHRPSVEEI 265

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  115 bits (289), Expect = 4e-28
 Identities = 61/331 (18%), Positives = 118/331 (35%), Gaps = 69/331 (20%)

Query: 247 VSKAMSITTRAFSSQGQCKENTEDVTVLESERTIIFSLEEIEEATNNFDESRIIGRGGFG 306
           V +   +   A +   +   ++ D+   + ++    + E I      +   + IG GG  
Sbjct: 11  VPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSS 70

Query: 307 NVYFGLLGDREA-AIKKM-RSNKSKE----FFAELKVLCKIHHINVFI-------ST--- 350
            V+  L   ++  AIK +       +    +  E+  L K+   +  I        T   
Sbjct: 71  KVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 130

Query: 351 ------FGNGSLSDHLHDPLLKGHQPLT-WTAR---TQIALDAAKGIEYIHDHTKARYVH 400
                  GN  L+  L        + +  W  +     +     + +  IH H     VH
Sbjct: 131 IYMVMECGNIDLNSWLKK-----KKSIDPWERKSYWKNML----EAVHTIHQH---GIVH 178

Query: 401 RDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFD 460
            D+K +N L+ DG   K+ DFG+    +      +  +  VG   Y+PPE I  K     
Sbjct: 179 SDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDS-QVGAVNYMPPEAI--KDMSSS 234

Query: 461 MHSSVMELQVTTKTDVFAFGVVLAELITGK-------------RALIRDDSEPT------ 501
             +   + +++ K+DV++ G +L  +  GK              A+I  + E        
Sbjct: 235 RENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPE 294

Query: 502 -KMKSLITIMAAVAEWCLNEDAVDRPEMRDI 531
             ++ ++         CL  D   R  + ++
Sbjct: 295 KDLQDVLK-------CCLKRDPKQRISIPEL 318

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  113 bits (285), Expect = 8e-28
 Identities = 57/280 (20%), Positives = 103/280 (36%), Gaps = 69/280 (24%)

Query: 298 RIIGRGGFGNVYFGLLGDREA-AIK-----KMRSNKSKEFFAELKVLCKIHHINVFIST- 350
           + IG GG   V+  L   ++  AIK     +  +     +  E+  L K+   +  I   
Sbjct: 15  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74

Query: 351 ---------------FGNGSLSDHLHDPLLKGHQPLT-WTART---QIALDAAKGIEYIH 391
                           GN  L+       LK  + +  W  ++    +     + +  IH
Sbjct: 75  YDYEITDQYIYMVMECGNIDLNS-----WLKKKKSIDPWERKSYWKNML----EAVHTIH 125

Query: 392 DHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEY 451
            H     VH D+K +N L+ DG   K+ DFG+    +      +  +  VGT  Y+PPE 
Sbjct: 126 QH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDS-QVGTVNYMPPEA 180

Query: 452 IFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK-------------RALIRDDS 498
           I  K       +   + +++ K+DV++ G +L  +  GK              A+I  + 
Sbjct: 181 I--KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH 238

Query: 499 EPT-------KMKSLITIMAAVAEWCLNEDAVDRPEMRDI 531
           E          ++ ++         CL  D   R  + ++
Sbjct: 239 EIEFPDIPEKDLQDVLK-------CCLKRDPKQRISIPEL 271

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  116 bits (291), Expect = 8e-28
 Identities = 57/286 (19%), Positives = 105/286 (36%), Gaps = 70/286 (24%)

Query: 298 RIIGRGGFGNVYFGLLGDREA--AIKKMRSNKS--KEFFAELKVLCKIHHINVFISTFG- 352
             +G G +G VY G+        A+K ++ +    +EF  E  V+ +I H N+ +   G 
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNL-VQLLGV 284

Query: 353 ---------------NGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKAR 397
                           G+L D+L +      Q ++      +A   +  +EY+       
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLREC---NRQEVSAVVLLYMATQISSAMEYLEKK---N 338

Query: 398 YVHRDIKTSNILLDDGLRAKVADFGLVKLEE----RTNEKEMLATRLVGTPGYLPPEYIF 453
           ++HR++   N L+ +    KVADFGL +L        +       +         PE + 
Sbjct: 339 FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW------TAPESLA 392

Query: 454 VKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRA---------LIRDDSEPTKM- 503
             +F             + K+DV+AFGV+L E+ T   +         +     +  +M 
Sbjct: 393 YNKF-------------SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME 439

Query: 504 ------KSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITST 543
                 + +  +M      C   +  DRP   +I      +   S+
Sbjct: 440 RPEGCPEKVYELM----RACWQWNPSDRPSFAEIHQAFETMFQESS 481

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  111 bits (279), Expect = 3e-27
 Identities = 50/279 (17%), Positives = 83/279 (29%), Gaps = 70/279 (25%)

Query: 293 NFDESRIIGRGGFGNVY--FGLLGDREAAIKKMRSNKS-----KEFFAELKVLCKI-HHI 344
           +F     +G G +G V+        R  A+K+  S            AE+    K+  H 
Sbjct: 58  SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117

Query: 345 NV--FISTFGN------------GSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYI 390
                   +               SL  H           L          D    + ++
Sbjct: 118 CCVRLEQAWEEGGILYLQTELCGPSLQQHCE----AWGASLPEAQVWGYLRDTLLALAHL 173

Query: 391 HDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPE 450
           H       VH D+K +NI L    R K+ DFGL+                 G P Y+ PE
Sbjct: 174 HSQGL---VHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG----AGEVQEGDPRYMAPE 226

Query: 451 YIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK---------RALIRDDSEPT 501
                         +++    T  DVF+ G+ + E+             + L +    P 
Sbjct: 227 --------------LLQGSYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPE 272

Query: 502 -------KMKSLITIMAAVAEWCLNEDAVDRPEMRDIVA 533
                  +++S++          L  D   R     ++A
Sbjct: 273 FTAGLSSELRSVLV-------MMLEPDPKLRATAEALLA 304

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  110 bits (278), Expect = 4e-27
 Identities = 64/314 (20%), Positives = 106/314 (33%), Gaps = 96/314 (30%)

Query: 298 RIIGRGGFGNVYFGLL---GDREA---AIKKMRSNKS----KEFFAELKVLCKIHHINVF 347
           R +G G FG V         D      A+K ++++        +  E+ +L  ++H ++ 
Sbjct: 37  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI- 95

Query: 348 ISTFG------------------NGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEY 389
           I   G                   GSL D+L    +   Q L +    QI     +G+ Y
Sbjct: 96  IKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQ--QIC----EGMAY 149

Query: 390 IHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLP- 448
           +H      Y+HRD+   N+LLD+    K+ DFGL K     +E        V   G  P 
Sbjct: 150 LHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYR-----VREDGDSPV 201

Query: 449 ----PEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIRDDSEPTKM 503
               PE +   +F                +DV++FGV L EL+T    +          +
Sbjct: 202 FWYAPECLKEYKF-------------YYASDVWSFGVTLYELLTHCDSSQSPPTKFLELI 248

Query: 504 -----------------------------KSLITIMAAVAEWCLNEDAVDRPEMRDIVAI 534
                                          +  +M      C   +A  RP   +++ I
Sbjct: 249 GIAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKN----CWETEASFRPTFENLIPI 304

Query: 535 LSQIMITSTEWEAS 548
           L   +    + +A 
Sbjct: 305 LKT-VHEKYQGQAP 317

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  110 bits (276), Expect = 4e-27
 Identities = 57/269 (21%), Positives = 97/269 (36%), Gaps = 67/269 (24%)

Query: 299 IIGRGGFGNVYFGLLGD--REAAIKKMR-SNKSKE----FFAELKVLCKIHH-------- 343
            IGRG F  VY GL  +   E A  +++    +K     F  E ++L  + H        
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92

Query: 344 -----------INVFISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHD 392
                      I +      +G+L        LK  + +             KG++++H 
Sbjct: 93  SWESTVKGKKCIVLVTELMTSGTLKT-----YLKRFKVMKIKVLRSWCRQILKGLQFLHT 147

Query: 393 HTKARYVHRDIKTSNILLD--DGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPE 450
            T    +HRD+K  NI +    G   K+ D GL  L+  +  K +     +GTP ++ PE
Sbjct: 148 RTPP-IIHRDLKCDNIFITGPTGS-VKIGDLGLATLKRASFAKAV-----IGTPEFMAPE 200

Query: 451 YIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK---------RALIRDDSEPT 501
                           E +     DV+AFG+ + E+ T +           + R  +   
Sbjct: 201 MY--------------EEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGV 246

Query: 502 KMKSLITIMAAVA----EWCLNEDAVDRP 526
           K  S   +         E C+ ++  +R 
Sbjct: 247 KPASFDKVAIPEVKEIIEGCIRQNKDERY 275

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  112 bits (281), Expect = 4e-27
 Identities = 79/368 (21%), Positives = 130/368 (35%), Gaps = 81/368 (22%)

Query: 229 ILLRRKRPEEKITEDAKHVSKAMSITTRAFSSQGQCKENTE-DVTVLESERTIIFSLEEI 287
           IL+ R  P        + +S ++     + +   Q       D++ L  E         I
Sbjct: 25  ILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSALNPELVQAVQHVVI 84

Query: 288 EEATNNFDESRIIGRGGFGNVYFGLLGDREA-----AIKKMRSNKS----KEFFAELKVL 338
             ++     + +IGRG FG VY G L D +      A+K +          +F  E  ++
Sbjct: 85  GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 144

Query: 339 CKIHHINVFISTFG-----------------NGSLSDHL--HDPLLKGHQPLTWTARTQI 379
               H NV +S  G                 +G L + +            +        
Sbjct: 145 KDFSHPNV-LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI------GF 197

Query: 380 ALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATR 439
            L  AKG++++      ++VHRD+   N +LD+    KVADFGL +         +    
Sbjct: 198 GLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK- 253

Query: 440 LVGTPGYLP-----PEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKR-- 491
              T   LP      E +  ++F             TTK+DV++FGV+L EL+T G    
Sbjct: 254 ---TGAKLPVKWMALESLQTQKF-------------TTKSDVWSFGVLLWELMTRGAPPY 297

Query: 492 ---------ALIRDD---SEPTK-MKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQI 538
                      +       +P      L  +M      C +  A  RP   ++V+ +S I
Sbjct: 298 PDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLK----CWHPKAEMRPSFSELVSRISAI 353

Query: 539 MITSTEWE 546
             T     
Sbjct: 354 FSTFIGEH 361

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  114 bits (286), Expect = 4e-27
 Identities = 74/282 (26%), Positives = 112/282 (39%), Gaps = 63/282 (22%)

Query: 298 RIIGRGGFGNVYFGLL-GDREAAIKKMRSNKS--KEFFAELKVLCKIHHINVFISTFG-- 352
             +G+G FG V+ G   G    AIK ++      + F  E +V+ K+ H  + +  +   
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKL-VQLYAVV 331

Query: 353 -------------NGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYV 399
                         GSL D L        + L       +A   A G+ Y+       YV
Sbjct: 332 SEEPIYIVTEYMSKGSLLDFLKGE---TGKYLRLPQLVDMAAQIASGMAYVERM---NYV 385

Query: 400 HRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP-GYLPPEYIFVKRFR 458
           HRD++ +NIL+ + L  KVADFGL +L E   + E  A +    P  +  PE     RF 
Sbjct: 386 HRDLRAANILVGENLVCKVADFGLARLIE---DNEYTARQGAKFPIKWTAPEAALYGRF- 441

Query: 459 FDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIR-DDSEPTKM------------- 503
                       T K+DV++FG++L EL T G+       + E                 
Sbjct: 442 ------------TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC 489

Query: 504 -KSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITSTE 544
            +SL  +M      C  ++  +RP    + A L     TSTE
Sbjct: 490 PESLHDLM----CQCWRKEPEERPTFEYLQAFLED-YFTSTE 526

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  110 bits (278), Expect = 5e-27
 Identities = 61/225 (27%), Positives = 97/225 (43%), Gaps = 62/225 (27%)

Query: 298 RIIGRGGFGNVYFGL---LGDREA---AIKKMR---SNKSKEFFAELKVLCKIHHINVFI 348
             +G+G FG+V       LGD      A+K+++    ++ ++F  E+++L  +H   + +
Sbjct: 29  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFI-V 87

Query: 349 STFG------------------NGSLSDHL--HDPLLKGHQPLTWTARTQIALDAAKGIE 388
              G                  +G L D L  H   L   + L +++  QI     KG+E
Sbjct: 88  KYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSS--QIC----KGME 141

Query: 389 YIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLP 448
           Y+      R VHRD+   NIL++     K+ADFGL KL     +       +V  PG  P
Sbjct: 142 YLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKD-----YYVVREPGQSP 193

Query: 449 -----PEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
                PE +    F             + ++DV++FGVVL EL T
Sbjct: 194 IFWYAPESLSDNIF-------------SRQSDVWSFGVVLYELFT 225

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  110 bits (276), Expect = 5e-27
 Identities = 58/307 (18%), Positives = 102/307 (33%), Gaps = 97/307 (31%)

Query: 298 RIIGRGGFGNVYFGLL---GDREA---AIKKMRSNKS----KEFFAELKVLCKIHHINVF 347
           R +G G FG V        GD      A+K ++         +   E+++L  ++H N+ 
Sbjct: 27  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI- 85

Query: 348 ISTFG------------------NGSLSDHL--HDPLLKGHQPLTWTARTQIALDAAKGI 387
           +   G                  +GSL ++L  +   +   Q L +    QI     KG+
Sbjct: 86  VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAV--QIC----KGM 139

Query: 388 EYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYL 447
           +Y+      +YVHRD+   N+L++   + K+ DFGL K  E   E        V      
Sbjct: 140 DYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKE-----YYTVKDDRDS 191

Query: 448 P-----PEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIRDDSEPT 501
           P     PE +   +F                +DV++FGV L EL+T              
Sbjct: 192 PVFWYAPECLMQSKF-------------YIASDVWSFGVTLHELLTYCDSDSSPMALFLK 238

Query: 502 KMKS-----------------------------LITIMAAVAEWCLNEDAVDRPEMRDIV 532
            +                               +  +M      C      +R   ++++
Sbjct: 239 MIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRK----CWEFQPSNRTSFQNLI 294

Query: 533 AILSQIM 539
                ++
Sbjct: 295 EGFEALL 301

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  112 bits (282), Expect = 8e-27
 Identities = 74/282 (26%), Positives = 112/282 (39%), Gaps = 63/282 (22%)

Query: 298 RIIGRGGFGNVYFGLL-GDREAAIKKMRSNKS--KEFFAELKVLCKIHHINVFISTFG-- 352
             +G+G FG V+ G   G    AIK ++      + F  E +V+ K+ H  + +  +   
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKL-VQLYAVV 248

Query: 353 -------------NGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYV 399
                         GSL D L        + L       +A   A G+ Y+       YV
Sbjct: 249 SEEPIYIVTEYMSKGSLLDFLKGE---TGKYLRLPQLVDMAAQIASGMAYVERM---NYV 302

Query: 400 HRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP-GYLPPEYIFVKRFR 458
           HRD++ +NIL+ + L  KVADFGL +L E   + E  A +    P  +  PE     RF 
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLIE---DNEYTARQGAKFPIKWTAPEAALYGRF- 358

Query: 459 FDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIR-DDSEPTKM------------- 503
                       T K+DV++FG++L EL T G+       + E                 
Sbjct: 359 ------------TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC 406

Query: 504 -KSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITSTE 544
            +SL  +M      C  ++  +RP    + A L     TSTE
Sbjct: 407 PESLHDLM----CQCWRKEPEERPTFEYLQAFLED-YFTSTE 443

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  108 bits (273), Expect = 1e-26
 Identities = 75/310 (24%), Positives = 120/310 (38%), Gaps = 85/310 (27%)

Query: 286 EIEEATNNFDESRIIGRGGFGNVYFGLLGDREA-----AIKKMRSNKS----KEFFAELK 336
            I          R+IG+G FG VY G   D+       AIK +         + F  E  
Sbjct: 15  LIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGL 74

Query: 337 VLCKIHHINVFISTFG-----------------NGSLSDHLHDPLLKGHQPLTWTARTQI 379
           ++  ++H NV ++  G                 +G L   +  P     +  T       
Sbjct: 75  LMRGLNHPNV-LALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSP----QRNPTVKDLISF 129

Query: 380 ALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATR 439
            L  A+G+EY+ +    ++VHRD+   N +LD+    KVADFGL +      ++E  + +
Sbjct: 130 GLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDIL---DREYYSVQ 183

Query: 440 LVGTPGYLP-----PEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT------ 488
                  LP      E +   RF             TTK+DV++FGV+L EL+T      
Sbjct: 184 -QHRHARLPVKWTALESLQTYRF-------------TTKSDVWSFGVLLWELLTRGAPPY 229

Query: 489 --------------GKRALIRDDSEPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI 534
                         G+R L + +  P    SL  +M    + C   D   RP  R +V  
Sbjct: 230 RHIDPFDLTHFLAQGRR-LPQPEYCP---DSLYQVM----QQCWEADPAVRPTFRVLVGE 281

Query: 535 LSQIMITSTE 544
           + Q ++++  
Sbjct: 282 VEQ-IVSALL 290

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  110 bits (277), Expect = 1e-26
 Identities = 61/315 (19%), Positives = 120/315 (38%), Gaps = 97/315 (30%)

Query: 298 RIIGRGGFGNVY----FGLLGDREA-----AIKKMRSNKS----KEFFAELKVLCKI-HH 343
           + +G G FG V      G+  D+       A+K ++ + +     +  +E++++  I  H
Sbjct: 87  KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 146

Query: 344 INVFISTFG----------------NGSLSDHL-----------HDPLLKGHQPLTWTAR 376
            N+ I+  G                 G+L ++L           +D      + +T+   
Sbjct: 147 KNI-INLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205

Query: 377 TQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEML 436
                  A+G+EY+      + +HRD+   N+L+ +    K+ADFGL +     +  +  
Sbjct: 206 VSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK-- 260

Query: 437 ATRLVGTPGYLP-----PEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT--- 488
                 T G LP     PE +F + +             T ++DV++FGV++ E+ T   
Sbjct: 261 ----KTTNGRLPVKWMAPEALFDRVY-------------THQSDVWSFGVLMWEIFTLGG 303

Query: 489 -----------------GKRALIRDDSEPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDI 531
                            G R + +  +   ++     +M      C +     RP  + +
Sbjct: 304 SPYPGIPVEELFKLLKEGHR-MDKPANCTNELYM---MM----RDCWHAVPSQRPTFKQL 355

Query: 532 VAILSQIMITSTEWE 546
           V  L +I+  +T  E
Sbjct: 356 VEDLDRILTLTTNEE 370

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  108 bits (273), Expect = 1e-26
 Identities = 72/303 (23%), Positives = 120/303 (39%), Gaps = 89/303 (29%)

Query: 298 RIIGRGGFGNVYFGL---LGDREA---AIKKMRSN---KSKEFFAELKVLCKIHHINVFI 348
           + +G+G FG+V       L D      A+KK++ +     ++F  E+++L  + H N+ +
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI-V 74

Query: 349 STFG------------------NGSLSDHL--HDPLLKGHQPLTWTARTQIALDAAKGIE 388
              G                   GSL D+L  H   +   + L +T+  QI     KG+E
Sbjct: 75  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS--QIC----KGME 128

Query: 389 YIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLP 448
           Y+      RY+HRD+ T NIL+++  R K+ DFGL K+    +++          PG  P
Sbjct: 129 YLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLP-QDKEFFKVK----EPGESP 180

Query: 449 -----PEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKM 503
                PE +   +F             +  +DV++FGVVL EL T         +E  +M
Sbjct: 181 IFWYAPESLTESKF-------------SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRM 227

Query: 504 K--------SLITIMAAVAE-------------------WCLNEDAVDRPEMRDIVAILS 536
                     +  ++  +                      C N +   RP  RD+   + 
Sbjct: 228 IGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 287

Query: 537 QIM 539
           QI 
Sbjct: 288 QIR 290

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  108 bits (272), Expect = 2e-26
 Identities = 70/302 (23%), Positives = 111/302 (36%), Gaps = 80/302 (26%)

Query: 286 EIEEATNNFDESRIIGRGGFGNVYFGLLGDREA-----AIKKMRSNKS----KEFFAELK 336
            I  ++     + +IGRG FG VY G L D +      A+K +          +F  E  
Sbjct: 19  VIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGI 78

Query: 337 VLCKIHHINVFISTFG-----------------NGSLSDHL--HDPLLKGHQPLTWTART 377
           ++    H NV +S  G                 +G L + +            +      
Sbjct: 79  IMKDFSHPNV-LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI------ 131

Query: 378 QIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLA 437
              L  AKG++Y+      ++VHRD+   N +LD+    KVADFGL +         +  
Sbjct: 132 GFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHN 188

Query: 438 TRLVGTPGYLP-----PEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKR 491
                T   LP      E +  ++F             TTK+DV++FGV+L EL+T G  
Sbjct: 189 K----TGAKLPVKWMALESLQTQKF-------------TTKSDVWSFGVLLWELMTRGAP 231

Query: 492 -----------ALIRDD---SEPTK-MKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILS 536
                        +       +P      L  +M      C +  A  RP   ++V+ +S
Sbjct: 232 PYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLK----CWHPKAEMRPSFSELVSRIS 287

Query: 537 QI 538
            I
Sbjct: 288 AI 289

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  108 bits (273), Expect = 2e-26
 Identities = 68/296 (22%), Positives = 118/296 (39%), Gaps = 81/296 (27%)

Query: 298 RIIGRGGFGNVYFGLL----GDREAAIKKMRSNKS----KEFFAELKVLCKI-HHINVFI 348
            +IG G FG V    +       +AAIK+M+   S    ++F  EL+VLCK+ HH N+ I
Sbjct: 31  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI-I 89

Query: 349 STFG----------------NGSLSDHL-----------HDPLLKGHQPLTWTARTQIAL 381
           +  G                +G+L D L                     L+       A 
Sbjct: 90  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149

Query: 382 DAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEE--RTNEKEMLATR 439
           D A+G++Y+      +++HRD+   NIL+ +   AK+ADFGL + +E         L  R
Sbjct: 150 DVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVR 206

Query: 440 LVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GK-------- 490
                 ++  E +    +             TT +DV+++GV+L E+++ G         
Sbjct: 207 ------WMAIESLNYSVY-------------TTNSDVWSYGVLLWEIVSLGGTPYCGMTC 247

Query: 491 RALIRDDSEPTKM-------KSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIM 539
             L     +  ++         +  +M      C  E   +RP    I+  L++++
Sbjct: 248 AELYEKLPQGYRLEKPLNCDDEVYDLMRQ----CWREKPYERPSFAQILVSLNRML 299

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  109 bits (273), Expect = 2e-26
 Identities = 73/312 (23%), Positives = 117/312 (37%), Gaps = 98/312 (31%)

Query: 298 RIIGRGGFGNVYFGL---LGDREA---AIKKMR---SNKSKEFFAELKVLCKIHHINVFI 348
           + +G+G FG+V       L D      A+KK++       ++F  E+++L  + H N+ +
Sbjct: 47  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI-V 105

Query: 349 STFG------------------NGSLSDHL--HDPLLKGHQPLTWTARTQIALDAAKGIE 388
              G                   GSL D+L  H   +   + L +T+  QI     KG+E
Sbjct: 106 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS--QIC----KGME 159

Query: 389 YIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLP 448
           Y+      RY+HRD+ T NIL+++  R K+ DFGL K+    +++          PG  P
Sbjct: 160 YLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLP-QDKEYYKVK----EPGESP 211

Query: 449 -----PEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKM 503
                PE +   +F             +  +DV++FGVVL EL T         +E  +M
Sbjct: 212 IFWYAPESLTESKF-------------SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRM 258

Query: 504 KSLI-------------------------------TIMAAVAEWCLNEDAVDRPEMRDIV 532
                                               IM      C N +   RP  RD+ 
Sbjct: 259 IGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTE----CWNNNVNQRPSFRDLA 314

Query: 533 AILSQIMITSTE 544
             + Q +     
Sbjct: 315 LRVDQ-IRDQMA 325

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  108 bits (272), Expect = 3e-26
 Identities = 61/227 (26%), Positives = 91/227 (40%), Gaps = 62/227 (27%)

Query: 298 RIIGRGGFGNVYFGLLGDREA------AIKKMRSNKS----KEFFAELKVLCKIHHINVF 347
           +++G G FG VY GL            AIK++R   S    KE   E  V+  + + +V 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV- 79

Query: 348 ISTFG---------------NGSLSDHL--HDPLLKGHQPLTWTARTQIALDAAKGIEYI 390
               G                G L D++  H   +     L W       +  AKG+ Y+
Sbjct: 80  CRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYL 133

Query: 391 HDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLP-- 448
            D    R VHRD+   N+L+      K+ DFGL KL     EKE  A       G +P  
Sbjct: 134 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA-EEKEYHAEG-----GKVPIK 184

Query: 449 ---PEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKR 491
               E I  + +             T ++DV+++GV + EL+T G +
Sbjct: 185 WMALESILHRIY-------------THQSDVWSYGVTVWELMTFGSK 218

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  106 bits (268), Expect = 5e-26
 Identities = 59/214 (27%), Positives = 91/214 (42%), Gaps = 50/214 (23%)

Query: 298 RIIGRGGFGNVYFGLL-GDREAAIKKMRSNKS--KEFFAELKVLCKIHHINVFISTFG-- 352
             +G G FG V+ G   G  + A+K ++        F AE  ++ ++ H  + +  +   
Sbjct: 19  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRL-VRLYAVV 77

Query: 353 -------------NGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYV 399
                        NGSL D L  P       LT      +A   A+G+ +I +     Y+
Sbjct: 78  TQEPIYIITEYMENGSLVDFLKTP---SGIKLTINKLLDMAAQIAEGMAFIEER---NYI 131

Query: 400 HRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLP-----PEYIFV 454
           HRD++ +NIL+ D L  K+ADFGL +L E         T   G     P     PE I  
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNE-----YTAREG--AKFPIKWTAPEAINY 184

Query: 455 KRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
             F             T K+DV++FG++L E++T
Sbjct: 185 GTF-------------TIKSDVWSFGILLTEIVT 205

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  107 bits (269), Expect = 6e-26
 Identities = 66/299 (22%), Positives = 111/299 (37%), Gaps = 88/299 (29%)

Query: 298 RIIGRGGFGNVYFGLL-------GDREAAIKKMRSNKS----KEFFAELKVLCKIHHINV 346
           R +G+G FG VY G+         +   AIK +    S     EF  E  V+ + +  +V
Sbjct: 31  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90

Query: 347 FISTFG----------------NGSLSDHL-----HDPLLKGHQPLTWTARTQIALDAAK 385
            +   G                 G L  +L              P + +   Q+A + A 
Sbjct: 91  -VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 149

Query: 386 GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLV-KLEE----RTNEKEMLATRL 440
           G+ Y++ +   ++VHRD+   N ++ +    K+ DFG+   + E    R   K +L  R 
Sbjct: 150 GMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR- 205

Query: 441 VGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT------------ 488
                ++ PE +    F             TT +DV++FGVVL E+ T            
Sbjct: 206 -----WMSPESLKDGVF-------------TTYSDVWSFGVVLWEIATLAEQPYQGLSNE 247

Query: 489 --------GKRALIRDDSEPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIM 539
                   G   L + D+ P  +  L   M      C   +   RP   +I++ + + M
Sbjct: 248 QVLRFVMEGGL-LDKPDNCPDMLFEL---MRM----CWQYNPKMRPSFLEIISSIKEEM 298

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  106 bits (267), Expect = 7e-26
 Identities = 52/216 (24%), Positives = 86/216 (39%), Gaps = 52/216 (24%)

Query: 298 RIIGRGGFGNVYFGLLGDREA--AIKKMRSNKS--KEFFAELKVLCKIHHINVFISTFG- 352
             +G G +G VY G+        A+K ++ +    +EF  E  V+ +I H N+ +   G 
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNL-VQLLGV 77

Query: 353 ---------------NGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKAR 397
                           G+L D+L +      Q ++      +A   +  +EY+       
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYLREC---NRQEVSAVVLLYMATQISSAMEYLEKK---N 131

Query: 398 YVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLP-----PEYI 452
           ++HRD+   N L+ +    KVADFGL +L          A          P     PE +
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLMT---GDTYTAH----AGAKFPIKWTAPESL 184

Query: 453 FVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
              +F             + K+DV+AFGV+L E+ T
Sbjct: 185 AYNKF-------------SIKSDVWAFGVLLWEIAT 207

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  108 bits (272), Expect = 8e-26
 Identities = 38/299 (12%), Positives = 74/299 (24%), Gaps = 84/299 (28%)

Query: 298 RIIGRGGFGNVYFG--LLGDREAAIKKMRSNKS---------KEFFAELKVLCKIHHINV 346
            ++G+                   +      +          KE    L++L  I +   
Sbjct: 84  TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143

Query: 347 FISTFGNGSLSDHLHDP----------------------------------------LLK 366
                      D + DP                                           
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203

Query: 367 GHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKL 426
            H+ L   AR Q+ L   + +  +H +     VH  ++  +I+LD      +  F  +  
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVR 260

Query: 427 EERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAEL 486
           +  +              G+ PPE    +   F  H       +T   D +  G+ +  +
Sbjct: 261 DGAS-------AVSPIGRGFAPPETTAERMLPFGQHH---PTLMTFAFDTWTLGLAIYWI 310

Query: 487 ITGK------------RALIRDDSE-PTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIV 532
                             + R     P  +++L+       E  L     DR      +
Sbjct: 311 WCADLPNTDDAALGGSEWIFRSCKNIPQPVRALL-------EGFLRYPKEDRLLPLQAM 362

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  106 bits (266), Expect = 9e-26
 Identities = 54/216 (25%), Positives = 90/216 (41%), Gaps = 54/216 (25%)

Query: 298 RIIGRGGFGNVYFGLL-GDREAAIKKMRSNKS--KEFFAELKVLCKIHHINV-------- 346
           + +G G FG V +G   G  + AIK ++       EF  E KV+  + H  +        
Sbjct: 30  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 89

Query: 347 -----FIST--FGNGSLSDHL--HDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKAR 397
                FI T    NG L ++L       +  Q L      ++  D  + +EY+      +
Sbjct: 90  KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLL------EMCKDVCEAMEYLESK---Q 140

Query: 398 YVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLP-----PEYI 452
           ++HRD+   N L++D    KV+DFGL +            T  VG     P     PE +
Sbjct: 141 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-----YTSSVG--SKFPVRWSPPEVL 193

Query: 453 FVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
              +F             ++K+D++AFGV++ E+ +
Sbjct: 194 MYSKF-------------SSKSDIWAFGVLMWEIYS 216

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  109 bits (274), Expect = 9e-26
 Identities = 69/286 (24%), Positives = 106/286 (37%), Gaps = 71/286 (24%)

Query: 298 RIIGRGGFGNVYFGLL-GDREAAIKKMRSNKS--KEFFAELKVLCKIHHINVFISTFG-- 352
           + +G G FG V+        + A+K M+      + F AE  V+  + H  + +      
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKL-VKLHAVV 252

Query: 353 -------------NGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYV 399
                         GSL D L                   +   A+G+ +I       Y+
Sbjct: 253 TKEPIYIITEFMAKGSLLDFLKSD---EGSKQPLPKLIDFSAQIAEGMAFIEQR---NYI 306

Query: 400 HRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLP-----PEYIFV 454
           HRD++ +NIL+   L  K+ADFGL ++ E   + E  A          P     PE I  
Sbjct: 307 HRDLRAANILVSASLVCKIADFGLARVIE---DNEYTAR----EGAKFPIKWTAPEAINF 359

Query: 455 KRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GK------------RALIRDDSEPT 501
             F             T K+DV++FG++L E++T G+            RAL R    P 
Sbjct: 360 GSF-------------TIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPR 406

Query: 502 KM---KSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITSTE 544
                + L  IM      C      +RP    I ++L     T+TE
Sbjct: 407 PENCPEELYNIM----MRCWKNRPEERPTFEYIQSVLDD-FYTATE 447

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  106 bits (267), Expect = 1e-25
 Identities = 58/300 (19%), Positives = 101/300 (33%), Gaps = 89/300 (29%)

Query: 298 RIIGRGGFGNVYFGLLGDREA-----AIKKMRSNKS-----KEFFAELKVLCKIHHINVF 347
           R++G+G FG+V    L   +      A+K ++++       +EF  E   + +  H +V 
Sbjct: 29  RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV- 87

Query: 348 ISTFG----------------------NGSLSDHLHDPLLKGH-QPLTWTARTQIALDAA 384
               G                      +G L   L    +  +   L      +  +D A
Sbjct: 88  AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147

Query: 385 KGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP 444
            G+EY+       ++HRD+   N +L + +   VADFGL +     +          G  
Sbjct: 148 CGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYR------QGCA 198

Query: 445 GYLP-----PEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT----------- 488
             LP      E +    +             T  +DV+AFGV + E++T           
Sbjct: 199 SKLPVKWLALESLADNLY-------------TVHSDVWAFGVTMWEIMTRGQTPYAGIEN 245

Query: 489 ---------GKRALIRDDSEPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIM 539
                    G R L +        + +  +M      C + D   RP    +   L  I+
Sbjct: 246 AEIYNYLIGGNR-LKQPPECM---EEVYDLMYQ----CWSADPKQRPSFTCLRMELENIL 297

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  106 bits (267), Expect = 1e-25
 Identities = 67/299 (22%), Positives = 110/299 (36%), Gaps = 88/299 (29%)

Query: 298 RIIGRGGFGNVYFGLLGDREA-----AIKKMRSNKS-----KEFFAELKVLCKIHHINVF 347
           +I+G G FG+V  G L   +      A+K M+ + S     +EF +E   +    H NV 
Sbjct: 40  KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV- 98

Query: 348 ISTFG---------------------NGSLSDHLHDPLLKGH-QPLTWTARTQIALDAAK 385
           I   G                      G L  +L    L+   + +      +  +D A 
Sbjct: 99  IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158

Query: 386 GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPG 445
           G+EY+ +     ++HRD+   N +L D +   VADFGL K     +          G   
Sbjct: 159 GMEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYR------QGRIA 209

Query: 446 YLP-----PEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT------------ 488
            +P      E +  + +             T+K+DV+AFGV + E+ T            
Sbjct: 210 KMPVKWIAIESLADRVY-------------TSKSDVWAFGVTMWEIATRGMTPYPGVQNH 256

Query: 489 --------GKRALIRDDSEPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIM 539
                   G R L + +    +   L  IM +    C   D +DRP    +   L +++
Sbjct: 257 EMYDYLLHGHR-LKQPEDCLDE---LYEIMYS----CWRTDPLDRPTFSVLRLQLEKLL 307

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  106 bits (268), Expect = 1e-25
 Identities = 59/301 (19%), Positives = 108/301 (35%), Gaps = 86/301 (28%)

Query: 298 RIIGRGGFGNVY----FGLLGDREA---AIKKMRSNKS----KEFFAELKVLCKI-HHIN 345
           + +G G FG V     FGL  +      A+K ++S       +   +ELK++  +  H N
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111

Query: 346 VFISTFG----------------NGSLSDHL---------HDPLLKGHQPLTWTARTQIA 380
           + ++  G                 G L + L                +   +       +
Sbjct: 112 I-VNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170

Query: 381 LDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRL 440
              A+G+ ++        +HRD+   N+LL +G  AK+ DFGL +     +         
Sbjct: 171 SQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI------ 221

Query: 441 VGTPGYLP-----PEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GK---- 490
           V     LP     PE IF   +             T ++DV+++G++L E+ + G     
Sbjct: 222 VKGNARLPVKWMAPESIFDCVY-------------TVQSDVWSYGILLWEIFSLGLNPYP 268

Query: 491 -----RALIRDDSEPTKM-------KSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQI 538
                    +   +  +M       K++ +IM A    C   +   RP  + I + L + 
Sbjct: 269 GILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQA----CWALEPTHRPTFQQICSFLQEQ 324

Query: 539 M 539
            
Sbjct: 325 A 325

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  105 bits (264), Expect = 1e-25
 Identities = 50/212 (23%), Positives = 87/212 (41%), Gaps = 46/212 (21%)

Query: 298 RIIGRGGFGNVYFGLL-GDREAAIKKMRSNKS--KEFFAELKVLCKIHHIN--------- 345
           + IG G FG V+ G      + AIK +R      ++F  E +V+ K+ H           
Sbjct: 14  QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 73

Query: 346 ----VFIST--FGNGSLSDHL--HDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKAR 397
               + + T    +G LSD+L     L      L       + LD  +G+ Y+ +     
Sbjct: 74  EQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLL------GMCLDVCEGMAYLEEA---C 124

Query: 398 YVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP-GYLPPEYIFVKR 456
            +HRD+   N L+ +    KV+DFG+ +            T+    P  +  PE     R
Sbjct: 125 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKF---PVKWASPEVFSFSR 181

Query: 457 FRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
           +             ++K+DV++FGV++ E+ +
Sbjct: 182 Y-------------SSKSDVWSFGVLMWEVFS 200

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  106 bits (267), Expect = 1e-25
 Identities = 60/313 (19%), Positives = 119/313 (38%), Gaps = 97/313 (30%)

Query: 298 RIIGRGGFGNVY----FGLLGDREA-----AIKKMRSNKS----KEFFAELKVLCKI-HH 343
           + +G G FG V      G+  D+       A+K ++ + +     +  +E++++  I  H
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100

Query: 344 INVFISTFG----------------NGSLSDHL-----------HDPLLKGHQPLTWTAR 376
            N+ I+  G                 G+L ++L           +D      + +T+   
Sbjct: 101 KNI-INLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159

Query: 377 TQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEML 436
                  A+G+EY+      + +HRD+   N+L+ +    K+ADFGL +     +  +  
Sbjct: 160 VSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK-- 214

Query: 437 ATRLVGTPGYLP-----PEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT--- 488
                 T G LP     PE +F + +             T ++DV++FGV++ E+ T   
Sbjct: 215 ----KTTNGRLPVKWMAPEALFDRVY-------------THQSDVWSFGVLMWEIFTLGG 257

Query: 489 -----------------GKRALIRDDSEPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDI 531
                            G R + +  +   ++     +M      C +     RP  + +
Sbjct: 258 SPYPGIPVEELFKLLKEGHR-MDKPANCTNELYM---MMRD----CWHAVPSQRPTFKQL 309

Query: 532 VAILSQIMITSTE 544
           V  L +I+  +T 
Sbjct: 310 VEDLDRILTLTTN 322

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  108 bits (271), Expect = 2e-25
 Identities = 52/274 (18%), Positives = 99/274 (36%), Gaps = 52/274 (18%)

Query: 293 NFDESRIIGRGGFGNVYF-GLLGDREAAIKKMRSNKSKEFFAELKVLCKI-HHINV--FI 348
           +F    ++G G  G + + G+  +R+ A+K++          E+++L +   H NV  + 
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYF 84

Query: 349 STFGN------------GSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKA 396
            T  +             +L +++             T   Q       G+ ++H     
Sbjct: 85  CTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTT----SGLAHLHSL--- 137

Query: 397 RYVHRDIKTSNILL-----DDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEY 451
             VHRD+K  NIL+        ++A ++DFGL K            + + GT G++ PE 
Sbjct: 138 NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEM 197

Query: 452 IFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG----------KRALIRDDSEPT 501
           +          S   +   T   D+F+ G V   +I+           ++A I   +   
Sbjct: 198 L----------SEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSL 247

Query: 502 KMKSLITIMAAVA----EWCLNEDAVDRPEMRDI 531
                      +A    E  +  D   RP  + +
Sbjct: 248 DCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHV 281

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  106 bits (266), Expect = 2e-25
 Identities = 63/295 (21%), Positives = 107/295 (36%), Gaps = 74/295 (25%)

Query: 298 RIIGRGGFGNVYFG--LLGDREAAIKKMRSNKSKEF---FAELKVLCKI-HHINV--FIS 349
           R++  GGF  VY    +   RE A+K++ SN+ ++      E+  + K+  H N+  F S
Sbjct: 34  RVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCS 93

Query: 350 TFG--------------------NGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEY 389
                                   G L + L     +G  PL+     +I     + +++
Sbjct: 94  AASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRG--PLSCDTVLKIFYQTCRAVQH 151

Query: 390 IHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEK----------EMLATR 439
           +H   K   +HRD+K  N+LL +    K+ DFG         +           E   TR
Sbjct: 152 MHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITR 210

Query: 440 LVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK--------R 491
              TP Y  PE          +        +  K D++A G +L  L   +         
Sbjct: 211 -NTTPMYRTPE----------IIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL 259

Query: 492 ALIR-------DDSEPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIM 539
            ++         D++ T   SLI  M       L  +  +R  + ++V  L +I 
Sbjct: 260 RIVNGKYSIPPHDTQYTVFHSLIRAM-------LQVNPEERLSIAEVVHQLQEIA 307

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  105 bits (265), Expect = 2e-25
 Identities = 57/295 (19%), Positives = 105/295 (35%), Gaps = 81/295 (27%)

Query: 298 RIIGRGGFGNVYFGLLGDREA------AIKKMRSNKS----KEFFAELKVLCKIHHINVF 347
           +++G G FG V+ G+             IK +         +     +  +  + H ++ 
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI- 77

Query: 348 ISTFG---------------NGSLSDHL--HDPLLKGHQPLTWTARTQIALDAAKGIEYI 390
           +   G                GSL DH+  H   L     L W    QIA    KG+ Y+
Sbjct: 78  VRLLGLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGV--QIA----KGMYYL 131

Query: 391 HDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLP-- 448
            +H     VHR++   N+LL    + +VADFG+  L    +++ +       +    P  
Sbjct: 132 EEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLL------YSEAKTPIK 182

Query: 449 ---PEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKR-----------AL 493
               E I   ++             T ++DV+++GV + EL+T G              L
Sbjct: 183 WMALESIHFGKY-------------THQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDL 229

Query: 494 IRDD---SEPTK-MKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITSTE 544
           +      ++P      +  +M      C   D   RP  +++    +++      
Sbjct: 230 LEKGERLAQPQICTIDVYMVMVK----CWMIDENIRPTFKELANEFTRMARDPPR 280

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  105 bits (265), Expect = 2e-25
 Identities = 68/316 (21%), Positives = 117/316 (37%), Gaps = 102/316 (32%)

Query: 298 RIIGRGGFGNVY----FGLLGDREA---AIKKMRSNKS----KEFFAELKVLCKIHHINV 346
           + +G G FG V     F L G       A+K ++ N S    ++  +E  VL +++H +V
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88

Query: 347 FISTFG----------------NGSLSDHL-------------------HDPLLKGHQPL 371
            I  +G                 GSL   L                           + L
Sbjct: 89  -IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147

Query: 372 TWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTN 431
           T       A   ++G++Y+ +    + VHRD+   NIL+ +G + K++DFGL +     +
Sbjct: 148 TMGDLISFAWQISQGMQYLAEM---KLVHRDLAARNILVAEGRKMKISDFGLSRDVYEED 204

Query: 432 EKEMLATRLVGTPGYLP-----PEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAEL 486
                      + G +P      E +F   +             TT++DV++FGV+L E+
Sbjct: 205 SYV------KRSQGRIPVKWMAIESLFDHIY-------------TTQSDVWSFGVLLWEI 245

Query: 487 IT--------------------GKRALIRDDSEPTKMKSLITIMAAVAEWCLNEDAVDRP 526
           +T                    G R + R D+   +M     +M      C  ++   RP
Sbjct: 246 VTLGGNPYPGIPPERLFNLLKTGHR-MERPDNCSEEMYR---LMLQ----CWKQEPDKRP 297

Query: 527 EMRDIVAILSQIMITS 542
              DI   L ++M+  
Sbjct: 298 VFADISKDLEKMMVKR 313

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  103 bits (260), Expect = 4e-25
 Identities = 50/217 (23%), Positives = 92/217 (42%), Gaps = 56/217 (25%)

Query: 298 RIIGRGGFGNVYFGLL-GDREAAIKKMRSNKS--KEFFAELKVLCKIHHINVFISTFG-- 352
           + +G G FG V  G   G  + A+K ++       EFF E + + K+ H  + +  +G  
Sbjct: 14  KELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKL-VKFYGVC 72

Query: 353 --------------NGSLSDHL--HDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKA 396
                         NG L ++L  H   L+  Q L      ++  D  +G+ ++  H   
Sbjct: 73  SKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLL------EMCYDVCEGMAFLESH--- 123

Query: 397 RYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLP-----PEY 451
           +++HRD+   N L+D  L  KV+DFG+ +          + T+        P     PE 
Sbjct: 124 QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTK-------FPVKWSAPEV 176

Query: 452 IFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
               ++             ++K+DV+AFG+++ E+ +
Sbjct: 177 FHYFKY-------------SSKSDVWAFGILMWEVFS 200

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  105 bits (263), Expect = 4e-25
 Identities = 56/228 (24%), Positives = 83/228 (36%), Gaps = 60/228 (26%)

Query: 298 RIIGRGGFGNVYFGLLGDREA-------AIKKMRSNKS----KEFFAELKVLCKIHHINV 346
           R +G G FG VY G +            A+K +    S     +F  E  ++ K +H N+
Sbjct: 36  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95

Query: 347 FISTFG----------------NGSLSDHL--HDPLLKGHQPLTWTARTQIALDAAKGIE 388
            +   G                 G L   L    P       L       +A D A G +
Sbjct: 96  -VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154

Query: 389 YIHDHTKARYVHRDIKTSNILLD---DGLRAKVADFGLVKLEERTNEKEMLATRLVGTPG 445
           Y+ ++    ++HRDI   N LL     G  AK+ DFG+ +   R +          G   
Sbjct: 155 YLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS------YYRKGGCA 205

Query: 446 YLP-----PEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
            LP     PE      F             T+KTD ++FGV+L E+ +
Sbjct: 206 MLPVKWMPPEAFMEGIF-------------TSKTDTWSFGVLLWEIFS 240

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  105 bits (264), Expect = 4e-25
 Identities = 56/271 (20%), Positives = 97/271 (35%), Gaps = 46/271 (16%)

Query: 241 TEDAKHVSKAMSITTRAFSSQGQCKENTEDVTVLESERTIIFSLEEIEEATNNFDESRII 300
                 ++K  S  +      G   E+ E V + E  + + +   E  E  +       +
Sbjct: 10  AHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDY---EYREEVHWMTHQPRV 66

Query: 301 GRGGFGNVYFGLLGD--REAAIKKMRSNKSKEFFAELKVLCKIHHINV-----------F 347
           GRG FG V+         + A+KK+R    +    EL     +    +           +
Sbjct: 67  GRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRV--EELVACAGLSSPRIVPLYGAVREGPW 124

Query: 348 ISTF----GNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDI 403
           ++ F      GSL       L+K    L           A +G+EY+H       +H D+
Sbjct: 125 VNIFMELLEGGSLGQ-----LIKQMGCLPEDRALYYLGQALEGLEYLHTRRI---LHGDV 176

Query: 404 KTSNILLD-DGLRAKVADFGLVKLEERTNEKEMLATR--LVGTPGYLPPEYIFVKRFRFD 460
           K  N+LL  DG RA + DFG     +     + L T   + GT  ++ PE +        
Sbjct: 177 KADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVV-------- 228

Query: 461 MHSSVMELQVTTKTDVFAFGVVLAELITGKR 491
                M      K D+++   ++  ++ G  
Sbjct: 229 -----MGKPCDAKVDIWSSCCMMLHMLNGCH 254

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  105 bits (263), Expect = 5e-25
 Identities = 71/293 (24%), Positives = 115/293 (39%), Gaps = 77/293 (26%)

Query: 298 RIIGRGGFGNVYFGLLGDREA-----AIKKMRSNKS----KEFFAELKVLCKIHHINVFI 348
           +IIG G  G V +G L          AIK +++  +    ++F +E  ++ +  H N+ I
Sbjct: 55  KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNI-I 113

Query: 349 STFG----------------NGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHD 392
              G                NGSL   L           T      +      G+ Y+ D
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFLR----THDGQFTIMQLVGMLRGVGAGMRYLSD 169

Query: 393 HTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLP---- 448
                YVHRD+   N+L+D  L  KV+DFGL ++ E   +     T      G +P    
Sbjct: 170 L---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTG-----GKIPIRWT 221

Query: 449 -PEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKR-----------ALIR 495
            PE I  + F             ++ +DV++FGVV+ E++  G+R           + + 
Sbjct: 222 APEAIAFRTF-------------SSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVE 268

Query: 496 DD---SEPTK-MKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITSTE 544
           +      P     +L  +M      C ++D   RP    IV++L   +I S E
Sbjct: 269 EGYRLPAPMGCPHALHQLM----LDCWHKDRAQRPRFSQIVSVLDA-LIRSPE 316

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  105 bits (263), Expect = 6e-25
 Identities = 69/309 (22%), Positives = 112/309 (36%), Gaps = 94/309 (30%)

Query: 298 RIIGRGGFGNVY----FGLLGDREA---AIKKMRSNKS----KEFFAELKVLCKIHHINV 346
           R IG G FG V+     GLL        A+K ++   S     +F  E  ++ +  + N+
Sbjct: 53  RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 112

Query: 347 FISTFG----------------NGSLSDHL-------------------HDPLLKGHQPL 371
            +   G                 G L++ L                         G  PL
Sbjct: 113 -VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171

Query: 372 TWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTN 431
           +   +  IA   A G+ Y+ +    ++VHRD+ T N L+ + +  K+ADFGL +     +
Sbjct: 172 SCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 228

Query: 432 EKEMLATRLVGTPGYLP-----PEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAEL 486
             +            +P     PE IF  R+             TT++DV+A+GVVL E+
Sbjct: 229 YYKA------DGNDAIPIRWMPPESIFYNRY-------------TTESDVWAYGVVLWEI 269

Query: 487 IT-GKR-----------ALIRD----DSEPTKMKSLITIMAAVAEWCLNEDAVDRPEMRD 530
            + G +             +RD             L  +M      C ++   DRP    
Sbjct: 270 FSYGLQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRL----CWSKLPADRPSFCS 325

Query: 531 IVAILSQIM 539
           I  IL ++ 
Sbjct: 326 IHRILQRMC 334

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  106 bits (266), Expect = 7e-25
 Identities = 49/230 (21%), Positives = 90/230 (39%), Gaps = 41/230 (17%)

Query: 292 NNFDESRIIGRGGFGNVYF-GLLGDREAAIKKMRSNKSKEFFAELKVLCKI-HHINV--F 347
           N     +I+G G  G V F G    R  A+K+M  +       E+K+L +   H NV  +
Sbjct: 15  NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRY 74

Query: 348 ISTFG------------NGSLSDHL--HDPLLKGHQPLTWTARTQIALDAAKGIEYIHDH 393
             +              N +L D +   +   +  +         +    A G+ ++H  
Sbjct: 75  YCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL 134

Query: 394 TKARYVHRDIKTSNILLD-------------DGLRAKVADFGL-VKLEERTNEKEMLATR 439
              + +HRD+K  NIL+              + LR  ++DFGL  KL+   +        
Sbjct: 135 ---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNN 191

Query: 440 LVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
             GT G+  PE +       + ++   + ++T   D+F+ G V   +++ 
Sbjct: 192 PSGTSGWRAPELL------EESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  104 bits (261), Expect = 7e-25
 Identities = 67/311 (21%), Positives = 114/311 (36%), Gaps = 89/311 (28%)

Query: 298 RIIGRGGFGNVY----FGLLGDREA---AIKKMRSNKS----KEFFAELKVLCKI-HHIN 345
           + +GRG FG V     FG+         A+K ++   +    +   +ELK+L  I HH+N
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92

Query: 346 VFISTFG-----------------NGSLSDHL-----------HDPLLKGHQPLTWTART 377
           V ++  G                  G+LS +L             P       LT     
Sbjct: 93  V-VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151

Query: 378 QIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLA 437
             +   AKG+E++      + +HRD+   NILL +    K+ DFGL +   +  +     
Sbjct: 152 CYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV--- 205

Query: 438 TRLVGTPGYLP-----PEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT---- 488
                    LP     PE IF + +             T ++DV++FGV+L E+ +    
Sbjct: 206 ---RKGDARLPLKWMAPETIFDRVY-------------TIQSDVWSFGVLLWEIFSLGAS 249

Query: 489 ------GKRALIRDDSEPTKM-------KSLITIMAAVAEWCLNEDAVDRPEMRDIVAIL 535
                       R   E T+M         +   M      C + +   RP   ++V  L
Sbjct: 250 PYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLD----CWHGEPSQRPTFSELVEHL 305

Query: 536 SQIMITSTEWE 546
             ++  + + +
Sbjct: 306 GNLLQANAQQD 316

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  104 bits (261), Expect = 9e-25
 Identities = 72/295 (24%), Positives = 123/295 (41%), Gaps = 80/295 (27%)

Query: 298 RIIGRGGFGNVYFGLL------GDREAAIKKMRSNKS----KEFFAELKVLCKIHHINV- 346
           ++IG G FG VY G+L       +   AIK +++  +     +F  E  ++ +  H N+ 
Sbjct: 50  KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNII 109

Query: 347 ------------FIST--FGNGSLSDHL--HDPLLKGHQPLTWTARTQIALDAAKGIEYI 390
                        I T    NG+L   L   D      Q +       +    A G++Y+
Sbjct: 110 RLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLV------GMLRGIAAGMKYL 163

Query: 391 HDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLP-- 448
            +     YVHRD+   NIL++  L  KV+DFGL ++ E   E     +      G +P  
Sbjct: 164 ANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSG-----GKIPIR 215

Query: 449 ---PEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKR-----------AL 493
              PE I  ++F             T+ +DV++FG+V+ E++T G+R             
Sbjct: 216 WTAPEAISYRKF-------------TSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKA 262

Query: 494 IRD----DSEPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITSTE 544
           I D     +      ++  +M      C  ++   RP+  DIV+IL + +I + +
Sbjct: 263 INDGFRLPTPMDCPSAIYQLM----MQCWQQERARRPKFADIVSILDK-LIRAPD 312

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  105 bits (263), Expect = 1e-24
 Identities = 64/318 (20%), Positives = 122/318 (38%), Gaps = 97/318 (30%)

Query: 298 RIIGRGGFGNVY----FGLLGDREA-----AIKKMRSNKS----KEFFAELKVLCKI-HH 343
           + +G G FG V      GL  D+       A+K ++S+ +     +  +E++++  I  H
Sbjct: 75  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 134

Query: 344 INVFISTFG----------------NGSLSDHL-----------HDPLLKGHQPLTWTAR 376
            N+ I+  G                 G+L ++L           ++P     + L+    
Sbjct: 135 KNI-INLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193

Query: 377 TQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEML 436
              A   A+G+EY+      + +HRD+   N+L+ +    K+ADFGL +     +  +  
Sbjct: 194 VSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK-- 248

Query: 437 ATRLVGTPGYLP-----PEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT--- 488
                 T G LP     PE +F + +             T ++DV++FGV+L E+ T   
Sbjct: 249 ----KTTNGRLPVKWMAPEALFDRIY-------------THQSDVWSFGVLLWEIFTLGG 291

Query: 489 -----------------GKRALIRDDSEPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDI 531
                            G R + +  +   ++     +M      C +     RP  + +
Sbjct: 292 SPYPGVPVEELFKLLKEGHR-MDKPSNCTNELYM---MMRD----CWHAVPSQRPTFKQL 343

Query: 532 VAILSQIMITSTEWEASL 549
           V  L +I+  ++  E   
Sbjct: 344 VEDLDRIVALTSNQEMGY 361

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  105 bits (262), Expect = 1e-24
 Identities = 38/299 (12%), Positives = 74/299 (24%), Gaps = 83/299 (27%)

Query: 298 RIIGRGGFGNVYFG--LLGDREAAIKKMRSNKS---------KEFFAELKVLCKIHHINV 346
            ++G+                   +      +          KE    L++L  I +   
Sbjct: 79  TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 138

Query: 347 FISTFGNGSLSDHLHDP----------------------------------------LLK 366
                      D + DP                                           
Sbjct: 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 198

Query: 367 GHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKL 426
            H+ L   AR Q+ L   + +  +H +     VH  ++  +I+LD      +  F  +  
Sbjct: 199 THKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVR 255

Query: 427 EERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAEL 486
           +               + G+ PPE    +              +T   D +A G+V+  +
Sbjct: 256 DGAR-------VVSSVSRGFEPPELEARRATISYHRDR--RTLMTFSFDAWALGLVIYWI 306

Query: 487 ITGK------------RALIRDDSE-PTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIV 532
                             + R     P  +++L+       E  L     DR      +
Sbjct: 307 WCADLPITKDAALGGSEWIFRSCKNIPQPVRALL-------EGFLRYPKEDRLLPLQAM 358

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  103 bits (260), Expect = 1e-24
 Identities = 65/284 (22%), Positives = 101/284 (35%), Gaps = 79/284 (27%)

Query: 293 NFDESRIIGRGGFGNVYFG--LLGDREAAIK-----KMRSNKSKE-FFAELKVLCKIHHI 344
            +   R +G+GGF   +           A K      +     +E    E+ +   + H 
Sbjct: 42  RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ 101

Query: 345 NV--FISTF-------------GNGSLSDHLHDPLLKGHQPLT-WTART---QIALDAAK 385
           +V  F   F                SL +       K  + LT   AR    QI      
Sbjct: 102 HVVGFHGFFEDNDFVFVVLELCRRRSLLELH-----KRRKALTEPEARYYLRQIV----L 152

Query: 386 GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPG 445
           G +Y+H +   R +HRD+K  N+ L++ L  K+ DFGL    E   E+      L GTP 
Sbjct: 153 GCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER--KKV-LCGTPN 206

Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG-------------KRA 492
           Y+ PE +  K      HS         + DV++ G ++  L+ G              R 
Sbjct: 207 YIAPEVLSKK-----GHSF--------EVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI 253

Query: 493 LIRDDSEPTKM----KSLITIMAAVAEWCLNEDAVDRPEMRDIV 532
              + S P  +     SLI          L  D   RP + +++
Sbjct: 254 KKNEYSIPKHINPVAASLIQ-------KMLQTDPTARPTINELL 290

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  104 bits (261), Expect = 2e-24
 Identities = 57/228 (25%), Positives = 83/228 (36%), Gaps = 60/228 (26%)

Query: 298 RIIGRGGFGNVY----FGLLGDREA---AIKKMRSNKS----KEFFAELKVLCKIHHINV 346
           R +G G FG VY     G+  D      A+K +    S     +F  E  ++ K +H N+
Sbjct: 77  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 136

Query: 347 FISTFG----------------NGSLSDHL--HDPLLKGHQPLTWTARTQIALDAAKGIE 388
            +   G                 G L   L    P       L       +A D A G +
Sbjct: 137 -VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 195

Query: 389 YIHDHTKARYVHRDIKTSNILLD---DGLRAKVADFGLVKLEERTNEKEMLATRLVGTPG 445
           Y+ ++    ++HRDI   N LL     G  AK+ DFG+ +   R            G   
Sbjct: 196 YLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAG------YYRKGGCA 246

Query: 446 YLP-----PEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
            LP     PE      F             T+KTD ++FGV+L E+ +
Sbjct: 247 MLPVKWMPPEAFMEGIF-------------TSKTDTWSFGVLLWEIFS 281

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  102 bits (257), Expect = 2e-24
 Identities = 65/280 (23%), Positives = 108/280 (38%), Gaps = 62/280 (22%)

Query: 298 RIIGRGGFGNVYFG--LLGDREAAIKKMRSNKSKE------FFAELKVLCKIHHINVFIS 349
             +G GG   VY     + + + AIK +     ++      F  E+    ++ H N+ +S
Sbjct: 17  DKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNI-VS 75

Query: 350 TFGNGSLSDH------------LHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKAR 397
                   D             L +  ++ H PL+             GI++ HD    R
Sbjct: 76  MIDVDEEDDCYYLVMEYIEGPTLSE-YIESHGPLSVDTAINFTNQILDGIKHAHDM---R 131

Query: 398 YVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLV-GTPGYLPPEYIFVKR 456
            VHRDIK  NIL+D     K+ DFG+ K     +E  +  T  V GT  Y  PE      
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKA---LSETSLTQTNHVLGTVQYFSPE------ 182

Query: 457 FRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKR----------AL--IRDD--SEPTK 502
                            TD+++ G+VL E++ G+           A+  I+D   +  T 
Sbjct: 183 -------QAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTD 235

Query: 503 MKSLITI-MAAVAEWCLNEDAVDRP----EMR-DIVAILS 536
           ++  I   ++ V      +D  +R     EM+ D+ ++L 
Sbjct: 236 VRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH 275

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  103 bits (258), Expect = 2e-24
 Identities = 50/215 (23%), Positives = 80/215 (37%), Gaps = 42/215 (19%)

Query: 298 RIIGRGGFGNVYFG--LLGDREAAIKKMRSNKSKE------FFAELKVLCKIHHINVFIS 349
           R++GRGG G+VY     + +R  A+K M    S +         E +   ++   +V + 
Sbjct: 40  RLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHV-VP 98

Query: 350 TFGNGSLSDH------------LHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKAR 397
               G +               L   +L+   PL       I       ++  H      
Sbjct: 99  IHDFGEIDGQLYVDMRLINGVDLAA-MLRRQGPLAPPRAVAIVRQIGSALDAAHAA---G 154

Query: 398 YVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLAT-RLVGTPGYLPPEYIFVKR 456
             HRD+K  NIL+     A + DFG+      T ++++      VGT  Y+ PE     R
Sbjct: 155 ATHRDVKPENILVSADDFAYLVDFGIAS---ATTDEKLTQLGNTVGTLYYMAPE-----R 206

Query: 457 FRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKR 491
           F             T + D++A   VL E +TG  
Sbjct: 207 FSESH--------ATYRADIYALTCVLYECLTGSP 233

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  103 bits (258), Expect = 2e-24
 Identities = 60/223 (26%), Positives = 89/223 (39%), Gaps = 61/223 (27%)

Query: 298 RIIGRGGFGNVYFGLLGDREA------AIKKMRSNKS----KEFFAELKVLCKIHHINVF 347
           +++G G FG VY GL            AIK++R   S    KE   E  V+  + + +V 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV- 79

Query: 348 ISTFG---------------NGSLSDHL--HDPLLKGHQPLTWTARTQIALDAAKGIEYI 390
               G                G L D++  H   +     L W       +  AKG+ Y+
Sbjct: 80  CRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYL 133

Query: 391 HDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLP-- 448
            D    R VHRD+   N+L+      K+ DFGL KL     EKE  A       G +P  
Sbjct: 134 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA-EEKEYHAEG-----GKVPIK 184

Query: 449 ---PEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
               E I  + +             T ++DV+++GV + EL+T
Sbjct: 185 WMALESILHRIY-------------THQSDVWSYGVTVWELMT 214

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  102 bits (256), Expect = 2e-24
 Identities = 51/222 (22%), Positives = 86/222 (38%), Gaps = 61/222 (27%)

Query: 298 RIIGRGGFGNVYFGLLGDREA-----AIKKMRSNKS----KEFFAELKVLCKIHHINVFI 348
           RI+G G FG VY G+  + +      A+K  + + +    ++F +E  ++  + H ++ +
Sbjct: 18  RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHI-V 76

Query: 349 STFG---------------NGSLSDHL--HDPLLKGHQPLTWTARTQIALDAAKGIEYIH 391
              G                G L  +L  +   LK    +        +L   K + Y+ 
Sbjct: 77  KLIGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLV------LYSLQICKAMAYLE 130

Query: 392 DHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLP--- 448
                  VHRDI   NIL+      K+ DFGL +  E  +       +       LP   
Sbjct: 131 SI---NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY-----YKASV--TRLPIKW 180

Query: 449 --PEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
             PE I  +RF             TT +DV+ F V + E+++
Sbjct: 181 MSPESINFRRF-------------TTASDVWMFAVCMWEILS 209

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  103 bits (258), Expect = 2e-24
 Identities = 74/310 (23%), Positives = 115/310 (37%), Gaps = 84/310 (27%)

Query: 298 RIIGRGGFGNVY----FGLLGDREA---AIKKMRSNKSKE---FFAELKVLCKIHHINVF 347
             +G G FG V+      LL +++    A+K ++         F  E ++L  + H ++ 
Sbjct: 47  WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHI- 105

Query: 348 ISTFG----------------NGSLSDHL--HDPLLKGH--------QPLTWTARTQIAL 381
           +  FG                +G L+  L  H P  K           PL       +A 
Sbjct: 106 VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165

Query: 382 DAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLV 441
             A G+ Y+       +VHRD+ T N L+  GL  K+ DFG+ +    T+       R V
Sbjct: 166 QVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD-----YYR-V 216

Query: 442 GTPGYLP-----PEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKR---- 491
           G    LP     PE I  ++F             TT++DV++FGVVL E+ T GK+    
Sbjct: 217 GGRTMLPIRWMPPESILYRKF-------------TTESDVWSFGVVLWEIFTYGKQPWYQ 263

Query: 492 -------ALIRDD---SEPTK-MKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMI 540
                    I        P      +  IM      C   +   R  ++D+ A L  +  
Sbjct: 264 LSNTEAIDCITQGRELERPRACPPEVYAIMRG----CWQREPQQRHSIKDVHARLQALAQ 319

Query: 541 TSTEWEASLG 550
               +   LG
Sbjct: 320 APPVYLDVLG 329

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  102 bits (256), Expect = 2e-24
 Identities = 57/225 (25%), Positives = 87/225 (38%), Gaps = 55/225 (24%)

Query: 293 NFDESRIIGRGGFGNVYFG--LLGDREAAIK-----KMRSNKSKE-FFAELKVLCKIHHI 344
            +   R +G+GGF   +           A K      +     +E    E+ +   + H 
Sbjct: 16  RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ 75

Query: 345 NV--FISTF-------------GNGSLSDHLHDPLLKGHQPLT-WTART---QIALDAAK 385
           +V  F   F                SL +     L K  + LT   AR    QI      
Sbjct: 76  HVVGFHGFFEDNDFVFVVLELCRRRSLLE-----LHKRRKALTEPEARYYLRQIV----L 126

Query: 386 GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPG 445
           G +Y+H +   R +HRD+K  N+ L++ L  K+ DFGL    E   E+      L GTP 
Sbjct: 127 GCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER--KKV-LCGTPN 180

Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
           Y+ PE +  K      HS         + DV++ G ++  L+ GK
Sbjct: 181 YIAPEVLSKK-----GHSF--------EVDVWSIGCIMYTLLVGK 212

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  102 bits (257), Expect = 3e-24
 Identities = 67/310 (21%), Positives = 114/310 (36%), Gaps = 90/310 (29%)

Query: 298 RIIGRGGFGNVY----FGLLGDREA---AIKKMRSNKS----KEFFAELKVLCKI-HHIN 345
           + +G G FG V     +GL+    A   A+K ++ +      +   +ELKVL  + +H+N
Sbjct: 29  KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88

Query: 346 VFISTFG----------------NGSLSDHL-------------HDPLLKGHQPLTWTAR 376
           + ++  G                 G L + L                +      L     
Sbjct: 89  I-VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147

Query: 377 TQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEML 436
              +   AKG+ ++        +HRD+   NILL  G   K+ DFGL +  +  +     
Sbjct: 148 LSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSN---- 200

Query: 437 ATRLVGTPGYLP-----PEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GK 490
              +V     LP     PE IF   +             T ++DV+++G+ L EL + G 
Sbjct: 201 --YVVKGNARLPVKWMAPESIFNCVY-------------TFESDVWSYGIFLWELFSLGS 245

Query: 491 R--ALIRDDSEPTKM--------------KSLITIMAAVAEWCLNEDAVDRPEMRDIVAI 534
                +  DS+  KM                +  IM      C + D + RP  + IV +
Sbjct: 246 SPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKT----CWDADPLKRPTFKQIVQL 301

Query: 535 LSQIMITSTE 544
           + + +  ST 
Sbjct: 302 IEKQISESTN 311

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  101 bits (255), Expect = 3e-24
 Identities = 49/225 (21%), Positives = 94/225 (41%), Gaps = 55/225 (24%)

Query: 296 ESRIIGRGGFGNVYFGLLGDREA----AIKKMRSNKS-----KEFFAELKVLCKIHHINV 346
           E + +G G FG V  G    ++     A+K +++  +      E  AE  V+ ++ +  +
Sbjct: 21  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 80

Query: 347 ------------FIST--FGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHD 392
                        +       G L+ +L     + ++ +      ++    + G++Y+ +
Sbjct: 81  VRMIGICEAESWMLVMEMAELGPLNKYL-----QQNRHVKDKNIIELVHQVSMGMKYLEE 135

Query: 393 HTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLP---- 448
                +VHRD+   N+LL     AK++DFGL K     +E    A     T G  P    
Sbjct: 136 S---NFVHRDLAARNVLLVTQHYAKISDFGLSKALR-ADENYYKAQ----THGKWPVKWY 187

Query: 449 -PEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKR 491
            PE I   +F             ++K+DV++FGV++ E  + G++
Sbjct: 188 APECINYYKF-------------SSKSDVWSFGVLMWEAFSYGQK 219

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  101 bits (255), Expect = 3e-24
 Identities = 65/303 (21%), Positives = 113/303 (37%), Gaps = 85/303 (28%)

Query: 298 RIIGRGGFGNVY----FGLLGDREA---AIKKMR---SNKSKEFFAELKVLCKIHHINVF 347
           R +G G FG V+    + L   ++    A+K ++       K+F  E ++L  + H ++ 
Sbjct: 21  RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI- 79

Query: 348 ISTFG----------------NGSLSDHL-----------HDPLLKGHQPLTWTARTQIA 380
           +  +G                +G L+  L                +    L  +    IA
Sbjct: 80  VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139

Query: 381 LDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRL 440
              A G+ Y+       +VHRD+ T N L+   L  K+ DFG+ +    T+       R 
Sbjct: 140 SQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTD-----YYR- 190

Query: 441 VGTPGYLP-----PEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKR--- 491
           VG    LP     PE I  ++F             TT++DV++FGV+L E+ T GK+   
Sbjct: 191 VGGHTMLPIRWMPPESIMYRKF-------------TTESDVWSFGVILWEIFTYGKQPWF 237

Query: 492 --------ALIRDDSEPTKMK----SLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIM 539
                     I       + +     +  +M      C   +   R  +++I  IL  + 
Sbjct: 238 QLSNTEVIECITQGRVLERPRVCPKEVYDVMLG----CWQREPQQRLNIKEIYKILHALG 293

Query: 540 ITS 542
             +
Sbjct: 294 KAT 296

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  101 bits (253), Expect = 5e-24
 Identities = 52/221 (23%), Positives = 82/221 (37%), Gaps = 59/221 (26%)

Query: 298 RIIGRGGFGNVYFGLLGDREA-----AIKKMRSNKS----KEFFAELKVLCKIHHINV-- 346
           R IG G FG+V+ G+    E      AIK  ++  S    ++F  E   + +  H ++  
Sbjct: 21  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 80

Query: 347 ----------FIST--FGNGSLSDHL--HDPLLKGHQPLTWTARTQIALDAAKGIEYIHD 392
                     +I       G L   L      L     +        A   +  + Y+  
Sbjct: 81  LIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLI------LYAYQLSTALAYLES 134

Query: 393 HTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLP---- 448
               R+VHRDI   N+L+      K+ DFGL +  E +        +     G LP    
Sbjct: 135 K---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY-----YKASK--GKLPIKWM 184

Query: 449 -PEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
            PE I  +RF             T+ +DV+ FGV + E++ 
Sbjct: 185 APESINFRRF-------------TSASDVWMFGVCMWEILM 212

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  101 bits (253), Expect = 5e-24
 Identities = 64/297 (21%), Positives = 103/297 (34%), Gaps = 86/297 (28%)

Query: 298 RIIGRGGFGNVYFGLLGDREA-------AIKKMRSNKS----KEFFAELKVLCKIHHINV 346
             +G   FG VY G L            AIK ++        +EF  E  +  ++ H NV
Sbjct: 15  EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74

Query: 347 FISTFG----------------NGSLSDHL-----------HDPLLKGHQPLTWTARTQI 379
            +   G                +G L + L            D        L       +
Sbjct: 75  -VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133

Query: 380 ALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATR 439
               A G+EY+  H     VH+D+ T N+L+ D L  K++D GL +     +  ++    
Sbjct: 134 VAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKL---- 186

Query: 440 LVGTPGYLP-----PEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKR-- 491
                  LP     PE I   +F             +  +D++++GVVL E+ + G +  
Sbjct: 187 --LGNSLLPIRWMAPEAIMYGKF-------------SIDSDIWSYGVVLWEVFSYGLQPY 231

Query: 492 ---------ALIRDD---SEPTK-MKSLITIMAAVAEWCLNEDAVDRPEMRDIVAIL 535
                     +IR+      P      +  +M      C NE    RP  +DI + L
Sbjct: 232 CGYSNQDVVEMIRNRQVLPCPDDCPAWVYALMIE----CWNEFPSRRPRFKDIHSRL 284

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  101 bits (255), Expect = 7e-24
 Identities = 60/323 (18%), Positives = 110/323 (34%), Gaps = 111/323 (34%)

Query: 298 RIIGRGGFGNVY----FGLLGDREA---AIKKMRSNKS----KEFFAELKVLCKI-HHIN 345
           +++G G FG V     +G+     +   A+K ++        +   +ELK++ ++  H N
Sbjct: 51  KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110

Query: 346 VFISTFG----------------NGSLSDHL------------------HDPLLKGHQPL 371
           + ++  G                 G L ++L                       +    L
Sbjct: 111 I-VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169

Query: 372 TWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTN 431
           T+      A   AKG+E++        VHRD+   N+L+  G   K+ DFGL        
Sbjct: 170 TFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGL-------- 218

Query: 432 EKEMLATRLV--------GTPGYLP-----PEYIFVKRFRFDMHSSVMELQVTTKTDVFA 478
                  R +             LP     PE +F   +             T K+DV++
Sbjct: 219 ------ARDIMSDSNYVVRGNARLPVKWMAPESLFEGIY-------------TIKSDVWS 259

Query: 479 FGVVLAELIT-GK---------RALIRDDSEPTKM-------KSLITIMAAVAEWCLNED 521
           +G++L E+ + G              +      KM       + +  IM    + C   D
Sbjct: 260 YGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIM----QSCWAFD 315

Query: 522 AVDRPEMRDIVAILSQIMITSTE 544
           +  RP   ++ + L   +  + E
Sbjct: 316 SRKRPSFPNLTSFLGCQLADAEE 338

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  100 bits (250), Expect = 1e-23
 Identities = 48/224 (21%), Positives = 80/224 (35%), Gaps = 61/224 (27%)

Query: 298 RIIGRGGFGNVYFGLLGDREA-----AIKKMRSN------KSKEFFAELKVLCKIHHINV 346
             +G G FG V  G            A+K ++ +         +F  E+  +  + H N+
Sbjct: 24  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83

Query: 347 FISTFG---------------NGSLSDHL--HDPLLKGHQPLTWTARTQIALDAAKGIEY 389
            I  +G                GSL D L  H           +      A+  A+G+ Y
Sbjct: 84  -IRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRY------AVQVAEGMGY 136

Query: 390 IHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLP- 448
           +      R++HRD+   N+LL      K+ DFGL++     N+   +          +P 
Sbjct: 137 LESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALP-QNDDHYVMQ----EHRKVPF 188

Query: 449 ----PEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
               PE +  + F             +  +D + FGV L E+ T
Sbjct: 189 AWCAPESLKTRTF-------------SHASDTWMFGVTLWEMFT 219

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  101 bits (254), Expect = 2e-23
 Identities = 70/287 (24%), Positives = 117/287 (40%), Gaps = 74/287 (25%)

Query: 298 RIIGRGGFGNVYFGLL-----GDREAAIKKMRSNKS----KEFFAELKVLCKIHHINV-- 346
           +++G G FG V  G L      +   AIK ++   +    ++F  E  ++ +  H N+  
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110

Query: 347 -----------FIST--FGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDH 393
                       I T    NGSL   L     K     T      +    A G++Y+ D 
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLR----KHDAQFTVIQLVGMLRGIASGMKYLSDM 166

Query: 394 TKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLP----- 448
               YVHRD+   NIL++  L  KV+DFGL ++ E   E            G +P     
Sbjct: 167 ---GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRG-----GKIPIRWTS 218

Query: 449 PEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKR-----------ALIRD 496
           PE I  ++F             T+ +DV+++G+VL E+++ G+R             + +
Sbjct: 219 PEAIAYRKF-------------TSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDE 265

Query: 497 D---SEPTK-MKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIM 539
                 P     +L  +M      C  +D  +RP+   IV+IL +++
Sbjct: 266 GYRLPPPMDCPAALYQLM----LDCWQKDRNNRPKFEQIVSILDKLI 308

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  100 bits (250), Expect = 2e-23
 Identities = 59/281 (20%), Positives = 113/281 (40%), Gaps = 59/281 (20%)

Query: 298 RIIGRGGFGNVYFG--LLGDREAAIKKMRSNKSKE------FFAELKVLCKIHHINVFIS 349
            I+G GG   V+    L   R+ A+K +R++ +++      F  E +    ++H  + ++
Sbjct: 18  EILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAI-VA 76

Query: 350 TFGNGSLSDHLHDP---------------LLKGHQPLTWTARTQIALDAAKGIEYIHDHT 394
            +  G                        ++    P+T     ++  DA + + + H + 
Sbjct: 77  VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQN- 135

Query: 395 KARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFV 454
               +HRD+K +NI++      KV DFG+ +    +         ++GT  YL PE    
Sbjct: 136 --GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE---- 189

Query: 455 KRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKR----------AL--IRDDSEP-- 500
                          V  ++DV++ G VL E++TG+           A   +R+D  P  
Sbjct: 190 ---------QARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPS 240

Query: 501 TKMKSLITIMAAVAEWCLNEDAVDRP----EMR-DIVAILS 536
            + + L   + AV    L ++  +R     EMR D+V + +
Sbjct: 241 ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 281

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 98.8 bits (247), Expect = 3e-23
 Identities = 57/226 (25%), Positives = 92/226 (40%), Gaps = 54/226 (23%)

Query: 292 NNFDESRIIGRGGFGNVYFG--LLGDREAAIK-----KMRSNKSKE-FFAELKVLCKIHH 343
            +F    ++G+G F  VY    +    E AIK      M      +    E+K+ C++ H
Sbjct: 11  EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70

Query: 344 INV--FISTF-------------GNGSLSDHLHDPLLKGHQPLT-WTART---QIALDAA 384
            ++    + F              NG ++ +L        +P +   AR    QI     
Sbjct: 71  PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLK----NRVKPFSENEARHFMHQII---- 122

Query: 385 KGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP 444
            G+ Y+H H     +HRD+  SN+LL   +  K+ADFGL    +  +EK    T L GTP
Sbjct: 123 TGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEK--HYT-LCGTP 176

Query: 445 GYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
            Y+ PE           H          ++DV++ G +   L+ G+
Sbjct: 177 NYISPEIATRS-----AHGL--------ESDVWSLGCMFYTLLIGR 209

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score = 98.6 bits (246), Expect = 5e-23
 Identities = 54/295 (18%), Positives = 89/295 (30%), Gaps = 91/295 (30%)

Query: 291 TNNFDESRIIGRGGFGNVYFGL-LGDREA-AIKKMRSNKSKEFFAE--------LKVLCK 340
           T  F E   IG G FG+V+  +   D    AIK+ +   +     +          VL  
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLG- 68

Query: 341 IHHINV--FISTF-------------GNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAK 385
             H +V  + S +               GSL+D + +                + L   +
Sbjct: 69  -QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIM-SYFKEAELKDLLLQVGR 126

Query: 386 GIEYIHDHTKARYVHRDIKTSNILLD-------------------DGLRAKVADFGLVKL 426
           G+ YIH  +    VH DIK SNI +                    + +  K+ D G V  
Sbjct: 127 GLRYIHSMSL---VHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR 183

Query: 427 EERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAEL 486
                 +E       G   +L  E +  + +               K D+FA  + +   
Sbjct: 184 ISSPQVEE-------GDSRFLANE-VLQENYTHL-----------PKADIFALALTVVCA 224

Query: 487 ITGKRAL--------IRDDSEPT-------KMKSLITIMAAVAEWCLNEDAVDRP 526
              +           IR    P        +   L+       +  ++ D   RP
Sbjct: 225 AGAEPLPRNGDQWHEIRQGRLPRIPQVLSQEFTELL-------KVMIHPDPERRP 272

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score = 98.7 bits (246), Expect = 7e-23
 Identities = 49/226 (21%), Positives = 80/226 (35%), Gaps = 41/226 (18%)

Query: 292 NNFDESRIIGRGGFGNVYFG--LLGDREAAIKKMRSNKSKE----FFAELKVLCKIHHIN 345
           + +  S I+G+G   NV+ G         AIK   +            E +VL K++H N
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68

Query: 346 V-----FISTFGN------------GSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIE 388
           +                        GSL   L +P       L  +    +  D   G+ 
Sbjct: 69  IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEP--SNAYGLPESEFLIVLRDVVGGMN 126

Query: 389 YIHDHTKARYVHRDIKTSNILL----DDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP 444
           ++ ++     VHR+IK  NI+     D     K+ DFG  +  E   + E   + L GT 
Sbjct: 127 HLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE---DDEQFVS-LYGTE 179

Query: 445 GYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
            YL P+          +     + +     D+++ GV      TG 
Sbjct: 180 EYLHPDMY-----ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 97.3 bits (243), Expect = 1e-22
 Identities = 55/289 (19%), Positives = 109/289 (37%), Gaps = 75/289 (25%)

Query: 300 IGRGGFGNVYFGLL----GDREAAIKKMRSNKS----KEFFAELKVLCKIHHINV----- 346
           +G G FG+V  G+        + AIK ++        +E   E +++ ++ +  +     
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77

Query: 347 -------FIST--FGNGSLSDHLHDPLLKGHQP-LTWTARTQIALDAAKGIEYIHDHTKA 396
                   +     G G L   L      G +  +  +   ++    + G++Y+ +    
Sbjct: 78  VCQAEALMLVMEMAGGGPLHKFL-----VGKREEIPVSNVAELLHQVSMGMKYLEEK--- 129

Query: 397 RYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLP-----PEY 451
            +VHRD+   N+LL +   AK++DFGL K     ++    A     + G  P     PE 
Sbjct: 130 NFVHRDLAARNVLLVNRHYAKISDFGLSKALGA-DDSYYTAR----SAGKWPLKWYAPEC 184

Query: 452 IFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKR-----------ALIRDD-- 497
           I  ++F             ++++DV+++GV + E ++ G++           A I     
Sbjct: 185 INFRKF-------------SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR 231

Query: 498 -SEPTK-MKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITSTE 544
              P +    L  +M+     C      DRP+   +   +      S  
Sbjct: 232 MECPPECPPELYALMSD----CWIYKWEDRPDFLTVEQRMRA-CYYSLA 275

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 97.6 bits (243), Expect = 2e-22
 Identities = 45/199 (22%), Positives = 70/199 (35%), Gaps = 40/199 (20%)

Query: 353 NGSLSDHLHDPLLKGHQPLTWTAR--TQIALDAAKGIEYIHDHTKARYVHRDIKTSNILL 410
             +L D ++       +          QIA      +E++H       +HRD+K SNI  
Sbjct: 145 KENLKDWMNRRCSLEDREHGVCLHIFIQIAE----AVEFLHSK---GLMHRDLKPSNIFF 197

Query: 411 DDGLRAKVADFGLVKLEERTNE---------KEMLATRLVGTPGYLPPEYIFVKRFRFDM 461
                 KV DFGLV   ++  E              T  VGT  Y+ PE I    +    
Sbjct: 198 TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNY---- 253

Query: 462 HSSVMELQVTTKTDVFAFGVVLAELITGKRAL---------IRDDSEPTKMKSLITIMAA 512
                    + K D+F+ G++L EL+               +R+   P            
Sbjct: 254 ---------SHKVDIFSLGLILFELLYSFSTQMERVRIITDVRNLKFPLLFTQKYPQEHM 304

Query: 513 VAEWCLNEDAVDRPEMRDI 531
           + +  L+    +RPE  DI
Sbjct: 305 MVQDMLSPSPTERPEATDI 323

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 43.3 bits (102), Expect = 1e-04
 Identities = 18/61 (29%), Positives = 31/61 (50%), Gaps = 6/61 (9%)

Query: 292 NNFDESRIIGRGGFGNVYFG--LLGDREAAIKKMRSNKS----KEFFAELKVLCKIHHIN 345
            +F+  + +GRGGFG V+     + D   AIK++R        ++   E+K L K+ H  
Sbjct: 6   TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65

Query: 346 V 346
           +
Sbjct: 66  I 66

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 96.6 bits (241), Expect = 2e-22
 Identities = 65/290 (22%), Positives = 112/290 (38%), Gaps = 67/290 (23%)

Query: 276 SERTIIFSLEEIEEATN---NFDESRIIGRGGFGNVYFG--LLGDREAAIKKM---RSNK 327
           S+  I+  L  I    +    +     IG+G  G VY    +   +E AI++M   +  K
Sbjct: 1   SDEEILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK 60

Query: 328 SKEFFAELKVLCKIHHINV--FISTF-------------GNGSLSDHLHDPLLKGHQPLT 372
            +    E+ V+ +  + N+  ++ ++               GSL+D +          + 
Sbjct: 61  KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT------ETCMD 114

Query: 373 WTARTQIAL---DAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEER 429
                QIA    +  + +E++H +     +HRDIK+ NILL      K+ DFG       
Sbjct: 115 ---EGQIAAVCRECLQALEFLHSNQV---IHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168

Query: 430 TNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
              K    + +VGTP ++ PE +   R  +             K D+++ G++  E+I G
Sbjct: 169 EQSK---RSTMVGTPYWMAPEVV--TRKAYG-----------PKVDIWSLGIMAIEMIEG 212

Query: 490 K---------RAL--IRDDSEPT--KMKSLITIMAAVAEWCLNEDAVDRP 526
           +         RAL  I  +  P     + L  I       CL  D   R 
Sbjct: 213 EPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRG 262

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score = 97.8 bits (243), Expect = 3e-22
 Identities = 18/243 (7%), Positives = 47/243 (19%), Gaps = 70/243 (28%)

Query: 298 RIIGRGGFGNVYFG--LLGDREAAIKKMRSNKS------KEFFAELKVLCKIHHIN---- 345
             +  G    V+    +    + A+K             +          ++   +    
Sbjct: 68  EPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEA 127

Query: 346 ------------------------------------VFISTFGNGSLSD--HLHDPLLKG 367
                                               + +    +  L       D +   
Sbjct: 128 RDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVF 187

Query: 368 HQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLE 427
                  A   +     +    +        VH      N+ +    R  + D   +   
Sbjct: 188 RGDEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLFIMPDGRLMLGDVSALW-- 242

Query: 428 ERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELI 487
            +   +            Y P E++      F           T   + +  G+ +  + 
Sbjct: 243 -KVGTR---GPASSVPVTYAPREFLNASTATF-----------THALNAWQLGLSIYRVW 287

Query: 488 TGK 490
              
Sbjct: 288 CLF 290

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score = 98.0 bits (244), Expect = 3e-22
 Identities = 49/226 (21%), Positives = 80/226 (35%), Gaps = 41/226 (18%)

Query: 292 NNFDESRIIGRGGFGNVYFGL--LGDREAAIKKMRSNKSKE----FFAELKVLCKIHHIN 345
           + +  S I+G+G   NV+ G         AIK   +            E +VL K++H N
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68

Query: 346 V-----FISTFGN------------GSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIE 388
           +                        GSL   L +P       L  +    +  D   G+ 
Sbjct: 69  IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEP--SNAYGLPESEFLIVLRDVVGGMN 126

Query: 389 YIHDHTKARYVHRDIKTSNILL----DDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP 444
           ++ ++     VHR+IK  NI+     D     K+ DFG  +  E   + E   + L GT 
Sbjct: 127 HLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE---DDEQFVS-LYGTE 179

Query: 445 GYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
            YL P+          +     + +     D+++ GV      TG 
Sbjct: 180 EYLHPDMY-----ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 99.5 bits (248), Expect = 4e-22
 Identities = 52/222 (23%), Positives = 84/222 (37%), Gaps = 61/222 (27%)

Query: 298 RIIGRGGFGNVYFGLLGDREA-----AIKKMRSNKS----KEFFAELKVLCKIHHINVFI 348
           R IG G FG+V+ G+    E      AIK  ++  S    ++F  E   + +  H ++ +
Sbjct: 396 RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI-V 454

Query: 349 STFG---------------NGSLSDHL--HDPLLKGHQPLTWTARTQIALDAAKGIEYIH 391
              G                G L   L      L     + +      A   +  + Y+ 
Sbjct: 455 KLIGVITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILY------AYQLSTALAYLE 508

Query: 392 DHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLP--- 448
                R+VHRDI   N+L+      K+ DFGL +  E +   +        + G LP   
Sbjct: 509 SK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYK-------ASKGKLPIKW 558

Query: 449 --PEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
             PE I  +RF             T+ +DV+ FGV + E++ 
Sbjct: 559 MAPESINFRRF-------------TSASDVWMFGVCMWEILM 587

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score = 99.4 bits (247), Expect = 5e-22
 Identities = 57/255 (22%), Positives = 96/255 (37%), Gaps = 61/255 (23%)

Query: 288 EEATNNFDESRIIGRGGFGNVYFG--LLGDREAAIKKMRSNKSKE----FFAELKVLCKI 341
            +    ++    +G GGFG V          + AIK+ R   S +    +  E++++ K+
Sbjct: 10  TQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKL 69

Query: 342 HHINV-----FISTFGN----------------GSLSDHLHDPLLKGHQPLT-WTART-- 377
           +H NV                            G L  +L+    +    L     RT  
Sbjct: 70  NHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQF--ENCCGLKEGPIRTLL 127

Query: 378 -QIALDAAKGIEYIHDHTKARYVHRDIKTSNILLD---DGLRAKVADFGLVKLEERTNEK 433
             I+      + Y+H++   R +HRD+K  NI+L      L  K+ D G  K  +   + 
Sbjct: 128 SDISS----ALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD---QG 177

Query: 434 EMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRAL 493
           E+     VGT  YL PE +  K++             T   D ++FG +  E ITG R  
Sbjct: 178 ELCTE-FVGTLQYLAPELLEQKKY-------------TVTVDYWSFGTLAFECITGFRP- 222

Query: 494 IRDDSEPTKMKSLIT 508
              + +P +    + 
Sbjct: 223 FLPNWQPVQWHGKVR 237

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 94.7 bits (236), Expect = 1e-21
 Identities = 61/290 (21%), Positives = 108/290 (37%), Gaps = 67/290 (23%)

Query: 276 SERTIIFSLEEIEEATN---NFDESRIIGRGGFGNVYFG--LLGDREAAIKKM---RSNK 327
           +      +L  + +  +     D    IG G  G V         R+ A+K M   +  +
Sbjct: 26  THEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQR 85

Query: 328 SKEFFAELKVLCKIHHINV--FISTF-------------GNGSLSDHLHDPLLKGHQPLT 372
            +  F E+ ++    H NV     ++               G+L+D +          L 
Sbjct: 86  RELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVS------QVRLN 139

Query: 373 WTARTQIAL---DAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEER 429
                QIA       + + Y+H       +HRDIK+ +ILL    R K++DFG      +
Sbjct: 140 ---EEQIATVCEAVLQALAYLHAQGV---IHRDIKSDSILLTLDGRVKLSDFGFCAQISK 193

Query: 430 TNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
              K      LVGTP ++ PE I   R  +            T+ D+++ G+++ E++ G
Sbjct: 194 DVPK---RKSLVGTPYWMAPEVI--SRSLYA-----------TEVDIWSLGIMVIEMVDG 237

Query: 490 K---------RAL--IRDDSEPT--KMKSLITIMAAVAEWCLNEDAVDRP 526
           +         +A+  +RD   P       +  ++    E  L  D  +R 
Sbjct: 238 EPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERA 287

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 95.4 bits (237), Expect = 2e-21
 Identities = 43/289 (14%), Positives = 84/289 (29%), Gaps = 59/289 (20%)

Query: 285 EEIEEATNNFDESRIIGRGGFGNVYFGLLGDREA-------AIKKMRSNKSKEFFAELKV 337
            E +  +       ++G G F  VY    GD           +K  +     EF+   ++
Sbjct: 58  TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQL 117

Query: 338 LCKI-----HHINVFISTF-------------GNGSLSDHLHDPLLKGHQPLTWTARTQI 379
           + ++     H    F S                 G+L + ++       + +        
Sbjct: 118 MERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISF 177

Query: 380 ALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRA-----------KVADFGLVKLEE 428
           A+     IE +H       +H DIK  N +L +G               + D G    + 
Sbjct: 178 AMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSI-DM 233

Query: 429 RTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
           +   K  + T    T G+   E +  K +               + D F     +  ++ 
Sbjct: 234 KLFPKGTIFTAKCETSGFQCVEMLSNKPW-------------NYQIDYFGVAATVYCMLF 280

Query: 489 GKRALIRDDSEPTKMKSLI------TIMAAVAEWCLNEDAVDRPEMRDI 531
           G    ++++    K + L        +        LN          D+
Sbjct: 281 GTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDL 329

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 93.9 bits (234), Expect = 2e-21
 Identities = 50/300 (16%), Positives = 97/300 (32%), Gaps = 97/300 (32%)

Query: 298 RIIGRGGFGNVYFGLLGDREA---------AIKKMR---SNKSKEFFAELKVLCKIHHIN 345
             +G+G F  ++ G+  +             +K +     N S+ FF    ++ K+ H +
Sbjct: 14  ESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKH 73

Query: 346 VFISTFG----------------NGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEY 389
           + +  +G                 GSL  +L     K    +    + ++A   A  + +
Sbjct: 74  L-VLNYGVCVCGDENILVQEFVKFGSLDTYLK----KNKNCINILWKLEVAKQLAAAMHF 128

Query: 390 IHDHTKARYVHRDIKTSNILLD--------DGLRAKVADFGLVKLEERTNEKEMLATRLV 441
           + ++     +H ++   NILL         +    K++D G+              +  V
Sbjct: 129 LEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGI--------------SITV 171

Query: 442 GTPGYL-------PPEYI-FVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKR- 491
                L       PPE I   K                  TD ++FG  L E+ + G + 
Sbjct: 172 LPKDILQERIPWVPPECIENPKNL-------------NLATDKWSFGTTLWEICSGGDKP 218

Query: 492 ----------ALIRDDS--EPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIM 539
                         D       K   L  ++      C++ +   RP  R I+  L+ + 
Sbjct: 219 LSALDSQRKLQFYEDRHQLPAPKAAELANLINN----CMDYEPDHRPSFRAIIRDLNSLF 274

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 93.9 bits (234), Expect = 2e-21
 Identities = 48/277 (17%), Positives = 100/277 (36%), Gaps = 73/277 (26%)

Query: 294 FDESRIIGRGGFGNVYFG--LLGDREAAIKKM---RSNKSKEFFAELKVLCKIHHINV-- 346
           ++    +G G FG VY          AA K +      + +++  E+++L    H  +  
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80

Query: 347 FISTF-------------GNGSLSDHLHDPLLKGHQ-PLTWTARTQIAL---DAAKGIEY 389
            +  +               G++       ++      LT     QI +      + + +
Sbjct: 81  LLGAYYHDGKLWIMIEFCPGGAVDA-----IMLELDRGLT---EPQIQVVCRQMLEALNF 132

Query: 390 IHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPP 449
           +H       +HRD+K  N+L+      ++ADFG+     +T +K       +GTP ++ P
Sbjct: 133 LHSKRI---IHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQK---RDSFIGTPYWMAP 186

Query: 450 EYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK---------RAL--IRDDS 498
           E +  +  +        +     K D+++ G+ L E+   +         R L  I    
Sbjct: 187 EVVMCETMK--------DTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSD 238

Query: 499 EPT---------KMKSLITIMAAVAEWCLNEDAVDRP 526
            PT         + +  +       +  L+++   RP
Sbjct: 239 PPTLLTPSKWSVEFRDFL-------KIALDKNPETRP 268

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 96.9 bits (241), Expect = 2e-21
 Identities = 42/217 (19%), Positives = 89/217 (41%), Gaps = 54/217 (24%)

Query: 300 IGRGGFGNVYFGLL----GDREAAIKKMRSNKS----KEFFAELKVLCKIHHINVFISTF 351
           +G G FG+V  G+        + AIK ++        +E   E +++ ++ +  + +   
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYI-VRLI 402

Query: 352 G---------------NGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKA 396
           G                G L   L     +    +  +   ++    + G++Y+ +    
Sbjct: 403 GVCQAEALMLVMEMAGGGPLHKFLVGK--REE--IPVSNVAELLHQVSMGMKYLEEK--- 455

Query: 397 RYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLP-----PEY 451
            +VHR++   N+LL +   AK++DFGL K     ++    A     + G  P     PE 
Sbjct: 456 NFVHRNLAARNVLLVNRHYAKISDFGLSKALGA-DDSYYTAR----SAGKWPLKWYAPEC 510

Query: 452 IFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
           I  ++F             ++++DV+++GV + E ++
Sbjct: 511 INFRKF-------------SSRSDVWSYGVTMWEALS 534

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 92.8 bits (231), Expect = 5e-21
 Identities = 67/296 (22%), Positives = 113/296 (38%), Gaps = 77/296 (26%)

Query: 275 ESERTIIFSLEEIEEATN---NFDESRIIGRGGFGNVYFG--LLGDREAAIKKMR-SNKS 328
              R  +  L+E          FD    +G G +G+VY        +  AIK++   +  
Sbjct: 9   NPPRRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDL 68

Query: 329 KEFFAELKVLCKIHHINV--FISTF-------------GNGSLSDHLHDPLLKGHQPLTW 373
           +E   E+ ++ +    +V  +  ++             G GS+SD +       ++ LT 
Sbjct: 69  QEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIR----LRNKTLT- 123

Query: 374 TARTQIAL---DAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERT 430
               +IA       KG+EY+H   K   +HRDIK  NILL+    AK+ADFG+      T
Sbjct: 124 --EDEIATILQSTLKGLEYLHFMRK---IHRDIKAGNILLNTEGHAKLADFGVAGQLTDT 178

Query: 431 NEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
             K      ++GTP ++ PE I  +   ++              D+++ G+   E+  GK
Sbjct: 179 MAK---RNTVIGTPFWMAPEVI--QEIGYN-----------CVADIWSLGITAIEMAEGK 222

Query: 491 ---------RAL--IRDDSEPT---------KMKSLITIMAAVAEWCLNEDAVDRP 526
                    RA+  I  +  PT              +       + CL +    R 
Sbjct: 223 PPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFV-------KQCLVKSPEQRA 271

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 91.2 bits (227), Expect = 2e-20
 Identities = 73/290 (25%), Positives = 120/290 (41%), Gaps = 67/290 (23%)

Query: 276 SERTIIFSLEEIEEATNN----FDESRIIGRGGFGNVYFG--LLGDREAAIKKM----RS 325
           +   +   L  ++    +    F +   IG+G FG V+ G      +  AIK +      
Sbjct: 2   AHSPVQSGLPGMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE 61

Query: 326 NKSKEFFAELKVLCKIHHINV--FISTF-------------GNGSLSDHLHDPLLKGHQP 370
           ++ ++   E+ VL +     V  +  ++             G GS  D     LL+   P
Sbjct: 62  DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALD-----LLE-PGP 115

Query: 371 LTWTARTQIAL---DAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLE 427
           L     TQIA    +  KG++Y+H   K   +HRDIK +N+LL +    K+ADFG+    
Sbjct: 116 LD---ETQIATILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQL 169

Query: 428 ERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELI 487
             T  K       VGTP ++ PE I  K+  +D           +K D+++ G+   EL 
Sbjct: 170 TDTQIK---RNTFVGTPFWMAPEVI--KQSAYD-----------SKADIWSLGITAIELA 213

Query: 488 TGK---------RAL--IRDDSEPTKMKSLITIMAAVAEWCLNEDAVDRP 526
            G+         + L  I  ++ PT   +    +    E CLN++   RP
Sbjct: 214 RGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRP 263

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 91.7 bits (228), Expect = 2e-20
 Identities = 45/242 (18%), Positives = 80/242 (33%), Gaps = 66/242 (27%)

Query: 292 NNFDESRIIGRGGFGNVYFGLLGDREAAIK---KMRSNKSKEFFA--------------- 333
           N++   R + +G F  +      ++  A+K   K    K ++F                 
Sbjct: 31  NDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDF 90

Query: 334 --ELKVLCKIHHINV-----FISTF----------GNGSLSDHLHDPLLKGHQPLTWTAR 376
             EL+++  I +         I+ +           N S+              L     
Sbjct: 91  KNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEY-----FFVLDKNYT 145

Query: 377 TQIALDAAK--------GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEE 428
             I +   K           YIH+       HRD+K SNIL+D   R K++DFG  +   
Sbjct: 146 CFIPIQVIKCIIKSVLNSFSYIHNEKNI--CHRDVKPSNILMDKNGRVKLSDFGESEYM- 202

Query: 429 RTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
                + +     GT  ++PPE  F     ++            K D+++ G+ L  +  
Sbjct: 203 ---VDKKIKG-SRGTYEFMPPE-FFSNESSYN----------GAKVDIWSLGICLYVMFY 247

Query: 489 GK 490
             
Sbjct: 248 NV 249

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 91.3 bits (227), Expect = 3e-20
 Identities = 71/300 (23%), Positives = 115/300 (38%), Gaps = 79/300 (26%)

Query: 282 FSLEEIEEATNNFDESRIIGRGGFGNVYFGL--LGDREAAIKKM--RSNKSKEFFAELKV 337
             L  + +    F+   ++G G +G VY G      + AAIK M    ++ +E   E+ +
Sbjct: 14  IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINM 73

Query: 338 LCKI-HHINV--FISTF-------------------GNGSLSDHLHDPLLKGH--QPLTW 373
           L K  HH N+  +   F                   G GS++D     L+K      L  
Sbjct: 74  LKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD-----LIKNTKGNTLK- 127

Query: 374 TARTQIAL---DAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERT 430
                IA    +  +G+ ++H H     +HRDIK  N+LL +    K+ DFG+    +RT
Sbjct: 128 --EEWIAYICREILRGLSHLHQHKV---IHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT 182

Query: 431 NEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
             +       +GTP ++ PE I              +     K+D+++ G+   E+  G 
Sbjct: 183 VGR---RNTFIGTPYWMAPEVIACDENP--------DATYDFKSDLWSLGITAIEMAEGA 231

Query: 491 ---------RAL--IRDDSEPT--------KMKSLITIMAAVAEWCLNEDAVDRPEMRDI 531
                    RAL  I  +  P         K +S I       E CL ++   RP    +
Sbjct: 232 PPLCDMHPMRALFLIPRNPAPRLKSKKWSKKFQSFI-------ESCLVKNHSQRPATEQL 284

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 90.1 bits (224), Expect = 6e-20
 Identities = 57/244 (23%), Positives = 95/244 (38%), Gaps = 47/244 (19%)

Query: 274 LESERTIIFSLEEIEEAT-NNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNKS-- 328
           +ES   +  S E+  + T  +  +   IGRG +G+V   +     +  A+K++RS     
Sbjct: 3   IESSGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEK 62

Query: 329 --KEFFAELKVLCK-IHHINVFISTFG---------------NGSLSDHLHDPLLKGHQP 370
             K+   +L V+ +      + +  +G               + S               
Sbjct: 63  EQKQLLMDLDVVMRSSDCPYI-VQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDV 121

Query: 371 LTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFG----LVKL 426
           +      +I L   K + ++ ++ K   +HRDIK SNILLD     K+ DFG    LV  
Sbjct: 122 IPEEILGKITLATVKALNHLKENLKI--IHRDIKPSNILLDRSGNIKLCDFGISGQLV-- 177

Query: 427 EERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAEL 486
                   +  TR  G   Y+ PE I           S        ++DV++ G+ L EL
Sbjct: 178 ------DSIAKTRDAGCRPYMAPERI---------DPSASRQGYDVRSDVWSLGITLYEL 222

Query: 487 ITGK 490
            TG+
Sbjct: 223 ATGR 226

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score = 89.2 bits (222), Expect = 6e-20
 Identities = 53/227 (23%), Positives = 84/227 (37%), Gaps = 59/227 (25%)

Query: 292 NNFDESRIIGRGGFGNVYFG--LLGDREAAIKKM------RSNKSKEFFAELKVLCKIHH 343
            +F+  R +G+G FGNVY           A+K +      ++    +   E+++   + H
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68

Query: 344 INVFISTFG----------------NGSLSDHLHDPLLKGHQPLT-WTART---QIALDA 383
            N+ +  +G                 G++   L     +           T   ++A   
Sbjct: 69  PNI-LRLYGYFHDATRVYLILEYAPLGTVYREL-----QKLSKFDEQRTATYITELAN-- 120

Query: 384 AKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGT 443
              + Y H     R +HRDIK  N+LL      K+ADFG                 L GT
Sbjct: 121 --ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVH----APSSRRTD-LCGT 170

Query: 444 PGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
             YLPPE I  +     MH          K D+++ GV+  E + GK
Sbjct: 171 LDYLPPEMIEGR-----MHDE--------KVDLWSLGVLCYEFLVGK 204

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 88.9 bits (221), Expect = 1e-19
 Identities = 61/275 (22%), Positives = 107/275 (38%), Gaps = 65/275 (23%)

Query: 300 IGRGGFGNVYFG--LLGDREAAIKKM----RSNKSKEFFAELKVLCKIHHINV--FISTF 351
           IG G    V          + AIK++          E   E++ + + HH N+  + ++F
Sbjct: 23  IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSF 82

Query: 352 -------------GNGSLSDHLHDPLLKGHQPLTWTARTQIAL---DAAKGIEYIHDHTK 395
                          GS+ D +   + KG         + IA    +  +G+EY+H + +
Sbjct: 83  VVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQ 142

Query: 396 ARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATR--LVGTPGYLPPEYIF 453
              +HRD+K  NILL +    ++ADFG+        +      R   VGTP ++ PE   
Sbjct: 143 ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPE--- 196

Query: 454 VKRFRFDMHSSVMELQVT--TKTDVFAFGVVLAELITGK---------RALIR-DDSEPT 501
                      VME       K D+++FG+   EL TG          + L+    ++P 
Sbjct: 197 -----------VMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPP 245

Query: 502 KMKSLITIMAAVAEW----------CLNEDAVDRP 526
            +++ +     + ++          CL +D   RP
Sbjct: 246 SLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRP 280

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 90.4 bits (224), Expect = 1e-19
 Identities = 42/231 (18%), Positives = 75/231 (32%), Gaps = 51/231 (22%)

Query: 291 TNNFDESRIIGRG--GFGNVYFGL--LGDREAAIKKM---RSNKS--KEFFAELKVLCKI 341
              ++   +IG+G      V             ++++     +         EL V    
Sbjct: 24  GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83

Query: 342 HHINV--FISTF-------------GNGSLSDHLHDPLLKGHQPLTWTARTQIAL---DA 383
           +H N+  + +TF               GS  D     L+  H          IA      
Sbjct: 84  NHPNIVPYRATFIADNELWVVTSFMAYGSAKD-----LICTHFMDGMN-ELAIAYILQGV 137

Query: 384 AKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFG----LVKLEERTNEKEMLATR 439
            K ++YIH      YVHR +K S+IL+    +  ++       ++   +R          
Sbjct: 138 LKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKY 194

Query: 440 LVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
            V    +L PE +      +D            K+D+++ G+   EL  G 
Sbjct: 195 SVKVLPWLSPEVLQQNLQGYD-----------AKSDIYSVGITACELANGH 234

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 89.1 bits (221), Expect = 2e-19
 Identities = 54/309 (17%), Positives = 105/309 (33%), Gaps = 63/309 (20%)

Query: 265 KENTEDVTVLESERTIIFSLEEIEEATNNFDESRIIGRGGFGNVYFGLL--GDREAAIKK 322
           +   ++      E  +    +  E   ++F++   +G G  G V+           A K 
Sbjct: 6   ELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKL 65

Query: 323 MRSNKSKEFFA----ELKVLCKIHHINV--FISTF-------------GNGSLSDHLHDP 363
           +              EL+VL + +   +  F   F               GSL       
Sbjct: 66  IHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ----- 120

Query: 364 LLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFG- 422
           +LK    +      ++++   KG+ Y+ +  K + +HRD+K SNIL++     K+ DFG 
Sbjct: 121 VLKKAGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGV 178

Query: 423 ---LVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAF 479
              L+     +          VGT  Y+ PE +                  + ++D+++ 
Sbjct: 179 SGQLIDSMANSF---------VGTRSYMSPERL-------------QGTHYSVQSDIWSM 216

Query: 480 GVVLAELITGK---------RALIRDDSEPTKMKSLITIMAAVAEWCLNEDAVDRPEMRD 530
           G+ L E+  G+            +    +     +            LN+  +D      
Sbjct: 217 GLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMA 276

Query: 531 IVAILSQIM 539
           I  +L  I+
Sbjct: 277 IFELLDYIV 285

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score = 88.1 bits (219), Expect = 2e-19
 Identities = 58/218 (26%), Positives = 88/218 (40%), Gaps = 46/218 (21%)

Query: 298 RIIGRGGFGNVYFGLLGD--REAAIKKMRSNKSKEFFA---ELKVLCKIHHINV------ 346
            ++G+G +G VY G         AIK++    S+       E+ +   + H N+      
Sbjct: 28  VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGS 87

Query: 347 -----FISTF----GNGSLSDHLHDPL--LKGHQPLTWTARTQIALDAAKGIEYIHDHTK 395
                FI  F      GSLS  L      LK ++        QI L   +G++Y+HD+  
Sbjct: 88  FSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQI-L---EGLKYLHDNQI 143

Query: 396 ARYVHRDIKTSNILLD--DGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIF 453
              VHRDIK  N+L++   G+  K++DFG  K   R            GT  Y+ PE I 
Sbjct: 144 ---VHRDIKGDNVLINTYSGV-LKISDFGTSK---RLAGINPCTETFTGTLQYMAPEII- 195

Query: 454 VKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKR 491
                 D              D+++ G  + E+ TGK 
Sbjct: 196 ------DKGPR----GYGKAADIWSLGCTIIEMATGKP 223

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 87.5 bits (217), Expect = 5e-19
 Identities = 74/272 (27%), Positives = 106/272 (38%), Gaps = 68/272 (25%)

Query: 294 FDESRIIGRGGFGNVYFG--LLGDREAAIKKM------RSNKSKEFFAELKVLCKIHHIN 345
           F + R IG G FG VYF   +      AIKKM       + K ++   E++ L K+ H N
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115

Query: 346 V--FISTF--GN----------GSLSDHLHDPLLKGHQ-PLTWTARTQIAL---DAAKGI 387
              +   +   +          GS SD     LL+ H+ PL      +IA     A +G+
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCLGSASD-----LLEVHKKPLQ---EVEIAAVTHGALQGL 167

Query: 388 EYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLV-KLEERTNEKEMLATRLVGTPGY 446
            Y+H H     +HRD+K  NILL +    K+ DFG    +    +         VGTP +
Sbjct: 168 AYLHSHNM---IHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS--------FVGTPYW 216

Query: 447 LPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK---------RAL--IR 495
           + PE I              E Q   K DV++ G+   EL   K          AL  I 
Sbjct: 217 MAPEVILAMD----------EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA 266

Query: 496 DDSEPT-KMKSLITIMAAVAEWCLNEDAVDRP 526
            +  P  +            + CL +   DRP
Sbjct: 267 QNESPALQSGHWSEYFRNFVDSCLQKIPQDRP 298

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 86.1 bits (214), Expect = 7e-19
 Identities = 52/226 (23%), Positives = 82/226 (36%), Gaps = 57/226 (25%)

Query: 292 NNFDESRIIGRGGFGNVYFG--LLGDREAAIKKM------RSNKSKEFFAELKVLCKIHH 343
           ++FD  R +G+G FGNVY           A+K +      +     +   E+++   + H
Sbjct: 14  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73

Query: 344 INV--------------FISTF-GNGSLSDHLHDPLLKGHQPLT-WTART---QIALDAA 384
            N+               +  F   G L   L     + H       + T   ++A    
Sbjct: 74  PNILRMYNYFHDRKRIYLMLEFAPRGELYKEL-----QKHGRFDEQRSATFMEELAD--- 125

Query: 385 KGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP 444
             + Y H+    + +HRDIK  N+L+      K+ADFG               T + GT 
Sbjct: 126 -ALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVH----APSLRRRT-MCGTL 176

Query: 445 GYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
            YLPPE I  K                 K D++  GV+  E + G 
Sbjct: 177 DYLPPEMIEGKTH-------------DEKVDLWCAGVLCYEFLVGM 209

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 84.2 bits (209), Expect = 4e-18
 Identities = 48/221 (21%), Positives = 82/221 (37%), Gaps = 49/221 (22%)

Query: 298 RIIGRGGFGNVYFG--LLGDREAAIK-----KMRSNKSKEF--FAELKVLCKIHHINV-- 346
            ++G G +G V            A+K     K+R   + E     E+++L ++ H NV  
Sbjct: 11  DLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQ 70

Query: 347 --------------FISTFGNGSLSDHLHDPLLKGHQPLTWTART---QIALDAAKGIEY 389
                          +  +    + + + D + +   P    A     Q+      G+EY
Sbjct: 71  LVDVLYNEEKQKMYMVMEYCVCGMQE-MLDSVPEKRFP-VCQAHGYFCQLID----GLEY 124

Query: 390 IHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPP 449
           +H       VH+DIK  N+LL  G   K++  G+ +        +   T   G+P + PP
Sbjct: 125 LHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTS-QGSPAFQPP 180

Query: 450 EYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
           E I      F             K D+++ GV L  + TG 
Sbjct: 181 E-IANGLDTFS----------GFKVDIWSAGVTLYNITTGL 210

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 83.9 bits (208), Expect = 5e-18
 Identities = 58/246 (23%), Positives = 91/246 (36%), Gaps = 80/246 (32%)

Query: 298 RIIGRGGFGNVYFG--LLGDREAAIK---KMRSNKSKEFFA------------------- 333
             IG+G +G V        +   A+K   K +  +   F                     
Sbjct: 19  DEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRG 78

Query: 334 -------ELKVLCKIHHINVFISTFGNGSLSDHLHDP----------LLKG--------H 368
                  E+ +L K+ H NV         L + L DP          L+           
Sbjct: 79  PIEQVYQEIAILKKLDHPNVV-------KLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL 131

Query: 369 QPLT-WTART---QIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLV 424
           +PL+   AR     +      GIEY+H     + +HRDIK SN+L+ +    K+ADFG+ 
Sbjct: 132 KPLSEDQARFYFQDLIK----GIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVS 184

Query: 425 KLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLA 484
              + ++   +L+   VGTP ++ PE +   R  F               DV+A GV L 
Sbjct: 185 NEFKGSD--ALLSNT-VGTPAFMAPESLSETRKIFS----------GKALDVWAMGVTLY 231

Query: 485 ELITGK 490
             + G+
Sbjct: 232 CFVFGQ 237

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 84.7 bits (210), Expect = 7e-18
 Identities = 55/237 (23%), Positives = 88/237 (37%), Gaps = 67/237 (28%)

Query: 288 EEATNNFDESRIIGRGGFGNVYFGLLGD-REAAIKKMRSNKSKEFFAELKVLCKIHHINV 346
           E+    +   ++IG G FG V+   L +  E AIKK+  +K  +   EL+++  + H NV
Sbjct: 36  EQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKN-RELQIMRIVKHPNV 94

Query: 347 FISTFGNGSLSDHLHDPLLKG----------------HQPLTWTARTQIALDAA------ 384
                    L    +    K                 ++     A+ +  +         
Sbjct: 95  V-------DLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYM 147

Query: 385 ----KGIEYIHDHTKARYVHRDIKTSNILLD---DGLRAKVADFGL----VKLEERTNEK 433
               + + YIH        HRDIK  N+LLD     L  K+ DFG     +  E   +  
Sbjct: 148 YQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVL--KLIDFGSAKILIAGEPNVSY- 201

Query: 434 EMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
             + +R      Y  PE IF                 TT  D+++ G V+AEL+ G+
Sbjct: 202 --ICSRY-----YRAPELIFGAT------------NYTTNIDIWSTGCVMAELMQGQ 239

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 83.2 bits (206), Expect = 1e-17
 Identities = 58/279 (20%), Positives = 101/279 (36%), Gaps = 81/279 (29%)

Query: 298 RIIGRGGFGNVYFG--LLGDREAAIKKMRSNKSKEFFA---------ELKVLCKIHHI-- 344
            ++G GGFG+VY G  +  +   AIK +  ++  ++           E+ +L K+     
Sbjct: 49  PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 108

Query: 345 NV-----FIST-----------FGNGSLSDHLHDPLLKGHQPLT-WTART---QIALDAA 384
            V     +                   L D + +        L    AR+   Q+     
Sbjct: 109 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-----RGALQEELARSFFWQVL---- 159

Query: 385 KGIEYIHDHTKARYVHRDIKTSNILLD-DGLRAKVADFGLVKLEERTNEKEMLATRLVGT 443
           + + + H+      +HRDIK  NIL+D +    K+ DFG   L + T    +      GT
Sbjct: 160 EAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTD-FDGT 211

Query: 444 PGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG-------KRALIRD 496
             Y PPE+I   R+                  V++ G++L +++ G       +  +   
Sbjct: 212 RVYSPPEWIRYHRYH------------GRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQ 259

Query: 497 DSEPTKM----KSLITIMAAVAEWCLNEDAVDRPEMRDI 531
                ++    + LI        WCL     DRP   +I
Sbjct: 260 VFFRQRVSSECQHLIR-------WCLALRPSDRPTFEEI 291

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 82.7 bits (205), Expect = 1e-17
 Identities = 40/219 (18%), Positives = 88/219 (40%), Gaps = 35/219 (15%)

Query: 292 NNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNKS----KEFFAELKVLCK-IHHI 344
           ++ +    +GRG +G V         +  A+K++R+  +    K    +L +  + +   
Sbjct: 7   DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 66

Query: 345 NV---FISTFGNGSLS----------DHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIH 391
                + + F  G +           D  +  ++   Q +      +IA+   K +E++H
Sbjct: 67  FTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH 126

Query: 392 DHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEY 451
                  +HRD+K SN+L++   + K+ DFG+           +      G   Y+ PE 
Sbjct: 127 SKLSV--IHRDVKPSNVLINALGQVKMCDFGISGYLVDD----VAKDIDAGCKPYMAPER 180

Query: 452 IFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
           I         +  + +   + K+D+++ G+ + EL   +
Sbjct: 181 I---------NPELNQKGYSVKSDIWSLGITMIELAILR 210

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 81.6 bits (202), Expect = 3e-17
 Identities = 48/225 (21%), Positives = 84/225 (37%), Gaps = 31/225 (13%)

Query: 283 SLEEIEEATNNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNKSKEFFA----ELK 336
             +  +   N+ +    +G G  G V+           A+K+MR + +KE       +L 
Sbjct: 16  GGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLD 75

Query: 337 VLCK-IHHINV---FISTFGNGSLS-------DHLHDPLLKGHQPLTWTARTQIALDAAK 385
           V+ K      +   F +   N  +                +   P+      ++ +   K
Sbjct: 76  VVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVK 135

Query: 386 GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPG 445
            + Y+ +  K   +HRD+K SNILLD+  + K+ DFG+               R  G   
Sbjct: 136 ALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD----KAKDRSAGCAA 189

Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
           Y+ PE I              +     + DV++ G+ L EL TG+
Sbjct: 190 YMAPERI--------DPPDPTKPDYDIRADVWSLGISLVELATGQ 226

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 83.3 bits (206), Expect = 4e-17
 Identities = 58/228 (25%), Positives = 95/228 (41%), Gaps = 55/228 (24%)

Query: 292 NNFDESRIIGRGGFGNVYFGLLGDREA-----AIKKMRSNKSKE------FFAELKVLCK 340
           + F + R++GRGGFG V+       +A     A KK+   + K+         E K+L K
Sbjct: 185 DWFLDFRVLGRGGFGEVF---ACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAK 241

Query: 341 IHH---INV-----------FISTFGN-GSLSDHLHDPLLKGHQPLTWTAR---TQIALD 382
           +H    +++            + T  N G +  H+++            A     QI   
Sbjct: 242 VHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVS- 300

Query: 383 AAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVG 442
              G+E++H       ++RD+K  N+LLDD    +++D GL    E    +        G
Sbjct: 301 ---GLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAV--ELKAGQTKTKGY-AG 351

Query: 443 TPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
           TPG++ PE +  + + F    SV         D FA GV L E+I  +
Sbjct: 352 TPGFMAPELLLGEEYDF----SV---------DYFALGVTLYEMIAAR 386

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 82.0 bits (203), Expect = 5e-17
 Identities = 50/242 (20%), Positives = 84/242 (34%), Gaps = 64/242 (26%)

Query: 285 EEIEEATNNFDESRIIGRGGFGNVYFGLLGD--REAAIKKMRSNKSKEFFA-----ELKV 337
           E   +  + F   R+ G+G FG V  G         AIKK+  +     F       ++ 
Sbjct: 16  ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR---FRNRELQIMQD 72

Query: 338 LCKIHHINVFISTFGNGSLSDHLHDPLLKG-----------------HQPLTWTARTQIA 380
           L  +HH N+         L  + +    +                  H+      R Q+A
Sbjct: 73  LAVLHHPNIV-------QLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVA 125

Query: 381 LDAA----------KGIEYIHDHTKARYVHRDIKTSNILLDDG-LRAKVADFGLVKLEER 429
                         + I  +H  +     HRDIK  N+L+++     K+ DFG  K    
Sbjct: 126 PPPILIKVFLFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSP 184

Query: 430 TNEK-EMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
           +      + +R      Y  PE IF  +              TT  D+++ G + AE++ 
Sbjct: 185 SEPNVAYICSRY-----YRAPELIFGNQ------------HYTTAVDIWSVGCIFAEMML 227

Query: 489 GK 490
           G+
Sbjct: 228 GE 229

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 81.7 bits (202), Expect = 1e-16
 Identities = 58/230 (25%), Positives = 88/230 (38%), Gaps = 58/230 (25%)

Query: 291 TNNFDESRIIGRGGFGNVYFGLLGD--REAAIKKMRSNKSKEFFAELKVLCKIHHINVFI 348
             ++ ++++IG G FG VY   L D     AIKK+  +K +    EL+++ K+ H N+  
Sbjct: 53  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-RFKNRELQIMRKLDHCNIV- 110

Query: 349 STFGNGSLSDHLHDPLLKG----------------HQPLTWTARTQIALDAA-------- 384
                  L    +    K                 ++     +R +  L           
Sbjct: 111 ------RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 164

Query: 385 --KGIEYIHDHTKARYVHRDIKTSNILLD-DGLRAKVADFGLVK-LEERTNEKEMLATRL 440
             + + YIH        HRDIK  N+LLD D    K+ DFG  K L         + +R 
Sbjct: 165 LFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY 221

Query: 441 VGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
                Y  PE IF                 T+  DV++ G VLAEL+ G+
Sbjct: 222 -----YRAPELIFGAT------------DYTSSIDVWSAGCVLAELLLGQ 254

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 80.7 bits (200), Expect = 1e-16
 Identities = 58/240 (24%), Positives = 98/240 (40%), Gaps = 54/240 (22%)

Query: 292 NNFDESRIIGRGGFGNVYFGLLGDRE----AAIKKMRSNKSKEFFA-----ELKVLCKIH 342
           + +++   IG+G FG V+      R+     A+KK+     KE F      E+K+L  + 
Sbjct: 17  SKYEKLAKIGQGTFGEVFKAR--HRKTGQKVALKKVLMENEKEGFPITALREIKILQLLK 74

Query: 343 HINV---------FISTFGNGSLSDHL------HDPLLKG-----HQPLTWTARTQIALD 382
           H NV           S +     S +L      HD  L G         T +   ++   
Sbjct: 75  HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHD--LAGLLSNVLVKFTLSEIKRVMQM 132

Query: 383 AAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGL---VKLEERTNEKEMLATR 439
              G+ YIH +   + +HRD+K +N+L+      K+ADFGL     L + +       T 
Sbjct: 133 LLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY--TN 187

Query: 440 LVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE 499
            V T  Y PPE +  +R                  D++  G ++AE+ T    +++ ++E
Sbjct: 188 RVVTLWYRPPELLLGER------------DYGPPIDLWGAGCIMAEMWTRS-PIMQGNTE 234

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 79.9 bits (197), Expect = 2e-16
 Identities = 51/279 (18%), Positives = 85/279 (30%), Gaps = 77/279 (27%)

Query: 275 ESERTIIFSLEEIEEATNNFDESRIIGRGGFGNVYFG--LLGDREAAIKKMRSNKSKEFF 332
                + F    + E    +     IG+G +G V            AIK M  NK ++  
Sbjct: 9   SGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQIN 68

Query: 333 A--------ELKVLCKIHHINV---------------------------FISTFGNGSLS 357
                    E++++ K+HH N+                            ++ F + S  
Sbjct: 69  PKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTG 128

Query: 358 DHLHDPLLKGHQPLTWTARTQIAL----------------DAAK-------GIEYIHDHT 394
               D +     P        I                    +         + Y+H+  
Sbjct: 129 KCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ- 187

Query: 395 KARYVHRDIKTSNILL--DDGLRAKVADFGL-VKLEERTNEKEMLATRLVGTPGYLPPEY 451
                HRDIK  N L   +     K+ DFGL  +  +  N +    T   GTP ++ PE 
Sbjct: 188 --GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEV 245

Query: 452 IFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
           +      +             K D ++ GV+L  L+ G 
Sbjct: 246 LNTTNESYG-----------PKCDAWSAGVLLHLLLMGA 273

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 81.0 bits (200), Expect = 3e-16
 Identities = 64/252 (25%), Positives = 105/252 (41%), Gaps = 59/252 (23%)

Query: 269 EDVTVLESERTIIFSLEEIEEAT-NNFDESRIIGRGGFGNVYFGLLGDREA-----AIKK 322
           + +  +   R + +   E +  T N F + R++G+GGFG V         A     A KK
Sbjct: 160 DYLDSIYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVC---ACQVRATGKMYACKK 216

Query: 323 MRSNKSKE------FFAELKVLCKIHHINV--------------FISTFGN-GSLSDHLH 361
           +   + K+         E ++L K++   V               + T  N G L  H++
Sbjct: 217 LEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIY 276

Query: 362 ---DPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKV 418
                     + + + A  +I      G+E +H     R V+RD+K  NILLDD    ++
Sbjct: 277 HMGQAGFPEARAVFYAA--EICC----GLEDLHRE---RIVYRDLKPENILLDDHGHIRI 327

Query: 419 ADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFA 478
           +D GL        E + +  R VGT GY+ PE +  +R+ F    S          D +A
Sbjct: 328 SDLGLAV---HVPEGQTIKGR-VGTVGYMAPEVVKNERYTF----SP---------DWWA 370

Query: 479 FGVVLAELITGK 490
            G +L E+I G+
Sbjct: 371 LGCLLYEMIAGQ 382

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 78.5 bits (194), Expect = 4e-16
 Identities = 56/219 (25%), Positives = 87/219 (39%), Gaps = 54/219 (24%)

Query: 298 RIIGRGGFGNVYFG--LLGDREAAIK-----KMRSNKSKEFFAELKVLCKIHHINVF--- 347
           + IG+G F  V     +L  RE AIK     ++     ++ F E++++  ++H N+    
Sbjct: 21  KTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLF 80

Query: 348 --IST----------FGNGSLSDHLHDPLLKGHQPLT-WTAR---TQIALDAAKGIEYIH 391
             I T             G + D+L       H  +    AR    QI       ++Y H
Sbjct: 81  EVIETEKTLYLIMEYASGGEVFDYL-----VAHGRMKEKEARSKFRQIVS----AVQYCH 131

Query: 392 DHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEY 451
                R VHRD+K  N+LLD  +  K+ADFG             L     G P Y  PE 
Sbjct: 132 QK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFT---VGGKLDA-FCGAPPYAAPEL 184

Query: 452 IFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
              K++               + DV++ GV+L  L++G 
Sbjct: 185 FQGKKY------------DGPEVDVWSLGVILYTLVSGS 211

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 77.6 bits (192), Expect = 5e-16
 Identities = 46/217 (21%), Positives = 82/217 (37%), Gaps = 50/217 (23%)

Query: 298 RIIGRGGFGNVYFG--LLGDREAAIKKMRSNKSKEFFA----ELKVLCKIHHINVF---- 347
           + +G G +G V      + +   A+K +   ++ +       E+ +   ++H NV     
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72

Query: 348 -IST----------FGNGSLSDHLHDPLLKGHQPLT-WTART---QIALDAAKGIEYIHD 392
                            G L D +     +    +    A+    Q+      G+ Y+H 
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMA----GVVYLHG 123

Query: 393 HTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYI 452
                  HRDIK  N+LLD+    K++DFGL  +    N + +L     GT  Y+ PE +
Sbjct: 124 I---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM-CGTLPYVAPELL 179

Query: 453 FVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
             + F                 DV++ G+VL  ++ G
Sbjct: 180 KRREFH------------AEPVDVWSCGIVLTAMLAG 204

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 79.5 bits (196), Expect = 8e-16
 Identities = 58/230 (25%), Positives = 92/230 (40%), Gaps = 61/230 (26%)

Query: 292 NNFDESRIIGRGGFGNVYFGLLGDREA----AIKKMR-----SNKSKEF-FAELKVLCKI 341
           N+F   RIIGRGGFG VY       +     A+K +        + +     E  +L  +
Sbjct: 189 NDFSVHRIIGRGGFGEVY--GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLV 246

Query: 342 HHINV-----------------FISTFGN-GSLSDHL-HDPLLKGHQPLTWTARTQIALD 382
              +                  FI    N G L  HL    +        + A  +I L 
Sbjct: 247 STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAA--EIIL- 303

Query: 383 AAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK--LEERTNEKEMLATRL 440
              G+E++H+      V+RD+K +NILLD+    +++D GL     +++ +         
Sbjct: 304 ---GLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH------AS- 350

Query: 441 VGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
           VGT GY+ PE +  K   +D   S          D F+ G +L +L+ G 
Sbjct: 351 VGTHGYMAPE-VLQKGVAYDS--SA---------DWFSLGCMLFKLLRGH 388

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 77.2 bits (191), Expect = 1e-15
 Identities = 55/242 (22%), Positives = 87/242 (35%), Gaps = 70/242 (28%)

Query: 292 NNFDESRIIGRGGFGNVYFGLLGDREA----AIKKMRSNKSKEFFA-----ELKVLCKIH 342
             +++   IG G +G V+     +R+     AIKK   ++           E+++L ++ 
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCR--NRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLK 60

Query: 343 HIN------VFISTFGNGSLS------DH-LHDPLLKGHQPLTWTARTQIALDAAKGIEY 389
           H N      VF        L       DH +   L +  + +       I     + + +
Sbjct: 61  HPNLVNLLEVFRR---KRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNF 117

Query: 390 IHDHTKARYVHRDIKTSNILLDDGLRAKVADFGL-----VKLEERTNEKEMLATR----- 439
            H H     +HRD+K  NIL+      K+ DFG         +   +E   +ATR     
Sbjct: 118 CHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDE---VATRWYRSP 171

Query: 440 --LVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDD 497
             LVG   Y PP                         DV+A G V AEL++G   L    
Sbjct: 172 ELLVGDTQYGPP------------------------VDVWAIGCVFAELLSG-VPLWPGK 206

Query: 498 SE 499
           S+
Sbjct: 207 SD 208

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 77.2 bits (191), Expect = 1e-15
 Identities = 57/237 (24%), Positives = 87/237 (36%), Gaps = 52/237 (21%)

Query: 292 NNFDESRIIGRGGFGNVYFGL---LGDREAAIKKMRSNKSKEFF--------AELKVLCK 340
             ++    IG G +G V+       G R  A+K++R    +E          A L+ L  
Sbjct: 11  QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 70

Query: 341 IHHIN------VFISTFGNGSLSDHL------HDPLLKG---HQPLTWTARTQI---ALD 382
             H N      V   +  +      L       D  L       P        I      
Sbjct: 71  FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQD--LTTYLDKVPEPGVPTETIKDMMFQ 128

Query: 383 AAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVG 442
             +G++++H H   R VHRD+K  NIL+    + K+ADFGL     R    +M  T +V 
Sbjct: 129 LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLA----RIYSFQMALTSVVV 181

Query: 443 TPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE 499
           T  Y  PE +    +              T  D+++ G + AE+   K  L R  S+
Sbjct: 182 TLWYRAPEVLLQSSY-------------ATPVDLWSVGCIFAEMFRRK-PLFRGSSD 224

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 77.3 bits (190), Expect = 2e-15
 Identities = 43/212 (20%), Positives = 77/212 (36%), Gaps = 48/212 (22%)

Query: 355 SLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGL 414
           S  +    P       LT       +   AKG+E++      + +HRD+   NILL +  
Sbjct: 174 SDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKN 230

Query: 415 RAKVADFGLVKLEERTNEKEMLATRLVGTPGYLP-----PEYIFVKRFRFDMHSSVMELQ 469
             K+ DFGL +   +  +              LP     PE IF + +            
Sbjct: 231 VVKICDFGLARDIYKDPDYV------RKGDARLPLKWMAPETIFDRVY------------ 272

Query: 470 VTTKTDVFAFGVVLAELIT-GKR--ALIRDDSEPTKM--------------KSLITIMAA 512
            T ++DV++FGV+L E+ + G      ++ D E  +                 +   M  
Sbjct: 273 -TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLD 331

Query: 513 VAEWCLNEDAVDRPEMRDIVAILSQIMITSTE 544
               C + +   RP   ++V  L  ++  + +
Sbjct: 332 ----CWHGEPSQRPTFSELVEHLGNLLQANAQ 359

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 76.4 bits (189), Expect = 2e-15
 Identities = 48/235 (20%), Positives = 86/235 (36%), Gaps = 55/235 (23%)

Query: 292 NNFDESRIIGRGGFGNVYFG--LLGDREAAIKKMRSNKSKEFFA-----ELKVLCKIHHI 344
             +++   IG G +G V+           A+K++R +   E        E+ +L ++ H 
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61

Query: 345 N------VFISTFGNGSLS---DHL-HDPLLKGH-----QPLTWTARTQIALDAAKGIEY 389
           N      V      +  L+   +    D  LK +       L             KG+ +
Sbjct: 62  NIVRLHDVLH---SDKKLTLVFEFCDQD--LKKYFDSCNGDLDPEIVKSFLFQLLKGLGF 116

Query: 390 IHDHTKARYVHRDIKTSNILLDDGLRAKVADFGL-----VKLEERTNEKEMLATRLVGTP 444
            H       +HRD+K  N+L++     K+A+FGL     + +   + E        V T 
Sbjct: 117 CHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAE--------VVTL 165

Query: 445 GYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE 499
            Y PP+ +F  +              +T  D+++ G + AEL    R L   +  
Sbjct: 166 WYRPPDVLFGAK------------LYSTSIDMWSAGCIFAELANAGRPLFPGNDV 208

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 76.6 bits (189), Expect = 2e-15
 Identities = 46/217 (21%), Positives = 82/217 (37%), Gaps = 50/217 (23%)

Query: 298 RIIGRGGFGNVYFG--LLGDREAAIKKMRSNKSKEFFA----ELKVLCKIHHINVF---- 347
           + +G G +G V      + +   A+K +   ++ +       E+ +   ++H NV     
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72

Query: 348 -IST----------FGNGSLSDHLHDPLLKGHQPLT-WTART---QIALDAAKGIEYIHD 392
                            G L D +     +    +    A+    Q+      G+ Y+H 
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMA----GVVYLHG 123

Query: 393 HTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYI 452
                  HRDIK  N+LLD+    K++DFGL  +    N + +L     GT  Y+ PE +
Sbjct: 124 I---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM-CGTLPYVAPELL 179

Query: 453 FVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
             + F                 DV++ G+VL  ++ G
Sbjct: 180 KRREFH------------AEPVDVWSCGIVLTAMLAG 204

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 78.3 bits (193), Expect = 2e-15
 Identities = 45/279 (16%), Positives = 96/279 (34%), Gaps = 45/279 (16%)

Query: 231 LRRKRPEEKITEDAKHVSKAMSITTRAFSSQGQCKENTEDVTVLESERTIIFSLEEIEEA 290
                 +E+       V +   I     +          D+      + +    + + + 
Sbjct: 99  PVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLD- 157

Query: 291 TNNFDESRIIGRGGFGNVYFG---LLGDREAA--IKKMRSNKSKEFFAELKVLCKIHHIN 345
             ++D    +G G FG V+       G+  AA  +     +  +    E++ +  + H  
Sbjct: 158 --HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPT 215

Query: 346 VFISTFGNGSLSDHLH------------DPLLKGHQPLTWTARTQIALDAAKGIEYIHDH 393
           + ++        + +             + +   H  ++     +      KG+ ++H++
Sbjct: 216 L-VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN 274

Query: 394 TKARYVHRDIKTSNILL--DDGLRAKVADFGL-VKLEERTNEKEMLATRLVGTPGYLPPE 450
               YVH D+K  NI+         K+ DFGL   L+ + + K        GT  +  PE
Sbjct: 275 ---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT-----TGTAEFAAPE 326

Query: 451 YIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
              V   +           V   TD+++ GV+   L++G
Sbjct: 327 ---VAEGKP----------VGYYTDMWSVGVLSYILLSG 352

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 76.1 bits (188), Expect = 2e-15
 Identities = 55/243 (22%), Positives = 88/243 (36%), Gaps = 58/243 (23%)

Query: 290 ATNNFDESRIIGRGGFGNVYFG--LLGDREAAIKKMRSNKSKEFFAE-----------LK 336
           AT+ ++    IG G +G VY           A+K +R                     L+
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66

Query: 337 VLCKIHHIN------VFISTFGNGSLSDHL------HDPLLKGHQPLTWTARTQIALDAA 384
            L    H N      V  ++  +  +   L       D  L+ +  L       +  +  
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQD--LRTY--LDKAPPPGLPAETI 122

Query: 385 K--------GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEML 436
           K        G++++H +     VHRD+K  NIL+  G   K+ADFGL     R    +M 
Sbjct: 123 KDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLA----RIYSYQMA 175

Query: 437 ATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRD 496
            T +V T  Y  PE +    +              T  D+++ G + AE+   K  L   
Sbjct: 176 LTPVVVTLWYRAPEVLLQSTY-------------ATPVDMWSVGCIFAEMFRRK-PLFCG 221

Query: 497 DSE 499
           +SE
Sbjct: 222 NSE 224

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 76.1 bits (188), Expect = 2e-15
 Identities = 53/228 (23%), Positives = 89/228 (39%), Gaps = 57/228 (25%)

Query: 292 NNFDESRIIGRGGFGNVYFG--LLGDREAAIKKM------RSNKSKEFFAELKVLCKIHH 343
            +F   +I+G G F  V     L   RE AIK +      + NK      E  V+ ++ H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89

Query: 344 INVFI----STF-------------GNGSLSDHLHDPLLKGHQPLTWTAR---TQIALDA 383
              F      TF              NG L  ++     K         R    +I    
Sbjct: 90  P--FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAEIVS-- 141

Query: 384 AKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGT 443
              +EY+H       +HRD+K  NILL++ +  ++ DFG  K+    +++    +  VGT
Sbjct: 142 --ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANS-FVGT 195

Query: 444 PGYLPPEYIFVKRFRFDMHSSVMELQVTTKT-DVFAFGVVLAELITGK 490
             Y+ PE              ++  +   K+ D++A G ++ +L+ G 
Sbjct: 196 AQYVSPE--------------LLTEKSACKSSDLWALGCIIYQLVAGL 229

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 75.4 bits (186), Expect = 4e-15
 Identities = 59/281 (20%), Positives = 94/281 (33%), Gaps = 83/281 (29%)

Query: 298 RIIGRGGFGNVYFG--LLGDREAAIK---KMRSNKSKEFFAELKVLCKIH---------- 342
            ++G+GGFG V+ G  L    + AIK   + R          +    ++           
Sbjct: 37  PLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGG 96

Query: 343 HINV-----FISTFGN-----------GSLSDHLHDPLLKGHQPLT-WTART---QIALD 382
           H  V     +  T                L D++ +       PL    +R    Q+   
Sbjct: 97  HPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITE-----KGPLGEGPSRCFFGQVVA- 150

Query: 383 AAKGIEYIHDHTKARYVHRDIKTSNILLD-DGLRAKVADFGLVKLEERTNEKEMLATRLV 441
               I++ H       VHRDIK  NIL+D     AK+ DFG   L               
Sbjct: 151 ---AIQHCHSR---GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE----PYTD-FD 199

Query: 442 GTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG-------KRALI 494
           GT  Y PPE+I   ++                  V++ G++L +++ G       +  L 
Sbjct: 200 GTRVYSPPEWISRHQYH------------ALPATVWSLGILLYDMVCGDIPFERDQEILE 247

Query: 495 RDDSEPTKM----KSLITIMAAVAEWCLNEDAVDRPEMRDI 531
            +   P  +     +LI         CL      RP + +I
Sbjct: 248 AELHFPAHVSPDCCALIR-------RCLAPKPSSRPSLEEI 281

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 75.1 bits (185), Expect = 6e-15
 Identities = 50/285 (17%), Positives = 91/285 (31%), Gaps = 79/285 (27%)

Query: 293 NFDESRIIGRGGFGNVYFG--LLGDREAAIK-----------KMRSNKSKEFFAELKVLC 339
            +     +G G FG V+       ++E  +K            +   K  +   E+ +L 
Sbjct: 25  KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84

Query: 340 KIHHINV-----FIST----------FGNGS-LSDHLHDPLLKGHQPLT-WTART---QI 379
           ++ H N+                    G+G  L   +       H  L    A     Q+
Sbjct: 85  RVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDR-----HPRLDEPLASYIFRQL 139

Query: 380 ALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATR 439
                  + Y+        +HRDIK  NI++ +    K+ DFG     ER    ++  T 
Sbjct: 140 VS----AVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLER---GKLFYT- 188

Query: 440 LVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG-------KRA 492
             GT  Y  PE +    +R              + ++++ GV L  L+         +  
Sbjct: 189 FCGTIEYCAPEVLMGNPYR------------GPELEMWSLGVTLYTLVFEENPFCELEET 236

Query: 493 LIRDDSEPTKM----KSLITIMAAVAEWCLNEDAVDRPEMRDIVA 533
           +      P  +     SL++ +       L      R  +  +V 
Sbjct: 237 VEAAIHPPYLVSKELMSLVSGL-------LQPVPERRTTLEKLVT 274

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 75.0 bits (185), Expect = 7e-15
 Identities = 53/242 (21%), Positives = 81/242 (33%), Gaps = 70/242 (28%)

Query: 292 NNFDESRIIGRGGFGNVYFGLLGDRE----AAIKKMRSNKSKEFFA-----ELKVLCKIH 342
             ++   ++G G +G V      +++     AIKK   +   +        E+K+L ++ 
Sbjct: 25  EKYENLGLVGEGSYGMVMKCR--NKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLR 82

Query: 343 HIN------VFISTFGNGSLS------DH-LHDPLLKGHQPLTWTARTQIALDAAKGIEY 389
           H N      V                 DH + D L      L +    +       GI +
Sbjct: 83  HENLVNLLEVCKK---KKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGF 139

Query: 390 IHDHTKARYVHRDIKTSNILLDDGLRAKVADFGL-----VKLEERTNEKEMLATR----- 439
            H H     +HRDIK  NIL+      K+ DFG         E   +E   +ATR     
Sbjct: 140 CHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDE---VATRWYRAP 193

Query: 440 --LVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDD 497
             LVG   Y                            DV+A G ++ E+  G   L   D
Sbjct: 194 ELLVGDVKYGKA------------------------VDVWAIGCLVTEMFMG-EPLFPGD 228

Query: 498 SE 499
           S+
Sbjct: 229 SD 230

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 75.1 bits (185), Expect = 9e-15
 Identities = 54/246 (21%), Positives = 96/246 (39%), Gaps = 58/246 (23%)

Query: 292 NNFDESRIIGRGGFGNVYFGLLGDREA----AIKKMRSN---KSKEF---FAELKVLCKI 341
           ++F+  R IG+G FG V   ++   +     A+K M      +  E    F EL+++  +
Sbjct: 15  DHFEILRAIGKGSFGKVC--IVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGL 72

Query: 342 HH---INV-----------FISTFGN-GSLSDHLHDPLLKGHQPLT----WTARTQIALD 382
            H   +N+            +      G L  HL       H        +    ++ + 
Sbjct: 73  EHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQ---NVHFKEETVKLFIC--ELVM- 126

Query: 383 AAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVG 442
               ++Y+ +    R +HRD+K  NILLD+     + DF +  +      +E   T + G
Sbjct: 127 ---ALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAM----LPRETQITTMAG 176

Query: 443 TPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRA-LIRDDSEPT 501
           T  Y+ PE +F  R       +V         D ++ GV   EL+ G+R   IR  +   
Sbjct: 177 TKPYMAPE-MFSSRKGAGYSFAV---------DWWSLGVTAYELLRGRRPYHIRSSTSSK 226

Query: 502 KMKSLI 507
           ++    
Sbjct: 227 EIVHTF 232

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 75.9 bits (187), Expect = 1e-14
 Identities = 56/236 (23%), Positives = 90/236 (38%), Gaps = 59/236 (25%)

Query: 287 IEEATNNFDE----SRIIGRGGFGNVYFG--LLGDREAAIK-----KMRSNKSKEFFAEL 335
           I     +  E     + +G G +G V      +   E AIK      + ++ + +   E+
Sbjct: 28  ITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEV 87

Query: 336 KVLCKIHHINV--FISTFGN-------------GSLSDHLHDPLLKGHQPLTWTART--Q 378
            VL  + H N+      F +             G L D +     +        A    Q
Sbjct: 88  AVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIH---RMKFNEVDAAVIIKQ 144

Query: 379 IALDAAKGIEYIHDHTKARYVHRDIKTSNILL---DDGLRAKVADFGLVKLEERTNEKEM 435
           +      G+ Y+H H     VHRD+K  N+LL   +     K+ DFGL  + E  N+K+M
Sbjct: 145 VL----SGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE--NQKKM 195

Query: 436 LATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKR 491
                +GT  Y+ PE              V+  +   K DV++ GV+L  L+ G  
Sbjct: 196 --KERLGTAYYIAPE--------------VLRKKYDEKCDVWSIGVILFILLAGYP 235

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 74.7 bits (184), Expect = 1e-14
 Identities = 58/246 (23%), Positives = 91/246 (36%), Gaps = 52/246 (21%)

Query: 274 LESERTIIFSLEEIEEATNNFDESRIIGRGGFGNVYFGLLGDREA----AIKKMR----- 324
           L+    I+  L+E+    ++F+  ++IGRG F  V   ++  ++     A+K M      
Sbjct: 43  LQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVA--VVKMKQTGQVYAMKIMNKWDML 100

Query: 325 -SNKSKEFFAELKVLCKIHHINVFI----STF--------------GNGSLSDHL--HDP 363
              +   F  E  VL        +I      F              G G L   L     
Sbjct: 101 KRGEVSCFREERDVLVNGDR--RWITQLHFAFQDENYLYLVMEYYVG-GDLLTLLSKFGE 157

Query: 364 LLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGL 423
            +       + A  +I +     I+ +H      YVHRDIK  NILLD     ++ADFG 
Sbjct: 158 RIPAEMARFYLA--EIVM----AIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGS 208

Query: 424 VKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVL 483
               +   +  + +   VGTP YL PE +        +           + D +A GV  
Sbjct: 209 CL--KLRADGTVRSLVAVGTPDYLSPEIL------QAVGGGPGTGSYGPECDWWALGVFA 260

Query: 484 AELITG 489
            E+  G
Sbjct: 261 YEMFYG 266

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 74.7 bits (184), Expect = 2e-14
 Identities = 55/257 (21%), Positives = 99/257 (38%), Gaps = 61/257 (23%)

Query: 265 KENTEDVTVLESERTIIFSLEEIEEATNNFDESRIIGRGGFGNVYFGLLGDREA----AI 320
           ++N      L   +  I  + ++     +++  ++IGRG FG V   L+  +      A+
Sbjct: 42  RKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQ--LVRHKSTRKVYAM 99

Query: 321 KKMR------SNKSKEFFAELKVLCKIHHINVFI----STF--------------GNGSL 356
           K +        + S  F+ E  ++   +    ++      F              G G L
Sbjct: 100 KLLSKFEMIKRSDSAFFWEERDIMAFANS--PWVVQLFYAFQDDRYLYMVMEYMPG-GDL 156

Query: 357 SDHLHDPLLKGHQPLTWTAR---TQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDG 413
            + +         P  W AR    ++ L     ++ IH      ++HRD+K  N+LLD  
Sbjct: 157 VNLMS----NYDVPEKW-ARFYTAEVVL----ALDAIHSM---GFIHRDVKPDNMLLDKS 204

Query: 414 LRAKVADFGLVKLEERTNEKEMLATR-LVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTT 472
              K+ADFG      + N++ M+     VGTP Y+ PE +  +                 
Sbjct: 205 GHLKLADFGTCM---KMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGREC------- 254

Query: 473 KTDVFAFGVVLAELITG 489
             D ++ GV L E++ G
Sbjct: 255 --DWWSVGVFLYEMLVG 269

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 74.3 bits (183), Expect = 2e-14
 Identities = 60/276 (21%), Positives = 99/276 (35%), Gaps = 52/276 (18%)

Query: 234 KRPEEKITEDAKHVSKAMSITTRAFSSQGQCKENTEDVTVLES---ERTIIFSLEEIEEA 290
            +       +AK V     +T R      +      D+    +    R +      +   
Sbjct: 29  DQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSF 88

Query: 291 TNNFDESRIIGRGGFGNVYFGLL---GDREAA--IKKMRSNKSKEFFAELKVLCKIHHIN 345
                ++ I+G G FG V+       G + AA  IK       +E   E+ V+ ++ H N
Sbjct: 89  YT-VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHAN 147

Query: 346 V--FISTFGN-------------GSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYI 390
           +      F +             G L D + D   + +  LT            +GI ++
Sbjct: 148 LIQLYDAFESKNDIVLVMEYVDGGELFDRIID---ESYN-LTELDTILFMKQICEGIRHM 203

Query: 391 HDHTKARYVHRDIKTSNILL--DDGLRAKVADFGL-VKLEERTNEKEMLATRLVGTPGYL 447
           H       +H D+K  NIL    D  + K+ DFGL  + + R   K        GTP +L
Sbjct: 204 HQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVN-----FGTPEFL 255

Query: 448 PPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVL 483
            PE   V  + F          V+  TD+++ GV+ 
Sbjct: 256 APE---VVNYDF----------VSFPTDMWSVGVIA 278

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 74.3 bits (183), Expect = 2e-14
 Identities = 52/228 (22%), Positives = 79/228 (34%), Gaps = 52/228 (22%)

Query: 289 EATNNFDESRIIGRGGFGNVYFGLLGDREA----AIKKMRSNKSKEFFA-----ELKVLC 339
                +   + IG G  G V      D       AIKK+      +  A     EL ++ 
Sbjct: 22  TVLKRYQNLKPIGSGAQGIVCAAY--DAILERNVAIKKLSRPFQNQTHAKRAYRELVLMK 79

Query: 340 KIHH------INVFISTFGNGSLSD----------HLHDPLLKGHQPLTWTARTQIAL-D 382
            ++H      +NVF          D          +L   +      L    R    L  
Sbjct: 80  CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVI---QMELD-HERMSYLLYQ 135

Query: 383 AAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVG 442
              GI+++H    A  +HRD+K SNI++      K+ DFGL     RT     + T  V 
Sbjct: 136 MLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA----RTAGTSFMMTPYVV 188

Query: 443 TPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
           T  Y  PE I    +                 D+++ G ++ E+I G 
Sbjct: 189 TRYYRAPEVILGMGY-------------KENVDIWSVGCIMGEMIKGG 223

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 74.8 bits (184), Expect = 2e-14
 Identities = 52/259 (20%), Positives = 95/259 (36%), Gaps = 50/259 (19%)

Query: 259 SSQGQCKENTEDVTVLESERTIIFSLEEIEEATNNFDESRIIGRGGFGNVYFGLLGDREA 318
            +    +     +  LE  +     ++++     +F+  ++IGRG FG V   ++  + A
Sbjct: 41  CNNSPLRREKNILEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVA--VVKLKNA 98

Query: 319 ----AIKKMR-----SNKSKEFF-AELKVLCKIHH---INV-----------FISTFGNG 354
               A+K +             F  E  VL          +            +  +  G
Sbjct: 99  DKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVG 158

Query: 355 -SLSDHLHDPLLKGHQPLTWTAR---TQIALDAAKGIEYIHDHTKARYVHRDIKTSNILL 410
             L   L     +   P    AR    ++ +     I+ +H      YVHRDIK  NIL+
Sbjct: 159 GDLLTLLSK--FEDRLPEEM-ARFYLAEMVI----AIDSVHQL---HYVHRDIKPDNILM 208

Query: 411 DDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQV 470
           D     ++ADFG     +   +  + ++  VGTP Y+ PE +         +        
Sbjct: 209 DMNGHIRLADFGSCL--KLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRY-------- 258

Query: 471 TTKTDVFAFGVVLAELITG 489
             + D ++ GV + E++ G
Sbjct: 259 GPECDWWSLGVCMYEMLYG 277

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 73.0 bits (180), Expect = 2e-14
 Identities = 54/232 (23%), Positives = 87/232 (37%), Gaps = 49/232 (21%)

Query: 276 SERTIIFSLEEIEEATNNFDESRIIGRGGFGNVYFG--LLGDREAAIKKMRSNKSKE--- 330
           S R  ++    I++    F   R +G G FG+V+         E  IK +  ++S+    
Sbjct: 9   SGRENLYFQGTIDD---LFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPME 65

Query: 331 -FFAELKVLCKIHHINV--FISTF-------------GNGSLSDHLHDPLLKGHQPLTWT 374
              AE++VL  + H N+      F               G L + +     +G   L+  
Sbjct: 66  QIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKA-LSEG 124

Query: 375 ARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILL---DDGLRAKVADFGLVKLEERTN 431
              ++       + Y H       VH+D+K  NIL          K+ DFGL +L +   
Sbjct: 125 YVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK--- 178

Query: 432 EKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVL 483
             E       GT  Y+ PE              V +  VT K D+++ GVV+
Sbjct: 179 SDEHSTNA-AGTALYMAPE--------------VFKRDVTFKCDIWSAGVVM 215

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 73.5 bits (181), Expect = 2e-14
 Identities = 56/219 (25%), Positives = 88/219 (40%), Gaps = 54/219 (24%)

Query: 298 RIIGRGGFGNVYFG--LLGDREAAIK-----KMRSNKSKE-FFAELKVLCKIHHINVF-- 347
             +G G FG V         ++ A+K      ++ +        E+  L  + H ++   
Sbjct: 15  ETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL 74

Query: 348 ---IST---------FGNGSLSDHLHDPLLKGHQPLT-WTART---QIALDAAKGIEYIH 391
              I+T         +  G L D++        + +T    R    QI       IEY H
Sbjct: 75  YDVITTPTDIVMVIEYAGGELFDYI-----VEKKRMTEDEGRRFFQQII----CAIEYCH 125

Query: 392 DHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEY 451
            H   + VHRD+K  N+LLDD L  K+ADFGL  +     +   L T   G+P Y  PE 
Sbjct: 126 RH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMT---DGNFLKT-SCGSPNYAAPEV 178

Query: 452 IFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
           I  K +               + DV++ G+VL  ++ G+
Sbjct: 179 INGKLYA------------GPEVDVWSCGIVLYVMLVGR 205

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 72.6 bits (179), Expect = 2e-14
 Identities = 59/222 (26%), Positives = 89/222 (40%), Gaps = 59/222 (26%)

Query: 298 RIIGRGGFGNVYFG--LLGDREAAIKKMRSNKSK--------EFFAELKVLCKIHHINVF 347
             +G G FG V  G   L   + A+K +  N+ K        +   E++ L    H ++ 
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKIL--NRQKIRSLDVVGKIKREIQNLKLFRHPHII 74

Query: 348 -----IST----------FGNGSLSDHLHDPLLKGHQPLT-WTART---QIALDAAKGIE 388
                IST             G L D++       H  +    AR    QI       ++
Sbjct: 75  KLYQVISTPTDFFMVMEYVSGGELFDYI-----CKHGRVEEMEARRLFQQIL----SAVD 125

Query: 389 YIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLP 448
           Y H H     VHRD+K  N+LLD  + AK+ADFGL  +     + E L T   G+P Y  
Sbjct: 126 YCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMS---DGEFLRTS-CGSPNYAA 178

Query: 449 PEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
           PE I  + +               + D+++ GV+L  L+ G 
Sbjct: 179 PEVISGRLY------------AGPEVDIWSCGVILYALLCGT 208

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 73.0 bits (180), Expect = 3e-14
 Identities = 53/234 (22%), Positives = 93/234 (39%), Gaps = 55/234 (23%)

Query: 292 NNFDESRIIGRGGFGNVYFGL-LGDREAAIKKMRSNKSKEFFA-----ELKVLCKIHHIN 345
             + +   +G G +G VY       R  A+K++R +   E        E+ +L ++HH N
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPN 80

Query: 346 ------VFISTFGNGSLS---DHL-HDPLLKGH-----QPLTWTARTQIALDAAKGIEYI 390
                 V         L+   + +  D  LK         L  +          +G+ + 
Sbjct: 81  IVSLIDVIH---SERCLTLVFEFMEKD--LKKVLDENKTGLQDSQIKIYLYQLLRGVAHC 135

Query: 391 HDHTKARYVHRDIKTSNILLDDGLRAKVADFGL-----VKLEERTNEKEMLATRLVGTPG 445
           H H   R +HRD+K  N+L++     K+ADFGL     + +   T+E        V T  
Sbjct: 136 HQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHE--------VVTLW 184

Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE 499
           Y  P+ +   +            + +T  D+++ G + AE+ITGK  L    ++
Sbjct: 185 YRAPDVLMGSK------------KYSTSVDIWSIGCIFAEMITGK-PLFPGVTD 225

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 72.2 bits (178), Expect = 4e-14
 Identities = 48/209 (22%), Positives = 86/209 (41%), Gaps = 49/209 (23%)

Query: 298 RIIGRGGFGNVYFGL---LGDREAA--IKKMRSNKSKEFFAELKVLCKIHHINV--FIST 350
            ++G G F  V+       G   A   IKK  + +      E+ VL KI H N+      
Sbjct: 15  EVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDI 74

Query: 351 FGNGSLSDHLH------------DPLL-KGHQPLTWTARTQIALDAAKGIEYIHDHTKAR 397
           + +   + H +            D +L +G    T    + +       ++Y+H++    
Sbjct: 75  YES---TTHYYLVMQLVSGGELFDRILERGV--YTEKDASLVIQQVLSAVKYLHEN---G 126

Query: 398 YVHRDIKTSNILL---DDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFV 454
            VHRD+K  N+L    ++  +  + DFGL K+E    +  +++T   GTPGY+ PE +  
Sbjct: 127 IVHRDLKPENLLYLTPEENSKIMITDFGLSKME----QNGIMST-ACGTPGYVAPEVLAQ 181

Query: 455 KRFRFDMHSSVMELQVTTKTDVFAFGVVL 483
           K +             +   D ++ GV+ 
Sbjct: 182 KPY-------------SKAVDCWSIGVIT 197

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 73.3 bits (180), Expect = 5e-14
 Identities = 49/227 (21%), Positives = 79/227 (34%), Gaps = 50/227 (22%)

Query: 289 EATNNFDESRIIGRGGFGNVYFGLLGDREA----AIKKMRSNKSKEFFA-----ELKVLC 339
                +   + IG G  G V      D       AIKK+      +  A     EL ++ 
Sbjct: 59  TVLKRYQNLKPIGSGAQGIVCAAY--DAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMK 116

Query: 340 KIHH------INVFISTFGNGSLSD----------HLHDPLLKGHQPLTWTARTQIALDA 383
            ++H      +NVF          D          +L   +      L     + +    
Sbjct: 117 CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI---QMELDHERMSYLLYQM 173

Query: 384 AKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGT 443
             GI+++H    A  +HRD+K SNI++      K+ DFGL     RT     + T  V T
Sbjct: 174 LCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA----RTAGTSFMMTPYVVT 226

Query: 444 PGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
             Y  PE I    +                 D+++ G ++ E++  K
Sbjct: 227 RYYRAPEVILGMGY-------------KENVDIWSVGCIMGEMVRHK 260

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 72.3 bits (178), Expect = 6e-14
 Identities = 58/232 (25%), Positives = 90/232 (38%), Gaps = 61/232 (26%)

Query: 289 EATNNFDESRIIGRGGFGNVYFGLLGDREA----AIKKMRSNKSKEFFA-----ELKVLC 339
           E    +     +G G +G+V   +  D+ +    AIKK+      E FA     EL +L 
Sbjct: 21  ELPKTYVSPTHVGSGAYGSVCSAI--DKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLK 78

Query: 340 KIHH------INVFISTFGNGSLSD----------HLHD----PLLKGH-QPLTWTARTQ 378
            + H      ++VF       +  D           L         +   Q L +    Q
Sbjct: 79  HMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVY----Q 134

Query: 379 IALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLAT 438
           +     KG++YIH    A  VHRD+K  N+ +++    K+ DFGL     R  + EM  T
Sbjct: 135 ML----KGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLA----RHADAEM--T 181

Query: 439 RLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
             V T  Y  PE I                      D+++ G ++AE++TGK
Sbjct: 182 GYVVTRWYRAPEVILSWM------------HYNQTVDIWSVGCIMAEMLTGK 221

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 71.9 bits (177), Expect = 8e-14
 Identities = 48/243 (19%), Positives = 86/243 (35%), Gaps = 68/243 (27%)

Query: 292 NNFDESRIIGRGGFGNVYFGLLGDRE----AAIKKMRSNKSKEFFA-----ELKVLCKIH 342
           + +     +G G +G VY  +  D       AIK++R    +E        E+ +L ++ 
Sbjct: 34  DRYRRITKLGEGTYGEVYKAI--DTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQ 91

Query: 343 HINVFISTFGNGSLSDHLHDP----------------LLKGHQPLTWTARTQIALDAAKG 386
           H N+         L   +H                   +  +  ++             G
Sbjct: 92  HRNII-------ELKSVIHHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLING 144

Query: 387 IEYIHDHTKARYVHRDIKTSNILLDDGLRA-----KVADFGL-----VKLEERTNEKEML 436
           + + H     R +HRD+K  N+LL     +     K+ DFGL     + + + T+E    
Sbjct: 145 VNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHE---- 197

Query: 437 ATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRD 496
               + T  Y PPE +   R              +T  D+++   + AE++     L   
Sbjct: 198 ----IITLWYRPPEILLGSR------------HYSTSVDIWSIACIWAEMLMKT-PLFPG 240

Query: 497 DSE 499
           DSE
Sbjct: 241 DSE 243

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 72.1 bits (177), Expect = 9e-14
 Identities = 48/248 (19%), Positives = 86/248 (34%), Gaps = 51/248 (20%)

Query: 265 KENTEDVTVLESERTIIFSLEEIEEATNNFDESRIIGRGGFGNVYFGL---LGDREAA-- 319
            +  ED+      + +      + +    +D    +G G FG V+  +    G    A  
Sbjct: 27  DKFYEDIWKKYVPQPVEVKQGSVYD---YYDILEELGSGAFGVVHRCVEKATGRVFVAKF 83

Query: 320 IKKMRSNKSKEFFAELKVLCKIHHINV--FISTFGN-------------GSLSDHLHDPL 364
           I             E+ ++ ++HH  +      F +             G L D +    
Sbjct: 84  INTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAA-- 141

Query: 365 LKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILL--DDGLRAKVADFG 422
            + ++ ++          A +G++++H+H     VH DIK  NI+         K+ DFG
Sbjct: 142 -EDYK-MSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFG 196

Query: 423 L-VKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGV 481
           L  KL      K         T  +  PE   +               V   TD++A GV
Sbjct: 197 LATKLNPDEIVKVT-----TATAEFAAPE---IVDRE----------PVGFYTDMWAIGV 238

Query: 482 VLAELITG 489
           +   L++G
Sbjct: 239 LGYVLLSG 246

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 72.4 bits (178), Expect = 1e-13
 Identities = 55/235 (23%), Positives = 95/235 (40%), Gaps = 60/235 (25%)

Query: 287 IEEATNNFDE----SRIIGRGGFGNVYFG--LLGDREAAIK-----KMRSNKSKE-FFAE 334
           ++ +T  F +     R++G+G FG V      +  +E A+K     +++    KE    E
Sbjct: 17  VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLRE 76

Query: 335 LKVLCKIHHINV--FISTFGN-------------GSLSDHLHDPLLKGHQPLTWTART-- 377
           +++L ++ H N+      F +             G L D +     +        AR   
Sbjct: 77  VQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIIS---RKRFSEVDAARIIR 133

Query: 378 QIALDAAKGIEYIHDHTKARYVHRDIKTSNILL---DDGLRAKVADFGLVKLEERTNEKE 434
           Q+      GI Y+H +   + VHRD+K  N+LL         ++ DFGL    E + +  
Sbjct: 134 QVL----SGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK-- 184

Query: 435 MLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
                 +GT  Y+ PE              V+      K DV++ GV+L  L++G
Sbjct: 185 --MKDKIGTAYYIAPE--------------VLHGTYDEKCDVWSTGVILYILLSG 223

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 71.5 bits (176), Expect = 1e-13
 Identities = 44/235 (18%), Positives = 86/235 (36%), Gaps = 54/235 (22%)

Query: 289 EATNNFDESRIIGRGGFGNVYFGL--LGDREAAIKKMRSNKSKEFFAELKVLCKI-HHIN 345
              +++   R +GRG +  V+  +    + +  +K ++  K K+   E+K+L  +    N
Sbjct: 33  GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPN 92

Query: 346 VFISTFGNGSLSDHLHDP----------------LLKGHQPLT-WTAR---TQIALDAAK 385
           +        +L+D + DP                  + +Q LT +  R    +I     K
Sbjct: 93  II-------TLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEIL----K 141

Query: 386 GIEYIHDHTKARYVHRDIKTSNILLDDGLRA-KVADFGLVKLEERTNEKEMLATRLVGTP 444
            ++Y H       +HRD+K  N+++D   R  ++ D+GL                 V + 
Sbjct: 142 ALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA----EFYHPGQEYNVRVASR 194

Query: 445 GYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE 499
            +  PE +            V         D+++ G +LA +I  K         
Sbjct: 195 YFKGPELL------------VDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN 237

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 72.4 bits (178), Expect = 1e-13
 Identities = 45/227 (19%), Positives = 85/227 (37%), Gaps = 60/227 (26%)

Query: 297 SRIIGRGGFGNVYFGLLGDR----EAAIK-----------KMRSNKSKEFFAELKVLCKI 341
           S+ +G G  G V   L  +R    + AI+              ++ +     E+++L K+
Sbjct: 140 SKTLGSGACGEVK--LAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKL 197

Query: 342 HHINVFISTFGNGSLSDHLHDP-------LLKG---------HQPLTWTARTQIALDAAK 385
           +H  +         + +            L++G         ++ L              
Sbjct: 198 NHPCII-------KIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL 250

Query: 386 GIEYIHDHTKARYVHRDIKTSNILL---DDGLRAKVADFGLVKLEERTNEKEMLATRLVG 442
            ++Y+H++     +HRD+K  N+LL   ++    K+ DFG  K+     E  ++ T L G
Sbjct: 251 AVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG---ETSLMRT-LCG 303

Query: 443 TPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
           TP YL PE +                      D ++ GV+L   ++G
Sbjct: 304 TPTYLAPEVLVSVGTA----------GYNRAVDCWSLGVILFICLSG 340

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 72.4 bits (178), Expect = 1e-13
 Identities = 55/240 (22%), Positives = 92/240 (38%), Gaps = 56/240 (23%)

Query: 276 SERTIIFSLEEIEEATNNFDESRIIGRGGFGNVYFG--LLGDREAAIK-----KMRSNKS 328
           S R  ++      E    ++   ++G+G FG V      +  +E A+K       ++  +
Sbjct: 9   SGRENLYFQGTFAE---RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDT 65

Query: 329 KEFFAELKVLCKIHHINV--FISTF--------------GNGSLSDHLHDPLLKGHQPLT 372
                E+++L K+ H N+                     G G L D +     +     +
Sbjct: 66  STILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTG-GELFDEIIK---RKR--FS 119

Query: 373 WTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILL---DDGLRAKVADFGLVKLEER 429
                +I      GI Y+H H     VHRD+K  NILL   +     K+ DFGL    + 
Sbjct: 120 EHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ- 175

Query: 430 TNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
             +   +  R +GT  Y+ PE              V+      K DV++ GV+L  L++G
Sbjct: 176 --QNTKMKDR-IGTAYYIAPE--------------VLRGTYDEKCDVWSAGVILYILLSG 218

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 71.2 bits (175), Expect = 1e-13
 Identities = 55/226 (24%), Positives = 90/226 (39%), Gaps = 48/226 (21%)

Query: 289 EATNNFDESRIIGRGGFGNVY--FGLLGDREAAIKKMRSNKSKEFFA-----ELKVLCKI 341
           E    +     +G G +G+V   F        A+KK+         A     EL++L  +
Sbjct: 26  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 85

Query: 342 HH------INVFISTFGNGSLSD----------HLHDPLLKGHQPLTWTARTQ-IALDAA 384
            H      ++VF         +D           L++ ++K  Q LT     Q +     
Sbjct: 86  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN-IVK-CQKLT-DDHVQFLIYQIL 142

Query: 385 KGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP 444
           +G++YIH    A  +HRD+K SN+ +++    K+ DFGL     R    EM  T  V T 
Sbjct: 143 RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGL----ARHTADEM--TGYVATR 193

Query: 445 GYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
            Y  PE +                      D+++ G ++AEL+TG+
Sbjct: 194 WYRAPEIMLNWM------------HYNQTVDIWSVGCIMAELLTGR 227

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 70.0 bits (172), Expect = 2e-13
 Identities = 50/214 (23%), Positives = 84/214 (39%), Gaps = 43/214 (20%)

Query: 291 TNNFDESRIIGRGGFGNVYFG--LLGDREAAIK-----KMRSNKSKEFFAELKVLCKIHH 343
              ++   ++G+G FG V      +  +E A+K       ++  +     E+++L K+ H
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80

Query: 344 INV--FISTFGNGSLSDHLHDPLLKG---------HQPLTWTARTQIALDAAKGIEYIHD 392
            N+          S S ++   L  G          +  +     +I      GI Y+H 
Sbjct: 81  PNIMKLFEIL-EDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHK 139

Query: 393 HTKARYVHRDIKTSNILL---DDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPP 449
           H     VHRD+K  NILL   +     K+ DFGL    +   +   +  R +GT  Y+ P
Sbjct: 140 H---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ---QNTKMKDR-IGTAYYIAP 192

Query: 450 EYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVL 483
           E              V+      K DV++ GV+L
Sbjct: 193 E--------------VLRGTYDEKCDVWSAGVIL 212

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 69.8 bits (172), Expect = 2e-13
 Identities = 57/234 (24%), Positives = 89/234 (38%), Gaps = 55/234 (23%)

Query: 292 NNFDESRIIGRGGFGNVYFGL-LGDREAAIKKMRSNKSKEFFA-----ELKVLCKIHHIN 345
             +     IG G +G VY          A+KK+R  K  E        E+ +L ++ H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61

Query: 346 ------VFISTFGNGSLS---DHL-HDPLLKGH-----QPLTWTARTQIALDAAKGIEYI 390
                 V  +      L    +HL  D  LK         L         L    GI Y 
Sbjct: 62  IVKLYDVIHT---KKRLVLVFEHLDQD--LKKLLDVCEGGLESVTAKSFLLQLLNGIAYC 116

Query: 391 HDHTKARYVHRDIKTSNILLDDGLRAKVADFGL-----VKLEERTNEKEMLATRLVGTPG 445
           HD    R +HRD+K  N+L++     K+ADFGL     + + + T+E        + T  
Sbjct: 117 HDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHE--------IVTLW 165

Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE 499
           Y  P+ +   +            + +T  D+++ G + AE++ G   L    SE
Sbjct: 166 YRAPDVLMGSK------------KYSTTIDIWSVGCIFAEMVNG-TPLFPGVSE 206

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 71.0 bits (174), Expect = 2e-13
 Identities = 52/242 (21%), Positives = 88/242 (36%), Gaps = 59/242 (24%)

Query: 300 IGRGGFGNVYFGLLGD----REAAIKKMRS-NKSKEFFAELKVLCKIHHINV-----FIS 349
           +GRG +G+VY     D    ++ A+K++     S     E+ +L ++ H NV        
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 88

Query: 350 TFGNGSLS---DHL-HDPLLKG---HQPLTWTARTQIALDAA----------KGIEYIHD 392
           +  +  +    D+  HD  L         +   +  + L              GI Y+H 
Sbjct: 89  SHADRKVWLLFDYAEHD--LWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA 146

Query: 393 HTKARYVHRDIKTSNILLDDGLRA----KVADFGL-----VKLEERTNEKEMLATRLVGT 443
           +     +HRD+K +NIL+          K+AD G        L+   +        +V T
Sbjct: 147 N---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLAD-----LDPVVVT 198

Query: 444 PGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKM 503
             Y  PE +   R              T   D++A G + AEL+T    +     E  K 
Sbjct: 199 FWYRAPELLLGAR------------HYTKAIDIWAIGCIFAELLT-SEPIFHCRQEDIKT 245

Query: 504 KS 505
            +
Sbjct: 246 SN 247

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 71.4 bits (175), Expect = 2e-13
 Identities = 60/220 (27%), Positives = 89/220 (40%), Gaps = 55/220 (25%)

Query: 298 RIIGRGGFGNVYFG--LLGDREAAIK-----KMRSNKSKE-FFAELKVLCKIHHINVF-- 347
             +G G FG V  G   L   + A+K     K+RS         E++ L    H ++   
Sbjct: 22  DTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL 81

Query: 348 ---IST----------FGNGSLSDHLHDPLLKGHQPLT-WTART---QIALDAAKGIEYI 390
              IST             G L D++       +  L    +R    QI      G++Y 
Sbjct: 82  YQVISTPSDIFMVMEYVSGGELFDYI-----CKNGRLDEKESRRLFQQIL----SGVDYC 132

Query: 391 HDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPE 450
           H H     VHRD+K  N+LLD  + AK+ADFGL  +     + E L T   G+P Y  PE
Sbjct: 133 HRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMS---DGEFLRTS-CGSPNYAAPE 185

Query: 451 YIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
            I  + +               + D+++ GV+L  L+ G 
Sbjct: 186 VISGRLY------------AGPEVDIWSSGVILYALLCGT 213

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 69.9 bits (172), Expect = 3e-13
 Identities = 59/238 (24%), Positives = 94/238 (39%), Gaps = 59/238 (24%)

Query: 292 NNFDESRIIGRGGFGNVYFG--LLGDREAAIKKMRSNKSKEFFA--------ELKVLCKI 341
             +++   +G G F  VY       ++  AIKK++     E           E+K+L ++
Sbjct: 10  KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 69

Query: 342 HHIN------VFISTFGNGSLS---DHL-HDPLLKGH-----QPLTWTARTQIALDAAKG 386
            H N       F       ++S   D +  D  L+         LT +      L   +G
Sbjct: 70  SHPNIIGLLDAFGH---KSNISLVFDFMETD--LEVIIKDNSLVLTPSHIKAYMLMTLQG 124

Query: 387 IEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGL-----VKLEERTNEKEMLATRLV 441
           +EY+H H     +HRD+K +N+LLD+    K+ADFGL           T++        V
Sbjct: 125 LEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQ--------V 173

Query: 442 GTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE 499
            T  Y  PE +F  R                  D++A G +LAEL+      +  DS+
Sbjct: 174 VTRWYRAPELLFGAR------------MYGVGVDMWAVGCILAELLLRV-PFLPGDSD 218

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 68.8 bits (169), Expect = 4e-13
 Identities = 48/209 (22%), Positives = 74/209 (35%), Gaps = 49/209 (23%)

Query: 298 RIIGRGGFGNVYFG---LLGDREAA--IKKMRSNKSKEFFAELKVLCKIHHINV--FIST 350
             IGRG +G V          R AA  I K        F  E++++  + H N+     T
Sbjct: 15  NTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYET 74

Query: 351 F-------------GNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKAR 397
           F               G L + +     K       +   +I  D    + Y H      
Sbjct: 75  FEDNTDIYLVMELCTGGELFERVVH---KRV--FRESDAARIMKDVLSAVAYCHKL---N 126

Query: 398 YVHRDIKTSNILL---DDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFV 454
             HRD+K  N L          K+ DFGL    +     +M+ T+ VGTP Y+ P+    
Sbjct: 127 VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK---PGKMMRTK-VGTPYYVSPQ---- 178

Query: 455 KRFRFDMHSSVMELQVTTKTDVFAFGVVL 483
                     V+E     + D ++ GV++
Sbjct: 179 ----------VLEGLYGPECDEWSAGVMM 197

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 69.6 bits (171), Expect = 4e-13
 Identities = 47/232 (20%), Positives = 88/232 (37%), Gaps = 64/232 (27%)

Query: 288 EEATNNFDESRIIGRGGFGNVYFGL--LGDREAAIK-----KMRSNKSKE------FFAE 334
           +   + +  S+ +G G  G V         ++ AIK     K     ++E         E
Sbjct: 6   KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 65

Query: 335 LKVLCKIHHINVFISTFGNGSLSDHLHDP-------LLKG---------HQPLT-WTART 377
           +++L K++H  +         + +            L++G         ++ L   T + 
Sbjct: 66  IEILKKLNHPCII-------KIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKL 118

Query: 378 ---QIALDAAKGIEYIHDHTKARYVHRDIKTSNILL---DDGLRAKVADFGLVKLEERTN 431
              Q+       ++Y+H++     +HRD+K  N+LL   ++    K+ DFG  K+     
Sbjct: 119 YFYQML----LAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--- 168

Query: 432 EKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVL 483
           E  ++ T L GTP YL PE +                      D ++ GV+L
Sbjct: 169 ETSLMRT-LCGTPTYLAPEVLVSVGTA----------GYNRAVDCWSLGVIL 209

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 68.6 bits (168), Expect = 5e-13
 Identities = 25/223 (11%), Positives = 42/223 (18%), Gaps = 72/223 (32%)

Query: 300 IGRGGFGNVYFG---LLGDREAAIKKMRSNKS------KEFFAELKVLCKIHHINVFIST 350
            G       +      L DR+ A+  +           +E  +    L +I    V    
Sbjct: 39  HGGVPPLQFWQALDTAL-DRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGV-ARV 96

Query: 351 FGNGSLSDH------------LHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARY 398
                                L + +           R       A   +  H    A  
Sbjct: 97  LDVVHTRAGGLVVAEWIRGGSLQE-VADTSPSPVGAIR--AMQSLAAAADAAHR---AGV 150

Query: 399 VHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFR 458
                  S + +           G V L                 P  +P          
Sbjct: 151 ALSIDHPSRVRVSID--------GDVVL---------------AYPATMPD--------- 178

Query: 459 FDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPT 501
                         + D+   G  L  L+  +  L        
Sbjct: 179 -----------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSG 210

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 68.4 bits (168), Expect = 8e-13
 Identities = 30/99 (30%), Positives = 43/99 (43%), Gaps = 14/99 (14%)

Query: 385 KGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP 444
           + I  +H       VHRD+K  NILLDD +  K+ DFG     +     E L   + GTP
Sbjct: 135 EVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLD---PGEKLRE-VCGTP 187

Query: 445 GYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVL 483
            YL PE I                    + D+++ GV++
Sbjct: 188 SYLAPEIIECSMNDNHPG-------YGKEVDMWSTGVIM 219

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 68.9 bits (169), Expect = 8e-13
 Identities = 60/227 (26%), Positives = 92/227 (40%), Gaps = 50/227 (22%)

Query: 289 EATNNFDESRIIGRGGFGNVYFGLLGDREA----AIKKMRSNKSKEFFA-----ELKVLC 339
           E    + + + +G G +G V   +  D       AIKK+      E FA     EL++L 
Sbjct: 22  EVRAVYRDLQPVGSGAYGAVCSAV--DGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLK 79

Query: 340 KIHH------INVFISTFGNGSLSD----------HLHDPLLKGHQPLTWTARTQIALDA 383
            + H      ++VF         +D           L   L+K H+ L       +    
Sbjct: 80  HMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGK-LMK-HEKLGEDRIQFLVYQM 137

Query: 384 AKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGT 443
            KG+ YIH    A  +HRD+K  N+ +++    K+ DFGL     R  + EM  T  V T
Sbjct: 138 LKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLA----RQADSEM--TGYVVT 188

Query: 444 PGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
             Y  PE I                + T   D+++ G ++AE+ITGK
Sbjct: 189 RWYRAPEVILNWM------------RYTQTVDIWSVGCIMAEMITGK 223

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 68.0 bits (167), Expect = 1e-12
 Identities = 50/235 (21%), Positives = 89/235 (37%), Gaps = 57/235 (24%)

Query: 292 NNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNKSKEFFA-----ELKVLCKIHHI 344
             + +   +G G +  VY G     D   A+K++R    +E        E+ +L  + H 
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEH-EEGAPCTAIREVSLLKDLKHA 60

Query: 345 N------VFISTFGNGSLS---DHL-HDPLLKGH-----QPLTWTARTQIALDAAKGIEY 389
           N      +  +     SL+   ++L  D  LK +       +             +G+ Y
Sbjct: 61  NIVTLHDIIHT---EKSLTLVFEYLDKD--LKQYLDDCGNIINMHNVKLFLFQLLRGLAY 115

Query: 390 IHDHTKARYVHRDIKTSNILLDDGLRAKVADFGL-----VKLEERTNEKEMLATRLVGTP 444
            H     + +HRD+K  N+L+++    K+ADFGL     +  +   NE        V T 
Sbjct: 116 CHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNE--------VVTL 164

Query: 445 GYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE 499
            Y PP+ +                  +T+ D++  G +  E+ TG R L    + 
Sbjct: 165 WYRPPDILLGST------------DYSTQIDMWGVGCIFYEMATG-RPLFPGSTV 206

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 68.0 bits (167), Expect = 1e-12
 Identities = 50/242 (20%), Positives = 101/242 (41%), Gaps = 62/242 (25%)

Query: 290 ATNNFDESRIIGRGGFGNVYFG--LLGDREAAIKKMRSNKSKEFFA-----ELKVLCKIH 342
           +++ F +   +G G +  VY G         A+K+++ + S+E        E+ ++ ++ 
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLD-SEEGTPSTAIREISLMKELK 61

Query: 343 HIN------VFISTFGNGSLS---DHL-HDPLLKGHQPLTWTARTQIALDAA-------- 384
           H N      V  +      L+   + + +D  LK +        T   L+          
Sbjct: 62  HENIVRLYDVIHT---ENKLTLVFEFMDND--LKKYMDSRTVGNTPRGLELNLVKYFQWQ 116

Query: 385 --KGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGL-----VKLEERTNEKEMLA 437
             +G+ + H++   + +HRD+K  N+L++   + K+ DFGL     + +   ++E     
Sbjct: 117 LLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSE----- 168

Query: 438 TRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDD 497
              V T  Y  P+ +   R              +T  D+++ G +LAE+ITGK  L    
Sbjct: 169 ---VVTLWYRAPDVLMGSR------------TYSTSIDIWSCGCILAEMITGK-PLFPGT 212

Query: 498 SE 499
           ++
Sbjct: 213 ND 214

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 68.2 bits (167), Expect = 2e-12
 Identities = 41/247 (16%), Positives = 75/247 (30%), Gaps = 39/247 (15%)

Query: 229 ILLRRKRPEEKITEDAKHVSKAMSITTRAFSSQGQCKENTEDVTVLESERTIIFSLEEIE 288
           +L   +     +   A                        +       +  +      I 
Sbjct: 1   MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAII 60

Query: 289 EATNNFDESRIIGRGGFGNVY--FGLLGDREAAIKKMRSNKSKEFFAELKVLCKI-HHIN 345
           +      +  ++G G  G V   F      + A+K ++     +   E+++  +     +
Sbjct: 61  DDYKVTSQ--VLGLGINGKVLQIFNKRTQEKFALKMLQ--DCPKARREVELHWRASQCPH 116

Query: 346 V--FISTFGN-----------------GSLSDHLHDPLLKGHQPLTWTARTQIALDAAKG 386
           +   +  + N                 G L   + D   +G Q  T    ++I     + 
Sbjct: 117 IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQD---RGDQAFTEREASEIMKSIGEA 173

Query: 387 IEYIHDHTKARYVHRDIKTSNILL---DDGLRAKVADFGLVKLEERTNEKEMLATRLVGT 443
           I+Y+H        HRD+K  N+L          K+ DFG  K    T     L T    T
Sbjct: 174 IQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHNSLTTP-CYT 226

Query: 444 PGYLPPE 450
           P Y+ PE
Sbjct: 227 PYYVAPE 233

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 68.6 bits (168), Expect = 2e-12
 Identities = 58/271 (21%), Positives = 94/271 (34%), Gaps = 69/271 (25%)

Query: 259 SSQGQCKENTEDVTVLESERTIIFSLEEIEEATNNFDESRIIGRGGFGNVYFG--LLGDR 316
                 +        +     +     +I E   ++ + R +G G +G V       G  
Sbjct: 6   HHSSGRENLYFQGIAINPGMYVRKKEGKIGE---SYFKVRKLGSGAYGEVLLCKEKNGHS 62

Query: 317 EAAIK----------------KMRSNKSKEFFAELKVLCKIHHINV--FISTFGN----- 353
           E AIK                K      +E + E+ +L  + H N+      F +     
Sbjct: 63  EKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFY 122

Query: 354 --------GSLSDHLHDPLLKGHQPLTWTART--QIALDAAKGIEYIHDHTKARYVHRDI 403
                   G L + + +   +        A    QI      GI Y+H H     VHRDI
Sbjct: 123 LVTEFYEGGELFEQIIN---RHKFDECDAANIMKQIL----SGICYLHKH---NIVHRDI 172

Query: 404 KTSNILL---DDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFD 460
           K  NILL   +  L  K+ DFGL        + ++     +GT  Y+ PE          
Sbjct: 173 KPENILLENKNSLLNIKIVDFGLSSFFS--KDYKL--RDRLGTAYYIAPE---------- 218

Query: 461 MHSSVMELQVTTKTDVFAFGVVLAELITGKR 491
               V++ +   K DV++ GV++  L+ G  
Sbjct: 219 ----VLKKKYNEKCDVWSCGVIMYILLCGYP 245

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 67.8 bits (166), Expect = 2e-12
 Identities = 32/99 (32%), Positives = 48/99 (48%), Gaps = 14/99 (14%)

Query: 385 KGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP 444
           + + ++H +     VHRD+K  NILLDD ++ +++DFG     E     E L   L GTP
Sbjct: 211 EAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLE---PGEKLRE-LCGTP 263

Query: 445 GYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVL 483
           GYL PE +                    + D++A GV+L
Sbjct: 264 GYLAPEILKCSMDETHPGYG-------KEVDLWACGVIL 295

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 67.1 bits (164), Expect = 4e-12
 Identities = 45/260 (17%), Positives = 79/260 (30%), Gaps = 80/260 (30%)

Query: 288 EEATNNFDESRIIGRGGFGNVYFGLLGD--REAAIKKMRSNKSKEFFAELKVLCKIHHIN 345
           E ++  +   + +G G FG V      +  +  A+KK+  +   +   EL ++  + H+N
Sbjct: 3   ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKN-RELDIMKVLDHVN 61

Query: 346 ------VFISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAA--------------- 384
                  F +T           D   K             ++                  
Sbjct: 62  IIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP 121

Query: 385 ------------------------------KGIEYIHDHTKARYVHRDIKTSNILLD--- 411
                                         + + +IH        HRDIK  N+L++   
Sbjct: 122 DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH---SLGICHRDIKPQNLLVNSKD 178

Query: 412 DGLRAKVADFGLVKLEERTNEK-EMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQV 470
           + L  K+ DFG  K    +      + +R      Y  PE +                + 
Sbjct: 179 NTL--KLCDFGSAKKLIPSEPSVAYICSRF-----YRAPELMLGAT------------EY 219

Query: 471 TTKTDVFAFGVVLAELITGK 490
           T   D+++ G V  ELI GK
Sbjct: 220 TPSIDLWSIGCVFGELILGK 239

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 66.9 bits (164), Expect = 4e-12
 Identities = 51/235 (21%), Positives = 93/235 (39%), Gaps = 62/235 (26%)

Query: 289 EATNNFDESRIIGRGGFGNVYFGLLGDREA----AIKKMRSNKSKEFFA-----ELKVLC 339
           +    +     IG G +G V      D       AIKK+ S    + +      E+K+L 
Sbjct: 24  DVGPRYTNLSYIGEGAYGMVCSAY--DNLNKVRVAIKKI-SPFEHQTYCQRTLREIKILL 80

Query: 340 KIHHINVFISTFGNGSLSDHLHDPLLKG---------------HQPLTWTARTQIALDA- 383
           +  H N+         ++D +  P ++                ++ L    +TQ   +  
Sbjct: 81  RFRHENII-------GINDIIRAPTIEQMKDVYIVQDLMETDLYKLL----KTQHLSNDH 129

Query: 384 --------AKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEM 435
                    +G++YIH    A  +HRD+K SN+LL+     K+ DFGL ++ +  ++   
Sbjct: 130 ICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTG 186

Query: 436 LATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
             T  V T  Y  PE +   +              T   D+++ G +LAE+++ +
Sbjct: 187 FLTEYVATRWYRAPEIMLNSK------------GYTKSIDIWSVGCILAEMLSNR 229

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 66.5 bits (163), Expect = 4e-12
 Identities = 52/233 (22%), Positives = 87/233 (37%), Gaps = 57/233 (24%)

Query: 288 EEATNNFDESRIIGRGGFGNVYFGLL---GDREAA--IKKMRSNKSK------EFFAELK 336
           ++  + +D    +G G F  V        G   AA  IKK +S  S+      E   E+ 
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67

Query: 337 VLCKIHHINV--FISTF-------------GNGSLSDHLHDPLLKGHQPLTWTARTQIAL 381
           +L ++ H NV      +               G L D L     K    L+    T    
Sbjct: 68  ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQ---KES--LSEEEATSFIK 122

Query: 382 DAAKGIEYIHDHTKARYVHRDIKTSNILL----DDGLRAKVADFGL-VKLEERTNEKEML 436
               G+ Y+H     +  H D+K  NI+L          K+ DFGL  ++E+    K + 
Sbjct: 123 QILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNI- 178

Query: 437 ATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
                GTP ++ PE   +  +            +  + D+++ GV+   L++G
Sbjct: 179 ----FGTPEFVAPE---IVNYEP----------LGLEADMWSIGVITYILLSG 214

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 66.6 bits (163), Expect = 5e-12
 Identities = 48/235 (20%), Positives = 78/235 (33%), Gaps = 55/235 (23%)

Query: 289 EATNNFDESRIIGRGGFGNVYFGLLGDREA---AIKKMRSNKSKEFFA------------ 333
              + +   R I  G +G V  G+  D E    AIK++ +  S                 
Sbjct: 19  AMQSPYTVQRFISSGSYGAVCAGV--DSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRV 76

Query: 334 --ELKVLCKIHHINV-----FISTFGNGSLSD----------HLHDPLLKGHQPLTWTAR 376
             E+++L   HH N+         F   ++             L   +      ++    
Sbjct: 77  LREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVIS-PQH 135

Query: 377 TQ-IALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEM 435
            Q        G+  +H+   A  VHRD+   NILL D     + DF L     R +  + 
Sbjct: 136 IQYFMYHILLGLHVLHE---AGVVHRDLHPGNILLADNNDITICDFNLA----REDTADA 188

Query: 436 LATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
             T  V    Y  PE +   +              T   D+++ G V+AE+   K
Sbjct: 189 NKTHYVTHRWYRAPELVMQFK------------GFTKLVDMWSAGCVMAEMFNRK 231

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 66.1 bits (162), Expect = 6e-12
 Identities = 40/224 (17%), Positives = 78/224 (34%), Gaps = 47/224 (20%)

Query: 288 EEATNNFDESRIIGRGGFGNVYFGL---LGDREAA--IKKMRSNKSKEFFAELKVLCKIH 342
           +E    +  +  +GRG FG V+  +         A  +K  +         E+ +L    
Sbjct: 1   KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV-KGTDQVLVKKEISILNIAR 59

Query: 343 HINV--FISTFGNGSLSDHLH------------DPLLKGHQPLTWTARTQIALDAAKGIE 388
           H N+     +F +    + L             + +      L             + ++
Sbjct: 60  HRNILHLHESFES---MEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQ 116

Query: 389 YIHDHTKARYVHRDIKTSNILL--DDGLRAKVADFGL-VKLEERTNEKEMLATRLVGTPG 445
           ++H H      H DI+  NI+         K+ +FG   +L+   N + +        P 
Sbjct: 117 FLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL-----FTAPE 168

Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
           Y  PE   V +             V+T TD+++ G ++  L++G
Sbjct: 169 YYAPE---VHQHDV----------VSTATDMWSLGTLVYVLLSG 199

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 65.7 bits (161), Expect = 6e-12
 Identities = 39/189 (20%), Positives = 67/189 (35%), Gaps = 41/189 (21%)

Query: 291 TNNFDE----SRIIGRGGFGNVYFGL--LGDREAAIK-----KMRSNKSKEFFAELKVLC 339
           +  F +       +G+G F  V   +      E A K     K+ +   ++   E ++  
Sbjct: 1   STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60

Query: 340 KIHHINV--FISTFGNGSLSDHLH------------DPLL-KGHQPLTWTARTQIALDAA 384
           K+ H N+     +          +            + ++ +     +    +       
Sbjct: 61  KLQHPNIVRLHDSIQE---ESFHYLVFDLVTGGELFEDIVAREF--YSEADASHCIQQIL 115

Query: 385 KGIEYIHDHTKARYVHRDIKTSNILL---DDGLRAKVADFGLVKLEERTNEKEMLATRLV 441
           + I Y H +     VHR++K  N+LL     G   K+ADFGL        + E       
Sbjct: 116 ESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN---DSEAWHG-FA 168

Query: 442 GTPGYLPPE 450
           GTPGYL PE
Sbjct: 169 GTPGYLSPE 177

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 66.2 bits (162), Expect = 7e-12
 Identities = 55/242 (22%), Positives = 84/242 (34%), Gaps = 57/242 (23%)

Query: 298 RIIGRGGFGNVYFG--LLGDREAAIKKM-RSNKSKEFFA-ELKVLCKIHHINVF-----I 348
           + IG G FG        L     A+K + R     E    E+     + H N+      I
Sbjct: 26  KDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVI 85

Query: 349 ST----------FGNGSLSDHLHDPLLKGHQPLT-WTART---QIALDAAKGIEYIHDHT 394
            T             G L + +           +   AR    Q+      G+ Y H   
Sbjct: 86  LTPTHLAIIMEYASGGELYERI-----CNAGRFSEDEARFFFQQLLS----GVSYCHSM- 135

Query: 395 KARYVHRDIKTSNILLDD--GLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYI 452
             +  HRD+K  N LLD     R K+ DFG  K            +  VGTP Y+ PE +
Sbjct: 136 --QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV---LHSQPKST-VGTPAYIAPEVL 189

Query: 453 FVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKM--KSLITIM 510
             + +                 DV++ GV L  ++ G  A   +D E  +   K++  I+
Sbjct: 190 LRQEY------------DGKIADVWSCGVTLYVMLVG--AYPFEDPEEPRDYRKTIQRIL 235

Query: 511 AA 512
           + 
Sbjct: 236 SV 237

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 65.4 bits (160), Expect = 9e-12
 Identities = 38/177 (21%), Positives = 64/177 (36%), Gaps = 38/177 (21%)

Query: 299 IIGRGGFGNVY--FGLLGDREAAIKKMRSNKSKEFFAELKVLCKI-HHINV--FISTFGN 353
           ++G G  G V   F     ++ A+K +    S +   E+    +     ++   +  + N
Sbjct: 36  VLGLGVNGKVLECFHRRTGQKCALKLL--YDSPKARQEVDHHWQASGGPHIVCILDVYEN 93

Query: 354 -----------------GSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKA 396
                            G L   + +   +G Q  T     +I  D    I+++H H   
Sbjct: 94  MHHGKRCLLIIMECMEGGELFSRIQE---RGDQAFTEREAAEIMRDIGTAIQFLHSH--- 147

Query: 397 RYVHRDIKTSNILL---DDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPE 450
              HRD+K  N+L    +     K+ DFG  K       +  L T    TP Y+ PE
Sbjct: 148 NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET----TQNALQTP-CYTPYYVAPE 199

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 65.5 bits (160), Expect = 1e-11
 Identities = 51/233 (21%), Positives = 87/233 (37%), Gaps = 57/233 (24%)

Query: 288 EEATNNFDESRIIGRGGFGNVYFGLL---GDREAA--IKKMRSNKSK------EFFAELK 336
           ++  + +D    +G G F  V        G   AA  IKK +S  S+      E   E+ 
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVS 67

Query: 337 VLCKIHHINV--FISTF-------------GNGSLSDHLHDPLLKGHQPLTWTARTQIAL 381
           +L ++ H N+      +               G L D L     K    L+    T    
Sbjct: 68  ILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQ---KES--LSEEEATSFIK 122

Query: 382 DAAKGIEYIHDHTKARYVHRDIKTSNILL----DDGLRAKVADFGL-VKLEERTNEKEML 436
               G+ Y+H     +  H D+K  NI+L          K+ DFGL  ++E+    K + 
Sbjct: 123 QILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNI- 178

Query: 437 ATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
                GTP ++ PE   +  +            +  + D+++ GV+   L++G
Sbjct: 179 ----FGTPEFVAPE---IVNYEP----------LGLEADMWSIGVITYILLSG 214

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 65.0 bits (159), Expect = 1e-11
 Identities = 56/226 (24%), Positives = 87/226 (38%), Gaps = 60/226 (26%)

Query: 292 NNFDESRIIGRGGFGNVYFGLLGDREA--AIKKMRSN---KSKEF---FAELKVLCKIHH 343
           + FD  + +G G FG V      +     A+K +      K K+      E ++L  ++ 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100

Query: 344 --INVFISTFGN-------------GSLSDHLHDPLLKGHQPLTWTAR---TQIALDAAK 385
             +     +F +             G +  HL      G       AR    QI L    
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR---IGRFSEP-HARFYAAQIVL---- 152

Query: 386 GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK-LEERTNEKEMLATRLVGTP 444
             EY+H       ++RD+K  N+L+D     +V DFG  K ++ RT       T L GTP
Sbjct: 153 TFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW------T-LCGTP 202

Query: 445 GYLPPEYIFVKRFRFDMHS-SVMELQVTTKTDVFAFGVVLAELITG 489
             L PE I  K      ++ +V         D +A GV++ E+  G
Sbjct: 203 EALAPEIILSKG-----YNKAV---------DWWALGVLIYEMAAG 234

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 65.0 bits (159), Expect = 1e-11
 Identities = 48/181 (26%), Positives = 75/181 (41%), Gaps = 47/181 (25%)

Query: 298 RIIGRGGFGNVYFGL--LGDREAAIKKMRSNKSKE-FFAELKVLCKIHHINV--FISTFG 352
             +GRG    VY        +  A+K ++    K+    E+ VL ++ H N+      F 
Sbjct: 59  SELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFE 118

Query: 353 N-------------GSLSDHLHDPLLKGHQPLTWTARTQIALDAAK-------GIEYIHD 392
                         G L D + +   KG+    ++ R     DAA         + Y+H+
Sbjct: 119 TPTEISLVLELVTGGELFDRIVE---KGY----YSER-----DAADAVKQILEAVAYLHE 166

Query: 393 HTKARYVHRDIKTSNILL---DDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPP 449
           +     VHRD+K  N+L          K+ADFGL K+ E    + ++ T + GTPGY  P
Sbjct: 167 N---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE---HQVLMKT-VCGTPGYCAP 219

Query: 450 E 450
           E
Sbjct: 220 E 220

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 64.1 bits (157), Expect = 2e-11
 Identities = 55/224 (24%), Positives = 85/224 (37%), Gaps = 57/224 (25%)

Query: 291 TNNFDESRIIGRGGFGNVYFG---LLGDREAA--IKKMRSNKSK------EFFAELKVLC 339
            ++++    +G G F  V        G   AA  IKK R + S+      E   E+ +L 
Sbjct: 4   EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63

Query: 340 KIHHINV--FISTFGN-------------GSLSDHLHDPLLKGHQPLTWTARTQIALDAA 384
           +I H N+      F N             G L D L +   K    LT    TQ      
Sbjct: 64  EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAE---KES--LTEDEATQFLKQIL 118

Query: 385 KGIEYIHDHTKARYVHRDIKTSNILL----DDGLRAKVADFGL-VKLEERTNEKEMLATR 439
            G+ Y+H     R  H D+K  NI+L        R K+ DFG+  K+E     K +    
Sbjct: 119 DGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNI---- 171

Query: 440 LVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVL 483
             GTP ++ PE   +  +            +  + D+++ GV+ 
Sbjct: 172 -FGTPEFVAPE---IVNYEP----------LGLEADMWSIGVIT 201

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 64.6 bits (158), Expect = 2e-11
 Identities = 40/195 (20%), Positives = 73/195 (37%), Gaps = 44/195 (22%)

Query: 285 EEIEEATNNFDE----SRIIGRGGFGNVYFGLLGDR----EAAIKKMRSNKSKE-FFAEL 335
           +++   +  F +       IG G +      +   +    E A+K +  +KSK     E+
Sbjct: 11  QQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCI--HKATNMEFAVKII--DKSKRDPTEEI 66

Query: 336 KVLCK-IHHINV--FISTFGN-------------GSLSDHLHDPLLKGHQPLTWTARTQI 379
           ++L +   H N+      + +             G L D +     +     +    + +
Sbjct: 67  EILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILR---QKF--FSEREASAV 121

Query: 380 ALDAAKGIEYIHDHTKARYVHRDIKTSNILL----DDGLRAKVADFGLVKLEERTNEKEM 435
                K +EY+H       VHRD+K SNIL      +    ++ DFG  K  +   E  +
Sbjct: 122 LFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAK--QLRAENGL 176

Query: 436 LATRLVGTPGYLPPE 450
           L T    T  ++ PE
Sbjct: 177 LMT-PCYTANFVAPE 190

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 64.2 bits (157), Expect = 2e-11
 Identities = 50/221 (22%), Positives = 82/221 (37%), Gaps = 51/221 (23%)

Query: 296 ESRIIGRGGFGNVYFG---LLGDREAA--IKKMRSNKS--KEFFAELKVLCKI-HHINV- 346
            S+ +GRG F  V        G   AA  +KK R  +    E   E+ VL        V 
Sbjct: 33  TSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVI 92

Query: 347 -FISTFGN-------------GSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHD 392
                + N             G +         +  + ++     ++     +G+ Y+H 
Sbjct: 93  NLHEVYENTSEIILILEYAAGGEIFSLCLP---ELAEMVSENDVIRLIKQILEGVYYLHQ 149

Query: 393 HTKARYVHRDIKTSNILL---DDGLRAKVADFGL-VKLEERTNEKEMLATRLVGTPGYLP 448
           +     VH D+K  NILL         K+ DFG+  K+      +E+     +GTP YL 
Sbjct: 150 N---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREI-----MGTPEYLA 201

Query: 449 PEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
           PE   +  +            +TT TD++  G++   L+T 
Sbjct: 202 PE---ILNYD----------PITTATDMWNIGIIAYMLLTH 229

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 63.9 bits (156), Expect = 3e-11
 Identities = 35/189 (18%), Positives = 67/189 (35%), Gaps = 51/189 (26%)

Query: 298 RIIGRGGFGNVYFG---LLGDREAA--IKKMRSNKS-----KEFFAELKVLCKIHHINV- 346
            +IG+G F  V        G + A   +   +   S     ++   E  +   + H ++ 
Sbjct: 30  EVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 89

Query: 347 ----FISTFGN----------GSLSDHLHDPLLKGHQPLTWTARTQIALDAAK------- 385
                 S+ G             L   +   + +      ++        A+        
Sbjct: 90  ELLETYSSDGMLYMVFEFMDGADLCFEI---VKRADAGFVYSEA-----VASHYMRQILE 141

Query: 386 GIEYIHDHTKARYVHRDIKTSNILL---DDGLRAKVADFGL-VKLEERTNEKEMLATRLV 441
            + Y HD+     +HRD+K   +LL   ++    K+  FG+ ++L E      +   R V
Sbjct: 142 ALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGE---SGLVAGGR-V 194

Query: 442 GTPGYLPPE 450
           GTP ++ PE
Sbjct: 195 GTPHFMAPE 203

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 63.9 bits (156), Expect = 4e-11
 Identities = 41/193 (21%), Positives = 72/193 (37%), Gaps = 37/193 (19%)

Query: 285 EEIEEATNNFDES----RIIGRGGFGNVYFGL--LGDREAAIK-----KMRSNKSKEFFA 333
           E +  A+  F ++      +G+G F  V   +      E A K     K+ +   ++   
Sbjct: 18  EFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLER 77

Query: 334 ELKVLCKIHHINVFISTFGNGSLSDHLH------------DPLL-KGHQPLTWTARTQIA 380
           E ++  K+ H N+ +    +       +            + ++ +     +    +   
Sbjct: 78  EARICRKLQHPNI-VRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF--YSEADASHCI 134

Query: 381 LDAAKGIEYIHDHTKARYVHRDIKTSNILL---DDGLRAKVADFGLVKLEERTNEKEMLA 437
               + I Y H +     VHR++K  N+LL     G   K+ADFGL        + E   
Sbjct: 135 QQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN---DSEAWH 188

Query: 438 TRLVGTPGYLPPE 450
               GTPGYL PE
Sbjct: 189 GF-AGTPGYLSPE 200

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 63.1 bits (154), Expect = 6e-11
 Identities = 49/240 (20%), Positives = 96/240 (40%), Gaps = 63/240 (26%)

Query: 289 EATNNFDESRIIGRGGFGNVYFGLLGDREA----AIKKM---RSNKSKEFFAELKVLCKI 341
           +  + + + + +G GG G V+  +  D +     AIKK+        K    E+K++ ++
Sbjct: 8   DLGSRYMDLKPLGCGGNGLVFSAV--DNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRL 65

Query: 342 HHINV----------FISTFGNGSLSDHLHD-------------------PLLKGH-QPL 371
            H N+                +      L+                    PLL+ H +  
Sbjct: 66  DHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLF 125

Query: 372 TWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLD-DGLRAKVADFGLVKLEERT 430
            +    Q+     +G++YIH    A  +HRD+K +N+ ++ + L  K+ DFGL ++ +  
Sbjct: 126 MY----QLL----RGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPH 174

Query: 431 NEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
              +   +  + T  Y  P  +        +  +      T   D++A G + AE++TGK
Sbjct: 175 YSHKGHLSEGLVTKWYRSPRLL--------LSPN----NYTKAIDMWAAGCIFAEMLTGK 222

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 63.9 bits (156), Expect = 6e-11
 Identities = 40/186 (21%), Positives = 73/186 (39%), Gaps = 52/186 (27%)

Query: 298 RIIGRGGFGNVYFG--LLGDREAAIK-----KMRSNKSKEFFAELKVLCKIHHINV--FI 348
             +G+G F  V     +L  +E A       K+ +   ++   E ++   + H N+    
Sbjct: 17  EELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLH 76

Query: 349 STFGNGSLSDHLH------------DPLL-KGHQPLTWTARTQIALDAAK-------GIE 388
            +    S   H +            + ++ + +    ++       DA+         + 
Sbjct: 77  DSI---SEEGHHYLIFDLVTGGELFEDIVAREY----YSEA-----DASHCIQQILEAVL 124

Query: 389 YIHDHTKARYVHRDIKTSNILL---DDGLRAKVADFGL-VKLEERTNEKEMLATRLVGTP 444
           + H       VHR++K  N+LL     G   K+ADFGL +++E    E++       GTP
Sbjct: 125 HCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE---GEQQAWFGF-AGTP 177

Query: 445 GYLPPE 450
           GYL PE
Sbjct: 178 GYLSPE 183

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 63.1 bits (154), Expect = 6e-11
 Identities = 38/175 (21%), Positives = 62/175 (35%), Gaps = 32/175 (18%)

Query: 297 SRIIGRGGFGNVYFG--LLGDREAAIKKMRSNKSKEFFAELKVLCKI-HHINV--FISTF 351
            + +G G F           ++  A+K +          E+  L     H N+      F
Sbjct: 16  DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVF 75

Query: 352 GN-------------GSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARY 398
            +             G L + +     K H   + T  + I       + ++HD      
Sbjct: 76  HDQLHTFLVMELLNGGELFERIKK---KKH--FSETEASYIMRKLVSAVSHMHDV---GV 127

Query: 399 VHRDIKTSNILL---DDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPE 450
           VHRD+K  N+L    +D L  K+ DFG  +L+    + + L T    T  Y  PE
Sbjct: 128 VHRDLKPENLLFTDENDNLEIKIIDFGFARLKP--PDNQPLKTP-CFTLHYAAPE 179

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 62.5 bits (152), Expect = 1e-10
 Identities = 41/166 (24%), Positives = 58/166 (34%), Gaps = 42/166 (25%)

Query: 298 RIIGRGGFGNVYFG-------LLGDREAAIKKMRSNKSKEFFAELKV---LCKIHHINVF 347
             IG+GGFG +Y         +  D    +K   S  +   F ELK      K   I  +
Sbjct: 41  LPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPS-DNGPLFTELKFYQRAAKPEQIQKW 99

Query: 348 ISTFGNGSL---------------SDH-----------LHDPLLKGHQPLTWTARTQIAL 381
           I T     L                 +           L        +  +     Q++L
Sbjct: 100 IRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSL 159

Query: 382 DAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKV--ADFGLVK 425
                +EYIH+H    YVH DIK SN+LL+     +V   D+GL  
Sbjct: 160 RILDILEYIHEH---EYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 61.9 bits (151), Expect = 1e-10
 Identities = 54/227 (23%), Positives = 86/227 (37%), Gaps = 57/227 (25%)

Query: 288 EEATNNFDESRIIGRGGFGNVYFGL---LGDREAA--IKKMRSNKSK------EFFAELK 336
           E   + +D    +G G F  V        G + AA  IKK R+  S+      +   E+ 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66

Query: 337 VLCKIHHINV--FISTFGN-------------GSLSDHLHDPLLKGHQPLTWTARTQIAL 381
           +L +I H NV      + N             G L D L +   K    LT    T+   
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE---KES--LTEEEATEFLK 121

Query: 382 DAAKGIEYIHDHTKARYVHRDIKTSNILL----DDGLRAKVADFGL-VKLEERTNEKEML 436
               G+ Y+H     +  H D+K  NI+L        R K+ DFGL  K++     K + 
Sbjct: 122 QILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI- 177

Query: 437 ATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVL 483
                GTP ++ PE   +  +            +  + D+++ GV+ 
Sbjct: 178 ----FGTPEFVAPE---IVNYEP----------LGLEADMWSIGVIT 207

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 62.1 bits (151), Expect = 1e-10
 Identities = 37/163 (22%), Positives = 58/163 (35%), Gaps = 39/163 (23%)

Query: 298 RIIGRGGFGNVYFG--LLGDREAAIK--KMRSNKSKEFFAELKV---LCKIHHINVFIST 350
           + IG GGFG +Y         + A    K+   ++   F+ELK    + K   I  +I  
Sbjct: 43  KKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIER 102

Query: 351 -------------FGNGSLSDH-------------LHDPLLKGHQPLTWTARTQIALDAA 384
                         G                    L   +   +     +   Q+ +   
Sbjct: 103 KQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQK-ISGQNGTFKKSTVLQLGIRML 161

Query: 385 KGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKV--ADFGLVK 425
             +EYIH++    YVH DIK +N+LL      +V  AD+GL  
Sbjct: 162 DVLEYIHEN---EYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 61.4 bits (150), Expect = 2e-10
 Identities = 60/241 (24%), Positives = 93/241 (38%), Gaps = 90/241 (37%)

Query: 292 NNFDESRIIGRGGFGNVYFGLLGDREAAIKKMRSNKSKEFFAELKVLCK--------IHH 343
            +F   R +G G FG V+             +RS  +  ++A +KVL K        + H
Sbjct: 6   QDFQILRTLGTGSFGRVHL------------IRSRHNGRYYA-MKVLKKEIVVRLKQVEH 52

Query: 344 INV-----------FI----STF--------------GNGSLSDHLHDPLLKGHQPLTWT 374
            N            FI     TF              G G L   L         P    
Sbjct: 53  TNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEG-GELFSLLRK---SQRFPNP-V 107

Query: 375 AR---TQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLD-DGLRAKVADFGLVK-LEER 429
           A+    ++ L     +EY+H       ++RD+K  NILLD +G   K+ DFG  K + + 
Sbjct: 108 AKFYAAEVCL----ALEYLHSKD---IIYRDLKPENILLDKNG-HIKITDFGFAKYVPDV 159

Query: 430 TNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHS-SVMELQVTTKTDVFAFGVVLAELIT 488
           T       T L GTP Y+ PE +  K      ++ S+         D ++FG+++ E++ 
Sbjct: 160 TY------T-LCGTPDYIAPEVVSTKP-----YNKSI---------DWWSFGILIYEMLA 198

Query: 489 G 489
           G
Sbjct: 199 G 199

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 60.9 bits (148), Expect = 3e-10
 Identities = 27/195 (13%), Positives = 58/195 (29%), Gaps = 54/195 (27%)

Query: 298 RIIGRGGFGNVYFG----------LLGDREAAIKKMRSNKSKEFFAELKVL---CKIHHI 344
               R   G +Y                ++ ++K + +   + F  E        K   +
Sbjct: 48  SFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFN-EQNFFQRAAKPLQV 105

Query: 345 NVFISTFGNG---------------------------SLSDHLHDPLLKGHQPLTWTART 377
           N +   +                              SL   L    +     L+  +  
Sbjct: 106 NKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALD---VSPKHVLSERSVL 162

Query: 378 QIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKV--ADFGLVKLEERTNE--- 432
           Q+A      +E++H++    YVH ++   NI +D   +++V  A +G       + +   
Sbjct: 163 QVACRLLDALEFLHEN---EYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVA 219

Query: 433 -KEMLATRLVGTPGY 446
             E   +   G   +
Sbjct: 220 YVEGSRSPHEGDLEF 234

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 61.4 bits (149), Expect = 3e-10
 Identities = 45/257 (17%), Positives = 88/257 (34%), Gaps = 62/257 (24%)

Query: 289 EATNNFDESRIIGRGGFGNVYFGLLGDREA----AIKKMRSNKSKEFFA-----ELKVLC 339
           +  + ++   +IG G +G+V      D+      AIKK+               E+ +L 
Sbjct: 50  QIPDRYEIRHLIGTGSYGHVCEAY--DKLEKRVVAIKKILRVFEDLIDCKRILREIAILN 107

Query: 340 KIHHINVFISTFGNGSLSDHLHDPLLKG---------------HQPLTWTARTQIALDAA 384
           +++H +V         + D +    ++                 +      RT + L   
Sbjct: 108 RLNHDHVV-------KVLDIVIPKDVEKFDELYVVLEIADSDFKKLF----RTPVYLTEL 156

Query: 385 ----------KGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKE 434
                      G++Y+H    A  +HRD+K +N L++     KV DFGL +  +      
Sbjct: 157 HIKTLLYNLLVGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGN 213

Query: 435 MLATRLVGTPGYLPPEYIFVKRFRFDMHSSVM-------EL-----QVTTKTDVFAFGVV 482
                           +   K  +  +   V+       EL       T   DV++ G +
Sbjct: 214 SQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCI 273

Query: 483 LAELITGKRALIRDDSE 499
            AEL+   +  +   ++
Sbjct: 274 FAELLNMIKENVAYHAD 290

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 61.3 bits (149), Expect = 4e-10
 Identities = 62/290 (21%), Positives = 105/290 (36%), Gaps = 71/290 (24%)

Query: 233 RKRPEEKITEDAKHVSKAMSITTRAFSSQGQCKENTEDVTVLESERTIIFSLEEIEEATN 292
           R+     I   A  + K  +      S         E++ V  ++     ++        
Sbjct: 96  REEWTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMN------- 148

Query: 293 NFDESRIIGRGGFGNVYFGLLGDREA-----AIKKMRSNKSKEFF----------AELKV 337
            F+  +++G+G FG V   +L   +A     A+K ++    KE             E +V
Sbjct: 149 EFEYLKLLGKGTFGKV---ILVKEKATGRYYAMKILK----KEVIVAKDEVAHTLTENRV 201

Query: 338 LCKIHH---INV-----------FISTFGNG-SLSDHLH-DPLLKGHQPLTWTARTQIAL 381
           L    H     +           F+  + NG  L  HL  + +    +   + A    AL
Sbjct: 202 LQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSAL 261

Query: 382 DAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLV 441
           D        + H++   V+RD+K  N++LD     K+ DFGL K   +            
Sbjct: 262 D--------YLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT---MKTFC 310

Query: 442 GTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKT-DVFAFGVVLAELITGK 490
           GTP YL PE              V+E     +  D +  GVV+ E++ G+
Sbjct: 311 GTPEYLAPE--------------VLEDNDYGRAVDWWGLGVVMYEMMCGR 346

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 60.4 bits (147), Expect = 4e-10
 Identities = 40/180 (22%), Positives = 69/180 (38%), Gaps = 36/180 (20%)

Query: 299 IIGRGGFGNVYFG--LLGDREAAIK---KMRSNKSKEFFAELKVLCKI-HHINV--FIST 350
           ++G G    V     L+  +E A+K   K   +     F E+++L +   H NV   I  
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79

Query: 351 FGN-------------GSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKAR 397
           F               GS+  H+H    + H        + +  D A  ++++H+     
Sbjct: 80  FEEEDRFYLVFEKMRGGSILSHIHK---RRH--FNELEASVVVQDVASALDFLHNK---G 131

Query: 398 YVHRDIKTSNILL---DDGLRAKVADFGL-VKLEERTNEKEMLATRL---VGTPGYLPPE 450
             HRD+K  NIL    +     K+ DF L   ++   +   +    L    G+  Y+ PE
Sbjct: 132 IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPE 191

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 59.6 bits (145), Expect = 8e-10
 Identities = 46/242 (19%), Positives = 84/242 (34%), Gaps = 69/242 (28%)

Query: 289 EATNNFDESRIIGRGGFGNVYFGLLGDREA----AIKKMR--SNKS--KEFFAELKVLCK 340
             +++F    ++G G +G V       +      AIKK+              E+K+L  
Sbjct: 8   NISSDFQLKSLLGEGAYGVVCSAT--HKPTGEIVAIKKIEPFDKPLFALRTLREIKILKH 65

Query: 341 IHHINVFISTFGNGSLSDHLHDPLLKG---------------HQPLTWTARTQIALDA-- 383
             H N+        ++ +       +                H+ +     TQ+  D   
Sbjct: 66  FKHENII-------TIFNIQRPDSFENFNEVYIIQELMQTDLHRVI----STQMLSDDHI 114

Query: 384 -------AKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGL--------VKLEE 428
                   + ++ +H    +  +HRD+K SN+L++     KV DFGL            E
Sbjct: 115 QYFIYQTLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSE 171

Query: 429 RTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
            T ++  +    V T  Y  PE +                + +   DV++ G +LAEL  
Sbjct: 172 PTGQQSGM-VEFVATRWYRAPEVMLTSA------------KYSRAMDVWSCGCILAELFL 218

Query: 489 GK 490
            +
Sbjct: 219 RR 220

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 59.3 bits (144), Expect = 9e-10
 Identities = 39/159 (24%), Positives = 60/159 (37%), Gaps = 34/159 (21%)

Query: 292 NNFDESRIIGRGGFGNVYFG--LLGDREAAIKKMRSN-KSKEFFAE---LKVLCKIHHI- 344
            ++   R IG G FG ++ G  LL +++ AIK       + +   E    K+L     I 
Sbjct: 10  VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIP 69

Query: 345 -----------NVFISTFGNGSLSDHLHDPLLKGHQPLTWTART--QIALDAAKGIEYIH 391
                      NV +      SL D      L       ++ +T    A      ++ IH
Sbjct: 70  NVYYFGQEGLHNVLVIDLLGPSLED------LLDLCGRKFSVKTVAMAAKQMLARVQSIH 123

Query: 392 DHTKARYVHRDIKTSNILLDDGLRAK-----VADFGLVK 425
           + +    V+RDIK  N L+            V DFG+VK
Sbjct: 124 EKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 59.3 bits (144), Expect = 1e-09
 Identities = 49/230 (21%), Positives = 87/230 (37%), Gaps = 59/230 (25%)

Query: 298 RIIGRGGFGNVY--FGLLGDREAAIKKMRSNKS--KEFFAELKVLCKI------------ 341
           R +G G F  V+    ++ +   A+K +R +K   +    E+K+L ++            
Sbjct: 25  RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 84

Query: 342 -HHINVFISTF----GNGS--------LSDHLHDPLLK--GHQPLTWTARTQIALDAAKG 386
            +HI   +  F     NG         L ++L   L+K   H+ +      QI+     G
Sbjct: 85  ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLA-LIKKYEHRGIPLIYVKQISKQLLLG 143

Query: 387 IEYIHDHTKARYVHRDIKTSNILLDDGLRA------KVADFGLVKLEERTNEKEMLATRL 440
           ++Y+H   +   +H DIK  N+L++           K+AD G           E   T  
Sbjct: 144 LDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLG-----NACWYDEHY-TNS 195

Query: 441 VGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
           + T  Y  PE +             +        D+++   ++ ELITG 
Sbjct: 196 IQTREYRSPEVL-------------LGAPWGCGADIWSTACLIFELITGD 232

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 58.5 bits (142), Expect = 2e-09
 Identities = 38/159 (23%), Positives = 55/159 (34%), Gaps = 34/159 (21%)

Query: 292 NNFDESRIIGRGGFGNVYFG--LLGDREAAIK--KMRSNKSKEFF--AELKVLCKIHHI- 344
            NF   + IG G FG +  G  L  +   AIK   M+S   +        K L     I 
Sbjct: 9   PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIP 68

Query: 345 -----------NVFISTFGNGSLSDHLHDPLLKGHQPLTWTART--QIALDAAKGIEYIH 391
                      N  +      SL D      L      T++ +T   IA+     +EY+H
Sbjct: 69  QVYYFGPCGKYNAMVLELLGPSLED------LFDLCDRTFSLKTVLMIAIQLISRMEYVH 122

Query: 392 DHTKARYVHRDIKTSNILLDDGLRAK-----VADFGLVK 425
                  ++RD+K  N L+            + DF L K
Sbjct: 123 SKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 58.3 bits (142), Expect = 2e-09
 Identities = 51/229 (22%), Positives = 93/229 (40%), Gaps = 59/229 (25%)

Query: 292 NNFDESRIIGRGGFGNVY-----FGLLGDREAAIKKMR-----SNKSKEFFAELKVLCKI 341
           + F+  +++G+G FG V+      G    +  A+K ++              E  +L ++
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV 83

Query: 342 HH---INV-----------FISTFGN-GSLSDHLHDPLLKGHQPLTWTAR---TQIALDA 383
           +H   + +            I  F   G L   L     +         +    ++AL  
Sbjct: 84  NHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSK---EVMFTEED-VKFYLAELAL-- 137

Query: 384 AKGIEYIHDHTKARYVHRDIKTSNILLD-DGLRAKVADFGLVKLEERTNEKEMLATRLVG 442
              ++++H       ++RD+K  NILLD +G   K+ DFGL K      +K   A    G
Sbjct: 138 --ALDHLHSL---GIIYRDLKPENILLDEEG-HIKLTDFGLSKESIDHEKK---AYSFCG 188

Query: 443 TPGYLPPEYIFVKRFRFDMHSSVMELQVTTKT-DVFAFGVVLAELITGK 490
           T  Y+ PE              V+  +  T++ D ++FGV++ E++TG 
Sbjct: 189 TVEYMAPE--------------VVNRRGHTQSADWWSFGVLMFEMLTGT 223

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 58.6 bits (142), Expect = 2e-09
 Identities = 54/248 (21%), Positives = 88/248 (35%), Gaps = 51/248 (20%)

Query: 289 EATNNFDESRIIGRGGFGNVYFGLLGDREA----AIKKMRSNKSKEFFA-----ELKVLC 339
              +N+    +IGRG +G VY     D+      AIKK+               E+ +L 
Sbjct: 23  HVPDNYIIKHLIGRGSYGYVYLAY--DKNTEKNVAIKKVNRMFEDLIDCKRILREITILN 80

Query: 340 KIHH------INVFISTFGNGSLSD----------HLHDPLLKGHQPLTWTARTQ-IALD 382
           ++         ++ I         +           L   L K    LT     + I  +
Sbjct: 81  RLKSDYIIRLYDLIIPD-DLLKFDELYIVLEIADSDLKK-LFKTPIFLT-EEHIKTILYN 137

Query: 383 AAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVG 442
              G  +IH+   +  +HRD+K +N LL+     KV DFGL     RT   E     +  
Sbjct: 138 LLLGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLA----RTINSEKDTNIVND 190

Query: 443 TPGYLPPEYIFVKRFRFDMHSSVM-------EL-----QVTTKTDVFAFGVVLAELITGK 490
                 P        +  + S V+       EL       T   D+++ G + AEL+   
Sbjct: 191 LEENEEPGPHNKNLKKQ-LTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNML 249

Query: 491 RALIRDDS 498
           ++ I D +
Sbjct: 250 QSHINDPT 257

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 58.1 bits (141), Expect = 3e-09
 Identities = 33/106 (31%), Positives = 50/106 (47%), Gaps = 18/106 (16%)

Query: 386 GIEYIHDHTKARYVHRDIKTSNILLD-DGLRAKVADFGLVKLEERTNEKEMLATRLVGTP 444
            +E++H       ++RDIK  NILLD +G    + DFGL K E   +E E       GT 
Sbjct: 171 ALEHLHKL---GIIYRDIKLENILLDSNG-HVVLTDFGLSK-EFVADETERAYD-FCGTI 224

Query: 445 GYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
            Y+ P+ +       D   +V         D ++ GV++ EL+TG 
Sbjct: 225 EYMAPDIVRGGDSGHDK--AV---------DWWSLGVLMYELLTGA 259

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 58.5 bits (141), Expect = 3e-09
 Identities = 48/238 (20%), Positives = 79/238 (33%), Gaps = 78/238 (32%)

Query: 292 NNFDESRIIGRGGFGNVYFGLLGDREAAIKKMRSNKSKEFFAELKVLCK--------IHH 343
            +F+   ++G+G FG V                   + E +A +K+L K        +  
Sbjct: 341 TDFNFLMVLGKGSFGKVMLS------------ERKGTDELYA-VKILKKDVVIQDDDVEC 387

Query: 344 INV----------------------------FISTFGNG-SLSDHLHDPLLKGHQPLTWT 374
             V                            F+  + NG  L  H+              
Sbjct: 388 TMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQ------QVGRFKE 441

Query: 375 ARTQI-ALDAAKGIEYIHDHTKARYVHRDIKTSNILLD-DGLRAKVADFGLVKLEERTNE 432
                 A + A G+ ++        ++RD+K  N++LD +G   K+ADFG+ K       
Sbjct: 442 PHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEG-HIKIADFGMCKENIWDGV 497

Query: 433 KEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
                    GTP Y+ PE I                      D +AFGV+L E++ G+
Sbjct: 498 T---TKTFCGTPDYIAPEII-------------AYQPYGKSVDWWAFGVLLYEMLAGQ 539

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 58.1 bits (140), Expect = 3e-09
 Identities = 42/157 (26%), Positives = 60/157 (38%), Gaps = 32/157 (20%)

Query: 292 NNFDESRIIGRGGFGNVYFG--LLGDREAAIKKMRSN-KSKEFFAELKVL---------C 339
           N F   R IG G FG +Y G  +  + E AIK      K  +   E K+           
Sbjct: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIP 66

Query: 340 KIHHI------NVFISTFGNGSLSDHLHDPLLKGHQPLTWTART--QIALDAAKGIEYIH 391
            +         NV +      SL D      L        + +T   +A      +E++H
Sbjct: 67  NVRWFGVEGDYNVLVMDLLGPSLED------LFNFCSRKLSLKTVLMLADQMINRVEFVH 120

Query: 392 DHTKARYVHRDIKTSNILLDDGLRAK---VADFGLVK 425
             +   ++HRDIK  N L+  G RA    + DFGL K
Sbjct: 121 SKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 56.6 bits (137), Expect = 5e-09
 Identities = 42/157 (26%), Positives = 59/157 (37%), Gaps = 32/157 (20%)

Query: 292 NNFDESRIIGRGGFGNVYFG--LLGDREAAIKKMRSN-KSKEFFAELKVL---------C 339
           N +   R IG G FG++Y G  +    E AIK      K  +   E K+           
Sbjct: 9   NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIP 68

Query: 340 KIHHI------NVFISTFGNGSLSDHLHDPLLKGHQPLTWTART--QIALDAAKGIEYIH 391
            I         NV +      SL D      L       ++ +T   +A      IEYIH
Sbjct: 69  TIRWCGAEGDYNVMVMELLGPSLED------LFNFCSRKFSLKTVLLLADQMISRIEYIH 122

Query: 392 DHTKARYVHRDIKTSNILLDDGLRAK---VADFGLVK 425
                 ++HRD+K  N L+  G +     + DFGL K
Sbjct: 123 SKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 56.8 bits (138), Expect = 6e-09
 Identities = 62/234 (26%), Positives = 90/234 (38%), Gaps = 71/234 (30%)

Query: 292 NNFDESRIIGRGGFGNVYFGLLGDREA-----AIKKMRSNKSKEFF----------AELK 336
           N+FD  +++G+G FG V   +L   +A     A+K +R    KE             E +
Sbjct: 5   NDFDYLKLLGKGTFGKV---ILVREKATGRYYAMKILR----KEVIIAKDEVAHTVTESR 57

Query: 337 VLCKIHH---INV-----------FISTFGNG-SLSDHLHDPLLKGHQPLTWTAR---TQ 378
           VL    H     +           F+  + NG  L  HL     +        AR    +
Sbjct: 58  VLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR---ERVFTEE-RARFYGAE 113

Query: 379 IALDAAKGIEYIHDHTKARYVHRDIKTSNILLD-DGLRAKVADFGLVKLEERTNEKEMLA 437
           I       +EY+H       V+RDIK  N++LD DG   K+ DFGL K            
Sbjct: 114 IVS----ALEYLHSR---DVVYRDIKLENLMLDKDG-HIKITDFGLCKEGISDGAT---M 162

Query: 438 TRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKT-DVFAFGVVLAELITGK 490
               GTP YL PE              V+E     +  D +  GVV+ E++ G+
Sbjct: 163 KTFCGTPEYLAPE--------------VLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 57.0 bits (138), Expect = 7e-09
 Identities = 43/219 (19%), Positives = 87/219 (39%), Gaps = 49/219 (22%)

Query: 298 RIIGRGGFGNVY--FGLLGDREAAIKKMRSNKSKEFFA----ELKVLCKI--------HH 343
            +IG+G FG V   +  +     AIK +++ K+  F      E+++L  +        ++
Sbjct: 60  SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKA--FLNQAQIEVRLLELMNKHDTEMKYY 117

Query: 344 INVFISTFGNGS--------LSDHLHDPLLK--GHQPLTWTARTQIALDAAKGIEYIHDH 393
           I      F   +        LS +L+D LL+    + ++     + A      + ++   
Sbjct: 118 IVHLKRHFMFRNHLCLVFEMLSYNLYD-LLRNTNFRGVSLNLTRKFAQQMCTALLFLATP 176

Query: 394 TKARYVHRDIKTSNILLDDGLRA--KVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEY 451
            +   +H D+K  NILL +  R+  K+ DFG           + +   +  +  Y  PE 
Sbjct: 177 -ELSIIHCDLKPENILLCNPKRSAIKIVDFG-----SSCQLGQRIYQYIQ-SRFYRSPEV 229

Query: 452 IFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
           +             + +      D+++ G +L E+ TG+
Sbjct: 230 L-------------LGMPYDLAIDMWSLGCILVEMHTGE 255

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 56.7 bits (137), Expect = 9e-09
 Identities = 48/217 (22%), Positives = 91/217 (41%), Gaps = 47/217 (21%)

Query: 298 RIIGRGGFGNVY--FGLLGDREAAIKKMRSNKS--KEFFAELKVLCKI--------HHIN 345
           ++IG+G FG V   +     +  A+K +R+ K   ++   E+++L  +         ++ 
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVI 162

Query: 346 VFISTFGNGS--------LSDHLHDPLLKGH--QPLTWTARTQIALDAAKGIEYIHDHTK 395
             +  F   +        LS +L++ L+K +  Q  +     + A    + ++ +H +  
Sbjct: 163 HMLENFTFRNHICMTFELLSMNLYE-LIKKNKFQGFSLPLVRKFAHSILQCLDALHKN-- 219

Query: 396 ARYVHRDIKTSNILLDDGLRA--KVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIF 453
            R +H D+K  NILL    R+  KV DFG    E +           + +  Y  PE I 
Sbjct: 220 -RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQR------VYTYIQSRFYRAPEVI- 271

Query: 454 VKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
                       +  +     D+++ G +LAEL+TG 
Sbjct: 272 ------------LGARYGMPIDMWSLGCILAELLTGY 296

>4eby_A Chitin elicitor receptor kinase 1; pathogen-associated molecular patterns, pattern recognition receptors, LYSM, lysine chitin oligomer; HET: NAG BMA; 1.65A {Arabidopsis thaliana} PDB: 4ebz_A* Length = 212

 Score = 54.4 bits (130), Expect = 1e-08
 Identities = 36/216 (16%), Positives = 68/216 (31%), Gaps = 57/216 (26%)

Query: 42  CNEHINTCNALL--YHINQGLPVERIASFYSANPSQIK-----PIFRGN---------QK 85
           C     +C   L  Y++  G  +  I    +++ +        PI R N         Q 
Sbjct: 1   CR---TSCPLALASYYLENGTTLSVINQNLNSSIAPYDQINFDPILRYNSNIKDKDRIQM 57

Query: 86  DYLITVPCSCKDVNSTR------------------AMIYSG-----QAWKV--GGEENYF 120
              + VP  C+                        A+         ++ +          
Sbjct: 58  GSRVLVPFPCECQPGDFLGHNFSYSVRQEDTYERVAISNYANLTTMESLQARNPFPATNI 117

Query: 121 IAGVAVPIHLLCGC----VETGTQVVVTYTVQQQDTLSIIATLLSAEISGIESMNKMVAQ 176
                + + + C C    V     + VTY ++ +D+LS IA         ++  N  V  
Sbjct: 118 PLSATLNVLVNCSCGDESVSKDFGLFVTYPLRPEDSLSSIARSSGVSADILQRYNPGVNF 177

Query: 177 NPGYIDVCWVLFVPM-ELNG----LPTAEKSGKTHK 207
           N G      +++VP  + NG      ++++ G  H 
Sbjct: 178 NSGN----GIVYVPGRDPNGAFPPFKSSKQDGVHHH 209

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 55.3 bits (134), Expect = 2e-08
 Identities = 56/239 (23%), Positives = 89/239 (37%), Gaps = 82/239 (34%)

Query: 292 NNFDESRIIGRGGFGNVYFGLLGDREAAIKKMRSNKSKEFFAELKVLCK--------IHH 343
            +F   +++G+G FG V+                 K+ +FFA +K L K        +  
Sbjct: 17  EDFILHKMLGKGSFGKVFLA------------EFKKTNQFFA-IKALKKDVVLMDDDVEC 63

Query: 344 INV----------------------------FISTFGN-GSLSDHLHDPLLKGHQPLTWT 374
             V                            F+  + N G L  H+          L+  
Sbjct: 64  TMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS---CHKFDLS-R 119

Query: 375 AR---TQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLD-DGLRAKVADFGLVKLEERT 430
           A     +I L    G++++H       V+RD+K  NILLD DG   K+ADFG+ K     
Sbjct: 120 ATFYAAEIIL----GLQFLHSK---GIVYRDLKLDNILLDKDG-HIKIADFGMCKENMLG 171

Query: 431 NEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG 489
           + K        GTP Y+ PE +             +  +     D ++FGV+L E++ G
Sbjct: 172 DAK---TNTFCGTPDYIAPEIL-------------LGQKYNHSVDWWSFGVLLYEMLIG 214

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 55.2 bits (134), Expect = 2e-08
 Identities = 45/231 (19%), Positives = 89/231 (38%), Gaps = 61/231 (26%)

Query: 292 NNFDESRIIGRGGFGNVY----FGLLGDREA-AIKKMR----SNKSKEF---FAELKVLC 339
             F+  R++G+GG+G V+           +  A+K ++       +K+     AE  +L 
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76

Query: 340 KIHH---INV-----------FISTFGN-GSLSDHLHDPLLKGHQPLTWTAR---TQIAL 381
           ++ H   +++            I  + + G L   L     +G      TA     +I++
Sbjct: 77  EVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLER---EGIFMED-TACFYLAEISM 132

Query: 382 DAAKGIEYIHDHTKARYVHRDIKTSNILLD-DGLRAKVADFGLVKLEERTNEKEMLATRL 440
                + ++H       ++RD+K  NI+L+  G   K+ DFGL K               
Sbjct: 133 ----ALGHLHQK---GIIYRDLKPENIMLNHQG-HVKLTDFGLCKESIHDGTV---THTF 181

Query: 441 VGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKT-DVFAFGVVLAELITGK 490
            GT  Y+ PE              ++      +  D ++ G ++ +++TG 
Sbjct: 182 CGTIEYMAPE--------------ILMRSGHNRAVDWWSLGALMYDMLTGA 218

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 55.3 bits (134), Expect = 2e-08
 Identities = 34/107 (31%), Positives = 45/107 (42%), Gaps = 23/107 (21%)

Query: 386 GIEYIHDHTKARYVHRDIKTSNILLD-DGLRAKVADFGLVKLEERTNEKEMLATRLVGTP 444
            + Y+H       V+RD+K  NILLD  G    + DFGL K     N      +   GTP
Sbjct: 151 ALGYLHSLN---IVYRDLKPENILLDSQG-HIVLTDFGLCKENIEHNST---TSTFCGTP 203

Query: 445 GYLPPEYIFVKRFRFDMHSSVMELQVTTKT-DVFAFGVVLAELITGK 490
            YL PE              V+  Q   +T D +  G VL E++ G 
Sbjct: 204 EYLAPE--------------VLHKQPYDRTVDWWCLGAVLYEMLYGL 236

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 53.8 bits (130), Expect = 5e-08
 Identities = 55/239 (23%), Positives = 91/239 (38%), Gaps = 80/239 (33%)

Query: 292 NNFDESRIIGRGGFGNVYFGLLGDREAAIKKMRSNKSKEFFAELKVLCK--------IHH 343
            +FD  R+IGRG +  V               R  K+   +A +KV+ K        I  
Sbjct: 9   QDFDLLRVIGRGSYAKVLLV------------RLKKTDRIYA-MKVVKKELVNDDEDIDW 55

Query: 344 INV----------------------------FISTFGN-GSLSDHLHDPLLKGHQPLTWT 374
           +                              F+  + N G L  H+     +   P    
Sbjct: 56  VQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQR---QRKLPEEH- 111

Query: 375 AR---TQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTN 431
           AR    +I+L     + Y+H+      ++RD+K  N+LLD     K+ D+G+ K  E   
Sbjct: 112 ARFYSAEISL----ALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLR 162

Query: 432 EKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
             +  +T   GTP Y+ PE +  + + F    SV         D +A GV++ E++ G+
Sbjct: 163 PGDTTST-FCGTPNYIAPEILRGEDYGF----SV---------DWWALGVLMFEMMAGR 207

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 53.8 bits (130), Expect = 6e-08
 Identities = 51/240 (21%), Positives = 83/240 (34%), Gaps = 82/240 (34%)

Query: 292 NNFDESRIIGRGGFGNVYFGLLGDREAAIKKMRSNKSKEFFAELKVLCK--------IHH 343
           +NF+  R++G+G FG V               R  ++ + +A +KVL K        +  
Sbjct: 23  DNFEFIRVLGKGSFGKVMLA------------RVKETGDLYA-VKVLKKDVILQDDDVEC 69

Query: 344 INV----------------------------FISTFGNG-SLSDHLHDPLLKGHQPLTWT 374
                                          F+  F NG  L  H+              
Sbjct: 70  TMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQK---SRRFDEA-R 125

Query: 375 AR---TQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTN 431
           AR    +I       + ++HD      ++RD+K  N+LLD     K+ADFG+ K      
Sbjct: 126 ARFYAAEIIS----ALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG 178

Query: 432 EKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKT-DVFAFGVVLAELITGK 490
                     GTP Y+ PE              +++  +     D +A GV+L E++ G 
Sbjct: 179 VT---TATFCGTPDYIAPE--------------ILQEMLYGPAVDWWAMGVLLYEMLCGH 221

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 54.5 bits (130), Expect = 7e-08
 Identities = 53/360 (14%), Positives = 104/360 (28%), Gaps = 116/360 (32%)

Query: 226 LIIILLRRKRPE--EKITEDA------------KHVSKAMSITTRAFSSQGQCKENTED- 270
            +   L  K+ E  +K  E+             K   +  S+ TR +  Q     N    
Sbjct: 66  RLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQV 125

Query: 271 -----VTVLESERTIIFSLEEIEEATNNFDESRII--GRGGFG-NVYFGLLGDREAAIKK 322
                V+ L+    +  +L E+  A N      ++  G  G G       +     A+  
Sbjct: 126 FAKYNVSRLQPYLKLRQALLELRPAKN------VLIDGVLGSGKTW----V-----ALDV 170

Query: 323 MRSNKSKEFFAELKVLCKIHHINVFISTFGNGSLSDHLHDPLLKGHQPL------TWTAR 376
             S K +          KI  +N       N     +  + +L+  Q L       WT+R
Sbjct: 171 CLSYKVQCKMD-----FKIFWLN-----LKN----CNSPETVLEMLQKLLYQIDPNWTSR 216

Query: 377 TQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEML 436
           +  + +    I  I    +     +  +   ++L +     V +                
Sbjct: 217 SDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLN-----VQNAKAWNA---------- 261

Query: 437 ATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTK-TDVFAFGVVLAELITGKRALIR 495
                                 F++   ++   +TT+   V  F   L+   T   +L  
Sbjct: 262 ----------------------FNLSCKIL---LTTRFKQVTDF---LSAATTTHISLDH 293

Query: 496 DDSEPTKMKSLITIMAAVAEWCLNEDAVDRP-EMRD--------IVAILSQIMITSTEWE 546
                T  +      + + ++ L+    D P E+          I   +   + T   W+
Sbjct: 294 HSMTLTPDEVK----SLLLKY-LDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWK 348

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 53.1 bits (128), Expect = 9e-08
 Identities = 26/148 (17%), Positives = 52/148 (35%), Gaps = 27/148 (18%)

Query: 298 RIIGRGGFGNVYFGL--LGDREAAIKKMRSNKSKEFFAELKVLCKI-HHINV--FISTFG 352
           +++G G  G V          + A+K ++     +   E+++  +     ++   +  + 
Sbjct: 24  QVLGLGINGKVLQIFNKRTQEKFALKMLQ--DCPKARREVELHWRASQCPHIVRIVDVYE 81

Query: 353 NGSLSDH-------------LHDPLL-KGHQPLTWTARTQIALDAAKGIEYIHDHTKARY 398
           N                   L   +  +G Q  T    ++I     + I+Y+H       
Sbjct: 82  NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NI 138

Query: 399 VHRDIKTSNILL---DDGLRAKVADFGL 423
            HRD+K  N+L          K+ DFG 
Sbjct: 139 AHRDVKPENLLYTSKRPNAILKLTDFGF 166

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 53.0 bits (128), Expect = 1e-07
 Identities = 30/107 (28%), Positives = 50/107 (46%), Gaps = 23/107 (21%)

Query: 386 GIEYIHDHTKARYVHRDIKTSNILLD-DGLRAKVADFGLVKLEERTNEKEMLATRLVGTP 444
           G+ ++        ++RD+K  N++LD +G   K+ADFG+ K                GTP
Sbjct: 133 GLFFLQSK---GIIYRDLKLDNVMLDSEG-HIKIADFGMCKENIWDGVT---TKTFCGTP 185

Query: 445 GYLPPEYIFVKRFRFDMHSSVMELQVTTKT-DVFAFGVVLAELITGK 490
            Y+ PE              ++  Q   K+ D +AFGV+L E++ G+
Sbjct: 186 DYIAPE--------------IIAYQPYGKSVDWWAFGVLLYEMLAGQ 218

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 53.1 bits (128), Expect = 1e-07
 Identities = 29/105 (27%), Positives = 51/105 (48%), Gaps = 19/105 (18%)

Query: 386 GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPG 445
            + Y+H+      ++RD+K  N+LLD     K+ D+G+ K   R  +     +   GTP 
Sbjct: 165 ALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT---TSTFCGTPN 218

Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
           Y+ PE +  + + F    SV         D +A GV++ E++ G+
Sbjct: 219 YIAPEILRGEDYGF----SV---------DWWALGVLMFEMMAGR 250

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 51.2 bits (123), Expect = 5e-07
 Identities = 35/125 (28%), Positives = 52/125 (41%), Gaps = 35/125 (28%)

Query: 385 KGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGL-------------------VK 425
           K I+Y+H       +HRD+K SNILL+     KVADFGL                     
Sbjct: 120 KVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINEN 176

Query: 426 LEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAE 485
            E   +++ +L T  V T  Y  PE +                + T   D+++ G +L E
Sbjct: 177 TENFDDDQPIL-TDYVATRWYRAPEILLGST------------KYTKGIDMWSLGCILGE 223

Query: 486 LITGK 490
           ++ GK
Sbjct: 224 ILCGK 228

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 48.7 bits (115), Expect = 2e-06
 Identities = 26/195 (13%), Positives = 43/195 (22%), Gaps = 61/195 (31%)

Query: 290 ATNNFDESRIIGRGGFGNVYFGLLGDREAAIKKMR-----------SNKSKEFFAELKVL 338
            T        IG G FG V+  +      AIK +                +E   E+ + 
Sbjct: 18  PTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIIS 77

Query: 339 CKIHHI------------------------------------------NVFISTFGNGSL 356
            ++  +                                          N     F +  L
Sbjct: 78  KELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQL 137

Query: 357 ------SDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILL 410
                      D      +  +      I       +         R+ HRD+   N+LL
Sbjct: 138 FIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAE--ASLRFEHRDLHWGNVLL 195

Query: 411 DDGLRAKVADFGLVK 425
                 K+      K
Sbjct: 196 KKTSLKKLHYTLNGK 210

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 44.1 bits (104), Expect = 9e-05
 Identities = 49/275 (17%), Positives = 91/275 (33%), Gaps = 62/275 (22%)

Query: 298 RIIGRGGFGNVYFG--LLGDREAAIKKMRSNKSKEFFA--ELKVLCKI----------HH 343
           R +G G F  V+    + G +  A+K ++S +     A  E+++L  +            
Sbjct: 43  RKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREM 102

Query: 344 INVFISTF----GNGS--------LSDHLHDPLLK-GHQPLTWTARTQIALDAAKGIEYI 390
           +   +  F     NG+        L  HL   ++K  +Q L      +I     +G++Y+
Sbjct: 103 VVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYL 162

Query: 391 HDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPE 450
           H  TK R +H DIK  NILL    +            +R+       + +   P      
Sbjct: 163 H--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNF 220

Query: 451 YIFVKR-----------------FRFDMHSS-------------VMELQVTTKTDVFAFG 480
            +                          H +             ++     T  D+++  
Sbjct: 221 LVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYNTPADIWSTA 280

Query: 481 VVLAELITGKRAL--IRDDSEPTKMKSLITIMAAV 513
            +  EL TG   L       E T+ +  I ++  +
Sbjct: 281 CMAFELATG-DYLFEPHSGEEYTRDEDHIALIIEL 314

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 43.1 bits (102), Expect = 2e-04
 Identities = 50/237 (21%), Positives = 76/237 (32%), Gaps = 69/237 (29%)

Query: 298 RIIGRGGFGNV---YFGLLGDREAAIKKMRSNKSKEFFA----ELKVLCKI--------H 342
             +G G FG V        G  + A+K +R+     +      E+ VL KI         
Sbjct: 25  GNLGEGTFGKVVECLDHARGKSQVALKIIRNVGK--YREAARLEINVLKKIKEKDKENKF 82

Query: 343 HINVFISTFG--------NGSLSDHLHDPLLK--GHQPLTWTARTQIALDAAKGIEYIHD 392
              +    F            L  +  +  LK    QP        +A      + ++H+
Sbjct: 83  LCVLMSDWFNFHGHMCIAFELLGKNTFE-FLKENNFQPYPLPHVRHMAYQLCHALRFLHE 141

Query: 393 HTKARYVHRDIKTSNILLDDGLRA-------------------KVADFGLVKLEERTNEK 433
           +   +  H D+K  NIL  +                       +VADFG       T + 
Sbjct: 142 N---QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG-----SATFDH 193

Query: 434 EMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
           E   T +  T  Y PPE I             +EL      DV++ G +L E   G 
Sbjct: 194 EHHTTIVA-TRHYRPPEVI-------------LELGWAQPCDVWSIGCILFEYYRGF 236

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 42.7 bits (101), Expect = 2e-04
 Identities = 46/235 (19%), Positives = 77/235 (32%), Gaps = 61/235 (25%)

Query: 298 RIIGRGGFGNVY--FGLLGDREAAIKKMRSNKSKEFFA----ELKVLCKI-------HHI 344
           R +G G FG V     +   +  A+K +R+ K   +      E  +L KI       ++I
Sbjct: 41  RKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKK--YTRSAKIEADILKKIQNDDINNNNI 98

Query: 345 NVFISTFGNGS--------LSDHLHDPLLK--GHQPLTWTARTQIALDAAKGIEYIHDHT 394
             +   F            L   L++ ++    +            ++  K + Y+    
Sbjct: 99  VKYHGKFMYYDHMCLIFEPLGPSLYE-IITRNNYNGFHIEDIKLYCIEILKALNYLRKM- 156

Query: 395 KARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLA----------------- 437
                H D+K  NILLDD    K         + +  +                      
Sbjct: 157 --SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD 214

Query: 438 --TRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
               ++ T  Y  PE I             + L     +D+++FG VLAEL TG 
Sbjct: 215 YHGSIINTRQYRAPEVI-------------LNLGWDVSSDMWSFGCVLAELYTGS 256

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 40.7 bits (96), Expect = 8e-04
 Identities = 47/237 (19%), Positives = 76/237 (32%), Gaps = 69/237 (29%)

Query: 298 RIIGRGGFGNV---YFGLLGDREAAIKKMRSNKSKEFFA----ELKVLCKI--------H 342
             +G G FG V        G R  A+K +++     +      E++VL  +         
Sbjct: 20  DTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDR--YCEAARSEIQVLEHLNTTDPNSTF 77

Query: 343 HINVFISTFGNGS--------LSDHLHDPLLK--GHQPLTWTARTQIALDAAKGIEYIHD 392
                +  F +          L    +D  +K  G  P       ++A    K + ++H 
Sbjct: 78  RCVQMLEWFEHHGHICIVFELLGLSTYD-FIKENGFLPFRLDHIRKMAYQICKSVNFLHS 136

Query: 393 HTKARYVHRDIKTSNILLDDGLRA-------------------KVADFGLVKLEERTNEK 433
           +   +  H D+K  NIL                          KV DFG       T + 
Sbjct: 137 N---KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG-----SATYDD 188

Query: 434 EMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK 490
           E  +T +  T  Y  PE I             + L  +   DV++ G +L E   G 
Sbjct: 189 EHHSTLVS-TRHYRAPEVI-------------LALGWSQPCDVWSIGCILIEYYLGF 231

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	563
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.92
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.9
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.85
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.76
4eby_A	212	Chitin elicitor receptor kinase 1; pathogen-associ	99.72
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.53
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	98.94
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.76
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	98.74
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.72
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.39
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.92
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	97.88
4eby_A	212	Chitin elicitor receptor kinase 1; pathogen-associ	97.8
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	97.79
3ats_A	357	Putative uncharacterized protein; hypothetical pro	97.67
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	97.61
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.52
2djp_A	77	Hypothetical protein SB145; LYSM, structural genom	97.38
1e0g_A	48	Membrane-bound lytic murein transglycosylase D; ce	97.23
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.02
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.01
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	96.88
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	96.85
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	96.85
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.76
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	96.68
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	96.42
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	96.17
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	96.07
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	95.79
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	95.72
2l9y_A	167	CVNH-LYSM lectin; carbohydrate, sugar binding prot	95.7
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	95.12
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	94.75
4a1k_A	165	Putative L, D-transpeptidase YKUD; transferase, pe	94.07
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	93.72
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	93.68
2l9y_A	167	CVNH-LYSM lectin; carbohydrate, sugar binding prot	93.45
2l2t_A	44	Receptor tyrosine-protein kinase ERBB-4; transmemb	93.43
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	93.23
3mes_A	424	Choline kinase; malaria, structural genomics, stru	92.8
2jwa_A	44	Receptor tyrosine-protein kinase ERBB-2; transmemb	88.21
2gu1_A	361	Zinc peptidase; alpha/beta, beta barrel, structura	87.07
1e0g_A	48	Membrane-bound lytic murein transglycosylase D; ce	84.96
2knc_A	54	Integrin alpha-IIB; transmembrane signaling, prote	83.5
2djp_A	77	Hypothetical protein SB145; LYSM, structural genom	83.34
2k9y_A	41	Ephrin type-A receptor 2; receptor tyrosine kinase	81.96
2l8s_A	54	Integrin alpha-1; transmembrane region, detergent	81.86
2gu1_A	361	Zinc peptidase; alpha/beta, beta barrel, structura	80.9

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=2.7e-51  Score=415.94  Aligned_cols=232  Identities=27%  Similarity=0.454  Sum_probs=189.5

Q ss_pred             hcCCCccceecccCcEEEEEEEECCceEEEEEeccCC-----hHHHHHHHHHHHhccccce--------------EEEee
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLLGDREAAIKKMRSNK-----SKEFFAELKVLCKIHHINV--------------FISTF  351 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~vavK~~~~~~-----~~~f~~Ei~~l~~l~H~ni--------------V~e~~  351 (563)
                      .+++...++||+|+||.||+|++++ .||||.++...     .++|.+|+++|++++||||              |+||+
T Consensus        35 ~~~l~l~~~iG~G~fG~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~iVmEy~  113 (307)
T 3omv_A           35 ASEVMLSTRIGSGSFGTVYKGKWHG-DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWC  113 (307)
T ss_dssp             TTSCCEEEECCCCSSSEEEEEESSS-EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEEECC
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECC-cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEECCeEEEEEEcC
Confidence            4567788999999999999999865 59999987432     3679999999999999997              68999


Q ss_pred             cCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccccccc
Q 044997          352 GNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTN  431 (563)
Q Consensus       352 ~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~  431 (563)
                      ++|+|.++|+.    ....++|.+++.|+.|||+||+|||+++   ||||||||+||||++++.+||+|||+|+......
T Consensus       114 ~gGsL~~~l~~----~~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~  186 (307)
T 3omv_A          114 EGSSLYKHLHV----QETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWS  186 (307)
T ss_dssp             SSCBHHHHHHT----SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC-----
T ss_pred             CCCCHHHHHhh----cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCC
Confidence            99999999975    2457999999999999999999999987   9999999999999999999999999998754332


Q ss_pred             ccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc-----------
Q 044997          432 EKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP-----------  500 (563)
Q Consensus       432 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~-----------  500 (563)
                      .. ......+||+.|||||++.+..          .+.++.++|||||||+||||+||+.||.......           
T Consensus       187 ~~-~~~~~~~GT~~ymAPE~l~~~~----------~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~  255 (307)
T 3omv_A          187 GS-QQVEQPTGSVLWMAPEVIRMQD----------NNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYA  255 (307)
T ss_dssp             --------CCCCTTSCCHHHHHCCS----------SCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCC
T ss_pred             cc-eeecccccCCCccCHHHhhccC----------CCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCC
Confidence            21 2234568999999999985432          2356899999999999999999999996543211           


Q ss_pred             -----hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 044997          501 -----TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMIT  541 (563)
Q Consensus       501 -----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~  541 (563)
                           .....+++.+.+|+.+||+.||++||||.||++.|+.+..+
T Consensus       256 ~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~  301 (307)
T 3omv_A          256 SPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHS  301 (307)
T ss_dssp             CCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTT
T ss_pred             CCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcc
Confidence                 11234556799999999999999999999999999877543

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=3.7e-51  Score=420.00  Aligned_cols=237  Identities=25%  Similarity=0.424  Sum_probs=188.6

Q ss_pred             cCCCccceecccCcEEEEEEEEC-------CceEEEEEeccCC---hHHHHHHHHHHHhccccce---------------
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG-------DREAAIKKMRSNK---SKEFFAELKVLCKIHHINV---------------  346 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~-------~~~vavK~~~~~~---~~~f~~Ei~~l~~l~H~ni---------------  346 (563)
                      ++|...++||+|+||.||+|++.       ++.||||+++...   .++|.+|+++|++++||||               
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l  120 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM  120 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            45677899999999999999874       5679999997643   3679999999999999998               


Q ss_pred             EEEeecCCCcccccccccc----------cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcE
Q 044997          347 FISTFGNGSLSDHLHDPLL----------KGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRA  416 (563)
Q Consensus       347 V~e~~~~gsL~~~L~~~~~----------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~  416 (563)
                      |+||+++|+|.++|+....          ....+++|.+++.|+.|||+||+|||+++   ||||||||+||||++++.+
T Consensus       121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~  197 (329)
T 4aoj_A          121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV  197 (329)
T ss_dssp             EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence            6899999999999975321          12357999999999999999999999987   9999999999999999999


Q ss_pred             EEeecCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCCCcC
Q 044997          417 KVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIR  495 (563)
Q Consensus       417 kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p~~~  495 (563)
                      ||+|||+|+....... ....+...||+.|||||++.+..|             +.++|||||||+||||+| |+.||..
T Consensus       198 Ki~DFGla~~~~~~~~-~~~~~~~~gt~~ymAPE~~~~~~~-------------~~~sDvwS~Gvvl~Ellt~G~~Pf~~  263 (329)
T 4aoj_A          198 KIGDFGMSRDIYSTDY-YRVGGRTMLPIRWMPPESILYRKF-------------TTESDVWSFGVVLWEIFTYGKQPWYQ  263 (329)
T ss_dssp             EECCCC-----------------CCCCGGGCCHHHHTTCCC-------------CHHHHHHHHHHHHHHHHTTSCCTTCS
T ss_pred             EEcccccceeccCCCc-ceecCcccccccccChhhhcCCCC-------------CccccccchHHHHHHHHcCCCCCCCC
Confidence            9999999986544322 122345679999999999866554             899999999999999999 8999865


Q ss_pred             CCC-----------CchhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcChhh
Q 044997          496 DDS-----------EPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITSTEW  545 (563)
Q Consensus       496 ~~~-----------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~w  545 (563)
                      ...           ....+..+++.+.+|+.+||+.||++||||+||++.|+.+.+..+.+
T Consensus       264 ~~~~~~~~~i~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~pp~~  324 (329)
T 4aoj_A          264 LSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVY  324 (329)
T ss_dssp             SCHHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHSCC--
T ss_pred             CCHHHHHHHHHcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhCCccc
Confidence            432           11223345667999999999999999999999999999998876544

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1.6e-51  Score=417.15  Aligned_cols=236  Identities=25%  Similarity=0.406  Sum_probs=194.0

Q ss_pred             cCCCccceecccCcEEEEEEEEC-------CceEEEEEeccCC---hHHHHHHHHHHHhccccce---------------
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG-------DREAAIKKMRSNK---SKEFFAELKVLCKIHHINV---------------  346 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~-------~~~vavK~~~~~~---~~~f~~Ei~~l~~l~H~ni---------------  346 (563)
                      ++|...+.||+|+||.||+|++.       +..||||+++...   .++|.+|+++|++++||||               
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l   92 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   92 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            46778899999999999999873       5679999997643   3679999999999999998               


Q ss_pred             EEEeecCCCccccccccc--------ccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEE
Q 044997          347 FISTFGNGSLSDHLHDPL--------LKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKV  418 (563)
Q Consensus       347 V~e~~~~gsL~~~L~~~~--------~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl  418 (563)
                      |+||+++|+|.++|+...        ......++|.++++|+.|+|+||+|||+++   ||||||||+|||+++++.+||
T Consensus        93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki  169 (299)
T 4asz_A           93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI  169 (299)
T ss_dssp             EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence            689999999999997521        122457999999999999999999999987   999999999999999999999


Q ss_pred             eecCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCCCcCCC
Q 044997          419 ADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIRDD  497 (563)
Q Consensus       419 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p~~~~~  497 (563)
                      +|||+|+........ .......||+.|||||++.+..|             +.++|||||||+||||+| |+.||....
T Consensus       170 ~DFGla~~~~~~~~~-~~~~~~~gt~~ymAPE~~~~~~~-------------~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~  235 (299)
T 4asz_A          170 GDFGMSRDVYSTDYY-RVGGHTMLPIRWMPPESIMYRKF-------------TTESDVWSLGVVLWEIFTYGKQPWYQLS  235 (299)
T ss_dssp             CCCSCHHHHTGGGCE-EETTTEEECGGGCCHHHHHHCCC-------------CHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred             CCcccceecCCCCce-eecCceecChhhcCHHHHcCCCC-------------CchhhHHHHHHHHHHHHcCCCCCCCCCC
Confidence            999999865433221 12233569999999999865554             899999999999999999 899996543


Q ss_pred             CC-----------chhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcChh
Q 044997          498 SE-----------PTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITSTE  544 (563)
Q Consensus       498 ~~-----------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~  544 (563)
                      ..           ...+..+++.+.+|+.+||+.||++||||+||++.|+++.+.++.
T Consensus       236 ~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~p~  293 (299)
T 4asz_A          236 NNEVIECITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKASPV  293 (299)
T ss_dssp             HHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCC
T ss_pred             HHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCCc
Confidence            21           122334566799999999999999999999999999999876553

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=5.5e-51  Score=414.92  Aligned_cols=229  Identities=25%  Similarity=0.353  Sum_probs=189.4

Q ss_pred             CCCccceecccCcEEEEEEEEC-------CceEEEEEeccC----ChHHHHHHHHHHHhccccce---------------
Q 044997          293 NFDESRIIGRGGFGNVYFGLLG-------DREAAIKKMRSN----KSKEFFAELKVLCKIHHINV---------------  346 (563)
Q Consensus       293 ~f~~~~~LG~G~fG~Vy~g~~~-------~~~vavK~~~~~----~~~~f~~Ei~~l~~l~H~ni---------------  346 (563)
                      +++..++||+|+||.||+|++.       ++.||||+++..    ..++|.+|+.+|++++||||               
T Consensus        27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l  106 (308)
T 4gt4_A           27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM  106 (308)
T ss_dssp             GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence            3556789999999999999873       467999999754    24789999999999999998               


Q ss_pred             EEEeecCCCccccccccccc-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCc
Q 044997          347 FISTFGNGSLSDHLHDPLLK-----------GHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLR  415 (563)
Q Consensus       347 V~e~~~~gsL~~~L~~~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~  415 (563)
                      |+||+++|+|.++|+.....           ....++|.++++|+.|||+||+|||+++   ||||||||+||||+++++
T Consensus       107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~~  183 (308)
T 4gt4_A          107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLN  183 (308)
T ss_dssp             EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGC
T ss_pred             EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCCC
Confidence            68999999999999653211           1246999999999999999999999987   999999999999999999


Q ss_pred             EEEeecCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCCCc
Q 044997          416 AKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALI  494 (563)
Q Consensus       416 ~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p~~  494 (563)
                      +||+|||+|+.....+. ....+...||++|||||++.++.             ++.++|||||||+||||+| |+.||.
T Consensus       184 ~Ki~DFGlar~~~~~~~-~~~~~~~~gt~~ymAPE~l~~~~-------------~s~ksDVwSfGvvl~El~t~g~~Pf~  249 (308)
T 4gt4_A          184 VKISDLGLFREVYAADY-YKLLGNSLLPIRWMAPEAIMYGK-------------FSIDSDIWSYGVVLWEVFSYGLQPYC  249 (308)
T ss_dssp             EEECCSCCBCGGGGGGC-BCSSSSSCBCGGGCCHHHHHHCC-------------CCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred             EEECCcccceeccCCCc-eeEecccccCCcccCHHHHhCCC-------------CCccchhhhHHHHHHHHHhCCCCCCC
Confidence            99999999987654322 22334567999999999986554             4899999999999999999 889986


Q ss_pred             CCCC-----------CchhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 044997          495 RDDS-----------EPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQI  538 (563)
Q Consensus       495 ~~~~-----------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  538 (563)
                      +...           ....+..+++.+.+|+.+||+.||++||||.||++.|+.+
T Consensus       250 ~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~  304 (308)
T 4gt4_A          250 GYSNQDVVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW  304 (308)
T ss_dssp             TCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             CCCHHHHHHHHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            5432           1122334566799999999999999999999999999854

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1.3e-49  Score=404.72  Aligned_cols=237  Identities=24%  Similarity=0.362  Sum_probs=186.8

Q ss_pred             cCCCccceecccCcEEEEEEEECCceEEEEEeccCChHHHHHHH--HHHHhccccce-------------------EEEe
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLGDREAAIKKMRSNKSKEFFAEL--KVLCKIHHINV-------------------FIST  350 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~~~~vavK~~~~~~~~~f~~Ei--~~l~~l~H~ni-------------------V~e~  350 (563)
                      ++|...++||+|+||.||+|+++|+.||||+++....+++.+|.  ..+.+++||||                   |+||
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey   82 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDY   82 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEEC
T ss_pred             cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecC
Confidence            45677899999999999999999999999999877766665554  45568899997                   5799


Q ss_pred             ecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCceEeCCCCCCCeEecCCCcEEEeecCCCc
Q 044997          351 FGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDH-----TKARYVHRDIKTSNILLDDGLRAKVADFGLVK  425 (563)
Q Consensus       351 ~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-----~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~  425 (563)
                      +++|+|.++|+.      ..++|..+.+++.|+++||+|||++     ..++||||||||+|||||+++++||+|||+|+
T Consensus        83 ~~~gsL~~~l~~------~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~  156 (303)
T 3hmm_A           83 HEHGSLFDYLNR------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  156 (303)
T ss_dssp             CTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             CCCCcHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence            999999999975      4599999999999999999999986     23459999999999999999999999999998


Q ss_pred             cccccccc-ccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCC-----
Q 044997          426 LEERTNEK-EMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE-----  499 (563)
Q Consensus       426 ~~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~-----  499 (563)
                      ........ .......+||+.|||||++.+...       .....+++++|||||||+||||+||+.|+......     
T Consensus       157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~-------~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~  229 (303)
T 3hmm_A          157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSIN-------MKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY  229 (303)
T ss_dssp             EEETTTTEESCC-----CCGGGCCHHHHTTCSC-------TTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTT
T ss_pred             cccCCCCceeeecccccccccccCHHHhccccc-------ccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccch
Confidence            76543322 112234679999999999865421       11223578999999999999999998765322110     


Q ss_pred             -------------------------chh--hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 044997          500 -------------------------PTK--MKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMIT  541 (563)
Q Consensus       500 -------------------------~~~--~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~  541 (563)
                                               +..  .....+.+.+|+.+||+.||++||||.||++.|+++.+.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~  298 (303)
T 3hmm_A          230 DLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  298 (303)
T ss_dssp             TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             hcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence                                     000  113445689999999999999999999999999998753

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1.2e-49  Score=412.29  Aligned_cols=246  Identities=24%  Similarity=0.368  Sum_probs=202.9

Q ss_pred             ccCHHHHHHHhcCCCccceecccCcEEEEEEEECC-------ceEEEEEeccCC----hHHHHHHHHHHHhccc-cce--
Q 044997          281 IFSLEEIEEATNNFDESRIIGRGGFGNVYFGLLGD-------REAAIKKMRSNK----SKEFFAELKVLCKIHH-INV--  346 (563)
Q Consensus       281 ~~~~~el~~~~~~f~~~~~LG~G~fG~Vy~g~~~~-------~~vavK~~~~~~----~~~f~~Ei~~l~~l~H-~ni--  346 (563)
                      .+...+|+...++|+..+.||+|+||.||+|++.+       +.||||+++...    .++|.+|+++|.+++| |||  
T Consensus        53 p~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~  132 (353)
T 4ase_A           53 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN  132 (353)
T ss_dssp             CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             CCCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEE
Confidence            35566777778899999999999999999998743       469999997643    3569999999999965 887  


Q ss_pred             --------------EEEeecCCCcccccccccc-----------cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeC
Q 044997          347 --------------FISTFGNGSLSDHLHDPLL-----------KGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHR  401 (563)
Q Consensus       347 --------------V~e~~~~gsL~~~L~~~~~-----------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHr  401 (563)
                                    |+||+++|+|.++|+....           .....++|.+++.++.|||+||+|||+++   ||||
T Consensus       133 l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHR  209 (353)
T 4ase_A          133 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHR  209 (353)
T ss_dssp             EEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred             EEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecC
Confidence                          5899999999999975321           11346999999999999999999999997   9999


Q ss_pred             CCCCCCeEecCCCcEEEeecCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHH
Q 044997          402 DIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGV  481 (563)
Q Consensus       402 DLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGv  481 (563)
                      ||||+|||+++++.+||+|||+|+........ ...+...||+.|||||++.+..|             +.++|||||||
T Consensus       210 DLK~~NILl~~~~~vKi~DFGlar~~~~~~~~-~~~~~~~gt~~ymAPE~l~~~~y-------------~~ksDVwS~Gv  275 (353)
T 4ase_A          210 DLAARNILLSEKNVVKICDFGLARDIYKDPDY-VRKGDARLPLKWMAPETIFDRVY-------------TIQSDVWSFGV  275 (353)
T ss_dssp             CCSGGGEEECGGGCEEECCCGGGSCTTTCTTS-EEETTEEECGGGCCHHHHHHCCC-------------CHHHHHHHHHH
T ss_pred             ccCccceeeCCCCCEEECcchhhhhcccCCCc-eeeccccccccccCHHHHhcCCC-------------CCcccEeehHH
Confidence            99999999999999999999999876543221 22344679999999999866554             89999999999


Q ss_pred             HHHHHHc-CCCCCcCCCCCch------------hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcCh
Q 044997          482 VLAELIT-GKRALIRDDSEPT------------KMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITST  543 (563)
Q Consensus       482 vl~Ellt-g~~p~~~~~~~~~------------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~  543 (563)
                      +||||+| |+.||.+......            .+..+++.+.+++.+||+.||++||||.||++.|+++++.+.
T Consensus       276 ~l~El~t~G~~Pf~~~~~~~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~~  350 (353)
T 4ase_A          276 LLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA  350 (353)
T ss_dssp             HHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred             HHHHHHhCCCCCCCCCCHHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHhh
Confidence            9999998 8999976443221            122345669999999999999999999999999999987654

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=9.7e-49  Score=403.06  Aligned_cols=220  Identities=25%  Similarity=0.378  Sum_probs=181.8

Q ss_pred             cCCCccceecccCcEEEEEEEEC--CceEEEEEeccCC-----hHHHHHHHHHHHhccccce---------------EEE
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNK-----SKEFFAELKVLCKIHHINV---------------FIS  349 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~-----~~~f~~Ei~~l~~l~H~ni---------------V~e  349 (563)
                      ++|+..+.||+|+||.||+|+..  ++.||||+++...     .+.|.+|+++|++++||||               |||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE  103 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD  103 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence            57999999999999999999874  7899999996542     3578999999999999998               689


Q ss_pred             eecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccccc
Q 044997          350 TFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEER  429 (563)
Q Consensus       350 ~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~  429 (563)
                      |+++|+|.++|..   .+...+++.+++.|+.||+.||+|||+++   ||||||||+||||++++++||+|||+|+....
T Consensus       104 y~~gg~L~~~i~~---~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~  177 (350)
T 4b9d_A          104 YCEGGDLFKRINA---QKGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS  177 (350)
T ss_dssp             CCTTCBHHHHHHH---TTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCH
T ss_pred             CCCCCcHHHHHHH---cCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecC
Confidence            9999999999975   23456899999999999999999999998   99999999999999999999999999987543


Q ss_pred             ccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc---------
Q 044997          430 TNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP---------  500 (563)
Q Consensus       430 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~---------  500 (563)
                      ..   ...+..+||+.|||||++.+..|             +.++|||||||+||||++|+.||.......         
T Consensus       178 ~~---~~~~~~~GT~~YmAPE~l~~~~y-------------~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~  241 (350)
T 4b9d_A          178 TV---ELARACIGTPYYLSPEICENKPY-------------NNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGS  241 (350)
T ss_dssp             HH---HHHHHHHSCCTTCCHHHHTTCCC-------------CHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC
T ss_pred             Cc---ccccccCCCccccCHHHHCCCCC-------------CcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCC
Confidence            22   12344679999999999876554             889999999999999999999997653211         


Q ss_pred             --hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          501 --TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       501 --~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                        .....+++.+.+|+.+||+.||++|||+.|+++
T Consensus       242 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          242 FPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence              112244567999999999999999999999986

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.3e-48  Score=400.35  Aligned_cols=228  Identities=21%  Similarity=0.269  Sum_probs=189.0

Q ss_pred             cCCCccceecccCcEEEEEEEEC--CceEEEEEeccCChHHHHHHHHHHHhccccce---------------EEEeecCC
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNKSKEFFAELKVLCKIHHINV---------------FISTFGNG  354 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~f~~Ei~~l~~l~H~ni---------------V~e~~~~g  354 (563)
                      +.|...++||+|+||.||+|+..  ++.||||+++.+..  +.+|+++|++++||||               ||||+++|
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~--~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg  135 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF--RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGG  135 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTC
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh--HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCC
Confidence            45778899999999999999974  78999999976533  2479999999999998               68999999


Q ss_pred             CcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCC-cEEEeecCCCccccccccc
Q 044997          355 SLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGL-RAKVADFGLVKLEERTNEK  433 (563)
Q Consensus       355 sL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~-~~kl~DFGla~~~~~~~~~  433 (563)
                      +|.++|..     ...+++.++..++.||+.||+|||+++   ||||||||+||||+.++ ++||+|||+|+........
T Consensus       136 ~L~~~l~~-----~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~  207 (336)
T 4g3f_A          136 SLGQLIKQ-----MGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG  207 (336)
T ss_dssp             BHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC------
T ss_pred             cHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcc
Confidence            99999975     356999999999999999999999997   99999999999999987 6999999999976543322


Q ss_pred             cc--ccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc-----------
Q 044997          434 EM--LATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP-----------  500 (563)
Q Consensus       434 ~~--~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~-----------  500 (563)
                      ..  .....+||+.|||||++.+..|             +.++|||||||++|||++|+.||.......           
T Consensus       208 ~~~~~~~~~~GT~~YmAPE~~~~~~y-------------~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~  274 (336)
T 4g3f_A          208 KSLLTGDYIPGTETHMAPEVVMGKPC-------------DAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPP  274 (336)
T ss_dssp             ------CCCCCCGGGCCHHHHTTCCC-------------CTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCG
T ss_pred             cceecCCccccCccccCHHHHCCCCC-------------CcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCC
Confidence            11  1233679999999999876554             889999999999999999999997654321           


Q ss_pred             --hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcC
Q 044997          501 --TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITS  542 (563)
Q Consensus       501 --~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~  542 (563)
                        .....+++.+.+++.+||+.||.+|||+.|+++.|.+++...
T Consensus       275 ~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~  318 (336)
T 4g3f_A          275 IREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEV  318 (336)
T ss_dssp             GGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             chhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhh
Confidence              112345677999999999999999999999999998887643

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=7.9e-48  Score=387.66  Aligned_cols=214  Identities=25%  Similarity=0.436  Sum_probs=178.5

Q ss_pred             CccceecccCcEEEEEEEEC--CceEEEEEeccCC-----hHHHHHHHHHHHhccccce-------------------EE
Q 044997          295 DESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNK-----SKEFFAELKVLCKIHHINV-------------------FI  348 (563)
Q Consensus       295 ~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~-----~~~f~~Ei~~l~~l~H~ni-------------------V~  348 (563)
                      +..++||+|+||.||+|+..  +..||+|++....     .+.|.+|+++|++++||||                   ||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            45678999999999999985  6789999986432     3569999999999999997                   46


Q ss_pred             EeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecC-CCcEEEeecCCCccc
Q 044997          349 STFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDD-GLRAKVADFGLVKLE  427 (563)
Q Consensus       349 e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~-~~~~kl~DFGla~~~  427 (563)
                      ||+++|+|.++|..     ...+++..+..++.||+.||+|||+++ ++||||||||+||||++ ++.+||+|||+|+..
T Consensus       109 Ey~~gg~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~  182 (290)
T 3fpq_A          109 ELMTSGTLKTYLKR-----FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK  182 (290)
T ss_dssp             ECCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred             eCCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeC
Confidence            99999999999975     357999999999999999999999985 45999999999999985 799999999999853


Q ss_pred             ccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc-------
Q 044997          428 ERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP-------  500 (563)
Q Consensus       428 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~-------  500 (563)
                      ...     .....+||+.|||||++.+              .++.++|||||||++|||+||+.||.......       
T Consensus       183 ~~~-----~~~~~~GTp~YmAPE~~~~--------------~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~  243 (290)
T 3fpq_A          183 RAS-----FAKAVIGTPEFMAPEMYEE--------------KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVT  243 (290)
T ss_dssp             CTT-----SBEESCSSCCCCCGGGGGT--------------CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHT
T ss_pred             CCC-----ccCCcccCccccCHHHcCC--------------CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHH
Confidence            321     2345689999999998732              35899999999999999999999996543211       


Q ss_pred             ------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          501 ------TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       501 ------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                            ......++.+.+|+.+||+.||++|||+.|+++
T Consensus       244 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          244 SGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             TTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cCCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                  112233456899999999999999999999876

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=6.3e-48  Score=396.39  Aligned_cols=217  Identities=22%  Similarity=0.409  Sum_probs=186.3

Q ss_pred             cCCCccceecccCcEEEEEEEEC--CceEEEEEeccC---ChHHHHHHHHHHHhccccce---------------EEEee
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSN---KSKEFFAELKVLCKIHHINV---------------FISTF  351 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~---~~~~f~~Ei~~l~~l~H~ni---------------V~e~~  351 (563)
                      +.|+..++||+|+||.||+|+..  ++.||||+++..   ..+.+.+|+++|++++||||               ||||+
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  153 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  153 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            46888999999999999999984  789999998643   34668899999999999998               68999


Q ss_pred             cCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccccccc
Q 044997          352 GNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTN  431 (563)
Q Consensus       352 ~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~  431 (563)
                      ++|+|.+++..      ..+++.++..++.||+.||+|||+++   ||||||||+||||++++++||+|||+|+......
T Consensus       154 ~gg~L~~~l~~------~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~  224 (346)
T 4fih_A          154 EGGALTDIVTH------TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV  224 (346)
T ss_dssp             TTEEHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSS
T ss_pred             CCCcHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCC
Confidence            99999998864      35999999999999999999999998   9999999999999999999999999998654332


Q ss_pred             ccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCC------------
Q 044997          432 EKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE------------  499 (563)
Q Consensus       432 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~------------  499 (563)
                      .   ..+..+||+.|||||++.+..|             +.++|||||||++|||++|+.||......            
T Consensus       225 ~---~~~~~~GTp~YmAPEvl~~~~y-------------~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~  288 (346)
T 4fih_A          225 P---RRKSLVGTPYWMAPELISRLPY-------------GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPP  288 (346)
T ss_dssp             C---CBCCCCSCGGGCCHHHHTTCCB-------------CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCC
T ss_pred             C---cccccccCcCcCCHHHHCCCCC-------------CcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCC
Confidence            1   2345789999999999866554             89999999999999999999999764321            


Q ss_pred             -chhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          500 -PTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       500 -~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                       ......+++.+.+|+.+||+.||++|||+.|+++
T Consensus       289 ~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~  323 (346)
T 4fih_A          289 RLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  323 (346)
T ss_dssp             CCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence             1122345677999999999999999999999876

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=4.5e-48  Score=391.77  Aligned_cols=234  Identities=24%  Similarity=0.381  Sum_probs=193.7

Q ss_pred             cCCCccceecccCcEEEEEEEE--CCceEEEEEeccC------ChHHHHHHHHHHHhccccce---------------EE
Q 044997          292 NNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSN------KSKEFFAELKVLCKIHHINV---------------FI  348 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~------~~~~f~~Ei~~l~~l~H~ni---------------V~  348 (563)
                      ++|+..+.||+|+||.||+|+.  +++.||||.+++.      ..+.+.+|+++|++++||||               ||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            4699999999999999999987  4789999998642      34679999999999999998               68


Q ss_pred             EeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccc
Q 044997          349 STFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEE  428 (563)
Q Consensus       349 e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~  428 (563)
                      ||+++|+|.+++..     ...+++.++..++.||+.||+|||+++   |+||||||+|||+++++.+||+|||+|+...
T Consensus       112 Ey~~gG~L~~~i~~-----~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~  183 (311)
T 4aw0_A          112 SYAKNGELLKYIRK-----IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLS  183 (311)
T ss_dssp             CCCTTEEHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             ecCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecC
Confidence            99999999999975     356999999999999999999999998   9999999999999999999999999999765


Q ss_pred             cccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc--------
Q 044997          429 RTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP--------  500 (563)
Q Consensus       429 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~--------  500 (563)
                      .... .......+||+.|||||++.+..|             +.++||||+||++|||++|+.||...+...        
T Consensus       184 ~~~~-~~~~~~~~GTp~YmAPEvl~~~~y-------------~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~  249 (311)
T 4aw0_A          184 PESK-QARANSFVGTAQYVSPELLTEKSA-------------CKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKL  249 (311)
T ss_dssp             TTTT-CCCBCCCCSCGGGCCHHHHHHSCB-------------CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT
T ss_pred             CCCC-cccccCcccCcccCCHHHHcCCCC-------------CcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC
Confidence            3322 223345789999999999976655             789999999999999999999997643211        


Q ss_pred             --hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH---HHHhhhcChhhhc
Q 044997          501 --TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI---LSQIMITSTEWEA  547 (563)
Q Consensus       501 --~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~---L~~i~~~~~~w~~  547 (563)
                        ..+..+++.+.+|+.+||+.||++|||++|++..   ++.-.-...+|+.
T Consensus       250 ~~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~  301 (311)
T 4aw0_A          250 EYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWEN  301 (311)
T ss_dssp             CCCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTT
T ss_pred             CCCCCcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHH
Confidence              1123345678999999999999999999987532   3333334567765

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=2.6e-47  Score=380.70  Aligned_cols=217  Identities=25%  Similarity=0.398  Sum_probs=172.5

Q ss_pred             cCCCccceecccCcEEEEEEEE--CCceEEEEEeccC------ChHHHHHHHHHHHhccccce---------------EE
Q 044997          292 NNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSN------KSKEFFAELKVLCKIHHINV---------------FI  348 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~------~~~~f~~Ei~~l~~l~H~ni---------------V~  348 (563)
                      ++|+..+.||+|+||.||+|+.  +++.||||.++..      ..+.+.+|+++|++++||||               ||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            5899999999999999999987  4789999998643      23578999999999999998               57


Q ss_pred             EeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccc
Q 044997          349 STFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEE  428 (563)
Q Consensus       349 e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~  428 (563)
                      ||+ +|+|.+++..     ...+++.++..++.|++.||+|||+++   |+||||||+|||+++++++||+|||+|+...
T Consensus        93 Ey~-~g~L~~~l~~-----~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~  163 (275)
T 3hyh_A           93 EYA-GNELFDYIVQ-----RDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMT  163 (275)
T ss_dssp             ECC-CEEHHHHHHH-----SCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC----
T ss_pred             eCC-CCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecC
Confidence            988 6899998864     357999999999999999999999998   9999999999999999999999999998654


Q ss_pred             cccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc--------
Q 044997          429 RTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP--------  500 (563)
Q Consensus       429 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~--------  500 (563)
                      ...    .....+||+.|||||++.+..|            .+.++||||+||++|||++|+.||.......        
T Consensus       164 ~~~----~~~~~~GT~~Y~APE~~~~~~y------------~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~  227 (275)
T 3hyh_A          164 DGN----FLKTSCGSPNYAAPEVISGKLY------------AGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNG  227 (275)
T ss_dssp             ---------------CTTSCHHHHSSSSC------------CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT
T ss_pred             CCC----ccCCeeECcccCChhhhcCCCC------------CCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC
Confidence            322    2334689999999999976654            2689999999999999999999997543211        


Q ss_pred             --hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          501 --TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       501 --~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                        ..+..+++.+.+|+.+||+.||++|||++|+++
T Consensus       228 ~~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~  262 (275)
T 3hyh_A          228 VYTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ  262 (275)
T ss_dssp             CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             CCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence              112234566899999999999999999999987

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=7.3e-47  Score=397.85  Aligned_cols=218  Identities=22%  Similarity=0.409  Sum_probs=186.7

Q ss_pred             hcCCCccceecccCcEEEEEEEEC--CceEEEEEeccC---ChHHHHHHHHHHHhccccce---------------EEEe
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSN---KSKEFFAELKVLCKIHHINV---------------FIST  350 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~---~~~~f~~Ei~~l~~l~H~ni---------------V~e~  350 (563)
                      .+.|+..+.||+|+||.||+|+..  ++.||||+++..   ..+.+.+|+++|++++||||               ||||
T Consensus       150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy  229 (423)
T 4fie_A          150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF  229 (423)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence            356899999999999999999984  789999999643   34678999999999999998               6899


Q ss_pred             ecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccccc
Q 044997          351 FGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERT  430 (563)
Q Consensus       351 ~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~  430 (563)
                      +++|+|.+++..      ..+++.++..++.||+.||+|||+++   ||||||||+||||+.++.+||+|||+|+.....
T Consensus       230 ~~gG~L~~~i~~------~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~  300 (423)
T 4fie_A          230 LEGGALTDIVTH------TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE  300 (423)
T ss_dssp             CTTEEHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSS
T ss_pred             CCCCcHHHHHhc------cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCC
Confidence            999999998864      35899999999999999999999998   999999999999999999999999999865433


Q ss_pred             cccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc----------
Q 044997          431 NEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP----------  500 (563)
Q Consensus       431 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~----------  500 (563)
                      ..   ..+..+||+.|||||++.+..|             +.++|||||||++|||++|+.||.......          
T Consensus       301 ~~---~~~~~~GTp~YmAPEvl~~~~y-------------~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~  364 (423)
T 4fie_A          301 VP---RRKSLVGTPYWMAPELISRLPY-------------GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP  364 (423)
T ss_dssp             CC---CBCCCEECTTTCCHHHHTTCCB-------------CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC
T ss_pred             Cc---cccccccCcCcCCHHHHCCCCC-------------CcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC
Confidence            21   2345789999999999876555             899999999999999999999997543211          


Q ss_pred             ---hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          501 ---TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       501 ---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                         .....+.+.+.+|+.+||+.||++|||+.|+++
T Consensus       365 ~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~  400 (423)
T 4fie_A          365 PRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  400 (423)
T ss_dssp             CCCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence               112244567899999999999999999999876

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1.6e-47  Score=387.45  Aligned_cols=232  Identities=22%  Similarity=0.351  Sum_probs=181.2

Q ss_pred             cCCCccceecccCcEEEEEEEE-----CCceEEEEEeccC-----ChHHHHHHHHHHHhccccce---------------
Q 044997          292 NNFDESRIIGRGGFGNVYFGLL-----GDREAAIKKMRSN-----KSKEFFAELKVLCKIHHINV---------------  346 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~-----~~~~vavK~~~~~-----~~~~f~~Ei~~l~~l~H~ni---------------  346 (563)
                      ++|+..+.||+|+||.||+|+.     .++.||||.++..     ...++.+|+++|++++||||               
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            4689999999999999999976     2567999998643     23568899999999999998               


Q ss_pred             EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcc
Q 044997          347 FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKL  426 (563)
Q Consensus       347 V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~  426 (563)
                      ||||+++|+|.+++..     ...+++.++..++.|++.||+|||+++   |+||||||+|||+++++++||+|||+|+.
T Consensus       104 vmEy~~gg~L~~~l~~-----~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~  175 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSK-----EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKE  175 (304)
T ss_dssp             EECCCTTCEEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC
T ss_pred             EEEcCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEeccccccee
Confidence            5899999999999975     356999999999999999999999998   99999999999999999999999999986


Q ss_pred             cccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc------
Q 044997          427 EERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP------  500 (563)
Q Consensus       427 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~------  500 (563)
                      .....   ......+||+.|||||++.+..|             +.++||||+||++|||++|+.||...+...      
T Consensus       176 ~~~~~---~~~~~~~GT~~YmAPE~~~~~~y-------------~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~  239 (304)
T 3ubd_A          176 SIDHE---KKAYSFCGTVEYMAPEVVNRRGH-------------TQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMIL  239 (304)
T ss_dssp             --------CCCCSCCCCGGGCCHHHHHTSCC-------------CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             ccCCC---ccccccccCcccCCHHHhccCCC-------------CCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHH
Confidence            43322   12345689999999999866554             889999999999999999999997644211      


Q ss_pred             ----hhhHHHHHHHHHHHHHhhccCCCCCCCHHH--HHHHHHHhhhcChhhhc
Q 044997          501 ----TKMKSLITIMAAVAEWCLNEDAVDRPEMRD--IVAILSQIMITSTEWEA  547 (563)
Q Consensus       501 ----~~~~~~~~~l~~li~~cl~~dP~~RPs~~e--vl~~L~~i~~~~~~w~~  547 (563)
                          ..+..+++.+.+|+.+||+.||++|||+..  +-+.|+.-.-...+|+.
T Consensus       240 ~~~~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw~~  292 (304)
T 3ubd_A          240 KAKLGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNK  292 (304)
T ss_dssp             HCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCCHHH
T ss_pred             cCCCCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCCHHH
Confidence                112345567999999999999999998531  22233333334457765

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=9.4e-46  Score=375.13  Aligned_cols=221  Identities=28%  Similarity=0.446  Sum_probs=169.2

Q ss_pred             cCCCccceecccCcEEEEEEEEC--CceEEEEEeccCC----hHHHHHHHHHHHhccccce-------------------
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNK----SKEFFAELKVLCKIHHINV-------------------  346 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~----~~~f~~Ei~~l~~l~H~ni-------------------  346 (563)
                      ++|+..+.||+|+||.||+|+..  ++.||||+++...    .+.+.+|+++|++++||||                   
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            46889999999999999999874  7899999986432    3568999999999999997                   


Q ss_pred             --------EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEE
Q 044997          347 --------FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKV  418 (563)
Q Consensus       347 --------V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl  418 (563)
                              ||||+.+|+|.+++....  .....++..++.++.|+++||+|||+++   |+||||||+|||++.++.+||
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~--~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl  159 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRC--TIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKV  159 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCC--SGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEE
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcC--CCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEE
Confidence                    368899999999997531  1234567788999999999999999998   999999999999999999999


Q ss_pred             eecCCCcccccccccc---------cccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcC
Q 044997          419 ADFGLVKLEERTNEKE---------MLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG  489 (563)
Q Consensus       419 ~DFGla~~~~~~~~~~---------~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg  489 (563)
                      +|||+|+.........         ...+..+||+.|||||++.+..|             +.++|||||||++|||++ 
T Consensus       160 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y-------------~~~~DiwSlGvilyell~-  225 (299)
T 4g31_A          160 GDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSY-------------SHKVDIFSLGLILFELLY-  225 (299)
T ss_dssp             CCCCCC--------------------------CCCTTSCHHHHTTCCC-------------CTHHHHHHHHHHHHHHHS-
T ss_pred             ccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCC-------------CCHHHHHHHHHHHHHHcc-
Confidence            9999998765432211         11234579999999999866554             899999999999999997 


Q ss_pred             CCCCcCCCC------------CchhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          490 KRALIRDDS------------EPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       490 ~~p~~~~~~------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                        ||.....            .+.......+...+|+.+||+.||.+|||+.|+++
T Consensus       226 --Pf~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          226 --PFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             --CCSSHHHHHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             --CCCCccHHHHHHHHHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence              6643211            11122233445788999999999999999999876

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=8.1e-44  Score=374.54  Aligned_cols=222  Identities=22%  Similarity=0.350  Sum_probs=181.3

Q ss_pred             cCCCccceecccCcEEEEEEEEC--CceEEEEEeccCC-----hHHHHHHHHHHHhccccce------------------
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNK-----SKEFFAELKVLCKIHHINV------------------  346 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~-----~~~f~~Ei~~l~~l~H~ni------------------  346 (563)
                      ++|+..+.||+|+||.||+|+..  ++.||||+++...     .+.+.+|+++|++++||||                  
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            57999999999999999999874  7899999997542     3568899999999999997                  


Q ss_pred             ---EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCC
Q 044997          347 ---FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGL  423 (563)
Q Consensus       347 ---V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGl  423 (563)
                         ||||++ |+|.+++..     ...+++.++..++.||+.||+|||+++   ||||||||+|||++.++.+||+|||+
T Consensus       134 ~~ivmE~~~-g~L~~~i~~-----~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGl  204 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIHS-----SQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGM  204 (398)
T ss_dssp             EEEEEECCS-EEHHHHHTS-----SSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred             EEEEEeCCC-CCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecce
Confidence               568875 778888864     467999999999999999999999998   99999999999999999999999999


Q ss_pred             Ccccccccc-cccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCchh
Q 044997          424 VKLEERTNE-KEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTK  502 (563)
Q Consensus       424 a~~~~~~~~-~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~~  502 (563)
                      |+.+..... .....+..+||+.|||||++.+..+            ++.++||||+||++|||++|+.||.+.+.....
T Consensus       205 a~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~------------~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l  272 (398)
T 4b99_A          205 ARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHE------------YTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQL  272 (398)
T ss_dssp             CBCC-------CCCCCSSCCCCTTCCHHHHTTCSC------------CCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHH
T ss_pred             eeecccCccccccccccceeChHhcCHHHhcCCCC------------CCChhheehhHHHHHHHHHCCCCCCCCCHHHHH
Confidence            986543321 1223445789999999999865432            488999999999999999999999754321000


Q ss_pred             -----------------------------------------hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          503 -----------------------------------------MKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       503 -----------------------------------------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                                                               ...+.+.+.+|+.+||..||.+|||+.|+++.
T Consensus       273 ~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  345 (398)
T 4b99_A          273 QLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH  345 (398)
T ss_dssp             HHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             HHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence                                                     01123567899999999999999999998873

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=3.1e-43  Score=365.95  Aligned_cols=222  Identities=24%  Similarity=0.368  Sum_probs=179.1

Q ss_pred             HHhcCCCccceecccCcEEEEEEEEC-----CceEEEEEeccCC-hHHHHHHHHHHHhc-cccce---------------
Q 044997          289 EATNNFDESRIIGRGGFGNVYFGLLG-----DREAAIKKMRSNK-SKEFFAELKVLCKI-HHINV---------------  346 (563)
Q Consensus       289 ~~~~~f~~~~~LG~G~fG~Vy~g~~~-----~~~vavK~~~~~~-~~~f~~Ei~~l~~l-~H~ni---------------  346 (563)
                      ...+.|+..+.||+|+||.||+|+.+     ++.||||++.... ..++.+|+++|+++ +||||               
T Consensus        18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~l   97 (361)
T 4f9c_A           18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVI   97 (361)
T ss_dssp             GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEE
T ss_pred             CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEE
Confidence            34678999999999999999999752     5789999986543 46788999999998 69997               


Q ss_pred             EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCC-CcEEEeecCCCc
Q 044997          347 FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDG-LRAKVADFGLVK  425 (563)
Q Consensus       347 V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~-~~~kl~DFGla~  425 (563)
                      |+||+++|+|.+++.        .+++.++..++.|++.||+|||+++   |+||||||+|||++.+ +.+||+|||+|+
T Consensus        98 vmE~~~g~~L~~~~~--------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~  166 (361)
T 4f9c_A           98 AMPYLEHESFLDILN--------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQ  166 (361)
T ss_dssp             EEECCCCCCHHHHHT--------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             EEeCCCcccHHHHHc--------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCc
Confidence            689999999999874        3899999999999999999999998   9999999999999877 799999999998


Q ss_pred             cccccccc-------------------------ccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHH
Q 044997          426 LEERTNEK-------------------------EMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFG  480 (563)
Q Consensus       426 ~~~~~~~~-------------------------~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfG  480 (563)
                      ........                         ....+..+||+.|||||++.+..            .++.++||||+|
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~------------~y~~~~DiWSlG  234 (361)
T 4f9c_A          167 GTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCP------------NQTTAIDMWSAG  234 (361)
T ss_dssp             ECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCS------------CCCTHHHHHHHH
T ss_pred             ccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCC------------CCCCccchhhhH
Confidence            54332110                         01123457999999999986543            248899999999


Q ss_pred             HHHHHHHcCCCCCcCCCCCchhh---------------------------------------------------------
Q 044997          481 VVLAELITGKRALIRDDSEPTKM---------------------------------------------------------  503 (563)
Q Consensus       481 vvl~Elltg~~p~~~~~~~~~~~---------------------------------------------------------  503 (563)
                      |++|||++|+.||..........                                                         
T Consensus       235 ~il~ell~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~  314 (361)
T 4f9c_A          235 VIFLSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQG  314 (361)
T ss_dssp             HHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC---------------
T ss_pred             HHHHHHHHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhcccccccccccccccc
Confidence            99999999999996544321110                                                         


Q ss_pred             --------HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          504 --------KSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       504 --------~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                              ..+++.+.+|+.+||+.||++|||++|+++
T Consensus       315 ~~~~~~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~  352 (361)
T 4f9c_A          315 HATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALL  352 (361)
T ss_dssp             -------CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             ccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence                    012345789999999999999999999875

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=1.3e-41  Score=374.46  Aligned_cols=218  Identities=20%  Similarity=0.287  Sum_probs=186.4

Q ss_pred             cCCCccceecccCcEEEEEEEEC--CceEEEEEeccCC---hHHHHHHHHHHHhccccce---------------EEEee
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNK---SKEFFAELKVLCKIHHINV---------------FISTF  351 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~---~~~f~~Ei~~l~~l~H~ni---------------V~e~~  351 (563)
                      ++|+..+.||+|+||.||+|+..  ++.||+|.++...   .+.+.+|+++|++++||||               ||||+
T Consensus       157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~  236 (573)
T 3uto_A          157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM  236 (573)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence            67999999999999999999884  7899999987543   3568899999999999997               58999


Q ss_pred             cCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCC--CcEEEeecCCCccccc
Q 044997          352 GNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDG--LRAKVADFGLVKLEER  429 (563)
Q Consensus       352 ~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~--~~~kl~DFGla~~~~~  429 (563)
                      .+|+|.++|..    ....+++.++..++.||+.||+|||+++   |+||||||+|||++.+  +.+||+|||+|+.+..
T Consensus       237 ~gg~L~~~i~~----~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~  309 (573)
T 3uto_A          237 SGGELFEKVAD----EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP  309 (573)
T ss_dssp             CCCBHHHHHTC----TTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCT
T ss_pred             CCCcHHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccC
Confidence            99999999864    2356999999999999999999999998   9999999999999854  8999999999987653


Q ss_pred             ccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCC----------
Q 044997          430 TNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE----------  499 (563)
Q Consensus       430 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~----------  499 (563)
                      ..    .....+||+.|||||++.+..|             +.++||||+||++|||++|+.||.+....          
T Consensus       310 ~~----~~~~~~GT~~y~APEv~~~~~y-------------~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~  372 (573)
T 3uto_A          310 KQ----SVKVTTGTAEFAAPEVAEGKPV-------------GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCD  372 (573)
T ss_dssp             TS----EEEEECSSGGGCCHHHHTTCCB-------------CHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTC
T ss_pred             CC----ceeeeEECccccCHHHhCCCCC-------------CcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCC
Confidence            32    2234679999999999976655             78999999999999999999999754321          


Q ss_pred             ----chhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          500 ----PTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       500 ----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                          ......+.+.+.+|+.+||+.||.+||++.|+++
T Consensus       373 ~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~  410 (573)
T 3uto_A          373 WNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE  410 (573)
T ss_dssp             CCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                1222345677899999999999999999999987

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=3.4e-41  Score=345.05  Aligned_cols=245  Identities=33%  Similarity=0.571  Sum_probs=201.1

Q ss_pred             ccCHHHHHHHhcCCCccceecccCcEEEEEEEEC-CceEEEEEeccCC---hHHHHHHHHHHHhccccce----------
Q 044997          281 IFSLEEIEEATNNFDESRIIGRGGFGNVYFGLLG-DREAAIKKMRSNK---SKEFFAELKVLCKIHHINV----------  346 (563)
Q Consensus       281 ~~~~~el~~~~~~f~~~~~LG~G~fG~Vy~g~~~-~~~vavK~~~~~~---~~~f~~Ei~~l~~l~H~ni----------  346 (563)
                      .+++.++...+++|+..+.||+|+||.||+|+.. ++.||||++....   .+++.+|++++++++||||          
T Consensus        28 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  107 (321)
T 2qkw_B           28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDER  107 (321)
T ss_dssp             --CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCT
T ss_pred             eecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence            4555666778899999999999999999999975 7899999987543   4678999999999999997          


Q ss_pred             -----EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeec
Q 044997          347 -----FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADF  421 (563)
Q Consensus       347 -----V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DF  421 (563)
                           |+||+++|+|.+++.... .....++|.+++.++.|++.||+|||+++   ++||||||+|||++.++.+||+||
T Consensus       108 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Df  183 (321)
T 2qkw_B          108 NEMILIYKYMENGNLKRHLYGSD-LPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDF  183 (321)
T ss_dssp             TCCEEEEECCTTCBTGGGSSSSC-CCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCC
T ss_pred             CeEEEEEEcCCCCcHHHHHhccC-CCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeec
Confidence                 679999999999997632 12346999999999999999999999987   999999999999999999999999


Q ss_pred             CCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc-
Q 044997          422 GLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP-  500 (563)
Q Consensus       422 Gla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~-  500 (563)
                      |+++........ .......||+.|+|||.+.+..             ++.++||||||+++|||++|+.||....... 
T Consensus       184 g~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~-------------~~~~~Di~slG~il~ell~g~~p~~~~~~~~~  249 (321)
T 2qkw_B          184 GISKKGTELDQT-HLSTVVKGTLGYIDPEYFIKGR-------------LTEKSDVYSFGVVLFEVLCARSAIVQSLPREM  249 (321)
T ss_dssp             TTCEECSSSSCC-CCBCCCEEETTTCCHHHHHHCB-------------CCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSC
T ss_pred             cccccccccccc-ccccccCCCccccCHHHhcCCC-------------CCcccchHhHHHHHHHHHhCCCcccccCcHHH
Confidence            999864322211 1223356899999999885544             4899999999999999999999986432110 


Q ss_pred             --------------------------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcCh
Q 044997          501 --------------------------TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITST  543 (563)
Q Consensus       501 --------------------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~  543 (563)
                                                .........+.+++.+||+.||++||++.|+++.|+.++....
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~~  318 (321)
T 2qkw_B          250 VNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQE  318 (321)
T ss_dssp             CCHHHHTHHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSC
T ss_pred             HHHHHHhhhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhccc
Confidence                                      1123556778999999999999999999999999999886543

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=4.9e-41  Score=339.78  Aligned_cols=232  Identities=24%  Similarity=0.357  Sum_probs=189.2

Q ss_pred             hcCCCccceecccCcEEEEEEEECCceEEEEEeccCChHHHHHHHHHHHh--ccccce-------------------EEE
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLLGDREAAIKKMRSNKSKEFFAELKVLCK--IHHINV-------------------FIS  349 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~vavK~~~~~~~~~f~~Ei~~l~~--l~H~ni-------------------V~e  349 (563)
                      .++|+..+.||+|+||.||+|+.+++.||||+++....+.+.+|.+++..  ++||||                   |+|
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e   86 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITH   86 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEEC
T ss_pred             cCcEEEEEeeccCCCcEEEEEEECCEEEEEEEeccccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehh
Confidence            46788999999999999999999999999999988888888888888887  799997                   568


Q ss_pred             eecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCceEeCCCCCCCeEecCCCcEEEeec
Q 044997          350 TFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIH--------DHTKARYVHRDIKTSNILLDDGLRAKVADF  421 (563)
Q Consensus       350 ~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH--------~~~~~~ivHrDLk~~NILl~~~~~~kl~DF  421 (563)
                      |+++|+|.+++..      ..+++..++.++.|++.||+|||        +++   |+||||||+|||++.++.+||+||
T Consensus        87 ~~~~g~L~~~l~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~Df  157 (301)
T 3q4u_A           87 YHEMGSLYDYLQL------TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIADL  157 (301)
T ss_dssp             CCTTCBHHHHHTT------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEECCC
T ss_pred             hccCCCHHHHHhh------cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEeeC
Confidence            8899999999954      46999999999999999999999        665   999999999999999999999999


Q ss_pred             CCCcccccccccc-cccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcC----------C
Q 044997          422 GLVKLEERTNEKE-MLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG----------K  490 (563)
Q Consensus       422 Gla~~~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg----------~  490 (563)
                      |+++......... .......||+.|+|||++.+....       ....+++++||||||+++|||++|          +
T Consensus       158 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-------~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~  230 (301)
T 3q4u_A          158 GLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQV-------DCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYK  230 (301)
T ss_dssp             TTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCT-------TCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred             CCeeecccccccccccccccccccceeChhhhcCcCCC-------CcccCCchhhHHHHHHHHHHHHhhhcCcccccccc
Confidence            9997654332221 112335799999999998654210       000235799999999999999999          7


Q ss_pred             CCCcCCCCCch----------------------hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 044997          491 RALIRDDSEPT----------------------KMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQI  538 (563)
Q Consensus       491 ~p~~~~~~~~~----------------------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  538 (563)
                      .||........                      ........+.+++.+||+.||.+|||+.||++.|+++
T Consensus       231 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          231 PPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             CTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             ccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            78754321110                      1123556799999999999999999999999999875

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=2.4e-40  Score=336.03  Aligned_cols=241  Identities=38%  Similarity=0.667  Sum_probs=202.0

Q ss_pred             cccCHHHHHHHhcCCCcc------ceecccCcEEEEEEEECCceEEEEEeccC-------ChHHHHHHHHHHHhccccce
Q 044997          280 IIFSLEEIEEATNNFDES------RIIGRGGFGNVYFGLLGDREAAIKKMRSN-------KSKEFFAELKVLCKIHHINV  346 (563)
Q Consensus       280 ~~~~~~el~~~~~~f~~~------~~LG~G~fG~Vy~g~~~~~~vavK~~~~~-------~~~~f~~Ei~~l~~l~H~ni  346 (563)
                      ..|+++++..++++|+..      +.||+|+||.||+|..+++.||||++...       ..+.+.+|++++++++||||
T Consensus        13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i   92 (307)
T 2nru_A           13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENL   92 (307)
T ss_dssp             EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTB
T ss_pred             CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCe
Confidence            568999999999999988      89999999999999999999999998642       13678999999999999997


Q ss_pred             ---------------EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEec
Q 044997          347 ---------------FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLD  411 (563)
Q Consensus       347 ---------------V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~  411 (563)
                                     |+||+++|+|.+++...  ....+++|..+..++.|++.||+|||+++   ++||||||+||+++
T Consensus        93 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili~  167 (307)
T 2nru_A           93 VELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL--DGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLD  167 (307)
T ss_dssp             CCEEEEECSSSSCEEEEECCTTCBHHHHHHTG--GGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEC
T ss_pred             EEEEEEEecCCceEEEEEecCCCcHHHHHHhc--cCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEc
Confidence                           57999999999998752  23457999999999999999999999997   99999999999999


Q ss_pred             CCCcEEEeecCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCC
Q 044997          412 DGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKR  491 (563)
Q Consensus       412 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~  491 (563)
                      +++.+||+|||+++........ .......||+.|+|||.+.+              .++.++||||||+++|||++|+.
T Consensus       168 ~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~--------------~~~~~~Dv~slG~il~~l~~g~~  232 (307)
T 2nru_A          168 EAFTAKISDFGLARASEKFAQT-VMTSRIVGTTAYMAPEALRG--------------EITPKSDIYSFGVVLLEIITGLP  232 (307)
T ss_dssp             TTCCEEECCCTTCEECCSCSSC-EECSSCCSCGGGCCHHHHTT--------------EECTHHHHHHHHHHHHHHHHCCC
T ss_pred             CCCcEEEeeccccccccccccc-ccccccCCCcCcCChHHhcC--------------CCCccchhHHHHHHHHHHHHCCC
Confidence            9999999999999865432211 12234579999999998743              24789999999999999999999


Q ss_pred             CCcCCCCCch-------------------------hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhh
Q 044997          492 ALIRDDSEPT-------------------------KMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMI  540 (563)
Q Consensus       492 p~~~~~~~~~-------------------------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~  540 (563)
                      ||........                         ......+.+.+++.+||+.||.+||++.++++.|+++..
T Consensus       233 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~  306 (307)
T 2nru_A          233 AVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA  306 (307)
T ss_dssp             SBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred             CcccCcchHHHHHHHHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence            9865432110                         112345668999999999999999999999999998754

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=6.6e-41  Score=343.37  Aligned_cols=244  Identities=36%  Similarity=0.657  Sum_probs=201.8

Q ss_pred             ccccCHHHHHHHhcCCCccceecccCcEEEEEEEE-CCceEEEEEeccCC----hHHHHHHHHHHHhccccce-------
Q 044997          279 TIIFSLEEIEEATNNFDESRIIGRGGFGNVYFGLL-GDREAAIKKMRSNK----SKEFFAELKVLCKIHHINV-------  346 (563)
Q Consensus       279 ~~~~~~~el~~~~~~f~~~~~LG~G~fG~Vy~g~~-~~~~vavK~~~~~~----~~~f~~Ei~~l~~l~H~ni-------  346 (563)
                      ...|++.++....++|+..+.||+|+||.||+|+. +++.||||+++...    ...+.+|++++++++||||       
T Consensus        17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~   96 (326)
T 3uim_A           17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC   96 (326)
T ss_dssp             CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred             cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence            45789999999999999999999999999999987 47889999987543    2468999999999999997       


Q ss_pred             --------EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEE
Q 044997          347 --------FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKV  418 (563)
Q Consensus       347 --------V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl  418 (563)
                              |+||+.+|+|.+++.... ....+++|..+..++.|++.||+|||++..++|+||||||+|||+++++.+||
T Consensus        97 ~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl  175 (326)
T 3uim_A           97 MTPTERLLVYPYMANGSVASCLRERP-ESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV  175 (326)
T ss_dssp             CCSSCCEEEEECCTTCBHHHHHHCCS-TTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEE
T ss_pred             ecCCceEEEEEeccCCCHHHHHHhcc-ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEe
Confidence                    689999999999997632 23456999999999999999999999983333999999999999999999999


Q ss_pred             eecCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCC--
Q 044997          419 ADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRD--  496 (563)
Q Consensus       419 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~--  496 (563)
                      +|||+++.......  .......||+.|+|||.+.+..+             +.++||||||+++|||++|+.||...  
T Consensus       176 ~Dfg~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~-------------~~~~Di~slG~il~~l~~g~~pf~~~~~  240 (326)
T 3uim_A          176 GDFGLAKLMDYKDT--HVTTAVRGTIGHIAPEYLSTGKS-------------SEKTDVFGYGVMLLELITGQRAFDLARL  240 (326)
T ss_dssp             CCCSSCEECCSSSS--CEECCCCSCGGGCCHHHHHHSEE-------------CHHHHHHHHHHHHHHHHHCCCSBCHHHH
T ss_pred             ccCccccccCcccc--cccccccCCcCccCHHHhccCCC-------------CccccchhHHHHHHHHHhCCCccccccc
Confidence            99999986543222  12334569999999998865544             88999999999999999999998410  


Q ss_pred             --CC-------------------------CchhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 044997          497 --DS-------------------------EPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQI  538 (563)
Q Consensus       497 --~~-------------------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  538 (563)
                        ..                         ...........+.+++.+||+.||.+|||+.||++.|+..
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~  309 (326)
T 3uim_A          241 ANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD  309 (326)
T ss_dssp             TTTSCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred             ccccchhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence              00                         0111234567799999999999999999999999999864

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=2e-41  Score=372.34  Aligned_cols=228  Identities=25%  Similarity=0.387  Sum_probs=182.9

Q ss_pred             cCCCccceecccCcEEEEEEEEC--CceEEEEEeccC------ChHHHHH---HHHHHHhccccce--------------
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSN------KSKEFFA---ELKVLCKIHHINV--------------  346 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~------~~~~f~~---Ei~~l~~l~H~ni--------------  346 (563)
                      ++|+..++||+|+||.||+|+..  ++.||||.+++.      ......+   ++.+++.++||||              
T Consensus       189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly  268 (689)
T 3v5w_A          189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS  268 (689)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence            57999999999999999999884  789999998643      2223333   4667778899997              


Q ss_pred             -EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCc
Q 044997          347 -FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK  425 (563)
Q Consensus       347 -V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~  425 (563)
                       ||||+.+|+|.++|..     ...+++..+..++.||+.||+|||+++   ||||||||+||||+.+|++||+|||+|+
T Consensus       269 lVmEy~~GGdL~~~l~~-----~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~  340 (689)
T 3v5w_A          269 FILDLMNGGDLHYHLSQ-----HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLAC  340 (689)
T ss_dssp             EEECCCCSCBHHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             EEEecCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceee
Confidence             6899999999999975     356999999999999999999999998   9999999999999999999999999998


Q ss_pred             ccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCch----
Q 044997          426 LEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPT----  501 (563)
Q Consensus       426 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~----  501 (563)
                      .....     .....+||+.|||||++..+            ..++.++||||+||+||||++|+.||........    
T Consensus       341 ~~~~~-----~~~t~~GTp~YmAPEvl~~~------------~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~  403 (689)
T 3v5w_A          341 DFSKK-----KPHASVGTHGYMAPEVLQKG------------VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID  403 (689)
T ss_dssp             ECSSC-----CCCSCCSCGGGCCHHHHSTT------------CCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHH
T ss_pred             ecCCC-----CCCCccCCcCccCHHHHhCC------------CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence            65432     12346899999999998532            1348899999999999999999999976433211    


Q ss_pred             ---------hhHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHHHHHhhhcChhhhc
Q 044997          502 ---------KMKSLITIMAAVAEWCLNEDAVDRPE-----MRDIVAILSQIMITSTEWEA  547 (563)
Q Consensus       502 ---------~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~L~~i~~~~~~w~~  547 (563)
                               .+..++..+.+|+.+||+.||.+|++     +.||++   .-.-...+|+.
T Consensus       404 ~~i~~~~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~---HpfF~~idW~~  460 (689)
T 3v5w_A          404 RMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE---SPFFRSLDWQM  460 (689)
T ss_dssp             HHHHHCCCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT---SGGGTTCCHHH
T ss_pred             HhhcCCCCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc---CccccCCCHHH
Confidence                     11234566999999999999999998     566544   33334455554

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=1e-40  Score=340.30  Aligned_cols=235  Identities=28%  Similarity=0.469  Sum_probs=185.3

Q ss_pred             HHhcCCCccceecccCcEEEEEEEECCceEEEEEeccCC-----hHHHHHHHHHHHhccccce---------------EE
Q 044997          289 EATNNFDESRIIGRGGFGNVYFGLLGDREAAIKKMRSNK-----SKEFFAELKVLCKIHHINV---------------FI  348 (563)
Q Consensus       289 ~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~vavK~~~~~~-----~~~f~~Ei~~l~~l~H~ni---------------V~  348 (563)
                      ...++|+..+.||+|+||.||+|+.+++.||||.+....     .++|.+|++++++++||||               |+
T Consensus        34 i~~~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  113 (309)
T 3p86_A           34 IPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT  113 (309)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEE
T ss_pred             CChhHceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEE
Confidence            345678899999999999999999999999999987543     2568899999999999997               67


Q ss_pred             EeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccc
Q 044997          349 STFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEE  428 (563)
Q Consensus       349 e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~  428 (563)
                      ||+++|+|.+++....  ....+++..++.++.|++.||+|||+++ ++|+||||||+|||++.++.+||+|||+++...
T Consensus       114 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~  190 (309)
T 3p86_A          114 EYLSRGSLYRLLHKSG--AREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA  190 (309)
T ss_dssp             ECCTTCBHHHHHHSTT--HHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC------
T ss_pred             ecCCCCcHHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCcccc
Confidence            9999999999997521  1124899999999999999999999985 349999999999999999999999999997543


Q ss_pred             cccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc--------
Q 044997          429 RTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP--------  500 (563)
Q Consensus       429 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~--------  500 (563)
                      ...   .......||+.|+|||.+.+..             ++.++||||||+++|||++|+.||.......        
T Consensus       191 ~~~---~~~~~~~gt~~y~aPE~~~~~~-------------~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~  254 (309)
T 3p86_A          191 STF---LSSKSAAGTPEWMAPEVLRDEP-------------SNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFK  254 (309)
T ss_dssp             --------------CCTTSCHHHHTTCC-------------CCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHS
T ss_pred             ccc---cccccCCCCccccChhhhcCCC-------------CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Confidence            221   1223457999999999886544             4889999999999999999999996543211        


Q ss_pred             ----hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcC
Q 044997          501 ----TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITS  542 (563)
Q Consensus       501 ----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~  542 (563)
                          .....+...+.+++.+||+.||.+||++.++++.|+.+++..
T Consensus       255 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~  300 (309)
T 3p86_A          255 CKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA  300 (309)
T ss_dssp             CCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred             CCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence                112234566899999999999999999999999999998753

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=9.3e-41  Score=342.94  Aligned_cols=233  Identities=27%  Similarity=0.463  Sum_probs=189.5

Q ss_pred             cCCCccceecccCcEEEEEEEEC-----CceEEEEEeccCC----hHHHHHHHHHHHhccccce---------------E
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG-----DREAAIKKMRSNK----SKEFFAELKVLCKIHHINV---------------F  347 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~-----~~~vavK~~~~~~----~~~f~~Ei~~l~~l~H~ni---------------V  347 (563)
                      ++|...+.||+|+||.||+|+..     +..||||.++...    .++|.+|++++++++||||               |
T Consensus        49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  128 (325)
T 3kul_A           49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV  128 (325)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred             hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence            56788899999999999999883     3459999997642    3568999999999999997               6


Q ss_pred             EEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccc
Q 044997          348 ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLE  427 (563)
Q Consensus       348 ~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~  427 (563)
                      +||+++|+|.+++..    ....+++.+++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus       129 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  201 (325)
T 3kul_A          129 TEYMENGSLDTFLRT----HDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVL  201 (325)
T ss_dssp             EECCTTCBHHHHHHT----TTTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred             eeCCCCCcHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCccccc
Confidence            899999999999964    2356999999999999999999999997   999999999999999999999999999876


Q ss_pred             ccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCCCcCCCCCc------
Q 044997          428 ERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIRDDSEP------  500 (563)
Q Consensus       428 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p~~~~~~~~------  500 (563)
                      ..............+|+.|+|||++.+..+             +.++||||||+++|||++ |+.||.......      
T Consensus       202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-------------~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~  268 (325)
T 3kul_A          202 EDDPDAAYTTTGGKIPIRWTAPEAIAFRTF-------------SSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVE  268 (325)
T ss_dssp             C----CCEECC---CCGGGSCHHHHHHCEE-------------CHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHH
T ss_pred             ccCccceeeccCCCCcccccCHhHhcCCCC-------------CcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH
Confidence            543322222333456788999999865554             789999999999999999 999986543211      


Q ss_pred             -----hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcChh
Q 044997          501 -----TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITSTE  544 (563)
Q Consensus       501 -----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~  544 (563)
                           .....+++.+.+++.+||+.||.+||++.||++.|+.++.....
T Consensus       269 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~  317 (325)
T 3kul_A          269 EGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPES  317 (325)
T ss_dssp             TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC-
T ss_pred             cCCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCccc
Confidence                 11223456689999999999999999999999999999876443

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=6.3e-41  Score=343.59  Aligned_cols=236  Identities=27%  Similarity=0.339  Sum_probs=189.7

Q ss_pred             hcCCCccceecccCcEEEEEEEECCceEEEEEeccCCh--HHHHHHHHHHHhccccce-------------------EEE
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLLGDREAAIKKMRSNKS--KEFFAELKVLCKIHHINV-------------------FIS  349 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~vavK~~~~~~~--~~f~~Ei~~l~~l~H~ni-------------------V~e  349 (563)
                      .++|+..+.||+|+||.||+|+..++.||||+++....  ..+.+|+.+|++++||||                   |+|
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e  102 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITA  102 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred             hhhchhhheecccCceEEEEEEECCCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEe
Confidence            35788999999999999999999999999999976543  345668888999999997                   578


Q ss_pred             eecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhc-------CCCceEeCCCCCCCeEecCCCcEEEeecC
Q 044997          350 TFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDH-------TKARYVHRDIKTSNILLDDGLRAKVADFG  422 (563)
Q Consensus       350 ~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-------~~~~ivHrDLk~~NILl~~~~~~kl~DFG  422 (563)
                      |+++|+|.+++..      ..++|..+..++.|++.||+|||+.       ..++|+||||||+|||++.++.+||+|||
T Consensus       103 ~~~~g~L~~~l~~------~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg  176 (322)
T 3soc_A          103 FHEKGSLSDFLKA------NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFG  176 (322)
T ss_dssp             CCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCT
T ss_pred             cCCCCCHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCC
Confidence            8999999999964      3599999999999999999999987       01129999999999999999999999999


Q ss_pred             CCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCch-
Q 044997          423 LVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPT-  501 (563)
Q Consensus       423 la~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~-  501 (563)
                      +++........ .......||+.|+|||++.+...        ....++.++|||||||++|||++|+.||........ 
T Consensus       177 ~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~--------~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~  247 (322)
T 3soc_A          177 LALKFEAGKSA-GDTHGQVGTRRYMAPEVLEGAIN--------FQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML  247 (322)
T ss_dssp             TCEEECTTSCC-CCCTTCCCCGGGCCHHHHTTCCC--------CCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCC
T ss_pred             cccccccccCc-cccccCccCccccCHhhcccccc--------cCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhcc
Confidence            99865433221 12233579999999999865321        012346789999999999999999999865432100 


Q ss_pred             --------------------------------hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 044997          502 --------------------------------KMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMIT  541 (563)
Q Consensus       502 --------------------------------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~  541 (563)
                                                      ......+.+.+++.+||+.||++|||+.|+++.|+++.+.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~  319 (322)
T 3soc_A          248 PFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL  319 (322)
T ss_dssp             TTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             chhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence                                            0012234589999999999999999999999999998653

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=2.4e-40  Score=336.91  Aligned_cols=230  Identities=24%  Similarity=0.406  Sum_probs=188.1

Q ss_pred             cCCCccceecccCcEEEEEEEEC--CceEEEEEeccCC---hHHHHHHHHHHHhccccce---------------EEEee
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNK---SKEFFAELKVLCKIHHINV---------------FISTF  351 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~---~~~f~~Ei~~l~~l~H~ni---------------V~e~~  351 (563)
                      ++|...+.||+|+||.||+|...  ++.||+|++....   .+.|.+|++++++++||||               |+||+
T Consensus        10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~   89 (310)
T 3s95_A           10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI   89 (310)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence            46788999999999999999984  7889999886543   4678999999999999997               57999


Q ss_pred             cCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccccccc
Q 044997          352 GNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTN  431 (563)
Q Consensus       352 ~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~  431 (563)
                      ++|+|.+++..    ....++|.++..++.|+++||+|||+++   ++||||||+|||++.++.+||+|||+++......
T Consensus        90 ~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  162 (310)
T 3s95_A           90 KGGTLRGIIKS----MDSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK  162 (310)
T ss_dssp             TTCBHHHHHHH----CCTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred             CCCcHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence            99999999975    2456999999999999999999999998   9999999999999999999999999998654322


Q ss_pred             ccc-----------cccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc
Q 044997          432 EKE-----------MLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP  500 (563)
Q Consensus       432 ~~~-----------~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~  500 (563)
                      ...           .......||+.|+|||++.+..             ++.++||||||+++|||++|..|+.......
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------------~~~~~Di~slG~~l~el~~g~~~~~~~~~~~  229 (310)
T 3s95_A          163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRS-------------YDEKVDVFSFGIVLCEIIGRVNADPDYLPRT  229 (310)
T ss_dssp             -----------------CCCCSCGGGCCHHHHTTCC-------------CCTHHHHHHHHHHHHHHHHTCCSSTTTSCBC
T ss_pred             ccccccccccccccccccccCCCcceeCHHHhcCCC-------------CCcHHHHHHHHHHHHHHhcCCCCCcchhhhH
Confidence            111           0111457999999999886544             4889999999999999999999886533221


Q ss_pred             h----h---------hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 044997          501 T----K---------MKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMIT  541 (563)
Q Consensus       501 ~----~---------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~  541 (563)
                      .    .         ...+++.+.+++.+||+.||++||++.|+++.|+++...
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~  283 (310)
T 3s95_A          230 MDFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH  283 (310)
T ss_dssp             TTSSBCHHHHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHhhhhhccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            1    0         112234589999999999999999999999999988653

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=1.2e-40  Score=336.53  Aligned_cols=230  Identities=26%  Similarity=0.400  Sum_probs=184.8

Q ss_pred             cCCCccceecccCcEEEEEEEE------CCceEEEEEeccCCh---HHHHHHHHHHHhccccce----------------
Q 044997          292 NNFDESRIIGRGGFGNVYFGLL------GDREAAIKKMRSNKS---KEFFAELKVLCKIHHINV----------------  346 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~------~~~~vavK~~~~~~~---~~f~~Ei~~l~~l~H~ni----------------  346 (563)
                      ++|+..+.||+|+||.||+|++      .++.||||+++....   +.|.+|++++++++||||                
T Consensus        10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   89 (295)
T 3ugc_A           10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK   89 (295)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCE
T ss_pred             HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceE
Confidence            5688899999999999999985      467899999976543   568899999999999997                


Q ss_pred             -EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCc
Q 044997          347 -FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK  425 (563)
Q Consensus       347 -V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~  425 (563)
                       |+||+++|+|.+++...    ...+++..+..++.|++.||+|||+++   ++||||||+|||++.++++||+|||+++
T Consensus        90 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~  162 (295)
T 3ugc_A           90 LIMEYLPYGSLRDYLQKH----KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTK  162 (295)
T ss_dssp             EEEECCTTCBHHHHHHHC----GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred             EEEEeCCCCCHHHHHHhc----ccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCcccc
Confidence             57999999999999752    345999999999999999999999997   9999999999999999999999999998


Q ss_pred             ccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCC-------
Q 044997          426 LEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDS-------  498 (563)
Q Consensus       426 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~-------  498 (563)
                      ................++..|+|||.+.+..             ++.++||||||+++|||++|..|+.....       
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-------------~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~  229 (295)
T 3ugc_A          163 VLPQDKEFFKVKEPGESPIFWYAPESLTESK-------------FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIG  229 (295)
T ss_dssp             -------------CTTCGGGGCCHHHHHHCC-------------CCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHC
T ss_pred             cccCCcceeeeccCCCCccceeCcHHhcCCC-------------CChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhc
Confidence            7654332222223345778899999885544             48999999999999999999988743210       


Q ss_pred             --------------------CchhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 044997          499 --------------------EPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMIT  541 (563)
Q Consensus       499 --------------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~  541 (563)
                                          .......+++.+.+++.+||+.||++|||+.|+++.|+++.+.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~  292 (295)
T 3ugc_A          230 NDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN  292 (295)
T ss_dssp             TTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             CccccchhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence                                0001123345689999999999999999999999999998764

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=3.8e-40  Score=344.63  Aligned_cols=235  Identities=22%  Similarity=0.369  Sum_probs=190.9

Q ss_pred             hcCCCccceecccCcEEEEEEEEC---------CceEEEEEeccCC----hHHHHHHHHHHHhc-cccce----------
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLLG---------DREAAIKKMRSNK----SKEFFAELKVLCKI-HHINV----------  346 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~~---------~~~vavK~~~~~~----~~~f~~Ei~~l~~l-~H~ni----------  346 (563)
                      .++|...+.||+|+||.||+|+..         +..||||.++...    .+++.+|+++|+++ +||||          
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  159 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  159 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence            367888999999999999999862         2469999997653    35689999999999 89997          


Q ss_pred             -----EEEeecCCCcccccccccc-----------cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEe
Q 044997          347 -----FISTFGNGSLSDHLHDPLL-----------KGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILL  410 (563)
Q Consensus       347 -----V~e~~~~gsL~~~L~~~~~-----------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl  410 (563)
                           |+||+++|+|.+++.....           .....+++.+++.++.|++.||+|||+++   |+||||||+|||+
T Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll  236 (370)
T 2psq_A          160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV  236 (370)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred             CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence                 6899999999999975321           01245899999999999999999999997   9999999999999


Q ss_pred             cCCCcEEEeecCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-C
Q 044997          411 DDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-G  489 (563)
Q Consensus       411 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g  489 (563)
                      +.++.+||+|||+++........ .......+|+.|+|||++.+..             ++.++|||||||++|||++ |
T Consensus       237 ~~~~~~kl~DFG~a~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~-------------~~~~~DvwslG~il~ellt~g  302 (370)
T 2psq_A          237 TENNVMKIADFGLARDINNIDYY-KKTTNGRLPVKWMAPEALFDRV-------------YTHQSDVWSFGVLMWEIFTLG  302 (370)
T ss_dssp             CTTCCEEECCCSSCEETTCCCTT-CTTTTTTSCGGGCCHHHHHTCC-------------CCHHHHHHHHHHHHHHHHTTS
T ss_pred             CCCCCEEEccccCCcccCcccce-ecccCCCcccceECHhHhcCCC-------------CCcHHHHHHHHHHHHHHHcCC
Confidence            99999999999999865432211 1223346788999999886544             4899999999999999999 8


Q ss_pred             CCCCcCCCCCc-----------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcC
Q 044997          490 KRALIRDDSEP-----------TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITS  542 (563)
Q Consensus       490 ~~p~~~~~~~~-----------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~  542 (563)
                      +.||.......           .....+...+.+++.+||+.||.+||++.|+++.|++++...
T Consensus       303 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~  366 (370)
T 2psq_A          303 GSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT  366 (370)
T ss_dssp             CCSSTTCCGGGHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             CCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence            98886543211           112234557899999999999999999999999999998644

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=3.8e-40  Score=338.99  Aligned_cols=238  Identities=24%  Similarity=0.402  Sum_probs=186.8

Q ss_pred             hcCCCccceecccCcEEEEEEEECCceEEEEEeccCChHHHHHHHHHHH--hccccce--------------------EE
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLLGDREAAIKKMRSNKSKEFFAELKVLC--KIHHINV--------------------FI  348 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~vavK~~~~~~~~~f~~Ei~~l~--~l~H~ni--------------------V~  348 (563)
                      .++|+..+.||+|+||.||+|+.+++.||||+++......+..|.+++.  .++|+||                    |+
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~   91 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVM   91 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEE
T ss_pred             hHHhheeeecccCCCeEEEEEEECCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEE
Confidence            3578889999999999999999999999999998777777777766654  5899986                    57


Q ss_pred             EeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcC------CCceEeCCCCCCCeEecCCCcEEEeecC
Q 044997          349 STFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHT------KARYVHRDIKTSNILLDDGLRAKVADFG  422 (563)
Q Consensus       349 e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------~~~ivHrDLk~~NILl~~~~~~kl~DFG  422 (563)
                      ||+++|+|.+++..      ...+|..+..++.|+++||+|||+..      .++|+||||||+|||++.++.+||+|||
T Consensus        92 e~~~~g~L~~~l~~------~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG  165 (336)
T 3g2f_A           92 EYYPNGSLXKYLSL------HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFG  165 (336)
T ss_dssp             CCCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCT
T ss_pred             ecCCCCcHHHHHhh------cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeecc
Confidence            88999999999964      34589999999999999999999981      1129999999999999999999999999


Q ss_pred             CCcccccccc-----cccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCC
Q 044997          423 LVKLEERTNE-----KEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDD  497 (563)
Q Consensus       423 la~~~~~~~~-----~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~  497 (563)
                      +++.......     .........||+.|+|||++.+....      .....++.++|||||||++|||++|+.|+....
T Consensus       166 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~------~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~  239 (336)
T 3g2f_A          166 LSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNL------RDXESALKQVDMYALGLIYWEIFMRCTDLFPGE  239 (336)
T ss_dssp             TCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCG------GGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTS
T ss_pred             ceeecccccccCccccccccccCCCccceeCchhhcCCccc------ccccccccccchHHHHHHHHHHHhcCCcCCCcc
Confidence            9986543211     11122345799999999998653210      011234689999999999999999988775432


Q ss_pred             CCch------------------------------------hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhh
Q 044997          498 SEPT------------------------------------KMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMI  540 (563)
Q Consensus       498 ~~~~------------------------------------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~  540 (563)
                      ....                                    ......+.+.+++.+||+.||++|||+.|+++.|++++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~  318 (336)
T 3g2f_A          240 SVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMM  318 (336)
T ss_dssp             CCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             chhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHH
Confidence            2110                                    001244569999999999999999999999999999985

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=2.2e-40  Score=346.83  Aligned_cols=232  Identities=27%  Similarity=0.457  Sum_probs=178.4

Q ss_pred             cCCCccceecccCcEEEEEEEEC-----CceEEEEEeccCC----hHHHHHHHHHHHhccccce---------------E
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG-----DREAAIKKMRSNK----SKEFFAELKVLCKIHHINV---------------F  347 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~-----~~~vavK~~~~~~----~~~f~~Ei~~l~~l~H~ni---------------V  347 (563)
                      ++|+..+.||+|+||.||+|+..     +..||||.++...    .++|.+|+++|++++||||               |
T Consensus        45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  124 (373)
T 2qol_A           45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV  124 (373)
T ss_dssp             GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence            57889999999999999999864     5679999997542    3579999999999999997               6


Q ss_pred             EEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccc
Q 044997          348 ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLE  427 (563)
Q Consensus       348 ~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~  427 (563)
                      +||+++|+|.+++..    ....+++.+++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus       125 ~e~~~~~sL~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  197 (373)
T 2qol_A          125 TEYMENGSLDSFLRK----HDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVL  197 (373)
T ss_dssp             EECCTTCBHHHHHHT----TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC------
T ss_pred             EeCCCCCcHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence            899999999999975    2356999999999999999999999997   999999999999999999999999999866


Q ss_pred             ccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCCCcCCCCCc------
Q 044997          428 ERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIRDDSEP------  500 (563)
Q Consensus       428 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p~~~~~~~~------  500 (563)
                      ..............++..|+|||++.+..             ++.++||||||+++|||++ |+.||.......      
T Consensus       198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-------------~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~  264 (373)
T 2qol_A          198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRK-------------FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD  264 (373)
T ss_dssp             ----------------CTTSCHHHHHHCC-------------CCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHH
T ss_pred             ccCCccceeccCCCcCCCccChhhhccCC-------------cCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            54322211222234577899999885544             4889999999999999998 999986543211      


Q ss_pred             -----hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcCh
Q 044997          501 -----TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITST  543 (563)
Q Consensus       501 -----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~  543 (563)
                           .....++..+.+++.+||+.||.+||++.+|++.|+++.....
T Consensus       265 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~~  312 (373)
T 2qol_A          265 EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPG  312 (373)
T ss_dssp             TTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCGG
T ss_pred             cCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCcc
Confidence                 0112334568999999999999999999999999999976543

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=5.9e-40  Score=352.09  Aligned_cols=227  Identities=27%  Similarity=0.443  Sum_probs=191.4

Q ss_pred             HhcCCCccceecccCcEEEEEEEECCceEEEEEeccCC-hHHHHHHHHHHHhccccce----------------EEEeec
Q 044997          290 ATNNFDESRIIGRGGFGNVYFGLLGDREAAIKKMRSNK-SKEFFAELKVLCKIHHINV----------------FISTFG  352 (563)
Q Consensus       290 ~~~~f~~~~~LG~G~fG~Vy~g~~~~~~vavK~~~~~~-~~~f~~Ei~~l~~l~H~ni----------------V~e~~~  352 (563)
                      ..++|+..+.||+|+||.||+|.++++.||||.++... .++|.+|+++|++++||||                |+||++
T Consensus       191 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~  270 (450)
T 1k9a_A          191 NMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA  270 (450)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEESSCTTSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCT
T ss_pred             ChHHeEEEeeecCcCCeeEEEEEecCCeEEEEEeCCchHHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecC
Confidence            34678889999999999999999999999999998653 5789999999999999997                579999


Q ss_pred             CCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccccccc
Q 044997          353 NGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNE  432 (563)
Q Consensus       353 ~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~  432 (563)
                      +|+|.+++...   +...+++..++.++.|++.||+|||+++   ++||||||+|||+++++.+||+|||+++.....  
T Consensus       271 ~g~L~~~l~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--  342 (450)
T 1k9a_A          271 KGSLVDYLRSR---GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--  342 (450)
T ss_dssp             TCBHHHHHHHH---CTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC----
T ss_pred             CCcHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccccc--
Confidence            99999999752   3345899999999999999999999997   999999999999999999999999999853321  


Q ss_pred             cccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCCCcCCCCCc-----------
Q 044997          433 KEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIRDDSEP-----------  500 (563)
Q Consensus       433 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p~~~~~~~~-----------  500 (563)
                          .....++..|+|||.+.+..             ++.++|||||||++|||++ |+.||.......           
T Consensus       343 ----~~~~~~~~~y~aPE~~~~~~-------------~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~  405 (450)
T 1k9a_A          343 ----QDTGKLPVKWTAPEALREKK-------------FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM  405 (450)
T ss_dssp             --------CCCTTTSCHHHHHSSC-------------CCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCC
T ss_pred             ----ccCCCCCcceeCHHHhcCCC-------------CCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC
Confidence                11235788999999886544             4899999999999999998 999986543321           


Q ss_pred             hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 044997          501 TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMIT  541 (563)
Q Consensus       501 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~  541 (563)
                      ..+..+++.+.+++.+||+.||.+|||+.++++.|+++...
T Consensus       406 ~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~  446 (450)
T 1k9a_A          406 DAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH  446 (450)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence            11233456799999999999999999999999999998764

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=7.9e-40  Score=331.66  Aligned_cols=219  Identities=24%  Similarity=0.444  Sum_probs=185.2

Q ss_pred             hcCCCccceecccCcEEEEEEEE--CCceEEEEEeccC---ChHHHHHHHHHHHhccccce---------------EEEe
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSN---KSKEFFAELKVLCKIHHINV---------------FIST  350 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~---~~~~f~~Ei~~l~~l~H~ni---------------V~e~  350 (563)
                      .++|+..+.||+|+||.||+|..  +++.||||++...   ..+.+.+|+.++++++||||               |+||
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   98 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence            46799999999999999999986  5789999998643   35678999999999999997               5799


Q ss_pred             ecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccccc
Q 044997          351 FGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERT  430 (563)
Q Consensus       351 ~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~  430 (563)
                      +++|+|.+++..      ..+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus        99 ~~~~~L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  169 (297)
T 3fxz_A           99 LAGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  169 (297)
T ss_dssp             CTTCBHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             CCCCCHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCc
Confidence            999999999864      35899999999999999999999997   999999999999999999999999998865432


Q ss_pred             cccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCC-----------
Q 044997          431 NEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE-----------  499 (563)
Q Consensus       431 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~-----------  499 (563)
                      ..   ......||+.|+|||.+.+..+             +.++||||||+++|||++|+.||......           
T Consensus       170 ~~---~~~~~~gt~~y~aPE~~~~~~~-------------~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  233 (297)
T 3fxz_A          170 QS---KRSTMVGTPYWMAPEVVTRKAY-------------GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT  233 (297)
T ss_dssp             TC---CBCCCCSCGGGCCHHHHHCSCB-------------CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCS
T ss_pred             cc---ccCCccCCcCccChhhhcCCCC-------------CcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC
Confidence            21   2334579999999998865544             88999999999999999999999654321           


Q ss_pred             --chhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          500 --PTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       500 --~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                        ......+...+.+++.+||+.||++|||+.|+++.
T Consensus       234 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  270 (297)
T 3fxz_A          234 PELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  270 (297)
T ss_dssp             CCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             CCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence              11223455668999999999999999999999873

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=4.8e-40  Score=341.32  Aligned_cols=244  Identities=25%  Similarity=0.369  Sum_probs=198.0

Q ss_pred             ccCHHHHHHHhcCCCccceecccCcEEEEEEEEC-------CceEEEEEeccCC----hHHHHHHHHHHHhc-cccce--
Q 044997          281 IFSLEEIEEATNNFDESRIIGRGGFGNVYFGLLG-------DREAAIKKMRSNK----SKEFFAELKVLCKI-HHINV--  346 (563)
Q Consensus       281 ~~~~~el~~~~~~f~~~~~LG~G~fG~Vy~g~~~-------~~~vavK~~~~~~----~~~f~~Ei~~l~~l-~H~ni--  346 (563)
                      .+...+++...++|...+.||+|+||.||+|++.       ++.||||+++...    .+.+.+|++++.++ +||||  
T Consensus        11 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~   90 (359)
T 3vhe_A           11 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN   90 (359)
T ss_dssp             CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             CCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceee
Confidence            4566677777889999999999999999999852       3689999997643    24689999999999 88997  


Q ss_pred             --------------EEEeecCCCccccccccccc----------------------------------------------
Q 044997          347 --------------FISTFGNGSLSDHLHDPLLK----------------------------------------------  366 (563)
Q Consensus       347 --------------V~e~~~~gsL~~~L~~~~~~----------------------------------------------  366 (563)
                                    |+||+.+|+|.+++......                                              
T Consensus        91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (359)
T 3vhe_A           91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE  170 (359)
T ss_dssp             EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred             eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence                          57999999999998753210                                              


Q ss_pred             ---------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccccccc
Q 044997          367 ---------------GHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTN  431 (563)
Q Consensus       367 ---------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~  431 (563)
                                     ....+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++......
T Consensus       171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~  247 (359)
T 3vhe_A          171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDP  247 (359)
T ss_dssp             -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred             cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence                           0122899999999999999999999997   9999999999999999999999999998654332


Q ss_pred             ccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCCCcCCCCCchhh-------
Q 044997          432 EKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIRDDSEPTKM-------  503 (563)
Q Consensus       432 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p~~~~~~~~~~~-------  503 (563)
                      .. .......||+.|+|||++.+..             ++.++||||||+++|||++ |+.||..........       
T Consensus       248 ~~-~~~~~~~~t~~y~aPE~~~~~~-------------~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~  313 (359)
T 3vhe_A          248 DY-VRKGDARLPLKWMAPETIFDRV-------------YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT  313 (359)
T ss_dssp             TC-EEC--CEECGGGCCHHHHHHCC-------------CCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTC
T ss_pred             cc-hhccccCCCceeEChhhhcCCC-------------CCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCC
Confidence            21 1233456889999999885444             4899999999999999998 999997654332211       


Q ss_pred             -----HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 044997          504 -----KSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMIT  541 (563)
Q Consensus       504 -----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~  541 (563)
                           ....+.+.+++.+||+.||.+||++.|+++.|+++++.
T Consensus       314 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~  356 (359)
T 3vhe_A          314 RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  356 (359)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence                 22345689999999999999999999999999999864

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=1.8e-39  Score=332.82  Aligned_cols=229  Identities=24%  Similarity=0.410  Sum_probs=191.4

Q ss_pred             ccCHHHHHHHhcC----------CCccceecccCcEEEEEEEEC--CceEEEEEeccC---ChHHHHHHHHHHHhccccc
Q 044997          281 IFSLEEIEEATNN----------FDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSN---KSKEFFAELKVLCKIHHIN  345 (563)
Q Consensus       281 ~~~~~el~~~~~~----------f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~---~~~~f~~Ei~~l~~l~H~n  345 (563)
                      .+++++++.+++.          |+..+.||+|+||.||+|+..  ++.||||.++..   ..+.+.+|+.++++++|||
T Consensus        24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n  103 (321)
T 2c30_A           24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN  103 (321)
T ss_dssp             -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTT
T ss_pred             cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCC
Confidence            5788898888865          667789999999999999884  789999998643   3467899999999999999


Q ss_pred             e---------------EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEe
Q 044997          346 V---------------FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILL  410 (563)
Q Consensus       346 i---------------V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl  410 (563)
                      |               |+||+++|+|.+++..      ..++|..+..++.|++.||+|||+++   ++||||||+|||+
T Consensus       104 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~------~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll  174 (321)
T 2c30_A          104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ------VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILL  174 (321)
T ss_dssp             BCCEEEEEEETTEEEEEECCCCSCBHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEE
T ss_pred             cceEEEEEEECCEEEEEEecCCCCCHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEE
Confidence            7               5799999999998864      45999999999999999999999997   9999999999999


Q ss_pred             cCCCcEEEeecCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCC
Q 044997          411 DDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK  490 (563)
Q Consensus       411 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~  490 (563)
                      +.++++||+|||+++.......   ......||+.|+|||++.+..             ++.++||||||+++|||++|+
T Consensus       175 ~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~-------------~~~~~Dv~slG~il~el~~g~  238 (321)
T 2c30_A          175 TLDGRVKLSDFGFCAQISKDVP---KRKSLVGTPYWMAPEVISRSL-------------YATEVDIWSLGIMVIEMVDGE  238 (321)
T ss_dssp             CTTCCEEECCCTTCEECCSSSC---CBCCCCSCGGGCCHHHHTTCC-------------BCTHHHHHHHHHHHHHHHHSS
T ss_pred             CCCCcEEEeeeeeeeecccCcc---ccccccCCccccCHhhhcCCC-------------CCchhhHHHHHHHHHHHHhCC
Confidence            9999999999999986543221   123457999999999886544             488999999999999999999


Q ss_pred             CCCcCCCCCc-------------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          491 RALIRDDSEP-------------TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       491 ~p~~~~~~~~-------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                      .||.......             .....+...+.+++.+||+.||++||++.|+++.
T Consensus       239 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  295 (321)
T 2c30_A          239 PPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDH  295 (321)
T ss_dssp             CTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             CCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            9996543211             1122345668999999999999999999999874

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=7e-40  Score=326.41  Aligned_cols=228  Identities=25%  Similarity=0.416  Sum_probs=190.4

Q ss_pred             cCCCccceecccCcEEEEEEEE-CCceEEEEEeccCC--hHHHHHHHHHHHhccccce---------------EEEeecC
Q 044997          292 NNFDESRIIGRGGFGNVYFGLL-GDREAAIKKMRSNK--SKEFFAELKVLCKIHHINV---------------FISTFGN  353 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~-~~~~vavK~~~~~~--~~~f~~Ei~~l~~l~H~ni---------------V~e~~~~  353 (563)
                      ++|+..+.||+|+||.||+|+. +++.||+|+++...  .+++.+|++++++++||||               |+||+++
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   89 (269)
T 4hcu_A           10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEH   89 (269)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTT
T ss_pred             hhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCC
Confidence            4688889999999999999998 57889999997653  5779999999999999997               5799999


Q ss_pred             CCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccccccccc
Q 044997          354 GSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEK  433 (563)
Q Consensus       354 gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~  433 (563)
                      |+|.+++..    ....+++..+..++.|++.||+|||+++   ++||||||+||+++.++.+||+|||+++....... 
T Consensus        90 ~~L~~~l~~----~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-  161 (269)
T 4hcu_A           90 GCLSDYLRT----QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-  161 (269)
T ss_dssp             CBHHHHHHT----TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH-
T ss_pred             CcHHHHHHh----cCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEecccccccccccccc-
Confidence            999999965    2456999999999999999999999998   99999999999999999999999999986543221 


Q ss_pred             ccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCCCcCCCCCc-----------h
Q 044997          434 EMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIRDDSEP-----------T  501 (563)
Q Consensus       434 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p~~~~~~~~-----------~  501 (563)
                       .......+|+.|+|||.+.+..             ++.++||||||+++|||++ |+.||.......           .
T Consensus       162 -~~~~~~~~~~~y~aPE~~~~~~-------------~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~  227 (269)
T 4hcu_A          162 -TSSTGTKFPVKWASPEVFSFSR-------------YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLY  227 (269)
T ss_dssp             -HSTTSTTCCGGGCCHHHHHHCC-------------CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC
T ss_pred             -ccccCcccccccCCHHHhcCCC-------------CCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCC
Confidence             1223345778899999885444             4889999999999999999 888886543211           1


Q ss_pred             hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 044997          502 KMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMIT  541 (563)
Q Consensus       502 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~  541 (563)
                      ......+.+.+++.+||+.||.+||++.|+++.|+++.++
T Consensus       228 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~  267 (269)
T 4hcu_A          228 KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES  267 (269)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             CCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence            1122345689999999999999999999999999999865

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.6e-39  Score=332.39  Aligned_cols=242  Identities=21%  Similarity=0.343  Sum_probs=189.3

Q ss_pred             HHHhcCCCccceecccCcEEEEEEEECCceEEEEEeccCChHHHHHHHHHHHhc--cccce-------------------
Q 044997          288 EEATNNFDESRIIGRGGFGNVYFGLLGDREAAIKKMRSNKSKEFFAELKVLCKI--HHINV-------------------  346 (563)
Q Consensus       288 ~~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~vavK~~~~~~~~~f~~Ei~~l~~l--~H~ni-------------------  346 (563)
                      ....++|+..+.||+|+||.||+|+.+++.||||++.......+.+|.+++..+  +||||                   
T Consensus        33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~l  112 (337)
T 3mdy_A           33 RTIAKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYL  112 (337)
T ss_dssp             TTHHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEE
T ss_pred             cccccceEEEeEeecCCCeEEEEEEECCceEEEEEEeccccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEE
Confidence            445578999999999999999999999999999999877777777787777665  89986                   


Q ss_pred             EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCceEeCCCCCCCeEecCCCcEEEeec
Q 044997          347 FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHT-----KARYVHRDIKTSNILLDDGLRAKVADF  421 (563)
Q Consensus       347 V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~ivHrDLk~~NILl~~~~~~kl~DF  421 (563)
                      |+||+++|+|.+++..      ..+++..++.++.|++.||+|||++.     .++|+||||||+|||++.++.+||+||
T Consensus       113 v~e~~~~g~L~~~l~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Df  186 (337)
T 3mdy_A          113 ITDYHENGSLYDYLKS------TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADL  186 (337)
T ss_dssp             EECCCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCC
T ss_pred             EEeccCCCcHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeC
Confidence            5788999999999964      35899999999999999999999871     113999999999999999999999999


Q ss_pred             CCCccccccccc-ccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcC----------C
Q 044997          422 GLVKLEERTNEK-EMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG----------K  490 (563)
Q Consensus       422 Gla~~~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg----------~  490 (563)
                      |+++........ ........||+.|+|||++.+..+.       .....+.++|||||||++|||++|          +
T Consensus       187 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-------~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~  259 (337)
T 3mdy_A          187 GLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNR-------NHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQ  259 (337)
T ss_dssp             TTCEECC---------CCSSCSCGGGCCHHHHTTCCCT-------TCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred             CCceeeccccccccCCCCCCccCcceeChhhcccccCC-------ccccCccccchHHHHHHHHHHHhccCccccccccc
Confidence            999765433221 1112245799999999998655431       000112359999999999999999          5


Q ss_pred             CCCcCCCCCc----------------------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcC
Q 044997          491 RALIRDDSEP----------------------TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITS  542 (563)
Q Consensus       491 ~p~~~~~~~~----------------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~  542 (563)
                      .||.......                      .....+.+.+.+++.+||+.||.+||++.|+++.|+++.++.
T Consensus       260 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~  333 (337)
T 3mdy_A          260 LPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ  333 (337)
T ss_dssp             CTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred             ccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence            5654321110                      001256677999999999999999999999999999988753

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=3.9e-40  Score=338.45  Aligned_cols=232  Identities=25%  Similarity=0.394  Sum_probs=185.6

Q ss_pred             cCCCccceecccCcEEEEEEEEC--Cc----eEEEEEeccC----ChHHHHHHHHHHHhccccce--------------E
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG--DR----EAAIKKMRSN----KSKEFFAELKVLCKIHHINV--------------F  347 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~--~~----~vavK~~~~~----~~~~f~~Ei~~l~~l~H~ni--------------V  347 (563)
                      ++|+..+.||+|+||.||+|++.  ++    +||+|.++..    ..++|.+|++++++++||||              |
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~v   94 (327)
T 3poz_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLI   94 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSSEEEE
T ss_pred             HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEE
Confidence            46888999999999999999873  33    3688887543    34679999999999999997              5


Q ss_pred             EEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccc
Q 044997          348 ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLE  427 (563)
Q Consensus       348 ~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~  427 (563)
                      ++|+.+|+|.+++..    ....+++..++.++.|++.||+|||+++   |+||||||+|||++.++++||+|||+++..
T Consensus        95 ~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~  167 (327)
T 3poz_A           95 TQLMPFGCLLDYVRE----HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL  167 (327)
T ss_dssp             EECCTTCBHHHHHHH----STTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred             EEecCCCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEc
Confidence            789999999999875    2456999999999999999999999997   999999999999999999999999999865


Q ss_pred             ccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCCCcCCCCCc------
Q 044997          428 ERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIRDDSEP------  500 (563)
Q Consensus       428 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p~~~~~~~~------  500 (563)
                      ...... .......+|..|+|||++.+..             ++.++|||||||++|||++ |+.||.......      
T Consensus       168 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~-------------~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~  233 (327)
T 3poz_A          168 GAEEKE-YHAEGGKVPIKWMALESILHRI-------------YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE  233 (327)
T ss_dssp             TTTCC--------CCCGGGSCHHHHHHCC-------------CCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH
T ss_pred             cCCccc-ccccCCCccccccChHHhccCC-------------CCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHH
Confidence            433221 1223345788999999886544             4899999999999999999 999986543211      


Q ss_pred             -----hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcChh
Q 044997          501 -----TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITSTE  544 (563)
Q Consensus       501 -----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~  544 (563)
                           .........+.+++.+||+.||.+||++.|+++.|+++......
T Consensus       234 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~~~  282 (327)
T 3poz_A          234 KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQR  282 (327)
T ss_dssp             TTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTSHHH
T ss_pred             cCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhhhhh
Confidence                 11122345689999999999999999999999999998875443

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=1.9e-39  Score=327.59  Aligned_cols=229  Identities=20%  Similarity=0.272  Sum_probs=188.6

Q ss_pred             cCCCccceecccCcEEEEEEEE--CCceEEEEEeccC-ChHHHHHHHHHHHhc-cccce---------------EEEeec
Q 044997          292 NNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSN-KSKEFFAELKVLCKI-HHINV---------------FISTFG  352 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~-~~~~f~~Ei~~l~~l-~H~ni---------------V~e~~~  352 (563)
                      ++|+..+.||+|+||.||+|+.  +++.||||.+... ..+.+.+|++++.++ +|+|+               |+||+ 
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-   88 (298)
T 1csn_A           10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-   88 (298)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-
T ss_pred             cceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-
Confidence            5688999999999999999985  5789999998654 345688999999999 67765               67888 


Q ss_pred             CCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCc-----EEEeecCCCccc
Q 044997          353 NGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLR-----AKVADFGLVKLE  427 (563)
Q Consensus       353 ~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~-----~kl~DFGla~~~  427 (563)
                      +|+|.+++..    ....+++..+..++.|++.||+|||+++   |+||||||+|||++.++.     +||+|||+++..
T Consensus        89 ~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~  161 (298)
T 1csn_A           89 GPSLEDLLDL----CGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY  161 (298)
T ss_dssp             CCBHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred             CCCHHHHHHH----hccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECcccccc
Confidence            9999999975    2356999999999999999999999987   999999999999987766     999999999866


Q ss_pred             ccccccc----cccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCchh-
Q 044997          428 ERTNEKE----MLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTK-  502 (563)
Q Consensus       428 ~~~~~~~----~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~~-  502 (563)
                      .......    .......||+.|+|||.+.+..             ++.++||||||+++|||++|+.||......... 
T Consensus       162 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------------~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~  228 (298)
T 1csn_A          162 RDPVTKQHIPYREKKNLSGTARYMSINTHLGRE-------------QSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQ  228 (298)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC-------------CCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHH
T ss_pred             ccccccccccccCccCCCCCcccCCchhhcCCC-------------CChHHHHHHHHHHHHHHHcCCCCcchhhccccHH
Confidence            5432211    1123467999999999885544             488999999999999999999999765432110 


Q ss_pred             -h----------------HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 044997          503 -M----------------KSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMIT  541 (563)
Q Consensus       503 -~----------------~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~  541 (563)
                       .                ..+++.+.+++.+||+.||.+||++++|++.|++++..
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~  284 (298)
T 1csn_A          229 KYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER  284 (298)
T ss_dssp             HHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHhhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHh
Confidence             0                12345689999999999999999999999999998753

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=9.4e-40  Score=336.05  Aligned_cols=220  Identities=24%  Similarity=0.383  Sum_probs=184.5

Q ss_pred             hcCCCccceecccCcEEEEEEEE--CCceEEEEEeccCC-----hHHHHHHHHHHHhccccce---------------EE
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNK-----SKEFFAELKVLCKIHHINV---------------FI  348 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~-----~~~f~~Ei~~l~~l~H~ni---------------V~  348 (563)
                      .++|...+.||+|+||.||+|+.  +++.||||++....     .+.+.+|+++|++++||||               |+
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   93 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM   93 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            35789999999999999999987  57899999986532     3568899999999999997               57


Q ss_pred             EeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccc
Q 044997          349 STFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEE  428 (563)
Q Consensus       349 e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~  428 (563)
                      ||+++|+|.+++..     ...+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus        94 e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~  165 (328)
T 3fe3_A           94 EYASGGEVFDYLVA-----HGRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFT  165 (328)
T ss_dssp             CCCTTCBHHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGS
T ss_pred             ECCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecC
Confidence            99999999999865     256999999999999999999999997   9999999999999999999999999998654


Q ss_pred             cccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCch-------
Q 044997          429 RTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPT-------  501 (563)
Q Consensus       429 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~-------  501 (563)
                      ...    ......||+.|+|||++.+..+            .++++|||||||++|||++|+.||........       
T Consensus       166 ~~~----~~~~~~gt~~y~aPE~~~~~~~------------~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~  229 (328)
T 3fe3_A          166 VGG----KLDAFCGAPPYAAPELFQGKKY------------DGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRG  229 (328)
T ss_dssp             SSC----GGGTTSSSGGGCCHHHHHTCCC------------CSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC
T ss_pred             CCC----ccccccCCcceeCcccccCCCc------------CCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Confidence            322    2344679999999999866544            25799999999999999999999975432111       


Q ss_pred             ---hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          502 ---KMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       502 ---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                         .+......+.+++.+||+.||.+|||++|+++.
T Consensus       230 ~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  265 (328)
T 3fe3_A          230 KYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD  265 (328)
T ss_dssp             CCCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred             CCCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence               111234568999999999999999999999874

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=2.4e-39  Score=332.72  Aligned_cols=235  Identities=19%  Similarity=0.306  Sum_probs=192.8

Q ss_pred             cCCCccceecccCcEEEEEEEE--CCceEEEEEeccC-ChHHHHHHHHHHHhc-cccce---------------EEEeec
Q 044997          292 NNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSN-KSKEFFAELKVLCKI-HHINV---------------FISTFG  352 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~-~~~~f~~Ei~~l~~l-~H~ni---------------V~e~~~  352 (563)
                      ++|+..+.||+|+||.||+|+.  +++.||||.+... ..+.+.+|+++++++ +|+||               |+||+ 
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-   87 (330)
T 2izr_A            9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-   87 (330)
T ss_dssp             TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-
T ss_pred             CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-
Confidence            5788999999999999999986  5789999998754 345688999999999 99997               57888 


Q ss_pred             CCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCc-----EEEeecCCCccc
Q 044997          353 NGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLR-----AKVADFGLVKLE  427 (563)
Q Consensus       353 ~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~-----~kl~DFGla~~~  427 (563)
                      +|+|.+++...    ...+++..++.++.|++.||+|||+++   |+||||||+|||++.++.     +||+|||+++..
T Consensus        88 ~~~L~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~  160 (330)
T 2izr_A           88 GPSLEDLFDLC----DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY  160 (330)
T ss_dssp             CCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred             CCCHHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence            89999998752    357999999999999999999999997   999999999999998887     999999999865


Q ss_pred             cccccccc----ccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCchh-
Q 044997          428 ERTNEKEM----LATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTK-  502 (563)
Q Consensus       428 ~~~~~~~~----~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~~-  502 (563)
                      ........    ......||+.|+|||++.+..             ++.++|||||||++|||++|+.||......... 
T Consensus       161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------------~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~  227 (330)
T 2izr_A          161 IDPETKKHIPYREHKSLTGTARYMSINTHLGKE-------------QSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKE  227 (330)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC-------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHH
T ss_pred             ecCCCCccccccccCCcCCCccccChHHHcCCC-------------CCchhHHHHHHHHHHHHhcCCCCccccccccHHH
Confidence            43322111    123467999999999886544             488999999999999999999999765432210 


Q ss_pred             -hH----------------HHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc-------Chhhhcc
Q 044997          503 -MK----------------SLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMIT-------STEWEAS  548 (563)
Q Consensus       503 -~~----------------~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~-------~~~w~~~  548 (563)
                       ..                ..+ .+.+++.+||+.||.+||++.+|.+.|+++...       ..+|+..
T Consensus       228 ~~~~i~~~~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~~~  296 (330)
T 2izr_A          228 RYQKIGDTKRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMFDYEYDWIGK  296 (330)
T ss_dssp             HHHHHHHHHHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCCSCCCTTTTS
T ss_pred             HHHHHHhhhccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCCCCCCCccCCCC
Confidence             00                122 789999999999999999999999999988764       3578753

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=2.9e-39  Score=325.70  Aligned_cols=231  Identities=23%  Similarity=0.322  Sum_probs=187.0

Q ss_pred             HhcCCCccceecccCcEEEEEEEE--CCceEEEEEeccC-ChHHHHHHHHHHHhccccce----------------EEEe
Q 044997          290 ATNNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSN-KSKEFFAELKVLCKIHHINV----------------FIST  350 (563)
Q Consensus       290 ~~~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~-~~~~f~~Ei~~l~~l~H~ni----------------V~e~  350 (563)
                      ..++|+..+.||+|+||.||+|+.  .++.||||.+... ..+++.+|++++++++|+++                |+||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~   86 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL   86 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEc
Confidence            457899999999999999999986  5789999987544 34568899999999998774                5788


Q ss_pred             ecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEe---cCCCcEEEeecCCCccc
Q 044997          351 FGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILL---DDGLRAKVADFGLVKLE  427 (563)
Q Consensus       351 ~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl---~~~~~~kl~DFGla~~~  427 (563)
                      + +|+|.+++..    ....+++..+..++.|++.||.|||+++   |+||||||+|||+   ++++.+||+|||+++..
T Consensus        87 ~-~~~L~~~~~~----~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~  158 (296)
T 4hgt_A           87 L-GPSLEDLFNF----CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  158 (296)
T ss_dssp             C-CCBHHHHHHH----TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred             c-CCCHHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence            8 9999999864    2356999999999999999999999998   9999999999999   78899999999999865


Q ss_pred             ccccccc----cccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc--h
Q 044997          428 ERTNEKE----MLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP--T  501 (563)
Q Consensus       428 ~~~~~~~----~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~--~  501 (563)
                      .......    .......||+.|+|||.+.+..             ++.++|||||||++|||++|+.||.......  .
T Consensus       159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------------~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~  225 (296)
T 4hgt_A          159 RDARTHQHIPYRENKNLTGTARYASINTHLGIE-------------QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQ  225 (296)
T ss_dssp             BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCC-------------CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSS
T ss_pred             cCcccCccCCCCcccccCCCccccchHHhcCCC-------------CCchhHHHHHHHHHHHHhcCCCCCcccchhhhhh
Confidence            5432211    1123467999999999886544             4889999999999999999999997643321  0


Q ss_pred             hh----------------HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 044997          502 KM----------------KSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMIT  541 (563)
Q Consensus       502 ~~----------------~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~  541 (563)
                      ..                ..+++.+.+++.+||+.||++||++.++++.|++++..
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~  281 (296)
T 4hgt_A          226 KYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR  281 (296)
T ss_dssp             HHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHH
T ss_pred             hhhhhhcccccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHH
Confidence            00                12245689999999999999999999999999998863

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=3.9e-39  Score=327.98  Aligned_cols=231  Identities=27%  Similarity=0.456  Sum_probs=185.8

Q ss_pred             cCCCccceecccCcEEEEEEEECCceEEEEEeccCC-hHHHHHHHHHHHhccccce-------------EEEeecCCCcc
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLGDREAAIKKMRSNK-SKEFFAELKVLCKIHHINV-------------FISTFGNGSLS  357 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~~~~vavK~~~~~~-~~~f~~Ei~~l~~l~H~ni-------------V~e~~~~gsL~  357 (563)
                      ++|+..+.||+|+||.||+|++.++.||||.+.... .+.|.+|++++++++||||             |+||+++|+|.
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~lv~e~~~~~~L~   87 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACLNPVCLVMEYAEGGSLY   87 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEETTEEEEEEECSSTTHHHHHHHHHHHHHHCCCTTBCCEEEBCTTTTEEEEECCTTCBHH
T ss_pred             hHeeeeeEeecCCCceEEEEEECCeeEEEEEecChhHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCcEEEEEcCCCCCHH
Confidence            467888999999999999999999999999997654 4679999999999999997             68999999999


Q ss_pred             cccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCc-EEEeecCCCcccccccccccc
Q 044997          358 DHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLR-AKVADFGLVKLEERTNEKEML  436 (563)
Q Consensus       358 ~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~-~kl~DFGla~~~~~~~~~~~~  436 (563)
                      +++....  ....+++..++.++.|+++||+|||+.+..+|+||||||+|||++.++. +||+|||+++.....      
T Consensus        88 ~~l~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~------  159 (307)
T 2eva_A           88 NVLHGAE--PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH------  159 (307)
T ss_dssp             HHHHCSS--SEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-------------
T ss_pred             HHHhccC--CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc------
Confidence            9997521  1235789999999999999999999943234999999999999998886 799999999754321      


Q ss_pred             cccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCch-------------hh
Q 044997          437 ATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPT-------------KM  503 (563)
Q Consensus       437 ~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~-------------~~  503 (563)
                      .....||+.|+|||.+.+..             ++.++||||||+++|||++|+.||........             ..
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~-------------~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  226 (307)
T 2eva_A          160 MTNNKGSAAWMAPEVFEGSN-------------YSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLI  226 (307)
T ss_dssp             -----CCTTSSCHHHHTCCC-------------CCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCB
T ss_pred             cccCCCCCceEChhhhCCCC-------------CCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCcc
Confidence            12346899999999885443             48999999999999999999999965432211             12


Q ss_pred             HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcCh
Q 044997          504 KSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITST  543 (563)
Q Consensus       504 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~  543 (563)
                      ..++..+.+++.+||+.||.+|||+.|+++.|+++.....
T Consensus       227 ~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~  266 (307)
T 2eva_A          227 KNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFP  266 (307)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCC
T ss_pred             cccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhcc
Confidence            2345668999999999999999999999999999876544

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=4e-40  Score=353.76  Aligned_cols=235  Identities=23%  Similarity=0.417  Sum_probs=194.0

Q ss_pred             HHHHhcCCCccceecccCcEEEEEEEEC-CceEEEEEeccC--ChHHHHHHHHHHHhccccce--------------EEE
Q 044997          287 IEEATNNFDESRIIGRGGFGNVYFGLLG-DREAAIKKMRSN--KSKEFFAELKVLCKIHHINV--------------FIS  349 (563)
Q Consensus       287 l~~~~~~f~~~~~LG~G~fG~Vy~g~~~-~~~vavK~~~~~--~~~~f~~Ei~~l~~l~H~ni--------------V~e  349 (563)
                      ++...++|+..+.||+|+||.||+|.++ +..||||.++..  ..++|.+|+++|++++||||              |+|
T Consensus       183 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~lv~e  262 (454)
T 1qcf_A          183 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITE  262 (454)
T ss_dssp             SBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEEC
T ss_pred             eeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEeCCccEEEEe
Confidence            3445677889999999999999999985 678999999864  35789999999999999997              689


Q ss_pred             eecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccccc
Q 044997          350 TFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEER  429 (563)
Q Consensus       350 ~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~  429 (563)
                      |+.+|+|.+++...   ....+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus       263 ~~~~g~L~~~l~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~  336 (454)
T 1qcf_A          263 FMAKGSLLDFLKSD---EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIED  336 (454)
T ss_dssp             CCTTCBHHHHHHSH---HHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCC
T ss_pred             ecCCCcHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCC
Confidence            99999999999752   1235899999999999999999999997   99999999999999999999999999986543


Q ss_pred             ccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCCCcCCCCCc--------
Q 044997          430 TNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIRDDSEP--------  500 (563)
Q Consensus       430 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p~~~~~~~~--------  500 (563)
                      ...  .......++..|+|||++....             ++.++|||||||++|||++ |+.||.......        
T Consensus       337 ~~~--~~~~~~~~~~~y~aPE~~~~~~-------------~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~  401 (454)
T 1qcf_A          337 NEY--TAREGAKFPIKWTAPEAINFGS-------------FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG  401 (454)
T ss_dssp             HHH--HTTCSSSSCGGGSCHHHHHHCC-------------CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHT
T ss_pred             Cce--eccCCCcccccccCHHHhccCC-------------CCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence            211  1122345678899999885443             4899999999999999999 999986533211        


Q ss_pred             ---hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcC
Q 044997          501 ---TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITS  542 (563)
Q Consensus       501 ---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~  542 (563)
                         .....+++.+.+++.+||+.||++|||+.+|++.|+++....
T Consensus       402 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~  446 (454)
T 1qcf_A          402 YRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTAT  446 (454)
T ss_dssp             CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSS
T ss_pred             CCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcc
Confidence               112234567899999999999999999999999999987643

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=3.8e-39  Score=325.13  Aligned_cols=230  Identities=23%  Similarity=0.323  Sum_probs=189.9

Q ss_pred             hcCCCccceecccCcEEEEEEEE--CCceEEEEEeccC-ChHHHHHHHHHHHhccccce----------------EEEee
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSN-KSKEFFAELKVLCKIHHINV----------------FISTF  351 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~-~~~~f~~Ei~~l~~l~H~ni----------------V~e~~  351 (563)
                      .++|+..+.||+|+||.||+|+.  +++.||||.+... ..+++.+|++++++++|+++                |+||+
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~   87 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL   87 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec
Confidence            46789999999999999999996  5789999998654 34678999999999998773                67888


Q ss_pred             cCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEe---cCCCcEEEeecCCCcccc
Q 044997          352 GNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILL---DDGLRAKVADFGLVKLEE  428 (563)
Q Consensus       352 ~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl---~~~~~~kl~DFGla~~~~  428 (563)
                       +|+|.+++..    ....+++..+..++.|++.||+|||+++   ++||||||+|||+   ++++.+||+|||+++...
T Consensus        88 -~~~L~~~~~~----~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~  159 (296)
T 3uzp_A           88 -GPSLEDLFNF----CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  159 (296)
T ss_dssp             -CCBHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             -CCCHHHHHHh----hccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence             8999999863    2356999999999999999999999997   9999999999999   488999999999998655


Q ss_pred             cccccc----cccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc--hh
Q 044997          429 RTNEKE----MLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP--TK  502 (563)
Q Consensus       429 ~~~~~~----~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~--~~  502 (563)
                      ......    .......||+.|+|||.+.+..             ++.++||||||+++|||++|+.||.......  ..
T Consensus       160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------------~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~  226 (296)
T 3uzp_A          160 DARTHQHIPYRENKNLTGTARYASINTHLGIE-------------QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK  226 (296)
T ss_dssp             CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCC-------------CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSH
T ss_pred             ccccccccccccccccccccccCChhhhcCCC-------------CCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhh
Confidence            432211    1123467999999999886544             4889999999999999999999997643211  00


Q ss_pred             h----------------HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 044997          503 M----------------KSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMIT  541 (563)
Q Consensus       503 ~----------------~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~  541 (563)
                      .                ..+++.+.+++.+||+.||.+||++.+|++.|+++...
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  281 (296)
T 3uzp_A          227 YERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR  281 (296)
T ss_dssp             HHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHH
T ss_pred             hhhhcccccCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHh
Confidence            0                12345689999999999999999999999999998754

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=1.7e-39  Score=323.56  Aligned_cols=223  Identities=29%  Similarity=0.451  Sum_probs=179.5

Q ss_pred             cCCCccceecccCcEEEEEEEECCceEEEEEeccCC-------hHHHHHHHHHHHhccccce---------------EEE
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLGDREAAIKKMRSNK-------SKEFFAELKVLCKIHHINV---------------FIS  349 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~~~~vavK~~~~~~-------~~~f~~Ei~~l~~l~H~ni---------------V~e  349 (563)
                      ++|+..+.||+|+||.||+|...++.+|||.++...       .+.+.+|++++++++||||               |+|
T Consensus         7 ~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (271)
T 3dtc_A            7 AELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVME   86 (271)
T ss_dssp             TSEEEEEEEEEETTEEEEEEEETTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEE
T ss_pred             hheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEE
Confidence            578889999999999999999999999999986432       3678899999999999997               579


Q ss_pred             eecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecC--------CCcEEEeec
Q 044997          350 TFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDD--------GLRAKVADF  421 (563)
Q Consensus       350 ~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~--------~~~~kl~DF  421 (563)
                      |+++|+|.+++..      ..+++..+..++.|++.||+|||+++..+++||||||+|||++.        ++.+||+||
T Consensus        87 ~~~~~~L~~~~~~------~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df  160 (271)
T 3dtc_A           87 FARGGPLNRVLSG------KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF  160 (271)
T ss_dssp             CCTTEEHHHHHTS------SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred             cCCCCCHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence            9999999988853      46899999999999999999999987666999999999999986        778999999


Q ss_pred             CCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc-
Q 044997          422 GLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP-  500 (563)
Q Consensus       422 Gla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~-  500 (563)
                      |+++......     .....||+.|+|||.+.+..             +++++||||||+++|||++|+.||....... 
T Consensus       161 g~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~-------------~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~  222 (271)
T 3dtc_A          161 GLAREWHRTT-----KMSAAGAYAWMAPEVIRASM-------------FSKGSDVWSYGVLLWELLTGEVPFRGIDGLAV  222 (271)
T ss_dssp             CC------------------CCGGGSCHHHHHHCC-------------CSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHH
T ss_pred             Cccccccccc-----ccCCCCccceeCHHHhccCC-------------CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            9998544322     12346899999999875443             4889999999999999999999996543211 


Q ss_pred             -----------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 044997          501 -----------TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQI  538 (563)
Q Consensus       501 -----------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  538 (563)
                                 .....+++.+.+++.+||+.||.+||++.|+++.|+++
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          223 AYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             HHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             HHhhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence                       11223456689999999999999999999999999864

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1.6e-39  Score=328.82  Aligned_cols=231  Identities=24%  Similarity=0.368  Sum_probs=187.1

Q ss_pred             cCCCccceecccCcEEEEEEEE--CCceEEEEEeccCC------hHHHHHHHHHHHhccccce---------------EE
Q 044997          292 NNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNK------SKEFFAELKVLCKIHHINV---------------FI  348 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~------~~~f~~Ei~~l~~l~H~ni---------------V~  348 (563)
                      ++|+..+.||+|+||.||+++.  .++.||+|.+....      .+.|.+|++++++++||||               |+
T Consensus        11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   90 (294)
T 4eqm_A           11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVM   90 (294)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEE
Confidence            5788899999999999999987  47889999985321      2578899999999999997               67


Q ss_pred             EeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccc
Q 044997          349 STFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEE  428 (563)
Q Consensus       349 e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~  428 (563)
                      ||+++|+|.+++..     ..++++..+..++.|++.||+|||+++   ++||||||+|||++.++++||+|||+++...
T Consensus        91 e~~~g~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~  162 (294)
T 4eqm_A           91 EYIEGPTLSEYIES-----HGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALS  162 (294)
T ss_dssp             ECCCSCBHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred             eCCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence            99999999999865     246999999999999999999999997   9999999999999999999999999998654


Q ss_pred             cccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCch-------
Q 044997          429 RTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPT-------  501 (563)
Q Consensus       429 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~-------  501 (563)
                      ....  .......||+.|+|||.+.+..             ++.++||||||+++|||++|+.||........       
T Consensus       163 ~~~~--~~~~~~~gt~~y~aPE~~~~~~-------------~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~  227 (294)
T 4eqm_A          163 ETSL--TQTNHVLGTVQYFSPEQAKGEA-------------TDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQD  227 (294)
T ss_dssp             --------------CCSSCCHHHHHTCC-------------CCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSS
T ss_pred             cccc--cccCccccCccccCHhHhcCCC-------------CCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhc
Confidence            3221  1223457999999999886544             47899999999999999999999975442110       


Q ss_pred             --------hhHHHHHHHHHHHHHhhccCCCCCC-CHHHHHHHHHHhhhcChhh
Q 044997          502 --------KMKSLITIMAAVAEWCLNEDAVDRP-EMRDIVAILSQIMITSTEW  545 (563)
Q Consensus       502 --------~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~i~~~~~~w  545 (563)
                              ....+++.+.+++.+||+.||.+|| +++++.+.|++++......
T Consensus       228 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~~~  280 (294)
T 4eqm_A          228 SVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRAN  280 (294)
T ss_dssp             CCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSSTT
T ss_pred             cCCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhccCC
Confidence                    1123456799999999999999998 9999999999887765433

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=9.6e-39  Score=321.10  Aligned_cols=225  Identities=31%  Similarity=0.496  Sum_probs=186.4

Q ss_pred             cCCCccceecccCcEEEEEEEE--CCceEEEEEeccCC----------hHHHHHHHHHHHhccccce-------------
Q 044997          292 NNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNK----------SKEFFAELKVLCKIHHINV-------------  346 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~----------~~~f~~Ei~~l~~l~H~ni-------------  346 (563)
                      ++|+..+.||+|+||.||+|+.  +++.||+|.+....          .+++.+|++++++++||||             
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~l   98 (287)
T 4f0f_A           19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPRM   98 (287)
T ss_dssp             TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTTEE
T ss_pred             ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCCeE
Confidence            5788899999999999999998  47889999986432          1678999999999999997             


Q ss_pred             EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCc-----EEEeec
Q 044997          347 FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLR-----AKVADF  421 (563)
Q Consensus       347 V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~-----~kl~DF  421 (563)
                      |+||+.+|+|.+++..    ....+++..++.++.|++.||+|||+++ ++++||||||+|||++.++.     +||+||
T Consensus        99 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~Df  173 (287)
T 4f0f_A           99 VMEFVPCGDLYHRLLD----KAHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADF  173 (287)
T ss_dssp             EEECCTTCBHHHHHHC----TTSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECCC
T ss_pred             EEEecCCCCHHHHHhc----ccCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCCC
Confidence            6899999999888865    2457999999999999999999999985 34999999999999988776     999999


Q ss_pred             CCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCch
Q 044997          422 GLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPT  501 (563)
Q Consensus       422 Gla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~  501 (563)
                      |+++....      ......||+.|+|||.+...           ...++.++||||||+++|||++|+.||........
T Consensus       174 g~~~~~~~------~~~~~~g~~~y~aPE~~~~~-----------~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~  236 (287)
T 4f0f_A          174 GLSQQSVH------SVSGLLGNFQWMAPETIGAE-----------EESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI  236 (287)
T ss_dssp             TTCBCCSS------CEECCCCCCTTSCGGGSSCS-----------SCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHH
T ss_pred             Cccccccc------cccccCCCccccCchhhccC-----------CCCcCchhhHHHHHHHHHHHHcCCCCCccccccHH
Confidence            99974332      12335789999999987432           12347899999999999999999999975543221


Q ss_pred             --------------hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 044997          502 --------------KMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQI  538 (563)
Q Consensus       502 --------------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  538 (563)
                                    ....+++.+.+++.+||+.||.+||++.|+++.|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          237 KFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             HHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             HHHHHHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence                          1123455689999999999999999999999999864

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=2.5e-39  Score=337.46  Aligned_cols=230  Identities=21%  Similarity=0.284  Sum_probs=182.9

Q ss_pred             hcCCCccceecccCcEEEEEEEEC-------CceEEEEEeccCCh--------------HHHHHHHHHHHhccccce---
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLLG-------DREAAIKKMRSNKS--------------KEFFAELKVLCKIHHINV---  346 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~~-------~~~vavK~~~~~~~--------------~~f~~Ei~~l~~l~H~ni---  346 (563)
                      .++|...+.||+|+||.||+|.+.       ++.||||.+.....              ..+..|+..+.+++|+||   
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~  113 (364)
T 3op5_A           34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY  113 (364)
T ss_dssp             CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred             CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence            467899999999999999999874       36799999875532              123345556667778876   


Q ss_pred             ----------------EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEe
Q 044997          347 ----------------FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILL  410 (563)
Q Consensus       347 ----------------V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl  410 (563)
                                      |+||+ +|+|.+++..    ....+++..++.++.|++.||+|||+++   |+||||||+|||+
T Consensus       114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~----~~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill  185 (364)
T 3op5_A          114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA----NAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLL  185 (364)
T ss_dssp             EEEEEEEETTEEEEEEEEECE-EEEHHHHHHH----TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEE
T ss_pred             EeeeeeccCCcceEEEEEeCC-CCCHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEE
Confidence                            57888 8999999865    2467999999999999999999999997   9999999999999


Q ss_pred             c--CCCcEEEeecCCCccccccccccc----ccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHH
Q 044997          411 D--DGLRAKVADFGLVKLEERTNEKEM----LATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLA  484 (563)
Q Consensus       411 ~--~~~~~kl~DFGla~~~~~~~~~~~----~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~  484 (563)
                      +  .++.+||+|||+++..........    ......||+.|+|||++.+..             ++.++|||||||++|
T Consensus       186 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------------~~~~~Di~slG~~l~  252 (364)
T 3op5_A          186 NYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVA-------------PSRRGDLEILGYCMI  252 (364)
T ss_dssp             ESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCC-------------CCHHHHHHHHHHHHH
T ss_pred             ecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCC-------------CCchhhHHHHHHHHH
Confidence            9  889999999999986554322111    113356999999999886544             489999999999999


Q ss_pred             HHHcCCCCCcCCCCCchhh---------------------HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 044997          485 ELITGKRALIRDDSEPTKM---------------------KSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMIT  541 (563)
Q Consensus       485 Elltg~~p~~~~~~~~~~~---------------------~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~  541 (563)
                      ||++|+.||..........                     ...+..+.+++..||+.||.+||++.+|++.|++++..
T Consensus       253 el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~  330 (364)
T 3op5_A          253 QWLTGHLPWEDNLKDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKA  330 (364)
T ss_dssp             HHHHSCCTTGGGTTCHHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             HHHhCCCCccccccCHHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Confidence            9999999998543322111                     11145689999999999999999999999999998863

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=9e-40  Score=342.60  Aligned_cols=229  Identities=24%  Similarity=0.356  Sum_probs=187.8

Q ss_pred             hcCCCccceecccCcEEEEEEEEC--CceEEEEEeccCC----hHHHHHHHHHHHhccccce---------------EEE
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNK----SKEFFAELKVLCKIHHINV---------------FIS  349 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~----~~~f~~Ei~~l~~l~H~ni---------------V~e  349 (563)
                      .++|...+.||+|+||.||+|++.  ++.||||.++...    .++|.+|+++|++++||||               |+|
T Consensus       113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  192 (377)
T 3cbl_A          113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME  192 (377)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence            457888999999999999999984  7889999987543    2458899999999999997               689


Q ss_pred             eecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccccc
Q 044997          350 TFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEER  429 (563)
Q Consensus       350 ~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~  429 (563)
                      |+++|+|.+++...    ...+++..+..++.|++.||+|||+++   ++||||||+|||+++++.+||+|||+++....
T Consensus       193 ~~~~g~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~  265 (377)
T 3cbl_A          193 LVQGGDFLTFLRTE----GARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEAD  265 (377)
T ss_dssp             CCTTCBHHHHHHHH----GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTT
T ss_pred             cCCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCC
Confidence            99999999999752    245899999999999999999999997   99999999999999999999999999985432


Q ss_pred             ccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCCCcCCCCC---------
Q 044997          430 TNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIRDDSE---------  499 (563)
Q Consensus       430 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p~~~~~~~---------  499 (563)
                      ... ........++..|+|||.+.+..+             +.++|||||||++|||++ |+.||......         
T Consensus       266 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~-------------~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~  331 (377)
T 3cbl_A          266 GVY-AASGGLRQVPVKWTAPEALNYGRY-------------SSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKG  331 (377)
T ss_dssp             SEE-ECCSSCCEEEGGGSCHHHHHHCEE-------------EHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTT
T ss_pred             Cce-eecCCCCCCCcCcCCHhHhccCCC-------------CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence            211 111112235678999999865544             789999999999999998 88888653321         


Q ss_pred             --chhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhh
Q 044997          500 --PTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMI  540 (563)
Q Consensus       500 --~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~  540 (563)
                        ......+++.+.+++.+||+.||++|||+.+|++.|+++.+
T Consensus       332 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~  374 (377)
T 3cbl_A          332 GRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK  374 (377)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHh
Confidence              11122345678999999999999999999999999998865

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=4.1e-39  Score=335.80  Aligned_cols=235  Identities=15%  Similarity=0.209  Sum_probs=193.1

Q ss_pred             HhcCCCccceecccCcEEEEEEE-------ECCceEEEEEeccCChHHHHHHHHHHHhcc---ccce-------------
Q 044997          290 ATNNFDESRIIGRGGFGNVYFGL-------LGDREAAIKKMRSNKSKEFFAELKVLCKIH---HINV-------------  346 (563)
Q Consensus       290 ~~~~f~~~~~LG~G~fG~Vy~g~-------~~~~~vavK~~~~~~~~~f~~Ei~~l~~l~---H~ni-------------  346 (563)
                      ..++|...+.||+|+||.||+|.       ..++.||||+++.....++.+|++++.+++   |+||             
T Consensus        63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~  142 (365)
T 3e7e_A           63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGS  142 (365)
T ss_dssp             SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCE
T ss_pred             CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCc
Confidence            34678899999999999999994       247889999999888889999999999987   7776             


Q ss_pred             --EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecC-----------C
Q 044997          347 --FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDD-----------G  413 (563)
Q Consensus       347 --V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~-----------~  413 (563)
                        |+||+++|+|.+++..........++|..++.|+.|++.||+|||+++   |+||||||+|||++.           +
T Consensus       143 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~~~~~  219 (365)
T 3e7e_A          143 VLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDEDDLS  219 (365)
T ss_dssp             EEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC------C
T ss_pred             EEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCcccccccc
Confidence              689999999999997532223567999999999999999999999987   999999999999998           8


Q ss_pred             CcEEEeecCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCC
Q 044997          414 LRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRAL  493 (563)
Q Consensus       414 ~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~  493 (563)
                      +.+||+|||+++....... ........||++|+|||++.+..+             +.++|||||||++|||++|+.||
T Consensus       220 ~~~kl~DFG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~-------------~~~~DiwslG~il~elltg~~pf  285 (365)
T 3e7e_A          220 AGLALIDLGQSIDMKLFPK-GTIFTAKCETSGFQCVEMLSNKPW-------------NYQIDYFGVAATVYCMLFGTYMK  285 (365)
T ss_dssp             TTEEECCCTTCEEGGGSCT-TEEECCSSCTTSCCCHHHHTTCCB-------------STHHHHHHHHHHHHHHHHSSCCC
T ss_pred             CCEEEeeCchhhhhhccCC-CceeeeecCCCCCCChHHhcCCCC-------------CccccHHHHHHHHHHHHhCCCcc
Confidence            9999999999975542221 122345679999999999866544             89999999999999999999998


Q ss_pred             cCCCCCch------hhHHHHHHHHHHHHHhhccCCCCC-CCHHHHHHHHHHhhhc
Q 044997          494 IRDDSEPT------KMKSLITIMAAVAEWCLNEDAVDR-PEMRDIVAILSQIMIT  541 (563)
Q Consensus       494 ~~~~~~~~------~~~~~~~~l~~li~~cl~~dP~~R-Ps~~evl~~L~~i~~~  541 (563)
                      ........      ......+.+.+++..|++.+|.+| |+++++.+.|++++..
T Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~  340 (365)
T 3e7e_A          286 VKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ  340 (365)
T ss_dssp             EEEETTEEEECSCCTTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             ccCCCCceeechhccccCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence            64332111      011224567889999999999998 6899999999988765

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=4.1e-39  Score=324.65  Aligned_cols=231  Identities=28%  Similarity=0.455  Sum_probs=179.5

Q ss_pred             hcCCCccceecccCcEEEEEEEECCceEEEEEeccCC-----hHHHHHHHHHHHhccccce--------------EEEee
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLLGDREAAIKKMRSNK-----SKEFFAELKVLCKIHHINV--------------FISTF  351 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~vavK~~~~~~-----~~~f~~Ei~~l~~l~H~ni--------------V~e~~  351 (563)
                      .++|...+.||+|+||.||+|+..+ .+|+|.++...     .+.|.+|++++++++||||              |+||+
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~~~~~~-~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~lv~e~~  101 (289)
T 3og7_A           23 DGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLAIVTQWC  101 (289)
T ss_dssp             TTSCEEEEEEEECSSEEEEEEESSS-EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEEECC
T ss_pred             ccceeeeeEecCCCCeEEEEEEEcC-ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeeccCCccEEEEEec
Confidence            4578899999999999999998765 59999986432     3568999999999999997              57899


Q ss_pred             cCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccccccc
Q 044997          352 GNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTN  431 (563)
Q Consensus       352 ~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~  431 (563)
                      .+|+|.+++..    ....+++..++.++.|++.||+|||+++   ++||||||+|||++.++.+||+|||+++......
T Consensus       102 ~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  174 (289)
T 3og7_A          102 EGSSLYHHLHA----SETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS  174 (289)
T ss_dssp             CEEEHHHHHTT----C---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC---------
T ss_pred             CCCcHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceecccccccc
Confidence            99999998864    2456999999999999999999999997   9999999999999999999999999997554322


Q ss_pred             ccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCchh---------
Q 044997          432 EKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTK---------  502 (563)
Q Consensus       432 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~~---------  502 (563)
                      .. .......||+.|+|||.+....          ...++.++||||||+++|||++|+.||.........         
T Consensus       175 ~~-~~~~~~~gt~~y~aPE~~~~~~----------~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~  243 (289)
T 3og7_A          175 GS-HQFEQLSGSILWMAPEVIRMQD----------SNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSL  243 (289)
T ss_dssp             ----------CCCTTCCHHHHC--------------CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSC
T ss_pred             cc-ccccccCCCccccCchhhcccC----------CCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhccccc
Confidence            11 1223457999999999885221          234588999999999999999999999764332111         


Q ss_pred             -------hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhh
Q 044997          503 -------MKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMI  540 (563)
Q Consensus       503 -------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~  540 (563)
                             ...+++.+.+++.+||+.||.+||++.|+++.|+++..
T Consensus       244 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~  288 (289)
T 3og7_A          244 SPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR  288 (289)
T ss_dssp             CCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             CcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence                   12344668999999999999999999999999998864

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1.6e-39  Score=352.84  Aligned_cols=232  Identities=24%  Similarity=0.394  Sum_probs=193.6

Q ss_pred             HhcCCCccceecccCcEEEEEEEEC--CceEEEEEeccC--ChHHHHHHHHHHHhccccce---------------EEEe
Q 044997          290 ATNNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSN--KSKEFFAELKVLCKIHHINV---------------FIST  350 (563)
Q Consensus       290 ~~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~--~~~~f~~Ei~~l~~l~H~ni---------------V~e~  350 (563)
                      ..++|...+.||+|+||.||+|++.  +..||||.++..  ..++|.+|+++|++++||||               |+||
T Consensus       218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~  297 (495)
T 1opk_A          218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF  297 (495)
T ss_dssp             CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence            3466888999999999999999986  688999999765  35789999999999999997               6899


Q ss_pred             ecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccccc
Q 044997          351 FGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERT  430 (563)
Q Consensus       351 ~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~  430 (563)
                      +.+|+|.+++..   .....+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus       298 ~~~g~L~~~l~~---~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  371 (495)
T 1opk_A          298 MTYGNLLDYLRE---CNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGD  371 (495)
T ss_dssp             CTTCBHHHHHHH---SCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTC
T ss_pred             cCCCCHHHHHHh---cCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCC
Confidence            999999999975   23456999999999999999999999997   999999999999999999999999999865432


Q ss_pred             cccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCCCcCCCCCc---------
Q 044997          431 NEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIRDDSEP---------  500 (563)
Q Consensus       431 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p~~~~~~~~---------  500 (563)
                      ..  .......++..|+|||.+....+             +.++|||||||++|||++ |+.||.......         
T Consensus       372 ~~--~~~~~~~~~~~y~aPE~~~~~~~-------------~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~  436 (495)
T 1opk_A          372 TY--TAHAGAKFPIKWTAPESLAYNKF-------------SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY  436 (495)
T ss_dssp             CE--ECCTTCCCCGGGCCHHHHHHCEE-------------CHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC
T ss_pred             ce--eecCCCcCCcceeCHhHHhcCCC-------------CcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence            21  11223456789999999865554             889999999999999999 888886543221         


Q ss_pred             --hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcC
Q 044997          501 --TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITS  542 (563)
Q Consensus       501 --~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~  542 (563)
                        .....+++.+.+|+.+||+.||.+||++.+|++.|+.++...
T Consensus       437 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~~  480 (495)
T 1opk_A          437 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES  480 (495)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSSS
T ss_pred             CCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhcc
Confidence              112234567899999999999999999999999999987643

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=8.7e-40  Score=335.47  Aligned_cols=237  Identities=24%  Similarity=0.351  Sum_probs=188.6

Q ss_pred             cCCCccceecccCcEEEEEEEE------CCceEEEEEeccCCh---HHHHHHHHHHHhccccce----------------
Q 044997          292 NNFDESRIIGRGGFGNVYFGLL------GDREAAIKKMRSNKS---KEFFAELKVLCKIHHINV----------------  346 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~------~~~~vavK~~~~~~~---~~f~~Ei~~l~~l~H~ni----------------  346 (563)
                      ++|+..+.||+|+||.||++++      .++.||||++.....   +.+.+|++++++++|+||                
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~  102 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR  102 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence            5688899999999999999985      467899999976543   568999999999999997                


Q ss_pred             -EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCc
Q 044997          347 -FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK  425 (563)
Q Consensus       347 -V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~  425 (563)
                       |+||+++|+|.+++...    ...+++..++.++.|++.||+|||+++   ++||||||+|||++.++.+||+|||+++
T Consensus       103 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~  175 (327)
T 3lxl_A          103 LVMEYLPSGCLRDFLQRH----RARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAK  175 (327)
T ss_dssp             EEEECCTTCBHHHHHHHH----GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred             EEEeecCCCCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccce
Confidence             57899999999998752    245899999999999999999999997   9999999999999999999999999998


Q ss_pred             ccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCC------
Q 044997          426 LEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE------  499 (563)
Q Consensus       426 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~------  499 (563)
                      ................||..|+|||.+.+..+             +.++||||||+++|||++|+.||......      
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-------------~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~  242 (327)
T 3lxl_A          176 LLPLDKDYYVVREPGQSPIFWYAPESLSDNIF-------------SRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMG  242 (327)
T ss_dssp             ECCTTCSEEECSSCCCSCGGGSCHHHHHHCEE-------------EHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC
T ss_pred             ecccCCccceeeccCCccccccCHHHhccCCC-------------ChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcc
Confidence            76543332223334568889999999865544             78999999999999999999998542210      


Q ss_pred             ----c----------------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcChhhhcc
Q 044997          500 ----P----------------TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITSTEWEAS  548 (563)
Q Consensus       500 ----~----------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~w~~~  548 (563)
                          .                .....+.+.+.+++.+||+.||.+||++.|+++.|+.+.....+|+..
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~~  311 (327)
T 3lxl_A          243 CERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCETH  311 (327)
T ss_dssp             ----CCHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----------
T ss_pred             cccccccHHHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcCcccc
Confidence                0                001123456899999999999999999999999999998877777654

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.4e-39  Score=337.87  Aligned_cols=240  Identities=23%  Similarity=0.371  Sum_probs=193.6

Q ss_pred             hcCCCccceecccCcEEEEEEEEC---------CceEEEEEeccCCh----HHHHHHHHHHHhc-cccce----------
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLLG---------DREAAIKKMRSNKS----KEFFAELKVLCKI-HHINV----------  346 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~~---------~~~vavK~~~~~~~----~~f~~Ei~~l~~l-~H~ni----------  346 (563)
                      .++|...+.||+|+||.||+|+..         +..||||+++....    +++.+|+++++++ +||||          
T Consensus        68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  147 (382)
T 3tt0_A           68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD  147 (382)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence            467888999999999999999863         25699999976532    5688999999999 99997          


Q ss_pred             -----EEEeecCCCcccccccccc-----------cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEe
Q 044997          347 -----FISTFGNGSLSDHLHDPLL-----------KGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILL  410 (563)
Q Consensus       347 -----V~e~~~~gsL~~~L~~~~~-----------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl  410 (563)
                           |+||+++|+|.+++.....           .....+++.+++.++.|++.||+|||+++   |+||||||+|||+
T Consensus       148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll  224 (382)
T 3tt0_A          148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV  224 (382)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEE
T ss_pred             CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEEE
Confidence                 6899999999999975321           11246999999999999999999999997   9999999999999


Q ss_pred             cCCCcEEEeecCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-C
Q 044997          411 DDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-G  489 (563)
Q Consensus       411 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g  489 (563)
                      ++++.+||+|||+++........ .......+|+.|+|||++.+..             ++.++|||||||++|||++ |
T Consensus       225 ~~~~~~kL~DFG~a~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~-------------~~~~~DiwslG~il~ellt~g  290 (382)
T 3tt0_A          225 TEDNVMKIADFGLARDIHHIDYY-KKTTNGRLPVKWMAPEALFDRI-------------YTHQSDVWSFGVLLWEIFTLG  290 (382)
T ss_dssp             CTTCCEEECSCSCCCCSSCCCTT-CCCTTCCCGGGGSCHHHHHSCC-------------CCHHHHHHHHHHHHHHHHTTS
T ss_pred             cCCCcEEEcccCccccccccccc-ccccCCCCCcceeCHHHhcCCC-------------CCchhHHHHHHHHHHHHHhCC
Confidence            99999999999999865433211 1223346788999999885544             4899999999999999999 9


Q ss_pred             CCCCcCCCCCc-----------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcChhhhc
Q 044997          490 KRALIRDDSEP-----------TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITSTEWEA  547 (563)
Q Consensus       490 ~~p~~~~~~~~-----------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~w~~  547 (563)
                      +.||.......           .....+.+.+.+++.+||+.||++||++.||++.|++++.....++.
T Consensus       291 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~  359 (382)
T 3tt0_A          291 GSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQEM  359 (382)
T ss_dssp             CCSSTTCCHHHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC-
T ss_pred             CCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCCC
Confidence            99986543211           11123446689999999999999999999999999999876654443

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.3e-38  Score=325.46  Aligned_cols=234  Identities=24%  Similarity=0.285  Sum_probs=190.0

Q ss_pred             cCCCccceecccCcEEEEEEEEC--CceEEEEEeccC----ChHHHHHHHHHHHhccccce-----------------EE
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSN----KSKEFFAELKVLCKIHHINV-----------------FI  348 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~----~~~~f~~Ei~~l~~l~H~ni-----------------V~  348 (563)
                      ++|...+.||+|+||.||+|+..  ++.||||+++..    ..+.+.+|++++++++||||                 |+
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (319)
T 4euu_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM   88 (319)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence            56888999999999999999985  789999998753    34678899999999999997                 57


Q ss_pred             EeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEe----cCCCcEEEeecCCC
Q 044997          349 STFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILL----DDGLRAKVADFGLV  424 (563)
Q Consensus       349 e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl----~~~~~~kl~DFGla  424 (563)
                      ||+++|+|.+++....  ....+++.+++.++.|++.||+|||+++   |+||||||+|||+    +.++.+||+|||++
T Consensus        89 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a  163 (319)
T 4euu_A           89 EFCPCGSLYTVLEEPS--NAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA  163 (319)
T ss_dssp             ECCTTCBHHHHHHSGG--GTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred             eCCCCCCHHHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence            9999999999997632  2344999999999999999999999997   9999999999999    88889999999999


Q ss_pred             cccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc----
Q 044997          425 KLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP----  500 (563)
Q Consensus       425 ~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~----  500 (563)
                      +......    ......||+.|+|||++......     ......++.++|||||||++|||++|+.||.......    
T Consensus       164 ~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~-----~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~  234 (319)
T 4euu_A          164 RELEDDE----QFVSLYGTEEYLHPDMYERAVLR-----KDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKE  234 (319)
T ss_dssp             EECCTTC----CBCCCCSCGGGCCHHHHHHHTSC-----CCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHH
T ss_pred             eecCCCC----ceeecccCCCccCHHHhhhcccc-----ccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHH
Confidence            8654332    12335699999999987532110     0113456899999999999999999999986432211    


Q ss_pred             -----------------------------------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhh
Q 044997          501 -----------------------------------TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIM  539 (563)
Q Consensus       501 -----------------------------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~  539 (563)
                                                         .....+...+.+++.+||+.||++||+++|+++..++..
T Consensus       235 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~  308 (319)
T 4euu_A          235 VMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL  308 (319)
T ss_dssp             HHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred             HHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence                                               112355667899999999999999999999999887543

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=3.2e-39  Score=320.89  Aligned_cols=227  Identities=20%  Similarity=0.320  Sum_probs=188.9

Q ss_pred             cCCCccceecccCcEEEEEEEECCceEEEEEeccCC-----hHHHHHHHHHHHhccccce-----------------EEE
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLGDREAAIKKMRSNK-----SKEFFAELKVLCKIHHINV-----------------FIS  349 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~~~~vavK~~~~~~-----~~~f~~Ei~~l~~l~H~ni-----------------V~e  349 (563)
                      ++|...+.||+|+||.||+|+.+++.+|||.++...     .++|.+|++++++++||||                 |+|
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e   89 (271)
T 3kmu_A           10 KQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITH   89 (271)
T ss_dssp             GGCEEEEEEEEETTEEEEEEEETTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEE
T ss_pred             HHhHHHHHhcCCCcceEEEEEECCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeec
Confidence            468889999999999999999999999999997543     3568999999999999997                 578


Q ss_pred             eecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccccc
Q 044997          350 TFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEER  429 (563)
Q Consensus       350 ~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~  429 (563)
                      |+++|+|.+++..   .....+++..+..++.|++.||+|||+++ ++++||||||+|||++.++.+||+|||++.....
T Consensus        90 ~~~~~~L~~~l~~---~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~  165 (271)
T 3kmu_A           90 WMPYGSLYNVLHE---GTNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQS  165 (271)
T ss_dssp             CCTTCBHHHHHHS---CSSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC
T ss_pred             ccCCCcHHHHHhh---cccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeecc
Confidence            9999999999975   23346999999999999999999999975 3499999999999999999999999988754221


Q ss_pred             ccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCC----------
Q 044997          430 TNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE----------  499 (563)
Q Consensus       430 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~----------  499 (563)
                              ....||+.|+|||.+.+..+          ..++.++||||||+++|||++|+.||......          
T Consensus       166 --------~~~~~t~~y~aPE~~~~~~~----------~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~  227 (271)
T 3kmu_A          166 --------PGRMYAPAWVAPEALQKKPE----------DTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEG  227 (271)
T ss_dssp             --------TTCBSCGGGSCHHHHHSCGG----------GSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSC
T ss_pred             --------cCccCCccccChhhhccCCC----------CCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcC
Confidence                    22468999999999876543          22345899999999999999999999654321          


Q ss_pred             --chhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhh
Q 044997          500 --PTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMI  540 (563)
Q Consensus       500 --~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~  540 (563)
                        ......+.+.+.+++.+||+.||.+|||+.|+++.|+++.+
T Consensus       228 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~  270 (271)
T 3kmu_A          228 LRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD  270 (271)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred             CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence              11122345678999999999999999999999999998754

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=3.6e-39  Score=320.90  Aligned_cols=228  Identities=21%  Similarity=0.385  Sum_probs=189.1

Q ss_pred             hcCCCccceecccCcEEEEEEEECC-ceEEEEEeccC--ChHHHHHHHHHHHhccccce---------------EEEeec
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLLGD-REAAIKKMRSN--KSKEFFAELKVLCKIHHINV---------------FISTFG  352 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~~~-~~vavK~~~~~--~~~~f~~Ei~~l~~l~H~ni---------------V~e~~~  352 (563)
                      .++|+..+.||+|+||.||+|...+ ..||+|.++..  ..+++.+|++++.+++||||               |+||++
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   86 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYIS   86 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred             hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccC
Confidence            3568889999999999999998864 57999999765  35779999999999999997               679999


Q ss_pred             CCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccccccc
Q 044997          353 NGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNE  432 (563)
Q Consensus       353 ~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~  432 (563)
                      +|+|.+++...    ...+++..+..++.|++.||+|||+++   ++||||||+||+++.++.+||+|||+++.......
T Consensus        87 ~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  159 (268)
T 3sxs_A           87 NGCLLNYLRSH----GKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY  159 (268)
T ss_dssp             TCBHHHHHHHH----GGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE
T ss_pred             CCcHHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhh
Confidence            99999998752    345999999999999999999999997   99999999999999999999999999986543322


Q ss_pred             cccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCCCcCCCCCc-----------
Q 044997          433 KEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIRDDSEP-----------  500 (563)
Q Consensus       433 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p~~~~~~~~-----------  500 (563)
                      .  ......+|+.|+|||.+.+..+             +.++||||||+++|||++ |+.||.......           
T Consensus       160 ~--~~~~~~~~~~y~aPE~~~~~~~-------------~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~  224 (268)
T 3sxs_A          160 V--SSVGTKFPVKWSAPEVFHYFKY-------------SSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRL  224 (268)
T ss_dssp             E--ECCSCCCCGGGCCHHHHHHSEE-------------ETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC
T ss_pred             h--cccCCCcCcccCCHHHHhccCC-------------chhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCC
Confidence            1  1223456778999999865544             789999999999999999 999986433211           


Q ss_pred             hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhh
Q 044997          501 TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMI  540 (563)
Q Consensus       501 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~  540 (563)
                      .......+.+.+++.+||+.||.+|||+.|+++.|+.+.+
T Consensus       225 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (268)
T 3sxs_A          225 YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE  264 (268)
T ss_dssp             CCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred             CCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence            1112234568999999999999999999999999998864

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=2.4e-39  Score=333.74  Aligned_cols=237  Identities=27%  Similarity=0.428  Sum_probs=191.6

Q ss_pred             HHHhcCCCccceecccCcEEEEEEEECC-------ceEEEEEeccCC----hHHHHHHHHHHHhccccce----------
Q 044997          288 EEATNNFDESRIIGRGGFGNVYFGLLGD-------REAAIKKMRSNK----SKEFFAELKVLCKIHHINV----------  346 (563)
Q Consensus       288 ~~~~~~f~~~~~LG~G~fG~Vy~g~~~~-------~~vavK~~~~~~----~~~f~~Ei~~l~~l~H~ni----------  346 (563)
                      ....++|+..+.||+|+||.||+|+..+       +.||||.++...    .+.|.+|++++++++||||          
T Consensus        43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~  122 (343)
T 1luf_A           43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG  122 (343)
T ss_dssp             BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC
Confidence            3346789999999999999999998853       789999997653    3568999999999999997          


Q ss_pred             -----EEEeecCCCccccccccccc-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCC
Q 044997          347 -----FISTFGNGSLSDHLHDPLLK-------------------GHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRD  402 (563)
Q Consensus       347 -----V~e~~~~gsL~~~L~~~~~~-------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrD  402 (563)
                           |+||+++|+|.+++......                   ....+++.+++.++.|+++||+|||+++   |+|||
T Consensus       123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~D  199 (343)
T 1luf_A          123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRD  199 (343)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred             CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCC
Confidence                 57999999999998752110                   1257999999999999999999999997   99999


Q ss_pred             CCCCCeEecCCCcEEEeecCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHH
Q 044997          403 IKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVV  482 (563)
Q Consensus       403 Lk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvv  482 (563)
                      |||+|||++.++.+||+|||+++........ .......||+.|+|||.+.+..             ++.++||||||++
T Consensus       200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~-------------~~~~~Di~slG~i  265 (343)
T 1luf_A          200 LATRNCLVGENMVVKIADFGLSRNIYSADYY-KADGNDAIPIRWMPPESIFYNR-------------YTTESDVWAYGVV  265 (343)
T ss_dssp             CSGGGEEECGGGCEEECCCSCHHHHTGGGCB-C----CCBCGGGCCHHHHHHCC-------------CCHHHHHHHHHHH
T ss_pred             CCcceEEECCCCeEEEeecCCCcccccCccc-cccCCCcccceecChhhhccCC-------------cCcccccHHHHHH
Confidence            9999999999999999999999765432211 1223356889999999885443             4889999999999


Q ss_pred             HHHHHc-CCCCCcCCCCCc-----------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 044997          483 LAELIT-GKRALIRDDSEP-----------TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMIT  541 (563)
Q Consensus       483 l~Ellt-g~~p~~~~~~~~-----------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~  541 (563)
                      +|||++ |+.||.......           .....++..+.+++.+||+.||.+||++.++++.|+++.+.
T Consensus       266 l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~  336 (343)
T 1luf_A          266 LWEIFSYGLQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER  336 (343)
T ss_dssp             HHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred             HHHHHhcCCCcCCCCChHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence            999999 999986543211           11223456789999999999999999999999999998764

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=3.5e-39  Score=329.89  Aligned_cols=230  Identities=23%  Similarity=0.359  Sum_probs=187.8

Q ss_pred             CCccceecccCcEEEEEEEE------CCceEEEEEeccCC----hHHHHHHHHHHHhccccce-----------------
Q 044997          294 FDESRIIGRGGFGNVYFGLL------GDREAAIKKMRSNK----SKEFFAELKVLCKIHHINV-----------------  346 (563)
Q Consensus       294 f~~~~~LG~G~fG~Vy~g~~------~~~~vavK~~~~~~----~~~f~~Ei~~l~~l~H~ni-----------------  346 (563)
                      |+..+.||+|+||.||++.+      +++.||||+++...    .+.+.+|++++++++||||                 
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l  112 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL  112 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence            48889999999999999875      46789999998653    3568999999999999997                 


Q ss_pred             EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcc
Q 044997          347 FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKL  426 (563)
Q Consensus       347 V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~  426 (563)
                      |+||+++|+|.+++..      ..+++..++.++.|++.||+|||+++   ++||||||+|||++.++.+||+|||+++.
T Consensus       113 v~e~~~~~~L~~~l~~------~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~  183 (318)
T 3lxp_A          113 VMEYVPLGSLRDYLPR------HSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKA  183 (318)
T ss_dssp             EECCCTTCBHHHHGGG------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred             EEecccCCcHHHHHhh------CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccccc
Confidence            5788889999999865      34899999999999999999999998   99999999999999999999999999987


Q ss_pred             cccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCC-------
Q 044997          427 EERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE-------  499 (563)
Q Consensus       427 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~-------  499 (563)
                      ...............||..|+|||.+.+..+             +.++||||||+++|||++|+.||......       
T Consensus       184 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-------------~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~  250 (318)
T 3lxp_A          184 VPEGHEYYRVREDGDSPVFWYAPECLKEYKF-------------YYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGI  250 (318)
T ss_dssp             CCTTCSEEEC---CCCCGGGCCHHHHHHCEE-------------EHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCS
T ss_pred             ccccccccccccCCCCCceeeChHHhcCCCC-------------CcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcc
Confidence            6543322222334568889999999865554             78999999999999999999998542110       


Q ss_pred             -------------------chhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcChhh
Q 044997          500 -------------------PTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITSTEW  545 (563)
Q Consensus       500 -------------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~w  545 (563)
                                         ......++..+.+++.+||+.||.+||++.|+++.|+++.+.....
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~  315 (318)
T 3lxp_A          251 AQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQ  315 (318)
T ss_dssp             CCHHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC-
T ss_pred             cccchhHHHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhccC
Confidence                               0011223456899999999999999999999999999987654433

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=8.4e-39  Score=323.64  Aligned_cols=220  Identities=25%  Similarity=0.401  Sum_probs=177.5

Q ss_pred             cCCCccceecccCcEEEEEEEE--CCceEEEEEeccCC-----------------------------hHHHHHHHHHHHh
Q 044997          292 NNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNK-----------------------------SKEFFAELKVLCK  340 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~-----------------------------~~~f~~Ei~~l~~  340 (563)
                      ++|...+.||+|+||.||+|+.  +++.||||.++...                             .+++.+|+++|++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~   92 (298)
T 2zv2_A           13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK   92 (298)
T ss_dssp             TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred             cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence            5788999999999999999987  47889999986432                             2568899999999


Q ss_pred             ccccce-----------------EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCC
Q 044997          341 IHHINV-----------------FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDI  403 (563)
Q Consensus       341 l~H~ni-----------------V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDL  403 (563)
                      ++||||                 |+||+++|+|.+++..      ..+++.++..++.|++.||+|||+++   |+||||
T Consensus        93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dl  163 (298)
T 2zv2_A           93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL------KPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDI  163 (298)
T ss_dssp             CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCC
T ss_pred             CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCC
Confidence            999997                 5788889998876542      56999999999999999999999997   999999


Q ss_pred             CCCCeEecCCCcEEEeecCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHH
Q 044997          404 KTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVL  483 (563)
Q Consensus       404 k~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl  483 (563)
                      ||+|||++.++++||+|||+++.......   ......||+.|+|||.+.+...          ...+.++|||||||++
T Consensus       164 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~----------~~~~~~~Di~slG~~l  230 (298)
T 2zv2_A          164 KPSNLLVGEDGHIKIADFGVSNEFKGSDA---LLSNTVGTPAFMAPESLSETRK----------IFSGKALDVWAMGVTL  230 (298)
T ss_dssp             CGGGEEECTTSCEEECCCTTCEECSSSSC---EECCCCSCGGGCCGGGCCTTCC----------CEESHHHHHHHHHHHH
T ss_pred             CHHHEEECCCCCEEEecCCCccccccccc---cccCCcCCccccChhhhccCCC----------CCCCchhhhHhHHHHH
Confidence            99999999999999999999986543221   2234579999999998854331          1126789999999999


Q ss_pred             HHHHcCCCCCcCCCCCc------------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          484 AELITGKRALIRDDSEP------------TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       484 ~Elltg~~p~~~~~~~~------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                      |||++|+.||.......            .....+.+.+.+++.+||+.||.+||++.|+++
T Consensus       231 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          231 YCFVFGQCPFMDERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             HHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             HHHHHCCCCCCCccHHHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence            99999999996543210            011134466899999999999999999999875

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=2.5e-39  Score=327.54  Aligned_cols=229  Identities=21%  Similarity=0.370  Sum_probs=187.7

Q ss_pred             cCCCccceecccCcEEEEEEEE------CCceEEEEEeccC----ChHHHHHHHHHHHhccccce---------------
Q 044997          292 NNFDESRIIGRGGFGNVYFGLL------GDREAAIKKMRSN----KSKEFFAELKVLCKIHHINV---------------  346 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~------~~~~vavK~~~~~----~~~~f~~Ei~~l~~l~H~ni---------------  346 (563)
                      +.|+..+.||+|+||.||+|++      .++.||+|.++..    ..+.+.+|++++++++||||               
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  100 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI  100 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence            4578889999999999999985      4688999998754    24678999999999999997               


Q ss_pred             --EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCC
Q 044997          347 --FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLV  424 (563)
Q Consensus       347 --V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla  424 (563)
                        |+||+++|+|.+++...    ...+++..++.++.|++.||+|||+++   ++||||||+|||++.++.+||+|||++
T Consensus       101 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~  173 (302)
T 4e5w_A          101 KLIMEFLPSGSLKEYLPKN----KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLT  173 (302)
T ss_dssp             EEEEECCTTCBHHHHHHHH----TTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred             EEEEEeCCCCcHHHHHHhc----cccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECccccc
Confidence              57899999999998642    356999999999999999999999997   999999999999999999999999999


Q ss_pred             cccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCC-------
Q 044997          425 KLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDD-------  497 (563)
Q Consensus       425 ~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~-------  497 (563)
                      +................||..|+|||.+.+..+             +.++||||||+++|||++|+.|+....       
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-------------~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~  240 (302)
T 4e5w_A          174 KAIETDKEYYTVKDDRDSPVFWYAPECLMQSKF-------------YIASDVWSFGVTLHELLTYCDSDSSPMALFLKMI  240 (302)
T ss_dssp             EECCTTCCEEECCCCTTCCGGGCCHHHHHHCEE-------------EHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHH
T ss_pred             ccccCCCcceeccCCCCCCccccCCeeecCCCC-------------CcchhHHHHHHHHHHHHHccCCCcchhhHHhhcc
Confidence            876544332233344668889999998866554             789999999999999999998753210       


Q ss_pred             ---CCc----------------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhh
Q 044997          498 ---SEP----------------TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMI  540 (563)
Q Consensus       498 ---~~~----------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~  540 (563)
                         ...                .....+++.+.+++.+||+.||.+|||+.|+++.|+++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll~  302 (302)
T 4e5w_A          241 GPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK  302 (302)
T ss_dssp             CSCCGGGHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred             CCcccccCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhC
Confidence               000                0011234568999999999999999999999999998863

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=7.9e-39  Score=328.37  Aligned_cols=223  Identities=24%  Similarity=0.392  Sum_probs=185.1

Q ss_pred             hcCCCccceecccCcEEEEEEEEC--CceEEEEEeccCC----hHHHHHHHHHHHhccccce---------------EEE
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNK----SKEFFAELKVLCKIHHINV---------------FIS  349 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~----~~~f~~Ei~~l~~l~H~ni---------------V~e  349 (563)
                      .++|+..+.||+|+||.||+|+..  ++.||||.+....    .+.+.+|+.++++++||||               |+|
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   85 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence            367899999999999999999874  7889999986443    3568899999999999997               579


Q ss_pred             eecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccccc
Q 044997          350 TFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEER  429 (563)
Q Consensus       350 ~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~  429 (563)
                      |+++|+|.+++..     ...+++.++..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus        86 ~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  157 (323)
T 3tki_A           86 YCSGGELFDRIEP-----DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRY  157 (323)
T ss_dssp             CCTTEEGGGGSBT-----TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred             cCCCCcHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceecc
Confidence            9999999999864     356999999999999999999999997   99999999999999999999999999986543


Q ss_pred             ccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCch--------
Q 044997          430 TNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPT--------  501 (563)
Q Consensus       430 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~--------  501 (563)
                      ... ........||+.|+|||++.+..+            .+.++|||||||++|||++|+.||........        
T Consensus       158 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~------------~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~  224 (323)
T 3tki_A          158 NNR-ERLLNKMCGTLPYVAPELLKRREF------------HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK  224 (323)
T ss_dssp             TTE-ECCBCSCCSCGGGSCHHHHHCSSB------------CHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTT
T ss_pred             CCc-ccccCCCccCcCccCcHHhccCCC------------CCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcc
Confidence            322 122344679999999999865433            26789999999999999999999976543221        


Q ss_pred             -----hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          502 -----KMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       502 -----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                           ....+...+.+|+.+||+.||.+|||+.|+++.
T Consensus       225 ~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h  262 (323)
T 3tki_A          225 KTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (323)
T ss_dssp             CTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             cccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence                 123445668999999999999999999999864

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.6e-39  Score=331.39  Aligned_cols=235  Identities=25%  Similarity=0.397  Sum_probs=185.2

Q ss_pred             cCCCccceecccCcEEEEEEEEC--Cce----EEEEEeccC----ChHHHHHHHHHHHhccccce--------------E
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG--DRE----AAIKKMRSN----KSKEFFAELKVLCKIHHINV--------------F  347 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~----vavK~~~~~----~~~~f~~Ei~~l~~l~H~ni--------------V  347 (563)
                      ++|+..+.||+|+||.||+|+..  ++.    ||+|.++..    ..+++.+|++++++++||||              |
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~v   94 (327)
T 3lzb_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLI   94 (327)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSSEEEE
T ss_pred             hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCCceEE
Confidence            56889999999999999999873  333    578877532    35789999999999999997              5


Q ss_pred             EEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccc
Q 044997          348 ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLE  427 (563)
Q Consensus       348 ~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~  427 (563)
                      ++|+.+|+|.+++..    ....+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus        95 ~~~~~~g~L~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~  167 (327)
T 3lzb_A           95 TQLMPFGCLLDYVRE----HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL  167 (327)
T ss_dssp             ECCCSSCBHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred             EEecCCCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence            688999999999875    2356999999999999999999999997   999999999999999999999999999865


Q ss_pred             ccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCCCcCCCCCc------
Q 044997          428 ERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIRDDSEP------  500 (563)
Q Consensus       428 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p~~~~~~~~------  500 (563)
                      ...... .......+|+.|+|||.+.+..             ++.++||||||+++|||++ |+.||.......      
T Consensus       168 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~-------------~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~  233 (327)
T 3lzb_A          168 GAEEKE-YHAEGGKVPIKWMALESILHRI-------------YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE  233 (327)
T ss_dssp             -------------CCCGGGSCHHHHHHCC-------------CCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH
T ss_pred             cCcccc-ccccCCCccccccCHHHHcCCC-------------CChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH
Confidence            433221 1222345788999999886544             4889999999999999999 999986543221      


Q ss_pred             -----hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcChhhhc
Q 044997          501 -----TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITSTEWEA  547 (563)
Q Consensus       501 -----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~w~~  547 (563)
                           .........+.+++.+||+.||.+||++.|+++.|+++......|-.
T Consensus       234 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~  285 (327)
T 3lzb_A          234 KGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDPQRYLV  285 (327)
T ss_dssp             TTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSHHHHBC
T ss_pred             cCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCcCceEE
Confidence                 11123445689999999999999999999999999999877665543

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=9.1e-39  Score=332.95  Aligned_cols=218  Identities=22%  Similarity=0.345  Sum_probs=183.9

Q ss_pred             hcCCCccceecccCcEEEEEEEEC--CceEEEEEeccCC---------hHHHHHHHHHHHhccccce-------------
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNK---------SKEFFAELKVLCKIHHINV-------------  346 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~---------~~~f~~Ei~~l~~l~H~ni-------------  346 (563)
                      .+.|+..+.||+|+||.||+++..  ++.+|+|.++...         .+.+.+|+++|++++||||             
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   90 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV   90 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence            457889999999999999999884  7889999986432         3678999999999999997             


Q ss_pred             --EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCC----cEEEee
Q 044997          347 --FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGL----RAKVAD  420 (563)
Q Consensus       347 --V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~----~~kl~D  420 (563)
                        |+||+.+|+|.+++..     ...+++..+..++.|++.||+|||+++   |+||||||+|||+++++    .+||+|
T Consensus        91 ~lv~e~~~gg~L~~~l~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~D  162 (361)
T 2yab_A           91 VLILELVSGGELFDFLAQ-----KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLID  162 (361)
T ss_dssp             EEEEECCCSCBHHHHHTT-----CSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred             EEEEEcCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEe
Confidence              5799999999999864     356999999999999999999999997   99999999999998876    799999


Q ss_pred             cCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCC-
Q 044997          421 FGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE-  499 (563)
Q Consensus       421 FGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~-  499 (563)
                      ||+++......    ......||+.|+|||++.+..             ++.++|||||||++|||++|+.||...... 
T Consensus       163 FG~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~-------------~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~  225 (361)
T 2yab_A          163 FGLAHEIEDGV----EFKNIFGTPEFVAPEIVNYEP-------------LGLEADMWSIGVITYILLSGASPFLGDTKQE  225 (361)
T ss_dssp             CSSCEECCTTC----CCCCCCSCGGGCCHHHHTTCC-------------CCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH
T ss_pred             cCCceEcCCCC----ccccCCCCccEECchHHcCCC-------------CCccccHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            99998654322    223457999999999886544             488999999999999999999999754321 


Q ss_pred             -------------chhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          500 -------------PTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       500 -------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                                   ......+.+.+.+++.+||..||.+|||+.|+++
T Consensus       226 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          226 TLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             HHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHHHHhcCCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence                         1112234566899999999999999999999885

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=3e-39  Score=324.10  Aligned_cols=229  Identities=23%  Similarity=0.400  Sum_probs=187.0

Q ss_pred             hcCCCccceecccCcEEEEEEEECC-ceEEEEEeccC--ChHHHHHHHHHHHhccccce---------------EEEeec
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLLGD-REAAIKKMRSN--KSKEFFAELKVLCKIHHINV---------------FISTFG  352 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~~~-~~vavK~~~~~--~~~~f~~Ei~~l~~l~H~ni---------------V~e~~~  352 (563)
                      .++|+..+.||+|+||.||+|.+.+ ..||+|+++..  ..+++.+|++++++++|+||               |+||+.
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~  102 (283)
T 3gen_A           23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA  102 (283)
T ss_dssp             GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCT
T ss_pred             HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccC
Confidence            4578889999999999999998864 58999999865  35779999999999999997               578999


Q ss_pred             CCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccccccc
Q 044997          353 NGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNE  432 (563)
Q Consensus       353 ~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~  432 (563)
                      +|+|.+++...    ...+++.++..++.|++.||+|||+++   ++||||||+|||++.++++||+|||+++.......
T Consensus       103 ~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~  175 (283)
T 3gen_A          103 NGCLLNYLREM----RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY  175 (283)
T ss_dssp             TCBHHHHHHCG----GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH
T ss_pred             CCcHHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEcccccccccccccc
Confidence            99999999752    345999999999999999999999997   99999999999999999999999999986543221


Q ss_pred             cccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCCCcCCCCCc-----------
Q 044997          433 KEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIRDDSEP-----------  500 (563)
Q Consensus       433 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p~~~~~~~~-----------  500 (563)
                        .......+|+.|+|||.+.+..             ++.++||||||+++|||++ |+.||.......           
T Consensus       176 --~~~~~~~~~~~y~aPE~~~~~~-------------~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~  240 (283)
T 3gen_A          176 --TSSVGSKFPVRWSPPEVLMYSK-------------FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL  240 (283)
T ss_dssp             --HSTTSTTSCGGGCCHHHHHHCC-------------CSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC
T ss_pred             --ccccCCccCcccCCHHHhccCC-------------CCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCC
Confidence              1122345678899999885443             4889999999999999998 999986533211           


Q ss_pred             hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 044997          501 TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMIT  541 (563)
Q Consensus       501 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~  541 (563)
                      .......+.+.+++.+||+.||.+||++.|+++.|.+++..
T Consensus       241 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~  281 (283)
T 3gen_A          241 YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE  281 (283)
T ss_dssp             CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence            11122345689999999999999999999999999998764

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.6e-39  Score=322.17  Aligned_cols=231  Identities=20%  Similarity=0.363  Sum_probs=189.9

Q ss_pred             cCCCccc-eecccCcEEEEEEEE----CCceEEEEEeccCC----hHHHHHHHHHHHhccccce--------------EE
Q 044997          292 NNFDESR-IIGRGGFGNVYFGLL----GDREAAIKKMRSNK----SKEFFAELKVLCKIHHINV--------------FI  348 (563)
Q Consensus       292 ~~f~~~~-~LG~G~fG~Vy~g~~----~~~~vavK~~~~~~----~~~f~~Ei~~l~~l~H~ni--------------V~  348 (563)
                      ++|...+ .||+|+||.||+|..    .+..||||.++...    .+++.+|++++++++||||              |+
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~lv~   88 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVM   88 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEE
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEecCCCcEEEE
Confidence            3455555 899999999999986    36779999997643    3568899999999999997              57


Q ss_pred             EeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccc
Q 044997          349 STFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEE  428 (563)
Q Consensus       349 e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~  428 (563)
                      ||+++|+|.+++..    ....+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+|||+++...
T Consensus        89 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~  161 (287)
T 1u59_A           89 EMAGGGPLHKFLVG----KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALG  161 (287)
T ss_dssp             ECCTTEEHHHHHTT----CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred             EeCCCCCHHHHHHh----CCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeec
Confidence            99999999999864    2456999999999999999999999997   9999999999999999999999999998664


Q ss_pred             cccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCCCcCCCCCc-------
Q 044997          429 RTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIRDDSEP-------  500 (563)
Q Consensus       429 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p~~~~~~~~-------  500 (563)
                      .............||+.|+|||.+.+..+             +.++||||||+++|||++ |+.||.......       
T Consensus       162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-------------~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~  228 (287)
T 1u59_A          162 ADDSYYTARSAGKWPLKWYAPECINFRKF-------------SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ  228 (287)
T ss_dssp             TCSCEECCCCSSCCCGGGCCHHHHHHCEE-------------CHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHT
T ss_pred             cCcceeeccccccccccccCHHHhccCCC-------------CchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhc
Confidence            33322222233457889999998865443             789999999999999999 999986543211       


Q ss_pred             ----hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcC
Q 044997          501 ----TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITS  542 (563)
Q Consensus       501 ----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~  542 (563)
                          .....+++.+.+++.+||+.||.+||++.++++.|++++.+.
T Consensus       229 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~  274 (287)
T 1u59_A          229 GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL  274 (287)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             CCcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence                112344567999999999999999999999999999998653

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=8.9e-39  Score=329.95  Aligned_cols=219  Identities=26%  Similarity=0.397  Sum_probs=183.4

Q ss_pred             cCCCccceecccCcEEEEEEEEC--CceEEEEEeccC------ChHHHHHHHHHHHhccccce---------------EE
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSN------KSKEFFAELKVLCKIHHINV---------------FI  348 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~------~~~~f~~Ei~~l~~l~H~ni---------------V~  348 (563)
                      ++|+..+.||+|+||.||+++..  ++.||+|.++..      ..+.+.+|+++|++++||||               |+
T Consensus         5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~   84 (337)
T 1o6l_A            5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence            57888999999999999999884  788999998643      34678899999999999997               68


Q ss_pred             EeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccc
Q 044997          349 STFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEE  428 (563)
Q Consensus       349 e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~  428 (563)
                      ||+++|+|.+++..     ...+++..+..++.|++.||+|||+++   |+||||||+|||++.++++||+|||+++...
T Consensus        85 E~~~gg~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~  156 (337)
T 1o6l_A           85 EYANGGELFFHLSR-----ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGI  156 (337)
T ss_dssp             ECCTTCBHHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred             eCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhcc
Confidence            99999999998864     256899999999999999999999997   9999999999999999999999999998533


Q ss_pred             cccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCch-------
Q 044997          429 RTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPT-------  501 (563)
Q Consensus       429 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~-------  501 (563)
                      ...   .......||+.|+|||++.+..+             +.++|||||||++|||++|+.||...+....       
T Consensus       157 ~~~---~~~~~~~gt~~y~aPE~~~~~~~-------------~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~  220 (337)
T 1o6l_A          157 SDG---ATMKTFCGTPEYLAPEVLEDNDY-------------GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME  220 (337)
T ss_dssp             CTT---CCBCCCEECGGGCCGGGGSSSCB-------------CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC
T ss_pred             cCC---CcccccccChhhCChhhhcCCCC-------------CchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence            221   12334679999999999865544             8899999999999999999999975432111       


Q ss_pred             ---hhHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 044997          502 ---KMKSLITIMAAVAEWCLNEDAVDRP-----EMRDIVAI  534 (563)
Q Consensus       502 ---~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  534 (563)
                         .+..+...+.+++.+||+.||.+||     ++.|+++.
T Consensus       221 ~~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h  261 (337)
T 1o6l_A          221 EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             CCCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence               1123456689999999999999999     88888764

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=7.7e-39  Score=325.46  Aligned_cols=236  Identities=24%  Similarity=0.398  Sum_probs=192.3

Q ss_pred             hcCCCccceecccCcEEEEEEEE-------CCceEEEEEeccCC----hHHHHHHHHHHHhc-cccce------------
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLL-------GDREAAIKKMRSNK----SKEFFAELKVLCKI-HHINV------------  346 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~-------~~~~vavK~~~~~~----~~~f~~Ei~~l~~l-~H~ni------------  346 (563)
                      .++|...+.||+|+||.||+|+.       .++.||||.++...    .+.+.+|+++++++ +||||            
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~  101 (313)
T 1t46_A           22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (313)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence            46788899999999999999985       24689999997543    36689999999999 99997            


Q ss_pred             ---EEEeecCCCcccccccccc-------------cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEe
Q 044997          347 ---FISTFGNGSLSDHLHDPLL-------------KGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILL  410 (563)
Q Consensus       347 ---V~e~~~~gsL~~~L~~~~~-------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl  410 (563)
                         |+||+++|+|.+++.....             .....+++..++.++.|++.||.|||+++   ++||||||+|||+
T Consensus       102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~  178 (313)
T 1t46_A          102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL  178 (313)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred             cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEE
Confidence               5799999999999875311             11235999999999999999999999997   9999999999999


Q ss_pred             cCCCcEEEeecCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-C
Q 044997          411 DDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-G  489 (563)
Q Consensus       411 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g  489 (563)
                      +.++.+||+|||+++........ .......||+.|+|||.+.+..             ++.++||||||+++|||++ |
T Consensus       179 ~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~-------------~~~~~Di~slG~il~ellt~g  244 (313)
T 1t46_A          179 THGRITKICDFGLARDIKNDSNY-VVKGNARLPVKWMAPESIFNCV-------------YTFESDVWSYGIFLWELFSLG  244 (313)
T ss_dssp             ETTTEEEECCCGGGSCTTSCTTS-EECSSSEECGGGCCHHHHHHCC-------------CCHHHHHHHHHHHHHHHHTTT
T ss_pred             cCCCCEEEccccccccccccccc-eeccCCCCcceeeChHHhcCCC-------------CChHHHHHHHHHHHHHHHhCC
Confidence            99999999999999865543221 1223345788999999875443             4899999999999999999 9


Q ss_pred             CCCCcCCCCCchh------------hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcCh
Q 044997          490 KRALIRDDSEPTK------------MKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITST  543 (563)
Q Consensus       490 ~~p~~~~~~~~~~------------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~  543 (563)
                      +.||.........            ....+..+.+++.+||+.||.+||++.|+++.|++++.+..
T Consensus       245 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~  310 (313)
T 1t46_A          245 SSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISEST  310 (313)
T ss_dssp             CCSSTTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred             CCCCCcccchhHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHhh
Confidence            9998765433211            12334568999999999999999999999999999987654

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.2e-39  Score=338.38  Aligned_cols=236  Identities=24%  Similarity=0.367  Sum_probs=189.6

Q ss_pred             hcCCCccceecccCcEEEEEEEEC-------CceEEEEEeccCC----hHHHHHHHHHHHhccccce-------------
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLLG-------DREAAIKKMRSNK----SKEFFAELKVLCKIHHINV-------------  346 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~~-------~~~vavK~~~~~~----~~~f~~Ei~~l~~l~H~ni-------------  346 (563)
                      .++|...+.||+|+||.||+|++.       ++.||||+++...    ..++.+|+.++++++||||             
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  149 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  149 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            356888999999999999999853       4579999996542    3468899999999999997             


Q ss_pred             --EEEeecCCCcccccccccc--cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCC---cEEEe
Q 044997          347 --FISTFGNGSLSDHLHDPLL--KGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGL---RAKVA  419 (563)
Q Consensus       347 --V~e~~~~gsL~~~L~~~~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~---~~kl~  419 (563)
                        |+||+++|+|.+++.....  .....+++.+++.++.|++.||+|||+++   |+||||||+|||++.++   .+||+
T Consensus       150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~  226 (367)
T 3l9p_A          150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG  226 (367)
T ss_dssp             EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence              6899999999999975321  12246999999999999999999999998   99999999999999554   59999


Q ss_pred             ecCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCCCcCCCC
Q 044997          420 DFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIRDDS  498 (563)
Q Consensus       420 DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p~~~~~~  498 (563)
                      |||+++........ .......||+.|+|||++.+..             ++.++|||||||++|||++ |+.||.....
T Consensus       227 DFG~a~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~-------------~~~~~DvwslG~il~ellt~g~~pf~~~~~  292 (367)
T 3l9p_A          227 DFGMARDIYRAGYY-RKGGCAMLPVKWMPPEAFMEGI-------------FTSKTDTWSFGVLLWEIFSLGYMPYPSKSN  292 (367)
T ss_dssp             CCHHHHHHHHHSSC-TTCCGGGSCGGGCCHHHHHHCC-------------CCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred             CCcccccccccccc-ccCCCcCCcccEECHHHhcCCC-------------CCcHHHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            99999854332211 1223356889999999885544             4899999999999999998 8888865432


Q ss_pred             C-----------chhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcCh
Q 044997          499 E-----------PTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITST  543 (563)
Q Consensus       499 ~-----------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~  543 (563)
                      .           ......+...+.+|+.+||+.||.+||++.+|++.|+.+.....
T Consensus       293 ~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~  348 (367)
T 3l9p_A          293 QEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD  348 (367)
T ss_dssp             HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred             HHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhChh
Confidence            1           11122345568999999999999999999999999998876544

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=1.6e-38  Score=327.50  Aligned_cols=239  Identities=23%  Similarity=0.353  Sum_probs=193.7

Q ss_pred             HHHHhcCCCccceecccCcEEEEEEEECCceEEEEEeccCChHHHHHHHHHHHh--ccccce------------------
Q 044997          287 IEEATNNFDESRIIGRGGFGNVYFGLLGDREAAIKKMRSNKSKEFFAELKVLCK--IHHINV------------------  346 (563)
Q Consensus       287 l~~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~vavK~~~~~~~~~f~~Ei~~l~~--l~H~ni------------------  346 (563)
                      -....++|...+.||+|+||.||+|+.+++.||||.++....+.+.+|.+++..  ++||||                  
T Consensus        37 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~  116 (342)
T 1b6c_B           37 QRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW  116 (342)
T ss_dssp             HHHHHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEE
T ss_pred             cccccccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCchhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeE
Confidence            345567899999999999999999999999999999988878889999999988  789997                  


Q ss_pred             -EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCceEeCCCCCCCeEecCCCcEE
Q 044997          347 -FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIH--------DHTKARYVHRDIKTSNILLDDGLRAK  417 (563)
Q Consensus       347 -V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH--------~~~~~~ivHrDLk~~NILl~~~~~~k  417 (563)
                       |+||+++|+|.+++..      ..+++.+++.++.|++.||+|||        +.+   ++||||||+|||++.++++|
T Consensus       117 lv~e~~~~g~L~~~l~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~~~~k  187 (342)
T 1b6c_B          117 LVSDYHEHGSLFDYLNR------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGTCC  187 (342)
T ss_dssp             EEECCCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTTSCEE
T ss_pred             EEEeecCCCcHHHHHhc------cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCCCCEE
Confidence             5688889999999864      35899999999999999999999        665   99999999999999999999


Q ss_pred             EeecCCCcccccccccc-cccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcC-------
Q 044997          418 VADFGLVKLEERTNEKE-MLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITG-------  489 (563)
Q Consensus       418 l~DFGla~~~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg-------  489 (563)
                      |+|||+++......... .......||+.|+|||++.+....       ....++.++||||||+++|||++|       
T Consensus       188 L~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-------~~~~~~~~~Di~slG~il~el~tg~~~~~~~  260 (342)
T 1b6c_B          188 IADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINM-------KHFESFKRADIYAMGLVFWEIARRCSIGGIH  260 (342)
T ss_dssp             ECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCT-------TCHHHHHHHHHHHHHHHHHHHHTTBCBTTBC
T ss_pred             EEECCCceeccccccccccccccCCcCcccCCHhhhcccccc-------cccccCCcccHHHHHHHHHHHHhccCcCCcc
Confidence            99999998654332211 122345799999999998654210       001224789999999999999999       


Q ss_pred             ---CCCCcCCCCCc-----------------h-----hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 044997          490 ---KRALIRDDSEP-----------------T-----KMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMIT  541 (563)
Q Consensus       490 ---~~p~~~~~~~~-----------------~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~  541 (563)
                         +.||.......                 .     ......+.+.+|+.+||+.||++||++.||++.|+++.+.
T Consensus       261 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~  337 (342)
T 1b6c_B          261 EDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  337 (342)
T ss_dssp             CCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             cccccCccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHH
Confidence               67775432110                 0     0124556799999999999999999999999999998764

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=4e-39  Score=330.48  Aligned_cols=233  Identities=21%  Similarity=0.346  Sum_probs=186.9

Q ss_pred             cCCCccceecccCcEEEEEEEEC--Cce----EEEEEeccCC----hHHHHHHHHHHHhccccce--------------E
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG--DRE----AAIKKMRSNK----SKEFFAELKVLCKIHHINV--------------F  347 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~----vavK~~~~~~----~~~f~~Ei~~l~~l~H~ni--------------V  347 (563)
                      ++|+..+.||+|+||.||+|++.  ++.    ||+|.+....    .+.+.+|+.++++++||||              |
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v   92 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGSSLQLV   92 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECBSSEEEE
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCccEEE
Confidence            46888999999999999999874  333    7888875332    3567789999999999997              5


Q ss_pred             EEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccc
Q 044997          348 ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLE  427 (563)
Q Consensus       348 ~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~  427 (563)
                      +||+.+|+|.+++...    ...+++..+..++.|++.||+|||+++   |+||||||+|||++.++++||+|||+++..
T Consensus        93 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~  165 (325)
T 3kex_A           93 TQYLPLGSLLDHVRQH----RGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLL  165 (325)
T ss_dssp             EECCTTCBSHHHHHSS----GGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred             EEeCCCCCHHHHHHHc----cccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCccccc
Confidence            7999999999998752    346899999999999999999999997   999999999999999999999999999876


Q ss_pred             ccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCCCcCCCCCch-----
Q 044997          428 ERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIRDDSEPT-----  501 (563)
Q Consensus       428 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p~~~~~~~~~-----  501 (563)
                      ...... .......||..|+|||.+.+..             ++.++||||||+++|||++ |+.||........     
T Consensus       166 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~-------------~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~  231 (325)
T 3kex_A          166 PPDDKQ-LLYSEAKTPIKWMALESIHFGK-------------YTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE  231 (325)
T ss_dssp             CCCTTC-CC-----CCTTTSCHHHHHHCC-------------CCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHH
T ss_pred             Cccccc-ccccCCCCcccccChHHhccCC-------------CChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHH
Confidence            443221 2233456888999999885444             4899999999999999999 9999976443211     


Q ss_pred             ------hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcChhh
Q 044997          502 ------KMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITSTEW  545 (563)
Q Consensus       502 ------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~w  545 (563)
                            ........+.+++.+||+.||.+||++.|+++.|+++......+
T Consensus       232 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~~~~~  281 (325)
T 3kex_A          232 KGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDPPRY  281 (325)
T ss_dssp             TTCBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTSHHHH
T ss_pred             cCCCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcchhh
Confidence                  11122334788999999999999999999999999998765443

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7e-39  Score=330.00  Aligned_cols=233  Identities=26%  Similarity=0.466  Sum_probs=182.6

Q ss_pred             cCCCccceecccCcEEEEEEEECC------ceEEEEEeccCC----hHHHHHHHHHHHhccccce---------------
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLGD------REAAIKKMRSNK----SKEFFAELKVLCKIHHINV---------------  346 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~~------~~vavK~~~~~~----~~~f~~Ei~~l~~l~H~ni---------------  346 (563)
                      ++|...+.||+|+||.||+|....      ..||||.++...    ..++.+|++++++++||||               
T Consensus        44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  123 (333)
T 1mqb_A           44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI  123 (333)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence            456778999999999999998742      359999997543    3468899999999999997               


Q ss_pred             EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcc
Q 044997          347 FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKL  426 (563)
Q Consensus       347 V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~  426 (563)
                      |+||+++|+|.+++..    ....+++.+++.++.|++.||+|||+++   ++||||||+|||++.++.+||+|||+++.
T Consensus       124 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~  196 (333)
T 1mqb_A          124 ITEYMENGALDKFLRE----KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRV  196 (333)
T ss_dssp             EEECCTTEEHHHHHHH----TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred             EEeCCCCCcHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchh
Confidence            6799999999999864    2356999999999999999999999997   99999999999999999999999999986


Q ss_pred             cccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCCCcCCCCC------
Q 044997          427 EERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIRDDSE------  499 (563)
Q Consensus       427 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p~~~~~~~------  499 (563)
                      ...............+|+.|+|||.+.+..             ++.++||||||+++|||++ |+.||......      
T Consensus       197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-------------~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~  263 (333)
T 1mqb_A          197 LEDDPEATYTTSGGKIPIRWTAPEAISYRK-------------FTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI  263 (333)
T ss_dssp             --------------CCCGGGSCHHHHHSCC-------------CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH
T ss_pred             hccccccccccCCCCccccccCchhcccCC-------------CCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHH
Confidence            544322222222345678999999885443             4889999999999999999 99998643221      


Q ss_pred             -----chhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcChh
Q 044997          500 -----PTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITSTE  544 (563)
Q Consensus       500 -----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~  544 (563)
                           ......+...+.+++.+||+.||.+||++.++++.|++++.....
T Consensus       264 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~  313 (333)
T 1mqb_A          264 NDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDS  313 (333)
T ss_dssp             HTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGG
T ss_pred             HCCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcchh
Confidence                 111123446689999999999999999999999999998875543

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=3.2e-39  Score=323.94  Aligned_cols=229  Identities=24%  Similarity=0.380  Sum_probs=178.8

Q ss_pred             hcCCCccceecccCcEEEEEEEEC-----CceEEEEEeccCC----hHHHHHHHHHHHhccccce--------------E
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLLG-----DREAAIKKMRSNK----SKEFFAELKVLCKIHHINV--------------F  347 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~~-----~~~vavK~~~~~~----~~~f~~Ei~~l~~l~H~ni--------------V  347 (563)
                      .++|+..+.||+|+||.||+|...     +..||+|.++...    .+.|.+|+.++++++||||              |
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~lv   93 (281)
T 1mp8_A           14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWII   93 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSCEEE
T ss_pred             hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEccCccEEE
Confidence            357888999999999999999874     3469999987543    3568899999999999997              5


Q ss_pred             EEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccc
Q 044997          348 ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLE  427 (563)
Q Consensus       348 ~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~  427 (563)
                      +||+.+|+|.+++..    ....+++..+..++.|++.||.|||+++   ++||||||+|||++.++.+||+|||+++..
T Consensus        94 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  166 (281)
T 1mp8_A           94 MELCTLGELRSFLQV----RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM  166 (281)
T ss_dssp             EECCTTEEHHHHHHH----TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-------
T ss_pred             EecCCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECcccccccc
Confidence            799999999999874    2346999999999999999999999997   999999999999999999999999999865


Q ss_pred             ccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCCCcCCCCCc------
Q 044997          428 ERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIRDDSEP------  500 (563)
Q Consensus       428 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p~~~~~~~~------  500 (563)
                      .....  .......+++.|+|||.+.+..             ++.++||||||+++|||++ |+.||.......      
T Consensus       167 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~-------------~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~  231 (281)
T 1mp8_A          167 EDSTY--YKASKGKLPIKWMAPESINFRR-------------FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE  231 (281)
T ss_dssp             --------------CCGGGCCHHHHHHCC-------------CSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH
T ss_pred             Ccccc--cccccCCCcccccChhhcccCC-------------CCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHH
Confidence            43221  1122345678999999885443             4889999999999999997 888986543221      


Q ss_pred             -----hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 044997          501 -----TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMIT  541 (563)
Q Consensus       501 -----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~  541 (563)
                           .....+++.+.+++.+||+.||++||++.|+++.|+++++.
T Consensus       232 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  277 (281)
T 1mp8_A          232 NGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  277 (281)
T ss_dssp             TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             cCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence                 11223456689999999999999999999999999998764

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=6.9e-39  Score=320.80  Aligned_cols=232  Identities=27%  Similarity=0.487  Sum_probs=191.3

Q ss_pred             HhcCCCccceecccCcEEEEEEEEC-CceEEEEEeccC--ChHHHHHHHHHHHhccccce--------------EEEeec
Q 044997          290 ATNNFDESRIIGRGGFGNVYFGLLG-DREAAIKKMRSN--KSKEFFAELKVLCKIHHINV--------------FISTFG  352 (563)
Q Consensus       290 ~~~~f~~~~~LG~G~fG~Vy~g~~~-~~~vavK~~~~~--~~~~f~~Ei~~l~~l~H~ni--------------V~e~~~  352 (563)
                      ..++|+..+.||+|+||.||+|... +..||+|.++..  ..+.+.+|++++++++||||              |+||++
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~~   90 (279)
T 1qpc_A           11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYME   90 (279)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEEECCT
T ss_pred             CHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEcCCCcEEEEecCC
Confidence            3467888999999999999999986 468999999754  35789999999999999997              579999


Q ss_pred             CCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccccccc
Q 044997          353 NGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNE  432 (563)
Q Consensus       353 ~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~  432 (563)
                      +|+|.+++...   ....+++..+..++.|++.||+|||+++   ++||||||+|||+++++.+||+|||+++.......
T Consensus        91 ~~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  164 (279)
T 1qpc_A           91 NGSLVDFLKTP---SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY  164 (279)
T ss_dssp             TCBHHHHTTSH---HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred             CCCHHHHHhcC---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCccc
Confidence            99999999752   1236999999999999999999999997   99999999999999999999999999986543221


Q ss_pred             cccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCCCcCCCCCc-----------
Q 044997          433 KEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIRDDSEP-----------  500 (563)
Q Consensus       433 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p~~~~~~~~-----------  500 (563)
                        .......++..|+|||.+.+..+             +.++||||||+++|||++ |+.||.......           
T Consensus       165 --~~~~~~~~~~~y~aPE~~~~~~~-------------~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~  229 (279)
T 1qpc_A          165 --TAREGAKFPIKWTAPEAINYGTF-------------TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRM  229 (279)
T ss_dssp             --ECCTTCCCCTTTSCHHHHHHCEE-------------CHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC
T ss_pred             --ccccCCCCccCccChhhhccCCC-------------CchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCC
Confidence              11223457889999998865443             789999999999999999 888886533211           


Q ss_pred             hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcC
Q 044997          501 TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITS  542 (563)
Q Consensus       501 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~  542 (563)
                      .....+.+.+.+++.+||+.||++||++.++++.|++++...
T Consensus       230 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~  271 (279)
T 1qpc_A          230 VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT  271 (279)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             CCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhc
Confidence            111234467899999999999999999999999999987653

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.9e-39  Score=327.71  Aligned_cols=220  Identities=16%  Similarity=0.257  Sum_probs=185.3

Q ss_pred             hcCCCccceecccCcEEEEEEEEC--CceEEEEEeccCC--hHHHHHHHHHHHhccccce---------------EEEee
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNK--SKEFFAELKVLCKIHHINV---------------FISTF  351 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~--~~~f~~Ei~~l~~l~H~ni---------------V~e~~  351 (563)
                      .++|...+.||+|+||.||++...  ++.+|+|.++...  .+.+.+|+++|++++||||               |+||+
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~   83 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI   83 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeC
Confidence            467899999999999999999884  6889999987553  3568899999999999997               57999


Q ss_pred             cCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecC--CCcEEEeecCCCccccc
Q 044997          352 GNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDD--GLRAKVADFGLVKLEER  429 (563)
Q Consensus       352 ~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~--~~~~kl~DFGla~~~~~  429 (563)
                      ++|+|.+++..    ....+++.++..++.|++.||+|||+++   |+||||||+|||++.  ++.+||+|||+++....
T Consensus        84 ~g~~L~~~l~~----~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~  156 (321)
T 1tki_A           84 SGLDIFERINT----SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP  156 (321)
T ss_dssp             CCCBHHHHHTS----SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred             CCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC
Confidence            99999999865    2356999999999999999999999997   999999999999987  78999999999986543


Q ss_pred             ccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc---------
Q 044997          430 TNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP---------  500 (563)
Q Consensus       430 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~---------  500 (563)
                      ..    ......||+.|+|||++.+..+             +.++|||||||++|||++|+.||.......         
T Consensus       157 ~~----~~~~~~gt~~y~aPE~~~~~~~-------------~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~  219 (321)
T 1tki_A          157 GD----NFRLLFTAPEYYAPEVHQHDVV-------------STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAE  219 (321)
T ss_dssp             TC----EEEEEESCGGGSCHHHHTTCEE-------------CHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC
T ss_pred             CC----ccccccCChhhcCcHHhcCCCC-------------CchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCC
Confidence            32    1233568999999999865543             789999999999999999999996543211         


Q ss_pred             -----hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          501 -----TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       501 -----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                           .....++..+.+++.+||+.||.+|||+.|+++.
T Consensus       220 ~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h  258 (321)
T 1tki_A          220 YTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             CCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             CCCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence                 1122445678999999999999999999999874

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=1.8e-38  Score=320.88  Aligned_cols=230  Identities=28%  Similarity=0.389  Sum_probs=184.5

Q ss_pred             cCCCccceecccCcEEEEEEEECC-----ceEEEEEeccCC----hHHHHHHHHHHHhccccce----------------
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLGD-----REAAIKKMRSNK----SKEFFAELKVLCKIHHINV----------------  346 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~~-----~~vavK~~~~~~----~~~f~~Ei~~l~~l~H~ni----------------  346 (563)
                      .+|+..+.||+|+||.||+|+..+     ..+|+|.++...    .+.+.+|++++++++||||                
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  104 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  104 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred             eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence            357788999999999999998632     248999987543    3568899999999999997                


Q ss_pred             EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcc
Q 044997          347 FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKL  426 (563)
Q Consensus       347 V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~  426 (563)
                      |+||+++|+|.+++..    ....+++..+..++.|++.||+|||+++   ++||||||+|||+++++.+||+|||+++.
T Consensus       105 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~  177 (298)
T 3f66_A          105 VLPYMKHGDLRNFIRN----ETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARD  177 (298)
T ss_dssp             EEECCTTCBHHHHHHC----TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCC
T ss_pred             EEeCCCCCCHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECccccccc
Confidence            5799999999999965    2456899999999999999999999997   99999999999999999999999999986


Q ss_pred             cccccccc-cccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCch----
Q 044997          427 EERTNEKE-MLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPT----  501 (563)
Q Consensus       427 ~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~----  501 (563)
                      ........ .......||+.|+|||.+.+..             ++.++||||||+++|||++|..|+........    
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-------------~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~  244 (298)
T 3f66_A          178 MYDKEYYSVHNKTGAKLPVKWMALESLQTQK-------------FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY  244 (298)
T ss_dssp             CSCGGGCBC-----CCBCGGGSCHHHHHHCC-------------CCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHH
T ss_pred             ccccchhccccccCCCCCccccChHHhcCCC-------------CChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHH
Confidence            54332211 1223356788999999885444             48899999999999999996555433322111    


Q ss_pred             --------hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 044997          502 --------KMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMIT  541 (563)
Q Consensus       502 --------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~  541 (563)
                              ....+++.+.+++.+||+.||.+||++.|+++.|++++..
T Consensus       245 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~  292 (298)
T 3f66_A          245 LLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST  292 (298)
T ss_dssp             HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             HhcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence                    1123456689999999999999999999999999999864

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=6.2e-39  Score=332.78  Aligned_cols=228  Identities=12%  Similarity=0.162  Sum_probs=187.4

Q ss_pred             cCCCccceecccCcEEEEEEEEC----------CceEEEEEeccCChHHHHHHHHHHHhccccce---------------
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG----------DREAAIKKMRSNKSKEFFAELKVLCKIHHINV---------------  346 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~----------~~~vavK~~~~~~~~~f~~Ei~~l~~l~H~ni---------------  346 (563)
                      ++|...+.||+|+||.||+|+..          ++.||||.++..  +.+.+|++++++++||||               
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i  119 (352)
T 2jii_A           42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAI  119 (352)
T ss_dssp             CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSC
T ss_pred             CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--chHHHHHHHHHHhcccchhhhhhhhccCCccCc
Confidence            57889999999999999999874          578999999765  468899999999999764               


Q ss_pred             ----------------EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEe
Q 044997          347 ----------------FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILL  410 (563)
Q Consensus       347 ----------------V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl  410 (563)
                                      |+||+ +|+|.+++...   ....+++..++.++.|++.||+|||+++   |+||||||+|||+
T Consensus       120 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIl~  192 (352)
T 2jii_A          120 PTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS---PKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFV  192 (352)
T ss_dssp             CCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS---GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGEEE
T ss_pred             cchhhccccCCcEEEEEecCC-CcCHHHHHHhC---CcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEE
Confidence                            56888 89999999752   2357999999999999999999999997   9999999999999


Q ss_pred             cCCC--cEEEeecCCCcccccccccc----cccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHH
Q 044997          411 DDGL--RAKVADFGLVKLEERTNEKE----MLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLA  484 (563)
Q Consensus       411 ~~~~--~~kl~DFGla~~~~~~~~~~----~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~  484 (563)
                      +.++  .+||+|||+++.........    .......||+.|+|||++.+..             ++.++||||||+++|
T Consensus       193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------------~~~~~Di~slG~il~  259 (352)
T 2jii_A          193 DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCG-------------PSRRSDLQSLGYCML  259 (352)
T ss_dssp             ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCC-------------CCHHHHHHHHHHHHH
T ss_pred             cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCC-------------CCchhhHHHHHHHHH
Confidence            9998  99999999998655432211    1123357999999999886543             488999999999999


Q ss_pred             HHHcCCCCCcCCCCCchhhH---------------------HHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 044997          485 ELITGKRALIRDDSEPTKMK---------------------SLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMIT  541 (563)
Q Consensus       485 Elltg~~p~~~~~~~~~~~~---------------------~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~  541 (563)
                      ||++|+.||...........                     .+...+.+++.+||+.||.+||++.++++.|++++..
T Consensus       260 el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~  337 (352)
T 2jii_A          260 KWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQD  337 (352)
T ss_dssp             HHHHSCCTTGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             HHHhCCCCcccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHh
Confidence            99999999976542221111                     1246799999999999999999999999999999854

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=3.1e-39  Score=323.90  Aligned_cols=232  Identities=25%  Similarity=0.423  Sum_probs=188.1

Q ss_pred             hcCCCccceecccCcEEEEEEEECC-----ceEEEEEeccCC----hHHHHHHHHHHHhccccce--------------E
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLLGD-----REAAIKKMRSNK----SKEFFAELKVLCKIHHINV--------------F  347 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~~~-----~~vavK~~~~~~----~~~f~~Ei~~l~~l~H~ni--------------V  347 (563)
                      .++|...+.||+|+||.||+|+..+     ..||+|.++...    .+.|.+|++++++++||||              |
T Consensus        11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v   90 (281)
T 3cc6_A           11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEPTWII   90 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSSSCEEE
T ss_pred             ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCEEE
Confidence            4578889999999999999998632     349999987652    4678999999999999997              5


Q ss_pred             EEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccc
Q 044997          348 ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLE  427 (563)
Q Consensus       348 ~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~  427 (563)
                      +||+++|+|.+++...    ...+++..+..++.|++.||.|||+++   ++||||||+|||++.++.+||+|||+++..
T Consensus        91 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  163 (281)
T 3cc6_A           91 MELYPYGELGHYLERN----KNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYI  163 (281)
T ss_dssp             EECCTTCBHHHHHHHH----TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred             EecCCCCCHHHHHHhc----cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCccc
Confidence            7999999999998652    356899999999999999999999997   999999999999999999999999999865


Q ss_pred             ccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCCCcCCCCCc------
Q 044997          428 ERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIRDDSEP------  500 (563)
Q Consensus       428 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p~~~~~~~~------  500 (563)
                      ......  ......+++.|+|||.+.+..             ++.++||||||+++|||++ |+.||.......      
T Consensus       164 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~-------------~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~  228 (281)
T 3cc6_A          164 EDEDYY--KASVTRLPIKWMSPESINFRR-------------FTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLE  228 (281)
T ss_dssp             -----------CCCCCGGGCCHHHHHHCC-------------CCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHH
T ss_pred             cccccc--ccccCCCCcceeCchhhccCC-------------CCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHh
Confidence            432211  123345788999999885443             4889999999999999998 999986433221      


Q ss_pred             -----hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcChh
Q 044997          501 -----TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITSTE  544 (563)
Q Consensus       501 -----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~  544 (563)
                           .....+.+.+.+++.+||+.||.+||++.|+++.|+++.+...+
T Consensus       229 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~  277 (281)
T 3cc6_A          229 KGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQMEKD  277 (281)
T ss_dssp             HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred             cCCCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhhhh
Confidence                 11123345689999999999999999999999999999876544

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.4e-38  Score=326.94  Aligned_cols=218  Identities=24%  Similarity=0.370  Sum_probs=183.2

Q ss_pred             cCCCccceecccCcEEEEEEEEC--CceEEEEEeccC---------ChHHHHHHHHHHHhccccce--------------
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSN---------KSKEFFAELKVLCKIHHINV--------------  346 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~---------~~~~f~~Ei~~l~~l~H~ni--------------  346 (563)
                      ++|...+.||+|+||.||++...  ++.+|+|.++..         ..+++.+|+++|++++||||              
T Consensus        11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   90 (326)
T 2y0a_A           11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   90 (326)
T ss_dssp             HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            46889999999999999999884  788999998643         24679999999999999997              


Q ss_pred             -EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCC----cEEEeec
Q 044997          347 -FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGL----RAKVADF  421 (563)
Q Consensus       347 -V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~----~~kl~DF  421 (563)
                       |+||+++|+|.+++..     ...+++..+..++.|++.||.|||+++   |+||||||+|||++.++    .+||+||
T Consensus        91 lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Df  162 (326)
T 2y0a_A           91 LILELVAGGELFDFLAE-----KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDF  162 (326)
T ss_dssp             EEEECCCSCBHHHHHTT-----SSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred             EEEEcCCCCCHHHHHHh-----cCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence             5799999999999864     356999999999999999999999997   99999999999999887    8999999


Q ss_pred             CCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc-
Q 044997          422 GLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP-  500 (563)
Q Consensus       422 Gla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~-  500 (563)
                      |+++......    ......||+.|+|||++.+..             ++.++|||||||++|||++|+.||....... 
T Consensus       163 g~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~-------------~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~  225 (326)
T 2y0a_A          163 GLAHKIDFGN----EFKNIFGTPEFVAPEIVNYEP-------------LGLEADMWSIGVITYILLSGASPFLGDTKQET  225 (326)
T ss_dssp             TTCEECCTTS----CCCCCCSCTTTCCHHHHTTCC-------------CCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH
T ss_pred             CCCeECCCCC----ccccccCCcCcCCceeecCCC-------------CCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH
Confidence            9998654322    123457999999999885444             4889999999999999999999996543211 


Q ss_pred             -------------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          501 -------------TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       501 -------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                                   .........+.+++.+||+.||.+|||+.|+++.
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  272 (326)
T 2y0a_A          226 LANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH  272 (326)
T ss_dssp             HHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             HHHHHhcCCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                         1112334568999999999999999999999873

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=2.5e-39  Score=347.40  Aligned_cols=232  Identities=26%  Similarity=0.429  Sum_probs=187.5

Q ss_pred             HhcCCCccceecccCcEEEEEEEECC-ceEEEEEeccC--ChHHHHHHHHHHHhccccce--------------EEEeec
Q 044997          290 ATNNFDESRIIGRGGFGNVYFGLLGD-REAAIKKMRSN--KSKEFFAELKVLCKIHHINV--------------FISTFG  352 (563)
Q Consensus       290 ~~~~f~~~~~LG~G~fG~Vy~g~~~~-~~vavK~~~~~--~~~~f~~Ei~~l~~l~H~ni--------------V~e~~~  352 (563)
                      ..++|...+.||+|+||.||+|.+++ ..||||.++..  ..++|.+|+++|++++||||              |+||++
T Consensus       182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~iv~e~~~  261 (452)
T 1fmk_A          182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMS  261 (452)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEECCCT
T ss_pred             ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcCCceEEEehhhc
Confidence            45678889999999999999999965 67999999864  34789999999999999997              689999


Q ss_pred             CCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccccccc
Q 044997          353 NGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNE  432 (563)
Q Consensus       353 ~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~  432 (563)
                      +|+|.+++...   ....+++.+++.++.|++.||+|||+++   |+||||||+|||+++++.+||+|||+++.......
T Consensus       262 ~gsL~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  335 (452)
T 1fmk_A          262 KGSLLDFLKGE---TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY  335 (452)
T ss_dssp             TCBHHHHHSHH---HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred             CCCHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCCce
Confidence            99999999752   2346899999999999999999999997   99999999999999999999999999986543211


Q ss_pred             cccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCCCcCCCCC-----------c
Q 044997          433 KEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIRDDSE-----------P  500 (563)
Q Consensus       433 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p~~~~~~~-----------~  500 (563)
                        .......++..|+|||.+....             ++.++|||||||++|||++ |+.||......           .
T Consensus       336 --~~~~~~~~~~~y~aPE~~~~~~-------------~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~  400 (452)
T 1fmk_A          336 --TARQGAKFPIKWTAPEAALYGR-------------FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM  400 (452)
T ss_dssp             ---------CCGGGSCHHHHHHCC-------------CCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC
T ss_pred             --ecccCCcccccccCHhHHhcCC-------------CCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC
Confidence              1122345778999999885444             4899999999999999999 89888653321           1


Q ss_pred             hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcC
Q 044997          501 TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITS  542 (563)
Q Consensus       501 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~  542 (563)
                      .....+++.+.+++.+||+.||++|||+.++++.|+.+....
T Consensus       401 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~  442 (452)
T 1fmk_A          401 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  442 (452)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred             CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccC
Confidence            112234566899999999999999999999999999987643

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=4.9e-39  Score=329.01  Aligned_cols=237  Identities=22%  Similarity=0.353  Sum_probs=179.5

Q ss_pred             HhcCCCccceecccCcEEEEEEEECC-----ceEEEEEeccC-----ChHHHHHHHHHHHhccccce-------------
Q 044997          290 ATNNFDESRIIGRGGFGNVYFGLLGD-----REAAIKKMRSN-----KSKEFFAELKVLCKIHHINV-------------  346 (563)
Q Consensus       290 ~~~~f~~~~~LG~G~fG~Vy~g~~~~-----~~vavK~~~~~-----~~~~f~~Ei~~l~~l~H~ni-------------  346 (563)
                      ..++|+..+.||+|+||.||+|+...     ..||||.++..     ..+++.+|++++++++||||             
T Consensus        21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  100 (323)
T 3qup_A           21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK  100 (323)
T ss_dssp             C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred             ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence            35679999999999999999998743     27999998753     23679999999999999997             


Q ss_pred             --------EEEeecCCCccccccccccc-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEE
Q 044997          347 --------FISTFGNGSLSDHLHDPLLK-GHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAK  417 (563)
Q Consensus       347 --------V~e~~~~gsL~~~L~~~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~k  417 (563)
                              |+||+.+|+|.+++...... ....+++..+..++.|++.||+|||+++   ++||||||+|||+++++.+|
T Consensus       101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~k  177 (323)
T 3qup_A          101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVC  177 (323)
T ss_dssp             ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEE
T ss_pred             cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCEE
Confidence                    46888999999998653221 2236999999999999999999999997   99999999999999999999


Q ss_pred             EeecCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCCCcCC
Q 044997          418 VADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIRD  496 (563)
Q Consensus       418 l~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p~~~~  496 (563)
                      |+|||+++........ .......+++.|+|||.+.+..             ++.++||||||+++|||++ |+.||...
T Consensus       178 l~Dfg~a~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~-------------~~~~~Di~slG~il~ell~~g~~p~~~~  243 (323)
T 3qup_A          178 VADFGLSRKIYSGDYY-RQGCASKLPVKWLALESLADNL-------------YTVHSDVWAFGVTMWEIMTRGQTPYAGI  243 (323)
T ss_dssp             ECCCCC------------------CCGGGCCHHHHHHCC-------------CCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred             Eeeccccccccccccc-cccccccCcccccCchhhcCCC-------------CCCccchhhHHHHHHHHHhCCCCCcccc
Confidence            9999999865433211 1122345678999999885544             4899999999999999999 88888654


Q ss_pred             CCCc-----------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcCh
Q 044997          497 DSEP-----------TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITST  543 (563)
Q Consensus       497 ~~~~-----------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~  543 (563)
                      ....           .....+.+.+.+++.+||+.||.+||++.++++.|++++....
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~  301 (323)
T 3qup_A          244 ENAEIYNYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLS  301 (323)
T ss_dssp             CGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred             ChHHHHHHHhcCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhh
Confidence            3221           1122345678999999999999999999999999999987543

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-38  Score=328.43  Aligned_cols=236  Identities=22%  Similarity=0.368  Sum_probs=189.2

Q ss_pred             HhcCCCccceecccCcEEEEEEEE-------CCceEEEEEeccC----ChHHHHHHHHHHHhc-cccce-----------
Q 044997          290 ATNNFDESRIIGRGGFGNVYFGLL-------GDREAAIKKMRSN----KSKEFFAELKVLCKI-HHINV-----------  346 (563)
Q Consensus       290 ~~~~f~~~~~LG~G~fG~Vy~g~~-------~~~~vavK~~~~~----~~~~f~~Ei~~l~~l-~H~ni-----------  346 (563)
                      ..++|...+.||+|+||.||+|+.       .+..||||.++..    ..+.+.+|++++.++ +||||           
T Consensus        43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  122 (344)
T 1rjb_A           43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG  122 (344)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence            457899999999999999999986       2457999998753    346799999999999 99997           


Q ss_pred             ----EEEeecCCCccccccccccc------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCC
Q 044997          347 ----FISTFGNGSLSDHLHDPLLK------------------GHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIK  404 (563)
Q Consensus       347 ----V~e~~~~gsL~~~L~~~~~~------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk  404 (563)
                          |+||+++|+|.+++......                  ....+++..++.++.|++.||+|||+++   |+|||||
T Consensus       123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dik  199 (344)
T 1rjb_A          123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLA  199 (344)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCS
T ss_pred             ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCC
Confidence                67999999999999753110                  0134899999999999999999999997   9999999


Q ss_pred             CCCeEecCCCcEEEeecCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHH
Q 044997          405 TSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLA  484 (563)
Q Consensus       405 ~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~  484 (563)
                      |+|||++.++.+||+|||+++........ .......||+.|+|||.+.+..             ++.++||||||+++|
T Consensus       200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~-------------~~~~~Di~slG~il~  265 (344)
T 1rjb_A          200 ARNVLVTHGKVVKICDFGLARDIMSDSNY-VVRGNARLPVKWMAPESLFEGI-------------YTIKSDVWSYGILLW  265 (344)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCGGGCTTS-EEETTEEECGGGCCHHHHHHCC-------------CCHHHHHHHHHHHHH
T ss_pred             hhhEEEcCCCcEEeCCCccCcccccCccc-eeccCccCccCccCHHHhccCC-------------CChhHhHHHHHHHHH
Confidence            99999999999999999999865433221 1223356788999999875443             489999999999999


Q ss_pred             HHHc-CCCCCcCCCCCchh------------hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcC
Q 044997          485 ELIT-GKRALIRDDSEPTK------------MKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITS  542 (563)
Q Consensus       485 Ellt-g~~p~~~~~~~~~~------------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~  542 (563)
                      ||++ |+.||.........            .....+.+.+++.+||+.||.+||++.|+++.|+.++...
T Consensus       266 el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~  336 (344)
T 1rjb_A          266 EIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADA  336 (344)
T ss_dssp             HHTTTSCCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred             HHHcCCCCCcccCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHH
Confidence            9998 99998765432211            1223566899999999999999999999999999987653

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.8e-38  Score=319.02  Aligned_cols=230  Identities=27%  Similarity=0.379  Sum_probs=186.4

Q ss_pred             CCCccceecccCcEEEEEEEEC--C---ceEEEEEeccCC----hHHHHHHHHHHHhccccce----------------E
Q 044997          293 NFDESRIIGRGGFGNVYFGLLG--D---REAAIKKMRSNK----SKEFFAELKVLCKIHHINV----------------F  347 (563)
Q Consensus       293 ~f~~~~~LG~G~fG~Vy~g~~~--~---~~vavK~~~~~~----~~~f~~Ei~~l~~l~H~ni----------------V  347 (563)
                      .|...+.||+|+||.||+|.+.  +   ..+|+|.++...    .+.|.+|++++++++||||                |
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            3556789999999999999862  2   269999987543    3568899999999999997                5


Q ss_pred             EEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccc
Q 044997          348 ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLE  427 (563)
Q Consensus       348 ~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~  427 (563)
                      +||+.+|+|.+++..    ....+++..+..++.|++.||+|||+++   ++||||||+|||+++++.+||+|||+++..
T Consensus       102 ~e~~~~~~L~~~~~~----~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~  174 (298)
T 3pls_A          102 LPYMCHGDLLQFIRS----PQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDI  174 (298)
T ss_dssp             ECCCTTCBHHHHHHC----TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTT
T ss_pred             EecccCCCHHHHHhc----cccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccc
Confidence            788899999999875    2466899999999999999999999997   999999999999999999999999999865


Q ss_pred             cccccc-ccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCchh----
Q 044997          428 ERTNEK-EMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTK----  502 (563)
Q Consensus       428 ~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~~----  502 (563)
                      ...... ........+|..|+|||.+.+..             ++.++||||||+++|||++|+.|+.........    
T Consensus       175 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-------------~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~  241 (298)
T 3pls_A          175 LDREYYSVQQHRHARLPVKWTALESLQTYR-------------FTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFL  241 (298)
T ss_dssp             TTGGGGCSCCSSCTTCGGGGSCHHHHTTCC-------------CCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHH
T ss_pred             cCCcccccccCcCCCCCccccChhhhccCC-------------CChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHh
Confidence            432211 11223356788999999885544             488999999999999999977776543332211    


Q ss_pred             --------hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcC
Q 044997          503 --------MKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITS  542 (563)
Q Consensus       503 --------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~  542 (563)
                              ...+.+.+.+++.+||+.||.+|||+.++++.|++++..-
T Consensus       242 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l  289 (298)
T 3pls_A          242 AQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSAL  289 (298)
T ss_dssp             HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             hcCCCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHH
Confidence                    1233456899999999999999999999999999998754

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=7.7e-39  Score=325.91  Aligned_cols=245  Identities=24%  Similarity=0.374  Sum_probs=197.1

Q ss_pred             ccCHHHHHHHhcCCCccceecccCcEEEEEEEE-------CCceEEEEEeccCC----hHHHHHHHHHHHhc-cccce--
Q 044997          281 IFSLEEIEEATNNFDESRIIGRGGFGNVYFGLL-------GDREAAIKKMRSNK----SKEFFAELKVLCKI-HHINV--  346 (563)
Q Consensus       281 ~~~~~el~~~~~~f~~~~~LG~G~fG~Vy~g~~-------~~~~vavK~~~~~~----~~~f~~Ei~~l~~l-~H~ni--  346 (563)
                      .+...++....++|...+.||+|+||.||+|+.       .++.||||.++...    .+.+.+|++++.++ +||||  
T Consensus        16 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~   95 (316)
T 2xir_A           16 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN   95 (316)
T ss_dssp             CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             cccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeee
Confidence            455566666678999999999999999999985       24789999997643    24688999999999 78997  


Q ss_pred             --------------EEEeecCCCccccccccccc-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeC
Q 044997          347 --------------FISTFGNGSLSDHLHDPLLK-----------GHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHR  401 (563)
Q Consensus       347 --------------V~e~~~~gsL~~~L~~~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHr  401 (563)
                                    |+||+++|+|.+++......           ....+++..+..++.|++.||.|||+++   ++||
T Consensus        96 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~  172 (316)
T 2xir_A           96 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHR  172 (316)
T ss_dssp             EEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred             EEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccc
Confidence                          57899999999998753210           0123899999999999999999999997   9999


Q ss_pred             CCCCCCeEecCCCcEEEeecCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHH
Q 044997          402 DIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGV  481 (563)
Q Consensus       402 DLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGv  481 (563)
                      ||||+|||++.++.+||+|||+++........ .......||+.|+|||.+.+..             ++.++||||||+
T Consensus       173 dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~-------------~~~~~Di~slG~  238 (316)
T 2xir_A          173 DLAARNILLSEKNVVKICDFGLARDIYKDPDY-VRKGDARLPLKWMAPETIFDRV-------------YTIQSDVWSFGV  238 (316)
T ss_dssp             CCSGGGEEECGGGCEEECCCGGGSCTTTCTTS-EEETTEEECGGGCCHHHHHHCC-------------CCHHHHHHHHHH
T ss_pred             cCccceEEECCCCCEEECCCccccccccCccc-eeccCCCcceeecCchhhcccc-------------ccchhHHHHHHH
Confidence            99999999999999999999999865433221 1223356788999999885443             488999999999


Q ss_pred             HHHHHHc-CCCCCcCCCCCchhh------------HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcC
Q 044997          482 VLAELIT-GKRALIRDDSEPTKM------------KSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITS  542 (563)
Q Consensus       482 vl~Ellt-g~~p~~~~~~~~~~~------------~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~  542 (563)
                      ++|||++ |+.||..........            ......+.+++.+||+.||.+||++.|+++.|+++++..
T Consensus       239 il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  312 (316)
T 2xir_A          239 LLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN  312 (316)
T ss_dssp             HHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHhCCCCCCcccchhHHHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence            9999998 999986654332211            223456899999999999999999999999999998653

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=9.5e-39  Score=322.13  Aligned_cols=231  Identities=22%  Similarity=0.336  Sum_probs=187.4

Q ss_pred             cCCCccc-eecccCcEEEEEEEEC----CceEEEEEeccCC-----hHHHHHHHHHHHhccccce--------------E
Q 044997          292 NNFDESR-IIGRGGFGNVYFGLLG----DREAAIKKMRSNK-----SKEFFAELKVLCKIHHINV--------------F  347 (563)
Q Consensus       292 ~~f~~~~-~LG~G~fG~Vy~g~~~----~~~vavK~~~~~~-----~~~f~~Ei~~l~~l~H~ni--------------V  347 (563)
                      ++|...+ .||+|+||.||+|.+.    ++.||||.++...     .+++.+|++++++++||||              |
T Consensus        16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv   95 (291)
T 1xbb_A           16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLV   95 (291)
T ss_dssp             GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESSSEEEE
T ss_pred             hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEECCCCcEEE
Confidence            4567777 9999999999999652    4789999987542     4678999999999999997              5


Q ss_pred             EEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccc
Q 044997          348 ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLE  427 (563)
Q Consensus       348 ~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~  427 (563)
                      +||+++|+|.+++..     ...+++..++.++.|++.||+|||+++   ++||||||+|||++.++.+||+|||+++..
T Consensus        96 ~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~  167 (291)
T 1xbb_A           96 MEMAELGPLNKYLQQ-----NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKAL  167 (291)
T ss_dssp             EECCTTEEHHHHHHH-----CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEeCCCCCHHHHHHh-----CcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence            799999999999865     356999999999999999999999997   999999999999999999999999999865


Q ss_pred             ccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCCCcCCCCC-------
Q 044997          428 ERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIRDDSE-------  499 (563)
Q Consensus       428 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p~~~~~~~-------  499 (563)
                      ..............+++.|+|||.+.+..+             +.++||||||+++|||++ |+.||......       
T Consensus       168 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-------------~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~  234 (291)
T 1xbb_A          168 RADENYYKAQTHGKWPVKWYAPECINYYKF-------------SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE  234 (291)
T ss_dssp             CTTCSEEEC----CCCGGGCCHHHHHHCEE-------------EHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH
T ss_pred             ccCCCcccccccCCCCceeeChHHhccCCC-------------ChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence            443322222233456789999998865544             789999999999999999 99998654321       


Q ss_pred             ----chhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcCh
Q 044997          500 ----PTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITST  543 (563)
Q Consensus       500 ----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~  543 (563)
                          ......+++.+.+++.+||+.||.+||++.++++.|++++....
T Consensus       235 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~  282 (291)
T 1xbb_A          235 KGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV  282 (291)
T ss_dssp             TTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHH
T ss_pred             cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence                11122345679999999999999999999999999999987654

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1e-38  Score=324.63  Aligned_cols=234  Identities=25%  Similarity=0.396  Sum_probs=190.5

Q ss_pred             hcCCCccceecccCcEEEEEEEEC-------CceEEEEEeccCC----hHHHHHHHHHHHhccccce-------------
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLLG-------DREAAIKKMRSNK----SKEFFAELKVLCKIHHINV-------------  346 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~~-------~~~vavK~~~~~~----~~~f~~Ei~~l~~l~H~ni-------------  346 (563)
                      .++|...+.||+|+||.||+|...       ++.||||.++...    .+++.+|++++++++||||             
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  101 (314)
T 2ivs_A           22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL  101 (314)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred             hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence            567888999999999999999762       3679999997543    2568899999999999997             


Q ss_pred             --EEEeecCCCccccccccccc-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCC
Q 044997          347 --FISTFGNGSLSDHLHDPLLK-------------------GHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKT  405 (563)
Q Consensus       347 --V~e~~~~gsL~~~L~~~~~~-------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~  405 (563)
                        |+||+++|+|.+++......                   ....+++.+++.++.|++.||+|||+++   ++||||||
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dikp  178 (314)
T 2ivs_A          102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLAA  178 (314)
T ss_dssp             EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCSG
T ss_pred             EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccch
Confidence              57999999999998753210                   1234899999999999999999999997   99999999


Q ss_pred             CCeEecCCCcEEEeecCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHH
Q 044997          406 SNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAE  485 (563)
Q Consensus       406 ~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~E  485 (563)
                      +|||+++++.+||+|||+++........ .......+|+.|+|||.+.+..+             +.++||||||+++||
T Consensus       179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~-------------~~~~Di~slG~il~e  244 (314)
T 2ivs_A          179 RNILVAEGRKMKISDFGLSRDVYEEDSY-VKRSQGRIPVKWMAIESLFDHIY-------------TTQSDVWSFGVLLWE  244 (314)
T ss_dssp             GGEEEETTTEEEECCCTTCEECTTTSCE-ECSSCCCSCGGGCCHHHHHHCEE-------------CHHHHHHHHHHHHHH
T ss_pred             heEEEcCCCCEEEccccccccccccccc-eeccCCCCcccccChhhhcCCCc-------------CchhhHHHHHHHHHH
Confidence            9999999999999999999865433211 12233457889999998865544             789999999999999


Q ss_pred             HHc-CCCCCcCCCCCc-----------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 044997          486 LIT-GKRALIRDDSEP-----------TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMIT  541 (563)
Q Consensus       486 llt-g~~p~~~~~~~~-----------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~  541 (563)
                      |++ |+.||.......           .....+.+.+.+++.+||+.||.+||++.|+++.|++++..
T Consensus       245 l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  312 (314)
T 2ivs_A          245 IVTLGGNPYPGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK  312 (314)
T ss_dssp             HHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             HHhCCCCCCCCCCHHHHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence            999 999986543221           11123456789999999999999999999999999998753

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=1e-38  Score=354.93  Aligned_cols=229  Identities=20%  Similarity=0.353  Sum_probs=183.4

Q ss_pred             CCCccc-eecccCcEEEEEEEEC----CceEEEEEeccC----ChHHHHHHHHHHHhccccce--------------EEE
Q 044997          293 NFDESR-IIGRGGFGNVYFGLLG----DREAAIKKMRSN----KSKEFFAELKVLCKIHHINV--------------FIS  349 (563)
Q Consensus       293 ~f~~~~-~LG~G~fG~Vy~g~~~----~~~vavK~~~~~----~~~~f~~Ei~~l~~l~H~ni--------------V~e  349 (563)
                      ++...+ .||+|+||.||+|.+.    +..||||.++..    ..++|.+|+++|++++||||              |+|
T Consensus       336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~lv~E  415 (613)
T 2ozo_A          336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVME  415 (613)
T ss_dssp             SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEESSSEEEEEE
T ss_pred             ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEeccCCeEEEEE
Confidence            333344 7999999999999873    456999999753    34789999999999999997              689


Q ss_pred             eecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccccc
Q 044997          350 TFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEER  429 (563)
Q Consensus       350 ~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~  429 (563)
                      |+++|+|.+++..    ....+++..+..++.|++.||+|||+++   |+||||||+|||+++++.+||+|||+++....
T Consensus       416 ~~~~g~L~~~l~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~  488 (613)
T 2ozo_A          416 MAGGGPLHKFLVG----KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGA  488 (613)
T ss_dssp             CCTTCBHHHHHTT----CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC-
T ss_pred             eCCCCcHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccC
Confidence            9999999999975    2456999999999999999999999997   99999999999999999999999999987643


Q ss_pred             ccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCCCcCCCCCc--------
Q 044997          430 TNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIRDDSEP--------  500 (563)
Q Consensus       430 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p~~~~~~~~--------  500 (563)
                      ............+++.|+|||++.+..             ++.++|||||||++|||++ |+.||.......        
T Consensus       489 ~~~~~~~~~~~~~~~~y~APE~~~~~~-------------~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~  555 (613)
T 2ozo_A          489 DDSYYTARSAGKWPLKWYAPECINFRK-------------FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG  555 (613)
T ss_dssp             -------------CCTTSCHHHHHHCC-------------CCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTT
T ss_pred             CCceeeeccCCCCccceeCHhhhcCCC-------------CCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC
Confidence            322211122234678999999885444             4899999999999999998 999987544321        


Q ss_pred             ---hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 044997          501 ---TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMIT  541 (563)
Q Consensus       501 ---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~  541 (563)
                         .....+++.+.+|+.+||+.||++||++.+|++.|+.+...
T Consensus       556 ~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~  599 (613)
T 2ozo_A          556 KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS  599 (613)
T ss_dssp             CCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence               11223456799999999999999999999999999988654

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=4.2e-38  Score=321.08  Aligned_cols=220  Identities=23%  Similarity=0.324  Sum_probs=177.0

Q ss_pred             hcCCCccceecccCcEEEEEEEE-CCceEEEEEeccCC-----hHHHHHHHHHHHhccccce---------------EEE
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLL-GDREAAIKKMRSNK-----SKEFFAELKVLCKIHHINV---------------FIS  349 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~-~~~~vavK~~~~~~-----~~~f~~Ei~~l~~l~H~ni---------------V~e  349 (563)
                      .++|+..+.||+|+||.||+|+. +++.||+|+++...     .+.+.+|++++++++||||               |+|
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   99 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE   99 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred             HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence            46788999999999999999998 57889999987432     2568899999999999997               467


Q ss_pred             eecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccccc
Q 044997          350 TFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEER  429 (563)
Q Consensus       350 ~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~  429 (563)
                      |++ |+|.+++..    ....+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus       100 ~~~-~~l~~~~~~----~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~  171 (311)
T 3niz_A          100 FME-KDLKKVLDE----NKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGI  171 (311)
T ss_dssp             CCS-EEHHHHHHT----CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTS
T ss_pred             CCC-CCHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCC
Confidence            776 477777654    2356999999999999999999999997   99999999999999999999999999986542


Q ss_pred             ccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCchhh------
Q 044997          430 TNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKM------  503 (563)
Q Consensus       430 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~~~------  503 (563)
                      ...   ......||+.|+|||++.+.            ..++.++|||||||++|||++|+.||..........      
T Consensus       172 ~~~---~~~~~~~t~~y~aPE~~~~~------------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~  236 (311)
T 3niz_A          172 PVR---SYTHEVVTLWYRAPDVLMGS------------KKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSIL  236 (311)
T ss_dssp             CCC------CCCCCCTTCCHHHHTTC------------CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHH
T ss_pred             Ccc---cccCCcccCCcCCHHHhcCC------------CCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHH
Confidence            211   22345789999999987542            234889999999999999999999996543321110      


Q ss_pred             ----------------------------------HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          504 ----------------------------------KSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       504 ----------------------------------~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                                                        ......+.+|+.+||+.||.+|||+.|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          237 GTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             CCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             CCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence                                              012345789999999999999999999986

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=5.3e-39  Score=323.08  Aligned_cols=225  Identities=20%  Similarity=0.335  Sum_probs=182.1

Q ss_pred             cCCCccceecccCcEEEEEEEECC---------ceEEEEEeccC---ChHHHHHHHHHHHhccccce-------------
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLGD---------REAAIKKMRSN---KSKEFFAELKVLCKIHHINV-------------  346 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~~---------~~vavK~~~~~---~~~~f~~Ei~~l~~l~H~ni-------------  346 (563)
                      ++|...+.||+|+||.||+|+...         ..||+|.++..   ..+.+.+|++++++++||||             
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   87 (289)
T 4fvq_A            8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDEN   87 (289)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCC
T ss_pred             hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCC
Confidence            568889999999999999997742         46999998653   34679999999999999997             


Q ss_pred             --EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCc--------E
Q 044997          347 --FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLR--------A  416 (563)
Q Consensus       347 --V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~--------~  416 (563)
                        |+||+++|+|.+++...    ...+++..+..++.|++.||.|||+++   ++||||||+|||++.++.        +
T Consensus        88 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~  160 (289)
T 4fvq_A           88 ILVQEFVKFGSLDTYLKKN----KNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFI  160 (289)
T ss_dssp             EEEEECCTTCBHHHHHHHT----GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred             EEEEECCCCCCHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCccccccccee
Confidence              57999999999999752    344899999999999999999999998   999999999999998887        9


Q ss_pred             EEeecCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCC
Q 044997          417 KVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRD  496 (563)
Q Consensus       417 kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~  496 (563)
                      ||+|||+++.....       ....||+.|+|||.+.+.            ..++.++||||||+++|||++|..|+...
T Consensus       161 kl~Dfg~~~~~~~~-------~~~~~~~~y~aPE~~~~~------------~~~~~~~DiwslG~il~el~~g~~~~~~~  221 (289)
T 4fvq_A          161 KLSDPGISITVLPK-------DILQERIPWVPPECIENP------------KNLNLATDKWSFGTTLWEICSGGDKPLSA  221 (289)
T ss_dssp             EECCCCSCTTTSCH-------HHHHHTTTTSCHHHHHCG------------GGCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred             eeccCcccccccCc-------cccCCcCcccCHHHhCCC------------CCCCchhHHHHHHHHHHHHHcCCCCCccc
Confidence            99999998754321       123578899999988642            23488999999999999999976665543


Q ss_pred             CCCchhhH----------HHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcC
Q 044997          497 DSEPTKMK----------SLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITS  542 (563)
Q Consensus       497 ~~~~~~~~----------~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~  542 (563)
                      ........          .....+.+++.+||+.||.+|||+.|+++.|++++...
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~  277 (289)
T 4fvq_A          222 LDSQRKLQFYEDRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPD  277 (289)
T ss_dssp             SCHHHHHHHHHTTCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC---
T ss_pred             cchHHHHHHhhccCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence            32211111          11234889999999999999999999999999998743

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1.2e-38  Score=326.32  Aligned_cols=226  Identities=27%  Similarity=0.420  Sum_probs=179.1

Q ss_pred             HhcCCCccceecccCcEEEEEEEEC--CceEEEEEeccC----ChHHHHHHHHHHHhccccceE----------------
Q 044997          290 ATNNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSN----KSKEFFAELKVLCKIHHINVF----------------  347 (563)
Q Consensus       290 ~~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~----~~~~f~~Ei~~l~~l~H~niV----------------  347 (563)
                      ..++|+..+.||+|+||.||+|+..  ++.||||+++..    ..+.+.+|+++|++++|||||                
T Consensus         4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~   83 (332)
T 3qd2_B            4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE   83 (332)
T ss_dssp             HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred             hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence            3467899999999999999999984  789999998643    236799999999999999873                


Q ss_pred             --------------------------------------------------------EEeecCCCcccccccccccCCCCC
Q 044997          348 --------------------------------------------------------ISTFGNGSLSDHLHDPLLKGHQPL  371 (563)
Q Consensus       348 --------------------------------------------------------~e~~~~gsL~~~L~~~~~~~~~~l  371 (563)
                                                                              +||+++|+|.+++....  .....
T Consensus        84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~  161 (332)
T 3qd2_B           84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC--SLEDR  161 (332)
T ss_dssp             HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCC--SGGGS
T ss_pred             hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc--Cccch
Confidence                                                                    46777889999887532  22346


Q ss_pred             CHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccccccccc---------cccccccC
Q 044997          372 TWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKE---------MLATRLVG  442 (563)
Q Consensus       372 ~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~---------~~~~~~~g  442 (563)
                      ++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.........         .......|
T Consensus       162 ~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~g  238 (332)
T 3qd2_B          162 EHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVG  238 (332)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-
T ss_pred             hhHHHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCC
Confidence            77889999999999999999997   9999999999999999999999999998765432111         11233579


Q ss_pred             CCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCC---------CCCchhhHHHHHHHHHH
Q 044997          443 TPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRD---------DSEPTKMKSLITIMAAV  513 (563)
Q Consensus       443 t~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~---------~~~~~~~~~~~~~l~~l  513 (563)
                      |+.|+|||.+.+..             ++.++||||||+++|||++|..|+...         ...+.......+.+.++
T Consensus       239 t~~y~aPE~~~~~~-------------~~~~~Di~slG~il~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  305 (332)
T 3qd2_B          239 TKLYMSPEQIHGNN-------------YSHKVDIFSLGLILFELLYSFSTQMERVRIITDVRNLKFPLLFTQKYPQEHMM  305 (332)
T ss_dssp             CGGGSCHHHHHCCC-------------CCTHHHHHHHHHHHHHHHSCCCCHHHHHHHHHHHHTTCCCHHHHHHCHHHHHH
T ss_pred             CcCccChHHhcCCC-------------CcchhhHHHHHHHHHHHHHcCCChhHHHHHHHHhhccCCCcccccCChhHHHH
Confidence            99999999886544             489999999999999999998775321         11222334455668999


Q ss_pred             HHHhhccCCCCCCCHHHHHH
Q 044997          514 AEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       514 i~~cl~~dP~~RPs~~evl~  533 (563)
                      +.+||+.||.+||++.|+++
T Consensus       306 i~~~l~~~p~~Rps~~~~l~  325 (332)
T 3qd2_B          306 VQDMLSPSPTERPEATDIIE  325 (332)
T ss_dssp             HHHHHCSSGGGSCCHHHHHH
T ss_pred             HHHHccCCCCcCCCHHHHhh
Confidence            99999999999999999986

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1e-38  Score=317.03  Aligned_cols=228  Identities=25%  Similarity=0.414  Sum_probs=189.3

Q ss_pred             cCCCccceecccCcEEEEEEEE-CCceEEEEEeccC--ChHHHHHHHHHHHhccccce---------------EEEeecC
Q 044997          292 NNFDESRIIGRGGFGNVYFGLL-GDREAAIKKMRSN--KSKEFFAELKVLCKIHHINV---------------FISTFGN  353 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~-~~~~vavK~~~~~--~~~~f~~Ei~~l~~l~H~ni---------------V~e~~~~  353 (563)
                      ++|+..+.||+|+||.||+|.. +++.||+|.++..  ..+++.+|++++++++||||               |+||+++
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   87 (267)
T 3t9t_A            8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEH   87 (267)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTT
T ss_pred             hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCC
Confidence            5688899999999999999998 5678999999765  34779999999999999997               5789999


Q ss_pred             CCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccccccccc
Q 044997          354 GSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEK  433 (563)
Q Consensus       354 gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~  433 (563)
                      |+|.+++..    ....+++..+..++.|++.||+|||+++   ++||||||+||+++.++.+||+|||+++......  
T Consensus        88 ~~L~~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~--  158 (267)
T 3t9t_A           88 GCLSDYLRT----QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ--  158 (267)
T ss_dssp             CBHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH--
T ss_pred             CcHHHHHhh----CcccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccccccccc--
Confidence            999999865    2356899999999999999999999997   9999999999999999999999999998653321  


Q ss_pred             ccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCCCcCCCCCc-----------h
Q 044997          434 EMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIRDDSEP-----------T  501 (563)
Q Consensus       434 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p~~~~~~~~-----------~  501 (563)
                      ........++..|+|||.+.+..             ++.++||||||+++|||++ |+.||.......           .
T Consensus       159 ~~~~~~~~~~~~y~aPE~~~~~~-------------~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~  225 (267)
T 3t9t_A          159 YTSSTGTKFPVKWASPEVFSFSR-------------YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLY  225 (267)
T ss_dssp             HHSTTSTTCCGGGCCHHHHHHCC-------------CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC
T ss_pred             ccccccccccccccChhhhcCCC-------------ccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCC
Confidence            11223345778899999885443             4889999999999999999 888886543211           1


Q ss_pred             hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 044997          502 KMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMIT  541 (563)
Q Consensus       502 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~  541 (563)
                      ........+.+++.+||+.||.+||++.++++.|+++.++
T Consensus       226 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (267)
T 3t9t_A          226 KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES  265 (267)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             CCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            1122345689999999999999999999999999998764

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=2.8e-39  Score=325.02  Aligned_cols=232  Identities=24%  Similarity=0.386  Sum_probs=193.4

Q ss_pred             HhcCCCccceecccCcEEEEEEEEC--CceEEEEEeccCC--hHHHHHHHHHHHhccccce---------------EEEe
Q 044997          290 ATNNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNK--SKEFFAELKVLCKIHHINV---------------FIST  350 (563)
Q Consensus       290 ~~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~--~~~f~~Ei~~l~~l~H~ni---------------V~e~  350 (563)
                      ..++|+..+.||+|+||.||+|...  +..||+|.++...  .+.+.+|++++++++||||               |+||
T Consensus        11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   90 (288)
T 3kfa_A           11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF   90 (288)
T ss_dssp             CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred             cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEc
Confidence            4567888999999999999999985  6789999997654  4679999999999999997               5799


Q ss_pred             ecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccccc
Q 044997          351 FGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERT  430 (563)
Q Consensus       351 ~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~  430 (563)
                      +.+|+|.+++..   .....+++..+..++.|++.||+|||+++   ++||||||+||+++.++.+||+|||+++.....
T Consensus        91 ~~~~~L~~~~~~---~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~  164 (288)
T 3kfa_A           91 MTYGNLLDYLRE---CNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD  164 (288)
T ss_dssp             CTTEEHHHHHHH---CCTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSS
T ss_pred             CCCCcHHHHHHh---cccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCC
Confidence            999999999975   23466999999999999999999999998   999999999999999999999999999865433


Q ss_pred             cccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCCCcCCCCCc---------
Q 044997          431 NEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIRDDSEP---------  500 (563)
Q Consensus       431 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p~~~~~~~~---------  500 (563)
                      ..  .......+|+.|+|||.+.+..             ++.++||||||+++|||++ |+.||.......         
T Consensus       165 ~~--~~~~~~~~~~~y~aPE~~~~~~-------------~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~  229 (288)
T 3kfa_A          165 TY--TAHAGAKFPIKWTAPESLAYNK-------------FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY  229 (288)
T ss_dssp             SS--EEETTEEECGGGCCHHHHHHCC-------------CCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC
T ss_pred             cc--ccccCCccccCcCChhhhccCC-------------CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccC
Confidence            21  1223345788999999885443             4889999999999999999 888886543221         


Q ss_pred             --hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcC
Q 044997          501 --TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITS  542 (563)
Q Consensus       501 --~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~  542 (563)
                        .....+++.+.+++.+||+.||.+||++.|+++.|++++...
T Consensus       230 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~  273 (288)
T 3kfa_A          230 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES  273 (288)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             CCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhc
Confidence              112234566899999999999999999999999999988754

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=1.2e-38  Score=328.94  Aligned_cols=218  Identities=25%  Similarity=0.372  Sum_probs=182.8

Q ss_pred             cCCCccceecccCcEEEEEEEE--CCceEEEEEeccC------ChHHHHHHHHHHHhccccce---------------EE
Q 044997          292 NNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSN------KSKEFFAELKVLCKIHHINV---------------FI  348 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~------~~~~f~~Ei~~l~~l~H~ni---------------V~  348 (563)
                      ++|...+.||+|+||.||+|+.  .++.||||.++..      ..+.+.+|++++++++||||               |+
T Consensus         9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   88 (336)
T 3h4j_B            9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI   88 (336)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            5788999999999999999997  5789999998643      24578999999999999997               46


Q ss_pred             EeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccc
Q 044997          349 STFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEE  428 (563)
Q Consensus       349 e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~  428 (563)
                      ||+ +|+|.+++..     ...+++.++..++.|++.||+|||+++   |+||||||+|||+++++.+||+|||+++...
T Consensus        89 E~~-~g~l~~~l~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~  159 (336)
T 3h4j_B           89 EYA-GGELFDYIVE-----KKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMT  159 (336)
T ss_dssp             CCC-CEEHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTT
T ss_pred             ECC-CCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceecc
Confidence            887 6888888864     256999999999999999999999998   9999999999999999999999999998654


Q ss_pred             cccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCC---------
Q 044997          429 RTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE---------  499 (563)
Q Consensus       429 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~---------  499 (563)
                      ...    ......||+.|+|||.+.+..+            .++++|||||||++|||++|+.||......         
T Consensus       160 ~~~----~~~~~~gt~~y~aPE~~~~~~~------------~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~  223 (336)
T 3h4j_B          160 DGN----FLKTSCGSPNYAAPEVINGKLY------------AGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSC  223 (336)
T ss_dssp             TSB----TTCCCTTSTTTSCGGGSCCSGG------------GCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSS
T ss_pred             CCc----ccccccCCcCcCCHHHHcCCCC------------CCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcC
Confidence            322    2234579999999999876554            268999999999999999999999654321         


Q ss_pred             -chhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          500 -PTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       500 -~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                       ...+..+.+.+.+++.+||+.||.+|||+.|+++.
T Consensus       224 ~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  259 (336)
T 3h4j_B          224 VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD  259 (336)
T ss_dssp             CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred             CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence             11223456678999999999999999999999874

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=1.1e-38  Score=330.09  Aligned_cols=235  Identities=20%  Similarity=0.258  Sum_probs=182.0

Q ss_pred             cCCCccceecccCcEEEEEEEEC-----CceEEEEEeccCC--------------hHHHHHHHHHHHhccccce------
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG-----DREAAIKKMRSNK--------------SKEFFAELKVLCKIHHINV------  346 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~-----~~~vavK~~~~~~--------------~~~f~~Ei~~l~~l~H~ni------  346 (563)
                      ++|...+.||+|+||.||+|+..     +..+|||.+....              .+.+.+|+..+..++||||      
T Consensus        37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~  116 (345)
T 2v62_A           37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS  116 (345)
T ss_dssp             CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred             ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence            57888999999999999999984     4679999986542              1346778889999999987      


Q ss_pred             -------------EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCC
Q 044997          347 -------------FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDG  413 (563)
Q Consensus       347 -------------V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~  413 (563)
                                   |+||+ +|+|.+++...     ..+++.+++.++.|++.||+|||+++   |+||||||+|||++.+
T Consensus       117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~  187 (345)
T 2v62_A          117 GLTEFKGRSYRFMVMERL-GIDLQKISGQN-----GTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYK  187 (345)
T ss_dssp             EEEESSSCEEEEEEEECE-EEEHHHHCBGG-----GBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESS
T ss_pred             cccccCCCcEEEEEEecc-CCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccC
Confidence                         56888 88999998752     37999999999999999999999997   9999999999999988


Q ss_pred             C--cEEEeecCCCccccccccc----ccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHH
Q 044997          414 L--RAKVADFGLVKLEERTNEK----EMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELI  487 (563)
Q Consensus       414 ~--~~kl~DFGla~~~~~~~~~----~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ell  487 (563)
                      +  .+||+|||+++........    ........||+.|+|||++.+..             ++.++|||||||++|||+
T Consensus       188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------------~~~~~Di~slG~il~ell  254 (345)
T 2v62_A          188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVA-------------LSRRSDVEILGYCMLRWL  254 (345)
T ss_dssp             STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCC-------------CCHHHHHHHHHHHHHHHH
T ss_pred             CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCC-------------CCchhhHHHHHHHHHHHH
Confidence            7  9999999999866433211    11123457999999999885443             489999999999999999


Q ss_pred             cCCCCCcCCCCCchhh------------H---------HHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcChhhh
Q 044997          488 TGKRALIRDDSEPTKM------------K---------SLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITSTEWE  546 (563)
Q Consensus       488 tg~~p~~~~~~~~~~~------------~---------~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~w~  546 (563)
                      +|+.||..........            .         .++..+.+++.+||+.||.+||++.+|++.|+++......++
T Consensus       255 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~d  334 (345)
T 2v62_A          255 CGKLPWEQNLKDPVAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGIPLGPLD  334 (345)
T ss_dssp             HSSCTTGGGTTCHHHHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCCCCCCCC
T ss_pred             hCCCCccccccccHHHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCCcccCCC
Confidence            9999996533221110            0         233468999999999999999999999999998765444444


Q ss_pred             cc
Q 044997          547 AS  548 (563)
Q Consensus       547 ~~  548 (563)
                      .+
T Consensus       335 ~~  336 (345)
T 2v62_A          335 FS  336 (345)
T ss_dssp             CC
T ss_pred             cc
Confidence            33

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=2.5e-38  Score=328.37  Aligned_cols=223  Identities=18%  Similarity=0.310  Sum_probs=183.2

Q ss_pred             hcCCCccceecccCcEEEEEEEEC--CceEEEEEeccC--------ChHHHHHHHHHHHhccccce--------------
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSN--------KSKEFFAELKVLCKIHHINV--------------  346 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~--------~~~~f~~Ei~~l~~l~H~ni--------------  346 (563)
                      .++|+..+.||+|+||.||+|+..  ++.||||.++..        ..+.+.+|++++++++||||              
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  102 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY  102 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            356899999999999999999874  789999998532        35679999999999999997              


Q ss_pred             -EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCc---EEEeecC
Q 044997          347 -FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLR---AKVADFG  422 (563)
Q Consensus       347 -V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~---~kl~DFG  422 (563)
                       |+||+++|+|.+++.... .....+++..+..++.|++.||+|||+++   |+||||||+|||++.++.   +||+|||
T Consensus       103 lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg  178 (351)
T 3c0i_A          103 MVFEFMDGADLCFEIVKRA-DAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFG  178 (351)
T ss_dssp             EEEECCSSCBHHHHHHHHH-HTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred             EEEeCCCCCCHHHHHHHhc-ccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCc
Confidence             579999999988886432 22356899999999999999999999997   999999999999986654   9999999


Q ss_pred             CCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCC---
Q 044997          423 LVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE---  499 (563)
Q Consensus       423 la~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~---  499 (563)
                      +++......   .......||+.|+|||++.+..+             +.++|||||||++|||++|+.||......   
T Consensus       179 ~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~-------------~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~  242 (351)
T 3c0i_A          179 VAIQLGESG---LVAGGRVGTPHFMAPEVVKREPY-------------GKPVDVWGCGVILFILLSGCLPFYGTKERLFE  242 (351)
T ss_dssp             TCEECCTTS---CBCCCCCSCGGGCCHHHHTTCCB-------------CTHHHHHHHHHHHHHHHHSSCSSCSSHHHHHH
T ss_pred             ceeEecCCC---eeecCCcCCcCccCHHHHcCCCC-------------CchHhhHHHHHHHHHHHHCCCCCCCcHHHHHH
Confidence            998654322   12334579999999999865443             88999999999999999999999753211   


Q ss_pred             ----------chhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          500 ----------PTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       500 ----------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                                ......+.+.+.+++.+||+.||.+||++.|+++
T Consensus       243 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          243 GIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             HHHHTCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHcCCCCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence                      1111234567899999999999999999999986

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=2.3e-38  Score=330.08  Aligned_cols=221  Identities=23%  Similarity=0.360  Sum_probs=184.3

Q ss_pred             HHhcCCCccceecccCcEEEEEEEEC--CceEEEEEeccCC-----hHHHHHHHHHHHhccccce---------------
Q 044997          289 EATNNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNK-----SKEFFAELKVLCKIHHINV---------------  346 (563)
Q Consensus       289 ~~~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~-----~~~f~~Ei~~l~~l~H~ni---------------  346 (563)
                      ...++|+..+.||+|+||.||+|...  ++.||+|.++...     .+.+.+|++++++++||||               
T Consensus        26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l  105 (362)
T 2bdw_A           26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL  105 (362)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence            34567999999999999999999884  7899999996542     2568899999999999997               


Q ss_pred             EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCC---CcEEEeecCC
Q 044997          347 FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDG---LRAKVADFGL  423 (563)
Q Consensus       347 V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~---~~~kl~DFGl  423 (563)
                      |+||+.+|+|.+++..     ...+++..+..++.|++.||+|||+++   |+||||||+|||++.+   +.+||+|||+
T Consensus       106 v~e~~~gg~L~~~l~~-----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~  177 (362)
T 2bdw_A          106 VFDLVTGGELFEDIVA-----REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGL  177 (362)
T ss_dssp             EECCCCSCBHHHHHTT-----CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             EEecCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCc
Confidence            5789999999988864     356899999999999999999999997   9999999999999865   4599999999


Q ss_pred             CcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCC----
Q 044997          424 VKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE----  499 (563)
Q Consensus       424 a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~----  499 (563)
                      ++......    ......||+.|+|||++.+..             ++.++|||||||++|||++|+.||...+..    
T Consensus       178 a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~-------------~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~  240 (362)
T 2bdw_A          178 AIEVNDSE----AWHGFAGTPGYLSPEVLKKDP-------------YSKPVDIWACGVILYILLVGYPPFWDEDQHRLYA  240 (362)
T ss_dssp             CBCCTTCC----SCCCSCSCTTTCCHHHHTTCC-------------CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred             ceEecCCc----ccccCCCCccccCHHHHccCC-------------CCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence            98654322    223467999999999886544             488999999999999999999999654321    


Q ss_pred             ----------chhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          500 ----------PTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       500 ----------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                                ......+.+.+.+++.+||+.||.+||++.|+++.
T Consensus       241 ~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  285 (362)
T 2bdw_A          241 QIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  285 (362)
T ss_dssp             HHHHTCCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             HHHhCCCCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                      11223456678999999999999999999998764

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=2.3e-38  Score=333.51  Aligned_cols=233  Identities=24%  Similarity=0.393  Sum_probs=186.7

Q ss_pred             hcCCCccceecccCcEEEEEEEEC--CceEEEEEeccCC------hHHHHHHHHHHHhc-cccce---------------
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNK------SKEFFAELKVLCKI-HHINV---------------  346 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~------~~~f~~Ei~~l~~l-~H~ni---------------  346 (563)
                      .++|+..++||+|+||.||+++..  ++.+|+|+++...      .+.+.+|..+|.++ +||||               
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  130 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF  130 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence            357899999999999999999885  6789999987532      24578899999887 89997               


Q ss_pred             EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcc
Q 044997          347 FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKL  426 (563)
Q Consensus       347 V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~  426 (563)
                      |+||+.+|+|.+++..     ...+++..+..++.|++.||+|||+++   |+||||||+|||++.++++||+|||+++.
T Consensus       131 V~E~~~gg~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~  202 (396)
T 4dc2_A          131 VIEYVNGGDLMFHMQR-----QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKE  202 (396)
T ss_dssp             EEECCTTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EEEcCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeee
Confidence            6899999999998875     256999999999999999999999998   99999999999999999999999999985


Q ss_pred             cccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc------
Q 044997          427 EERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP------  500 (563)
Q Consensus       427 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~------  500 (563)
                      .....   ......+||+.|+|||++.+..|             +.++|||||||++|||++|+.||.......      
T Consensus       203 ~~~~~---~~~~~~~gt~~Y~aPE~l~~~~~-------------~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~  266 (396)
T 4dc2_A          203 GLRPG---DTTSTFCGTPNYIAPEILRGEDY-------------GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNT  266 (396)
T ss_dssp             CCCTT---CCBCCCCBCGGGCCHHHHTTCCB-------------CTHHHHHHHHHHHHHHHHSSCSSTTTTC------CC
T ss_pred             cccCC---CccccccCCcccCCchhhcCCCC-------------ChHHHHHHHHHHHHHHHhCCCCCcccccccccchhh
Confidence            32221   12344689999999999866554             889999999999999999999996432110      


Q ss_pred             -------------hhhHHHHHHHHHHHHHhhccCCCCCCCHH---HHHHHHHHhhhcChhhhc
Q 044997          501 -------------TKMKSLITIMAAVAEWCLNEDAVDRPEMR---DIVAILSQIMITSTEWEA  547 (563)
Q Consensus       501 -------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~---evl~~L~~i~~~~~~w~~  547 (563)
                                   ..+..+...+.+|+.+||+.||.+||++.   .+.+.++.-.-...+|+.
T Consensus       267 ~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w~~  329 (396)
T 4dc2_A          267 EDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDM  329 (396)
T ss_dssp             HHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCHHH
T ss_pred             HHHHHHHHhccccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCHHH
Confidence                         01122345689999999999999999962   344555544445556654

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-38  Score=333.31  Aligned_cols=231  Identities=27%  Similarity=0.392  Sum_probs=177.0

Q ss_pred             CCCccceecccCcEEEEEEEEC--C---ceEEEEEeccCC----hHHHHHHHHHHHhccccce----------------E
Q 044997          293 NFDESRIIGRGGFGNVYFGLLG--D---REAAIKKMRSNK----SKEFFAELKVLCKIHHINV----------------F  347 (563)
Q Consensus       293 ~f~~~~~LG~G~fG~Vy~g~~~--~---~~vavK~~~~~~----~~~f~~Ei~~l~~l~H~ni----------------V  347 (563)
                      .|...+.||+|+||.||+|++.  +   ..||+|.++...    .++|.+|++++++++||||                |
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv  169 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  169 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence            4666789999999999999863  2   358999986532    3679999999999999997                5


Q ss_pred             EEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccc
Q 044997          348 ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLE  427 (563)
Q Consensus       348 ~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~  427 (563)
                      +||+++|+|.+++..    ....+++.++..++.|+++||+|||+++   |+||||||+|||+++++.+||+|||+++..
T Consensus       170 ~e~~~~g~L~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~  242 (373)
T 3c1x_A          170 LPYMKHGDLRNFIRN----ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDM  242 (373)
T ss_dssp             EECCTTCBHHHHHHC----TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC------
T ss_pred             EECCCCCCHHHHHhh----cccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeeccccccc
Confidence            799999999999975    2456899999999999999999999997   999999999999999999999999999865


Q ss_pred             ccccccc-cccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCCCcCCCCCc-----
Q 044997          428 ERTNEKE-MLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIRDDSEP-----  500 (563)
Q Consensus       428 ~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p~~~~~~~~-----  500 (563)
                      ....... .......+|+.|+|||.+.+..             ++.++||||||+++|||++ |..||.......     
T Consensus       243 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-------------~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~  309 (373)
T 3c1x_A          243 YDKEFDSVHNKTGAKLPVKWMALESLQTQK-------------FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL  309 (373)
T ss_dssp             ---------------CCGGGSCHHHHHHCC-------------CCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHH
T ss_pred             cccccccccccCCCCCcccccChHHhcCCC-------------CCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHH
Confidence            4322111 1123346788999999885544             4899999999999999999 555554432211     


Q ss_pred             ------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcCh
Q 044997          501 ------TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITST  543 (563)
Q Consensus       501 ------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~  543 (563)
                            .....+++.+.+++.+||+.||.+||++.|+++.|+++.....
T Consensus       310 ~~~~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~  358 (373)
T 3c1x_A          310 LQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI  358 (373)
T ss_dssp             HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred             HcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence                  1122345678999999999999999999999999999987543

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=1.3e-38  Score=339.52  Aligned_cols=236  Identities=22%  Similarity=0.290  Sum_probs=190.3

Q ss_pred             cCHHHHHHHhcCCCccceecccCcEEEEEEEEC--CceEEEEEeccC------ChHHHHHHHHHHHhccccce-------
Q 044997          282 FSLEEIEEATNNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSN------KSKEFFAELKVLCKIHHINV-------  346 (563)
Q Consensus       282 ~~~~el~~~~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~------~~~~f~~Ei~~l~~l~H~ni-------  346 (563)
                      +.+.++...+++|+..++||+|+||.||+|+..  ++.+|+|+++..      ..+.+.+|.+++.+++||||       
T Consensus        64 ~~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~  143 (437)
T 4aw2_A           64 SKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF  143 (437)
T ss_dssp             HHHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred             chhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence            345566667789999999999999999999985  578999998642      22348899999999999997       


Q ss_pred             --------EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEE
Q 044997          347 --------FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKV  418 (563)
Q Consensus       347 --------V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl  418 (563)
                              |+||+++|+|.+++..    ....+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||
T Consensus       144 ~~~~~~~lV~Ey~~gg~L~~~l~~----~~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL  216 (437)
T 4aw2_A          144 QDDNNLYLVMDYYVGGDLLTLLSK----FEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRL  216 (437)
T ss_dssp             ECSSEEEEEECCCTTCBHHHHHHT----TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEE
T ss_pred             eeCCEEEEEEecCCCCcHHHHHHH----ccCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEE
Confidence                    6899999999999975    2356999999999999999999999997   999999999999999999999


Q ss_pred             eecCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCC
Q 044997          419 ADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDS  498 (563)
Q Consensus       419 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~  498 (563)
                      +|||+++.......  ......+||+.|+|||++.....        ....++.++|||||||++|||++|+.||.....
T Consensus       217 ~DFGla~~~~~~~~--~~~~~~~GT~~Y~APE~l~~~~~--------~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~  286 (437)
T 4aw2_A          217 ADFGSCLKLMEDGT--VQSSVAVGTPDYISPEILQAMEG--------GKGRYGPECDWWSLGVCMYEMLYGETPFYAESL  286 (437)
T ss_dssp             CCCTTCEECCTTSC--EECCSCCSCGGGCCHHHHHHHHT--------SCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred             cchhhhhhcccCCC--cccccccCCcCeeChHHHhhccc--------CCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCCh
Confidence            99999976543222  12334679999999999852110        122358999999999999999999999976542


Q ss_pred             Cchh---------------hHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 044997          499 EPTK---------------MKSLITIMAAVAEWCLNEDAVD--RPEMRDIVAI  534 (563)
Q Consensus       499 ~~~~---------------~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~  534 (563)
                      ....               ...+.+.+.+|+.+||..+|.+  ||+++|+++.
T Consensus       287 ~~~~~~i~~~~~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H  339 (437)
T 4aw2_A          287 VETYGKIMNHKERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH  339 (437)
T ss_dssp             HHHHHHHHTHHHHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred             hHHHHhhhhccccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence            2110               0124566899999999888888  9999998763

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.6e-38  Score=326.10  Aligned_cols=229  Identities=26%  Similarity=0.412  Sum_probs=187.8

Q ss_pred             cCCCccceecccCcEEEEEEEE------CCceEEEEEeccCC---hHHHHHHHHHHHhccccce----------------
Q 044997          292 NNFDESRIIGRGGFGNVYFGLL------GDREAAIKKMRSNK---SKEFFAELKVLCKIHHINV----------------  346 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~------~~~~vavK~~~~~~---~~~f~~Ei~~l~~l~H~ni----------------  346 (563)
                      ++|+..+.||+|+||.||++++      .++.||||+++...   .+.+.+|++++++++||||                
T Consensus        41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  120 (326)
T 2w1i_A           41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK  120 (326)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCE
T ss_pred             HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceE
Confidence            4688899999999999999985      46889999997643   3578999999999999997                


Q ss_pred             -EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCc
Q 044997          347 -FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK  425 (563)
Q Consensus       347 -V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~  425 (563)
                       |+||+++|+|.+++...    ...+++..++.++.|++.||+|||+++   ++||||||+|||++.++++||+|||+++
T Consensus       121 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~  193 (326)
T 2w1i_A          121 LIMEYLPYGSLRDYLQKH----KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTK  193 (326)
T ss_dssp             EEECCCTTCBHHHHHHHS----TTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred             EEEECCCCCCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchh
Confidence             56888899999998752    356999999999999999999999997   9999999999999999999999999998


Q ss_pred             ccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCC--------
Q 044997          426 LEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDD--------  497 (563)
Q Consensus       426 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~--------  497 (563)
                      ................++..|+|||.+.+..+             +.++||||||+++|||++|+.|+....        
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-------------~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~  260 (326)
T 2w1i_A          194 VLPQDKEYYKVKEPGESPIFWYAPESLTESKF-------------SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIG  260 (326)
T ss_dssp             ECCSSCSEEECSSCCSCCGGGCCHHHHHHCEE-------------EHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHC
T ss_pred             hccccccccccccCCCCceeEECchhhcCCCC-------------CchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhc
Confidence            76543322222233457788999998865544             789999999999999999998875321        


Q ss_pred             --CC-----------------chhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhh
Q 044997          498 --SE-----------------PTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMI  540 (563)
Q Consensus       498 --~~-----------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~  540 (563)
                        ..                 ......+++.+.+++.+||+.||.+||++.|+++.|+++..
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~  322 (326)
T 2w1i_A          261 NDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD  322 (326)
T ss_dssp             TTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cccchhhhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence              00                 00112234568999999999999999999999999998865

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=3.9e-38  Score=320.28  Aligned_cols=220  Identities=23%  Similarity=0.321  Sum_probs=175.7

Q ss_pred             HhcCCCccceecccCcEEEEEEEE--CCceEEEEEeccCC--------hHHHHHHHHHHHhcc---ccce----------
Q 044997          290 ATNNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNK--------SKEFFAELKVLCKIH---HINV----------  346 (563)
Q Consensus       290 ~~~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~--------~~~f~~Ei~~l~~l~---H~ni----------  346 (563)
                      ..++|+..+.||+|+||.||+|+.  .++.||||.++...        ...+.+|++++++++   ||||          
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            357899999999999999999985  57899999986321        356778888877775   9997          


Q ss_pred             ----------EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcE
Q 044997          347 ----------FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRA  416 (563)
Q Consensus       347 ----------V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~  416 (563)
                                |+||+. |+|.+++...   ....+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~  159 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKA---PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTV  159 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTC---CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCE
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhc---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCE
Confidence                      345554 6888888652   2345999999999999999999999998   9999999999999999999


Q ss_pred             EEeecCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCC
Q 044997          417 KVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRD  496 (563)
Q Consensus       417 kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~  496 (563)
                      ||+|||+++......    ......||+.|+|||++.+..             ++.++|||||||++|||++|+.||...
T Consensus       160 kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~-------------~~~~~DiwslG~il~~l~~g~~pf~~~  222 (308)
T 3g33_A          160 KLADFGLARIYSYQM----ALTPVVVTLWYRAPEVLLQST-------------YATPVDMWSVGCIFAEMFRRKPLFCGN  222 (308)
T ss_dssp             EECSCSCTTTSTTCC----CSGGGGCCCSSCCHHHHHTSC-------------CCSTHHHHHHHHHHHHTTTSSCSCCCS
T ss_pred             EEeeCccccccCCCc----ccCCccccccccCchHHcCCC-------------CCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence            999999998654322    223467899999999886544             488999999999999999999998654


Q ss_pred             CCCchh-------------------------------------hHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          497 DSEPTK-------------------------------------MKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       497 ~~~~~~-------------------------------------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                      ......                                     ...+.+.+.+++.+||+.||.+|||+.|+++
T Consensus       223 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          223 SEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             SHHHHHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CHHHHHHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence            321100                                     0123456789999999999999999999886

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=4.7e-38  Score=336.23  Aligned_cols=221  Identities=21%  Similarity=0.316  Sum_probs=183.2

Q ss_pred             HhcCCCccceecccCcEEEEEEEE--CCceEEEEEeccCC-----hHHHHHHHHHHHhccccce---------------E
Q 044997          290 ATNNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNK-----SKEFFAELKVLCKIHHINV---------------F  347 (563)
Q Consensus       290 ~~~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~-----~~~f~~Ei~~l~~l~H~ni---------------V  347 (563)
                      ..++|+..+.||+|+||.||++..  .++.+|+|.++...     .+.+.+|+++|++++||||               |
T Consensus         9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv   88 (444)
T 3soa_A            9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI   88 (444)
T ss_dssp             HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred             ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence            456799999999999999999987  47899999987543     3568899999999999997               5


Q ss_pred             EEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEec---CCCcEEEeecCCC
Q 044997          348 ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLD---DGLRAKVADFGLV  424 (563)
Q Consensus       348 ~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~---~~~~~kl~DFGla  424 (563)
                      +||+.+|+|.+++..     ...+++..+..++.|++.||+|||+++   |+||||||+|||++   .++.+||+|||++
T Consensus        89 ~E~~~gg~L~~~i~~-----~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a  160 (444)
T 3soa_A           89 FDLVTGGELFEDIVA-----REYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLA  160 (444)
T ss_dssp             ECCCBCCBHHHHHHH-----CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSC
T ss_pred             EEeCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCcee
Confidence            799999999998875     356999999999999999999999997   99999999999998   4678999999999


Q ss_pred             cccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCC-----
Q 044997          425 KLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE-----  499 (563)
Q Consensus       425 ~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~-----  499 (563)
                      +......   .......||+.|+|||++.+..|             +.++||||+||++|||++|+.||......     
T Consensus       161 ~~~~~~~---~~~~~~~gt~~Y~APE~l~~~~~-------------~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~  224 (444)
T 3soa_A          161 IEVEGEQ---QAWFGFAGTPGYLSPEVLRKDPY-------------GKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQ  224 (444)
T ss_dssp             BCCCTTC---CBCCCSCSCGGGCCHHHHTTCCB-------------CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred             EEecCCC---ceeecccCCcccCCHHHhcCCCC-------------CCccccHHHHHHHHHHHhCCCCCCCccHHHHHHH
Confidence            8654322   12234679999999999865544             88999999999999999999999654321     


Q ss_pred             ---------chhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          500 ---------PTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       500 ---------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                               ......+.+.+.+++.+||+.||.+|||+.|+++.
T Consensus       225 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h  268 (444)
T 3soa_A          225 IKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKH  268 (444)
T ss_dssp             HHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence                     11123445679999999999999999999999873

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=4.2e-38  Score=317.57  Aligned_cols=219  Identities=21%  Similarity=0.336  Sum_probs=176.8

Q ss_pred             cCCCccceecccCcEEEEEEEEC--CceEEEEEeccCC-----hHHHHHHHHHHHhccccce---------------EEE
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNK-----SKEFFAELKVLCKIHHINV---------------FIS  349 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~-----~~~f~~Ei~~l~~l~H~ni---------------V~e  349 (563)
                      ++|+..+.||+|+||.||+|+..  ++.||||+++...     .+.+.+|++++++++||||               |+|
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            57889999999999999999984  6889999986432     2678899999999999997               467


Q ss_pred             eecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccccc
Q 044997          350 TFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEER  429 (563)
Q Consensus       350 ~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~  429 (563)
                      |+++ ++.+++..    ....+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus        82 ~~~~-~l~~~~~~----~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  153 (292)
T 3o0g_A           82 FCDQ-DLKKYFDS----CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGI  153 (292)
T ss_dssp             CCSE-EHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCS
T ss_pred             cCCC-CHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCC
Confidence            7764 45444432    2467999999999999999999999997   99999999999999999999999999986542


Q ss_pred             ccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCchhh------
Q 044997          430 TNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKM------  503 (563)
Q Consensus       430 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~~~------  503 (563)
                      ..   .......||+.|+|||++.+..            .++.++|||||||++|||++|+.|+..........      
T Consensus       154 ~~---~~~~~~~~t~~y~aPE~~~~~~------------~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~  218 (292)
T 3o0g_A          154 PV---RCYSAEVVTLWYRPPDVLFGAK------------LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRL  218 (292)
T ss_dssp             CC---SCCCSCCSCGGGCCHHHHTTCS------------CCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHH
T ss_pred             cc---ccccCCccccCCcChHHHcCCC------------CcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHH
Confidence            21   1223457899999999885433            24899999999999999999999875443221111      


Q ss_pred             ----------------------------------HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          504 ----------------------------------KSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       504 ----------------------------------~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                                                        ..+...+.+++.+||+.||++|||++|+++
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          219 LGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             HCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence                                              123456789999999999999999999986

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=1e-38  Score=325.36  Aligned_cols=230  Identities=23%  Similarity=0.395  Sum_probs=178.1

Q ss_pred             hcCCCccceecccCcEEEEEEEE--CCceEEEEEeccCC------hHHHHHHHHHHHhccccce----------------
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNK------SKEFFAELKVLCKIHHINV----------------  346 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~------~~~f~~Ei~~l~~l~H~ni----------------  346 (563)
                      .++|+..+.||+|+||.||+++.  +++.||||.++...      .+.+.+|++++++++||||                
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence            35788999999999999999986  47899999997542      2468899999999999997                


Q ss_pred             ---EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCC
Q 044997          347 ---FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGL  423 (563)
Q Consensus       347 ---V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGl  423 (563)
                         |+||+++|+|.+++..     ...+++.++..++.|++.||+|||+++   ++||||||+|||++.++.+||+|||+
T Consensus        91 ~~lv~e~~~g~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~  162 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVHT-----EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGI  162 (311)
T ss_dssp             EEEEEECCCEEEHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSC
T ss_pred             cEEEEecCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccC
Confidence               5688889999999865     246999999999999999999999997   99999999999999999999999999


Q ss_pred             CcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCchh-
Q 044997          424 VKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTK-  502 (563)
Q Consensus       424 a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~~-  502 (563)
                      ++................||+.|+|||++.+..             ++.++||||||+++|||++|+.||......... 
T Consensus       163 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------------~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~  229 (311)
T 3ork_A          163 ARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS-------------VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAY  229 (311)
T ss_dssp             C------------------CCTTCCHHHHHTCC-------------CCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred             cccccccccccccccccCcCcccCCHHHhcCCC-------------CCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence            986554332222233457999999999886544             488999999999999999999999654321110 


Q ss_pred             -------------hHHHHHHHHHHHHHhhccCCCCCCCHHH-HHHHHHHhhhc
Q 044997          503 -------------MKSLITIMAAVAEWCLNEDAVDRPEMRD-IVAILSQIMIT  541 (563)
Q Consensus       503 -------------~~~~~~~l~~li~~cl~~dP~~RPs~~e-vl~~L~~i~~~  541 (563)
                                   ...+...+.+++.+||+.||.+||+..+ +...+.++...
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~  282 (311)
T 3ork_A          230 QHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNG  282 (311)
T ss_dssp             HHHHCCCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTT
T ss_pred             HHhcCCCCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcC
Confidence                         1124566899999999999999996554 55566666543

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=6.6e-39  Score=320.97  Aligned_cols=226  Identities=27%  Similarity=0.444  Sum_probs=183.7

Q ss_pred             hcCCCccceecccCcEEEEEEEECCceEEEEEeccCC-hHHHHHHHHHHHhccccce----------------EEEeecC
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLLGDREAAIKKMRSNK-SKEFFAELKVLCKIHHINV----------------FISTFGN  353 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~vavK~~~~~~-~~~f~~Ei~~l~~l~H~ni----------------V~e~~~~  353 (563)
                      .++|+..+.||+|+||.||+|..+++.||||.++... .+.+.+|++++++++||||                |+||+++
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~   99 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK   99 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTT
T ss_pred             hhhceEEeEEecCCCceEEEEEEcCCEEEEEEecchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCC
Confidence            3578889999999999999999999999999998654 5679999999999999997                5688888


Q ss_pred             CCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccccccccc
Q 044997          354 GSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEK  433 (563)
Q Consensus       354 gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~  433 (563)
                      |+|.+++...   ....+++..+..++.|++.||+|||+++   ++||||||+||+++.++.+||+|||+++......  
T Consensus       100 ~~L~~~l~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~--  171 (278)
T 1byg_A          100 GSLVDYLRSR---GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--  171 (278)
T ss_dssp             EEHHHHHHHH---HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred             CCHHHHHHhc---ccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeeccccccccccc--
Confidence            9999988652   1234889999999999999999999997   9999999999999999999999999987543221  


Q ss_pred             ccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCCCcCCCCCc-----------h
Q 044997          434 EMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIRDDSEP-----------T  501 (563)
Q Consensus       434 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p~~~~~~~~-----------~  501 (563)
                          ....+++.|+|||.+.+..             ++.++||||||+++|||++ |+.||.......           .
T Consensus       172 ----~~~~~~~~y~aPE~~~~~~-------------~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~  234 (278)
T 1byg_A          172 ----DTGKLPVKWTAPEALREKK-------------FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMD  234 (278)
T ss_dssp             --------CCTTTSCHHHHHHCC-------------CCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCC
T ss_pred             ----cCCCccccccCHHHhCCCC-------------CCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCC
Confidence                2235788999999875443             4889999999999999998 999986543211           1


Q ss_pred             hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 044997          502 KMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMIT  541 (563)
Q Consensus       502 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~  541 (563)
                      ....+++.+.+++.+||+.||.+||++.|+++.|+++...
T Consensus       235 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~  274 (278)
T 1byg_A          235 APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH  274 (278)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence            1223456789999999999999999999999999998654

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.3e-38  Score=330.80  Aligned_cols=214  Identities=22%  Similarity=0.373  Sum_probs=175.6

Q ss_pred             hcCCCccceecccCcEEEEEEEEC--CceEEEEEeccC------ChHHHHHHHHHHHhc-cccce---------------
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSN------KSKEFFAELKVLCKI-HHINV---------------  346 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~------~~~~f~~Ei~~l~~l-~H~ni---------------  346 (563)
                      .++|+..+.||+|+||.||+|+..  ++.||||.++..      ..+.+.+|.+++.++ +||||               
T Consensus        22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  101 (353)
T 3txo_A           22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF  101 (353)
T ss_dssp             -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence            468999999999999999999884  688999998743      345688899999988 79997               


Q ss_pred             EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcc
Q 044997          347 FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKL  426 (563)
Q Consensus       347 V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~  426 (563)
                      |+||+.+|+|.+++..     ...+++..+..++.|++.||+|||+++   |+||||||+|||++.++++||+|||+++.
T Consensus       102 v~E~~~gg~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~  173 (353)
T 3txo_A          102 VMEFVNGGDLMFHIQK-----SRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKE  173 (353)
T ss_dssp             EEECCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EEeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceee
Confidence            6899999999999875     256999999999999999999999997   99999999999999999999999999985


Q ss_pred             cccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCch-----
Q 044997          427 EERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPT-----  501 (563)
Q Consensus       427 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~-----  501 (563)
                      .....   ......+||+.|+|||++.+..|             +.++|||||||++|||++|+.||........     
T Consensus       174 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~-------------~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~  237 (353)
T 3txo_A          174 GICNG---VTTATFCGTPDYIAPEILQEMLY-------------GPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAIL  237 (353)
T ss_dssp             SCC------------CCGGGCCHHHHHHHHC-------------TTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             cccCC---ccccccCCCcCeEChhhcCCCCc-------------CCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            33221   12344679999999999866554             8899999999999999999999976542211     


Q ss_pred             -----hhHHHHHHHHHHHHHhhccCCCCCCCH
Q 044997          502 -----KMKSLITIMAAVAEWCLNEDAVDRPEM  528 (563)
Q Consensus       502 -----~~~~~~~~l~~li~~cl~~dP~~RPs~  528 (563)
                           ....+...+.+++.+||+.||.+||++
T Consensus       238 ~~~~~~p~~~~~~~~~li~~lL~~dP~~R~~~  269 (353)
T 3txo_A          238 NDEVVYPTWLHEDATGILKSFMTKNPTMRLGS  269 (353)
T ss_dssp             HCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTS
T ss_pred             cCCCCCCCCCCHHHHHHHHHHhhhCHHHccCC
Confidence                 112244568999999999999999998

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=1.6e-38  Score=330.41  Aligned_cols=228  Identities=25%  Similarity=0.339  Sum_probs=184.8

Q ss_pred             cccCHHHHHHHhcCCCccceecccCcEEEEEEEE--CCceEEEEEeccCC--hHHHHHHHHHHHhcc-----ccce----
Q 044997          280 IIFSLEEIEEATNNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNK--SKEFFAELKVLCKIH-----HINV----  346 (563)
Q Consensus       280 ~~~~~~el~~~~~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~--~~~f~~Ei~~l~~l~-----H~ni----  346 (563)
                      ..+++++.....++|...+.||+|+||.||+|+.  +++.||||.++...  .+.+..|++++++++     ||||    
T Consensus        23 ~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~  102 (360)
T 3llt_A           23 VHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYH  102 (360)
T ss_dssp             GSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEE
T ss_pred             eeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeeccc
Confidence            3455556566678999999999999999999998  57889999997543  356788999999997     9997    


Q ss_pred             -----------EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecC---
Q 044997          347 -----------FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDD---  412 (563)
Q Consensus       347 -----------V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~---  412 (563)
                                 |+||+ +|+|.+++...   ....+++..+..++.|++.||+|||+++   |+||||||+|||++.   
T Consensus       103 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~  175 (360)
T 3llt_A          103 GKFMYYDHMCLIFEPL-GPSLYEIITRN---NYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYF  175 (360)
T ss_dssp             EEEEETTEEEEEECCC-CCBHHHHHHHT---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTC
T ss_pred             ceeeECCeeEEEEcCC-CCCHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccccc
Confidence                       46777 88999998752   3346999999999999999999999997   999999999999975   


Q ss_pred             ----------------------CCcEEEeecCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCC
Q 044997          413 ----------------------GLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQV  470 (563)
Q Consensus       413 ----------------------~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~  470 (563)
                                            ++.+||+|||+++.....      .....||+.|+|||++.+..             +
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~------~~~~~gt~~y~aPE~~~~~~-------------~  236 (360)
T 3llt_A          176 EKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY------HGSIINTRQYRAPEVILNLG-------------W  236 (360)
T ss_dssp             CEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC------CCSCCSCGGGCCHHHHTTCC-------------C
T ss_pred             cccccchhcccccccccccccCCCCEEEEeccCceecCCC------CcCccCcccccCcHHHcCCC-------------C
Confidence                                  789999999999853321      23457899999999986544             4


Q ss_pred             CCcchHHHHHHHHHHHHcCCCCCcCCCCCchhh----------H------------------------------------
Q 044997          471 TTKTDVFAFGVVLAELITGKRALIRDDSEPTKM----------K------------------------------------  504 (563)
Q Consensus       471 s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~~~----------~------------------------------------  504 (563)
                      +.++|||||||++|||++|+.||..........          .                                    
T Consensus       237 ~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~  316 (360)
T 3llt_A          237 DVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKH  316 (360)
T ss_dssp             CTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHH
T ss_pred             CCccchHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhh
Confidence            899999999999999999999996533110000          0                                    


Q ss_pred             ----------HHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          505 ----------SLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       505 ----------~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                                ...+.+.+|+.+||+.||.+|||+.|+++
T Consensus       317 ~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~  355 (360)
T 3llt_A          317 VKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLK  355 (360)
T ss_dssp             HHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             hhhcccccccchHHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence                      00145779999999999999999999875

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=1.7e-38  Score=323.99  Aligned_cols=217  Identities=23%  Similarity=0.274  Sum_probs=173.6

Q ss_pred             hcCCCccceecccCcEEEEEEEEC--CceEEEEEeccCC-----hHHHHHHHHHHHhc-cccce---------------E
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNK-----SKEFFAELKVLCKI-HHINV---------------F  347 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~-----~~~f~~Ei~~l~~l-~H~ni---------------V  347 (563)
                      .++|+..++||+|+||.||+|+..  ++.||||++....     ..++.+|+..+.++ +|+||               |
T Consensus        56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv  135 (311)
T 3p1a_A           56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ  135 (311)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence            357999999999999999999984  7899999986432     23455666666665 89997               4


Q ss_pred             EEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccc
Q 044997          348 ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLE  427 (563)
Q Consensus       348 ~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~  427 (563)
                      +||+ +|+|.+++...    ...++|..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus       136 ~e~~-~~~L~~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~  207 (311)
T 3p1a_A          136 TELC-GPSLQQHCEAW----GASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVEL  207 (311)
T ss_dssp             EECC-CCBHHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEEC
T ss_pred             Eecc-CCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeec
Confidence            6777 67888888652    356999999999999999999999997   999999999999999999999999998765


Q ss_pred             ccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCC---------
Q 044997          428 ERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDS---------  498 (563)
Q Consensus       428 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~---------  498 (563)
                      ....    ......||++|+|||++.+              .++.++|||||||++|||++|..|+.....         
T Consensus       208 ~~~~----~~~~~~gt~~y~aPE~~~~--------------~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~  269 (311)
T 3p1a_A          208 GTAG----AGEVQEGDPRYMAPELLQG--------------SYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYL  269 (311)
T ss_dssp             C----------CCCCCGGGCCGGGGGT--------------CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHHHHTTTCC
T ss_pred             ccCC----CCcccCCCccccCHhHhcC--------------CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHhccCC
Confidence            4322    2233569999999998743              358899999999999999999877643211         


Q ss_pred             CchhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          499 EPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       499 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                      .......+.+.+.+++.+||+.||++|||+.|+++
T Consensus       270 ~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          270 PPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence            11222344567999999999999999999999986

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1.8e-38  Score=329.28  Aligned_cols=219  Identities=22%  Similarity=0.337  Sum_probs=169.7

Q ss_pred             HhcCCCccceecccCcEEEEEEEEC--CceEEEEEeccCC-hHHHHHHHHHHHhccccce---------------EEEee
Q 044997          290 ATNNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNK-SKEFFAELKVLCKIHHINV---------------FISTF  351 (563)
Q Consensus       290 ~~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~-~~~f~~Ei~~l~~l~H~ni---------------V~e~~  351 (563)
                      ..++|+..+.||+|+||.||+|+..  ++.||||.++... .+.+.+|+++|++++||||               |+||+
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  130 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELV  130 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeC
Confidence            4567999999999999999999985  5789999997653 4568899999999999997               57999


Q ss_pred             cCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecC---CCcEEEeecCCCcccc
Q 044997          352 GNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDD---GLRAKVADFGLVKLEE  428 (563)
Q Consensus       352 ~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~---~~~~kl~DFGla~~~~  428 (563)
                      ++|+|.+++..     ...+++.++..++.|++.||+|||+++   |+||||||+|||++.   ++.+||+|||+++...
T Consensus       131 ~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~  202 (349)
T 2w4o_A          131 TGGELFDRIVE-----KGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE  202 (349)
T ss_dssp             CSCBHHHHHTT-----CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred             CCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence            99999998865     356899999999999999999999997   999999999999975   8899999999998654


Q ss_pred             cccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCchh------
Q 044997          429 RTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTK------  502 (563)
Q Consensus       429 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~~------  502 (563)
                      ...    ......||+.|+|||++.+..             ++.++|||||||++|||++|+.||.........      
T Consensus       203 ~~~----~~~~~~gt~~y~aPE~~~~~~-------------~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~  265 (349)
T 2w4o_A          203 HQV----LMKTVCGTPGYCAPEILRGCA-------------YGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILN  265 (349)
T ss_dssp             --------------CGGGSCHHHHTTCC-------------CCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHT
T ss_pred             ccc----ccccccCCCCccCHHHhcCCC-------------CCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHh
Confidence            321    223457899999999886543             488999999999999999999999755432211      


Q ss_pred             ---------hHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          503 ---------MKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       503 ---------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                               ...+...+.+++.+||+.||++||++.|+++
T Consensus       266 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  305 (349)
T 2w4o_A          266 CEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ  305 (349)
T ss_dssp             TCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CCCccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                     1234566899999999999999999999987

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=7.3e-38  Score=332.77  Aligned_cols=225  Identities=21%  Similarity=0.343  Sum_probs=178.3

Q ss_pred             HHHhcCCCccceecccCcEEEEEEEEC--CceEEEEEeccCC-----------hHHHHHHHHHHHhccccce--------
Q 044997          288 EEATNNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNK-----------SKEFFAELKVLCKIHHINV--------  346 (563)
Q Consensus       288 ~~~~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~-----------~~~f~~Ei~~l~~l~H~ni--------  346 (563)
                      ....++|...+.||+|+||.||+|...  ++.||||.+....           ...+.+|+++|++++||||        
T Consensus       131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  210 (419)
T 3i6u_A          131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD  210 (419)
T ss_dssp             HHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE
T ss_pred             hhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence            345688999999999999999999884  6799999986432           1248899999999999997        


Q ss_pred             ------EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCC---CcEE
Q 044997          347 ------FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDG---LRAK  417 (563)
Q Consensus       347 ------V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~---~~~k  417 (563)
                            |+||+++|+|.+++..     ...+++..+..++.|++.||+|||+++   |+||||||+|||++.+   +.+|
T Consensus       211 ~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~k  282 (419)
T 3i6u_A          211 AEDYYIVLELMEGGELFDKVVG-----NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIK  282 (419)
T ss_dssp             SSEEEEEEECCTTCBGGGGTSS-----SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEE
T ss_pred             cCceEEEEEcCCCCcHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEE
Confidence                  5899999999998864     356999999999999999999999997   9999999999999754   4599


Q ss_pred             EeecCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCC
Q 044997          418 VADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDD  497 (563)
Q Consensus       418 l~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~  497 (563)
                      |+|||+++......    ......||+.|+|||++....          ...++.++|||||||++|||++|+.||....
T Consensus       283 l~DFG~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~----------~~~~~~~~DiwslG~il~~lltg~~pf~~~~  348 (419)
T 3i6u_A          283 ITDFGHSKILGETS----LMRTLCGTPTYLAPEVLVSVG----------TAGYNRAVDCWSLGVILFICLSGYPPFSEHR  348 (419)
T ss_dssp             ECCSSTTTSCC---------------CTTCCTTTTC--------------CTTHHHHHHHHHHHHHHHHHHSSCSSCCCS
T ss_pred             EeecccceecCCCc----cccccCCCCCccCceeeecCC----------CCCCCchhhhHhHHHHHHHHHHCCCCCCCCc
Confidence            99999998654321    223467999999999875321          2345789999999999999999999997543


Q ss_pred             CCc---------------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          498 SEP---------------TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       498 ~~~---------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                      ...               .....+.+.+.+++.+||+.||.+||++.|+++.
T Consensus       349 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  400 (419)
T 3i6u_A          349 TQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH  400 (419)
T ss_dssp             SSCCHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             chHHHHHHHhcCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence            321               1112345678999999999999999999998863

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=1.9e-38  Score=353.90  Aligned_cols=223  Identities=22%  Similarity=0.348  Sum_probs=180.8

Q ss_pred             ceecccCcEEEEEEEE----CCceEEEEEeccCC-----hHHHHHHHHHHHhccccce--------------EEEeecCC
Q 044997          298 RIIGRGGFGNVYFGLL----GDREAAIKKMRSNK-----SKEFFAELKVLCKIHHINV--------------FISTFGNG  354 (563)
Q Consensus       298 ~~LG~G~fG~Vy~g~~----~~~~vavK~~~~~~-----~~~f~~Ei~~l~~l~H~ni--------------V~e~~~~g  354 (563)
                      +.||+|+||.||+|.+    .++.||||+++...     .++|.+|+++|++++||||              |+||+.+|
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~lv~E~~~~g  454 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELG  454 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEEECCTTE
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEEEccCCC
Confidence            5799999999999976    24679999997532     3679999999999999997              68999999


Q ss_pred             CcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccccccccc
Q 044997          355 SLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKE  434 (563)
Q Consensus       355 sL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~  434 (563)
                      +|.+++..     ...+++..++.|+.||+.||+|||+++   |+||||||+|||+++++.+||+|||+++.........
T Consensus       455 ~L~~~l~~-----~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  526 (635)
T 4fl3_A          455 PLNKYLQQ-----NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY  526 (635)
T ss_dssp             EHHHHHHH-----CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred             CHHHHHhh-----CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence            99999964     356999999999999999999999997   9999999999999999999999999998665433222


Q ss_pred             cccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCCCcCCCCCc-----------hh
Q 044997          435 MLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIRDDSEP-----------TK  502 (563)
Q Consensus       435 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p~~~~~~~~-----------~~  502 (563)
                      .......+|+.|+|||++.+..             ++.++|||||||++|||++ |+.||.......           ..
T Consensus       527 ~~~~~~~~t~~y~APE~~~~~~-------------~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~  593 (635)
T 4fl3_A          527 KAQTHGKWPVKWYAPECINYYK-------------FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGC  593 (635)
T ss_dssp             --------CGGGSCHHHHHHCC-------------CCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC
T ss_pred             ccccCCCCceeeeChhhhcCCC-------------CCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence            2233345788999999885544             4899999999999999998 999996543211           11


Q ss_pred             hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 044997          503 MKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMIT  541 (563)
Q Consensus       503 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~  541 (563)
                      ...+++.+.+|+.+||+.||++||++.+|++.|+++...
T Consensus       594 p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~  632 (635)
T 4fl3_A          594 PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD  632 (635)
T ss_dssp             CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence            233456789999999999999999999999999988653

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=3.7e-38  Score=320.99  Aligned_cols=241  Identities=24%  Similarity=0.366  Sum_probs=184.0

Q ss_pred             HHHHHhcCCCccceecccCcEEEEEEEEC-----CceEEEEEeccCC-----hHHHHHHHHHHHhccccce---------
Q 044997          286 EIEEATNNFDESRIIGRGGFGNVYFGLLG-----DREAAIKKMRSNK-----SKEFFAELKVLCKIHHINV---------  346 (563)
Q Consensus       286 el~~~~~~f~~~~~LG~G~fG~Vy~g~~~-----~~~vavK~~~~~~-----~~~f~~Ei~~l~~l~H~ni---------  346 (563)
                      ++....++|...+.||+|+||.||+|...     +..||+|.++...     .+.+.+|++++++++||||         
T Consensus        28 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~  107 (313)
T 3brb_A           28 DVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIE  107 (313)
T ss_dssp             TTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC
T ss_pred             hcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEee
Confidence            33444567888999999999999999763     2479999987442     2568999999999999997         


Q ss_pred             -----------EEEeecCCCcccccccccc-cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCC
Q 044997          347 -----------FISTFGNGSLSDHLHDPLL-KGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGL  414 (563)
Q Consensus       347 -----------V~e~~~~gsL~~~L~~~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~  414 (563)
                                 |+||+++|+|.+++..... .....+++..++.++.|++.||.|||+++   ++||||||+|||++.++
T Consensus       108 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~  184 (313)
T 3brb_A          108 MSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDM  184 (313)
T ss_dssp             -------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTS
T ss_pred             ccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCC
Confidence                       4688899999999854322 23467999999999999999999999997   99999999999999999


Q ss_pred             cEEEeecCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCCC
Q 044997          415 RAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRAL  493 (563)
Q Consensus       415 ~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p~  493 (563)
                      .+||+|||+++........ .......+++.|+|||.+.+..             ++.++||||||+++|||++ |+.||
T Consensus       185 ~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~-------------~~~~~Di~slG~il~el~~~g~~p~  250 (313)
T 3brb_A          185 TVCVADFGLSKKIYSGDYY-RQGRIAKMPVKWIAIESLADRV-------------YTSKSDVWAFGVTMWEIATRGMTPY  250 (313)
T ss_dssp             CEEECSCSCC-----------------CCGGGSCHHHHHSSC-------------CCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred             cEEEeecCcceeccccccc-CcccccCCCccccCchhhcCCC-------------ccchhhhHHHHHHHHHHHhcCCCCC
Confidence            9999999999865432211 1122345788999999885443             4889999999999999999 88887


Q ss_pred             cCCCCCc-----------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcCh
Q 044997          494 IRDDSEP-----------TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITST  543 (563)
Q Consensus       494 ~~~~~~~-----------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~  543 (563)
                      .......           .....+.+.+.+++.+||+.||.+||++.++++.|+++++.-+
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp  311 (313)
T 3brb_A          251 PGVQNHEMYDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP  311 (313)
T ss_dssp             TTCCGGGHHHHHHTTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred             ccCCHHHHHHHHHcCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence            6543221           1122345678999999999999999999999999999987543

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=5.3e-38  Score=331.30  Aligned_cols=236  Identities=24%  Similarity=0.279  Sum_probs=190.8

Q ss_pred             cCCCccceecccCcEEEEEEEEC--CceEEEEEeccC----ChHHHHHHHHHHHhccccce-----------------EE
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSN----KSKEFFAELKVLCKIHHINV-----------------FI  348 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~----~~~~f~~Ei~~l~~l~H~ni-----------------V~  348 (563)
                      ++|...+.||+|+||.||+|+..  ++.||||.++..    ..+.+.+|+++|++++||||                 |+
T Consensus         9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~   88 (396)
T 4eut_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM   88 (396)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence            46888999999999999999985  789999998753    34678899999999999997                 57


Q ss_pred             EeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEe----cCCCcEEEeecCCC
Q 044997          349 STFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILL----DDGLRAKVADFGLV  424 (563)
Q Consensus       349 e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl----~~~~~~kl~DFGla  424 (563)
                      ||+.+|+|.+++....  ....+++..++.++.|++.||+|||+++   |+||||||+|||+    +.++.+||+|||++
T Consensus        89 e~~~~g~L~~~l~~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a  163 (396)
T 4eut_A           89 EFCPCGSLYTVLEEPS--NAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA  163 (396)
T ss_dssp             CCCTTEEHHHHTTSGG--GTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred             ecCCCCCHHHHHHhhh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence            8899999999997632  2234999999999999999999999997   9999999999999    78888999999999


Q ss_pred             cccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc----
Q 044997          425 KLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP----  500 (563)
Q Consensus       425 ~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~----  500 (563)
                      +......    ......||+.|+|||++.+....     ......++.++|||||||++|||++|+.||.......    
T Consensus       164 ~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~-----~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~  234 (396)
T 4eut_A          164 RELEDDE----QFVSLYGTEEYLHPDMYERAVLR-----KDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKE  234 (396)
T ss_dssp             EECCCGG----GSSCSSSCCTTCCHHHHHHHCC-------CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHH
T ss_pred             eEccCCC----ccccccCCccccCHHHhhccccc-----cccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHH
Confidence            8654322    12345799999999988542110     0001234789999999999999999999986422110    


Q ss_pred             -----------------------------------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 044997          501 -----------------------------------TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMIT  541 (563)
Q Consensus       501 -----------------------------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~  541 (563)
                                                         .....+...+.+++.+||+.||++||++.|+++.+.+++..
T Consensus       235 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~  310 (396)
T 4eut_A          235 VMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR  310 (396)
T ss_dssp             HHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred             HHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence                                               01145667789999999999999999999999999998763

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=1.3e-38  Score=325.63  Aligned_cols=243  Identities=24%  Similarity=0.370  Sum_probs=194.3

Q ss_pred             cCHHHHHHHhcCCCccceecccCcEEEEEEEEC-------CceEEEEEeccCC----hHHHHHHHHHHHhccccce----
Q 044997          282 FSLEEIEEATNNFDESRIIGRGGFGNVYFGLLG-------DREAAIKKMRSNK----SKEFFAELKVLCKIHHINV----  346 (563)
Q Consensus       282 ~~~~el~~~~~~f~~~~~LG~G~fG~Vy~g~~~-------~~~vavK~~~~~~----~~~f~~Ei~~l~~l~H~ni----  346 (563)
                      +..++++...++|...+.||+|+||.||+|+..       ++.||||.++...    ..+|.+|++++++++||||    
T Consensus        15 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~   94 (322)
T 1p4o_A           15 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLL   94 (322)
T ss_dssp             CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred             cChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeE
Confidence            334455556778999999999999999999764       4679999997543    2468899999999999997    


Q ss_pred             -----------EEEeecCCCcccccccccc-----cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEe
Q 044997          347 -----------FISTFGNGSLSDHLHDPLL-----KGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILL  410 (563)
Q Consensus       347 -----------V~e~~~~gsL~~~L~~~~~-----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl  410 (563)
                                 |+||+++|+|.+++.....     .....+++..++.++.|++.||+|||+++   |+||||||+|||+
T Consensus        95 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli  171 (322)
T 1p4o_A           95 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMV  171 (322)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEE
T ss_pred             EEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEE
Confidence                       5799999999999875210     11246799999999999999999999997   9999999999999


Q ss_pred             cCCCcEEEeecCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-C
Q 044997          411 DDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-G  489 (563)
Q Consensus       411 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g  489 (563)
                      +.++.+||+|||+++........ .......||+.|+|||.+.+..             ++.++||||||+++|||++ |
T Consensus       172 ~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~-------------~~~~~Di~slG~il~el~~~g  237 (322)
T 1p4o_A          172 AEDFTVKIGDFGMTRDIYETDYY-RKGGKGLLPVRWMSPESLKDGV-------------FTTYSDVWSFGVVLWEIATLA  237 (322)
T ss_dssp             CTTCCEEECCTTCCCGGGGGGCE-EGGGSSEECGGGCCHHHHHHCC-------------CCHHHHHHHHHHHHHHHHHTS
T ss_pred             cCCCeEEECcCcccccccccccc-ccccCCCCCCCccChhhhccCC-------------CCchhhHHHHHHHHHHHHhcC
Confidence            99999999999999865433211 1222345788999999875443             4889999999999999999 7


Q ss_pred             CCCCcCCCCC-----------chhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 044997          490 KRALIRDDSE-----------PTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMIT  541 (563)
Q Consensus       490 ~~p~~~~~~~-----------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~  541 (563)
                      +.||......           ......+++.+.+++.+||+.||.+||++.|+++.|++++..
T Consensus       238 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~  300 (322)
T 1p4o_A          238 EQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP  300 (322)
T ss_dssp             CCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred             CCccccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhcc
Confidence            8887543211           111223456689999999999999999999999999988663

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=8.8e-39  Score=350.18  Aligned_cols=233  Identities=26%  Similarity=0.426  Sum_probs=192.1

Q ss_pred             HHhcCCCccceecccCcEEEEEEEECC-ceEEEEEeccC--ChHHHHHHHHHHHhccccce--------------EEEee
Q 044997          289 EATNNFDESRIIGRGGFGNVYFGLLGD-REAAIKKMRSN--KSKEFFAELKVLCKIHHINV--------------FISTF  351 (563)
Q Consensus       289 ~~~~~f~~~~~LG~G~fG~Vy~g~~~~-~~vavK~~~~~--~~~~f~~Ei~~l~~l~H~ni--------------V~e~~  351 (563)
                      ...++|+..+.||+|+||.||+|.+++ ..||||.++..  ..++|.+|+++|++++|+||              |+||+
T Consensus       264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~lv~e~~  343 (535)
T 2h8h_A          264 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYM  343 (535)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEECCC
T ss_pred             cchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEeeccceEeeehh
Confidence            345678889999999999999999965 67999999764  34789999999999999997              57999


Q ss_pred             cCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccccccc
Q 044997          352 GNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTN  431 (563)
Q Consensus       352 ~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~  431 (563)
                      .+|+|.++|...   ....+++.+++.|+.|++.||+|||+++   |+||||||+|||+++++.+||+|||+++......
T Consensus       344 ~~gsL~~~l~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  417 (535)
T 2h8h_A          344 SKGSLLDFLKGE---TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE  417 (535)
T ss_dssp             TTEEHHHHHSHH---HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH
T ss_pred             cCCcHHHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCCc
Confidence            999999999752   2346899999999999999999999997   9999999999999999999999999998654321


Q ss_pred             ccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCCCcCCCCCc----------
Q 044997          432 EKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIRDDSEP----------  500 (563)
Q Consensus       432 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p~~~~~~~~----------  500 (563)
                      .  .......++..|+|||.+....             ++.++|||||||+||||++ |+.||.......          
T Consensus       418 ~--~~~~~~~~~~~y~aPE~~~~~~-------------~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~  482 (535)
T 2h8h_A          418 Y--TARQGAKFPIKWTAPEAALYGR-------------FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR  482 (535)
T ss_dssp             H--HTTCSTTSCGGGSCHHHHHHCC-------------CCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCC
T ss_pred             e--ecccCCcCcccccCHHHhccCC-------------CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Confidence            1  1122345678999999885444             4899999999999999999 888886533211          


Q ss_pred             -hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcC
Q 044997          501 -TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITS  542 (563)
Q Consensus       501 -~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~  542 (563)
                       .....+.+.+.+|+.+||+.||++||++.+|++.|++++...
T Consensus       483 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~  525 (535)
T 2h8h_A          483 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  525 (535)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCC
T ss_pred             CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhcc
Confidence             111234566899999999999999999999999999987643

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=6.5e-38  Score=322.60  Aligned_cols=236  Identities=22%  Similarity=0.385  Sum_probs=190.1

Q ss_pred             hcCCCccceecccCcEEEEEEEEC---------CceEEEEEeccCC----hHHHHHHHHHHHhc-cccce----------
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLLG---------DREAAIKKMRSNK----SKEFFAELKVLCKI-HHINV----------  346 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~~---------~~~vavK~~~~~~----~~~f~~Ei~~l~~l-~H~ni----------  346 (563)
                      .++|...+.||+|+||.||+|+..         +..||||.++...    .+++.+|+++++++ +||||          
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  113 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  113 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence            467889999999999999999863         4579999997643    35688999999999 99997          


Q ss_pred             -----EEEeecCCCccccccccccc-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEe
Q 044997          347 -----FISTFGNGSLSDHLHDPLLK-----------GHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILL  410 (563)
Q Consensus       347 -----V~e~~~~gsL~~~L~~~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl  410 (563)
                           |+||+++|+|.+++......           ....+++..++.++.|++.||+|||+++   ++||||||+|||+
T Consensus       114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll  190 (334)
T 2pvf_A          114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV  190 (334)
T ss_dssp             SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEE
T ss_pred             CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEEE
Confidence                 67999999999999753210           1235899999999999999999999997   9999999999999


Q ss_pred             cCCCcEEEeecCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-C
Q 044997          411 DDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-G  489 (563)
Q Consensus       411 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g  489 (563)
                      +.++.+||+|||+++........ .......+|+.|+|||++.+..+             +.++||||||+++|||++ |
T Consensus       191 ~~~~~~kL~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~-------------~~~~Di~slG~il~ellt~g  256 (334)
T 2pvf_A          191 TENNVMKIADFGLARDINNIDYY-KKTTNGRLPVKWMAPEALFDRVY-------------THQSDVWSFGVLMWEIFTLG  256 (334)
T ss_dssp             CTTCCEEECCCTTCEECTTTSSE-ECCSCCCCCGGGCCHHHHHHCEE-------------CHHHHHHHHHHHHHHHHTTS
T ss_pred             cCCCCEEEccccccccccccccc-cccCCCCcccceeChHHhcCCCc-------------ChHHHHHHHHHHHHHHHhCC
Confidence            99999999999999865432211 11233457889999998865544             789999999999999999 9


Q ss_pred             CCCCcCCCCCc-----------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcCh
Q 044997          490 KRALIRDDSEP-----------TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITST  543 (563)
Q Consensus       490 ~~p~~~~~~~~-----------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~  543 (563)
                      +.||.......           .....+...+.+++.+||+.||.+||++.|+++.|++++....
T Consensus       257 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~  321 (334)
T 2pvf_A          257 GSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT  321 (334)
T ss_dssp             CCSSTTCCHHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             CCCcCcCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccc
Confidence            99986543211           1112334568999999999999999999999999999987543

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=8.5e-38  Score=328.68  Aligned_cols=226  Identities=19%  Similarity=0.262  Sum_probs=182.8

Q ss_pred             cCCCccceeccc--CcEEEEEEEEC--CceEEEEEeccCC-----hHHHHHHHHHHHhccccce---------------E
Q 044997          292 NNFDESRIIGRG--GFGNVYFGLLG--DREAAIKKMRSNK-----SKEFFAELKVLCKIHHINV---------------F  347 (563)
Q Consensus       292 ~~f~~~~~LG~G--~fG~Vy~g~~~--~~~vavK~~~~~~-----~~~f~~Ei~~l~~l~H~ni---------------V  347 (563)
                      ++|+..+.||+|  +||.||+|+..  ++.||||+++...     .+.+.+|++++++++||||               |
T Consensus        25 ~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  104 (389)
T 3gni_B           25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVV  104 (389)
T ss_dssp             GGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             CcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEE
Confidence            568889999999  99999999985  7899999997542     2567889999999999997               5


Q ss_pred             EEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccc
Q 044997          348 ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLE  427 (563)
Q Consensus       348 ~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~  427 (563)
                      +||+++|+|.+++...   ....+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||.+...
T Consensus       105 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~  178 (389)
T 3gni_B          105 TSFMAYGSAKDLICTH---FMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSM  178 (389)
T ss_dssp             EECCTTCBHHHHHHHT---CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred             EEccCCCCHHHHHhhh---cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceee
Confidence            7999999999998752   2356999999999999999999999997   999999999999999999999999998754


Q ss_pred             cccccc----ccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCchh-
Q 044997          428 ERTNEK----EMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTK-  502 (563)
Q Consensus       428 ~~~~~~----~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~~-  502 (563)
                      ......    ........||+.|+|||++.+..           ..++.++|||||||++|||++|+.||......... 
T Consensus       179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----------~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~  247 (389)
T 3gni_B          179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNL-----------QGYDAKSDIYSVGITACELANGHVPFKDMPATQMLL  247 (389)
T ss_dssp             EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTS-----------SCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHH
T ss_pred             ccccccccccccccccccccccccCHHHHhccC-----------CCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence            322211    11122347899999999986521           23588999999999999999999999654332111 


Q ss_pred             -------------------------------------------------------hHHHHHHHHHHHHHhhccCCCCCCC
Q 044997          503 -------------------------------------------------------MKSLITIMAAVAEWCLNEDAVDRPE  527 (563)
Q Consensus       503 -------------------------------------------------------~~~~~~~l~~li~~cl~~dP~~RPs  527 (563)
                                                                             ...+...+.+|+.+||+.||.+|||
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt  327 (389)
T 3gni_B          248 EKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPS  327 (389)
T ss_dssp             HC--------------------------------------------------------CCHHHHHHHHHHTCSCTTTSCC
T ss_pred             HHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCC
Confidence                                                                   0112345889999999999999999


Q ss_pred             HHHHHHH
Q 044997          528 MRDIVAI  534 (563)
Q Consensus       528 ~~evl~~  534 (563)
                      +.|+++.
T Consensus       328 a~ell~h  334 (389)
T 3gni_B          328 ASTLLNH  334 (389)
T ss_dssp             HHHHTTS
T ss_pred             HHHHhcC
Confidence            9999864

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=1.5e-37  Score=326.13  Aligned_cols=231  Identities=23%  Similarity=0.407  Sum_probs=186.7

Q ss_pred             cCCCccceecccCcEEEEEEEEC--CceEEEEEeccC------ChHHHHHHHHHHHhccccce---------------EE
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSN------KSKEFFAELKVLCKIHHINV---------------FI  348 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~------~~~~f~~Ei~~l~~l~H~ni---------------V~  348 (563)
                      ++|+..+.||+|+||.||+++..  ++.+|+|.++..      ..+.+.+|+++|++++||||               |+
T Consensus        15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   94 (384)
T 4fr4_A           15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV   94 (384)
T ss_dssp             GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence            56888999999999999999884  678999998643      34678899999999999997               57


Q ss_pred             EeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccc
Q 044997          349 STFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEE  428 (563)
Q Consensus       349 e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~  428 (563)
                      ||+.+|+|.+++..     ...+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus        95 e~~~gg~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~  166 (384)
T 4fr4_A           95 DLLLGGDLRYHLQQ-----NVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLP  166 (384)
T ss_dssp             CCCTTEEHHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             ecCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeecc
Confidence            99999999999864     356999999999999999999999998   9999999999999999999999999998654


Q ss_pred             cccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCchh------
Q 044997          429 RTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTK------  502 (563)
Q Consensus       429 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~~------  502 (563)
                      ...    ......||+.|+|||++....          ...++.++|||||||++|||++|+.||.........      
T Consensus       167 ~~~----~~~~~~gt~~Y~aPE~~~~~~----------~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~  232 (384)
T 4fr4_A          167 RET----QITTMAGTKPYMAPEMFSSRK----------GAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTF  232 (384)
T ss_dssp             TTC----CBCCCCSCGGGCCGGGTCCCS----------SCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHH
T ss_pred             CCC----ceeccCCCccccCCeeeccCC----------CCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHH
Confidence            322    234467999999999985422          223588999999999999999999999754432211      


Q ss_pred             -------hHHHHHHHHHHHHHhhccCCCCCCC-HHHHHHHHHHhhhcChhhhc
Q 044997          503 -------MKSLITIMAAVAEWCLNEDAVDRPE-MRDIVAILSQIMITSTEWEA  547 (563)
Q Consensus       503 -------~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~~L~~i~~~~~~w~~  547 (563)
                             ...+...+.+|+.+||+.||.+||+ +.++.+   .-.-...+|+.
T Consensus       233 ~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~---hp~f~~~~w~~  282 (384)
T 4fr4_A          233 ETTVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN---FPYMNDINWDA  282 (384)
T ss_dssp             HHCCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT---SGGGTTCCHHH
T ss_pred             hhcccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc---ChhhhcCCHHH
Confidence                   1233456899999999999999998 665543   22233456654

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=4.5e-38  Score=326.69  Aligned_cols=230  Identities=24%  Similarity=0.397  Sum_probs=185.4

Q ss_pred             hcCCCccceecccCcEEEEEEEEC--CceEEEEEeccC------ChHHHHHHHHHHHhc-cccce---------------
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSN------KSKEFFAELKVLCKI-HHINV---------------  346 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~------~~~~f~~Ei~~l~~l-~H~ni---------------  346 (563)
                      .++|+..+.||+|+||.||+|+..  ++.||||.++..      ..+.+.+|.++|.++ +||||               
T Consensus        19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   98 (353)
T 2i0e_A           19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF   98 (353)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence            468999999999999999999985  578999998643      346688999999988 79887               


Q ss_pred             EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcc
Q 044997          347 FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKL  426 (563)
Q Consensus       347 V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~  426 (563)
                      |+||+++|+|.+++..     ...+++..+..++.|++.||+|||+++   |+||||||+|||++.++++||+|||+++.
T Consensus        99 v~E~~~gg~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~  170 (353)
T 2i0e_A           99 VMEYVNGGDLMYHIQQ-----VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE  170 (353)
T ss_dssp             EEECCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EEeCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCcccc
Confidence            6899999999999875     245899999999999999999999997   99999999999999999999999999985


Q ss_pred             cccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc------
Q 044997          427 EERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP------  500 (563)
Q Consensus       427 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~------  500 (563)
                      .....   .......||+.|+|||++.+..+             +.++|||||||++|||++|+.||.......      
T Consensus       171 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~-------------~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~  234 (353)
T 2i0e_A          171 NIWDG---VTTKTFCGTPDYIAPEIIAYQPY-------------GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM  234 (353)
T ss_dssp             CCCTT---CCBCCCCSCGGGCCHHHHTTCCB-------------STHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             cccCC---cccccccCCccccChhhhcCCCc-------------CCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHH
Confidence            32221   12334679999999999865544             889999999999999999999997543211      


Q ss_pred             ----hhhHHHHHHHHHHHHHhhccCCCCCCCH-----HHHHHHHHHhhhcChhhhc
Q 044997          501 ----TKMKSLITIMAAVAEWCLNEDAVDRPEM-----RDIVAILSQIMITSTEWEA  547 (563)
Q Consensus       501 ----~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~~L~~i~~~~~~w~~  547 (563)
                          ..+..+...+.+++.+||+.||.+||++     +|+++   .-.-...+|+.
T Consensus       235 ~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~---h~~f~~~~w~~  287 (353)
T 2i0e_A          235 EHNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE---HAFFRYIDWEK  287 (353)
T ss_dssp             HCCCCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT---SGGGTTCCHHH
T ss_pred             hCCCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc---CccccCCCHHH
Confidence                1112345668999999999999999964     55543   33333455654

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=3.1e-38  Score=324.24  Aligned_cols=213  Identities=21%  Similarity=0.311  Sum_probs=162.1

Q ss_pred             cceecccCcEEEEEEEEC--CceEEEEEeccCChHHHHHHHHHHHhcc-ccce---------------EEEeecCCCccc
Q 044997          297 SRIIGRGGFGNVYFGLLG--DREAAIKKMRSNKSKEFFAELKVLCKIH-HINV---------------FISTFGNGSLSD  358 (563)
Q Consensus       297 ~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~f~~Ei~~l~~l~-H~ni---------------V~e~~~~gsL~~  358 (563)
                      .+.||+|+||.||+|+..  ++.||||.+.......+.+|+++++++. ||||               |+||+++|+|.+
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~   95 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFE   95 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGGGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHH
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChhhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHHH
Confidence            478999999999999984  7889999998887788999999999997 9997               579999999999


Q ss_pred             ccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCC---cEEEeecCCCccccccccccc
Q 044997          359 HLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGL---RAKVADFGLVKLEERTNEKEM  435 (563)
Q Consensus       359 ~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~---~~kl~DFGla~~~~~~~~~~~  435 (563)
                      ++..     ...+++.++..++.|++.||+|||+++   |+||||||+|||++.++   .+||+|||+++.......   
T Consensus        96 ~l~~-----~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~---  164 (325)
T 3kn6_A           96 RIKK-----KKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ---  164 (325)
T ss_dssp             HHHH-----CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC------
T ss_pred             HHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC---
Confidence            9875     357999999999999999999999997   99999999999997665   899999999985443221   


Q ss_pred             ccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCC----------------
Q 044997          436 LATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE----------------  499 (563)
Q Consensus       436 ~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~----------------  499 (563)
                      ......||+.|+|||++.+..             ++.++||||||+++|||++|+.||......                
T Consensus       165 ~~~~~~~t~~y~aPE~~~~~~-------------~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~  231 (325)
T 3kn6_A          165 PLKTPCFTLHYAAPELLNQNG-------------YDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKG  231 (325)
T ss_dssp             -------------------CC-------------CCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTT
T ss_pred             cccccCCCcCccCHHHhcCCC-------------CCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcC
Confidence            223456899999999886544             488999999999999999999999654321                


Q ss_pred             -----chhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          500 -----PTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       500 -----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                           ......+.+.+.+|+.+||+.||.+||++.|+++
T Consensus       232 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  270 (325)
T 3kn6_A          232 DFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY  270 (325)
T ss_dssp             CCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred             CCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence                 1111234567999999999999999999999874

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=6.8e-38  Score=329.32  Aligned_cols=220  Identities=21%  Similarity=0.307  Sum_probs=184.0

Q ss_pred             hcCCCccceecccCcEEEEEEEEC--CceEEEEEeccCC---hHHHHHHHHHHHhccccce---------------EEEe
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNK---SKEFFAELKVLCKIHHINV---------------FIST  350 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~---~~~f~~Ei~~l~~l~H~ni---------------V~e~  350 (563)
                      .++|+..+.||+|+||.||+|...  ++.+|+|.+....   ...+.+|+++|++++||||               |+||
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~  129 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  129 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence            467999999999999999999884  6889999987653   3568899999999999997               5799


Q ss_pred             ecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecC--CCcEEEeecCCCcccc
Q 044997          351 FGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDD--GLRAKVADFGLVKLEE  428 (563)
Q Consensus       351 ~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~--~~~~kl~DFGla~~~~  428 (563)
                      +.+|+|.+++..    ....+++..+..++.|++.||+|||+++   |+||||||+|||++.  ++.+||+|||+++...
T Consensus       130 ~~gg~L~~~l~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~  202 (387)
T 1kob_A          130 LSGGELFDRIAA----EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLN  202 (387)
T ss_dssp             CCCCBHHHHTTC----TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred             CCCCcHHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecC
Confidence            999999998875    2346999999999999999999999997   999999999999974  5789999999998654


Q ss_pred             cccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCC---------
Q 044997          429 RTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE---------  499 (563)
Q Consensus       429 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~---------  499 (563)
                      ...    ......||+.|+|||++.+..             ++.++|||||||++|||++|+.||......         
T Consensus       203 ~~~----~~~~~~gt~~y~aPE~~~~~~-------------~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~  265 (387)
T 1kob_A          203 PDE----IVKVTTATAEFAAPEIVDREP-------------VGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRC  265 (387)
T ss_dssp             TTS----CEEEECSSGGGCCHHHHTTCC-------------BCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHC
T ss_pred             CCc----ceeeeccCCCccCchhccCCC-------------CCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Confidence            322    123346999999999886544             378999999999999999999999754321         


Q ss_pred             -----chhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          500 -----PTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       500 -----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                           ......+...+.+++.+||+.||.+||++.|+++.
T Consensus       266 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  305 (387)
T 1kob_A          266 DWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  305 (387)
T ss_dssp             CCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             CCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence                 11122445678999999999999999999999874

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=8.8e-38  Score=320.47  Aligned_cols=215  Identities=19%  Similarity=0.324  Sum_probs=180.7

Q ss_pred             cCCCccceecccCcEEEEEEEE--CCceEEEEEeccCChHHHHHHHHHHHhcc-ccce-----------------EEEee
Q 044997          292 NNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNKSKEFFAELKVLCKIH-HINV-----------------FISTF  351 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~~~~f~~Ei~~l~~l~-H~ni-----------------V~e~~  351 (563)
                      ++|+..+.||+|+||.||+|+.  +++.||||.++....+.+.+|++++++++ ||||                 |+||+
T Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~  115 (330)
T 3nsz_A           36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHV  115 (330)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECC
T ss_pred             CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEecc
Confidence            5788999999999999999987  47899999999888899999999999997 9987                 57888


Q ss_pred             cCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCC-cEEEeecCCCcccccc
Q 044997          352 GNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGL-RAKVADFGLVKLEERT  430 (563)
Q Consensus       352 ~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~-~~kl~DFGla~~~~~~  430 (563)
                      .+++|.+++..        +++..+..++.|++.||+|||+++   |+||||||+|||++.++ .+||+|||+++.....
T Consensus       116 ~~~~l~~~~~~--------~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~  184 (330)
T 3nsz_A          116 NNTDFKQLYQT--------LTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG  184 (330)
T ss_dssp             CCCCHHHHGGG--------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred             CchhHHHHHHh--------CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence            88998887742        889999999999999999999998   99999999999999776 8999999999865433


Q ss_pred             cccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCchhh-------
Q 044997          431 NEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKM-------  503 (563)
Q Consensus       431 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~~~-------  503 (563)
                      ..    .....|+..|+|||.+.+.            ..++.++|||||||++|||++|+.||..........       
T Consensus       185 ~~----~~~~~~~~~y~aPE~~~~~------------~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~  248 (330)
T 3nsz_A          185 QE----YNVRVASRYFKGPELLVDY------------QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVL  248 (330)
T ss_dssp             CC----CCSCCSCGGGCCHHHHTTC------------CCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHH
T ss_pred             Cc----cccccccccccChhhhcCC------------CcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhc
Confidence            21    2335689999999987542            235899999999999999999999996443211100       


Q ss_pred             -----------------------------------------HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          504 -----------------------------------------KSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       504 -----------------------------------------~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                                                               ..+...+.+++.+||+.||.+|||+.|+++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~  319 (330)
T 3nsz_A          249 GTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  319 (330)
T ss_dssp             CHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             CCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                                                     013566889999999999999999999987

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=3.2e-38  Score=324.36  Aligned_cols=229  Identities=20%  Similarity=0.347  Sum_probs=176.5

Q ss_pred             cCCCccceecccCcEEEEEEEE-----CCceEEEEEeccCC-------hHHHHHHHHHHHhccccce-------------
Q 044997          292 NNFDESRIIGRGGFGNVYFGLL-----GDREAAIKKMRSNK-------SKEFFAELKVLCKIHHINV-------------  346 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~-----~~~~vavK~~~~~~-------~~~f~~Ei~~l~~l~H~ni-------------  346 (563)
                      ++|+..+.||+|+||.||+++.     .++.+|+|.++...       ...+.+|+++|++++||||             
T Consensus        17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   96 (327)
T 3a62_A           17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKL   96 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCE
T ss_pred             HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEE
Confidence            5688999999999999999986     46889999987532       3457889999999999997             


Q ss_pred             --EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCC
Q 044997          347 --FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLV  424 (563)
Q Consensus       347 --V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla  424 (563)
                        |+||+++|+|.+++..     ...+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++
T Consensus        97 ~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~  168 (327)
T 3a62_A           97 YLILEYLSGGELFMQLER-----EGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLC  168 (327)
T ss_dssp             EEEEECCTTEEHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC
T ss_pred             EEEEeCCCCCcHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCcc
Confidence              5799999999998864     246899999999999999999999997   999999999999999999999999999


Q ss_pred             cccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCch---
Q 044997          425 KLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPT---  501 (563)
Q Consensus       425 ~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~---  501 (563)
                      +......   .......||+.|+|||++.+..             ++.++||||||+++|||++|+.||........   
T Consensus       169 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~-------------~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~  232 (327)
T 3a62_A          169 KESIHDG---TVTHTFCGTIEYMAPEILMRSG-------------HNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDK  232 (327)
T ss_dssp             -------------CTTSSCCTTSCHHHHTTSC-------------CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred             cccccCC---ccccccCCCcCccCHhhCcCCC-------------CCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence            7533221   1223457999999999885543             48899999999999999999999975432111   


Q ss_pred             -------hhHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHHHHHhhhcChhhhc
Q 044997          502 -------KMKSLITIMAAVAEWCLNEDAVDRP-----EMRDIVAILSQIMITSTEWEA  547 (563)
Q Consensus       502 -------~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~L~~i~~~~~~w~~  547 (563)
                             ....+...+.+++.+||+.||.+||     ++.|+++   .-.-...+|+.
T Consensus       233 i~~~~~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~---hp~f~~~~~~~  287 (327)
T 3a62_A          233 ILKCKLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA---HPFFRHINWEE  287 (327)
T ss_dssp             HHHTCCCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH---SGGGSSCCHHH
T ss_pred             HHhCCCCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc---CCcccCCCHHH
Confidence                   1123346689999999999999999     5666654   33333445544

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=4.2e-38  Score=317.04  Aligned_cols=219  Identities=23%  Similarity=0.337  Sum_probs=174.7

Q ss_pred             cCCCccceecccCcEEEEEEEEC-CceEEEEEeccCC-----hHHHHHHHHHHHhccccce---------------EEEe
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG-DREAAIKKMRSNK-----SKEFFAELKVLCKIHHINV---------------FIST  350 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~vavK~~~~~~-----~~~f~~Ei~~l~~l~H~ni---------------V~e~  350 (563)
                      ++|+..+.||+|+||.||+|+.. ++.+|+|+++...     .+.+.+|++++++++||||               |+||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            56888999999999999999885 7889999986432     3678899999999999998               4577


Q ss_pred             ecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccccc
Q 044997          351 FGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERT  430 (563)
Q Consensus       351 ~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~  430 (563)
                      +++ +|.+++..    ....+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus        82 ~~~-~l~~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  153 (288)
T 1ob3_A           82 LDQ-DLKKLLDV----CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIP  153 (288)
T ss_dssp             CSE-EHHHHHHT----STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred             cCC-CHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCcc
Confidence            664 77777754    2356899999999999999999999997   999999999999999999999999998754322


Q ss_pred             cccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCch---------
Q 044997          431 NEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPT---------  501 (563)
Q Consensus       431 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~---------  501 (563)
                      ..   ......||+.|+|||++.+.            ..++.++|||||||++|||++|+.||........         
T Consensus       154 ~~---~~~~~~~t~~y~aPE~~~~~------------~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  218 (288)
T 1ob3_A          154 VR---KYTHEIVTLWYRAPDVLMGS------------KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILG  218 (288)
T ss_dssp             -----------CCCTTCCHHHHTTC------------CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred             cc---ccccccccccccCchheeCC------------CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHC
Confidence            11   12335689999999987542            2358999999999999999999999864321100         


Q ss_pred             ------------------------------hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          502 ------------------------------KMKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       502 ------------------------------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                                                    ....+.+.+.+++.+||+.||++|||+.|+++
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          219 TPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             CCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence                                          00123456789999999999999999999876

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=4.4e-38  Score=323.31  Aligned_cols=235  Identities=21%  Similarity=0.344  Sum_probs=189.9

Q ss_pred             HhcCCCccceecccCcEEEEEEEECC-------ceEEEEEeccCC----hHHHHHHHHHHHhc-cccce-----------
Q 044997          290 ATNNFDESRIIGRGGFGNVYFGLLGD-------REAAIKKMRSNK----SKEFFAELKVLCKI-HHINV-----------  346 (563)
Q Consensus       290 ~~~~f~~~~~LG~G~fG~Vy~g~~~~-------~~vavK~~~~~~----~~~f~~Ei~~l~~l-~H~ni-----------  346 (563)
                      ..++|...+.||+|+||.||+|...+       ..||+|.++...    .+.+.+|+++++++ +||||           
T Consensus        44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  123 (333)
T 2i1m_A           44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGG  123 (333)
T ss_dssp             CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC
Confidence            45789999999999999999998742       369999997653    35688999999999 89997           


Q ss_pred             ----EEEeecCCCcccccccccc---------cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCC
Q 044997          347 ----FISTFGNGSLSDHLHDPLL---------KGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDG  413 (563)
Q Consensus       347 ----V~e~~~~gsL~~~L~~~~~---------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~  413 (563)
                          |+||+++|+|.+++.....         .....+++..++.++.|++.||+|||+++   |+||||||+|||++.+
T Consensus       124 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~  200 (333)
T 2i1m_A          124 PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNG  200 (333)
T ss_dssp             SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEEGG
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEECCC
Confidence                5799999999999864211         01346899999999999999999999997   9999999999999999


Q ss_pred             CcEEEeecCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCC
Q 044997          414 LRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRA  492 (563)
Q Consensus       414 ~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p  492 (563)
                      +.+||+|||+++........ .......||+.|+|||.+.+..             ++.++||||||+++|||++ |+.|
T Consensus       201 ~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~-------------~~~~~Di~slG~il~el~t~g~~p  266 (333)
T 2i1m_A          201 HVAKIGDFGLARDIMNDSNY-IVKGNARLPVKWMAPESIFDCV-------------YTVQSDVWSYGILLWEIFSLGLNP  266 (333)
T ss_dssp             GEEEBCCCGGGCCGGGCTTS-EECSSCEECGGGSCHHHHHHCC-------------CCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred             CeEEECccccccccccccce-eecCCCCCCccccCHHHhccCC-------------CChHHHHHHHHHHHHHHHcCCCCC
Confidence            99999999999865433221 1223345788999999875443             4899999999999999999 8888


Q ss_pred             CcCCCCCchh------------hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 044997          493 LIRDDSEPTK------------MKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMIT  541 (563)
Q Consensus       493 ~~~~~~~~~~------------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~  541 (563)
                      |.........            ....++.+.+++.+||+.||.+||++.|+++.|+++...
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~  327 (333)
T 2i1m_A          267 YPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE  327 (333)
T ss_dssp             STTCCSSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CcccchhHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHh
Confidence            8654432211            112345689999999999999999999999999988753

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=3.6e-38  Score=326.52  Aligned_cols=232  Identities=25%  Similarity=0.398  Sum_probs=184.1

Q ss_pred             cCCCccceecccCcEEEEEEEEC--CceEEEEEeccCC------hHHHHHHHHHHHhc-cccce---------------E
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNK------SKEFFAELKVLCKI-HHINV---------------F  347 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~------~~~f~~Ei~~l~~l-~H~ni---------------V  347 (563)
                      ++|+..+.||+|+||.||+++..  ++.+|+|.++...      .+.+.+|.+++.++ +||||               |
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv   88 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV   88 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence            46888999999999999999985  6889999997532      24578899999988 89997               5


Q ss_pred             EEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccc
Q 044997          348 ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLE  427 (563)
Q Consensus       348 ~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~  427 (563)
                      +||+++|+|.+++..     ...+++..+..++.|++.||+|||+++   |+||||||+|||++.++++||+|||+++..
T Consensus        89 ~e~~~gg~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~  160 (345)
T 3a8x_A           89 IEYVNGGDLMFHMQR-----QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEG  160 (345)
T ss_dssp             ECCCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCS
T ss_pred             EeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccc
Confidence            799999999999864     246899999999999999999999997   999999999999999999999999999853


Q ss_pred             ccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc-------
Q 044997          428 ERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP-------  500 (563)
Q Consensus       428 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~-------  500 (563)
                      ....   .......||+.|+|||++.+..+             +.++|||||||++|||++|+.||.......       
T Consensus       161 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~-------------~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~  224 (345)
T 3a8x_A          161 LRPG---DTTSTFCGTPNYIAPEILRGEDY-------------GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTE  224 (345)
T ss_dssp             CCTT---CCBCCCCSCGGGCCHHHHTTCCB-------------CTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CH
T ss_pred             cCCC---CcccccCCCccccCccccCCCCC-------------ChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccH
Confidence            3221   12344679999999999865544             889999999999999999999996422110       


Q ss_pred             h------------hhHHHHHHHHHHHHHhhccCCCCCCCHH---HHHHHHHHhhhcChhhhc
Q 044997          501 T------------KMKSLITIMAAVAEWCLNEDAVDRPEMR---DIVAILSQIMITSTEWEA  547 (563)
Q Consensus       501 ~------------~~~~~~~~l~~li~~cl~~dP~~RPs~~---evl~~L~~i~~~~~~w~~  547 (563)
                      .            .+..+...+.+++.+||+.||.+||++.   .+.+.+..-.-...+|+.
T Consensus       225 ~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w~~  286 (345)
T 3a8x_A          225 DYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDM  286 (345)
T ss_dssp             HHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCHHH
T ss_pred             HHHHHHHHcCCCCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCHHH
Confidence            0            0112345689999999999999999962   233344433334456654

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=7.6e-38  Score=320.41  Aligned_cols=215  Identities=24%  Similarity=0.378  Sum_probs=181.4

Q ss_pred             cCCCccceecccCcEEEEEEEEC--CceEEEEEeccC------ChHHHHHHHHHHHhccccce---------------EE
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSN------KSKEFFAELKVLCKIHHINV---------------FI  348 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~------~~~~f~~Ei~~l~~l~H~ni---------------V~  348 (563)
                      ++|+..+.||+|+||.||+++..  ++.+|+|.++..      ..+.+.+|..++++++||||               |+
T Consensus         6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~   85 (318)
T 1fot_A            6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   85 (318)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence            56888999999999999999884  789999998643      34668899999999999997               57


Q ss_pred             EeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccc
Q 044997          349 STFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEE  428 (563)
Q Consensus       349 e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~  428 (563)
                      ||+++|+|.+++..     ...+++..+..++.|++.||+|||+++   |+||||||+|||++.++++||+|||+++...
T Consensus        86 e~~~gg~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~  157 (318)
T 1fot_A           86 DYIEGGELFSLLRK-----SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVP  157 (318)
T ss_dssp             CCCCSCBHHHHHHH-----TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred             eCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecC
Confidence            99999999999865     356899999999999999999999997   9999999999999999999999999998643


Q ss_pred             cccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCch-------
Q 044997          429 RTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPT-------  501 (563)
Q Consensus       429 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~-------  501 (563)
                      ..      .....||+.|+|||++.+..+             +.++|||||||++|||++|+.||........       
T Consensus       158 ~~------~~~~~gt~~y~aPE~~~~~~~-------------~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~  218 (318)
T 1fot_A          158 DV------TYTLCGTPDYIAPEVVSTKPY-------------NKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA  218 (318)
T ss_dssp             SC------BCCCCSCTTTCCHHHHTTCCB-------------CTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHC
T ss_pred             Cc------cccccCCccccCHhHhcCCCC-------------CcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Confidence            21      234579999999999865544             7899999999999999999999975432111       


Q ss_pred             ---hhHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 044997          502 ---KMKSLITIMAAVAEWCLNEDAVDRP-----EMRDIVA  533 (563)
Q Consensus       502 ---~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  533 (563)
                         ....+...+.+++.+||+.||.+||     +++|+++
T Consensus       219 ~~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~  258 (318)
T 1fot_A          219 ELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  258 (318)
T ss_dssp             CCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             CCCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence               1122345689999999999999999     7888775

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=2.7e-38  Score=327.36  Aligned_cols=220  Identities=25%  Similarity=0.422  Sum_probs=182.0

Q ss_pred             HHhcCCCccceecccCcEEEEEEEEC--CceEEEEEeccC------ChHHHHHHHHHHHhc-cccce-------------
Q 044997          289 EATNNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSN------KSKEFFAELKVLCKI-HHINV-------------  346 (563)
Q Consensus       289 ~~~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~------~~~~f~~Ei~~l~~l-~H~ni-------------  346 (563)
                      ...++|...+.||+|+||.||+|+..  ++.||||.++..      ..+.+..|.+++.++ +||||             
T Consensus        14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~   93 (345)
T 1xjd_A           14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL   93 (345)
T ss_dssp             --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred             CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence            34578999999999999999999984  688999998643      346688899999987 99997             


Q ss_pred             --EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCC
Q 044997          347 --FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLV  424 (563)
Q Consensus       347 --V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla  424 (563)
                        |+||+++|+|.+++..     ...+++..+..++.|++.||+|||+++   |+||||||+|||++.++++||+|||++
T Consensus        94 ~lv~E~~~gg~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a  165 (345)
T 1xjd_A           94 FFVMEYLNGGDLMYHIQS-----CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMC  165 (345)
T ss_dssp             EEEEECCTTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EEEEeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhh
Confidence              6899999999999865     246899999999999999999999997   999999999999999999999999999


Q ss_pred             cccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc----
Q 044997          425 KLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP----  500 (563)
Q Consensus       425 ~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~----  500 (563)
                      +......   .......||+.|+|||++.+..+             +.++|||||||++|||++|+.||...+...    
T Consensus       166 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~-------------~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~  229 (345)
T 1xjd_A          166 KENMLGD---AKTNTFCGTPDYIAPEILLGQKY-------------NHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHS  229 (345)
T ss_dssp             BCCCCTT---CCBCCCCSCGGGCCHHHHTTCCB-------------CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred             hhcccCC---CcccCCCCCcccCChhhhcCCCC-------------CChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence            8543221   12344679999999999865544             889999999999999999999997543211    


Q ss_pred             ------hhhHHHHHHHHHHHHHhhccCCCCCCCHH-HHH
Q 044997          501 ------TKMKSLITIMAAVAEWCLNEDAVDRPEMR-DIV  532 (563)
Q Consensus       501 ------~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl  532 (563)
                            .....+...+.+++.+||+.||.+||++. |++
T Consensus       230 i~~~~~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~  268 (345)
T 1xjd_A          230 IRMDNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR  268 (345)
T ss_dssp             HHHCCCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             HHhCCCCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence                  11123446689999999999999999997 554

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=2.1e-38  Score=317.51  Aligned_cols=229  Identities=27%  Similarity=0.414  Sum_probs=186.6

Q ss_pred             HhcCCCccceecccCcEEEEEEEEC--CceEEEEEeccCChHHHHHHHHHHHhccccceE--------------------
Q 044997          290 ATNNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNKSKEFFAELKVLCKIHHINVF--------------------  347 (563)
Q Consensus       290 ~~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~f~~Ei~~l~~l~H~niV--------------------  347 (563)
                      ..++|+..+.||+|+||.||+|+..  ++.||+|.++... +.+.+|++++++++||||+                    
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~   87 (284)
T 2a19_B            9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNS   87 (284)
T ss_dssp             HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC--------
T ss_pred             hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccc
Confidence            4467899999999999999999985  7899999997654 4677899999999999972                    


Q ss_pred             -----------EEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcE
Q 044997          348 -----------ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRA  416 (563)
Q Consensus       348 -----------~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~  416 (563)
                                 +||+++|+|.+++...   ....+++..++.++.|++.||.|||+++   ++||||||+|||+++++.+
T Consensus        88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~  161 (284)
T 2a19_B           88 SRSKTKCLFIQMEFCDKGTLEQWIEKR---RGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQV  161 (284)
T ss_dssp             -CCEEEEEEEEECCCCSCBHHHHHHHG---GGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEE
T ss_pred             cccCcceEEEEEeccCCCCHHHHHhhc---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCCE
Confidence                       4677889999999652   2356999999999999999999999997   9999999999999999999


Q ss_pred             EEeecCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCC
Q 044997          417 KVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRD  496 (563)
Q Consensus       417 kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~  496 (563)
                      ||+|||+++......    ......||+.|+|||.+.+..             ++.++||||||+++|||++|..|+...
T Consensus       162 kl~Dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~-------------~~~~~Di~slG~il~~l~~~~~~~~~~  224 (284)
T 2a19_B          162 KIGDFGLVTSLKNDG----KRTRSKGTLRYMSPEQISSQD-------------YGKEVDLYALGLILAELLHVCDTAFET  224 (284)
T ss_dssp             EECCCTTCEESSCCS----CCCCCCSCCTTSCHHHHHCSC-------------CCTHHHHHHHHHHHHHHHSCCSSHHHH
T ss_pred             EECcchhheeccccc----cccccCCcccccChhhhccCC-------------CcchhhhHHHHHHHHHHHhcCCcchhH
Confidence            999999998654322    123356899999999885443             488999999999999999999887422


Q ss_pred             CCCc------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcC
Q 044997          497 DSEP------TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITS  542 (563)
Q Consensus       497 ~~~~------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~  542 (563)
                      ....      .....+...+.+++.+||+.||.+||++.|+++.|..+....
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~  276 (284)
T 2a19_B          225 SKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP  276 (284)
T ss_dssp             HHHHHHHHTTCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC--
T ss_pred             HHHHHHhhcccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCC
Confidence            1000      001123455889999999999999999999999999876543

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=1.7e-38  Score=327.53  Aligned_cols=221  Identities=20%  Similarity=0.352  Sum_probs=183.1

Q ss_pred             HhcCCCccceecccCcEEEEEEEE--CCceEEEEEeccCC-----------hHHHHHHHHHHHhccccce----------
Q 044997          290 ATNNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNK-----------SKEFFAELKVLCKIHHINV----------  346 (563)
Q Consensus       290 ~~~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~-----------~~~f~~Ei~~l~~l~H~ni----------  346 (563)
                      ..++|+..+.||+|+||.||+|+.  +++.||||.++...           .+.+.+|+++|++++||||          
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~  101 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ  101 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence            457899999999999999999986  47889999987542           2357789999999999997          


Q ss_pred             -----EEEeecCC-CcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEee
Q 044997          347 -----FISTFGNG-SLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVAD  420 (563)
Q Consensus       347 -----V~e~~~~g-sL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~D  420 (563)
                           |+||+..| +|.+++..     ...+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|
T Consensus       102 ~~~~lv~e~~~~g~~l~~~~~~-----~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~D  173 (335)
T 3dls_A          102 GFFQLVMEKHGSGLDLFAFIDR-----HPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLID  173 (335)
T ss_dssp             SEEEEEEECCTTSCBHHHHHHT-----CCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECC
T ss_pred             CEEEEEEEeCCCCccHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEee
Confidence                 56888777 88888864     356999999999999999999999997   99999999999999999999999


Q ss_pred             cCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCC-
Q 044997          421 FGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE-  499 (563)
Q Consensus       421 FGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~-  499 (563)
                      ||+++......    ......||+.|+|||++.+..+            .+.++||||||+++|||++|+.||...... 
T Consensus       174 fg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~------------~~~~~DiwslG~il~el~~g~~pf~~~~~~~  237 (335)
T 3dls_A          174 FGSAAYLERGK----LFYTFCGTIEYCAPEVLMGNPY------------RGPELEMWSLGVTLYTLVFEENPFCELEETV  237 (335)
T ss_dssp             CTTCEECCTTC----CBCEECSCGGGCCHHHHTTCCB------------CSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT
T ss_pred             cccceECCCCC----ceeccCCCccccChhhhcCCCC------------CCCcccchhHHHHHHHHHhCCCchhhHHHHH
Confidence            99998654332    1233579999999999865443            278999999999999999999998643211 


Q ss_pred             ---chhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          500 ---PTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       500 ---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                         ......+.+.+.+++.+||+.||.+||++.|+++.
T Consensus       238 ~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          238 EAAIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             TTCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             hhccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence               11122345678999999999999999999999885

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=1.4e-37  Score=335.51  Aligned_cols=237  Identities=23%  Similarity=0.360  Sum_probs=192.9

Q ss_pred             hcCCCccceecccCcEEEEEEEEC--CceEEEEEeccC-ChHHHHHHHHHHHhccccc----------------eEEEee
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSN-KSKEFFAELKVLCKIHHIN----------------VFISTF  351 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~-~~~~f~~Ei~~l~~l~H~n----------------iV~e~~  351 (563)
                      .++|+..++||+|+||.||+|+..  ++.||||.++.. ..+++.+|+++++.++|++                +|+||+
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~   85 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL   85 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC
Confidence            367899999999999999999874  789999988654 3456889999999998854                267888


Q ss_pred             cCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEe---cCCCcEEEeecCCCcccc
Q 044997          352 GNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILL---DDGLRAKVADFGLVKLEE  428 (563)
Q Consensus       352 ~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl---~~~~~~kl~DFGla~~~~  428 (563)
                       +|+|.+++..    ....+++..++.|+.||+.||+|||+++   |+||||||+|||+   +.++.+||+|||+++...
T Consensus        86 -g~sL~~ll~~----~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~  157 (483)
T 3sv0_A           86 -GPSLEDLFNF----CSRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR  157 (483)
T ss_dssp             -CCBHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             -CCCHHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence             9999999864    2356999999999999999999999997   9999999999999   688999999999998765


Q ss_pred             cccccc----cccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCchh--
Q 044997          429 RTNEKE----MLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTK--  502 (563)
Q Consensus       429 ~~~~~~----~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~~--  502 (563)
                      ......    .......||..|+|||++.+..             ++.++|||||||+||||++|+.||.........  
T Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-------------~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~  224 (483)
T 3sv0_A          158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIE-------------QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQK  224 (483)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC-------------CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHH
T ss_pred             CCccccccccccccccCCCccccCHHHhcCCC-------------CChHHHHHHHHHHHHHHHhCCCCCccccchhHHHH
Confidence            432211    1122467999999999886544             488999999999999999999999765432110  


Q ss_pred             ----------------hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcC-------hhhhcc
Q 044997          503 ----------------MKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITS-------TEWEAS  548 (563)
Q Consensus       503 ----------------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~-------~~w~~~  548 (563)
                                      ...++..+.+++.+||+.||++||++.+|++.|++++...       .+|+.-
T Consensus       225 ~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~~~~~~~dW~~~  293 (483)
T 3sv0_A          225 YEKISEKKVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQFDYVFDWTIL  293 (483)
T ss_dssp             HHHHHHHHHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCSSCCHHHHH
T ss_pred             HHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCCCccCCcCchhh
Confidence                            0122356899999999999999999999999999987633       367653

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=7.5e-38  Score=326.11  Aligned_cols=220  Identities=20%  Similarity=0.308  Sum_probs=173.1

Q ss_pred             hcCCCccceecccCcEEEEEEEE--CCceEEEEEeccCC--hHHHHHHHHHHHhccccce---------------EEEee
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNK--SKEFFAELKVLCKIHHINV---------------FISTF  351 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~--~~~f~~Ei~~l~~l~H~ni---------------V~e~~  351 (563)
                      .++|+..+.||+|+||.||+++.  .++.||||.+....  .+.+.+|+.++++++||||               |+||+
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   98 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYA   98 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeC
Confidence            35788999999999999999988  47889999997543  4778999999999999997               57999


Q ss_pred             cCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCc--EEEeecCCCccccc
Q 044997          352 GNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLR--AKVADFGLVKLEER  429 (563)
Q Consensus       352 ~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~--~kl~DFGla~~~~~  429 (563)
                      .+|+|.+++..     ...+++..+..++.|++.||+|||+++   |+||||||+|||++.++.  +||+|||+++....
T Consensus        99 ~~~~L~~~l~~-----~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~  170 (361)
T 3uc3_A           99 SGGELYERICN-----AGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL  170 (361)
T ss_dssp             CSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC-----
T ss_pred             CCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCccccccc
Confidence            99999998864     246999999999999999999999998   999999999999987765  99999999974322


Q ss_pred             ccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCchhh------
Q 044997          430 TNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKM------  503 (563)
Q Consensus       430 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~~~------  503 (563)
                      ..    ......||+.|+|||++.+..+            .+.++|||||||++|||++|+.||..........      
T Consensus       171 ~~----~~~~~~gt~~y~aPE~~~~~~~------------~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~  234 (361)
T 3uc3_A          171 HS----QPKSTVGTPAYIAPEVLLRQEY------------DGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRI  234 (361)
T ss_dssp             --------------CTTSCHHHHHCSSC------------CHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHH
T ss_pred             cC----CCCCCcCCCCcCChhhhcCCCC------------CCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHH
Confidence            21    2234579999999999865543            1345999999999999999999997643321111      


Q ss_pred             ----------HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          504 ----------KSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       504 ----------~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                                ..+...+.+|+.+||+.||.+|||+.|+++.
T Consensus       235 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  275 (361)
T 3uc3_A          235 LSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTH  275 (361)
T ss_dssp             HTTCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             hcCCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence                      1234568999999999999999999999874

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=3.1e-38  Score=334.16  Aligned_cols=231  Identities=21%  Similarity=0.321  Sum_probs=188.6

Q ss_pred             HHHHHHHhcCCCccceecccCcEEEEEEEEC--CceEEEEEeccC------ChHHHHHHHHHHHhccccce---------
Q 044997          284 LEEIEEATNNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSN------KSKEFFAELKVLCKIHHINV---------  346 (563)
Q Consensus       284 ~~el~~~~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~------~~~~f~~Ei~~l~~l~H~ni---------  346 (563)
                      +.++....++|+..+.||+|+||.||+|+..  ++.+|+|+++..      ..+.+.+|+++++.++||||         
T Consensus        61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~  140 (410)
T 3v8s_A           61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD  140 (410)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence            3455556788999999999999999999984  678999998642      33458899999999999997         


Q ss_pred             ------EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEee
Q 044997          347 ------FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVAD  420 (563)
Q Consensus       347 ------V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~D  420 (563)
                            |+||+++|+|.+++..      ..+++..+..++.|++.||+|||+++   |+||||||+|||++.++++||+|
T Consensus       141 ~~~~~lV~E~~~gg~L~~~l~~------~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~D  211 (410)
T 3v8s_A          141 DRYLYMVMEYMPGGDLVNLMSN------YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLAD  211 (410)
T ss_dssp             SSEEEEEECCCTTEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECC
T ss_pred             CCEEEEEEeCCCCCcHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEec
Confidence                  6899999999998864      35899999999999999999999998   99999999999999999999999


Q ss_pred             cCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc
Q 044997          421 FGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP  500 (563)
Q Consensus       421 FGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~  500 (563)
                      ||+++.......  ......+||+.|+|||++.+...         .+.++.++|||||||++|||++|+.||.......
T Consensus       212 FG~a~~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~---------~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~  280 (410)
T 3v8s_A          212 FGTCMKMNKEGM--VRCDTAVGTPDYISPEVLKSQGG---------DGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG  280 (410)
T ss_dssp             CTTCEECCTTSE--EECCSCCSCGGGCCHHHHHTTTT---------TCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHH
T ss_pred             cceeEeeccCCc--ccccCCcCCccccCHHHhhccCC---------CcCCCCcceEecchHHHHHHHhCCCCCCCCChhh
Confidence            999986543321  12234679999999999865431         1224789999999999999999999997654221


Q ss_pred             hh--------------hHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 044997          501 TK--------------MKSLITIMAAVAEWCLNEDAVD--RPEMRDIVAI  534 (563)
Q Consensus       501 ~~--------------~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~  534 (563)
                      ..              ...+...+.+|+.+||..+|.+  ||+++||++.
T Consensus       281 ~~~~i~~~~~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H  330 (410)
T 3v8s_A          281 TYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  330 (410)
T ss_dssp             HHHHHHTHHHHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred             HHHHHHhccccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence            10              0124466899999999999988  9999998864

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=1.2e-37  Score=328.96  Aligned_cols=218  Identities=19%  Similarity=0.332  Sum_probs=172.4

Q ss_pred             cCCCcc-ceecccCcEEEEEEEEC--CceEEEEEeccCChHHHHHHHHHHH-hccccce-------------------EE
Q 044997          292 NNFDES-RIIGRGGFGNVYFGLLG--DREAAIKKMRSNKSKEFFAELKVLC-KIHHINV-------------------FI  348 (563)
Q Consensus       292 ~~f~~~-~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~f~~Ei~~l~-~l~H~ni-------------------V~  348 (563)
                      ++|... +.||+|+||.||++...  ++.||||+++.  ...+.+|++++. ..+||||                   |+
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~--~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~  138 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVM  138 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC--SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc--chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEE
Confidence            456555 78999999999999884  68899999964  356778999874 4588886                   57


Q ss_pred             EeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecC---CCcEEEeecCCCc
Q 044997          349 STFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDD---GLRAKVADFGLVK  425 (563)
Q Consensus       349 e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~---~~~~kl~DFGla~  425 (563)
                      ||+.+|+|.+++..   .....+++..+..|+.|++.||+|||+++   |+||||||+|||++.   ++.+||+|||+++
T Consensus       139 E~~~gg~L~~~l~~---~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~  212 (400)
T 1nxk_A          139 ECLDGGELFSRIQD---RGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAK  212 (400)
T ss_dssp             ECCCSEEHHHHHHC---C---CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred             EeCCCCcHHHHHHH---hCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEeccccc
Confidence            88999999999975   23456999999999999999999999997   999999999999997   7899999999998


Q ss_pred             ccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCch----
Q 044997          426 LEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPT----  501 (563)
Q Consensus       426 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~----  501 (563)
                      ......    ......||+.|+|||++.+..             ++.++|||||||++|||++|+.||........    
T Consensus       213 ~~~~~~----~~~~~~gt~~y~aPE~~~~~~-------------~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~  275 (400)
T 1nxk_A          213 ETTSHN----SLTTPCYTPYYVAPEVLGPEK-------------YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM  275 (400)
T ss_dssp             ECC---------------CTTCCGGGSCCCC-------------SSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSH
T ss_pred             ccCCCC----ccccCCCCCCccCHhhcCCCC-------------CCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHH
Confidence            543221    223457899999999986544             48899999999999999999999976443210    


Q ss_pred             --------------hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          502 --------------KMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       502 --------------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                                    ....+...+.+|+.+||+.||.+|||+.|+++.
T Consensus       276 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  322 (400)
T 1nxk_A          276 KTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  322 (400)
T ss_dssp             HHHHHHTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             HHHHHcCcccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence                          112345679999999999999999999999874

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=8.8e-38  Score=319.48  Aligned_cols=224  Identities=20%  Similarity=0.319  Sum_probs=167.4

Q ss_pred             hcCCCccceecccCcEEEEEEEEC--CceEEEEEeccC----ChHHHHHHHHHHHhccccce---------------EEE
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSN----KSKEFFAELKVLCKIHHINV---------------FIS  349 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~----~~~~f~~Ei~~l~~l~H~ni---------------V~e  349 (563)
                      .++|+..+.||+|+||.||+|...  ++.||+|.++..    ..+.+.+|++++++++||||               |+|
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            457888999999999999999874  788999998643    23678999999999999997               578


Q ss_pred             eecCCCcccccccccc-cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccc
Q 044997          350 TFGNGSLSDHLHDPLL-KGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEE  428 (563)
Q Consensus       350 ~~~~gsL~~~L~~~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~  428 (563)
                      |++ |+|.+++..... .....+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus        84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  159 (317)
T 2pmi_A           84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG  159 (317)
T ss_dssp             CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred             ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence            887 689888865321 12346899999999999999999999997   9999999999999999999999999998654


Q ss_pred             cccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCchh------
Q 044997          429 RTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTK------  502 (563)
Q Consensus       429 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~~------  502 (563)
                      ....   ......||+.|+|||++.+.            ..++.++|||||||++|||++|+.||.........      
T Consensus       160 ~~~~---~~~~~~~t~~y~aPE~~~~~------------~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~  224 (317)
T 2pmi_A          160 IPVN---TFSSEVVTLWYRAPDVLMGS------------RTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDI  224 (317)
T ss_dssp             SCCC---CCCCCCSCCTTCCHHHHTTC------------CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred             CCcc---cCCCCcccccccCchHhhCC------------CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence            2211   12345789999999987542            23588999999999999999999998643311000      


Q ss_pred             --------------------------------------hHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          503 --------------------------------------MKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       503 --------------------------------------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                                                            ...+...+.+++.+||+.||.+|||+.|+++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  293 (317)
T 2pmi_A          225 MGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH  293 (317)
T ss_dssp             HCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hCCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence                                                  0023456889999999999999999999876

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.1e-37  Score=321.86  Aligned_cols=234  Identities=23%  Similarity=0.306  Sum_probs=183.3

Q ss_pred             HHHHHhcCCCccceecccCcEEEEEEEEC--CceEEEEEeccC--------ChHHHHHHHHHHHhccccce---------
Q 044997          286 EIEEATNNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSN--------KSKEFFAELKVLCKIHHINV---------  346 (563)
Q Consensus       286 el~~~~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~--------~~~~f~~Ei~~l~~l~H~ni---------  346 (563)
                      ++....++|...+.||+|+||.||+|+..  ++.+|+|.++..        ..+.+.+|++++++++||||         
T Consensus        20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~   99 (345)
T 3hko_A           20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED   99 (345)
T ss_dssp             CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence            34566788999999999999999999884  678999998532        23679999999999999997         


Q ss_pred             ------EEEeecCCCccccccccccc-----------------------------------CCCCCCHHHHHHHHHHHHH
Q 044997          347 ------FISTFGNGSLSDHLHDPLLK-----------------------------------GHQPLTWTARTQIALDAAK  385 (563)
Q Consensus       347 ------V~e~~~~gsL~~~L~~~~~~-----------------------------------~~~~l~~~~~~~i~~~ia~  385 (563)
                            |+||+++|+|.+++......                                   ....+++..+..++.|++.
T Consensus       100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~  179 (345)
T 3hko_A          100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS  179 (345)
T ss_dssp             SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred             CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence                  57999999999988521100                                   0122457778899999999


Q ss_pred             HHHHHHhcCCCceEeCCCCCCCeEecCCC--cEEEeecCCCccccccccc-ccccccccCCCcccCcccccccccccccc
Q 044997          386 GIEYIHDHTKARYVHRDIKTSNILLDDGL--RAKVADFGLVKLEERTNEK-EMLATRLVGTPGYLPPEYIFVKRFRFDMH  462 (563)
Q Consensus       386 gL~yLH~~~~~~ivHrDLk~~NILl~~~~--~~kl~DFGla~~~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~~~  462 (563)
                      ||+|||+++   |+||||||+|||++.++  .+||+|||+++........ ........||+.|+|||.+.+.       
T Consensus       180 ~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------  249 (345)
T 3hko_A          180 ALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTT-------  249 (345)
T ss_dssp             HHHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCS-------
T ss_pred             HHHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccC-------
Confidence            999999997   99999999999998776  8999999999865432221 1123346799999999988532       


Q ss_pred             cccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCC--------------chhhHHHHHHHHHHHHHhhccCCCCCCCH
Q 044997          463 SSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE--------------PTKMKSLITIMAAVAEWCLNEDAVDRPEM  528 (563)
Q Consensus       463 ~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~--------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~  528 (563)
                          ...++.++||||||+++|||++|+.||......              ......+.+.+.+++.+||+.||.+||++
T Consensus       250 ----~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  325 (345)
T 3hko_A          250 ----NESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDA  325 (345)
T ss_dssp             ----SSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCH
T ss_pred             ----CCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCH
Confidence                234588999999999999999999999654321              11122345679999999999999999999


Q ss_pred             HHHHH
Q 044997          529 RDIVA  533 (563)
Q Consensus       529 ~evl~  533 (563)
                      .|+++
T Consensus       326 ~~~l~  330 (345)
T 3hko_A          326 MRALQ  330 (345)
T ss_dssp             HHHHH
T ss_pred             HHHhc
Confidence            99987

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=1.7e-37  Score=317.73  Aligned_cols=219  Identities=22%  Similarity=0.340  Sum_probs=183.2

Q ss_pred             hcCCCccceecccCcEEEEEEEEC--CceEEEEEeccCC---------hHHHHHHHHHHHhccccce-------------
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNK---------SKEFFAELKVLCKIHHINV-------------  346 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~---------~~~f~~Ei~~l~~l~H~ni-------------  346 (563)
                      .++|+..+.||+|+||.||+++..  ++.+|+|.++...         .+++.+|++++++++||||             
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            356889999999999999999884  7889999986432         4679999999999999997             


Q ss_pred             --EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCC----cEEEee
Q 044997          347 --FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGL----RAKVAD  420 (563)
Q Consensus       347 --V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~----~~kl~D  420 (563)
                        |+||+++|+|.+++..     ...+++..+..++.|++.||+|||+++   ++||||||+|||++.++    .+||+|
T Consensus        91 ~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~D  162 (321)
T 2a2a_A           91 VLILELVSGGELFDFLAQ-----KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLID  162 (321)
T ss_dssp             EEEECCCCSCBHHHHHHT-----CSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred             EEEEEcCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEcc
Confidence              5789999999999864     356899999999999999999999997   99999999999999887    899999


Q ss_pred             cCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc
Q 044997          421 FGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP  500 (563)
Q Consensus       421 FGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~  500 (563)
                      ||+++......    ......||+.|+|||.+.+..             ++.++||||||+++|||++|+.||.......
T Consensus       163 fg~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~-------------~~~~~Di~slG~il~~l~~g~~pf~~~~~~~  225 (321)
T 2a2a_A          163 FGLAHEIEDGV----EFKNIFGTPEFVAPEIVNYEP-------------LGLEADMWSIGVITYILLSGASPFLGDTKQE  225 (321)
T ss_dssp             CTTCEECCTTC----CCCCCCSCGGGCCHHHHTTCC-------------CCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH
T ss_pred             CccceecCccc----cccccCCCCCccCcccccCCC-------------CCCccccHHHHHHHHHHHHCCCCCCCCCHHH
Confidence            99998654322    123456899999999885443             4889999999999999999999996543211


Q ss_pred             --------------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          501 --------------TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       501 --------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                                    .........+.+++.+||+.||.+|||+.|+++.
T Consensus       226 ~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h  273 (321)
T 2a2a_A          226 TLANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRH  273 (321)
T ss_dssp             HHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred             HHHHHHhcccccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                          1112344568999999999999999999999873

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=6.9e-38  Score=318.59  Aligned_cols=229  Identities=24%  Similarity=0.378  Sum_probs=177.6

Q ss_pred             cCCCccceecccCcEEEEEEEE--CCceEEEEEeccC------ChHHHHHHHHHHHhccccce---------------EE
Q 044997          292 NNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSN------KSKEFFAELKVLCKIHHINV---------------FI  348 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~------~~~~f~~Ei~~l~~l~H~ni---------------V~  348 (563)
                      ++|...+.||+|+||.||+|..  +++.||||+++..      ..+++.+|++++++++||||               |+
T Consensus        32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  111 (310)
T 2wqm_A           32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL  111 (310)
T ss_dssp             GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence            5688999999999999999987  4789999998742      23568899999999999997               57


Q ss_pred             EeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccc
Q 044997          349 STFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEE  428 (563)
Q Consensus       349 e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~  428 (563)
                      ||+.+|+|.+++.... .....+++..++.++.|++.||.|||+++   ++||||||+||+++.++.+||+|||+++...
T Consensus       112 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~  187 (310)
T 2wqm_A          112 ELADAGDLSRMIKHFK-KQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS  187 (310)
T ss_dssp             ECCCSCBHHHHHHHHH-HTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred             ecCCCCCHHHHHHHhc-ccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence            9999999999886421 23467999999999999999999999997   9999999999999999999999999987654


Q ss_pred             cccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCchh------
Q 044997          429 RTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTK------  502 (563)
Q Consensus       429 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~~------  502 (563)
                      ....   ......|++.|+|||.+.+..             ++.++||||||+++|||++|+.||.........      
T Consensus       188 ~~~~---~~~~~~~~~~y~aPE~~~~~~-------------~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~  251 (310)
T 2wqm_A          188 SKTT---AAHSLVGTPYYMSPERIHENG-------------YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIE  251 (310)
T ss_dssp             --------------CCSSCCHHHHTTCC-------------CCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHH
T ss_pred             CCCc---cccccCCCeeEeChHHhCCCC-------------CCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhh
Confidence            3221   123356899999999875443             488999999999999999999999754332111      


Q ss_pred             --------hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhh
Q 044997          503 --------MKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMI  540 (563)
Q Consensus       503 --------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~  540 (563)
                              ...+.+.+.+++.+||+.||.+||++.++++.|+++..
T Consensus       252 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~  297 (310)
T 2wqm_A          252 QCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHA  297 (310)
T ss_dssp             TTCSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cccCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence                    12345679999999999999999999999999998864

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=8.7e-38  Score=324.24  Aligned_cols=215  Identities=23%  Similarity=0.351  Sum_probs=181.5

Q ss_pred             cCCCccceecccCcEEEEEEEEC--CceEEEEEeccC------ChHHHHHHHHHHHhccccce---------------EE
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSN------KSKEFFAELKVLCKIHHINV---------------FI  348 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~------~~~~f~~Ei~~l~~l~H~ni---------------V~  348 (563)
                      ++|+..+.||+|+||.||+++..  ++.||+|.++..      ..+.+.+|+++|++++||||               |+
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  120 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence            56888999999999999999984  789999998643      34678899999999999997               68


Q ss_pred             EeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccc
Q 044997          349 STFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEE  428 (563)
Q Consensus       349 e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~  428 (563)
                      ||+++|+|.+++..     ...+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus       121 e~~~gg~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~  192 (350)
T 1rdq_E          121 EYVAGGEMFSHLRR-----IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK  192 (350)
T ss_dssp             ECCTTCBHHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             cCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceecc
Confidence            99999999999975     246899999999999999999999998   9999999999999999999999999998653


Q ss_pred             cccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc--------
Q 044997          429 RTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP--------  500 (563)
Q Consensus       429 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~--------  500 (563)
                      ..      .....||+.|+|||++.+..+             +.++|||||||++|||++|+.||.......        
T Consensus       193 ~~------~~~~~gt~~y~aPE~~~~~~~-------------~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~  253 (350)
T 1rdq_E          193 GR------TWTLCGTPEALAPEIILSKGY-------------NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG  253 (350)
T ss_dssp             SC------BCCCEECGGGCCHHHHTTCCB-------------CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC
T ss_pred             CC------cccccCCccccCHHHhcCCCC-------------CCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcC
Confidence            21      223579999999999865544             889999999999999999999997543211        


Q ss_pred             --hhhHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 044997          501 --TKMKSLITIMAAVAEWCLNEDAVDRPE-----MRDIVA  533 (563)
Q Consensus       501 --~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~  533 (563)
                        ..+..+...+.+++.+||+.||.+||+     ++||++
T Consensus       254 ~~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~  293 (350)
T 1rdq_E          254 KVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             CCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             CCCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence              111234566899999999999999998     777755

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=5.8e-38  Score=328.41  Aligned_cols=215  Identities=23%  Similarity=0.335  Sum_probs=174.9

Q ss_pred             CccceecccCcEEEEEEEE--CCceEEEEEeccCC---hHHHHHHHHHHHhccccce---------------EEEeecCC
Q 044997          295 DESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNK---SKEFFAELKVLCKIHHINV---------------FISTFGNG  354 (563)
Q Consensus       295 ~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~---~~~f~~Ei~~l~~l~H~ni---------------V~e~~~~g  354 (563)
                      ...+.||+|+||.||+|+.  +++.||+|.++...   .+++.+|+++|++++||||               |+||+++|
T Consensus        92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~  171 (373)
T 2x4f_A           92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG  171 (373)
T ss_dssp             EEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred             ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence            3357899999999999987  47899999997653   4678999999999999997               57999999


Q ss_pred             CcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEe--cCCCcEEEeecCCCcccccccc
Q 044997          355 SLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILL--DDGLRAKVADFGLVKLEERTNE  432 (563)
Q Consensus       355 sL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl--~~~~~~kl~DFGla~~~~~~~~  432 (563)
                      +|.+++..    ....+++..+..++.|++.||+|||+++   |+||||||+|||+  +.++++||+|||+++...... 
T Consensus       172 ~L~~~l~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~-  243 (373)
T 2x4f_A          172 ELFDRIID----ESYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE-  243 (373)
T ss_dssp             EEHHHHHH----TGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC-
T ss_pred             cHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc-
Confidence            99998864    2346899999999999999999999998   9999999999999  667899999999998654332 


Q ss_pred             cccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCC-------------
Q 044997          433 KEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE-------------  499 (563)
Q Consensus       433 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~-------------  499 (563)
                         ......||+.|+|||++.+..             ++.++|||||||++|||++|+.||......             
T Consensus       244 ---~~~~~~gt~~y~aPE~~~~~~-------------~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~  307 (373)
T 2x4f_A          244 ---KLKVNFGTPEFLAPEVVNYDF-------------VSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDL  307 (373)
T ss_dssp             ---BCCCCCSSCTTCCHHHHTTCB-------------CCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCS
T ss_pred             ---ccccccCCCcEeChhhccCCC-------------CCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC
Confidence               123346999999999885444             478999999999999999999999754321             


Q ss_pred             -chhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          500 -PTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       500 -~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                       ......+.+.+.+++.+||+.||.+||++.|+++
T Consensus       308 ~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~  342 (373)
T 2x4f_A          308 EDEEFQDISEEAKEFISKLLIKEKSWRISASEALK  342 (373)
T ss_dssp             CSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence             1112345567999999999999999999999987

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=2.6e-38  Score=318.18  Aligned_cols=230  Identities=22%  Similarity=0.374  Sum_probs=179.0

Q ss_pred             cCCCccceecccCcEEEEEEEEC---C--ceEEEEEeccC------ChHHHHHHHHHHHhccccce--------------
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG---D--REAAIKKMRSN------KSKEFFAELKVLCKIHHINV--------------  346 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~---~--~~vavK~~~~~------~~~~f~~Ei~~l~~l~H~ni--------------  346 (563)
                      ++|+..+.||+|+||.||+|++.   +  ..||||.++..      ..+++.+|++++++++||||              
T Consensus        18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   97 (291)
T 1u46_A           18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKM   97 (291)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEE
T ss_pred             hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCCcee
Confidence            56888999999999999999863   2  25899998643      23678999999999999997              


Q ss_pred             EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcc
Q 044997          347 FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKL  426 (563)
Q Consensus       347 V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~  426 (563)
                      |+||+++|+|.+++...    ...+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+|||+++.
T Consensus        98 v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~  170 (291)
T 1u46_A           98 VTELAPLGSLLDRLRKH----QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA  170 (291)
T ss_dssp             EEECCTTCBHHHHHHHH----GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             eEecccCCCHHHHHHhc----cCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccccccc
Confidence            57899999999998752    245899999999999999999999997   99999999999999999999999999987


Q ss_pred             cccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCCCcCCCCC------
Q 044997          427 EERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIRDDSE------  499 (563)
Q Consensus       427 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p~~~~~~~------  499 (563)
                      ...............+|..|+|||.+.+..+             +.++||||||+++|||++ |+.||......      
T Consensus       171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-------------~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~  237 (291)
T 1u46_A          171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTF-------------SHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI  237 (291)
T ss_dssp             CCC-CCEEEC-----CCGGGCCHHHHHHCEE-------------EHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH
T ss_pred             ccccccchhhhccCCCCceeeCchhhcCCCC-------------CchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHH
Confidence            6543332222334567889999998865544             789999999999999999 99998654321      


Q ss_pred             ------chhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 044997          500 ------PTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMIT  541 (563)
Q Consensus       500 ------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~  541 (563)
                            ......++..+.+++.+||+.||.+||++.++++.|+++...
T Consensus       238 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  285 (291)
T 1u46_A          238 DKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT  285 (291)
T ss_dssp             HTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred             HccCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence                  111223456789999999999999999999999999988654

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=4.9e-38  Score=330.48  Aligned_cols=224  Identities=22%  Similarity=0.341  Sum_probs=169.8

Q ss_pred             HHhcCCCccceecccCcEEEEEEEE--CCceEEEEEeccC-----ChHHHHHHHHHHHhcc-ccce--------------
Q 044997          289 EATNNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSN-----KSKEFFAELKVLCKIH-HINV--------------  346 (563)
Q Consensus       289 ~~~~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~-----~~~~f~~Ei~~l~~l~-H~ni--------------  346 (563)
                      ...++|+..+.||+|+||.||+|..  .++.||||++...     ..+.+.+|+.+|.++. ||||              
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~   85 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD   85 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence            3467899999999999999999987  4789999998543     2356789999999997 9997              


Q ss_pred             ---EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCC
Q 044997          347 ---FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGL  423 (563)
Q Consensus       347 ---V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGl  423 (563)
                         |+||++ |+|.+++..      ..+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+
T Consensus        86 ~~lv~e~~~-~~L~~~~~~------~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~  155 (388)
T 3oz6_A           86 VYLVFDYME-TDLHAVIRA------NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGL  155 (388)
T ss_dssp             EEEEEECCS-EEHHHHHHH------TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             EEEEecccC-cCHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCcc
Confidence               456666 577777653      46899999999999999999999998   99999999999999999999999999


Q ss_pred             Cccccccc------------------ccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHH
Q 044997          424 VKLEERTN------------------EKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAE  485 (563)
Q Consensus       424 a~~~~~~~------------------~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~E  485 (563)
                      ++......                  ......+..+||+.|+|||++.+.            ..++.++|||||||++||
T Consensus       156 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------------~~~~~~~DiwSlG~il~e  223 (388)
T 3oz6_A          156 SRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGS------------TKYTKGIDMWSLGCILGE  223 (388)
T ss_dssp             CEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTC------------CCCCTHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCC------------CCCCChhhHHHHHHHHHH
Confidence            98643210                  011123446899999999988542            235899999999999999


Q ss_pred             HHcCCCCCcCCCCCchhh--------------------------------------------H-------------HHHH
Q 044997          486 LITGKRALIRDDSEPTKM--------------------------------------------K-------------SLIT  508 (563)
Q Consensus       486 lltg~~p~~~~~~~~~~~--------------------------------------------~-------------~~~~  508 (563)
                      |++|+.||.+........                                            .             ...+
T Consensus       224 ll~g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (388)
T 3oz6_A          224 ILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNE  303 (388)
T ss_dssp             HHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCH
T ss_pred             HHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCH
Confidence            999999996543210000                                            0             1234


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          509 IMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       509 ~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                      .+.+|+.+||+.||.+|||+.|+++.
T Consensus       304 ~~~dll~~~L~~dP~~R~t~~e~l~H  329 (388)
T 3oz6_A          304 EALDLLDKLLQFNPNKRISANDALKH  329 (388)
T ss_dssp             HHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             HHHHHHHHhhccCcccCCCHHHHhCC
Confidence            58899999999999999999999875

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=1.2e-37  Score=317.54  Aligned_cols=238  Identities=21%  Similarity=0.259  Sum_probs=188.0

Q ss_pred             hcCCCccceecccCcEEEEEEEE--CCceEEEEEeccCC---hHHHHHHHHHHHhccccce-------------------
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNK---SKEFFAELKVLCKIHHINV-------------------  346 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~---~~~f~~Ei~~l~~l~H~ni-------------------  346 (563)
                      .++|+..+.||+|+||.||+++.  +++.||||++....   .+.+.+|++++++++||||                   
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  107 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL  107 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence            35788999999999999999986  57899999986543   4668899999999999997                   


Q ss_pred             EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcc
Q 044997          347 FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKL  426 (563)
Q Consensus       347 V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~  426 (563)
                      |+||+.+|+|.+++.... .....+++.+++.++.|++.||+|||+++   ++||||||+|||++.++.+||+|||+++.
T Consensus       108 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~  183 (317)
T 2buj_A          108 LLPFFKRGTLWNEIERLK-DKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQ  183 (317)
T ss_dssp             EEECCTTCBHHHHHHHHH-TTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred             EEEeCCCCcHHHHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence            468889999999887522 23467999999999999999999999997   99999999999999999999999999875


Q ss_pred             cccccccc------cccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCC---C
Q 044997          427 EERTNEKE------MLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRD---D  497 (563)
Q Consensus       427 ~~~~~~~~------~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~---~  497 (563)
                      ........      .......||+.|+|||.+....          ...+++++||||||+++|||++|+.||...   .
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----------~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~  253 (317)
T 2buj_A          184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQS----------HCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG  253 (317)
T ss_dssp             SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCS----------EEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTT
T ss_pred             cccccccccccccccccccccCCcccCCHhHhccCC----------CcCCCchhhHHHHHHHHHHHHhCCCChhhhhccc
Confidence            43211100      0112345799999999885432          122478999999999999999999998431   1


Q ss_pred             CC----------chhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcC
Q 044997          498 SE----------PTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITS  542 (563)
Q Consensus       498 ~~----------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~  542 (563)
                      ..          ..........+.+++.+||+.||.+||++.++++.|+.+....
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~  308 (317)
T 2buj_A          254 DSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPA  308 (317)
T ss_dssp             SCHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCC
T ss_pred             chhhHHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCC
Confidence            00          0111234566899999999999999999999999999886543

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=9.3e-38  Score=312.42  Aligned_cols=219  Identities=24%  Similarity=0.435  Sum_probs=165.6

Q ss_pred             cCCCccceecccCcEEEEEEEE--CCceEEEEEeccC------ChHHHHHHHHHHHhccccce---------------EE
Q 044997          292 NNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSN------KSKEFFAELKVLCKIHHINV---------------FI  348 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~------~~~~f~~Ei~~l~~l~H~ni---------------V~  348 (563)
                      ++|...+.||+|+||.||+|+.  +++.||||.+...      ..+.+.+|++++++++||||               |+
T Consensus        11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   90 (278)
T 3cok_A           11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL   90 (278)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence            5688899999999999999987  5789999998643      23678999999999999997               57


Q ss_pred             EeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccc
Q 044997          349 STFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEE  428 (563)
Q Consensus       349 e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~  428 (563)
                      ||+++|+|.+++..    ....+++..+..++.|++.||+|||+++   ++||||||+||+++.++.+||+|||+++...
T Consensus        91 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~  163 (278)
T 3cok_A           91 EMCHNGEMNRYLKN----RVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLK  163 (278)
T ss_dssp             ECCTTEEHHHHHHT----CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             ecCCCCcHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence            99999999999875    2357999999999999999999999997   9999999999999999999999999998654


Q ss_pred             cccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc--------
Q 044997          429 RTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP--------  500 (563)
Q Consensus       429 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~--------  500 (563)
                      ....   ......||+.|+|||.+.+..             ++.++||||||+++|||++|+.||.......        
T Consensus       164 ~~~~---~~~~~~~~~~y~aPE~~~~~~-------------~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~  227 (278)
T 3cok_A          164 MPHE---KHYTLCGTPNYISPEIATRSA-------------HGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLA  227 (278)
T ss_dssp             --------------------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSS
T ss_pred             CCCC---cceeccCCCCcCCcchhcCCC-------------CCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhc
Confidence            3221   122356899999999885543             3789999999999999999999986543211        


Q ss_pred             --hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          501 --TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       501 --~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                        .....+...+.+++.+||+.||.+||++.++++
T Consensus       228 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          228 DYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             ccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence              112234567899999999999999999999986

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=3.4e-37  Score=321.26  Aligned_cols=222  Identities=23%  Similarity=0.354  Sum_probs=179.3

Q ss_pred             hcCCCccceecccCcEEEEEEEEC--CceEEEEEeccCC----hHHHHHHHHHHHhccccceE-----------------
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNK----SKEFFAELKVLCKIHHINVF-----------------  347 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~----~~~f~~Ei~~l~~l~H~niV-----------------  347 (563)
                      .++|+..+.||+|+||.||+|+..  ++.||||++....    .+.+.+|+++|++++||||+                 
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  105 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV  105 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence            457999999999999999999874  6789999997533    25688999999999999973                 


Q ss_pred             ---EEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCC
Q 044997          348 ---ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLV  424 (563)
Q Consensus       348 ---~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla  424 (563)
                         +||++ |+|.+++..      ..+++.++..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++
T Consensus       106 ~iv~e~~~-~~L~~~l~~------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a  175 (364)
T 3qyz_A          106 YIVQDLME-TDLYKLLKT------QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLA  175 (364)
T ss_dssp             EEEEECCS-EEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEcccC-cCHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcce
Confidence               34444 567776643      45999999999999999999999997   999999999999999999999999999


Q ss_pred             cccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCchhh-
Q 044997          425 KLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKM-  503 (563)
Q Consensus       425 ~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~~~-  503 (563)
                      +................||+.|+|||++.+..            .++.++|||||||++|||++|+.||.......... 
T Consensus       176 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------------~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~  243 (364)
T 3qyz_A          176 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSK------------GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNH  243 (364)
T ss_dssp             EECCGGGCBCCTTCCCCSCGGGCCHHHHHTBC------------SCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHH
T ss_pred             EecCCCCCccccccccccccCCCCCHHhcCCC------------CCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHH
Confidence            87654333222334568999999999864332            35899999999999999999999996544221100 


Q ss_pred             ----------------------------------------HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          504 ----------------------------------------KSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       504 ----------------------------------------~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                                                              ......+.+|+.+||+.||.+|||+.|+++.
T Consensus       244 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  314 (364)
T 3qyz_A          244 ILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  314 (364)
T ss_dssp             HHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                                                    1123558899999999999999999999873

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.3e-37  Score=316.56  Aligned_cols=220  Identities=22%  Similarity=0.341  Sum_probs=175.9

Q ss_pred             cCCCccceecccCcEEEEEEEEC--CceEEEEEeccCC-----hHHHHHHHHHHHhccccce---------------EEE
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNK-----SKEFFAELKVLCKIHHINV---------------FIS  349 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~-----~~~f~~Ei~~l~~l~H~ni---------------V~e  349 (563)
                      ++|+..+.||+|+||.||+|+..  ++.||||++....     .+.+.+|++++++++||||               |+|
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE   82 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence            67889999999999999999984  7889999986543     3567899999999999997               578


Q ss_pred             eecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccccc
Q 044997          350 TFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEER  429 (563)
Q Consensus       350 ~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~  429 (563)
                      |+++++|.+++..     ...+++..+..++.|++.||+|||+++   ++||||||+|||++.++.+||+|||+++....
T Consensus        83 ~~~~~~l~~~~~~-----~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  154 (311)
T 4agu_A           83 YCDHTVLHELDRY-----QRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTG  154 (311)
T ss_dssp             CCSEEHHHHHHHT-----SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred             eCCCchHHHHHhh-----hcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccC
Confidence            8888888887754     356999999999999999999999997   99999999999999999999999999986543


Q ss_pred             ccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCchh-------
Q 044997          430 TNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTK-------  502 (563)
Q Consensus       430 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~~-------  502 (563)
                      ...   ......||..|+|||.+.+.            ..++.++||||||+++|||++|+.||.........       
T Consensus       155 ~~~---~~~~~~~~~~y~aPE~~~~~------------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~  219 (311)
T 4agu_A          155 PSD---YYDDEVATRWYRSPELLVGD------------TQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTL  219 (311)
T ss_dssp             --------------GGGCCHHHHHTC------------SCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred             ccc---ccCCCcCCccccChHHHhcC------------CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence            221   22345789999999987542            23589999999999999999999998654321100       


Q ss_pred             ----------------------------------hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          503 ----------------------------------MKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       503 ----------------------------------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                                                        ...+...+.+++.+||+.||.+|||++|+++.
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  285 (311)
T 4agu_A          220 GDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH  285 (311)
T ss_dssp             CSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred             cccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence                                              01233457899999999999999999999863

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=1.6e-37  Score=318.70  Aligned_cols=235  Identities=28%  Similarity=0.450  Sum_probs=188.0

Q ss_pred             cCCCccceecccCcEEEEEEEE--CCce--EEEEEeccC----ChHHHHHHHHHHHhc-cccce---------------E
Q 044997          292 NNFDESRIIGRGGFGNVYFGLL--GDRE--AAIKKMRSN----KSKEFFAELKVLCKI-HHINV---------------F  347 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~--~~~~--vavK~~~~~----~~~~f~~Ei~~l~~l-~H~ni---------------V  347 (563)
                      ++|+..+.||+|+||.||+|+.  ++..  +|+|.++..    ..+.+.+|+++++++ +||||               |
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv  104 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA  104 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence            5688899999999999999986  3444  499988643    235689999999999 99997               5


Q ss_pred             EEeecCCCcccccccccc-----------cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcE
Q 044997          348 ISTFGNGSLSDHLHDPLL-----------KGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRA  416 (563)
Q Consensus       348 ~e~~~~gsL~~~L~~~~~-----------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~  416 (563)
                      +||+++|+|.+++.....           .....+++.+++.++.|++.||+|||+++   ++||||||+|||++.++.+
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~  181 (327)
T 1fvr_A          105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA  181 (327)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred             EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence            799999999999975320           11347999999999999999999999997   9999999999999999999


Q ss_pred             EEeecCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCCCcC
Q 044997          417 KVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIR  495 (563)
Q Consensus       417 kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p~~~  495 (563)
                      ||+|||+++......    ......+++.|+|||.+.+..+             +.++||||||+++|||++ |+.||..
T Consensus       182 kL~Dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~-------------~~~~Di~slG~il~ellt~g~~pf~~  244 (327)
T 1fvr_A          182 KIADFGLSRGQEVYV----KKTMGRLPVRWMAIESLNYSVY-------------TTNSDVWSYGVLLWEIVSLGGTPYCG  244 (327)
T ss_dssp             EECCTTCEESSCEEC----CC----CCTTTCCHHHHHHCEE-------------CHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred             EEcccCcCccccccc----cccCCCCCccccChhhhccccC-------------CchhcchHHHHHHHHHHcCCCCCCCC
Confidence            999999987432211    1223457889999998865544             789999999999999998 9999865


Q ss_pred             CCCC-----------chhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcChhhh
Q 044997          496 DDSE-----------PTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITSTEWE  546 (563)
Q Consensus       496 ~~~~-----------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~w~  546 (563)
                      ....           ......+.+.+.+++.+||+.||.+||++.|+++.|.+++.....+.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~  306 (327)
T 1fvr_A          245 MTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYV  306 (327)
T ss_dssp             CCHHHHHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSCSB
T ss_pred             CcHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcCcc
Confidence            4321           11122345678999999999999999999999999999988665443

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=4e-37  Score=307.08  Aligned_cols=222  Identities=24%  Similarity=0.399  Sum_probs=184.7

Q ss_pred             hcCCCccceecccCcEEEEEEEEC--CceEEEEEeccCC----hHHHHHHHHHHHhccccce---------------EEE
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNK----SKEFFAELKVLCKIHHINV---------------FIS  349 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~----~~~f~~Ei~~l~~l~H~ni---------------V~e  349 (563)
                      .++|+..+.||+|+||.||+|...  ++.||||.++...    .+.+.+|++++++++||||               |+|
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence            467889999999999999999884  7889999986432    3678999999999999997               579


Q ss_pred             eecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccccc
Q 044997          350 TFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEER  429 (563)
Q Consensus       350 ~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~  429 (563)
                      |+++|+|.+++..     ...+++..+..++.|++.||+|||+++   ++||||||+||+++.++.+||+|||+++....
T Consensus        86 ~~~~~~L~~~l~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~  157 (276)
T 2yex_A           86 YCSGGELFDRIEP-----DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRY  157 (276)
T ss_dssp             CCTTEEGGGGSBT-----TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred             ecCCCcHHHHHhh-----ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCC
Confidence            9999999998864     356899999999999999999999997   99999999999999999999999999986543


Q ss_pred             ccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCch--------
Q 044997          430 TNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPT--------  501 (563)
Q Consensus       430 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~--------  501 (563)
                      ... ........||+.|+|||.+.+..+            .+.++||||||+++|||++|+.||........        
T Consensus       158 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~------------~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~  224 (276)
T 2yex_A          158 NNR-ERLLNKMCGTLPYVAPELLKRREF------------HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK  224 (276)
T ss_dssp             TTE-ECCBCCCCSCGGGCCGGGGTCSSB------------CHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTT
T ss_pred             Ccc-hhcccCCccccCccChHHHhcCCC------------CCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhc
Confidence            221 112334678999999998864432            26789999999999999999999976543221        


Q ss_pred             -----hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          502 -----KMKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       502 -----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                           ....+.+.+.+++.+||+.||.+|||+.|+++
T Consensus       225 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          225 KTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             CTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ccccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence                 12234567899999999999999999999986

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.5e-37  Score=321.36  Aligned_cols=230  Identities=23%  Similarity=0.328  Sum_probs=173.4

Q ss_pred             cCCCccceecccCcEEEEEEEEC-CceEEEEEeccCC-----hHHHHHHHHHHHhccc--cce---------------EE
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG-DREAAIKKMRSNK-----SKEFFAELKVLCKIHH--INV---------------FI  348 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~vavK~~~~~~-----~~~f~~Ei~~l~~l~H--~ni---------------V~  348 (563)
                      ++|+..+.||+|+||.||++... ++.||||+++...     .+.+.+|+++|.+++|  +||               |+
T Consensus         9 ~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~   88 (343)
T 3dbq_A            9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM   88 (343)
T ss_dssp             CEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             CEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEE
Confidence            46888999999999999999874 6789999986432     2568899999999987  887               35


Q ss_pred             EeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccc
Q 044997          349 STFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEE  428 (563)
Q Consensus       349 e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~  428 (563)
                      | +.+|+|.+++..     ...+++.++..++.|++.||+|||+++   |+||||||+|||++ ++.+||+|||+++...
T Consensus        89 e-~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~  158 (343)
T 3dbq_A           89 E-CGNIDLNSWLKK-----KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQ  158 (343)
T ss_dssp             C-CCSEEHHHHHHH-----SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC-
T ss_pred             e-CCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccC
Confidence            5 567889888865     356999999999999999999999997   99999999999997 5789999999998654


Q ss_pred             cccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCchhh-----
Q 044997          429 RTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKM-----  503 (563)
Q Consensus       429 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~~~-----  503 (563)
                      .... ........||+.|+|||++.+.....  ........++.++|||||||++|||++|+.||..........     
T Consensus       159 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~--~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~  235 (343)
T 3dbq_A          159 PDTT-SVVKDSQVGTVNYMPPEAIKDMSSSR--ENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID  235 (343)
T ss_dssp             ------------CCCCSSCCHHHHHHCC-------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHC
T ss_pred             cccc-cccCCCCcCCcCcCCHHHHhhccccc--cccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhc
Confidence            3321 11223467999999999986422100  000112456899999999999999999999996533221111     


Q ss_pred             --------HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          504 --------KSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       504 --------~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                              ......+.+++.+||+.||.+|||+.|+++.
T Consensus       236 ~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h  274 (343)
T 3dbq_A          236 PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  274 (343)
T ss_dssp             TTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             CCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence                    1122458899999999999999999999874

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=2e-37  Score=310.84  Aligned_cols=219  Identities=23%  Similarity=0.368  Sum_probs=181.9

Q ss_pred             hcCCCccceecccCcEEEEEEEEC--CceEEEEEeccCC-----hHHHHHHHHHHHhccccce---------------EE
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNK-----SKEFFAELKVLCKIHHINV---------------FI  348 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~-----~~~f~~Ei~~l~~l~H~ni---------------V~  348 (563)
                      .++|+..+.||+|+||.||+|...  ++.||+|.+....     .+.+.+|++++++++||||               |+
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   84 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   84 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence            468999999999999999999874  7889999986542     3568899999999999997               57


Q ss_pred             EeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCc---EEEeecCCCc
Q 044997          349 STFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLR---AKVADFGLVK  425 (563)
Q Consensus       349 e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~---~kl~DFGla~  425 (563)
                      ||+.+|+|.+++..     ...+++..+..++.|++.||+|||+++   ++||||||+||+++.++.   +||+|||++.
T Consensus        85 e~~~~~~l~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~  156 (284)
T 3kk8_A           85 DLVTGGELFEDIVA-----REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAI  156 (284)
T ss_dssp             CCCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred             ecCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeE
Confidence            88999999888865     256899999999999999999999997   999999999999986655   9999999997


Q ss_pred             ccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc-----
Q 044997          426 LEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP-----  500 (563)
Q Consensus       426 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~-----  500 (563)
                      ......    ......||+.|+|||.+.+..             ++.++||||||+++|||++|+.||.......     
T Consensus       157 ~~~~~~----~~~~~~~~~~y~aPE~~~~~~-------------~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~  219 (284)
T 3kk8_A          157 EVNDSE----AWHGFAGTPGYLSPEVLKKDP-------------YSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI  219 (284)
T ss_dssp             ECCSSC----BCCCSCSCGGGCCHHHHTTCC-------------BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             EcccCc----cccCCCCCcCCcCchhhcCCC-------------CCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHH
Confidence            654322    123357899999999886544             3889999999999999999999996543211     


Q ss_pred             ---------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          501 ---------TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       501 ---------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                               .....+.+.+.+++.+||+.||++||++.|+++.
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  262 (284)
T 3kk8_A          220 KAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  262 (284)
T ss_dssp             HHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             HhccccCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence                     1112345678999999999999999999999873

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.3e-37  Score=317.06  Aligned_cols=229  Identities=24%  Similarity=0.310  Sum_probs=180.6

Q ss_pred             hcCCCccceecccCcEEEEEEEE--CCceEEEEEeccCC------hHHHHHHHHHHHhccccce---------------E
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNK------SKEFFAELKVLCKIHHINV---------------F  347 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~------~~~f~~Ei~~l~~l~H~ni---------------V  347 (563)
                      .++|...+.||+|+||.||+|+.  +++.||+|.++...      .+.+.+|++++++++||||               |
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  112 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD  112 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence            47899999999999999999987  47889999987542      2568899999999999997               5


Q ss_pred             EEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccc
Q 044997          348 ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLE  427 (563)
Q Consensus       348 ~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~  427 (563)
                      +||+++++|.+++..     ...+++.++..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus       113 ~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~  184 (309)
T 2h34_A          113 MRLINGVDLAAMLRR-----QGPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASAT  184 (309)
T ss_dssp             EECCCCEEHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC----
T ss_pred             EEecCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCccc
Confidence            788999999999875     246999999999999999999999997   999999999999999999999999998765


Q ss_pred             ccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCC--------
Q 044997          428 ERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE--------  499 (563)
Q Consensus       428 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~--------  499 (563)
                      .....  .......|++.|+|||.+.+..             ++.++||||||+++|||++|+.||......        
T Consensus       185 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~-------------~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~  249 (309)
T 2h34_A          185 TDEKL--TQLGNTVGTLYYMAPERFSESH-------------ATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQ  249 (309)
T ss_dssp             --------------CCGGGCCGGGTCC-----------------CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHS
T ss_pred             ccccc--ccccccCCCcCccCHHHHcCCC-------------CCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhcc
Confidence            43221  1223456899999999886544             478999999999999999999999654321        


Q ss_pred             -----chhhHHHHHHHHHHHHHhhccCCCCCC-CHHHHHHHHHHhhhcC
Q 044997          500 -----PTKMKSLITIMAAVAEWCLNEDAVDRP-EMRDIVAILSQIMITS  542 (563)
Q Consensus       500 -----~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~i~~~~  542 (563)
                           ......++..+.+++.+||+.||++|| +++++++.|++++...
T Consensus       250 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~  298 (309)
T 2h34_A          250 AIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA  298 (309)
T ss_dssp             CCCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred             CCCCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence                 011123455689999999999999999 9999999999887654

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=1.4e-37  Score=335.02  Aligned_cols=218  Identities=25%  Similarity=0.412  Sum_probs=184.2

Q ss_pred             cCCCccceecccCcEEEEEEEEC--CceEEEEEeccC------ChHHHHHHHHHHHhccccce---------------EE
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSN------KSKEFFAELKVLCKIHHINV---------------FI  348 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~------~~~~f~~Ei~~l~~l~H~ni---------------V~  348 (563)
                      ++|...+.||+|+||.||+|+..  ++.||||.++..      ..+.+.+|+++|++++||||               |+
T Consensus        16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~   95 (476)
T 2y94_A           16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM   95 (476)
T ss_dssp             TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            56888999999999999999884  789999998643      23578899999999999997               57


Q ss_pred             EeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccc
Q 044997          349 STFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEE  428 (563)
Q Consensus       349 e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~  428 (563)
                      ||+++|+|.+++..     ...+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus        96 E~~~gg~L~~~l~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~  167 (476)
T 2y94_A           96 EYVSGGELFDYICK-----NGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMS  167 (476)
T ss_dssp             ECCSSEEHHHHTTS-----SSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred             eCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhcc
Confidence            99999999999864     356999999999999999999999997   9999999999999999999999999998654


Q ss_pred             cccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCch-------
Q 044997          429 RTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPT-------  501 (563)
Q Consensus       429 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~-------  501 (563)
                      ...    ......||+.|+|||++.+..+            .+.++|||||||++|||++|+.||........       
T Consensus       168 ~~~----~~~~~~gt~~y~aPE~~~~~~~------------~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~  231 (476)
T 2y94_A          168 DGE----FLRTSCGSPNYAAPEVISGRLY------------AGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDG  231 (476)
T ss_dssp             TTC----CBCCCCSCSTTCCHHHHTTCCB------------CSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTT
T ss_pred             ccc----cccccCCCcCeEChhhccCCCC------------CCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcC
Confidence            322    2234579999999999865543            26799999999999999999999975443211       


Q ss_pred             ---hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          502 ---KMKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       502 ---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                         ....+.+.+.+|+.+||+.||.+|||+.|+++
T Consensus       232 ~~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~  266 (476)
T 2y94_A          232 IFYTPQYLNPSVISLLKHMLQVDPMKRATIKDIRE  266 (476)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CcCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence               11123456899999999999999999999987

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=2.2e-37  Score=310.29  Aligned_cols=223  Identities=23%  Similarity=0.378  Sum_probs=182.2

Q ss_pred             cCCCccceecccCcEEEEEEEEC--CceEEEEEeccC---------ChHHHHHHHHHHHhccccce--------------
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSN---------KSKEFFAELKVLCKIHHINV--------------  346 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~---------~~~~f~~Ei~~l~~l~H~ni--------------  346 (563)
                      ++|...+.||+|+||.||+++..  ++.+|+|.++..         ..+.+.+|++++++++||||              
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV   84 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence            56888999999999999999985  789999998643         24679999999999999997              


Q ss_pred             -EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCC----cEEEeec
Q 044997          347 -FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGL----RAKVADF  421 (563)
Q Consensus       347 -V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~----~~kl~DF  421 (563)
                       |+||+++++|.+++..     ...+++..+..++.|++.||.|||+++   ++||||||+||+++.++    ++||+||
T Consensus        85 lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~df  156 (283)
T 3bhy_A           85 LILELVSGGELFDFLAE-----KESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDF  156 (283)
T ss_dssp             EEEECCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCC
T ss_pred             EEEeecCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEec
Confidence             5799999999999864     246899999999999999999999997   99999999999998877    8999999


Q ss_pred             CCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc-
Q 044997          422 GLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP-  500 (563)
Q Consensus       422 Gla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~-  500 (563)
                      |+++......    ......|++.|+|||.+.+..             ++.++||||||+++|||++|+.||....... 
T Consensus       157 g~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~-------------~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~  219 (283)
T 3bhy_A          157 GIAHKIEAGN----EFKNIFGTPEFVAPEIVNYEP-------------LGLEADMWSIGVITYILLSGASPFLGETKQET  219 (283)
T ss_dssp             TTCEECC------------CCCGGGCCHHHHTTCC-------------CCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH
T ss_pred             ccceeccCCC----cccccCCCcCccCcceecCCC-------------CCcchhhhhHHHHHHHHHHCCCCCCCcchHHH
Confidence            9998654322    123356899999999875443             4889999999999999999999986543211 


Q ss_pred             -------------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH--HHHHhh
Q 044997          501 -------------TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVA--ILSQIM  539 (563)
Q Consensus       501 -------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~i~  539 (563)
                                   .......+.+.+++.+||+.||.+||++.|+++  .++.+.
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  273 (283)
T 3bhy_A          220 LTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIR  273 (283)
T ss_dssp             HHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHH
T ss_pred             HHHhHhcccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHH
Confidence                         111233456899999999999999999999997  345443

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=2.6e-37  Score=332.61  Aligned_cols=216  Identities=23%  Similarity=0.327  Sum_probs=169.9

Q ss_pred             hcCCCccceecccCcEEEEEEEE--CCceEEEEEeccC-----ChHHHHHHHHHHHhccccceE----------------
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSN-----KSKEFFAELKVLCKIHHINVF----------------  347 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~-----~~~~f~~Ei~~l~~l~H~niV----------------  347 (563)
                      .++|+..+.||+|+||.||+|+.  .++.||||++...     ..+++.+|+++|++++|||||                
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            46799999999999999999987  4788999999643     236688999999999999983                


Q ss_pred             -----EEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecC
Q 044997          348 -----ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFG  422 (563)
Q Consensus       348 -----~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFG  422 (563)
                           +||+++ +|.+.+.       ..+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||
T Consensus       141 ~~~lv~E~~~~-~l~~~~~-------~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG  209 (464)
T 3ttj_A          141 DVYLVMELMDA-NLCQVIQ-------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG  209 (464)
T ss_dssp             EEEEEEECCSE-EHHHHHT-------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCC
T ss_pred             eEEEEEeCCCC-CHHHHHh-------hcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEE
Confidence                 455443 3433332       24899999999999999999999997   9999999999999999999999999


Q ss_pred             CCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCch-
Q 044997          423 LVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPT-  501 (563)
Q Consensus       423 la~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~-  501 (563)
                      +++.....    ...+..+||+.|+|||++.+..             ++.++|||||||++|||++|+.||.+.+.... 
T Consensus       210 ~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~-------------~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~  272 (464)
T 3ttj_A          210 LARTAGTS----FMMTPYVVTRYYRAPEVILGMG-------------YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQW  272 (464)
T ss_dssp             CC-----C----CCC----CCCTTCCHHHHTTCC-------------CCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred             eeeecCCC----cccCCCcccccccCHHHHcCCC-------------CCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            99865432    1234467999999999986554             48899999999999999999999975431100 


Q ss_pred             ---------------------------------------------------hhHHHHHHHHHHHHHhhccCCCCCCCHHH
Q 044997          502 ---------------------------------------------------KMKSLITIMAAVAEWCLNEDAVDRPEMRD  530 (563)
Q Consensus       502 ---------------------------------------------------~~~~~~~~l~~li~~cl~~dP~~RPs~~e  530 (563)
                                                                         ........+.+|+.+||+.||.+|||+.|
T Consensus       273 ~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e  352 (464)
T 3ttj_A          273 NKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDD  352 (464)
T ss_dssp             HHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred             HHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHH
Confidence                                                               00111456899999999999999999999


Q ss_pred             HHHH
Q 044997          531 IVAI  534 (563)
Q Consensus       531 vl~~  534 (563)
                      +++.
T Consensus       353 ~L~H  356 (464)
T 3ttj_A          353 ALQH  356 (464)
T ss_dssp             HHTS
T ss_pred             HhcC
Confidence            9874

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=2.6e-37  Score=309.06  Aligned_cols=218  Identities=20%  Similarity=0.314  Sum_probs=182.3

Q ss_pred             HhcCCCccceecccCcEEEEEEEEC--CceEEEEEecc---CChHHHHHHHHHHHhccccce---------------EEE
Q 044997          290 ATNNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRS---NKSKEFFAELKVLCKIHHINV---------------FIS  349 (563)
Q Consensus       290 ~~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~---~~~~~f~~Ei~~l~~l~H~ni---------------V~e  349 (563)
                      ..++|...+.||+|+||.||+|...  +..+|+|++..   ...+.+.+|++++++++||||               |+|
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (277)
T 3f3z_A            7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME   86 (277)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence            3467899999999999999999885  46789999864   345789999999999999997               579


Q ss_pred             eecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEe---cCCCcEEEeecCCCcc
Q 044997          350 TFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILL---DDGLRAKVADFGLVKL  426 (563)
Q Consensus       350 ~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl---~~~~~~kl~DFGla~~  426 (563)
                      |+++|+|.+++..     ...+++..+..++.|++.||+|||+++   ++||||||+|||+   +.++.+||+|||+++.
T Consensus        87 ~~~~~~L~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~  158 (277)
T 3f3z_A           87 LCTGGELFERVVH-----KRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR  158 (277)
T ss_dssp             CCCSCBHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred             ccCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEeccccee
Confidence            9999999988865     356899999999999999999999998   9999999999999   7889999999999986


Q ss_pred             cccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc------
Q 044997          427 EERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP------  500 (563)
Q Consensus       427 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~------  500 (563)
                      .....    ......||+.|+|||.+.+              .+++++||||||+++|||++|+.||.......      
T Consensus       159 ~~~~~----~~~~~~~t~~y~aPE~~~~--------------~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~  220 (277)
T 3f3z_A          159 FKPGK----MMRTKVGTPYYVSPQVLEG--------------LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIR  220 (277)
T ss_dssp             CCTTS----CBCCCCSCTTTCCHHHHTT--------------CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             ccCcc----chhccCCCCCccChHHhcc--------------cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence            54322    2233569999999998743              24889999999999999999999996543211      


Q ss_pred             --------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          501 --------TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       501 --------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                              .....+.+.+.+++.+||+.||.+||++.|+++
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          221 EGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE  261 (277)
T ss_dssp             HCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             hCCCCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                    111134567899999999999999999999986

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.7e-38  Score=333.73  Aligned_cols=247  Identities=23%  Similarity=0.284  Sum_probs=192.9

Q ss_pred             cCHHHHHHHhcCCCccceecccCcEEEEEEEEC--CceEEEEEeccC------ChHHHHHHHHHHHhccccce-------
Q 044997          282 FSLEEIEEATNNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSN------KSKEFFAELKVLCKIHHINV-------  346 (563)
Q Consensus       282 ~~~~el~~~~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~------~~~~f~~Ei~~l~~l~H~ni-------  346 (563)
                      +.++++....++|+..+.||+|+||.||+++..  ++.||||++++.      ..+.+.+|.+++.+++||||       
T Consensus        51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~  130 (412)
T 2vd5_A           51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF  130 (412)
T ss_dssp             HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred             hhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence            455566666789999999999999999999984  789999999643      22458899999999999997       


Q ss_pred             --------EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEE
Q 044997          347 --------FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKV  418 (563)
Q Consensus       347 --------V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl  418 (563)
                              |+||+++|+|.+++...    ...+++..+..++.|++.||+|||+++   |+||||||+|||++.++++||
T Consensus       131 ~~~~~~~lVmE~~~gg~L~~~l~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL  203 (412)
T 2vd5_A          131 QDENYLYLVMEYYVGGDLLTLLSKF----GERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRL  203 (412)
T ss_dssp             ECSSEEEEEECCCCSCBHHHHHHHH----SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEE
T ss_pred             eeCCEEEEEEcCCCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEE
Confidence                    68999999999999742    246999999999999999999999997   999999999999999999999


Q ss_pred             eecCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCC
Q 044997          419 ADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDS  498 (563)
Q Consensus       419 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~  498 (563)
                      +|||+++.......  ......+||+.|+|||++.....      ......++.++|||||||++|||++|+.||.....
T Consensus       204 ~DFGla~~~~~~~~--~~~~~~~Gt~~Y~APE~l~~~~~------~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~  275 (412)
T 2vd5_A          204 ADFGSCLKLRADGT--VRSLVAVGTPDYLSPEILQAVGG------GPGTGSYGPECDWWALGVFAYEMFYGQTPFYADST  275 (412)
T ss_dssp             CCCTTCEECCTTSC--EECSSCCSCGGGCCHHHHHHHHT------CTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred             eechhheeccCCCc--cccceeccccCcCCHHHHhhccc------CcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCH
Confidence            99999986543221  11234579999999999863210      00123458999999999999999999999976543


Q ss_pred             Cchh---------------hHHHHHHHHHHHHHhhccCCCCC---CCHHHHHHHHHHhhhcChhhhc
Q 044997          499 EPTK---------------MKSLITIMAAVAEWCLNEDAVDR---PEMRDIVAILSQIMITSTEWEA  547 (563)
Q Consensus       499 ~~~~---------------~~~~~~~l~~li~~cl~~dP~~R---Ps~~evl~~L~~i~~~~~~w~~  547 (563)
                      ....               ...++..+.+|+.+||. +|.+|   |+++|+++.   -.-...+|+.
T Consensus       276 ~~~~~~i~~~~~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H---pff~~i~w~~  338 (412)
T 2vd5_A          276 AETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH---PFFFGLDWDG  338 (412)
T ss_dssp             HHHHHHHHTHHHHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS---GGGTTCCSTT
T ss_pred             HHHHHHHHhcccCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC---CCcCCCCHHH
Confidence            2110               12345668999999999 99998   588887543   2223445654

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=1.3e-37  Score=322.83  Aligned_cols=218  Identities=30%  Similarity=0.462  Sum_probs=179.0

Q ss_pred             cCCCccceecccCcEEEEEEEE--CCceEEEEEeccCC------hHHHHHHHHHHHhccccce---------------EE
Q 044997          292 NNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNK------SKEFFAELKVLCKIHHINV---------------FI  348 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~------~~~f~~Ei~~l~~l~H~ni---------------V~  348 (563)
                      +.|...+.||+|+||.||+|+.  +++.||||++....      .+++.+|++++++++||||               |+
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            4588899999999999999986  57899999986432      2568899999999999997               56


Q ss_pred             EeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccc
Q 044997          349 STFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEE  428 (563)
Q Consensus       349 e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~  428 (563)
                      ||+. |+|.+++..    ....+++..+..++.|++.||+|||+++   |+||||||+|||+++++.+||+|||+++...
T Consensus       134 e~~~-g~l~~~l~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~  205 (348)
T 1u5q_A          134 EYCL-GSASDLLEV----HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMA  205 (348)
T ss_dssp             ECCS-EEHHHHHHH----HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSS
T ss_pred             ecCC-CCHHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecC
Confidence            8876 677777753    2357999999999999999999999997   9999999999999999999999999998643


Q ss_pred             cccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc--------
Q 044997          429 RTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP--------  500 (563)
Q Consensus       429 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~--------  500 (563)
                      ..       ....||+.|+|||++...          ....++.++|||||||++|||++|+.||.......        
T Consensus       206 ~~-------~~~~gt~~y~aPE~~~~~----------~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~  268 (348)
T 1u5q_A          206 PA-------NSFVGTPYWMAPEVILAM----------DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN  268 (348)
T ss_dssp             SB-------CCCCSCGGGCCHHHHHTT----------SSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS
T ss_pred             CC-------CcccCCcceeCHhhhccc----------cCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc
Confidence            22       235699999999987421          12345889999999999999999999986543211        


Q ss_pred             ----hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          501 ----TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       501 ----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                          .....+.+.+.+++.+||+.||.+|||+.++++.
T Consensus       269 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h  306 (348)
T 1u5q_A          269 ESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  306 (348)
T ss_dssp             CCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             CCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence                1112345668999999999999999999999864

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=4.3e-37  Score=320.84  Aligned_cols=230  Identities=24%  Similarity=0.344  Sum_probs=187.7

Q ss_pred             HHHHHHhcCCCccceecccCcEEEEEEEEC--CceEEEEEeccCC-----------hHHHHHHHHHHHhc-cccce----
Q 044997          285 EEIEEATNNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNK-----------SKEFFAELKVLCKI-HHINV----  346 (563)
Q Consensus       285 ~el~~~~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~-----------~~~f~~Ei~~l~~l-~H~ni----  346 (563)
                      .......++|+..+.||+|+||.||+|+..  ++.||||.++...           .+.+.+|+++++++ +||||    
T Consensus        87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~  166 (365)
T 2y7j_A           87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI  166 (365)
T ss_dssp             HHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred             hhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence            344556678999999999999999999984  7899999986543           34678999999999 79997    


Q ss_pred             -----------EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCc
Q 044997          347 -----------FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLR  415 (563)
Q Consensus       347 -----------V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~  415 (563)
                                 |+||+.+|+|.+++..     ...+++..+..++.|++.||.|||+++   ++||||||+|||++.++.
T Consensus       167 ~~~~~~~~~~lv~e~~~g~~L~~~l~~-----~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~  238 (365)
T 2y7j_A          167 DSYESSSFMFLVFDLMRKGELFDYLTE-----KVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQ  238 (365)
T ss_dssp             EEEEBSSEEEEEECCCTTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCC
T ss_pred             EEEeeCCEEEEEEEeCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCC
Confidence                       5799999999999864     246999999999999999999999997   999999999999999999


Q ss_pred             EEEeecCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcC
Q 044997          416 AKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIR  495 (563)
Q Consensus       416 ~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~  495 (563)
                      +||+|||+++......    ......||+.|+|||++.+...       .....++.++|||||||++|||++|+.||..
T Consensus       239 ikl~DfG~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~-------~~~~~~~~~~Di~slG~il~ell~g~~pf~~  307 (365)
T 2y7j_A          239 IRLSDFGFSCHLEPGE----KLRELCGTPGYLAPEILKCSMD-------ETHPGYGKEVDLWACGVILFTLLAGSPPFWH  307 (365)
T ss_dssp             EEECCCTTCEECCTTC----CBCCCCSCGGGCCHHHHHHTTC-------TTSCCBCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             EEEEecCcccccCCCc----ccccCCCCCCccChhhcccccc-------ccCcCCCchhhHHhHHHHHHHHHHCCCCCCC
Confidence            9999999998654322    1234679999999998854321       1123468899999999999999999999965


Q ss_pred             CCCCc--------------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          496 DDSEP--------------TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       496 ~~~~~--------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                      .....              .........+.+++.+||+.||.+||++.|+++
T Consensus       308 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          308 RRQILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             SSHHHHHHHHHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CCHHHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            43211              111123445899999999999999999999986

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=2.7e-38  Score=330.42  Aligned_cols=218  Identities=9%  Similarity=0.040  Sum_probs=167.8

Q ss_pred             hcCCCccceecccCcEEEEEEEE--CCceEEEEEeccCC------hHHHHHHHHHHHhc--cccce--------------
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNK------SKEFFAELKVLCKI--HHINV--------------  346 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~------~~~f~~Ei~~l~~l--~H~ni--------------  346 (563)
                      ..+|...+.||+|+||.||+|+.  +++.||||+++...      .+.+.+|++++..+  +||||              
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence            34588899999999999999997  47889999998643      24567785544444  59982              


Q ss_pred             -------------------------EEEeecCCCcccccccccccCCCCCCHHHH------HHHHHHHHHHHHHHHhcCC
Q 044997          347 -------------------------FISTFGNGSLSDHLHDPLLKGHQPLTWTAR------TQIALDAAKGIEYIHDHTK  395 (563)
Q Consensus       347 -------------------------V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~------~~i~~~ia~gL~yLH~~~~  395 (563)
                                               |+||++ |+|.+++...    ...+.+..+      ..++.|++.||+|||+++ 
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~----~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~-  214 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL----DFVYVFRGDEGILALHILTAQLIRLAANLQSKG-  214 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH----HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh----ccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC-
Confidence                                     467777 8999988752    223466666      788899999999999998 


Q ss_pred             CceEeCCCCCCCeEecCCCcEEEeecCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcch
Q 044997          396 ARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTD  475 (563)
Q Consensus       396 ~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksD  475 (563)
                        |+||||||+|||++.++.+||+|||+++.....      .....+|+.|+|||++.+..           ..++.++|
T Consensus       215 --ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~------~~~~~~t~~y~aPE~~~~~~-----------~~~~~~~D  275 (371)
T 3q60_A          215 --LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR------GPASSVPVTYAPREFLNAST-----------ATFTHALN  275 (371)
T ss_dssp             --EEETTCSGGGEEECTTSCEEECCGGGEEETTCE------EEGGGSCGGGCCHHHHTCSE-----------EECCHHHH
T ss_pred             --CccCcCCHHHEEECCCCCEEEEecceeeecCCC------ccCccCCcCCcChhhccCCC-----------CCcCcccc
Confidence              999999999999999999999999999854321      11345679999999985411           23489999


Q ss_pred             HHHHHHHHHHHHcCCCCCcCCCCC-------------------chhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          476 VFAFGVVLAELITGKRALIRDDSE-------------------PTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       476 VwSfGvvl~Elltg~~p~~~~~~~-------------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                      ||||||++|||++|+.||......                   ......+.+.+.+|+.+||+.||++||++.|+++
T Consensus       276 iwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  352 (371)
T 3q60_A          276 AWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME  352 (371)
T ss_dssp             HHHHHHHHHHHHHSSCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred             HHHHHHHHHHHHhCCCCCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            999999999999999999765211                   0111245677999999999999999999999975

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=6.2e-38  Score=335.95  Aligned_cols=219  Identities=24%  Similarity=0.382  Sum_probs=174.5

Q ss_pred             hcCCCccceecccCcEEEEEEEE--CCceEEEEEeccC------ChHHHHHHHHHHHhccccce---------------E
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSN------KSKEFFAELKVLCKIHHINV---------------F  347 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~------~~~~f~~Ei~~l~~l~H~ni---------------V  347 (563)
                      .++|+..+.||+|+||.||+|+.  .++.||||.++..      ....+.+|++++++++||||               |
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv  226 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV  226 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence            36789999999999999999987  4789999998643      23567889999999999997               6


Q ss_pred             EEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCceEeCCCCCCCeEecCCCcEEEeecCCCcc
Q 044997          348 ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHD-HTKARYVHRDIKTSNILLDDGLRAKVADFGLVKL  426 (563)
Q Consensus       348 ~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~  426 (563)
                      +||+++|+|.+++..     ...+++..+..++.|++.||+|||+ ++   |+||||||+|||++.++.+||+|||+++.
T Consensus       227 ~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~  298 (446)
T 4ejn_A          227 MEYANGGELFFHLSR-----ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKE  298 (446)
T ss_dssp             ECCCSSCBHHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCT
T ss_pred             EeeCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCcee
Confidence            799999999998864     3569999999999999999999998 76   99999999999999999999999999985


Q ss_pred             cccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc------
Q 044997          427 EERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP------  500 (563)
Q Consensus       427 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~------  500 (563)
                      .....   .......||+.|+|||++.+..             ++.++|||||||++|||++|+.||.......      
T Consensus       299 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~-------------~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~  362 (446)
T 4ejn_A          299 GIKDG---ATMKTFCGTPEYLAPEVLEDND-------------YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL  362 (446)
T ss_dssp             TCC--------CCSSSCGGGCCHHHHHTSC-------------CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             ccCCC---cccccccCCccccCHhhcCCCC-------------CCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHH
Confidence            33221   1234467999999999885544             4899999999999999999999997543211      


Q ss_pred             ----hhhHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 044997          501 ----TKMKSLITIMAAVAEWCLNEDAVDRP-----EMRDIVA  533 (563)
Q Consensus       501 ----~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  533 (563)
                          .....+.+.+.+|+.+||+.||.+||     +++|+++
T Consensus       363 ~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~  404 (446)
T 4ejn_A          363 MEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ  404 (446)
T ss_dssp             HCCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             hCCCCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence                11123456689999999999999999     9998876

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=3.2e-37  Score=329.07  Aligned_cols=223  Identities=25%  Similarity=0.350  Sum_probs=172.1

Q ss_pred             hcCCCccceecccCcEEEEEEEEC--CceEEEEEeccCC-----hHHHHHHHHHHHhccccce-----------------
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNK-----SKEFFAELKVLCKIHHINV-----------------  346 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~-----~~~f~~Ei~~l~~l~H~ni-----------------  346 (563)
                      .++|...+.||+|+||.||+|+..  ++.||||+++...     .+++.+|+++|++++|+||                 
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            467999999999999999999874  6889999997532     3578899999999999997                 


Q ss_pred             ---EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCC
Q 044997          347 ---FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGL  423 (563)
Q Consensus       347 ---V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGl  423 (563)
                         |+||++ |+|.+++..     ...+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+
T Consensus       105 ~~lv~e~~~-~~L~~~~~~-----~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGl  175 (432)
T 3n9x_A          105 LYIVLEIAD-SDLKKLFKT-----PIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGL  175 (432)
T ss_dssp             EEEEEECCS-EEHHHHHHS-----SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             EEEEEecCC-cCHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCC
Confidence               345544 577777754     456999999999999999999999998   99999999999999999999999999


Q ss_pred             Ccccccccccc-------------------cccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHH
Q 044997          424 VKLEERTNEKE-------------------MLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLA  484 (563)
Q Consensus       424 a~~~~~~~~~~-------------------~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~  484 (563)
                      ++.........                   ...+..+||+.|+|||++...            ..++.++|||||||++|
T Consensus       176 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~------------~~~~~~~DiwSlG~il~  243 (432)
T 3n9x_A          176 ARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQ------------ENYTKSIDIWSTGCIFA  243 (432)
T ss_dssp             CEEC-------------------------------CCCCCTTCCHHHHTTC------------SCCCTHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcC------------CCCCcccccchHHHHHH
Confidence            98654322110                   123456899999999986332            23589999999999999


Q ss_pred             HHHcCCCCCcC----------CCCC----------------------------------------c--------------
Q 044997          485 ELITGKRALIR----------DDSE----------------------------------------P--------------  500 (563)
Q Consensus       485 Elltg~~p~~~----------~~~~----------------------------------------~--------------  500 (563)
                      ||++|..|+..          ....                                        .              
T Consensus       244 ell~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~  323 (432)
T 3n9x_A          244 ELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRK  323 (432)
T ss_dssp             HHHTTCTTTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCC
T ss_pred             HHHhcccccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCC
Confidence            99986444321          1100                                        0              


Q ss_pred             -----hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          501 -----TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       501 -----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                           .....+.+.+.+|+.+||+.||.+|||+.|+++.
T Consensus       324 ~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  362 (432)
T 3n9x_A          324 PINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDH  362 (432)
T ss_dssp             CCCHHHHSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTC
T ss_pred             CCCHHHHCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence                 0001234568899999999999999999999873

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-37  Score=322.64  Aligned_cols=232  Identities=22%  Similarity=0.342  Sum_probs=185.3

Q ss_pred             cCCCccceecccCcEEEEEEEE-----CCceEEEEEeccC-------ChHHHHHHHHHHHhc-cccce------------
Q 044997          292 NNFDESRIIGRGGFGNVYFGLL-----GDREAAIKKMRSN-------KSKEFFAELKVLCKI-HHINV------------  346 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~-----~~~~vavK~~~~~-------~~~~f~~Ei~~l~~l-~H~ni------------  346 (563)
                      ++|+..+.||+|+||.||+++.     .++.||||+++..       ..+.+.+|+++|.++ +||||            
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  133 (355)
T 1vzo_A           54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  133 (355)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence            5789999999999999999987     5788999998642       235677899999999 69987            


Q ss_pred             ---EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCC
Q 044997          347 ---FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGL  423 (563)
Q Consensus       347 ---V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGl  423 (563)
                         |+||+++|+|.+++..     ...+++..+..++.|++.||.|||+++   |+||||||+|||++.++++||+|||+
T Consensus       134 ~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~  205 (355)
T 1vzo_A          134 LHLILDYINGGELFTHLSQ-----RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGL  205 (355)
T ss_dssp             EEEEECCCCSCBHHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred             EEEEeecCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCC
Confidence               6799999999999975     246899999999999999999999997   99999999999999999999999999


Q ss_pred             CcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCch--
Q 044997          424 VKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPT--  501 (563)
Q Consensus       424 a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~--  501 (563)
                      ++.......  .......||+.|+|||++.+..           ..++.++|||||||++|||++|+.||........  
T Consensus       206 a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~-----------~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~  272 (355)
T 1vzo_A          206 SKEFVADET--ERAYDFCGTIEYMAPDIVRGGD-----------SGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQA  272 (355)
T ss_dssp             EEECCGGGG--GGGCGGGSCCTTCCHHHHTTCC--------------CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHH
T ss_pred             CeecccCCC--CcccCcccCcCccChhhhcCCC-----------CCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHH
Confidence            986543221  1223457999999999986422           2347899999999999999999999975433211  


Q ss_pred             ------------hhHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHHHHHhhhcChhhhc
Q 044997          502 ------------KMKSLITIMAAVAEWCLNEDAVDRP-----EMRDIVAILSQIMITSTEWEA  547 (563)
Q Consensus       502 ------------~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~L~~i~~~~~~w~~  547 (563)
                                  ....+...+.+|+.+||+.||.+||     +++|+++..   .-...+|+.
T Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~---~f~~~~~~~  332 (355)
T 1vzo_A          273 EISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL---FFQKINWDD  332 (355)
T ss_dssp             HHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG---GGTTCCHHH
T ss_pred             HHHHHHhccCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc---chhcCChhH
Confidence                        1122345688999999999999999     888887643   223345554

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=3.5e-37  Score=314.04  Aligned_cols=227  Identities=19%  Similarity=0.309  Sum_probs=175.7

Q ss_pred             cCCCc-cceecccCcEEEEEEEE--CCceEEEEEeccC---ChHHHHHHHHHHHhc-cccce---------------EEE
Q 044997          292 NNFDE-SRIIGRGGFGNVYFGLL--GDREAAIKKMRSN---KSKEFFAELKVLCKI-HHINV---------------FIS  349 (563)
Q Consensus       292 ~~f~~-~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~---~~~~f~~Ei~~l~~l-~H~ni---------------V~e  349 (563)
                      +.|.. .+.||+|+||.||+|+.  +++.||||.++..   ..+.+.+|++++.++ +||||               |+|
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e   91 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE   91 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence            45666 47899999999999986  4789999998654   346789999999994 79997               679


Q ss_pred             eecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCc---EEEeecCCCcc
Q 044997          350 TFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLR---AKVADFGLVKL  426 (563)
Q Consensus       350 ~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~---~kl~DFGla~~  426 (563)
                      |+++|+|.+++..     ...+++..+..++.|++.||+|||+++   |+||||||+|||++.++.   +||+|||+++.
T Consensus        92 ~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~  163 (316)
T 2ac3_A           92 KMRGGSILSHIHK-----RRHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSG  163 (316)
T ss_dssp             CCTTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC-
T ss_pred             cCCCCcHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCccc
Confidence            9999999999875     246899999999999999999999997   999999999999998766   99999999876


Q ss_pred             ccccccc----ccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc--
Q 044997          427 EERTNEK----EMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP--  500 (563)
Q Consensus       427 ~~~~~~~----~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~--  500 (563)
                      .......    ........||+.|+|||++.....        ....++.++|||||||++|||++|+.||.......  
T Consensus       164 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--------~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~  235 (316)
T 2ac3_A          164 IKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSE--------EASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCG  235 (316)
T ss_dssp             ------------------CCSGGGCCHHHHHHTSH--------HHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSC
T ss_pred             cccCCccccccccccccccCCcCccChHHhhcccc--------cccCCCcccccHhHHHHHHHHHHCCCCCccccccccc
Confidence            5422211    111223469999999999854110        01234789999999999999999999997643211  


Q ss_pred             ---------------------------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          501 ---------------------------TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       501 ---------------------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                                                 .....+...+.+++.+||+.||.+|||+.|+++.
T Consensus       236 ~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  296 (316)
T 2ac3_A          236 WDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH  296 (316)
T ss_dssp             C----CCHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             ccccccchhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence                                       0011234568999999999999999999999873

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=2.4e-38  Score=331.62  Aligned_cols=230  Identities=16%  Similarity=0.141  Sum_probs=173.3

Q ss_pred             hcCCCccceecccCcEEEEEEEE--CCceEEEEEeccC------ChHHHHHHH---HHHHhccccce-------------
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSN------KSKEFFAEL---KVLCKIHHINV-------------  346 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~------~~~~f~~Ei---~~l~~l~H~ni-------------  346 (563)
                      .++|...+.||+|+||.||+|+.  +++.||||+++..      ..+.|.+|+   ++|++++||||             
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            46788899999999999999986  4789999998632      236788999   56666689886             


Q ss_pred             --------------------------EEEeecCCCcccccccccc--cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCce
Q 044997          347 --------------------------FISTFGNGSLSDHLHDPLL--KGHQPLTWTARTQIALDAAKGIEYIHDHTKARY  398 (563)
Q Consensus       347 --------------------------V~e~~~~gsL~~~L~~~~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i  398 (563)
                                                |+||+ +|+|.+++.....  .....++|..++.|+.|++.||+|||+++   |
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i  227 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L  227 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence                                      34555 6899998875211  11234567899999999999999999997   9


Q ss_pred             EeCCCCCCCeEecCCCcEEEeecCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHH
Q 044997          399 VHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFA  478 (563)
Q Consensus       399 vHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwS  478 (563)
                      +||||||+|||++.++++||+|||+++....      ......| +.|+|||++.+....  .........++.++||||
T Consensus       228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~------~~~~~~g-~~y~aPE~~~~~~~~--~~~~~~~~~~~~~~DvwS  298 (377)
T 3byv_A          228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA------RVVSSVS-RGFEPPELEARRATI--SYHRDRRTLMTFSFDAWA  298 (377)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTC------EEECCCC-TTCCCHHHHHHHTST--HHHHCCEEECCHHHHHHH
T ss_pred             ecCCCCHHHEEEcCCCCEEEEechhheecCC------cccCCCC-cCccChhhhcccccc--cccccccccCChhhhHHH
Confidence            9999999999999999999999999985321      2234567 999999998655000  000000113589999999


Q ss_pred             HHHHHHHHHcCCCCCcCCCCCch------hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          479 FGVVLAELITGKRALIRDDSEPT------KMKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       479 fGvvl~Elltg~~p~~~~~~~~~------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                      |||++|||++|+.||........      ....+++.+.+++.+||+.||.+||++.|+++
T Consensus       299 lG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  359 (377)
T 3byv_A          299 LGLVIYWIWCADLPITKDAALGGSEWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAME  359 (377)
T ss_dssp             HHHHHHHHHHSSCCC------CCSGGGGSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred             HHHHHHHHHHCCCCCcccccccchhhhhhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence            99999999999999965432211      11244567899999999999999999999986

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=1.6e-37  Score=312.45  Aligned_cols=220  Identities=26%  Similarity=0.381  Sum_probs=176.9

Q ss_pred             cCCCccceecccCcEEEEEEEEC--CceEEEEEeccC----ChHHHHHHHHHHHhccccce---------------EEEe
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSN----KSKEFFAELKVLCKIHHINV---------------FIST  350 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~----~~~~f~~Ei~~l~~l~H~ni---------------V~e~  350 (563)
                      ++|...+.||+|+||.||++...  +..+|+|.+...    ..+.+.+|++++++++||||               |+||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  101 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET  101 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence            46888999999999999999874  688999998653    24779999999999999997               5799


Q ss_pred             ecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEe---cCCCcEEEeecCCCccc
Q 044997          351 FGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILL---DDGLRAKVADFGLVKLE  427 (563)
Q Consensus       351 ~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl---~~~~~~kl~DFGla~~~  427 (563)
                      +++|+|.+++.... .....+++..+..++.|++.||+|||+++   |+||||||+|||+   +.++.+||+|||+++..
T Consensus       102 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~  177 (285)
T 3is5_A          102 CEGGELLERIVSAQ-ARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELF  177 (285)
T ss_dssp             CSCCBHHHHHHHHH-HHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred             CCCCcHHHHHHhhh-hcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence            99999999886532 12367999999999999999999999997   9999999999999   45688999999999865


Q ss_pred             ccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCch------
Q 044997          428 ERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPT------  501 (563)
Q Consensus       428 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~------  501 (563)
                      ....    ......||+.|+|||.+.              ..++.++||||||+++|||++|+.||........      
T Consensus       178 ~~~~----~~~~~~~t~~y~aPE~~~--------------~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~  239 (285)
T 3is5_A          178 KSDE----HSTNAAGTALYMAPEVFK--------------RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATY  239 (285)
T ss_dssp             -------------CTTGGGCCHHHHT--------------TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             CCcc----cCcCcccccCcCChHHhc--------------cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhcc
Confidence            4322    123456899999999873              2358899999999999999999999965432111      


Q ss_pred             -------hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          502 -------KMKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       502 -------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                             ....+.+.+.+++.+||+.||.+||++.|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          240 KEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             CCCCCCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             CCcccccccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                   01123456889999999999999999999985

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=3e-37  Score=331.62  Aligned_cols=222  Identities=23%  Similarity=0.344  Sum_probs=161.3

Q ss_pred             cCCCccceecccCcEEEEEEEEC--CceEEEEEeccC-----ChHHHHHHHHHHHhccccceE-----------------
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSN-----KSKEFFAELKVLCKIHHINVF-----------------  347 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~-----~~~~f~~Ei~~l~~l~H~niV-----------------  347 (563)
                      ++|+..+.||+|+||.||+|+..  ++.||||++...     ..+++.+|+++|++++|||||                 
T Consensus        53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  132 (458)
T 3rp9_A           53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL  132 (458)
T ss_dssp             TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred             CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence            67999999999999999999774  789999998653     236788999999999999983                 


Q ss_pred             ---EEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCC
Q 044997          348 ---ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLV  424 (563)
Q Consensus       348 ---~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla  424 (563)
                         +||+ +|+|.+++..     ...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||++
T Consensus       133 ~lv~e~~-~~~L~~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla  203 (458)
T 3rp9_A          133 YVVLEIA-DSDFKKLFRT-----PVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLA  203 (458)
T ss_dssp             EEEECCC-SEEHHHHHHS-----SCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEecc-ccchhhhccc-----CCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccc
Confidence               3433 4566666643     456999999999999999999999997   999999999999999999999999999


Q ss_pred             ccccccccc------------------------ccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHH
Q 044997          425 KLEERTNEK------------------------EMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFG  480 (563)
Q Consensus       425 ~~~~~~~~~------------------------~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfG  480 (563)
                      +........                        ....+..+||+.|+|||++...            ..++.++||||||
T Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~------------~~~~~~~DiwSlG  271 (458)
T 3rp9_A          204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQ------------ENYTEAIDVWSIG  271 (458)
T ss_dssp             BCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTC------------CCCCTHHHHHHHH
T ss_pred             hhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCC------------CCCCcHhHHHHHH
Confidence            865432111                        0123446789999999976322            2358999999999


Q ss_pred             HHHHHHHc-----------CCCCCcCCCCCc-------------------h-----------------------------
Q 044997          481 VVLAELIT-----------GKRALIRDDSEP-------------------T-----------------------------  501 (563)
Q Consensus       481 vvl~Ellt-----------g~~p~~~~~~~~-------------------~-----------------------------  501 (563)
                      |++|||++           |+.+|.+....+                   .                             
T Consensus       272 ~il~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~  351 (458)
T 3rp9_A          272 CIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYI  351 (458)
T ss_dssp             HHHHHHHTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHH
T ss_pred             HHHHHHHHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHH
Confidence            99999999           444443321100                   0                             


Q ss_pred             -------------hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          502 -------------KMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       502 -------------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                                   ........+.+|+.+||..||.+|||+.|+++.
T Consensus       352 ~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~H  397 (458)
T 3rp9_A          352 RIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAH  397 (458)
T ss_dssp             TTSCCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HhcCCCCCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence                         001124557899999999999999999998874

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=6e-38  Score=328.15  Aligned_cols=232  Identities=25%  Similarity=0.396  Sum_probs=179.2

Q ss_pred             cCCCccceecccCcEEEEEEEEC--CceEEEEEeccCC------hHHHHHHHHH-HHhccccce---------------E
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNK------SKEFFAELKV-LCKIHHINV---------------F  347 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~------~~~f~~Ei~~-l~~l~H~ni---------------V  347 (563)
                      ++|+..+.||+|+||.||+++..  ++.+|||.++...      .+.+.+|..+ ++.++||||               |
T Consensus        38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv  117 (373)
T 2r5t_A           38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV  117 (373)
T ss_dssp             GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence            56889999999999999999985  5789999986532      2446677776 577899997               6


Q ss_pred             EEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccc
Q 044997          348 ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLE  427 (563)
Q Consensus       348 ~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~  427 (563)
                      +||+.+|+|.+++..     ...+++..+..++.|++.||+|||+++   |+||||||+|||++.++++||+|||+++..
T Consensus       118 ~E~~~gg~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~  189 (373)
T 2r5t_A          118 LDYINGGELFYHLQR-----ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKEN  189 (373)
T ss_dssp             EECCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGG
T ss_pred             EeCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCcccccc
Confidence            899999999999865     246889999999999999999999998   999999999999999999999999999853


Q ss_pred             ccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCch------
Q 044997          428 ERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPT------  501 (563)
Q Consensus       428 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~------  501 (563)
                      ....   .......||+.|+|||++.+..             ++.++|||||||++|||++|+.||........      
T Consensus       190 ~~~~---~~~~~~~gt~~y~aPE~~~~~~-------------~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~  253 (373)
T 2r5t_A          190 IEHN---STTSTFCGTPEYLAPEVLHKQP-------------YDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN  253 (373)
T ss_dssp             BCCC---CCCCSBSCCCCCCCHHHHTTCC-------------CCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHH
T ss_pred             ccCC---CccccccCCccccCHHHhCCCC-------------CCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Confidence            3221   1234467999999999986544             48899999999999999999999975432111      


Q ss_pred             ----hhHHHHHHHHHHHHHhhccCCCCCCCHHHHH-HHHHHhhhcChhhhc
Q 044997          502 ----KMKSLITIMAAVAEWCLNEDAVDRPEMRDIV-AILSQIMITSTEWEA  547 (563)
Q Consensus       502 ----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl-~~L~~i~~~~~~w~~  547 (563)
                          ....+...+.+++.+||+.||.+||++.+.+ +.+..-.-...+|+.
T Consensus       254 ~~~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w~~  304 (373)
T 2r5t_A          254 KPLQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWDD  304 (373)
T ss_dssp             SCCCCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCCHHH
T ss_pred             cccCCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCCHHH
Confidence                1123345689999999999999999986433 344444445556765

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=5.7e-37  Score=335.51  Aligned_cols=220  Identities=26%  Similarity=0.405  Sum_probs=183.6

Q ss_pred             hcCCCccceecccCcEEEEEEEE--CCceEEEEEeccC------ChHHHHHHHHHHHhccccce---------------E
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSN------KSKEFFAELKVLCKIHHINV---------------F  347 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~------~~~~f~~Ei~~l~~l~H~ni---------------V  347 (563)
                      .++|+..+.||+|+||.||+|+.  +++.||+|.++..      ..+.+.+|+++|++++||||               |
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  262 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV  262 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence            35688899999999999999988  4789999998642      34568899999999999997               6


Q ss_pred             EEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccc
Q 044997          348 ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLE  427 (563)
Q Consensus       348 ~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~  427 (563)
                      +||+++|+|.+++...   +...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus       263 mEy~~gg~L~~~l~~~---~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~  336 (576)
T 2acx_A          263 LTLMNGGDLKFHIYHM---GQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHV  336 (576)
T ss_dssp             ECCCCSCBHHHHHHSS---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEcCCCCcHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceec
Confidence            7999999999998752   3345999999999999999999999997   999999999999999999999999999865


Q ss_pred             ccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc--hh---
Q 044997          428 ERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP--TK---  502 (563)
Q Consensus       428 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~--~~---  502 (563)
                      ....    ......||+.|+|||++.+..|             +.++|||||||++|||++|+.||.......  ..   
T Consensus       337 ~~~~----~~~~~~GT~~Y~APEvl~~~~~-------------~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~  399 (576)
T 2acx_A          337 PEGQ----TIKGRVGTVGYMAPEVVKNERY-------------TFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVER  399 (576)
T ss_dssp             CTTC----CEECCCSCGGGCCHHHHTTCEE-------------SSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHH
T ss_pred             ccCc----cccccCCCccccCHHHHcCCCC-------------CccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHH
Confidence            4322    1233579999999999876554             789999999999999999999997654321  11   


Q ss_pred             ---------hHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 044997          503 ---------MKSLITIMAAVAEWCLNEDAVDRP-----EMRDIVA  533 (563)
Q Consensus       503 ---------~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  533 (563)
                               ...+...+.+|+.+||+.||.+||     ++.|+++
T Consensus       400 ~i~~~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~  444 (576)
T 2acx_A          400 LVKEVPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE  444 (576)
T ss_dssp             HHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred             HhhcccccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence                     122345689999999999999999     6677664

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.5e-37  Score=318.95  Aligned_cols=236  Identities=22%  Similarity=0.342  Sum_probs=170.1

Q ss_pred             cCCCccceecccCcEEEEEEEE--CCceEEEEEeccCC---hHHHHHHHHHHHhcc-ccceE------------------
Q 044997          292 NNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNK---SKEFFAELKVLCKIH-HINVF------------------  347 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~---~~~f~~Ei~~l~~l~-H~niV------------------  347 (563)
                      .+|+..+.||+|+||.||+|+.  .++.||||++....   .+.+.+|+.++.++. ||||+                  
T Consensus        28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~  107 (337)
T 3ll6_A           28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQA  107 (337)
T ss_dssp             EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSE
T ss_pred             ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCc
Confidence            4688899999999999999998  57899999986544   356889999999996 99973                  


Q ss_pred             -----EEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecC
Q 044997          348 -----ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFG  422 (563)
Q Consensus       348 -----~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFG  422 (563)
                           +||+ +|+|.+++...  .....+++..++.++.|++.||+|||+++ ++++||||||+|||++.++.+||+|||
T Consensus       108 ~~~lv~e~~-~g~L~~~l~~~--~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg  183 (337)
T 3ll6_A          108 EFLLLTELC-KGQLVEFLKKM--ESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFG  183 (337)
T ss_dssp             EEEEEEECC-SEEHHHHHHHH--HTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCT
T ss_pred             eEEEEEEec-CCCHHHHHHHh--hccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCc
Confidence                 3444 47888877542  23456999999999999999999999974 349999999999999999999999999


Q ss_pred             CCcccccccccc---------cccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCC
Q 044997          423 LVKLEERTNEKE---------MLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRAL  493 (563)
Q Consensus       423 la~~~~~~~~~~---------~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~  493 (563)
                      +++.........         .......||+.|+|||++...          ....++.++||||||+++|||++|+.||
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~----------~~~~~~~~~Dv~slG~il~el~~g~~p~  253 (337)
T 3ll6_A          184 SATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLY----------SNFPIGEKQDIWALGCILYLLCFRQHPF  253 (337)
T ss_dssp             TCBCCSSCC-------------------------------CC----------TTSCSSHHHHHHHHHHHHHHHHHSSCCC
T ss_pred             cceeccccCcccccccccccchhhccccCCCCcCChhhhhcc----------ccCCCChHHhHHHHHHHHHHHHhCCCCC
Confidence            998654322111         011134689999999987321          1334588999999999999999999998


Q ss_pred             cCCCCCc--------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 044997          494 IRDDSEP--------TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMIT  541 (563)
Q Consensus       494 ~~~~~~~--------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~  541 (563)
                      .......        .........+.+++.+||+.||.+||++.|+++.|.++...
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~  309 (337)
T 3ll6_A          254 EDGAKLRIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAA  309 (337)
T ss_dssp             ------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             cchhHHHhhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            6533211        11112234478999999999999999999999999988764

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=3.2e-37  Score=312.63  Aligned_cols=218  Identities=28%  Similarity=0.457  Sum_probs=182.2

Q ss_pred             cCCCccceecccCcEEEEEEEEC--CceEEEEEeccC----ChHHHHHHHHHHHhccccce---------------EEEe
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSN----KSKEFFAELKVLCKIHHINV---------------FIST  350 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~----~~~~f~~Ei~~l~~l~H~ni---------------V~e~  350 (563)
                      +.|...+.||+|+||.||+|+..  ++.||||.++..    ..+.+.+|+.++++++||||               |+||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  101 (303)
T 3a7i_A           22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY  101 (303)
T ss_dssp             GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence            45888999999999999999874  788999998643    34779999999999999997               5799


Q ss_pred             ecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccccc
Q 044997          351 FGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERT  430 (563)
Q Consensus       351 ~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~  430 (563)
                      +++|+|.+++..      ..+++..+..++.|++.||.|||+++   ++||||||+||+++.++++||+|||+++.....
T Consensus       102 ~~~~~L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~  172 (303)
T 3a7i_A          102 LGGGSALDLLEP------GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT  172 (303)
T ss_dssp             CTTEEHHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTT
T ss_pred             CCCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCcc
Confidence            999999998863      46899999999999999999999997   999999999999999999999999999765432


Q ss_pred             cccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc----------
Q 044997          431 NEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP----------  500 (563)
Q Consensus       431 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~----------  500 (563)
                      .   .......||+.|+|||.+.+..             ++.++||||||+++|||++|+.||.......          
T Consensus       173 ~---~~~~~~~~~~~y~aPE~~~~~~-------------~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~  236 (303)
T 3a7i_A          173 Q---IKRNTFVGTPFWMAPEVIKQSA-------------YDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP  236 (303)
T ss_dssp             B---CCBCCCCSCGGGCCHHHHTTCC-------------BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC
T ss_pred             c---cccCccCCCcCccCHHHHhcCC-------------CCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCC
Confidence            2   1223457899999999886544             3789999999999999999999986432211          


Q ss_pred             -hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          501 -TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       501 -~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                       .....+...+.+++.+||+.||.+||++.|+++.
T Consensus       237 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  271 (303)
T 3a7i_A          237 PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  271 (303)
T ss_dssp             CCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred             CCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence             1111334568999999999999999999999874

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=4.1e-37  Score=319.90  Aligned_cols=229  Identities=21%  Similarity=0.285  Sum_probs=178.6

Q ss_pred             cCHHHHHHHhcCCCccceecccCcEEEEEEEE-CCceEEEEEeccCC--------------hHHHHHHHHHHHhccccce
Q 044997          282 FSLEEIEEATNNFDESRIIGRGGFGNVYFGLL-GDREAAIKKMRSNK--------------SKEFFAELKVLCKIHHINV  346 (563)
Q Consensus       282 ~~~~el~~~~~~f~~~~~LG~G~fG~Vy~g~~-~~~~vavK~~~~~~--------------~~~f~~Ei~~l~~l~H~ni  346 (563)
                      ....++....++|...+.||+|+||.||+|.. +++.||||++....              .+.+.+|++++++++||||
T Consensus        12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i   91 (362)
T 3pg1_A           12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI   91 (362)
T ss_dssp             HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred             HHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence            45678888999999999999999999999977 47889999985421              1678999999999999997


Q ss_pred             --------------------EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCC
Q 044997          347 --------------------FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTS  406 (563)
Q Consensus       347 --------------------V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~  406 (563)
                                          |+||+. |+|.+++..    ....+++..+..++.|++.||.|||+++   |+||||||+
T Consensus        92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~  163 (362)
T 3pg1_A           92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD----QRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPG  163 (362)
T ss_dssp             CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC----TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGG
T ss_pred             cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChH
Confidence                                346665 677777764    3457999999999999999999999997   999999999


Q ss_pred             CeEecCCCcEEEeecCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHH
Q 044997          407 NILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAEL  486 (563)
Q Consensus       407 NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~El  486 (563)
                      |||++.++.+||+|||+++......    ......||+.|+|||.+.+.            ..++.++|||||||++|||
T Consensus       164 NIl~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~t~~y~aPE~~~~~------------~~~~~~~DiwslG~il~~l  227 (362)
T 3pg1_A          164 NILLADNNDITICDFNLAREDTADA----NKTHYVTHRWYRAPELVMQF------------KGFTKLVDMWSAGCVMAEM  227 (362)
T ss_dssp             GEEECTTCCEEECCTTC-------------------CGGGCCHHHHTTC------------TTCCTHHHHHHHHHHHHHH
T ss_pred             HEEEcCCCCEEEEecCccccccccc----ccceecccceecCcHHhcCC------------CCCCcHhHHHhHHHHHHHH
Confidence            9999999999999999997543222    22345789999999987542            2358999999999999999


Q ss_pred             HcCCCCCcCCCCCchh------------------------------------------hHHHHHHHHHHHHHhhccCCCC
Q 044997          487 ITGKRALIRDDSEPTK------------------------------------------MKSLITIMAAVAEWCLNEDAVD  524 (563)
Q Consensus       487 ltg~~p~~~~~~~~~~------------------------------------------~~~~~~~l~~li~~cl~~dP~~  524 (563)
                      ++|+.||.........                                          .....+.+.+|+.+||+.||.+
T Consensus       228 ~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~  307 (362)
T 3pg1_A          228 FNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQR  307 (362)
T ss_dssp             HHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGG
T ss_pred             HhCCCCCCCCCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhh
Confidence            9999999754311000                                          0112345889999999999999


Q ss_pred             CCCHHHHHHH
Q 044997          525 RPEMRDIVAI  534 (563)
Q Consensus       525 RPs~~evl~~  534 (563)
                      |||+.|+++.
T Consensus       308 Rpt~~ell~h  317 (362)
T 3pg1_A          308 RISTEQALRH  317 (362)
T ss_dssp             SCCHHHHHTS
T ss_pred             CCCHHHHHcC
Confidence            9999999873

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=1.7e-37  Score=321.15  Aligned_cols=220  Identities=22%  Similarity=0.342  Sum_probs=180.4

Q ss_pred             HhcCCCccceecccCcEEEEEEEEC--CceEEEEEeccCChHHHHHHHHHHHhc-cccce---------------EEEee
Q 044997          290 ATNNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNKSKEFFAELKVLCKI-HHINV---------------FISTF  351 (563)
Q Consensus       290 ~~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~f~~Ei~~l~~l-~H~ni---------------V~e~~  351 (563)
                      ..++|+..+.||+|+||.||+++..  ++.+|||.++.... .+.+|++++.++ +||||               |+||+
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~   98 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELM   98 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCC
Confidence            4567999999999999999999884  78899999976532 345789999888 79997               57999


Q ss_pred             cCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCC----CcEEEeecCCCccc
Q 044997          352 GNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDG----LRAKVADFGLVKLE  427 (563)
Q Consensus       352 ~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~----~~~kl~DFGla~~~  427 (563)
                      .+|+|.+++..     ...+++..+..++.|++.||+|||+++   |+||||||+|||+.++    +.+||+|||+++..
T Consensus        99 ~gg~L~~~i~~-----~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~  170 (342)
T 2qr7_A           99 KGGELLDKILR-----QKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQL  170 (342)
T ss_dssp             CSCBHHHHHHT-----CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred             CCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence            99999998864     356999999999999999999999998   9999999999998543    35999999999865


Q ss_pred             ccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCch------
Q 044997          428 ERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPT------  501 (563)
Q Consensus       428 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~------  501 (563)
                      .....   ......||+.|+|||++.+..|             +.++|||||||++|||++|+.||........      
T Consensus       171 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~-------------~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~  234 (342)
T 2qr7_A          171 RAENG---LLMTPCYTANFVAPEVLERQGY-------------DAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILAR  234 (342)
T ss_dssp             BCTTC---CBCCSSCCSSCCCHHHHHHHHH-------------HHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHH
T ss_pred             cCCCC---ceeccCCCccccCHHHhcCCCC-------------CCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHH
Confidence            43221   2234578999999999866554             6899999999999999999999975432111      


Q ss_pred             -----------hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          502 -----------KMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       502 -----------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                                 ....+.+.+.+|+.+||+.||++||++.|+++.
T Consensus       235 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h  278 (342)
T 2qr7_A          235 IGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH  278 (342)
T ss_dssp             HHHCCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             HccCCcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence                       112345678999999999999999999998863

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=4.1e-37  Score=314.87  Aligned_cols=222  Identities=22%  Similarity=0.350  Sum_probs=180.4

Q ss_pred             HhcCCCccceecccCcEEEEEEEEC--CceEEEEEeccCC-----------hHHHHHHHHHHHhccccce----------
Q 044997          290 ATNNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNK-----------SKEFFAELKVLCKIHHINV----------  346 (563)
Q Consensus       290 ~~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~-----------~~~f~~Ei~~l~~l~H~ni----------  346 (563)
                      ..++|...+.||+|+||.||+|+..  ++.||||.++...           ...+.+|+++|++++||||          
T Consensus         8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   87 (322)
T 2ycf_A            8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE   87 (322)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred             hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence            3467999999999999999999884  6889999986432           2348899999999999997          


Q ss_pred             ----EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCc---EEEe
Q 044997          347 ----FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLR---AKVA  419 (563)
Q Consensus       347 ----V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~---~kl~  419 (563)
                          |+||+++|+|.+++..     ...+++..+..++.|++.||+|||+++   ++||||||+|||++.++.   +||+
T Consensus        88 ~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~  159 (322)
T 2ycf_A           88 DYYIVLELMEGGELFDKVVG-----NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKIT  159 (322)
T ss_dssp             SEEEEEECCTTEETHHHHST-----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEEC
T ss_pred             ceEEEEecCCCCcHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEc
Confidence                5799999999988864     357999999999999999999999997   999999999999987654   9999


Q ss_pred             ecCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCC
Q 044997          420 DFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE  499 (563)
Q Consensus       420 DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~  499 (563)
                      |||+++......    ......||+.|+|||++...          ....++.++||||||+++|||++|+.||......
T Consensus       160 Dfg~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~----------~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~  225 (322)
T 2ycf_A          160 DFGHSKILGETS----LMRTLCGTPTYLAPEVLVSV----------GTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ  225 (322)
T ss_dssp             CCTTCEECCCCH----HHHHHHSCCTTCCHHHHHHT----------TTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCS
T ss_pred             cCccceeccccc----ccccccCCcCccCchhhccC----------CCCCCCchhhHHHHHHHHHHHHhCCCCCcccchH
Confidence            999998654321    12235689999999987421          1234588999999999999999999999754432


Q ss_pred             ch---------------hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          500 PT---------------KMKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       500 ~~---------------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                      ..               ....+...+.+++.+||+.||.+||++.|+++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          226 VSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             SCHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHHHHHHhCccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence            11               11233566899999999999999999999985

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=2.6e-37  Score=309.49  Aligned_cols=218  Identities=25%  Similarity=0.388  Sum_probs=178.4

Q ss_pred             hcCCCccceecccCcEEEEEEEEC--CceEEEEEeccC------ChHHHHHHHHHHHhccccce---------------E
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSN------KSKEFFAELKVLCKIHHINV---------------F  347 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~------~~~~f~~Ei~~l~~l~H~ni---------------V  347 (563)
                      .++|+..+.||+|+||.||+|...  +..||+|.+...      ..+.+.+|++++++++||||               |
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   87 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   87 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence            357888999999999999999885  567999998543      24568899999999999997               5


Q ss_pred             EEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccc
Q 044997          348 ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLE  427 (563)
Q Consensus       348 ~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~  427 (563)
                      +||+++|+|.+++..     ...+++..+..++.|++.||+|||+++   ++||||||+|||++.++.+||+|||++...
T Consensus        88 ~e~~~~~~l~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~  159 (279)
T 3fdn_A           88 LEYAPLGTVYRELQK-----LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHA  159 (279)
T ss_dssp             ECCCTTEEHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC
T ss_pred             EecCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccC
Confidence            788889999988865     246899999999999999999999987   999999999999999999999999998643


Q ss_pred             ccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCch------
Q 044997          428 ERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPT------  501 (563)
Q Consensus       428 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~------  501 (563)
                      ...     ......|++.|+|||.+.+..             ++.++||||||+++|||++|+.||........      
T Consensus       160 ~~~-----~~~~~~~~~~y~aPE~~~~~~-------------~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~  221 (279)
T 3fdn_A          160 PSS-----RRTDLCGTLDYLPPEMIEGRM-------------HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR  221 (279)
T ss_dssp             -------------CCCCTTCCHHHHTTCC-------------CCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH
T ss_pred             Ccc-----cccccCCCCCccCHhHhccCC-------------CCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHh
Confidence            322     123357899999999885543             47899999999999999999999975432111      


Q ss_pred             ----hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          502 ----KMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       502 ----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                          ......+.+.+++.+||+.||.+||++.|+++.
T Consensus       222 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h  258 (279)
T 3fdn_A          222 VEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH  258 (279)
T ss_dssp             TCCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred             CCCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence                112234568999999999999999999999974

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=5.6e-37  Score=316.84  Aligned_cols=220  Identities=21%  Similarity=0.287  Sum_probs=183.5

Q ss_pred             hcCCCccceecccCcEEEEEEEECCceEEEEEeccCCh--------------------HHHHHHHHHHHhccccce----
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLLGDREAAIKKMRSNKS--------------------KEFFAELKVLCKIHHINV----  346 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~vavK~~~~~~~--------------------~~f~~Ei~~l~~l~H~ni----  346 (563)
                      .++|...+.||+|+||.||+|..+++.||||.+.....                    +.+.+|++++++++||||    
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~  109 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCE  109 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCS
T ss_pred             cCceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEE
Confidence            36799999999999999999999999999999864311                    789999999999999997    


Q ss_pred             -----------EEEeecCCCcccc------cccccccCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCceEeCCCCCCCe
Q 044997          347 -----------FISTFGNGSLSDH------LHDPLLKGHQPLTWTARTQIALDAAKGIEYIHD-HTKARYVHRDIKTSNI  408 (563)
Q Consensus       347 -----------V~e~~~~gsL~~~------L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDLk~~NI  408 (563)
                                 |+||+++|+|.++      +..   .....+++..+..++.|++.||.|||+ ++   ++||||||+||
T Consensus       110 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~---~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Ni  183 (348)
T 2pml_X          110 GIITNYDEVYIIYEYMENDSILKFDEYFFVLDK---NYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNI  183 (348)
T ss_dssp             EEEESSSEEEEEEECCTTCBSSEESSSEESSCS---SSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGE
T ss_pred             EEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh---ccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhE
Confidence                       6899999999999      443   124679999999999999999999999 87   99999999999


Q ss_pred             EecCCCcEEEeecCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCC-cchHHHHHHHHHHHH
Q 044997          409 LLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTT-KTDVFAFGVVLAELI  487 (563)
Q Consensus       409 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~-ksDVwSfGvvl~Ell  487 (563)
                      |++.++.+||+|||+++.....     ......|+..|+|||.+.+..            .++. ++||||||+++|||+
T Consensus       184 l~~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~------------~~~~~~~Di~slG~il~~l~  246 (348)
T 2pml_X          184 LMDKNGRVKLSDFGESEYMVDK-----KIKGSRGTYEFMPPEFFSNES------------SYNGAKVDIWSLGICLYVMF  246 (348)
T ss_dssp             EECTTSCEEECCCTTCEECBTT-----EECSSCSCGGGCCGGGGSSCC------------CEEHHHHHHHHHHHHHHHHH
T ss_pred             EEcCCCcEEEeccccccccccc-----cccCCCCCcCccCchhhcCCC------------CCCcchhhHHHHHHHHHHHH
Confidence            9999999999999999865332     223457899999999886541            1244 999999999999999


Q ss_pred             cCCCCCcCCCCCchh-----------h-------------------HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          488 TGKRALIRDDSEPTK-----------M-------------------KSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       488 tg~~p~~~~~~~~~~-----------~-------------------~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                      +|+.||.........           .                   ..+...+.+++.+||+.||.+||++.|+++
T Consensus       247 ~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          247 YNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             HSSCSSCCSSCSHHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             hCCCCCCCCCcHHHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            999999754431110           0                   234567899999999999999999999987

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=4.8e-37  Score=323.38  Aligned_cols=230  Identities=22%  Similarity=0.323  Sum_probs=174.5

Q ss_pred             cCCCccceecccCcEEEEEEEEC-CceEEEEEeccCC-----hHHHHHHHHHHHhcc--ccce---------------EE
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG-DREAAIKKMRSNK-----SKEFFAELKVLCKIH--HINV---------------FI  348 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~vavK~~~~~~-----~~~f~~Ei~~l~~l~--H~ni---------------V~  348 (563)
                      ++|...+.||+|+||.||++... ++.||||.++...     .+.+.+|+++|.+++  |+||               |+
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~  135 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM  135 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence            45888999999999999999874 6789999986432     367899999999996  4887               45


Q ss_pred             EeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccc
Q 044997          349 STFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEE  428 (563)
Q Consensus       349 e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~  428 (563)
                      | +.+|+|.+++..     ...+++.++..++.|++.||+|||+++   |+||||||+|||++ ++.+||+|||+++...
T Consensus       136 E-~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~  205 (390)
T 2zmd_A          136 E-CGNIDLNSWLKK-----KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQ  205 (390)
T ss_dssp             E-CCSEEHHHHHHH-----CSSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC-
T ss_pred             e-cCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCcccccc
Confidence            6 567889888865     346899999999999999999999997   99999999999996 5799999999998654


Q ss_pred             cccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCchhh-----
Q 044997          429 RTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKM-----  503 (563)
Q Consensus       429 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~~~-----  503 (563)
                      .... ........||+.|+|||++.+.....  ........++.++|||||||++|||++|+.||..........     
T Consensus       206 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~--~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~  282 (390)
T 2zmd_A          206 PDTT-SVVKDSQVGAVNYMPPEAIKDMSSSR--ENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID  282 (390)
T ss_dssp             ---------CCSCCCGGGCCHHHHHCC--------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHC
T ss_pred             CCCc-cccCCCCCcCCCccChHHhhhccccc--cccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhC
Confidence            3321 11223467999999999986422100  000112356899999999999999999999996543221111     


Q ss_pred             --------HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          504 --------KSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       504 --------~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                              ......+.+++.+||+.||.+||++.|+++.
T Consensus       283 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  321 (390)
T 2zmd_A          283 PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  321 (390)
T ss_dssp             TTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence                    1113458999999999999999999999864

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=6.7e-37  Score=326.31  Aligned_cols=217  Identities=24%  Similarity=0.357  Sum_probs=175.5

Q ss_pred             hcCCCccceecccCcEEEEEEEEC--CceEEEEEeccCC--hHHHHHHHHHHHhc------cccce--------------
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNK--SKEFFAELKVLCKI------HHINV--------------  346 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~--~~~f~~Ei~~l~~l------~H~ni--------------  346 (563)
                      ..+|+..+.||+|+||.||+|+..  ++.||||+++...  .+.+.+|+++++.+      +|+||              
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~  175 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHIC  175 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEE
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEE
Confidence            356899999999999999999874  6889999997654  35678899999888      45575              


Q ss_pred             -EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCc--EEEeecCC
Q 044997          347 -FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLR--AKVADFGL  423 (563)
Q Consensus       347 -V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~--~kl~DFGl  423 (563)
                       |+||+. |+|.+++...   ....+++..+..++.|++.||+|||+++   |+||||||+|||++.++.  +||+|||+
T Consensus       176 lv~e~~~-~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~  248 (429)
T 3kvw_A          176 MTFELLS-MNLYELIKKN---KFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGS  248 (429)
T ss_dssp             EEECCCC-CBHHHHHHHT---TTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred             EEEeccC-CCHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeeccc
Confidence             467775 6888888652   3356999999999999999999999997   999999999999999887  99999999


Q ss_pred             CcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCchhh
Q 044997          424 VKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKM  503 (563)
Q Consensus       424 a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~~~  503 (563)
                      ++.....      .....||+.|+|||++.+..             ++.++|||||||++|||++|+.||..........
T Consensus       249 a~~~~~~------~~~~~gt~~y~aPE~~~~~~-------------~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~  309 (429)
T 3kvw_A          249 SCYEHQR------VYTYIQSRFYRAPEVILGAR-------------YGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLA  309 (429)
T ss_dssp             CEETTCC------CCSSCSCGGGCCHHHHHTBC-------------CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred             ceecCCc------ccccCCCCCccChHHHhCCC-------------CCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            9753321      22357899999999986554             4899999999999999999999986543210000


Q ss_pred             -------------------------------------------------------------H--------HHHHHHHHHH
Q 044997          504 -------------------------------------------------------------K--------SLITIMAAVA  514 (563)
Q Consensus       504 -------------------------------------------------------------~--------~~~~~l~~li  514 (563)
                                                                                   .        ...+.+.+|+
T Consensus       310 ~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli  389 (429)
T 3kvw_A          310 CMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFL  389 (429)
T ss_dssp             HHHHHHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHH
T ss_pred             HHHHHcCCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHH
Confidence                                                                         0        0134578999


Q ss_pred             HHhhccCCCCCCCHHHHHH
Q 044997          515 EWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       515 ~~cl~~dP~~RPs~~evl~  533 (563)
                      .+||+.||++|||+.|+++
T Consensus       390 ~~~L~~dP~~Rpta~e~L~  408 (429)
T 3kvw_A          390 KQCLEWDPAVRMTPGQALR  408 (429)
T ss_dssp             HHHTCSSTTTSCCHHHHHT
T ss_pred             HHHCCCChhhCCCHHHHhC
Confidence            9999999999999999987

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=2.7e-37  Score=316.85  Aligned_cols=236  Identities=25%  Similarity=0.388  Sum_probs=184.7

Q ss_pred             hcCCCccceecccCcEEEEEEEE-------CCceEEEEEeccCC----hHHHHHHHHHHHhccccce-------------
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLL-------GDREAAIKKMRSNK----SKEFFAELKVLCKIHHINV-------------  346 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~-------~~~~vavK~~~~~~----~~~f~~Ei~~l~~l~H~ni-------------  346 (563)
                      .++|...+.||+|+||.||+|++       .++.||||.+....    ..++.+|+.++++++||||             
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  108 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence            36788999999999999999984       34679999996442    3568899999999999997             


Q ss_pred             --EEEeecCCCccccccccccc--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecC---CCcEEEe
Q 044997          347 --FISTFGNGSLSDHLHDPLLK--GHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDD---GLRAKVA  419 (563)
Q Consensus       347 --V~e~~~~gsL~~~L~~~~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~---~~~~kl~  419 (563)
                        |+||+++|+|.+++......  ....+++.+++.++.|++.||.|||+++   ++||||||+|||++.   +..+||+
T Consensus       109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl~  185 (327)
T 2yfx_A          109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG  185 (327)
T ss_dssp             EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEEC
Confidence              57999999999999753211  1245899999999999999999999997   999999999999984   4569999


Q ss_pred             ecCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCCCcCCCC
Q 044997          420 DFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIRDDS  498 (563)
Q Consensus       420 DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p~~~~~~  498 (563)
                      |||+++........ .......||+.|+|||.+.+..             ++.++||||||+++|||++ |+.||.....
T Consensus       186 Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~-------------~~~~~Di~slG~il~ellt~g~~p~~~~~~  251 (327)
T 2yfx_A          186 DFGMARDIYRASYY-RKGGCAMLPVKWMPPEAFMEGI-------------FTSKTDTWSFGVLLWEIFSLGYMPYPSKSN  251 (327)
T ss_dssp             CCHHHHHHHC-------CCGGGSCGGGCCHHHHHHCC-------------CCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred             cccccccccccccc-ccCCCcCCCcceeCHhHhcCCC-------------CCchhhHHHHHHHHHHHHcCCCCCCCCcCH
Confidence            99998754332211 1123356789999999875443             4889999999999999998 8888865432


Q ss_pred             Cc-----------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcCh
Q 044997          499 EP-----------TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITST  543 (563)
Q Consensus       499 ~~-----------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~  543 (563)
                      ..           .....+...+.+++.+||+.||.+||++.++++.|..+.....
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~  307 (327)
T 2yfx_A          252 QEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD  307 (327)
T ss_dssp             HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred             HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCHH
Confidence            11           1112344568999999999999999999999999998876543

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=4.8e-37  Score=315.42  Aligned_cols=226  Identities=22%  Similarity=0.322  Sum_probs=181.9

Q ss_pred             HHHHHhcCCCcc-ceecccCcEEEEEEEEC--CceEEEEEeccC-----ChHHHHHHHHHHHhcc-ccce----------
Q 044997          286 EIEEATNNFDES-RIIGRGGFGNVYFGLLG--DREAAIKKMRSN-----KSKEFFAELKVLCKIH-HINV----------  346 (563)
Q Consensus       286 el~~~~~~f~~~-~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~-----~~~~f~~Ei~~l~~l~-H~ni----------  346 (563)
                      ..+...+.|... +.||+|+||.||+|+..  ++.||+|.++..     ..+++.+|+.++.++. ||||          
T Consensus        22 ~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~  101 (327)
T 3lm5_A           22 SMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENT  101 (327)
T ss_dssp             CHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred             HHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeC
Confidence            344556667776 89999999999999885  789999998643     2467899999999995 5886          


Q ss_pred             -----EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecC---CCcEEE
Q 044997          347 -----FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDD---GLRAKV  418 (563)
Q Consensus       347 -----V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~---~~~~kl  418 (563)
                           |+||+.+|+|.+++...   ....+++.++..++.|++.||+|||+++   ++||||||+|||++.   ++.+||
T Consensus       102 ~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL  175 (327)
T 3lm5_A          102 SEIILILEYAAGGEIFSLCLPE---LAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKI  175 (327)
T ss_dssp             SEEEEEEECCTTEEGGGGGSSC---C-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEE
T ss_pred             CeEEEEEEecCCCcHHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEE
Confidence                 68999999999998652   2467999999999999999999999997   999999999999998   789999


Q ss_pred             eecCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCC
Q 044997          419 ADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDS  498 (563)
Q Consensus       419 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~  498 (563)
                      +|||+++......    ......||+.|+|||++.+..             ++.++||||||+++|||++|+.||.....
T Consensus       176 ~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~-------------~~~~~DiwslG~il~~ll~g~~pf~~~~~  238 (327)
T 3lm5_A          176 VDFGMSRKIGHAC----ELREIMGTPEYLAPEILNYDP-------------ITTATDMWNIGIIAYMLLTHTSPFVGEDN  238 (327)
T ss_dssp             CCGGGCEEC-------------CCCGGGCCHHHHTTCC-------------CCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             eeCccccccCCcc----ccccccCCcCccCCeeecCCC-------------CCchhhHHHHHHHHHHHHhCCCCCCCCCc
Confidence            9999998654322    123357999999999885544             48899999999999999999999965432


Q ss_pred             C--------------chhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          499 E--------------PTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       499 ~--------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                      .              ......+...+.+++.+||+.||.+||++.|+++.
T Consensus       239 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h  288 (327)
T 3lm5_A          239 QETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH  288 (327)
T ss_dssp             HHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred             hHHHHHHHhcccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence            1              11122345668999999999999999999998763

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.1e-37  Score=319.04  Aligned_cols=216  Identities=25%  Similarity=0.388  Sum_probs=170.6

Q ss_pred             hcCCCccceecccCcEEEEEEEE--CCceEEEEEeccCC-----hHHHHHHHHHHHhccccce-----------------
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNK-----SKEFFAELKVLCKIHHINV-----------------  346 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~-----~~~f~~Ei~~l~~l~H~ni-----------------  346 (563)
                      .++|...+.||+|+||.||+|..  +++.||||++....     .+++.+|+++|++++||||                 
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            46789999999999999999987  47899999985432     3568899999999999997                 


Q ss_pred             ----EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecC
Q 044997          347 ----FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFG  422 (563)
Q Consensus       347 ----V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFG  422 (563)
                          |+||+ +++|.+++..      ..+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~------~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg  173 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKH------EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFG  173 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCT
T ss_pred             eEEEEEecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeee
Confidence                34555 5677776653      45899999999999999999999998   9999999999999999999999999


Q ss_pred             CCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCchh
Q 044997          423 LVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTK  502 (563)
Q Consensus       423 la~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~~  502 (563)
                      +++.....      .+...||+.|+|||++.+.            ..++.++||||+||++|||++|+.||.+.+.....
T Consensus       174 ~a~~~~~~------~~~~~~t~~y~aPE~~~~~------------~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l  235 (367)
T 1cm8_A          174 LARQADSE------MTGYVVTRWYRAPEVILNW------------MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQL  235 (367)
T ss_dssp             TCEECCSS------CCSSCSCGGGCCTHHHHTT------------TCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred             cccccccc------cCcCcCCCCcCCHHHHhCC------------CCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            99864321      2345789999999987542            23589999999999999999999999754321100


Q ss_pred             -----------------------------------------hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          503 -----------------------------------------MKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       503 -----------------------------------------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                                                               .....+.+.+|+.+||+.||.+|||+.|+++.
T Consensus       236 ~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h  308 (367)
T 1cm8_A          236 KEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH  308 (367)
T ss_dssp             HHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence                                                     01124558899999999999999999999873

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.4e-37  Score=316.94  Aligned_cols=224  Identities=26%  Similarity=0.351  Sum_probs=174.5

Q ss_pred             HHHhcCCCccceecccCcEEEEEEEEC--CceEEEEEeccCC--------hHHHHHHHHHHHhccccce-----------
Q 044997          288 EEATNNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNK--------SKEFFAELKVLCKIHHINV-----------  346 (563)
Q Consensus       288 ~~~~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~--------~~~f~~Ei~~l~~l~H~ni-----------  346 (563)
                      ....++|...+.||+|+||.||+|+..  ++.||||.++...        .+.+.+|++++++++||||           
T Consensus         6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   85 (346)
T 1ua2_A            6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS   85 (346)
T ss_dssp             -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred             HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC
Confidence            344578999999999999999999874  7889999986422        2468899999999999998           


Q ss_pred             ----EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecC
Q 044997          347 ----FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFG  422 (563)
Q Consensus       347 ----V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFG  422 (563)
                          |+||+++ +|.+++..    ....+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||
T Consensus        86 ~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg  157 (346)
T 1ua2_A           86 NISLVFDFMET-DLEVIIKD----NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFG  157 (346)
T ss_dssp             CCEEEEECCSE-EHHHHHTT----CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCG
T ss_pred             ceEEEEEcCCC-CHHHHHHh----cCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecc
Confidence                4677764 77777754    2356899999999999999999999998   9999999999999999999999999


Q ss_pred             CCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCchh
Q 044997          423 LVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTK  502 (563)
Q Consensus       423 la~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~~  502 (563)
                      +++.......   ......||+.|+|||.+.+..            .++.++|||||||++|||++|..||.........
T Consensus       158 ~a~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~------------~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~  222 (346)
T 1ua2_A          158 LAKSFGSPNR---AYTHQVVTRWYRAPELLFGAR------------MYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQL  222 (346)
T ss_dssp             GGSTTTSCCC---CCCCSCCCCTTCCHHHHTTCS------------CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred             cceeccCCcc---cCCcccccccccCchHhhCCC------------CCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHH
Confidence            9986543221   223457899999999875432            3488999999999999999999888654311000


Q ss_pred             --------------------------------------hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          503 --------------------------------------MKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       503 --------------------------------------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                                                            .....+.+.+++.+||+.||.+|||+.|+++.
T Consensus       223 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  292 (346)
T 1ua2_A          223 TRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  292 (346)
T ss_dssp             HHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             HHHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence                                                  01223568999999999999999999999874

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=8.5e-37  Score=333.05  Aligned_cols=218  Identities=24%  Similarity=0.403  Sum_probs=181.0

Q ss_pred             cCCCccceecccCcEEEEEEEEC--CceEEEEEeccC------ChHHHHHHHHHHHhccccce---------------EE
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSN------KSKEFFAELKVLCKIHHINV---------------FI  348 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~------~~~~f~~Ei~~l~~l~H~ni---------------V~  348 (563)
                      ++|...+.||+|+||.||+++..  ++.||+|+++..      ..+.+.+|+++|++++||||               |+
T Consensus       185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm  264 (543)
T 3c4z_A          185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM  264 (543)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence            67888899999999999999984  789999998643      34668899999999999997               57


Q ss_pred             EeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccc
Q 044997          349 STFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEE  428 (563)
Q Consensus       349 e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~  428 (563)
                      ||+++|+|.+++.... .....+++..+..++.||+.||+|||+++   |+||||||+|||++.++++||+|||+++...
T Consensus       265 E~~~gg~L~~~l~~~~-~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~  340 (543)
T 3c4z_A          265 TIMNGGDIRYHIYNVD-EDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK  340 (543)
T ss_dssp             CCCTTCBHHHHHHTSS-TTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EeccCCCHHHHHHHhh-cccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence            9999999999987521 12356999999999999999999999997   9999999999999999999999999998654


Q ss_pred             cccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCch-------
Q 044997          429 RTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPT-------  501 (563)
Q Consensus       429 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~-------  501 (563)
                      ....   ......||+.|+|||++.+..|             +.++|||||||++|||++|+.||........       
T Consensus       341 ~~~~---~~~~~~GT~~Y~APE~l~~~~~-------------~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~  404 (543)
T 3c4z_A          341 AGQT---KTKGYAGTPGFMAPELLLGEEY-------------DFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQR  404 (543)
T ss_dssp             TTCC---CBCCCCSCTTTSCHHHHTTCCB-------------CTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHH
T ss_pred             CCCc---ccccccCCccccChhhhcCCCC-------------ChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHH
Confidence            3221   1233579999999999865544             8899999999999999999999976543211       


Q ss_pred             -------hhHHHHHHHHHHHHHhhccCCCCCCCHH
Q 044997          502 -------KMKSLITIMAAVAEWCLNEDAVDRPEMR  529 (563)
Q Consensus       502 -------~~~~~~~~l~~li~~cl~~dP~~RPs~~  529 (563)
                             .+..+...+.+++.+||+.||.+||++.
T Consensus       405 i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~  439 (543)
T 3c4z_A          405 VLEQAVTYPDKFSPASKDFCEALLQKDPEKRLGFR  439 (543)
T ss_dssp             HHHCCCCCCTTSCHHHHHHHHHHSCSSGGGSCCCB
T ss_pred             HhhcccCCCcccCHHHHHHHHHhccCCHhHCCCCc
Confidence                   1123345689999999999999999763

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=1.4e-36  Score=306.03  Aligned_cols=216  Identities=25%  Similarity=0.425  Sum_probs=177.4

Q ss_pred             CCCccceecccCcEEEEEEEEC--CceEEEEEeccCC-----hHHHHHHHHHHHhccccce-------------------
Q 044997          293 NFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNK-----SKEFFAELKVLCKIHHINV-------------------  346 (563)
Q Consensus       293 ~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~-----~~~f~~Ei~~l~~l~H~ni-------------------  346 (563)
                      .|...+.||+|+||.||+|...  +..||+|.+....     .+.+.+|++++++++||||                   
T Consensus        27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  106 (290)
T 1t4h_A           27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL  106 (290)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred             eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence            3667789999999999999884  5779999986432     3568899999999999997                   


Q ss_pred             EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEec-CCCcEEEeecCCCc
Q 044997          347 FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLD-DGLRAKVADFGLVK  425 (563)
Q Consensus       347 V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~-~~~~~kl~DFGla~  425 (563)
                      |+||+++|+|.+++..     ...+++..+..++.|++.||.|||+++ ++++||||||+|||++ +++.+||+|||+++
T Consensus       107 v~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~  180 (290)
T 1t4h_A          107 VTELMTSGTLKTYLKR-----FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLAT  180 (290)
T ss_dssp             EEECCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred             EEEecCCCCHHHHHHH-----ccCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence            4688889999999864     256899999999999999999999985 3499999999999998 78999999999987


Q ss_pred             ccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCch----
Q 044997          426 LEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPT----  501 (563)
Q Consensus       426 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~----  501 (563)
                      .....     ......||+.|+|||.+.              +.++.++||||||+++|||++|+.||........    
T Consensus       181 ~~~~~-----~~~~~~~t~~y~aPE~~~--------------~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~  241 (290)
T 1t4h_A          181 LKRAS-----FAKAVIGTPEFMAPEMYE--------------EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRR  241 (290)
T ss_dssp             GCCTT-----SBEESCSSCCCCCGGGGG--------------TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHH
T ss_pred             ccccc-----ccccccCCcCcCCHHHHh--------------ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHH
Confidence            53322     123356899999999873              2358999999999999999999999965432111    


Q ss_pred             ---------hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          502 ---------KMKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       502 ---------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                               ......+.+.+++.+||+.||.+|||+.|+++
T Consensus       242 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          242 VTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             HTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HhccCCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence                     11223356899999999999999999999986

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=1.8e-37  Score=318.94  Aligned_cols=220  Identities=20%  Similarity=0.323  Sum_probs=171.1

Q ss_pred             HhcCCCccceecccCcEEEEEEEE--CCceEEEEEeccCC-----hHHHHHHHHHHHhccccce---------------E
Q 044997          290 ATNNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNK-----SKEFFAELKVLCKIHHINV---------------F  347 (563)
Q Consensus       290 ~~~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~-----~~~f~~Ei~~l~~l~H~ni---------------V  347 (563)
                      ..++|...+.||+|+||.||+|+.  +++.||||+++...     .+.+.+|++++++++||||               |
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  111 (329)
T 3gbz_A           32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI  111 (329)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred             chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence            346799999999999999999986  47899999997543     2457899999999999997               5


Q ss_pred             EEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEe-----cCCCcEEEeecC
Q 044997          348 ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILL-----DDGLRAKVADFG  422 (563)
Q Consensus       348 ~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl-----~~~~~~kl~DFG  422 (563)
                      +||++ |+|.+++..     ...+++..+..++.|++.||+|||+++   |+||||||+|||+     +.++.+||+|||
T Consensus       112 ~e~~~-~~L~~~~~~-----~~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg  182 (329)
T 3gbz_A          112 FEYAE-NDLKKYMDK-----NPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFG  182 (329)
T ss_dssp             EECCS-EEHHHHHHH-----CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTT
T ss_pred             EecCC-CCHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCC
Confidence            68777 588888864     346999999999999999999999997   9999999999999     455669999999


Q ss_pred             CCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCchh
Q 044997          423 LVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTK  502 (563)
Q Consensus       423 la~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~~  502 (563)
                      +++.......   ......||+.|+|||++.+..            .++.++|||||||++|||++|+.||.........
T Consensus       183 ~a~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~------------~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~  247 (329)
T 3gbz_A          183 LARAFGIPIR---QFTHEIITLWYRPPEILLGSR------------HYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQL  247 (329)
T ss_dssp             HHHHHC--------------CCTTCCHHHHTTCC------------CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred             CccccCCccc---ccCCCcCCccccCHHHhcCCC------------CCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHH
Confidence            9976532211   223456899999999885432            3589999999999999999999998654321100


Q ss_pred             ----------------------------------------hHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          503 ----------------------------------------MKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       503 ----------------------------------------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                                                              ...+.+.+.+|+.+||+.||.+|||+.|+++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          248 FKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             HHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence                                                    0013456889999999999999999999876

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=2e-37  Score=317.74  Aligned_cols=219  Identities=22%  Similarity=0.338  Sum_probs=171.8

Q ss_pred             cCCCccceecccCcEEEEEEEEC--CceEEEEEeccCCh----HHHHHHHHHHHhccccce---------------EEEe
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNKS----KEFFAELKVLCKIHHINV---------------FIST  350 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~----~~f~~Ei~~l~~l~H~ni---------------V~e~  350 (563)
                      ++|...+.||+|+||.||+|+..  ++.||+|.++....    ..+.+|++++++++||||               |+||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            57888999999999999999884  78899999875432    245679999999999997               5677


Q ss_pred             ecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccccc
Q 044997          351 FGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERT  430 (563)
Q Consensus       351 ~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~  430 (563)
                      ++ |+|.+++..    ....+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus        82 ~~-~~l~~~~~~----~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~  153 (324)
T 3mtl_A           82 LD-KDLKQYLDD----CGNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIP  153 (324)
T ss_dssp             CS-EEHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC---
T ss_pred             cc-cCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCC
Confidence            76 588887764    2456999999999999999999999998   999999999999999999999999998754322


Q ss_pred             cccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCch---------
Q 044997          431 NEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPT---------  501 (563)
Q Consensus       431 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~---------  501 (563)
                      .   .......||+.|+|||.+.+.            ..++.++|||||||++|||++|+.||........         
T Consensus       154 ~---~~~~~~~~t~~y~aPE~~~~~------------~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~  218 (324)
T 3mtl_A          154 T---KTYDNEVVTLWYRPPDILLGS------------TDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILG  218 (324)
T ss_dssp             ------------CGGGCCHHHHTTC------------CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred             c---cccccccCcccccChhhhcCC------------CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence            1   122335689999999987542            2358899999999999999999999965431110         


Q ss_pred             -------------------------------hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          502 -------------------------------KMKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       502 -------------------------------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                                                     ....+...+.+|+.+||+.||.+|||+.|+++
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  281 (324)
T 3mtl_A          219 TPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK  281 (324)
T ss_dssp             CCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             CCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence                                           00122345789999999999999999999987

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=4.8e-37  Score=309.93  Aligned_cols=219  Identities=23%  Similarity=0.385  Sum_probs=182.1

Q ss_pred             cCCCccceecccCcEEEEEEEEC--CceEEEEEeccC------ChHHHHHHHHHHHhccccce---------------EE
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSN------KSKEFFAELKVLCKIHHINV---------------FI  348 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~------~~~~f~~Ei~~l~~l~H~ni---------------V~  348 (563)
                      ++|...+.||+|+||.||++...  ++.+|+|.+...      ..+.+.+|++++++++|+||               |+
T Consensus        15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   94 (294)
T 2rku_A           15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL   94 (294)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEE
Confidence            56888999999999999999985  678999998643      23568899999999999997               57


Q ss_pred             EeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccc
Q 044997          349 STFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEE  428 (563)
Q Consensus       349 e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~  428 (563)
                      ||+++++|.+++..     ...+++.++..++.|++.||+|||+++   ++||||||+|||+++++++||+|||+++...
T Consensus        95 e~~~~~~L~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~  166 (294)
T 2rku_A           95 ELCRRRSLLELHKR-----RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVE  166 (294)
T ss_dssp             ECCTTCBHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             ecCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence            99999999988764     256899999999999999999999997   9999999999999999999999999998654


Q ss_pred             cccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc--------
Q 044997          429 RTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP--------  500 (563)
Q Consensus       429 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~--------  500 (563)
                      ....   ......||+.|+|||.+.+..             ++.++||||||+++|||++|+.||.......        
T Consensus       167 ~~~~---~~~~~~~~~~y~aPE~~~~~~-------------~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~  230 (294)
T 2rku_A          167 YDGE---RKKVLCGTPNYIAPEVLSKKG-------------HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN  230 (294)
T ss_dssp             STTC---CBCCCCSCCSSCCHHHHTTSC-------------BCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT
T ss_pred             cCcc---ccccccCCCCcCCcchhccCC-------------CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhc
Confidence            3221   123356899999999885543             3789999999999999999999986543211        


Q ss_pred             --hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          501 --TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       501 --~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                        .....+...+.+++.+||+.||++||++.|+++.
T Consensus       231 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~  266 (294)
T 2rku_A          231 EYSIPKHINPVAASLIQKMLQTDPTARPTINELLND  266 (294)
T ss_dssp             CCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             cCCCccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence              1112344568999999999999999999999874

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=3.5e-37  Score=316.75  Aligned_cols=220  Identities=25%  Similarity=0.378  Sum_probs=176.0

Q ss_pred             cCCCccceecccCcEEEEEEEEC--CceEEEEEeccCC-----hHHHHHHHHHHHhccccce---------------EEE
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNK-----SKEFFAELKVLCKIHHINV---------------FIS  349 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~-----~~~f~~Ei~~l~~l~H~ni---------------V~e  349 (563)
                      ++|+..+.||+|+||.||+|+..  ++.||||++....     .+.+.+|++++++++||||               |+|
T Consensus        25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  104 (331)
T 4aaa_A           25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE  104 (331)
T ss_dssp             GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence            56888999999999999999985  7889999986433     2457899999999999997               578


Q ss_pred             eecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccccc
Q 044997          350 TFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEER  429 (563)
Q Consensus       350 ~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~  429 (563)
                      |+++++|.+++..     ...+++..+..++.|++.||.|||+++   ++||||||+|||++.++.+||+|||+++....
T Consensus       105 ~~~~~~l~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  176 (331)
T 4aaa_A          105 FVDHTILDDLELF-----PNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAA  176 (331)
T ss_dssp             CCSEEHHHHHHHS-----TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred             cCCcchHHHHHhh-----ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence            8888888877643     356999999999999999999999997   99999999999999999999999999976543


Q ss_pred             ccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCchh-------
Q 044997          430 TNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTK-------  502 (563)
Q Consensus       430 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~~-------  502 (563)
                      ...   ......||+.|+|||.+.+.            ..++.++||||||+++|||++|+.||.........       
T Consensus       177 ~~~---~~~~~~~t~~y~aPE~~~~~------------~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  241 (331)
T 4aaa_A          177 PGE---VYDDEVATRWYRAPELLVGD------------VKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCL  241 (331)
T ss_dssp             ----------CCCCCTTCCHHHHTTC------------TTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred             Ccc---ccCCCcCCccccCcccccCC------------CCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHh
Confidence            221   22335689999999987543            23588999999999999999999998654321100       


Q ss_pred             ----------------------------------hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          503 ----------------------------------MKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       503 ----------------------------------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                                                        ...+.+.+.+|+.+||+.||.+|||+.|+++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  307 (331)
T 4aaa_A          242 GNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH  307 (331)
T ss_dssp             CSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             CCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence                                              01234568999999999999999999999873

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=1.1e-36  Score=319.86  Aligned_cols=217  Identities=20%  Similarity=0.269  Sum_probs=175.7

Q ss_pred             hcCCCccceecccCcEEEEEEEE--CCceEEEEEeccCC--hHHHHHHHHHHHhcc--------ccce------------
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNK--SKEFFAELKVLCKIH--------HINV------------  346 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~--~~~f~~Ei~~l~~l~--------H~ni------------  346 (563)
                      .++|...+.||+|+||.||+|+.  .++.||||+++...  .+.+.+|+++|++++        |+||            
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~  115 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGV  115 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEET
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCC
Confidence            36799999999999999999987  47889999997653  467889999999996        5665            


Q ss_pred             -------EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCceEeCCCCCCCeEecCCC----
Q 044997          347 -------FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDH-TKARYVHRDIKTSNILLDDGL----  414 (563)
Q Consensus       347 -------V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivHrDLk~~NILl~~~~----  414 (563)
                             |+||+ +|+|.+++..   .....+++..+..++.|++.||+|||++ +   |+||||||+|||++.++    
T Consensus       116 ~~~~~~lv~e~~-~~~l~~~~~~---~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~  188 (397)
T 1wak_A          116 NGTHICMVFEVL-GHHLLKWIIK---SNYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIR  188 (397)
T ss_dssp             TEEEEEEEECCC-CCBHHHHHHH---TTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHH
T ss_pred             CCceEEEEEecc-CccHHHHHHh---cccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhh
Confidence                   45666 5566666653   2235699999999999999999999998 7   99999999999999775    


Q ss_pred             ---------------------------------------------cEEEeecCCCcccccccccccccccccCCCcccCc
Q 044997          415 ---------------------------------------------RAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPP  449 (563)
Q Consensus       415 ---------------------------------------------~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~AP  449 (563)
                                                                   .+||+|||+++.....      .....||+.|+||
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~------~~~~~gt~~y~aP  262 (397)
T 1wak_A          189 RLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH------FTEDIQTRQYRSL  262 (397)
T ss_dssp             HHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC------SCSCCSCGGGCCH
T ss_pred             hhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc------CccCCCCCcccCC
Confidence                                                         8999999999864322      2335789999999


Q ss_pred             ccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCch----------------------------
Q 044997          450 EYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPT----------------------------  501 (563)
Q Consensus       450 E~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~----------------------------  501 (563)
                      |++.+..             ++.++|||||||++|||++|+.||........                            
T Consensus       263 E~~~~~~-------------~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~  329 (397)
T 1wak_A          263 EVLIGSG-------------YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYS  329 (397)
T ss_dssp             HHHHTSC-------------CCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTG
T ss_pred             hhhcCCC-------------CCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhccccc
Confidence            9886544             48899999999999999999999965432110                            


Q ss_pred             ------------------------------hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          502 ------------------------------KMKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       502 ------------------------------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                                                    ........+.+|+.+||+.||++|||+.|+++
T Consensus       330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          330 KEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             GGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             ccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence                                          01233456889999999999999999999986

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=1.1e-37  Score=311.89  Aligned_cols=227  Identities=20%  Similarity=0.315  Sum_probs=181.7

Q ss_pred             cCCCccceecccCcEEEEEEEEC--CceEEEEEeccCC-----hHHHHHHHHHHHhccccce-----------------E
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNK-----SKEFFAELKVLCKIHHINV-----------------F  347 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~-----~~~f~~Ei~~l~~l~H~ni-----------------V  347 (563)
                      ++|+..+.||+|+||.||+++..  ++.||+|.++...     .+.+.+|++++++++||||                 |
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   85 (279)
T 2w5a_A            6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   85 (279)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEE
T ss_pred             hheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEE
Confidence            57888999999999999999884  7889999986432     3568899999999999997                 5


Q ss_pred             EEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCceEeCCCCCCCeEecCCCcEEEeecCCCc
Q 044997          348 ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHT--KARYVHRDIKTSNILLDDGLRAKVADFGLVK  425 (563)
Q Consensus       348 ~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivHrDLk~~NILl~~~~~~kl~DFGla~  425 (563)
                      +||+++|+|.+++.... .....+++..++.++.|++.||+|||+.+  ..+++||||||+|||++.++.+||+|||+++
T Consensus        86 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~  164 (279)
T 2w5a_A           86 MEYCEGGDLASVITKGT-KERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  164 (279)
T ss_dssp             EECCTTEEHHHHHHHHH-HTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred             EeCCCCCCHHHHHHhhc-ccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence            78888999999987532 22456999999999999999999999975  1349999999999999999999999999987


Q ss_pred             ccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc-----
Q 044997          426 LEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP-----  500 (563)
Q Consensus       426 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~-----  500 (563)
                      .......   ......|++.|+|||.+.+..             ++.++||||||+++|||++|+.||.......     
T Consensus       165 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~-------------~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i  228 (279)
T 2w5a_A          165 ILNHDTS---FAKTFVGTPYYMSPEQMNRMS-------------YNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI  228 (279)
T ss_dssp             HC---CH---HHHHHHSCCTTCCHHHHHCC--------------CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             eeccccc---cccccCCCccccChHHhccCC-------------CCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHH
Confidence            6543211   122346899999999885443             4889999999999999999999986543211     


Q ss_pred             ------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 044997          501 ------TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAIL  535 (563)
Q Consensus       501 ------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  535 (563)
                            .....+...+.+++.+||+.||.+||++.|+++.+
T Consensus       229 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~  269 (279)
T 2w5a_A          229 REGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENP  269 (279)
T ss_dssp             HHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred             hhcccccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhCh
Confidence                  11123346689999999999999999999999865

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=1.1e-36  Score=315.62  Aligned_cols=223  Identities=23%  Similarity=0.310  Sum_probs=176.0

Q ss_pred             cCCCccceecccCcEEEEEEEE--CCceEEEEEeccCC-----hHHHHHHHHHHHhccccce------------------
Q 044997          292 NNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNK-----SKEFFAELKVLCKIHHINV------------------  346 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~-----~~~f~~Ei~~l~~l~H~ni------------------  346 (563)
                      ++|+..+.||+|+||.||+|+.  +++.||||++....     ...+.+|++++++++||||                  
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   96 (351)
T 3mi9_A           17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   96 (351)
T ss_dssp             GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred             cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence            5788999999999999999998  47899999985432     3578899999999999997                  


Q ss_pred             -----EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeec
Q 044997          347 -----FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADF  421 (563)
Q Consensus       347 -----V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DF  421 (563)
                           |+||++ |+|.+.+..    ....+++.++..++.|++.||+|||+++   |+||||||+|||++.++.+||+||
T Consensus        97 ~~~~lv~e~~~-~~l~~~l~~----~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Df  168 (351)
T 3mi9_A           97 GSIYLVFDFCE-HDLAGLLSN----VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADF  168 (351)
T ss_dssp             CEEEEEEECCS-EEHHHHHHC----TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred             ceEEEEEeccC-CCHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccc
Confidence                 345554 355555543    2356999999999999999999999997   999999999999999999999999


Q ss_pred             CCCccccccccc-ccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc
Q 044997          422 GLVKLEERTNEK-EMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP  500 (563)
Q Consensus       422 Gla~~~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~  500 (563)
                      |+++........ ........||+.|+|||++.+..            .++.++|||||||++|||++|+.||.......
T Consensus       169 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------------~~~~~~DiwslG~il~ell~g~~pf~~~~~~~  236 (351)
T 3mi9_A          169 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGER------------DYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH  236 (351)
T ss_dssp             TTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCC------------SCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             hhcccccccccccccccCCcccccCccCchhhcCCC------------CCCcHhHHHHHHHHHHHHHhCCCCCCCCChHH
Confidence            999865432211 12223467899999999875432            34889999999999999999999986543110


Q ss_pred             hh-------------------------------------hHH-----HHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          501 TK-------------------------------------MKS-----LITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       501 ~~-------------------------------------~~~-----~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                      ..                                     ...     ..+.+.+|+.+||+.||++|||+.|+++.
T Consensus       237 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  312 (351)
T 3mi9_A          237 QLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  312 (351)
T ss_dssp             HHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence            00                                     000     12447899999999999999999999874

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.4e-36  Score=309.41  Aligned_cols=221  Identities=26%  Similarity=0.391  Sum_probs=179.9

Q ss_pred             HhcCCCccceecccCcEEEEEEEEC--CceEEEEEeccC-ChHHHHHHHHHHHhccccce---------------EEEee
Q 044997          290 ATNNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSN-KSKEFFAELKVLCKIHHINV---------------FISTF  351 (563)
Q Consensus       290 ~~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~-~~~~f~~Ei~~l~~l~H~ni---------------V~e~~  351 (563)
                      ..++|+..+.||+|+||.||+|...  ++.||+|.++.. ..+++.+|++++++++||||               |+||+
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  106 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYC  106 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecC
Confidence            4567999999999999999999885  789999999754 35789999999999999997               57899


Q ss_pred             cCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccccccc
Q 044997          352 GNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTN  431 (563)
Q Consensus       352 ~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~  431 (563)
                      ++|+|.+++..    ....+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+|||+++......
T Consensus       107 ~~~~L~~~~~~----~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~  179 (314)
T 3com_A          107 GAGSVSDIIRL----RNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM  179 (314)
T ss_dssp             TTEEHHHHHHH----HTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTTB
T ss_pred             CCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhhc
Confidence            99999998863    2356999999999999999999999997   9999999999999999999999999997654321


Q ss_pred             ccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc-----------
Q 044997          432 EKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP-----------  500 (563)
Q Consensus       432 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~-----------  500 (563)
                      .   ......|++.|+|||.+.+..             ++.++||||||+++|||++|+.||.......           
T Consensus       180 ~---~~~~~~~~~~y~aPE~~~~~~-------------~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~  243 (314)
T 3com_A          180 A---KRNTVIGTPFWMAPEVIQEIG-------------YNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPP  243 (314)
T ss_dssp             S---CBCCCCSCGGGCCHHHHSSSC-------------BCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC
T ss_pred             c---ccCccCCCCCccChhhcCCCC-------------CCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCc
Confidence            1   123356899999999885544             4889999999999999999999986533210           


Q ss_pred             --hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          501 --TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       501 --~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                        .....+.+.+.+++.+||+.||.+||++.++++
T Consensus       244 ~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          244 TFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             CCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence              112234567899999999999999999999987

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=8.7e-37  Score=342.65  Aligned_cols=234  Identities=23%  Similarity=0.370  Sum_probs=186.6

Q ss_pred             HhcCCCccceecccCcEEEEEEEEC--CceEEEEEeccC------ChHHHHHHHHHHHhc-cccce--------------
Q 044997          290 ATNNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSN------KSKEFFAELKVLCKI-HHINV--------------  346 (563)
Q Consensus       290 ~~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~------~~~~f~~Ei~~l~~l-~H~ni--------------  346 (563)
                      ..++|+..+.||+|+||.||+|+..  ++.||||+++..      ..+.+..|.++|..+ +|+||              
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~  418 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY  418 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence            3568999999999999999999884  577999998642      346688899999987 67776              


Q ss_pred             -EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCc
Q 044997          347 -FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK  425 (563)
Q Consensus       347 -V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~  425 (563)
                       |+||+.+|+|.+++..     ...+++..+..++.||+.||+|||+++   |+||||||+||||+.++++||+|||+++
T Consensus       419 lV~E~~~gg~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~  490 (674)
T 3pfq_A          419 FVMEYVNGGDLMYHIQQ-----VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK  490 (674)
T ss_dssp             EEEECCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCE
T ss_pred             EEEeCcCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceee
Confidence             6899999999999975     246999999999999999999999997   9999999999999999999999999998


Q ss_pred             ccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc-----
Q 044997          426 LEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP-----  500 (563)
Q Consensus       426 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~-----  500 (563)
                      ......   .......||+.|+|||++.+..|             +.++|||||||++|||++|+.||...+...     
T Consensus       491 ~~~~~~---~~~~~~~GT~~Y~APE~l~~~~~-------------~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i  554 (674)
T 3pfq_A          491 ENIWDG---VTTKTFCGTPDYIAPEIIAYQPY-------------GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI  554 (674)
T ss_dssp             ECCCTT---CCBCCCCSCSSSCCHHHHTCCCB-------------STHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             ccccCC---cccccccCCCcccCHhhhcCCCC-------------CccceEechHHHHHHHHcCCCCCCCCCHHHHHHHH
Confidence            533221   12344689999999999865554             899999999999999999999997653211     


Q ss_pred             -----hhhHHHHHHHHHHHHHhhccCCCCCCCH--HHHHHHHHHhhhcChhhhc
Q 044997          501 -----TKMKSLITIMAAVAEWCLNEDAVDRPEM--RDIVAILSQIMITSTEWEA  547 (563)
Q Consensus       501 -----~~~~~~~~~l~~li~~cl~~dP~~RPs~--~evl~~L~~i~~~~~~w~~  547 (563)
                           ..+..+...+.+|+.+||+.||.+||++  ....+.++.-.-...+|+.
T Consensus       555 ~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~~  608 (674)
T 3pfq_A          555 MEHNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEK  608 (674)
T ss_dssp             HSSCCCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCHHH
T ss_pred             HhCCCCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCHHH
Confidence                 1123445679999999999999999997  2222233333334455554

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=7.5e-37  Score=306.98  Aligned_cols=217  Identities=24%  Similarity=0.358  Sum_probs=180.8

Q ss_pred             cCCCccceecccCcEEEEEEEEC--CceEEEEEeccC------ChHHHHHHHHHHHhccccce---------------EE
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSN------KSKEFFAELKVLCKIHHINV---------------FI  348 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~------~~~~f~~Ei~~l~~l~H~ni---------------V~  348 (563)
                      ++|+..+.||+|+||.||+|+..  ++.||+|.+...      ..+.+.+|++++++++||||               |+
T Consensus        14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   93 (284)
T 2vgo_A           14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML   93 (284)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence            56888999999999999999885  578999998542      24678999999999999997               57


Q ss_pred             EeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccc
Q 044997          349 STFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEE  428 (563)
Q Consensus       349 e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~  428 (563)
                      ||+++|+|.+++..     ...+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++....
T Consensus        94 e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~  165 (284)
T 2vgo_A           94 EFAPRGELYKELQK-----HGRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAP  165 (284)
T ss_dssp             CCCTTEEHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECS
T ss_pred             EeCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCc
Confidence            88889999998865     246899999999999999999999987   9999999999999999999999999987543


Q ss_pred             cccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCch-------
Q 044997          429 RTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPT-------  501 (563)
Q Consensus       429 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~-------  501 (563)
                      ...     .....|++.|+|||.+.+..             ++.++||||||+++|||++|+.||........       
T Consensus       166 ~~~-----~~~~~~~~~y~aPE~~~~~~-------------~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~  227 (284)
T 2vgo_A          166 SLR-----RRTMCGTLDYLPPEMIEGKT-------------HDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV  227 (284)
T ss_dssp             SSC-----BCCCCSCGGGCCHHHHTTCC-------------BCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT
T ss_pred             ccc-----cccccCCCCcCCHHHhccCC-------------CCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhcc
Confidence            211     22356899999999886544             37899999999999999999999965432110       


Q ss_pred             ---hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          502 ---KMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       502 ---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                         ....+...+.+++.+||+.||.+||++.|+++.
T Consensus       228 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h  263 (284)
T 2vgo_A          228 DLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEH  263 (284)
T ss_dssp             CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred             ccCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence               112345668999999999999999999999873

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=5.3e-37  Score=316.13  Aligned_cols=220  Identities=23%  Similarity=0.383  Sum_probs=182.5

Q ss_pred             hcCCCccceecccCcEEEEEEEEC--CceEEEEEeccC------ChHHHHHHHHHHHhccccce---------------E
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSN------KSKEFFAELKVLCKIHHINV---------------F  347 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~------~~~~f~~Ei~~l~~l~H~ni---------------V  347 (563)
                      .++|...+.||+|+||.||+++..  ++.+|+|.+...      ..+.+.+|++++++++|+||               |
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  119 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV  119 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            357888999999999999999985  678999998643      23668899999999999997               5


Q ss_pred             EEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccc
Q 044997          348 ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLE  427 (563)
Q Consensus       348 ~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~  427 (563)
                      +||+.+++|.+++..     ...+++.++..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus       120 ~e~~~~~~L~~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~  191 (335)
T 2owb_A          120 LELCRRRSLLELHKR-----RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKV  191 (335)
T ss_dssp             ECCCTTCBHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EecCCCCCHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceec
Confidence            788899999988764     256899999999999999999999997   999999999999999999999999999865


Q ss_pred             ccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc-------
Q 044997          428 ERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP-------  500 (563)
Q Consensus       428 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~-------  500 (563)
                      .....   ......||..|+|||++.+..             ++.++||||||+++|||++|+.||.......       
T Consensus       192 ~~~~~---~~~~~~gt~~y~aPE~~~~~~-------------~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~  255 (335)
T 2owb_A          192 EYDGE---RKKVLCGTPNYIAPEVLSKKG-------------HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKK  255 (335)
T ss_dssp             CSTTC---CBCCCCSCCSSCCHHHHHTSC-------------BCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH
T ss_pred             ccCcc---cccccCCCccccCHHHhccCC-------------CCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhc
Confidence            43221   123357899999999886544             3789999999999999999999996543211       


Q ss_pred             ---hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          501 ---TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       501 ---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                         .....+...+.+++.+||+.||.+||++.|+++.
T Consensus       256 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~  292 (335)
T 2owb_A          256 NEYSIPKHINPVAASLIQKMLQTDPTARPTINELLND  292 (335)
T ss_dssp             TCCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             CCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence               1112334568999999999999999999999873

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=3.6e-37  Score=320.24  Aligned_cols=217  Identities=21%  Similarity=0.383  Sum_probs=179.2

Q ss_pred             cCCCccceecccCcEEEEEEEEC--CceEEEEEeccCC----hHHHHHHHHHHHhccccce---------------EEEe
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNK----SKEFFAELKVLCKIHHINV---------------FIST  350 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~----~~~f~~Ei~~l~~l~H~ni---------------V~e~  350 (563)
                      ++|+..+.||+|+||.||++...  ++.||+|.++...    .+.+.+|++++++++||||               |+||
T Consensus        33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  112 (360)
T 3eqc_A           33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH  112 (360)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence            56888999999999999999985  7889999987542    3568899999999999997               5799


Q ss_pred             ecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCceEeCCCCCCCeEecCCCcEEEeecCCCccccc
Q 044997          351 FGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDH-TKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEER  429 (563)
Q Consensus       351 ~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~  429 (563)
                      +++|+|.+++..     ...+++..+..++.|++.||.|||+. +   |+||||||+|||++.++.+||+|||+++....
T Consensus       113 ~~~~~L~~~l~~-----~~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  184 (360)
T 3eqc_A          113 MDGGSLDQVLKK-----AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  184 (360)
T ss_dssp             CTTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred             CCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCccccc
Confidence            999999999975     24689999999999999999999985 6   99999999999999999999999999875432


Q ss_pred             ccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCch--------
Q 044997          430 TNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPT--------  501 (563)
Q Consensus       430 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~--------  501 (563)
                      .     ......||+.|+|||++.+..             ++.++||||||+++|||++|+.||........        
T Consensus       185 ~-----~~~~~~gt~~y~aPE~~~~~~-------------~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  246 (360)
T 3eqc_A          185 S-----MANSFVGTRSYMSPERLQGTH-------------YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQV  246 (360)
T ss_dssp             H-----C----CCCCTTCCHHHHTTCC-------------CSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---
T ss_pred             c-----cccCCCCCCCeECHHHHcCCC-------------CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccc
Confidence            1     123357899999999886544             48899999999999999999999864321100        


Q ss_pred             ----------------------------------------------hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          502 ----------------------------------------------KMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       502 ----------------------------------------------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                                                                    ....+...+.+++.+||+.||++|||+.|+++.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  325 (360)
T 3eqc_A          247 EGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH  325 (360)
T ss_dssp             ---------------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             cccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence                                                          000123458899999999999999999999874

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=8.6e-37  Score=309.75  Aligned_cols=218  Identities=22%  Similarity=0.403  Sum_probs=180.8

Q ss_pred             hcCCCccceecccCcEEEEEEEEC--CceEEEEEeccC---ChHHHHHHHHHHHhccccce---------------EEEe
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSN---KSKEFFAELKVLCKIHHINV---------------FIST  350 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~---~~~~f~~Ei~~l~~l~H~ni---------------V~e~  350 (563)
                      .++|...+.||+|+||.||+++..  ++.||+|.++..   ..+.+.+|++++++++||||               |+||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL   87 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence            457889999999999999999874  789999998754   23568899999999999997               5788


Q ss_pred             ecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEe---cCCCcEEEeecCCCccc
Q 044997          351 FGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILL---DDGLRAKVADFGLVKLE  427 (563)
Q Consensus       351 ~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl---~~~~~~kl~DFGla~~~  427 (563)
                      +++|+|.+++..     ...+++..+..++.|++.||.|||+++   ++||||||+||++   ++++.+||+|||+++..
T Consensus        88 ~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~  159 (304)
T 2jam_A           88 VSGGELFDRILE-----RGVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKME  159 (304)
T ss_dssp             CCSCBHHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCC
T ss_pred             CCCccHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceec
Confidence            999999998864     246899999999999999999999997   9999999999999   78899999999998754


Q ss_pred             ccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc-------
Q 044997          428 ERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP-------  500 (563)
Q Consensus       428 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~-------  500 (563)
                      ...     ......||+.|+|||.+.+..             ++.++||||||+++|||++|+.||.......       
T Consensus       160 ~~~-----~~~~~~~~~~y~aPE~~~~~~-------------~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~  221 (304)
T 2jam_A          160 QNG-----IMSTACGTPGYVAPEVLAQKP-------------YSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKE  221 (304)
T ss_dssp             CCB-----TTHHHHSCCCBCCTTTBSSCS-------------CCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH
T ss_pred             CCC-----ccccccCCCCccChHHhccCC-------------CCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc
Confidence            321     123346899999999885543             4889999999999999999999986543211       


Q ss_pred             -------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          501 -------TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       501 -------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                             .....+.+.+.+++.+||+.||.+||++.|+++.
T Consensus       222 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  262 (304)
T 2jam_A          222 GYYEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSH  262 (304)
T ss_dssp             CCCCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             CCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence                   1112345678999999999999999999999873

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=1.5e-36  Score=328.74  Aligned_cols=218  Identities=23%  Similarity=0.371  Sum_probs=181.8

Q ss_pred             hcCCCccceecccCcEEEEEEEEC--CceEEEEEecc-----CChHHHHHHHHHHHhccccce---------------EE
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRS-----NKSKEFFAELKVLCKIHHINV---------------FI  348 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~-----~~~~~f~~Ei~~l~~l~H~ni---------------V~  348 (563)
                      .++|+..+.||+|+||.||+++..  ++.||||.++.     ...+.+.+|+++|++++||||               |+
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  100 (486)
T 3mwu_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG  100 (486)
T ss_dssp             HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence            456999999999999999999884  78999999853     345779999999999999997               57


Q ss_pred             EeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEec---CCCcEEEeecCCCc
Q 044997          349 STFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLD---DGLRAKVADFGLVK  425 (563)
Q Consensus       349 e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~---~~~~~kl~DFGla~  425 (563)
                      ||+.+|+|.+++..     ...+++..+..++.|++.||.|||+++   |+||||||+|||++   .++.+||+|||+++
T Consensus       101 e~~~~~~L~~~~~~-----~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~  172 (486)
T 3mwu_A          101 ELYTGGELFDEIIK-----RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLST  172 (486)
T ss_dssp             CCCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTT
T ss_pred             EcCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCe
Confidence            88999999888865     246999999999999999999999998   99999999999995   45689999999998


Q ss_pred             ccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCC------
Q 044997          426 LEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE------  499 (563)
Q Consensus       426 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~------  499 (563)
                      ......    ......||+.|+|||++.+              .++.++||||+||++|||++|+.||......      
T Consensus       173 ~~~~~~----~~~~~~gt~~y~aPE~~~~--------------~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i  234 (486)
T 3mwu_A          173 CFQQNT----KMKDRIGTAYYIAPEVLRG--------------TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRV  234 (486)
T ss_dssp             TBCCC--------CCTTGGGGCCGGGGGS--------------CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             ECCCCC----ccCCCcCCCCCCCHHHhCC--------------CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            654322    2234579999999998743              3588999999999999999999999654321      


Q ss_pred             --------chhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          500 --------PTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       500 --------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                              ......+++.+.+++.+||+.||.+|||+.|+++.
T Consensus       235 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h  277 (486)
T 3mwu_A          235 ETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (486)
T ss_dssp             HHTCCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred             HhCCCCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                    12223456679999999999999999999999874

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=9.3e-37  Score=322.65  Aligned_cols=225  Identities=24%  Similarity=0.317  Sum_probs=161.3

Q ss_pred             CCc-cceecccCcEEEEEEEEC----CceEEEEEeccCC-hHHHHHHHHHHHhccccce-----------------EEEe
Q 044997          294 FDE-SRIIGRGGFGNVYFGLLG----DREAAIKKMRSNK-SKEFFAELKVLCKIHHINV-----------------FIST  350 (563)
Q Consensus       294 f~~-~~~LG~G~fG~Vy~g~~~----~~~vavK~~~~~~-~~~f~~Ei~~l~~l~H~ni-----------------V~e~  350 (563)
                      |.. .++||+|+||.||+|+..    ++.||||+++... .+.+.+|+++|++++||||                 |+||
T Consensus        22 y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~  101 (405)
T 3rgf_A           22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY  101 (405)
T ss_dssp             EECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEEC
T ss_pred             hhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeC
Confidence            444 568999999999999864    5789999997654 5678999999999999998                 3455


Q ss_pred             ecCCCcccccccccc----cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEe----cCCCcEEEeecC
Q 044997          351 FGNGSLSDHLHDPLL----KGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILL----DDGLRAKVADFG  422 (563)
Q Consensus       351 ~~~gsL~~~L~~~~~----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl----~~~~~~kl~DFG  422 (563)
                      ++ |+|.+++.....    .....+++..+..++.|++.||+|||+++   |+||||||+|||+    +.++.+||+|||
T Consensus       102 ~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg  177 (405)
T 3rgf_A          102 AE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMG  177 (405)
T ss_dssp             CS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEECCTT
T ss_pred             CC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEEEECC
Confidence            54 466666643211    11235999999999999999999999998   9999999999999    778999999999


Q ss_pred             CCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc--
Q 044997          423 LVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP--  500 (563)
Q Consensus       423 la~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~--  500 (563)
                      +++................||+.|+|||++.+..            .++.++|||||||++|||++|+.||.......  
T Consensus       178 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------------~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~  245 (405)
T 3rgf_A          178 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGAR------------HYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKT  245 (405)
T ss_dssp             CCC----------------CCCTTCCHHHHTTCC------------SCCHHHHHHHHHHHHHHHHHSSCTTCCCC-----
T ss_pred             CceecCCCCcccccCCCceecCcccCchhhcCCC------------cccchhhhHHHHHHHHHHHhCCCCCCCccccccc
Confidence            9986643322222234467999999999885432            35899999999999999999999996543210  


Q ss_pred             ------hhhHH-------------------------------------------------HHHHHHHHHHHhhccCCCCC
Q 044997          501 ------TKMKS-------------------------------------------------LITIMAAVAEWCLNEDAVDR  525 (563)
Q Consensus       501 ------~~~~~-------------------------------------------------~~~~l~~li~~cl~~dP~~R  525 (563)
                            .....                                                 ....+.+|+.+||+.||.+|
T Consensus       246 ~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R  325 (405)
T 3rgf_A          246 SNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKR  325 (405)
T ss_dssp             -CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGS
T ss_pred             cccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccC
Confidence                  00000                                                 03447799999999999999


Q ss_pred             CCHHHHHHH
Q 044997          526 PEMRDIVAI  534 (563)
Q Consensus       526 Ps~~evl~~  534 (563)
                      ||+.|+++.
T Consensus       326 ~ta~e~L~h  334 (405)
T 3rgf_A          326 ITSEQAMQD  334 (405)
T ss_dssp             CCHHHHHTS
T ss_pred             CCHHHHhcC
Confidence            999999874

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=7.9e-37  Score=341.97  Aligned_cols=231  Identities=23%  Similarity=0.372  Sum_probs=187.2

Q ss_pred             HHhcCCCccceecccCcEEEEEEEEC-----CceEEEEEeccCC----hHHHHHHHHHHHhccccce-------------
Q 044997          289 EATNNFDESRIIGRGGFGNVYFGLLG-----DREAAIKKMRSNK----SKEFFAELKVLCKIHHINV-------------  346 (563)
Q Consensus       289 ~~~~~f~~~~~LG~G~fG~Vy~g~~~-----~~~vavK~~~~~~----~~~f~~Ei~~l~~l~H~ni-------------  346 (563)
                      ...++|+..+.||+|+||.||+|.+.     +..||||.++...    .+.|.+|+.+|++++||||             
T Consensus       387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~  466 (656)
T 2j0j_A          387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVW  466 (656)
T ss_dssp             CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCE
T ss_pred             cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCceE
Confidence            34567889999999999999999874     3468999987543    2678999999999999997             


Q ss_pred             -EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCc
Q 044997          347 -FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK  425 (563)
Q Consensus       347 -V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~  425 (563)
                       |+||+++|+|.+++..    ....+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus       467 lv~E~~~~g~L~~~l~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~  539 (656)
T 2j0j_A          467 IIMELCTLGELRSFLQV----RKFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSR  539 (656)
T ss_dssp             EEEECCTTCBHHHHHHH----TTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCC
T ss_pred             EEEEcCCCCcHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCe
Confidence             6899999999999974    2356999999999999999999999997   9999999999999999999999999998


Q ss_pred             ccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCCCcCCCCCc----
Q 044997          426 LEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIRDDSEP----  500 (563)
Q Consensus       426 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p~~~~~~~~----  500 (563)
                      .......  .......+|+.|+|||.+.+..             ++.++||||||+++|||++ |+.||.......    
T Consensus       540 ~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~-------------~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~  604 (656)
T 2j0j_A          540 YMEDSTY--YKASKGKLPIKWMAPESINFRR-------------FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR  604 (656)
T ss_dssp             SCCC------------CCGGGCCHHHHHHCC-------------CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH
T ss_pred             ecCCCcc--eeccCCCCCcceeCHHHhcCCC-------------CCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHH
Confidence            6543221  1223345788999999885443             4889999999999999997 888886543211    


Q ss_pred             -------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 044997          501 -------TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMIT  541 (563)
Q Consensus       501 -------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~  541 (563)
                             .....++..+.+++.+||+.||.+||++.|+++.|+++++.
T Consensus       605 i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~  652 (656)
T 2j0j_A          605 IENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  652 (656)
T ss_dssp             HHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHcCCCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence                   11223446789999999999999999999999999998753

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.1e-36  Score=310.17  Aligned_cols=220  Identities=23%  Similarity=0.378  Sum_probs=169.1

Q ss_pred             cCCCccceecccCcEEEEEEEEC--CceEEEEEeccCC---hHHHHHHHHHHHhccccceE-------------------
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNK---SKEFFAELKVLCKIHHINVF-------------------  347 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~---~~~f~~Ei~~l~~l~H~niV-------------------  347 (563)
                      ++|...+.||+|+||.||+|+..  ++.||+|++....   .+++.+|++++++++||||+                   
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   90 (320)
T 2i6l_A           11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS   90 (320)
T ss_dssp             TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----
T ss_pred             CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccc
Confidence            57888999999999999999985  7899999987544   35688999999999999973                   


Q ss_pred             ----------EEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEec-CCCcE
Q 044997          348 ----------ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLD-DGLRA  416 (563)
Q Consensus       348 ----------~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~-~~~~~  416 (563)
                                +||++ |+|.+++..      ..+++..+..++.|++.||+|||+++   ++||||||+|||++ +++.+
T Consensus        91 ~~~~~~~~lv~e~~~-~~L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~  160 (320)
T 2i6l_A           91 LTELNSVYIVQEYME-TDLANVLEQ------GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVL  160 (320)
T ss_dssp             CCSCSEEEEEEECCS-EEHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEE
T ss_pred             ccccCceeEEeeccC-CCHHHHhhc------CCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeE
Confidence                      34444 567766643      46899999999999999999999997   99999999999997 56799


Q ss_pred             EEeecCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCC
Q 044997          417 KVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRD  496 (563)
Q Consensus       417 kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~  496 (563)
                      ||+|||+++................+|..|+|||.+...            ..++.++||||||+++|||++|+.||...
T Consensus       161 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~------------~~~~~~~Di~slG~il~el~~g~~pf~~~  228 (320)
T 2i6l_A          161 KIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSP------------NNYTKAIDMWAAGCIFAEMLTGKTLFAGA  228 (320)
T ss_dssp             EECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCT------------TCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             EEccCccccccCCCcccccccccccccccccCcHHhcCc------------ccCCchhhhHhHHHHHHHHHhCCCCCCCC
Confidence            999999998654332222223345679999999987432            24588999999999999999999999754


Q ss_pred             CCCch----------------------------------------hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          497 DSEPT----------------------------------------KMKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       497 ~~~~~----------------------------------------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                      .....                                        ....+...+.+++.+||+.||.+||++.|+++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (320)
T 2i6l_A          229 HELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS  305 (320)
T ss_dssp             SHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             CHHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence            32110                                        00123456899999999999999999999986

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=2.5e-36  Score=309.73  Aligned_cols=216  Identities=23%  Similarity=0.374  Sum_probs=177.8

Q ss_pred             cCCCccceecccCcEEEEEEEE---CCceEEEEEeccCC--hHHHHHHHHHHHhccccc------e--------------
Q 044997          292 NNFDESRIIGRGGFGNVYFGLL---GDREAAIKKMRSNK--SKEFFAELKVLCKIHHIN------V--------------  346 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~---~~~~vavK~~~~~~--~~~f~~Ei~~l~~l~H~n------i--------------  346 (563)
                      ++|+..+.||+|+||.||+|..   +++.||||.++...  .+.+.+|++++++++|+|      +              
T Consensus        14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~   93 (339)
T 1z57_A           14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHIC   93 (339)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEE
T ss_pred             CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEE
Confidence            5788999999999999999986   46889999997643  367889999999998865      2              


Q ss_pred             -EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecC-------------
Q 044997          347 -FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDD-------------  412 (563)
Q Consensus       347 -V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~-------------  412 (563)
                       |+||+ +++|.+++..   .+..++++..+..++.|++.||+|||+++   |+||||||+|||++.             
T Consensus        94 lv~e~~-~~~l~~~l~~---~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~  166 (339)
T 1z57_A           94 IVFELL-GLSTYDFIKE---NGFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKR  166 (339)
T ss_dssp             EEEECC-CCBHHHHHHH---TTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----C
T ss_pred             EEEcCC-CCCHHHHHHh---cCCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCcccc
Confidence             67888 8899998875   23357899999999999999999999997   999999999999987             


Q ss_pred             ------CCcEEEeecCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHH
Q 044997          413 ------GLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAEL  486 (563)
Q Consensus       413 ------~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~El  486 (563)
                            ++.+||+|||+++.....      .....||+.|+|||++.+..             ++.++||||||+++|||
T Consensus       167 ~~~~~~~~~~kl~Dfg~~~~~~~~------~~~~~gt~~y~aPE~~~~~~-------------~~~~~Di~slG~il~el  227 (339)
T 1z57_A          167 DERTLINPDIKVVDFGSATYDDEH------HSTLVSTRHYRAPEVILALG-------------WSQPCDVWSIGCILIEY  227 (339)
T ss_dssp             EEEEESCCCEEECCCSSCEETTSC------CCSSCSCGGGCCHHHHTTSC-------------CCTHHHHHHHHHHHHHH
T ss_pred             ccccccCCCceEeeCcccccCccc------cccccCCccccChHHhhCCC-------------CCcchhhHHHHHHHHHH
Confidence                  678999999999753321      23357899999999886544             48899999999999999


Q ss_pred             HcCCCCCcCCCCCchh------------------------------------------------------hHHHHHHHHH
Q 044997          487 ITGKRALIRDDSEPTK------------------------------------------------------MKSLITIMAA  512 (563)
Q Consensus       487 ltg~~p~~~~~~~~~~------------------------------------------------------~~~~~~~l~~  512 (563)
                      ++|+.||...+.....                                                      .....+.+.+
T Consensus       228 ~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  307 (339)
T 1z57_A          228 YLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFD  307 (339)
T ss_dssp             HHSSCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHH
T ss_pred             HhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHH
Confidence            9999999654321100                                                      0122456889


Q ss_pred             HHHHhhccCCCCCCCHHHHHH
Q 044997          513 VAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       513 li~~cl~~dP~~RPs~~evl~  533 (563)
                      ++.+||+.||.+|||+.|+++
T Consensus       308 li~~~L~~dP~~Rpt~~ell~  328 (339)
T 1z57_A          308 LIQKMLEYDPAKRITLREALK  328 (339)
T ss_dssp             HHHHHTCSSTTTSCCHHHHTT
T ss_pred             HHHHHhCcCcccccCHHHHhc
Confidence            999999999999999999986

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=2.1e-36  Score=316.27  Aligned_cols=216  Identities=23%  Similarity=0.322  Sum_probs=166.1

Q ss_pred             hcCCCccceecccCcEEEEEEEE--CCceEEEEEeccCC-----hHHHHHHHHHHHhccccceE----------------
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNK-----SKEFFAELKVLCKIHHINVF----------------  347 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~-----~~~f~~Ei~~l~~l~H~niV----------------  347 (563)
                      .++|...+.||+|+||.||+|+.  .++.||||+++...     .+.+.+|++++++++||||+                
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            36789999999999999999987  47889999986532     35688999999999999983                


Q ss_pred             -----EEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecC
Q 044997          348 -----ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFG  422 (563)
Q Consensus       348 -----~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFG  422 (563)
                           +||+. |+|.+++.       ..+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||
T Consensus       104 ~~~lv~e~~~-~~l~~~~~-------~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg  172 (371)
T 2xrw_A          104 DVYIVMELMD-ANLCQVIQ-------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG  172 (371)
T ss_dssp             EEEEEEECCS-EEHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCC
T ss_pred             ceEEEEEcCC-CCHHHHHh-------hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEee
Confidence                 34443 34555443       34899999999999999999999997   9999999999999999999999999


Q ss_pred             CCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc--
Q 044997          423 LVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP--  500 (563)
Q Consensus       423 la~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~--  500 (563)
                      +++......    ......||+.|+|||++.+..             ++.++|||||||++|||++|+.||...+...  
T Consensus       173 ~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~-------------~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~  235 (371)
T 2xrw_A          173 LARTAGTSF----MMTPYVVTRYYRAPEVILGMG-------------YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQW  235 (371)
T ss_dssp             C--------------------CTTCCHHHHTTCC-------------CCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred             ccccccccc----ccCCceecCCccCHHHhcCCC-------------CCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            998643221    223457899999999986544             4889999999999999999999996543110  


Q ss_pred             --------------------------------------------------hhhHHHHHHHHHHHHHhhccCCCCCCCHHH
Q 044997          501 --------------------------------------------------TKMKSLITIMAAVAEWCLNEDAVDRPEMRD  530 (563)
Q Consensus       501 --------------------------------------------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~e  530 (563)
                                                                        .........+.+|+.+||+.||.+|||++|
T Consensus       236 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e  315 (371)
T 2xrw_A          236 NKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDE  315 (371)
T ss_dssp             HHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred             HHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHH
Confidence                                                              001122556899999999999999999999


Q ss_pred             HHHH
Q 044997          531 IVAI  534 (563)
Q Consensus       531 vl~~  534 (563)
                      +++.
T Consensus       316 ~l~h  319 (371)
T 2xrw_A          316 ALQH  319 (371)
T ss_dssp             HHHS
T ss_pred             HhCC
Confidence            9874

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=1.3e-36  Score=303.47  Aligned_cols=219  Identities=24%  Similarity=0.397  Sum_probs=174.5

Q ss_pred             cCCCccceecccCcEEEEEEEEC--CceEEEEEeccC------ChHHHHHHHHHHHhccccce---------------EE
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSN------KSKEFFAELKVLCKIHHINV---------------FI  348 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~------~~~~f~~Ei~~l~~l~H~ni---------------V~  348 (563)
                      ++|...+.||+|+||.||+|+..  ++.||||.++..      ..+.+.+|++++++++||||               |+
T Consensus        11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   90 (276)
T 2h6d_A           11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM   90 (276)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence            57888999999999999999884  789999998643      24578899999999999997               57


Q ss_pred             EeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccc
Q 044997          349 STFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEE  428 (563)
Q Consensus       349 e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~  428 (563)
                      ||+++++|.+++..     ...+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+|||+++...
T Consensus        91 e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~  162 (276)
T 2h6d_A           91 EYVSGGELFDYICK-----HGRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMS  162 (276)
T ss_dssp             ECCCSCBHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCC
T ss_pred             eccCCCcHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccC
Confidence            99999999999865     246899999999999999999999998   9999999999999999999999999988654


Q ss_pred             cccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCch-------
Q 044997          429 RTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPT-------  501 (563)
Q Consensus       429 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~-------  501 (563)
                      ...    ......|++.|+|||.+.+..+            .+.++||||||+++|||++|+.||........       
T Consensus       163 ~~~----~~~~~~~~~~y~aPE~~~~~~~------------~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~  226 (276)
T 2h6d_A          163 DGE----FLRTSCGSPNYAAPEVISGRLY------------AGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGG  226 (276)
T ss_dssp             C-----------------CCTGGGTTSCC------------CHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC
T ss_pred             CCc----ceecccCCccccCHHHHcCCCC------------CCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC
Confidence            321    1223468999999998854432            25799999999999999999999865432110       


Q ss_pred             ---hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          502 ---KMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       502 ---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                         ....+...+.+++.+||+.||.+||++.|+++.
T Consensus       227 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h  262 (276)
T 2h6d_A          227 VFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH  262 (276)
T ss_dssp             CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             cccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence               111234568999999999999999999999874

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=5e-37  Score=314.32  Aligned_cols=235  Identities=26%  Similarity=0.441  Sum_probs=181.7

Q ss_pred             CHHHHHHHhcCCCccceecccCcEEEEEEEE--CCceEEEEEeccC--ChHHHHHHHHHHHhc-cccce-----------
Q 044997          283 SLEEIEEATNNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSN--KSKEFFAELKVLCKI-HHINV-----------  346 (563)
Q Consensus       283 ~~~el~~~~~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~--~~~~f~~Ei~~l~~l-~H~ni-----------  346 (563)
                      ++.++....++|+..+.||+|+||.||+|+.  +++.||||.+...  ..+++.+|+++++++ +||||           
T Consensus        15 ~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   94 (326)
T 2x7f_A           15 DLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKN   94 (326)
T ss_dssp             -CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC
T ss_pred             cchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeecc
Confidence            3344455678899999999999999999998  5789999998643  457899999999999 79986           


Q ss_pred             ----------EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcE
Q 044997          347 ----------FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRA  416 (563)
Q Consensus       347 ----------V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~  416 (563)
                                |+||+++|+|.+++...   ....+++..+..++.|++.||.|||+++   ++||||||+|||++.++.+
T Consensus        95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~  168 (326)
T 2x7f_A           95 PPGMDDQLWLVMEFCGAGSVTDLIKNT---KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEV  168 (326)
T ss_dssp             --CCCCEEEEEEECCTTEEHHHHHHHS---GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCE
T ss_pred             CccccceEEEEEEcCCCCcHHHHHHhc---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCE
Confidence                      46788888999988752   2356899999999999999999999997   9999999999999999999


Q ss_pred             EEeecCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCC
Q 044997          417 KVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRD  496 (563)
Q Consensus       417 kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~  496 (563)
                      ||+|||+++.......   ......||+.|+|||.+.....        ....++.++||||||+++|||++|+.||...
T Consensus       169 kl~Dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~--------~~~~~~~~~Di~slG~il~~l~~g~~p~~~~  237 (326)
T 2x7f_A          169 KLVDFGVSAQLDRTVG---RRNTFIGTPYWMAPEVIACDEN--------PDATYDFKSDLWSLGITAIEMAEGAPPLCDM  237 (326)
T ss_dssp             EECCCTTTC----------------CCGGGCCHHHHC----------------CCTTHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred             EEeeCcCceecCcCcc---ccccccCCccccChhhhccccc--------cCcCCCccchHHHHHHHHHHHHhCCCCCCCC
Confidence            9999999886543211   1233568999999998853211        1345689999999999999999999998654


Q ss_pred             CCCch------------hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          497 DSEPT------------KMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       497 ~~~~~------------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                      .....            ....+...+.+++.+||+.||.+||++.++++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  287 (326)
T 2x7f_A          238 HPMRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH  287 (326)
T ss_dssp             CHHHHHHHHHHSCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             cHHHHHHHhhcCccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            32111            011234568999999999999999999999873

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=9.2e-37  Score=305.59  Aligned_cols=221  Identities=23%  Similarity=0.308  Sum_probs=179.2

Q ss_pred             HhcCCCccceecccCcEEEEEEEEC--CceEEEEEeccC-----ChHHHHHHHHHHHhc-cccce---------------
Q 044997          290 ATNNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSN-----KSKEFFAELKVLCKI-HHINV---------------  346 (563)
Q Consensus       290 ~~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~-----~~~~f~~Ei~~l~~l-~H~ni---------------  346 (563)
                      ..++|+..+.||+|+||.||+|+..  ++.||||.++..     ...++.+|+..+.++ +||||               
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l   88 (289)
T 1x8b_A            9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI   88 (289)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred             ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence            3567899999999999999999984  789999998753     235688999999999 99997               


Q ss_pred             EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecC--------------
Q 044997          347 FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDD--------------  412 (563)
Q Consensus       347 V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~--------------  412 (563)
                      |+||+++|+|.+++.... .....+++..+..++.|++.||+|||+++   |+||||||+|||++.              
T Consensus        89 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~  164 (289)
T 1x8b_A           89 QNEYCNGGSLADAISENY-RIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDED  164 (289)
T ss_dssp             EEECCTTCBHHHHHHHHH-HHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC---------------
T ss_pred             EEEecCCCcHHHHHHhhc-ccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcccccccccc
Confidence            579999999999997532 11256899999999999999999999997   999999999999984              


Q ss_pred             -----CCcEEEeecCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHH
Q 044997          413 -----GLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELI  487 (563)
Q Consensus       413 -----~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ell  487 (563)
                           ...+||+|||+++.....       ....||+.|+|||.+.+..            .+++++||||||+++|||+
T Consensus       165 ~~~~~~~~~kl~Dfg~~~~~~~~-------~~~~gt~~y~aPE~~~~~~------------~~~~~~Di~slG~il~~l~  225 (289)
T 1x8b_A          165 DWASNKVMFKIGDLGHVTRISSP-------QVEEGDSRFLANEVLQENY------------THLPKADIFALALTVVCAA  225 (289)
T ss_dssp             -----CCCEEECCCTTCEETTCS-------CCCCCCGGGCCHHHHTTCC------------TTHHHHHHHHHHHHHHHHT
T ss_pred             cccCCceEEEEcccccccccCCc-------cccCCCccccChhHhcCCC------------CCCchhhHHHHHHHHHHHh
Confidence                 448999999998865432       1235899999999885431            2367999999999999999


Q ss_pred             cCCCCCcCCCC--------CchhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          488 TGKRALIRDDS--------EPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       488 tg~~p~~~~~~--------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                      +|+.++.....        .+.....+.+.+.+++.+||+.||.+||++.|+++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  279 (289)
T 1x8b_A          226 GAEPLPRNGDQWHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK  279 (289)
T ss_dssp             TCCCCCSSSHHHHHHHTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             cCCCCCcchhHHHHHHcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence            99877643211        11112234567899999999999999999999986

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=2e-36  Score=329.21  Aligned_cols=219  Identities=24%  Similarity=0.395  Sum_probs=181.0

Q ss_pred             HhcCCCccceecccCcEEEEEEEEC--CceEEEEEeccC----------------ChHHHHHHHHHHHhccccce-----
Q 044997          290 ATNNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSN----------------KSKEFFAELKVLCKIHHINV-----  346 (563)
Q Consensus       290 ~~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~----------------~~~~f~~Ei~~l~~l~H~ni-----  346 (563)
                      ..++|...+.||+|+||.||+|+..  ++.+|||.++..                ..+.+.+|+++|++++||||     
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  113 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD  113 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            3578999999999999999999884  678999998642                23568899999999999997     


Q ss_pred             ----------EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCC--
Q 044997          347 ----------FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGL--  414 (563)
Q Consensus       347 ----------V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~--  414 (563)
                                |+||+++|+|.+++..     ...+++..+..++.|++.||+|||+++   |+||||||+|||++.++  
T Consensus       114 ~~~~~~~~~lv~e~~~gg~L~~~l~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~  185 (504)
T 3q5i_A          114 VFEDKKYFYLVTEFYEGGELFEQIIN-----RHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSL  185 (504)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCC
T ss_pred             EEEcCCEEEEEEecCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCC
Confidence                      5799999999998865     256999999999999999999999997   99999999999998775  


Q ss_pred             -cEEEeecCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCC
Q 044997          415 -RAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRAL  493 (563)
Q Consensus       415 -~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~  493 (563)
                       .+||+|||+++......    ......||+.|+|||++.+              .++.++||||+||++|||++|+.||
T Consensus       186 ~~~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~--------------~~~~~~DiwslG~il~~ll~g~~pf  247 (504)
T 3q5i_A          186 LNIKIVDFGLSSFFSKDY----KLRDRLGTAYYIAPEVLKK--------------KYNEKCDVWSCGVIMYILLCGYPPF  247 (504)
T ss_dssp             SSEEECCCTTCEECCTTS----CBCCCCSCTTTCCHHHHTT--------------CBCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred             ccEEEEECCCCEEcCCCC----ccccccCCcCCCCHHHhcc--------------CCCchHHHHHHHHHHHHHHhCCCCC
Confidence             69999999998654322    2234579999999998742              3488999999999999999999999


Q ss_pred             cCCCCCc--------------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          494 IRDDSEP--------------TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       494 ~~~~~~~--------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                      .......              .....+++.+.+++.+||+.||.+|||+.|+++.
T Consensus       248 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h  302 (504)
T 3q5i_A          248 GGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNS  302 (504)
T ss_dssp             CCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             CCCCHHHHHHHHHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence            7643211              1123345679999999999999999999999863

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=1.9e-36  Score=316.21  Aligned_cols=216  Identities=24%  Similarity=0.382  Sum_probs=159.6

Q ss_pred             hcCCCccceecccCcEEEEEEEE--CCceEEEEEeccC-----ChHHHHHHHHHHHhccccceE----------------
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSN-----KSKEFFAELKVLCKIHHINVF----------------  347 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~-----~~~~f~~Ei~~l~~l~H~niV----------------  347 (563)
                      .++|...+.||+|+||.||+|..  .++.||||++...     ..+.+.+|+++|++++||||+                
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            36789999999999999999986  4789999998653     235688999999999999983                


Q ss_pred             -----EEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecC
Q 044997          348 -----ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFG  422 (563)
Q Consensus       348 -----~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFG  422 (563)
                           ++++ +++|.+++..      ..+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||
T Consensus       108 ~~~lv~e~~-~~~L~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG  177 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFG  177 (367)
T ss_dssp             CCEEEEECC-CEECC-----------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC--
T ss_pred             eEEEEeccc-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecc
Confidence                 2333 5666666643      46999999999999999999999997   9999999999999999999999999


Q ss_pred             CCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCchh
Q 044997          423 LVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTK  502 (563)
Q Consensus       423 la~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~~  502 (563)
                      +++.....      .+...||+.|+|||++.+.            ..++.++|||||||++|||++|+.||.+.+.....
T Consensus       178 ~a~~~~~~------~~~~~~t~~y~aPE~~~~~------------~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l  239 (367)
T 2fst_X          178 LARHTADE------MTGYVATRWYRAPEIMLNW------------MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQL  239 (367)
T ss_dssp             -------------------CCCTTCCHHHHTTC------------CSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred             cccccccc------CCCcCcCcCccChHHHcCC------------cCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            99854321      2345789999999987542            23589999999999999999999999654321000


Q ss_pred             -----------------------------------------hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          503 -----------------------------------------MKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       503 -----------------------------------------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                                                               .....+.+.+|+.+||+.||.+|||+.|+++.
T Consensus       240 ~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h  312 (367)
T 2fst_X          240 KLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  312 (367)
T ss_dssp             HHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence                                                     00113457899999999999999999999874

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=3.6e-36  Score=303.16  Aligned_cols=222  Identities=25%  Similarity=0.375  Sum_probs=178.7

Q ss_pred             CCCccceecccCcEEEEEEEE--CCceEEEEEeccCC---hHHHHHHHHHHHhccccce---------------EEEeec
Q 044997          293 NFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNK---SKEFFAELKVLCKIHHINV---------------FISTFG  352 (563)
Q Consensus       293 ~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~---~~~f~~Ei~~l~~l~H~ni---------------V~e~~~  352 (563)
                      +|.....||+|+||.||+|+.  +++.||||.++...   .+.+.+|+.++++++||||               |+||++
T Consensus        23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  102 (295)
T 2clq_A           23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP  102 (295)
T ss_dssp             TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred             CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence            455667999999999999997  46789999987543   4678999999999999997               578999


Q ss_pred             CCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecC-CCcEEEeecCCCccccccc
Q 044997          353 NGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDD-GLRAKVADFGLVKLEERTN  431 (563)
Q Consensus       353 ~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~-~~~~kl~DFGla~~~~~~~  431 (563)
                      +|+|.+++...  .....+++..+..++.|++.||+|||+++   ++||||||+||+++. ++.+||+|||+++......
T Consensus       103 ~~~L~~~l~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~  177 (295)
T 2clq_A          103 GGSLSALLRSK--WGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN  177 (295)
T ss_dssp             EEEHHHHHHHT--TCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC--
T ss_pred             CCCHHHHHHhh--ccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCC
Confidence            99999998752  12345789999999999999999999997   999999999999987 8999999999998654321


Q ss_pred             ccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc-----------
Q 044997          432 EKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP-----------  500 (563)
Q Consensus       432 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~-----------  500 (563)
                      .   ......||+.|+|||.+.+..           ..++.++||||||+++|||++|+.||.......           
T Consensus       178 ~---~~~~~~~~~~y~aPE~~~~~~-----------~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  243 (295)
T 2clq_A          178 P---CTETFTGTLQYMAPEIIDKGP-----------RGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKV  243 (295)
T ss_dssp             ------CCCCCCGGGCCHHHHHHGG-----------GGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCC
T ss_pred             C---cccccCCCccccChhhhcCCC-----------CCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccc
Confidence            1   123456899999999885432           124789999999999999999999996533211           


Q ss_pred             --hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          501 --TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       501 --~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                        .....+...+.+++.+||+.||++||++.|+++
T Consensus       244 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          244 HPEIPESMSAEAKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             CCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             cccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence              111234566899999999999999999999976

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=7.5e-37  Score=330.88  Aligned_cols=218  Identities=24%  Similarity=0.397  Sum_probs=183.1

Q ss_pred             hcCCCccceecccCcEEEEEEEEC--CceEEEEEeccC------ChHHHHHHHHHHHhccccce---------------E
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSN------KSKEFFAELKVLCKIHHINV---------------F  347 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~------~~~~f~~Ei~~l~~l~H~ni---------------V  347 (563)
                      .++|+..+.||+|+||.||+++..  ++.||||.+...      ..+.+.+|+++|++++||||               |
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  104 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV  104 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            456889999999999999999884  789999998532      34679999999999999997               5


Q ss_pred             EEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEe---cCCCcEEEeecCCC
Q 044997          348 ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILL---DDGLRAKVADFGLV  424 (563)
Q Consensus       348 ~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl---~~~~~~kl~DFGla  424 (563)
                      +||+.+|+|.+++..     ...+++..+..++.|++.||.|||+++   |+||||||+|||+   +.++.+||+|||++
T Consensus       105 ~e~~~~~~L~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a  176 (484)
T 3nyv_A          105 GEVYTGGELFDEIIS-----RKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLS  176 (484)
T ss_dssp             ECCCCSCBHHHHHHT-----CSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHH
T ss_pred             EecCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeee
Confidence            788999999988864     356999999999999999999999997   9999999999999   56789999999999


Q ss_pred             cccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCC-----
Q 044997          425 KLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE-----  499 (563)
Q Consensus       425 ~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~-----  499 (563)
                      +......    ......||+.|+|||++.+              .++.++||||+||++|||++|+.||......     
T Consensus       177 ~~~~~~~----~~~~~~gt~~y~aPE~~~~--------------~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  238 (484)
T 3nyv_A          177 THFEASK----KMKDKIGTAYYIAPEVLHG--------------TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKK  238 (484)
T ss_dssp             HHBCCCC----SHHHHTTGGGTCCHHHHHT--------------CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred             EEccccc----ccccCCCCccccCceeecC--------------CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence            8654322    1233579999999998743              3588999999999999999999999654321     


Q ss_pred             ---------chhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          500 ---------PTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       500 ---------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                               ......+++.+.+++.+||+.||.+|||+.|+++.
T Consensus       239 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  282 (484)
T 3nyv_A          239 VEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDH  282 (484)
T ss_dssp             HHHCCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             HHcCCCCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence                     12223456779999999999999999999999873

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1.3e-36  Score=314.72  Aligned_cols=221  Identities=21%  Similarity=0.331  Sum_probs=174.4

Q ss_pred             hcCCCccceecccCcEEEEEEEEC--CceEEEEEeccCC----hHHHHHHHHHHHhccccceE-----------------
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNK----SKEFFAELKVLCKIHHINVF-----------------  347 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~----~~~f~~Ei~~l~~l~H~niV-----------------  347 (563)
                      .++|...+.||+|+||.||+|+..  ++.||||.++...    ..++.+|++++++++||||+                 
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   89 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV   89 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence            467899999999999999999985  7889999997543    34678999999999999983                 


Q ss_pred             ---EEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCC
Q 044997          348 ---ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLV  424 (563)
Q Consensus       348 ---~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla  424 (563)
                         +||+. |+|.+++..      ..+++..+..++.|++.||+|||+++   ++||||||+|||++.++.+||+|||++
T Consensus        90 ~lv~e~~~-~~L~~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a  159 (353)
T 2b9h_A           90 YIIQELMQ-TDLHRVIST------QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLA  159 (353)
T ss_dssp             EEEECCCS-EEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEeccC-ccHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEecccc
Confidence               34443 466666543      46899999999999999999999997   999999999999999999999999999


Q ss_pred             cccccccccc-------cccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCC
Q 044997          425 KLEERTNEKE-------MLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDD  497 (563)
Q Consensus       425 ~~~~~~~~~~-------~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~  497 (563)
                      +.........       .......||+.|+|||++..            ...++.++|||||||++|||++|+.||....
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------------~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  227 (353)
T 2b9h_A          160 RIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLT------------SAKYSRAMDVWSCGCILAELFLRRPIFPGRD  227 (353)
T ss_dssp             EECC----------------CCCCCCGGGCCHHHHHS------------CCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             cccccccccccCccccccchhhccccccccCCeeecc------------CCCccchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            8654322111       01223578999999998743            2345889999999999999999999986543


Q ss_pred             CCc------------------------------------------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          498 SEP------------------------------------------TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       498 ~~~------------------------------------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                      ...                                          .....+...+.+++.+||+.||.+|||+.|+++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (353)
T 2b9h_A          228 YRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE  305 (353)
T ss_dssp             HHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            100                                          000123456889999999999999999999987

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=1.3e-36  Score=305.54  Aligned_cols=225  Identities=18%  Similarity=0.282  Sum_probs=167.7

Q ss_pred             hcCCCccceecccCcEEEEEEEE--CCceEEEEEeccCCh-----HHHHHHHHHHHhccccce---------------EE
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNKS-----KEFFAELKVLCKIHHINV---------------FI  348 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~~-----~~f~~Ei~~l~~l~H~ni---------------V~  348 (563)
                      .++|+..+.||+|+||.||+++.  +++.||+|+++....     +.+.++...++.++||||               |+
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~   85 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM   85 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence            46788999999999999999998  578999999975422     224445556888999997               46


Q ss_pred             EeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCceEeCCCCCCCeEecCCCcEEEeecCCCccc
Q 044997          349 STFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDH-TKARYVHRDIKTSNILLDDGLRAKVADFGLVKLE  427 (563)
Q Consensus       349 e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~  427 (563)
                      ||++ |+|.+++.... .....+++..+..++.|++.||+|||++ +   ++||||||+|||++.++.+||+|||+++..
T Consensus        86 e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  160 (290)
T 3fme_A           86 ELMD-TSLDKFYKQVI-DKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYL  160 (290)
T ss_dssp             ECCS-EEHHHHHHHHH-HTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred             ehhc-cchHHHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence            7776 57777765421 2346799999999999999999999997 7   999999999999999999999999999865


Q ss_pred             ccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCchh-----
Q 044997          428 ERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTK-----  502 (563)
Q Consensus       428 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~~-----  502 (563)
                      ....    ......||+.|+|||.+....         ....++.++||||||+++|||++|+.||.........     
T Consensus       161 ~~~~----~~~~~~~t~~y~aPE~~~~~~---------~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~  227 (290)
T 3fme_A          161 VDDV----AKDIDAGCKPYMAPERINPEL---------NQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVV  227 (290)
T ss_dssp             -------------CCCCCCSCHHHHSCCT---------TC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHH
T ss_pred             cccc----cccccCCCccccChhhcChhh---------cCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHh
Confidence            4322    122346899999999873211         2334688999999999999999999999653321111     


Q ss_pred             --------hHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          503 --------MKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       503 --------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                              ...+...+.+++.+||+.||.+|||+.|+++
T Consensus       228 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          228 EEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             HSCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             ccCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence                    1234566899999999999999999999987

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=1.8e-36  Score=328.90  Aligned_cols=218  Identities=24%  Similarity=0.397  Sum_probs=178.7

Q ss_pred             hcCCCccceecccCcEEEEEEEEC--CceEEEEEeccC-----ChHHHHHHHHHHHhccccce---------------EE
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSN-----KSKEFFAELKVLCKIHHINV---------------FI  348 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~-----~~~~f~~Ei~~l~~l~H~ni---------------V~  348 (563)
                      .++|+..+.||+|+||.||+|+..  +..+|+|.++..     ..+.+.+|+++|++++||||               |+
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  115 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM  115 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            456899999999999999999984  678999998643     34678999999999999997               57


Q ss_pred             EeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCC---CcEEEeecCCCc
Q 044997          349 STFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDG---LRAKVADFGLVK  425 (563)
Q Consensus       349 e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~---~~~kl~DFGla~  425 (563)
                      ||+.+|+|.+++..     ...+++..+..++.|++.||.|||+++   |+||||||+|||++.+   +.+||+|||+++
T Consensus       116 e~~~~g~L~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~  187 (494)
T 3lij_A          116 ECYKGGELFDEIIH-----RMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSA  187 (494)
T ss_dssp             ECCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred             ecCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCe
Confidence            99999999888864     256899999999999999999999997   9999999999999764   559999999998


Q ss_pred             ccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCC------
Q 044997          426 LEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE------  499 (563)
Q Consensus       426 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~------  499 (563)
                      ......    ......||+.|+|||++..              .++.++||||+||++|||++|+.||......      
T Consensus       188 ~~~~~~----~~~~~~gt~~y~aPE~l~~--------------~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i  249 (494)
T 3lij_A          188 VFENQK----KMKERLGTAYYIAPEVLRK--------------KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKV  249 (494)
T ss_dssp             ECBTTB----CBCCCCSCTTTCCHHHHTT--------------CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             ECCCCc----cccccCCCcCeeCHHHHcc--------------cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            654322    2234579999999998742              3488999999999999999999999654321      


Q ss_pred             --------chhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          500 --------PTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       500 --------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                              ......++..+.+++.+||+.||.+|||+.|+++.
T Consensus       250 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  292 (494)
T 3lij_A          250 EKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEH  292 (494)
T ss_dssp             HHTCCCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             HhCCCCCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence                    11223455678999999999999999999999863

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=9.6e-37  Score=324.24  Aligned_cols=220  Identities=26%  Similarity=0.354  Sum_probs=170.6

Q ss_pred             CCCccceecccCcEEEEEEEE--CCceEEEEEeccCChHHHHHHHHHHHhccccceE---------------------EE
Q 044997          293 NFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNKSKEFFAELKVLCKIHHINVF---------------------IS  349 (563)
Q Consensus       293 ~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~~~~f~~Ei~~l~~l~H~niV---------------------~e  349 (563)
                      +|+..+.||+|+||.||+|+.  .++.||||++.... +.+.+|+++|++++|+|||                     +|
T Consensus        55 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e  133 (420)
T 1j1b_A           55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLD  133 (420)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT-TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEE
T ss_pred             eEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc-hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehh
Confidence            578889999999999999998  47899999986543 2344799999999999984                     23


Q ss_pred             eecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCC-CcEEEeecCCCcccc
Q 044997          350 TFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDG-LRAKVADFGLVKLEE  428 (563)
Q Consensus       350 ~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~-~~~kl~DFGla~~~~  428 (563)
                      |+++ +|.+.+.. .......+++..+..++.|+++||+|||+++   |+||||||+|||++.+ +.+||+|||+++...
T Consensus       134 ~~~~-~l~~~~~~-~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~  208 (420)
T 1j1b_A          134 YVPE-TVYRVARH-YSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV  208 (420)
T ss_dssp             CCCE-EHHHHHHH-HHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred             cccc-cHHHHHHH-HhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhhhcc
Confidence            3332 33333321 1123467999999999999999999999987   9999999999999965 678999999998654


Q ss_pred             cccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCchhh-----
Q 044997          429 RTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKM-----  503 (563)
Q Consensus       429 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~~~-----  503 (563)
                      ...    ......||+.|+|||++.+.            ..++.++|||||||++|||++|+.||..........     
T Consensus       209 ~~~----~~~~~~~t~~y~aPE~~~~~------------~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~  272 (420)
T 1j1b_A          209 RGE----PNVSYICSRYYRAPELIFGA------------TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV  272 (420)
T ss_dssp             TTC----CCCSCCSCTTSCCHHHHTTC------------SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred             cCC----CceeeeeCCCcCCHHHHcCC------------CCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence            322    12335789999999988543            235889999999999999999999997643211000     


Q ss_pred             ----------------------------------HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          504 ----------------------------------KSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       504 ----------------------------------~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                                                        ......+.+|+.+||+.||.+||++.|+++.
T Consensus       273 lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h  337 (420)
T 1j1b_A          273 LGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH  337 (420)
T ss_dssp             HCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence                                              1123568999999999999999999999863

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=1.9e-36  Score=305.89  Aligned_cols=225  Identities=24%  Similarity=0.325  Sum_probs=184.7

Q ss_pred             HhcCCCccceecccCcEEEEEEEEC--CceEEEEEeccCC------------hHHHHHHHHHHHhcc-ccce--------
Q 044997          290 ATNNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNK------------SKEFFAELKVLCKIH-HINV--------  346 (563)
Q Consensus       290 ~~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~------------~~~f~~Ei~~l~~l~-H~ni--------  346 (563)
                      ..++|+..+.||+|+||.||+|...  ++.||||.++...            .+.+.+|+++++++. ||||        
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (298)
T 1phk_A           15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE   94 (298)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence            3568999999999999999999984  6889999986432            256789999999995 9997        


Q ss_pred             -------EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEe
Q 044997          347 -------FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVA  419 (563)
Q Consensus       347 -------V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~  419 (563)
                             |+||+++|+|.+++..     ...+++..+..++.|++.||+|||+++   ++||||||+||+++.++.+||+
T Consensus        95 ~~~~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~  166 (298)
T 1phk_A           95 TNTFFFLVFDLMKKGELFDYLTE-----KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLT  166 (298)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEEC
T ss_pred             cCCeEEEEEeccCCCcHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEe
Confidence                   5799999999999875     256899999999999999999999997   9999999999999999999999


Q ss_pred             ecCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCC
Q 044997          420 DFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE  499 (563)
Q Consensus       420 DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~  499 (563)
                      |||+++......    ......|++.|+|||.+.+...       .....++.++||||||+++|||++|+.||......
T Consensus       167 dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~-------~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~  235 (298)
T 1phk_A          167 DFGFSCQLDPGE----KLREVCGTPSYLAPEIIECSMN-------DNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM  235 (298)
T ss_dssp             CCTTCEECCTTC----CBCCCCSCGGGCCHHHHHHHHC-------TTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred             cccchhhcCCCc----ccccccCCccccCHHHhccccc-------cccccCCcccccHhHHHHHHHHHHCCCCCcCccHH
Confidence            999998654322    1233568999999998853321       11334588999999999999999999998653321


Q ss_pred             --------------chhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          500 --------------PTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       500 --------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                                    ......+...+.+++.+||+.||.+||++.|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          236 LMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             HHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HHHHHHhcCCcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence                          1112345567999999999999999999999986

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=7.2e-37  Score=321.07  Aligned_cols=224  Identities=21%  Similarity=0.303  Sum_probs=173.0

Q ss_pred             HHHhcCCCccceecccCcEEEEEEEE--CCceEEEEEeccCChHHHHHHHHHHHhccccceE------------------
Q 044997          288 EEATNNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNKSKEFFAELKVLCKIHHINVF------------------  347 (563)
Q Consensus       288 ~~~~~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~~~~f~~Ei~~l~~l~H~niV------------------  347 (563)
                      +...++|...+.||+|+||.||+|+.  +++.||||++..+. +...+|+++|++++|||||                  
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~   81 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP-RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQ   81 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT-TSCCHHHHHHTTCCCTTBCCEEEEEEEC---------
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc-chHHHHHHHHHHcCCCCccchhheeeecCcccccccc
Confidence            44567899999999999999999987  47899999986543 2234799999999999974                  


Q ss_pred             -----------------------------------EEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 044997          348 -----------------------------------ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHD  392 (563)
Q Consensus       348 -----------------------------------~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~  392 (563)
                                                         +||++ |+|.+.+... ......+++..+..++.|++.||+|||+
T Consensus        82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~~~~~l~~~~~~~i~~qi~~aL~~LH~  159 (383)
T 3eb0_A           82 PPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSF-IRSGRSIPMNLISIYIYQLFRAVGFIHS  159 (383)
T ss_dssp             ----------------------------CCEEEEEECCCS-EEHHHHHHHH-HHTTCCCCHHHHHHHHHHHHHHHHHHHT
T ss_pred             cccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHH-HhcCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence                                               22333 3444444321 1234679999999999999999999999


Q ss_pred             cCCCceEeCCCCCCCeEec-CCCcEEEeecCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCC
Q 044997          393 HTKARYVHRDIKTSNILLD-DGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVT  471 (563)
Q Consensus       393 ~~~~~ivHrDLk~~NILl~-~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s  471 (563)
                      ++   |+||||||+|||++ .++.+||+|||+++......    ......||+.|+|||.+.+..            .++
T Consensus       160 ~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~----~~~~~~~t~~y~aPE~~~~~~------------~~~  220 (383)
T 3eb0_A          160 LG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE----PSVAYICSRFYRAPELMLGAT------------EYT  220 (383)
T ss_dssp             TT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS----CCCCCCCCSSCCCHHHHTTCS------------SCC
T ss_pred             Cc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC----CCcCcccCCCccCHHHhcCCC------------CCC
Confidence            97   99999999999998 68899999999998654332    123356899999999875432            358


Q ss_pred             CcchHHHHHHHHHHHHcCCCCCcCCCCCchh---------------------------------------hHHHHHHHHH
Q 044997          472 TKTDVFAFGVVLAELITGKRALIRDDSEPTK---------------------------------------MKSLITIMAA  512 (563)
Q Consensus       472 ~ksDVwSfGvvl~Elltg~~p~~~~~~~~~~---------------------------------------~~~~~~~l~~  512 (563)
                      .++|||||||++|||++|+.||.........                                       ....+..+.+
T Consensus       221 ~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (383)
T 3eb0_A          221 PSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAID  300 (383)
T ss_dssp             THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHH
T ss_pred             cchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHH
Confidence            9999999999999999999999754321100                                       0112345889


Q ss_pred             HHHHhhccCCCCCCCHHHHHH
Q 044997          513 VAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       513 li~~cl~~dP~~RPs~~evl~  533 (563)
                      |+.+||+.||.+|||+.|+++
T Consensus       301 li~~~L~~dP~~R~t~~e~l~  321 (383)
T 3eb0_A          301 LLEQILRYEPDLRINPYEAMA  321 (383)
T ss_dssp             HHHHHCCSSGGGSCCHHHHHT
T ss_pred             HHHHHccCChhhCCCHHHHhc
Confidence            999999999999999999986

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=2.5e-37  Score=315.43  Aligned_cols=244  Identities=23%  Similarity=0.349  Sum_probs=184.6

Q ss_pred             HHHHhcCCCccceecccCcEEEEEEEECCceEEEEEeccC-----ChHHHHHHHHHHHhccccce---------------
Q 044997          287 IEEATNNFDESRIIGRGGFGNVYFGLLGDREAAIKKMRSN-----KSKEFFAELKVLCKIHHINV---------------  346 (563)
Q Consensus       287 l~~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~vavK~~~~~-----~~~~f~~Ei~~l~~l~H~ni---------------  346 (563)
                      +....++|+..+.||+|+||.||+|..++ .+|+|.++..     ..+.|.+|++++++++|+||               
T Consensus        28 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~-~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i  106 (319)
T 2y4i_B           28 WDIPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAI  106 (319)
T ss_dssp             SSSCCSCEECCCBCCCSSSSEEEEEEESS-SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEE
T ss_pred             ccCCHHHeEEeeEeccCCceEEEEEEEcC-eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEE
Confidence            33345788999999999999999999865 5999998643     23567889999999999997               


Q ss_pred             EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcc
Q 044997          347 FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKL  426 (563)
Q Consensus       347 V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~  426 (563)
                      |+||+++|+|.+++..    ....+++..+..++.|++.||+|||+++   ++||||||+|||++ ++.+||+|||+++.
T Consensus       107 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~  178 (319)
T 2y4i_B          107 ITSLCKGRTLYSVVRD----AKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSI  178 (319)
T ss_dssp             ECBCCCSEEHHHHTTS----SCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC-
T ss_pred             EeecccCCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCccc
Confidence            5688999999999975    2356999999999999999999999997   99999999999998 67999999999875


Q ss_pred             cccccc--cccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCchh--
Q 044997          427 EERTNE--KEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTK--  502 (563)
Q Consensus       427 ~~~~~~--~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~~--  502 (563)
                      ......  .........||+.|+|||.+......    .......++.++||||||+++|||++|+.||.........  
T Consensus       179 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~----~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~  254 (319)
T 2y4i_B          179 SGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPD----TEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQ  254 (319)
T ss_dssp             ---------CCSCBCCSGGGGTSCHHHHSCBSCC------CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHH
T ss_pred             cccccccccccccccCCCcccccChHHhhhcccc----ccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            432111  11122335689999999998653211    0011345689999999999999999999999654321100  


Q ss_pred             ----------hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcCh
Q 044997          503 ----------MKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITST  543 (563)
Q Consensus       503 ----------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~  543 (563)
                                ...+...+.+++.+||+.||.+||++.++++.|+++.....
T Consensus       255 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~  305 (319)
T 2y4i_B          255 MGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNR  305 (319)
T ss_dssp             HHTTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-----
T ss_pred             hccCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhc
Confidence                      01234458999999999999999999999999998876543

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=3.8e-36  Score=304.60  Aligned_cols=226  Identities=20%  Similarity=0.272  Sum_probs=178.7

Q ss_pred             HhcCCCccceecccCcEEEEEEEE--CCceEEEEEeccC-------ChHHHHHHHHHHHhccccce--------------
Q 044997          290 ATNNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSN-------KSKEFFAELKVLCKIHHINV--------------  346 (563)
Q Consensus       290 ~~~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~-------~~~~f~~Ei~~l~~l~H~ni--------------  346 (563)
                      ..++|...+.||+|+||.||++..  +++.+|+|.++..       ..+.+.+|++++++++||||              
T Consensus         3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (305)
T 2wtk_C            3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK   82 (305)
T ss_dssp             --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred             cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence            347899999999999999999988  4678999998643       24678999999999999998              


Q ss_pred             ---EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCC
Q 044997          347 ---FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGL  423 (563)
Q Consensus       347 ---V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGl  423 (563)
                         |+||+.+| |.+++..   .....+++..+..++.|++.||+|||+++   ++||||||+|||++.++.+||+|||+
T Consensus        83 ~~lv~e~~~~~-l~~~~~~---~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~  155 (305)
T 2wtk_C           83 MYMVMEYCVCG-MQEMLDS---VPEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGV  155 (305)
T ss_dssp             EEEEEECCSEE-HHHHHHH---STTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             EEEEehhccCC-HHHHHHh---CcccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeecccc
Confidence               35666655 5555543   12456999999999999999999999997   99999999999999999999999999


Q ss_pred             CcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCch--
Q 044997          424 VKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPT--  501 (563)
Q Consensus       424 a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~--  501 (563)
                      ++........ .......||+.|+|||++.+..           ...+.++||||||+++|||++|+.||........  
T Consensus       156 ~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~-----------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~  223 (305)
T 2wtk_C          156 AEALHPFAAD-DTCRTSQGSPAFQPPEIANGLD-----------TFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFE  223 (305)
T ss_dssp             CEECCTTCSS-CEECCCCSCGGGCCHHHHTCCS-----------CEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred             ccccCccccc-cccccCCCCCCCcChhhccCcc-----------cCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHH
Confidence            9865432211 1223456899999999875432           1236799999999999999999999975432110  


Q ss_pred             --------hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          502 --------KMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       502 --------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                              ......+.+.+++.+||+.||.+||++.|+++.
T Consensus       224 ~i~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  264 (305)
T 2wtk_C          224 NIGKGSYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH  264 (305)
T ss_dssp             HHHHCCCCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             HHhcCCCCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                    111234568999999999999999999999974

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=4.2e-36  Score=310.29  Aligned_cols=217  Identities=22%  Similarity=0.329  Sum_probs=175.4

Q ss_pred             hcCCCccceecccCcEEEEEEEEC--C-ceEEEEEeccCC--hHHHHHHHHHHHhccccc------e-------------
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLLG--D-REAAIKKMRSNK--SKEFFAELKVLCKIHHIN------V-------------  346 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~~--~-~~vavK~~~~~~--~~~f~~Ei~~l~~l~H~n------i-------------  346 (563)
                      .++|+..+.||+|+||.||+|...  + +.||+|.++...  .+.+.+|++++++++|++      +             
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~   97 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHM   97 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEE
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeE
Confidence            367999999999999999999873  3 689999997643  466888999999998765      2             


Q ss_pred             --EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEe--------------
Q 044997          347 --FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILL--------------  410 (563)
Q Consensus       347 --V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl--------------  410 (563)
                        |+||+ +|+|.+++..   .....+++.++..++.|++.||+|||+++   |+||||||+|||+              
T Consensus        98 ~lv~e~~-~~~l~~~l~~---~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~  170 (355)
T 2eu9_A           98 CIAFELL-GKNTFEFLKE---NNFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKS  170 (355)
T ss_dssp             EEEEECC-CCBHHHHHHH---TTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred             EEEEecc-CCChHHHHHh---ccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeccccccccccccc
Confidence              57888 6677777754   23357999999999999999999999997   9999999999999              


Q ss_pred             -----cCCCcEEEeecCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHH
Q 044997          411 -----DDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAE  485 (563)
Q Consensus       411 -----~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~E  485 (563)
                           +.++.+||+|||+++.....      .....||+.|+|||++.+..             ++.++|||||||++||
T Consensus       171 ~~~~~~~~~~~kl~Dfg~~~~~~~~------~~~~~gt~~y~aPE~~~~~~-------------~~~~~Di~slG~il~e  231 (355)
T 2eu9_A          171 CEEKSVKNTSIRVADFGSATFDHEH------HTTIVATRHYRPPEVILELG-------------WAQPCDVWSIGCILFE  231 (355)
T ss_dssp             CCEEEESCCCEEECCCTTCEETTSC------CCSSCSCGGGCCHHHHTTCC-------------CCTHHHHHHHHHHHHH
T ss_pred             ccccccCCCcEEEeecCcccccccc------ccCCcCCCcccCCeeeecCC-------------CCCccchHHHHHHHHH
Confidence                 66889999999999753321      23357999999999886544             4889999999999999


Q ss_pred             HHcCCCCCcCCCCCchh------------------------------------------------------hHHHHHHHH
Q 044997          486 LITGKRALIRDDSEPTK------------------------------------------------------MKSLITIMA  511 (563)
Q Consensus       486 lltg~~p~~~~~~~~~~------------------------------------------------------~~~~~~~l~  511 (563)
                      |++|+.||.........                                                      .......+.
T Consensus       232 l~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  311 (355)
T 2eu9_A          232 YYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLF  311 (355)
T ss_dssp             HHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHH
T ss_pred             HHhCCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHH
Confidence            99999999654321100                                                      001134688


Q ss_pred             HHHHHhhccCCCCCCCHHHHHH
Q 044997          512 AVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       512 ~li~~cl~~dP~~RPs~~evl~  533 (563)
                      +|+.+||+.||++|||+.|+++
T Consensus       312 ~li~~~L~~dP~~Rpt~~e~l~  333 (355)
T 2eu9_A          312 DLMRRMLEFDPAQRITLAEALL  333 (355)
T ss_dssp             HHHHHHTCSSTTTSCCHHHHTT
T ss_pred             HHHHHHhcCChhhCcCHHHHhc
Confidence            9999999999999999999975

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=3.2e-37  Score=311.83  Aligned_cols=229  Identities=23%  Similarity=0.421  Sum_probs=167.6

Q ss_pred             HhcCCCccceecccCcEEEEEEEE--CCceEEEEEeccC----ChHHHHHHHHHHHhccccce---------------EE
Q 044997          290 ATNNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSN----KSKEFFAELKVLCKIHHINV---------------FI  348 (563)
Q Consensus       290 ~~~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~----~~~~f~~Ei~~l~~l~H~ni---------------V~  348 (563)
                      ..++|...+.||+|+||.||+|..  +++.||||.+...    ..+++.+|++++++++||||               |+
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   92 (303)
T 2vwi_A           13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM   92 (303)
T ss_dssp             CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred             chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence            357899999999999999999976  5789999998643    24668899999999999997               57


Q ss_pred             EeecCCCcccccccccc---cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCc
Q 044997          349 STFGNGSLSDHLHDPLL---KGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK  425 (563)
Q Consensus       349 e~~~~gsL~~~L~~~~~---~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~  425 (563)
                      ||+++|+|.+++.....   .....+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+|||+++
T Consensus        93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~  169 (303)
T 2vwi_A           93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSA  169 (303)
T ss_dssp             ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred             hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccchh
Confidence            99999999998864211   12356999999999999999999999997   9999999999999999999999999987


Q ss_pred             cccccccc--ccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCchh-
Q 044997          426 LEERTNEK--EMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTK-  502 (563)
Q Consensus       426 ~~~~~~~~--~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~~-  502 (563)
                      ........  ........||+.|+|||.+.+.            ..++.++||||||+++|||++|+.||......... 
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~------------~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~  237 (303)
T 2vwi_A          170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQV------------RGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLM  237 (303)
T ss_dssp             HCC---------------CCCTTCCHHHHHHH------------HCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHH
T ss_pred             eeccCCCccchhhhcccCCCccccCHHHhccc------------cCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHH
Confidence            65432211  1112335789999999987532            23488999999999999999999998653321100 


Q ss_pred             -------------------hHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          503 -------------------MKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       503 -------------------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                                         .......+.+++.+||+.||.+||++.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          238 LTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             HHHTSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HHhccCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence                               1123456899999999999999999999986

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=4e-36  Score=311.90  Aligned_cols=229  Identities=21%  Similarity=0.289  Sum_probs=169.7

Q ss_pred             HHHHHHhcCCCccceecccCcEEEEEEEEC--CceEEEEEeccC--ChHHHHHHHHHHHhccccceE-------------
Q 044997          285 EEIEEATNNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSN--KSKEFFAELKVLCKIHHINVF-------------  347 (563)
Q Consensus       285 ~el~~~~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~--~~~~f~~Ei~~l~~l~H~niV-------------  347 (563)
                      .+.....++|...+.||+|+||.||+|+..  ++.||||++...  ..+.+.+|++.+.+++||||+             
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~   95 (360)
T 3e3p_A           16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD   95 (360)
T ss_dssp             HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred             hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence            456677889999999999999999999984  789999988654  245677899999999999973             


Q ss_pred             ---------EEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH--hcCCCceEeCCCCCCCeEecC-CCc
Q 044997          348 ---------ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIH--DHTKARYVHRDIKTSNILLDD-GLR  415 (563)
Q Consensus       348 ---------~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH--~~~~~~ivHrDLk~~NILl~~-~~~  415 (563)
                               +||+++ +|.+.+... ......+++..+..++.|++.||.|||  +++   |+||||||+|||++. ++.
T Consensus        96 ~~~~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~  170 (360)
T 3e3p_A           96 RRDIYLNVVMEYVPD-TLHRCCRNY-YRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGT  170 (360)
T ss_dssp             TTCEEEEEEEECCSC-BHHHHHHHH-HTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTE
T ss_pred             ccceeEEEEeecccc-cHHHHHHHH-hhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCc
Confidence                     344443 443333221 123567899999999999999999999  776   999999999999997 899


Q ss_pred             EEEeecCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcC
Q 044997          416 AKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIR  495 (563)
Q Consensus       416 ~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~  495 (563)
                      +||+|||+++......    ......||+.|+|||++.+..            .++.++|||||||++|||++|+.||..
T Consensus       171 ~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~------------~~~~~~Di~slG~il~ell~g~~pf~~  234 (360)
T 3e3p_A          171 LKLCDFGSAKKLSPSE----PNVAYICSRYYRAPELIFGNQ------------HYTTAVDIWSVGCIFAEMMLGEPIFRG  234 (360)
T ss_dssp             EEECCCTTCBCCCTTS----CCCSTTSCGGGCCHHHHTTCS------------SCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             EEEeeCCCceecCCCC----CcccccCCcceeCHHHHcCCC------------CCCcHHHHHHHHHHHHHHHhCCCCcCC
Confidence            9999999998654332    123456899999999875432            358999999999999999999999976


Q ss_pred             CCCCchhhH------------------------------------------HHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          496 DDSEPTKMK------------------------------------------SLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       496 ~~~~~~~~~------------------------------------------~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                      .........                                          .....+.+|+.+||+.||.+|||+.|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  314 (360)
T 3e3p_A          235 DNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC  314 (360)
T ss_dssp             SSHHHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CChHHHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence            432110000                                          02456899999999999999999999987


Q ss_pred             H
Q 044997          534 I  534 (563)
Q Consensus       534 ~  534 (563)
                      .
T Consensus       315 h  315 (360)
T 3e3p_A          315 H  315 (360)
T ss_dssp             S
T ss_pred             C
Confidence            3

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=6.1e-36  Score=306.05  Aligned_cols=220  Identities=23%  Similarity=0.363  Sum_probs=176.9

Q ss_pred             HhcCCCccceecccCcEEEEEEEE---CCceEEEEEeccCC-----hHHHHHHHHHHHhc---cccce------------
Q 044997          290 ATNNFDESRIIGRGGFGNVYFGLL---GDREAAIKKMRSNK-----SKEFFAELKVLCKI---HHINV------------  346 (563)
Q Consensus       290 ~~~~f~~~~~LG~G~fG~Vy~g~~---~~~~vavK~~~~~~-----~~~f~~Ei~~l~~l---~H~ni------------  346 (563)
                      +.++|+..+.||+|+||.||+|+.   +++.||+|.++...     ...+.+|+++++++   +||||            
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            456799999999999999999987   36789999986432     24577888887776   89997            


Q ss_pred             --------EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEE
Q 044997          347 --------FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKV  418 (563)
Q Consensus       347 --------V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl  418 (563)
                              |+||+. |+|.+++...   ....+++..+..++.|++.||.|||+++   ++||||||+|||++.++.+||
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl  161 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDKV---PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKL  161 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHHS---CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEE
T ss_pred             CCCceEEEEEecCC-CCHHHHHHhc---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEE
Confidence                    345665 6888888652   2345899999999999999999999997   999999999999999999999


Q ss_pred             eecCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCC
Q 044997          419 ADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDS  498 (563)
Q Consensus       419 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~  498 (563)
                      +|||+++......    ......||..|+|||.+.+..             ++.++||||||+++|||++|+.||.....
T Consensus       162 ~Dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~-------------~~~~~Di~slG~il~~l~~g~~pf~~~~~  224 (326)
T 1blx_A          162 ADFGLARIYSFQM----ALTSVVVTLWYRAPEVLLQSS-------------YATPVDLWSVGCIFAEMFRRKPLFRGSSD  224 (326)
T ss_dssp             CSCCSCCCCCGGG----GGCCCCCCCTTCCHHHHTTCC-------------CCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             ecCcccccccCCC----CccccccccceeCHHHHhcCC-------------CCcchhHHHHHHHHHHHHcCCCCCCCCCH
Confidence            9999998654321    223457899999999885443             48899999999999999999999865432


Q ss_pred             Cch-------------------------------------hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          499 EPT-------------------------------------KMKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       499 ~~~-------------------------------------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                      ...                                     ....+...+.+++.+||+.||.+||++.|+++
T Consensus       225 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          225 VDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             HHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHHHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            100                                     01223456889999999999999999999985

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=1.7e-36  Score=306.76  Aligned_cols=225  Identities=18%  Similarity=0.334  Sum_probs=180.2

Q ss_pred             hcCCCccceecccCcEEEEEEEEC--CceEEEEEeccC---ChHHHHHHHHHHHhccccce---------------EEEe
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSN---KSKEFFAELKVLCKIHHINV---------------FIST  350 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~---~~~~f~~Ei~~l~~l~H~ni---------------V~e~  350 (563)
                      .++|+..+.||+|+||.||+|+..  ++.+|+|.+...   ..+++.+|++++++++||||               |+||
T Consensus        18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   97 (302)
T 2j7t_A           18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF   97 (302)
T ss_dssp             GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred             ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence            467888999999999999999985  788999998643   34779999999999999997               5799


Q ss_pred             ecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccccc
Q 044997          351 FGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERT  430 (563)
Q Consensus       351 ~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~  430 (563)
                      +++|+|.+++...    ...+++..+..++.|++.||.|||+++   ++||||||+|||++.++.+||+|||++......
T Consensus        98 ~~~~~l~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  170 (302)
T 2j7t_A           98 CPGGAVDAIMLEL----DRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT  170 (302)
T ss_dssp             CTTEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH
T ss_pred             CCCCcHHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCcccccc
Confidence            9999999888642    356999999999999999999999997   999999999999999999999999987642211


Q ss_pred             cccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc----------
Q 044997          431 NEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP----------  500 (563)
Q Consensus       431 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~----------  500 (563)
                      .   .......||+.|+|||.+.....        ....++.++||||||+++|||++|+.||.......          
T Consensus       171 ~---~~~~~~~~~~~y~aPE~~~~~~~--------~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~  239 (302)
T 2j7t_A          171 L---QKRDSFIGTPYWMAPEVVMCETM--------KDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDP  239 (302)
T ss_dssp             H---HC-----CCGGGCCHHHHHHHHT--------TSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC
T ss_pred             c---cccccccCChhhcCCeeeccccC--------CCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCC
Confidence            1   11223568999999998743211        13345889999999999999999999986543211          


Q ss_pred             ---hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          501 ---TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       501 ---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                         .....+...+.+++.+||+.||.+|||+.++++
T Consensus       240 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          240 PTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             CCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             cccCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence               112334566899999999999999999999986

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=9.4e-36  Score=311.30  Aligned_cols=215  Identities=24%  Similarity=0.364  Sum_probs=170.4

Q ss_pred             hcCCCccceecccCcEEEEEEEEC--CceEEEEEeccCC-----hHHHHHHHHHHHhccccceE----------------
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNK-----SKEFFAELKVLCKIHHINVF----------------  347 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~-----~~~f~~Ei~~l~~l~H~niV----------------  347 (563)
                      .++|...+.||+|+||.||+|...  ++.||||+++...     .+.+.+|++++++++||||+                
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            467889999999999999999874  7899999997532     35688999999999999983                


Q ss_pred             -----EEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecC
Q 044997          348 -----ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFG  422 (563)
Q Consensus       348 -----~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFG  422 (563)
                           +||+. |+|.+++.       ..+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||
T Consensus       121 ~~~lv~e~~~-~~l~~~~~-------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg  189 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIMG-------MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFG  189 (371)
T ss_dssp             CCEEEEECCC-EEHHHHTT-------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTT
T ss_pred             eEEEEEcccc-ccHHHHhh-------cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecC
Confidence                 33333 34444442       34899999999999999999999997   9999999999999999999999999


Q ss_pred             CCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCchh
Q 044997          423 LVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTK  502 (563)
Q Consensus       423 la~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~~  502 (563)
                      +++.....      .....||+.|+|||++.+.            ..++.++|||||||++|||++|+.||.........
T Consensus       190 ~a~~~~~~------~~~~~~t~~y~aPE~~~~~------------~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~  251 (371)
T 4exu_A          190 LARHADAE------MTGYVVTRWYRAPEVILSW------------MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQL  251 (371)
T ss_dssp             CC--------------CTTCCCTTSCHHHHSCC------------SCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred             cccccccC------cCCcccCccccCHHHhcCC------------CCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence            99854321      2335789999999987542            23589999999999999999999999754311000


Q ss_pred             -----------------------------------------hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          503 -----------------------------------------MKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       503 -----------------------------------------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                                                               .....+.+.+|+.+||+.||.+|||+.|+++.
T Consensus       252 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  324 (371)
T 4exu_A          252 TQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  324 (371)
T ss_dssp             HHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             HHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence                                                     01124568999999999999999999999864

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=9.5e-36  Score=312.45  Aligned_cols=183  Identities=20%  Similarity=0.316  Sum_probs=149.7

Q ss_pred             HhcCCCccceecccCcEEEEEEEEC--CceEEEEEeccCC--hHHHHHHHHHHHhcc-ccc-------------------
Q 044997          290 ATNNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNK--SKEFFAELKVLCKIH-HIN-------------------  345 (563)
Q Consensus       290 ~~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~--~~~f~~Ei~~l~~l~-H~n-------------------  345 (563)
                      ..++|+..+.||+|+||.||+|+..  ++.||||+++...  .+++.+|+++++.++ |+|                   
T Consensus        52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~  131 (382)
T 2vx3_A           52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHL  131 (382)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEE
T ss_pred             eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCce
Confidence            3578999999999999999999874  6789999997653  356778999988885 443                   


Q ss_pred             -eEEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEec--CCCcEEEeecC
Q 044997          346 -VFISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLD--DGLRAKVADFG  422 (563)
Q Consensus       346 -iV~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~--~~~~~kl~DFG  422 (563)
                       +|+||++ |+|.+++...   ....+++..+..++.|++.||.|||++ ..+|+||||||+|||++  .++.+||+|||
T Consensus       132 ~lv~e~~~-~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG  206 (382)
T 2vx3_A          132 CLVFEMLS-YNLYDLLRNT---NFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFG  206 (382)
T ss_dssp             EEEEECCC-CBHHHHHHHT---TTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCT
T ss_pred             EEEEecCC-CCHHHHHhhc---CcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEecc
Confidence             2678885 5999988752   235699999999999999999999963 12499999999999994  57889999999


Q ss_pred             CCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCC
Q 044997          423 LVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRD  496 (563)
Q Consensus       423 la~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~  496 (563)
                      +++.....      .....||+.|+|||++.+..             ++.++|||||||++|||++|+.||...
T Consensus       207 ~a~~~~~~------~~~~~~t~~y~aPE~~~~~~-------------~~~~~DiwSlG~il~elltg~~pf~~~  261 (382)
T 2vx3_A          207 SSCQLGQR------IYQYIQSRFYRSPEVLLGMP-------------YDLAIDMWSLGCILVEMHTGEPLFSGA  261 (382)
T ss_dssp             TCEETTCC------CCSSCSCGGGCCHHHHTTCC-------------CCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             Cceecccc------cccccCCccccChHHHcCCC-------------CCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            99865321      23357899999999986544             489999999999999999999999754

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=5.6e-36  Score=312.13  Aligned_cols=217  Identities=21%  Similarity=0.321  Sum_probs=174.1

Q ss_pred             cCCCccceecccCcEEEEEEEE--CCceEEEEEeccCC--hHHHHHHHHHHHhcc-----------ccce----------
Q 044997          292 NNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNK--SKEFFAELKVLCKIH-----------HINV----------  346 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~--~~~f~~Ei~~l~~l~-----------H~ni----------  346 (563)
                      ++|...+.||+|+||.||+|+.  +++.||||.++...  .+.+.+|++++++++           |+||          
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~   98 (373)
T 1q8y_A           19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK   98 (373)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred             CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhcc
Confidence            5788999999999999999986  57899999997653  466889999999887           6676          


Q ss_pred             ---------EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCceEeCCCCCCCeEec-----
Q 044997          347 ---------FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDH-TKARYVHRDIKTSNILLD-----  411 (563)
Q Consensus       347 ---------V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivHrDLk~~NILl~-----  411 (563)
                               |+|++ +|+|.+++...   ....+++..+..++.|++.||+|||++ +   |+||||||+|||++     
T Consensus        99 ~~~~~~~~lv~e~~-~~~L~~~~~~~---~~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~  171 (373)
T 1q8y_A           99 GPNGVHVVMVFEVL-GENLLALIKKY---EHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSP  171 (373)
T ss_dssp             ETTEEEEEEEECCC-CEEHHHHHHHT---TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETT
T ss_pred             CCCCceEEEEEecC-CCCHHHHHHHh---hccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCC
Confidence                     34555 78888888652   235699999999999999999999997 7   99999999999994     


Q ss_pred             -CCCcEEEeecCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCC
Q 044997          412 -DGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK  490 (563)
Q Consensus       412 -~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~  490 (563)
                       ..+.+||+|||+++.....      .....||+.|+|||++.+..             ++.++|||||||++|||++|+
T Consensus       172 ~~~~~~kl~Dfg~a~~~~~~------~~~~~~t~~y~aPE~~~~~~-------------~~~~~Di~slG~il~el~~g~  232 (373)
T 1q8y_A          172 ENLIQIKIADLGNACWYDEH------YTNSIQTREYRSPEVLLGAP-------------WGCGADIWSTACLIFELITGD  232 (373)
T ss_dssp             TTEEEEEECCCTTCEETTBC------CCSCCSCGGGCCHHHHHTCC-------------CCTHHHHHHHHHHHHHHHHSS
T ss_pred             cCcceEEEcccccccccCCC------CCCCCCCccccCcHHHhCCC-------------CCchHhHHHHHHHHHHHHhCC
Confidence             4458999999999865322      23347899999999886544             489999999999999999999


Q ss_pred             CCCcCCCCCc----------------------------------------------------------hhhHHHHHHHHH
Q 044997          491 RALIRDDSEP----------------------------------------------------------TKMKSLITIMAA  512 (563)
Q Consensus       491 ~p~~~~~~~~----------------------------------------------------------~~~~~~~~~l~~  512 (563)
                      .||.......                                                          .........+.+
T Consensus       233 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (373)
T 1q8y_A          233 FLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISD  312 (373)
T ss_dssp             CCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHH
T ss_pred             CCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHH
Confidence            9997543210                                                          001234566889


Q ss_pred             HHHHhhccCCCCCCCHHHHHHH
Q 044997          513 VAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       513 li~~cl~~dP~~RPs~~evl~~  534 (563)
                      |+.+||+.||.+|||+.|+++.
T Consensus       313 li~~~L~~dP~~Rpt~~ell~h  334 (373)
T 1q8y_A          313 FLSPMLQLDPRKRADAGGLVNH  334 (373)
T ss_dssp             HHGGGGCSSTTTCBCHHHHHTC
T ss_pred             HHHHHhccCccccCCHHHHhhC
Confidence            9999999999999999999873

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=1.8e-35  Score=306.71  Aligned_cols=214  Identities=24%  Similarity=0.365  Sum_probs=170.7

Q ss_pred             cCCCccceecccCcEEEEEEEEC--CceEEEEEeccCC-----hHHHHHHHHHHHhccccceE-----------------
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNK-----SKEFFAELKVLCKIHHINVF-----------------  347 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~-----~~~f~~Ei~~l~~l~H~niV-----------------  347 (563)
                      ++|...+.||+|+||.||+|+..  ++.||||.+....     .+++.+|+.++++++||||+                 
T Consensus        24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  103 (353)
T 3coi_A           24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD  103 (353)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred             ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence            56888999999999999999874  7899999986532     35688999999999999983                 


Q ss_pred             ----EEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCC
Q 044997          348 ----ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGL  423 (563)
Q Consensus       348 ----~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGl  423 (563)
                          +||+. |+|.+++.       ..+++..+..++.|++.||+|||+++   ++||||||+|||++.++.+||+|||+
T Consensus       104 ~~lv~e~~~-~~l~~~~~-------~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~  172 (353)
T 3coi_A          104 FYLVMPFMQ-TDLQKIMG-------LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGL  172 (353)
T ss_dssp             CEEEEECCS-EEGGGTTT-------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTC
T ss_pred             EEEEecccc-CCHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeeccc
Confidence                34444 45555543       34899999999999999999999997   99999999999999999999999999


Q ss_pred             CcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCch--
Q 044997          424 VKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPT--  501 (563)
Q Consensus       424 a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~--  501 (563)
                      ++.....      .....||+.|+|||.+.+.            ..++.++||||||+++|||++|+.||........  
T Consensus       173 ~~~~~~~------~~~~~~t~~y~aPE~~~~~------------~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~  234 (353)
T 3coi_A          173 ARHADAE------MTGYVVTRWYRAPEVILSW------------MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLT  234 (353)
T ss_dssp             TTC--------------CCSBCCSCHHHHSCC------------SCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHH
T ss_pred             ccCCCCC------ccccccCcCcCCHHHHhCc------------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            9854321      2335689999999987542            2358899999999999999999999975432100  


Q ss_pred             ---------------------------------------hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          502 ---------------------------------------KMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       502 ---------------------------------------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                                                             ........+.+++.+||+.||.+||++.|+++.
T Consensus       235 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  306 (353)
T 3coi_A          235 QILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  306 (353)
T ss_dssp             HHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             HHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence                                                   011234568999999999999999999999863

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.9e-36  Score=321.50  Aligned_cols=224  Identities=23%  Similarity=0.333  Sum_probs=170.6

Q ss_pred             cCCCccceecccCcEE-EEEEEECCceEEEEEeccCChHHHHHHHHHHHhc-cccce---------------EEEeecCC
Q 044997          292 NNFDESRIIGRGGFGN-VYFGLLGDREAAIKKMRSNKSKEFFAELKVLCKI-HHINV---------------FISTFGNG  354 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~-Vy~g~~~~~~vavK~~~~~~~~~f~~Ei~~l~~l-~H~ni---------------V~e~~~~g  354 (563)
                      .+|...+.||+|+||. ||++..+++.||||++.....+.+.+|+++|+++ +||||               |+||+. |
T Consensus        24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g  102 (432)
T 3p23_A           24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-A  102 (432)
T ss_dssp             EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-E
T ss_pred             EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-C
Confidence            4588889999999998 5666778999999999877666677899999999 89998               467775 6


Q ss_pred             CcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecC-----CCcEEEeecCCCccccc
Q 044997          355 SLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDD-----GLRAKVADFGLVKLEER  429 (563)
Q Consensus       355 sL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~-----~~~~kl~DFGla~~~~~  429 (563)
                      +|.+++...    ...+.+..+..++.|++.||+|||+++   |+||||||+|||++.     ..++||+|||+++....
T Consensus       103 ~L~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~  175 (432)
T 3p23_A          103 TLQEYVEQK----DFAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV  175 (432)
T ss_dssp             EHHHHHHSS----SCCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--
T ss_pred             CHHHHHHhc----CCCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeeccC
Confidence            999988752    234555567789999999999999997   999999999999943     34688999999987654


Q ss_pred             ccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCCCcCCCCCc--------
Q 044997          430 TNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIRDDSEP--------  500 (563)
Q Consensus       430 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p~~~~~~~~--------  500 (563)
                      ............||+.|+|||++....          ...++.++|||||||++|||++ |+.||.......        
T Consensus       176 ~~~~~~~~~~~~gt~~y~APE~l~~~~----------~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~  245 (432)
T 3p23_A          176 GRHSFSRRSGVPGTEGWIAPEMLSEDC----------KENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGAC  245 (432)
T ss_dssp             ----------CCSCTTSCCGGGTSCC-------------CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCC
T ss_pred             CCcceeeccccCCCcCccChhhhhccc----------ccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccC
Confidence            322222234467999999999986321          2345789999999999999999 888885432211        


Q ss_pred             -----hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          501 -----TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       501 -----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                           .........+.+|+.+||+.||.+||++.|+++
T Consensus       246 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          246 SLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             CCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence                 111233455889999999999999999999984

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=4.6e-36  Score=316.30  Aligned_cols=221  Identities=24%  Similarity=0.305  Sum_probs=170.4

Q ss_pred             cCCCccceecccCcEEEEEEEEC-CceEEEEEeccCChHHHHHHHHHHHhccccceE---------------------EE
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG-DREAAIKKMRSNKSKEFFAELKVLCKIHHINVF---------------------IS  349 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~vavK~~~~~~~~~f~~Ei~~l~~l~H~niV---------------------~e  349 (563)
                      .+|...+.||+|+||.||+|+.. +..+|+|++..... ...+|+++|++++|||||                     +|
T Consensus        40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~-~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e  118 (394)
T 4e7w_A           40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR-FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLE  118 (394)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT-SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEE
T ss_pred             ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc-hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEee
Confidence            45888999999999999999984 56699998864322 223699999999999983                     34


Q ss_pred             eecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEec-CCCcEEEeecCCCcccc
Q 044997          350 TFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLD-DGLRAKVADFGLVKLEE  428 (563)
Q Consensus       350 ~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~-~~~~~kl~DFGla~~~~  428 (563)
                      |++++.+......  ......+++..+..++.|++.||+|||+++   |+||||||+|||++ .++.+||+|||+++...
T Consensus       119 ~~~~~l~~~~~~~--~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~  193 (394)
T 4e7w_A          119 YVPETVYRASRHY--AKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILI  193 (394)
T ss_dssp             CCSEEHHHHHHHH--HHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred             ccCccHHHHHHHH--HhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCccccc
Confidence            4443222211111  112467999999999999999999999997   99999999999999 79999999999998654


Q ss_pred             cccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCchhh-----
Q 044997          429 RTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKM-----  503 (563)
Q Consensus       429 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~~~-----  503 (563)
                      ....    .....||+.|+|||++.+..            .++.++|||||||++|||++|+.||.+........     
T Consensus       194 ~~~~----~~~~~~t~~y~aPE~~~~~~------------~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~  257 (394)
T 4e7w_A          194 AGEP----NVSYICSRYYRAPELIFGAT------------NYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKV  257 (394)
T ss_dssp             TTCC----CCSSCSCGGGCCHHHHTTCS------------SCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred             CCCC----CcccccCcCccCHHHHcCCC------------CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence            3321    23457899999999875432            35899999999999999999999997654211000     


Q ss_pred             ----------------------------------HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          504 ----------------------------------KSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       504 ----------------------------------~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                                                        ....+.+.+|+.+||+.||.+|||+.|+++.
T Consensus       258 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  322 (394)
T 4e7w_A          258 LGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH  322 (394)
T ss_dssp             HCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             hCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence                                              0133568999999999999999999999863

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=9.5e-36  Score=300.52  Aligned_cols=226  Identities=24%  Similarity=0.386  Sum_probs=172.4

Q ss_pred             HhcCCCccceecccCcEEEEEEEE--CCceEEEEEeccCC--hHHHHHHHHHHHhccccce-------------------
Q 044997          290 ATNNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNK--SKEFFAELKVLCKIHHINV-------------------  346 (563)
Q Consensus       290 ~~~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~--~~~f~~Ei~~l~~l~H~ni-------------------  346 (563)
                      ..++|+..+.||+|+||.||+|+.  +++.||||.++...  .+.+.+|++++++++||||                   
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (303)
T 1zy4_A            4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA   83 (303)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred             ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence            356789999999999999999987  47899999986543  3678899999999999986                   


Q ss_pred             ---------EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEE
Q 044997          347 ---------FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAK  417 (563)
Q Consensus       347 ---------V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~k  417 (563)
                               |+||+++|+|.+++..    ....+++..++.++.|++.||+|||+++   ++||||||+|||++.++.+|
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~k  156 (303)
T 1zy4_A           84 VKKKSTLFIQMEYCENGTLYDLIHS----ENLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVK  156 (303)
T ss_dssp             --CEEEEEEEEECCCSCBHHHHHHH----SCGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEE
T ss_pred             cccCCceEEEEecCCCCCHHHhhhc----cccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEE
Confidence                     3578889999999974    2345788999999999999999999997   99999999999999999999


Q ss_pred             EeecCCCcccccccc-----------cccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHH
Q 044997          418 VADFGLVKLEERTNE-----------KEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAEL  486 (563)
Q Consensus       418 l~DFGla~~~~~~~~-----------~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~El  486 (563)
                      |+|||+++.......           .........||+.|+|||.+.+.            +.++.++||||||+++|||
T Consensus       157 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~------------~~~~~~~Di~slG~il~~l  224 (303)
T 1zy4_A          157 IGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGT------------GHYNEKIDMYSLGIIFFEM  224 (303)
T ss_dssp             ECCCCCCSCTTC-------------------------CTTSCHHHHTSC------------SCCCTHHHHHHHHHHHHHH
T ss_pred             EeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCC------------CCCcchhhHHHHHHHHHHH
Confidence            999999986542210           01112345689999999987532            2458999999999999999


Q ss_pred             HcCCCCCcC------------CCCCchhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          487 ITGKRALIR------------DDSEPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       487 ltg~~p~~~------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                      +++..+...            ..............+.+++.+||+.||.+|||+.|+++.
T Consensus       225 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  284 (303)
T 1zy4_A          225 IYPFSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS  284 (303)
T ss_dssp             HSCCSSHHHHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             HhccCCchhHHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence            983221100            000111112334558899999999999999999999873

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.9e-36  Score=308.22  Aligned_cols=224  Identities=27%  Similarity=0.402  Sum_probs=176.7

Q ss_pred             HHHHHhcCCCccceecccCcEEEEEEEE--CCceEEEEEeccCC---------hHHHHHHHHHHHhc----cccce----
Q 044997          286 EIEEATNNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNK---------SKEFFAELKVLCKI----HHINV----  346 (563)
Q Consensus       286 el~~~~~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~---------~~~f~~Ei~~l~~l----~H~ni----  346 (563)
                      +.....++|...+.||+|+||.||+|+.  +++.||||.++...         ...+.+|++++.++    +|+||    
T Consensus        25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~  104 (312)
T 2iwi_A           25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL  104 (312)
T ss_dssp             --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred             chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence            3455568899999999999999999987  47889999996542         23356799999999    89998    


Q ss_pred             -----------EEEe-ecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEec-CC
Q 044997          347 -----------FIST-FGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLD-DG  413 (563)
Q Consensus       347 -----------V~e~-~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~-~~  413 (563)
                                 |+|+ +.+++|.+++..     ...+++..+..++.|++.||+|||+++   ++||||||+||+++ ++
T Consensus       105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~  176 (312)
T 2iwi_A          105 DWFETQEGFMLVLERPLPAQDLFDYITE-----KGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRR  176 (312)
T ss_dssp             EEC-----CEEEEECCSSEEEHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTT
T ss_pred             EEEecCCeEEEEEEecCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCC
Confidence                       4576 678899988865     246999999999999999999999997   99999999999999 88


Q ss_pred             CcEEEeecCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCC
Q 044997          414 LRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRAL  493 (563)
Q Consensus       414 ~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~  493 (563)
                      +.+||+|||+++......     .....|+..|+|||++.+..+            .+.++||||||+++|||++|+.||
T Consensus       177 ~~~kl~dfg~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~------------~~~~~Di~slG~il~~l~~g~~pf  239 (312)
T 2iwi_A          177 GCAKLIDFGSGALLHDEP-----YTDFDGTRVYSPPEWISRHQY------------HALPATVWSLGILLYDMVCGDIPF  239 (312)
T ss_dssp             TEEEECCCSSCEECCSSC-----BCCCCSCTTTSCHHHHHHSCB------------CHHHHHHHHHHHHHHHHHHSSCSC
T ss_pred             CeEEEEEcchhhhcccCc-----ccccCCcccccCceeeecCCC------------CCccchHHHHHHHHHHHHHCCCCC
Confidence            999999999998654321     234568999999998865433            245899999999999999999998


Q ss_pred             cCCCC----CchhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          494 IRDDS----EPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       494 ~~~~~----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                      .....    .......+...+.+++.+||+.||++||++.|+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  284 (312)
T 2iwi_A          240 ERDQEILEAELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD  284 (312)
T ss_dssp             CSHHHHHHTCCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             CChHHHhhhccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            54211    001112345668999999999999999999999873

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=1e-35  Score=306.77  Aligned_cols=218  Identities=19%  Similarity=0.330  Sum_probs=156.4

Q ss_pred             hcCCCcc-ceecccCcEEEEEEEEC--CceEEEEEeccCChHHHHHHHHHHHhccccce-------------------EE
Q 044997          291 TNNFDES-RIIGRGGFGNVYFGLLG--DREAAIKKMRSNKSKEFFAELKVLCKIHHINV-------------------FI  348 (563)
Q Consensus       291 ~~~f~~~-~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~f~~Ei~~l~~l~H~ni-------------------V~  348 (563)
                      .++|... +.||+|+||.||+|+..  ++.||||++..... ...+....+..++||||                   |+
T Consensus        27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~  105 (336)
T 3fhr_A           27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK-ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIM  105 (336)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHH-HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHH-HHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEE
Confidence            4578874 46999999999999885  78999999965422 22223334667788886                   57


Q ss_pred             EeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecC---CCcEEEeecCCCc
Q 044997          349 STFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDD---GLRAKVADFGLVK  425 (563)
Q Consensus       349 e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~---~~~~kl~DFGla~  425 (563)
                      ||+.+|+|.+++...   ....+++.++..++.|++.||.|||+++   ++||||||+|||++.   ++.+||+|||+++
T Consensus       106 e~~~gg~L~~~l~~~---~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~  179 (336)
T 3fhr_A          106 ECMEGGELFSRIQER---GDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAK  179 (336)
T ss_dssp             ECCTTEEHHHHHHTC----CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred             eccCCCCHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEeccccce
Confidence            899999999999752   3457999999999999999999999997   999999999999986   4569999999997


Q ss_pred             ccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCch----
Q 044997          426 LEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPT----  501 (563)
Q Consensus       426 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~----  501 (563)
                      .....     ......||+.|+|||++.+..+             +.++||||||+++|||++|+.||........    
T Consensus       180 ~~~~~-----~~~~~~~t~~y~aPE~~~~~~~-------------~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~  241 (336)
T 3fhr_A          180 ETTQN-----ALQTPCYTPYYVAPEVLGPEKY-------------DKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGM  241 (336)
T ss_dssp             EC---------------------------CHH-------------HHHHHHHHHHHHHHHHHHSSCCC------------
T ss_pred             ecccc-----ccccCCCCcCccChhhhCCCCC-------------CchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhH
Confidence            54322     1233568999999999865554             7899999999999999999999865432110    


Q ss_pred             --------------hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          502 --------------KMKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       502 --------------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                                    ....+...+.+++.+||+.||.+|||+.|+++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  287 (336)
T 3fhr_A          242 KRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN  287 (336)
T ss_dssp             ---------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHhhhccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence                          11234567899999999999999999999997

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=1.4e-36  Score=311.03  Aligned_cols=224  Identities=25%  Similarity=0.431  Sum_probs=178.9

Q ss_pred             HHHHHhcCCCccceecccCcEEEEEEEE--CCceEEEEEeccCC---------hHHHHHHHHHHHhccc--cce------
Q 044997          286 EIEEATNNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNK---------SKEFFAELKVLCKIHH--INV------  346 (563)
Q Consensus       286 el~~~~~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~---------~~~f~~Ei~~l~~l~H--~ni------  346 (563)
                      +.....++|+..+.||+|+||.||+|+.  +++.||||.++...         .+.+.+|++++++++|  +||      
T Consensus        37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~  116 (320)
T 3a99_A           37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW  116 (320)
T ss_dssp             ---CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred             ccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEE
Confidence            3444567899999999999999999987  47889999986532         2457789999999964  887      


Q ss_pred             ---------EEEeecC-CCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEec-CCCc
Q 044997          347 ---------FISTFGN-GSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLD-DGLR  415 (563)
Q Consensus       347 ---------V~e~~~~-gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~-~~~~  415 (563)
                               |+|++.. ++|.+++..     ...+++..+..++.|++.||+|||+++   |+||||||+|||++ +++.
T Consensus       117 ~~~~~~~~lv~e~~~~~~~L~~~l~~-----~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~  188 (320)
T 3a99_A          117 FERPDSFVLILERPEPVQDLFDFITE-----RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGE  188 (320)
T ss_dssp             EECSSEEEEEEECCSSEEEHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTE
T ss_pred             EecCCcEEEEEEcCCCCccHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCC
Confidence                     4577765 788888864     356899999999999999999999997   99999999999999 7899


Q ss_pred             EEEeecCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcC
Q 044997          416 AKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIR  495 (563)
Q Consensus       416 ~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~  495 (563)
                      +||+|||+++.....     ......||+.|+|||++.+..+            .+.++||||||+++|||++|+.||..
T Consensus       189 ~kL~Dfg~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~------------~~~~~Di~slG~il~el~~g~~pf~~  251 (320)
T 3a99_A          189 LKLIDFGSGALLKDT-----VYTDFDGTRVYSPPEWIRYHRY------------HGRSAAVWSLGILLYDMVCGDIPFEH  251 (320)
T ss_dssp             EEECCCTTCEECCSS-----CBCCCCSCGGGSCHHHHHHSCB------------CHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred             EEEeeCccccccccc-----cccCCCCCccCCChHHhccCCC------------CCccchHHhHHHHHHHHHHCCCCCCC
Confidence            999999999865432     1233568999999998855432            26789999999999999999999854


Q ss_pred             CCC----CchhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          496 DDS----EPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       496 ~~~----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                      ...    .......+.+.+.+++.+||+.||.+||++.|+++.
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  294 (320)
T 3a99_A          252 DEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH  294 (320)
T ss_dssp             HHHHHHCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             hhhhhcccccccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            321    001112345668999999999999999999999873

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=6.3e-36  Score=319.25  Aligned_cols=231  Identities=24%  Similarity=0.351  Sum_probs=169.5

Q ss_pred             CCCccceecccCcEEEEE-EEECCceEEEEEeccCChHHHHHHHHHHHhc-cccce---------------EEEeecCCC
Q 044997          293 NFDESRIIGRGGFGNVYF-GLLGDREAAIKKMRSNKSKEFFAELKVLCKI-HHINV---------------FISTFGNGS  355 (563)
Q Consensus       293 ~f~~~~~LG~G~fG~Vy~-g~~~~~~vavK~~~~~~~~~f~~Ei~~l~~l-~H~ni---------------V~e~~~~gs  355 (563)
                      .|...+.||+|+||.||. +..+++.||||++..+..+.+.+|+++|.++ +||||               |+||+. |+
T Consensus        16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gs   94 (434)
T 2rio_A           16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LN   94 (434)
T ss_dssp             CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGGHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EE
T ss_pred             eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CC
Confidence            345568899999999964 4557899999999887777889999999986 89998               467774 79


Q ss_pred             cccccccccccCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCC-------------CcEEEee
Q 044997          356 LSDHLHDPLLKGH--QPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDG-------------LRAKVAD  420 (563)
Q Consensus       356 L~~~L~~~~~~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~-------------~~~kl~D  420 (563)
                      |.+++........  ...++..++.++.|++.||+|||+++   |+||||||+|||++.+             +++||+|
T Consensus        95 L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~D  171 (434)
T 2rio_A           95 LQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISD  171 (434)
T ss_dssp             HHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECC
T ss_pred             HHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEEEEcc
Confidence            9999875321111  11234456789999999999999997   9999999999999754             5899999


Q ss_pred             cCCCccccccccc-ccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCCCcCCCC
Q 044997          421 FGLVKLEERTNEK-EMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIRDDS  498 (563)
Q Consensus       421 FGla~~~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p~~~~~~  498 (563)
                      ||+++........ ........||+.|+|||++.+...      ......++.++|||||||++|||++ |+.||.....
T Consensus       172 FG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~------~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~  245 (434)
T 2rio_A          172 FGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNN------LQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS  245 (434)
T ss_dssp             CTTCEECCC--------------CCTTSCHHHHSCCCT------TSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTT
T ss_pred             cccceecCCCCccceeeecCCCCCCCccCHHHhccccc------cccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchh
Confidence            9999876543211 111234579999999999865221      0123456899999999999999999 8999864322


Q ss_pred             Cc---------------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          499 EP---------------TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       499 ~~---------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                      ..               .....+...+.+++.+||+.||.+||++.|+++
T Consensus       246 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          246 RESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             HHHHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hHHHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence            11               012345677999999999999999999999986

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=9.8e-36  Score=305.16  Aligned_cols=226  Identities=23%  Similarity=0.354  Sum_probs=158.6

Q ss_pred             cCCCccceecccCcEEEEEEEEC--CceEEEEEeccCC----hHHHHHHHH-HHHhccccce---------------EEE
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNK----SKEFFAELK-VLCKIHHINV---------------FIS  349 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~----~~~f~~Ei~-~l~~l~H~ni---------------V~e  349 (563)
                      ++|+..+.||+|+||.||+|...  ++.||||.++...    ..++..|+. +++.++||||               |+|
T Consensus        22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e  101 (327)
T 3aln_A           22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICME  101 (327)
T ss_dssp             CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEe
Confidence            67888999999999999999985  7899999997643    234566666 7788899998               456


Q ss_pred             eecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCceEeCCCCCCCeEecCCCcEEEeecCCCcccc
Q 044997          350 TFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDH-TKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEE  428 (563)
Q Consensus       350 ~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~  428 (563)
                      |+. |+|.+++..........+++..+..++.|++.||.|||+. +   ++||||||+|||++.++.+||+|||+++...
T Consensus       102 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~  177 (327)
T 3aln_A          102 LMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQLV  177 (327)
T ss_dssp             CCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC--
T ss_pred             ecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceecc
Confidence            666 4666666432212346799999999999999999999998 7   9999999999999999999999999998654


Q ss_pred             cccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc--------
Q 044997          429 RTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP--------  500 (563)
Q Consensus       429 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~--------  500 (563)
                      ...    ......||+.|+|||.+....         ....++.++||||||+++|||++|+.||.......        
T Consensus       178 ~~~----~~~~~~gt~~y~aPE~~~~~~---------~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~  244 (327)
T 3aln_A          178 DSI----AKTRDAGCRPYMAPERIDPSA---------SRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVK  244 (327)
T ss_dssp             -----------------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCC
T ss_pred             ccc----ccccCCCCccccCceeecccc---------CcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhc
Confidence            321    122346899999999874221         12345899999999999999999999986532110        


Q ss_pred             --------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          501 --------TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       501 --------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                              .....+...+.+++.+||+.||.+||++.|+++.
T Consensus       245 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  286 (327)
T 3aln_A          245 GDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH  286 (327)
T ss_dssp             SCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             CCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence                    0012355678999999999999999999999763

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=1.8e-35  Score=297.46  Aligned_cols=219  Identities=23%  Similarity=0.371  Sum_probs=180.5

Q ss_pred             HHhcCCCccceecccCcEEEEEEEE--CCceEEEEEeccC-----ChHHHHHHHHHHHhccccce---------------
Q 044997          289 EATNNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSN-----KSKEFFAELKVLCKIHHINV---------------  346 (563)
Q Consensus       289 ~~~~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~-----~~~~f~~Ei~~l~~l~H~ni---------------  346 (563)
                      ...++|+..+.||+|+||.||+|+.  +++.||+|.++..     ..+.+.+|++++++++||||               
T Consensus        19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   98 (287)
T 2wei_A           19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI   98 (287)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence            3456799999999999999999988  4789999998542     34679999999999999997               


Q ss_pred             EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCC---CcEEEeecCC
Q 044997          347 FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDG---LRAKVADFGL  423 (563)
Q Consensus       347 V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~---~~~kl~DFGl  423 (563)
                      |+||+.+++|.+++..     ...+++..+..++.|++.||.|||+++   ++||||||+||+++.+   +.+||+|||+
T Consensus        99 v~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~  170 (287)
T 2wei_A           99 VGELYTGGELFDEIIK-----RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGL  170 (287)
T ss_dssp             EECCCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTG
T ss_pred             EEEccCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCc
Confidence            5688889999888864     246899999999999999999999997   9999999999999754   4799999999


Q ss_pred             CcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCC----
Q 044997          424 VKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE----  499 (563)
Q Consensus       424 a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~----  499 (563)
                      ++.......    .....||+.|+|||.+.+              .++.++||||||+++|||++|+.||......    
T Consensus       171 ~~~~~~~~~----~~~~~~~~~y~aPE~~~~--------------~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~  232 (287)
T 2wei_A          171 STCFQQNTK----MKDRIGTAYYIAPEVLRG--------------TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILK  232 (287)
T ss_dssp             GGTBCCCSS----CSCHHHHHTTCCHHHHTT--------------CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred             ceeecCCCc----cccccCcccccChHHhcC--------------CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            886543221    123457889999998742              3588999999999999999999998654321    


Q ss_pred             ----------chhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          500 ----------PTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       500 ----------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                                ......+.+.+.+++.+||+.||.+||++.|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  276 (287)
T 2wei_A          233 RVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (287)
T ss_dssp             HHHHCCCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHcCCCCCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence                      1112344567899999999999999999999987

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=4.3e-36  Score=318.47  Aligned_cols=230  Identities=17%  Similarity=0.154  Sum_probs=172.2

Q ss_pred             hcCCCccceecccCcEEEEEEEEC--CceEEEEEeccC------ChHHHHHHHHHHHhcccc-ce---------------
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSN------KSKEFFAELKVLCKIHHI-NV---------------  346 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~------~~~~f~~Ei~~l~~l~H~-ni---------------  346 (563)
                      ..+|...+.||+|+||.||+|+..  ++.||||+++..      ..+.|.+|+.+++.++|. |.               
T Consensus        77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~  156 (413)
T 3dzo_A           77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  156 (413)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred             ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence            345777899999999999999975  889999998732      246789999999999872 11               


Q ss_pred             -------------------------EEEeecCCCccccccccc--ccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceE
Q 044997          347 -------------------------FISTFGNGSLSDHLHDPL--LKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYV  399 (563)
Q Consensus       347 -------------------------V~e~~~~gsL~~~L~~~~--~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iv  399 (563)
                                               ++..+..|+|.+++....  ......++|..++.++.|+++||+|||+++   |+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ii  233 (413)
T 3dzo_A          157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LV  233 (413)
T ss_dssp             EECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred             cccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cc
Confidence                                     112234567776663110  012356889999999999999999999997   99


Q ss_pred             eCCCCCCCeEecCCCcEEEeecCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHH
Q 044997          400 HRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAF  479 (563)
Q Consensus       400 HrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSf  479 (563)
                      ||||||+|||++.++.+||+|||+++.....      .....| +.|+|||++......+.   ......++.++|||||
T Consensus       234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~------~~~~~g-~~y~aPE~~~~~~~~~~---~~~~~~~~~~~DvwSl  303 (413)
T 3dzo_A          234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS------AVSPIG-RGFAPPETTAERMLPFG---QHHPTLMTFAFDTWTL  303 (413)
T ss_dssp             CSCCCGGGEEECTTCCEEECCGGGCEETTEE------ECCCCC-TTTCCHHHHHHHTSTTG---GGCCEEECHHHHHHHH
T ss_pred             cCCcccceEEEecCCeEEEEeccceeecCCc------cccCCC-CceeCchhhhccccccc---cccCcCCCchhhHHHH
Confidence            9999999999999999999999998854322      233567 99999999843210000   0022345889999999


Q ss_pred             HHHHHHHHcCCCCCcCCCCCch------hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          480 GVVLAELITGKRALIRDDSEPT------KMKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       480 Gvvl~Elltg~~p~~~~~~~~~------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                      ||++|||++|+.||........      ....+++.+.+|+.+||+.||.+||++.|+++
T Consensus       304 Gvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~  363 (413)
T 3dzo_A          304 GLAIYWIWCADLPNTDDAALGGSEWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAME  363 (413)
T ss_dssp             HHHHHHHHHSSCCCCTTGGGSCSGGGGSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHHHHHHHHCCCCCCCcchhhhHHHHHhhcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            9999999999999975432111      01245577999999999999999999877744

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=1.7e-35  Score=301.54  Aligned_cols=233  Identities=23%  Similarity=0.326  Sum_probs=173.6

Q ss_pred             HHhcCCCccceecccCcEEEEEEEEC-CceEEEEEeccCC-----hHHHHHHHHHHHhccc--cce--------------
Q 044997          289 EATNNFDESRIIGRGGFGNVYFGLLG-DREAAIKKMRSNK-----SKEFFAELKVLCKIHH--INV--------------  346 (563)
Q Consensus       289 ~~~~~f~~~~~LG~G~fG~Vy~g~~~-~~~vavK~~~~~~-----~~~f~~Ei~~l~~l~H--~ni--------------  346 (563)
                      ...++|+..+.||+|+||.||++... ++.||||.++...     .+.+.+|++++.+++|  +||              
T Consensus        25 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~  104 (313)
T 3cek_A           25 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY  104 (313)
T ss_dssp             ETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEE
T ss_pred             eccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEE
Confidence            34567889999999999999999874 6789999986432     3668899999999975  887              


Q ss_pred             -EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCc
Q 044997          347 -FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK  425 (563)
Q Consensus       347 -V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~  425 (563)
                       |+| +.+|+|.+++..     ...+++..+..++.|+++||.|||+++   ++||||||+|||+++ +.+||+|||+++
T Consensus       105 lv~e-~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg~~~  174 (313)
T 3cek_A          105 MVME-CGNIDLNSWLKK-----KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFGIAN  174 (313)
T ss_dssp             EEEC-CCSEEHHHHHHH-----CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCSSSC
T ss_pred             EEEe-cCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeeccccc
Confidence             345 567788888864     356899999999999999999999997   999999999999975 899999999998


Q ss_pred             ccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCchhh--
Q 044997          426 LEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKM--  503 (563)
Q Consensus       426 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~~~--  503 (563)
                      ....... ........||+.|+|||.+.+.....  ........++.++||||||+++|||++|+.||..........  
T Consensus       175 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~--~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~  251 (313)
T 3cek_A          175 QMQPDTT-SVVKDSQVGTVNYMPPEAIKDMSSSR--ENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHA  251 (313)
T ss_dssp             C---------------CCGGGCCHHHHTTCC------------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHH
T ss_pred             cccCccc-cccccCCCCCCCcCCHHHHhhccccc--ccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHH
Confidence            6543221 11223456899999999986421100  000112356889999999999999999999996543221111  


Q ss_pred             -----------HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          504 -----------KSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       504 -----------~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                                 ......+.+++.+||+.||.+||++.|+++.
T Consensus       252 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  293 (313)
T 3cek_A          252 IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  293 (313)
T ss_dssp             HHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence                       1223568999999999999999999999874

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=1.3e-34  Score=294.90  Aligned_cols=224  Identities=22%  Similarity=0.347  Sum_probs=157.4

Q ss_pred             hcCCCccceecccCcEEEEEEEEC--CceEEEEEeccCCh-----HHHHHHHHHHHhccccce---------------EE
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNKS-----KEFFAELKVLCKIHHINV---------------FI  348 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~-----~~f~~Ei~~l~~l~H~ni---------------V~  348 (563)
                      .++|+..+.||+|+||.||+|+..  ++.||||.++....     +.+.++..+++.++||||               |+
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~  103 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM  103 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence            356888999999999999999984  78999999975432     224445557888899998               34


Q ss_pred             EeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCceEeCCCCCCCeEecCCCcEEEeecCCCccc
Q 044997          349 STFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDH-TKARYVHRDIKTSNILLDDGLRAKVADFGLVKLE  427 (563)
Q Consensus       349 e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~  427 (563)
                      ||+  |.+.+.+..   .....+++..+..++.|++.||.|||+. +   ++||||||+|||++.++.+||+|||+++..
T Consensus       104 e~~--~~~~~~l~~---~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  175 (318)
T 2dyl_A          104 ELM--GTCAEKLKK---RMQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRL  175 (318)
T ss_dssp             CCC--SEEHHHHHH---HHTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC---
T ss_pred             ecc--CCcHHHHHH---HhccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhc
Confidence            555  233333322   1235689999999999999999999984 7   999999999999999999999999999755


Q ss_pred             ccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCchhh----
Q 044997          428 ERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKM----  503 (563)
Q Consensus       428 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~~~----  503 (563)
                      ....    ......||+.|+|||.+.....        ....++.++||||||+++|||++|+.||..........    
T Consensus       176 ~~~~----~~~~~~~~~~y~aPE~~~~~~~--------~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~  243 (318)
T 2dyl_A          176 VDDK----AKDRSAGCAAYMAPERIDPPDP--------TKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVL  243 (318)
T ss_dssp             ---------------CCTTCCHHHHC----------------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHH
T ss_pred             cCCc----cccccCCCccccChhhcccccc--------cccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHh
Confidence            4322    1233568999999999853211        23456889999999999999999999997533221111    


Q ss_pred             ----------HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          504 ----------KSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       504 ----------~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                                ..+...+.+++.+||+.||.+||++.|+++.
T Consensus       244 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  284 (318)
T 2dyl_A          244 QEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH  284 (318)
T ss_dssp             HSCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             ccCCCCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence                      1234568999999999999999999999873

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=1.5e-34  Score=319.83  Aligned_cols=227  Identities=26%  Similarity=0.373  Sum_probs=180.6

Q ss_pred             cCCCccceecccCcEEEEEEEE--CCceEEEEEeccCC----hHHHHHHHHHHHhccccce-------------------
Q 044997          292 NNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNK----SKEFFAELKVLCKIHHINV-------------------  346 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~----~~~f~~Ei~~l~~l~H~ni-------------------  346 (563)
                      ++|...+.||+|+||.||+|..  +++.||||+++...    .+.+.+|++++++++||||                   
T Consensus        14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~   93 (676)
T 3qa8_A           14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP   93 (676)
T ss_dssp             ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred             CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence            6799999999999999999987  47899999987542    3568899999999999997                   


Q ss_pred             --EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCc---EEEeec
Q 044997          347 --FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLR---AKVADF  421 (563)
Q Consensus       347 --V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~---~kl~DF  421 (563)
                        |+||+++|+|.+++...  .....+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.   +||+||
T Consensus        94 ~LVmEy~~ggsL~~~L~~~--~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DF  168 (676)
T 3qa8_A           94 LLAMEYCEGGDLRKYLNQF--ENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDL  168 (676)
T ss_dssp             CCEEECCSSCBHHHHHHSS--SCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred             EEEEEeCCCCCHHHHHHhc--ccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEccc
Confidence              57899999999998752  22346899999999999999999999997   999999999999997664   999999


Q ss_pred             CCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCC---
Q 044997          422 GLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDS---  498 (563)
Q Consensus       422 Gla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~---  498 (563)
                      |+++......    ......||+.|+|||.+.+..             ++.++||||||+++|||++|+.||.....   
T Consensus       169 G~a~~~~~~~----~~~~~~gt~~Y~APE~l~~~~-------------~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~  231 (676)
T 3qa8_A          169 GYAKELDQGE----LCTEFVGTLQYLAPELLEQKK-------------YTVTVDYWSFGTLAFECITGFRPFLPNWQPVQ  231 (676)
T ss_dssp             CCCCBTTSCC----CCCCCCSCCTTCSSCSSCCSC-------------CSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHH
T ss_pred             cccccccccc----ccccccCCcccCChHHhccCC-------------CCchhHHHHHHHHHHHHHHCCCCCCcccchhh
Confidence            9998654322    223457999999999885544             48899999999999999999999854210   


Q ss_pred             -------------------------------CchhhHHHHHHHHHHHHHhhccCCCCCCCHHH-----HHHHHHHhhh
Q 044997          499 -------------------------------EPTKMKSLITIMAAVAEWCLNEDAVDRPEMRD-----IVAILSQIMI  540 (563)
Q Consensus       499 -------------------------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e-----vl~~L~~i~~  540 (563)
                                                     .......+.+.+.+++.+||+.||++|||+.|     ..+.+..++.
T Consensus       232 ~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~  309 (676)
T 3qa8_A          232 WHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILS  309 (676)
T ss_dssp             SSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHC
T ss_pred             hhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHh
Confidence                                           00112346778999999999999999999988     4566666654

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=5.6e-34  Score=321.00  Aligned_cols=217  Identities=22%  Similarity=0.330  Sum_probs=176.1

Q ss_pred             cCCCccceecccCcEEEEEEEE---CCceEEEEEeccCC----hHHHHHHHHHHHhccccce------------------
Q 044997          292 NNFDESRIIGRGGFGNVYFGLL---GDREAAIKKMRSNK----SKEFFAELKVLCKIHHINV------------------  346 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~---~~~~vavK~~~~~~----~~~f~~Ei~~l~~l~H~ni------------------  346 (563)
                      ++|...+.||+|+||.||+|..   +++.||||.+....    .+.|.+|+++|++++||||                  
T Consensus        80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~  159 (681)
T 2pzi_A           80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG  159 (681)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence            6899999999999999999987   36889999986543    2468899999999999997                  


Q ss_pred             --EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCC
Q 044997          347 --FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLV  424 (563)
Q Consensus       347 --V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla  424 (563)
                        |+||+++++|.+++..       .++|.+++.++.|++.||.|||+++   |+||||||+|||++.+ .+||+|||++
T Consensus       160 ~lv~E~~~g~~L~~~~~~-------~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a  228 (681)
T 2pzi_A          160 YIVMEYVGGQSLKRSKGQ-------KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAV  228 (681)
T ss_dssp             EEEEECCCCEECC----C-------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTC
T ss_pred             EEEEEeCCCCcHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccc
Confidence              4688888888876642       5999999999999999999999998   9999999999999986 8999999999


Q ss_pred             cccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCC----Cc
Q 044997          425 KLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDS----EP  500 (563)
Q Consensus       425 ~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~----~~  500 (563)
                      +.....       ....||++|+|||++.+.              .+.++|||||||++|||++|..|+.....    ..
T Consensus       229 ~~~~~~-------~~~~gt~~y~aPE~~~~~--------------~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~~~  287 (681)
T 2pzi_A          229 SRINSF-------GYLYGTPGFQAPEIVRTG--------------PTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPED  287 (681)
T ss_dssp             EETTCC-------SCCCCCTTTSCTTHHHHC--------------SCHHHHHHHHHHHHHHHHSCCCEETTEECSSCCTT
T ss_pred             hhcccC-------CccCCCccccCHHHHcCC--------------CCCceehhhhHHHHHHHHhCCCCCccccccccccc
Confidence            864322       335699999999987432              27899999999999999999988754221    11


Q ss_pred             hhhHHHHHHHHHHHHHhhccCCCCCC-CHHHHHHHHHHhhh
Q 044997          501 TKMKSLITIMAAVAEWCLNEDAVDRP-EMRDIVAILSQIMI  540 (563)
Q Consensus       501 ~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~i~~  540 (563)
                      .......+.+.+++.+||+.||.+|| +++++...|..++.
T Consensus       288 ~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~  328 (681)
T 2pzi_A          288 DPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLR  328 (681)
T ss_dssp             CHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHH
T ss_pred             ccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHH
Confidence            12233456789999999999999999 57777777776653

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=5.5e-34  Score=287.32  Aligned_cols=198  Identities=14%  Similarity=0.106  Sum_probs=165.7

Q ss_pred             cCCCccceecccCcEEEEEEEEC--CceEEEEEeccCCh------HHHHHHHHHHHhccccce---------------EE
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNKS------KEFFAELKVLCKIHHINV---------------FI  348 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~------~~f~~Ei~~l~~l~H~ni---------------V~  348 (563)
                      ++|+..+.||+|+||.||+|+..  ++.||||.++....      ++|.+|++++.+++||||               |+
T Consensus        31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  110 (286)
T 3uqc_A           31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA  110 (286)
T ss_dssp             TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence            56889999999999999999985  78999999975432      679999999999999997               57


Q ss_pred             EeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccc
Q 044997          349 STFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEE  428 (563)
Q Consensus       349 e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~  428 (563)
                      ||+++|+|.+++..      . ....+..+++.|++.||+|||+++   |+||||||+|||+++++.+||+++|      
T Consensus       111 e~~~g~~L~~~l~~------~-~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~------  174 (286)
T 3uqc_A          111 EWIRGGSLQEVADT------S-PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA------  174 (286)
T ss_dssp             ECCCEEEHHHHHTT------C-CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC------
T ss_pred             EecCCCCHHHHHhc------C-CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc------
Confidence            99999999999853      2 355578899999999999999998   9999999999999999999998543      


Q ss_pred             cccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc--------
Q 044997          429 RTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP--------  500 (563)
Q Consensus       429 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~--------  500 (563)
                                       |++|.                    +.++|||||||++|||++|+.||.......        
T Consensus       175 -----------------~~~~~--------------------~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~  217 (286)
T 3uqc_A          175 -----------------TMPDA--------------------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERD  217 (286)
T ss_dssp             -----------------CCTTC--------------------CHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBC
T ss_pred             -----------------ccCCC--------------------CchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHH
Confidence                             34442                    789999999999999999999997643211        


Q ss_pred             ---------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcCh
Q 044997          501 ---------TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITST  543 (563)
Q Consensus       501 ---------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~  543 (563)
                               .....+++.+.+++.+||+.||.+| |+.|+++.|+++.....
T Consensus       218 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~  268 (286)
T 3uqc_A          218 TAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVAD  268 (286)
T ss_dssp             TTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC---
T ss_pred             hccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCC
Confidence                     1112456679999999999999999 99999999999876544

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=6.7e-33  Score=280.66  Aligned_cols=197  Identities=18%  Similarity=0.330  Sum_probs=161.3

Q ss_pred             cCCCcc-ceecccCcEEEEEEEE--CCceEEEEEeccCChHHHHHHHHHH-Hhccccce-------------------EE
Q 044997          292 NNFDES-RIIGRGGFGNVYFGLL--GDREAAIKKMRSNKSKEFFAELKVL-CKIHHINV-------------------FI  348 (563)
Q Consensus       292 ~~f~~~-~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~~~~f~~Ei~~l-~~l~H~ni-------------------V~  348 (563)
                      ++|... +.||+|+||.||++..  +++.||+|.++.  .+.+.+|++++ +..+||||                   |+
T Consensus        17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~   94 (299)
T 3m2w_A           17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVM   94 (299)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC--SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc--cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEE
Confidence            456665 7899999999999987  478899999964  35677899988 66689997                   56


Q ss_pred             EeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecC---CCcEEEeecCCCc
Q 044997          349 STFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDD---GLRAKVADFGLVK  425 (563)
Q Consensus       349 e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~---~~~~kl~DFGla~  425 (563)
                      ||+++|+|.+++..   .....+++..+..++.|++.||+|||+++   ++||||||+|||++.   ++.+||+|||+++
T Consensus        95 e~~~~~~L~~~l~~---~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~  168 (299)
T 3m2w_A           95 ECLDGGELFSRIQD---RGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAK  168 (299)
T ss_dssp             CCCCSCBHHHHHHH---CTTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred             eecCCCcHHHHHHh---ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEecccccc
Confidence            88889999999975   23457999999999999999999999997   999999999999998   7899999999986


Q ss_pred             ccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCC------
Q 044997          426 LEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE------  499 (563)
Q Consensus       426 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~------  499 (563)
                      ....                         .             .++.++|||||||++|||++|+.||......      
T Consensus       169 ~~~~-------------------------~-------------~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~  210 (299)
T 3m2w_A          169 ETTG-------------------------E-------------KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM  210 (299)
T ss_dssp             ECTT-------------------------C-------------GGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCS
T ss_pred             cccc-------------------------c-------------cCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHH
Confidence            3210                         0             1267999999999999999999998543211      


Q ss_pred             ------------chhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          500 ------------PTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       500 ------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                                  ......+.+.+.+++.+||+.||.+||++.|+++.
T Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h  257 (299)
T 3m2w_A          211 KTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  257 (299)
T ss_dssp             CCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence                        01113456779999999999999999999999873

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=4.7e-33  Score=286.52  Aligned_cols=205  Identities=15%  Similarity=0.174  Sum_probs=167.5

Q ss_pred             cCCCccceecccCcEEEEEEEECCceEEEEEeccCC-----------hHHHHHHHHHHHhcc------------------
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLGDREAAIKKMRSNK-----------SKEFFAELKVLCKIH------------------  342 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~~~~vavK~~~~~~-----------~~~f~~Ei~~l~~l~------------------  342 (563)
                      ++|+..+.||+|+||.||+|+.+++.||||+++...           .+.+.+|+++|++++                  
T Consensus        20 ~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~   99 (336)
T 2vuw_A           20 EKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNS   99 (336)
T ss_dssp             HHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEE
T ss_pred             ccchheeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhcc
Confidence            467889999999999999999999999999997542           277899999999886                  


Q ss_pred             --------ccc----------------------------eEEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHH
Q 044997          343 --------HIN----------------------------VFISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKG  386 (563)
Q Consensus       343 --------H~n----------------------------iV~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~g  386 (563)
                              |||                            +|+||+.+|++.+.+..      ..+++..+..++.|++.|
T Consensus       100 ~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~------~~~~~~~~~~i~~qi~~a  173 (336)
T 2vuw_A          100 VHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT------KLSSLATAKSILHQLTAS  173 (336)
T ss_dssp             EEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT------TCCCHHHHHHHHHHHHHH
T ss_pred             eeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh------cCCCHHHHHHHHHHHHHH
Confidence                    332                            36889999987776643      458999999999999999


Q ss_pred             HHHHH-hcCCCceEeCCCCCCCeEecCCC--------------------cEEEeecCCCcccccccccccccccccCCCc
Q 044997          387 IEYIH-DHTKARYVHRDIKTSNILLDDGL--------------------RAKVADFGLVKLEERTNEKEMLATRLVGTPG  445 (563)
Q Consensus       387 L~yLH-~~~~~~ivHrDLk~~NILl~~~~--------------------~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~  445 (563)
                      |+||| +++   |+||||||+|||++.++                    .+||+|||+|+.....        ...||+.
T Consensus       174 L~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~--------~~~gt~~  242 (336)
T 2vuw_A          174 LAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG--------IVVFCDV  242 (336)
T ss_dssp             HHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT--------EEECCCC
T ss_pred             HHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC--------cEEEeec
Confidence            99999 887   99999999999999887                    9999999999864321        2479999


Q ss_pred             ccCcccccccccccccccccccCCCCCcchHHHHHHH-HHHHHcCCCCCcCC------------------CCCchhhHHH
Q 044997          446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVV-LAELITGKRALIRD------------------DSEPTKMKSL  506 (563)
Q Consensus       446 y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvv-l~Elltg~~p~~~~------------------~~~~~~~~~~  506 (563)
                      |+|||++.+.              .+.++||||+|++ .+++++|..||...                  .........+
T Consensus       243 y~aPE~~~g~--------------~~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (336)
T 2vuw_A          243 SMDEDLFTGD--------------GDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQI  308 (336)
T ss_dssp             TTCSGGGCCC--------------SSHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHH
T ss_pred             ccChhhhcCC--------------CccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhc
Confidence            9999988532              2679999998777 78888999987431                  1112234567


Q ss_pred             HHHHHHHHHHhhccCCCCCCCHHHHH
Q 044997          507 ITIMAAVAEWCLNEDAVDRPEMRDIV  532 (563)
Q Consensus       507 ~~~l~~li~~cl~~dP~~RPs~~evl  532 (563)
                      .+.+.+|+.+||+.|     |+.|++
T Consensus       309 s~~~~dli~~~L~~d-----sa~e~l  329 (336)
T 2vuw_A          309 KRKIQEFHRTMLNFS-----SATDLL  329 (336)
T ss_dssp             HHHHHHHHHHGGGSS-----SHHHHH
T ss_pred             CHHHHHHHHHHhccC-----CHHHHH
Confidence            788999999999976     888887

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.92  E-value=3.1e-26  Score=251.82  Aligned_cols=198  Identities=14%  Similarity=0.065  Sum_probs=125.5

Q ss_pred             eecccCcEEEEEEE--ECCceEEEEEeccCC-------------hHHHHHHHHHHHhc-cccce---------------E
Q 044997          299 IIGRGGFGNVYFGL--LGDREAAIKKMRSNK-------------SKEFFAELKVLCKI-HHINV---------------F  347 (563)
Q Consensus       299 ~LG~G~fG~Vy~g~--~~~~~vavK~~~~~~-------------~~~f~~Ei~~l~~l-~H~ni---------------V  347 (563)
                      ..+.|++|.+..++  +-|+.+|+|.+..+.             .++|.+|+++|+++ +|+||               |
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV  320 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV  320 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence            45666666655543  358899999986431             25699999999999 68886               7


Q ss_pred             EEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccc
Q 044997          348 ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLE  427 (563)
Q Consensus       348 ~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~  427 (563)
                      |||+++|+|.++|..     ..+++..   +|+.||+.||+|+|+++   ||||||||+|||+++++++||+|||+|+..
T Consensus       321 MEyv~G~~L~d~i~~-----~~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~  389 (569)
T 4azs_A          321 MEKLPGRLLSDMLAA-----GEEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTT  389 (569)
T ss_dssp             EECCCSEEHHHHHHT-----TCCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESC
T ss_pred             EecCCCCcHHHHHHh-----CCCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeC
Confidence            999999999999975     3556654   58899999999999998   999999999999999999999999999865


Q ss_pred             ccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCC-CchhhHHH
Q 044997          428 ERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDS-EPTKMKSL  506 (563)
Q Consensus       428 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~-~~~~~~~~  506 (563)
                      ....   ...+..+||++|||||++.+.              +..++|+||+|++++++.++..++..... .+....  
T Consensus       390 ~~~~---~~~~t~vGTp~YmAPE~l~g~--------------~~~~~d~~s~g~~~~~l~~~~~~~~~~l~~~~~~~~--  450 (569)
T 4azs_A          390 PQDC---SWPTNLVQSFFVFVNELFAEN--------------KSWNGFWRSAPVHPFNLPQPWSNWLYAVWQEPVERW--  450 (569)
T ss_dssp             C------CCSHHHHHHHHHHHHHHC-------------------------------CCCCTTHHHHHHHHHTSCGGGC--
T ss_pred             CCCC---ccccCceechhhccHHHhCCC--------------CCCcccccccccchhhhccccchhHHHhhcCCCCCC--
Confidence            4322   123446899999999988543              36789999999999888776554321100 000000  


Q ss_pred             HHHHHHHHHHhhccCCCCCCCH
Q 044997          507 ITIMAAVAEWCLNEDAVDRPEM  528 (563)
Q Consensus       507 ~~~l~~li~~cl~~dP~~RPs~  528 (563)
                        .+..+...+...+|..||..
T Consensus       451 --~~~~l~~~l~~~~~~~~~~~  470 (569)
T 4azs_A          451 --NFVLLLALFEKKAKLPSAEQ  470 (569)
T ss_dssp             --SHHHHHHHHHTGGGSCCGGG
T ss_pred             --cHHHHHHHHhCCCCCCCCCh
Confidence              13345555666777666554

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.90  E-value=6.7e-25  Score=239.88  Aligned_cols=170  Identities=18%  Similarity=0.209  Sum_probs=131.3

Q ss_pred             CccceecccCcEEEEEEEECCceEEEEEeccCC-----------hHHHHHHHHHHHhccccce---------------EE
Q 044997          295 DESRIIGRGGFGNVYFGLLGDREAAIKKMRSNK-----------SKEFFAELKVLCKIHHINV---------------FI  348 (563)
Q Consensus       295 ~~~~~LG~G~fG~Vy~g~~~~~~vavK~~~~~~-----------~~~f~~Ei~~l~~l~H~ni---------------V~  348 (563)
                      ...+.||+|+||.||+|...++.+++|+.....           .++|.+|+++|++++||||               |+
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVm  418 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMM  418 (540)
T ss_dssp             ---------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEE
T ss_pred             CCCCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEE
Confidence            456799999999999998889999999864321           2458999999999999998               47


Q ss_pred             EeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccc
Q 044997          349 STFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEE  428 (563)
Q Consensus       349 e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~  428 (563)
                      ||+++|+|.+++..             +..++.|+++||+|||+++   |+||||||+|||+++  ++||+|||+++...
T Consensus       419 E~~~ggsL~~~l~~-------------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~  480 (540)
T 3en9_A          419 SYINGKLAKDVIED-------------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISN  480 (540)
T ss_dssp             ECCCSEEHHHHSTT-------------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECC
T ss_pred             ECCCCCCHHHHHHH-------------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECC
Confidence            99999999999864             4589999999999999997   999999999999999  99999999999765


Q ss_pred             cccccc----cccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCC
Q 044997          429 RTNEKE----MLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRAL  493 (563)
Q Consensus       429 ~~~~~~----~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~  493 (563)
                      ......    .......||+.|||||++.....           .|+.++|+|+...-..+-+.++.++
T Consensus       481 ~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~-----------~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          481 LDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLE-----------GYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             CHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHH-----------HHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             CccccccchhhhhhhhcCCCCcCCHHHHHHHHH-----------HHHHHHhHHHHHHHHHHHHHhcccc
Confidence            432211    01234679999999999975211           2367789999999888888777654

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.85  E-value=2.1e-21  Score=194.84  Aligned_cols=139  Identities=14%  Similarity=0.098  Sum_probs=112.1

Q ss_pred             HHHHHHHhcCCCccceecccCcEEEEEEEE-CCceEEEEEeccCC---------------------hHHHHHHHHHHHhc
Q 044997          284 LEEIEEATNNFDESRIIGRGGFGNVYFGLL-GDREAAIKKMRSNK---------------------SKEFFAELKVLCKI  341 (563)
Q Consensus       284 ~~el~~~~~~f~~~~~LG~G~fG~Vy~g~~-~~~~vavK~~~~~~---------------------~~~f~~Ei~~l~~l  341 (563)
                      +..+......|...+.||+|+||.||+|.. +++.||||.++...                     ...+.+|+++|+++
T Consensus        82 l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l  161 (282)
T 1zar_A           82 LHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL  161 (282)
T ss_dssp             HHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc
Confidence            344455556677789999999999999998 47899999986421                     34588999999999


Q ss_pred             cccce-----------EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEe
Q 044997          342 HHINV-----------FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILL  410 (563)
Q Consensus       342 ~H~ni-----------V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl  410 (563)
                      +|+++           |+||+++|+|.+ +..           .....++.|++.||.|||+++   |+||||||+|||+
T Consensus       162 ~~~~v~~~~~~~~~~lvmE~~~g~~L~~-l~~-----------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl  226 (282)
T 1zar_A          162 QGLAVPKVYAWEGNAVLMELIDAKELYR-VRV-----------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLV  226 (282)
T ss_dssp             TTSSSCCEEEEETTEEEEECCCCEEGGG-CCC-----------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEE
T ss_pred             cCCCcCeEEeccceEEEEEecCCCcHHH-cch-----------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEE
Confidence            76443           789999999988 432           123469999999999999998   9999999999999


Q ss_pred             cCCCcEEEeecCCCcccccccccccccccccCCCcccCcccccc
Q 044997          411 DDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFV  454 (563)
Q Consensus       411 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~  454 (563)
                      + ++.+||+|||+++.                +..|+|||++..
T Consensus       227 ~-~~~vkl~DFG~a~~----------------~~~~~a~e~l~r  253 (282)
T 1zar_A          227 S-EEGIWIIDFPQSVE----------------VGEEGWREILER  253 (282)
T ss_dssp             E-TTEEEECCCTTCEE----------------TTSTTHHHHHHH
T ss_pred             E-CCcEEEEECCCCeE----------------CCCCCHHHHHHH
Confidence            9 99999999999862                234789998743

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.76  E-value=1.1e-18  Score=172.67  Aligned_cols=125  Identities=18%  Similarity=0.164  Sum_probs=97.4

Q ss_pred             CCccceecccCcEEEEEEEE--CCce--EEEEEeccCC---------------------------hHHHHHHHHHHHhcc
Q 044997          294 FDESRIIGRGGFGNVYFGLL--GDRE--AAIKKMRSNK---------------------------SKEFFAELKVLCKIH  342 (563)
Q Consensus       294 f~~~~~LG~G~fG~Vy~g~~--~~~~--vavK~~~~~~---------------------------~~~f~~Ei~~l~~l~  342 (563)
                      |...+.||+|+||.||+|..  +++.  ||||.++...                           ...+.+|+++|.+++
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            56778999999999999988  7888  9999875321                           025788999999998


Q ss_pred             ccc-------------eEEEeec-CCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCceEeCCCCCCC
Q 044997          343 HIN-------------VFISTFG-NGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIH-DHTKARYVHRDIKTSN  407 (563)
Q Consensus       343 H~n-------------iV~e~~~-~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~~ivHrDLk~~N  407 (563)
                      |++             +||||++ +|.+...|.+...    ..++.....++.|++.||.||| +.+   |+||||||+|
T Consensus       129 ~~~i~~p~~~~~~~~~lVmE~~g~~g~~~~~L~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~g---ivHrDlkp~N  201 (258)
T 1zth_A          129 EAGVSVPQPYTYMKNVLLMEFIGEDELPAPTLVELGR----ELKELDVEGIFNDVVENVKRLYQEAE---LVHADLSEYN  201 (258)
T ss_dssp             HTTCCCCCEEEEETTEEEEECCEETTEECCBHHHHGG----GGGGSCHHHHHHHHHHHHHHHHHTSC---EECSSCSTTS
T ss_pred             hCCCCCCeEEEcCCCEEEEEecCCCCCccccHHHHhh----ccChHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHH
Confidence            765             3789995 3533333322110    1234567789999999999999 887   9999999999


Q ss_pred             eEecCCCcEEEeecCCCccc
Q 044997          408 ILLDDGLRAKVADFGLVKLE  427 (563)
Q Consensus       408 ILl~~~~~~kl~DFGla~~~  427 (563)
                      ||+++  .++|+|||+|...
T Consensus       202 ILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          202 IMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             EEESS--SEEECCCTTCEET
T ss_pred             EEEcC--cEEEEECcccccC
Confidence            99998  9999999999753

>4eby_A Chitin elicitor receptor kinase 1; pathogen-associated molecular patterns, pattern recognition receptors, LYSM, lysine chitin oligomer; HET: NAG BMA; 1.65A {Arabidopsis thaliana} PDB: 4ebz_A*

Probab=99.72  E-value=2.8e-17  Score=156.13  Aligned_cols=142  Identities=20%  Similarity=0.270  Sum_probs=112.1

Q ss_pred             CCcc-cee-eeccCCCCHHHHHHhhCCCc--------ccccccc-cC-------CCccEEEEeeccccCCCCc-------
Q 044997           47 NTCN-ALL-YHINQGLPVERIASFYSANP--------SQIKPIF-RG-------NQKDYLITVPCSCKDVNST-------  101 (563)
Q Consensus        47 ~~C~-~~~-~~~~~~~~~~~i~~l~~~~~--------~~i~~~n-~~-------~~~~~~vp~~C~C~~~~~~-------  101 (563)
                      ++|+ ++. |+..++.||..||..|+++.        .+|+.+| +.       .+|.++||++|+|.++.+.       
T Consensus         3 ~~C~~a~~~Y~V~~GDTL~~IA~~~~vsv~~~~~~~~~~I~~~Np~l~~~~~l~~Gq~L~IP~~~~~~~~~~~~~~~~Y~   82 (212)
T 4eby_A            3 TSCPLALASYYLENGTTLSVINQNLNSSIAPYDQINFDPILRYNSNIKDKDRIQMGSRVLVPFPCECQPGDFLGHNFSYS   82 (212)
T ss_dssp             CCCSCEEEEEECCTTCCHHHHHHHTCCSSSCCCSSCCHHHHTTCTTCSCTTSCCTTCEEEEEECCEEETTTEEEEEEEEE
T ss_pred             CCCccceEEEEeCCCCCHHHHHHHHCCCchhccccCHHHHHHhccCCCCcCccCCCCEEEEeccccccCCccccCceEEE
Confidence            6899 665 77789999999999999998        8999999 42       5899999999999855321       


Q ss_pred             --ccc--------ccccc-------cccCCCCCcceecCcEEEEeeeeecCCC----CceeEEEEEccCCCcHHHHHHHh
Q 044997          102 --RAM--------IYSGQ-------AWKVGGEENYFIAGVAVPIHLLCGCVET----GTQVVVTYTVQQQDTLSIIATLL  160 (563)
Q Consensus       102 --~~~--------ty~~~-------a~~~~~~~~l~~~g~~l~vpl~C~C~~~----~~~~llTY~~~~gd~ls~ia~~f  160 (563)
                        .|+        .|.|+       ++|...... +.+|++|.||.+|+|++.    +.+++++|.|++||++..||.+|
T Consensus        83 V~~GDTL~~IA~~~y~~lvt~~~L~~~N~~~~~~-l~~Gq~L~IP~~~~~~~~~~~~~~~~~~~Y~V~~GDTL~~IA~~f  161 (212)
T 4eby_A           83 VRQEDTYERVAISNYANLTTMESLQARNPFPATN-IPLSATLNVLVNCSCGDESVSKDFGLFVTYPLRPEDSLSSIARSS  161 (212)
T ss_dssp             CCTTCCHHHHHHTTTTTSSCHHHHHHHCCSCTTC-CCTTCEEEEEEECCCCCTTTCSSCCCEEEEECCTTCCHHHHHHHH
T ss_pred             ecCCCcHHHHHHHhcCCCCCHHHHHHhcCCCccc-CCCCCEEEEcCCCcCCCcccccCCCCeEEEEECCCCcHHHHHHHH
Confidence              123        34432       246533334 499999999999999864    36788999999999999999999


Q ss_pred             cCCccchhhcccccccCCcccccceeeeecCcC
Q 044997          161 SAEISGIESMNKMVAQNPGYIDVCWVLFVPMEL  193 (563)
Q Consensus       161 ~~s~~~i~~~N~~~~~~~~~~~~~~~~~vp~~~  193 (563)
                      |++.+.|..+|+..  +.  ..+...++||...
T Consensus       162 gvsv~~L~~~N~~~--~~--~~~~g~l~IP~~~  190 (212)
T 4eby_A          162 GVSADILQRYNPGV--NF--NSGNGIVYVPGRD  190 (212)
T ss_dssp             TSCHHHHHHHSTTC--CT--TSCSSEEEEECCC
T ss_pred             CcCHHHHHHhcCCC--cc--CCCCCEEEecCCC
Confidence            99999999999975  32  2334458999854

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.53  E-value=1.1e-14  Score=150.64  Aligned_cols=120  Identities=13%  Similarity=0.147  Sum_probs=93.5

Q ss_pred             CCCccceecccCcEEEEEEEE-CCceEEEEEeccCC-----------------hHH--------HHHHHHHHHhccccc-
Q 044997          293 NFDESRIIGRGGFGNVYFGLL-GDREAAIKKMRSNK-----------------SKE--------FFAELKVLCKIHHIN-  345 (563)
Q Consensus       293 ~f~~~~~LG~G~fG~Vy~g~~-~~~~vavK~~~~~~-----------------~~~--------f~~Ei~~l~~l~H~n-  345 (563)
                      -|.+.+.||+|+||.||+|.. +|+.||||.++...                 ...        ..+|...|.++++.. 
T Consensus        96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv  175 (397)
T 4gyi_A           96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF  175 (397)
T ss_dssp             CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            388899999999999999987 57899999875310                 011        235777788775533 


Q ss_pred             ------------eEEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCC
Q 044997          346 ------------VFISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDG  413 (563)
Q Consensus       346 ------------iV~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~  413 (563)
                                  |||||++++.|.++...           .....++.|++.+|.|||+++   ||||||||.|||++++
T Consensus       176 ~vp~p~~~~~~~LVME~i~G~~L~~l~~~-----------~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~~d  241 (397)
T 4gyi_A          176 PVPEPIAQSRHTIVMSLVDALPMRQVSSV-----------PDPASLYADLIALILRLAKHG---LIHGDFNEFNILIREE  241 (397)
T ss_dssp             SCCCEEEEETTEEEEECCSCEEGGGCCCC-----------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEEEE
T ss_pred             CCCeeeeccCceEEEEecCCccHhhhccc-----------HHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeCC
Confidence                        58999998888665432           123467899999999999997   9999999999999877


Q ss_pred             C----------cEEEeecCCCcc
Q 044997          414 L----------RAKVADFGLVKL  426 (563)
Q Consensus       414 ~----------~~kl~DFGla~~  426 (563)
                      +          .+.|+||+-+-.
T Consensus       242 gd~~d~~~~~~~~~iID~~Q~V~  264 (397)
T 4gyi_A          242 KDAEDPSSITLTPIIIXFPQMVS  264 (397)
T ss_dssp             ECSSCTTSEEEEEEECCCTTCEE
T ss_pred             CCcccccccccceEEEEeCCccc
Confidence            6          489999998754

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=98.94  E-value=1.7e-09  Score=106.23  Aligned_cols=129  Identities=16%  Similarity=0.163  Sum_probs=96.8

Q ss_pred             HHHHhcCCCccceecccCcEEEEEEEECCceEEEEEecc---CChHHHHHHHHHHHhccc-cc---------------eE
Q 044997          287 IEEATNNFDESRIIGRGGFGNVYFGLLGDREAAIKKMRS---NKSKEFFAELKVLCKIHH-IN---------------VF  347 (563)
Q Consensus       287 l~~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~vavK~~~~---~~~~~f~~Ei~~l~~l~H-~n---------------iV  347 (563)
                      +.....+|.....++.|+.+.||+....++.+++|....   ....++.+|+++|+.+.+ .+               +|
T Consensus         9 l~~~l~~~~~~~~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv   88 (263)
T 3tm0_A            9 LKKLIEKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL   88 (263)
T ss_dssp             HHHHHTTSEEEECCSCCSSSEEEEEECSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred             HHHHhccceeEeeccCCCCCeEEEEECCCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence            344556788888888888899999988889999999875   344568899999998853 22               25


Q ss_pred             EEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhc----------------------------------
Q 044997          348 ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDH----------------------------------  393 (563)
Q Consensus       348 ~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~----------------------------------  393 (563)
                      ||++++.+|.+.+..          ......++.+++++|..||+.                                  
T Consensus        89 ~e~i~G~~l~~~~~~----------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (263)
T 3tm0_A           89 MSEADGVLCSEEYED----------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW  158 (263)
T ss_dssp             EECCSSEEHHHHCCT----------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGG
T ss_pred             EEecCCeehhhccCC----------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccc
Confidence            677777766554311          122347889999999999981                                  


Q ss_pred             ----------------------CCCceEeCCCCCCCeEecCCCcEEEeecCCCc
Q 044997          394 ----------------------TKARYVHRDIKTSNILLDDGLRAKVADFGLVK  425 (563)
Q Consensus       394 ----------------------~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~  425 (563)
                                            ..+.++|+|+++.|||++++..+.|+||+.+.
T Consensus       159 ~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             STTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                                  11458999999999999876666799999875

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.76  E-value=8e-09  Score=103.93  Aligned_cols=179  Identities=18%  Similarity=0.206  Sum_probs=108.1

Q ss_pred             cceecccCcEEEEEEEECCceEEEEEeccC-ChHHHHHHHHHHHhc-cccce--------------------EEEeecCC
Q 044997          297 SRIIGRGGFGNVYFGLLGDREAAIKKMRSN-KSKEFFAELKVLCKI-HHINV--------------------FISTFGNG  354 (563)
Q Consensus       297 ~~~LG~G~fG~Vy~g~~~~~~vavK~~~~~-~~~~f~~Ei~~l~~l-~H~ni--------------------V~e~~~~g  354 (563)
                      .+.++.|....||+..   ..+++|..... ....+.+|.++|+.+ .+..+                    ||+++++.
T Consensus        25 i~~~~~G~~n~v~~v~---~~~vlR~~~~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G~  101 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN---RDFIFKFPKHSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKGV  101 (304)
T ss_dssp             CCEEEECSSEEEEEST---TSEEEEEESSHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCCE
T ss_pred             eEecCCCCcceEEEEC---CEEEEEecCCcchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCCe
Confidence            4568999999999853   67889886544 246788999999888 33332                    23333333


Q ss_pred             CcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhc-----------------------------------------
Q 044997          355 SLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDH-----------------------------------------  393 (563)
Q Consensus       355 sL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-----------------------------------------  393 (563)
                      .|.+...       ..++..++..++.++++.|..||+.                                         
T Consensus       102 ~l~~~~~-------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  174 (304)
T 3sg8_A          102 PLTPLLL-------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD  174 (304)
T ss_dssp             ECCHHHH-------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred             ECCcccc-------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence            3322110       1356667788889999999999862                                         


Q ss_pred             --------------CCCceEeCCCCCCCeEecC--CCcEEEeecCCCcccccccccccccccccCCCcc---cCcccccc
Q 044997          394 --------------TKARYVHRDIKTSNILLDD--GLRAKVADFGLVKLEERTNEKEMLATRLVGTPGY---LPPEYIFV  454 (563)
Q Consensus       394 --------------~~~~ivHrDLk~~NILl~~--~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y---~APE~l~~  454 (563)
                                    ..+.++|+|+++.||++++  +..+.|+||+.+.......+-..       ...+   ..|+....
T Consensus       175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~-------~~~~~~~~~~~~~~~  247 (304)
T 3sg8_A          175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFIS-------LMEDDEEYGMEFVSK  247 (304)
T ss_dssp             HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHT-------TCCTTTSCCHHHHHH
T ss_pred             HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHH-------HHhhccccCHHHHHH
Confidence                          1245899999999999998  55688999999865322111100       0001   12221111


Q ss_pred             c--cccccccc-ccccCCCCCcchHHHHHHHHHHHHcCCCCCc
Q 044997          455 K--RFRFDMHS-SVMELQVTTKTDVFAFGVVLAELITGKRALI  494 (563)
Q Consensus       455 ~--~~~~~~~~-~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~  494 (563)
                      -  .|..  .. ...........+.|++|.++|++.+|..++.
T Consensus       248 ~l~~Y~~--~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~  288 (304)
T 3sg8_A          248 ILNHYKH--KDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY  288 (304)
T ss_dssp             HHHHHTC--SCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred             HHHHcCC--CCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence            0  0000  00 0000001123689999999999999987653

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=98.74  E-value=1.1e-08  Score=99.70  Aligned_cols=120  Identities=17%  Similarity=0.101  Sum_probs=82.7

Q ss_pred             CCCccceecccCcEEEEEEEEC-CceEEEEEeccCChHHHHHHHHHHHhccccce-----------------EEEeecCC
Q 044997          293 NFDESRIIGRGGFGNVYFGLLG-DREAAIKKMRSNKSKEFFAELKVLCKIHHINV-----------------FISTFGNG  354 (563)
Q Consensus       293 ~f~~~~~LG~G~fG~Vy~g~~~-~~~vavK~~~~~~~~~f~~Ei~~l~~l~H~ni-----------------V~e~~~~g  354 (563)
                      ++......+.|..+.||+.... ++.+++|.........+.+|+++++.+.+.++                 |+||+++.
T Consensus        21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~  100 (264)
T 1nd4_A           21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQ  100 (264)
T ss_dssp             TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSE
T ss_pred             CCceEecccCCCCceEEEEecCCCCeEEEEeCCcccchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCc
Confidence            3443333335556899999764 56799999876555667889999998865443                 34555544


Q ss_pred             CcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcC----------------------------------------
Q 044997          355 SLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHT----------------------------------------  394 (563)
Q Consensus       355 sL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~----------------------------------------  394 (563)
                      +|.  ..        ..   ....++.++++.|..||+..                                        
T Consensus       101 ~l~--~~--------~~---~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (264)
T 1nd4_A          101 DLL--SS--------HL---APAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAP  167 (264)
T ss_dssp             ETT--TS--------CC---CHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCH
T ss_pred             ccC--cC--------cC---CHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccH
Confidence            442  11        01   12367788888888888743                                        


Q ss_pred             ---------------CCceEeCCCCCCCeEecCCCcEEEeecCCCc
Q 044997          395 ---------------KARYVHRDIKTSNILLDDGLRAKVADFGLVK  425 (563)
Q Consensus       395 ---------------~~~ivHrDLk~~NILl~~~~~~kl~DFGla~  425 (563)
                                     .+.++|+|++|.|||++++..++|+|||.+.
T Consensus       168 ~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          168 AELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             HHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                           1239999999999999887667799999875

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.72  E-value=4.2e-08  Score=101.01  Aligned_cols=124  Identities=15%  Similarity=0.158  Sum_probs=91.4

Q ss_pred             ccceecccCcEEEEEEEECCceEEEEEec--cCC----hHHHHHHHHHHHhccccc--------------------eEEE
Q 044997          296 ESRIIGRGGFGNVYFGLLGDREAAIKKMR--SNK----SKEFFAELKVLCKIHHIN--------------------VFIS  349 (563)
Q Consensus       296 ~~~~LG~G~fG~Vy~g~~~~~~vavK~~~--~~~----~~~f~~Ei~~l~~l~H~n--------------------iV~e  349 (563)
                      ..+.|+.|.++.||+....+..+++|+..  ...    ...+.+|.++++.+.+.+                    +|+|
T Consensus        42 ~~~~l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme  121 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTPGQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME  121 (359)
T ss_dssp             EEEECCC-CCSCEEEEECSSCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred             eEEEcCCcccceEEEEEECCceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence            45788999999999998888889999876  332    346788999999887432                    2455


Q ss_pred             eecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----------------------------------
Q 044997          350 TFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHT-----------------------------------  394 (563)
Q Consensus       350 ~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----------------------------------  394 (563)
                      |+++..+.+..       ...++..++..++.++++.|..||...                                   
T Consensus       122 ~v~G~~l~~~~-------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (359)
T 3dxp_A          122 FVSGRVLWDQS-------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI  194 (359)
T ss_dssp             CCCCBCCCCTT-------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred             ecCCeecCCCc-------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence            55554443211       123678888999999999999999731                                   


Q ss_pred             --------------------CCceEeCCCCCCCeEecCCCc--EEEeecCCCcc
Q 044997          395 --------------------KARYVHRDIKTSNILLDDGLR--AKVADFGLVKL  426 (563)
Q Consensus       395 --------------------~~~ivHrDLk~~NILl~~~~~--~kl~DFGla~~  426 (563)
                                          .+.++|+|+++.|||++.++.  +.|.||+.+..
T Consensus       195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                246999999999999997753  68999999875

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=97.88  E-value=6.3e-05  Score=75.43  Aligned_cols=120  Identities=17%  Similarity=0.181  Sum_probs=79.5

Q ss_pred             cceecccCcEEEEEEEECCceEEEEEeccC-ChHHHHHHHHHHHhcccc-c------------------eEEEeecCCCc
Q 044997          297 SRIIGRGGFGNVYFGLLGDREAAIKKMRSN-KSKEFFAELKVLCKIHHI-N------------------VFISTFGNGSL  356 (563)
Q Consensus       297 ~~~LG~G~fG~Vy~g~~~~~~vavK~~~~~-~~~~f~~Ei~~l~~l~H~-n------------------iV~e~~~~gsL  356 (563)
                      .+.++.|....||+.   ++.+++|.-... ....+.+|.++|..+.+. .                  +|++++++..+
T Consensus        24 v~~l~~G~~n~v~~v---g~~~VlR~~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~l  100 (306)
T 3tdw_A           24 VESLGEGFRNYAILV---NGDWVFRFPKSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQIL  100 (306)
T ss_dssp             EEEEEECSSEEEEEE---TTTEEEEEESSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEEC
T ss_pred             eeecCCCcceeEEEE---CCEEEEEecCCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeEC
Confidence            456788888899987   678888885432 235788999999998652 1                  24555555544


Q ss_pred             ccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhc-------------------------------------------
Q 044997          357 SDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDH-------------------------------------------  393 (563)
Q Consensus       357 ~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-------------------------------------------  393 (563)
                      .+...       ..++..++..++.++++.|..||+.                                           
T Consensus       101 ~~~~~-------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~  173 (306)
T 3tdw_A          101 GEDGM-------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT  173 (306)
T ss_dssp             HHHHH-------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred             chhhh-------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence            33110       1134444555555555555555542                                           


Q ss_pred             --------------CCCceEeCCCCCCCeEecC---CCc-EEEeecCCCcc
Q 044997          394 --------------TKARYVHRDIKTSNILLDD---GLR-AKVADFGLVKL  426 (563)
Q Consensus       394 --------------~~~~ivHrDLk~~NILl~~---~~~-~kl~DFGla~~  426 (563)
                                    ..+.++|+|+++.|||++.   +++ ..|+||+.+..
T Consensus       174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                          2335799999999999987   455 48999998764

>4eby_A Chitin elicitor receptor kinase 1; pathogen-associated molecular patterns, pattern recognition receptors, LYSM, lysine chitin oligomer; HET: NAG BMA; 1.65A {Arabidopsis thaliana} PDB: 4ebz_A*

Probab=97.80  E-value=3e-05  Score=73.21  Aligned_cols=73  Identities=19%  Similarity=0.303  Sum_probs=60.9

Q ss_pred             CcceecCcEEEEeeeeecCCCC-ceeEEEEEccCCCcHHHHH-HHhc--CCccchhhcccccccCCcccccceeeeecCc
Q 044997          117 ENYFIAGVAVPIHLLCGCVETG-TQVVVTYTVQQQDTLSIIA-TLLS--AEISGIESMNKMVAQNPGYIDVCWVLFVPME  192 (563)
Q Consensus       117 ~~l~~~g~~l~vpl~C~C~~~~-~~~llTY~~~~gd~ls~ia-~~f~--~s~~~i~~~N~~~~~~~~~~~~~~~~~vp~~  192 (563)
                      .+.+.+|+.|.||..|.|.+.. ..-..+|.|++|||+..|| .+|+  ++.+.|..+|+.   ++..+.++..+.||..
T Consensus        52 ~~~l~~Gq~L~IP~~~~~~~~~~~~~~~~Y~V~~GDTL~~IA~~~y~~lvt~~~L~~~N~~---~~~~l~~Gq~L~IP~~  128 (212)
T 4eby_A           52 KDRIQMGSRVLVPFPCECQPGDFLGHNFSYSVRQEDTYERVAISNYANLTTMESLQARNPF---PATNIPLSATLNVLVN  128 (212)
T ss_dssp             TTSCCTTCEEEEEECCEEETTTEEEEEEEEECCTTCCHHHHHHTTTTTSSCHHHHHHHCCS---CTTCCCTTCEEEEEEE
T ss_pred             cCccCCCCEEEEeccccccCCccccCceEEEecCCCcHHHHHHHhcCCCCCHHHHHHhcCC---CcccCCCCCEEEEcCC
Confidence            3444999999999999998643 3456899999999999999 7999  999999999993   3456788999999974

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=97.67  E-value=0.00013  Score=74.53  Aligned_cols=32  Identities=25%  Similarity=0.348  Sum_probs=26.7

Q ss_pred             CCceEeCCCCCCCeEecCCCcEEEeecCCCcc
Q 044997          395 KARYVHRDIKTSNILLDDGLRAKVADFGLVKL  426 (563)
Q Consensus       395 ~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~  426 (563)
                      .+.++|+|+.+.|||++++..+.|+||+.+..
T Consensus       221 ~~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~~  252 (357)
T 3ats_A          221 EPVLLWGDARVGNVLYRDFQPVAVLDWEMVAL  252 (357)
T ss_dssp             CCEEECSSCSGGGEEEETTEEEEECCGGGCEE
T ss_pred             CceEEeCCCCCCeEEEeCCcEEEEEccccccc
Confidence            35699999999999999654578999998763

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=97.61  E-value=0.00013  Score=71.25  Aligned_cols=118  Identities=16%  Similarity=0.131  Sum_probs=76.6

Q ss_pred             eecccCcE-EEEEEEEC--CceEEEEEeccCChHHHHHHHHHHHhccc----c------------ceEEEeecCCCcccc
Q 044997          299 IIGRGGFG-NVYFGLLG--DREAAIKKMRSNKSKEFFAELKVLCKIHH----I------------NVFISTFGNGSLSDH  359 (563)
Q Consensus       299 ~LG~G~fG-~Vy~g~~~--~~~vavK~~~~~~~~~f~~Ei~~l~~l~H----~------------niV~e~~~~gsL~~~  359 (563)
                      .+..|..| .||+....  +..+.+|+-......++.+|...|+.+..    |            .+||+++++.++.+.
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~  110 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGSVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQV  110 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEETHHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHHH
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCCCCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccccc
Confidence            44555555 68987653  56789998877666788899999988742    1            235676666554432


Q ss_pred             cccccccCCCCCCHHHHHHHHHHHHHHHHHHHhc----------------------------------------------
Q 044997          360 LHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDH----------------------------------------------  393 (563)
Q Consensus       360 L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~----------------------------------------------  393 (563)
                      ...         .......++.+++..|.-||..                                              
T Consensus       111 ~~~---------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  181 (272)
T 4gkh_A          111 LEE---------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK  181 (272)
T ss_dssp             HHH---------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred             ccC---------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence            211         1112233445555555555531                                              


Q ss_pred             ---------CCCceEeCCCCCCCeEecCCCcEEEeecCCCc
Q 044997          394 ---------TKARYVHRDIKTSNILLDDGLRAKVADFGLVK  425 (563)
Q Consensus       394 ---------~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~  425 (563)
                               ..+.++|+|+.+.|||+++++.+-|+||+.+.
T Consensus       182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          182 EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             HHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence                     11248999999999999988777899999875

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.52  E-value=0.0004  Score=70.00  Aligned_cols=43  Identities=21%  Similarity=0.259  Sum_probs=33.8

Q ss_pred             HHHHHHHHHh----------cCCCceEeCCCCCCCeEecCCCcEEEeecCCCc
Q 044997          383 AAKGIEYIHD----------HTKARYVHRDIKTSNILLDDGLRAKVADFGLVK  425 (563)
Q Consensus       383 ia~gL~yLH~----------~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~  425 (563)
                      +..++++|++          ...+.++|+|+++.|||++.++.+.|+||+.+.
T Consensus       199 ~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          199 GLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             HHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             HHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            3446677763          123569999999999999888899999999875

>2djp_A Hypothetical protein SB145; LYSM, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens}

Probab=97.38  E-value=0.00017  Score=56.50  Aligned_cols=52  Identities=17%  Similarity=0.224  Sum_probs=45.1

Q ss_pred             eeEEEEEccCCCcHHHHHHHhcCCccchhhcccccccCCcccccceeeeecCcC
Q 044997          140 QVVVTYTVQQQDTLSIIATLLSAEISGIESMNKMVAQNPGYIDVCWVLFVPMEL  193 (563)
Q Consensus       140 ~~llTY~~~~gd~ls~ia~~f~~s~~~i~~~N~~~~~~~~~~~~~~~~~vp~~~  193 (563)
                      +...+|.|++||++..||.+|+++.+.|..+|+..  ++..+.++..+.||...
T Consensus        13 ~~~~~y~V~~GDTL~~IA~~~~~~~~~l~~~N~l~--~~~~l~~Gq~l~iP~~~   64 (77)
T 2djp_A           13 ERRLEHQLEPGDTLAGLALKYGVTMEQIKRANRLY--TNDSIFLKKTLYIPILT   64 (77)
T ss_dssp             EEEEEECCCTTCCHHHHHHHHTCCHHHHHHHHTCC--CSSCGGGSSCEEEEEEC
T ss_pred             CCcEEEEECCCCcHHHHHHHHCcCHHHHHHHcCCC--CccccCCCCEEEECCCC
Confidence            46789999999999999999999999999999863  45567888899999854

>1e0g_A Membrane-bound lytic murein transglycosylase D; cell WALL, hydrolase, glycosidase, lipoprotein, outer membrane, multigene family; NMR {Escherichia coli} SCOP: d.7.1.1

Probab=97.23  E-value=0.00025  Score=49.74  Aligned_cols=45  Identities=24%  Similarity=0.274  Sum_probs=39.0

Q ss_pred             EEEEccCCCcHHHHHHHhcCCccchhhcccccccCCcccccceeeeecC
Q 044997          143 VTYTVQQQDTLSIIATLLSAEISGIESMNKMVAQNPGYIDVCWVLFVPM  191 (563)
Q Consensus       143 lTY~~~~gd~ls~ia~~f~~s~~~i~~~N~~~~~~~~~~~~~~~~~vp~  191 (563)
                      .+|.+++||++..||.+|+++...+..+|+    ++..+.++..+.||.
T Consensus         3 ~~y~V~~GDtl~~Ia~~~~~~~~~l~~~N~----~~~~l~~G~~l~ip~   47 (48)
T 1e0g_A            3 ITYRVRKGDSLSSIAKRHGVNIKDVMRWNS----DTANLQPGDKLTLFV   47 (48)
T ss_dssp             CEEEECTTCCHHHHHHHHTCCHHHHHHHCS----CGGGCCTTEEEECCC
T ss_pred             EEEEEcCCCcHHHHHHHHCcCHHHHHHhCC----CCCcCCcCCEEEEec
Confidence            479999999999999999999999999998    345577888888875

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.02  E-value=0.0025  Score=63.80  Aligned_cols=145  Identities=13%  Similarity=0.156  Sum_probs=83.5

Q ss_pred             cCHHHHHHHhcCCCc-----cceecccCcEEEEEEEECCceEEEEEeccC-ChHHHHHHHHHHHhccccc----------
Q 044997          282 FSLEEIEEATNNFDE-----SRIIGRGGFGNVYFGLLGDREAAIKKMRSN-KSKEFFAELKVLCKIHHIN----------  345 (563)
Q Consensus       282 ~~~~el~~~~~~f~~-----~~~LG~G~fG~Vy~g~~~~~~vavK~~~~~-~~~~f~~Ei~~l~~l~H~n----------  345 (563)
                      ++.+++......|..     .+.|+.|....+|+....+..+++|..... ..+++..|++++..+....          
T Consensus         7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g~~vlk~~~~~~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~   86 (322)
T 2ppq_A            7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDPLILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPRK   86 (322)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCCEEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCBT
T ss_pred             CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCccEEEEEeCCCCCHHHHHHHHHHHHHHHHCCCCCCcccCCC
Confidence            456677777666754     245667878899999887778999998763 4456677888877664211          


Q ss_pred             -------------eEEEeecCCCcccc--------------ccccc--ccCC--CC---CCHHHHHH------------H
Q 044997          346 -------------VFISTFGNGSLSDH--------------LHDPL--LKGH--QP---LTWTARTQ------------I  379 (563)
Q Consensus       346 -------------iV~e~~~~gsL~~~--------------L~~~~--~~~~--~~---l~~~~~~~------------i  379 (563)
                                   ++++++++..+...              +|...  ....  ..   ..|.....            +
T Consensus        87 ~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l  166 (322)
T 2ppq_A           87 DGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGL  166 (322)
T ss_dssp             TCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTH
T ss_pred             CCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhh
Confidence                         24566665443210              11100  0000  00   12332111            0


Q ss_pred             HHHHHHHHHHHHhc----CCCceEeCCCCCCCeEecCCCcEEEeecCCCcc
Q 044997          380 ALDAAKGIEYIHDH----TKARYVHRDIKTSNILLDDGLRAKVADFGLVKL  426 (563)
Q Consensus       380 ~~~ia~gL~yLH~~----~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~  426 (563)
                      ...+...++++++.    ....++|+|+.+.|||++++..+.|+||+.+..
T Consensus       167 ~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          167 REEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             HHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence            11244556666542    134699999999999999876668999998763

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.01  E-value=0.0024  Score=66.10  Aligned_cols=46  Identities=22%  Similarity=0.183  Sum_probs=33.2

Q ss_pred             cceecccCcEEEEEEEE--CCceEEEEEeccC----------ChHHHHHHHHHHHhcc
Q 044997          297 SRIIGRGGFGNVYFGLL--GDREAAIKKMRSN----------KSKEFFAELKVLCKIH  342 (563)
Q Consensus       297 ~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~----------~~~~f~~Ei~~l~~l~  342 (563)
                      .+.||.|..+.||++..  .++.++||.....          ..+++..|.++|..+.
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~   92 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQG   92 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHH
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhh
Confidence            56799999999999965  4678999976432          1245678988888763

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=96.88  E-value=0.0039  Score=65.48  Aligned_cols=47  Identities=11%  Similarity=0.131  Sum_probs=35.1

Q ss_pred             cceecccCcEEEEEEEEC---------CceEEEEEeccCCh-HHHHHHHHHHHhccc
Q 044997          297 SRIIGRGGFGNVYFGLLG---------DREAAIKKMRSNKS-KEFFAELKVLCKIHH  343 (563)
Q Consensus       297 ~~~LG~G~fG~Vy~g~~~---------~~~vavK~~~~~~~-~~f~~Ei~~l~~l~H  343 (563)
                      .+.|+.|-...+|+....         ++.+++|+...... +.+.+|..++..+..
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~~~~li~E~~~l~~L~~  134 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSE  134 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHH
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCcHHHHHHHHHHHHHHHh
Confidence            456788888999999874         36788888754233 677789999888754

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=96.85  E-value=0.0036  Score=58.76  Aligned_cols=150  Identities=12%  Similarity=0.125  Sum_probs=95.4

Q ss_pred             CcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccccccccc
Q 044997          355 SLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKE  434 (563)
Q Consensus       355 sL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~  434 (563)
                      +|.+.|..    .+.++++.+++.++.|.+.+|.-+-....+  ..+=+-|..|++..+|.+.+.+ +.+.         
T Consensus        34 SL~eIL~~----~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~--~~~i~~~~~i~l~~dG~V~f~~-~~s~---------   97 (229)
T 2yle_A           34 SLEEILRL----YNQPINEEQAWAVCYQCCGSLRAAARRRQP--RHRVRSAAQIRVWRDGAVTLAP-AADD---------   97 (229)
T ss_dssp             EHHHHHHH----HTSCCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred             cHHHHHHH----cCCCcCHHHHHHHHHHHHHHHHhhhhcccC--CceecCCcceEEecCCceeccc-cccc---------
Confidence            35566653    358999999999999999998776221111  1233446889999999888774 2111         


Q ss_pred             cccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCchhhHHHHHHHHHHH
Q 044997          435 MLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKMKSLITIMAAVA  514 (563)
Q Consensus       435 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~~~~~~~~~l~~li  514 (563)
                            .....+.|||...              ...+.+.=|||+|+++|.-+-=..|       +.....+.+.|..|+
T Consensus        98 ------~~~~~~~~pe~~~--------------~~~te~~~IysLG~tLY~ALDygL~-------e~eE~eLS~~LE~LL  150 (229)
T 2yle_A           98 ------AGEPPPVAGKLGY--------------SQCMETEVIESLGIIIYKALDYGLK-------ENEERELSPPLEQLI  150 (229)
T ss_dssp             ---------------CCSS--------------SSSCHHHHHHHHHHHHHHHHTTTCC-------TTEEECCCHHHHHHH
T ss_pred             ------ccccCCCChhhcc--------------ccchHHHHHHHHHHHHHHHhhcCCC-------cccchhhCHHHHHHH
Confidence                  0122367888642              1236788899999999998853332       233345566677788


Q ss_pred             HHhhcc-------------------------CCCCCCCHHHHHHHHHHhhhcChhhhc
Q 044997          515 EWCLNE-------------------------DAVDRPEMRDIVAILSQIMITSTEWEA  547 (563)
Q Consensus       515 ~~cl~~-------------------------dP~~RPs~~evl~~L~~i~~~~~~w~~  547 (563)
                      ..|...                         .+..|++.++|++.-..-+....+++.
T Consensus       151 ~~Mt~~~~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~~C~~hl~~ps~A~~  208 (229)
T 2yle_A          151 DHMANTVEADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMKLCAAHLPTESDAPN  208 (229)
T ss_dssp             HHHTTCCC--------------------CCSCCCCCCSHHHHHHHHHTTSSSGGGHHH
T ss_pred             HHHHhcccccccccccccccccccccccccccccCcCCHHHHHHHHHhhccCcccchH
Confidence            877755                         346889999999988877776554443

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=96.85  E-value=0.0039  Score=62.50  Aligned_cols=127  Identities=13%  Similarity=0.143  Sum_probs=81.1

Q ss_pred             CccceecccCcEEEEEEEECCceEEEEEeccCChHHHHHHHHHHHhcccc------------------ceEEEeecCCCc
Q 044997          295 DESRIIGRGGFGNVYFGLLGDREAAIKKMRSNKSKEFFAELKVLCKIHHI------------------NVFISTFGNGSL  356 (563)
Q Consensus       295 ~~~~~LG~G~fG~Vy~g~~~~~~vavK~~~~~~~~~f~~Ei~~l~~l~H~------------------niV~e~~~~gsL  356 (563)
                      ...+.|+.|....+|+...+++.+++|.........|.+|.+.|+.+...                  -+|+|++++..+
T Consensus        39 ~~~~~l~gG~~n~~y~v~~~~~~~vlK~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~  118 (312)
T 3jr1_A           39 KHKEKLYSGEMNEIWLINDEVQTVFVKINERSYRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKN  118 (312)
T ss_dssp             CEEEEECCSSSSEEEEEESSSCEEEEEEEEGGGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCC
T ss_pred             eeeEEeCCccceeeeEEEECCCeEEEEeCCcccHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCC
Confidence            34567899999999999888888999988766667788999988887421                  247888887764


Q ss_pred             cc-----------ccccccc-c----------C------CCCCCHHHHH---HHHH--H--------------HHHH-HH
Q 044997          357 SD-----------HLHDPLL-K----------G------HQPLTWTART---QIAL--D--------------AAKG-IE  388 (563)
Q Consensus       357 ~~-----------~L~~~~~-~----------~------~~~l~~~~~~---~i~~--~--------------ia~g-L~  388 (563)
                      ..           .||.... .          +      ...-+|....   ++..  +              +... ..
T Consensus       119 ~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l~~  198 (312)
T 3jr1_A          119 KQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIVAD  198 (312)
T ss_dssp             CTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHHHH
T ss_pred             CchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHHHH
Confidence            21           1221100 0          0      0012565322   1111  1              1111 12


Q ss_pred             HHHh-cCCCceEeCCCCCCCeEecCCCcEEEeecC
Q 044997          389 YIHD-HTKARYVHRDIKTSNILLDDGLRAKVADFG  422 (563)
Q Consensus       389 yLH~-~~~~~ivHrDLk~~NILl~~~~~~kl~DFG  422 (563)
                      .|.. ...+.++|+|+.+.|++++.++ +.|.||.
T Consensus       199 ~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          199 TLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            3432 2357899999999999999887 8899984

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.76  E-value=0.0082  Score=63.50  Aligned_cols=49  Identities=16%  Similarity=0.010  Sum_probs=32.3

Q ss_pred             cceecccCcEEEEEEEECC--ceEEEEEeccCCh--HHHHHHHHHHHhccccc
Q 044997          297 SRIIGRGGFGNVYFGLLGD--REAAIKKMRSNKS--KEFFAELKVLCKIHHIN  345 (563)
Q Consensus       297 ~~~LG~G~fG~Vy~g~~~~--~~vavK~~~~~~~--~~f~~Ei~~l~~l~H~n  345 (563)
                      .+.|+.|-...+|+....+  ..+++|+......  -+..+|..++..+...+
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~g  165 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKN  165 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSS
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcC
Confidence            4678888888999998876  7888887743321  11247888888886433

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=96.68  E-value=0.0083  Score=59.47  Aligned_cols=30  Identities=27%  Similarity=0.320  Sum_probs=25.5

Q ss_pred             CceEeCCCCCCCeEecCCCcEEEeecCCCcc
Q 044997          396 ARYVHRDIKTSNILLDDGLRAKVADFGLVKL  426 (563)
Q Consensus       396 ~~ivHrDLk~~NILl~~~~~~kl~DFGla~~  426 (563)
                      +.++|+|+.+.||+ ..++++.|+||..+..
T Consensus       173 ~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          173 LAACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             CEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             ceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence            34899999999999 5667889999998764

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=96.42  E-value=0.0076  Score=59.33  Aligned_cols=63  Identities=13%  Similarity=0.010  Sum_probs=46.4

Q ss_pred             CCCccceecccCcEEEEEEEEC-CceEEEEEeccCC---hHHHHHHHHHHHhccc------cc--------eEEEeecCC
Q 044997          293 NFDESRIIGRGGFGNVYFGLLG-DREAAIKKMRSNK---SKEFFAELKVLCKIHH------IN--------VFISTFGNG  354 (563)
Q Consensus       293 ~f~~~~~LG~G~fG~Vy~g~~~-~~~vavK~~~~~~---~~~f~~Ei~~l~~l~H------~n--------iV~e~~~~g  354 (563)
                      .+...+.+|.|..+.||+.+.. |+.+.+|+-....   ...|.+|.+.|+.+..      |.        +|+||+..+
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~~~~lv~e~l~~~   95 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWDDRTLAMEWVDER   95 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEETTEEEEECCCCC
T ss_pred             CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEeccCceEEEEeeccc
Confidence            3455678999999999999984 6889999865432   3468889999988742      21        267887765


Q ss_pred             C
Q 044997          355 S  355 (563)
Q Consensus       355 s  355 (563)
                      .
T Consensus        96 ~   96 (288)
T 3f7w_A           96 P   96 (288)
T ss_dssp             C
T ss_pred             C
Confidence            4

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=96.17  E-value=0.0068  Score=60.95  Aligned_cols=33  Identities=36%  Similarity=0.474  Sum_probs=28.1

Q ss_pred             CCceEeCCCCCCCeEecCC----CcEEEeecCCCccc
Q 044997          395 KARYVHRDIKTSNILLDDG----LRAKVADFGLVKLE  427 (563)
Q Consensus       395 ~~~ivHrDLk~~NILl~~~----~~~kl~DFGla~~~  427 (563)
                      .+.++|+|+.+.|||++.+    ..+.|+||+.+..-
T Consensus       182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence            4469999999999999874    68999999988743

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=96.07  E-value=0.018  Score=60.00  Aligned_cols=32  Identities=16%  Similarity=0.284  Sum_probs=27.8

Q ss_pred             CCceEeCCCCCCCeEecCCCcEEEeecCCCccc
Q 044997          395 KARYVHRDIKTSNILLDDGLRAKVADFGLVKLE  427 (563)
Q Consensus       395 ~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~  427 (563)
                      .+.++|+|+++.|||++.++ ++|+||+.+..-
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G  262 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYG  262 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEE
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccC
Confidence            45699999999999998876 999999998753

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=95.79  E-value=0.027  Score=57.91  Aligned_cols=130  Identities=12%  Similarity=0.110  Sum_probs=72.6

Q ss_pred             cceecccCcEEEEEEEEC---------CceEEEEEeccC--ChHHHHHHHHHHHhccc----cc--------eEEEeecC
Q 044997          297 SRIIGRGGFGNVYFGLLG---------DREAAIKKMRSN--KSKEFFAELKVLCKIHH----IN--------VFISTFGN  353 (563)
Q Consensus       297 ~~~LG~G~fG~Vy~g~~~---------~~~vavK~~~~~--~~~~f~~Ei~~l~~l~H----~n--------iV~e~~~~  353 (563)
                      .+.|..|-...+|+....         ++.+++|+....  ....+.+|.++++.+..    |.        .|+||+++
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~g~v~e~i~G  134 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFPEGRLEQYIPS  134 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEETTEEEEECCSE
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCCccEEEEecC
Confidence            355666777788988764         367888876332  34567789998887743    22        25677765


Q ss_pred             CCcccc-----------------cccccccCCCCC--CHHHHHHHHHHHH-------------------HHHHHHH----
Q 044997          354 GSLSDH-----------------LHDPLLKGHQPL--TWTARTQIALDAA-------------------KGIEYIH----  391 (563)
Q Consensus       354 gsL~~~-----------------L~~~~~~~~~~l--~~~~~~~i~~~ia-------------------~gL~yLH----  391 (563)
                      ..|..-                 ||.......+..  -|.++.++..++.                   ..+..|.    
T Consensus       135 ~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~~L~  214 (379)
T 3feg_A          135 RPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRKLLE  214 (379)
T ss_dssp             EECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHHHHH
T ss_pred             ccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHHHHh
Confidence            444311                 111000011112  2444444443332                   2233333    


Q ss_pred             hc-CCCceEeCCCCCCCeEecCC----CcEEEeecCCCcc
Q 044997          392 DH-TKARYVHRDIKTSNILLDDG----LRAKVADFGLVKL  426 (563)
Q Consensus       392 ~~-~~~~ivHrDLk~~NILl~~~----~~~kl~DFGla~~  426 (563)
                      .. ....++|+|+.+.|||++.+    +.+.|+||..+..
T Consensus       215 ~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          215 STPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             TSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             hcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            22 22368999999999999876    7899999998764

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=95.72  E-value=0.042  Score=54.80  Aligned_cols=44  Identities=14%  Similarity=0.088  Sum_probs=31.9

Q ss_pred             ceecccCcEEEEEEEEC-CceEEEEEeccC--ChHHHHHHHHHHHhcc
Q 044997          298 RIIGRGGFGNVYFGLLG-DREAAIKKMRSN--KSKEFFAELKVLCKIH  342 (563)
Q Consensus       298 ~~LG~G~fG~Vy~g~~~-~~~vavK~~~~~--~~~~f~~Ei~~l~~l~  342 (563)
                      ..++ |....||+.... ++.+++|..+..  ..+++..|..++..+.
T Consensus        32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~   78 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLV   78 (328)
T ss_dssp             EEEC-CSSSEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHH
T ss_pred             Eeec-CcccceEEEEcCCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHH
Confidence            4566 777889988764 557999998743  3466777888877764

>2l9y_A CVNH-LYSM lectin; carbohydrate, sugar binding protein; NMR {Magnaporthe oryzae 70-15}

Probab=95.70  E-value=0.012  Score=53.14  Aligned_cols=50  Identities=36%  Similarity=0.327  Sum_probs=44.9

Q ss_pred             EEEEEccCCCcHHHHHHHhcCCccchhhcccccccCCcccccceeeeecCcC
Q 044997          142 VVTYTVQQQDTLSIIATLLSAEISGIESMNKMVAQNPGYIDVCWVLFVPMEL  193 (563)
Q Consensus       142 llTY~~~~gd~ls~ia~~f~~s~~~i~~~N~~~~~~~~~~~~~~~~~vp~~~  193 (563)
                      --+|.|++||||..||.+|+++...|..+|++  .+|+.+.++..+.||...
T Consensus        62 ~~~y~V~~GDTL~~IA~~~~~~~~~l~~~N~~--~~~~~i~~Gq~L~ip~~~  111 (167)
T 2l9y_A           62 TATVTVQQGDTLRDIGRRFDCDFHEIARRNNI--QNEDLIYPGQVLQVPTKG  111 (167)
T ss_dssp             CEEEEECTTCCHHHHHHHTTCCHHHHHHHHTC--CGGGCCCTTEEEEESCCC
T ss_pred             CceEEECCCCcHHHHHHHcCCCHHHHHHHcCC--CCcccccCCCEEEEcCCC
Confidence            46899999999999999999999999999975  577889999999999743

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=95.12  E-value=0.044  Score=55.81  Aligned_cols=30  Identities=20%  Similarity=0.433  Sum_probs=25.1

Q ss_pred             CceEeCCCCCCCeEecCCCcEEEeecCCCcc
Q 044997          396 ARYVHRDIKTSNILLDDGLRAKVADFGLVKL  426 (563)
Q Consensus       396 ~~ivHrDLk~~NILl~~~~~~kl~DFGla~~  426 (563)
                      ..++|+|+.+.|||++++. +.|+||..+..
T Consensus       212 ~~l~HgDl~~~Nil~~~~~-~~lID~e~a~~  241 (369)
T 3c5i_A          212 IVFCHNDLQENNIINTNKC-LRLIDFEYSGF  241 (369)
T ss_dssp             EEEECSCCCGGGEEECC-C-EEECCCTTCEE
T ss_pred             eEEEeCCCCcccEEecCCc-EEEEEecCCCC
Confidence            3589999999999998654 89999998764

>4a1k_A Putative L, D-transpeptidase YKUD; transferase, peptidoglycan synthesis; HET: CME; 1.75A {Bacillus subtilis} PDB: 4a1j_A 4a1i_A* 1y7m_A 3zqd_A 4a52_A*

Probab=94.07  E-value=0.031  Score=50.34  Aligned_cols=47  Identities=26%  Similarity=0.383  Sum_probs=38.8

Q ss_pred             EEEEEccCCCcHHHHHHHhcCCccchhhcccccccCCcccccceeeeecC
Q 044997          142 VVTYTVQQQDTLSIIATLLSAEISGIESMNKMVAQNPGYIDVCWVLFVPM  191 (563)
Q Consensus       142 llTY~~~~gd~ls~ia~~f~~s~~~i~~~N~~~~~~~~~~~~~~~~~vp~  191 (563)
                      +++|.|+.||++..||.+|+++...|.++|+..  ++. ..++..+.||.
T Consensus         2 ~~~y~V~~GdtL~~IA~~f~~g~~~l~~aNp~v--d~~-l~~g~~i~ip~   48 (165)
T 4a1k_A            2 MLTYQVKQGDTLNSIAADFRISTAALLQANPSL--QAG-LTAGQSIVIPG   48 (165)
T ss_dssp             CEEEECCTTCCHHHHHHHTTCCHHHHHHHCGGG--GGC-CCTTCEEEETT
T ss_pred             CEEEEECCCCCHHHHHHHhCCCHHHHHHhCccC--CCc-cCCCccccCcc
Confidence            579999999999999999999999999999875  222 34566777774

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=93.72  E-value=0.22  Score=50.14  Aligned_cols=31  Identities=23%  Similarity=0.312  Sum_probs=27.8

Q ss_pred             CceEeCCCCCCCeEecCCCcEEEeecCCCcc
Q 044997          396 ARYVHRDIKTSNILLDDGLRAKVADFGLVKL  426 (563)
Q Consensus       396 ~~ivHrDLk~~NILl~~~~~~kl~DFGla~~  426 (563)
                      ..++|+|+.+.||++++++.+.|+||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            4699999999999999888899999988764

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=93.68  E-value=0.025  Score=38.48  Aligned_cols=24  Identities=29%  Similarity=0.368  Sum_probs=12.2

Q ss_pred             EEehhhHHHHHHHHHHHhhhhhhc
Q 044997          210 TVIALLSAVALFSVITLIIILLRR  233 (563)
Q Consensus       210 i~i~~~~~v~~~~~~~~~~~~~~r  233 (563)
                      |+.++++++++++++++++++++|
T Consensus        13 IA~gVVgGv~~~~ii~~~~~~~~R   36 (44)
T 2ks1_B           13 IATGMVGALLLLLVVALGIGLFMR   36 (44)
T ss_dssp             STHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEeehhHHHHHHHHHHHHHHHHhh
Confidence            555666656555554444443333

>2l9y_A CVNH-LYSM lectin; carbohydrate, sugar binding protein; NMR {Magnaporthe oryzae 70-15}

Probab=93.45  E-value=0.011  Score=53.41  Aligned_cols=90  Identities=10%  Similarity=0.022  Sum_probs=61.2

Q ss_pred             eeeccCCCCHHHHHHhhCCCcccccccccCCCccEEEEeeccccCCCCccccccccccccCCCCCcceecCcEEEEeeee
Q 044997           53 LYHINQGLPVERIASFYSANPSQIKPIFRGNQKDYLITVPCSCKDVNSTRAMIYSGQAWKVGGEENYFIAGVAVPIHLLC  132 (563)
Q Consensus        53 ~~~~~~~~~~~~i~~l~~~~~~~i~~~n~~~~~~~~vp~~C~C~~~~~~~~~ty~~~a~~~~~~~~l~~~g~~l~vpl~C  132 (563)
                      .|...++-||..||.-|+++..+|+.+|+..                                .++++.||++|.||-.-
T Consensus        64 ~y~V~~GDTL~~IA~~~~~~~~~l~~~N~~~--------------------------------~~~~i~~Gq~L~ip~~~  111 (167)
T 2l9y_A           64 TVTVQQGDTLRDIGRRFDCDFHEIARRNNIQ--------------------------------NEDLIYPGQVLQVPTKG  111 (167)
T ss_dssp             EEEECTTCCHHHHHHHTTCCHHHHHHHHTCC--------------------------------GGGCCCTTEEEEESCCC
T ss_pred             eEEECCCCcHHHHHHHcCCCHHHHHHHcCCC--------------------------------CcccccCCCEEEEcCCC
Confidence            3666789999999999999999999888632                                11223555555555422


Q ss_pred             ec----CCCCceeEEEEEccCCCcHHHHHHHhcCCccchhhccccc
Q 044997          133 GC----VETGTQVVVTYTVQQQDTLSIIATLLSAEISGIESMNKMV  174 (563)
Q Consensus       133 ~C----~~~~~~~llTY~~~~gd~ls~ia~~f~~s~~~i~~~N~~~  174 (563)
                      .=    +.....--..|.+..||++..||.++|.+.....+.|...
T Consensus       112 ~~~~~~~~~~~~~~~~~~v~~GdtL~aIA~r~G~~v~s~i~Ln~~I  157 (167)
T 2l9y_A          112 GSGGGAGNFWDSARDVRLVDGGKVLEAELRYSGGWNRSRIYLDEHI  157 (167)
T ss_dssp             CCSSSSCCGGGGEEEEEEETTTTEEEEEEEETTEEEEEEECGGGTE
T ss_pred             CccccccccccccceEEEeCCcCChHHHHHHcCCceEEEEEccccc
Confidence            11    0000011357889999999999999998877777777754

>2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens}

Probab=93.43  E-value=0.026  Score=38.33  Aligned_cols=26  Identities=15%  Similarity=0.397  Sum_probs=12.6

Q ss_pred             EEehhhHHHHHHHHHHHhhh-hhhccC
Q 044997          210 TVIALLSAVALFSVITLIII-LLRRKR  235 (563)
Q Consensus       210 i~i~~~~~v~~~~~~~~~~~-~~~r~~  235 (563)
                      ++.++++++++++++++.++ ++|||+
T Consensus        12 IA~gVVgGv~~v~ii~~~~~~~~RRRr   38 (44)
T 2l2t_A           12 IAAGVIGGLFILVIVGLTFAVYVRRKS   38 (44)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEEeehHHHHHHHHHHHHHHHHhhhhh
Confidence            45555555555444444433 334433

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=93.23  E-value=0.24  Score=51.06  Aligned_cols=29  Identities=28%  Similarity=0.509  Sum_probs=25.1

Q ss_pred             eEeCCCCCCCeEe------cCCCcEEEeecCCCcc
Q 044997          398 YVHRDIKTSNILL------DDGLRAKVADFGLVKL  426 (563)
Q Consensus       398 ivHrDLk~~NILl------~~~~~~kl~DFGla~~  426 (563)
                      ++|+|+.+.|||+      +++..++++||..|..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            5799999999999      4567899999998864

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=92.80  E-value=0.2  Score=52.15  Aligned_cols=30  Identities=17%  Similarity=0.434  Sum_probs=26.6

Q ss_pred             CceEeCCCCCCCeEecCCCcEEEeecCCCcc
Q 044997          396 ARYVHRDIKTSNILLDDGLRAKVADFGLVKL  426 (563)
Q Consensus       396 ~~ivHrDLk~~NILl~~~~~~kl~DFGla~~  426 (563)
                      ..++|+|+.+.||+ +.++.+.|+||..+..
T Consensus       262 ~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~  291 (424)
T 3mes_A          262 LVFAHNDLQENNLL-QTQNNIRMIDYEYSAI  291 (424)
T ss_dssp             EEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             ceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence            35899999999999 8888999999998864

>2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A

Probab=88.21  E-value=0.16  Score=34.43  Aligned_cols=7  Identities=43%  Similarity=1.066  Sum_probs=2.7

Q ss_pred             hhhhccC
Q 044997          229 ILLRRKR  235 (563)
Q Consensus       229 ~~~~r~~  235 (563)
                      +|+|||+
T Consensus        33 ~~~RRR~   39 (44)
T 2jwa_A           33 ILIKRRQ   39 (44)
T ss_dssp             HHHHHHC
T ss_pred             hheehhh
Confidence            3334443

>2gu1_A Zinc peptidase; alpha/beta, beta barrel, structural genomics, PSI, protein structure initiative; 1.90A {Vibrio cholerae}

Probab=87.07  E-value=1.7  Score=44.10  Aligned_cols=122  Identities=9%  Similarity=0.061  Sum_probs=74.3

Q ss_pred             eeccCCCCHHHHHHhhCCCccccccccc-----------CCCccEEEEeeccccCCCCccccccccccccCCCCCcceec
Q 044997           54 YHINQGLPVERIASFYSANPSQIKPIFR-----------GNQKDYLITVPCSCKDVNSTRAMIYSGQAWKVGGEENYFIA  122 (563)
Q Consensus        54 ~~~~~~~~~~~i~~l~~~~~~~i~~~n~-----------~~~~~~~vp~~C~C~~~~~~~~~ty~~~a~~~~~~~~l~~~  122 (563)
                      |...++-||..|+.-+|++..+|..+|+           .++|.+.||..   ..+ .....+|+-            .+
T Consensus        10 ~~Vk~GDTL~~Ia~r~gvs~~~l~~~n~~~~~~~~~~~L~~Gq~L~i~~~---~~~-~l~~l~~~~------------~~   73 (361)
T 2gu1_A           10 YMVKVGDTLSGIFAQLGVPYSILQKILSVDLDHLQLDMIQPGEELELMMD---DMG-QLSRLIYHM------------SI   73 (361)
T ss_dssp             EECCTTCCHHHHHHHTTCCHHHHHHHHHHGGGTCCGGGCCTTCEEEEEEC---TTS-CEEEEEEEE------------ET
T ss_pred             EEECCCCcHHHHHHHcCCCHHHHHHHHhhcccccchhcCCCCCEEEEEEC---CCC-cceEEEEEc------------Cc
Confidence            5567799999999999999999988775           26788888864   111 111111111            00


Q ss_pred             CcEEEEeeeee-------cCCCCceeEEEEEccCCCcHHHHHHHhcCCccchhhcccccccCCcc---cccceeeeecC
Q 044997          123 GVAVPIHLLCG-------CVETGTQVVVTYTVQQQDTLSIIATLLSAEISGIESMNKMVAQNPGY---IDVCWVLFVPM  191 (563)
Q Consensus       123 g~~l~vpl~C~-------C~~~~~~~llTY~~~~gd~ls~ia~~f~~s~~~i~~~N~~~~~~~~~---~~~~~~~~vp~  191 (563)
                      ...+.+...=.       =+.....-..+|.+..+|++..+|.++|++...+..+|..+..+.++   +.++..+-|+.
T Consensus        74 ~~~~~~~~~~~g~f~~~~~~~~~~~~~~~~~v~igdSL~~iA~~~Gvs~~~i~~ln~i~~~~idf~~~Lr~GD~l~V~~  152 (361)
T 2gu1_A           74 VEKAIYTRENDGSFSYDFQEISGEWREILFSGEINGSFSVSARRVGLTSSQVANITQVMKDKIDFSRSLRAGDRFDILV  152 (361)
T ss_dssp             TEEEEEEECTTSCEEEEEEECCCEEEEEEEEEESSSCHHHHHHHTTCCHHHHHHHHHHHTTTCCTTTCCCC-CEEEEEE
T ss_pred             cceEEEEecCCCcceeeecccCceEEEEEEEEEECCcHHHHHHHcCCCHHHHHHHHHhhcccccccccCCCCCEEEEEE
Confidence            01111110000       00111233567999999999999999999999999999987543222   44555555543

>1e0g_A Membrane-bound lytic murein transglycosylase D; cell WALL, hydrolase, glycosidase, lipoprotein, outer membrane, multigene family; NMR {Escherichia coli} SCOP: d.7.1.1

Probab=84.96  E-value=0.39  Score=32.85  Aligned_cols=38  Identities=16%  Similarity=0.163  Sum_probs=29.9

Q ss_pred             eeccCCCCHHHHHHhhCCCccccccccc-----CCCccEEEEe
Q 044997           54 YHINQGLPVERIASFYSANPSQIKPIFR-----GNQKDYLITV   91 (563)
Q Consensus        54 ~~~~~~~~~~~i~~l~~~~~~~i~~~n~-----~~~~~~~vp~   91 (563)
                      |...++-|+..||.-|+++..+|..+|+     .++|.+.||+
T Consensus         5 y~V~~GDtl~~Ia~~~~~~~~~l~~~N~~~~~l~~G~~l~ip~   47 (48)
T 1e0g_A            5 YRVRKGDSLSSIAKRHGVNIKDVMRWNSDTANLQPGDKLTLFV   47 (48)
T ss_dssp             EEECTTCCHHHHHHHHTCCHHHHHHHCSCGGGCCTTEEEECCC
T ss_pred             EEEcCCCcHHHHHHHHCcCHHHHHHhCCCCCcCCcCCEEEEec
Confidence            5567799999999999999999998885     1455566664

>2knc_A Integrin alpha-IIB; transmembrane signaling, protein structure, cell A cleavage on PAIR of basic residues, disease mutation, disul bond, glycoprotein; NMR {Homo sapiens}

Probab=83.50  E-value=0.31  Score=34.59  Aligned_cols=24  Identities=17%  Similarity=0.534  Sum_probs=15.3

Q ss_pred             cceEEEehhhHHHHHHHHHHHhhh
Q 044997          206 HKWVTVIALLSAVALFSVITLIII  229 (563)
Q Consensus       206 ~~~~i~i~~~~~v~~~~~~~~~~~  229 (563)
                      ..|+++++++++++++++++++++
T Consensus        11 p~wiIi~svl~GLllL~li~~~Lw   34 (54)
T 2knc_A           11 PIWWVLVGVLGGLLLLTILVLAMW   34 (54)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             chHHHHHHHHHHHHHHHHHHHHHH
Confidence            356677777777766666655544

>2djp_A Hypothetical protein SB145; LYSM, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens}

Probab=83.34  E-value=0.61  Score=35.71  Aligned_cols=39  Identities=23%  Similarity=0.210  Sum_probs=32.8

Q ss_pred             eeccCCCCHHHHHHhhCCCcccccccccC-------CCccEEEEee
Q 044997           54 YHINQGLPVERIASFYSANPSQIKPIFRG-------NQKDYLITVP   92 (563)
Q Consensus        54 ~~~~~~~~~~~i~~l~~~~~~~i~~~n~~-------~~~~~~vp~~   92 (563)
                      |...++-||..||.-|+++..+|+.+|+.       ++|.++||..
T Consensus        18 y~V~~GDTL~~IA~~~~~~~~~l~~~N~l~~~~~l~~Gq~l~iP~~   63 (77)
T 2djp_A           18 HQLEPGDTLAGLALKYGVTMEQIKRANRLYTNDSIFLKKTLYIPIL   63 (77)
T ss_dssp             ECCCTTCCHHHHHHHHTCCHHHHHHHHTCCCSSCGGGSSCEEEEEE
T ss_pred             EEECCCCcHHHHHHHHCcCHHHHHHHcCCCCccccCCCCEEEECCC
Confidence            55677999999999999999999999873       4677788864

>2k9y_A Ephrin type-A receptor 2; receptor tyrosine kinase, membrane protein, dimeric transmembrane domain, ephrin receptor, ATP-binding, glycoprotein; NMR {Homo sapiens}

Probab=81.96  E-value=0.49  Score=31.56  Aligned_cols=25  Identities=16%  Similarity=0.287  Sum_probs=10.5

Q ss_pred             EEehhhHHHHHHHHHHHhhhhhhcc
Q 044997          210 TVIALLSAVALFSVITLIIILLRRK  234 (563)
Q Consensus       210 i~i~~~~~v~~~~~~~~~~~~~~r~  234 (563)
                      +++++++++++++++++++++++||
T Consensus        15 I~~~vv~Gv~ll~~iv~~~~~~~rR   39 (41)
T 2k9y_A           15 VIGGVAVGVVLLLVLAGVGFFIHRR   39 (41)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHSSSSS
T ss_pred             EEeehhHHHHHHHHHHHHheeEeee
Confidence            3444445554444233333343443

>2l8s_A Integrin alpha-1; transmembrane region, detergent micelle, CE adhesion; NMR {Homo sapiens}

Probab=81.86  E-value=0.52  Score=33.32  Aligned_cols=24  Identities=17%  Similarity=0.491  Sum_probs=15.4

Q ss_pred             cceEEEehhhHHHHHHHHHHHhhh
Q 044997          206 HKWVTVIALLSAVALFSVITLIII  229 (563)
Q Consensus       206 ~~~~i~i~~~~~v~~~~~~~~~~~  229 (563)
                      ..|+++++++++++++++++++++
T Consensus         8 p~WiIi~svl~GLLLL~Lii~~Lw   31 (54)
T 2l8s_A            8 PLWVILLSAFAGLLLLMLLILALW   31 (54)
T ss_dssp             CTHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             chHHHHHHHHHHHHHHHHHHHHHH
Confidence            356677777777776666665544

>2gu1_A Zinc peptidase; alpha/beta, beta barrel, structural genomics, PSI, protein structure initiative; 1.90A {Vibrio cholerae}

Probab=80.90  E-value=1  Score=45.62  Aligned_cols=51  Identities=24%  Similarity=0.154  Sum_probs=41.6

Q ss_pred             EEEEEccCCCcHHHHHHHhcCCccchhhccccccc--CCcccccceeeeecCc
Q 044997          142 VVTYTVQQQDTLSIIATLLSAEISGIESMNKMVAQ--NPGYIDVCWVLFVPME  192 (563)
Q Consensus       142 llTY~~~~gd~ls~ia~~f~~s~~~i~~~N~~~~~--~~~~~~~~~~~~vp~~  192 (563)
                      -.+|.|+.||||..||.++|++.+.+..+|.....  +...+.++..+.+|.+
T Consensus         7 ~~~~~Vk~GDTL~~Ia~r~gvs~~~l~~~n~~~~~~~~~~~L~~Gq~L~i~~~   59 (361)
T 2gu1_A            7 RIHYMVKVGDTLSGIFAQLGVPYSILQKILSVDLDHLQLDMIQPGEELELMMD   59 (361)
T ss_dssp             CEEEECCTTCCHHHHHHHTTCCHHHHHHHHHHGGGTCCGGGCCTTCEEEEEEC
T ss_pred             ceEEEECCCCcHHHHHHHcCCCHHHHHHHHhhcccccchhcCCCCCEEEEEEC
Confidence            36899999999999999999999999999986421  2345678888888864

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	563
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	2e-51
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	3e-46
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	3e-46
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	4e-45
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	4e-45
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	7e-45
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	6e-44
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	7e-43
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	1e-42
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	2e-42
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	6e-42
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	9e-42
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	1e-41
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	1e-41
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	5e-41
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	6e-41
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	1e-40
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	2e-40
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	3e-40
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	6e-40
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	1e-39
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	2e-39
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	4e-39
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	9e-38
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	2e-37
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	2e-37
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	4e-37
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	1e-36
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	7e-36
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	5e-35
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	2e-34
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	9e-33
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	1e-32
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	2e-31
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	5e-31
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	1e-30
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	1e-30
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	1e-29
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	3e-29
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	3e-29
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	5e-29
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	1e-28
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	2e-28
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	2e-28
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	3e-28
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	9e-28
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	1e-27
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	2e-27
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	5e-27
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	6e-27
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	6e-27
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	9e-26
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	2e-25
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	2e-25
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	4e-25
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	6e-25
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	3e-24
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	3e-24
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	8e-23
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	7e-20
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	1e-19
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	4e-18
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	3e-15

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (445), Expect = 2e-51
 Identities = 67/290 (23%), Positives = 111/290 (38%), Gaps = 56/290 (19%)

Query: 285 EEIEEATNNFDESRIIGRGGFGNVYFGLLGDREAAIKKMRSNKS-----KEFFAELKVLC 339
           ++ E         + IG G FG VY G     + A+K +          + F  E+ VL 
Sbjct: 1   DDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLR 59

Query: 340 KIHHINVFISTFG---------------NGSLSDHLHDPLLKGHQPLTWTARTQIALDAA 384
           K  H+N+ +   G                 SL  HLH                 IA   A
Sbjct: 60  KTRHVNI-LLFMGYSTAPQLAIVTQWCEGSSLYHHLH----IIETKFEMIKLIDIARQTA 114

Query: 385 KGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTP 444
           +G++Y+H       +HRD+K++NI L + L  K+ DFGL  ++ R +       +L G+ 
Sbjct: 115 QGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQF-EQLSGSI 170

Query: 445 GYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRAL----------- 493
            ++ PE I ++               + ++DV+AFG+VL EL+TG+              
Sbjct: 171 LWMAPEVIRMQDKN----------PYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIF 220

Query: 494 -----IRDDSEPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQI 538
                           +    M  +   CL +   +RP    I+A +  +
Sbjct: 221 MVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELL 270

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (408), Expect = 3e-46
 Identities = 63/276 (22%), Positives = 110/276 (39%), Gaps = 54/276 (19%)

Query: 292 NNFDESRIIGRGGFGNVYFGLLGDREAAIKKMRSNKS-KEFFAELKVLCKIHHINV---- 346
                 + IG+G FG+V  G     + A+K ++++ + + F AE  V+ ++ H N+    
Sbjct: 7   KELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLL 66

Query: 347 --FISTFG----------NGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHT 394
              +   G           GSL D+L     +G   L      + +LD  + +EY+  + 
Sbjct: 67  GVIVEEKGGLYIVTEYMAKGSLVDYLRS---RGRSVLGGDCLLKFSLDVCEAMEYLEGN- 122

Query: 395 KARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFV 454
              +VHRD+   N+L+ +   AKV+DFGL K    T               +  PE +  
Sbjct: 123 --NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ------DTGKLPVKWTAPEALRE 174

Query: 455 KRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKR------------ALIRDDSEPTK 502
           K+F             +TK+DV++FG++L E+ +  R              +    +   
Sbjct: 175 KKF-------------STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDA 221

Query: 503 MKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQI 538
                  +  V + C + DA  RP    +   L  I
Sbjct: 222 PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (408), Expect = 3e-46
 Identities = 65/283 (22%), Positives = 109/283 (38%), Gaps = 53/283 (18%)

Query: 292 NNFDESRIIGRGGFGNVYFGLL-GDREAAIKKMRSNKS--KEFFAELKVLCKIHHINVFI 348
                   +G G FG V+ G   G  + A+K ++        F AE  ++ ++ H  + +
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRL-V 71

Query: 349 STFG---------------NGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDH 393
             +                NGSL D L  P       LT      +A   A+G+ +I + 
Sbjct: 72  RLYAVVTQEPIYIITEYMENGSLVDFLKTP---SGIKLTINKLLDMAAQIAEGMAFIEER 128

Query: 394 TKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIF 453
               Y+HRD++ +NIL+ D L  K+ADFGL +L E  + +            +  PE I 
Sbjct: 129 ---NYIHRDLRAANILVSDTLSCKIADFGLARLIE--DNEYTAREGAKFPIKWTAPEAI- 182

Query: 454 VKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKR------------ALIRDDSEPT 501
                            T K+DV++FG++L E++T  R              +       
Sbjct: 183 ------------NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMV 230

Query: 502 KMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITSTE 544
           +  +    +  +   C  E   DRP    + ++L     T+TE
Sbjct: 231 RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF-FTATE 272

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  159 bits (402), Expect = 4e-45
 Identities = 69/305 (22%), Positives = 116/305 (38%), Gaps = 67/305 (21%)

Query: 282 FSLEEIEEATNNFDES---------RIIGRGGFGNVYFGLL---GDREA--AIKKMRSNK 327
           F+ E+  EA   F +          ++IG G FG V  G L   G RE   AIK ++S  
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 328 S----KEFFAELKVLCKIHHINV--FISTF-------------GNGSLSDHLHDPLLKGH 368
           +    ++F +E  ++ +  H NV                     NGSL   L        
Sbjct: 67  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQN----D 122

Query: 369 QPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKL-- 426
              T      +    A G++Y+ D     YVHRD+   NIL++  L  KV+DFGL +   
Sbjct: 123 GQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179

Query: 427 EERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAEL 486
           ++ ++     A        +  PE I                + T+ +DV+++G+V+ E+
Sbjct: 180 DDTSDPTYTSALGGKIPIRWTAPEAI-------------QYRKFTSASDVWSYGIVMWEV 226

Query: 487 ITGKRA------------LIRDDSEPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI 534
           ++                 I  D          + +  +   C  +D   RP+   IV  
Sbjct: 227 MSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286

Query: 535 LSQIM 539
           L +++
Sbjct: 287 LDKMI 291

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (402), Expect = 4e-45
 Identities = 63/301 (20%), Positives = 105/301 (34%), Gaps = 72/301 (23%)

Query: 298 RIIGRGGFGNVYFGLLGDREAAIKKMRSNKSKEFF--AELKVLCKIHHINV--FISTF-- 351
             IG+G FG V+ G     E A+K   S + + +F  AE+     + H N+  FI+    
Sbjct: 9   ESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNK 68

Query: 352 ---------------GNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDH--- 393
                           +GSL D+L+         +T     ++AL  A G+ ++H     
Sbjct: 69  DNGTWTQLWLVSDYHEHGSLFDYLN------RYTVTVEGMIKLALSTASGLAHLHMEIVG 122

Query: 394 --TKARYVHRDIKTSNILLDDGLRAKVADFGLVKL-EERTNEKEMLATRLVGTPGYLPPE 450
              K    HRD+K+ NIL+       +AD GL    +  T+  ++     VGT  Y+ PE
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 182

Query: 451 YIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKMKSLIT-- 508
                    D   ++   +   + D++A G+V  E+          +        L+   
Sbjct: 183 V-------LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235

Query: 509 ------------------------------IMAAVAEWCLNEDAVDRPEMRDIVAILSQI 538
                                         +MA +   C   +   R     I   LSQ+
Sbjct: 236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295

Query: 539 M 539
            
Sbjct: 296 S 296

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  158 bits (401), Expect = 7e-45
 Identities = 66/315 (20%), Positives = 114/315 (36%), Gaps = 76/315 (24%)

Query: 283 SLEEIEEATNNFDESRIIGRGGFGNVYFGLLGD-------REAAIKKMRSNKS----KEF 331
            L  +E   NN +  R IG G FG V+                A+K ++   S     +F
Sbjct: 4   KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63

Query: 332 FAELKVLCKIHHINVFISTFG----------------NGSLSDHLHD------------- 362
             E  ++ +  + N  +   G                 G L++ L               
Sbjct: 64  QREAALMAEFDNPN-IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSD 122

Query: 363 ------PLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRA 416
                     G  PL+   +  IA   A G+ Y+ +    ++VHRD+ T N L+ + +  
Sbjct: 123 LSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVV 179

Query: 417 KVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDV 476
           K+ADFGL +    + +             ++PPE IF               + TT++DV
Sbjct: 180 KIADFGLSRNIY-SADYYKADGNDAIPIRWMPPESIF-------------YNRYTTESDV 225

Query: 477 FAFGVVLAELITGKR------------ALIRDDSEPTKMKSLITIMAAVAEWCLNEDAVD 524
           +A+GVVL E+ +                 +RD +     ++    +  +   C ++   D
Sbjct: 226 WAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPAD 285

Query: 525 RPEMRDIVAILSQIM 539
           RP    I  IL ++ 
Sbjct: 286 RPSFCSIHRILQRMC 300

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (393), Expect = 6e-44
 Identities = 63/288 (21%), Positives = 112/288 (38%), Gaps = 53/288 (18%)

Query: 286 EIEEATNNFDESRIIGRGGFGNVYFGLLGD------REAAIKKMRSNKS----KEFFAEL 335
           EI    +     ++IG G FG VY G+L           AIK +++  +     +F  E 
Sbjct: 3   EIH--PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEA 60

Query: 336 KVLCKIHHINVFISTFGNGSLSDHL------------HDPLLKGHQPLTWTARTQIALDA 383
            ++ +  H N+ I   G  S    +               L +     +      +    
Sbjct: 61  GIMGQFSHHNI-IRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGI 119

Query: 384 AKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGT 443
           A G++Y+ +     YVHRD+   NIL++  L  KV+DFGL ++ E   E     +     
Sbjct: 120 AAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIP 176

Query: 444 PGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKR------------ 491
             +  PE I  ++F              + +DV++FG+V+ E++T               
Sbjct: 177 IRWTAPEAISYRKFT-------------SASDVWSFGIVMWEVMTYGERPYWELSNHEVM 223

Query: 492 ALIRDDSEPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIM 539
             I D           + +  +   C  ++   RP+  DIV+IL +++
Sbjct: 224 KAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 271

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (388), Expect = 7e-43
 Identities = 49/260 (18%), Positives = 100/260 (38%), Gaps = 38/260 (14%)

Query: 287 IEEATNNFDESRIIGRGGFGNVYFG--LLGDREAAIKKMRSNKS----KEFFAELKVLCK 340
           +E   ++F++   +G G  G V+           A K +          +   EL+VL +
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60

Query: 341 IHHINVFISTFGNGSLSDHLH-----------DPLLKGHQPLTWTARTQIALDAAKGIEY 389
            +   + +  +G       +            D +LK    +      ++++   KG+ Y
Sbjct: 61  CNSPYI-VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTY 119

Query: 390 IHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPP 449
           + +  K + +HRD+K SNIL++     K+ DFG+      +     +A   VGT  Y+ P
Sbjct: 120 LRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-----MANSFVGTRSYMSP 172

Query: 450 EYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKMKSLITI 509
           E +                  + ++D+++ G+ L E+  G+  +   D++  ++     +
Sbjct: 173 ERL-------------QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQV 219

Query: 510 MAAVAEWCLNEDAVDRPEMR 529
               AE         RP   
Sbjct: 220 EGDAAETPPRPRTPGRPLSS 239

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (383), Expect = 1e-42
 Identities = 57/277 (20%), Positives = 102/277 (36%), Gaps = 52/277 (18%)

Query: 292 NNFDESRIIGRGGFGNVYFG-LLGDREAAIKKMRSNKS--KEFFAELKVLCKIHHINV-- 346
           +     + IG G FG V+ G  L   + AIK +R      ++F  E +V+ K+ H  +  
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQ 64

Query: 347 FISTF-------------GNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDH 393
                              +G LSD+L                  + LD  +G+ Y+ + 
Sbjct: 65  LYGVCLEQAPICLVFEFMEHGCLSDYLR----TQRGLFAAETLLGMCLDVCEGMAYLEEA 120

Query: 394 TKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIF 453
                +HRD+   N L+ +    KV+DFG+ +            T+      +  PE   
Sbjct: 121 ---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTK--FPVKWASPEVFS 175

Query: 454 VKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKR------------ALIRDDSEPT 501
             R+             ++K+DV++FGV++ E+ +  +              I       
Sbjct: 176 FSRY-------------SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLY 222

Query: 502 KMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQI 538
           K +   T +  +   C  E   DRP    ++  L++I
Sbjct: 223 KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (383), Expect = 2e-42
 Identities = 68/289 (23%), Positives = 108/289 (37%), Gaps = 55/289 (19%)

Query: 286 EIEEATNNFDESRIIGRGGFGNVYFGLL-GDREAAIKKMRSNK--SKEFFAELKVLCKIH 342
           EI     +      +G+G FG V+ G   G    AIK ++      + F  E +V+ K+ 
Sbjct: 13  EIPR--ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLR 70

Query: 343 HINVFISTFG---------------NGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGI 387
           H  + +  +                 GSL D L     +  + L       +A   A G+
Sbjct: 71  HEKL-VQLYAVVSEEPIYIVTEYMSKGSLLDFLKG---ETGKYLRLPQLVDMAAQIASGM 126

Query: 388 EYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYL 447
            Y+       YVHRD++ +NIL+ + L  KVADFGL +L    + +            + 
Sbjct: 127 AYVERM---NYVHRDLRAANILVGENLVCKVADFGLARL--IEDNEYTARQGAKFPIKWT 181

Query: 448 PPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKMKSLI 507
            PE     RF             T K+DV++FG++L EL T  R           +  + 
Sbjct: 182 APEAALYGRF-------------TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 228

Query: 508 TI------------MAAVAEWCLNEDAVDRPEMRDIVAILSQIMITSTE 544
                         +  +   C  ++  +RP    + A L     TSTE
Sbjct: 229 RGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY-FTSTE 276

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  150 bits (379), Expect = 6e-42
 Identities = 58/288 (20%), Positives = 106/288 (36%), Gaps = 52/288 (18%)

Query: 283 SLEEIEEATNNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNKS--KEFFAELKVL 338
           + ++ E    +      +G G +G VY G+        A+K ++ +    +EF  E  V+
Sbjct: 8   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVM 67

Query: 339 CKIHHINV--FISTF-------------GNGSLSDHLHDPLLKGHQPLTWTARTQIALDA 383
            +I H N+   +                  G+L D+L +      Q ++      +A   
Sbjct: 68  KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE---CNRQEVSAVVLLYMATQI 124

Query: 384 AKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGT 443
           +  +EY+       ++HRD+   N L+ +    KVADFGL +L   T +           
Sbjct: 125 SSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRL--MTGDTYTAHAGAKFP 179

Query: 444 PGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKR------------ 491
             +  PE +   +F             + K+DV+AFGV+L E+ T               
Sbjct: 180 IKWTAPESLAYNKF-------------SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY 226

Query: 492 ALIRDDSEPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIM 539
            L+  D    + +     +  +   C   +  DRP   +I      + 
Sbjct: 227 ELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (376), Expect = 9e-42
 Identities = 52/277 (18%), Positives = 106/277 (38%), Gaps = 52/277 (18%)

Query: 292 NNFDESRIIGRGGFGNVYFGLL-GDREAAIKKMRSNKS--KEFFAELKVLCKIHHINV-- 346
            +    + +G G FG V +G   G  + AIK ++       EF  E KV+  + H  +  
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQ 63

Query: 347 FISTF-------------GNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDH 393
                              NG L ++L +               ++  D  + +EY+   
Sbjct: 64  LYGVCTKQRPIFIITEYMANGCLLNYLREM----RHRFQTQQLLEMCKDVCEAMEYLESK 119

Query: 394 TKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIF 453
              +++HRD+   N L++D    KV+DFGL +     +++   +        + PPE + 
Sbjct: 120 ---QFLHRDLAARNCLVNDQGVVKVSDFGLSRY--VLDDEYTSSVGSKFPVRWSPPEVLM 174

Query: 454 VKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKR------------ALIRDDSEPT 501
             +F             ++K+D++AFGV++ E+ +  +              I       
Sbjct: 175 YSKF-------------SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLY 221

Query: 502 KMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQI 538
           +       +  +   C +E A +RP  + +++ +  +
Sbjct: 222 RPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  150 bits (379), Expect = 1e-41
 Identities = 67/283 (23%), Positives = 103/283 (36%), Gaps = 55/283 (19%)

Query: 281 IFSLEEIEEATNNFDESRIIGRGGFGNVYFG--LLGDREAAIKKMRSNKS------KEFF 332
           +F  ++ E+    F + R IG G FG VYF   +      AIKKM  +        ++  
Sbjct: 7   LFFKDDPEK---LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDII 63

Query: 333 AELKVLCKIHHINVFISTFGNGSLSDHLH-----------DPLLKGHQPLTWTARTQIAL 381
            E++ L K+ H N  I   G                    D L    +PL       +  
Sbjct: 64  KEVRFLQKLRHPNT-IQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTH 122

Query: 382 DAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLV 441
            A +G+ Y+H H     +HRD+K  NILL +    K+ DFG   +    N         V
Sbjct: 123 GALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN-------SFV 172

Query: 442 GTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK----------- 490
           GTP ++ PE I                Q   K DV++ G+   EL   K           
Sbjct: 173 GTPYWMAPEVILAMDEG----------QYDGKVDVWSLGITCIELAERKPPLFNMNAMSA 222

Query: 491 -RALIRDDSEPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIV 532
              + +++S   +            + CL +   DRP    ++
Sbjct: 223 LYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLL 265

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (376), Expect = 1e-41
 Identities = 52/279 (18%), Positives = 99/279 (35%), Gaps = 58/279 (20%)

Query: 296 ESRIIGRGGFGNVYFGLLGD----REAAIKKMRSNKS-----KEFFAELKVLCKIHHINV 346
           E + +G G FG V  G        +  A+K +++  +      E  AE  V+ ++ +  +
Sbjct: 11  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70

Query: 347 FISTFG---------------NGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIH 391
            +   G                G L+ +L       ++ +      ++    + G++Y+ 
Sbjct: 71  -VRMIGICEAESWMLVMEMAELGPLNKYLQQ-----NRHVKDKNIIELVHQVSMGMKYLE 124

Query: 392 DHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEY 451
           +     +VHRD+   N+LL     AK++DFGL K            T       +  PE 
Sbjct: 125 ES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC 181

Query: 452 IFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKR------------ALIRDDSE 499
           I   +F             ++K+DV++FGV++ E  +  +            A++     
Sbjct: 182 INYYKF-------------SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER 228

Query: 500 PTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQI 538
                     M  +   C   D  +RP    +   L   
Sbjct: 229 MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (372), Expect = 5e-41
 Identities = 50/270 (18%), Positives = 101/270 (37%), Gaps = 47/270 (17%)

Query: 292 NNFDESRIIGRGGFGNVYFG--LLGDREAAIKKMRSNKS----KEFFAELKVLCKIHHIN 345
            ++D  + +G G +G V      + +   A+K +   ++    +    E+ +   ++H N
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64

Query: 346 VFISTFGNGSLSDHLH-----------DPLLKGHQPLTWTARTQIALDAAKGIEYIHDHT 394
           V +  +G+    +  +              ++    +      +       G+ Y+H   
Sbjct: 65  V-VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI- 122

Query: 395 KARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFV 454
                HRDIK  N+LLD+    K++DFGL  +    N + +L  ++ GT  Y+ PE +  
Sbjct: 123 --GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL-NKMCGTLPYVAPELLKR 179

Query: 455 KRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK-------------RALIRDDSEPT 501
           + F                 DV++ G+VL  ++ G+                    +   
Sbjct: 180 REFH------------AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN 227

Query: 502 KMKSLITIMAAVAEWCLNEDAVDRPEMRDI 531
             K + +   A+    L E+   R  + DI
Sbjct: 228 PWKKIDSAPLALLHKILVENPSARITIPDI 257

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (372), Expect = 6e-41
 Identities = 49/292 (16%), Positives = 105/292 (35%), Gaps = 55/292 (18%)

Query: 285 EEIEEATNNFDESRI-IGRGGFGNVYFGLL----GDREAAIKKMRSNKS----KEFFAEL 335
           +++    +N   + I +G G FG+V  G+        + AIK ++        +E   E 
Sbjct: 1   KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60

Query: 336 KVLCKIHHINV--FISTF------------GNGSLSDHLHDPLLKGHQPLTWTARTQIAL 381
           +++ ++ +  +   I               G G L   L        + +  +   ++  
Sbjct: 61  QIMHQLDNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGK----REEIPVSNVAELLH 116

Query: 382 DAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLV 441
             + G++Y+ +     +VHRD+   N+LL +   AK++DFGL K     +      +   
Sbjct: 117 QVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 173

Query: 442 GTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKR---------- 491
               +  PE I                + ++++DV+++GV + E ++  +          
Sbjct: 174 WPLKWYAPECI-------------NFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE 220

Query: 492 --ALIRDDSEPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMIT 541
             A I               + A+   C      DRP+   +   +     +
Sbjct: 221 VMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (369), Expect = 1e-40
 Identities = 57/275 (20%), Positives = 102/275 (37%), Gaps = 65/275 (23%)

Query: 298 RIIGRGGFGNVYFGLL--GDREAAIKKMRSNKS-----KEFFAELKVLCKIHHIN----- 345
             IGRG F  VY GL      E A  +++  K      + F  E ++L  + H N     
Sbjct: 15  IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 74

Query: 346 -VFISTFG-------------NGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIH 391
             + ST               +G+L  +L        + +             KG++++H
Sbjct: 75  DSWESTVKGKKCIVLVTELMTSGTLKTYLKR-----FKVMKIKVLRSWCRQILKGLQFLH 129

Query: 392 DHTKARYVHRDIKTSNILLDD-GLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPE 450
                  +HRD+K  NI +       K+ D GL  L+  +      A  ++GTP ++ PE
Sbjct: 130 TR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS-----FAKAVIGTPEFMAPE 183

Query: 451 YIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK-------------RALIRDD 497
                           E +     DV+AFG+ + E+ T +             R +    
Sbjct: 184 MY--------------EEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGV 229

Query: 498 SEPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIV 532
              +  K  I  +  + E C+ ++  +R  ++D++
Sbjct: 230 KPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLL 264

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (367), Expect = 2e-40
 Identities = 57/274 (20%), Positives = 92/274 (33%), Gaps = 59/274 (21%)

Query: 292 NNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMR------SNKSKEFFAELKVLCKIHH 343
            +F+  R +G+G FGNVY           A+K +       +    +   E+++   + H
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65

Query: 344 INV--FISTF-------------GNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIE 388
            N+      F               G++   L                     + A  + 
Sbjct: 66  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQK-----LSKFDEQRTATYITELANALS 120

Query: 389 YIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLP 448
           Y H     R +HRDIK  N+LL      K+ADFG       +       T L GT  YLP
Sbjct: 121 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-----RTTLCGTLDYLP 172

Query: 449 PEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDD----------S 498
           PE I  +                 K D+++ GV+  E + GK     +            
Sbjct: 173 PEMIEGRMH-------------DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 219

Query: 499 EPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIV 532
           E T    +      +    L  +   RP +R+++
Sbjct: 220 EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 253

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (369), Expect = 3e-40
 Identities = 65/295 (22%), Positives = 116/295 (39%), Gaps = 67/295 (22%)

Query: 292 NNFDESRIIGRGGFGNVYFGLLGD----REAAIKKMRSNKS----KEFFAELKVLCKI-H 342
           N+     +IG G FG V    +       +AAIK+M+   S    ++F  EL+VLCK+ H
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69

Query: 343 HINV--FISTF-------------GNGSLSDHLH-----------DPLLKGHQPLTWTAR 376
           H N+   +                 +G+L D L                     L+    
Sbjct: 70  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 377 TQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEML 436
              A D A+G++Y+      +++HRD+   NIL+ +   AK+ADFGL + +E   +K   
Sbjct: 130 LHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK--- 183

Query: 437 ATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRA---- 492
            T       ++  E +    +             TT +DV+++GV+L E+++        
Sbjct: 184 -TMGRLPVRWMAIESLNYSVY-------------TTNSDVWSYGVLLWEIVSLGGTPYCG 229

Query: 493 --------LIRDDSEPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIM 539
                    +       K  +    +  +   C  E   +RP    I+  L++++
Sbjct: 230 MTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 284

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (367), Expect = 6e-40
 Identities = 62/278 (22%), Positives = 110/278 (39%), Gaps = 49/278 (17%)

Query: 294 FDESRIIGRGGFGNVYFGLL---GDREA---AIKKMRSNKS----KEFFAELKVLCKIHH 343
           F + +++G G FG VY GL    G++     AIK++R   S    KE   E  V+  + +
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70

Query: 344 INV--FISTFGNGSL--------SDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDH 393
            +V   +      ++           L D + +    +         +  AKG+ Y+ D 
Sbjct: 71  PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 130

Query: 394 TKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIF 453
              R VHRD+   N+L+      K+ DFGL KL     EKE  A        ++  E I 
Sbjct: 131 ---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG-AEEKEYHAEGGKVPIKWMALESIL 186

Query: 454 VKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKR------------ALIRDDSEPT 501
            + +             T ++DV+++GV + EL+T               +++       
Sbjct: 187 HRIY-------------THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 233

Query: 502 KMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIM 539
           +       +  +   C   DA  RP+ R+++   S++ 
Sbjct: 234 QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 271

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (361), Expect = 1e-39
 Identities = 50/277 (18%), Positives = 91/277 (32%), Gaps = 54/277 (19%)

Query: 293 NFDESRIIGRGGFGNVYFG--LLGDREAAIKKMRSNKSKE-----FFAELKVLCKIHHIN 345
           +++    IG G +G           +    K++      E       +E+ +L ++ H N
Sbjct: 5   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64

Query: 346 V------FISTFG-----------NGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIE 388
           +       I                G L+  +     K  Q L      ++       ++
Sbjct: 65  IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGT-KERQYLDEEFVLRVMTQLTLALK 123

Query: 389 YIHDHTKA--RYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGY 446
             H  +      +HRD+K +N+ LD     K+ DFGL ++          A   VGTP Y
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS---FAKAFVGTPYY 180

Query: 447 LPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKR-----------ALIR 495
           + PE +    +               K+D+++ G +L EL                  IR
Sbjct: 181 MSPEQMNRMSY-------------NEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIR 227

Query: 496 DDSEPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIV 532
           +             +  +    LN     RP + +I+
Sbjct: 228 EGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEIL 264

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (363), Expect = 2e-39
 Identities = 63/305 (20%), Positives = 117/305 (38%), Gaps = 63/305 (20%)

Query: 273 VLESERTIIFSLEEIEEATNNFDESRIIGRGGFGNVYFGLLGDREA-----AIKKMRSNK 327
           ++++ + ++     +     +F+E  +IGRG FG VY G L D +      A+K +    
Sbjct: 13  LVQAVQHVVIGPSSL---IVHFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT 67

Query: 328 S----KEFFAELKVLCKIHHINV----------------FISTFGNGSLSDHLHDPLLKG 367
                 +F  E  ++    H NV                 +    +G L + + +     
Sbjct: 68  DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE---- 123

Query: 368 HQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK-L 426
               T        L  AKG++++      ++VHRD+   N +LD+    KVADFGL + +
Sbjct: 124 THNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDM 180

Query: 427 EERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAEL 486
            ++  +     T       ++  E +                + TTK+DV++FGV+L EL
Sbjct: 181 YDKEFDSVHNKTGAKLPVKWMALESL-------------QTQKFTTKSDVWSFGVLLWEL 227

Query: 487 ITGKR------------ALIRDDSEPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI 534
           +T                 +       + +     +  V   C +  A  RP   ++V+ 
Sbjct: 228 MTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287

Query: 535 LSQIM 539
           +S I 
Sbjct: 288 ISAIF 292

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (359), Expect = 4e-39
 Identities = 51/264 (19%), Positives = 97/264 (36%), Gaps = 45/264 (17%)

Query: 298 RIIGRGGFGNVYFGLL--GDREAAIKKMRSNKSKE---FFAELKVLCKIHHINVFISTFG 352
             +G G FG VY          AA K + +   +E   +  E+ +L    H N+ +    
Sbjct: 18  GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNI-VKLLD 76

Query: 353 NGSLSDH------------LHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVH 400
                ++            +   +L+  +PLT +    +       + Y+HD+   + +H
Sbjct: 77  AFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN---KIIH 133

Query: 401 RDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFD 460
           RD+K  NIL       K+ADFG+     RT ++       +GTP ++ PE +        
Sbjct: 134 RDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR---RDSFIGTPYWMAPEVV-------- 182

Query: 461 MHSSVMELQVTTKTDVFAFGVVLAELITGK------------RALIRDDSEPTKMKSLIT 508
           M  +  +     K DV++ G+ L E+   +              + + +       S  +
Sbjct: 183 MCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWS 242

Query: 509 IMA-AVAEWCLNEDAVDRPEMRDI 531
                  + CL ++   R     +
Sbjct: 243 SNFKDFLKKCLEKNVDARWTTSQL 266

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (352), Expect = 9e-38
 Identities = 52/302 (17%), Positives = 106/302 (35%), Gaps = 75/302 (24%)

Query: 292 NNFDESRIIGRGGFGNVYFGLLGD-------REAAIKKMRSNKS----KEFFAELKVLCK 340
            N +  +++G G FG V               + A+K ++        +   +ELK++ +
Sbjct: 37  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96

Query: 341 I-HHINV--FISTF-------------GNGSLSDHLHD------------------PLLK 366
           +  H N+   +                  G L ++L                       +
Sbjct: 97  LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156

Query: 367 GHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKL 426
               LT+      A   AKG+E++        VHRD+   N+L+  G   K+ DFGL + 
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARD 213

Query: 427 EERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAEL 486
              ++   ++         ++ PE +              E   T K+DV+++G++L E+
Sbjct: 214 IM-SDSNYVVRGNARLPVKWMAPESL-------------FEGIYTIKSDVWSYGILLWEI 259

Query: 487 ITGKR-------------ALIRDDSEPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVA 533
            +                 LI++  +  +       +  + + C   D+  RP   ++ +
Sbjct: 260 FSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTS 319

Query: 534 IL 535
            L
Sbjct: 320 FL 321

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (349), Expect = 2e-37
 Identities = 56/305 (18%), Positives = 106/305 (34%), Gaps = 70/305 (22%)

Query: 292 NNFDESRIIGRGGFGNVYFGLL-------GDREAAIKKMRSNKS----KEFFAELKVLCK 340
           N     + +G G FG V                 A+K ++ +      +   +ELKVL  
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 341 I-HHINV--FISTF-------------GNGSLSDHLHD-------------PLLKGHQPL 371
           + +H+N+   +                  G L + L                +      L
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 372 TWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTN 431
                   +   AKG+ ++        +HRD+   NILL  G   K+ DFGL +  +  +
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKN-D 198

Query: 432 EKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKR 491
              ++         ++ PE IF   +             T ++DV+++G+ L EL +   
Sbjct: 199 SNYVVKGNARLPVKWMAPESIFNCVY-------------TFESDVWSYGIFLWELFSLGS 245

Query: 492 -------------ALIRDDSEPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQI 538
                         +I++       +     M  + + C + D + RP  + IV ++ + 
Sbjct: 246 SPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305

Query: 539 MITST 543
           +  ST
Sbjct: 306 ISEST 310

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (348), Expect = 2e-37
 Identities = 61/303 (20%), Positives = 114/303 (37%), Gaps = 62/303 (20%)

Query: 281 IFSLEEIEEATNNFDESRIIGRGGFGNVYFGLL-------GDREAAIKKMRSNKS----K 329
           ++  +E E A      SR +G+G FG VY G+         +   AIK +    S     
Sbjct: 9   VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI 68

Query: 330 EFFAELKVLCKIHHINVFISTFG----------------NGSLSDHLHDP-----LLKGH 368
           EF  E  V+ + +  +V +   G                 G L  +L             
Sbjct: 69  EFLNEASVMKEFNCHHV-VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVL 127

Query: 369 QPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEE 428
            P + +   Q+A + A G+ Y++ +   ++VHRD+   N ++ +    K+ DFG+ +   
Sbjct: 128 APPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY 184

Query: 429 RTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT 488
            T+       + +    ++ PE +    F             TT +DV++FGVVL E+ T
Sbjct: 185 ETDYYRK-GGKGLLPVRWMSPESLKDGVF-------------TTYSDVWSFGVVLWEIAT 230

Query: 489 GKRA------------LIRDDSEPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILS 536
                            + +     K  +   ++  +   C   +   RP   +I++ + 
Sbjct: 231 LAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 290

Query: 537 QIM 539
           + M
Sbjct: 291 EEM 293

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (344), Expect = 4e-37
 Identities = 59/285 (20%), Positives = 101/285 (35%), Gaps = 51/285 (17%)

Query: 286 EIEEATNNFDESRIIGRGGFGNVYFGLLGDRE-----AAIKKMRSNKS----KEFFAELK 336
           EI+      +  R IG G FG+V+ G+    E      AIK  ++  S    ++F  E  
Sbjct: 3   EIQR--ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 60

Query: 337 VLCKIHHINV--FISTFGNGSL--------SDHLHDPLLKGHQPLTWTARTQIALDAAKG 386
            + +  H ++   I       +           L   L      L   +    A   +  
Sbjct: 61  TMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA 120

Query: 387 IEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGY 446
           + Y+      R+VHRDI   N+L+      K+ DFGL +  E  +     A++      +
Sbjct: 121 LAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME--DSTYYKASKGKLPIKW 175

Query: 447 LPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKR------------ALI 494
           + PE I  +RF                +DV+ FGV + E++                  I
Sbjct: 176 MAPESINFRRFTS-------------ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 222

Query: 495 RDDSEPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIM 539
            +        +    + ++   C   D   RP   ++ A LS I+
Sbjct: 223 ENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 267

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (341), Expect = 1e-36
 Identities = 48/281 (17%), Positives = 94/281 (33%), Gaps = 50/281 (17%)

Query: 292 NNFDESRIIGRGGFGNVYFGLL-----GDREAAIKKMRSNKS------KEFFAELKVLCK 340
            +      +G G FG V  G            A+K ++ +         +F  E+  +  
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67

Query: 341 IHHINV--FISTFGNGSLS--------DHLHDPLLKGHQPLTWTARTQIALDAAKGIEYI 390
           + H N+           +           L D L K          ++ A+  A+G+ Y+
Sbjct: 68  LDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL 127

Query: 391 HDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPE 450
                 R++HRD+   N+LL      K+ DFGL++   + ++  ++         +  PE
Sbjct: 128 ESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 184

Query: 451 YIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKR-------------ALIRDD 497
            +  + F             +  +D + FGV L E+ T  +              + ++ 
Sbjct: 185 SLKTRTF-------------SHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEG 231

Query: 498 SEPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQI 538
               + +     +  V   C      DRP    +   L + 
Sbjct: 232 ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (337), Expect = 7e-36
 Identities = 57/300 (19%), Positives = 105/300 (35%), Gaps = 69/300 (23%)

Query: 292 NNFDESRIIGRGGFGNVYFGLLGD-------REAAIKKMRSNKS----KEFFAELKVLCK 340
           +     + +GRG FG V              R  A+K ++   +    +   +ELK+L  
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72

Query: 341 IHHINVFISTFG-----------------NGSLSDHLHD-----------PLLKGHQPLT 372
           I H    ++  G                  G+LS +L             P       LT
Sbjct: 73  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132

Query: 373 WTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNE 432
                  +   AKG+E++      + +HRD+   NILL +    K+ DFGL +   + + 
Sbjct: 133 LEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYK-DP 188

Query: 433 KEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKR- 491
             +          ++ PE IF + +             T ++DV++FGV+L E+ +    
Sbjct: 189 DYVRKGDARLPLKWMAPETIFDRVY-------------TIQSDVWSFGVLLWEIFSLGAS 235

Query: 492 ------------ALIRDDSEPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIM 539
                         +++ +           M      C + +   RP   ++V  L  ++
Sbjct: 236 PYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 295

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (330), Expect = 5e-35
 Identities = 58/292 (19%), Positives = 114/292 (39%), Gaps = 62/292 (21%)

Query: 273 VLESERTIIFSLEEIEEATNNFDESRIIGRGGFGNVYFG--LLGDREAAIKKMR---SNK 327
           +LE  R+I+     + +    +     IG+G  G VY    +   +E AI++M      K
Sbjct: 5   ILEKLRSIV----SVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK 60

Query: 328 SKEFFAELKVLCKIHHINV--FISTF-------------GNGSLSDHLHDPLLKGHQPLT 372
            +    E+ V+ +  + N+  ++ ++               GSL+D +          + 
Sbjct: 61  KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT------ETCMD 114

Query: 373 WTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNE 432
                 +  +  + +E++H +   + +HRDIK+ NILL      K+ DFG          
Sbjct: 115 EGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171

Query: 433 KEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRA 492
           K    + +VGTP ++ PE +  K +               K D+++ G++  E+I G+  
Sbjct: 172 K---RSTMVGTPYWMAPEVVTRKAY-------------GPKVDIWSLGIMAIEMIEGEPP 215

Query: 493 LIRDDS-------------EPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDI 531
            + ++              E    + L  I       CL+ D   R   +++
Sbjct: 216 YLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKEL 267

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (326), Expect = 2e-34
 Identities = 55/304 (18%), Positives = 113/304 (37%), Gaps = 70/304 (23%)

Query: 292 NNFDESRIIGRGGFGNVYFGLL---------GDREAAIKKMRSNKS----KEFFAELKVL 338
           +     + +G G FG V                 + A+K ++S+ +     +  +E++++
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72

Query: 339 CKIHHINVFISTFG----------------NGSLSDHLH-----------DPLLKGHQPL 371
             I      I+  G                 G+L ++L            +P     + L
Sbjct: 73  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132

Query: 372 TWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTN 431
           +       A   A+G+EY+      + +HRD+   N+L+ +    K+ADFGL +     +
Sbjct: 133 SSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189

Query: 432 EKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKR 491
             +           ++ PE +F + +             T ++DV++FGV+L E+ T   
Sbjct: 190 YYKKTTNG-RLPVKWMAPEALFDRIY-------------THQSDVWSFGVLLWEIFTLGG 235

Query: 492 ------------ALIRDDSEPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIM 539
                        L+++     K  +    +  +   C +     RP  + +V  L +I+
Sbjct: 236 SPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295

Query: 540 -ITS 542
            +TS
Sbjct: 296 ALTS 299

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  124 bits (313), Expect = 9e-33
 Identities = 52/289 (17%), Positives = 90/289 (31%), Gaps = 57/289 (19%)

Query: 292 NNFDESRIIGRGGFGNVYFG--LLGDREAAIKKMRSNKS----KEFFAELKVLCKIHHIN 345
            ++   R IG G FG ++ G  LL +++ AIK           ++ +   K+L     I 
Sbjct: 5   VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIP 64

Query: 346 VFISTFGNGS--------LSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKAR 397
                   G         L   L D L    +  +       A      ++ IH+     
Sbjct: 65  NVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK---S 121

Query: 398 YVHRDIKTSNILLDDGL-----RAKVADFGLVKLEERTNEKEML----ATRLVGTPGYLP 448
            V+RDIK  N L+            V DFG+VK       K+ +       L GT  Y+ 
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 181

Query: 449 PEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRAL--------------I 494
                 +               + + D+ A G V    + G                  I
Sbjct: 182 INTHLGRE-------------QSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI 228

Query: 495 RDDSEPTKMKSLI----TIMAAVAEWCLNEDAVDRPEMRDIVAILSQIM 539
            +  + T ++ L             +  N      P+   +  + S+++
Sbjct: 229 GEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL 277

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (313), Expect = 1e-32
 Identities = 61/288 (21%), Positives = 102/288 (35%), Gaps = 52/288 (18%)

Query: 293 NFDESRIIGRGGFGNVYFG--LLGDREAAIKKMR------SNKSKEFFAELKVLCKIHHI 344
           +F   +I+G G F  V     L   RE AIK +        NK      E  V+ ++ H 
Sbjct: 9   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68

Query: 345 NVFISTFGNGSLSDHLH-----------DPLLKGHQPLTWTARTQIALDAAKGIEYIHDH 393
              +  +      + L+              ++       T       +    +EY+H  
Sbjct: 69  FF-VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 127

Query: 394 TKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIF 453
                +HRD+K  NILL++ +  ++ DFG  K+      K+  A   VGT  Y+ PE + 
Sbjct: 128 ---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP-ESKQARANSFVGTAQYVSPELL- 182

Query: 454 VKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKMKSLITI---- 509
                        E      +D++A G ++ +L+ G     R  +E    + +I +    
Sbjct: 183 ------------TEKSACKSSDLWALGCIIYQLVAGLP-PFRAGNEYLIFQKIIKLEYDF 229

Query: 510 -------MAAVAEWCLNEDAVDRP---EMRDIVAILSQIMITSTEWEA 547
                     + E  L  DA  R    EM     + +     S  WE 
Sbjct: 230 PEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWEN 277

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  120 bits (303), Expect = 2e-31
 Identities = 51/283 (18%), Positives = 84/283 (29%), Gaps = 63/283 (22%)

Query: 293 NFDESRIIGRGGFGNVYFG--LLGDREAAIKKMRSNKS------------KEFFAELKVL 338
           N++   I+GRG    V         +E A+K +                 +    E+ +L
Sbjct: 4   NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63

Query: 339 CKIHHINVFISTFG----------------NGSLSDHLHDPLLKGHQPLTWTARTQIALD 382
            K+      I                     G L D+L +        L+     +I   
Sbjct: 64  RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE-----KVTLSEKETRKIMRA 118

Query: 383 AAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVG 442
             + I  +H       VHRD+K  NILLDD +  K+ DFG     +   +       + G
Sbjct: 119 LLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK----LREVCG 171

Query: 443 TPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE--- 499
           TP YL PE I                    + D+++ GV++  L+ G             
Sbjct: 172 TPSYLAPEIIECSMND-------NHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML 224

Query: 500 -----------PTKMKSLITIMAAVAEWCLNEDAVDRPEMRDI 531
                        +       +  +    L      R    + 
Sbjct: 225 RMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEA 267

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  119 bits (300), Expect = 5e-31
 Identities = 58/290 (20%), Positives = 113/290 (38%), Gaps = 63/290 (21%)

Query: 291 TNNFDESRIIGRGGFGNVYFG--LLGDREAAIKKMRSNKS------KEFFAELKVLCKIH 342
           ++ ++   I+G GG   V+    L   R+ A+K +R++ +        F  E +    ++
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65

Query: 343 HINV--FISTF-----------------GNGSLSDHLHDPLLKGHQPLTWTARTQIALDA 383
           H  +     T                     +L D +H        P+T     ++  DA
Sbjct: 66  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT-----EGPMTPKRAIEVIADA 120

Query: 384 AKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGT 443
            + + + H +     +HRD+K +NI++      KV DFG+ +    +         ++GT
Sbjct: 121 CQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 177

Query: 444 PGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKR------------ 491
             YL PE                   V  ++DV++ G VL E++TG+             
Sbjct: 178 AQYLSPEQA-------------RGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAY 224

Query: 492 ALIRDDSEP--TKMKSLITIMAAVAEWCLNEDAVDRPE-MRDIVAILSQI 538
             +R+D  P   + + L   + AV    L ++  +R +   ++ A L ++
Sbjct: 225 QHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  119 bits (298), Expect = 1e-30
 Identities = 52/290 (17%), Positives = 86/290 (29%), Gaps = 55/290 (18%)

Query: 292 NNFDESRIIGRGGFGNVYFG--LLGDREAAIKKMR-SNKSKEFFAELKVLCKIHHINVFI 348
           N +   R IG G FG++Y G  +    E AIK      K  +   E K+   +       
Sbjct: 7   NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIP 66

Query: 349 STFGNGSLSDH-----------LHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKAR 397
           +    G+  D+           L D      +  +      +A      IEYIH      
Sbjct: 67  TIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---N 123

Query: 398 YVHRDIKTSNIL---LDDGLRAKVADFGLVKL----EERTNEKEMLATRLVGTPGYLPPE 450
           ++HRD+K  N L      G    + DFGL K         +        L GT  Y    
Sbjct: 124 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASIN 183

Query: 451 YIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE----------- 499
                          + ++ + + D+ + G VL     G        +            
Sbjct: 184 TH-------------LGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE 230

Query: 500 -------PTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITS 542
                      K   +  A    +C +    D+P+   +  +   +    
Sbjct: 231 KKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  120 bits (302), Expect = 1e-30
 Identities = 44/276 (15%), Positives = 86/276 (31%), Gaps = 60/276 (21%)

Query: 292 NNFDESRIIGRGGFGNVYFG--LLGDREAAIKKMRSNKS---KEFFAELKVLCKIHHINV 346
           +++D    +G G FG V+           A K + +      +    E++ +  + H  +
Sbjct: 26  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85

Query: 347 --FISTF-------------GNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIH 391
                 F               G L + + D     H  ++     +      KG+ ++H
Sbjct: 86  VNLHDAFEDDNEMVMIYEFMSGGELFEKVADE----HNKMSEDEAVEYMRQVCKGLCHMH 141

Query: 392 DHTKARYVHRDIKTSNILL--DDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPP 449
           ++    YVH D+K  NI+         K+ DFGL    +     ++      GT  +  P
Sbjct: 142 EN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT----TGTAEFAAP 194

Query: 450 EYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE---------- 499
           E    K                  TD+++ GV+   L++G      ++ +          
Sbjct: 195 EVAEGKPV-------------GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCD 241

Query: 500 ----PTKMKSLITIMAAVAEWCLNEDAVDRPEMRDI 531
                +    +           L  D   R  +   
Sbjct: 242 WNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQA 277

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  117 bits (294), Expect = 1e-29
 Identities = 48/276 (17%), Positives = 86/276 (31%), Gaps = 60/276 (21%)

Query: 292 NNFDESRIIGRGGFGNVYFG--LLGDREAAIKKMRSNKS---KEFFAELKVLCKIHHINV 346
           + +D    +G G FG V+        R    K + +           E+ ++ ++HH  +
Sbjct: 29  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88

Query: 347 --FISTF-------------GNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIH 391
                 F               G L D +          ++          A +G++++H
Sbjct: 89  INLHDAFEDKYEMVLILEFLSGGELFDRIA----AEDYKMSEAEVINYMRQACEGLKHMH 144

Query: 392 DHTKARYVHRDIKTSNILLD--DGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPP 449
           +H     VH DIK  NI+ +       K+ DFGL            +      T  +  P
Sbjct: 145 EH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE----IVKVTTATAEFAAP 197

Query: 450 EYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKMK----- 504
           E +                 V   TD++A GV+   L++G      +D   T        
Sbjct: 198 EIV-------------DREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCD 244

Query: 505 ---------SLITIMAAVAEWCLNEDAVDRPEMRDI 531
                    S+        +  L ++   R  + D 
Sbjct: 245 WEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDA 280

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (287), Expect = 3e-29
 Identities = 55/264 (20%), Positives = 91/264 (34%), Gaps = 51/264 (19%)

Query: 298 RIIGRGGFGNVYFG--LLGDREAAIKKMRSNK---------SKEFFAELKVLCKIH--HI 344
            ++G GGFG+VY G  +  +   AIK +  ++               E+ +L K+     
Sbjct: 10  PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 69

Query: 345 NV--FISTFGNGSL---------SDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDH 393
            V   +  F                      +     L             + + + H+ 
Sbjct: 70  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 129

Query: 394 TKARYVHRDIKTSNILLD-DGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYI 452
                +HRDIK  NIL+D +    K+ DFG   L + T       T   GT  Y PPE+I
Sbjct: 130 ---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV-----YTDFDGTRVYSPPEWI 181

Query: 453 FVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKMKSLI----- 507
              R+                  V++ G++L +++ G       D E  + +        
Sbjct: 182 RYHRYH------------GRSAAVWSLGILLYDMVCGDI-PFEHDEEIIRGQVFFRQRVS 228

Query: 508 TIMAAVAEWCLNEDAVDRPEMRDI 531
           +    +  WCL     DRP   +I
Sbjct: 229 SECQHLIRWCLALRPSDRPTFEEI 252

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (291), Expect = 3e-29
 Identities = 50/238 (21%), Positives = 85/238 (35%), Gaps = 36/238 (15%)

Query: 289 EATNNFDESRIIGRGGFGNVYFG--LLGDREAAIKKMRSNKS----KEFFAELKVLCKIH 342
           +    +     IG G +G V      +     AIKK+   +     +    E+K+L +  
Sbjct: 5   DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR 64

Query: 343 HINV--FISTFGNGS------------LSDHLHDPLLKGHQPLTWTARTQIALDAAKGIE 388
           H N+          +            L       LLK  Q L+            +G++
Sbjct: 65  HENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLK-TQHLSNDHICYFLYQILRGLK 123

Query: 389 YIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLP 448
           YIH       +HRD+K SN+LL+     K+ DFGL ++ +  ++     T  V T  Y  
Sbjct: 124 YIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 180

Query: 449 PEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKMKSL 506
           PE +                  T   D+++ G +LAE+++ +               L
Sbjct: 181 PEIML------------NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 226

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (287), Expect = 5e-29
 Identities = 54/249 (21%), Positives = 95/249 (38%), Gaps = 50/249 (20%)

Query: 290 ATNNFDESRIIGRGGFGNVYFG---LLGDREAAIKKMRSNKSKE--------FFAELKVL 338
           A   ++    IG G +G V+       G R  A+K++R    +E          A L+ L
Sbjct: 5   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64

Query: 339 CKIHHINVFISTFGNGSLSDHLHDPLL-----------------KGHQPLTWTARTQIAL 381
               H NV +  F   ++S    +  L                      +       +  
Sbjct: 65  ETFEHPNV-VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123

Query: 382 DAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLV 441
              +G++++H H   R VHRD+K  NIL+    + K+ADFGL ++           T +V
Sbjct: 124 QLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL----TSVV 176

Query: 442 GTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPT 501
            T  Y  PE +    +              T  D+++ G + AE+   K  L R  S+  
Sbjct: 177 VTLWYRAPEVLLQSSY-------------ATPVDLWSVGCIFAEMFRRKP-LFRGSSDVD 222

Query: 502 KMKSLITIM 510
           ++  ++ ++
Sbjct: 223 QLGKILDVI 231

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  113 bits (284), Expect = 1e-28
 Identities = 47/282 (16%), Positives = 90/282 (31%), Gaps = 57/282 (20%)

Query: 285 EEIEEATNNFDESRIIGRGGFGNVYFG--LLGDREAAIKKMR----SNKSKEFFAELKVL 338
           ++ E+  + +D   ++G G F  V         +  AIK +       K      E+ VL
Sbjct: 2   KQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVL 61

Query: 339 CKIHHINV--FISTF-------------GNGSLSDHLHDPLLKGHQPLTWTARTQIALDA 383
            KI H N+      +               G L D + +         T    +++    
Sbjct: 62  HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVE-----KGFYTERDASRLIFQV 116

Query: 384 AKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGT 443
              ++Y+HD        +        LD+  +  ++DFGL K+E+  +    + +   GT
Sbjct: 117 LDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS----VLSTACGT 172

Query: 444 PGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE---- 499
           PGY+ PE +  K +             +   D ++ GV+   L+ G      ++      
Sbjct: 173 PGYVAPEVLAQKPY-------------SKAVDCWSIGVIAYILLCGYPPFYDENDAKLFE 219

Query: 500 ----------PTKMKSLITIMAAVAEWCLNEDAVDRPEMRDI 531
                           +           + +D   R      
Sbjct: 220 QILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQA 261

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (285), Expect = 2e-28
 Identities = 63/261 (24%), Positives = 99/261 (37%), Gaps = 47/261 (18%)

Query: 293 NFDESRIIGRGGFGNVYFGLLGD--REAAIKKMRSNKSKEFFAELKVLCKIHHINV---- 346
           ++ ++++IG G FG VY   L D     AIKK+  +K +    EL+++ K+ H N+    
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-RFKNRELQIMRKLDHCNIVRLR 79

Query: 347 --FISTF---------------GNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEY 389
             F S+                         H    +  Q L             + + Y
Sbjct: 80  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARH--YSRAKQTLPVIYVKLYMYQLFRSLAY 137

Query: 390 IHDHTKARYVHRDIKTSNILLD-DGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLP 448
           IH        HRDIK  N+LLD D    K+ DFG  K   R           + +  Y  
Sbjct: 138 IHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS----YICSRYYRA 190

Query: 449 PEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKMKSLIT 508
           PE IF                 T+  DV++ G VLAEL+ G+  +   DS   ++  +I 
Sbjct: 191 PELIF------------GATDYTSSIDVWSAGCVLAELLLGQP-IFPGDSGVDQLVEIIK 237

Query: 509 IMAAVAEWCLNEDAVDRPEMR 529
           ++       + E   +  E +
Sbjct: 238 VLGTPTREQIREMNPNYTEFK 258

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (284), Expect = 2e-28
 Identities = 58/287 (20%), Positives = 91/287 (31%), Gaps = 51/287 (17%)

Query: 292 NNFDESRIIGRGGFGNVYFG--LLGDREAAIKKMRSNKS------KEFFAELKVLCKIHH 343
           N+FD  +++G+G FG V         R  A+K +R               E +VL    H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 344 INV-----------FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHD 392
             +            +      +    L    L   +  T         +    +EY+H 
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFF-HLSRERVFTEERARFYGAEIVSALEYLHS 123

Query: 393 HTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYI 452
                 V+RDIK  N++LD     K+ DFGL K                GTP YL PE +
Sbjct: 124 R---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT---MKTFCGTPEYLAPEVL 177

Query: 453 FVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKMKSLITI--- 509
               +                 D +  GVV+ E++ G+      D E      L+     
Sbjct: 178 EDNDY-------------GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF 224

Query: 510 -------MAAVAEWCLNEDAVDRPEMRDIVA--ILSQIMITSTEWEA 547
                    ++    L +D   R       A  ++      S  W+ 
Sbjct: 225 PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQD 271

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (282), Expect = 3e-28
 Identities = 59/290 (20%), Positives = 101/290 (34%), Gaps = 60/290 (20%)

Query: 292 NNFDESRIIGRGGFGNVYFG--LLGDREAAIKKMRSNKS------KEFFAELKVL-CKIH 342
            +F   +++G+G FG V+       ++  AIK ++ +        +    E +VL     
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 343 HINV--FISTF-------------GNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGI 387
           H  +     TF               G L  H+             +  T  A +   G+
Sbjct: 62  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS-----CHKFDLSRATFYAAEIILGL 116

Query: 388 EYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYL 447
           +++H       V+RD+K  NILLD     K+ADFG+ K     + K        GTP Y+
Sbjct: 117 QFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT---NTFCGTPDYI 170

Query: 448 PPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDD---------- 497
            PE +  +++                 D ++FGV+L E++ G+      D          
Sbjct: 171 APEILLGQKY-------------NHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM 217

Query: 498 SEPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITSTEWEA 547
             P   + L      +       +   R  +R    I    +     WE 
Sbjct: 218 DNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRG--DIRQHPLFREINWEE 265

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  112 bits (281), Expect = 9e-28
 Identities = 62/297 (20%), Positives = 100/297 (33%), Gaps = 66/297 (22%)

Query: 292 NNFDESRIIGRGGFGNVYFGLLGD--REAAIKKMRSNKSK---------EFFAELKVLCK 340
           N+F   RIIGRGGFG VY     D  +  A+K +   + K              L ++  
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 341 IHHINV--FISTF-------------GNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAK 385
                +      F               G L  HL       H   +       A +   
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ-----HGVFSEADMRFYAAEIIL 118

Query: 386 GIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPG 445
           G+E++H+      V+RD+K +NILLD+    +++D GL     +           VGT G
Sbjct: 119 GLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-----PHASVGTHG 170

Query: 446 YLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKMKS 505
           Y+ PE +               +   +  D F+ G +L +L+ G     +  ++      
Sbjct: 171 YMAPEVL------------QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID 218

Query: 506 LITIMAAVAEW-------------CLNEDAVDRPEMRDIVA--ILSQIMITSTEWEA 547
            +T+  AV                 L  D   R       A  +       S +W+ 
Sbjct: 219 RMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQM 275

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (278), Expect = 1e-27
 Identities = 39/279 (13%), Positives = 86/279 (30%), Gaps = 59/279 (21%)

Query: 288 EEATNNFDESRIIGRGGFGNVYFG--LLGDREAAIKKMRSNKSKE--FFAELKVLCKIHH 343
           +E    +  +  +GRG FG V+        +    K ++   + +     E+ +L    H
Sbjct: 1   KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARH 60

Query: 344 INV--FISTF-------------GNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIE 388
            N+     +F                 + + ++         L             + ++
Sbjct: 61  RNILHLHESFESMEELVMIFEFISGLDIFERIN----TSAFELNEREIVSYVHQVCEALQ 116

Query: 389 YIHDHTKARYVHRDIKTSNILLD--DGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGY 446
           ++H H      H DI+  NI+         K+ +FG  +  +  +        L   P Y
Sbjct: 117 FLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN----FRLLFTAPEY 169

Query: 447 LPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE------- 499
             PE                   V+T TD+++ G ++  L++G    + + ++       
Sbjct: 170 YAPEVH-------------QHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIM 216

Query: 500 -------PTKMKSLITIMAAVAEWCLNEDAVDRPEMRDI 531
                      K +        +  L ++   R    + 
Sbjct: 217 NAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEA 255

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  110 bits (276), Expect = 2e-27
 Identities = 51/261 (19%), Positives = 91/261 (34%), Gaps = 50/261 (19%)

Query: 292 NNFDESRIIGRGGFGNVYFG--LLGDREAAIKKMRSNKS------KEFFAELKVLCKIHH 343
            +F   R +G G FG V+        R  A+K ++          +    E  +L  + H
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63

Query: 344 INVFISTFGNGSLSDHLH-----------DPLLKGHQPLTWTARTQIALDAAKGIEYIHD 392
             + I  +G    +  +              LL+  Q          A +    +EY+H 
Sbjct: 64  PFI-IRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS 122

Query: 393 HTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYI 452
                 ++RD+K  NILLD     K+ DFG  K              L GTP Y+ PE +
Sbjct: 123 K---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT------YTLCGTPDYIAPEVV 173

Query: 453 FVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKMKSLITIMAA 512
             K +                 D ++FG+++ E++ G          P    + +     
Sbjct: 174 STKPY-------------NKSIDWWSFGILIYEMLAGYT--------PFYDSNTMKTYEK 212

Query: 513 VAEWCLNEDAVDRPEMRDIVA 533
           +    L        +++D+++
Sbjct: 213 ILNAELRFPPFFNEDVKDLLS 233

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (274), Expect = 5e-27
 Identities = 44/261 (16%), Positives = 86/261 (32%), Gaps = 50/261 (19%)

Query: 297 SRIIGRGGFGNVYFG--LLGDREAAIKKMRSNKSKEFFAELKVLCKI-HHINV--FISTF 351
           S+++G G  G V          + A+K ++     +   E+++  +     ++   +  +
Sbjct: 17  SQVLGLGINGKVLQIFNKRTQEKFALKMLQ--DCPKARREVELHWRASQCPHIVRIVDVY 74

Query: 352 -----------------GNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHT 394
                              G L   + D   +G Q  T    ++I     + I+Y+H   
Sbjct: 75  ENLYAGRKCLLIVMECLDGGELFSRIQD---RGDQAFTEREASEIMKSIGEAIQYLHSI- 130

Query: 395 KARYVHRDIKTSNILLD---DGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEY 451
                HRD+K  N+L          K+ DFG  K     N           TP Y+ PE 
Sbjct: 131 --NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY----TPYYVAPEV 184

Query: 452 IFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKMKSLITIMA 511
           +                +     D+++ GV++  L+ G      +            I  
Sbjct: 185 L-------------GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM 231

Query: 512 AVAEWCLNEDAVDRPEMRDIV 532
              E+   E +    E++ ++
Sbjct: 232 GQYEFPNPEWSEVSEEVKMLI 252

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (271), Expect = 6e-27
 Identities = 53/260 (20%), Positives = 92/260 (35%), Gaps = 50/260 (19%)

Query: 293 NFDESRIIGRGGFGNVYFG--LLGDREAAIKKMRSNKSKE-----FFAELKVLCKIHHIN 345
           NF +   IG G +G VY     L     A+KK+R +   E        E+ +L +++H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62

Query: 346 V--------------FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIH 391
           +               +  F +  L   +          +             +G+ + H
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQDLKKFMD---ASALTGIPLPLIKSYLFQLLQGLAFCH 119

Query: 392 DHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEY 451
            H   R +HRD+K  N+L++     K+ADFGL +            T  V T  Y  PE 
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY---THEVVTLWYRAPEI 173

Query: 452 IFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKMKSLITIMA 511
           +   +              +T  D+++ G + AE++T +              S I  + 
Sbjct: 174 LLGCK------------YYSTAVDIWSLGCIFAEMVTRRA--------LFPGDSEIDQLF 213

Query: 512 AVAEWCLNEDAVDRPEMRDI 531
            +       D V  P +  +
Sbjct: 214 RIFRTLGTPDEVVWPGVTSM 233

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (271), Expect = 6e-27
 Identities = 58/283 (20%), Positives = 94/283 (33%), Gaps = 48/283 (16%)

Query: 298 RIIGRGGFGNVYFG--LLGDREAAIKKMRSNKS--------KEFFAELKVLCKIHHINVF 347
             +G G F  VY       ++  AIKK++            +    E+K+L ++ H N+ 
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNI- 62

Query: 348 ISTFGNGSLSDHL-----------HDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKA 396
           I          ++              +      LT +      L   +G+EY+H H   
Sbjct: 63  IGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH--- 119

Query: 397 RYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKR 456
             +HRD+K +N+LLD+    K+ADFGL K            T  V T  Y  PE +F  R
Sbjct: 120 WILHRDLKPNNLLLDENGVLKLADFGLAK---SFGSPNRAYTHQVVTRWYRAPELLFGAR 176

Query: 457 FRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKMKSLITIMAAVAEW 516
                             D++A G +LAEL+                 S +  +  + E 
Sbjct: 177 ------------MYGVGVDMWAVGCILAELLLRVP--------FLPGDSDLDQLTRIFET 216

Query: 517 CLNEDAVDRPEMRDIVAILSQIMITSTEWEASLGGDSQVFSGL 559
                    P+M  +   ++                      L
Sbjct: 217 LGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDL 259

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  105 bits (263), Expect = 9e-26
 Identities = 50/262 (19%), Positives = 95/262 (36%), Gaps = 43/262 (16%)

Query: 292 NNFDESRIIGRGGFGNVYFG--LLGDREAAIKKMRSNKSKE-----FFAELKVLCKIHHI 344
           + +++   IG+G FG V+        ++ A+KK+     KE        E+K+L  + H 
Sbjct: 10  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69

Query: 345 NV-------FISTFGNGSLSDHL--------HDPLLKGHQPLTWTARTQIALDAAKGIEY 389
           NV                    +        HD        L     ++I       +  
Sbjct: 70  NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNG 129

Query: 390 IHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK-LEERTNEKEMLATRLVGTPGYLP 448
           ++   + + +HRD+K +N+L+      K+ADFGL +      N +    T  V T  Y P
Sbjct: 130 LYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRP 189

Query: 449 PEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKMKSLIT 508
           PE +  +R                  D++  G ++AE+ T             +  +   
Sbjct: 190 PELLLGER------------DYGPPIDLWGAGCIMAEMWTRSP--------IMQGNTEQH 229

Query: 509 IMAAVAEWCLNEDAVDRPEMRD 530
            +A +++ C +      P + +
Sbjct: 230 QLALISQLCGSITPEVWPNVDN 251

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  103 bits (258), Expect = 2e-25
 Identities = 53/235 (22%), Positives = 85/235 (36%), Gaps = 35/235 (14%)

Query: 292 NNFDESRIIGRGGFGNVYFGLLGD-REAAIKKMRSNKSKE-----FFAELKVLCKIHHIN 345
             +     IG G +G VY          A+KK+R  K  E        E+ +L ++ H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61

Query: 346 V--FISTFGNGS--------LSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTK 395
           +                   L   L   L      L         L    GI Y HD   
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR-- 119

Query: 396 ARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVK 455
            R +HRD+K  N+L++     K+ADFGL +       K       + T  Y  P+ +   
Sbjct: 120 -RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT---HEIVTLWYRAPDVLMGS 175

Query: 456 RFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKMKSLITIM 510
           +            + +T  D+++ G + AE++ G   L    SE  ++  +  I+
Sbjct: 176 K------------KYSTTIDIWSVGCIFAEMVNGTP-LFPGVSEADQLMRIFRIL 217

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  104 bits (260), Expect = 2e-25
 Identities = 37/238 (15%), Positives = 90/238 (37%), Gaps = 32/238 (13%)

Query: 292 NNFDESRIIGRGGFGNVYFG--LLGDREAAIKKMRSNKSKEFFAELKVLCKI-HHINV-- 346
           +++   R +GRG +  V+    +  + +  +K ++  K K+   E+K+L  +    N+  
Sbjct: 35  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIIT 94

Query: 347 ---FISTFGNGSLS----DHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYV 399
               +    + + +       +    + +Q LT         +  K ++Y H       +
Sbjct: 95  LADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSM---GIM 151

Query: 400 HRDIKTSNILLD-DGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFR 458
           HRD+K  N+++D +  + ++ D+GL +      E        V +  +  PE +   +  
Sbjct: 152 HRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY----NVRVASRYFKGPELLVDYQM- 206

Query: 459 FDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKMKSLITIMAAVAEW 516
                           D+++ G +LA +I  K           ++  +  ++     +
Sbjct: 207 -----------YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLY 253

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  104 bits (260), Expect = 4e-25
 Identities = 50/287 (17%), Positives = 85/287 (29%), Gaps = 54/287 (18%)

Query: 292 NNFDESRIIGRGGFGNVYFG--LLGDREAAIKKMRSNKS------KEFFAELKVLCKIHH 343
           + FD  + +G G FG V            A+K +   K       +    E ++L  ++ 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100

Query: 344 INV-----------FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHD 392
             +            +           +   L +     +       A       EY+H 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR-IGRFSEPHARFYAAQIVLTFEYLHS 159

Query: 393 HTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYI 452
                 ++RD+K  N+L+D     +V DFG  K  +           L GTP  L PE I
Sbjct: 160 L---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT------WTLCGTPEALAPEII 210

Query: 453 FVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDS----------EPTK 502
                        +        D +A GV++ E+  G      D            +   
Sbjct: 211 -------------LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF 257

Query: 503 MKSLITIMAAVAEWCLNEDAVDRPEMRDIVA--ILSQIMITSTEWEA 547
                + +  +    L  D   R          I +     +T+W A
Sbjct: 258 PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIA 304

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  102 bits (255), Expect = 6e-25
 Identities = 46/236 (19%), Positives = 88/236 (37%), Gaps = 35/236 (14%)

Query: 292 NNFDESRIIGRGGFGNVYFG--LLGDREAAIKKMRSNKSKE-----FFAELKVLCKIHHI 344
             +++   IG G +G V+           A+K++R +   E        E+ +L ++ H 
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61

Query: 345 NV------FISTFGNGSLSDHLHDPLLK----GHQPLTWTARTQIALDAAKGIEYIHDHT 394
           N+        S      + +     L K     +  L             KG+ + H   
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR- 120

Query: 395 KARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFV 454
               +HRD+K  N+L++     K+A+FGL +            +  V T  Y PP+ +F 
Sbjct: 121 --NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC---YSAEVVTLWYRPPDVLFG 175

Query: 455 KRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKMKSLITIM 510
            +              +T  D+++ G + AEL    R L   +    ++K +  ++
Sbjct: 176 AKL------------YSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLL 219

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  101 bits (253), Expect = 3e-24
 Identities = 55/249 (22%), Positives = 91/249 (36%), Gaps = 48/249 (19%)

Query: 282 FSLEEIEEAT----NNFDESRIIGRGGFGNVYFG--LLGDREAAIKKMRSNKSKE----- 330
           F  +E+ +        + + + +G G +G V          + AIKK+      E     
Sbjct: 4   FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63

Query: 331 FFAELKVLCKIHHINVFISTFGNGSLSDHLHDPL---------------LKGHQPLTWTA 375
            + EL++L  + H NV I      +  + L D                 L  H+ L    
Sbjct: 64  AYRELRLLKHMRHENV-IGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDR 122

Query: 376 RTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEM 435
              +     KG+ YIH       +HRD+K  N+ +++    K+ DFGL +  +       
Sbjct: 123 IQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADSE----- 174

Query: 436 LATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIR 495
             T  V T  Y  PE I                + T   D+++ G ++AE+ITGK     
Sbjct: 175 -MTGYVVTRWYRAPEVILNWM------------RYTQTVDIWSVGCIMAEMITGKTLFKG 221

Query: 496 DDSEPTKMK 504
            D      +
Sbjct: 222 SDHLDQLKE 230

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  100 bits (251), Expect = 3e-24
 Identities = 58/309 (18%), Positives = 108/309 (34%), Gaps = 67/309 (21%)

Query: 281 IFSLEEIEEATNNFDESRIIGRGGFGNVYFG--LLGDREAAIKKMRSNKS---------K 329
           +F  E ++   + +D    +G G F  V          + A K ++  ++         +
Sbjct: 2   VFRQENVD---DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRE 58

Query: 330 EFFAELKVLCKIHHINV--FISTFGNGS---------LSDHLHDPLLKGHQPLTWTARTQ 378
           +   E+ +L +I H NV      + N +             L D L +  + LT    T+
Sbjct: 59  DIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE-KESLTEEEATE 117

Query: 379 IALDAAKGIEYIHDHTKARYVHRDIKTSNILLDD----GLRAKVADFGLVKLEERTNEKE 434
                  G+ Y+H     +  H D+K  NI+L D      R K+ DFGL    +  NE  
Sbjct: 118 FLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-- 172

Query: 435 MLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALI 494
                + GTP ++ PE +  +                 + D+++ GV+   L++G    +
Sbjct: 173 --FKNIFGTPEFVAPEIVNYEPL-------------GLEADMWSIGVITYILLSGASPFL 217

Query: 495 RDDSE--------------PTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMI 540
            D  +                   +   +        L +D   R  ++D    L    I
Sbjct: 218 GDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQD---SLQHPWI 274

Query: 541 TSTEWEASL 549
              + + +L
Sbjct: 275 KPKDTQQAL 283

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 97.2 bits (241), Expect = 8e-23
 Identities = 52/295 (17%), Positives = 94/295 (31%), Gaps = 55/295 (18%)

Query: 292 NNFDESRIIGRGGFGNVYFGLLG-----DREAAIKKMRSNK-------SKEFFAELKVLC 339
            NF+  +++G G +G V+           +  A+K ++          ++    E +VL 
Sbjct: 24  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83

Query: 340 KIHHINVFISTFGNGSLSDHLH-----------DPLLKGHQPLTWTARTQIALDAAKGIE 388
            I      ++          LH              L   +  T         +    +E
Sbjct: 84  HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALE 143

Query: 389 YIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLP 448
           ++H       ++RDIK  NILLD      + DFGL K       +        GT  Y+ 
Sbjct: 144 HLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERA--YDFCGTIEYMA 198

Query: 449 PEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKMKSLIT 508
           P+ +       D              D ++ GV++ EL+TG      D  + ++ +    
Sbjct: 199 PDIVRGGDSGHD-----------KAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRR 247

Query: 509 IMAAVAEW--------------CLNEDAVDRPEMRDIVA--ILSQIMITSTEWEA 547
           I+ +   +               L +D   R       A  I   +      W+ 
Sbjct: 248 ILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDD 302

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 88.8 bits (219), Expect = 7e-20
 Identities = 51/243 (20%), Positives = 92/243 (37%), Gaps = 43/243 (17%)

Query: 289 EATNNFDESRIIGRGGFGNVYFG--LLGDREAAIKKMRSNKS-----KEFFAELKVLCKI 341
           E    +     +G G +G+V            A+KK+          K  + EL++L  +
Sbjct: 15  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 74

Query: 342 HHINV-----------FISTFGNGSLSDHLHDPL---LKGHQPLTWTARTQIALDAAKGI 387
            H NV            +  F +  L  HL       +   Q LT      +     +G+
Sbjct: 75  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 134

Query: 388 EYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYL 447
           +YIH       +HRD+K SN+ +++    K+ DFGL +  +      +       T  Y 
Sbjct: 135 KYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV------ATRWYR 185

Query: 448 PPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKMKSLI 507
            PE +               +      D+++ G ++AEL+TG R L        ++K ++
Sbjct: 186 APEIML------------NWMHYNQTVDIWSVGCIMAELLTG-RTLFPGTDHIDQLKLIL 232

Query: 508 TIM 510
            ++
Sbjct: 233 RLV 235

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 88.5 bits (218), Expect = 1e-19
 Identities = 47/233 (20%), Positives = 81/233 (34%), Gaps = 40/233 (17%)

Query: 292 NNFDESRIIGRGGFGNVYFG--LLGDREAAIKKMR-----SNKSKEFFAELKVLCKIHHI 344
             +   + IG G  G V      + DR  AIKK+         +K  + EL ++  ++H 
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76

Query: 345 NV-----FISTFGNGSLSDHL--------HDPLLKGHQPLTWTARTQIALDAAKGIEYIH 391
           N+       +          +         +        L     + +      GI+++H
Sbjct: 77  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 136

Query: 392 DHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEY 451
                  +HRD+K SNI++      K+ DFGL     RT     + T  V T  Y  PE 
Sbjct: 137 SA---GIIHRDLKPSNIVVKSDCTLKILDFGLA----RTAGTSFMMTPYVVTRYYRAPEV 189

Query: 452 IFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKMK 504
           I             + +      D+++ G ++ E++  K      D      K
Sbjct: 190 I-------------LGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK 229

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 83.9 bits (206), Expect = 4e-18
 Identities = 42/235 (17%), Positives = 80/235 (34%), Gaps = 47/235 (20%)

Query: 298 RIIGRGGFGNVYFG--LLGDREAAIKKMRSNK--SKEFFAELKVLCKIHHIN-------- 345
           R +G G F  V+    ++ +   A+K +R +K  ++    E+K+L +++  +        
Sbjct: 19  RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 78

Query: 346 ---------VFISTFGNGSL---------SDHLHDPLLKGHQPLTWTARTQIALDAAKGI 387
                     F     NG            + L       H+ +      QI+     G+
Sbjct: 79  ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138

Query: 388 EYIHDHTKARYVHRDIKTSNILLD-DGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGY 446
           +Y+H       +H DIK  N+L++       +    +  L       E   T  + T  Y
Sbjct: 139 DYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH-YTNSIQTREY 195

Query: 447 LPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPT 501
             PE +    +                 D+++   ++ ELITG      D+    
Sbjct: 196 RSPEVLLGAPW-------------GCGADIWSTACLIFELITGDFLFEPDEGHSY 237

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 72.5 bits (177), Expect = 3e-15
 Identities = 25/196 (12%), Positives = 59/196 (30%), Gaps = 37/196 (18%)

Query: 298 RIIGRGGFGNVYFGLLGD-REAAIKKMRSNKS---------------------KEFFAEL 335
           +++G G    V+        E  +K  +   +                     +    E 
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 336 KVLCKIHHINVFIS-TFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHT 394
           + L K+  + V     +   ++   L D        +       +     + +   +   
Sbjct: 66  RALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDE--VLDMILEEVAKFYHR- 122

Query: 395 KARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFV 454
               VH D+   N+L+ +     + DF           +E+L   +     Y      F 
Sbjct: 123 --GIVHGDLSQYNVLVSEE-GIWIIDFPQSVEVGEEGWREILERDVRNIITY------FS 173

Query: 455 KRFRF--DMHSSVMEL 468
           + +R   D++S++  +
Sbjct: 174 RTYRTEKDINSAIDRI 189

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	563
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.84
d1y7ma2	48	Hypothetical protein YkuD, N-terminal domain {Baci	97.81
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	97.7
d1e0ga_	48	Membrane-bound lytic murein transclycosylase D, Ml	97.37
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	96.77
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.36
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	95.69
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	95.21
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	94.58
d1y7ma2	48	Hypothetical protein YkuD, N-terminal domain {Baci	94.52
d1e0ga_	48	Membrane-bound lytic murein transclycosylase D, Ml	93.28

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-50  Score=400.03  Aligned_cols=232  Identities=28%  Similarity=0.458  Sum_probs=190.0

Q ss_pred             hcCCCccceecccCcEEEEEEEECCceEEEEEeccC-----ChHHHHHHHHHHHhccccce--------------EEEee
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLLGDREAAIKKMRSN-----KSKEFFAELKVLCKIHHINV--------------FISTF  351 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~vavK~~~~~-----~~~~f~~Ei~~l~~l~H~ni--------------V~e~~  351 (563)
                      .++|+..+.||+|+||.||+|++++ .||||+++..     ..++|.+|+++|++++||||              |+||+
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~lv~Ey~   85 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLAIVTQWC   85 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESSS-EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEEECC
T ss_pred             cccEEEEEEEeeCCCcEEEEEEECC-EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEeccEEEEEEecC
Confidence            4678889999999999999998765 5999998643     23679999999999999998              68999


Q ss_pred             cCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccccccc
Q 044997          352 GNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTN  431 (563)
Q Consensus       352 ~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~  431 (563)
                      ++|+|.+++..    ....++|..++.|+.|+|+||+|||+++   ||||||||+|||+++++.+||+|||+|+......
T Consensus        86 ~~g~L~~~l~~----~~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~  158 (276)
T d1uwha_          86 EGSSLYHHLHI----IETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS  158 (276)
T ss_dssp             CEEEHHHHHHT----SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred             CCCCHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence            99999999975    2356999999999999999999999987   9999999999999999999999999998765432


Q ss_pred             ccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCch----------
Q 044997          432 EKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPT----------  501 (563)
Q Consensus       432 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~----------  501 (563)
                      .. .......||+.|||||++.+..          ...++.++|||||||++|||+||+.||........          
T Consensus       159 ~~-~~~~~~~gt~~y~APE~l~~~~----------~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~  227 (276)
T d1uwha_         159 GS-HQFEQLSGSILWMAPEVIRMQD----------KNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYL  227 (276)
T ss_dssp             --------CCCCGGGCCHHHHTTCS----------SCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSC
T ss_pred             Cc-ccccccccCcccCCHHHHhccc----------CCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCC
Confidence            21 2234567999999999986432          23468999999999999999999999975433211          


Q ss_pred             ------hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 044997          502 ------KMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMIT  541 (563)
Q Consensus       502 ------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~  541 (563)
                            ....+++.+.+|+.+||+.||.+||||+||++.|+.+.++
T Consensus       228 ~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~  273 (276)
T d1uwha_         228 SPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS  273 (276)
T ss_dssp             CCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             CCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence                  1123456799999999999999999999999999988764

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-49  Score=396.10  Aligned_cols=231  Identities=27%  Similarity=0.494  Sum_probs=194.6

Q ss_pred             hcCCCccceecccCcEEEEEEEEC-CceEEEEEeccC--ChHHHHHHHHHHHhccccce--------------EEEeecC
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLLG-DREAAIKKMRSN--KSKEFFAELKVLCKIHHINV--------------FISTFGN  353 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~~-~~~vavK~~~~~--~~~~f~~Ei~~l~~l~H~ni--------------V~e~~~~  353 (563)
                      .++|+..+.||+|+||.||+|+++ ++.||||+++..  ..++|.+|+++|++++||||              |+||+++
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~iv~Ey~~~   91 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMEN   91 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEEECCTT
T ss_pred             HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeeccCCeEEEEEeCCC
Confidence            457888999999999999999996 578999999754  35789999999999999997              6899999


Q ss_pred             CCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccccccccc
Q 044997          354 GSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEK  433 (563)
Q Consensus       354 gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~  433 (563)
                      |+|.+++...   ....++|.++++|+.||++||+|||+++   |+||||||+||||++++.+||+|||+|+....... 
T Consensus        92 g~L~~~~~~~---~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~-  164 (272)
T d1qpca_          92 GSLVDFLKTP---SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-  164 (272)
T ss_dssp             CBHHHHTTSH---HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE-
T ss_pred             CcHHHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCcc-
Confidence            9999988653   2346999999999999999999999987   99999999999999999999999999987654322 


Q ss_pred             ccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc------------h
Q 044997          434 EMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP------------T  501 (563)
Q Consensus       434 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~------------~  501 (563)
                       .......||+.|||||++..+.+             +.++|||||||++|||+||+.|+.......            .
T Consensus       165 -~~~~~~~gt~~y~APE~~~~~~~-------------~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~  230 (272)
T d1qpca_         165 -TAREGAKFPIKWTAPEAINYGTF-------------TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMV  230 (272)
T ss_dssp             -ECCTTCCCCTTTSCHHHHHHCEE-------------CHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC
T ss_pred             -ccccccCCcccccChHHHhCCCC-------------CchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC
Confidence             22344678999999999866554             899999999999999999877765433221            1


Q ss_pred             hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcC
Q 044997          502 KMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITS  542 (563)
Q Consensus       502 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~  542 (563)
                      .+..+++.+.+|+.+||+.||++||||+||++.|+++++++
T Consensus       231 ~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ftst  271 (272)
T d1qpca_         231 RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT  271 (272)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             CcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhcC
Confidence            22345567999999999999999999999999999988754

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.3e-49  Score=388.60  Aligned_cols=228  Identities=24%  Similarity=0.402  Sum_probs=182.2

Q ss_pred             cCCCccceecccCcEEEEEEEEC-CceEEEEEeccC--ChHHHHHHHHHHHhccccce---------------EEEeecC
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG-DREAAIKKMRSN--KSKEFFAELKVLCKIHHINV---------------FISTFGN  353 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~vavK~~~~~--~~~~f~~Ei~~l~~l~H~ni---------------V~e~~~~  353 (563)
                      ++|+..+.||+|+||.||+|++. ++.||||+++..  ..++|.+|++++++++||||               |+||+++
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~   84 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEH   84 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCC
Confidence            46788899999999999999985 678999999754  35789999999999999998               6899999


Q ss_pred             CCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccccccccc
Q 044997          354 GSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEK  433 (563)
Q Consensus       354 gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~  433 (563)
                      |+|.+++..    ....++|..++.++.|+|+||+|||+++   |+||||||+|||+|+++.+||+|||+++........
T Consensus        85 g~L~~~l~~----~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~  157 (263)
T d1sm2a_          85 GCLSDYLRT----QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT  157 (263)
T ss_dssp             CBHHHHHHT----TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC-----------
T ss_pred             CcHHHHhhc----cccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCce
Confidence            999999875    3467999999999999999999999987   999999999999999999999999999865433221


Q ss_pred             ccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCchh-----------
Q 044997          434 EMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTK-----------  502 (563)
Q Consensus       434 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~~-----------  502 (563)
                        ......||+.|+|||++.+..             ++.++|||||||++|||+|++.|+.........           
T Consensus       158 --~~~~~~gt~~y~aPE~l~~~~-------------~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~  222 (263)
T d1sm2a_         158 --SSTGTKFPVKWASPEVFSFSR-------------YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLY  222 (263)
T ss_dssp             ---------CTTSCCHHHHTTCC-------------CCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCC
T ss_pred             --eecceecCcccCChHHhcCCC-------------CCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCC
Confidence              223357899999999986554             489999999999999999976665443322111           


Q ss_pred             -hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 044997          503 -MKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMIT  541 (563)
Q Consensus       503 -~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~  541 (563)
                       +...++.+.+++.+||+.||++||||+||++.|+++.++
T Consensus       223 ~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es  262 (263)
T d1sm2a_         223 KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES  262 (263)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence             123345689999999999999999999999999999765

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=7.2e-49  Score=396.15  Aligned_cols=230  Identities=27%  Similarity=0.437  Sum_probs=178.2

Q ss_pred             CCCccceecccCcEEEEEEEEC--C---ceEEEEEeccCC----hHHHHHHHHHHHhccccce---------------EE
Q 044997          293 NFDESRIIGRGGFGNVYFGLLG--D---REAAIKKMRSNK----SKEFFAELKVLCKIHHINV---------------FI  348 (563)
Q Consensus       293 ~f~~~~~LG~G~fG~Vy~g~~~--~---~~vavK~~~~~~----~~~f~~Ei~~l~~l~H~ni---------------V~  348 (563)
                      +|+..++||+|+||.||+|++.  +   ..||||.+....    .++|.+|+++|++++||||               |+
T Consensus        27 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~  106 (299)
T d1jpaa_          27 CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIIT  106 (299)
T ss_dssp             GEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             hcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEE
Confidence            4555689999999999999874  2   258999986543    3579999999999999998               58


Q ss_pred             EeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccc
Q 044997          349 STFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEE  428 (563)
Q Consensus       349 e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~  428 (563)
                      ||+++|+|.+++..    ....++|.+++.++.|+|+||+|||+++   |+||||||+||||++++++||+|||+++...
T Consensus       107 Ey~~~g~L~~~~~~----~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~  179 (299)
T d1jpaa_         107 EFMENGSLDSFLRQ----NDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLE  179 (299)
T ss_dssp             ECCTTEEHHHHHHT----TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             EecCCCcceeeecc----ccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEcc
Confidence            99999999998865    2456999999999999999999999987   9999999999999999999999999998765


Q ss_pred             cccccccc--cccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCCCcCCCCC------
Q 044997          429 RTNEKEML--ATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIRDDSE------  499 (563)
Q Consensus       429 ~~~~~~~~--~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p~~~~~~~------  499 (563)
                      ........  .....||+.|||||.+.++.             ++.++|||||||++|||+| |+.||......      
T Consensus       180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-------------~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i  246 (299)
T d1jpaa_         180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRK-------------FTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAI  246 (299)
T ss_dssp             ----------------CGGGSCHHHHHSCC-------------CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH
T ss_pred             CCCCcceeeecccccCCccccCHHHHhcCC-------------CCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            43222111  12245789999999886544             4899999999999999998 88888653321      


Q ss_pred             -----chhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcC
Q 044997          500 -----PTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITS  542 (563)
Q Consensus       500 -----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~  542 (563)
                           ......+++.+.+|+.+||+.||.+||||.||++.|+++++++
T Consensus       247 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~p  294 (299)
T d1jpaa_         247 EQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNP  294 (299)
T ss_dssp             HTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred             HcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcCh
Confidence                 1122344567899999999999999999999999999998753

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4.6e-49  Score=395.24  Aligned_cols=235  Identities=23%  Similarity=0.361  Sum_probs=196.4

Q ss_pred             HHHHhcCCCccceecccCcEEEEEEEEC--CceEEEEEeccC--ChHHHHHHHHHHHhccccce---------------E
Q 044997          287 IEEATNNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSN--KSKEFFAELKVLCKIHHINV---------------F  347 (563)
Q Consensus       287 l~~~~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~--~~~~f~~Ei~~l~~l~H~ni---------------V  347 (563)
                      ++...++|+..+.||+|+||.||+|++.  ++.||||+++.+  ..++|.+|+++|++++||||               |
T Consensus        12 wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv   91 (287)
T d1opja_          12 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII   91 (287)
T ss_dssp             TBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred             cEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEE
Confidence            3334567888999999999999999984  678999999754  35789999999999999998               5


Q ss_pred             EEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccc
Q 044997          348 ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLE  427 (563)
Q Consensus       348 ~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~  427 (563)
                      +||+++|+|.+++..   .....++|..++.|+.|+++||+|||+++   |+||||||+|||+++++.+||+|||+|+..
T Consensus        92 ~E~~~~g~l~~~l~~---~~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~  165 (287)
T d1opja_          92 TEFMTYGNLLDYLRE---CNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLM  165 (287)
T ss_dssp             EECCTTCBHHHHHHH---SCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTC
T ss_pred             eecccCcchHHHhhh---ccccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeec
Confidence            899999999999875   23567999999999999999999999987   999999999999999999999999999875


Q ss_pred             ccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc-------
Q 044997          428 ERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP-------  500 (563)
Q Consensus       428 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~-------  500 (563)
                      .....  .......|++.|+|||++.+..             ++.++|||||||++|||++|+.|+.......       
T Consensus       166 ~~~~~--~~~~~~~g~~~y~aPE~~~~~~-------------~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~  230 (287)
T d1opja_         166 TGDTY--TAHAGAKFPIKWTAPESLAYNK-------------FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE  230 (287)
T ss_dssp             CSSSS--EEETTEEECGGGCCHHHHHHCC-------------CSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH
T ss_pred             CCCCc--eeeccccccccccChHHHcCCC-------------CCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHh
Confidence            43322  1223356889999999886554             4899999999999999999888775443321       


Q ss_pred             -----hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcC
Q 044997          501 -----TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITS  542 (563)
Q Consensus       501 -----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~  542 (563)
                           .....+++.+.+|+.+||+.||.+|||+.||++.|+.+.+.+
T Consensus       231 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~~  277 (287)
T d1opja_         231 KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES  277 (287)
T ss_dssp             TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSSS
T ss_pred             cCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhC
Confidence                 122345567999999999999999999999999999987654

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-48  Score=387.20  Aligned_cols=229  Identities=21%  Similarity=0.365  Sum_probs=190.8

Q ss_pred             cCCCccc-eecccCcEEEEEEEEC----CceEEEEEeccCC----hHHHHHHHHHHHhccccce--------------EE
Q 044997          292 NNFDESR-IIGRGGFGNVYFGLLG----DREAAIKKMRSNK----SKEFFAELKVLCKIHHINV--------------FI  348 (563)
Q Consensus       292 ~~f~~~~-~LG~G~fG~Vy~g~~~----~~~vavK~~~~~~----~~~f~~Ei~~l~~l~H~ni--------------V~  348 (563)
                      ++|...+ +||+|+||.||+|.+.    +..||||.++...    .++|.+|+++|++++||||              |+
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~lvm   87 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVM   87 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccCeEEEEE
Confidence            3455566 4999999999999763    3469999997543    3679999999999999998              68


Q ss_pred             EeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccc
Q 044997          349 STFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEE  428 (563)
Q Consensus       349 e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~  428 (563)
                      ||+++|+|.+++..    ....++|.++..++.|+++||+|||+++   |+||||||+|||+++++.+||+|||+++...
T Consensus        88 E~~~~g~L~~~l~~----~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~  160 (285)
T d1u59a_          88 EMAGGGPLHKFLVG----KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALG  160 (285)
T ss_dssp             ECCTTEEHHHHHTT----CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred             EeCCCCcHHHHhhc----cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhccc
Confidence            99999999998864    2457999999999999999999999987   9999999999999999999999999999765


Q ss_pred             cccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCCCcCCCCC--------
Q 044997          429 RTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIRDDSE--------  499 (563)
Q Consensus       429 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p~~~~~~~--------  499 (563)
                      .............||+.|+|||++..+.+             +.++|||||||++|||+| |+.||......        
T Consensus       161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-------------~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~  227 (285)
T d1u59a_         161 ADDSYYTARSAGKWPLKWYAPECINFRKF-------------SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ  227 (285)
T ss_dssp             TCSCEECCCCSSCCCGGGCCHHHHHHCEE-------------CHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHT
T ss_pred             ccccccccccccccCccccChHHHhCCCC-------------CccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence            54433333344678999999999866554             889999999999999998 89998654321        


Q ss_pred             ---chhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhh
Q 044997          500 ---PTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMI  540 (563)
Q Consensus       500 ---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~  540 (563)
                         ...+..+++.+.+|+.+||+.||++||||.+|++.|+.+..
T Consensus       228 ~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~  271 (285)
T d1u59a_         228 GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY  271 (285)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence               12223456679999999999999999999999999987764

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-48  Score=386.49  Aligned_cols=231  Identities=26%  Similarity=0.447  Sum_probs=182.6

Q ss_pred             cCCCccceecccCcEEEEEEEECC------ceEEEEEeccCC----hHHHHHHHHHHHhccccce---------------
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLGD------REAAIKKMRSNK----SKEFFAELKVLCKIHHINV---------------  346 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~~------~~vavK~~~~~~----~~~f~~Ei~~l~~l~H~ni---------------  346 (563)
                      +.|+..++||+|+||.||+|++++      ..||||+++...    .++|.+|+++|++++||||               
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~   86 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI   86 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence            457788999999999999998743      369999997543    3468999999999999998               


Q ss_pred             EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcc
Q 044997          347 FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKL  426 (563)
Q Consensus       347 V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~  426 (563)
                      |+||+.+|++.+++..    ....++|.+++.++.|++.||+|||+++   |+||||||+||||++++.+||+|||+++.
T Consensus        87 v~e~~~~~~l~~~~~~----~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~  159 (283)
T d1mqba_          87 ITEYMENGALDKFLRE----KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRV  159 (283)
T ss_dssp             EEECCTTEEHHHHHHH----TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred             EEEecccCcchhhhhc----ccccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhc
Confidence            5789999998887764    3467999999999999999999999987   99999999999999999999999999987


Q ss_pred             cccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc------
Q 044997          427 EERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP------  500 (563)
Q Consensus       427 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~------  500 (563)
                      ...............||+.|||||++.++.             ++.++|||||||++|||++|+.|+.......      
T Consensus       160 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~-------------~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i  226 (283)
T d1mqba_         160 LEDDPEATYTTSGGKIPIRWTAPEAISYRK-------------FTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI  226 (283)
T ss_dssp             --------------CCCGGGSCHHHHHSCC-------------CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH
T ss_pred             ccCCCccceEeccCCCCccccCHHHHccCC-------------CCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHH
Confidence            654433222333456899999999886554             4899999999999999999877765443221      


Q ss_pred             ------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcC
Q 044997          501 ------TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITS  542 (563)
Q Consensus       501 ------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~  542 (563)
                            .....++..+.+|+.+||+.||++||||.||++.|+++++..
T Consensus       227 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p  274 (283)
T d1mqba_         227 NDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP  274 (283)
T ss_dssp             HTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred             hccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhCc
Confidence                  112234566999999999999999999999999999998753

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.1e-48  Score=382.61  Aligned_cols=221  Identities=24%  Similarity=0.398  Sum_probs=186.2

Q ss_pred             cCCCccceecccCcEEEEEEEEC--CceEEEEEeccCC----hHHHHHHHHHHHhccccce---------------EEEe
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNK----SKEFFAELKVLCKIHHINV---------------FIST  350 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~----~~~f~~Ei~~l~~l~H~ni---------------V~e~  350 (563)
                      ++|+..+.||+|+||.||+|+..  ++.||||+++...    .+++.+|+++|++++||||               ||||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy   84 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   84 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence            57889999999999999999874  7899999986542    3568999999999999998               6899


Q ss_pred             ecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccccc
Q 044997          351 FGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERT  430 (563)
Q Consensus       351 ~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~  430 (563)
                      +++|+|.+++..     ...+++.++..++.|+++||+|||+++   |+||||||+|||+++++++||+|||+|+.....
T Consensus        85 ~~gg~L~~~l~~-----~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~  156 (271)
T d1nvra_          85 CSGGELFDRIEP-----DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYN  156 (271)
T ss_dssp             CTTEEGGGGSBT-----TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEET
T ss_pred             cCCCcHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccC
Confidence            999999999864     357999999999999999999999998   999999999999999999999999999876543


Q ss_pred             cccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCch---------
Q 044997          431 NEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPT---------  501 (563)
Q Consensus       431 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~---------  501 (563)
                      ... ...+..+||+.|||||++.+..+            ++.++|||||||++|||++|+.||........         
T Consensus       157 ~~~-~~~~~~~GT~~Y~APE~~~~~~~------------~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~  223 (271)
T d1nvra_         157 NRE-RLLNKMCGTLPYVAPELLKRREF------------HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK  223 (271)
T ss_dssp             TEE-CCBCCCCSCGGGSCTHHHHCSSB------------CHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTC
T ss_pred             Ccc-ccccceeeCcCccCHhHhcCCCC------------CCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC
Confidence            322 23345789999999999866554            26789999999999999999999975543221         


Q ss_pred             ----hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          502 ----KMKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       502 ----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                          ....+++.+.+|+.+||+.||++|||++|+++
T Consensus       224 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         224 TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence                12345667899999999999999999999865

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.2e-48  Score=384.13  Aligned_cols=223  Identities=22%  Similarity=0.359  Sum_probs=184.3

Q ss_pred             ceecccCcEEEEEEEEC----CceEEEEEeccCC-----hHHHHHHHHHHHhccccce--------------EEEeecCC
Q 044997          298 RIIGRGGFGNVYFGLLG----DREAAIKKMRSNK-----SKEFFAELKVLCKIHHINV--------------FISTFGNG  354 (563)
Q Consensus       298 ~~LG~G~fG~Vy~g~~~----~~~vavK~~~~~~-----~~~f~~Ei~~l~~l~H~ni--------------V~e~~~~g  354 (563)
                      ++||+|+||.||+|.+.    ++.||||+++...     .++|.+|+++|++++||||              |+||+++|
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~~~~lvmE~~~~g   92 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELG   92 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESSSEEEEEECCTTE
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccCCEEEEEEcCCCC
Confidence            57999999999999873    3579999986432     3579999999999999997              68999999


Q ss_pred             CcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccccccccc
Q 044997          355 SLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKE  434 (563)
Q Consensus       355 sL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~  434 (563)
                      +|.+++..     ...++|..++.++.||+.||+|||+++   |+||||||+|||+++++.+||+|||+++.........
T Consensus        93 ~L~~~l~~-----~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~  164 (277)
T d1xbba_          93 PLNKYLQQ-----NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY  164 (277)
T ss_dssp             EHHHHHHH-----CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred             cHHHHHhh-----ccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence            99999875     467999999999999999999999987   9999999999999999999999999998765443333


Q ss_pred             cccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCCCcCCCC-----------Cchh
Q 044997          435 MLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIRDDS-----------EPTK  502 (563)
Q Consensus       435 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p~~~~~~-----------~~~~  502 (563)
                      .......||+.|||||.+.+..+             +.++|||||||++|||+| |+.||.....           ....
T Consensus       165 ~~~~~~~gt~~y~APE~l~~~~~-------------~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~  231 (277)
T d1xbba_         165 KAQTHGKWPVKWYAPECINYYKF-------------SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGC  231 (277)
T ss_dssp             EC----CCCGGGCCHHHHHHCEE-------------EHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC
T ss_pred             ccccccCCCceecCchhhcCCCC-------------CchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence            33344678999999999876554             789999999999999998 8999865331           1122


Q ss_pred             hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 044997          503 MKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMIT  541 (563)
Q Consensus       503 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~  541 (563)
                      +..+++.+.+|+.+||+.||++|||+++|++.|+.....
T Consensus       232 p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~  270 (277)
T d1xbba_         232 PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD  270 (277)
T ss_dssp             CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             CcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence            234567799999999999999999999999999887654

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.2e-47  Score=372.49  Aligned_cols=225  Identities=23%  Similarity=0.406  Sum_probs=189.2

Q ss_pred             cCCCccceecccCcEEEEEEEEC-CceEEEEEeccC--ChHHHHHHHHHHHhccccce---------------EEEeecC
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG-DREAAIKKMRSN--KSKEFFAELKVLCKIHHINV---------------FISTFGN  353 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~vavK~~~~~--~~~~f~~Ei~~l~~l~H~ni---------------V~e~~~~  353 (563)
                      ++|+..+.||+|+||.||+|+++ ++.||||+++..  ..++|.+|++++++++||||               |+||+++
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~   83 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMAN   83 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTT
T ss_pred             HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCC
Confidence            57889999999999999999996 568999999754  45789999999999999998               5799999


Q ss_pred             CCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccccccccc
Q 044997          354 GSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEK  433 (563)
Q Consensus       354 gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~  433 (563)
                      |+|.+++...    ...++|..+.+++.|+++||+|||+++   |+||||||+|||+++++.+||+|||+++........
T Consensus        84 g~l~~~~~~~----~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~  156 (258)
T d1k2pa_          84 GCLLNYLREM----RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT  156 (258)
T ss_dssp             EEHHHHHHSG----GGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC
T ss_pred             CcHHHhhhcc----ccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCce
Confidence            9999987652    456899999999999999999999987   999999999999999999999999999865543221


Q ss_pred             ccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCCCcCCCCC-----------ch
Q 044997          434 EMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIRDDSE-----------PT  501 (563)
Q Consensus       434 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p~~~~~~~-----------~~  501 (563)
                        ......||+.|+|||.+....             ++.++|||||||++|||+| |+.||......           ..
T Consensus       157 --~~~~~~~t~~y~aPE~~~~~~-------------~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~  221 (258)
T d1k2pa_         157 --SSVGSKFPVRWSPPEVLMYSK-------------FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLY  221 (258)
T ss_dssp             --CCCCSCCCGGGCCHHHHHHCC-------------CCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCC
T ss_pred             --eecccCCCCCcCCcHHhcCCC-------------CCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCC
Confidence              233457899999999986554             4899999999999999998 78888654321           11


Q ss_pred             hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 044997          502 KMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQI  538 (563)
Q Consensus       502 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  538 (563)
                      .+...++.+.+|+.+||+.||++|||++||++.|.+|
T Consensus       222 ~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di  258 (258)
T d1k2pa_         222 RPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV  258 (258)
T ss_dssp             CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred             CcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence            1223345689999999999999999999999998653

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.5e-47  Score=384.32  Aligned_cols=238  Identities=26%  Similarity=0.407  Sum_probs=191.3

Q ss_pred             HHHHHhcCCCccceecccCcEEEEEEEECC-------ceEEEEEeccCC----hHHHHHHHHHHHhccccce--------
Q 044997          286 EIEEATNNFDESRIIGRGGFGNVYFGLLGD-------REAAIKKMRSNK----SKEFFAELKVLCKIHHINV--------  346 (563)
Q Consensus       286 el~~~~~~f~~~~~LG~G~fG~Vy~g~~~~-------~~vavK~~~~~~----~~~f~~Ei~~l~~l~H~ni--------  346 (563)
                      +++..+++|+..+.||+|+||.||+|++.+       +.||||+++...    .++|.+|+++|++++||||        
T Consensus         7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~   86 (301)
T d1lufa_           7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA   86 (301)
T ss_dssp             HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence            344456789999999999999999998743       679999997543    3579999999999999998        


Q ss_pred             -------EEEeecCCCccccccccc-------------------ccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEe
Q 044997          347 -------FISTFGNGSLSDHLHDPL-------------------LKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVH  400 (563)
Q Consensus       347 -------V~e~~~~gsL~~~L~~~~-------------------~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH  400 (563)
                             ++||+++|+|.++++...                   ......++|.+++.|+.|++.||+|||+++   +||
T Consensus        87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivH  163 (301)
T d1lufa_          87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVH  163 (301)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEe
Confidence                   579999999999886421                   112345899999999999999999999987   999


Q ss_pred             CCCCCCCeEecCCCcEEEeecCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHH
Q 044997          401 RDIKTSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFG  480 (563)
Q Consensus       401 rDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfG  480 (563)
                      |||||+|||+|.++.+||+|||+|+....... ....+...||+.|+|||.+.+..             ++.++||||||
T Consensus       164 rDlKp~NILld~~~~~Kl~DFGls~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~-------------~t~ksDVwS~G  229 (301)
T d1lufa_         164 RDLATRNCLVGENMVVKIADFGLSRNIYSADY-YKADGNDAIPIRWMPPESIFYNR-------------YTTESDVWAYG  229 (301)
T ss_dssp             SCCSGGGEEECGGGCEEECCCSCHHHHTGGGC-BC----CCBCGGGCCHHHHHHCC-------------CCHHHHHHHHH
T ss_pred             eEEcccceEECCCCcEEEccchhheeccCCcc-ccccCCCCcCcCcCCHHHHccCC-------------CChhhhhccch
Confidence            99999999999999999999999986543322 22234467899999999986554             48999999999


Q ss_pred             HHHHHHHcCCC-CCcCCCCC-----------chhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhh
Q 044997          481 VVLAELITGKR-ALIRDDSE-----------PTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMI  540 (563)
Q Consensus       481 vvl~Elltg~~-p~~~~~~~-----------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~  540 (563)
                      |++|||++|.. ||......           +..+..++..+.+|+.+||+.||++||||.||++.|+++.+
T Consensus       230 vvl~ell~~~~~p~~~~~~~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~  301 (301)
T d1lufa_         230 VVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE  301 (301)
T ss_dssp             HHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             hhHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            99999999975 45433211           11223455679999999999999999999999999998853

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.9e-47  Score=373.92  Aligned_cols=216  Identities=25%  Similarity=0.401  Sum_probs=184.3

Q ss_pred             cCCCccceecccCcEEEEEEEEC--CceEEEEEecc------CChHHHHHHHHHHHhccccce---------------EE
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRS------NKSKEFFAELKVLCKIHHINV---------------FI  348 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~------~~~~~f~~Ei~~l~~l~H~ni---------------V~  348 (563)
                      ++|+..+.||+|+||.||+|+..  ++.||+|.+..      ...+.+.+|+++|++++||||               |+
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            46889999999999999999984  68899999853      234678999999999999997               68


Q ss_pred             EeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccc
Q 044997          349 STFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEE  428 (563)
Q Consensus       349 e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~  428 (563)
                      ||+++|+|.+++..     ...+++.++..++.|+++||+|||+++   |+||||||+|||+++++++||+|||+|+...
T Consensus        86 Ey~~~g~L~~~l~~-----~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~  157 (263)
T d2j4za1          86 EYAPLGTVYRELQK-----LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP  157 (263)
T ss_dssp             ECCTTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCC
T ss_pred             eecCCCcHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecC
Confidence            99999999999875     356999999999999999999999997   9999999999999999999999999998654


Q ss_pred             cccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc--------
Q 044997          429 RTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP--------  500 (563)
Q Consensus       429 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~--------  500 (563)
                      ..     ......||+.|||||++.+..|             +.++|||||||++|||++|+.||.......        
T Consensus       158 ~~-----~~~~~~Gt~~Y~APE~~~~~~~-------------~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~  219 (263)
T d2j4za1         158 SS-----RRTTLCGTLDYLPPEMIEGRMH-------------DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV  219 (263)
T ss_dssp             CC-----CCEETTEEGGGCCHHHHTTCCC-------------CTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT
T ss_pred             CC-----cccccCCCCcccCHHHHcCCCC-------------CchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence            32     1234579999999999866544             889999999999999999999996543211        


Q ss_pred             --hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          501 --TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       501 --~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                        ..+..+++.+.+|+.+||+.||.+|||++|+++
T Consensus       220 ~~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         220 EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence              112234567999999999999999999999986

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-46  Score=376.46  Aligned_cols=217  Identities=24%  Similarity=0.453  Sum_probs=185.4

Q ss_pred             cCCCccceecccCcEEEEEEEE--CCceEEEEEeccC---ChHHHHHHHHHHHhccccce---------------EEEee
Q 044997          292 NNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSN---KSKEFFAELKVLCKIHHINV---------------FISTF  351 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~---~~~~f~~Ei~~l~~l~H~ni---------------V~e~~  351 (563)
                      ++|+..+.||+|+||.||+|+.  +++.||||+++..   ..+.+.+|+++|++++||||               ||||+
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~   99 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence            4699999999999999999986  4889999998643   34679999999999999997               68999


Q ss_pred             cCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccccccc
Q 044997          352 GNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTN  431 (563)
Q Consensus       352 ~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~  431 (563)
                      ++|+|.+++..      ..+++.++..++.|++.||+|||+++   |+||||||+|||++.++++||+|||+|+......
T Consensus       100 ~gg~L~~~~~~------~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~  170 (293)
T d1yhwa1         100 AGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  170 (293)
T ss_dssp             TTCBHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             CCCcHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeecccc
Confidence            99999987754      45999999999999999999999998   9999999999999999999999999998654332


Q ss_pred             ccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCC------------
Q 044997          432 EKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE------------  499 (563)
Q Consensus       432 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~------------  499 (563)
                      .   .....+||+.|+|||++.+..|             +.++|||||||++|||++|+.||......            
T Consensus       171 ~---~~~~~~gt~~Y~aPE~~~~~~~-------------~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~  234 (293)
T d1yhwa1         171 S---KRSTMVGTPYWMAPEVVTRKAY-------------GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP  234 (293)
T ss_dssp             C---CBCCCCSCGGGCCHHHHSSSCB-------------CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSC
T ss_pred             c---cccccccCCCccChhhhcCCCC-------------CchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCC
Confidence            1   2344679999999999866554             88999999999999999999999654321            


Q ss_pred             -chhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          500 -PTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       500 -~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                       ......+.+.+.+|+.+||+.||.+|||+.|+++
T Consensus       235 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         235 ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             CCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             CCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             1122345667999999999999999999999875

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-47  Score=378.68  Aligned_cols=225  Identities=20%  Similarity=0.325  Sum_probs=176.7

Q ss_pred             cCCCccceecccCcEEEEEEEEC--CceEEEEEeccCC-----hHHHHHHHHHHHhccccce-----------------E
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNK-----SKEFFAELKVLCKIHHINV-----------------F  347 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~-----~~~f~~Ei~~l~~l~H~ni-----------------V  347 (563)
                      ++|+..+.||+|+||.||+|+..  ++.||||.++...     .+.|.+|+++|++++||||                 |
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            57889999999999999999874  7889999986543     2558899999999999997                 5


Q ss_pred             EEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCC--CceEeCCCCCCCeEecCCCcEEEeecCCCc
Q 044997          348 ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTK--ARYVHRDIKTSNILLDDGLRAKVADFGLVK  425 (563)
Q Consensus       348 ~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~--~~ivHrDLk~~NILl~~~~~~kl~DFGla~  425 (563)
                      +||+++|+|.+++.... .....+++..++.++.|++.||+|||+++.  .+|+||||||+|||+++++.+||+|||+|+
T Consensus        84 mEy~~~g~L~~~i~~~~-~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~  162 (269)
T d2java1          84 MEYCEGGDLASVITKGT-KERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  162 (269)
T ss_dssp             EECCTTEEHHHHHHHHH-HHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred             EecCCCCcHHHHHHhcc-ccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence            79999999999986422 234679999999999999999999998652  359999999999999999999999999998


Q ss_pred             ccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc-----
Q 044997          426 LEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP-----  500 (563)
Q Consensus       426 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~-----  500 (563)
                      ......   .......||+.|||||++.+..             +++++|||||||++|||++|+.||.......     
T Consensus       163 ~~~~~~---~~~~~~~gt~~Y~APE~l~~~~-------------~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i  226 (269)
T d2java1         163 ILNHDT---SFAKAFVGTPYYMSPEQMNRMS-------------YNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI  226 (269)
T ss_dssp             HC--------------CCCSCCCHHHHTTCC-------------CCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred             ecccCC---CccccCCCCcccCCHHHHcCCC-------------CChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHH
Confidence            764322   1234468999999999986554             4899999999999999999999996543211     


Q ss_pred             ------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          501 ------TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       501 ------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                            .....+++.+.+|+.+||+.||.+|||+.|+++
T Consensus       227 ~~~~~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         227 REGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             HHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence                  112344567999999999999999999999975

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-46  Score=379.30  Aligned_cols=242  Identities=24%  Similarity=0.349  Sum_probs=184.3

Q ss_pred             HHHHHHHhcCCCccceecccCcEEEEEEEEC-------CceEEEEEeccCC----hHHHHHHHHHHHhc-cccce-----
Q 044997          284 LEEIEEATNNFDESRIIGRGGFGNVYFGLLG-------DREAAIKKMRSNK----SKEFFAELKVLCKI-HHINV-----  346 (563)
Q Consensus       284 ~~el~~~~~~f~~~~~LG~G~fG~Vy~g~~~-------~~~vavK~~~~~~----~~~f~~Ei~~l~~l-~H~ni-----  346 (563)
                      ..+++...++|+..+.||+|+||.||+|++.       ++.||||+++...    .+.+.+|.+++.++ +|+||     
T Consensus         5 ~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~   84 (299)
T d1ywna1           5 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG   84 (299)
T ss_dssp             HHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             CccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeee
Confidence            3444444578999999999999999999863       2579999997543    35688888888887 56776     


Q ss_pred             -----------EEEeecCCCcccccccccc-----------cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCC
Q 044997          347 -----------FISTFGNGSLSDHLHDPLL-----------KGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIK  404 (563)
Q Consensus       347 -----------V~e~~~~gsL~~~L~~~~~-----------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk  404 (563)
                                 |+||+++|+|.++|+....           .....++|.+++.++.|+++||+|||+++   |||||||
T Consensus        85 ~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlK  161 (299)
T d1ywna1          85 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLA  161 (299)
T ss_dssp             EECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCC
T ss_pred             eeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCC
Confidence                       5799999999999975321           01346899999999999999999999997   9999999


Q ss_pred             CCCeEecCCCcEEEeecCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHH
Q 044997          405 TSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLA  484 (563)
Q Consensus       405 ~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~  484 (563)
                      |+|||+++++.+||+|||+|+........ ...+...||+.|||||++.+..             ++.++|||||||++|
T Consensus       162 p~NILl~~~~~~Kl~DFGla~~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~-------------~~~~sDiwS~Gvil~  227 (299)
T d1ywna1         162 ARNILLSEKNVVKICDFGLARDIYKDPDY-VRKGDARLPLKWMAPETIFDRV-------------YTIQSDVWSFGVLLW  227 (299)
T ss_dssp             GGGEEECGGGCEEECC------CCSCTTS-CCTTSCCCGGGGCCHHHHHHCC-------------CCHHHHHHHHHHHHH
T ss_pred             ccceeECCCCcEEEccCcchhhccccccc-cccCceeeCccccchhHhhcCC-------------CCcccceeehHHHHH
Confidence            99999999999999999999865433222 2234467999999999986554             489999999999999


Q ss_pred             HHHcCCC-CCcCCCCCch------------hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcC
Q 044997          485 ELITGKR-ALIRDDSEPT------------KMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITS  542 (563)
Q Consensus       485 Elltg~~-p~~~~~~~~~------------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~  542 (563)
                      ||++|.. ||........            .+..+++.+.+++.+||+.||.+|||+.||++.|++++++.
T Consensus       228 ellt~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~n  298 (299)
T d1ywna1         228 EIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN  298 (299)
T ss_dssp             HHHTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCC
Confidence            9999765 5544332211            11234566999999999999999999999999999998753

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-46  Score=376.50  Aligned_cols=230  Identities=27%  Similarity=0.429  Sum_probs=187.5

Q ss_pred             cCCCccceecccCcEEEEEEEEC-CceEEEEEeccCC--hHHHHHHHHHHHhccccce--------------EEEeecCC
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG-DREAAIKKMRSNK--SKEFFAELKVLCKIHHINV--------------FISTFGNG  354 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~vavK~~~~~~--~~~f~~Ei~~l~~l~H~ni--------------V~e~~~~g  354 (563)
                      ++|+..+.||+|+||.||+|+++ ++.||||+++...  .++|.+|+.+|++++||||              |+||+++|
T Consensus        17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~lv~Ey~~~g   96 (285)
T d1fmka3          17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKG   96 (285)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEECCCTTC
T ss_pred             HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEecCCeEEEEEecCCC
Confidence            56889999999999999999986 4679999997554  4779999999999999998              68999999


Q ss_pred             CcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccccccccc
Q 044997          355 SLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKE  434 (563)
Q Consensus       355 sL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~  434 (563)
                      +|..++...   ....++|.+++.|+.||+.||+|||+++   |+||||||+|||||+++.+||+|||+++.......  
T Consensus        97 ~l~~~~~~~---~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~--  168 (285)
T d1fmka3          97 SLLDFLKGE---TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY--  168 (285)
T ss_dssp             BHHHHHSHH---HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred             chhhhhhhc---ccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCc--
Confidence            999888753   2356999999999999999999999997   99999999999999999999999999986543322  


Q ss_pred             cccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc------------hh
Q 044997          435 MLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP------------TK  502 (563)
Q Consensus       435 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~------------~~  502 (563)
                      .......||+.|+|||++..+.             ++.++|||||||++|||++|+.|+.......            ..
T Consensus       169 ~~~~~~~gt~~y~aPE~~~~~~-------------~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~  235 (285)
T d1fmka3         169 TARQGAKFPIKWTAPEAALYGR-------------FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC  235 (285)
T ss_dssp             -------CCGGGSCHHHHHHCC-------------CCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC
T ss_pred             eeeccccccccccChHHHhCCC-------------CCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCC
Confidence            1233457899999999886544             4899999999999999999877765443221            12


Q ss_pred             hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcC
Q 044997          503 MKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITS  542 (563)
Q Consensus       503 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~  542 (563)
                      ...+++.+.+++.+||+.||++||+|++|++.|++.+.+.
T Consensus       236 ~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~  275 (285)
T d1fmka3         236 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  275 (285)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred             CcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence            2344567999999999999999999999999999887654

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-46  Score=376.72  Aligned_cols=224  Identities=22%  Similarity=0.369  Sum_probs=187.3

Q ss_pred             cCCCccceecccCcEEEEEEEEC--CceEEEEEeccC---ChHHHHHHHHHHHhccccce---------------EEEee
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSN---KSKEFFAELKVLCKIHHINV---------------FISTF  351 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~---~~~~f~~Ei~~l~~l~H~ni---------------V~e~~  351 (563)
                      +.|+..+.||+|+||.||+|+..  ++.||||+++..   ..+.|.+|+++|++++||||               ||||+
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~   91 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   91 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence            45888999999999999999984  678999998653   33678999999999999998               68999


Q ss_pred             cCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccccccc
Q 044997          352 GNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTN  431 (563)
Q Consensus       352 ~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~  431 (563)
                      ++|+|.+++..    ...++++.++..++.|++.||+|||+++   |+||||||+|||++.++++||+|||+|+......
T Consensus        92 ~~g~L~~~~~~----~~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~  164 (288)
T d2jfla1          92 AGGAVDAVMLE----LERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI  164 (288)
T ss_dssp             TTEEHHHHHHH----HTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHH
T ss_pred             CCCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCCc
Confidence            99999998764    2357999999999999999999999998   9999999999999999999999999997543321


Q ss_pred             ccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc-----------
Q 044997          432 EKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP-----------  500 (563)
Q Consensus       432 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~-----------  500 (563)
                         .......||+.|||||++.....        ....++.++|||||||++|||++|+.||.......           
T Consensus       165 ---~~~~~~~Gt~~y~APE~l~~~~~--------~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~  233 (288)
T d2jfla1         165 ---QRRDSFIGTPYWMAPEVVMCETS--------KDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPP  233 (288)
T ss_dssp             ---HHHTCCCSCCTTCCHHHHTTCST--------TTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCC
T ss_pred             ---ccccccccccccCCHHHHhhccc--------CCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCC
Confidence               12234679999999999854322        24456899999999999999999999996543211           


Q ss_pred             --hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          501 --TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       501 --~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                        .....+++.+.+|+.+||+.||.+|||+.|+++
T Consensus       234 ~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         234 TLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             CCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence              122355677999999999999999999999876

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-46  Score=382.53  Aligned_cols=230  Identities=22%  Similarity=0.382  Sum_probs=186.7

Q ss_pred             HhcCCCccceecccCcEEEEEEEECC-------ceEEEEEeccC----ChHHHHHHHHHHHhc-cccce-----------
Q 044997          290 ATNNFDESRIIGRGGFGNVYFGLLGD-------REAAIKKMRSN----KSKEFFAELKVLCKI-HHINV-----------  346 (563)
Q Consensus       290 ~~~~f~~~~~LG~G~fG~Vy~g~~~~-------~~vavK~~~~~----~~~~f~~Ei~~l~~l-~H~ni-----------  346 (563)
                      ..++|+..++||+|+||.||+|++.+       ..||+|.+...    ....|.+|+.+|.++ +||||           
T Consensus        35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~  114 (325)
T d1rjba_          35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG  114 (325)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC
Confidence            34678899999999999999998742       25899998643    246789999999998 89997           


Q ss_pred             ----EEEeecCCCcccccccccc------------------cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCC
Q 044997          347 ----FISTFGNGSLSDHLHDPLL------------------KGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIK  404 (563)
Q Consensus       347 ----V~e~~~~gsL~~~L~~~~~------------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk  404 (563)
                          |+||+++|+|.++|+....                  .....++|..++.++.|+++||+|||+++   |||||||
T Consensus       115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlK  191 (325)
T d1rjba_         115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLA  191 (325)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCS
T ss_pred             eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCc
Confidence                6899999999999975321                  01246899999999999999999999997   9999999


Q ss_pred             CCCeEecCCCcEEEeecCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHH
Q 044997          405 TSNILLDDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLA  484 (563)
Q Consensus       405 ~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~  484 (563)
                      |+|||++.++.+||+|||+|+........ .......||+.|||||++.+..             ++.++|||||||++|
T Consensus       192 p~Nill~~~~~~Kl~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~-------------~~~~~DiwS~Gvil~  257 (325)
T d1rjba_         192 ARNVLVTHGKVVKICDFGLARDIMSDSNY-VVRGNARLPVKWMAPESLFEGI-------------YTIKSDVWSYGILLW  257 (325)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCGGGCTTS-EEETTEEECGGGCCHHHHHHCC-------------CCHHHHHHHHHHHHH
T ss_pred             hhccccccCCeEEEeeccccccccCCCce-eeeccccCCCccCChHHHcCCC-------------CCcceeccchhHHHH
Confidence            99999999999999999999865543321 2233456899999999886554             489999999999999


Q ss_pred             HHHc-CCCCCcCCCCCch------------hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 044997          485 ELIT-GKRALIRDDSEPT------------KMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILS  536 (563)
Q Consensus       485 Ellt-g~~p~~~~~~~~~------------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  536 (563)
                      ||+| |+.||.+......            .+..+++.+.+|+.+||+.||++||||+||++.|.
T Consensus       258 emlt~g~~Pf~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         258 EIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             HHTTTSCCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            9998 8999876443221            12344567999999999999999999999999985

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-46  Score=380.20  Aligned_cols=233  Identities=25%  Similarity=0.396  Sum_probs=187.2

Q ss_pred             cCCCccceecccCcEEEEEEEEC--Cc----eEEEEEeccC----ChHHHHHHHHHHHhccccce--------------E
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG--DR----EAAIKKMRSN----KSKEFFAELKVLCKIHHINV--------------F  347 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~--~~----~vavK~~~~~----~~~~f~~Ei~~l~~l~H~ni--------------V  347 (563)
                      .+|+..++||+|+||.||+|++.  ++    +||+|+++..    ..++|.+|+++|++++||||              +
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~v   88 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLI   88 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeeEE
Confidence            35889999999999999999874  32    5899988643    34689999999999999998              4


Q ss_pred             EEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccc
Q 044997          348 ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLE  427 (563)
Q Consensus       348 ~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~  427 (563)
                      ++|+.+|+|.+++..    ....++|..+++++.|||.||+|||+++   |+||||||+|||+++++.+||+|||+++..
T Consensus        89 ~e~~~~~~l~~~~~~----~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~  161 (317)
T d1xkka_          89 TQLMPFGCLLDYVRE----HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL  161 (317)
T ss_dssp             EECCTTCBHHHHHHH----TSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred             EEeccCCcccccccc----cccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceec
Confidence            788999999888764    3567999999999999999999999987   999999999999999999999999999876


Q ss_pred             ccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCCCcCCCCC-------
Q 044997          428 ERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIRDDSE-------  499 (563)
Q Consensus       428 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p~~~~~~~-------  499 (563)
                      ...... .......||+.|+|||++.++.             ++.++|||||||++|||+| |+.||......       
T Consensus       162 ~~~~~~-~~~~~~~gt~~y~APE~l~~~~-------------~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~  227 (317)
T d1xkka_         162 GAEEKE-YHAEGGKVPIKWMALESILHRI-------------YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE  227 (317)
T ss_dssp             TTTCC---------CCTTTSCHHHHHHCC-------------CCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHH
T ss_pred             cccccc-ccccccccCccccChHHHhcCC-------------CChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHH
Confidence            543322 2233456899999999886554             4899999999999999999 67776543221       


Q ss_pred             ----chhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcChhh
Q 044997          500 ----PTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITSTEW  545 (563)
Q Consensus       500 ----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~w  545 (563)
                          ...+..+++.+.+|+.+||+.||.+|||+.||++.|.++......|
T Consensus       228 ~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~~~~~  277 (317)
T d1xkka_         228 KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRY  277 (317)
T ss_dssp             HTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSHHHH
T ss_pred             cCCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhChHhh
Confidence                1112344566999999999999999999999999999887654443

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-46  Score=372.44  Aligned_cols=224  Identities=28%  Similarity=0.445  Sum_probs=183.4

Q ss_pred             cCCCccceecccCcEEEEEEEECCceEEEEEeccCC-hHHHHHHHHHHHhccccce----------------EEEeecCC
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLGDREAAIKKMRSNK-SKEFFAELKVLCKIHHINV----------------FISTFGNG  354 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~~~~vavK~~~~~~-~~~f~~Ei~~l~~l~H~ni----------------V~e~~~~g  354 (563)
                      ++|+..+.||+|+||.||+|+++++.||||+++.+. .++|.+|+++|++++||||                |+||+++|
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g   86 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKG   86 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTE
T ss_pred             HHeEEeEEEecCCCeEEEEEEECCeEEEEEEECcHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCC
Confidence            457788999999999999999999999999997654 5779999999999999997                67999999


Q ss_pred             CcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccccccccc
Q 044997          355 SLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTNEKE  434 (563)
Q Consensus       355 sL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~~~~  434 (563)
                      +|.++|...   ....++|..+++|+.||+.||.|||+.+   ++||||||+|||++.++.+||+|||+++.....    
T Consensus        87 ~L~~~l~~~---~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~----  156 (262)
T d1byga_          87 SLVDYLRSR---GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----  156 (262)
T ss_dssp             EHHHHHHHH---HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred             CHHHHHHhc---CCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCC----
Confidence            999999752   2345899999999999999999999987   999999999999999999999999999854322    


Q ss_pred             cccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCCCcCCCCC-----------chh
Q 044997          435 MLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIRDDSE-----------PTK  502 (563)
Q Consensus       435 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p~~~~~~~-----------~~~  502 (563)
                        .....+|..|+|||++.+..             +++++|||||||++|||+| |+.|+......           +..
T Consensus       157 --~~~~~~~~~y~aPE~l~~~~-------------~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~  221 (262)
T d1byga_         157 --QDTGKLPVKWTAPEALREKK-------------FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDA  221 (262)
T ss_dssp             -------CCTTTSCHHHHHHCC-------------CCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCC
T ss_pred             --CccccccccCCChHHHhCCC-------------CChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence              22345789999999885444             5899999999999999999 56666543221           122


Q ss_pred             hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhh
Q 044997          503 MKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMI  540 (563)
Q Consensus       503 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~  540 (563)
                      ...+++.+.+|+.+||+.||.+||||.|+++.|+++.+
T Consensus       222 ~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~  259 (262)
T d1byga_         222 PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT  259 (262)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence            23445679999999999999999999999999998854

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.7e-46  Score=367.46  Aligned_cols=214  Identities=25%  Similarity=0.435  Sum_probs=177.6

Q ss_pred             CccceecccCcEEEEEEEEC--CceEEEEEeccCC-----hHHHHHHHHHHHhccccce-------------------EE
Q 044997          295 DESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNK-----SKEFFAELKVLCKIHHINV-------------------FI  348 (563)
Q Consensus       295 ~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~-----~~~f~~Ei~~l~~l~H~ni-------------------V~  348 (563)
                      +..+.||+|+||.||+|+..  ++.||+|.+....     .+.|.+|+++|++++||||                   ||
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm   91 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT   91 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence            44568999999999999885  6789999986432     3568999999999999997                   57


Q ss_pred             EeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEec-CCCcEEEeecCCCccc
Q 044997          349 STFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLD-DGLRAKVADFGLVKLE  427 (563)
Q Consensus       349 e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~-~~~~~kl~DFGla~~~  427 (563)
                      ||+++|+|.+++..     ...+++..+..++.|+++||+|||+++ ++|+||||||+|||++ +++.+||+|||+|+..
T Consensus        92 E~~~~g~L~~~l~~-----~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~  165 (270)
T d1t4ha_          92 ELMTSGTLKTYLKR-----FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK  165 (270)
T ss_dssp             ECCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred             eCCCCCcHHHHHhc-----cccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceec
Confidence            99999999999865     356999999999999999999999975 4599999999999996 5789999999999854


Q ss_pred             ccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc-------
Q 044997          428 ERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP-------  500 (563)
Q Consensus       428 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~-------  500 (563)
                      ...     .....+||+.|||||++.+              .++.++|||||||++|||++|+.||.......       
T Consensus       166 ~~~-----~~~~~~GT~~Y~aPE~~~~--------------~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~  226 (270)
T d1t4ha_         166 RAS-----FAKAVIGTPEFMAPEMYEE--------------KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVT  226 (270)
T ss_dssp             CTT-----SBEESCSSCCCCCGGGGGT--------------CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHT
T ss_pred             cCC-----ccCCcccCccccCHHHhCC--------------CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHH
Confidence            322     2234679999999998742              35899999999999999999999996543221       


Q ss_pred             ------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          501 ------TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       501 ------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                            .......+.+.+|+.+||+.||++|||+.|+++
T Consensus       227 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         227 SGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             TTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cCCCCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence                  111233456899999999999999999999976

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.8e-46  Score=375.02  Aligned_cols=236  Identities=25%  Similarity=0.366  Sum_probs=187.8

Q ss_pred             cCCCccceecccCcEEEEEEEECCceEEEEEeccCChHHHHHHHHH--HHhccccce-------------------EEEe
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLGDREAAIKKMRSNKSKEFFAELKV--LCKIHHINV-------------------FIST  350 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~~~~vavK~~~~~~~~~f~~Ei~~--l~~l~H~ni-------------------V~e~  350 (563)
                      ++|...+.||+|+||.||+|+++++.||||+++.+..+++.+|.++  +.+++||||                   |+||
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey   82 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDY   82 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEEC
T ss_pred             cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEec
Confidence            4567789999999999999999999999999987776666666554  457899997                   5799


Q ss_pred             ecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCceEeCCCCCCCeEecCCCcEEEeecCCCc
Q 044997          351 FGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHT-----KARYVHRDIKTSNILLDDGLRAKVADFGLVK  425 (563)
Q Consensus       351 ~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~ivHrDLk~~NILl~~~~~~kl~DFGla~  425 (563)
                      +.+|+|.++|+.      ..++|.++++++.|+|.||+|||+..     .++|+||||||+||||+.++.+||+|||+++
T Consensus        83 ~~~g~L~~~l~~------~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~  156 (303)
T d1vjya_          83 HEHGSLFDYLNR------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  156 (303)
T ss_dssp             CTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             ccCCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence            999999999975      35999999999999999999999741     2459999999999999999999999999998


Q ss_pred             ccccccccc-cccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCC-----
Q 044997          426 LEERTNEKE-MLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE-----  499 (563)
Q Consensus       426 ~~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~-----  499 (563)
                      ......... .......||++|+|||++.....       .....++.++|||||||+||||+||..|+......     
T Consensus       157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-------~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~  229 (303)
T d1vjya_         157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSIN-------MKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY  229 (303)
T ss_dssp             EEETTTTEECC----CCSCGGGCCHHHHTTCSC-------TTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTT
T ss_pred             cccCCCcceeccccceecccCcCChhhcccccc-------ccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchh
Confidence            765443222 22345689999999999865421       11223578999999999999999998776332110     


Q ss_pred             -------------------------ch--hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhh
Q 044997          500 -------------------------PT--KMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMI  540 (563)
Q Consensus       500 -------------------------~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~  540 (563)
                                               +.  ........+.+|+.+||+.||++||||.||++.|+++.+
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~  297 (303)
T d1vjya_         230 DLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ  297 (303)
T ss_dssp             TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             hcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence                                     00  012344568999999999999999999999999998875

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-46  Score=372.97  Aligned_cols=227  Identities=22%  Similarity=0.378  Sum_probs=180.3

Q ss_pred             cCCCccceecccCcEEEEEEEECC-----ceEEEEEeccCC------hHHHHHHHHHHHhccccce--------------
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLGD-----REAAIKKMRSNK------SKEFFAELKVLCKIHHINV--------------  346 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~~-----~~vavK~~~~~~------~~~f~~Ei~~l~~l~H~ni--------------  346 (563)
                      ++|+..+.||+|+||.||+|++.+     ..||||+++...      .++|.+|+++|++++||||              
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~~~~l   87 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKM   87 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeecchhe
Confidence            468889999999999999998732     368999986432      3679999999999999998              


Q ss_pred             EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcc
Q 044997          347 FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKL  426 (563)
Q Consensus       347 V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~  426 (563)
                      |+||+++|++.+++...    ...++|..+++++.|+|+||+|||+++   |+||||||+|||++.++.+||+|||+++.
T Consensus        88 v~e~~~~~~l~~~~~~~----~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~  160 (273)
T d1u46a_          88 VTELAPLGSLLDRLRKH----QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA  160 (273)
T ss_dssp             EEECCTTCBHHHHHHHH----GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             eeeeecCcchhhhhhcc----cCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhh
Confidence            57999999999887652    356999999999999999999999987   99999999999999999999999999997


Q ss_pred             cccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCCCcCCCC-------
Q 044997          427 EERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIRDDS-------  498 (563)
Q Consensus       427 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p~~~~~~-------  498 (563)
                      ...............|+..|+|||.+.+..+             +.++|||||||++|||+| |+.||.....       
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-------------~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i  227 (273)
T d1u46a_         161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTF-------------SHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI  227 (273)
T ss_dssp             CCC-CCEEEC-----CCGGGCCHHHHHHCEE-------------EHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH
T ss_pred             cccCCCcceecCccccCcccCCHHHHhCCCC-------------CcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHH
Confidence            6554443333445678899999999876654             789999999999999998 8999864321       


Q ss_pred             -----CchhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 044997          499 -----EPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQI  538 (563)
Q Consensus       499 -----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  538 (563)
                           .......+++.+.+|+.+||+.||.+||||.||++.|.++
T Consensus       228 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         228 DKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             HTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HhCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence                 1222344567799999999999999999999999988764

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-46  Score=375.28  Aligned_cols=221  Identities=24%  Similarity=0.369  Sum_probs=183.2

Q ss_pred             cCCCccceecccCcEEEEEEEEC--CceEEEEEecc------CChHHHHHHHHHHHhccccce---------------EE
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRS------NKSKEFFAELKVLCKIHHINV---------------FI  348 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~------~~~~~f~~Ei~~l~~l~H~ni---------------V~  348 (563)
                      ++|+..+.||+|+||.||+|+..  ++.||||.++.      ...+.+.+|+++|++++||||               ||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            46889999999999999999874  78999999863      234679999999999999998               68


Q ss_pred             EeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccc
Q 044997          349 STFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEE  428 (563)
Q Consensus       349 e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~  428 (563)
                      ||+++|+|.+++..     ...+++..+..++.|++.||+|||+++   |+||||||+|||+++++.+||+|||+|+...
T Consensus        88 Ey~~gg~L~~~~~~-----~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~  159 (288)
T d1uu3a_          88 SYAKNGELLKYIRK-----IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLS  159 (288)
T ss_dssp             CCCTTEEHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EccCCCCHHHhhhc-----cCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecc
Confidence            99999999998865     356999999999999999999999998   9999999999999999999999999998765


Q ss_pred             cccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCC---------
Q 044997          429 RTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE---------  499 (563)
Q Consensus       429 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~---------  499 (563)
                      ..... .......||+.|||||++.+..|             +.++|||||||++|||++|+.||...+..         
T Consensus       160 ~~~~~-~~~~~~~GT~~Y~APE~~~~~~~-------------~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~  225 (288)
T d1uu3a_         160 PESKQ-ARANSFVGTAQYVSPELLTEKSA-------------CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL  225 (288)
T ss_dssp             -----------CCCCGGGCCHHHHHTCCC-------------CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTT
T ss_pred             cCCcc-cccccccCCccccCceeeccCCC-------------CcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcC
Confidence            33221 22344679999999999865544             88999999999999999999999754321         


Q ss_pred             -chhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          500 -PTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       500 -~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                       ...+..+.+.+.+|+.+||+.||.+|||++|++..
T Consensus       226 ~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~  261 (288)
T d1uu3a_         226 EYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY  261 (288)
T ss_dssp             CCCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred             CCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence             11123455678999999999999999999997653

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-46  Score=378.75  Aligned_cols=218  Identities=22%  Similarity=0.408  Sum_probs=182.1

Q ss_pred             hcCCCccceecccCcEEEEEEEEC--CceEEEEEeccCC----hHHHHHHHHHHHhccccce---------------EEE
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNK----SKEFFAELKVLCKIHHINV---------------FIS  349 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~----~~~f~~Ei~~l~~l~H~ni---------------V~e  349 (563)
                      .++|+..+.||+|+||.||+|+..  ++.||+|+++...    .+++.+|+++|++++||||               |+|
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE   84 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   84 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            467999999999999999999974  7889999986432    3578999999999999998               689


Q ss_pred             eecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccc
Q 044997          350 TFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHD-HTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEE  428 (563)
Q Consensus       350 ~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~  428 (563)
                      |+++|+|.+++..     ...+++..+..++.|++.||.|||+ ++   |+||||||+|||+++++++||+|||+|+...
T Consensus        85 y~~gg~L~~~l~~-----~~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~  156 (322)
T d1s9ja_          85 HMDGGSLDQVLKK-----AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI  156 (322)
T ss_dssp             CCTTEEHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred             cCCCCcHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccC
Confidence            9999999999975     2469999999999999999999997 46   9999999999999999999999999998653


Q ss_pred             cccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCchhh-----
Q 044997          429 RTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTKM-----  503 (563)
Q Consensus       429 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~~~-----  503 (563)
                      ..     .....+||+.|||||++.+..|             ++++||||+||++|||++|+.||...+......     
T Consensus       157 ~~-----~~~~~~GT~~Y~APEvl~~~~y-------------~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~  218 (322)
T d1s9ja_         157 DS-----MANSFVGTRSYMSPERLQGTHY-------------SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQ  218 (322)
T ss_dssp             HH-----TC---CCSSCCCCHHHHHCSCC-------------CTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---
T ss_pred             CC-----ccccccCCccccCchHHcCCCC-------------CcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHH
Confidence            22     2334689999999999876554             899999999999999999999996543221000     


Q ss_pred             -------------------------------------------------HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          504 -------------------------------------------------KSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       504 -------------------------------------------------~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                                                                       ......+.+++.+||+.||.+|||++|+++.
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H  298 (322)
T d1s9ja_         219 VEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH  298 (322)
T ss_dssp             ---------------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             hcCCcccCCcccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence                                                             0012457899999999999999999999873

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.8e-46  Score=369.57  Aligned_cols=229  Identities=24%  Similarity=0.379  Sum_probs=180.0

Q ss_pred             hcCCCccceecccCcEEEEEEEECC-----ceEEEEEeccCC----hHHHHHHHHHHHhccccce--------------E
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLLGD-----REAAIKKMRSNK----SKEFFAELKVLCKIHHINV--------------F  347 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~~~-----~~vavK~~~~~~----~~~f~~Ei~~l~~l~H~ni--------------V  347 (563)
                      .++|+..+.||+|+||.||+|++..     ..||||.++...    .+.|.+|+++|++++||||              |
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~iv   85 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWII   85 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSCEEE
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCeEEEE
Confidence            4578889999999999999998742     458999886432    3569999999999999997              6


Q ss_pred             EEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccc
Q 044997          348 ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLE  427 (563)
Q Consensus       348 ~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~  427 (563)
                      +||+++|+|.+++..    ....+++.+++.++.|+++||+|||+++   ++||||||+|||+++++.+||+|||+|+..
T Consensus        86 ~E~~~~g~l~~~~~~----~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~  158 (273)
T d1mp8a_          86 MELCTLGELRSFLQV----RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM  158 (273)
T ss_dssp             EECCTTEEHHHHHHH----TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-------
T ss_pred             EEeccCCcHHhhhhc----cCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheec
Confidence            899999999988764    3457999999999999999999999997   999999999999999999999999999865


Q ss_pred             ccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-CCCCCcCCCCC-------
Q 044997          428 ERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-GKRALIRDDSE-------  499 (563)
Q Consensus       428 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g~~p~~~~~~~-------  499 (563)
                      .....  ...+...||+.|+|||.+.+..             ++.++|||||||++|||++ |+.||......       
T Consensus       159 ~~~~~--~~~~~~~gt~~y~apE~l~~~~-------------~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~  223 (273)
T d1mp8a_         159 EDSTY--YKASKGKLPIKWMAPESINFRR-------------FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE  223 (273)
T ss_dssp             --------------CCGGGCCHHHHHHCC-------------CSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH
T ss_pred             cCCcc--eeccceecCcccchhhHhccCC-------------CCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence            43322  1233457899999999986554             4889999999999999998 78887654321       


Q ss_pred             ----chhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 044997          500 ----PTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMIT  541 (563)
Q Consensus       500 ----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~  541 (563)
                          ...+..+++.+.+|+.+||+.||.+|||+.||++.|+++++.
T Consensus       224 ~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~  269 (273)
T d1mp8a_         224 NGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  269 (273)
T ss_dssp             TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             cCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence                122334567799999999999999999999999999998754

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=7.9e-46  Score=375.16  Aligned_cols=217  Identities=28%  Similarity=0.437  Sum_probs=181.8

Q ss_pred             cCCCccceecccCcEEEEEEEE--CCceEEEEEeccCC------hHHHHHHHHHHHhccccce---------------EE
Q 044997          292 NNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNK------SKEFFAELKVLCKIHHINV---------------FI  348 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~------~~~f~~Ei~~l~~l~H~ni---------------V~  348 (563)
                      +.|+..+.||+|+||.||+|+.  +++.||||.++...      .++|.+|+++|++++||||               |+
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~   94 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence            3488899999999999999987  47889999986542      2468899999999999998               57


Q ss_pred             EeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccc
Q 044997          349 STFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEE  428 (563)
Q Consensus       349 e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~  428 (563)
                      ||+.+|+|..++..     ..++++.++..++.||+.||.|||+++   |+||||||+|||+++++++||+|||+|+...
T Consensus        95 E~~~~g~l~~~~~~-----~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~  166 (309)
T d1u5ra_          95 EYCLGSASDLLEVH-----KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMA  166 (309)
T ss_dssp             ECCSEEHHHHHHHH-----TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSS
T ss_pred             EecCCCchHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccC
Confidence            99999998766543     367999999999999999999999998   9999999999999999999999999998643


Q ss_pred             cccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc--------
Q 044997          429 RTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP--------  500 (563)
Q Consensus       429 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~--------  500 (563)
                      ..       ....||+.|||||++.+..          ...++.++|||||||++|||++|+.||.......        
T Consensus       167 ~~-------~~~~GT~~Y~APE~~~~~~----------~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~  229 (309)
T d1u5ra_         167 PA-------NSFVGTPYWMAPEVILAMD----------EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN  229 (309)
T ss_dssp             SB-------CCCCSCGGGCCHHHHTTTT----------SCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS
T ss_pred             CC-------CccccCccccCHHHHhccC----------CCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC
Confidence            22       2357999999999985432          2346899999999999999999999996543211        


Q ss_pred             ----hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          501 ----TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       501 ----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                          .....+++.+.+|+.+||+.||.+|||+.|+++
T Consensus       230 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         230 ESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             CCCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CCCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence                111234567999999999999999999999976

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.8e-45  Score=367.66  Aligned_cols=225  Identities=28%  Similarity=0.405  Sum_probs=185.3

Q ss_pred             cceecccCcEEEEEEEECC-----ceEEEEEeccCC----hHHHHHHHHHHHhccccce----------------EEEee
Q 044997          297 SRIIGRGGFGNVYFGLLGD-----REAAIKKMRSNK----SKEFFAELKVLCKIHHINV----------------FISTF  351 (563)
Q Consensus       297 ~~~LG~G~fG~Vy~g~~~~-----~~vavK~~~~~~----~~~f~~Ei~~l~~l~H~ni----------------V~e~~  351 (563)
                      .++||+|+||+||+|++.+     ..||||+++...    .++|.+|+++|++++||||                |+||+
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            4789999999999998742     258999986432    3679999999999999998                68999


Q ss_pred             cCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccccccc
Q 044997          352 GNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERTN  431 (563)
Q Consensus       352 ~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~~  431 (563)
                      ++|+|.+++..    ....+++..+++++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||+++......
T Consensus       112 ~~g~l~~~~~~----~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~  184 (311)
T d1r0pa_         112 KHGDLRNFIRN----ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE  184 (311)
T ss_dssp             TTCBHHHHHHC----TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred             ecCchhhhhcc----ccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccc
Confidence            99999998875    3456889999999999999999999987   9999999999999999999999999998765433


Q ss_pred             ccc-cccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc----------
Q 044997          432 EKE-MLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP----------  500 (563)
Q Consensus       432 ~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~----------  500 (563)
                      ... .......||+.|+|||.+...             .++.++||||||+++|||+||+.||.......          
T Consensus       185 ~~~~~~~~~~~gt~~y~aPE~~~~~-------------~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~  251 (311)
T d1r0pa_         185 FDSVHNKTGAKLPVKWMALESLQTQ-------------KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR  251 (311)
T ss_dssp             CCCTTCTTCSSCCGGGSCHHHHHHC-------------CCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTC
T ss_pred             cccceecccccccccccChHHHhcC-------------CCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC
Confidence            221 222345789999999987544             45899999999999999999988876543221          


Q ss_pred             --hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 044997          501 --TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMIT  541 (563)
Q Consensus       501 --~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~  541 (563)
                        ..+..+++.+.+|+.+||+.||.+||+|.||++.|+++.++
T Consensus       252 ~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~  294 (311)
T d1r0pa_         252 RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST  294 (311)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             CCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence              12233456799999999999999999999999999999864

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-45  Score=370.96  Aligned_cols=234  Identities=27%  Similarity=0.427  Sum_probs=188.5

Q ss_pred             cCCCccceecccCcEEEEEEEEC--Cc--eEEEEEeccC----ChHHHHHHHHHHHhc-cccce---------------E
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG--DR--EAAIKKMRSN----KSKEFFAELKVLCKI-HHINV---------------F  347 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~--~~--~vavK~~~~~----~~~~f~~Ei~~l~~l-~H~ni---------------V  347 (563)
                      ++|+..++||+|+||.||+|+++  +.  .||||+++..    ..++|.+|+++|+++ +||||               |
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            56888899999999999999884  33  5788988643    345799999999999 79998               5


Q ss_pred             EEeecCCCccccccccc-----------ccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcE
Q 044997          348 ISTFGNGSLSDHLHDPL-----------LKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRA  416 (563)
Q Consensus       348 ~e~~~~gsL~~~L~~~~-----------~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~  416 (563)
                      +||+++|+|.++|+...           ......++|.++++++.|||.||.|||+++   ++||||||+|||++.++.+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence            79999999999997531           112467999999999999999999999997   9999999999999999999


Q ss_pred             EEeecCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCC
Q 044997          417 KVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRD  496 (563)
Q Consensus       417 kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~  496 (563)
                      ||+|||+++......    ......||..|+|||.+....|             +.++|||||||++|||++|..|+...
T Consensus       167 kl~DfG~a~~~~~~~----~~~~~~gt~~y~aPE~l~~~~~-------------~~~sDvwSfGvil~ell~~~~~p~~~  229 (309)
T d1fvra_         167 KIADFGLSRGQEVYV----KKTMGRLPVRWMAIESLNYSVY-------------TTNSDVWSYGVLLWEIVSLGGTPYCG  229 (309)
T ss_dssp             EECCTTCEESSCEEC----CC----CCTTTCCHHHHHHCEE-------------CHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred             EEccccccccccccc----cccceecCCcccchHHhccCCC-------------CccceeehhHHHHHHHHhcCCCCCCC
Confidence            999999998544322    1223468999999999866554             89999999999999999987654332


Q ss_pred             CCC------------chhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcChhh
Q 044997          497 DSE------------PTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITSTEW  545 (563)
Q Consensus       497 ~~~------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~w  545 (563)
                      ...            ......+++.+.+|+.+||+.||++||||+||++.|+++++....+
T Consensus       230 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~~~  290 (309)
T d1fvra_         230 MTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTY  290 (309)
T ss_dssp             CCHHHHHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSCS
T ss_pred             CCHHHHHHHHHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCcCC
Confidence            221            1122345677999999999999999999999999999998755443

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.2e-45  Score=371.60  Aligned_cols=219  Identities=23%  Similarity=0.399  Sum_probs=171.2

Q ss_pred             hcCCCccceecccCcEEEEEEEEC--CceEEEEEeccCC----hHHHHHHHHHHHhccccce---------------EEE
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNK----SKEFFAELKVLCKIHHINV---------------FIS  349 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~----~~~f~~Ei~~l~~l~H~ni---------------V~e  349 (563)
                      .+.|+..+.||+|+||.||+|+..  ++.||||.++...    .+.+.+|+++|++++||||               |||
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE   87 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ   87 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            456899999999999999999884  7889999987532    3567899999999999997               689


Q ss_pred             eecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEec---CCCcEEEeecCCCcc
Q 044997          350 TFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLD---DGLRAKVADFGLVKL  426 (563)
Q Consensus       350 ~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~---~~~~~kl~DFGla~~  426 (563)
                      |+++|+|.+++..     ...+++.++..++.|++.||+|||+++   |+||||||+|||+.   +++.+||+|||+|+.
T Consensus        88 ~~~gg~L~~~l~~-----~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~  159 (307)
T d1a06a_          88 LVSGGELFDRIVE-----KGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKM  159 (307)
T ss_dssp             CCCSCBHHHHHHT-----CSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC-----
T ss_pred             ccCCCcHHHhhhc-----ccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEE
Confidence            9999999999964     357999999999999999999999997   99999999999994   578999999999986


Q ss_pred             cccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCC-------
Q 044997          427 EERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE-------  499 (563)
Q Consensus       427 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~-------  499 (563)
                      .....    .....+||+.|||||++.+..             +++++|||||||++|||++|+.||......       
T Consensus       160 ~~~~~----~~~~~~GT~~y~APE~~~~~~-------------~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~  222 (307)
T d1a06a_         160 EDPGS----VLSTACGTPGYVAPEVLAQKP-------------YSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQIL  222 (307)
T ss_dssp             -----------------CTTSCHHHHTTCC-------------CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred             ccCCC----eeeeeeeCccccCcHHHcCCC-------------CCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHh
Confidence            54322    223467999999999986554             489999999999999999999999654321       


Q ss_pred             -------chhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          500 -------PTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       500 -------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                             ......+++.+.+|+.+||+.||.+|||+.|+++.
T Consensus       223 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  264 (307)
T d1a06a_         223 KAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH  264 (307)
T ss_dssp             TTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             ccCCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence                   11123456779999999999999999999999873

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=6.1e-45  Score=363.42  Aligned_cols=228  Identities=24%  Similarity=0.405  Sum_probs=183.1

Q ss_pred             hcCCCccceecccCcEEEEEEEE--CCceEEEEEeccCC------hHHHHHHHHHHHhccccce----------------
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNK------SKEFFAELKVLCKIHHINV----------------  346 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~------~~~f~~Ei~~l~~l~H~ni----------------  346 (563)
                      .++|+..+.||+|+||.||+|+.  +++.||||.++...      .+.|.+|+++|++++||||                
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            36789999999999999999987  47899999997532      2468999999999999997                


Q ss_pred             ---EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCC
Q 044997          347 ---FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGL  423 (563)
Q Consensus       347 ---V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGl  423 (563)
                         ||||+++|+|.+++..     ...+++.++..++.|++.||+|||+++   |+||||||+|||++.++..+|+|||.
T Consensus        86 ~~lvmE~~~g~~L~~~~~~-----~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~  157 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHT-----EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGI  157 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTT
T ss_pred             EEEEEECCCCCEehhhhcc-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhh
Confidence               5799999999988764     357999999999999999999999997   99999999999999999999999999


Q ss_pred             CcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc---
Q 044997          424 VKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP---  500 (563)
Q Consensus       424 a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~---  500 (563)
                      ++................||+.|||||++.+..             +++++|||||||++|||+||+.||.......   
T Consensus       158 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-------------~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~  224 (277)
T d1o6ya_         158 ARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS-------------VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAY  224 (277)
T ss_dssp             CEECC----------------TTCCHHHHTTCC-------------CCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred             hhhhccccccccccccccCcccccCHHHHcCCC-------------CCcceecccchHHHHHHHhCCCCCCCcCHHHHHH
Confidence            876544433333344568999999999986544             4889999999999999999999997543211   


Q ss_pred             -----------hhhHHHHHHHHHHHHHhhccCCCCCC-CHHHHHHHHHHhh
Q 044997          501 -----------TKMKSLITIMAAVAEWCLNEDAVDRP-EMRDIVAILSQIM  539 (563)
Q Consensus       501 -----------~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~i~  539 (563)
                                 .....+++.+.+++.+||+.||.+|| |+++++..|.++.
T Consensus       225 ~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~  275 (277)
T d1o6ya_         225 QHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  275 (277)
T ss_dssp             HHHHCCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             HHHhcCCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence                       11124556799999999999999999 8999999998875

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.4e-44  Score=372.00  Aligned_cols=219  Identities=20%  Similarity=0.284  Sum_probs=185.5

Q ss_pred             cCCCccceecccCcEEEEEEEEC--CceEEEEEeccCC---hHHHHHHHHHHHhccccce---------------EEEee
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNK---SKEFFAELKVLCKIHHINV---------------FISTF  351 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~---~~~f~~Ei~~l~~l~H~ni---------------V~e~~  351 (563)
                      ++|+..+.||+|+||.||+|+..  ++.||||++....   .+.+.+|+++|++++||||               ||||+
T Consensus        26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  105 (350)
T d1koaa2          26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM  105 (350)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            57999999999999999999874  7899999997654   3568899999999999998               68999


Q ss_pred             cCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEec--CCCcEEEeecCCCccccc
Q 044997          352 GNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLD--DGLRAKVADFGLVKLEER  429 (563)
Q Consensus       352 ~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~--~~~~~kl~DFGla~~~~~  429 (563)
                      ++|+|.+++..    ....+++..+..++.||+.||+|||+++   ||||||||+|||++  .++.+||+|||+++....
T Consensus       106 ~gg~L~~~l~~----~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~  178 (350)
T d1koaa2         106 SGGELFEKVAD----EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP  178 (350)
T ss_dssp             CSCBHHHHHTC----TTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCT
T ss_pred             CCCCHHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheeccc
Confidence            99999999864    2456999999999999999999999998   99999999999996  467899999999986543


Q ss_pred             ccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCC----------
Q 044997          430 TNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE----------  499 (563)
Q Consensus       430 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~----------  499 (563)
                      ..    ......||+.|||||++.+..|             +.++|||||||++|||++|+.||......          
T Consensus       179 ~~----~~~~~~gT~~Y~aPEv~~~~~~-------------~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~  241 (350)
T d1koaa2         179 KQ----SVKVTTGTAEFAAPEVAEGKPV-------------GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCD  241 (350)
T ss_dssp             TS----CEEEECSCTTTCCHHHHHTCCB-------------CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC
T ss_pred             cc----ccceecCcccccCHHHHcCCCC-------------ChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCC
Confidence            32    2234579999999999876554             78999999999999999999999654321          


Q ss_pred             ----chhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          500 ----PTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       500 ----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                          ......+++.+.+|+.+||+.||++|||+.|+++.
T Consensus       242 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         242 WNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             CCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             CCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                11223455678999999999999999999999874

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-44  Score=363.06  Aligned_cols=217  Identities=24%  Similarity=0.375  Sum_probs=183.8

Q ss_pred             cCCCccceecccCcEEEEEEEEC--CceEEEEEeccC---------ChHHHHHHHHHHHhccccce--------------
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSN---------KSKEFFAELKVLCKIHHINV--------------  346 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~---------~~~~f~~Ei~~l~~l~H~ni--------------  346 (563)
                      ++|+..+.||+|+||.||+|+..  ++.||||.++..         ..+.|.+|+++|++++||||              
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   89 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   89 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            57899999999999999999974  789999998532         23679999999999999998              


Q ss_pred             -EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCC----cEEEeec
Q 044997          347 -FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGL----RAKVADF  421 (563)
Q Consensus       347 -V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~----~~kl~DF  421 (563)
                       |+||+++|+|.+++..     ...+++..+..++.|++.||+|||+++   |+||||||+|||++.++    .+||+||
T Consensus        90 iv~E~~~gg~L~~~i~~-----~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~Df  161 (293)
T d1jksa_          90 LILELVAGGELFDFLAE-----KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDF  161 (293)
T ss_dssp             EEEECCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred             EEEEcCCCccccchhcc-----ccccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecch
Confidence             6899999999999875     256999999999999999999999998   99999999999998776    5999999


Q ss_pred             CCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCC--
Q 044997          422 GLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE--  499 (563)
Q Consensus       422 Gla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~--  499 (563)
                      |+++......    ......||+.|+|||++.+..+             +.++|||||||++|||++|+.||.+....  
T Consensus       162 G~a~~~~~~~----~~~~~~~t~~y~APE~~~~~~~-------------~~~~DiwSlGvilyell~g~~Pf~~~~~~~~  224 (293)
T d1jksa_         162 GLAHKIDFGN----EFKNIFGTPEFVAPEIVNYEPL-------------GLEADMWSIGVITYILLSGASPFLGDTKQET  224 (293)
T ss_dssp             TTCEECTTSC----BCSCCCCCGGGCCHHHHTTCCB-------------CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             hhhhhcCCCc----cccccCCCCcccCHHHHcCCCC-------------CCcccchhhhHHHHHHHcCCCCCCCCCHHHH
Confidence            9998654332    2234578999999999865544             89999999999999999999999754321  


Q ss_pred             ------------chhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          500 ------------PTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       500 ------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                                  ......++..+.+|+.+||+.||.+|||++|+++
T Consensus       225 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         225 LANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             HHHHHTTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             HHHHHhcCCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                        1112334566899999999999999999999976

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-44  Score=363.11  Aligned_cols=235  Identities=23%  Similarity=0.385  Sum_probs=191.3

Q ss_pred             hcCCCccceecccCcEEEEEEEEC-------CceEEEEEeccCC----hHHHHHHHHHHHhc-cccce------------
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLLG-------DREAAIKKMRSNK----SKEFFAELKVLCKI-HHINV------------  346 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~~-------~~~vavK~~~~~~----~~~f~~Ei~~l~~l-~H~ni------------  346 (563)
                      .++|+..++||+|+||.||+|++.       ++.||||+++...    ..+|.+|+.+++++ +||||            
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~  101 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence            467888999999999999999863       3579999997543    35689999999999 79998            


Q ss_pred             ---EEEeecCCCcccccccccc-------------cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEe
Q 044997          347 ---FISTFGNGSLSDHLHDPLL-------------KGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILL  410 (563)
Q Consensus       347 ---V~e~~~~gsL~~~L~~~~~-------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl  410 (563)
                         |+||+++|+|.++++....             .....+++..+.+++.||++||+|||+++   +|||||||+|||+
T Consensus       102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~  178 (311)
T d1t46a_         102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL  178 (311)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred             EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccccc
Confidence               5799999999999875321             12346999999999999999999999997   9999999999999


Q ss_pred             cCCCcEEEeecCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCC
Q 044997          411 DDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGK  490 (563)
Q Consensus       411 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~  490 (563)
                      +.++.+|++|||+++....... ....+...||+.|+|||.+...             .++.++|||||||++|||+|++
T Consensus       179 ~~~~~~ki~DfG~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-------------~~~~~~DIwS~G~~l~ellt~g  244 (311)
T d1t46a_         179 THGRITKICDFGLARDIKNDSN-YVVKGNARLPVKWMAPESIFNC-------------VYTFESDVWSYGIFLWELFSLG  244 (311)
T ss_dssp             ETTTEEEECCCGGGSCTTSCTT-SEECSSSEECGGGCCHHHHHHC-------------CCCHHHHHHHHHHHHHHHHTTT
T ss_pred             cccCcccccccchheeccCCCc-ceEeeecccChHHcCHHHhcCC-------------CCCCcccccchHHHHHHHHhCC
Confidence            9999999999999987654332 2233446789999999988544             4589999999999999999966


Q ss_pred             CCCcCCCCCchhh-------------HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcC
Q 044997          491 RALIRDDSEPTKM-------------KSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITS  542 (563)
Q Consensus       491 ~p~~~~~~~~~~~-------------~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~  542 (563)
                      .|+..........             ..+++.+.+|+.+||+.||.+||||.||++.|+++++++
T Consensus       245 ~p~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~~  309 (311)
T d1t46a_         245 SSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES  309 (311)
T ss_dssp             CCSSTTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             CCCCCCCCHHHHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhccC
Confidence            6654433322221             234466999999999999999999999999999888764

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-44  Score=362.99  Aligned_cols=235  Identities=23%  Similarity=0.367  Sum_probs=185.6

Q ss_pred             hcCCCccceecccCcEEEEEEEECC---------ceEEEEEeccCC----hHHHHHHHHHHHhc-cccce----------
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLLGD---------REAAIKKMRSNK----SKEFFAELKVLCKI-HHINV----------  346 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~~~---------~~vavK~~~~~~----~~~f~~Ei~~l~~l-~H~ni----------  346 (563)
                      .++|...+.||+|+||.||+|+..+         ..||||+++.+.    ..++.+|...+.++ +||||          
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~   91 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   91 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence            3568889999999999999997632         369999997654    35688899999998 89998          


Q ss_pred             -----EEEeecCCCcccccccccc-----------cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEe
Q 044997          347 -----FISTFGNGSLSDHLHDPLL-----------KGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILL  410 (563)
Q Consensus       347 -----V~e~~~~gsL~~~L~~~~~-----------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl  410 (563)
                           |+||+.+|+|.+++.....           .....+++.++++++.|++.||+|||+++   ||||||||+|||+
T Consensus        92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl  168 (299)
T d1fgka_          92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV  168 (299)
T ss_dssp             SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred             CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceee
Confidence                 5899999999999975321           12356999999999999999999999997   9999999999999


Q ss_pred             cCCCcEEEeecCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHc-C
Q 044997          411 DDGLRAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELIT-G  489 (563)
Q Consensus       411 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Ellt-g  489 (563)
                      +.++.+||+|||+++........ .......||+.|+|||.+.++.             +++++|||||||++|||++ |
T Consensus       169 ~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~l~~~~-------------y~~k~DiwS~Gvvl~ell~~g  234 (299)
T d1fgka_         169 TEDNVMKIADFGLARDIHHIDYY-KKTTNGRLPVKWMAPEALFDRI-------------YTHQSDVWSFGVLLWEIFTLG  234 (299)
T ss_dssp             CTTCCEEECSTTCCCCGGGCCTT-CCCTTSCCGGGGSCHHHHHHCC-------------CCHHHHHHHHHHHHHHHHTTS
T ss_pred             cCCCCeEeccchhhccccccccc-cccccCCCChhhhhhhHhcCCC-------------CCchhhhHHhHHHHHHhccCC
Confidence            99999999999999876543322 2234467899999999886554             4899999999999999998 5


Q ss_pred             CCCCcCCCC-----------CchhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcC
Q 044997          490 KRALIRDDS-----------EPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITS  542 (563)
Q Consensus       490 ~~p~~~~~~-----------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~  542 (563)
                      +.||.....           ....+..+++.+.+|+.+||+.||.+|||+.||++.|++++..+
T Consensus       235 ~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~~  298 (299)
T d1fgka_         235 GSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALT  298 (299)
T ss_dssp             CCSSTTCCHHHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             CCCCCCCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhcC
Confidence            666643321           11112234566999999999999999999999999999997643

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-44  Score=366.55  Aligned_cols=236  Identities=25%  Similarity=0.363  Sum_probs=191.2

Q ss_pred             HhcCCCccceecccCcEEEEEEEEC-------CceEEEEEeccCCh----HHHHHHHHHHHhccccce------------
Q 044997          290 ATNNFDESRIIGRGGFGNVYFGLLG-------DREAAIKKMRSNKS----KEFFAELKVLCKIHHINV------------  346 (563)
Q Consensus       290 ~~~~f~~~~~LG~G~fG~Vy~g~~~-------~~~vavK~~~~~~~----~~f~~Ei~~l~~l~H~ni------------  346 (563)
                      ..++|...+.||+|+||.||+|++.       ++.||||+++....    ..|.+|++++++++||||            
T Consensus        18 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~   97 (308)
T d1p4oa_          18 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   97 (308)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSS
T ss_pred             cHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCc
Confidence            3467888999999999999999874       36799999975432    458999999999999998            


Q ss_pred             ---EEEeecCCCccccccccc-----ccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEE
Q 044997          347 ---FISTFGNGSLSDHLHDPL-----LKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKV  418 (563)
Q Consensus       347 ---V~e~~~~gsL~~~L~~~~-----~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl  418 (563)
                         |+||+++|+|.+++....     ......++|..+.+++.|+|+||.|||+++   |+||||||+|||+|+++++||
T Consensus        98 ~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl  174 (308)
T d1p4oa_          98 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI  174 (308)
T ss_dssp             CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEE
T ss_pred             eeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEE
Confidence               589999999999886421     112346899999999999999999999987   999999999999999999999


Q ss_pred             eecCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCC
Q 044997          419 ADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDS  498 (563)
Q Consensus       419 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~  498 (563)
                      +|||+++....... ........||+.|+|||.+.+..             +++++||||||+++|||+||+.|+.....
T Consensus       175 ~DFGla~~~~~~~~-~~~~~~~~~t~~y~aPe~l~~~~-------------~~~~~Dv~S~G~il~El~t~~~~p~~~~~  240 (308)
T d1p4oa_         175 GDFGMTRDIYETDY-YRKGGKGLLPVRWMSPESLKDGV-------------FTTYSDVWSFGVVLWEIATLAEQPYQGLS  240 (308)
T ss_dssp             CCTTCCCGGGGGGC-EEGGGSSEECGGGCCHHHHHHCC-------------CCHHHHHHHHHHHHHHHHHTSCCTTTTSC
T ss_pred             eecccceeccCCcc-eeeccceecccccCCHHHHccCC-------------CCcccccccHHHHHHHHHhCCCCCCCCCC
Confidence            99999987654332 22234457899999999886544             48899999999999999999654433222


Q ss_pred             Cc------------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcC
Q 044997          499 EP------------TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMITS  542 (563)
Q Consensus       499 ~~------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~  542 (563)
                      ..            ..+..++..+.+++.+||+.||.+||||+||++.|++.++..
T Consensus       241 ~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~  296 (308)
T d1p4oa_         241 NEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPG  296 (308)
T ss_dssp             HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTT
T ss_pred             HHHHHHHHHhCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence            11            112344567999999999999999999999999999887644

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=4e-44  Score=368.97  Aligned_cols=218  Identities=21%  Similarity=0.311  Sum_probs=185.2

Q ss_pred             cCCCccceecccCcEEEEEEEE--CCceEEEEEeccCC---hHHHHHHHHHHHhccccce---------------EEEee
Q 044997          292 NNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNK---SKEFFAELKVLCKIHHINV---------------FISTF  351 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~---~~~f~~Ei~~l~~l~H~ni---------------V~e~~  351 (563)
                      ++|+..+.||+|+||.||+|+.  +++.||||.++...   .+.+.+|+++|++++||||               ||||+
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  108 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL  108 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            4689999999999999999987  47899999997654   3568899999999999998               68999


Q ss_pred             cCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEec--CCCcEEEeecCCCccccc
Q 044997          352 GNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLD--DGLRAKVADFGLVKLEER  429 (563)
Q Consensus       352 ~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~--~~~~~kl~DFGla~~~~~  429 (563)
                      ++|+|.+++..    ...++++.++..|+.||+.||+|||+++   |+||||||+|||++  .++++||+|||+|+....
T Consensus       109 ~gg~L~~~~~~----~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~  181 (352)
T d1koba_         109 SGGELFDRIAA----EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNP  181 (352)
T ss_dssp             CCCBHHHHTTC----TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred             CCChHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCC
Confidence            99999887764    2456999999999999999999999998   99999999999998  578999999999987654


Q ss_pred             ccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCC----------
Q 044997          430 TNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE----------  499 (563)
Q Consensus       430 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~----------  499 (563)
                      ..    ......||+.|+|||++.+..|             +.++||||+||++|||++|+.||.+....          
T Consensus       182 ~~----~~~~~~gt~~y~aPE~~~~~~~-------------~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~  244 (352)
T d1koba_         182 DE----IVKVTTATAEFAAPEIVDREPV-------------GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCD  244 (352)
T ss_dssp             TS----CEEEECSSGGGCCHHHHTTCCB-------------CHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCC
T ss_pred             CC----ceeeccCcccccCHHHHcCCCC-------------CCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC
Confidence            32    2334579999999999876554             88999999999999999999999654321          


Q ss_pred             ----chhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          500 ----PTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       500 ----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                          ......+++.+.+|+.+||+.||.+|||+.|+++
T Consensus       245 ~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  282 (352)
T d1koba_         245 WEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE  282 (352)
T ss_dssp             CCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             CCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                1122345677899999999999999999999986

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.8e-44  Score=364.93  Aligned_cols=218  Identities=26%  Similarity=0.399  Sum_probs=185.2

Q ss_pred             cCCCccceecccCcEEEEEEEE--CCceEEEEEeccC------ChHHHHHHHHHHHhccccce---------------EE
Q 044997          292 NNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSN------KSKEFFAELKVLCKIHHINV---------------FI  348 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~------~~~~f~~Ei~~l~~l~H~ni---------------V~  348 (563)
                      ++|+..+.||+|+||.||+|+.  +++.||||++++.      ..+.+.+|+++|++++||||               |+
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~   84 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence            5789999999999999999987  4789999998643      34678999999999999998               68


Q ss_pred             EeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccc
Q 044997          349 STFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEE  428 (563)
Q Consensus       349 e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~  428 (563)
                      ||+++|+|.+++..     ...+++..+..++.|++.||+|||+++   |+||||||+|||+++++++||+|||+|+...
T Consensus        85 ey~~gg~L~~~~~~-----~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~  156 (337)
T d1o6la_          85 EYANGGELFFHLSR-----ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGI  156 (337)
T ss_dssp             ECCTTCBHHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred             eccCCCchhhhhhc-----ccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccc
Confidence            99999999998875     356899999999999999999999998   9999999999999999999999999998654


Q ss_pred             cccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc--------
Q 044997          429 RTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP--------  500 (563)
Q Consensus       429 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~--------  500 (563)
                      ...   ......+||+.|+|||++.+..|             +.++||||+||++|||++|+.||...+...        
T Consensus       157 ~~~---~~~~~~~GT~~Y~aPE~~~~~~y-------------~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~  220 (337)
T d1o6la_         157 SDG---ATMKTFCGTPEYLAPEVLEDNDY-------------GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME  220 (337)
T ss_dssp             CTT---CCBCCCEECGGGCCGGGGSSSCB-------------CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC
T ss_pred             cCC---cccccceeCHHHhhhhhccCCCC-------------ChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcC
Confidence            322   12345689999999999876655             889999999999999999999997654311        


Q ss_pred             --hhhHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 044997          501 --TKMKSLITIMAAVAEWCLNEDAVDRPE-----MRDIVA  533 (563)
Q Consensus       501 --~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~  533 (563)
                        ..+..+++.+.+|+.+||+.||.+||+     ++|+++
T Consensus       221 ~~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         221 EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             CCCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence              112345567899999999999999995     777765

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=9.8e-44  Score=354.27  Aligned_cols=223  Identities=24%  Similarity=0.335  Sum_probs=188.4

Q ss_pred             cCCCccceecccCcEEEEEEEE--CCceEEEEEeccCC------------hHHHHHHHHHHHhcc-ccce----------
Q 044997          292 NNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNK------------SKEFFAELKVLCKIH-HINV----------  346 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~------------~~~f~~Ei~~l~~l~-H~ni----------  346 (563)
                      ++|+..+.||+|+||+||+|+.  +++.+|||+++...            .+.+.+|+++|++++ ||||          
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            6789999999999999999987  57899999986432            135889999999997 9997          


Q ss_pred             -----EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeec
Q 044997          347 -----FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADF  421 (563)
Q Consensus       347 -----V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DF  421 (563)
                           |+||+++|+|.++|..     ...+++.++..++.||+.||+|||+++   |+||||||+|||++.++.+||+||
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~~-----~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DF  154 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLTE-----KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDF  154 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCC
T ss_pred             cceEEEEEcCCCchHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccc
Confidence                 6899999999999975     356999999999999999999999997   999999999999999999999999


Q ss_pred             CCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCC--
Q 044997          422 GLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE--  499 (563)
Q Consensus       422 Gla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~--  499 (563)
                      |+++......    ......||+.|+|||.+.+...       .....++.++||||+||++|||++|+.||......  
T Consensus       155 G~a~~~~~~~----~~~~~~gt~~y~~PE~~~~~~~-------~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~  223 (277)
T d1phka_         155 GFSCQLDPGE----KLREVCGTPSYLAPEIIECSMN-------DNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM  223 (277)
T ss_dssp             TTCEECCTTC----CBCCCCSCGGGCCHHHHHHHHC-------TTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             hheeEccCCC----ceeeeeccCCCCCHHHhhcccc-------ccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHH
Confidence            9998765432    2244679999999999976543       23445689999999999999999999999765421  


Q ss_pred             ------------chhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          500 ------------PTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       500 ------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                                  ......+++.+.+|+.+||+.||.+|||+.|+++
T Consensus       224 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         224 LRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             HHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HHHHHhCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence                        1122356677999999999999999999999875

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.5e-43  Score=359.61  Aligned_cols=215  Identities=23%  Similarity=0.374  Sum_probs=183.0

Q ss_pred             cCCCccceecccCcEEEEEEEEC--CceEEEEEeccC------ChHHHHHHHHHHHhccccce---------------EE
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSN------KSKEFFAELKVLCKIHHINV---------------FI  348 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~------~~~~f~~Ei~~l~~l~H~ni---------------V~  348 (563)
                      ++|+..+.||+|+||.||+|+..  ++.||||+++..      ..+.+.+|+++|++++||||               |+
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            56889999999999999999974  789999998632      34679999999999999998               68


Q ss_pred             EeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccc
Q 044997          349 STFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEE  428 (563)
Q Consensus       349 e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~  428 (563)
                      ||+.+|+|..++..     ...+++..+..++.|++.||+|||+++   |+||||||+|||+++++++||+|||+|+...
T Consensus        84 E~~~gg~l~~~~~~-----~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~  155 (316)
T d1fota_          84 DYIEGGELFSLLRK-----SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVP  155 (316)
T ss_dssp             CCCCSCBHHHHHHH-----TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred             eecCCccccccccc-----cccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEec
Confidence            99999999888865     456889999999999999999999997   9999999999999999999999999998654


Q ss_pred             cccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc--------
Q 044997          429 RTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP--------  500 (563)
Q Consensus       429 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~--------  500 (563)
                      ..      .....||+.|||||++.+..|             +.++|||||||++|||++|+.||...+...        
T Consensus       156 ~~------~~~~~Gt~~Y~APE~l~~~~y-------------~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~  216 (316)
T d1fota_         156 DV------TYTLCGTPDYIAPEVVSTKPY-------------NKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA  216 (316)
T ss_dssp             SC------BCCCCSCTTTCCHHHHTTCCB-------------CTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHC
T ss_pred             cc------cccccCcccccCHHHHcCCCC-------------CchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcC
Confidence            22      234679999999999866554             789999999999999999999997543211        


Q ss_pred             --hhhHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 044997          501 --TKMKSLITIMAAVAEWCLNEDAVDRP-----EMRDIVA  533 (563)
Q Consensus       501 --~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  533 (563)
                        ..+..+++.+.+++.+||+.||.+||     +++|+++
T Consensus       217 ~~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~  256 (316)
T d1fota_         217 ELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  256 (316)
T ss_dssp             CCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             CCCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence              11233456689999999999999996     8888875

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-43  Score=359.01  Aligned_cols=217  Identities=19%  Similarity=0.353  Sum_probs=181.2

Q ss_pred             cCCCcc-ceecccCcEEEEEEEE--CCceEEEEEeccCChHHHHHHHHHHHhc-cccce-------------------EE
Q 044997          292 NNFDES-RIIGRGGFGNVYFGLL--GDREAAIKKMRSNKSKEFFAELKVLCKI-HHINV-------------------FI  348 (563)
Q Consensus       292 ~~f~~~-~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~~~~f~~Ei~~l~~l-~H~ni-------------------V~  348 (563)
                      ++|... +.||+|+||.||+|+.  +++.||||+++.  .+.+.+|++++.++ +||||                   |+
T Consensus        11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~--~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivm   88 (335)
T d2ozaa1          11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVM   88 (335)
T ss_dssp             GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC--SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC--cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEE
Confidence            568766 4699999999999987  478999999964  45678899987655 89997                   57


Q ss_pred             EeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecC---CCcEEEeecCCCc
Q 044997          349 STFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDD---GLRAKVADFGLVK  425 (563)
Q Consensus       349 e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~---~~~~kl~DFGla~  425 (563)
                      ||+++|+|.++|..   .+...+++.++..++.|++.||+|||+++   |+||||||+|||+++   ++.+||+|||+|+
T Consensus        89 Ey~~gg~L~~~i~~---~~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~  162 (335)
T d2ozaa1          89 ECLDGGELFSRIQD---RGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAK  162 (335)
T ss_dssp             ECCCSEEHHHHHHS---CSCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred             ECCCCCcHHHHHHh---cCCCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccceee
Confidence            99999999999975   23467999999999999999999999998   999999999999985   5679999999998


Q ss_pred             ccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc-----
Q 044997          426 LEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP-----  500 (563)
Q Consensus       426 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~-----  500 (563)
                      ......    ......||+.|||||++.+..|             +.++|||||||++|||++|+.||.+.....     
T Consensus       163 ~~~~~~----~~~~~~gt~~y~aPE~~~~~~y-------------~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~  225 (335)
T d2ozaa1         163 ETTSHN----SLTTPCYTPYYVAPEVLGPEKY-------------DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM  225 (335)
T ss_dssp             ECCCCC----CCCCCSCCCSSCCCCCCCGGGG-------------SHHHHHHHHHHHHHHHTTSSCSCEETTCC------
T ss_pred             eccCCC----ccccccCCcccCCcHHHcCCCC-------------CHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHH
Confidence            654332    2234679999999999876655             789999999999999999999996543211     


Q ss_pred             -------------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          501 -------------TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       501 -------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                                   .....+++.+.+|+.+||+.||++|||+.|+++
T Consensus       226 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  271 (335)
T d2ozaa1         226 KTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  271 (335)
T ss_dssp             --CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence                         122345677999999999999999999999987

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.3e-43  Score=363.10  Aligned_cols=215  Identities=23%  Similarity=0.351  Sum_probs=182.7

Q ss_pred             cCCCccceecccCcEEEEEEEEC--CceEEEEEeccC------ChHHHHHHHHHHHhccccce---------------EE
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSN------KSKEFFAELKVLCKIHHINV---------------FI  348 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~------~~~~f~~Ei~~l~~l~H~ni---------------V~  348 (563)
                      ++|+..+.||+|+||.||+|+..  ++.||||+++..      ..+.+.+|+++|++++||||               |+
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            47899999999999999999874  789999998632      34678999999999999998               57


Q ss_pred             EeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccc
Q 044997          349 STFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEE  428 (563)
Q Consensus       349 e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~  428 (563)
                      ||+.+|+|.+++..     ...+++.++..++.||+.||.|||+++   ||||||||+|||++.++++||+|||+|+...
T Consensus       121 e~~~~g~l~~~l~~-----~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~  192 (350)
T d1rdqe_         121 EYVAGGEMFSHLRR-----IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK  192 (350)
T ss_dssp             ECCTTCBHHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             ccccccchhhhHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecc
Confidence            99999999998865     246999999999999999999999998   9999999999999999999999999998654


Q ss_pred             cccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc--------
Q 044997          429 RTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP--------  500 (563)
Q Consensus       429 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~--------  500 (563)
                      ..      .....||+.|||||++.+..|             +.++|||||||++|||++|+.||.......        
T Consensus       193 ~~------~~~~~Gt~~Y~APE~~~~~~~-------------~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~  253 (350)
T d1rdqe_         193 GR------TWTLCGTPEALAPEIILSKGY-------------NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG  253 (350)
T ss_dssp             SC------BCCCEECGGGCCHHHHTTCCB-------------CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC
T ss_pred             cc------cccccCccccCCHHHHcCCCC-------------CccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcC
Confidence            22      234579999999999876554             789999999999999999999997543211        


Q ss_pred             --hhhHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 044997          501 --TKMKSLITIMAAVAEWCLNEDAVDRP-----EMRDIVA  533 (563)
Q Consensus       501 --~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  533 (563)
                        ..+..+.+.+.+++.+||+.||.+|+     +++|+++
T Consensus       254 ~~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         254 KVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             CCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             CCCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence              11223456799999999999999994     8888875

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.8e-43  Score=354.45  Aligned_cols=219  Identities=16%  Similarity=0.263  Sum_probs=184.7

Q ss_pred             hcCCCccceecccCcEEEEEEEEC--CceEEEEEeccCCh--HHHHHHHHHHHhccccce---------------EEEee
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNKS--KEFFAELKVLCKIHHINV---------------FISTF  351 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~--~~f~~Ei~~l~~l~H~ni---------------V~e~~  351 (563)
                      .++|...+.||+|+||.||+|+..  ++.||||.++....  ..+.+|+++|++++||||               |+||+
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~   83 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI   83 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecC
Confidence            467899999999999999999874  78899999986653  458899999999999997               68999


Q ss_pred             cCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecC--CCcEEEeecCCCccccc
Q 044997          352 GNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDD--GLRAKVADFGLVKLEER  429 (563)
Q Consensus       352 ~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~--~~~~kl~DFGla~~~~~  429 (563)
                      .+|+|.+++..    ....+++.++..++.||+.||+|||+++   |+||||||+|||++.  ...+||+|||+++....
T Consensus        84 ~gg~L~~~i~~----~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~  156 (321)
T d1tkia_          84 SGLDIFERINT----SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP  156 (321)
T ss_dssp             CCCBHHHHHTS----SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred             CCCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhcccc
Confidence            99999999975    2346999999999999999999999998   999999999999985  45899999999986543


Q ss_pred             ccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc---------
Q 044997          430 TNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP---------  500 (563)
Q Consensus       430 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~---------  500 (563)
                      ..    ......||+.|+|||.+.+..|             +.++||||+||++|||++|+.||.......         
T Consensus       157 ~~----~~~~~~~t~~y~ape~~~~~~~-------------~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~  219 (321)
T d1tkia_         157 GD----NFRLLFTAPEYYAPEVHQHDVV-------------STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAE  219 (321)
T ss_dssp             TC----EEEEEESCGGGSCHHHHTTCEE-------------CHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC
T ss_pred             CC----cccccccccccccchhccCCCC-------------CchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC
Confidence            22    1233568999999998866554             789999999999999999999997654211         


Q ss_pred             -----hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          501 -----TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       501 -----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                           .....+++.+.+|+.+||+.||.+|||+.|+++
T Consensus       220 ~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         220 YTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             CCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CCCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                 111234566899999999999999999999987

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=7.3e-43  Score=361.25  Aligned_cols=217  Identities=26%  Similarity=0.384  Sum_probs=179.1

Q ss_pred             cCCCccceecccCcEEEEEEEEC--CceEEEEEeccC------ChHHHHHH---HHHHHhccccce--------------
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSN------KSKEFFAE---LKVLCKIHHINV--------------  346 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~------~~~~f~~E---i~~l~~l~H~ni--------------  346 (563)
                      ++|+..+.||+|+||.||+|+..  ++.||||.+...      ....+.+|   +++++.++||||              
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~   83 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS   83 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence            57999999999999999999884  789999998642      22334444   667778889997              


Q ss_pred             -EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCc
Q 044997          347 -FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK  425 (563)
Q Consensus       347 -V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~  425 (563)
                       ||||+++|+|.++|..     ...+++..+..++.||+.||+|||+++   ||||||||+|||+++++.+||+|||+|+
T Consensus        84 ivmE~~~gg~L~~~l~~-----~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~  155 (364)
T d1omwa3          84 FILDLMNGGDLHYHLSQ-----HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLAC  155 (364)
T ss_dssp             EEECCCCSCBHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCE
T ss_pred             EEEEecCCCcHHHHHHh-----cccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceee
Confidence             6899999999999975     356899999999999999999999998   9999999999999999999999999998


Q ss_pred             ccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCch----
Q 044997          426 LEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPT----  501 (563)
Q Consensus       426 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~----  501 (563)
                      ......     .....||+.|+|||++....            .+++++|||||||++|||++|+.||........    
T Consensus       156 ~~~~~~-----~~~~~GT~~y~APE~~~~~~------------~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~  218 (364)
T d1omwa3         156 DFSKKK-----PHASVGTHGYMAPEVLQKGV------------AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID  218 (364)
T ss_dssp             ECSSSC-----CCSCCSCGGGCCHHHHSTTC------------CCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHH
T ss_pred             ecCCCc-----ccccccccccchhHHhhcCC------------CCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            654321     23457999999999985332            348999999999999999999999976543211    


Q ss_pred             ---------hhHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 044997          502 ---------KMKSLITIMAAVAEWCLNEDAVDRPE-----MRDIVA  533 (563)
Q Consensus       502 ---------~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~  533 (563)
                               ....+++.+.+|+.+||+.||.+|||     ++|+++
T Consensus       219 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         219 RMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             HHSSSCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             HhcccCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence                     12245667999999999999999999     577765

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-43  Score=355.94  Aligned_cols=218  Identities=25%  Similarity=0.432  Sum_probs=182.2

Q ss_pred             cCCCccceecccCcEEEEEEEE--CCceEEEEEecc------CChHHHHHHHHHHH-hccccce---------------E
Q 044997          292 NNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRS------NKSKEFFAELKVLC-KIHHINV---------------F  347 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~------~~~~~f~~Ei~~l~-~l~H~ni---------------V  347 (563)
                      ++|+..+.||+|+||+||+|+.  +++.||||+++.      ...+.+..|..++. .++||||               |
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            5789999999999999999988  478999999963      23456778888765 6899998               6


Q ss_pred             EEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccc
Q 044997          348 ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLE  427 (563)
Q Consensus       348 ~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~  427 (563)
                      +||+++|+|.+++..     ...+++.++..++.||+.||+|||+++   |+||||||+|||+++++++||+|||+++..
T Consensus        82 mEy~~~g~L~~~i~~-----~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~  153 (320)
T d1xjda_          82 MEYLNGGDLMYHIQS-----CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKEN  153 (320)
T ss_dssp             EECCTTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred             EeecCCCcHHHHhhc-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhc
Confidence            899999999999975     356899999999999999999999997   999999999999999999999999999865


Q ss_pred             ccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc-------
Q 044997          428 ERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP-------  500 (563)
Q Consensus       428 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~-------  500 (563)
                      ....   ...+...||+.|+|||++.+..|             ++++|||||||++|||++|+.||.+.....       
T Consensus       154 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~-------------~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~  217 (320)
T d1xjda_         154 MLGD---AKTNTFCGTPDYIAPEILLGQKY-------------NHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM  217 (320)
T ss_dssp             CCTT---CCBCCCCSCGGGCCHHHHTTCCB-------------CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             cccc---ccccccCCCCCcCCHHHHcCCCC-------------CchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHc
Confidence            4322   22344679999999999876554             899999999999999999999997543211       


Q ss_pred             ---hhhHHHHHHHHHHHHHhhccCCCCCCCHH-HHHH
Q 044997          501 ---TKMKSLITIMAAVAEWCLNEDAVDRPEMR-DIVA  533 (563)
Q Consensus       501 ---~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl~  533 (563)
                         ..+..+++.+.+|+.+||+.||.+||++. |+++
T Consensus       218 ~~~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         218 DNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             CCCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             CCCCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence               11223456799999999999999999995 6653

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.5e-43  Score=351.29  Aligned_cols=215  Identities=26%  Similarity=0.316  Sum_probs=172.9

Q ss_pred             ccceecccCcEEEEEEEE--CCceEEEEEeccCC--------hHHHHHHHHHHHhccccce---------------EEEe
Q 044997          296 ESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNK--------SKEFFAELKVLCKIHHINV---------------FIST  350 (563)
Q Consensus       296 ~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~--------~~~f~~Ei~~l~~l~H~ni---------------V~e~  350 (563)
                      ..++||+|+||+||+|+.  +++.||||+++...        .+.+.+|+++|++++||||               |+||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence            357899999999999987  47889999986432        2468899999999999997               6788


Q ss_pred             ecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccccc
Q 044997          351 FGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERT  430 (563)
Q Consensus       351 ~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~  430 (563)
                      +.+|++..+...     ...+++.++..++.||+.||+|||+++   |+||||||+|||+++++.+||+|||+++.....
T Consensus        82 ~~~~~~~~~~~~-----~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~  153 (299)
T d1ua2a_          82 METDLEVIIKDN-----SLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP  153 (299)
T ss_dssp             CSEEHHHHHTTC-----CSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC
T ss_pred             hcchHHhhhhhc-----ccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCC
Confidence            888877655542     466899999999999999999999998   999999999999999999999999999865433


Q ss_pred             cccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCch---------
Q 044997          431 NEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPT---------  501 (563)
Q Consensus       431 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~---------  501 (563)
                      ..   .....+||+.|+|||++....            .++.++|||||||++|||++|+.||........         
T Consensus       154 ~~---~~~~~~gt~~y~aPE~~~~~~------------~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~  218 (299)
T d1ua2a_         154 NR---AYTHQVVTRWYRAPELLFGAR------------MYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLG  218 (299)
T ss_dssp             CC---CCCCSCCCCTTCCHHHHTTCS------------CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred             cc---cccceecChhhccHHHHccCC------------CCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcC
Confidence            21   223457999999999875432            348999999999999999999988854321000         


Q ss_pred             -----------------------------hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          502 -----------------------------KMKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       502 -----------------------------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                                                   ......+.+.+|+.+||+.||++|||++|+++
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~  279 (299)
T d1ua2a_         219 TPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  279 (299)
T ss_dssp             CCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             CCChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence                                         00123456899999999999999999999876

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-43  Score=350.69  Aligned_cols=217  Identities=25%  Similarity=0.429  Sum_probs=176.4

Q ss_pred             cCCCccceecccCcEEEEEEEEC--CceEEEEEeccCC---------hHHHHHHHHHHHhcc--ccce------------
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNK---------SKEFFAELKVLCKIH--HINV------------  346 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~---------~~~f~~Ei~~l~~l~--H~ni------------  346 (563)
                      ++|+..+.||+|+||.||+|+..  ++.||||+++...         ..++.+|+++|++++  ||||            
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~   83 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS   83 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence            57899999999999999999874  7899999986432         234678999999997  8997            


Q ss_pred             ---EEEeecC-CCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecC-CCcEEEeec
Q 044997          347 ---FISTFGN-GSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDD-GLRAKVADF  421 (563)
Q Consensus       347 ---V~e~~~~-gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~-~~~~kl~DF  421 (563)
                         |+||+.+ +++.+++..     ...+++.++..++.|++.||+|||+++   |+||||||+|||++. ++.+||+||
T Consensus        84 ~~lv~e~~~~~~~l~~~~~~-----~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DF  155 (273)
T d1xwsa_          84 FVLILERPEPVQDLFDFITE-----RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDF  155 (273)
T ss_dssp             EEEEEECCSSEEEHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCC
T ss_pred             EEEEEEeccCcchHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECcc
Confidence               4677765 466666653     356999999999999999999999997   999999999999985 479999999


Q ss_pred             CCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCC---
Q 044997          422 GLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDS---  498 (563)
Q Consensus       422 Gla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~---  498 (563)
                      |+|+.....     ..+...||+.|+|||++.+..+            ++.++||||+||++|||++|+.||...+.   
T Consensus       156 G~a~~~~~~-----~~~~~~GT~~y~aPE~~~~~~~------------~~~~~DiwSlGvilyell~g~~Pf~~~~~i~~  218 (273)
T d1xwsa_         156 GSGALLKDT-----VYTDFDGTRVYSPPEWIRYHRY------------HGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR  218 (273)
T ss_dssp             TTCEECCSS-----CBCCCCSCGGGSCHHHHHHSCB------------CHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHH
T ss_pred             ccceecccc-----cccccccCCCcCCHHHHcCCCC------------CCcccccccceeeehhHhhCCCCCCCchHHhh
Confidence            999864322     2344679999999999876544            25789999999999999999999965321   


Q ss_pred             -CchhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          499 -EPTKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       499 -~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                       .......+++.+.+|+.+||+.||++|||++|+++
T Consensus       219 ~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         219 GQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             CCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             cccCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence             11112345677899999999999999999999986

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-42  Score=349.09  Aligned_cols=221  Identities=23%  Similarity=0.338  Sum_probs=177.2

Q ss_pred             cCCCccceecccCcEEEEEEEEC--CceEEEEEeccC-----ChHHHHHHHHHHHhccccce---------------EEE
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSN-----KSKEFFAELKVLCKIHHINV---------------FIS  349 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~-----~~~~f~~Ei~~l~~l~H~ni---------------V~e  349 (563)
                      ++|+..+.||+|+||.||+|+..  ++.||||+++..     ..+.+.+|+++|++++||||               |+|
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            57999999999999999999874  789999998643     24678999999999999998               467


Q ss_pred             eecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccccc
Q 044997          350 TFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEER  429 (563)
Q Consensus       350 ~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~  429 (563)
                      |+.++ +.+++..   .....+++.++..++.|++.||+|||+++   ||||||||+|||++.++.+||+|||+|+....
T Consensus        82 ~~~~~-~~~~~~~---~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~  154 (298)
T d1gz8a_          82 FLHQD-LKKFMDA---SALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGV  154 (298)
T ss_dssp             CCSEE-HHHHHHH---TTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCC
T ss_pred             ecCCc-hhhhhhh---hcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccC
Confidence            76654 3344432   23456999999999999999999999998   99999999999999999999999999986543


Q ss_pred             ccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCch--------
Q 044997          430 TNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPT--------  501 (563)
Q Consensus       430 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~--------  501 (563)
                      ...   ......||+.|+|||.+....+            .+.++|||||||++|||++|+.||...+....        
T Consensus       155 ~~~---~~~~~~gt~~y~apE~~~~~~~------------~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~  219 (298)
T d1gz8a_         155 PVR---TYTHEVVTLWYRAPEILLGCKY------------YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL  219 (298)
T ss_dssp             CSB---CTTCCBCCCTTCCHHHHTTCSS------------CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred             Ccc---cceeecccceeeehhhhccccC------------CCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhc
Confidence            221   2334579999999998755432            47899999999999999999999864321000        


Q ss_pred             -------------------------------hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          502 -------------------------------KMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       502 -------------------------------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                                                     ....+...+.+|+.+||+.||.+|||++|+++.
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H  283 (298)
T d1gz8a_         220 GTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH  283 (298)
T ss_dssp             CCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             CCCchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence                                           011223558899999999999999999999873

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-41  Score=350.14  Aligned_cols=223  Identities=23%  Similarity=0.369  Sum_probs=181.1

Q ss_pred             hcCCCccceecccCcEEEEEEEEC--CceEEEEEeccCC----hHHHHHHHHHHHhccccce------------------
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNK----SKEFFAELKVLCKIHHINV------------------  346 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~----~~~f~~Ei~~l~~l~H~ni------------------  346 (563)
                      +.+|+..+.||+|+||+||+|+..  ++.||||+++...    .+.+.+|+++|++++||||                  
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence            356889999999999999999874  7899999997543    3568899999999999997                  


Q ss_pred             -EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCc
Q 044997          347 -FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVK  425 (563)
Q Consensus       347 -V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~  425 (563)
                       +++|+.+|+|.+++..      ..+++..+..++.|++.||+|||+++   ||||||||+|||+++++.+||+|||+++
T Consensus        87 ~l~~~~~~g~L~~~l~~------~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~  157 (345)
T d1pmea_          87 YLVTHLMGADLYKLLKT------QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLAR  157 (345)
T ss_dssp             EEEEECCCEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEeecCCchhhhhhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCcee
Confidence             3578889999999864      35899999999999999999999997   9999999999999999999999999998


Q ss_pred             ccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCch----
Q 044997          426 LEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPT----  501 (563)
Q Consensus       426 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~----  501 (563)
                      ...............+||+.|+|||++....            .+++++||||+||++|||++|+.||........    
T Consensus       158 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~------------~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~  225 (345)
T d1pmea_         158 VADPDHDHTGFLTEYVATRWYRAPEIMLNSK------------GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI  225 (345)
T ss_dssp             ECCGGGCBCCTTCCCCSCGGGCCGGGTTTBC------------SCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred             eccCCCccceeeccccccceechHHHhhcCC------------CCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHH
Confidence            6654433333345567999999999875432            347899999999999999999999865431100    


Q ss_pred             -------------------------------------hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          502 -------------------------------------KMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       502 -------------------------------------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                                                           ....+...+.+|+.+||+.||.+|||+.|+++.
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         226 LGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             HHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                                                 001123458899999999999999999999874

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=9.8e-42  Score=343.81  Aligned_cols=228  Identities=22%  Similarity=0.314  Sum_probs=182.0

Q ss_pred             cCCCccceecccCcEEEEEEEEC--CceEEEEEeccCC-hHHHHHHHHHHHhccccce----------------EEEeec
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNK-SKEFFAELKVLCKIHHINV----------------FISTFG  352 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~-~~~f~~Ei~~l~~l~H~ni----------------V~e~~~  352 (563)
                      ++|+..+.||+|+||.||+|+..  ++.||||.++... .+++.+|++++++++|+|+                |+||+ 
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~-   85 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-   85 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc-
Confidence            46899999999999999999874  7899999886543 4568899999999988774                45655 


Q ss_pred             CCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEec---CCCcEEEeecCCCccccc
Q 044997          353 NGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLD---DGLRAKVADFGLVKLEER  429 (563)
Q Consensus       353 ~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~---~~~~~kl~DFGla~~~~~  429 (563)
                      +|+|.+.+..    ....+++..+..++.|++.||+|||+++   |+||||||+|||++   .+..+||+|||+|+....
T Consensus        86 ~~~l~~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~  158 (299)
T d1ckia_          86 GPSLEDLFNF----CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  158 (299)
T ss_dssp             CCBHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred             CCchhhhhhh----ccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence            5666665543    2467999999999999999999999998   99999999999986   456799999999997654


Q ss_pred             ccccc----cccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCchh---
Q 044997          430 TNEKE----MLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTK---  502 (563)
Q Consensus       430 ~~~~~----~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~~---  502 (563)
                      .....    .......||+.|||||.+.+..             +++++|||||||++|||++|+.||.........   
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------------~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~  225 (299)
T d1ckia_         159 ARTHQHIPYRENKNLTGTARYASINTHLGIE-------------QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY  225 (299)
T ss_dssp             TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBC-------------CCHHHHHHHHHHHHHHHHHSSCTTCCCC-------H
T ss_pred             cccccceeccccCCcCCCccccCHHHHhCCC-------------CCChhhEEecCHHHHHHHhCCCcccccchHHHHHHH
Confidence            32211    1223467999999999886554             489999999999999999999999754332110   


Q ss_pred             ---------------hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhh
Q 044997          503 ---------------MKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMI  540 (563)
Q Consensus       503 ---------------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~  540 (563)
                                     ...+++.+.+++..||+.||.+||++.++.+.|+++..
T Consensus       226 ~~~~~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~  278 (299)
T d1ckia_         226 ERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH  278 (299)
T ss_dssp             HHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred             HHhhcccCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence                           11234668999999999999999999999999988754

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-41  Score=343.32  Aligned_cols=219  Identities=21%  Similarity=0.326  Sum_probs=173.4

Q ss_pred             hcCCCccceecccCcEEEEEEEEC---CceEEEEEeccC-----ChHHHHHHHHHHHhc---cccceE------------
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLLG---DREAAIKKMRSN-----KSKEFFAELKVLCKI---HHINVF------------  347 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~~---~~~vavK~~~~~-----~~~~f~~Ei~~l~~l---~H~niV------------  347 (563)
                      .++|+..+.||+|+||.||+|+..   ++.||||+++..     ....+.+|+++|+.+   +|||||            
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            367999999999999999999873   457999998643     234577888887766   799983            


Q ss_pred             --------EEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEe
Q 044997          348 --------ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVA  419 (563)
Q Consensus       348 --------~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~  419 (563)
                              +||+.+|.+.....    .....+++..+..++.|++.||+|||+++   |+||||||+|||+++++.+||+
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~----~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~  158 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDK----VPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLA  158 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHH----SCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred             cCceEEEEEEeccCCchhhhhh----ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeec
Confidence                    35555555443332    23466899999999999999999999998   9999999999999999999999


Q ss_pred             ecCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCC
Q 044997          420 DFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSE  499 (563)
Q Consensus       420 DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~  499 (563)
                      |||+++......    ......||+.|+|||++.+..|             +.++||||+||++|||++|+.||......
T Consensus       159 dfg~~~~~~~~~----~~~~~~gT~~Y~APE~~~~~~y-------------~~~~DiwSlG~il~ell~g~~pf~~~~~~  221 (305)
T d1blxa_         159 DFGLARIYSFQM----ALTSVVVTLWYRAPEVLLQSSY-------------ATPVDLWSVGCIFAEMFRRKPLFRGSSDV  221 (305)
T ss_dssp             SCCSCCCCCGGG----GGCCCCCCCTTCCHHHHTTCCC-------------CTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             chhhhhhhcccc----cCCCcccChhhcCcchhcCCCC-------------ChhehhhchHHHHHHHHHCCCCCCCCCHH
Confidence            999988644322    2345679999999999865554             89999999999999999999999654211


Q ss_pred             c-------------------------------------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          500 P-------------------------------------TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       500 ~-------------------------------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                      .                                     .....+.+.+.+|+.+||+.||++|||+.|+++
T Consensus       222 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~  292 (305)
T d1blxa_         222 DQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  292 (305)
T ss_dssp             HHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHHHHHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            0                                     001123456889999999999999999999876

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=1.5e-41  Score=340.25  Aligned_cols=219  Identities=22%  Similarity=0.316  Sum_probs=174.1

Q ss_pred             cCCCccceecccCcEEEEEEEEC-CceEEEEEeccCC-----hHHHHHHHHHHHhccccceE---------------EEe
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG-DREAAIKKMRSNK-----SKEFFAELKVLCKIHHINVF---------------IST  350 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~vavK~~~~~~-----~~~f~~Ei~~l~~l~H~niV---------------~e~  350 (563)
                      ++|+..+.||+|+||+||+|+.+ ++.||||+++...     .+.+.+|+++|++++|||||               +++
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            57899999999999999999885 6889999986542     46799999999999999983               455


Q ss_pred             ecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCcccccc
Q 044997          351 FGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEERT  430 (563)
Q Consensus       351 ~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~~  430 (563)
                      +.++.+..+..     ....+++..+..++.||+.||+|||+++   ||||||||+|||++.++.+||+|||++......
T Consensus        82 ~~~~~~~~~~~-----~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~  153 (286)
T d1ob3a_          82 LDQDLKKLLDV-----CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIP  153 (286)
T ss_dssp             CSEEHHHHHHT-----STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred             ehhhhHHHHHh-----hcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccC
Confidence            55555544443     2467999999999999999999999987   999999999999999999999999999865432


Q ss_pred             cccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc----------
Q 044997          431 NEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP----------  500 (563)
Q Consensus       431 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~----------  500 (563)
                      ..   ......|++.|+|||.+.+..            .++.++|||||||++|||++|+.||.......          
T Consensus       154 ~~---~~~~~~~~~~y~~pE~~~~~~------------~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~  218 (286)
T d1ob3a_         154 VR---KYTHEIVTLWYRAPDVLMGSK------------KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILG  218 (286)
T ss_dssp             -----------CCCTTCCHHHHTTCC------------SCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred             cc---ccceecccchhhhHHHHhCCC------------CCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhC
Confidence            21   223346899999999885433            35899999999999999999999985432100          


Q ss_pred             -----------------------------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          501 -----------------------------TKMKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       501 -----------------------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                                                   .....+...+.+++++||+.||++|||++|+++
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         219 TPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             CCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                                         011223456889999999999999999999975

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=1e-40  Score=335.39  Aligned_cols=228  Identities=20%  Similarity=0.267  Sum_probs=184.4

Q ss_pred             cCCCccceecccCcEEEEEEEEC--CceEEEEEeccC-ChHHHHHHHHHHHhccc-cce---------------EEEeec
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSN-KSKEFFAELKVLCKIHH-INV---------------FISTFG  352 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~-~~~~f~~Ei~~l~~l~H-~ni---------------V~e~~~  352 (563)
                      ++|+..+.||+|+||.||+|+..  ++.||||.++.. ..+.+.+|++.+++++| +|+               |+||+ 
T Consensus         5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-   83 (293)
T d1csna_           5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-   83 (293)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-
T ss_pred             CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-
Confidence            57899999999999999999874  789999998654 34567789999998876 454               46666 


Q ss_pred             CCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecC-----CCcEEEeecCCCccc
Q 044997          353 NGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDD-----GLRAKVADFGLVKLE  427 (563)
Q Consensus       353 ~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~-----~~~~kl~DFGla~~~  427 (563)
                      +|+|.+++..    ....+++.++..++.|++.||+|||+++   |+||||||+|||++.     ++.+||+|||+|+..
T Consensus        84 ~~~l~~~~~~----~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~  156 (293)
T d1csna_          84 GPSLEDLLDL----CGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY  156 (293)
T ss_dssp             CCBHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred             CCCHHHHHHh----hccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence            6899888764    2457999999999999999999999998   999999999999974     578999999999876


Q ss_pred             ccccccc----cccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCchh-
Q 044997          428 ERTNEKE----MLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTK-  502 (563)
Q Consensus       428 ~~~~~~~----~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~~-  502 (563)
                      .......    .......||+.|||||.+.+..             +++++|||||||++|||++|+.||......... 
T Consensus       157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~-------------~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~  223 (293)
T d1csna_         157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGRE-------------QSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQ  223 (293)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC-------------CCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHH
T ss_pred             ccCccccceeecccCceEEchhhcCHHHhcCCC-------------CChHHHHHHhhHHHHHHHhCCCcCCCccchhHHH
Confidence            5332211    1223467999999999886544             489999999999999999999999765433211 


Q ss_pred             -----------------hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhh
Q 044997          503 -----------------MKSLITIMAAVAEWCLNEDAVDRPEMRDIVAILSQIMI  540 (563)
Q Consensus       503 -----------------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~  540 (563)
                                       ...+++.+.+++..|++.+|++||+++.+.+.|+++++
T Consensus       224 ~~~~i~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~  278 (293)
T d1csna_         224 KYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE  278 (293)
T ss_dssp             HHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred             HHHHHHhccCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHH
Confidence                             01234568999999999999999999999999988875

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-40  Score=337.04  Aligned_cols=222  Identities=22%  Similarity=0.283  Sum_probs=171.9

Q ss_pred             cCCCccceecccCcEEEEEEEE--CCceEEEEEeccC-----ChHHHHHHHHHHHhccccceE-----------------
Q 044997          292 NNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSN-----KSKEFFAELKVLCKIHHINVF-----------------  347 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~-----~~~~f~~Ei~~l~~l~H~niV-----------------  347 (563)
                      ++|+..+.||+|+||+||+|+.  +++.||||+++..     ..+++.+|+++|++++|+|++                 
T Consensus        10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~   89 (318)
T d3blha1          10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   89 (318)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred             CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence            6788999999999999999997  4789999998533     246789999999999999972                 


Q ss_pred             ------EEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeec
Q 044997          348 ------ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADF  421 (563)
Q Consensus       348 ------~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DF  421 (563)
                            +||++++.+..+..     ....++...+..++.|++.||+|||+++   |+||||||+|||++.++.+||+||
T Consensus        90 ~~~~iv~e~~~~~~~~~~~~-----~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~df  161 (318)
T d3blha1          90 GSIYLVFDFCEHDLAGLLSN-----VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADF  161 (318)
T ss_dssp             -CEEEEEECCCEEHHHHHTC-----TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCC
T ss_pred             ceEEEEEeccCCCccchhhh-----cccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeec
Confidence                  45555554443332     2456889999999999999999999997   999999999999999999999999


Q ss_pred             CCCccccccccc-ccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc
Q 044997          422 GLVKLEERTNEK-EMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP  500 (563)
Q Consensus       422 Gla~~~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~  500 (563)
                      |+++........ ........||+.|+|||.+.+..            .+++++|||||||++|||++|+.||.......
T Consensus       162 g~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~------------~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~  229 (318)
T d3blha1         162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGER------------DYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH  229 (318)
T ss_dssp             TTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCS------------SCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             ceeeecccccccccccccceecCHHHhhHHHHcCCC------------CCCcHHHcccCCceeeeHhhCCCCCCCCCHHH
Confidence            999765432211 11223357999999999885432            34899999999999999999999985432100


Q ss_pred             h-------------------------------------hhH-----HHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          501 T-------------------------------------KMK-----SLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       501 ~-------------------------------------~~~-----~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                      .                                     ...     .....+.+|+.+||+.||++|||++|+++
T Consensus       230 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~  304 (318)
T d3blha1         230 QLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  304 (318)
T ss_dssp             HHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence            0                                     000     01234678999999999999999999885

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=3.7e-40  Score=336.58  Aligned_cols=215  Identities=19%  Similarity=0.308  Sum_probs=179.4

Q ss_pred             cCCCccceecccCcEEEEEEEEC--CceEEEEEeccCChHHHHHHHHHHHhcc-ccce-----------------EEEee
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNKSKEFFAELKVLCKIH-HINV-----------------FISTF  351 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~f~~Ei~~l~~l~-H~ni-----------------V~e~~  351 (563)
                      ++|+..++||+|+||+||+|+..  ++.||||+++....+++.+|+++|++++ ||||                 |+||+
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~  114 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHV  114 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECC
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeec
Confidence            57999999999999999999874  7899999999888889999999999995 9997                 57888


Q ss_pred             cCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCC-cEEEeecCCCcccccc
Q 044997          352 GNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGL-RAKVADFGLVKLEERT  430 (563)
Q Consensus       352 ~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~-~~kl~DFGla~~~~~~  430 (563)
                      .+|+|..+.        +.+++.++..++.||+.||+|||+++   |+||||||+|||++.++ .+||+|||+|+.....
T Consensus       115 ~~~~L~~~~--------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~  183 (328)
T d3bqca1         115 NNTDFKQLY--------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG  183 (328)
T ss_dssp             CSCBGGGTT--------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred             CCCcHHHHh--------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccCC
Confidence            888886653        34899999999999999999999998   99999999999998655 6999999999865433


Q ss_pred             cccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCchh--------
Q 044997          431 NEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTK--------  502 (563)
Q Consensus       431 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~~--------  502 (563)
                      .    ......||+.|+|||.+.+..            .++.++||||+||++||+++|+.||.........        
T Consensus       184 ~----~~~~~~~t~~y~aPE~~~~~~------------~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~  247 (328)
T d3bqca1         184 Q----EYNVRVASRYFKGPELLVDYQ------------MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVL  247 (328)
T ss_dssp             C----CCCSCCSCGGGCCHHHHTTCC------------CCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHH
T ss_pred             C----cccccccCccccCcccccCCC------------CCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHH
Confidence            2    223457899999999875433            3488999999999999999999998654321100        


Q ss_pred             ----------------------------------------hHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          503 ----------------------------------------MKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       503 ----------------------------------------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                                                              ...+.+.+.+|+.+||+.||.+|||++|+++
T Consensus       248 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         248 GTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             CHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                                                    0123345789999999999999999999976

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.3e-41  Score=344.13  Aligned_cols=224  Identities=26%  Similarity=0.344  Sum_probs=174.1

Q ss_pred             CCCccceecccCcEEEEEEEEC--CceEEEEEeccCChHHHHHHHHHHHhccccce---------------------EEE
Q 044997          293 NFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNKSKEFFAELKVLCKIHHINV---------------------FIS  349 (563)
Q Consensus       293 ~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~f~~Ei~~l~~l~H~ni---------------------V~e  349 (563)
                      +|+..++||+|+||+||+|+..  ++.||||+++.+. +.+.+|+++|++++|+||                     |+|
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~-~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~E   99 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLD   99 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-SSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccc-hHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEe
Confidence            4777899999999999999984  7889999997543 234479999999999997                     346


Q ss_pred             eecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCC-cEEEeecCCCcccc
Q 044997          350 TFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGL-RAKVADFGLVKLEE  428 (563)
Q Consensus       350 ~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~-~~kl~DFGla~~~~  428 (563)
                      |+++|.+....+.  ......+++.++..++.|++.||+|||+++   |+||||||+|||++.++ .+||+|||+++...
T Consensus       100 y~~~~~~~~l~~~--~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~  174 (350)
T d1q5ka_         100 YVPETVYRVARHY--SRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV  174 (350)
T ss_dssp             CCSEEHHHHHHHH--HHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEECC
T ss_pred             ccCCccHHHHHhh--hhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhcc
Confidence            6655433222211  123567999999999999999999999997   99999999999999775 89999999998654


Q ss_pred             cccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCchh------
Q 044997          429 RTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTK------  502 (563)
Q Consensus       429 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~~------  502 (563)
                      ...    ......||..|+|||.+.+.            ..++.++||||+||++|||++|+.||.........      
T Consensus       175 ~~~----~~~~~~gt~~y~aPE~~~~~------------~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~  238 (350)
T d1q5ka_         175 RGE----PNVSYICSRYYRAPELIFGA------------TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV  238 (350)
T ss_dssp             TTS----CCCSCCSCTTSCCHHHHTTC------------SSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHH
T ss_pred             CCc----ccccccccccccChHHhhcc------------cCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHH
Confidence            332    22335799999999987543            23589999999999999999999998654321100      


Q ss_pred             ---------------------------------hHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHHh
Q 044997          503 ---------------------------------MKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI--LSQI  538 (563)
Q Consensus       503 ---------------------------------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~i  538 (563)
                                                       .....+.+.+|+.+||+.||.+|||+.|+++.  ++++
T Consensus       239 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~  309 (350)
T d1q5ka_         239 LGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL  309 (350)
T ss_dssp             HCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred             hCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence                                             01234458899999999999999999999863  4444

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-40  Score=337.71  Aligned_cols=220  Identities=26%  Similarity=0.400  Sum_probs=170.7

Q ss_pred             hcCCCccceecccCcEEEEEEEEC--CceEEEEEeccCC-----hHHHHHHHHHHHhccccceE----------------
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNK-----SKEFFAELKVLCKIHHINVF----------------  347 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~-----~~~f~~Ei~~l~~l~H~niV----------------  347 (563)
                      .++|+..+.||+|+||.||+|+..  ++.||||+++...     .+.+.+|+++|++++|||||                
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            467999999999999999999874  7899999997532     35688999999999999983                


Q ss_pred             -----EEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecC
Q 044997          348 -----ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFG  422 (563)
Q Consensus       348 -----~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFG  422 (563)
                           +||+ +++|..+..      ...+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+|++|||
T Consensus        97 ~~~lv~e~~-~~~l~~~~~------~~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg  166 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMK------HEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFG  166 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHH------HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCT
T ss_pred             eEEEEEecc-cccHHHHHH------hccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhccccccccccccc
Confidence                 3444 334444432      246999999999999999999999998   9999999999999999999999999


Q ss_pred             CCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCch-
Q 044997          423 LVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPT-  501 (563)
Q Consensus       423 la~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~-  501 (563)
                      +|+....      ..+...||+.|+|||.+.+..            .++.++||||+||++|||++|+.||...+.... 
T Consensus       167 ~a~~~~~------~~~~~~~t~~y~aPE~~~~~~------------~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~  228 (346)
T d1cm8a_         167 LARQADS------EMTGYVVTRWYRAPEVILNWM------------RYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQL  228 (346)
T ss_dssp             TCEECCS------SCCSSCSCGGGCCTHHHHTTT------------CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred             ceeccCC------ccccccccccccCHHHHcCCC------------CCCccchhhcchHHHHHHHHCcCCCCCCChHHHH
Confidence            9985432      123467999999999885433            348899999999999999999999865431100 


Q ss_pred             ----------------------------------------hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHHh
Q 044997          502 ----------------------------------------KMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI--LSQI  538 (563)
Q Consensus       502 ----------------------------------------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~i  538 (563)
                                                              ......+.+.+|+.+||..||.+|||+.|+++.  ++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~  307 (346)
T d1cm8a_         229 KEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL  307 (346)
T ss_dssp             HHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred             HHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence                                                    001223457899999999999999999999874  4443

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-40  Score=329.95  Aligned_cols=219  Identities=21%  Similarity=0.310  Sum_probs=178.5

Q ss_pred             cCCCccceecccCcEEEEEEEE--CCceEEEEEeccCC-----hHHHHHHHHHHHhccccce---------------EEE
Q 044997          292 NNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNK-----SKEFFAELKVLCKIHHINV---------------FIS  349 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~-----~~~f~~Ei~~l~~l~H~ni---------------V~e  349 (563)
                      ++|+..+.||+|+||.||+|+.  +++.||||+++...     .+.+.+|+++|++++||||               |++
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            5789999999999999999997  46789999986432     3678999999999999997               457


Q ss_pred             eecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCCCccccc
Q 044997          350 TFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGLVKLEER  429 (563)
Q Consensus       350 ~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~~~~~  429 (563)
                      ++.+++|..++..     ...+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||.++....
T Consensus        82 ~~~~~~l~~~~~~-----~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~  153 (292)
T d1unla_          82 FCDQDLKKYFDSC-----NGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGI  153 (292)
T ss_dssp             CCSEEHHHHHHHT-----TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             ecccccccccccc-----ccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccC
Confidence            7777777766643     467899999999999999999999997   99999999999999999999999999986543


Q ss_pred             ccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCchh-------
Q 044997          430 TNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPTK-------  502 (563)
Q Consensus       430 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~~-------  502 (563)
                      ...   ......++..|+|||.+....            .++.++|||||||++|||++|+.||.........       
T Consensus       154 ~~~---~~~~~~~~~~~~~pe~~~~~~------------~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~  218 (292)
T d1unla_         154 PVR---CYSAEVVTLWYRPPDVLFGAK------------LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRL  218 (292)
T ss_dssp             CCS---CCCSCCSCGGGCCHHHHTTCS------------CCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHH
T ss_pred             CCc---cceeeccccchhhhhHhccCC------------CCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhh
Confidence            322   223346788999999875443            2489999999999999999999997543321111       


Q ss_pred             ---------------------------------hHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 044997          503 ---------------------------------MKSLITIMAAVAEWCLNEDAVDRPEMRDIVA  533 (563)
Q Consensus       503 ---------------------------------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  533 (563)
                                                       ...+...+.+|+.+||+.||.+|||++|+++
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         219 LGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             HCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             cCCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                                             1122345889999999999999999999876

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.2e-40  Score=333.30  Aligned_cols=221  Identities=23%  Similarity=0.326  Sum_probs=179.9

Q ss_pred             cCCCccceecccCcEEEEEEEE-----CCceEEEEEeccC-------ChHHHHHHHHHHHhccc-cce------------
Q 044997          292 NNFDESRIIGRGGFGNVYFGLL-----GDREAAIKKMRSN-------KSKEFFAELKVLCKIHH-INV------------  346 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~-----~~~~vavK~~~~~-------~~~~f~~Ei~~l~~l~H-~ni------------  346 (563)
                      ++|+..+.||+|+||.||+|+.     +++.||||.++..       ..+.+.+|+++|++++| |||            
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            5699999999999999999976     3678999998632       24568899999999977 687            


Q ss_pred             ---EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCC
Q 044997          347 ---FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGL  423 (563)
Q Consensus       347 ---V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGl  423 (563)
                         ++||+.+|+|.+++..     ...++......++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus       104 ~~~v~e~~~~~~L~~~i~~-----~~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~  175 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQ-----RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGL  175 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred             eeeeeecccccHHHHHHHh-----cccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccc
Confidence               5799999999999865     345788899999999999999999997   99999999999999999999999999


Q ss_pred             CcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCch--
Q 044997          424 VKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPT--  501 (563)
Q Consensus       424 a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~--  501 (563)
                      ++........  ......|++.|+|||.+.+..+           .++.++|||||||+||||++|+.||........  
T Consensus       176 a~~~~~~~~~--~~~~~~g~~~~~~pe~~~~~~~-----------~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~  242 (322)
T d1vzoa_         176 SKEFVADETE--RAYDFCGTIEYMAPDIVRGGDS-----------GHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQA  242 (322)
T ss_dssp             EEECCGGGGG--GGCGGGSCCTTCCHHHHTTCC--------------CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHH
T ss_pred             hhhhcccccc--cccccccccccchhHHhhcCCc-----------CCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            9865433221  2234579999999999865432           347899999999999999999999976543221  


Q ss_pred             ------------hhHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 044997          502 ------------KMKSLITIMAAVAEWCLNEDAVDRPE-----MRDIVA  533 (563)
Q Consensus       502 ------------~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~  533 (563)
                                  .+..+++.+.+++.+||+.||.+|||     ++|+++
T Consensus       243 ~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         243 EISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             HHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             HHHHhcccCCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence                        11245567999999999999999995     677764

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-39  Score=335.26  Aligned_cols=217  Identities=24%  Similarity=0.378  Sum_probs=176.5

Q ss_pred             hcCCCccceecccCcEEEEEEEE--CCceEEEEEeccCC-----hHHHHHHHHHHHhccccce-----------------
Q 044997          291 TNNFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNK-----SKEFFAELKVLCKIHHINV-----------------  346 (563)
Q Consensus       291 ~~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~-----~~~f~~Ei~~l~~l~H~ni-----------------  346 (563)
                      .++|+..+.||+|+||+||+|+.  +++.||||+++...     .+++.+|+++|++++|||+                 
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            45799999999999999999987  47899999997542     2468899999999999997                 


Q ss_pred             ---EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCC
Q 044997          347 ---FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGL  423 (563)
Q Consensus       347 ---V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGl  423 (563)
                         +++|+.+|+|.+++..      +.+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+|++|||+
T Consensus        97 ~~~i~~~~~gg~L~~~~~~------~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~  167 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGL  167 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC--
T ss_pred             eEEEEEeecCCchhhhccc------ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccch
Confidence               4688889999998853      46999999999999999999999998   99999999999999999999999999


Q ss_pred             CcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCch--
Q 044997          424 VKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEPT--  501 (563)
Q Consensus       424 a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~~--  501 (563)
                      +......      .....||+.|+|||.+.+..            .++.++|||||||++|||++|+.||.+.+....  
T Consensus       168 a~~~~~~------~~~~~g~~~y~apE~~~~~~------------~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~  229 (348)
T d2gfsa1         168 ARHTDDE------MTGYVATRWYRAPEIMLNWM------------HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLK  229 (348)
T ss_dssp             --CCTGG------GSSSCHHHHTSCHHHHTTCS------------CCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred             hcccCcc------cccccccccccCchhhcCCc------------cCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHH
Confidence            8754321      23356899999999875443            348899999999999999999999865431100  


Q ss_pred             ---------------------------------------hhHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 044997          502 ---------------------------------------KMKSLITIMAAVAEWCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       502 ---------------------------------------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  534 (563)
                                                             ......+.+.+|+.+||+.||.+|||+.|+++.
T Consensus       230 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H  301 (348)
T d2gfsa1         230 LILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  301 (348)
T ss_dssp             HHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence                                                   001223557899999999999999999999873

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-38  Score=327.90  Aligned_cols=215  Identities=23%  Similarity=0.310  Sum_probs=165.7

Q ss_pred             cCCCccceecccCcEEEEEEEEC--CceEEEEEeccCC-----hHHHHHHHHHHHhccccce------------------
Q 044997          292 NNFDESRIIGRGGFGNVYFGLLG--DREAAIKKMRSNK-----SKEFFAELKVLCKIHHINV------------------  346 (563)
Q Consensus       292 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~-----~~~f~~Ei~~l~~l~H~ni------------------  346 (563)
                      ++|+..++||+|+||+||+|+..  ++.||||+++...     .+++.+|+++|++++||||                  
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            57999999999999999999874  7999999997532     2468899999999999997                  


Q ss_pred             ---EEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeecCC
Q 044997          347 ---FISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADFGL  423 (563)
Q Consensus       347 ---V~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DFGl  423 (563)
                         |+||+.++.+. .+.       ..+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+|++|||+
T Consensus        97 ~~iv~Ey~~~~l~~-~~~-------~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~  165 (355)
T d2b1pa1          97 VYLVMELMDANLCQ-VIQ-------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  165 (355)
T ss_dssp             EEEEEECCSEEHHH-HHT-------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred             eEEEEeccchHHHH-hhh-------cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhh
Confidence               45776554433 332       34899999999999999999999998   99999999999999999999999999


Q ss_pred             CcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCCcCCCCCc---
Q 044997          424 VKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRALIRDDSEP---  500 (563)
Q Consensus       424 a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~~~~~~~~---  500 (563)
                      ++......    ..+...||+.|+|||++.+..             +++++||||+||++|||++|+.||...+...   
T Consensus       166 ~~~~~~~~----~~~~~~~t~~y~aPE~l~~~~-------------~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~  228 (355)
T d2b1pa1         166 ARTAGTSF----MMTPYVVTRYYRAPEVILGMG-------------YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWN  228 (355)
T ss_dssp             -------------------CCTTCCHHHHTTCC-------------CCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred             hhcccccc----ccccccccccccChhhhcCCC-------------CCCCcccccccchHHHHhhCCCCCCCCCHHHHHH
Confidence            88544322    234457899999999986554             4889999999999999999999985432100   


Q ss_pred             -------------------------------------------------hhhHHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 044997          501 -------------------------------------------------TKMKSLITIMAAVAEWCLNEDAVDRPEMRDI  531 (563)
Q Consensus       501 -------------------------------------------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev  531 (563)
                                                                       .........+.+|+.+||+.||++|||++|+
T Consensus       229 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~el  308 (355)
T d2b1pa1         229 KVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA  308 (355)
T ss_dssp             HHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred             HHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHH
Confidence                                                             0112345568899999999999999999999


Q ss_pred             HHH
Q 044997          532 VAI  534 (563)
Q Consensus       532 l~~  534 (563)
                      ++.
T Consensus       309 L~H  311 (355)
T d2b1pa1         309 LQH  311 (355)
T ss_dssp             HTS
T ss_pred             hcC
Confidence            864

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.3e-35  Score=306.54  Aligned_cols=218  Identities=22%  Similarity=0.274  Sum_probs=164.8

Q ss_pred             CCCccceecccCcEEEEEEEE--CCceEEEEEeccCC--hHHHHHHHHHHHhccccc-----------eE--E-------
Q 044997          293 NFDESRIIGRGGFGNVYFGLL--GDREAAIKKMRSNK--SKEFFAELKVLCKIHHIN-----------VF--I-------  348 (563)
Q Consensus       293 ~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~--~~~f~~Ei~~l~~l~H~n-----------iV--~-------  348 (563)
                      +|+..++||+|+||.||+|+.  +++.||||+++.+.  .+.+.+|++++++++|+|           ||  +       
T Consensus        14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~   93 (362)
T d1q8ya_          14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKG   93 (362)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEE
T ss_pred             cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeecc
Confidence            488999999999999999987  47899999998764  367889999999998755           32  1       


Q ss_pred             --------EeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCceEeCCCCCCCeEecCCC-----
Q 044997          349 --------STFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHD-HTKARYVHRDIKTSNILLDDGL-----  414 (563)
Q Consensus       349 --------e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDLk~~NILl~~~~-----  414 (563)
                              +++..+.......  .......+++..+..++.|++.||+|||+ ++   |+||||||+|||++.++     
T Consensus        94 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~  168 (362)
T d1q8ya_          94 PNGVHVVMVFEVLGENLLALI--KKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENL  168 (362)
T ss_dssp             TTEEEEEEEECCCCEEHHHHH--HHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTE
T ss_pred             ccceeeeeeeccccccccccc--ccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCccccc
Confidence                    1111111111111  11234678999999999999999999998 65   99999999999998654     


Q ss_pred             -cEEEeecCCCcccccccccccccccccCCCcccCcccccccccccccccccccCCCCCcchHHHHHHHHHHHHcCCCCC
Q 044997          415 -RAKVADFGLVKLEERTNEKEMLATRLVGTPGYLPPEYIFVKRFRFDMHSSVMELQVTTKTDVFAFGVVLAELITGKRAL  493 (563)
Q Consensus       415 -~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~~~~~~~~s~ksDVwSfGvvl~Elltg~~p~  493 (563)
                       .+|++|||.++.....      .....||+.|+|||.+....             ++.++||||+||+++||++|+.||
T Consensus       169 ~~~kl~dfg~s~~~~~~------~~~~~gt~~y~aPE~~~~~~-------------~~~~~DiwSlG~il~el~~g~~pF  229 (362)
T d1q8ya_         169 IQIKIADLGNACWYDEH------YTNSIQTREYRSPEVLLGAP-------------WGCGADIWSTACLIFELITGDFLF  229 (362)
T ss_dssp             EEEEECCCTTCEETTBC------CCSCCSCGGGCCHHHHHTCC-------------CCTHHHHHHHHHHHHHHHHSSCCC
T ss_pred             ceeeEeecccccccccc------cccccccccccChhhccccC-------------CCccccccchHHHHHHHHHCCCCC
Confidence             4999999998753321      23457999999999886544             489999999999999999999998


Q ss_pred             cCCCCCc----------------------------------------------------------hhhHHHHHHHHHHHH
Q 044997          494 IRDDSEP----------------------------------------------------------TKMKSLITIMAAVAE  515 (563)
Q Consensus       494 ~~~~~~~----------------------------------------------------------~~~~~~~~~l~~li~  515 (563)
                      .......                                                          .........+.+|+.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~  309 (362)
T d1q8ya_         230 EPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLS  309 (362)
T ss_dssp             ---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHG
T ss_pred             CCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHH
Confidence            6432210                                                          001233456899999


Q ss_pred             HhhccCCCCCCCHHHHHHH
Q 044997          516 WCLNEDAVDRPEMRDIVAI  534 (563)
Q Consensus       516 ~cl~~dP~~RPs~~evl~~  534 (563)
                      +||+.||.+|||++|+++.
T Consensus       310 ~mL~~dP~~Rpta~e~L~H  328 (362)
T d1q8ya_         310 PMLQLDPRKRADAGGLVNH  328 (362)
T ss_dssp             GGGCSSTTTCBCHHHHHTC
T ss_pred             HHCCCChhHCcCHHHHhcC
Confidence            9999999999999999863

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.84  E-value=1.2e-21  Score=182.71  Aligned_cols=118  Identities=14%  Similarity=0.147  Sum_probs=91.0

Q ss_pred             CccceecccCcEEEEEEEE-CCceEEEEEeccCC---------------------hHHHHHHHHHHHhccccceE-----
Q 044997          295 DESRIIGRGGFGNVYFGLL-GDREAAIKKMRSNK---------------------SKEFFAELKVLCKIHHINVF-----  347 (563)
Q Consensus       295 ~~~~~LG~G~fG~Vy~g~~-~~~~vavK~~~~~~---------------------~~~f~~Ei~~l~~l~H~niV-----  347 (563)
                      .+.++||+|+||.||+|+. +|+.||||.++...                     ...+.+|...+.+++|++++     
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence            3578999999999999986 57899999875311                     12345688899999998863     


Q ss_pred             ------EEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceEeCCCCCCCeEecCCCcEEEeec
Q 044997          348 ------ISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDHTKARYVHRDIKTSNILLDDGLRAKVADF  421 (563)
Q Consensus       348 ------~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl~~~~~~kl~DF  421 (563)
                            +||++++.+.            .+++....+++.|++.+|+|||+++   |+||||||+|||++++ .++|+||
T Consensus        83 ~~~~lvme~~~~~~~~------------~l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~liDF  146 (191)
T d1zara2          83 EGNAVLMELIDAKELY------------RVRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWIIDF  146 (191)
T ss_dssp             ETTEEEEECCCCEEGG------------GCCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEECCC
T ss_pred             cCCEEEEEeecccccc------------chhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEEEEC
Confidence                  4444433221            2444556789999999999999998   9999999999999965 5899999


Q ss_pred             CCCcccc
Q 044997          422 GLVKLEE  428 (563)
Q Consensus       422 Gla~~~~  428 (563)
                      |+|+...
T Consensus       147 G~a~~~~  153 (191)
T d1zara2         147 PQSVEVG  153 (191)
T ss_dssp             TTCEETT
T ss_pred             CCcccCC
Confidence            9997543

>d1y7ma2 d.7.1.1 (A:1-48) Hypothetical protein YkuD, N-terminal domain {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: LysM domain
superfamily: LysM domain
family: LysM domain
domain: Hypothetical protein YkuD, N-terminal domain
species: Bacillus subtilis [TaxId: 1423]

Probab=97.81  E-value=9.3e-06  Score=55.63  Aligned_cols=47  Identities=23%  Similarity=0.308  Sum_probs=41.3

Q ss_pred             EEEEEccCCCcHHHHHHHhcCCccchhhcccccccCCcccccceeeeecC
Q 044997          142 VVTYTVQQQDTLSIIATLLSAEISGIESMNKMVAQNPGYIDVCWVLFVPM  191 (563)
Q Consensus       142 llTY~~~~gd~ls~ia~~f~~s~~~i~~~N~~~~~~~~~~~~~~~~~vp~  191 (563)
                      +++|.|++|||+.+||.+|+++.+.|..+|+..  ++ .+.++..+.||.
T Consensus         1 ~i~y~V~~GDTL~~IA~~y~v~~~~i~~~N~~~--~~-~l~~Gq~L~IPg   47 (48)
T d1y7ma2           1 MLTYQVKQGDTLNSIAADFRISTAALLQANPSL--QA-GLTAGQSIVIPG   47 (48)
T ss_dssp             CEEEECCTTCCHHHHHHHTTSCCCCCCCTSCTT--CS-SCCTTCEEEETT
T ss_pred             CEEEEECCCCCHHHHHHHhCCCHHHHHHHcCCC--CC-CCCCCCEEEeCC
Confidence            479999999999999999999999999999974  33 477888888884

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=97.70  E-value=4.2e-05  Score=72.05  Aligned_cols=131  Identities=17%  Similarity=0.153  Sum_probs=82.2

Q ss_pred             HHHHHHhcCCCccceecccCcEEEEEEEECCceEEEEEeccCC---hHHHHHHHHHHHhccc----cc------------
Q 044997          285 EEIEEATNNFDESRIIGRGGFGNVYFGLLGDREAAIKKMRSNK---SKEFFAELKVLCKIHH----IN------------  345 (563)
Q Consensus       285 ~el~~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~vavK~~~~~~---~~~f~~Ei~~l~~l~H----~n------------  345 (563)
                      .|+......|...+..+-++...||+...+++.+.+|+.....   ...+.+|...+..+.-    |-            
T Consensus         7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~   86 (263)
T d1j7la_           7 PELKKLIEKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN   86 (263)
T ss_dssp             HHHHHHHTTSEEEECSCCCSSSEEEEEECSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred             HHHHHhhhceEEEEcCCCCCCCcEEEEEeCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence            3666666777766554444456899998888889999886543   3456778888776631    22            


Q ss_pred             eEEEeecCCCcccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhc--------------------------------
Q 044997          346 VFISTFGNGSLSDHLHDPLLKGHQPLTWTARTQIALDAAKGIEYIHDH--------------------------------  393 (563)
Q Consensus       346 iV~e~~~~gsL~~~L~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~--------------------------------  393 (563)
                      +|++++++..+.+....          ......++.++++.|..||+.                                
T Consensus        87 lv~~~l~G~~~~~~~~~----------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (263)
T d1j7la_          87 LLMSEADGVLCSEEYED----------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCE  156 (263)
T ss_dssp             EEEECCSSEEHHHHTTT----------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGG
T ss_pred             EEEEecccccccccccc----------cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhh
Confidence            35566655544322211          011223344455555555531                                


Q ss_pred             ------------------------CCCceEeCCCCCCCeEecCCCcEEEeecCCCc
Q 044997          394 ------------------------TKARYVHRDIKTSNILLDDGLRAKVADFGLVK  425 (563)
Q Consensus       394 ------------------------~~~~ivHrDLk~~NILl~~~~~~kl~DFGla~  425 (563)
                                              ..+.++|+|+.+.|||++++...-|.||+.+.
T Consensus       157 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         157 NWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             GGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                                    11237999999999999987667799999875

>d1e0ga_ d.7.1.1 (A:) Membrane-bound lytic murein transclycosylase D, MltD {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: LysM domain
superfamily: LysM domain
family: LysM domain
domain: Membrane-bound lytic murein transclycosylase D, MltD
species: Escherichia coli [TaxId: 562]

Probab=97.37  E-value=6.1e-05  Score=51.30  Aligned_cols=45  Identities=24%  Similarity=0.235  Sum_probs=38.8

Q ss_pred             EEEEccCCCcHHHHHHHhcCCccchhhcccccccCCcccccceeeeecC
Q 044997          143 VTYTVQQQDTLSIIATLLSAEISGIESMNKMVAQNPGYIDVCWVLFVPM  191 (563)
Q Consensus       143 lTY~~~~gd~ls~ia~~f~~s~~~i~~~N~~~~~~~~~~~~~~~~~vp~  191 (563)
                      ++|.|++|||+..||.+|+++.+.|.++|+..    +.+.++..+.+|.
T Consensus         3 v~y~V~~GDTl~~IA~~y~vs~~~i~~~N~l~----~~l~~Gq~L~i~v   47 (48)
T d1e0ga_           3 ITYRVRKGDSLSSIAKRHGVNIKDVMRWNSDT----ANLQPGDKLTLFV   47 (48)
T ss_dssp             CEEEECTTCCHHHHHHHHTCCHHHHHHHCSCG----GGCCTTEEEECCC
T ss_pred             EEEEECCCCCHHHHHHHHCCCHHHHHHHcCCc----ccCcCCCEEEEEe
Confidence            58999999999999999999999999999853    2467888777774

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=96.77  E-value=0.0014  Score=60.81  Aligned_cols=45  Identities=16%  Similarity=-0.055  Sum_probs=31.8

Q ss_pred             eecccCc-EEEEEEEECC-ceEEEEEeccCChHHHHHHHHHHHhccc
Q 044997          299 IIGRGGF-GNVYFGLLGD-REAAIKKMRSNKSKEFFAELKVLCKIHH  343 (563)
Q Consensus       299 ~LG~G~f-G~Vy~g~~~~-~~vavK~~~~~~~~~f~~Ei~~l~~l~H  343 (563)
                      .+..|.. +.||+...++ ..+.+|.-......++..|...|+.+..
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~~~l~~E~~~l~~L~~   63 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGALNELQDEAARLSWLAT   63 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSCTTSCHHHHHHHHHHHHT
T ss_pred             EcCCcccCCeEEEEEeCCCCEEEEEeCCccCHhHHHHHHHHHHHHHh
Confidence            3444543 5789988764 4578888777666677889988887754

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.36  E-value=0.0054  Score=58.76  Aligned_cols=65  Identities=6%  Similarity=0.098  Sum_probs=44.8

Q ss_pred             cCHHHHHHHhcCCCccceec-----ccCcEEEEEEEECCceEEEEEeccC-ChHHHHHHHHHHHhccccce
Q 044997          282 FSLEEIEEATNNFDESRIIG-----RGGFGNVYFGLLGDREAAIKKMRSN-KSKEFFAELKVLCKIHHINV  346 (563)
Q Consensus       282 ~~~~el~~~~~~f~~~~~LG-----~G~fG~Vy~g~~~~~~vavK~~~~~-~~~~f~~Ei~~l~~l~H~ni  346 (563)
                      .+.+|++....+|..++...     .|---..|+...++...++|+.... ..++...|+++|..+.+.++
T Consensus         3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~yVLri~~~~~~~~~l~~~~~~l~~L~~~g~   73 (316)
T d2ppqa1           3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDPLILTLYEKRVEKNDLPFFLGLMQHLAAKGL   73 (316)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCCEEEEEECC---CCHHHHHHHHHHHHHHTTC
T ss_pred             CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCcEEEEEcCCCCCHHHHHHHHHHHHhhhhccc
Confidence            46678888888998765443     4444568999888888999998654 44566678888888865443

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=95.69  E-value=0.015  Score=57.71  Aligned_cols=30  Identities=23%  Similarity=0.358  Sum_probs=25.9

Q ss_pred             CceEeCCCCCCCeEecCCCcEEEeecCCCcc
Q 044997          396 ARYVHRDIKTSNILLDDGLRAKVADFGLVKL  426 (563)
Q Consensus       396 ~~ivHrDLk~~NILl~~~~~~kl~DFGla~~  426 (563)
                      ..++|+|+.+.|||++++ .++|+||..+..
T Consensus       223 ~~LiHGDl~~gNIlv~~~-~~~vID~E~a~~  252 (392)
T d2pula1         223 ETLIHGDLHTGSIFASEH-ETKVIDPEFAFY  252 (392)
T ss_dssp             CEEECSCCCGGGEEECSS-CEEECCCTTCEE
T ss_pred             cceeccCCcCCceeEcCC-ceEEechhhccc
Confidence            359999999999999876 489999988764

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=95.21  E-value=0.03  Score=53.75  Aligned_cols=38  Identities=16%  Similarity=0.145  Sum_probs=29.7

Q ss_pred             EEEEEEE-CCceEEEEEeccC--ChHHHHHHHHHHHhcccc
Q 044997          307 NVYFGLL-GDREAAIKKMRSN--KSKEFFAELKVLCKIHHI  344 (563)
Q Consensus       307 ~Vy~g~~-~~~~vavK~~~~~--~~~~f~~Ei~~l~~l~H~  344 (563)
                      .||+... +|+.+++|..++.  ..+++..|.+.|..|...
T Consensus        37 ~vy~v~~~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~   77 (325)
T d1zyla1          37 RVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVND   77 (325)
T ss_dssp             EEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHT
T ss_pred             eeEEEEcCCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhc
Confidence            6999987 4678999998765  356788899988887543

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=94.58  E-value=0.062  Score=52.90  Aligned_cols=49  Identities=10%  Similarity=0.125  Sum_probs=30.4

Q ss_pred             cceecccCcEEEEEEEECC---------ceEEEEEeccC-ChHHHHHHHHHHHhccccc
Q 044997          297 SRIIGRGGFGNVYFGLLGD---------REAAIKKMRSN-KSKEFFAELKVLCKIHHIN  345 (563)
Q Consensus       297 ~~~LG~G~fG~Vy~g~~~~---------~~vavK~~~~~-~~~~f~~Ei~~l~~l~H~n  345 (563)
                      .+.|+.|-.=.+|+....+         +.+.++..... ...+..+|..+++.+.-.+
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~idr~~E~~i~~~ls~~g  105 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERH  105 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTT
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchhhHHHHHHHHHHHHHhCC
Confidence            4567778788899987642         33555544322 2234567888888775434

>d1y7ma2 d.7.1.1 (A:1-48) Hypothetical protein YkuD, N-terminal domain {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: LysM domain
superfamily: LysM domain
family: LysM domain
domain: Hypothetical protein YkuD, N-terminal domain
species: Bacillus subtilis [TaxId: 1423]

Probab=94.52  E-value=0.017  Score=38.72  Aligned_cols=37  Identities=16%  Similarity=0.288  Sum_probs=31.1

Q ss_pred             eeccCCCCHHHHHHhhCCCcccccccccC------CCccEEEE
Q 044997           54 YHINQGLPVERIASFYSANPSQIKPIFRG------NQKDYLIT   90 (563)
Q Consensus        54 ~~~~~~~~~~~i~~l~~~~~~~i~~~n~~------~~~~~~vp   90 (563)
                      |...++-|+..||.-|+++..+|+.+|+.      .+|.+.||
T Consensus         4 y~V~~GDTL~~IA~~y~v~~~~i~~~N~~~~~~l~~Gq~L~IP   46 (48)
T d1y7ma2           4 YQVKQGDTLNSIAADFRISTAALLQANPSLQAGLTAGQSIVIP   46 (48)
T ss_dssp             EECCTTCCHHHHHHHTTSCCCCCCCTSCTTCSSCCTTCEEEET
T ss_pred             EEECCCCCHHHHHHHhCCCHHHHHHHcCCCCCCCCCCCEEEeC
Confidence            66678999999999999999999999983      45666665

>d1e0ga_ d.7.1.1 (A:) Membrane-bound lytic murein transclycosylase D, MltD {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: LysM domain
superfamily: LysM domain
family: LysM domain
domain: Membrane-bound lytic murein transclycosylase D, MltD
species: Escherichia coli [TaxId: 562]

Probab=93.28  E-value=0.019  Score=38.42  Aligned_cols=39  Identities=15%  Similarity=0.158  Sum_probs=31.6

Q ss_pred             eeeccCCCCHHHHHHhhCCCcccccccccC-----CCccEEEEe
Q 044997           53 LYHINQGLPVERIASFYSANPSQIKPIFRG-----NQKDYLITV   91 (563)
Q Consensus        53 ~~~~~~~~~~~~i~~l~~~~~~~i~~~n~~-----~~~~~~vp~   91 (563)
                      .|...++-|+..||.-|+++..+|+.+|+.     ++|.+.|||
T Consensus         4 ~y~V~~GDTl~~IA~~y~vs~~~i~~~N~l~~~l~~Gq~L~i~v   47 (48)
T d1e0ga_           4 TYRVRKGDSLSSIAKRHGVNIKDVMRWNSDTANLQPGDKLTLFV   47 (48)
T ss_dssp             EEEECTTCCHHHHHHHHTCCHHHHHHHCSCGGGCCTTEEEECCC
T ss_pred             EEEECCCCCHHHHHHHHCCCHHHHHHHcCCcccCcCCCEEEEEe
Confidence            366678999999999999999999999973     455665654